<SEC-DOCUMENT>0001178913-24-001020.txt : 20240321
<SEC-HEADER>0001178913-24-001020.hdr.sgml : 20240321
<ACCEPTANCE-DATETIME>20240321080834
ACCESSION NUMBER:		0001178913-24-001020
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		131
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240321
DATE AS OF CHANGE:		20240321

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MediWound Ltd.
		CENTRAL INDEX KEY:			0001593984
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36349
		FILM NUMBER:		24769548

	BUSINESS ADDRESS:	
		STREET 1:		42 HAYARKON STREET
		CITY:			YAVNE
		STATE:			L3
		ZIP:			8122745
		BUSINESS PHONE:		97289324010

	MAIL ADDRESS:	
		STREET 1:		42 HAYARKON STREET
		CITY:			YAVNE
		STATE:			L3
		ZIP:			8122745
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>zk2431143.htm
<DESCRIPTION>20-F
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--INTEGIX by Ez-XBRL-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full" xmlns:mdwd="http://mediwound.com/20231231" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:srt-types="http://fasb.org/srt-types/2023"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><title>MediWound Ltd. - 1593984 - 2024</title></head><body><div style="font-size: 10pt;"><div style="font-size: 10pt;">
        <div style="display:none">
        <ix:header><ix:hidden><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20220101to20221231" id="Fxbrl_20220218193953855" unitRef="USD" xsi:nil="true"/><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" id="Fxbrl_20220218194046617" unitRef="USD" xsi:nil="true"/><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" id="Fxbrl_20220218194059574" unitRef="USD" xsi:nil="true"/><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" id="Fxbrl_20220309121931734" unitRef="USD" xsi:nil="true"/><ix:footnote id="FN20240318102551464" xml:lang="en-US">Represents an amount lower than $1.</ix:footnote>
<ix:footnote id="FN20240316192532725" xml:lang="en-US">In December 2007, the Company's board of directors approved one&#8209;time bonus payments to the Chief Medical Officer in the amounts of $ 120, which was recorded in profit and loss in December 2022 upon achieving marketing approval in the United States.</ix:footnote>
<ix:footnote id="FN20240316192515677" xml:lang="en-US">One-time expenses amounted $309 for the year ended December 31, 2022, are  associated with the management changes.</ix:footnote>
<ix:footnote id="FN20240319204647723" xml:lang="en-US">During 2023 two key officers were replaced. At the end of 2023 the total key officers consist of six officers.</ix:footnote>
<ix:footnote id="FN20240316191303229" xml:lang="en-US">During 2023 three members of the board have left and one member of the board was replaced. At the end of 2023, the total board member consisted of five members.</ix:footnote>
<ix:footnote id="FN20240316191743916" xml:lang="en-US">During 2022 two members of the board of directors were replaced.</ix:footnote>
<ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="C_20230101to20231231" id="Fdei_EntityCentralIndexKey20211016114616654">0001593984</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="C_20230101to20231231" id="Fdei_AmendmentFlag20211016114715534">false</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="C_20230101to20231231" id="Fdei_DocumentFiscalPeriodFocus20211016115332090">FY</ix:nonNumeric><ix:nonFraction name="ifrs-full:ProceedsFromExerciseOfOptions" contextRef="C_20220101to20221231" id="Fxbrl_20220218200654710" unitRef="USD" xsi:nil="true"/><ix:footnote id="FN20240316174026696" xml:lang="en-US">The salary costs for the year ended December 31,2022 includes one time payment of $205 derived from termination agreement with the CMO of the company.</ix:footnote>
<ix:footnote id="FN20240317194142255" xml:lang="en-US">Leasehold improvements are depreciated on a straight&#8209;line basis over the shorter of the lease term (including the renewal option held by the Company which is expected to be exercised) and the expected life of the improvement.</ix:footnote>
<ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="C_20230101to20231231" id="Fxbrl_20220108004247413">IL</ix:nonNumeric><ix:footnote id="FN20240316133250491" xml:lang="en-US">The USD deposits bear annual interest of 6.26%-6.55% for the period of 91-365 days for 2023.</ix:footnote>
<ix:footnote id="FN20240318102527335" xml:lang="en-US">Restricted bank deposits which are primarily used as security for the Company&#8217;s office leases.</ix:footnote>
<ix:footnote id="FN20240318102449496" xml:lang="en-US">Restricted bank deposits which are primarily used as security for the Company&#8217;s office leases.</ix:footnote>
<ix:footnote id="FN20240316140122939" xml:lang="en-US">Including write-down of $326</ix:footnote>
</ix:hidden>
<ix:references>
        <link:schemaRef xlink:type="simple" xlink:href="mdwd-20231231.xsd"/>
        </ix:references><ix:resources><xbrli:context id="C_20231231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mdwd:AgreementAxis">mdwd:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdNexoBridMember_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember_srtRangeAxis_srtMaximumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:NexoBridMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mdwd:AgreementAxis">mdwd:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdNexoBridMember_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:NexoBridMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mdwd:AgreementAxis">mdwd:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230508to20230509_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mdwd:AgreementAxis">mdwd:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-05-08</xbrli:startDate>
        <xbrli:endDate>2023-05-09</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230508to20230509_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdNexoBridMember_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember_srtRangeAxis_srtMaximumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:NexoBridMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mdwd:AgreementAxis">mdwd:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-05-08</xbrli:startDate>
        <xbrli:endDate>2023-05-09</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mdwd:AgreementAxis">mdwd:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20190501to20190506_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdLicenseAgreementWithVericelMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:LicenseAgreementWithVericelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2019-05-01</xbrli:startDate>
        <xbrli:endDate>2019-05-06</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20190501to20190506_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdLicenseAgreementWithVericelMember_srtRangeAxis_srtMaximumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:LicenseAgreementWithVericelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2019-05-01</xbrli:startDate>
        <xbrli:endDate>2019-05-06</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdLicenseAgreementWithVericelMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:LicenseAgreementWithVericelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230701to20230717_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTurnkeyScaleUpAgreementWithBiopharmaxGroupMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:TurnkeyScaleUpAgreementWithBiopharmaxGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-07-17</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220201to20220217_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdUsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-02-01</xbrli:startDate>
        <xbrli:endDate>2022-02-17</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdUsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullClassesOfOrdinarySharesAxis_mdwdDilutedWeightedAverageNumberMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">mdwd:DilutedWeightedAverageNumberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullClassesOfOrdinarySharesAxis_mdwdDilutedWeightedAverageNumberMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">mdwd:DilutedWeightedAverageNumberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullOtherRelatedPartiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullOtherRelatedPartiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20071201to20071231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdChiefExecutiveOfficerAndChiefMedicalOfficerMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ChiefExecutiveOfficerAndChiefMedicalOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2007-12-01</xbrli:startDate>
        <xbrli:endDate>2007-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullOtherRelatedPartiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullOtherRelatedPartiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullOtherRelatedPartiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdChiefExecutiveOfficerAndChiefMedicalOfficerMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ChiefExecutiveOfficerAndChiefMedicalOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdKeyOfficerMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:KeyOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdKeyOfficerMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:KeyOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:DepreciatedCostMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:DepreciatedCostMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:DepreciatedCostMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:DepreciatedCostMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:DepreciatedCostMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:DepreciatedCostMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:DepreciatedCostMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:DepreciatedCostMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:DepreciatedCostMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:DepreciatedCostMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullTypesOfRisksAxis_mdwdInterestRateForLoanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mdwd:InterestRateForLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullTypesOfRisksAxis_mdwdUncertaintyInFutureDefaultsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mdwd:UncertaintyInFutureDefaultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_mdwdSensitivityAnalysisAxis_mdwdFivePercentageIncreaseInExchangeRateMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mdwd:SensitivityAnalysisAxis">mdwd:FivePercentageIncreaseInExchangeRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_mdwdSensitivityAnalysisAxis_mdwdFivePercentageIncreaseInExchangeRateMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mdwd:SensitivityAnalysisAxis">mdwd:FivePercentageIncreaseInExchangeRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_mdwdSensitivityAnalysisAxis_mdwdFivePercentageDecreaseInExchangeRateMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mdwd:SensitivityAnalysisAxis">mdwd:FivePercentageDecreaseInExchangeRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_mdwdSensitivityAnalysisAxis_mdwdFivePercentageDecreaseInExchangeRateMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mdwd:SensitivityAnalysisAxis">mdwd:FivePercentageDecreaseInExchangeRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mdwd:LaterThanTwoYearAndNotLaterThanFifteenYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mdwd:LaterThanTwoYearAndNotLaterThanFifteenYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240306_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mdwd:SubsequentEventsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2024-03-06</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240301to20240306_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mdwd:SubsequentEventsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-03-06</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240101to20240131_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesOfficersBoardMembersCeoAndConsultantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mdwd:SubsequentEventsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-01-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240101_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mdwd:SubsequentEventsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2024-01-01</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240101to20240131_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mdwd:SubsequentEventsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-01-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240226_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesOfficersBoardMembersCeoAndConsultantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mdwd:SubsequentEventsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2024-02-26</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240201to20240226_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesOfficersBoardMembersCeoAndConsultantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mdwd:SubsequentEventsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-02-01</xbrli:startDate>
        <xbrli:endDate>2024-02-26</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdAmortizedCostMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:AmortizedCostMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdAmortizedCostMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:AmortizedCostMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221101to20221128"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-11-01</xbrli:startDate>
        <xbrli:endDate>2022-11-28</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220301to20221031"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2022-10-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230201to20230207"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-02-07</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230207"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-02-07</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtRangeAxis_srtMinimumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtRangeAxis_srtMaximumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtCurrencyAxis_currencyILS"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230701to20230731"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230701to20230731_srtCurrencyAxis_currencyILS"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullSegmentsAxis_mdwdUsaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mdwd:UsaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullSegmentsAxis_mdwdUsaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mdwd:UsaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSegmentsAxis_mdwdUsaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mdwd:UsaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSegmentsAxis_mdwdOtherCountriesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mdwd:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullSegmentsAxis_mdwdOtherCountriesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mdwd:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullSegmentsAxis_mdwdOtherCountriesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mdwd:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdBardaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mdwd:BardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdBardaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mdwd:BardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdBardaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mdwd:BardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdVericelMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mdwd:VericelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdOtherCustomerContributedMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mdwd:OtherCustomerContributedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdVericelMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mdwd:VericelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdMtecMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mdwd:MtecMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdMtecMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mdwd:MtecMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_mdwdBuildingAndEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mdwd:BuildingAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221127"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-11-27</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221128"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-11-28</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221205"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-05</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230531"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-05-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220307to20220307"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-03-07</xbrli:startDate>
        <xbrli:endDate>2022-03-07</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220307to20220307_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdCertainEntitiesAffiliatedWithCbiMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:CertainEntitiesAffiliatedWithCbiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-03-07</xbrli:startDate>
        <xbrli:endDate>2022-03-07</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220926to20220926"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-09-26</xbrli:startDate>
        <xbrli:endDate>2022-09-26</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220926"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-09-26</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220901to20220928"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-09-01</xbrli:startDate>
        <xbrli:endDate>2022-09-28</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221006to20221006_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mdwd:AgreementAxis">mdwd:PrivateIssuancePurchaseEquityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-10-06</xbrli:startDate>
        <xbrli:endDate>2022-10-06</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221006_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mdwd:AgreementAxis">mdwd:PrivateIssuancePurchaseEquityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-10-06</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mdwd:AgreementAxis">mdwd:PrivateIssuancePurchaseEquityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mdwd:AgreementAxis">mdwd:PrivateIssuancePurchaseEquityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230207to20230207"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-02-07</xbrli:startDate>
        <xbrli:endDate>2023-02-07</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryDE"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryDE"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullGeographicalAreasAxis_countryDE"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullTypesOfInterestRatesAxis_ifrsfullFixedInterestRateMember_srtCurrencyAxis_currencyUSD_srtRangeAxis_srtMinimumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullTypesOfInterestRatesAxis_ifrsfullFixedInterestRateMember_srtCurrencyAxis_currencyUSD_srtRangeAxis_srtMaximumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:TevaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:TevaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ThirdPartiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_ifrsfullMethodsOfGenerationAxis_mdwdSubLicensingOfPatentsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ThirdPartiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">mdwd:SubLicensingOfPatentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_ifrsfullMethodsOfGenerationAxis_mdwdSubLicensingOfPatentsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ThirdPartiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">mdwd:SubLicensingOfPatentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ThirdPartiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdResearchAndDevelopmentLawMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ResearchAndDevelopmentLawMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdResearchAndDevelopmentLawMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ResearchAndDevelopmentLawMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:TevaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:TevaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ThirdPartiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_ifrsfullMethodsOfGenerationAxis_mdwdSubLicensingOfPatentsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ThirdPartiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">mdwd:SubLicensingOfPatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesAndDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdIsraeliShareOptionPlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesAndDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:IsraeliShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20140301to20140331_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdEquityIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesAndDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2014-03-01</xbrli:startDate>
        <xbrli:endDate>2014-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesAndDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesAndDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdCostOfRevenuesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:CostOfRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdCostOfRevenuesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:CostOfRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdCostOfRevenuesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:CostOfRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdResearchAndDevelopmentExpensesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdResearchAndDevelopmentExpensesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdResearchAndDevelopmentExpensesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdSellingAndMarketingExpensesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:SellingAndMarketingExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdSellingAndMarketingExpensesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:SellingAndMarketingExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdSellingAndMarketingExpensesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:SellingAndMarketingExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdGeneralAndAdministrativeExpensesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:GeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdGeneralAndAdministrativeExpensesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:GeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdGeneralAndAdministrativeExpensesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:GeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesTwoMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesTwoMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesThreeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesThreeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesAndDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesFourMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesFourMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesFiveMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesFiveMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesSixMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesSixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesSixMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesSixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesServenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesServenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesServenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesServenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesEightMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesEightMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2021-03-04</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdRestrictedSharesUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2021-03-04</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2021-03-04</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdRestrictedSharesUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2021-03-04</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesAndDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-03-04</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsAndCeoMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsAndCeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsAndCeoMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsAndCeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220801to20220818_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdChairmanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-08-01</xbrli:startDate>
        <xbrli:endDate>2022-08-18</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-02-15</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdRestrictedSharesUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-02-15</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesOfficersBoardMembersCeoAndConsultantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-02-15</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdRestrictedSharesUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesOfficersBoardMembersCeoAndConsultantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-02-15</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesOfficersBoardMembersCeoAndConsultantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-02-15</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesOfficersBoardMembersCeoAndConsultantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-02-15</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230401to20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-04-03</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-04-03</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-04-03</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-02-15</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230501to20230531_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-05-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230501to20230531_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-05-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230801to20230815_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-08-01</xbrli:startDate>
        <xbrli:endDate>2023-08-15</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230801to20230815_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-08-01</xbrli:startDate>
        <xbrli:endDate>2023-08-15</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231101to20231120_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-11-01</xbrli:startDate>
        <xbrli:endDate>2023-11-20</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231120_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-11-20</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231120_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-11-20</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231101to20231120_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-11-01</xbrli:startDate>
        <xbrli:endDate>2023-11-20</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:unit id="Directors"><xbrli:measure>mdwd:Directors</xbrli:measure></xbrli:unit>
<xbrli:unit id="NIS"><xbrli:measure>iso4217:ILS</xbrli:measure></xbrli:unit>
<xbrli:unit id="NIS_per_share"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:ILS</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:unit id="Officers"><xbrli:measure>mdwd:Officers</xbrli:measure></xbrli:unit>
<xbrli:unit id="Percent"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit>
<xbrli:unit id="Share"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit>
<xbrli:unit id="Square_Meters"><xbrli:measure>utr:sqm</xbrli:measure></xbrli:unit>
<xbrli:unit id="Squaremeters"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD_Per_Share"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:unit id="Vehicles"><xbrli:measure>mdwd:Vehicles</xbrli:measure></xbrli:unit>
<xbrli:unit id="shares"><xbrli:measure>mdwd:shares</xbrli:measure></xbrli:unit>
<ix:relationship fromRefs="Fxbrl_20220218193953855" toRefs="FN20240318102551464"/><ix:relationship fromRefs="Fxbrl_20220218194046617" toRefs="FN20240318102551464"/><ix:relationship fromRefs="Fxbrl_20220218194059574" toRefs="FN20240318102551464"/><ix:relationship fromRefs="Fxbrl_20220309121931734" toRefs="FN20240318102551464"/><ix:relationship fromRefs="Fxbrl_20211012144415541" toRefs="FN20240316192532725"/><ix:relationship fromRefs="Fxbrl_20211012144415541" toRefs="FN20240316192515677"/><ix:relationship fromRefs="Fxbrl_20211012144421658" toRefs="FN20240316192515677"/><ix:relationship fromRefs="Fxbrl_20211012144421658" toRefs="FN20240316192532725"/><ix:relationship fromRefs="Fxbrl_20211012144424590" toRefs="FN20240316192532725"/><ix:relationship fromRefs="Fxbrl_20211012144424590" toRefs="FN20240316192515677"/><ix:relationship fromRefs="Fxbrl_20211012144654818_xbrl_20211012144614988_xbrl_20211012144424590" toRefs="FN20240319204647723"/><ix:relationship fromRefs="Fxbrl_20211012144654818_xbrl_20211012144614988_xbrl_20211012144421658" toRefs="FN20240319204647723"/><ix:relationship fromRefs="Fxbrl_20211012144654818_xbrl_20211012144614988_xbrl_20211012144415541" toRefs="FN20240319204647723"/><ix:relationship fromRefs="Fxbrl_20240316191227790" toRefs="FN20240316191303229"/><ix:relationship fromRefs="Fxbrl_20240316191236117" toRefs="FN20240316191743916"/><ix:relationship fromRefs="Fxbrl_20211012105744786" toRefs="FN20240316174026696"/><ix:relationship fromRefs="Fxbrl_20211012105756275" toRefs="FN20240316174026696"/><ix:relationship fromRefs="Fxbrl_20211012105807825" toRefs="FN20240316174026696"/><ix:relationship fromRefs="Fxbrl_20240317194123497" toRefs="FN20240317194142255"/><ix:relationship fromRefs="Fxbrl_20210924141709230" toRefs="FN20240316133250491"/><ix:relationship fromRefs="Fxbrl_20210924142234692_xbrl_20210924141809083" toRefs="FN20240318102527335"/><ix:relationship fromRefs="Fxbrl_20210924142234692_xbrl_20210924141709230" toRefs="FN20240318102449496"/><ix:relationship fromRefs="Fxbrl_20240317133507442" toRefs="FN20240316133250491"/><ix:relationship fromRefs="Fxbrl_20240320231728040" toRefs="FN20240316140122939"/></ix:resources></ix:header></div><div><div style="">
  <div>
    <hr style="border:none;border-bottom:1px solid black;border-top:4px solid black;height:10px;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center"/>
    <div>
      <div style="text-align:center;line-height:1.25;font-weight:bold">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:14pt"><span style="font-family:Times New Roman,Times,serif"><span style="background-color:rgb(255, 255, 255);font-weight:bold;color:rgb(0, 0, 0);font-style:normal;font-variant:normal;text-transform:none">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION</span></span></span><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">WASHINGTON, D.C. 20549</span></span></div>
      <div style="text-align:center;line-height:1.25;font-weight:bold">&#160;</div>
      <div style="text-align:center;line-height:1.25">
        <hr style="height:2px;width:100%;color:#000000;background-color:#000000;margin-left:auto;margin-right:auto;border:none;text-align:center"/>
        <div>&#160;</div>
      </div>
      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:14pt;font-weight:bold;background-color:rgb(255, 255, 255);color:rgb(0, 0, 0);font-style:normal;font-variant:normal;text-transform:none"><span style="font-size:14pt"><span style="font-family:Times New Roman,Times,serif">FORM <ix:nonNumeric id="Fxbrl_20211016114637958" name="dei:DocumentType" contextRef="C_20230101to20231231">20-F</ix:nonNumeric></span></span></div>
      <div style="text-align:center;line-height:1.25;font-weight:bold">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold">
        <hr style="height:2px;width:100%;color:#000000;background-color:#000000;margin-left:auto;margin-right:auto;border:none;text-align:center"/>
      </div>
      <div style="text-align:center;line-height:1.25">&#160;</div>
      <table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:4%;vertical-align:middle">
              <div style="line-height:1.25;font-family:'Segoe UI Symbol',sans-serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20211207224002008" name="dei:DocumentRegistrationStatement" contextRef="C_20230101to20231231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></div>
            </td>
            <td style="width:96%;vertical-align:top">
              <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934</span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">OR</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:4%;vertical-align:middle">
              <div style="line-height:1.25;font-family:'Segoe UI Symbol', sans-serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20211016115158444" name="dei:DocumentAnnualReport" contextRef="C_20230101to20231231" format="ixt:fixed-true">&#9746;</ix:nonNumeric></span></span></div>
            </td>
            <td style="width:96%;vertical-align:top">
              <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the fiscal year ended <ix:nonNumeric id="Fxbrl_20211016114658516" name="dei:DocumentPeriodEndDate" contextRef="C_20230101to20231231" format="ixt:date-monthname-day-year-en"><ix:nonNumeric id="Fxbrl_20220218160357327" name="dei:CurrentFiscalYearEndDate" contextRef="C_20230101to20231231" format="ixt:date-monthname-day-en">December 31</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20220218160419913" name="dei:DocumentFiscalYearFocus" contextRef="C_20230101to20231231">2023</ix:nonNumeric></ix:nonNumeric></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">OR</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:4%;vertical-align:middle">
              <div style="line-height:1.25;font-family:'Segoe UI Symbol', sans-serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20211016115219588" name="dei:DocumentTransitionReport" contextRef="C_20230101to20231231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></div>
            </td>
            <td style="width:96%;vertical-align:top">
              <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the transition period from ____________________ to ____________________</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">OR</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:4%;vertical-align:middle">
              <div style="line-height:1.25;font-family:'Segoe UI Symbol', sans-serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20211207224718783" name="dei:DocumentShellCompanyReport" contextRef="C_20230101to20231231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></div>
            </td>
            <td style="width:96%;vertical-align:top">
              <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Date of event requiring this shell company report____________________</span></span></div>
      <div style="text-align:center;line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Commission file number <ix:nonNumeric id="Fxbrl_20211016121555520" name="dei:EntityFileNumber" contextRef="C_20230101to20231231">001-36349</ix:nonNumeric></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><img alt="image00001.jpg" src="mdwd_img01.jpg"/></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:16pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold;background-color:rgb(255, 255, 255);color:rgb(0, 0, 0);font-style:normal;font-variant:normal;text-transform:none"><ix:nonNumeric id="Fxbrl_20211016114600589" name="dei:EntityRegistrantName" contextRef="C_20230101to20231231">MEDIWOUND LTD.</ix:nonNumeric></span></span></span><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Exact name of Registrant as specified in its charter)</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Not applicable</span></span></div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Translation of Registrant&#8217;s name into English)</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"><span style="-sec-ix-hidden:Fxbrl_20220108004247413">ISRAEL</span></span><br/>(Jurisdiction of incorporation or organization)</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"><ix:nonNumeric id="Fxbrl_20211016122123998" name="dei:EntityAddressAddressLine1" contextRef="C_20230101to20231231">42 Hayarkon Street</ix:nonNumeric></span><br/>&#160;<span style="font-weight:bold"><ix:nonNumeric id="Fxbrl_20211016122147155" name="dei:EntityAddressCityOrTown" contextRef="C_20230101to20231231">Yavne</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20211016122203226" name="dei:EntityAddressPostalZipCode" contextRef="C_20230101to20231231">8122745</ix:nonNumeric>&#160;<ix:nonNumeric id="Fxbrl_20211016122220190" name="dei:EntityAddressCountry" contextRef="C_20230101to20231231" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></span><br/>(Address of principal executive offices)</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20211016122249282" name="dei:ContactPersonnelName" contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">Yaron Meyer</ix:nonNumeric>, Adv.</span></span></div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Executive Vice President, General Counsel and Corporate Secretary<br/>Telephone: +<ix:nonNumeric id="Fxbrl_20211016122326538" name="dei:CityAreaCode" contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">972</ix:nonNumeric> (77) <ix:nonNumeric id="Fxbrl_20211016122346833" name="dei:LocalPhoneNumber" contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">971-4100</ix:nonNumeric><br/>E-mail: <ix:nonNumeric id="Fxbrl_20211207223529679" name="dei:ContactPersonnelEmailAddress" contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">yaronm@mediwound.com</ix:nonNumeric><br/>MediWound Ltd.<br/><ix:nonNumeric id="Fxbrl_20211207221757498" name="dei:EntityAddressAddressLine1" contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">42 Hayarkon Street</ix:nonNumeric><br/><ix:nonNumeric id="Fxbrl_20211207221833313" name="dei:EntityAddressCityOrTown" contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">Yavne</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20211207221851141" name="dei:EntityAddressPostalZipCode" contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">8122745</ix:nonNumeric> <ix:nonNumeric id="Fxbrl_20220108004307270" name="dei:EntityAddressCountry" contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></span></span></div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Name, telephone, e-mail and/or facsimile number and address of company contact person)</span></span></div>
      <div style="text-align:center;line-height:1.25">&#160;</div>
      <div style="line-height:1.25">
        <hr style="height:2px;width:100%;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center"/>
      </div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Securities registered or to be registered pursuant to Section 12(b) of the Act:</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:30%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)">
              <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Title of each class</span></span></div>
            </td>
            <td colspan="1" style="width:1%;vertical-align:top;padding-bottom:2px">&#160;</td>
            <td style="width:30%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)">
              <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trading Symbol(s)</span></span></div>
            </td>
            <td colspan="1" style="width:1%;vertical-align:top;padding-bottom:2px">&#160;</td>
            <td style="width:30%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)">
              <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Name of each exchange on which registered</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="width:30%;vertical-align:top">
              <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20211016122422552" name="dei:Security12bTitle" contextRef="C_20230101to20231231">Ordinary shares, par value NIS 0.07 per share</ix:nonNumeric></span></span></div>
            </td>
            <td colspan="1" style="width:1%;vertical-align:top">&#160;</td>
            <td style="width:30%;vertical-align:top">
              <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20211016122438792" name="dei:TradingSymbol" contextRef="C_20230101to20231231">MDWD</ix:nonNumeric></span></span></div>
            </td>
            <td colspan="1" style="width:1%;vertical-align:top">&#160;</td>
            <td style="width:30%;vertical-align:top">
              <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20211016122517742" name="dei:SecurityExchangeName" contextRef="C_20230101to20231231" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric> Global Market</span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Securities registered or to be registered pursuant to Section 12(g) of the Act: <span style="font-weight:bold">None.</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: <span style="font-weight:bold">None.</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate the number of outstanding shares of each of the issuer&#8217;s classes of capital or common stock as of the close of the period covered by the annual report: <span style="font-weight:bold">As of December 31, 2023, the registrant had <ix:nonFraction id="Fxbrl_20240319220101414" name="dei:EntityCommonStockSharesOutstanding" contextRef="C_20231231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">9,221,764</ix:nonFraction> ordinary shares, par value NIS 0.07 per share, outstanding.</span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
      </div>
      <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
        <div style="page-break-after:always">
          <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
        </div>
      </div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Yes&#160;<span>&#9744;&#160; &#160; &#160; &#160; &#160; &#160;&#160;</span> <ix:nonNumeric id="Fxbrl_20211016121344180" name="dei:EntityWellKnownSeasonedIssuer" contextRef="C_20230101to20231231">No</ix:nonNumeric>&#160;<span>&#9746;</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Yes&#160;<span>&#9744;&#160; &#160; &#160; &#160; &#160; &#160;&#160;</span> <ix:nonNumeric id="Fxbrl_20211016121357418" name="dei:EntityVoluntaryFilers" contextRef="C_20230101to20231231">No</ix:nonNumeric>&#160;<span>&#9746;</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20211016121951653" name="dei:EntityCurrentReportingStatus" contextRef="C_20230101to20231231">Yes</ix:nonNumeric>&#160;<span>&#9746;</span>&#160; &#160; &#160; &#160; &#160; &#160; &#160;No&#160;<span>&#9744;</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20211016121406185" name="dei:EntityInteractiveDataCurrent" contextRef="C_20230101to20231231">Yes</ix:nonNumeric>&#160;<span>&#9746;</span>&#160; &#160; &#160; &#160; &#160; &#160; &#160;No&#160;<span>&#9744;</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated file, a non-accelerated filer, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; and &#8220;accelerated filer,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:25%;vertical-align:top">
              <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Large accelerated filer <span>&#9744;</span></span></span></div>
            </td>
            <td style="width:25%;vertical-align:top">
              <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240319231951241" name="dei:EntityFilerCategory" contextRef="C_20230101to20231231" format="ixt-sec:entityfilercategoryen">Accelerated filer</ix:nonNumeric> <span>&#9746;</span></span></span></div>
            </td>
            <td style="width:25%;vertical-align:top">
              <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Non-accelerated filer &#9744;</span></span></span></div>
            </td>
            <td style="width:25%;vertical-align:top">
              <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Emerging Growth Company <ix:nonNumeric id="Fxbrl_20211016115135705" name="dei:EntityEmergingGrowthCompany" contextRef="C_20230101to20231231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards&#8224; provided pursuant to Section&#160;</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13(a) of the Exchange Act. <span>&#9744;</span></span></span></div>
      <div>&#160;</div>
      <div>
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b) by the registered public accounting firm that prepared or issued its audit report. <span><ix:nonNumeric id="Fxbrl_20240102104348194" name="dei:IcfrAuditorAttestationFlag" contextRef="C_20230101to20231231" format="ixt:fixed-true">&#9746;</ix:nonNumeric></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. <ix:nonNumeric id="Fxbrl_20240102104625952" name="dei:DocumentFinStmtErrorCorrectionFlag" contextRef="C_20230101to20231231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark which basis for accounting the registrant has used to prepare the financing statements included in this filing:</span></span></div>
      </div>&#160;<table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:25%;vertical-align:top">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">U.S. GAAP <span>&#9744;</span></span></span></div>
            </td>
            <td style="width:50%;vertical-align:top">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240319231348902" name="dei:DocumentAccountingStandard" contextRef="C_20230101to20231231">International Financial Reporting Standards</ix:nonNumeric> as issued<br/>by the International Accounting Standards Board <span>&#9746;</span></span></span></div>
            </td>
            <td style="width:25%;vertical-align:top">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Other &#9744;</span></span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If &#8220;Other&#8221; has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#9744;</span> Item 17&#160; &#160; &#160; &#160; &#160; &#160; &#160;<span>&#9744;</span> Item 18</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Yes&#160;<span>&#9744;</span>&#160; &#160; &#160; &#160; &#160; &#160; &#160;No&#160;<span><ix:nonNumeric id="Fxbrl_20220107225043049" name="dei:EntityShellCompany" contextRef="C_20230101to20231231" format="ixt:fixed-false">&#9746;</ix:nonNumeric></span></span></span></div>
    </div>
    <div>&#160;</div>
  </div>
  <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always"/>
  <div style="line-height:1.25">&#160;<!-- Field: Include-Text; File: PF\body.htm; Date: 2024%2D03%2D21T13:51:33; Size: 0x0013D7EA; Options: XMLPreprocess -->
<div>

<div style="line-height: 1.25"> <hr style="border-style: none; height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto"/></div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold">MEDIWOUND LTD.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 100%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> <br/> </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">FORM 20-F<br/> ANNUAL REPORT FOR THE FISCAL YEAR ENDED DECEMBER
        31, 2023</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> <br/> </div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-family: Times New Roman,Times,serif; font-variant: small-caps; font-weight: bold">TABLE
OF CONTENTS</div>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="2" border="0" style="font: 10pt Times New Roman,Times,serif; width: 100%; text-align: left; color: rgb(0, 0, 0)">
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#INTRODUCTION">INTRODUCTION</a></div> </td>
    <td style="width: 6.84%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25; font-family: Times New Roman, Times, serif">i</div> </td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#INTRODUCTION">SPECIAL NOTE REGARDING FORWARD-LOOKING
        STATEMENTS</a></div> </td>
    <td style="width: 6.84%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25; font-family: Times New Roman, Times, serif">i</div> </td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">&#160;</td>
    <td style="width: 6.84%; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 93.16%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="#PARTI">PART I</a></div> </td>
    <td rowspan="1" style="width: 6.84%; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">&#160;</td>
    <td style="width: 6.84%; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#PARTI">Item 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT
        AND ADVISERS</a></div> </td>
    <td style="width: 6.84%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25; font-family: Times New Roman, Times, serif">1</div> </td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#PARTI">Item 2. OFFER STATISTICS AND EXPECTED TIMETABLE</a></div>
        </td>
    <td style="width: 6.84%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25; font-family: Times New Roman, Times, serif">1</div> </td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#PARTI"><span style="font-family: Times New Roman, Times, serif">Item 3. KEY INFORMATION<br/>
        </span></a></div> </td>
    <td style="width: 6.84%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25; font-family: Times New Roman, Times, serif">1</div> </td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25"><span style="font-family: Times New Roman, Times, serif"><a href="#tem4.">Item 4. INFORMATION ON THE COMPANY</a><br/>
        </span></div> </td>
    <td style="width: 6.84%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25; font-family: Times New Roman, Times, serif">37<br/> </div> </td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#Item4A">Item 4A. UNRESOLVED STAFF COMMENTS</a></div>
        </td>
    <td style="width: 6.84%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25; font-family: Times New Roman, Times, serif">76<br/> </div> </td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25"><span style="font-family: Times New Roman, Times, serif"><a href="#Item4A">Item 5. OPERATING AND FINANCIAL
        REVIEW AND PROSPECTS</a><br/> </span></div> </td>
    <td style="width: 6.84%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25; font-family: Times New Roman, Times, serif">76<br/> </div> </td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#Item6.">Item 6. DIRECTORS, SENIOR MANAGEMENT AND
        EMPLOYEES</a></div> </td>
    <td style="width: 6.84%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25; font-family: Times New Roman, Times, serif">90<br/> </div> </td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#Item7.">Item 7. MAJOR SHAREHOLDERS AND RELATED PARTY
        TRANSACTIONS</a></div> </td>
    <td style="width: 6.84%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25; font-family: Times New Roman, Times, serif">108</div> </td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25"><span style="font-family: Times New Roman, Times, serif"><a href="#tem8.">Item 8. FINANCIAL INFORMATION</a><br/>
        </span></div> </td>
    <td style="width: 6.84%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25; font-family: Times New Roman, Times, serif">113</div> </td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25"><span style="font-family: Times New Roman, Times, serif"><a href="#Item9.">Item 9. THE OFFER AND LISTING</a><br/>
        </span></div> </td>
    <td style="width: 6.84%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25; font-family: Times New Roman, Times, serif">114</div> </td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25"><span style="font-family: Times New Roman, Times, serif"><a href="#Item9.">Item 10. ADDITIONAL INFORMATION</a><br/>
        </span></div> </td>
    <td style="width: 6.84%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25; font-family: Times New Roman, Times, serif">114</div> </td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#Item11.">Item 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES
        ABOUT MARKET RISK</a></div> </td>
    <td style="width: 6.84%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25; font-family: Times New Roman, Times, serif">123</div> </td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#Item12.">Item 12. DESCRIPTION OF SECURITIES OTHER
        THAN EQUITY SECURITIES</a></div> </td>
    <td style="width: 6.84%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25; font-family: Times New Roman, Times, serif">124</div> </td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">&#160;</td>
    <td style="width: 6.84%; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 93.16%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#PARTII">PART II</a></div> </td>
    <td rowspan="1" style="width: 6.84%; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">&#160;</td>
    <td style="width: 6.84%; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#PARTII">Item 13. DEFAULTS, DIVIDEND ARREARAGES AND
        DELINQUENCIES</a></div> </td>
    <td style="width: 6.84%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25; font-family: Times New Roman, Times, serif">124</div> </td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#PARTII">Item 14. MATERIAL MODIFICATIONS TO THE RIGHTS
        OF SECURITY HOLDERS AND USE OF PROCEEDS</a></div> </td>
    <td style="width: 6.84%; vertical-align: bottom; text-align: right">124</td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#PARTII">Item 15. CONTROLS AND PROCEDURES</a></div>
        </td>
    <td style="width: 6.84%; vertical-align: bottom; text-align: right">124</td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#PARTII"><span style="font-family: Times New Roman, Times, serif">Item 16A. AUDIT COMMITTEE FINANCIAL
        EXPERT<br/> </span></a></div> </td>
    <td style="width: 6.84%; vertical-align: bottom; text-align: right">124</td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item16B"><span style="font-family: Times New Roman, Times, serif">Item 16B. CODE OF ETHICS<br/>
        </span></a></div> </td>
    <td style="width: 6.84%; vertical-align: bottom; text-align: right">125</td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item16B"><span style="font-family: Times New Roman, Times, serif">Item 16C. PRINCIPAL ACCOUNTANT
        FEES AND SERVICES<br/> </span></a></div> </td>
    <td style="width: 6.84%; vertical-align: bottom; text-align: right">125<br/> </td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#Item16B">Item 16D. EXEMPTIONS FROM THE LISTING STANDARDS
        FOR AUDIT COMMITTEES</a></div> </td>
    <td style="width: 6.84%; vertical-align: bottom; text-align: right">125</td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#Item16B">Item 16E. PURCHASES OF EQUITY SECURITIES
        BY THE ISSUER AND AFFILIATED PURCHASERS</a></div> </td>
    <td style="width: 6.84%; vertical-align: bottom; text-align: right">125</td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#Item16B">Item 16F. CHANGE IN REGISTRANT&#8217;S CERTIFYING
        ACCOUNTANT</a></div> </td>
    <td style="width: 6.84%; vertical-align: bottom; text-align: right">125</td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item16G."><span style="font-family: Times New Roman, Times, serif">Item 16G. CORPORATE GOVERNANCE<br/>
        </span></a></div> </td>
    <td style="width: 6.84%; vertical-align: bottom; text-align: right">126</td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#Item16G.">Item 16H. MINE SAFETY DISCLOSURE</a></div>
        </td>
    <td style="width: 6.84%; vertical-align: bottom; text-align: right">126</td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#Item16G.">Item 16I.&#160; DISCLOSURE REGARDING FOREIGN
        JURISDICTIONS THAT PREVENT INSPECTIONS</a></div> </td>
    <td style="width: 6.84%; vertical-align: bottom; text-align: right">126</td> </tr>
  <tr>
    <td rowspan="1" style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#Item16G."><span style="text-decoration: underline">Item
        16J. INSIDER TRADING POLICIE</span><span style="text-decoration: underline">S</span></a></div> </td>
    <td rowspan="1" style="width: 6.84%; vertical-align: bottom; text-align: right">126 <br/> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#Item16G."><span style="text-decoration: underline">Item
        16K. CYBERSECURITY</span></a></div> </td>
    <td rowspan="1" style="width: 6.84%; vertical-align: bottom; text-align: right">&#160;126</td> </tr>
  <tr>
    <td rowspan="1" style="width: 93.16%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 6.84%; vertical-align: bottom; text-align: right">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 93.16%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#PARTIII">PART III</a></div> </td>
    <td rowspan="1" style="width: 6.84%; vertical-align: bottom; text-align: right">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 93.16%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 6.84%; vertical-align: bottom; text-align: right">&#160;</td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#PARTIII"><span style="font-family: Times New Roman, Times, serif">Item 17. FINANCIAL STATEMENTS<br/>
        </span></a></div> </td>
    <td style="width: 6.84%; vertical-align: bottom; text-align: right">128</td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#PARTIII"><span style="font-family: Times New Roman, Times, serif">Item 18. FINANCIAL STATEMENTS<br/>
        </span></a></div> </td>
    <td style="width: 6.84%; vertical-align: bottom; text-align: right">128</td> </tr>
  <tr>
    <td style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#PARTIII">Item 19. EXHIBITS</a></div> </td>
    <td style="width: 6.84%; vertical-align: bottom; text-align: right">128</td> </tr>
  <tr>
    <td rowspan="1" style="width: 93.16%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#SIGNATURES">SIGNATURES</a></div> </td>
    <td rowspan="1" style="width: 6.84%; vertical-align: bottom; text-align: right">131 <br/> </td> </tr>
  </table>

<div> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="INTRODUCTION"><!--Anchor--></span>INTRODUCTION</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In this annual report, the terms &#8220;MediWound,&#8221; &#8220;we,&#8221;
&#8220;us,&#8221; &#8220;our&#8221; and &#8220;the company&#8221; refer to MediWound Ltd. and its subsidiaries.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">This annual report includes other statistical, market and industry
data and forecasts which we obtained from publicly available information and independent industry publications and reports that we believe
to be reliable sources. These publicly available industry publications and reports generally state that they obtain their information
from sources that they believe to be reliable, but they do not guarantee the accuracy or completeness of the information. Although we
believe that these sources are reliable, we have not independently verified the information contained in such publications. Certain estimates
and forecasts involve uncertainties and risks and are subject to change based on various factors, including those discussed under the
headings &#8220;Special Note Regarding Forward-Looking Statements&#8221; and &#8220;ITEM 3.D. Risk Factors&#8221; in this annual report.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">Throughout this annual report, we refer to various
trademarks, service marks and trade names that we use in our business. Solely for convenience, the trademarks, service marks and trade
names are referred to herein without the use of &#174; and &#8482; symbols. However, the omission of such symbols are not intended to
indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable
licensors to these trademarks, service marks and trade names. The &#8220;MediWound&#8221; design logo, &#8220;MediWound,&#8221; &#8220;NexoBrid,&#8221;
&#8220;EscharEx&#8221; and other trademarks or service marks of MediWound Ltd. appearing in this annual report are the property of MediWound
Ltd. We have several other trademarks, service marks and pending applications relating to our solutions. Other trademarks and service
marks appearing in this annual report are the property of their respective holders. Our use or display of other companies&#8217; trademarks,
service marks or trade names is not intended to imply a relationship with, or endorsement or sponsorship of us by, any other companies.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">All historical share and per-share numbers for the year ended December
31, 2022 and any prior fiscal periods appearing in this annual report reflect a retroactive adjustment for our 1-for-7 reverse share split
effected on December 20, 2022.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition to historical facts, this annual report on Form 20-F
contains forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), Section 21E of the U.S. Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) and the safe harbor
provisions of the U.S. Private Securities Litigation Reform Act of 1995. We make forward-looking statements in this annual report that
are subject to risks and uncertainties. These forward-looking statements include information about possible or assumed future results
of our business, financial condition, results of operations, liquidity, plans and objectives. In some cases, you can identify forward-looking
statements by terminology such as &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221;
&#8220;intend,&#8221; &#8220;should,&#8221; &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221;
or the negative of these terms or other similar expressions. The statements we make regarding the following matters are forward-looking
by their nature:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze622a0e013b74b3f93893f8bd65b7cee" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">our commercialization, marketing and manufacturing capabilities and strategy and the
        ability of our marketing team to cover European regional burn centers and units;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the timing and conduct of our trials of NexoBrid, EscharEx and our other pipeline
        product candidates, including statements regarding the timing, progress and results of current and future preclinical studies and clinical
        trials, and our research and development programs;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the clinical utility, potential advantages and timing or likelihood of regulatory
        filings and approvals of EscharEx and our other pipeline products;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">our expectations regarding future growth, including our ability to develop new products;</div>
        </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">our estimates regarding expenses, future revenues, capital requirements and our need
        for additional financing;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div><br/> </div>

<div style="text-align: center">i<br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div><br/> </div>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">anticipated funding under our contracts with the U.S. Biomedical Advanced Research
        and Development Authority;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">our ability to maintain adequate protection of our intellectual property;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">our estimates regarding the market opportunity for NexoBrid, EscharEx and our other
        pipeline products;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">our expectation regarding the duration of our inventory of intermediate drug substances
        and products;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the impact of our research and development expenses as we continue developing product
        candidates; and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the impact of government laws and regulations.&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">The preceding list is not intended to be an exhaustive
list of all our forward-looking statements. The forward-looking statements are based on our beliefs, assumptions and expectations of future
performance, taking into consideration the information currently available to us. These statements are only predictions based upon our
current expectations and projections about future events. These statements may be found in the sections of this annual report on Form
20-F entitled &#8220;ITEM 3.D. Risk Factors,&#8221; &#8220;ITEM 4. Information on the Company,&#8221; &#8220;ITEM 5. Operating and Financial
Review and Prospects,&#8221; &#8220;ITEM 10.E. Taxation-United States Federal Income Taxation-Passive Foreign Investment Company Considerations&#8221;
and elsewhere in this annual report, including the section entitled &#8220;ITEM 4.B. Business Overview&#8221; and &#8220;ITEM 4.B. Business
Overview-Our Focus,&#8221; which contain information obtained from independent industry sources. Actual results could differ materially
from those anticipated in these forward-looking statements due to various important factors, including all the risks discussed in &#8220;ITEM
3.D. Risk Factors&#8221; and information contained in other documents filed with or furnished to the Securities and Exchange Commission.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">You should not rely upon forward-looking statements as predictions
of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee
that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be
achieved or will occur. Except as required by law, we undertake no obligation to publicly update any forward-looking statements for any
reason after the date of this annual report to conform these statements to actual results or to changes in our expectations.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div style="text-align: center; line-height: 1.25; font-family: Times New Roman,Times,serif">ii<br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>
<!--PROfilePageNumberReset%Num%1%%%-->

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="PARTI"><!--Anchor--></span>PART I</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">

<div style="line-height: 1.25; font-weight: bold">Item 1.&#160; IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="margin-left: 36pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">

<div style="line-height: 1.25; font-weight: bold">Item 2.&#160; OFFER STATISTICS AND EXPECTED TIMETABLE</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 36pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">

<div style="line-height: 1.25; font-weight: bold">Item 3.&#160; KEY INFORMATION</div> </div>

<div style="line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zd01e35444de64c60877dd912c84c7947" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">A.</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">[Reserved]</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" id="z976d067010924ca1ba8393ad21716e20" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">B.</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Capitalization and Indebtedness</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 36pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb79bc7a7b2a043578633185b6d68aeff" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">C.</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Reasons for the Offer and Use of Proceeds</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 36pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" border="0" id="z77d471fcdcda4933a97e7a3cce602b04" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">D.</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Risk Factors</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">Our business faces significant risks. You should
carefully consider all of the information set forth in this annual report and in our other filings with the United States Securities and
Exchange Commission (the &#8220;SEC&#8221;), including the following risk factors which we face and which are faced by our industry. Our
business, financial condition and results of operations could be materially and adversely affected by any of these risks. In that event,
the trading price of our ordinary shares would likely decline and you might lose all or part of your investment. This report also contains
forward-looking statements that involve risks and uncertainties. Our results could materially differ from those anticipated in these forward-looking
statements, as a result of certain important factors including the risks described below and elsewhere in this report and our other SEC
filings. See &#8220;Special Note Regarding Forward-Looking Statements&#8221; on page i.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">1</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Risks Related to Development, Clinical Testing and Regulatory Approval</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Product development is a lengthy and expensive
process, with an uncertain outcome.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We intend to develop and commercialize pipeline product candidates
based on our patented enzymatic technology platform for (i) marketing authorization of EscharEx in the U.S. and other jurisdictions, (ii)
NexoBrid in the U.S. for children and for all ages in other jurisdictions and (iii) our other pipeline products in variety of jurisdictions
across the world. However, before obtaining regulatory approval for the sale of our pipeline product candidates in any jurisdiction, we
must conduct, at our own expense, clinical studies to demonstrate that the products are safe and effective.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Preclinical and clinical testing is expensive, is difficult to
design and implement, can take many years to complete and is uncertain as to outcome. A failure of one or more of our clinical trials
can occur at any stage of testing. We may experience numerous unforeseen events during, or as a result of, preclinical testing and the
clinical trial process. Even if preclinical or clinical trials are successful, we still may be unable to commercialize the product, as
success in preclinical trials, clinical trials or previous clinical trials does not ensure that later clinical trials will be successful.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">A number of events could delay or prevent our ability to complete
necessary clinical trials for our pipeline product candidates, including:</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zf3e07c4b2bc8423e8a9b6193f68b63b3" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">regulators may not authorize us to conduct a clinical trial within a country or at
        a prospective trial site or may require us to change the design of a study;&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">delays may occur in reaching agreement on acceptable clinical trial terms with regulatory
        authorities or prospective sites, or obtaining institutional review board or ethics committee approval or opinion;&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">our preclinical tests or clinical trials may produce negative or inconclusive results,
        and we may decide, or regulators may require us, to conduct additional trials or to abandon strategic projects;&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the number of patients required for our clinical trials may be larger than we anticipate,
        enrollment in our clinical trials may be slower or more difficult than we expect, or patients may not participate in necessary follow-up
        visits to obtain required data, any of which would result in significant delays in our clinical testing process;&#160;</div>
        <div style="text-align: justify; line-height: 1.25"> <br/> </div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">our third-party contractors, such as a research institute, may fail to comply with
        regulatory requirements or meet their contractual obligations to us. For example, due to a deviation associated with a third-party testing
        lab used during the manufacturing process, our commercial partner in the U.S., Vericel, was unable to release NexoBrid in into the commercial
        channel until an agreement with the FDA on this matter, resulting a delay of few month in the launch of NexoBrid in the U.S.;&#160;</div>
        <div style="text-align: justify; line-height: 1.25"> <br/> </div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">we may be forced to suspend or terminate our clinical trials if the participants are
        being exposed, or are thought to be exposed, to unacceptable health risks or if any participant experiences an unexpected serious adverse
        event;&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">regulators or institutional review boards may require that we hold, suspend or terminate
        clinical research for various reasons, including noncompliance with regulatory requirements;&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">undetected or concealed fraudulent activity by a clinical researcher, if discovered,
        could preclude the submission of clinical data prepared by that researcher, lead to the suspension or substantive scientific review of
        one or more of our marketing applications by regulatory agencies, and result in the recall of any approved product distributed pursuant
        to data determined to be fraudulent;&#160;</div>
        <div style="text-align: justify; line-height: 1.25"> <br/> </div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the cost of our clinical trials may be greater than we anticipate;&#160;</div> </td>
        </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">an audit of preclinical or clinical studies by regulatory authorities may reveal noncompliance
        with applicable protocols or regulations, which could lead to disqualification of the results and the need to perform additional studies;&#160;</div>
        </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">political unrest and wars, such as the war in Gaza and the conflict between Russia
        and Ukraine, which could delay or disrupt business activity, and if such political unrest escalates or spills over to or otherwise impacts
        additional regions, it could also heighten many of the other risk factors described in this Annual Report;&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">delays may occur in obtaining our clinical materials; and&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">epidemics or pandemics, such as the COVID-19 pandemic, which can affect the overall
        healthcare infrastructure, including the ability to recruit patients, the ability to conduct studies at medical sites and the pace with
        which governmental agencies, such as the FDA and foreign regulatory authorities, will review and approve regulatory submissions.&#160;</div>
        </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Moreover, we do not know whether preclinical tests or clinical
trials will begin or be completed as planned or will need to be restructured. Significant delays could also shorten the patent protection
period during which we may have the exclusive right to commercialize our pipeline product candidates or could allow our competitors to
bring products to the market before we do, impairing our ability to commercialize our pipeline product candidates.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">2</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Development and commercialization of EscharEx
and NexoBrid for pediatric use in the United States as well as our pipeline product candidates worldwide requires successful completion
of the regulatory approval process, which may suffer delays or fail.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In the United States, as well as other jurisdictions, we are required
to apply for and receive marketing authorization before we can market our products, as we have already received for NexoBrid in the United
States, the European Union (&#8220;EU&#8221;) and other international markets. This process can be time-consuming and complicated and
may result in unanticipated delays. To secure marketing authorization, an applicant generally is required to submit an application that
includes the data supporting preclinical and clinical safety and efficacy as well as detailed information on the manufacturing and control
of the product, proposed labeling and other information. Before marketing authorization is granted, regulatory authorities generally require
the inspection of the manufacturing facility or facilities and quality systems (including those of third parties) at which the product
candidate is manufactured and tested, to assess compliance with strictly enforced current good manufacturing practices (&#8220;cGMP&#8221;)
and similar foreign requirements such as Good Manufacturing Practices (&#8220;GMP&#8221;) in the EU, as well as potential audits of the
non-clinical and clinical trial sites that generated the data cited in the marketing authorization application to assess compliance with
requisite good clinical practices (&#8220;GCP&#8221;).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We cannot predict how long the applicable regulatory authority
or agency will take to grant marketing authorization or whether any such authorizations will ultimately be granted. Regulatory agencies,
including the FDA and the European Medicines Agency (the &#8220;EMA&#8221;), have substantial discretion in the approval process, and
the approval process and the requirements governing clinical trials vary from country to country. The policies of the FDA, the EMA or
other regulatory authorities may change or may not be explicit, and additional government regulations may be enacted that could prevent,
limit or delay regulatory approval of EscharEx, NexoBrid or our pipeline product candidates. For instance, the regulatory landscape related
to clinical trials in the EU recently evolved. The EU Clinical Trials Regulation (&#8220;CTR&#8221;) which was adopted in April 2014 and
repeals the EU Clinical Trials Directive, became applicable on January 31, 2022. While the EU Clinical Trials Directive required a separate
clinical trial application (&#8220;CTA&#8221;) to be submitted in each member state in which the clinical trial takes place, to both the
competent national health authority and an independent ethics committee, the CTR introduces a centralized process and only requires the
submission of a single application for multi-center trials. The CTR allows sponsors to make a single submission to both the competent
authority and an ethics committee in each member state, leading to a single decision per member state. The assessment procedure of the
CTA has been harmonized as well, including a joint assessment by all member states concerned, and a separate assessment by each member
state with respect to specific requirements related to its own territory, including ethics rules. Each member state&#8217;s decision is
communicated to the sponsor via the centralized EU portal. Once the CTA is approved, clinical study development may proceed. The CTR foresees
a three-year transition period. The extent to which ongoing and new clinical trials will be governed by the CTR varies. Clinical trials
for which an application was submitted (i) prior to January 31, 2022 under the EU Clinical Trials Directive, or (ii) between January 31,
2022 and January 31, 2023 and for which the sponsor has opted for the application of the EU Clinical Trials Directive remain governed
by said Directive until January 31, 2025. After this date, all clinical trials (including those which are ongoing) will become subject
to the provisions of the CTR. Compliance with the CTR requirements may impact our development plans. It is currently unclear to what extent
the United Kingdom (&#8220;UK&#8221;) will seek to align its regulations with the EU. The UK regulatory framework in relation to clinical
trials is derived from existing EU legislation (as implemented into UK law, through secondary legislation). On January 17, 2022, the UK
Medicines and Healthcare products Regulatory Agency (&#8220;MHRA&#8221;) launched an eight-week consultation on reframing the UK legislation
for clinical, which aims to streamline clinical trials approvals, enable innovation, enhance clinical trials transparency, enable greater
risk proportionality, and promote patient and public involvement in clinical trials. The MHRA published its consultation outcome on March
21, 2023 in which it confirmed that it would update the existing legislation. The resulting legislative changes will ultimately determine
the extent to which the UK regulations align with the CTR. A decision by the UK not to closely align its regulations with the new approach
that has been adopted in the EU may have an effect on the cost of conducting clinical trials in the UK as opposed to other countries.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">3</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Additionally, the EU pharmaceutical legislation is currently undergoing
a complete review process, in the context of the Pharmaceutical Strategy for Europe initiative, launched by the European Commission in
November 2020. The European Commission&#8217;s proposal for revision of several legislative instruments related to medicinal products
(potentially reducing the duration of regulatory data protection, revising the eligibility for expedited pathways, etc.) was published
on April 26, 2023. The proposed revisions, remain to be agreed and adopted by the European Parliament and European Council and the proposals
may, however, therefore be substantially revised before adoption, which is not anticipated before early 2026. The revisions may have a
significant impact on the biopharmaceutical industry in the long term. If we are slow or unable to adapt to changes in existing requirements
or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing authorization
that we may have obtained and we may not achieve or sustain profitability. We also cannot predict the likelihood, nature or extent of
government regulation that may arise from future legislation or administrative or executive action, either in the United States or abroad.
If such actions impose constraints on the FDA&#8217;s ability to engage in oversight and implementation activities in the normal course,
or if we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are
unable to maintain regulatory compliance, we may be subject to enforcement action and our business may be negatively impacted.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, any regulatory approval that we will receive may also
contain requirements for potentially costly post-marketing testing, including Phase IV clinical trials, and surveillance to monitor the
safety and efficacy of the product candidate. For example, as part of the EMA regulatory approval process, we agreed to provide further
data from a post-marketing U.S. Phase III clinical trial of NexoBrid, which serves to address this post-marketing commitment to EMA. Once
a product is approved, the manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage, advertising,
promotion, import, export and recordkeeping for the product will be subject to extensive and ongoing regulatory requirements. These requirements
include submission of safety and other post-marketing information and reports, registration and continued compliance with cGMP and similar
foreign requirements and GCP for any clinical trials that we conduct post-approval. Although our manufacturing facility is cGMP-certified,
we may face difficulties in obtaining regulatory approval for the manufacturing and quality control process of our pipeline product candidates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Any delays or failures in obtaining regulatory and marketing authorization
for EscharEx in the United States, or for NexoBrid or our pipeline product candidates worldwide, would adversely affect our business,
prospects, financial condition and results of operations.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">4</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Even though the FDA has approved NexoBrid for eschar removal in
adults with deep partial thickness and/or full thickness thermal burns, we will still face extensive and ongoing regulatory requirements
and obligations for EscharEx, NexoBrid for pediatric use, and for any product candidates for which we obtain approval.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Any regulatory approvals that we have received for NexoBrid and
may receive for NexoBrid, EscharEx or any of our product candidates will require the submission of reports to regulatory authorities and
surveillance to monitor the safety and efficacy of the product, may contain significant limitations related to use restrictions for specified
age groups, warnings, precautions or contraindications, and may include burdensome post-approval study or risk management requirements.
For example, the FDA-approved label for NexoBrid includes certain warnings and precautions regarding hypersensitivity reactions, pain
management, proteolytic injury to non-target tissue and coagulopathy.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, the manufacturing processes, labeling, packaging,
distribution, adverse event reporting, storage, advertising, promotion, import, export and recordkeeping for NexoBrid are and will remain
subject to extensive and ongoing regulatory requirements. These requirements include submissions of safety and other post-marketing information
and reports, registration, as well as on-going compliance with cGMPs, and GCPs for any clinical trials that we conduct post-approval.
In addition, manufacturers of drug products and their facilities are subject to continual review and periodic, unannounced inspections
by the FDA and other regulatory authorities for compliance with cGMP regulations and standards. If we or a regulatory authority discover
previously unknown problems with a product, such as adverse events of unanticipated severity or frequency, or problems with the facilities
where the product is manufactured, a regulatory authority may impose restrictions on that product, the manufacturing facility or us, including
requiring recall or withdrawal of the product from the market or suspension of manufacturing.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, later discovery of previously unknown adverse events
or other problems with our products, manufacturers or manufacturing processes or failure to comply with regulatory requirements, may yield
various results, including:</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
restrictions on manufacturing such products;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#8226; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
restrictions on the labeling or marketing of products;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#8226; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
restrictions on product manufacturing, distribution or use;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#8226; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
requirements to conduct post-marketing studies or clinical trials;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#8226; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; warning
letters or untitled letters;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#8226; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; withdrawal
of the products from the market;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#8226; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; refusal
to approve pending applications or supplements to approved applications that we submit;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#8226; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
recall of products;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#8226; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; fines,
restitution or disgorgement of profits or revenues;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#8226; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; suspension
or withdrawal of marketing authorizations;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#8226; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
refusal to permit the import or export of our products;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#8226; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; product
seizure; or</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#8226; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
injunctions or the imposition of civil or criminal penalties.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">5</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Further, the policies of the FDA and other regulatory authorities
may change, and additional government regulations may be enacted that could impose extensive and ongoing regulatory requirements and obligations
on any product candidate for which we obtain marketing authorization. We also cannot predict the likelihood, nature or extent of government
regulation that may arise from future legislation or administrative or executive action, either in the United States or abroad.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Changes in funding or disruptions at FDA and
other government agencies caused by funding shortages or global health concerns could hinder their ability to hire and retain key leadership
and other personnel, or otherwise prevent new or modified products from being developed, approved or commercialized in a timely manner
or at all, or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely,
which could negatively impact our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The ability of FDA and foreign regulatory authorities to review
and approve new products can be affected by a variety of factors, including government budget and funding levels, statutory, regulatory,
and policy changes, FDA&#8217;s and foreign regulatory authorities&#8217; ability to hire and retain key personnel and accept the payment
of user fees, and other events that may otherwise affect FDA&#8217;s and foreign regulatory authorities&#8217; ability to perform routine
functions. Average review times at the FDA and foreign regulatory authorities have fluctuated in recent years as a result. In addition,
government funding of other government agencies that fund research and development activities is subject to the political process, which
is inherently fluid and unpredictable. Disruptions at FDA and other agencies such as the EMA, following its relocation to Amsterdam and
resulting staff changes, may also slow the time necessary for new drugs and biologics to be reviewed and/or approved by necessary regulatory
authorities, which would adversely affect our business. For example, over the last several years, including for 35 days beginning on December
22, 2018, the U.S. government has shut down several times and certain regulatory agencies, such as FDA, have had to furlough critical
FDA employees and stop critical activities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">Separately, in response to the COVID-19 pandemic,
the FDA postponed most inspections of domestic and foreign manufacturing facilities at various points. Even though the FDA has since resumed
standard inspection operations, the FDA has continued to monitor and implement changes to its inspectional activities to ensure the safety
of its employees and those of the firms it regulates as it adapts to the evolving COVID-19 pandemic, and any resurgence of the virus or
emergence of new variants may lead to further inspectional or administrative delays. Regulatory authorities outside the United States
have adopted similar restrictions or other policy measures in response to the COVID-19 pandemic. If a prolonged government shutdown occurs,
or if global health concerns continue to prevent FDA or other regulatory authorities&#160; from conducting their regular inspections,
reviews, or other regulatory activities, it could significantly impact the ability of FD or, other regulatory authorities&#160; to timely
review and process our regulatory submissions, which could have a material adverse effect on our business.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">NexoBrid, EscharEx or our pipeline product
candidates may cause unanticipated and undesirable side effects or have other properties, which are currently unknown to us.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">NexoBrid, EscharEx and all of our current pipeline product candidates
rely on our patented enzymatic platform technology, although their specific formulations or mode of applications may vary. Like most pharmaceutical
products, our approval labels for NexoBrid in the United States, Europe and other international markets list certain side effects. If
we or others identify previously unknown problems with NexoBrid, EscharEx or their underlying proteolytic enzymes, including adverse events
of unanticipated severity or frequency, problems with our manufacturers or manufacturing processes, or failure to comply with regulatory
requirements, the following consequences, among others, may result, including, without limitation:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2e97e1a3a01a448c8d9dd39d32f33554" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">restrictions on the marketing or manufacturing of the product, withdrawal of the product
        from the market or voluntary or mandatory product recalls;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">fines, warning letters or holds on clinical trials;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">harm to our reputation, reduced demand for our products and loss of market acceptance;</div>
        </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">refusal by the applicable regulatory authority to approve pending applications or
        supplements to approved applications filed by us, or suspension or revocation of product license approvals;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">product seizure or detention, or refusal to permit the import or export of products;
        and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">&#8226;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">injunctions or the imposition of civil or criminal penalties.</div> </td> </tr>
  </table>

<div style="text-align: justify; line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Any of these events could prevent us from achieving or maintaining
market acceptance of NexoBrid, and future market acceptance of EscharEx, our pipeline product candidates or future product candidates,
which would adversely affect our business, prospects, financial condition and results of operations.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">6</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Regulatory approval for NexoBrid, EscharEx
and other pipeline product candidates is and may be limited to specific indications and conditions for which clinical safety and efficacy
have been demonstrated, and the prescription of off-label uses could adversely affect our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The marketing authorization for NexoBrid in the European Union
and other international markets is limited to the treatment of deep partial- and full-thickness burns in adults. In the United States,
the marketing authorization for NexoBrid is limited to eschar removal in adults with deep partial thickness and/or full thickness thermal
burns. Any additional regulatory approval of NexoBrid for severe burns and any regulatory approval we may receive for any of our pipeline
product candidates in the future, would be limited to those specific indications for which such pipeline product candidate had been deemed
safe and effective by the FDA, EMA, or another regulatory authority Additionally, labeling restrictions in the U.S. and EU limit the manner
in which a product may be used. For example, NexoBrid&#8217;s label in the U.S. and EU provides that it may only be used in specialized
burns centers or by burn specialists and that it is not to be applied to more than 30% and 15% of the patient&#8217;s total body surface
area, respectively. If physicians prescribe the medication for unapproved, or &#8220;off-label,&#8221; uses or in a manner that is inconsistent
with the manufacturer&#8217;s labeling, it could produce results such as reduced efficacy or other adverse effects, and the reputation
of our products in the marketplace may suffer. In addition, should any of our future products have a significant price difference and
if they are used interchangeably, off-label uses may cause a decline in our revenues or potential revenues. Furthermore, while physicians
may choose to prescribe treatments for uses that are not described in the product&#8217;s labeling and for uses that differ from those
approved by regulatory authorities, we cannot promote the products for any indications other than those that are specifically approved
by the European Commission, the FDA or other regulatory authorities. Regulatory authorities restrict communications by companies on the
subject of off-label use. If our promotional activities fail to comply with these regulations or guidelines, we may be subject to enforcement
actions by those authorities. In the United States, &#8220;off-label promotion&#8221; by pharmaceutical companies has resulted in significant
litigation under the Federal False Claims Act, violations of which may result in substantial civil penalties and fines as well as exclusion
from government health care programs. More generally, failure to follow the rules and guidelines of regulatory agencies relating to promotion
and advertising, such as that promotional materials not be false or misleading, can result in refusal to approve a product, the suspension
or withdrawal of an approved product from the market, product recalls, fines, disgorgement of money, operating restrictions, injunctions
or criminal prosecution<span style="font-weight: bold; font-style: italic">.</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Risks Related to Manufacturing</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We may not be able to expand our production
or processing capabilities or satisfy future demand.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our global demand for NexoBrid surpasses the current manufacturing
capabilities. We are currently seeking to expand our manufacturing capabilities in order to increase our capacity to manufacture NexoBrid
and future product candidates and satisfy near term demand. The new GMP-compliant state-of-the-art manufacturing facility is projected
to be completed by mid-2024, with full-scale manufacturing currently expected to commence in 2025. However, we cannot guarantee that we
will be able to obtain the requisite approvals, including meeting regulatory and quality requirements, or if we do, that the facility
will satisfy additional growing demand. Conversely, there can be no assurance that even if we obtain a new facility, demand for our products
will increase proportionately to the increased production capability. Furthermore, we cannot assure that this or similar projects will
be implemented in a timely and cost-efficient manner, and that our current production will not be adversely affected by the operational
challenges of implementing the expansion project.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">7</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">If our manufacturing facility in Yavne, Israel
was to suffer a serious accident, or if a force majeure event were to materially affect our ability to operate and produce NexoBrid, EscharEx
and our pipeline product candidates, all of our manufacturing capacity could be shut down for an extended period.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">We currently rely on a single manufacturing facility
in Yavne, Israel, and we expect that all of our revenues in the near future will be derived from products manufactured at this facility.
If this facility were to suffer an accident or a force majeure event such as war, missile or terrorist attack, earthquake, major fire
or explosion, major equipment failure or power failure lasting beyond the capabilities of our backup generators or similar event, our
revenues would be materially adversely affected and any of our clinical trials could be materially delayed. In this situation, our manufacturing
capacity could be shut down for an extended period, we could experience a loss of raw materials, work in process or finished goods inventory
and our ability to operate our business would be harmed. In addition, in any such event, the reconstruction of our manufacturing facility
and storage facilities, and obtaining regulatory approval for the new facilities could be time-consuming. During this period, we would
be unable to manufacture NexoBrid or our pipeline product candidates. In addition, we currently have a limited inventory of NexoBrid that
we can supply to our customers if we are unable to further manufacture NexoBrid.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">

<div style="line-height: 1.25; font-family: Times New Roman, serif; font-style: italic; font-weight: bold">We are subject to a number
of other manufacturing risks, any of which could substantially increase our costs and limit the supply of NexoBrid, EscharEx and our pipeline
product candidates.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The process of manufacturing NexoBrid, EscharEx and our pipeline
product candidates is complex, highly regulated and subject to the risk of product loss due to contamination, equipment failure or improper
installation or operation of equipment, or vendor or operator error. Even minor deviations from normal manufacturing processes or quality
requirements for our products could result in reduced production yields, product defects and other supply disruptions. If microbial, viral
or other contaminations are discovered in NexoBrid, EscharEx or our pipeline product candidates or in the manufacturing facilities in
which NexoBrid, EscharEx or our pipeline product candidates are or will be made, such manufacturing facilities may need to be closed to
investigate and remedy the contamination.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We may experience any contaminations, major equipment failures,
or other similar manufacturing problems of such magnitude, any adverse developments affecting manufacturing operations for NexoBrid, EscharEx
or our pipeline product candidates which may result in additional shipment delays, inventory shortages, lot failures, withdrawals or recalls,
or other interruptions in the supply of NexoBrid, EscharEx or our pipeline product candidates. We may also have to take inventory write-offs
and incur other charges and expenses for our products that fail to meet specifications, undertake costly remediation efforts, or seek
costlier manufacturing alternatives.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Our ability to continue manufacturing and distributing
our products depends on our continued adherence to cGMP regulations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The manufacturing processes for our products are governed by detailed
cGMP and similar foreign regulations, both for our marketed products in the EU and the U.S. and product candidates in clinical testing
in the U.S., EU and Israel. Failure by our manufacturing and quality operations unit to adhere to established regulations or to meet a
specification or procedure set forth in cGMP and similar foreign requirements could require that a product or material be rejected and
destroyed. Our adherence to cGMP and similar foreign regulations and the effectiveness of our quality control systems are periodically
assessed through inspections of our manufacturing facility by regulatory authorities. Such inspections could result in deficiency citations,
which would require us to take action to correct those deficiencies to the satisfaction of the applicable regulatory authorities. If critical
deficiencies are noted or if we are unable to prevent recurrences, we may have to recall products or suspend operations until appropriate
measures can be implemented. Since cGMP and similar foreign regulations reflect ever-evolving standards, we need to regularly update our
manufacturing processes and procedures to comply with cGMP and similar foreign regulations. These changes may cause us to incur additional
costs and may adversely impact our profitability. For example, more sensitive testing assays (if and when they become available, or due
to the discontinuation of the availability of the disposables currently used in production) may be required, or existing procedures or
processes may require revalidation, all of which may be costly and time-consuming and could delay or prevent the manufacturing of NexoBrid
or launch of a new product.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">8</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We depend on a sole supplier to obtain our
intermediate drug substance, bromelain SP, which is necessary for the production of our products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We currently procure bromelain SP, a key substance starting material
in the manufacturing of NexoBrid, EscharEx and our pipeline product candidates, from a single supplier, Challenge Bioproducts Corporation
Ltd. (&#8220;CBC&#8221;). CBC&#8217;s manufacturing facilities are located in the Republic of China and it uses proprietary methods to
manufacture bromelain SP. Our supply agreement with CBC has no fixed expiration date and can be voluntarily terminated by us, with at
least six months&#8217; advance written notice, or by CBC, with at least 24 months&#8217; advance written notice. Although we have a contractual
right to procure this material from other suppliers, subject to payment of a one-time, non-material licensing fee to CBC, procuring this
material from any other source would require time and effort which may interrupt our supply of bromelain SP and may cause an interruption
of the supply of NexoBrid, EscharEx and our pipeline product candidates to the marketplace and for future clinical trials or other development
purposes. Regulatory authorities could require that we conduct additional studies in support of a new supplier, which could result in
significant additional costs or delays. Furthermore, there can be no assurance that we would be able to procure alternative supplies of
bromelain SP at all or at comparable quality or competitive prices or upon fair and reasonable contractual terms and conditions. Although
we believe that we currently store sufficient inventory of bromelain SP in our warehouse and CBC warehouse to continue full capacity operations
for non-EU markets for approximately two years, this inventory may prove insufficient, and any interruption or failure to source additional
bromelain SP from CBC or other third parties in a timely manner, or at all, would adversely affect our business, prospects, financial
condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, we rely on CBC to successfully scale-up its CBC&#8217;s
manufacturing facilities in order to meet future demand of our products pipelines. If CBC will not be able to obtain the requisite approvals,
including meeting regulatory and quality requirements or will not be able to scale-up its manufacturing facility in a timely manner, then
we may not be able to satisfy demand for our future products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Our sole supplier of intermediate drug substance,
bromelain SP, is located in Taiwan, which exposes us to risks that harm our ability to manufacture NexoBrid, EscharEx and our pipeline
product candidates and substantially harm our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The manufacturing facilities of CBC, our sole supplier of bromelain
SP, a key substance as starting material in the manufacturing of NexoBrid, EscharEx and our pipeline product candidates, are located in
Taiwan.<span style="font-weight: bold; font-style: italic">&#160;</span>We believe one of the most significant risks associated with these
facilities being located in Taiwan is the risk that production may be interrupted or limited due to strains on the local infrastructure.
In addition, facilities located in Taiwan may be adversely affected by tensions, hostilities or trade disputes involving China, the United
States or other countries. There is considerable potential political instability in Taiwan<span style="font-weight: bold; font-style: italic">&#160;</span>related
to its disputes with China. Although we do not do business in North Korea, any future increase<span style="font-weight: bold; font-style: italic">&#160;</span>in
tensions between South Korea and North Korea, such as an outbreak or escalation of military<span style="font-weight: bold; font-style: italic">&#160;</span>hostilities,
or between Taiwan and China could materially adversely affect our operations in Asia or the<span style="font-weight: bold; font-style: italic">&#160;</span>global
economy, which in turn may seriously harm our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, if CBC experiences any closures and labor shortages
as a result of rising tensions between the People&#8217;s Republic of China and Taiwan, we may face difficulty sourcing bromelain SP,
which could negatively affect our revenues.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">9</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Risks Related to Commercialization</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Our revenue growth depends initially on our
ability to commercialize NexoBrid.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We currently have a marketing authorization in the United States,
the European Economic Area (&#8220;EEA&#8221;) (which consists of the 27 EU member states plus Norway, Liechtenstein, Switzerland and
Iceland), U.K., Israel, Russia, Ukraine, South Korea, Taiwan, United Arab Emirates Eurasian countries, Japan and India for a single product,
NexoBrid for eschar removal in adults with deep partial thickness and/or full thickness thermal burns, which we refer to as severe burns.
We are currently relying, for a significant portion of our revenues from sales of products, on sales of NexoBrid in the U.S., Europe and
in other international markets for the treatment of severe burns. We anticipate that, for at least the next several years, our ability
to generate revenues and become profitable will depend on the commercial success of NexoBrid in these markets, the procurement of the
Biomedical Advanced Research and Development Authority (&#8220;BARDA&#8221;) as well as successful launches in new markets such as the
U.S. and Japan.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">The commercialization success of NexoBrid in
the U.S. is dependent on the actions of our partner Vericel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">On May 6, 2019, we entered into an exclusive license and supply agreements with Vericel
Corporation (&#8221;Vericel&#8221;) to commercialize NexoBrid in all countries of North America (the &#8220;Vericel License Agreement&#8221;).
In accordance with the Vericel License Agreement, Vericel paid us $17.5 million in cash as an upfront payment at the execution of the
Vericel License Agreement and an additional milestone payment of $7.5 million upon the achievement of BLA approval for NexoBrid. Vericel
is obligated to pay us up to $125 million, in the aggregate, upon attainment of certain sales milestones. Vericel is also obligated to
pay us tiered royalties on net sales of NexoBrid ranging from mid-high single-digit to mid-teen percentages, subject to certain customary
reductions, as well as a percentage of gross profits on committed purchases by BARDA and a royalty on additional sales to BARDA. The success
of our business depends largely on Vericel's success in commercializing NexoBrid. If Vericel does not succeed in launching and commercializing
NexoBrid in the U.S. or does not comply with the terms of our agreement, and as a result a dispute between us and Vericel arises, our
ability to generate revenues from NexoBrid will be substantially harmed.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We are dependent on our contract with BARDA
and/or MTEC/DOD to procure from us NexoBrid or to fund our development activities for NexoBrid for field use in the United States. If
these contracts will be suspend or terminate their procurement obligation of NexoBrid it will adversely impact our future revenues.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In September 2015, we were awarded the first BARDA Contract for
treatment of thermal burn injuries. This contract was amended several times over the years to extend its term until September 2024 (the
Company is pursuing an extension of the contract) and its aggregate amount which was awarded to $165 million as of the end of 2022. In
March 2023 BARDA expanded its awarded contract by providing supplemental funding of $10 million to support a $3 million replenishment
of expired product previously procured for emergency preparedness, the pediatric indication sBLA submission to the FDA, and enrollment
of an additional 50 patients in the expanded access treatment protocol (NEXT) (collectively the "First BARDA Contract").</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The First BARDA Contract provided funding and technical support
for the pivotal U.S. Phase 3 clinical study (DETECT), the randomized, controlled pivotal clinical trial for use in the pediatric population
(CIDS), the marketing approval registration process for NexoBrid as well as its procurement and availability under the expanded access
treatment protocol (NEXT) in the U.S.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, Times, serif">The total amount of the First BARDA Contract
is comprised of up to $110 million to support research and development activities and up to $65 million to procure NexoBrid for U.S. emergency
preparedness.</div>

<div style="line-height: 1.25">&#160;</div> </div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As of December 31, 2023, the Company has received approximately
$88 million in funding in the aggregate, under the First BARDA Contract, and an additional $16.5 million for procurement of NexoBrid for
U.S. emergency preparedness.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In Addition, In February, 2023, the Company was entered in to a
contract with the U.S. Department of Defense (DOD), through the Medical Technology Enterprise Consortium (MTEC), to develop NexoBrid as
a non-surgical solution for field-care burn treatment for the U.S. Army. The contract provided funding up to $2.7 million. During 2023,
the DOD through MTEC and directly through MTEC awarded the Company additional funding of $10.3 million to advance the development of a
new temperature stable formulation of NexoBrid.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25">

<div style="text-indent: 35.45pt; line-height: 1.25; font-family: Times New Roman, serif">

<div style="text-indent: 35.45pt; line-height: 1.25; font-family: Times New Roman, Times, serif">However, BARDA and/or MTEC/DOD may terminate
the contract at any time, at its convenience, without any further funding obligations. There can be no assurances that BARDA and/or MTEC/DOD
will not terminate the contract. Changes in government budgets and agendas may result in a decreased and de-prioritized emphasis on supporting
the development of NexoBrid for field use. Any reduction or delay in MTEC/DOD funding may force us to suspend the program or seek alternative
funding, which may not be available on non-dilutive terms, terms favorable to us or at all. Further, we cannot provide any assurances
as to when or whether BARDA's to further fund $48.5 million (which includes $3 million allocated for replenishing of expired product,
which was a part of the supplemental funding in March 2023) for additional procurement of NexoBrid will be exercised.</div>

<div style="line-height: 1.25">&#160;</div> </div> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">10</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">The commercial success of NexoBrid, EscharEx
and our pipeline product candidates will depend upon their degree of market acceptance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">NexoBrid, EscharEx and our pipeline product candidates may not
gain market acceptance by physicians and their teams, healthcare payors, patients and others in the medical community. Although many physicians
in burn centers throughout Europe, the United States and other international markets have used NexoBrid for severe burns as part of our
clinical trials or since NexoBrid&#8217;s commercial launch in Europe, and other international markets, we cannot guarantee that use of
NexoBrid will be accepted in the market. We need to successfully integrate NexoBrid into the overall treatment of burns in burn centers.
If NexoBrid, EscharEx and our pipeline product candidates do not achieve an adequate level of acceptance, we may not generate revenue
and we may not achieve or sustain profitability. The degree of market acceptance of NexoBrid in U.S., Europe and in other international
countries where we receive marketing authorization, and of EscharEx and our pipeline product candidates, will depend on a number of factors,
some of which are beyond our control, including:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z32fbc9ae02fa4843aee1c5e15aa1574f" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><br/> &#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the willingness of physicians, burn care teams and hospital administrators to administer
        our products and the acceptance of our products as part of the medical department routine;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the consent of hospitals to fund/purchase NexoBrid or obtain third-party coverage
        or reimbursement for our products;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the ability to offer NexoBrid, EscharEx and our pipeline product candidates for sale
        at an attractive value;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the efficacy and potential advantages of NexoBrid, EscharEx and our pipeline product
        candidates relative to current standard of care;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><br/> &#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the prevalence and severity of any side effects; and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the efficacy, potential advantages and timing of introduction to the market of alternative
        treatments.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Failure to achieve market acceptance for NexoBrid, EscharEx or
any of our pipeline product candidates, if and when they are approved for commercial sale, will have a material adverse effect on our
business, financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We may be unsuccessful in commercializing our
products due to unfavorable pricing regulations or third-party coverage and reimbursement policies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We cannot predict the pricing and reimbursement of NexoBrid, EscharEx
or our pipeline product candidates. The regulations that govern marketing authorizations, pricing and reimbursement for new products vary
widely from country to country, among regions within some countries and among some hospitals. In some foreign jurisdictions, including
the EU, the pricing of prescription pharmaceuticals is subject to governmental control. In other countries, coverage negotiations must
occur at the regional or hospital level in order to be included in the hospital formulary. Pricing negotiations with governmental authorities
at the regional or hospital level can take considerable time after the receipt of marketing authorization for a product candidate. Additionally,
while we are executing a country-specific market access strategy, which includes pricing and/or reimbursement targets for NexoBrid in
most of Europe, we cannot guarantee that we will receive favorable hospital, regional or national funding or pricing and reimbursement.
As a result, even after obtaining regulatory approval for a product in a particular country, we may be subject to price regulations or
denied or limited by reimbursement or formulary inclusion, which may delay or limit our commercial launch of the product and negatively
impact the revenue we are able to generate from the sale of the product in that country. Adverse pricing limitations may hinder our ability
to recoup our investment in NexoBrid, EscharEx or our pipeline product candidates, even after obtaining regulatory approval.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Additionally, we cannot be sure that coverage and reimbursement
will be available for NexoBrid, EscharEx or any pipeline product candidate that we commercialize in the future, and, if reimbursement
is available, whether the level of reimbursement will be adequate. Coverage and reimbursement may affect the demand for, the price of,
or the budget allocated for reimbursement for any product for which we obtain marketing authorization. Obtaining coverage and adequate
reimbursement for our products may be particularly difficult because of the higher prices often associated with products administered
under the supervision of a physician. If coverage and reimbursement are not available or are available only at limited levels, we may
not be able to successfully commercialize NexoBrid, EscharEx or any pipeline product candidate that we successfully develop. Eligibility
for reimbursement does not guarantee that any product will be paid for in all cases or at a rate that covers our costs. Interim payments
for new products, if applicable, may also not be sufficient to cover our costs and may not be made permanent. Payment rates may vary according
to the use of the product and the clinical setting in which it is used, may be based on payments allowed for lower cost products that
are already reimbursed and may be incorporated into existing payments for other services. Net prices for products may be reduced by mandatory
discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently
restrict imports of products from countries where they may be sold at lower prices than in certain other countries, such as the United
States. In the United States, third-party payors often rely on the coverage policies and payment limitations imposed by Medicare and other
government payors, in setting their own coverage policies and reimbursement rates. Our inability to promptly obtain coverage and profitable
payment rates from hospital budget, government-funded and private payors for NexoBrid, EscharEx or any pipeline product candidate could
have a material adverse effect on our operating results, our ability to raise capital needed to commercialize products and our overall
financial condition.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">11</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Recently enacted and future legislation in
the United States may increase the difficulty and cost for us to commercialize NexoBrid and seek marketing authorizations for and, if
approved, commercialize EscharEx and our pipeline product candidates in the United States and in foreign jurisdictions and affect the
prices at which our products may be sold.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The United States and several other jurisdictions are considering,
or have already enacted, a number of legislative and regulatory proposals to change the healthcare system in ways that may affect the
ability to sell NexoBrid, EscharEx or any of our pipeline product candidates profitably, if approved. We cannot predict the initiatives
that may be adopted in the future. The continuing efforts of hospitals, governments, insurance companies, managed care organizations and
other payors of healthcare services to contain or reduce costs of healthcare may adversely affect:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z488a6c069d004531a1b973e6e59a97ba" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the market acceptance or demand for NexoBrid, EscharEx or any of our pipeline product
        candidates, if approved;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the ability to set a price that we believe is fair for NexoBrid, EscharEx or any of
        our pipeline product candidates, if approved;</div>
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">our ability to generate revenues and achieve or maintain profitability;</div> </td>
        </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the level of taxes that we are required to pay; and</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="text-align: justify; line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="text-align: justify; line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">&#160;the availability of capital.&#160;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; Among policy makers and payors in the United States
and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare
costs, improving quality and/or expanding access. In the United States, the pharmaceutical industry has been a particular focus of these
efforts and has been significantly affected by major legislative initiatives. In March 2010, the Patient Protection and Affordable Care
Act, as amended by the Health Care and Education Reconciliation Act, or collectively, the Affordable Care Act(the &#8220;ACA&#8221;) was
signed into law and intended to broaden access to health insurance, reduce or constrain the growth of healthcare spending, enhance remedies
against fraud and abuse, add new transparency requirements for the healthcare and health insurance industries, impose new taxes and fees
on the health industry and impose additional health policy reforms.</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Among the provisions of the ACA of importance to our potential
product candidates are the following:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9f49c6bd08114c1996dce41fc5f3d97e" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">an annual, nondeductible fee on any entity that manufactures or imports certain branded
        prescription drugs and biologic agents, apportioned among these entities according to their market share in certain government healthcare
        programs;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">an increase in the statutory minimum rebates a manufacturer must pay under the Medicaid
        Drug Rebate Program to 23.1% and 13.0% of the average manufacturer price for branded and generic drugs, respectively;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">addressed a new methodology by which rebates owed by manufacturers under the Medicaid
        Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">a new Medicare Part D coverage gap discount program, in which manufacturers must agree
        to offer 70% point-of-sale discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap
        period, as a condition for the manufacturer&#8217;s outpatient drugs to be covered under Medicare Part D;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">extension of manufacturers&#8217; Medicaid rebate liability to covered drugs dispensed
        to individuals who are enrolled in Medicaid managed care organizations;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><br/> <span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">expansion of eligibility criteria for Medicaid programs by, among other things, allowing
        states to offer Medicaid coverage to additional individuals and by adding new mandatory eligibility categories for certain individuals
        with income at or below 133% of the Federal Poverty Level, thereby potentially increasing manufacturers&#8217; Medicaid rebate liability;</div>
        </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">expansion of the entities eligible for discounts under the Public Health Service pharmaceutical
        pricing program;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><br/> &#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">a new requirement to annually report drug samples that manufacturers and distributors
        provide to physicians; and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="line-height: 1.25">a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative
        clinical effectiveness research.&#160;</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">12</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Since its enactment, there have been judicial, executive and congressional
challenges to certain aspects of the ACA. On June 17, 2021, the U.S. Supreme Court dismissed the most recent judicial challenge to the
ACA brought by several states without specifically ruling on the constitutionality of the ACA. Thus, the ACA will remain in effect in
its current form. Further, prior to the U.S. Supreme Court ruling, President Biden issued an executive order that initiated a special
enrollment period for purposes of obtaining health insurance coverage through the ACA marketplace from February 15, 2021 through August
15, 2021. The executive order instructed certain governmental agencies to review and reconsider their existing policies and rules that
limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work
requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, other legislative changes have been proposed and adopted
since the Affordable Care Act was enacted. These changes included aggregate reductions to Medicare payments to providers, which went into
effect in April 2013 and, due to subsequent legislative amendments, will stay in effect through 2031, with the exception of a temporary
suspension from May 1, 2020 through March 31, 2022, unless additional Congressional action is taken. In January 2013, the American Taxpayer
Relief Act of 2012 was signed into law, which, among other things, further reduced Medicare payments to several providers, and increased
the statute of limitations period for the government to recover overpayments to providers from three to five years. These laws may result
in additional reductions in Medicare and other healthcare funding, which could negatively impact the market for NexoBrid, EscharEx and
our other product candidates, if approved, and, accordingly, our financial operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">There has been heightened governmental scrutiny recently over the
manner in which drug manufacturers set prices for their marketed products, which have resulted in several Congressional inquiries and
proposed bills designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and
manufacturer patient programs, and reform government program reimbursement methodologies for drug products. In March 2021, the American
Rescue Plan Act of 2021 was signed into law, which eliminates the statutory Medicaid drug rebate cap for single source and innovator multiple
source drugs, beginning January 1, 2024. The rebate was previously capped at 100% of a drug&#8217;s average manufacturer price, In August
2022, the Inflation Reduction Act of 2022, or IRA, was signed into law. Among other things, the IRA requires manufacturers of certain
drugs to engage in price negotiations with Medicare (beginning in 2026), with prices that can be negotiated subject to a cap; imposes
rebates under Medicare Part B and Medicare Part D to penalize price increases that outpace inflation (first due in 2023); and replaces
the Part D coverage gap discount program with a new discounting program (beginning in 2025). The IRA permits the Secretary of the Department
of Health and Human Services to implement many of these provisions through guidance, as opposed to regulation, for the initial years.
On August 29, 2023, HHS announced the list of the first ten drugs that will be subject to price negotiations, although the drug price
negotiation program is currently subject to legal challenges. For that and other reasons, it is currently unclear how the IRA will be
effectuated, or the impact of the IRA on our business. At the state level, legislatures have increasingly passed legislation and implemented
regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts,
restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage
importation from other countries and bulk purchasing.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">13</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We expect that other possible healthcare reform measures may result
in additional reductions in Medicare and other healthcare funding, more rigorous coverage criteria, new payment methodologies and additional
downward pressure on the price that we receive for any approved product. Any reduction in reimbursement from Medicare or other government
programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare
reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our drugs. Legislative and regulatory
proposals have been made to expand post-approval requirements and restrict sales and promotional activities for drugs. We cannot be sure
whether additional legislative changes will be enacted, or whether the FDA or comparable regulations, guidance or interpretations will
be changed, or what the impact of such changes on the marketing authorizations of our product candidates, if any, may be. In addition,
increased scrutiny by the U.S. Congress of the FDA&#8217;s approval process may significantly delay or prevent marketing authorization,
as well as subject us to more stringent product labeling and post-marketing testing and other requirements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In the EU, similar developments may affect our ability to profitably
commercialize our product candidates, if approved. In addition to continuing pressure on prices and cost containment measures, legislative
developments at the EU or member state level may result in significant additional requirements or obstacles that may increase our operating
costs. The delivery of healthcare in the EU, including the establishment and operation of health services and the pricing and reimbursement
of medicines, is almost exclusively a matter for national, rather than EU, law and policy. National governments and health service providers
have different priorities and approaches to the delivery of health care and the pricing and reimbursement of products in that context.
In general, however, the healthcare budgetary constraints in most EU member states have resulted in restrictions on the pricing and reimbursement
of medicines by relevant health service providers. Coupled with ever-increasing EU and national regulatory burdens on those wishing to
develop and market products, this could prevent or delay marketing authorization of our product candidates, restrict or regulate post-approval
activities and affect our ability to commercialize our product candidates, if approved. In markets outside of the United States and EU,
reimbursement and healthcare payment systems vary significantly by country, and many countries have instituted price ceilings on specific
products and therapies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In December 2021, Regulation No 2021/2282 on Health Technology
Assessment (&#8220;HTA&#8221;) amending Directive 2011/24/EU, was adopted. This regulation which entered into force in January 2022 intends
to boost cooperation among EU member states in assessing health technologies, including new medicinal products, and providing the basis
for cooperation at the EU level for joint clinical assessments in these areas. The regulation foresees a three-year transitional period
and will permit EU member states to use common HTA tools, methodologies, and procedures across the EU, working together in four main areas,
including joint clinical assessment of the innovative health technologies with the most potential impact for patients, joint scientific
consultations whereby developers can seek advice from HTA authorities, identification of emerging health technologies to identify promising
technologies early, and continuing voluntary cooperation in other areas. Individual EU member states will continue to be responsible for
assessing non-clinical (e.g., economic, social, ethical) aspects of health technology, and making decisions on pricing and reimbursement.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We face competition from the existing standard
of care, and we are furthermore subject to the risk that potential changes in medical practice and technology, or the development by our
competitors of products, treatments or procedures that are similar, more advanced, safer or more effective than ours, will render our
product candidates obsolete.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The medical, biotechnology and pharmaceutical industries are intensely
competitive and subject to significant technological and practice changes. We may face competition from many different sources with respect
to NexoBrid, EscharEx and our pipeline product candidates or any product candidates that we may seek to develop or commercialize in the
future. Possible competitors may be medical practitioners, pharmaceutical and wound care companies, academic and medical institutions,
governmental agencies and public and private research institutions, among others. Should any competitor&#8217;s product candidates receive
regulatory or marketing authorization prior to ours, they may establish a strong market position and be difficult to displace, or may
diminish the need for our products.<br/> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">14</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our commercial opportunity could be reduced or eliminated if our
competitors develop and commercialize products, treatments or procedures that are safer, more effective, have fewer or less severe side
effects, are more convenient or are less expensive than any product that we may develop. In addition, we face competition from the current
standard of care for eschar removal in severe burns, which includes surgery, where eschar removal can occur by tangential excision, dermabrasion
or hydro jet, and non-surgical alternatives, such as topical medications applied to the eschar to facilitate the natural healing process.
In chronic and other hard-to-heal wounds, we expect to face competition from current standard of care for debridement via sharp debridement
or from the current non-surgical standard of care, either enzymatic debridement, primarily Smith &amp; Nephew Plc&#8217;s SANTYL<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">&#174;</sup>,
a collagenase-based product indicated for debriding chronic dermal ulcers and severely burned areas, or autolytic debridement. Many of
our current or future competitors may have significantly greater financial resources and expertise in research and development, manufacturing,
preclinical testing, conducting clinical trials, obtaining regulatory approvals and marketing approved products than we may have. Mergers
and acquisitions in the pharmaceutical and biotechnology industries or wound care markets may result in even more resources being concentrated
among a smaller number of our competitors. For example, Healthpoint Biotherapeutics, which marketed SANTYL, was acquired by Smith &amp;
Nephew Plc in 2012. Smaller and other early-stage companies may also prove to be significant competitors, particularly through collaborative
arrangements with large and established companies. These companies compete with us in recruiting and retaining qualified scientific and
management personnel, establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies
complementary to, or necessary for, our programs</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Risks Related to Our Financial Position and Need for Additional
Capital</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If we fail to manage our growth effectively, our business could
be disrupted.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our future financial performance and ability to successfully commercialize
our products and to compete effectively will depend, in part, on our ability to manage any future growth effectively. We have made and
expect to continue to make significant investments to enable our future growth through, among other things, new product development, clinical
trials for new indications, expansion of our marketing and sales infrastructure and continued exploring for potential business development
opportunities. Our global demand for NexoBrid surpasses the current manufacturing capabilities. We are currently seeking to expand our
manufacturing capabilities in order to increase our capacity to manufacture NexoBrid and future product candidates and satisfy near term
demand., we initiated a facility scale-up in 2022 to meet the growing global demand for NexoBrid. The new GMP-compliant state-of-the-art
manufacturing facility is projected to be completed by mid-2024, with full-scale manufacturing currently expected to commence in 2025.
We expect the cost will be approximately $12.7 million. We must also be prepared to expand our workforce and train, motivate and manage
additional employees as the need for additional personnel arises. Even following expansion, our facilities, personnel, systems, procedures
and controls may not be adequate to support our future operations, or we may expand, but then fail to grow our sales of NexoBrid or our
pipeline product candidates sufficiently to support such operational growth. Any failure to manage future growth effectively could have
a material adverse effect on our business and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We have a history of net losses. We expect
to continue to incur substantial and increasing net losses in the coming years, and we may never achieve or maintain profitability.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have incurred significant net losses, including a net loss of
$6.7 million for the year ended December 31, 2023 and $19.6 million for the year ended December 31, 2022. As of December 31, 2023, we
had an accumulated deficit of $174.8 million. We expect to incur substantial net losses in the coming years. These losses and negative
cash flows have had, and will continue to have, an adverse effect on our shareholder's equity and working capital.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">15</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We expect to incur significant expenses and
increasing operating losses in the coming years.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We anticipate that our expenses and future capital requirements
may increase if and as we:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbd9d9d0ae2f448ad8156aaefbfff1603" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">accelerate our clinical development activities, particularly with respect to our clinical
        development of EscharEx for the debridement of chronic and other hard-to-heal wounds and our clinical trials for our other pipeline product
        candidates;</div>
        <div style="text-align: justify; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">further scale-up the manufacturing process for NexoBrid;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">seek regulatory and marketing authorizations for our products and any pipeline product
        candidate that successfully completes clinical trials;</div>
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">initiate additional preclinical, clinical or other studies for NexoBrid, EscharEx
        and our pipeline product candidates, and seek to identify and validate new products;</div>
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">commercialize NexoBrid and any pipeline product candidates for which we obtain marketing
        authorization;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">acquire rights to other product candidates and technologies;&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">&#160;</td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">change or add suppliers;&#160;</div>
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">&#160;</td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">maintain, expand and protect our intellectual property portfolio;&#160;</div>
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">&#160;</td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">attract and retain skilled personnel; and&#160;</div>
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">&#160;</td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">experience any delays or encounter issues with any of the above.&#160;</div> </td>
        </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><br/> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In
addition, we maintain cash, cash equivalents and bank deposits at financial institutions in Israel, Germany and the United States. Our
funds at these institutions exceed insured limits and some are not insured at all. Although we spread our cash, cash equivalents and bank
deposits among several financial institutions in order to reduce the risks associated with maintaining all of our balances at one financial
institution, in the event of failure of any financial institution where we maintain our cash and cash equivalents or bank deposits, there
can be no assurance that we would be able to access uninsured funds in such financial institution in a timely manner or at all. Any inability
to access or delay in accessing these funds could adversely affect our business and financial position.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We may need additional capital in the future, which may cause dilution
to our existing shareholders, restrict our operations or require us to relinquish rights to our pipeline product candidates or intellectual
property. If additional capital is not available, we may have to delay, reduce or cease operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We may seek additional funding in the future, which may consist
of equity offerings, collaborations, licensing arrangements or any other means to develop our pipeline product candidates, increase our
commercial manufacturing capabilities, operate our sales and marketing capabilities or other general corporate purposes.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our prior registered equity offerings diluted then-existing shareholders,
and to the extent that we raise additional capital through, for example, the sale of equity or convertible debt securities under our shelf
registration statement, our existing shareholders&#8217; ownership interest will be further diluted, and the terms may include liquidation
or other preferences that adversely affect our shareholders&#8217; rights. The incurrence of indebtedness or the issuance of certain equity
securities could result in increased fixed payment obligations and could also result in certain restrictive covenants, such as limitations
on our ability to incur additional debt or to issue additional equity, limitations on our ability to acquire or license intellectual property
rights and other operating restrictions that could adversely impact our ability to conduct our business. In addition, the issuance of
additional equity securities by us, or the possibility of such issuance, may cause the market price of our ordinary shares to decline.
Securing additional financing may also divert our management&#8217;s attention from our day-to-day activities, which may adversely affect
our ability to develop and commercialize NexoBrid, EscharEx and our pipeline product candidates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Additional funding may not be available to us on acceptable terms,
or at all. In the event that we enter into collaborations or licensing arrangements in order to raise capital, we may be required to accept
unfavorable terms, including relinquishing or licensing to a third party on unfavorable terms our rights to product candidates or intellectual
property that we otherwise would seek to develop or commercialize ourselves or reserve for future potential arrangements when we might
be able to achieve more favorable terms.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">16</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">If we are unable to raise additional capital when required or on
acceptable terms, we may be required to:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z7c1456ea528448189e9c640acd6771df" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">delay, scale back or discontinue the development, manufacturing scale-up or commercialization
        of NexoBrid, EscharEx or our pipeline product candidates;&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">seek additional corporate partners for NexoBrid, EscharEx or one or more of our pipeline
        product candidates on terms that are less favorable than might otherwise be available; or&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">relinquish or license to additional parties, on unfavorable terms, our rights to NexoBrid,
        EscharEx or our pipeline product candidates that we otherwise would seek to develop or commercialize ourselves.&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">any such consequence will have a material adverse effect on our business, operating
        results and prospects and on our ability to develop our pipeline product candidates.&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We believe that our existing cash and cash equivalents, short-term
and restricted bank deposits will be sufficient to fund our operations and capital expenditure for at least twelve months from the date
of this report. Our estimates may prove to be wrong, and we could use our available capital resources sooner than we currently expect.
Further, changing circumstances, some of which may be beyond our control, could cause us to consume capital significantly faster than
we currently anticipate, and we may need to seek additional funds sooner than planned.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We make business decisions based on forecasts
of future sales of our products and pipeline product candidates that may be inaccurate.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our market estimates are based on many assumptions, including,
but not limited to, reliance on external market research, our own internal research, population estimates, estimates of disease diagnostic
rates, treatment trends, and market estimates by third parties. Any of these assumptions can materially impact our forecasts and we cannot
be assured that the assumptions are accurate. If the market for any of our products or product candidates is less than this data would
suggest, the potential sales for the product or pipeline product candidates in question could be adversely affected, and our inventories
and net losses could increase.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Because of the numerous risks and uncertainties associated with
biopharmaceutical product development and commercialization, we are unable to accurately predict the timing or amount of future expenses
or when, or if, we will be able to achieve or maintain profitability. We have financed our operations primarily through the sale of equity
securities, licensing agreements and government grants. The size of our future net losses will depend, in part, on the rate of growth
or contraction of our expenses and the level and rate of growth, if any, of our revenues. If we are unable to successfully commercialize
NexoBrid, EscharEx or one or more of our pipeline product candidates or if revenue from NexoBrid, EscharEx or any pipeline product candidate
that receives marketing authorization is insufficient, we will not achieve profitability. Even if we do achieve profitability, we may
not be able to sustain or increase profitability.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Exchange rate fluctuations between the U.S.
dollar and the Israeli shekel, the Euro and other non-U.S. currencies may negatively affect our earnings.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The dollar is our functional and reporting currency. However, a
significant portion of our operating expenses are incurred in Israeli shekels and Euros. As a result, we are exposed to the risks that
the shekel may appreciate relative to the dollar, or, if the shekel instead devalues relative to the dollar, that the inflation rate in
Israel may exceed such rate of devaluation of the shekel, or that the timing of such devaluation may lag behind inflation in Israel. In
any such event, the dollar cost of our operations in Israel would increase and our dollar-denominated results of operations would be adversely
affected. We cannot predict any future trends in the rate of inflation in Israel or the rate of devaluation (if any) of the shekel against
the dollar. For example, the shekel depreciated relative to the dollar, on average, by 3.1% in 2023, by 13.2% in 2022 and appreciated
by 3.3% on average in 2021. If the dollar or Euro cost of our operations in Israel increases, our dollar- and Euro-measured results of
operations will be adversely affected. Our operations also could be adversely affected if we are unable to effectively hedge against currency
fluctuations in the future.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">To the extent that we may receive revenues from sales in certain
countries, such as certain countries in the Asia Pacific region, where our sales are expected to be denominated in dollars, a strengthening
of the dollar in relation to other currencies could make our products less competitive in those foreign markets and collection of receivables
more difficult. For further information, see &#8220;ITEM 11. Quantitative and Qualitative Disclosures About Market Risk&#8221; elsewhere
in this annual report.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">17</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Risks Related to Healthcare Laws and Other Legal Compliance Matters</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Certain of our business practices could become
subject to scrutiny by regulatory authorities, as well as to lawsuits brought by private citizens. Failure to comply with applicable law
or an adverse decision in lawsuits may result in adverse consequences to us.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The laws governing our conduct in the United States and in foreign
jurisdictions are enforceable by criminal, civil and administrative penalties. In the United States, violations of laws such as the Federal
Food, Drug and Cosmetic Act (the &#8220;FDCA&#8221;), the Public Health Service Act, the Federal False Claims Act, provisions of the U.S.
Social Security Act, including the &#8220;Anti-Kickback Statute,&#8221; or any regulations promulgated under their authority, may result
in significant administrative, civil and criminal sanctions, jail sentences, fines or exclusion from federal and state programs, as may
be determined by the U.S. Department of Justice, the Office of Inspector General of the U.S. Department of Health and Human Services (the
&#8220;OIG&#8221;), the Centers for Medicare &amp; Medicaid Services, (&#8220;CMS&#8220;) other regulatory authorities and the courts.
There can be no assurance that our activities will not come under the scrutiny of regulators and other government authorities or that
our practices will not be found to violate applicable laws, rules and regulations or prompt lawsuits by private citizen &#8220;relators&#8221;
under federal or state false claims laws.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The federal Anti-Kickback Statute prohibits, among other things,
knowingly and willfully offering, paying, soliciting or receiving any remuneration (including any kickback, bribe or rebate), directly
or indirectly, overtly or covertly, to induce or in return for purchasing, leasing, ordering or arranging for or recommending the purchase,
lease or order of any good, facility, item or service reimbursable, in whole or in part, under Medicare, Medicaid or other federal healthcare
programs. The term &#8220;remuneration&#8221; has been broadly interpreted to include anything of value. Although there are a number of
statutory exceptions and regulatory safe harbors protecting some common activities from prosecution, the exceptions and safe harbors are
drawn narrowly. Practices that involve remuneration that may be alleged to be intended to induce prescribing, purchases or recommendations
may be subject to scrutiny if they do not qualify for an exception or safe harbor.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">For example, even common business arrangements, such as discounted
terms and volume incentives for customers in a position to recommend or choose drugs and devices for patients, such as physicians and
hospitals, can result in substantial legal penalties, including, among other things, exclusion from Medicare and Medicaid programs if
not carefully structured to comply with applicable requirements. Also, certain business practices, such as payment of consulting fees
to healthcare providers, sponsorship of educational or research grants, charitable donations, interactions with healthcare providers and
financial support for continuing medical education programs, must be conducted within narrowly prescribed and controlled limits to avoid
any possibility of unlawfully inducing healthcare providers to prescribe or purchase particular products or rewarding past prescribing.
Failure to meet all of the requirements of a particular applicable statutory exception or regulatory safe harbor does not make the conduct
per se illegal under the Anti-Kickback Statute. Instead, the legality of the arrangement will be evaluated on a case-by-case basis based
on a cumulative review of all its facts and circumstances. Several courts have interpreted the statute&#8217;s intent requirement to mean
that if any one purpose of an arrangement involving remuneration is to induce referrals of federal healthcare covered business, the Anti-Kickback
Statute has been violated. In addition, a person or entity does not need to have actual knowledge of the statute or specific intent to
violate it in order to have committed a violation. Violations of the federal Anti-Kickback Statute may result in significant civil monetary
penalties for each violation, plus up to three times the remuneration involved. Moreover, a claim including items or services resulting
from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil False
Claims Act. Accordingly, civil penalties for such conduct can further be assessed under the federal False Claims Act. Violations can also
result in criminal penalties, including criminal fines and imprisonment. Similarly, violations can result in exclusion from participation
in government healthcare programs, including Medicare and Medicaid.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Significant enforcement activity has also taken place under federal
and state false claims act statutes. Violations of the federal False Claims Act can result in treble damages, and a penalty for each false
claim submitted for payment. Pharmaceutical, device and other healthcare companies have been prosecuted under these laws for, among other
things, allegedly providing free product to customers with the expectation that the customers would bill federal programs for the product.
Companies have been prosecuted for causing false claims to be submitted because of the companies&#8217; marketing of products for unapproved,
and thus non-covered, uses. The government may further prosecute conduct constituting a false claim under the criminal False Claims Act.
The criminal False Claims Act prohibits the making or presenting of a claim to the government knowing such claim to be false, fictitious,
or fraudulent and, unlike the civil False Claims Act, requires proof of intent to submit a false claim.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">18</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The federal False Claims Act, as well as certain state false claims
acts, also permits relators to file complaints in the name of the United States (and if applicable, particular states). These relators
may be entitled to receive up to 30% of total recoveries and have been active in pursuing cases against pharmaceutical companies. Where
practices have been found to involve improper incentives to use products, the submission of false claims, or other improper conduct, government
investigations and assessments of penalties against manufacturers have resulted in substantial damages and fines. In addition, to avoid
exclusion from participation in federal healthcare programs, many manufacturers have been required to enter into Corporate Integrity Agreements
that prescribe allowable corporate conduct and impose reporting and disclosure obligations by the manufacturer to the government. Failure
to satisfy requirements under the FDCA can also result in a variety of administrative, civil and criminal penalties, including injunctions
or consent decrees that prescribe allowable corporate conduct.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The federal Health Insurance Portability and Accountability Act
of 1996, or HIPAA, created additional federal criminal statutes that prohibit, among other things, knowingly and willfully executing,
or attempting to execute, a scheme to defraud any healthcare benefit program, including private third-party payors, knowingly and willfully
embezzling or stealing from a healthcare benefit program, willfully obstructing a criminal investigation of a healthcare offense, and
knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent
statement in connection with the delivery of or payment for healthcare benefits, items or services. Like the Anti-Kickback Statute, a
person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Additionally, there has been a recent trend of increased federal
and state regulation of payments and transfers of value provided to healthcare professionals and/or entities. The ACA, among other things,
imposed annual reporting requirements on certain manufacturers of drugs, devices, biologicals and medical supplies for payments and other
transfers of value provided by them, directly or indirectly, to physicians (defined to include doctors, dentists, optometrists, podiatrists
and chiropractors), certain non-physician practitioners (physician assistants, nurse practitioners, clinical nurse specialists, certified
registered nurse anesthetists, anesthesiologist assistants, and certified nurse midwives), and teaching hospitals, as well as ownership
and investment interests held by physicians and their family members. A manufacturer&#8217;s failure to submit timely, accurately and
completely the required information for all payments, transfers of value or ownership or investment interests may result in significant
civil monetary penalties.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, we are subject to analogous state and foreign laws
and regulations, such as state anti-kickback and false claims laws, which may apply to sales or marketing arrangements and claims involving
healthcare items or services reimbursed by non-governmental third-party payors, including private insurers; state and foreign laws that
require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance
guidance promulgated by the governments or otherwise restrict payments that may be made to healthcare providers. For instance, payments
made to physicians in certain EU member states must be publicly disclosed. Moreover, agreements with physicians must often be subject
of prior notification and/or approval by the physician&#8217;s employer, their competent professional organization, and/or the competent
authorities of the individual EU member states, state and foreign laws that require drug manufacturers to report information related to
payments and other transfers of value to physicians and other healthcare providers or marketing expenditures; and state and foreign laws
requiring the registration of pharmaceutical sales representatives.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Efforts to ensure that our business arrangements with third parties
will comply with applicable healthcare laws and regulations may involve substantial costs. It is possible that governmental authorities
will conclude that our business practices do not comply with current or future statutes, regulations or case law involving applicable
fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of these laws or any other
governmental regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, including,
without limitation, damages, fines, imprisonment, exclusion from participation in government healthcare programs, such as Medicare and
Medicaid, and the curtailment or restructuring of our operations, which could have a material adverse effect on our business. If any of
the physicians or other healthcare providers or entities with whom we expect to do business is found not to be in compliance with applicable
laws, it may be subject to criminal, civil or administrative sanctions, including exclusions from participation in government healthcare
programs, which could also materially affect our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As a public company with securities registered under the U.S. Securities
Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), we are subject to the U.S. Foreign Corrupt Practices Act (the &#8220;FCPA&#8221;).
The FCPA and similar worldwide anti-bribery laws generally prohibit companies and their intermediaries from making improper payments to
officials for the purpose of obtaining or retaining business. While we continue to maintain and enhance internal policies mandating compliance
with these anti-bribery laws, we may operate in parts of the world that have experienced governmental corruption to some degree and in
certain circumstances, strict compliance with anti-bribery laws may conflict with local customs and practices or may require us to interact
with doctors and hospitals, some of which may be state controlled, in a manner that is different than in the United States. Our internal
control policies and procedures may not be sufficient to effectively protect us against reckless or criminal acts committed by our employees
or agents. Violations of these laws, or allegations of such violations, could disrupt our business and result in a material adverse effect
on our financial condition, results of operations and cash flows.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">19</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Actual or perceived failures to comply with
applicable data protection, privacy and security laws, regulations, standards and other requirements could adversely affect our business,
results of operations, and financial condition.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The global data protection landscape is rapidly evolving, and we
are or may become subject to numerous state, federal and foreign laws, requirements and regulations governing the collection, use, disclosure,
retention, and security of personal information, such as information that we may collect in connection with clinical trials. Implementation
standards and enforcement practices are likely to remain uncertain for the foreseeable future, and we cannot yet determine the impact
future laws, regulations, standards, or perception of their requirements may have on our business. This evolution may create uncertainty
in our business, affect our ability to operate in certain jurisdictions or to collect, store, transfer use and share personal information,
necessitate the acceptance of more onerous obligations in our contracts, result in liability or impose additional costs on us. The cost
of compliance with these laws, regulations and standards is high and is likely to increase in the future. Any failure or perceived failure
by us to comply with federal, state or foreign laws or regulations, our internal policies and procedures or our contracts governing our
processing of personal information could result in negative publicity, government investigations and enforcement actions, claims by third
parties and damage to our reputation, any of which could have a material adverse effect on our operations, financial performance and business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In the United States, HIPAA, as amended by the Health Information
Technology for Economic and Clinical Health Act of 2009 and its implementing regulations, or collectively HIPAA, imposes, among other
things, certain standards relating to the privacy, security, transmission and breach reporting of individually identifiable health information.
While we do not believe that we are currently acting as a covered entity or business associate under HIPAA and thus are not directly regulated
under HIPAA, any person may be prosecuted under HIPAA&#8217;s criminal provisions either directly or under aiding-and-abetting or conspiracy
principles. Consequently, depending on the facts and circumstances, we could face substantial criminal penalties if we knowingly receive
individually identifiable health information from a HIPAA-covered healthcare provider or research institution that has not satisfied HIPAA&#8217;s
requirements for disclosure of individually identifiable health information. Certain states have also adopted comparable privacy and security
laws and regulations, some of which may be more stringent than HIPAA. Such laws and regulations will be subject to interpretation by various
courts and other governmental authorities, thus creating potentially complex compliance issues for us and our customers and strategic
partners. For example, the California Consumer Privacy Act (&#8220;CCPA&#8221;), which went into effect on January 1, 2020, among other
things, creates new data privacy obligations for covered companies and provides individual privacy rights to California residents, including
the right to opt out of certain disclosures of their information. The CCPA also creates a private right of action with statutory damages
for certain data breaches, thereby potentially increasing risks associated with a data breach. Although the law includes limited exceptions,
including for &#8220;protected health information&#8221; maintained by a covered entity or business associate, it may regulate or impact
our processing of personal information depending on the context. Further, the California Privacy Rights Act (&#8220;CPRA&#8221;) recently
passed in California. The CPRA generally went into effect on January 1, 2023, and&#160; imposes additional data protection obligations
on covered businesses, including additional consumer rights processes, limitations on data uses, new audit requirements for higher risk
data, and opt outs for certain uses of sensitive data. It also created a new California data protection agency authorized to issue substantive
regulations and could result in increased privacy and information security enforcement. Additional compliance investment and potential
business process changes may be required. Similar laws have passed in other states and are continuing to be proposed at the state and
federal level, reflecting a trend toward more stringent privacy legislation in the United States. The enactment of such laws could have
potentially conflicting requirements that would make compliance challenging.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">20</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Furthermore, the Federal Trade Commission (&#8220;FTC&#8221;) and
many state Attorneys General continue to enforce federal and state consumer protection laws against companies for online collection, use,
dissemination and security practices that appear to be unfair or deceptive. For example, according to the FTC, failing to take appropriate
steps to keep consumers&#8217; personal information secure can constitute unfair acts or practices in or affecting commerce in violation
of Section 5(a) of the Federal Trade Commission Act. The FTC expects a company&#8217;s data security measures to be reasonable and appropriate
in light of the sensitivity and volume of consumer information it holds, the size and complexity of its business, and the cost of available
tools to improve security and reduce vulnerabilities.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In the event that we are subject to or affected by HIPAA, the CCPA,
the CPRA or other domestic privacy and data protection laws, any liability from failure to comply with the requirements of these laws
could adversely affect our financial condition.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are subject to data privacy and security laws in the EU as well
as the EEA, including Regulation 2016/679, or the General Data Protection Regulation (&#8220;GDPR&#8221;) with respect to our collection,
control, processing, sharing, disclosure and other use of personal data of individuals located in the EEA or in the context of our activities
within the EEA. In addition, some of the personal data we process in respect of clinical trial participants is special category or sensitive
personal data under the GDPR, and subject to additional compliance obligations and to local law derogations. The GDPR went into effect
in May 2018, and companies that must comply with the GDPR face increased compliance obligations and risk, including more robust regulatory
enforcement of data protection requirements and potential fines for noncompliance of up to &#8364;20 million or 4% of the annual global
revenues of the noncompliant company, whichever is greater. In addition to fines, a breach of the GDPR may result in regulatory investigations,
reputational damage, orders to cease/ change our data processing activities, enforcement notices, assessment notices (for a compulsory
audit) and/ or civil claims (including class actions). Among other requirements, the GDPR regulates transfers of personal data subject
to the GDPR to third countries that have not been found to provide adequate protection to such personal data, including the United States,
and the efficacy and longevity of current transfer mechanisms between the EEA and the United States remains uncertain. Case law from the
Court of Justice of the EU (&#8220;CJEU&#8221;) states that reliance on the standard contractual clauses, or SCCs - a standard form of
contract approved by the European Commission as an adequate personal data transfer mechanism - alone may not necessarily be sufficient
in all circumstances and that transfers must be assessed on a case-by-case basis. On October 7, 2022, President Biden signed an Executive
Order on &#8220;Enhancing Safeguards for United States Signals Intelligence Activities,&#8221;&#160; which introduced new redress mechanisms
and binding safeguards to address the concerns raised by the CJEU in relation to data transfers from the EEA to the United States and
which formed the basis of the new EU-US Data Privacy Framework (&#8220;DPF&#8221;), as released on December 13, 2022. The European Commission
adopted its Adequacy Decision in relation to the DPF on July 10, 2023, rendering the DPF effective as a GDPR transfer mechanism to U.S.
entities self-certified under the DPF. The DPF also introduced a new redress mechanism for EU citizens which addresses a key concern in
the previous CJEU judgments and may mean transfers under SCCs are less likely to be challenged in future.&#160; We currently rely on the
EU standard contractual clauses We expect the existing legal complexity and uncertainty regarding international personal data transfers
to continue. In particular, we expect the DPF Adequacy Decision to be challenged and international transfers to the United States and
to other jurisdictions more generally to continue to be subject to enhanced scrutiny by regulators.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As supervisory authorities issue further guidance on personal data
export mechanisms, including circumstances where the SCCs cannot be used, and/or start taking enforcement action, we could suffer additional
costs, complaints and/or regulatory investigations or fines, and/or if we are otherwise unable to transfer personal data between and among
countries and regions in which we operate, it could affect the manner in which we provide our services, the geographical location or segregation
of our relevant systems and operations, and could adversely affect our financial results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Further, since January 2021, we may also be subject to the UK GDPR,
which, together with the UK Data Protection Act 2018, retains the GDPR in UK national law. The UK GDPR mirrors the fines under the GDPR,
meaning the potential of parallel fines of up to the greater of &#163;17.5 million or 4% of global turnover. On October 12, 2023, the
UK Extension to the DPF came into effect (as approved by the UK Government), as a UK GDPR data transfer mechanism to U.S. entities self-certified
under the UK Extension to the DPF. The European Commission has adopted an adequacy decision in favor of the UK, enabling data transfers
from EU member states to the UK without additional safeguards. However, the UK adequacy decision will automatically expire in June 2025
unless the European Commission re-assesses and renews/extends that decision and remains under review by the Commission during this period.
In September 2021, the UK government launched a consultation on its proposals for wide-ranging reform of UK data protection laws following
Brexit. There is a risk that any material changes which are made to the UK data protection regime could result in the European Commission
reviewing the UK adequacy decision, and the UK losing its adequacy decision if the European Commission deems the UK to no longer provide
adequate protection for personal data. The relationship between the UK and the EU in relation to certain aspects of data protection law
remains uncertain, and it is unclear how UK data protection laws and regulations will develop in the medium to longer term.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">21</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Our business and operations may suffer in the
event of information technology system failures, cyberattacks or deficiencies in our cybersecurity.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We collect and maintain information in digital form that is necessary
to conduct our business, and we are increasingly dependent on information technology systems and infrastructure to operate our business.
In the ordinary course of our business, we collect, store and transmit large amounts of confidential information, including intellectual
property, proprietary business information and personal information of customers and our employees and contractors. It is critical that
we do so in a secure manner to maintain the confidentiality and integrity of such confidential information. We have implemented physical
and electronic security measures to protect our proprietary information, maintain standard operation procedures and conduct business continuity
and disaster recovery simulations, penetration testing and train our employees. However, we cannot provide assurances that our data protection
and security measures will be fully implemented or complied with, will not be breached or will provide adequate protection for our confidential
information or information technology systems.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our information technology systems and those of our third-party
service providers, strategic partners and other contractors or consultants are vulnerable to attack and damage or interruption from computer
viruses and malware (e.g. ransomware), malicious code, natural disasters, terrorism, war, telecommunication and electrical failures, hacking,
cyberattacks, phishing attacks, worms/trojans and other social engineering schemes, employee theft or misuse, human error, fraud, denial
or degradation of service attacks, sophisticated nation-state and nation-state-supported actors or unauthorized access or use by persons
inside our organization, or persons with access to systems inside our organization. We have also outsourced elements of our information
technology infrastructure, and as a result a number of third-party vendors may or could have access to our confidential information. Data
breaches, cyber-attacks and other similar incidents are increasing in frequency, levels of persistence, sophistication and intensity and
are evolving in nature. Moreover, geopolitical tensions, particularly the Hamas-Israel and the Russia-Ukraine conflicts, have contributed
to a surge in cyber-attacks targeting Israeli companies and products globally, posing a threat to critical infrastructure.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">There is a risk that third parties may obtain and improperly utilize
our proprietary information to our competitive disadvantage. Attacks upon information technology systems are increasing in their frequency,
levels of persistence, sophistication and intensity, and are being conducted by sophisticated and organized groups and individuals with
a wide range of motives and expertise. We may also face increased cybersecurity risks due to our reliance on internet technology and the
number of our employees continue to work remotely, which may create additional opportunities for cybercriminals to exploit vulnerabilities.
Furthermore, because the techniques used to obtain unauthorized access to, or to sabotage, systems change frequently and often are not
recognized until launched against a target, we may be unable to anticipate these techniques or implement adequate preventative measures.
We may also experience security breaches that may remain undetected for an extended period. Even if identified, we may be unable to adequately
investigate or remediate incidents or breaches due to attackers increasingly using tools and techniques that are designed to circumvent
controls, to avoid detection, and to remove or obfuscate forensic evidence. We may not be able to detect or prevent the unauthorized use
of our confidential information or take appropriate and timely steps to enforce our intellectual property rights.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We and certain of our service providers are from time to time subject
to cyberattacks and security incidents. While we do not believe that we have experienced any significant system failure, accident or security
breach to date, if such an event were to occur and cause interruptions in our operations, it could result in a material disruption of
our development programs and our business operations, whether due to a loss, corruption or unauthorized disclosure of our trade secrets,
personal information or other proprietary or sensitive information or other similar disruptions. It could also expose us to risks, including
an inability to provide our services and fulfill contractual demands, and could cause management distraction and the obligation to devote
significant financial and other resources to mitigate such problems. If a security breach or other incident were to result in the unauthorized
access to or unauthorized use, disclosure, release or other processing of personal information, it may be necessary to notify individuals,
governmental authorities, supervisory bodies, the media and other parties pursuant to privacy and security laws, and the costs associated
with the investigation, remediation and potential notification of the breach to counter-parties and data subjects could be material. Any
security compromise affecting us, our service providers, strategic partners, other contractors, consultants, or our industry, whether
real or perceived, could harm our reputation, erode confidence in the effectiveness of our security measures and lead to regulatory scrutiny.
To the extent that any disruption or security breach were to result in a loss of, or damage to, our data or systems, or inappropriate
disclosure of confidential or proprietary or personal information, we could incur liability, including litigation exposure, penalties
and fines, we could become the subject of regulatory action or investigation, our competitive position could be harmed and the further
development and commercialization of our products and services could be delayed.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">22</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Laws and regulations affecting government contracts
make it more costly and difficult for us to successfully conduct our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We must comply with numerous laws and regulations relating to the
formation, administration and performance of government contracts, which can make it more difficult for us to retain our rights under
our BARDA contracts. These laws and regulations affect how we conduct business with government agencies. Among the most significant government
contracting regulations that affect our business are:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2f8e8c5b9f7847d995757dce06fe4860" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the Federal Acquisition Regulations (&#8220;FAR&#8221;) and agency-specific regulations
        supplemental to the FAR, which comprehensively regulate the procurement, formation, administration and performance of government contracts;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">&#160;</td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">business ethics and public integrity obligations, which govern conflicts of interest
        and the hiring of former government employees, restrict the granting of gratuities and funding of lobbying activities and include other
        requirements such as the Anti-Kickback Statute and Foreign Corrupt Practices Act;&#160;</div> </td> </tr>
  </table>

<div><br/> </div>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">export and import control laws and regulations; and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><br/> &#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">laws, regulations and executive orders restricting the use and dissemination of information
        classified for national security purposes and the exportation of certain products and technical data.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> Any material changes in applicable laws and regulations could
restrict our ability to maintain our BARDA contracts or obtain new contracts with the U.S. federal government.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We could be subject to product liability lawsuits,
which could result in costly and time-consuming litigation and significant liabilities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The development of biopharmaceutical products involves an inherent
risk of product liability claims and associated adverse publicity. Our products may be found to be harmful or to contain harmful substances.
This exposes us to substantial risk of litigation and liability or may force us to discontinue production of certain products. Although
we have product liability insurance covering up to $10 million for claims in countries where NexoBrid is sold through our sales force
or through our distributors, the coverage may not insure us against all claims that may be asserted against us. Product liability insurance
is costly and often limited in scope. There can be no assurance that we will be able to obtain or maintain insurance on reasonable terms
or to otherwise protect ourselves against potential product liability claims that could impede or prevent commercialization of NexoBrid,
EscharEx or our pipeline product candidates. Furthermore, a product liability claim could damage our reputation, whether or not such claims
are covered by insurance or are with or without merit. A product liability claim against us or the withdrawal of a product from the market
could have a material adverse effect on our business or financial condition. Furthermore, product liability lawsuits, regardless of their
success, would likely be time-consuming and expensive to resolve and would divert management&#8217;s time and attention, which could seriously
harm our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">23</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We are subject to extensive environmental,
health and safety, and other laws and regulations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our business involves the controlled use of chemicals. The risk
of accidental contamination or injury from these materials cannot be eliminated. If an accident, spill or release of any such chemicals
or substances occurs, we could be held liable for resulting damages, including for investigation, remediation and monitoring of the contamination,
including natural resource damages, the costs of which could be substantial. We are also subject to numerous environmental, health and
workplace safety laws and regulations, including those governing laboratory procedures. Although we maintain workers&#8217; compensation
insurance to cover the costs and expenses that may be incurred because of injuries to our employees resulting from the use of these materials,
this insurance may not provide adequate coverage against potential liabilities. Additional or more stringent laws and regulations affecting
our operations may be adopted in the future. We may incur substantial capital costs and operating expenses and may be required to obtain
consents to comply with any of these or certain other laws or regulations and the terms and conditions of any permits required pursuant
to such laws and regulations, including costs to install new or updated pollution control equipment, modify our operations or perform
other corrective actions at our respective facilities. In addition, fines and penalties may be imposed for noncompliance with environmental,
health and safety and other laws and regulations or for the failure to have, or comply with the terms and conditions of, required environmental
or other permits or consents.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">The enactment of legislation implementing changes in tax legislation
or policies in different geographic jurisdictions could materially impact our business, financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We conduct business globally and file income tax returns in multiple
jurisdictions. Our consolidated effective income tax rate could be materially adversely affected by several factors, including: changing
tax laws, regulations and treaties, or the interpretation thereof (such as the Inflation Reduction Act of 2022 signed into law in the
United States on August 16, 2022 which, among other changes, introduced a 15% corporate minimum tax on certain corporations and a 1% excise
tax on certain stock repurchases by United States corporations, which the U.S. Treasury indicated may also apply to certain stock redemptions
by a foreign corporation funded by certain United States affiliates); tax policy initiatives and reforms in effect and under consideration
(such as those related to the Organization for Economic Co-Operation and Development&#8217;s (&#8220;OECD&#8221;) Base Erosion and Profit
Shifting, or BEPS, project, the European Commission&#8217;s state aid investigations and other initiatives); the practices of tax authorities
in jurisdictions in which we operate; the resolution of issues arising from tax audits or examinations and any related interest or penalties.
Such changes may include (but are not limited to) the taxation of operating income, investment income, dividends received or (in the specific
context of withholding tax) dividends, royalties and interest paid.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are unable to predict what tax reforms may be proposed or enacted
in the future or what effect such changes would have on our business, but such changes, to the extent they are brought into tax legislation,
regulations, policies or practices in jurisdictions in which we operate, could increase the estimated tax liability that we have expensed
to date and paid or accrued on our consolidated financial statements, and otherwise affect our future results of operations, cash flows
in a particular period and overall or effective tax rates in the future in countries where we have operations, reduce post-tax returns
to our shareholders and increase the complexity, burden and cost of tax compliance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Risks Related to Our Intellectual Property Rights</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Our success depends in part on our ability
to obtain and maintain protection for the intellectual property relating to, or incorporated into, our technology and products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our commercial success depends in part on our ability to obtain
and maintain patent protection and trade secret protection for our intellectual property and proprietary technologies, our products and
their uses, as well as our ability to operate without infringing upon the proprietary rights of others. We rely on a combination of patents,
trademark and trade secret laws, non-disclosure and confidentiality agreements, licenses, assignments of invention agreements and other
restrictions on disclosure and use to protect our intellectual property rights.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As of December 31, 2023, we had been granted a total of 88 patents
and have 19 pending patent applications. The family of patents that covers NexoBrid specifically includes 35 granted patents worldwide.
EscharEx is covered in 15 patents and 4 national phase applications. However, there can be no assurance that patent applications relating
to our products, processes or technologies will result in patents being issued, that any patents that have been issued will be adequate
to protect our intellectual property or that we will enjoy patent protection for any significant period of time. Additionally, any issued
patents may be challenged by third parties, and patents that we hold may be found by a judicial authority to be invalid or unenforceable.
Other parties may independently develop similar or competing technology or design around any patents that may be issued to or held by
us. Our current patents will expire or they may otherwise cease to provide meaningful competitive advantage, and we may be unable to adequately
develop new technologies and obtain future patent protection to preserve our competitive advantage or avoid adverse effects on our business.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">24</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our patent protection may be limited, subjecting us to challenges
by competitors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">At present, we consider our patents relating to our enzymatic platform
technology, which underlies NexoBrid, EscharEx and our current pipeline product candidates, to be material to the operation of our business
as a whole. Our patents which cover NexoBrid claim specific mixtures of proteolytic enzymes, methods of producing such mixtures and methods
of treatment using such mixtures. Although the protection achieved is significant for NexoBrid, EscharEx and our pipeline product candidates,
when looking at our patents&#8217; ability to block competition, the protection offered by our patents may be, to some extent, more limited
than the protection provided by patents which claim chemical structures that were previously unknown. If our patents covering NexoBrid
in various jurisdictions were subject to a successful challenge or if a competitor were able to successfully design around them, our business
and competitive advantage could be significantly affected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, the patent landscape in the biotechnology field is
highly uncertain and involves complex legal, factual and scientific questions, and changes in either patent laws or in the interpretation
of patent laws in the United States and other countries may diminish the value and strength of our intellectual property or narrow the
scope of our patent protection. In addition, we may fail to apply for or be unable to obtain patents necessary to protect our technology
or products or enforce our patents due to lack of information about the exact use of our process by third parties. Even if patents are
issued to us, they may be challenged, narrowed, invalidated, held to be unenforceable or circumvented, which could limit our ability to
prevent competitors from using similar technology or marketing similar products, or limit the length of time our technologies and products
have patent protection. In addition, we are a party to license agreement with Mark Klein, that imposes various obligations upon us as
a licensee, including the obligation to make milestone and royalty payments contingent on the sales of NexoBrid. If we fail to comply
with these obligations, the licensor may terminate the license, in which event we might not be able to market any product that is covered
by the licensed intellectual property, including NexoBrid.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In order to preserve and enforce our patents and other intellectual
property rights, we may need to assert claims or file lawsuits against third parties. Such lawsuits could entail significant costs to
us and divert our management&#8217;s attention from developing and commercializing our products. Lawsuits may ultimately be unsuccessful
and may also subject us to counterclaims and cause our intellectual property rights to be challenged, narrowed, invalidated or held to
be unenforceable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">The timing of a patent application, grant,
and expiration may put us at a disadvantage compared to our competitors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our material patents also may not afford us protection against
competitors with similar technology. Because patent applications in the United States and many other jurisdictions are typically not published
until 18 months after their filing, if at all, and because publications of discoveries in scientific literature often lag behind actual
discoveries, neither we nor our licensors can be certain that we or they were the first to make the inventions claimed in our or their
issued patents or pending patent applications, or that we or they were the first to file for protection of the inventions set forth in
such patent applications. As a result, the patents we own and license may be invalidated in the future, and the patent applications we
own and license may not be granted. For example, if a third party has also filed a patent application covering an invention similar to
one covered in one of our patent applications, we may be required to participate in an adversarial proceeding known as an &#8220;interference
proceeding,&#8221; declared by the U.S. Patent and Trademark Office or its foreign counterparts, to determine priority of invention. The
costs of these proceedings could be substantial and our efforts in them could be unsuccessful, resulting in a loss of our anticipated
patent position. In addition, if a third party prevails in such a proceeding and obtains an issued patent, we may be prevented from practicing
technology or marketing products covered by that patent. Additionally, patents and patent applications owned by third parties may prevent
us from pursuing certain opportunities such as entering into specific markets or developing certain products. Finally, we may choose to
enter into markets where certain competitors have patents or patent protection over technology that may impede our ability to compete
effectively.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">25</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We may not be able to protect our intellectual
property rights in all jurisdictions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Effective protection of our intellectual property rights may be
unavailable or limited in some countries, and even if available, we may fail to pursue or obtain necessary intellectual property protection
in such countries, because filing, prosecuting, maintaining and defending patents on product candidates in all countries throughout the
world would be prohibitively expensive. In addition, the legal systems of certain countries do not favor the aggressive enforcement of
patents and other intellectual property rights, and the laws of certain foreign countries do not protect our rights to the same extent
as the laws of the United States. As a result, our intellectual property may not provide us with sufficient rights to exclude others from
commercializing products similar or identical to ours. Competitors may use our technologies in jurisdictions where we have not obtained
patent protection to develop their own products, and we may be unable to prevent such competitors from importing such infringing products
into territories where we have patent protection but where enforcement is not as strong as in the United States or into jurisdictions
in which we do not have patent protection. These products may compete with our product candidates and our patents and other intellectual
property rights may not be effective or sufficient to prevent them from competing in those jurisdictions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our currently issued NexoBrid patents are nominally due to expire
at various dates between 2025 and 2029. However, because of the extensive time required for development, testing and regulatory review
of a potential product, and although such delays may entitle us to patent term extensions, it is possible that, before NexoBrid can be
commercialized in additional international jurisdictions and/or before any of our future products can be commercialized, any related patent
may expire or remain in force for only a short period following commercialization, thereby reducing any advantages of the patent. The
international PCT patent applications relating to EscharEx were filed on January 30, 2017. National phase applications corresponding to
these PCT applications were filed in several jurisdictions and the expiration date of the 15 patents that issued and those that will be
issued is January 30, 2037, absent patent-term adjustment and/or extensions. Our pending and future patent applications may not lead to
the issuance of patents or, if issued, the patents may not provide us with any competitive advantage. We also cannot guarantee that:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5000032378f3493092317d54741f8767" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">any of our present or future patents or patent claims or other intellectual property
        rights will not lapse or be invalidated, circumvented, challenged or abandoned;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">our intellectual property rights will provide competitive advantages or prevent competitors
        from making or selling competing products;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">our ability to assert our intellectual property rights against potential competitors
        or to settle current or future disputes will not be limited by our agreements with third parties;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">any of our pending or future patent applications will be issued or have the coverage
        originally sought;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">our intellectual property rights will be enforced in jurisdictions where competition
        may be intense or where legal protection may be weak; or</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><br/> </div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">we will not lose the ability to assert our intellectual property rights against, or
        to license our technology to, others and collect royalties or other payments.</div> </td> </tr>
  </table>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold"> <br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We may be unable to identify all past or future
unauthorized uses of our intellectual property.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Additionally, unauthorized use of our intellectual property may
have occurred or may occur in the future. Any failure to identify unauthorized use of, and otherwise adequately protect, our intellectual
property could adversely affect our business, including by reducing the demand for our products. Any reported adverse events involving
counterfeit products that purport to be our products could harm our reputation and the sale of our products. Moreover, if we are required
to commence litigation related to unauthorized use, whether as a plaintiff or defendant, such litigation would be time-consuming, force
us to incur significant costs and divert our attention and the efforts of our management and other employees, which could, in turn, result
in lower revenue and higher expenses.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">26</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">In addition to patented technology, we rely
on our unpatented proprietary technology, trade secrets, processes and know-how.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We rely on proprietary information, such as trade secrets, know-how
and confidential information, to protect intellectual property that may not be patentable or that we believe is best protected by means
that do not require public disclosure. We generally seek to protect this proprietary information by entering into confidentiality agreements,
or consulting, services or employment agreements that contain non-disclosure and non-use provisions with our employees, consultants, contractors,
scientific advisors and third parties. However, we may fail to enter into the necessary agreements, and even if entered into, these agreements
may be breached or otherwise fail to prevent disclosure, third-party infringement or misappropriation of our proprietary information,
may be limited as to their term and may not provide an adequate remedy in the event of unauthorized disclosure or use of proprietary information.
We have limited control over the protection of trade secrets used by our suppliers and service providers and could lose future trade secret
protection if any unauthorized disclosure of such information occurs. In addition, our proprietary information may otherwise become known
or be independently developed by our competitors or other third parties. To the extent that our employees, consultants, contractors, scientific
advisors and other third parties use intellectual property owned by others in their work for us, disputes may arise as to the related
rights or resulting know-how and inventions. Costly and time-consuming litigation could be necessary to enforce and determine the scope
of our and relevant third parties&#8217; proprietary rights and failure to obtain or maintain protection for our proprietary information
could adversely affect our competitive business position. In addition, if a third party is able to establish that we are using their proprietary
information without their permission, we may be required to obtain a license to such information or, if such a license is not available,
re-design our products to avoid any such unauthorized use or temporarily delay or permanently stop manufacturing or sales of the affected
products. Furthermore, laws regarding trade secret rights in certain markets where we operate may afford little or no protection to our
trade secrets.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Some of our employees were previously employed at universities
or other biotechnology or pharmaceutical companies, including potential competitors. While we take steps to prevent our employees from
using the proprietary information or know-how of others in their work for us, we may be subject to claims that we or these employees have
inadvertently or otherwise used or disclosed intellectual property, trade secrets or other proprietary information of any such employee&#8217;s
former employer. Litigation may be necessary to defend against these claims and, even if we are successful in defending ourselves, could
result in substantial costs to us or be distracting to our management. If we fail to defend any such claims successfully, in addition
to paying monetary damages, we may lose valuable intellectual property rights or personnel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">If we are unable to protect our trademarks
from infringement, our business prospects may be harmed.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We own trademarks that identify &#8220;MediWound,&#8221; &#8220;NexoBrid&#8221;
and &#8220;EscharEx,&#8221; among others, and have registered these trademarks in certain key markets. Although we take steps to monitor
the possible infringement or misuse of our trademarks, it is possible that third parties may infringe, dilute or otherwise violate our
trademark rights. Any unauthorized use of our trademarks could harm our reputation or commercial interests. In addition, our enforcement
against third-party infringers or violators may be unduly expensive and time-consuming, and the outcome may be an inadequate remedy.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We may be subject to claims that we infringe,
misappropriate or otherwise violate the intellectual property rights of third parties.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our development, marketing or sale of NexoBrid, EscharEx or our
pipeline product candidates may infringe or be accused of infringing one or more claims of an issued patent to which we do not hold a
license or other rights. We may also be subject to claims that we are infringing, misappropriating or otherwise violating other intellectual
property rights, such as trademarks, copyrights or trade secrets. Third parties could therefore bring claims against us or our strategic
partners that would cause us to incur substantial expenses, including litigation costs or costs associated with settlement, and, if successful
against us, could cause us to pay substantial damages. Further, if such a claim were brought against us, we could be forced to temporarily
delay or permanently stop manufacturing or sales of NexoBrid, EscharEx or our pipeline product candidates that are the subject of the
suit.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">If we are found to be infringing, misappropriating or otherwise
violating the patent or other intellectual property rights of a third party, or in order to avoid or settle claims, we may choose or be
required to seek a license from a third party and be required to pay license fees or royalties or both, which could be substantial. These
licenses may not be available on acceptable terms, or at all. Even if we were able to obtain a license, the rights may be nonexclusive,
which could result in our competitors gaining access to the same intellectual property. Ultimately, we could be prevented from commercializing
a product, or be forced to cease some aspect of our business operations, if, as a result of actual or threatened claims, we or our strategic
partners are unable to enter into licenses on acceptable terms.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">27</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">There have been substantial litigation and other proceedings regarding
patent and other intellectual property rights in the pharmaceutical and biotechnology industries. In addition, to the extent that we gain
greater visibility and market exposure as a public company in the United States, we face a greater risk of being involved in such litigation.
In addition to infringement claims against us, we may become a party to other patent litigation and other proceedings, including interference,
opposition, re-examination and similar proceedings before the U.S. Patent and Trademark Office and its foreign counterparts, regarding
intellectual property rights with respect to NexoBrid, EscharEx or our pipeline product candidates. The cost to us of any patent litigation
or other proceeding, even if resolved in our favor, could be substantial. A negative outcome could result in liability for monetary damages,
including treble damages and attorneys&#8217; fees if, for example, we are found to have willfully infringed a patent. A finding of infringement
could prevent us from developing, marketing or selling a product or force us to cease some or all of our business operations. Some of
our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their substantially
greater financial resources. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could
have a material adverse effect on our ability to compete in the marketplace, and patent litigation and other proceedings may also absorb
significant management time.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Under applicable employment laws, we may not
be able to enforce covenants not to compete.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We generally enter into non-competition agreements with our employees.
These agreements prohibit our employees, if they cease working for us, from competing directly with us or working for our competitors
or clients for a limited period. We may be unable to enforce these agreements under the laws of the jurisdictions in which our employees
work and it may be difficult for us to restrict our competitors from benefitting from the expertise our former employees or consultants
developed while working for us. For example, Israeli labor courts have required employers seeking to enforce non-compete undertakings
of a former employee to demonstrate that the competitive activities of the former employee will harm one of a limited number of material
interests of the employer which have been recognized by the courts, such as the protection of a company&#8217;s trade secrets or other
intellectual property. If we cannot demonstrate that such interests will be harmed, we may be unable to prevent our competitors from benefiting
from the expertise of our former Israeli employees or consultants and our ability to remain competitive may be diminished. As to our U.S.
operations, on the U.S. federal level, there was movement in 2023 by federal agencies to make noncompete agreements unenforceable in general.
The Federal Trade Commission proposed a new rule to ban employers nationwide from using non-compete agreements with their employees and
independent contractors, and the General Counsel of the National Labor Relations Board issued a memo in March 2023 opining that many types
of non-compete and non-solicitation restrictions unlawfully interfere with employees&#8217; protected rights under Section 7 of the National
Labor Relations Act. If any of these proposed new U.S. federal restrictions becomes effective, or if any state in which we have operations
continues to expand restrictions or bans the use of non-compete restrictions, that could adversely impact our ability to protect our investment
in our key employees in our U.S. locations, and harm our competitive position.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-weight: bold; font-style: italic">We may become subject to<span style="font-weight: bold; font-style: italic">
</span>claims for remuneration or royalties for assigned service invention rights by our employees, which could result in litigation and
adversely affect our business.</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">A significant portion of our intellectual property has been developed
for us by our employees in the course of their employment. Under the Israeli Patent Law, 5727-1967, or the Patent Law, inventions conceived
by an employee in the course and as a result of or arising from his or her employment with a company are regarded as &#8220;service inventions,&#8221;
which belong to the employer, absent a specific agreement between the employee and employer giving the employee proprietary rights. The
Patent Law also provides under Section 134 that if there is no agreement between an employer and an employee as to whether the employee
is entitled to consideration for service inventions, and to what extent and under which conditions, the Israeli Compensation and Royalties
Committee, or the Committee, a body constituted under the Patent Law, shall determine these issues. Section 135 of the Patent Law provides
criteria for assisting the Committee in making its decisions. According to case law handed down by the Committee, an employee&#8217;s
right to receive consideration for service inventions is a personal right and is entirely separate from the proprietary rights in such
invention. Therefore, this right must be explicitly waived by the employee. A decision handed down in May 2014 by the Committee clarifies
that the right to receive consideration under Section 134 can be waived and that such waiver can be made orally, in writing or by behavior
like any other contract. The Committee will examine, on a case by case basis, the general contractual framework between the parties, using
interpretation rules of the general Israeli contract laws. Further, the Committee has not yet determined one specific formula for calculating
this remuneration, nor the criteria or circumstances under which an employee&#8217;s waiver of his right to remuneration will be disregarded.
Similarly, it remains unclear whether waivers by employees in their employment agreements of the alleged right to receive consideration
for service inventions should be declared as void being a depriving provision in a standard contract. We generally enter into assignment-of-invention
agreements with our employees pursuant to which such individuals assign to us all rights to any inventions created in the scope of their
employment or engagement with us. Although our employees have agreed to assign to us service invention rights and have specifically waived
their right to receive any special remuneration for such service inventions beyond their regular salary and benefits, we may face claims
demanding remuneration in consideration for assigned inventions. As a consequence of such claims, we could be required to pay additional
remuneration or royalties to our current or former employees or be forced to litigate such claims, which could negatively affect our business.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">28</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Risks Related to an Investment in Our Ordinary Shares</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">The market price of our ordinary shares may
be subject to fluctuation and you could lose all or part of your investment.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our ordinary shares were first offered publicly in our IPO in March
2014 at a price of $98.00 per share, and our ordinary shares have subsequently traded as high as $127.12 per share and as low as $7.10
per share through December 31, 2023. The market price of our ordinary shares on the Nasdaq Global Market may fluctuate as a result of
a number of factors, some of which are beyond our control, including, but not limited to:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z1b84bd27440e4879a3c763554dd5359c" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">actual or anticipated variations in our and our competitors&#8217; results of operations
        and financial condition;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">market acceptance of our products;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">general economic and market conditions and other factors, including factors unrelated
        to our operating performance;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the mix of products that we sell and related services that we provide;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">changes in earnings estimates or recommendations by securities analysts, if our ordinary
        shares continue to be covered by analysts;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">publication of the results of preclinical or clinical trials for NexoBrid, EscharEx
        or any of our pipeline product candidates;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">&#160;</td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="line-height: 1.25">failure by us to achieve a publicly announced milestone;&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">delays between our expenditures to develop and market new or enhanced products and
        the generation of sales from those products;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">development of technological innovations or new competitive products by others;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">announcements of technological innovations or new products by us;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table> <br/>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">29</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">regulatory developments and the decisions of regulatory authorities as to the marketing
        of our current products or the approval or rejection of new or modified products;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">developments concerning intellectual property rights, including our involvement in
        litigation;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">changes in our expenditures to develop, acquire or license new products, technologies
        or businesses;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">changes in our expenditures to promote our products;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">changes in the structure of healthcare payment systems;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">our sale or proposed sale, or the sale by our significant shareholders, of our ordinary
        shares or other securities in the future;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">changes in key personnel;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">success or failure of our research and development projects or those of our competitors;
        and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><br/> </div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the trading volume of our ordinary shares.</div> </td> </tr>
  </table>

<div style="text-align: left; line-height: 1.25"><br/> </div> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
These factors and any corresponding price fluctuations may materially and adversely affect the market price of our ordinary shares and
result in substantial losses being incurred by our investors. In the past, following periods of market volatility, public company shareholders
have often instituted securities class action litigation. If we were involved in securities litigation, it could impose a substantial
cost upon us and divert the resources and attention of our management from our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Future sales of our ordinary shares could reduce the market price
of our ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">If we or our existing shareholders, our directors or their affiliates
or certain of our executive officers, sell a substantial number of our ordinary shares in the public market, the market price of our ordinary
shares could decrease significantly. The perception in the public market that we or our shareholders might sell our ordinary shares could
also depress the market price of our ordinary shares and could impair our future ability to obtain capital, especially through an offering
of equity securities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have made significant offerings of our ordinary shares in the
past and may do so again in the future. For example, on April 23, 2019, the SEC declared effective our shelf registration statement on
Form F-3, which registered the resale of 1,605,732 shares that are subject to registration rights. All shares sold pursuant to an offering
covered by that registration statement (or a subsequent shelf registration that we may file to replace it after it expires) will be freely
transferable. See &#8220;ITEM 7.B. Related Party Transactions-Registration Rights Agreement.&#8221; Sales by us or our shareholders of
a substantial number of ordinary shares in the public market could cause the market price of our ordinary shares to decline or could impair
our ability to raise capital through a future sale of, or pay for acquisitions using, our equity securities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25; font-family: Times New Roman,serif; text-indent: 36pt">&#160;In addition, as of March 15, 2024, 1,161,033
ordinary shares were subject to outstanding option and RSU awards granted to employees and office holders under our share incentive plans,
including 430,675 ordinary shares issuable under currently exercisable share options and RSUs. We have filed a registration statements
on Form S-8 registering the issuance of all such ordinary shares issuable under our share incentive plans. As of March 15, 2024, 680,108
shares remained available for future awards under our 2014 Equity Incentive Plan, which shares will be rolled over to a new share incentive
plan&#8212; the 2024 Share Incentive Plan&#8212; that we will adopt and bring for shareholder approval soon.&#160; Shares included in
such registration statements on Form S-8 may be freely sold in the public market upon issuance, except for shares held by affiliates,
who have certain restrictions on their ability to sell.</div> </div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">30</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">As a foreign private issuer, we are permitted
to, and actually do, follow certain home country corporate governance practices instead of otherwise applicable SEC and Nasdaq requirements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As a foreign private issuer, we are permitted to, and do, follow
certain home country corporate governance practices instead of those otherwise required under the Nasdaq Stock Market listing rules for
domestic U.S. issuers. For instance, we follow home country practice in Israel with regard to the (i) quorum requirement for shareholder
meetings (ii) shareholder approval for certain transactions other than a public offering involving issuances of a 20% or more interest
in the company. See &#8220;ITEM 16G. Corporate Governance.&#8221; We may in the future elect to follow home country practices in Israel
with regard to other matters as well, such as the formation and composition of the nominating and corporate governance committee, separate
executive sessions of independent directors and the requirement to obtain shareholder approval for certain dilutive events (such as for
the establishment or amendment of certain equity-based compensation plans, issuances that will result in a change of control of the company,
and certain acquisitions of the stock or assets of another company). Following our home country governance practices as opposed to the
requirements that would otherwise apply to a U.S. company listed on the Nasdaq Global Market may provide less protection to you than what
is accorded to investors under the Nasdaq Stock Market listing rules applicable to domestic U.S. issuers. See &#8220;ITEM 16G. Corporate
Governance.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">As a foreign private issuer, we are not subject to the provisions
of Regulation FD or U.S. proxy rules and are exempt from filing certain Exchange Act reports. Loss of our foreign private issuer status
would be accompanied by a significant increase in compliance costs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As a foreign private issuer, we are exempt from the rules and regulations
under the Exchange Act related to the furnishing and content of proxy statements, and our officers, directors and principal shareholders
are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition, we
are not required under the Exchange Act to file annual and current reports and financial statements with the SEC as frequently or as promptly
as U.S. domestic companies whose securities are registered under the Exchange Act, and we are generally exempt from filing quarterly reports
with the SEC under the Exchange Act. Moreover, we are not required to comply with Regulation FD, which prohibits the selective disclosure
of material nonpublic information to, among others, broker-dealers and holders of a company&#8217;s securities under circumstances in
which it is reasonably foreseeable that the holder will trade in the company&#8217;s securities on the basis of the information. Even
though we intend to comply voluntarily with Regulation FD, these exemptions and leniencies will reduce the frequency and scope of information
and protections to which you are entitled as an investor.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">For so long as we qualify as a foreign private issuer, we are not
required to comply with the proxy rules applicable to U.S. domestic companies, including the requirement applicable to emerging growth
companies to disclose the compensation of our Chief Executive Officer and other two most highly compensated executive officers on an individual,
rather than an aggregate, basis. Nevertheless, the regulations promulgated under the Israeli Companies Law, 5759-1999 (the &#8220;Israeli
Companies Law&#8221;) require us to disclose the annual compensation of our five most highly compensated officers on an individual, rather
than on an aggregate, basis. See &#8220;ITEM 6.B. Compensation.&#8221; Under the Companies Law regulations, this disclosure is required
to be included in the proxy statement for our annual meeting of shareholders each year, which we furnish to the SEC under cover of a Report
of Foreign Private Issuer on Form 6-K. Because of that disclosure requirement under Israeli law, we are also including such information
in this annual report, pursuant to the disclosure requirements of Form 20-F.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We would lose our foreign private issuer status if a majority of
our outstanding ordinary shares are held of record by U.S. shareholders and we fail to meet additional requirements necessary to avoid
loss of foreign private issuer status. Although we have elected to comply with certain U.S. regulatory provisions, our loss of foreign
private issuer status would make such provisions mandatory. The regulatory and compliance costs to us under U.S. securities laws as a
U.S. domestic issuer may be significantly higher. If we lose our foreign private issuer status, we will be required to file periodic reports
and registration statements on U.S. domestic issuer forms with the SEC, which are more detailed and extensive than the forms available
to a foreign private issuer. We would also be required to follow U.S. proxy disclosure requirements, including the requirement to disclose
more detailed information about the compensation of our senior executive officers on an individual basis. We may also be required to modify
certain of our policies to comply with accepted governance practices associated with U.S. domestic issuers. Such conversion and modifications
will involve additional costs. In addition, we would lose our ability to rely upon exemptions from certain corporate governance requirements
on U.S. stock exchanges that are available to foreign private issuers.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">31</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We have never paid cash dividends on our share
capital, and we do not anticipate paying any cash dividends in the foreseeable future.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have never declared or paid cash dividends on our share capital,
nor do we anticipate paying any cash dividends on our share capital in the foreseeable future. We currently intend to retain all available
funds and any future earnings to fund the development and growth of our business. As a result, capital appreciation, if any, of our ordinary
shares will be an investor&#8217;s sole source of gain for the foreseeable future. In addition, Israeli law limits our ability to declare
and pay dividends, and may subject our dividends to Israeli withholding taxes. See &#8220;ITEM 8.A. Consolidated Statements and Other
Financial Information-Dividend Policy,&#8221; &#8220;ITEM 10.B. Articles of Association-Dividend and liquidation rights&#8221; and &#8220;ITEM
10.E. Taxation-Israeli Tax Considerations and Government Programs.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">If we are unable to satisfy the requirements
of Section 404 of the Sarbanes-Oxley Act, or if our internal control over financial reporting or our disclosure controls and procedures
are not effective, investors may lose confidence in the accuracy and the completeness of the reports we furnish or file with the SEC,
the reliability of our financial statements may be questioned and our share price may suffer.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are required to comply with the internal control, evaluation
and certification requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (the &#8220;Sarbanes-Oxley Act&#8221;). Pursuant to Section
404(a) of the Sarbanes-Oxley Act, we are required to furnish a report by management on the effectiveness of our internal control over
financial reporting. Because we have become an accelerated filer (as would be the case if we were furthermore to qualify as or a large
accelerated filer), we are required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes Oxley Act.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">To maintain the effectiveness of our disclosure controls and procedures
and our internal control over financial reporting, we expect that we will need to continue to enhance existing, and implement new, financial
reporting and management systems, procedures and controls to manage our business effectively and support our growth in the future. The
process of evaluating our internal control over financial reporting requires an investment of substantial time and resources, including
by our Chief Financial Officer and other members of our senior management. The determination and any remedial actions required could divert
internal resources and take a significant amount of time and effort to complete and could result in us incurring additional costs that
we did not anticipate, including the hiring of outside consultants.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Irrespective of compliance with Section 404, any failure of our
internal controls could have a material adverse effect on our stated results of operations and harm our reputation. As a result, we may
experience higher than anticipated operating expenses, as well as higher independent auditor fees during and after the implementation
of these changes. If we are unable to implement any of the required changes to our internal control over financial reporting effectively
or efficiently, it could adversely affect our operations, financial reporting or results of operations. Further, if our internal controls
over financial reporting are not effective, the reliability of our financial statements may be questioned and our share price may suffer.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our U.S. shareholders may suffer adverse tax consequences if we
are characterized as a passive foreign investment company.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Generally, if for any taxable year 75% or more of our gross income
is passive income, or at least 50% of the average quarterly value of our assets (which may be determined in part by the market value of
our ordinary shares, which is subject to change) are held for the production of, or produce, passive income, we would be characterized
as a passive foreign investment company (&#8220;PFIC&#8221;) for U.S. federal income tax purposes. Based on our current estimates of our
gross income and gross assets and the nature of our business, we do not believe we were classified as a PFIC for the taxable year ended
December 31, 2023. There can be no assurance that we will not be considered a PFIC for the current or any future taxable year. PFIC status
is determined as of the end of the taxable year and depends on a number of factors, including the value of a corporation&#8217;s assets
and the amount and type of its gross income. Furthermore, the value of our gross assets is likely to be determined in large part by reference
to our market capitalization. As such, a decline in the value of our ordinary shares or an increase in the value of our passive assets
(including cash and short term investments), for example, may result in our becoming a PFIC. If we are characterized as a PFIC, our U.S.
shareholders may suffer adverse tax consequences, including having gains realized on the sale of our ordinary shares treated as ordinary
income, rather than as capital gain, the loss of the preferential rate that may be applicable to dividends received on our ordinary shares
by individuals who are U.S. Holders (as defined in &#8220;ITEM 10.E. Taxation-United States Federal Income Taxation&#8221;), and having
interest charges apply to distributions by us and the proceeds of share sales. Certain elections exist that may alleviate some of the
adverse consequences of PFIC status and would result in an alternative treatment (such as mark-to-market treatment) of our ordinary shares.
However, we do not intend to provide the information necessary for U.S. holders to make qualified electing fund elections if we are classified
as a PFIC. See &#8220;ITEM 10.E. Taxation-United States Federal Income Taxation-Passive Foreign Investment Company Considerations.&#8221;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">32</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">If a U.S. person is treated as owning at least
10% of our ordinary shares, such holder may be subject to adverse U.S. federal income tax consequences.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">If a U.S. person is treated as owning (directly, indirectly, or
constructively) at least 10% of the value or voting power of our ordinary shares, such person may be treated as a &#8220;U.S. shareholder&#8221;
with respect to each &#8220;controlled foreign corporation&#8221; in our group (if any). Since our group includes one or more U.S. subsidiaries,
certain of our non-U.S. subsidiaries will be treated as controlled foreign corporations (regardless of whether or not we are treated as
a controlled foreign corporation). A U.S. shareholder of a controlled foreign corporation may be required to report annually and include
in its U.S. taxable income its pro rata share of &#8220;Subpart F income,&#8221; &#8220;global intangible low-taxed income,&#8221; and
investments in U.S. property by controlled foreign corporations, regardless of whether the Company makes any distributions. An individual
that is a U.S. shareholder with respect to a controlled foreign corporation generally would not be allowed certain tax deductions or foreign
tax credits that would be allowed to a U.S. shareholder that is a U.S. corporation. Failure to comply with these reporting obligations
may subject a U.S. shareholder to significant monetary penalties and may prevent the statute of limitations with respect to such U.S.
shareholder&#8217;s U.S. federal income tax return for the year for which reporting was due from starting. We cannot provide any assurances
that we will assist holders of ordinary shares in determining whether any of our non-U.S. subsidiaries is treated as a controlled foreign
corporation or whether any holder of ordinary shares is treated as a U.S. shareholder with respect to any such controlled foreign corporation
or furnish to any U.S. shareholders information that may be necessary to comply with the aforementioned reporting and tax paying obligations.
The United States Internal Revenue Service has provided limited guidance on situations in which investors may rely on publicly available
information to comply with their reporting and taxpaying obligations with respect to foreign-controlled controlled foreign corporations.
A U.S. holder should consult its tax advisors regarding the potential application of these rules to an investment in the ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Risks Primarily Related to our Operations in Israel</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Our headquarters, manufacturing and other significant
operations are located in Israel and, therefore, our operations may be disrupted and our results of operations or financial condition
may be adversely affected by Israel&#8217;s current war against the terrorist organization Hamas and other terrorist organizations and
by any adverse consequences of that war.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Our
headquarters, manufacturing and research and development facilities are located in Yavne, Israel. In addition, the majority of our key
employees and officers are residents of Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In recent years, Israel has been engaged in sporadic armed conflicts
with Hamas, an Islamist terrorist group that controls the Gaza Strip, with Hezbollah, an Islamist terrorist group that controls large
portions of southern Lebanon, and with Iranian-backed military forces in Syria. In addition, Iran has threatened to attack Israel, may
be developing nuclear weapons and has targeted cyber-attacks against Israeli entities. On October 7, 2023, Hamas terrorists infiltrated
Israel&#8217;s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas also launched
extensive rocket attacks on Israeli population within the State of Israel, mostly in southern and central Israel, including areas near
our headquarters, manufacturing and research and development facilities. These attacks resulted in extensive deaths, injuries and kidnapping
of civilians and soldiers. Following the attack, Israel&#8217;s security cabinet declared war against Hamas and a military campaign against
this terrorist organization, accompanied by the draft of several hundred thousand Israeli military reservists, commenced in parallel to
Hamas&#8217; continued rocket and terror attacks. Following the attack by Hamas on Israel&#8217;s southern border, Hezbollah in Lebanon
also launched missile, rocket and shooting attacks against Israeli military sites, troops and Israeli towns in northern Israel. In response
to these attacks, the Israeli army has carried out a number of targeted strikes on sites belonging to Hezbollah in southern Lebanon, and
the two sides have been trading attacks on one another since that time. Furthermore, the Houthi movement, which controls parts of Yemen,
has been launching attacks on marine vessels traversing the Red Sea, which were thought to either be in route towards Israel or to be
partly owned by Israeli businessmen. It is possible that other terrorist organizations, including Palestinian military organizations in
the West Bank, as well as other hostile countries, such as Iran, will join the hostilities. It is currently not possible to predict the
duration or severity of the ongoing conflict. Up to the present time, the war has not had a material effect on our business, operations
and financial conditions. However, the ongoing conflict is still evolving and developing, and could still disrupt our business and operations.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">33</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As of December 31, 2023, we had 88 employees based in Israel. Certain
of our employees, were and may be in the future called perform military reserve duty in connection with the current war. Even in the absence
of an active military conflict, our employees could be called in the future to perform reserve military duty for up to 54 days (and in
the case of non-officer commanders or officers, up to 70 or 84 days, respectively) of each three-year period until they reach the age
of 40 (and in some cases, depending on their specific military profession, up to 45 or even 49 years of age). In certain emergency circumstances
(as was the case with the current war), these employees may be called to immediate and unlimited active duty. Our business and results
of operations could be disrupted by the absence of a significant number of employees related to military service, for a significant period
of time.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our commercial insurance does not cover losses that may occur as
a result of an event associated with the current war, or any other terrorist attack that might cause us damages. The reinstatement value
of direct damages that are caused by terrorist attacks or acts of war that the Israeli government is currently committed to covering might
not be maintained or, if maintained, might not be sufficient to compensate us fully for damages incurred. Any losses or damages incurred
by us as a result of the current (or any other) armed conflict involving Israel could have a material adverse effect on our business and
results of operations</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">

<div style="line-height: 1.25; font-family: Times New Roman, serif; font-style: italic; font-weight: bold">Boycotts and similar activities
promoted by certain&#160; Middle Eastern countries and other political groups against Israeli businesses may adversely impact our operations
and our ability to sell our products.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Several countries, principally in the Middle East, restrict doing
business with Israel and Israeli companies, and anti-Israel political activists have been encouraging additional countries to impose restrictions
on doing business with, and to boycott the products of,&#160; Israel and Israeli companies whether as a result of hostilities in the region
or otherwise. More countries may impose restrictions on doing business with Israel and Israeli companies if hostilities on Israel continue
or increase. Recently, Israel has signed bilateral peace agreements with several Middle Eastern (including Arab) countries, forging new
economic ties with them. Nevertheless, if the actions of boycott activists become more widespread and successful, that may adversely impact
our ability to sell our products. Israel&#8217;s ongoing war against the terrorist group Hamas may assist those activists seeking to harm
the economic interest of Israeli companies such as ours. For example, in light of the ongoing war, Moody&#8217;s decided to downgrade
Israel&#8217;s credit rating from A1 to A2, as well as Israel&#8217;s outlook rating from &#8220;stable&#8221; to &#8220;negative&#8221;.
This downgrade and similar economic measures could slow the flow of international investment to Israel, negatively impacting the business
environment in which we operate.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Provisions of Israeli law and our articles of association may delay,
prevent or otherwise impede a merger with, or an acquisition of, us, even when the terms of such a transaction are favorable to us and
our shareholders.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Israeli corporate law regulates mergers, requires tender offers
for acquisitions of shares above specified thresholds, requires special approvals for transactions involving directors, officers or significant
shareholders and regulates other matters that may be relevant to such types of transactions. For example, a tender offer for all of a
company&#8217;s issued and outstanding shares can only be completed if the acquirer receives positive responses from the holders of at
least 95% of the issued share capital. Completion of the tender offer also requires approval of a majority of the offerees that do not
have a personal interest in the tender offer, unless, following consummation of the tender offer, the acquirer would hold at least 98%
of the company&#8217;s outstanding shares. Furthermore, the shareholders, including those who indicated their acceptance of the tender
offer, may, at any time within six months following the completion of the tender offer, petition an Israeli court to alter the consideration
for the acquisition, unless the acquirer stipulated in its tender offer that a shareholder that accepts the offer may not seek such appraisal
rights. See &#8220;ITEM 10.B. Articles of Association-Acquisitions Under Israeli law&#8221; for additional information.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">34</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Furthermore, Israeli tax considerations may make potential transactions
unappealing to us or to our shareholders whose country of residence does not have a tax treaty with Israel exempting such shareholders
from Israeli tax. For example, Israeli tax law does not recognize tax-free share exchanges to the same extent as U.S. tax law. With respect
to mergers, Israeli tax law allows for tax deferral in certain circumstances but makes the deferral contingent on the fulfillment of a
number of conditions, including, in some cases, a holding period of two years from the date of the transaction during which sales and
dispositions of shares of the participating companies are subject to certain restrictions. Moreover, with respect to certain share swap
transactions, the tax deferral is limited in time, and when such time expires, the tax becomes payable even if no disposition of the shares
has occurred.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We have received Israeli government grants
for certain research and development activities. The terms of those grants require us to satisfy specified conditions and to pay penalties
in addition to repayment of the grants upon certain events.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">Our research and development efforts have been
financed in part through grants from the Israeli Innovation Authority (&#8220;IIA&#8221;), formerly operating as the Israeli Office of
the Chief Scientist (the &#8220;OCS&#8221;). The total gross amount of grants actually received by us from the IIA, including accrued
interest (or such other interest rate that the IIA may set in the future) and net of royalties actually paid as of December 31, 2023,
totaled approximately $13.8 million and the amortized cost (using the interest method) of the liability as of that date totaled approximately
$7.8 million. As of December 31, 2023, we had accrued and paid net royalties to the IIA in an amount of $1.9 million. As of December 31,
2018 we determined that we will no longer be supported by the IIA. As a result, since 2020 we did not submit applications for IIA grants
and we do not plan to submit in 2024.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The IIA grants that we have received are repayable by payment of
royalties from the sale of products developed as part of the programs for which grants were received. Our obligation to pay these royalties
is contingent on our actual sale of such products and services. In the absence of such sales, no payment of such royalties is required.
Even following full repayment of any IIA grants, we must nevertheless continue to comply with the requirements of the Encouragement of
Research, Development and Technological Innovation in the Industry Law, 5744-1984 (formerly known as the Law for the Encouragement of
Industrial Research and Development, 5744-1984), and related regulations (collectively, the &#8220;Innovation Law&#8221;). When a company
develops know-how, technology or products using IIA grants, the terms of these grants and the Innovation Law restrict the transfer outside
of Israel of such know-how, and the manufacturing or manufacturing rights of such products, technologies or know-how, without the prior
approval of the IIA. Therefore, if aspects of our technologies are deemed to have been developed with IIA funding, the discretionary approval
of an IIA committee would be required for any transfer to third parties outside of Israel of know-how or manufacturing or manufacturing
rights related to those aspects of such technologies. We may not receive those approvals. Furthermore, the IIA may impose certain conditions
on any arrangement under which it permits us to transfer technology or development out of Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The transfer of IIA-supported technology or know-how or manufacturing
or manufacturing rights related to aspects of such technologies outside of Israel may involve the payment of significant penalties and
other amounts, depending upon the value of the transferred technology or know-how, the amount of IIA support, the time of completion of
the IIA-supported research project and other factors. If our products are manufactured outside of Israel, assuming we receive prior approval
from the IIA for the foreign manufacturing, we may be required to pay increased royalties. The increase in royalties depends on the manufacturing
volume that is performed outside of Israel. These restrictions and requirements for payment may impair our ability to sell our technology
assets outside of Israel or to outsource or transfer development or manufacturing activities with respect to any product or technology
outside of Israel. Furthermore, the consideration available to our shareholders in a transaction involving the transfer outside of Israel
of technology or know-how developed with IIA funding (such as a merger or similar transaction) may be reduced by any amounts that we are
required to pay to the IIA.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">It may be difficult to enforce a judgment of
a U.S. court against us, our officers and directors or the Israeli experts named in this annual report in Israel or the United States,
to assert U.S. securities laws claims in Israel or to serve process on our officers and directors and these experts.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are incorporated in Israel. All of our executive officers and
three of our directors listed in this annual report reside outside of the United States, and most of our assets and most of the assets
of these persons are located outside of the United States. Therefore, a judgment obtained against us, or any of these persons, including
a judgment based on the civil liability provisions of the U.S. federal securities laws, may not be collectible in the United States and
may not be enforced by an Israeli court. It also may be difficult for you to effect service of process on these persons in the United
States or to assert U.S. securities law claims in original actions instituted in Israel. Israeli courts may refuse to hear a claim based
on an alleged violation of U.S. securities laws reasoning that Israel is not the most appropriate forum in which to bring such a claim.
In addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable to the
claim. If U.S. law is found to be applicable, the content of applicable U.S. law must be proven as a fact by expert witnesses, which can
be a time-consuming and costly process. Certain matters of procedure will also be governed by Israeli law. There is little binding case
law in Israel that addresses the matters described above. As a result of the difficulty associated with enforcing a judgment against us
in Israel, you may not be able to collect any damages awarded by either a U.S. or foreign court.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">35</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Your rights and responsibilities as a shareholder
will be governed by Israeli law, which differs in some material respects from the rights and responsibilities of shareholders of U.S.
companies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Since we are incorporated under Israeli law, the rights and responsibilities
of our shareholders are governed by our articles of association and Israeli law. These rights and responsibilities differ in some respects
from the rights and responsibilities of shareholders in U.S.-based corporations. In particular, a shareholder of an Israeli company has
a duty to act in good faith and in a customary manner in exercising its rights and performing its obligations towards the company and
other shareholders and to refrain from abusing its power in the company, including, among other things, in voting at the general meeting
of shareholders on certain matters, such as an amendment to the company&#8217;s articles of association, an increase of the company&#8217;s
authorized share capital, a merger of the company and approval of related party transactions that require shareholder approval. A shareholder
also has a general duty to refrain from discriminating against other shareholders. In addition, a controlling shareholder or a shareholder
who knows that it possesses the power to determine the outcome of a shareholders&#8217; vote or to appoint or prevent the appointment
of an office holder in the company or has another power with respect to the company, has a duty to act in fairness towards the company.
However, Israeli law does not define the substance of this duty of fairness. See &#8220;ITEM 6.C. Board Practices.&#8221; Some of the
parameters and implications of the provisions that govern shareholder behavior have not been clearly determined. These provisions may
be interpreted to impose additional obligations and liabilities on our shareholders that are not typically imposed on shareholders of
U.S. corporations. Additionally, the quorum requirements for meetings of our shareholders are lower than is customary for domestic issuers.
As permitted under the Companies Law, pursuant to our articles of association, the quorum required for an ordinary meeting of shareholders
will consist of at least two shareholders present in person, by proxy or by other voting instrument in accordance with the Companies Law,
who hold at least 25% of our outstanding ordinary shares. For an adjourned meeting at which a quorum is not present, the meeting may generally
proceed irrespective of the number of shareholders present at the end of half an hour following the time fixed for the meeting.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">General Risk Factors</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold">If equity research analysts
do not continue to publish research or reports about our business or if they issue unfavorable commentary or downgrade our ordinary shares,
the price of our ordinary shares could decline.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The trading market for our ordinary shares relies in part on the
research and reports that equity research analysts publish about us and our business. We do not have control over these analysts and we
do not have commitments from them to write research reports about us. The price of our ordinary shares could decline if no research reports
are published about us or our business, or if one or more equity research analysts downgrades our ordinary shares or if those analysts
issue other unfavorable commentary or cease publishing reports about us or our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold">Our business could be adversely
impacted by climate change.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The intensifying effects of climate change present physical, liability,
and transition risks with both macro and micro implications for companies and financial markets. There is increasing concern that a gradual
increase in global average temperatures due to increased concentration of carbon dioxide and other greenhouse gases in the atmosphere
are causing significant changes in weather patterns around the globe and an increase in the frequency and severity of natural disasters
(such as floods, droughts, wildfires and severe storms). Such events could, among other things, disrupt our operations, including by damaging
or destroying our facilities or those of our suppliers, which may cause us to suffer losses and additional costs to maintain or resume
operations or as a result of supply chain-related delays or cancellations, which could have an adverse impact on our business and results
of operations. In addition, implementing changes to mitigate risks associated with such events may result in substantial short- and long-term
additional operational expenses, which may materially affect our profitability.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold">Expectations, regulations and scrutiny relating
to environmental, social and governance (ESG) matters&#160; may impose additional costs and expose us to new risks.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">There is an increasing focus from certain investors, clients, regulators,
employees and other key stakeholders or third parties concerning environmental, social and governance (&#8220;ESG&#8221;) factors, including
those relating to climate change, supply chain matters and human capital management. Such increased scrutiny may result in increased costs,
increased risk of litigation or reputational damage relating to our ESG practices or performance, enhanced compliance or disclosure obligations,
or other adverse impacts on our business, financial condition or results of operations. In addition, if we communicate certain initiatives
and goals regarding ESG matters, we could fail, or be perceived to fail, in our achievement of such initiatives or goals, or we could
be criticized for the scope of such initiatives or goals. If we fail to satisfy the expectations of investors and other key stakeholders
or our initiatives are not executed as planned, our reputation and financial results could be materially and adversely affected. Additionally,
the emphasis on ESG matters has resulted and may result in the adoption of new laws and regulations, including new reporting requirements
in various jurisdictions. Our failure to comply with any applicable rules or regulations could lead to penalties and adversely impact
our reputation, customer attraction and retention, access to capital and employee retention. Such ESG matters may also impact our suppliers,
customers and business partners, which may augment or cause additional impacts on our business, financial condition or results of operations.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">36</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: -54pt; margin-left: 54pt; line-height: 1.25; font-weight: bold">Item 4. <span id="tem4."><!--Anchor--></span>&#160;
INFORMATION ON THE COMPANY</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zacfcf8d7cbb2457299aa6a24bba319b4" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25"><br/> &#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">A.</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">History and Development of the Company</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;<span style="font-weight: bold">Our History</span></div>

<div style="line-height: 1.25"><span style="font-weight: bold"> <br/> </span></div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our legal name is MediWound Ltd. and our commercial name is MediWound.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are a company limited by shares organized under the laws of
the State of Israel. MediWound was founded in January 2000. We are registered with the Israeli Registrar of Companies. Our registration
number is 51-289494-0. Our principal executive offices are located at 42 Hayarkon Street, Yavne 8122745, Israel, and our telephone number
is +972 (77)-971-4100.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our agent for service of process in the United States is Puglisi
&amp; Associates, located at 850 Library Avenue, Suite 204, Newark, Delaware 19711, and its telephone number is +1 (302) 738-6680.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The SEC maintains an internet site that contains reports, proxy
and information statements, and other information regarding issuers that file electronically with the SEC at: http://www.sec.gov. Our
website address is www.MediWound.com. Information contained on, or that can be accessed through, our website does not constitute a part
of this annual report and is not incorporated by reference herein. We have included our website address in this annual report solely for
informational purposes.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Principal Capital Expenditures</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; For a description of our
principal capital expenditures and divestitures, see Item 5. &#8220;Operating and Financial Review and Prospects-Liquidity and Capital
Resources&#8221; and Note 15A(3) to our consolidated financial statements included elsewhere in this Annual Report.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8d0f5793724c4451a6fd5ddc425fda51" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">B.</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Business Overview</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are a global leader in next-generation enzymatic therapeutics
focused on non-surgical tissue repair. We specialize in the development, production and commercialization of solutions that seek to improve
existing standards of care. We are committed to providing rapid and effective biologics that improve patient experiences and outcomes,
while reducing costs and unnecessary surgeries.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our first drug, NexoBrid, is an FDA-approved orphan biologic for
eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. NexoBrid is a
topically administered biological product that enzymatically removes nonviable burn tissue, or eschar, in patients with deep partial and/or
full-thickness thermal burns without harming viable tissue. NexoBrid is approved in over 40 countries, including in the United States,
European Union and Japan, where it has been designated as an orphan biologic drug.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">Utilizing the same core biotherapeutic enzymatic
platform technology, we have developed a strong R&amp;D pipeline including our lead drug under development, EscharEx. EscharEx, a phase
III-ready biologic, is a multimodal debridement therapy for the treatment of chronic wounds, with significant potential advantages over
the $360 million dominant product and an opportunity to expand the market. It is a concentrate of proteolytic enzymes enriched in bromelain
for topical, easy to use daily applications. In several Phase II trials, EscharEx was shown to be well-tolerated, and demonstrated positive
efficacy results in debridement and promotion of granulation tissue in various hard-to-heal wounds, with only a few daily applications.
EscharEx&#8217;s mechanism of action is mediated by proteolytic enzymes that cleave to and remove necrotic tissue preparing the wound
bed for healing. The Phase III study in patients with VLU, is expected to initiate in the second half of 2024.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">MediWound&#8217;s pipeline also includes MW005, a topical therapeutic
for the treatment of basal cell carcinoma that has demonstrated positive results in Phase I/II study.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We manufacture NexoBrid and our product candidates in our cGMP
certified sterile manufacturing facility at our headquarters in Yavne, Israel.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">37</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Key Recent Developments</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-weight: bold"><span style="text-decoration: underline">NexoBrid</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#160;In May 2023, we were awarded an additional $10 million from
BARDA. The supplemental funding was intended to support a $3 million replenishment of expired product previously procured for emergency
preparedness, the pediatric indication sBLA submission to the FDA, and enrollment of an additional 50 patients in the ongoing expanded
access treatment protocol (NEXT). &#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In September 2023, NexoBrid was launched in the U.S. by our partner,
Vericel, with more than 50 burn centers submitting packages to Pharmacy and Therapeutics (P&amp;T) committees and more than 25 already
approved. Also, in the third quarter of 2023, NexoBrid was launched in Japan for treating adults and pediatric burn patients, and launched
in the fourth quarter in India.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In September 2023, the Supplemental BLA for pediatric indication
was accepted for review by the U.S. Food and Drug Administration (FDA), with a decision expected in the second half of 2024.In December
2023 we received European Commission approval for the removal of eschar in deep partial- and full-thickness thermal burns for all ages.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In November 2023, we expanded NexoBrid&#8217;s European market
presence by establishing a collaboration with PolyMedics Innovations (PMI) for the promotion of NexoBrid in Germany, Austria, Belgium,
the Netherlands, and Luxembourg.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">During 2023, the DOD through MTEC and directly through MTEC awarded
the Company additional funding of $10.3 million to advance the development and production of a new, temperature-stable formulation of
NexoBrid, positioning it as the first-line non-surgical solution for treating severe burn injuries in pre-hospital settings.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-weight: bold"><span style="text-decoration: underline">EscharEx</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">During 2023 we aligned the U.S. Phase III clinical study protocol
with the European Medicine Agency (EMA) and the FDA, and are expected to submit a final protocol in the first half of 2024. 216 patients
will be treated globally across 40 sites with either EscharEx or a gel vehicle placebo, with an interim assessment to be performed once
67% of participants complete the study. Study initiation is expected in the second half of 2024.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">During 2023 we established research collaborations with 3M, M&#246;lnlycke
and MIMEDX to support the EscharEx Phase III clinical study.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, Times, serif">In February 2024 we published a post-hoc
head-to-head comparative analysis of EscharEx vs SANTYL&#174; using data from a Phase II randomized controlled study, which demonstrated
that EscharEx showed significant superiority over SANTYL in multiple clinical outcome measures: incidence of complete debridement; median
time to achieve complete debridement; incidence of achieving wound bed preparation (WBP); median time to achieve WBP; and time to wound
closure.</div>

<div style="line-height: 1.25">&#160;</div> </div> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">38</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-weight: bold"><span style="text-decoration: underline">MW005</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">In July 2023, we announced positive results in
our U.S. Phase I/II study of MW005 for the treatment of basal cell carcinoma. Fifteen patients were treated with MW005 and completed the
study. Results showed MW005 was well-tolerated, with a high level of patient compliance. Based on clinical assessments, eleven out of
fifteen patients achieved complete clearance of their BCCs; the majority of these patients also had histologically confirmed complete
clearance.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-weight: bold"><span style="text-decoration: underline">Operations</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In July 2023, we signed a turnkey scale-up agreement (the &#8220;Scale-up
Agreement&#8221;) to establish, commission, and validate a cutting-edge, sterile, and GMP-compliant manufacturing facility. Construction
of the new GMP-compliant state-of-the-art manufacturing facility is on track for mid-2024 completion, and is projected to achieve 6-fold
manufacturing capacity increase in 2025.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Alongside entering the Scale-Up agreement, we have also secured
a new lease agreement (the &#8220;Lease Agreement&#8221;) with the current property owner. This agreement allows us to continue the utilization
of our existing facilities and the planned manufacturing site. This property, located in Yavne, Israel, serves as the base for our administrative
headquarters, research and development laboratories, and manufacturing plant. The duration of the lease extends until 2035, with an option
for a further three-year extension until 2038.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Our Focus:</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold"><span style="text-decoration: underline">Burn
Care</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">NexoBrid, a concentrate of proteolytic enzymes enriched in bromelain,
is an easy to use, topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues. Eschar
removal is a critical first step in the successful healing of severe burns. Under existing SOC, burn eschar may be removed either by employing
certain existing topical agents that have been found to be minimally effective or that take a significantly longer period of time to work,
or by resorting to non-selective surgery, which is traumatic and may result in loss of blood and viable tissue. NexoBrid&#8217;s rapid
and selective debridement alleviates the known risks associated with eschar, such as infection, eventual sepsis, wound deterioration and
consequential scarring, and it allows physicians to reach an informed decision on further treatment at an earlier stage by direct visual
assessment of the actual burn depth. Furthermore, NexoBrid minimizes the burden associated with invasive surgical procedures, reduces
the need for skin grafting and sacrifice of healthy tissue from donor sites on a patient&#8217;s body and generally results in a more
favorable overall long-term patient outcome. NexoBrid has been investigated in hundreds of patients across more than 22 countries and
four continents in ten completed Phase II, Phase III and post-marketing clinical studies. Over 14,000 burn patients have been treated
with NexoBrid in the market since 2013 and the safety and efficacy data reported from post-marketing data sources are consistent with
the data available from clinical trials and no new safety signals have been observed. There have been hundreds of presentations and several
award winning abstracts of NexoBrid in international and national scientific conferences, as well as about 120 peer-reviewed papers, resulting
in the support of burn specialists and key opinion leaders. Awareness of NexoBrid continues to grow through our marketing efforts in countries
where the drug is approved.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">39</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="line-height: 1.25; font-style: italic"><span style="text-decoration: underline">Burn Wounds</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Burns are life threatening and debilitating traumatic injuries
causing considerable morbidity and mortality. A burn may result from thermal, electrical or chemical means that destroy the skin to varying
depths. According to Critical Care, an international clinical medical journal, burns are also among the most expensive traumatic injuries
because of long and costly hospitalization, rehabilitation and wound and scar treatment.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Most burn injuries involve part of or the entire thickness of the
skin and in some cases, the deeper subcutaneous fat tissue or underlying structures. The severity of the burn depends on three main factors:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z42e3ebf75a6143fa81abccfcc12c57ec" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">The extent of the surface that the burn occupies is usually referred to as percent
        of total body surface area (&#8220;TBSA&#8221;). A burn on an adult&#8217;s entire palm would generally amount to 1% TBSA, and the average
        hospitalized patient has a burn covering approximately 9% TBSA. Burns covering more than 15-20% TBSA usually require hospitalization and
        may result in dehydration, shock and increased risk of mortality.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="line-height: 1.25">The depth of the burn, referred to in terms of &#8220;degree&#8221; is generally classified into four categories:</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 9%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-style: italic">&#9675;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Superficial or first-degree burns. </span>Such burns
        do not penetrate the basal membrane and usually heal naturally.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 9%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-style: italic">&#9675;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Dermal/partial thickness or second-degree burns.</span>
        Such burns are characterized by varying amounts of damaged dermis and can be further subdivided into superficial and deep partial-thickness
        burns. Superficial partial-thickness burns may heal spontaneously after removal of the covering thin eschar. Conversely, deep partial-thickness
        burns are often difficult for physicians to accurately diagnose before eschar removal and may progress and transform into full-thickness
        burns if not debrided in a timely manner, depending on the magnitude of latent tissue death of the surrounding skin.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 9%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-style: italic">&#9675;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Full thickness or third-degree burns.</span> Such
        burns are characterized by death of the entire dermal tissue down to the subcutaneous fat and must be debrided and treated by autografting,
        which is the process of harvesting skin from healthy donor sites on a patient&#8217;s body and transplanting it on the post-debridement,
        clean wound bed.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 9%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-style: italic">&#9675;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Fourth-degree burns.</span> Such burns, which are
        rare, extend beyond the subcutaneous fat tissue into the underlying structures, such as muscle or bone, and also require debridement and
        further substantial treatment.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Other factors include the age of the victim, the body part where the burn occurred
        and any co-morbidities of the patient. For example, some patients may require hospitalization regardless of the TBSA or degree of the
        burn, such as children, the elderly or victims with burns to the extremities, joints or head/neck area or with co-morbidities such as
        smoke inhalation, diabetes or obesity.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">When patients are hospitalized for a severe burn, the first step
in the treatment after patient stabilization and resuscitation is usually eschar removal. The eschar is the burned tissue in the wound,
which is deprived of blood and isolated from all natural systemic defense mechanisms. Eschar removal is an essential first step in the
treatment of patients with severe burns, allowing for:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf42ee68237cb491c9843bc9810c10cd8" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the prevention of local infection, sepsis (a systemic inflammatory response caused
        by severe infection) and additional damage to surrounding viable tissue; and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the initiation of the body&#8217;s healing process and scar prevention.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">40</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition to minimizing the possibility of additional complications,
once the eschar is removed, a physician may properly diagnose the true extent of the trauma by a direct visual assessment of the clean
wound bed. An informed treatment strategy can be decided upon only if the depth of the burn and extent of the tissue damage is known.
Diagnosis of burn depth is difficult, especially because the burn commonly changes its appearance during the first days after injury due
to burn progression. Burns that are initially difficult to classify due to the presence of eschar are referred to as &#8220;indeterminate&#8221;
burns. This ambiguity can delay the assessment of the burn depth and formulation of proper treatment. Unless the burns are life-threatening,
definitive treatment is postponed for several days post-injury until diagnosis is clearer, when burn progression by death of the surrounding
and underlying tissue has already occurred and ended. During this delay, local and systemic effects of post-burn inflammation and bacterial
contamination can occur. Therefore, earlier, selective eschar removal is essential to prevent eschar-related complications and to allow
the physician to reach an informed decision on further treatment.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">Currently, there are two main treatment modalities for debridement:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd4c9403ce0b5495da29be304ec000859" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="line-height: 1.25">Surgical debridement&#160;</div> </td> </tr>
  </table>

<div><br/> </div>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 9%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#9675;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Surgical debridement predominantly includes tangential excision, a procedure in which
        a surgeon amputates the entire dead tissue mass, layer after layer, down to healthy, viable tissue. The excision is extended into healthy
        intact tissue to make sure that no trace of the eschar remains, resulting in up to an estimated 30-50% of healthy tissue being excised
        during this procedure. Other methods include dermabrasion, in which a mechanically powered, hand-held rotating abrading cylinder is used
        to slowly scrape off tissue, and hydro surgery, in which a high-pressure flow of water abrades the tissue. These alternative methods have
        attempted to limit the trauma associated with tangential excision, but entail spray of contaminated eschar or take a significantly longer
        time to complete than tangential excision.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 9%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#9675;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">The benefits of surgical eschar removal are that it is usually fast and effective.
        Disadvantages include the significant trauma of the procedure, associated blood loss, risk of surgery in delicate areas of the body such
        as hands, added costs, and, most importantly, the loss of viable tissue that necessitates additional surgical procedures for harvesting
        skin from healthy donor sites and autografting.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 9%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#9675;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Due to the disadvantages of surgery in extensive burns some surgeons limit their debriding
        surgery to only a part of the affected area in a single session (15-30% TBSA in most centers), thus delaying full debridement by days.
        After several days, complications related to eschar contamination may begin and some of the benefits of the earlier debridement may not
        be realized. On the other hand, when excising burns immediately, all suspected necrotic tissue will be excised, inevitably resulting in
        over-excision, especially in &#8220;indeterminate&#8221; burns, as after surgical excision, the remaining skin often no longer has any
        spontaneous healing potential and will heal only by autografting.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="line-height: 1.25">Non-surgical debridement&#160;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 9%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#9675;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Non-surgical debridement includes many different treatment options that do not require
        direct surgical removal of the skin to remove eschar. With non-surgical debridement, the eschar is naturally, but slowly, removed by contaminant
        microorganisms, tissue autolysis, or self-decomposition, and the inflammatory process that may lead to serious local and systemic complications.
        In seeking to facilitate such natural processes, topical medication, anti-microbial agents, enzymes and biological/chemical applications
        are often applied onto the eschar.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 9%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#9675;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">The benefits of this approach are that it is non-surgical, reduces trauma to the patient
        and is easier to apply. Disadvantages include numerous dressing changes and mechanical scraping with limited debridement efficacy. This
        prolongs the eschar removal process, which may lead to death of the tissue surrounding the initial burn wound, causing partial-thickness
        wounds to transform into full-thickness wounds and forming granulation tissue that may develop into heavy scars.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As demonstrated in our clinical trials, NexoBrid combines the advantages
of surgical and non-surgical debridement modalities by providing rapid and effective eschar removal while not harming viable tissue. This
allows for earlier direct visual assessment of the burn wound in order to formulate proper treatment.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">41</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic"><span style="text-decoration: underline">Market Opportunity</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Severe burns require specialized care in hospitals or burn centers.
Approximately 160,000 patients with severe burns are hospitalized every year in the United States and Europe. The prevalence of patients
with severe burns is even higher in emerging economies. For example, approximately 400,000 patients are hospitalized every year with burns
in India according to a study conducted by IMS Health. The severe burn patients are predominantly treated by specialists in approximately
250 burn centers in Europe and the United States, as well as at burn units of large hospitals in Europe. We believe these patients can
benefit from NexoBrid&#8217;s effective and selective, non-surgical eschar removal.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition to our current marketing of NexoBrid in Europe and
the United States, we have signed local distribution agreements for distribution of NexoBrid in Europe, Asia-Pacific countries, members
of the Commonwealth of Independent States (&#8220;CIS&#8221;) and the Middle East and we plan to target additional markets in these territories
by leveraging our approved registration file for additional regional marketing authorizations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition to the market opportunities for NexoBrid discussed
above, we believe that NexoBrid has the potential to play a critical role in the event of a burn mass casualty incident (&#8220;BMCI&#8221;),
which is generally defined as any incident in which emergency medical services resources, such as personnel and equipment, are overwhelmed
by the number and severity of casualties. A variety of public emergencies may give rise to a BMCI, such as terrorist attacks, natural
disasters, fires and explosions. One example of a BMCI is a mass burn casualty disaster, which is defined by the American Burn Association
as a catastrophic event in which the number of burn victims exceeds the capacity of the local burn center to provide optimal care. If
a significant number of burn victims arrive at a burn center following an event, some victims may go untreated until the bottleneck is
resolved. The use of non-surgical means that are capable of providing rapid eschar removal without harming healthy tissue, particularly
during public health emergencies, could potentially reduce the time, labor and resource burdens associated with the current standard-of-care,
thereby enabling the treatment of more patients. In the event of a mass burn casualty disaster, healthcare professionals can use NexoBrid
to begin treatment at the patient&#8217;s bedside without the need for a surgical team and facilities. NexoBrid has demonstrated in clinical
studies, with statistical significance, its ability to non-surgically and rapidly remove eschar in a single four-hour application. Once
the acute treatment has been completed, the wound can be covered with available means and further managed once the BMCI is under control
and the bottlenecks resolved. NexoBrid has been recognized by BARDA as a medical countermeasure for treatment of burns in the event of
a BMCI. Additionally, during the war in Israel, the entire non-U.S. NexoBrid inventory has been deployed to hospitals in Israel and the
military, to effectively treat those affected by the war.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic"><span style="text-decoration: underline">BARDA Contracts</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In In September 2015, we were awarded the First BARDA Contract
for treatment of thermal burn injuries. This contract was amended several times over the years to extend its term until September 2024
(the Company is pursuing an extension of the contract) and its total value, up to a total amount of $165 million as of the end of 2022.
In May 2023 BARDA expanded its awarded contract by providing supplemental funding of $10 million to support a $3 million replenishment
of expired product previously procured for emergency preparedness, the pediatric indication sBLA submission to the FDA, and enrollment
of an additional 50 patients in the expanded access treatment protocol (NEXT).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The First BARDA Contract provided funding and technical support
for the pivotal U.S. Phase 3 clinical study (DETECT), the randomized, controlled pivotal clinical trial for use in the pediatric population
(CIDS), the marketing approval registration process for NexoBrid as well as its procurement and availability under the expanded access
treatment protocol (NEXT) in the U.S.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25">The total amount of the First BARDA Contract is comprised of up to $110 million to support
research and development activities and up to $65 million to procure NexoBrid for U.S. emergency preparedness.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">42</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As of December 31, 2023, the Company has received approximately
$88 million in funding in the aggregate, under the First BARDA Contract, and an additional $16.5 million for procurement of NexoBrid for
U.S. emergency preparedness.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The first BARDA Contract may be terminated by BARDA at any time
at BARDA&#8217;s discretion.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25">In September 2018, we were awarded an additional, separate BARDA contract (the &#8220;Second
BARDA Contract&#8221;), to develop NexoBrid for the treatment of Sulfur Mustard injuries as part of BARDA&#8217;s preparedness for mass
casualty events. The Second BARDA Contract provides approximately $12 million of funding to support research and development activities
up to pivotal studies in animals under the U.S. FDA Animal Rule, and contains options for BARDA to provide additional funding of up to
$29 million for additional development activities, animal pivotal studies, and the BLA submission for licensure of NexoBrid for the treatment
of sulfur mustard injuries. The Second BARDA Contract was expired in 2023. As of December 31, 2023, the Company has received approximately
$4.4 million of funding from the Second BARDA contract.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic"><span style="text-decoration: underline">DOD and MTEC contracts</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In February, 2023, the Company was entered in to a contract with
the U.S. Department of Defense (DoD), through the Medical Technology Enterprise Consortium (MTEC), for development and production of a
new, temperature-stable formulation of NexoBrid, positioning it as the first-line non-surgical solution for treating severe burn injuries
in pre-hospital settings. The contract provides funding up to $2.7 million.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">During 2023, the DOD through MTEC and directly through MTEC awarded
the Company additional funding of $10.3 million to advance this development of a new temperature stable formulation of NexoBrid.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The MTEC contract may be terminated by MTEC at any time at MTEC&#8217;s
discretion.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic"><span style="text-decoration: underline">NexoBrid Clinical History</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">NexoBrid, our innovative biopharmaceutical product, has received
marketing authorizations from the U.S., European Commission and the Israeli, Argentinean, South Korean, Russian, Peruvian, Chilean, Taiwanese,
Ukrainian, other Eurasian states, United Arab Emirates, Japanese and Indian Ministries of Health for the removal of eschar in adults with
deep partial- and full-thickness thermal burns. The active ingredient of NexoBrid is a concentrate of proteolytic enzymes enriched in
bromelain extracted from pineapple stems. Proteolysis is a breakdown of proteins into smaller building blocks, polypeptides or amino acids.
Our research and development strategy is centered around our validated proteolytic enzyme platform technology, focused on next-generation
bio-active therapies for burn and wound care and biological medicinal products for tissue repair. For each indication, our research and
development team further develops and optimizes our enzymatic platform technology, creating unique and differentiated products meeting
separate needs based on the specific indication, which is the basis for NexoBrid, EscharEx and all other pipeline product candidates.
One vial of NexoBrid containing 2 grams of concentrate of proteolytic enzymes enriched in bromelain is sufficient for treating a burn
wound area of 1% total body surface area (&#8220;TBSA&#8221;). We developed NexoBrid to fulfill the previously unmet need for a non-surgical
effective and selective debriding agent that combines the efficacy and speed of surgery with the non-invasiveness of non-surgical methods.
NexoBrid enhances the ability of physicians to conduct an earlier direct visual assessment of the burn depth to reach an informed decision
on further treatment as well as to reduce the surgical burden and achieve a favorable long-term patient outcome.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">NexoBrid has been investigated in hundreds of patients across 22
countries and four continents in ten completed Phase II and Phase III and post-marketing clinical studies. While we are marketing our
product for the removal of eschar in burn wounds under the name &#8220;NexoBrid,&#8221; in clinical trials the product has been referred
to as &#8220;Debridase&#8221; and &#8220;Debrase.&#8221;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">43</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The following table sets forth information regarding the completed
clinical trials of NexoBrid:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="3" border="0" id="z171ae2aac49341c7a704e22e98c38547" style="font: 10pt Times New Roman,Times,serif; width: 100%; text-align: left; color: rgb(0, 0, 0)">
  <tr>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 7.7%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 9.19%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Trial 1</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.36%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Trial 2</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.55%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Trial 3</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.97%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Trial 4</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.69%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Trial 5</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.6%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Trial 6</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Trial 7</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 10%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Trial 8</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.78%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Trial 9</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 10.56%; vertical-align: top; border-right: rgb(0, 0, 0) 1px solid; border-left: rgb(0, 0, 0) 1px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Trial 10</div> </td>
        </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 7.7%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="margin-left: 1.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Study Type</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 9.19%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Retrospective Phase II</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Investigator initiated</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.36%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Dose range Phase II</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.55%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Prospective Phase II</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">IND/FDA</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.97%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Phase II</div>
        <div style="text-indent: -8.65pt; margin-left: 18.7pt; line-height: 1.25; font-family: Times New Roman, Times, serif">IND/FDA</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.69%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Phase III</div>
        <div style="text-indent: -8.65pt; margin-left: 18.7pt; line-height: 1.25; font-family: Times New Roman, Times, serif">EMA</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.6%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="text-indent: -8.65pt; margin-left: 9.35pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Phase IIIb</div>
        <div style="text-indent: -8.65pt; margin-left: 18.7pt; line-height: 1.25; font-family: Times New Roman, Times, serif">EMA</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="text-indent: -8.65pt; margin-left: 9.35pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Phase II</div>
        <div style="text-indent: -8.65pt; margin-left: 18.7pt; line-height: 1.25; font-family: Times New Roman, Times, serif">EMA</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 10%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Post approval safety study</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">EMA</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.78%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Phase III</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">IND/FDA</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 10.56%; vertical-align: top; border-right: rgb(0, 0, 0) 1px solid; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Phase III</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">IND/FDA</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 7.7%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="margin-left: 1.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Design</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 9.19%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Data collected from files of patients treated with NexoBrid</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.36%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Parallel, controlled, observer-<br/> blind, randomized, single-center</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.55%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Parallel, controlled, observer-<br/> blind, three-arm, randomized,
        multi-center</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.97%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Parallel, controlled, open label, three-arm, randomized, single-center</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.69%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Parallel, controlled, open label, two-arm, randomized, multi-center</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.6%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Parallel, controlled, blinded, two-arm, multi-center</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Open label,<br/> single-arm,<br/> multi-center</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 10%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Observational retrospective data collection</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.78%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Parallel, controlled, open label, three-arm, randomized, multi-center</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 10.56%; vertical-align: top; border-right: rgb(0, 0, 0) 1px solid; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">multicenter, multinational, randomized, controlled, open-label
        study in children</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 7.7%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="margin-left: 0.7pt; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Main Objectives</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 9.19%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Safety and efficacy</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.36%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="margin-left: 0.7pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Comparison of efficacy and safety</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.55%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Safety and efficacy</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.97%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="text-indent: -8.65pt; margin-left: 18.7pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Safety</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.69%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Safety</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Efficacy</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.6%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Long-term scar assessment</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Quality of life</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Safety and pharmacokinetics</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Efficacy</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 10%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Effectiveness of the risk minimization activities</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.78%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Safety</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Efficacy</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 10.56%; vertical-align: top; border-right: rgb(0, 0, 0) 1px solid; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Safety</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Efficacy</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 7.7%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="margin-left: 1.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Wound Types</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 9.19%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Deep partial/full thickness thermal burns</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.36%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Deep partial /full thickness thermal burns</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.55%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Deep partial /full thickness thermal burns</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.97%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Deep partial /full thickness thermal burns</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.69%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Deep partial/ full thickness thermal burns</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.6%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Scar formation</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Deep partial/full thickness thermal burns</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 10%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Burns which were treated with NexoBrid in the market</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.78%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Deep partial/ full thickness thermal burns</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 10.56%; vertical-align: top; border-right: rgb(0, 0, 0) 1px solid; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Deep partial/ full thickness thermal burns</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 7.7%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="margin-left: 0.7pt; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Number of Patients</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 9.19%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">154</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.36%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">20</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.55%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">140</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.97%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="text-indent: -8.65pt; margin-left: 18.7pt; line-height: 1.25; font-family: Times New Roman, Times, serif">30</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.69%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">182</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.6%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">89</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">36</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 10%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">160</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.78%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">175</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 10.56%; vertical-align: top; border-right: rgb(0, 0, 0) 1px solid; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">145</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 7.7%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="margin-left: 1.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Study Length</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 9.19%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">1985-2000</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.36%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">2002-2005</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.55%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">2003-2004</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.97%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="text-indent: -8.65pt; margin-left: 9.35pt; line-height: 1.25; font-family: Times New Roman, Times, serif">2006-2007</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.69%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">2006-2009</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.6%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">2011</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">2009-2015</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 10%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">2017-2019</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.78%; vertical-align: top; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">2015-2020</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 10.56%; vertical-align: top; border-right: rgb(0, 0, 0) 1px solid; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">2015-2023</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 7.7%; vertical-align: top; border-bottom: rgb(0, 0, 0) 1px solid; border-left: rgb(0, 0, 0) 1px solid">
        <div style="margin-left: 1.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Location</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 9.19%; vertical-align: top; border-bottom: rgb(0, 0, 0) 1px solid; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Israel</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.36%; vertical-align: top; border-bottom: rgb(0, 0, 0) 1px solid; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Israel</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.55%; vertical-align: top; border-bottom: rgb(0, 0, 0) 1px solid; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">International</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.97%; vertical-align: top; border-bottom: rgb(0, 0, 0) 1px solid; border-left: rgb(0, 0, 0) 1px solid">
        <div style="text-indent: -8.65pt; margin-left: 9.35pt; line-height: 1.25; font-family: Times New Roman, Times, serif">United States</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.69%; vertical-align: top; border-bottom: rgb(0, 0, 0) 1px solid; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">International</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.6%; vertical-align: top; border-bottom: rgb(0, 0, 0) 1px solid; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">International</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; vertical-align: top; border-bottom: rgb(0, 0, 0) 1px solid; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">International</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 10%; vertical-align: top; border-bottom: rgb(0, 0, 0) 1px solid; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Europe</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 1px solid; width: 8.78%; vertical-align: top; border-bottom: rgb(0, 0, 0) 1px solid; border-left: rgb(0, 0, 0) 1px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">International</div>
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;</div> </td>
    <td style="border: rgb(0, 0, 0) 1px solid; width: 10.56%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">International</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic"><span style="text-decoration: underline">Completed clinical trails</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Pediatric investigational plan - CIDS study</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The CIDS study was a Phase III, multicenter, multinational, randomized,
controlled, open-label study in children with thermal burns. The study objectives were to evaluate the efficacy and safety of treatment
with NexoBrid compared with SOC in hospitalized children with severe thermal burns of 1% to 30% TBSA. We expanded this study also to United
States burn centers, following approval of the study protocol by the FDA. The study was conducted in accordance with a study design endorsed
by the FDA and the EMA as part of the agreed Pediatric Investigational Plan (&#8220;PIP&#8221;) to support extension of the indication
to pediatric patients. The CIDS study included pediatric patients of all ages, from newborn to eighteen years of age, offering NexoBrid
to this important and sensitive group of patients. The primary endpoints evaluate early eschar removal, surgical burden, and cosmesis
and function with a 12-month follow-up. Secondary endpoints included reduction in the need for surgical excision for eschar removal (surgical
need), blood loss, reduction of the need for autograft in DPT wounds and non-inferiority in cosmesis and function at twenty-four months
follow-up from wound closure. Additional extended long term cosmesis and function assessment at more than 30 months from wound closure
was added to the protocol. Non-inferiority of the time to complete wound closure and other standard safety measurements were also compared
with the SOC control arm.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">44</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The study was expanded to include burn centers in the United States
following agreement with the FDA, under the same protocol with alignment to the U.S. Phase III study (DETECT) protocol for the adult population.
The non-inferiority of cosmesis and function at twelve months and twenty-four months from wound closure were defined as safety measurements.
In addition, reduction in surgical need was measured only by reduction in incidence of surgical excision for eschar removal.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#160;The Phase III study met its three primary endpoints with
a high degree of statistical significance. NexoBrid demonstrated a significant reduction in the time to achieve complete eschar removal
and a significant reduction in the wound area requiring surgical excision (surgical need) while demonstrating non-inferiority to SOC in
quality of scars as measured by MVSS. The study also met certain secondary endpoints showing statistically significant reduction in the
incidence of surgical excision and a reduction in the need for autograft in deep partial thickness burns, as well as a favorable trend
in the reduction of blood loss during the eschar removal process. In addition, the study confirmed NexoBrid to be safe and well-tolerated
for all ages.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Based on these results, we received in December 2023 the European
Commission approval for the removal of eschar in deep partial- and full-thickness thermal burns for all ages.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Additionally, In September 2023, the Supplemental BLA for pediatric
indication was accepted for review by the U.S. Food and Drug Administration (FDA), with a decision expected in the second half of 2024.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic"><span style="text-decoration: underline">Ongoing clinical trials</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Expanded access treatment protocol (&#8220;NEXT&#8221;)</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25">The NEXT protocol, which we initiated in October 2019, is an
open-label, single-arm treatment protocol which allows for the treatment of up to 250 burn patients with deep partial- and full-thickness
thermal burns up to 30% TBSA. In September 2020, the FDA agreed to allow the NEXT protocol to be expanded to include pediatric as well
as adult burn patients. The NEXT protocol is being funded by BARDA. See &#8220;BARDA Contracts&#8221; above. NEXT has been designed to
be consistent with current real-life burn treatment practices in the U.S. and up to 30 U.S. burn centers are anticipated to participate.
We received FDA concurrence that patients can be treated under the NEXT protocol in a burn MCI that is not a declared national emergency.
Following the commercial availability of NexoBrid in the U.S., NEXT is scheduled to be closed during the first half of 2024.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold"><span style="text-decoration: underline">Wound
Care</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">EscharEx, a phase III-ready biologic, is a multimodal
debridement therapy for the treatment of chronic wounds, with significant potential advantages over the $360 million dominant product
and an opportunity to expand the market. It is a concentrate of proteolytic enzymes enriched in bromelain for topical, easy to use daily
applications. In several Phase II trials, EscharEx was shown to be well-tolerated, and demonstrated its positive efficacy results in debridement
and promotion of granulation tissue in various hard-to-heal wounds, with only a few daily applications. EscharEx&#8217;s mechanism of
action is mediated by proteolytic enzymes that may cleave to and remove the necrotic tissue, preparing wound bed for healing.</div> </div>
</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic"><span style="text-decoration: underline">Chronic and Other Hard-to-Heal Wounds</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The chronic and other hard-to-heal wound market consists of a broader
addressable population of more than 14 million patients in Europe and the United States alone suffering from chronic wounds such as VLUs,
DFUs, pressure ulcers and additional patients suffering from surgical/traumatic hard-to-heal wounds. Chronic and other hard-to-heal wounds
represent a $25 billion burden to the U.S. healthcare system. Chronic and hard-to-heal wounds are caused by impairment in the biochemical
and cellular healing processes due to local or systemic conditions and generally can take several weeks to heal, if not longer. Such wounds
can lead to significant morbidity, including pain, infection, impaired mobility, hospitalization, reduced productivity, amputation and
mortality. In each of the various wound types, the presence of the eschar and/or other devitalized tissue is a frequent cause for &#8220;chronification&#8221;
of wounds and the removal of this non-viable material is the key step to commence healing. The non-viable material needs to be removed
to prevent further deterioration of the wound that may result in additional adverse patient outcomes. If not effectively treated, these
wounds can lead to potentially severe complications including further infection, osteomyelitis, fasciitis, amputation and mortality. Most
advanced wound care therapies, including negative pressure wound therapy, such as V.A.C. Therapy, and skin substitutes such as Apligraf
and Dermagraft and human amniotic tissue products, are complementary to our lead product candidate, EscharEx, as these products require
a clean wound bed to effectively heal a wound. Four common chronic and other hard-to-heal wounds are:</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">45</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zba8b823082004ae7acacbba931c66ead" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Venous leg ulcers</span>. VLUs develop as a result
        of vascular insufficiency, or the inability for the vasculature of the leg to return blood back toward the heart properly. Based on our
        comprehensive market research study on EscharEx that involved more than 200 healthcare professionals in the U.S. and Europe, which was
        last updated in 2022, the VLU overall prevalence is approximately 3.3 million (1% of total U.S. population). Furthermore, the annual incidence
        of VLUs in the U.S. alone, is approximately 960,000 (accounting for 45% recurrence), of which approximately 690,000 undergo debridement
        in a given year. These ulcers usually form on the sides of the lower leg, above the ankle and below the calf, and are slow to heal and
        often recur if preventative steps are not taken. The risk of VLUs can increase as a result of a blood clot forming in the deep veins of
        the legs, obesity, smoking, lack of physical activity or work that requires many hours of standing.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Diabetic foot ulcers</span>. Diabetes can lead to
        a reduction in blood flow, which can cause patients to lose sensation in their feet and may prevent them from noticing injuries, sometimes
        leading to the development of DFUs, which are open sores or ulcers on the feet that may take several weeks to heal, if ever. Based on
        our comprehensive market research study conducted in 2015 on EscharEx that involved more than 200 healthcare professionals in the U.S.
        and Europe and, which was updated in 2022, there were estimated 31 million diabetics in the United States in 2019 (9.4% of the U.S. population).
        The annual incidence of DFUs in the United States alone is approximately 990,000 (accounting for 45% recurrence), of which approximately
        820,000 undergo debridement in a given year.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Pressure ulcers.</span> Pressure ulcers , also known
        as pressure sores, or bed sores, are injuries to the skin or the tissue beneath the skin caused by pressure applied to the skin and subsequent
        death of the tissue as a result of the reduced blood supply. These often occur in patients who are hospitalized or confined to a chair
        or bed, and usually form over bony areas, where there is little cushion between the bone and the skin, such as heels, elbows, the sacral
        area, and back of the head. Annually, 2.5 million pressure ulcers are treated in the United States in acute care facilities alone.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Surgical/traumatic wounds.</span> Surgical wounds
        form as a result of various types of surgical procedures such as investigative or corrective, minor or major, open (traditional) or minimal
        access surgery, elective or emergency, and incisions (simple cuts) or excision (removal of tissue), among others. Traumatic wounds form
        as a result of cuts, lacerations or puncture wounds, which have caused damage to the skin and underlying tissue. Severe traumatic wounds
        may require surgical intervention to close the wound and stabilize the patient. Surgical/traumatic hard-to-heal wounds develop for various
        reasons, such as local surgical complications, suboptimal closure techniques, presence of foreign materials, exposed bones or tendons
        and infection. In the United States, millions receive post-surgical wound care annually.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="line-height: 1.25; font-style: italic"><span style="text-decoration: underline">Market Opportunity</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Currently, surgery (sharp debridement) is generally considered
a first-line option. Sharp debridement is an effective method to debride a wound. However, this method requires surgically skilled physicians
performing surgery with patients under, anesthesia, which in elderly patients with various co-morbidities is accompanied with a higher
risk of local and systemic complications. Surgery may also involve hemorrhage which could be more difficult to control due to a high incidence
of use of anticoagulants in this population. Surgery on wounds may very easily become infected, with the infection propagating to surrounding
soft and boney tissues ending in life threatening major complication or amputation. Very often even minor, limited sharp debridement exposes
other sensitive tissue, such as tendons, deep vessels/nerves and bones that may become infected or may be severely damaged, necessitating
additional, more extensive debridement or even amputation. Due to these limitations, chronic wounds are treated by conservative methods,
with autolytic and enzymatic debridement being the most commonly-used non-sharp methods. This includes a collagenase-based enzymatic debriding
ointment, hydrogels and other topical dressings, which require numerous application sessions and a long time (6-8 weeks) to achieve a
clean wound bed, if they achieve this at all. Thus, there is an unmet medical need for a non-surgical rapid and effective debridement
agent for all care settings. Given the high demand for an effective non-surgical debridement technique and the clinical data generated
to date, EscharEx has the potential to expand the current use of enzymatic debridement across all sites of care and achieve substantial
market share. As documented in the Phase II study described below, EscharEx significantly improved the rate of complete debridement after
few once-daily applications, thus potentially facilitating wound debridement without the need for surgery. Based on our comprehensive
market research study on EscharEx that involved more than 200 healthcare professionals in the U.S. and Europe, which was last updated
in 2022, the EscharEx TAM for VLUs and DFUs is estimated at approximately $2 billion in the U.S. This market research and physician feedback
suggests potential market share for EscharEx at approximately 30%. Due to traditional drug pricing disparities between the U.S. and countries
within the EU, we expect the TAM for the market in the EU to be less than that of the U.S., but to be roughly similar on a unit volume
basis.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">46</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic"><span style="text-decoration: underline">EscharEx Clinical History</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">EscharEx is a topical agent being developed for
debridement of chronic wounds, in order to fulfill an unmet need for a non-surgical rapid and effective debridement option. EscharEx is
based on the same active substance as NexoBrid but differs in other aspects, such as in formulation and presentation. Based on our current
pre-clinical studies, EscharEx demonstrated even higher potency in lower doses, which could further contribute to EscharEx&#8217;s potential
efficacy and tolerability. EscharEx has been designed in accordance with the current treatment workflow and reimbursement programs, providing
a non-surgical easy-to-use, potent product for daily application, which we believe will enhance patient compliance and improve quality
of care. Based on the feedback received from different stakeholders, we believe that EscharEx can address the unmet medical need for a
non-surgical rapid and effective product, particularly in the outpatient setting, where the majority of patients are treated, and has
a greater potential to achieve substantial market share.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">EscharEx is more differentiated from NexoBrid, which further limits
the chances for competition between the two products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Non-clinical safety studies performed with NexoBrid support EscharEx
development, and we have already completed successful bridging toxicology studies. In a pre-IND meeting the FDA stated that existing toxicology
data for EscharEx, including cross-referenced NexoBrid data, could be sufficient to support initiation of clinical studies in the product.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">Following discussions with the regulatory authorities,
we aligned the Phase III study protocol with EMA and the FDA, and are on track to submit a final protocol in the first half of 2024. 216
patients will be treated globally across 40 sites with either EscharEx or a gel vehicle placebo, with an interim assessment to be performed
once 67% of participants complete the study. Study initiation is expected in the second half of 2024. Additionally, we established research
collaborations with 3M, M&#246;lnlycke and MIMEDX to support the EscharEx Phase III clinical study.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic"><span style="text-decoration: underline">Completed clinical trials</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We completed a first Phase II feasibility study in Israel for chronic
and other hard-to-heal wounds. In January 2017 we completed and announced the final results of a second Phase II prospective study in
Israel and Europe. In November 2017, we announced the final results of a second cohort of the second Phase II study. Based on the completed
studies, we believe that our product candidate may be effective for debridement of chronic and other hard-to-heal wounds.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">First Phase II feasibility study-Israel</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">This first Phase II feasibility study was conducted
in Israel to study the efficacy of our technology on chronic and other hard-to-heal wounds. The study assessed 24 patients at two sites.
The results showed that our technology demonstrated positive efficacy results in debriding various chronic and other hard-to-heal wound
etiologies, such as VLUs, DFUs, pressure sores and trauma on diseased skin.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Second Phase II study-Israel/E.U. - First Cohort</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">This second Phase II study was a prospective, controlled, assessor-blinded,
randomized, multi-center Phase II study in Israel and Europe. The study objectives were to evaluate the efficacy and safety of EscharEx
in comparison to the Gel Vehicle at a ratio of 2:1 for the treatment of a variety of chronic and other hard-to-heal wounds in three etiologies:
DFUs, VLUs and post-surgical or traumatic hard-to-heal wounds.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">47</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The primary endpoint assessed incidence of complete non-viable
tissue removal (debridement) at the end of the debridement period (within up to 10 daily applications) and the secondary endpoints assessed
various efficacy and safety endpoints, including wound bed preparation and wound healing.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">In January 2017 we reported final results of the
first cohort of 73 patients<span style="font-style: italic">.</span> The average wound age in the EscharEx arm was more than double (72.8
weeks) that of the gel vehicle group (30.8 weeks). The average wound size was 33.6 cm2 in the EscharEx arm vs. 25.8 cm2 in the gel vehicle
group. Despite the larger wounds and that wounds treated with EscharEx were older than wounds treated with gel vehicle (72.8 vs. 30.8
weeks), the study met its primary endpoint. EscharEx demonstrated a statistically significantly higher incidence of complete debridement
at the end of the debridement period. Patients treated with EscharEx demonstrated a higher incidence of complete debridement (55% or 27/49)
compared with patients treated with the hydrogel6 vehicle (29% or 7/24) with p=0.047.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; text-indent: 36pt; line-height: 1.25"><img src="image0.jpg" alt="" style="width: 216px; height: 217px"/>*w/i
10 daily applications</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Predefined sub-group analyses showed that 50% of patients with
DFUs treated with EscharEx (8/16) achieved complete debridement at the end of the debridement period compared with 14.3% of patients with
DFUs treated with hydrogel vehicle (1/7). In addition, 62.5% of patients with VLUs treated with EscharEx (10/16) achieved complete debridement
at the end of the debridement period compared with 25% of patients with VLUs treated with hydrogel vehicle (2/8). Post hoc analysis showed
that 56.3% of patients with VLU or DFU in the EscharEx group had complete debridement at the end of the debridement period compared with
20.0% in hydrogel vehicle group (p=0.028).</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">48</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">The study included secondary endpoints that provide
further insight into number of efficacy and safety parameters. The secondary endpoint of time to complete debridement demonstrated a clear
trend (p=0.075) that strongly suggests that not only was there a difference in the incidence of debridement, as demonstrated by the primary
endpoint, but that debridement occurred earlier in the group treated by EscharEx. The advantage in time to complete debridement was corroborated
by the statistically significant post hoc result in the subgroup of patients with VLUs or DFUs that were treated with EscharEx (p=0.024).</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25"><img src="image1.jpg" alt="" style="width: 354px; height: 596px"/></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Post hoc analysis showed that of patients who achieved complete
debridement in the EscharEx group, 93% (25/27) completed the debridement within 7 days (4-5 applications on average).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">The overall patient demographics were comparable
across both arms. No deleterious effect on wound healing was observed and no material differences were found in reported adverse events.
The overall safety data were comparable between the arms.</div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">49</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Second Phase II study-Israel/E.U. - Second Cohort</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">After successfully completing the first cohort
of the study which included 73 patients recruited in 15 clinical sites, we initiated a second cohort of patients to evaluate safety and
tolerability over extended periods of application. In this second cohort, we recruited 38 patients from two etiologies, either VLUs or
DFUs, over extended periods of application (24-72 hours) with up to eight applications, randomizing the patients to two study arms EscharEx
or gel vehicle at a ratio of 2:1. The primary objective was to assess safety.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">EscharEx met its primary safety endpoint in this cohort, and the
overall patient demographics and wound baseline characteristics were comparable across the arms in the second cohort. No related systemic
adverse events were reported and adverse events related to local application were mild to moderate, reversible and resolved during the
trial. Vital signs, pain scores, infection rates, laboratory parameters and blood loss were comparable between the two arms of the trial.
Overall, no material safety concerns were identified.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">EscharEx U.S. Phase II Study in Venous Leg Ulcer (VLU) Patients</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25; text-align: justify">In December 2019, we initiated a U.S. Phase II adaptive design
clinical study of EscharEx for the treatment of VLUs. The study was a multicenter, prospective, randomized, placebo-controlled, adaptive
design study, evaluating the safety and efficacy of EscharEx in debridement of VLUs compared to gel vehicle (placebo control) and non-surgical
standard-of-care of either enzymatic or autolytic debridement (NSSOC). The study enrolled 120 patients, with 119 treated at approximately
20 clinical sites, primarily in the U.S. Study participants were treated with either EscharEx (n=46), gel vehicle control (n=43), or non-surgical
standard-of-care (n=30), with a three-month follow-up. The single primary endpoint was incidence of complete debridement (non-viable tissue
removal), clinically assessed, within up to 8 treatment applications during the assessment period (within 14 days), compared to gel vehicle
placebo control. Secondary and exploratory endpoints assessed time to achieve complete debridement, reduction of pain, reduction of wound
area, granulation tissue and wound quality of life, enabling evaluation of clinical benefits compared to both gel vehicle and NSSOC. Incidence
and time to achieve wound closure were assessed as safety measurements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">

<div style="text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25">In May 2022 we announced our results from this study. The study met its primary endpoint
with a high degree of statistical significance, demonstrating that patients treated with EscharEx had a statistically significant higher
incidence of complete debridement during the 14-day measurement period within up to 8 applications compared to gel vehicle (EscharEx:
63% (29/46) vs. gel vehicle: 30% (13/43), p-value=0.004). EscharEx efficacy results remained statistically significant compared to gel
vehicle after adjusting for pre-specified covariates ascribed to patient baseline characteristics, wound size, wound age and region.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; text-indent: 36pt; line-height: 1.25"><img src="image2.jpg" alt="" style="width: 332px; height: 380px"/></div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">50</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The study met key secondary and exploratory endpoints. Patients
treated with EscharEx had a statistically significant higher incidence of complete debridement, during the same 14-day measurement period,
compared to patients treated by non-surgical standard-of-care ("NSSOC") (EscharEx: 63% (29/46) vs. NSSOC: 13% (4/30)) and the time to
achieve complete debridement was significantly shorter. Estimated median time to complete debridement was 9 days for patients treated
with EscharEx and 59 days for patients treated with NSSOC (p-value=0.016). On average, complete debridement was achieved after 3.6 applications
of EscharEx compared to 12.8 applications with NSSOC. Patients treated with EscharEx demonstrated significantly higher incidence of greater
than 75% granulation tissue at the end of the treatment period compared to gel vehicle (p-value &lt;0.0001). Favorable trends were observed
in wound area reduction and reduction of pain compared to gel vehicle.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; text-indent: 36pt; line-height: 1.25"><img src="image3.jpg" alt="" style="width: 536px; height: 428px"/>

<div><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">51</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; text-indent: 36pt; line-height: 1.25"><img src="image4.jpg" alt="" style="width: 492px; height: 420px"/></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">In addition, the study showed that EscharEx was
well tolerated, and the overall safety results were comparable between the arms as assessed by the data safety monitoring board. Importantly,
there were no observed deleterious effects on wound closure and no material differences in reported adverse events. Estimated time to
complete wound closure was 64 days for patients treated with EscharEx compared to 78 days for patients treated with NSSOC.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="line-height: 1.25">

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif"><span style="color: #000000">Post-hoc
analyses from this study assessed the incidence and time to wound bed completely covered with granulation tissue. The incidence of achieving
complete debridement and complete cover of the wound bed with granulation tissue (i.e., wound bed preparation, WBP) during the daily treatment
period was 50.0% for EscharEx vs. 25% for the Gel Vehicle (p-value= </span>0.01) <span style="color: #000000">and 10% for NSSOC</span>&#160;<span style="color: #000000">(p-value&lt;
</span>0.0001)<span style="color: #000000">. The estimated median time to achieve WBP was 11 days for EscharEx vs. 85 days for the Gel
Vehicle (p-value= </span>0.002) <span style="color: #000000">and 63 days for the NSSOC (p-value= </span>0.0106)<span style="color: #000000">.
Furthermore, it was shown that patients reaching WBP in the study are 4 times more likely to achieve wound closure (p=0004).</span></div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">Post-hoc analyses from this study assessed the
incidence and time to complete debridement, complete granulation, and wound closure in patients treated with EscharEx (n=46) compared
to a sub-group of patients who were treated with SANTYL (n=8). Baseline characteristics (age, gender, wound age, wound size) were comparable
in both groups. The incidence of complete debridement during the daily treatment period (the first two weeks of the study) was 63.0% (95%
CI=47.5-76.8) for EscharEx vs. 0% for SANTYL; p=0.001. The estimated median time to achieve complete debridement during the study was
9 days (95% CI=5-15 days) for EscharEx vs. not achieved for SANTYL (95% CI=22-Not Applicable); p=0.023. The incidence of achieving complete
debridement and complete cover of the wound bed with granulation tissue (i.e., wound bed preparation, WBP) during the daily treatment
period was 50.0% (95% CI = 34.9%-65.1%) for EscharEx vs. 0% for SANTYL; p=0.015. The incidence of achieving WBP throughout the study was
78.3% (95% CI = 63.6-89.1) for EscharEx vs. 37.5% for SANTYL (95% CI=8.5-75.5); p=0.03. The estimated median time to achieve WBP was 11
days (95% CI =7-50 days) for EscharEx vs. not achieved for SANTYL (95% CI=22-Not Applicable); p=0.014. 15 of the 46 patients (32.6%) treated
with EscharEx completely closed their wounds during the study, compared to 2 out of 8 patients (25%) treated with SANTYL (NSS).&#160;
In those patients who achieved complete wound closure, the average time to wound closure was 48.4 days (SD=23.5) for EscharEx vs. 76.0
days (SD=2.8) for SANTYL; p=0.05. Patient reported applicational pain was comparable in both groups. The safety results and overall incidence
of adverse wound reactions were comparable between arms.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">52</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">EscharEx Pharmacology Study</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In May 2022, we announced positive results from our U.S. Phase
II pharmacology study of EscharEx for debridement of lower leg ulcers. The study was a prospective, open label, single-arm study, conducted
at three U.S. clinical sites. The study evaluated the clinical performance, safety, and pharmacology effect of EscharEx in the debridement
of lower leg ulcers (VLUs and DFUs). The study evaluated the safety and efficacy of debridement as measured by incidence of, and time
to complete debridement. In addition, the study evaluated the pharmacological effects of EscharEx as measured by the changes from baseline
to end of treatment period in (1) wound biofilm presence in wound biopsies, (2) bacterial burden measured by MolecuLight&#174; fluorescence
images, and (3) biomarkers of wound healing and inflammation in wound fluid. Twelve patients with either VLUs or DFUs were enrolled in
the study. Patients were treated with up to eight daily applications of EscharEx and then continued follow-up for 2 weeks. Punch biopsies
and wound fluids were collected prior to the first, and after the last treatment. Biofilm presence was analyzed from wound biopsies. Wound
fluids were analyzed to evaluate biomarkers of wound healing and inflammation, i.e., MMPs, cytokines, chemokines, growth factors and HNE.
Fluorescent imaging was used during treatment to measure wound size and bacterial load. Fluorescent imaging was also utilized to identify
the highest fluorescence area to obtain the biopsy. EscharEx demonstrated safe and effective debridement with a few daily applications.
In addition, evaluation of wounds&#8217; tissue samples (biopsies) and fluorescence images, indicated reduction of wound area, biofilm
and bacterial bioburden following the treatment with EscharEx.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">Seventy percent of patients achieved complete debridement
during the course of treatment within up to 8 applications. On average, complete debridement was achieved after 3.9 applications of EscharEx.
Additionally, an average reduction of 35% in wound size was achieved by the end of the 2-week follow-up period. In all patients that were
positive for biofilm at baseline, the biofilm was reduced substantially to single individual microorganisms or completely removed by the
end of treatment. Seven patients had positive red fluorescence (indicative of bacteria) at baseline and average red fluorescence was reduced
from 1.69 cm2 pre-treatment to 0.60 cm2 post treatment. Biomarker analysis from wound fluid safety data showed that EscharEx was well-tolerated.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The development of EscharEx for the debridement of chronic and
other hard-to-heal wound indications is in Phase 2 studies, and there is no certainty that EscharEx will achieve all of the objectives
of the trials as required or that the FDA will allow at this stage to initiate further studies or that we will successfully complete the
development to obtain a marketing authorization for EscharEx. See &#8220;ITEM 3.D. Risk Factors-Development and commercialization of EscharEx
in the United States and our pipeline product candidates worldwide requires successful completion of the regulatory approval process,
and may suffer delays or fail.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold"><span style="text-decoration: underline">Non-Melanoma
Skin Cancer</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">MW005 is a topically applied biological product candidate for the
treatment of non-melanoma skin cancers, based on the same active substance of NexoBrid and EscharEx, a concentrate of proteolytic enzymes
enriched in bromelain. The clinical development plan of MW005 is supported by the results from several toxicological and other preclinical
studies, as well as vast clinical experience from NexoBrid and EscharEx, which share the same API. We launched a new clinical program
to evaluate our drug product candidate MW005 in patients with non-melanoma skin cancer.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">In July 2023, we announced the final results of
this study. Fifteen patients were treated with MW005 and completed the study. Results showed MW005 was well-tolerated, with a high level
of patient compliance. Based on clinical assessments, eleven out of fifteen patients achieved complete clearance of their BCCs; the majority
of these patients also had histologically confirmed complete clearance.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Although we have conducted preclinical trials, the development
of MW005 for non-melanoma skin cancer indications is still in its preliminary phase and there is no certainty that it will achieve all
the aims of the trials as required and/or successfully complete the approval process for such indication. See &#8220;ITEM 3.D. Risk Factors-Development
and commercialization of EscharEx in the United States and our pipeline product candidates worldwide requires successful completion of
the regulatory approval process, and may suffer delays or fail.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">53</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Research and Development</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our research and development strategy is centered around our validated
proteolytic enzyme platform technology, focused on next-generation protein-based therapies for burn and wound care, and for tissue repair,
which underlies NexoBrid and EscharEx, into additional product candidates for high-value indications. For more information regarding our
research and development expenses, see &#8220;ITEM 5.C. Research and Development, Patents and Licenses, etc.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Pre-Clinical Clinical Studies</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We conduct clinical studies and preclinical studies to support
the efficacy and safety of our products and their ingredients and to extend and validate their benefits for human health. Preclinical
studies allow us to substantiate the safety of our products and obtain preliminarily indications of their pharmacological and safety profile.
As of the date hereof, we have conducted more than 50 non-GLP and GLP preclinical studies. All pre-clinical safety and toxicology studies
were conducted according to the principles of Good Laboratory Practices (&#8220;GLP&#8221;), and thirteen clinical studies, according
to the principles of Good Clinical Practices (&#8220;GCP&#8221;), for NexoBrid, EscharEx and our pipeline product candidates. As a result,
we have developed significant experience in planning, designing, executing, analyzing and publishing clinical studies. Our research and
development team manages our clinical studies and coordinates the project planning, trial design, execution, outcome analyses and clinical
study report submission. During the design, execution and analyses of our studies, our research and development team consults with key
opinion leaders and top-tier consultants in the relevant field of research to optimize both design and execution, as well as to strengthen
the scientific, medical and regulatory compliance level of the investigational plan. Our clinical studies have been conducted in collaboration
with leading medical and research centers throughout the world.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Manufacturing, Supply and Production</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">We operate a manufacturing facility in Yavne, Israel.
This facility allows us to manufacture sterile biopharmaceutical products, such as NexoBrid. The facility is designed to meet current
cGMP requirements and similar foreign requirements, as certified by the U.S., EU member states competent authorities, the Israeli Ministry
of Health, South Korean ministry of health and Japanese ministry of health. Our facility is subject to audits for reassessment of cGMP
compliance and similar foreign requirements, which are performed periodically by regulatory authorities and was re-approved as cGMP-compliant
for an additional three year term as of the audit date, until 2025. Additionally, as part of the regulatory approval process for NexoBrid
our plant was inspected in 2022 by the FDA and the Pharmaceuticals and Medical Devices Agency (&#8220;PMDA&#8221;) of Japan to confirm
it meets all regulatory requirements. In addition, other regional applicable authorities may also need to inspect our plant to confirm
it meets all regulatory requirements in order to obtain marketing authorization in these jurisdictions. Applicable changes in our production
processes for NexoBrid must be approved by the EMA and similar authorities in other jurisdictions.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#160;Our global demand for NexoBrid surpasses the current manufacturing
capabilities. We are currently seeking to expand our manufacturing capabilities in order to increase our capacity to manufacture NexoBrid
and future product candidates and satisfy near term demand. The new GMP-compliant state-of-the-art manufacturing facility is projected
to be completed by mid-2024, with full-scale manufacturing currently expected to commence in 2025. We expect the cost will be approximately
$12.7 million.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The starting material used by us in the manufacturing of NexoBrid
and our other product candidates is bromelain SP, which is derived from pineapple plant stems. We have entered into an agreement with
CBC, dated January 11, 2001, as amended on February 28, 2010, pursuant to which CBC uses proprietary methods to manufacture bromelain
SP and supplies us with this intermediate drug substance in bulk quantities. According to the terms of the agreement, CBC shall not, and
shall not permit related companies or a third party to, manufacture, use, supply or sell the raw materials for the use or production of
a product directly or indirectly competing with any of our products. Our supply agreement with CBC has no fixed expiration date and can
be voluntarily terminated by us, with at least six months&#8217; advance written notice, or by CBC, with at least 24 months&#8217; advance
written notice.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Upon obtaining bromelain SP from CBC, we further process it into
the drug substance and then into the drug product to finally create the powder form of NexoBrid. The necessary inactive ingredients contained
in NexoBrid, or the excipients, are readily available and generally sold to us by multiple suppliers. In addition to this powder, we manufacture
a sterile gel substance by combining water for injections produced by us at our facility and additional excipients.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">54</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Marketing, Sales and Distribution</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We commercialize globally NexoBrid via multiple sales channels:</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold"><span style="text-decoration: underline">Europe</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In Europe and Israel, we sell NexoBrid, primarily through our own
sales force consisting of a marketing team of specialized and knowledgeable sales representatives in Europe, focusing on leading burn
centers and Key Opinion Leaders (KOL) management. We have obtained national reimbursement for NexoBrid in Belgium, Italy, and Greece and
we continue to locally execute our market access strategy for most of Europe to obtain procurement by burn centers and hospitals as part
of their budget, or under local, regional or national reimbursement, depending on the specific process required in each country. We believe
that additional burn units in large hospitals as well as smaller hospitals will follow the treatment trends once established by the burn
centers. See &#8220;-Government Legislation and Regulation-Pharmaceutical Coverage, Pricing and Reimbursement.&#8221; Furthermore, we
are establishing additional distribution channels through local partners to extend outreach in EU (Sweden, Finland, France, Switzerland,
Greece, Malta, Bulgaria and Cyprus,), where NexoBrid is already approved for marketing as part of the European marketing authorization.&#160;
On November 2023, we expanded NexoBrid&#8217;s European market presence by establishing a collaboration with PolyMedics Innovations (PMI)
for the promotion of NexoBrid in Germany, Austria, Belgium, the Netherlands and Luxembourg. In addition to receiving marketing authorization
for NexoBrid in the European Union, key opinion leaders in the burn care field worldwide are already aware of NexoBrid&#8217;s efficiency
in removing eschar due to hundreds of scientific presentations and several award-winning abstracts at international and national conferences
and about 120 peer-reviewed papers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold"><span style="text-decoration: underline">North
America</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Vericel License and Supply Agreements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">On May 6, 2019, we entered into exclusive license and supply agreements with Vericel
to commercialize NexoBrid in all countries of North America (which we refer to as the &#8220;Territory&#8221;).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">License Agreement.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We entered into the Vericel License Agreement pursuant to which
we granted Vericel an exclusive license, with the right to grant sublicenses, to develop and commercialize NexoBrid and any improvements
of NexoBrid (the &#8220;Licensed Product&#8221;) in the Territory.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Pursuant to the terms of the Vericel License Agreement, Vericel
will have exclusive control regarding the commercialization of Licensed Products in the Territory and must use commercially reasonable
efforts to commercialize Licensed Products within the Territory. We and Vericel have made customary representations and warranties and
have agreed to certain customary covenants, including confidentiality and indemnification.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Within 10 days of signing the Vericel License Agreement, Vericel
paid us an upfront fee of $17.5 million (the &#8220;Upfront Payment&#8221;) and upon the U.S. regulatory approval of the BLA for NexoBrid
Vericel paid us $7.5 million. Vericel is obligated to pay us up to $125 million, in the aggregate, upon attainment of certain sales milestones.
The first sales milestone of $7.5 million is triggered when annual net sales of the Licensed Products in the Territory exceed $75 million.
Vericel is also obligated to pay us tiered royalties on net sales of Licensed Products at rates ranging from mid-high single-digit to
mid-teen percentages, subject to certain customary reductions, as well as a percentage of gross profits on committed purchases by BARDA
and a royalty on additional sales to BARDA. The royalties will expire on a product-by-product and country-by-country basis upon the latest
to occur of (i) twelve years following the first commercial sale of such Licensed Product in such country, (ii) the earliest date on which
there are no valid claims of MediWound patent rights covering such Licensed Product in such country, and (iii) the expiration of the regulatory
exclusivity period for such Licensed Product in such country (the &#8220;Royalty Term&#8221;). Such royalties are subject to reduction
in the event that (a) Vericel must license additional third-party intellectual property in order to develop, manufacture or commercialize
a Licensed Product, or (b) biosimilar competition occurs with respect to the Licensed Product in any country within the Territory. After
the expiration of the applicable royalties for the Licensed Product in any country within the Territory, the license for such Licensed
Product in such country would become a fully paid-up, royalty-free, perpetual and irrevocable license.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The Vericel License Agreement expires on the date of expiration
of all royalty obligations due under the agreement unless earlier terminated in accordance with its terms. Either party may terminate
the agreement upon the failure of the other party to comply with its material obligations under the agreement if that failure is not remedied
within certain specified cure periods or in the event of a party&#8217;s insolvency. In addition, Vericel may terminate the agreement
upon a 150-day written notice to us.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">55</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25; font-style: italic">Supply Agreement.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">On May 6, 2019, concurrently with our entry into the License Agreement,
we entered into a supply agreement with Vericel (the &#8220;Supply Agreement&#8221;) pursuant to which we are obligated to supply Vericel
with NexoBrid for sale in the Territory on an exclusive basis for the first five years of the term of the Supply Agreement. The Supply
Agreement requires us to take steps to ensure that our manufacturing capacity meets Vericel&#8217;s demand for NexoBrid. In addition,
after the exclusivity period or upon supply failure, Vericel will be permitted to establish an additional or alternate source of supply.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Pursuant to the Supply Agreement, we will supply NexoBrid to Vericel
based on Vericel&#8217;s fixed orders on a unit price basis. After a specified period, the unit price, on an annual basis, may be increased
based on the United States Producer Price Index for Chemical Manufacturing published by the Bureau of Labor Statistics.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">The Supply Agreement&#8217;s initial term is five
years (the &#8220;Initial Term&#8221;), with Vericel required to provide us with notice regarding whether it plans to extend the Initial
Term for an additional two years by the third anniversary of the Supply Agreement. In May 2022, Vericel notified us on its election to
extend the Initial Term for an additional 2 years until 2026. After the Initial Term and optional two-year extension, Vericel, at its
sole discretion, may choose to extend the Supply Agreement&#8217;s term for additional one-year periods for a potential total term of
fifteen years.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In September 2023, NexoBrid was launched in the U.S. by Vericel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The Supply Agreement will automatically terminate upon the expiration
or termination of the License Agreement. Either party may terminate the Supply Agreement upon the failure of the other party to comply
with its material obligations under the Supply Agreement if such failure is not remedied within certain specified cure periods. After
the Initial Term, Vericel may terminate the Supply Agreement upon 12 months&#8217; prior written notice to us, and we may terminate the
Supply Agreement upon 36 months prior written notice to Vericel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">BARDA</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Pursuant to the First BARDA Contract, BARDA has completed the procurement
of NexoBrid valued at $16.5 million, for emergency stockpile as part of the HHS mission to build national preparedness for public health
medical emergencies. BARDA purchased inventory is being managed by MediWound under vendor managed inventory.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under our exclusive license and supply agreements with Vericel,
we will receive a double-digit royalty on any additional future BARDA purchases of NexoBrid. Please see &#8220;Vericel License and Supply
Agreements&#8221; above.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold"><span style="text-decoration: underline">Other
International Markets</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In other international markets, we sell NexoBrid through local
distributors with which we have distribution agreements, focusing on Asia Pacific, EMEA and CEE. We have signed local distribution agreements
for distribution in Russia, Mexico, India, Bangladesh, Sri Lanka, Japan, Australia, New-Zealand, Singapore, Ukraine, Taiwan and United
Arab Emirates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">&#160;Our distributors in Russia, South Korea, Taiwan, Japan, India, United Arab Emirates
and Eurasian countries have obtained marketing authorization. Our additional distributors have filed or are in the process of filing for
market authorization in their respective territories and are expected to launch NexoBrid after receipt of local regulatory approval, which
may take a year or more to be granted, and, consequently, may occur in certain markets during 2023. We have launched NexoBrid in South
Korea, Russia, Taiwan Japan and India and expect additional launches following receipt of local marketing authorizations. We plan to enter
other international markets through collaboration with local distributors and leverage our approved registration file in Europe to obtain
regional marketing authorizations. For a breakdown of our consolidated revenues by geographic markets and by categories of operations
for the years ended December 31, 2022 and 2023, please see &#8220;Item 5.A Operating and Financial Review and Prospects-Operating Results.&#8221;</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">56</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Intellectual Property</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our intellectual property and proprietary technology are important
to the development, manufacture and sale of NexoBrid, EscharEx and our future pipeline product candidates. We seek to protect our intellectual
property, core technologies and other know-how through a combination of patents, trademarks, trade secrets, non-disclosure and confidentiality
agreements, licenses, assignments of invention and other contractual arrangements with our employees, consultants, partners, suppliers,
customers and others. Additionally, we rely on our research and development program, clinical trials, know-how and marketing and distribution
programs to advance our products and product candidates. As of December 31, 2023, we had been granted a total of 88 patents and have 19
pending patent applications. The family of patents that covers NexoBrid specifically includes 35 granted patents worldwide. EscharEx is
covered by 15 patents and 4 national phase applications.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The main patents for our proteolytic enzyme technology which underlies
NexoBrid, EscharEx and our current pipeline product candidates have been issued in Europe, the United States and other international markets.
Our patents which cover NexoBrid claim specific mixtures of proteolytic enzymes, methods of producing such mixtures and methods of treatment
using such mixtures. Although the protection achieved is significant for NexoBrid, EscharEx and our pipeline product candidates, when
looking at our patents&#8217; ability to block competition, the protection offered by our patents may be, to some extent, more limited
than the protection provided by patents which claim chemical structures which were previously unknown. Absent patent-term extensions,
the NexoBrid patents are nominally set to expire in 2025 and in 2029 in the United States. The NexoBrid patents issued in Europe and in
other foreign jurisdictions are nominally set to expire in 2025. The patents and the national phase applications relating to EscharEx,
if the national phase applications are granted, will expire on January 30, 2037, absent any patent-term adjustment and/or extensions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">While our policy is to obtain patents by application, license or
otherwise, to maintain trade secrets and to seek to operate without infringing on the intellectual property rights of third parties, technologies
related to our business have been rapidly developing in recent years. Additionally, patent applications that we may file or license from
third parties may not result in the issuance of patents, and our issued patents and any issued patents that we may receive in the future
may be challenged, invalidated or circumvented. For example, we cannot predict the extent of claims that may be granted or enforceable
in our patents nor can we be certain of the priority of inventions covered by pending third&#8209;party patent applications filed in the
U.S. If third parties prepare and file patent applications that also claim technology or therapeutics to which we have rights, we may
have to participate in proceedings to determine priority of invention, which could result in substantial costs to us, even if the eventual
outcome is favorable to us. Moreover, because of the extensive time required for clinical development and regulatory review of a product
we may develop, it is possible that, before NexoBrid can be commercialized in additional jurisdictions and/or before any of our future
products can be commercialized, related patents will expire a short period following commercialization, thereby reducing the advantage
of such patent. Loss or invalidation of certain of our patents, or a finding of unenforceability or limited scope of certain of our intellectual
property rights, could have a material adverse effect on us. See &#8220;ITEM 3.D. Risk Factors - Our success depends in part on our ability
to obtain and maintain protection for the intellectual property relating to, or incorporated into, our technology and products.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition to patent protection, we also rely on trade secrets,
including unpatented know&#8209;how, technology innovation, drawings, technical specifications and other proprietary information in attempting
to develop and maintain our competitive position. We also rely on protection available under trademark laws, and we currently hold various
registered trademarks, including &#8220;MediWound,&#8221; &#8220;NexoBrid&#8221; and &#8220;EscharEx&#8221; in various jurisdictions,
including the United States, the European Union and Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Klein License Agreement</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In September 2000, we signed an exclusive license agreement, as
amended in June 2007, with Mark Klein, a third party, for use of certain patents and intellectual property (the &#8220;Klein License Agreement&#8221;).
Under the Klein License Agreement, we received an exclusive license to use the third party&#8217;s patents and intellectual property to
develop, manufacture, market and commercialize NexoBrid and its pipeline product candidates for the treatment of burns and other wounds.
The claims of such patents are directed to a process of preparing a mixture of escharase and proteolytic enzymes and cover the underlying
proteolytic mixture of escharase and proteolytic enzymes prepared by that specific process. Pursuant to the Klein License Agreement, we
are obligated to keep accounting records related to the sales of NexoBrid and its pipeline product candidates and pay royalties as discussed
below. The Klein License Agreement may be terminated by Mark Klein, subject to notice and dispute resolution provisions of the Klein License
Agreement, in the event of our breach, bankruptcy petition, insolvency or failure to achieve a development milestone within six months
of a target date. We have already achieved all development milestones under the Klein License Agreement.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">57</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As consideration under the Klein License Agreement, we paid an
aggregate amount of $1.0 million following the achievement of certain development milestones. In addition, we undertook to pay royalties
of 1.5&#8209;2.5% from revenues, 10% of royalties received from sublicensing and 2% of lump&#8209;sum payments received from sublicensing
up to $1 million and 4% above $1 million, in each case relating to products based on the licensed patents and intellectual property, for
a term of 10&#8209;15 years, as applicable, from the date of the first commercial delivery in a major country. In addition, under the
Klein License Agreement, we agreed to pay a one&#8209;time lump&#8209;sum amount of $1.5 million upon reaching aggregate revenues of $100
million from the sale of such products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Competition</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The medical, biotechnology and pharmaceutical industries are intensely
competitive and subject to significant technological change and changes in practice. While we believe that our innovative technology,
knowledge, experience and scientific resources provide us with competitive advantages, we may face competition from many different sources
with respect to NexoBrid, EscharEx, and our existing pipeline product candidates or any product candidates that we may seek to develop
or commercialize in the future. Possible competitors may include medical practitioners, pharmaceutical and wound care companies, academic
and medical institutions, governmental agencies and public and private research institutions, among others. Any product that we successfully
develop and commercialize will compete with existing therapies and new therapies that may become available in the future.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, we face competition from the current SOC. The current
SOC for eschar removal in severe burns is surgery, where eschar removal can be performed by tangential excision, dermabrasion or hydro
jet, or non&#8209;surgical alternatives, such as applying topical medications to the eschar to facilitate the natural healing process.
Consequently, we face competition from traditional surgical procedures and topical agents. However, based on our clinical trials, we believe
that NexoBrid has a sustainable competitive advantage over the current non&#8209;surgical alternatives and is less invasive than surgery
in removing eschar in patients with burn wounds. See &#8220;-NexoBrid and Our Clinical History&#8221; for the results of our clinical
trials. Although we are in the clinical and preclinical phases for our pipeline product candidates for debridement of chronic and other
hard&#8209;to&#8209;heal wounds and treatment of low-risk basal cell carcinoma and connective tissue disorders and other indications,
respectively, if one of our pipeline product candidates receives approval in the future, we would compete with traditional surgery and
existing non&#8209;surgical and other treatments. In chronic and other hard&#8209;to&#8209;heal wounds, we expect to face competition
from current standard of care for debridement by sharp debridement or from the current non-surgical standard of care, either enzymatic
debridement, primarily Smith &amp; Nephew Plc&#8217;s SANTYL, a collagenase-based ointment, approved by the FDA for debriding chronic&#160;dermal&#160;ulcers.
SANTYL is currently the market-leading enzymatic debridement product, with more than $360 million in estimated annual sales in the United
States.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition to the currently available products, other products
may be introduced to debride chronic and other hard&#8209;to&#8209;heal wounds or treat superficial and nodular basal cell carcinoma and
connective tissue disorders during the time that we engage in necessary development. Accordingly, if one of our pipeline product candidates
is approved, our main challenge in the market would be to educate physicians seeking alternatives to surgery or less effective non-surgical
methods to use our product instead of already existing treatments. While we are still in the development stages, based on our studies,
we believe that our pipeline product candidates will be more effective than the current non&#8209;surgical alternatives and less invasive
than surgery in removing non-viable material in chronic and other hard&#8209;to&#8209;heal wounds or in tumor resection and may be comparable
or perhaps better than currently available treatments for connective tissue disorders.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">NexoBrid received orphan drug status in the United States on August
20, 2003 for debridement of deep partial&#8209; and full&#8209;thickness burns in hospitalized patients. In the United States, a sponsor
that develops an orphan drug has marketing exclusivity for seven years post&#8209;approval by the FDA. The exclusive marketing rights
in both regions are subject to certain exceptions, including the development of a clinically significant benefit over the prevalent SOC.
Once the market exclusivity for our orphan indication expires in a given jurisdiction, subject to other protections such as patents, we
could face competition from other companies that may attempt to develop other products for the same indication.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">58</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Government Legislation and Regulation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our business is subject to extensive government regulation. Regulation
by governmental authorities in the United States, the European Union and other jurisdictions is a significant factor in the development,
manufacture and marketing of NexoBrid and in ongoing research and development activities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">European Union</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The approval process of medicinal products in the European Union
generally involves satisfactorily completing each of the following:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z1d25f66227b84d7e8355cb9357115bc5" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">laboratory tests, animal studies and formulation studies all performed in accordance
        with the applicable EU GLP or GMP regulations;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">submission to the relevant authorities of a CTA, which must be approved before human
        clinical trials may begin;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">performance of adequate and well&#8209;controlled clinical trials to establish the
        safety and efficacy of the product for each proposed indication;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">submission to the relevant competent authorities of a marketing authorization application
        (&#8220;MAA&#8221;), which includes the data supporting preclinical and clinical safety and efficacy as well as detailed information on
        the manufacture and composition and control of the product development and proposed labeling as well as other information;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">inspection by the relevant national authorities of the manufacturing facility or facilities
        and quality systems (including those of third parties) at which the product is produced, to assess compliance with strictly enforced GMP;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">potential audits of the non&#8209;clinical and clinical trial sites that generated
        the data in support of the MAA; and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">review and approval by the relevant competent authority of the MAA before any commercial
        marketing, sale or shipment of the product.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Quality/preclinical studies</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In order to assess the potential safety and efficacy of a product,
tests include laboratory evaluations of product characterization, analytical tests and controls, as well as studies to evaluate toxicity
and pharmacological effects in animal studies. The conduct of the preclinical tests and formulation of the compounds for testing must
comply with the relevant E.U. regulations and requirements. The results of such tests, together with relevant manufacturing control information
and analytical data, are submitted as part of the CTA. Non-clinical studies are performed to demonstrate the health or environmental safety
of new biological substances. Non-clinical studies must be conducted in compliance with the principles of GLP as set forth in EU Directive
2004/10/EC. In particular, non-clinical studies, both in vitro and in vivo, must be planned, performed, monitored, recorded, reported
and archived in accordance with the GLP principles, which define a set of rules and criteria for a quality system for the organizational
process and the conditions for non-clinical studies. These GLP standards reflect the Organization for Economic Co-operation and Development
requirements.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">59</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Clinical trial approval</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Clinical drug development is often described as consisting of four
temporal phases (Phase I&#8209;IV). See, for example, the EMA&#8217;s note for guidance on general considerations for clinical trials
(CPMP/ICH/291/95).</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z104a6a40c7404149b941b08b3b6f1184" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="line-height: 1.25">Phase I (Most typical kind of study: Human Pharmacology);</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="line-height: 1.25">Phase II (Most typical kind of study: Therapeutic Exploratory);</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Phase III (Most typical kind of study: Therapeutic Confirmatory); and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Phase IV (Variety of Studies: Therapeutic Use).</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Studies in Phase IV are all studies other than routine surveillance
performed after drug approval and are related to the approved indication.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The phase of development provides an inadequate basis for classification
of clinical trials because one type of trial may occur in several phases. The phase concept is a description, not a set of requirements.
The temporal phases do not imply a fixed order of studies since for some drugs in a development plan the typical sequence will not be
appropriate or necessary.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Clinical trials of medicinal products in the EU must be conducted
in accordance with EU and national regulations and the International Conference on Harmonization (&#8220;ICH&#8221;) guidelines on GCP
as well as the applicable regulatory requirements and the ethical principles that have their origin in the Declaration of Helsinki. If
the sponsor of the clinical trial is not established within the EU, it must appoint an EU entity to act as its legal representative. The
sponsor must take out a clinical trial insurance policy, and in most EU member states, the sponsor is liable to provide &#8216;no fault&#8217;
compensation to any study subject injured in the clinical trial. The regulatory landscape related to clinical trials in the EU has been
subject to recent changes. The EU Clinical Trials Regulation (&#8220;CTR&#8221;) which was adopted in April 2014 and repeals the EU Clinical
Trials Directive, became applicable on January 31, 2022. Unlike directives, the CTR is directly applicable in all EU member states without
the need for member states to further implement it into national law. The CTR notably harmonizes the assessment and supervision processes
for clinical trials throughout the EU via a Clinical Trials Information System, which contains a centralized EU portal and database.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">While the Clinical Trials Directive required a separate CTA to
be submitted in each member state, to both the competent national health authority and an independent ethics committee, much like the
FDA and IRB respectively, the CTR introduces a centralized process and only requires the submission of a single application to all member
states concerned. The CTR allows sponsors to make a single submission to both the competent authority and an ethics committee in each
member state, leading to a single decision per member state. The CTA must include, among other things, a copy of the trial protocol and
an investigational medicinal product dossier containing information about the manufacture and quality of the medicinal product under investigation.
The assessment procedure of the CTA has been harmonized as well, including a joint assessment by all member states concerned, and a separate
assessment by each member state with respect to specific requirements related to its own territory, including ethics rules. Each member
state&#8217;s decision is communicated to the sponsor via the centralized EU portal. Once the CTA is approved, clinical study development
may proceed.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The CTR foresees a three-year transition period. The extent to
which ongoing and new clinical trials will be governed by the CTR varies. Clinical trials for which an application was submitted (i) prior
to January 31, 2022 under the Clinical Trials Directive, or (ii) between January 31, 2022 and January 31, 2023 and for which the sponsor
has opted for the application of the Clinical Trials Directive remain governed by said Directive until January 31, 2025. After this date,
all clinical trials (including those which are ongoing) will become subject to the provisions of the CTR.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Medicines used in clinical trials must be manufactured in accordance
with GMP. Other national and EU-wide regulatory requirements may also apply.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">60</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Pediatric investigation plan (&#8220;PIP&#8221;)</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We initiated a PIP study in November 2014.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">On January 26, 2007, Regulation (EC) 1901/2006 came into force
with its primary purpose being the improvement of the health of children without subjecting children to unnecessary trials, or delaying
the authorization of medicinal products for use in adults. The regulation established the Pediatric Committee (&#8220;PDCO&#8221;), which
is responsible for coordinating the EMA&#8217;s activities regarding medicinal products for children. The PDCO&#8217;s main role is to
determine which studies the applicant needs to perform in the pediatric population as part of the PIP.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">All applications for marketing authorization for new medicinal
products that were not authorized in the EU prior to January 26, 2007 must include the results of studies carried out in children of different
ages. The PDCO determines the requirements and procedures of such studies, describing them in a PIP. This requirement also applies when
a company wants to add a new indication, pharmaceutical form or route of administration for a medicine that is already authorized. The
PDCO can grant deferrals for some medicines, allowing a company to delay development of the medicine in children until there is enough
information to demonstrate its effectiveness and safety in adults. The PDCO can also grant waivers when development of a medicine in children
is not needed or is not appropriate, because the product is likely to be ineffective or unsafe in children, the disease or condition for
which the product is intended occurs only in adult populations, or when the product does not represent a significant therapeutic benefit
over existing treatments for pediatric patients. Before an MAA can be filed, or an existing marketing authorization can be amended, the
EMA confirms that the applicant complied with the studies&#8217; requirements and measures listed in the PIP. Since the regulation became
effective, several incentives for the development of medicines for children become available in the European Union, including:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zda76963be2a7403bbde1b1d284fd7cf4" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">medicines that have been authorized for marketing in the EU with the results of PIP
        studies included in the product information are eligible for an extension of their supplementary protection certificate extension (if
        any is in effect at the time of approval) by six months. This is the case even when the studies&#8217; results are negative;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">for orphan medicines, such as NexoBrid, the incentive is an additional two years of
        market exclusivity instead of one;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">scientific advice and protocol assistance at the EMA are free of charge for questions
        relating to the development of medicines for children; and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">medicines developed specifically for children that are already authorized, but are
        not protected by a patent or supplementary protection certificate, can apply for a pediatric use marketing authorization (&#8220;PUMA&#8221;).
        If a PUMA is granted, the product will benefit from 10 years of market protection as an incentive.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#160;In December 2023 we received European Commission approval
for the removal of eschar in deep partial- and full-thickness thermal burns for all ages.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Marketing authorization</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Authorization to market a product in the EU member states proceeds
under one of four procedures: a centralized authorization procedure, a mutual recognition procedure, a decentralized procedure or a national
procedure. Marketing authorization may be granted only to an applicant established in the European Union. Through our wholly&#8209;owned
German subsidiary, we received approval for NexoBrid pursuant to the centralized authorization procedure.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">61</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The centralized procedure provides for the grant of a single marketing
authorization, issued by the European Commission based on the opinion of the EMA&#8217;s Committee for Medicinal Products for Human Use
(&#8220;CHMP&#8221;), that is valid throughout the EU and the EEA countries, and including Norway, Iceland and Lichtenstein. The centralized
procedure is compulsory for medicines produced by certain biotechnological processes, products designated as orphan medicinal products,
advanced therapy medicinal products (&#8220;ATMPs&#8221;) and products with a new active substance indicated for the treatment of certain
diseases, and is optional for products which constitute a significant therapeutic, scientific, or technical innovation or for which a
centralized process is in the interest of patients. Products that have received orphan designation in the EU, such as NexoBrid, will qualify
for this centralized procedure, under which each product&#8217;s MAA is submitted to the EMA. Under the centralized procedure in the European
Union, the maximum time frame for the evaluation of an MAA by the EMA is 210 days (excluding clock stops, when additional written or oral
information is to be provided by the applicant in response to questions asked by the Committee of Medicinal Products for Human Use). In
general, if the centralized procedure is not followed, there are three alternative procedures where applications are filed with one or
more members state medicines regulators, each of which will grant a national marketing authorization:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6faf569173204cfeb27688a548d5a1a3" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Mutual recognition procedure.</span> If an authorization
        has been granted by one-member state, or the Reference Member State, an application may be made for mutual recognition in one or more
        other member states, or the Concerned Member State(s).</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Decentralized procedure.</span> The decentralized
        procedure may be used to obtain a marketing authorization in several European member states when the applicant does not yet have a marketing
        authorization in any country.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">National procedure.</span> Applicants following the
        national procedure will be granted a marketing authorization that is valid only in a single member state. Furthermore, this marketing
        authorization is not based on recognition of another marketing authorization for the same product awarded by an assessment authority of
        another member state. If marketing authorization in only one-member state is preferred, an application can be filed with the national
        competent authority of a member state. The national procedure can also serve as the first phase of a mutual recognition procedure.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">It is not always possible for applicants to follow the national
procedure. In the case of medicinal products in the category for which the centralized authorization procedure is compulsory, that procedure
must be followed. In addition, the national procedure is not available in the case of medicinal product dossiers where the same applicant
has already obtained marketing authorization in one of the other European Union member state or has already submitted an application for
marketing authorization in another member state and the application is under consideration. In the latter case, applicants must follow
a mutual recognition procedure.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">After a drug has been authorized and launched, it is a condition
of maintaining the marketing authorization that all aspects relating to its quality, safety and efficacy must be kept under review. Sanctions
may be imposed for failure to adhere to the conditions of the marketing authorization. In extreme cases, the authorization may be revoked,
resulting in withdrawal of the product from sale.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Period of authorization and renewals</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under the above-described procedures, in order to grant the marketing
authorization, the EMA or the competent authorities of the EU member states make an assessment of the risk benefit balance of the product
on the basis of scientific criteria concerning its quality, safety and efficacy. Marketing authorization is valid for an initial five&#8209;year
period and may be renewed thereafter on the basis of a re&#8209;evaluation of the risk&#8209;benefit balance by the EMA or by the competent
authority of the authorizing member state. To this end, the marketing authorization holder shall provide the EMA or other applicable competent
authority a consolidated version of the file in respect of quality, safety and efficacy, including all variations introduced since the
marketing authorization was granted, at least six months before the end of the initial five&#8209;year period. Once renewed, the marketing
authorization is valid for an unlimited period, unless the EMA or other applicable competent authority decides, on justified grounds relating
to pharmacovigilance, to proceed with one additional five&#8209;year renewal. Any authorization which is not followed by the actual placing
of the drug on the E.U. market (in case of centralized procedure) or on the market of the authorizing member state within three years
after authorization shall cease to be valid.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">62</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Regulatory data protection</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Without prejudice to the law on the protection of industrial and
commercial property, some marketing authorizations benefit from an &#8220;8+2(+1)&#8221; year period of regulatory protection. During
the first eight years from the grant of the innovator company&#8217;s marketing authorization, data exclusivity applies. If granted, the
data exclusivity period prevents generic or biosimilar applicants from relying on the pre-clinical and clinical trial data contained in
the dossier of the reference product when applying for a generic or biosimilar MA in the EU during a period of eight years from the date
on which the reference product was first authorized in the EU. After the eight years have expired, a generic company can make use of the
preclinical and clinical trial data of the originator in their regulatory applications but still cannot market their product until the
end of the 10 year market exclusivity period. An additional one year of market exclusivity can be obtained if, during the first eight
years of those 10 years, the marketing authorization holder obtains an approval for one or more new therapeutic indications which, during
the scientific evaluation prior to their approval, are determined to bring a significant clinical benefit in comparison with existing
therapies. However, there is no guarantee that a product will be considered by the EU&#8217;s regulatory authorities to be a new chemical
or biological entity, and products may not qualify for data exclusivity. Under the current rules, a third party may reference the preclinical
and clinical data of the reference product beginning eight years after first approval, but the third party may market a generic version
only after 10 (or 11) years have lapsed.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">There is a special regime for biosimilars, or biological medicinal products that are
similar to a reference medicinal product but that do not meet the definition of a generic medicinal product, for example, because of differences
in raw materials or manufacturing processes. For such products, the results of appropriate preclinical or clinical trials must be provided,
and guidelines from the EMA detail the type of quantity of supplementary data to be provided for different types of biological product.
There are no such guidelines for complex biological products, such as gene or cell therapy medicinal products, and so it is unlikely that
biosimilars of those products will currently be approved in the EU. However, guidance from the EMA states that they will be considered
in the future in light of the scientific knowledge and regulatory experience gained at the time.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Additional data protection can be applied for when an applicant
has complied with all requirements as set forth in an approved PIP.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Post-Approval Requirements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Similar to the United States, both marketing authorization holders
and manufacturers of medicinal products are subject to comprehensive regulatory oversight by the EMA, the European Commission and/or the
competent regulatory authorities of the member states. The holder of a marketing authorization must establish and maintain a pharmacovigilance
system and appoint an individual qualified person for pharmacovigilance who is responsible for oversight of that system. Key obligations
include expedited reporting of suspected serious adverse reactions and submission of periodic safety update reports (&#8220;PSURs&#8221;).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">All new MAA must include a risk management plan (&#8220;RMP&#8221;)
describing the risk management system that the company will put in place and documenting measures to prevent or minimize the risks associated
with the product. The regulatory authorities may also impose specific obligations as a condition of the marketing authorization. Such
risk-minimization measures or post-authorization obligations may include additional safety monitoring, more frequent submission of PSURs,
or the conduct of additional clinical trials or post-authorization safety studies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Failure to comply with the aforementioned EU and member state laws
may result in administrative, civil or criminal penalties. These penalties could include delays or refusal to authorize the conduct of
clinical trials, or to grant marketing authorization, product withdrawals and recalls, product seizures, suspension, withdrawal or variation
of the marketing authorization, total or partial suspension of production, distribution, manufacturing or clinical trials, operating restrictions,
injunctions, suspension of licenses, fines and criminal penalties. These penalties could include delays or refusal to authorize the conduct
of clinical trials, or to grant the marketing authorization, product withdrawals and recalls, product seizures, suspension, withdrawal
or variation of the marketing authorization, total or partial suspension of production, distribution, manufacturing or clinical trials,
operating restrictions, injunctions, suspension of licenses, fines and criminal penalties.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The aforementioned EU rules are generally applicable in the EEA.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Brexit</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The UK left the EU on January 31, 2020, following which existing
EU medicinal product legislation continued to apply in the United Kingdom during the transition period under the terms of the EU-UK Withdrawal
Agreement. The transition period, which ended on December 31, 2020, maintained access to the EU single market and to the global trade
deals negotiated by the EU on behalf of its members. The transition period provided time for the UK and EU to negotiate a framework for
partnership for the future, which was then crystallized in the Trade and Cooperation Agreement (&#8220;TCA&#8221;) and became effective
on January 1, 2021. The TCA includes specific provisions concerning pharmaceuticals, which include the mutual recognition of GMP inspections
of manufacturing facilities for medicinal products and GMP documents issued but does not foresee wholesale mutual recognition of UK and
EU pharmaceutical regulations.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">63</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">EU laws which have been transposed into UK law through secondary
legislation continue to be applicable as &#8220;retained EU law&#8221;. However, under the Retained EU Law (Revocation and Reform) Bill
2022, which is currently before the UK parliament, any retained EU law not expressly preserved and &#8220;assimilated&#8221; into domestic
law or extended by ministerial regulations (to no later than 23 June 2026) will automatically expire and be revoked by December 31, 2023.
In addition, new legislation such as the EU CTR or in relation to orphan medicines will not be applicable. The UK government has passed
a new Medicines and Medical Devices Act 2021, which introduces delegated powers in favor of the Secretary of State or an &#8216;appropriate
authority&#8217; to amend or supplement existing regulations in the area of medicinal products and medical devices. This allows new rules
to be introduced in the future by way of secondary legislation, which aims to allow flexibility in addressing regulatory gaps and future
changes in the fields of human medicines, clinical trials and medical devices. As of January 1, 2021, the Medicines and Healthcare Products
Regulatory Agency (&#8220;MHRA&#8221;) is the UK&#8217;s standalone medicines and medical devices regulator. As a result of the Northern
Ireland protocol, different rules will apply in Northern Ireland than in England, Wales, and Scotland, together, Great Britain (&#8220;GB&#8221;);
broadly, Northern Ireland will continue to follow the EU regulatory regime, but its national competent authority will remain the MHRA.
The MHRA has published a guidance on how various aspects of the UK regulatory regime for medicines will operate in GB and in Northern
Ireland following the expiry of the Brexit transition period on December 31, 2020. The guidance includes clinical trials, importing, exporting,
and pharmacovigilance and is relevant to any business involved in the research, development, or commercialization of medicines in the
UK. The new guidance was given effect via the Human Medicines Regulations (Amendment etc.) (EU Exit) Regulations 2019 (the &#8220;Exit
Regulations&#8221;).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The MHRA has introduced changes to national licensing procedures,
including procedures to prioritize access to new medicines that will benefit patients, including a 150-day assessment and a rolling review
procedure. All existing EU MAs for centrally authorized products were automatically converted or grandfathered into UK MAs, effective
in GB (only), free of charge on January 1, 2021, unless the MA holder chose to opt-out. After Brexit, companies established in the UK
cannot use the centralized procedure and instead must follow one of the UK national authorization procedures or one of the remaining post-Brexit
international cooperation procedures to obtain an MA to commercialize products in the UK. For a period of three years from January 1,
2021, the MHRA may rely on a decision taken by the an Commission on the approval of a new (centralized procedure) MA when determining
an application for a GB authorization; or use the MHRA&#8217;s decentralized or mutual recognition procedures which enable MAs approved
in EU member states (or Iceland, Liechtenstein, Norway) to be granted in GB.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">There will be no pre-MA orphan designation. Instead, the MHRA will
review applications for orphan designation in parallel to the corresponding MA application. The criteria are essentially the same, but
have been tailored for the market, i.e., the prevalence of the condition in GB, rather than the EU, must not be more than five in 10,000.
Should an orphan designation be granted, the period or market exclusivity will be set from the date of first approval of the product in
GB.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Data Privacy and Security Laws</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Numerous state, federal and foreign laws, regulations, and standards
govern the collection, use, access to, confidentiality and security of health-related and other personal information, and could apply
now or in the future to our operations or the operations of our partners. In the United States, numerous federal and state laws and regulations,
including data breach notification laws, health information privacy and security laws and consumer protection laws and regulations govern
the collection, use, disclosure, and protection of health-related and other personal information. In addition, certain laws govern the
privacy and security of personal data, including health-related data in the EU/EEA and in other foreign jurisdictions. Privacy and security
laws, regulations, and other obligations are constantly evolving, may conflict with each other to complicate compliance efforts, and can
result in investigations, proceedings, or actions that lead to significant civil and/or criminal penalties and restrictions on data processing.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Manufacturing</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The manufacturing of authorized drugs, for which a separate manufacturer&#8217;s
license is mandatory, must be conducted in strict compliance with the EMA&#8217;s cGMP requirements and comparable requirements of other
regulatory bodies, which mandate the methods, facilities and controls used in manufacturing, processing and packing of drugs to assure
their safety and proper identification. The EMA monitors compliance with its GMP requirements through mandatory registration of facilities
and inspections of those facilities. The EMA may have a coordinating role for these inspections while the responsibility for carrying
them out rests with the competent authority of the member state under whose responsibility the manufacturer falls. Failure to comply with
these requirements could interrupt supply and result in delays, unanticipated costs and lost revenues, and could subject the applicant
to potential legal or regulatory action, including but not limited to warning letters, suspension of manufacturing, seizure of product,
injunctive action or possible civil and criminal penalties. In January 2013, the EU and Israel signed the Protocol on Conformity Assessment
and Acceptance of Industrial Products (the &#8220;ACAA&#8221;), which covers medicinal products. The ACAA provides for mutual recognition
of the conclusions of inspections of compliance of manufacturers and importers with the principles and guidelines of EU GMP and equivalent
Israeli cGMP. Certification of the conformity of each batch to its specifications by either the importer or the manufacturer established
in Israel or in the EU shall be recognized by the other party without re&#8209;control at import from one party to the other.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">64</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Marketing and promotion</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The marketing and promotion of authorized medicinal products, including
industry&#8209;sponsored continuing medical education and advertising directed toward the prescribers of drugs and/or the general public,
are strictly regulated in the European Union, notably under Directive 2001/83 and subject to laws concerning promotion of medicinal products,
interactions with physicians, misleading and comparative advertising and unfair commercial practices. The applicable legislation aims
to ensure that information provided by holders of marketing authorizations regarding their products is truthful, balanced and accurately
reflects the safety and efficacy claims authorized by the EMA or by the applicable national authority of the authorizing member state.
All advertising and promotional activities for the product must be consistent with the approved summary of product characteristics, and
therefore all off-label promotion is prohibited. Direct-to-consumer advertising of prescription medicines is also prohibited in the EU.
Although general requirements for advertising and promotion of medicinal products are established under EU directives, the details are
governed by regulations in each member state and can differ from one country to another. Failure to comply with these requirements can
result in adverse publicity, warning letters, mandated corrective advertising and potential civil and criminal penalties.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">United States</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Review and approval of biologics</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition to E.U. regulations, NexoBrid is marketed as a biologic
product in the United States for eschar removal in adults with deep partial thickness and/or full thickness thermal burns and is therefore
subject to various U.S. regulations. In the United States, the FDA regulates biologics under the Federal, Food, Drug and Cosmetic Act
(&#8220;FDCA&#8221;), the Public Health Service Act, and their respective implementation regulations. Biologics require the submission
of a BLA and licensure by the FDA prior to being marketed in the United States. The process of obtaining regulatory approvals and the
subsequent compliance with appropriate federal, state, local and foreign statutes and regulations requires the expenditure of substantial
time and financial resources. Failure to comply with the applicable U.S. requirements at any time during the product development process,
approval process or after approval may subject an applicant to a variety of administrative or judicial sanctions as well as enforcement
actions brought by the FDA, the U.S. Department of Justice or other governmental entities. Possible sanctions may include the FDA&#8217;s
refusal to approve pending BLAs or supplements, withdrawal of an approval, imposition of a clinical hold, issuance of warning letters,
product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, refusals of government
contracts, restitution, disgorgement and civil or criminal penalties.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">65</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The process required by the FDA prior to marketing and distributing
a biologic in the United States generally involves the following:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z0968062e5f484aec834ef918d4188b02" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">completion of laboratory tests, animal studies and formulation studies in compliance
        with the FDA&#8217;s GLP and GMP regulations, as applicable;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">submission to the FDA of an investigational new drug application (&#8220;IND&#8221;),
        which must become effective before clinical trials may begin;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">approval by an independent institutional review board (&#8220;IRB&#8221;) at each
        clinical site before each trial may be initiated;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">performance of adequate and well&#8209;controlled clinical trials in accordance with
        GCP to establish the safety and efficacy of the product for each indication;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">preparation and submission to the FDA of a BLA;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">satisfactory completion of an FDA advisory committee review, if applicable;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">satisfactory completion of one or more FDA inspections of the manufacturing facility
        or facilities at which the product, or components thereof, are produced to assess compliance with cGMP requirements, and to assure that
        the facilities, methods and controls are adequate to preserve the product&#8217;s safety, purity and potency, and of selected clinical
        investigation sites to assess compliance with GCP; and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">payment of user fees and FDA review and approval of the BLA to permit commercial marketing
        of the product for particular indications for use in the United States.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Preclinical studies</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Preclinical studies include laboratory evaluation of product chemistry,
toxicity and formulation, as well as animal studies to assess the potential safety and efficacy of the product candidate. Preclinical
safety tests must be conducted in compliance with FDA regulations regarding good laboratory practices. The results of the preclinical
tests, together with manufacturing information and analytical data, are submitted to the FDA as part of an IND which must become effective
before clinical trials may commence. Some preclinical testing may continue even after the IND is submitted.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Clinical trials in support of a BLA</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Clinical trials involve the administration of an investigational
product to human subjects under the supervision of qualified investigators in accordance with GCP requirements, which include, among other
things, the requirement that all research subjects provide their informed consent in writing before their participation in any clinical
trial. Clinical trials are conducted under written study protocols detailing, among other things, the objectives of the study, the parameters
to be used in monitoring safety and the effectiveness criteria to be evaluated. A protocol for each clinical trial and any subsequent
protocol amendments must be submitted to the FDA as part of the IND. An IND automatically becomes effective 30 days after receipt by the
FDA, unless before that time the FDA raises concerns or questions related to a proposed clinical trial and places the trial on clinical
hold. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before the clinical trial can begin.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, an IRB representing each institution participating
in the clinical trial must review and approve the plan for any clinical trial before it commences at that institution, and the IRB must
conduct continuing review and reapprove the study at least annually. The IRB must review and approve, among other things, the study protocol
and informed consent information to be provided to study subjects. An IRB must operate in compliance with FDA regulations. Information
about certain clinical trials must be submitted within specific timeframes to the National Institutes of Health for public dissemination
on their website, ClinicalTrials.gov.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">66</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">For purposes of BLA approval, clinical trials are typically conducted
in three sequential phases, which may overlap or be combined. In the United States, the three phases are generally described as follows:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" border="0" id="z4dd811601a784299acb7d58e332a6b54" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><br/> &#160;</div> </td>
    <td style="width: 10%; vertical-align: top">
        <div style="line-height: 1.25">Phase I:</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 85%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">The investigational product is initially
        introduced into healthy human subjects or patients with the target disease or condition and tested for safety, dosage tolerance, absorption,
        metabolism, distribution, excretion and, if possible, to gain an early indication of its effectiveness and to determine optimal dosage.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><br/> &#160;</div> </td>
    <td style="width: 10%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Phase II:</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 85%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">The investigational product is administered to a limited patient population to identify
        possible adverse effects and safety risks, to preliminarily evaluate the efficacy of the product for specific targeted diseases and to
        determine dosage tolerance and optimal dosage.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><br/> &#160;</div> </td>
    <td style="width: 10%; vertical-align: top">
        <div style="line-height: 1.25">Phase III:</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 85%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">The investigational product is administered to an expanded patient population, generally
        at geographically dispersed clinical trial sites, in well&#8209;controlled clinical trials to generate enough data to statistically evaluate
        the efficacy and safety of the product for approval, to establish the overall risk&#8209;benefit profile of the product, and to provide
        adequate information for the labeling of the product.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In some cases, the FDA may require, or companies may voluntarily
pursue, additional clinical trials after a product is approved to gain more information about the product. These so-called Phase IV studies
may be made a condition to approval of the BLA.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Progress reports detailing the results of the clinical trials must
be submitted at least annually to the FDA and more frequently if serious adverse events occur. Phase I, Phase II and Phase III clinical
trials may not be completed successfully within any specified period, or at all. Furthermore, the FDA or the sponsor may suspend or terminate
a clinical trial at any time on various grounds, including a finding that the research subjects are being exposed to an unacceptable health
risk. Similarly, an IRB can suspend or terminate approval of a clinical trial at its institution if the clinical trial is not being conducted
in accordance with the IRB&#8217;s requirements or if the drug has been associated with unexpected serious harm to patients.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Submission of a BLA to the FDA</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The results of the preclinical studies and clinical trials, together
with other detailed information, including information on the manufacture, control and composition of the product, are submitted to the
FDA as part of a BLA requesting approval to market the product candidate for a proposed indication. Under the Prescription Drug User Fee
Act (PDUFA), as amended, applicants are required to pay user fees to the FDA for reviewing a BLA. These user fees, as well as the annual
program fees required for approved products, can be substantial. Each BLA submitted to the FDA for approval is typically reviewed for
administrative completeness and reviewability within 60 days following submission of the application. If found complete, the FDA will
&#8220;file&#8221; the BLA, which triggers a full review of the application. The FDA may refuse to file any BLA that it deems incomplete
or not properly reviewable at the time of submission. The FDA&#8217;s established goals are to review and act on standard applications
within ten months after it accepts the application for filing, or, if the application qualifies for priority review, six months after
the FDA accepts the application for filing. In both standard and priority reviews, the review process is often significantly extended
by FDA requests for additional information or clarification. The FDA reviews a BLA to determine, among other things, whether a product
is safe, pure and potent and the facility in which it is manufactured, processed, packed, or held meets standards designed to assure the
product&#8217;s continued safety, purity and potency. The FDA may convene an advisory committee to provide clinical insight on application
review questions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Before approving a BLA, the FDA generally inspects the facilities
at which the product is manufactured or facilities that are significantly involved in the product development and distribution process,
and will not approve the product unless cGMP compliance is satisfactory. Additionally, before approving a BLA, the FDA will typically
inspect one or more clinical sites to assure compliance with GCP. If the FDA determines that the application, manufacturing process or
manufacturing facilities are not acceptable, it will outline the deficiencies in the submission and often will request additional testing
or information. Notwithstanding the submission of any requested additional information, the FDA ultimately may decide that the application
does not satisfy the regulatory criteria for approval. After the FDA evaluates a BLA and conducts inspections of manufacturing facilities
where the investigational product will be produced, the FDA may issue an approval letter or a Complete Response letter. An approval letter
authorizes commercial marketing of the product with specific prescribing information for specific indications. A Complete Response letter
will describe all of the deficiencies that the FDA has identified in the BLA, except that where the FDA determines that the data supporting
the application are inadequate to support approval, the FDA may issue the Complete Response letter without first conducting required inspections,
testing submitted product lots, and/or reviewing proposed labeling. In issuing the Complete Response letter, the FDA may recommend actions
that the applicant might take to place the BLA in condition for approval, including requests for additional information or clarification.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">67</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The FDA may deny approval of a BLA if applicable statutory or regulatory
criteria are not satisfied, or may require additional testing or information, which can delay the approval process. FDA approval of any
application may include many delays or may never be granted. If a product is approved, the approval will impose limitations on the indicated
uses for which the product may be marketed, will require that warning statements be included in the product labeling, may impose additional
warnings to be specifically highlighted in the labeling (e.g., a Black Box Warning), which can significantly affect promotion and sales
of the product, may require that additional studies be conducted following approval as a condition of the approval and may impose restrictions
and conditions on product distribution, prescribing or dispensing. For example, the FDA may approve the BLA with a Risk Evaluation and
Mitigation Strategy, or REMS, to ensure the benefits of the product outweigh its risks. A REMS is a safety strategy to manage a known
or potential serious risk associated with a product and to enable patients to have continued access to such medicines by managing their
safe use. A REMS program may be required to include various elements, such as a medication guide or patient package insert, a communication
plan to educate healthcare providers of the drug&#8217;s risks, or other elements to assure safe use, such as limitations on who may prescribe
or dispense the drug, dispensing only under certain circumstances, special monitoring and the use of patient registries. Once a product
is approved, marketing the product for other indicated uses or making certain manufacturing or other changes requires FDA review and approval
of a supplemental BLA or a new BLA, which may require additional clinical data. In addition, further post&#8209;marketing testing and
surveillance to monitor the safety or efficacy of a product may be required. Also, product approvals may be withdrawn if compliance with
regulatory standards is not maintained or if safety or manufacturing problems occur following initial marketing. In addition, new government
requirements may be established that could delay or prevent regulatory approval of our product candidates under development.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Post&#8209;approval requirements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Any biologic products for which we receive FDA approvals are subject
to pervasive continuing regulation by the FDA. Certain requirements include, among other things, record&#8209;keeping requirements, reporting
adverse experiences with the product, providing the FDA with updated safety and efficacy information annually or more frequently for specific
events, product sampling and distribution requirements, complying with certain electronic records and signature requirements and complying
with FDA promotion and advertising requirements. These promotion and advertising requirements include, among others, standards for direct&#8209;to&#8209;consumer
advertising, prohibitions against promoting drugs for uses or in patient populations that are not described in the drug&#8217;s approved
labeling, known as &#8220;off&#8209;label use,&#8221; and other promotional activities, such as those considered to be false or misleading.
Failure to comply with FDA requirements can have negative consequences, including the immediate discontinuation of noncomplying materials,
adverse publicity, enforcement letters from the FDA, mandated corrective advertising or communications with doctors, and civil or criminal
penalties. Such enforcement may also lead to scrutiny and enforcement by other government and regulatory bodies. Although physicians may
prescribe legally available drugs for off&#8209;label uses, manufacturers may not encourage, market or promote such off&#8209;label uses.
As a result, &#8220;off&#8209;label promotion&#8221; has formed the basis for litigation under the Federal False Claims Act, violations
of which are subject to significant civil fines and penalties.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The manufacturing of NexoBrid, EscharEx and our pipeline product
candidates are and will be required to comply with applicable FDA manufacturing requirements contained in the FDA&#8217;s cGMP regulations.
NexoBrid is manufactured at our production plant in Yavne, Israel, which is cGMP certified. The FDA&#8217;s cGMP regulations require,
among other things, quality control and quality assurance, as well as the corresponding maintenance of comprehensive records and documentation.
Biologic manufacturers and other entities involved in the manufacture and distribution of approved drugs and biologics are also required
to register their establishments and list any products they make with the FDA and to comply with related requirements in certain states.
These entities are further subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMP
and other laws. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control
to maintain cGMP compliance. In addition, a BLA holder must comply with post&#8209;marketing requirements, such as reporting of certain
adverse events. Such reports can present liability exposure, as well as increase regulatory scrutiny that could lead to additional inspections,
labeling restrictions or other corrective action to minimize further patient risk. Discovery of problems with a product after approval
may result in serious and extensive restrictions on the product, manufacturer or holder of an approved BLA, as well as lead to potential
market disruptions. These restrictions may include recalls, fines, warning letters, or untitled letters, clinical holds on clinical studies,
refusal of the FDA to approve pending applicants or supplements to approved applications, product seizure or detention, or refusal to
permit the import or export of products, suspension or revocation of a product license approval until the FDA is assured that quality
standards can be met, and continuing oversight of manufacturing by the FDA under a &#8220;consent decree,&#8221; which frequently includes
the imposition of costs and continuing inspections over a period of many years, as well as possible withdrawal of the product from the
market. In addition, changes to the manufacturing process generally require prior FDA approval before being implemented. Other types of
changes to the approved product, such as adding new indications and additional labeling claims, are also subject to further FDA review
and approval. The FDA also may impose a number of post&#8209;approval requirements as a condition of approval of a BLA. For example, the
FDA may require post&#8209;marketing testing, or Phase IV testing, as well as REMS and/or surveillance to monitor the effects of an approved
product or place other conditions on an approval that could otherwise restrict the distribution or use of NexoBrid.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">68</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Orphan designation and exclusivity</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">On August 20, 2003, NexoBrid received orphan drug designation in
the United States. Under the Orphan Drug Act, the FDA may designate a drug product as an &#8220;orphan drug&#8221; if it is intended to
treat a rare disease or condition, meaning that it affects fewer than 200,000 individuals in the United States, or more in cases in which
there is no reasonable expectation that the cost of developing and making a drug product available in the United States for treatment
of the disease or condition will be recovered from sales of the product. A company must request orphan product designation before submitting
a BLA. If the request is granted, the FDA will disclose the identity of the therapeutic agent and its potential use. Orphan drug designation
does not convey any advantage in or shorten the duration of the regulatory review and approval process.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">If a product with orphan status receives the first FDA approval
for the disease or condition for which it has such designation, the product will be entitled to orphan product exclusivity. Orphan product
exclusivity means that FDA may not approve any other applications for the same product for the same disease or condition for seven years,
except in certain limited circumstances, such as a showing of clinical superiority to the product with orphan drug exclusivity. Competitors
may receive approval of different products for the disease or condition for which the orphan product has exclusivity and may obtain approval
for the same product but for a different indication. If a drug or drug product designated as an orphan product ultimately receives marketing
authorization for a disease or condition broader than that designated in its orphan product application, it may not be entitled to exclusivity.
In addition, exclusive marketing rights in the United States may be lost if the FDA later determines that the request for designation
was materially defective or if the manufacturer is unable to assure sufficient quantities of the product to meet the needs of patients
with the rare disease or condition.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Expedited Development and Review Programs</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The FDA offers a number of expedited development and review programs
for qualifying product candidates. The fast track program is intended to expedite or facilitate the process for reviewing new products
that meet certain criteria. Specifically, new products are eligible for fast track designation if they are intended to treat a serious
or life-threatening disease or condition and demonstrate the potential to address unmet medical needs for the disease or condition. Fast
track designation applies to the combination of the product and the specific indication for which it is being studied. The sponsor of
a fast track product has opportunities for frequent interactions with the review team during product development and, once a BLA is submitted,
the product may be eligible for priority review. A fast track product may also be eligible for rolling review, where the FDA may consider
for review sections of the BLA on a rolling basis before the complete application is submitted, if the sponsor provides a schedule for
the submission of the sections of the BLA, the FDA agrees to accept sections of the BLA and determines that the schedule is acceptable,
and the sponsor pays any required user fees upon submission of the first section of the BLA.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">A product intended to treat a serious or life-threatening disease
or condition may also be eligible for breakthrough therapy designation to expedite its development and review. A product can receive breakthrough
therapy designation if preliminary clinical evidence indicates that the product may demonstrate substantial improvement over existing
therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development.
The designation includes all of the fast track program features, as well as more intensive FDA interaction and guidance beginning as early
as Phase I and an organizational commitment to expedite the development and review of the product, including involvement of senior managers.
Any marketing application for a biologic submitted to the FDA for approval, including a product with a fast track designation and/or breakthrough
therapy designation, may be eligible for other types of FDA programs intended to expedite the FDA review and approval process, such as
priority review and accelerated approval. A product is eligible for priority review if it has the potential to provide a significant improvement
in the treatment, diagnosis or prevention of a serious disease or condition compared to marketed products. For products containing new
molecular entities, priority review designation means the FDA&#8217;s goal is to take action on the marketing application within six months
of the 60-day filing date, compared with ten months under standard review.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">69</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Additionally, products studied for their safety and effectiveness
in treating serious or life-threatening diseases or conditions may receive accelerated approval upon a determination that the product
has an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit, or on a clinical endpoint that can be measured
earlier than irreversible morbidity or mortality, that is reasonably likely to predict an effect on irreversible morbidity or mortality
or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative
treatments. As a condition of accelerated approval, the FDA will generally require the sponsor to perform adequate and well-controlled
post-marketing clinical studies to verify and describe the anticipated effect on irreversible morbidity or mortality or other clinical
benefit. In addition, the FDA currently requires as a condition for accelerated approval pre-approval of promotional materials, which
could adversely impact the timing of the commercial launch of the product.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In 2017, FDA established a new regenerative medicine advanced therapy,
or RMAT, designation as part of its implementation of the 21st Century Cures Act, which was signed into law in December 2016. To qualify
for RMAT designation, the product candidate must meet the following criteria: (1) it qualifies as a RMAT, which is defined as a cell therapy,
therapeutic tissue engineering product, human cell and tissue product, or any combination product using such therapies or products, with
limited exceptions; (2) it is intended to treat, modify, reverse, or cure a serious or life-threatening disease or condition; and (3)
preliminary clinical evidence indicates that the drug has the potential to address unmet medical needs for such a disease or condition.
Like fast track and breakthrough therapy designation, RMAT designation provides potential benefits that include more frequent meetings
with FDA to discuss the development plan for the product candidate and eligibility for rolling review and priority review. Products granted
RMAT designation may also be eligible for accelerated approval on the basis of a surrogate or intermediate endpoint reasonably likely
to predict long-term clinical benefit, or reliance upon data obtained from a meaningful number of sites, including through expansion to
additional sites. Once approved, when appropriate, the FDA can permit fulfillment of post-approval requirements under accelerated approval
through the submission of clinical evidence, clinical studies, patient registries, or other sources of real world evidence such as electronic
health records; through the collection of larger confirmatory datasets; or through post-approval monitoring of all patients treated with
the therapy prior to approval.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Fast track designation, breakthrough therapy designation, priority
review, accelerated approval, and RMAT designation do not change the standards for approval but may expedite the development or approval
process.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Pediatric studies and exclusivity</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under the Pediatric Research Equity Act of 2003, a BLA or supplement
thereto must contain data that are adequate to assess the safety and effectiveness of the drug product for the claimed indications in
all relevant pediatric subpopulations, and to support dosing and administration for each pediatric subpopulation for which the product
is safe and effective. Sponsors must also submit pediatric study plans prior to the assessment data. Those plans must contain an outline
of the proposed pediatric study or studies the applicant plans to conduct, including study objectives and design, any deferral or waiver
requests, and other information required by regulation. The applicant, the FDA, and the FDA&#8217;s internal review committee must then
review the information submitted, consult with each other and agree upon a final plan. The FDA or the applicant may request an amendment
to the plan at any time. The FDA may, on its own initiative or at the request of the applicant, grant deferrals for submission of some
or all pediatric data until after approval of the product for use in adults, or full or partial waivers from the pediatric data requirements.
Additional requirements and procedures relating to deferral requests and requests for extension of deferrals are contained in the FDASIA.
Unless otherwise required by regulation, the pediatric data requirements do not apply to products with orphan designation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Separately, in the event the FDA issues a Written Request for pediatric
data relating to a product, a BLA sponsor who submits such data may be entitled to pediatric exclusivity. Pediatric exclusivity is another
type of non&#8209;patent marketing exclusivity in the United States which, if granted, provides for the attachment of an additional six
months of marketing protection to the term of any existing exclusivity, including other non&#8209;patent and orphan exclusivity. This
six&#8209;month exclusivity may be granted if a BLA sponsor submits pediatric data that fairly respond to the Written Request from the
FDA for such data. The data do not need to show that the product is effective in the pediatric population studied; rather, if the clinical
trial is deemed to fairly respond to the FDA&#8217;s request, the additional protection is granted. If reports of requested pediatric
studies are submitted to and accepted by the FDA within the statutory time limits, whatever statutory or regulatory periods of exclusivity
or patent protection cover the product are extended by six months. This is not a patent term extension, but it effectively extends the
regulatory period during which the FDA cannot accept or approve another application.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">70</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Patent term restoration and extension</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">A patent claiming a new drug product may be eligible for a limited
patent term extension under the Drug Price Competition and Patent Term Restoration Act of 1984 (the &#8220;Hatch&#8209;Waxman Act&#8221;),
which permits a patent restoration of up to five years for the patent term lost during product development and the FDA regulatory review.
The restoration period granted is typically one&#8209;half the time between the effective date of an IND and the submission date of a
BLA, plus the time between the submission date of a BLA and the ultimate approval date. Patent term restoration cannot be used to extend
the remaining term of a patent past a total of fourteen years from the product&#8217;s approval date. Only one patent applicable to an
approved drug product is eligible for the extension, and the application for the extension must be submitted prior to the expiration of
the patent in question. A patent that covers multiple drugs for which approval is sought can only be extended in connection with one of
the approvals. The U.S. Patent and Trademark Office reviews and approves the application for any patent term extension or restoration
in consultation with the FDA.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Biosimilars and reference product exclusivity</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The Patient Protection and Affordable Care Act, as amended by the
Health Care and Education Reconciliation Act (collectively, the &#8220;ACA&#8221;), which was signed into law in 2010, includes a subtitle
called the Biologics Price Competition and Innovation Act of 2009 (&#8220;BPCIA&#8221;), which created an abbreviated approval pathway
for biological products that are biosimilar to or interchangeable with an FDA-approved reference biological product.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Biosimilarity, which requires that there be no clinically meaningful
differences between the biological product and the reference product in terms of safety, purity, and potency, can be shown through analytical
studies, animal studies, and a clinical study or studies. Interchangeability requires that a product is biosimilar to the reference product
and the product must demonstrate that it can be expected to produce the same clinical results as the reference product in any given patient
and, for products that are administered multiple times to an individual, the biologic and the reference biologic may be alternated or
switched after one has been previously administered without increasing safety risks or risks of diminished efficacy relative to exclusive
use of the reference biologic. However, complexities associated with the larger, and often more complex, structures of biological products,
as well as the processes by which such products are manufactured, pose significant hurdles to implementation of the abbreviated approval
pathway that are still being worked out by the FDA.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under the BPCIA, an application for a biosimilar product may not
be submitted to the FDA until four years following the date that the reference product was first licensed by the FDA. In addition, the
approval of a biosimilar product may not be made effective by the FDA until 12 years from the date on which the reference product was
first licensed. During this 12&#8209;year period of exclusivity, another company may still market a competing version of the reference
product if the FDA approves a full BLA for the competing product containing the sponsor&#8217;s own preclinical data and data from adequate
and well&#8209;controlled clinical trials to demonstrate the safety, purity and potency of their product.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The BPCIA also created certain exclusivity periods for biosimilars
approved as interchangeable products. At this juncture, it is unclear whether products deemed &#8220;interchangeable&#8221; by the FDA
will, in fact, be readily substituted by pharmacies, which are governed by state pharmacy law. The BPCIA is complex and continues to be
interpreted and implemented by the FDA. In addition, recent government proposals have sought to reduce the 12&#8209;year reference product
exclusivity period. Other aspects of the BPCIA, some of which may impact the BPCIA exclusivity provisions, have also been the subject
of recent litigation. As a result, the ultimate impact, implementation, and meaning of the BPCIA remains subject to significant uncertainty.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">71</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Review and Approval of Drug Products Outside
the European Union and the United States</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition to the above regulations, we must obtain approval of
a product by the comparable regulatory authorities of foreign countries outside of the European Union and the United States before we
can commence clinical trials or marketing of NexoBrid in those countries. The approval process varies from country to country and the
time may be longer or shorter than that required for FDA or EU approval. In addition, the requirements governing the conduct of clinical
trials, product licensing, pricing and reimbursement vary greatly from country to country. In all cases, clinical trials are conducted
in accordance with GCP and the applicable regulatory requirements and the ethical principles that have their origin in the Declaration
of Helsinki.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">If we fail to comply with applicable regulatory requirements, we
may be subject to, among other things, fines, suspension or withdrawal of regulatory approvals, product recalls, seizure of products,
operating restrictions and criminal prosecution.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Pharmaceutical Coverage, Pricing and Reimbursement</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Significant uncertainty exists as to the coverage and reimbursement
status of any products for which we obtain regulatory approval. In the United States, EU and other markets, sales of any products for
which we receive regulatory approval for commercial sale will depend to a large extent on the availability of reimbursement from third&#8209;party
payors. Third&#8209;party payors include governments, government health administrative authorities, managed care providers, private health
insurers and other organizations. The process for determining whether a payor will provide coverage for a drug product may be separate
from the process for setting the price or reimbursement rate that the payor will pay for the drug product. Third&#8209;party payors may
limit coverage to specific drug products on an approved list, or formulary, which might not include all of the drug products approved
for a particular indication by the FDA, European Commission or National Ministries of Health. Third&#8209;party payors are increasingly
challenging the price and examining the medical necessity and cost&#8209;effectiveness of medical products and services, in addition to
their safety and efficacy. We may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and
cost&#8209;effectiveness of NexoBrid, in addition to the costs required to obtain the FDA or other Ministry of Health approvals. Additionally,
NexoBrid may not be considered medically necessary or cost&#8209;effective. A payor&#8217;s decision to provide coverage for a drug product
does not guarantee that an adequate reimbursement rate will be approved. Adequate third&#8209;party reimbursement may not be available
to enable us to maintain price levels sufficient to realize an appropriate return on our investment in product development.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In the United States, the ACA substantially changed the way healthcare
is financed by both governmental and private insurers and significantly impacted the pharmaceutical industry. The ACA contains a number
of provisions, including those governing enrollment in federal healthcare programs, reimbursement changes and fraud and abuse provisions,
which will impact existing government healthcare programs and will result in the development of new programs, including Medicare payment
for performance initiatives and improvements to the physician quality reporting system and feedback program. Additionally, the ACA:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc76cc9bbfeb7459a9b618e95456007dc" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">increases the minimum level of Medicaid rebates payable by manufacturers of brand&#8209;name
        drugs from 15.1% to 23.1%;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">requires collection of rebates for drugs paid by Medicaid managed care organizations;
        and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">imposes a non&#8209;deductible annual fee on pharmaceutical manufacturers or importers
        who sell certain &#8220;branded prescription drugs&#8221; to specified federal government programs.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">72</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Since its enactment, there have been judicial, executive and congressional
challenges to certain aspects of the ACA. On June 17, 2021, the U.S. Supreme Court dismissed the most recent judicial challenge to the
ACA brought by several states without specifically ruling on the constitutionality of the ACA. Thus, the ACA will remain in effect in
its current form. Further, prior to the U.S. Supreme Court ruling, President Biden issued an executive order that initiated a special
enrollment period for purposes of obtaining health insurance coverage through the ACA marketplace from February 15, 2021 through August
15, 2021. The executive order instructed certain governmental agencies to review and reconsider their existing policies and rules that
limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work
requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">There has been heightened governmental scrutiny recently over the
manner in which drug manufacturers set prices for their marketed products, which have resulted in several Congressional inquiries and
proposed bills designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and
manufacturer patient programs, and reform government program reimbursement methodologies for drug products. . In March 2021, the American
Rescue Plan Act of 2021 was signed into law, which eliminates the statutory Medicaid drug rebate cap, currently set at 100% of a drug&#8217;s
average manufacturer price, for single source and innovator multiple source drugs, beginning January 1, 2024. In August 2022, the Inflation
Reduction Act of 2022, or IRA, was signed into law. Among other things, the IRA requires manufacturers of certain drugs to engage in price
negotiations with Medicare (beginning in 2026), with prices that can be negotiated subject to a cap; imposes rebates under Medicare Part
B and Medicare Part D to penalize price increases that outpace inflation (first due in 2023); and replaces the Part D coverage gap discount
program with a new discounting program (beginning in 2025). The IRA permits the Secretary of the Department of Health and Human Services
to implement many of these provisions through guidance, as opposed to regulation, for the initial years. For that and other reasons, it
is currently unclear how the IRA will be effectuated, or the impact of the IRA on our business. We expect that additional U.S. federal
healthcare reform measures will be adopted in the future, any of which could limit the amounts that the U.S. federal government will pay
for healthcare products and services, which could result in reduced demand for our products or additional pricing pressures. At the state
level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical and biological
product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing
cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing.
In the EU, pricing and reimbursement schemes vary widely from country to country and often within regions or provinces of countries. Some
countries may limit the annual budget of coverage or request that the company participate in the cost above certain use levels or for
treatments perceived as unsuccessful and impose monitoring processes on the use of the product. Some countries and hospitals may require
inclusion into the hospital formulary for payment from the hospital budget. Some countries and hospitals may require the completion of
additional studies that compare the cost&#8209;effectiveness of a particular drug candidate to currently available therapies. For example,
the EU provides options for its member states to restrict the range of medicinal products for which their national health insurance systems
provide reimbursement and to control the prices of medicinal products for human use. This Health Technology Assessment (&#8220;HTA process&#8221;)
which is currently governed by the national laws of the individual EU member states, is the procedure according to which the assessment
of the public health impact, therapeutic impact and the economic and societal impact of use of a given medicinal product in the national
healthcare systems of the individual country is conducted. The outcome of HTA regarding specific medicinal products will often influence
the pricing and reimbursement status granted to these medicinal products by the competent authorities of individual EU Member States.
On December 15, 2021, the Health Technology Regulation (&#8220;HTA Regulation&#8221;) was adopted. The HTA Regulation is intended to boost
cooperation among EU member states in assessing health technologies, including new medicinal products, and providing the basis for cooperation
at EU level for joint clinical assessments in these areas. When it enters into application in 2025, the HTA Regulation will be intended
to harmonize the clinical benefit assessment of HTA across the EU.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Further, EU member states may approve a specific price for a drug
product or may instead adopt a system of direct or indirect controls on the profitability of the company placing the drug product on the
market. Other member states allow companies to fix their own prices for drug products, but monitor and control company profits. The downward
pressure on health care costs in general, particularly prescription drugs, has become intense. As a result, increasingly high barriers
are being erected to the entry of new products. In addition, in some countries, cross&#8209;border imports from low&#8209;priced markets
exert competitive pressure that may reduce pricing within a country. Any country that has price controls or reimbursement limitations
for drug products may not allow favorable reimbursement and pricing arrangements. Historically, products launched in the EU do not follow
price structures of the United States and generally prices tend to be significantly lower.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">73</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Healthcare Law and Regulation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Healthcare providers, physicians and third&#8209;party payors play
a primary role in the recommendation and prescription of drug products that are granted marketing authorization. Arrangements with healthcare
providers, third&#8209;party payors and other customers are subject to broadly applicable fraud and abuse and other healthcare laws and
regulations. Such restrictions under applicable federal, state and foreign healthcare laws and regulations, include the following:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z491ec3b8faf94495ae24b60efaf40b0a" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the federal healthcare Anti&#8209;Kickback Statute prohibits, among other things,
        persons from knowingly and willfully soliciting, offering, receiving or providing remuneration, directly or indirectly, in cash or in
        kind, to induce or reward either the referral of an individual for, or the purchase, order or recommendation of, any good or service for
        which payment may be made, in whole or in part, under a federal healthcare program such as Medicare and Medicaid. A person or entity does
        not need to have actual knowledge of this statute or specific intent to violate it in order to have committed a violation;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the federal False Claims Act imposes civil penalties, and provides for civil whistleblower
        or qui tam actions, against individuals or entities for knowingly presenting, or causing to be presented, to the federal government, claims
        for payment that are false or fraudulent or making a false statement to avoid, decrease or conceal an obligation to pay money to the federal
        government. In addition, the government may assert that a claim including items or services resulting from a violation of the federal
        Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">HIPAA, imposes criminal and civil liability for executing a scheme to defraud any
        healthcare benefit program or making false statements relating to healthcare matters;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the federal false statements statute prohibits knowingly and willfully falsifying,
        concealing or covering up a material fact or making any materially false statement in connection with the delivery of or payment for healthcare
        benefits, items or services;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the federal physician payment transparency requirements under the Affordable Care
        Act require certain manufacturers of drugs, devices and medical supplies to report to Centers for Medicare &amp; Medicaid Services information
        related to payments and other transfers of value to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors),
        certain other non-physician practitioners such as physician assistants and nurse practitioners, and teaching hospitals and physician ownership
        and investment interests;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">analogous state and foreign laws and regulations, such as state anti&#8209;kickback
        and false claims laws, may apply to sales or marketing arrangements and claims involving healthcare items or services reimbursed by non&#8209;governmental
        third&#8209;party payors, including private insurers.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Violations of any of these laws or any other governmental laws
and regulations that may apply include, without limitation, significant civil, criminal and administrative penalties, damages, fines,
imprisonment, exclusion of products from government funded healthcare programs, such as Medicare and Medicaid, disgorgement, contractual
damages, reputational harm, diminished profits and the curtailment or restructuring of our operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Some state laws require pharmaceutical companies to comply with
the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government
in addition to requiring drug manufacturers to report information related to payments to physicians and other health care providers or
marketing expenditures. Additionally, certain state and local laws require the registration of pharmaceutical sales representatives.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">74</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Environmental, Health and Safety Matters</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are subject to extensive environmental, health and safety laws
and regulations in a number of jurisdictions, primarily Israel, governing, among other things: the use, storage, registration, handling,
emission and disposal of chemicals, waste materials and sewage; chemicals, air, water and ground contamination; air emissions and the
cleanup of contaminated sites, including any contamination that results from spills due to our failure to properly dispose of chemicals,
waste materials and sewage. Our operations at our Yavne manufacturing facility use chemicals and produce waste materials and sewage. Our
activities require permits from various governmental authorities including, local municipal authorities, the Ministry of Environmental
Protection and the Ministry of Health. The Ministry of Environmental Protection and the Ministry of Health, local authorities and the
municipal water and sewage company conduct periodic inspections in order to review and ensure our compliance with the various regulations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">These laws, regulations and permits could potentially require the
expenditure by us of significant amounts for compliance or remediation. If we fail to comply with such laws, regulations or permits, we
may be subject to fines and other civil, administrative or criminal sanctions, including the revocation of permits and licenses necessary
to continue our business activities. In addition, we may be required to pay damages or civil judgments in respect of third&#8209;party
claims, including those relating to personal injury (including exposure to hazardous substances we use, store, handle, transport, manufacture
or dispose of), property damage or contribution claims. Some environmental, health and safety laws allow for strict, joint and several
liability for remediation costs, regardless of comparative fault. We may be identified as a responsible party under such laws. Such developments
could have a material adverse effect on our business, financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, laws and regulations relating to environmental, health
and safety matters are often subject to change. In the event of any changes or new laws or regulations, we could be subject to new compliance
measures or to penalties for activities which were previously permitted. For instance, new Israeli regulations were promulgated in 2012
relating to the discharge of industrial sewage into the sewer system. These regulations establish new and potentially significant fines
for discharging forbidden or irregular sewage into the sewage system.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Properties</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our principal executive offices are located at 42 Hayarkon Street,
Yavne 8122745, Israel. We have leased these facilities from a third party. The lease agreement will expire on 2035, with an option for
a further three year extension until 2038. The facilities consist of approximately 32,300 square feet of space, and the yearly lease fee
is approximately $648,000. These facilities house our administrative headquarters, our research and development laboratories and our manufacturing
plant.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">During 2023 we initiated the expansion of the Company&#8217;s manufacturing
facility to address the increasing global demand for NexoBrid. This expansion project is scheduled for completion by the end of 2024 and
is projected to achieve 6-fold manufacturing capacity increase in 2025.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In July 2023, we entered into a turnkey scale-up agreement with
Biopharmax Group Ltd. To bolster our manufacturing infrastructure and support our long-term growth trajectory. The objective of this agreement
is to establish, commission, and validate a cutting-edge, sterile, and GMP-compliant manufacturing facility. The venture aims to increase
our production capacity significantly, projected to expand to six times the current capacity, aligning with our strategic plan to meet
the escalating global demand for NexoBrid. The new facility, equipped with fully operational clean rooms, will be exclusively designed
for NexoBrid production. It will comply with stringent regulations from the GMP, FDA, EMA, Israeli Ministry of Health, and relevant Israeli
regulatory bodies. An estimated $12.7 million will be invested in the project, set for completion by mid-2024, with full-scale manufacturing
expected to commence in 2025.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have furthermore leased additional office space in Yavne, Israel,
consisting of approximately 4,000 square feet, for a term of 2 years, commencing in January 1, 2024, with an option for a further three
year extension until 2028. The yearly lease fee is approximately $120,000. For the initial two years of the lease term, the majority of
our lease payments are being covered by the DOD.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">75</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-weight: bold">C.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
<span style="font-weight: bold">Organizational Structure</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The legal name of our company is MediWound Ltd. and we are organized
under the laws of the State of Israel. Our corporate structure consists of MediWound Ltd., our Israeli parent company, (i) MediWound Germany
GmbH, our active wholly&#8209;owned subsidiary, which was incorporated on April 16, 2013 under the laws of the Federal Republic of Germany
(ii) MediWound US, Inc., which was incorporated on December 8, 2020 under the laws of the State of Delaware and (iii) MediWound UK Limited,
our inactive wholly&#8209;owned subsidiary, which was incorporated on July 26, 2004 under the laws of England.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25"><span style="font-weight: bold">D.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;&#160; <span style="font-weight: bold">Property, Plants and Equipment</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">See &#8220;ITEM 4.B. Business Overview-Properties&#8221;, &#8220;ITEM
4.B. Business Overview-Manufacturing, Supply and Production&#8221; and &#8220;ITEM 4.B. Business Overview-Environmental, Health and Safety
Matters&#8221;.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Item 4A<span id="Item4A"><!--Anchor--></span>. UNRESOLVED STAFF
COMMENTS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">None.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Item 5.&#160; OPERATING AND FINANCIAL REVIEW AND PROSPECTS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25; font-weight: bold">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Operating
Results</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">The information contained in this section should
be read in conjunction with our consolidated financial statements for the year ended December 31, 2023 and related notes, and the information
contained elsewhere in this annual report. Our financial statements have been prepared in accordance with IFRS, as issued by the IASB.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Company Overview</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are a biopharmaceutical company that develops, manufactures,
and commercializes novel, cost effective, bio&#8209;therapeutic, non-surgical solutions for tissue repair and regeneration. Our strategy
leverages our breakthrough enzymatic technology platform into diversified portfolio of biotherapeutics across multiple indications to
pioneer solutions for unmet medical needs. Our current portfolio is focused on next-generation protein-based therapies for burn care,
wound care and tissue repair.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our first innovative biopharmaceutical product, NexoBrid&#174;,
has received marketing authorization from the FDA and marketing authorization from the European Medicines Agency (the &#8220;EMA&#8221;)
and other international markets for removal of dead or damaged tissue, known as eschar, in adults with deep partial-thickness and full-thickness
thermal burns, also referred to as severe burns. NexoBrid, a concentrate of proteolytic enzymes enriched in bromelain, represents a new
paradigm in burn care management, and our clinical trials have demonstrated, with statistical significance, its ability to non&#8209;surgically
and rapidly remove the eschar, without harming viable tissues, earlier relative to existing standard of care.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We commercialize NexoBrid globally through multiple sales channels.
We sell NexoBrid to burn centers in the European Union, United Kingdom and Israel, primarily through our direct sales force, focusing
on key burn centers and KOLs. In the United States, we entered into exclusive license and supply agreements with Vericel Corporation (Nasdaq:
VCEL) to commercialize NexoBrid in North America. We have established local distribution channels in multiple international markets, focusing
on Asia Pacific, EMEA, CEE and LATAM, which local distributors are also responsible for obtaining local marketing authorization within
the relevant territories.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have been awarded two contracts with the U.S. Biomedical Advanced
Research and Development Authority ("BARDA"), for the advancement of the development and manufacturing, as well as the procurement of
NexoBrid which has initiated on January 2020, as a medical countermeasure as part of BARDA preparedness for mass casualty events.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">76</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">EscharEx, our next-generation enzymatic therapy under development,
is a topical biological drug candidate for the debridement of chronic and other hard-to-heal wounds. Designed for the outpatient setting,
EscharEx is an easy-to-use concentrate of proteolytic enzymes enriched in bromelain; having the same API as NexoBrid. In several Phase
II trials, EscharEx was shown to be well-tolerated and demonstrated safety and efficacy in the debridement of various chronic and other
hard-to-heal wounds with only few daily applications. EscharEx&#8217;s mechanism of action is mediated by the proteolytic enzymes that
cleave and remove the necrotic tissue and prepare the wound bed for healing. On May 12, 2022, we announced positive results from our U.S.
Phase II clinical study of EscharEx for the debridement of VLUs. The study met its primary endpoint with a high degree of statistical
significance, demonstrating that patients treated with EscharEx had a statistically significant higher incidence of complete debridement
during the 14-day measurement period within up to 8 applications, compared to gel vehicle (EscharEx: 63% (29/46) vs. gel vehicle: 30%
(13/43), p-value=0.004). EscharEx efficacy superiority remained statistically significant after adjusting for pre-specified covariates
ascribed to patient baseline characteristics, wound size, wound age and regions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The study met key secondary and exploratory endpoints. Patients
treated with EscharEx had a statistically significant higher incidence of complete debridement, during the same 14-day measurement period,
compared to patients treated by non-surgical standard-of-care ("NSSOC") (EscharEx: 63% (29/46) vs. NSSOC: 13% (4/30)) and the time to
achieve complete debridement was significantly shorter. Estimated median time to complete debridement was 9 days for patients treated
with EscharEx and 59 days for patients treated with NSSOC (p-value=0.016). On average, complete debridement was achieved after 3.6 applications
of EscharEx compared to 12.8 applications with NSSOC. Patients treated with EscharEx demonstrated significantly higher incidence of at
least 75% granulation tissue at the end of the treatment period compared to gel vehicle (p-value &lt;0.0001). Favorable trends were observed
in wound area reduction and reduction of pain compared to gel vehicle.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, the study showed that EscharEx was safe and well tolerated,
and the overall safety was comparable between the arms as assessed by the data safety monitoring board. Importantly, there were no observed
deleterious effects on wound closure and no material differences in reported adverse events. Estimated time to complete wound closure
was 64 days for patients treated with EscharEx compared to 78 days for patients treated with NSSOC.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">EscharEx was also evaluated in a U.S. Phase II pharmacology study.
The study was prospective, open label, single-arm and conducted at three U.S. clinical sites. On July 7, 2022, we announced positive results
from this study. 70% of patients achieved complete debridement during the course of treatment within up to 8 applications. On average,
complete debridement was achieved after 3.9 applications of EscharEx. Additionally, an average reduction of 35% in wound size was achieved
by the end of the 2-week follow-up period. In all patients that were positive for biofilm at baseline, the biofilm was reduced substantially
to single individual microorganisms or completely removed by the end of treatment. Seven patients had positive red fluorescence (indicative
of bacteria) at baseline and average red fluorescence was reduced from 1.69 cm2 pre-treatment to 0.60 cm2 post treatment. Biomarker analysis
from wound fluid safety data showed that EscharEx is safe and well-tolerated.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our third innovative product candidate, MW005, is a topically applied
biological drug candidate for the treatment of non-melanoma skin cancers, based on the same API as NexoBrid and EscharEx (a concentrate
of proteolytic enzymes enriched in bromelain). In July 2021, we initiated a phase I/II study of MW005 for the treatment of low-risk BCC.
On July 11, 2022, we announced positive initial data from this study. In the first cohort, eleven patients with either superficial or
nodular BCC were treated. Patients enrolled into the study received seven topical applications of MW005, once every other day. At the
end of eight weeks post treatment period, all patients undergo complete excision, and the specimen is subject to an independent histological
clearance examination.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">In July 2023, we again announced positive results in our U.S. Phase I/II study of MW005
for the treatment of basal cell carcinoma. Fifteen patients were treated with MW005 and completed the study. Results showed MW005 to be
safe and well-tolerated, with a high level of patient compliance. Based on clinical assessments, eleven out of fifteen patients achieved
complete clearance of their BCCs; the majority of these patients also had histologically confirmed complete clearance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Based on the data generated to date, MW005 is safe, well-tolerated
and an effective treatment for BCC with a majority of patients who completed the study demonstrating a complete histological clearance
of target lesions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We manufacture NexoBrid and our product candidates in our cGMP
certified sterile manufacturing facility at our headquarters in Yavne, Israel. As of December 31, 2023, we had cash and cash equivalents
and short term and restricted bank deposits of $41.7 million. Our revenues were $18.7 million and $26.5 in 2023 and 2022, respectively.
Our net operating loss was $15.3 million and $8.3 in 2023 and 2022, respectively. We had an accumulated deficit of $174.8 million as of
December 31, 2023. We expect to incur significant expenses and operating losses in the coming years, as research and development activities
are central to our operations, which will offset by cash inflows from NexoBrid.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We expect to continue to invest in our research and development
efforts, including in respect of our NexoBrid ongoing clinical trials which are fully funded by BARDA, as well as the clinical development
and trials of EscharEx, MW005 and our other pipeline product candidates. In addition, we expect to continue to advance NexoBrid as a standard
of care, and expand its commercial reach in international markets, including for potential use as a medical countermeasure during mass
casualty events.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">77</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Key Components of Statements of Operations</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Revenues</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-style: italic">Sources of revenues. </span>We
derive revenues from sales of NexoBrid to burn centers and hospitals burn units in USA, Europe and Israel as well as to local distributors
in other countries in accordance with distribution agreements we have in place, which also include revenues from licenses. We generate
revenues from BARDA procurement of NexoBrid for emergency stockpile pursuant to BARDA contract.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We generate revenues from development services provided to BARDA,
and to DOD/MTEC.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our ability to generate additional, more significant revenues will
depend on the successful commercialization of NexoBrid.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Cost of Revenues</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our total cost of revenues includes expenses for the manufacturing
of NexoBrid, including: the cost of raw materials; employee&#8209;related expenses, including salaries, equity based&#8209;compensation
and other benefits and related expenses, lease payments, utility payments, depreciation, changes in inventory of finished products, royalties
and other manufacturing expenses. These expenses are partially reduced by an allotment of manufacturing costs associated with research
and development activities to research and development expenses.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Cost of revenues includes costs associated with the research and
development services provided to BARDA and MTEC, including salaries and related expenses, clinical trials, sub&#8209;contractors and external
advisors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We expect that our cost of revenues from sale of products will
continue to increase as we expand the sale of NexoBrid throughout the European Union, the United States and other international markets.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Operating Expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Research and Development Expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Research and development activities are central to our business
model. Product candidates in later stages of clinical development generally have higher development costs than those in earlier stages
of clinical development, primarily due to the increased size and duration of later&#8209;stage clinical trials. We expect research and
development costs to increase significantly for the foreseeable future as EscharEx progresses in its clinical program in the U.S. and
our other pipeline product candidates' progress in clinical trials. However, we do not believe that it is possible at this time to accurately
project total program&#8209;specific expenses to reach commercialization. There are numerous factors associated with the successful development
of any of our product candidates, including future trial design and various regulatory requirements, many of which cannot be determined
with accuracy at this time based on our stage of development. Additionally, future commercial and regulatory factors beyond our control
will affect our clinical development programs and plans. Our actual spending could differ as our plans change and we invest in other drugs
or potentially reduce our anticipated funding on research for existing products. Research and development expenses consist primarily of
compensation for employees engaged in research and development activities, including salaries, equity&#8209;based compensation, benefits
and related expenses, clinical trials, contract research organization sub&#8209;contractors, development materials, external advisors
and the allotted cost of our manufacturing facility for research and development purposes.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">78</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Selling and Marketing Expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Selling and marketing expenses consist primarily of compensation
expenses for personnel engaged in sales and marketing, including salaries, equity based&#8209;compensation and benefits and related expenses,
as well as promotion, marketing, market access, medical, and sales and distribution activities. These expenses are primarily comprised
of costs related to our subsidiary in Germany, which is focused on marketing NexoBrid in E.U., and costs related to maintain marketing
authorization.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">General and Administrative Expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">General and administrative expenses consist principally of compensation
for employees in executive and administrative functions, including salaries, equity&#8209;based compensation, benefits and other related
expenses, professional consulting services, including legal and audit fees, as well as costs of office and overhead. We expect general
and administrative expenses to remain stable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Financial Income/Financial Expense</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Financial income includes interest income, revaluation of financial
instruments and exchange rate differences. Financial expense consists primarily of revaluation of financial instruments, financial expenses
in respect of deferred revenue, revaluation of lease liabilities and exchange rate differences. The market interest due on government
grants received from the IIA is also considered a financial expense, and is recognized beginning on the date we receive the grant until
the date on which the grant is expected to be repaid as part of the revaluation to fair value of liabilities in respect of government
grants.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Taxes on Income</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The standard corporate tax rate in Israel is 23%.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">We do not generate taxable income in Israel, as
we have historically incurred operating losses resulting in carry forward tax losses and other temporarily differences from R&amp;D expenses
totaling approximately $172 million as of December 31, 2023. We anticipate that we will be able to carry forward these tax losses indefinitely
to future tax years. Accordingly, we do not expect to pay taxes in Israel until we have taxable income after the full utilization of our
carry forward tax losses.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under the Law for the Encouragement of Capital Investments, 5719&#8209;1959
(the &#8220;Investment Law&#8221;), we have been granted &#8220;Beneficiary Enterprise&#8221; status, which provides certain benefits,
including tax exemptions and reduced corporate tax rates. Income not eligible for Beneficiary Enterprise benefits is taxed at the regular
corporate tax rate. The benefit entitlement period starts from the first year that the Beneficiary Enterprise first earns taxable income,
and is limited to 12 years from the year in which the company requested to have tax benefits apply.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">79</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Comparison of Period to Period Results of Operations</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25">We are providing within this section a supplemental discussion
that compares our historical statement of operations data in accordance with IFRS, as issued by the IASB. The below table and the below
discussion provides data for each of the years ended December 31, 2023 and 2022. The below discussion of our results of operations omits
a comparison of our results for the years ended December 31, 2022 and 2021. In order to view that discussion, please see &#8220;Item 5.
Operating and Financial Review and Prospects-A. Operating Results-<span style="font-weight: bold">&#160;</span>Comparison of Period to
Period Results of Operations-<span style="font-weight: bold; font-style: italic">&#160;</span>Year Ended December 31, 2022 Compared to
Year Ended December 31, 2021&#8221; in our Annual Report on Form 20-F for the year ended December 31, 2022, which we filed with the SEC
on March 16, 2023.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" class="cfttable" id="zc6f9ea67af464839bdf4e73a50d6150f" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Years Ended December 31,</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2023</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2022</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-style: italic">(in thousands)</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-weight: bold">Condensed statements of operations data:</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Revenues&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">18,686</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">26,496</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Cost of revenues&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">15,108</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">13,331</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Gross profit&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">3,578</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">13,165</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25; font-weight: bold">Operating expenses:</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Research and development&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">7,467</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">10,181</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Selling and marketing&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">4,844</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">3,725</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">General and administrative&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">6,768</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">6,920</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Other (income) expenses&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(211</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">
        <div style="line-height: 1.25">)</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">684</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Operating loss&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(15,290</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(8,345</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Financial income (expenses), net&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">8,759</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(11,176</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Loss before taxes on income&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(6,531</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
        <div style="line-height: 1.25">)</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(19,521</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Taxes on income&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(185</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
        <div style="line-height: 1.25">)</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(78</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Net loss&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(6,716</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">
        <div style="line-height: 1.25">)</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(19,599</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">
        <div style="line-height: 1.25">)</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Year Ended December&#160;31, 2023 Compared to Year Ended December&#160;31,
2022</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Revenues&#160;</div>

<table cellspacing="0" cellpadding="0" class="cfttable" id="zcc8ad3a0864a43d4b9725d1029c1e7c9" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Years Ended December 31,</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2023</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2022</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-style: italic">(in thousands)</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Revenues from sale of products&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">6,261</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">5,347</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Revenues from development services&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">12,265</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">12,943</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Revenues from license agreements and royalties&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">160</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">8,206</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">18,686</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">26,496</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">We generated total revenues of approximately $18.7
million for the year ended December 31, 2023 compared to approximately $26.5 million for the year ended December 31, 2022. The decrease
is primarily attributed to the BLA approval millstone payment from Vericel that took place in 2022.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">80</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Revenues from sale of products</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Revenues from sales of products in 2023 were $6.3 million, a 17%
increase compared to $5.3 million in 2022 mainly attributed to new customers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Revenues from development services</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">Revenues from development services decreased by 5% from $12.9 million in 2022 to $12.3
million in 2023. The decrease mainly driven from BARDA.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">&#160;<span style="font-style: italic">Revenues from license agreements and royalties</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In 2023, revenues from license agreements and royalties were $0.2
million compared to $8.2 million in 2022, the decrease mainly driven by the BLA approval milestone of $7.5 million from Vericel in 2022.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our revenues, as reported in our consolidated financial statements,
are based on the location of the customers, as shown in the below table:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" class="cfttable" id="z6680fc10739a41979fe9530e7e38f171" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Years Ended December 31,</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2023</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2022</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">(<span style="font-style: italic">in thousands</span>)</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">International (excluding U.S.)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">5,608</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">4,624</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px">
        <div style="line-height: 1.25">U.S.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">13,078</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">21,872</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">18,686</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">26,496</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">BARDA contributed 56% and 51% of the Company&#8217;s total revenues
in 2023 and 2022 respectively. Vericel contributed 4% and 28% of the Company&#8217;s total revenues in 2023 and 2022 respectively. DoD/MTEC
contributed 10% and 2.8% of the Company&#8217;s total revenues in 2023 and 2022 respectively.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Costs and Expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Cost of revenues</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" class="cfttable" id="zc4f436f332a24db68efcd71e3503bf16" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Years Ended December 31,</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2023</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2022</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">(<span style="font-style: italic">in thousands</span>)</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Cost of revenues from sales of products&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">4,927</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">3,184</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25">Cost of revenues from development services&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">10,177</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">9,829</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Cost of revenues from license agreements&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">4</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">318</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">15,108</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">13,331</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="text-indent: 36pt; line-height: 1.25">Cost of revenues as a percentage of total revenues increased from 50% for 2022 to 81%
for 2023.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">Cost of revenues from sales of products as a percentage of revenues from sales of products
increased to approximately 79% for the year ended December 31, 2023, from approximately 60% in the year ended December 31, 2022. The increase
of cost of revenues from sales of product is primarily driven by revenue mix changes.</div>

<div style="text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">81</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Cost of revenues from development services as a percentage of revenues
from development services was approximately 83% in the year ended December 31, 2023, compared to approximately 76% in the year ended December
31, 2022, mainly attributed to BARDA.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Cost of revenues from license agreements and royalties as a percentage
of revenues from license agreements was 3% in the year ended December 31, 2023 compared to approximately 4% in the year ended December
31,2022.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Research and development expenses,</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Research and development expenses decreased by 27% from approximately
$10.2 million in the year ended December 31, 2022 to approximately $7.5 million in the year ended December 31, 2023, attributed mainly
to the completion of EscharEx Phase II study.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Selling and marketing expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Selling and marketing expenses increased by 30% in 2023 compared
to 2022, from approximately $3.7 million in the year ended December 31, 2022 to approximately $4.8 million in the year ended December
31, 2023, mainly related to consulting services, and various marketing expenses.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">General and administrative expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">General and administrative expenses decreased by 2% in 2023 compared
to 2022 from approximately $6.9 million in the year ended December 31, 2022 to approximately $6.8 million in the year ended December 31,
2023.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Other (income) expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25">Other one-time incomes for the year ended December 31, 2023
were $(0.2) million associated with non-cash income resulted with termination of sub-lease agreement with CBI. Other one-time expenses
for the year ended December 31, 2022 were $0.7 million associated with management replacement and Vericel milestone payment fee.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" class="cfttable" id="zf4b4330836cf4029a3a6af445d5217ec" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25; font-weight: bold">Financial income, net</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Years Ended December 31,</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2023</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2022</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">(<span style="font-style: italic">in thousands</span>)</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Financial income&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">10,651</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">461</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px">
        <div style="line-height: 1.25">Financial expenses&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(1,892</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
        <div style="line-height: 1.25">)</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(11,637</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">8,759</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(11,176</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Financial income</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Financial income increased from approximately $0.5 million in the
year ended December 31, 2022 to approximately $10.7 million in the year ended December 31, 2023. The increase was primarily driven by
an $8.3 million adjustment resulting from the revaluation of warrants and by $2.3 million of interest income from short term deposits
in 2023.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Financial expense</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Financial expenses decreased from approximately $11.6 million in
the year ended December 31, 2022 to approximately $1.9 million in the year ended December 31, 2023. The decrease in financial expenses
was primarily driven by $9 million adjustment resulting from the revaluation of warrants in 2022.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">82</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-weight: bold">B.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
<span style="font-weight: bold">Liquidity and Capital Resources</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our primary uses of cash are to fund working capital requirements,
manufacturing costs, research and development activities related to EscharEx and other products candidates, capital expenditure requirements,
as well as sales and marketing activities associated with the commercialization of NexoBrid in Europe.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">On March 7, 2022, the Company completed a public offering in total
of 744,048 new ordinary shares which were issued in consideration to offering price of $13.44 per share. The net proceeds were $8,653,
after deducting commissions and other offering expenses. In addition, on March 22, 2022 the underwriters exercised their options to purchase
an additional 89,012 ordinary shares at the same public offering price. The net consideration to the Company, less underwriting discounts
and commissions was at additional of $1,021.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">On September 26, 2022, the Company completed a registered direct
(the &#8220;RD&#8221;) offering in an aggregate amount of $13,257 represent a combine purchase price of $12.25 for issuance of 1,082,223
ordinary shares and 1,082,223 warrants that become exercisable on November 28, 2022, at an exercise price of $13.475 per ordinary share
which will expire in four years, The net proceeds from this offering in the amount of $11,698 have been received on September 28, 2022.
The issuance expenses related to the non-current financial liability were recorded through profit and lost and the issuance expenses related
to the issuance of shares recorded as a deduction from the proceed in equity.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">On October 6, 2022 we entered the PIPE Securities Purchase Agreement
with the several purchasers listed on the signature pages thereto (the &#8220;PIPE Purchasers&#8221;), in connection with the offer and
sale of 1,407,583 pre-funded warrants to purchase up to 1,407,583 Ordinary Shares (the &#8220;Pre-Funded Warrants&#8221;) and 1,407,583
ordinary warrants to purchase up to 1,407,583 Ordinary Shares (the &#8220;PIPE Ordinary Warrants,&#8221; and together with the Pre-Funded
Warrants, the &#8220;PIPE Warrants&#8221;) (the &#8220;PIPE Offering&#8221;). The combined purchase price for one Pre-Funded Warrant and
associated PIPE Ordinary Warrant was $12.243. The Pre-Funded Warrants have an exercise price of $0.007 per Ordinary Share and the PIPE
Ordinary Warrants have an exercise price of $13.475 per Ordinary Share and each become exercisable on November 28, 2022. The PIPE Offering
closed on October 6, 2022. The gross proceeds from the PIPE Offering were approximately $17.23 million. As of December 31, 2022, all Pre-Funded
Warrants have been exercised and none of the PIPE Ordinary Warrants have been exercised.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">H.C. Wainwright &amp; Co., LLC (&#8220;Wainwright&#8221;) acted
as the exclusive placement agent for the RD Offering and the PIPE Offering (together, the &#8220;2022 Offerings&#8221;). Upon closing
of the Offerings, we issued Wainwright (or its designees) the warrants to purchase up to 124,491 ordinary shares (the &#8220;Wainwright
Warrants&#8221;). The warrants have substantially the same terms as the RD Warrants and the Series A Warrants, except that the Wainwright
Warrants have an exercise price equal to $15.3125 per share (which represents 125% of the offering price per Ordinary Share in the Offerings)
and will expire four (4) years after November 28, 2022, but no more than five (5) years following the commencement of the sales pursuant
to the RD Offering.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#160;On February 3, 2023, we entered into a securities purchase
agreement (the &#8220;2023 Securities Purchase Agreement&#8221;) with the purchasers listed on the signature pages thereto (the &#8220;2023
Purchasers&#8221;), in connection with the offer and sale of 1,964,286 ordinary shares (the &#8220;2023 Offering&#8221;). The purchase
price per ordinary share was $14.00. The 2023 Offering closed on February 7, 2023. The gross proceeds from the Offering were approximately
$27.5 million.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25">The Company believes that its existing cash and cash equivalents, short-term and restricted
bank deposits of $41.7 million as of December 31, 2023, will be sufficient to fund its operations and capital expenditure for at least
twelve months from the date of issuance of these consolidated financial statements.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our future capital requirements will depend on many factors, including
our revenue growth, timing of milestone payments, the timing and extent of our spending on research and development efforts, and international
expansion. We may also seek to invest in or acquire complementary businesses or technologies. To the extent that existing cash and cash
from operations are insufficient to fund our future activities, we may need to raise additional funding through debt and equity financing.
Additional funds may not be available on favorable terms or at all</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The accompanying consolidated financial statements have been prepared
on a basis which assumes that the Company will continue as a going concern. From inception to December 31, 2023, the Company has incurred
cash outflows from operations, losses from operations, and has an accumulated deficit of $174.8 million.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">83</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-weight: bold">Cash Flows</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">The following table summarizes our consolidated
statement of cash flows for the periods presented. The below discussion beneath the table omits a description of our cash flows for the
year ended December 31, 2023. In order to view that discussion, please see &#8220;Item 5. Operating and Financial Review and Prospects
Liquidity and Capital Resources&#8221; in our Annual Report on Form 20-F for the year ended December 31, 2022, which we filed with the
SEC on March 16, 2023:</div>

<div style="line-height: 1.25">&#160;</div> </div>

<table cellspacing="0" cellpadding="0" class="cfttable" id="z5b1ccc819ebc4efeb30f09b86a73d485" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Year Ended December 31,</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2023</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2022</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Net cash provided by (used in):</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Operating activities&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(10,465</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(11,885</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Investing activities&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(34,321</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(481</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Financing activities&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">22,917</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">35,764</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic">Net cash used in operating activities</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">Net cash used in all periods resulted primarily
from our net loss adjusted for non-cash charges and measurements and changes in components of working capital. Adjustments for non-cash
items include depreciation and amortization, equity-based compensation, revaluation of contingent liabilities warrants, and lease liability,
and changes in assets and liabilities items.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Net cash used in operating activities decreased to approximately
$10.5 million in the year ended December 31, 2023 compared to net cash used in operating activities of approximately $11.9 million in
the year ended December 31, 2022, primarily as a result of our operational net loss, partially offset by various non-cash items such as
depreciation, shared based compensation, financial income, net and revaluation of contingent considerations and warrants.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">

<div style="line-height: 1.25; font-family: Times New Roman, serif; font-style: italic">Net cash used in investing activities</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Net cash used in investing activities primarily derives from investment
in short term banks deposits and from purchases of property and equipment mainly related to scaling up our production facility, offset
by interest received from short term bank deposit. Net cash used in investing activities was $34.3 million in the year ended December
31, 2023, compared to $0.5 million provided during the year ended December 31, 2022, primarily result of investment in short- term bank
deposits and investments in property and equipment.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Net cash provided by financing activities</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">Net cash provided by financing activities was $22.9
million in the year ended December 31, 2023 compared to $35.8 million in the year ended December 31, 2022. The decrease in net cash provided
by financing activities was primarily a result of the proceeds from the company&#8217;s 2022 Offerings, net of issuance expenses.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">84</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Israeli Corporate-Level Tax Considerations and Government Programs</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The following is a brief summary of the material Israeli tax laws
applicable to us, and certain Israeli Government programs that benefit us and therefore impact our results of operations and financial
condition. To the extent that the discussion is based on new tax legislation that has not yet been subject to judicial or administrative
interpretation, we cannot assure you that the appropriate tax authorities or the courts will accept the views expressed in this discussion.
The discussion below is subject to change, including due to amendments under Israeli law or changes to the applicable judicial or administrative
interpretations of Israeli law, which change could affect the tax consequences described below.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">General Corporate Tax Structure in Israel</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Generally, Israeli companies are subject to a corporate tax on
their taxable income. Effective January 1, 2018 and thereafter, the corporate tax rate is 23%. However, the effective tax rate payable
by a company that derives income from an Approved Enterprise, a Beneficiary Enterprise, a Preferred Enterprise or Technology Enterprise
(as discussed below) may be considerably less. Capital gains derived by an Israeli company are generally subject to the prevailing regular
corporate tax rate.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Law for the Encouragement of Industry (Taxes), 5729-1969</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The Law for the Encouragement of Industry (Taxes), 5729-1969 (the
&#8220;Industry Encouragement Law&#8221;), provides several tax benefits for &#8220;Industrial Companies.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The Industry Encouragement Law defines an &#8220;Industrial Company&#8221;
as an Israeli resident-company which was incorporated in Israel, of which 90% or more of its income in any tax year, other than income
from certain government loans, is derived from an &#8220;Industrial Enterprise&#8221; owned by it and located in Israel or in the &#8220;Area&#8221;,
in accordance with the definition under section 3A of the Israeli Income Tax Ordinance (New Version) 1961. An &#8220;Industrial Enterprise&#8221;
is defined as an enterprise whose principal activity in a given tax year is industrial production.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The following tax benefits, among others, are available to Industrial
Companies:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z22718b1f73e64b3faf4608c7b3a0015c" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><br/> &#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">amortization of the cost of purchased a patent, rights to use a patent, and know-how,
        which are used for the development or advancement of the Industrial Enterprise, over an eight-year period, commencing on the year in which
        such rights were first exercised;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">under limited conditions, an election to file consolidated tax returns with related
        Israeli Industrial Companies controlled by it; and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">expenses related to a public offering are deductible in equal amounts over a three
        years period commencing on the year of the offering.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Eligibility for benefits under the Industry Encouragement Law is
not contingent upon approval of any governmental authority.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We believe that we currently qualify as an Industrial Company within
the meaning of the Industry Encouragement Law. However, there can be no assurance that we will continue to qualify as an Industrial Company
or that the benefits described above will be available in the future.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Law for the Encouragement of Capital Investments, 5719-1959</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The Investment Law provides certain incentives for capital investments
in production facilities (or other eligible assets).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The Investment Law was significantly amended several times during
recent years, with the three most significant changes effective as of April 1, 2005 (the &#8220;2005 Amendment&#8221;), as of January
1, 2011 (the &#8220;2011 Amendment&#8221;), and as of January 1, 2017 (the &#8220;2017 Amendment&#8221;). Pursuant to the 2005 Amendment,
tax benefits granted in accordance with the provisions of the Investment Law prior to its revision by the 2005 Amendment remain in force
but any benefits granted subsequently are subject to the provisions of the amended Investment Law. Similarly, the 2011 Amendment introduced
new benefits to replace those granted in accordance with the provisions of the Investment Law in effect prior to the 2011 Amendment. However,
companies entitled to benefits under the Investment Law as in effect prior to January 1, 2011 were entitled to choose to continue to enjoy
such benefits, provided that certain conditions are met, or elect instead, irrevocably, to forego such benefits and have the benefits
of the 2011 Amendment apply. The 2017 Amendment introduces new benefits for Technological Enterprises, alongside the existing tax benefits.
Prior to 2011, we did not utilize any of the benefits for which we were eligible under the Investment Law.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">85</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The following is a summary of the Investment Law subsequent to
its amendments as well as the relevant changes contained in the new legislation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Tax Benefits Subsequent to the 2005 Amendment</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The 2005 Amendment applies to new investment programs and investment
programs commencing after 2004, but does not apply to investment programs approved prior to April 1, 2005 (&#8220;Approved Enterprise&#8221;).
The 2005 Amendment provides that terms and benefits included in any certificate of approval that was granted before the 2005 Amendment
became effective (April 1, 2005) will remain subject to the provisions of the Investment Law as in effect on the date of such approval.
Pursuant to the 2005 Amendment, the Israeli Authority for Investments and Development of the Israeli Ministry of Economy (the &#8220;Investment
Center&#8221;) will continue to grant Approved Enterprise status to qualifying investments. The 2005 Amendment, however, limits the scope
of enterprises that may be approved by the Investment Center by setting criteria for the approval of a facility as an Approved Enterprise.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The 2005 Amendment provides that Approved Enterprise status will
only be necessary for receiving cash grants. As a result, it is no longer necessary for a company to obtain the advance approval of the
Investment Center in order to receive the tax benefits previously available under the alternative benefits track. Rather, a company may
claim the tax benefits offered by the Investment Law directly in its tax returns, provided that its facilities meet the criteria for tax
benefits set forth in the 2005 Amendment. Companies or programs under the new provisions receiving these tax benefits are referred to
as Beneficiary Enterprises. Companies that have a Beneficiary Enterprise, are entitled to approach the Israel Tax Authority for a pre&#8209;ruling
regarding their eligibility for tax benefits under the Investment Law, as amended. Tax benefits are available under the 2005 Amendment
to production facilities (or other eligible facilities), which are generally required to derive more than 25% of their business income
from export to specific markets with a population of at least 14 million in 2012 (such export criteria will further increase in the future
by 1.4% per annum). In order to receive the tax benefits, the 2005 Amendment states that a company must make an investment which meets
certain conditions, including exceeding a minimum investment amount specified in the Investment Law. Such investment allows a company
to receive &#8220;Beneficiary Enterprise&#8221; status, and may be made over a period of no more than three years ending in the year in
which the company chose to have the tax benefits apply to its Beneficiary Enterprise. Where the company requests to apply the tax benefits
to an expansion of existing facilities, only the expansion will be considered to be a Beneficiary Enterprise and the company&#8217;s effective
tax rate will be the weighted average of the applicable rates. In this case, the minimum investment required in order to qualify as a
Beneficiary Enterprise is required to exceed a certain percentage of the value of the company&#8217;s production assets before the expansion.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The extent of the tax benefits available under the 2005 Amendment
to qualifying income of a Beneficiary Enterprise depends on, among other things, the geographic location in Israel of the Beneficiary
Enterprise. The location will also determine the period for which tax benefits are available. Such tax benefits include an exemption from
corporate tax on undistributed income for a period of between two to ten years, depending on the geographic location of the Beneficiary
Enterprise in Israel, and a reduced corporate tax rate of between 10% to 25% for the remainder of the benefits period, depending on the
level of foreign investment in the company in each year. A company qualifying for tax benefits under the 2005 Amendment which pays a dividend
out of income attributed to its Beneficiary Enterprise during the tax exemption period will be subject to corporate tax in respect of
the amount of the dividend distributed (grossed&#8209;up to reflect the pre&#8209;tax income that it would have had to earn in order to
distribute the dividend) at the corporate tax rate that would have otherwise been applicable. Dividends paid to Israeli shareholders out
of income attributed to a Beneficiary Enterprise (or out of dividends received from a company whose income is attributed to a Beneficiary
Enterprise) are generally subject to withholding tax at source at the rate of 15% (in the case of non-Israeli shareholders - subject to
the receipt in advance of a valid certificate from the ITA allowing for a reduced tax rate, 15% or such lower rate as may be provided
in an applicable tax treaty, applicable to dividends and distributions out of income attributed to a Beneficiary Enterprise). The reduced
rate of 15% is limited to dividends and distributions out of income attributed to a Beneficiary Enterprise during the benefits period
and actually paid at any time up to 12 years thereafter, except with respect to a qualified Foreign Investment Company (as such term is
defined in the Investment Law), in which case the 12&#8209;year limit does not apply.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">86</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-indent: 36pt; line-height: 1.25">The benefits available to a Beneficiary Enterprise are subject to the fulfillment of
conditions stipulated in the Investment Law and its regulations. If a company does not meet these conditions, it would be required to
refund the amount of tax benefits, as adjusted by the Israeli consumer price index, and interest, or other monetary penalties.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We currently have Beneficiary Enterprise programs under the Investment
Law, which we believe will entitle us to certain tax benefits. The majority of any taxable income from our Beneficiary Enterprise programs
(once generated) would be tax exempt for a period of ten years commencing in the year in which we will first earn taxable income relating
to such enterprises, subject to the 12-year limitation from the year the company chose to have its tax benefits apply.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Tax Benefits Under the 2011 Amendment</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The 2011 Amendment canceled the availability of the tax benefits
granted under the Investment Law prior to 2011 and, instead, introduced new tax benefits for income generated by a &#8220;Preferred Company&#8221;
through its &#8220;Preferred Enterprise&#8221; (as such terms are defined in the Investment Law) as of January 1, 2011. The definition
of a Preferred Company includes a company incorporated in Israel that is not fully owned by a governmental entity, and that has, among
other things, Preferred Enterprise status and is controlled and managed from Israel. The tax benefits under the 2011 Amendment for a Preferred
Company meeting the criteria of the law include, among others, a reduced corporate tax rate of 15% for preferred income attributed to
a Preferred Enterprise in 2011 and 2012, unless the Preferred Enterprise was located in a specified development zone, in which case the
rate was 10%. Under the 2011 Amendment, such corporate tax rate was reduced in 2013 from 15% and 10%, respectively, to 12.5% and 7%, respectively,
and then increased to 16% and 9%, respectively, in 2014 and thereafter until 2016. Pursuant to the 2017 Amendment, in 2017 and thereafter,
the corporate tax rate for Preferred Enterprise which is located in a specified development zone was decreased to 7.5%, while the reduced
corporate tax rate for other development zones remains 16%. Income attributed to a Preferred Company from a &#8220;Special Preferred Enterprise&#8221;
(as such term is defined in the Investment Law) would be entitled, during a benefits period of 10 years, to reduced tax rates of 8%, or
5% if the Special Preferred Enterprise is located in a certain development zone. As of January 1, 2017, the definition of &#8220;Special
Preferred Enterprise&#8221; includes less stringent conditions. Dividends paid to Israeli shareholders out of preferred income attributed
to a Preferred Enterprise or to a Special Preferred Enterprise are generally subject to withholding tax at source at the rate of 20% (in
the case of non-Israeli shareholders - subject to the receipt in advance of a valid certificate from the ITA allowing for a reduced tax
rate, 20%, or such lower rate as may be provided in an applicable tax treaty(. However, if such dividends are paid to an Israeli company,
no tax is required to be withheld (although, if such dividends are subsequently distributed to individuals or a non&#8209;Israeli company,
the aforesaid will apply).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The 2011 Amendment also provided transitional provisions to address
companies already enjoying existing tax benefits under the Investment Law. These transitional provisions provide, among other things,
that: unless an irrevocable request is made to apply the provisions of the Investment Law as amended in 2011 with respect to income to
be derived as of January 1, 2011, a Beneficiary Enterprise can elect to continue to benefit from the benefits provided to it before the
2011 Amendment came into effect, provided that certain conditions are met.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have examined the possible effect, if any, of these provisions
of the 2011 Amendment on our financial statements and have decided, at this time, not to opt to apply the new benefits under the 2011
Amendment. There can be no assurance that we will comply with the conditions required to remain eligible for benefits under the Investment
Law in the future or that we will be entitled to any additional benefits thereunder.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">New Tax benefits under the 2017 Amendment that
became effective on January 1, 2017.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The 2017 Amendment was enacted as part of the Economic Efficiency
Law that was published on December 29, 2016, and is effective as of January 1, 2017. The 2017 Amendment provides new tax benefits for
two types of &#8220;Technology Enterprises,&#8221; as described below, and is in addition to the other existing tax beneficial programs
under the Investment Law.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The 2017 Amendment provides that a technology company satisfying
certain conditions will qualify as a &#8220;Preferred Technology Enterprise&#8221; and will thereby enjoy a reduced corporate tax rate
of 12% on income that qualifies as &#8220;Preferred Technology Income,&#8221; as defined in the Investment Law. The tax rate is further
reduced to 7.5% for a Preferred Technology Enterprise located in development zone A. In addition, a Preferred Technology Company will
enjoy a reduced corporate tax rate of 12% on capital gain derived from the sale of certain &#8220;Benefitted Intangible Assets&#8221;
(as defined in the Investment Law) to a related foreign company if the Benefitted Intangible Assets were acquired from a foreign company
on or after January 1, 2017 for at least NIS 200 million, and the sale receives prior approval from the Israeli Innovation Authority (the
&#8220;IIA&#8221;).</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">87</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The 2017 Amendment further provides that a technology company satisfying
certain conditions will qualify as a &#8220;Special Preferred Technology Enterprise&#8221; and will thereby enjoy a reduced corporate
tax rate of 6% on &#8220;Preferred Technology Income&#8221; regardless of the company&#8217;s geographic location within Israel. In addition,
a Special Preferred Technology Enterprise will enjoy a reduced corporate tax rate of 6% on capital gain derived from the sale of certain
&#8220;Benefitted Intangible Assets&#8221; to a related foreign company if the Benefitted Intangible Assets were either developed by Special
Preferred Technology Enterprise or acquired from a foreign company on or after January 1, 2017, and the sale received prior approval from
IIA. A Special Preferred Technology Enterprise that acquires Benefitted Intangible Assets from a foreign company for more than NIS 500
million will be eligible for these benefits for at least ten years, subject to certain approvals as specified in the Investment Law. Dividends
distributed by a Preferred Technology Enterprise or a Special Preferred Technology Enterprise, to Israeli shareholders paid out of Preferred
Technology Income, are generally subject to withholding tax at source at the rate of 20% (in the case of non-Israeli shareholders - subject
to the receipt in advance of a valid certificate from the ITA allowing for a reduced tax rate, 20%, or such lower rate as may be provided
in an applicable tax treaty. However, if such dividends are paid to an Israeli company, no tax is required to be withheld (although, if
such dividends are subsequently distributed to individuals or a non-Israeli company, the aforesaid will apply). If such dividends are
distributed to a foreign company that holds solely or together with other foreign companies 90% or more in the Israeli company and other
conditions are met, the withholding tax rate will be 4% (or a lower under the tax treaty, if applicable, subject to the receipt in advance
of a valid certificate from the Israeli Tax Authority allowing for a reduced tax rate).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-weight: bold">C.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
<span style="font-weight: bold">Research and Development, Patents and Licenses, etc.</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our research and development strategy is centered on developing
our patented proteolytic enzyme technology, which underlies NexoBrid and EscharEx, into additional products for high value indications.
Our research and development team is located at our facilities in Yavne, Israel, and consists of 26 employees as of December 31, 2022
and is supported by highly experienced consultants in various research and development disciplines.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have received government grants (subject to our obligation to
pay royalties) as part of the NexoBrid and EscharEx research and development programs approved by the IIA. The total gross amount of grants
actually received by us from the IIA, including accrued interest and net of royalties actually paid, totaled approximately $13.8 million
as of December 31, 2023 and the amortized cost (using the interest method) of the liability totaled approximately $7.8 million and $7.6
million as of December 31, 2023 and 2022, respectively. Because the repayment of IIA grants is in the form of future royalties, the balance
of the commitments to the IIA is presented as an amortized liability on our balance sheet. As of December 31, 2022, we had accrued and
paid royalties to the IIA totaling $2 million.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">We received funds from BARDA in accordance with the terms of our BARDA contracts. As
of December 31, 2023 we had accrued $93 million of BARDA&#8217;s participation in NexoBrid&#8217;s research and development programs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">For a description of our research and development policies for
the last three years, see &#8220;ITEM 4.B. Business Overview-Research and Development.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25"><span style="font-weight: bold">D.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
<span style="font-weight: bold">Trend Information</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25">We continue to closely monitor macro-economic conditions, including
the headwinds caused by supply chain problems, inflation, increased interest rates and other trends that have been adversely impacting
economic activity on a global scale. We have been assessing, on an ongoing basis, the implications of those global conditions for our
operations, supply chain, liquidity, cash flow and product orders, and will act in an effort to mitigate adverse consequences as needed.
To the extent inflation increases our costs and expenses, we could consider price increases to offset those cost pressures.</div>

<div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">88</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Specific developments that may potentially impact our operating
performance in an adverse manner include:</div>

<div style="line-height: 1.25; text-align: justify">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2b4f40c76954451da7c38249e587ec29" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25; text-align: justify"><br/> &#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; text-align: justify">&#8226;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="line-height: 1.25; text-align: justify">further actions taken by central banks in Europe and the U.S. to increase interest
        rates as a means to slow down inflation, which may worsen credit/financing conditions for our customers who purchase our products;</div>
        <div style="line-height: 1.25; text-align: justify">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25; text-align: justify"><br/> &#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; text-align: justify">&#8226;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="line-height: 1.25; text-align: justify">potential contraction of economic activities and recessionary conditions that could
        arise as a result of interest rate increases and a decrease in consumer demand; and</div>
        <div style="line-height: 1.25; text-align: justify">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25; text-align: justify"><br/> &#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; text-align: justify">&#8226;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="line-height: 1.25; text-align: justify">the continued depreciated value of the Euro relative to the U.S. dollar, which may
        have an adverse impact on the U.S.- denominated value of our European-derived revenues for purposes of our financial statements.</div>
        <div style="line-height: 1.25; text-align: justify">&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We cannot provide any assurances as to the extent of our resilience
to the adverse impact of these specific developments in future periods. See also &#8220;ITEM 3.D. - Risk Factors -&#8220;We depend on
a sole supplier to obtain our intermediate drug substance, bromelain SP, which is necessary for the production of our products.&#8221;<span style="font-weight: bold; font-style: italic">&#160;</span></div>

<div style="line-height: 1.25; text-align: justify">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Other than the foregoing and as disclosed elsewhere in this annual
report, we are not aware of any trends, uncertainties, demands, commitments or events for the period from January 1, 2022 to the present
time that are reasonably likely to have a material adverse effect on our net revenue, income, profitability, liquidity or capital resources,
or that would cause the disclosed financial information to be not necessarily indicative of future operating results or financial condition.</div>

<div style="line-height: 1.25; text-align: justify">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-weight: bold">E.</span>&#160;<span style="font-weight: bold">Critical
Accounting Estimates</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our consolidated financial statements are prepared in conformity
with IFRS, as issued by the IASB. The preparation of these historical financial statements in conformity with IFRS requires management
to make estimates, assumptions and judgments in certain circumstances that affect the reported amounts of assets, liabilities and contingencies
as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. We evaluate
our assumptions and estimates on an ongoing basis. We base our estimates on historical experience and on various other assumptions that
we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values
of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different
assumptions or conditions. Our critical accounting estimates are described in Note 2 to our consolidated financial statements included
elsewhere in this annual report.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">89</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: -18pt; margin-left: 18pt; line-height: 1.25; font-weight: bold">Item 6. <span id="Item6."><!--Anchor--></span>DIRECTORS,
SENIOR MANAGEMENT AND EMPLOYEES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25"><span style="font-weight: bold">A.</span>&#160;<span style="font-weight: bold">Directors
and Senior Management</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The following table sets forth the name, age and position of each
of our executive officers and directors as of March 15, 2024:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2db8fe6914284d6bbac38a1ba7b44f44" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 31.81%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Name</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="border-bottom: #000000 2px solid; width: 3.8%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Age</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 0.56%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="border-bottom: #000000 2px solid; width: 62.14%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Position</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 31.81%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25; font-style: italic">Executive Officers</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.7%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.8%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 0.56%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 62.14%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 31.81%; vertical-align: top">
        <div style="line-height: 1.25">Ofer Gonen</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.8%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">51</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 0.56%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 62.14%; vertical-align: top">
        <div style="line-height: 1.25">Chief Executive Officer</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 31.81%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">Shmulik Hess</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.7%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.8%; vertical-align: top; background-color: #CCEEFF">
        <div style="text-align: center; line-height: 1.25">51</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 0.56%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 62.14%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">Chief Operating Officer &amp; Chief Commercial Officer</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 31.81%; vertical-align: top">
        <div style="line-height: 1.25">Ety Klinger&#160;</div> </td>
    <td style="width: 1.7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.8%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">62</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 0.56%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 62.14%; vertical-align: top">
        <div style="line-height: 1.25">Chief Research and Development Officer</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 31.81%; vertical-align: top; background-color: #CCEEFF">
        <div style="margin-right: 3.1pt; line-height: 1.25">Hani Luxenburg</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.7%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.8%; vertical-align: top; background-color: #CCEEFF">
        <div style="text-align: center; line-height: 1.25">51</div>
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 0.56%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 62.14%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">Chief Financial Officer</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 31.81%; vertical-align: top">
        <div style="line-height: 1.25">Yaron Meyer&#160;</div> </td>
    <td style="width: 1.7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.8%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">45</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 0.56%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 62.14%; vertical-align: top">
        <div style="line-height: 1.25">Executive Vice President, General Counsel and Corporate Secretary</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 31.81%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">Robert J. Snyder</div>
        <div style="line-height: 1.25"> <br/> </div> </td>
    <td style="width: 1.7%; vertical-align: top; background-color: #CCEEFF">&#160;</td>
    <td style="width: 3.8%; vertical-align: top; background-color: #CCEEFF">
        <div style="text-align: center; line-height: 1.25">74</div> </td>
    <td style="width: 0.56%; vertical-align: top; background-color: #CCEEFF">&#160;</td>
    <td style="width: 62.14%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">Chief Medical Officer</div> </td> </tr>
  <tr>
    <td style="width: 31.81%; vertical-align: top">&#160;</td>
    <td style="width: 1.7%; vertical-align: top">&#160;</td>
    <td style="width: 3.8%; vertical-align: top">&#160;</td>
    <td style="width: 0.56%; vertical-align: top">&#160;</td>
    <td style="width: 62.14%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 31.81%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25; font-style: italic">Directors</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.7%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.8%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25"><br/> &#160;</div> </td>
    <td style="width: 0.56%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 62.14%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25"><br/> &#160;</div> </td> </tr>
  <tr>
    <td style="width: 31.81%; vertical-align: top">
        <div style="line-height: 1.25">Nachum (Homi) Shamir (1)(2)(3)(5)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.8%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">69</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 0.56%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 62.14%; vertical-align: top">
        <div style="line-height: 1.25">Chairman of the Board of Directors</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 31.81%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">Vickie R. Driver (1)(4)(5)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.7%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.8%; vertical-align: top; background-color: #CCEEFF">
        <div style="text-align: center; line-height: 1.25">70</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 0.56%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 62.14%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">Director</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 31.81%; vertical-align: top">
        <div style="line-height: 1.25">David Fox (2)(3)(5)&#160;</div> </td>
    <td style="width: 1.7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.8%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">66</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 0.56%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 62.14%; vertical-align: top">
        <div style="line-height: 1.25">Director&#160;</div> </td> </tr>
  <tr>
    <td style="width: 31.81%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">Shmuel (Milky) Rubinstein (4)(5)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.7%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.8%; vertical-align: top; background-color: #CCEEFF">
        <div style="text-align: center; line-height: 1.25">84</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 0.56%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 62.14%; vertical-align: top; background-color: #CCEEFF">
        <div style="line-height: 1.25">Director</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 31.81%; vertical-align: top">
        <div style="line-height: 1.25">Stephen T. Willis (1)(2)(4)(5)</div> </td>
    <td style="width: 1.7%; vertical-align: top">&#160;</td>
    <td style="width: 3.8%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">67</div> </td>
    <td style="width: 0.56%; vertical-align: top">&#160;</td>
    <td style="width: 62.14%; vertical-align: top">
        <div style="line-height: 1.25">Director</div> </td> </tr>
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 31.81%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="4" style="width: 68.19%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" id="z3455f3814d0445b5baee20a17133d698" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5.26%; vertical-align: top">
        <div style="line-height: 1.25">(1)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 94.74%; vertical-align: top">
        <div style="line-height: 1.25">Member of our audit committee.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5.26%; vertical-align: top">
        <div style="line-height: 1.25">(2)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 94.74%; vertical-align: top">
        <div style="line-height: 1.25">Member of our compensation committee.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5.26%; vertical-align: top">
        <div style="line-height: 1.25">(3)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 94.74%; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25; color: #000000; font-family: Times New Roman, serif">Member of our nominating and governance committee.&#160;</div>
        </div> </td> </tr>
  <tr>
    <td style="width: 5.27%; vertical-align: top">
        <div style="line-height: 1.25">(4)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 94.73%; vertical-align: top">
        <div style="line-height: 1.25">Member of our research and development committee.&#160;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5.26%; vertical-align: top">
        <div style="line-height: 1.25">(5)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 94.74%; vertical-align: top">
        <div style="line-height: 1.25">Independent director under the listing rules of the Nasdaq Stock Market.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold"> <br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">90</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">&#160;Executive Officers</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-style: italic">Ofer Gonen </span>has served as
our Chief Executive Officer since July 2022 and on our board of directors since September 2003. Mr. Gonen is also the Chief Executive
Officer of Cactus Acquisition Corp. 1 (Nasdaq: CCTS) and served as the Chief Executive Officer of Call Biotechnology Industries (TASE:
CBI) from February 2017 until June 2022. Mr. Gonen has more than 20 years of experience in managing life science investments and business
collaborations in both the US and Israel. Mr. Gonen serves as a board member of several private and publicly-traded portfolio companies
of CBI, including Gamida Cell (Nasdaq: GMDA) and Cactus, as well as a managing partner at the Anatomy Medical Fund. Before joining CBI,
Mr. Gonen was the General Manager of Biomedical Investments Ltd., a partner at Arte Venture Group, as well as a technology consultant
to various Israeli venture capital funds. Mr. Gonen gained extensive experience in R&amp;D and management of defense-oriented projects
at the prestigious &#8220;Talpiot&#8221; program of the Israeli Defense Forces. He holds a B.Sc. in Physics, Mathematics and Chemistry
from the Hebrew University of Jerusalem, and an M.A. in Economics and Finance from Tel Aviv University, with distinction.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-style: italic">Shmulik Hess</span> has served
as our Chief Operating Officer since December 2023. Dr. Hess has over two decades of extensive expertise in drug development and commercial
operations in healthcare. Prior to joining MediWound, he served as Chief Executive Officer at Tabby Therapeutics, Enlivex Therapeutics
(Nasdaq: ENLV), and Valin Technologies. Formerly, Dr. Hess served as a global operations executive at SciGen Ltd (acquired by VBI Vaccines).
Dr. Hess is the inventor of multiple patents and author of numerous publications in peer reviewed scientific journals. He received his
Ph.D. in Pharmaceutical Science from the Hebrew University, Israel and was a research fellow at Harvard-MIT Health Sciences and Technology
(HST).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-style: italic">Ety Klinger</span> has served
as our Chief Research and Development Officer since May 2014. Prior to joining MediWound, Dr. Klinger was Vice President of Research and
Development at Proteologics Ltd since July 2011, where she was responsible for discovery projects in the ubiquitin system, conducted in
collaboration with GlaxoSmithKline plc and Teva. Prior to this, Dr. Klinger served for 17 years in numerous leadership positions at Teva&#8217;s
global innovative R&amp;D division and served as Teva&#8217;s Board representative at various biotechnology companies. Dr. Klinger was
a key member of the Copaxone<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">&#174;</sup> development team. As
a project leader she led the chemistry, manufacture and control, preclinical, clinical and post&#8209;marketing R&amp;D activities of
various innovative treatments for multiple sclerosis (MS), autoimmune and neurological diseases. From 2006 to 2011, as a Senior Director
at Teva, Dr. Klinger was a member of Teva&#8217;s global innovative R&amp;D management team. From 2006 to 2008, she served as the Head
of MS and Autoimmune Diseases at Teva, and led the Life Cycle Management (LCM) of innovative R&amp;D. Dr. Klinger holds a B.Sc. in Biology
from the Hebrew University in Jerusalem, a M.S. and a Ph.D. in Biochemistry from Tel&#8209;Aviv University and an MBA degree from Tel
Aviv University and Northwestern University.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-style: italic">Hani Luxenburg</span> has served
as our Chief Financial Officer since May 2023. Ms. Luxenberg has over two decades of progressive leadership experience managing financial
and accounting operations. Prior joining MediWound, Ms. Luxenburg served as Chief Financial Officer at BIRD Aerosystems. Prior to that,
she held senior finance roles at AstraZeneca, Alvarion Technologies Ltd., and Ernst &amp; Young. Ms. Luxenburg is a certified public accountant
and holds a Bachelor of Arts in Economics and Accounting from the University of Haifa, along with a Bachelor of Law from IDC Herzliya.
In addition, she is a member of the Israel Bar Association.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-style: italic">Yaron Meyer</span> has served
as our Executive Vice President since March 2019 and as our General Counsel and Corporate Secretary since December 2013. From April 2008
to November 2013, he served as the Corporate Secretary of CBI. From November 2010 to November 2013, he served as the General Counsel and
Corporate Secretary of D&#8209;Pharm Ltd. From April 2008 to May 2010, he served as a legal counsel of Clal Industries Ltd. From May 2005
to April 2008, he worked as an associate at Shibolet &amp; Co. Advocates. Mr. Meyer holds an LL.B. degree from Haifa University, Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-style: italic">Dr. Robert Snyder</span> has served
as our Chief Medical Officer since January 2023. Dr. Robert J. Snyder (DPM, MSc, MBA, CWSP, FFPM RCPS) is Dean, Professor, Director of
Clinical Research and Fellowship Director in Wound Care and Research at Barry University School of Podiatric Medicine. He is certified
in foot and ankle surgery by the American Board of Podiatric Surgery and is also a board-certified wound specialist. Dr. Snyder is past-president
of the Association for the Advancement of Wound Care and past-president of the American Board of Wound Management. Dr. Snyder has completed
an MBA in Health Management from The George Washington University and the Global Clinical Scholars Research Training Program at Harvard
Medical School. Dr. Snyder is a key opinion leader and sought-after speaker, lecturing extensively throughout the United States and abroad.
He has published several book chapters and over 165 papers in peer reviewed and trade journals on wound care, and was the recipient of
the Dr. Robert Warriner Memorial Award for excellence in wound management. Dr. Snyder serves as the Associate Editor for JAPMA and on
the editorial advisory boards of Ostomy Wound Management, Wounds and as a periodic reviewer for the Lancet and NEJM. He has been a Principal
Investigator on more than 65 randomized controlled trials for innovative wound healing modalities and products.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">91</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Directors</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-style: italic">Nachum (Homi) Shamir </span>has
served as Chairman of our board of directors since August 2022. Mr. Shamir most recently the Chairman, and Chief Executive Officer of
Luminex Corporation from 2014 through its sale to DiaSorin S.p.A.(&#8220;DiaSorin&#8221;) in 2021. Mr. Shamir continued to serve as President
of Luminex after its sale to DiaSorin pursuant to a transition agreement with DiaSorin until June 2022. Additionally, Mr. Shamir has served
as President and Chief Executive Officer of Given Imaging from 2006 through its sale to Covidien (now Medtronic) in 2014. Mr. Shamir currently
serves on the Board of Directors of IsoPlexis Corporation (Nasdaq: ISO) and Strata Skin Sciences (Nasdaq: SSKN); and as Chairman of the
Board of Cactus Acquisition Corp. (Nasdaq: CCTS). Mr. Shamir holds a Bachelor of Science degree from the Hebrew University of Jerusalem
and a Masters of Public Administration from Harvard University.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-style: italic">Vickie R. Driver </span>has served
as a member of our Board since May 2017. She is board certified in foot surgery by the American Board of Podiatric Surgery and is a Fellow
at the American College of Foot and Ankle Surgeons, licensed in Virginia, Massachusetts, and Rhode Island. Dr Driver serves as Chair,
Board of Directors for the Wound Care Collaborative Community, an important collaboration with the FDA, CMS and the NIH and has received
a prestigious honor of receiving The Robert A. Warriner III, MD Memorial Award. She is System Wide Medical Director of the Wound Care
and Hyperbaric Centers at INOVA Healthcare in the DC Metropolitan area and is Professor, University of Virginia, School of Medicine. She
is also Fellow, Royal College of Physicians and Surgeons-Glasgow, PM and Inaugural Fellow, Assoc for the Advancement of Wound Care, FAAWC.
She currently serves as Honorary Visiting Professor at Cardiff University (UK) in the Department of Medicine and Professor at Barry University
(USA). She proudly serves as a member of the Wound Healing Society (WHS) Board of Directors and as member Board of Directors for the Critical
Limb Ischemia (CLI) Global Society. She has completed her tenure as president for the Advancement of Wound Care Association (AAWC) and
served for 9 years on the Board of Directors. Dr. Driver is a former Professor of Surgery in the Department of Orthopedics at Brown University
(Clinical) and Associate Professor of Surgery at Boston University. She has also chaired the Wound Care Experts and U.S. Food and Drug
Administration (&#8220;FDA&#8221;) Clinical Endpoints Project [WEF-CEP]. The project was successful in developing the research to expand
the wound healing clinical endpoints considered by FDA. She and her team proposed a combined effort to develop the Wound-care Experts/FDA-Clinical
Endpoints Project [WEF-CEP] to strategically identify clinically meaningful, evidence-based, and patient-centered wound care endpoints
that are relevant for clinical research and trials. The goal was to collaboratively work with the FDA to expand the list of acceptable
primary endpoints, recognizing that new and innovative treatments, devices, and drugs may not have complete healing as the focus. She
has served as a senior investigator for more than 70 important multi&#8209;center randomized clinical trials, as well as developed and
supervised multiple research fellowship training programs. She has served and chaired multiple committees for large national and international
pivotal clinical trials, has authored over 150 publications and abstracts and is former Director, Translational Medicine at Novartis Institute
for BioMedical Research. Dr. Driver is credited with the development and directorship of multiple major multidisciplinary Limb Preservation-
Wound Healing Centers of Excellence, including Military/VA, Hospital and University based programs. Dr. Driver served on the Inaugural
Educational Committee at the American College of Wound Healing and Tissue Repair at University of Illinois School of Medicine and was
Scientific Director, Colorado Prevention Center, Wound Care Laboratory at the University of Colorado. Dr. Driver has held several leadership,
teaching, research and clinical positions at Academic Medical Centers, Veterans Administration Medical Centers, and Military Medical Centers.
Dr. Driver received a Doctorate of Podiatric Medicine and Surgery from the California College of Podiatric Medicine and Surgery and a
master&#8217;s degree in medical education from Samuel Merritt University.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-style: italic">Mr. David Fox</span> has served
as a member of our board of directors since April 2020. Mr. Fox has served as a member of our board of directors since April 2020.&#160;
Mr. Fox was most recently a partner at Kirkland &amp; Ellis LLP and served as a member of its Global Executive Management Committee until
2019.&#160; Prior to joining Kirkland, Mr. Fox was a partner at Skadden, Arps, Slate, Meagher &amp; Flom LLP, where he was a member of
its governing committee.&#160; Mr. Fox is a member of the executive committee and board of directors of the Park Avenue Armory, which
enables artists to create and audiences to experience epic, adventurous work while also offering arts education programs at no cost to
public school students, and is chairman of the advisory board of New Alternatives for Children, an organization that provides support
to families caring for medically fragile children.&#160; Mr. Fox is the principal of David Fox &amp; Co. LLC an advisory business and
CEO of Bald Productions LLC, a movie and television development and production company.&#160; He is also an advisor to Longacre Square
Partners, a communications and special situations advisory firm and to Nardello &amp; Co, a global investigations firm.&#160; In addition,
Mr. Fox serves on the executive committee and the board of governors, and is an honorary fellow, of the Hebrew University, Jerusalem.&#160;
He holds an LL.B. degree from Jerusalem University, Israel.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">92</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-style: italic">Shmuel "Milky" Rubinstein </span>has
served as a member of our board since August 2023. Mr. Rubinstein brings a distinguished record of leadership in the pharmaceutical and
biotechnology sectors to our board. Currently serving as Chairman of Trima Pharma, Milky's expertise extends across various prominent
board roles, including Strata Skin Sciences (SSKN), Medison Biotech, and Keystone Dental. Notably, he held the esteemed position of CEO
at Taro Pharmaceuticals (TARO), overseeing its successful acquisition by SUN Pharma. Milky's extensive board engagements also encompass
Kamada (KMDA), Exalenz (Acquired by VIVO), and Clal Biotechnology Industries (CBI). With a proven track record, Milky Rubinstein's insights
are poised to contribute significantly to our company's strategic direction and growth<span style="font-style: italic">.</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif"><span style="font-style: italic">Stephen T. Wills</span>
has served as a member of our Board since May 2017, as Chairman of our Board since October 2017 and as Executive Chairman of our board
since May 2019. Mr. Wills serves as Chief Financial Officer (since 1997) and Chief Operating Officer (since 2011) of Palatin Technologies,
Inc. (NYSE: PTN), a biopharmaceutical company developing targeted, receptor&#8209;specific peptide therapeutics for the treatment of diseases
with significant unmet medical need and commercial potential. He also serves as Chief Financial Officer of Cactus Acquisition Corp. 1
Limited (Nasdaq: CCTS), a special purpose acquisition company, since 2021 until <span style="color: #000000">February 2024, when majority
ownership was acquired by a new Sponsor</span>. Mr. Wills serves on the boards of Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular
and immune therapeutics company since March 2019 (audit chairperson and compensation and finance committee member) and of Amryt Pharma,
a biopharmaceutical company focused on developing and delivering treatments to help improve lives of patients with rare and orphan diseases
since September 2019 (chairman of audit committee and member of the compensation and finance committee) <span style="color: #000000">until
April 2023, when Amryt was acquired by Chiesi Farmaceutici</span>. Mr. Wills also serves on the board of trustees and executive committee
of The Hun School of Princeton, a college preparatory day and boarding school since 2013, and its chairman since June 2018<span style="color: #000000">
until his retirement in June 2023</span>. Mr. Wills served on the board of directors of Caliper Corporation, a psychological assessment
and talent development company since March 2016 and as chairman from December 2016 until December 2019, when Caliper was acquired by PSI.
Mr. Wills served as executive chairman and interim principal executive officer of Derma Sciences Inc. a provider of advanced wound care
product from December 2015 to February 2017, when Derma Sciences was acquired by Integra Lifesciences (Nasdaq: IART). Previously, Mr.
Wills served on the Board of Derma Sciences as the lead director and chairman of the audit committee from June 2000 to December 2015.
Mr. Wills served as the Chief Financial Officer of Derma Sciences from 1997 to 2000. Mr. Wills served as the president and Chief Operating
Officer of Wills, Owens &amp; Baker, P.C., a public accounting firm from 1991 to 2000. Mr. Wills, a certified public accountant, earned
his Bachelor of Science in accounting from West Chester University, and a Master of Science in taxation from Temple University.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-indent: 36pt; line-height: 1.25">There are no family relationships among any of our executive officers or directors.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-indent: 36pt; line-height: 1.25">There are no arrangements or understandings with major shareholders, customers, suppliers
or others, pursuant to which any person referred to above was selected as a director or member of senior management.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">93</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-indent: 36pt; line-height: 1.25"><span style="font-weight: bold">B.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
<span style="font-weight: bold">Compensation</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Compensation of Directors and Executive Officers</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The table below reflects the compensation granted to our five most
highly compensated officers during or with respect to the year ended December 31, 2023. All amounts reported in the table reflect the
cost to the company, as recognized in our financial statements for the year ended December 31, 2023.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" class="cfttable" id="z4530c1ed747f4d41b8f1227aa4b3cdb3" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25; font-weight: bold">Name and Position</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25"><span style="font-weight: bold">Salary &amp;</span><br/> <span style="font-weight: bold">Social</span><br/>
        <span style="font-weight: bold">Benefits</span>(1)</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Bonus</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25"><span style="font-weight: bold">Share-Based</span><br/> <span style="font-weight: bold">Payment</span>(2)</div>
        </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25"><span style="font-weight: bold">Other Compensation</span><br/> (3)</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Total</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="18" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25"><span style="font-style: italic">(thousand U.S. dollars)</span>(4)</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">
        <div style="line-height: 1.25; font-family: Times New Roman, serif">Ofer Gonen, <span style="font-style: italic">Chief Executive Officer</span></div>
        </div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">480</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">152</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">484</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">17</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,133</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 40%">
        <div style="text-indent: -0.05pt; margin-left: 0.05pt; line-height: 1.25">Ety Klinger, <span style="font-style: italic">Chief Research
        &amp; Development Officer</span></div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">297</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">58</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">102</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">22</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">479</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 0.05pt; line-height: 1.25">Yaron Meyer, <span style="font-style: italic">Executive Vice President, General Counsel
        &amp; Corporate Secretary</span></div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">250</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">44</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">80</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">5</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">379</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 40%">
        <div style="margin-left: 0.05pt; line-height: 1.25">Hani Luxenburg, <span style="font-style: italic">Chief Financial Office</span>r (5)</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">166</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">43</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">9</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">26</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">244</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 0.05pt; line-height: 1.25">Boaz Gur-Lavie, <span style="font-style: italic">former</span>&#160;<span style="font-style: italic">Chief
        Financial Office</span>r (6)</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">140</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">22</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">46</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">16</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">224</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" id="z2e25f01217ac4175b030802cb2a3c533" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 2.5%; vertical-align: top">
        <div style="line-height: 1.25">(1)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 97.5%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Represents the officer&#8217;s gross salary plus payment of mandatory social benefits
        made by the company on behalf of such officer. Such benefits may include, to the extent applicable to the executive, payments, contributions
        and/or allocations for savings funds (e.g., Managers&#8217; Life Insurance Policy), education funds (referred to in Hebrew as &#8220;keren
        hishtalmut&#8221;), pension, severance, risk insurances (e.g., life or work disability insurance) and payments for social security.&#160;</div>
        </td> </tr>
  <tr>
    <td style="width: 2.5%; vertical-align: top">
        <div style="line-height: 1.25">(2)</div> </td>
    <td style="width: 97.5%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Represents the equity&#8209;based compensation expenses recorded in the company&#8217;s
        consolidated financial statements for the year ended December 31, 2023 based on the options&#8217; grant date fair value in accordance
        with accounting guidance for equity&#8209;based compensation.&#160;</div> </td> </tr>
  <tr>
    <td style="width: 2.5%; vertical-align: top">
        <div style="line-height: 1.25">(3)</div> </td>
    <td style="width: 97.5%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Represents the other benefits to such officer, which includes either or both of (i)
        car expenses, including lease costs, gas and maintenance, provided to the officers, (ii) vacation benefits and (iii) severance payment.&#160;</div>
        </td> </tr>
  <tr>
    <td style="width: 2.5%; vertical-align: top">
        <div style="line-height: 1.25">(4)</div> </td>
    <td style="width: 97.5%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Converted (i) from NIS into U.S. dollars at the rate of NIS 3.69 = U.S$1, based on
        the average representative rate of exchange between the NIS and the U.S. dollar in the year ended December 31, 2023 as reported by the
        Bank of Israel in the year ended December 31, 2023.</div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 2.5%; vertical-align: top">
        <div style="line-height: 1.25">(5)</div> </td>
    <td rowspan="1" style="width: 97.5%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Ms. Luxenburg Joined the Company in May 2023.</div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 2.5%; vertical-align: top">
        <div style="line-height: 1.25">(6)</div> </td>
    <td rowspan="1" style="width: 97.5%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Mr. Gur Lavie worked in the Company until July 2023.</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">The aggregate compensation paid and equity&#8209;based
compensation and other payments expensed by us and our subsidiaries to our directors and executive officers with respect to the year ended
December 31, 2023 was $3.8 million. As of December 31, 2023, options to purchase 467,146 ordinary shares, exercisable at a weighted average
exercise price of $15.3 per share, and restricted share units (&#8220;RSUs&#8221;) that may be settled for 44,067 ordinary shares, in
each case granted to our directors and executive officers, were outstanding under our equity incentive plans. We do not have any written
agreements with any director for benefits upon the termination of such director&#8217;s relationship with our company or its subsidiaries.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">94</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-weight: bold">Employment Agreements with Executive Officers</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have entered into written employment agreements with all of
our executive officers, which include standard provisions for a company in our industry regarding non&#8209;competition/solicitation,
confidentiality of information and assignment of inventions. Except for Ofer Gonen, our Chief Executive Officer, our executive officers
will not receive benefits upon the termination of their respective employment with us, other than payment of salary and benefits (and
limited accrual of vacation days) during the required notice period for termination of their employment, which varies for each individual.
Upon termination of his employment, Mr. Gonen is entitled to a one&#8209;time termination payment of six months of salary.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Directors&#8217; Service Contracts</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Other than with respect to our directors that are also executive
officers, there are no arrangements or understandings between us, on the one hand, and any of our directors, on the other hand, providing
for benefits upon termination of their service as directors of our company.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Share Incentive Plans</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">2014 Equity Incentive Plan</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In March 2014, we adopted and obtained shareholder approval for
our 2014 Equity Incentive Plan, which was amended as of December 18, 2018 (the &#8220;2014 Plan&#8221;). The 2014 Plan provides for the
grant of options, restricted shares, RSUs and other share&#8209;based awards to our and our subsidiaries&#8217; and affiliates&#8217;
directors, employees, officers, consultants and advisors, among others and to any other person whose services are considered valuable
to us or them, to continue as service providers, to increase their efforts on our behalf or behalf of a subsidiary or affiliate and to
promote the success of our business. Following the approval of the 2014 Plan by the Israeli tax authorities, we are only granting options
or other equity incentive awards under the 2014 Plan, which shares will be rolled over to a new share incentive plan&#8212; the 2024 Share
Incentive Plan&#8212; that we will adopted and bring for shareholder approval soon.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The 2014 Plan is administered by our board of directors or by a
committee designated by the board of directors, which determine, subject to Israeli law, the grantees of awards and the terms of the grant,
including exercise prices, vesting schedules, acceleration of vesting and the other matters necessary in the administration of the 2014
Plan. The 2014 Plan enables us to issue awards under various tax regimes, including, without limitation, pursuant to Sections 102 and
3(i) of the Ordinance, as discussed under &#8220;-2003 Share Incentive Plan&#8221; above, and under Section 422 of the U.S. Internal Revenue
Code of 1986, as amended (the &#8220;Code&#8221;).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Options granted under the 2014 Plan to U.S. residents may qualify
as &#8220;incentive stock options&#8221; within the meaning of Section 422 of the Code, or may be non&#8209;qualified. The exercise price
for &#8220;incentive stock options&#8221; must not be less than the fair market value on the date on which an option is granted, or 110%
of the fair market value if the option holder holds more than 10% of our share capital.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We currently intend to grant awards under the 204 Plan under the
capital gains track of Section 102(b)(2) of the Ordinance only to our employees, directors and officers who are not controlling shareholders
and are considered Israeli residents.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Awards under the 2014 Plan may be granted until ten years from
the date on which the 2014 Plan was approved by our board of directors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Options granted under the 2014 Plan generally vest over three or
four years commencing on the date of grant, such that 33% or 25%, respectively, vests annually on the anniversary of the date of grant.
Options, other than certain incentive share options, that are not exercised within ten years from the grant date expire, unless otherwise
determined by our board of directors or its designated committee, as applicable. Share options that qualify as &#8220;incentive stock
options&#8221; and are granted to a person holding more than 10% of our voting power will expire within five years from the date of the
grant. In the event of the death of a grantee while employed by or performing service for us or a subsidiary or within three months thereafter,
or the termination of a grantee&#8217;s employment or services for reasons of disability, the grantee, or in the case of death, his or
her legal successor, may exercise options that have vested prior to termination within a period of one year from the date of disability
or death. If we terminate a grantee&#8217;s employment or service for cause, all of the grantee&#8217;s vested and unvested options will
expire on the date of termination. If a grantee&#8217;s employment or service is terminated for any other reason, the grantee may exercise
his or her vested options within three months of the date of termination. Any expired or unvested options return to the pool for reissuance.
In the event of a merger or consolidation of our company or a sale of all, or substantially all, of our shares or assets or other transaction
having a similar effect on us, then without the consent of the option holder, our board of directors or its designated committee, as applicable,
may but is not required to (i) cause any outstanding award to be assumed or an equivalent award to be substituted by such successor corporation,
or (ii) in case the successor corporation refuses to assume or substitute the award (a) provide the grantee with the option to exercise
the award as to all or part of the shares or (b) cancel the options against payment in cash in an amount determined by the board of directors
or the committee as fair in the circumstances. Notwithstanding the foregoing, our board of directors or its designated committee may upon
such event amend or terminate the terms of any award, including conferring the right to purchase any other security or asset that the
board of directors shall deem, in good faith, appropriate. Our board of directors or its designated committee may, in its discretion,
approve that any awards granted under the 2014 Plan shall be subject to additional conditions in the case of a merger or a consolidation.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">95</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Restricted share awards are ordinary shares that are awarded to
a participant subject to the satisfaction of the terms and conditions established by the board of directors or a committee designated
by the board of directors. Until such time as the applicable restrictions lapse, restricted shares are subject to forfeiture and may not
be sold, assigned, pledged or otherwise disposed of by the participant who holds those shares. Generally, if a grantee&#8217;s employment
or service is terminated for any reason prior to the expiration of the time when the restrictions lapse, shares that are still restricted
will be forfeited.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Prospective 2024 Share Incentive Plan</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Because the 2014 Plan expires in March 2024, we expect to adopt
a new share incentive plan&#8212;the 2024 Share Incentive Plan (the &#8220;2024 Plan&#8221;) - in the near future and bring it to our
shareholders for approval. Outstanding grants under the 2014 Plan will remain subject to the 2014 Plan even after the expiration of that
plan, but any ordinary shares available under the 2014 Plan as of the adoption of the 2024 Plan, or that subsequently become available
under the 2014 Plan due to the expiration, cancellation, forfeiture or other surrender of outstanding grants under the 2014 Plan, will
become available for new grants under the 2024 Plan. We will provide a description of the new 2024 Plan in the proxy statement for the
general meeting of shareholders at which such plan will be presented for shareholder approval, and in subsequent documents filed with
or furnished to, the SEC.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The following table provides information regarding the outstanding
options to purchase our ordinary shares, and RSUs held by each of our directors and executive officers who beneficially owns greater than
1% of our ordinary shares (after including shares underlying options or RSUs) as of March 15, 2024:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8fa88b546f6d402eb41096a0f11273c2" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 16.73%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Name</div> </td>
    <td style="width: 1.02%; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: #000000 2px solid; width: 9.92%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Number of<br/> Options</div> </td>
    <td style="width: 1.14%; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: #000000 2px solid; width: 14.24%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Number of<br/> RSUs</div> </td>
    <td style="width: 1.14%; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: #000000 2px solid; width: 14.24%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Grant Date</div> </td>
    <td style="width: 1.05%; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: #000000 2px solid; width: 9.92%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Exercise<br/> Price - $</div> </td>
    <td style="width: 1.14%; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: #000000 2px solid; width: 14.24%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Vested<br/> Options/RSU's</div> </td>
    <td style="width: 1.14%; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: #000000 2px solid; width: 14.08%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Expiration Date</div> </td> </tr>
  <tr>
    <td style="width: 16.73%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Ofer Gonen</div> </td>
    <td style="width: 1.02%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 9.92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">85,700</div> </td>
    <td style="width: 1.14%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 14.24%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 1.14%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 14.24%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">07/06/2022</div> </td>
    <td style="width: 1.05%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 9.92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">14.42</div> </td>
    <td style="width: 1.14%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 14.24%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">37,500</div> </td>
    <td style="width: 1.14%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 14.08%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">06/06/2032</div> </td> </tr>
  <tr>
    <td style="width: 16.73%; vertical-align: top">&#160;</td>
    <td style="width: 1.02%; vertical-align: top">&#160;</td>
    <td style="width: 9.92%; vertical-align: top">&#160;</td>
    <td style="width: 1.14%; vertical-align: top">&#160;</td>
    <td style="width: 14.24%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">20,089</div> </td>
    <td style="width: 1.14%; vertical-align: top">&#160;</td>
    <td style="width: 14.24%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">07/06/2022</div> </td>
    <td style="width: 1.05%; vertical-align: top">&#160;</td>
    <td style="width: 9.92%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">0</div> </td>
    <td style="width: 1.14%; vertical-align: top">&#160;</td>
    <td style="width: 14.24%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">15,625</div> </td>
    <td style="width: 1.14%; vertical-align: top">&#160;</td>
    <td style="width: 14.08%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">06/06/2032</div> </td> </tr>
  <tr>
    <td style="width: 16.73%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 1.02%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 9.92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">86,000</div> </td>
    <td style="width: 1.14%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 14.24%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 1.14%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 14.24%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">31/05/2023</div> </td>
    <td style="width: 1.05%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 9.92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">11.89</div> </td>
    <td style="width: 1.14%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 14.24%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">21,500</div> </td>
    <td style="width: 1.14%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 14.08%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">30/05/2033</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-weight: bold">C.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
<span style="font-weight: bold">Board Practices</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Board of Directors</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Authorities</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under the Israeli Companies Law, the management of our company
is vested in our board of directors. Our board of directors may exercise all powers and may take all actions that are not specifically
granted to our shareholders or to management. Our executive officers are responsible for our day&#8209;to&#8209;day management and have
individual responsibilities established by our board of directors. Our Chief Executive Officer is appointed by, and serves at the discretion
of, our board of directors, subject to the employment agreement that we have entered into with him. All other executive officers are also
appointed by our board of directors, and are subject to the terms of any applicable employment agreements that we may enter into with
them.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">96</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Composition</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under our articles of association, our board of directors must
consist of at least five and not more than nine directors, including, to the extent then required to appoint them, at least two external
directors, who may be required to be appointed under the Israeli Companies Law. At any time the minimum number of directors (other than
the external directors) shall not fall below three. Other than external directors, for whom special election requirements apply under
the Israeli Companies Law when they are required to be elected, as detailed below, the Israeli Companies Law and our articles of association
provide that directors are elected annually at the general meeting of our shareholders by a vote of the holders of a majority of the voting
power represented present and voting, in person or by proxy, at that meeting. We have only one class of directors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In accordance with the exemption available to foreign private issuers
under Nasdaq rules, we are not required to comply with the requirements of the Nasdaq rules with regard to having a majority of independent
directors on our board of directors, as long as we follow Israeli law and practice, in accordance with which our board of directors includes
at least two external directors. However, because we have elected under the Israeli Companies Law regulations to opt-out from compliance
with Israeli law requirements related to appointment of external directors and audit and compensation committee composition (as described
under &#8220;External Directors&#8221; below), we are not permitted to also exempt ourselves from the Nasdaq majority independent directors
requirement. Our board of directors has determined that six of our eight current directors are independent under the Nasdaq Stock Market
listing rules such that we comply with the Nasdaq majority independence rule.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under the Israeli Companies Law, our board of directors must determine
the minimum number of directors who are required to have accounting and financial expertise. In determining the number of directors required
to have such expertise, our board of directors must consider, among other things, the type and size of the company and the scope and complexity
of its operations. Our board of directors has determined that the minimum number of directors of our company who are required to have
accounting and financial expertise is one.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Nominations and Election</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In accordance with the Nasdaq listing rules, we have appointed
a committee of the board of directors&#160; that is authorized to recommend to our board, for nomination for election by our shareholders,
director nominees. Please see &#8220;Committees of the Board of Directors&#8212; Nominating and Governance Committee&#8221; below for
more information.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under the Israeli Companies Law and our articles of association,
nominees for directors may also be proposed by any shareholder holding at least 1% of our outstanding voting power. However, any such
shareholder may propose a nominee only if a written notice of such shareholder&#8217;s intent to propose a nominee has been given to our
Secretary (or, if we have no such Secretary, our Chief Executive Officer). Pursuant to our Articles of Association, any such notice must
include certain information, including, among other things, a description of all arrangements between the nominating shareholder and the
proposed director nominee(s) and any other person pursuant to which the nomination(s) are to be made by the nominating shareholder, the
consent of the proposed director nominee(s) to serve as our director(s) if elected and a declaration signed by the nominee(s) declaring
that there is no limitation under the Israeli Companies Law preventing their election, and that all of the information that is required
under the Israeli Companies Law to be provided to us in connection with such election has been provided. Under the Israeli Companies Law
regulations, any such shareholder nomination must be delivered to our registered Israeli office within seven days after we publish notice
of our upcoming annual general meeting of shareholders (or within 14 days after we publish a preliminary notification of an upcoming annual
general meeting).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, our articles of association allow our board of directors
to appoint directors to fill vacancies on our board of directors for a term of office equal to the remaining period of the term of office
of the director(s) whose office(s) have been vacated.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are not a party to, and are not aware of, any voting agreements
among our shareholders. In addition, there are no family relationships among our executive officers and directors.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">97</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">External Directors</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under the Israeli Companies Law, the boards of directors of companies,
whose shares are publicly traded, including companies with shares traded in the United States, are generally required to include at least
two members who qualify as external directors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under regulations promulgated under the Israeli Companies Law,
Israeli public companies whose shares are traded on certain U.S. stock exchanges, such as the Nasdaq Global Market, and that lack a controlling
shareholder (as defined below) are exempt from the requirement to appoint external directors. Any such company is also exempt from the
Israeli Companies Law requirements related to the composition of the audit and compensation committees of the Board. Eligibility for these
exemptions is conditioned on compliance with U.S. stock exchange listing rules related to majority Board independence and the composition
of the audit and compensation committees of the Board, as applicable to all listed domestic U.S. companies. Eligibility is furthermore
conditioned on our election of a female or male director at any time when we hold elections of directors and the Board is then composed
of solely male or solely female members.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">On December 5, 2022, in light of our Board&#8217;s determination
that Clal Biotechnology Industries Ltd. was no longer a &#8220;controlling shareholder&#8221; of our company under the Israeli Companies
Law definition (provided further below), the Board elected, pursuant to the Israeli Companies Law regulations, to exempt our company from
compliance with the (i) requirement to appoint external directors, and (ii) required composition of the audit committee and compensation
committees of the Board under the Israeli Companies Law. At the time that it made that election, our Board affirmatively determined that
we meet the conditions for exemption from the external director requirement, including that a majority of the members of our Board, along
with each of the members of the audit and compensation committees of the Board, are independent under the Nasdaq Listing Rules. Our Board
has confirmed subsequently in an ongoing manner that we continue to fulfill those conditions for exemption from the Israeli Companies
Law requirements related to (i) the appointment of external directors, and (ii) the composition of the audit committee and compensation
committees of the Board.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25">Our election to exempt our company from compliance with the
external director and related requirements can be reversed at any time by our Board, in which case we would need to hold a shareholder
meeting to once again to appoint external directors, whose election would be for a three-year term. The election of each external director
would require a majority vote of the shares present and voting at a shareholders meeting, provided that either:</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25">&#8226; the majority voted in favor of election includes a majority
of the shares held by non-controlling shareholders who do not have a personal interest in the election of the external director (other
than a personal interest not deriving from a relationship with a controlling shareholder) that are voted at the meeting, excluding abstentions,
which we refer to as a disinterested majority; or</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25">&#8226; the total number of shares held by non-controlling,
disinterested shareholders (as described in the previous bullet-point) voted against the election of the director does not exceed two
percent (2%) of the aggregate voting rights in the company.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25">The term &#8220;controlling shareholder&#8221; is defined in
the Israeli Companies Law as a shareholder with the ability to direct the activities of the company, other than by virtue of being an
office holder. A shareholder is presumed to be a controlling shareholder if the shareholder holds 50% or more of the voting rights in
a company or has the right to appoint the majority of the directors of the company or its general manager (i.e., its CEO).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">For further information concerning the Israeli Companies Law provisions
related to external directors, please see &#8220;Item 6. Directors, Senior Management and Employees- C. Board Practices- Board of Directors-
External Directors&#8221; in our annual report on Form 20-F for the year ended December 31, 2022, which we filed with the SEC on March
16, 2023.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Leadership Structure of the Board</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In accordance with the Israeli Companies Law and our articles of
association, our board of directors is required to appoint one of its members to serve as chairman of the board of directors. Our board
of directors has appointed Homi Shamir to serve as chairman of the board of directors.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">98</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="line-height: 1.25; font-weight: bold">Committees of the Board of Directors</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Audit Committee</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Israeli Companies Law composition requirements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under the Israeli Companies Law, we are required to have an audit
committee comprised of at least three directors. To the extent we are then required to appoint external directors, this committee must
include all of the external directors, one of whom must serve as chairman of the committee. There are additional requirements as to the
composition of the audit committee under the Israeli Companies Law. However, when we elected to exempt our company from the external director
requirement, we concurrently elected to exempt our company from all of such requirements (which exemption is conditioned on our fulfillment
of all Nasdaq listing requirements related to the composition of the audit committee).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Nasdaq listing rules composition requirements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under the Nasdaq Stock Market listing rules, we are required to
maintain an audit committee consisting of at least three independent directors, each of whom is financially literate and one of whom has
accounting or related financial management expertise.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">Our audit committee consists of Stephen T. Wills
(chairperson),<span style="font-style: italic">&#160;</span>Vickie R. Driver&#160; and Nachum Shamir, each of whom is an independent director
in accordance with Rule 10A&#8209;3(b)(1) under the Exchange Act and satisfies the independent director requirements under the Nasdaq
Stock Market listing rules. All members of our audit committee meet the requirements for financial literacy under the applicable listing
rules of the Nasdaq Stock Market. Our board of directors has determined that Stephen T Wills is an &#8220;audit committee financial expert,&#8221;
as defined in the SEC regulations, and possesses accounting and financial expertise, as defined under the Israeli Companies Law.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="line-height: 1.25; font-style: italic">Audit committee role</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our audit committee provides assistance to our board of directors
in fulfilling its legal and fiduciary obligations in matters involving our accounting, auditing, financial reporting, internal control
and legal compliance functions by pre&#8209;approving the services performed by our independent accountants and reviewing their reports
regarding our accounting practices and systems of internal control over financial reporting. Our audit committee also oversees the audit
efforts of our independent accountants and takes those actions that it deems necessary to satisfy itself that the accountants are independent
of management.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our board of directors has adopted an audit committee charter that
sets forth the responsibilities of the audit committee consistent with the rules and regulations of the SEC and the Nasdaq Stock Market
listing rules, as well as the requirements for such committee under the Israeli Companies Law, including the following:</div>

<div style="line-height: 1.25">&#160;</div>

<div> <br/> </div>

<table cellspacing="0" cellpadding="1" border="0" id="ze732e7a4df884e52b817729d5f191b46" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#160;&#8226;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">overseeing our independent registered public accounting firm and recommending the
        engagement, compensation or termination of engagement of our independent registered public accounting firm to the board of directors in
        accordance with Israeli law;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#160;&#8226;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">recommending the engagement or termination of the person filling the office of our
        internal auditor;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#160;&#8226;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">recommending the terms of audit and non&#8209;audit services provided by the independent
        registered public accounting firm for pre&#8209;approval by our board of directors;</div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226;</td>
    <td rowspan="1" style="width: 91%; vertical-align: top">pre-approving all audit, audit-related and all permitted non-audit services, and related
        fees and terms, to be provided to the Company by the independent auditor under applicable law and regulations;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226;</td>
    <td rowspan="1" style="width: 91%; vertical-align: top">Establishing policies for hiring employees or former employees of the independent
        auditor in accordance with applicable law and regulations;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226;</td>
    <td rowspan="1" style="width: 91%; vertical-align: top">reviewing periodically with management, the internal auditor and the independent auditor,
        the adequacy and effectiveness of the Company&#8217;s system of internal control over financial reporting;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226;</td>
    <td rowspan="1" style="width: 91%; vertical-align: top">evaluating whether management is effectively communicating to employees and other
        persons retained by MediWound the importance of internal accounting and financial control effectiveness;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226;</td>
    <td rowspan="1" style="width: 91%; vertical-align: top">reviewing with management and the independent auditor the annual and quarterly financial
        statements of MediWound prior to filing (or submission, as the case may be) with the SEC;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226;</td>
    <td rowspan="1" style="width: 91%; vertical-align: top">discussing with management, and review prior to submission, any responses to SEC comments
        regarding the Company&#8217;s financial statements or financial reporting;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226;</td>
    <td rowspan="1" style="width: 91%; vertical-align: top">discussing with management and MediWound&#8217;s independent auditors generally the
        types of financial information (including earnings guidance) to be disclosed in earnings press releases and earnings calls, as well as
        to analysts and rating agencies;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226;</td>
    <td rowspan="1" style="width: 91%; vertical-align: top">reviewing and discussing with management and MediWound independent auditors MediWound&#8217;s
        earnings press releases, including the use of any pro forma, adjusted or other non-GAAP financial information, before their release to
        the public;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226;</td>
    <td rowspan="1" style="width: 91%; vertical-align: top">reviewing with the MediWound&#8217;s general counsel and/or external counsel legal
        and regulatory matters that could have a material impact on the financial statements; <br/> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226;</td>
    <td rowspan="1" style="width: 91%; vertical-align: top">establishing procedures for (i) the receipt, retention, and treatment of complaints
        received by MediWound regarding accounting, internal accounting controls or auditing matters; and (ii) the confidential, anonymous submission
        by employees of MediWound of concerns regarding questionable accounting or auditing matters, and review any complaints or concerns received
        pursuant to such procedures;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226;</td>
    <td rowspan="1" style="width: 91%; vertical-align: top">reviewing with management and the independent auditor risks of material misstatements
        due to fraud, and the process and controls implemented by the Company to manage the risks;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226;</td>
    <td rowspan="1" style="width: 91%; vertical-align: top">recommending to the Board the retention and termination of the internal auditor, and
        the internal auditor&#8217;s engagement fees and terms, in accordance with the Companies Law, approve the internal auditor&#8217;s work
        plan, and review and discuss the internal auditor&#8217;s work on a quarterly basis;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226;</td>
    <td rowspan="1" style="width: 91%; vertical-align: top">reviewing and monitoring, as appropriate, (i) litigation or other legal matters that
        could have a significant impact on MediWound&#8217;s financial results; and (ii) significant findings of any examination by regulatory
        authorities or agencies, in the areas of securities, accounting or tax;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226;</td>
    <td rowspan="1" style="width: 91%; vertical-align: top">receiving reports of suspected business irregularities and legal compliance issues
        through periodic and, when appropriate, immediate reporting by members of MediWound&#8217;s management, legal counsel, the independent
        or internal auditor or pursuant to any &#8220;whistleblower policy&#8221; adopted by the Committee.</td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226;</td>
    <td rowspan="1" style="width: 91%; vertical-align: top">establishing procedures for handling complaints by MediWound&#8217;s employees with
        respect to deficiencies in its business operations, including the protection to be granted to such complaining employees;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226;</td>
    <td rowspan="1" style="width: 91%; vertical-align: top">overseeing MediWound&#8217;s policies and procedures regarding compliance with applicable
        financial and accounting related standards, rules and regulations;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226;</td>
    <td rowspan="1" style="width: 91%; vertical-align: top">reviewing and considering the approval of related party transactions, including transactions
        between MediWound and a controlling shareholder (as defined under the Israeli Companies Law) or a transaction with another person in which
        a controlling shareholder has a personal interest, and transactions involving an office holder of MediWound (as defined in the Israeli
        Companies Law) that may present a conflict of interest between the duties of such office holder to the Company and his or her personal
        interests, in each case in accordance with Nasdaq listing rules, the Israeli Companies Law or as referred by the Board;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226;</td>
    <td rowspan="1" style="width: 91%; vertical-align: top">confirming that MediWound&#8217;s independent auditors are informed of the committee&#8217;s
        understanding of the Company&#8217;s related party transactions that are significant to the Company; and reviewing and discussing with
        the Company&#8217;s independent auditors the auditors&#8217; evaluation of the Company&#8217;s identification of, accounting for, and
        disclosure of, its related party transactions, including any significant matters arising from the audit regarding MediWound&#8217;s related
        party transactions;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226;</td>
    <td rowspan="1" style="width: 91%; vertical-align: top">discussing MediWound&#8217;s policies with respect to risk assessment and risk management,
        and reviewing contingent liabilities and risks that may be material to MediWound and relevant major legislative and regulatory developments
        that could materially impact MediWound&#8217;s contingent liabilities and risks;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226; <br/> </td>
    <td rowspan="1" style="width: 91%; vertical-align: top">reviewing periodically the Company&#8217;s major financial risk exposures and the
        Company&#8217;s policies for managing such risks;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226;</td>
    <td rowspan="1" style="width: 91%; vertical-align: top">conducting or authorizing investigations into any matters within the committee&#8217;s
        scope of responsibilities; and</td> </tr>
  <tr>
    <td rowspan="1" style="width: 5%; vertical-align: middle">&#160;</td>
    <td rowspan="1" style="width: 3.85%; vertical-align: top">&#160;&#8226;</td>
    <td rowspan="1" style="width: 91%; vertical-align: top">reviewing and approving any material change or waiver in MediWound&#8217;s Code of
        Conduct regarding directors or executive officers, and disclosures made in the Company&#8217;s annual report.</td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our audit committee may not approve any actions requiring its approval
(see &#8220;-Approval of Related Party Transactions Under Israeli Law&#8221;), unless at the time of the approval a majority of the committee&#8217;s
members are present, which majority consists of unaffiliated directors including at least one external director, to the extent we then
have external directors serving on the Board).</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">99</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Compensation Committee</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Israeli Companies Law composition requirements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under the Israeli Companies Law, the board of directors of a public
company must appoint a compensation committee. If a company is required to appoint external directors, the committee must consist of at
least three members, including all of the external directors, one of whom must serve as chairman of the committee. There are additional
requirements as to the composition of the compensation committee under the Companies Law. However, when we elected to exempt our company
from the external director requirement, we concurrently elected to exempt our company from all of such requirements (including the three-member
minimum). Our exemption under the Companies Law is conditioned on our fulfillment of all Nasdaq listing requirements related to the composition
of the compensation committee.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Israeli Companies Law committee duties</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The duties of the compensation committee include the recommendation
to the company&#8217;s board of directors of a policy regarding the terms of engagement of office holders, which we refer to as a compensation
policy. That policy must be adopted by the company&#8217;s board of directors, after considering the recommendations of the compensation
committee, and must be approved by the company&#8217;s shareholders, which approval requires what we refer to as a Special Majority Approval
for Compensation. A Special Majority Approval for Compensation requires shareholder approval by a majority vote of the shares present
and voting at a meeting of shareholders called for such purpose, provided that either (a) such majority includes at least a majority of
the shares held by all shareholders who are not controlling shareholders and do not have a conflict of interest (referred to under the
Israeli Companies Law as a &#8220;personal interest&#8221;) in such compensation arrangement or (b) the total number of shares of non-controlling
shareholders and shareholders who do not have a personal interest in the compensation arrangement and who vote against the arrangement
does not exceed 2% of the company&#8217;s aggregate voting rights.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Compensation policy requirements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have adopted a compensation policy, most recently at the extraordinary
general meeting of shareholders held on November 28, 2022, which policy serves as the basis for decisions concerning the financial terms
of employment or engagement of office holders, including exculpation, insurance, indemnification or any monetary payment or obligation
of payment or other benefit in respect of employment or engagement. Under the Israeli Companies Law, the compensation policy must relate
to certain factors, including advancement of the company&#8217;s objectives, the company&#8217;s business plan and its long-term strategy,
and creation of appropriate incentives for office holders. It must also consider, among other things, the company&#8217;s risk management,
size and the nature of its operations. The compensation policy must furthermore consider the following additional factors:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd77dbd730c6a46a6a203f5463205a3fb" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the knowledge, skills, expertise and accomplishments of the relevant office holder;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the office holder&#8217;s roles and responsibilities and prior compensation agreements
        with him or her;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the relationship between the terms offered and the average compensation of the other
        employees of the company, including those employed through manpower companies;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the impact of disparities in salary upon work relationships in the company;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the possibility of reducing variable compensation at the discretion of the board of
        directors;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the possibility of setting a limit on the exercise value of non-cash variable equity-based
        compensation; and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">as to severance compensation, the period of service of the office holder, the terms
        of his or her compensation during such service period, the company&#8217;s performance during that period of service, the person&#8217;s
        contribution towards the company&#8217;s achievement of its goals and the maximization of its profits, and the circumstances under which
        the person is leaving the company.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">100</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="line-height: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The compensation policy
must also include the following principles:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2edea8aae4384f52b1f11619815dc005" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the link between variable compensation and long-term performance, which variable compensation
        shall, other than office holder who report to the CEO, be primarily based on measurable criteria;</div>
        <div style="line-height: 1.25; text-align: justify">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the relationship between variable and fixed compensation, and the ceiling for the
        value of variable compensation;</div>
        <div style="line-height: 1.25; text-align: justify">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the conditions under which an office holder would be required to repay compensation
        paid to him or her if it was later shown that the data upon which such compensation was based was inaccurate and was required to be restated
        in the company&#8217;s financial statements;</div>
        <div style="line-height: 1.25; text-align: justify">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the minimum holding or vesting period for variable, equity-based compensation; and</div>
        <div style="line-height: 1.25; text-align: justify">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">maximum limits for severance compensation.</div>
        <div style="line-height: 1.25; text-align: justify">&#160;</div> </td> </tr>
  </table>

<div style="line-height: 1.25; text-align: justify">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The
compensation committee is responsible for (a) recommending the compensation policy to the company&#8217;s board of directors for its approval
(and subsequent approval by its shareholders) and (b) duties related to the compensation policy and to the compensation of a company&#8217;s
office holders as well as functions previously fulfilled by a company&#8217;s audit committee with respect to matters related to approval
of the terms of engagement of office holders, including:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze79cbecd15f1481785f394d3a23b8247" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">recommending whether a compensation policy should continue in effect, if the then-current
        policy has a term of greater than three years (approval of either a new compensation policy or the continuation of an existing compensation
        policy must in any case occur every three years, other than following a company&#8217;s initial public offering, in which case such approval
        must occur within 5 years of the initial public offering);</div>
        <div style="line-height: 1.25; text-align: justify">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">recommending to the board of directors periodic updates to the compensation policy
        and assessing implementation of the compensation policy;</div>
        <div style="line-height: 1.25; text-align: justify">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">approving compensation terms of executive officers, directors and employees that require
        approval of the compensation committee;</div>
        <div style="line-height: 1.25; text-align: justify">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">determining whether the compensation terms of a chief executive officer nominee, which
        were determined pursuant to the compensation policy, will be exempt from approval of the shareholders because such approval would harm
        the ability to engage with such nominee; and</div>
        <div style="line-height: 1.25; text-align: justify">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">determining, subject to the approval of the board and under special circumstances,
        whether to override a determination of the company&#8217;s shareholders regarding certain compensation related issues.</div>
        <div style="line-height: 1.25; text-align: justify">&#160;</div> </td> </tr>
  </table>

<div style="text-indent: 35.45pt; line-height: 1.25">A copy of our current compensation policy serves as an exhibit to this annual report
on Form 20-F.</div>

<div style="text-indent: 35.45pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">101</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Nasdaq listing rules</span>&#160;<span style="font-style: italic">composition
requirements</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under Nasdaq corporate governance rules, we are required to maintain
a wholly-independent compensation committee consisting of at least two independent directors or, if we choose to follow requirements under
Israeli law, we must disclose that fact in this annual report. Each of the members of the compensation committee is required to be independent
under the Nasdaq rules relating to compensation committee members and Rule 10C&#8209;1(b)(1) under the Exchange Act, which are different
than the general test for independence of board members.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our compensation committee consists of Nachum Shamir (chairperson),
David Fox and Stephen T. Wills, each of whom is an independent director under the Nasdaq Stock Market listing rules and each of whom satisfies
the above-described additional requirements for compensation committee members under the Nasdaq rules and Exchange Act.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Compensation committee charter and role</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our board of directors has adopted a compensation committee charter
setting forth the responsibilities of the compensation committee, which include:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2d438136775a4c8aa25ebc11df2d10d8" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the responsibilities set forth in the compensation policy;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">reviewing and approving the granting of options and other incentive awards to the
        extent such authority is delegated by our board of directors; and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">reviewing, evaluating and making recommendations regarding the compensation and benefits
        for our non-employee directors.</div> </td> </tr>
  </table>

<div style="line-height: 1.25; font-weight: bold"> <br/> </div>

<div style="line-height: 1.25; font-weight: bold">Nominating and Governance Committee</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25; font-family: Times New Roman, serif">Under Nasdaq corporate governance rules, director nominees must either
be selected, or recommended for the Board's selection, either by independent directors constituting a majority of the Board's independent
directors in a vote in which only independent directors participate, or a nominations committee comprised solely of independent directors.
If we choose to exempt ourselves from that requirement in accordance with our home country practices, we must disclose that fact in this
annual report. Each of the members of the nominating committee is required to be independent under the Nasdaq rules.<br/>

<div><br/> </div>

<div style="line-height: 1.25">Our Board has established a nominating and governance committee, whose members consist of Nachum Shamir
and David Fox, each of whom has been determined by our Board to meet that Nasdaq independence requirement, with Mr. Fox serving as chair.
Our board of directors has adopted a nominating and governance committee charter setting forth the responsibilities of the committee,
which include:</div> </div>

<div style="line-height: 1.25">&#160;</div> </div>

<table cellspacing="0" cellpadding="0" id="z61b51c1a28eb44b18a4b7d6ad8f7a8f3" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="line-height: 1.25">overseeing and assisting our board in reviewing and recommending nominees for election of directors;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="line-height: 1.25">assessing the performance of the members of our board; and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="line-height: 1.25">establishing and maintaining effective corporate governance policies and practices, including, but not
        limited to, developing and recommending to our board a set of corporate governance guidelines applicable to our business.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="line-height: 1.25; font-weight: bold">Research and Development Committee</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our Board has established a research and development committee,
which is composed of Vickie R Driver, Stephen T. Wills and Sharon Malka, with Dr. Driver serving as chairperson. The primary functions
of the research and development committee include:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z47ba70c15c6643199d50465deac86ab8" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">overseeing the Company's scientific, technical, research and development strategy,
        and the implementation thereof; and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">advising our board of directors and management regarding program prioritization, clinical
        development strategy, regulatory strategy and interactions, and related matters.&#160;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">102</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Board Diversity Matrix (As of March&#160;1, 2024)</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z61785cfc3892449b81c61fa402a5a3b4" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 72.77%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; line-height: 1.25">Country of Principal Executive Offices&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td style="width: 27.23%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; line-height: 1.25">Israel</div> </td> </tr>
  <tr>
    <td style="width: 72.77%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Foreign Private Issuer&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td style="width: 27.23%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Yes</div> </td> </tr>
  <tr>
    <td style="width: 72.77%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; line-height: 1.25">Disclosure Prohibited under Home Country Law&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td style="width: 27.23%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; line-height: 1.25">No</div> </td> </tr>
  <tr>
    <td style="width: 72.77%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Total Number of Directors&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td style="width: 27.23%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">5</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" id="zb21990c9413044d8995944d9c492467e" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 49.98%; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 12.5%; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Female</div> </div> </td>
    <td colspan="1" style="width: 1%; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 12.52%; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Male</div> </div> </td>
    <td colspan="1" style="width: 1%; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 12.5%; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Non&#8209;Binary</div> </div> </td>
    <td colspan="1" style="width: 1%; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 12.5%; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Did Not Disclose Gender</div> </div> </td> </tr>
  <tr>
    <td style="width: 49.98%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; text-indent: -5.4pt; margin-left: 5.4pt; line-height: 1.25; font-weight: bold">Part I: Gender Identity</div>
        </td>
    <td style="width: 12.5%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 12.52%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 12.5%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 12.5%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td> </tr>
  <tr>
    <td style="width: 49.98%; vertical-align: bottom">
        <div style="text-align: justify; text-indent: -5.4pt; margin-left: 5.4pt; line-height: 1.25">Directors</div> </td>
    <td style="width: 12.5%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">1</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="width: 12.52%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">4</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="width: 12.5%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">0</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="width: 12.5%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">0</div> </td> </tr>
  <tr>
    <td style="width: 49.98%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; text-indent: -5.4pt; margin-left: 5.4pt; line-height: 1.25; font-weight: bold">Part II: Demographic Background</div>
        </td>
    <td style="width: 12.5%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 12.52%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 12.5%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 12.5%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td> </tr>
  <tr>
    <td style="width: 49.98%; vertical-align: bottom">
        <div style="text-align: justify; text-indent: -5.4pt; margin-left: 5.4pt; line-height: 1.25">Underrepresented Individual in Home Country
        Jurisdiction</div> </td>
    <td style="width: 12.5%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">*</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="width: 12.52%; vertical-align: bottom">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="width: 12.5%; vertical-align: bottom">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="width: 12.5%; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="width: 49.98%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; text-indent: -5.4pt; margin-left: 5.4pt; line-height: 1.25">LGBTQ+&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td style="width: 12.5%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">*</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 12.52%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 12.5%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 12.5%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td> </tr>
  <tr>
    <td style="width: 49.98%; vertical-align: bottom">
        <div style="text-align: justify; text-indent: -5.4pt; margin-left: 5.4pt; line-height: 1.25">Did Not Disclose Demographic Background</div>
        </td>
    <td style="width: 12.5%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">*</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="width: 12.52%; vertical-align: bottom">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="width: 12.5%; vertical-align: bottom">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="width: 12.5%; vertical-align: bottom">&#160;</td> </tr>
  </table>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25">(*) There are no directors who fall into any demographic background category who have agreed to disclose
that information publicly.</div> </div>

<div style="line-height: 1.25; font-weight: bold"><br/> Internal Auditor</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under the Israeli Companies Law, the board of directors of an Israeli
public company must appoint an internal auditor recommended by the audit committee. An internal auditor may not be:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z93e3b9aeaf794968a8c8e799d99c7a1a" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">a person (or a relative of a person) who holds 5% or more of the company&#8217;s outstanding
        shares or voting rights;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">a person (or a relative of a person) who has the power to appoint a director or the
        general manager of the company (i.e., the chief executive officer);</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">an office holder (including a director) of the company (or a relative thereof); or</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">a member of the company&#8217;s independent accounting firm, or anyone on its behalf.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The role of the internal auditor is to examine, among other things,
our compliance with applicable law and orderly business procedures.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The audit committee is required to oversee the activities and to
assess the performance of the internal auditor as well as to review the internal auditor&#8217;s work plan. Our internal auditor is Mr.
Yisrael Gewirtz.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">103</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-weight: bold"><br/> <br/> Fiduciary Duties of Directors and Executive Officers</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The Israeli Companies Law codifies the fiduciary duties that office
holders owe to a company. Each person listed in the table under &#8220;Executive Officers and Directors&#8221; is an office holder under
the Israeli Companies Law.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">An office holder&#8217;s fiduciary duties consist of a duty of
care and a duty of loyalty. The duty of care requires an office holder to act with the level of care with which a reasonable office holder
in the same position would have acted under the same circumstances. The duty of loyalty requires that an office holder act in good faith
and in the best interests of the company.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The duty of care includes a duty to use reasonable means to obtain:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf5d0cf832b80473cb040cf6e4f631032" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">information on the advisability of a given action brought for his or her approval
        or performed by virtue of his or her position; and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">all other important information pertaining to any such action.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="text-indent: 36pt; line-height: 1.25">The duty of loyalty includes a duty to:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6db69d2bf6994c2f967b392336f21ada" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">refrain from any conflict of interest between the performance of his or her duties
        to the company and his or her other duties or personal affairs;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">refrain from any activity that is competitive with the business of the company;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">refrain from exploiting any business opportunity of the company to receive a personal
        gain for himself or herself or others; and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">disclose to the company any information or documents relating to the company&#8217;s
        affairs which the office holder received as a result of his or her position as an office holder.</div> </td> </tr>
  </table>

<div style="line-height: 1.25; font-style: italic"> <br/> </div>

<div style="line-height: 1.25; font-style: italic">Disclosure of personal interests of an office holder and approval of certain transactions</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The Israeli Companies Law requires that an office holder promptly
disclose to the board of directors any personal interest that he or she may be aware of and all related material information or documents
concerning any existing or proposed transaction with the company. An interested office holder&#8217;s disclosure must be made promptly
and in any event no later than the first meeting of the board of directors at which the transaction is considered. A personal interest
includes an interest of any person in an act or transaction of a company, including a personal interest of such person&#8217;s relative
or of a corporate body in which such person or a relative of such person is a 5% or greater shareholder, director or general manager or
in which he or she has the right to appoint at least one director or the general manager, but excluding a personal interest stemming from
one&#8217;s ownership of shares in the company.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">A personal interest furthermore includes the personal interest
of a person for whom the office holder holds a voting proxy or the personal interest of the office holder with respect to his or her vote
on behalf of a person for whom he or she holds a proxy even if such shareholder has no personal interest in the matter. An office holder
is not, however, obliged to disclose a personal interest if it derives solely from the personal interest of his or her relative in a transaction
that is not considered an extraordinary transaction. Under the Israeli Companies Law, an extraordinary transaction is defined as any of
the following:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z3e72323d50c24a80a4632ce16954724c" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">a transaction other than in the ordinary course of business;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">a transaction that is not on market terms; or</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">a transaction that may have a material impact on a company&#8217;s profitability,
        assets or liabilities.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">104</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">If it is determined that an office holder has a personal interest
in a transaction which is not an extraordinary transaction, approval by the board of directors is required for the transaction, unless
the company&#8217;s articles of association provide for a different method of approval. Further, so long as an office holder has disclosed
his or her personal interest in a transaction, the board of directors may approve an action by the office holder that would otherwise
be deemed a breach of his or her duty of loyalty. However, a company may not approve a transaction or action that is not in the best interest
of the company or that is not performed by the office holder in good faith. An extraordinary transaction in which an office holder has
a personal interest requires approval first by the company&#8217;s audit committee and subsequently by the board of directors. The compensation
of, or an undertaking to indemnify or insure, an office holder who is not a director requires approval first by the company&#8217;s compensation
committee, then by the company&#8217;s board of directors. If such compensation arrangement or an undertaking to indemnify or insure is
inconsistent with the company&#8217;s stated compensation policy, or if the office holder is the chief executive officer (apart from a
number of specific exceptions), then such arrangement is further subject to a Special Majority Approval for Compensation. Arrangements
regarding the compensation, indemnification or insurance of a director require the approval of the compensation committee, board of directors
and shareholders by ordinary majority, in that order, and under certain circumstances, a Special Majority Approval for Compensation. Generally,
a person who has a personal interest in a matter which is considered at a meeting of the board of directors or the audit committee may
not be present at such a meeting or vote on that matter unless the chairman of the relevant committee or board of directors (as applicable)
determines that he or she should be present in order to present the transaction that is subject to approval. If a majority of the members
of the audit committee or the board of directors (as applicable) has a personal interest in the approval of a transaction, then all directors
may participate in discussions of the audit committee or the board of directors (as applicable) on such transaction and the voting on
approval thereof, but shareholder approval is also required for such transaction.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Disclosure of personal interests of controlling shareholders and
approval of certain transactions</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Pursuant to Israeli law, the disclosure requirements regarding
personal interests that apply to directors and executive officers also apply to a controlling shareholder of a public company. In the
context of a transaction involving a shareholder of the company, a controlling shareholder also includes a shareholder who holds 25% or
more of the voting rights in the company if no other shareholder holds more than 50% of the voting rights in the company. For this purpose,
the holdings of all shareholders who have a personal interest in the same transaction will be aggregated. The approval of the audit committee
or the compensation committee, the board of directors and the shareholders of the company, in that order, is required for (a) extraordinary
transactions with a controlling shareholder or in which a controlling shareholder has a personal interest, (b) the engagement with a controlling
shareholder or his or her relative, directly or indirectly, including through a company under the control of the controlling shareholder,
for the provision of services to the company, (c) the terms of engagement and compensation of a controlling shareholder or his or her
relative who is an office holder or (d) the employment of a controlling shareholder or his or her relative by the company, other than
as an office holder. In addition, the shareholder approval requires one of the following, which we refer to as a Special Majority:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5d4b13bb08a24a98bf1c7372ebc3d14d" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">at least a majority of the shares held by all shareholders who do not have a personal
        interest in the transaction and who are present and voting at the meeting approves the transaction, excluding abstentions; or</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the shares voted against the transaction by shareholders who have no personal interest
        in the transaction and who are present and voting at the meeting do not exceed 2% of the voting rights in the company.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">To the extent that any such transaction with a controlling shareholder
is for a period extending beyond three years, approval is required once every three years, unless, with respect to certain transactions,
the audit committee determines that the duration of the transaction is reasonable given the circumstances related thereto. Arrangements
regarding the compensation, indemnification or insurance of a controlling shareholder in his or her capacity as an office holder require
the approval of the compensation committee, board of directors and shareholders by a Special Majority, in that order, and the terms thereof
may not be inconsistent with the company&#8217;s stated compensation policy.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Pursuant to regulations promulgated under the Israeli Companies
Law, certain transactions with a controlling shareholder or his or her relative, or with directors, that would otherwise require approval
of a company&#8217;s shareholders may be exempt from shareholder approval upon certain determinations of the audit committee and board
of directors.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">105</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Shareholder duties</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Pursuant to the Israeli Companies Law, a shareholder has a duty
to act in good faith and in a customary manner toward the company and other shareholders and to refrain from abusing his or her power
in the company, including, among other things, in voting at a general meeting and at shareholder class meetings with respect to the following
matters:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc16a3e2fa5b7402697d826dbe018205d" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">an amendment to the company&#8217;s articles of association;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">an increase of the company&#8217;s authorized share capital;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">a merger; or</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">the approval of related party transactions and acts of office holders that require
        shareholder approval.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">A shareholder also has a general duty to refrain from discriminating
against other shareholders. In addition, certain shareholders have a duty of fairness toward the company. These shareholders include any
controlling shareholder, any shareholder who knows that he or she has the power to determine the outcome of a shareholder vote and any
shareholder who has the power to appoint or to prevent the appointment of an office holder of the company or other power towards the company.
The Israeli Companies Law does not define the substance of the duty of fairness, except to state that the remedies generally available
upon a breach of contract will also apply in the event of a breach of the duty to act with fairness.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Exculpation, Insurance and Indemnification of Directors and Officers</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under the Israeli Companies Law, a company may not exculpate an
office holder from liability for a breach of the duty of loyalty. An Israeli company may exculpate an office holder in advance from liability
to the company, in whole or in part, for damages caused to the company as a result of a breach of duty of care but only if a provision
authorizing such exculpation is included in its articles of association. Our articles of association include such a provision. A company
may not exculpate in advance a director from liability arising out of a prohibited dividend or distribution to shareholders.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under the Israeli Companies Law, a company may indemnify an office
holder in respect of the following liabilities and expenses incurred for acts performed by him or her as an office holder, either pursuant
to an undertaking made in advance of an event or following an event, provided its articles of association include a provision authorizing
such indemnification:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6dde4e4436ae40349b6a42de722635f8" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">financial liability imposed on him or her in favor of another person pursuant to a
        judgment, including a settlement or arbitrator&#8217;s award approved by a court. However, if an undertaking to indemnify an office holder
        with respect to such liability is provided in advance, then such an undertaking must be limited to events which, in the opinion of the
        board of directors, can be foreseen based on the company&#8217;s activities when the undertaking to indemnify is given, and to an amount
        or according to criteria determined by the board of directors as reasonable under the circumstances, and such undertaking shall detail
        the abovementioned foreseen events and amount or criteria;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">reasonable litigation expenses, including attorneys&#8217; fees, incurred by the office
        holder (1) as a result of an investigation or proceeding instituted against him or her by an authority authorized to conduct such investigation
        or proceeding, provided that (i) no indictment was filed against such office holder as a result of such investigation or proceeding, and
        (ii) no financial liability was imposed upon him or her as a substitute for the criminal proceeding as a result of such investigation
        or proceeding or, if such financial liability was imposed, it was imposed with respect to an offense that does not require proof of criminal
        intent; and (2) in connection with a monetary sanction; and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">reasonable litigation expenses, including attorneys&#8217; fees, incurred by the office
        holder or imposed by a court in proceedings instituted against him or her by the company, on its behalf, or by a third party, or in connection
        with criminal proceedings in which the office holder was acquitted, or as a result of a conviction for an offense that does not require
        proof of criminal intent.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">106</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under the Israeli Companies Law, a company may insure an office
holder against the following liabilities incurred for acts performed by him or her as an office holder, if and to the extent provided
in the company&#8217;s articles of association:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z0708ff8a8db44d559734dad5f758edd9" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">a breach of the duty of loyalty to the company, provided that the office holder acted
        in good faith and had a reasonable basis to believe that the act would not harm the company;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">a breach of duty of care to the company or to a third party, to the extent such a
        breach arises out of the negligent conduct of the office holder; and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">a financial liability imposed on the office holder in favor of a third party.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Under the Israeli Companies
Law, a company may not indemnify, exculpate or insure an office holder against any of the following:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc5fbb2347574456db9d4e572723d4dd8" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">a breach of the duty of loyalty, except for indemnification and insurance for a breach
        of the duty of loyalty to the company to the extent that the office holder acted in good faith and had a reasonable basis to believe that
        the act would not harm the company;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">a breach of duty of care committed intentionally or recklessly, excluding a breach
        arising out of the negligent conduct of the office holder;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">an act or omission committed with intent to derive illegal personal benefit; or</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 5%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">a fine or forfeit levied against the office holder.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Under the Israeli Companies
Law, exculpation, indemnification and insurance of office holders in a public company must be approved by the compensation committee and
the board of directors and, with respect to certain office holders or under certain circumstances, also by the shareholders. See &#8220;-Approval
of Related Party Transactions Under Israeli Law.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our articles of association permit us to exculpate, indemnify and
insure our office holders to the fullest extent permitted or to be permitted by the Israeli Companies Law. We have obtained directors&#8217;
and officers&#8217; liability insurance for the benefit of our office holders and intend to continue to maintain such coverage and pay
all premiums thereunder to the fullest extent permitted by the Israeli Companies Law. In addition, we have entered into agreements with
each of our directors and executive officers exculpating them from liability to us for damages caused to us as a result of a breach of
duty of care and undertaking to indemnify them, in each case, to the fullest extent permitted by our articles of association and Israeli
Law.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The maximum indemnification amount set forth in those agreements
is limited to an amount equal to the greater of (i) 25% of our total shareholders&#8217; equity based on our most recently financial statements
of the time of the actual payment of the indemnification; (ii) $50 million; (iii) 40% of our total market cap (which shall mean the average
closing price of the Company&#8217;s ordinary shares over the 30 trading days prior to the actual payment of indemnification multiplied
by the total number of issued and outstanding shares of the Company as of the date of actual payment); and (iv) in connection with or
arising out of a public offering of our securities, the aggregate amount of proceeds from the sale by us and/or any shareholder of ours
securities in such offering. The maximum amount set forth in those agreements is in addition to amounts actually paid, if any, under insurance
policies and/or by a third-party pursuant to an indemnification arrangement.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">107</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z4447bcbe7bc744a5bd7fb47f596b7130" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">D.</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25; font-weight: bold">Employees</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; As of December 31,
2023, we had 100 employees, 88 of whom were based in Israel and 12 based throughout Europe and employed by our German subsidiary. The
distribution of our employees according to main areas of activity is as follows: 14 employees in the administrative department, 26 employees
in the research and development department, 48 employees in the manufacturing department and 12 employees in the sales and marketing department.
As of December 31, 2023, we did not employ a significant number of temporary employees.</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Israeli labor laws govern the length of the workday and workweek,
minimum wages for employees, procedures for hiring and dismissing employees, determination of severance pay, annual leave, sick days,
advance notice of termination, payments to the National Insurance Institute and other conditions of employment, and include equal opportunity
and anti-discrimination laws. While none of our employees is party to any collective bargaining agreements, certain provisions of the
collective bargaining agreements between the Histadrut (General Federation of Labor in Israel) and the Coordination Bureau of Economic
Organizations (including the Industrialists&#8217; Associations) are applicable to our employees in Israel by order of the Israeli Ministry
of the Economy. These provisions primarily concern pension fund benefits for all employees, insurance for work-related accidents, recuperation
pay and travel expenses. We generally provide our employees with benefits and working conditions beyond the required minimums.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have never experienced any employment-related work stoppages
and believe our relationships with our employees are good.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc3c4986400914d87a1096086a9bf578c" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">E.</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25; font-weight: bold">Share Ownership</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;&#160;&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;&#160;&#160; &#160; &#160; &#160; &#160;&#160;&#160; For information regarding the share ownership
of our directors and executive officers, see &#8220;ITEM 6.B. Compensation-2014 Equity Incentive Plan&#8221; and &#8220;ITEM 7.A. Major
Shareholders.&#8221;</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25"><span style="font-weight: bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
F.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; <span style="font-weight: bold">Disclosure of Any Action to Recover
Erroneously Awarded Compensation</span></div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">None.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; text-indent: -54pt; margin-left: 54pt; line-height: 1.25; font-weight: bold">Item 7.&#160; <span id="Item7."><!--Anchor--></span>MAJOR
SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za9a838d1cf71419fb9cc1ef35cd2d88d" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">A.</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25; font-weight: bold">Major Shareholders</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; The following table sets forth
information with respect to the beneficial ownership of our shares as of March 15, 2024 by:</div>

<div style="line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z77ee375e5b50485b98d1fc7842dc86d1" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="line-height: 1.25">each person or entity known by us to own beneficially more than 5% of our outstanding shares;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="line-height: 1.25">each of our directors and executive officers individually; and</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="line-height: 1.25">all of our executive officers and directors as a group.</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">&#160; The beneficial ownership of ordinary shares
is determined in accordance with the rules of the SEC and generally includes any ordinary shares over which a person exercises sole or
shared voting or investment power. The percentage of shares beneficially owned is based on 9,491,718 ordinary shares issued and outstanding
as of March 15, 2024. Ordinary shares that are issuable under stock options or RSUs that are currently exercisable or exercisable within
60 days of March 15, 2024 are deemed to be outstanding and to be beneficially owned by the person holding the stock option for the purpose
of computing the number of shares and percentage ownership of that person. Those shares are not deemed outstanding, however, for the purpose
of computing the percentage ownership of any other person. All of our shareholders, including the shareholders listed below, have the
same voting rights attached to their ordinary shares. See &#8220;ITEM 10.B. Articles of Association.&#8221; None of our principal shareholders
nor our directors or executive officers possesses different or special voting rights with respect to their ordinary shares. Unless otherwise
noted below, each shareholder&#8217;s address is c/o MediWound Ltd., 42 Hayarkon Street, Yavne 8122745, Israel.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">108</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">A description of any material relationship that our principal shareholders
have had with us or any of our predecessors or affiliates within the past three years is included under &#8220;ITEM 7.B. Related Party
Transactions.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" class="cfttable" id="z9e853671c5db44c7b38cf4d360696032" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25; font-weight: bold">Name of Beneficial Owner</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Number of<br/> Shares<br/> Beneficially<br/> Held</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Percentage of<br/> Class</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25; font-style: italic; font-weight: bold">Directors
        and Executive Officers</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">
        <div style="text-align: justify; text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Nachum (Homi) Shamir <br/> </div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Ofer Gonen <br/> </div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">98,730</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1.1</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">
        <div style="text-align: justify; text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Vickie R. Driver</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">David Fox <br/> </div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">*</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">*</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">
        <div style="text-align: justify; text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Shmuel (Milky) Rubinstein <br/> </div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Stephen T. Wills <br/> </div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">*</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">*</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">
        <div style="text-align: justify; text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Shmulik Hess <br/> </div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Ety Klinger <br/> </div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">*</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">*</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">
        <div style="text-align: justify; text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Hany Luxenburg <br/> </div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Yaron Meyer <br/> </div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">*</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">*</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">
        <div style="text-align: justify; text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Robert Snyder <br/> </div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; line-height: 1.25">All executive officers and directors as a group (11 persons)(1) <br/> </div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25; font-family: Times New Roman,serif">346,126</div> </div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">3.8</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25; font-style: italic; font-weight: bold">Principal
        Shareholders (who are not Directors or Executive Officers)</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">
        <div style="text-align: justify; text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Clal Biotechnology Industries Ltd. and
        affiliates (2) <br/> </div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1,481,522</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">16.0</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Israel Biotech Fund II, L.P. and affiliates
        (3) <br/> </div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">959,652</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">9.9</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">
        <div style="text-align: justify; text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Deep Insight Limited Partnership and affiliates
        (4) <br/> </div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">959.652</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">9.9</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Point72 Associates, LLC and affiliates
        (5) <br/> </div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">821,500</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">8.9</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">
        <div style="text-align: justify; text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Rosalind Advisors, Inc. and affiliates
        (6) <br/> </div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">643,255</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">6.8</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z077290f666be47558b5a981e47b5dfdb" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">*</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Less than 1%.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z596ea5e072ba4a94bae5e75ae96ddf28" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">(1)</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Shares beneficially owned consist of 79,068 ordinary shares held directly or indirectly by such executive officers and directors
        and 267,058 ordinary shares issuable upon exercise of outstanding options that are currently exercisable or exercisable within 60 days
        of March 15, 2024.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z8e9c9a44ea824893848f1810d021adaf" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">(2)</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>
        <div style="color: #000000; font-family: Times New Roman, serif">Based solely on Schedule 13D/A filed on September 1, 2023, Clal Biotechnology
        Industries Ltd. (&#8220;CBI&#8221;) owns directly 308,811 ordinary shares, and may be deemed to share voting and investment power over
        the 1,172,710 ordinary shares owned directly by Clal Life Sciences L.P. (&#8220;CLS&#8221;), the general partner of which, Clal Application
        Center Ltd., is wholly owned by CBI. Each of Access Industries Holdings LLC (&#8220;AIH&#8221;), Access Industries, LLC (&#8220;Access
        LLC&#8221;), Access Industries Management, LLC (&#8220;AIM&#8221;), Clal Industries Ltd. (&#8220;Clal Industries&#8221;) and Mr. Blavatnik
        may be deemed to share voting and investment power over the ordinary shares owned directly by CBI and CLS because (i) Len Blavatnik controls
        AIM, AIH, Access LLC and AI International GP Limited (the general partner of AI SMS, as defined below), (ii) AIM controls Access LLC and
        AIH, (iii) Access LLC controls a majority of the outstanding voting interests in AIH, (iv) AIH owns a majority of the equity of AI SMS
        L.P. (&#8220;AI SMS&#8221;), (v) AI SMS controls AI Diversified Holdings Ltd. (&#8220;Holdings Limited&#8221;), (vi) Holdings Limited
        owns AI Diversified Parent S.&#224; r.l., which owns AI Diversified Holdings S.&#224; r.l., which owns Access AI Ltd (&#8220;Access AI&#8221;),
        (vii) Access AI wholly owns Clal Industries, (viii) Clal Industries is the controlling shareholder of CBI, and (ix) CBI is the sole shareholder
        of Clal Application Center Ltd. The Reporting Persons, other than CBI and CLS, and each of their affiliated entities and the officers,
        partners, members and managers thereof, disclaims beneficial ownership of these securities. The address of Clal Industries Ltd. is the
        Triangular Tower, 3 Azrieli Center, Tel Aviv 67023, Israel and the address of Access Industries Holdings LLC is c/o Access Industries
        Inc., 40 West 57th Street, New York, New York 10019, United States.</div> </div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">109</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z0683be02d5454650808e585a280568ef" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-family: Times New Roman,Times,serif">&#160;(3)</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Based solely on Schedule 13G/A filed on January 8, 2024, the 959,652 ordinary shares include 408,397 ordinary shares that are issuable
        upon the exercise of warrants held directly by Israel Biotech Fund II, L.P. (&#8220;IBF II&#8221;). Israel Biotech Fund GP Partners II,
        L.P. (&#8220;IBF GP&#8221;) is the sole general partner of IBF II, and I.B.F Management Ltd. (&#8220;IBF Management&#8221;) is the sole
        general partner of IBF GP. IBF GP and IBF Management may be deemed to share voting and dispositive power with respect to the ordinary
        shares that are beneficially owned by IBF II. The address IBF Management is HaOgen Tower, 4 Oppenheimer St., Rehovot 7670104, Israel and
        the address of the other reporting persons is 75 Fort Street, Clifton House, PO Box, 1350, KY1-1108, Grand Cayman.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zcf853e08c555460f8769daf74510d425" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">(4)</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Based solely on Schedule 13G/A filed on January 8, 2024, the 959,652 ordinary shares include 408,397 ordinary shares that are issuable
        upon the exercise of warrants held directly by Deep Insight Limited Partnership (&#8220;Deep Insight&#8221;). Deep Insight Fund GP Limited
        Partnership (&#8220;Deep Insight GP LP&#8221;) is the sole general partner of Deep Insight, Deep Insight GP Ltd. (&#8220;Deep Insight
        GP Company&#8221;) is the sole general partner of Deep Insight GP LP, Deep Insight Management Ltd. (&#8220;Deep Insight Management&#8221;)
        is the management company of Deep Insight GP LP and each of Barak Ben-Eliezer and Dr. Eyal Kishon hold 50% of the outstanding shares of
        Deep Insight GP Company and Deep Insight Management. Deep Insight GP LP, Deep Insight GP Company, Deep Insight Management, Barak Ben-Eliezer
        and Dr. Eyal Kishon may be deemed to share voting and dispositive power with respect to the Ordinary Shares that are beneficially owned
        by Deep Insight. Barak Ben-Eliezer and Dr. Eyal Kishon disclaim beneficial ownership of the Ordinary Shares reported by Deep Insight herein.
        The address of each of the reporting persons is 2 Rachel Imeinu St., Modiin, Israel&#160; 7177190.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">

<div style="line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-family: Times New Roman,Times,serif">&#160;(5)</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Based solely on Schedule 13G filed on January 8, 2024, Point72 Associates, LLC (&#8220;Point72 Associates&#8221;) owns 821,500 ordinary
        shares. Pursuant to an investment management agreement, Point72 Asset Management, L.P. (&#8220;Point72 Asset Management&#8221;) maintains
        investment and voting power with respect to the securities held by Point72 Associates. Point72 Capital Advisors Inc. is the general partner
        of Point72 Asset Management. Steven Cohen controls each of Point72 Asset Management and Point72 Capital Advisors Inc. The address of the
        reporting persons is 72 Cummings Point Road, Stamford, CT 06902.</div> </td> </tr>
  </table> <br/> </div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z1b41c1741d5e46bb91e93e939129be36" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">(6)</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Based solely on Schedule 13G/A filed on February 14, 2024, Rosalind Master Fund L.P. (&#8220;RMF&#8221;) is the record owner of 479,990
        shares of ordinary shares and 163,265 shares of ordinary shares issuable upon exercise of warrants. Rosalind Advisors, Inc. is the investment
        advisor to RMF and may be deemed to be the beneficial owner of shares held by RMF. Steven Salamon is the portfolio manager of Rosalind
        Advisors, Inc. and may be deemed to be the beneficial owner of shares held by RMF. Gilad Aharon is the portfolio manager and member of
        the Advisor which advises RMF. Notwithstanding the foregoing, Rosalind Advisors, Inc. and Mr. Salamon disclaim beneficial ownership of
        the shares. The address of RMF is P.O. Box 309 Ugland House, Grand Cayman KY1-1104, Cayman Islands, and the address of the rest of the
        reporting persons is 15 Wellesley Street West, Suite 326, Toronto, Ontario M4Y 0G7 Canada.</div> </td> </tr>
  </table>

<div style="line-height: 1.25; font-style: italic; font-weight: bold"><br/> Changes in Ownership of Major Shareholders</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">To our knowledge, other than as disclosed in the
table above, our other filings with the SEC and this Annual Report, there has been no significant change in the percentage ownership held
by any major shareholder since January 1, 2021, except as follows: as reported in their filings with the SEC, during 2023, CBI and its
affiliates have decreased their holdings from approximately 34% to 16.1% as a result of a dilution from the 2023 Offering t as described
in Item 5. &#8220;Operating and Financial Review and Prospects-Liquidity and Capital Resources.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Voting Rights</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The major shareholders listed above do not have voting rights with
respect to their ordinary shares that are different from the voting rights of other holders of our ordinary shares.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">110</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Change in Control Arrangements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are not aware of any arrangement that may at a subsequent date,
result in a change of control of the Company.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Registered Holders</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">As of March 15, 2024, we had one holder of record
of our ordinary shares in the United States, which is Cede &amp; Co., the nominee of The Depository Trust Company. This shareholder held
in the aggregate 82.8% of the 9,256,368 ordinary shares issued and outstanding as of March 15, 2024. The number of record holders in the
United States is not representative of the number of beneficial holders nor is it representative of where such beneficial holders are
resident since many of these ordinary shares were held by brokers or other nominees.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<table cellspacing="0" cellpadding="0" id="z1cd14755788c4e21ac9ef6e1255305fc" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">B.</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25; font-weight: bold">Related Party Transactions</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Information Rights Agreement</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have entered into an information rights agreement with CBI,
which provides CBI with certain information rights relating to our financial information of the company and certain other information
necessary for CBI to meet Israeli Securities Law requirements. CBI is not required to reimburse us for expenses we incur in providing
such information.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">2021 Registration Rights Agreement</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are party to an amended and restated registration rights agreement,
dated April 6, 2021, with certain of our shareholders (the &#8220;2021 Registration Rights Agreement&#8221;). The 2021 Registration Rights
Agreement, which was approved by our shareholders at our 2021 annual general meeting of shareholders, replaced the registration rights
agreement, dated March 3, 2014 (the &#8220;Original Registration Rights Agreement&#8221;), that we had entered into in connection with
our initial public offering with certain of our pre-IPO shareholders, which expired by its own terms on its seven-year anniversary. The
ordinary shares held by most of our pre-IPO shareholders who were party to the Original Registration Rights Agreement were no longer entitled
to registration rights under that agreement as of the time that it expired, given their ability to freely sell their shares in the open
market under Rule 144 of the Securities Act. However, each of CBI and Professor Lior Rosenberg, and their affiliated entities that hold
ordinary shares (consisting of Clal Life Sciences LP and L.R. Research &amp; Development Ltd., respectively) remained entitled to registration
rights as of the time of the expiration of the Original Registration Rights Agreement, and we therefore entered into the Registration
Rights Agreement with them as a means of extending those rights. The 2021 Registration Rights Agreement provides to the holders of our
ordinary shares that are party to the agreement the right to demand that we file a registration statement or request that their ordinary
shares be covered by a registration statement that we are otherwise filing. In May 2022, we filed, and the SEC declared effective, on
June 3, 2022, a shelf registration statement on Form F-3 that registered the resale of the 1,819,780 shares that were then entitled to
registration rights under the 2021 Registration Rights Agreement. That registration statement remains in effect as of the date of this
Annual Report. The registration rights under the 2021 Registration Rights Agreement are described in more detail in Exhibit 2.1 to this
Annual Report, which is incorporated by reference in ITEM 10.B. Articles of Association.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Founders&#8217; and Shareholders&#8217; Agreement</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; In January 2001,
we entered into a founders&#8217; and shareholders&#8217; agreement (the &#8220;Founders Agreement&#8221;), with CBI, Prof. Lior Rosenberg,
and LR, a private company which is wholly-owned by Prof. Rosenberg. The Founders Agreement was amended in 2006. Pursuant to the Founders
Agreement, in exchange for the issuance of ordinary shares and certain rights thereunder and the payment of certain fixed amounts, Prof.
Rosenberg granted to us a perpetual, exclusive, non-revocable, royalty-free, sub-licensable, worldwide license for intellectual property
relating to debridement using products based on our proteolytic enzyme technology. As of the date hereof, all of the payments under the
Founders Agreement were paid by us to Prof. Rosenberg in accordance with the Founders Agreement. The Founders Agreement also provided
for anti-dilution, pre-emptive rights, a right of first refusal on the sale of our ordinary shares and bring-along rights, all of which
were subsequently terminated. In September 2022 we entered into an additional license agreement with LR for intellectual property rights
related to the development of a synthetic hyaluronic acid polyurethane dressing for debrided and non-debrided burns. Under this license
LR received an upfront payment of $150,000.</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">111</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Agreements with Directors and Officers</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">Employment Agreements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have entered into employment agreements with each of our executive
officers, which include standard provisions for a company in our industry regarding non-competition/solicitation, confidentiality of information
and assignment of inventions. However, the enforceability of the non-competition provisions may be limited under applicable law. Our executive
officers, other than our CEO, will not receive benefits upon the termination of their respective employment with us, other than payment
of salary and benefits (and limited accrual of vacation days) during the required notice period for termination of their employment, which
varies for each individual. Our CEO, is entitled upon termination of employment (other than a termination by the Company for Cause, as
defined below), to receive a single lump-sum payment equal 6 times his salary as of the last day of employment, less deductions and withholdings
under applicable law, subject him signing a separation agreement and release of known and unknown claims in a customary form provided
by the Company.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">Options</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Since our inception, we have granted options to purchase our ordinary
shares to our directors and executive officers. Such option agreements may contain acceleration provisions upon certain merger, acquisition
or change of control transactions. We describe our option plans under &#8220;ITEM 6.B. Compensation-2003 Israeli Share Option Plan&#8221;
and &#8220;ITEM 6.B. Compensation-2014 Equity Incentive Plan.&#8221; Upon the consummation of a merger or acquisition transaction, an
executive officer&#8217;s options will be assumed or substituted by the surviving company, if applicable, or, in the compensation committee&#8217;s
sole discretion, will vest immediately or be amended, modified or terminated. Our compensation committee approved accelerated vesting
in the case of a merger or an acquisition transaction for certain of our directors and executive officers with respect to the option agreements
dated December 23, 2015, June 22, 2017, January 16, 2018, December 31, 2018, May 2, 2019, April 23, 2020, March 4, 2021 and February 15,
2023, April 3, 2023, August 15, 2023, December 1, 2023 and February 26, 2024.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">RSUs</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under the 2014 Plan, we have granted RSUs to our executive officers
and our chairman of the board. The RSU agreements generally provide for vesting of RSUs over a four-year period of continuous employment
or service, with 25% of the RSUs vesting at the lapse of one year following the vesting commencement date, and the remaining 75% of the
RSUs vesting in three equal installments, at the lapse of each of the following three years. Absent a specific acceleration provision,
if a grantee&#8217;s service is terminated for any reason, all RSUs that have not vested will immediately terminate. RSUs that have vested
but have not been settled yet for underlying ordinary shares may generally be settled within the three months following the termination
of the service of the grantee, other than in the case of termination due to death or disability (in which case the grantee or his/her
estate will have one year to settle the vested RSUs for underlying ordinary shares) or termination for cause (in which case all unsettled
RSUs will immediately terminate). Upon the consummation of a merger or acquisition transaction, an executive officer&#8217;s or the chairman&#8217;s
RSUs will be assumed or substituted by the surviving company, if applicable, or, in the compensation committee&#8217;s sole discretion,
will vest immediately or be amended, modified or terminated. The RSUs that we grant may contain acceleration provisions upon certain merger,
acquisition or change of control transactions, if approved by our board of directors with respect to a specific grant. The RSUs are generally
subject to the further terms of the 2014 Plan, which we describe under &#8220;ITEM 6.B. Compensation-2014 Equity Incentive Plan.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">Exculpation, indemnification and insurance</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our articles of association permit us to exculpate, indemnify and
insure each of our directors and office holders to the fullest extent permitted by the Israeli Companies Law. Additionally, we have entered
into indemnification agreements with each of our directors and executive officers, undertaking to indemnify them to the fullest extent
permitted by Israeli law, including with respect to liabilities resulting from a public offering of our shares, to the extent that these
liabilities are not covered by insurance. We have also obtained Directors and Officers insurance for each of our executive officers and
directors. See &#8220;ITEM 6.C. Board Practices-Exculpation, Insurance and Indemnification of Directors and Officers.&#8221;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">112</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z1695823275e54ef497c40b1066b6d739" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25"><br/> </div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">C.</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Interests of Experts and Counsel</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">None.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zca0272465fee46d5bc5374e31032038b" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Item 8.<span id="tem8."><!--Anchor--></span></div> </td>
    <td style="width: 97%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">FINANCIAL INFORMATION</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" id="z94ab2a7f91e84e6c9dd7498e506f4791" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">A.</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Consolidated Statements and Other Financial Information</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-weight: bold">Consolidated Financial Statements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">See Item 18. &#8220;Financial Statements&#8221;.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Legal and Arbitration Proceedings</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">From time to time, we may be party to litigation or subject to
claims incident to the ordinary course of business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">Settlement of Litigation Involving Our Company
and Teva</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under a previously reported settlement agreement, as amended, we
were obligated to pay Teva $10.2 million, of which twelve quarterly equal installments were paid from January 1, 2021 until December 31,
2023. In addition, commencing on January 1, 2021, we agreed to pay Teva an aggregate annual amount of $1 million in four quarterly equal
installments, unless we do not recognize any revenues generated from the sale or license of NexoBrid in any such quarter, up to an aggregate
amount equal to $7.2 million regardless of the number of quarters required for purposes of the payment of such aggregate amount. We also
agreed to indemnify Teva and its controlled affiliates from and against claims relating to a certain milestone related to PolyHeal under
an agreement associated with our collaboration agreements with Teva, for up to an amount of $10.2 million, if a notice of such claim had
been received by us prior to December 31, 2023, however, no notice of a claim was received by such date and therefore the indemnification
rights under this settlement agreement expired.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Dividend Policy</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have never declared or paid cash dividends to our shareholders
and we do not intend to pay cash dividends in the foreseeable future. We intend to reinvest any earnings in developing and expanding our
business. Any future determination relating to our dividend policy will be at the discretion of our board of directors and will depend
on a number of factors, including future earnings, our financial condition, operating results, contractual restrictions, capital requirements,
business prospects, our strategic goals and plans to expand our business, applicable law and other factors that our board of directors
may deem relevant.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf3ea20d81a8042bc928e6aa42176ff7e" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">B.</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Significant Changes</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">No significant changes have occurred since December 31, 2022, except
as otherwise disclosed in this annual report.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">113</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zfa6610dea71541eb90dc318115243797" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="vertical-align: top; width: 3%">
        <div style="line-height: 1.25; font-weight: bold"><span id="Item9."><!--Anchor--></span>Item 9.</div> </td>
    <td style="width: 97%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">THE OFFER AND LISTING</div> </td> </tr>
  </table>

<div><br/> </div>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">A.</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Listing Details</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our ordinary shares trade on the Nasdaq Global Market under the
symbol &#8220;MDWD&#8221;.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd74d7744528447cf895f79eafebe824b" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25"><br/> </div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">B.</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Plan of Distribution</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 36pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd9385572835c4fefbfbd289735ff8c6a" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">C.</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Markets</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 36pt; line-height: 1.25">See &#8220;-Listing Details&#8221; above.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze895ad41d98c4fd485fa3c7c738aa4a9" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">D.</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Selling Shareholders</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 36pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z419846da5fd045568f6c91f827c48162" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">E.</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Dilution</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 36pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za2e9a3ec779947be9bc20c9b45ef94b0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">F.</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Expenses of the Issue</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="margin-left: 36pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td rowspan="1" style="width: 3%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Item 10. ADDITIONAL INFORMATION</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zd61e62c75d354f5f96278eec728928e3" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">A.</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Share Capital</div> </td> </tr>
  </table>

<div style="margin-left: 36pt; line-height: 1.25"><br/> </div>

<div style="margin-left: 36pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z51e0fe3320214a1489a8362534135393" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">B.</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Articles of Association</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">A copy of our amended and restated articles of association is attached
as Exhibit 1.1 to this Annual Report. Other than as disclosed below, the information called for by this Item is set forth in Exhibit 2.1
to this Annual Report on Form 20-F, which information is incorporated by reference into this Item 10.B. of this annual report.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zcb48eb551b4541bca1cb878abd3d400d" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25"><br/> </div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">C.</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Material Contracts</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">"Except described below or otherwise described in this annual report
in Item 4.A &#8220;History and Development of the Company&#8221;, Item 4.B &#8220;Business Overview&#8221;, &#8220;Item 5.B 'Operating
and Financial Review and Prospects&#8212;Liquidity and Capital Resources&#8221;, Item 6.C &#8220;Board Practices&#8221; and Item 7.B &#8220;Related
Party Transactions&#8221;, we are not currently, nor have we been for the two years immediately preceding the date of this Annual Report,
party to any material contract other than contracts entered into in the ordinary course of business."</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">114</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">For a description of the registration rights that are subject to
our 2021 Registration Rights Agreement, see &#8220;Item 7.B. Related Party Transactions &#8211; 2021 Registration Rights Agreement.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">For a description of our exclusive license and supply agreements
with Vericel, see &#8220;Item 4.B. Business Overview- Marketing, Sales and Distribution-<span style="font-weight: bold; font-style: italic">&#160;</span>Vericel
License and Supply Agreements.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">For a description of our license agreement with Mark Klein, see
&#8220;Item 4.B. Business Overview-Intellectual Property-Klein License Agreement.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have entered into an agreement with Challenge Bioproducts Corporation
Ltd. (&#8220;CBC&#8221;), a corporation organized and existing under the laws of the Republic of China, dated January 11, 2001, as amended
on February 28, 2010, pursuant to which CBC uses proprietary methods to manufacture bromelain SP and supplies us with this intermediate
drug substance in bulk quantities. According to the terms of the agreement, CBC shall not, and shall not permit related companies or a
third party to, manufacture, use, supply or sell the raw materials for the use or production of a product directly or indirectly competing
with any of our products. Our supply agreement with CBC has no fixed expiration date and can be voluntarily terminated by us, with at
least six months&#8217; advance written notice, or by CBC, with at least 24 months&#8217; advance written notice.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">For a description of the main lease agreement, see &#8220;Item
4. Properties.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">For a description of the turnkey scale-up agreement with Biopharmax
Group Ltd., see &#8220;Item 4. Properties.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">2022 Registration Rights Agreement</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In connection with the PIPE Offering (as described in &#8220;ITEM
5. Operating and Financial Review and Prospects&#8212; B. Liquidity and Capital Resources&#8221;), in October 2022, we entered into a
registration rights agreement with the several investors named in the PIPE Securities Purchase Agreement (the &#8220;2022 Registration
Rights Agreement&#8221;). Pursuant to the 2022 Registration Rights Agreement, within 45 calendar days of the date of the closing of the
PIPE, we were required to file a registration statement to register for resale of (i) Pre-Funded Warrant Shares, (ii) the PIPE Ordinary
Warrant Shares and (iii) the RD Ordinary Share Warrant (together, the &#8220;Registrable Securities&#8221;). Pursuant to the 2022 Registration
Rights Agreement, we agreed to cause such registration statement to be declared effective under the Securities Act of 1933, as amended
(the &#8220;Securities Act&#8221;), as promptly as possible after the filing thereof, but in any event no later 75 days, or in the event
of a full review by the SEC, 110 days, after the closing date of the PIPE. We further agreed to use our best efforts to keep such registration
statement continuously effective under the Securities Act until the date that all Registrable Securities covered by such registration
statement have been sold or otherwise may be sold pursuant to Rule 144 under the Securities Act. On November 10, 202, we filed a registration
statement on Form F-1 pursuant to our obligations under the 2022 Registration Rights Agreement, which became effective on November 25,
2022.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zee9b3ba2a0bb4344a066f31a48b4ae4c" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">D.</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Exchange Controls</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#160;In 1998, Israeli currency control regulations were liberalized
significantly, so that Israeli residents generally may freely deal in foreign currency and foreign assets, and non-residents may freely
deal in Israeli currency and Israeli assets. There are currently no Israeli currency control restrictions on remittances of dividends
on the ordinary shares or the proceeds from the sale of the shares provided that all taxes were paid or withheld; however, legislation
remains in effect pursuant to which currency controls can be imposed by administrative action at any time.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Non-residents of Israel may freely hold and trade our securities.
Neither our articles of association nor the laws of the State of Israel restrict in any way the ownership or voting of ordinary shares
by non-residents, except that such restrictions may exist with respect to citizens of countries which are in a state of war with Israel.
Israeli residents are allowed to purchase our ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf90c54ca5c8e41959d2c3f70bb6ed8a9" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3%; vertical-align: middle">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">E.</div> </td>
    <td style="width: 93%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Taxation</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The following description is not intended to constitute a complete
analysis of all tax consequences relating to the acquisition, ownership and disposition of our ordinary shares. You should consult your
own tax advisor concerning the tax consequences of your particular situation, as well as any tax consequences that may arise under the
laws of any state, local, foreign or other taxing jurisdiction.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">115</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Israeli Tax Considerations for Our Shareholders</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Capital gains taxes applicable to non&#8209;Israeli resident shareholders</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">A non&#8209;Israeli resident (whether an individual or a corporation)
who derives capital gains from the sale of shares in an Israeli resident company that were purchased after the company was listed for
trading on the Tel Aviv Stock Exchange or on a recognized stock exchange outside of Israel, will generally be exempt from Israeli capital
gain tax so long as the shares were not held through a permanent establishment that the non&#8209;resident maintains in Israel (and with
respect to shares listed on a recognized stock exchange outside of Israel, so long as the particular capital gain is otherwise subject
to the Israeli Income Tax Law (Inflationary Adjustments) 5745&#8209;1985. These provisions dealing with capital gain are not applicable
to a person whose gains from selling or otherwise disposing of the shares are deemed to be business income. However, non&#8209;Israeli
corporations will not be entitled to the foregoing exemption if Israeli residents (i) have a controlling interest of more than 25% in
such non&#8209;Israeli corporation or (ii) are the beneficiaries of, or are entitled to, 25% or more of the revenues or profits of such
non&#8209;Israeli corporation, whether directly or indirectly.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">If not exempt, a non-Israeli resident shareholder would generally
be subject to tax on capital gain at the ordinary corporate tax rate (23% in 2023), if generated by a company, or at the rate of 25%,
if generated by an individual, or 30%, if generated by an individual who is a &#8220;substantial shareholder&#8221; (as defined under
the Tax Ordinance), at the time of sale or at any time during the preceding 12-month period (or if the shareholder claims a deduction
for interest and linkage differences expenses in connection with the purchase and holding of such shares). A &#8220;substantial shareholder&#8221;
is generally a person who alone or together with such person&#8217;s relative or another person who collaborates with such person on a
permanent basis, holds, directly or indirectly, at least 10% of any of the &#8220;means of control&#8221; of the corporation. &#8220;Means
of control&#8221; generally include, among others, the right to vote, receive profits, nominate a director or an executive officer, receive
assets upon liquidation, or order someone who holds any of the aforesaid rights how to act, regardless of the source of such right. Individual
and corporate shareholders dealing in securities in Israel are taxed at the tax rates applicable to business income (a corporate tax rate
for a corporation (23% in 2023) and a marginal tax rate of up to 47% for an individual in 2023 (excluding excess tax as discussed below))
unless contrary provisions in a relevant tax treaty apply.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Additionally, a sale of shares by a non&#8209;Israeli resident
may also be exempt from Israeli capital gains tax under the provisions of an applicable tax treaty. For example, under the Convention
Between the Government of the United States of America and the Government of the State of Israel with respect to Taxes on Income, as amended
(the &#8220;United States&#8209;Israel Tax Treaty&#8221;), the sale, exchange or other disposition of shares by a shareholder who is a
United States resident (for purposes of the United States&#8209;Israel Tax Treaty) holding the shares as a capital asset and is entitled
to claim the benefits afforded to such a resident by the United States&#8209;Israel Tax Treaty (a &#8220;Treaty U.S. Resident&#8221;)
is generally exempt from Israeli capital gains tax unless: (i) the capital gain arising from such sale, exchange or disposition is attributed
to real estate located in Israel; (ii) the capital gain arising from such sale, exchange or disposition is attributed to royalties; (iii)
the capital gain arising from the such sale, exchange or disposition can be attributable to a permanent establishment of the shareholder
maintained in Israel, under certain terms; (iv) such Treaty U.S. Resident holds, directly or indirectly, shares representing 10% or more
of the voting capital of a company during any part of the 12&#8209;month period preceding such sale, exchange or disposition, subject
to certain conditions; or (v) such Treaty U.S. Resident is an individual and was present in Israel for a period or periods aggregating
to 183 days or more during the relevant taxable year. In each case, the sale, exchange or disposition of our ordinary shares would be
subject to such Israeli tax, to the extent applicable; However, under the United States&#8209;Israel Tax Treaty, such Treaty U.S. Resident
would be permitted to claim a credit for such taxes against the U.S. federal income tax imposed with respect to such sale, exchange or
disposition, subject to the limitations in U.S. laws applicable to foreign tax credits. The United States-Israel Tax Treaty does not provide
such credit against any U.S. state or local taxes. In some instances where our shareholders may be liable for Israeli tax on the sale
of their ordinary shares, the payment of the consideration may be subject to the withholding of Israeli tax at source. Shareholders may
be required to demonstrate that they are exempt from tax on their capital gains in order to avoid withholding at source at the time of
sale. Specifically, in transactions involving a sale of all of the shares of an Israeli resident company, in the form of a merger or otherwise,
the Israel Tax Authority may require from shareholders who are not liable for Israeli tax to sign declarations in forms specified by this
authority or obtain a specific exemption from the Israel Tax Authority to confirm their status as non&#8209;Israeli resident, and, in
the absence of such declarations or exemptions, may require the purchaser of the shares to withhold taxes at source.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">116</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Taxation of non&#8209;Israeli shareholders on receipt of dividends</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Non&#8209;Israeli residents (whether individuals or corporations)
are generally subject to Israeli income tax on the receipt of dividends paid on our ordinary shares at the rate of 25% unless a relief
is provided in a treaty between Israel and a shareholder's country of residence (provided that a valid certificate from the Israeli Tax
Authority allowing for a reduced withholding tax rate is obtained in advance). With respect to a person who is a &#8220;substantial shareholder&#8221;
at the time of receiving the dividend or on any time during the preceding 12 months, the applicable tax rate is 30%. Such dividends are
generally subject to Israeli withholding tax at a rate of 25% so long as the shares are registered with a nominee company (whether or
not the recipient is a substantial shareholder), unless relief is provided in a treaty between Israel and the shareholder&#8217;s country
of residence and provided that a valid certificate from the Israel Tax Authority allowing for a reduced withholding tax rate is obtained
in advance. However, a distribution of dividends to non&#8209;Israeli residents is generally subject to withholding tax at source at a
rate of 15% if the dividend is distributed from income attributed to a Beneficiary Enterprise, or such a reduced tax rate as may be provided
under an applicable tax treaty (provided that a valid certificate from the Israel Tax Authority allowing for a reduced withholding tax
rate or such lower tax rate as may be provided in an applicable tax treaty is obtained in advance). For example, under the United States&#8209;Israel
Tax Treaty, the maximum rate of tax withheld at source in Israel on dividends paid to a holder of our ordinary shares who is a Treaty
U.S. Resident is 25%. However, generally, the maximum rate of withholding tax on dividends, not generated by an Approved Enterprise or
Beneficiary Enterprise, that are paid to a U.S. corporation holding 10% or more of the outstanding voting capital throughout the tax year
in which the dividend is distributed as well as during the previous tax year, is 12.5%, provided that not more than 25% of the gross income
for such preceding year consists of certain types of dividends and interest. Notwithstanding the foregoing, dividends distributed from
income attributed to an Approved Enterprise or Beneficiary Enterprise are not entitled to such reduction under the tax treaty but are
subject to a withholding tax rate of 15% for such a U.S. corporation, provided that the condition related to our gross income for the
previous year (as set forth in the previous sentence) is met. The aforementioned rates under the United States-Israel Tax Treaty would
not apply if the dividend income is derived through a permanent establishment of the U.S. resident in Israel. If the dividend is attributable
partly to income derived from an Approved Enterprise, Beneficiary Enterprise or Preferred Enterprise, and partly to other sources of income,
the withholding rate will be a blended rate reflecting the relative portions of the two types of income. We cannot assure you that we
will designate the profits that we may distribute in a way that will reduce shareholders&#8217; tax liability.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">A non&#8209;Israeli resident who receives dividends from which
tax was withheld, is generally exempt from the obligation to file tax returns in Israel with respect to such income, provided that (i)
such income was not derived from a business conducted in Israel by the taxpayer, (ii) the taxpayer has no other taxable sources of income
in Israel with respect to which a tax return is required to be filed and (iii) the tax payer is not obligated to pay the excess tax (as
further explained below).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Excess Tax</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Individuals who are subject to tax in Israel (whether any such
individual is an Israeli resident or non-Israeli resident) are also subject to an additional tax at a rate of 3% on annual income exceeding
a certain level, which amount is linked to the annual change in the Israeli consumer price index, including but not limited to, dividends,
interest and capital gain. In 2023, the additional tax was at a rate of 3% on annual income exceeding NIS 698,280.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">117</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">United States Federal Income Taxation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The following is a description of the material U.S. federal income
tax consequences of the ownership and disposition of our ordinary shares by a U.S. Holder that holds the ordinary shares as capital assets.
This description does not address tax considerations applicable to holders that may be subject to special tax rules, including, without
limitation:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zac0792b522014a4fabd2338930e98980" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">banks, financial institutions or insurance companies;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">real estate investment trusts, regulated investment companies or grantor trusts;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">dealers or traders in securities, commodities or currencies;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">tax&#8209;exempt entities or organizations, including an &#8220;individual retirement
        account&#8221; or &#8220;Roth IRA&#8221; as defined in Section 408 or 408A of the Code, respectively;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">certain former citizens or long&#8209;term residents of the United States;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">persons that received our shares as compensation for the performance of services;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">persons that holds our shares as part of a &#8220;hedging,&#8221; &#8220;integrated&#8221;
        or &#8220;conversion&#8221; transaction or as a position in a &#8220;straddle&#8221; for U.S. federal income tax purposes;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">partnerships (including entities classified as partnerships for U.S. federal income
        tax purposes) or other pass&#8209;through entities, or holders that will hold our shares through such an entity;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">S corporations;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">holders that acquired ordinary shares as a result of holding or owning our preferred
        shares;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">U.S. Holders (as defined below) whose &#8220;functional currency&#8221; is not the
        U.S. dollar;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">persons that are residents of ordinarily resident in or have a permanent establishment
        in a jurisdiction outside the United States; or</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">holders that own directly, indirectly or through attribution 10.0% or more of the
        voting power or value of our shares.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Moreover, this description does not address the U.S. federal estate,
gift or alternative minimum tax consequences, Medicare consequences, or any state, local or foreign tax consequences, of the ownership
and disposition of our ordinary shares.<br/> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">118</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">This summary is based on the Internal Revenue Code of 1986, as
amended (the &#8220;Code&#8221;), administrative pronouncements, judicial decisions and final, temporary and proposed Treasury regulations,
all as currently in effect and available. These authorities are subject to change or differing interpretation, possibly with retroactive
effect. U.S. Holders should consult their tax advisors concerning the U.S. federal, state, local and foreign tax consequences of owning
and disposing of our ordinary shares in their particular circumstances. For purposes of this summary, a &#8220;U.S. Holder&#8221; is a
beneficial owner of our ordinary shares who is, for U.S. federal income tax purposes:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z032da4de4c2d433abd6de476f122e5c0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">an individual who is a citizen or individual resident of the United States;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">a corporation, or other entity taxable as a corporation for U.S. federal income tax
        purposes, created or organized in or under the laws of the United States, any state thereof, or the District of Columbia;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">an estate, the income of which is subject to U.S. federal income taxation regardless
        of its source; or</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">a trust that (1) is subject to the primary supervision of a U.S. Court and one or
        more U.S. persons that have the authority to control all substantial decisions of the trust or (2) has a valid election in effect under
        applicable Treasury regulations to be treated as a U.S. person.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">If a partnership (or other entity treated as a partnership for
U.S. federal income tax purposes) holds our ordinary shares, the tax treatment of a partner in such partnership generally will depend
upon the status of the partner and upon the activities of the partnership. Investors who are partners in a partnership should consult
their tax advisors as to the particular U.S. federal income tax consequences of owning and disposing of our ordinary shares in their particular
circumstances.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">A &#8220;Non&#8209;U.S. Holder&#8221; is a beneficial owner of
our ordinary shares that is neither a U.S. Holder nor a partnership for U.S. federal income tax purposes.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Unless otherwise indicated, this discussion assumes that the company
is not, and will not become, a &#8220;passive foreign investment company,&#8221; or a PFIC, for U.S. federal income tax purposes. See
&#8220;ITEM 10.E. Taxation-United States Federal Income Taxation-Passive Foreign Investment Company Considerations&#8221; below. Further,
this summary does not address the U.S. federal estate and gift, state, local or non&#8209;U.S. tax consequences to U.S. Holders of owning
and disposing of our ordinary shares. Investors should consult their own tax advisors regarding the U.S. federal, state and local, as
well as non&#8209;U.S. income and other tax consequences of owning and disposing of our ordinary shares in their particular circumstances.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Distributions</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">If you are a U.S. Holder, the gross amount of any
distribution made to you with respect to our ordinary shares before reduction for any Israeli taxes withheld therefrom, other than certain
distributions, if any, of our ordinary shares distributed pro rata to all our shareholders, generally will be includible in your income
as dividend income to the extent such distribution is paid out of our current or accumulated earnings and profits as determined under
U.S. federal income tax principles. We do not expect to maintain calculations of our earnings and profits under U.S. federal income tax
principles. Therefore, if you are a U.S. Holder you should expect that the entire amount of any distribution generally will be taxable
as dividend income to you. Non&#8209;corporate U.S. Holders may qualify for the lower rates of taxation with respect to dividends on ordinary
shares applicable to long&#8209;term capital gains (i.e., gains from the sale of capital assets held for more than one year), provided
that certain conditions are met, including certain holding period requirements and the absence of certain risk reduction transactions.
However, such dividends will not be eligible for the dividends received deduction generally allowed to corporate U.S. Holders. If you
are a U.S. Holder, dividends paid to you with respect to our ordinary shares will generally be treated as foreign source income, which
may be relevant in calculating your foreign tax credit limitation. Subject to certain conditions and limitations, Israeli tax withheld
on dividends may be deducted from your taxable income or credited against your U.S. federal income tax liability. The limitation on foreign
taxes eligible for credit is calculated separately with respect to specific classes of income. For this purpose, dividends that we distribute
generally should constitute &#8220;passive category income.&#8221; A foreign tax credit for foreign taxes imposed on distributions may
be denied if you do not satisfy certain minimum holding period requirements. Applicable U.S. Treasury Regulations have imposed additional
requirements that must be met for a foreign tax to be creditable, <span style="color: #212529">depending on the nature of such foreign
tax, although temporary relief from the application of certain aspects of these Regulations has been provided until new guidance or regulations
are issued</span>. The rules relating to the determination of the foreign tax credit are complex, and you should consult your tax advisor
to determine whether and to what extent you will be entitled to this credit.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Subject to the discussion below under &#8220;-Backup Withholding
Tax and Information Reporting Requirements,&#8221; if you are a Non&#8209;U.S. Holder, you generally will not be subject to U.S. federal
income (or withholding) tax on dividends received by you on your ordinary shares, unless you conduct a trade or business in the United
States and such income is effectively connected with that trade or business (or, if required by an applicable income tax treaty, the dividends
are attributable to a permanent establishment or fixed base that such holder maintains in the United States).</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">119</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Sale, Exchange or Other Taxable Disposition
of Ordinary Shares</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">If you are a U.S. Holder, you generally will recognize
gain or loss on the sale, exchange or other taxable disposition of our ordinary shares equal to the difference between the amount realized
on such sale, exchange or other taxable disposition and your adjusted tax basis in our ordinary shares, and such gain or loss will be
capital gain or loss. The initial tax basis in an ordinary share generally will be equal to the cost of such ordinary share. Except with
respect to foreign currency gain or loss, if you are a non&#8209;corporate U.S. Holder, capital gain from the sale, exchange or other
taxable disposition of ordinary shares is generally eligible for a preferential rate of taxation applicable to capital gains, if your
holding period for such ordinary shares exceeds one year (i.e., such gain is long&#8209;term capital gain). The deductibility of capital
losses for U.S. federal income tax purposes is subject to limitations under the Code. Any such gain or loss that a U.S. Holder recognizes
generally will be treated as U.S. source income or loss for foreign tax credit limitation purposes. Because a U.S. Holder may use foreign
tax credits against only the portion of United States federal income tax liability that is attributed to foreign source income in the
same category, a U.S. Holder&#8217;s ability to utilize a foreign tax credit with respect to the foreign tax imposed on any such sale
or other taxable disposition, if any, may be significantly limited.<span style="font-family: Calibri, sans-serif; font-size: 11pt">&#160;</span>Applicable
U.S. Treasury Regulations further restrict the availability of any such credit. However, a recent notice from the IRS indicates that the
U.S. Department of the Treasury and the IRS are considering proposing amendments to such Regulations and allows, subject to certain conditions,
taxpayers to defer the application of many aspects of such Regulations for taxable years beginning on or after December 28, 2021 and ending
before the date that a notice or other guidance withdrawing or modifying the temporary relief is issued (or any later date specified in
such notice or other guidance).</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Subject to the discussion below under &#8220;-Backup Withholding
Tax and Information Reporting Requirements,&#8221; if you are a Non&#8209;U.S. Holder, you generally will not be subject to U.S. federal
income or withholding tax on any gain realized on the sale or exchange of such ordinary shares unless:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd34f070990fc458785cdaea4db9c1ba4" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">such gain is effectively connected with your conduct of a trade or business in the
        United States (or, if required by an applicable income tax treaty, the gain is attributable to a permanent establishment or fixed base
        that such holder maintains in the United States); or</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">you are an individual and have been present in the United States for 183 days or more
        in the taxable year of such sale or exchange and certain other conditions are met.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Passive Foreign Investment Company Considerations</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">If we were to be classified as a &#8220;passive foreign investment
company,&#8221; or &#8220;PFIC,&#8221; in any taxable year, a U.S. Holder would be subject to special rules generally intended to reduce
or eliminate any benefits from the deferral of U.S. federal income tax that a U.S. Holder could derive from investing in a non&#8209;U.S.
company that does not distribute all of its earnings on a current basis.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">A non&#8209;U.S. corporation will be classified as a PFIC for federal
income tax purposes in any taxable year in which, after applying certain look&#8209;through rules with respect to the income and assets
of subsidiaries, either:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8349e3ccef024f4e836ce87be8a5c1e6" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">at least 75% of its gross income is &#8220;passive income&#8221;; or</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">at least 50% of the average quarterly value of its total gross assets (which may be
        determined in part by the market value of our ordinary shares, which is subject to change) is attributable to assets that produce &#8220;passive
        income&#8221; or are held for the production of passive income.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Passive income for this purpose generally includes dividends, interest,
royalties, rents, gains from commodities and securities transactions, the excess of gains over losses from the disposition of assets which
produce passive income, and includes amounts derived by reason of the temporary investment of funds raised in offerings of our ordinary
shares. If a non&#8209;U.S. corporation owns at least 25% by value of the stock of another corporation, the non&#8209;U.S. corporation
is treated for purposes of the PFIC tests as owning its proportionate share of the assets of the other corporation and as receiving directly
its proportionate share of the other corporation&#8217;s income. If we are classified as a PFIC in any year with respect to which a U.S.
Holder owns our ordinary shares, we will continue to be treated as a PFIC with respect to such U.S. Holder in all succeeding years during
which the U.S. Holder owns our ordinary shares unless we cease to be a PFIC and the U.S. holder has made a &#8220;deemed sale&#8221; election
under the PFIC rules.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">120</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">Based on our current estimates of our gross income
and the estimated fair market value of our gross assets and the nature of our business, we do not believe we were classified as a PFIC
for the taxable year ending December 31, 2023. However, we must determine our PFIC status annually based on tests which are factual in
nature, and our status in future years will depend on our income, assets and activities in those years. Further, because the value of
our gross assets is likely to be determined in large part by reference to our market capitalization, a decline in the value of our ordinary
shares or an increase in the value of our passive assets (including cash and short term investments) may result in our becoming a PFIC.
There can be no assurance that we will not be considered a PFIC for any taxable year. If we were a PFIC and you are a U.S. Holder, then
unless you make one of the elections described below, a special tax regime will apply to both (a) any &#8220;excess distribution&#8221;
by us to you (generally, your ratable portion of distributions in any year which are greater than 125% of the average annual distribution
received by you in the shorter of the three preceding years or your holding period for our ordinary shares) and (b) any gain realized
on the sale or other disposition of the ordinary shares. Under this regime, any excess distribution and realized gain will be treated
as ordinary income and will be subject to tax as if (a) the excess distribution or gain had been realized ratably over your holding period,
(b) the amount deemed realized in each year had been subject to tax in each year of that holding period at the highest marginal rate for
such year (other than income allocated to the current period or any taxable period before we became a PFIC, which would be subject to
tax at the U.S. Holder&#8217;s regular ordinary income rate for the current year and would not be subject to the interest charge discussed
below) and (c) the interest charge generally applicable to underpayments of tax had been imposed on the taxes deemed to have been payable
in those years. In addition, dividend distributions made to you will not qualify for the lower rates of taxation applicable to long&#8209;term
capital gains discussed above under &#8220;Distributions.&#8221; Certain elections may be available that would result in an alternative
treatment (such as mark&#8209;to&#8209;market treatment) of our ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">If a U.S. Holder makes a valid mark&#8209;to&#8209;market election
for the first tax year in which such U.S. Holder holds (or is deemed to hold) ordinary shares in a corporation and for which such corporation
is determined to be a PFIC, the U.S. Holder generally will recognize as ordinary income any excess of the fair market value of the ordinary
shares at the end of each taxable year over their adjusted tax basis, and will recognize an ordinary loss in respect of any excess of
the adjusted tax basis of the ordinary shares over their fair market value at the end of the taxable year (but only to the extent of the
net amount of income previously included as a result of the mark&#8209;to&#8209;market election). If a U.S. Holder makes the election,
the U.S. Holder&#8217;s tax basis in the ordinary shares will be adjusted to reflect these income or loss amounts. Any gain recognized
on the sale or other disposition of ordinary shares in a year when we are a PFIC will be treated as ordinary income and any loss will
be treated as an ordinary loss (but only to the extent of the net amount of income previously included as a result of the mark&#8209;to&#8209;market
election). The mark&#8209;to&#8209;market election is available only if we are a PFIC and our ordinary shares are &#8220;regularly traded&#8221;
on a &#8220;qualified exchange.&#8221; Our ordinary shares will be treated as &#8220;regularly traded&#8221; in any calendar year in which
more than a de minimis quantity of the ordinary shares, are traded on a qualified exchange on at least 15 days during each calendar quarter.
Nasdaq is a qualified exchange for this purpose and, consequently, if the ordinary shares are regularly traded, the mark&#8209;to&#8209;market
election will be available to a U.S. Holder. If we are a PFIC, the general tax treatment for U.S. Holders described in this section would
apply to indirect distributions and gains deemed to be realized by U.S. Holders in respect of any entity in which we hold equity that
is also a PFIC (a "lower tier PFIC"). Because a mark&#8209;to&#8209;market election generally would not be available with respect to any
lower&#8209;tier PFICs, a U.S. Holder may continue to be subject to the PFIC rules with respect to such holder&#8217;s indirect interest
in any investments held by us that are treated as an equity interest in such lower-tiers PFICs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We do not intend to provide the information necessary for U.S.
Holders to make qualified electing fund elections if we are classified as a PFIC. U.S. Holders should consult their tax advisors to determine
whether any of these elections would be available and if so, what the consequences of the alternative treatments would be in their particular
circumstances.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">If a U.S. Holder owns ordinary shares during any year in which
we are a PFIC, the U.S. Holder generally will be required to file an IRS Form 8621 (Information Return by a Shareholder of a Passive Foreign
Investment Company or Qualified Electing Fund) or successor form with respect to the company, generally with the U.S. Holder&#8217;s federal
income tax return for that year. If the company was a PFIC for a given taxable year, then you should consult your tax advisor concerning
your annual filing requirements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">U.S. Holders should consult their tax advisors regarding whether
we are a PFIC and the potential application of the PFIC rules.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">121</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Backup Withholding Tax and Information Reporting
Requirements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">U.S. backup withholding tax and information reporting requirements
may apply to certain payments to certain holders of stock. Information reporting generally will apply to distributions on, and to proceeds
from the sale, exchange or redemption of, our ordinary shares made within the United States, or by a United States payor or United States
middleman, to a holder of our ordinary shares, other than an exempt recipient (including a payee that is not a United States person that
provides an appropriate certification and certain other persons). Payments made (and sales or other dispositions effected at an office)
outside the U.S. will be subject to information reporting in limited circumstances. A payor will be required to withhold backup withholding
tax from any payments of dividends on, or the proceeds from the sale or redemption of, ordinary shares within the United States, or by
a United States payor or United States middleman, to a holder, other than an exempt recipient, if such holder fails to furnish its correct
taxpayer identification number or otherwise fails to comply with, or establish an exemption from, such backup withholding tax requirements,
or to report dividends required to be shown on the holder&#8217;s U.S. federal income tax returns. Back up withholding is not an additional
tax. Any amounts withheld under the backup withholding rules will be allowed as a credit against the beneficial owner&#8217;s U.S. federal
income tax liability, if any, and any excess amounts withheld under the backup withholding rules may be refunded, provided that the required
information is timely furnished to the IRS.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Foreign Asset Reporting</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Certain U.S. Holders who are individuals and certain entities may
be required to report information relating to an interest in our ordinary shares, subject to certain exceptions (including an exception
for shares held in accounts maintained by certain financial institutions) by filing IRS Form 8938 (Statement of Specified Foreign Financial
Assets) with their federal income tax return. U.S. Holders are urged to consult their tax advisors regarding their information reporting
obligations, if any, with respect to their ownership and disposition of our ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25"><span style="font-weight: bold">F.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
<span style="font-weight: bold">Dividends and Paying Agents</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25"><span style="font-weight: bold">G.</span>&#160;<span style="font-weight: bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Statement by Experts</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25"><span style="font-weight: bold">H.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
<span style="font-weight: bold">Documents on Display</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are required to make certain filings with the SEC. The SEC maintains
an internet website that contains reports, proxy statements and other information about issuers, like us, that file electronically with
the SEC. The address of that site is www.sec.gov.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We also make available on our website, free of charge, our annual
reports on Form 20-F and the text of our reports on Form 6-K, including any amendments to these reports, as well as certain other SEC
filings, as soon as reasonably practicable after they are electronically filed with or furnished to the SEC. Our website address is www.mediwound.com.
The information contained on our website is not incorporated by reference in this document.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25"><span style="font-weight: bold">I.</span>&#160;<span style="font-weight: bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Subsidiary Information</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25"><span style="font-weight: bold">J.</span>&#160;<span style="font-weight: bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Annual Report to Security Holders</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">Not Applicable.</div>

<div style="text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">122</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Item 11. <span id="Item11."><!--Anchor--></span>QUANTITATIVE AND QUALITATIVE DISCLOSURES
ABOUT MARKET RISK</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are exposed to a variety of risks, including foreign currency
exchange fluctuations, changes in interest rates and inflation. We regularly assess currency, interest rate and inflation risks to minimize
any adverse effects on our business as a result of those factors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Foreign Currency Risk</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The U.S. dollar is our functional and reporting currency. A significant
portion of our operating expenses are denominated in Israeli shekels, accounting for approximately 45%, 45% and 44% of our operating expenses
in the years ended December 31, 2023, 2022 and 2021, respectively. We also have expenses in other non&#8209;dollar currencies, in particular
the Euro, and for the next few years, we expect that a substantial portion of our revenues will be denominated in U.S dollar. A devaluation
of the shekel in relation to the U.S. dollar has the effect of reducing the U.S. dollar amount of our expenses or payables that are payable
in shekels, unless those expenses or payables are linked to the U.S. dollar. Conversely, any increase in the value of the shekel in relation
to the U.S. dollar has the effect of increasing the U.S. dollar value of our unlinked shekel expenses, which would have a negative impact
on our profit margins.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Because exchange rates between the U.S. dollar and both the shekel
and the Euro (as well as between the U.S. dollar and other currencies) fluctuate continuously, such fluctuations have an impact on our
results and period&#8209;to&#8209;period comparisons of our results. The effects of foreign currency re&#8209;measurements are reported
in our consolidated financial statements of operations. The following table presents information about the changes in the exchange rates
of the shekel against the U.S. dollar and changes in the exchange rates of the Euro against the U.S. dollar:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb9a3e607fa114fd885dd8c7d57e52b8f" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25"><span style="font-weight: bold">Appreciation (Devaluation) of</span> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25; font-weight: bold">Period</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Shekel against the U.S. dollar<br/> (%)</div>
        <div style="line-height: 1.25"> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Euro<br/> against the U.S. dollar<br/> (%)</div>
        <div style="line-height: 1.25"> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25"></div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
        <div style="line-height: 1.25">2021</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">3.3</div>
        <div style="line-height: 1.25"></div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">7.7</div>
        <div style="line-height: 1.25"></div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25">2022</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(13.2</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">5.8</div>
        <div style="line-height: 1.25"></div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
        <div style="line-height: 1.25">2023</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(3.1</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(3.7</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">A 10% increase (decrease) in the value of the NIS and Euro against
the U.S. dollar would have increased (decreased) our net profit by (loss) approximately $1.54 million for the year ended December 31,
2023.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As we are marketing and selling NexoBrid in Europe and conducting
clinical trials of outside the United States, we will continue to monitor exposure to currency fluctuations. We do not currently engage
in currency hedging activities in order to reduce this currency exposure, but we may begin to do so in the future. Instruments that may
be used to hedge future risks may include foreign currency forward and swap contracts. These instruments may be used to selectively manage
risks, but there can be no assurance that we will be fully protected against material foreign currency fluctuations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Other Market Risks</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We do not believe that we have material exposure to interest rate
risk due to the fact that we have no long&#8209;term debt.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We do not believe that we have any material exposure to inflationary
risks. We do not believe that the rate of inflation in Israel has had a material impact on our business to date. However, our costs in
Israel will increase if inflation in Israel exceeds the devaluation of the shekel against the U.S. dollar (to the extent that it devalues
at all) or if the timing of such devaluation lags behind inflation in Israel.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">123</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Item 12.<span id="Item12."><!--Anchor--></span> DESCRIPTION OF
SECURITIES OTHER THAN EQUITY SECURITIES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold; text-align: center"><span id="PARTII"><!--Anchor--></span> PART II</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Item 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">None.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: -42.55pt; margin-left: 42.55pt; line-height: 1.25; font-weight: bold">Item 14. MATERIAL
MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">None.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Item 15. CONTROLS AND PROCEDURES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">(a) Disclosure Controls and Procedures</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our management, including our Chief Executive Officer and Chief
Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a&#8209;15(e)
and 15d&#8209;15(e) under the Exchange Act) as of December 31, 2023. Based on such evaluation, our Chief Executive Officer and Chief Financial
Officer have concluded that, as of December 31, 2023, our disclosure controls and procedures were effective.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">(b) Management Annual Report on Internal Control over Financial
Reporting</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our management, under the supervision of our Chief Executive Officer
and Chief Financial Officer, is responsible for establishing and maintaining adequate internal control over financial reporting as defined
in Rules 13a&#8209;15(f) and 15d&#8209;15(f) under the Exchange Act.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our management, including our Chief Executive Officer and Chief
Financial Officer, assessed the effectiveness of our internal control over financial reporting as of December 31, 2023. In making this
assessment, our management used the criteria established in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring
Organizations of the Treadway Commission (COSO). Our management has concluded, based on its assessment, that our internal control over
financial reporting was effective as of December 31, 2023.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">(c) Attestation report of the registered public accounting firm</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Somekh Chaikin, a member firm of KPMG International, an independent
registered public accounting firm, to which we refer as KPMG Israel, which audited the financial statements included in this annual report
containing the disclosure required by this Item 15 has issued an attestation report regarding the effectiveness of our internal control
over financial reporting. That report is included in &#8220;Item 18. Financial Statements&#8221; on page F-[1] of this annual report,
which attestation report is incorporated by reference in this Item 15(c).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">(d) Changes in Internal Control over Financial Reporting</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">There were no changes in our internal control over financial reporting
(as such term is defined in Rules 13a&#8209;15(f) and 15d&#8209;15(f) under the Exchange Act) that occurred during the period covered
by this annual report that have materially affected, or that are reasonably likely to materially affect, our internal control over financial
reporting.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Item 16. [Reserved]</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Item 16A. AUDIT COMMITTEE FINANCIAL EXPERT</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our board of directors has determined that Stephen Wills qualifies
as an &#8220;audit committee financial expert,&#8221; as defined under the U.S. federal securities laws and has the requisite financial
experience defined by the Nasdaq Marketplace Rules. In addition, Stephen Wills is independent as such term is defined in Rule 10A&#8209;3(b)(1)
under the Exchange Act and under the listing standards of the Nasdaq Global Market.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">124</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Item 16B<span id="Item16B"><!--Anchor--></span>. CODE OF ETHICS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have adopted a code of business conduct and ethics applicable
to our executive officers, directors and all other employees. A copy of the code is delivered to every employee of MediWound Ltd. and
its subsidiaries and is available to our investors and others on our website http://ir.mediwound.com/ or by contacting our investor relations
department. Information contained on, or that can be accessed through, our website does not constitute a part of this annual report and
is not incorporated by reference herein. Any waivers of this code for executive officers or directors will be disclosed through the filing
of a Form 6&#8209;K or on our website. We granted no waivers under our code of ethics in 2023.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Item 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Principal Accountant Fees and Services</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The cost for the following professional services rendered by Somekh
Chaikin, a member firm of KPMG International Haifa, Israel, Auditor firm ID: 1057, our independent registered public accounting firm for
the year ended December 31, 2023 and 2022:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf55dc3f9af1248d385c2d54219976153" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25"></div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25"><span style="font-weight: bold"> 2023</span> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25"><span style="font-weight: bold">2022</span> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
        <div style="line-height: 1.25">Audit Fees</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">375,000</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">270,000</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px">
        <div style="line-height: 1.25">Tax Fees</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">23,395</div>
        <div style="line-height: 1.25"></div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">28,549</div>
        <div style="line-height: 1.25"></div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 4px">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25; font-weight: bold">Total</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: #000000 4px double; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: #000000 4px double; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">398,395</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: #000000 4px double; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: #000000 4px double; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">298,549</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#8220;<span style="font-weight: bold">Audit fees</span>&#8221;
are the aggregate fees paid for the audit of our annual financial statements for the years 2023 and 2022. This category also includes
services that generally the independent accountant provides, such as consents and assistance with and review of documents filed with the
SEC.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#8220;<span style="font-weight: bold">Tax fees</span>&#8221; include
fees for professional services rendered by our independent registered public accounting firm for tax compliance, transfer pricing and
tax advice on actual or contemplated transactions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The Audit Committee pre&#8209;approves all audit and non&#8209;audit
services provided by the independent registered public accounting firm.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Item 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Item 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED
PURCHASERS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Item 16F. CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Not applicable.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">125</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Item 16G. <span id="Item16G."><!--Anchor--></span>CORPORATE GOVERNANCE</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As a foreign private issuer, we are permitted to comply with Israeli
corporate governance practices instead of the Nasdaq Stock Market requirements, provided that we disclose those Nasdaq Stock Market requirements
with which we do not comply and the equivalent Israeli requirement that we follow instead. We currently rely on this &#8220;foreign private
issuer exemption&#8221; with respect to the following requirements:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zdb72598ea3404828ac201f29ec6b7b9a" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><br/> &#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Quorum</span>. As permitted under the Israeli Companies
        Law pursuant to our articles of association, the quorum required for an ordinary meeting of shareholders will consist of at least two
        shareholders present in person, by proxy or by other voting instrument in accordance with the Israeli Companies Law, who hold at least
        25% of the voting power of our shares (and in an adjourned meeting, with some exceptions, at least two shareholders), instead of 33 1/3%
        of the issued share capital required under the Nasdaq Stock Market listing rules.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: middle">
        <div style="line-height: 1.25"><br/> &#160;</div> </td>
    <td style="width: 3.85%; vertical-align: top">
        <div style="line-height: 1.25">&#8226;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Shareholder approval. </span>We do not intend to
        follow Nasdaq Stock Market rules which require shareholder approval in order to enter into any transaction, other than a public offering,
        involving the sale, issuance or potential issuance by the Company of ordinary shares (or securities convertible into or exercisable for
        ordinary shares) equal to 20% or more of the outstanding share capital of the Company or 20% or more of the voting power outstanding before
        the issuance for less than the greater of book or market value of the ordinary shares. We will follow Israeli law with respect to any
        requirement to obtain shareholder approval in connection with any private placements of equity securities.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Item 16H. MINE SAFETY DISCLOSURE</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Item 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT
INSPECTIONS.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Item 16J. DISCLOSURE REGARDING INSIDER TRADING POLICIES.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The disclosure under this item is not yet required in this annual
report.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Item 16K. CYBERSECURITY</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-family: Times New Roman, serif; font-weight: bold">Cybersecurity Risk Management and Strategy</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">We have adopted a risk-based
approach to protecting our information technology systems and confidential information through the adoption of certain technical and administrative
safeguards, including certain information technology policies intended to protect the confidentiality, integrity, and availability of
our critical systems and information. Key elements of our cybersecurity risk management program include:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" id="za50cc663652040c18d929e46c1c4b715" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 18pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, serif">technical controls deployed to protect more critical systems and data,
        such as multi-factor authentication, firewalls, network segregation, and secure file transfer protocols;</div> </td> </tr>
  </table> </div>

<div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zc4ff776594be47d885946e0fc83db28a" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 18pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, serif">disaster recovery and business continuity plan;</div> </td> </tr>
  </table> </div>

<div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z31f3e225e0e14cb694a42f058232b706" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 18pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, serif">monitoring of our information technology systems for information security
        risks;</div> </td> </tr>
  </table> </div>

<div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zfe7613cce37941678b668d7d319931a7" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 18pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, serif">based on their level of risk, cybersecurity assessments of third-party
        software / platforms; and</div> </td> </tr>
  </table> </div>

<div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z5f4ac792c182467098c20cc296526519" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 18pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, serif">regular cybersecurity awareness training of our employees, designed
        to help identify any new threats and to address security incidents.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman, serif">We have not identified risks from known cybersecurity
threats, including as a result of any prior cybersecurity incidents, that have materially affected or are reasonably likely to materially
affect us, including our operations, business strategy, results of operations, or financial condition. See &#8220;Risk Factors&#8212;Risks
Related to Healthcare Laws and Other Legal Compliance Matters&#8212;Our business and operations may suffer in the event of information
technology system failures, cyberattacks or deficiencies in our cybersecurity.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">126</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="line-height: 1.25; font-family: Times New Roman, serif; font-weight: bold">Cybersecurity Governance</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">Our Board considers cybersecurity risk as part
of its overall risk oversight function and oversees management&#8217;s implementation of our cybersecurity risk management program.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">The Committee receives periodic reports from management
on our cybersecurity risks. In addition, management updates the Committee, as necessary, regarding any material cybersecurity incidents,
as well as any incidents with lesser impact potential.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">The full Board also receives briefings from management
on our cyber risk management program.&#160; Board members receive presentations on cybersecurity topics from our Chief Operations Officer
(CISO), internal security staff or external experts as part of the Board&#8217;s continuing education on topics that impact public companies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">The Committee reports to the full Board regarding
its activities, including those related to cybersecurity. The full Board also receives periodic briefings from management on our cyber
risk management program, as well as from internal security staff or external experts engaged from time to time as part of the Board&#8217;s
continuing education on topics that impact public companies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">Our management team, including Chief Operations
Officer, is responsible for assessing and managing our material risks from cybersecurity threats. The team has primary responsibility
for our overall cybersecurity risk management program and supervises both our internal cybersecurity personnel and any retained external
cybersecurity consultants which are engaged as required. Our management team&#8217;s combined experience includes over 10 years of organizational
risk management experience.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25; font-family: Times New Roman, serif">Our management team supervises efforts to prevent,
detect, mitigate, and remediate cybersecurity risks and incidents through various means, which may include briefings from internal security
personnel; threat intelligence and other information obtained from governmental, public or private sources, including external consultants
engaged by us; and alerts and reports produced by security tools deployed in the IT environment.</div>

<div style="text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">127</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="PARTIII"><!--Anchor--></span>PART III</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Item 17. FINANCIAL STATEMENTS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Item 18. FINANCIAL STATEMENTS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">See pages F&#8209;1 through F-47 of this annual report.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Item 19. EXHIBITS</div> &#160; <br/>

<div style="line-height: 1.25">

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 8.14%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Exhibit No.</div> </td>
    <td style="width: 91.86%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Description</div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: bottom">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="exhibit_1-1.htm">1.1</a></div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="exhibit_1-1.htm">Amended and Restated Articles of Association of the Registrant,
        as amended</a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000104746914001699/a2218612zex-3_3.htm">1.2</a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000104746914001699/a2218612zex-3_3.htm"><span style="text-decoration: underline">Memorandum
        of Association of the Registrant</span><span style="text-decoration: underline">(1)</span></a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="exhibit_2-1.htm">2.1</a></div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="exhibit_2-1.htm">Description of Securities</a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891321001611/exhibit_99-1.htm">4.1</a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891321001611/exhibit_99-1.htm"><span style="font-family: Times New Roman,serif"><span style="text-decoration: underline">Amended
        and Restated Registration Rights Agreement dated April 6, 2021 by and among the Registrant and certain shareholders of the Registrant</span><span style="text-decoration: underline">(2)</span></span></a></div>
        </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000104746914001699/a2218612zex-4_3.htm">4.2</a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000104746914001699/a2218612zex-4_3.htm"><span style="text-decoration: underline">Information
        Rights Agreement by and between Clal Biotechnology Industries Ltd. and the Registrant</span><span style="text-decoration: underline">(1)</span></a></div>
        </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000104746914000737/a2218177zex-10_2.htm">4.3</a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000104746914000737/a2218177zex-10_2.htm"><span style="text-decoration: underline">Founders
        and Shareholders Agreement, dated January 2001, by and among Clal Biotechnology Industries Ltd., L.R. R &amp; D Ltd., Professor Lior Rosenberg
        and the Registrant</span><span style="text-decoration: underline">(3)</span></a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000104746914000737/a2218177zex-10_4.htm">4.4</a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000104746914000737/a2218177zex-10_4.htm"><span style="text-decoration: underline">Patent
        Purchase Agreement, dated November 24, 2010, by and between the Registrant and L.R. R &amp; D Ltd.</span><span style="text-decoration: underline">(3)</span></a></div>
        </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891321001611/exhibit_99-1.htm">4.5*</a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891321001611/exhibit_99-1.htm"><span style="text-decoration: underline">Form
        of Indemnification Agreement</span><span style="text-decoration: underline">(16)</span></a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000104746914000737/a2218177zex-10_6.htm">4.6</a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000104746914000737/a2218177zex-10_6.htm"><span style="text-decoration: underline">Supply
        Agreement, dated January 11, 2001, as amended, by and between the Registrant and Challenge Bioproducts Corporation Ltd.&#8224;</span><span style="text-decoration: underline">(3)</span></a></div>
        </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000104746914000737/a2218177zex-10_7.htm">4.7</a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000104746914000737/a2218177zex-10_7.htm"><span style="text-decoration: underline">License
        Agreement, dated September 22, 2000, as amended, by and between the Registrant and Mark Klein&#8224;</span><span style="text-decoration: underline">(3)</span></a></div>
        </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891320000640/exhibit_4-9.htm">4.8*</a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891320000640/exhibit_4-9.htm"><span style="text-decoration: underline">2014
        Equity Incentive Plan</span><span style="text-decoration: underline">(4)</span></a></div> </div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891322003676/exhibit_99-1.htm">4.10*</a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891322003676/exhibit_99-1.htm"><span style="text-decoration: underline">MediWound
        Ltd.&#8217;s Compensation Policy for Executive Officers and Directors</span><span style="text-decoration: underline">(5)</span></a></div>
        </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891321000779/exhibit4_11-1.htm">4.11.1</a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891321000779/exhibit4_11-1.htm"><span style="text-decoration: underline">BARDA
        Contract, dated September 29, 2015, by and between the Registrant and the U.S. Biomedical Advanced Research and Development Authority&#8224;</span><span style="text-decoration: underline">(6)</span></a></div>
        </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891316004033/exhibit_4-14.htm">4.11.2</a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891316004033/exhibit_4-14.htm"><span style="text-decoration: underline">Modification
        to the BARDA Contract, dated October 7, 2015, by and between the Registrant and the U.S. Biomedical Advanced Research and Development
        Authority</span><span style="text-decoration: underline">(7)</span></a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891317000577/exhibit_4-15.htm">4.11.3</a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891317000577/exhibit_4-15.htm"><span style="text-decoration: underline">Modification
        to the BARDA Contract, dated January 29, 2017, by and between the Registrant and the U.S. Biomedical Advanced Research and Development
        Authority&#8224;</span><span style="text-decoration: underline">(8)</span></a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891318000887/exhibit_4-15.htm">4.11.4</a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891318000887/exhibit_4-15.htm"><span style="text-decoration: underline">Modification
        to the BARDA Contract, dated July 9, 2017, by and between the Registrant and the U.S. Biomedical Advanced Research and Development Authority</span><span style="text-decoration: underline">(9)</span></a></div>
        </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891320000640/exhibit_4-115.htm">4.11.5</a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891320000640/exhibit_4-115.htm"><span style="text-decoration: underline">Modification
        to the BARDA Contract, dated May 24, 2019, by and between the Registrant and the U.S. Biomedical Advanced Research and Development Authority</span><span style="text-decoration: underline">(4)</span></a></div>
        </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891321000779/exhibit4_11-6.htm">4.11.6</a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891321000779/exhibit4_11-6.htm"><span style="text-decoration: underline">Modification
        to the BARDA Contract, dated February 28, 2020, by and between the Registrant and the U.S. Biomedical Advanced Research and Development
        Authority</span><span style="text-decoration: underline">(6)</span></a></div> </td> </tr>
  </table>

<div><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal; font-family: Times New Roman,Times,serif">128</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891322001161/exhibit4_11-7.htm"><span style="text-decoration: underline">4.11.7</span></a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891322001161/exhibit4_11-7.htm">Modification
        to the BARDA Contract, dated February 9, 2022, by and between the Registrant and the U.S. Biomedical Advanced Research and Development
        Authority&#8224;(17)</a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891319000913/exhibit_4-17.htm">4.12</a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891319000913/exhibit_4-17.htm"><span style="text-decoration: underline">BARDA
        Contract, dated September 30, 2018, by and between the Registrant and the U.S. Biomedical Advanced Research and Development Authority&#8224;</span><span style="text-decoration: underline">(10)</span></a></div>
        </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top; text-align: center"><a href="exhibit_4-14.htm">&#160;4.14</a></td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="exhibit_4-14.htm">Unprotected Lease Agreement, dated July 13, 2023 between the Registrant and
        Yezum-Tech</a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top; text-align: center"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891319000913/exhibit_4-21.htm">&#160;4.15</a></td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891319000913/exhibit_4-21.htm"><span style="text-decoration: underline">Settlement
        Agreement and Mutual General Release, dated as of March 24, 2019, by and among Teva Pharmaceuticals Ltd. and MediWound Ltd. and Certain
        Indemnity in connection with Settlement Agreement dated as of March 24, 2019 by MediWound Ltd.</span><span style="text-decoration: underline">(13)</span></a></div>
        </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891321000779/exhibit_4-16.htm">4.16</a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891321000779/exhibit_4-16.htm"><span style="text-decoration: underline">Amendment
        No. 1 to Settlement Agreement and Mutual General Release as of December 13, 2020, by and among Teva Pharmaceuticals Ltd. and MediWound
        Ltd.</span><span style="text-decoration: underline">(6)</span></a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/887359/000162828019010077/ex109-mediwoundlicense.htm">4.17</a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/887359/000162828019010077/ex109-mediwoundlicense.htm"><span style="text-decoration: underline">License
        Agreement, dated as of May 6, 2019, by and between the Registrant and Vericel Corporation&#8224; </span><span style="text-decoration: underline">(14)</span></a></div>
        </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/887359/000162828019010077/ex1010-mediwoundsupply.htm">4.18</a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/887359/000162828019010077/ex1010-mediwoundsupply.htm"><span style="text-decoration: underline">Supply
        Agreement, dated as of May 6, 2019, by and between the Registrant and Vericel Corporation&#8224; </span><span style="text-decoration: underline">(15)</span></a></div>
        </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top; text-align: center"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891322003522/exhibit_4-1.htm">4.19<br/>
        </a></td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">
        <div style="line-height: 1.25; color: #000000; font-family: Times New Roman, serif"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891322003522/exhibit_4-1.htm">Form
        of Series A Ordinary Share Purchase Warrant issued in September 2022 pursuant to a registered direct offering of the Registrant (18)</a></div>
        </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top; text-align: center"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891322003522/exhibit_4-2.htm">4.20<br/>
        </a></td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, serif"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891322003522/exhibit_4-2.htm">Form
        of <span style="font-family: Times New Roman,serif">Series A Ordinary Share Purchase Warrant issued in October 2022 pursuant to a private
        placement (PIPE) of the Registrant (19)</span></a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top; text-align: center"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891322003522/exhibit_4-4.htm">4.21<br/>
        </a></td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, serif"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891322003522/exhibit_4-4.htm">Form
        of <span style="font-family: Times New Roman,serif">Placement Agent Ordinary Share Purchase Warrant issued by the Registrant in October
        2022 to its exclusive placement agent for its registered direct offering and PIPE (20)</span></a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top; text-align: center">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top; text-align: center"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891322003522/exhibit_10-3.htm">4.22
        <br/> </a></td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, serif"><a href="https://www.sec.gov/Archives/edgar/data/1593984/000117891322003522/exhibit_10-3.htm">Registration
        Rights Agreement, entered into in October 2022, by and between the Registrant and the purchasers of its securities in a <span style="font-family: Times New Roman,serif">registered
        direct offering (21)</span></a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top; text-align: center">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top; text-align: center"><a href="exhibit_4-23.htm">&#160;4.23</a></td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="exhibit_4-23.htm">turnkey scale-up agreement with Biopharmax Group Ltd.</a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1593984/000117891323001021/zk2329372.htm">8.1</a></div>
        </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1593984/000117891323001021/zk2329372.htm"><span style="text-decoration: underline">List
        of subsidiaries of the Registrant</span><span style="text-decoration: underline">(6)</span></a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="exhibit_12-1.htm">12.1</a></div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="exhibit_12-1.htm">Certificate of Chief Executive Officer pursuant to Securities
        Exchange Act Rules 13a&#8209;14(a) and 15d&#8209;14(a) as adopted pursuant to &#167;302 of the Sarbanes&#8209;Oxley Act of 2002</a></div>
        </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="exhibit_12-2.htm">12.2</a></div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="exhibit_12-2.htm">Certificate of Chief Financial Officer pursuant to Securities
        Exchange Act Rules 13a&#8209;14(a) and 15d&#8209;14(a) as adopted pursuant to &#167;302 of the Sarbanes&#8209;Oxley Act of 2002</a></div>
        </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top"><a href="exhibit_13-1.htm">&#160;</a></td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top"><a href="exhibit_13-1.htm">&#160;</a></td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="exhibit_13-1.htm">13.1</a></div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="exhibit_13-1.htm">Certificate of Chief Executive Officer pursuant to 18 U.S.C.
        &#167;1350, as adopted pursuant to &#167;906 of the Sarbanes&#8209;Oxley Act of 2002, furnished herewith</a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="exhibit_13-2.htm">13.2</a></div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="exhibit_13-2.htm">Certificate of Chief Financial Officer pursuant to 18 U.S.C.
        &#167;1350, as adopted pursuant to &#167;906 of the Sarbanes&#8209;Oxley Act of 2002, furnished herewith</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="exhibit_15-1.htm">15.1</a></div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="exhibit_15-1.htm">Consent of Somekh Chaikin, a member firm of KPMG International,
        an independent registered public accounting firm</a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.14%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 91.86%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><a href="exhibit_97-1.htm">97.1</a></div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25"><a href="exhibit_97-1.htm">Policy for Recovery of Erroneously Awarded Compensation</a></div> </div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 8.44%; vertical-align: bottom">
        <div style="line-height: 1.25; margin-left: 27pt">101.INS</div> </td>
    <td style="width: 91.56%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Inline XBRL Instance Document</div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.44%; vertical-align: bottom">
        <div style="margin-left: 27pt">&#160;</div> </td>
    <td rowspan="1" style="width: 91.56%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.44%; vertical-align: bottom">
        <div style="line-height: 1.25; margin-left: 27pt">101.SCH&#160;</div> </td>
    <td style="width: 91.56%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Inline XBRL Taxonomy Extension Schema Document</div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.44%; vertical-align: bottom">
        <div style="margin-left: 27pt">&#160;</div> </td>
    <td rowspan="1" style="width: 91.56%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.44%; vertical-align: bottom">
        <div style="line-height: 1.25; margin-left: 27pt">101.CAL</div> </td>
    <td style="width: 91.56%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Inline XBRL Taxonomy Extension Calculation Linkbase Document</div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.44%; vertical-align: bottom">
        <div style="margin-left: 27pt">&#160;</div> </td>
    <td rowspan="1" style="width: 91.56%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.44%; vertical-align: bottom">
        <div style="line-height: 1.25; margin-left: 27pt">101.DEF&#160;</div> </td>
    <td style="width: 91.56%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Inline XBRL Taxonomy Definition Linkbase Document</div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.44%; vertical-align: bottom">
        <div style="margin-left: 27pt">&#160;</div> </td>
    <td rowspan="1" style="width: 91.56%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.44%; vertical-align: bottom">
        <div style="line-height: 1.25; margin-left: 27pt">101.LAB</div> </td>
    <td style="width: 91.56%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Inline XBRL Taxonomy Extension Label Linkbase Document</div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.44%; vertical-align: bottom">
        <div style="margin-left: 27pt">&#160;</div> </td>
    <td rowspan="1" style="width: 91.56%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.44%; vertical-align: bottom">
        <div style="line-height: 1.25; margin-left: 27pt">101.PRE</div> </td>
    <td style="width: 91.56%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Inline XBRL Taxonomy Extension Presentation Linkbase Document</div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8.44%; vertical-align: bottom">
        <div style="margin-left: 27pt">&#160;</div> </td>
    <td rowspan="1" style="width: 91.56%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 8.44%; vertical-align: bottom">
        <div style="line-height: 1.25; margin-left: 27pt">104</div> </td>
    <td style="width: 91.56%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Cover Page Interactive Data File (the cover page iXBRL tags are embedded within the
        Inline XBRL document)</div> </td> </tr>
  </table>

<div style="line-height: 1.25">

<div><br/> </div>

<div style="text-align: center">129<br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div> <br/>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">&#8224;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Portions of this exhibit have been omitted pursuant to Instruction 4(a) to Exhibits
        to Form 20-F because they are both (i) not material and (ii) the type that the Registrant treats as private or confidential.&#160;</div>
        </td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">*</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Indicates management contract or compensatory plan or arrangement.</div> </td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">(1)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Previously filed with the SEC on March 3, 2014 pursuant to the Registrant&#8217;s
        registration statement on Form F&#8209;1 (File No. 333&#8209;193856) and incorporated by reference herein.&#160;</div> </td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">(2)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Previously furnished to the SEC on May 5, 2021 as Appendix B to the Registrant&#8217;s
        proxy statement for its 2021 annual general meeting of shareholders held on June 15, 2021, attached as Exhibit 99.1 to the Registrant&#8217;s
        report of foreign private issuer on Form 6&#8209;K (File No. 001&#8209;36349) and incorporated by reference herein.&#160;</div> </td>
        </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">(3)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Previously filed with the SEC on February 10, 2014 pursuant to the Registrant&#8217;s
        registration statement on Form F&#8209;1 (File No. 333&#8209;193856) and incorporated by reference herein.</div> </td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">(4)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Previously filed with the SEC on February 25, 2020 pursuant to the Registrant&#8217;s
        annual report on Form 20-F for the year ended December 31, 2019 (File No. 001-36349) and incorporated by reference herein.&#160;</div>
        </td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">(5)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Previously furnished to the SEC on October 21, 2022 as Appendix A to the Registrant&#8217;s
        proxy statement for its extraordinary general meeting of shareholders held on November 28, 2022, attached as Exhibit 99.1 to the Registrant&#8217;s
        report of foreign private issuer on Form 6&#8209;K (File No. 001&#8209;36349) and incorporated by reference herein.&#160;</div>
        <div style="text-align: justify; line-height: 1.25"> <br/> </div> </td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">(6)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Previously filed with the SEC on February 25, 2021 pursuant to the Registrant&#8217;s
        annual report on Form 20-F for the year ended December 31, 2020 (File No. 001-36349) and incorporated by reference herein.</div> </td>
        </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">(7)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Previously filed with the SEC on January 25, 2016 as Exhibit 4.14 to the Registrant&#8217;s
        annual report on Form 20&#8209;F for the year ended December 31, 2015 (File No. 001&#8209;36349) and incorporated by reference herein.&#160;</div>
        </td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">(8)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Previously filed with the SEC on February 21, 2017 as Exhibit 4.15 to the Registrant&#8217;s
        annual report on Form 20&#8209;F for the year ended December 31, 2016 (File No. 001&#8209;36349) and incorporated by reference herein.&#160;</div>
        </td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">(9)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Previously filed with the SEC on March 19, 2018 as Exhibit 4.16 to the Registrant&#8217;s
        annual report on Form 20&#8209;F for the year ended December 31, 2017 (File No. 001&#8209;36349) and incorporated by reference herein.&#160;</div>
        </td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">(10)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Previously filed with the SEC on March 25, 2019 as Exhibit 4.17 to the Registrant&#8217;s
        annual report on Form 20&#8209;F for the year ended December 31, 2018 (File No. 001&#8209;36349) and incorporated by reference herein.&#160;</div>
        </td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">(11)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Previously filed with the SEC on March 19, 2018 as Exhibit 4.17 to the Registrant&#8217;s
        annual report on Form 20&#8209;F for the year ended December 31, 2017 (File No. 001&#8209;36349) and incorporated by reference herein.&#160;</div>
        </td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">(12)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Previously filed with the SEC on March 25, 2019 as Exhibit 4.20 to the Registrant&#8217;s
        annual report on Form 20&#8209;F for the year ended December 31, 2018 (File No. 001&#8209;36349) and incorporated by reference herein.&#160;</div>
        </td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">(13)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Previously filed with the SEC on March 25, 2019 as Exhibit 4.21 to the Registrant&#8217;s
        annual report on Form 20&#8209;F for the year ended December 31, 2018 (File No. 001&#8209;36349) and incorporated by reference herein.&#160;</div>
        </td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">(14)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Previously filed with the SEC by Vericel Corporation on August 6, 2019 as Exhibit
        10.9 to its quarterly report on Form 10-Q for the quarter ended June 30, 2019 (File No. 001&#8209;35280) and incorporated by reference
        herein.&#160;</div> </td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">(15)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Previously filed with the SEC by Vericel Corporation on August 6, 2019 as Exhibit
        10.10 to its quarterly report on Form 10-Q for the quarter ended June 30, 2019 (File No. 001&#8209;35280) and incorporated by reference
        herein.&#160;</div> </td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">(16)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Previously furnished to the SEC on June 9, 2022 as Appendix A to the Registrant&#8217;s
        proxy statement for its 2022 annual general meeting of shareholders held on July 19, 2022, attached as Exhibit 99.1 to the Registrant&#8217;s
        report of foreign private issuer on Form 6&#8209;K (File No. 001&#8209;36349) and incorporated by reference herein.&#160;</div>
        <div style="text-align: justify; line-height: 1.25"> <br/> </div> </td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">(17)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Previously filed with the SEC on March 17, 2022 as Exhibit 4.11.7 to the Registrant&#8217;s
        annual report on Form 20&#8209;F for the year ended December 31, 2021 (File No. 001&#8209;36349) and incorporated by reference herein.&#160;</div>
        </td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">(18)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Previously furnished to the SEC on September 26, 2022 as Exhibit 4.1 to the Registrant&#8217;s
        report of foreign private issuer on Form 6&#8209;K (File No. 001&#8209;36349) and incorporated by reference herein.&#160;</div> </td>
        </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">(19)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Previously furnished to the SEC on September 26, 2022 as Exhibit 4.2 to the Registrant&#8217;s
        report of foreign private issuer on Form 6&#8209;K (File No. 001&#8209;36349) and incorporated by reference herein.&#160;</div> </td>
        </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">(20)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Previously furnished to the SEC on September 26, 2022 as Exhibit 4.4 to the Registrant&#8217;s
        report of foreign private issuer on Form 6&#8209;K (File No. 001&#8209;36349) and incorporated by reference herein.<br/> &#160;&#160;</div>
        </td> </tr>
  <tr>
    <td style="width: 8.14%; vertical-align: top">
        <div style="line-height: 1.25">(21)</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 91.86%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Previously furnished to the SEC on September 26, 2022 as Exhibit 10.3 to the Registrant&#8217;s
        report of foreign private issuer on Form 6&#8209;K (File No. 001&#8209;36349) and incorporated by reference herein.</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table> <br/> </div> </div>

<div style="line-height: 1.25; text-align: center">130<br/> </div> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div><br/>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="SIGNATURES"><!--Anchor--></span>SIGNATURES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The registrant hereby certifies that it meets all of the requirements
for filing on Form 20&#8209;F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z00c26918523e4b148a3922bd9be6d423" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 47.83%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 50.81%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">MediWound Ltd.</div> </td>
    <td style="width: 1.36%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 47.83%; vertical-align: top">
        <div style="line-height: 1.25">Date: March 21, 2024</div> </td>
    <td style="border-bottom: #000000 2px solid; width: 50.81%; vertical-align: top">
        <div style="line-height: 1.25">By: /s/ Hani Luxenburg <br/> </div> </td>
    <td style="width: 1.36%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 47.83%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 50.81%; vertical-align: top">
        <div style="line-height: 1.25">Hani Luxenburg&#160;</div>
        <div style="line-height: 1.25">Chief Financial Officer</div> </td>
    <td style="width: 1.36%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div><br/> </div> <br/>

<div style="text-align: center"> 131<br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div> <br/> </div> <br/> </div>

<div> <br/> </div> </div>
<!-- Field: /Include-Text -->

</div>
  <div style="line-height:1.25">&#160;</div>
</div><div style="">
  <div>
    <div>
      <div>
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">MEDIWOUND LTD. AND ITS SUBSIDIARIES</span></span></div>
        <div style="line-height:1.25">&#160;</div>
      </div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED FINANCIAL STATEMENTS</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">DECEMBER 31, 2023</span></span></div>
      <div style="text-align:center;line-height:1.25;font-weight:bold">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INDEX</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:86%;vertical-align:bottom">&#160;</td>
            <td style="width:14%;vertical-align:bottom;border-bottom:2px solid #000000">
              <div style="line-height:1.25">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Page</span></span></div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width:86%;vertical-align:top">&#160;</td>
            <td style="width:14%;vertical-align:bottom">&#160;</td>
          </tr>
          <tr>
            <td style="width:86%;vertical-align:top">
              <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#Report_integixAnchor">Report of Independent Registered Public Accounting Firm</a></span></span></div>
            </td>
            <td style="width:14%;vertical-align:bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-2 &#8211; F3</span></span></div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width:86%;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong style="color:rgb(0, 0, 0);font-size:13.3333px;font-style:normal;font-variant-ligatures:normal;font-variant-caps:normal;letter-spacing:normal;orphans:2;text-indent:0px;text-transform:none;widows:2;word-spacing:0px;-webkit-text-stroke-width:0px;white-space:normal;background-color:rgb(255, 255, 255);text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial">(Firm Name: KPMG (<ix:nonNumeric id="Fxbrl_20240318092711906" name="dei:AuditorName" contextRef="C_20230101to20231231">Somekh Chaikin</ix:nonNumeric>) / PCAOB ID No. <ix:nonNumeric id="Fxbrl_20240318092354984" name="dei:AuditorFirmId" contextRef="C_20230101to20231231">1057</ix:nonNumeric>)</strong></span></span></td>
            <td rowspan="1" style="width:14%;vertical-align:bottom">&#160;</td>
          </tr>
          <tr>
            <td style="width:86%;vertical-align:top">&#160;</td>
            <td style="width:14%;vertical-align:bottom">&#160;</td>
          </tr>
          <tr>
            <td style="width:86%;vertical-align:top">
              <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#Financial_integixAnchor">Consolidated Statements of Financial Position</a></span></span></div>
            </td>
            <td style="width:14%;vertical-align:bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-4</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="width:86%;vertical-align:top">&#160;</td>
            <td style="width:14%;vertical-align:bottom">&#160;</td>
          </tr>
          <tr>
            <td style="width:86%;vertical-align:top">
              <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#Loss_integixAnchor">Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss</a></span></span></div>
            </td>
            <td style="width:14%;vertical-align:bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-5</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="width:86%;vertical-align:top">&#160;</td>
            <td style="width:14%;vertical-align:bottom">&#160;</td>
          </tr>
          <tr>
            <td style="width:86%;vertical-align:top">
              <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#Equity_integixAnchor">Consolidated Statements of Changes in Shareholders' Equity (Deficit)</a></span></span></div>
            </td>
            <td style="width:14%;vertical-align:bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-6</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="width:86%;vertical-align:top">&#160;</td>
            <td style="width:14%;vertical-align:bottom">&#160;</td>
          </tr>
          <tr>
            <td style="width:86%;vertical-align:top">
              <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#Cash_integixAnchor">Consolidated Statements of Cash Flows</a></span></span></div>
            </td>
            <td style="width:14%;vertical-align:bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-7 - F-8</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="width:86%;vertical-align:top">&#160;</td>
            <td style="width:14%;vertical-align:bottom">&#160;</td>
          </tr>
          <tr>
            <td style="width:86%;vertical-align:top">
              <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#Notes_integixAnchor">Notes to Consolidated Financial Statements</a></span></span></div>
            </td>
            <td style="width:14%;vertical-align:bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-9 - F-47</span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
        <div style="page-break-after:always">
          <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
        </div>
      </div>
    </div>
  </div>
</div><div style="">
  <div>
    <div>
      <div>
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">MEDIWOUND LTD. AND ITS SUBSIDIARIES</span></span></div>
      </div>&#160;<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span id="Report_integixAnchor"></span>Report of Independent Registered Public Accounting Firm</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">To the Shareholders and Board of Directors<br/>MediWound Ltd.:</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Opinions on the Consolidated Financial Statements and Internal Control Over Financial Reporting</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We have audited the accompanying consolidated statements of financial position of MediWound Ltd. and its subsidiaries (the Company) as of December 31, 2023 and 2022, the related consolidated statements of profit or loss and other comprehensive income (loss), changes in shareholders&#8217; equity (deficit), and cash flows for each of the years in the three&#8209;year period ended December 31, 2023, and the related notes (collectively, the consolidated financial statements). We also have audited the Company&#8217;s internal control over financial reporting as of December 31, 2023, based on criteria established in <span style="font-style:italic">Internal Control &#8211; Integrated Framework</span>&#160;<span style="font-style:italic">(2013)</span> issued by the Committee of Sponsoring Organizations of the Treadway Commission.</span></span></div>
      <div style="line-height:1.25;text-align:justify">&#160;</div>
      <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2023, in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2023 based on criteria established in <span style="font-style:italic">Internal Control &#8211; Integrated Framework (2013)</span> issued by the Committee of Sponsoring Organizations of the Treadway Commission.</span></span></div>
      <div style="line-height:1.25;text-align:justify">&#160;</div>
      <div style="line-height:1.25;font-style:italic;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basis for Opinions</span></span></div>
      <div style="line-height:1.25;text-align:justify">&#160;</div>
      <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements and an opinion on the Company&#8217;s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></span></div>
      <div style="line-height:1.25;text-align:justify">&#160;</div>
      <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.</span></span></div>
      <div style="line-height:1.25;text-align:justify">&#160;</div>
      <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</span></span></div>
      <div style="line-height:1.25;text-align:justify">&#160;</div>
      <div style="line-height:1.25;font-style:italic;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Definition and Limitations of Internal Control Over Financial Reporting</span></span></div>
      <div style="line-height:1.25;text-align:justify">&#160;</div>
      <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
        <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">F - 2</span></span></span></div>
        <div style="page-break-after:always">
          <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
        </div>
      </div>
      <div style="line-height:1.25">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">MEDIWOUND LTD. AND ITS SUBSIDIARIES</span></span></div>
      </div>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></span></div>
      <div style="line-height:1.25;text-align:justify">&#160;</div>
      <div style="line-height:1.25;font-style:italic;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Critical Audit Matter</span></span></div>
      <div style="line-height:1.25;text-align:justify">&#160;</div>
      <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></span></div>
      <div style="line-height:1.25;text-align:justify">&#160;</div>
      <div style="text-align:justify;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Israeli Innovation Authority grant liability</span></span></div>
      <div style="text-align:justify;line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As discussed in Notes 2c, 3d and 14 to the consolidated financial statements, in previous years the Company received grants from the Israeli Innovation Authority (&#8220;IIA&#8221;) to finance its research and development efforts. These grants were recognized as a liability to the extent the Company expected to refund them through royalties on its revenues derived from sales of products or services developed in whole or in part using the grants. The amount of the liability is reexamined each period using the Company&#8217;s updated future revenue forecasts discounted to their present value. Any changes in the IIA grant liability are recognized in profit or loss. The IIA grant liability was $7,803 thousand as of December 31, 2023.</span></span></div>
      </div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We identified the evaluation of the subsequent period end measurement of the IIA grant liability as a critical audit matter. Specifically, a high degree of subjective auditor judgment was involved in evaluating certain significant assumptions used by the Company to develop its future revenue forecasts, including the likelihood and timing of achievement of regulatory approvals and potential market demand and market share for the Company&#8217;s products, which were based on market research. These significant assumptions were forward-looking and could be affected by future economic and market conditions.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and effectiveness of certain internal controls related to the Company&#8217;s process for measuring the IIA grant liability, including controls related to the determination of the above referenced significant assumptions used to develop future revenue forecasts. We compared the Company&#8217;s assumption of the likelihood and timing for obtaining regulatory approvals for its products, based on the specific phases of their development, to relevant data in industry research reports. We evaluated the Company&#8217;s assumption of potential market demand and market share by evaluating the relevance and reliability of the market research upon which the Company based its future revenue forecasts. We performed sensitivity analyses over these significant assumptions to assess the impact of changes in the assumptions on the period end IIA grant liability.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">/s/ <ix:nonNumeric id="Fxbrl_20220310125452702" name="dei:AuditorName" contextRef="C_20230101to20231231">Somekh Chaikin</ix:nonNumeric></span></span></div>
      </div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Somekh Chaikin</span></span></div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Member Firm of KPMG International</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We have served as the Company&#8217;s auditor since 2021.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220310125513773" name="dei:AuditorLocation" contextRef="C_20230101to20231231">Haifa, Israel</ix:nonNumeric></span></span></div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 21, 2024</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
        <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">F - 3</span></span></span></div>
        <div style="page-break-after:always">
          <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
        </div>
      </div>
    </div>
  </div>
</div><div style="">
  <div>
    <div style="line-height:1.25">
      <div style="text-align:justify;line-height:1.25;font-weight:bold">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>MEDIWOUND LTD. AND ITS SUBSIDIARIES</span></span></span></p>
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Consolidated Statements of <span id="Financial_integixAnchor"></span>Financial Position</span></span></span>
        <hr style="height:1px;width:100%;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center"/>
      </div>
    </div>
    <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>U.S. dollars in thousands</span></span></span></div>
    <div style="text-align:justify;line-height:1.25;font-weight:bold">&#160;</div>
    <table cellpadding="0" cellspacing="0" style="width:100%">

        <tr>
          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="6" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>As of December 31,</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Note</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2023</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2022</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Cash and cash equivalents</span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>4</span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_37" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,866</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_311" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,895</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Short-term and restricted bank deposits</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>5</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_57" name="ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,842</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_511" name="ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Trade receivables</span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>6</span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_67" name="ifrs-full:CurrentTradeReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,700</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_611" name="ifrs-full:CurrentTradeReceivables" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,332</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Inventories</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>7</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_77" name="ifrs-full:Inventories" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,846</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_711" name="ifrs-full:Inventories" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,963</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Other receivables</span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>8</span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_87" name="ifrs-full:OtherCurrentReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,441</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_811" name="ifrs-full:OtherCurrentReceivables" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">650</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="padding-bottom:2px;vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Total current assets</span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:center;padding-bottom:2px;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_107" name="ifrs-full:CurrentAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">49,695</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_1011" name="ifrs-full:CurrentAssets" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">45,840</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:65%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:center;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Other receivables</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>9</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20220217123218245_xbrl_20211012150141054_127" name="ifrs-full:OtherNoncurrentReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">233</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20220217123218245_xbrl_20211012150141054_1211" name="ifrs-full:OtherNoncurrentReceivables" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">180</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Long-term restricted bank deposits</span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:center;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20240316123518325_xbrl_20211012150141054_127" name="ifrs-full:LongtermDeposits" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">440</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20240316123518325_xbrl_20211012150141054_1211" name="ifrs-full:LongtermDeposits" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">184</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Property, plant and equipment, net</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>10</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_127" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,228</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_1211" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,366</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Right-of-use assets, net</span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>11</span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_137" name="ifrs-full:RightofuseAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,698</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_1311" name="ifrs-full:RightofuseAssets" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,215</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="padding-bottom:2px;vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Intangible assets, net</span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;padding-bottom:2px;vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>12</span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_147" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">165</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_1411" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">231</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Total non-current assets</span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:center;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_167" name="ifrs-full:NoncurrentAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,764</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_1611" name="ifrs-full:NoncurrentAssets" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,176</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:65%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:center;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Total assets</span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:center;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_187" name="ifrs-full:Assets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66,459</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_1811" name="ifrs-full:Assets" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,016</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:65%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:center;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Current maturities of long-term liabilities</span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:center;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_207" name="mdwd:NonCurrentLiabilitiesCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,410</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_2011" name="mdwd:NonCurrentLiabilitiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,242</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Trade payables and accrued expenses</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:center;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_217" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,528</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_2111" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,656</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Other payables</span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>13</span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_227" name="ifrs-full:OtherCurrentPayables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,891</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_2211" name="ifrs-full:OtherCurrentPayables" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,159</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="padding-bottom:2px;vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Total current liabilities</span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:center;padding-bottom:2px;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_247" name="ifrs-full:CurrentLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,829</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_2411" name="ifrs-full:CurrentLiabilities" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,057</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:65%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:center;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Warrants, net</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>19c</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20240316122906641_xbrl_20211012150141054_277" name="ifrs-full:NoncurrentWarrantLiability" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,296</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20240316122906641_xbrl_20211012150141054_2711" name="ifrs-full:NoncurrentWarrantLiability" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,606</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Liabilities in respect of IIA grants</span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>14, 17b</span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_277" name="ifrs-full:NoncurrentGovernmentGrants" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,677</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_2711" name="ifrs-full:NoncurrentGovernmentGrants" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,445</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Liabilities in respect of TEVA</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>17c</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_287" name="ifrs-full:OtherNoncurrentLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,256</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_2811" name="ifrs-full:OtherNoncurrentLiabilities" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,788</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Lease liabilities</span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>11</span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_297" name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,350</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_2911" name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">846</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="padding-bottom:2px;vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Severance pay liability, net</span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;padding-bottom:2px;vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>16</span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_307" name="ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">456</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_3011" name="ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">360</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Total non-current liabilities</span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:center;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_327" name="ifrs-full:NoncurrentLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,035</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_3211" name="ifrs-full:NoncurrentLiabilities" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,045</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:65%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:center;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Total liabilities</span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:center;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20220217112245655_xbrl_20211012150141054_327" name="ifrs-full:Liabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">34,864</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20220217112245655_xbrl_20211012150141054_3211" name="ifrs-full:Liabilities" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,102</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:65%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:center;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Shareholders' equity:</span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>19</span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Ordinary shares of NIS <ix:nonFraction id="Fxbrl_20211012185741260" name="ifrs-full:ParValuePerShare" contextRef="C_20221231" unitRef="NIS_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20211012185726744" name="ifrs-full:ParValuePerShare" contextRef="C_20231231" unitRef="NIS_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.07</ix:nonFraction></ix:nonFraction> par value:</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:center;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:65%">
            <div style="text-align:justify;margin-left:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Authorized <ix:nonFraction id="Fxbrl_20220217112505767" name="ifrs-full:NumberOfSharesAuthorised" contextRef="C_20231231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">20,000,000</ix:nonFraction> shares as of December 31, 2023 and <ix:nonFraction id="Fxbrl_20240316122829362" name="ifrs-full:NumberOfSharesAuthorised" contextRef="C_20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">12,857,143</ix:nonFraction><br/>shares as of December 31, 2022; Issued and Outstanding <ix:nonFraction id="Fxbrl_20221102021354405" name="ifrs-full:NumberOfSharesOutstanding" contextRef="C_20231231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20221102021346372" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20231231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">9,221,764</ix:nonFraction></ix:nonFraction><br/>shares as of December 31, 2023 and <ix:nonFraction id="Fxbrl_20220217112601459" name="ifrs-full:NumberOfSharesOutstanding" contextRef="C_20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220218125114303" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">7,240,020</ix:nonFraction></ix:nonFraction> shares as of December 31, 2022</span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:center;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20220217112748263_xbrl_20211012150141054_367" name="ifrs-full:IssuedCapital" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">184</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20220217112748263_xbrl_20211012150141054_3611" name="ifrs-full:IssuedCapital" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">143</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Share premium</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_367" name="ifrs-full:SharePremium" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">206,251</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_3611" name="ifrs-full:SharePremium" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">178,882</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Foreign currency translation reserve</span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20211012150141054_377" name="ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreads" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">18</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20211012150141054_3711" name="ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreads" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom:2px;vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Accumulated deficit</span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;padding-bottom:2px;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20211012150141054_387" name="ifrs-full:RetainedEarnings" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">174,822</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20211012150141054_3811" name="ifrs-full:RetainedEarnings" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">168,106</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Total equity</span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_407" name="ifrs-full:Equity" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,595</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_4011" name="ifrs-full:Equity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,914</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:65%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>
        <tr>
          <td style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:65%">
            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Total liabilities and equity</span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
          <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_427" name="ifrs-full:EquityAndLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66,459</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
          <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
          <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20211012150141054_4211" name="ifrs-full:EquityAndLiabilities" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,016</ix:nonFraction></span></span></span></div>
          </td>
          <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
        </tr>

    </table>
    <div style="text-align:justify;line-height:1.25">&#160;</div>
    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The accompanying notes are an integral part of the consolidated financial statements.</span></span></span></span></span></div>
    <div style="text-align:justify;line-height:1.25">
      <p style="margin:0pt">&#160;</p>
      <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 4</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always;margin-bottom:10pt"/></div></div>
    </div>
  </div>
</div><div style="">
  <div>
    <div style="line-height:1.25">
      <div style="text-align:justify;line-height:1.25;font-weight:bold">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">MEDIWOUND LTD. AND ITS SUBSIDIARIES</span></p>
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consolidated Statements of Profit or Loss and Other Comprehensive Income or <span id="Loss_integixAnchor"></span>Loss</span></span>
        <hr style="height:1px;width:100%;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center"/>
      </div>
    </div>
    <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">U.S. dollars in thousands (except of share and per share data)</span></span></div>
    <div style="text-align:justify;line-height:1.25;font-weight:bold">&#160;</div>
    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

        <tr>
          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from sale of products</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_26" name="ifrs-full:RevenueFromSaleOfGoods" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,261</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_210" name="ifrs-full:RevenueFromSaleOfGoods" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,347</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_214" name="ifrs-full:RevenueFromSaleOfGoods" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,613</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from development services</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_36" name="ifrs-full:RevenueFromRenderingOfServices" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,265</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_310" name="ifrs-full:RevenueFromRenderingOfServices" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,943</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_314" name="ifrs-full:RevenueFromRenderingOfServices" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,372</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from license agreements and royalties</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_46" name="ifrs-full:LicenceFeeIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">160</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_410" name="ifrs-full:LicenceFeeIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,206</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_414" name="ifrs-full:LicenceFeeIncome" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,778</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:52.5%;vertical-align:bottom">
            <div style="text-align:justify;line-height:1.25;font-weight:bold;margin-left:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total revenues</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22a</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_57" name="ifrs-full:Revenue" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,686</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_511" name="ifrs-full:Revenue" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,496</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_515" name="ifrs-full:Revenue" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,763</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:52.5%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenues from sale of products</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316125531684_xbrl_20211012190257994_26" name="mdwd:CostOfSalesFromSaleOfProducts" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,927</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316125531684_xbrl_20211012190257994_210" name="mdwd:CostOfSalesFromSaleOfProducts" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,184</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316125531684_xbrl_20211012190257994_214" name="mdwd:CostOfSalesFromSaleOfProducts" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,983</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenues from development services</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316125610223_xbrl_20240316125531684_xbrl_20211012190257994_26" name="ifrs-full:ServicesExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,177</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316125610223_xbrl_20240316125531684_xbrl_20211012190257994_210" name="ifrs-full:ServicesExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,829</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316125610223_xbrl_20240316125531684_xbrl_20211012190257994_214" name="ifrs-full:ServicesExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,907</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;padding-bottom:2px;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenues from license agreements</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316125641963_xbrl_20240316125610223_xbrl_20240316125531684_xbrl_20211012190257994_26" name="mdwd:CostOfLicenseAgreements" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316125641963_xbrl_20240316125610223_xbrl_20240316125531684_xbrl_20211012190257994_210" name="mdwd:CostOfLicenseAgreements" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">318</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316125641963_xbrl_20240316125610223_xbrl_20240316125531684_xbrl_20211012190257994_214" name="mdwd:CostOfLicenseAgreements" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">102</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold;margin-left:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total cost of revenues</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22b</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_77" name="ifrs-full:CostOfSales" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,108</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_711" name="ifrs-full:CostOfSales" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,331</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_715" name="ifrs-full:CostOfSales" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,992</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:52.5%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:52.5%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-align:justify;line-height:1.25;font-weight:bold;margin-left:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross profit</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_97" name="ifrs-full:GrossProfit" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,578</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_911" name="ifrs-full:GrossProfit" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,165</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_915" name="ifrs-full:GrossProfit" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,771</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:52.5%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22c</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_117" name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,467</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_1111" name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,181</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_1115" name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,256</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Selling and marketing</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22d</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_127" name="ifrs-full:SalesAndMarketingExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,844</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_1211" name="ifrs-full:SalesAndMarketingExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,725</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_1215" name="ifrs-full:SalesAndMarketingExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,388</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22e</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_137" name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,768</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_1311" name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,920</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_1315" name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,348</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;padding-bottom:2px;vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other (income) expenses</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;padding-bottom:2px;vertical-align:bottom">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22f</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211012190257994_1415" name="ifrs-full:OtherOperatingIncomeExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">211</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_1511" name="ifrs-full:OtherOperatingIncomeExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">684</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_1515" name="ifrs-full:OtherOperatingIncomeExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:20pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total operating expenses</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_177" name="ifrs-full:OperatingExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,868</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_1711" name="ifrs-full:OperatingExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,510</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_1715" name="ifrs-full:OperatingExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,992</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:20pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating loss</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211012190257994_197" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">15,290</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211012190257994_1911" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,345</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211012190257994_1915" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">11,221</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial income</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_217" name="ifrs-full:FinanceIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,651</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_2111" name="ifrs-full:FinanceIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">461</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_2115" name="ifrs-full:FinanceIncome" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;padding-bottom:2px;vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial expense</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211012190257994_227" name="ifrs-full:FinanceCosts" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,892</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211012190257994_2211" name="ifrs-full:FinanceCosts" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,637</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211012190257994_2215" name="ifrs-full:FinanceCosts" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,314</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:20pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financing income (expenses), net</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22g</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217133934902_xbrl_20211012190257994_247" name="mdwd:FinanceIncomeExpenseNet" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,759</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217133934902_xbrl_20211012190257994_2411" name="mdwd:FinanceIncomeExpenseNet" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">11,176</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217133934902_xbrl_20211012190257994_2415" name="mdwd:FinanceIncomeExpenseNet" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,303</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:20pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss before taxes on income</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220309114736665_xbrl_20211012190257994_177" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,531</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220309114736665_xbrl_20211012190257994_1711" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,521</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220309114736665_xbrl_20211012190257994_1715" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13,524</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Taxes on income</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217133937404_xbrl_20211012190257994_247" name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">185</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217133937404_xbrl_20211012190257994_2411" name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">78</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217133937404_xbrl_20211012190257994_2415" name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217131713303" name="ifrs-full:ProfitLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,716</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211012190257994_2715" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,599</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211012190257994_2711" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13,551</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other comprehensive income (loss):</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;padding-bottom:2px;vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation adjustments</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211012190257994_307" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_3011" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">14</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012190257994_3015" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">21</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:20pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total comprehensive loss</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211012190257994_327" name="ifrs-full:ComprehensiveIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,729</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211012190257994_3211" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,585</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211012190257994_3215" name="ifrs-full:ComprehensiveIncome" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13,530</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-align:justify;line-height:1.25;font-weight:bold;margin-left:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss per share data:</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23,19</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="vertical-align:bottom;width:52.5%;vertical-align:bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:52.5%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic and diluted net loss per share - USD</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="text-align:right;width:9.12%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240316125912811" name="ifrs-full:DilutedEarningsLossPerShare" contextRef="C_20230101to20231231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-"><ix:nonFraction id="Fxbrl_20240316125902068_xbrl_20220217133620944_xbrl_20211012190257994_377" name="ifrs-full:BasicEarningsLossPerShare" contextRef="C_20230101to20231231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.75</ix:nonFraction></ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
          <td colspan="1" style="width:1.01%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
          <td colspan="1" style="text-align:right;width:9.12%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240316125930326" name="ifrs-full:DilutedEarningsLossPerShare" contextRef="C_20220101to20221231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-"><ix:nonFraction id="Fxbrl_20240316125902068_xbrl_20220217133620944_xbrl_20211012190257994_3711" name="ifrs-full:BasicEarningsLossPerShare" contextRef="C_20220101to20221231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">3.93</ix:nonFraction></ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
          <td colspan="1" style="width:1.01%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
          <td colspan="1" style="text-align:right;width:9.12%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240316125957134" name="ifrs-full:DilutedEarningsLossPerShare" contextRef="C_20210101to20211231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-"><ix:nonFraction id="Fxbrl_20240316125902068_xbrl_20220217133620944_xbrl_20211012190257994_3715" name="ifrs-full:BasicEarningsLossPerShare" contextRef="C_20210101to20211231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">3.48</ix:nonFraction></ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:52.5%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:20pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of shares used in calculating basic and diluted loss per share</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316130027024" name="ifrs-full:AdjustedWeightedAverageShares" contextRef="C_20230101to20231231" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220217133620944_xbrl_20211012190257994_377" name="ifrs-full:WeightedAverageShares" contextRef="C_20230101to20231231" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">9,013,144</ix:nonFraction></ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316130041301" name="ifrs-full:AdjustedWeightedAverageShares" contextRef="C_20220101to20221231" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220217133620944_xbrl_20211012190257994_3711" name="ifrs-full:WeightedAverageShares" contextRef="C_20220101to20221231" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">4,987,069</ix:nonFraction></ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.12%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316130058379" name="ifrs-full:AdjustedWeightedAverageShares" contextRef="C_20210101to20211231" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220217133620944_xbrl_20211012190257994_3715" name="ifrs-full:WeightedAverageShares" contextRef="C_20210101to20211231" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">3,892,068</ix:nonFraction></ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1.01%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>

    </table>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of the consolidated financial statements.</span></span></div>
    <div style="text-align:justify;line-height:1.25">
      <p style="margin:0pt">&#160;</p>
      <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 5</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always;margin-bottom:10pt"/></div></div>
    </div>
  </div>
</div><div style="">
  <div>
    <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">
      <div style="text-align:justify;line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt">
        <p style="text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">MEDIWOUND LTD. AND ITS SUBSIDIARIES</span></p>
        <p style="text-align:right;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:5pt;text-align:left"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Consolidated Statements of Changes in Shareholders&#8217; <span id="Equity_integixAnchor" style="margin-top:0pt;margin-bottom:0pt"></span>Equity (Deficit)</span></span></p>
        <hr style="height:1px;width:100%;color:rgb(0, 0, 0);background-color:rgb(0, 0, 0);margin:0pt auto;border:none;text-align:center"/>
      </div>
    </div>
    <div style="text-align:justify;line-height:1.25;font-weight:bold;margin-top:5pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">U.S. dollars in thousands</span></span></div>
    <div style="text-align:justify;line-height:1.25;font-weight:bold">&#160;</div>
    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

        <tr>
          <td colspan="1" style="vertical-align:bottom;padding-left:9pt;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share</span></span></div>
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">capital</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share</span></span></div>
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">premium</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation reserve</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated</span></span></div>
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">deficit</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">equity (deficit)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:bottom;padding-left:9pt;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2023</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_23" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">143</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_27" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">178,882</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_211" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_215" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">168,106</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_219" name="ifrs-full:Equity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,914</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218183142353" name="ifrs-full:ProfitLoss" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218183236223" name="ifrs-full:ProfitLoss" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218183606464" name="ifrs-full:ProfitLoss" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_415" name="ifrs-full:ProfitLoss" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,716</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_419" name="ifrs-full:ProfitLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,716</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other comprehensive loss</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218183644912" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218183702968" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_511" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218185638679" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_519" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total comprehensive loss</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218183734528" name="ifrs-full:ComprehensiveIncome" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218183811938" name="ifrs-full:ComprehensiveIncome" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_611" name="ifrs-full:ComprehensiveIncome" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_615" name="ifrs-full:ComprehensiveIncome" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,716</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_619" name="ifrs-full:ComprehensiveIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,729</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of RSU</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316131746801_xbrl_20240316131704093_xbrl_20220218184005423" name="mdwd:IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316131746801_xbrl_20240316131704093_xbrl_20220217153716014_87" name="mdwd:IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316131746801_xbrl_20240316131704093_xbrl_20220218184125991" name="mdwd:IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316131746801_xbrl_20240316131704093_xbrl_20220218184147944" name="mdwd:IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316131746801_xbrl_20240316131704093_xbrl_20220217153716014_819" name="mdwd:IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance of ordinary shares, net of issuance expenses (see note 19c)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316131704093_xbrl_20220218184005423" name="ifrs-full:IssueOfEquity" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316131704093_xbrl_20220217153716014_87" name="ifrs-full:IssueOfEquity" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,429</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316131704093_xbrl_20220218184125991" name="ifrs-full:IssueOfEquity" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316131704093_xbrl_20220218184147944" name="ifrs-full:IssueOfEquity" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316131704093_xbrl_20220217153716014_819" name="ifrs-full:IssueOfEquity" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,469</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218184005423" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_87" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,940</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218184125991" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218184147944" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_819" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,940</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2023</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_103" name="ifrs-full:Equity" contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">184</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_107" name="ifrs-full:Equity" contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">206,251</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_1011" name="ifrs-full:Equity" contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">18</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_1015" name="ifrs-full:Equity" contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">174,822</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_1019" name="ifrs-full:Equity" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,595</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2022</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_123" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_127" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">143,869</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_1211" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_1215" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">148,507</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_1219" name="ifrs-full:Equity" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,582</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218184310993" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218184248929" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218184225104" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_1415" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,599</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_1419" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,599</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other comprehensive income</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218184420936" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218184348799" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_1511" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218185823297" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_1519" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total comprehensive loss</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218184514288" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218184446200" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_1611" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_1615" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,599</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_1619" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,585</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of options</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<span style="-sec-ix-hidden:Fxbrl_20220218194046617">*</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<span style="-sec-ix-hidden:Fxbrl_20220309121931734">*</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220309122138424" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218184714249" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<span style="-sec-ix-hidden:Fxbrl_20220218193953855">*</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance of ordinary shares, net of issuance expenses (see note 19c)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316131219840_xbrl_20220218185921665" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316131219840_xbrl_20220217153716014_187" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,389</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316131219840_xbrl_20220218184754752" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316131219840_xbrl_20220218184812008" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316131219840_xbrl_20220217153716014_1819" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,429</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of pre-funded warrants (see note 19c)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316131501539_xbrl_20240316131219840_xbrl_20220218185921665" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316131501539_xbrl_20240316131219840_xbrl_20220217153716014_187" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,678</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316131501539_xbrl_20240316131219840_xbrl_20220218184754752" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316131501539_xbrl_20240316131219840_xbrl_20220218184812008" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316131501539_xbrl_20240316131219840_xbrl_20220217153716014_1819" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,706</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218185921665" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_187" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,946</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218184754752" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218184812008" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_1819" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,946</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:4px;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2022</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_193" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">143</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_197" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">178,882</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_1911" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_1915" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">168,106</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_1919" name="ifrs-full:Equity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,914</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2021</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_213" name="ifrs-full:Equity" contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_217" name="ifrs-full:Equity" contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">142,193</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_2111" name="ifrs-full:Equity" contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">40</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_2115" name="ifrs-full:Equity" contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">134,956</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_2119" name="ifrs-full:Equity" contextRef="C_20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,272</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218184923239" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218184950407" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218185019824" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_2315" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13,551</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_2319" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13,551</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other comprehensive income</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218185103905" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218185119152" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_2411" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218185137255" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_2419" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total comprehensive loss</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218185220488" name="ifrs-full:ComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218185232968" name="ifrs-full:ComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_2511" name="ifrs-full:ComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_2515" name="ifrs-full:ComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13,551</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_2519" name="ifrs-full:ComprehensiveIncome" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13,530</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of options</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<span style="-sec-ix-hidden:Fxbrl_20220218194059574">*</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220309122501805" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220309122512511" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218185315392" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218194110309" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px;vertical-align:bottom">
            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218185335904" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_277" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,673</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218185356192" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218185413288" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_2719" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,673</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:4px;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_283" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217153716014_287" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">143,869</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_2811" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_2815" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">148,507</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217153716014_2819" name="ifrs-full:Equity" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,582</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>

    </table>
    <div style="text-align:justify;line-height:1.25">&#160;</div>
    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">* Represents an amount lower than $1.</span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of the consolidated financial statements.</span></span></div>
    <div style="text-align:justify;line-height:1.25">
      <p style="margin:0pt">&#160;</p>
      <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 6</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always;margin-bottom:10pt"/></div></div>
    </div>
  </div>
</div><div style="">
  <div>
    <div style="line-height:1.25">
      <div style="text-align:justify;line-height:1.25;font-weight:bold">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">MEDIWOUND LTD. AND ITS SUBSIDIARIES</span></p>
        <p style="text-align:right;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      </div>
    </div>
    <div style="line-height:1.25">
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">
        <div style="text-align:justify;line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt">
          <p style="margin-top:0pt;margin-bottom:5pt;text-align:left"><span id="Cash_integixAnchor"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Consolidated Statements of Cash Flows</span></span></p>
          <hr style="height:1px;width:100%;color:rgb(0, 0, 0);background-color:rgb(0, 0, 0);margin:0pt auto;border:none;text-align:center"/>
        </div>
      </div>
      <div style="text-align:justify;line-height:1.25;font-weight:bold;margin-top:5pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">U.S. dollars in thousands</span></div>
      <div style="text-align:justify;line-height:1.25;font-weight:bold">&#160;</div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

        <tr>
          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31,</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Cash flows from operating activities:</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211016101215111" name="ifrs-full:ProfitLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,716</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211016101231434" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,599</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211016101235471" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13,551</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments to reconcile net loss to net cash used in operating activities:</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments to profit and loss items:</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,303</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,272</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,238</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,940</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,946</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,673</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revaluation of warrants accounted at fair value</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240316141511211_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111" name="mdwd:AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,310</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316141511211_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434" name="mdwd:AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,977</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316141511211_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471" name="mdwd:AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance expenses of warrants through profit and loss</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316141550249_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111" name="mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316141550249_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434" name="mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,911</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316141550249_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471" name="mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revaluation of liabilities in respect of IIA grants</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111" name="mdwd:AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">427</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434" name="mdwd:AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">132</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471" name="mdwd:AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">919</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revaluation of liabilities in respect of TEVA</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111" name="ifrs-full:OtherAdjustmentsToReconcileProfitLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">468</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434" name="ifrs-full:OtherAdjustmentsToReconcileProfitLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">533</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471" name="ifrs-full:OtherAdjustmentsToReconcileProfitLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">590</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financing income and exchange differences of lease liability</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316141620137_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111" name="mdwd:AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">257</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240316141620137_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434" name="mdwd:AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">109</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316141620137_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471" name="mdwd:AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">188</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase in severance pay liability, net</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">83</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">109</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other income</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240316141632821_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111" name="ifrs-full:OtherIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">211</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316141632821_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434" name="ifrs-full:OtherIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316141632821_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471" name="ifrs-full:OtherIncome" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial income, net</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111" name="ifrs-full:AdjustmentsForFinanceIncomeCost" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,231</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434" name="ifrs-full:AdjustmentsForFinanceIncomeCost" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471" name="ifrs-full:AdjustmentsForFinanceIncomeCost" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Un-realized foreign currency loss (gain)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">189</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">525</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">137</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211016101618017" name="ifrs-full:AdjustmentsForReconcileProfitLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,085</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101634034" name="ifrs-full:AdjustmentsForReconcileProfitLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,958</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101639522" name="ifrs-full:AdjustmentsForReconcileProfitLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,473</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in asset and liability items:</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Decrease (increase) in trade receivables</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,658</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,582</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">929</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Decrease (increase) in inventories</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">906</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">721</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">257</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Decrease (increase) in other receivables</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">894</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">364</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">763</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase (decrease) in trade payables and accrued expenses</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211016101805291_xbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">594</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101805291_xbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">414</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101805291_xbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,723</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase (decrease) in other payables</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211016101824923_xbrl_20211016101805291_xbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111" name="mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">928</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101824923_xbrl_20211016101805291_xbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434" name="mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">281</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211016101824923_xbrl_20211016101805291_xbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471" name="mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,984</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101852444" name="mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,336</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211016101905860" name="mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,244</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211016101913746" name="mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">162</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash used in operating activities</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211016102741060_xbrl_20211016102706044_xbrl_20211016101930446_xbrl_20211016101824923_xbrl_20211016101805291_xbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">10,465</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211016102741060_xbrl_20211016102706044_xbrl_20211016101930446_xbrl_20211016101824923_xbrl_20211016101805291_xbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">11,885</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211016102741060_xbrl_20211016102706044_xbrl_20211016101930446_xbrl_20211016101824923_xbrl_20211016101805291_xbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,916</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>

    </table>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of the consolidated financial statements.</span></span></div>
    <div style="text-align:justify;line-height:1.25">
      <p style="margin:0pt">&#160;</p>
      <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 7</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always;margin-bottom:10pt"/></div></div>
    </div>
    <div style="line-height:1.25">
      <div style="text-align:justify;line-height:1.25;font-weight:bold">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">MEDIWOUND LTD. AND ITS SUBSIDIARIES</span></span></div>
      </div>
      <div style="text-align:justify;line-height:1.25;font-weight:bold">&#160;</div>
      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consolidated Statements of Cash Flows</span></span>
        <hr style="height:1px;width:100%;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center"/>
      </div>
    </div>
    <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">U.S. dollars in thousands</span></span></div>
    <div style="text-align:justify;line-height:1.25;font-weight:bold">&#160;</div>
    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

        <tr>
          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31,</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Cash flows from investing activities:</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchase of property and equipment</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217142047413_43" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,464</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217142047413_47" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">555</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217142047413_411" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">489</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest received</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217142047413_53" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,947</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217142047413_57" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217142047413_511" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds from (investment in) short term bank deposits, net</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217142047413_63" name="ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">29,804</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217142047413_67" name="ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217142047413_611" name="ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,002</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash (used in) provided by investing activities</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217142047413_123" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">34,321</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217142047413_127" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">481</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217142047413_1211" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,548</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Cash flows from financing activities:</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Repayment of leases liabilities</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217142047413_163" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">778</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217142047413_167" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">701</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217142047413_1611" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">693</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds from exercise of options</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217142047413_173" name="ifrs-full:ProceedsFromExerciseOfOptions" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<span style="-sec-ix-hidden:Fxbrl_20220218200654710">*</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218200700141" name="ifrs-full:ProceedsFromExerciseOfOptions" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds from exercise of pre-funded warrants</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316143424385_xbrl_20220217145205091_xbrl_20220217142047413_163" name="ifrs-full:ProceedsFromExerciseOfWarrants" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316143424385_xbrl_20220217145205091_xbrl_20220217142047413_167" name="ifrs-full:ProceedsFromExerciseOfWarrants" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316143424385_xbrl_20220217145205091_xbrl_20220217142047413_1611" name="ifrs-full:ProceedsFromExerciseOfWarrants" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds from issuance of shares and warrants, net</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316143455726_xbrl_20220217145205091_xbrl_20220217142047413_163" name="mdwd:ProceedsFromIssuanceOfSharesAndWarrantsNet" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,909</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316143455726_xbrl_20220217145205091_xbrl_20220217142047413_167" name="mdwd:ProceedsFromIssuanceOfSharesAndWarrantsNet" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,380</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316143455726_xbrl_20220217145205091_xbrl_20220217142047413_1611" name="mdwd:ProceedsFromIssuanceOfSharesAndWarrantsNet" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Repayment of IIA grants, net</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217145205091_xbrl_20220217142047413_163" name="mdwd:RepaymentsOfIiaGrantsNet" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">380</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217145205091_xbrl_20220217142047413_167" name="mdwd:RepaymentsOfIiaGrantsNet" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">258</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217145205091_xbrl_20220217142047413_1611" name="mdwd:RepaymentsOfIiaGrantsNet" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">360</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Repayment of liabilities in respect of TEVA</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240316143540953_xbrl_20220217145205091_xbrl_20220217142047413_163" name="mdwd:RepaymentOfLiabilitiesInRespectOfTeva" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">834</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240316143540953_xbrl_20220217145205091_xbrl_20220217142047413_167" name="mdwd:RepaymentOfLiabilitiesInRespectOfTeva" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,667</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316143540953_xbrl_20220217145205091_xbrl_20220217142047413_1611" name="mdwd:RepaymentOfLiabilitiesInRespectOfTeva" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash provided by (used in) financing activities</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217142047413_203" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,917</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217142047413_207" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,764</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217142047413_2011" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,050</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchange rate differences on cash and cash equivalent balances</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217142047413_223" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">160</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217142047413_227" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">549</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217142047413_2211" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">88</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase (decrease) in cash and cash equivalents</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217142047413_243" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">22,029</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217142047413_247" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,849</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217142047413_2411" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,330</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance of cash and cash equivalents at the beginning of the year</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217144517553_xbrl_20220217142047413_313" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,895</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217144517553_xbrl_20220217142047413_317" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,046</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217144517553_xbrl_20220217142047413_3111" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,376</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance of cash and cash equivalents at the end of the year</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217144520381_xbrl_20220217142047413_313" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,866</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217144520381_xbrl_20220217142047413_317" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,895</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217144520381_xbrl_20220217142047413_3111" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,046</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Supplement disclosure of non-cash transactions:</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ROU asset, net recognized with corresponding lease liability</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217142047413_313" name="ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,825</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217142047413_317" name="ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">117</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217142047413_3111" name="ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">155</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
            <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchase of property and equipment</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240316144915962_xbrl_20220217142047413_313" name="mdwd:PurchaseOfPropertyAndEquipment" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,011</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316144915962_xbrl_20220217142047413_317" name="mdwd:PurchaseOfPropertyAndEquipment" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240316144915962_xbrl_20220217142047413_3111" name="mdwd:PurchaseOfPropertyAndEquipment" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>

    </table>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">* Represents an amount lower than $1.</span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of the consolidated financial statements.</span></span></div>
    <div style="text-align:justify;line-height:1.25">
      <p style="margin:0pt">&#160;</p>
      <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 8</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always;margin-bottom:10pt"/></div></div>
    </div>
  </div>
</div><div style="">
  <div style="margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman, Times, serif;font-size:10pt;font-style:normal;color:rgb(0, 0, 0);line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></div>
  <div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div>
  <div>
    <div style="text-align:justify">
      <p style="margin-top:0pt;margin-bottom:4pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left"><span id="Notes_integixAnchor"><strong>Notes to the Consolidated Financial Statements</strong></span></p>
      <hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/>
    </div>
  </div>
  <div style="text-align:justify"><span style="font-family:Times New Roman, Times, serif;font-size:10pt;font-style:normal;color:rgb(0, 0, 0);line-height:1;font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></div>
  <div style="text-align:justify">&#160;</div>
  <div>
    <ix:nonNumeric id="Fxbrl_20240317140107121" name="ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" contextRef="C_20230101to20231231" escape="true">
      <div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 1:</span></span></td>
              <td style="width:auto;vertical-align:top">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Description of the Company and its operations:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">MediWound Ltd. Was incorporated in Israel in January 2000. The Company which is located in Yavne, Israel (The "Company" or "MediWound"), is biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic, non-surgical solutions for tissue repair and regeneration. The Company&#8217;s strategy leverages its breakthrough enzymatic technology platform into diversified portfolio of biotherapeutics across multiple indications to pioneer solutions for unmet medical needs. The Company&#8217;s current portfolio is focused on next-generation protein-based therapies for burn care, wound care and tissue repair.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25">
          <div style="line-height:1.25;font-family:'Times New Roman',serif">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's first innovative biopharmaceutical product, Nexobrid, has received in December 2022, an approval from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) and marketing approval in each of India, Switzerland and Japan. In addition, it has a marketing authorization from the European Medicines Agency (&#8220;EMA&#8221;) and regulatory agencies in other international markets for removal of dead or damaged tissue, known as eschar, in adults with deep partial and full thickness thermal burns.</span></span></div>
          </div>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company commercialize Nexobrid globally through multiple sales channels.</span></span></div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',serif">&#160;</div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company sells Nexobrid to burn centers in the European Union, United Kingdom and Israel, primarily through its commercial organizations.</span></span></div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',serif">&#160;</div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has established local distribution channels in multiple international markets, focusing on Asia Pacific, EMEA, CEE and LATAM, which local distributors are also responsible for obtaining local marketing authorization within the relevant territories.</span></span></div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',serif">&#160;</div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In the United States, the Company entered into an exclusive license and supply agreements with Vericel Corporation (&#8220;Vericel&#8221;) to commercialize Nexobrid in North America upon FDA approval. On September 21, 2023, the Company announced the U.S. commercial availability of Nexobrid&#174; for the removal of eschar in adults with deep partial- and/or full-thickness thermal burns.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25">
          <div style="line-height:1.25;font-family:'Times New Roman',serif">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On September 20, 2022, The Company announced that EMA has validated for review the Type II Variation to expand the currently approved indication for Nexobrid (removal of eschar in adults with deep partial-and full-thickness thermal burn wounds) into the pediatric population.</span></span></div>
          </div>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s second investigational next-generation enzymatic therapy product, EscharEx, a topical biological drug being developed for debridement of chronic and other hard-to-heal wounds,</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On November 21, 2023 the Company announced in relate to EscharEx clinical trial that an updated Phase III protocol will be submitted during first half of 2024 in accordance with recent discussions with the U.S. FDA and EMA. Study initiation is expected to commence in the second half of 2024.</span></span></div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25">&#160;</div>
        <div><ix:exclude>
          <div style="line-height:1.25">
            <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 9</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
          </div>
          <div style="text-align:justify;line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                <tr>
                  <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 1:</span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">General&#160;</span><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">(Cont.)</span></div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="text-align:justify;line-height:1.25">&#160;</div>
        </ix:exclude></div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

              <tr style="vertical-align:top">
                <td style="width:56.7pt">&#160;</td>
                <td style="text-align:right;vertical-align:top;width:28.35pt">
                  <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">b.</span></span></span></div>
                </td>
                <td style="text-align:left;vertical-align:top;width:auto">
                  <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's securities are listed for trading on NASDAQ since March 2014.</span></span></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On November 28, 2022, the Company&#8217;s shareholders general meeting approved a reverse stock split. Following that approval, on December 5, 2022, the Company&#8217;s board of directors approved a reverse stock split, in a range of <ix:nonNumeric id="Fxbrl_20240317135305955" name="mdwd:ReverseStockSplit" contextRef="C_20221101to20221128">1-for-7 ratio</ix:nonNumeric>. The reverse split went effective on December 20, 2022. (see also Note 19b).</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During March, September and October 2022, the Company completed a series of capital public and private offerings. The gross proceeds before deducting underwriting discounts and commissions and offering expenses, were approximately $<ix:nonFraction id="Fxbrl_20240317140125003" name="mdwd:GrossProceedsFromPublicAndPrivateOfferings" contextRef="C_20220301to20221031" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,700</ix:nonFraction>. The net proceeds were approximately $<ix:nonFraction id="Fxbrl_20240317140246682" name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" contextRef="C_20220301to20221031" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">37,292</ix:nonFraction> (see also Note 19).</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On February 7, 2023, the Company completed a registered direct offering. A total of <ix:nonFraction id="Fxbrl_20240317140806785" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20230207" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">1,964,286</ix:nonFraction> new ordinary shares were issued in consideration to offering price of $<ix:nonFraction id="Fxbrl_20240317140933686" name="ifrs-full:ParValuePerShare" contextRef="C_20230207" unitRef="USD_Per_Share" scale="0" decimals="0" format="ixt:num-dot-decimal">14</ix:nonFraction> per share. The gross proceeds were $<ix:nonFraction id="Fxbrl_20240317140644952" name="mdwd:GrossProceedsFromPublicAndPrivateOfferings" contextRef="C_20230201to20230207" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,500</ix:nonFraction>, before deducting commissions and other offering expenses. The net proceeds were approximately $<ix:nonFraction id="Fxbrl_20240317140624101" name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" contextRef="C_20230201to20230207" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,469</ix:nonFraction>.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has three wholly owned subsidiaries: MediWound Germany GmbH, acting as Europe (&#8220;EU&#8221;) marketing authorization holder and EU sales and marketing arm, and MediWound UK Limited and MediWound US, Inc. which are currently inactive companies.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div>
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In October 2023, Israel was attacked by a terrorist organization and entered a state of war. As of the date of these consolidated financial statements, the war in Israel is ongoing and continues to evolve. The company&#8217;s head quarter, manufacturing and R&amp;D facilities are located in Israel. Currently, such activities in Israel remain largely unaffected. During the year ended December 31, 2023, the impact of this war on the company&#8217;s results of operations and financial condition was immaterial.</span></span></p>
                </div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying consolidated financial statements have been prepared on a basis which assumes that the Company will continue as a going concern. From inception to December 31, 2023, the Company has incurred cash outflows from operations, losses from operations, and has an accumulated deficit of $<ix:nonFraction id="Fxbrl_20240317141029683" name="ifrs-full:RetainedEarnings" contextRef="C_20231231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal" sign="-">174.8</ix:nonFraction> million.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="text-align:justify;margin-left:81.8pt;line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company believes that its existing cash and cash equivalents, short-term and restricted bank deposits of $<ix:nonFraction id="Fxbrl_20240317193548688" name="mdwd:CashAndCashEquivalentsShortTermAndRestrictedBankDeposits" contextRef="C_20231231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">41.7</ix:nonFraction> million as of December 31, 2023, will be sufficient to fund its operations and capital expenditure for at least twelve months from the date of issuance of these consolidated financial statements.</span></span></div>
      </div>
    </ix:nonNumeric>
    <p style="margin:0pt">&#160;</p>
    <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 10</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
  </div>
</div><div style="">
  <ix:nonNumeric id="Fxbrl_20240316160706785" name="ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" contextRef="C_20230101to20231231" escape="true">
    <div>
      <div style="text-align:justify;line-height:1.25;font-weight:bold">
        <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 2:</span></td>
              <td style="width:auto;vertical-align:top">
                <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Basis of Preparation of the Consolidated Financial Statements</span></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:56.7pt">&#160;</td>
            <td style="width:28.35pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
            <td style="width:auto;vertical-align:top;text-align:justify">
              <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Statement of compliance with International Financial Reporting Standards</span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB").</span></span></div>
      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These consolidated financial statements were approved by the board of directors on March 21, 2024.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:56.7pt">&#160;</td>
            <td style="width:28.35pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
            <td style="width:auto;vertical-align:top;text-align:justify">
              <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Functional currency, reporting currency and foreign currency:</span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:85.05pt">&#160;</td>
            <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
            <td style="width:auto;vertical-align:top;text-align:justify">
              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Functional currency and reporting currency:</span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The reporting currency of the financial statements is the U.S. dollar.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company determines the functional currency based on the currency in which it primarily generates and expends cash. The Company determined that its functional currency is the U.S. dollar since most of the Company's revenues are in U.S. dollars and the economic environment in which the Company operates in and performs its transactions is mostly affected by the U.S dollar. A certain portion of the Company's costs are denominated in NIS mainly due to payroll and related benefit costs incurred in Israel. To further support the Company's determination, the Company has analyzed the currency in which funds from financing activities are generated or held and the currency in which receipts from operating activities are usually retained. In this respect, funds from financing activities were principally derived from significant funds raising in U.S. dollars and U.S governmental funds.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company operates and plans its activities in U.S. dollars and accordingly its periodic budgets and internal management reports are prepared and monitored using the U.S. dollar as the primary currency and provides the basis for the determination of share-based compensation.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The&#160;</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt">functional currency of the Company's subsidiary in Germany has been determined to be its local currency - the EURO. Assets and liabilities of this subsidiary are translated at year end exchange rates and its statement of operations&#160;</span><span style="font-family:Times New Roman, Times, serif;font-size:10pt">items are translated using the average exchange rates at the quarter of which those items are recognized. Such translation adjustments are recorded as a separate component of accumulated other comprehensive income (loss) in shareholders' equity (deficit).</span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:85.05pt">&#160;</td>
            <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
            <td style="width:auto;vertical-align:top;text-align:justify">
              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transactions, assets and liabilities in foreign currency:</span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transactions denominated in foreign currency are recorded upon initial recognition at the exchange rate on the date of the transaction. After initial recognition, monetary assets and liabilities denominated in foreign currency are translated at the end of each reporting period into the functional currency at the exchange rate at that date.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchange differences are recognized in profit or loss.</span></span></div>
      <div style="text-align:justify;margin-left:113.4pt;line-height:1.25">&#160;</div>
      <div><ix:exclude>
        <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
          <div style="text-align:center;margin-top:0pt;margin-bottom:0pt">
            <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 11</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
          </div>
        </div>
        <div style="text-align:justify;line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt">
          <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 2:</span></td>
                <td style="width:auto;vertical-align:top">
                  <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Basis of Preparation of the Consolidated Financial Statements&#160;</span><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman, Times, serif">(Cont.)</span></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="text-align:justify;line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      </ix:exclude></div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:56.7pt">&#160;</td>
            <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
            <td style="width:auto;vertical-align:top;text-align:justify">
              <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Use of estimates and judgments</span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of financial statements in conformity with IFRSs requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates.</span></span></div>
      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Discussed below are the key assumptions made in the financial statements concerning uncertainties at the end of the reporting period and the critical estimates computed by the Company that may result in a material adjustment to the carrying amounts of assets and liabilities within the next financial year.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:56.7pt">&#160;</td>
            <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
            <td style="width:auto;vertical-align:top;text-align:justify">
              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Determining the fair value of share-based compensation to employees and directors:</span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25;margin-left:85pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of share-based compensation to employees and directors is determined using the binomial option pricing models. The assumptions used in the models include the expected volatility, early exercise factor, expected dividend and risk-free interest rate.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:56.7pt">&#160;</td>
            <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
            <td style="width:auto;vertical-align:top;text-align:justify">
              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Liabilities in respect to IIA grants:</span></span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government grants received from the IIA are recognized as a liability if future economic benefits are expected from the research and development activity that will result in royalty&#8209;bearing sales. As the contingent liability is calculated based on future royalty-bearing sales, there is uncertainty regarding the estimated future cash flows and the estimated discount rate used to measure the amortized cost of the liability.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25">
        <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#8226;</span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Fair value estimations of warrants</span></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25;margin-left:85pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company completed financing transactions in which it issued shares and warrants to purchase additional shares. The fair value of the warrants, which are not traded on an active market, is determined by using valuation techniques. These valuation techniques maximize the use of observable market data where it is available and rely as little as possible on entity specific estimates.</span></span></div>
    </div>
  </ix:nonNumeric>
  <p style="margin:0pt">&#160;</p>
  <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 12</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
</div><div style="">
  <div>
    <div>
      <div>
        <div>
          <div>
            <ix:nonNumeric id="Fxbrl_20240317144956402" name="ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory" contextRef="C_20230101to20231231" escape="true">
              <div>
                <div style="line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 3:</span></td>
                        <td style="width:auto;vertical-align:top">
                          <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">Material Accounting Policies</span></div>
                        </td>
                      </tr>

                  </table>
                </div>
                <div style="text-align:justify;margin-left:36pt;line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accounting policies set out below have been consistently applied for all periods presented in these consolidated financial statements:</span></span></div>
                <div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25">&#160;</div>
                <div>
                  <div>
                    <ix:nonNumeric id="Fxbrl_20240317155148965" name="mdwd:DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory" contextRef="C_20230101to20231231" escape="true">
                      <div>
                        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                            <tr>
                              <td style="width:56.7pt">&#160;</td>
                              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                              <td style="width:auto;vertical-align:top;text-align:justify">
                                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basis of consolidation:</span></span></div>
                              </td>
                            </tr>

                        </table>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consolidated financial statements include the financial statements of companies that the Company controls (subsidiaries). Control is achieved when the Company is exposed, or has rights, to variable returns from its investment with the investee and has the ability to affect those returns through its power over the investee.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The financial statements of the Company and its subsidiaries are prepared as of the same dates and periods. The consolidated financial statements are prepared using uniform accounting policies by all entities in the Group.</span></span></div>
                      </div>
                    </ix:nonNumeric>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                  </div>
                </div>
                <ix:nonNumeric id="Fxbrl_20240317152649731" name="ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories" contextRef="C_20230101to20231231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories are measured at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated selling costs. The Company periodically evaluates the condition and age of inventories and makes provisions for slow moving inventories accordingly.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of inventories is determined as follows:</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="margin-left:90pt">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="width:19.52%;vertical-align:top">
                              <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Raw materials</span></span></div>
                            </td>
                            <td style="width:3.54%;vertical-align:top">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                            </td>
                            <td style="width:76.94%;vertical-align:top">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At cost of purchase using the first-in, first-out method.</span></span></div>
                            </td>
                          </tr>
                          <tr>
                            <td style="width:19.52%;vertical-align:top">
                              <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished goods</span></span></div>
                            </td>
                            <td style="width:3.54%;vertical-align:top">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                            </td>
                            <td style="width:76.94%;vertical-align:top">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On the basis of average standard costs (which approximates actual cost on a weighted average basis) including materials, labor and other direct and indirect manufacturing costs based on practical capacity.</span></span></div>
                            </td>
                          </tr>

                      </table>
                    </div>
                  </div>
                </ix:nonNumeric>
                <div>&#160;</div>
                <ix:nonNumeric id="Fxbrl_20240317152657840" name="ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" contextRef="C_20230101to20231231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment, net:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment are measured at cost, including directly attributable costs, less accumulated depreciation and accumulated impairment losses. Cost includes spare parts and auxiliary equipment that are used in connection with the plant and equipment.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation is calculated on a straight&#8209;line basis over the useful life of the assets at annual rates as follows:</span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div style="margin-left:90pt">
                      <ix:nonNumeric id="Fxbrl_20240317155248766" name="mdwd:DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory" contextRef="C_20230101to20231231" escape="true">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="width:70.35%;vertical-align:bottom">&#160;</td>
                              <td style="width:2.82%;vertical-align:top">&#160;</td>
                              <td style="width:26.82%;vertical-align:bottom;border-bottom:#000000 2px solid">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:70.35%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office furniture</span></span></div>
                              </td>
                              <td style="width:2.82%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                              <td style="width:26.82%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20210923195823270" name="ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">7-10</ix:nonNumeric></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:70.35%;vertical-align:top">
                                <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacturing machinery and lab equipment</span></span></div>
                              </td>
                              <td style="width:2.82%;vertical-align:top">&#160;</td>
                              <td style="width:26.82%;vertical-align:bottom">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20210923200118067" name="ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember">15-33</ix:nonNumeric></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:70.35%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computers</span></span></div>
                              </td>
                              <td style="width:2.82%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                              <td style="width:26.82%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20210923200133291" name="ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">33</ix:nonNumeric></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:70.35%;vertical-align:top">
                                <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold improvements</span></span></div>
                              </td>
                              <td style="width:2.82%;vertical-align:top">&#160;</td>
                              <td style="width:26.82%;vertical-align:bottom">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240317194123497" name="ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">See below</ix:nonNumeric></span></span></div>
                              </td>
                            </tr>

                        </table>
                      </ix:nonNumeric>
                    </div>
                    <p style="margin:0pt">&#160;</p>
                    <div><ix:exclude>
                      <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 13</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 3:</span></span></td>
                            <td style="width:auto;vertical-align:top">
                              <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Material Accounting Policies (Cont.)</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
                    </ix:exclude></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold improvements are depreciated on a straight&#8209;line basis over the shorter of the lease term (including the renewal option held by the Company which is expected to be exercised) and the expected life of the improvement.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The useful life, depreciation method and residual value of an asset are reviewed at least each year-end and any changes are accounted for prospectively as a change in accounting estimate.</span></span></div>
                  </div>
                </ix:nonNumeric>
                <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20240317152705727" name="ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants" contextRef="C_20230101to20231231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liability in respect of Israeli Innovation Authority ("IIA"):</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Grants from the IIA in respect of research and development projects are accounted for as forgivable loans according to IAS 20. Grants received from the IIA are recognized as a liability according to their fair value on the date of their receipt, unless on that date it is reasonably certain that the amount received will not be refunded. If future economic benefits are expected from the project that will result in royalty-bearing revenues from sale of products it will be treated as a contingent liability.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At the end of each reporting period, the Company evaluates whether there is reasonable assurance that the liability recognized, in whole or in part, will not be repaid based on its best estimate of future sales and any changes in the present value of the cash flows discounted at the original interest rate of the grant are recognized in profit or loss. The difference between the amount received and the fair value on the date of receiving the grant is recognized as a deduction of research and development expenses.</span></span></div>
                  </div>
                </ix:nonNumeric>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20240317152713358" name="ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory" contextRef="C_20230101to20231231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leases:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for a contract as a lease when the contract terms convey the right to control the use of an identified asset for a period of time in exchange for consideration.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For these excluded leases, the Company has elected to recognize the lease payments as an expense in profit or loss on a straight-line basis over the lease term. In measuring the lease liability, the Company has elected to apply the practical expedient in the Standard and does not separate the lease components from the non-lease components (such as management and maintenance services, etc.) included in a single contract.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Following are the amortization periods of the ROU assets by class of underlying asset:</span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div style="margin-left:90pt">
                      <ix:nonNumeric id="Fxbrl_20240317155308861" name="mdwd:ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock" contextRef="C_20230101to20231231" escape="true">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="width:65.06%;vertical-align:top">&#160;</td>
                              <td style="width:3.87%;vertical-align:top">&#160;</td>
                              <td style="width:27.2%;vertical-align:top;border-bottom:#000000 2px solid">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Years</span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:65.06%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-indent:-7.1pt;margin-left:7.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                              </td>
                              <td style="width:3.87%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                              <td style="width:27.2%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220309191248728" name="mdwd:AmortizationPeriodsOfRightOfUseAssets" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember">3</ix:nonNumeric></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:65.06%;vertical-align:bottom">
                                <div style="text-indent:-7.1pt;margin-left:7.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
                              </td>
                              <td style="width:3.87%;vertical-align:bottom">&#160;</td>
                              <td style="width:27.2%;vertical-align:bottom">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20210923195737956" name="mdwd:AmortizationPeriodsOfRightOfUseAssets" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_mdwdBuildingAndEquipmentMember">6-15</ix:nonNumeric></span></span></div>
                              </td>
                            </tr>

                        </table>
                      </ix:nonNumeric>
                    </div>
                    <p style="margin:0pt">&#160;</p>
                    <div><ix:exclude>
                      <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 14</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 3:</span></span></td>
                            <td style="width:auto;vertical-align:top">
                              <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Material Accounting Policies (Cont.)</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
                    </ix:exclude></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company tests for impairment of the ROU asset whenever there are indications of impairment pursuant to the provisions of IAS 36.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Variable lease payments that depend on an index:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:104.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On the commencement date, the Company uses the index rate prevailing on the commencement date to calculate the future lease payments.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:104.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For leases in which the Company is the lessee, the aggregate changes in future lease payments resulting from a change in the index are discounted (without a change in the discount rate applicable to the lease liability) and recorded as an adjustment of the lease liability and the ROU assets, only when there is a change in the cash flows resulting from the change in the index (that is, when the adjustment to the lease payments takes effect).</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease extension and termination options:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:104.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A non-cancelable lease term includes both the periods covered by an option to extend the lease when it is reasonably certain that the extension option will be exercised and the periods covered by a lease termination option when it is reasonably certain that the termination option will not be exercised.</span></span></div>
                  </div>
                </ix:nonNumeric>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20240317152726559" name="ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue" contextRef="C_20230101to20231231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">f.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues recognition:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="text-align:justify;text-indent:-7.05pt;margin-left:56.7pt;line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes revenue when the customer obtains control over the promised goods or services. The revenue is measured according to the amount of the consideration to which the Company expects to be entitled in exchange for the goods or services promised to the customer, other than amounts collected for third parties.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company determines transaction price based on the amount of consideration the Company expects to receive for transferring the promised goods or services in the contract.</span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consideration may be fixed, variable, or a combination of both. At contract inception for arrangements that include variable consideration, the Company estimates the probability and extent of consideration it expects to receive under the contract utilizing either the most likely amount method or expected amount method, whichever best estimates the amount expected to be received. The Company then considers any constraints on the variable consideration and includes in the transaction price variable consideration to the extent it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. The Company then allocates the transaction price to each performance obligation based on the relative standalone selling price and recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) control is transferred to the customer and the performance obligation is satisfied.</span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div><ix:exclude>
                      <div style="text-align:justify;line-height:1.25">
                        <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 15</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
                      </div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 3:</span></span></td>
                            <td style="width:auto;vertical-align:top">
                              <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Material Accounting Policies (Cont.)</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
                    </ix:exclude></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company records amounts as accounts receivable when the right to consideration is deemed unconditional. Amounts received, or that are unconditionally due, from a customer prior to transferring goods or services to the customer under the terms of a contract are recognized as deferred revenue. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as the current portion of deferred revenue. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s revenue-generating arrangements typically include licensing arrangements, which comprise of upfront license fees, milestone payments and/or royalties and products sale arrangements.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The promised goods or services in the Company&#8217;s licensing arrangements typically consist of a license to the Company&#8217;s intellectual property and/or research and development services.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If a license is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenue from nonrefundable, up-front fees allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For arrangements that include sales-based royalties, including milestone payments based on the level of sales, where the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <div style="line-height:1.25;font-family:'Times New Roman',serif">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In 2019, the Company entered into exclusive license and supply agreements with Vericel to commercialize Nexobrid in North America (see Note 22). The Company identified three distinct performance obligations: (1) license rights (2) development services for BLA approval and (3) manufacturing and supply of Nexobrid.</span></span></div>
                        </div>
                      </div>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of the closing date of the agreement the manufacturing and development services were at market value, therefore the upfront payment was fully attributed to the license performance obligation and as such revenues are recognized at the point in time that control of the license is transferred to the customer.</span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div><ix:exclude>
                      <div style="text-align:justify;line-height:1.25">
                        <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 16</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
                      </div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 3:</span></span></td>
                            <td style="width:auto;vertical-align:top">
                              <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Material Accounting Policies (Cont.)</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
                    </ix:exclude></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Future milestone payments are considered variable consideration and are subject to the variable consideration constraint, i.e. will be recognized once concluded that it is &#8220;probable&#8221; that a significant reversal of the cumulative revenues recognized under the contract will not occur in future periods when the uncertainty related to the variable considerations are resolved. (see Note 18b).</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from royalties under this agreement will be payable based on future commercial sales, up on an occurrence.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from the sale of products to Vericel will be recognized when all the significant risks and rewards of ownership of the products have passed to the buyer and the seller no longer retains continuing managerial involvement. The delivery date of the products is usually the date of which ownership passes.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from distribution licensing arrangements:</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for the bundled license provided to the distributers and related high specialized services as a single performance obligation and consequently recognize revenue using the cost-to-cost method, where the extent of progress towards completion is measured based on the ratio of actual costs incurred to the total estimated costs expected to be incurred upon satisfying such single performance obligation. The revenues from such bundled performance obligation are included within &#8220;Revenues from license agreements&#8221;. Significant finance components related to such arrangements are recognized as finance expense.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from development services:</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from development services are recognized over time, during the period the customer receives and consumes the benefits provided by the Company's performance.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from the sale of products:</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <div style="line-height:1.25;font-family:'Times New Roman',serif">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company generates revenues from sales of its innovative biopharmaceutical product, Nexobrid, to burn centers and hospital burn units in Europe, U.S Israel and local international markets through its commercial organizations and local distributors.</span></span></div>
                        </div>
                      </div>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from sale of goods is recognized in profit or loss at the point in time when the control of the goods is transferred to the customer, generally upon delivery of the goods to the customer. &#160;The transaction price is the amount of the consideration that is expected to be received based on the contract terms.</span></span></div>
                  </div>
                </ix:nonNumeric>
                <p style="margin:0pt">&#160;</p>
                <div><ix:exclude>
                  <div style="text-align:justify;line-height:1.25">
                    <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 17</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
                  </div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 3:</span></span></td>
                        <td style="width:auto;vertical-align:top">
                          <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Material Accounting Policies (Cont.)</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
                </ix:exclude></div>
                <ix:nonNumeric id="Fxbrl_20240317152733200" name="ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" contextRef="C_20230101to20231231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">g.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development expenses:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development expenses are recognized in profit or loss when incurred. An intangible asset arising from a development project or from the development phase of an internal project is recognized if the Company can demonstrate the technical feasibility of completing the intangible asset so that it will be available for use or sale; the Company's intention to complete the intangible asset and use or sell it; the Company's ability to use or sell the intangible asset; how the intangible asset will generate future economic benefits; the availability of adequate technical, financial and other resources to complete the intangible asset; and the Company's ability to measure reliably the expenditure attributable to the intangible asset during its development. Since the Company's research and development projects are often subject to regulatory approval procedures and other uncertainties, the conditions for the capitalization of costs incurred before receipt of approvals are not normally satisfied and, therefore, research and development expenses are recognized in profit or loss when incurred.</span></span></div>
                  </div>
                </ix:nonNumeric>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20240317152744327" name="ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" contextRef="C_20230101to20231231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">h.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial instruments:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accounting policy for financial instruments in accordance with IFRS 9, "Financial Instruments" ("the Standard") is as follows:</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial liabilities:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:113.4pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a)</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial liabilities measured at amortized cost:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:141.75pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of the financial liability.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:141.75pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">After initial recognition, the Company measures all financial liabilities at amortized cost using the effective interest rate method, except for financial liabilities at fair value through profit or loss such as derivatives;</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:113.4pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b)</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial liabilities measured at fair value through profit or loss:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:141.75pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At initial recognition, the Company measures financial liabilities that are not measured at amortized cost at fair value. Transaction costs are recognized in profit or loss.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:28.35pt;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">After initial recognition, changes in fair value are recognized in profit or loss.</span></span></div>
                    <div style="text-align:justify;text-indent:28.35pt;margin-left:113.4pt;line-height:1.25">&#160;</div>
                    <div><ix:exclude>
                      <div style="text-align:justify;line-height:1.25">
                        <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 18</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
                      </div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 3:</span></span></td>
                            <td style="width:auto;vertical-align:top">
                              <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Material Accounting Policies (Cont.)</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
                    </ix:exclude></div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value measurement is based on the assumption that the transaction will take place in the asset's or the liability's principal market, or in the absence of a principal market, in the most advantageous market.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.</span></span></div>
                    <div style="margin-left:113.4pt;line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A fair value measurement of a non-financial asset takes into account a market participant's ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.</span></span></div>
                  </div>
                </ix:nonNumeric>
                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20240317152751341" name="ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory" contextRef="C_20230101to20231231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrants:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:86.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Receipts in respect of warrants are classified as equity to the extent that they confer the right to purchase a fixed number of shares for a fixed exercise price. In the event that the exercise price or the numbers of shares to be issued are not deemed to be fixed (for example, in case of net share settlement provision), or warrants redemption in cash on the occurrence of Fundamental Transaction the warrants are classified as a non-current derivative financial liability. This liability is initially recognized at its fair value on the date the contract is entered into and subsequently accounted for at fair value at each reporting date. The fair value changes are charged to non-operating income and expense on the statement of comprehensive income or loss. Issuance costs allocable to warrants are also recorded as non-operating expense on the statement of comprehensive income or loss.</span></span></div>
                  </div>
                </ix:nonNumeric>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20240317152756457" name="ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory" contextRef="C_20230101to20231231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">j.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provisions:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:86.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A provision in accordance with IAS 37 is recognized when the Company has a present (legal or constructive) obligation as a result of a past event, it is expected to require the use of economic resources to clear the obligation and a reliable estimate has been made.</span></span></div>
                  </div>
                </ix:nonNumeric>
                <p style="margin:0pt">&#160;</p>
                <div><ix:exclude>
                  <div style="line-height:1.25">
                    <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 19</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
                  </div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 3:</span></span></td>
                        <td style="width:auto;vertical-align:top">
                          <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Material Accounting Policies (Cont.)</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
                </ix:exclude></div>
                <ix:nonNumeric id="Fxbrl_20240317152801869" name="ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" contextRef="C_20230101to20231231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">k.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term employee benefits and severance pay liability, net:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has several employee benefit plans:</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                          <tr style="vertical-align:top">
                            <td style="width:85.05pt">&#160;</td>
                            <td style="text-align:right;vertical-align:top;width:28.35pt">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>1.</span></span></span></div>
                            </td>
                            <td style="text-align:left;vertical-align:top;width:auto">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Short-term employee benefits:</span></span></span></div>
                            </td>
                          </tr>

                      </table>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term employee benefits include salaries, paid annual leave, recreation and social security contributions are recognized as expenses as the services are rendered.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                          <tr style="vertical-align:top">
                            <td style="width:85.05pt">&#160;</td>
                            <td style="text-align:right;vertical-align:top;width:28.35pt">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2.</span></span></span></div>
                            </td>
                            <td style="text-align:left;vertical-align:top;width:auto">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Post-employment benefits:</span></span></span></div>
                            </td>
                          </tr>

                      </table>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25">
                      <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has liabilities for severance pay for its employees in several of jurisdictions and in Israel.</span></span></div>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes liability for severance pay mainly due to its employees in EU in accordance with local laws.</span></span></div>
                  </div>
                </ix:nonNumeric>
                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20240317152806254" name="ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" contextRef="C_20230101to20231231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">l.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certain Company employees and directors are entitled to remuneration in the form of equity-settled share-based compensation.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Equity-settled transactions</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The cost of equity-settled transactions with employees is measured at the fair value of their equity instruments granted at grant date. The fair value is determined using the binomial option pricing model.</span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The cost of equity-settled transactions is recognized in profit or loss, together with a corresponding increase in equity, during the period which the performance or service conditions are to be satisfied, ending on the date on which the relevant employees become fully entitled to the award.</span></span></div>
                  </div>
                </ix:nonNumeric>
                <p style="margin:0pt">&#160;</p>
                <div><ix:exclude>
                  <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 20</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 3:</span></span></td>
                        <td style="width:auto;vertical-align:top">
                          <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Material Accounting Policies (Cont.)</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
                </ix:exclude></div>
                <ix:nonNumeric id="Fxbrl_20240317152811702" name="ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" contextRef="C_20230101to20231231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">m.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Profit / Loss per share:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company presents basic and diluted earnings per share (EPS) data for its ordinary shares. Basic EPS is calculated by dividing the profit or loss attributable to ordinary shareholders of the Company by the weighted average number of ordinary shares outstanding during the year, adjusted for treasury shares. Diluted EPS is determined by adjusting the profit or loss attributable to ordinary shareholders of the Company and the weighted average number of ordinary shares outstanding, after adjustment for treasury shares, for the effects of all dilutive potential ordinary shares, which comprise of warrants, share options and share options granted to employees.</span></span></div>
                  </div>
                </ix:nonNumeric>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20240317152816766" name="mdwd:DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory" contextRef="C_20230101to20231231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">n.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold">
                              <div style="line-height:1.25;font-family:'Times New Roman',serif;font-weight:bold">
                                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New standards, amendments to standards and interpretations not yet adopted:</span></span></div>
                              </div>
                            </div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:84.75pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amendment to IAS 1, Presentation of Financial Statements: "Disclosure of Accounting Policies&#8221;</span></span></div>
                    <div style="text-align:justify;margin-left:84.75pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As a result of applying the Amendment, the extent of the accounting policy disclosure provided in the financial statements for 2023 was reduced and adjusted according to the Company&#8217;s specific circumstances.</span></span></div>
                  </div>
                </ix:nonNumeric>
                <p style="margin:0pt">&#160;</p>
                <ix:nonNumeric id="Fxbrl_20240317152822094" name="mdwd:PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent" contextRef="C_20230101to20231231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">o.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Presentation of Financial Statements: Classification of Liabilities as Current or Non-Current (amendment to IAS 1)</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:84.75pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As a result of applying the Amendment the warrants presented in these financial statements (see note 19c), will be classified as a current liability pursuant to the conversion option.</span></span></div>
                  </div>
                </ix:nonNumeric>
              </div>
            </ix:nonNumeric>
            <p style="margin:0pt">&#160;</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div><div style="">
  <ix:nonNumeric id="Fxbrl_20210923204025899" name="ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory" contextRef="C_20230101to20231231" escape="true">
    <div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">
      <div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold">Note 4:</td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold">Cash and Cash Equivalents</div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <div style="margin-left:63pt">
            <ix:nonNumeric id="Fxbrl_20240316131040302" name="mdwd:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" contextRef="C_20230101to20231231" escape="true">
              <div>
                <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">December 31</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2023</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2022</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Balance in USD</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20210923203720228" name="ifrs-full:CashOnHand" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,151</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20210923203827155" name="ifrs-full:CashOnHand" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,475</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Balance in other currencies</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20210923203855089_xbrl_20210923203720228" name="mdwd:CashOnHandInNonUsd" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,715</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20210923203855089_xbrl_20210923203827155" name="mdwd:CashOnHandInNonUsd" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,420</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20210923203931881" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,866</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20210923203943140" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,895</ix:nonFraction></div>
                      </td>
                    </tr>

                </table>
              </div>
            </ix:nonNumeric>
          </div>
        </div>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin:0pt">&#160;</p>
</div><div style="">
  <ix:nonNumeric id="Fxbrl_20210924142615341" name="ifrs-full:DisclosureOfDepositsFromBanksExplanatory" contextRef="C_20230101to20231231" escape="true">
    <div>
      <div style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
        <table cellpadding="0" cellspacing="0" style="font-size:10pt;width:100%">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-weight:bold">Note 5:</td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold">Short-term and restricted bank deposits</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div>
          <div style="margin-top:0pt;margin-bottom:0pt">&#160;</div>
        </div>
      </div>
      <ix:nonNumeric id="Fxbrl_20240316132740771" name="mdwd:DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory" contextRef="C_20230101to20231231" escape="true">
        <div>
          <div>
            <div>
              <div style="margin-left:63pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">December 31</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2023</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2022</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Restricted bank deposits (1)</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20210924142234692_xbrl_20210924141709230" name="ifrs-full:RestrictedCashAndCashEquivalents" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">167</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20210924142234692_xbrl_20210924141809083" name="ifrs-full:RestrictedCashAndCashEquivalents" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">USD Bank deposits (2)</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20210924141709230" name="ifrs-full:BalancesWithBanks" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,675</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240317133507442" name="ifrs-full:BalancesWithBanks" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20210924142451838" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,842</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20210924142550763" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt">&#160;</td>
                    <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif">(1)</td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div>Restricted bank deposits which are primarily used as security for the Company&#8217;s office leases.</div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt">&#160;</td>
                    <td style="width:28.35pt;vertical-align:top">(2)</td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div>The USD deposits bear annual interest of <ix:nonFraction id="Fxbrl_20211217150651059" name="mdwd:DepositInterestRate" contextRef="C_20231231_ifrsfullTypesOfInterestRatesAxis_ifrsfullFixedInterestRateMember_srtCurrencyAxis_currencyUSD_srtRangeAxis_srtMinimumMember" unitRef="Percent" scale="-2" decimals="4" format="ixt:num-dot-decimal">6.26</ix:nonFraction>%-<ix:nonFraction id="Fxbrl_20240317132944227" name="mdwd:DepositInterestRate" contextRef="C_20231231_ifrsfullTypesOfInterestRatesAxis_ifrsfullFixedInterestRateMember_srtCurrencyAxis_currencyUSD_srtRangeAxis_srtMaximumMember" unitRef="Percent" scale="-2" decimals="4" format="ixt:num-dot-decimal">6.55</ix:nonFraction>% for the period of<ix:nonNumeric id="Fxbrl_20211217150658109" name="mdwd:PeriodOfBankDeposits" contextRef="C_20230101to20231231"> 91-365</ix:nonNumeric> days for 2023.</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </ix:nonNumeric>
    </div>
  </ix:nonNumeric>
  <p style="margin:0pt">&#160;</p>
  <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 21</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
</div><div style="">
  <ix:nonNumeric id="Fxbrl_20210924144658278" name="mdwd:DisclosureOfTradeReceivablesExplanatory" contextRef="C_20230101to20231231" escape="true">
    <div>
      <div style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
        <table cellpadding="0" cellspacing="0" style="font-size:10pt;width:100%">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-weight:bold">Note 6:</td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold">Trade Receivables</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div>
          <div>&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240316133512236" name="mdwd:DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory" contextRef="C_20230101to20231231" escape="true">
            <div>
              <div style="margin-left:63pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">December 31</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2023</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2022</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Vericel (Note 18b)</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20240316134842901" name="mdwd:CurrentVericel" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">236</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240316134911632" name="mdwd:CurrentVericel" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,500</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">BARDA (Note 18a)</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20210924144534542" name="mdwd:CurrentBarda" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,245</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20210924144539605" name="mdwd:CurrentBarda" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">701</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">MTEC (Note 18c)</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20240316135046488" name="mdwd:CurrentMtec" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">617</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240316135059120" name="mdwd:CurrentMtec" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">362</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Other trade receivables</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220217182003093_xbrl_20210924144551693_xbrl_20210924144534542" name="ifrs-full:OtherReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,608</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220217182003093_xbrl_20210924144551693_xbrl_20210924144539605" name="ifrs-full:OtherReceivables" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">771</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Less provision for impairment</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">(<ix:nonFraction id="Fxbrl_20220217182936923_xbrl_20210924144551693_xbrl_20210924144534542" name="mdwd:ProvisionForImpairment" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;padding-top:2pt">
                        <div style="line-height:1.25;font-weight:bold">)</div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220217182936923_xbrl_20210924144551693_xbrl_20210924144539605" name="mdwd:ProvisionForImpairment" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;padding-top:2pt">
                        <div style="line-height:1.25">)</div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20210924144621034" name="ifrs-full:CurrentTradeReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,700</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20210924144632488" name="ifrs-full:CurrentTradeReceivables" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,332</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>
        </div>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin:0pt">&#160;</p>
</div><div style="">
  <ix:nonNumeric id="Fxbrl_20240317140901199" name="ifrs-full:DisclosureOfInventoriesExplanatory" contextRef="C_20230101to20231231" escape="true">
    <div>
      <div style="text-align:justify;line-height:1.25">
        <table cellpadding="0" cellspacing="0" style="font-size:10pt;width:100%;border:0px">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 7:</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">Inventories</span></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="margin-left:63pt">&#160;</div>
      <ix:nonNumeric id="Fxbrl_20240317140920119" name="mdwd:DisclosureOfDetailedInformationAboutInventoriesExplanatory" contextRef="C_20230101to20231231" escape="true">
        <div>
          <div style="margin-left:63pt">
            <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Raw materials</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210924150042093" name="ifrs-full:RawMaterials" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">995</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210924150050154" name="ifrs-full:RawMaterials" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">913</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                    <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished goods</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*<ix:nonFraction id="Fxbrl_20240320231728040" name="ifrs-full:FinishedGoods" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,851</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210924150321233_xbrl_20210924150050154" name="ifrs-full:FinishedGoods" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,050</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210924150338938" name="ifrs-full:Inventories" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,846</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210924150354121" name="ifrs-full:Inventories" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,963</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;text-indent:0pt;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*Including write-down of $<ix:nonFraction id="Fxbrl_20240317140827055" name="ifrs-full:InventoryWritedown2011" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">326</ix:nonFraction></span></span></div>
        </div>
      </ix:nonNumeric>
    </div>
  </ix:nonNumeric>
  <p style="margin:0pt">&#160;</p>
</div><div style="">
  <div>
    <ix:nonNumeric id="Fxbrl_20240316151307597" name="ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory" contextRef="C_20230101to20231231" escape="true">
      <div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-weight:bold">Note 8:</td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold">Other Receivables- Short Term</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <ix:nonNumeric id="Fxbrl_20240316151347294" name="mdwd:DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div style="margin-left:63pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">December 31,</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2023</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2022</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Government authorities</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20210924151623228" name="mdwd:CurrentGovernmentAuthoritiesReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">322</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20210924151628521" name="mdwd:CurrentGovernmentAuthoritiesReceivables" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">193</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;vertical-align:bottom">
                      <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Income receivables</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20240316151939172_xbrl_20210924151721850_xbrl_20210924151623228" name="mdwd:IncomeReceivablesShortTerm" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">397</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240316151939172_xbrl_20210924151721850_xbrl_20210924151628521" name="mdwd:IncomeReceivablesShortTerm" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">170</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Prepaid expenses and other</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20210924151721850_xbrl_20210924151623228" name="ifrs-full:CurrentPrepaidExpenses" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">722</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20210924151721850_xbrl_20210924151628521" name="ifrs-full:CurrentPrepaidExpenses" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">287</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20210924151748068" name="ifrs-full:OtherCurrentReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,441</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20210924151757346" name="ifrs-full:OtherCurrentReceivables" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">650</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </ix:nonNumeric>
      </div>
    </ix:nonNumeric>
    <p style="margin:0pt">&#160;</p>
    <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 22</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
  </div>
</div><div style="">
  <div>
    <div>
      <ix:nonNumeric id="Fxbrl_20220310134452125" name="mdwd:DisclosureOfOtherReceivablesLongTermExplanatory" contextRef="C_20230101to20231231" escape="true">
        <div>
          <div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt;vertical-align:top;font-weight:bold">Note 9:</td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div style="font-weight:bold">Other Receivables- Long Term</div>
                    </td>
                  </tr>

              </table>
              <div>&#160;</div>
              <ix:nonNumeric id="Fxbrl_20240316152949574" name="mdwd:DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory" contextRef="C_20230101to20231231" escape="true">
                <div>
                  <div style="margin-left:63pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">December 31,</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2023</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2022</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Income receivables</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220310134332404_33" name="mdwd:IncomeReceivablesLongTerm" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50</ix:nonFraction></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220310134332404_37" name="mdwd:IncomeReceivablesLongTerm" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">180</ix:nonFraction></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Prepaid expenses</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20240316152856204" name="mdwd:PrepaidExpensesLongTerm" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">183</ix:nonFraction></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240316152930510" name="mdwd:PrepaidExpensesLongTerm" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220310134332404_63" name="ifrs-full:OtherNoncurrentReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">233</ix:nonFraction></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220310134332404_67" name="ifrs-full:OtherNoncurrentReceivables" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">180</ix:nonFraction></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </ix:nonNumeric>
            </div>
          </div>
        </div>
      </ix:nonNumeric>
      <p style="margin:0pt">&#160;</p>
    </div>
  </div>
</div><div style="">
  <div>
    <ix:nonNumeric id="Fxbrl_20240317131134657" name="ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory" contextRef="C_20230101to20231231" escape="true">
      <div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-weight:bold">Note 10:</td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold">Property, Plant and Equipment, Net</div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="Fxbrl_20240317131228387" name="ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div style="margin-left:63pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">furniture</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacturing machinery and lab equipment</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computers</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">improvements</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;font-weight:bold">Cost</div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of January 1, 2023</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001253082_xbrl_20210924153656867" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">293</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001253082_xbrl_20210924153705013" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,091</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001253082_xbrl_20210924153707696" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">166</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001253082_xbrl_20210924153713215" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,279</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001253082_xbrl_20210924153716030" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,829</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Additions</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001357144_xbrl_20210924161654441" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001357144_xbrl_20210924161913174" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,312</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001357144_xbrl_20210924162033935" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">101</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001357144_xbrl_20210924162142196" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">37</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001357144_xbrl_20210924162246088" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,475</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Capitalization of depreciation of ROU assets</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20240317130440422_xbrl_20220218001357144_xbrl_20210924161654441" name="mdwd:ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20240317130440422_xbrl_20220218001357144_xbrl_20210924161913174" name="mdwd:ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20240317130440422_xbrl_20220218001357144_xbrl_20210924162033935" name="mdwd:ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20240317130440422_xbrl_20220218001357144_xbrl_20210924162142196" name="mdwd:ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20240317130440422_xbrl_20220218001357144_xbrl_20210924162246088" name="mdwd:ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Foreign currency translation</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001419992_xbrl_20210924161736718" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001419992_xbrl_20210924161950294" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001419992_xbrl_20210924162057894" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001419992_xbrl_20210924162200828" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001419992_xbrl_20210924162306679" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of December 31, 2023</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001257788_xbrl_20210924153656867" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">319</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001257788_xbrl_20210924153705013" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,403</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001257788_xbrl_20210924153707696" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">267</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001257788_xbrl_20210924153713215" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,375</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001257788_xbrl_20210924153716030" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,364</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of January 1, 2022</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001305045_xbrl_20210924153656867" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">257</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001305045_xbrl_20210924153705013" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,764</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001305045_xbrl_20210924153707696" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">176</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001305045_xbrl_20210924153713215" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,137</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001305045_xbrl_20210924153716030" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,334</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Additions</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001400268_xbrl_20210924161654441" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">37</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001400268_xbrl_20210924161913174" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">327</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001400268_xbrl_20210924162033935" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">49</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001400268_xbrl_20210924162142196" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">142</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001400268_xbrl_20210924162246088" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">555</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Disposals</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001338591_xbrl_20210924161445150" name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001338591_xbrl_20210924161845231" name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220218001338591_xbrl_20210924162004535" name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001338591_xbrl_20210924162111672" name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220218001338591_xbrl_20210924162222312" name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Foreign currency translation</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220218001415991_xbrl_20210924161736718" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001415991_xbrl_20210924161950294" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001415991_xbrl_20210924162057894" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001415991_xbrl_20210924162200828" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220218001415991_xbrl_20210924162306679" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of December 31, 2022</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001311644_xbrl_20210924153656867" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">293</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001311644_xbrl_20210924153705013" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,091</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001311644_xbrl_20210924153707696" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">166</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001311644_xbrl_20210924153713215" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,279</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001311644_xbrl_20210924153716030" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,829</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:center;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold">Accumulated Depreciation</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of January 1, 2023</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001538117_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153656867" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">157</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001538117_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153705013" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3,818</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001538117_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153707696" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">97</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001538117_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153713215" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,391</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001538117_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153716030" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,463</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Additions</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001601004_xbrl_20210924162453767_xbrl_20210924161654441" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001601004_xbrl_20210924162453767_xbrl_20210924161913174" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">448</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001601004_xbrl_20210924162453767_xbrl_20210924162033935" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001601004_xbrl_20210924162453767_xbrl_20210924162142196" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">140</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001601004_xbrl_20210924162453767_xbrl_20210924162246088" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">672</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Foreign currency translation</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001634405_xbrl_20210924162504566_xbrl_20210924161736718" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001634405_xbrl_20210924162504566_xbrl_20210924161950294" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001634405_xbrl_20210924162504566_xbrl_20210924162057894" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001634405_xbrl_20210924162504566_xbrl_20210924162200828" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001634405_xbrl_20210924162504566_xbrl_20210924162306679" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of December 31, 2023</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001534988_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153656867" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">184</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001534988_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153705013" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,266</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001534988_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153707696" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">155</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001534988_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153713215" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,531</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001534988_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153716030" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,136</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of January 1, 2022</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001530900_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153656867" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">133</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001530900_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153705013" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3,370</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001530900_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153707696" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">94</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001530900_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153713215" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,259</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001530900_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153716030" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,856</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Additions</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001550860_xbrl_20210924162453767_xbrl_20210924161654441" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001550860_xbrl_20210924162453767_xbrl_20210924161913174" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">448</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001550860_xbrl_20210924162453767_xbrl_20210924162033935" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001550860_xbrl_20210924162453767_xbrl_20210924162142196" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">132</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001550860_xbrl_20210924162453767_xbrl_20210924162246088" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">667</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Disposals</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001617749_xbrl_20210924162429973_xbrl_20210924161445150" name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001617749_xbrl_20210924162429973_xbrl_20210924161845231" name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220218001617749_xbrl_20210924162429973_xbrl_20210924162004535" name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">59</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001617749_xbrl_20210924162429973_xbrl_20210924162111672" name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220218001617749_xbrl_20210924162429973_xbrl_20210924162222312" name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">59</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Foreign currency translation</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                      <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220218001637859_xbrl_20210924162504566_xbrl_20210924161736718" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001637859_xbrl_20210924162504566_xbrl_20210924161950294" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001637859_xbrl_20210924162504566_xbrl_20210924162057894" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001637859_xbrl_20210924162504566_xbrl_20210924162200828" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                      <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220218001637859_xbrl_20210924162504566_xbrl_20210924162306679" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of December 31, 2022</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240317121911253" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">157</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001527479_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153705013" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3,818</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001527479_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153707696" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">97</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001527479_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153713215" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,391</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001527479_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153716030" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,463</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold">Carrying amounts of all fixed asset items</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:19pt;line-height:1.25;font-family:'Times New Roman',Times,serif">December 31, 2023</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001516344_xbrl_20210924162800912_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153656867" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">135</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001516344_xbrl_20210924162800912_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153705013" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,137</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001516344_xbrl_20210924162800912_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153707696" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">112</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001516344_xbrl_20210924162800912_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153713215" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">844</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220218001516344_xbrl_20210924162800912_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153716030" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,228</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;padding-bottom:4px;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:19pt;line-height:1.25;font-family:'Times New Roman',Times,serif">December 31, 2022</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001518606_xbrl_20210924162800912_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153656867" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">136</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001518606_xbrl_20210924162800912_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153705013" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,273</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001518606_xbrl_20210924162800912_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153707696" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001518606_xbrl_20210924162800912_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153713215" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">888</ix:nonFraction></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220218001518606_xbrl_20210924162800912_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153716030" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,366</ix:nonFraction></div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="margin-left:63pt">
              <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
            </div>
          </div>
        </ix:nonNumeric>
      </div>
    </ix:nonNumeric>
    <p style="margin:0pt">&#160;</p>
    <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 23</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
  </div>
</div><div style="">
  <div>
    <ix:nonNumeric id="Fxbrl_20220218041540503" name="ifrs-full:DisclosureOfLeasesExplanatory" contextRef="C_20230101to20231231" escape="true">
      <div>
        <div>
          <div>
            <div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 11:</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leases</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:56.7pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease Agreements:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="line-height:1.25">
                  <div style="text-align:justify;margin-left:81.8pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's offices and its production facility in Israel are located in a building that the Company leased from its Related party (see Note 24a), in accordance with a sub-lease agreement. The Company subleased approximately <ix:nonFraction id="Fxbrl_20240317163043929" name="mdwd:SubsidiariesLeaseArea" contextRef="C_20230101to20231231" unitRef="Squaremeters" scale="0" decimals="0" format="ixt:num-dot-decimal">3,000</ix:nonFraction> square meters of laboratory, office and clean rooms space at a monthly rent fee NIS <ix:nonFraction id="Fxbrl_20240317163057065" name="mdwd:SubsidiariesLeaseMonthlyRent" contextRef="C_20230101to20231231_srtCurrencyAxis_currencyILS" unitRef="NIS" scale="0" decimals="0" format="ixt:num-dot-decimal">125</ix:nonFraction> (approximately $<span><ix:nonFraction id="Fxbrl_20240317163152432" name="mdwd:SubsidiariesLeaseMonthlyRent" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35</ix:nonFraction></span>). This sub-lease agreement was amended in October 2021, to extend the period up to October 2025 which was included in the calculation of the lease liability and RoU asset.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In July 2023, the company signed a termination agreement for the sub-lease agreement and signed on a new lease agreement for the same area of approximately <ix:nonFraction id="Fxbrl_20240317163238200" name="mdwd:SubsidiariesLeaseArea" contextRef="C_20230701to20230731" unitRef="Squaremeters" scale="0" decimals="0" format="ixt:num-dot-decimal">3,000</ix:nonFraction> square meters in the same building with the owner of the building<span> at a monthly rent fee of NIS <ix:nonFraction id="Fxbrl_20240319215053559" name="mdwd:SubsidiariesLeaseMonthlyRent" contextRef="C_20230701to20230731_srtCurrencyAxis_currencyILS" unitRef="NIS" scale="0" decimals="0" format="ixt:num-dot-decimal">195</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20240319215059951" name="mdwd:SubsidiariesLeaseMonthlyRent" contextRef="C_20230701to20230731_srtCurrencyAxis_currencyILS" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">54</ix:nonFraction>).</span> The lease agreement is for <ix:nonNumeric id="Fxbrl_20240317163653480" name="mdwd:SubsidiariesLeaseExpirationPeriod" contextRef="C_20230701to20230731" format="ixt-sec:durwordsen">12 years</ix:nonNumeric> with an option for an additional <ix:nonNumeric id="Fxbrl_20240317163435552" name="mdwd:SubsidiariesLeaseExtentionPeriod" contextRef="C_20230701to20230731" format="ixt-sec:durwordsen">3 years</ix:nonNumeric>. The company estimation is to use the <ix:nonNumeric id="Fxbrl_20240317163643112" name="mdwd:SubsidiariesLeaseEstimatedUsefulLife" contextRef="C_20230701to20230731" format="ixt-sec:durwordsen">3 years</ix:nonNumeric> option</span></span></div>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In addition, the Company and its subsidiary have lease agreements for <ix:nonFraction id="Fxbrl_20240317164533128" name="mdwd:NumberOfVehiclesInOperatingLeaseArrangements" contextRef="C_20230701to20230731" unitRef="Vehicles" scale="0" decimals="0" format="ixt:num-dot-decimal">16</ix:nonFraction> vehicles for the remaining period of <ix:nonNumeric id="Fxbrl_20240317164559016" name="mdwd:PeriodOfVehiclesOperatingLeaseArrangements" contextRef="C_20230701to20230731">1.75 years</ix:nonNumeric> on average.</span></span></div>
              </div>
            </div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amounts recognized in profit or loss and in the statement of cash flows</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:90pt">
              <ix:nonNumeric id="Fxbrl_20240317164757863" name="mdwd:DisclosureOfAdditionalInformationAboutLeaseExplanatory" contextRef="C_20230101to20231231" escape="true">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31,</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest expense on lease liabilities</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211006163601471" name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">274</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211006164040252" name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">102</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation expenses</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211006164053253_xbrl_20211006163601471" name="ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">565</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211006164053253_xbrl_20211006164040252" name="ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">537</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash outflow for leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211006164127597_xbrl_20211006164053253_xbrl_20211006163601471" name="ifrs-full:CashOutflowForLeases" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">778</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211006164127597_xbrl_20211006164053253_xbrl_20211006164040252" name="ifrs-full:CashOutflowForLeases" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">701</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </ix:nonNumeric>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company determined the appropriate interest rate for discounting leases, with the assistance of a third party. The valuation was based on: credit risk, the weighted average term of the leases and other economic variables. A weighted average interest rate in a range of <ix:nonFraction id="Fxbrl_20220310023934257" name="ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" contextRef="C_20231231_srtRangeAxis_srtMinimumMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">1</ix:nonFraction>% to <ix:nonFraction id="Fxbrl_20220310023942322" name="ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" contextRef="C_20231231_srtRangeAxis_srtMaximumMember" unitRef="Percent" scale="-2" decimals="4" format="ixt:num-dot-decimal">8.47</ix:nonFraction>% was used to discount future lease payments in the calculation of the lease liability on the date of initial application of the standard (IFRS 16).</span></span></div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
            <div><ix:exclude>
              <div style="text-align:justify;line-height:1.25">
                <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 24</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
              </div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                    <tr>
                      <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 11:</span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Leases&#160;</span><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">(Cont.)</span></div>
                      </td>
                    </tr>

                </table>
                <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </div>
            </ix:exclude></div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disclosures in respect of Right- of- Use assets:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20240317164913455" name="ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" contextRef="C_20230101to20231231" escape="true">
              <div style="margin-left:90pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040003632_xbrl_20211006165239957_xbrl_20211006164413105" name="ifrs-full:RightofuseAssetsRevaluedAssetsAtCost" contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,341</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040003632_xbrl_20211006165239957_xbrl_20211006164610160" name="ifrs-full:RightofuseAssetsRevaluedAssetsAtCost" contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">550</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040003632_xbrl_20211006165239957_xbrl_20211006164613511" name="ifrs-full:RightofuseAssetsRevaluedAssetsAtCost" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,891</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040121884_xbrl_20211006164720297" name="mdwd:AdditionsToRightOfUseAssetsNewLeases" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,460</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040121884_xbrl_20211006164713615" name="mdwd:AdditionsToRightOfUseAssetsNewLeases" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">407</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040121884_xbrl_20211006164634125" name="mdwd:AdditionsToRightOfUseAssetsNewLeases" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,867</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments for indexation</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040143841_xbrl_20211006164738151_xbrl_20211006164720297" name="mdwd:AdditionsToRightOfUseAssetsAdjustmentsForIndexation" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">78</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040143841_xbrl_20211006164738151_xbrl_20211006164713615" name="mdwd:AdditionsToRightOfUseAssetsAdjustmentsForIndexation" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040143841_xbrl_20211006164738151_xbrl_20211006164634125" name="mdwd:AdditionsToRightOfUseAssetsAdjustmentsForIndexation" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">81</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040211842_xbrl_20211006165127812_xbrl_20211006164738151_xbrl_20211006164720297" name="mdwd:AdditionsToRightOfUseAssetsDisposals" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,368</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040211842_xbrl_20211006165127812_xbrl_20211006164738151_xbrl_20211006164713615" name="mdwd:AdditionsToRightOfUseAssetsDisposals" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">308</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040211842_xbrl_20211006165127812_xbrl_20211006164738151_xbrl_20211006164634125" name="mdwd:AdditionsToRightOfUseAssetsDisposals" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,676</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040000138_xbrl_20211006165239957_xbrl_20211006164413105" name="ifrs-full:RightofuseAssetsRevaluedAssetsAtCost" contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,511</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040000138_xbrl_20211006165239957_xbrl_20211006164610160" name="ifrs-full:RightofuseAssetsRevaluedAssetsAtCost" contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">652</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040000138_xbrl_20211006165239957_xbrl_20211006164613511" name="ifrs-full:RightofuseAssetsRevaluedAssetsAtCost" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,163</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated depreciation</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040102835_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164413105" name="mdwd:RightOfUseAssetsAccumulatedDepreciation" contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,342</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040102835_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164610160" name="mdwd:RightOfUseAssetsAccumulatedDepreciation" contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">334</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040102835_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164613511" name="mdwd:RightOfUseAssetsAccumulatedDepreciation" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,676</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;margin-left:9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040235044_xbrl_20211006165400552_xbrl_20211006164720297" name="ifrs-full:DepreciationRightofuseAssets" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">334</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040235044_xbrl_20211006165400552_xbrl_20211006164713615" name="ifrs-full:DepreciationRightofuseAssets" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">231</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040235044_xbrl_20211006165400552_xbrl_20211006164634125" name="ifrs-full:DepreciationRightofuseAssets" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">565</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capitalized to Leasehold improvements</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317162803410" name="mdwd:RightOfUseAssetReclassifiedToLeaseholdImprovements" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317162809601" name="mdwd:RightOfUseAssetReclassifiedToLeaseholdImprovements" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317162833865" name="mdwd:RightOfUseAssetReclassifiedToLeaseholdImprovements" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25;margin-left:9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040326083_xbrl_20211006165447023_xbrl_20211006165426095_xbrl_20211006165400552_xbrl_20211006164720297" name="mdwd:RightOfUseAssetDisposals" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,527</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040326083_xbrl_20211006165447023_xbrl_20211006165426095_xbrl_20211006165400552_xbrl_20211006164713615" name="mdwd:RightOfUseAssetDisposals" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">308</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040326083_xbrl_20211006165447023_xbrl_20211006165426095_xbrl_20211006165400552_xbrl_20211006164634125" name="mdwd:RightOfUseAssetDisposals" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,835</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040057685_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164413105" name="mdwd:RightOfUseAssetsAccumulatedDepreciation" contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">208</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040057685_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164610160" name="mdwd:RightOfUseAssetsAccumulatedDepreciation" contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">257</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040036483_xbrl_20211006165539151_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164613511" name="mdwd:RightOfUseAssetsAccumulatedDepreciation" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">465</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciated cost</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040036483_xbrl_20211006165539151_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164413105" name="ifrs-full:RightofuseAssets" contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,303</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040036483_xbrl_20211006165539151_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164610160" name="ifrs-full:RightofuseAssets" contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">395</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317162900057" name="ifrs-full:RightofuseAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,698</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:90pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040009306_xbrl_20211006165239957_xbrl_20211006164413105" name="ifrs-full:RightofuseAssetsRevaluedAssetsAtCost" contextRef="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,267</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040009306_xbrl_20211006165239957_xbrl_20211006164610160" name="ifrs-full:RightofuseAssetsRevaluedAssetsAtCost" contextRef="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">654</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040009306_xbrl_20211006165239957_xbrl_20211006164613511" name="ifrs-full:RightofuseAssetsRevaluedAssetsAtCost" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,921</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040126625_xbrl_20211006164720297" name="mdwd:AdditionsToRightOfUseAssetsNewLeases" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040126625_xbrl_20211006164713615" name="mdwd:AdditionsToRightOfUseAssetsNewLeases" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">125</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040126625_xbrl_20211006164634125" name="mdwd:AdditionsToRightOfUseAssetsNewLeases" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">125</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments for indexation</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040148923_xbrl_20211006164738151_xbrl_20211006164720297" name="mdwd:AdditionsToRightOfUseAssetsAdjustmentsForIndexation" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">74</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040148923_xbrl_20211006164738151_xbrl_20211006164713615" name="mdwd:AdditionsToRightOfUseAssetsAdjustmentsForIndexation" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">9</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040148923_xbrl_20211006164738151_xbrl_20211006164634125" name="mdwd:AdditionsToRightOfUseAssetsAdjustmentsForIndexation" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">83</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040206289_xbrl_20211006165127812_xbrl_20211006164738151_xbrl_20211006164720297" name="mdwd:AdditionsToRightOfUseAssetsDisposals" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240317162921970" name="mdwd:AdditionsToRightOfUseAssetsDisposals" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">238</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240317162926649" name="mdwd:AdditionsToRightOfUseAssetsDisposals" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">238</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040012242_xbrl_20211006165239957_xbrl_20211006164413105" name="ifrs-full:RightofuseAssetsRevaluedAssetsAtCost" contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,341</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040012242_xbrl_20211006165239957_xbrl_20211006164610160" name="ifrs-full:RightofuseAssetsRevaluedAssetsAtCost" contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">550</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040012242_xbrl_20211006165239957_xbrl_20211006164613511" name="ifrs-full:RightofuseAssetsRevaluedAssetsAtCost" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,891</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated depreciation</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040053082_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164413105" name="mdwd:RightOfUseAssetsAccumulatedDepreciation" contextRef="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,028</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040053082_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164610160" name="mdwd:RightOfUseAssetsAccumulatedDepreciation" contextRef="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">345</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040053082_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164613511" name="mdwd:RightOfUseAssetsAccumulatedDepreciation" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,373</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;margin-left:9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040228152_xbrl_20211006165400552_xbrl_20211006164720297" name="ifrs-full:DepreciationRightofuseAssets" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">314</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040228152_xbrl_20211006165400552_xbrl_20211006164713615" name="ifrs-full:DepreciationRightofuseAssets" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">225</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040228152_xbrl_20211006165400552_xbrl_20211006164634125" name="ifrs-full:DepreciationRightofuseAssets" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">539</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25;margin-left:9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040321260_xbrl_20211006165447023_xbrl_20211006165426095_xbrl_20211006165400552_xbrl_20211006164720297" name="mdwd:RightOfUseAssetDisposals" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040321260_xbrl_20211006165447023_xbrl_20211006165426095_xbrl_20211006165400552_xbrl_20211006164713615" name="mdwd:RightOfUseAssetDisposals" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">236</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040321260_xbrl_20211006165447023_xbrl_20211006165426095_xbrl_20211006165400552_xbrl_20211006164634125" name="mdwd:RightOfUseAssetDisposals" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">236</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040049913_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164413105" name="mdwd:RightOfUseAssetsAccumulatedDepreciation" contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,342</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040049913_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164610160" name="mdwd:RightOfUseAssetsAccumulatedDepreciation" contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">334</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040049913_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164613511" name="mdwd:RightOfUseAssetsAccumulatedDepreciation" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,676</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciated cost</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040027656_xbrl_20211006165539151_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164413105" name="ifrs-full:RightofuseAssets" contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">999</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040027656_xbrl_20211006165539151_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164610160" name="ifrs-full:RightofuseAssets" contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">216</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040027656_xbrl_20211006165539151_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164613511" name="ifrs-full:RightofuseAssets" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,215</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </ix:nonNumeric>
            <p style="margin:0pt">&#160;</p>
            <div><ix:exclude>
              <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 25</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 11:</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leases (Cont.)</span></span></div>
                    </td>
                  </tr>

              </table>
              <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
            </ix:exclude></div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                  <tr style="vertical-align:top">
                    <td style="width:56.7pt">&#160;</td>
                    <td style="text-align:right;vertical-align:top;width:28.35pt">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">d.</span></span></span></div>
                    </td>
                    <td style="text-align:left;vertical-align:top;width:auto">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Disclosures of the Company's lease liabilities:</span></span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20240317165333406" name="ifrs-full:DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory" contextRef="C_20230101to20231231" escape="true">
              <div style="margin-left:90pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040613201_xbrl_20211006171353466" name="ifrs-full:LeaseLiabilities" contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,199</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040613201_xbrl_20211006171439303" name="ifrs-full:LeaseLiabilities" contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">179</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040613201_xbrl_20211006171457014" name="ifrs-full:LeaseLiabilities" contextRef="C_20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,378</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Repayment of leases liabilities</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040613207_xbrl_20211006171800553" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">588</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040613207_xbrl_20211006171753939" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">190</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040613207_xbrl_20211006171730097" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">778</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect of changes in exchange rates</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040613212_xbrl_20211006171824556_xbrl_20211006171800553" name="mdwd:EffectOfChangesInExchangeRatesForLeaseLiabilities" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040613212_xbrl_20211006171824556_xbrl_20211006171753939" name="mdwd:EffectOfChangesInExchangeRatesForLeaseLiabilities" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040613212_xbrl_20211006171824556_xbrl_20211006171730097" name="mdwd:EffectOfChangesInExchangeRatesForLeaseLiabilities" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">17</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New finance lease obligation recognized</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040613215_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171800553" name="mdwd:NewFinanceLeaseObligationRecognized" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,460</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040613215_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171753939" name="mdwd:NewFinanceLeaseObligationRecognized" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">365</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040613215_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171730097" name="mdwd:NewFinanceLeaseObligationRecognized" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,825</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments for indexation</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040613219_xbrl_20211006171902478_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171800553" name="mdwd:AdjustmentsForIndexation" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">78</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040613219_xbrl_20211006171902478_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171753939" name="mdwd:AdjustmentsForIndexation" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040613219_xbrl_20211006171902478_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171730097" name="mdwd:AdjustmentsForIndexation" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">81</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial expenses</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040613223_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171800553" name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">257</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040613223_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171753939" name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040613223_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171730097" name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">274</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals-Termination of leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040613226_xbrl_20211006175815046_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171800553" name="mdwd:DisposalsTerminationOfLeases" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,041</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040613226_xbrl_20211006175815046_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171753939" name="mdwd:DisposalsTerminationOfLeases" contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040613226_xbrl_20211006175815046_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171730097" name="mdwd:DisposalsTerminationOfLeases" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,052</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040613230_xbrl_20211006175920802_xbrl_20211006171353466" name="ifrs-full:LeaseLiabilities" contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,346</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040613230_xbrl_20211006175920802_xbrl_20211006171439303" name="ifrs-full:LeaseLiabilities" contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">365</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040613230_xbrl_20211006175920802_xbrl_20211006171457014" name="ifrs-full:LeaseLiabilities" contextRef="C_20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,711</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current maturities of long-term leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040613234_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171353466" name="ifrs-full:CurrentLeaseLiabilities" contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">180</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040613234_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171439303" name="ifrs-full:CurrentLeaseLiabilities" contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">181</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040613234_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171457014" name="ifrs-full:CurrentLeaseLiabilities" contextRef="C_20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">361</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liability Balance as of December 31, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040613241_xbrl_20211006180028212_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171353466" name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,166</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040613241_xbrl_20211006180028212_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171439303" name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">184</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040613241_xbrl_20211006180028212_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171457014" name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="C_20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,350</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:90pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040600448_xbrl_20211006171353466" name="ifrs-full:LeaseLiabilities" contextRef="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,691</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040600448_xbrl_20211006171439303" name="ifrs-full:LeaseLiabilities" contextRef="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">299</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040600448_xbrl_20211006171457014" name="ifrs-full:LeaseLiabilities" contextRef="C_20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,990</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Repayment of leases liabilities</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040600452_xbrl_20211006171800553" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">477</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040600452_xbrl_20211006171753939" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">224</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040600452_xbrl_20211006171730097" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20220101to20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">701</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect of changes in exchange rates</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040600455_xbrl_20211006171824556_xbrl_20211006171800553" name="mdwd:EffectOfChangesInExchangeRatesForLeaseLiabilities" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">182</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040600455_xbrl_20211006171824556_xbrl_20211006171753939" name="mdwd:EffectOfChangesInExchangeRatesForLeaseLiabilities" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">28</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040600455_xbrl_20211006171824556_xbrl_20211006171730097" name="mdwd:EffectOfChangesInExchangeRatesForLeaseLiabilities" contextRef="C_20220101to20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">210</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New finance lease obligation recognized</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040600458_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171800553" name="mdwd:NewFinanceLeaseObligationRecognized" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040600458_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171753939" name="mdwd:NewFinanceLeaseObligationRecognized" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">117</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040600458_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171730097" name="mdwd:NewFinanceLeaseObligationRecognized" contextRef="C_20220101to20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">117</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments for indexation</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040600460_xbrl_20211006171902478_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171800553" name="mdwd:AdjustmentsForIndexation" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">74</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040600460_xbrl_20211006171902478_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171753939" name="mdwd:AdjustmentsForIndexation" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">9</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040600460_xbrl_20211006171902478_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171730097" name="mdwd:AdjustmentsForIndexation" contextRef="C_20220101to20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">83</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial expenses</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040600463_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171800553" name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">93</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040600463_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171753939" name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040600463_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171730097" name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="C_20220101to20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">101</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals-Termination of leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040600467_xbrl_20211006175815046_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171800553" name="mdwd:DisposalsTerminationOfLeases" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040600467_xbrl_20211006175815046_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171753939" name="mdwd:DisposalsTerminationOfLeases" contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040600467_xbrl_20211006175815046_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171730097" name="mdwd:DisposalsTerminationOfLeases" contextRef="C_20220101to20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040600470_xbrl_20211006175920802_xbrl_20211006171353466" name="ifrs-full:LeaseLiabilities" contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,199</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040600470_xbrl_20211006175920802_xbrl_20211006171439303" name="ifrs-full:LeaseLiabilities" contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">179</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040600470_xbrl_20211006175920802_xbrl_20211006171457014" name="ifrs-full:LeaseLiabilities" contextRef="C_20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,378</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current maturities of long-term leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040600473_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171353466" name="ifrs-full:CurrentLeaseLiabilities" contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">399</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040600473_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171439303" name="ifrs-full:CurrentLeaseLiabilities" contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">133</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218040600473_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171457014" name="ifrs-full:CurrentLeaseLiabilities" contextRef="C_20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">532</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liability Balance as of December 31, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040600476_xbrl_20211006180028212_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171353466" name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">800</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040600476_xbrl_20211006180028212_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171439303" name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220218040600476_xbrl_20211006180028212_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171457014" name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="C_20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">846</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </ix:nonNumeric>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
    <p style="margin:0pt">&#160;</p>
    <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 26</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
  </div>
</div><div style="">
  <ix:nonNumeric id="Fxbrl_20211007110113928" name="ifrs-full:DisclosureOfIntangibleAssetsExplanatory" contextRef="C_20230101to20231231" escape="true">
    <div>
      <div style="line-height:1.25">
        <div style="line-height:1.25">
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0);border:0px">

                <tr>
                  <td style="width:56.7pt;vertical-align:top;font-weight:bold">
                    <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt">Note 12:</span></p>
                  </td>
                  <td style="vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span>Intangible Assets, Net</span></strong></span></div>
                  </td>
                </tr>

            </table>
            <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
          </div>
        </div>
      </div>
      <div>
        <div>
          <ix:nonNumeric id="Fxbrl_20240316152352370" name="ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" contextRef="C_20230101to20231231" escape="true">
            <div>
              <div style="margin-left:63pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>License and</span></span></span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Knowhow</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cost</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of January 1,</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211007102522384" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,538</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211007102540717" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,538</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additions</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211007102555515" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211007102623483" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of December 31,</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211007102636331_xbrl_20211007102522384" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,538</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211007102636331_xbrl_20211007102540717" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,538</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Accumulated Amortization</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of January 1,</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211007102702467_xbrl_20211007102522384" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,307</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211007102702467_xbrl_20211007102540717" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,241</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additions</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211007103508501_xbrl_20211007102555515" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211007103508501_xbrl_20211007102623483" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of December 31,</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211007103529800_xbrl_20211007102702467_xbrl_20211007102522384" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,373</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211007103529800_xbrl_20211007102702467_xbrl_20211007102540717" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,307</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Amortized cost</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of December 31,</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211007103254291" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdAmortizedCostMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">165</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211007103557580" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdAmortizedCostMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">231</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>
          <div style="margin-left:63pt">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Intangible assets include exclusive licenses to use patents, know-how and intellectual property for the development, manufacturing and marketing of products related to burn treatments and other products in the field of wound care. These licenses were purchased from third parties and from one of the Company's shareholders.</span></span></span></span></div>
        </div>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin:0pt">&#160;</p>
</div><div style="">
  <div>
    <div>
      <ix:nonNumeric id="Fxbrl_20240316152554225" name="ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory" contextRef="C_20230101to20231231" escape="true">
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 13:</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other Payables</span></span></div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240316152609269" name="mdwd:DisclosureOfDetailedInformationAboutOtherPayablesExplanatory" contextRef="C_20230101to20231231" escape="true">
            <div>
              <div style="margin-left:63pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employees and payroll accruals</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211007110918777_33" name="ifrs-full:ShorttermEmployeeBenefitsAccruals" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,109</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211007110918777_37" name="ifrs-full:ShorttermEmployeeBenefitsAccruals" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,471</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liability in respect of TEVA (see Note 17c)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211007110918777_43" name="mdwd:LiabilityInRespectForPurchaseOfShares" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,250</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211007110918777_47" name="mdwd:LiabilityInRespectForPurchaseOfShares" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">417</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Related parties</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211007110918777_53" name="ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">83</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211007110918777_57" name="ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">307</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred revenues</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211007110918777_63" name="mdwd:DeferredRevenues" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211007110918777_67" name="mdwd:DeferredRevenues" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">63</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211007110918777_73" name="mdwd:OtherCurrentPayable" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">425</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211007110918777_77" name="mdwd:OtherCurrentPayable" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">901</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211007110918777_93" name="ifrs-full:OtherCurrentPayables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,891</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211007110918777_97" name="ifrs-full:OtherCurrentPayables" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,159</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>
        </div>
      </ix:nonNumeric>
      <p style="margin:0pt">&#160;</p>
    </div>
  </div>
</div><div style="">
  <ix:nonNumeric id="Fxbrl_20211007120324242" name="ifrs-full:DisclosureOfGovernmentGrantsExplanatory" contextRef="C_20230101to20231231" escape="true">
    <div>
      <div style="line-height:1.25">
        <div style="line-height:1.25">
          <div style="line-height:1.25">
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)">

                    <tr>
                      <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Note 14:</span></span></span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Liabilities in Respect of IIA Grants</span></span></span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div>
        <div>
          <div>&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240316153030893" name="mdwd:DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory" contextRef="C_20230101to20231231" escape="true">
            <div>
              <div style="margin-left:63pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of January 1,</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211007115552736_33" name="ifrs-full:GovernmentGrants" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,566</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211007115552736_37" name="ifrs-full:GovernmentGrants" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,105</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Royalties</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20211007115552736_53" name="ifrs-full:RoyaltyExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">190</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20211007115552736_57" name="ifrs-full:RoyaltyExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">407</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Amounts carried to Profit or Loss</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211007115552736_63" name="mdwd:RevaluationOfLiabilitiesInRespectOfGrants" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">427</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20211007115552736_67" name="mdwd:RevaluationOfLiabilitiesInRespectOfGrants" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">132</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of December 31,</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211007115552736_73" name="ifrs-full:GovernmentGrants" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,803</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211007115552736_77" name="ifrs-full:GovernmentGrants" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,566</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Current maturities</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20211007115552736_93" name="ifrs-full:CurrentGovernmentGrants" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">126</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20211007115552736_97" name="ifrs-full:CurrentGovernmentGrants" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">121</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Long term liabilities in respect of IIA grants</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211007115552736_113" name="ifrs-full:NoncurrentGovernmentGrants" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,677</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211007115552736_117" name="ifrs-full:NoncurrentGovernmentGrants" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,445</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>
          <div style="margin-left:63pt">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company is committed to pay royalties to the IIA up to the total grants received plus the applicable accrued interest. The total amount of grants received from IIA including accrued interest, net of royalties as of December 31, 2023 is approximately $<ix:nonFraction id="Fxbrl_20220310041213331" name="mdwd:GrantsReceivedNetOfRoyalties" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,783</ix:nonFraction>, while the amortized cost of this liability as of that date is $ <ix:nonFraction id="Fxbrl_20220310041221124" name="mdwd:AmortizedCostOfGrantsReceived" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,803</ix:nonFraction>, using the interest method.</span></span></span></span></div>
        </div>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin:0pt">&#160;</p>
  <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 27</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
</div><div style="">
  <div>
    <div>
      <ix:nonNumeric id="Fxbrl_20240317142229517" name="ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory" contextRef="C_20230101to20231231" escape="true">
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 15:</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial Instruments</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Risk management:</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Board of Directors has overall responsibility for the establishment and oversight of the Company&#8217;s risk management framework.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s risk management practice was formulated to identify and analyze the risks that the Company faces, to set appropriate limits for the risks and controls, and to monitor the risks and their compliance within the limits. The risk policy and risk management methods are reviewed regularly to reflect changes in market conditions and in the Company&#8217;s operations.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:85.05pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company Audit Committee oversees how management monitors compliance with the Company&#8217;s risk management policies and procedures and reviews the adequacy of the risk management framework in relation to the risks faced by the Company. The Company Audit Committee is assisted in its oversight role by Internal Audit. Internal Audit undertakes both regular and ad hoc reviews of risk management controls and procedures, the results of which are reported to the Audit Committee.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's activities expose it to various financial market risks, mainly foreign currency risk, interest rate risk and liquidity risk.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:85.05pt">&#160;</td>
                <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency risk</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company operates primarily in an international environment and is exposed to foreign exchange risk resulting from the fact that a certain portion of the Company's costs are denominated in NIS and EURO, mainly due to payroll and related benefit costs incurred in Israel and additionally due to marketing expenses incurred in Europe.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:85.05pt">&#160;</td>
                <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sensitivity tests relating to changes in market factors:</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company operates in an international environment and is exposed to foreign exchange risk resulting from the exposure to different currencies, mainly NIS and EURO. Foreign exchange risks arise from recognized assets and liabilities denominated in a foreign currency other than the functional currency.</span></span></div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240317142254346" name="ifrs-full:SensitivityAnalysisForEachTypeOfMarketRisk" contextRef="C_20230101to20231231" escape="true">
            <div>
              <div>
                <div style="margin-left:108pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gain (loss) from change:</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5% increase in NIS and EURO exchange rate</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142018369_xbrl_20220310051203872_xbrl_20211007120906569" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" contextRef="C_20230101to20231231_mdwdSensitivityAnalysisAxis_mdwdFivePercentageIncreaseInExchangeRateMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">176</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142018369_xbrl_20220310051203872_xbrl_20211007120921721" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" contextRef="C_20220101to20221231_mdwdSensitivityAnalysisAxis_mdwdFivePercentageIncreaseInExchangeRateMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">257</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5% decrease in NIS and EURO exchange rate</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240317142018372_xbrl_20220310051224050_xbrl_20211007120956439_xbrl_20211007120906569" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" contextRef="C_20230101to20231231_mdwdSensitivityAnalysisAxis_mdwdFivePercentageDecreaseInExchangeRateMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">176</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240317142018372_xbrl_20220310051224050_xbrl_20211007120956439_xbrl_20211007120921721" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" contextRef="C_20220101to20221231_mdwdSensitivityAnalysisAxis_mdwdFivePercentageDecreaseInExchangeRateMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">257</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          </ix:nonNumeric>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has performed sensitivity tests of principal market risk factors that may affect its reported operating results or financial position.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The sensitivity tests present the profit or loss for the relevant risk variables chosen as of each reporting date.</span></span></div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25">&#160;</div>
          <div><ix:exclude>
            <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 28</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
            <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                <tr>
                  <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 15:</span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Financial Instruments (Cont.)</span></div>
                  </td>
                </tr>

            </table>
            <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </ix:exclude></div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:85.05pt">&#160;</td>
                <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liquidity risk</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:106.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company&#8217;s approach to managing liquidity is to ensure, as far as possible, that it will always have sufficient liquidity to timely meet its liabilities, under both normal and stressed conditions, without incurring unwanted losses.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:106.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company manages the liquidity risk by holding cash balances, short-term deposits and secured bank credit facilities.</span></span></div>
          <div>
            <div style="line-height:1.25">
              <div style="margin-left:108pt">&#160;</div>
            </div>
          </div>
          <ix:nonNumeric id="Fxbrl_20240317142241951" name="ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities" contextRef="C_20230101to20231231" escape="true">
            <div>
              <div>
                <div style="line-height:1.25">
                  <div style="margin-left:108pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="14" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2023</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12 months</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">amount</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">or less</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1-2 years</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2-15 years</span></span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-derivative financial liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Current maturities of long-term liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040395_xbrl_20220310051614244_53" name="mdwd:CurrentMaturitiesOfLongTermLiabilities" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,249</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040395_xbrl_20220310051614244_57" name="mdwd:CurrentMaturitiesOfLongTermLiabilities" contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,249</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040395_xbrl_20230304161353722" name="mdwd:CurrentMaturitiesOfLongTermLiabilities" contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040395_xbrl_20230304161402072" name="mdwd:CurrentMaturitiesOfLongTermLiabilities" contextRef="C_20231231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Trade payables and accrued expenses</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040406_xbrl_20220310051614244_63" name="mdwd:TradePayablesAndAccruedExpenses" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,528</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040406_xbrl_20220310051614244_67" name="mdwd:TradePayablesAndAccruedExpenses" contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,528</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040406_xbrl_20230304161408496" name="mdwd:TradePayablesAndAccruedExpenses" contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040406_xbrl_20230304161416808" name="mdwd:TradePayablesAndAccruedExpenses" contextRef="C_20231231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Other payables</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040419_xbrl_20220310051614244_73" name="ifrs-full:OtherPayables" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,891</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040419_xbrl_20220310051614244_77" name="ifrs-full:OtherPayables" contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,891</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040419_xbrl_20230304161424239" name="ifrs-full:OtherPayables" contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040419_xbrl_20230304161427921" name="ifrs-full:OtherPayables" contextRef="C_20231231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Liabilities in respect of IIA grants</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040432_xbrl_20220310051614244_93" name="mdwd:LiabilitiesInRespectOfGrants" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,927</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040432_xbrl_20230304161530672" name="mdwd:LiabilitiesInRespectOfGrants" contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040432_xbrl_20220310051614244_911" name="mdwd:LiabilitiesInRespectOfGrants" contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">359</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040432_xbrl_20220310051614244_915" name="mdwd:LiabilitiesInRespectOfGrants" contextRef="C_20231231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,568</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Liabilities in respect of TEVA</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040441_xbrl_20220310051614244_103" name="mdwd:LiabilitiesInRespectOfTeva" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,200</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040441_xbrl_20230304161536494" name="mdwd:LiabilitiesInRespectOfTeva" contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040441_xbrl_20220310051614244_1011" name="mdwd:LiabilitiesInRespectOfTeva" contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,000</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040441_xbrl_20220310051614244_1015" name="mdwd:LiabilitiesInRespectOfTeva" contextRef="C_20231231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,200</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Lease liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040451_xbrl_20220310051614244_113" name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,189</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040451_xbrl_20230304161551304" name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040451_xbrl_20220310051614244_1111" name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">813</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142040451_xbrl_20220310051614244_1115" name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="C_20231231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,376</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:108pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="14" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2022</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12 months</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">amount</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">or less</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1-2 years</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2-8 years</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-derivative financial liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Current maturities of long-term liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047888_xbrl_20230303142041162_xbrl_20220310051614244_53" name="mdwd:CurrentMaturitiesOfLongTermLiabilities" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,814</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047888_xbrl_20230303142041162_xbrl_20220310051614244_57" name="mdwd:CurrentMaturitiesOfLongTermLiabilities" contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,814</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047888_xbrl_20230304161752975" name="mdwd:CurrentMaturitiesOfLongTermLiabilities" contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047888_xbrl_20230304161756407" name="mdwd:CurrentMaturitiesOfLongTermLiabilities" contextRef="C_20221231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Trade payables and accrued expenses</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047897_xbrl_20230303142041164_xbrl_20220310051614244_63" name="mdwd:TradePayablesAndAccruedExpenses" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,656</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047897_xbrl_20230303142041164_xbrl_20220310051614244_67" name="mdwd:TradePayablesAndAccruedExpenses" contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,656</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047897_xbrl_20230304161805815" name="mdwd:TradePayablesAndAccruedExpenses" contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047897_xbrl_20230304161808936" name="mdwd:TradePayablesAndAccruedExpenses" contextRef="C_20221231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Other payables</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047906_xbrl_20230303142041165_xbrl_20220310051614244_73" name="ifrs-full:OtherPayables" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,159</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047906_xbrl_20230303142041165_xbrl_20220310051614244_77" name="ifrs-full:OtherPayables" contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,159</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047906_xbrl_20230304161814832" name="ifrs-full:OtherPayables" contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047906_xbrl_20230304161825960" name="ifrs-full:OtherPayables" contextRef="C_20221231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Liabilities in respect of IIA grants</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047915_xbrl_20230303142041166_xbrl_20220310051614244_93" name="mdwd:LiabilitiesInRespectOfGrants" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,464</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047915_xbrl_20230304161832386" name="mdwd:LiabilitiesInRespectOfGrants" contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047915_xbrl_20230303142041166_xbrl_20220310051614244_911" name="mdwd:LiabilitiesInRespectOfGrants" contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">312</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047915_xbrl_20230303142041166_xbrl_20220310051614244_915" name="mdwd:LiabilitiesInRespectOfGrants" contextRef="C_20221231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,152</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Liabilities in respect of TEVA</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047925_xbrl_20230303142041168_xbrl_20220310051614244_103" name="mdwd:LiabilitiesInRespectOfTeva" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,200</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047925_xbrl_20230304161842471" name="mdwd:LiabilitiesInRespectOfTeva" contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047925_xbrl_20230303142041168_xbrl_20220310051614244_1011" name="mdwd:LiabilitiesInRespectOfTeva" contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,000</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047925_xbrl_20230303142041168_xbrl_20220310051614244_1015" name="mdwd:LiabilitiesInRespectOfTeva" contextRef="C_20221231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,200</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Lease liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047933_xbrl_20230303142041169_xbrl_20220310051614244_113" name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">902</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047933_xbrl_20230304161850232" name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047933_xbrl_20230303142041169_xbrl_20220310051614244_1111" name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">508</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317142047933_xbrl_20230303142041169_xbrl_20220310051614244_1115" name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="C_20221231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">394</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </div>
            </div>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <div><ix:exclude>
            <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 29</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
            <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                <tr>
                  <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 15:</span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Financial Instruments (Cont.)</span></div>
                  </td>
                </tr>

            </table>
            <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </ix:exclude></div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value:</span></span></div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:85.05pt">&#160;</td>
                <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1)</span></span></td>
                <td style="width:auto;vertical-align:top">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial instruments measured at fair value for disclosure purposes only.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The carrying amounts of certain financial assets and liabilities, including cash, trade receivables, other receivables, deposits, trade and other payables are the same as or approximate to their fair value.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:85.05pt">&#160;</td>
                <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2)</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value hierarchy of financial instruments measured at fair value.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The financial instruments measured at fair value on a temporal basis, use valuation methodology in accordance with the fair value hierarchy levels when determining the fair value of an asset or liability, the Company uses observable market data as much as possible.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Details regarding fair value measurement at Level 2</span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of the warrants which are classified as non-currents liabilities was measured by using Black and Scholes model. The following inputs were used to determine the fair value:</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected period of warrants&#8211; <ix:nonNumeric id="Fxbrl_20240317195120003" name="mdwd:ExpectedTermOfWarrant" contextRef="C_20230101to20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" format="ixt-sec:duryear">2.91</ix:nonNumeric> years.</span></span></div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected volatility &#8211; <ix:nonFraction id="Fxbrl_20240317141940007" name="mdwd:ExpectedVolatilityWarrants" contextRef="C_20230101to20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="Percent" scale="-2" decimals="3" format="ixt:num-dot-decimal">67.1</ix:nonFraction>%</span></span></div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Risk-free interest rate (3) &#8211; <ix:nonFraction id="Fxbrl_20240317141946406" name="mdwd:RiskFreeRateOfWarrants" contextRef="C_20230101to20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Percent" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.03</ix:nonFraction>%</span></span></div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected dividend yield &#8211; <ix:nonFraction id="Fxbrl_20240317141951921" name="mdwd:ExpectedDividendAsPercentageOfWarrants" contextRef="C_20230101to20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">0</ix:nonFraction>%.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of liabilities in respect to IIA grants with fixed interest is based on a calculation of the present value of the cash flows at the interest rate for a loan with similar terms. The Company used a discount rate of <ix:nonFraction id="Fxbrl_20240317141956744" name="ifrs-full:DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse" contextRef="C_20231231_ifrsfullTypesOfRisksAxis_mdwdInterestRateForLoanMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">12</ix:nonFraction>% based in part of the Company&#8217;s estimation at the time of the Company&#8217;s recognition of the IIA grants which approximates the fair value at the respective balance sheet date.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The liability in respect of TEVA as presented in balance sheet which is approximate its fair value, based on a calculation of the present value of future payments. The expected cash flows already reflect assumptions about the uncertainty in future defaults, and therefore the Company used a discount rate of <ix:nonFraction id="Fxbrl_20240317142004696" name="ifrs-full:DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse" contextRef="C_20231231_ifrsfullTypesOfRisksAxis_mdwdUncertaintyInFutureDefaultsMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">14</ix:nonFraction>% that is commensurate with the risk inherent in the expected cash flows (Note 17c).</span></span></div>
        </div>
      </ix:nonNumeric>
      <p style="margin:0pt">&#160;</p>
    </div>
  </div>
</div><div style="">
  <ix:nonNumeric id="Fxbrl_20211007123216164" name="ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory" contextRef="C_20230101to20231231" escape="true">
    <div>
      <div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 16:</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Severance Pay Liability, Net</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has liabilities for severance pay for its employees in Israel and in several EU jurisdictions. The Company&#8217;s liability for employee benefits is based on local laws, valid labor agreements, the employee&#8217;s salary and the applicable terms of employment, which together generate a right to severance compensation. Post&#8209;employment employee benefits are partially financed by deposits with defined contribution plans, as detailed below.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Israeli Severance Pay Law, 1963 (&#8220;Severance Pay Law&#8221;), specifies that Israeli employees are entitled to severance payment, following the termination of their employment.</span></span></div>
          <div style="line-height:1.25">
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under the Severance Pay Law, the severance payment is calculated as one month salary for each year of employment, or a portion thereof. Under Section 14 of the Severance Pay Law (&#8220;Section 14&#8221;), employees are entitled to have monthly deposits, at a rate of <ix:nonFraction id="Fxbrl_20211007123204045" name="mdwd:PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans" contextRef="C_20230101to20231231" unitRef="Percent" scale="-2" decimals="4" format="ixt:num-dot-decimal">8.33</ix:nonFraction>% of their monthly salary, made on their behalf to their insurance funds. Payments in accordance with Section 14 release the Company from the liability for any future severance payments in respect of those employees.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The majority of the Company&#8217;s liability for severance pay is covered by Section 14. Accordingly, the Company does not recognize any liability for severance pay due to these employees and the deposits under Section 14 are not recorded as an asset in the Company&#8217;s balance sheet. These contributions for compensation represent defined contribution plans. The Company recognizes liability for severance pay due to its employees in EU in accordance with local laws and its Israeli employees which are not under Section 14.</span></span></div>
          </div>
        </div>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin:0pt">&#160;</p>
  <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 30</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
</div><div style="">
  <div>
    <div>
      <ix:nonNumeric id="Fxbrl_20240316155825162" name="ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" contextRef="C_20230101to20231231" escape="true">
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 17:</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liabilities and Commitments</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;font-weight:normal;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In 2000, the Company signed an exclusive license agreement (as amended in 2007) with a third party with regard to its patents and intellectual property. Pursuant to the agreement, the Company received an exclusive license to use the third party&#8217;s patents and intellectual property, for the purpose of developing, manufacturing, marketing, and commercializing products for treatment of burns and other wounds.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company paid an aggregate amount of $ <ix:nonFraction id="Fxbrl_20220217171315317" name="ifrs-full:TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">950 </ix:nonFraction>and undertook to pay royalties of <ix:nonNumeric id="Fxbrl_20220217171322419" name="mdwd:PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">1.5% to 2.5</ix:nonNumeric>% from future revenues from sales of products which are based on this patent for a period of <ix:nonNumeric id="Fxbrl_20220217171334260" name="mdwd:PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">12 years</ix:nonNumeric> from the first commercial delivery in a major country, and thereafter the Company will have a fully paid-up royalty-free license for these patents. In addition, royalties will be paid at the rate of <ix:nonNumeric id="Fxbrl_20240320211135383" name="mdwd:PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_ifrsfullMethodsOfGenerationAxis_mdwdSubLicensingOfPatentsMember">10%</ix:nonNumeric>&#160;from sub-licensing of such patents and for lump sum amounts paid to the Company by a third party, the Company will pay <ix:nonFraction id="Fxbrl_20220217171356972" name="mdwd:PercentageOfOneTimeLumpSumPaymentAmount" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_ifrsfullMethodsOfGenerationAxis_mdwdSubLicensingOfPatentsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">2</ix:nonFraction>% of the proceeds up to $<ix:nonFraction id="Fxbrl_20220217171406812" name="mdwd:OneTimeLumpsumAmount" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_ifrsfullMethodsOfGenerationAxis_mdwdSubLicensingOfPatentsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,000</ix:nonFraction> and <ix:nonFraction id="Fxbrl_20220217171416772" name="mdwd:PercentageOfOneTimeLumpSumPaymentAmount" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_ifrsfullMethodsOfGenerationAxis_mdwdSubLicensingOfPatentsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">4</ix:nonFraction>% above this amount. Moreover, the Company agreed to pay a one-time lump-sum amount of $ <ix:nonFraction id="Fxbrl_20220217171428748" name="mdwd:OneTimeLumpsumAmount" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,500</ix:nonFraction> when the aggregate revenues based on these patents reach $ <ix:nonFraction id="Fxbrl_20220217171439516" name="ifrs-full:RevenueFromRoyalties" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">100,000</ix:nonFraction>. The royalty payments for the years 2021, 2022 and 2023 amounted to $<ix:nonFraction id="Fxbrl_20240316155752438" name="ifrs-full:RoyaltyExpense" contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">149</ix:nonFraction>, $<ix:nonFraction id="Fxbrl_20220217171503398" name="ifrs-full:RoyaltyExpense" contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">363 </ix:nonFraction>and $<ix:nonFraction id="Fxbrl_20220217171507148" name="ifrs-full:RoyaltyExpense" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">98 </ix:nonFraction>respectively.</span></span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>b.</span></span></span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Under the Research and Development Law, (the &#8220;R&amp;D Law&#8221;) the Company undertook to pay royalties of <ix:nonNumeric id="Fxbrl_20220310102520248" name="mdwd:PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdResearchAndDevelopmentLawMember">3</ix:nonNumeric>% on the revenues derived from sales of products or services developed in whole or in part using IIA grants. The maximum aggregate royalties paid cannot exceed <ix:nonFraction id="Fxbrl_20220310102528652" name="mdwd:MaximumAggregateRoyaltiesPaidInPercentage" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdResearchAndDevelopmentLawMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>% of the grants received by the Company, plus annual interest equal to the <ix:nonNumeric id="Fxbrl_20220310102535910" name="ifrs-full:BorrowingsInterestRateBasis" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdResearchAndDevelopmentLawMember">12-month interest</ix:nonNumeric> applicable to dollar deposits, as published on the first business day of each calendar year. The total royalties amount paid as of December 31, 2023 is $<ix:nonFraction id="Fxbrl_20220310102629529" name="ifrs-full:RoyaltyExpense" contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdResearchAndDevelopmentLawMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,942</ix:nonFraction>. (Note 14).</span></span></span></span></div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>c.</span></span></span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div>
                    <div style="line-height:1.25;font-family:'Times New Roman',serif">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In December 2020, Teva has agreed to revise the Settlement Agreement from March 2019, which was comprised of past agreement for collaboration in the development, manufacturing and commercialization of solutions for the burn and chronic wound care markets, as well as the Company&#8217;s repurchase of shares from Teva. Under the new settlement the Company paid $<ix:nonFraction id="Fxbrl_20211007134902507" name="ifrs-full:ConsiderationPaidReceived" contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,000</ix:nonFraction> in cash and became obligated to pay an amount of $<ix:nonFraction id="Fxbrl_20211007134927283" name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" contextRef="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,000</ix:nonFraction> over three years and an addition amount of $<ix:nonFraction id="Fxbrl_20211007134952751" name="ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,200</ix:nonFraction> in quarterly fixed payments starting 2021 as long as there are revenues generated from sales of Nexobrid.</span></span></span></span></div>
                    </div>
                  </div>
                  <div style="font-family:'Times New Roman',Times,serif">&#160;<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total liabilities recorded as of December 31, 2023 and 2022 were approximately $<ix:nonFraction id="Fxbrl_20220310103821242" name="ifrs-full:Liabilities" contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,428</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20220310103831381" name="ifrs-full:Liabilities" contextRef="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,794</ix:nonFraction> respectively, and financial expenses of $<ix:nonFraction id="Fxbrl_20220310105227733" name="mdwd:FinancialIncomeAndExpenses" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">468</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20220310105251716" name="mdwd:FinancialIncomeAndExpenses" contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">533</ix:nonFraction>, respectively, were recorded in profit or loss within financial expenses.</span></span></span></span></div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </ix:nonNumeric>
      <p style="margin:0pt">&#160;</p>
      <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 31</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
    </div>
  </div>
</div><div style="">
  <div>
    <ix:nonNumeric id="Fxbrl_20240319221000469" name="mdwd:DisclosureOfMaterialAgreementsExplanatory" contextRef="C_20230101to20231231" escape="true">
      <div>
        <div style="text-align:justify;line-height:1.25;font-weight:bold">
          <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Note 18:</span></span></span></strong></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Materials Agreements</span></span></span></strong></p>
                </td>
              </tr>

          </table>
        </div>
        <div style="text-align:justify;text-indent:-56.7pt;margin-left:56.7pt;line-height:1.25;font-weight:bold">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BARDA<span style="font-style:italic">&#160;</span>Contracts</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In September 2015, the Company was awarded BARDA Contract for treatment of thermal burn injuries. This contract was amended multiple times to extend its term until September 2024 (the Company is pursuing an extension of the contract) and its total value, up to a total amount of $<ix:nonFraction id="Fxbrl_20220310110347319" name="ifrs-full:TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions" contextRef="C_20220101to20221231_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">165,000</ix:nonFraction> as of the end of 2022.</span></span></div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        <div style="text-align:justify;margin-left:85.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>In</span> May 2023 BARDA has awarded an additional approximately $<ix:nonFraction id="Fxbrl_20220310125150154" name="mdwd:ProceedsFromAdditionalFunding" contextRef="C_20230508to20230509_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,000</ix:nonFraction> to the Company. The total amount of the contract is comprised of $<ix:nonFraction id="Fxbrl_20220310130047637" name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="C_20230508to20230509_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">110,000</ix:nonFraction> to support research and development activities and up to $<ix:nonFraction id="Fxbrl_20220310125620778" name="mdwd:ProceedsFromProcurement" contextRef="C_20230508to20230509_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdNexoBridMember_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember_srtRangeAxis_srtMaximumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65,000</ix:nonFraction> to procure <span>Nexobrid</span> for U.S. emergency preparedness (which will be split between the Company and Vericel following Vericel agreement (see Note 18b)).</span></span></div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, the Company has received approximately $<ix:nonFraction id="Fxbrl_20220310130314690" name="mdwd:AccumulatedFunding" contextRef="C_20230101to20231231_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">88,282</ix:nonFraction> in funding in the aggregate, from BARDA under the first contract, and an additional $<ix:nonFraction id="Fxbrl_20220310130923083" name="mdwd:ProceedsFromProcurement" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdNexoBridMember_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,500</ix:nonFraction> for procurement of <span>Nexobrid</span> for U.S. emergency preparedness, which were recorded at the net amount of approximately $<ix:nonFraction id="Fxbrl_20220310130949922" name="ifrs-full:Revenue" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdNexoBridMember_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,500</ix:nonFraction> following the split of gross profit agreement with Vericel for the initial BARDA procurement.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In September 2018 the Company was awarded the second BARDA contract, to develop Nexobrid for the treatment of Sulfur Mustard injuries as part of BARDA&#8217;s preparedness for mass casualty events. The contract provides up to $<ix:nonFraction id="Fxbrl_20220310124811281" name="mdwd:ProceedsFromFunding" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdNexoBridMember_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember_srtRangeAxis_srtMaximumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,000</ix:nonFraction> of funding to support research and development activities and contains options to provide additional funding of up to $<ix:nonFraction id="Fxbrl_20220310124823616" name="mdwd:ProceedsFromAdditionalFunding" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdNexoBridMember_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,000</ix:nonFraction> for additional development activities, animal pivotal studies, and the BLA submission for licensure of Nexobrid for the treatment of Sulfur Mustard injuries. The second BARDA contract expired in 2023. As of December 31, 2023, the Company has received approximately $<ix:nonFraction id="Fxbrl_20240317171927554" name="mdwd:AmountOfSecondContractExpired" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdNexoBridMember_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,368</ix:nonFraction> of funding from the second BARDA contract.</span></span></div>
          <div style="text-align:justify;margin-left:85.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div><ix:exclude>
            <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 32</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
            <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                <tr>
                  <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Note 18:</span></span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span>Materials Agreements&#160;</span><span>(Cont.)</span></strong></span></span></p>
                  </td>
                </tr>

            </table>
            <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </ix:exclude></div>
        </div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b<span style="font-style:italic">.</span></span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vericel Agreement:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="text-align:justify;margin-left:74.7pt;line-height:1.25">
          <div style="margin-left:74.7pt;line-height:1.25;font-family:'Times New Roman', serif;font-size:11pt">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:justify;margin-left:83.7pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On May 6, 2019, the Company entered into exclusive license and supply agreements with Vericel to commercialize <span>Nexobrid</span> in North America (the &#8220;Collaboration Agreements&#8221;). Pursuant to the Collaboration Agreements, Vericel will obtain the authority over and control of the development, regulatory approval and commercialization of licensed products in the North America territory. MediWound will be responsible for the development of the product through BLA approval, supported and funded by BARDA, as well as the manufacture and supply of <span>Nexobrid</span>. In addition, MediWound retains the commercial rights to <span>Nexobrid</span> in non-North American territory.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:83.7pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under the terms of the license agreement, Vericel has made an upfront payment to MediWound of $<ix:nonFraction id="Fxbrl_20220310131158066" name="mdwd:UpfrontPayment" contextRef="C_20190501to20190506_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdLicenseAgreementWithVericelMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,500</ix:nonFraction> which was recorded as revenues from license agreements in 2019 as well as an additional milestone payment of $<ix:nonFraction id="Fxbrl_20220310131209150" name="mdwd:AdditionalUpfrontPayment" contextRef="C_20190501to20190506_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdLicenseAgreementWithVericelMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,500</ix:nonFraction> recorded as revenues from license agreements in 2022 upon BLA approval received in December 2022. Furthermore, Vericel has also agreed to pay MediWound up to $<ix:nonFraction id="Fxbrl_20220310131235149" name="mdwd:AdditionalUpfrontPayment" contextRef="C_20190501to20190506_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdLicenseAgreementWithVericelMember_srtRangeAxis_srtMaximumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">125,000</ix:nonFraction> in payments contingent upon meeting certain annual sales milestones, tiered royalties on net sales ranging from high single-digit to teen-digit percentages, a split of gross profit on committed BARDA procurement orders and a teen-digits royalty on any additional future BARDA purchases of <span>Nexobrid</span>. Under the terms of the supply agreement, Vericel will procure <span>Nexobrid</span> from MediWound at a fixed transfer price.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:83.7pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total revenue from royalties as of December 31, 2023 <span>was</span> approximately $<ix:nonFraction id="Fxbrl_20240317171749249" name="ifrs-full:Revenue" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdLicenseAgreementWithVericelMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">82</ix:nonFraction>.</span></span></div>
          <div style="text-align:justify;margin-left:83.7pt;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        </div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">DOD and MTEC contracts:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="text-align:justify;margin-left:74.7pt;line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif">
          <div style="line-height:1.25;font-family:'Times New Roman',serif">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On February 17, 2022, the Company was entered into a contract with the U.S. Department of Defense (DoD), through the Medical Technology Enterprise Consortium (MTEC), to develop Nexobrid as a non-surgical solution for field-care burn treatment for the U.S. Army. The contract provides funding up to $<ix:nonFraction id="Fxbrl_20240317174017762" name="mdwd:ProceedsFromFunding" contextRef="C_20220201to20220217_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdUsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,727</ix:nonFraction>.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
          </div>
        </div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif">
          <div style="line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During 2023, the DOD through MTEC awarded the Company additional funding of $<ix:nonFraction id="Fxbrl_20240317174021385" name="mdwd:ProceedsFromAdditionalFunding" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdUsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,117</ix:nonFraction> in addition, the company awarded directly through MTEC funding of $<ix:nonFraction id="Fxbrl_20240317174024689" name="mdwd:ProceedsFromAdditionalProcurement" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdUsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,190</ix:nonFraction>, to advance the development of a new temperature stable formulation of Nexobrid. The total additional fund from the DOD and MTEC during 2023 was $<ix:nonFraction id="Fxbrl_20240317174027863" name="mdwd:AccumulatedFunding" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdUsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,307</ix:nonFraction>.</span></span></div>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Biopharmax Group Ltd. contract:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="margin-left:85.05pt;line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:90pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 17, 2023 the<span style="font-weight:bold">&#160;</span>company signed a turnkey scale-up agreement with Biopharmax Group Ltd. This strategic agreement is designed to bolster our manufacturing infrastructure to support our long-term growth trajectory. The objective of this agreement is to establish, commission, and validate a cutting-edge, sterile, and GMP-compliant manufacturing facility. The venture aims to increase the company&#8217;s production capacity significantly, to expand up to six times the current capacity.</span></span></div>
        <div style="text-align:justify;margin-left:90pt;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        <div style="text-align:justify;margin-left:90pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The new facility, equipped with fully operational clean rooms, will be exclusively designed for <span>Nexobrid</span> production. It will comply with stringent regulations from the GMP, FDA, EMA, Israeli Ministry of Health, and relevant Israeli regulatory bodies. An estimated $<ix:nonFraction id="Fxbrl_20240317174013877" name="mdwd:AmountOfInvestedInProject" contextRef="C_20230701to20230717_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTurnkeyScaleUpAgreementWithBiopharmaxGroupMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">12.7</ix:nonFraction> million will be invested in the project, set for <span>constructions </span>completion by mid-2024, with full-scale manufacturing expected to commence in 2025 (see also note 10).</span></span></div>
      </div>
    </ix:nonNumeric>
    <div style="line-height:1.25">
      <p style="margin:0pt">&#160;</p>
      <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 33</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
    </div>
  </div>
</div><div style="">
  <ix:nonNumeric id="Fxbrl_20211007144020202" name="ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" contextRef="C_20230101to20231231" escape="true">
    <div>
      <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

          <tr>
            <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 19:</span></td>
            <td style="width:auto;vertical-align:top;text-align:justify">
              <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span>Equity</span></strong></span></div>
            </td>
          </tr>

      </table>
      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>
    </div>
    <ix:nonNumeric id="Fxbrl_20220217161603641" name="ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory" contextRef="C_20230101to20231231" escape="true">
      <div>
        <div>
          <div style="line-height:1.25">
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                    <tr>
                      <td style="width:56.7pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">a.</span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span><span><span style="font-family:'Times New Roman', Times, serif">Share capital:</span></span></span></strong></span></div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          </div>
          <div style="margin-left:85.05pt">
            <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
            <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:90%">

                <tr>
                  <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>December 31</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2023</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2022</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Authorized number of shares</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double black;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double black;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><span><span><ix:nonFraction id="Fxbrl_20211007143749334" name="ifrs-full:NumberOfSharesAuthorised" contextRef="C_20231231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">20,000,000</ix:nonFraction></span></span></span></span></strong></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double black;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double black;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20211007143809954" name="ifrs-full:NumberOfSharesAuthorised" contextRef="C_20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">12,857,143</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom">
                    <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Issued and outstanding number of shares</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><span><span><ix:nonFraction id="Fxbrl_20211007143935452_xbrl_20211007143749334" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20231231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">9,221,764</ix:nonFraction></span></span></span></span></strong></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20211007143935452_xbrl_20211007143809954" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">7,240,020</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
    <div style="line-height:1.25;clear:both">
      <p style="margin-left:56.7pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <div>
        <div style="margin-left:85.05pt;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>An ordinary share confers upon its holder(s) a right to vote at the general meeting, a right to participate in distribution of dividends, and a right to participate in the distribution of surplus assets upon liquidation of the Company.</span></span></span></span></span></span></span></div>
        <div style="margin-left:85.05pt;margin-top:0pt;margin-bottom:0pt;text-align:justify">&#160;</div>
      </div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

        <tr>
          <td style="width:56.7pt">&#160;</td>
          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">b.</span></td>
          <td style="width:auto;vertical-align:top;text-align:justify">
            <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Movement in share capital:</span></div>
          </td>
        </tr>
        <tr>
          <td style="width:56.7pt">&#160;</td>
          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</td>
          <td style="width:auto;vertical-align:top;text-align:justify">&#160;</td>
        </tr>

    </table>
    <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)">

        <tr>
          <td style="width:85.05pt">&#160;</td>
          <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span>1.</span></span></td>
          <td style="width:auto;vertical-align:top;text-align:justify">
            <div><span style="font-size:10pt"><span>During 2021, 2022 and 2023 the Company issued additional <ix:nonFraction id="Fxbrl_20240317131214562" name="mdwd:AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits" contextRef="C_20210101to20211231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">4,852</ix:nonFraction>, <ix:nonFraction id="Fxbrl_20240317131221971" name="mdwd:AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits" contextRef="C_20220101to20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">41,395</ix:nonFraction> and <ix:nonFraction id="Fxbrl_20240317131229794" name="mdwd:AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits" contextRef="C_20230101to20231231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">17,458</ix:nonFraction> ordinary shares for each year upon vesting of outstanding RSU&#8217;s, respectively.</span></span></div>
          </td>
        </tr>

    </table>
    <div>
      <div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:85.05pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On November 28, 2022, at the Company&#8217;s extraordinary general meeting of shareholders, its shareholders approved:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:103.05pt">&#160;</td>
              <td style="width:20.4pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(a)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">An increase&#160;of the Company&#8217;s authorized share capital from NIS <ix:nonFraction id="Fxbrl_20240317133531639" name="mdwd:AuthorizedShareCapital" contextRef="C_20221127" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">500,000</ix:nonFraction>, consisting of <ix:nonFraction id="Fxbrl_20240317133550680" name="ifrs-full:NumberOfSharesAuthorised" contextRef="C_20221127" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">50,000,000</ix:nonFraction> ordinary shares, per value NIS <ix:nonFraction id="Fxbrl_20240317133740342" name="ifrs-full:ParValuePerShare" contextRef="C_20221128" unitRef="NIS_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.01</ix:nonFraction> per share to NIS <ix:nonFraction id="Fxbrl_20240317133805968" name="mdwd:AuthorizedShareCapital" contextRef="C_20221128" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">900,000</ix:nonFraction> consisting of <ix:nonFraction id="Fxbrl_20240317133812919" name="mdwd:IncreaseInSharesIssued" contextRef="C_20221128" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">90,000,000</ix:nonFraction> ordinary shares, per value NIS <ix:nonFraction id="Fxbrl_20240317133825272" name="ifrs-full:ParValuePerShare" contextRef="C_20221128" unitRef="NIS_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.01</ix:nonFraction> per share.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

              <tr style="vertical-align:top">
                <td style="width:103.05pt">&#160;</td>
                <td style="text-align:right;vertical-align:top;width:20.4pt">
                  <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(b)</span></span></div>
                </td>
                <td style="text-align:left;vertical-align:top;width:auto">
                  <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 5, 2022, the Company&#8217;s board of directors approved a reverse split of <ix:nonNumeric id="Fxbrl_20240317133941138" name="mdwd:ReverseStockSplit" contextRef="C_20230101to20231231">1-for-7 ratio</ix:nonNumeric>. The reverse split went effective on December 20, 2022.</span></span></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:121.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No fractional shares were issued as a result of the reverse share split. Instead, such shares were rounded up to the next whole number of shares. The reverse share split affected all shareholders uniformly and did not alter any person&#8217;s percentage interest in our outstanding ordinary shares, except for negligible adjustments that may have resulted from the treatment of fractional shares.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:121.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In connection with the reverse share split, The Company also amended and reduced the authorized number of ordinary shares from <ix:nonFraction id="Fxbrl_20240317134110863" name="ifrs-full:NumberOfSharesAuthorised" contextRef="C_20221205" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">90,000,000</ix:nonFraction> to <ix:nonFraction id="Fxbrl_20240317134043504" name="ifrs-full:NumberOfSharesAuthorised" contextRef="C_20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">12,857,143</ix:nonFraction>, which reflected a reduction at the same 1-for-7 ratio as the reduction to the number of issued and outstanding ordinary shares.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:121.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Concurrently, the par value of the Company&#8217;s ordinary shares was increased proportionately, from NIS <ix:nonFraction id="Fxbrl_20240317134231526" name="ifrs-full:ParValuePerShare" contextRef="C_20221205" unitRef="NIS_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.01</ix:nonFraction> per share to NIS <ix:nonFraction id="Fxbrl_20240317134258134" name="ifrs-full:ParValuePerShare" contextRef="C_20231231" unitRef="NIS_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.07</ix:nonFraction> per share, in order to maintain the same overall authorized share capital under our Amended and Restated Articles of Association.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:121.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On May 31, 2023 the Shareholders of the Company approved an amendment to Article 6 of the Company&#8217;s Amended and Restated Articles of Association, which increased the Company&#8217;s authorized share capital from <ix:nonFraction id="Fxbrl_20240317134411624" name="mdwd:IncreaseInAuthorizedShareCapital" contextRef="C_20230531" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">900,000</ix:nonFraction> NIS consisting of <ix:nonFraction id="Fxbrl_20240317134444392" name="ifrs-full:NumberOfSharesAuthorised" contextRef="C_20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">12,857,143</ix:nonFraction> ordinary shares par value NIS <ix:nonFraction id="Fxbrl_20240317134453088" name="ifrs-full:ParValuePerShare" contextRef="C_20230531" unitRef="NIS_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.07</ix:nonFraction> to NIS <ix:nonFraction id="Fxbrl_20240317134517207" name="ifrs-full:NumberOfSharesAuthorised" contextRef="C_20230531" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">1,400,000</ix:nonFraction>, consisting of <ix:nonFraction id="Fxbrl_20240317134528487" name="ifrs-full:NumberOfSharesAuthorised" contextRef="C_20231231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">20,000,000</ix:nonFraction> ordinary shares, par value NIS <ix:nonFraction id="Fxbrl_20240317134503695" name="ifrs-full:ParValuePerShare" contextRef="C_20230531" unitRef="NIS_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.07</ix:nonFraction> per share.</span></span><br/>&#160;</div>
        <div><ix:exclude>
          <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 34</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
          <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 19:</span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Equity (Cont.)</span></div>
                </td>
              </tr>

          </table>
          <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
        </ix:exclude></div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial transactions:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:85.05pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 7, 2022, the Company completed a public offering in total of <ix:nonFraction id="Fxbrl_20240317134823880" name="ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding" contextRef="C_20220307to20220307" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">744,048</ix:nonFraction> new ordinary shares which were issued in consideration to offering price of $<ix:nonFraction id="Fxbrl_20240317134957166" name="mdwd:PricePerShareOfSharesIssued" contextRef="C_20220307to20220307" unitRef="NIS_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.44</ix:nonFraction> per share. The net proceeds were $<ix:nonFraction id="Fxbrl_20240317135139702" name="ifrs-full:ProceedsFromIssuingShares" contextRef="C_20220307to20220307" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,653</ix:nonFraction>, after deducting commissions and other offering expenses. In addition, on March 22, 2022 the underwriters exercised their options to purchase an additional <ix:nonFraction id="Fxbrl_20240317135231295" name="mdwd:ExercisedOptionsToPurchaseAdditionalOrdinaryShares" contextRef="C_20220307to20220307" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">89,012</ix:nonFraction> ordinary shares at the same public offering price. The net consideration to the Company, less underwriting discounts and commissions was at additional of $<ix:nonFraction id="Fxbrl_20240317135325800" name="mdwd:AmountOfUnderwritingDiscountsAndCommissions" contextRef="C_20220307to20220307" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,021</ix:nonFraction>.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As part of the above- mentioned public offering, certain entities affiliated with CBI purchased <ix:nonFraction id="Fxbrl_20240317135350079" name="ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding" contextRef="C_20220307to20220307_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdCertainEntitiesAffiliatedWithCbiMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">208,334</ix:nonFraction> of ordinary shares at the public offering price.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:85.05pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On September 26, 2022, the Company completed a registered direct (the &#8220;RD&#8221;) offering in an aggregate amount of $<ix:nonFraction id="Fxbrl_20240317135427583" name="mdwd:AggregateAmountOfRegisteredDirectOffering" contextRef="C_20220926to20220926" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,257</ix:nonFraction> represent a combine purchase price of $<ix:nonFraction id="Fxbrl_20240317135454946" name="mdwd:PurchasePriceOfRegisteredDirectOffering" contextRef="C_20220926" unitRef="NIS_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">12.25</ix:nonFraction> for issuance of <ix:nonFraction id="Fxbrl_20240317135519462" name="ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding" contextRef="C_20220926to20220926" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">1,082,223</ix:nonFraction> ordinary shares and <ix:nonFraction id="Fxbrl_20240317135530982" name="mdwd:NumberOfWarrantsIssued" contextRef="C_20220926to20220926" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">1,082,223</ix:nonFraction> warrants that become exercisable on November 28, 2022, at an exercise price of $<ix:nonFraction id="Fxbrl_20240317135800439" name="mdwd:ExercisePriceOfWarrants" contextRef="C_20220926" unitRef="NIS_per_share" scale="0" decimals="3" format="ixt:num-dot-decimal">13.475</ix:nonFraction> per ordinary share which will expire in <ix:nonNumeric id="Fxbrl_20240317135857510" name="mdwd:WarrantsExpirationPeriod" contextRef="C_20220926to20220926" format="ixt-sec:durwordsen">four years</ix:nonNumeric> (see also note 25.3).</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The warrants issued have been classified as a non-current financial liability due to a net share settlement provision and as they can be settled in cash on the occurrence of Fundamental Transaction as determined in the agreement. This liability was initially recognized at its fair value on the date the contract was entered into and is subsequently accounted for fair value at each balance sheet date and recorded through profit and loss.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of the warrants has been evaluated with the assistance of external independent valuator and was computed based on then current price of the shares, a risk-free interest rate of <ix:nonFraction id="Fxbrl_20240317140130918" name="mdwd:RiskFreeInterestRateOfWarrants" contextRef="C_20230101to20231231" unitRef="Percent" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.37</ix:nonFraction>% and an average standard deviation of <ix:nonFraction id="Fxbrl_20240317140148870" name="mdwd:AverageStandardDeviationOfWarrants" contextRef="C_20230101to20231231" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">68</ix:nonFraction>%.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The net proceeds from this offering in the amount of $<ix:nonFraction id="Fxbrl_20240317140246366" name="mdwd:NetProceedsFromOfferingAmount" contextRef="C_20220901to20220928" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,698</ix:nonFraction> have been received on September 28, 2022. The issuance expenses related to the non-current financial liability were recorded through profit and loss and the issuance expenses related to the issuance of shares recorded as a deduction from the proceeds in equity.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:85.05pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Concurrently, on October 6, 2022, the Company entered into a Private Issuance Purchase Equity agreement (the &#8220;PIPE&#8221;) with several purchasers, in connection with the offering of <ix:nonFraction id="Fxbrl_20240317140404038" name="mdwd:UnregisteredPreFundedWarrantsIssued" contextRef="C_20221006to20221006_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">1,407,583</ix:nonFraction> unregistered pre-funded warrants to purchase up to <ix:nonFraction id="Fxbrl_20240317140559742" name="mdwd:UnregisteredPreFundedWarrantsToPurchaseCommonStock" contextRef="C_20221006to20221006_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">1,407,583</ix:nonFraction> ordinary shares and <ix:nonFraction id="Fxbrl_20240317140641309" name="mdwd:NumberOfWarrantsIssued" contextRef="C_20221006to20221006_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">1,407,583</ix:nonFraction> warrants to purchase up to <ix:nonFraction id="Fxbrl_20240317140722830" name="mdwd:WarrantsToPurchaseOrdinaryShares" contextRef="C_20221006to20221006_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">1,407,583</ix:nonFraction> ordinary shares. Pre-Funded warrants become exercisable on November 28, 2022, at an exercise price of $<ix:nonFraction id="Fxbrl_20240317140748878" name="mdwd:IncreaseInPreFundedWarrantsExercisePrice" contextRef="C_20221006_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember" unitRef="NIS_per_share" scale="0" decimals="3" format="ixt:num-dot-decimal">0.007</ix:nonFraction> per ordinary share and the warrants would be also exercisable upon the Authorized Share Increase Date at an exercise price of $<ix:nonFraction id="Fxbrl_20240317140849604" name="mdwd:ExercisePriceOfWarrants" contextRef="C_20221006_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember" unitRef="NIS_per_share" scale="-4" decimals="7" format="ixt:num-dot-decimal">13.475</ix:nonFraction> per ordinary share and expire in four years.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Pre-Funded warrants and warrants issued have been classified as a non-current financial liabilities due to a net share settlement provision and they can be redeemed in cash on the occurrence of Fundamental Transaction as determined in the agreement. The initial fair value of the financial liabilities issued in the transaction was approximately $<ix:nonFraction id="Fxbrl_20240317140948901" name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="C_20231231_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,788</ix:nonFraction>, which comprised of: 1. The warrants which were valuated by Black and Sholtes model based on the current price of the shares and a risk-free interest rate of <ix:nonFraction id="Fxbrl_20240317141053221" name="mdwd:RiskFreeInterestRateOfWarrants" contextRef="C_20230101to20231231_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember" unitRef="Percent" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.26</ix:nonFraction>%, and 2. The pre-funded warrants which were valued in an amount which is approximate its share price upon their issuance.</span></span></div>
        <div style="text-align:justify;margin-left:103.05pt;line-height:1.25">&#160;</div>
        <div><ix:exclude>
          <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 35</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
          <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 19:</span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Equity (Cont.)</span></div>
                </td>
              </tr>

          </table>
          <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
        </ix:exclude></div>
        <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The consideration received from this transaction was $<ix:nonFraction id="Fxbrl_20240317141149118" name="ifrs-full:ProceedsFromExerciseOfWarrants" contextRef="C_20230101to20231231_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,233</ix:nonFraction>. As the fair value on initial recognition of the warrants differs from the transaction price, the difference, represents the First day loss at the amount of $<ix:nonFraction id="Fxbrl_20240317141356412" name="mdwd:LossFromWarrantsTransactions" contextRef="C_20231231_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,555</ix:nonFraction>, and has been allocated to the warrants with respect to this transaction and is amortized on a straight line basis over the term of the warrants.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The net proceeds from this offering amounted to approximately $<ix:nonFraction id="Fxbrl_20240317141452589" name="ifrs-full:ProceedsFromIssuingShares" contextRef="C_20230101to20231231_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,920</ix:nonFraction>. The issuance expenses were recorded through profit and loss.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During December 2022, the <ix:nonFraction id="Fxbrl_20240317141600836" name="mdwd:UnregisteredPreFundedWarrantsIssued" contextRef="C_20230101to20231231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">1,407,583</ix:nonFraction> pre-funded warrants were exercised into ordinary shares.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:85.05pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Upon closing of the RD and PIPE Offerings, the Company also issued the placement agent up to <ix:nonFraction id="Fxbrl_20240317141701724" name="mdwd:NumberOfWarrantsIssued" contextRef="C_20230101to20231231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">124,491</ix:nonFraction> warrants to purchase up to <ix:nonFraction id="Fxbrl_20240317141734276" name="mdwd:WarrantsToPurchaseOrdinaryShares" contextRef="C_20230101to20231231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">124,491</ix:nonFraction> ordinary Shares. The warrants have substantially the same terms as the RD and PIPE Warrants, except that the placement agent&#8217;s warrants have an exercise price equal to $<ix:nonFraction id="Fxbrl_20240317141817859" name="mdwd:ExercisePriceOfWarrants" contextRef="C_20231231" unitRef="NIS_per_share" scale="-4" decimals="7" format="ixt:num-dot-decimal">15.312</ix:nonFraction> per share (which represents 125% of the offering price per ordinary Share in the offerings). The Fair value of the placement agent&#8217;s options was recorded as an issuance expenses through profit and loss and as a deduction from proceed in equity based on the financial treatment of both RD and PIPE offering and in accordance with&#160;their part.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:85.05pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On February 7, 2023, the Company completed a registered direct (the &#8220;RD&#8221;) offering of <ix:nonFraction id="Fxbrl_20240317141940876" name="ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding" contextRef="C_20230207to20230207" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">1,964,286</ix:nonFraction> new ordinary shares which were issued in consideration to offering price of $<ix:nonFraction id="Fxbrl_20240317142117396" name="mdwd:PricePerShareOfSharesIssued" contextRef="C_20230207to20230207" unitRef="NIS_per_share" scale="-4" decimals="5" format="ixt:num-dot-decimal">14.0</ix:nonFraction> per share. The gross proceeds were $<ix:nonFraction id="Fxbrl_20240317142159492" name="ifrs-full:ProceedsFromIssuingShares" contextRef="C_20230207to20230207" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,500</ix:nonFraction>, before deducting commissions and other offering expenses in the amount of $<ix:nonFraction id="Fxbrl_20240317143051211" name="mdwd:CommissionsAndOtherOfferingExpenses" contextRef="C_20230207to20230207" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,031</ix:nonFraction>.</span></span></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin:0pt">&#160;</p>
</div><div style="">
  <ix:nonNumeric id="Fxbrl_20220217192613468" name="ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory" contextRef="C_20230101to20231231" escape="true">
    <div>
      <div>
        <div>
          <div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 20:</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share&#8209;Based Compensation</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt">&#160;</td>
                    <td style="width:28.35pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expense recognized in the financial statements:</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The expenses recognized for services received from employees and directors is as follows:</span></span></div>
              <div style="line-height:1.25">&#160;</div>
            </div>
          </div>
          <ix:nonNumeric id="Fxbrl_20211011115035258" name="ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions" contextRef="C_20230101to20231231" escape="true">
            <div style="margin-left:85.05pt">
              <div>
                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenues</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011105152384_23" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20230101to20231231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdCostOfRevenuesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">271</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011105152384_27" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20220101to20221231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdCostOfRevenuesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">184</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011105152384_211" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdCostOfRevenuesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">153</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;vertical-align:bottom">
                          <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011105152384_33" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20230101to20231231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdResearchAndDevelopmentExpensesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">485</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011105152384_37" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20220101to20221231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdResearchAndDevelopmentExpensesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">406</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011105152384_311" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdResearchAndDevelopmentExpensesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">333</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Selling and marketing</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011105152384_43" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20230101to20231231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdSellingAndMarketingExpensesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">87</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011105152384_47" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20220101to20221231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdSellingAndMarketingExpensesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011105152384_411" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdSellingAndMarketingExpensesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011105152384_53" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20230101to20231231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdGeneralAndAdministrativeExpensesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,097</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011105152384_57" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20220101to20221231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdGeneralAndAdministrativeExpensesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,314</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011105152384_511" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdGeneralAndAdministrativeExpensesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,187</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
                          <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total share-based compensation</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011105152384_73" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,940</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011105152384_77" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,946</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011105152384_711" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,673</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          </ix:nonNumeric>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;line-height:1.25">
          <div><ix:exclude>
            <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 36</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
            <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                <tr>
                  <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 20:</span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Share&#8209;Based Compensation&#160;</span><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(Cont.)</span></div>
                  </td>
                </tr>

            </table>
            <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </ix:exclude></div>
        </div>
      </div>
    </div>
    <div>
      <div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based payment plan for employees and directors:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has granted options and restricted stock units ("RSUs") for a total of <ix:nonFraction id="Fxbrl_20211011094456612" name="mdwd:SharesAvailableForFutureGrant" contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">990,201</ix:nonFraction> ordinary shares.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, <ix:nonFraction id="Fxbrl_20240317200046923" name="mdwd:SharesAvailableForFutureGrant" contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">861,255</ix:nonFraction> ordinary shares of the Company were still available for a future grant.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Any options or RSUs, which are forfeited or not exercised before expiration, become available for future grants.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options granted under the Company's 2003 Israeli Share Option Plan ("The Plan") are exercisable in accordance with the terms of the Plan, within <ix:nonNumeric id="Fxbrl_20211011094727033" name="ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdIsraeliShareOptionPlanMember">5-10 years</ix:nonNumeric> from the date of grant, against payment of an exercise price or cashless exercise. The options generally vest over a period of <ix:nonNumeric id="Fxbrl_20211011094734109" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdIsraeliShareOptionPlanMember">3-4 years</ix:nonNumeric>.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In March 2014, the Company adopted and obtained shareholder approval for its 2014 Equity Incentive Plan (the &#8220;2014 Plan&#8221;). Options and RSU's granted under the Company's 2014 Plan are exercisable in accordance with the terms of the Plan. Options are exercisable within <ix:nonNumeric id="Fxbrl_20211011094832496" name="ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement" contextRef="C_20140301to20140331_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdEquityIncentivePlanMember">5-10 years</ix:nonNumeric> from the date of grant, against payment of an exercise price or cashless exercise and share units are granted immediately upon vesting of the RSU's. The options and the RSU's generally vest over a period of <ix:nonNumeric id="Fxbrl_20211011094936755" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" contextRef="C_20140301to20140331_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdEquityIncentivePlanMember">1-4 years</ix:nonNumeric>.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share options activity:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table lists the number of share options, the weighted average exercise prices of share options and changes that were made in the option plan to employees and directors</span></span></div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
      </div>
    </div>
    <div>
      <ix:nonNumeric id="Fxbrl_20211011115914767" name="ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" contextRef="C_20230101to20231231" escape="true">
        <div style="margin-left:85.05pt">
          <div>
            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding Options at beginning of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011105508273" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20221231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">764,767</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011105529220" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20221231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">30.44</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011110705437" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20211231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">537,288</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011110724951" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20211231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">44.45</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217181223455" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20201231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">513,973</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217181240273" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20201231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">45.85</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options Granted</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011110136712" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20230101to20231231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">346,950</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011110213996" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">11.87</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011110755767" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20220101to20221231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">320,775</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011110823303" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20220101to20221231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.25</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217181425941" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20210101to20211231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">53,970</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217181438704" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20210101to20211231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">37.52</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options Exercised</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011110330919" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="C_20230101to20231231" unitRef="shares" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011110347304" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231" unitRef="USD_Per_Share" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211011110920734" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="C_20220101to20221231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">807</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011110932597" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20220101to20221231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">12.23</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217181502634" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="C_20210101to20211231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">536</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217181508696" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20210101to20211231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">20.16</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options Forfeited and/or expired</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211011110403119" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="C_20230101to20231231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">154,230</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011110419950" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">57.55</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211011110948329" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="C_20220101to20221231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">92,489</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011110958094" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20220101to20221231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">55.58</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217181808699" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="C_20210101to20211231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">30,119</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217181814524" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20210101to20211231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">56.91</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding options at end of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011110528692" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20231231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">957,487</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011110619313" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20231231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">19.34</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011111114585" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20221231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">764,767</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011111126569" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20221231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">30.44</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217181831109" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20211231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">537,288</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217181842926" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20211231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">44.45</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Option's Exercisable at end of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011110601397" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" contextRef="C_20231231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">462,045</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011110631755" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20231231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">26.25</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011111151531" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" contextRef="C_20221231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">373,681</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011111204168" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20221231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">46.18</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217181858277" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" contextRef="C_20211231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">333,618</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217181919621" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20211231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">58.38</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </ix:nonNumeric>
      <div style="line-height:1.25;clear:both">&#160;</div>
      <div style="text-align:justify;line-height:1.25">
        <div><ix:exclude>
          <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 37</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
          <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 20:</span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Share&#8209;Based Compensation&#160;</span><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(Cont.)</span></div>
                </td>
              </tr>

          </table>
          <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
        </ix:exclude></div>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-left:56.7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table summarizes information about share options outstanding:</span></span></p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
      </div>
      <ix:nonNumeric id="Fxbrl_20211011121843256" name="ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" contextRef="C_20230101to20231231" escape="true">
        <div style="margin-left:56.7pt">
          <div>
            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding as of</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Range of exercise prices ($ )</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Remaining</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">contractual</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">life</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average exercise</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">price</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.26-9.64</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011111419230" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesOneMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">55,950</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20211011111429715" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20230101to20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesOneMember" format="ixt-sec:duryear">9.85</ix:nonNumeric></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011111506242" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesOneMember" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">8.44</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11.89-14.42</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011111744684_xbrl_20211011111419230" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesTwoMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">711,124</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20211011111744684_xbrl_20211011111429715" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20230101to20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesTwoMember" format="ixt-sec:duryear">7.89</ix:nonNumeric></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011111744684_xbrl_20211011111506242" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesTwoMember" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.20</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.88-37.52</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011112233159_xbrl_20211011111744684_xbrl_20211011111419230" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesThreeMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">125,535</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20211011112233159_xbrl_20211011111744684_xbrl_20211011111429715" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20230101to20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesThreeMember" format="ixt-sec:duryear">5.62</ix:nonNumeric></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011112233159_xbrl_20211011111744684_xbrl_20211011111506242" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesThreeMember" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">35.99</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">42.14-67.06</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317123026800_xbrl_20211011112233159_xbrl_20211011111744684_xbrl_20211011111419230" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesFourMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">64,878</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240317123026800_xbrl_20211011112233159_xbrl_20211011111744684_xbrl_20211011111429715" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20230101to20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesFourMember" format="ixt-sec:duryear">1.85</ix:nonNumeric></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317123026800_xbrl_20211011112233159_xbrl_20211011111744684_xbrl_20211011111506242" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesFourMember" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">63.84</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011112241296_xbrl_20211011112233159_xbrl_20211011111744684_xbrl_20211011111419230" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20231231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">957,487</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20211011112241296_xbrl_20211011112233159_xbrl_20211011111744684_xbrl_20211011111429715" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20230101to20231231" format="ixt-sec:duryear">7.29</ix:nonNumeric></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011112241296_xbrl_20211011112233159_xbrl_20211011111744684_xbrl_20211011111506242" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20231231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">19.34</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
              <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
              <div>
                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding as of</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Range of exercise prices ($ )</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">options</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Remaining</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">contractual</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">life</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average exercise</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">price</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.25-14.42</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317123236828" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesFiveMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">470,693</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240317123250871" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20220101to20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesFiveMember" format="ixt-sec:duryear">7.84</ix:nonNumeric></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317123310070" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesFiveMember" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.60</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.88-37.52</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317123409984_xbrl_20240317123236828" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesSixMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">145,354</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240317123409984_xbrl_20240317123250871" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20220101to20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesSixMember" format="ixt-sec:duryear">6.43</ix:nonNumeric></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317123409984_xbrl_20240317123310070" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesSixMember" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">35.95</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">42.14-67.06</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317123529965_xbrl_20240317123409984_xbrl_20240317123236828" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesServenMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">68,662</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240317123529965_xbrl_20240317123409984_xbrl_20240317123250871" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20220101to20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesServenMember" format="ixt-sec:duryear">2.85</ix:nonNumeric></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317123529965_xbrl_20240317123409984_xbrl_20240317123310070" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesServenMember" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">63.94</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">90.23-96.32</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317123614289_xbrl_20240317123529965_xbrl_20240317123409984_xbrl_20240317123236828" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesEightMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">80,058</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240317123614289_xbrl_20240317123529965_xbrl_20240317123409984_xbrl_20240317123250871" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20220101to20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesEightMember" format="ixt-sec:duryear">0.91</ix:nonNumeric></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317123614289_xbrl_20240317123529965_xbrl_20240317123409984_xbrl_20240317123310070" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesEightMember" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">90.65</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317123636436_xbrl_20240317123614289_xbrl_20240317123529965_xbrl_20240317123409984_xbrl_20240317123236828" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20221231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">764,767</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240317123636436_xbrl_20240317123614289_xbrl_20240317123529965_xbrl_20240317123409984_xbrl_20240317123250871" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20220101to20221231" format="ixt-sec:duryear">6.40</ix:nonNumeric></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240317123636436_xbrl_20240317123614289_xbrl_20240317123529965_xbrl_20240317123409984_xbrl_20240317123310070" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20221231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">30.44</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          </div>
        </div>
      </ix:nonNumeric>
      <div style="line-height:1.25;clear:both">
        <p style="margin:0pt 0pt 0pt 56.7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; &#160; &#160; &#160;<br/>The following table summarizes information about RSU's outstanding:</span></span><br/>&#160;</p>
      </div>
      <ix:nonNumeric id="Fxbrl_20211011120957799" name="ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" escape="true">
        <div style="margin-left:56.7pt">
          <div>
            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSU's</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSU's</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSU's</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at beginning of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011112511276" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">42,013</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011112522803" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20211231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">14,581</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011112527378" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20201231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">10,655</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011112831192" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">9,100</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011112839195" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">39,286</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011112849355" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20210101to20211231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">8,992</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Forfeited</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217183013448" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">941</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211011112922539" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">27</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211011112944465" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="C_20210101to20211231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">215</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vested</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217183002340" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">17,458</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211011112955754_xbrl_20211011112922539" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">11,827</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211011112955754_xbrl_20211011112944465" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" contextRef="C_20210101to20211231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">4,851</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">) </span></span></td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at the end of the period</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011113019497_xbrl_20211011112511276" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">32,714</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011113019497_xbrl_20211011112522803" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">42,013</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011113019497_xbrl_20211011112527378" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20211231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">14,581</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </ix:nonNumeric>
      <div style="line-height:1.25;clear:both">&#160;</div>
      <div style="text-align:justify;text-indent:0pt;ine-height:1.25">
        <div>
          <div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of the options and RSU's granted to employees and directors at the grant date for the years ended December 31, 2023, 2022 and 2021 was $<ix:nonFraction id="Fxbrl_20211011095047643" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" contextRef="C_20211231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,320</ix:nonFraction>, $<ix:nonFraction id="Fxbrl_20220217183740349" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" contextRef="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,970</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20211011095123085" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,392</ix:nonFraction> respectively.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The options and RSU&#8217;s of the Company are managed by a trustee.</span></span></div>
            <div style="line-height:1.25">
              <p style="margin:0pt">&#160;</p>
              <div><ix:exclude>
                <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 38</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
                <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                    <tr>
                      <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 20:</span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Share&#8209;Based Compensation&#160;</span><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(Cont.)</span></div>
                      </td>
                    </tr>

                </table>
                <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </ix:exclude></div>
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 4, 2021, the Company's Board of Directors approved the grant of: (a) <ix:nonFraction id="Fxbrl_20240317124829713" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">34,013</ix:nonFraction> options to purchase ordinary shares and <ix:nonFraction id="Fxbrl_20240317124853844" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdRestrictedSharesUnitsMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">5,669</ix:nonFraction> RSU's under the "2014 Share Incentive Plan" to its CEO, officers and board members of the Company at a fair value of $<ix:nonFraction id="Fxbrl_20240317124907927" name="ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" contextRef="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">663</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20240317124920149" name="ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" contextRef="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdRestrictedSharesUnitsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">196</ix:nonFraction>, respectively, and (b) <ix:nonFraction id="Fxbrl_20240317124933079" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">19,958</ix:nonFraction> options to purchase ordinary shares and <ix:nonFraction id="Fxbrl_20240317124947595" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdRestrictedSharesUnitsMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">3,324</ix:nonFraction> RSU's under the "2014 Share Incentive Plan" to its employees at a fair value of $<ix:nonFraction id="Fxbrl_20240317125008420" name="ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" contextRef="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">417</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20240317125023135" name="ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" contextRef="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdRestrictedSharesUnitsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">116</ix:nonFraction>, respectively. The options are exercisable for an exercise price of $ <ix:nonFraction id="Fxbrl_20240317125035071" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">37.52</ix:nonFraction> per share.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over the second quarter of 2022, the Company&#8217;s Board of Directors approved the grant of <ix:nonFraction id="Fxbrl_20240317125531368" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">292,203</ix:nonFraction> options to purchase the Company&#8217;s ordinary shares, for an exercise price of $ <ix:nonFraction id="Fxbrl_20240317125646839" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.42</ix:nonFraction> per share as well as <ix:nonFraction id="Fxbrl_20240317125804502" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">39,286</ix:nonFraction> restricted share units (&#8220;RSU&#8217;s&#8221;) to its CEO, officers and employees. The fair value of the options and RSU&#8217;s as of the grant date, was estimated at $<ix:nonFraction id="Fxbrl_20240317125911352" name="ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" contextRef="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,314</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20240317130002926" name="ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" contextRef="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">498</ix:nonFraction> respectively.</span></span></div>
                          <div>&#160;</div>
                          <div>
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The above-mentioned grant includes the grant of <ix:nonFraction id="Fxbrl_20240317130915295" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsAndCeoMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">151,786</ix:nonFraction> options to purchase the Company&#8217;s ordinary shares and <ix:nonFraction id="Fxbrl_20240317130954409" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsAndCeoMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">39,286</ix:nonFraction> restricted share units (&#8220;RSU&#8217;s&#8221;) to the directors and the CEO of the Company which are required to be approved by the Company&#8217;s General meeting as well. The fair value of the options and RSU&#8217;s, as of the approval date, was estimated at approximately $<ix:nonFraction id="Fxbrl_20240317131046659" name="ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" contextRef="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsAndCeoMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,171</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20240317131059309" name="ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" contextRef="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsAndCeoMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">498</ix:nonFraction>, respectively.</span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <div style="text-align:justify;text-indent:-0.55pt;margin-left:36pt;line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 19, 2022, the Company&#8217;s Shareholders General meeting approved the abovementioned grants (Note 19) to the directors and the CEO, the compensation terms of Mr. Ofer Gonen as the Company&#8217;s new Chief Executive Officer, which terms will be effective as of July 1, 2022 and the termination terms for the previous CEO.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On August 18, 2022, the Company&#8217;s Shareholders General meeting approved the compensation terms and grant of <ix:nonFraction id="Fxbrl_20240317131214029" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="C_20220801to20220818_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdChairmanMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">28,572</ix:nonFraction> options to the Chairman of the Board of Directors which approved earlier by the board. The fair value of the options as of the grant date&#160;was estimated at $<ix:nonFraction id="Fxbrl_20240317131253160" name="ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" contextRef="C_20220801to20220818_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdChairmanMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">284</ix:nonFraction>.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On February 15, 2023, the Company's Board of Directors approved the grant of <ix:nonFraction id="Fxbrl_20240317131514299" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">130,600</ix:nonFraction> options to purchase ordinary shares and <ix:nonFraction id="Fxbrl_20240317131618151" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdRestrictedSharesUnitsMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">9,100</ix:nonFraction> RSU's under the "2014 Share Incentive Plan" to<span style="font-weight:bold">&#160;</span>employees, officers, board members, CEO and some consultants at fair value of $<ix:nonFraction id="Fxbrl_20240317131640425" name="ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" contextRef="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,012</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20240317131654690" name="ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" contextRef="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdRestrictedSharesUnitsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">117</ix:nonFraction>, respectively. The share options vest over a period of <ix:nonNumeric id="Fxbrl_20240317133303544" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" contextRef="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember">1-4 years</ix:nonNumeric> and the options are exercisable for an exercise price of $ <ix:nonFraction id="Fxbrl_20240317133441401" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.32</ix:nonFraction> per share.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On April 3, 2023, the Company's Board of Directors approved the grant of <ix:nonFraction id="Fxbrl_20240317133546295" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="C_20230401to20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">160,400</ix:nonFraction> options to purchase ordinary shares under the "2014 Share Incentive Plan", for an exercise price of $<ix:nonFraction id="Fxbrl_20240317133636205" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">11.89</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20240317134221986" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">11.91</ix:nonFraction> per share to management and board members of the Company. The share options vest over a period of <ix:nonNumeric id="Fxbrl_20240317134634484" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" contextRef="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember">1-4 years</ix:nonNumeric>. The fair value of the options granted, as of the grant date, was estimated at approximately $<ix:nonFraction id="Fxbrl_20240317134713216" name="ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" contextRef="C_20230401to20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">884</ix:nonFraction>.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On May 31, 2023 the Shareholders of the Company approved the increase by <ix:nonFraction id="Fxbrl_20240317134958097" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="C_20230501to20230531_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">1,000,000</ix:nonFraction> in the number of ordinary shares available for issuance under the Company&#8217;s 2014 Equity Incentive Plan.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:100%">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On May 31, 2023 the Shareholders of the Company approved the extension to the exercise period of options which were granted to certain of the company&#8217;s directors on April 23, 2020 for an additional <ix:nonNumeric id="Fxbrl_20240317141423510" name="ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement" contextRef="C_20230501to20230531_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember">five years</ix:nonNumeric>, until April 23, 2030. According to this extension, an expense of $<ix:nonFraction id="Fxbrl_20240317141906525" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" contextRef="C_20230501to20230531_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">146</ix:nonFraction> was recognized.</span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div>
      <div style="line-height:1.25">
        <p style="margin:0pt">&#160;</p>
        <div><ix:exclude>
          <div style="margin-bottom:0px">
            <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 39</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
            <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                <tr>
                  <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 20:</span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Share&#8209;Based Compensation&#160;</span><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(Cont.)</span></div>
                  </td>
                </tr>

            </table>
            <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </div>
        </ix:exclude></div>
      </div>
      <div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">
        <div style="text-align:left">
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">9.</span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt;font-family:Times New Roman, Times, serif">On August 15, 2023, the Company's Board of Directors approved the grant of <ix:nonFraction id="Fxbrl_20240317142844763" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="C_20230801to20230815_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">7,200</ix:nonFraction> options to purchase ordinary shares under the "2014 Share Incentive Plan", for an exercise price of $ <ix:nonFraction id="Fxbrl_20240317142952667" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember" unitRef="NIS_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">9.63</ix:nonFraction> per share to a board member of the Company. The share options vest over a <ix:nonNumeric id="Fxbrl_20240317143122577" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" contextRef="C_20230801to20230815_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember">1 year</ix:nonNumeric>. &#160;The fair value of the options granted, as of the grant date, was estimated at approximately $<ix:nonFraction id="Fxbrl_20240317143141795" name="ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" contextRef="C_20230801to20230815_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42</ix:nonFraction>.</span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;width:100%;border:0px">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">10.</span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt;font-family:Times New Roman, Times, serif">On November 20, 2023, the Company's Board of Directors approved the grant of <ix:nonFraction id="Fxbrl_20240317143156343" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="C_20231101to20231120_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">48,750</ix:nonFraction> options to purchase ordinary shares under the "2014 Share Incentive Plan", for an exercise price of $ <ix:nonFraction id="Fxbrl_20240317143227517" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20231120_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">8.78</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20240317143303823" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20231120_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">8.13</ix:nonFraction> per share to an officer and a consultant of the Company. The share options vest over a period of <ix:nonNumeric id="Fxbrl_20240317143336092" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" contextRef="C_20231101to20231120_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember">1-4 years</ix:nonNumeric>. &#160;The fair value of the options granted, as of the grant date, was estimated at approximately $<ix:nonFraction id="Fxbrl_20240317143342038" name="ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" contextRef="C_20231101to20231120_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">265</ix:nonFraction>.</span></div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="text-align:justify;text-indent:0pt;line-height:1.25">&#160;<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                <tr>
                  <td style="width:85.05pt">&#160;</td>
                  <td style="width:25pt;vertical-align:top"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">a.</span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div>The&#160;fair value of the Company's share options granted to employees and directors for the years ended December 31, 2023, 2022 and 2021 was estimated using the binomial option pricing models using the following assumptions:</div>
                  </td>
                </tr>

            </table>
            <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </div>
        </div>
      </div>
      <ix:nonNumeric id="Fxbrl_20211011122033323" name="ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" contextRef="C_20230101to20231231" escape="true">
        <div style="margin-left:108pt">
          <div>
            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dividend yield (%)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011113359686" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="C_20230101to20231231" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">0</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011113422532" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="C_20220101to20221231" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">0</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011113425964" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="C_20210101to20211231" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">0</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected volatility of the share prices (%)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011113503697" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">61</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20211011113509899" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">77</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011113515947" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="C_20220101to20221231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">59</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20211011113615220" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="C_20220101to20221231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">77</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011113623298" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">55</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20211011113825130" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">78</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Risk&#8209;free interest rate (%)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011114051305" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Percent" scale="-2" decimals="3" format="ixt:num-dot-decimal">2.1</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20211011114101344" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Percent" scale="-2" decimals="4" format="ixt:num-dot-decimal">5.36</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011114109537" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="C_20220101to20221231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Percent" scale="-2" decimals="3" format="ixt:num-dot-decimal">2.1</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20211011114115793" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="C_20220101to20221231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Percent" scale="-2" decimals="3" format="ixt:num-dot-decimal">5.2</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011114122049" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Percent" scale="-2" decimals="3" format="ixt:num-dot-decimal">0.1</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20220218150705857" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Percent" scale="-2" decimals="3" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Early exercise factor (%)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011114526724" name="mdwd:ExercisePriceShareOptionsGrantedPercentage" contextRef="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20211011114707053" name="mdwd:ExercisePriceShareOptionsGrantedPercentage" contextRef="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">150</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220217192023692" name="mdwd:ExercisePriceShareOptionsGrantedPercentage" contextRef="C_20220101to20221231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20220217192154197" name="mdwd:ExercisePriceShareOptionsGrantedPercentage" contextRef="C_20220101to20221231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">150</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011114821129" name="mdwd:ExercisePriceShareOptionsGrantedPercentage" contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20240317144733098" name="mdwd:ExercisePriceShareOptionsGrantedPercentage" contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">150</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted average share prices (Dollar)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011114907682" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="C_20230101to20231231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">10.71</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011114932397" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="C_20220101to20221231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.22</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211011114947996" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="C_20210101to20211231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">36.33</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </ix:nonNumeric>
      <div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</div>
      <div>
        <div style="text-align:justify;margin-left:103.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Measurement inputs include the share price on the measurement date, the exercise price of the instrument, expected volatility (based on the weighted average volatility of the Company&#8217;s shares, over the expected term of the options), expected term of the options (based on general option holder behavior and expected share price), expected dividends, and the risk-free interest rate (based on government debentures).</span></span></div>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin:0pt">&#160;</p>
</div><div style="">
  <ix:nonNumeric id="Fxbrl_20220217161449771" name="ifrs-full:DisclosureOfIncomeTaxExplanatory" contextRef="C_20230101to20231231" escape="true">
    <div>
      <div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Note 21:</span></span></span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Income Tax</span></span></span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>a.</span></span></span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company operates in two main tax jurisdictions: Israel and Germany. As such, the Company is subject to the applicable tax rates in the jurisdictions in which it conducts its business.</span></span></span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>b.</span></span></span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Corporate tax rate in Israel:</span></span></span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The standard tax rate in the years 2021-2023 is <ix:nonFraction id="Fxbrl_20211216162732413" name="ifrs-full:ApplicableTaxRate" contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20211216162723195" name="ifrs-full:ApplicableTaxRate" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220217193331179" name="ifrs-full:ApplicableTaxRate" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">23</ix:nonFraction></ix:nonFraction></ix:nonFraction>%.</span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>c.</span></span></span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Benefits under the Law for the Encouragement of Capital Investments:</span></span></span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Tax benefits under the Israel Law for the Encouragement of Capital Investments, 1959 (the "Investment Law"):</span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Under the Investment Law, the Company has been granted "Beneficiary Enterprise" status which provides certain benefits, including tax exemptions and reduced tax rates. Income not eligible for Beneficiary Enterprise benefits is taxed at a regular rate.</span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div><ix:exclude>
          <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
            <div style="margin-top:0pt;margin-bottom:0pt">
              <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 40</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
            </div>
          </div>
          <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">

              <tr style="margin-top:0pt;margin-bottom:0pt">
                <td style="width:56.7pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">Note 21:</span></span></span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt">
                  <div style="font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">Income Tax (Cont.)</span></span></span></span></div>
                </td>
              </tr>

          </table>
          <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
        </ix:exclude></div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>During the benefit period, the Company will be tax exempt in the first two years of the benefit period and subject to tax at the reduced rate of <ix:nonNumeric id="Fxbrl_20211011123814087" name="ifrs-full:ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod" contextRef="C_20230101to20231231">10%- 25%</ix:nonNumeric> for an additional period of <ix:nonNumeric id="Fxbrl_20211011123837055" name="mdwd:DescriptionOfTaxBenefitPeriod" contextRef="C_20230101to20231231">five to eight years</ix:nonNumeric> (depending on the percentage of foreign investments in the Company) of the benefit period. The benefit entitlement period starts from the first year that the Beneficiary Enterprise first earned taxable income and is limited to <ix:nonNumeric id="Fxbrl_20211011123937696" name="mdwd:LimitOfBenefitEntitlementPeriod" contextRef="C_20230101to20231231">12 years</ix:nonNumeric> from the year in which the Company requested to have tax benefits apply. In the event of distribution of dividends from the said tax-exempt income, the amount distributed will be subject to corporate tax at the reduced rate ordinarily applicable to the Beneficiary Enterprise's income.</span></span></span></span></div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Tax exempt income generated under the Company's "Beneficiary Enterprise" program will be subject to taxes upon dividend distribution or complete liquidation. The entitlement to the above benefits is conditional upon the Company's fulfilling the conditions stipulated by the Investment Law and regulations published thereunder. Should the Company fail to meet such requirements in the future, income attributable to its Beneficiary Enterprise programs could be subject to the statutory Israeli corporate tax rate and the Company could be required to refund a portion of the tax benefits already received, with respect to such programs.</span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>d.</span></span></span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The principal tax rates applicable to the subsidiary whose place of incorporation is outside of Israel is:</span></span></span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;line-height:1.25;margin-left:85pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The statutory corporate tax rate in Germany was <ix:nonFraction id="Fxbrl_20211011124115580" name="ifrs-full:ApplicableTaxRate" contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_countryDE" unitRef="Percent" scale="-2" decimals="4" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20211011124115036" name="ifrs-full:ApplicableTaxRate" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryDE" unitRef="Percent" scale="-2" decimals="4" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20211217164412812" name="ifrs-full:ApplicableTaxRate" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryDE" unitRef="Percent" scale="-2" decimals="4" format="ixt:num-dot-decimal">29.79</ix:nonFraction></ix:nonFraction></ix:nonFraction>% in 2023, 2022 and 2021.</span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>e.</span></span></span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Final tax assessments:</span></span></span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company has finalized its tax assessments through the 2016 tax year.</span></span></span></span></div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company's subsidiary has received the final tax assessment for the year 2021.</span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>f.</span></span></span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Net operating carryforward losses for tax purposes and other temporary differences:</span></span></span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of December 31, 2023, the Company had carryforward losses and other temporary differences mainly from R&amp;D expenses together amounting to approximately $<ix:nonFraction id="Fxbrl_20211011124151818" name="mdwd:OtherTemporaryDifferencesMainlyFromRAndDExpenses" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">171,757</ix:nonFraction>.</span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>g.</span></span></span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Deferred taxes:</span></span></span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company did not recognize deferred tax assets for temporary differences because their utilization in the foreseeable future is not probable.</span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>h.</span></span></span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Current taxes on income:</span></span></span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company did not record any current taxes for MediWound Ltd. in Israel for the years ended December 31, 2023, 2022 and 2021 as a result of its carryforward losses.</span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The current tax expenses are in respect of taxes charged outside of Israel.</span></span></span></span></div>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin:0pt">&#160;</p>
  <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 41</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
</div><div style="">
  <ix:nonNumeric id="Fxbrl_20220107213928383" name="mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory" contextRef="C_20230101to20231231" escape="true">
    <div>
      <div>
        <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Note 22:</span></span></span></span></td>
              <td style="width:auto;vertical-align:top">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss</span></span></span></span></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div>
          <div style="text-indent:-56.7pt;margin-left:56.7pt;line-height:1.25">&#160;</div>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                <tr style="vertical-align:top">
                  <td style="width:56.7pt">&#160;</td>
                  <td style="text-align:right;vertical-align:top;width:28.35pt">
                    <div style="text-align:left;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">a.</span></span></span></span></span></div>
                  </td>
                  <td style="text-align:left;vertical-align:top;width:auto">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Additional information on Revenues:</span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Major customers:</span></span></span></span></div>
          <div style="text-align:justify;margin-left:94.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>BARDA contributed <ix:nonFraction id="Fxbrl_20211217165217151" name="mdwd:ConcentrationRiskPercentage" contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdBardaMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">56</ix:nonFraction>%, <ix:nonFraction id="Fxbrl_20211217165228599" name="mdwd:ConcentrationRiskPercentage" contextRef="C_20220101to20221231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdBardaMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">51</ix:nonFraction>% and <ix:nonFraction id="Fxbrl_20211217165242679" name="mdwd:ConcentrationRiskPercentage" contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdBardaMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">76</ix:nonFraction>% of the Company&#8217;s total revenues in 2023, 2022 and 2021<span style="font-weight:bold">&#160;</span>respectively. Vericel contributed <ix:nonFraction id="Fxbrl_20220309173115943" name="mdwd:ConcentrationRiskPercentage" contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdVericelMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">4</ix:nonFraction>% and <ix:nonFraction id="Fxbrl_20240316163236771" name="mdwd:ConcentrationRiskPercentage" contextRef="C_20220101to20221231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdVericelMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">28</ix:nonFraction>% of the Company&#8217;s total revenues in 2023 and 2022 respectively. MTEC contributed <ix:nonFraction id="Fxbrl_20240316163420321" name="mdwd:ConcentrationRiskPercentage" contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdMtecMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction>% and <ix:nonFraction id="Fxbrl_20240316163441762" name="mdwd:ConcentrationRiskPercentage" contextRef="C_20220101to20221231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdMtecMember" unitRef="Percent" scale="-2" decimals="3" format="ixt:num-dot-decimal">2.8</ix:nonFraction>% of the Company&#8217;s total revenues in 2023 and 2022 respectively (see also Note 18).</span></span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:94.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>No other customer contributed 10% or more of the Company&#8217;s revenues in 2023, 2022 and 2021.</span></span></span></span></div>
          <div style="text-align:justify;line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Geographic information:</span></span></span></span></div>
          <div>
            <div style="text-align:justify;margin-left:94.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The revenues reported in the financial statements are based on the location of the customers, as follows:</span></span></span></span></div>
            <div style="text-align:justify;margin-left:94.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
            <div style="margin-left:99pt">
              <ix:nonNumeric id="Fxbrl_20240317175952689" name="ifrs-full:DisclosureOfGeographicalAreasExplanatory" contextRef="C_20230101to20231231" escape="true">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>USA (see also Note 18a, 18b, 18c)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104049277" name="ifrs-full:Revenue" contextRef="C_20230101to20231231_ifrsfullSegmentsAxis_mdwdUsaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,078</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104100151" name="ifrs-full:Revenue" contextRef="C_20220101to20221231_ifrsfullSegmentsAxis_mdwdUsaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,872</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104107678" name="ifrs-full:Revenue" contextRef="C_20210101to20211231_ifrsfullSegmentsAxis_mdwdUsaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,102</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>EU and other international markets</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104113542_xbrl_20211012104049277" name="ifrs-full:Revenue" contextRef="C_20230101to20231231_ifrsfullSegmentsAxis_mdwdOtherCountriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,608</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104113542_xbrl_20211012104100151" name="ifrs-full:Revenue" contextRef="C_20220101to20221231_ifrsfullSegmentsAxis_mdwdOtherCountriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,624</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104113542_xbrl_20211012104107678" name="ifrs-full:Revenue" contextRef="C_20210101to20211231_ifrsfullSegmentsAxis_mdwdOtherCountriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,661</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104121662" name="ifrs-full:Revenue" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,686</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104139487" name="ifrs-full:Revenue" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,496</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104358314" name="ifrs-full:Revenue" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,763</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </ix:nonNumeric>
            </div>
          </div>
          <div style="margin-left:99pt">&#160;</div>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                <tr style="vertical-align:top">
                  <td style="width:56.7pt">&#160;</td>
                  <td style="text-align:right;vertical-align:top;width:28.35pt">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">b.</span></span></span></span></span></div>
                  </td>
                  <td style="text-align:left;vertical-align:top;width:auto">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Cost of Revenues:</span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:85.05pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cost of Revenues from sale of products</span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div style="margin-left:108pt">
              <ix:nonNumeric id="Fxbrl_20240317180024874" name="ifrs-full:DisclosureOfCostOfSalesExplanatory" contextRef="C_20230101to20231231" escape="true">
                <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Salary and benefits (including share-based compensation)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104546843" name="ifrs-full:WagesAndSalaries" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,703</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104552688" name="ifrs-full:WagesAndSalaries" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,828</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104600634" name="ifrs-full:WagesAndSalaries" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,047</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Subcontractors</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104613519_xbrl_20211012104546843" name="mdwd:SubcontractorsExpenses" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">230</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104613519_xbrl_20211012104552688" name="mdwd:SubcontractorsExpenses" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104613519_xbrl_20211012104600634" name="mdwd:SubcontractorsExpenses" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">190</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Depreciation and amortization</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104546843" name="ifrs-full:DepreciationAndAmortisationExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">672</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104552688" name="ifrs-full:DepreciationAndAmortisationExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">426</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104600634" name="ifrs-full:DepreciationAndAmortisationExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">559</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cost of materials</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104651455_xbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104546843" name="ifrs-full:CostOfMerchandiseSold" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">916</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104651455_xbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104552688" name="ifrs-full:CostOfMerchandiseSold" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">636</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104651455_xbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104600634" name="ifrs-full:CostOfMerchandiseSold" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,039</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other manufacturing expenses</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104711486_xbrl_20211012104651455_xbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104546843" name="ifrs-full:MiscellaneousOtherOperatingExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,207</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104711486_xbrl_20211012104651455_xbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104552688" name="ifrs-full:MiscellaneousOtherOperatingExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">779</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104711486_xbrl_20211012104651455_xbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104600634" name="ifrs-full:MiscellaneousOtherOperatingExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">906</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Decrease (increase) in inventory of finished products</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20211012104731975_xbrl_20211012104711486_xbrl_20211012104651455_xbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104546843" name="ifrs-full:ChangesInInventoriesOfFinishedGoodsAndWorkInProgress" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">801</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20211012104731975_xbrl_20211012104711486_xbrl_20211012104651455_xbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104552688" name="ifrs-full:ChangesInInventoriesOfFinishedGoodsAndWorkInProgress" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">543</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104731975_xbrl_20211012104711486_xbrl_20211012104651455_xbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104600634" name="ifrs-full:ChangesInInventoriesOfFinishedGoodsAndWorkInProgress" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">242</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104841959" name="mdwd:CostOfSalesFromSaleOfProducts" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,927</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104847256" name="mdwd:CostOfSalesFromSaleOfProducts" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,184</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012104857658" name="mdwd:CostOfSalesFromSaleOfProducts" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,983</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </ix:nonNumeric>
            </div>
          </div>
          <p style="margin:0pt">&#160;</p>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:85.05pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cost of Revenues from development services</span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div style="margin-left:108pt">
              <ix:nonNumeric id="Fxbrl_20240317180111201" name="mdwd:DisclosureOfCostOfSalesServicesExplanatory" contextRef="C_20230101to20231231" escape="true">
                <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Salary and benefits</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012105153443" name="mdwd:SalaryAndBenefits" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,995</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012105209147" name="mdwd:SalaryAndBenefits" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,691</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012105220487" name="mdwd:SalaryAndBenefits" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,003</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Subcontractors</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012105242465_xbrl_20211012105153443" name="mdwd:Subcontractors" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,182</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012105242465_xbrl_20211012105209147" name="mdwd:Subcontractors" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,138</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012105242465_xbrl_20211012105220487" name="mdwd:Subcontractors" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,904</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012105322071" name="mdwd:CostOfSalesFromLicenseAgreements" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,177</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012105332456" name="mdwd:CostOfSalesFromLicenseAgreements" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,829</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012105338607" name="mdwd:CostOfSalesFromLicenseAgreements" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,907</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </ix:nonNumeric>
            </div>
          </div>
          <div style="margin-left:108pt">&#160;</div>
          <div><ix:exclude>
            <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
              <div style="margin-top:0pt;margin-bottom:0pt">
                <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 42</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
              </div>
            </div>
            <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">

                <tr style="margin-top:0pt;margin-bottom:0pt">
                  <td style="width:56.7pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">Note 22:</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
                    <div style="font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Cont.)</span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </ix:exclude></div>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:85.05pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cost of Revenues from license agreements</span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div style="margin-left:108pt">
              <ix:nonNumeric id="Fxbrl_20240317181121128" name="mdwd:ScheduleOfCostOfRevenuesLicense" contextRef="C_20230101to20231231" escape="true">
                <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Salary and benefits</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220217131933539_xbrl_20211012105531774_33" name="mdwd:SalaryAndBenefitsExpensesRelatedToLicenseAgreements" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220217131933539_xbrl_20211012105531774_37" name="mdwd:SalaryAndBenefitsExpensesRelatedToLicenseAgreements" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220217131933539_xbrl_20211012105531774_311" name="mdwd:SalaryAndBenefitsExpensesRelatedToLicenseAgreements" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">102</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Royalties payments</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012105531774_33" name="mdwd:RoyaltiesPayments" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012105531774_37" name="mdwd:RoyaltiesPayments" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">280</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012105531774_311" name="mdwd:RoyaltiesPayments" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012105531774_53" name="mdwd:TotalRoyaltiesPayments" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012105531774_57" name="mdwd:TotalRoyaltiesPayments" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">318</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012105531774_511" name="mdwd:TotalRoyaltiesPayments" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">102</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total Cost of Revenues</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220309182949536_xbrl_20211012105531774_53" name="ifrs-full:CostOfSales" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,108</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220309182949536_xbrl_20211012105531774_57" name="ifrs-full:CostOfSales" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,331</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220309182949536_xbrl_20211012105531774_511" name="ifrs-full:CostOfSales" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,992</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </ix:nonNumeric>
            </div>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                  <tr style="vertical-align:top">
                    <td style="width:56.7pt">&#160;</td>
                    <td style="text-align:right;vertical-align:top;width:28.35pt">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">c.</span></span></span></span></span></div>
                    </td>
                    <td style="text-align:left;vertical-align:top;width:auto">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Research and development expenses:</span></span></span></span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:90pt">
              <ix:nonNumeric id="Fxbrl_20240317181145688" name="ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory" contextRef="C_20230101to20231231" escape="true">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Salary and benefits (including share-based compensation) (1)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012105744786" name="ifrs-full:EmployeeBenefitsExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,148</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012105756275" name="ifrs-full:EmployeeBenefitsExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,494</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012105807825" name="ifrs-full:EmployeeBenefitsExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,864</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Subcontractors</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012105931729_xbrl_20211012105744786" name="mdwd:SubcontractorsExpensesRelatedToResearchAndDevelopment" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,833</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012105931729_xbrl_20211012105756275" name="mdwd:SubcontractorsExpensesRelatedToResearchAndDevelopment" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,054</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012105931729_xbrl_20211012105807825" name="mdwd:SubcontractorsExpensesRelatedToResearchAndDevelopment" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,323</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Depreciation and amortization</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110033550_xbrl_20211012105931729_xbrl_20211012105744786" name="mdwd:DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">396</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110033550_xbrl_20211012105931729_xbrl_20211012105756275" name="mdwd:DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">571</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110033550_xbrl_20211012105931729_xbrl_20211012105807825" name="mdwd:DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">396</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cost of materials</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110116897_xbrl_20211012110033550_xbrl_20211012105931729_xbrl_20211012105744786" name="mdwd:CostOfMaterials" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">785</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110116897_xbrl_20211012110033550_xbrl_20211012105931729_xbrl_20211012105756275" name="mdwd:CostOfMaterials" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">572</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110116897_xbrl_20211012110033550_xbrl_20211012105931729_xbrl_20211012105807825" name="mdwd:CostOfMaterials" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">347</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other research and development expenses</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110200433_xbrl_20211012110136946_xbrl_20211012110116897_xbrl_20211012110033550_xbrl_20211012105931729_xbrl_20211012105744786" name="mdwd:OtherResearchAndDevelopmentExpenses" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">305</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110200433_xbrl_20211012110136946_xbrl_20211012110116897_xbrl_20211012110033550_xbrl_20211012105931729_xbrl_20211012105756275" name="mdwd:OtherResearchAndDevelopmentExpenses" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">490</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110200433_xbrl_20211012110136946_xbrl_20211012110116897_xbrl_20211012110033550_xbrl_20211012105931729_xbrl_20211012105807825" name="mdwd:OtherResearchAndDevelopmentExpenses" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">326</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total Research and development</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110359244" name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,467</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110413322" name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,181</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110428110" name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,256</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </ix:nonNumeric>
            </div>
            <div style="text-indent:-56.7pt;margin-left:56.7pt;line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:85.05pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(1)</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The salary costs for the year ended December 31,2022 includes one-time payment of $<ix:nonFraction id="Fxbrl_20220310152853615" name="ifrs-full:OtherExpenseByFunction" contextRef="C_20220101to20221231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdOtherCustomerContributedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">205</ix:nonFraction> derived from termination agreement with the CMO of the company.</span></span></span></span></div>
                  </td>
                </tr>

            </table>
          </div>
          <div>&#160;</div>
          <div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                  <tr style="vertical-align:top">
                    <td style="width:56.7pt">&#160;</td>
                    <td style="text-align:right;vertical-align:top;width:28.35pt">
                      <div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>d.</span></span></span></span></div>
                    </td>
                    <td style="text-align:left;vertical-align:top;width:auto">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Selling and marketing expenses:</span></span></span></span></div>
                    </td>
                  </tr>

              </table>
              <div>&#160;</div>
            </div>
            <div style="margin-left:90pt">
              <ix:nonNumeric id="Fxbrl_20240317181206107" name="mdwd:DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory" contextRef="C_20230101to20231231" escape="true">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Salary and benefits (including share-based compensation)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110511438" name="ifrs-full:ShorttermEmployeeBenefitsExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,991</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110517905" name="ifrs-full:ShorttermEmployeeBenefitsExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,637</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110529196" name="ifrs-full:ShorttermEmployeeBenefitsExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,643</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Marketing and consulting</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110546992_xbrl_20211012110511438" name="mdwd:MarketingAndSalesExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,637</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110546992_xbrl_20211012110517905" name="mdwd:MarketingAndSalesExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,152</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110546992_xbrl_20211012110529196" name="mdwd:MarketingAndSalesExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">627</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Depreciation and amortization</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110652960_xbrl_20211012110546992_xbrl_20211012110511438" name="mdwd:DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110652960_xbrl_20211012110546992_xbrl_20211012110517905" name="mdwd:DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">49</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110652960_xbrl_20211012110546992_xbrl_20211012110529196" name="mdwd:DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shipping and delivery</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110732600_xbrl_20211012110652960_xbrl_20211012110546992_xbrl_20211012110511438" name="ifrs-full:DistributionCosts" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">356</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110732600_xbrl_20211012110652960_xbrl_20211012110546992_xbrl_20211012110517905" name="ifrs-full:DistributionCosts" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">385</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110732600_xbrl_20211012110652960_xbrl_20211012110546992_xbrl_20211012110529196" name="ifrs-full:DistributionCosts" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">490</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Registration and marketing license fees</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110754681_xbrl_20211012110732600_xbrl_20211012110652960_xbrl_20211012110546992_xbrl_20211012110511438" name="mdwd:RegistrationAndMarketingLicenseFees" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">810</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110754681_xbrl_20211012110732600_xbrl_20211012110652960_xbrl_20211012110546992_xbrl_20211012110517905" name="mdwd:RegistrationAndMarketingLicenseFees" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">502</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110754681_xbrl_20211012110732600_xbrl_20211012110652960_xbrl_20211012110546992_xbrl_20211012110529196" name="mdwd:RegistrationAndMarketingLicenseFees" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">584</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110815547" name="ifrs-full:SalesAndMarketingExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,844</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110830506" name="ifrs-full:SalesAndMarketingExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,725</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110840355" name="ifrs-full:SalesAndMarketingExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,388</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </ix:nonNumeric>
            </div>
          </div>
          <div style="margin-left:90pt">&#160;</div>
          <div><ix:exclude>
            <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
              <div style="margin-top:0pt;margin-bottom:0pt">
                <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 43</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
              </div>
            </div>
            <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">

                <tr style="margin-top:0pt;margin-bottom:0pt">
                  <td style="width:56.7pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">Note 22:</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
                    <div style="font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Cont.)</span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </ix:exclude></div>
          <div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                  <tr style="vertical-align:top">
                    <td style="width:56.7pt">&#160;</td>
                    <td style="text-align:right;vertical-align:top;width:28.35pt">
                      <div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>e.</span></span></span></span></div>
                    </td>
                    <td style="text-align:left;vertical-align:top;width:auto">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>General and administrative expenses:</span></span></span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:90pt">
              <ix:nonNumeric id="Fxbrl_20240317181227156" name="ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory" contextRef="C_20230101to20231231" escape="true">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Salary and benefits (including share&#8209;based compensation)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012110936659" name="mdwd:SalaryAndBenefitsIncludingShareBasedCompensation" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,521</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122403374" name="mdwd:SalaryAndBenefitsIncludingShareBasedCompensation" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,344</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122458446" name="mdwd:SalaryAndBenefitsIncludingShareBasedCompensation" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,905</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Professional fees</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122513574_xbrl_20211012110936659" name="ifrs-full:ProfessionalFeesExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,189</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122513574_xbrl_20211012122403374" name="ifrs-full:ProfessionalFeesExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,589</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122513574_xbrl_20211012122458446" name="ifrs-full:ProfessionalFeesExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,480</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Depreciation and amortization</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122531311_xbrl_20211012122513574_xbrl_20211012110936659" name="mdwd:DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">185</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122531311_xbrl_20211012122513574_xbrl_20211012122403374" name="mdwd:DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">225</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122531311_xbrl_20211012122513574_xbrl_20211012122458446" name="mdwd:DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">239</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122552165_xbrl_20211012122531311_xbrl_20211012122513574_xbrl_20211012110936659" name="mdwd:OtherSellingGeneralAndAdministrativeExpenses" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">873</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122552165_xbrl_20211012122531311_xbrl_20211012122513574_xbrl_20211012122403374" name="mdwd:OtherSellingGeneralAndAdministrativeExpenses" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">762</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122552165_xbrl_20211012122531311_xbrl_20211012122513574_xbrl_20211012122458446" name="mdwd:OtherSellingGeneralAndAdministrativeExpenses" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">724</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122612063" name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,768</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122622608" name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,920</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122631503" name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,348</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </ix:nonNumeric>
            </div>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>f.</span></span></span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other (income) expenses:</span></span></span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The other one-time income amounted $<ix:nonFraction id="Fxbrl_20240316163854859" name="ifrs-full:OtherIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">211</ix:nonFraction> for the year ended December 31, 2023, is associated with the termination of sub-lease agreement (see note 11a).</span></span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The other one-time expenses amounted $<ix:nonFraction id="Fxbrl_20220217134954773" name="ifrs-full:OtherExpenseByFunction" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">684</ix:nonFraction> for the year ended December 31, 2022, are associated with the management changes and FDA milestone payment fee (see Note 18b).</span></span></span></span></div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>g.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial income and expense:</span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div style="margin-left:90pt">
              <ix:nonNumeric id="Fxbrl_20240317181252033" name="ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory" contextRef="C_20230101to20231231" escape="true">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial income:</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" rowspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" rowspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" rowspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Interest income</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122709201" name="ifrs-full:RevenueFromInterest" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,341</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122714694" name="ifrs-full:RevenueFromInterest" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">270</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122725310" name="ifrs-full:RevenueFromInterest" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revaluation of liabilities in respect of IIA grants</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122737337_xbrl_20211012122709201" name="mdwd:RevaluationOfLiabilitiesInRespectOfIiaGrants" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122737337_xbrl_20211012122714694" name="mdwd:RevaluationOfLiabilitiesInRespectOfIiaGrants" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">132</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122737337_xbrl_20211012122725310" name="mdwd:RevaluationOfLiabilitiesInRespectOfIiaGrants" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revaluation of Warrants</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240316172306543_xbrl_20211012122737337_xbrl_20211012122709201" name="mdwd:RevaluationOfWarrantsAccountedAtFairValue" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,310</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240316172306543_xbrl_20211012122737337_xbrl_20211012122714694" name="mdwd:RevaluationOfWarrantsAccountedAtFairValue" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240316172306543_xbrl_20211012122737337_xbrl_20211012122725310" name="mdwd:RevaluationOfWarrantsAccountedAtFairValue" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Exchange differences, net</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122709201" name="ifrs-full:TradingIncomeExpenseOnForeignExchangeContracts" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694" name="ifrs-full:TradingIncomeExpenseOnForeignExchangeContracts" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310" name="ifrs-full:TradingIncomeExpenseOnForeignExchangeContracts" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122709201" name="ifrs-full:FinanceIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,651</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694" name="ifrs-full:FinanceIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">461</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310" name="ifrs-full:FinanceIncome" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial expense:</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revaluation of liabilities in respect of IIA grants</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240316173518090_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122709201" name="mdwd:RevaluationOfLiabilitiesInRespectOfIlaGrant" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">427</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240316173518090_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694" name="mdwd:RevaluationOfLiabilitiesInRespectOfIlaGrant" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240316173518090_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310" name="mdwd:RevaluationOfLiabilitiesInRespectOfIlaGrant" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">903</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financing income on net investment in lease</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240316173516270_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122709201" name="mdwd:FinancingIncomeOnNetInvestmentInLease" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">274</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240316173516270_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694" name="mdwd:FinancingIncomeOnNetInvestmentInLease" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">102</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240316173516270_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310" name="mdwd:FinancingIncomeOnNetInvestmentInLease" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">120</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Finance expenses in respect of deferred revenues</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122946911_xbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122709201" name="mdwd:FinanceExpensesInRespectOfDeferredRevenue" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122946911_xbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694" name="mdwd:FinanceExpensesInRespectOfDeferredRevenue" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">54</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122946911_xbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310" name="mdwd:FinanceExpensesInRespectOfDeferredRevenue" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">143</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revaluation of liabilities in respect of TEVA</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122709201" name="mdwd:RevaluationOfLiabilitiesInRespectOfPurchasesOfShares" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">468</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694" name="mdwd:RevaluationOfLiabilitiesInRespectOfPurchasesOfShares" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">533</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310" name="mdwd:RevaluationOfLiabilitiesInRespectOfPurchasesOfShares" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">590</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Exchange differences, net</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122709201" name="ifrs-full:NetForeignExchangeLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">654</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694" name="ifrs-full:NetForeignExchangeLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310" name="ifrs-full:NetForeignExchangeLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">511</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revaluation of Warrants</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240316172147051_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122709201" name="mdwd:RevaluationOfWarrant" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240316172147051_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694" name="mdwd:RevaluationOfWarrant" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,977</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240316172147051_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310" name="mdwd:RevaluationOfWarrant" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Issuance expenses of warrants through profit and loss</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240316173520261_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122709201" name="mdwd:IssuanceExpensesOfWarrantsThroughProfitAndLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240316173520261_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694" name="mdwd:IssuanceExpensesOfWarrantsThroughProfitAndLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,911</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240316173520261_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310" name="mdwd:IssuanceExpensesOfWarrantsThroughProfitAndLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012123003008_xbrl_20211012122946911_xbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122709201" name="ifrs-full:OtherFinanceCost" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012123003008_xbrl_20211012122946911_xbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694" name="ifrs-full:OtherFinanceCost" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">60</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012123003008_xbrl_20211012122946911_xbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310" name="ifrs-full:OtherFinanceCost" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220309184431276" name="ifrs-full:FinanceCosts" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,892</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012123022124_xbrl_20211012123003008_xbrl_20211012122946911_xbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694" name="ifrs-full:FinanceCosts" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,637</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20211012123022124_xbrl_20211012123003008_xbrl_20211012122946911_xbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310" name="ifrs-full:FinanceCosts" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,314</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial income (expenses), net</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220309185437093" name="mdwd:FinancialExpensesNet" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,759</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20220309185501942" name="mdwd:FinancialExpensesNet" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">11,176</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20220309185513891" name="mdwd:FinancialExpensesNet" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,303</ix:nonFraction></span></span></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                    </tr>

                </table>
              </ix:nonNumeric>
            </div>
          </div>
        </div>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin:0pt">&#160;</p>
  <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 44</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
</div><div style="">
  <div>
    <ix:nonNumeric id="Fxbrl_20240317171231174" name="ifrs-full:DisclosureOfEarningsPerShareExplanatory" contextRef="C_20230101to20231231" escape="true">
      <div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0);border:0px">

                  <tr>
                    <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 23:</span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">Net Loss Per Share</span></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Details of the number of shares and loss used in the computation of loss per share:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:90pt">
              <ix:nonNumeric id="Fxbrl_20240317171306022" name="mdwd:DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory" contextRef="C_20230101to20231231" escape="true">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td colspan="22" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">number of shares</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">number of shares</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">number of shares</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012123731780" name="ifrs-full:AdjustedWeightedAverageShares" contextRef="C_20230101to20231231" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">9,013,144</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211012123828392" name="ifrs-full:ProfitLossFromContinuingOperations" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,716</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012123850549" name="ifrs-full:AdjustedWeightedAverageShares" contextRef="C_20220101to20221231" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">4,987,069</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220218112914247" name="ifrs-full:ProfitLossFromContinuingOperations" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,599</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012123917243" name="ifrs-full:AdjustedWeightedAverageShares" contextRef="C_20210101to20211231" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">3,892,068</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211012124024529" name="ifrs-full:ProfitLossFromContinuingOperations" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13,551</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>

                </table>
              </ix:nonNumeric>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss per share:</span></span></div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div style="margin-left:90pt">
              <ix:nonNumeric id="Fxbrl_20240317171319046" name="mdwd:DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory" contextRef="C_20230101to20231231" escape="true">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic and diluted loss per share:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211012130838532_xbrl_20211012124230804" name="ifrs-full:BasicEarningsLossPerShare" contextRef="C_20230101to20231231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.75</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220217123037304" name="ifrs-full:BasicEarningsLossPerShare" contextRef="C_20220101to20221231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">3.93</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211012130838532_xbrl_20211012124316775" name="ifrs-full:BasicEarningsLossPerShare" contextRef="C_20210101to20211231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">3.48</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>

                </table>
              </ix:nonNumeric>
            </div>
            <div style="text-align:justify;line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In 2023, <ix:nonFraction id="Fxbrl_20240317172442772" name="mdwd:NumberOfWarrantsIssued" contextRef="C_20230101to20231231_ifrsfullClassesOfOrdinarySharesAxis_mdwdDilutedWeightedAverageNumberMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">2,614,297</ix:nonFraction> warrants, <ix:nonFraction id="Fxbrl_20240317172459212" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20230101to20231231_ifrsfullClassesOfOrdinarySharesAxis_mdwdDilutedWeightedAverageNumberMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">957,487</ix:nonFraction> options and <ix:nonFraction id="Fxbrl_20240317172503524" name="mdwd:NumberOfRestrictedShareUnitIssued" contextRef="C_20230101to20231231_ifrsfullClassesOfOrdinarySharesAxis_mdwdDilutedWeightedAverageNumberMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">32,714</ix:nonFraction> RSU&#8217;s were excluded from the diluted weighted average number of Ordinary Shares calculation as their effect would have been anti-dilutive.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In 2022, <ix:nonFraction id="Fxbrl_20240317172619219" name="mdwd:NumberOfWarrantsIssued" contextRef="C_20220101to20221231_ifrsfullClassesOfOrdinarySharesAxis_mdwdDilutedWeightedAverageNumberMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">2,614,297</ix:nonFraction> warrants, <ix:nonFraction id="Fxbrl_20240317172734058" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20220101to20221231_ifrsfullClassesOfOrdinarySharesAxis_mdwdDilutedWeightedAverageNumberMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">764,767</ix:nonFraction> options and <ix:nonFraction id="Fxbrl_20240317172741716" name="mdwd:NumberOfRestrictedShareUnitIssued" contextRef="C_20220101to20221231_ifrsfullClassesOfOrdinarySharesAxis_mdwdDilutedWeightedAverageNumberMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">42,013</ix:nonFraction> RSU&#8217;s were excluded from the diluted weighted average number of Ordinary Shares calculation as their effect would have been anti-dilutive. In addition, the impact of <ix:nonFraction id="Fxbrl_20240317172814635" name="mdwd:UnregisteredPreFundedWarrantsIssued" contextRef="C_20230101to20231231_ifrsfullClassesOfOrdinarySharesAxis_mdwdDilutedWeightedAverageNumberMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">1,407,583</ix:nonFraction> pre-funded warrants which were exercised in December 2022, have not taken in the diluted weighted average number of Ordinary Shares calculation as their effect would have been anti-dilutive as well.</span></span></div>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
    <p style="margin:0pt">&#160;</p>
  </div>
</div><div style="">
  <ix:nonNumeric id="Fxbrl_20220217110309795" name="ifrs-full:DisclosureOfRelatedPartyExplanatory" contextRef="C_20230101to20231231" escape="true">
    <div>
      <div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <div style="line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0);border:0px">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 24:</span></td>
                        <td style="width:auto;vertical-align:top">
                          <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">Balances and Transactions with Related Parties and Key Officers</span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div>
      <div>
        <div style="text-align:justify;line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Related parties consist of:</span></span></div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

            <tr>
              <td style="width:103.05pt">&#160;</td>
              <td style="width:10.35pt;vertical-align:top"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#8226;</span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Clal Biotechnologies Industries Ltd.- Related party (see also note 11)</span></div>
              </td>
            </tr>

        </table>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:103.05pt">&#160;</td>
              <td style="width:10.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Directors of the Company.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:85.05pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balances with related parties:</span></span></div>
              </td>
            </tr>

        </table>
        <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
      </div>
    </div>
    <div>
      <ix:nonNumeric id="Fxbrl_20211012144923382" name="mdwd:DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory" contextRef="C_20230101to20231231" escape="true">
        <div style="margin-left:110pt">
          <div>
            <div>
              <div>
                <div>
                  <div style="margin-left:0px">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold">Other Payables</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25"><span style="font-weight:bold;font-style:italic">Related Party</span>:</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25">As of December 31, 2023</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20211012143721709" name="ifrs-full:AmountsPayableRelatedPartyTransactions" contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25">As of December 31, 2022</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20211012143736561" name="ifrs-full:AmountsPayableRelatedPartyTransactions" contextRef="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">177</ix:nonFraction></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25;font-style:italic;font-weight:bold">Directors:</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25">As of December 31, 2023</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20211012143750161" name="ifrs-full:AmountsPayableRelatedPartyTransactions" contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullOtherRelatedPartiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">83</ix:nonFraction></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25">As of December 31, 2022</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20211012143755097" name="ifrs-full:AmountsPayableRelatedPartyTransactions" contextRef="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullOtherRelatedPartiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">130</ix:nonFraction></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </ix:nonNumeric>
      <p style="margin:0pt">&#160;</p>
      <div>
        <div>
          <div>
            <div><ix:exclude>
              <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
                <div style="text-align:center;margin-top:0pt;margin-bottom:0pt">
                  <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 45</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
                </div>
              </div>
              <div style="text-align:justify;line-height:1.25;margin-top:0pt;margin-bottom:0pt">
                <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0);border:0px">

                    <tr>
                      <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 24:</span></td>
                      <td style="width:auto;vertical-align:top">
                        <div style="font-weight:bold"><span style="font-size:10pt;font-weight:bold;font-family:Times New Roman, Times, serif">Balances and Transactions with Related Parties and Key Officers&#160;</span><span style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;font-weight:bold">(Cont.)</span></div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="text-align:justify;line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
            </ix:exclude></div>
          </div>
        </div>
        <ix:nonNumeric id="Fxbrl_20240316191851102" name="ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:85.05pt">&#160;</td>
                      <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transactions with related parties:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="line-height:1.25;font-weight:bold">
                  <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rental fee:</span></span></div>
                  <div style="text-align:justify;margin-left:103.05pt;line-height:1.25">&#160;</div>
                </div>
                <div style="margin-left:108pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;text-indent:-113.4pt;margin-left:113.4pt;line-height:1.25;font-weight:bold">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Related party</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220309163345905" name="mdwd:RelatedPartiesRentaLexpenseAndOther" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">267</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220309163427268" name="mdwd:RelatedPartiesRentaLexpenseAndOther" contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">457</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220309163436972" name="mdwd:RelatedPartiesRentaLexpenseAndOther" contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">469</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <div style="line-height:1.25;font-weight:bold">
                  <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Professional fee *:</span></span></div>
                  <div style="text-align:justify;margin-left:103.05pt;line-height:1.25">&#160;</div>
                </div>
                <div style="margin-left:108pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;text-indent:-7.1pt;margin-left:7.1pt;line-height:1.25;font-weight:bold">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Directors</span></span></div>
                        </td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220309161451001" name="mdwd:ProfessionalFeeAndShareBasedCompensationExpenses" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullOtherRelatedPartiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">502</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220309161440681" name="mdwd:ProfessionalFeeAndShareBasedCompensationExpenses" contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullOtherRelatedPartiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">484</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220309161433449" name="mdwd:ProfessionalFeeAndShareBasedCompensationExpenses" contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullOtherRelatedPartiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">375</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Related party</span></span></div>
                        </td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220309161400935" name="mdwd:ProfessionalFeeAndShareBasedCompensationExpenses" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220309161349823" name="mdwd:ProfessionalFeeAndShareBasedCompensationExpenses" contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">63</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220309161330642" name="mdwd:ProfessionalFeeAndShareBasedCompensationExpenses" contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">85</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220309161908772" name="mdwd:ProfessionalFeeAndShareBasedCompensationExpenses" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">527</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220309161917992" name="mdwd:ProfessionalFeeAndShareBasedCompensationExpenses" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">547</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220309162025741" name="mdwd:ProfessionalFeeAndShareBasedCompensationExpenses" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">460</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of Directors</span></span></div>
                        </td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">***<ix:nonFraction id="Fxbrl_20240316191227790" name="mdwd:NumberOfDirectors" contextRef="C_20231231" unitRef="Directors" scale="0" decimals="0" format="ixt:num-dot-decimal">9</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25;font-weight:bold">&#160;</div>
                        </td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">**<ix:nonFraction id="Fxbrl_20240316191236117" name="mdwd:NumberOfDirectors" contextRef="C_20221231" unitRef="Directors" scale="0" decimals="0" format="ixt:num-dot-decimal">10</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220309165118614" name="mdwd:NumberOfDirectors" contextRef="C_20211231" unitRef="Directors" scale="0" decimals="0" format="ixt:num-dot-decimal">8</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                      <tr style="vertical-align:top">
                        <td style="width:101.7pt">&#160;</td>
                        <td style="text-align:right;vertical-align:top;width:28.35pt">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>*</span></span></span></div>
                        </td>
                        <td style="text-align:left;vertical-align:top;width:auto">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Not included share- based compensation detailed in Note 20.</span></span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                      <tr style="vertical-align:top">
                        <td style="width:101.7pt">&#160;</td>
                        <td style="text-align:right;vertical-align:top;width:28.35pt">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>**</span></span></span></div>
                        </td>
                        <td style="text-align:left;vertical-align:top;width:auto">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>During 2022 two members of the board of directors were replaced.</span></span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:101.7pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">***</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During 2023 three members of the board have left and one member of the board was replaced. At the end of 2023, the total board member consisted of five members.</span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          </div>
        </ix:nonNumeric>
      </div>
      <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:100%">

          <tr>
            <td style="width:56.7pt">&#160;</td>
            <td style="width:auto;vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold">b.&#160; &#160; &#160; &#160; Key Officers:</td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div>
        <div>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:85.05pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top;font-weight:bold">1.</td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold">Balances with Key Officers of the Company</div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:108pt">
              <ix:nonNumeric id="Fxbrl_20240317191546352" name="mdwd:DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory" contextRef="C_20230101to20231231" escape="true">
                <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:center">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid black">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><strong><em>Other </em></strong></p>
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><strong><em>Payables</em></strong></p>
                      </td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><em><strong>Key Officers of the Company</strong></em></p>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="width:88%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25">As of December 31, 2023</div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220316194235309" name="ifrs-full:ProfessionalFeesExpense" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdKeyOfficerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">518</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="width:88%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25">As of December 31, 2022</div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240316192937837" name="ifrs-full:ProfessionalFeesExpense" contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdKeyOfficerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">754</ix:nonFraction></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>

                </table>
              </ix:nonNumeric>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:103.05pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top">&#8226;</td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div>Represents the officer&#8217;s gross salary, bonuses, and vacation provisions without share based compensation.</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
      <p style="margin:0pt">&#160;</p>
      <div>
        <div>
          <div><ix:exclude>
            <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
              <div style="margin-top:0pt;margin-bottom:0pt">
                <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 46</span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:4px;page-break-after:always"/></div></div><div style="text-align:left"><div><div><div style="margin-top:10pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"><span style="line-height:1.25"><span style="line-height:1.25"><span style="font-weight:bold">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:4pt"><strong>Notes to the Consolidated Financial Statements</strong></p><hr style="height:1px;color:#000000;background-color:#000000;text-align:center;border:none;margin-top:0pt;margin-bottom:4pt;text-align:center"/></div></div><div style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands (except of share and per share data)</span></span></span></span></span></span></div><div style="text-align:justify">&#160;</div></div></div></div>
              </div>
            </div>
            <div style="text-align:justify;line-height:1.25;margin-top:0pt;margin-bottom:0pt">
              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0);border:0px">

                  <tr>
                    <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 24:</span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt;font-weight:bold;font-family:Times New Roman, Times, serif">Balances and Transactions with Related Parties and Key Officers&#160;</span><span style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-weight:bold;font-family:Times New Roman, Times, serif">(Cont.)</span></div>
                    </td>
                  </tr>

              </table>
              <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
            </div>
          </ix:exclude></div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:85.05pt">&#160;</td>
                <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Compensation of Key Officers of the Company:</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following amounts disclosed in the table are recognized as an expense during the reporting period related to officers:</span></span></div>
        </div>
      </div>
      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
      <div>
        <div>
          <ix:nonNumeric id="Fxbrl_20240316192453665" name="ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory" contextRef="C_20230101to20231231" escape="true">
            <div>
              <div style="margin-left:108pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:85%">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="border-bottom:2px solid black;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td style="vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold">&#160;</div>
                      </td>
                      <td style="border-bottom:2px solid black;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="padding-bottom:2px;white-space:nowrap;border-bottom:2px solid black;vertical-align:bottom">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><strong><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2022</span></strong></p>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold">&#160;</div>
                      </td>
                      <td style="border-bottom:2px solid black;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="padding-bottom:2px;white-space:nowrap;border-bottom:2px solid black;vertical-align:bottom">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><strong><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2021</span></strong></p>
                      </td>
                    </tr>
                    <tr>
                      <td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:64%">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term employee benefits (*)(**)</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012144415541" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,084</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012144421658" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,880</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012144424590" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,788</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                    </tr>
                    <tr>
                      <td style="padding-bottom:2px;vertical-align:bottom;width:64%">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012144614988_xbrl_20211012144415541" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">757</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012144614988_xbrl_20211012144421658" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">797</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012144614988_xbrl_20211012144424590" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">518</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                    </tr>
                    <tr>
                      <td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:64%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                    </tr>
                    <tr>
                      <td style="padding-bottom:4px;vertical-align:bottom;width:64%">&#160;</td>
                      <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012144634961" name="ifrs-full:KeyManagementPersonnelCompensation" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,841</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012144640260" name="ifrs-full:KeyManagementPersonnelCompensation" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,677</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012144647356" name="ifrs-full:KeyManagementPersonnelCompensation" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,306</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                    </tr>
                    <tr>
                      <td style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:64%">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of officers</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;(***)</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012144654818_xbrl_20211012144614988_xbrl_20211012144415541" name="ifrs-full:NumberOfEmployees" contextRef="C_20231231" unitRef="Officers" scale="0" decimals="0" format="ixt:num-dot-decimal">8</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012144654818_xbrl_20211012144614988_xbrl_20211012144421658" name="ifrs-full:NumberOfEmployees" contextRef="C_20221231" unitRef="Officers" scale="0" decimals="0" format="ixt:num-dot-decimal">7</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211012144654818_xbrl_20211012144614988_xbrl_20211012144424590" name="ifrs-full:NumberOfEmployees" contextRef="C_20211231" unitRef="Officers" scale="0" decimals="0" format="ixt:num-dot-decimal">5</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(*) One-time expenses amounted $<ix:nonFraction id="Fxbrl_20220310172544306" name="ifrs-full:DirectorsRemunerationExpense" contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdChiefExecutiveOfficerAndChiefMedicalOfficerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">309</ix:nonFraction> for the year ended December 31, 2022, are associated with the management changes.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(**) In December 2007, the Company's board of directors approved one&#8209;time bonus payments to the Chief Medical Officer in the amounts of $ <ix:nonFraction id="Fxbrl_20220217110121705" name="ifrs-full:DirectorsRemunerationExpense" contextRef="C_20071201to20071231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdChiefExecutiveOfficerAndChiefMedicalOfficerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">120</ix:nonFraction>, which was recorded in profit and loss in December 2022 upon achieving marketing approval in the United States.</span></span></div>
              <div style="text-align:justify;margin-left:103.05pt;line-height:1.25">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><br/>(***) During 2023 two key officers were replaced. At the end of 2023 the total key officers consist of six officers.</p>
              </div>
            </div>
          </ix:nonNumeric>
        </div>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin:0pt">&#160;</p>
</div><div style="">
  <div>
    <ix:nonNumeric id="Fxbrl_20220309135654685" name="ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory" contextRef="C_20230101to20231231" escape="true">
      <div>
        <div>
          <div>
            <div style="text-align:justify;line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0);border:0px">

                  <tr>
                    <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Note 25:</span></span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Subsequent events:</span></span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="text-align:justify">
                      <div style="line-height:1.25;font-family:Times New Roman, serif;font-size:11pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>On January 1, 2024, the company entered into a new lease agreement for <ix:nonFraction id="Fxbrl_20240317214829043" name="mdwd:AreaOfLand" contextRef="C_20240101_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember" unitRef="Square_Meters" scale="0" decimals="2" format="ixt:num-dot-decimal">380.21</ix:nonFraction> square meters of office, in Yavne, Israel, close to the main office, the agreement is for <ix:nonNumeric id="Fxbrl_20240317235703560" name="mdwd:TermOfLease" contextRef="C_20240101to20240131_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember" format="ixt-sec:durwordsen">two years</ix:nonNumeric> with options for additional <ix:nonNumeric id="Fxbrl_20240317235708413" name="mdwd:AdditionalTermOfLease" contextRef="C_20240101to20240131_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember" format="ixt-sec:durwordsen">three years</ix:nonNumeric>. The additional leased area is needed to support the company in extending its activity. The annual fee for this agreement is ILS <ix:nonFraction id="Fxbrl_20240317175734031" name="mdwd:AmountOfAnnualFeeOfLeaseAgreement" contextRef="C_20240101to20240131_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember" unitRef="NIS" scale="0" decimals="0" format="ixt:num-dot-decimal">437</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20240317185323556" name="mdwd:AmountOfAnnualFeeOfLeaseAgreement" contextRef="C_20240101to20240131_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">120</ix:nonFraction>). </span></span></span></span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="text-align:justify">
                      <div style="line-height:1.25;font-family:Times New Roman, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>O</span></span></span></span>n February 26, 2024, the Company granted to employees, officers, board members, CEO and some consultants <ix:nonFraction id="Fxbrl_20240319203203617" name="ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding" contextRef="C_20240301to20240306_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">311,022</ix:nonFraction> share options for an exercise price of $<ix:nonFraction id="Fxbrl_20240319202717705" name="mdwd:ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare" contextRef="C_20240226_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">12.73</ix:nonFraction> per share and <ix:nonFraction id="Fxbrl_20240319203155732" name="mdwd:NumberOfSharesExerciseRestrictedStockUnits" contextRef="C_20240301to20240306_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">30,482</ix:nonFraction> RSUs. The share options vest over a period of <ix:nonNumeric id="Fxbrl_20240319202729447" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" contextRef="C_20240201to20240226_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember">1-4 years</ix:nonNumeric>. The grant to the directors and CEO is subject to the approval of the next shareholders annual meeting.</div>
                    </div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">
              <div>
                <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', serif;font-size:11pt;font-weight:bold">
                  <div>&#160;</div>
                </div>
              </div>
            </div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="text-align:justify">
                      <div style="text-align:left;line-height:1.25;font-family:'Times New Roman',serif">
                        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On March 6, 2024, <ix:nonFraction id="Fxbrl_20240317175620622" name="mdwd:NumberOfPreFundedWarrantsExercised" contextRef="C_20240301to20240306_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">37,106</ix:nonFraction> warrants were exercised to the Company shares for exercise price of $<ix:nonFraction id="Fxbrl_20240317175610612" name="mdwd:ExercisePriceOfWarrants" contextRef="C_20240306_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember" unitRef="USD_Per_Share" scale="0" decimals="3" format="ixt:num-dot-decimal">13.475</ix:nonFraction> per ordinary share, in accordance with the terms of the warrants (See also note 19 C.2).</span></span></span></span></div>
                      </div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
    <div style="text-align:center;margin-top:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">F - 47</span></span></span></div>
    <div style="text-align:center">
      <hr style="border:none;border-bottom:4px solid #000000;border-top:1px solid #000000;height:10px;width:100%;color:#000000;text-align:center;text-align:center"/>
    </div>
  </div>
</div></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>exhibit_1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" align="center">
    <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 1.1</font></u><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">______________________________________________________________________________<br>
        </font><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">AMENDED AND RESTATED</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">ARTICLES OF ASSOCIATION</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">OF</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">MEDIWOUND LTD.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">A COMPANY LIMITED BY SHARES</div>
    <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">UNDER THE COMPANIES LAW, 5759 &#8211; 1999</div>
    <div style="text-align: center; line-height: 1.25;">______________________________________________________________________________</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">INTERPRETATION</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">1.<br>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div>
      <table class="DSPFListTable" id="zd834f3c397db422baaae8e663ca4d11c" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">1.1.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">In these Articles, unless the context requires another meaning the words in the first column of the following table shall
                have the meanings set opposite them in the second column:</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="margin-left: 27pt;">
      <table style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;" id="zbf572bd4d3ec4a1dac754855a1a46375" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">Alternate Nominee</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25;">as defined in Article 77.1;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">Articles</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25;">these Articles of Association, as amended from time to time by a Resolution (as defined below);</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">Auditors</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25;">the auditors of the Company;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">Board of Directors</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25;">all of the directors of the Company holding office pursuant to these Articles, including alternates, substitutes or proxies;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">Chief Executive Officer</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25;">chief executive officer of the Company;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">Chairman of the Board of
                  Directors</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25;">as defined in Article 81;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">Companies Law</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25;">the Israeli Companies Law, 5759-1999,&#160; as amended from time to time, including the regulations promulgated thereunder, or any
                other law which may come in its stead, including all amendments made thereto;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">Company</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25;">MediWound Ltd. or &#1502;&#1491;&#1497;&#1493;&#1493;&#1504;&#1491; &#1489;&#1506;"&#1502;;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">Committee of Directors</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25;">as defined in Article 93;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">Compensation Committee</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25;">as defined in the Companies Law;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">Deed of Transfer</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25;">as defined in Article 44;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">Derivative Transaction</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25;">as defined in Article 56;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">Effective Time</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25;">the closing of the initial underwritten public offering of the Company&#8217;s Ordinary Shares, at which time these Articles shall
                first become effective;</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%- % -%-->
    <div style="margin-left: 27pt;">
      <table style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 95%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#8220;<font style="font-weight: bold;">Director(s)</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">a member or members of the Board of Directors elected to hold office as director(s);</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#8220;<font style="font-weight: bold;">External Directors</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">as defined in the Companies Law;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#8220;<font style="font-weight: bold;">General Meetings</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">all annual and extraordinary meetings of the Shareholders;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#8220;<font style="font-weight: bold;">Incapacitated Person</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">as defined under the Israeli Legal Capacity and Guardianship Law, 5722-1962, as amended from time to time, including a minor who
                has not yet attained the age of 18 years, a person unsound of mind and a bankrupt in respect of whom no rehabilitation has been granted;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#8220;<font style="font-weight: bold;">NIS</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">New Israeli Shekels;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#8220;<font style="font-weight: bold;">Nominees</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">as defined in Article 77.1;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#8220;<font style="font-weight: bold;">Ordinary Shares</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">as defined in Article 6;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#8220;<font style="font-weight: bold;">Office</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">the registered office of the Company at that time;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#8220;<font style="font-weight: bold;">Office Holder</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">as defined in the Companies Law;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#8220;<font style="font-weight: bold;">Person</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">includes an individual, corporation, company, cooperative society, partnership, trust of any kind or any other body of persons, whether incorporated or otherwise;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#8220;<font style="font-weight: bold;">Proposal Request</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">as defined in Article 56;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#8220;<font style="font-weight: bold;">Proposing Shareholder</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">as defined in Article 56;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#8220;<font style="font-weight: bold;">Register</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">the Register of Shareholders administered in accordance with the Companies Law;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#8220;<font style="font-weight: bold;">Resolution</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">a resolution of Shareholders. Except as
                required under the Companies Law or these Articles, any Resolution shall be adopted by a majority of the voting power present and voting at the applicable General Meeting, in person or by proxy;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#8220;<font style="font-weight: bold;">Rights</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">as defined in Article&#160;113.1;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#8220;<font style="font-weight: bold;">Shareholder(s)</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">shall mean the shareholder(s) of the Company, at any given time;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#8220;<font style="font-weight: bold;">Special Fund</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">as defined in Article 113.1;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#8220;<font style="font-weight: bold;">Transferor</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">as defined in Article 44;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#8220;<font style="font-weight: bold;">Transferee</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">as defined in Article 44;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#8220;<font style="font-weight: bold;">U.S. Rules</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">the applicable rules of the NASDAQ Stock Market and the U.S. securities rules and regulations, as amended from time to time; and</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#8220;<font style="font-weight: bold;">writing</font>&#8221;</div>
            </td>
            <td style="width: 70%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">handwriting, typewriting, photography, telex, email or any other legible form of writing.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 2 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div>
      <table class="DSPFListTable" id="z3d15ea6dbb5b4e258f6d151f3d6b8c9e" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">1.2.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Subject to the provisions of this Article 1, in these Articles, unless the context necessitates another meaning, terms
                and expressions which have been defined in the Companies Law shall have the meanings ascribed to them therein.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table class="DSPFListTable" id="zb8b6844d8a22463b83fb68e4f439c50e" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">1.3.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Words in the singular shall also include the plural, and vice versa. Words in the masculine shall include the feminine
                and vice versa, and words which refer to persons shall also include corporations, and vice versa.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table class="DSPFListTable" id="za2c0dbdbc5d74f6d8e75f5f5e317d644" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">1.4.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The captions to articles in these Articles are intended for the convenience of the reader only, and no use shall be made
                thereof in the interpretation of these Articles.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">LIMITED LIABILITY</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5faed495b7fb4d8db67d28dc0528eb55" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">2.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Company is a limited liability company and therefore each shareholder&#8217;s obligations for the Company&#8217;s obligations shall be limited to the payment of the nominal value of the shares held by such shareholder, subject to the provisions of the Companies Law.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">THE COMPANY&#8217;S OBJECTIVES</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z66e200a3c15b4bbb97c4f6ad16d0dc82" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">3.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Company&#8217;s objectives are to conduct all types of business as are permitted by law. The
              Company may donate a reasonable amount of money for any purpose that the Board of Directors finds appropriate, even if the donation is not for business considerations or for the purpose of achieving profits for the Company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">THE BUSINESS</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6fedc7a78a5e40058d38163a7d81e508" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">4.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Any branch or type of business that the Company is authorized to engage in, either expressly or implied, may be commenced or engaged in by the Board of Directors at all
              or any time as it deems fit. The Board of Directors shall be entitled to cease the conduct of any such branch or type of business, whether or not the actual conduct
                thereof has commenced at its own discretion.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">REGISTERED OFFICE</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6a9910ee8193406998522b2044ed1906" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">5.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The registered office shall be at such place as is decided from time to time by the Board
                of Directors.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">SHARE CAPITAL</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb57c1166e1dc451d8ec5b579356c2a5e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">6.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The share capital of the Company shall consist of NIS 1,400,000 divided into 20,000,000 Ordinary Shares, of a nominal value of NIS 0.07 each (the &#8220;<font style="font-weight: bold;">Ordinary Shares</font>&#8221;).</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">RIGHTS ATTACHING TO THE ORDINARY SHARES</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">7.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div>
      <table class="DSPFListTable" id="z73020851edd0444ebfc2bc2129c0af78" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">7.1.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Ordinary Shares in respect of which all calls have been fully paid shall confer on the holders thereof the right to
                attend and to vote at General Meetings of the Company, both ordinary as well as extraordinary meetings.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 3 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div>
      <table class="DSPFListTable" id="zacf21f3572f543c98d04265109d96403" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">7.2.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Ordinary Shares shall confer on a holder thereof the right to receive a dividend, to participate in a distribution of
                bonus shares and to participate in the distribution of the assets of the Company upon its winding-up, pro rata to the nominal amount paid up on the shares or credited as paid up in respect thereof, and without reference to any premium which
                may have been paid in respect thereof.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">MODIFICATION OF CLASS RIGHTS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -35.45pt; margin-left: 35.45pt; line-height: 1.25;">8.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div>
      <table class="DSPFListTable" id="z45f00abd455040c0bf04dd892711f6cf" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">8.1.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Subject to applicable law, if at any time the share capital of the Company is divided into different classes of shares
                and unless the terms of issue of such class of shares otherwise stipulate, the rights attaching to any class of shares (including rights prescribed in the
                  terms of issue of the shares) may be altered, modified or canceled, by a Resolution passed at a separate General Meeting of the Shareholders of that class.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;">&#160;</div>
    <div>
      <table class="DSPFListTable" id="zf3b1ccff61884af3b1ae1b69b5bff42f" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">8.2.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The provisions contained in these Articles with regard to General Meetings shall apply, <font style="font-style: italic;">mutatis mutandis</font> as the case may be, to every General Meeting of the
                  holders of each such class of the Company&#8217;s shares.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;">&#160;</div>
    <div>
      <table class="DSPFListTable" id="z40cb3bd0589a4ce2a49a54c82fcb5e7a" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">8.3.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Unless otherwise provided by these Articles, the increase of an authorized class of shares, or the issuance of additional
                shares thereof out of the authorized and unissued share capital, shall not be deemed, for purposes of this Article 8.30, to modify or abrogate the rights attached to previously issued shares of such class or of any other class.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">UNISSUED SHARE CAPITAL</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z87b4489432f149f197fba18a625958a7" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">9.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The unissued shares in the capital of the Company shall be under the control of the Board of Directors, which shall be entitled to allot or otherwise grant the same to
              such Persons under such restrictions and conditions as it shall deem fit, whether for consideration or otherwise, and whether for consideration in cash or for consideration which is not in cash, above their nominal value or at a discount, all
              on such conditions, in such manner and at such times as the Board of Directors shall deem fit, subject to the provisions of the Companies Law. The Board of Directors shall be entitled, <font style="font-style: italic;">inter alia</font>, to differentiate between Shareholders with regard to the amounts of calls in respect of the allotment of shares (to the extent that there are calls) and with regard to the time
              for payment thereof. The Board of Directors may also issue options or warrants for the purchase of shares of the Company and prescribe the manner of the exercise of such options or warrants, including the time and price for such exercise and
              any other provision which is relevant to the method for distributing the issued shares of the Company amongst the purchasers thereof.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zce60558e4fd5465ebce07f6917ada4a2" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">10.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors shall be entitled to prescribe the times for the issue of shares of the Company and the conditions therefore and any other matter which may arise
              in connection with the issue thereof.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z38cf773eb34c461e9619d8e4bfed2f09" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">11.</td>
          <td style="width: auto; vertical-align: top;">
            <div>In every case of a rights offering the Board of Directors shall be entitled, in its discretion, to resolve any problems and difficulties arising or that are likely to
              arise in regard to fractions of rights, and without prejudice to the generality of the foregoing, the Board of Directors shall be entitled to specify that no shares shall be allotted in respect of fractions of rights, or that fractions of
              rights shall be sold and the (net) proceeds shall be paid to the persons entitled to the fractions of rights, or, in accordance with a decision by the Board of Directors, to the benefit of the Company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z067b57896cc64466b9b196a98b14157d" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 34pt; vertical-align: top;">11A.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Company may, subject to applicable law, issue redeemable shares and redeem the same. Shares issued by the Company may be redeemable upon terms and conditions to be
              set forth in a written agreement between the Company and the holder of such shares.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 4 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">INCREASE OF AND ALTERATIONS TO CAPITAL</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze86bb157369d45f2814db0f6c93af50e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">12.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Company may, from time to time, by a Resolution, increase its share capital by way of the creation of new shares, whether or not all the existing shares have been
              issued up to the date of the resolution, whether or not it has been decided to issue same, and whether or not calls have been made on all the issued shares.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za98fad1c9e544514b0e92c5c8669243c" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">13.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The increase of share capital shall be in such amount and divided into shares of such nominal value, and with such restrictions and conditions and with such rights and
              privileges as the Resolution dealing with the creation of the shares prescribes, and if no provisions are contained in the Resolution, then as the Board of Directors shall prescribe.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1b2948280dc741baaeaeedbbfd1ba537" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">14.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Unless otherwise stated in the Resolution approving the increase of the share capital, the new shares shall be subject to those provisions in regard to issue,
              allotment, alteration of rights, payment of calls, liens, forfeiture, transfer, transmission and other provisions which apply to the shares of the Company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z25547f9d0c6e41a291d8d861b9732b52" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">15.</td>
          <td style="width: auto; vertical-align: top;">
            <div>By Resolution, the Company may, subject to any applicable provisions of the Companies Law:</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4cc14c8986b24dc3a4e86b5001361cd2" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">15.1.</td>
          <td style="width: auto; vertical-align: top;">
            <div>consolidate its existing share capital, or any part thereof, into shares of a larger denomination than the existing shares;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8d387a3b2488478ab71fa14c7963002b" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">15.2.</td>
          <td style="width: auto; vertical-align: top;">
            <div>sub-divide its share capital, in whole or in part, into shares of a smaller denomination than the nominal value of the existing shares and without prejudice to the
              foregoing, one or more of the shares so created may be granted any preferred or deferred rights or any special rights with regard to dividends, participation in assets upon winding-up, voting and so forth, subject to the provisions of these
              Articles;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbac7e39fa37145d588163ae78bb8f05a" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">15.3.</td>
          <td style="width: auto; vertical-align: top;">
            <div>reduce its share capital; or</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za56eff6445c54e5f90466f1529ae60b8" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">15.4.</td>
          <td style="width: auto; vertical-align: top;">
            <div>cancel any shares which on the date of passing of the Resolution have not been issued and to reduce its share capital by the amount of such shares.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7378fda5981747268db70ed1fdce1c81" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">16.</td>
          <td style="width: auto; vertical-align: top;">
            <div>In the event that the Company shall adopt any of the Resolutions described in Article 15 above, the Board of Directors shall be entitled to prescribe arrangements
              necessary in order to resolve any difficulty arising or that are likely to arise in connection with such Resolutions, including, in the event of a consolidation, it shall be entitled to (i) allot, in contemplation of or subsequent to such
              consolidation or other action, shares or fractional shares sufficient to preclude or remove fractional share holdings; (ii) redeem, in the case of redeemable shares, and subject to applicable law, such shares or fractional shares sufficient
              to preclude or remove fractional share holdings; (iii) round up, round down or round to the nearest whole number, any fractional shares resulting from the consolidation or from any other action which may result in fractional shares; or (iv)
              cause the transfer of fractional shares by certain Shareholders to other Shareholders thereof so as to most expediently preclude or remove any fractional shareholdings, and, cause the transferees of such fractional shares to pay the
              transferors thereof the fair value thereof, and the Board of Directors is hereby authorized to act in connection with such transfer, as agent for the transferors and transferees of any such fractional shares, with full power of substitution,
              for the purposes of implementing the provisions of this Article 16</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 5 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">SHARE CERTIFICATES</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7065ec31e4ea4d3d81ba9d890ce8e9e2" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">17.</td>
          <td style="width: auto; vertical-align: top;">
            <div>To the extent shares are certificated, share certificates evidencing title to the shares of the Company shall be issued under the seal or rubber stamp of the Company,
              and together with the signatures of two members of the Board of Directors, or one Director together with the Chief Executive Officer, the Chief Financial Officer, the Secretary of the Company or any other person designated by the Board of
              Directors. The Board of Directors shall be entitled to decide that the signatures be effected in any mechanical or electronic form, provided that the signature shall be effected under the supervision of the Board of Directors in such manner
              as it prescribes.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfd5a94a6f2d54305ad4139e652f59cc5" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">18.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Every Shareholder shall be entitled, free of charge, to one certificate in respect of all the shares of a single class registered in his name in the Register.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z14eeb26dd93b4240811a67a429f04ab2" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">19.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors shall not refuse a request by a Shareholder to obtain several certificates in place of one certificate, unless such request is, in the opinion of
              the Board of Directors, unreasonable. Where a Shareholder has sold or transferred some of his shares, he shall be entitled, free of charge, to receive a certificate in respect of his remaining shares, provided that the previous certificate is
              delivered to the Company before the issuance of a new certificate.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb72aad9cd0ce4238ad3be81c6c47fa11" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">20.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Every share certificate shall specify the number of the shares in respect of which such certificate is issued and also the amounts which have been paid up in respect of
              each share.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z916e15f0ca05449aa33c8adba699d745" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">21.</td>
          <td style="width: auto; vertical-align: top;">
            <div>No Person shall be recognized by the Company as having any right to a share unless such Person is the registered owner of the shares in the Register. The Company shall
              not be bound by and shall not recognize any right or privilege pursuant to the laws of equity, or a fiduciary relationship or a chose in action, future or partial, in any share, or a right or privilege to a fraction of a share, or (unless
              these Articles otherwise direct) any other right in respect of a share, except the absolute right to the share as a whole, where same is vested in the owner registered in the Register.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zad77dda838a44e0695f46c249fa0d45b" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">22.</td>
          <td style="width: auto; vertical-align: top;">
            <div>A share certificate registered in the names of two or more persons shall be delivered to one of the joint holders, and the Company shall not be obliged to issue more
              than one certificate to all the joint holders of shares and the delivery of such certificate to one of the joint holders shall be deemed to be delivery to all of them.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze241cc051eb944409c82dd4d221e08f6" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">23.</td>
          <td style="width: auto; vertical-align: top;">
            <div>If a share certificate should be lost, destroyed or defaced, the Board of Directors shall be entitled to issue a new certificate in its place, provided that the
              certificate is delivered to it and destroyed by it, or it is proved to the satisfaction of the Board of Directors that the certificate was lost or destroyed and security has been received to its satisfaction in respect of any possible damages
              and after payment of such amount as the Board of Directors shall prescribe.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CALLS ON SHARES</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1ad97d660caa4ac687001a47b48b7373" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">24.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors may from time to time, in its discretion, make calls on Shareholders in respect of amounts which are still unpaid in respect of the shares held
              by each of the Shareholders (including premiums), and the terms of issue which do not prescribe that same be paid at fixed times, and every Shareholder shall be obliged to pay the amount of the call made on him, at such time and at such place
              as stipulated by the Board of Directors.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 6 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z40b4d73c54f349ddbabf26f3f0c4b5ac" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">25.</td>
          <td style="width: auto; vertical-align: top;">
            <div>In respect of any such call, prior notice of at least fourteen (14) business days shall be given, stating to whom the amount called is to be paid, the time for payment
              and the place thereof, provided that prior to the due date for payment of such call, the Board of Directors may, by written notice to the Shareholders to which the call was made, cancel the call or extend the date of payment thereof.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd3c50055f0c943669eb7219da599366a" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">26.</td>
          <td style="width: auto; vertical-align: top;">
            <div>If according to the terms of issue of any share, or otherwise, any amount is required to be paid at a fixed time or in installments at fixed times, whether the payment
              is made on account of the share capital in respect of the share or in form of a premium, every such payment or every such installment shall be paid as if it was a call duly made by the Board of Directors, in respect of which notice was duly
              given, and all the provisions contained in these Articles in regard to calls shall apply to such amount or to such installment.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z26f63257a0bc4948a624efa4909085aa" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">27.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Joint holders of a share shall be jointly and severally liable for the payment of all installments and calls due in respect of such share.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z61c8a086d13e4f14ad6294f7c43bf479" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">28.</td>
          <td style="width: auto; vertical-align: top;">
            <div>In the event that a call or installment due on account of a share is not paid on or before the date fixed for payment thereof, the holder of the share, or the Person to
              whom the share has been allotted, shall be obliged to pay linkage differentials and interest on the amount of the call or the installment, at such rate as shall be determined by the Board of Directors, commencing from the date fixed for the
              payment thereof and until the date of actual payment. The Board of Directors may, however, waive the payment of the linkage differentials or the interest or part thereof.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zaf2ee63b839c40c58e2491033d5e9fef" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">29.</td>
          <td style="width: auto; vertical-align: top;">
            <div>A Shareholder shall not be entitled (i) to receive a dividend and (ii) to exercise any right as a Shareholder, including but not limited to, the right to attend and
              vote at a General Meeting of any type and to transfer the shares to another; unless he has paid all the calls payable from time to time and which apply to any of his shares, whether he holds same alone or jointly with another, plus linkage
              differentials, interest and expenses, if any.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc18dab7730a34cf5801bedb13637f4d2" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">30.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors may, if it deems fit, accept payment from a Shareholder wishing to advance the payment of all moneys which remain unpaid on account of his
              shares, or part thereof which are over and above the amounts which have actually been called, and the Board of Directors shall be entitled to pay such Shareholder linkage differentials and interest in respect of the amounts paid in advance,
              or that portion thereof which exceeds the amount called for the time being on account of the shares in respect of which the advance payment is made, at such rate as is agreed upon between the Board of Directors and the Shareholder, with this
              being in addition to dividends payable (if any) on the paid-up portion of the share in respect of which the advance payment is made.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="margin-left: 35.45pt; line-height: 1.25;">The Board of Directors may, at any time, repay the amount paid in advance as aforesaid, in whole or in part, in its
      sole discretion, without premium or penalty. Nothing in this Article 30 shall derogate from the right of the Board of Directors to make any call for payment before or after receipt by the Company of any such advance.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; margin-left: 28.35pt; line-height: 1.25; font-weight: bold;">FORFEITURE AND LIEN</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf6be136219da490f90ddc0ba1f2d1c77" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">31.</td>
          <td style="width: auto; vertical-align: top;">
            <div>If a Shareholder fails to make payment of any call or other installment on or before the date fixed for the payment thereof, the Board of Directors may, at any time
              thereafter and for as long as the part of the call or installment remains unpaid, serve on such Shareholder a notice demanding that he make payment thereof, together with the linkage differentials and interest at such rate as is specified by
              the Board of Directors and all the expenses incurred by the Company in consequence of such non-payment.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 7 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4848c0e8f9b745d094587927082262d5" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">32.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The notice shall specify a further date, which shall be at least fourteen (14) business days after the date of the delivery of the notice, and a place or places at
              which such call or installment is to be paid, together with linkage differentials and interest and expenses as aforesaid. The notice shall further state that, if the amount is not paid on or before the date specified, and at the place
              mentioned in such notice, the shares in respect of which the call was made, or the installment is due, shall be liable to forfeiture.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z79de149271f94a889dc808ea915f3549" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">33.</td>
          <td style="width: auto; vertical-align: top;">
            <div>If the demands contained in such notice are not complied with the Board of Directors may treat the shares in respect of which the notice referred to in Articles 31 and
              32 was given as forfeited. Such forfeiture shall include all dividends, bonus shares and other benefits which have been declared in respect of the forfeited shares which have not actually been paid prior to the forfeiture.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8dcea0c391fc4df5890b287ffec93430" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">34.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Any share so forfeited or waived shall be deemed to be the property of the Company and the Board of Directors shall be entitled, subject to the provisions of these
              Articles and the Companies Law, to sell, re-allot or otherwise dispose thereof, as it deems fit, whether the amount paid previously in respect of that share is credited, in whole or in part.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze88e734695974642a55da68211ae15fa" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">35.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors may, at any time before any share forfeited as aforesaid is sold or re-allotted or otherwise dispose of, cancel the forfeiture on such conditions
              as it deems fit.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4a1629196ec24fd3a8404f2c19a40fe5" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">36.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Any Person whose shares have been forfeited shall cease to be a Shareholder in respect of the forfeited shares, but shall, nonetheless remain liable for the payment to
              the Company of all calls, installments, linkage differentials, interest and expenses due on account of or in respect of such shares on the date of forfeiture, in respect of the forfeited shares, together with interest on such amounts reckoned
              from the date of forfeiture until the date of payment, at such rate as the Board of Directors shall from time to time specify. However, such Person&#8217;s liability shall cease after the Company has received all the amounts called in respect of
              the shares as well as any expenses incurred by the Company relating to collecting the amounts called. The Board of Directors shall be entitled to collect the moneys which have been forfeited, or part thereof, as it shall deem fit, but it
              shall not be obliged to do so.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z866db19d81664d9784bdaf275d15300e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">37.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The provisions of these Articles in regard to forfeiture shall also apply to cases of non-payment of any amount, which, according to the terms of issue of the share, or
              which under the conditions of allotment the due date for payment of which fell on a fixed date, whether this be on account of the nominal value of the share or in the form of a premium, as if such amount was payable pursuant to a call duly
              made and notified.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc41f1fa24f444ddbb2b04e5e837eb281" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">38.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Company shall have a first and paramount lien over all the shares which have not been fully paid up and which are registered in the name of any Shareholder (whether
              individually or jointly with others) and also over the proceeds of the sale thereof, as security for the debts and obligations of such Shareholder to the Company and his contractual engagements with it, either individually or together with
              others. This right of lien shall apply whether or not the due date for payment of such debts or the fulfillment or performance of such obligations has arrived, and no rights in equity shall be created in respect of any share, over which there
              is a lien as aforesaid. The aforesaid lien shall apply to all dividends or benefits which may be declared, from time to time, on such shares, unless the Board of Directors shall decide otherwise.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 8 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdd1dd7836ef0404bb6f23c0a66b4a437" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">39.</td>
          <td style="width: auto; vertical-align: top;">
            <div>In order to foreclose on such lien, the Board of Directors may sell the shares under lien at such time and in such manner as, it shall deem fit, but no share may be
              sold unless the period referred to below has elapsed and written notice has been given to the Shareholder, his trustee, liquidator, receiver, the executors of his estate, or anyone who acquires a right to shares in consequence of the
              bankruptcy of a Shareholder, as the case may be, stating that the Company intends to sell the shares, if he or they should fail to pay the aforesaid debts, or fail to discharge or fulfill the aforesaid obligations within fourteen (14)
              business days from the date of the delivery of the notice.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze5f3dec801f74a87a09198f460c45f51" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">40.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The net proceeds of any such sale of shares, as contemplated by Article 39 above, after deduction of the expenses of the sale, shall serve for the discharge of the
              debts of such shareholder or for performance of such Shareholder&#8217;s obligations (including debts, undertakings and contractual engagements the due date for the payment or performance of which has arrived) and the surplus, if any, shall be paid
              to the Shareholder, his trustee, liquidator, receiver, guardians, the executors of his estate, or to his successors-in-title.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcd569ac455ec4a388989aea8957810fd" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">41.</td>
          <td style="width: auto; vertical-align: top;">
            <div>In every case of a sale following forfeiture or waiver, or for purposes of executing a lien by exercising all of the powers conferred above, the Board of Directors
              shall be entitled to appoint a person to sign an instrument of transfer of the shares sold, and to arrange for the registration of the name of the buyer in the Register in respect of the shares sold.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0c8f5884a2e249cf83ee08ca6c9d461b" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">42.</td>
          <td style="width: auto; vertical-align: top;">
            <div>An affidavit signed by the Chairman of the Board of Directors that a particular share of the Company was forfeited, waived or sold by the Company by virtue of a lien,
              shall serve as conclusive evidence of the facts contained therein as against any person claiming a right in the share. The purchaser of a share who relies on such affidavit shall not be obliged to investigate whether the sale, re-allotment or
              transfer, or the amount of consideration and the manner of application of the proceeds of the sale, were lawfully effected, and after his name has been registered in the Register he shall have a full right of title to the share and such right
              shall not be adversely affected by a defect or invalidity which occurred in the forfeiture, waiver, sale, re-allotment or transfer of the share.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">TRANSFER AND TRANSMISSION OF SHARES</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7f0032f5222c492cbed8c811e420a6f5" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">43.</td>
          <td style="width: auto; vertical-align: top;">
            <div>No transfer of shares shall be registered unless a proper instrument of transfer is delivered to the Company or, in the case of shares registered with a transfer agent,
              delivered to such transfer agent or to such other place specified for this purpose by the Board of Directors. Subject to the provisions of these Articles, an instrument of transfer of a share in the Company shall be signed by the transferor
              and the transferee. The Board of Directors may approve other methods of recognizing the transfer of shares in order to facilitate the trading of the Company&#8217;s shares on the Nasdaq Global Market or on any other stock exchange.&#160; The transferor
              shall be deemed to remain the holder of the share up until the time the name of the transferee is registered in the Register in respect of the transferred share.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 9 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7552df9c8ce944dd9aa905af986390a3" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">44.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Insofar as the circumstances permit, the instrument of transfer of a share shall be substantially in the form set out below, or in any other form that the Board of
              Directors may approve (the &#8220;<font style="font-weight: bold;">Deed of Transfer</font>&#8221;).</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="margin-left: 56.7pt; line-height: 1.25;">I _______________, I.D. _______________ of _______________ (the &#8220;<font style="font-weight: bold;">Transferor</font>&#8221;), in consideration for an amount of NIS _______________ (in words) paid to me by _______________ I.D. _______________ of _______________ (hereinafter: the &#8220;<font style="font-weight: bold;">Transferee</font>&#8221;), hereby transfer to the Transferee _______________ ______________ shares of nominal value NIS _______________ each, marked with the numbers _______________ to
      _______________ (inclusive) of a company known as MediWound Ltd., to be held by the Transferee, the acquires of his rights and his successors-in title, under all the same conditions under which I held same prior to the signing of this instrument, and
      I, the Transferee, hereby agree to accept the aforementioned share in accordance with the above mentioned conditions.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 56.7pt; line-height: 1.25;">In witness whereof we have hereunto signed this _____ day of _______ 20__.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 56.7pt; line-height: 1.25;">Transferor _______________ Transferee _______________</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 56.7pt; line-height: 1.25;">Witnesses to Signature _______________</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0bdab58f825a4680911b952b2e381823" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">45.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Company may close the transfer registers and the Register for such period of time as the Board of Directors shall deem fit.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zca24f544d6054dd6bc0e607b5f1b2521" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">46.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Every instrument of transfer shall be submitted to the Office or to such other place as the Board of Directors shall prescribe, for purposes of registration, together
              with the share certificates to be transferred, or if no such certificate was issued, together with a letter of allotment of the shares to be transferred, and/or such other proof as the Board of Directors may demand in regard to the
              transferor&#8217;s right of title or his right to transfer the shares. The Board of Directors shall have the right to refuse to recognize an assignment of shares until the appropriate securities under the circumstances have been provided, as shall
              be determined by the Board of Directors in a specific case or from time to time in general. Instruments of transfer which serve as the basis for transfers that are registered shall remain with the Company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze7c4d28b4b6c4e58a92ba5da37af6c8c" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">47.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Every instrument of transfer shall relate to one class of shares only, unless the Board of Directors shall otherwise agree.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2611ac49cbe2422fbfb71603003bd330" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">48.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The executors of the will or administrator of a deceased Shareholder&#8217;s estate (such Shareholder not being one of a joint owners of a share) or, in the absence of an
              administrator of the estate or executor of the will, the persons specified in Article 49 below, shall be entitled to demand that the Company recognize them as owners of rights in the share. The provisions of Article 46 above shall apply, <font style="font-style: italic;">mutatis mutandis</font>, also in regard to this Article.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z089aa7ffdeaa4d26899d385c4c3aef61" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">49.</td>
          <td style="width: auto; vertical-align: top;">
            <div>In the case of the death of one of the holders of a share registered in the names of two or more Persons, the Company shall recognize only the surviving owners as
              Persons having rights in the share. However, the aforementioned shall not be construed as releasing the estate of a deceased joint Shareholder from any and all undertakings in respect of the shares. Any Person who shall become an owner of
              shares following the death of a Shareholder shall be entitled to be registered as owner of such shares after having presented to an officer of the Company to be designated by the Chief Executive Officer an inheritance order or probation order
              or order of appointment of an administrator of estate and any other proof as required - if these are sufficient in the opinion of such officer - testifying to such Person&#8217;s right to appear as shareholder in accordance with these Articles, and
              which shall testify to his title to such shares. The provisions of Article 46 above shall apply, <font style="font-style: italic;">mutatis mutandis</font>, also in regard to this
              Article.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 10 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z05b8b51a94114f30abac2a70b9fae553" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">50.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The receiver or liquidator of a Shareholder who is a company or the trustee in bankruptcy or the official receiver of a Shareholder who is bankrupt, upon presenting
              appropriate proof to the satisfaction of an officer of the Company to be designated by the Chief Executive Officer that such Shareholder has the right to appear in this capacity and which testifies to such Shareholder&#8217;s title, may, with the
              consent of the Board of Directors (the Board of Directors shall not be obligated to give such consent) be registered as the owner of such shares. Furthermore, such Shareholder may assign such shares in accordance with the rules prescribed in
              these Articles. The provisions of Article 46 above shall apply, <font style="font-style: italic;">mutatis mutandis</font>, also in regard to this Article.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z898ab33c41764abf811c401715930b6b" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">51.</td>
          <td style="width: auto; vertical-align: top;">
            <div>A Person entitled to be registered as a Shareholder following assignment pursuant to these Articles shall be entitled, if approved by the Board of Directors and to the
              extent and under the conditions prescribed by the Board of Directors, to dividends and any other monies paid in respect of the shares, and shall be entitled to give the Company confirmation of the payments; however, he shall not be entitled
              to be present or to vote at any General Meeting of the Company or, subject to the provisions of these Articles, to make use of any rights of Shareholders, until he has been registered as owner of such shares in the Register.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">GENERAL MEETING</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3b844f7bfdd44e5e8207a83a4f7d96d8" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">52.</td>
          <td style="width: auto; vertical-align: top;">
            <div>A General Meeting shall be held at least once in every year, not later than 15 (fifteen) months after the last General Meeting, at such time and at such place as the
              Board of Directors shall determine. Such General Meeting shall be called an annual meeting, and all other meetings of the Shareholders shall be called extraordinary meetings.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze6fad85659914a13a7f9a9be370e78af" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">53.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors may call an extraordinary meeting whenever it sees fit to do so.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze467e40517cd4c47b261a83ff3c802c5" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">54.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors shall be obliged to call an extraordinary meeting upon a requisition in writing in accordance with the Companies Law.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbc56b1c60264473192beeb03e3e7e230" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">55.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Company shall provide prior notice in regard to the holding of an annual meeting or an extraordinary meeting in accordance with the requirements of these Articles,
              the Companies Law and the regulations promulgated thereunder. Subject to the provisions of the Companies Law and the regulations promulgated thereunder, in counting the number of days of prior notice given, the day of publication of notice
              shall not be counted, but the day of the meeting shall be counted. The notice shall specify those items and contain such information as shall be required by the Companies Law, the regulations promulgated thereunder and any other applicable
              law and regulations.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1c7839dce13a4c92b4bba6b7175765cf" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">56.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Any Shareholder (a &#8220;<font style="font-weight: bold;">Proposing Shareholder</font>&#8221;)requesting to add an
              item to the agenda of a General Meeting may submit such a request (a &#8220;<font style="font-weight: bold;">Proposal Request</font>&#8221;) in accordance with the Companies Law.&#160; Subject to
              any requirements under the Law, to be considered timely and thereby be added to such agenda, a Proposal Request must be delivered, either in person or by certified mail, postage prepaid, and received at the Office, (i) in the case of a
              General Meeting that is an annual meeting, no less than sixty (60) days nor more than one-hundred twenty (120) days prior to the date of the first anniversary of the preceding year&#8217;s annual meeting, provided, however, that, in the event that
              the date of the annual meeting is advanced more than thirty (30) days prior to or delayed by more than thirty (30) days after the anniversary of the preceding year&#8217;s annual meeting, notice by the Proposing Shareholder to be timely must be so
              received not earlier than the close of business one-hundred twenty (120) days prior to such annual meeting and not later than the close of business on the later of ninety (90) days prior to such annual meeting or the tenth (10<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>)
              day following the day on which public announcement of the date of such meeting is first made, and (ii) in the case of a General Meeting that is an extraordinary meeting, no earlier than one-hundred twenty (120) days prior to such
              extraordinary meeting and no later than sixty (60) days prior to such extraordinary meeting or the tenth (10<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) day following the day on which public announcement of the date of such meeting is first made, subject to applicable
              law.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 11 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="margin-left: 35.45pt; line-height: 1.25;">In no event shall the public announcement of an adjournment or postponement of a General Meeting commence a new time
      period (or extend any time period) for the giving of a Shareholder&#8217;s notice as described above.&#160; Subject to any requirements under the Companies Law, nominations of persons for election to the Board of Directors may only be made at an extraordinary
      meeting if directors are to be elected at such meeting (a) by or at the direction of the Board of Directors, or (b) by any shareholder who is entitled to vote at the meeting and who complies with the notice procedures set forth in this Article.&#160; Such
      request shall also set forth: (i) the name and address of the Proposing Shareholder making the request; (ii) a representation that the Proposing Shareholder is a holder of record of shares of the Company entitled to vote at such meeting and intends
      to appear in person or by proxy at the meeting; (iii) a description of all arrangements or understandings between the Proposing Shareholder and any other Person or Persons (naming such Person or Persons) in connection with the subject which is
      requested to be included in the agenda; (iv) a description of all Derivative Transactions (as defined below) by the Proposing Shareholder during the previous twelve (12) month period, including the date of the transactions and the class, series and
      number of securities involved in, and the material economic terms of, such Derivative Transactions; and (v) a declaration that all the information that is required under the Companies Law and any other applicable law to be provided to the Company in
      connection with such subject, if any, has been provided. Furthermore, the Board of Directors, may, in its discretion, to the extent it deems necessary, request that the Proposing Shareholder(s) provide additional information necessary so as to
      include a subject in the agenda of a General Meeting, as the Board of Directors may reasonably require.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="margin-left: 35.45pt; line-height: 1.25;">A &#8220;<font style="font-weight: bold;">Derivative
        Transaction</font>&#8221; means any agreement, arrangement, interest or understanding entered into by, or on behalf or for the benefit of, any Proposing Shareholder or any of its affiliates or associates, whether of record or beneficial: (a) the value of
      which is derived in whole or in part from the value of any class or series of shares or other securities of the Company, (b) which otherwise provides any direct or indirect opportunity to gain or share in any gain derived from a change in the value
      of securities of the Company, (c) the effect or intent of which is to mitigate loss, manage risk or benefit of security value or price changes, or (d) which provides the right to vote or increase or decrease the voting power of such Proposing
      Shareholder, or any of its affiliates or associates, with respect to any shares or other securities of the Company, which agreement, arrangement, interest or understanding may include, without limitation, any option, warrant, debt position, note,
      bond, convertible security, swap, stock appreciation right, short position, profit interest, hedge, right to dividends, voting agreement, performance-related fee or arrangement to borrow or lend shares (whether or not subject to payment, settlement,
      exercise or conversion in any such class or series), and any proportionate interest of such Proposing Shareholder in the shares or other securities of the Company held by any general or limited partnership, or any limited liability company, of which
      such Proposing Shareholder is, directly or indirectly, a general partner or managing member.&#160; The information required pursuant to this Article 56 shall be updated as of the record date of the General Meeting, five (5) business days before the
      General Meeting, and any adjournment or postponement thereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 12 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z75400f226c564821bc467d100f0ded8d" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">57.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Subject to Article 65 below, in the event that the Company has established that an adjourned meeting shall be held on such date which is later than the date provided
              for in Section 78(b) of the Companies Law, such later date shall be included in the notice. The Company may add additional places for Shareholders to review the full text of the proposed resolutions, including an internet site.&#160; The notice
              shall be provided in the manner prescribed below under the heading &#8220;Notices&#8221; in Articles 128 to 131 below.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROCEEDINGS AT GENERAL MEETING</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zab24272c2c554cccbb24bde7151fd7f6" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">58.</td>
          <td style="width: auto; vertical-align: top;">
            <div>No business shall be conducted at a General Meeting unless a quorum is present, and no resolution shall be passed unless a quorum is present at the time the resolution
              is voted on. Except in cases where it is otherwise stipulated, a quorum shall be constituted when there are personally present, or represented by proxy, at least two (2) Shareholders who hold, in the aggregate, at least 25% of the voting
              rights in the Company. A proxy may be deemed to be two (2) or more Shareholders pursuant to the number of Shareholders he represents.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcddf8ac9467a4ec1a5d7067796865291" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">59.</td>
          <td style="width: auto; vertical-align: top;">
            <div>If within half an hour from the time appointed for the meeting, a quorum is not present, without there being an obligation to notify the Shareholders to that effect,
              the meeting shall be adjourned to the same day, in the following week, at the same hour and at the same place or to a later time and date if so specified in the notice of the meeting, unless such day shall fall on a statutory holiday (either
              in Israel or in the United States), in which case the meeting will be adjourned to the first business day afterwards which is not a statutory holiday.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="margin-left: 35.45pt; line-height: 1.25;">If the original meeting was convened upon requisition under Section 63 of the Companies Law, one or more
      Shareholders, present in person or by proxy, and holding the number of shares required for making such requisition, shall constitute a quorum at the adjourned meeting, but in any other case any two (2) Shareholders present in person or by proxy,
      shall constitute a quorum at the adjourned meeting.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z99a692ec15214ac29ac8fa697792579d" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">60.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Chairman of the Board of Directors, or any other Person appointed for this purpose by the Board of Directors, shall preside at every General Meeting.&#160; If within
              fifteen (15) minutes from the time appointed for the meeting, the designated chairman for the meeting shall not be present, the Shareholders present at the meeting shall elect one of their number to serve as chairman of the meeting.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze891d8e8145f4013b8bfbf6f4ef18f06" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">61.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Resolutions at the General Meeting shall be passed in accordance with the definition of &#8220;Resolution&#8221; set forth in Article 1.1 above, unless otherwise required by
              Companies Law or these Articles. Every vote at a General Meeting shall be conducted according to the number of votes to which each Shareholder is entitled on the basis of the number of Ordinary Shares held by such Shareholder (in accordance
              with the provisions of Article 7.1 above).</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z614450ea888c422ea7281a6ed7bcf7d6" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">62.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Where a poll has been demanded, the chairman of the meeting shall be entitled - but not obliged - to accede to the demand. Where the chairman of the meeting has decided
              to hold a poll, such poll shall be held in such manner, at such time and at such place as the chairman of the meeting directs, either immediately or after an interval or postponement, or in any other way, and the results of the vote shall be
              deemed to be the Resolution at the meeting at which the poll was demanded. A person demanding a poll may withdraw his demand prior to the poll being held.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 13 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z67c2f4fa2967426ea3041ac9b474ac4a" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">63.</td>
          <td style="width: auto; vertical-align: top;">
            <div>A demand for the holding of a poll shall not prevent the continued business of the meeting on all other questions apart of the question in respect of which a poll was
              demanded.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z063ec44813e6404ca8d8b127c04f3e01" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">64.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The announcement by the chairman of the meeting that a Resolution has been passed unanimously or by a particular majority, or has been rejected, and a note recorded to
              that effect in the Company&#8217;s minute book, shall serve as <font style="font-style: italic;">prima facie </font>proof of such fact, and there shall be no necessity for proving the
              number of votes or the proportion of votes given for or against the Resolution, unless otherwise required under applicable law and regulation.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8e259204adb14d599f8850bbd699a4ce" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">65.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Chairman of a General Meeting at which a quorum is present may, with the consent of holders of a majority of the voting power represented in person and by proxy and
              voting on the question of adjournment, adjourn the meeting from time to time and from place to place, but no business shall be transacted at any adjourned meeting except business which might lawfully have been transacted at the meeting as
              originally called. Subject to these Articles, it shall not be necessary to give any notice of an adjournment unless the meeting is adjourned for more than twenty-one (21) days, in which case notice thereof shall be given in the manner
              required for the meeting as originally called.&#160; Where a General Meeting has been adjourned without changing its agenda, to a date which is not more than twenty-one (21) days, notices shall be given for the new date, as early as possible, and
              by no later than seventy-two (72) hours before the General Meeting.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">VOTES OF SHAREHOLDERS</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfcdf16693dae4cf5ac024aa5b537461b" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">66.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The voting rights of every shareholder entitled to vote at a General Meeting shall be as set forth in Article 7.1 of these Articles.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc98aea5733fd436c8ecdb103792a0819" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">67.</td>
          <td style="width: auto; vertical-align: top;">
            <div>In the case of joint Shareholders, the vote of the senior joint holder, given personally or by proxy, shall be accepted, to the exclusion of the vote of the remaining
              joint Shareholders, and for these purposes the senior of the joint Shareholders shall be the Person amongst the joint holders whose name appears first in the Register.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6a00380491674166ab1620b8dbeadb64" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">68.</td>
          <td style="width: auto; vertical-align: top;">
            <div>A Shareholder who is an Incapacitated Person may vote solely through his guardian or other person who fulfills the function of such guardian and who was appointed by a
              court, and any guardian or other person as aforesaid shall be entitled to vote by way of a proxy, or in such manner as the court directs.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1ebe5010ff434768916fdfe51e11a98f" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">69.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Any corporation which is a Shareholder of the Company shall be entitled, by way of resolution of its board of directors or another organ which manages said corporation,
              to appoint such person which it deems fit, whether or not such person is a Shareholder of the Company, to act as its representative at any General Meeting of the Company or at a meeting of a class of shares in the Company which such
              corporation is entitled to attend and to vote thereat, and the appointed as aforesaid shall be entitled, on behalf of the corporation whom he represents, to exercise all of the same powers and authorities which the corporation itself could
              have exercised had it been a natural person holding shares of the Company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 14 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7b99ef2e112a49fd8521bba33c32bec9" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">70.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Every Shareholder who is entitled to attend and vote at a General Meeting of the Company, shall be entitled to appoint a proxy. A proxy can be appointed by more than
              one Shareholder, and vote in different ways on behalf of each principal.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="margin-left: 35.45pt; line-height: 1.25;">The instrument appointing a proxy shall be in writing signed by the Person making the appointment or by his
      authorized representative, and if the Person making the appointment is a corporation, the power of attorney shall be signed in the manner in which the corporation signs on documents which bind it, and a certificate of an attorney with regard to the
      authority of the signatories to bind the corporation shall be attached thereto. The proxy need not be a shareholder of the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdd506011d2a4402282cc416cd41a1150" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">71.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The instrument appointing a proxy, or a copy thereof certified by an attorney, shall be lodged at the Office, or at such other place as the Board of Directors shall
              specify, not less than forty-eight (48) hours prior to the meeting at which the proxy intends to vote based on such instrument of proxy. Notwithstanding the above, the chairman of the meeting shall have the right to waive the time requirement
              provided above with respect to all instruments of proxies and to accept any and all instruments of proxy until the beginning of a General Meeting. A document appointing a proxy shall be valid for every adjourned meeting of the meeting to
              which the document relates.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3a323458b33448a8b0843108f386aabf" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">72.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Every instrument appointing a proxy, whether for a meeting specifically indicated, or otherwise, shall, as far as circumstances permit, be substantially in the
              following form, or in any other form approved by the Board of Directors:</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="margin-left: 56.7pt; line-height: 1.25;">I ______________ of ______________ being a shareholder holding voting shares in MediWound Ltd., hereby appoint Mr.
      ______________ of ______________ or failing him, Mr. ______________ of ______________, or failing him, Mr. ______________ of ______________, to vote in my name, place and stead at the (ordinary/extraordinary) General Meeting of the Company to be held
      on the ____ of ______ 20__, and at any adjourned meeting thereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="margin-left: 56.7pt; line-height: 1.25;">In witness whereof I have hereto set my hand on the _____ day of _____.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z18fa49e1d0644ff9bbcd643b3db6d67a" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">73.</td>
          <td style="width: auto; vertical-align: top;">
            <div>No Shareholder shall be entitled to vote at a General Meeting unless he has paid all of the calls and all of the amounts due from him, for the time being, in respect of
              his shares.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z95b9fc4af1ac4e63914e7ca4ca9fa230" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">74.</td>
          <td style="width: auto; vertical-align: top;">
            <div>A vote given in accordance with the instructions contained in an instrument appointing a proxy shall be valid notwithstanding the death or bankruptcy of the appointer,
              or the revocation of the proxy, or the transfer of the share in respect of which the vote was given as aforesaid, unless notice in writing of the death, revocation or transfer is received at the Office, or by the chairman of the meeting,
              prior to such vote.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb7a0af491d464417b52af56c5d1a070f" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">75.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Subject to the Companies Law, an instrument appointing a proxy shall be deemed revoked (i) upon receipt by the Company or the chairman of the meeting, subsequent to
              receipt by the Company of such instrument, of written notice signed by the person signing such instrument or by the Shareholder appointing such proxy canceling the appointment thereunder (or the authority pursuant to which such instrument was
              signed) or of an instrument appointing a different proxy, provided such notice of cancellation or instrument appointing a different proxy were so received at the place and within the time for delivery of the instrument revoked thereby as
              referred to in Article 71 hereof, or (ii) if the appointing shareholder is present in person at the meeting for which such instrument of proxy was delivered, upon receipt by the chairman of such meeting of written notice from such shareholder
              of the revocation of such appointment, or if and when such Shareholder votes at such meeting. A vote cast in accordance with an instrument appointing a proxy shall be valid notwithstanding the revocation or purported cancellation of the
              appointment, or the presence in person or vote of the appointing Shareholder at a meeting for which it was rendered, unless such instrument of appointment was deemed revoked in accordance with the foregoing provisions of this Article 75 at or
              prior to the time such vote was cast.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 15 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">THE BOARD OF DIRECTORS</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z57a40a33ee744211878bf87a5503aa06" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">76.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Unless otherwise resolved by a Resolution, the prescribed number of Directors of the Company shall be between five (5) and nine (9) (including the External Directors),
              as may be fixed, from time to time, by the Board of Directors. At any time the minimum number of Directors (other than the External Directors) shall not fall below three (3). Any Director shall be eligible for re-election upon termination of
              his term of office, subject to applicable law.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z27831762ca9a4d8a87eb2ff5f48479ac" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">77.</td>
          <td style="width: auto; vertical-align: top;"><br>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table class="DSPFListTable" id="z297b239b2d3b4eb7a458dfcd9fd9090b" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">77.1.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Prior to every annual General Meeting of the Company, the Board of Directors of the Company (or a Committee of Directors) shall
                select, via a resolution adopted by a majority of the Board of Directors (or such committee), a number of persons to be proposed to the Shareholders for election as directors of the Company at such annual General Meeting for service until
                the annual General Meeting to be held in the next year following the year of their election (the &#8220;<font style="font-weight: bold;">Nominees</font>&#8221;). Any shareholder entitled
                under applicable law to nominate one or more persons for election as directors at a General Meeting (each such person, an<font style="font-weight: bold; font-style: italic;">&#160;</font>&#8220;<font style="font-weight: bold;">Alternate Nominee</font>&#8221;) may make such nomination only if a written notice of such shareholder&#8217;s intent to make such nomination or nominations has
                been given to the Secretary of the Company (or, if there is no such Secretary, the Chief Executive Officer).&#160; Each such notice shall set forth: (a) the name and address of the shareholder who intends to make the nomination and of the
                Alternate Nominees; (b) a representation that the shareholder is a holder of record of shares of the Company entitled to vote at such meeting (including the number of shares held of record by the shareholder) and intends to appear in person
                or by proxy at the meeting to nominate the Alternate Nominees; (c) a description of all arrangements or understandings between the shareholder and each Alternate Nominee and any other person or persons (naming such person or persons)
                pursuant to which the nomination or nominations are to be made by the shareholder; and (d) the consent of each Alternate Nominee to serve as a director of the Company if so elected and a declaration signed by each Alternate Nominee
                declaring that there is no limitation under the Companies Law for the appointment of such a nominee and that all of the information that is required under the Companies Law to be provided to the Company in connection with such an
                appointment has been provided.&#160; The Board of Directors may refuse to acknowledge the nomination of any person not made in compliance with the foregoing procedure.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;">&#160;</div>
    <div>
      <table class="DSPFListTable" id="z1a214c2d92734bab9791392c4a11bb6b" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">77.2.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Nominees or Alternate Nominees shall be elected by a Resolution at the annual General Meeting at which they are subject to
                election.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;">&#160;</div>
    <div>
      <table class="DSPFListTable" id="zb250ac4e8cc649e588ce0ef9db88362d" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">77.3.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Every director shall hold office until the end of the next annual General Meeting following the annual General Meeting at which he
                was elected, unless his office is vacated in accordance with Article 79 or Article 82 below. If, at an annual General Meeting, no Nominees or Alternate Nominees are elected, the directors then in office shall continue to hold office until
                the convening of a General Meeting at which Nominees or Alternate Nominees shall be elected.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 16 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div>
      <table class="DSPFListTable" id="z99a523ac18eb47cdac457068738cffad" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">77.4.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">If the office(s) of members(s) of the Board of Directors shall be vacated, the remaining members of the Board of Directors shall be
                entitled to appoint additional director(s) in place of the director(s) whose office(s) have been vacated, for a term of office equal to the remaining period of the term of office of the director(s) whose office(s) have been vacated.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2178da9462194442b31fe5d0e6f0b55b" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">78.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Directors in their capacity as such shall be entitled to receive remuneration as shall be determined in compliance with the Companies Law and the regulations
              promulgated thereunder.&#160; The conditions (including remuneration) of the terms of office of members of the Board of Directors shall be decided by the Board of Directors and/or any committee thereof, but the same shall be valid only if ratified
              in the manner required under the Companies Law.&#160; The remuneration of Directors may be fixed as an overall payment or other consideration and/or as a payment or other consideration in respect of attendance at meetings of the Board of
              Directors.&#160; In addition to his remuneration, each Director shall be entitled to be reimbursed, retroactively or in advance, in respect of his reasonable expenses connected with performing his functions and services as a Director.&#160; Such
              entitlement shall be determined in accordance with, and shall be subject to, a specific resolution or policy adopted by the Board of Directors regarding such matter and in accordance with the requirements of applicable law.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd1314a6ced864c28a977c5df3c3e6fb6" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">79.</td>
          <td style="width: auto; vertical-align: top;"><br>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table class="DSPFListTable" id="zd65ac0da561842c89fdf615172d225eb" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">79.1.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Subject to the provisions of the Companies Law with regard to External Directors and subject to Article 77 above and
                Article 82 below, the office of a member of the Board of Directors shall be vacated in any one of the following events:</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z600f7dcf78024cf89d7109d118c72f19" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 72.8pt;"><br>
          </td>
          <td style="width: 42.5pt; vertical-align: top;">79.1.1.</td>
          <td style="width: auto; vertical-align: top;">
            <div>if he resigns his office by way of a letter signed by him, lodged at the Office;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf6185d29c7f943dea8bc40cefd564a9c" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 72.8pt;"><br>
          </td>
          <td style="width: 42.5pt; vertical-align: top;">79.1.2.</td>
          <td style="width: auto; vertical-align: top;">
            <div>if he is declared bankrupt;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z39249ab6daf1411c9ea7d5ef64aeef89" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 72.8pt;"><br>
          </td>
          <td style="width: 42.5pt; vertical-align: top;">79.1.3.</td>
          <td style="width: auto; vertical-align: top;">
            <div>if he becomes insane or unsound of mind;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0b2d47feb9794c50a42814ab2c9b6fda" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 72.8pt;"><br>
          </td>
          <td style="width: 42.5pt; vertical-align: top;">79.1.4.</td>
          <td style="width: auto; vertical-align: top;">
            <div>upon his death;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z38eb9f6df6454956ab076c44e2ee5f65" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 72.8pt;"><br>
          </td>
          <td style="width: 42.5pt; vertical-align: top;">79.1.5.</td>
          <td style="width: auto; vertical-align: top;">
            <div>if he is prevented by applicable law from serving as a Director of the Company;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7b754391c8fd469fb2de549b64ce57cb" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 72.8pt;"><br>
          </td>
          <td style="width: 42.5pt; vertical-align: top;">79.1.6.</td>
          <td style="width: auto; vertical-align: top;">
            <div>if the Board terminates his office according to Section 231 of the Companies Law;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcd93a22521c841d38058639a8d112fec" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 72.8pt;"><br>
          </td>
          <td style="width: 42.5pt; vertical-align: top;">79.1.7.</td>
          <td style="width: auto; vertical-align: top;">
            <div>if a court order is given in accordance with Section 233 of the Companies Law;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z00b54487333a4a12b22ef67e67c1d57a" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 72.8pt;"><br>
          </td>
          <td style="width: 42.5pt; vertical-align: top;">79.1.8.</td>
          <td style="width: auto; vertical-align: top;">
            <div>if he is removed from office by a Resolution at a General Meeting of the Company adopted by a majority of the voting power in the Company; or</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9cf3aa3704314ac3913ed1acd32dcdbf" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 72.8pt;"><br>
          </td>
          <td style="width: 42.5pt; vertical-align: top;">79.1.9.</td>
          <td style="width: auto; vertical-align: top;">
            <div>if his period of office has terminated in accordance with the provisions of these Articles.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table class="DSPFListTable" id="z33a97f3ba90448b1b0ef4f46b720bb51" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">79.2.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">If the office of a member of the Board of Directors should be vacated, the remaining members of the Board of Directors shall be
                entitled to act for all purposes, for as long as their number does not fall below the minimum, for the time being, specified for the Directors, as prescribed in Article 76 above. Should their number fall below the aforesaid minimum, the
                Directors shall not be entitled to act, except for the appointment of additional directors, or for the purpose of calling a General Meeting for the appointment of additional directors, or for the purpose of calling a General Meeting for the
                appointment of a new Board of Directors.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 17 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div>
      <table class="DSPFListTable" id="zebb6b9d8349440c7944dfc05accf9a99" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">79.3.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The office of an External Director shall be vacated only in accordance with the provisions for the vacation of office and the
                removal of External Directors under the Companies Law.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; margin-left: 27pt; line-height: 1.25; font-weight: bold;">OTHER PROVISIONS REGARDING DIRECTORS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -35.45pt; margin-left: 35.45pt; line-height: 1.25;">80.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table class="DSPFListTable" id="za7ca8fc48f0742b6b5e8c32e3aacd9d1" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">80.1.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Subject to any mandatory provisions of applicable law, a Director shall not be disqualified by virtue of his office from holding
                another office in the Company or in any other company in which the Company is a shareholder or in which it has any other form of interest, or of entering into a contract with the Company, either as seller or buyer or otherwise. Likewise, no
                contract made by the Company or on its behalf in which a Director has any form of interest may be nullified and a Director shall not be obliged to account to the Company for any profit deriving from such office, or resulting from such
                contract, merely by virtue of the fact that he serves as a Director or by reason of the fiduciary relationship thereby created, but such Director shall be obliged to disclose to the Board of Directors the nature of any such interest at the
                first opportunity.</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
              </div>
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                <div style="line-height: 1.25;">A general notice to the effect that a Director is a shareholder or has any other form of interest in a particular firm
                  or a particular company and that he must be deemed to have an interest in any business with such firm or company shall be deemed to be adequate disclosure for purposes of this Article in relation to such Director, and after such general
                  notice has been given, such Director shall not be obliged to give special notice in relation to any particular business with such firm or such company.</div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table class="DSPFListTable" id="zf591c63647bb46caa00ca60d741f87b4" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">80.2.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Subject to the provisions of the Companies Law and these Articles, the Company shall be entitled to enter into a transaction in
                which an Office Holder of the Company has a personal interest, directly or indirectly, and may enter into any contract or otherwise transact any business with any third party in which contract or business an Office Holder has a personal
                interest, directly or indirectly.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze95aab6b1e924fb599d3e1b6e4a4fa28" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">81.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors shall elect one (1) or more of its members to serve as the Chairman of the Board of Directors (the &#8220;<font style="font-weight: bold;">Chairman of the Board of Directors</font>&#8221;), provided that, subject to the provisions of Section 121(c) of the Companies Law, the Chief Executive Officer of the Company shall not serve as
              Chairman of the Board of Directors. The office of Chairman of the Board of Directors shall be vacated in each of the cases mentioned in Articles 79.1 above and 82 below. The Board of Directors may also elect one or more members to serve as
              Vice Chairman, who shall have such duties and authorities as the Board of Directors may assign to him or her.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1ee55415688449928914da67c59a23a6" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">82.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Subject to the relevant provisions of the Companies Law, the Company may, in a General Meeting, by a Resolution adopted by a majority of the voting power in the
              Company, dismiss any Director, prior to the end of his term of office and the Board of Directors shall be entitled, by regular majority, with the exception of the External Directors who shall be appointed and removed in accordance with the
              Companies Law, to appoint another individual in his place as a Director. The individual so appointed shall hold such office only for that period of time during which the director whom he replaces would have held office.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 18 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2039dbb4af184afa9916a8ffb6ddbf90" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">83.</td>
          <td style="width: auto; vertical-align: top;">
            <div>A Director shall not be obliged to hold any share in the Company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CHIEF EXECUTIVE OFFICER</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -35.45pt; margin-left: 35.45pt; line-height: 1.25;">84.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table class="DSPFListTable" id="za2f48eb635db4d90b6f5cc074650a07c" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">84.1.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Board of Directors shall, from time to time, appoint a Chief Executive Officer and subject to the provisions of the Companies
                Law delineate his powers and authorities and his remuneration. Subject to any contract between the Chief Executive Officer and the Company, the Board of Directors may dismiss him or replace him at any time it deems fit.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;">&#160;</div>
    <div>
      <table class="DSPFListTable" id="zb9ac6189478d43c38c0d874076b486af" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">84.2.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">A Chief Executive Officer need not be a Director or Shareholder.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;">&#160;</div>
    <table class="DSPFListTable" id="4098573ef9f4479e891c58f59bbc7231" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"></td>
          <td style="width: 35.45pt; vertical-align: top;"><br>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Subject to the provisions of any contract between the Chief Executive Officer and the Company, if the Chief Executive
              Officer is also a Director, all of the same provisions with regard to appointment, resignation and removal from office shall apply to the Chief Executive Officer in his capacity as a Director, as apply to the Company's other Directors.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div>
      <table class="DSPFListTable" id="z4a122a48d1514cc7a2bd25f19cbc5497" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">84.3.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Board of Directors shall be entitled from time to time to delegate to the Chief Executive Officer for the time being such of
                the powers it has pursuant to these Articles as they deem appropriate, and the Board of Directors shall be entitled to grant such powers for such period and for such purposes and on such conditions and with such restrictions as it deem
                appropriate, and it shall be entitled to grant such powers without renouncing the powers and authorities of the Board of Directors in such regard, and it may, from time to time, revoke, annul and alter such delegated powers and authorities,
                in whole or in part.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze1f1ff8032a24674ae350ab36dc97339" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">84.4.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Subject to the provisions of any applicable law, the remuneration of the Chief Executive Officer shall be fixed from time to time by the Board of Directors (and, so
              long as required by the Companies Law, shall be approved by the Compensation Committee and by the Shareholders unless exempted from Shareholders approval) and such remuneration may be in the form of a fixed salary or commissions or a
              participation in profits, or in any other manner which may be decided by the Board of Directors (and approved according to this Article 84.4).</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROCEEDINGS OF THE BOARD OF DIRECTORS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -35.45pt; margin-left: 35.45pt; line-height: 1.25;">85.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table class="DSPFListTable" id="z9e7286fac2344812b86ea25b8f999389" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">85.1.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Board of Directors shall convene for a meeting at least once every fiscal quarter.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;">&#160;</div>
    <div>
      <table class="DSPFListTable" id="z99e25cf2e6c74cf6ad9a4ed45a8a7d3a" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">85.2.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Board of Directors may meet in order to exercise its powers pursuant to Section 92 of the Companies Law, including without
                limitation to supervise the Company&#8217;s affairs, and it may, subject to the provisions of the Companies Law, adjourn its meetings and regulate its proceedings and operations as it deems fit. It may also prescribe the quorum required for the
                conduct of business. Until otherwise decided a quorum shall be constituted if a majority of the Directors holding office for the time being are present.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 19 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div>
      <table class="DSPFListTable" id="zab106d1d21084c328bf57b7d5006c4b9" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">85.3.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Should a Director or Directors be barred from being present and voting at a meeting of the Board of Directors pursuant to Section
                278 of the Companies Law, the quorum shall be a majority of the Directors entitled to be present and to vote at the meeting of the Board of Directors.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2d1042851fad4344b6874f8b326e9342" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">86.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Any Director, the Chief Executive Officer or the auditor of the Company in the event stipulated in Section 169 of the Companies Law, may, at any time, demand the
              convening of a meeting of the Board of Directors. The Chairman of the Board shall be obliged, on such demand, to call such meeting on the date requested by the Director, the Chief Executive Officer or the auditor of the Company soliciting
              such a meeting, provided that proper notice pursuant to Article 87 is given.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfd7cd069e0954015be569da02e36d1dd" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">87.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Every Director shall be entitled to receive notice of meetings of the Board of Directors, and such notice may be in writing or by facsimile, or electronic mail, sent to
              the last address (whether physical or electronic) or facsimile number given by the Director for purposes of receiving notices, provided that the notice shall be given at least a reasonable amount of time prior to the meeting and in no event
              less than 48 (forty eight) hours prior notice, unless the urgency of the matter(s) to be discussed at the meeting reasonably require(s) a shorter notice period.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze0d2017ffd5b4270949c6907dabcd731" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">88.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Every meeting of the Board of Directors at which a quorum is present shall have all the powers and authorities vested for the time being in the Board of Directors.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z313db29fe8d14ff3ad4b38d415a8a265" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">89.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Questions which arise at meetings of the Board of Directors shall be decided by a simple majority of the members of the Board of Directors attending such meeting and
              voting on such matter. In the case of an equality of votes of the Board of Directors, the Chairman of the Board of Directors shall not have a second or casting vote, and the proposal shall be deemed to be defeated.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="margin-left: 35.45pt; line-height: 1.25;">If the Chairman of the Board of Directors is not present within 30 (thirty) minutes after the time appointed for the
      meeting, the Directors present shall elect one of their members to preside at such meeting.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc5e3cf6f6b4646e99d9807e2c77c7274" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">90.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors may adopt resolutions, without actually convening a meeting of the Board of Directors, provided that all the Directors entitled to participate in
              the meeting and to vote on the subject brought for decision agree thereto. If resolutions are made as stated in this Article 90, the Chairman of the Board of Directors shall record minutes of the decisions stating the manner of voting of each
              Director on the subjects brought for decision, as well as the fact that all the Directors agreed to take the decision without actually convening.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z914f79d65ee648a7b690780399d14fa0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">91.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors may hold meetings by use of any means of communication, on condition that all participating Directors can hear each other at the same time. In
              the case of a resolution passed by way of a telephone call or any such other means of communication, a copy of the text of the resolution shall be sent, as soon as possible thereafter, to the Directors.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">GENERAL POWERS OF THE BOARD OF DIRECTORS</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9cbeeeb55cc24725a68bd78ecc8d5c37" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">92.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The supervision of the Company&#8217;s affairs shall be in the hands of the Board of Directors, which shall be entitled to exercise all of the powers and authorities to
              perform any act and deed which the Company is entitled to exercise and to perform in accordance with these Articles or according to the Companies Law, and in respect of which there is no provision or requirement in these Articles, or in the
              Companies Law or/and in the U.S. Rules, that such powers and authorities may be exercised or done by the Shareholders in a General Meeting or by a Committee of Directors.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 20 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z62681f59923d405d9913b36e1ce7125f" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">93.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors may, as it deems fit and subject to any applicable law, delegate to a committee (a &#8220;<font style="font-weight: bold;">Committee of Directors</font>&#8221;) certain of its powers and authorities, in whole or in part (as appropriate). The curtailment or revocation of the powers and authorities of a Committee of Directors by the
              Board of Directors shall not invalidate a prior act of such Committee of Directors or an act taken in accordance with its instructions, which would have been valid had the powers and authorities of the Committee of Directors not been altered
              or revoked by the Board of Directors. Subject to applicable law, a Committee of Directors may be comprised of one (1) Director or of several Directors, and in the case of a Committee of Directors that is appointed to advise the Board of
              Directors only, persons who are not Directors may be appointed to it.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf70c6600033c4c4fb2cceb17ff52a64c" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">94.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The meetings and proceedings of every such Committee of Directors which is comprised of 2 (two) or more members shall be conducted in accordance with the provisions
              contained in these Articles in regard to the conduct of meetings and proceedings of the Board of Directors to the extent that the same are suitable for such committee, and so long as no provisions have been adopted in replacement thereof by
              the Board of Directors.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">RATIFICATION OF ACTIONS</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd870f3396ca742d98a83204da3cba13e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">95.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Subject to the Companies Law, all acts taken in good faith by the Board of Directors and/or a Committee of Directors or by an individual acting as a member thereof
              shall be valid even if it is subsequently discovered that there was a defect in the appointment of the Board of Directors, the Committee of Directors or the member, as the case may be, or that the members, or one of them, was/were
              disqualified from being appointed as a Director/s or to a Committee of Directors.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -35.45pt; margin-left: 35.45pt; line-height: 1.25;">96.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table class="DSPFListTable" id="zbcf69e582a08471c84aaf278cda5ba70" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">96.1.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Board of Directors or any Committee of Directors may ratify any act the performance of which at the time of the ratification
                was within the scope of the authority of the Board of Directors or the relevant Committee of Directors.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;">&#160;</div>
    <div>
      <table class="DSPFListTable" id="ze612c68b9844410aa223571fb8689e2a" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">96.2.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The General Meeting shall be entitled to ratify any act taken by the Board of Directors and/or any Committee of Directors without
                authority or which was tainted by some other defect.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;">&#160;</div>
    <div>
      <table class="DSPFListTable" id="zc7eef0fcf66941c487d95a2809005c0f" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 35.45pt;">&#160;</td>
            <td style="text-align: right; vertical-align: top; width: 35.45pt;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">96.3.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">From the time of the ratification, every act ratified as aforesaid, shall be treated as though lawfully performed from the outset.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z35bd2d9575ff4fb0bfc4750d0937712b" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">97.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors may, from time to time, in its absolute discretion, borrow or secure any amounts of money required by the Company for the conduct of its
              business.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z892351bdeb24472fa36ac05fbdfb8508" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">98.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors shall be entitled to raise or secure the repayment of an amount obtained by them, in such way and on such conditions and times as they deem fit.
              The Board of Directors shall be entitled to issue documents of undertaking, such as options, debentures or debenture stock, whether linked or redeemable, convertible debentures or debentures convertible into other securities, or debentures
              which carry a right to purchase shares or to purchase other securities, or any mortgage, pledge, collateral or other charge over the property of the Company and its undertaking, in whole or in part, whether present or future, including the
              uncalled share capital or the share capital which has been called but not yet paid.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="margin-left: 35.45pt; line-height: 1.25;">The deeds of undertaking, debentures of various types or other forms of collateral security may be issued at a
      discount, at a premium or otherwise and with such preferential or deferred or other rights, as the Board of Directors shall, from time to time, decide.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 21 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">SIGNING POWERS</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd0e8122958644cd7a517d3bc3cabeb8f" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">99.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Subject to any other resolution on the subject passed by the Board of Directors, the Company shall be bound only pursuant to a document in writing bearing its seal or
              its rubber stamp or its printed name, and the signature of whomever may be authorized by the Board of Directors, which shall be entitled to empower any person, either alone or jointly with another, even if he is not a Shareholder or a
              Director, to sign and act in the name and on behalf of the Company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze093f86e60f3460a9b4ec70baff511ee" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">100.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors shall be entitled to prescribe separate signing power in regard to different businesses of the Company and in respect of the limit of the amounts
              in respect of which various persons shall be authorized to sign.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">SECRETARY, OFFICE-HOLDERS, CLERKS AND REPRESENTATIVES</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za318a552075646c8b98ac7e256d14401" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">101.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors shall be entitled, from time to time, to appoint, or to delegate to the Chief Executive Officer, either alone or together with other persons
              designated by the Board of Directors, the ability to appoint Office Holders (other than Directors), a Secretary for the Company, employees and agents to such permanent, temporary or special positions, and to specify and change their titles,
              authorities and duties, and may set, or delegate to the Chief Executive Officer, either alone or together with other persons designated by the Board of Directors, the ability to set salaries, bonuses and other compensation of any employee or
              agent who is not an Office Holder.&#160; Salaries, bonuses and compensation of Office Holders who are not Directors shall be determined and approved by the Chief Executive Officer, and/or in such other manner as may be required from time to time
              under the Companies Law. The Board of Directors, or the Chief Executive Officer, either alone or together with other persons designated by the Board of Directors, (in the case of any Office Holder, employee or agent appointed thereby), shall
              be entitled at any time, in its, his or their (as applicable) sole and absolute discretion, to terminate the services of one of more of the foregoing persons (in the case of a Director, however, subject to compliance with Article 79 above),
              subject to any other requirements under applicable law.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z49accad7dd0c4a02bd7e09c73aab0c42" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">102.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors and the Chief Executive Officer may from time to time and at any time, subject to their powers under these Articles and the Companies Law,
              empower any person to serve as representative of the Company for such purposes and with such powers and authorities, instructions and discretions for such period and subject to such conditions as the Board of Directors (or the Chief Executive
              Officer, as the case may be) shall deem appropriate. Consistent with the preceding sentence, the Board of Directors (or the Chief Executive Officer, as the case may be) may grant such person, <font style="font-style: italic;">inter alia</font>, the power to transfer the authority, powers and discretions vested in him, in whole or in part. The Board of Directors may (or the Chief Executive Officer, as the case may
              be), from time to time, revoke, annul, vary or change any such power or authority, or all such powers or authorities collectively.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 22 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">DIVIDENDS, BONUS SHARES, FUNDS AND CAPITALIZATION OF FUNDS AND PROFITS</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1e06b92d560d4c1394eb4a4b633b1df5" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">103.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Unless otherwise permitted by the Companies Law, no dividends shall be paid other than out of the Company&#8217;s profits available for distribution as set forth in the
              Companies Law.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z332e749fd3724c15ab026beae116bb4f" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">104.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors may decide on the payment of a dividend or on the distribution of bonus shares.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z43fc0daf22624e779e661d9c7384e25b" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">105.</td>
          <td style="width: auto; vertical-align: top;">
            <div>A dividend in cash or bonus shares shall be paid or distributed, as the case may be, equally to the holders of the Ordinary Shares registered in the Register, pro rata
              to the nominal amount of capital paid up or credited as paid up on par value of the shares, without reference to any premium which may have been paid thereon. However, whenever the rights attached to any shares or the terms of issue of the
              shares do not provide otherwise, an amount paid on account of a share prior to the payment thereof having been called, or prior to the due date for payment thereof, and on which the Company is paying interest, shall not be taken into account
              for purposes of this Article as an amount paid-up on account of the share.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf75291b5f1d642d79e6aa5d99a07d09e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">106.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Unless other instructions are given, it shall be permissible to pay any dividend by way of a check or payment order to be sent by post to the registered address of the
              Shareholder or the Person entitled thereto, or in the case of joint Shareholders being registered, to the Shareholder whose name appears first in the Register in relation to the joint shareholding. Every such check shall be made in favor of
              the Person to whom it is sent. A receipt by the Person whose name, on the date of declaration of the dividend, was registered in the Register as the owner of the shares, or in the case of joint holders, by one of the joint holders, shall
              serve as a discharge with regard to all the payments made in connection with such share.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="margin-left: 35.45pt; line-height: 1.25;">The Board of Directors shall be entitled to invest any dividend which has not been claimed for a period of one (1)
      year after having been declared, or to make use thereof in any other way for the benefit of the Company until such time as it is claimed. The Company shall not be obliged to pay interest or linkage in respect of an unclaimed dividend. The payment by
      the Board of Directors of any unclaimed dividend into a separate account shall not constitute the Company a trustee in respect thereof, and any dividend unclaimed after a period of seven (7) years from the date of declaration of such dividend, shall
      be forfeited and shall revert to the Company, provided, however, that the Board of Directors may, at its discretion, cause the Company to pay any such dividend, or any part thereof, to a person who would have been entitled thereto had the same not
      reverted to the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z907f4fcf73d54b6db535e713251d2741" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">107.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Unless otherwise specified in the terms of issue of shares or securities convertible into, or which grant a right to purchase, shares, any shares that are fully paid-up
              or credited as paid-up shall at any time confer on their holders the right to participate in the full dividends and in any other distribution for which the determining date for the right to receive the same is the date at which the aforesaid
              shares were fully paid-up or credited as fully paid-up, as the case may be, or subsequent to such date.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze053373808b847db97cde3acc9c44f5b" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">108.</td>
          <td style="width: auto; vertical-align: top;">
            <div>A dividend or other beneficial rights in respect of shares shall not bear interest.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 23 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1f7e63c9df2f441ab23984a4102438db" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">109.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors shall be entitled to deduct from any dividend or other beneficial rights, all amounts of money which the holder of the share in respect of which
              the dividend is payable or in respect of which the other beneficial rights were given, may owe to the Company in respect of such share, whether or not the due date for payment thereof has arrived.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z25b2f45d27ac44558775aa8d8360380f" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">110.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors shall be entitled to retain any dividend or bonus shares or other beneficial rights in respect of a share in relation to which the Company has a
              lien, and to utilize any such amount or the proceeds received from the sale of any bonus shares or other beneficial rights, for the discharge of the debts or liabilities in respect of which the Company has a lien.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8bcc646c4206420fa097021cd7a42f92" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">111.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors may decide that a dividend is to be paid, in whole or in part, by way of a distribution of assets of the Company in kind, including by way of
              debentures or debenture stock of the Company, or shares or debentures or debenture stock of any other company, or in any other way.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z19465348ff5d4a839c541d078e61b8ef" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">112.</td>
          <td style="width: auto; vertical-align: top;"><br>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfa79a90c80f24a9899e36898def505bd" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">112.1.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors may, at any time and from time to time, decide that any portion of the amounts standing for the time being to the credit of any capital fund
              (including a fund created as a result of a revaluation of the assets of the Company), or which are held by the Company as profits available for distribution, shall be capitalized for distribution subject to and in accordance with the
              provisions of the Companies Law and of these Articles, amongst those Shareholders who are entitled thereto and pro rata to their entitlement under these Articles, provided that the same shall not be paid in cash but shall serve for the
              payment up in full either at par or with a premium as prescribed by the Company, of shares which have not yet been issued or of debentures of the Company which shall be allotted and distributed amongst the Shareholders in the aforesaid ratio
              as fully paid-up shares or debentures.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4faca798392944f594578366ffde5b74" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">112.2.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors shall be entitled to distribute bonus shares and to decide that the bonus shares shall be of the same class which confers on the Shareholders or
              the Persons entitled thereto the right to participate in the distribution of bonus shares, or may decide that the bonus shares shall be of a uniform class to be distributed to each of the Shareholders or Persons entitled to shares as
              aforesaid, without reference to the class of shares conferring the right to participate in the distribution on the holders of the shares or the Persons entitled thereto as aforesaid.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -35.45pt; margin-left: 35.45pt; line-height: 1.25;">113.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z05c79fbe3d7a4f869a2620fd4866521d" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">113.1.</td>
          <td style="width: auto; vertical-align: top;">
            <div>In every case that the Company issues bonus shares by way of a capitalization of profits or funds at a time at which securities issued by the Company are in circulation
              and confer on the holders thereof rights to convert the same into shares in the share capital of the Company, or options to purchase shares in the share capital of the Company (such rights of conversion or options shall henceforth be referred
              to as the &#8220;<font style="font-weight: bold;">Rights</font>&#8221;), the Board of Directors shall be entitled (in a case that the Rights or part thereof shall not be otherwise adjusted in
              accordance with the terms of their issue) to transfer to a special fund designated for the distribution of bonus shares in the future (to be called by any name that the Board of Directors may decide on and which shall henceforth be referred
              to as the &#8220;<font style="font-weight: bold;">Special Fund</font>&#8221;) an amount equivalent to the nominal amount of the share capital to which some or all of the Rights holders would
              have been entitled as a result of the issue of bonus shares, had they exercised their Rights prior to the determining date for the right to receive bonus shares, including rights to fractions of bonus shares, and in the case of a second or
              additional distribution of bonus shares in respect of which the Company acts pursuant to this Article, including entitlement stemming from a previous distribution of bonus shares.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 24 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zba4ce4a7f9b440e8bd85a24a18cc450e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">113.2.</td>
          <td style="width: auto; vertical-align: top;">
            <div>In the case of the allotment of shares by the Company as a consequence of the exercise of entitlement by the owners of shares in those cases in which the Board of
              Directors has made a transfer to the Special Fund in respect of the Rights pursuant to Article 113.1 above, the Board of Directors shall allot to each such shareholder, in addition to the shares to which he is entitled by virtue of having
              exercised his rights, such number of fully paid-up shares the nominal value of which is equivalent to the amount transferred to the Special Fund in respect of his rights, by way of a capitalization to be effected by the Board of Directors of
              an appropriate amount out of the Special Fund.&#160; The Board of Directors shall be entitled to decide on the manner of dealing with rights to fractions of shares in its sole discretion.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z79cb866320d84acc9399451f2376b7f1" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">113.3.</td>
          <td style="width: auto; vertical-align: top;">
            <div>If after any transfer to the Special Fund has been made the Rights should lapse, or the period should end for the exercise of Rights in respect of which the transfer
              was effected without such Rights being exercised, then any amount which was transferred to the Special Fund in respect of the aforesaid unexercised Rights shall be released from the Special Fund, and the Company may deal with the amount so
              released in any manner it would have been entitled to deal therewith had such amount not been transferred to the Special Fund.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z78430bfb58234ab8801463542c92de8f" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">114.</td>
          <td style="width: auto; vertical-align: top;">
            <div>For the implementation of any resolution regarding a distribution of shares or debentures by way of a capitalization of profits as aforesaid, the Board of Directors
              may:</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zab464135da804939898eccd4f19254bd" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">114.1.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Resolve any difficulty which arises or may arise in regard to the distribution in such manner as it deems fit and may take all of the steps that it deems appropriate in
              order to overcome such difficulty.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z43f3310e35d94966a3e6403517770d4b" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">114.2.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Issue certificates in respect of fractions of shares, or decide that fractions of less than an amount to be decided by the Board of Directors shall not be taken into
              account for purposes of adjusting the rights of the Shareholders or may sell the fractions of shares and pay the proceeds (net) to the Persons entitled thereto.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z302badd0364f4c5d8c0dfc2af4ff5a5e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">114.3.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Sign, or appoint a Person to sign, on behalf of the Shareholders on any contract or other document which may be required for purposes of giving effect to the
              distribution, and, in particular, shall be entitled to sign or appoint a Person who shall be entitled to appoint and submit a contract as referred to in Section 291 of the Companies Law.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z609731b931764239b864c4bdfedbf08e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">114.4.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Make any arrangement or other scheme which is required in the opinion of the Board of Directors in order to facilitate the distribution.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd24ee824beea47c285fee5b40d079ea7" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">115.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors shall be entitled, as it deems appropriate and expedient, to appoint trustees or nominees for those registered Shareholders who have failed to
              notify the Company of a change of their address and who have not applied to the Company in order to receive dividends, shares or debentures out of capital, or other benefits during the aforesaid period. Such trustees or nominees shall be
              appointed for the use, collection or receipt of dividends, shares or debentures out of capital and rights to subscribe for shares which have not yet been issued and which are offered to the Shareholders but they shall not be entitled to
              transfer the shares in respect of which they were appointed, or to vote on the basis of holding such shares.&#160; In all of the terms and conditions governing such trusts and the appointment of such nominees it shall be stipulated by the Company
              that upon the first demand by a beneficial holder of a share being held by the trustee or nominee, such trustee or nominee shall be obliged to return to such shareholder the share in question and/or all of those rights held by it on the
              Shareholder&#8217;s behalf (all as the case may be). Any act or arrangement effected by any such nominees or trustee and any agreement between the Board of Directors and a nominee or trustee shall be valid and binding in all respects.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 25 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4c28096d1ff74912a5f68c7125497638" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">116.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors may from time to time prescribe the manner for payment of dividends or the distribution of bonus shares and the arrangement connected therewith.
              Without derogating from the generality of the foregoing, the Board of Directors shall be entitled to pay any dividends or moneys in respect of shares by sending a check via the mails to the address of the holder of registered shares according
              to the address registered in the register of Shareholders. Any dispatch of a check as aforesaid shall be done at the risk of the shareholder.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="margin-left: 35.45pt; line-height: 1.25;">In those cases in which the Board of Directors specifies the payment of a dividend, distribution of shares or
      debentures out of capital, or the grant of a right to subscribe for shares which have not yet been issued and which are offered to the Shareholders against the delivery of an appropriate coupon attached to any share certificate, such payment,
      distribution or grant of right to subscribe against a suitable coupon to the holder of such coupon, shall constitute a discharge of the Company&#8217;s debt in respect of such operation as against any person claiming a right to such payment, distribution
      or grant of right to subscribe, as the case may be.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd175490cea5540008ef480e00d1b73ea" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">117.</td>
          <td style="width: auto; vertical-align: top;">
            <div>If two (2) or more Persons are registered as joint holders of a share, each of them shall be entitled to give a valid receipt in respect of any dividend, share or
              debenture out of capital, or other moneys, or benefits, paid or granted in respect of such share.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">BOOKS OF THE COMPANY</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6784048e3bc840af9dfeebca1490136a" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">118.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors shall comply with all the provisions of the Companies Law in regard to the recording of charges and the keeping and maintaining of a register of
              directors, register of Shareholders and register of charges.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb92def806cc2456d9d7a95ea3bde71c0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">119.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Any book, register and record that the Company is obliged to keep in accordance with the Companies Law or pursuant to these Articles shall be recorded in a regular
              book, or by digital, electronic or other means, as the Board of Directors shall decide.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8dbe26c8019a4f64ac92328fa3b8af7b" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">120.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Subject to and in accordance with the provisions of Sections 138 and 139 of the Companies Law, the Company may cause supplementary registers to be kept in any place
              outside Israel as the Board of Directors may deem fit, and, subject to all applicable requirements of the Companies Law, the Board of Directors may from time to time adopt such rules and procedures as it may deem fit in connection with the
              keeping of such supplementary registers.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 26 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">BOOKS OF ACCOUNT</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbf146918baae48888fc066ed68fe6c9e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">121.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Board of Directors shall keep proper books of account in accordance with the provisions of the Companies Law. The books of account shall be kept at the Office, or
              at such other place or places as the Board of Directors shall deem appropriate, and shall at all times be open to the inspection of members of the Board of Directors. A Shareholder of the Company who is not a member of the Board of Directors
              shall not have the right to inspect any books or accounts or documents of the Company, unless such right has been expressly granted to him by the Companies Law, or if he has been permitted to do so by the Board of Directors or by the
              Shareholders based on a Resolution adopted at a General Meeting.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0f5ec58d11304582a313d612c4ba7ae9" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">122.</td>
          <td style="width: auto; vertical-align: top;">
            <div>[RESERVED]</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8c2267064b154cefb4a00372bb90f09f" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">123.</td>
          <td style="width: auto; vertical-align: top;">
            <div>At least once each year the accounts of the Company and the correctness of the statement of income and the balance sheet shall be audited and confirmed by an
              independent auditor or auditors.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8aefdab16cab4775bace152232e3c783" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">124.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Company shall, in an annual General Meeting, appoint an independent auditor or auditors who shall hold such position until the next annual General Meeting, and
              their appointment, remuneration and rights and duties shall be subject to the provisions of the Companies Law, provided, however, that in exercising its authority to fix the remuneration of the auditor(s), the Shareholders in an annual
              General Meeting may, by a Resolution, act (and in the absence of any action in connection therewith shall be deemed to have so acted) to authorize the Board of Directors to fix such remuneration subject to such criteria or standards, if any,
              as may be provided in such Resolution, and if no such criteria or standards are so provided, such remuneration shall be fixed in an amount commensurate with both the volume and nature of the services rendered by the auditor(s).&#160; By an act
              appointing such auditors, the Company may appoint the auditor(s) to serve for a period of up to the end of completion of the audit of the yearly financial statements for the three (3) year period then ended.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z85a02216e1b44e25adea3bde1f8f3648" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">125.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The auditors shall be entitled to receive notices of every General Meeting of the Company and to attend such meetings and to express their opinions on all matters
              pertaining to their function as the auditors of the Company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2732e799150140cfa913b307318b0579" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">126.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Subject to the provisions of the Companies Law and the U.S. Rules, any act carried out by the auditors of the Company shall be valid as against any person doing
              business in good faith with the Company, notwithstanding any defect in the appointment or qualification of the auditors.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z88c9a1fe3c2d41eea796752370515585" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">127.</td>
          <td style="width: auto; vertical-align: top;">
            <div>For as long as the Company is a Public Company, as defined in the Companies Law, it shall appoint an internal auditor possessing the authorities set forth in the
              Companies Law. The internal auditor of the Company shall present all of its proposed work plans to the Audit Committee of the Board of Directors, which shall have the authority to approve them, subject to any modifications in its discretion.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">NOTICES</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -35.45pt; margin-left: 35.45pt; line-height: 1.25;">128.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcce298b0fbb64062a91c2668f4d39667" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">128.1.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Company may serve any written notice or other document on a Shareholder by way of delivery by hand, by facsimile transmission or by dispatch by prepaid registered
              mail to his address as recorded in the Register, or if there is no such recorded address, to the address given by him to the Company for the sending of notices to him.&#160; Notwithstanding the foregoing or any other provision to the contrary
              contained herein, notices or any other information or documents required to be delivered to a Shareholder shall be deemed to have been duly delivered if submitted, published, filed or lodged in any manner prescribed by applicable law. With
              respect to the manner of providing such notices or other disclosures, the Company may distinguish between the Shareholders listed on its regular Registry and those listed in any &#8220;additional registry&#8221;, as defined in Section 138(a) of the
              Companies Law, administered by a transfer agent or stock exchange registration company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 27 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5a309f656c4344fca4f8be72b613078c" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">128.2.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Any Shareholder may serve any written notice or other document on the Company by way of delivery by hand at the Office, by facsimile or email transmission to the
              Company or by dispatch by prepaid registered mail to the Company at the Office.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z958bb91ddedf4d1484168c599274341f" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">128.3.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Any notice or document which is delivered or sent to a Shareholder in accordance with these Articles shall be deemed to have been duly delivered and sent in respect of
              the shares held by him (whether in respect of shares held by him alone or jointly with others), notwithstanding the fact that such Shareholder has died or been declared bankrupt at such time (whether or not the Company knew of his death or
              bankruptcy), and shall be deemed to be sufficient delivery or dispatch to heirs, trustees, administrators or transferees and any other persons (if any) who have a right in the shares.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160; <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z72227e7cb5b94184a437120a29624137" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">128.4.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Any such notice or other document shall be deemed to have been served:</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc0bc600b279648a2b648c5b18863b526" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 63.8pt;"><br>
          </td>
          <td style="width: 44.2pt; vertical-align: top;">128.4.1.</td>
          <td style="width: auto; vertical-align: top;">
            <div>in the case of mailing, 48 hours after it has been posted, or when actually received by the addressee if sooner than 48 hours after it has been posted;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7dbc006bf0444153830e30c876b42505" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 63.8pt;"><br>
          </td>
          <td style="width: 44.2pt; vertical-align: top;">128.4.2.</td>
          <td style="width: auto; vertical-align: top;">
            <div>in the case of overnight air courier, on the next day following the day sent, with receipt confirmed by the courier, or when actually received by the addressee if
              sooner;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf60ecd3deeda496fb6e68f39aaa8f2bb" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 63.8pt;"><br>
          </td>
          <td style="width: 44.2pt; vertical-align: top;">128.4.3.</td>
          <td style="width: auto; vertical-align: top;">
            <div>in the case of personal delivery, when actually tendered in person to such Shareholder;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160; <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z644e3157adff40f384b9e6d798dd99ca" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 63.8pt;"><br>
          </td>
          <td style="width: 44.2pt; vertical-align: top;">128.4.4.</td>
          <td style="width: auto; vertical-align: top;">
            <div>in the case of facsimile or other electronic transmission (including email), the next day following the date on which the sender receives automatic electronic
              confirmation by the recipient&#8217;s facsimile machine or computer or other device that such notice was received by the addressee; or</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc76f90467236463e963bb19d50609e4d" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 63.8pt;"><br>
          </td>
          <td style="width: 44.2pt; vertical-align: top;">128.4.5.</td>
          <td style="width: auto; vertical-align: top;">
            <div>in the case a notice is, in fact, received by the addressee, when received, notwithstanding that it was defectively addressed or failed, in some other respect, to
              comply with the provisions of this Article 128.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160; <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0a70b278314944a0a9d053f832cad3db" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">129.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Any Shareholder whose address is not described in the Register, and who shall not have designated in writing an address for the receipt of notices, shall not be
              entitled to receive any notice from the Company.&#160; In the case of joint holders of a share, the Company shall be entitled to deliver a notice by dispatch to the joint holder whose name stands first in the Register in respect of such share.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za41212fbf6e24407bb07d428d94b64b2" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">130.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Whenever it is necessary to give notice of a particular number of days or a notice for another period, the day of delivery shall be counted in the number of calendar
              days or the period, unless otherwise specified.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z569651b09bde48898b9f5ab1e4fd3aad" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">131.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Notwithstanding anything to the contrary contained herein, notice by the Company of a General Meeting, containing the information required to be set forth in such
              notice under these Articles, which is published, within the time otherwise required for giving notice of such meeting, in:</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf90d6fbdd9e448d681340a85d9039ef1" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">131.1.</td>
          <td style="width: auto; vertical-align: top;">
            <div>at least two daily newspapers in the State of Israel shall be deemed to be notice of such meeting duly given, for the purposes of these Articles, to any Shareholder
              whose address as registered in the Register (or as designated in writing for the receipt of notices and other documents) is located in the State of Israel; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 28 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zae8234092efd4846ae77e9bbd65f8e40" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">131.2.</td>
          <td style="width: auto; vertical-align: top;">
            <div>one daily newspaper in New York, NY, United States, and in one international wire service shall be deemed to be notice of such meeting duly given, for the purposes of
              these Articles, to any shareholder whose address as registered in the Register (or as designated in writing for the receipt of notices and other documents) is located outside the State of Israel.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">INSURANCE, INDEMNITY AND EXCULPATION</div>
    <div style="line-height: 1.25">&#160; <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z317fd377e97b4bb7b1b8679153003c8e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">132.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Subject to the provisions of the Companies Law, the Company shall be entitled to enter into a contract to insure all or part of the liability of an Office Holder of the
              Company, imposed on him in consequence of an act which he has performed by virtue of being an Office Holder, in respect of any of the following:</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcf4dd592b42344908e8b85850d90fd3a" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">132.1.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The breach of a duty of care to the Company or to any other Person;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160; <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z804559eb97ab48fab0800b8f72ccbaee" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">132.2.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The breach of a fiduciary duty to the Company, provided that the Office Holder acted in good faith and had reasonable grounds for believing that the action would not
              adversely affect the best interests of the Company;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z524dffebde8d4392a241ac9aea3dc389" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">132.3.</td>
          <td style="width: auto; vertical-align: top;">
            <div> A pecuniary liability imposed on him in favor of any other person in respect of an act done in his capacity as an Office Holder.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0e91d4c5c72a41c487370f03290568e0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">132.4.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Any other circumstances arising under the law with respect to which the Company may, or will be able to, insure an Office Holder.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160; <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1b6b83d1ee6c4bb997cd8739fcddb238" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">133.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Subject to the provisions of the Companies Law, the Company shall be entitled to indemnify an Office Holder of the Company, to the fullest extent permitted by
              applicable law. Subject to the provisions of the Companies Law, including the receipt of all approvals as required therein or under any applicable law, the Company may resolve retroactively to indemnify an Office Holder with respect to the
              following liabilities and expenses, provided, in each of the below cases, that such liabilities or expenses were incurred by such Office Holder in such Office Holder&#8217;s capacity as an Office Holder of the Company:</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8dd752112d7b40c6b4991be582ead574" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">133.1.</td>
          <td style="width: auto; vertical-align: top;">
            <div>a monetary liability imposed on him in favor of a third party in any judgment, including any settlement confirmed as judgment and an arbitrator&#8217;s award which has been
              confirmed by the court, in respect of an act performed by the Office Holder by virtue of the Office Holder being an Office Holder of the Company; provided, however, that: (a) any indemnification undertaking with respect to the foregoing shall
              be limited (i) to events which, in the opinion of the Board of Directors, are foreseeable in light of the Company&#8217;s actual operations at the time of the granting of the indemnification undertaking, and (ii) to an amount or by criteria
              determined by the Board of Directors to be reasonable in the given circumstances; and (b) the events that in the opinion of the Board of Directors are foreseeable in light of the Company&#8217;s actual operations at the time of the granting of the
              indemnification undertaking are listed in the indemnification undertaking together with the amount or criteria determined by the Board of Directors to be reasonable in the given circumstances;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 29 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2ac1d3a0669446b9a429295c107231ec" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">133.2.</td>
          <td style="width: auto; vertical-align: top;">
            <div>reasonable litigation expenses, including legal fees, paid for by the Office Holder, in an investigation or proceeding conducted against such Office Holder by an agency
              authorized to conduct such investigation or proceeding, and which investigation or proceeding: (i) concluded without the filing of an indictment (as defined in the Companies Law) against such Office Holder and without there having been a
              monetary liability imposed against such Office Holder in lieu of a criminal proceeding (as defined in the Companies Law); (ii) concluded without the filing of an indictment against such Office Holder but with there having been a monetary
              liability imposed against such Office Holder in lieu of a criminal proceeding for an offense that does not require proof of criminal intent; or (iii) involves financial sanction;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2152a5e24f714d95892098f9dc40038e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">133.3.</td>
          <td style="width: auto; vertical-align: top;">
            <div>reasonable litigation expenses, including legal fees, paid for by the Office Holder, or which the Office Holder is obligated to pay under a court order, in a proceeding
              brought against the Office Holder by the Company, or on its behalf, or by a third party, or in a criminal proceeding in which the Office Holder is found innocent, or in a criminal proceeding in which the Office Holder was convicted of an
              offense that does not require proof of criminal intent; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9d211c7d25744764bc163d5fe973afc6" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">133.4.</td>
          <td style="width: auto; vertical-align: top;">
            <div>any other event, occurrence or circumstances in respect of which the Company may lawfully indemnify an Office Holder of the Company (including, without limitation,
              indemnification with respect to the matters referred to under Section 56h(b)(1) of the Israeli Securities Law 5728-1968, as amended.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3ebe0ffbfd394e978cf088157fd6ca7f" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">133.5.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Company may undertake to indemnify an Office Holder as aforesaid: (i) prospectively, provided that the undertaking is limited to categories of events which in the
              opinion of the Board of Directors can be foreseen when the undertaking to indemnify is given, and to an amount set by the Board of Directors as reasonable under the circumstances, and (ii) retroactively.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb40ad7fc766347d0bba9f26ad3078120" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">134.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Subject to the provisions of the Companies Law including the receipt of all approvals as required therein or under any applicable law, the Company may, to the maximum
              extent permitted by the Companies Law, exempt and release, in advance, any Office Holder from any liability for damages arising out of a breach of a duty of care towards the Company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -35.45pt; margin-left: 35.45pt; line-height: 1.25;">135.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za7c2ee3f0f744f44a63c79c775ed02cc" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">135.1.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Any amendment to the Companies Law adversely affecting the right of any Office Holder to be indemnified or insured pursuant to Articles 132, 133 and 134 and any
              amendments to Articles 132, 133 and 134 shall be prospective in effect, and shall not affect the Company&#8217;s obligation or ability to indemnify or insure an Office Holder for any act or omission occurring prior to such amendment, unless
              otherwise provided by applicable law.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7a7d903974e94be1998d9b02b5723919" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt;"><br>
          </td>
          <td style="width: 35.45pt; vertical-align: top;">135.2.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The provisions of Articles 132, 133 and 134 are not intended, and shall not be interpreted so as to restrict the Company, in any manner, in respect of the procurement
              of insurance and/or in respect of indemnification and/or exculpation, in favor of any person who is not an Office Holder, including, without limitation, any employee, agent, consultant or contractor of the Company who is not an Office Holder;
              and/or any Office Holder to the extent that such insurance and/or indemnification is not specifically prohibited under law.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 30 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">WINDING-UP AND REORGANIZATION</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za375e63f76ee422e9ddbc5f7a5814378" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">136.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Should the Company be wound up and the assets of the Company made available for distribution among Shareholders be insufficient to repay all of the Company&#8217;s paid-up
              capital, such assets shall be divided in a manner whereby the losses shall, as far as possible, be borne by the Shareholders pro rata to the nominal value of the paid-up capital on the shares held by each of them, and, if at the time of the
              winding-up, the property of the Company available for distribution among the Shareholders should exceed the amount sufficient for the repayment of the full nominal value of the paid-up capital at the time of commencement of the winding-up,
              the surplus shall be distributed to the Shareholders pro rata to the paid-up capital held by each of them.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb577b1a0d3f44272b94fd86fe79dfb57" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">137.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Upon the sale of the Company&#8217;s assets, the Board of Directors may, or in the case of a liquidation, the liquidators may, if authorized to do so by a Resolution of the
              Company, accept fully or partly paid-up shares, or securities of another company, Israeli or non-Israeli, whether in existence at such time or about to be formed, in order to purchase the property of the Company, or part thereof, and to the
              extent permitted under the Companies Law, the Board of Directors may (or in the case of a liquidation, the liquidators may) distribute the aforesaid shares or securities or any other property of the Company among the Shareholders without
              realizing the same, or may deposit the same in the hands of trustees for the Shareholders, and the General Meeting by a Resolution may decide, subject to the provisions of the Companies Law, on the distribution or allotment of cash, shares or
              other securities, or the property of the Company and on the valuation of the aforesaid securities or property at such price and in such manner as the Shareholders at such General Meeting shall decide, and all of the Shareholders shall be
              obliged to accept any valuation or distribution determined as aforesaid and to waive their rights in this regard, except, in a case in which the Company is about to be wound-up and is in the process of liquidation, for those legal rights (if
              any) which, according to the provisions of the Companies Law, may not be changed or modified.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; margin-left: 35.45pt; line-height: 1.25; font-weight: bold;">FORUM FOR ADJUDICATION OF DISPUTES</div>
    <div style="line-height: 1.25">&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zeafc5ecfbe1b45ed90c4f73acbfb1c6f" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 35.45pt; vertical-align: top;">138.</td>
          <td style="width: auto; vertical-align: top;">
            <div>(a) Unless the Company consents in writing to the selection of an alternative forum, with
                respect to any causes of action arising under the Securities Act of 1933 as amended, the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action
                arising under the Securities Act of 1933, as amended, against any person or entity, including such claims brought against the Company, its directors, officers, employees, advisors, attorneys, accountants, or underwriters; and (b) unless the Company consents in writing to the selection of an alternative forum, the Tel Aviv District Court shall be the exclusive forum for (i)&#160;any
                derivative action or proceeding brought on behalf of the Company, (ii)&#160;any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Company to the Company or the Company&#8217;s shareholders,
                or (iii)&#160;any action asserting a claim arising pursuant to any provision of the Israeli Companies Law 5759-1999 or the Israeli Securities Law 5728-1968. Any person or entity purchasing or otherwise acquiring&#160;or holding&#160;any interest in&#160;shares
                of the Company shall be deemed to have notice of and consented to these provisions.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">*</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="font-weight: bold;">*</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</font></div>
    <div style="line-height: 1.25">&#160;<br>
    </div>
  </div>
  <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 31 -</font>
    <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;" align="center"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>3
<FILENAME>exhibit_2-1.htm
<DESCRIPTION>EXHIBIT 2.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div class="BRPFPageHeader">
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> <br>
        </u></div>
      <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>EXHIBIT 2.1</u></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; text-indent: 36pt; line-height: 1.25; font-weight: bold;">DESCRIPTION OF SECURITIES</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our authorized share capital consists of 20,000,000 ordinary shares, par value NIS 0.07 per share, of which _______
        shares are issued and outstanding as of March 15, 2024.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">All of our outstanding ordinary shares are validly issued, fully paid and non-assessable. Our ordinary shares are
        not redeemable and do not have any preemptive rights.&#160; All ordinary shares have identical voting and other rights in all respects.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25; font-style: italic;">Transfer of shares</div>
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our fully paid ordinary shares are issued in registered form and may be freely transferred under our articles of
        association, unless the transfer is restricted or prohibited by another instrument, applicable law or the rules of a stock exchange on which the shares are listed for trade. The ownership or voting of our ordinary shares by non-residents of Israel
        is not restricted in any way by our articles of association or the laws of the State of Israel, except for ownership by nationals of some countries that are, or have been, in a state of war with Israel.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-style: italic;">Dividend and liquidation rights</div>
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We may declare a dividend to be paid to the holders of our ordinary shares in proportion to their respective
        shareholdings. Under the Israeli Companies Law, dividend distributions are determined by the board of directors and do not require the approval of the shareholders of a company unless the company&#8217;s articles of association provide otherwise. Our
        articles of association do not require shareholder approval of a dividend distribution and provide that dividend distributions may be determined by our board of directors.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the Israeli Companies Law, the distribution amount is limited to the greater of retained earnings or
        earnings generated over the previous two years, according to our then last reviewed or audited financial statements, provided that the end of the period to which the financial statements relate is not more than six months prior to the date of the
        distribution. If we do not meet such criteria, then we may distribute dividends only with court approval. An equity repurchase is generally treated as a deemed dividend for purposes of these limitations on dividend distributions. However, for a
        company such as ours listed on an exchange outside of Israel, even if we lack the requisite retained earnings or earnings, we still do not need to seek court approval for an equity repurchase, provided that we notify our creditors of the proposed
        equity repurchase and allow such creditors an opportunity to initiate a court proceeding to review the repurchase. If within 30 days of such notification, creditors do not file an objection, we may proceed with the repurchase without obtaining
        court approval. In each case, we are only permitted to distribute a dividend (or effect equity repurchases) if our board of directors and the court, if applicable, determines that there is no reasonable concern that payment of the dividend (or the
        repurchases) will prevent us from satisfying our existing and foreseeable obligations as they become due.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In the event of our liquidation, after satisfaction of liabilities to creditors, our assets will be distributed to
        the holders of our ordinary shares in proportion to their shareholdings. That right, as well as the right to receive dividends, may be affected by the grant of preferential dividend or distribution rights to the holders of a class of shares with
        preferential rights that may be authorized in the future.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25; font-style: italic;">Shareholder meetings</div>
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under Israeli law, we are required to hold an annual general meeting of our shareholders once every calendar year
        that must be held no later than 15 months after the date of the previous annual general meeting. All meetings other than the annual general meeting of shareholders are referred to in our articles of association as extraordinary general meetings.
        Our board of directors may call extraordinary general meetings whenever it sees fit, at such time and place, within or outside of Israel, as it may determine. In addition, the Israeli Companies Law provides that our board of directors is required
        to convene an extraordinary general meeting upon the written request of (i) any two or more of our directors or one-quarter or more of the members of our board of directors or (ii) since our company&#8217;s ordinary shares are listed on an exchange in
        the U.S., one or more shareholders holding, in the aggregate, either (a) 10% or more of our outstanding issued shares and 1% of our outstanding voting power or (b) 10% or more of our outstanding voting power.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Subject to the provisions of the Israeli Companies Law and the regulations promulgated thereunder, shareholders
        entitled to participate and vote at general meetings are the shareholders of record on a date to be decided by the board of directors, which may be for a company such as ours whose ordinary shares are traded publicly in the U.S., between four and
        60 days prior to the date of the meeting. Furthermore, the Israeli Companies Law requires that resolutions regarding the following matters must be adopted at a general meeting of our shareholders:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Israeli Companies Law requires that a notice of any annual general meeting or extraordinary general meeting be
        provided to shareholders at least 21 days prior to the meeting, and if the agenda of the meeting includes the appointment or removal of directors, the approval of transactions with office holders or interested or related parties, or an approval of
        a merger, notice must be provided at least 35 days prior to the meeting.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">Under Israeli law, generally, one or more shareholders holding at least 1% of the voting rights may request that
        the board of directors include a matter in the agenda of a general meeting of shareholders, provided that it is appropriate to discuss such a matter at the general meeting. However, for a company such as ours listed on an exchange outside of
        Israel, the regulations provide that a matter relating to the appointment or removal of a director may only be requested by one or more shareholders holding at least 5% of the voting rights. Our amended and restated articles of association contain
        procedural guidelines and disclosure items with respect to the submission of shareholder proposals for general meetings. Under the Israeli Companies Law regulations, the request from a shareholder to include an agenda item must be provided within
        three days (for a meeting that requires a 21-day notice period) or seven days (for a meeting that requires a 35-day notice period) following our publication of formal notice of the meeting, or within 14 days after we publish an advanced notice that
        precedes the formal notice for the meeting.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the Israeli Companies Law and our articles of association, shareholders are not permitted to take action by
        way of written consent in lieu of a meeting.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Voting Rights</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25; font-style: italic;">Quorum requirements</div>
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to our articles of association, holders of our ordinary shares are entitled to one vote for each ordinary
        share held on all matters submitted to a vote before the shareholders at a general meeting. As provided under our articles of association and as permitted under the Nasdaq Listing Rules due to our status as a foreign private issuer, the quorum
        required for our general meetings of shareholders consists of at least two shareholders present in person, by proxy or written ballot who hold or represent between them at least 25% of the total outstanding voting rights. A meeting adjourned for
        lack of a quorum is generally adjourned to the same day in the following week at the same time and place or to a later time or date if so specified in the notice of the meeting. At the reconvened meeting, any two or more shareholders present in
        person or by proxy (regardless of the number of ordinary shares held by them) shall constitute a lawful quorum.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25; font-style: italic;">Vote requirements</div>
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our articles of association provide that all resolutions of our shareholders require a simple majority vote to be
        adopted, unless otherwise required by the Israeli Companies Law or by our articles of association. Under the Israeli Companies Law, each of (i) the approval of an extraordinary transaction with a controlling shareholder,&#160; (ii) the terms of
        employment or other engagement of the controlling shareholder of the company or such controlling shareholder&#8217;s relative (even if such terms are not extraordinary), (iii) the terms of employment of the chief executive officer, (iv) the election of
        external directors and (v) the approval of the service by one individual as chairman of the board and chief executive officer simultaneously, for a maximum period of three years at a time, requires special majority approval under Israeli law. Under
        our articles of association, the alteration of the rights, privileges, preferences or obligations of any class of our shares requires a simple majority of the class so affected (or such other percentage of the relevant class that may be set forth
        in the governing documents relevant to such class), voting together at a shareholder meeting of that class.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Further exceptions to the simple majority vote requirement are a resolution for the voluntary winding up, or an
        approval of a scheme of arrangement or reorganization, of the company pursuant to Section 350 of the Israeli Companies Law, which requires the approval of holders of 75% of the voting rights represented at the meeting and voting on the resolution.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25; font-style: italic;">Election of directors</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">Our ordinary shares do not have cumulative voting rights for the election of directors. As a result, the holders
        of a majority of the voting power represented at a meeting of shareholders have the power to elect each of our directors. Under our articles of association, our board of directors must consist of at least five and not more than nine directors,
        including, when we are then required to appoint them (we are not current required to do so), at least two external directors appointed under the Israeli Companies Law. At any time the minimum number of directors (other than the external directors)
        shall not fall below three. Pursuant to our articles of association, each of our directors, other than the external directors, for whom special election requirements apply under the Israeli Companies Law, will be appointed by a simple majority vote
        of holders of our voting shares, participating and voting at an annual general meeting of our shareholders. Each director will serve until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal
        by a vote of the majority voting power of our shareholders at a general meeting of our shareholders or until his or her office expires by operation of law, in accordance with the Israeli Companies Law. Our articles of association allow our board of
        directors to appoint directors to fill vacancies on the board of directors to serve until the next annual general meeting of shareholders. External directors are elected for an initial term of three years, may be elected for additional terms of
        three years each under certain circumstances, and may be removed from office pursuant to the terms of the Israeli Companies Law. Under regulations promulgated under the Israeli Companies Law, Israeli public companies whose shares are traded in the
        United States and that lack a controlling shareholder are exempt from the requirement to appoint external directors.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Access to corporate records</div>
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the Israeli Companies Law, shareholders are provided access to: minutes of our general meetings; our
        shareholders register and principal shareholders register, articles of association and annual audited financial statements; and any document that we are required by law to file publicly with the Israeli Companies Registrar or the Israel Securities
        Authority. In addition, shareholders may request any document related to an action or transaction requiring shareholder approval under the related party transaction provisions of the Israeli Companies Law. We may deny this request if we believe it
        has not been made in good faith or if such denial is necessary to protect our interest or protect a trade secret or patent.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Modification of class rights</div>
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the Israeli Companies Law and our articles of association, the rights attached to any class of share, such as
        voting, liquidation and dividend rights, may be amended by adoption of a resolution by the holders of a majority of the shares of that class present at a separate class meeting, or otherwise in accordance with the rights attached to such class of
        shares, as set forth in our articles of association.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Registration rights</div>
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; font-style: italic;">2021 Registration Rights Agreement</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are party to an amended and restated registration rights agreement, dated April 6, 2021, with certain of our
        shareholders (the &#8220;2021 Registration Rights Agreement&#8221;). The 2021 Registration Rights Agreement, which was approved by our shareholders at our 2021 annual general meeting of shareholders, replaced the registration rights agreement, dated March 3,
        2014 (the &#8220;Original Registration Rights Agreement&#8221;), that we&#160;&#160;had entered into in connection with our initial public offering with certain of our pre-IPO shareholders, which expired by its own terms on its seven-year anniversary.&#160;The ordinary
        shares held by most of our pre-IPO shareholders who were party to the Original Registration Rights Agreement were no longer entitled to registration rights under that agreement as of the time that it expired, given their ability to freely sell
        their shares in the open market under Rule 144 of the Securities Act. However, each of CBI and Professor Lior Rosenberg, and their affiliated entities that hold ordinary shares (consisting of Clal Life Sciences LP and L.R. Research&#160;&amp;
        Development Ltd., respectively) remained entitled to registration rights as of the time of the expiration of the Original Registration Rights Agreement, and we therefore entered into the 2021 Registration Rights Agreement with them as a means of
        extending those rights.&#160;The 2021 Registration Rights Agreement provides to the holders of our ordinary shares that are party to the agreement the right to demand that we file a registration statement or request that their ordinary shares be covered
        by a registration statement that we are otherwise filing. In March 2019, we filed, and the SEC declared effective, on April 22, 2019, a shelf registration statement on Form F-3 that registered the resale of the 11,240,827 shares that were then
        entitled to registration rights under the Original Registration Rights Agreement. That registration statement remains in effect as of the date of this Annual Report.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"> <br>
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25; font-style: italic;">Demand registration rights</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">At any time, the holders of a majority of the registrable securities (as defined in the 2021 Registration Rights
        Agreement) then outstanding may request that we file a registration statement with respect to a majority of the registrable securities then outstanding (or a lesser percentage if the anticipated aggregate offering price, net of selling expenses,
        exceeds $5.0 million). Upon receipt of such registration request, we are obligated to file a registration statement. Currently, as we are eligible under applicable securities laws to file a registration statement on Form F-3, we may be required to
        effect up to two such registrations within any 12-month period.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We will not be obligated to file a registration statement at such time if in the good faith judgment of our board
        of directors, such registration would be materially detrimental to the company and its shareholders because such action would (i) materially interfere with a significant acquisition, corporate reorganization or other similar transaction involving
        us, (ii) require premature disclosure of material information that we have a bona fide business purpose for preserving as confidential or (iii) render us unable to comply with requirements under the Securities Act or Exchange Act. In addition, we
        have the right not to effect or take any action to effect a registration statement during the period that is 60 days (or 30 days in the case of a registration statement on Form F-3) before the date of filing our registration statement (as estimated
        by us in good faith), and ending on a date that is 180 days (or 90 days in the case of a registration statement on Form F-3) after the date of such filing.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25; font-style: italic;">Piggyback registration rights</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In addition, if we register any of our ordinary shares in connection with the public offering of such securities
        solely for cash, the holders of all registrable securities are entitled to at least 10 days&#8217; notice of the registration and to include all or a portion of their ordinary shares in the registration. If the public offering that we are effecting is
        underwritten, the right of any shareholder to include shares in the registration related thereto is conditioned upon the shareholder accepting the terms of the underwriting as agreed between us and the underwriters and then only in such quantity as
        the underwriters in their sole discretion determine will not jeopardize the success of our offering.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25; font-style: italic;">Other provisions</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We will pay all registration expenses (other than underwriting discounts and selling commissions) and the
        reasonable fees and expenses of a single counsel for the selling shareholders, related to any demand or piggyback registration. The demand and piggyback registration rights described above will expire on March 24, 2021, five years after our initial
        public offering.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; font-style: italic;">2022 PIPE Registration Rights Agreement</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 42.55pt; line-height: 1.25;">In connection with a private placement of ordinary shares and warrants of our company for which we entered into
        definitive agreements in September 2022 and closed in October 2022 (the &#8220;PIPE&#8221;), we entered into a registration rights agreement with the institutional investors participating in the PIPE (the &#8220;2022 PIPE Registration Rights Agreement&#8221;). Pursuant to
        the 2022 PIPE Registration Rights Agreement, within 45 calendar days of the date of the closing of the PIPE, we were required to file, and we filed, on November 10, 2022, a registration statement to register for resale (i) the ordinary shares
        issuable upon exercise of the ordinary warrants sold in the PIPE, and (ii) the ordinary shares issuable upon exercise of certain privately placed pre-funded warrants sold to the investors in connection with a concurrent registered direct offering
        (collectively, the &#8220;2022 Registrable Securities&#8221;). Pursuant to the 2022 PIPE Registration Rights Agreement, we agreed to cause the subject registration statement to be declared effective under the Securities Act as promptly as possible after the
        filing thereof, but in any event no later 75 days, or in the event of a full review by the SEC, 110 days, after the closing date of the PIPE, and use our best efforts to keep such registration statement continuously effective under the Securities
        Act until the date that all Registrable Securities covered by such registration statement have been sold or are otherwise may be sold pursuant to Rule 144 under the Securities Act. The subject registration statement was declared effective by the
        SEC on November 25, 2022.</div>
      <div style="text-align: justify; text-indent: 42.55pt; line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Acquisitions Under Israeli Law</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25; font-style: italic;">Full tender offer</div>
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">A person wishing to acquire shares of an Israeli public company and who would as a result hold over 90% of the
        target company&#8217;s issued and outstanding share capital is required by the Israeli Companies Law to make a tender offer to all of the company&#8217;s shareholders for the purchase of all of the issued and outstanding shares of the company. A person wishing
        to acquire shares of a public Israeli company and who would as a result hold over 90% of the issued and outstanding share capital of a certain class of shares is required to make a tender offer to all of the shareholders who hold shares of the
        relevant class for the purchase of all of the issued and outstanding shares of that class. If the shareholders who do not accept the offer hold less than 5% of the issued and outstanding share capital of the company or of the applicable class, and
        more than half of the shareholders who do not have a personal interest in the offer accept the offer, all of the shares that the acquirer offered to purchase will be transferred to the acquirer by operation of law. However, a tender offer will also
        be accepted if the shareholders who do not accept the offer hold less than 2% of the issued and outstanding share capital of the company or of the applicable class of shares.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Upon a successful completion of such a full tender offer, any shareholder that was an offeree in such tender offer,
        whether such shareholder accepted the tender offer or not, may, within six months from the date of acceptance of the tender offer, petition an Israeli court to determine whether the tender offer was for less than fair value and that the fair value
        should be paid as determined by the court. However, under certain conditions, the offeror may include in the terms of the tender offer that an offeree who accepted the offer will not be entitled to petition the Israeli court as described above.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If a tender offer is not accepted in accordance with the requirements set forth above, the acquirer may not acquire
        shares from shareholders who accepted the tender offer that will increase its holdings to more than 90% of the company&#8217;s issued and outstanding share capital or of the applicable class.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25; font-style: italic;">Special tender offer</div>
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Israeli Companies Law provides that an acquisition of shares of an Israeli public company must be made by means
        of a special tender offer if as a result of the acquisition the purchaser would become a holder of 25% or more of the voting rights in the company. This requirement does not apply if there is already another holder of at least 25% of the voting
        rights in the company. Similarly, the Israeli Companies Law provides that an acquisition of shares in a public company must be made by means of a special tender offer if as a result of the acquisition the purchaser would become a holder of more
        than 45% of the voting rights in the company, if there is no other shareholder of the company who holds more than 45% of the voting rights in the company, subject to certain exceptions. A special tender offer must be extended to all shareholders of
        a company but the offeror is not required to purchase shares representing more than 5% of the voting power attached to the company&#8217;s outstanding shares, regardless of how many shares are tendered by shareholders. A special tender offer may be
        consummated only if (i) the offeror acquired shares representing at least 5% of the voting power in the company and (ii) the number of shares tendered by shareholders who accept the offer exceeds the number of shares held by shareholders who object
        to the offer (excluding the purchaser, controlling shareholders, holders of 25% or more of the voting rights in the company or any person having a personal interest in the acceptance of the tender offer). If a special tender offer is accepted, the
        purchaser or any person or entity controlling it or under common control with the purchaser or such controlling person or entity may not make a subsequent tender offer for the purchase of shares of the target company and may not enter into a merger
        with the target company for a period of one year from the date of the offer, unless the purchaser or such person or entity undertook to effect such an offer or merger in the initial special tender offer.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br>
        <br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25; font-style: italic;">Merger</div>
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Israeli Companies Law permits merger transactions if approved by each party&#8217;s board of directors and, unless
        certain requirements described under the Israeli Companies Law are met, by a majority vote of each party&#8217;s shareholders. In the case of the target company, approval of the merger further requires a majority vote of each class of its shares.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">For purposes of the shareholder vote, unless a court rules otherwise, the merger requires the approval by a
        majority of the votes of shares represented at the meeting of shareholders, after excluding shares held by the other party to the merger and any person (or group of persons acting in concert) who holds (or hold, as the case may be) 25% or more of
        the voting rights or the right to appoint 25% or more of the directors of the other party to the merger. If, however, the merger involves a merger with a company&#8217;s own controlling shareholder or if the controlling shareholder has a personal
        interest in the merger, then the merger is instead subject to the same Special Majority approval that governs all extraordinary transactions with controlling shareholders.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If the transaction would have been approved by the shareholders of a merging company but for the separate approval
        of each class or the exclusion of the votes of certain shareholders as provided above, a court may still approve the merger upon the petition of holders of at least 25% of the voting rights of a company. For such petition to be granted, the court
        must find that the merger is fair and reasonable, taking into account the respective values assigned to each of the parties to the merger and the consideration offered to the shareholders of the target company. Upon the request of a creditor of
        either party to the proposed merger, the court may delay or prevent the merger if it concludes that there exists a reasonable concern that, as a result of the merger, the surviving company will be unable to satisfy the obligations of the merging
        entities, and may further give instructions to secure the rights of creditors.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">A merger may not be consummated unless at least 50 days have passed from the date on which a proposal for approval
        of the merger is filed with the Israeli Registrar of Companies and at least 30 days have passed from the date on which the merger was approved by the shareholders of each party.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25; font-style: italic;">Anti-takeover measures under Israeli law</div>
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Israeli Companies Law allows us to create and issue shares having rights different from those attached to our
        ordinary shares, including shares providing certain preferred rights with respect to voting, distributions or other matters and shares having preemptive rights. As of February 15, 2019, no preferred shares are authorized under our articles of
        association. In the future, if we do authorize, create and issue a specific class of preferred shares, such class of shares, depending on the specific rights that may be attached to it, may have the ability to frustrate or prevent a takeover or
        otherwise prevent our shareholders from realizing a potential premium over the market value of their ordinary shares. The authorization and designation of a class of preferred shares will require an amendment to our articles of association, which
        requires the prior approval of the holders of a majority of the voting power attaching to our issued and outstanding shares at a general meeting. The convening of the meeting, the shareholders entitled to participate and the majority vote required
        to be obtained at such a meeting will be subject to the requirements set forth in the Israeli Companies Law as described above in &#8220;&#8212;Voting Rights.&#8221;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageFooter">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.14
<SEQUENCE>4
<FILENAME>exhibit_4-14.htm
<DESCRIPTION>UNPROTECTED LEASE AGREEMENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"><u><font style="font-weight: bold;"> Exhibit 4.14</font></u><br>
    </div>
    <div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',serif; font-size: 11pt; font-weight: normal;">This exhibit is an English translation of the original document in Hebrew. In case of any </div>
        <div style="line-height: 1.25; font-family: 'Times New Roman',serif; font-size: 11pt; font-weight: normal;">discrepancy, the Hebrew version prevails</div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u> <br>
        </u></div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>Unprotected Lease Agreement</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Entered into and executed in Tel Aviv as of this 13<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day of July 2023</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zc3c742b21f054f3f85d00d04c037c803" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 19.98%; vertical-align: top;">
              <div style="line-height: 1.25; font-weight: bold;">Between:</div>
            </td>
            <td style="width: 80.02%; vertical-align: top;">
              <div style="line-height: 1.25; font-weight: bold;">YEZUM-TECH BUSINESS AND ASSETS LTD (Company Reg. No. 51-152477-9)</div>
              <div style="line-height: 1.25; font-weight: bold;"> <br>
              </div>
              <div style="line-height: 1.25;">Of 24 Shai Agnon St. (apt. 28), Tel Aviv</div>
              <div style="line-height: 1.25;">(Hereinafter: the &#8220;Lessor&#8221;)</div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
              <div style="text-align: right; line-height: 1.25;"><u><font style="font-weight: bold;">The first party</font>;</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 19.98%; vertical-align: top;">&#160;</td>
            <td style="width: 80.02%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 19.98%; vertical-align: top;">
              <div style="line-height: 1.25; font-weight: bold;">And between:</div>
            </td>
            <td style="width: 80.02%; vertical-align: top;">
              <div style="line-height: 1.25; font-weight: bold;">MEDIWOUND LTD, Company Reg. No. 512894940</div>
              <div style="line-height: 1.25; font-weight: bold;"> <br>
              </div>
              <div style="line-height: 1.25;">Of 42 HaYarkon St., Yavne</div>
              <div style="line-height: 1.25;">(Hereinafter: the &#8220;Lessee&#8221;)</div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
              <div style="text-align: right; line-height: 1.25;"><u><font style="font-weight: bold;">The second party</font>;</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z4b822d28e7144edc835bf5bbd1d9fd40" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 19.98%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Whereas:</div>
            </td>
            <td style="width: 80.02%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">The Lessor is the owner of a lot in an area of 2,985 sq.m., known as Lot 228 in accordance with detailed plan &#1497;&#1489;/223 that is situated in parcel 31 in block no. 5405 in the Industrial Zone
                in Yavne, and on which the building is built, as stated in Appendix A;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 19.98%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 80.02%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 19.98%; vertical-align: top;">
              <div style="text-align: justify; text-indent: -28.35pt; margin-left: 28.35pt; line-height: 1.25; font-weight: bold;">And whereas:</div>
            </td>
            <td style="width: 80.02%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">The Lessee acts for the purpose of conducting its business in the Leased Premises since 2001 in accordance with Sublease Agreement that the Lessee signed with Clal Life Sciences L.P.,
                Registered Partnership no. 55-020837-5 (hereinafter: &#8220;Clal&#8221;) that is the lessee of the existing property in accordance with the agreement that is in effect;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 19.98%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 80.02%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 19.98%; vertical-align: top;">
              <div style="text-align: justify; text-indent: -28.35pt; margin-left: 28.35pt; line-height: 1.25; font-weight: bold;">And whereas:</div>
            </td>
            <td style="width: 80.02%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">The Lessee has a full and detailed building file, updated as of the signing date of this Agreement, specifying the entire systems and utilities of any kind existing in the building;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 19.98%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 80.02%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 19.98%; vertical-align: top;">
              <div style="text-align: justify; text-indent: -28.35pt; margin-left: 28.35pt; line-height: 1.25; font-weight: bold;">And whereas:</div>
            </td>
            <td style="width: 80.02%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Clal requested to terminate the Term of Lease and the Lessor agreed to its request, subject to the signing of a new and separate lease agreement with the Lessee;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 19.98%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 80.02%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 19.98%; vertical-align: top;">
              <div style="text-align: justify; text-indent: -28.35pt; margin-left: 28.35pt; line-height: 1.25; font-weight: bold;">And whereas:</div>
            </td>
            <td style="width: 80.02%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">The parties agreed to lease the Leased Premises to the Lessee in accordance with the provisions set forth in this Agreement;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>Now, Therefore, it is Declared, Stipulated and Agreed between the Parties as Follows:</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z49df5abdf08c4a7eb591aef229e726f6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;"><u>Definitions:</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25;">The &#8220;Leased Premises&#8221; &#8211; a lot in an area of 2,985 sq.m., known as Lot 2028 in accordance with detailed plan &#1497;&#1489;/223 that is situated in parcel 31 in block no. 5405 in the
        Industrial Zone in Yavne, and on which the building as stated in <u>Appendix A</u> is built, including parking areas, lobby, landscape areas, storage units, plumbing, water, sewage, air-conditioning, cooling, electricity systems (including a 1000
        ampere connection, or as increased by the Lessee), security, production rooms (and laboratories), clean rooms (including filtration systems), dining rooms and offices, fire safety systems, and any other building or system that will be added in the
        future with the Lessor's approval in accordance with the provisions set forth in this Agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25;">In light of the relation of the Lessee to Clal, and the fact that the Lessee operates in the Leased Premises prior to and until the signing date of this Agreement, and
        possesses the Leased Premises and systems therein, it is clarified that by signing this Agreement the Lessee confirms that it is thoroughly familiar with the Leased Premises, including their different systems, and that it uses the Leased Premises
        for a long period of time and that the Leased Premises are in conformance to its requirements.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="za402ab96eaec4525aa8121fd9d7eeb34" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Without derogating from the effect of its declaration above, the Lessor confirms that it engaged in contacts with Clal, and that it received from Clal the entire information regarding the property, including planning and technical
                information, and any other information that is required for the purpose of continuing and operating its business in the Leased Premises, including the systems therein, and it releases the Lessor from any liability for the purpose of this
                matter.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z7325c18d2fef408290323b63e8d5d616" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;"><u>The transaction</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25;">The Lessor hereby undertakes to lease the Leased Premises to the Lessee and the Lessee hereby undertakes to lease the Leased Premises from the Lessor as stated in this
        Agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z4e92e540043041269d2702acab0e7366" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;"><u>Condition precedent</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25;">The coming into force is conditional on the signing of the Lessor on an agreement in the form attached as Appendix C of this Agreement (hereinafter: the &#8220;<font style="font-weight: bold;">Termination Agreement with Clal</font>&#8221;) for the purpose of terminating the Lease Agreement that was signed between the Lessor and Clal Life Sciences L.P. (Registered Partnership no. 55020837) on September 16, 2008.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z33490ffdaf4f44179535d0bf7da5e784" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;"><u>Declarations of the Lessor</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zc10f6ce45ff44416a6d773d3fb3e2201" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">5.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessor hereby declares and undertakes as follows:</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zf55798793bc84c6ba88791a0b77891aa" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 70.9pt;"><br>
            </td>
            <td style="width: 42.5pt; vertical-align: top;">5.1.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>It holds the capitalized long-term lease rights from Israel Land Administration with respect to the Leased Premises and it is entitled to lease the Leased Premises to the Lessee in accordance with the provisions set forth in this
                Agreement.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z8e5aa0928076447abb4ff800c64ee848" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 70.9pt;"><br>
            </td>
            <td style="width: 42.5pt; vertical-align: top;">5.1.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Its rights in the Leased Premises are free from any debt, charge and/or any other third-party right and there is no impediment which would prohibit it from leasing the Leased Premises to the Lessee in accordance with the provisions set
                forth in this Agreement.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="za64f9982690f464a97ae06222b4f1580" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 70.9pt;"><br>
            </td>
            <td style="width: 42.5pt; vertical-align: top;">5.1.3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lease Agreement that it signed with Clal Life Sciences L.P. (Registered Partnership no. 55020837) on September 16, 2008 shall be terminated on July 31, 2023 by the Termination Agreement in the form attached as Appendix C of this
                Agreement, and that Clal Life Sciences has no suit and/or demand and/or claim in connection with the Leased Premises and that the rights of the Lessor in the Leased Premises on the signing date of this Agreement are free and unencumbered
                from any right and/or suit and/or demand of Clal Life Sciences and/or any other third-party rights.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z8cb1c795499b405ea01252791a4b1ed3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 70.9pt;"><br>
            </td>
            <td style="width: 42.5pt; vertical-align: top;">5.1.4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>It desires to continue and lease the Leased Premises to the Lessee, subject to the provisions set forth in this Unprotected Lease Agreement.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zaaf2c0e557cb498bbdf01a8e0fd131bf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">6.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;"><u>Declarations of the Lessee</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z0237aa4b12ff4f1089f1853ab628427f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">6.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessee hereby declares the following:</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="ze3ad98fc1faa40e9b954391371a074c8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 70.9pt;"><br>
            </td>
            <td style="width: 28.35pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>It operates a business of research and manufacturing of pharmaceuticals.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z8d2bdab1cfe844f7b23780b6b35cb11d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 70.9pt;"><br>
            </td>
            <td style="width: 28.35pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>It inspected and it is familiar with the Leased Premises, their area, their location and the options of use therein, from a physical, planning and legal aspect, and in this regard, <font style="font-style: italic;">inter alia</font>, it
                is aware and it inspected the Urban Building Plan (UBP) applicable to the Leased Premises and the building permit issued for the purpose of building the Leased Premises, and the Lessee obtained from the competent authorities any information
                that appears to it relevant in connection with the Leased Premises, and found all of the aforesaid in conformance to its full satisfaction, and to its specifications and requirements, and therefore, and subject to the accuracy of the
                declarations of the Lessor, the Lessee hereby waives any claim on the grounds of non-conformity in connection with the Leased Premises, including in connection with their condition, location, area and options of use therein, except for in
                connection with a latent defect and/or fault that the Lessor knew and did not disclose to the Lessee.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="ze0e882b8b1e2495c9d8d4c0fadad718b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 70.9pt;"><br>
            </td>
            <td style="width: 28.35pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>It did not undertake towards the Lessor to perform any changes and additions in the Leased Premises and the entire changes and additions that it will perform shall be executed solely out of its own free will and by virtue of its
                occupation, and it shall not be obligated towards the Lessor to perform these changes and additions as said in any manner. The Lessee desires to lease the Leased Premises from the Lessor subject to the provisions set forth in this
                Unprotected Lease Agreement.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160; <br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zce4e505d5ba8490b82661a7d3c2f0715" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">7.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;"><u>The Term of Lease</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zb7d562129283423cbc0c21400664f130" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">7.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessor hereby undertakes to lease to the Lessee and the Lessee hereby undertakes to lease the Leased Premises from the Lessor for a period of 12 years, as of March 1, 2023 and until February 28, 2035 (hereinafter: the &#8220;<font style="font-weight: bold;">Term of Lease</font>&#8221;) and all in accordance with the provisions set forth in this Agreement.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z87f2a4e9923f4edaaec37ee2d1ccacc1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">7.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>If the Lessee does not commit a fundamental breach of this Agreement and the said breach was not cured afterwards after receiving a written notice from the Lessor, the Lessee is hereby granted a right of option to extend the Term of
                Lease by an additional period of three years, i.e., as of March 1, 2035 and until February 28, 2038 (hereinafter: the &#8220;<font style="font-weight: bold;">Option Term</font>&#8221;) solely on the condition that the Lessor receives, no less than 12
                months prior to the expiration of the Term of Lease (i.e., until March 1, 2034) a notice that the Lessee delivered regarding the exercise of the option and will extend the bank guarantee as stated in section 17 hereunder until the
                commencement of the Option Term.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z1954a485a7754bb7b50d5030382dcc45" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">7.3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>If the Lessee exercises the option to extend the Term of Lease, the lease shall be terminated upon expiration of the Option Term and the Term of Lease shall be deemed to have been entered into in advance until the expiration of the
                Option Term and the entire terms set forth in this Agreement shall apply also to the extended Term of Lease, <font style="font-style: italic;">mutatis mutandis</font>.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z60115eb5ee5b48ffa7789a2f3e3b4505" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">7.4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The duration of the Term of Lease and the Option Term, as the case may be, are material issues in this Agreement. The Lessee shall not be entitled to shorten the said periods without obtaining the prior and written approval of the
                Lessor. The Lessee shall be obligated to pay the full amount of the Rent, taxes, and additional payments in accordance with this Agreement even if the Lessee leaves the Leased Premises and/or vacates the Leased Premises prior to the
                expiration of the Term of Lease or the Option Term, if exercised, and even if the Lessee cannot or is unable to use any property controlled by the Lessor for any reason. If the Lessee is unable, or its ability to use the Leased Premises as
                a result of an act and/or omission of the Lessor is impaired, the Lessee shall not incur the payment of the Rent and/or any other payment applicable to it in accordance with the Agreement in respect of the preclusion period.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z765c2fff329349b1adee9b61abcd071d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">7.5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Notwithstanding the provisions of section 7.4 above, if, during the Term of Lease, the Lessee desires to terminate the lease prior to the expiration of the Term of Lease, the Lessee shall be entitled to act in such manner only after the
                entire following conditions have been met cumulatively:</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z92a7c529ea6e4469868f65de90c969a1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 70.9pt;"><br>
            </td>
            <td style="width: 42.5pt; vertical-align: top;">7.5.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessee procured a substitute lessee in its place, for the remaining part of the Term of Lease, and the said substitute lessee shall sign the Lease Agreement under terms that are identical to the terms set forth in this Agreement.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zdbe6b79840594e0cb2a571b5961384d1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 70.9pt;"><br>
            </td>
            <td style="width: 42.5pt; vertical-align: top;">7.5.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessor granted its prior and written approval to the identity of the substitute lessee and the Lessor shall not unreasonably withhold its approval to the identity of the substitute lessee.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z252d8eb8d8f146eb906bd2ddf27250a7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 70.9pt;"><br>
            </td>
            <td style="width: 42.5pt; vertical-align: top;">7.5.3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessor shall be entitled to stipulate its approval regarding the identity of the substitute lessee on the provision of securities that are identical to the securities that the Lessor received from the Lessee under this Agreement. The
                release of the Lessee from its undertakings under this Agreement is conditional on the actual provision of the said securities.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160; <br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z5f0ea25112ef4e90a890af63ed6309c5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 70.9pt;"><br>
            </td>
            <td style="width: 42.5pt; vertical-align: top;">7.5.4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Without derogating from the foregoing, it is agreed that the Lessee shall be entitled to lease the Leased Premises in unprotected lease to any sublessee at its discretion, provided that the Lessee remains responsible for the performance
                of its undertakings towards the Lessor under this Agreement. The parties agree that the Lessee shall notify the Lessor regarding the agreement that was signed with the sublessee, after its signing.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z39dd8d3c02a4430c9e83a624eaf0887e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">8.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;"><u>Rent and method of its payment</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z1e33e0fe529e4c56b42fe08847bd6e15" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">8.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The rent that shall be paid for March 2023 shall total an amount of ILS 195 thousand with the addition of statutory VAT (the &#8220;<font style="font-weight: bold;">Rent</font>&#8221;).</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="za15fbabb05444af2b09ba8125e943d54" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">8.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Rent for March in each year of lease after the first year shall be the higher of the following: (i) the Rent in respect of the month that preceded March, with the addition of the linkage of an additional month; or (ii) the Rent for
                March in the previous year of lease.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zc06f7d83dd524c05b3b1a40415f0c0e0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">8.3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The updated Rent, as stated in section 8.2 above, shall be increased by 6 additional percent at the end of every 3 years.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="za2e517893e0f458092c2686182033cdd" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">8.4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Rent after March in that year of lease shall be linked to the consumer price index, in such manner that the amount of the Rent on the payment date of each payment shall vary according to the rate that the known index increased or
                decreased compared to the index on the commencement date of the year of lease. Notwithstanding the said, it is clarified that the Lessee shall not be entitled to a refund in respect of a cumulative amount of negative linkage differentials
                for any year of lease.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z3b0cdf13d1d344af9146864caca207e1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">8.5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>In the beginning of each year of lease, the basic index for that year of lease shall be set; the said index is the index known in March of each year of lease (the &#8220;<font style="font-weight: bold;">Index on the Commencement Date of the
                  Year of Lease</font>&#8221;). For the avoidance of doubt, it is clarified that on the commencement date of this Agreement the determining index shall be the index of January 2023 that was published on February 15, 2023.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="ze65df5d219ab46489dfe6bb50984055b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">8.6.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The &#8220;Known Index&#8221; &#8211; the consumer price index known on the mandatory date of each payment.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z7957bc822c3e47da8d5f9cb5d3abe45d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">8.7.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Shortly after the expiration of each year of lease (the first year shall expire at the end of February 2024), the Lessee shall deliver to the Lessor a calculation in respect of the linkage of the Rent for each year. The Lessor shall
                review the calculation and deliver its comments, and after the parties reach agreement, the difference shall be paid in 30 days. If the Lessor did not deliver to the Lessee any response in 14 days as of the delivery date of the calculation,
                this shall be deemed as if the Lessor confirmed the linkage differentials and the payment shall be transferred on the first of the month subsequent to the commencement of the year of lease.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z97c3aefb05624586b88d360021deb635" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">8.8.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Statutory VAT shall be added to the Rent (with the addition of linkage differentials) according to its rate on each payment date of the Rent. VAT shall be paid jointly with any payment of the Rent.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z37508b60259a4fb098654445f7761aed" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">8.9.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Rent, with the addition of VAT as stated above, shall be paid for each month in advance, on the 1<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> of each month Rent is paid against invoice. It is
                agreed that the Lessee shall pay for the months of March until July 2023 only the difference in respect of the Rent that Clal paid for these months with respect to the Rent set out in section 8.1, for a total amount of ILS 379,275 in
                addition to VAT that shall be paid in 7 days as of the signing date of this Agreement and against invoice.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z4cdfa1e16c76422b97413b61320b36e6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">8.10.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessee shall pay the Rent by way of a wire transfer on the 1<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> of each month to the Lessor's bank account whose information is as stated in Appendix D.
                It is clarified that the Rent in each year of lease shall be fixed and the parties shall review the linkage differentials in the manner set out in section 8.7 above. The amount of the Rent in the direct debit shall be updated once in each
                year of lease, on March 1.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z6703f1dc962c408a8fc30003f3d942ca" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">8.11.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The parties shall have no right of setoff with respect to any claim or demand of any kind towards the other party and the Rent shall be paid fully, timely and unconditionally.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zc80a5dcad2d9467e8579277dcffeee3f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">9.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;"><u>Delivery of possession in the Leased Premises and changes</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z1426b39bfca3472086a522ebb31f85b9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">9.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Leased Premises shall be delivered on the lease commencement date to the possession of the Lessee in their condition &#8220;AS-IS&#8221; at the time of signing this Agreement.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z86535adf878048a6ad6d5bfbee6aa342" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">9.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>It is hereby agreed that the Lessee shall not be entitled to make any structural changes in the fixtures attached to the Leased Premises that cannot be removed without causing damage to the Leased Premises in the area of the offices that
                exist today without obtaining the prior and written approval of the Lessor, which approval shall not be unreasonably withheld. A decrease in the value of the building other than a marginal decrease shall be deemed as reasonable grounds for
                the objection. A change that implies the addition of a built-up area that exceeds cumulatively an area of 15 sq.m. shall be conditional on commercial agreements for the payment of the Rent (it is clarified that change other than structural
                changes, such as the relocation of electricity sockets or telephone jacks shall not be deemed as changes that require the Lessor's approval).</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 70.9pt; line-height: 1.25;">No structural changes in the other areas of the Leased Premises, other than the office area, in fixtures that are permanently attached to the Leased Premises and cannot be
        removed without causing damage to the Leased Premises shall be permitted without obtaining the prior and written approval of the Lessor, which approval shall not be unreasonably withheld, however with respect to changes other than structural
        changes as stated above (both in the area of the offices and in the other areas of the Leased Premises) and that do not require the Lessor's approval, the Lessor shall receive notice together with plans explaining the nature of the change that was
        performed, a reasonable time after the performance of the change.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 70.9pt; line-height: 1.25;">&#8220;Structural changes&#8221; shall mean any change that requires a building permit and/or a change in the area of the Leased Premises and/or changes in the construction of the building
        and/or changes in central systems and/or changes that require the involvement of a structure engineer and/or changes in the shell and/or in the skeleton frame of the building.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 70.9pt; line-height: 1.25;">The Lessee undertakes to keep an AS-MADE building file that reflects at any time the condition of the building as a result of changes that were made therein and allow the
        Lessor to inspect the said file at any reasonable time and following its demand.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="za4a8a30471ce4f1b86ab4e64be6b74e6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">9.3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>If and to the extent that the Lessor approves the structural changes requested by the Lessee in the Leased Premises as stated in section 9.2 above, the Lessee shall be entitled to perform in the Leased Premises the said changes
                (hereinafter: the &#8220;<font style="font-weight: bold;">Customization Works</font>&#8221;), provided that the Customization Works are approved in advance and in writing by the Lessor. For the purpose of obtaining the Lessor's approval, the Lessee
                shall deliver for the inspection and approval of the Lessor, and prior to the commencement of the Customization Works, technical specifications and execution plans and a proposal for an insurance policy for the works. The Lessor shall
                respond to the said plans (or to amended plans, if the Lessor demands changes in the plans) in 15 days as of the date the Lessor received the said plans. The Lessor shall be entitled to consult with an engineering supervision company that
                supervised the construction of the building on its behalf, or any other similar company or consultants as required in connection with the requested changes. The Lessee shall incur all costs in connection therewith, provided that these are
                customary costs in respect of consulting works as said and the Lessee shall approve such costs are approved by the Lessee in advance.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z81477c2227e7410b9e0894eac50da238" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">10.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;"><u>Operation of the Leased Premises for their purpose, licenses and permits</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z424379bb99434902bcc4cc94cb202b53" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">10.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessee shall use, operate, and maintain the Leased Premises at its expense and under its responsibility for the Purpose of Lease as stated above, and shall not be entitled to use the Leased Premises for any other purpose however only
                after obtaining the prior and written approval of the Lessor.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z007bf698a57b4e5b9b0bf23e24d14e58" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">10.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessee declares that at the time of signing this Agreement it obtained all permits, approvals and licenses that are required and the Lessee complies with the entire provisions of the law, including a business license, and any other
                permit required by the Ministry of Environmental Protection. The Lessee undertakes to keep these permits in effect during the entire Term of Lease and/or request and obtain, under its exclusive responsibility and at its full expense, any
                permit that will be required at the time for the purpose of performing its entire activities in the Leased Premises from time to time. The Lessor undertakes to cooperate with the Lessee for the purpose of obtaining any license and/or permit
                that is required for the purpose of performing the activities of the Lessee in the Leased Premises and sign any document that will be required for the purpose of this matter, provided that no liability and/or responsibility that are not
                imposed on the Lessor under this Agreement are imposed on the Lessor. For the avoidance of doubt, and notwithstanding the provisions of this Agreement, the Lessor shall not be obligated to agree to the issuance of a building permit that the
                Lessee will demand if the issuance of such a building permit as said requires the payment of betterment levy. In such circumstances as said, the Lessee shall be entitled to incur in person the betterment levy and the Lessor shall not
                withhold such approval only based on these grounds.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zc87af13c09cc40cea6a57ffe4ac023ee" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">10.3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>For the avoidance of doubt, it is clarified that failure to obtain any permit or license as said shall not release the Lessee from its undertakings under this Agreement unless the failure to obtain the license and/or the permit as said
                stems from lack of cooperation by the Lessor and/or as a result of an act and/or omission of the Lessor and/or anyone acting on its behalf &#8211; that is not related to the Leased Premises, their design, condition, or compliance with any
                conditions. The Lessee shall indemnify the Lessor for any penalty and/or any other damage caused to the Lessor in connection therewith as a result of failure by the Lessee to perform its undertakings under this section, provided that the
                Lessor gives to the Lessee a 14 days&#8217; prior and written notice and affords to the Lessee an opportunity to defend against any penalty and/or damage as said. Any indemnity shall be paid against a peremptory judgment whose execution was not
                suspended and the Lessor may not settle in the name of the Lessee with respect to any claim and/or suit as said without obtaining the prior and written approval of the Lessee in connection therewith (hereinafter jointly: the &#8220;<font style="font-weight: bold;">Conditions for Indemnity</font>&#8221;).</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z548411d9f284432b9386ce309ffa19e5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">11.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;"><u>Taxes and other payments</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z7455878bf6514afe859f20f7bcd85c51" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">11.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>As of the commencement date of the Term of Lease the Lessee shall incur and make timely payment of all taxes, municipal property taxes, fees and levies charged by law in the Leased Premises and that, by their nature, are charged from the
                possessor or the user of the Leased Premises or the operator or the manager of the business therein (including but without limiting the generality of the foregoing, business tax, signage tax, fees, permits and licenses for the business and
                for the management of the business), during the entire Term of Lease. The same shall also apply to water, electricity, telephone, sewage and municipal property tax bills or any other expense pertaining to the possession and/or the use
                and/or the operation of the Leased Premises.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160; <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">10</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zed04facc575145e59c743cc5561232a5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">11.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Without derogating from the foregoing, the Lessor shall incur and pay taxes that, by their nature, apply to the owner of a property, as opposed to a lessee (such as betterment levy and/or development levies etc.).</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zde5f532a77b74958b6095365d7bfdf0e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">12.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;"><u>Liability and insurance</u></font> &#8211;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zc5441d55ed434458965318a493dda4aa" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">12.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessee shall be held liable for all damage events that the Lessee and/or anyone acting on its behalf will cause in the Leased Premises during the Term of Lease, and that stem from an act or omission of the Lessee and/or anyone acting
                on its behalf, including but without limiting the generality of the foregoing, any bodily injury or property damage caused to the Leased Premises and the equipment situated therein or to any person who is in the Leased Premises at any time.
                The Lessee undertakes to indemnify the Lessor and compensate the Lessor for any amount of loss the Lessor sustains and in respect of any amount that the Lessor shall be obligated to pay to any party in connection with any damage event and
                expense and/or loss and/or penalty caused as said, including all expenses that will be reasonably required for the purpose of handling or defending against such a claim as said, subject to the Conditions for Indemnity as hereinabove
                defined.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zc455299e567c4ed98fceba9791c36f6e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">12.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Without derogating from its liability under section 12.1 above and from its liability in accordance with the other sections of this Agreement and under any law, the Lessee undertakes to purchase at its expense from a legally licensed and
                reputable insurance company in Israel and keep in effect during the entire Term of Lease the following insurances, in a scope of coverage as stated in the said sections:</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z3c728c7a8a3044f297990d97316002b6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 70.9pt;"><br>
            </td>
            <td style="width: 42.5pt; vertical-align: top;">12.2.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Structural defects insurance for the Leased Premises at full value (that will be updated upwards to the extent that the value of the Leased Premises increases) and insurance at replacement value of any change and/or addition to the
                Leased Premises that were made and/or that will be made by the Lessee and/or anyone acting on its behalf, against loss or damage in consequence of the customary risks in extended fire insurance, including fire, smoke, lighting, explosion,
                earthquake, storm and tempest, flood, damage caused by wear in pipes and splitting of pipes, any accidental impact, strikes, riots and civil commotion, malicious damage and break-in.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">11</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; margin-left: 113.4pt; line-height: 1.25;">In the event of damage to the Leased Premises exceeding an amount of USD 1.5 million, the insurance benefits shall be paid directly to the Lessor and the Lessor shall use the
        said benefits for the purpose of replacing the Leased Premises at the earliest opportunity. In addition, in the event of damage in the Leased Premises for an amount of less than USD 1.5 million, the insurance amounts shall be used solely for the
        purpose of replacing the Leased Premises and restoring the Leased Premises to their former state prior to the occurrence of the event, as a minimum.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zd25631b3d2574fc3bbc550ba17a90615" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 70.9pt;"><br>
            </td>
            <td style="width: 42.5pt; vertical-align: top;">12.2.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Third-party liability insurance &#8211; this policy shall provide insurance coverage for the liability of the Lessee towards any third party, including its guests, invitees, customers, the Lessor and anyone acting in its name and on its
                behalf, and in a liability limit that shall not fall below ILS 20,000,000 per event and for an annual period of insurance.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z451f43e62c1b49cd8438e68317e1d243" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 70.9pt;"><br>
            </td>
            <td style="width: 42.5pt; vertical-align: top;">12.2.3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Employers&#8217; liability insurance for the statutory liability of the Lessee towards anyone employed by the Lessee and on its behalf in a liability limit of no less than an amount in new Israeli shekels equal to ILS 20,000,000 per event and
                for an annual period of insurance.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160; <br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zc1cc5201635246ff95838028e47c8c75" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 70.9pt;"><br>
            </td>
            <td style="width: 42.5pt; vertical-align: top;">12.2.4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Loss of rent insurance, as stated in <u>Appendix B</u>.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z15c2285f7aba45e99c21e296b629c41c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">12.3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessee undertakes to observe the full terms of the guarantee and the protection requirements laid down by the insurer in the policy and provide to the Lessor confirmation from a safety examiner confirming their actual existence.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z440b4556a57e474da4891a2b76d56906" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">12.4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The insurance policies shall be in full compliance with the latest wording of the BIT insurance policies.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zdd424ddcab6143e79ffca20711fb06b4" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">12.5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessor and Mr. Daniel Bucke, a shareholder in the Lessor, shall be added as additional insureds to all insurance policies as stated above. The Lessee undertakes to cause that the said insurance policies will include a cross-liability
                clause and shall undertake not to cancel the policies or modify their conditions without delivery of written notice to the Lessor no less than 30 days in advance.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zdc916ac3c5154bd0b511b5c312a70b2e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">12.6.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessee shall incur any payment for the deductible required in connection with the said policies, except for earthquake.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">12</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="ze72fd7bc95e94902997631a328e55e3c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">12.7.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>During the entire Term of Lease the Lessee undertakes to keep the said insurances in effect, observe the entire terms set forth in the policies and make full and timely payment of the insurance premiums.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zaed68b7590954798b38f3684229fcfd1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">12.8.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessee undertakes to indemnify the Lessor for any damage caused to the Lessor as a result of breach of this section or breach of the provisions set forth in the said insurance policies.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z04b6d69729b4488786bac5ea74889c34" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">12.9.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Prior to the commencement date of this Agreement the Lessee shall provide to the Lessor a certificate of insurance in the form attached as <u>Appendix B</u> of this Agreement, and shall provide each the relevant certificate as said on
                the date of extension of any policy as said. Without derogating from the foregoing, the Lessee shall provide to the Lessor, whenever the Lessor presents such a demand, copies of the insurance policies in accordance with this Agreement.
                After the occurrence of the insured event and the repair of the damage, the Lessee shall be obligated to restore the sum insured to its previous amount and pay the insurance premiums at the earliest opportunity.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z6c8858a159e545ab8c9cb9ccf07f45d9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">12.10.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The parties shall endeavor to the best of their ability (within the present costs of the policy) for the purpose of removing the relevant provisions from the policy requirements in such manner that failure to comply with the said
                provisions shall not deny the said rights.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zb29eb1126c324ce68bf6a7b5a7b344a7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">12.11.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessee shall have no objection to the future extension of the policy, on the condition that the Lessor pays the insurance premiums for these additions.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z3be7424a76d04971bb4cbdac667d2a85" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">12.12.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessee shall not be entitled to reduce the insurance premiums for earthquakes after increase of the deductible.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z408b7993fe294873955c4acbf05535e5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">13.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;"><u>Undertaking of the Lessee regarding the use of the Leased Premises</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zcfebe636a5c54f4db924930e3c66cbec" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">13.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessee undertakes to observe and uphold the entire provisions of the law in connection with the operation and the management of its business in Leased Premises, and in this regard shall obtain business licenses and observe their
                entire terms, as required under any law. The Lessee undertakes that its activity in the Leased Premises shall be, in every respect, in compliance with and subject to the provisions of any law governing its actions. The Lessee shall notify
                the Lessor regarding any demand the Lessee received from any authority in connection with the existence of such a permit or a license.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">13</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zc5bad7ec1e574a7ca9b5c074034e3273" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">13.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessee undertakes to keep the Leased Premises in good condition, tidy and clean, and provide proper maintenance to the Leased Premises and report to the Lessor regarding any breakdown therein. The Lessee undertakes to repair at its
                expense and promptly any damage or breakdown that will be caused and/or that will be formed in the Leased Premises or any part thereof as a result of an act and/or omission of the Lessee during the Term of Lease (except for breakdowns that
                were caused as a result of an act and/or omission of the Lessor and/or breakdowns that are considered as reasonable wear and that are under the responsibility of the Lessor subject to the limitation as stated hereunder). If the Lessee fails
                to make the necessary repairs and the damages as stated above, the Lessor shall be entitled, however not obligated, after delivery of a 14 days&#8217; prior notice to the Lessee, to repair by itself and/or by anyone acting on its behalf any
                damage event at the Lessee's expense, and for that purpose enter the Leased Premises by appointment with the Lessee. The Lessee shall pay to the Lessor, in 14 days as of the date of receiving the written notice from the Lessor, any
                reasonable expense that the Lessor paid for the purpose of performing such a repair as said against receipts presented to the Lessee.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 70.9pt; line-height: 1.25;">The Lessor shall incur the repair costs of breakdowns that were formed in the Leased Premises as a result of ordinary and reasonable wear that are not the result of changes
        that were performed by the Lessee in the Leased Premises and/or as a result of unreasonable use by the Lessee in the Leased Premises. The Lessee shall present to the Lessor a quotation prepared by a professional for the purpose of performing the
        repair and the Lessor may decide whether it shall perform the repair by itself or whether the repair shall be performed by a professional on behalf of the Lessee at the Lessor's expense. If the Lessee performed a repair that the Lessor is
        responsible for performing in accordance with this Agreement, the Lessor shall return to the Lessee the costs of the repair against presentation of invoice proving the work costs. Breakdowns for the purpose of this matter this section shall only
        include breakdowns in the skeleton frame of the building, its exterior walls, the feed systems reaching the building and parking and utility areas. The Lessor shall not incur the cost of the repair in the systems of the building, including the
        sewage, water, air-conditioning systems and any other system in connection with the production process.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">14</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zb57a1b87db6d41d78a161a94a0b4115b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">13.3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessee undertakes to allow the Lessor and/or to its representatives to enter the Leased Premises at any reasonable time and by appointment with the Lessee, for the purpose of ensuring that the Lessee performs its entire undertakings
                in accordance with this Agreement. In addition, during the Term of Lease the Lessor shall be entitled to enter the Leased Premises as said for the purpose of showing the Leased Premises to potential buyers or lessees.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="ze5e1f4fc74d84c638c1dc94c458aa803" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">14.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;"><u>Vacating the Leased Premises</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z4e45081e072c46d8b2f982928ea272fb" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">14.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Upon expiration of the Term of Lease, or in the event that the Lessee commits a fundamental breach of this Agreement that, in accordance with the provisions set forth in this Agreement, entitles the Lessor to demand the evacuation of the
                Leased Premises prior to the expiration of the Term of Lease, the Lessee shall vacate the Leased Premises and shall return possession therein to the Lessor when the Leased Premises are free from any person and article owned by the Lessee
                and/or anyone acting on its behalf, in working order and on their condition on the lease commencement date, and to the extent that any changes were made &#8211; according to these changes, and except for reasonable wear as a result of the
                ordinary use of the Leased Premises. It is clarified that the Lessee shall be entitled to remove from the Leased Premises any item of equipment and/or change that the Lessee performed in the Leased Premises and that is not permanently
                attached to the Leased Premises.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zcdaf5fe25c3f46819958ec432dc58ed3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">14.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessee shall produce, in 30 days as of the expiration of the Term of Lease, approvals issued by all relevant authorities, including the municipality, Israel Electric Corp., Ministry of Environmental Protection (to the extent that
                this is required by law), confirming that the Lessee paid all payments due from it and performed its entire obligations.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z5310342fc60c4b99b8f5cfb53160a0c6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">14.3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessee shall pay to the Lessor for each day of delay in the event subject matter of the claim of the Leased Premises and returning possession therein to the Lessor in accordance with the terms set forth in paragraphs 12.1 and 12.2
                above pre-estimated liquidated damages for an amount equal to twice the amount of the Rent due to the Lessor for the last day of lease in the Term of Lease set out in this Agreement, without derogating from any other right or relief that
                the Lessor may seek in accordance with this Agreement.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">15</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z93ec7e884fe54fff8f25f6e0b7fa97e6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">15.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;"><u>Transfer of rights</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160; <br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z95b35613d4a54e23b91846011a486530" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">15.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessor shall be entitled to sell and transfer its rights in the Leased Premises and/or its rights under this Agreement and/or to charge and pledge the said rights without obtaining the prior approval of the Lessee, and on the
                condition that the rights of the Lessee under this Lease Agreement shall not be impaired thereby. To the extent that the approval or the consent of the Lessee are requested by a third party, a buyer or a party charging rights as said, the
                Lessee shall provide such approval solely based on the provisions set forth in this section.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z8ac898db3f70469a9ce4bc825f241d79" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">16.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;"><u>Non-applicability of tenancy protection laws</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zdb0e524cf5b24c48aefea0436721e6d5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">16.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The parties declare expressly that this lease is made under the express condition that it shall not be governed by tenancy protection laws. The Lessee declares that it did not pay and will not pay to the Lessor key money or any other
                consideration other than the Rent, and the Lessee or anyone acting on its behalf shall not be deemed as protected tenants in the Leased Premises in accordance with the law.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z258901604bd74fc9af32c5c94c1a4e73" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">16.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Leased Premises is an area in a new building, pursuant to section 14(a) of the Tenant Protection Law, and there was no tenant entitled to possess the Leased Premises on the commencement date of the Tenant Protection Law 5728-1968.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z39f512af66904a39b8be64ff1dca0199" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">16.3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Without derogating from the foregoing, it is hereby stated that the provisions of the Tenant Protection Law [Consolidated Version] 5732-1972 including all amendments thereof shall not apply to the lease of the Leased Premises by the
                Lessee in accordance with this Agreement.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="za471b3aa00fb4525883f98c86c518f2a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">16.4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>It is hereby clarified and agreed expressly and clearly that the Lessee is under no obligation to make any changes and/or additions and/or investments of any kind in the Leased Premises, and to the extent that the Lessee decided to
                perform these changes, it performed them voluntarily and without receiving any request from the Lessor and/or under no obligation imposed by the Lessor.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zb985660a626449c187ffb12672b69a9e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">16.5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessee declares that the entire investments it will make in the Leased Premises, including equipment and facilities, shall be made solely for its own purposes and the Lessee shall be precluded from claiming that these investments
                constitute key money or in lieu of key money or payment in accordance with section 82 of the law, and or any payment conferring on the Lessee any rights in the Leased Premises, and the Lessee shall be precluded from demanding any
                participation or reimbursement from the Lessor, whether in whole or in part, in respect of the said investments.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">16</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z1abd199aec5b40c6bab1fb87437e17e9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">17.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;"><u>Securities</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z6abc464e42934953850dda2d7dff4dfb" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">17.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>For the purpose of ensuring the performance of the entire undertakings of the Lessee in accordance with this Agreement, at the time of signing this Agreement the Lessee shall deposit with the Lessor an autonomous bank guarantee issued by
                an Israeli bank, exercisable unconditionally according to its terms, index-linked, for an amount of 6 months of lease with the addition of VAT. The Lessor shall be entitled to use the guarantee for the purpose of collecting any debt due to
                the Lessor from the Lessee under this Agreement, provided that the Lessor notifies the Lessee 14 days in advance regarding its intention to use the guarantee. The guarantee shall be in effect for a period of 3 years, provided that the last
                guarantee is in effect 90 days after the expiration of the Term of Lease or the Option Term, if exercised. The Lessor undertakes to provide a new guarantee and update the guarantee amount every three years in respect of an increase in the
                amount of the Rent in such manner that the value of the guarantee shall reflect the updated amount of the Rent. The Lessee shall provide the new guarantee 30 days prior to the date of update of the Rent as stated in section 8.3 above. If
                the Lessor used the guarantee for the purpose of recovering its losses, the Lessee undertakes to provide, within 7 days afterwards, a new guarantee in respect of the amount that was realized as said, in such manner that the Lessor shall
                have at all times a guarantee for the full amount. To the extent that the Lessor sells or transfers its rights in the Leased Premises in accordance with the provisions of section 15 above, the Lessee undertakes to provide a new guarantee in
                favor of the party that will step in and take over the Lessor in this Agreement, provided that on the deposit date of the new guarantee the Lessor returns to the Lessee the guarantee in its possession.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 70.9pt; line-height: 1.25;">For the avoidance of doubt, it is clarified that to the extent that the amount of the losses sustained by the Lessor exceeds the guarantee amount, the Lessor shall be entitled
        to recover and claim all the said damages exceeding the guarantee amount.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">17</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zfc1d31770e8b4f42950d57ed66b8cead" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">18.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;"><u>Reliefs and remedies</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z91a225af6c2a4e30bffcf50fe8646c42" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">18.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Breach of any of the conditions set forth in this Agreement shall entitle the injured party to seek all reliefs and remedies set out for the purpose of this matter in the Contracts Law (Remedies for Breach of Contract), 5731-1970 without
                derogating from any other relief set out in this Agreement.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zea747c52017c4b849667ea7793cbaf20" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">18.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>In addition to any other relief set out by law, the Lessor shall be entitled to rescind this Agreement and the rights of lease contemplated hereby, and the Lessee shall be obligated to vacate the Leased Premises forthwith and return
                possession therein to the Lessor in accordance with the terms set forth in section 14 above, if the Lessee committed a fundamental breach any of the provisions set forth in sections 6, 7, 8, 10, 13, 14, and 17 of this Agreement including
                subsections thereof, and failed to cure the breach even after receiving a 21 days&#8217; prior and written notice in connection therewith.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zd9bf230c8b104825842db5687a5f25bd" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">18.3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Any overdue payment shall entitle the Lessor, in addition to any other relief, to obtain from the Lessee interest on overdue amounts according to the customary interest rate at the time charged from overdrafts in current loan accounts in
                Bank Leumi le-Israel Ltd., calculated with respect to the overdue payment for the period the amount was overdue. It is clarified that a delay of up to 7 days in making any payment occurring three times during each year of lease shall not be
                deemed as breach of this Agreement and no interest on overdue amounts shall be paid in respect whereof as said.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zcf55013ce79b42b8b24ea67cae0b3c27" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt; vertical-align: top;">19.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;"><u>Miscellaneous</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z4ac4c124b19a4186927fdb600be9d105" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">19.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The preamble hereto shall be deemed an integral part of this Agreement.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z6d34c214300b48ffbd4bed152ec33b41" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">19.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>If a party to this Agreement paid to another party, after delivery of a 10 days&#8217; prior and written notice, any amount that the other party is obligated to pay by virtue of the provisions of any law or by virtue of the provisions set
                forth in this Agreement, the indebted party shall be obligated to return to the paying party the amount paid with the addition of interest, as stated in section 18.3 above.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z2157ede81b5d4485acae219ebe3e068e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">19.3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Any modification or amendment of this Agreement or any condition thereof or waiver executed under this Agreement shall be valid and binding only if executed in writing and signed by the parties hereto. The provisions of this Agreement
                include the entire contractual arrangement between the parties.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">18</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z2b2634992e00499d8abab9acbb09e703" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">19.4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessee shall incur the stamp duty in connection with this Agreement.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="za6a7e9c51d884829a3ae58e029c606fd" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">19.5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Lessee undertakes that as of the signing date of this Agreement, the Lessee shall not request an exemption from taxes to the municipalities on the grounds of &#8220;vacant property&#8221; during the Term of Lease, even in the event the Lessee is
                entitled to request such an exemption. Notwithstanding the aforesaid, the Lessee shall be entitled to request any exemption and/or discount in municipal property tax that shall not derogate from the right of the Lessor to demand an
                exemption for a &#8220;vacant property.&#8221;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zb800e9bc2d924f95bd5ed3d0491274a5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">19.6.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Any dispute or difference of opinion between the parties shall be decided by an arbitrator who is a retired District Court judge that will be appointed with the approval of the parties, or, in the absence of such approval, by the
                President of the Israeli Institute of Commercial Arbitration. The arbitrator shall be subject to substantive law however shall not be bound by the laws of evidence and the procedures of the law. The arbitrator shall be authorized to issue
                interim reliefs, permanent and temporary orders of any kind and type, and partial judgments, including for expulsion. A party filing a claim shall deposit with the arbitrator 5% of the sum claimed for the purpose of covering the expenses of
                the other party, in the event that the claim is dismissed.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z059ccfbb544048feb3f4fb2d727285dd" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">19.7.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>If the Lessee ceases to file reports in the stock exchange in the United States or in Israel, the Lessee shall provide to the Lessor, following its demand, once every six months, an unaudited financial statement, and an audited financial
                statement, once a year.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z6bc9ce402cb848b78b79f0176835c1d6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.35pt;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top;">19.8.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The addresses of the parties for the purpose of this Agreement are as stated in the preamble hereto (with respect to the Lessee, the address during the Term of Lease shall be the address of the Leased Premises) or any other address in
                Israel as notified by a party to the other party in a letter in registered mail. Notices in connection with this Agreement shall be exchanged between the parties, <font style="font-style: italic;">inter alia</font>, by email, to the CEO or
                to another manager in the Lessor, and to Mr. Daniel Bucke on behalf of the Lessor.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">19</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">In Witness Whereof The Parties Hereto Have Hereunto Set Their Hands And Seal </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">In The Place and On The Day, Month And Year First Hereinabove Written:</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z4c7e0b1fd60e4368a10e75daa0d6b484" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 42.63%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 1.25;">/s/ Yovel Nachmani</div>
            </td>
            <td style="width: 16.39%; vertical-align: top;">&#160;</td>
            <td style="width: 40.98%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="line-height: 1.25;">/s/ Ofer Gonen&#160; /s/ Hani Luxenburg</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.63%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">The Lessor</div>
            </td>
            <td style="width: 16.39%; vertical-align: top;">&#160;</td>
            <td style="width: 40.98%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">The Lessee</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.63%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 16.39%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 40.98%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 42.63%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-weight: bold;">I confirm that the signatures above are the signatures of the Messrs. ______________ and ______________, and that these signatures lawfully bind the Lessor.</div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
              <div style="text-align: justify; line-height: 1.25; font-weight: bold;">______________</div>
              <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-weight: bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, Adv.</div>
            </td>
            <td style="width: 16.39%; vertical-align: top;">&#160;</td>
            <td style="width: 40.98%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-weight: bold;">I confirm that the signatures above are the signatures of the Messrs. Asi Segal and Ofer Gonen, and that these signatures lawfully bind the Lessee.</div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
              <div style="line-height: 1.25;"><u>/s/Yaron Meyer</u></div>
              <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Yaron Meyer, Adv.</div>
              <div style="text-align: justify; line-height: 1.25; font-weight: bold;">License No. 40637</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
  </div>
  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">20</font>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.23
<SEQUENCE>5
<FILENAME>exhibit_4-23.htm
<DESCRIPTION>TURNKEY PROJECT AGREEMENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" align="center">
    <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 4.23</font></u><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: center; line-height: 1.25;">TURNKEY PROJECT<font style="font-weight: bold;">&#160;</font>AGREEMENT</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;">This Agreement is made the 17 day of July 2023</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">BETWEEN</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Mediwound Ltd.</font> registration number 512894940, a company incorporated in Israel and having its principal place of business at 42 Ha&#8217;Yarkon St., Yavne 8122745
        Israel<font style="font-weight: bold;">&#160;</font>(the &#8220;<font style="font-weight: bold;">Customer</font>&#8221;)</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">AND</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Biopharmax Group Ltd.</font> registration number 51-241021-8, a private company incorporated in Israel and having its principal place of business at 4 Hasadnaot
        St., Hertzelia (the &#8220;<font style="font-weight: bold;">Contractor</font>&#8221;)</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">WHEREAS:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Customer wishes to establish, commission and validate a state of the art, sterile, GMP manufacturing facility, with complete clean rooms, for production of NexoBrid<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> products all conforming to cGMP, FDA, EMA, MOH (as defined below) and other Israeli regulations and requirements (the &#8220;<font style="font-weight: bold;">Project</font>&#8221;)
        in the building located at 42 Ha&#8217;Yarkon St., Yavne 8122745, Israel (the &#8220;<font style="font-weight: bold;">Facility</font>&#8221;, or &#8220;<font style="font-weight: bold;">Site</font>&#8221;);</div>
      <div style="text-align: justify; line-height: 1.25;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor wishes to undertake the performance of all the Works, (as defined below), all subject to the terms and conditions of the Agreement as set forth herein below;</div>
      <div style="text-align: justify; line-height: 1.25;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor represents that it is an independent contractor, duly registered with the Israeli Contractor registrar and having the required license under applicable laws and
        regulations to perform the type of works contemplated under this Agreement, and that it has the know-how, expertise, financial and technical means and experience required for execution and completion of the Works all in accordance with and subject
        to the terms and conditions set forth herein;</div>
      <div style="text-align: justify; line-height: 1.25;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor has thoroughly examined and studied necessities and requirements, the premises set forth in Section 2 to this preamble above and its surroundings, as well as the annexes
        attached hereto, and represents and warrants that it is capable to perform and complete the Works in compliance with the terms of this Agreement, and in accordance with the best industry standards and within the Timetable; and</div>
      <div style="text-align: justify; line-height: 1.25;">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On the basis of Contractor&#8217;s warranties, representations and covenants set forth herein, Customer has agreed to engage the Contractor, as an independent contractor, to perform the Works
        in accordance with terms herein and Contractor has agreed to perform the Works as aforesaid.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">NOW THEREFORE, the parties declare, stipulate and agree as follows:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-right: 18pt; line-height: 1.25;"><font style="font-weight: bold;">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">DEFINITIONS AND INTERPRETATIONS</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">1.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The following terms shall have the meanings appearing alongside them:</div>
      <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">Agreement</font>&#8221; &#8211; means the this Turnkey Project Agreement and its Annexes and any document which has been / will be agreed upon in writing constitutes part of the Agreement even if
        not actually attached to the Agreement.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Bill of Quantity</font>&#8221; &#8211; means the bill of quantity setting forth all the Means required prepared by Contractor based on the requirements of the Design, User
        Requirement Specifications and the Basis of Design attached hereto as <font style="font-weight: bold;"><u>Annex A</u></font>.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">&#160;&#8220;<font style="font-weight: bold;">Detailed Design</font>&#8221; &#8211; means the basis of design prepared by Contractor and approved by the Customer and/or which will be attached in the future.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">cGMP</font>&#8221; &#8211; the current Good Manufacturing Practices.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><font style="font-weight: bold;">&#8220;Drawings&#8221;</font> &#8211; means the drawings for execution of the Work (as defined below) which are attached to the Agreement as <font style="font-weight: bold;"><u>Annex C1</u></font>,
        and/or which will be attached in the future.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">DQ</font>&#8221; &#8211; means the design qualifications.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">EMA</font>&#8221; &#8211; means the European Medicines Agency, or any successor agency.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">FDA</font>&#8221; &#8211; means the United States of America Food and Drug Administration, or any successor agency.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">Means</font>&#8221; &#8211; means the equipment, supplies, tools, materials, structures, scaffolding, installations and everything else that provided by the Contractor and required for execution
        of the Works or which will be used for the execution thereof.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">MOH</font>&#8221; &#8211; means the Israeli Ministry of Health, or any successor agency.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">IC</font>&#8221; &#8211; means the installation commission<font style="font-weight: bold;">.</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">IQ</font>&#8221; &#8211; installation qualifications.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">OC</font>&#8221; &#8211; means the operation commission.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">OQ</font>&#8221; &#8211; means the operation qualification.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">Regulations</font>&#8221; &#8211; means the applicable current cGMP, FDA, EMA, MOH and Israeli regulations required for the construction, maintenance and operation of the Facility.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Scope of Work</font>&#8221; &#8211; means the scope of work including the detailed design, management, supervision. implementation and execution of the Works (including but
        not limited to any and all necessary design, material and equipment procurement, construction, testing, validation, training, applicable licensing, and warranty of the Facility and overall scope for the Project, in the form attached as <font style="font-weight: bold;"><u>Annex B</u></font>, that may be updated by the Contractor in accordance with the progress of the Work, subject to Customers prior written consent.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">&#8220;<font style="font-weight: bold;">Specifications</font>&#8221; &#8211; means the specifications of the Facility as specified in and in accordance with the Design, Detailed Design and the Bill of Quantity.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Timetable</font>&#8221; &#8211; means the timetable for the performance and completion of specific stages of the Work as set forth in <font style="font-weight: bold;"><u>Annex
            D</u></font>.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Work</font>&#8221; and/or &#8220;<font style="font-weight: bold;">Works</font>&#8221; &#8211; means the execution, performance and completion of the Project on a turnkey basis, inclusive
        of all Means and services as set forth in the Scope of Work, meeting<font style="font-weight: bold;">&#160;</font>all of the Specifications.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">1.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Preamble hereof and all Annexes attached hereto form an integral part of this Agreement. The headings of the Sections, Sub-Sections or chapters in the Agreement
        are for convenience only, and shall not serve in interpretation of the Agreement.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">1.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In any case of discrepancy or contradiction between the provisions of this Agreement or between one of its provisions and one if its Annexes, the provisions of the
        Agreement will prevail. In case of conflict between the Annexes, the provisions of the Annexes shall govern in accordance with the following order: <font style="font-weight: bold;"><u>Annex C2</u></font> (detailed Design), <font style="font-weight: bold;"><u>Annex C1</u></font> (Drawings), <font style="font-weight: bold;"><u>Annex B</u></font> (Scope of Work), <font style="font-weight: bold;"><u>Annex A</u></font> (Bill of Quantity).</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="margin-right: 18pt; line-height: 1.25;"><font style="font-weight: bold;">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">THE ESSENCE OF THE AGREEMENT</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">2.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Customer hereby conveys to the Contractor and the Contractor hereby undertakes upon itself the execution and completion of the Works, on a turnkey basis, at
        Contractor&#8217;s own expense and on its own responsibility and in exchange for the Consideration (as defined below), all in accordance with the provisions of the Agreement and the Scope of Work.</div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">2.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except as explicitly provided in the Scope of Work as being excluded from the Work but subject to Section 4.3 below (the &#8220;<font style="font-weight: bold;">Excluded
          Items</font>&#8221;), the Contractor shall perform or cause to be performed all Work and services required in connection with the design, management, procurement, construction, DQ, IC OC, IQ and OQ and testing of the Works and the Facility, and provide
        all materials and equipment machinery, tools, labor, transportation, utilities, administration, training and other services, items and Means required to complete the Works on a turnkey basis in accordance with the Scope of Work and the
        Specifications and within the time schedule set forth in the Timetable, for the Consideration. Upon successful completion of DQ, IC OC, IQ and OQ testing of the Work and the Facility and issuance of a Certificate of Completion, all responsibilities
        regarding the Facility and Works shall pass to the Customer, subject to Contractor&#8217;s warranty as set forth in Section 17 below.</div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">2.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Facility shall be constructed by Contractor and operable in accordance with cGMP, and, in addition, will meet the current requirements in effect as of the date
        of this Agreement of the FDA, EMA, MOH and other relevant authorities of Israel. In addition, the Contractor will be responsible for the implementation of any comments that may be submitted following any inspection performed by any regulatory
        authorities (mainly but not limited to the FDA) in the Facility. Contractor shall fix any such rejects at its own costs, as long as the comments address issues and regulations that applied as of the Effective&#160;Date.</div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">2.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor undertakes to bear overall liability towards the Customer as the Main Contractor (&#8220;KABLAN RASHI&#8221;) of the Works and assume all liability and
        obligations thereof, and the Customer&#8217;s involvement, approval of (at any stage of the Work) or employment of subcontractors shall not derogate from the Contractor&#8217;s liability towards the Customer and/or any third party under any law and/or
        regulations and/or this Agreement.</div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">2.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In connection with the aforementioned in Section 2.4, the Customer will direct its employees and subcontractors that will access the Site (as defined below) during
        the Work, to comply with the Contractor&#8217;s instructions and to cooperate with Contractor. Notwithstanding, in any event the Contractor shall have overall liability over the Works and the Site as the Main Contractor.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-right: 18pt; line-height: 1.25;"><font style="font-weight: bold;">3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">ANNEXES</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">The Annexes to this Agreement are listed below:</div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">3.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Bill of Quantity Rev7 &#8211; <font style="font-weight: bold;"><u>Annex A</u></font>.</div>
      <div style="line-height: 1.25;">3.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Scope of Work &#8211; <font style="font-weight: bold;"><u>Annex B</u></font>.</div>
      <div style="line-height: 1.25;">3.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Drawings &#8211; <font style="font-weight: bold;"><u>Annex C1</u></font>.</div>
      <div style="line-height: 1.25;">3.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Detailed Design - <font style="font-weight: bold;"><u>Annex C 2</u></font>.</div>
      <div style="line-height: 1.25;">3.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Timetable &#8211; <font style="font-weight: bold;"><u>Annex D</u></font>.</div>
      <div style="line-height: 1.25;">3.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Certificate of Completion &#8211; <font style="font-weight: bold;"><u>Annex E</u></font>.</div>
      <div style="line-height: 1.25;">3.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Payment Schedule- <font style="font-weight: bold;"><u>Annex F</u></font>.</div>
      <div style="line-height: 1.25;">3.8&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Certificate of insurance by the Contractor- <font style="font-weight: bold;"><u>Annex G</u></font>.</div>
      <div style="line-height: 1.25;">3.9&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Lease Agreement &#8211; <font style="font-weight: bold;"><u>Annex I</u></font>.</div>
      <div style="line-height: 1.25;">3.10&#160;&#160;&#160;&#160;&#160;&#160;&#160; Bank Guarantee &#8211; <font style="font-weight: bold;"><u>Annex J</u></font>.</div>
      <div style="line-height: 1.25;">3.11&#160;&#160;&#160;&#160;&#160;&#160;&#160; Service Level Agreement &#8211; <font style="font-weight: bold;"><u>Annex K</u></font>.</div>
      <div style="line-height: 1.25;">3.12&#160;&#160;&#160;&#160;&#160;&#160;&#160; Validation Master Plan (part of the IQ and OQ) &#8211; <font style="font-weight: bold;"><u>Annex M</u></font>.</div>
      <div style="line-height: 1.25;">3.13&#160;&#160;&#160;&#160;&#160;&#160;&#160; List of Approvals to be provided by Contractor &#8211; <font style="font-weight: bold;"><u>Annex N</u></font>.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-right: 18pt; line-height: 1.25;"><font style="font-weight: bold;">4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>CONSTRUCTION SCHEDULE; LIQUIDATED DAMAGES; BANK GUARANTEE</u></font></div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">4.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor shall carry out the Works in accordance with the Scope of Work and time schedule set forth in the Timetable (<font style="font-weight: bold;"><u>Annex
            D</u></font>).</div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">4.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor shall complete the Works and by the completion date set forth in the Timetable (&#8220;<font style="font-weight: bold;">Project Completion Date</font>&#8221;).
        Contractor shall provide Customer with prompt notice upon it becoming aware of any reason which will cause a delay in the performance of the Work in accordance with the Timetable.</div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">4.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If in the opinion of the Customer and based upon the Timetable, the Contractor is behind schedule, the Customer will direct the Contractor to take, and Contractor
        shall accordingly take appropriate action to accelerate the performance of the Work so that the Project Completion Date is not jeopardized. Such action shall include but not be limited to overtime, shift work, additional construction equipment,
        extra work crews, etc. (as applicable), regardless of whether this was an Excluded Item. Any extra costs associated with such action will be borne by the Contractor, unless the delay was caused by an event that entitles the Contractor to a time
        extension, pursuant to Section 22 below or caused by the Customer or due to Customer&#8217;s instructions.</div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">4.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor shall be responsible for payment of liquidated damages for any delays in the completion of the Works by the Project Completion Date plus a grace
        period of 6 (Six) weeks (the &#8220;<font style="font-weight: bold;">Grace Period</font>&#8221;), caused by the Contractor, its employees, agents, subcontractors, suppliers or any other person or entity for whose acts the Contractor is liable, including but
        not limited to, delays caused by problems with the Design. In the event of delays in completion of the Work beyond the Grace Period, the Customer shall be entitled, following written notice to the Contractor, but without recourse to judicial
        proceedings or proving any damages, to collect from Contractor and Contractor shall pay Customer as liquidated damages (and not as a penalty) US$3,000 (Three Thousand US Dollars) per week for each week of delay up to maximum of US$20,000 Twenty
        Thousand US Dollars). The payment of any liquidated damages hereunder shall not affect Customer&#8217;s right to terminate the Agreement and the consequences thereof. Should the Contractor be delayed by any cause constituting an event of Force Majeure
        (as defined below), then the Project Completion Date shall be extended for a period equivalent to the time lost by reasons of any event of Force Majeure, subject to and in accordance with Section 22 below.</div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">4.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As a guarantee for execution in full of all the Contractor&#8217;s undertakings under this Agreement, on the Effective Date (as defined below), the Contractor shall
        provide to Customer an unconditional, autonomic, irrevocable bank guarantee, in the sum equal to 7.5% of the Total Price set forth in Section 14.1 below (i.e. USD&#160; 787,500) in NIS (the &#8220;<font style="font-weight: bold;">Bank Guarantee</font>&#8221;),
        sibilantly in the format attached hereto as <font style="font-weight: bold;"><u>Annex J</u></font>, which shall remain valid until issuance of Certificate of Completion (as defined below).</div>
      <div style="text-align: justify; line-height: 1.25;">Upon and as a condition to issuance of Certificate of Completion, as a guarantee for execution in full of all the Contractor&#8217;s undertakings under this Agreement during the Warranty Period, the
        Contractor will provide to Customer a new unconditional, autonomic irrevocable Bank Guarantee in the sum equal to 5% of the Total Price set forth in Section 14.1 below, which will expire at the end of the Warranty Period, unless the Customer
        complains of defects in the Work, in which case the Bank Guarantee will be extended until the completion of the repair of such defects by the Contractor (&#8220;<font style="font-weight: bold;">Repair Period</font>&#8221;). In the event that the Bank
        Guarantee(s) has been forfeited, in full or in part, for any reason, the Contractor undertakes to immediately provide the Customer with a new Bank Guarantee or to complete the forfeited Bank Guarantee, all within five (5) days as of the day of
        forfeiture. The Contractor undertakes to furnish the Customer with an extension of the Bank Guarantee until the laps of sixty (60) days following the issuance of Certificate of Completion end of the Warranty Period or Repair Period (as applicable),
        at least seven (7) days prior to expiration of the Bank Guarantee.</div>
      <div style="text-align: justify; line-height: 1.25;">If the Contractor fails to comply with any of the provisions in this Section 4.5 the Contractor shall be deemed to be in material breach of this Agreement and the Customer may exercise the Bank
        Guarantee.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-right: 18pt; line-height: 1.25;"><font style="font-weight: bold;">5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">SUBCONTRACTING</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">5.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor shall be entitled to subcontract all or part of the Works, provided that the subcontracting by Contractor of any portion of the Work valued at NIS
        400,000 (four Hundred Thousand New Israeli Shekels) or more, shall require the prior written consent of the Customer.<br>
        <br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">5.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Contractor shall remain fully responsible and liable for the performance of all Works and all of Contractor&#8217;s undertakings under this Agreement and for all acts and
        omissions of any of its subcontractors. Any breach of this Agreement by a subcontractor or supplier of Contractor shall be deemed a breach of this Agreement by the Contractor.<br>
        <br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">5.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Nothing contained in this Agreement and/or any agreement or arrangement between the Contractor and any subcontractors or suppliers shall create any contractual
        obligations on the part of the Customer to any subcontractor or supplier and Contractor shall be solely responsible for any payments due to any such subcontractor or supplier.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="line-height: 1.25;"><font style="font-weight: bold;">6.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">SUPERVISION; PROJECT MANAGER AND QUALIFIED PERSONNEL</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">6.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor shall designate a fulltime project manager (the &#8220;<font style="font-weight: bold;">Contractor</font>&#160;<font style="font-weight: bold;">Project Manager</font>&#8221;),
        agreed by the Customer, to be responsible for the execution of the Works. The Project Manager shall have the experience, skills and capability to timely complete the Work according to this Agreement.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">6.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The<font style="font-weight: bold;">&#160;</font>Contractor Project Manager shall act as single point of contact and have authority to act on behalf of the Contractor.
        The Contractor Project Manager will be available to attend weekly meetings with the Customer&#8217;s representatives and at any other time following Customer&#8217;s request.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">6.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Customer will appoint a project manager on its behalf (the &#8220;<font style="font-weight: bold;">Mediwound Project Manager</font>&#8221;), to be responsible for the
        supervision over performance of the Customer&#8217;s obligations related to&#160;the Work. The Mediwound Project Manager will be available to attend weekly meetings with the Contractor Project Manager. Without derogating from the Contractor&#8217;s responsibilities
        and obligations, the Contractor undertakes to fulfill the instructions of the Mediwound Project Manager and obey him.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">6.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Customer may appoint a person or entity to inspect the Work and the Site on behalf of Customer (the &#8220;<font style="font-weight: bold;">Inspector</font>&#8221;). The
        Inspector and the Mediwound Project Manager will have full authority to perform any action in connection with inspecting the Site and/or the Work during the term of this Agreement and Contractor shall grant such Inspector and/or Mediwound Project
        Manager, as applicable, with full access to the Site and the Works. From time to time, the Contractor Project Manager will write up (as directed by the Inspector) a list of repairs and/or completions, that are due to be performed in order to
        complete the Work according to the provisions of this Agreement, however such list or any other action taken by the Inspector and/or Mediwound Project Manager, as applicable, will not derogate from the Contractor&#8217;s obligations and responsibility
        under this Agreement. All communications and findings will be transferred directly to the Customer through the Contractor Project Manager or the Inspector and/or Mediwound Project Manager, as applicable, and Customer will than have the right to
        respond and/or to request adjustments to any such communications and/or findings, including, <font style="font-style: italic;">inter alia, </font>any design<font style="font-style: italic;">.</font></div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">6.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any changes or replacement of personnel mentioned in this Section 6, shall require the Customer&#8217;s prior written consent.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">6.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor shall be responsible for all aspects of Site maintenance during the Project and until receiving the relevant Certificate of completion including but
        not limited to, safety, but not including utility expenses (electricity, water, communication, waste etc.).</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-right: 18pt; line-height: 1.25;"><font style="font-weight: bold;">7.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">REPORTING</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">The Contractor shall submit to the Customer weekly and monthly progress reports on the Work performed, including updated Timetables showing, among other things, the relevant portion of the Work
        performed. The reports shall be in such form as shall be agreed upon by the parties. In addition, the Contractor shall provide Customer with any additional information regarding the Work as may be reasonably requested by the Customer from time to
        time.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="margin-right: 18pt; line-height: 1.25;"><font style="font-weight: bold;">8.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">COMPLIANCE</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">8.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor hereby warrants, represents and undertakes that it shall comply with the applicable laws, rules, regulations and/or ordinances applicable to the
        performance of the Work. The Contractor hereby warrants, represents and undertakes that it shall secure, and pay for maintaining in effect throughout the term of this Agreement, all permits, governmental fees and licenses necessary for Contractor
        to operate in Israel and to carry out the Work in accordance with this Agreement and applicable laws, rules, regulations and/or ordinances.</div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">8.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Contractor shall reasonably assist Customer in all technical matters relating to such permits and shall provide Customer with the approvals listed on <font style="font-weight: bold;"><u>Annex N</u></font> attached hereto and all other approvals required to be provided by Contractor in order to enable Customer to obtain a business permit for the Facility. Such approvals include, but are not limited
        to, the approval of the Association of Cities for Fire and Rescue Services, Standards Institute - for the fire detection system, Standard 1001 and approval by the Ministry of Health. It is clarified that licenses, permits and fees related to the
        Facility and Project itself shall be Customer&#8217;s responsibility.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">8.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Without derogating from the foregoing, the Contractor hereby warrants, represents and undertakes that it:</div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">8.3.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shall comply with the laws of Israel, including, without limitation, social insurance law, labor law, tax law, safety laws and all other laws, regulations and
        requirements that may be applicable to the performance of the Work;</div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">8.3.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shall be responsible for the safety of the entire Project, the Site and any person therein, and shall appoint an authorized work manager (&#1502;&#1504;&#1492;&#1500; &#1506;&#1489;&#1493;&#1491;&#1492;&#160;&#1502;&#1493;&#1505;&#1502;&#1498;) in
        accordance with the relevant laws, rules and regulations of the Israeli government authorities, which such work manager shall be present at the Site at all times when Work is carried out.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">8.3.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Contractor hereby warrants, represents and undertakes that it shall obtain and maintain in full effect, at its own cost and expenses, throughout the terms of this
        Agreement, all work permits, and licenses required under the laws of Israel, including but not limited to, permit the non-resident employees of Contractor to perform their duties pursuant to this Agreement (as applicable). Without derogating from
        the Contractor responsibilities above, Customer shall cooperate with Contractor, as may be reasonably required, in order to obtain such permits and licenses.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-right: 18pt; line-height: 1.25;">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">CLEARANCE OF THE SITE; NO INTERFERENCE</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">9.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor shall keep the Site and adjacent roads free from unnecessary obstruction and accumulation of waste material or rubbish caused by the Work. The
        Contractor will, from time to time, remove from the Site all accumulations of materials and waste accumulated during the Work, and will be responsible for maintaining the cleanliness of the Site.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">9.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Immediately upon completion of the Work or early termination of this Agreement for any reason, the Contractor shall clean the Site and its surroundings and remove
        and clear all construction surplus materials and equipment, tools, instruments, machines (not including any equipment or instruments which are to be provided as part of the Facility and the Works) garbage and rubbish and the temporary structures,
        of every and any kind attributable to the Work and/or caused by the Contractor, its employees, agents, subcontractors, suppliers and/or any other person or entity on its or their behalf (if any) to an authorized waste site and leave the Site and
        adjacent roads clean and will deliver the Facility such that the Site and its surroundings are clean to the full satisfaction of the Customer.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">9.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;During the course of the Work, Contractor (and its employees, agents, subcontractors, suppliers and/or any other person or entity on its or their behalf) shall not
        interfere with, or cause any obstructions to, the Customer and/or the daily operations of the Customer or the other persons or entities located at the Site or its surroundings. To this extent and without limiting its obligations hereunder, the
        Contractor shall coordinate the performance of the Work in advance with Customer, the Landlord<font style="font-weight: bold;">&#160;</font>(as defined below), and the municipality and other authorities as applicable, including regulatory required
        submissions and permits, it being understood that obtaining permits for the Facility is under Customer&#8217;s or Landlord&#8217;s responsibility, as applicable; however the Contractor shall be responsible for the achievement of the technical aspects of such
        permits. Customer will be responsible to obtain all relevant approvals from the Landlord for the Work and free access to site.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="margin-right: 18pt; line-height: 1.25;"><font style="font-weight: bold;">10.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">CONTRACTOR&#8217;S REPRESENTATIONS</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">The Contractor hereby warrants, represents and undertakes as follows:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">10.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Prior to signing this Agreement, the Contractor read all the Annexes and all documents connected to the performance of the Works and the Project.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">10.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor has visited and thoroughly examined, the Site, its environs, nature and locality, including but not limited to, its layout, and found them to be
        suitable for the execution of the Work as stipulated in this Agreement except for hidden defects and damages.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">10.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Site is ready for starting the execution of the Work.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">10.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor has all of the Means, the know-how and the qualifications required for the timely performance and completion of the Works pursuant to this
        Agreement.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">10.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor has received from Customer all the information and required explanations, as to the details and scope of the Works.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">10.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor has reviewed the lease agreement of the Site between the Yezum-Tech Business and Assets Ltd.<font style="font-weight: bold;">&#160;</font>(the &#8220;<font style="font-weight: bold;">Landlord</font>&#8221;) (the &#8220;<font style="font-weight: bold;">Lease Agreement</font>&#8221;) attached hereto as <font style="font-weight: bold;"><u>Annex I</u></font>, and it will ensure that its employees and subcontractors and
        others acting on its behalf will, conduct themselves during the performance of the Work in accordance with the Work Guidelines required by the Landlord and it is aware that its non-compliance with such Work Guidelines may cause the Customer to be
        in breach of the Lease Agreement. Contractor herby undertakes to comply with and preform any of the of the Customer&#8217;s obligations under the Lease Agreement in connection with the Project and the Work, including but not limited to obtaining any and
        all necessary permits, from the Landlord or any other authority for the performance of the Work.</div>
      <div style="text-align: justify; margin-right: 2.1pt; line-height: 1.25;"><font style="font-weight: bold;"> <br>
        </font></div>
      <div style="text-align: justify; margin-right: 2.1pt; line-height: 1.25;"><font style="font-weight: bold;">11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">LIABILITY; INDEMNIFICATION; INSURANCE</font></div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">11.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor shall be liable for any damages, demands or claims which may arise in respect of Contractor&#8217;s (and anyone acting on its behalf) acts and/or
        omissions&#160; pursuant to this Agreement and/or under any applicable laws and regulations.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 2.1pt; line-height: 1.25;">The Contractor shall be liable for, and shall at all times indemnify, defend, and hold harmless the Customer, its affiliates, parent company and its and their respective
        directors, officers, employees and agents (collectively, &#8220;<font style="font-weight: bold;">Customer Indemnitees</font>&#8221;) from and against any harm (whether physical or mental), damages, liabilities, expenses (including legal fees) and/or loss of
        any kind whatsoever, including without limitation, bodily injury and/or property damage, arising from: (i) any act, omission and/or breach of this Agreement and or breach of any applicable laws and regulations, by the Contractor and/or its
        employees and/or its subcontractors and/or all person or entities acting on their behalf; (ii) all claims issued against the Customer as a result of faulty or inadequate performance made by the Contractor; and/or (iii) any faulty or inadequate
        performance that Contractor is responsible for according to any applicable law or regulation or under this Agreement.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">11.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;It is clarified that the Contractor&#8217;s indemnification obligations hereunder shall not apply to a claim, to the extent that such claim is specifically related to
        any equipment provided by the Customer, unless such equipment was not used properly and in accordance with Customer&#8217;s instructions by Contractor and/or its employees and/or its subcontractors and/or any person or entity on its behalf.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">11.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Customer shall give Contractor prompt notice of any claim described in this Section 11 above that is made against the Customer Indemnitees (provided that
        failure to provide such notice, shall not relive the Contractor form its undertakings under this Section 11, except to the extent that Contractor is materially prejudiced by such failure). The Contractor shall forthwith defend any such claims and
        make settlements thereof at its own expense, <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">however</font>, that any settlement or solution, reached inside or outside of the court, shall not adversely affect
        the Customer&#8217;s rights under this Agreement or impose any obligations on the Customer in addition to those set forth herein, unless otherwise agreed to by the Customer in writing and in advance. Contractor shall keep Customer updated on the progress
        of the defense or settlement of any such claim. Customer shall have the right, but not the obligation, to be represented by counsel of its own selection and at its own expense.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">11.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Indemnification by Contractor of all costs, expenses and damages to the Customer for any claim for which indemnification was requested shall be made promptly upon
        adjudication and/or settlement of such claim whereby Contractor was held liable and/or responsible therefore.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">11.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Without derogating from Contractor&#8217;s liability under this Agreement and/or under any law, the Contractor hereby undertakes to take out and maintain in effect
        throughout the term of this Agreement and thereafter during the Warranty Period, an adequate insurance coverage with a reputable insurance company against liability which the Contractor or its subcontractor or its employees may incur to any other
        person, including but not limited to the Customer, in connection with performance of the Agreement, in accordance with the provisions set forth in <font style="font-weight: bold;"><u>Annex G</u></font>. The Contractor shall, on request, produce to
        the Customer a copy of such insurance certificates. The policies shall name the Customer as an additional insured.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">11.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The liability of the Contractor is limited to direct damages and no more than 1,100,000 USD, except that the foregoing limitation shall not apply with respect to
        liability due for human bodily injury or death, breach of confidentiality obligations hereunder,&#160; any third party claims and/or liability, and/or gross negligence, willful misconduct of Contractor and/or it employees and/or subcontractors.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 2.1pt; line-height: 1.25;"><font style="font-weight: bold;">12.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">PERFORMANCE TESTING; ACCEPTANCE; TRAINING</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">12.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As part of the Work, the Contractor shall perform the testing and qualifications set forth in the Scope of Work, including but not limited to those listed below,
        all in accordance with the time schedule set forth in the Timetable: (i) DQ tests, (ii) factory acceptance tests, (iii) commissioning tests for GMP and non GMP systems, and (iv) IQ and OQ tests (all of which tests form the acceptance tests
        hereunder); (all of the aforementioned tests shall hereinafter be referred to as the: &#8220;<font style="font-weight: bold;">Acceptance Tests</font>&#8221;). The performance of the Acceptance Tests and the obtaining of all required resources for performing
        them, shall be part of the Contractor&#8217;s obligations. Contractor shall give the Customer reasonable prior written notice of the intended performance of any such Acceptance Tests, and shall make sure that Customer (or its designated representative)
        shall join, attend and approve any such Acceptance Tests. Customer shall avail all required personnel and manpower on its part for the performance of the Acceptance Tests, excluding any IQ and OQ tests and any other tests as detailed in the SOW,
        including those tests set forth under <font style="font-weight: bold;"><u>Annex N</u></font>. Customer shall attend the Acceptance Tests at its own cost.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">12.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor shall perform all of the Acceptance Tests in accordance with MediWound SOPs and protocols with regard to; (i) the provisions of the Detailed Design;
        (ii) the validation protocols; and (iii) calibration methods based on MediWound&#8217;s SOP.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">12.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor will hand over to the Customer the Site and the Facility after full calibration of all instrumentations that will be provided by Contractor or on
        its behalf, by certified calibration bodies according to Customer&#8217;s calibration policies and requirements per system/equipment.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">12.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;At such time when the Facility operates in accordance with the provisions of the Scope of Work and the Detailed Design and Customer confirms in writing the
        successful completion of all of the Acceptance Tests, then, subject to the completion of the transactions and procedures set forth in Section 12.6, Customer shall provide a certificate of completion in the form attached hereto as <font style="font-weight: bold;"><u>Annex E</u></font> (the &#8220;<font style="font-weight: bold;">Certificate of Completion</font>&#8221;), at which point sign-off and hand-over of the Facility will take place. The Facility and all systems and equipment
        installed therein, shall be handed over to Customer free and clear of any encumbrances, liens or any other rights of any kind of any third party.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">12.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the event that the Customer, or its designated representative, shall determine, that the Facility has not successfully passed any Acceptance Test or does not
        operate in accordance with and/or does not conform to the provisions of the Scope of Work and/or the Detailed Design, Customer shall advise Contractor within five (5) business days, in writing thereof, setting forth the reasons for same to the
        extent known to the Customer. Upon receipt of said notification, Contractor shall carry out, at Contractor&#8217;s cost and expense, the required changes, repairs or replacements of parts, as shall be indicated by Customer in said notification, within 14
        (fourteen) days, unless otherwise agreed to in writing by the Customer. Upon completion of such changes, repairs or replacements, Contractor shall notify Customer, and repeated Acceptance Tests shall be carried out. The provisions herein contained
        shall apply to any repeated Acceptance Tests in whole or in part until all of the separate portions of the Work shall have successfully passed any and all such Acceptance Tests.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">12.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Upon successful completion of the Acceptance Tests, Contractor shall provide Customer with (i) all the updated diagrams, plans and any other updated documentation
        of the Facility bearing the signature &#8220;As Built&#8221; including the date of update; and (ii) a written Engineering File (Tik Mitkan), inclusive of all of the documentation, instructions and protocols (including qualification protocols) and any training
        required at this stage according to the Scope of Work, all as required in order to operate and maintain the Facility in accordance with the Specifications, including but not limited to FDA, EMA, MOH and all other certificates and approvals from the
        authorities needed according to the applicable law and regulations to enable the use of the Work, the Facility that related to the project and the systems, including but not limited to, approval of the fire authorities and all other applicable
        Israeli regulations; (iii) Customer shall provide Contractor with a Certificate of Completion;.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">12.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer shall be entitled, at its own expense, to bring an independent expert to attend any of the Acceptance Tests and to advise it as to the performance of the
        Works.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 2.1pt; line-height: 1.25;"><font style="font-weight: bold;">13.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">CHANGES</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">13.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Customer may issue written orders to the Contractor to include changes in the Work, consisting of additions, deletions or other revisions, and completion time
        shall be adjusted accordingly. The Contractor, prior to the commencement of such changed or revised Work, shall submit promptly to the Customer for Customer&#8217;s approval a written proposal for (i) adjustment to the Consideration, and (ii) completion
        time for such revised Work.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">13.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The parties hereby agree that in the event any changes to the Work are required due to the changes in the Regulations after the date of this Agreement, all costs
        and expenses stemming from such changes shall be born by the Customer.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">13.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Contractor shall not make any changes or substitutions to the Work, including but not limited to the Specifications, approved subcontractors and suppliers and/or
        layout of the Facility, without the prior written consent of the Customer. For the avoidance of doubt, any change recommended by the Contractor and agreed to in writing by the Customer, shall be deemed as a change order in terms of this Section 13.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 2.1pt; line-height: 1.25;"><font style="font-weight: bold;">14.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">CONSIDERATION &amp; TERMS OF PAYMENT</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">14.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In consideration for the performance of the Works and the delivery of all deliverables to Customer in accordance with this Agreement by the Contractor, the
        Customer shall pay the Contractor the following fees:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 3.15pt; line-height: 1.25;">A Total Price of USD 10,500,000<font style="font-weight: bold;">&#160;</font>(Ten Million and Five hundred thousand USD) (the &#8220;<font style="font-weight: bold;">Consideration</font>
        &#8220;) +VAT.<font style="font-weight: bold;">&#160;</font>Upon receipt of each payment, the Contractor shall submit to the Company a valid tax invoice and receipt.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">14.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer shall pay the Consideration in NIS in accordance with the milestones as specified in <font style="font-weight: bold;"><u>Annex F</u></font> hereto.</div>
      <div style="text-align: justify; line-height: 1.25;"><br>
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">14.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Customer will pay a cash bonus of US$ 200,000 in case the Contractor will complete the Works in 16 months.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">14.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The payments under this Section 14 will be remitted in accordance with the provisions set forth in <font style="font-weight: bold;"><u>Annex F</u></font>. The
        final payment set forth therein shall be made when the Work is fully performed in accordance with the requirements of this Agreement and Customer has issued the Certificate of Completion.
        <div><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">9</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
        </div>
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">14.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The budget of Section &#8220;Process Equipment list&#8221; from the BOQ <font style="font-weight: bold;"><u>Annex A</u></font> is limited to 4,000,000 USD and the cost will
        be checked with the Customer per clause in this BOQ Section while the target is to avoid deviation this budget.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 2.1pt; line-height: 1.25;">14.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; This Agreement is a turnkey, lump sum fixed price contract. The Contractor acknowledges that it has satisfied itself as to the correctness and sufficiency of the
        Consideration (or any part thereof, as applicable) as the consideration for the execution and completion of the Work in accordance with the Scope of Work and the terms of this Agreement, in strict conformance with the terms of this Agreement,
        subject only to change orders as provided for in Section 13 above. The Consideration constitutes the full and entire consideration for the performance and completion of the Work on a turnkey basis in accordance with this Agreement, and includes,
        for the avoidance of doubt, all the Contractor&#8217;s expenses including salaries, wages and social benefits, tools, the costs of all Means, storage, or any other expenses incurred in carrying out the Work.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">14.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Consideration is inclusive of all applicable taxes, with the exception of VAT, which shall be payable under and pursuant to applicable law. The Consideration
        shall be final and binding and shall not be subject to any escalation or modification, other than as specifically provided herein. The Contractor shall comply with all applicable laws and regulations in the performance of its obligations in respect
        of the Project and the Work. Without limiting the generality of the foregoing, the Contractor shall be responsible to pay all taxes, levies, social benefits, insurance, national insurance payments and any other payments required by law in
        connection with the performance of the Work under this Agreement, including, without limitation, payments to the income tax authorities, the value added tax authorities, etc., applicable to the Contractor with respect to any and all payments
        hereunder and/or as an independent contractor and/or for any taxes applicable to payments to its subcontractors, employees or any other person or entity on its behalf.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">14.8&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer shall be entitled to deduct any withholding taxes or other taxes from any payment to Contractor hereunder, unless Contractor has provided Customer with an
        appropriate certificate of exemption from such withholding tax.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">14.9&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor shall furnish with its final request for payment a release stating that it has received the entire Consideration. In the event the Contractor&#8217;s
        vendors and subcontractors make any claim for payment against the Customer regarding work, materials, supplies, equipment provided under this Agreement, or otherwise stemming from or related to this Agreement, Contractor shall defend, indemnify and
        hold harmless the Customer from all such claims immediately upon request for indemnification from the Customer.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 2.1pt; line-height: 1.25;"><font style="font-weight: bold;">15.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">OWNERSHIP</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">15.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Confidential Information (as defined below), and any other materials or information provided by Customer to Contractor and all inventions, processes, methods,
        products, compounds, materials, formulations and other intellectual property owned or controlled by Customer prior to the Effective Date or thereafter developed by or on behalf of Customer, independent of this Agreement (collectively, &#8220;<font style="font-weight: bold;">Customer Background IP</font>&#8221;), are and shall remain the sole and exclusive property of the Customer.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">15.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;All designs, Drawings, Specifications, software, programs, notes and other Works, copyrights, documentation and records developed in the performance of this
        Agreement shall become the sole and exclusive property of the Customer (collectively, &#8220;<font style="font-weight: bold;">Customer Proprietary Materials</font>&#8221;), at every stage of the Project,&#160;may be used by Customer on any other design or
        construction without any additional compensation to the Contractor.&#160;Contractor shall not be entitled to use any Confidential Information, including without limitation, any information and/or know-how of any type or nature and in any form or medium
        relating to Customer&#8217;s process, products and/or any aspect thereof, as may be changed pursuant hereto. All equipment that will be provided to the Site under the scope of the Project shall become the sole and exclusive property of the Customer,
        provided that such costs have been paid to Contractor.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 2.1pt; line-height: 1.25;"><font style="font-weight: bold;">16.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">CONFIDENTIALITY</font></div>
      <div style="text-align: justify; margin-right: 2.1pt; line-height: 1.25;"><font style="font-weight: bold;"> <br>
        </font></div>
      <div style="text-align: justify; line-height: 1.25;">16.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;During the term of this Agreement and for a period of 10 (ten) years thereafter, Contractor shall protect all of Confidential Information disclosed by Customer or a third party on its
        behalf or otherwise obtained by the Contractor. Other than to the extent required to perform its duties hereunder, Contractor shall not disclose such Confidential Information to third parties by any means whatsoever. Contractor further agrees not
        to use Confidential Information disclosed or owned by Customer for any purpose other than for the purpose of performance of its undertakings under this Agreement as contemplated hereby. The Confidential Information may only be disclosed by
        Contractor to those officers, directors, employees, agents and subcontractors of the Contractor (&#8220;<font style="font-weight: bold;">Representatives</font>&#8221;) who have a need to know, and only after such Representatives have been advised of the
        confidential nature of such information and agree to be bound by an obligation of confidentiality and restricted use to the Customer under terms substantially similar to the terms of this Agreement and provided that the Contractor shall remain
        responsible for any breach of this Agreement by it and/or any of the Contractor&#8217;s Representatives.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">16.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The obligations under Section 16.1 above shall not apply to information which:</div>
      <div style="text-align: justify; line-height: 1.25;">16.2.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Is or becomes part of the public domain without breach of the provisions hereof or is generally known in the industry; and/or</div>
      <div style="text-align: justify; line-height: 1.25;">16.2.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Is lawfully obtained by the Contractor from a third party under no obligation of confidentiality.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">16.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If and to the extent that the Contractor is required to make any disclosure of Confidential Information, in response to a valid order by a court or other governmental body, or as
        otherwise required by law, it will be permitted to do so, provided that the Contractor will give reasonable prior written notice to the Customer of such disclosure requirement and will use reasonable efforts to secure confidential treatment of such
        information required to be disclosed.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">16.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-weight: bold;">Confidential Information</font>&#8221; shall mean to include any all information, notes, data, sketches, drawings (including the Drawings), manuals,
        documents, blueprints, memoranda, specifications (including the Specifications), any of the items, financial reports, equipment, any information and/or know-how, inventions, ideas, process, methods, techniques, materials, formulations,
        compositions, compound and any other information, of any type or nature and in any form or medium relating to the Work, this Agreement, the Facility, the Site and/or Customer and/or its business, technology, products, plans, (including without
        limitation to Customer&#8217;s process and/or any aspect thereof), Customer Proprietary Materials, and/or any other information of a confidential or proprietary nature, whether written or oral, disclosed by the Customer or by a third party on its behalf
        (including confidential or proprietary information of third parties, subject to a duty on the Customer&#8217;s part to maintain the confidentiality of such information) or obtained by the Contractor in connection with this Agreement its provision of
        services during or before the term of this Agreement.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">16.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Upon the termination of this Agreement, for any reason, Contractor shall immediately return to the Customer all Confidential Information.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">16.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer shall remain the sole and exclusive owner of all Confidential Information.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">16.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor acknowledges and understands that the Customer&#8217;s parent company, is a public company traded on the NASDAQ, and accordingly, this Agreement and any Confidential
        Information may be considered as &#8220;inside information&#8221; pursuant to securities laws and regulations.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 2.1pt; line-height: 1.25;"><font style="font-weight: bold;">17.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">WARRANTY</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">17.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor hereby warrants to the Customer, that: (i) all materials and/or equipment used or supplied under this Agreement are of the best quality, shall be: (a) new and free from
        defects due to faulty design, material and workmanship; (b) free of any liens, encumbrances and/or any other third party rights of any kind and shall perform in accordance with the purpose to which they are intended; and (ii) the Work and the
        Facility shall conform with the Specifications, Drawings and the Detailed Design, and shall be prepared in a workmanlike manner and with professional diligence and skill; (iii) it has the requisite technical and professional knowledge, know-how,
        expertise, skills, resources, talent and experience required in order to perform the Work in a professional and efficient manner; (iv) the execution of this Agreement by Contractor and the performance of the obligations hereunder shall not
        constitute or result in a breach of any other obligation, contractual or otherwise, of Contractor; and (v) there are no restrictions, limitations, contractual obligations or statutory obligations or restrictions or any other factor whatsoever which
        prevents or restricts or is likely to prevent or restrict Contractor from fulfilling all its obligations under this Agreement and the performance of the Work, in accordance with the Timetable.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">17.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Contractor hereby undertakes to promptly replace any defective materials and/or equipment at its own expense, within the timeframes specified in the Service Level Agreement (SLA)
        attached hereto as <font style="font-weight: bold;"><u>Annex K</u></font> to this Agreement.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">17.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Further to the above the Contractor undertakes to repair any system operational defect in the Facility at its own expense within the timeframes specified in the Service Level
        Agreement (SLA) attached hereto as <font style="font-weight: bold;"><u>Annex K</u></font> to this Agreement.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">17.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The warranty hereunder excludes defects resulting from improper use of the equipment by the Customer or improper maintenance not in accordance with the maintenance manual provided by
        Contractor.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">17.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The warranty period shall be for a period of 12 (twelve) months from the date of Certificate of Completion (the &#8220;<font style="font-weight: bold;">Warranty Period</font>&#8221;). and in the
        event that the Contractor received a longer warranty period from a third party for any specific item, the warranty with respect to such item shall be extended for the extended period of time.</div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">Any part&#160;of component replaced by the Contractor during the Warranty Period shall be guaranteed for the longer of: a) the remaining Warranty Period; b) three (3) months from the
        date of replacement; or c) if a separate warranty for that part or component is generally offered by the manufacturer, the standard commercial warranty period offered by the manufacturer for the individual part or component.</div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: justify; margin-right: 2.1pt; line-height: 1.25;"><font style="font-weight: bold;">18.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">TERM AND TERMINATION</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">18.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Agreement shall enter into force on signing this Agreement (the &#8220;<font style="font-weight: bold;">Effective Date</font>&#8221;) and shall remain in effect until completion of the Work
        and the issuance of a Certificate of Completion, unless otherwise earlier terminated in accordance with this Section 18.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">18.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to Section 14.2 above, any actions taken by the parties or cost incurred prior to the Effective Date in preparation or for the performance thereof are for their own account
        and at their cost and expense.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">18.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the event of a material breach of a party&#8217;s obligations hereunder, the non&#8209;breaching party may terminate this Agreement by providing the breaching party with a prior written notice
        of termination hereof no less than 14 (fourteen) days prior to such termination becoming effective; <font style="font-style: italic;">provided</font>&#160;<font style="font-style: italic;">however</font>, that such termination shall not enter into
        effect if the other party cures such breach prior to the expiration of such 14 (fourteen) day period.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">18.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Either party is entitled to terminate this Agreement upon the occurrence of any of the following events: (i) a request for the liquidation and/or dissolution and/or winding up is
        filed against the other party, which request is not dismissed or otherwise set aside within thirty (30) days thereafter; (ii) a request for the appointment of a receiver or trustee over a material asset of the other party is filed against the other
        party with a competent court of jurisdiction (or execution office), which request is not dismissed or otherwise set aside within thirty (30) days thereafter; or (iii) the other party makes a general assignment for the benefit of its creditors.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">18.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Customer may at any time terminate this Agreement for the convenience of the Customer for any reason or without reason. In the event of such termination without cause, the
        Contractor shall receive, as its entire and sole compensation, a settlement computed in the following manner for Work that has commenced prior to notice of termination under this Section 18.5:</div>
      <div style="text-align: justify; margin-left: 21.3pt; line-height: 1.25;">18.5.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Contractor&#8217;s actual, necessary and reasonable cost actually incurred by Contractor in performing the Work in accordance with this Agreement up to the date of
        termination, as determined by audit of the Contractor&#8217;s records, including costs for equipment for manufacturing process, provided that such costs have been remitted and are nonrefundable, plus</div>
      <div style="text-align: justify; margin-left: 21.3pt; line-height: 1.25;">18.5.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A lump sum of NIS 500,000 (Five Hundred Thousand New Israeli Shekels);</div>
      <div style="text-align: justify; margin-right: 18pt; margin-left: 21.3pt; line-height: 1.25;">provided, that in no event shall such sum exceed the Total Price set forth in Section 14.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">18.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The expiration or termination for any reason of this Agreement shall not affect any rights or obligations of either party accrued prior to such termination or expiration. Upon
        termination of this Agreement, Contractor shall discontinue all further Work and shall promptly return or destroy, as directed by Company, all copies of Confidential Information, including any notes, memoranda or other materials containing such
        Confidential Information or relating thereto, and all copies thereof, and will destroy or delete any Confidential Information that has been recorded or stored in any electronic medium. In addition, upon early termination of this Agreement, for
        whatever reason, Contractor shall, if requested, and at no additional cost to Customer, assist Customer to smoothly Contractor&#8217;s obligations under this Agreement to another third party, at Customer&#8217;s choice.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">18.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The provisions of Sections 1, 3, 4.4, 4.5, 5.2, Error! Reference source not found., 9.2, 10, 11, 14.6 through 14.8, 15, 16, 17, 18.5, 18.6, 18.7&#160;20, 21, 22 and 23 and the Annexes
        shall survive expiration or termination for any reason of this Agreement and shall remain in effect thereafter.</div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 2.1pt; line-height: 1.25;"><font style="font-weight: bold;">19.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">SUSPENSION</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">The Contractor shall upon the written notification from the Customer suspend the progress of the Work or any part thereof for such period of time and in such manner as may be determined by the
        Customer, and shall during such suspension properly protect and secure (at Customer&#8217;s expense) the Work so far as is necessary in the opinion of the Customer. The extra costs, including those caused by the subsequent resumption of Work incurred by
        the Contractor in complying with the Customer&#8217;s written instructions, shall be borne and paid by the Customer against receipt by Customer of supporting documentation, unless such suspension is necessary due to the fault of the Contractor (or anyone
        on its behalf), in which case, such costs shall be borne and paid by Contractor. Any such suspension/s shall not exceed in the aggregate, in any event, 45 (forty five) days.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">20.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">GOVERNING LAW AND JURISDICTION</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">20.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Agreement shall be governed and construed in accordance with the laws of the State of Israel. The competent courts in Tel Aviv have the exclusive jurisdiction
        over any disputes and/or claims relating to and/or arising from this Agreement.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">20.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;All technical disputes and disputes regarding changes as specified in Section 13.1, which cannot be amicably resolved between the Parties within 14 (fourteen) days s following the
        receipt by either party of first written notice of such dispute form the other parties shall be resolved by arbitrator Mr. Eric Shem-Tov (&#8220;<font style="font-weight: bold;">Arbitrator</font>&#8221;). If, for any reason, the Arbitrator is unable to serve
        as an arbitrator between the parties, the parties shall agree upon a replacement independent arbitrator. If the parties are unable to reach an agreement regarding the identity of such replacement arbitrator within fourteen (14) days after the laps
        of the first fourteen (14) days, or such&#160;further period as the parties shall agree in writing, on the replacement arbitrator will be appointed by the Israeli Institute of Commercial Arbitration in accordance with its rules. Each of the parties
        hereby agrees that any and all expenses related to the arbitration (not including each party&#8217;s legal fees) will be paid equally by the parties, unless the expert determines that one party&#8217;s position was manifestly unreasonable, in which case such
        party shall bear all of such costs. The arbitrator shall provide a written decision. The decision of the arbitrator shall be final and binding upon the parties (in the absence of a manifest error).</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">20.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In any event of dispute or disagreement between the Contractor and the Customer, it is agreed that the Contractor shall not slow and/or delay the progress of the Work or suspend the
        Work, including any change order, or hinder in any way the completion and/or delivery thereof. The Work will continue to be executed as scheduled in spite of any disagreement between the parties, provided that Customer has not ceased, for a period
        of more than 1 (one) consecutive payment milestone, payment of the Consideration when same would become due pursuant to Section 14 above.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">20.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Contractor will not be entitled, under any circumstances, to petition for an injunction against the continuation of the construction of the Facility or any part of the performance
        of the Work. In addition, the Contractor shall not have the right to place a lien on and/or withhold (&#1494;&#1499;&#1493;&#1514; &#1506;&#1499;&#1489;&#1493;&#1503;) the Works and/or Facility and/or any components thereof. The Contractor will be entitled only to submit a monetary claim against the
        Customer in accordance with the provisions of this Agreement, but not to take any steps whatsoever which could delay performance of the Work. Until final determination of the dispute between the parties hereto the Contractor agrees to fully comply
        with the instructions of the Customer, provided that Customer has not ceased, for a period of more than 1 (one) consecutive payment milestones, payment of the Consideration when same would become due pursuant to Section 14 above.</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: justify; line-height: 1.25;">20.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The address of the parties for the purpose of service of process shall be as set forth in Section 21 below.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; margin-right: 2.1pt; line-height: 1.25;"><font style="font-weight: bold;">21.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">NOTICES</font></div>
      <div style="text-align: justify; margin-right: 2.1pt; line-height: 1.25;"><font style="font-weight: bold;"> <br>
        </font></div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">21.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;All legal notices, requests, consents and other communications required or permitted under this Agreement shall be in writing and shall be (as elected by the party
        giving such notice) hand delivered by messenger or courier service, sent by facsimile or other electronic means,, or mailed by registered or certified mail (postage prepaid), return receipt requested, or delivered by overnight delivery service,
        addressed to:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z4cf26f2c545748e6b29c1cf1db068f92" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 45pt;"><u><font style="font-family: 'Times New Roman', Times, serif;">If to Customer</font>:</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 45pt;"><font style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">Mediwound Ltd</font>.</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 45pt;">Address: 42 Ha&#8217;Yarkon St., Yavne 8122745, Israel</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 45pt;">Facsimile: 077-9714111</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 45pt;">Email: <font style="font-family: 'Times New Roman', Times, serif;"><u>tzvip@mediwound.com</u></font></div>
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 45pt;">Attention: Tzvi Palash, COO</div>
              <div style="line-height: 1.25; margin-left: 45pt;"><font style="line-height: 1.25;">&#160;</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 45pt;">If to Contractor:</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 45pt;">Biopharmax Group Ltd.</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 45pt;">4 Hasadnaot St.</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 45pt;">Herzelia 46728</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 45pt;">Israel</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 45pt;">Facsimile: 09-9716112</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 45pt;">Email: <font style="font-family: 'Times New Roman', Times, serif;"><u>sarel@biopharmax.com</u></font></div>
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 45pt;">Attention: Sarel Chen Tov CEO</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">21.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each such notice shall be deemed delivered: (a) on the date delivered if by personal delivery (including by an overnight delivery service, with proof of delivery);
        (b) on the date transmitted if by facsimile or other electronic means, and if transmitted on a non-business day &#8211; on the first business day following transmission; and (c) on the date upon which the return receipt is signed or delivery is refused,
        as the case may be, if mailed certified, return receipt requested.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;"><font style="font-weight: bold;">22.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">FORCE MAJEURE</font></div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">22.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any delay in or failure of performance by either party shall be excused if and to the extent that same has been caused by an event, incident or occurrence
        constituting Force Majeure. Each party shall notify the other party in writing of the occurrence of such Force Majeure event no later than 5 (five) working days from its occurrence, setting forth the estimated effect thereof on the performance of
        its obligations and undertakings hereunder and takes all commercially reasonable measures to mitigate and/or minimize such delay.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">22.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;For the purpose hereof, &#8220;<font style="font-weight: bold;">Force Majeure</font>&#8221; shall mean any one or more of the following events, occurrences and incidents
        directly creating any such delay in or failure of performance, that prevents the Contractor from performing its obligations under this Agreement:</div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb71b4283808d43bcbbe33872bf06ffab" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 21.3pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top;">
              <div>Floods, hurricanes and earthquakes and other natural disasters and occurrences;</div>
            </td>
          </tr>

      </table>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8783c40b8f104eb28ffba9e49930405e" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 21.3pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top;">
              <div>General domestic strikes in ports or customs, war and blockades;</div>
            </td>
          </tr>

      </table>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd6f15532ce1c408f820de28ae9a2d2d6" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 21.3pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top;">
              <div>War, blockades, sabotage, war-like and terror actions, and general mobilization of reserves or general lockdown preventing construction works;</div>
            </td>
          </tr>

      </table>
      <div style="margin-right: 108pt; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">22.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notwithstanding the above, it is agreed that no reason whatsoever, including without limitation, any event, incident or occurrence constituting Force Majeure in
        terms of this Agreement shall serve as an excuse or reason for non-conformity of the Work and/or the Facility and/or any components thereof to the provisions (except for timetables affected by the Force Majeure) of this Agreement. If an event of
        Force Majeure should continue for a period of more than sixty (60) days, the party not subject to the event of Force Majeure shall have the right, but not the obligation, to terminate this Agreement by giving written notice of termination to the
        other party hereto. In case Customer terminates this Agreement according to this Section, Customer shall not be required to pay Contractor the compensation under Section 18.5.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">14</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">23.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">MISCELLANEOUS</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">23.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each of the parties hereby represents and warrants to the other party that it has full right and authority to enter into this Agreement and to perform its
        obligations hereunder and that this Agreement constitutes its valid and binding obligation, enforceable against it in accordance with its terms.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">23.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Agreement is binding upon and is for the benefit of the parties hereto and their respective successors and permitted assigns. This Agreement is not made for
        the benefit of any person or entity not a party hereto, and no person or entity (including without limitation any sub-contractors, vendors, suppliers or customers) other than the parties hereto or their respective successors and permitted assigns
        will acquire, have or be entitled to any benefit, right, remedy or claim under or by reason of or may otherwise rely on any provision of this Agreement. Customer shall be entitled to assign this Agreement and/or its rights or obligations hereunder
        to any Affiliate thereof or to a successor of interest or purchase of all or substantially all of Customer&#8217;s business or asset relating the subject matter of this Agreement, upon written notice to the Contractor. Contractor shall not be entitled to
        assign its rights or obligations hereunder without the prior written consent of the Customer and any assignment or transfer not in accordance with the terms and conditions of this Agreement shall be null and void.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">23.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The provisions of this Agreement are severable and, in the event that any court of competent jurisdiction determines that any one or more of the provisions or part
        of a provision contained in this Agreement shall, for any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provision or part of a provision of this
        Agreement; but this Agreement shall be reformed and construed to the maximum extent possible as if such invalid, illegal or unenforceable provision, or part of a provision, had never been contained herein.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">23.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Nothing contained in this Agreement shall be deemed to establish any partnership, joint venture or agency relationship and the parties shall act at all times as
        independent contractors. Unless otherwise expressly provided herein, the employees of each party to this Agreement shall in no event be deemed employees of the other party by reason of this Agreement, and such employees shall not be entitled to
        participate in any benefits provided by such other party to its employees. Neither party shall have any authority to enter into any contracts, assume any obligations or make any warranties or representations on behalf of the other party.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">23.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Agreement and any of the Annexes attached hereto may not be amended, modified, altered, or supplemented except by a written agreement executed by both parties
        hereto.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">23.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Agreement and the Annexes attached hereto set forth the entire understanding between the parties hereto and supersedes all prior agreements, arrangements and
        communications, whether oral or written, with respect to the subject matter hereof, including, without limitation, the MOU executed between the parties on 11 December, 2022.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 18pt; line-height: 1.25;">23.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Agreement may be executed in counterparts (including counterparts transmitted by fax or email via PDF), each of which shall be deemed to be an original, but
        all of which taken together shall be deemed to constitute one and the same instrument.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><font style="font-weight: bold;">IN WITNESS WHEREOF</font>, the parties have signed this Agreement as of the Effective Date.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <table id="z84eba71b28d0460b8d0936182c115980" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 25%;"><font style="font-weight: bold;">Mediwound Ltd.</font></td>
              <td style="width: 75%;"><font style="font-weight: bold;">Biopharmax Group Ltd.</font></td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">SIGNATURE:/s/Ofer Gonen /s/Hani Luxemburg SIGNATURE:&#160;<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u><u>/s/ Asher Alkoby&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
        </u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">NAME:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Ofer Gonen&#160; Hani Luxenburg&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; NAME:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Asher Alkoby</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">TITLE:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;CEO&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;CFO&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; TITLE:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;President and Co-Owner</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
  </div>
  <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">15</font>
    <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;" align="center"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>6
<FILENAME>exhibit_12-1.htm
<DESCRIPTION>EXHIBIT 12.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> </u>
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> <br>
      </u></div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>EXHIBIT 12.1</u></div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATIONS</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">I, Ofer Gonen, certify that:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have reviewed this
        annual report on Form 20-F of MediWound Ltd.;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge,
        this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
        period covered by this report;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, the
        financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this
        report;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The company&#8217;s other
        certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
        Rules&#160;13a-15(f) and 15d-15(f)) for the company and have:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="za2bb413f328f41c2b2cc2ab7f0483047" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">a.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
              information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zca4a4cabda784d0b902536544de14be0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">b.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
              reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z0db1050a9d344c2baff9fb2309817d73" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">c.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure
              controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="za3a3f59718cf429a8c0113b45b860d63" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">d.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has
              materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The company&#8217;s other
        certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit committee of the company&#8217;s board of directors (or persons performing the equivalent
        functions):</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zdd2a613168fe49aa896b0759d86cf93a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">a.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
              affect the company&#8217;s ability to record, process, summarize and report financial information; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zb7c5b87e807841aa93a2ce60596a2ddf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">b.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;"><u>/s/ Ofer Gonen</u></div>
    <div style="line-height: 1.25;">Ofer Gonen</div>
    <div style="line-height: 1.25;">Chief Executive Officer</div>
    <div style="line-height: 1.25;">Date: March 21, 2024</div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
    <br>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <br>
    <br>
    <div class="BRPFPageFooter">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>7
<FILENAME>exhibit_12-2.htm
<DESCRIPTION>EXHIBIT 12.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> <br>
      </u></div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>EXHIBIT 12.2</u></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATIONS</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">I, Hani Luxenburg, certify that:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have reviewed this
        annual report on Form 20-F of MediWound Ltd.;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge,
        this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
        period covered by this report;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, the
        financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this
        report;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The company&#8217;s other
        certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
        Rules&#160;13a-15(f) and 15d-15(f)) for the company and have:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">a.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
              information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">b.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
              reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">c.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure
              controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">d.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has
              materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The company&#8217;s other
        certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit committee of the company&#8217;s board of directors (or persons performing the equivalent
        functions):</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">a.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
              affect the company&#8217;s ability to record, process, summarize and report financial information; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">b.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;"><u>/s/ Hani Luxenburg</u></div>
    <div style="line-height: 1.25;">Hani Luxenburg</div>
    <div style="line-height: 1.25;">Chief Financial Officer</div>
    <div style="line-height: 1.25;">Date: March 21, 2024</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>8
<FILENAME>exhibit_13-1.htm
<DESCRIPTION>EXHIBIT 13.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> </u>
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> <br>
      </u></div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>EXHIBIT 13.1</u></div>
    <div style="margin-left: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">18 U.S.C. SECTION 1350</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">AS ADOPTED PURSUANT TO SECTION 906</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In connection with the Annual Report of MediWound Ltd. (the &#8220;Company&#8221;) on Form 20-F for the fiscal year ended
      December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Ofer Gonen, do certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my
      knowledge:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Report fully complies
        with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The information contained
        in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;"><u>/s/ Ofer Gonen</u></div>
    <div style="line-height: 1.25;">Ofer Gonen</div>
    <div style="line-height: 1.25;">Chief Executive Officer</div>
    <div style="line-height: 1.25;">Date: March 21, 2024</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>9
<FILENAME>exhibit_13-2.htm
<DESCRIPTION>EXHIBIT 13.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> <br>
      </u></div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>EXHIBIT 13.2</u></div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">18 U.S.C. SECTION 1350</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">AS ADOPTED PURSUANT TO SECTION 906</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">In connection with the Annual Report of MediWound Ltd. (the &#8220;Company&#8221;) on Form 20-F for the fiscal year ended December
      31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Hani Luxenburg, do certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Report fully complies
        with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The information contained in
        the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;"><u>/s/ Hani Luxenburg</u></div>
    <div style="line-height: 1.25;">Hani Luxenburg</div>
    <div style="line-height: 1.25;">Chief Financial Officer</div>
    <div style="line-height: 1.25;">Date: March 21, 2024</div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>10
<FILENAME>exhibit_15-1.htm
<DESCRIPTION>EXHIBIT 15.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> </u>
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> <br>
      </u></div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>EXHIBIT 15.1</u></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">
      <div style="line-height: 1.25; font-family: 'Times New Roman', serif; font-weight: bold;">Consent of Independent Registered Public Accounting Firm</div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">
        <div style="line-height: 1.25;">We consent to the incorporation by reference in the registration statements (Nos. 333-223767, 333-195517, 333-210375, 333-230487,
          333-236635, 333-255784, 333-266697 and 333-273997) on Form S-8, and (Nos. 333-265203 and 333-268297) on Form F-3 of our report dated March 21, 2024, with respect to the consolidated financial statements of MediWound Ltd. and the effectiveness of
          internal control over financial reporting.</div>
      </div>
    </div>
    <div style="text-align: right; line-height: 1.25;">&#160;&#160; <br>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman', serif;"><u>/s/ Somekh Chaikin&#160;</u></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">Somekh Chaikin</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">Member Firm of KPMG International</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;">Haifa, Israel</div>
    <div style="line-height: 1.25;">March 21, 2024</div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>11
<FILENAME>exhibit_97-1.htm
<DESCRIPTION>EXHIBIT 97.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u> Exhibit 97.1</u><br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">MEDIWOUND LTD.<br>
      POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">MediWound Ltd. (the &#8220;<font style="font-weight: bold; font-style: italic;">Company</font>&#8221;) has adopted this Policy for Recovery of Erroneously Awarded Compensation (the &#8220;<font style="font-weight: bold; font-style: italic;">Policy</font>&#8221;),
      effective as of October 2, 2023 (the &#8220;<font style="font-weight: bold; font-style: italic;">Effective Date</font>&#8221;).&#160; Capitalized terms used in this Policy that are not otherwise defined
      herein shall have the respective meanings assigned thereto in Section 11.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z6f6de19d82ea4bae8ff9f55bd73f5adf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-weight: bold;">1.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;"><u>Persons Subject to Policy</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">This Policy shall apply to and be binding and enforceable upon current and former Officers. In addition, the Committee
      and the Board may apply this Policy to persons who are not Officers, and such application shall apply in the manner determined by the Committee and the Board in their sole discretion.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z68200259d64a43f5bd0316602535ee90" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-weight: bold;">2.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;"><u>Compensation Subject to Policy</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">This Policy shall apply to Incentive-Based Compensation received on or after the Effective Date. For purposes of this
      Policy, the date on which Incentive-Based Compensation is &#8220;received&#8221; shall be determined under the Applicable Rules, which generally provide that Incentive-Based Compensation is &#8220;received&#8221; in the Company&#8217;s fiscal period during which the relevant
      Financial Reporting Measure is attained or satisfied, without regard to whether the grant, vesting or payment of the Incentive-Based Compensation occurs after the end of that period.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z1bd578577116466d95e899edcce0dcf7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-weight: bold;">3.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;"><u>Recovery of Compensation</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">In the event that the Company is required
        to prepare a Restatement, the Company shall recover, reasonably promptly and in accordance with Section 4 below, the portion of any Incentive-Based Compensation that is Erroneously Awarded Compensation, unless the Committee and the Board have
        determined that recovery from the relevant current or former Officer would be Impracticable. Recovery shall be required in accordance with the preceding sentence regardless of whether the applicable Officer engaged in misconduct or otherwise caused
        or contributed to the requirement for the Restatement and regardless of whether or when restated financial statements are filed by the Company.&#160; For clarity, the recovery of Erroneously Awarded Compensation under this Policy will not give rise to
        any Officer&#8217;s right to voluntarily terminate employment for &#8220;good reason&#8221; or due to a &#8220;constructive termination&#8221; (or any similar term of like effect) under any plan, program or policy of or agreement with the Company or any of its affiliates.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z20e6930530d24aba8620771d456e62aa" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-weight: bold;">4.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;"><u>Manner of Recovery; Limitation on Duplicative Recovery</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">The Committee and the Board shall, in their
        sole discretion, determine the manner of recovery of any Erroneously Awarded Compensation, which may include, without limitation, reduction or cancellation by the Company or an affiliate of the Company of Incentive-Based Compensation or Erroneously
        Awarded Compensation, reimbursement or repayment by any person subject to this Policy, and, to the extent permitted by law, an offset of the Erroneously Awarded Compensation against other compensation payable by the Company or an affiliate of the
        Company to such person. Notwithstanding the foregoing, unless otherwise prohibited by the Applicable Rules, to the extent this Policy provides for recovery of Erroneously Awarded Compensation already recovered by the Company pursuant to Section 304
        of the Sarbanes-Oxley Act of 2002 or Other Recovery Arrangements, the amount of Erroneously Awarded Compensation already recovered by the Company from the recipient of such Erroneously Awarded Compensation may be credited to the amount of
        Erroneously Awarded Compensation required to be recovered pursuant to this Policy from such person.</div>
    <div style="text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zeb4f29f107694a8386d6368a8f03a00c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-weight: bold;">5.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;"><u>Administration</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">This Policy shall be administered, interpreted and construed by the Committee, which is authorized to make all
      determinations necessary, appropriate or advisable for such purpose. The Board may re-vest in itself the authority to administer, interpret and construe this Policy in accordance with applicable law, and in such event references herein to the
      &#8220;Committee&#8221; shall be deemed to be references to the Board.&#160; Subject to any permitted review by the applicable national securities exchange or association pursuant to the Applicable Rules, all determinations and decisions made by the Committee
      pursuant to the provisions of this Policy shall be final, conclusive and binding on all persons, including the Company and its affiliates, shareholders and employees. The Committee may delegate administrative duties with respect to this Policy to one
      or more directors or employees of the Company, as permitted under applicable law, including any Applicable Rules.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z9b6c0439adaf4d7ab031c4f3fa9384de" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-weight: bold;">6.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;"><u>Interpretation</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">This Policy shall be interpreted and applied in a manner that is consistent with the requirements of the Applicable
      Rules, and to the extent this Policy is inconsistent with such Applicable Rules, it shall be deemed amended to the minimum extent necessary to ensure compliance therewith.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z652df25c2b2445ea8f386d4c6ce6e90c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-weight: bold;">7.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;"><u>No Indemnification; No Liability</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">The Company shall not indemnify or insure any person against the loss of any Erroneously Awarded Compensation pursuant
      to this Policy, nor shall the Company directly or indirectly pay or reimburse any person for any premiums for third-party insurance policies that such person may elect to purchase to fund such person&#8217;s potential obligations under this Policy.&#160; None
      of the Company, an affiliate of the Company or any member of the Committee or the Board shall have any liability to any person as a result of actions taken under this Policy.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zc15eb36f3af541bc8c3c0c1acaa5b9b1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-weight: bold;">8.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;"><u>Application; Enforceability</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">Except as otherwise determined by the
        Committee or the Board, the adoption of this Policy does not limit, and is intended to apply in addition to, any Other Recovery Arrangements. Without limiting the foregoing, in the event of a conflict between this Policy and the
      Compensation Policy, the latter shall prevail, except with respect to the recovery of any portion of Incentive-Based Compensation that is Erroneously Awarded Compensation that would not be recoverable under the Compensation Policy, in which case this
      Policy shall prevail.&#160; Subject to Section 4, the remedy specified in this Policy shall not be exclusive and shall be in addition to every other right or remedy at law or in
        equity that may be available to the Company or an affiliate of the Company or is otherwise required by applicable law and regulations.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z87ecd0e9570947ccaaf3bd819128f687" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-weight: bold;">9.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;"><u>Severability</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">The provisions in this Policy are intended to be applied to the fullest extent of the law; provided, however, to the
      extent that any provision of this Policy is found to be unenforceable or invalid under any applicable law, such provision will be applied to the maximum extent permitted, and shall automatically be deemed amended in a manner consistent with its
      objectives to the extent necessary to conform to any limitations required under applicable law.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z5a00e638f9784bdd8c6bf7cda54347d0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-weight: bold;">10.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;"><u>Amendment and Termination</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">The Board or the Committee may amend, modify or terminate this Policy in whole or in part at any time and from time to
      time in its sole discretion. This Policy will terminate automatically when the Company does not have a class of securities listed on a national securities exchange or association in the U.S.</div>
    <div style="text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z37eee59a496a44b0b394081666fa33e5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-weight: bold;">11.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;"><u>Definitions</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold; font-style: italic;">Applicable
        Rules</font>&#8221; means Section 10D of the Exchange Act, Rule 10D-1 promulgated thereunder, the listing rules of the national securities exchange or association on which the Company&#8217;s securities are listed, and any applicable rules, standards or other
      guidance adopted by the Securities and Exchange Commission or any national securities exchange or association on which the Company&#8217;s securities are listed.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold; font-style: italic;">Board</font>&#8221;
      means the Board of Directors of the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold; font-style: italic;">Compensation Policy</font>&#8221; means the Company&#8217;s compensation policy for
      executive officers and directors, as adopted in accordance with the Israeli Companies Law 5759-1999 and as in effect from time to time.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold; font-style: italic;">Committee</font>&#8221;
      means the Compensation Committee of the Board or, in the absence of such a committee, a majority of the independent directors serving on the Board.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold; font-style: italic;">Erroneously
        Awarded Compensation</font>&#8221; means the amount of Incentive-Based Compensation received by a current or former Officer that exceeds the amount of Incentive-Based Compensation that would have been received by such current or former Officer based on a
      restated Financial Reporting Measure, as determined on a pre-tax basis in accordance with the Applicable Rules.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold; font-style: italic;">Exchange
        Act</font>&#8221; means the Securities Exchange Act of 1934, as amended.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold; font-style: italic;">Financial
        Reporting Measure</font>&#8221; means any measure determined and presented in accordance with the accounting principles used in preparing the Company&#8217;s financial statements, and any measures derived wholly or in part from such measures, including GAAP,
      IFRS and non-GAAP/IFRS financial measures, as well as share price and total shareholder return.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold; font-style: italic;">GAAP</font>&#8221;
      means United States generally accepted accounting principles.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold; font-style: italic;">IFRS</font>&#8221;
      means international financial reporting standards as adopted by the International Accounting Standards Board.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold; font-style: italic;">Impracticable</font>&#8221;
      means (a) the direct expense paid to third parties to assist in enforcing recovery would exceed the Erroneously Awarded Compensation; provided that the Company has (i) made reasonable attempt(s) to recover the Erroneously Awarded Compensation, (ii)
      documented such reasonable attempt(s) and (iii) provided such documentation to the relevant listing exchange or association, (b) the recovery would violate the Company&#8217;s home country laws adopted prior to November 28, 2022 pursuant to an opinion of
      home country counsel; provided that the Company has (i) obtained an opinion of home country counsel, acceptable to the relevant listing exchange or association, that recovery would result in such a violation and (ii) provided such opinion to the
      relevant listing exchange or association, or (c) recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of 26 U.S.C. 401(a)(13)
      or 26 U.S.C. 411(a) and the regulations thereunder.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold; font-style: italic;">Incentive-Based Compensation</font>&#8221; means, with respect to a Restatement, any
        compensation that is granted, earned, or vested based wholly or in part upon the attainment of one or more Financial Reporting Measures and received by a person: (a) after such person began service as an Officer; (b) who served as an Officer at any
        time during the performance period for that compensation; (c) while the Company has a class of securities listed on a national securities exchange or association; and (d) during the applicable Three-Year Period.</div>
    <div style="text-indent: 36pt; line-height: 1.25;"> <br>
      </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold; font-style: italic;">Officer</font>&#8221; means each person who the Company determines serves as a
      Company officer, as defined in Section 16 of the Securities Exchange Act of 1934, as amended.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">Other Recovery Arrangements</font><font style="font-style: italic;">&#8221;</font><font style="font-weight: bold; font-style: italic;">&#160;</font>means any clawback, recoupment, forfeiture or similar policies or provisions of the Company or its affiliates, including any such
      policies or provisions of such effect contained in any employment agreement, bonus plan, incentive plan, equity-based plan or award agreement thereunder or similar plan, program or agreement of the Company or an affiliate or required under applicable
      law (including, without limitation, the Compensation Policy).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold; font-style: italic;">Restatement</font>&#8221;
      means an accounting restatement to correct the Company&#8217;s material noncompliance with any financial reporting requirement under securities laws, including a restatement that corrects an error in previously issued financial statements (a) that is
      material to the previously issued financial statements or (b) that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period<font style="font-style: italic;">.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold; font-style: italic;">Three-Year Period</font>&#8221; means, with respect to a Restatement, the three completed
        fiscal years immediately preceding the date that the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the
        Company is required to prepare such Restatement, or, if earlier, the date on which a court, regulator or other legally authorized body directs the Company to prepare such Restatement.&#160;The &#8220;Three-Year Period&#8221; also includes any transition period (that results from a change in the Company&#8217;s fiscal year) within or immediately following the three completed fiscal years identified in the preceding sentence.&#160;However, a transition period between the last day of the Company&#8217;s previous fiscal year end and the first day of its new fiscal year that comprises a period of nine to 12 months
        shall be deemed a completed fiscal year.</div>
    <div style="text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">ACKNOWLEDGMENT OF AND CONSENT TO</font><br>
      <font style="font-weight: bold;">MEDIWOUND LTD. POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 35.45pt; line-height: 1.25;">The undersigned has received a copy of the Policy for Recovery of Erroneously Awarded Compensation (the &#8220;<font style="font-weight: bold; font-style: italic;">Policy</font>&#8221;) adopted by MediWound Ltd. (the &#8220;<font style="font-style: italic;">Company</font>&#8221;), and has read and understands the Policy. Capitalized terms used in this Acknowledgment that are not otherwise defined herein shall have the respective meanings ascribed to such terms in the Policy.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 35.45pt; line-height: 1.25;">As a condition of receiving Incentive-Based Compensation from the Company, the undersigned agrees that any
      Incentive-Based Compensation received on or after the Effective Date is subject to recovery pursuant to the terms of the Policy. To the extent the Company&#8217;s recovery right conflicts with any other contractual rights the undersigned may have with the
      Company, the undersigned understands that the terms of the Policy shall supersede any such contractual rights. The terms of the Policy shall apply in addition to any right of recoupment against the undersigned under the Compensation Policy or
      applicable law and regulations.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="za71337311ad145638abf6e6dbc07fb50" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27.86%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">___________________</div>
            <div style="text-align: justify; line-height: 1.25;">Date</div>
          </td>
          <td style="width: 72.14%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">________________________________________</div>
            <div style="text-align: justify; line-height: 1.25;">Signature</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 27.86%; vertical-align: top;">&#160;</td>
          <td style="width: 72.14%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">________________________________________</div>
            <div style="text-align: justify; line-height: 1.25;">Name</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 27.86%; vertical-align: top;">&#160;</td>
          <td style="width: 72.14%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">________________________________________</div>
            <div style="text-align: justify; line-height: 1.25;">Title</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; text-align: center;">
      <div><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font> <br>
      </div>
      <hr style="border-width: 1px medium 4px; border-style: solid none; border-color: black -moz-use-text-color; -moz-border-top-colors: none; -moz-border-right-colors: none; -moz-border-bottom-colors: none; -moz-border-left-colors: none; border-image: none; height: 10px; color: rgb(255, 255, 255); background-color: rgb(255, 255, 255); margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>mdwd-20231231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<schema xmlns:mdwd="http://mediwound.com/20231231" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full" xmlns:dei="http://xbrl.sec.gov/dei/2023" targetNamespace="http://mediwound.com/20231231" elementFormDefault="qualified">
  <!-- INTEGIX by Ez-XBRL -->
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
  <import namespace="http://xbrl.org/2020/extensible-enumerations-2.0" schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd"/>
  <import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
  <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd"/>
  <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd"/>
  <import namespace="https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full" schemaLocation="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://mediwound.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>0001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
        <link:definition>0002 - Statement - Consolidated Statements of Financial Position</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0003 - Statement - Consolidated Statements of Financial Position (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" id="ConsolidatedStatementsOfComprehensiveIncomeLoss">
        <link:definition>0004 - Statement - Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" id="ConsolidatedStatementsOfChangesInShareholdersEquity">
        <link:definition>0005 - Statement - Consolidated Statements of Changes in Shareholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
        <link:definition>0006 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/General" id="General">
        <link:definition>0007 - Disclosure - General</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SignificantAccountingJudgmentsEstimatesAndAssumptionsUsedInPreparationOfFinancialStatements" id="SignificantAccountingJudgmentsEstimatesAndAssumptionsUsedInPreparationOfFinancialStatements">
        <link:definition>0008 - Disclosure - Basis of Preparation of the Consolidated Financial Statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
        <link:definition>0009 - Disclosure - Material Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/CashAndCashEquivalents" id="CashAndCashEquivalents">
        <link:definition>0010 - Disclosure - Cash And Cash Equivalents</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/Short-termBankDeposits" id="Short-termBankDeposits">
        <link:definition>0011 - Disclosure - Short-term and restricted bank deposits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/TradeReceivables" id="TradeReceivables">
        <link:definition>0012 - Disclosure - Trade Receivables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/Inventories" id="Inventories">
        <link:definition>0013 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/OtherReceivables" id="OtherReceivables">
        <link:definition>0014 - Disclosure - Other Receivables Short Term</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/OtherReceivablesLongTerm" id="OtherReceivablesLongTerm">
        <link:definition>0015 - Disclosure - Other Receivables- Long Term</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/PropertyPlantAndEquipmentNet" id="PropertyPlantAndEquipmentNet">
        <link:definition>0016 - Disclosure - Property, Plant And Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/Leases" id="Leases">
        <link:definition>0017 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/IntangibleAssetsNet" id="IntangibleAssetsNet">
        <link:definition>0018 - Disclosure - Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/OtherPayables" id="OtherPayables">
        <link:definition>0019 - Disclosure - Other Payables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/LiabilitiesInRespectOfIiaGrants" id="LiabilitiesInRespectOfIiaGrants">
        <link:definition>0020 - Disclosure - Liabilities in Respect of IIA Grants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/FinancialInstruments" id="FinancialInstruments">
        <link:definition>0021 - Disclosure - Financial  Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SeverancePayLiabiltyNet" id="SeverancePayLiabiltyNet">
        <link:definition>0022 - Disclosure - Severance Pay Liability, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/ContingentLiabilitiesAndCommitments" id="ContingentLiabilitiesAndCommitments">
        <link:definition>0023 - Disclosure - Liabilities and Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/MaterialAgreements" id="MaterialAgreements">
        <link:definition>0024 - Disclosure - Materials Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/Equity" id="Equity">
        <link:definition>0025 - Disclosure - Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/Share-basedCompensation" id="Share-basedCompensation">
        <link:definition>0026 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/TaxesOnIncome" id="TaxesOnIncome">
        <link:definition>0027 - Disclosure - Income Tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLost" id="SupplementaryInformationToStatementsOfComprehensiveProfitOrLost">
        <link:definition>0028 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/NetProfitLossPerShare" id="NetProfitLossPerShare">
        <link:definition>0029 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficers" id="BalancesAndTransactionsWithRelatedPartiesAndKeyOfficers">
        <link:definition>0030 - Disclosure - Balances and Transactions With Related Parties and Key Officers</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>0031 - Disclosure - Subsiquents events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
        <link:definition>0032 - Disclosure - Material Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SignificantAccountingPoliciesTables" id="SignificantAccountingPoliciesTables">
        <link:definition>0033 - Disclosure - Material Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/CashAndCashEquivalentsTables" id="CashAndCashEquivalentsTables">
        <link:definition>0034 - Disclosure - Cash And Cash Equivalents (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/Short-termBankDepositsTables" id="Short-termBankDepositsTables">
        <link:definition>0035 - Disclosure - Short-term and restricted bank deposits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/TradeReceivablesTables" id="TradeReceivablesTables">
        <link:definition>0036 - Disclosure - Trade Receivables (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/InventoriesTables" id="InventoriesTables">
        <link:definition>0037 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/OtherReceivablesTables" id="OtherReceivablesTables">
        <link:definition>0038 - Disclosure - Other Receivables Short Term (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/OtherReceivablesLongTermTables" id="OtherReceivablesLongTermTables">
        <link:definition>0039 - Disclosure - Other Receivables- Long Term (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/PropertyPlantAndEquipmentNetTables" id="PropertyPlantAndEquipmentNetTables">
        <link:definition>0040 - Disclosure - Property, Plant And Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/LeasesTables" id="LeasesTables">
        <link:definition>0041 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/IntangibleAssetsNetTables" id="IntangibleAssetsNetTables">
        <link:definition>0042 - Disclosure - Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/OtherPayablesTables" id="OtherPayablesTables">
        <link:definition>0043 - Disclosure - Other Payables (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/LiabilitiesInRespectOfIiaGrantsTables" id="LiabilitiesInRespectOfIiaGrantsTables">
        <link:definition>0044 - Disclosure - Liabilities in Respect of IIA Grants (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/FinancialInstrumentsTables" id="FinancialInstrumentsTables">
        <link:definition>0045 - Disclosure - Financial  Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsTables" id="ContingentLiabilitiesAndCommitmentsTables">
        <link:definition>0046 - Disclosure - Liabilities and Commitments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/EquityTables" id="EquityTables">
        <link:definition>0047 - Disclosure - Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/Share-basedCompensationTables" id="Share-basedCompensationTables">
        <link:definition>0048 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables" id="SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables">
        <link:definition>0049 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/NetProfitLossPerShareTables" id="NetProfitLossPerShareTables">
        <link:definition>0050 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersTables" id="BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersTables">
        <link:definition>0051 - Disclosure - Balances and Transactions With Related Parties and Key Officers (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/GeneralDetails" id="GeneralDetails">
        <link:definition>0052 - Disclosure - General (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SignificantAccountingPoliciesNarrativeDetails" id="SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0053 - Disclosure - Material Accounting Policies (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfDepreciationOnStraight-lineBasisOverUsefulLifeOfAssetsDetails" id="SignificantAccountingPoliciesScheduleOfDepreciationOnStraight-lineBasisOverUsefulLifeOfAssetsDetails">
        <link:definition>0054 - Disclosure - Material Accounting Policies (Schedule of depreciation on straight line basis over useful life of assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfAmortizationPeriodsOfRight-of-useAssetsDetails" id="SignificantAccountingPoliciesScheduleOfAmortizationPeriodsOfRight-of-useAssetsDetails">
        <link:definition>0055 - Disclosure - Material Accounting Policies (Schedule of amortization periods of right of use assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails" id="CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails">
        <link:definition>0056 - Disclosure - Cash And Cash Equivalents (Schedule of cash and cash equivalents) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/Short-termBankDepositsNarrativeDetails" id="Short-termBankDepositsNarrativeDetails">
        <link:definition>0057 - Disclosure - Short-term and restricted bank deposits (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/Short-termBankDepositsScheduleOfShort-termBankDepositsDetail" id="Short-termBankDepositsScheduleOfShort-termBankDepositsDetail">
        <link:definition>0058 - Disclosure - Short-term and restricted bank deposits (Schedule of short-term bank deposits) (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/TradeReceivablesScheduleOfTradeReceivablesDetails" id="TradeReceivablesScheduleOfTradeReceivablesDetails">
        <link:definition>0059 - Disclosure - Trade Receivables (Schedule of trade receivables) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/InventoriesScheduleOfInventoriesDetails" id="InventoriesScheduleOfInventoriesDetails">
        <link:definition>0060 - Disclosure - Inventories (Schedule of inventories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/OtherReceivablesScheduleOfOtherReceivablesDetails" id="OtherReceivablesScheduleOfOtherReceivablesDetails">
        <link:definition>0061 - Disclosure - Other Receivables Short Term (Schedule of other receivables short term) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/OtherReceivablesLongTermDetails" id="OtherReceivablesLongTermDetails">
        <link:definition>0062 - Disclosure - Other Receivables- Long Term (Schedule of other receivables long term) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails" id="PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails">
        <link:definition>0063 - Disclosure - Property, Plant And Equipment, Net (Schedule of property, plant and equipment, net) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/LeasesNarrativeDetails" id="LeasesNarrativeDetails">
        <link:definition>0064 - Disclosure - Leases (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/LeasesScheduleOfInformationOnLeasesDetails" id="LeasesScheduleOfInformationOnLeasesDetails">
        <link:definition>0065 - Disclosure - Leases (Schedule of information on leases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails" id="LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails">
        <link:definition>0066 - Disclosure - Leases (Schedule of Disclosures of Right-of-Use Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails" id="LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails">
        <link:definition>0067 - Disclosure - Leases (Schedule of disclosures of lease liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails" id="IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails">
        <link:definition>0068 - Disclosure - Intangible Assets, Net (Schedule of intangible assets, net) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/OtherPayablesNarrativeDetails" id="OtherPayablesNarrativeDetails">
        <link:definition>0069 - Disclosure - Other Payables (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/OtherPayablesScheduleOfOtherPayablesDetails" id="OtherPayablesScheduleOfOtherPayablesDetails">
        <link:definition>0070 - Disclosure - Other Payables (Schedule of other payables) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/LiabilitiesInRespectOfIIAGrantsNarrativeDetails" id="LiabilitiesInRespectOfIIAGrantsNarrativeDetails">
        <link:definition>0071 - Disclosure - Liabilities in Respect of IIA Grants (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/LiabilitiesInRespectOfIiaGrantsScheduleOfIsraeliInnovationAuthorityGrantsDetails" id="LiabilitiesInRespectOfIiaGrantsScheduleOfIsraeliInnovationAuthorityGrantsDetails">
        <link:definition>0072 - Disclosure - Liabilities in Respect of IIA Grants (Schedule of israeli innovation authority grants) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/FinancialInstrumentsNarrativeDetails" id="FinancialInstrumentsNarrativeDetails">
        <link:definition>0073 - Disclosure - Financial  Instruments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/FinancialInstrumentsScheduleOfSensitivityTestsRelatingToChangesInMarketFactorsDetails" id="FinancialInstrumentsScheduleOfSensitivityTestsRelatingToChangesInMarketFactorsDetails">
        <link:definition>0074 - Disclosure - Financial  Instruments (Schedule of sensitivity tests relating to changes in market factors) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails" id="FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails">
        <link:definition>0075 - Disclosure - Financial Instruments (Schedule of liquidity risk by holding cash balances, short-term deposits and secured bank credit facilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SeverancePayLiabiltyNetDetails" id="SeverancePayLiabiltyNetDetails">
        <link:definition>0076 - Disclosure - Severance Pay Liability, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails" id="ContingentLiabilitiesAndCommitmentsDetails">
        <link:definition>0077 - Disclosure - Liabilities and Commitments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/MaterialAgreementsDetails" id="MaterialAgreementsDetails">
        <link:definition>0078 - Disclosure - Materials Agreements (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/EquityNarrativeDetails" id="EquityNarrativeDetails">
        <link:definition>0079 - Disclosure - Equity (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/EquityScheduleOfShareCapitalDetails" id="EquityScheduleOfShareCapitalDetails">
        <link:definition>0080 - Disclosure - Equity (Schedule of Share Capital) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/Share-basedCompensationNarrativeDetails" id="Share-basedCompensationNarrativeDetails">
        <link:definition>0081 - Disclosure - Share-Based Compensation (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/Share-basedCompensationScheduleOfExpenseRecognizedDetails" id="Share-basedCompensationScheduleOfExpenseRecognizedDetails">
        <link:definition>0082 - Disclosure - Share-Based Compensation (Schedule of Expense Recognized) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails" id="Share-basedCompensationScheduleOfShareOptionsActivityDetails">
        <link:definition>0083 - Disclosure - Share-Based Compensation (Schedule of Share Options Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails" id="Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails">
        <link:definition>0084 - Disclosure - Share-Based Compensation (Schedule of Information About Share Options Outstanding) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/Share-basedCompensationScheduleOfEstimatedUsingAcceptableOptionPricingModelsDetails" id="Share-basedCompensationScheduleOfEstimatedUsingAcceptableOptionPricingModelsDetails">
        <link:definition>0085 - Disclosure - Share-Based Compensation (Schedule of Estimated Using Acceptable Option Pricing Models) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/TaxesOnIncomeDetails" id="TaxesOnIncomeDetails">
        <link:definition>0086 - Disclosure - Income Tax (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails" id="SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails">
        <link:definition>0087 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeographicalInformationDetails" id="SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeographicalInformationDetails">
        <link:definition>0088 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesProductsDetails" id="SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesProductsDetails">
        <link:definition>0089 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Cost of Revenues Products) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesDetails" id="SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesDetails">
        <link:definition>0090 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss ( Schedule of Cost of Revenues) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenueLicenseDetails" id="SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenueLicenseDetails">
        <link:definition>0091 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Cost of Revenue License) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails" id="SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails">
        <link:definition>0092 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Research Expenses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails" id="SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails">
        <link:definition>0093 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Selling Expenses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeneralExpensesDetails" id="SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeneralExpensesDetails">
        <link:definition>0094 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of General Expenses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails" id="SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails">
        <link:definition>0095 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Financial Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/NetProfitLossPerShareNarrativeDetails" id="NetProfitLossPerShareNarrativeDetails">
        <link:definition>0096 - Disclosure - Net Loss Per Share (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/NetProfitLossPerShareScheduleOfDetailsOfNumberOfSharesAndLossUsedInComputationDetails" id="NetProfitLossPerShareScheduleOfDetailsOfNumberOfSharesAndLossUsedInComputationDetails">
        <link:definition>0097 - Disclosure - Net Loss Per Share (Schedule of Details of Number of Shares and Loss Used in Computation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/NetProfitLossPerShareScheduleOfNetProfitLossPerShareFromContinuingAndDiscontinuedOperationsDetails" id="NetProfitLossPerShareScheduleOfNetProfitLossPerShareFromContinuingAndDiscontinuedOperationsDetails">
        <link:definition>0098 - Disclosure - Net Loss Per Share (Schedule of Net Loss Per Share from Continuing and Discontinued Operations) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersNarrativeDetails" id="BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersNarrativeDetails">
        <link:definition>0099 - Disclosure - Balances and Transactions With Related Parties and Key Officers (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfRelatedPartiesDetails" id="BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfRelatedPartiesDetails">
        <link:definition>0100 - Disclosure - Balances and Transactions With Related Parties and Key Officers (Schedule of Balances of Related Parties) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfTransactionsWithRelatedPartiesDetails" id="BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfTransactionsWithRelatedPartiesDetails">
        <link:definition>0101 - Disclosure - Balances and Transactions With Related Parties and Key Officers (Schedule of Transactions with Related Parties) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfKeyOfficersOfTheCompanyDetails" id="BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfKeyOfficersOfTheCompanyDetails">
        <link:definition>0102 - Disclosure - Balances and Transactions With Related Parties and Key Officers (Schedule of Balances of Key Officers of the Company) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfCompensationOfOfficersOfCompanyDetails" id="BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfCompensationOfOfficersOfCompanyDetails">
        <link:definition>0103 - Disclosure - Balances and Transactions With Related Parties and Key Officers (Schedule of Compensation of Officers of Company) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SubsequentEventsDetailTextuals" id="SubsequentEventsDetailTextuals">
        <link:definition>0104 - Disclosure - Subsequent events (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="mdwd-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="mdwd-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="mdwd-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="mdwd-20231231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
    </appinfo>
  </annotation>
  <element name="AccumaletedEffectOfAdoptingIfrsFifteen" id="mdwd_AccumaletedEffectOfAdoptingIfrsFifteen" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AccumulatedFunding" id="mdwd_AccumulatedFunding" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdditionalInvestment" id="mdwd_AdditionalInvestment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits" id="mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AdditionalTermOfLease" id="mdwd_AdditionalTermOfLease" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AdditionalUpfrontPayment" id="mdwd_AdditionalUpfrontPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdditionsToRightOfUseAssetsAdjustmentsForIndexation" id="mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdditionsToRightOfUseAssetsDisposals" id="mdwd_AdditionsToRightOfUseAssetsDisposals" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdditionsToRightOfUseAssetsNewLeases" id="mdwd_AdditionsToRightOfUseAssetsNewLeases" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdditionsToRightOfUseAssetsTerminationOfLeases" id="mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustedWeightedAverageSharesContinuing" id="mdwd_AdjustedWeightedAverageSharesContinuing" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants" id="mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue" id="mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" id="mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability" id="mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForIncreaseDecreaseInOtherIncome" id="mdwd_AdjustmentsForIncreaseDecreaseInOtherIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" id="mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForIndexation" id="mdwd_AdjustmentsForIndexation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" id="mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsMember" id="mdwd_AdjustmentsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AdjustmentsToReconcileNetLossToNetCashProvidedByUsedInContinuingOperatingActivitiesAbstract" id="mdwd_AdjustmentsToReconcileNetLossToNetCashProvidedByUsedInContinuingOperatingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AggregateAmountOfRegisteredDirectOffering" id="mdwd_AggregateAmountOfRegisteredDirectOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AggregateSupplementalAmount" id="mdwd_AggregateSupplementalAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AgreementAxis" id="mdwd_AgreementAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="AgreementDomain" id="mdwd_AgreementDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AllotmentOfDevelopmentCostOfGoodsSold" id="mdwd_AllotmentOfDevelopmentCostOfGoodsSold" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AllotmentOfManufacturingCosts" id="mdwd_AllotmentOfManufacturingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AllotmentOfManufacturingCostsToResearchAndDevelopment" id="mdwd_AllotmentOfManufacturingCostsToResearchAndDevelopment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmortizationPeriodsOfRightOfUseAssets" id="mdwd_AmortizationPeriodsOfRightOfUseAssets" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmortizedCostMember" id="mdwd_AmortizedCostMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmortizedCostOfGrantsReceived" id="mdwd_AmortizedCostOfGrantsReceived" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfAnnualFeeOfLeaseAgreement" id="mdwd_AmountOfAnnualFeeOfLeaseAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfInvestedInProject" id="mdwd_AmountOfInvestedInProject" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfLeaseLiabilityUnderLongTermDebtAndCurrentMaturity" id="mdwd_AmountOfLeaseLiabilityUnderLongTermDebtAndCurrentMaturity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AmountOfOptionToFundDevelopmentOfOtherPotential" id="mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AmountOfSecondContractExpired" id="mdwd_AmountOfSecondContractExpired" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfTechnicalAssistance" id="mdwd_AmountOfTechnicalAssistance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AmountOfUnderwritingDiscountsAndCommissions" id="mdwd_AmountOfUnderwritingDiscountsAndCommissions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AreaOfLand" id="mdwd_AreaOfLand" type="dtr-types:areaItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AuthorizedNumberOfSharesIncreased" id="mdwd_AuthorizedNumberOfSharesIncreased" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AuthorizedNumberOfSharesNominalValue" id="mdwd_AuthorizedNumberOfSharesNominalValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AuthorizedShareCapital" id="mdwd_AuthorizedShareCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AverageStandardDeviationOfWarrants" id="mdwd_AverageStandardDeviationOfWarrants" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BardaFunds" id="mdwd_BardaFunds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="BardaMember" id="mdwd_BardaMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BasicAndDilutedEarningsPerShareAbstract" id="mdwd_BasicAndDilutedEarningsPerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BasicAndDilutedNetProfitLossPerShareFromContinuingOperations" id="mdwd_BasicAndDilutedNetProfitLossPerShareFromContinuingOperations" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations" id="mdwd_BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BiomedicalAdvancedResearchAndDevelopmentAuthorityMember" id="mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BoardMembersMember" id="mdwd_BoardMembersMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BoardOfDirectorsMember" id="mdwd_BoardOfDirectorsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BuildingAndEquipmentMember" id="mdwd_BuildingAndEquipmentMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CarryforwardLosses" id="mdwd_CarryforwardLosses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CashAndCashEquivalentsShortTermAndRestrictedBankDeposits" id="mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CashlessExerciseMember" id="mdwd_CashlessExerciseMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CashOnHandInNonUsd" id="mdwd_CashOnHandInNonUsd" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CertainEntitiesAffiliatedWithCbiMember" id="mdwd_CertainEntitiesAffiliatedWithCbiMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChairmanMember" id="mdwd_ChairmanMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets" id="mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ChangesInAssetAndLiabilityItemsAbstract" id="mdwd_ChangesInAssetAndLiabilityItemsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChiefExecutiveOfficerAndChiefMedicalOfficerMember" id="mdwd_ChiefExecutiveOfficerAndChiefMedicalOfficerMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChiefExecutiveOfficersMember" id="mdwd_ChiefExecutiveOfficersMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CollaborationAgreementsAmountRelatedToPolyheal" id="mdwd_CollaborationAgreementsAmountRelatedToPolyheal" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CommissionsAndOtherOfferingExpenses" id="mdwd_CommissionsAndOtherOfferingExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CompromisedDepreciationExpense" id="mdwd_CompromisedDepreciationExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ConcentrationRiskPercentage" id="mdwd_ConcentrationRiskPercentage" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ContractAmountForDevelopmentAndManufacturing" id="mdwd_ContractAmountForDevelopmentAndManufacturing" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ContractAssetRelatedToBarda" id="mdwd_ContractAssetRelatedToBarda" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ContractWithCustomers" id="mdwd_ContractWithCustomers" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CostOfLicenseAgreements" id="mdwd_CostOfLicenseAgreements" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CostOfMaterials" id="mdwd_CostOfMaterials" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CostOfRevenuesMember" id="mdwd_CostOfRevenuesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CostOfSalesFromLicenseAgreements" id="mdwd_CostOfSalesFromLicenseAgreements" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CostOfSalesFromSaleOfProducts" id="mdwd_CostOfSalesFromSaleOfProducts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrs15" id="mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrs15" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CumulativeEffectAdjustmentOnAccumulatedLiabilitiesAsResultOfAdoptingIfrs16" id="mdwd_CumulativeEffectAdjustmentOnAccumulatedLiabilitiesAsResultOfAdoptingIfrs16" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CurrentBarda" id="mdwd_CurrentBarda" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CurrentBardaFundsReceivables" id="mdwd_CurrentBardaFundsReceivables" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CurrentGovernmentAuthoritiesReceivables" id="mdwd_CurrentGovernmentAuthoritiesReceivables" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CurrentMaturitiesOfLongTermLiabilities" id="mdwd_CurrentMaturitiesOfLongTermLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CurrentMtec" id="mdwd_CurrentMtec" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CurrentVericel" id="mdwd_CurrentVericel" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DeferredRevenueNonCurrent" id="mdwd_DeferredRevenueNonCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeferredRevenues" id="mdwd_DeferredRevenues" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeferredRevenuesExpectedRecongnizedPeriod" id="mdwd_DeferredRevenuesExpectedRecongnizedPeriod" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DeferredTaxAssetsNotRecognized" id="mdwd_DeferredTaxAssetsNotRecognized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DepositInterestRate" id="mdwd_DepositInterestRate" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DepreciatedCostMember" id="mdwd_DepreciatedCostMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses" id="mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment" id="mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses" id="mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory" id="mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory" id="mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfAccountingPolicyForShortTermBankDepositsExplanatory" id="mdwd_DescriptionOfAccountingPolicyForShortTermBankDepositsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfTaxBenefitPeriod" id="mdwd_DescriptionOfTaxBenefitPeriod" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DilutedWeightedAverageNumberMember" id="mdwd_DilutedWeightedAverageNumberMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DirectorsAndCeoMember" id="mdwd_DirectorsAndCeoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DirectorsMember" id="mdwd_DirectorsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfAdditionalInformationAboutLeaseExplanatory" id="mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfAdditionalInformationRevenuesExplanatory" id="mdwd_DisclosureOfAdditionalInformationRevenuesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfBasisOfPreparationOfConsolidatedFinancialStatementsAbstract" id="mdwd_DisclosureOfBasisOfPreparationOfConsolidatedFinancialStatementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfCostOfSalesServicesExplanatory" id="mdwd_DisclosureOfCostOfSalesServicesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory" id="mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory" id="mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" id="mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory" id="mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory" id="mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory" id="mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutInventoriesExplanatory" id="mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory" id="mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory" id="mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutOtherPayablesExplanatory" id="mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory" id="mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory" id="mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory" id="mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory" id="mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory" id="mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory" id="mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDiscontinuedOperationAbstract" id="mdwd_DisclosureOfDiscontinuedOperationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems" id="mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable" id="mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="DisclosureOfGeneralInformationAbstract" id="mdwd_DisclosureOfGeneralInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfIncomeTaxesAbstract" id="mdwd_DisclosureOfIncomeTaxesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfIsraeliInnovationAuthorityGrantsAbstract" id="mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfMaterialAgreementsAbstract" id="mdwd_DisclosureOfMaterialAgreementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfMaterialAgreementsExplanatory" id="mdwd_DisclosureOfMaterialAgreementsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfOtherReceivablesLongTermExplanatory" id="mdwd_DisclosureOfOtherReceivablesLongTermExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfShortTermBankDepositsAbstract" id="mdwd_DisclosureOfShortTermBankDepositsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfSignificantAccountingPoliciesAbstract" id="mdwd_DisclosureOfSignificantAccountingPoliciesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory" id="mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract" id="mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfTradeReceivablesExplanatory" id="mdwd_DisclosureOfTradeReceivablesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisposalsMember" id="mdwd_DisposalsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisposalsTerminationOfLeases" id="mdwd_DisposalsTerminationOfLeases" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DocumentAndEntityInformationAbstract" id="mdwd_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EffectOfChangesInExchangeRatesForLeaseLiabilities" id="mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="EffectOfShareSplit" id="mdwd_EffectOfShareSplit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EffectOfTheInitialAdoptionOfTheNewStandardMember" id="mdwd_EffectOfTheInitialAdoptionOfTheNewStandardMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EmployeesAndDirectorsMember" id="mdwd_EmployeesAndDirectorsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EmployeesMember" id="mdwd_EmployeesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EmployeesOfficersBoardMembersCeoAndConsultantsMember" id="mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Equity1" id="mdwd_Equity1" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EquityIncentivePlanMember" id="mdwd_EquityIncentivePlanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EquityTablesAbstract" id="mdwd_EquityTablesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EUMember" id="mdwd_EUMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EventsAfterReportingPeriodMember" id="mdwd_EventsAfterReportingPeriodMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisedOptionsToPurchaseAdditionalOrdinaryShares" id="mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExerciseOfRsuOption" id="mdwd_ExerciseOfRsuOption" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExercisePriceOfWarrants" id="mdwd_ExercisePriceOfWarrants" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceShareOptionsGrantedPercentage" id="mdwd_ExercisePriceShareOptionsGrantedPercentage" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedDividendAsPercentageOfWarrants" id="mdwd_ExpectedDividendAsPercentageOfWarrants" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedTermOfWarrant" id="mdwd_ExpectedTermOfWarrant" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedVolatilityWarrants" id="mdwd_ExpectedVolatilityWarrants" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FinanceExpensesInRespectOfDeferredRevenue" id="mdwd_FinanceExpensesInRespectOfDeferredRevenue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FinanceIncomeExpenseNet" id="mdwd_FinanceIncomeExpenseNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FinancialExpensesNet" id="mdwd_FinancialExpensesNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FinancialIncomeAndExpenses" id="mdwd_FinancialIncomeAndExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FinancingExpensesAbstract" id="mdwd_FinancingExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FinancingIncomeAbstract" id="mdwd_FinancingIncomeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FinancingIncomeOnNetInvestmentInLease" id="mdwd_FinancingIncomeOnNetInvestmentInLease" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FivePercentageDecreaseInExchangeRateMember" id="mdwd_FivePercentageDecreaseInExchangeRateMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FivePercentageIncreaseInExchangeRateMember" id="mdwd_FivePercentageIncreaseInExchangeRateMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ForDevelopmentCostsOfNexoBridMember" id="mdwd_ForDevelopmentCostsOfNexoBridMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FormerShareholder" id="mdwd_FormerShareholder" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FundingByBardaPolicyTextBlock" id="mdwd_FundingByBardaPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FutureRoyaltyPaymentsMember" id="mdwd_FutureRoyaltyPaymentsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GeneralAndAdministrativeExpensesMember" id="mdwd_GeneralAndAdministrativeExpensesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantsReceived" id="mdwd_GrantsReceived" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="GrantsReceivedNetOfRoyalties" id="mdwd_GrantsReceivedNetOfRoyalties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="GrossProceedsFromPublicAndPrivateOfferings" id="mdwd_GrossProceedsFromPublicAndPrivateOfferings" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncomeReceivablesLongTerm" id="mdwd_IncomeReceivablesLongTerm" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncomeReceivablesShortTerm" id="mdwd_IncomeReceivablesShortTerm" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncomingCEOAndChairmanMember" id="mdwd_IncomingCEOAndChairmanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncomingCFOMember" id="mdwd_IncomingCFOMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits" id="mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseInAuthorizedShareCapital" id="mdwd_IncreaseInAuthorizedShareCapital" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseInPreFundedWarrantsExercisePrice" id="mdwd_IncreaseInPreFundedWarrantsExercisePrice" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseInSharesIssued" id="mdwd_IncreaseInSharesIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InitialInvestment" id="mdwd_InitialInvestment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InterestRateForLoanMember" id="mdwd_InterestRateForLoanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IsraeliShareOptionPlanMember" id="mdwd_IsraeliShareOptionPlanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IsraelMember" id="mdwd_IsraelMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceExpensesOfWarrantsThroughProfitAndLoss" id="mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="KeyOfficerMember" id="mdwd_KeyOfficerMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="KostForerGabbayAndKasiererMember" id="mdwd_KostForerGabbayAndKasiererMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="KpmgInternationalLimitedMember" id="mdwd_KpmgInternationalLimitedMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LaterThanTwoYearAndNotLaterThanEightYearsMember" id="mdwd_LaterThanTwoYearAndNotLaterThanEightYearsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LaterThanTwoYearAndNotLaterThanFifteenYearsMember" id="mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LeasesAbstract" id="mdwd_LeasesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LiabilitiesInRespectOfGrants" id="mdwd_LiabilitiesInRespectOfGrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LiabilitiesInRespectOfPurchaseOfShares" id="mdwd_LiabilitiesInRespectOfPurchaseOfShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LiabilitiesInRespectOfTeva" id="mdwd_LiabilitiesInRespectOfTeva" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LiabilityInRespectForPurchaseOfShares" id="mdwd_LiabilityInRespectForPurchaseOfShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities" id="mdwd_LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LicenseAgreementWithVericelMember" id="mdwd_LicenseAgreementWithVericelMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LicenseForPolyhealProductsMember" id="mdwd_LicenseForPolyhealProductsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LimitOfBenefitEntitlementPeriod" id="mdwd_LimitOfBenefitEntitlementPeriod" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LossFromWarrantsTransactions" id="mdwd_LossFromWarrantsTransactions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="MarketingAndSalesExpense" id="mdwd_MarketingAndSalesExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="MaximumAggregateRoyaltiesPaidInPercentage" id="mdwd_MaximumAggregateRoyaltiesPaidInPercentage" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ModifiedContractAmount" id="mdwd_ModifiedContractAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="MtecMember" id="mdwd_MtecMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NetProceedsFromOfferingAmount" id="mdwd_NetProceedsFromOfferingAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NewFinanceLeaseObligationRecognized" id="mdwd_NewFinanceLeaseObligationRecognized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NewPolyHealSettlementAgreementsMember" id="mdwd_NewPolyHealSettlementAgreementsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NexoBridMember" id="mdwd_NexoBridMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NoncancelableLeasePeriods" id="mdwd_NoncancelableLeasePeriods" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NonCashTransactionsAbstract" id="mdwd_NonCashTransactionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NonCurrentLiabilitiesCurrent" id="mdwd_NonCurrentLiabilitiesCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NumberAbstract" id="mdwd_NumberAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfDirectors" id="mdwd_NumberOfDirectors" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfOrdinarySharesIssuable" id="mdwd_NumberOfOrdinarySharesIssuable" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfPreFundedWarrantsExercised" id="mdwd_NumberOfPreFundedWarrantsExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfRestrictedShareUnitIssued" id="mdwd_NumberOfRestrictedShareUnitIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesExerciseRestrictedStockUnits" id="mdwd_NumberOfSharesExerciseRestrictedStockUnits" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesRepurchased" id="mdwd_NumberOfSharesRepurchased" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare" id="mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfVehiclesInOperatingLeaseArrangements" id="mdwd_NumberOfVehiclesInOperatingLeaseArrangements" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsIssued" id="mdwd_NumberOfWarrantsIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OneTimeLumpsumAmount" id="mdwd_OneTimeLumpsumAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OtherCountriesMember" id="mdwd_OtherCountriesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherCurrentPayable" id="mdwd_OtherCurrentPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="OtherCustomerContributedMember" id="mdwd_OtherCustomerContributedMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherReceivablesDiscontinuedOperations" id="mdwd_OtherReceivablesDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OtherResearchAndDevelopmentExpenses" id="mdwd_OtherResearchAndDevelopmentExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OtherSellingGeneralAndAdministrativeExpenses" id="mdwd_OtherSellingGeneralAndAdministrativeExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OtherTemporaryDifferencesMainlyFromRAndDExpenses" id="mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ParticipationsAbstract" id="mdwd_ParticipationsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PatentMember" id="mdwd_PatentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfFutureRoyaltyPayments" id="mdwd_PercentageOfFutureRoyaltyPayments" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans" id="mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfOneTimeLumpSumPaymentAmount" id="mdwd_PercentageOfOneTimeLumpSumPaymentAmount" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts" id="mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PeriodOfBankDeposits" id="mdwd_PeriodOfBankDeposits" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts" id="mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PeriodOfVehiclesOperatingLeaseArrangements" id="mdwd_PeriodOfVehiclesOperatingLeaseArrangements" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PolyhealLtdMember" id="mdwd_PolyhealLtdMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PolyhealMember" id="mdwd_PolyhealMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PolyhealSettlementAgreementsMember" id="mdwd_PolyhealSettlementAgreementsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrepaidExpensesLongTerm" id="mdwd_PrepaidExpensesLongTerm" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent" id="mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PricePerShareOfSharesIssued" id="mdwd_PricePerShareOfSharesIssued" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrivateIssuancePurchaseEquityAgreementMember" id="mdwd_PrivateIssuancePurchaseEquityAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ProceedsFromAdditionalFunding" id="mdwd_ProceedsFromAdditionalFunding" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromAdditionalProcurement" id="mdwd_ProceedsFromAdditionalProcurement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromFunding" id="mdwd_ProceedsFromFunding" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromIssuanceOfSharesAndWarrantsNet" id="mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromIssuingAdditionalShares" id="mdwd_ProceedsFromIssuingAdditionalShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromProcurement" id="mdwd_ProceedsFromProcurement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromRepaymentsOfGrants" id="mdwd_ProceedsFromRepaymentsOfGrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProfessionalFeeAndShareBasedCompensationExpenses" id="mdwd_ProfessionalFeeAndShareBasedCompensationExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProvisionForImpairment" id="mdwd_ProvisionForImpairment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PurchaseOfPropertyAndEquipment" id="mdwd_PurchaseOfPropertyAndEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PurchasePriceForResidualNumberOfShares" id="mdwd_PurchasePriceForResidualNumberOfShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PurchasePriceOfRegisteredDirectOffering" id="mdwd_PurchasePriceOfRegisteredDirectOffering" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesOfExercisePricesEightMember" id="mdwd_RangesOfExercisePricesEightMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesOfExercisePricesFiveMember" id="mdwd_RangesOfExercisePricesFiveMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesOfExercisePricesFourMember" id="mdwd_RangesOfExercisePricesFourMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesOfExercisePricesOneMember" id="mdwd_RangesOfExercisePricesOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesOfExercisePricesServenMember" id="mdwd_RangesOfExercisePricesServenMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesOfExercisePricesSixMember" id="mdwd_RangesOfExercisePricesSixMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesOfExercisePricesThreeMember" id="mdwd_RangesOfExercisePricesThreeMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesOfExercisePricesTwoMember" id="mdwd_RangesOfExercisePricesTwoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ReceivableFromBarda" id="mdwd_ReceivableFromBarda" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ReducedAggregateAmount" id="mdwd_ReducedAggregateAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ReducedRateOfPayments" id="mdwd_ReducedRateOfPayments" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RegistrationAndMarketingLicenseFees" id="mdwd_RegistrationAndMarketingLicenseFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RelatedPartiesRentaLexpenseAndOther" id="mdwd_RelatedPartiesRentaLexpenseAndOther" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RepaymentOfLiabilitiesInRespectOfTeva" id="mdwd_RepaymentOfLiabilitiesInRespectOfTeva" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RepaymentsOfIiaGrantsNet" id="mdwd_RepaymentsOfIiaGrantsNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ResearchAndDevelopmentExpenseGross" id="mdwd_ResearchAndDevelopmentExpenseGross" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ResearchAndDevelopmentExpensesMember" id="mdwd_ResearchAndDevelopmentExpensesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ResearchAndDevelopmentLawMember" id="mdwd_ResearchAndDevelopmentLawMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RestrictedBankDepositsLongTerm" id="mdwd_RestrictedBankDepositsLongTerm" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RestrictedSharesUnitsMember" id="mdwd_RestrictedSharesUnitsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RevaluationOfLeaseLiabilities" id="mdwd_RevaluationOfLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RevaluationOfLiabilitiesInRespectOfGrants" id="mdwd_RevaluationOfLiabilitiesInRespectOfGrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RevaluationOfLiabilitiesInRespectOfIfrsSixteen" id="mdwd_RevaluationOfLiabilitiesInRespectOfIfrsSixteen" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RevaluationOfLiabilitiesInRespectOfIiaGrants" id="mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RevaluationOfLiabilitiesInRespectOfIlaGrant" id="mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RevaluationOfLiabilitiesInRespectOfPurchaseOfShares" id="mdwd_RevaluationOfLiabilitiesInRespectOfPurchaseOfShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RevaluationOfLiabilitiesInRespectOfPurchasesOfShares" id="mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RevaluationOfWarrant" id="mdwd_RevaluationOfWarrant" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RevaluationOfWarrantsAccountedAtFairValue" id="mdwd_RevaluationOfWarrantsAccountedAtFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RevenuesFromDistributionAgreements" id="mdwd_RevenuesFromDistributionAgreements" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RevenuesFromSaleOfProcurement" id="mdwd_RevenuesFromSaleOfProcurement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ReverseStockSplit" id="mdwd_ReverseStockSplit" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RightOfUseAssetDisposals" id="mdwd_RightOfUseAssetDisposals" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RightOfUseAssetReclassifiedToLeaseholdImprovements" id="mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RightOfUseAssetsAccumulatedDepreciation" id="mdwd_RightOfUseAssetsAccumulatedDepreciation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RightOfUseAssetsAccumulatedDepreciationAbstract" id="mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RightOfUseAssetsAccumulatedDepreciationAdditionsDuringYearAbstract" id="mdwd_RightOfUseAssetsAccumulatedDepreciationAdditionsDuringYearAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RightOfUseAssetsAdditionsDuringYearAbstract" id="mdwd_RightOfUseAssetsAdditionsDuringYearAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RightOfUseAssetsCostAbstract" id="mdwd_RightOfUseAssetsCostAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RightOfUseAssetsDepreciationAbstract" id="mdwd_RightOfUseAssetsDepreciationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RiskFreeInterestRateOfWarrants" id="mdwd_RiskFreeInterestRateOfWarrants" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RiskFreeRateOfWarrants" id="mdwd_RiskFreeRateOfWarrants" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RoyaltiesPayments" id="mdwd_RoyaltiesPayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RoyaltyRightsArisingMember" id="mdwd_RoyaltyRightsArisingMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SalaryAndBenefits" id="mdwd_SalaryAndBenefits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="SalaryAndBenefitsExpensesRelatedToLicenseAgreements" id="mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="SalaryAndBenefitsIncludingShareBasedCompensation" id="mdwd_SalaryAndBenefitsIncludingShareBasedCompensation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock" id="mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfCostOfRevenuesLicense" id="mdwd_ScheduleOfCostOfRevenuesLicense" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SellingAndMarketingExpensesMember" id="mdwd_SellingAndMarketingExpensesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SensitivityAnalysisAxis" id="mdwd_SensitivityAnalysisAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="SensitivityAnalysisDomain" id="mdwd_SensitivityAnalysisDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract" id="mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SettlementAmountPaidByTeva" id="mdwd_SettlementAmountPaidByTeva" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ShareholderMember" id="mdwd_ShareholderMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareIncentivePlanMember" id="mdwd_ShareIncentivePlanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare" id="mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharesAvailableForFutureGrant" id="mdwd_SharesAvailableForFutureGrant" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharesIssuedPriceInInitialPublicOffering" id="mdwd_SharesIssuedPriceInInitialPublicOffering" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharesReceivedOfPolyheal" id="mdwd_SharesReceivedOfPolyheal" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockOptionValue" id="mdwd_StockOptionValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="Subcontractors" id="mdwd_Subcontractors" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="SubcontractorsExpenses" id="mdwd_SubcontractorsExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="SubcontractorsExpensesRelatedToResearchAndDevelopment" id="mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="SubLicensingOfPatentsMember" id="mdwd_SubLicensingOfPatentsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubsequentEventsMember" id="mdwd_SubsequentEventsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubsidiariesLeaseArea" id="mdwd_SubsidiariesLeaseArea" type="dtr-types:areaItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubsidiariesLeaseEstimatedUsefulLife" id="mdwd_SubsidiariesLeaseEstimatedUsefulLife" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubsidiariesLeaseExpirationDate" id="mdwd_SubsidiariesLeaseExpirationDate" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubsidiariesLeaseExpirationPeriod" id="mdwd_SubsidiariesLeaseExpirationPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubsidiariesLeaseExtentionPeriod" id="mdwd_SubsidiariesLeaseExtentionPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubsidiariesLeaseMonthlyRent" id="mdwd_SubsidiariesLeaseMonthlyRent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TermOfLease" id="mdwd_TermOfLease" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TevaMember" id="mdwd_TevaMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ThirdPartiesMember" id="mdwd_ThirdPartiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TotalBasicAndDilutedNetProfitLossPerShare" id="mdwd_TotalBasicAndDilutedNetProfitLossPerShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TotalMember" id="mdwd_TotalMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TotalRoyaltiesPayments" id="mdwd_TotalRoyaltiesPayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TradePayablesAndAccruedExpenses" id="mdwd_TradePayablesAndAccruedExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="TransactionOneMember" id="mdwd_TransactionOneMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TurnkeyScaleUpAgreementWithBiopharmaxGroupMember" id="mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TwoThousandAndTenPolyHealAgreementMember" id="mdwd_TwoThousandAndTenPolyHealAgreementMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TwoThousandTenPolyhealAgreementMember" id="mdwd_TwoThousandTenPolyhealAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UncertaintyInFutureDefaultsMember" id="mdwd_UncertaintyInFutureDefaultsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UndertookMember" id="mdwd_UndertookMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnearnedAmountsReceivedFromCustomers" id="mdwd_UnearnedAmountsReceivedFromCustomers" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="UnregisteredPreFundedWarrantsIssued" id="mdwd_UnregisteredPreFundedWarrantsIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnregisteredPreFundedWarrantsToPurchaseCommonStock" id="mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UpfrontPayment" id="mdwd_UpfrontPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="UsaMember" id="mdwd_UsaMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember" id="mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="USDepartmentOfDefenseMember" id="mdwd_USDepartmentOfDefenseMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="VericelMember" id="mdwd_VericelMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsExpirationPeriod" id="mdwd_WarrantsExpirationPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinaryShares" id="mdwd_WarrantsToPurchaseOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageExercisePriceAbstract" id="mdwd_WeightedAverageExercisePriceAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>13
<FILENAME>mdwd-20231231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#ConsolidatedBalanceSheets" roleURI="http://mediwound.com/role/ConsolidatedBalanceSheets"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#ConsolidatedStatementsOfComprehensiveIncomeLoss" roleURI="http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#ConsolidatedStatementsOfCashFlows" roleURI="http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails" roleURI="http://mediwound.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#TradeReceivablesScheduleOfTradeReceivablesDetails" roleURI="http://mediwound.com/role/TradeReceivablesScheduleOfTradeReceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#InventoriesScheduleOfInventoriesDetails" roleURI="http://mediwound.com/role/InventoriesScheduleOfInventoriesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#OtherReceivablesScheduleOfOtherReceivablesDetails" roleURI="http://mediwound.com/role/OtherReceivablesScheduleOfOtherReceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#OtherPayablesScheduleOfOtherPayablesDetails" roleURI="http://mediwound.com/role/OtherPayablesScheduleOfOtherPayablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesDetails" roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenueLicenseDetails" roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenueLicenseDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails" roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails" roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeneralExpensesDetails" roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeneralExpensesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails" roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfCompensationOfOfficersOfCompanyDetails" roleURI="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfCompensationOfOfficersOfCompanyDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#OtherReceivablesLongTermDetails" roleURI="http://mediwound.com/role/OtherReceivablesLongTermDetails"/>
  <calculationLink xlink:type="extended" xlink:role="http://mediwound.com/role/ConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="loc_ifrs-full_OtherCurrentReceivables_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentReceivables" xlink:label="loc_ifrs-full_OtherNoncurrentReceivables_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LongtermDeposits" xlink:label="loc_ifrs-full_LongtermDeposits_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NonCurrentLiabilitiesCurrent" xlink:label="loc_mdwd_NonCurrentLiabilitiesCurrent_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentPayables" xlink:label="loc_ifrs-full_OtherCurrentPayables_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentGovernmentGrants" xlink:label="loc_ifrs-full_NoncurrentGovernmentGrants_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentWarrantLiability" xlink:label="loc_ifrs-full_NoncurrentWarrantLiability_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredIncomeOtherThanContractLiabilities" xlink:label="loc_ifrs-full_DeferredIncomeOtherThanContractLiabilities_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads" xlink:label="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_29"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_CurrentAssets_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_CashAndCashEquivalents_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_CurrentTradeReceivables_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_Inventories_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_OtherCurrentReceivables_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_NoncurrentAssets_7" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_7" xlink:to="loc_ifrs-full_OtherNoncurrentReceivables_7" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_7" xlink:to="loc_ifrs-full_LongtermDeposits_8" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_7" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_9" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_7" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_10" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_7" xlink:to="loc_ifrs-full_RightofuseAssets_11" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_13" xlink:to="loc_ifrs-full_Liabilities_14" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities_14" xlink:to="loc_ifrs-full_CurrentLiabilities_14" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_14" xlink:to="loc_mdwd_NonCurrentLiabilitiesCurrent_14" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_14" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_15" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_14" xlink:to="loc_ifrs-full_OtherCurrentPayables_16" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities_14" xlink:to="loc_ifrs-full_NoncurrentLiabilities_18" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_18" xlink:to="loc_ifrs-full_NoncurrentGovernmentGrants_18" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_18" xlink:to="loc_ifrs-full_NoncurrentWarrantLiability_19" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_18" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_20" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_18" xlink:to="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_21" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_18" xlink:to="loc_ifrs-full_DeferredIncomeOtherThanContractLiabilities_22" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_18" xlink:to="loc_ifrs-full_OtherNoncurrentLiabilities_23" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_13" xlink:to="loc_ifrs-full_Equity_26" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_26" xlink:to="loc_ifrs-full_IssuedCapital_26" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_26" xlink:to="loc_ifrs-full_SharePremium_27" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_26" xlink:to="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads_28" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_26" xlink:to="loc_ifrs-full_RetainedEarnings_29" order="30" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinanceIncomeExpenseNet" xlink:label="loc_mdwd_FinanceIncomeExpenseNet_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromRenderingOfServices" xlink:label="loc_ifrs-full_RevenueFromRenderingOfServices_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LicenceFeeIncome" xlink:label="loc_ifrs-full_LicenceFeeIncome_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_9"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfLicenseAgreements" xlink:label="loc_mdwd_CostOfLicenseAgreements_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ServicesExpense" xlink:label="loc_ifrs-full_ServicesExpense_10"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfSalesFromSaleOfProducts" xlink:label="loc_mdwd_CostOfSalesFromSaleOfProducts_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_22"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_0" xlink:to="loc_ifrs-full_ProfitLoss_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_1" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_1" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_1" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_2" xlink:to="loc_mdwd_FinanceIncomeExpenseNet_2" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdwd_FinanceIncomeExpenseNet_2" xlink:to="loc_ifrs-full_FinanceCosts_2" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdwd_FinanceIncomeExpenseNet_2" xlink:to="loc_ifrs-full_FinanceIncome_3" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_2" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_5" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_5" xlink:to="loc_ifrs-full_GrossProfit_5" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_5" xlink:to="loc_ifrs-full_Revenue_5" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Revenue_5" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_5" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Revenue_5" xlink:to="loc_ifrs-full_RevenueFromRenderingOfServices_6" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Revenue_5" xlink:to="loc_ifrs-full_LicenceFeeIncome_7" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_5" xlink:to="loc_ifrs-full_CostOfSales_9" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CostOfSales_9" xlink:to="loc_mdwd_CostOfLicenseAgreements_9" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CostOfSales_9" xlink:to="loc_ifrs-full_ServicesExpense_10" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CostOfSales_9" xlink:to="loc_mdwd_CostOfSalesFromSaleOfProducts_11" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_5" xlink:to="loc_ifrs-full_OperatingExpense_14" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OperatingExpense_14" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_14" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OperatingExpense_14" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_15" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OperatingExpense_14" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_16" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OperatingExpense_14" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_17" order="30" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_0" xlink:to="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_22" order="10" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://mediwound.com/role/ConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet" xlink:label="loc_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RepaymentsOfIiaGrantsNet" xlink:label="loc_mdwd_RepaymentsOfIiaGrantsNet_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RepaymentOfLiabilitiesInRespectOfTeva" xlink:label="loc_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromExerciseOfWarrants" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfWarrants_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:label="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_13"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" xlink:label="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" xlink:label="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_19"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue" xlink:label="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue_20"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability" xlink:label="loc_mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability_21"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" xlink:label="loc_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_22"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xlink:label="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_31"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_1" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_1" xlink:to="loc_ifrs-full_ProceedsFromExerciseOfOptions_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_1" xlink:to="loc_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_1" xlink:to="loc_mdwd_RepaymentsOfIiaGrantsNet_4" order="30" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_1" xlink:to="loc_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_5" order="40" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_1" xlink:to="loc_ifrs-full_ProceedsFromExerciseOfWarrants_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_8" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_8" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_8" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_8" xlink:to="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_9" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_8" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_10" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_12" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_13" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_13" xlink:to="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_13" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_13" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_13" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_13" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_14" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_13" xlink:to="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_15" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_13" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_16" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_13" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_17" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_13" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_19" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_19" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_19" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_19" xlink:to="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue_20" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_19" xlink:to="loc_mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability_21" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_19" xlink:to="loc_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_22" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_19" xlink:to="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_23" order="40" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_19" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_24" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_19" xlink:to="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_25" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_19" xlink:to="loc_ifrs-full_OtherIncome_26" order="70" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_19" xlink:to="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_27" order="80" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_19" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_28" order="90" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_19" xlink:to="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_29" order="100" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_13" xlink:to="loc_ifrs-full_ProfitLoss_31" order="20" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://mediwound.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashOnHand" xlink:label="loc_ifrs-full_CashOnHand_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CashOnHandInNonUsd" xlink:label="loc_mdwd_CashOnHandInNonUsd_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashOnHand_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashAndCashEquivalents_0" xlink:to="loc_mdwd_CashOnHandInNonUsd_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://mediwound.com/role/TradeReceivablesScheduleOfTradeReceivablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-full_OtherReceivables_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentVericel" xlink:label="loc_mdwd_CurrentVericel_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentMtec" xlink:label="loc_mdwd_CurrentMtec_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentBarda" xlink:label="loc_mdwd_CurrentBarda_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ReceivableFromBarda" xlink:label="loc_mdwd_ReceivableFromBarda_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProvisionForImpairment" xlink:label="loc_mdwd_ProvisionForImpairment_6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentTradeReceivables_0" xlink:to="loc_ifrs-full_OtherReceivables_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentTradeReceivables_0" xlink:to="loc_mdwd_CurrentVericel_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentTradeReceivables_0" xlink:to="loc_mdwd_CurrentMtec_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentTradeReceivables_0" xlink:to="loc_mdwd_CurrentBarda_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentTradeReceivables_0" xlink:to="loc_mdwd_ReceivableFromBarda_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentTradeReceivables_0" xlink:to="loc_mdwd_ProvisionForImpairment_6" order="50" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://mediwound.com/role/InventoriesScheduleOfInventoriesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RawMaterials" xlink:label="loc_ifrs-full_RawMaterials_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinishedGoods" xlink:label="loc_ifrs-full_FinishedGoods_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Inventories_0" xlink:to="loc_ifrs-full_RawMaterials_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Inventories_0" xlink:to="loc_ifrs-full_FinishedGoods_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://mediwound.com/role/OtherReceivablesScheduleOfOtherReceivablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="loc_ifrs-full_OtherCurrentReceivables_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentGovernmentAuthoritiesReceivables" xlink:label="loc_mdwd_CurrentGovernmentAuthoritiesReceivables_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncomeReceivablesShortTerm" xlink:label="loc_mdwd_IncomeReceivablesShortTerm_3"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentReceivables_0" xlink:to="loc_mdwd_CurrentGovernmentAuthoritiesReceivables_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentReceivables_0" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentReceivables_0" xlink:to="loc_mdwd_IncomeReceivablesShortTerm_3" order="20" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://mediwound.com/role/OtherPayablesScheduleOfOtherPayablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentPayables" xlink:label="loc_ifrs-full_OtherCurrentPayables_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DeferredRevenueNonCurrent" xlink:label="loc_mdwd_DeferredRevenueNonCurrent_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherCurrentPayable" xlink:label="loc_mdwd_OtherCurrentPayable_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DeferredRevenues" xlink:label="loc_mdwd_DeferredRevenues_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilityInRespectForPurchaseOfShares" xlink:label="loc_mdwd_LiabilityInRespectForPurchaseOfShares_6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentPayables_0" xlink:to="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentPayables_0" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentPayables_0" xlink:to="loc_mdwd_DeferredRevenueNonCurrent_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentPayables_0" xlink:to="loc_mdwd_OtherCurrentPayable_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentPayables_0" xlink:to="loc_mdwd_DeferredRevenues_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentPayables_0" xlink:to="loc_mdwd_LiabilityInRespectForPurchaseOfShares_6" order="50" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesDetails">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfSalesFromLicenseAgreements" xlink:label="loc_mdwd_CostOfSalesFromLicenseAgreements_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SalaryAndBenefits" xlink:label="loc_mdwd_SalaryAndBenefits_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_Subcontractors" xlink:label="loc_mdwd_Subcontractors_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdwd_CostOfSalesFromLicenseAgreements_0" xlink:to="loc_mdwd_SalaryAndBenefits_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdwd_CostOfSalesFromLicenseAgreements_0" xlink:to="loc_mdwd_Subcontractors_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenueLicenseDetails">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TotalRoyaltiesPayments" xlink:label="loc_mdwd_TotalRoyaltiesPayments_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements" xlink:label="loc_mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RoyaltiesPayments" xlink:label="loc_mdwd_RoyaltiesPayments_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdwd_TotalRoyaltiesPayments_0" xlink:to="loc_mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdwd_TotalRoyaltiesPayments_0" xlink:to="loc_mdwd_RoyaltiesPayments_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment" xlink:label="loc_mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment" xlink:label="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfMaterials" xlink:label="loc_mdwd_CostOfMaterials_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EmployeeBenefitsExpense" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherResearchAndDevelopmentExpenses" xlink:label="loc_mdwd_OtherResearchAndDevelopmentExpenses_5"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense_0" xlink:to="loc_mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense_0" xlink:to="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense_0" xlink:to="loc_mdwd_CostOfMaterials_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense_0" xlink:to="loc_ifrs-full_EmployeeBenefitsExpense_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense_0" xlink:to="loc_mdwd_OtherResearchAndDevelopmentExpenses_5" order="40" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_MarketingAndSalesExpense" xlink:label="loc_mdwd_MarketingAndSalesExpense_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DistributionCosts" xlink:label="loc_ifrs-full_DistributionCosts_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RegistrationAndMarketingLicenseFees" xlink:label="loc_mdwd_RegistrationAndMarketingLicenseFees_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses" xlink:label="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses_5"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_SalesAndMarketingExpense_0" xlink:to="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_SalesAndMarketingExpense_0" xlink:to="loc_mdwd_MarketingAndSalesExpense_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_SalesAndMarketingExpense_0" xlink:to="loc_ifrs-full_DistributionCosts_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_SalesAndMarketingExpense_0" xlink:to="loc_mdwd_RegistrationAndMarketingLicenseFees_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_SalesAndMarketingExpense_0" xlink:to="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses_5" order="40" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeneralExpensesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SalaryAndBenefitsIncludingShareBasedCompensation" xlink:label="loc_mdwd_SalaryAndBenefitsIncludingShareBasedCompensation_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses" xlink:label="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherSellingGeneralAndAdministrativeExpenses" xlink:label="loc_mdwd_OtherSellingGeneralAndAdministrativeExpenses_4"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_0" xlink:to="loc_mdwd_SalaryAndBenefitsIncludingShareBasedCompensation_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_0" xlink:to="loc_ifrs-full_ProfessionalFeesExpense_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_0" xlink:to="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_0" xlink:to="loc_mdwd_OtherSellingGeneralAndAdministrativeExpenses_4" order="30" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromInterest" xlink:label="loc_ifrs-full_RevenueFromInterest_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfWarrantsAccountedAtFairValue" xlink:label="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradingIncomeExpenseOnForeignExchangeContracts" xlink:label="loc_ifrs-full_TradingIncomeExpenseOnForeignExchangeContracts_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinanceExpensesInRespectOfDeferredRevenue" xlink:label="loc_mdwd_FinanceExpensesInRespectOfDeferredRevenue_6"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherFinanceCost" xlink:label="loc_ifrs-full_OtherFinanceCost_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="loc_ifrs-full_NetForeignExchangeLoss_9"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant_10"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinancingIncomeOnNetInvestmentInLease" xlink:label="loc_mdwd_FinancingIncomeOnNetInvestmentInLease_11"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfWarrant" xlink:label="loc_mdwd_RevaluationOfWarrant_12"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss" xlink:label="loc_mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss_13"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncome_0" xlink:to="loc_ifrs-full_RevenueFromInterest_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncome_0" xlink:to="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncome_0" xlink:to="loc_ifrs-full_TradingIncomeExpenseOnForeignExchangeContracts_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncome_0" xlink:to="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_5" xlink:to="loc_mdwd_FinanceExpensesInRespectOfDeferredRevenue_6" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_5" xlink:to="loc_mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares_7" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_5" xlink:to="loc_ifrs-full_OtherFinanceCost_8" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_5" xlink:to="loc_ifrs-full_NetForeignExchangeLoss_9" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_5" xlink:to="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant_10" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_5" xlink:to="loc_mdwd_FinancingIncomeOnNetInvestmentInLease_11" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_5" xlink:to="loc_mdwd_RevaluationOfWarrant_12" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts_5" xlink:to="loc_mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss_13" order="70" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfCompensationOfOfficersOfCompanyDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://mediwound.com/role/OtherReceivablesLongTermDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentReceivables" xlink:label="loc_ifrs-full_OtherNoncurrentReceivables_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncomeReceivablesLongTerm" xlink:label="loc_mdwd_IncomeReceivablesLongTerm_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PrepaidExpensesLongTerm" xlink:label="loc_mdwd_PrepaidExpensesLongTerm_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentReceivables_0" xlink:to="loc_mdwd_IncomeReceivablesLongTerm_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentReceivables_0" xlink:to="loc_mdwd_PrepaidExpensesLongTerm_2" order="10" use="optional" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>mdwd-20231231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#DocumentAndEntityInformation" roleURI="http://mediwound.com/role/DocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#ConsolidatedStatementsOfChangesInShareholdersEquity" roleURI="http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#Share-basedCompensationTables" roleURI="http://mediwound.com/role/Share-basedCompensationTables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#GeneralDetails" roleURI="http://mediwound.com/role/GeneralDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SignificantAccountingPoliciesScheduleOfAmortizationPeriodsOfRight-of-useAssetsDetails" roleURI="http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfAmortizationPeriodsOfRight-of-useAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SignificantAccountingPoliciesScheduleOfDepreciationOnStraight-lineBasisOverUsefulLifeOfAssetsDetails" roleURI="http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfDepreciationOnStraight-lineBasisOverUsefulLifeOfAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#Short-termBankDepositsNarrativeDetails" roleURI="http://mediwound.com/role/Short-termBankDepositsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails" roleURI="http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#LeasesNarrativeDetails" roleURI="http://mediwound.com/role/LeasesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails" roleURI="http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails" roleURI="http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails" roleURI="http://mediwound.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#FinancialInstrumentsNarrativeDetails" roleURI="http://mediwound.com/role/FinancialInstrumentsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#FinancialInstrumentsScheduleOfSensitivityTestsRelatingToChangesInMarketFactorsDetails" roleURI="http://mediwound.com/role/FinancialInstrumentsScheduleOfSensitivityTestsRelatingToChangesInMarketFactorsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#ContingentLiabilitiesAndCommitmentsDetails" roleURI="http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#MaterialAgreementsDetails" roleURI="http://mediwound.com/role/MaterialAgreementsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#Share-basedCompensationNarrativeDetails" roleURI="http://mediwound.com/role/Share-basedCompensationNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#Share-basedCompensationScheduleOfExpenseRecognizedDetails" roleURI="http://mediwound.com/role/Share-basedCompensationScheduleOfExpenseRecognizedDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#Share-basedCompensationScheduleOfShareOptionsActivityDetails" roleURI="http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails" roleURI="http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#Share-basedCompensationScheduleOfEstimatedUsingAcceptableOptionPricingModelsDetails" roleURI="http://mediwound.com/role/Share-basedCompensationScheduleOfEstimatedUsingAcceptableOptionPricingModelsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#TaxesOnIncomeDetails" roleURI="http://mediwound.com/role/TaxesOnIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails" roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeographicalInformationDetails" roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeographicalInformationDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersNarrativeDetails" roleURI="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfRelatedPartiesDetails" roleURI="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfRelatedPartiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfTransactionsWithRelatedPartiesDetails" roleURI="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfTransactionsWithRelatedPartiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SubsequentEventsDetailTextuals" roleURI="http://mediwound.com/role/SubsequentEventsDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails" roleURI="http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfKeyOfficersOfTheCompanyDetails" roleURI="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfKeyOfficersOfTheCompanyDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#EquityNarrativeDetails" roleURI="http://mediwound.com/role/EquityNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#NetProfitLossPerShareNarrativeDetails" roleURI="http://mediwound.com/role/NetProfitLossPerShareNarrativeDetails"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"/>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesLineItems" xlink:label="loc_dei_EntityAddressesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesTable" xlink:label="loc_dei_EntityAddressesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_dei_DocumentShellCompanyReport_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelFaxNumber" xlink:label="loc_dei_ContactPersonnelFaxNumber_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelEmailAddress" xlink:label="loc_dei_ContactPersonnelEmailAddress_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_dei_DocumentAccountingStandard_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_dei_DocumentRegistrationStatement_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_45"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityAddressesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntityAddressesTable_1" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_1" xlink:to="loc_dei_AddressTypeDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_1" xlink:to="loc_dei_BusinessContactMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_1" xlink:to="loc_dei_AddressTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityRegistrantName_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityCentralIndexKey_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentType_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentPeriodEndDate_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_AmendmentFlag_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_CurrentFiscalYearEndDate_11" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_12" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityVoluntaryFilers_13" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityCurrentReportingStatus_14" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityFilerCategory_15" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityShellCompany_16" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityEmergingGrowthCompany_17" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentAnnualReport_18" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentTransitionReport_19" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentShellCompanyReport_20" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_21" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_22" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentFiscalYearFocus_23" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityInteractiveDataCurrent_24" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_25" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityFileNumber_26" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityAddressAddressLine1_27" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityAddressCityOrTown_28" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityAddressPostalZipCode_29" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityAddressCountry_30" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_ContactPersonnelName_31" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_CityAreaCode_32" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_LocalPhoneNumber_33" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_ContactPersonnelFaxNumber_34" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_Security12bTitle_35" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_TradingSymbol_36" order="310" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_SecurityExchangeName_37" order="320" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_ContactPersonnelEmailAddress_38" order="330" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentAccountingStandard_39" order="340" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentRegistrationStatement_40" order="350" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_AuditorFirmId_41" order="360" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_AuditorLocation_42" order="370" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_AuditorName_43" order="380" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_IcfrAuditorAttestationFlag_44" order="390" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_45" order="400" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremiumMember" xlink:label="loc_ifrs-full_SharePremiumMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" xlink:label="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_9"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AccumaletedEffectOfAdoptingIfrsFifteen" xlink:label="loc_mdwd_AccumaletedEffectOfAdoptingIfrsFifteen_10"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_Equity1" xlink:label="loc_mdwd_Equity1_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits" xlink:label="loc_mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfTreasuryShares" xlink:label="loc_ifrs-full_PurchaseOfTreasuryShares_18"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EffectOfShareSplit" xlink:label="loc_mdwd_EffectOfShareSplit_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_21"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_ifrs-full_IssuedCapitalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_ifrs-full_SharePremiumMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_ifrs-full_RetainedEarningsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_Equity_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_mdwd_AccumaletedEffectOfAdoptingIfrsFifteen_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_mdwd_Equity1_11" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_ProfitLoss_12" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_13" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_ComprehensiveIncome_14" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits_15" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_16" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_17" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_PurchaseOfTreasuryShares_18" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_mdwd_EffectOfShareSplit_19" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IssueOfEquity_20" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_21" order="130" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/Share-basedCompensationTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RestrictedSharesUnitsMember" xlink:label="loc_mdwd_RestrictedSharesUnitsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions" xlink:label="loc_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_9"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_mdwd_RestrictedSharesUnitsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_9" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/GeneralDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember" xlink:label="loc_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_USDepartmentOfDefenseMember" xlink:label="loc_mdwd_USDepartmentOfDefenseMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_12"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ReverseStockSplit" xlink:label="loc_mdwd_ReverseStockSplit_13"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_GrossProceedsFromPublicAndPrivateOfferings" xlink:label="loc_mdwd_GrossProceedsFromPublicAndPrivateOfferings_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_15"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ContractAmountForDevelopmentAndManufacturing" xlink:label="loc_mdwd_ContractAmountForDevelopmentAndManufacturing_16"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromFunding" xlink:label="loc_mdwd_ProceedsFromFunding_17"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ContractWithCustomers" xlink:label="loc_mdwd_ContractWithCustomers_18"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits" xlink:label="loc_mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits_19"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_1" xlink:to="loc_ifrs-full_BorrowingsByNameMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_1" xlink:to="loc_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_1" xlink:to="loc_ifrs-full_BorrowingsByNameMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" xlink:to="loc_dei_LegalEntityAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_5" xlink:to="loc_dei_EntityDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_5" xlink:to="loc_mdwd_USDepartmentOfDefenseMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_5" xlink:to="loc_dei_EntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesIssued_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ifrs-full_ParValuePerShare_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ifrs-full_RetainedEarnings_12" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_mdwd_ReverseStockSplit_13" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_mdwd_GrossProceedsFromPublicAndPrivateOfferings_14" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_15" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_mdwd_ContractAmountForDevelopmentAndManufacturing_16" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_mdwd_ProceedsFromFunding_17" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_mdwd_ContractWithCustomers_18" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits_19" order="100" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfAmortizationPeriodsOfRight-of-useAssetsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MotorVehiclesMember" xlink:label="loc_ifrs-full_MotorVehiclesMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BuildingAndEquipmentMember" xlink:label="loc_mdwd_BuildingAndEquipmentMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_Default"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmortizationPeriodsOfRightOfUseAssets" xlink:label="loc_mdwd_AmortizationPeriodsOfRightOfUseAssets_7"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_1" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_1" xlink:to="loc_ifrs-full_MotorVehiclesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_1" xlink:to="loc_mdwd_BuildingAndEquipmentMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_1" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_mdwd_AmortizationPeriodsOfRightOfUseAssets_7" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfDepreciationOnStraight-lineBasisOverUsefulLifeOfAssetsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="loc_ifrs-full_OfficeEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MachineryMember" xlink:label="loc_ifrs-full_MachineryMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_9"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_OfficeEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_MachineryMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_ComputerEquipmentMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_LeaseholdImprovementsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_9" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/Short-termBankDepositsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfInterestRatesAxis" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestRateTypesMember" xlink:label="loc_ifrs-full_InterestRateTypesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FixedInterestRateMember" xlink:label="loc_ifrs-full_FixedInterestRateMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestRateTypesMember" xlink:label="loc_ifrs-full_InterestRateTypesMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_USD" xlink:label="loc_currency_USD_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepositInterestRate" xlink:label="loc_mdwd_DepositInterestRate_15"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PeriodOfBankDeposits" xlink:label="loc_mdwd_PeriodOfBankDeposits_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_1" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_1" xlink:to="loc_ifrs-full_InterestRateTypesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_InterestRateTypesMember_1" xlink:to="loc_ifrs-full_FixedInterestRateMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_1" xlink:to="loc_ifrs-full_InterestRateTypesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_1" xlink:to="loc_srt_CurrencyAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_5" xlink:to="loc_currency_AllCurrenciesDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_5" xlink:to="loc_currency_USD_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_5" xlink:to="loc_currency_AllCurrenciesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_1" xlink:to="loc_srt_RangeAxis_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9" xlink:to="loc_srt_RangeMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9" xlink:to="loc_srt_MinimumMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9" xlink:to="loc_srt_MaximumMember_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_0" xlink:to="loc_mdwd_DepositInterestRate_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_0" xlink:to="loc_mdwd_PeriodOfBankDeposits_16" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepreciatedCostMember" xlink:label="loc_mdwd_DepreciatedCostMember_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TotalMember" xlink:label="loc_mdwd_TotalMember_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisposalsMember" xlink:label="loc_mdwd_DisposalsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="loc_ifrs-full_OfficeEquipmentMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MachineryMember" xlink:label="loc_ifrs-full_MachineryMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_19"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets" xlink:label="loc_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_21"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xlink:to="loc_ifrs-full_CarryingAmountMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_mdwd_DepreciatedCostMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_mdwd_TotalMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_mdwd_DisposalsMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xlink:to="loc_ifrs-full_CarryingAmountMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_9" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_9" xlink:to="loc_ifrs-full_OfficeEquipmentMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_9" xlink:to="loc_ifrs-full_MachineryMember_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_9" xlink:to="loc_ifrs-full_ComputerEquipmentMember_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_9" xlink:to="loc_ifrs-full_LeaseholdImprovementsMember_12" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_9" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_17" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_18" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_19" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets_20" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_21" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/LeasesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems" xlink:label="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable" xlink:label="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_ILS" xlink:label="loc_currency_ILS_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_10"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsequentEventsMember" xlink:label="loc_mdwd_SubsequentEventsMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_Default"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseArea" xlink:label="loc_mdwd_SubsidiariesLeaseArea_15"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseMonthlyRent" xlink:label="loc_mdwd_SubsidiariesLeaseMonthlyRent_16"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseExpirationDate" xlink:label="loc_mdwd_SubsidiariesLeaseExpirationDate_17"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseExpirationPeriod" xlink:label="loc_mdwd_SubsidiariesLeaseExpirationPeriod_18"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseExtentionPeriod" xlink:label="loc_mdwd_SubsidiariesLeaseExtentionPeriod_19"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseEstimatedUsefulLife" xlink:label="loc_mdwd_SubsidiariesLeaseEstimatedUsefulLife_20"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfVehiclesInOperatingLeaseArrangements" xlink:label="loc_mdwd_NumberOfVehiclesInOperatingLeaseArrangements_21"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PeriodOfVehiclesOperatingLeaseArrangements" xlink:label="loc_mdwd_PeriodOfVehiclesOperatingLeaseArrangements_22"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NoncancelableLeasePeriods" xlink:label="loc_mdwd_NoncancelableLeasePeriods_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:label="loc_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationExpense" xlink:label="loc_ifrs-full_DepreciationExpense_25"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CompromisedDepreciationExpense" xlink:label="loc_mdwd_CompromisedDepreciationExpense_26"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements" xlink:label="loc_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_27"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfLeaseLiabilityUnderLongTermDebtAndCurrentMaturity" xlink:label="loc_mdwd_AmountOfLeaseLiabilityUnderLongTermDebtAndCurrentMaturity_28"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0" xlink:to="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1" xlink:to="loc_srt_CurrencyAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_1" xlink:to="loc_currency_AllCurrenciesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_ILS_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_1" xlink:to="loc_currency_AllCurrenciesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1" xlink:to="loc_srt_RangeAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5" xlink:to="loc_srt_RangeMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5" xlink:to="loc_srt_MinimumMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5" xlink:to="loc_srt_MaximumMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_10" xlink:to="loc_ifrs-full_NonadjustingEventsMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsMember_10" xlink:to="loc_mdwd_SubsequentEventsMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_10" xlink:to="loc_ifrs-full_NonadjustingEventsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0" xlink:to="loc_mdwd_SubsidiariesLeaseArea_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0" xlink:to="loc_mdwd_SubsidiariesLeaseMonthlyRent_16" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0" xlink:to="loc_mdwd_SubsidiariesLeaseExpirationDate_17" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0" xlink:to="loc_mdwd_SubsidiariesLeaseExpirationPeriod_18" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0" xlink:to="loc_mdwd_SubsidiariesLeaseExtentionPeriod_19" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0" xlink:to="loc_mdwd_SubsidiariesLeaseEstimatedUsefulLife_20" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0" xlink:to="loc_mdwd_NumberOfVehiclesInOperatingLeaseArrangements_21" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0" xlink:to="loc_mdwd_PeriodOfVehiclesOperatingLeaseArrangements_22" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0" xlink:to="loc_mdwd_NoncancelableLeasePeriods_23" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_24" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0" xlink:to="loc_ifrs-full_DepreciationExpense_25" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0" xlink:to="loc_mdwd_CompromisedDepreciationExpense_26" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0" xlink:to="loc_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_27" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0" xlink:to="loc_mdwd_AmountOfLeaseLiabilityUnderLongTermDebtAndCurrentMaturity_28" order="140" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems" xlink:label="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable" xlink:label="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MotorVehiclesMember" xlink:label="loc_ifrs-full_MotorVehiclesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_Default"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetsCostAbstract" xlink:label="loc_mdwd_RightOfUseAssetsCostAbstract_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssetsRevaluedAssetsAtCost" xlink:label="loc_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionsToRightOfUseAssetsNewLeases" xlink:label="loc_mdwd_AdditionsToRightOfUseAssetsNewLeases_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation" xlink:label="loc_mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation_9"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionsToRightOfUseAssetsDisposals" xlink:label="loc_mdwd_AdditionsToRightOfUseAssetsDisposals_10"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases" xlink:label="loc_mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases_11"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract" xlink:label="loc_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract_13"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetsAccumulatedDepreciation" xlink:label="loc_mdwd_RightOfUseAssetsAccumulatedDepreciation_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements" xlink:label="loc_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_15"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetDisposals" xlink:label="loc_mdwd_RightOfUseAssetDisposals_16"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetsDepreciationAbstract" xlink:label="loc_mdwd_RightOfUseAssetsDepreciationAbstract_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_18"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0" xlink:to="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_1" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_1" xlink:to="loc_ifrs-full_BuildingsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_1" xlink:to="loc_ifrs-full_MotorVehiclesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_1" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0" xlink:to="loc_mdwd_RightOfUseAssetsCostAbstract_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_RightOfUseAssetsCostAbstract_7" xlink:to="loc_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_RightOfUseAssetsCostAbstract_7" xlink:to="loc_mdwd_AdditionsToRightOfUseAssetsNewLeases_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_RightOfUseAssetsCostAbstract_7" xlink:to="loc_mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_RightOfUseAssetsCostAbstract_7" xlink:to="loc_mdwd_AdditionsToRightOfUseAssetsDisposals_10" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_RightOfUseAssetsCostAbstract_7" xlink:to="loc_mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases_11" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0" xlink:to="loc_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract_13" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract_13" xlink:to="loc_mdwd_RightOfUseAssetsAccumulatedDepreciation_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract_13" xlink:to="loc_ifrs-full_DepreciationRightofuseAssets_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract_13" xlink:to="loc_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract_13" xlink:to="loc_mdwd_RightOfUseAssetDisposals_16" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0" xlink:to="loc_mdwd_RightOfUseAssetsDepreciationAbstract_18" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_RightOfUseAssetsDepreciationAbstract_18" xlink:to="loc_ifrs-full_RightofuseAssets_18" order="0" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MotorVehiclesMember" xlink:label="loc_ifrs-full_MotorVehiclesMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_12"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities" xlink:label="loc_mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities_13"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NewFinanceLeaseObligationRecognized" xlink:label="loc_mdwd_NewFinanceLeaseObligationRecognized_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForIndexation" xlink:label="loc_mdwd_AdjustmentsForIndexation_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_16"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisposalsTerminationOfLeases" xlink:label="loc_mdwd_DisposalsTerminationOfLeases_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_19"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_ifrs-full_LeaseLiabilitiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_5" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_5" xlink:to="loc_ifrs-full_BuildingsMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_5" xlink:to="loc_ifrs-full_MotorVehiclesMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_5" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_LeaseLiabilities_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_mdwd_NewFinanceLeaseObligationRecognized_14" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_mdwd_AdjustmentsForIndexation_15" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_16" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_mdwd_DisposalsTerminationOfLeases_17" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_18" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_19" order="90" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmortizedCostMember" xlink:label="loc_mdwd_AmortizedCostMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LicencesAndFranchisesMember" xlink:label="loc_ifrs-full_LicencesAndFranchisesMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_13"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xlink:to="loc_ifrs-full_CarryingAmountMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_mdwd_AmortizedCostMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xlink:to="loc_ifrs-full_CarryingAmountMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_7" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_7" xlink:to="loc_ifrs-full_LicencesAndFranchisesMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_7" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_13" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/FinancialInstrumentsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_InterestRateForLoanMember" xlink:label="loc_mdwd_InterestRateForLoanMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UncertaintyInFutureDefaultsMember" xlink:label="loc_mdwd_UncertaintyInFutureDefaultsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_Default"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExpectedTermOfWarrant" xlink:label="loc_mdwd_ExpectedTermOfWarrant_16"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExpectedVolatilityWarrants" xlink:label="loc_mdwd_ExpectedVolatilityWarrants_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse" xlink:label="loc_ifrs-full_DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse_18"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RiskFreeRateOfWarrants" xlink:label="loc_mdwd_RiskFreeRateOfWarrants_19"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExpectedDividendAsPercentageOfWarrants" xlink:label="loc_mdwd_ExpectedDividendAsPercentageOfWarrants_20"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_TypesOfRisksAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_1" xlink:to="loc_ifrs-full_TypesOfRisksMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksMember_1" xlink:to="loc_mdwd_InterestRateForLoanMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksMember_1" xlink:to="loc_mdwd_UncertaintyInFutureDefaultsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfRisksAxis_1" xlink:to="loc_ifrs-full_TypesOfRisksMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_6" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_6" xlink:to="loc_ifrs-full_Level3OfFairValueHierarchyMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_6" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_RangeAxis_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_10" xlink:to="loc_ifrs-full_RangesMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_10" xlink:to="loc_ifrs-full_BottomOfRangeMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_10" xlink:to="loc_ifrs-full_TopOfRangeMember_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_10" xlink:to="loc_ifrs-full_RangesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_mdwd_ExpectedTermOfWarrant_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_mdwd_ExpectedVolatilityWarrants_17" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse_18" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_mdwd_RiskFreeRateOfWarrants_19" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_mdwd_ExpectedDividendAsPercentageOfWarrants_20" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/FinancialInstrumentsScheduleOfSensitivityTestsRelatingToChangesInMarketFactorsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SensitivityAnalysisAxis" xlink:label="loc_mdwd_SensitivityAnalysisAxis_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SensitivityAnalysisDomain" xlink:label="loc_mdwd_SensitivityAnalysisDomain_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FivePercentageIncreaseInExchangeRateMember" xlink:label="loc_mdwd_FivePercentageIncreaseInExchangeRateMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FivePercentageDecreaseInExchangeRateMember" xlink:label="loc_mdwd_FivePercentageDecreaseInExchangeRateMember_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SensitivityAnalysisDomain" xlink:label="loc_mdwd_SensitivityAnalysisDomain_Default"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract" xlink:label="loc_mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_7"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_mdwd_SensitivityAnalysisAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_mdwd_SensitivityAnalysisAxis_1" xlink:to="loc_mdwd_SensitivityAnalysisDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_SensitivityAnalysisDomain_1" xlink:to="loc_mdwd_FivePercentageIncreaseInExchangeRateMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_SensitivityAnalysisDomain_1" xlink:to="loc_mdwd_FivePercentageDecreaseInExchangeRateMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_mdwd_SensitivityAnalysisAxis_1" xlink:to="loc_mdwd_SensitivityAnalysisDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract_7" xlink:to="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_7" order="0" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfContingentLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ThirdPartiesMember" xlink:label="loc_mdwd_ThirdPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TevaMember" xlink:label="loc_mdwd_TevaMember_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ResearchAndDevelopmentLawMember" xlink:label="loc_mdwd_ResearchAndDevelopmentLawMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:label="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodsOfGenerationAxis" xlink:label="loc_ifrs-full_MethodsOfGenerationAxis_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodsOfGenerationMember" xlink:label="loc_ifrs-full_MethodsOfGenerationMember_11"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubLicensingOfPatentsMember" xlink:label="loc_mdwd_SubLicensingOfPatentsMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodsOfGenerationMember" xlink:label="loc_ifrs-full_MethodsOfGenerationMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions" xlink:label="loc_ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions_21"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts" xlink:label="loc_mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_22"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts" xlink:label="loc_mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_23"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PercentageOfOneTimeLumpSumPaymentAmount" xlink:label="loc_mdwd_PercentageOfOneTimeLumpSumPaymentAmount_24"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OneTimeLumpsumAmount" xlink:label="loc_mdwd_OneTimeLumpsumAmount_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromRoyalties" xlink:label="loc_ifrs-full_RevenueFromRoyalties_26"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_MaximumAggregateRoyaltiesPaidInPercentage" xlink:label="loc_mdwd_MaximumAggregateRoyaltiesPaidInPercentage_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-full_BorrowingsInterestRateBasis_28"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfSharesRepurchased" xlink:label="loc_mdwd_NumberOfSharesRepurchased_29"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PercentageOfFutureRoyaltyPayments" xlink:label="loc_mdwd_PercentageOfFutureRoyaltyPayments_30"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SettlementAmountPaidByTeva" xlink:label="loc_mdwd_SettlementAmountPaidByTeva_31"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ReducedRateOfPayments" xlink:label="loc_mdwd_ReducedRateOfPayments_32"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ReducedAggregateAmount" xlink:label="loc_mdwd_ReducedAggregateAmount_33"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CollaborationAgreementsAmountRelatedToPolyheal" xlink:label="loc_mdwd_CollaborationAgreementsAmountRelatedToPolyheal_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="loc_ifrs-full_ConsiderationPaidReceived_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" xlink:label="loc_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_39"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinancialIncomeAndExpenses" xlink:label="loc_mdwd_FinancialIncomeAndExpenses_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RoyaltyExpense" xlink:label="loc_ifrs-full_RoyaltyExpense_41"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_ThirdPartiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_TevaMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_ResearchAndDevelopmentLawMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_7" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_7" xlink:to="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_7" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_MethodsOfGenerationAxis_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MethodsOfGenerationAxis_11" xlink:to="loc_ifrs-full_MethodsOfGenerationMember_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MethodsOfGenerationMember_11" xlink:to="loc_mdwd_SubLicensingOfPatentsMember_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MethodsOfGenerationAxis_11" xlink:to="loc_ifrs-full_MethodsOfGenerationMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_RangeAxis_15" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_15" xlink:to="loc_ifrs-full_RangesMember_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_15" xlink:to="loc_ifrs-full_BottomOfRangeMember_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_15" xlink:to="loc_ifrs-full_TopOfRangeMember_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_15" xlink:to="loc_ifrs-full_RangesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions_21" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_22" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_23" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_PercentageOfOneTimeLumpSumPaymentAmount_24" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_OneTimeLumpsumAmount_25" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_RevenueFromRoyalties_26" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_MaximumAggregateRoyaltiesPaidInPercentage_27" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_BorrowingsInterestRateBasis_28" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_NumberOfSharesRepurchased_29" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_PercentageOfFutureRoyaltyPayments_30" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_SettlementAmountPaidByTeva_31" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_ReducedRateOfPayments_32" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_ReducedAggregateAmount_33" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_CollaborationAgreementsAmountRelatedToPolyheal_34" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_35" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_ConsiderationPaidReceived_36" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_37" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_38" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_Liabilities_39" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_FinancialIncomeAndExpenses_40" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_RoyaltyExpense_41" order="210" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/MaterialAgreementsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfContingentLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NexoBridMember" xlink:label="loc_mdwd_NexoBridMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LicenseAgreementWithVericelMember" xlink:label="loc_mdwd_LicenseAgreementWithVericelMember_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember" xlink:label="loc_mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember" xlink:label="loc_mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AgreementAxis" xlink:label="loc_mdwd_AgreementAxis_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AgreementDomain" xlink:label="loc_mdwd_AgreementDomain_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember" xlink:label="loc_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AgreementDomain" xlink:label="loc_mdwd_AgreementDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions" xlink:label="loc_ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions_17"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AggregateSupplementalAmount" xlink:label="loc_mdwd_AggregateSupplementalAmount_18"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts" xlink:label="loc_mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_19"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts" xlink:label="loc_mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_20"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OneTimeLumpsumAmount" xlink:label="loc_mdwd_OneTimeLumpsumAmount_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromRoyalties" xlink:label="loc_ifrs-full_RevenueFromRoyalties_22"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_MaximumAggregateRoyaltiesPaidInPercentage" xlink:label="loc_mdwd_MaximumAggregateRoyaltiesPaidInPercentage_23"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ContractAmountForDevelopmentAndManufacturing" xlink:label="loc_mdwd_ContractAmountForDevelopmentAndManufacturing_24"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromFunding" xlink:label="loc_mdwd_ProceedsFromFunding_25"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromProcurement" xlink:label="loc_mdwd_ProceedsFromProcurement_26"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromAdditionalFunding" xlink:label="loc_mdwd_ProceedsFromAdditionalFunding_27"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromAdditionalProcurement" xlink:label="loc_mdwd_ProceedsFromAdditionalProcurement_28"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AccumulatedFunding" xlink:label="loc_mdwd_AccumulatedFunding_29"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfInvestedInProject" xlink:label="loc_mdwd_AmountOfInvestedInProject_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_31"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UpfrontPayment" xlink:label="loc_mdwd_UpfrontPayment_32"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionalUpfrontPayment" xlink:label="loc_mdwd_AdditionalUpfrontPayment_33"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevenuesFromSaleOfProcurement" xlink:label="loc_mdwd_RevenuesFromSaleOfProcurement_34"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfSecondContractExpired" xlink:label="loc_mdwd_AmountOfSecondContractExpired_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_36"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfTechnicalAssistance" xlink:label="loc_mdwd_AmountOfTechnicalAssistance_37"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential" xlink:label="loc_mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential_38"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_NexoBridMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_LicenseAgreementWithVericelMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_mdwd_AgreementAxis_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_mdwd_AgreementAxis_8" xlink:to="loc_mdwd_AgreementDomain_8" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_AgreementDomain_8" xlink:to="loc_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_8" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_mdwd_AgreementAxis_8" xlink:to="loc_mdwd_AgreementDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_srt_RangeAxis_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_12" xlink:to="loc_srt_RangeMember_12" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_12" xlink:to="loc_srt_MaximumMember_12" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_12" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions_17" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_AggregateSupplementalAmount_18" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_19" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_20" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_OneTimeLumpsumAmount_21" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_RevenueFromRoyalties_22" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_MaximumAggregateRoyaltiesPaidInPercentage_23" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_ContractAmountForDevelopmentAndManufacturing_24" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_ProceedsFromFunding_25" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_ProceedsFromProcurement_26" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_ProceedsFromAdditionalFunding_27" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_ProceedsFromAdditionalProcurement_28" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_AccumulatedFunding_29" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_AmountOfInvestedInProject_30" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_31" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_UpfrontPayment_32" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_AdditionalUpfrontPayment_33" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_RevenuesFromSaleOfProcurement_34" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_AmountOfSecondContractExpired_35" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_Revenue_36" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_AmountOfTechnicalAssistance_37" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential_38" order="220" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/Share-basedCompensationNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EmployeesAndDirectorsMember" xlink:label="loc_mdwd_EmployeesAndDirectorsMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ChiefExecutiveOfficersMember" xlink:label="loc_mdwd_ChiefExecutiveOfficersMember_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DirectorsMember" xlink:label="loc_mdwd_DirectorsMember_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EmployeesMember" xlink:label="loc_mdwd_EmployeesMember_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncomingCEOAndChairmanMember" xlink:label="loc_mdwd_IncomingCEOAndChairmanMember_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ChairmanMember" xlink:label="loc_mdwd_ChairmanMember_6"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncomingCFOMember" xlink:label="loc_mdwd_IncomingCFOMember_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DirectorsAndCeoMember" xlink:label="loc_mdwd_DirectorsAndCeoMember_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember" xlink:label="loc_mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember_9"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BoardMembersMember" xlink:label="loc_mdwd_BoardMembersMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RestrictedSharesUnitsMember" xlink:label="loc_mdwd_RestrictedSharesUnitsMember_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ShareIncentivePlanMember" xlink:label="loc_mdwd_ShareIncentivePlanMember_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_19"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IsraeliShareOptionPlanMember" xlink:label="loc_mdwd_IsraeliShareOptionPlanMember_19"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EquityIncentivePlanMember" xlink:label="loc_mdwd_EquityIncentivePlanMember_20"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RestrictedSharesUnitsMember" xlink:label="loc_mdwd_RestrictedSharesUnitsMember_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:label="loc_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_26"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SharesAvailableForFutureGrant" xlink:label="loc_mdwd_SharesAvailableForFutureGrant_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" xlink:label="loc_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_34"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_EmployeesAndDirectorsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_ChiefExecutiveOfficersMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_DirectorsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_EmployeesMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_IncomingCEOAndChairmanMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_ChairmanMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_IncomingCFOMember_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_DirectorsAndCeoMember_8" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember_9" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_BoardMembersMember_10" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_14" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_14" xlink:to="loc_mdwd_RestrictedSharesUnitsMember_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_14" xlink:to="loc_mdwd_ShareIncentivePlanMember_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_14" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_19" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_19" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_19" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_19" xlink:to="loc_mdwd_IsraeliShareOptionPlanMember_19" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_19" xlink:to="loc_mdwd_EquityIncentivePlanMember_20" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_19" xlink:to="loc_mdwd_RestrictedSharesUnitsMember_21" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_19" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_26" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_mdwd_SharesAvailableForFutureGrant_27" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement_28" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_29" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_30" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_31" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_32" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements_33" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_34" order="90" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/Share-basedCompensationScheduleOfExpenseRecognizedDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfRevenuesMember" xlink:label="loc_mdwd_CostOfRevenuesMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ResearchAndDevelopmentExpensesMember" xlink:label="loc_mdwd_ResearchAndDevelopmentExpensesMember_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SellingAndMarketingExpensesMember" xlink:label="loc_mdwd_SellingAndMarketingExpensesMember_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_GeneralAndAdministrativeExpensesMember" xlink:label="loc_mdwd_GeneralAndAdministrativeExpensesMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_9"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_mdwd_CostOfRevenuesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_mdwd_ResearchAndDevelopmentExpensesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_mdwd_SellingAndMarketingExpensesMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_mdwd_GeneralAndAdministrativeExpensesMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_9" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RestrictedSharesUnitsMember" xlink:label="loc_mdwd_RestrictedSharesUnitsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_Default"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberAbstract" xlink:label="loc_mdwd_NumberAbstract_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_11"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_WeightedAverageExercisePriceAbstract" xlink:label="loc_mdwd_WeightedAverageExercisePriceAbstract_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_17"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_mdwd_RestrictedSharesUnitsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_mdwd_NumberAbstract_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_NumberAbstract_6" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_NumberAbstract_6" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_NumberAbstract_6" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_NumberAbstract_6" xlink:to="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_NumberAbstract_6" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_NumberAbstract_6" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_11" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_mdwd_WeightedAverageExercisePriceAbstract_13" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_WeightedAverageExercisePriceAbstract_13" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_WeightedAverageExercisePriceAbstract_13" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_WeightedAverageExercisePriceAbstract_13" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_WeightedAverageExercisePriceAbstract_13" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_16" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_WeightedAverageExercisePriceAbstract_13" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_17" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesOneMember" xlink:label="loc_mdwd_RangesOfExercisePricesOneMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesTwoMember" xlink:label="loc_mdwd_RangesOfExercisePricesTwoMember_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesThreeMember" xlink:label="loc_mdwd_RangesOfExercisePricesThreeMember_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesFourMember" xlink:label="loc_mdwd_RangesOfExercisePricesFourMember_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesFiveMember" xlink:label="loc_mdwd_RangesOfExercisePricesFiveMember_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesSixMember" xlink:label="loc_mdwd_RangesOfExercisePricesSixMember_6"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesServenMember" xlink:label="loc_mdwd_RangesOfExercisePricesServenMember_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesEightMember" xlink:label="loc_mdwd_RangesOfExercisePricesEightMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_15"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_mdwd_RangesOfExercisePricesOneMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_mdwd_RangesOfExercisePricesTwoMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_mdwd_RangesOfExercisePricesThreeMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_mdwd_RangesOfExercisePricesFourMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_mdwd_RangesOfExercisePricesFiveMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_mdwd_RangesOfExercisePricesSixMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_mdwd_RangesOfExercisePricesServenMember_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_mdwd_RangesOfExercisePricesEightMember_8" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_0" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_13" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_14" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_15" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/Share-basedCompensationScheduleOfEstimatedUsingAcceptableOptionPricingModelsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_9"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExercisePriceShareOptionsGrantedPercentage" xlink:label="loc_mdwd_ExercisePriceShareOptionsGrantedPercentage_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_RangeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_1" xlink:to="loc_ifrs-full_RangesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_BottomOfRangeMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_TopOfRangeMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_1" xlink:to="loc_ifrs-full_RangesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_mdwd_ExercisePriceShareOptionsGrantedPercentage_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_11" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/TaxesOnIncomeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasMember" xlink:label="loc_ifrs-full_GeographicalAreasMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="loc_ifrs-full_CountryOfDomicileMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DE" xlink:label="loc_country_DE_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasMember" xlink:label="loc_ifrs-full_GeographicalAreasMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod" xlink:label="loc_ifrs-full_ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DescriptionOfTaxBenefitPeriod" xlink:label="loc_mdwd_DescriptionOfTaxBenefitPeriod_9"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LimitOfBenefitEntitlementPeriod" xlink:label="loc_mdwd_LimitOfBenefitEntitlementPeriod_10"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CarryforwardLosses" xlink:label="loc_mdwd_CarryforwardLosses_11"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses" xlink:label="loc_mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses_12"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DeferredTaxAssetsNotRecognized" xlink:label="loc_mdwd_DeferredTaxAssetsNotRecognized_13"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_1" xlink:to="loc_ifrs-full_CountryOfDomicileMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_1" xlink:to="loc_country_DE_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_ifrs-full_ApplicableTaxRate_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_ifrs-full_ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_mdwd_DescriptionOfTaxBenefitPeriod_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_mdwd_LimitOfBenefitEntitlementPeriod_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_mdwd_CarryforwardLosses_11" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses_12" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_mdwd_DeferredTaxAssetsNotRecognized_13" order="70" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BardaMember" xlink:label="loc_mdwd_BardaMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_VericelMember" xlink:label="loc_mdwd_VericelMember_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_MtecMember" xlink:label="loc_mdwd_MtecMember_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherCustomerContributedMember" xlink:label="loc_mdwd_OtherCustomerContributedMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherExpenseByFunction" xlink:label="loc_ifrs-full_OtherExpenseByFunction_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_10"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ConcentrationRiskPercentage" xlink:label="loc_mdwd_ConcentrationRiskPercentage_11"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevenuesFromDistributionAgreements" xlink:label="loc_mdwd_RevenuesFromDistributionAgreements_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_mdwd_BardaMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_mdwd_VericelMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_mdwd_MtecMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_mdwd_OtherCustomerContributedMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_OtherExpenseByFunction_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_OtherIncome_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_mdwd_ConcentrationRiskPercentage_11" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_mdwd_RevenuesFromDistributionAgreements_12" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeographicalInformationDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-full_SegmentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-full_SegmentsMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UsaMember" xlink:label="loc_mdwd_UsaMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherCountriesMember" xlink:label="loc_mdwd_OtherCountriesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-full_SegmentsMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_7"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_SegmentsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_1" xlink:to="loc_ifrs-full_SegmentsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_1" xlink:to="loc_mdwd_UsaMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsMember_1" xlink:to="loc_mdwd_OtherCountriesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_1" xlink:to="loc_ifrs-full_SegmentsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_Revenue_7" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ChiefExecutiveOfficerAndChiefMedicalOfficerMember" xlink:label="loc_mdwd_ChiefExecutiveOfficerAndChiefMedicalOfficerMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DirectorsRemunerationExpense" xlink:label="loc_ifrs-full_DirectorsRemunerationExpense_6"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_ChiefExecutiveOfficerAndChiefMedicalOfficerMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_DirectorsRemunerationExpense_6" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfRelatedPartiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RelatedPartiesMember" xlink:label="loc_ifrs-full_RelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherRelatedPartiesMember" xlink:label="loc_ifrs-full_OtherRelatedPartiesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_7"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_ifrs-full_RelatedPartiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_ifrs-full_OtherRelatedPartiesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_7" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfTransactionsWithRelatedPartiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherRelatedPartiesMember" xlink:label="loc_ifrs-full_OtherRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RelatedPartiesMember" xlink:label="loc_ifrs-full_RelatedPartiesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProfessionalFeeAndShareBasedCompensationExpenses" xlink:label="loc_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RelatedPartiesRentaLexpenseAndOther" xlink:label="loc_mdwd_RelatedPartiesRentaLexpenseAndOther_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfDirectors" xlink:label="loc_mdwd_NumberOfDirectors_9"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_ifrs-full_OtherRelatedPartiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_ifrs-full_RelatedPartiesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_mdwd_RelatedPartiesRentaLexpenseAndOther_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_mdwd_NumberOfDirectors_9" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/SubsequentEventsDetailTextuals">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsequentEventsMember" xlink:label="loc_mdwd_SubsequentEventsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember" xlink:label="loc_mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AreaOfLand" xlink:label="loc_mdwd_AreaOfLand_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" xlink:label="loc_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_11"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfSharesExerciseRestrictedStockUnits" xlink:label="loc_mdwd_NumberOfSharesExerciseRestrictedStockUnits_12"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfAnnualFeeOfLeaseAgreement" xlink:label="loc_mdwd_AmountOfAnnualFeeOfLeaseAgreement_13"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TermOfLease" xlink:label="loc_mdwd_TermOfLease_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionalTermOfLease" xlink:label="loc_mdwd_AdditionalTermOfLease_15"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare" xlink:label="loc_mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_17"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_StockOptionValue" xlink:label="loc_mdwd_StockOptionValue_18"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfPreFundedWarrantsExercised" xlink:label="loc_mdwd_NumberOfPreFundedWarrantsExercised_19"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExercisePriceOfWarrants" xlink:label="loc_mdwd_ExercisePriceOfWarrants_20"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="loc_ifrs-full_NonadjustingEventsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsMember_1" xlink:to="loc_mdwd_SubsequentEventsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="loc_ifrs-full_NonadjustingEventsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_mdwd_AreaOfLand_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_mdwd_NumberOfSharesExerciseRestrictedStockUnits_12" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_mdwd_AmountOfAnnualFeeOfLeaseAgreement_13" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_mdwd_TermOfLease_14" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_mdwd_AdditionalTermOfLease_15" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare_16" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_17" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_mdwd_StockOptionValue_18" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_mdwd_NumberOfPreFundedWarrantsExercised_19" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_mdwd_ExercisePriceOfWarrants_20" order="110" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember" xlink:label="loc_mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_12"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentMaturitiesOfLongTermLiabilities" xlink:label="loc_mdwd_CurrentMaturitiesOfLongTermLiabilities_12"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TradePayablesAndAccruedExpenses" xlink:label="loc_mdwd_TradePayablesAndAccruedExpenses_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherPayables" xlink:label="loc_ifrs-full_OtherPayables_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_16"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_LiabilitiesInRespectOfGrants_16"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilitiesInRespectOfTeva" xlink:label="loc_mdwd_LiabilitiesInRespectOfTeva_17"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilitiesInRespectOfPurchaseOfShares" xlink:label="loc_mdwd_LiabilitiesInRespectOfPurchaseOfShares_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_19"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7" xlink:to="loc_ifrs-full_CarryingAmountMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_7" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7" xlink:to="loc_ifrs-full_CarryingAmountMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_CurrentLiabilitiesAbstract_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_12" xlink:to="loc_mdwd_CurrentMaturitiesOfLongTermLiabilities_12" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_12" xlink:to="loc_mdwd_TradePayablesAndAccruedExpenses_13" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_12" xlink:to="loc_ifrs-full_OtherPayables_14" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_NoncurrentLiabilitiesAbstract_16" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_16" xlink:to="loc_mdwd_LiabilitiesInRespectOfGrants_16" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_16" xlink:to="loc_mdwd_LiabilitiesInRespectOfTeva_17" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_16" xlink:to="loc_mdwd_LiabilitiesInRespectOfPurchaseOfShares_18" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_16" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_19" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfKeyOfficersOfTheCompanyDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_KeyOfficerMember" xlink:label="loc_mdwd_KeyOfficerMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_6"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_KeyOfficerMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_ProfessionalFeesExpense_6" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/EquityNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CertainEntitiesAffiliatedWithCbiMember" xlink:label="loc_mdwd_CertainEntitiesAffiliatedWithCbiMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AgreementAxis" xlink:label="loc_mdwd_AgreementAxis_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AgreementDomain" xlink:label="loc_mdwd_AgreementDomain_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PrivateIssuancePurchaseEquityAgreementMember" xlink:label="loc_mdwd_PrivateIssuancePurchaseEquityAgreementMember_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AgreementDomain" xlink:label="loc_mdwd_AgreementDomain_Default"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits" xlink:label="loc_mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits_10"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AuthorizedShareCapital" xlink:label="loc_mdwd_AuthorizedShareCapital_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesAuthorised" xlink:label="loc_ifrs-full_NumberOfSharesAuthorised_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_13"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ReverseStockSplit" xlink:label="loc_mdwd_ReverseStockSplit_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" xlink:label="loc_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_15"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PricePerShareOfSharesIssued" xlink:label="loc_mdwd_PricePerShareOfSharesIssued_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_17"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfUnderwritingDiscountsAndCommissions" xlink:label="loc_mdwd_AmountOfUnderwritingDiscountsAndCommissions_18"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares" xlink:label="loc_mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares_19"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromIssuingAdditionalShares" xlink:label="loc_mdwd_ProceedsFromIssuingAdditionalShares_20"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AggregateAmountOfRegisteredDirectOffering" xlink:label="loc_mdwd_AggregateAmountOfRegisteredDirectOffering_21"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PurchasePriceOfRegisteredDirectOffering" xlink:label="loc_mdwd_PurchasePriceOfRegisteredDirectOffering_22"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfWarrantsIssued" xlink:label="loc_mdwd_NumberOfWarrantsIssued_23"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExercisePriceOfWarrants" xlink:label="loc_mdwd_ExercisePriceOfWarrants_24"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_WarrantsExpirationPeriod" xlink:label="loc_mdwd_WarrantsExpirationPeriod_25"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NetProceedsFromOfferingAmount" xlink:label="loc_mdwd_NetProceedsFromOfferingAmount_26"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RiskFreeInterestRateOfWarrants" xlink:label="loc_mdwd_RiskFreeInterestRateOfWarrants_27"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AverageStandardDeviationOfWarrants" xlink:label="loc_mdwd_AverageStandardDeviationOfWarrants_28"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UnregisteredPreFundedWarrantsIssued" xlink:label="loc_mdwd_UnregisteredPreFundedWarrantsIssued_29"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock" xlink:label="loc_mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock_30"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncreaseInPreFundedWarrantsExercisePrice" xlink:label="loc_mdwd_IncreaseInPreFundedWarrantsExercisePrice_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromExerciseOfWarrants" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfWarrants_33"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LossFromWarrantsTransactions" xlink:label="loc_mdwd_LossFromWarrantsTransactions_34"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfPreFundedWarrantsExercised" xlink:label="loc_mdwd_NumberOfPreFundedWarrantsExercised_35"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_WarrantsToPurchaseOrdinaryShares" xlink:label="loc_mdwd_WarrantsToPurchaseOrdinaryShares_36"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CommissionsAndOtherOfferingExpenses" xlink:label="loc_mdwd_CommissionsAndOtherOfferingExpenses_37"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncreaseInAuthorizedShareCapital" xlink:label="loc_mdwd_IncreaseInAuthorizedShareCapital_38"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncreaseInSharesIssued" xlink:label="loc_mdwd_IncreaseInSharesIssued_39"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_CertainEntitiesAffiliatedWithCbiMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_mdwd_AgreementAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_mdwd_AgreementAxis_5" xlink:to="loc_mdwd_AgreementDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_AgreementDomain_5" xlink:to="loc_mdwd_PrivateIssuancePurchaseEquityAgreementMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_mdwd_AgreementAxis_5" xlink:to="loc_mdwd_AgreementDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_AuthorizedShareCapital_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesAuthorised_12" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ParValuePerShare_13" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_ReverseStockSplit_14" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_15" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_PricePerShareOfSharesIssued_16" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_17" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_AmountOfUnderwritingDiscountsAndCommissions_18" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares_19" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_ProceedsFromIssuingAdditionalShares_20" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_AggregateAmountOfRegisteredDirectOffering_21" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_PurchasePriceOfRegisteredDirectOffering_22" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_NumberOfWarrantsIssued_23" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_ExercisePriceOfWarrants_24" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_WarrantsExpirationPeriod_25" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_NetProceedsFromOfferingAmount_26" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_RiskFreeInterestRateOfWarrants_27" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_AverageStandardDeviationOfWarrants_28" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_UnregisteredPreFundedWarrantsIssued_29" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock_30" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_IncreaseInPreFundedWarrantsExercisePrice_31" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValue_32" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromExerciseOfWarrants_33" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_LossFromWarrantsTransactions_34" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_NumberOfPreFundedWarrantsExercised_35" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_WarrantsToPurchaseOrdinaryShares_36" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_CommissionsAndOtherOfferingExpenses_37" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_IncreaseInAuthorizedShareCapital_38" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_IncreaseInSharesIssued_39" order="300" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/NetProfitLossPerShareNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareLineItems" xlink:label="loc_ifrs-full_EarningsPerShareLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareTable" xlink:label="loc_ifrs-full_EarningsPerShareTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="loc_ifrs-full_ClassesOfOrdinarySharesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DilutedWeightedAverageNumberMember" xlink:label="loc_mdwd_DilutedWeightedAverageNumberMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_Default"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfWarrantsIssued" xlink:label="loc_mdwd_NumberOfWarrantsIssued_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfRestrictedShareUnitIssued" xlink:label="loc_mdwd_NumberOfRestrictedShareUnitIssued_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UnregisteredPreFundedWarrantsIssued" xlink:label="loc_mdwd_UnregisteredPreFundedWarrantsIssued_9"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_0" xlink:to="loc_ifrs-full_EarningsPerShareTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_EarningsPerShareTable_1" xlink:to="loc_ifrs-full_ClassesOfOrdinarySharesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_1" xlink:to="loc_ifrs-full_OrdinarySharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OrdinarySharesMember_1" xlink:to="loc_mdwd_DilutedWeightedAverageNumberMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_1" xlink:to="loc_ifrs-full_OrdinarySharesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_0" xlink:to="loc_mdwd_NumberOfWarrantsIssued_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_0" xlink:to="loc_mdwd_NumberOfRestrictedShareUnitIssued_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_0" xlink:to="loc_mdwd_UnregisteredPreFundedWarrantsIssued_9" order="40" use="optional"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>mdwd-20231231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DE" xlink:label="loc_country_DE_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_ILS" xlink:label="loc_currency_ILS_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_ILS" xlink:label="loc_currency_ILS_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_USD" xlink:label="loc_currency_USD_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_USD" xlink:label="loc_currency_USD_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelEmailAddress" xlink:label="loc_dei_ContactPersonnelEmailAddress_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelFaxNumber" xlink:label="loc_dei_ContactPersonnelFaxNumber_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_dei_DocumentAccountingStandard_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_dei_DocumentRegistrationStatement_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_dei_DocumentShellCompanyReport_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesLineItems" xlink:label="loc_dei_EntityAddressesLineItems_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesTable" xlink:label="loc_dei_EntityAddressesTable_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_45"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_47"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_49"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_51"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_52"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_53"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_54"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_55"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_56"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_57"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_58"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_59"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_61"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_62"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_63"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_64"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_65"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_66"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_67"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_68"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_69"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_70"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_71"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_72"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_73"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_74"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_75"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_76"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_77"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_78"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_79"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_80"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_81"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_82"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_83"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_84"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_85"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_86"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BalancesWithBanks" xlink:label="loc_ifrs-full_BalancesWithBanks_87"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_88"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_89"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_90"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_91"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_92"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_93"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-full_BorrowingsInterestRateBasis_94"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_95"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_96"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_97"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_98"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_99"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_101"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_102"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_103"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_104"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_105"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_106"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_107"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:label="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_108"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:label="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_109"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_110"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_111"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_112"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_113"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_114"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_115"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_116"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_117"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_118"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_119"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_120"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_121"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashOnHand" xlink:label="loc_ifrs-full_CashOnHand_122"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashOnHand" xlink:label="loc_ifrs-full_CashOnHand_123"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashOutflowForLeases" xlink:label="loc_ifrs-full_CashOutflowForLeases_124"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashOutflowForLeases" xlink:label="loc_ifrs-full_CashOutflowForLeases_125"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_126"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_127"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ChangesInInventoriesOfFinishedGoodsAndWorkInProgress" xlink:label="loc_ifrs-full_ChangesInInventoriesOfFinishedGoodsAndWorkInProgress_128"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ChangesInInventoriesOfFinishedGoodsAndWorkInProgress" xlink:label="loc_ifrs-full_ChangesInInventoriesOfFinishedGoodsAndWorkInProgress_129"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_130"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_131"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_132"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_133"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_134"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="loc_ifrs-full_ClassesOfOrdinarySharesAxis_135"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_136"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_137"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_138"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_139"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_140"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_141"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_142"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_143"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_144"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_145"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_146"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="loc_ifrs-full_ConsiderationPaidReceived_147"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_148"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:label="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_149"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfMerchandiseSold" xlink:label="loc_ifrs-full_CostOfMerchandiseSold_150"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfMerchandiseSold" xlink:label="loc_ifrs-full_CostOfMerchandiseSold_151"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfMerchandiseSold" xlink:label="loc_ifrs-full_CostOfMerchandiseSold_152"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_153"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_154"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_155"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_156"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="loc_ifrs-full_CountryOfDomicileMember_157"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_158"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_159"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_160"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentGovernmentGrants" xlink:label="loc_ifrs-full_CurrentGovernmentGrants_161"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentGovernmentGrants" xlink:label="loc_ifrs-full_CurrentGovernmentGrants_162"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_163"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_164"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_165"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_166"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_167"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_168"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_169"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_170"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_171"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_172"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_173"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_174"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_175"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationExpense" xlink:label="loc_ifrs-full_DepreciationExpense_176"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_177"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_178"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_179"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_180"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_181"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_182"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_183"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_184"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_185"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_186"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_187"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_188"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_189"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_190"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_191"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_192"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_193"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_194"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_195"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_196"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_197"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_198"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_199"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory_200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_201"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_202"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_203"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_204"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_205"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_206"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_207"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_208"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_209"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_210"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse" xlink:label="loc_ifrs-full_DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse_211"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_212"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract_213"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_214"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_215"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement_216"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_217"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_218"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_219"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_220"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_221"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_222"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DirectorsRemunerationExpense" xlink:label="loc_ifrs-full_DirectorsRemunerationExpense_223"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DirectorsRemunerationExpense" xlink:label="loc_ifrs-full_DirectorsRemunerationExpense_224"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory_225"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory_226"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory_227"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory_228"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfBasisOfConsolidationExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_229"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfBasisOfConsolidationExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_230"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_231"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_232"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_233"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_234"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_235"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_236"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory_237"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory_238"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_239"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_240"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_241"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_242"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_243"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_244"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_245"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_246"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_247"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_248"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfContingentLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_249"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfCostOfSalesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCostOfSalesExplanatory_250"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfCostOfSalesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCostOfSalesExplanatory_251"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_252"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_253"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_254"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDepositaryReceiptsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_255"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDepositaryReceiptsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_256"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDepositsFromBanksExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDepositsFromBanksExplanatory_257"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDepositsFromBanksExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDepositsFromBanksExplanatory_258"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_259"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_260"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_261"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_262"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_263"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_264"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_265"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_266"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory_267"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory_268"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_269"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_270"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_271"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_272"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_273"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_274"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_275"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_276"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_277"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_278"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_279"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_280"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_281"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_282"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_283"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_284"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_285"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_286"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGovernmentGrantsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGovernmentGrantsExplanatory_287"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGovernmentGrantsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGovernmentGrantsExplanatory_288"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_289"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_290"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_291"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_292"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_293"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_294"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_295"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_296"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_297"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInventoriesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInventoriesExplanatory_298"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInventoriesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInventoriesExplanatory_299"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfLeasesExplanatory_300"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfLeasesExplanatory_301"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_302"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_303"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_304"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_305"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_306"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_307"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_308"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_309"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_310"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_311"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_312"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_313"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_314"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_315"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_316"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_317"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_318"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_319"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_320"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_321"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_322"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_323"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_324"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_325"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_326"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_327"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_328"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_329"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_330"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_331"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_332"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_333"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_334"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_335"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_336"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_337"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_338"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_339"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_340"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_341"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_342"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_343"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_344"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_345"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_346"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_347"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_348"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_349"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_350"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_351"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DistributionCosts" xlink:label="loc_ifrs-full_DistributionCosts_352"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_353"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareLineItems" xlink:label="loc_ifrs-full_EarningsPerShareLineItems_354"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareTable" xlink:label="loc_ifrs-full_EarningsPerShareTable_355"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_356"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EmployeeBenefitsExpense" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_357"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EmployeeBenefitsExpense" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_358"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_359"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_360"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_361"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_362"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_363"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_364"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_365"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_366"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_367"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_368"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_369"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_370"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="loc_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_371"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="loc_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_372"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="loc_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_373"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExplanationOfAccountingPoliciesAndMethodsOfComputationFollowedInInterimFinancialStatements" xlink:label="loc_ifrs-full_ExplanationOfAccountingPoliciesAndMethodsOfComputationFollowedInInterimFinancialStatements_374"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExplanationOfAccountingPoliciesAndMethodsOfComputationFollowedInInterimFinancialStatements" xlink:label="loc_ifrs-full_ExplanationOfAccountingPoliciesAndMethodsOfComputationFollowedInInterimFinancialStatements_375"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod" xlink:label="loc_ifrs-full_ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod_376"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions" xlink:label="loc_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions_377"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions" xlink:label="loc_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions_378"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_379"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_380"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_381"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_382"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_383"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_384"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinishedGoods" xlink:label="loc_ifrs-full_FinishedGoods_385"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FixedInterestRateMember" xlink:label="loc_ifrs-full_FixedInterestRateMember_386"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FixedInterestRateMember" xlink:label="loc_ifrs-full_FixedInterestRateMember_387"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_388"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_389"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_390"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasMember" xlink:label="loc_ifrs-full_GeographicalAreasMember_391"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GovernmentGrants" xlink:label="loc_ifrs-full_GovernmentGrants_392"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GovernmentGrants" xlink:label="loc_ifrs-full_GovernmentGrants_393"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GovernmentGrants" xlink:label="loc_ifrs-full_GovernmentGrants_394"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_395"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_396"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_397"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_398"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_399"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-full_IncomeStatementAbstract_400"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_401"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_402"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_403"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_404"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_405"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" xlink:label="loc_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_406"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" xlink:label="loc_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_407"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings_408"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_409"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_410"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_411"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_412"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_413"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" xlink:label="loc_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements_414"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_415"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_416"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_417"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_418"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_419"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_420"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_421"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_422"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_423"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InventoryWritedown2011" xlink:label="loc_ifrs-full_InventoryWritedown2011_424"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_425"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_426"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_427"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_428"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_429"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_430"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_431"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_432"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_433"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_434"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_435"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_436"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_437"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_438"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_439"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_440"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_441"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember_442"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember_443"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_444"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_445"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_446"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_447"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_448"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LicenceFeeIncome" xlink:label="loc_ifrs-full_LicenceFeeIncome_449"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LicenceFeeIncome" xlink:label="loc_ifrs-full_LicenceFeeIncome_450"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LicenceFeeIncome" xlink:label="loc_ifrs-full_LicenceFeeIncome_451"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LicencesAndFranchisesMember" xlink:label="loc_ifrs-full_LicencesAndFranchisesMember_452"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LongtermDeposits" xlink:label="loc_ifrs-full_LongtermDeposits_453"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LongtermDeposits" xlink:label="loc_ifrs-full_LongtermDeposits_454"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MachineryMember" xlink:label="loc_ifrs-full_MachineryMember_455"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xlink:label="loc_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_456"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xlink:label="loc_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_457"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_458"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodsOfGenerationAxis" xlink:label="loc_ifrs-full_MethodsOfGenerationAxis_459"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodsOfGenerationAxis" xlink:label="loc_ifrs-full_MethodsOfGenerationAxis_460"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MiscellaneousOtherOperatingExpense" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_461"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MotorVehiclesMember" xlink:label="loc_ifrs-full_MotorVehiclesMember_462"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MotorVehiclesMember" xlink:label="loc_ifrs-full_MotorVehiclesMember_463"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="loc_ifrs-full_NetForeignExchangeLoss_464"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="loc_ifrs-full_NetForeignExchangeLoss_465"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" xlink:label="loc_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_466"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_467"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_468"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_469"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_470"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_471"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentGovernmentGrants" xlink:label="loc_ifrs-full_NoncurrentGovernmentGrants_472"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentGovernmentGrants" xlink:label="loc_ifrs-full_NoncurrentGovernmentGrants_473"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_474"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_475"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_476"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_477"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_478"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_479"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_480"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentReceivablesAbstract" xlink:label="loc_ifrs-full_NoncurrentReceivablesAbstract_481"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_482"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentWarrantLiability" xlink:label="loc_ifrs-full_NoncurrentWarrantLiability_483"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentWarrantLiability" xlink:label="loc_ifrs-full_NoncurrentWarrantLiability_484"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_485"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_486"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfEmployees" xlink:label="loc_ifrs-full_NumberOfEmployees_487"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfEmployees" xlink:label="loc_ifrs-full_NumberOfEmployees_488"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_489"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_490"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_491"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_492"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_493"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_494"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_495"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_496"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_497"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_498"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_499"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_500"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_501"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_502"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_503"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_504"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesAuthorised" xlink:label="loc_ifrs-full_NumberOfSharesAuthorised_505"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesAuthorised" xlink:label="loc_ifrs-full_NumberOfSharesAuthorised_506"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_507"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_508"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_509"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="loc_ifrs-full_OfficeEquipmentMember_510"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_511"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_512"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_513"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xlink:label="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_514"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xlink:label="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_515"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_516"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_517"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract_518"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentPayables" xlink:label="loc_ifrs-full_OtherCurrentPayables_519"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentPayables" xlink:label="loc_ifrs-full_OtherCurrentPayables_520"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentPayables" xlink:label="loc_ifrs-full_OtherCurrentPayables_521"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentPayables" xlink:label="loc_ifrs-full_OtherCurrentPayables_522"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="loc_ifrs-full_OtherCurrentReceivables_523"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="loc_ifrs-full_OtherCurrentReceivables_524"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="loc_ifrs-full_OtherCurrentReceivables_525"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherExpenseByFunction" xlink:label="loc_ifrs-full_OtherExpenseByFunction_526"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherExpenseByNature" xlink:label="loc_ifrs-full_OtherExpenseByNature_527"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherExpenseByNature" xlink:label="loc_ifrs-full_OtherExpenseByNature_528"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherFinanceCost" xlink:label="loc_ifrs-full_OtherFinanceCost_529"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherFinanceCost" xlink:label="loc_ifrs-full_OtherFinanceCost_530"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_531"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_532"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_533"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_534"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_535"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_536"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentPayables" xlink:label="loc_ifrs-full_OtherNoncurrentPayables_537"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentReceivables" xlink:label="loc_ifrs-full_OtherNoncurrentReceivables_538"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentReceivables" xlink:label="loc_ifrs-full_OtherNoncurrentReceivables_539"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentReceivables" xlink:label="loc_ifrs-full_OtherNoncurrentReceivables_540"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_541"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_542"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_543"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_544"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_545"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherPayables" xlink:label="loc_ifrs-full_OtherPayables_546"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-full_OtherReceivables_547"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-full_OtherReceivables_548"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherRelatedPartiesMember" xlink:label="loc_ifrs-full_OtherRelatedPartiesMember_549"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherRelatedPartiesMember" xlink:label="loc_ifrs-full_OtherRelatedPartiesMember_550"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_551"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_552"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_553"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions_554"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromExerciseOfWarrants" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfWarrants_555"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromExerciseOfWarrants" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfWarrants_556"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromExerciseOfWarrants" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfWarrants_557"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_558"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_559"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_560"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_561"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_562"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_563"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_564"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_565"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_566"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_567"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_568"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_569"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_570"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_571"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_572"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_573"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_574"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_575"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_576"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_577"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_578"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_579"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_580"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_581"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_582"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_583"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_584"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_585"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfTreasuryShares" xlink:label="loc_ifrs-full_PurchaseOfTreasuryShares_586"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_587"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_588"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_589"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_590"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RawMaterials" xlink:label="loc_ifrs-full_RawMaterials_591"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_592"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_593"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_594"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RelatedPartiesMember" xlink:label="loc_ifrs-full_RelatedPartiesMember_595"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RelatedPartiesMember" xlink:label="loc_ifrs-full_RelatedPartiesMember_596"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_597"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_598"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_599"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_600"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads" xlink:label="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads_601"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads" xlink:label="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads_602"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" xlink:label="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember_603"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" xlink:label="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember_604"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-full_RestrictedCashAndCashEquivalents_605"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-full_RestrictedCashAndCashEquivalents_606"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_607"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_608"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_609"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_610"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_611"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_612"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_613"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromInterest" xlink:label="loc_ifrs-full_RevenueFromInterest_614"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromRenderingOfServices" xlink:label="loc_ifrs-full_RevenueFromRenderingOfServices_615"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromRoyalties" xlink:label="loc_ifrs-full_RevenueFromRoyalties_616"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_617"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_618"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_619"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_620"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus" xlink:label="loc_ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus_621"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssetsRevaluedAssetsAtCost" xlink:label="loc_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_622"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssetsRevaluedAssetsAtCost" xlink:label="loc_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_623"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssetsRevaluedAssetsAtCost" xlink:label="loc_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_624"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RoyaltyExpense" xlink:label="loc_ifrs-full_RoyaltyExpense_625"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RoyaltyExpense" xlink:label="loc_ifrs-full_RoyaltyExpense_626"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_627"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_628"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-full_SegmentsAxis_629"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-full_SegmentsMember_630"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_631"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_632"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk" xlink:label="loc_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk_633"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk" xlink:label="loc_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk_634"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ServicesExpense" xlink:label="loc_ifrs-full_ServicesExpense_635"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ServicesExpense" xlink:label="loc_ifrs-full_ServicesExpense_636"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_637"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium_638"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremiumMember" xlink:label="loc_ifrs-full_SharePremiumMember_639"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:label="loc_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_640"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_641"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_642"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_643"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_644"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals_645"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_646"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_647"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_648"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_649"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_650"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_651"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_652"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_653"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_654"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_655"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_656"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_657"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_658"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_659"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherPayablesAbstract_660"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradingIncomeExpenseOnForeignExchangeContracts" xlink:label="loc_ifrs-full_TradingIncomeExpenseOnForeignExchangeContracts_661"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions" xlink:label="loc_ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions_662"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfInterestRatesAxis" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_663"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_664"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_665"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_666"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-full_WagesAndSalaries_667"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_668"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_669"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_670"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_671"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_672"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_673"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_674"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_675"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_676"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_677"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_678"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:label="loc_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_679"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_680"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_681"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_682"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_683"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_684"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AccumaletedEffectOfAdoptingIfrsFifteen" xlink:label="loc_mdwd_AccumaletedEffectOfAdoptingIfrsFifteen_685"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AccumaletedEffectOfAdoptingIfrsFifteen" xlink:label="loc_mdwd_AccumaletedEffectOfAdoptingIfrsFifteen_686"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AccumaletedEffectOfAdoptingIfrsFifteen" xlink:label="loc_mdwd_AccumaletedEffectOfAdoptingIfrsFifteen_687"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AccumulatedFunding" xlink:label="loc_mdwd_AccumulatedFunding_688"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AccumulatedFunding" xlink:label="loc_mdwd_AccumulatedFunding_689"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionalInvestment" xlink:label="loc_mdwd_AdditionalInvestment_690"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionalInvestment" xlink:label="loc_mdwd_AdditionalInvestment_691"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits" xlink:label="loc_mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits_692"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits" xlink:label="loc_mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits_693"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits" xlink:label="loc_mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits_694"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionalTermOfLease" xlink:label="loc_mdwd_AdditionalTermOfLease_695"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionalTermOfLease" xlink:label="loc_mdwd_AdditionalTermOfLease_696"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionalTermOfLease" xlink:label="loc_mdwd_AdditionalTermOfLease_697"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionalUpfrontPayment" xlink:label="loc_mdwd_AdditionalUpfrontPayment_698"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionalUpfrontPayment" xlink:label="loc_mdwd_AdditionalUpfrontPayment_699"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation" xlink:label="loc_mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation_700"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation" xlink:label="loc_mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation_701"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation" xlink:label="loc_mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation_702"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionsToRightOfUseAssetsDisposals" xlink:label="loc_mdwd_AdditionsToRightOfUseAssetsDisposals_703"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionsToRightOfUseAssetsDisposals" xlink:label="loc_mdwd_AdditionsToRightOfUseAssetsDisposals_704"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionsToRightOfUseAssetsDisposals" xlink:label="loc_mdwd_AdditionsToRightOfUseAssetsDisposals_705"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionsToRightOfUseAssetsNewLeases" xlink:label="loc_mdwd_AdditionsToRightOfUseAssetsNewLeases_706"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionsToRightOfUseAssetsNewLeases" xlink:label="loc_mdwd_AdditionsToRightOfUseAssetsNewLeases_707"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionsToRightOfUseAssetsNewLeases" xlink:label="loc_mdwd_AdditionsToRightOfUseAssetsNewLeases_708"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases" xlink:label="loc_mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases_709"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases" xlink:label="loc_mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases_710"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases" xlink:label="loc_mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases_711"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustedWeightedAverageSharesContinuing" xlink:label="loc_mdwd_AdjustedWeightedAverageSharesContinuing_712"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustedWeightedAverageSharesContinuing" xlink:label="loc_mdwd_AdjustedWeightedAverageSharesContinuing_713"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustedWeightedAverageSharesContinuing" xlink:label="loc_mdwd_AdjustedWeightedAverageSharesContinuing_714"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_715"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_716"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_717"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_718"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_719"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue" xlink:label="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue_720"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue" xlink:label="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue_721"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue" xlink:label="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue_722"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue" xlink:label="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue_723"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" xlink:label="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_724"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" xlink:label="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_725"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" xlink:label="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_726"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" xlink:label="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_727"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability" xlink:label="loc_mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability_728"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability" xlink:label="loc_mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability_729"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability" xlink:label="loc_mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability_730"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForIncreaseDecreaseInOtherIncome" xlink:label="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherIncome_731"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForIncreaseDecreaseInOtherIncome" xlink:label="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherIncome_732"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForIncreaseDecreaseInOtherIncome" xlink:label="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherIncome_733"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" xlink:label="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_734"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" xlink:label="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_735"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" xlink:label="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_736"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForIndexation" xlink:label="loc_mdwd_AdjustmentsForIndexation_737"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForIndexation" xlink:label="loc_mdwd_AdjustmentsForIndexation_738"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForIndexation" xlink:label="loc_mdwd_AdjustmentsForIndexation_739"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" xlink:label="loc_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_740"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" xlink:label="loc_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_741"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" xlink:label="loc_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_742"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsMember" xlink:label="loc_mdwd_AdjustmentsMember_743"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsToReconcileNetLossToNetCashProvidedByUsedInContinuingOperatingActivitiesAbstract" xlink:label="loc_mdwd_AdjustmentsToReconcileNetLossToNetCashProvidedByUsedInContinuingOperatingActivitiesAbstract_744"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsToReconcileNetLossToNetCashProvidedByUsedInContinuingOperatingActivitiesAbstract" xlink:label="loc_mdwd_AdjustmentsToReconcileNetLossToNetCashProvidedByUsedInContinuingOperatingActivitiesAbstract_745"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AggregateAmountOfRegisteredDirectOffering" xlink:label="loc_mdwd_AggregateAmountOfRegisteredDirectOffering_746"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AggregateAmountOfRegisteredDirectOffering" xlink:label="loc_mdwd_AggregateAmountOfRegisteredDirectOffering_747"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AggregateAmountOfRegisteredDirectOffering" xlink:label="loc_mdwd_AggregateAmountOfRegisteredDirectOffering_748"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AggregateSupplementalAmount" xlink:label="loc_mdwd_AggregateSupplementalAmount_749"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AggregateSupplementalAmount" xlink:label="loc_mdwd_AggregateSupplementalAmount_750"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AggregateSupplementalAmount" xlink:label="loc_mdwd_AggregateSupplementalAmount_751"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AgreementAxis" xlink:label="loc_mdwd_AgreementAxis_752"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AgreementAxis" xlink:label="loc_mdwd_AgreementAxis_753"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AgreementAxis" xlink:label="loc_mdwd_AgreementAxis_754"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AgreementDomain" xlink:label="loc_mdwd_AgreementDomain_755"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AgreementDomain" xlink:label="loc_mdwd_AgreementDomain_756"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AllotmentOfDevelopmentCostOfGoodsSold" xlink:label="loc_mdwd_AllotmentOfDevelopmentCostOfGoodsSold_757"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AllotmentOfDevelopmentCostOfGoodsSold" xlink:label="loc_mdwd_AllotmentOfDevelopmentCostOfGoodsSold_758"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AllotmentOfDevelopmentCostOfGoodsSold" xlink:label="loc_mdwd_AllotmentOfDevelopmentCostOfGoodsSold_759"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AllotmentOfManufacturingCosts" xlink:label="loc_mdwd_AllotmentOfManufacturingCosts_760"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AllotmentOfManufacturingCosts" xlink:label="loc_mdwd_AllotmentOfManufacturingCosts_761"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AllotmentOfManufacturingCostsToResearchAndDevelopment" xlink:label="loc_mdwd_AllotmentOfManufacturingCostsToResearchAndDevelopment_762"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AllotmentOfManufacturingCostsToResearchAndDevelopment" xlink:label="loc_mdwd_AllotmentOfManufacturingCostsToResearchAndDevelopment_763"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AllotmentOfManufacturingCostsToResearchAndDevelopment" xlink:label="loc_mdwd_AllotmentOfManufacturingCostsToResearchAndDevelopment_764"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmortizationPeriodsOfRightOfUseAssets" xlink:label="loc_mdwd_AmortizationPeriodsOfRightOfUseAssets_765"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmortizationPeriodsOfRightOfUseAssets" xlink:label="loc_mdwd_AmortizationPeriodsOfRightOfUseAssets_766"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmortizationPeriodsOfRightOfUseAssets" xlink:label="loc_mdwd_AmortizationPeriodsOfRightOfUseAssets_767"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmortizedCostMember" xlink:label="loc_mdwd_AmortizedCostMember_768"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmortizedCostMember" xlink:label="loc_mdwd_AmortizedCostMember_769"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmortizedCostOfGrantsReceived" xlink:label="loc_mdwd_AmortizedCostOfGrantsReceived_770"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmortizedCostOfGrantsReceived" xlink:label="loc_mdwd_AmortizedCostOfGrantsReceived_771"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfAnnualFeeOfLeaseAgreement" xlink:label="loc_mdwd_AmountOfAnnualFeeOfLeaseAgreement_772"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfAnnualFeeOfLeaseAgreement" xlink:label="loc_mdwd_AmountOfAnnualFeeOfLeaseAgreement_773"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfAnnualFeeOfLeaseAgreement" xlink:label="loc_mdwd_AmountOfAnnualFeeOfLeaseAgreement_774"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfInvestedInProject" xlink:label="loc_mdwd_AmountOfInvestedInProject_775"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfInvestedInProject" xlink:label="loc_mdwd_AmountOfInvestedInProject_776"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfInvestedInProject" xlink:label="loc_mdwd_AmountOfInvestedInProject_777"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfLeaseLiabilityUnderLongTermDebtAndCurrentMaturity" xlink:label="loc_mdwd_AmountOfLeaseLiabilityUnderLongTermDebtAndCurrentMaturity_778"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfLeaseLiabilityUnderLongTermDebtAndCurrentMaturity" xlink:label="loc_mdwd_AmountOfLeaseLiabilityUnderLongTermDebtAndCurrentMaturity_779"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential" xlink:label="loc_mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential_780"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential" xlink:label="loc_mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential_781"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential" xlink:label="loc_mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential_782"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfSecondContractExpired" xlink:label="loc_mdwd_AmountOfSecondContractExpired_783"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfSecondContractExpired" xlink:label="loc_mdwd_AmountOfSecondContractExpired_784"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfSecondContractExpired" xlink:label="loc_mdwd_AmountOfSecondContractExpired_785"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfTechnicalAssistance" xlink:label="loc_mdwd_AmountOfTechnicalAssistance_786"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfTechnicalAssistance" xlink:label="loc_mdwd_AmountOfTechnicalAssistance_787"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfTechnicalAssistance" xlink:label="loc_mdwd_AmountOfTechnicalAssistance_788"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfUnderwritingDiscountsAndCommissions" xlink:label="loc_mdwd_AmountOfUnderwritingDiscountsAndCommissions_789"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfUnderwritingDiscountsAndCommissions" xlink:label="loc_mdwd_AmountOfUnderwritingDiscountsAndCommissions_790"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfUnderwritingDiscountsAndCommissions" xlink:label="loc_mdwd_AmountOfUnderwritingDiscountsAndCommissions_791"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AreaOfLand" xlink:label="loc_mdwd_AreaOfLand_792"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AreaOfLand" xlink:label="loc_mdwd_AreaOfLand_793"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AreaOfLand" xlink:label="loc_mdwd_AreaOfLand_794"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AuthorizedNumberOfSharesIncreased" xlink:label="loc_mdwd_AuthorizedNumberOfSharesIncreased_795"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AuthorizedNumberOfSharesIncreased" xlink:label="loc_mdwd_AuthorizedNumberOfSharesIncreased_796"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AuthorizedNumberOfSharesNominalValue" xlink:label="loc_mdwd_AuthorizedNumberOfSharesNominalValue_797"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AuthorizedNumberOfSharesNominalValue" xlink:label="loc_mdwd_AuthorizedNumberOfSharesNominalValue_798"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AuthorizedNumberOfSharesNominalValue" xlink:label="loc_mdwd_AuthorizedNumberOfSharesNominalValue_799"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AuthorizedShareCapital" xlink:label="loc_mdwd_AuthorizedShareCapital_800"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AuthorizedShareCapital" xlink:label="loc_mdwd_AuthorizedShareCapital_801"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AuthorizedShareCapital" xlink:label="loc_mdwd_AuthorizedShareCapital_802"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AverageStandardDeviationOfWarrants" xlink:label="loc_mdwd_AverageStandardDeviationOfWarrants_803"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AverageStandardDeviationOfWarrants" xlink:label="loc_mdwd_AverageStandardDeviationOfWarrants_804"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AverageStandardDeviationOfWarrants" xlink:label="loc_mdwd_AverageStandardDeviationOfWarrants_805"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BardaFunds" xlink:label="loc_mdwd_BardaFunds_806"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BardaFunds" xlink:label="loc_mdwd_BardaFunds_807"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BardaFunds" xlink:label="loc_mdwd_BardaFunds_808"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BardaMember" xlink:label="loc_mdwd_BardaMember_809"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BardaMember" xlink:label="loc_mdwd_BardaMember_810"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BardaMember" xlink:label="loc_mdwd_BardaMember_811"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BasicAndDilutedEarningsPerShareAbstract" xlink:label="loc_mdwd_BasicAndDilutedEarningsPerShareAbstract_812"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BasicAndDilutedNetProfitLossPerShareFromContinuingOperations" xlink:label="loc_mdwd_BasicAndDilutedNetProfitLossPerShareFromContinuingOperations_813"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BasicAndDilutedNetProfitLossPerShareFromContinuingOperations" xlink:label="loc_mdwd_BasicAndDilutedNetProfitLossPerShareFromContinuingOperations_814"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BasicAndDilutedNetProfitLossPerShareFromContinuingOperations" xlink:label="loc_mdwd_BasicAndDilutedNetProfitLossPerShareFromContinuingOperations_815"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BasicAndDilutedNetProfitLossPerShareFromContinuingOperations" xlink:label="loc_mdwd_BasicAndDilutedNetProfitLossPerShareFromContinuingOperations_816"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations" xlink:label="loc_mdwd_BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations_817"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations" xlink:label="loc_mdwd_BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations_818"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations" xlink:label="loc_mdwd_BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations_819"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations" xlink:label="loc_mdwd_BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations_820"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember" xlink:label="loc_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_821"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember" xlink:label="loc_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_822"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember" xlink:label="loc_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_823"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BoardMembersMember" xlink:label="loc_mdwd_BoardMembersMember_824"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BoardMembersMember" xlink:label="loc_mdwd_BoardMembersMember_825"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BoardMembersMember" xlink:label="loc_mdwd_BoardMembersMember_826"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BoardOfDirectorsMember" xlink:label="loc_mdwd_BoardOfDirectorsMember_827"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BuildingAndEquipmentMember" xlink:label="loc_mdwd_BuildingAndEquipmentMember_828"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BuildingAndEquipmentMember" xlink:label="loc_mdwd_BuildingAndEquipmentMember_829"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BuildingAndEquipmentMember" xlink:label="loc_mdwd_BuildingAndEquipmentMember_830"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CarryforwardLosses" xlink:label="loc_mdwd_CarryforwardLosses_831"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CarryforwardLosses" xlink:label="loc_mdwd_CarryforwardLosses_832"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits" xlink:label="loc_mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits_833"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits" xlink:label="loc_mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits_834"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits" xlink:label="loc_mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits_835"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CashlessExerciseMember" xlink:label="loc_mdwd_CashlessExerciseMember_836"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CashOnHandInNonUsd" xlink:label="loc_mdwd_CashOnHandInNonUsd_837"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CashOnHandInNonUsd" xlink:label="loc_mdwd_CashOnHandInNonUsd_838"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CashOnHandInNonUsd" xlink:label="loc_mdwd_CashOnHandInNonUsd_839"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CertainEntitiesAffiliatedWithCbiMember" xlink:label="loc_mdwd_CertainEntitiesAffiliatedWithCbiMember_840"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CertainEntitiesAffiliatedWithCbiMember" xlink:label="loc_mdwd_CertainEntitiesAffiliatedWithCbiMember_841"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CertainEntitiesAffiliatedWithCbiMember" xlink:label="loc_mdwd_CertainEntitiesAffiliatedWithCbiMember_842"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ChairmanMember" xlink:label="loc_mdwd_ChairmanMember_843"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ChairmanMember" xlink:label="loc_mdwd_ChairmanMember_844"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets" xlink:label="loc_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets_845"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets" xlink:label="loc_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets_846"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets" xlink:label="loc_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets_847"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ChangesInAssetAndLiabilityItemsAbstract" xlink:label="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_848"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ChangesInAssetAndLiabilityItemsAbstract" xlink:label="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_849"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ChiefExecutiveOfficerAndChiefMedicalOfficerMember" xlink:label="loc_mdwd_ChiefExecutiveOfficerAndChiefMedicalOfficerMember_850"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ChiefExecutiveOfficerAndChiefMedicalOfficerMember" xlink:label="loc_mdwd_ChiefExecutiveOfficerAndChiefMedicalOfficerMember_851"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ChiefExecutiveOfficersMember" xlink:label="loc_mdwd_ChiefExecutiveOfficersMember_852"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ChiefExecutiveOfficersMember" xlink:label="loc_mdwd_ChiefExecutiveOfficersMember_853"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ChiefExecutiveOfficersMember" xlink:label="loc_mdwd_ChiefExecutiveOfficersMember_854"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CollaborationAgreementsAmountRelatedToPolyheal" xlink:label="loc_mdwd_CollaborationAgreementsAmountRelatedToPolyheal_855"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CollaborationAgreementsAmountRelatedToPolyheal" xlink:label="loc_mdwd_CollaborationAgreementsAmountRelatedToPolyheal_856"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CommissionsAndOtherOfferingExpenses" xlink:label="loc_mdwd_CommissionsAndOtherOfferingExpenses_857"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CommissionsAndOtherOfferingExpenses" xlink:label="loc_mdwd_CommissionsAndOtherOfferingExpenses_858"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CommissionsAndOtherOfferingExpenses" xlink:label="loc_mdwd_CommissionsAndOtherOfferingExpenses_859"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CompromisedDepreciationExpense" xlink:label="loc_mdwd_CompromisedDepreciationExpense_860"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CompromisedDepreciationExpense" xlink:label="loc_mdwd_CompromisedDepreciationExpense_861"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CompromisedDepreciationExpense" xlink:label="loc_mdwd_CompromisedDepreciationExpense_862"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ConcentrationRiskPercentage" xlink:label="loc_mdwd_ConcentrationRiskPercentage_863"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ConcentrationRiskPercentage" xlink:label="loc_mdwd_ConcentrationRiskPercentage_864"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ConcentrationRiskPercentage" xlink:label="loc_mdwd_ConcentrationRiskPercentage_865"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ContractAmountForDevelopmentAndManufacturing" xlink:label="loc_mdwd_ContractAmountForDevelopmentAndManufacturing_866"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ContractAmountForDevelopmentAndManufacturing" xlink:label="loc_mdwd_ContractAmountForDevelopmentAndManufacturing_867"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ContractAmountForDevelopmentAndManufacturing" xlink:label="loc_mdwd_ContractAmountForDevelopmentAndManufacturing_868"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ContractAssetRelatedToBarda" xlink:label="loc_mdwd_ContractAssetRelatedToBarda_869"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ContractAssetRelatedToBarda" xlink:label="loc_mdwd_ContractAssetRelatedToBarda_870"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ContractAssetRelatedToBarda" xlink:label="loc_mdwd_ContractAssetRelatedToBarda_871"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ContractWithCustomers" xlink:label="loc_mdwd_ContractWithCustomers_872"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ContractWithCustomers" xlink:label="loc_mdwd_ContractWithCustomers_873"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ContractWithCustomers" xlink:label="loc_mdwd_ContractWithCustomers_874"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfLicenseAgreements" xlink:label="loc_mdwd_CostOfLicenseAgreements_875"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfLicenseAgreements" xlink:label="loc_mdwd_CostOfLicenseAgreements_876"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfLicenseAgreements" xlink:label="loc_mdwd_CostOfLicenseAgreements_877"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfMaterials" xlink:label="loc_mdwd_CostOfMaterials_878"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfMaterials" xlink:label="loc_mdwd_CostOfMaterials_879"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfMaterials" xlink:label="loc_mdwd_CostOfMaterials_880"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfRevenuesMember" xlink:label="loc_mdwd_CostOfRevenuesMember_881"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfRevenuesMember" xlink:label="loc_mdwd_CostOfRevenuesMember_882"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfRevenuesMember" xlink:label="loc_mdwd_CostOfRevenuesMember_883"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfSalesFromLicenseAgreements" xlink:label="loc_mdwd_CostOfSalesFromLicenseAgreements_884"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfSalesFromLicenseAgreements" xlink:label="loc_mdwd_CostOfSalesFromLicenseAgreements_885"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfSalesFromLicenseAgreements" xlink:label="loc_mdwd_CostOfSalesFromLicenseAgreements_886"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfSalesFromSaleOfProducts" xlink:label="loc_mdwd_CostOfSalesFromSaleOfProducts_887"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfSalesFromSaleOfProducts" xlink:label="loc_mdwd_CostOfSalesFromSaleOfProducts_888"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfSalesFromSaleOfProducts" xlink:label="loc_mdwd_CostOfSalesFromSaleOfProducts_889"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfSalesFromSaleOfProducts" xlink:label="loc_mdwd_CostOfSalesFromSaleOfProducts_890"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrs15" xlink:label="loc_mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrs15_891"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrs15" xlink:label="loc_mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrs15_892"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrs15" xlink:label="loc_mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrs15_893"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CumulativeEffectAdjustmentOnAccumulatedLiabilitiesAsResultOfAdoptingIfrs16" xlink:label="loc_mdwd_CumulativeEffectAdjustmentOnAccumulatedLiabilitiesAsResultOfAdoptingIfrs16_894"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CumulativeEffectAdjustmentOnAccumulatedLiabilitiesAsResultOfAdoptingIfrs16" xlink:label="loc_mdwd_CumulativeEffectAdjustmentOnAccumulatedLiabilitiesAsResultOfAdoptingIfrs16_895"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CumulativeEffectAdjustmentOnAccumulatedLiabilitiesAsResultOfAdoptingIfrs16" xlink:label="loc_mdwd_CumulativeEffectAdjustmentOnAccumulatedLiabilitiesAsResultOfAdoptingIfrs16_896"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentBarda" xlink:label="loc_mdwd_CurrentBarda_897"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentBarda" xlink:label="loc_mdwd_CurrentBarda_898"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentBarda" xlink:label="loc_mdwd_CurrentBarda_899"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentBardaFundsReceivables" xlink:label="loc_mdwd_CurrentBardaFundsReceivables_900"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentBardaFundsReceivables" xlink:label="loc_mdwd_CurrentBardaFundsReceivables_901"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentGovernmentAuthoritiesReceivables" xlink:label="loc_mdwd_CurrentGovernmentAuthoritiesReceivables_902"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentGovernmentAuthoritiesReceivables" xlink:label="loc_mdwd_CurrentGovernmentAuthoritiesReceivables_903"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentGovernmentAuthoritiesReceivables" xlink:label="loc_mdwd_CurrentGovernmentAuthoritiesReceivables_904"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentMaturitiesOfLongTermLiabilities" xlink:label="loc_mdwd_CurrentMaturitiesOfLongTermLiabilities_905"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentMaturitiesOfLongTermLiabilities" xlink:label="loc_mdwd_CurrentMaturitiesOfLongTermLiabilities_906"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentMaturitiesOfLongTermLiabilities" xlink:label="loc_mdwd_CurrentMaturitiesOfLongTermLiabilities_907"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentMtec" xlink:label="loc_mdwd_CurrentMtec_908"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentMtec" xlink:label="loc_mdwd_CurrentMtec_909"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentMtec" xlink:label="loc_mdwd_CurrentMtec_910"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentVericel" xlink:label="loc_mdwd_CurrentVericel_911"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentVericel" xlink:label="loc_mdwd_CurrentVericel_912"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentVericel" xlink:label="loc_mdwd_CurrentVericel_913"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DeferredRevenueNonCurrent" xlink:label="loc_mdwd_DeferredRevenueNonCurrent_914"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DeferredRevenueNonCurrent" xlink:label="loc_mdwd_DeferredRevenueNonCurrent_915"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DeferredRevenueNonCurrent" xlink:label="loc_mdwd_DeferredRevenueNonCurrent_916"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DeferredRevenues" xlink:label="loc_mdwd_DeferredRevenues_917"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DeferredRevenues" xlink:label="loc_mdwd_DeferredRevenues_918"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DeferredRevenues" xlink:label="loc_mdwd_DeferredRevenues_919"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DeferredRevenuesExpectedRecongnizedPeriod" xlink:label="loc_mdwd_DeferredRevenuesExpectedRecongnizedPeriod_920"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DeferredRevenuesExpectedRecongnizedPeriod" xlink:label="loc_mdwd_DeferredRevenuesExpectedRecongnizedPeriod_921"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DeferredTaxAssetsNotRecognized" xlink:label="loc_mdwd_DeferredTaxAssetsNotRecognized_922"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DeferredTaxAssetsNotRecognized" xlink:label="loc_mdwd_DeferredTaxAssetsNotRecognized_923"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepositInterestRate" xlink:label="loc_mdwd_DepositInterestRate_924"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepositInterestRate" xlink:label="loc_mdwd_DepositInterestRate_925"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepreciatedCostMember" xlink:label="loc_mdwd_DepreciatedCostMember_926"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepreciatedCostMember" xlink:label="loc_mdwd_DepreciatedCostMember_927"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses" xlink:label="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses_928"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses" xlink:label="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses_929"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses" xlink:label="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses_930"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment" xlink:label="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment_931"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment" xlink:label="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment_932"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment" xlink:label="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment_933"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses" xlink:label="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses_934"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses" xlink:label="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses_935"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses" xlink:label="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses_936"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory" xlink:label="loc_mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory_937"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory" xlink:label="loc_mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory_938"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory" xlink:label="loc_mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory_939"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory" xlink:label="loc_mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory_940"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory" xlink:label="loc_mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory_941"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory" xlink:label="loc_mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory_942"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DescriptionOfAccountingPolicyForShortTermBankDepositsExplanatory" xlink:label="loc_mdwd_DescriptionOfAccountingPolicyForShortTermBankDepositsExplanatory_943"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DescriptionOfAccountingPolicyForShortTermBankDepositsExplanatory" xlink:label="loc_mdwd_DescriptionOfAccountingPolicyForShortTermBankDepositsExplanatory_944"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DescriptionOfAccountingPolicyForShortTermBankDepositsExplanatory" xlink:label="loc_mdwd_DescriptionOfAccountingPolicyForShortTermBankDepositsExplanatory_945"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DescriptionOfTaxBenefitPeriod" xlink:label="loc_mdwd_DescriptionOfTaxBenefitPeriod_946"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DescriptionOfTaxBenefitPeriod" xlink:label="loc_mdwd_DescriptionOfTaxBenefitPeriod_947"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DescriptionOfTaxBenefitPeriod" xlink:label="loc_mdwd_DescriptionOfTaxBenefitPeriod_948"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DilutedWeightedAverageNumberMember" xlink:label="loc_mdwd_DilutedWeightedAverageNumberMember_949"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DilutedWeightedAverageNumberMember" xlink:label="loc_mdwd_DilutedWeightedAverageNumberMember_950"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DirectorsAndCeoMember" xlink:label="loc_mdwd_DirectorsAndCeoMember_951"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DirectorsAndCeoMember" xlink:label="loc_mdwd_DirectorsAndCeoMember_952"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DirectorsAndCeoMember" xlink:label="loc_mdwd_DirectorsAndCeoMember_953"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DirectorsMember" xlink:label="loc_mdwd_DirectorsMember_954"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DirectorsMember" xlink:label="loc_mdwd_DirectorsMember_955"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory" xlink:label="loc_mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory_956"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory" xlink:label="loc_mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory_957"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory" xlink:label="loc_mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory_958"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfAdditionalInformationRevenuesExplanatory" xlink:label="loc_mdwd_DisclosureOfAdditionalInformationRevenuesExplanatory_959"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfAdditionalInformationRevenuesExplanatory" xlink:label="loc_mdwd_DisclosureOfAdditionalInformationRevenuesExplanatory_960"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfAdditionalInformationRevenuesExplanatory" xlink:label="loc_mdwd_DisclosureOfAdditionalInformationRevenuesExplanatory_961"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfBasisOfPreparationOfConsolidatedFinancialStatementsAbstract" xlink:label="loc_mdwd_DisclosureOfBasisOfPreparationOfConsolidatedFinancialStatementsAbstract_962"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfCostOfSalesServicesExplanatory" xlink:label="loc_mdwd_DisclosureOfCostOfSalesServicesExplanatory_963"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfCostOfSalesServicesExplanatory" xlink:label="loc_mdwd_DisclosureOfCostOfSalesServicesExplanatory_964"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfCostOfSalesServicesExplanatory" xlink:label="loc_mdwd_DisclosureOfCostOfSalesServicesExplanatory_965"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory_966"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory_967"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory_968"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory_969"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory_970"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory_971"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_972"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_973"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_974"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory_975"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory_976"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory_977"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory_978"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory_979"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory_980"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory_981"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory_982"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory_983"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory_984"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory_985"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory_986"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory_987"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory_988"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory_989"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory_990"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory_991"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory_992"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory_993"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory_994"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory_995"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory_996"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory_997"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory_998"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory_999"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory_1000"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory_1001"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory_1002"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory_1003"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory_1004"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory_1005"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory_1006"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory_1007"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory_1008"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory_1009"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory_1010"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory_1011"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory_1012"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory_1013"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory_1014"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDiscontinuedOperationAbstract" xlink:label="loc_mdwd_DisclosureOfDiscontinuedOperationAbstract_1015"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems" xlink:label="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_1016"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems" xlink:label="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_1017"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems" xlink:label="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_1018"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems" xlink:label="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_1019"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable" xlink:label="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1020"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable" xlink:label="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1021"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable" xlink:label="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1022"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfGeneralInformationAbstract" xlink:label="loc_mdwd_DisclosureOfGeneralInformationAbstract_1023"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfGeneralInformationAbstract" xlink:label="loc_mdwd_DisclosureOfGeneralInformationAbstract_1024"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfIncomeTaxesAbstract" xlink:label="loc_mdwd_DisclosureOfIncomeTaxesAbstract_1025"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract" xlink:label="loc_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_1026"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract" xlink:label="loc_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_1027"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract" xlink:label="loc_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_1028"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfMaterialAgreementsAbstract" xlink:label="loc_mdwd_DisclosureOfMaterialAgreementsAbstract_1029"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfMaterialAgreementsExplanatory" xlink:label="loc_mdwd_DisclosureOfMaterialAgreementsExplanatory_1030"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfMaterialAgreementsExplanatory" xlink:label="loc_mdwd_DisclosureOfMaterialAgreementsExplanatory_1031"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfMaterialAgreementsExplanatory" xlink:label="loc_mdwd_DisclosureOfMaterialAgreementsExplanatory_1032"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfOtherReceivablesLongTermExplanatory" xlink:label="loc_mdwd_DisclosureOfOtherReceivablesLongTermExplanatory_1033"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfOtherReceivablesLongTermExplanatory" xlink:label="loc_mdwd_DisclosureOfOtherReceivablesLongTermExplanatory_1034"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfOtherReceivablesLongTermExplanatory" xlink:label="loc_mdwd_DisclosureOfOtherReceivablesLongTermExplanatory_1035"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfShortTermBankDepositsAbstract" xlink:label="loc_mdwd_DisclosureOfShortTermBankDepositsAbstract_1036"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfShortTermBankDepositsAbstract" xlink:label="loc_mdwd_DisclosureOfShortTermBankDepositsAbstract_1037"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfShortTermBankDepositsAbstract" xlink:label="loc_mdwd_DisclosureOfShortTermBankDepositsAbstract_1038"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfSignificantAccountingPoliciesAbstract" xlink:label="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_1039"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfSignificantAccountingPoliciesAbstract" xlink:label="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_1040"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfSignificantAccountingPoliciesAbstract" xlink:label="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_1041"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory" xlink:label="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory_1042"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory" xlink:label="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory_1043"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory" xlink:label="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory_1044"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract" xlink:label="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract_1045"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract" xlink:label="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract_1046"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfTradeReceivablesExplanatory" xlink:label="loc_mdwd_DisclosureOfTradeReceivablesExplanatory_1047"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfTradeReceivablesExplanatory" xlink:label="loc_mdwd_DisclosureOfTradeReceivablesExplanatory_1048"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfTradeReceivablesExplanatory" xlink:label="loc_mdwd_DisclosureOfTradeReceivablesExplanatory_1049"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisposalsMember" xlink:label="loc_mdwd_DisposalsMember_1050"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisposalsTerminationOfLeases" xlink:label="loc_mdwd_DisposalsTerminationOfLeases_1051"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisposalsTerminationOfLeases" xlink:label="loc_mdwd_DisposalsTerminationOfLeases_1052"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisposalsTerminationOfLeases" xlink:label="loc_mdwd_DisposalsTerminationOfLeases_1053"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DocumentAndEntityInformationAbstract" xlink:label="loc_mdwd_DocumentAndEntityInformationAbstract_1054"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities" xlink:label="loc_mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities_1055"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities" xlink:label="loc_mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities_1056"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities" xlink:label="loc_mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities_1057"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EffectOfShareSplit" xlink:label="loc_mdwd_EffectOfShareSplit_1058"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EffectOfShareSplit" xlink:label="loc_mdwd_EffectOfShareSplit_1059"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EffectOfTheInitialAdoptionOfTheNewStandardMember" xlink:label="loc_mdwd_EffectOfTheInitialAdoptionOfTheNewStandardMember_1060"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EmployeesAndDirectorsMember" xlink:label="loc_mdwd_EmployeesAndDirectorsMember_1061"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EmployeesAndDirectorsMember" xlink:label="loc_mdwd_EmployeesAndDirectorsMember_1062"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EmployeesMember" xlink:label="loc_mdwd_EmployeesMember_1063"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EmployeesMember" xlink:label="loc_mdwd_EmployeesMember_1064"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember" xlink:label="loc_mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember_1065"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember" xlink:label="loc_mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember_1066"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember" xlink:label="loc_mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember_1067"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_Equity1" xlink:label="loc_mdwd_Equity1_1068"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_Equity1" xlink:label="loc_mdwd_Equity1_1069"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_Equity1" xlink:label="loc_mdwd_Equity1_1070"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EquityIncentivePlanMember" xlink:label="loc_mdwd_EquityIncentivePlanMember_1071"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EquityIncentivePlanMember" xlink:label="loc_mdwd_EquityIncentivePlanMember_1072"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EquityIncentivePlanMember" xlink:label="loc_mdwd_EquityIncentivePlanMember_1073"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EquityTablesAbstract" xlink:label="loc_mdwd_EquityTablesAbstract_1074"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EUMember" xlink:label="loc_mdwd_EUMember_1075"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EventsAfterReportingPeriodMember" xlink:label="loc_mdwd_EventsAfterReportingPeriodMember_1076"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EventsAfterReportingPeriodMember" xlink:label="loc_mdwd_EventsAfterReportingPeriodMember_1077"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EventsAfterReportingPeriodMember" xlink:label="loc_mdwd_EventsAfterReportingPeriodMember_1078"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares" xlink:label="loc_mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares_1079"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares" xlink:label="loc_mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares_1080"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares" xlink:label="loc_mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares_1081"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExerciseOfRsuOption" xlink:label="loc_mdwd_ExerciseOfRsuOption_1082"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExerciseOfRsuOption" xlink:label="loc_mdwd_ExerciseOfRsuOption_1083"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExerciseOfRsuOption" xlink:label="loc_mdwd_ExerciseOfRsuOption_1084"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExercisePriceOfWarrants" xlink:label="loc_mdwd_ExercisePriceOfWarrants_1085"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExercisePriceOfWarrants" xlink:label="loc_mdwd_ExercisePriceOfWarrants_1086"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExercisePriceOfWarrants" xlink:label="loc_mdwd_ExercisePriceOfWarrants_1087"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExercisePriceShareOptionsGrantedPercentage" xlink:label="loc_mdwd_ExercisePriceShareOptionsGrantedPercentage_1088"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExercisePriceShareOptionsGrantedPercentage" xlink:label="loc_mdwd_ExercisePriceShareOptionsGrantedPercentage_1089"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExercisePriceShareOptionsGrantedPercentage" xlink:label="loc_mdwd_ExercisePriceShareOptionsGrantedPercentage_1090"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExpectedDividendAsPercentageOfWarrants" xlink:label="loc_mdwd_ExpectedDividendAsPercentageOfWarrants_1091"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExpectedDividendAsPercentageOfWarrants" xlink:label="loc_mdwd_ExpectedDividendAsPercentageOfWarrants_1092"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExpectedDividendAsPercentageOfWarrants" xlink:label="loc_mdwd_ExpectedDividendAsPercentageOfWarrants_1093"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExpectedTermOfWarrant" xlink:label="loc_mdwd_ExpectedTermOfWarrant_1094"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExpectedTermOfWarrant" xlink:label="loc_mdwd_ExpectedTermOfWarrant_1095"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExpectedTermOfWarrant" xlink:label="loc_mdwd_ExpectedTermOfWarrant_1096"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExpectedVolatilityWarrants" xlink:label="loc_mdwd_ExpectedVolatilityWarrants_1097"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExpectedVolatilityWarrants" xlink:label="loc_mdwd_ExpectedVolatilityWarrants_1098"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExpectedVolatilityWarrants" xlink:label="loc_mdwd_ExpectedVolatilityWarrants_1099"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinanceExpensesInRespectOfDeferredRevenue" xlink:label="loc_mdwd_FinanceExpensesInRespectOfDeferredRevenue_1100"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinanceExpensesInRespectOfDeferredRevenue" xlink:label="loc_mdwd_FinanceExpensesInRespectOfDeferredRevenue_1101"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinanceExpensesInRespectOfDeferredRevenue" xlink:label="loc_mdwd_FinanceExpensesInRespectOfDeferredRevenue_1102"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinanceIncomeExpenseNet" xlink:label="loc_mdwd_FinanceIncomeExpenseNet_1103"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinanceIncomeExpenseNet" xlink:label="loc_mdwd_FinanceIncomeExpenseNet_1104"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinanceIncomeExpenseNet" xlink:label="loc_mdwd_FinanceIncomeExpenseNet_1105"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinancialExpensesNet" xlink:label="loc_mdwd_FinancialExpensesNet_1106"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinancialExpensesNet" xlink:label="loc_mdwd_FinancialExpensesNet_1107"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinancialExpensesNet" xlink:label="loc_mdwd_FinancialExpensesNet_1108"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinancialIncomeAndExpenses" xlink:label="loc_mdwd_FinancialIncomeAndExpenses_1109"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinancialIncomeAndExpenses" xlink:label="loc_mdwd_FinancialIncomeAndExpenses_1110"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinancialIncomeAndExpenses" xlink:label="loc_mdwd_FinancialIncomeAndExpenses_1111"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinancingExpensesAbstract" xlink:label="loc_mdwd_FinancingExpensesAbstract_1112"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinancingExpensesAbstract" xlink:label="loc_mdwd_FinancingExpensesAbstract_1113"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinancingIncomeAbstract" xlink:label="loc_mdwd_FinancingIncomeAbstract_1114"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinancingIncomeAbstract" xlink:label="loc_mdwd_FinancingIncomeAbstract_1115"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinancingIncomeOnNetInvestmentInLease" xlink:label="loc_mdwd_FinancingIncomeOnNetInvestmentInLease_1116"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinancingIncomeOnNetInvestmentInLease" xlink:label="loc_mdwd_FinancingIncomeOnNetInvestmentInLease_1117"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinancingIncomeOnNetInvestmentInLease" xlink:label="loc_mdwd_FinancingIncomeOnNetInvestmentInLease_1118"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FivePercentageDecreaseInExchangeRateMember" xlink:label="loc_mdwd_FivePercentageDecreaseInExchangeRateMember_1119"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FivePercentageDecreaseInExchangeRateMember" xlink:label="loc_mdwd_FivePercentageDecreaseInExchangeRateMember_1120"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FivePercentageDecreaseInExchangeRateMember" xlink:label="loc_mdwd_FivePercentageDecreaseInExchangeRateMember_1121"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FivePercentageIncreaseInExchangeRateMember" xlink:label="loc_mdwd_FivePercentageIncreaseInExchangeRateMember_1122"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FivePercentageIncreaseInExchangeRateMember" xlink:label="loc_mdwd_FivePercentageIncreaseInExchangeRateMember_1123"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FivePercentageIncreaseInExchangeRateMember" xlink:label="loc_mdwd_FivePercentageIncreaseInExchangeRateMember_1124"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ForDevelopmentCostsOfNexoBridMember" xlink:label="loc_mdwd_ForDevelopmentCostsOfNexoBridMember_1125"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ForDevelopmentCostsOfNexoBridMember" xlink:label="loc_mdwd_ForDevelopmentCostsOfNexoBridMember_1126"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ForDevelopmentCostsOfNexoBridMember" xlink:label="loc_mdwd_ForDevelopmentCostsOfNexoBridMember_1127"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FormerShareholder" xlink:label="loc_mdwd_FormerShareholder_1128"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FormerShareholder" xlink:label="loc_mdwd_FormerShareholder_1129"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FormerShareholder" xlink:label="loc_mdwd_FormerShareholder_1130"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FundingByBardaPolicyTextBlock" xlink:label="loc_mdwd_FundingByBardaPolicyTextBlock_1131"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FundingByBardaPolicyTextBlock" xlink:label="loc_mdwd_FundingByBardaPolicyTextBlock_1132"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FundingByBardaPolicyTextBlock" xlink:label="loc_mdwd_FundingByBardaPolicyTextBlock_1133"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FutureRoyaltyPaymentsMember" xlink:label="loc_mdwd_FutureRoyaltyPaymentsMember_1134"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_GeneralAndAdministrativeExpensesMember" xlink:label="loc_mdwd_GeneralAndAdministrativeExpensesMember_1135"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_GeneralAndAdministrativeExpensesMember" xlink:label="loc_mdwd_GeneralAndAdministrativeExpensesMember_1136"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_GeneralAndAdministrativeExpensesMember" xlink:label="loc_mdwd_GeneralAndAdministrativeExpensesMember_1137"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_GrantsReceived" xlink:label="loc_mdwd_GrantsReceived_1138"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_GrantsReceived" xlink:label="loc_mdwd_GrantsReceived_1139"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_GrantsReceivedNetOfRoyalties" xlink:label="loc_mdwd_GrantsReceivedNetOfRoyalties_1140"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_GrantsReceivedNetOfRoyalties" xlink:label="loc_mdwd_GrantsReceivedNetOfRoyalties_1141"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_GrossProceedsFromPublicAndPrivateOfferings" xlink:label="loc_mdwd_GrossProceedsFromPublicAndPrivateOfferings_1142"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_GrossProceedsFromPublicAndPrivateOfferings" xlink:label="loc_mdwd_GrossProceedsFromPublicAndPrivateOfferings_1143"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_GrossProceedsFromPublicAndPrivateOfferings" xlink:label="loc_mdwd_GrossProceedsFromPublicAndPrivateOfferings_1144"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_GrossProceedsFromPublicAndPrivateOfferings" xlink:label="loc_mdwd_GrossProceedsFromPublicAndPrivateOfferings_1145"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_GrossProceedsFromPublicAndPrivateOfferings" xlink:label="loc_mdwd_GrossProceedsFromPublicAndPrivateOfferings_1146"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncomeReceivablesLongTerm" xlink:label="loc_mdwd_IncomeReceivablesLongTerm_1147"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncomeReceivablesLongTerm" xlink:label="loc_mdwd_IncomeReceivablesLongTerm_1148"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncomeReceivablesLongTerm" xlink:label="loc_mdwd_IncomeReceivablesLongTerm_1149"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncomeReceivablesShortTerm" xlink:label="loc_mdwd_IncomeReceivablesShortTerm_1150"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncomeReceivablesShortTerm" xlink:label="loc_mdwd_IncomeReceivablesShortTerm_1151"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncomeReceivablesShortTerm" xlink:label="loc_mdwd_IncomeReceivablesShortTerm_1152"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncomingCEOAndChairmanMember" xlink:label="loc_mdwd_IncomingCEOAndChairmanMember_1153"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncomingCEOAndChairmanMember" xlink:label="loc_mdwd_IncomingCEOAndChairmanMember_1154"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncomingCEOAndChairmanMember" xlink:label="loc_mdwd_IncomingCEOAndChairmanMember_1155"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncomingCFOMember" xlink:label="loc_mdwd_IncomingCFOMember_1156"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncomingCFOMember" xlink:label="loc_mdwd_IncomingCFOMember_1157"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncomingCFOMember" xlink:label="loc_mdwd_IncomingCFOMember_1158"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits" xlink:label="loc_mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits_1159"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits" xlink:label="loc_mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits_1160"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits" xlink:label="loc_mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits_1161"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncreaseInAuthorizedShareCapital" xlink:label="loc_mdwd_IncreaseInAuthorizedShareCapital_1162"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncreaseInAuthorizedShareCapital" xlink:label="loc_mdwd_IncreaseInAuthorizedShareCapital_1163"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncreaseInPreFundedWarrantsExercisePrice" xlink:label="loc_mdwd_IncreaseInPreFundedWarrantsExercisePrice_1164"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncreaseInPreFundedWarrantsExercisePrice" xlink:label="loc_mdwd_IncreaseInPreFundedWarrantsExercisePrice_1165"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncreaseInPreFundedWarrantsExercisePrice" xlink:label="loc_mdwd_IncreaseInPreFundedWarrantsExercisePrice_1166"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncreaseInSharesIssued" xlink:label="loc_mdwd_IncreaseInSharesIssued_1167"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncreaseInSharesIssued" xlink:label="loc_mdwd_IncreaseInSharesIssued_1168"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_InitialInvestment" xlink:label="loc_mdwd_InitialInvestment_1169"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_InitialInvestment" xlink:label="loc_mdwd_InitialInvestment_1170"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_InterestRateForLoanMember" xlink:label="loc_mdwd_InterestRateForLoanMember_1171"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_InterestRateForLoanMember" xlink:label="loc_mdwd_InterestRateForLoanMember_1172"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_InterestRateForLoanMember" xlink:label="loc_mdwd_InterestRateForLoanMember_1173"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IsraeliShareOptionPlanMember" xlink:label="loc_mdwd_IsraeliShareOptionPlanMember_1174"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IsraeliShareOptionPlanMember" xlink:label="loc_mdwd_IsraeliShareOptionPlanMember_1175"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IsraeliShareOptionPlanMember" xlink:label="loc_mdwd_IsraeliShareOptionPlanMember_1176"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IsraelMember" xlink:label="loc_mdwd_IsraelMember_1177"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss" xlink:label="loc_mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss_1178"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss" xlink:label="loc_mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss_1179"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss" xlink:label="loc_mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss_1180"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_KeyOfficerMember" xlink:label="loc_mdwd_KeyOfficerMember_1181"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_KeyOfficerMember" xlink:label="loc_mdwd_KeyOfficerMember_1182"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_KeyOfficerMember" xlink:label="loc_mdwd_KeyOfficerMember_1183"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_KostForerGabbayAndKasiererMember" xlink:label="loc_mdwd_KostForerGabbayAndKasiererMember_1184"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_KostForerGabbayAndKasiererMember" xlink:label="loc_mdwd_KostForerGabbayAndKasiererMember_1185"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_KostForerGabbayAndKasiererMember" xlink:label="loc_mdwd_KostForerGabbayAndKasiererMember_1186"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_KpmgInternationalLimitedMember" xlink:label="loc_mdwd_KpmgInternationalLimitedMember_1187"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_KpmgInternationalLimitedMember" xlink:label="loc_mdwd_KpmgInternationalLimitedMember_1188"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_KpmgInternationalLimitedMember" xlink:label="loc_mdwd_KpmgInternationalLimitedMember_1189"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LaterThanTwoYearAndNotLaterThanEightYearsMember" xlink:label="loc_mdwd_LaterThanTwoYearAndNotLaterThanEightYearsMember_1190"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LaterThanTwoYearAndNotLaterThanEightYearsMember" xlink:label="loc_mdwd_LaterThanTwoYearAndNotLaterThanEightYearsMember_1191"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LaterThanTwoYearAndNotLaterThanEightYearsMember" xlink:label="loc_mdwd_LaterThanTwoYearAndNotLaterThanEightYearsMember_1192"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember" xlink:label="loc_mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember_1193"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember" xlink:label="loc_mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember_1194"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember" xlink:label="loc_mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember_1195"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LeasesAbstract" xlink:label="loc_mdwd_LeasesAbstract_1196"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LeasesAbstract" xlink:label="loc_mdwd_LeasesAbstract_1197"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LeasesAbstract" xlink:label="loc_mdwd_LeasesAbstract_1198"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_LiabilitiesInRespectOfGrants_1199"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_LiabilitiesInRespectOfGrants_1200"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_LiabilitiesInRespectOfGrants_1201"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilitiesInRespectOfPurchaseOfShares" xlink:label="loc_mdwd_LiabilitiesInRespectOfPurchaseOfShares_1202"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilitiesInRespectOfPurchaseOfShares" xlink:label="loc_mdwd_LiabilitiesInRespectOfPurchaseOfShares_1203"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilitiesInRespectOfPurchaseOfShares" xlink:label="loc_mdwd_LiabilitiesInRespectOfPurchaseOfShares_1204"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilitiesInRespectOfTeva" xlink:label="loc_mdwd_LiabilitiesInRespectOfTeva_1205"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilitiesInRespectOfTeva" xlink:label="loc_mdwd_LiabilitiesInRespectOfTeva_1206"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilitiesInRespectOfTeva" xlink:label="loc_mdwd_LiabilitiesInRespectOfTeva_1207"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilityInRespectForPurchaseOfShares" xlink:label="loc_mdwd_LiabilityInRespectForPurchaseOfShares_1208"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilityInRespectForPurchaseOfShares" xlink:label="loc_mdwd_LiabilityInRespectForPurchaseOfShares_1209"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilityInRespectForPurchaseOfShares" xlink:label="loc_mdwd_LiabilityInRespectForPurchaseOfShares_1210"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities" xlink:label="loc_mdwd_LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities_1211"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities" xlink:label="loc_mdwd_LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities_1212"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities" xlink:label="loc_mdwd_LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities_1213"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LicenseAgreementWithVericelMember" xlink:label="loc_mdwd_LicenseAgreementWithVericelMember_1214"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LicenseAgreementWithVericelMember" xlink:label="loc_mdwd_LicenseAgreementWithVericelMember_1215"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LicenseForPolyhealProductsMember" xlink:label="loc_mdwd_LicenseForPolyhealProductsMember_1216"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LicenseForPolyhealProductsMember" xlink:label="loc_mdwd_LicenseForPolyhealProductsMember_1217"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LimitOfBenefitEntitlementPeriod" xlink:label="loc_mdwd_LimitOfBenefitEntitlementPeriod_1218"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LimitOfBenefitEntitlementPeriod" xlink:label="loc_mdwd_LimitOfBenefitEntitlementPeriod_1219"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LossFromWarrantsTransactions" xlink:label="loc_mdwd_LossFromWarrantsTransactions_1220"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LossFromWarrantsTransactions" xlink:label="loc_mdwd_LossFromWarrantsTransactions_1221"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LossFromWarrantsTransactions" xlink:label="loc_mdwd_LossFromWarrantsTransactions_1222"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_MarketingAndSalesExpense" xlink:label="loc_mdwd_MarketingAndSalesExpense_1223"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_MarketingAndSalesExpense" xlink:label="loc_mdwd_MarketingAndSalesExpense_1224"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_MarketingAndSalesExpense" xlink:label="loc_mdwd_MarketingAndSalesExpense_1225"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_MaximumAggregateRoyaltiesPaidInPercentage" xlink:label="loc_mdwd_MaximumAggregateRoyaltiesPaidInPercentage_1226"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_MaximumAggregateRoyaltiesPaidInPercentage" xlink:label="loc_mdwd_MaximumAggregateRoyaltiesPaidInPercentage_1227"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ModifiedContractAmount" xlink:label="loc_mdwd_ModifiedContractAmount_1228"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ModifiedContractAmount" xlink:label="loc_mdwd_ModifiedContractAmount_1229"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_MtecMember" xlink:label="loc_mdwd_MtecMember_1230"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_MtecMember" xlink:label="loc_mdwd_MtecMember_1231"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_MtecMember" xlink:label="loc_mdwd_MtecMember_1232"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NetProceedsFromOfferingAmount" xlink:label="loc_mdwd_NetProceedsFromOfferingAmount_1233"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NetProceedsFromOfferingAmount" xlink:label="loc_mdwd_NetProceedsFromOfferingAmount_1234"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NetProceedsFromOfferingAmount" xlink:label="loc_mdwd_NetProceedsFromOfferingAmount_1235"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NewFinanceLeaseObligationRecognized" xlink:label="loc_mdwd_NewFinanceLeaseObligationRecognized_1236"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NewFinanceLeaseObligationRecognized" xlink:label="loc_mdwd_NewFinanceLeaseObligationRecognized_1237"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NewPolyHealSettlementAgreementsMember" xlink:label="loc_mdwd_NewPolyHealSettlementAgreementsMember_1238"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NewPolyHealSettlementAgreementsMember" xlink:label="loc_mdwd_NewPolyHealSettlementAgreementsMember_1239"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NewPolyHealSettlementAgreementsMember" xlink:label="loc_mdwd_NewPolyHealSettlementAgreementsMember_1240"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NexoBridMember" xlink:label="loc_mdwd_NexoBridMember_1241"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NexoBridMember" xlink:label="loc_mdwd_NexoBridMember_1242"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NexoBridMember" xlink:label="loc_mdwd_NexoBridMember_1243"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NoncancelableLeasePeriods" xlink:label="loc_mdwd_NoncancelableLeasePeriods_1244"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NoncancelableLeasePeriods" xlink:label="loc_mdwd_NoncancelableLeasePeriods_1245"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NonCashTransactionsAbstract" xlink:label="loc_mdwd_NonCashTransactionsAbstract_1246"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NonCashTransactionsAbstract" xlink:label="loc_mdwd_NonCashTransactionsAbstract_1247"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NonCurrentLiabilitiesCurrent" xlink:label="loc_mdwd_NonCurrentLiabilitiesCurrent_1248"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NonCurrentLiabilitiesCurrent" xlink:label="loc_mdwd_NonCurrentLiabilitiesCurrent_1249"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NonCurrentLiabilitiesCurrent" xlink:label="loc_mdwd_NonCurrentLiabilitiesCurrent_1250"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberAbstract" xlink:label="loc_mdwd_NumberAbstract_1251"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberAbstract" xlink:label="loc_mdwd_NumberAbstract_1252"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfDirectors" xlink:label="loc_mdwd_NumberOfDirectors_1253"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfDirectors" xlink:label="loc_mdwd_NumberOfDirectors_1254"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfDirectors" xlink:label="loc_mdwd_NumberOfDirectors_1255"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfOrdinarySharesIssuable" xlink:label="loc_mdwd_NumberOfOrdinarySharesIssuable_1256"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfOrdinarySharesIssuable" xlink:label="loc_mdwd_NumberOfOrdinarySharesIssuable_1257"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfOrdinarySharesIssuable" xlink:label="loc_mdwd_NumberOfOrdinarySharesIssuable_1258"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfPreFundedWarrantsExercised" xlink:label="loc_mdwd_NumberOfPreFundedWarrantsExercised_1259"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfPreFundedWarrantsExercised" xlink:label="loc_mdwd_NumberOfPreFundedWarrantsExercised_1260"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfPreFundedWarrantsExercised" xlink:label="loc_mdwd_NumberOfPreFundedWarrantsExercised_1261"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfRestrictedShareUnitIssued" xlink:label="loc_mdwd_NumberOfRestrictedShareUnitIssued_1262"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfRestrictedShareUnitIssued" xlink:label="loc_mdwd_NumberOfRestrictedShareUnitIssued_1263"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfRestrictedShareUnitIssued" xlink:label="loc_mdwd_NumberOfRestrictedShareUnitIssued_1264"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfSharesExerciseRestrictedStockUnits" xlink:label="loc_mdwd_NumberOfSharesExerciseRestrictedStockUnits_1265"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfSharesExerciseRestrictedStockUnits" xlink:label="loc_mdwd_NumberOfSharesExerciseRestrictedStockUnits_1266"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfSharesExerciseRestrictedStockUnits" xlink:label="loc_mdwd_NumberOfSharesExerciseRestrictedStockUnits_1267"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfSharesRepurchased" xlink:label="loc_mdwd_NumberOfSharesRepurchased_1268"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfSharesRepurchased" xlink:label="loc_mdwd_NumberOfSharesRepurchased_1269"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare" xlink:label="loc_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_1270"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare" xlink:label="loc_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_1271"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare" xlink:label="loc_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_1272"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfVehiclesInOperatingLeaseArrangements" xlink:label="loc_mdwd_NumberOfVehiclesInOperatingLeaseArrangements_1273"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfVehiclesInOperatingLeaseArrangements" xlink:label="loc_mdwd_NumberOfVehiclesInOperatingLeaseArrangements_1274"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfWarrantsIssued" xlink:label="loc_mdwd_NumberOfWarrantsIssued_1275"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfWarrantsIssued" xlink:label="loc_mdwd_NumberOfWarrantsIssued_1276"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfWarrantsIssued" xlink:label="loc_mdwd_NumberOfWarrantsIssued_1277"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OneTimeLumpsumAmount" xlink:label="loc_mdwd_OneTimeLumpsumAmount_1278"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OneTimeLumpsumAmount" xlink:label="loc_mdwd_OneTimeLumpsumAmount_1279"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OneTimeLumpsumAmount" xlink:label="loc_mdwd_OneTimeLumpsumAmount_1280"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherCountriesMember" xlink:label="loc_mdwd_OtherCountriesMember_1281"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherCountriesMember" xlink:label="loc_mdwd_OtherCountriesMember_1282"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherCountriesMember" xlink:label="loc_mdwd_OtherCountriesMember_1283"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherCurrentPayable" xlink:label="loc_mdwd_OtherCurrentPayable_1284"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherCurrentPayable" xlink:label="loc_mdwd_OtherCurrentPayable_1285"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherCurrentPayable" xlink:label="loc_mdwd_OtherCurrentPayable_1286"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherCustomerContributedMember" xlink:label="loc_mdwd_OtherCustomerContributedMember_1287"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherCustomerContributedMember" xlink:label="loc_mdwd_OtherCustomerContributedMember_1288"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherCustomerContributedMember" xlink:label="loc_mdwd_OtherCustomerContributedMember_1289"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherReceivablesDiscontinuedOperations" xlink:label="loc_mdwd_OtherReceivablesDiscontinuedOperations_1290"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherReceivablesDiscontinuedOperations" xlink:label="loc_mdwd_OtherReceivablesDiscontinuedOperations_1291"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherResearchAndDevelopmentExpenses" xlink:label="loc_mdwd_OtherResearchAndDevelopmentExpenses_1292"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherResearchAndDevelopmentExpenses" xlink:label="loc_mdwd_OtherResearchAndDevelopmentExpenses_1293"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherSellingGeneralAndAdministrativeExpenses" xlink:label="loc_mdwd_OtherSellingGeneralAndAdministrativeExpenses_1294"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherSellingGeneralAndAdministrativeExpenses" xlink:label="loc_mdwd_OtherSellingGeneralAndAdministrativeExpenses_1295"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherSellingGeneralAndAdministrativeExpenses" xlink:label="loc_mdwd_OtherSellingGeneralAndAdministrativeExpenses_1296"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses" xlink:label="loc_mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses_1297"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses" xlink:label="loc_mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses_1298"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses" xlink:label="loc_mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses_1299"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ParticipationsAbstract" xlink:label="loc_mdwd_ParticipationsAbstract_1300"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ParticipationsAbstract" xlink:label="loc_mdwd_ParticipationsAbstract_1301"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PatentMember" xlink:label="loc_mdwd_PatentMember_1302"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PatentMember" xlink:label="loc_mdwd_PatentMember_1303"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PatentMember" xlink:label="loc_mdwd_PatentMember_1304"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PercentageOfFutureRoyaltyPayments" xlink:label="loc_mdwd_PercentageOfFutureRoyaltyPayments_1305"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PercentageOfFutureRoyaltyPayments" xlink:label="loc_mdwd_PercentageOfFutureRoyaltyPayments_1306"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans" xlink:label="loc_mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans_1307"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans" xlink:label="loc_mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans_1308"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans" xlink:label="loc_mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans_1309"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PercentageOfOneTimeLumpSumPaymentAmount" xlink:label="loc_mdwd_PercentageOfOneTimeLumpSumPaymentAmount_1310"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PercentageOfOneTimeLumpSumPaymentAmount" xlink:label="loc_mdwd_PercentageOfOneTimeLumpSumPaymentAmount_1311"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PercentageOfOneTimeLumpSumPaymentAmount" xlink:label="loc_mdwd_PercentageOfOneTimeLumpSumPaymentAmount_1312"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts" xlink:label="loc_mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_1313"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts" xlink:label="loc_mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_1314"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PeriodOfBankDeposits" xlink:label="loc_mdwd_PeriodOfBankDeposits_1315"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PeriodOfBankDeposits" xlink:label="loc_mdwd_PeriodOfBankDeposits_1316"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts" xlink:label="loc_mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_1317"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts" xlink:label="loc_mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_1318"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PeriodOfVehiclesOperatingLeaseArrangements" xlink:label="loc_mdwd_PeriodOfVehiclesOperatingLeaseArrangements_1319"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PeriodOfVehiclesOperatingLeaseArrangements" xlink:label="loc_mdwd_PeriodOfVehiclesOperatingLeaseArrangements_1320"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PolyhealLtdMember" xlink:label="loc_mdwd_PolyhealLtdMember_1321"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PolyhealLtdMember" xlink:label="loc_mdwd_PolyhealLtdMember_1322"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PolyhealMember" xlink:label="loc_mdwd_PolyhealMember_1323"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PolyhealMember" xlink:label="loc_mdwd_PolyhealMember_1324"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PolyhealSettlementAgreementsMember" xlink:label="loc_mdwd_PolyhealSettlementAgreementsMember_1325"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PolyhealSettlementAgreementsMember" xlink:label="loc_mdwd_PolyhealSettlementAgreementsMember_1326"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PrepaidExpensesLongTerm" xlink:label="loc_mdwd_PrepaidExpensesLongTerm_1327"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PrepaidExpensesLongTerm" xlink:label="loc_mdwd_PrepaidExpensesLongTerm_1328"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PrepaidExpensesLongTerm" xlink:label="loc_mdwd_PrepaidExpensesLongTerm_1329"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent" xlink:label="loc_mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent_1330"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent" xlink:label="loc_mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent_1331"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent" xlink:label="loc_mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent_1332"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PricePerShareOfSharesIssued" xlink:label="loc_mdwd_PricePerShareOfSharesIssued_1333"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PricePerShareOfSharesIssued" xlink:label="loc_mdwd_PricePerShareOfSharesIssued_1334"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PricePerShareOfSharesIssued" xlink:label="loc_mdwd_PricePerShareOfSharesIssued_1335"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PrivateIssuancePurchaseEquityAgreementMember" xlink:label="loc_mdwd_PrivateIssuancePurchaseEquityAgreementMember_1336"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PrivateIssuancePurchaseEquityAgreementMember" xlink:label="loc_mdwd_PrivateIssuancePurchaseEquityAgreementMember_1337"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromAdditionalFunding" xlink:label="loc_mdwd_ProceedsFromAdditionalFunding_1338"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromAdditionalFunding" xlink:label="loc_mdwd_ProceedsFromAdditionalFunding_1339"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromAdditionalFunding" xlink:label="loc_mdwd_ProceedsFromAdditionalFunding_1340"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromAdditionalFunding" xlink:label="loc_mdwd_ProceedsFromAdditionalFunding_1341"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromAdditionalProcurement" xlink:label="loc_mdwd_ProceedsFromAdditionalProcurement_1342"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromAdditionalProcurement" xlink:label="loc_mdwd_ProceedsFromAdditionalProcurement_1343"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromAdditionalProcurement" xlink:label="loc_mdwd_ProceedsFromAdditionalProcurement_1344"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromFunding" xlink:label="loc_mdwd_ProceedsFromFunding_1345"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromFunding" xlink:label="loc_mdwd_ProceedsFromFunding_1346"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromFunding" xlink:label="loc_mdwd_ProceedsFromFunding_1347"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromFunding" xlink:label="loc_mdwd_ProceedsFromFunding_1348"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet" xlink:label="loc_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_1349"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet" xlink:label="loc_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_1350"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet" xlink:label="loc_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_1351"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet" xlink:label="loc_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_1352"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet" xlink:label="loc_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_1353"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromIssuingAdditionalShares" xlink:label="loc_mdwd_ProceedsFromIssuingAdditionalShares_1354"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromIssuingAdditionalShares" xlink:label="loc_mdwd_ProceedsFromIssuingAdditionalShares_1355"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromIssuingAdditionalShares" xlink:label="loc_mdwd_ProceedsFromIssuingAdditionalShares_1356"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromProcurement" xlink:label="loc_mdwd_ProceedsFromProcurement_1357"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromProcurement" xlink:label="loc_mdwd_ProceedsFromProcurement_1358"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromProcurement" xlink:label="loc_mdwd_ProceedsFromProcurement_1359"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromRepaymentsOfGrants" xlink:label="loc_mdwd_ProceedsFromRepaymentsOfGrants_1360"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromRepaymentsOfGrants" xlink:label="loc_mdwd_ProceedsFromRepaymentsOfGrants_1361"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromRepaymentsOfGrants" xlink:label="loc_mdwd_ProceedsFromRepaymentsOfGrants_1362"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProfessionalFeeAndShareBasedCompensationExpenses" xlink:label="loc_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses_1363"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProfessionalFeeAndShareBasedCompensationExpenses" xlink:label="loc_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses_1364"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProfessionalFeeAndShareBasedCompensationExpenses" xlink:label="loc_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses_1365"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProfessionalFeeAndShareBasedCompensationExpenses" xlink:label="loc_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses_1366"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProvisionForImpairment" xlink:label="loc_mdwd_ProvisionForImpairment_1367"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProvisionForImpairment" xlink:label="loc_mdwd_ProvisionForImpairment_1368"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProvisionForImpairment" xlink:label="loc_mdwd_ProvisionForImpairment_1369"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProvisionForImpairment" xlink:label="loc_mdwd_ProvisionForImpairment_1370"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PurchaseOfPropertyAndEquipment" xlink:label="loc_mdwd_PurchaseOfPropertyAndEquipment_1371"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PurchaseOfPropertyAndEquipment" xlink:label="loc_mdwd_PurchaseOfPropertyAndEquipment_1372"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PurchaseOfPropertyAndEquipment" xlink:label="loc_mdwd_PurchaseOfPropertyAndEquipment_1373"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PurchasePriceForResidualNumberOfShares" xlink:label="loc_mdwd_PurchasePriceForResidualNumberOfShares_1374"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PurchasePriceForResidualNumberOfShares" xlink:label="loc_mdwd_PurchasePriceForResidualNumberOfShares_1375"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PurchasePriceOfRegisteredDirectOffering" xlink:label="loc_mdwd_PurchasePriceOfRegisteredDirectOffering_1376"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PurchasePriceOfRegisteredDirectOffering" xlink:label="loc_mdwd_PurchasePriceOfRegisteredDirectOffering_1377"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PurchasePriceOfRegisteredDirectOffering" xlink:label="loc_mdwd_PurchasePriceOfRegisteredDirectOffering_1378"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesEightMember" xlink:label="loc_mdwd_RangesOfExercisePricesEightMember_1379"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesEightMember" xlink:label="loc_mdwd_RangesOfExercisePricesEightMember_1380"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesEightMember" xlink:label="loc_mdwd_RangesOfExercisePricesEightMember_1381"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesFiveMember" xlink:label="loc_mdwd_RangesOfExercisePricesFiveMember_1382"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesFiveMember" xlink:label="loc_mdwd_RangesOfExercisePricesFiveMember_1383"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesFiveMember" xlink:label="loc_mdwd_RangesOfExercisePricesFiveMember_1384"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesFourMember" xlink:label="loc_mdwd_RangesOfExercisePricesFourMember_1385"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesFourMember" xlink:label="loc_mdwd_RangesOfExercisePricesFourMember_1386"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesFourMember" xlink:label="loc_mdwd_RangesOfExercisePricesFourMember_1387"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesOneMember" xlink:label="loc_mdwd_RangesOfExercisePricesOneMember_1388"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesOneMember" xlink:label="loc_mdwd_RangesOfExercisePricesOneMember_1389"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesOneMember" xlink:label="loc_mdwd_RangesOfExercisePricesOneMember_1390"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesServenMember" xlink:label="loc_mdwd_RangesOfExercisePricesServenMember_1391"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesServenMember" xlink:label="loc_mdwd_RangesOfExercisePricesServenMember_1392"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesServenMember" xlink:label="loc_mdwd_RangesOfExercisePricesServenMember_1393"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesSixMember" xlink:label="loc_mdwd_RangesOfExercisePricesSixMember_1394"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesSixMember" xlink:label="loc_mdwd_RangesOfExercisePricesSixMember_1395"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesSixMember" xlink:label="loc_mdwd_RangesOfExercisePricesSixMember_1396"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesThreeMember" xlink:label="loc_mdwd_RangesOfExercisePricesThreeMember_1397"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesThreeMember" xlink:label="loc_mdwd_RangesOfExercisePricesThreeMember_1398"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesThreeMember" xlink:label="loc_mdwd_RangesOfExercisePricesThreeMember_1399"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesTwoMember" xlink:label="loc_mdwd_RangesOfExercisePricesTwoMember_1400"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesTwoMember" xlink:label="loc_mdwd_RangesOfExercisePricesTwoMember_1401"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesTwoMember" xlink:label="loc_mdwd_RangesOfExercisePricesTwoMember_1402"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ReceivableFromBarda" xlink:label="loc_mdwd_ReceivableFromBarda_1403"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ReceivableFromBarda" xlink:label="loc_mdwd_ReceivableFromBarda_1404"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ReceivableFromBarda" xlink:label="loc_mdwd_ReceivableFromBarda_1405"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ReducedAggregateAmount" xlink:label="loc_mdwd_ReducedAggregateAmount_1406"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ReducedAggregateAmount" xlink:label="loc_mdwd_ReducedAggregateAmount_1407"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ReducedRateOfPayments" xlink:label="loc_mdwd_ReducedRateOfPayments_1408"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ReducedRateOfPayments" xlink:label="loc_mdwd_ReducedRateOfPayments_1409"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RegistrationAndMarketingLicenseFees" xlink:label="loc_mdwd_RegistrationAndMarketingLicenseFees_1410"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RegistrationAndMarketingLicenseFees" xlink:label="loc_mdwd_RegistrationAndMarketingLicenseFees_1411"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RelatedPartiesRentaLexpenseAndOther" xlink:label="loc_mdwd_RelatedPartiesRentaLexpenseAndOther_1412"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RelatedPartiesRentaLexpenseAndOther" xlink:label="loc_mdwd_RelatedPartiesRentaLexpenseAndOther_1413"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RepaymentOfLiabilitiesInRespectOfTeva" xlink:label="loc_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_1414"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RepaymentOfLiabilitiesInRespectOfTeva" xlink:label="loc_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_1415"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RepaymentOfLiabilitiesInRespectOfTeva" xlink:label="loc_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_1416"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RepaymentsOfIiaGrantsNet" xlink:label="loc_mdwd_RepaymentsOfIiaGrantsNet_1417"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RepaymentsOfIiaGrantsNet" xlink:label="loc_mdwd_RepaymentsOfIiaGrantsNet_1418"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RepaymentsOfIiaGrantsNet" xlink:label="loc_mdwd_RepaymentsOfIiaGrantsNet_1419"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ResearchAndDevelopmentExpenseGross" xlink:label="loc_mdwd_ResearchAndDevelopmentExpenseGross_1420"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ResearchAndDevelopmentExpenseGross" xlink:label="loc_mdwd_ResearchAndDevelopmentExpenseGross_1421"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ResearchAndDevelopmentExpenseGross" xlink:label="loc_mdwd_ResearchAndDevelopmentExpenseGross_1422"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ResearchAndDevelopmentExpensesMember" xlink:label="loc_mdwd_ResearchAndDevelopmentExpensesMember_1423"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ResearchAndDevelopmentExpensesMember" xlink:label="loc_mdwd_ResearchAndDevelopmentExpensesMember_1424"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ResearchAndDevelopmentExpensesMember" xlink:label="loc_mdwd_ResearchAndDevelopmentExpensesMember_1425"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ResearchAndDevelopmentLawMember" xlink:label="loc_mdwd_ResearchAndDevelopmentLawMember_1426"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ResearchAndDevelopmentLawMember" xlink:label="loc_mdwd_ResearchAndDevelopmentLawMember_1427"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ResearchAndDevelopmentLawMember" xlink:label="loc_mdwd_ResearchAndDevelopmentLawMember_1428"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RestrictedBankDepositsLongTerm" xlink:label="loc_mdwd_RestrictedBankDepositsLongTerm_1429"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RestrictedBankDepositsLongTerm" xlink:label="loc_mdwd_RestrictedBankDepositsLongTerm_1430"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RestrictedBankDepositsLongTerm" xlink:label="loc_mdwd_RestrictedBankDepositsLongTerm_1431"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RestrictedSharesUnitsMember" xlink:label="loc_mdwd_RestrictedSharesUnitsMember_1432"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RestrictedSharesUnitsMember" xlink:label="loc_mdwd_RestrictedSharesUnitsMember_1433"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RestrictedSharesUnitsMember" xlink:label="loc_mdwd_RestrictedSharesUnitsMember_1434"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLeaseLiabilities" xlink:label="loc_mdwd_RevaluationOfLeaseLiabilities_1435"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLeaseLiabilities" xlink:label="loc_mdwd_RevaluationOfLeaseLiabilities_1436"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLeaseLiabilities" xlink:label="loc_mdwd_RevaluationOfLeaseLiabilities_1437"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_1438"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_1439"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_1440"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_1441"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_1442"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfIfrsSixteen" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIfrsSixteen_1443"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfIfrsSixteen" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIfrsSixteen_1444"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfIfrsSixteen" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIfrsSixteen_1445"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants_1446"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants_1447"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants_1448"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants_1449"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant_1450"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant_1451"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant_1452"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfPurchaseOfShares" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfPurchaseOfShares_1453"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfPurchaseOfShares" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfPurchaseOfShares_1454"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares_1455"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares_1456"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares_1457"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfWarrant" xlink:label="loc_mdwd_RevaluationOfWarrant_1458"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfWarrant" xlink:label="loc_mdwd_RevaluationOfWarrant_1459"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfWarrant" xlink:label="loc_mdwd_RevaluationOfWarrant_1460"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfWarrant" xlink:label="loc_mdwd_RevaluationOfWarrant_1461"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfWarrantsAccountedAtFairValue" xlink:label="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_1462"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfWarrantsAccountedAtFairValue" xlink:label="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_1463"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfWarrantsAccountedAtFairValue" xlink:label="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_1464"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfWarrantsAccountedAtFairValue" xlink:label="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_1465"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevenuesFromDistributionAgreements" xlink:label="loc_mdwd_RevenuesFromDistributionAgreements_1466"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevenuesFromDistributionAgreements" xlink:label="loc_mdwd_RevenuesFromDistributionAgreements_1467"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevenuesFromSaleOfProcurement" xlink:label="loc_mdwd_RevenuesFromSaleOfProcurement_1468"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevenuesFromSaleOfProcurement" xlink:label="loc_mdwd_RevenuesFromSaleOfProcurement_1469"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ReverseStockSplit" xlink:label="loc_mdwd_ReverseStockSplit_1470"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ReverseStockSplit" xlink:label="loc_mdwd_ReverseStockSplit_1471"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ReverseStockSplit" xlink:label="loc_mdwd_ReverseStockSplit_1472"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetDisposals" xlink:label="loc_mdwd_RightOfUseAssetDisposals_1473"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetDisposals" xlink:label="loc_mdwd_RightOfUseAssetDisposals_1474"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetDisposals" xlink:label="loc_mdwd_RightOfUseAssetDisposals_1475"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetDisposals" xlink:label="loc_mdwd_RightOfUseAssetDisposals_1476"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements" xlink:label="loc_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_1477"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements" xlink:label="loc_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_1478"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements" xlink:label="loc_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_1479"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements" xlink:label="loc_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_1480"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetsAccumulatedDepreciation" xlink:label="loc_mdwd_RightOfUseAssetsAccumulatedDepreciation_1481"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetsAccumulatedDepreciation" xlink:label="loc_mdwd_RightOfUseAssetsAccumulatedDepreciation_1482"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetsAccumulatedDepreciation" xlink:label="loc_mdwd_RightOfUseAssetsAccumulatedDepreciation_1483"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetsAccumulatedDepreciation" xlink:label="loc_mdwd_RightOfUseAssetsAccumulatedDepreciation_1484"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract" xlink:label="loc_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract_1485"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract" xlink:label="loc_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract_1486"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetsAccumulatedDepreciationAdditionsDuringYearAbstract" xlink:label="loc_mdwd_RightOfUseAssetsAccumulatedDepreciationAdditionsDuringYearAbstract_1487"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetsAdditionsDuringYearAbstract" xlink:label="loc_mdwd_RightOfUseAssetsAdditionsDuringYearAbstract_1488"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetsCostAbstract" xlink:label="loc_mdwd_RightOfUseAssetsCostAbstract_1489"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetsCostAbstract" xlink:label="loc_mdwd_RightOfUseAssetsCostAbstract_1490"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetsDepreciationAbstract" xlink:label="loc_mdwd_RightOfUseAssetsDepreciationAbstract_1491"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetsDepreciationAbstract" xlink:label="loc_mdwd_RightOfUseAssetsDepreciationAbstract_1492"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RiskFreeInterestRateOfWarrants" xlink:label="loc_mdwd_RiskFreeInterestRateOfWarrants_1493"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RiskFreeInterestRateOfWarrants" xlink:label="loc_mdwd_RiskFreeInterestRateOfWarrants_1494"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RiskFreeInterestRateOfWarrants" xlink:label="loc_mdwd_RiskFreeInterestRateOfWarrants_1495"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RiskFreeRateOfWarrants" xlink:label="loc_mdwd_RiskFreeRateOfWarrants_1496"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RiskFreeRateOfWarrants" xlink:label="loc_mdwd_RiskFreeRateOfWarrants_1497"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RiskFreeRateOfWarrants" xlink:label="loc_mdwd_RiskFreeRateOfWarrants_1498"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RoyaltiesPayments" xlink:label="loc_mdwd_RoyaltiesPayments_1499"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RoyaltiesPayments" xlink:label="loc_mdwd_RoyaltiesPayments_1500"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RoyaltyRightsArisingMember" xlink:label="loc_mdwd_RoyaltyRightsArisingMember_1501"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SalaryAndBenefits" xlink:label="loc_mdwd_SalaryAndBenefits_1502"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SalaryAndBenefits" xlink:label="loc_mdwd_SalaryAndBenefits_1503"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements" xlink:label="loc_mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements_1504"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements" xlink:label="loc_mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements_1505"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements" xlink:label="loc_mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements_1506"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SalaryAndBenefitsIncludingShareBasedCompensation" xlink:label="loc_mdwd_SalaryAndBenefitsIncludingShareBasedCompensation_1507"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SalaryAndBenefitsIncludingShareBasedCompensation" xlink:label="loc_mdwd_SalaryAndBenefitsIncludingShareBasedCompensation_1508"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SalaryAndBenefitsIncludingShareBasedCompensation" xlink:label="loc_mdwd_SalaryAndBenefitsIncludingShareBasedCompensation_1509"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock" xlink:label="loc_mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock_1510"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock" xlink:label="loc_mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock_1511"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock" xlink:label="loc_mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock_1512"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ScheduleOfCostOfRevenuesLicense" xlink:label="loc_mdwd_ScheduleOfCostOfRevenuesLicense_1513"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ScheduleOfCostOfRevenuesLicense" xlink:label="loc_mdwd_ScheduleOfCostOfRevenuesLicense_1514"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ScheduleOfCostOfRevenuesLicense" xlink:label="loc_mdwd_ScheduleOfCostOfRevenuesLicense_1515"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SellingAndMarketingExpensesMember" xlink:label="loc_mdwd_SellingAndMarketingExpensesMember_1516"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SellingAndMarketingExpensesMember" xlink:label="loc_mdwd_SellingAndMarketingExpensesMember_1517"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SellingAndMarketingExpensesMember" xlink:label="loc_mdwd_SellingAndMarketingExpensesMember_1518"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SensitivityAnalysisAxis" xlink:label="loc_mdwd_SensitivityAnalysisAxis_1519"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SensitivityAnalysisAxis" xlink:label="loc_mdwd_SensitivityAnalysisAxis_1520"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SensitivityAnalysisAxis" xlink:label="loc_mdwd_SensitivityAnalysisAxis_1521"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract" xlink:label="loc_mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract_1522"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract" xlink:label="loc_mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract_1523"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SettlementAmountPaidByTeva" xlink:label="loc_mdwd_SettlementAmountPaidByTeva_1524"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SettlementAmountPaidByTeva" xlink:label="loc_mdwd_SettlementAmountPaidByTeva_1525"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ShareholderMember" xlink:label="loc_mdwd_ShareholderMember_1526"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ShareIncentivePlanMember" xlink:label="loc_mdwd_ShareIncentivePlanMember_1527"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ShareIncentivePlanMember" xlink:label="loc_mdwd_ShareIncentivePlanMember_1528"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ShareIncentivePlanMember" xlink:label="loc_mdwd_ShareIncentivePlanMember_1529"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare" xlink:label="loc_mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare_1530"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare" xlink:label="loc_mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare_1531"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare" xlink:label="loc_mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare_1532"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SharesAvailableForFutureGrant" xlink:label="loc_mdwd_SharesAvailableForFutureGrant_1533"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SharesAvailableForFutureGrant" xlink:label="loc_mdwd_SharesAvailableForFutureGrant_1534"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SharesIssuedPriceInInitialPublicOffering" xlink:label="loc_mdwd_SharesIssuedPriceInInitialPublicOffering_1535"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SharesIssuedPriceInInitialPublicOffering" xlink:label="loc_mdwd_SharesIssuedPriceInInitialPublicOffering_1536"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SharesReceivedOfPolyheal" xlink:label="loc_mdwd_SharesReceivedOfPolyheal_1537"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SharesReceivedOfPolyheal" xlink:label="loc_mdwd_SharesReceivedOfPolyheal_1538"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_StockOptionValue" xlink:label="loc_mdwd_StockOptionValue_1539"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_StockOptionValue" xlink:label="loc_mdwd_StockOptionValue_1540"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_StockOptionValue" xlink:label="loc_mdwd_StockOptionValue_1541"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_Subcontractors" xlink:label="loc_mdwd_Subcontractors_1542"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_Subcontractors" xlink:label="loc_mdwd_Subcontractors_1543"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_Subcontractors" xlink:label="loc_mdwd_Subcontractors_1544"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubcontractorsExpenses" xlink:label="loc_mdwd_SubcontractorsExpenses_1545"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubcontractorsExpenses" xlink:label="loc_mdwd_SubcontractorsExpenses_1546"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubcontractorsExpenses" xlink:label="loc_mdwd_SubcontractorsExpenses_1547"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment" xlink:label="loc_mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment_1548"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment" xlink:label="loc_mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment_1549"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment" xlink:label="loc_mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment_1550"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubLicensingOfPatentsMember" xlink:label="loc_mdwd_SubLicensingOfPatentsMember_1551"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubLicensingOfPatentsMember" xlink:label="loc_mdwd_SubLicensingOfPatentsMember_1552"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsequentEventsMember" xlink:label="loc_mdwd_SubsequentEventsMember_1553"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsequentEventsMember" xlink:label="loc_mdwd_SubsequentEventsMember_1554"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseArea" xlink:label="loc_mdwd_SubsidiariesLeaseArea_1555"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseArea" xlink:label="loc_mdwd_SubsidiariesLeaseArea_1556"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseEstimatedUsefulLife" xlink:label="loc_mdwd_SubsidiariesLeaseEstimatedUsefulLife_1557"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseEstimatedUsefulLife" xlink:label="loc_mdwd_SubsidiariesLeaseEstimatedUsefulLife_1558"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseEstimatedUsefulLife" xlink:label="loc_mdwd_SubsidiariesLeaseEstimatedUsefulLife_1559"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseExpirationDate" xlink:label="loc_mdwd_SubsidiariesLeaseExpirationDate_1560"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseExpirationDate" xlink:label="loc_mdwd_SubsidiariesLeaseExpirationDate_1561"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseExpirationDate" xlink:label="loc_mdwd_SubsidiariesLeaseExpirationDate_1562"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseExpirationPeriod" xlink:label="loc_mdwd_SubsidiariesLeaseExpirationPeriod_1563"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseExpirationPeriod" xlink:label="loc_mdwd_SubsidiariesLeaseExpirationPeriod_1564"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseExpirationPeriod" xlink:label="loc_mdwd_SubsidiariesLeaseExpirationPeriod_1565"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseExtentionPeriod" xlink:label="loc_mdwd_SubsidiariesLeaseExtentionPeriod_1566"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseExtentionPeriod" xlink:label="loc_mdwd_SubsidiariesLeaseExtentionPeriod_1567"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseMonthlyRent" xlink:label="loc_mdwd_SubsidiariesLeaseMonthlyRent_1568"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseMonthlyRent" xlink:label="loc_mdwd_SubsidiariesLeaseMonthlyRent_1569"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TermOfLease" xlink:label="loc_mdwd_TermOfLease_1570"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TermOfLease" xlink:label="loc_mdwd_TermOfLease_1571"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TermOfLease" xlink:label="loc_mdwd_TermOfLease_1572"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TevaMember" xlink:label="loc_mdwd_TevaMember_1573"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TevaMember" xlink:label="loc_mdwd_TevaMember_1574"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ThirdPartiesMember" xlink:label="loc_mdwd_ThirdPartiesMember_1575"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ThirdPartiesMember" xlink:label="loc_mdwd_ThirdPartiesMember_1576"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ThirdPartiesMember" xlink:label="loc_mdwd_ThirdPartiesMember_1577"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TotalBasicAndDilutedNetProfitLossPerShare" xlink:label="loc_mdwd_TotalBasicAndDilutedNetProfitLossPerShare_1578"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TotalBasicAndDilutedNetProfitLossPerShare" xlink:label="loc_mdwd_TotalBasicAndDilutedNetProfitLossPerShare_1579"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TotalBasicAndDilutedNetProfitLossPerShare" xlink:label="loc_mdwd_TotalBasicAndDilutedNetProfitLossPerShare_1580"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TotalBasicAndDilutedNetProfitLossPerShare" xlink:label="loc_mdwd_TotalBasicAndDilutedNetProfitLossPerShare_1581"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TotalMember" xlink:label="loc_mdwd_TotalMember_1582"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TotalRoyaltiesPayments" xlink:label="loc_mdwd_TotalRoyaltiesPayments_1583"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TotalRoyaltiesPayments" xlink:label="loc_mdwd_TotalRoyaltiesPayments_1584"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TotalRoyaltiesPayments" xlink:label="loc_mdwd_TotalRoyaltiesPayments_1585"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TradePayablesAndAccruedExpenses" xlink:label="loc_mdwd_TradePayablesAndAccruedExpenses_1586"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TradePayablesAndAccruedExpenses" xlink:label="loc_mdwd_TradePayablesAndAccruedExpenses_1587"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TradePayablesAndAccruedExpenses" xlink:label="loc_mdwd_TradePayablesAndAccruedExpenses_1588"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TransactionOneMember" xlink:label="loc_mdwd_TransactionOneMember_1589"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember" xlink:label="loc_mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember_1590"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember" xlink:label="loc_mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember_1591"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember" xlink:label="loc_mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember_1592"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TwoThousandAndTenPolyHealAgreementMember" xlink:label="loc_mdwd_TwoThousandAndTenPolyHealAgreementMember_1593"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TwoThousandTenPolyhealAgreementMember" xlink:label="loc_mdwd_TwoThousandTenPolyhealAgreementMember_1594"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TwoThousandTenPolyhealAgreementMember" xlink:label="loc_mdwd_TwoThousandTenPolyhealAgreementMember_1595"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UncertaintyInFutureDefaultsMember" xlink:label="loc_mdwd_UncertaintyInFutureDefaultsMember_1596"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UncertaintyInFutureDefaultsMember" xlink:label="loc_mdwd_UncertaintyInFutureDefaultsMember_1597"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UndertookMember" xlink:label="loc_mdwd_UndertookMember_1598"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UnearnedAmountsReceivedFromCustomers" xlink:label="loc_mdwd_UnearnedAmountsReceivedFromCustomers_1599"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UnearnedAmountsReceivedFromCustomers" xlink:label="loc_mdwd_UnearnedAmountsReceivedFromCustomers_1600"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UnearnedAmountsReceivedFromCustomers" xlink:label="loc_mdwd_UnearnedAmountsReceivedFromCustomers_1601"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UnregisteredPreFundedWarrantsIssued" xlink:label="loc_mdwd_UnregisteredPreFundedWarrantsIssued_1602"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UnregisteredPreFundedWarrantsIssued" xlink:label="loc_mdwd_UnregisteredPreFundedWarrantsIssued_1603"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UnregisteredPreFundedWarrantsIssued" xlink:label="loc_mdwd_UnregisteredPreFundedWarrantsIssued_1604"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock" xlink:label="loc_mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock_1605"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock" xlink:label="loc_mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock_1606"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock" xlink:label="loc_mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock_1607"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UpfrontPayment" xlink:label="loc_mdwd_UpfrontPayment_1608"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UpfrontPayment" xlink:label="loc_mdwd_UpfrontPayment_1609"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UsaMember" xlink:label="loc_mdwd_UsaMember_1610"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UsaMember" xlink:label="loc_mdwd_UsaMember_1611"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UsaMember" xlink:label="loc_mdwd_UsaMember_1612"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember" xlink:label="loc_mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember_1613"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember" xlink:label="loc_mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember_1614"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember" xlink:label="loc_mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember_1615"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_USDepartmentOfDefenseMember" xlink:label="loc_mdwd_USDepartmentOfDefenseMember_1616"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_USDepartmentOfDefenseMember" xlink:label="loc_mdwd_USDepartmentOfDefenseMember_1617"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_USDepartmentOfDefenseMember" xlink:label="loc_mdwd_USDepartmentOfDefenseMember_1618"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_VericelMember" xlink:label="loc_mdwd_VericelMember_1619"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_VericelMember" xlink:label="loc_mdwd_VericelMember_1620"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_WarrantsExpirationPeriod" xlink:label="loc_mdwd_WarrantsExpirationPeriod_1621"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_WarrantsExpirationPeriod" xlink:label="loc_mdwd_WarrantsExpirationPeriod_1622"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_WarrantsExpirationPeriod" xlink:label="loc_mdwd_WarrantsExpirationPeriod_1623"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_WarrantsToPurchaseOrdinaryShares" xlink:label="loc_mdwd_WarrantsToPurchaseOrdinaryShares_1624"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_WarrantsToPurchaseOrdinaryShares" xlink:label="loc_mdwd_WarrantsToPurchaseOrdinaryShares_1625"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_WarrantsToPurchaseOrdinaryShares" xlink:label="loc_mdwd_WarrantsToPurchaseOrdinaryShares_1626"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_WeightedAverageExercisePriceAbstract" xlink:label="loc_mdwd_WeightedAverageExercisePriceAbstract_1627"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_WeightedAverageExercisePriceAbstract" xlink:label="loc_mdwd_WeightedAverageExercisePriceAbstract_1628"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_1629"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_1630"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1631"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1632"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1633"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1634"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_DE_0" xml:lang="en-US">Germany [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_ILS_0" xml:lang="en-US">NIS [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_currency_ILS_1" xml:lang="en-US">NIS [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_USD_0" xml:lang="en-US">USD [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_currency_USD_1" xml:lang="en-US">USD [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AddressTypeDomain_0" xml:lang="en-US">Address Type [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag_0" xml:lang="en-US">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorFirmId_0" xml:lang="en-US">Auditor Firm ID</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorLocation_0" xml:lang="en-US">Auditor Location</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorName_0" xml:lang="en-US">Auditor Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_BusinessContactMember_0" xml:lang="en-US">Business Contact [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_dei_BusinessContactMember_1" xml:lang="en-US">Business Contact [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CityAreaCode_0" xml:lang="en-US">City Area Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_ContactPersonnelEmailAddress_0" xml:lang="en-US">Contact Personnel Email Address</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_ContactPersonnelFaxNumber_0" xml:lang="en-US">Contact Personnel Fax Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_ContactPersonnelName_0" xml:lang="en-US">Contact Personnel Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CurrentFiscalYearEndDate_0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentAccountingStandard_0" xml:lang="en-US">Document Accounting Standard</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentAnnualReport_0" xml:lang="en-US">Document Annual Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag_0" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalPeriodFocus_0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalYearFocus_0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentPeriodEndDate_0" xml:lang="en-US">Document Period End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentRegistrationStatement_0" xml:lang="en-US">Document Registration Statement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentShellCompanyReport_0" xml:lang="en-US">Document Shell Company Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentTransitionReport_0" xml:lang="en-US">Document Transition Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType_0" xml:lang="en-US">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine1_0" xml:lang="en-US">Entity Address, Address Line One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCityOrTown_0" xml:lang="en-US">Entity Address, City or Town</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCountry_0" xml:lang="en-US">Entity Address, Country</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressesAddressTypeAxis_0" xml:lang="en-US">Entity Addresses, Address Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressesLineItems_0" xml:lang="en-US">Entity Addresses [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressesTable_0" xml:lang="en-US">Entity Addresses [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressPostalZipCode_0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey_0" xml:lang="en-US">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCurrentReportingStatus_0" xml:lang="en-US">Entity Current Reporting Status</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityDomain_0" xml:lang="en-US">Entity [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityEmergingGrowthCompany_0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFileNumber_0" xml:lang="en-US">Entity File Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFilerCategory_0" xml:lang="en-US">Entity Filer Category</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityIncorporationStateCountryCode_0" xml:lang="en-US">Entity Incorporation State Country Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityInteractiveDataCurrent_0" xml:lang="en-US">Entity Interactive Data Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName_0" xml:lang="en-US">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityShellCompany_0" xml:lang="en-US">Entity Shell Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityVoluntaryFilers_0" xml:lang="en-US">Entity Voluntary Filers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer_0" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_IcfrAuditorAttestationFlag_0" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LegalEntityAxis_0" xml:lang="en-US">Legal Entity [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LocalPhoneNumber_0" xml:lang="en-US">Local Phone Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_Security12bTitle_0" xml:lang="en-US">Title of 12(b) Security</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_SecurityExchangeName_0" xml:lang="en-US">Security Exchange Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_TradingSymbol_0" xml:lang="en-US">Trading Symbol</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_0" xml:lang="en-US">Accumulated Amortization [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_0" xml:lang="en-US">Accumulated Depreciation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_0" xml:lang="en-US">Consideration paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Additions other than through business combinations, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Additions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_0" xml:lang="en-US">Additions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares_0" xml:lang="en-US">Weighted average number of ordinary shares used in calculating diluted earnings per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares_1" xml:lang="en-US">Weighted average number of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares_2" xml:lang="en-US">Number of shares used in calculating diluted loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_0" xml:lang="en-US">Decrease in inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_1" xml:lang="en-US">Decrease (increase) in inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_0" xml:lang="en-US">Decrease (increase) in other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_0" xml:lang="en-US">Decrease (increase) in trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_0" xml:lang="en-US">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AdjustmentsForFinanceIncomeCost_0" xml:lang="en-US">Financial income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForFinanceIncomeCost_1" xml:lang="en-US">Adjustments for finance income (cost)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_0" xml:lang="en-US">Increase of deferred revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_0" xml:lang="en-US">Increase (decrease) in severance pay liability, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_1" xml:lang="en-US">Increase in severance pay liability, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_0" xml:lang="en-US">Increase (decrease) in trade payables and accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLoss_0" xml:lang="en-US">Adjustments to reconcile profit (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLoss_1" xml:lang="en-US">Adjustments to profit and loss items, total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLoss_2" xml:lang="en-US">Adjustments to profit and loss items, total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_0" xml:lang="en-US">Adjustments to profit and loss items:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments_0" xml:lang="en-US">Total share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AggregatedTimeBandsMember_0" xml:lang="en-US">Aggregated time bands [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AllLevelsOfFairValueHierarchyMember_0" xml:lang="en-US">All levels of fair value hierarchy [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AmountsPayableRelatedPartyTransactions_0" xml:lang="en-US">Payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ApplicableTaxRate_0" xml:lang="en-US">Income tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ApplicableTaxRate_1" xml:lang="en-US">Income tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Assets_0" xml:lang="en-US">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Assets_1" xml:lang="en-US">Total assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BalancesWithBanks_0" xml:lang="en-US">USD bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare_0" xml:lang="en-US">Basic earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare_1" xml:lang="en-US">Basic and diluted loss per share:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare_2" xml:lang="en-US">Basic net loss per share - USD</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsByNameAxis_0" xml:lang="en-US">Borrowings by name [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BorrowingsByNameAxis_1" xml:lang="en-US">Borrowings by name [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsByNameMember_0" xml:lang="en-US">Borrowings by name [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsInterestRateBasis_0" xml:lang="en-US">Interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BottomOfRangeMember_0" xml:lang="en-US">Bottom of range [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BuildingsMember_0" xml:lang="en-US">Buildings [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BuildingsMember_1" xml:lang="en-US">Buildings [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BusinessCombinationsAxis_0" xml:lang="en-US">Business combinations [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BusinessCombinationsAxis_1" xml:lang="en-US">Business combinations [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_0" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CarryingAmountMember_0" xml:lang="en-US">Carrying amount [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents_0" xml:lang="en-US">Balance of cash and cash equivalents at the end of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents_1" xml:lang="en-US">Balance of cash and cash equivalents at the beginning of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashAndCashEquivalents_2" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents_3" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashAndCashEquivalentsAbstract_0" xml:lang="en-US">Cash and cash equivalents [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_0" xml:lang="en-US">Proceeds from (investments in) short term bank deposits, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_1" xml:lang="en-US">Proceeds from (investment in) short term bank deposits, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_0" xml:lang="en-US">Net cash flows from (used in) financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_1" xml:lang="en-US">Cash flows from (used in) financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_2" xml:lang="en-US">Net cash provided by (used in) financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_0" xml:lang="en-US">Cash Flows from Financing Activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_0" xml:lang="en-US">Cash flows from (used in) financing activities, continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_1" xml:lang="en-US">Net cash used in continuing financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_0" xml:lang="en-US">Cash flows from (used in) investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_1" xml:lang="en-US">Net cash (used in) provided by investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_0" xml:lang="en-US">Cash Flows from Investing Activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_0" xml:lang="en-US">Cash flows from (used in) operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xml:lang="en-US">Net cash used in operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">Cash Flows from Operating Activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashOnHand_0" xml:lang="en-US">USD cash for immediate withdrawal</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashOnHand_1" xml:lang="en-US">Balance in USD</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashOutflowForLeases_0" xml:lang="en-US">Total cash outflow for leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashOutflowForLeases_1" xml:lang="en-US">Cash outflow for leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_0" xml:lang="en-US">Categories of related parties [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xml:lang="en-US">Categories of related parties [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ChangesInInventoriesOfFinishedGoodsAndWorkInProgress_0" xml:lang="en-US">Decrease in inventory of finished products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ChangesInInventoriesOfFinishedGoodsAndWorkInProgress_1" xml:lang="en-US">Decrease (increase) in inventory of finished products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfAssetsAxis_0" xml:lang="en-US">Classes of assets [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfAssetsMember_0" xml:lang="en-US">Assets [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_0" xml:lang="en-US">Classes of intangible assets other than goodwill [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfInventoriesAbstract_0" xml:lang="en-US">Classes of current inventories [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfOrdinarySharesAxis_0" xml:lang="en-US">Classes of ordinary shares [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_0" xml:lang="en-US">Classes of property, plant and equipment [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xml:lang="en-US">Classes of property, plant and equipment [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfShareCapitalAxis_0" xml:lang="en-US">Classes of share capital [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ClassesOfShareCapitalAxis_1" xml:lang="en-US">Classes of share capital [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis_0" xml:lang="en-US">Components of equity [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis_1" xml:lang="en-US">Components of equity [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComprehensiveIncome_0" xml:lang="en-US">Comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ComprehensiveIncome_1" xml:lang="en-US">Total comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ComprehensiveIncome_2" xml:lang="en-US">Total comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ComprehensiveIncome_3" xml:lang="en-US">Total comprehensive income (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComputerEquipmentMember_0" xml:lang="en-US">Computers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ConsiderationPaidReceived_0" xml:lang="en-US">Revised cash consideration paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_0" xml:lang="en-US">Obligation for contingent consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_0" xml:lang="en-US">Patents and intellectual property [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CostOfMerchandiseSold_0" xml:lang="en-US">Cost of merchandise sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CostOfMerchandiseSold_1" xml:lang="en-US">Cost of revenues from sale of products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CostOfMerchandiseSold_2" xml:lang="en-US">Cost of materials</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CostOfSales_0" xml:lang="en-US">Cost of sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CostOfSales_1" xml:lang="en-US">Cost of revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CostOfSales_2" xml:lang="en-US">Total cost of revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CostOfSales_3" xml:lang="en-US">Total Cost of Revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CountryOfDomicileMember_0" xml:lang="en-US">Israel [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssets_0" xml:lang="en-US">Current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentAssets_1" xml:lang="en-US">Total current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssetsAbstract_0" xml:lang="en-US">CURRENT ASSETS:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CurrentGovernmentGrants_0" xml:lang="en-US">Current maturities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentGovernmentGrants_1" xml:lang="en-US">Current government grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities_0" xml:lang="en-US">Current maturities of long-term leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities_1" xml:lang="en-US">Current lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities_2" xml:lang="en-US">Annual fee of lease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLiabilities_0" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentLiabilities_1" xml:lang="en-US">Total current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract_0" xml:lang="en-US">Current liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract_1" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentPrepaidExpenses_0" xml:lang="en-US">Prepaid expenses and other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentTradeReceivables_0" xml:lang="en-US">Current trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentTradeReceivables_1" xml:lang="en-US">Trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentTradeReceivables_2" xml:lang="en-US">Trade Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationAndAmortisationExpense_0" xml:lang="en-US">Depreciation and amortisation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DepreciationAndAmortisationExpense_1" xml:lang="en-US">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationExpense_0" xml:lang="en-US">Depreciation expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationRightofuseAssets_0" xml:lang="en-US">Depreciation, right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DepreciationRightofuseAssets_1" xml:lang="en-US">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_0" xml:lang="en-US">Discontinued operation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_0" xml:lang="en-US">Profit / Loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_1" xml:lang="en-US">Profit / Loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_0" xml:lang="en-US">Short-term employee benefits and severance pay liability, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_1" xml:lang="en-US">Short-term employee benefits and severance pay liability, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_0" xml:lang="en-US">Financial instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_1" xml:lang="en-US">Financial instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_0" xml:lang="en-US">Liability in respect of IIA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_1" xml:lang="en-US">Liability in respect of Israeli Innovation Authority ("IIA")</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_0" xml:lang="en-US">Impairment of non-financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_0" xml:lang="en-US">Description of accounting policy for intangible assets other than goodwill [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_1" xml:lang="en-US">Intangible assets, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_0" xml:lang="en-US">Description of accounting policy for leases [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_1" xml:lang="en-US">Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_2" xml:lang="en-US">Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_0" xml:lang="en-US">Description of accounting policy for measuring inventories [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_1" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_0" xml:lang="en-US">Description of accounting policy for property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_1" xml:lang="en-US">Property, plant and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_0" xml:lang="en-US">Provisions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_1" xml:lang="en-US">Provisions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory_0" xml:lang="en-US">Reclassification</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_0" xml:lang="en-US">Description of accounting policy for recognition of revenue [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_1" xml:lang="en-US">Revenues recognition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_0" xml:lang="en-US">Description of accounting policy for research and development expense [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_1" xml:lang="en-US">Research and development expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_0" xml:lang="en-US">Description of accounting policy for share-based payment transactions [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_2" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_0" xml:lang="en-US">Description of accounting policy for warrants [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_1" xml:lang="en-US">Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_0" xml:lang="en-US">Cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse_0" xml:lang="en-US">Discount rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_0" xml:lang="en-US">DISCLOSURE OF NEW STANDARDS IN THE PERIOD PRIOR TO THEIR ADOPTION</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract_0" xml:lang="en-US">Disclosure of expected impact of initial application of new standards or interpretations [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_0" xml:lang="en-US">Expected volatility of the share prices (%)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_1" xml:lang="en-US">Expected volatility of the share prices (%)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement_0" xml:lang="en-US">Exercisable period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_0" xml:lang="en-US">Risk-free interest rate (%)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_0" xml:lang="en-US">Useful life of assets at annual rates (in %)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_0" xml:lang="en-US">Description of vesting requirements for share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_1" xml:lang="en-US">Vesting period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare_0" xml:lang="en-US">Diluted earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare_1" xml:lang="en-US">Diluted net loss per share - USD</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DirectorsRemunerationExpense_0" xml:lang="en-US">One-time bonus payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DirectorsRemunerationExpense_1" xml:lang="en-US">One-time payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory_0" xml:lang="en-US">Schedule of Disclosures of Lease Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory_1" xml:lang="en-US">Schedule of maturity analysis of the Group's lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory_0" xml:lang="en-US">Schedule of Compensation of Officers of Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory_1" xml:lang="en-US">Schedule of compensation of officers of company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_0" xml:lang="en-US">Disclosure of basis of consolidation [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_1" xml:lang="en-US">Basis of consolidation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_0" xml:lang="en-US">Disclosure of basis of preparation of financial statements [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_1" xml:lang="en-US">Basis of Preparation of the Consolidated Financial Statements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xml:lang="en-US">Disclosure of detailed information about business combination [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsTable_0" xml:lang="en-US">Disclosure of detailed information about business combination [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_0" xml:lang="en-US">Disclosure of cash and cash equivalents [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_1" xml:lang="en-US">Cash And Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory_0" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory_1" xml:lang="en-US">Material Accounting Policies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xml:lang="en-US">Disclosure of classes of share capital [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_0" xml:lang="en-US">Schedule of Share Capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_1" xml:lang="en-US">Schedule of share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xml:lang="en-US">Disclosure of classes of share capital [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable_0" xml:lang="en-US">Disclosure of classes of share capital [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_0" xml:lang="en-US">CONTINGENT LIABILITIES AND COMMITMENTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_1" xml:lang="en-US">Contingent Liabilities And Commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_2" xml:lang="en-US">Liabilities and Commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0" xml:lang="en-US">Disclosure of contingent liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xml:lang="en-US">Disclosure of contingent liabilities [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesTable_0" xml:lang="en-US">Disclosure of contingent liabilities [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfCostOfSalesExplanatory_0" xml:lang="en-US">Schedule of Cost of Revenues Products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfCostOfSalesExplanatory_1" xml:lang="en-US">Schedule of cost of revenues products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_0" xml:lang="en-US">Disclosure of defined benefit plans [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_0" xml:lang="en-US">SEVERANCE PAY LIABILTY, NET</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_1" xml:lang="en-US">Severance Pay Liability, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_0" xml:lang="en-US">Disclosure of depositary receipts [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_1" xml:lang="en-US">Loss per share data:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDepositsFromBanksExplanatory_0" xml:lang="en-US">SHORT-TERM BANK DEPOSITS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDepositsFromBanksExplanatory_1" xml:lang="en-US">Short-term and restricted bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_0" xml:lang="en-US">FINANCIAL INSTRUMENTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_1" xml:lang="en-US">Financial Instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_0" xml:lang="en-US">Schedule of Intangible Assets, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_1" xml:lang="en-US">Schedule of intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_0" xml:lang="en-US">Schedule of Property, Plant and Equipment, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_1" xml:lang="en-US">Schedule of property, plant and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xml:lang="en-US">Disclosure of disaggregation of revenue from contracts with customers [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_0" xml:lang="en-US">Disclosure of disaggregation of revenue from contracts with customers [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory_0" xml:lang="en-US">DISCONTINUED OPERATION</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory_1" xml:lang="en-US">Discontinued Operation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_0" xml:lang="en-US">NET PROFIT (LOSS) PER SHARE</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1" xml:lang="en-US">Net Profit (Loss) Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_2" xml:lang="en-US">Net Loss Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_0" xml:lang="en-US">SUBSEQUENT EVENTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_1" xml:lang="en-US">Subsequent events</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_0" xml:lang="en-US">Schedule of Financial Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_1" xml:lang="en-US">Schedule of financial expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xml:lang="en-US">Disclosure of detailed information about financial instruments [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_0" xml:lang="en-US">Disclosure of financial instruments by type of interest rate [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_0" xml:lang="en-US">Disclosure of financial instruments by type of interest rate [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xml:lang="en-US">Disclosure of detailed information about financial instruments [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable_0" xml:lang="en-US">Disclosure of detailed information about financial instruments [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_0" xml:lang="en-US">Schedule of General Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_1" xml:lang="en-US">Schedule of general expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_0" xml:lang="en-US">GENERAL</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_1" xml:lang="en-US">General</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory_0" xml:lang="en-US">Schedule of Geographical Information</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory_1" xml:lang="en-US">Schedule of geographical information</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGovernmentGrantsExplanatory_0" xml:lang="en-US">LIABILITIES IN RESPECT OF IIA GRANTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfGovernmentGrantsExplanatory_1" xml:lang="en-US">Liabilities in Respect of IIA Grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_0" xml:lang="en-US">Disclosure of income tax [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_1" xml:lang="en-US">Income Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_0" xml:lang="en-US">Schedule of Fair Value Assumptions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_1" xml:lang="en-US">Schedule of fair value assumptions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0" xml:lang="en-US">Disclosure of detailed information about intangible assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_0" xml:lang="en-US">INTANGIBLE ASSETS, NET</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_1" xml:lang="en-US">Intangible Assets, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xml:lang="en-US">Disclosure of detailed information about intangible assets [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsTable_0" xml:lang="en-US">Disclosure of detailed information about intangible assets [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInventoriesExplanatory_0" xml:lang="en-US">INVENTORIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfInventoriesExplanatory_1" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfLeasesExplanatory_0" xml:lang="en-US">LEASES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfLeasesExplanatory_1" xml:lang="en-US">Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_0" xml:lang="en-US">Disclosure of maturity analysis for non-derivative financial liabilities [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_0" xml:lang="en-US">Disclosure of maturity analysis for non-derivative financial liabilities [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_0" xml:lang="en-US">Schedule of Minimum Future Lease Fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xml:lang="en-US">Disclosure of maturity analysis of operating lease payments [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_0" xml:lang="en-US">Disclosure of maturity analysis of operating lease payments [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_0" xml:lang="en-US">Schedule of Share Options Activity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_1" xml:lang="en-US">Schedule of share options activity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_0" xml:lang="en-US">Schedule of Information About Share Options Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_1" xml:lang="en-US">Schedule of information about share options outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_0" xml:lang="en-US">Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_0" xml:lang="en-US">Disclosure of number and weighted average remaining contractual life of outstanding share options [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_0" xml:lang="en-US">PROPERTY, PLANT AND EQUIPMENT, NET</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_1" xml:lang="en-US">Property, Plant And Equipment, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_0" xml:lang="en-US">Schedule of Disclosures of Right-of-Use Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_1" xml:lang="en-US">Schedule of carrying amounts of right-of-use assets and movement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_0" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_0" xml:lang="en-US">BALANCES AND TRANSACTIONS WITH RELATED PARTIES AND KEY OFFICERS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_1" xml:lang="en-US">Balances And Transactions With Related Parties And Key Officers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_0" xml:lang="en-US">Schedule of Research Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_1" xml:lang="en-US">Schedule of research expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_0" xml:lang="en-US">SHARE-BASED COMPENSATION</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_1" xml:lang="en-US">Share Based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_0" xml:lang="en-US">Disclosure of share capital, reserves and other equity interest [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_1" xml:lang="en-US">Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xml:lang="en-US">Disclosure of associates [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_0" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_0" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_0" xml:lang="en-US">OTHER PAYABLES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_1" xml:lang="en-US">Other Payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_0" xml:lang="en-US">OTHER RECEIVABLES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1" xml:lang="en-US">Other Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_2" xml:lang="en-US">Other Receivables- Short Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xml:lang="en-US">Disclosure of transactions between related parties [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_0" xml:lang="en-US">Schedule of Transactions with Related Parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_1" xml:lang="en-US">Schedule of transactions with related parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xml:lang="en-US">Disclosure of transactions between related parties [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_0" xml:lang="en-US">Disclosure of transactions between related parties [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_0" xml:lang="en-US">Disposals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_1" xml:lang="en-US">Disposals, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_2" xml:lang="en-US">Disposals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DistributionCosts_0" xml:lang="en-US">Shipping and delivery</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EarningsPerShareAbstract_0" xml:lang="en-US">Earnings per share [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EarningsPerShareLineItems_0" xml:lang="en-US">Earnings per share [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EarningsPerShareTable_0" xml:lang="en-US">Earnings per share [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_0" xml:lang="en-US">Exchange rate differences on cash and cash equivalent balances</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EmployeeBenefitsExpense_0" xml:lang="en-US">Employee benefits expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_EmployeeBenefitsExpense_1" xml:lang="en-US">Salary and benefits (including share-based compensation)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EntitysTotalForRelatedPartiesMember_0" xml:lang="en-US">Entity's total for related parties [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_Equity_0" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_Equity_1" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Equity_2" xml:lang="en-US">Equity [Default Label]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Equity_3" xml:lang="en-US">Total equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAbstract_0" xml:lang="en-US">SHAREHOLDERS' EQUITY:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAndLiabilities_0" xml:lang="en-US">Equity and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_EquityAndLiabilities_1" xml:lang="en-US">Total liabilities and equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_0" xml:lang="en-US">Dividend yield (%)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_1" xml:lang="en-US">Dividend yield (%)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_0" xml:lang="en-US">Expense from share-based payment transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_1" xml:lang="en-US">Expense from share-based payment transitions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_0" xml:lang="en-US">Depreciation expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_1" xml:lang="en-US">Expenses relating to short-term leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_2" xml:lang="en-US">Depreciation expenses relating to short-term leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExplanationOfAccountingPoliciesAndMethodsOfComputationFollowedInInterimFinancialStatements_0" xml:lang="en-US">Basis of presentation of financial statements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExplanationOfAccountingPoliciesAndMethodsOfComputationFollowedInInterimFinancialStatements_1" xml:lang="en-US">Basis of consolidation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod_0" xml:lang="en-US">Change in tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions_0" xml:lang="en-US">Schedule of Expense Recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions_1" xml:lang="en-US">Schedule of expense recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_FinanceCosts_0" xml:lang="en-US">Financial expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinanceCosts_1" xml:lang="en-US">Finance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_FinanceCosts_2" xml:lang="en-US">Financial expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinanceIncome_0" xml:lang="en-US">Financial income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_FinanceIncome_1" xml:lang="en-US">Financial income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValue_0" xml:lang="en-US">Financial liabilities, at fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinishedGoods_0" xml:lang="en-US">Finished goods</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FixedInterestRateMember_0" xml:lang="en-US">Fixed interest rate [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FixedInterestRateMember_1" xml:lang="en-US">Fixed interest rate [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_0" xml:lang="en-US">Un-realized foreign currency loss (gain)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_1" xml:lang="en-US">Gain (loss) from change in exchange rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GeographicalAreasAxis_0" xml:lang="en-US">Geographical areas [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GeographicalAreasMember_0" xml:lang="en-US">Geographical areas [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_GovernmentGrants_0" xml:lang="en-US">Balance as of December 31</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_GovernmentGrants_1" xml:lang="en-US">Balance as of January 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GovernmentGrants_2" xml:lang="en-US">Government grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossCarryingAmountMember_0" xml:lang="en-US">Gross carrying amount [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GrossCarryingAmountMember_1" xml:lang="en-US">Carrying amount [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GrossCarryingAmountMember_2" xml:lang="en-US">Cost [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossProfit_0" xml:lang="en-US">Gross profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_GrossProfit_1" xml:lang="en-US">Gross profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeStatementAbstract_0" xml:lang="en-US">Profit or loss [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xml:lang="en-US">Taxes on income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_1" xml:lang="en-US">Tax expense (income)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_2" xml:lang="en-US">Taxes on income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xml:lang="en-US">Increase (decrease) in cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_1" xml:lang="en-US">Increase (decrease) in cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_0" xml:lang="en-US">Increase (decrease) in number of shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_1" xml:lang="en-US">Number of common shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings_0" xml:lang="en-US">Increase of accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_0" xml:lang="en-US">Exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_0" xml:lang="en-US">Exercise of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_1" xml:lang="en-US">Exercise of pre-funded warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_0" xml:lang="en-US">Foreign currency translation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_0" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements_0" xml:lang="en-US">Fair value of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Balance, ending</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Balance, opening</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_2" xml:lang="en-US">Intangible assets, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_0" xml:lang="en-US">Financial expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_1" xml:lang="en-US">Interest expense on lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_2" xml:lang="en-US">Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_0" xml:lang="en-US">Interest received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Inventories_0" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Inventories_1" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InventoryWritedown2011_0" xml:lang="en-US">Inventory write-down</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssuedCapital_0" xml:lang="en-US">Issued Capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IssuedCapital_1" xml:lang="en-US">Ordinary shares of NIS 0.07 par value: Authorized 20,000,000 shares as of December 31, 2023 and 12,857,143 shares as of December 31, 2022; Issued and Outstanding 9,221,764 shares as of December 31, 2023 and 7,240,020 shares as of December 31, 2022</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssuedCapitalMember_0" xml:lang="en-US">Share capital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssueOfEquity_0" xml:lang="en-US">Issuance of ordinary shares, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IssueOfEquity_1" xml:lang="en-US">Issuance of ordinary shares, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation_0" xml:lang="en-US">Key management personnel compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation_1" xml:lang="en-US">Compensation of officers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_0" xml:lang="en-US">Key management personnel compensation, share-based payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_0" xml:lang="en-US">Short-term employee benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_0" xml:lang="en-US">Later than one year and not later than two years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_1" xml:lang="en-US">1-2 years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LeaseholdImprovementsMember_0" xml:lang="en-US">Leasehold improvements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_LeaseLiabilities_0" xml:lang="en-US">Balance as of December 31,</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_LeaseLiabilities_1" xml:lang="en-US">Balance as of December 31,</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LeaseLiabilities_2" xml:lang="en-US">Lease liabilities [Default Label]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LeaseLiabilitiesMember_0" xml:lang="en-US">Lease liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Level3OfFairValueHierarchyMember_0" xml:lang="en-US">Level 3 of fair value hierarchy [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Level3OfFairValueHierarchyMember_1" xml:lang="en-US">Fair value measurement at Level 3 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LevelsOfFairValueHierarchyAxis_0" xml:lang="en-US">Levels of fair value hierarchy [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Liabilities_0" xml:lang="en-US">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Liabilities_1" xml:lang="en-US">Total liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_0" xml:lang="en-US">Liabilities arising from financing activities [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_0" xml:lang="en-US">Liabilities arising from financing activities [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LicenceFeeIncome_0" xml:lang="en-US">Revenues from license agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LicenceFeeIncome_1" xml:lang="en-US">Revenues from license agreements and royalties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LicenceFeeIncome_2" xml:lang="en-US">Revenues from sale or license</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LicencesAndFranchisesMember_0" xml:lang="en-US">License and Knowhow [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LongtermDeposits_0" xml:lang="en-US">Long-term deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LongtermDeposits_1" xml:lang="en-US">Long-term restricted bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MachineryMember_0" xml:lang="en-US">Manufacturing machinery and lab equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_0" xml:lang="en-US">Disclosure of maturity analysis for non-derivative financial liabilities [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_1" xml:lang="en-US">Schedule of liquidity risk by holding cash balances, short-term deposits and secured bank credit facilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MaturityAxis_0" xml:lang="en-US">Maturity [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MethodsOfGenerationAxis_0" xml:lang="en-US">Methods of generation [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_MethodsOfGenerationAxis_1" xml:lang="en-US">Methods of generation [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MiscellaneousOtherOperatingExpense_0" xml:lang="en-US">Other manufacturing expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MotorVehiclesMember_0" xml:lang="en-US">Motor vehicles [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MotorVehiclesMember_1" xml:lang="en-US">Motor vehicles [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NetForeignExchangeLoss_0" xml:lang="en-US">Net foreign exchange loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NetForeignExchangeLoss_1" xml:lang="en-US">Exchange differences, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_0" xml:lang="en-US">Modified contingent consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_0" xml:lang="en-US">Non-adjusting events after reporting period [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NonadjustingEventsMember_0" xml:lang="en-US">Non-adjusting events after reporting period [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssets_0" xml:lang="en-US">Non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentAssets_1" xml:lang="en-US">Total non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract_0" xml:lang="en-US">LONG-TERM ASSETS:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentGovernmentGrants_0" xml:lang="en-US">Liabilities in respect of IIA grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentGovernmentGrants_1" xml:lang="en-US">Long term liabilities in respect of IIA grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities_0" xml:lang="en-US">Lease liability Balance as of December 31,</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities_1" xml:lang="en-US">Non-current lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities_2" xml:lang="en-US">Lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLiabilities_0" xml:lang="en-US">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentLiabilities_1" xml:lang="en-US">Total non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLiabilitiesAbstract_0" xml:lang="en-US">Non-current liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentLiabilitiesAbstract_1" xml:lang="en-US">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentReceivablesAbstract_0" xml:lang="en-US">Trade and other non-current receivables [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_0" xml:lang="en-US">Severance pay liability, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentWarrantLiability_0" xml:lang="en-US">Non-current warrant liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentWarrantLiability_1" xml:lang="en-US">Warrants, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember_0" xml:lang="en-US">Not later than one year [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember_1" xml:lang="en-US">12 months or less [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfEmployees_0" xml:lang="en-US">Number of officers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfEmployees_1" xml:lang="en-US">Number of employees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_0" xml:lang="en-US">Number of other equity instruments granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_1" xml:lang="en-US">Number of RSUs granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_2" xml:lang="en-US">Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_0" xml:lang="en-US">Option's Vested</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of other equity instruments exercised or vested in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions_0" xml:lang="en-US">Outstanding options and at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions_1" xml:lang="en-US">Outstanding Options at beginning of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions_2" xml:lang="en-US">Number of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_0" xml:lang="en-US">Option's Exercisable at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of share options exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_0" xml:lang="en-US">Option's Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of share options exercised in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_0" xml:lang="en-US">Option's Forfeited and/or expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of share options forfeited in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_0" xml:lang="en-US">Number of share options granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfSharesAuthorised_0" xml:lang="en-US">Number of shares authorised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfSharesAuthorised_1" xml:lang="en-US">Authorized number of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfSharesIssued_0" xml:lang="en-US">Number of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfSharesIssued_1" xml:lang="en-US">Issued and outstanding number of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding_0" xml:lang="en-US">Ordinary shares, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OfficeEquipmentMember_0" xml:lang="en-US">Office furniture [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OperatingExpense_0" xml:lang="en-US">Operating expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OperatingExpense_1" xml:lang="en-US">Total operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OrdinarySharesMember_0" xml:lang="en-US">Ordinary shares [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_0" xml:lang="en-US">Revaluation of liabilities in respect of purchase of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_1" xml:lang="en-US">Revaluation of liabilities in respect of TEVA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncome_0" xml:lang="en-US">Other comprehensive income (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncome_1" xml:lang="en-US">Other comprehensive Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeAbstract_0" xml:lang="en-US">Other comprehensive income (loss):</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherCurrentPayables_0" xml:lang="en-US">Other current payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherCurrentPayables_1" xml:lang="en-US">Other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OtherCurrentPayables_2" xml:lang="en-US">Other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherCurrentPayables_3" xml:lang="en-US">Other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherCurrentReceivables_0" xml:lang="en-US">Other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OtherCurrentReceivables_1" xml:lang="en-US">Other Receivables- Short Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherCurrentReceivables_2" xml:lang="en-US">Other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherExpenseByFunction_0" xml:lang="en-US">One-time expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherExpenseByNature_0" xml:lang="en-US">Other expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherExpenseByNature_1" xml:lang="en-US">Other (income) expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherFinanceCost_0" xml:lang="en-US">Other finance cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherFinanceCost_1" xml:lang="en-US">Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_OtherIncome_0" xml:lang="en-US">Other income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherIncome_1" xml:lang="en-US">Other income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherIncome_2" xml:lang="en-US">One-time income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherIncome_3" xml:lang="en-US">Other income from settlement agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherNoncurrentLiabilities_0" xml:lang="en-US">Liabilities in respect of purchase of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherNoncurrentLiabilities_1" xml:lang="en-US">Liabilities in respect of TEVA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherNoncurrentPayables_0" xml:lang="en-US">Provision for other payable on discountinue operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherNoncurrentReceivables_0" xml:lang="en-US">Other non-current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherNoncurrentReceivables_1" xml:lang="en-US">Other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OtherNoncurrentReceivables_2" xml:lang="en-US">Other Receivables- Long Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_OtherOperatingIncomeExpense_0" xml:lang="en-US">Other (income) expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_OtherOperatingIncomeExpense_1" xml:lang="en-US">Other expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherOperatingIncomeExpense_2" xml:lang="en-US">Other operating income (expense)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherOperatingIncomeExpense_3" xml:lang="en-US">Other expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherOperatingIncomeExpense_4" xml:lang="en-US">Other (income) expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherPayables_0" xml:lang="en-US">Other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherReceivables_0" xml:lang="en-US">Other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherReceivables_1" xml:lang="en-US">Other trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherRelatedPartiesMember_0" xml:lang="en-US">Other related parties [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherRelatedPartiesMember_1" xml:lang="en-US">Directors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ParValuePerShare_0" xml:lang="en-US">Par value per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_0" xml:lang="en-US">Repayment of leases liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromExerciseOfOptions_0" xml:lang="en-US">Proceeds from exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromExerciseOfWarrants_0" xml:lang="en-US">Proceeds from exercise of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromExerciseOfWarrants_1" xml:lang="en-US">Proceeds from warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProceedsFromExerciseOfWarrants_2" xml:lang="en-US">Proceeds from exercise of pre-funded warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromIssueOfOrdinaryShares_0" xml:lang="en-US">Proceeds from issue of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_0" xml:lang="en-US">Proceeds from shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_1" xml:lang="en-US">Proceeds from issuing shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_2" xml:lang="en-US">Proceeds from issuance of shares and warrants, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_3" xml:lang="en-US">Proceeds from issuance of shares and warrants, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfessionalFeesExpense_0" xml:lang="en-US">Professional fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfessionalFeesExpense_1" xml:lang="en-US">Professional Fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfessionalFeesExpense_2" xml:lang="en-US">Professional fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLoss_0" xml:lang="en-US">Profit (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLoss_1" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLoss_2" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLoss_3" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossBeforeTax_0" xml:lang="en-US">Profit (loss) before tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossBeforeTax_1" xml:lang="en-US">Loss before taxes on income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperations_0" xml:lang="en-US">Basic and diluted profit (loss) from continued operation, Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperations_1" xml:lang="en-US">Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperations_2" xml:lang="en-US">Profit (loss) from continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_0" xml:lang="en-US">Profit from discontinued operation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_1" xml:lang="en-US">Profit from discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_2" xml:lang="en-US">Basic and diluted profit (loss) from discontinued operation, Profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_3" xml:lang="en-US">Profit (loss) from discontinued operation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_0" xml:lang="en-US">Profit (loss) from operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_1" xml:lang="en-US">Operating loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_0" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_1" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_2" xml:lang="en-US">Property, plant and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_0" xml:lang="en-US">Purchase of property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_1" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfTreasuryShares_0" xml:lang="en-US">Purchase of treasury shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangeAxis_0" xml:lang="en-US">Range [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangesMember_0" xml:lang="en-US">Ranges [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_0" xml:lang="en-US">Ranges of exercise prices for outstanding share options [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1" xml:lang="en-US">Ranges of exercise prices for outstanding share options [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RawMaterials_0" xml:lang="en-US">Raw materials</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_0" xml:lang="en-US">Foreign currency translation adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_1" xml:lang="en-US">Reclassification adjustments on change in value of foreign currency basis spreads, net of tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_2" xml:lang="en-US">Foreign currency translation adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RelatedPartiesMember_0" xml:lang="en-US">Related parties [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RelatedPartiesMember_1" xml:lang="en-US">Related Party [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense_0" xml:lang="en-US">Research and development, net of Participations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense_1" xml:lang="en-US">Research and development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense_2" xml:lang="en-US">Total Research and development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense_3" xml:lang="en-US">Research and development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads_0" xml:lang="en-US">Foreign currency translation adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads_1" xml:lang="en-US">Foreign currency translation reserve</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember_0" xml:lang="en-US">Foreign currency translation Adjustments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember_1" xml:lang="en-US">Foreign currency translation reserve [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RestrictedCashAndCashEquivalents_0" xml:lang="en-US">Restricted deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RestrictedCashAndCashEquivalents_1" xml:lang="en-US">Restricted bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RetainedEarnings_0" xml:lang="en-US">Retained earnings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RetainedEarnings_1" xml:lang="en-US">Total accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RetainedEarnings_2" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RetainedEarningsMember_0" xml:lang="en-US">Accumulated deficit [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Revenue_0" xml:lang="en-US">Revenues net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Revenue_1" xml:lang="en-US">Total revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Revenue_2" xml:lang="en-US">Revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RevenueFromInterest_0" xml:lang="en-US">Interest income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RevenueFromRenderingOfServices_0" xml:lang="en-US">Revenues from development services</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RevenueFromRoyalties_0" xml:lang="en-US">Aggregate revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RevenueFromSaleOfGoods_0" xml:lang="en-US">Revenues from sale of products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RevenueFromSaleOfGoods_1" xml:lang="en-US">Revenues from sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_RightofuseAssets_0" xml:lang="en-US">December 31,</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RightofuseAssets_1" xml:lang="en-US">Right-of-use assets, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus_0" xml:lang="en-US">ROU asset, net recognized with corresponding lease liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_0" xml:lang="en-US">Balance as of December 31,</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_1" xml:lang="en-US">Balance as of January 1,</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_2" xml:lang="en-US">Right-of-use assets, revalued assets, at cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_RoyaltyExpense_0" xml:lang="en-US">Royalties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RoyaltyExpense_1" xml:lang="en-US">Royalty expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SalesAndMarketingExpense_0" xml:lang="en-US">Selling and marketing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_SalesAndMarketingExpense_1" xml:lang="en-US">Selling and marketing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SegmentsAxis_0" xml:lang="en-US">Segments [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SegmentsMember_0" xml:lang="en-US">Segments [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_0" xml:lang="en-US">General and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_1" xml:lang="en-US">General and administrative expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk_0" xml:lang="en-US">Schedule of Sensitivity Tests Relating to Changes in Market Factors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk_1" xml:lang="en-US">Schedule of sensitivity tests relating to changes in market factors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ServicesExpense_0" xml:lang="en-US">Services expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ServicesExpense_1" xml:lang="en-US">Cost of revenues from development services</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SharebasedPaymentArrangementsMember_0" xml:lang="en-US">Share-based payment arrangements [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SharePremium_0" xml:lang="en-US">Share premium</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SharePremiumMember_0" xml:lang="en-US">Share premium [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_0" xml:lang="en-US">Shares reserved for issuance stock options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_0" xml:lang="en-US">Short-term bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_1" xml:lang="en-US">Short-term and restricted bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_0" xml:lang="en-US">Short-term deposits, not classified as cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_1" xml:lang="en-US">Short-term and restricted bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShorttermEmployeeBenefitsAccruals_0" xml:lang="en-US">Employees and payroll accruals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShorttermEmployeeBenefitsExpense_0" xml:lang="en-US">Salary and benefits (including share based compensation)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ShorttermEmployeeBenefitsExpense_1" xml:lang="en-US">Salary and benefits (including share-based compensation)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfCashFlowsAbstract_0" xml:lang="en-US">Statement of cash flows [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityAbstract_0" xml:lang="en-US">Statement of changes in equity [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityLineItems_0" xml:lang="en-US">Statement of changes in equity [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityTable_0" xml:lang="en-US">Statement of changes in equity [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract_0" xml:lang="en-US">Statement of comprehensive income [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfFinancialPositionAbstract_0" xml:lang="en-US">Statement of financial position [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TopOfRangeMember_0" xml:lang="en-US">Top of range [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_0" xml:lang="en-US">Current payables to related parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_1" xml:lang="en-US">Related parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_0" xml:lang="en-US">Trade payables and accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_1" xml:lang="en-US">Trade payables and accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xml:lang="en-US">Trade and other current receivables [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherPayablesAbstract_0" xml:lang="en-US">Trade and other payables [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradingIncomeExpenseOnForeignExchangeContracts_0" xml:lang="en-US">Exchange differences, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions_0" xml:lang="en-US">License costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfInterestRatesAxis_0" xml:lang="en-US">Types of interest rates [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfRisksAxis_0" xml:lang="en-US">Types of risks [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0" xml:lang="en-US">Types of share-based payment arrangements [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xml:lang="en-US">Types of share-based payment arrangements [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WagesAndSalaries_0" xml:lang="en-US">Salary and benefits (including share-based compensation)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Options granted, exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Option's Exercisable at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Weighted average exercise price of share options exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Option's Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Option's Forfeited and/or expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of share options granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Option's Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Outstanding options and at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Outstanding Options at beginning of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2" xml:lang="en-US">Weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_0" xml:lang="en-US">Fair value of options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_0" xml:lang="en-US">Weighted average incremental borrowing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_0" xml:lang="en-US">Weighted Average Remaining contractual life</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_0" xml:lang="en-US">Weighted average share prices (Dollar)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_1" xml:lang="en-US">Weighted average share prices (Dollar)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageShares_0" xml:lang="en-US">Weighted average number of ordinary shares used in calculating basic earnings per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageShares_1" xml:lang="en-US">Number of shares used in calculating basic loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AccumaletedEffectOfAdoptingIfrsFifteen_0" xml:lang="en-US">Accumaleted effect of implementing IFRS 15.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AccumaletedEffectOfAdoptingIfrsFifteen_1" xml:lang="en-US">Accumaleted Effect Of Adopting Ifrs Fifteen</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AccumaletedEffectOfAdoptingIfrsFifteen_2" xml:lang="en-US">Cumulative effect adjustment on accumulated deficit as a result of adopting new standard</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AccumulatedFunding_0" xml:lang="en-US">Accumulated funding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AccumulatedFunding_1" xml:lang="en-US">Accumulated funding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdditionalInvestment_0" xml:lang="en-US">Additional Investment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdditionalInvestment_1" xml:lang="en-US">Additional Investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits_0" xml:lang="en-US">Additional ordinary shares issued upon vesting of outstanding RSU&#8217;s during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits_1" xml:lang="en-US">Additional Ordinary Shares Issued Upon Vesting Of Outstanding Restricted Stock Units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits_2" xml:lang="en-US">Additional ordinary shares issued upon vesting of outstanding RSU's</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdditionalTermOfLease_0" xml:lang="en-US">Information about additional term of lease.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdditionalTermOfLease_1" xml:lang="en-US">Additional Term Of Lease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AdditionalTermOfLease_2" xml:lang="en-US">Additional term of lease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdditionalUpfrontPayment_0" xml:lang="en-US">Additional upfront payment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdditionalUpfrontPayment_1" xml:lang="en-US">Additional upfront payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation_0" xml:lang="en-US">Additions due to adjustments for indexation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation_1" xml:lang="en-US">Adjustments for indexation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation_2" xml:lang="en-US">Additions To Right Of Use Assets Adjustments For Indexation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdditionsToRightOfUseAssetsDisposals_0" xml:lang="en-US">Additions due to Disposals.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_AdditionsToRightOfUseAssetsDisposals_1" xml:lang="en-US">Disposals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdditionsToRightOfUseAssetsDisposals_2" xml:lang="en-US">Additions To Right Of Use Assets Disposals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdditionsToRightOfUseAssetsNewLeases_0" xml:lang="en-US">Additions due to new leases.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdditionsToRightOfUseAssetsNewLeases_1" xml:lang="en-US">Additions To Right Of Use Assets New Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_AdditionsToRightOfUseAssetsNewLeases_2" xml:lang="en-US">New leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases_0" xml:lang="en-US">Additions due to termination of leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases_1" xml:lang="en-US">Termination of leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases_2" xml:lang="en-US">Additions To Right Of Use Assets Termination Of Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdjustedWeightedAverageSharesContinuing_0" xml:lang="en-US">The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdjustedWeightedAverageSharesContinuing_1" xml:lang="en-US">Adjusted Weighted Average Shares Continuing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AdjustedWeightedAverageSharesContinuing_2" xml:lang="en-US">Basic and diluted profit (loss) from continued operation, Weighted average number of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_0" xml:lang="en-US">Represents the amount of adjustment for increase decrease in revaluation of liabilities in respect of grants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_1" xml:lang="en-US">Revaluation of liabilities in respect of IIA grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_2" xml:lang="en-US">Amounts carried to Profit or Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_3" xml:lang="en-US">Adjustment For Increase Decrease In Revaluation Of Liabilities In Respect Of Grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_4" xml:lang="en-US">Revaluation of liabilities in respect of IIA grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue_0" xml:lang="en-US">Adjustment for increase decrease in revaluation of warrants accounted at fair value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue_1" xml:lang="en-US">Revaluation of warrants accounted at fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue_2" xml:lang="en-US">Adjustment For Increase Decrease In Revaluation Of Warrants Accounted At Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue_3" xml:lang="en-US">Revaluation of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_0" xml:lang="en-US">Changes in asset and liability items, total.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_1" xml:lang="en-US">Adjustments For Changes In Increase Decrease In Asset And Liability Items</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_2" xml:lang="en-US">Changes in asset and liability items, total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_3" xml:lang="en-US">Changes in asset and liability items, total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability_0" xml:lang="en-US">Represents the amount of adjustment for financing income and exchange differences of lease liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability_1" xml:lang="en-US">Adjustments For Financing Income And Exchange Differences Of Lease Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability_2" xml:lang="en-US">Financing income and exchange differences of lease liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdjustmentsForIncreaseDecreaseInOtherIncome_0" xml:lang="en-US">Adjustments for increase (decrease) in other income to reconcile profit (loss) to net cash flow from (used in) operating activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdjustmentsForIncreaseDecreaseInOtherIncome_1" xml:lang="en-US">Adjustments For Increase Decrease In Other Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AdjustmentsForIncreaseDecreaseInOtherIncome_2" xml:lang="en-US">Other income from settlement agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_0" xml:lang="en-US">Adjustment for increase in other payables and deferred revenues.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_1" xml:lang="en-US">Adjustments For Increase Decrease In Other Payables And Deferred Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_2" xml:lang="en-US">Increase (decrease) in other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdjustmentsForIndexation_0" xml:lang="en-US">Adjustments for indexation during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdjustmentsForIndexation_1" xml:lang="en-US">Adjustments For Indexation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AdjustmentsForIndexation_2" xml:lang="en-US">Adjustments for indexation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_0" xml:lang="en-US">Represents the amount of adjustment for issuance expenses of warrants through profit and loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_1" xml:lang="en-US">Adjustments For Issuance Expenses Of Warrants Through Profit And Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_2" xml:lang="en-US">Issuance expenses of warrants through profit and loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdjustmentsMember_0" xml:lang="en-US">Adjustments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdjustmentsToReconcileNetLossToNetCashProvidedByUsedInContinuingOperatingActivitiesAbstract_0" xml:lang="en-US">Adjustments To Reconcile Net Loss To Net Cash Provided By Used In Continuing Operating Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AdjustmentsToReconcileNetLossToNetCashProvidedByUsedInContinuingOperatingActivitiesAbstract_1" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AggregateAmountOfRegisteredDirectOffering_0" xml:lang="en-US">Represents amount of aggregate amount of registered direct offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AggregateAmountOfRegisteredDirectOffering_1" xml:lang="en-US">Aggregate Amount Of Registered Direct Offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AggregateAmountOfRegisteredDirectOffering_2" xml:lang="en-US">Aggregate amount of registered direct offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AggregateSupplementalAmount_0" xml:lang="en-US">It represents aggregate supplemental amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AggregateSupplementalAmount_1" xml:lang="en-US">Aggregate Supplemental Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AggregateSupplementalAmount_2" xml:lang="en-US">Aggregate supplemental amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AgreementAxis_0" xml:lang="en-US">Represents information of agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AgreementAxis_1" xml:lang="en-US">Agreement [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AgreementAxis_2" xml:lang="en-US">Borrowings by name [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AgreementDomain_0" xml:lang="en-US">Represents information of agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AgreementDomain_1" xml:lang="en-US">Agreement [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AllotmentOfDevelopmentCostOfGoodsSold_0" xml:lang="en-US">Allotment of development cost of goods sold.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AllotmentOfDevelopmentCostOfGoodsSold_1" xml:lang="en-US">Allotment Of Development Cost Of Goods Sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AllotmentOfDevelopmentCostOfGoodsSold_2" xml:lang="en-US">Other research and development expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AllotmentOfManufacturingCosts_0" xml:lang="en-US">Allotment of manufacturing costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AllotmentOfManufacturingCosts_1" xml:lang="en-US">Allotment of manufacturing costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AllotmentOfManufacturingCostsToResearchAndDevelopment_0" xml:lang="en-US">Allotment of manufacturing costs to research and development.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_AllotmentOfManufacturingCostsToResearchAndDevelopment_1" xml:lang="en-US">Allotment of manufacturing costs to R&amp;D</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AllotmentOfManufacturingCostsToResearchAndDevelopment_2" xml:lang="en-US">Allotment Of Manufacturing Costs To Research And Development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AmortizationPeriodsOfRightOfUseAssets_0" xml:lang="en-US">Amortization periods of the right-of-use assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AmortizationPeriodsOfRightOfUseAssets_1" xml:lang="en-US">Amortization Periods Of Right Of Use Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_AmortizationPeriodsOfRightOfUseAssets_2" xml:lang="en-US">Amortization periods of the ROU assets (in years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AmortizedCostMember_0" xml:lang="en-US">Amortized cost [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AmortizedCostMember_1" xml:lang="en-US">Amortized cost [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AmortizedCostOfGrantsReceived_0" xml:lang="en-US">Amortized cost of grants received.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AmortizedCostOfGrantsReceived_1" xml:lang="en-US">Amortized cost of grants received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AmountOfAnnualFeeOfLeaseAgreement_0" xml:lang="en-US">Amount of annual fee of lease agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AmountOfAnnualFeeOfLeaseAgreement_1" xml:lang="en-US">Amount Of Annual Fee Of Lease Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AmountOfAnnualFeeOfLeaseAgreement_2" xml:lang="en-US">Annual fee of lease agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AmountOfInvestedInProject_0" xml:lang="en-US">Information about invested in the project.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AmountOfInvestedInProject_1" xml:lang="en-US">Amount Of Invested In Project</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AmountOfInvestedInProject_2" xml:lang="en-US">Amount of invested in the project</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AmountOfLeaseLiabilityUnderLongTermDebtAndCurrentMaturity_0" xml:lang="en-US">Amount of lease liability under long term debt and current maturity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AmountOfLeaseLiabilityUnderLongTermDebtAndCurrentMaturity_1" xml:lang="en-US">Amount of lease liability under long term debt and current maturity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential_0" xml:lang="en-US">It represents amount of option to fund development of other potential.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential_1" xml:lang="en-US">Amount Of Option To Fund Development Of Other Potential</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential_2" xml:lang="en-US">Amount of option to fund development of other potential</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AmountOfSecondContractExpired_0" xml:lang="en-US">Information about second contract was expired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AmountOfSecondContractExpired_1" xml:lang="en-US">Amount Of Second Contract Expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AmountOfSecondContractExpired_2" xml:lang="en-US">Amount of second contract was expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AmountOfTechnicalAssistance_0" xml:lang="en-US">It represents amount of technical assistance.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AmountOfTechnicalAssistance_1" xml:lang="en-US">Amount Of Technical Assistance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AmountOfTechnicalAssistance_2" xml:lang="en-US">Amount of technical assistance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AmountOfUnderwritingDiscountsAndCommissions_0" xml:lang="en-US">It represents amount of underwriting discounts and commissions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AmountOfUnderwritingDiscountsAndCommissions_1" xml:lang="en-US">Amount Of Underwriting Discounts And Commissions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AmountOfUnderwritingDiscountsAndCommissions_2" xml:lang="en-US">Amount of underwriting discounts and commissions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AreaOfLand_0" xml:lang="en-US">Area of land.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AreaOfLand_1" xml:lang="en-US">Area Of Land</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_AreaOfLand_2" xml:lang="en-US">Area of office</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AuthorizedNumberOfSharesIncreased_0" xml:lang="en-US">Authorized number of shares increased during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AuthorizedNumberOfSharesIncreased_1" xml:lang="en-US">Authorized number of shares increased</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AuthorizedNumberOfSharesNominalValue_0" xml:lang="en-US">The nominal value of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AuthorizedNumberOfSharesNominalValue_1" xml:lang="en-US">Authorized Number Of Shares Nominal Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AuthorizedNumberOfSharesNominalValue_2" xml:lang="en-US">Nominal value of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AuthorizedShareCapital_0" xml:lang="en-US">Represents amount of share capital of an entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AuthorizedShareCapital_1" xml:lang="en-US">Authorized Share Capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AuthorizedShareCapital_2" xml:lang="en-US">Authorized share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AverageStandardDeviationOfWarrants_0" xml:lang="en-US">Represents average standard deviation of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AverageStandardDeviationOfWarrants_1" xml:lang="en-US">Average Standard Deviation Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_AverageStandardDeviationOfWarrants_2" xml:lang="en-US">Average standard deviation of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_BardaFunds_0" xml:lang="en-US">BARDA funds.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_BardaFunds_1" xml:lang="en-US">BARDA funds</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_BardaFunds_2" xml:lang="en-US">Barda Funds</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_BardaMember_0" xml:lang="en-US">BARDA [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_BardaMember_1" xml:lang="en-US">Barda [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_BardaMember_2" xml:lang="en-US">BARDA [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_BasicAndDilutedEarningsPerShareAbstract_0" xml:lang="en-US">Basic And Diluted Earnings Per Share [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_BasicAndDilutedNetProfitLossPerShareFromContinuingOperations_0" xml:lang="en-US">Represents the basic and diluted earnings (loss) per share from continuing operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_BasicAndDilutedNetProfitLossPerShareFromContinuingOperations_1" xml:lang="en-US">Basic And Diluted Net Profit (Loss) Per Share From Continuing Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_BasicAndDilutedNetProfitLossPerShareFromContinuingOperations_2" xml:lang="en-US">Basic and diluted net profit (loss) per share from continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_BasicAndDilutedNetProfitLossPerShareFromContinuingOperations_3" xml:lang="en-US">Profit (loss) from from continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations_0" xml:lang="en-US">Represents the basic and diluted earnings (loss) per share from discontinued operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations_1" xml:lang="en-US">Basic And Diluted Net Profit Per Share From Discontinued Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations_2" xml:lang="en-US">Basic and diluted net profit per share from discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations_3" xml:lang="en-US">Profit from discontinued operation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_0" xml:lang="en-US">BARDA [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_1" xml:lang="en-US">Biomedical Advanced Research And Development Authority [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_2" xml:lang="en-US">BARDA [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_BoardMembersMember_0" xml:lang="en-US">Board Members [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_BoardMembersMember_1" xml:lang="en-US">Board Members [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_BoardMembersMember_2" xml:lang="en-US">Board Members [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_BoardOfDirectorsMember_0" xml:lang="en-US">Board of Directors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_BuildingAndEquipmentMember_0" xml:lang="en-US">Building and Equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_BuildingAndEquipmentMember_1" xml:lang="en-US">Building and Equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_BuildingAndEquipmentMember_2" xml:lang="en-US">Building and equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CarryforwardLosses_0" xml:lang="en-US">Carryforward losses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CarryforwardLosses_1" xml:lang="en-US">Carryforward losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits_0" xml:lang="en-US">Cash and cash equivalents, short-term and restricted bank deposits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits_1" xml:lang="en-US">Cash And Cash Equivalents Short Term And Restricted Bank Deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits_2" xml:lang="en-US">Cash and cash equivalents, short-term and restricted bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CashlessExerciseMember_0" xml:lang="en-US">Cashless exercise [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CashOnHandInNonUsd_0" xml:lang="en-US">The amount of cash held by the entity in Non USD. This does not include demand deposits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CashOnHandInNonUsd_1" xml:lang="en-US">Cash On Hand In Non Usd</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_CashOnHandInNonUsd_2" xml:lang="en-US">Balance in other currencies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CertainEntitiesAffiliatedWithCbiMember_0" xml:lang="en-US">Certain entities affiliated with CBI.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CertainEntitiesAffiliatedWithCbiMember_1" xml:lang="en-US">Certain Entities Affiliated With Cbi [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_CertainEntitiesAffiliatedWithCbiMember_2" xml:lang="en-US">Certain entities affiliated with CBI [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ChairmanMember_0" xml:lang="en-US">Chairman [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ChairmanMember_1" xml:lang="en-US">Chairman [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets_0" xml:lang="en-US">Represent the amount of Capitalization of depreciation of ROU assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets_1" xml:lang="en-US">Change In Property Plant And Equipment Capitalization Of Depreciation Of Rou Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets_2" xml:lang="en-US">Capitalization of depreciation of ROU assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ChangesInAssetAndLiabilityItemsAbstract_0" xml:lang="en-US">Changes In Asset And Liability Items [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ChangesInAssetAndLiabilityItemsAbstract_1" xml:lang="en-US">Changes in asset and liability items:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ChiefExecutiveOfficerAndChiefMedicalOfficerMember_0" xml:lang="en-US">Chief Executive Officer and Chief Medical Officer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ChiefExecutiveOfficerAndChiefMedicalOfficerMember_1" xml:lang="en-US">Chief Executive Officer and Chief Medical Officer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ChiefExecutiveOfficersMember_0" xml:lang="en-US">CEO [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ChiefExecutiveOfficersMember_1" xml:lang="en-US">Chief Executive Officers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ChiefExecutiveOfficersMember_2" xml:lang="en-US">CEO [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CollaborationAgreementsAmountRelatedToPolyheal_0" xml:lang="en-US">Collaboration agreements amount related to Polyheal.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CollaborationAgreementsAmountRelatedToPolyheal_1" xml:lang="en-US">Collaboration agreements amount related to Polyheal</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CommissionsAndOtherOfferingExpenses_0" xml:lang="en-US">Represents the amount of commissions and other offering expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CommissionsAndOtherOfferingExpenses_1" xml:lang="en-US">Commissions And Other Offering Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_CommissionsAndOtherOfferingExpenses_2" xml:lang="en-US">Commissions and other offering expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CompromisedDepreciationExpense_0" xml:lang="en-US">Represents the amount of compromised depreciation expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CompromisedDepreciationExpense_1" xml:lang="en-US">Compromised Depreciation Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_CompromisedDepreciationExpense_2" xml:lang="en-US">Comprised depreciation expenses recorded in the profit and loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ConcentrationRiskPercentage_0" xml:lang="en-US">For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ConcentrationRiskPercentage_1" xml:lang="en-US">Concentration Risk Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ConcentrationRiskPercentage_2" xml:lang="en-US">Percentage of revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ContractAmountForDevelopmentAndManufacturing_0" xml:lang="en-US">Represents the amount of contract for development and manufacturing.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ContractAmountForDevelopmentAndManufacturing_1" xml:lang="en-US">Contract Amount For Development And Manufacturing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ContractAmountForDevelopmentAndManufacturing_2" xml:lang="en-US">Contract amount for development and manufacturing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ContractAssetRelatedToBarda_0" xml:lang="en-US">Represent the contract asset related to BARDA.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ContractAssetRelatedToBarda_1" xml:lang="en-US">Contract Asset Related To Barda</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ContractAssetRelatedToBarda_2" xml:lang="en-US">Contract asset related to BARDA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ContractWithCustomers_0" xml:lang="en-US">Contract With Customers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ContractWithCustomers_1" xml:lang="en-US">Contract With Customers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ContractWithCustomers_2" xml:lang="en-US">Contracts with customers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CostOfLicenseAgreements_0" xml:lang="en-US">Represents the amount of cost of license agreements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CostOfLicenseAgreements_1" xml:lang="en-US">Cost Of License Agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_CostOfLicenseAgreements_2" xml:lang="en-US">Cost of revenues from license agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CostOfMaterials_0" xml:lang="en-US">Cost of materials.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CostOfMaterials_1" xml:lang="en-US">Cost Of Materials</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_CostOfMaterials_2" xml:lang="en-US">Cost of materials</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CostOfRevenuesMember_0" xml:lang="en-US">Cost of revenues [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CostOfRevenuesMember_1" xml:lang="en-US">Cost of Revenues [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_CostOfRevenuesMember_2" xml:lang="en-US">Cost of revenues [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CostOfSalesFromLicenseAgreements_0" xml:lang="en-US">The amount of costs relating to expenses directly or indirectly attributed to license agreements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CostOfSalesFromLicenseAgreements_1" xml:lang="en-US">Cost Of Sales From License Agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_mdwd_CostOfSalesFromLicenseAgreements_2" xml:lang="en-US">Cost of revenues from development services</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CostOfSalesFromSaleOfProducts_0" xml:lang="en-US">The amount of costs relating to expenses directly or indirectly attributed to sale of products.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CostOfSalesFromSaleOfProducts_1" xml:lang="en-US">Cost Of Sales From Sale Of Products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_CostOfSalesFromSaleOfProducts_2" xml:lang="en-US">Cost of revenues from sale of products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_CostOfSalesFromSaleOfProducts_3" xml:lang="en-US">Cost of revenues from sale of products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrs15_0" xml:lang="en-US">Cumulative effect adjustment on accumulated deficit as a result of adopting IFRS 15.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrs15_1" xml:lang="en-US">Cumulative Effect Adjustment On Accumulated Deficit As Result Of Adopting Ifrs 15</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrs15_2" xml:lang="en-US">Cumulative effect adjustment on accumulated ROU assets as a result of adopting IFRS 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CumulativeEffectAdjustmentOnAccumulatedLiabilitiesAsResultOfAdoptingIfrs16_0" xml:lang="en-US">Cumulative effect adjustment on accumulated liabilities&#160;as a result of adopting IFRS 16.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CumulativeEffectAdjustmentOnAccumulatedLiabilitiesAsResultOfAdoptingIfrs16_1" xml:lang="en-US">Cumulative Effect Adjustment On Accumulated Liabilities As Result Of Adopting Ifrs 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_CumulativeEffectAdjustmentOnAccumulatedLiabilitiesAsResultOfAdoptingIfrs16_2" xml:lang="en-US">Cumulative effect adjustment on accumulated liabilities as a result of adopting IFRS 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CurrentBarda_0" xml:lang="en-US">BARDA.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CurrentBarda_1" xml:lang="en-US">Current Barda</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_CurrentBarda_2" xml:lang="en-US">BARDA (Note 18a)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CurrentBardaFundsReceivables_0" xml:lang="en-US">BARDA funds receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CurrentBardaFundsReceivables_1" xml:lang="en-US">Current Barda Funds Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CurrentGovernmentAuthoritiesReceivables_0" xml:lang="en-US">Government authorities receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CurrentGovernmentAuthoritiesReceivables_1" xml:lang="en-US">Current Government Authorities Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_CurrentGovernmentAuthoritiesReceivables_2" xml:lang="en-US">Government authorities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CurrentMaturitiesOfLongTermLiabilities_0" xml:lang="en-US">Represent the amount of current maturities of long-term liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CurrentMaturitiesOfLongTermLiabilities_1" xml:lang="en-US">Current Maturities Of Long Term Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_CurrentMaturitiesOfLongTermLiabilities_2" xml:lang="en-US">Current maturities of long-term liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CurrentMtec_0" xml:lang="en-US">MTEC.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CurrentMtec_1" xml:lang="en-US">Current Mtec</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_CurrentMtec_2" xml:lang="en-US">MTEC (Note 18c)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CurrentVericel_0" xml:lang="en-US">Vericel.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CurrentVericel_1" xml:lang="en-US">Current Vericel</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_CurrentVericel_2" xml:lang="en-US">Vericel (Note 18b)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DeferredRevenueNonCurrent_0" xml:lang="en-US">Represents the deferred revenue non current.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DeferredRevenueNonCurrent_1" xml:lang="en-US">Deferred Revenue Non Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_DeferredRevenueNonCurrent_2" xml:lang="en-US">Deferred revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DeferredRevenues_0" xml:lang="en-US">Represents Deferred Revenues .</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DeferredRevenues_1" xml:lang="en-US">Deferred Revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_DeferredRevenues_2" xml:lang="en-US">Deferred revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DeferredRevenuesExpectedRecongnizedPeriod_0" xml:lang="en-US">Deferred revenues expected recongnized period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DeferredRevenuesExpectedRecongnizedPeriod_1" xml:lang="en-US">Deferred revenues expected recongnized period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DeferredTaxAssetsNotRecognized_0" xml:lang="en-US">Deferred tax assets not recognized because their utilization in the foreseeable future is not probable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DeferredTaxAssetsNotRecognized_1" xml:lang="en-US">Deferred tax assets not recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DepositInterestRate_0" xml:lang="en-US">Deposit interest rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DepositInterestRate_1" xml:lang="en-US">Deposit interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DepreciatedCostMember_0" xml:lang="en-US">Depreciated cost [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DepreciatedCostMember_1" xml:lang="en-US">Depreciated cost [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses_0" xml:lang="en-US">Depreciation and amortization expense related to general and administrative expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses_1" xml:lang="en-US">Depreciation And Amortisation Expense Related To General And Administrative Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses_2" xml:lang="en-US">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment_0" xml:lang="en-US">The amount of depreciation and amortisation expense related to research and development.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment_1" xml:lang="en-US">Depreciation And Amortisation Expense Related To Research And Development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment_2" xml:lang="en-US">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses_0" xml:lang="en-US">The amount of depreciation and amortisation expense related to selling and marketing expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses_1" xml:lang="en-US">Depreciation And Amortisation Expense Related To Selling And Marketing Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses_2" xml:lang="en-US">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory_0" xml:lang="en-US">The disclosure of the basis used for consolidation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory_1" xml:lang="en-US">Description Of Accounting Policy For Basis Of Consolidation Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory_2" xml:lang="en-US">Basis of consolidation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory_0" xml:lang="en-US">The description of the entity's accounting policy for new standards, amendments to standards and interpretations not yet adopted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory_1" xml:lang="en-US">Description Of Accounting Policy For New Standards, Amendments To Standards And Interpretations Not Yet Adopted Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory_2" xml:lang="en-US">New standards, amendments to standards and interpretations not yet adopted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DescriptionOfAccountingPolicyForShortTermBankDepositsExplanatory_0" xml:lang="en-US">The description of the entity's accounting policy for short-term bank deposits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DescriptionOfAccountingPolicyForShortTermBankDepositsExplanatory_1" xml:lang="en-US">Description Of Accounting Policy For Short Term Bank Deposits Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DescriptionOfAccountingPolicyForShortTermBankDepositsExplanatory_2" xml:lang="en-US">Short-term bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DescriptionOfTaxBenefitPeriod_0" xml:lang="en-US">Description of tax benefit period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DescriptionOfTaxBenefitPeriod_1" xml:lang="en-US">Description Of Tax Benefit Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DescriptionOfTaxBenefitPeriod_2" xml:lang="en-US">Tax benefit period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DilutedWeightedAverageNumberMember_0" xml:lang="en-US">Diluted weighted average number.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DilutedWeightedAverageNumberMember_1" xml:lang="en-US">Diluted Weighted Average Number [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DirectorsAndCeoMember_0" xml:lang="en-US">Directors And CEO [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DirectorsAndCeoMember_1" xml:lang="en-US">Directors And Ceo [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DirectorsAndCeoMember_2" xml:lang="en-US">Directors and CEO [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DirectorsMember_0" xml:lang="en-US">Directors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DirectorsMember_1" xml:lang="en-US">Directors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory_0" xml:lang="en-US">Schedule of information on leases.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory_1" xml:lang="en-US">Disclosure Of Additional Information About Lease Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory_2" xml:lang="en-US">Schedule of amounts recognized in profit or loss and in the statement of cash flows</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfAdditionalInformationRevenuesExplanatory_0" xml:lang="en-US">The disclosure of additional information on revenues.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfAdditionalInformationRevenuesExplanatory_1" xml:lang="en-US">Disclosure Of Additional Information Revenues Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfAdditionalInformationRevenuesExplanatory_2" xml:lang="en-US">Schedule of additional information on revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfBasisOfPreparationOfConsolidatedFinancialStatementsAbstract_0" xml:lang="en-US">Disclosure Of Basis Of Preparation Of Consolidated Financial Statements [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfCostOfSalesServicesExplanatory_0" xml:lang="en-US">The disclosure of the cost of sales from services. [Refer: Cost of sales]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfCostOfSalesServicesExplanatory_1" xml:lang="en-US">Disclosure Of Cost Of Sales Services Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfCostOfSalesServicesExplanatory_2" xml:lang="en-US">Schedule of cost of revenues services</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory_0" xml:lang="en-US">The disclosure of detailed information about balances with key officers of the company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Balances With Key Officers Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory_2" xml:lang="en-US">Schedule of balances of key officers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about balances with related parties.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Balances With Related Parties Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory_2" xml:lang="en-US">Schedule of balances of related parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about cash and cash equivalents.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Cash And Cash Equivalents Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_2" xml:lang="en-US">Schedule of cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory_0" xml:lang="en-US">The disclosure of detailed information about condensed interim consolidated statement of financial position.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Condensed Interim Consolidated Statement Of Financial Position Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory_2" xml:lang="en-US">Schedule of condensed interim consolidated statement of financial position</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory_0" xml:lang="en-US">The disclosure of detailed information about condensed interim consolidated statement of profit or loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Condensed Interim Consolidated Statement Of Profit Or Loss Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory_2" xml:lang="en-US">Schedule of condensed interim consolidated statement of profit or loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory_0" xml:lang="en-US">The disclosure of detailed information about details of number of shares and loss used in computation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Details Of Number Of Shares And Loss Used In Computation Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory_2" xml:lang="en-US">Schedule of details of number of shares and loss used in computation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about inventories.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Inventories Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory_2" xml:lang="en-US">Schedule of inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about israeli innovation authority grants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Israeli Innovation Authority Grants Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory_2" xml:lang="en-US">Schedule of Israeli innovation authority grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory_3" xml:lang="en-US">Schedule of Israeli Innovation Authority Grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about net loss per share from continuing and discontinued operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Net Loss Per Share From Continuing And Discontinued Operations Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory_2" xml:lang="en-US">Schedule of net profit (loss) per share from continuing and discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about other payables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Other Payables Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory_2" xml:lang="en-US">Schedule of other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about other receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Other Receivables Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory_2" xml:lang="en-US">Schedule of other short term receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory_0" xml:lang="en-US">The disclosure of detailed information about other receivables long term.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Other Receivables Long Term Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory_2" xml:lang="en-US">Schedule of other long term receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about selling and marketing expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Selling And Marketing Expenses Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory_2" xml:lang="en-US">Schedule of selling expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about short-term bank deposits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Short Term Bank Deposits Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory_2" xml:lang="en-US">Schedule of short-term bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about trade receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Trade Receivables Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory_2" xml:lang="en-US">Schedule of trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory_0" xml:lang="en-US">The disclosure of detailed information about useful lives for property, plant and equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Useful Life Of Property Plant And Equipment Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory_2" xml:lang="en-US">Schedule of depreciation on straight-line basis over useful life of assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfDiscontinuedOperationAbstract_0" xml:lang="en-US">Disclosure of discontinued operation [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0" xml:lang="en-US">Disclosure of Finance Lease and Operating Lease by Lessee Line Items</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_1" xml:lang="en-US">Disclosure Of Finance Lease And Operating Lease By Lessee [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_2" xml:lang="en-US">Disclosure Of Finance Lease And Operating Lease By Lessee [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_3" xml:lang="en-US">Disclosure Of Finance Lease And Operating Lease By Lessee [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_0" xml:lang="en-US">Disclosure Of Finance Lease And Operating Lease By Lessee Table</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1" xml:lang="en-US">Disclosure Of Finance Lease And Operating Lease By Lessee [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_2" xml:lang="en-US">Disclosure Of Finance Lease And Operating Lease By Lessee [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfGeneralInformationAbstract_0" xml:lang="en-US">Disclosure Of General Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfGeneralInformationAbstract_1" xml:lang="en-US">Disclosure of general [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfIncomeTaxesAbstract_0" xml:lang="en-US">Disclosure Of Income Taxes [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_0" xml:lang="en-US">Disclosure of israeli innovation authority grants [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_1" xml:lang="en-US">Liabilities In Respect Of Iia Grants Narrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_2" xml:lang="en-US">Liabilities In Respect Of Iia Grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfMaterialAgreementsAbstract_0" xml:lang="en-US">Disclosure Of Material Agreements [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfMaterialAgreementsExplanatory_0" xml:lang="en-US">The disclosure of material agreements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfMaterialAgreementsExplanatory_1" xml:lang="en-US">Disclosure Of Material Agreements Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfMaterialAgreementsExplanatory_2" xml:lang="en-US">Materials Agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfOtherReceivablesLongTermExplanatory_0" xml:lang="en-US">The entire disclosure for other receivables long term.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfOtherReceivablesLongTermExplanatory_1" xml:lang="en-US">Disclosure Of Other Receivables Long Term Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_DisclosureOfOtherReceivablesLongTermExplanatory_2" xml:lang="en-US">Other Receivables- Long Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfShortTermBankDepositsAbstract_0" xml:lang="en-US">Disclosure Of Short Term Bank Deposits [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_DisclosureOfShortTermBankDepositsAbstract_1" xml:lang="en-US">Short-term Bank Deposits Schedule Of Short-term Bank Deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfShortTermBankDepositsAbstract_2" xml:lang="en-US">Short-term Bank Deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xml:lang="en-US">Disclosure of significant accounting policies [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_1" xml:lang="en-US">Significant Accounting Policies Narrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_2" xml:lang="en-US">Significant Accounting Policies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory_0" xml:lang="en-US">The entire disclosure for supplementary information to the statements of profit and lost and other comprehensive loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory_1" xml:lang="en-US">Disclosure Of Supplementary Information To Statements Of Comprehensive Loss Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory_2" xml:lang="en-US">Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract_0" xml:lang="en-US">Disclosure of supplementary information to the statements of profit and lost and other comprehensive loss [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract_1" xml:lang="en-US">Supplementary Information To Statements Of Comprehensive Profit Or Lost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfTradeReceivablesExplanatory_0" xml:lang="en-US">The entire disclosure of trade receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfTradeReceivablesExplanatory_1" xml:lang="en-US">Disclosure Of Trade Receivables Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfTradeReceivablesExplanatory_2" xml:lang="en-US">Trade Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisposalsMember_0" xml:lang="en-US">Disposals [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisposalsTerminationOfLeases_0" xml:lang="en-US">Disposals- Termination of leases.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_DisposalsTerminationOfLeases_1" xml:lang="en-US">Disposals-Termination of leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisposalsTerminationOfLeases_2" xml:lang="en-US">Disposals-Termination of leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DocumentAndEntityInformationAbstract_0" xml:lang="en-US">Document And Entity Information [Abstract}</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities_0" xml:lang="en-US">Effect of changes in exchange rates.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities_1" xml:lang="en-US">Effect Of Changes In Exchange Rates For Lease Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities_2" xml:lang="en-US">Effect of changes in exchange rates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_EffectOfShareSplit_0" xml:lang="en-US">Effect of share split.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_EffectOfShareSplit_1" xml:lang="en-US">Effect of share split</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_EffectOfTheInitialAdoptionOfTheNewStandardMember_0" xml:lang="en-US">Effect of the initial adoption of the new Standard [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_EmployeesAndDirectorsMember_0" xml:lang="en-US">Employees and directors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_EmployeesAndDirectorsMember_1" xml:lang="en-US">Employees and directors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_EmployeesMember_0" xml:lang="en-US">Employees [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_EmployeesMember_1" xml:lang="en-US">Employees [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember_0" xml:lang="en-US">Employees Officers Board Members CEO And Consultants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember_1" xml:lang="en-US">Employees Officers Board Members Ceo And Consultants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember_2" xml:lang="en-US">Employees, Officers, Board Members CEO and Consultants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_Equity1_0" xml:lang="en-US">The amount of residual interest in the assets of the entity after deducting all its liabilities after adjustment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_mdwd_Equity1_1" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_Equity1_2" xml:lang="en-US">Equity1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_EquityIncentivePlanMember_0" xml:lang="en-US">2014 Equity Incentive Plan (the "2014 Plan") [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_EquityIncentivePlanMember_1" xml:lang="en-US">Equity Incentive Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_EquityIncentivePlanMember_2" xml:lang="en-US">2014 Equity Incentive Plan (the "2014 Plan") [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_EquityTablesAbstract_0" xml:lang="en-US">Equity Tables [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_EUMember_0" xml:lang="en-US">EU [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_EventsAfterReportingPeriodMember_0" xml:lang="en-US">This member stands for events after reporting period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_EventsAfterReportingPeriodMember_1" xml:lang="en-US">Events After Reporting Period [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_EventsAfterReportingPeriodMember_2" xml:lang="en-US">Events after reporting period [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares_0" xml:lang="en-US">Represents exercised options to purchase additional ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares_1" xml:lang="en-US">Exercised Options To Purchase Additional Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares_2" xml:lang="en-US">Exercised options to purchase additional ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ExerciseOfRsuOption_0" xml:lang="en-US">Exercise of RSU's</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ExerciseOfRsuOption_1" xml:lang="en-US">Exercise Of Rsu Option</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ExerciseOfRsuOption_2" xml:lang="en-US">Exercise of RSU&#8217;s</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ExercisePriceOfWarrants_0" xml:lang="en-US">Represents exercise price of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ExercisePriceOfWarrants_1" xml:lang="en-US">Exercise Price Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ExercisePriceOfWarrants_2" xml:lang="en-US">Exercise price of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ExercisePriceShareOptionsGrantedPercentage_0" xml:lang="en-US">The expected exercise price percentage of the share price used to calculate the fair value of the share options granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ExercisePriceShareOptionsGrantedPercentage_1" xml:lang="en-US">Exercise Price Share Options Granted Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ExercisePriceShareOptionsGrantedPercentage_2" xml:lang="en-US">Early exercise factor (%)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ExpectedDividendAsPercentageOfWarrants_0" xml:lang="en-US">Represents the percent of expected dividend as percentage of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ExpectedDividendAsPercentageOfWarrants_1" xml:lang="en-US">Expected Dividend As Percentage Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ExpectedDividendAsPercentageOfWarrants_2" xml:lang="en-US">Expected dividend yield, warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ExpectedTermOfWarrant_0" xml:lang="en-US">Represents the duration of expected term of warrant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ExpectedTermOfWarrant_1" xml:lang="en-US">Expected Term Of Warrant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ExpectedTermOfWarrant_2" xml:lang="en-US">Expected period of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ExpectedVolatilityWarrants_0" xml:lang="en-US">Represents the percent of expected volatility of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ExpectedVolatilityWarrants_1" xml:lang="en-US">Expected Volatility Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ExpectedVolatilityWarrants_2" xml:lang="en-US">Expected volatility, warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_FinanceExpensesInRespectOfDeferredRevenue_0" xml:lang="en-US">Finance expenses in respect of deferred revenue.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_FinanceExpensesInRespectOfDeferredRevenue_1" xml:lang="en-US">Finance expenses in respect of deferred Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_FinanceExpensesInRespectOfDeferredRevenue_2" xml:lang="en-US">Finance expenses in respect of deferred Revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_FinanceIncomeExpenseNet_0" xml:lang="en-US">Financing income (expenses), net.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_FinanceIncomeExpenseNet_1" xml:lang="en-US">Finance Income Expense Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_mdwd_FinanceIncomeExpenseNet_2" xml:lang="en-US">Financing income (expenses), net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_FinancialExpensesNet_0" xml:lang="en-US">The net amount of financial income (expense).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_FinancialExpensesNet_1" xml:lang="en-US">Financial Expenses Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_FinancialExpensesNet_2" xml:lang="en-US">Financial income (expenses), net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_FinancialIncomeAndExpenses_0" xml:lang="en-US">It represents financial income and expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_FinancialIncomeAndExpenses_1" xml:lang="en-US">Financial Income And Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_FinancialIncomeAndExpenses_2" xml:lang="en-US">Financial expenses (income)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_FinancingExpensesAbstract_0" xml:lang="en-US">Financing Expenses [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_FinancingExpensesAbstract_1" xml:lang="en-US">Financial expense:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_FinancingIncomeAbstract_0" xml:lang="en-US">Financing Income [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_FinancingIncomeAbstract_1" xml:lang="en-US">Financial income:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_FinancingIncomeOnNetInvestmentInLease_0" xml:lang="en-US">Represents the amount of financing income on net investment in lease.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_FinancingIncomeOnNetInvestmentInLease_1" xml:lang="en-US">Financing Income On Net Investment In Lease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_FinancingIncomeOnNetInvestmentInLease_2" xml:lang="en-US">Financing income on net investment in lease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_FivePercentageDecreaseInExchangeRateMember_0" xml:lang="en-US">5% decrease in exchange rate [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_FivePercentageDecreaseInExchangeRateMember_1" xml:lang="en-US">Five Percentage Decrease In Exchange Rate [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_FivePercentageDecreaseInExchangeRateMember_2" xml:lang="en-US">5% decrease in NIS and EURO exchange rate [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_FivePercentageIncreaseInExchangeRateMember_0" xml:lang="en-US">5% increase in exchange rate [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_FivePercentageIncreaseInExchangeRateMember_1" xml:lang="en-US">Five Percentage Increase In Exchange Rate [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_FivePercentageIncreaseInExchangeRateMember_2" xml:lang="en-US">5% increase in NIS and EURO exchange rate [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ForDevelopmentCostsOfNexoBridMember_0" xml:lang="en-US">For development costs of NexoBrid [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ForDevelopmentCostsOfNexoBridMember_1" xml:lang="en-US">For Development Costs Of Nexo Brid [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ForDevelopmentCostsOfNexoBridMember_2" xml:lang="en-US">For development costs of NexoBrid [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_FormerShareholder_0" xml:lang="en-US">Amount of other payables to former shareholder.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_FormerShareholder_1" xml:lang="en-US">Former Shareholder</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_FormerShareholder_2" xml:lang="en-US">Former shareholder (see Note 16b)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_FundingByBardaPolicyTextBlock_0" xml:lang="en-US">Funding by BARDA policy text block.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_FundingByBardaPolicyTextBlock_1" xml:lang="en-US">Funding By Barda [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_FundingByBardaPolicyTextBlock_2" xml:lang="en-US">Funding by BARDA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_FutureRoyaltyPaymentsMember_0" xml:lang="en-US">Future royalty payments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_GeneralAndAdministrativeExpensesMember_0" xml:lang="en-US">General and administrative [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_GeneralAndAdministrativeExpensesMember_1" xml:lang="en-US">General And Administrative Expenses [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_GeneralAndAdministrativeExpensesMember_2" xml:lang="en-US">General and administrative [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_GrantsReceived_0" xml:lang="en-US">Grants received.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_GrantsReceived_1" xml:lang="en-US">Grants received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_GrantsReceivedNetOfRoyalties_0" xml:lang="en-US">Grants received net of royalties.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_GrantsReceivedNetOfRoyalties_1" xml:lang="en-US">Grants received net of royalties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_GrossProceedsFromPublicAndPrivateOfferings_0" xml:lang="en-US">Amount of gross proceeds from public and private offerings.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_mdwd_GrossProceedsFromPublicAndPrivateOfferings_1" xml:lang="en-US">Gross proceeds</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_GrossProceedsFromPublicAndPrivateOfferings_2" xml:lang="en-US">Gross Proceeds From Public And Private Offerings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_GrossProceedsFromPublicAndPrivateOfferings_3" xml:lang="en-US">Net proceeds from ordinary shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_GrossProceedsFromPublicAndPrivateOfferings_4" xml:lang="en-US">Proceeds from issuance of shares and warrants, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_IncomeReceivablesLongTerm_0" xml:lang="en-US">Represents the income receivables, long term.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_IncomeReceivablesLongTerm_1" xml:lang="en-US">Income Receivables, Long Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_IncomeReceivablesLongTerm_2" xml:lang="en-US">Income receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_IncomeReceivablesShortTerm_0" xml:lang="en-US">Represents the income receivables, short term.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_IncomeReceivablesShortTerm_1" xml:lang="en-US">Income Receivables Short Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_IncomeReceivablesShortTerm_2" xml:lang="en-US">Income receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_IncomingCEOAndChairmanMember_0" xml:lang="en-US">Incoming CEO and chairman [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_IncomingCEOAndChairmanMember_1" xml:lang="en-US">Incoming C E O And Chairman [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_IncomingCEOAndChairmanMember_2" xml:lang="en-US">Incoming CEO and chairman [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_IncomingCFOMember_0" xml:lang="en-US">Incoming CFO [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_IncomingCFOMember_1" xml:lang="en-US">Incoming C F O [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_IncomingCFOMember_2" xml:lang="en-US">Incoming CFO [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits_0" xml:lang="en-US">Represents the amount of increase (decrease) in equity resulting from the exercise of restricted share units.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits_1" xml:lang="en-US">Increase Decrease In Equity Through Exercise Of Restricted Share Units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits_2" xml:lang="en-US">Exercise of RSU</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_IncreaseInAuthorizedShareCapital_0" xml:lang="en-US">It represents Increase In authorized share capital.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_IncreaseInAuthorizedShareCapital_1" xml:lang="en-US">Increase In Authorized Share Capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_IncreaseInPreFundedWarrantsExercisePrice_0" xml:lang="en-US">Represents increase in pre funded warrants exercise price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_IncreaseInPreFundedWarrantsExercisePrice_1" xml:lang="en-US">Increase In Pre Funded Warrants Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_IncreaseInPreFundedWarrantsExercisePrice_2" xml:lang="en-US">Increase in pre funded warrants exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_IncreaseInSharesIssued_0" xml:lang="en-US">Increase In Shares Issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_IncreaseInSharesIssued_1" xml:lang="en-US">Increase In Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_InitialInvestment_0" xml:lang="en-US">Initial Investment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_InitialInvestment_1" xml:lang="en-US">Initial Investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_InterestRateForLoanMember_0" xml:lang="en-US">Interest rate for a loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_InterestRateForLoanMember_1" xml:lang="en-US">Interest Rate For Loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_InterestRateForLoanMember_2" xml:lang="en-US">Interest rate for a loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_IsraeliShareOptionPlanMember_0" xml:lang="en-US">2003 Israeli Share Option Plan ("Plan") [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_IsraeliShareOptionPlanMember_1" xml:lang="en-US">Israeli Share Option Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_IsraeliShareOptionPlanMember_2" xml:lang="en-US">2003 Israeli Share Option Plan ("Plan") [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_IsraelMember_0" xml:lang="en-US">Israel [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss_0" xml:lang="en-US">Represents the amount of issuance expenses of warrants through profit and loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss_1" xml:lang="en-US">Issuance Expenses Of Warrants Through Profit And Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss_2" xml:lang="en-US">Issuance expenses of warrants through profit and loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_KeyOfficerMember_0" xml:lang="en-US">KeyOfficer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_KeyOfficerMember_1" xml:lang="en-US">Key Officer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_KeyOfficerMember_2" xml:lang="en-US">Key Officer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_KostForerGabbayAndKasiererMember_0" xml:lang="en-US">This member stand for Kost Forer Gabbay And Kasierer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_KostForerGabbayAndKasiererMember_1" xml:lang="en-US">Kost Forer Gabbay And Kasierer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_KostForerGabbayAndKasiererMember_2" xml:lang="en-US">KOST FORER GABBAY &amp; KASIERER [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_KpmgInternationalLimitedMember_0" xml:lang="en-US">This member stand for KPMG International Limited.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_KpmgInternationalLimitedMember_1" xml:lang="en-US">Kpmg International Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_KpmgInternationalLimitedMember_2" xml:lang="en-US">KPMG [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_LaterThanTwoYearAndNotLaterThanEightYearsMember_0" xml:lang="en-US">This member stands for a time band of later than two year and not later than eight years.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_LaterThanTwoYearAndNotLaterThanEightYearsMember_1" xml:lang="en-US">Later Than Two Year And Not Later Than Eight Years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_LaterThanTwoYearAndNotLaterThanEightYearsMember_2" xml:lang="en-US">2-8 years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember_0" xml:lang="en-US">This member stands for a time band of later than two year and not later than fifteen years.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember_1" xml:lang="en-US">Later Than Two Year And Not Later Than Fifteen Years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember_2" xml:lang="en-US">2-15 years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_LeasesAbstract_0" xml:lang="en-US">Leases [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_LeasesAbstract_1" xml:lang="en-US">Leases Schedule Of Information On Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_LeasesAbstract_2" xml:lang="en-US">Leases Schedule Of Information On Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_LiabilitiesInRespectOfGrants_0" xml:lang="en-US">Represent the amount of liabilities in respect of grants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_LiabilitiesInRespectOfGrants_1" xml:lang="en-US">Liabilities In Respect Of Grants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_LiabilitiesInRespectOfGrants_2" xml:lang="en-US">Liabilities in respect of IIA grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_LiabilitiesInRespectOfPurchaseOfShares_0" xml:lang="en-US">Represent the amount of liabilities in respect of purchase of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_LiabilitiesInRespectOfPurchaseOfShares_1" xml:lang="en-US">Liabilities In Respect Of Purchase Of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_LiabilitiesInRespectOfPurchaseOfShares_2" xml:lang="en-US">Liabilities in respect of purchase of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_LiabilitiesInRespectOfTeva_0" xml:lang="en-US">Represent the amount of liabilities in respect of TEVA.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_LiabilitiesInRespectOfTeva_1" xml:lang="en-US">Liabilities In Respect Of Teva</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_LiabilitiesInRespectOfTeva_2" xml:lang="en-US">Liabilities in respect of TEVA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_LiabilityInRespectForPurchaseOfShares_0" xml:lang="en-US">Liability in respect for purchase of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_LiabilityInRespectForPurchaseOfShares_1" xml:lang="en-US">Liability In Respect For Purchase Of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_LiabilityInRespectForPurchaseOfShares_2" xml:lang="en-US">Liability in respect of TEVA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities_0" xml:lang="en-US">Represent the amount of liability in respect of purchase of shares to current maturities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities_1" xml:lang="en-US">Liability In Respect Of Purchase Of Shares To Current Maturities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities_2" xml:lang="en-US">Liability in respect of purchase of shares to current maturities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_LicenseAgreementWithVericelMember_0" xml:lang="en-US">License Agreement with Vericel [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_LicenseAgreementWithVericelMember_1" xml:lang="en-US">License Agreement with Vericel [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_LicenseForPolyhealProductsMember_0" xml:lang="en-US">License for Polyheal Products [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_LicenseForPolyhealProductsMember_1" xml:lang="en-US">License for Polyheal Products [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_LimitOfBenefitEntitlementPeriod_0" xml:lang="en-US">Limit of benefit entitlement period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_LimitOfBenefitEntitlementPeriod_1" xml:lang="en-US">Limit of benefit entitlement period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_LossFromWarrantsTransactions_0" xml:lang="en-US">Represents amount of loss from warrants transactions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_LossFromWarrantsTransactions_1" xml:lang="en-US">Loss From Warrants Transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_LossFromWarrantsTransactions_2" xml:lang="en-US">Loss from warrants transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_MarketingAndSalesExpense_0" xml:lang="en-US">Marketing and sales expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_MarketingAndSalesExpense_1" xml:lang="en-US">Marketing And Sales Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_MarketingAndSalesExpense_2" xml:lang="en-US">Marketing and consulting</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_MaximumAggregateRoyaltiesPaidInPercentage_0" xml:lang="en-US">Maximum aggregate royalties paid in percentage.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_MaximumAggregateRoyaltiesPaidInPercentage_1" xml:lang="en-US">Maximum aggregate royalties paid in percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ModifiedContractAmount_0" xml:lang="en-US">Modified contract amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ModifiedContractAmount_1" xml:lang="en-US">Modified contract amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_MtecMember_0" xml:lang="en-US">MTEC [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_MtecMember_1" xml:lang="en-US">Mtec [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_MtecMember_2" xml:lang="en-US">MTEC [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NetProceedsFromOfferingAmount_0" xml:lang="en-US">It represents net proceeds from offering amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NetProceedsFromOfferingAmount_1" xml:lang="en-US">Net Proceeds From Offering Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_NetProceedsFromOfferingAmount_2" xml:lang="en-US">Net proceeds from offering amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NewFinanceLeaseObligationRecognized_0" xml:lang="en-US">New finance lease obligation recognized.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NewFinanceLeaseObligationRecognized_1" xml:lang="en-US">New finance lease obligation recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NewPolyHealSettlementAgreementsMember_0" xml:lang="en-US">New PolyHeal Settlement Agreements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NewPolyHealSettlementAgreementsMember_1" xml:lang="en-US">New Poly Heal Settlement Agreements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_NewPolyHealSettlementAgreementsMember_2" xml:lang="en-US">New PolyHeal Settlement Agreements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NexoBridMember_0" xml:lang="en-US">NexoBrid [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NexoBridMember_1" xml:lang="en-US">Nexo Brid [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_NexoBridMember_2" xml:lang="en-US">NexoBrid [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NoncancelableLeasePeriods_0" xml:lang="en-US">Noncancelable lease periods.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NoncancelableLeasePeriods_1" xml:lang="en-US">Noncancelable lease periods</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NonCashTransactionsAbstract_0" xml:lang="en-US">Non Cash Transactions [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_NonCashTransactionsAbstract_1" xml:lang="en-US">Supplement disclosure of non-cash transactions:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NonCurrentLiabilitiesCurrent_0" xml:lang="en-US">Current maturities of noncurrent liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NonCurrentLiabilitiesCurrent_1" xml:lang="en-US">Non Current Liabilities Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_NonCurrentLiabilitiesCurrent_2" xml:lang="en-US">Current maturities of long-term liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NumberAbstract_0" xml:lang="en-US">Number [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_NumberAbstract_1" xml:lang="en-US">Number of Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NumberOfDirectors_0" xml:lang="en-US">The number of directors by the entity at a date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NumberOfDirectors_1" xml:lang="en-US">Number Of Directors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_NumberOfDirectors_2" xml:lang="en-US">Number of Directors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NumberOfOrdinarySharesIssuable_0" xml:lang="en-US">Represents the number of ordinary shares issuable on exercising the options granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NumberOfOrdinarySharesIssuable_1" xml:lang="en-US">Number Of Ordinary Shares Issuable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_NumberOfOrdinarySharesIssuable_2" xml:lang="en-US">Number of ordinary shares issuable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NumberOfPreFundedWarrantsExercised_0" xml:lang="en-US">Represents number of pre funded warrants exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NumberOfPreFundedWarrantsExercised_1" xml:lang="en-US">Number Of Pre Funded Warrants Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_NumberOfPreFundedWarrantsExercised_2" xml:lang="en-US">Number of pre funded warrants exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NumberOfRestrictedShareUnitIssued_0" xml:lang="en-US">Represents the number of restricted share unit Issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NumberOfRestrictedShareUnitIssued_1" xml:lang="en-US">Number Of Restricted Share Unit Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_NumberOfRestrictedShareUnitIssued_2" xml:lang="en-US">Number of restricted share unit issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NumberOfSharesExerciseRestrictedStockUnits_0" xml:lang="en-US">It represents as a restricted stock units.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NumberOfSharesExerciseRestrictedStockUnits_1" xml:lang="en-US">Number Of Shares Exercise Restricted Stock Units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_NumberOfSharesExerciseRestrictedStockUnits_2" xml:lang="en-US">Number of restricted stock units issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NumberOfSharesRepurchased_0" xml:lang="en-US">Number of shares repurchased.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NumberOfSharesRepurchased_1" xml:lang="en-US">Number of shares repurchased</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_0" xml:lang="en-US">Represents the number of shares used in calculating basic and diluted profit (loss) per share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_1" xml:lang="en-US">Number Of Shares Used In Calculating Basic And Diluted Profit (Loss) Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_2" xml:lang="en-US">Number of shares used in calculating basic and diluted profit (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NumberOfVehiclesInOperatingLeaseArrangements_0" xml:lang="en-US">Number of vehicles in operating lease arrangements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NumberOfVehiclesInOperatingLeaseArrangements_1" xml:lang="en-US">Number of vehicles in operating lease arrangements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NumberOfWarrantsIssued_0" xml:lang="en-US">Represents number of warrants issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NumberOfWarrantsIssued_1" xml:lang="en-US">Number Of Warrants Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_NumberOfWarrantsIssued_2" xml:lang="en-US">Number of warrants issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_OneTimeLumpsumAmount_0" xml:lang="en-US">One-time lump-sum amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_OneTimeLumpsumAmount_1" xml:lang="en-US">One Time Lumpsum Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_OneTimeLumpsumAmount_2" xml:lang="en-US">One-time lump-sum amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_OtherCountriesMember_0" xml:lang="en-US">Others [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_OtherCountriesMember_1" xml:lang="en-US">Other Countries [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_OtherCountriesMember_2" xml:lang="en-US">EU and other international markets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_OtherCurrentPayable_0" xml:lang="en-US">Other payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_OtherCurrentPayable_1" xml:lang="en-US">Other Current Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_OtherCurrentPayable_2" xml:lang="en-US">Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_OtherCustomerContributedMember_0" xml:lang="en-US">Other Customer Contributed [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_OtherCustomerContributedMember_1" xml:lang="en-US">Other Customer Contributed [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_OtherCustomerContributedMember_2" xml:lang="en-US">Other Customers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_OtherReceivablesDiscontinuedOperations_0" xml:lang="en-US">The amount of other receivables related to discontinued operation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_OtherReceivablesDiscontinuedOperations_1" xml:lang="en-US">Other receivables - discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_OtherResearchAndDevelopmentExpenses_0" xml:lang="en-US">The other amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_OtherResearchAndDevelopmentExpenses_1" xml:lang="en-US">Other research and development expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_OtherSellingGeneralAndAdministrativeExpenses_0" xml:lang="en-US">The other amount of expense relating to selling, general and administrative activities of the entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_OtherSellingGeneralAndAdministrativeExpenses_1" xml:lang="en-US">Other Selling General And Administrative Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_OtherSellingGeneralAndAdministrativeExpenses_2" xml:lang="en-US">Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses_0" xml:lang="en-US">Other temporary differences mainly from research and development expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses_1" xml:lang="en-US">Other Temporary Differences Mainly From R And D Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses_2" xml:lang="en-US">Other temporary differences mainly from R&amp;D expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ParticipationsAbstract_0" xml:lang="en-US">Participations [Abstract']</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ParticipationsAbstract_1" xml:lang="en-US">Participations:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_PatentMember_0" xml:lang="en-US">Patents [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_PatentMember_1" xml:lang="en-US">Patent [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_PatentMember_2" xml:lang="en-US">Patents [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_PercentageOfFutureRoyaltyPayments_0" xml:lang="en-US">Percentage of future royalty payments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_PercentageOfFutureRoyaltyPayments_1" xml:lang="en-US">Percentage of future royalty payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans_0" xml:lang="en-US">Percentage of monthly deposit by employee of their monthly salary in defined contribution plans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans_1" xml:lang="en-US">Percentage of monthly deposit by employee of their monthly salary in defined contribution plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans_2" xml:lang="en-US">Percentage of monthly deposit by employee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_PercentageOfOneTimeLumpSumPaymentAmount_0" xml:lang="en-US">Percentage of one-time lump sum payment amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_PercentageOfOneTimeLumpSumPaymentAmount_1" xml:lang="en-US">Percentage Of One Time Lump Sum Payment Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_PercentageOfOneTimeLumpSumPaymentAmount_2" xml:lang="en-US">Percentage of one-time lump sum payment amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_0" xml:lang="en-US">Percentage of royalties to pay for future revenues from sales of products.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_1" xml:lang="en-US">Percentage of royalties to pay for future revenues from sales of products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_PeriodOfBankDeposits_0" xml:lang="en-US">Period of bank deposits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_PeriodOfBankDeposits_1" xml:lang="en-US">Period of bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_0" xml:lang="en-US">Period of royalties to pay for future revenues from sales of products.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_1" xml:lang="en-US">Period of royalties to pay for future revenues from sales of products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_PeriodOfVehiclesOperatingLeaseArrangements_0" xml:lang="en-US">Period of vehicles operating lease arrangements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_PeriodOfVehiclesOperatingLeaseArrangements_1" xml:lang="en-US">Period of vehicles operating lease arrangements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_PolyhealLtdMember_0" xml:lang="en-US">PolyHeal Ltd. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_PolyhealLtdMember_1" xml:lang="en-US">Polyheal Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_PolyhealMember_0" xml:lang="en-US">Polyheal [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_PolyhealMember_1" xml:lang="en-US">Polyheal [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_PolyhealSettlementAgreementsMember_0" xml:lang="en-US">Polyheal Settlement Agreements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_PolyhealSettlementAgreementsMember_1" xml:lang="en-US">PolyHeal Settlement Agreements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_PrepaidExpensesLongTerm_0" xml:lang="en-US">Prepaid expenses long term.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_PrepaidExpensesLongTerm_1" xml:lang="en-US">Prepaid Expenses Long Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_PrepaidExpensesLongTerm_2" xml:lang="en-US">Prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent_0" xml:lang="en-US">Represents the presentation of Financial Statements Classification of Liabilities as Current or Non Current.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent_1" xml:lang="en-US">Presentation Of Financial Statements Classification Of Liabilities As Current Or Non Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent_2" xml:lang="en-US">Presentation of Financial Statements: Classification of Liabilities as Current or Non-Current (amendment to IAS 1)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_PricePerShareOfSharesIssued_0" xml:lang="en-US">Represents the per share or per unit amount of equity securities issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_PricePerShareOfSharesIssued_1" xml:lang="en-US">Price Per Share Of Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_PricePerShareOfSharesIssued_2" xml:lang="en-US">Price per common shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_PrivateIssuancePurchaseEquityAgreementMember_0" xml:lang="en-US">Represents information of Private Issuance Purchase Equity agreement .</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_PrivateIssuancePurchaseEquityAgreementMember_1" xml:lang="en-US">Private Issuance Purchase Equity Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ProceedsFromAdditionalFunding_0" xml:lang="en-US">Additional funding amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ProceedsFromAdditionalFunding_1" xml:lang="en-US">Proceeds From Additional Funding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ProceedsFromAdditionalFunding_2" xml:lang="en-US">Supplemental funding support the NexoBrid BLA resubmission</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ProceedsFromAdditionalFunding_3" xml:lang="en-US">Additional funding amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ProceedsFromAdditionalProcurement_0" xml:lang="en-US">Additional procurement amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ProceedsFromAdditionalProcurement_1" xml:lang="en-US">Proceeds From Additional Procurement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ProceedsFromAdditionalProcurement_2" xml:lang="en-US">Additional procurement amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ProceedsFromFunding_0" xml:lang="en-US">Funding amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ProceedsFromFunding_1" xml:lang="en-US">Proceeds From Funding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ProceedsFromFunding_2" xml:lang="en-US">Supplemental funding support the NexoBrid BLA resubmission</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ProceedsFromFunding_3" xml:lang="en-US">Funding amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_0" xml:lang="en-US">Amount of proceeds from issuance of shares and warrants, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="lab_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_1" xml:lang="en-US">Proceeds from shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_2" xml:lang="en-US">Proceeds From Issuance Of Shares And Warrants, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_3" xml:lang="en-US">Proceeds from issuance of shares and warrants, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_4" xml:lang="en-US">Proceeds from issuance of shares and warrants, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ProceedsFromIssuingAdditionalShares_0" xml:lang="en-US">The cash inflow from issuing additional shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ProceedsFromIssuingAdditionalShares_1" xml:lang="en-US">Proceeds From Issuing Additional Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ProceedsFromIssuingAdditionalShares_2" xml:lang="en-US">Net proceeds from issue of additional shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ProceedsFromProcurement_0" xml:lang="en-US">Procurement amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ProceedsFromProcurement_1" xml:lang="en-US">Proceeds From Procurement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ProceedsFromProcurement_2" xml:lang="en-US">Procurement amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ProceedsFromRepaymentsOfGrants_0" xml:lang="en-US">Proceeds from (repayments of) grants during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ProceedsFromRepaymentsOfGrants_1" xml:lang="en-US">Proceeds From Repayments Of Grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ProceedsFromRepaymentsOfGrants_2" xml:lang="en-US">Proceeds from (repayment of) IIA grants, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses_0" xml:lang="en-US">Represents the professional fee and share based compensation expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses_1" xml:lang="en-US">Professional Fee And Share Based Compensation Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses_2" xml:lang="en-US">Professional Fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses_3" xml:lang="en-US">Professional fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ProvisionForImpairment_0" xml:lang="en-US">Provision For Impairment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_ProvisionForImpairment_1" xml:lang="en-US">Less provision for impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ProvisionForImpairment_2" xml:lang="en-US">Provision For Impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ProvisionForImpairment_3" xml:lang="en-US">Less provision for impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_PurchaseOfPropertyAndEquipment_0" xml:lang="en-US">Represents the amount of purchase of property and equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_PurchaseOfPropertyAndEquipment_1" xml:lang="en-US">Purchase Of Property And Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_PurchaseOfPropertyAndEquipment_2" xml:lang="en-US">Purchase of property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_PurchasePriceForResidualNumberOfShares_0" xml:lang="en-US">Purchase price for residual number of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_PurchasePriceForResidualNumberOfShares_1" xml:lang="en-US">Purchase price for residual number of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_PurchasePriceOfRegisteredDirectOffering_0" xml:lang="en-US">Represents purchase price per share of registered direct offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_PurchasePriceOfRegisteredDirectOffering_1" xml:lang="en-US">Purchase Price Of Registered Direct Offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_PurchasePriceOfRegisteredDirectOffering_2" xml:lang="en-US">Purchase price of registered direct offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RangesOfExercisePricesEightMember_0" xml:lang="en-US">90.23-96.32 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RangesOfExercisePricesEightMember_1" xml:lang="en-US">Ranges Of Exercise Prices Eight [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_RangesOfExercisePricesEightMember_2" xml:lang="en-US">90.23-96.32 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RangesOfExercisePricesFiveMember_0" xml:lang="en-US">12.25-14.42 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RangesOfExercisePricesFiveMember_1" xml:lang="en-US">Ranges Of Exercise Prices Five [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_RangesOfExercisePricesFiveMember_2" xml:lang="en-US">12.25-14.42 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RangesOfExercisePricesFourMember_0" xml:lang="en-US">12.89 - 13.76 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RangesOfExercisePricesFourMember_1" xml:lang="en-US">Ranges Of Exercise Prices Four [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_RangesOfExercisePricesFourMember_2" xml:lang="en-US">42.14-67.06 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RangesOfExercisePricesOneMember_0" xml:lang="en-US">0.09 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RangesOfExercisePricesOneMember_1" xml:lang="en-US">Ranges Of Exercise Prices One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_RangesOfExercisePricesOneMember_2" xml:lang="en-US">8.26-9.64 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RangesOfExercisePricesServenMember_0" xml:lang="en-US">42.14-67.06 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RangesOfExercisePricesServenMember_1" xml:lang="en-US">Ranges Of Exercise Prices Serven [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_RangesOfExercisePricesServenMember_2" xml:lang="en-US">42.14-67.06 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RangesOfExercisePricesSixMember_0" xml:lang="en-US">26.88-37.52 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RangesOfExercisePricesSixMember_1" xml:lang="en-US">Ranges Of Exercise Prices Six [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_RangesOfExercisePricesSixMember_2" xml:lang="en-US">26.88-37.52 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RangesOfExercisePricesThreeMember_0" xml:lang="en-US">7.26 - 9.82 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RangesOfExercisePricesThreeMember_1" xml:lang="en-US">Ranges Of Exercise Prices Three [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_RangesOfExercisePricesThreeMember_2" xml:lang="en-US">26.88-37.52 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RangesOfExercisePricesTwoMember_0" xml:lang="en-US">2.63 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RangesOfExercisePricesTwoMember_1" xml:lang="en-US">Ranges Of Exercise Prices Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_RangesOfExercisePricesTwoMember_2" xml:lang="en-US">11.89-14.42 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ReceivableFromBarda_0" xml:lang="en-US">Receivable from BARDA.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ReceivableFromBarda_1" xml:lang="en-US">Receivable From Barda</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_mdwd_ReceivableFromBarda_2" xml:lang="en-US">Receivable from BARDA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ReducedAggregateAmount_0" xml:lang="en-US">Reduced aggregate amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ReducedAggregateAmount_1" xml:lang="en-US">Reduced aggregate amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ReducedRateOfPayments_0" xml:lang="en-US">Reduced rate of payments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ReducedRateOfPayments_1" xml:lang="en-US">Reduced rate of payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RegistrationAndMarketingLicenseFees_0" xml:lang="en-US">Registration and marketing license fees.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RegistrationAndMarketingLicenseFees_1" xml:lang="en-US">Registration and marketing license fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RelatedPartiesRentaLexpenseAndOther_0" xml:lang="en-US">The amount of rental expense and other classified under related party transactions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RelatedPartiesRentaLexpenseAndOther_1" xml:lang="en-US">Related Parties Renta Lexpense And Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_0" xml:lang="en-US">Represent the amount of Repayment of liabilities in respect of TEVA.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_1" xml:lang="en-US">Repayment of liabilities in respect of TEVA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_2" xml:lang="en-US">Repayment Of Liabilities In Respect Of Teva</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RepaymentsOfIiaGrantsNet_0" xml:lang="en-US">The cash outflow as repayment of IIA grants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_RepaymentsOfIiaGrantsNet_1" xml:lang="en-US">Repayment of IIA grants, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RepaymentsOfIiaGrantsNet_2" xml:lang="en-US">Repayments Of Iia Grants, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ResearchAndDevelopmentExpenseGross_0" xml:lang="en-US">The gross amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ResearchAndDevelopmentExpenseGross_1" xml:lang="en-US">Research And Development Expense Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_mdwd_ResearchAndDevelopmentExpenseGross_2" xml:lang="en-US">Research and development, gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ResearchAndDevelopmentExpensesMember_0" xml:lang="en-US">Research and development [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ResearchAndDevelopmentExpensesMember_1" xml:lang="en-US">Research And Development Expenses [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ResearchAndDevelopmentExpensesMember_2" xml:lang="en-US">Research and development [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ResearchAndDevelopmentLawMember_0" xml:lang="en-US">R&amp;amp;amp;amp;amp;amp;amp;D Law [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ResearchAndDevelopmentLawMember_1" xml:lang="en-US">Research And Development Law [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ResearchAndDevelopmentLawMember_2" xml:lang="en-US">R&amp;D Law [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RestrictedBankDepositsLongTerm_0" xml:lang="en-US">Represents the restricted bank deposits, long term.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RestrictedBankDepositsLongTerm_1" xml:lang="en-US">Restricted Bank Deposits, Long Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_RestrictedBankDepositsLongTerm_2" xml:lang="en-US">Restricted bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RestrictedSharesUnitsMember_0" xml:lang="en-US">Restricted Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RestrictedSharesUnitsMember_1" xml:lang="en-US">Restricted Shares Units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_RestrictedSharesUnitsMember_2" xml:lang="en-US">Restricted Shares Unit [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RevaluationOfLeaseLiabilities_0" xml:lang="en-US">Revaluation of lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_RevaluationOfLeaseLiabilities_1" xml:lang="en-US">Revaluation of lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RevaluationOfLeaseLiabilities_2" xml:lang="en-US">Revaluation Of Lease Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_0" xml:lang="en-US">Revaluation of liabilities in respect of IIA grants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_1" xml:lang="en-US">Revaluation of liabilities in respect of IIA grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_2" xml:lang="en-US">Amounts carried to Profit or Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_3" xml:lang="en-US">Revaluation Of Liabilities In Respect Of Grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_4" xml:lang="en-US">Revaluation of liabilities in respect of IIA grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfIfrsSixteen_0" xml:lang="en-US">Revaluation of liabilities in respect of IFRS16.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfIfrsSixteen_1" xml:lang="en-US">Revaluation Of Liabilities In Respect Of Ifrs Sixteen</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfIfrsSixteen_2" xml:lang="en-US">Revaluation of liabilities in respect of IFRS16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants_0" xml:lang="en-US">Revaluation of liabilities in respect of IIA grants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants_1" xml:lang="en-US">Revaluation of liabilities in respect of IIA grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants_2" xml:lang="en-US">Revaluation Of Liabilities In Respect Of Iia Grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants_3" xml:lang="en-US">Revaluation of liabilities in respect of IIA grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant_0" xml:lang="en-US">Represents the amount of revaluation of liabilities in respect of IIA grant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant_1" xml:lang="en-US">Revaluation Of Liabilities In Respect Of Ila Grant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant_2" xml:lang="en-US">Revaluation of liabilities in respect of IIA grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfPurchaseOfShares_0" xml:lang="en-US">Revaluation of liabilities in respect of the purchase of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfPurchaseOfShares_1" xml:lang="en-US">Revaluation of liabilities in respect of the purchase of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares_0" xml:lang="en-US">Revaluation of liabilities in respect of the purchase of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares_1" xml:lang="en-US">Revaluation Of Liabilities In Respect Of Purchases Of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares_2" xml:lang="en-US">Revaluation of liabilities in respect of TEVA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RevaluationOfWarrant_0" xml:lang="en-US">Represents the amount of revaluation of Warrant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RevaluationOfWarrant_1" xml:lang="en-US">Revaluation Of Warrant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_RevaluationOfWarrant_2" xml:lang="en-US">Revaluation of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_RevaluationOfWarrant_3" xml:lang="en-US">Revaluation of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RevaluationOfWarrantsAccountedAtFairValue_0" xml:lang="en-US">Represent the amount of Revaluation of warrants accounted at fair value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_RevaluationOfWarrantsAccountedAtFairValue_1" xml:lang="en-US">Revaluation of warrants accounted at fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RevaluationOfWarrantsAccountedAtFairValue_2" xml:lang="en-US">Revaluation Of Warrants Accounted At Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_RevaluationOfWarrantsAccountedAtFairValue_3" xml:lang="en-US">Revaluation of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RevenuesFromDistributionAgreements_0" xml:lang="en-US">Revenues from distribution agreements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RevenuesFromDistributionAgreements_1" xml:lang="en-US">Revenues from distribution agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RevenuesFromSaleOfProcurement_0" xml:lang="en-US">Revenues from sale of procurement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RevenuesFromSaleOfProcurement_1" xml:lang="en-US">Revenues from sale of procurement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ReverseStockSplit_0" xml:lang="en-US">Represents the information about reverse stock split ratio.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ReverseStockSplit_1" xml:lang="en-US">Reverse Stock Split</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ReverseStockSplit_2" xml:lang="en-US">Reverse stock split ratio</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RightOfUseAssetDisposals_0" xml:lang="en-US">Accumulated depreciation on right of use assets disposals.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_RightOfUseAssetDisposals_1" xml:lang="en-US">Disposals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RightOfUseAssetDisposals_2" xml:lang="en-US">Right Of Use Asset Disposals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_RightOfUseAssetDisposals_3" xml:lang="en-US">Disposals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_0" xml:lang="en-US">Accumulated depreciation on right of use assets re-classified to leasehold improvements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_1" xml:lang="en-US">Right Of Use Asset Reclassified To Leasehold Improvements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_2" xml:lang="en-US">Capitalized to Leasehold improvements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_3" xml:lang="en-US">Re-classified to leasehold improvements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RightOfUseAssetsAccumulatedDepreciation_0" xml:lang="en-US">Accumulated depreciation on right of use assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_mdwd_RightOfUseAssetsAccumulatedDepreciation_1" xml:lang="en-US">Balance as of December 31,</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_mdwd_RightOfUseAssetsAccumulatedDepreciation_2" xml:lang="en-US">Balance as of January 1,</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RightOfUseAssetsAccumulatedDepreciation_3" xml:lang="en-US">Right Of Use Assets Accumulated Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract_0" xml:lang="en-US">Right Of Use Assets Accumulated Depreciation [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract_1" xml:lang="en-US">Accumulated depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_RightOfUseAssetsAccumulatedDepreciationAdditionsDuringYearAbstract_0" xml:lang="en-US">Additions during the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RightOfUseAssetsAdditionsDuringYearAbstract_0" xml:lang="en-US">Right Of Use Assets Additions During Year [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RightOfUseAssetsCostAbstract_0" xml:lang="en-US">Right Of Use Assets Cost [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_RightOfUseAssetsCostAbstract_1" xml:lang="en-US">Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RightOfUseAssetsDepreciationAbstract_0" xml:lang="en-US">Right Of Use Assets Depreciation [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_RightOfUseAssetsDepreciationAbstract_1" xml:lang="en-US">Depreciated cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RiskFreeInterestRateOfWarrants_0" xml:lang="en-US">Represents risk free interest rate of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RiskFreeInterestRateOfWarrants_1" xml:lang="en-US">Risk Free Interest Rate Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_RiskFreeInterestRateOfWarrants_2" xml:lang="en-US">Risk free interest rate of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RiskFreeRateOfWarrants_0" xml:lang="en-US">Represents the percent of risk-free rate of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RiskFreeRateOfWarrants_1" xml:lang="en-US">Risk Free Rate Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_RiskFreeRateOfWarrants_2" xml:lang="en-US">Risk-free interest rate, warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RoyaltiesPayments_0" xml:lang="en-US">Royalties payments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RoyaltiesPayments_1" xml:lang="en-US">Royalties payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RoyaltyRightsArisingMember_0" xml:lang="en-US">Royalty rights arising [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SalaryAndBenefits_0" xml:lang="en-US">Salary and benefits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SalaryAndBenefits_1" xml:lang="en-US">Salary and benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements_0" xml:lang="en-US">Represents the salary and benefits expenses related to license agreements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements_1" xml:lang="en-US">Salary And Benefits Expenses Related To License Agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements_2" xml:lang="en-US">Salary and benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SalaryAndBenefitsIncludingShareBasedCompensation_0" xml:lang="en-US">Salary and benefits (including share-based compensation).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SalaryAndBenefitsIncludingShareBasedCompensation_1" xml:lang="en-US">Salary And Benefits Including Share Based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_SalaryAndBenefitsIncludingShareBasedCompensation_2" xml:lang="en-US">Salary and benefits (including share-based compensation)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock_0" xml:lang="en-US">The disclosure of detailed information about amortization periods of the right-of-use assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock_1" xml:lang="en-US">Schedule Of Amortization Periods Of Right Of Use Assets [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock_2" xml:lang="en-US">Schedule of amortization periods of right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ScheduleOfCostOfRevenuesLicense_0" xml:lang="en-US">The disclosure of the cost of sales from license services. [Refer: Cost of sales]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ScheduleOfCostOfRevenuesLicense_1" xml:lang="en-US">Schedule of Cost of Revenues License</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ScheduleOfCostOfRevenuesLicense_2" xml:lang="en-US">Schedule of cost of revenues license</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SellingAndMarketingExpensesMember_0" xml:lang="en-US">Selling and marketing [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SellingAndMarketingExpensesMember_1" xml:lang="en-US">Selling And Marketing Expenses [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_SellingAndMarketingExpensesMember_2" xml:lang="en-US">Selling and marketing [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SensitivityAnalysisAxis_0" xml:lang="en-US">Sensitivity Analysis [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SensitivityAnalysisAxis_1" xml:lang="en-US">Sensitivity Analysis [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_SensitivityAnalysisAxis_2" xml:lang="en-US">SensitivityAnalysisAxis [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract_0" xml:lang="en-US">Sensitivity Test To Changes In Nis And Euro Exchange Rates [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract_1" xml:lang="en-US">Sensitivity test to changes in NIS and EURO exchange rates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SettlementAmountPaidByTeva_0" xml:lang="en-US">Settlement amount paid by Teva.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SettlementAmountPaidByTeva_1" xml:lang="en-US">Settlement amount paid by Teva</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ShareholderMember_0" xml:lang="en-US">Shareholder [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ShareIncentivePlanMember_0" xml:lang="en-US">2014 Share Incentive Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ShareIncentivePlanMember_1" xml:lang="en-US">Share Incentive Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ShareIncentivePlanMember_2" xml:lang="en-US">2014 Share Incentive Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare_0" xml:lang="en-US">Represents the amount of exercise price per share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare_1" xml:lang="en-US">Share Options In Sharebased Payment Arrangement Exercise Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare_2" xml:lang="en-US">Exercise price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SharesAvailableForFutureGrant_0" xml:lang="en-US">Shares available for future grant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SharesAvailableForFutureGrant_1" xml:lang="en-US">Shares available for future grant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SharesIssuedPriceInInitialPublicOffering_0" xml:lang="en-US">Shares issued price in initial public offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SharesIssuedPriceInInitialPublicOffering_1" xml:lang="en-US">Shares issued price in initial public offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SharesReceivedOfPolyheal_0" xml:lang="en-US">Shares received of Polyheal.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SharesReceivedOfPolyheal_1" xml:lang="en-US">Shares received of Polyheal</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_StockOptionValue_0" xml:lang="en-US">Amount of stock option value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_StockOptionValue_1" xml:lang="en-US">Stock Option Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_StockOptionValue_2" xml:lang="en-US">Total value of stock option</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_Subcontractors_0" xml:lang="en-US">Amount of subcontractors during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_Subcontractors_1" xml:lang="en-US">Subcontractors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_Subcontractors_2" xml:lang="en-US">Subcontractors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SubcontractorsExpenses_0" xml:lang="en-US">Subcontractors expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SubcontractorsExpenses_1" xml:lang="en-US">Subcontractors Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_SubcontractorsExpenses_2" xml:lang="en-US">Subcontractors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment_0" xml:lang="en-US">Subcontractors expenses related to research and development.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment_1" xml:lang="en-US">Subcontractors Expenses Related To Research And Development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment_2" xml:lang="en-US">Subcontractors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SubLicensingOfPatentsMember_0" xml:lang="en-US">Sub-licensing of patents [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SubLicensingOfPatentsMember_1" xml:lang="en-US">Sub-licensing of patents [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SubsequentEventsMember_0" xml:lang="en-US">Identifies event that occurred after the balance sheet date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SubsequentEventsMember_1" xml:lang="en-US">Subsequent Events [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SubsidiariesLeaseArea_0" xml:lang="en-US">Subsidiaries Lease Area</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SubsidiariesLeaseArea_1" xml:lang="en-US">Subsidiaries lease, area</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SubsidiariesLeaseEstimatedUsefulLife_0" xml:lang="en-US">Subsidiaries Lease, Estimated Useful Life.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SubsidiariesLeaseEstimatedUsefulLife_1" xml:lang="en-US">Subsidiaries Lease, Estimated Useful Life</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_SubsidiariesLeaseEstimatedUsefulLife_2" xml:lang="en-US">Subsidiaries lease, extented useful life</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SubsidiariesLeaseExpirationDate_0" xml:lang="en-US">Subsidiaries Lease Expiration Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SubsidiariesLeaseExpirationDate_1" xml:lang="en-US">Subsidiaries Lease Expiration Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_SubsidiariesLeaseExpirationDate_2" xml:lang="en-US">Subsidiaries lease, expiration date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SubsidiariesLeaseExpirationPeriod_0" xml:lang="en-US">Subsidiaries Lease Expiration Period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SubsidiariesLeaseExpirationPeriod_1" xml:lang="en-US">Subsidiaries Lease Expiration Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_SubsidiariesLeaseExpirationPeriod_2" xml:lang="en-US">Subsidiaries lease, expiration period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SubsidiariesLeaseExtentionPeriod_0" xml:lang="en-US">Subsidiaries Lease Extension Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SubsidiariesLeaseExtentionPeriod_1" xml:lang="en-US">Subsidiaries lease, extention period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SubsidiariesLeaseMonthlyRent_0" xml:lang="en-US">Subsidiaries Lease Monthly Rent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SubsidiariesLeaseMonthlyRent_1" xml:lang="en-US">Subsidiaries lease, monthly rent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_TermOfLease_0" xml:lang="en-US">Information about term of lease.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_TermOfLease_1" xml:lang="en-US">Term Of Lease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_TermOfLease_2" xml:lang="en-US">Term of lease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_TevaMember_0" xml:lang="en-US">Teva [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_TevaMember_1" xml:lang="en-US">Teva [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ThirdPartiesMember_0" xml:lang="en-US">Third party [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ThirdPartiesMember_1" xml:lang="en-US">Third Parties [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ThirdPartiesMember_2" xml:lang="en-US">Third party [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_TotalBasicAndDilutedNetProfitLossPerShare_0" xml:lang="en-US">Represents the basic and diluted earnings (loss) per share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_TotalBasicAndDilutedNetProfitLossPerShare_1" xml:lang="en-US">Total Basic And Diluted Net Profit (Loss) Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_TotalBasicAndDilutedNetProfitLossPerShare_2" xml:lang="en-US">Total Basic and diluted net profit (loss) per share - USD</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_mdwd_TotalBasicAndDilutedNetProfitLossPerShare_3" xml:lang="en-US">Profit (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_TotalMember_0" xml:lang="en-US">Total [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_TotalRoyaltiesPayments_0" xml:lang="en-US">Amount of total royalties payments during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_TotalRoyaltiesPayments_1" xml:lang="en-US">Total Royalties Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_mdwd_TotalRoyaltiesPayments_2" xml:lang="en-US">Total Royalties payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_TradePayablesAndAccruedExpenses_0" xml:lang="en-US">Represent the amount of trade payables and accrued expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_TradePayablesAndAccruedExpenses_1" xml:lang="en-US">Trade Payables And Accrued Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_TradePayablesAndAccruedExpenses_2" xml:lang="en-US">Trade payables and accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_TransactionOneMember_0" xml:lang="en-US">Transaction One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember_0" xml:lang="en-US">Information about turnkey scale-up agreement with Biopharmax Group Ltd.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember_1" xml:lang="en-US">Turnkey Scale Up Agreement With Biopharmax Group [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember_2" xml:lang="en-US">Biopharmax Group Ltd. contract [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_TwoThousandAndTenPolyHealAgreementMember_0" xml:lang="en-US">2010 PolyHeal Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_TwoThousandTenPolyhealAgreementMember_0" xml:lang="en-US">2010 PolyHeal Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_TwoThousandTenPolyhealAgreementMember_1" xml:lang="en-US">Two Thousand Ten Polyheal Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_UncertaintyInFutureDefaultsMember_0" xml:lang="en-US">Uncertainty in future defaults [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_UncertaintyInFutureDefaultsMember_1" xml:lang="en-US">Uncertainty in future defaults [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_UndertookMember_0" xml:lang="en-US">Undertook [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_UnearnedAmountsReceivedFromCustomers_0" xml:lang="en-US">Unearned amounts from customers not yet recognized.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_UnearnedAmountsReceivedFromCustomers_1" xml:lang="en-US">Unearned Amounts Received From Customers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_UnearnedAmountsReceivedFromCustomers_2" xml:lang="en-US">Unearned amounts from customers not yet recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_UnregisteredPreFundedWarrantsIssued_0" xml:lang="en-US">Represents unregistered Pre-Funded warrants issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_UnregisteredPreFundedWarrantsIssued_1" xml:lang="en-US">Unregistered Pre Funded Warrants Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_UnregisteredPreFundedWarrantsIssued_2" xml:lang="en-US">Unregistered pre funded warrants issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock_0" xml:lang="en-US">Represents unregistered pre funded warrants to purchase common stock.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock_1" xml:lang="en-US">Unregistered Pre Funded Warrants To Purchase Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock_2" xml:lang="en-US">Unregistered pre funded warrants to purchase common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_UpfrontPayment_0" xml:lang="en-US">Upfront payment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_UpfrontPayment_1" xml:lang="en-US">Upfront payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_UsaMember_0" xml:lang="en-US">USA [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_UsaMember_1" xml:lang="en-US">Usa [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_UsaMember_2" xml:lang="en-US">USA [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember_0" xml:lang="en-US">Information about U.S. Department of Defense (DoD), through the Medical Technology Enterprise Consortium (MTEC) contract .</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember_1" xml:lang="en-US">Us Department Of Defense Medical Technology Enterprise Consortium Contract [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember_2" xml:lang="en-US">DOD and MTEC contracts [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_USDepartmentOfDefenseMember_0" xml:lang="en-US">U S Department Of Defense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_USDepartmentOfDefenseMember_1" xml:lang="en-US">U S Department Of Defense [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_USDepartmentOfDefenseMember_2" xml:lang="en-US">U.S. Department of Defense (DoD) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_VericelMember_0" xml:lang="en-US">Vericel [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_VericelMember_1" xml:lang="en-US">Vericel [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_WarrantsExpirationPeriod_0" xml:lang="en-US">Represents warrants expiration period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_WarrantsExpirationPeriod_1" xml:lang="en-US">Warrants Expiration Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_WarrantsExpirationPeriod_2" xml:lang="en-US">Warrants expiration period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_WarrantsToPurchaseOrdinaryShares_0" xml:lang="en-US">Represents warrants to purchase ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_WarrantsToPurchaseOrdinaryShares_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_WarrantsToPurchaseOrdinaryShares_2" xml:lang="en-US">Warrants to purchase ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_WeightedAverageExercisePriceAbstract_0" xml:lang="en-US">Weighted Average Exercise Price [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_WeightedAverageExercisePriceAbstract_1" xml:lang="en-US">Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_CurrencyAxis_0" xml:lang="en-US">Currency [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MaximumMember_0" xml:lang="en-US">Maximum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MinimumMember_0" xml:lang="en-US">Minimum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeAxis_0" xml:lang="en-US">Range [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_srt_RangeAxis_1" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeMember_0" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_DE_1" xlink:to="lab_country_DE_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_ILS_2" xlink:to="lab_currency_ILS_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_ILS_3" xlink:to="lab_currency_ILS_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD_4" xlink:to="lab_currency_USD_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD_5" xlink:to="lab_currency_USD_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain_6" xlink:to="lab_dei_AddressTypeDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_7" xlink:to="lab_dei_AmendmentFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId_8" xlink:to="lab_dei_AuditorFirmId_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation_9" xlink:to="lab_dei_AuditorLocation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName_10" xlink:to="lab_dei_AuditorName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_BusinessContactMember_11" xlink:to="lab_dei_BusinessContactMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_BusinessContactMember_12" xlink:to="lab_dei_BusinessContactMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_13" xlink:to="lab_dei_CityAreaCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelEmailAddress_14" xlink:to="lab_dei_ContactPersonnelEmailAddress_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelFaxNumber_15" xlink:to="lab_dei_ContactPersonnelFaxNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelName_16" xlink:to="lab_dei_ContactPersonnelName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_17" xlink:to="lab_dei_CurrentFiscalYearEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAccountingStandard_18" xlink:to="lab_dei_DocumentAccountingStandard_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport_19" xlink:to="lab_dei_DocumentAnnualReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag_20" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_21" xlink:to="lab_dei_DocumentFiscalPeriodFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_22" xlink:to="lab_dei_DocumentFiscalYearFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_23" xlink:to="lab_dei_DocumentPeriodEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentRegistrationStatement_24" xlink:to="lab_dei_DocumentRegistrationStatement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentShellCompanyReport_25" xlink:to="lab_dei_DocumentShellCompanyReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport_26" xlink:to="lab_dei_DocumentTransitionReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_27" xlink:to="lab_dei_DocumentType_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_28" xlink:to="lab_dei_EntityAddressAddressLine1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_29" xlink:to="lab_dei_EntityAddressCityOrTown_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry_30" xlink:to="lab_dei_EntityAddressCountry_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_31" xlink:to="lab_dei_EntityAddressesAddressTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesLineItems_32" xlink:to="lab_dei_EntityAddressesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesTable_33" xlink:to="lab_dei_EntityAddressesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_34" xlink:to="lab_dei_EntityAddressPostalZipCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_35" xlink:to="lab_dei_EntityCentralIndexKey_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_36" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_37" xlink:to="lab_dei_EntityCurrentReportingStatus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain_38" xlink:to="lab_dei_EntityDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_39" xlink:to="lab_dei_EntityEmergingGrowthCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_40" xlink:to="lab_dei_EntityFileNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_41" xlink:to="lab_dei_EntityFilerCategory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_42" xlink:to="lab_dei_EntityIncorporationStateCountryCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent_43" xlink:to="lab_dei_EntityInteractiveDataCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_44" xlink:to="lab_dei_EntityRegistrantName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany_45" xlink:to="lab_dei_EntityShellCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers_46" xlink:to="lab_dei_EntityVoluntaryFilers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer_47" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag_48" xlink:to="lab_dei_IcfrAuditorAttestationFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis_49" xlink:to="lab_dei_LegalEntityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_50" xlink:to="lab_dei_LocalPhoneNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_51" xlink:to="lab_dei_Security12bTitle_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_52" xlink:to="lab_dei_SecurityExchangeName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_53" xlink:to="lab_dei_TradingSymbol_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_54" xlink:to="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_55" xlink:to="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_56" xlink:to="lab_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_57" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_58" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_59" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_60" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_61" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_62" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_63" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_64" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_65" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_66" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_67" xlink:to="lab_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_68" xlink:to="lab_ifrs-full_AdjustmentsForFinanceIncomeCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_69" xlink:to="lab_ifrs-full_AdjustmentsForFinanceIncomeCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_70" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_71" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_72" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_73" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_74" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_75" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_76" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_77" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_78" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_79" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_80" xlink:to="lab_ifrs-full_AggregatedTimeBandsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_81" xlink:to="lab_ifrs-full_AllLevelsOfFairValueHierarchyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_82" xlink:to="lab_ifrs-full_AmountsPayableRelatedPartyTransactions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ApplicableTaxRate_83" xlink:to="lab_ifrs-full_ApplicableTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ApplicableTaxRate_84" xlink:to="lab_ifrs-full_ApplicableTaxRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets_85" xlink:to="lab_ifrs-full_Assets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets_86" xlink:to="lab_ifrs-full_Assets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BalancesWithBanks_87" xlink:to="lab_ifrs-full_BalancesWithBanks_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShare_88" xlink:to="lab_ifrs-full_BasicEarningsLossPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShare_89" xlink:to="lab_ifrs-full_BasicEarningsLossPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShare_90" xlink:to="lab_ifrs-full_BasicEarningsLossPerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_91" xlink:to="lab_ifrs-full_BorrowingsByNameAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_92" xlink:to="lab_ifrs-full_BorrowingsByNameAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameMember_93" xlink:to="lab_ifrs-full_BorrowingsByNameMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsInterestRateBasis_94" xlink:to="lab_ifrs-full_BorrowingsInterestRateBasis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BottomOfRangeMember_95" xlink:to="lab_ifrs-full_BottomOfRangeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BuildingsMember_96" xlink:to="lab_ifrs-full_BuildingsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BuildingsMember_97" xlink:to="lab_ifrs-full_BuildingsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_98" xlink:to="lab_ifrs-full_BusinessCombinationsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_99" xlink:to="lab_ifrs-full_BusinessCombinationsAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_100" xlink:to="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_101" xlink:to="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountMember_102" xlink:to="lab_ifrs-full_CarryingAmountMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_103" xlink:to="lab_ifrs-full_CashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_104" xlink:to="lab_ifrs-full_CashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_105" xlink:to="lab_ifrs-full_CashAndCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_106" xlink:to="lab_ifrs-full_CashAndCashEquivalents_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_107" xlink:to="lab_ifrs-full_CashAndCashEquivalentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_108" xlink:to="lab_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_109" xlink:to="lab_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_110" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_111" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_112" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_113" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_114" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_115" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_116" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_117" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_118" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_119" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_120" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_121" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashOnHand_122" xlink:to="lab_ifrs-full_CashOnHand_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashOnHand_123" xlink:to="lab_ifrs-full_CashOnHand_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashOutflowForLeases_124" xlink:to="lab_ifrs-full_CashOutflowForLeases_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashOutflowForLeases_125" xlink:to="lab_ifrs-full_CashOutflowForLeases_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_126" xlink:to="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_127" xlink:to="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ChangesInInventoriesOfFinishedGoodsAndWorkInProgress_128" xlink:to="lab_ifrs-full_ChangesInInventoriesOfFinishedGoodsAndWorkInProgress_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ChangesInInventoriesOfFinishedGoodsAndWorkInProgress_129" xlink:to="lab_ifrs-full_ChangesInInventoriesOfFinishedGoodsAndWorkInProgress_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_130" xlink:to="lab_ifrs-full_ClassesOfAssetsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_131" xlink:to="lab_ifrs-full_ClassesOfAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_132" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_133" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_134" xlink:to="lab_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_135" xlink:to="lab_ifrs-full_ClassesOfOrdinarySharesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_136" xlink:to="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_137" xlink:to="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_138" xlink:to="lab_ifrs-full_ClassesOfShareCapitalAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_139" xlink:to="lab_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_140" xlink:to="lab_ifrs-full_ComponentsOfEquityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_141" xlink:to="lab_ifrs-full_ComponentsOfEquityAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_142" xlink:to="lab_ifrs-full_ComprehensiveIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_143" xlink:to="lab_ifrs-full_ComprehensiveIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_144" xlink:to="lab_ifrs-full_ComprehensiveIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_145" xlink:to="lab_ifrs-full_ComprehensiveIncome_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerEquipmentMember_146" xlink:to="lab_ifrs-full_ComputerEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ConsiderationPaidReceived_147" xlink:to="lab_ifrs-full_ConsiderationPaidReceived_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_148" xlink:to="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_149" xlink:to="lab_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfMerchandiseSold_150" xlink:to="lab_ifrs-full_CostOfMerchandiseSold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfMerchandiseSold_151" xlink:to="lab_ifrs-full_CostOfMerchandiseSold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfMerchandiseSold_152" xlink:to="lab_ifrs-full_CostOfMerchandiseSold_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales_153" xlink:to="lab_ifrs-full_CostOfSales_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales_154" xlink:to="lab_ifrs-full_CostOfSales_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales_155" xlink:to="lab_ifrs-full_CostOfSales_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales_156" xlink:to="lab_ifrs-full_CostOfSales_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CountryOfDomicileMember_157" xlink:to="lab_ifrs-full_CountryOfDomicileMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets_158" xlink:to="lab_ifrs-full_CurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets_159" xlink:to="lab_ifrs-full_CurrentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_160" xlink:to="lab_ifrs-full_CurrentAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentGovernmentGrants_161" xlink:to="lab_ifrs-full_CurrentGovernmentGrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentGovernmentGrants_162" xlink:to="lab_ifrs-full_CurrentGovernmentGrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLeaseLiabilities_163" xlink:to="lab_ifrs-full_CurrentLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLeaseLiabilities_164" xlink:to="lab_ifrs-full_CurrentLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLeaseLiabilities_165" xlink:to="lab_ifrs-full_CurrentLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities_166" xlink:to="lab_ifrs-full_CurrentLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities_167" xlink:to="lab_ifrs-full_CurrentLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_168" xlink:to="lab_ifrs-full_CurrentLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_169" xlink:to="lab_ifrs-full_CurrentLiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPrepaidExpenses_170" xlink:to="lab_ifrs-full_CurrentPrepaidExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTradeReceivables_171" xlink:to="lab_ifrs-full_CurrentTradeReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTradeReceivables_172" xlink:to="lab_ifrs-full_CurrentTradeReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTradeReceivables_173" xlink:to="lab_ifrs-full_CurrentTradeReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationAndAmortisationExpense_174" xlink:to="lab_ifrs-full_DepreciationAndAmortisationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationAndAmortisationExpense_175" xlink:to="lab_ifrs-full_DepreciationAndAmortisationExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationExpense_176" xlink:to="lab_ifrs-full_DepreciationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationRightofuseAssets_177" xlink:to="lab_ifrs-full_DepreciationRightofuseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationRightofuseAssets_178" xlink:to="lab_ifrs-full_DepreciationRightofuseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_179" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_180" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_181" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_182" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_183" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_184" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_185" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_186" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_187" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_188" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_189" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_190" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_191" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_192" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_193" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_194" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_195" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_196" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_197" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_198" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_199" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory_200" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_201" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_202" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_203" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_204" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_205" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_206" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_207" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_208" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_209" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_210" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse_211" xlink:to="lab_ifrs-full_DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_212" xlink:to="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract_213" xlink:to="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_214" xlink:to="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_215" xlink:to="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement_216" xlink:to="lab_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_217" xlink:to="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_218" xlink:to="lab_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_219" xlink:to="lab_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_220" xlink:to="lab_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare_221" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare_222" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DirectorsRemunerationExpense_223" xlink:to="lab_ifrs-full_DirectorsRemunerationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DirectorsRemunerationExpense_224" xlink:to="lab_ifrs-full_DirectorsRemunerationExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory_225" xlink:to="lab_ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory_226" xlink:to="lab_ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory_227" xlink:to="lab_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory_228" xlink:to="lab_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_229" xlink:to="lab_ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_230" xlink:to="lab_ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_231" xlink:to="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_232" xlink:to="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_233" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_234" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_235" xlink:to="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_236" xlink:to="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory_237" xlink:to="lab_ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory_238" xlink:to="lab_ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_239" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_240" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_241" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_242" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_243" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_244" xlink:to="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_245" xlink:to="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_246" xlink:to="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_247" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_248" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_249" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCostOfSalesExplanatory_250" xlink:to="lab_ifrs-full_DisclosureOfCostOfSalesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCostOfSalesExplanatory_251" xlink:to="lab_ifrs-full_DisclosureOfCostOfSalesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_252" xlink:to="lab_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_253" xlink:to="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_254" xlink:to="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_255" xlink:to="lab_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_256" xlink:to="lab_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDepositsFromBanksExplanatory_257" xlink:to="lab_ifrs-full_DisclosureOfDepositsFromBanksExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDepositsFromBanksExplanatory_258" xlink:to="lab_ifrs-full_DisclosureOfDepositsFromBanksExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_259" xlink:to="lab_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_260" xlink:to="lab_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_261" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_262" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_263" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_264" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_265" xlink:to="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_266" xlink:to="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory_267" xlink:to="lab_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory_268" xlink:to="lab_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_269" xlink:to="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_270" xlink:to="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_271" xlink:to="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_272" xlink:to="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_273" xlink:to="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_274" xlink:to="lab_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_275" xlink:to="lab_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_276" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_277" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_278" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_279" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_280" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_281" xlink:to="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_282" xlink:to="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_283" xlink:to="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_284" xlink:to="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_285" xlink:to="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_286" xlink:to="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGovernmentGrantsExplanatory_287" xlink:to="lab_ifrs-full_DisclosureOfGovernmentGrantsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGovernmentGrantsExplanatory_288" xlink:to="lab_ifrs-full_DisclosureOfGovernmentGrantsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_289" xlink:to="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_290" xlink:to="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_291" xlink:to="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_292" xlink:to="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_293" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_294" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_295" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_296" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_297" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInventoriesExplanatory_298" xlink:to="lab_ifrs-full_DisclosureOfInventoriesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInventoriesExplanatory_299" xlink:to="lab_ifrs-full_DisclosureOfInventoriesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfLeasesExplanatory_300" xlink:to="lab_ifrs-full_DisclosureOfLeasesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfLeasesExplanatory_301" xlink:to="lab_ifrs-full_DisclosureOfLeasesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_302" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_303" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_304" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_305" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_306" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_307" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_308" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_309" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_310" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_311" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_312" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_313" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_314" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_315" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_316" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_317" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_318" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_319" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_320" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_321" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_322" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_323" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_324" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_325" xlink:to="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_326" xlink:to="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_327" xlink:to="lab_ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_328" xlink:to="lab_ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_329" xlink:to="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_330" xlink:to="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_331" xlink:to="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_332" xlink:to="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_333" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_334" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_335" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_336" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_337" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_338" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_339" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_340" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_341" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_342" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_343" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_344" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_345" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_346" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_347" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_348" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_349" xlink:to="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_350" xlink:to="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_351" xlink:to="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DistributionCosts_352" xlink:to="lab_ifrs-full_DistributionCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_353" xlink:to="lab_ifrs-full_EarningsPerShareAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_354" xlink:to="lab_ifrs-full_EarningsPerShareLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareTable_355" xlink:to="lab_ifrs-full_EarningsPerShareTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_356" xlink:to="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_357" xlink:to="lab_ifrs-full_EmployeeBenefitsExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_358" xlink:to="lab_ifrs-full_EmployeeBenefitsExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_359" xlink:to="lab_ifrs-full_EntitysTotalForRelatedPartiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_360" xlink:to="lab_ifrs-full_Equity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_361" xlink:to="lab_ifrs-full_Equity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_362" xlink:to="lab_ifrs-full_Equity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_363" xlink:to="lab_ifrs-full_Equity_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAbstract_364" xlink:to="lab_ifrs-full_EquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilities_365" xlink:to="lab_ifrs-full_EquityAndLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilities_366" xlink:to="lab_ifrs-full_EquityAndLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_367" xlink:to="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_368" xlink:to="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_369" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_370" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_371" xlink:to="lab_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_372" xlink:to="lab_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_373" xlink:to="lab_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExplanationOfAccountingPoliciesAndMethodsOfComputationFollowedInInterimFinancialStatements_374" xlink:to="lab_ifrs-full_ExplanationOfAccountingPoliciesAndMethodsOfComputationFollowedInInterimFinancialStatements_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExplanationOfAccountingPoliciesAndMethodsOfComputationFollowedInInterimFinancialStatements_375" xlink:to="lab_ifrs-full_ExplanationOfAccountingPoliciesAndMethodsOfComputationFollowedInInterimFinancialStatements_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod_376" xlink:to="lab_ifrs-full_ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions_377" xlink:to="lab_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions_378" xlink:to="lab_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts_379" xlink:to="lab_ifrs-full_FinanceCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts_380" xlink:to="lab_ifrs-full_FinanceCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts_381" xlink:to="lab_ifrs-full_FinanceCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncome_382" xlink:to="lab_ifrs-full_FinanceIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncome_383" xlink:to="lab_ifrs-full_FinanceIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtFairValue_384" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinishedGoods_385" xlink:to="lab_ifrs-full_FinishedGoods_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FixedInterestRateMember_386" xlink:to="lab_ifrs-full_FixedInterestRateMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FixedInterestRateMember_387" xlink:to="lab_ifrs-full_FixedInterestRateMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_388" xlink:to="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_389" xlink:to="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeographicalAreasAxis_390" xlink:to="lab_ifrs-full_GeographicalAreasAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeographicalAreasMember_391" xlink:to="lab_ifrs-full_GeographicalAreasMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GovernmentGrants_392" xlink:to="lab_ifrs-full_GovernmentGrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GovernmentGrants_393" xlink:to="lab_ifrs-full_GovernmentGrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GovernmentGrants_394" xlink:to="lab_ifrs-full_GovernmentGrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember_395" xlink:to="lab_ifrs-full_GrossCarryingAmountMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember_396" xlink:to="lab_ifrs-full_GrossCarryingAmountMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember_397" xlink:to="lab_ifrs-full_GrossCarryingAmountMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit_398" xlink:to="lab_ifrs-full_GrossProfit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit_399" xlink:to="lab_ifrs-full_GrossProfit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeStatementAbstract_400" xlink:to="lab_ifrs-full_IncomeStatementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_401" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_402" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_403" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_404" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_405" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_406" xlink:to="lab_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_407" xlink:to="lab_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings_408" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_409" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_410" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_411" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_412" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_413" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements_414" xlink:to="lab_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_415" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_416" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_417" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_418" xlink:to="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_419" xlink:to="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_420" xlink:to="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_421" xlink:to="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Inventories_422" xlink:to="lab_ifrs-full_Inventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Inventories_423" xlink:to="lab_ifrs-full_Inventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoryWritedown2011_424" xlink:to="lab_ifrs-full_InventoryWritedown2011_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital_425" xlink:to="lab_ifrs-full_IssuedCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital_426" xlink:to="lab_ifrs-full_IssuedCapital_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapitalMember_427" xlink:to="lab_ifrs-full_IssuedCapitalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfEquity_428" xlink:to="lab_ifrs-full_IssueOfEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfEquity_429" xlink:to="lab_ifrs-full_IssueOfEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_430" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_431" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_432" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_433" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_434" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_435" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_436" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseholdImprovementsMember_437" xlink:to="lab_ifrs-full_LeaseholdImprovementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_438" xlink:to="lab_ifrs-full_LeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_439" xlink:to="lab_ifrs-full_LeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_440" xlink:to="lab_ifrs-full_LeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilitiesMember_441" xlink:to="lab_ifrs-full_LeaseLiabilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level3OfFairValueHierarchyMember_442" xlink:to="lab_ifrs-full_Level3OfFairValueHierarchyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level3OfFairValueHierarchyMember_443" xlink:to="lab_ifrs-full_Level3OfFairValueHierarchyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_444" xlink:to="lab_ifrs-full_LevelsOfFairValueHierarchyAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_445" xlink:to="lab_ifrs-full_Liabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_446" xlink:to="lab_ifrs-full_Liabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_447" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_448" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LicenceFeeIncome_449" xlink:to="lab_ifrs-full_LicenceFeeIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LicenceFeeIncome_450" xlink:to="lab_ifrs-full_LicenceFeeIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LicenceFeeIncome_451" xlink:to="lab_ifrs-full_LicenceFeeIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LicencesAndFranchisesMember_452" xlink:to="lab_ifrs-full_LicencesAndFranchisesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermDeposits_453" xlink:to="lab_ifrs-full_LongtermDeposits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermDeposits_454" xlink:to="lab_ifrs-full_LongtermDeposits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MachineryMember_455" xlink:to="lab_ifrs-full_MachineryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_456" xlink:to="lab_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_457" xlink:to="lab_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityAxis_458" xlink:to="lab_ifrs-full_MaturityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MethodsOfGenerationAxis_459" xlink:to="lab_ifrs-full_MethodsOfGenerationAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MethodsOfGenerationAxis_460" xlink:to="lab_ifrs-full_MethodsOfGenerationAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MiscellaneousOtherOperatingExpense_461" xlink:to="lab_ifrs-full_MiscellaneousOtherOperatingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MotorVehiclesMember_462" xlink:to="lab_ifrs-full_MotorVehiclesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MotorVehiclesMember_463" xlink:to="lab_ifrs-full_MotorVehiclesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetForeignExchangeLoss_464" xlink:to="lab_ifrs-full_NetForeignExchangeLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetForeignExchangeLoss_465" xlink:to="lab_ifrs-full_NetForeignExchangeLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_466" xlink:to="lab_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_467" xlink:to="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsMember_468" xlink:to="lab_ifrs-full_NonadjustingEventsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets_469" xlink:to="lab_ifrs-full_NoncurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets_470" xlink:to="lab_ifrs-full_NoncurrentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_471" xlink:to="lab_ifrs-full_NoncurrentAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentGovernmentGrants_472" xlink:to="lab_ifrs-full_NoncurrentGovernmentGrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentGovernmentGrants_473" xlink:to="lab_ifrs-full_NoncurrentGovernmentGrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLeaseLiabilities_474" xlink:to="lab_ifrs-full_NoncurrentLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLeaseLiabilities_475" xlink:to="lab_ifrs-full_NoncurrentLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLeaseLiabilities_476" xlink:to="lab_ifrs-full_NoncurrentLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities_477" xlink:to="lab_ifrs-full_NoncurrentLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities_478" xlink:to="lab_ifrs-full_NoncurrentLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_479" xlink:to="lab_ifrs-full_NoncurrentLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_480" xlink:to="lab_ifrs-full_NoncurrentLiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentReceivablesAbstract_481" xlink:to="lab_ifrs-full_NoncurrentReceivablesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_482" xlink:to="lab_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentWarrantLiability_483" xlink:to="lab_ifrs-full_NoncurrentWarrantLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentWarrantLiability_484" xlink:to="lab_ifrs-full_NoncurrentWarrantLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneYearMember_485" xlink:to="lab_ifrs-full_NotLaterThanOneYearMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneYearMember_486" xlink:to="lab_ifrs-full_NotLaterThanOneYearMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfEmployees_487" xlink:to="lab_ifrs-full_NumberOfEmployees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfEmployees_488" xlink:to="lab_ifrs-full_NumberOfEmployees_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_489" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_490" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_491" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_492" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_493" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions_494" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions_495" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions_496" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_497" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_498" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_499" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_500" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_501" xlink:to="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_502" xlink:to="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_503" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_504" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesAuthorised_505" xlink:to="lab_ifrs-full_NumberOfSharesAuthorised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesAuthorised_506" xlink:to="lab_ifrs-full_NumberOfSharesAuthorised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_507" xlink:to="lab_ifrs-full_NumberOfSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_508" xlink:to="lab_ifrs-full_NumberOfSharesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding_509" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OfficeEquipmentMember_510" xlink:to="lab_ifrs-full_OfficeEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OperatingExpense_511" xlink:to="lab_ifrs-full_OperatingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OperatingExpense_512" xlink:to="lab_ifrs-full_OperatingExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OrdinarySharesMember_513" xlink:to="lab_ifrs-full_OrdinarySharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_514" xlink:to="lab_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_515" xlink:to="lab_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_516" xlink:to="lab_ifrs-full_OtherComprehensiveIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_517" xlink:to="lab_ifrs-full_OtherComprehensiveIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_518" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentPayables_519" xlink:to="lab_ifrs-full_OtherCurrentPayables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentPayables_520" xlink:to="lab_ifrs-full_OtherCurrentPayables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentPayables_521" xlink:to="lab_ifrs-full_OtherCurrentPayables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentPayables_522" xlink:to="lab_ifrs-full_OtherCurrentPayables_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentReceivables_523" xlink:to="lab_ifrs-full_OtherCurrentReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentReceivables_524" xlink:to="lab_ifrs-full_OtherCurrentReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentReceivables_525" xlink:to="lab_ifrs-full_OtherCurrentReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherExpenseByFunction_526" xlink:to="lab_ifrs-full_OtherExpenseByFunction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherExpenseByNature_527" xlink:to="lab_ifrs-full_OtherExpenseByNature_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherExpenseByNature_528" xlink:to="lab_ifrs-full_OtherExpenseByNature_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherFinanceCost_529" xlink:to="lab_ifrs-full_OtherFinanceCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherFinanceCost_530" xlink:to="lab_ifrs-full_OtherFinanceCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIncome_531" xlink:to="lab_ifrs-full_OtherIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIncome_532" xlink:to="lab_ifrs-full_OtherIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIncome_533" xlink:to="lab_ifrs-full_OtherIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIncome_534" xlink:to="lab_ifrs-full_OtherIncome_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentLiabilities_535" xlink:to="lab_ifrs-full_OtherNoncurrentLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentLiabilities_536" xlink:to="lab_ifrs-full_OtherNoncurrentLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentPayables_537" xlink:to="lab_ifrs-full_OtherNoncurrentPayables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentReceivables_538" xlink:to="lab_ifrs-full_OtherNoncurrentReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentReceivables_539" xlink:to="lab_ifrs-full_OtherNoncurrentReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentReceivables_540" xlink:to="lab_ifrs-full_OtherNoncurrentReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense_541" xlink:to="lab_ifrs-full_OtherOperatingIncomeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense_542" xlink:to="lab_ifrs-full_OtherOperatingIncomeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense_543" xlink:to="lab_ifrs-full_OtherOperatingIncomeExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense_544" xlink:to="lab_ifrs-full_OtherOperatingIncomeExpense_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense_545" xlink:to="lab_ifrs-full_OtherOperatingIncomeExpense_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherPayables_546" xlink:to="lab_ifrs-full_OtherPayables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherReceivables_547" xlink:to="lab_ifrs-full_OtherReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherReceivables_548" xlink:to="lab_ifrs-full_OtherReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherRelatedPartiesMember_549" xlink:to="lab_ifrs-full_OtherRelatedPartiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherRelatedPartiesMember_550" xlink:to="lab_ifrs-full_OtherRelatedPartiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ParValuePerShare_551" xlink:to="lab_ifrs-full_ParValuePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_552" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_553" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromExerciseOfOptions_554" xlink:to="lab_ifrs-full_ProceedsFromExerciseOfOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromExerciseOfWarrants_555" xlink:to="lab_ifrs-full_ProceedsFromExerciseOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromExerciseOfWarrants_556" xlink:to="lab_ifrs-full_ProceedsFromExerciseOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromExerciseOfWarrants_557" xlink:to="lab_ifrs-full_ProceedsFromExerciseOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_558" xlink:to="lab_ifrs-full_ProceedsFromIssueOfOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_559" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_560" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_561" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_562" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfessionalFeesExpense_563" xlink:to="lab_ifrs-full_ProfessionalFeesExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfessionalFeesExpense_564" xlink:to="lab_ifrs-full_ProfessionalFeesExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfessionalFeesExpense_565" xlink:to="lab_ifrs-full_ProfessionalFeesExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_566" xlink:to="lab_ifrs-full_ProfitLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_567" xlink:to="lab_ifrs-full_ProfitLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_568" xlink:to="lab_ifrs-full_ProfitLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_569" xlink:to="lab_ifrs-full_ProfitLoss_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_570" xlink:to="lab_ifrs-full_ProfitLossBeforeTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_571" xlink:to="lab_ifrs-full_ProfitLossBeforeTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_572" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_573" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_574" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_575" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_576" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_577" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_578" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_579" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_580" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_581" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_582" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_583" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_584" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_585" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfTreasuryShares_586" xlink:to="lab_ifrs-full_PurchaseOfTreasuryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangeAxis_587" xlink:to="lab_ifrs-full_RangeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesMember_588" xlink:to="lab_ifrs-full_RangesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_589" xlink:to="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_590" xlink:to="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RawMaterials_591" xlink:to="lab_ifrs-full_RawMaterials_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_592" xlink:to="lab_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_593" xlink:to="lab_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_594" xlink:to="lab_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RelatedPartiesMember_595" xlink:to="lab_ifrs-full_RelatedPartiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RelatedPartiesMember_596" xlink:to="lab_ifrs-full_RelatedPartiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense_597" xlink:to="lab_ifrs-full_ResearchAndDevelopmentExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense_598" xlink:to="lab_ifrs-full_ResearchAndDevelopmentExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense_599" xlink:to="lab_ifrs-full_ResearchAndDevelopmentExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense_600" xlink:to="lab_ifrs-full_ResearchAndDevelopmentExpense_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads_601" xlink:to="lab_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads_602" xlink:to="lab_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember_603" xlink:to="lab_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember_604" xlink:to="lab_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RestrictedCashAndCashEquivalents_605" xlink:to="lab_ifrs-full_RestrictedCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RestrictedCashAndCashEquivalents_606" xlink:to="lab_ifrs-full_RestrictedCashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_607" xlink:to="lab_ifrs-full_RetainedEarnings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_608" xlink:to="lab_ifrs-full_RetainedEarnings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_609" xlink:to="lab_ifrs-full_RetainedEarnings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsMember_610" xlink:to="lab_ifrs-full_RetainedEarningsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue_611" xlink:to="lab_ifrs-full_Revenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue_612" xlink:to="lab_ifrs-full_Revenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue_613" xlink:to="lab_ifrs-full_Revenue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromInterest_614" xlink:to="lab_ifrs-full_RevenueFromInterest_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromRenderingOfServices_615" xlink:to="lab_ifrs-full_RevenueFromRenderingOfServices_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromRoyalties_616" xlink:to="lab_ifrs-full_RevenueFromRoyalties_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromSaleOfGoods_617" xlink:to="lab_ifrs-full_RevenueFromSaleOfGoods_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromSaleOfGoods_618" xlink:to="lab_ifrs-full_RevenueFromSaleOfGoods_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets_619" xlink:to="lab_ifrs-full_RightofuseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets_620" xlink:to="lab_ifrs-full_RightofuseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus_621" xlink:to="lab_ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_622" xlink:to="lab_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_623" xlink:to="lab_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_624" xlink:to="lab_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RoyaltyExpense_625" xlink:to="lab_ifrs-full_RoyaltyExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RoyaltyExpense_626" xlink:to="lab_ifrs-full_RoyaltyExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SalesAndMarketingExpense_627" xlink:to="lab_ifrs-full_SalesAndMarketingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SalesAndMarketingExpense_628" xlink:to="lab_ifrs-full_SalesAndMarketingExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SegmentsAxis_629" xlink:to="lab_ifrs-full_SegmentsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SegmentsMember_630" xlink:to="lab_ifrs-full_SegmentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_631" xlink:to="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_632" xlink:to="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk_633" xlink:to="lab_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk_634" xlink:to="lab_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ServicesExpense_635" xlink:to="lab_ifrs-full_ServicesExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ServicesExpense_636" xlink:to="lab_ifrs-full_ServicesExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_637" xlink:to="lab_ifrs-full_SharebasedPaymentArrangementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharePremium_638" xlink:to="lab_ifrs-full_SharePremium_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharePremiumMember_639" xlink:to="lab_ifrs-full_SharePremiumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_640" xlink:to="lab_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_641" xlink:to="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_642" xlink:to="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_643" xlink:to="lab_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_644" xlink:to="lab_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals_645" xlink:to="lab_ifrs-full_ShorttermEmployeeBenefitsAccruals_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_646" xlink:to="lab_ifrs-full_ShorttermEmployeeBenefitsExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_647" xlink:to="lab_ifrs-full_ShorttermEmployeeBenefitsExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_648" xlink:to="lab_ifrs-full_StatementOfCashFlowsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_649" xlink:to="lab_ifrs-full_StatementOfChangesInEquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_650" xlink:to="lab_ifrs-full_StatementOfChangesInEquityLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_651" xlink:to="lab_ifrs-full_StatementOfChangesInEquityTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_652" xlink:to="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_653" xlink:to="lab_ifrs-full_StatementOfFinancialPositionAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TopOfRangeMember_654" xlink:to="lab_ifrs-full_TopOfRangeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_655" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_656" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_657" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_658" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_659" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesAbstract_660" xlink:to="lab_ifrs-full_TradeAndOtherPayablesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradingIncomeExpenseOnForeignExchangeContracts_661" xlink:to="lab_ifrs-full_TradingIncomeExpenseOnForeignExchangeContracts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions_662" xlink:to="lab_ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_663" xlink:to="lab_ifrs-full_TypesOfInterestRatesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfRisksAxis_664" xlink:to="lab_ifrs-full_TypesOfRisksAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_665" xlink:to="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_666" xlink:to="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WagesAndSalaries_667" xlink:to="lab_ifrs-full_WagesAndSalaries_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_668" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_669" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_670" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_671" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_672" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_673" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_674" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_675" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_676" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_677" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_678" xlink:to="lab_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_679" xlink:to="lab_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_680" xlink:to="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_681" xlink:to="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_682" xlink:to="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares_683" xlink:to="lab_ifrs-full_WeightedAverageShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares_684" xlink:to="lab_ifrs-full_WeightedAverageShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AccumaletedEffectOfAdoptingIfrsFifteen_685" xlink:to="lab_mdwd_AccumaletedEffectOfAdoptingIfrsFifteen_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AccumaletedEffectOfAdoptingIfrsFifteen_686" xlink:to="lab_mdwd_AccumaletedEffectOfAdoptingIfrsFifteen_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AccumaletedEffectOfAdoptingIfrsFifteen_687" xlink:to="lab_mdwd_AccumaletedEffectOfAdoptingIfrsFifteen_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AccumulatedFunding_688" xlink:to="lab_mdwd_AccumulatedFunding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AccumulatedFunding_689" xlink:to="lab_mdwd_AccumulatedFunding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionalInvestment_690" xlink:to="lab_mdwd_AdditionalInvestment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionalInvestment_691" xlink:to="lab_mdwd_AdditionalInvestment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits_692" xlink:to="lab_mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits_693" xlink:to="lab_mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits_694" xlink:to="lab_mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionalTermOfLease_695" xlink:to="lab_mdwd_AdditionalTermOfLease_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionalTermOfLease_696" xlink:to="lab_mdwd_AdditionalTermOfLease_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionalTermOfLease_697" xlink:to="lab_mdwd_AdditionalTermOfLease_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionalUpfrontPayment_698" xlink:to="lab_mdwd_AdditionalUpfrontPayment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionalUpfrontPayment_699" xlink:to="lab_mdwd_AdditionalUpfrontPayment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation_700" xlink:to="lab_mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation_701" xlink:to="lab_mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation_702" xlink:to="lab_mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionsToRightOfUseAssetsDisposals_703" xlink:to="lab_mdwd_AdditionsToRightOfUseAssetsDisposals_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionsToRightOfUseAssetsDisposals_704" xlink:to="lab_mdwd_AdditionsToRightOfUseAssetsDisposals_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionsToRightOfUseAssetsDisposals_705" xlink:to="lab_mdwd_AdditionsToRightOfUseAssetsDisposals_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionsToRightOfUseAssetsNewLeases_706" xlink:to="lab_mdwd_AdditionsToRightOfUseAssetsNewLeases_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionsToRightOfUseAssetsNewLeases_707" xlink:to="lab_mdwd_AdditionsToRightOfUseAssetsNewLeases_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionsToRightOfUseAssetsNewLeases_708" xlink:to="lab_mdwd_AdditionsToRightOfUseAssetsNewLeases_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases_709" xlink:to="lab_mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases_710" xlink:to="lab_mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases_711" xlink:to="lab_mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustedWeightedAverageSharesContinuing_712" xlink:to="lab_mdwd_AdjustedWeightedAverageSharesContinuing_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustedWeightedAverageSharesContinuing_713" xlink:to="lab_mdwd_AdjustedWeightedAverageSharesContinuing_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustedWeightedAverageSharesContinuing_714" xlink:to="lab_mdwd_AdjustedWeightedAverageSharesContinuing_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_715" xlink:to="lab_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_716" xlink:to="lab_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_717" xlink:to="lab_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_718" xlink:to="lab_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_719" xlink:to="lab_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue_720" xlink:to="lab_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue_721" xlink:to="lab_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue_722" xlink:to="lab_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue_723" xlink:to="lab_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_724" xlink:to="lab_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_725" xlink:to="lab_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_726" xlink:to="lab_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_727" xlink:to="lab_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability_728" xlink:to="lab_mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability_729" xlink:to="lab_mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability_730" xlink:to="lab_mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherIncome_731" xlink:to="lab_mdwd_AdjustmentsForIncreaseDecreaseInOtherIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherIncome_732" xlink:to="lab_mdwd_AdjustmentsForIncreaseDecreaseInOtherIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherIncome_733" xlink:to="lab_mdwd_AdjustmentsForIncreaseDecreaseInOtherIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_734" xlink:to="lab_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_735" xlink:to="lab_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_736" xlink:to="lab_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForIndexation_737" xlink:to="lab_mdwd_AdjustmentsForIndexation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForIndexation_738" xlink:to="lab_mdwd_AdjustmentsForIndexation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForIndexation_739" xlink:to="lab_mdwd_AdjustmentsForIndexation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_740" xlink:to="lab_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_741" xlink:to="lab_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_742" xlink:to="lab_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsMember_743" xlink:to="lab_mdwd_AdjustmentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsToReconcileNetLossToNetCashProvidedByUsedInContinuingOperatingActivitiesAbstract_744" xlink:to="lab_mdwd_AdjustmentsToReconcileNetLossToNetCashProvidedByUsedInContinuingOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsToReconcileNetLossToNetCashProvidedByUsedInContinuingOperatingActivitiesAbstract_745" xlink:to="lab_mdwd_AdjustmentsToReconcileNetLossToNetCashProvidedByUsedInContinuingOperatingActivitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AggregateAmountOfRegisteredDirectOffering_746" xlink:to="lab_mdwd_AggregateAmountOfRegisteredDirectOffering_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AggregateAmountOfRegisteredDirectOffering_747" xlink:to="lab_mdwd_AggregateAmountOfRegisteredDirectOffering_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AggregateAmountOfRegisteredDirectOffering_748" xlink:to="lab_mdwd_AggregateAmountOfRegisteredDirectOffering_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AggregateSupplementalAmount_749" xlink:to="lab_mdwd_AggregateSupplementalAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AggregateSupplementalAmount_750" xlink:to="lab_mdwd_AggregateSupplementalAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AggregateSupplementalAmount_751" xlink:to="lab_mdwd_AggregateSupplementalAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AgreementAxis_752" xlink:to="lab_mdwd_AgreementAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AgreementAxis_753" xlink:to="lab_mdwd_AgreementAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AgreementAxis_754" xlink:to="lab_mdwd_AgreementAxis_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AgreementDomain_755" xlink:to="lab_mdwd_AgreementDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AgreementDomain_756" xlink:to="lab_mdwd_AgreementDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AllotmentOfDevelopmentCostOfGoodsSold_757" xlink:to="lab_mdwd_AllotmentOfDevelopmentCostOfGoodsSold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AllotmentOfDevelopmentCostOfGoodsSold_758" xlink:to="lab_mdwd_AllotmentOfDevelopmentCostOfGoodsSold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AllotmentOfDevelopmentCostOfGoodsSold_759" xlink:to="lab_mdwd_AllotmentOfDevelopmentCostOfGoodsSold_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AllotmentOfManufacturingCosts_760" xlink:to="lab_mdwd_AllotmentOfManufacturingCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AllotmentOfManufacturingCosts_761" xlink:to="lab_mdwd_AllotmentOfManufacturingCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AllotmentOfManufacturingCostsToResearchAndDevelopment_762" xlink:to="lab_mdwd_AllotmentOfManufacturingCostsToResearchAndDevelopment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AllotmentOfManufacturingCostsToResearchAndDevelopment_763" xlink:to="lab_mdwd_AllotmentOfManufacturingCostsToResearchAndDevelopment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AllotmentOfManufacturingCostsToResearchAndDevelopment_764" xlink:to="lab_mdwd_AllotmentOfManufacturingCostsToResearchAndDevelopment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmortizationPeriodsOfRightOfUseAssets_765" xlink:to="lab_mdwd_AmortizationPeriodsOfRightOfUseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmortizationPeriodsOfRightOfUseAssets_766" xlink:to="lab_mdwd_AmortizationPeriodsOfRightOfUseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmortizationPeriodsOfRightOfUseAssets_767" xlink:to="lab_mdwd_AmortizationPeriodsOfRightOfUseAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmortizedCostMember_768" xlink:to="lab_mdwd_AmortizedCostMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmortizedCostMember_769" xlink:to="lab_mdwd_AmortizedCostMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmortizedCostOfGrantsReceived_770" xlink:to="lab_mdwd_AmortizedCostOfGrantsReceived_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmortizedCostOfGrantsReceived_771" xlink:to="lab_mdwd_AmortizedCostOfGrantsReceived_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmountOfAnnualFeeOfLeaseAgreement_772" xlink:to="lab_mdwd_AmountOfAnnualFeeOfLeaseAgreement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmountOfAnnualFeeOfLeaseAgreement_773" xlink:to="lab_mdwd_AmountOfAnnualFeeOfLeaseAgreement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmountOfAnnualFeeOfLeaseAgreement_774" xlink:to="lab_mdwd_AmountOfAnnualFeeOfLeaseAgreement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmountOfInvestedInProject_775" xlink:to="lab_mdwd_AmountOfInvestedInProject_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmountOfInvestedInProject_776" xlink:to="lab_mdwd_AmountOfInvestedInProject_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmountOfInvestedInProject_777" xlink:to="lab_mdwd_AmountOfInvestedInProject_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmountOfLeaseLiabilityUnderLongTermDebtAndCurrentMaturity_778" xlink:to="lab_mdwd_AmountOfLeaseLiabilityUnderLongTermDebtAndCurrentMaturity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmountOfLeaseLiabilityUnderLongTermDebtAndCurrentMaturity_779" xlink:to="lab_mdwd_AmountOfLeaseLiabilityUnderLongTermDebtAndCurrentMaturity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential_780" xlink:to="lab_mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential_781" xlink:to="lab_mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential_782" xlink:to="lab_mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmountOfSecondContractExpired_783" xlink:to="lab_mdwd_AmountOfSecondContractExpired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmountOfSecondContractExpired_784" xlink:to="lab_mdwd_AmountOfSecondContractExpired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmountOfSecondContractExpired_785" xlink:to="lab_mdwd_AmountOfSecondContractExpired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmountOfTechnicalAssistance_786" xlink:to="lab_mdwd_AmountOfTechnicalAssistance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmountOfTechnicalAssistance_787" xlink:to="lab_mdwd_AmountOfTechnicalAssistance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmountOfTechnicalAssistance_788" xlink:to="lab_mdwd_AmountOfTechnicalAssistance_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmountOfUnderwritingDiscountsAndCommissions_789" xlink:to="lab_mdwd_AmountOfUnderwritingDiscountsAndCommissions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmountOfUnderwritingDiscountsAndCommissions_790" xlink:to="lab_mdwd_AmountOfUnderwritingDiscountsAndCommissions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AmountOfUnderwritingDiscountsAndCommissions_791" xlink:to="lab_mdwd_AmountOfUnderwritingDiscountsAndCommissions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AreaOfLand_792" xlink:to="lab_mdwd_AreaOfLand_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AreaOfLand_793" xlink:to="lab_mdwd_AreaOfLand_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AreaOfLand_794" xlink:to="lab_mdwd_AreaOfLand_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AuthorizedNumberOfSharesIncreased_795" xlink:to="lab_mdwd_AuthorizedNumberOfSharesIncreased_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AuthorizedNumberOfSharesIncreased_796" xlink:to="lab_mdwd_AuthorizedNumberOfSharesIncreased_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AuthorizedNumberOfSharesNominalValue_797" xlink:to="lab_mdwd_AuthorizedNumberOfSharesNominalValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AuthorizedNumberOfSharesNominalValue_798" xlink:to="lab_mdwd_AuthorizedNumberOfSharesNominalValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AuthorizedNumberOfSharesNominalValue_799" xlink:to="lab_mdwd_AuthorizedNumberOfSharesNominalValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AuthorizedShareCapital_800" xlink:to="lab_mdwd_AuthorizedShareCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AuthorizedShareCapital_801" xlink:to="lab_mdwd_AuthorizedShareCapital_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AuthorizedShareCapital_802" xlink:to="lab_mdwd_AuthorizedShareCapital_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AverageStandardDeviationOfWarrants_803" xlink:to="lab_mdwd_AverageStandardDeviationOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AverageStandardDeviationOfWarrants_804" xlink:to="lab_mdwd_AverageStandardDeviationOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AverageStandardDeviationOfWarrants_805" xlink:to="lab_mdwd_AverageStandardDeviationOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BardaFunds_806" xlink:to="lab_mdwd_BardaFunds_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BardaFunds_807" xlink:to="lab_mdwd_BardaFunds_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BardaFunds_808" xlink:to="lab_mdwd_BardaFunds_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BardaMember_809" xlink:to="lab_mdwd_BardaMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BardaMember_810" xlink:to="lab_mdwd_BardaMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BardaMember_811" xlink:to="lab_mdwd_BardaMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BasicAndDilutedEarningsPerShareAbstract_812" xlink:to="lab_mdwd_BasicAndDilutedEarningsPerShareAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BasicAndDilutedNetProfitLossPerShareFromContinuingOperations_813" xlink:to="lab_mdwd_BasicAndDilutedNetProfitLossPerShareFromContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BasicAndDilutedNetProfitLossPerShareFromContinuingOperations_814" xlink:to="lab_mdwd_BasicAndDilutedNetProfitLossPerShareFromContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BasicAndDilutedNetProfitLossPerShareFromContinuingOperations_815" xlink:to="lab_mdwd_BasicAndDilutedNetProfitLossPerShareFromContinuingOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BasicAndDilutedNetProfitLossPerShareFromContinuingOperations_816" xlink:to="lab_mdwd_BasicAndDilutedNetProfitLossPerShareFromContinuingOperations_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations_817" xlink:to="lab_mdwd_BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations_818" xlink:to="lab_mdwd_BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations_819" xlink:to="lab_mdwd_BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations_820" xlink:to="lab_mdwd_BasicAndDilutedNetProfitPerShareFromDiscontinuedOperations_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_821" xlink:to="lab_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_822" xlink:to="lab_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_823" xlink:to="lab_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BoardMembersMember_824" xlink:to="lab_mdwd_BoardMembersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BoardMembersMember_825" xlink:to="lab_mdwd_BoardMembersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BoardMembersMember_826" xlink:to="lab_mdwd_BoardMembersMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BoardOfDirectorsMember_827" xlink:to="lab_mdwd_BoardOfDirectorsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BuildingAndEquipmentMember_828" xlink:to="lab_mdwd_BuildingAndEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BuildingAndEquipmentMember_829" xlink:to="lab_mdwd_BuildingAndEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BuildingAndEquipmentMember_830" xlink:to="lab_mdwd_BuildingAndEquipmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CarryforwardLosses_831" xlink:to="lab_mdwd_CarryforwardLosses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CarryforwardLosses_832" xlink:to="lab_mdwd_CarryforwardLosses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits_833" xlink:to="lab_mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits_834" xlink:to="lab_mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits_835" xlink:to="lab_mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CashlessExerciseMember_836" xlink:to="lab_mdwd_CashlessExerciseMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CashOnHandInNonUsd_837" xlink:to="lab_mdwd_CashOnHandInNonUsd_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CashOnHandInNonUsd_838" xlink:to="lab_mdwd_CashOnHandInNonUsd_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CashOnHandInNonUsd_839" xlink:to="lab_mdwd_CashOnHandInNonUsd_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CertainEntitiesAffiliatedWithCbiMember_840" xlink:to="lab_mdwd_CertainEntitiesAffiliatedWithCbiMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CertainEntitiesAffiliatedWithCbiMember_841" xlink:to="lab_mdwd_CertainEntitiesAffiliatedWithCbiMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CertainEntitiesAffiliatedWithCbiMember_842" xlink:to="lab_mdwd_CertainEntitiesAffiliatedWithCbiMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ChairmanMember_843" xlink:to="lab_mdwd_ChairmanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ChairmanMember_844" xlink:to="lab_mdwd_ChairmanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets_845" xlink:to="lab_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets_846" xlink:to="lab_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets_847" xlink:to="lab_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_848" xlink:to="lab_mdwd_ChangesInAssetAndLiabilityItemsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_849" xlink:to="lab_mdwd_ChangesInAssetAndLiabilityItemsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ChiefExecutiveOfficerAndChiefMedicalOfficerMember_850" xlink:to="lab_mdwd_ChiefExecutiveOfficerAndChiefMedicalOfficerMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ChiefExecutiveOfficerAndChiefMedicalOfficerMember_851" xlink:to="lab_mdwd_ChiefExecutiveOfficerAndChiefMedicalOfficerMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ChiefExecutiveOfficersMember_852" xlink:to="lab_mdwd_ChiefExecutiveOfficersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ChiefExecutiveOfficersMember_853" xlink:to="lab_mdwd_ChiefExecutiveOfficersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ChiefExecutiveOfficersMember_854" xlink:to="lab_mdwd_ChiefExecutiveOfficersMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CollaborationAgreementsAmountRelatedToPolyheal_855" xlink:to="lab_mdwd_CollaborationAgreementsAmountRelatedToPolyheal_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CollaborationAgreementsAmountRelatedToPolyheal_856" xlink:to="lab_mdwd_CollaborationAgreementsAmountRelatedToPolyheal_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CommissionsAndOtherOfferingExpenses_857" xlink:to="lab_mdwd_CommissionsAndOtherOfferingExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CommissionsAndOtherOfferingExpenses_858" xlink:to="lab_mdwd_CommissionsAndOtherOfferingExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CommissionsAndOtherOfferingExpenses_859" xlink:to="lab_mdwd_CommissionsAndOtherOfferingExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CompromisedDepreciationExpense_860" xlink:to="lab_mdwd_CompromisedDepreciationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CompromisedDepreciationExpense_861" xlink:to="lab_mdwd_CompromisedDepreciationExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CompromisedDepreciationExpense_862" xlink:to="lab_mdwd_CompromisedDepreciationExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ConcentrationRiskPercentage_863" xlink:to="lab_mdwd_ConcentrationRiskPercentage_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ConcentrationRiskPercentage_864" xlink:to="lab_mdwd_ConcentrationRiskPercentage_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ConcentrationRiskPercentage_865" xlink:to="lab_mdwd_ConcentrationRiskPercentage_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ContractAmountForDevelopmentAndManufacturing_866" xlink:to="lab_mdwd_ContractAmountForDevelopmentAndManufacturing_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ContractAmountForDevelopmentAndManufacturing_867" xlink:to="lab_mdwd_ContractAmountForDevelopmentAndManufacturing_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ContractAmountForDevelopmentAndManufacturing_868" xlink:to="lab_mdwd_ContractAmountForDevelopmentAndManufacturing_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ContractAssetRelatedToBarda_869" xlink:to="lab_mdwd_ContractAssetRelatedToBarda_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ContractAssetRelatedToBarda_870" xlink:to="lab_mdwd_ContractAssetRelatedToBarda_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ContractAssetRelatedToBarda_871" xlink:to="lab_mdwd_ContractAssetRelatedToBarda_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ContractWithCustomers_872" xlink:to="lab_mdwd_ContractWithCustomers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ContractWithCustomers_873" xlink:to="lab_mdwd_ContractWithCustomers_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ContractWithCustomers_874" xlink:to="lab_mdwd_ContractWithCustomers_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CostOfLicenseAgreements_875" xlink:to="lab_mdwd_CostOfLicenseAgreements_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CostOfLicenseAgreements_876" xlink:to="lab_mdwd_CostOfLicenseAgreements_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CostOfLicenseAgreements_877" xlink:to="lab_mdwd_CostOfLicenseAgreements_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CostOfMaterials_878" xlink:to="lab_mdwd_CostOfMaterials_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CostOfMaterials_879" xlink:to="lab_mdwd_CostOfMaterials_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CostOfMaterials_880" xlink:to="lab_mdwd_CostOfMaterials_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CostOfRevenuesMember_881" xlink:to="lab_mdwd_CostOfRevenuesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CostOfRevenuesMember_882" xlink:to="lab_mdwd_CostOfRevenuesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CostOfRevenuesMember_883" xlink:to="lab_mdwd_CostOfRevenuesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CostOfSalesFromLicenseAgreements_884" xlink:to="lab_mdwd_CostOfSalesFromLicenseAgreements_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CostOfSalesFromLicenseAgreements_885" xlink:to="lab_mdwd_CostOfSalesFromLicenseAgreements_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CostOfSalesFromLicenseAgreements_886" xlink:to="lab_mdwd_CostOfSalesFromLicenseAgreements_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CostOfSalesFromSaleOfProducts_887" xlink:to="lab_mdwd_CostOfSalesFromSaleOfProducts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CostOfSalesFromSaleOfProducts_888" xlink:to="lab_mdwd_CostOfSalesFromSaleOfProducts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CostOfSalesFromSaleOfProducts_889" xlink:to="lab_mdwd_CostOfSalesFromSaleOfProducts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CostOfSalesFromSaleOfProducts_890" xlink:to="lab_mdwd_CostOfSalesFromSaleOfProducts_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrs15_891" xlink:to="lab_mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrs15_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrs15_892" xlink:to="lab_mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrs15_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrs15_893" xlink:to="lab_mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrs15_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CumulativeEffectAdjustmentOnAccumulatedLiabilitiesAsResultOfAdoptingIfrs16_894" xlink:to="lab_mdwd_CumulativeEffectAdjustmentOnAccumulatedLiabilitiesAsResultOfAdoptingIfrs16_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CumulativeEffectAdjustmentOnAccumulatedLiabilitiesAsResultOfAdoptingIfrs16_895" xlink:to="lab_mdwd_CumulativeEffectAdjustmentOnAccumulatedLiabilitiesAsResultOfAdoptingIfrs16_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CumulativeEffectAdjustmentOnAccumulatedLiabilitiesAsResultOfAdoptingIfrs16_896" xlink:to="lab_mdwd_CumulativeEffectAdjustmentOnAccumulatedLiabilitiesAsResultOfAdoptingIfrs16_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CurrentBarda_897" xlink:to="lab_mdwd_CurrentBarda_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CurrentBarda_898" xlink:to="lab_mdwd_CurrentBarda_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CurrentBarda_899" xlink:to="lab_mdwd_CurrentBarda_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CurrentBardaFundsReceivables_900" xlink:to="lab_mdwd_CurrentBardaFundsReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CurrentBardaFundsReceivables_901" xlink:to="lab_mdwd_CurrentBardaFundsReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CurrentGovernmentAuthoritiesReceivables_902" xlink:to="lab_mdwd_CurrentGovernmentAuthoritiesReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CurrentGovernmentAuthoritiesReceivables_903" xlink:to="lab_mdwd_CurrentGovernmentAuthoritiesReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CurrentGovernmentAuthoritiesReceivables_904" xlink:to="lab_mdwd_CurrentGovernmentAuthoritiesReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CurrentMaturitiesOfLongTermLiabilities_905" xlink:to="lab_mdwd_CurrentMaturitiesOfLongTermLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CurrentMaturitiesOfLongTermLiabilities_906" xlink:to="lab_mdwd_CurrentMaturitiesOfLongTermLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CurrentMaturitiesOfLongTermLiabilities_907" xlink:to="lab_mdwd_CurrentMaturitiesOfLongTermLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CurrentMtec_908" xlink:to="lab_mdwd_CurrentMtec_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CurrentMtec_909" xlink:to="lab_mdwd_CurrentMtec_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CurrentMtec_910" xlink:to="lab_mdwd_CurrentMtec_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CurrentVericel_911" xlink:to="lab_mdwd_CurrentVericel_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CurrentVericel_912" xlink:to="lab_mdwd_CurrentVericel_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CurrentVericel_913" xlink:to="lab_mdwd_CurrentVericel_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DeferredRevenueNonCurrent_914" xlink:to="lab_mdwd_DeferredRevenueNonCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DeferredRevenueNonCurrent_915" xlink:to="lab_mdwd_DeferredRevenueNonCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DeferredRevenueNonCurrent_916" xlink:to="lab_mdwd_DeferredRevenueNonCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DeferredRevenues_917" xlink:to="lab_mdwd_DeferredRevenues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DeferredRevenues_918" xlink:to="lab_mdwd_DeferredRevenues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DeferredRevenues_919" xlink:to="lab_mdwd_DeferredRevenues_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DeferredRevenuesExpectedRecongnizedPeriod_920" xlink:to="lab_mdwd_DeferredRevenuesExpectedRecongnizedPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DeferredRevenuesExpectedRecongnizedPeriod_921" xlink:to="lab_mdwd_DeferredRevenuesExpectedRecongnizedPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DeferredTaxAssetsNotRecognized_922" xlink:to="lab_mdwd_DeferredTaxAssetsNotRecognized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DeferredTaxAssetsNotRecognized_923" xlink:to="lab_mdwd_DeferredTaxAssetsNotRecognized_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DepositInterestRate_924" xlink:to="lab_mdwd_DepositInterestRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DepositInterestRate_925" xlink:to="lab_mdwd_DepositInterestRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DepreciatedCostMember_926" xlink:to="lab_mdwd_DepreciatedCostMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DepreciatedCostMember_927" xlink:to="lab_mdwd_DepreciatedCostMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses_928" xlink:to="lab_mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses_929" xlink:to="lab_mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses_930" xlink:to="lab_mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment_931" xlink:to="lab_mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment_932" xlink:to="lab_mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment_933" xlink:to="lab_mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses_934" xlink:to="lab_mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses_935" xlink:to="lab_mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses_936" xlink:to="lab_mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory_937" xlink:to="lab_mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory_938" xlink:to="lab_mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory_939" xlink:to="lab_mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory_940" xlink:to="lab_mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory_941" xlink:to="lab_mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory_942" xlink:to="lab_mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DescriptionOfAccountingPolicyForShortTermBankDepositsExplanatory_943" xlink:to="lab_mdwd_DescriptionOfAccountingPolicyForShortTermBankDepositsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DescriptionOfAccountingPolicyForShortTermBankDepositsExplanatory_944" xlink:to="lab_mdwd_DescriptionOfAccountingPolicyForShortTermBankDepositsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DescriptionOfAccountingPolicyForShortTermBankDepositsExplanatory_945" xlink:to="lab_mdwd_DescriptionOfAccountingPolicyForShortTermBankDepositsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DescriptionOfTaxBenefitPeriod_946" xlink:to="lab_mdwd_DescriptionOfTaxBenefitPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DescriptionOfTaxBenefitPeriod_947" xlink:to="lab_mdwd_DescriptionOfTaxBenefitPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DescriptionOfTaxBenefitPeriod_948" xlink:to="lab_mdwd_DescriptionOfTaxBenefitPeriod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DilutedWeightedAverageNumberMember_949" xlink:to="lab_mdwd_DilutedWeightedAverageNumberMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DilutedWeightedAverageNumberMember_950" xlink:to="lab_mdwd_DilutedWeightedAverageNumberMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DirectorsAndCeoMember_951" xlink:to="lab_mdwd_DirectorsAndCeoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DirectorsAndCeoMember_952" xlink:to="lab_mdwd_DirectorsAndCeoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DirectorsAndCeoMember_953" xlink:to="lab_mdwd_DirectorsAndCeoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DirectorsMember_954" xlink:to="lab_mdwd_DirectorsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DirectorsMember_955" xlink:to="lab_mdwd_DirectorsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory_956" xlink:to="lab_mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory_957" xlink:to="lab_mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory_958" xlink:to="lab_mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfAdditionalInformationRevenuesExplanatory_959" xlink:to="lab_mdwd_DisclosureOfAdditionalInformationRevenuesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfAdditionalInformationRevenuesExplanatory_960" xlink:to="lab_mdwd_DisclosureOfAdditionalInformationRevenuesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfAdditionalInformationRevenuesExplanatory_961" xlink:to="lab_mdwd_DisclosureOfAdditionalInformationRevenuesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfBasisOfPreparationOfConsolidatedFinancialStatementsAbstract_962" xlink:to="lab_mdwd_DisclosureOfBasisOfPreparationOfConsolidatedFinancialStatementsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfCostOfSalesServicesExplanatory_963" xlink:to="lab_mdwd_DisclosureOfCostOfSalesServicesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfCostOfSalesServicesExplanatory_964" xlink:to="lab_mdwd_DisclosureOfCostOfSalesServicesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfCostOfSalesServicesExplanatory_965" xlink:to="lab_mdwd_DisclosureOfCostOfSalesServicesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory_966" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory_967" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory_968" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory_969" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory_970" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory_971" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_972" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_973" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_974" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory_975" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory_976" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory_977" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory_978" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory_979" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory_980" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory_981" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory_982" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory_983" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory_984" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory_985" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory_986" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory_987" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory_988" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory_989" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory_990" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory_991" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory_992" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory_993" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory_994" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory_995" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory_996" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory_997" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory_998" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory_999" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory_1000" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory_1001" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory_1002" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory_1003" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory_1004" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory_1005" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory_1006" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory_1007" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory_1008" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory_1009" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory_1010" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory_1011" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory_1012" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory_1013" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory_1014" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDiscontinuedOperationAbstract_1015" xlink:to="lab_mdwd_DisclosureOfDiscontinuedOperationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_1016" xlink:to="lab_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_1017" xlink:to="lab_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_1018" xlink:to="lab_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_1019" xlink:to="lab_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1020" xlink:to="lab_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1021" xlink:to="lab_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1022" xlink:to="lab_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfGeneralInformationAbstract_1023" xlink:to="lab_mdwd_DisclosureOfGeneralInformationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfGeneralInformationAbstract_1024" xlink:to="lab_mdwd_DisclosureOfGeneralInformationAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfIncomeTaxesAbstract_1025" xlink:to="lab_mdwd_DisclosureOfIncomeTaxesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_1026" xlink:to="lab_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_1027" xlink:to="lab_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_1028" xlink:to="lab_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfMaterialAgreementsAbstract_1029" xlink:to="lab_mdwd_DisclosureOfMaterialAgreementsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfMaterialAgreementsExplanatory_1030" xlink:to="lab_mdwd_DisclosureOfMaterialAgreementsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfMaterialAgreementsExplanatory_1031" xlink:to="lab_mdwd_DisclosureOfMaterialAgreementsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfMaterialAgreementsExplanatory_1032" xlink:to="lab_mdwd_DisclosureOfMaterialAgreementsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfOtherReceivablesLongTermExplanatory_1033" xlink:to="lab_mdwd_DisclosureOfOtherReceivablesLongTermExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfOtherReceivablesLongTermExplanatory_1034" xlink:to="lab_mdwd_DisclosureOfOtherReceivablesLongTermExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfOtherReceivablesLongTermExplanatory_1035" xlink:to="lab_mdwd_DisclosureOfOtherReceivablesLongTermExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfShortTermBankDepositsAbstract_1036" xlink:to="lab_mdwd_DisclosureOfShortTermBankDepositsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfShortTermBankDepositsAbstract_1037" xlink:to="lab_mdwd_DisclosureOfShortTermBankDepositsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfShortTermBankDepositsAbstract_1038" xlink:to="lab_mdwd_DisclosureOfShortTermBankDepositsAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_1039" xlink:to="lab_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_1040" xlink:to="lab_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_1041" xlink:to="lab_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory_1042" xlink:to="lab_mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory_1043" xlink:to="lab_mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory_1044" xlink:to="lab_mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract_1045" xlink:to="lab_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract_1046" xlink:to="lab_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfTradeReceivablesExplanatory_1047" xlink:to="lab_mdwd_DisclosureOfTradeReceivablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfTradeReceivablesExplanatory_1048" xlink:to="lab_mdwd_DisclosureOfTradeReceivablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfTradeReceivablesExplanatory_1049" xlink:to="lab_mdwd_DisclosureOfTradeReceivablesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisposalsMember_1050" xlink:to="lab_mdwd_DisposalsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisposalsTerminationOfLeases_1051" xlink:to="lab_mdwd_DisposalsTerminationOfLeases_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisposalsTerminationOfLeases_1052" xlink:to="lab_mdwd_DisposalsTerminationOfLeases_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisposalsTerminationOfLeases_1053" xlink:to="lab_mdwd_DisposalsTerminationOfLeases_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DocumentAndEntityInformationAbstract_1054" xlink:to="lab_mdwd_DocumentAndEntityInformationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities_1055" xlink:to="lab_mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities_1056" xlink:to="lab_mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities_1057" xlink:to="lab_mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EffectOfShareSplit_1058" xlink:to="lab_mdwd_EffectOfShareSplit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EffectOfShareSplit_1059" xlink:to="lab_mdwd_EffectOfShareSplit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EffectOfTheInitialAdoptionOfTheNewStandardMember_1060" xlink:to="lab_mdwd_EffectOfTheInitialAdoptionOfTheNewStandardMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EmployeesAndDirectorsMember_1061" xlink:to="lab_mdwd_EmployeesAndDirectorsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EmployeesAndDirectorsMember_1062" xlink:to="lab_mdwd_EmployeesAndDirectorsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EmployeesMember_1063" xlink:to="lab_mdwd_EmployeesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EmployeesMember_1064" xlink:to="lab_mdwd_EmployeesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember_1065" xlink:to="lab_mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember_1066" xlink:to="lab_mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember_1067" xlink:to="lab_mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_Equity1_1068" xlink:to="lab_mdwd_Equity1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_Equity1_1069" xlink:to="lab_mdwd_Equity1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_Equity1_1070" xlink:to="lab_mdwd_Equity1_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EquityIncentivePlanMember_1071" xlink:to="lab_mdwd_EquityIncentivePlanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EquityIncentivePlanMember_1072" xlink:to="lab_mdwd_EquityIncentivePlanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EquityIncentivePlanMember_1073" xlink:to="lab_mdwd_EquityIncentivePlanMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EquityTablesAbstract_1074" xlink:to="lab_mdwd_EquityTablesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EUMember_1075" xlink:to="lab_mdwd_EUMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EventsAfterReportingPeriodMember_1076" xlink:to="lab_mdwd_EventsAfterReportingPeriodMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EventsAfterReportingPeriodMember_1077" xlink:to="lab_mdwd_EventsAfterReportingPeriodMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EventsAfterReportingPeriodMember_1078" xlink:to="lab_mdwd_EventsAfterReportingPeriodMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares_1079" xlink:to="lab_mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares_1080" xlink:to="lab_mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares_1081" xlink:to="lab_mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExerciseOfRsuOption_1082" xlink:to="lab_mdwd_ExerciseOfRsuOption_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExerciseOfRsuOption_1083" xlink:to="lab_mdwd_ExerciseOfRsuOption_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExerciseOfRsuOption_1084" xlink:to="lab_mdwd_ExerciseOfRsuOption_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExercisePriceOfWarrants_1085" xlink:to="lab_mdwd_ExercisePriceOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExercisePriceOfWarrants_1086" xlink:to="lab_mdwd_ExercisePriceOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExercisePriceOfWarrants_1087" xlink:to="lab_mdwd_ExercisePriceOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExercisePriceShareOptionsGrantedPercentage_1088" xlink:to="lab_mdwd_ExercisePriceShareOptionsGrantedPercentage_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExercisePriceShareOptionsGrantedPercentage_1089" xlink:to="lab_mdwd_ExercisePriceShareOptionsGrantedPercentage_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExercisePriceShareOptionsGrantedPercentage_1090" xlink:to="lab_mdwd_ExercisePriceShareOptionsGrantedPercentage_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExpectedDividendAsPercentageOfWarrants_1091" xlink:to="lab_mdwd_ExpectedDividendAsPercentageOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExpectedDividendAsPercentageOfWarrants_1092" xlink:to="lab_mdwd_ExpectedDividendAsPercentageOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExpectedDividendAsPercentageOfWarrants_1093" xlink:to="lab_mdwd_ExpectedDividendAsPercentageOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExpectedTermOfWarrant_1094" xlink:to="lab_mdwd_ExpectedTermOfWarrant_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExpectedTermOfWarrant_1095" xlink:to="lab_mdwd_ExpectedTermOfWarrant_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExpectedTermOfWarrant_1096" xlink:to="lab_mdwd_ExpectedTermOfWarrant_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExpectedVolatilityWarrants_1097" xlink:to="lab_mdwd_ExpectedVolatilityWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExpectedVolatilityWarrants_1098" xlink:to="lab_mdwd_ExpectedVolatilityWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExpectedVolatilityWarrants_1099" xlink:to="lab_mdwd_ExpectedVolatilityWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinanceExpensesInRespectOfDeferredRevenue_1100" xlink:to="lab_mdwd_FinanceExpensesInRespectOfDeferredRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinanceExpensesInRespectOfDeferredRevenue_1101" xlink:to="lab_mdwd_FinanceExpensesInRespectOfDeferredRevenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinanceExpensesInRespectOfDeferredRevenue_1102" xlink:to="lab_mdwd_FinanceExpensesInRespectOfDeferredRevenue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinanceIncomeExpenseNet_1103" xlink:to="lab_mdwd_FinanceIncomeExpenseNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinanceIncomeExpenseNet_1104" xlink:to="lab_mdwd_FinanceIncomeExpenseNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinanceIncomeExpenseNet_1105" xlink:to="lab_mdwd_FinanceIncomeExpenseNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinancialExpensesNet_1106" xlink:to="lab_mdwd_FinancialExpensesNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinancialExpensesNet_1107" xlink:to="lab_mdwd_FinancialExpensesNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinancialExpensesNet_1108" xlink:to="lab_mdwd_FinancialExpensesNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinancialIncomeAndExpenses_1109" xlink:to="lab_mdwd_FinancialIncomeAndExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinancialIncomeAndExpenses_1110" xlink:to="lab_mdwd_FinancialIncomeAndExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinancialIncomeAndExpenses_1111" xlink:to="lab_mdwd_FinancialIncomeAndExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinancingExpensesAbstract_1112" xlink:to="lab_mdwd_FinancingExpensesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinancingExpensesAbstract_1113" xlink:to="lab_mdwd_FinancingExpensesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinancingIncomeAbstract_1114" xlink:to="lab_mdwd_FinancingIncomeAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinancingIncomeAbstract_1115" xlink:to="lab_mdwd_FinancingIncomeAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinancingIncomeOnNetInvestmentInLease_1116" xlink:to="lab_mdwd_FinancingIncomeOnNetInvestmentInLease_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinancingIncomeOnNetInvestmentInLease_1117" xlink:to="lab_mdwd_FinancingIncomeOnNetInvestmentInLease_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinancingIncomeOnNetInvestmentInLease_1118" xlink:to="lab_mdwd_FinancingIncomeOnNetInvestmentInLease_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FivePercentageDecreaseInExchangeRateMember_1119" xlink:to="lab_mdwd_FivePercentageDecreaseInExchangeRateMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FivePercentageDecreaseInExchangeRateMember_1120" xlink:to="lab_mdwd_FivePercentageDecreaseInExchangeRateMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FivePercentageDecreaseInExchangeRateMember_1121" xlink:to="lab_mdwd_FivePercentageDecreaseInExchangeRateMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FivePercentageIncreaseInExchangeRateMember_1122" xlink:to="lab_mdwd_FivePercentageIncreaseInExchangeRateMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FivePercentageIncreaseInExchangeRateMember_1123" xlink:to="lab_mdwd_FivePercentageIncreaseInExchangeRateMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FivePercentageIncreaseInExchangeRateMember_1124" xlink:to="lab_mdwd_FivePercentageIncreaseInExchangeRateMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ForDevelopmentCostsOfNexoBridMember_1125" xlink:to="lab_mdwd_ForDevelopmentCostsOfNexoBridMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ForDevelopmentCostsOfNexoBridMember_1126" xlink:to="lab_mdwd_ForDevelopmentCostsOfNexoBridMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ForDevelopmentCostsOfNexoBridMember_1127" xlink:to="lab_mdwd_ForDevelopmentCostsOfNexoBridMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FormerShareholder_1128" xlink:to="lab_mdwd_FormerShareholder_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FormerShareholder_1129" xlink:to="lab_mdwd_FormerShareholder_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FormerShareholder_1130" xlink:to="lab_mdwd_FormerShareholder_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FundingByBardaPolicyTextBlock_1131" xlink:to="lab_mdwd_FundingByBardaPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FundingByBardaPolicyTextBlock_1132" xlink:to="lab_mdwd_FundingByBardaPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FundingByBardaPolicyTextBlock_1133" xlink:to="lab_mdwd_FundingByBardaPolicyTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FutureRoyaltyPaymentsMember_1134" xlink:to="lab_mdwd_FutureRoyaltyPaymentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_GeneralAndAdministrativeExpensesMember_1135" xlink:to="lab_mdwd_GeneralAndAdministrativeExpensesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_GeneralAndAdministrativeExpensesMember_1136" xlink:to="lab_mdwd_GeneralAndAdministrativeExpensesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_GeneralAndAdministrativeExpensesMember_1137" xlink:to="lab_mdwd_GeneralAndAdministrativeExpensesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_GrantsReceived_1138" xlink:to="lab_mdwd_GrantsReceived_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_GrantsReceived_1139" xlink:to="lab_mdwd_GrantsReceived_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_GrantsReceivedNetOfRoyalties_1140" xlink:to="lab_mdwd_GrantsReceivedNetOfRoyalties_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_GrantsReceivedNetOfRoyalties_1141" xlink:to="lab_mdwd_GrantsReceivedNetOfRoyalties_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_GrossProceedsFromPublicAndPrivateOfferings_1142" xlink:to="lab_mdwd_GrossProceedsFromPublicAndPrivateOfferings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_GrossProceedsFromPublicAndPrivateOfferings_1143" xlink:to="lab_mdwd_GrossProceedsFromPublicAndPrivateOfferings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_GrossProceedsFromPublicAndPrivateOfferings_1144" xlink:to="lab_mdwd_GrossProceedsFromPublicAndPrivateOfferings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_GrossProceedsFromPublicAndPrivateOfferings_1145" xlink:to="lab_mdwd_GrossProceedsFromPublicAndPrivateOfferings_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_GrossProceedsFromPublicAndPrivateOfferings_1146" xlink:to="lab_mdwd_GrossProceedsFromPublicAndPrivateOfferings_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncomeReceivablesLongTerm_1147" xlink:to="lab_mdwd_IncomeReceivablesLongTerm_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncomeReceivablesLongTerm_1148" xlink:to="lab_mdwd_IncomeReceivablesLongTerm_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncomeReceivablesLongTerm_1149" xlink:to="lab_mdwd_IncomeReceivablesLongTerm_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncomeReceivablesShortTerm_1150" xlink:to="lab_mdwd_IncomeReceivablesShortTerm_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncomeReceivablesShortTerm_1151" xlink:to="lab_mdwd_IncomeReceivablesShortTerm_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncomeReceivablesShortTerm_1152" xlink:to="lab_mdwd_IncomeReceivablesShortTerm_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncomingCEOAndChairmanMember_1153" xlink:to="lab_mdwd_IncomingCEOAndChairmanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncomingCEOAndChairmanMember_1154" xlink:to="lab_mdwd_IncomingCEOAndChairmanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncomingCEOAndChairmanMember_1155" xlink:to="lab_mdwd_IncomingCEOAndChairmanMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncomingCFOMember_1156" xlink:to="lab_mdwd_IncomingCFOMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncomingCFOMember_1157" xlink:to="lab_mdwd_IncomingCFOMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncomingCFOMember_1158" xlink:to="lab_mdwd_IncomingCFOMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits_1159" xlink:to="lab_mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits_1160" xlink:to="lab_mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits_1161" xlink:to="lab_mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseInAuthorizedShareCapital_1162" xlink:to="lab_mdwd_IncreaseInAuthorizedShareCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseInAuthorizedShareCapital_1163" xlink:to="lab_mdwd_IncreaseInAuthorizedShareCapital_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseInPreFundedWarrantsExercisePrice_1164" xlink:to="lab_mdwd_IncreaseInPreFundedWarrantsExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseInPreFundedWarrantsExercisePrice_1165" xlink:to="lab_mdwd_IncreaseInPreFundedWarrantsExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseInPreFundedWarrantsExercisePrice_1166" xlink:to="lab_mdwd_IncreaseInPreFundedWarrantsExercisePrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseInSharesIssued_1167" xlink:to="lab_mdwd_IncreaseInSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseInSharesIssued_1168" xlink:to="lab_mdwd_IncreaseInSharesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_InitialInvestment_1169" xlink:to="lab_mdwd_InitialInvestment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_InitialInvestment_1170" xlink:to="lab_mdwd_InitialInvestment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_InterestRateForLoanMember_1171" xlink:to="lab_mdwd_InterestRateForLoanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_InterestRateForLoanMember_1172" xlink:to="lab_mdwd_InterestRateForLoanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_InterestRateForLoanMember_1173" xlink:to="lab_mdwd_InterestRateForLoanMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IsraeliShareOptionPlanMember_1174" xlink:to="lab_mdwd_IsraeliShareOptionPlanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IsraeliShareOptionPlanMember_1175" xlink:to="lab_mdwd_IsraeliShareOptionPlanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IsraeliShareOptionPlanMember_1176" xlink:to="lab_mdwd_IsraeliShareOptionPlanMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IsraelMember_1177" xlink:to="lab_mdwd_IsraelMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss_1178" xlink:to="lab_mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss_1179" xlink:to="lab_mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss_1180" xlink:to="lab_mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_KeyOfficerMember_1181" xlink:to="lab_mdwd_KeyOfficerMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_KeyOfficerMember_1182" xlink:to="lab_mdwd_KeyOfficerMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_KeyOfficerMember_1183" xlink:to="lab_mdwd_KeyOfficerMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_KostForerGabbayAndKasiererMember_1184" xlink:to="lab_mdwd_KostForerGabbayAndKasiererMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_KostForerGabbayAndKasiererMember_1185" xlink:to="lab_mdwd_KostForerGabbayAndKasiererMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_KostForerGabbayAndKasiererMember_1186" xlink:to="lab_mdwd_KostForerGabbayAndKasiererMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_KpmgInternationalLimitedMember_1187" xlink:to="lab_mdwd_KpmgInternationalLimitedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_KpmgInternationalLimitedMember_1188" xlink:to="lab_mdwd_KpmgInternationalLimitedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_KpmgInternationalLimitedMember_1189" xlink:to="lab_mdwd_KpmgInternationalLimitedMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LaterThanTwoYearAndNotLaterThanEightYearsMember_1190" xlink:to="lab_mdwd_LaterThanTwoYearAndNotLaterThanEightYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LaterThanTwoYearAndNotLaterThanEightYearsMember_1191" xlink:to="lab_mdwd_LaterThanTwoYearAndNotLaterThanEightYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LaterThanTwoYearAndNotLaterThanEightYearsMember_1192" xlink:to="lab_mdwd_LaterThanTwoYearAndNotLaterThanEightYearsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember_1193" xlink:to="lab_mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember_1194" xlink:to="lab_mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember_1195" xlink:to="lab_mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LeasesAbstract_1196" xlink:to="lab_mdwd_LeasesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LeasesAbstract_1197" xlink:to="lab_mdwd_LeasesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LeasesAbstract_1198" xlink:to="lab_mdwd_LeasesAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LiabilitiesInRespectOfGrants_1199" xlink:to="lab_mdwd_LiabilitiesInRespectOfGrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LiabilitiesInRespectOfGrants_1200" xlink:to="lab_mdwd_LiabilitiesInRespectOfGrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LiabilitiesInRespectOfGrants_1201" xlink:to="lab_mdwd_LiabilitiesInRespectOfGrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LiabilitiesInRespectOfPurchaseOfShares_1202" xlink:to="lab_mdwd_LiabilitiesInRespectOfPurchaseOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LiabilitiesInRespectOfPurchaseOfShares_1203" xlink:to="lab_mdwd_LiabilitiesInRespectOfPurchaseOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LiabilitiesInRespectOfPurchaseOfShares_1204" xlink:to="lab_mdwd_LiabilitiesInRespectOfPurchaseOfShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LiabilitiesInRespectOfTeva_1205" xlink:to="lab_mdwd_LiabilitiesInRespectOfTeva_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LiabilitiesInRespectOfTeva_1206" xlink:to="lab_mdwd_LiabilitiesInRespectOfTeva_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LiabilitiesInRespectOfTeva_1207" xlink:to="lab_mdwd_LiabilitiesInRespectOfTeva_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LiabilityInRespectForPurchaseOfShares_1208" xlink:to="lab_mdwd_LiabilityInRespectForPurchaseOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LiabilityInRespectForPurchaseOfShares_1209" xlink:to="lab_mdwd_LiabilityInRespectForPurchaseOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LiabilityInRespectForPurchaseOfShares_1210" xlink:to="lab_mdwd_LiabilityInRespectForPurchaseOfShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities_1211" xlink:to="lab_mdwd_LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities_1212" xlink:to="lab_mdwd_LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities_1213" xlink:to="lab_mdwd_LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LicenseAgreementWithVericelMember_1214" xlink:to="lab_mdwd_LicenseAgreementWithVericelMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LicenseAgreementWithVericelMember_1215" xlink:to="lab_mdwd_LicenseAgreementWithVericelMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LicenseForPolyhealProductsMember_1216" xlink:to="lab_mdwd_LicenseForPolyhealProductsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LicenseForPolyhealProductsMember_1217" xlink:to="lab_mdwd_LicenseForPolyhealProductsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LimitOfBenefitEntitlementPeriod_1218" xlink:to="lab_mdwd_LimitOfBenefitEntitlementPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LimitOfBenefitEntitlementPeriod_1219" xlink:to="lab_mdwd_LimitOfBenefitEntitlementPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LossFromWarrantsTransactions_1220" xlink:to="lab_mdwd_LossFromWarrantsTransactions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LossFromWarrantsTransactions_1221" xlink:to="lab_mdwd_LossFromWarrantsTransactions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LossFromWarrantsTransactions_1222" xlink:to="lab_mdwd_LossFromWarrantsTransactions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_MarketingAndSalesExpense_1223" xlink:to="lab_mdwd_MarketingAndSalesExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_MarketingAndSalesExpense_1224" xlink:to="lab_mdwd_MarketingAndSalesExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_MarketingAndSalesExpense_1225" xlink:to="lab_mdwd_MarketingAndSalesExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_MaximumAggregateRoyaltiesPaidInPercentage_1226" xlink:to="lab_mdwd_MaximumAggregateRoyaltiesPaidInPercentage_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_MaximumAggregateRoyaltiesPaidInPercentage_1227" xlink:to="lab_mdwd_MaximumAggregateRoyaltiesPaidInPercentage_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ModifiedContractAmount_1228" xlink:to="lab_mdwd_ModifiedContractAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ModifiedContractAmount_1229" xlink:to="lab_mdwd_ModifiedContractAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_MtecMember_1230" xlink:to="lab_mdwd_MtecMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_MtecMember_1231" xlink:to="lab_mdwd_MtecMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_MtecMember_1232" xlink:to="lab_mdwd_MtecMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NetProceedsFromOfferingAmount_1233" xlink:to="lab_mdwd_NetProceedsFromOfferingAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NetProceedsFromOfferingAmount_1234" xlink:to="lab_mdwd_NetProceedsFromOfferingAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NetProceedsFromOfferingAmount_1235" xlink:to="lab_mdwd_NetProceedsFromOfferingAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NewFinanceLeaseObligationRecognized_1236" xlink:to="lab_mdwd_NewFinanceLeaseObligationRecognized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NewFinanceLeaseObligationRecognized_1237" xlink:to="lab_mdwd_NewFinanceLeaseObligationRecognized_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NewPolyHealSettlementAgreementsMember_1238" xlink:to="lab_mdwd_NewPolyHealSettlementAgreementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NewPolyHealSettlementAgreementsMember_1239" xlink:to="lab_mdwd_NewPolyHealSettlementAgreementsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NewPolyHealSettlementAgreementsMember_1240" xlink:to="lab_mdwd_NewPolyHealSettlementAgreementsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NexoBridMember_1241" xlink:to="lab_mdwd_NexoBridMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NexoBridMember_1242" xlink:to="lab_mdwd_NexoBridMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NexoBridMember_1243" xlink:to="lab_mdwd_NexoBridMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NoncancelableLeasePeriods_1244" xlink:to="lab_mdwd_NoncancelableLeasePeriods_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NoncancelableLeasePeriods_1245" xlink:to="lab_mdwd_NoncancelableLeasePeriods_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NonCashTransactionsAbstract_1246" xlink:to="lab_mdwd_NonCashTransactionsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NonCashTransactionsAbstract_1247" xlink:to="lab_mdwd_NonCashTransactionsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NonCurrentLiabilitiesCurrent_1248" xlink:to="lab_mdwd_NonCurrentLiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NonCurrentLiabilitiesCurrent_1249" xlink:to="lab_mdwd_NonCurrentLiabilitiesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NonCurrentLiabilitiesCurrent_1250" xlink:to="lab_mdwd_NonCurrentLiabilitiesCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberAbstract_1251" xlink:to="lab_mdwd_NumberAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberAbstract_1252" xlink:to="lab_mdwd_NumberAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfDirectors_1253" xlink:to="lab_mdwd_NumberOfDirectors_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfDirectors_1254" xlink:to="lab_mdwd_NumberOfDirectors_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfDirectors_1255" xlink:to="lab_mdwd_NumberOfDirectors_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfOrdinarySharesIssuable_1256" xlink:to="lab_mdwd_NumberOfOrdinarySharesIssuable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfOrdinarySharesIssuable_1257" xlink:to="lab_mdwd_NumberOfOrdinarySharesIssuable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfOrdinarySharesIssuable_1258" xlink:to="lab_mdwd_NumberOfOrdinarySharesIssuable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfPreFundedWarrantsExercised_1259" xlink:to="lab_mdwd_NumberOfPreFundedWarrantsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfPreFundedWarrantsExercised_1260" xlink:to="lab_mdwd_NumberOfPreFundedWarrantsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfPreFundedWarrantsExercised_1261" xlink:to="lab_mdwd_NumberOfPreFundedWarrantsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfRestrictedShareUnitIssued_1262" xlink:to="lab_mdwd_NumberOfRestrictedShareUnitIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfRestrictedShareUnitIssued_1263" xlink:to="lab_mdwd_NumberOfRestrictedShareUnitIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfRestrictedShareUnitIssued_1264" xlink:to="lab_mdwd_NumberOfRestrictedShareUnitIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfSharesExerciseRestrictedStockUnits_1265" xlink:to="lab_mdwd_NumberOfSharesExerciseRestrictedStockUnits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfSharesExerciseRestrictedStockUnits_1266" xlink:to="lab_mdwd_NumberOfSharesExerciseRestrictedStockUnits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfSharesExerciseRestrictedStockUnits_1267" xlink:to="lab_mdwd_NumberOfSharesExerciseRestrictedStockUnits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfSharesRepurchased_1268" xlink:to="lab_mdwd_NumberOfSharesRepurchased_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfSharesRepurchased_1269" xlink:to="lab_mdwd_NumberOfSharesRepurchased_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_1270" xlink:to="lab_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_1271" xlink:to="lab_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_1272" xlink:to="lab_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfVehiclesInOperatingLeaseArrangements_1273" xlink:to="lab_mdwd_NumberOfVehiclesInOperatingLeaseArrangements_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfVehiclesInOperatingLeaseArrangements_1274" xlink:to="lab_mdwd_NumberOfVehiclesInOperatingLeaseArrangements_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfWarrantsIssued_1275" xlink:to="lab_mdwd_NumberOfWarrantsIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfWarrantsIssued_1276" xlink:to="lab_mdwd_NumberOfWarrantsIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfWarrantsIssued_1277" xlink:to="lab_mdwd_NumberOfWarrantsIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OneTimeLumpsumAmount_1278" xlink:to="lab_mdwd_OneTimeLumpsumAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OneTimeLumpsumAmount_1279" xlink:to="lab_mdwd_OneTimeLumpsumAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OneTimeLumpsumAmount_1280" xlink:to="lab_mdwd_OneTimeLumpsumAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OtherCountriesMember_1281" xlink:to="lab_mdwd_OtherCountriesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OtherCountriesMember_1282" xlink:to="lab_mdwd_OtherCountriesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OtherCountriesMember_1283" xlink:to="lab_mdwd_OtherCountriesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OtherCurrentPayable_1284" xlink:to="lab_mdwd_OtherCurrentPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OtherCurrentPayable_1285" xlink:to="lab_mdwd_OtherCurrentPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OtherCurrentPayable_1286" xlink:to="lab_mdwd_OtherCurrentPayable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OtherCustomerContributedMember_1287" xlink:to="lab_mdwd_OtherCustomerContributedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OtherCustomerContributedMember_1288" xlink:to="lab_mdwd_OtherCustomerContributedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OtherCustomerContributedMember_1289" xlink:to="lab_mdwd_OtherCustomerContributedMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OtherReceivablesDiscontinuedOperations_1290" xlink:to="lab_mdwd_OtherReceivablesDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OtherReceivablesDiscontinuedOperations_1291" xlink:to="lab_mdwd_OtherReceivablesDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OtherResearchAndDevelopmentExpenses_1292" xlink:to="lab_mdwd_OtherResearchAndDevelopmentExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OtherResearchAndDevelopmentExpenses_1293" xlink:to="lab_mdwd_OtherResearchAndDevelopmentExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OtherSellingGeneralAndAdministrativeExpenses_1294" xlink:to="lab_mdwd_OtherSellingGeneralAndAdministrativeExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OtherSellingGeneralAndAdministrativeExpenses_1295" xlink:to="lab_mdwd_OtherSellingGeneralAndAdministrativeExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OtherSellingGeneralAndAdministrativeExpenses_1296" xlink:to="lab_mdwd_OtherSellingGeneralAndAdministrativeExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses_1297" xlink:to="lab_mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses_1298" xlink:to="lab_mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses_1299" xlink:to="lab_mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ParticipationsAbstract_1300" xlink:to="lab_mdwd_ParticipationsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ParticipationsAbstract_1301" xlink:to="lab_mdwd_ParticipationsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PatentMember_1302" xlink:to="lab_mdwd_PatentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PatentMember_1303" xlink:to="lab_mdwd_PatentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PatentMember_1304" xlink:to="lab_mdwd_PatentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PercentageOfFutureRoyaltyPayments_1305" xlink:to="lab_mdwd_PercentageOfFutureRoyaltyPayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PercentageOfFutureRoyaltyPayments_1306" xlink:to="lab_mdwd_PercentageOfFutureRoyaltyPayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans_1307" xlink:to="lab_mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans_1308" xlink:to="lab_mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans_1309" xlink:to="lab_mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PercentageOfOneTimeLumpSumPaymentAmount_1310" xlink:to="lab_mdwd_PercentageOfOneTimeLumpSumPaymentAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PercentageOfOneTimeLumpSumPaymentAmount_1311" xlink:to="lab_mdwd_PercentageOfOneTimeLumpSumPaymentAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PercentageOfOneTimeLumpSumPaymentAmount_1312" xlink:to="lab_mdwd_PercentageOfOneTimeLumpSumPaymentAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_1313" xlink:to="lab_mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_1314" xlink:to="lab_mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PeriodOfBankDeposits_1315" xlink:to="lab_mdwd_PeriodOfBankDeposits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PeriodOfBankDeposits_1316" xlink:to="lab_mdwd_PeriodOfBankDeposits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_1317" xlink:to="lab_mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_1318" xlink:to="lab_mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PeriodOfVehiclesOperatingLeaseArrangements_1319" xlink:to="lab_mdwd_PeriodOfVehiclesOperatingLeaseArrangements_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PeriodOfVehiclesOperatingLeaseArrangements_1320" xlink:to="lab_mdwd_PeriodOfVehiclesOperatingLeaseArrangements_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PolyhealLtdMember_1321" xlink:to="lab_mdwd_PolyhealLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PolyhealLtdMember_1322" xlink:to="lab_mdwd_PolyhealLtdMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PolyhealMember_1323" xlink:to="lab_mdwd_PolyhealMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PolyhealMember_1324" xlink:to="lab_mdwd_PolyhealMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PolyhealSettlementAgreementsMember_1325" xlink:to="lab_mdwd_PolyhealSettlementAgreementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PolyhealSettlementAgreementsMember_1326" xlink:to="lab_mdwd_PolyhealSettlementAgreementsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PrepaidExpensesLongTerm_1327" xlink:to="lab_mdwd_PrepaidExpensesLongTerm_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PrepaidExpensesLongTerm_1328" xlink:to="lab_mdwd_PrepaidExpensesLongTerm_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PrepaidExpensesLongTerm_1329" xlink:to="lab_mdwd_PrepaidExpensesLongTerm_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent_1330" xlink:to="lab_mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent_1331" xlink:to="lab_mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent_1332" xlink:to="lab_mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PricePerShareOfSharesIssued_1333" xlink:to="lab_mdwd_PricePerShareOfSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PricePerShareOfSharesIssued_1334" xlink:to="lab_mdwd_PricePerShareOfSharesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PricePerShareOfSharesIssued_1335" xlink:to="lab_mdwd_PricePerShareOfSharesIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PrivateIssuancePurchaseEquityAgreementMember_1336" xlink:to="lab_mdwd_PrivateIssuancePurchaseEquityAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PrivateIssuancePurchaseEquityAgreementMember_1337" xlink:to="lab_mdwd_PrivateIssuancePurchaseEquityAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromAdditionalFunding_1338" xlink:to="lab_mdwd_ProceedsFromAdditionalFunding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromAdditionalFunding_1339" xlink:to="lab_mdwd_ProceedsFromAdditionalFunding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromAdditionalFunding_1340" xlink:to="lab_mdwd_ProceedsFromAdditionalFunding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromAdditionalFunding_1341" xlink:to="lab_mdwd_ProceedsFromAdditionalFunding_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromAdditionalProcurement_1342" xlink:to="lab_mdwd_ProceedsFromAdditionalProcurement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromAdditionalProcurement_1343" xlink:to="lab_mdwd_ProceedsFromAdditionalProcurement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromAdditionalProcurement_1344" xlink:to="lab_mdwd_ProceedsFromAdditionalProcurement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromFunding_1345" xlink:to="lab_mdwd_ProceedsFromFunding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromFunding_1346" xlink:to="lab_mdwd_ProceedsFromFunding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromFunding_1347" xlink:to="lab_mdwd_ProceedsFromFunding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromFunding_1348" xlink:to="lab_mdwd_ProceedsFromFunding_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_1349" xlink:to="lab_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_1350" xlink:to="lab_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_1351" xlink:to="lab_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_1352" xlink:to="lab_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_1353" xlink:to="lab_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromIssuingAdditionalShares_1354" xlink:to="lab_mdwd_ProceedsFromIssuingAdditionalShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromIssuingAdditionalShares_1355" xlink:to="lab_mdwd_ProceedsFromIssuingAdditionalShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromIssuingAdditionalShares_1356" xlink:to="lab_mdwd_ProceedsFromIssuingAdditionalShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromProcurement_1357" xlink:to="lab_mdwd_ProceedsFromProcurement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromProcurement_1358" xlink:to="lab_mdwd_ProceedsFromProcurement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromProcurement_1359" xlink:to="lab_mdwd_ProceedsFromProcurement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromRepaymentsOfGrants_1360" xlink:to="lab_mdwd_ProceedsFromRepaymentsOfGrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromRepaymentsOfGrants_1361" xlink:to="lab_mdwd_ProceedsFromRepaymentsOfGrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromRepaymentsOfGrants_1362" xlink:to="lab_mdwd_ProceedsFromRepaymentsOfGrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses_1363" xlink:to="lab_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses_1364" xlink:to="lab_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses_1365" xlink:to="lab_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses_1366" xlink:to="lab_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProvisionForImpairment_1367" xlink:to="lab_mdwd_ProvisionForImpairment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProvisionForImpairment_1368" xlink:to="lab_mdwd_ProvisionForImpairment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProvisionForImpairment_1369" xlink:to="lab_mdwd_ProvisionForImpairment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProvisionForImpairment_1370" xlink:to="lab_mdwd_ProvisionForImpairment_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PurchaseOfPropertyAndEquipment_1371" xlink:to="lab_mdwd_PurchaseOfPropertyAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PurchaseOfPropertyAndEquipment_1372" xlink:to="lab_mdwd_PurchaseOfPropertyAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PurchaseOfPropertyAndEquipment_1373" xlink:to="lab_mdwd_PurchaseOfPropertyAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PurchasePriceForResidualNumberOfShares_1374" xlink:to="lab_mdwd_PurchasePriceForResidualNumberOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PurchasePriceForResidualNumberOfShares_1375" xlink:to="lab_mdwd_PurchasePriceForResidualNumberOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PurchasePriceOfRegisteredDirectOffering_1376" xlink:to="lab_mdwd_PurchasePriceOfRegisteredDirectOffering_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PurchasePriceOfRegisteredDirectOffering_1377" xlink:to="lab_mdwd_PurchasePriceOfRegisteredDirectOffering_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PurchasePriceOfRegisteredDirectOffering_1378" xlink:to="lab_mdwd_PurchasePriceOfRegisteredDirectOffering_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesEightMember_1379" xlink:to="lab_mdwd_RangesOfExercisePricesEightMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesEightMember_1380" xlink:to="lab_mdwd_RangesOfExercisePricesEightMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesEightMember_1381" xlink:to="lab_mdwd_RangesOfExercisePricesEightMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesFiveMember_1382" xlink:to="lab_mdwd_RangesOfExercisePricesFiveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesFiveMember_1383" xlink:to="lab_mdwd_RangesOfExercisePricesFiveMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesFiveMember_1384" xlink:to="lab_mdwd_RangesOfExercisePricesFiveMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesFourMember_1385" xlink:to="lab_mdwd_RangesOfExercisePricesFourMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesFourMember_1386" xlink:to="lab_mdwd_RangesOfExercisePricesFourMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesFourMember_1387" xlink:to="lab_mdwd_RangesOfExercisePricesFourMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesOneMember_1388" xlink:to="lab_mdwd_RangesOfExercisePricesOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesOneMember_1389" xlink:to="lab_mdwd_RangesOfExercisePricesOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesOneMember_1390" xlink:to="lab_mdwd_RangesOfExercisePricesOneMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesServenMember_1391" xlink:to="lab_mdwd_RangesOfExercisePricesServenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesServenMember_1392" xlink:to="lab_mdwd_RangesOfExercisePricesServenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesServenMember_1393" xlink:to="lab_mdwd_RangesOfExercisePricesServenMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesSixMember_1394" xlink:to="lab_mdwd_RangesOfExercisePricesSixMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesSixMember_1395" xlink:to="lab_mdwd_RangesOfExercisePricesSixMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesSixMember_1396" xlink:to="lab_mdwd_RangesOfExercisePricesSixMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesThreeMember_1397" xlink:to="lab_mdwd_RangesOfExercisePricesThreeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesThreeMember_1398" xlink:to="lab_mdwd_RangesOfExercisePricesThreeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesThreeMember_1399" xlink:to="lab_mdwd_RangesOfExercisePricesThreeMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesTwoMember_1400" xlink:to="lab_mdwd_RangesOfExercisePricesTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesTwoMember_1401" xlink:to="lab_mdwd_RangesOfExercisePricesTwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RangesOfExercisePricesTwoMember_1402" xlink:to="lab_mdwd_RangesOfExercisePricesTwoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ReceivableFromBarda_1403" xlink:to="lab_mdwd_ReceivableFromBarda_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ReceivableFromBarda_1404" xlink:to="lab_mdwd_ReceivableFromBarda_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ReceivableFromBarda_1405" xlink:to="lab_mdwd_ReceivableFromBarda_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ReducedAggregateAmount_1406" xlink:to="lab_mdwd_ReducedAggregateAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ReducedAggregateAmount_1407" xlink:to="lab_mdwd_ReducedAggregateAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ReducedRateOfPayments_1408" xlink:to="lab_mdwd_ReducedRateOfPayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ReducedRateOfPayments_1409" xlink:to="lab_mdwd_ReducedRateOfPayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RegistrationAndMarketingLicenseFees_1410" xlink:to="lab_mdwd_RegistrationAndMarketingLicenseFees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RegistrationAndMarketingLicenseFees_1411" xlink:to="lab_mdwd_RegistrationAndMarketingLicenseFees_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RelatedPartiesRentaLexpenseAndOther_1412" xlink:to="lab_mdwd_RelatedPartiesRentaLexpenseAndOther_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RelatedPartiesRentaLexpenseAndOther_1413" xlink:to="lab_mdwd_RelatedPartiesRentaLexpenseAndOther_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_1414" xlink:to="lab_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_1415" xlink:to="lab_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_1416" xlink:to="lab_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RepaymentsOfIiaGrantsNet_1417" xlink:to="lab_mdwd_RepaymentsOfIiaGrantsNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RepaymentsOfIiaGrantsNet_1418" xlink:to="lab_mdwd_RepaymentsOfIiaGrantsNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RepaymentsOfIiaGrantsNet_1419" xlink:to="lab_mdwd_RepaymentsOfIiaGrantsNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ResearchAndDevelopmentExpenseGross_1420" xlink:to="lab_mdwd_ResearchAndDevelopmentExpenseGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ResearchAndDevelopmentExpenseGross_1421" xlink:to="lab_mdwd_ResearchAndDevelopmentExpenseGross_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ResearchAndDevelopmentExpenseGross_1422" xlink:to="lab_mdwd_ResearchAndDevelopmentExpenseGross_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ResearchAndDevelopmentExpensesMember_1423" xlink:to="lab_mdwd_ResearchAndDevelopmentExpensesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ResearchAndDevelopmentExpensesMember_1424" xlink:to="lab_mdwd_ResearchAndDevelopmentExpensesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ResearchAndDevelopmentExpensesMember_1425" xlink:to="lab_mdwd_ResearchAndDevelopmentExpensesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ResearchAndDevelopmentLawMember_1426" xlink:to="lab_mdwd_ResearchAndDevelopmentLawMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ResearchAndDevelopmentLawMember_1427" xlink:to="lab_mdwd_ResearchAndDevelopmentLawMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ResearchAndDevelopmentLawMember_1428" xlink:to="lab_mdwd_ResearchAndDevelopmentLawMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RestrictedBankDepositsLongTerm_1429" xlink:to="lab_mdwd_RestrictedBankDepositsLongTerm_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RestrictedBankDepositsLongTerm_1430" xlink:to="lab_mdwd_RestrictedBankDepositsLongTerm_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RestrictedBankDepositsLongTerm_1431" xlink:to="lab_mdwd_RestrictedBankDepositsLongTerm_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RestrictedSharesUnitsMember_1432" xlink:to="lab_mdwd_RestrictedSharesUnitsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RestrictedSharesUnitsMember_1433" xlink:to="lab_mdwd_RestrictedSharesUnitsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RestrictedSharesUnitsMember_1434" xlink:to="lab_mdwd_RestrictedSharesUnitsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLeaseLiabilities_1435" xlink:to="lab_mdwd_RevaluationOfLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLeaseLiabilities_1436" xlink:to="lab_mdwd_RevaluationOfLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLeaseLiabilities_1437" xlink:to="lab_mdwd_RevaluationOfLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_1438" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_1439" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_1440" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_1441" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_1442" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIfrsSixteen_1443" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfIfrsSixteen_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIfrsSixteen_1444" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfIfrsSixteen_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIfrsSixteen_1445" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfIfrsSixteen_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants_1446" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants_1447" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants_1448" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants_1449" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant_1450" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant_1451" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant_1452" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfPurchaseOfShares_1453" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfPurchaseOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfPurchaseOfShares_1454" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfPurchaseOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares_1455" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares_1456" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares_1457" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfWarrant_1458" xlink:to="lab_mdwd_RevaluationOfWarrant_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfWarrant_1459" xlink:to="lab_mdwd_RevaluationOfWarrant_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfWarrant_1460" xlink:to="lab_mdwd_RevaluationOfWarrant_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfWarrant_1461" xlink:to="lab_mdwd_RevaluationOfWarrant_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_1462" xlink:to="lab_mdwd_RevaluationOfWarrantsAccountedAtFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_1463" xlink:to="lab_mdwd_RevaluationOfWarrantsAccountedAtFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_1464" xlink:to="lab_mdwd_RevaluationOfWarrantsAccountedAtFairValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_1465" xlink:to="lab_mdwd_RevaluationOfWarrantsAccountedAtFairValue_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevenuesFromDistributionAgreements_1466" xlink:to="lab_mdwd_RevenuesFromDistributionAgreements_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevenuesFromDistributionAgreements_1467" xlink:to="lab_mdwd_RevenuesFromDistributionAgreements_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevenuesFromSaleOfProcurement_1468" xlink:to="lab_mdwd_RevenuesFromSaleOfProcurement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevenuesFromSaleOfProcurement_1469" xlink:to="lab_mdwd_RevenuesFromSaleOfProcurement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ReverseStockSplit_1470" xlink:to="lab_mdwd_ReverseStockSplit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ReverseStockSplit_1471" xlink:to="lab_mdwd_ReverseStockSplit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ReverseStockSplit_1472" xlink:to="lab_mdwd_ReverseStockSplit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RightOfUseAssetDisposals_1473" xlink:to="lab_mdwd_RightOfUseAssetDisposals_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RightOfUseAssetDisposals_1474" xlink:to="lab_mdwd_RightOfUseAssetDisposals_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RightOfUseAssetDisposals_1475" xlink:to="lab_mdwd_RightOfUseAssetDisposals_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RightOfUseAssetDisposals_1476" xlink:to="lab_mdwd_RightOfUseAssetDisposals_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_1477" xlink:to="lab_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_1478" xlink:to="lab_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_1479" xlink:to="lab_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_1480" xlink:to="lab_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RightOfUseAssetsAccumulatedDepreciation_1481" xlink:to="lab_mdwd_RightOfUseAssetsAccumulatedDepreciation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RightOfUseAssetsAccumulatedDepreciation_1482" xlink:to="lab_mdwd_RightOfUseAssetsAccumulatedDepreciation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RightOfUseAssetsAccumulatedDepreciation_1483" xlink:to="lab_mdwd_RightOfUseAssetsAccumulatedDepreciation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RightOfUseAssetsAccumulatedDepreciation_1484" xlink:to="lab_mdwd_RightOfUseAssetsAccumulatedDepreciation_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract_1485" xlink:to="lab_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract_1486" xlink:to="lab_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RightOfUseAssetsAccumulatedDepreciationAdditionsDuringYearAbstract_1487" xlink:to="lab_mdwd_RightOfUseAssetsAccumulatedDepreciationAdditionsDuringYearAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RightOfUseAssetsAdditionsDuringYearAbstract_1488" xlink:to="lab_mdwd_RightOfUseAssetsAdditionsDuringYearAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RightOfUseAssetsCostAbstract_1489" xlink:to="lab_mdwd_RightOfUseAssetsCostAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RightOfUseAssetsCostAbstract_1490" xlink:to="lab_mdwd_RightOfUseAssetsCostAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RightOfUseAssetsDepreciationAbstract_1491" xlink:to="lab_mdwd_RightOfUseAssetsDepreciationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RightOfUseAssetsDepreciationAbstract_1492" xlink:to="lab_mdwd_RightOfUseAssetsDepreciationAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RiskFreeInterestRateOfWarrants_1493" xlink:to="lab_mdwd_RiskFreeInterestRateOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RiskFreeInterestRateOfWarrants_1494" xlink:to="lab_mdwd_RiskFreeInterestRateOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RiskFreeInterestRateOfWarrants_1495" xlink:to="lab_mdwd_RiskFreeInterestRateOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RiskFreeRateOfWarrants_1496" xlink:to="lab_mdwd_RiskFreeRateOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RiskFreeRateOfWarrants_1497" xlink:to="lab_mdwd_RiskFreeRateOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RiskFreeRateOfWarrants_1498" xlink:to="lab_mdwd_RiskFreeRateOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RoyaltiesPayments_1499" xlink:to="lab_mdwd_RoyaltiesPayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RoyaltiesPayments_1500" xlink:to="lab_mdwd_RoyaltiesPayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RoyaltyRightsArisingMember_1501" xlink:to="lab_mdwd_RoyaltyRightsArisingMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SalaryAndBenefits_1502" xlink:to="lab_mdwd_SalaryAndBenefits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SalaryAndBenefits_1503" xlink:to="lab_mdwd_SalaryAndBenefits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements_1504" xlink:to="lab_mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements_1505" xlink:to="lab_mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements_1506" xlink:to="lab_mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SalaryAndBenefitsIncludingShareBasedCompensation_1507" xlink:to="lab_mdwd_SalaryAndBenefitsIncludingShareBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SalaryAndBenefitsIncludingShareBasedCompensation_1508" xlink:to="lab_mdwd_SalaryAndBenefitsIncludingShareBasedCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SalaryAndBenefitsIncludingShareBasedCompensation_1509" xlink:to="lab_mdwd_SalaryAndBenefitsIncludingShareBasedCompensation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock_1510" xlink:to="lab_mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock_1511" xlink:to="lab_mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock_1512" xlink:to="lab_mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ScheduleOfCostOfRevenuesLicense_1513" xlink:to="lab_mdwd_ScheduleOfCostOfRevenuesLicense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ScheduleOfCostOfRevenuesLicense_1514" xlink:to="lab_mdwd_ScheduleOfCostOfRevenuesLicense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ScheduleOfCostOfRevenuesLicense_1515" xlink:to="lab_mdwd_ScheduleOfCostOfRevenuesLicense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SellingAndMarketingExpensesMember_1516" xlink:to="lab_mdwd_SellingAndMarketingExpensesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SellingAndMarketingExpensesMember_1517" xlink:to="lab_mdwd_SellingAndMarketingExpensesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SellingAndMarketingExpensesMember_1518" xlink:to="lab_mdwd_SellingAndMarketingExpensesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SensitivityAnalysisAxis_1519" xlink:to="lab_mdwd_SensitivityAnalysisAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SensitivityAnalysisAxis_1520" xlink:to="lab_mdwd_SensitivityAnalysisAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SensitivityAnalysisAxis_1521" xlink:to="lab_mdwd_SensitivityAnalysisAxis_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract_1522" xlink:to="lab_mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract_1523" xlink:to="lab_mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SettlementAmountPaidByTeva_1524" xlink:to="lab_mdwd_SettlementAmountPaidByTeva_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SettlementAmountPaidByTeva_1525" xlink:to="lab_mdwd_SettlementAmountPaidByTeva_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ShareholderMember_1526" xlink:to="lab_mdwd_ShareholderMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ShareIncentivePlanMember_1527" xlink:to="lab_mdwd_ShareIncentivePlanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ShareIncentivePlanMember_1528" xlink:to="lab_mdwd_ShareIncentivePlanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ShareIncentivePlanMember_1529" xlink:to="lab_mdwd_ShareIncentivePlanMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare_1530" xlink:to="lab_mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare_1531" xlink:to="lab_mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare_1532" xlink:to="lab_mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SharesAvailableForFutureGrant_1533" xlink:to="lab_mdwd_SharesAvailableForFutureGrant_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SharesAvailableForFutureGrant_1534" xlink:to="lab_mdwd_SharesAvailableForFutureGrant_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SharesIssuedPriceInInitialPublicOffering_1535" xlink:to="lab_mdwd_SharesIssuedPriceInInitialPublicOffering_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SharesIssuedPriceInInitialPublicOffering_1536" xlink:to="lab_mdwd_SharesIssuedPriceInInitialPublicOffering_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SharesReceivedOfPolyheal_1537" xlink:to="lab_mdwd_SharesReceivedOfPolyheal_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SharesReceivedOfPolyheal_1538" xlink:to="lab_mdwd_SharesReceivedOfPolyheal_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_StockOptionValue_1539" xlink:to="lab_mdwd_StockOptionValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_StockOptionValue_1540" xlink:to="lab_mdwd_StockOptionValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_StockOptionValue_1541" xlink:to="lab_mdwd_StockOptionValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_Subcontractors_1542" xlink:to="lab_mdwd_Subcontractors_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_Subcontractors_1543" xlink:to="lab_mdwd_Subcontractors_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_Subcontractors_1544" xlink:to="lab_mdwd_Subcontractors_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubcontractorsExpenses_1545" xlink:to="lab_mdwd_SubcontractorsExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubcontractorsExpenses_1546" xlink:to="lab_mdwd_SubcontractorsExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubcontractorsExpenses_1547" xlink:to="lab_mdwd_SubcontractorsExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment_1548" xlink:to="lab_mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment_1549" xlink:to="lab_mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment_1550" xlink:to="lab_mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubLicensingOfPatentsMember_1551" xlink:to="lab_mdwd_SubLicensingOfPatentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubLicensingOfPatentsMember_1552" xlink:to="lab_mdwd_SubLicensingOfPatentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubsequentEventsMember_1553" xlink:to="lab_mdwd_SubsequentEventsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubsequentEventsMember_1554" xlink:to="lab_mdwd_SubsequentEventsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubsidiariesLeaseArea_1555" xlink:to="lab_mdwd_SubsidiariesLeaseArea_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubsidiariesLeaseArea_1556" xlink:to="lab_mdwd_SubsidiariesLeaseArea_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubsidiariesLeaseEstimatedUsefulLife_1557" xlink:to="lab_mdwd_SubsidiariesLeaseEstimatedUsefulLife_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubsidiariesLeaseEstimatedUsefulLife_1558" xlink:to="lab_mdwd_SubsidiariesLeaseEstimatedUsefulLife_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubsidiariesLeaseEstimatedUsefulLife_1559" xlink:to="lab_mdwd_SubsidiariesLeaseEstimatedUsefulLife_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubsidiariesLeaseExpirationDate_1560" xlink:to="lab_mdwd_SubsidiariesLeaseExpirationDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubsidiariesLeaseExpirationDate_1561" xlink:to="lab_mdwd_SubsidiariesLeaseExpirationDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubsidiariesLeaseExpirationDate_1562" xlink:to="lab_mdwd_SubsidiariesLeaseExpirationDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubsidiariesLeaseExpirationPeriod_1563" xlink:to="lab_mdwd_SubsidiariesLeaseExpirationPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubsidiariesLeaseExpirationPeriod_1564" xlink:to="lab_mdwd_SubsidiariesLeaseExpirationPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubsidiariesLeaseExpirationPeriod_1565" xlink:to="lab_mdwd_SubsidiariesLeaseExpirationPeriod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubsidiariesLeaseExtentionPeriod_1566" xlink:to="lab_mdwd_SubsidiariesLeaseExtentionPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubsidiariesLeaseExtentionPeriod_1567" xlink:to="lab_mdwd_SubsidiariesLeaseExtentionPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubsidiariesLeaseMonthlyRent_1568" xlink:to="lab_mdwd_SubsidiariesLeaseMonthlyRent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubsidiariesLeaseMonthlyRent_1569" xlink:to="lab_mdwd_SubsidiariesLeaseMonthlyRent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TermOfLease_1570" xlink:to="lab_mdwd_TermOfLease_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TermOfLease_1571" xlink:to="lab_mdwd_TermOfLease_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TermOfLease_1572" xlink:to="lab_mdwd_TermOfLease_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TevaMember_1573" xlink:to="lab_mdwd_TevaMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TevaMember_1574" xlink:to="lab_mdwd_TevaMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ThirdPartiesMember_1575" xlink:to="lab_mdwd_ThirdPartiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ThirdPartiesMember_1576" xlink:to="lab_mdwd_ThirdPartiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ThirdPartiesMember_1577" xlink:to="lab_mdwd_ThirdPartiesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TotalBasicAndDilutedNetProfitLossPerShare_1578" xlink:to="lab_mdwd_TotalBasicAndDilutedNetProfitLossPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TotalBasicAndDilutedNetProfitLossPerShare_1579" xlink:to="lab_mdwd_TotalBasicAndDilutedNetProfitLossPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TotalBasicAndDilutedNetProfitLossPerShare_1580" xlink:to="lab_mdwd_TotalBasicAndDilutedNetProfitLossPerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TotalBasicAndDilutedNetProfitLossPerShare_1581" xlink:to="lab_mdwd_TotalBasicAndDilutedNetProfitLossPerShare_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TotalMember_1582" xlink:to="lab_mdwd_TotalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TotalRoyaltiesPayments_1583" xlink:to="lab_mdwd_TotalRoyaltiesPayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TotalRoyaltiesPayments_1584" xlink:to="lab_mdwd_TotalRoyaltiesPayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TotalRoyaltiesPayments_1585" xlink:to="lab_mdwd_TotalRoyaltiesPayments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TradePayablesAndAccruedExpenses_1586" xlink:to="lab_mdwd_TradePayablesAndAccruedExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TradePayablesAndAccruedExpenses_1587" xlink:to="lab_mdwd_TradePayablesAndAccruedExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TradePayablesAndAccruedExpenses_1588" xlink:to="lab_mdwd_TradePayablesAndAccruedExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TransactionOneMember_1589" xlink:to="lab_mdwd_TransactionOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember_1590" xlink:to="lab_mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember_1591" xlink:to="lab_mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember_1592" xlink:to="lab_mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TwoThousandAndTenPolyHealAgreementMember_1593" xlink:to="lab_mdwd_TwoThousandAndTenPolyHealAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TwoThousandTenPolyhealAgreementMember_1594" xlink:to="lab_mdwd_TwoThousandTenPolyhealAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TwoThousandTenPolyhealAgreementMember_1595" xlink:to="lab_mdwd_TwoThousandTenPolyhealAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UncertaintyInFutureDefaultsMember_1596" xlink:to="lab_mdwd_UncertaintyInFutureDefaultsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UncertaintyInFutureDefaultsMember_1597" xlink:to="lab_mdwd_UncertaintyInFutureDefaultsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UndertookMember_1598" xlink:to="lab_mdwd_UndertookMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UnearnedAmountsReceivedFromCustomers_1599" xlink:to="lab_mdwd_UnearnedAmountsReceivedFromCustomers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UnearnedAmountsReceivedFromCustomers_1600" xlink:to="lab_mdwd_UnearnedAmountsReceivedFromCustomers_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UnearnedAmountsReceivedFromCustomers_1601" xlink:to="lab_mdwd_UnearnedAmountsReceivedFromCustomers_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UnregisteredPreFundedWarrantsIssued_1602" xlink:to="lab_mdwd_UnregisteredPreFundedWarrantsIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UnregisteredPreFundedWarrantsIssued_1603" xlink:to="lab_mdwd_UnregisteredPreFundedWarrantsIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UnregisteredPreFundedWarrantsIssued_1604" xlink:to="lab_mdwd_UnregisteredPreFundedWarrantsIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock_1605" xlink:to="lab_mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock_1606" xlink:to="lab_mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock_1607" xlink:to="lab_mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UpfrontPayment_1608" xlink:to="lab_mdwd_UpfrontPayment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UpfrontPayment_1609" xlink:to="lab_mdwd_UpfrontPayment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UsaMember_1610" xlink:to="lab_mdwd_UsaMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UsaMember_1611" xlink:to="lab_mdwd_UsaMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UsaMember_1612" xlink:to="lab_mdwd_UsaMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember_1613" xlink:to="lab_mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember_1614" xlink:to="lab_mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember_1615" xlink:to="lab_mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_USDepartmentOfDefenseMember_1616" xlink:to="lab_mdwd_USDepartmentOfDefenseMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_USDepartmentOfDefenseMember_1617" xlink:to="lab_mdwd_USDepartmentOfDefenseMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_USDepartmentOfDefenseMember_1618" xlink:to="lab_mdwd_USDepartmentOfDefenseMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_VericelMember_1619" xlink:to="lab_mdwd_VericelMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_VericelMember_1620" xlink:to="lab_mdwd_VericelMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_WarrantsExpirationPeriod_1621" xlink:to="lab_mdwd_WarrantsExpirationPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_WarrantsExpirationPeriod_1622" xlink:to="lab_mdwd_WarrantsExpirationPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_WarrantsExpirationPeriod_1623" xlink:to="lab_mdwd_WarrantsExpirationPeriod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_WarrantsToPurchaseOrdinaryShares_1624" xlink:to="lab_mdwd_WarrantsToPurchaseOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_WarrantsToPurchaseOrdinaryShares_1625" xlink:to="lab_mdwd_WarrantsToPurchaseOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_WarrantsToPurchaseOrdinaryShares_1626" xlink:to="lab_mdwd_WarrantsToPurchaseOrdinaryShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_WeightedAverageExercisePriceAbstract_1627" xlink:to="lab_mdwd_WeightedAverageExercisePriceAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_WeightedAverageExercisePriceAbstract_1628" xlink:to="lab_mdwd_WeightedAverageExercisePriceAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis_1629" xlink:to="lab_srt_CurrencyAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_1630" xlink:to="lab_srt_MaximumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_1631" xlink:to="lab_srt_MinimumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_1632" xlink:to="lab_srt_RangeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_1633" xlink:to="lab_srt_RangeAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember_1634" xlink:to="lab_srt_RangeMember_0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>mdwd-20231231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#DocumentAndEntityInformation" roleURI="http://mediwound.com/role/DocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#ConsolidatedBalanceSheets" roleURI="http://mediwound.com/role/ConsolidatedBalanceSheets"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#ConsolidatedBalanceSheetsParenthetical" roleURI="http://mediwound.com/role/ConsolidatedBalanceSheetsParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#ConsolidatedStatementsOfComprehensiveIncomeLoss" roleURI="http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#ConsolidatedStatementsOfChangesInShareholdersEquity" roleURI="http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#ConsolidatedStatementsOfCashFlows" roleURI="http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#General" roleURI="http://mediwound.com/role/General"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SignificantAccountingPolicies" roleURI="http://mediwound.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SignificantAccountingJudgmentsEstimatesAndAssumptionsUsedInPreparationOfFinancialStatements" roleURI="http://mediwound.com/role/SignificantAccountingJudgmentsEstimatesAndAssumptionsUsedInPreparationOfFinancialStatements"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#CashAndCashEquivalents" roleURI="http://mediwound.com/role/CashAndCashEquivalents"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#Short-termBankDeposits" roleURI="http://mediwound.com/role/Short-termBankDeposits"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#TradeReceivables" roleURI="http://mediwound.com/role/TradeReceivables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#Inventories" roleURI="http://mediwound.com/role/Inventories"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#OtherReceivables" roleURI="http://mediwound.com/role/OtherReceivables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#PropertyPlantAndEquipmentNet" roleURI="http://mediwound.com/role/PropertyPlantAndEquipmentNet"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#Leases" roleURI="http://mediwound.com/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#IntangibleAssetsNet" roleURI="http://mediwound.com/role/IntangibleAssetsNet"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#OtherPayables" roleURI="http://mediwound.com/role/OtherPayables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#LiabilitiesInRespectOfIiaGrants" roleURI="http://mediwound.com/role/LiabilitiesInRespectOfIiaGrants"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#FinancialInstruments" roleURI="http://mediwound.com/role/FinancialInstruments"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SeverancePayLiabiltyNet" roleURI="http://mediwound.com/role/SeverancePayLiabiltyNet"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#ContingentLiabilitiesAndCommitments" roleURI="http://mediwound.com/role/ContingentLiabilitiesAndCommitments"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#MaterialAgreements" roleURI="http://mediwound.com/role/MaterialAgreements"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#Equity" roleURI="http://mediwound.com/role/Equity"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#Share-basedCompensation" roleURI="http://mediwound.com/role/Share-basedCompensation"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#TaxesOnIncome" roleURI="http://mediwound.com/role/TaxesOnIncome"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SupplementaryInformationToStatementsOfComprehensiveProfitOrLost" roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLost"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#NetProfitLossPerShare" roleURI="http://mediwound.com/role/NetProfitLossPerShare"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#BalancesAndTransactionsWithRelatedPartiesAndKeyOfficers" roleURI="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficers"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SubsequentEvents" roleURI="http://mediwound.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SignificantAccountingPoliciesPolicies" roleURI="http://mediwound.com/role/SignificantAccountingPoliciesPolicies"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SignificantAccountingPoliciesTables" roleURI="http://mediwound.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#CashAndCashEquivalentsTables" roleURI="http://mediwound.com/role/CashAndCashEquivalentsTables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#Short-termBankDepositsTables" roleURI="http://mediwound.com/role/Short-termBankDepositsTables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#TradeReceivablesTables" roleURI="http://mediwound.com/role/TradeReceivablesTables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#InventoriesTables" roleURI="http://mediwound.com/role/InventoriesTables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#OtherReceivablesTables" roleURI="http://mediwound.com/role/OtherReceivablesTables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#PropertyPlantAndEquipmentNetTables" roleURI="http://mediwound.com/role/PropertyPlantAndEquipmentNetTables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#LeasesTables" roleURI="http://mediwound.com/role/LeasesTables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#IntangibleAssetsNetTables" roleURI="http://mediwound.com/role/IntangibleAssetsNetTables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#OtherPayablesTables" roleURI="http://mediwound.com/role/OtherPayablesTables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#LiabilitiesInRespectOfIiaGrantsTables" roleURI="http://mediwound.com/role/LiabilitiesInRespectOfIiaGrantsTables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#FinancialInstrumentsTables" roleURI="http://mediwound.com/role/FinancialInstrumentsTables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#ContingentLiabilitiesAndCommitmentsTables" roleURI="http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsTables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#EquityTables" roleURI="http://mediwound.com/role/EquityTables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#Share-basedCompensationTables" roleURI="http://mediwound.com/role/Share-basedCompensationTables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables" roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#NetProfitLossPerShareTables" roleURI="http://mediwound.com/role/NetProfitLossPerShareTables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersTables" roleURI="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersTables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#GeneralDetails" roleURI="http://mediwound.com/role/GeneralDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SignificantAccountingPoliciesNarrativeDetails" roleURI="http://mediwound.com/role/SignificantAccountingPoliciesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SignificantAccountingPoliciesScheduleOfAmortizationPeriodsOfRight-of-useAssetsDetails" roleURI="http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfAmortizationPeriodsOfRight-of-useAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SignificantAccountingPoliciesScheduleOfDepreciationOnStraight-lineBasisOverUsefulLifeOfAssetsDetails" roleURI="http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfDepreciationOnStraight-lineBasisOverUsefulLifeOfAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails" roleURI="http://mediwound.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#Short-termBankDepositsNarrativeDetails" roleURI="http://mediwound.com/role/Short-termBankDepositsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#Short-termBankDepositsScheduleOfShort-termBankDepositsDetail" roleURI="http://mediwound.com/role/Short-termBankDepositsScheduleOfShort-termBankDepositsDetail"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#TradeReceivablesScheduleOfTradeReceivablesDetails" roleURI="http://mediwound.com/role/TradeReceivablesScheduleOfTradeReceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#InventoriesScheduleOfInventoriesDetails" roleURI="http://mediwound.com/role/InventoriesScheduleOfInventoriesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#OtherReceivablesScheduleOfOtherReceivablesDetails" roleURI="http://mediwound.com/role/OtherReceivablesScheduleOfOtherReceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails" roleURI="http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#LeasesNarrativeDetails" roleURI="http://mediwound.com/role/LeasesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#LeasesScheduleOfInformationOnLeasesDetails" roleURI="http://mediwound.com/role/LeasesScheduleOfInformationOnLeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails" roleURI="http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails" roleURI="http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails" roleURI="http://mediwound.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#OtherPayablesScheduleOfOtherPayablesDetails" roleURI="http://mediwound.com/role/OtherPayablesScheduleOfOtherPayablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#LiabilitiesInRespectOfIiaGrantsScheduleOfIsraeliInnovationAuthorityGrantsDetails" roleURI="http://mediwound.com/role/LiabilitiesInRespectOfIiaGrantsScheduleOfIsraeliInnovationAuthorityGrantsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#FinancialInstrumentsNarrativeDetails" roleURI="http://mediwound.com/role/FinancialInstrumentsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#FinancialInstrumentsScheduleOfSensitivityTestsRelatingToChangesInMarketFactorsDetails" roleURI="http://mediwound.com/role/FinancialInstrumentsScheduleOfSensitivityTestsRelatingToChangesInMarketFactorsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SeverancePayLiabiltyNetDetails" roleURI="http://mediwound.com/role/SeverancePayLiabiltyNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#ContingentLiabilitiesAndCommitmentsDetails" roleURI="http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#MaterialAgreementsDetails" roleURI="http://mediwound.com/role/MaterialAgreementsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#EquityScheduleOfShareCapitalDetails" roleURI="http://mediwound.com/role/EquityScheduleOfShareCapitalDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#Share-basedCompensationNarrativeDetails" roleURI="http://mediwound.com/role/Share-basedCompensationNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#Share-basedCompensationScheduleOfExpenseRecognizedDetails" roleURI="http://mediwound.com/role/Share-basedCompensationScheduleOfExpenseRecognizedDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#Share-basedCompensationScheduleOfShareOptionsActivityDetails" roleURI="http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails" roleURI="http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#Share-basedCompensationScheduleOfEstimatedUsingAcceptableOptionPricingModelsDetails" roleURI="http://mediwound.com/role/Share-basedCompensationScheduleOfEstimatedUsingAcceptableOptionPricingModelsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#TaxesOnIncomeDetails" roleURI="http://mediwound.com/role/TaxesOnIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails" roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeographicalInformationDetails" roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeographicalInformationDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesProductsDetails" roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesProductsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesDetails" roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenueLicenseDetails" roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenueLicenseDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails" roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails" roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeneralExpensesDetails" roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeneralExpensesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails" roleURI="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#NetProfitLossPerShareScheduleOfDetailsOfNumberOfSharesAndLossUsedInComputationDetails" roleURI="http://mediwound.com/role/NetProfitLossPerShareScheduleOfDetailsOfNumberOfSharesAndLossUsedInComputationDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#NetProfitLossPerShareScheduleOfNetProfitLossPerShareFromContinuingAndDiscontinuedOperationsDetails" roleURI="http://mediwound.com/role/NetProfitLossPerShareScheduleOfNetProfitLossPerShareFromContinuingAndDiscontinuedOperationsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersNarrativeDetails" roleURI="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfRelatedPartiesDetails" roleURI="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfRelatedPartiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfTransactionsWithRelatedPartiesDetails" roleURI="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfTransactionsWithRelatedPartiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfCompensationOfOfficersOfCompanyDetails" roleURI="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfCompensationOfOfficersOfCompanyDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#SubsequentEventsDetailTextuals" roleURI="http://mediwound.com/role/SubsequentEventsDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#OtherPayablesNarrativeDetails" roleURI="http://mediwound.com/role/OtherPayablesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#LiabilitiesInRespectOfIIAGrantsNarrativeDetails" roleURI="http://mediwound.com/role/LiabilitiesInRespectOfIIAGrantsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails" roleURI="http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#OtherReceivablesLongTerm" roleURI="http://mediwound.com/role/OtherReceivablesLongTerm"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#OtherReceivablesLongTermDetails" roleURI="http://mediwound.com/role/OtherReceivablesLongTermDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#OtherReceivablesLongTermTables" roleURI="http://mediwound.com/role/OtherReceivablesLongTermTables"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfKeyOfficersOfTheCompanyDetails" roleURI="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfKeyOfficersOfTheCompanyDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#EquityNarrativeDetails" roleURI="http://mediwound.com/role/EquityNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20231231.xsd#NetProfitLossPerShareNarrativeDetails" roleURI="http://mediwound.com/role/NetProfitLossPerShareNarrativeDetails"/>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DocumentAndEntityInformationAbstract" xlink:label="loc_mdwd_DocumentAndEntityInformationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesTable" xlink:label="loc_dei_EntityAddressesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesLineItems" xlink:label="loc_dei_EntityAddressesLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_dei_DocumentShellCompanyReport_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelFaxNumber" xlink:label="loc_dei_ContactPersonnelFaxNumber_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelEmailAddress" xlink:label="loc_dei_ContactPersonnelEmailAddress_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_dei_DocumentAccountingStandard_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_dei_DocumentRegistrationStatement_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_43"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityAddressesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesTable_1" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_1" xlink:to="loc_dei_AddressTypeDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_1" xlink:to="loc_dei_BusinessContactMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesTable_1" xlink:to="loc_dei_EntityAddressesLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityRegistrantName_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityCentralIndexKey_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentType_6" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentPeriodEndDate_7" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_AmendmentFlag_8" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_CurrentFiscalYearEndDate_9" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityVoluntaryFilers_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityCurrentReportingStatus_12" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityFilerCategory_13" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityShellCompany_14" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityEmergingGrowthCompany_15" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentAnnualReport_16" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentTransitionReport_17" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentShellCompanyReport_18" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_19" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentFiscalPeriodFocus_20" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentFiscalYearFocus_21" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityInteractiveDataCurrent_22" order="180" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_23" order="190" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityFileNumber_24" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityAddressAddressLine1_25" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityAddressCityOrTown_26" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityAddressPostalZipCode_27" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityAddressCountry_28" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_ContactPersonnelName_29" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_CityAreaCode_30" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_LocalPhoneNumber_31" order="270" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_ContactPersonnelFaxNumber_32" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_Security12bTitle_33" order="290" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_TradingSymbol_34" order="300" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_SecurityExchangeName_35" order="310" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_ContactPersonnelEmailAddress_36" order="320" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentAccountingStandard_37" order="330" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentRegistrationStatement_38" order="340" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_AuditorFirmId_39" order="350" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_AuditorLocation_40" order="360" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_AuditorName_41" order="370" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_IcfrAuditorAttestationFlag_42" order="380" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_43" order="390" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/ConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="loc_ifrs-full_OtherCurrentReceivables_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentReceivables" xlink:label="loc_ifrs-full_OtherNoncurrentReceivables_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LongtermDeposits" xlink:label="loc_ifrs-full_LongtermDeposits_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_16"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NonCurrentLiabilitiesCurrent" xlink:label="loc_mdwd_NonCurrentLiabilitiesCurrent_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentPayables" xlink:label="loc_ifrs-full_OtherCurrentPayables_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentWarrantLiability" xlink:label="loc_ifrs-full_NoncurrentWarrantLiability_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentGovernmentGrants" xlink:label="loc_ifrs-full_NoncurrentGovernmentGrants_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads" xlink:label="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_35"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_CurrentAssetsAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_CashAndCashEquivalents_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_CurrentTradeReceivables_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_Inventories_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_OtherCurrentReceivables_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_CurrentAssets_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_NoncurrentAssetsAbstract_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_8" xlink:to="loc_ifrs-full_OtherNoncurrentReceivables_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_8" xlink:to="loc_ifrs-full_LongtermDeposits_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_8" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_10" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_8" xlink:to="loc_ifrs-full_RightofuseAssets_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_8" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_12" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_8" xlink:to="loc_ifrs-full_NoncurrentAssets_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_Assets_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_CurrentLiabilitiesAbstract_16" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_16" xlink:to="loc_mdwd_NonCurrentLiabilitiesCurrent_16" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_16" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_17" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_16" xlink:to="loc_ifrs-full_OtherCurrentPayables_18" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_16" xlink:to="loc_ifrs-full_CurrentLiabilities_19" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_NoncurrentLiabilitiesAbstract_21" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_21" xlink:to="loc_ifrs-full_NoncurrentWarrantLiability_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_21" xlink:to="loc_ifrs-full_NoncurrentGovernmentGrants_22" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_21" xlink:to="loc_ifrs-full_OtherNoncurrentLiabilities_23" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_21" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_24" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_21" xlink:to="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_25" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_21" xlink:to="loc_ifrs-full_NoncurrentLiabilities_26" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_Liabilities_28" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_EquityAbstract_29" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_29" xlink:to="loc_ifrs-full_IssuedCapital_29" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_29" xlink:to="loc_ifrs-full_SharePremium_30" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_29" xlink:to="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads_31" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_29" xlink:to="loc_ifrs-full_RetainedEarnings_32" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_29" xlink:to="loc_ifrs-full_Equity_33" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_EquityAndLiabilities_35" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/ConsolidatedBalanceSheetsParenthetical">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesAuthorised" xlink:label="loc_ifrs-full_NumberOfSharesAuthorised_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_ParValuePerShare_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_NumberOfSharesAuthorised_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_NumberOfSharesIssued_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_4" order="30" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-full_IncomeStatementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromRenderingOfServices" xlink:label="loc_ifrs-full_RevenueFromRenderingOfServices_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LicenceFeeIncome" xlink:label="loc_ifrs-full_LicenceFeeIncome_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfSalesFromSaleOfProducts" xlink:label="loc_mdwd_CostOfSalesFromSaleOfProducts_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ServicesExpense" xlink:label="loc_ifrs-full_ServicesExpense_6"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfLicenseAgreements" xlink:label="loc_mdwd_CostOfLicenseAgreements_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_17"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinanceIncomeExpenseNet" xlink:label="loc_mdwd_FinanceIncomeExpenseNet_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDepositaryReceiptsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_28"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_RevenueFromRenderingOfServices_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_LicenceFeeIncome_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_Revenue_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_mdwd_CostOfSalesFromSaleOfProducts_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ServicesExpense_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_mdwd_CostOfLicenseAgreements_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_CostOfSales_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_GrossProfit_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_11" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_12" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_OperatingExpense_14" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_15" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_FinanceIncome_16" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_FinanceCosts_17" order="160" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_mdwd_FinanceIncomeExpenseNet_18" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_19" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_20" order="190" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ProfitLoss_21" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeAbstract_22" order="210" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_22" xlink:to="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_22" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_22" xlink:to="loc_ifrs-full_ComprehensiveIncome_23" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_25" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_25" xlink:to="loc_ifrs-full_BasicEarningsLossPerShare_25" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_25" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShare_26" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_25" xlink:to="loc_ifrs-full_WeightedAverageShares_27" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_25" xlink:to="loc_ifrs-full_AdjustedWeightedAverageShares_28" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremiumMember" xlink:label="loc_ifrs-full_SharePremiumMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" xlink:label="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AccumaletedEffectOfAdoptingIfrsFifteen" xlink:label="loc_mdwd_AccumaletedEffectOfAdoptingIfrsFifteen_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_Equity1" xlink:label="loc_mdwd_Equity1_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_12"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits" xlink:label="loc_mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfTreasuryShares" xlink:label="loc_ifrs-full_PurchaseOfTreasuryShares_16"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EffectOfShareSplit" xlink:label="loc_mdwd_EffectOfShareSplit_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_20"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_0" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_IssuedCapitalMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_SharePremiumMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_RetainedEarningsMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityMember_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_Equity_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_mdwd_AccumaletedEffectOfAdoptingIfrsFifteen_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_mdwd_Equity1_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_ProfitLoss_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_ComprehensiveIncome_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_15" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_PurchaseOfTreasuryShares_16" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_mdwd_EffectOfShareSplit_17" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_IssueOfEquity_18" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_19" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_Equity_20" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/ConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsToReconcileNetLossToNetCashProvidedByUsedInContinuingOperatingActivitiesAbstract" xlink:label="loc_mdwd_AdjustmentsToReconcileNetLossToNetCashProvidedByUsedInContinuingOperatingActivitiesAbstract_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue" xlink:label="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" xlink:label="loc_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xlink:label="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability" xlink:label="loc_mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_13"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ChangesInAssetAndLiabilityItemsAbstract" xlink:label="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_19"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" xlink:label="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_20"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" xlink:label="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:label="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromExerciseOfWarrants" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfWarrants_32"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet" xlink:label="loc_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_33"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RepaymentsOfIiaGrantsNet" xlink:label="loc_mdwd_RepaymentsOfIiaGrantsNet_34"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RepaymentOfLiabilitiesInRespectOfTeva" xlink:label="loc_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_41"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NonCashTransactionsAbstract" xlink:label="loc_mdwd_NonCashTransactionsAbstract_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus" xlink:label="loc_ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus_42"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PurchaseOfPropertyAndEquipment" xlink:label="loc_mdwd_PurchaseOfPropertyAndEquipment_43"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_ProfitLoss_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_mdwd_AdjustmentsToReconcileNetLossToNetCashProvidedByUsedInContinuingOperatingActivitiesAbstract_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_AdjustmentsToReconcileNetLossToNetCashProvidedByUsedInContinuingOperatingActivitiesAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_2" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants_6" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_7" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability_8" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_9" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_OtherIncome_10" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_11" order="90" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_12" order="100" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_13" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_16" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_16" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_16" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_16" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_17" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_16" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_18" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_16" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_19" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_16" xlink:to="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_20" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_16" xlink:to="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_21" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_23" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_25" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_25" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_25" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_25" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_26" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_25" xlink:to="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_27" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_25" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_28" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_30" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_30" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_30" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_30" xlink:to="loc_ifrs-full_ProceedsFromExerciseOfOptions_31" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_30" xlink:to="loc_ifrs-full_ProceedsFromExerciseOfWarrants_32" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_30" xlink:to="loc_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet_33" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_30" xlink:to="loc_mdwd_RepaymentsOfIiaGrantsNet_34" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_30" xlink:to="loc_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_35" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_30" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_36" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_38" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_39" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashAndCashEquivalents_40" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashAndCashEquivalents_41" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_mdwd_NonCashTransactionsAbstract_42" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_NonCashTransactionsAbstract_42" xlink:to="loc_ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus_42" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_NonCashTransactionsAbstract_42" xlink:to="loc_mdwd_PurchaseOfPropertyAndEquipment_43" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/General">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfGeneralInformationAbstract" xlink:label="loc_mdwd_DisclosureOfGeneralInformationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfGeneralInformationAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfSignificantAccountingPoliciesAbstract" xlink:label="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SignificantAccountingJudgmentsEstimatesAndAssumptionsUsedInPreparationOfFinancialStatements">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfBasisOfPreparationOfConsolidatedFinancialStatementsAbstract" xlink:label="loc_mdwd_DisclosureOfBasisOfPreparationOfConsolidatedFinancialStatementsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfBasisOfPreparationOfConsolidatedFinancialStatementsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/CashAndCashEquivalents">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/Short-termBankDeposits">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfShortTermBankDepositsAbstract" xlink:label="loc_mdwd_DisclosureOfShortTermBankDepositsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDepositsFromBanksExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDepositsFromBanksExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfShortTermBankDepositsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDepositsFromBanksExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/TradeReceivables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfTradeReceivablesExplanatory" xlink:label="loc_mdwd_DisclosureOfTradeReceivablesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_mdwd_DisclosureOfTradeReceivablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/Inventories">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInventoriesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInventoriesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfInventoriesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/OtherReceivables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/PropertyPlantAndEquipmentNet">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/Leases">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LeasesAbstract" xlink:label="loc_mdwd_LeasesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfLeasesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_LeasesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfLeasesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/IntangibleAssetsNet">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/OtherPayables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherPayablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherPayablesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/LiabilitiesInRespectOfIiaGrants">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract" xlink:label="loc_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGovernmentGrantsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGovernmentGrantsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfGovernmentGrantsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/FinancialInstruments">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SeverancePayLiabiltyNet">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/ContingentLiabilitiesAndCommitments">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/MaterialAgreements">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfMaterialAgreementsAbstract" xlink:label="loc_mdwd_DisclosureOfMaterialAgreementsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfMaterialAgreementsExplanatory" xlink:label="loc_mdwd_DisclosureOfMaterialAgreementsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfMaterialAgreementsAbstract_0" xlink:to="loc_mdwd_DisclosureOfMaterialAgreementsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/Equity">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/Share-basedCompensation">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/TaxesOnIncome">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfIncomeTaxesAbstract" xlink:label="loc_mdwd_DisclosureOfIncomeTaxesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfIncomeTaxesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLost">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract" xlink:label="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory" xlink:label="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract_0" xlink:to="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/NetProfitLossPerShare">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficers">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SignificantAccountingPoliciesPolicies">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfSignificantAccountingPoliciesAbstract" xlink:label="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory" xlink:label="loc_mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_13"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory" xlink:label="loc_mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent" xlink:label="loc_mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent_15"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory_14" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent_15" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfSignificantAccountingPoliciesAbstract" xlink:label="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock" xlink:label="loc_mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/CashAndCashEquivalentsTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_0" xlink:to="loc_mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/Short-termBankDepositsTables">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfShortTermBankDepositsAbstract" xlink:label="loc_mdwd_DisclosureOfShortTermBankDepositsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfShortTermBankDepositsAbstract_0" xlink:to="loc_mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/TradeReceivablesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/InventoriesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/OtherReceivablesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/PropertyPlantAndEquipmentNetTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/LeasesTables">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LeasesAbstract" xlink:label="loc_mdwd_LeasesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory" xlink:label="loc_mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_LeasesAbstract_0" xlink:to="loc_mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_LeasesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_LeasesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/IntangibleAssetsNetTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/OtherPayablesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherPayablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherPayablesAbstract_0" xlink:to="loc_mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/LiabilitiesInRespectOfIiaGrantsTables">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract" xlink:label="loc_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_0" xlink:to="loc_mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/FinancialInstrumentsTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk" xlink:label="loc_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xlink:label="loc_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/EquityTables">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EquityTablesAbstract" xlink:label="loc_mdwd_EquityTablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_EquityTablesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/Share-basedCompensationTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RestrictedSharesUnitsMember" xlink:label="loc_mdwd_RestrictedSharesUnitsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions" xlink:label="loc_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_mdwd_RestrictedSharesUnitsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract" xlink:label="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfAdditionalInformationRevenuesExplanatory" xlink:label="loc_mdwd_DisclosureOfAdditionalInformationRevenuesExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfCostOfSalesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCostOfSalesExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfCostOfSalesServicesExplanatory" xlink:label="loc_mdwd_DisclosureOfCostOfSalesServicesExplanatory_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ScheduleOfCostOfRevenuesLicense" xlink:label="loc_mdwd_ScheduleOfCostOfRevenuesLicense_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_6"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract_0" xlink:to="loc_mdwd_DisclosureOfAdditionalInformationRevenuesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfCostOfSalesExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract_0" xlink:to="loc_mdwd_DisclosureOfCostOfSalesServicesExplanatory_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract_0" xlink:to="loc_mdwd_ScheduleOfCostOfRevenuesLicense_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract_0" xlink:to="loc_mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/NetProfitLossPerShareTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/GeneralDetails">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfGeneralInformationAbstract" xlink:label="loc_mdwd_DisclosureOfGeneralInformationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember" xlink:label="loc_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_USDepartmentOfDefenseMember" xlink:label="loc_mdwd_USDepartmentOfDefenseMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_9"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ReverseStockSplit" xlink:label="loc_mdwd_ReverseStockSplit_10"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_GrossProceedsFromPublicAndPrivateOfferings" xlink:label="loc_mdwd_GrossProceedsFromPublicAndPrivateOfferings_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_12"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ContractAmountForDevelopmentAndManufacturing" xlink:label="loc_mdwd_ContractAmountForDevelopmentAndManufacturing_13"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromFunding" xlink:label="loc_mdwd_ProceedsFromFunding_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ContractWithCustomers" xlink:label="loc_mdwd_ContractWithCustomers_15"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits" xlink:label="loc_mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfGeneralInformationAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_1" xlink:to="loc_ifrs-full_BorrowingsByNameMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_1" xlink:to="loc_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" xlink:to="loc_dei_LegalEntityAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_4" xlink:to="loc_dei_EntityDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_4" xlink:to="loc_mdwd_USDepartmentOfDefenseMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_7" xlink:to="loc_ifrs-full_NumberOfSharesIssued_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_7" xlink:to="loc_ifrs-full_ParValuePerShare_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_7" xlink:to="loc_ifrs-full_RetainedEarnings_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_7" xlink:to="loc_mdwd_ReverseStockSplit_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_7" xlink:to="loc_mdwd_GrossProceedsFromPublicAndPrivateOfferings_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_7" xlink:to="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_7" xlink:to="loc_mdwd_ContractAmountForDevelopmentAndManufacturing_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_7" xlink:to="loc_mdwd_ProceedsFromFunding_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_7" xlink:to="loc_mdwd_ContractWithCustomers_15" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_7" xlink:to="loc_mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits_16" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SignificantAccountingPoliciesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfSignificantAccountingPoliciesAbstract" xlink:label="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UnearnedAmountsReceivedFromCustomers" xlink:label="loc_mdwd_UnearnedAmountsReceivedFromCustomers_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DeferredRevenuesExpectedRecongnizedPeriod" xlink:label="loc_mdwd_DeferredRevenuesExpectedRecongnizedPeriod_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_mdwd_UnearnedAmountsReceivedFromCustomers_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_mdwd_DeferredRevenuesExpectedRecongnizedPeriod_4" order="30" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfAmortizationPeriodsOfRight-of-useAssetsDetails">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfSignificantAccountingPoliciesAbstract" xlink:label="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MotorVehiclesMember" xlink:label="loc_ifrs-full_MotorVehiclesMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BuildingAndEquipmentMember" xlink:label="loc_mdwd_BuildingAndEquipmentMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmortizationPeriodsOfRightOfUseAssets" xlink:label="loc_mdwd_AmortizationPeriodsOfRightOfUseAssets_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_1" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_1" xlink:to="loc_ifrs-full_MotorVehiclesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_1" xlink:to="loc_mdwd_BuildingAndEquipmentMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_5" xlink:to="loc_mdwd_AmortizationPeriodsOfRightOfUseAssets_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfDepreciationOnStraight-lineBasisOverUsefulLifeOfAssetsDetails">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfSignificantAccountingPoliciesAbstract" xlink:label="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="loc_ifrs-full_OfficeEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MachineryMember" xlink:label="loc_ifrs-full_MachineryMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_OfficeEquipmentMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_MachineryMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_ComputerEquipmentMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_LeaseholdImprovementsMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_7" xlink:to="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_7" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashOnHand" xlink:label="loc_ifrs-full_CashOnHand_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CashOnHandInNonUsd" xlink:label="loc_mdwd_CashOnHandInNonUsd_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_0" xlink:to="loc_ifrs-full_CashOnHand_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_0" xlink:to="loc_mdwd_CashOnHandInNonUsd_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_0" xlink:to="loc_ifrs-full_CashAndCashEquivalents_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/Short-termBankDepositsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfShortTermBankDepositsAbstract" xlink:label="loc_mdwd_DisclosureOfShortTermBankDepositsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfInterestRatesAxis" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestRateTypesMember" xlink:label="loc_ifrs-full_InterestRateTypesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FixedInterestRateMember" xlink:label="loc_ifrs-full_FixedInterestRateMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_USD" xlink:label="loc_currency_USD_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_11"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepositInterestRate" xlink:label="loc_mdwd_DepositInterestRate_11"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PeriodOfBankDeposits" xlink:label="loc_mdwd_PeriodOfBankDeposits_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfShortTermBankDepositsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_1" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_1" xlink:to="loc_ifrs-full_InterestRateTypesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InterestRateTypesMember_1" xlink:to="loc_ifrs-full_FixedInterestRateMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_1" xlink:to="loc_srt_CurrencyAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_4" xlink:to="loc_currency_AllCurrenciesDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_4" xlink:to="loc_currency_USD_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_1" xlink:to="loc_srt_RangeAxis_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7" xlink:to="loc_srt_RangeMember_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7" xlink:to="loc_srt_MinimumMember_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7" xlink:to="loc_srt_MaximumMember_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable_1" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_11" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_11" xlink:to="loc_mdwd_DepositInterestRate_11" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_11" xlink:to="loc_mdwd_PeriodOfBankDeposits_12" order="10" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/Short-termBankDepositsScheduleOfShort-termBankDepositsDetail">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfShortTermBankDepositsAbstract" xlink:label="loc_mdwd_DisclosureOfShortTermBankDepositsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-full_RestrictedCashAndCashEquivalents_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BalancesWithBanks" xlink:label="loc_ifrs-full_BalancesWithBanks_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfShortTermBankDepositsAbstract_0" xlink:to="loc_ifrs-full_RestrictedCashAndCashEquivalents_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfShortTermBankDepositsAbstract_0" xlink:to="loc_ifrs-full_BalancesWithBanks_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfShortTermBankDepositsAbstract_0" xlink:to="loc_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/TradeReceivablesScheduleOfTradeReceivablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentVericel" xlink:label="loc_mdwd_CurrentVericel_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentBarda" xlink:label="loc_mdwd_CurrentBarda_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentMtec" xlink:label="loc_mdwd_CurrentMtec_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-full_OtherReceivables_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProvisionForImpairment" xlink:label="loc_mdwd_ProvisionForImpairment_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ReceivableFromBarda" xlink:label="loc_mdwd_ReceivableFromBarda_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_mdwd_CurrentVericel_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_mdwd_CurrentBarda_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_mdwd_CurrentMtec_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_ifrs-full_OtherReceivables_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_mdwd_ProvisionForImpairment_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_mdwd_ReceivableFromBarda_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_ifrs-full_CurrentTradeReceivables_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/InventoriesScheduleOfInventoriesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RawMaterials" xlink:label="loc_ifrs-full_RawMaterials_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinishedGoods" xlink:label="loc_ifrs-full_FinishedGoods_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InventoryWritedown2011" xlink:label="loc_ifrs-full_InventoryWritedown2011_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_RawMaterials_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_FinishedGoods_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_Inventories_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_InventoryWritedown2011_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/OtherReceivablesScheduleOfOtherReceivablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentGovernmentAuthoritiesReceivables" xlink:label="loc_mdwd_CurrentGovernmentAuthoritiesReceivables_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncomeReceivablesShortTerm" xlink:label="loc_mdwd_IncomeReceivablesShortTerm_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="loc_ifrs-full_OtherCurrentReceivables_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_mdwd_CurrentGovernmentAuthoritiesReceivables_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_mdwd_IncomeReceivablesShortTerm_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_ifrs-full_OtherCurrentReceivables_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepreciatedCostMember" xlink:label="loc_mdwd_DepreciatedCostMember_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TotalMember" xlink:label="loc_mdwd_TotalMember_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisposalsMember" xlink:label="loc_mdwd_DisposalsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="loc_ifrs-full_OfficeEquipmentMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MachineryMember" xlink:label="loc_ifrs-full_MachineryMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_16"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets" xlink:label="loc_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_19"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xlink:to="loc_ifrs-full_CarryingAmountMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_mdwd_DepreciatedCostMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_mdwd_TotalMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_mdwd_DisposalsMember_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_8" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_8" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_8" xlink:to="loc_ifrs-full_OfficeEquipmentMember_8" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_8" xlink:to="loc_ifrs-full_MachineryMember_9" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_8" xlink:to="loc_ifrs-full_ComputerEquipmentMember_10" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_8" xlink:to="loc_ifrs-full_LeaseholdImprovementsMember_11" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_14" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_14" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_14" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_15" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_14" xlink:to="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_16" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_14" xlink:to="loc_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets_17" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_14" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_18" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_14" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_19" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/LeasesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LeasesAbstract" xlink:label="loc_mdwd_LeasesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable" xlink:label="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_ILS" xlink:label="loc_currency_ILS_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsequentEventsMember" xlink:label="loc_mdwd_SubsequentEventsMember_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems" xlink:label="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_11"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseArea" xlink:label="loc_mdwd_SubsidiariesLeaseArea_11"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseMonthlyRent" xlink:label="loc_mdwd_SubsidiariesLeaseMonthlyRent_12"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseExpirationDate" xlink:label="loc_mdwd_SubsidiariesLeaseExpirationDate_13"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseExpirationPeriod" xlink:label="loc_mdwd_SubsidiariesLeaseExpirationPeriod_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseExtentionPeriod" xlink:label="loc_mdwd_SubsidiariesLeaseExtentionPeriod_15"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsidiariesLeaseEstimatedUsefulLife" xlink:label="loc_mdwd_SubsidiariesLeaseEstimatedUsefulLife_16"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfVehiclesInOperatingLeaseArrangements" xlink:label="loc_mdwd_NumberOfVehiclesInOperatingLeaseArrangements_17"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PeriodOfVehiclesOperatingLeaseArrangements" xlink:label="loc_mdwd_PeriodOfVehiclesOperatingLeaseArrangements_18"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NoncancelableLeasePeriods" xlink:label="loc_mdwd_NoncancelableLeasePeriods_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:label="loc_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationExpense" xlink:label="loc_ifrs-full_DepreciationExpense_21"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CompromisedDepreciationExpense" xlink:label="loc_mdwd_CompromisedDepreciationExpense_22"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements" xlink:label="loc_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_23"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfLeaseLiabilityUnderLongTermDebtAndCurrentMaturity" xlink:label="loc_mdwd_AmountOfLeaseLiabilityUnderLongTermDebtAndCurrentMaturity_24"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_LeasesAbstract_0" xlink:to="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1" xlink:to="loc_srt_CurrencyAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_1" xlink:to="loc_currency_AllCurrenciesDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_ILS_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1" xlink:to="loc_srt_RangeAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4" xlink:to="loc_srt_RangeMember_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4" xlink:to="loc_srt_MinimumMember_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4" xlink:to="loc_srt_MaximumMember_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_8" xlink:to="loc_ifrs-full_NonadjustingEventsMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsMember_8" xlink:to="loc_mdwd_SubsequentEventsMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1" xlink:to="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_11" xlink:to="loc_mdwd_SubsidiariesLeaseArea_11" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_11" xlink:to="loc_mdwd_SubsidiariesLeaseMonthlyRent_12" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_11" xlink:to="loc_mdwd_SubsidiariesLeaseExpirationDate_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_11" xlink:to="loc_mdwd_SubsidiariesLeaseExpirationPeriod_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_11" xlink:to="loc_mdwd_SubsidiariesLeaseExtentionPeriod_15" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_11" xlink:to="loc_mdwd_SubsidiariesLeaseEstimatedUsefulLife_16" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_11" xlink:to="loc_mdwd_NumberOfVehiclesInOperatingLeaseArrangements_17" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_11" xlink:to="loc_mdwd_PeriodOfVehiclesOperatingLeaseArrangements_18" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_11" xlink:to="loc_mdwd_NoncancelableLeasePeriods_19" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_11" xlink:to="loc_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_20" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_11" xlink:to="loc_ifrs-full_DepreciationExpense_21" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_11" xlink:to="loc_mdwd_CompromisedDepreciationExpense_22" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_11" xlink:to="loc_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_23" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_11" xlink:to="loc_mdwd_AmountOfLeaseLiabilityUnderLongTermDebtAndCurrentMaturity_24" order="130" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/LeasesScheduleOfInformationOnLeasesDetails">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LeasesAbstract" xlink:label="loc_mdwd_LeasesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="loc_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashOutflowForLeases" xlink:label="loc_ifrs-full_CashOutflowForLeases_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_LeasesAbstract_0" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_LeasesAbstract_0" xlink:to="loc_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_LeasesAbstract_0" xlink:to="loc_ifrs-full_CashOutflowForLeases_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LeasesAbstract" xlink:label="loc_mdwd_LeasesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable" xlink:label="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MotorVehiclesMember" xlink:label="loc_ifrs-full_MotorVehiclesMember_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems" xlink:label="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetsCostAbstract" xlink:label="loc_mdwd_RightOfUseAssetsCostAbstract_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssetsRevaluedAssetsAtCost" xlink:label="loc_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionsToRightOfUseAssetsNewLeases" xlink:label="loc_mdwd_AdditionsToRightOfUseAssetsNewLeases_6"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation" xlink:label="loc_mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionsToRightOfUseAssetsDisposals" xlink:label="loc_mdwd_AdditionsToRightOfUseAssetsDisposals_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases" xlink:label="loc_mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssetsRevaluedAssetsAtCost" xlink:label="loc_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_10"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract" xlink:label="loc_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract_12"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetsAccumulatedDepreciation" xlink:label="loc_mdwd_RightOfUseAssetsAccumulatedDepreciation_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_13"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements" xlink:label="loc_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetDisposals" xlink:label="loc_mdwd_RightOfUseAssetDisposals_15"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetsAccumulatedDepreciation" xlink:label="loc_mdwd_RightOfUseAssetsAccumulatedDepreciation_16"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RightOfUseAssetsDepreciationAbstract" xlink:label="loc_mdwd_RightOfUseAssetsDepreciationAbstract_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_18"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_LeasesAbstract_0" xlink:to="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_1" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_1" xlink:to="loc_ifrs-full_BuildingsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_1" xlink:to="loc_ifrs-full_MotorVehiclesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable_1" xlink:to="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_5" xlink:to="loc_mdwd_RightOfUseAssetsCostAbstract_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_RightOfUseAssetsCostAbstract_5" xlink:to="loc_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_RightOfUseAssetsCostAbstract_5" xlink:to="loc_mdwd_AdditionsToRightOfUseAssetsNewLeases_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_RightOfUseAssetsCostAbstract_5" xlink:to="loc_mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_RightOfUseAssetsCostAbstract_5" xlink:to="loc_mdwd_AdditionsToRightOfUseAssetsDisposals_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_RightOfUseAssetsCostAbstract_5" xlink:to="loc_mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_RightOfUseAssetsCostAbstract_5" xlink:to="loc_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_10" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_5" xlink:to="loc_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract_12" xlink:to="loc_mdwd_RightOfUseAssetsAccumulatedDepreciation_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract_12" xlink:to="loc_ifrs-full_DepreciationRightofuseAssets_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract_12" xlink:to="loc_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract_12" xlink:to="loc_mdwd_RightOfUseAssetDisposals_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract_12" xlink:to="loc_mdwd_RightOfUseAssetsAccumulatedDepreciation_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems_5" xlink:to="loc_mdwd_RightOfUseAssetsDepreciationAbstract_18" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_RightOfUseAssetsDepreciationAbstract_18" xlink:to="loc_ifrs-full_RightofuseAssets_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LeasesAbstract" xlink:label="loc_mdwd_LeasesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MotorVehiclesMember" xlink:label="loc_ifrs-full_MotorVehiclesMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_9"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities" xlink:label="loc_mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities_10"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NewFinanceLeaseObligationRecognized" xlink:label="loc_mdwd_NewFinanceLeaseObligationRecognized_11"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdjustmentsForIndexation" xlink:label="loc_mdwd_AdjustmentsForIndexation_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_13"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisposalsTerminationOfLeases" xlink:label="loc_mdwd_DisposalsTerminationOfLeases_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_17"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_LeasesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_ifrs-full_LeaseLiabilitiesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_4" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_4" xlink:to="loc_ifrs-full_BuildingsMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_4" xlink:to="loc_ifrs-full_MotorVehiclesMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8" xlink:to="loc_ifrs-full_LeaseLiabilities_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8" xlink:to="loc_mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8" xlink:to="loc_mdwd_NewFinanceLeaseObligationRecognized_11" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8" xlink:to="loc_mdwd_AdjustmentsForIndexation_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8" xlink:to="loc_mdwd_DisposalsTerminationOfLeases_14" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8" xlink:to="loc_ifrs-full_LeaseLiabilities_15" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_16" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_17" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmortizedCostMember" xlink:label="loc_mdwd_AmortizedCostMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LicencesAndFranchisesMember" xlink:label="loc_ifrs-full_LicencesAndFranchisesMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_11"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xlink:to="loc_ifrs-full_CarryingAmountMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_mdwd_AmortizedCostMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_6" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_6" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_6" xlink:to="loc_ifrs-full_LicencesAndFranchisesMember_6" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_9" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_9" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_9" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/OtherPayablesScheduleOfOtherPayablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherPayablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilityInRespectForPurchaseOfShares" xlink:label="loc_mdwd_LiabilityInRespectForPurchaseOfShares_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DeferredRevenues" xlink:label="loc_mdwd_DeferredRevenues_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherCurrentPayable" xlink:label="loc_mdwd_OtherCurrentPayable_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentPayables" xlink:label="loc_ifrs-full_OtherCurrentPayables_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherPayablesAbstract_0" xlink:to="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherPayablesAbstract_0" xlink:to="loc_mdwd_LiabilityInRespectForPurchaseOfShares_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherPayablesAbstract_0" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherPayablesAbstract_0" xlink:to="loc_mdwd_DeferredRevenues_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherPayablesAbstract_0" xlink:to="loc_mdwd_OtherCurrentPayable_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherPayablesAbstract_0" xlink:to="loc_ifrs-full_OtherCurrentPayables_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/LiabilitiesInRespectOfIiaGrantsScheduleOfIsraeliInnovationAuthorityGrantsDetails">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract" xlink:label="loc_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GovernmentGrants" xlink:label="loc_ifrs-full_GovernmentGrants_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_GrantsReceived" xlink:label="loc_mdwd_GrantsReceived_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RoyaltyExpense" xlink:label="loc_ifrs-full_RoyaltyExpense_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GovernmentGrants" xlink:label="loc_ifrs-full_GovernmentGrants_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentGovernmentGrants" xlink:label="loc_ifrs-full_CurrentGovernmentGrants_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentGovernmentGrants" xlink:label="loc_ifrs-full_NoncurrentGovernmentGrants_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_0" xlink:to="loc_ifrs-full_GovernmentGrants_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_0" xlink:to="loc_mdwd_GrantsReceived_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_0" xlink:to="loc_ifrs-full_RoyaltyExpense_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_0" xlink:to="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_0" xlink:to="loc_ifrs-full_GovernmentGrants_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_0" xlink:to="loc_ifrs-full_CurrentGovernmentGrants_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_0" xlink:to="loc_ifrs-full_NoncurrentGovernmentGrants_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/FinancialInstrumentsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_InterestRateForLoanMember" xlink:label="loc_mdwd_InterestRateForLoanMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UncertaintyInFutureDefaultsMember" xlink:label="loc_mdwd_UncertaintyInFutureDefaultsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_12"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExpectedTermOfWarrant" xlink:label="loc_mdwd_ExpectedTermOfWarrant_12"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExpectedVolatilityWarrants" xlink:label="loc_mdwd_ExpectedVolatilityWarrants_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse" xlink:label="loc_ifrs-full_DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RiskFreeRateOfWarrants" xlink:label="loc_mdwd_RiskFreeRateOfWarrants_15"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExpectedDividendAsPercentageOfWarrants" xlink:label="loc_mdwd_ExpectedDividendAsPercentageOfWarrants_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_TypesOfRisksAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksAxis_1" xlink:to="loc_ifrs-full_TypesOfRisksMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksMember_1" xlink:to="loc_mdwd_InterestRateForLoanMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksMember_1" xlink:to="loc_mdwd_UncertaintyInFutureDefaultsMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_5" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_5" xlink:to="loc_ifrs-full_Level3OfFairValueHierarchyMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_RangeAxis_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_8" xlink:to="loc_ifrs-full_RangesMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_8" xlink:to="loc_ifrs-full_BottomOfRangeMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_8" xlink:to="loc_ifrs-full_TopOfRangeMember_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_12" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_12" xlink:to="loc_mdwd_ExpectedTermOfWarrant_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_12" xlink:to="loc_mdwd_ExpectedVolatilityWarrants_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_12" xlink:to="loc_ifrs-full_DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse_14" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_12" xlink:to="loc_mdwd_RiskFreeRateOfWarrants_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_12" xlink:to="loc_mdwd_ExpectedDividendAsPercentageOfWarrants_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/FinancialInstrumentsScheduleOfSensitivityTestsRelatingToChangesInMarketFactorsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SensitivityAnalysisAxis" xlink:label="loc_mdwd_SensitivityAnalysisAxis_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SensitivityAnalysisDomain" xlink:label="loc_mdwd_SensitivityAnalysisDomain_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FivePercentageIncreaseInExchangeRateMember" xlink:label="loc_mdwd_FivePercentageIncreaseInExchangeRateMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FivePercentageDecreaseInExchangeRateMember" xlink:label="loc_mdwd_FivePercentageDecreaseInExchangeRateMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract" xlink:label="loc_mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_mdwd_SensitivityAnalysisAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_SensitivityAnalysisAxis_1" xlink:to="loc_mdwd_SensitivityAnalysisDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_SensitivityAnalysisDomain_1" xlink:to="loc_mdwd_FivePercentageIncreaseInExchangeRateMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_SensitivityAnalysisDomain_1" xlink:to="loc_mdwd_FivePercentageDecreaseInExchangeRateMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_5" xlink:to="loc_mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract_5" xlink:to="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_5" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SeverancePayLiabiltyNetDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans" xlink:label="loc_mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_0" xlink:to="loc_mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfContingentLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ThirdPartiesMember" xlink:label="loc_mdwd_ThirdPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TevaMember" xlink:label="loc_mdwd_TevaMember_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ResearchAndDevelopmentLawMember" xlink:label="loc_mdwd_ResearchAndDevelopmentLawMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:label="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodsOfGenerationAxis" xlink:label="loc_ifrs-full_MethodsOfGenerationAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodsOfGenerationMember" xlink:label="loc_ifrs-full_MethodsOfGenerationMember_9"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubLicensingOfPatentsMember" xlink:label="loc_mdwd_SubLicensingOfPatentsMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions" xlink:label="loc_ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions_16"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts" xlink:label="loc_mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_17"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts" xlink:label="loc_mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_18"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PercentageOfOneTimeLumpSumPaymentAmount" xlink:label="loc_mdwd_PercentageOfOneTimeLumpSumPaymentAmount_19"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OneTimeLumpsumAmount" xlink:label="loc_mdwd_OneTimeLumpsumAmount_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromRoyalties" xlink:label="loc_ifrs-full_RevenueFromRoyalties_21"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_MaximumAggregateRoyaltiesPaidInPercentage" xlink:label="loc_mdwd_MaximumAggregateRoyaltiesPaidInPercentage_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-full_BorrowingsInterestRateBasis_23"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfSharesRepurchased" xlink:label="loc_mdwd_NumberOfSharesRepurchased_24"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PercentageOfFutureRoyaltyPayments" xlink:label="loc_mdwd_PercentageOfFutureRoyaltyPayments_25"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SettlementAmountPaidByTeva" xlink:label="loc_mdwd_SettlementAmountPaidByTeva_26"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ReducedRateOfPayments" xlink:label="loc_mdwd_ReducedRateOfPayments_27"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ReducedAggregateAmount" xlink:label="loc_mdwd_ReducedAggregateAmount_28"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CollaborationAgreementsAmountRelatedToPolyheal" xlink:label="loc_mdwd_CollaborationAgreementsAmountRelatedToPolyheal_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="loc_ifrs-full_ConsiderationPaidReceived_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" xlink:label="loc_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_34"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinancialIncomeAndExpenses" xlink:label="loc_mdwd_FinancialIncomeAndExpenses_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RoyaltyExpense" xlink:label="loc_ifrs-full_RoyaltyExpense_36"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_ThirdPartiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_TevaMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_ResearchAndDevelopmentLawMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_6" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_6" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_6" xlink:to="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_6" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_MethodsOfGenerationAxis_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MethodsOfGenerationAxis_9" xlink:to="loc_ifrs-full_MethodsOfGenerationMember_9" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MethodsOfGenerationMember_9" xlink:to="loc_mdwd_SubLicensingOfPatentsMember_9" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_RangeAxis_12" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_12" xlink:to="loc_ifrs-full_RangesMember_12" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_12" xlink:to="loc_ifrs-full_BottomOfRangeMember_12" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_12" xlink:to="loc_ifrs-full_TopOfRangeMember_13" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" xlink:to="loc_ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions_16" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" xlink:to="loc_mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_17" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" xlink:to="loc_mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_18" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" xlink:to="loc_mdwd_PercentageOfOneTimeLumpSumPaymentAmount_19" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" xlink:to="loc_mdwd_OneTimeLumpsumAmount_20" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" xlink:to="loc_ifrs-full_RevenueFromRoyalties_21" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" xlink:to="loc_mdwd_MaximumAggregateRoyaltiesPaidInPercentage_22" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" xlink:to="loc_ifrs-full_BorrowingsInterestRateBasis_23" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" xlink:to="loc_mdwd_NumberOfSharesRepurchased_24" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" xlink:to="loc_mdwd_PercentageOfFutureRoyaltyPayments_25" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" xlink:to="loc_mdwd_SettlementAmountPaidByTeva_26" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" xlink:to="loc_mdwd_ReducedRateOfPayments_27" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" xlink:to="loc_mdwd_ReducedAggregateAmount_28" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" xlink:to="loc_mdwd_CollaborationAgreementsAmountRelatedToPolyheal_29" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_30" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" xlink:to="loc_ifrs-full_ConsiderationPaidReceived_31" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_32" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" xlink:to="loc_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_33" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" xlink:to="loc_ifrs-full_Liabilities_34" order="180" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" xlink:to="loc_mdwd_FinancialIncomeAndExpenses_35" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_16" xlink:to="loc_ifrs-full_RoyaltyExpense_36" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/MaterialAgreementsDetails">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfMaterialAgreementsAbstract" xlink:label="loc_mdwd_DisclosureOfMaterialAgreementsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfContingentLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NexoBridMember" xlink:label="loc_mdwd_NexoBridMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LicenseAgreementWithVericelMember" xlink:label="loc_mdwd_LicenseAgreementWithVericelMember_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember" xlink:label="loc_mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember" xlink:label="loc_mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AgreementAxis" xlink:label="loc_mdwd_AgreementAxis_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AgreementDomain" xlink:label="loc_mdwd_AgreementDomain_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember" xlink:label="loc_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions" xlink:label="loc_ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions_13"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AggregateSupplementalAmount" xlink:label="loc_mdwd_AggregateSupplementalAmount_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts" xlink:label="loc_mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_15"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts" xlink:label="loc_mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_16"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OneTimeLumpsumAmount" xlink:label="loc_mdwd_OneTimeLumpsumAmount_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromRoyalties" xlink:label="loc_ifrs-full_RevenueFromRoyalties_18"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_MaximumAggregateRoyaltiesPaidInPercentage" xlink:label="loc_mdwd_MaximumAggregateRoyaltiesPaidInPercentage_19"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ContractAmountForDevelopmentAndManufacturing" xlink:label="loc_mdwd_ContractAmountForDevelopmentAndManufacturing_20"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromFunding" xlink:label="loc_mdwd_ProceedsFromFunding_21"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromProcurement" xlink:label="loc_mdwd_ProceedsFromProcurement_22"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromAdditionalFunding" xlink:label="loc_mdwd_ProceedsFromAdditionalFunding_23"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromAdditionalProcurement" xlink:label="loc_mdwd_ProceedsFromAdditionalProcurement_24"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AccumulatedFunding" xlink:label="loc_mdwd_AccumulatedFunding_25"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfInvestedInProject" xlink:label="loc_mdwd_AmountOfInvestedInProject_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_27"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UpfrontPayment" xlink:label="loc_mdwd_UpfrontPayment_28"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionalUpfrontPayment" xlink:label="loc_mdwd_AdditionalUpfrontPayment_29"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevenuesFromSaleOfProcurement" xlink:label="loc_mdwd_RevenuesFromSaleOfProcurement_30"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfSecondContractExpired" xlink:label="loc_mdwd_AmountOfSecondContractExpired_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_32"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfTechnicalAssistance" xlink:label="loc_mdwd_AmountOfTechnicalAssistance_33"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential" xlink:label="loc_mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential_34"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfMaterialAgreementsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_NexoBridMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_LicenseAgreementWithVericelMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_mdwd_AgreementAxis_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_AgreementAxis_7" xlink:to="loc_mdwd_AgreementDomain_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_AgreementDomain_7" xlink:to="loc_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_srt_RangeAxis_10" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_10" xlink:to="loc_srt_RangeMember_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_10" xlink:to="loc_srt_MaximumMember_10" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions_13" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_mdwd_AggregateSupplementalAmount_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_15" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts_16" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_mdwd_OneTimeLumpsumAmount_17" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_ifrs-full_RevenueFromRoyalties_18" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_mdwd_MaximumAggregateRoyaltiesPaidInPercentage_19" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_mdwd_ContractAmountForDevelopmentAndManufacturing_20" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_mdwd_ProceedsFromFunding_21" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_mdwd_ProceedsFromProcurement_22" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_mdwd_ProceedsFromAdditionalFunding_23" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_mdwd_ProceedsFromAdditionalProcurement_24" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_mdwd_AccumulatedFunding_25" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_mdwd_AmountOfInvestedInProject_26" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_27" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_mdwd_UpfrontPayment_28" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_mdwd_AdditionalUpfrontPayment_29" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_mdwd_RevenuesFromSaleOfProcurement_30" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_mdwd_AmountOfSecondContractExpired_31" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_ifrs-full_Revenue_32" order="190" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_mdwd_AmountOfTechnicalAssistance_33" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_13" xlink:to="loc_mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential_34" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/EquityScheduleOfShareCapitalDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesAuthorised" xlink:label="loc_ifrs-full_NumberOfSharesAuthorised_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_NumberOfSharesAuthorised_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_NumberOfSharesIssued_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/Share-basedCompensationNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EmployeesAndDirectorsMember" xlink:label="loc_mdwd_EmployeesAndDirectorsMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ChiefExecutiveOfficersMember" xlink:label="loc_mdwd_ChiefExecutiveOfficersMember_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DirectorsMember" xlink:label="loc_mdwd_DirectorsMember_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EmployeesMember" xlink:label="loc_mdwd_EmployeesMember_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncomingCEOAndChairmanMember" xlink:label="loc_mdwd_IncomingCEOAndChairmanMember_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ChairmanMember" xlink:label="loc_mdwd_ChairmanMember_6"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncomingCFOMember" xlink:label="loc_mdwd_IncomingCFOMember_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DirectorsAndCeoMember" xlink:label="loc_mdwd_DirectorsAndCeoMember_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember" xlink:label="loc_mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember_9"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BoardMembersMember" xlink:label="loc_mdwd_BoardMembersMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_13"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RestrictedSharesUnitsMember" xlink:label="loc_mdwd_RestrictedSharesUnitsMember_13"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ShareIncentivePlanMember" xlink:label="loc_mdwd_ShareIncentivePlanMember_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_17"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IsraeliShareOptionPlanMember" xlink:label="loc_mdwd_IsraeliShareOptionPlanMember_17"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EquityIncentivePlanMember" xlink:label="loc_mdwd_EquityIncentivePlanMember_18"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RestrictedSharesUnitsMember" xlink:label="loc_mdwd_RestrictedSharesUnitsMember_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:label="loc_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_22"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SharesAvailableForFutureGrant" xlink:label="loc_mdwd_SharesAvailableForFutureGrant_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements" xlink:label="loc_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_30"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_EmployeesAndDirectorsMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_ChiefExecutiveOfficersMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_DirectorsMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_EmployeesMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_IncomingCEOAndChairmanMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_ChairmanMember_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_IncomingCFOMember_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_DirectorsAndCeoMember_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_BoardMembersMember_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_13" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_13" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_13" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_13" xlink:to="loc_mdwd_RestrictedSharesUnitsMember_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_13" xlink:to="loc_mdwd_ShareIncentivePlanMember_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_17" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_17" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_17" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_17" xlink:to="loc_mdwd_IsraeliShareOptionPlanMember_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_17" xlink:to="loc_mdwd_EquityIncentivePlanMember_18" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_17" xlink:to="loc_mdwd_RestrictedSharesUnitsMember_19" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_22" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_22" xlink:to="loc_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_22" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_22" xlink:to="loc_mdwd_SharesAvailableForFutureGrant_23" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_22" xlink:to="loc_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement_24" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_22" xlink:to="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_25" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_22" xlink:to="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_26" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_22" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_27" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_22" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_28" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_22" xlink:to="loc_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements_29" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_22" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_30" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/Share-basedCompensationScheduleOfExpenseRecognizedDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfRevenuesMember" xlink:label="loc_mdwd_CostOfRevenuesMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ResearchAndDevelopmentExpensesMember" xlink:label="loc_mdwd_ResearchAndDevelopmentExpensesMember_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SellingAndMarketingExpensesMember" xlink:label="loc_mdwd_SellingAndMarketingExpensesMember_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_GeneralAndAdministrativeExpensesMember" xlink:label="loc_mdwd_GeneralAndAdministrativeExpensesMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_mdwd_CostOfRevenuesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_mdwd_ResearchAndDevelopmentExpensesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_mdwd_SellingAndMarketingExpensesMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_mdwd_GeneralAndAdministrativeExpensesMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_7" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RestrictedSharesUnitsMember" xlink:label="loc_mdwd_RestrictedSharesUnitsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberAbstract" xlink:label="loc_mdwd_NumberAbstract_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_10"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_WeightedAverageExercisePriceAbstract" xlink:label="loc_mdwd_WeightedAverageExercisePriceAbstract_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_17"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_mdwd_RestrictedSharesUnitsMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_mdwd_NumberAbstract_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_NumberAbstract_4" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_NumberAbstract_4" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_NumberAbstract_4" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_NumberAbstract_4" xlink:to="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_NumberAbstract_4" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_NumberAbstract_4" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_NumberAbstract_4" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_mdwd_WeightedAverageExercisePriceAbstract_12" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_WeightedAverageExercisePriceAbstract_12" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_WeightedAverageExercisePriceAbstract_12" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_WeightedAverageExercisePriceAbstract_12" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_14" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_WeightedAverageExercisePriceAbstract_12" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_15" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_WeightedAverageExercisePriceAbstract_12" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_WeightedAverageExercisePriceAbstract_12" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_17" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesOneMember" xlink:label="loc_mdwd_RangesOfExercisePricesOneMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesTwoMember" xlink:label="loc_mdwd_RangesOfExercisePricesTwoMember_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesThreeMember" xlink:label="loc_mdwd_RangesOfExercisePricesThreeMember_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesFourMember" xlink:label="loc_mdwd_RangesOfExercisePricesFourMember_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesFiveMember" xlink:label="loc_mdwd_RangesOfExercisePricesFiveMember_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesSixMember" xlink:label="loc_mdwd_RangesOfExercisePricesSixMember_6"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesServenMember" xlink:label="loc_mdwd_RangesOfExercisePricesServenMember_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RangesOfExercisePricesEightMember" xlink:label="loc_mdwd_RangesOfExercisePricesEightMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_mdwd_RangesOfExercisePricesOneMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_mdwd_RangesOfExercisePricesTwoMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_mdwd_RangesOfExercisePricesThreeMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_mdwd_RangesOfExercisePricesFourMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_mdwd_RangesOfExercisePricesFiveMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_mdwd_RangesOfExercisePricesSixMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_mdwd_RangesOfExercisePricesServenMember_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_1" xlink:to="loc_mdwd_RangesOfExercisePricesEightMember_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_11" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_11" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_11" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_11" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_12" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_11" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_13" order="20" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/Share-basedCompensationScheduleOfEstimatedUsingAcceptableOptionPricingModelsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExercisePriceShareOptionsGrantedPercentage" xlink:label="loc_mdwd_ExercisePriceShareOptionsGrantedPercentage_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_RangeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_1" xlink:to="loc_ifrs-full_RangesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_BottomOfRangeMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_TopOfRangeMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_5" xlink:to="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_5" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_5" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_5" xlink:to="loc_mdwd_ExercisePriceShareOptionsGrantedPercentage_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_5" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/TaxesOnIncomeDetails">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfIncomeTaxesAbstract" xlink:label="loc_mdwd_DisclosureOfIncomeTaxesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasMember" xlink:label="loc_ifrs-full_GeographicalAreasMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="loc_ifrs-full_CountryOfDomicileMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DE" xlink:label="loc_country_DE_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod" xlink:label="loc_ifrs-full_ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod_6"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DescriptionOfTaxBenefitPeriod" xlink:label="loc_mdwd_DescriptionOfTaxBenefitPeriod_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LimitOfBenefitEntitlementPeriod" xlink:label="loc_mdwd_LimitOfBenefitEntitlementPeriod_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CarryforwardLosses" xlink:label="loc_mdwd_CarryforwardLosses_9"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses" xlink:label="loc_mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses_10"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DeferredTaxAssetsNotRecognized" xlink:label="loc_mdwd_DeferredTaxAssetsNotRecognized_11"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfIncomeTaxesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_1" xlink:to="loc_ifrs-full_CountryOfDomicileMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_1" xlink:to="loc_country_DE_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_5" xlink:to="loc_ifrs-full_ApplicableTaxRate_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_5" xlink:to="loc_ifrs-full_ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_5" xlink:to="loc_mdwd_DescriptionOfTaxBenefitPeriod_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_5" xlink:to="loc_mdwd_LimitOfBenefitEntitlementPeriod_8" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_5" xlink:to="loc_mdwd_CarryforwardLosses_9" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_5" xlink:to="loc_mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses_10" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_5" xlink:to="loc_mdwd_DeferredTaxAssetsNotRecognized_11" order="60" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_BardaMember" xlink:label="loc_mdwd_BardaMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_VericelMember" xlink:label="loc_mdwd_VericelMember_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_MtecMember" xlink:label="loc_mdwd_MtecMember_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherCustomerContributedMember" xlink:label="loc_mdwd_OtherCustomerContributedMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherExpenseByFunction" xlink:label="loc_ifrs-full_OtherExpenseByFunction_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ConcentrationRiskPercentage" xlink:label="loc_mdwd_ConcentrationRiskPercentage_9"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevenuesFromDistributionAgreements" xlink:label="loc_mdwd_RevenuesFromDistributionAgreements_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_mdwd_BardaMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_mdwd_VericelMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_mdwd_MtecMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_mdwd_OtherCustomerContributedMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_7" xlink:to="loc_ifrs-full_OtherExpenseByFunction_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_7" xlink:to="loc_ifrs-full_OtherIncome_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_7" xlink:to="loc_mdwd_ConcentrationRiskPercentage_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_7" xlink:to="loc_mdwd_RevenuesFromDistributionAgreements_10" order="30" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeographicalInformationDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-full_SegmentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-full_SegmentsMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UsaMember" xlink:label="loc_mdwd_UsaMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherCountriesMember" xlink:label="loc_mdwd_OtherCountriesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_SegmentsAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsAxis_1" xlink:to="loc_ifrs-full_SegmentsMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_1" xlink:to="loc_mdwd_UsaMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsMember_1" xlink:to="loc_mdwd_OtherCountriesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_5" xlink:to="loc_ifrs-full_Revenue_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesProductsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-full_WagesAndSalaries_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubcontractorsExpenses" xlink:label="loc_mdwd_SubcontractorsExpenses_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfMerchandiseSold" xlink:label="loc_ifrs-full_CostOfMerchandiseSold_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MiscellaneousOtherOperatingExpense" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ChangesInInventoriesOfFinishedGoodsAndWorkInProgress" xlink:label="loc_ifrs-full_ChangesInInventoriesOfFinishedGoodsAndWorkInProgress_6"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfSalesFromSaleOfProducts" xlink:label="loc_mdwd_CostOfSalesFromSaleOfProducts_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_WagesAndSalaries_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_mdwd_SubcontractorsExpenses_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_DepreciationAndAmortisationExpense_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_CostOfMerchandiseSold_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_ChangesInInventoriesOfFinishedGoodsAndWorkInProgress_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_mdwd_CostOfSalesFromSaleOfProducts_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SalaryAndBenefits" xlink:label="loc_mdwd_SalaryAndBenefits_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_Subcontractors" xlink:label="loc_mdwd_Subcontractors_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfSalesFromLicenseAgreements" xlink:label="loc_mdwd_CostOfSalesFromLicenseAgreements_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_0" xlink:to="loc_mdwd_SalaryAndBenefits_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_0" xlink:to="loc_mdwd_Subcontractors_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_0" xlink:to="loc_mdwd_CostOfSalesFromLicenseAgreements_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenueLicenseDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements" xlink:label="loc_mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RoyaltiesPayments" xlink:label="loc_mdwd_RoyaltiesPayments_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TotalRoyaltiesPayments" xlink:label="loc_mdwd_TotalRoyaltiesPayments_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_0" xlink:to="loc_mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_0" xlink:to="loc_mdwd_RoyaltiesPayments_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_0" xlink:to="loc_mdwd_TotalRoyaltiesPayments_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_0" xlink:to="loc_ifrs-full_CostOfSales_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EmployeeBenefitsExpense" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment" xlink:label="loc_mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment" xlink:label="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CostOfMaterials" xlink:label="loc_mdwd_CostOfMaterials_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherResearchAndDevelopmentExpenses" xlink:label="loc_mdwd_OtherResearchAndDevelopmentExpenses_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_EmployeeBenefitsExpense_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_mdwd_CostOfMaterials_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_mdwd_OtherResearchAndDevelopmentExpenses_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_MarketingAndSalesExpense" xlink:label="loc_mdwd_MarketingAndSalesExpense_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses" xlink:label="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DistributionCosts" xlink:label="loc_ifrs-full_DistributionCosts_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RegistrationAndMarketingLicenseFees" xlink:label="loc_mdwd_RegistrationAndMarketingLicenseFees_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_mdwd_MarketingAndSalesExpense_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_DistributionCosts_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_mdwd_RegistrationAndMarketingLicenseFees_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeneralExpensesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SalaryAndBenefitsIncludingShareBasedCompensation" xlink:label="loc_mdwd_SalaryAndBenefitsIncludingShareBasedCompensation_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses" xlink:label="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_OtherSellingGeneralAndAdministrativeExpenses" xlink:label="loc_mdwd_OtherSellingGeneralAndAdministrativeExpenses_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_mdwd_SalaryAndBenefitsIncludingShareBasedCompensation_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_ProfessionalFeesExpense_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_mdwd_OtherSellingGeneralAndAdministrativeExpenses_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinancingIncomeAbstract" xlink:label="loc_mdwd_FinancingIncomeAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromInterest" xlink:label="loc_ifrs-full_RevenueFromInterest_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfWarrantsAccountedAtFairValue" xlink:label="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradingIncomeExpenseOnForeignExchangeContracts" xlink:label="loc_ifrs-full_TradingIncomeExpenseOnForeignExchangeContracts_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinancingExpensesAbstract" xlink:label="loc_mdwd_FinancingExpensesAbstract_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinancingIncomeOnNetInvestmentInLease" xlink:label="loc_mdwd_FinancingIncomeOnNetInvestmentInLease_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinanceExpensesInRespectOfDeferredRevenue" xlink:label="loc_mdwd_FinanceExpensesInRespectOfDeferredRevenue_9"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="loc_ifrs-full_NetForeignExchangeLoss_11"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RevaluationOfWarrant" xlink:label="loc_mdwd_RevaluationOfWarrant_12"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss" xlink:label="loc_mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherFinanceCost" xlink:label="loc_ifrs-full_OtherFinanceCost_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_15"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_FinancialExpensesNet" xlink:label="loc_mdwd_FinancialExpensesNet_17"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_mdwd_FinancingIncomeAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_FinancingIncomeAbstract_1" xlink:to="loc_ifrs-full_RevenueFromInterest_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_FinancingIncomeAbstract_1" xlink:to="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_FinancingIncomeAbstract_1" xlink:to="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_FinancingIncomeAbstract_1" xlink:to="loc_ifrs-full_TradingIncomeExpenseOnForeignExchangeContracts_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_FinancingIncomeAbstract_1" xlink:to="loc_ifrs-full_FinanceIncome_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_mdwd_FinancingExpensesAbstract_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_FinancingExpensesAbstract_7" xlink:to="loc_mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_FinancingExpensesAbstract_7" xlink:to="loc_mdwd_FinancingIncomeOnNetInvestmentInLease_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_FinancingExpensesAbstract_7" xlink:to="loc_mdwd_FinanceExpensesInRespectOfDeferredRevenue_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_FinancingExpensesAbstract_7" xlink:to="loc_mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_FinancingExpensesAbstract_7" xlink:to="loc_ifrs-full_NetForeignExchangeLoss_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_FinancingExpensesAbstract_7" xlink:to="loc_mdwd_RevaluationOfWarrant_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_FinancingExpensesAbstract_7" xlink:to="loc_mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_FinancingExpensesAbstract_7" xlink:to="loc_ifrs-full_OtherFinanceCost_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_FinancingExpensesAbstract_7" xlink:to="loc_ifrs-full_FinanceCosts_15" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_mdwd_FinancialExpensesNet_17" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/NetProfitLossPerShareScheduleOfDetailsOfNumberOfSharesAndLossUsedInComputationDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_AdjustedWeightedAverageShares_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_ProfitLossFromContinuingOperations_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/NetProfitLossPerShareScheduleOfNetProfitLossPerShareFromContinuingAndDiscontinuedOperationsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_BasicEarningsLossPerShare_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ChiefExecutiveOfficerAndChiefMedicalOfficerMember" xlink:label="loc_mdwd_ChiefExecutiveOfficerAndChiefMedicalOfficerMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DirectorsRemunerationExpense" xlink:label="loc_ifrs-full_DirectorsRemunerationExpense_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_ChiefExecutiveOfficerAndChiefMedicalOfficerMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_4" xlink:to="loc_ifrs-full_DirectorsRemunerationExpense_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfRelatedPartiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RelatedPartiesMember" xlink:label="loc_ifrs-full_RelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherRelatedPartiesMember" xlink:label="loc_ifrs-full_OtherRelatedPartiesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_ifrs-full_RelatedPartiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_ifrs-full_OtherRelatedPartiesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5" xlink:to="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_5" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfTransactionsWithRelatedPartiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherRelatedPartiesMember" xlink:label="loc_ifrs-full_OtherRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RelatedPartiesMember" xlink:label="loc_ifrs-full_RelatedPartiesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProfessionalFeeAndShareBasedCompensationExpenses" xlink:label="loc_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RelatedPartiesRentaLexpenseAndOther" xlink:label="loc_mdwd_RelatedPartiesRentaLexpenseAndOther_6"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfDirectors" xlink:label="loc_mdwd_NumberOfDirectors_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_ifrs-full_OtherRelatedPartiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_ifrs-full_RelatedPartiesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5" xlink:to="loc_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5" xlink:to="loc_mdwd_RelatedPartiesRentaLexpenseAndOther_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_5" xlink:to="loc_mdwd_NumberOfDirectors_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfCompensationOfOfficersOfCompanyDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfEmployees" xlink:label="loc_ifrs-full_NumberOfEmployees_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensation_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_NumberOfEmployees_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SubsequentEventsDetailTextuals">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_SubsequentEventsMember" xlink:label="loc_mdwd_SubsequentEventsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember" xlink:label="loc_mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AreaOfLand" xlink:label="loc_mdwd_AreaOfLand_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" xlink:label="loc_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfSharesExerciseRestrictedStockUnits" xlink:label="loc_mdwd_NumberOfSharesExerciseRestrictedStockUnits_9"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfAnnualFeeOfLeaseAgreement" xlink:label="loc_mdwd_AmountOfAnnualFeeOfLeaseAgreement_10"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TermOfLease" xlink:label="loc_mdwd_TermOfLease_11"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionalTermOfLease" xlink:label="loc_mdwd_AdditionalTermOfLease_12"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare" xlink:label="loc_mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_StockOptionValue" xlink:label="loc_mdwd_StockOptionValue_15"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfPreFundedWarrantsExercised" xlink:label="loc_mdwd_NumberOfPreFundedWarrantsExercised_16"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExercisePriceOfWarrants" xlink:label="loc_mdwd_ExercisePriceOfWarrants_17"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="loc_ifrs-full_NonadjustingEventsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsMember_1" xlink:to="loc_mdwd_SubsequentEventsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_4" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_4" xlink:to="loc_mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_7" xlink:to="loc_mdwd_AreaOfLand_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_7" xlink:to="loc_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_7" xlink:to="loc_mdwd_NumberOfSharesExerciseRestrictedStockUnits_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_7" xlink:to="loc_mdwd_AmountOfAnnualFeeOfLeaseAgreement_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_7" xlink:to="loc_mdwd_TermOfLease_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_7" xlink:to="loc_mdwd_AdditionalTermOfLease_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_7" xlink:to="loc_mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_7" xlink:to="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_7" xlink:to="loc_mdwd_StockOptionValue_15" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_7" xlink:to="loc_mdwd_NumberOfPreFundedWarrantsExercised_16" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_7" xlink:to="loc_mdwd_ExercisePriceOfWarrants_17" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/OtherPayablesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherPayablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities" xlink:label="loc_mdwd_LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherPayablesAbstract_0" xlink:to="loc_mdwd_LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/LiabilitiesInRespectOfIIAGrantsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract" xlink:label="loc_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_GrantsReceivedNetOfRoyalties" xlink:label="loc_mdwd_GrantsReceivedNetOfRoyalties_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmortizedCostOfGrantsReceived" xlink:label="loc_mdwd_AmortizedCostOfGrantsReceived_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_0" xlink:to="loc_mdwd_GrantsReceivedNetOfRoyalties_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract_0" xlink:to="loc_mdwd_AmortizedCostOfGrantsReceived_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember" xlink:label="loc_mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_9"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CurrentMaturitiesOfLongTermLiabilities" xlink:label="loc_mdwd_CurrentMaturitiesOfLongTermLiabilities_9"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_TradePayablesAndAccruedExpenses" xlink:label="loc_mdwd_TradePayablesAndAccruedExpenses_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherPayables" xlink:label="loc_ifrs-full_OtherPayables_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_13"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_LiabilitiesInRespectOfGrants_13"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilitiesInRespectOfTeva" xlink:label="loc_mdwd_LiabilitiesInRespectOfTeva_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LiabilitiesInRespectOfPurchaseOfShares" xlink:label="loc_mdwd_LiabilitiesInRespectOfPurchaseOfShares_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_6" xlink:to="loc_ifrs-full_CarryingAmountMember_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_6" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_9" xlink:to="loc_ifrs-full_CurrentLiabilitiesAbstract_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_9" xlink:to="loc_mdwd_CurrentMaturitiesOfLongTermLiabilities_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_9" xlink:to="loc_mdwd_TradePayablesAndAccruedExpenses_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_9" xlink:to="loc_ifrs-full_OtherPayables_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_9" xlink:to="loc_ifrs-full_NoncurrentLiabilitiesAbstract_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_13" xlink:to="loc_mdwd_LiabilitiesInRespectOfGrants_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_13" xlink:to="loc_mdwd_LiabilitiesInRespectOfTeva_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_13" xlink:to="loc_mdwd_LiabilitiesInRespectOfPurchaseOfShares_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_13" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_16" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/OtherReceivablesLongTerm">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentReceivablesAbstract" xlink:label="loc_ifrs-full_NoncurrentReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfOtherReceivablesLongTermExplanatory" xlink:label="loc_mdwd_DisclosureOfOtherReceivablesLongTermExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentReceivablesAbstract_0" xlink:to="loc_mdwd_DisclosureOfOtherReceivablesLongTermExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/OtherReceivablesLongTermDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentReceivablesAbstract" xlink:label="loc_ifrs-full_NoncurrentReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncomeReceivablesLongTerm" xlink:label="loc_mdwd_IncomeReceivablesLongTerm_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PrepaidExpensesLongTerm" xlink:label="loc_mdwd_PrepaidExpensesLongTerm_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentReceivables" xlink:label="loc_ifrs-full_OtherNoncurrentReceivables_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentReceivablesAbstract_0" xlink:to="loc_mdwd_IncomeReceivablesLongTerm_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentReceivablesAbstract_0" xlink:to="loc_mdwd_PrepaidExpensesLongTerm_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentReceivablesAbstract_0" xlink:to="loc_ifrs-full_OtherNoncurrentReceivables_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/OtherReceivablesLongTermTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentReceivablesAbstract" xlink:label="loc_ifrs-full_NoncurrentReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentReceivablesAbstract_0" xlink:to="loc_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfKeyOfficersOfTheCompanyDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_KeyOfficerMember" xlink:label="loc_mdwd_KeyOfficerMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_KeyOfficerMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_4" xlink:to="loc_ifrs-full_ProfessionalFeesExpense_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/EquityNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CertainEntitiesAffiliatedWithCbiMember" xlink:label="loc_mdwd_CertainEntitiesAffiliatedWithCbiMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AgreementAxis" xlink:label="loc_mdwd_AgreementAxis_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AgreementDomain" xlink:label="loc_mdwd_AgreementDomain_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PrivateIssuancePurchaseEquityAgreementMember" xlink:label="loc_mdwd_PrivateIssuancePurchaseEquityAgreementMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits" xlink:label="loc_mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AuthorizedShareCapital" xlink:label="loc_mdwd_AuthorizedShareCapital_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesAuthorised" xlink:label="loc_ifrs-full_NumberOfSharesAuthorised_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_10"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ReverseStockSplit" xlink:label="loc_mdwd_ReverseStockSplit_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" xlink:label="loc_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_12"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PricePerShareOfSharesIssued" xlink:label="loc_mdwd_PricePerShareOfSharesIssued_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AmountOfUnderwritingDiscountsAndCommissions" xlink:label="loc_mdwd_AmountOfUnderwritingDiscountsAndCommissions_15"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares" xlink:label="loc_mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares_16"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ProceedsFromIssuingAdditionalShares" xlink:label="loc_mdwd_ProceedsFromIssuingAdditionalShares_17"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AggregateAmountOfRegisteredDirectOffering" xlink:label="loc_mdwd_AggregateAmountOfRegisteredDirectOffering_18"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_PurchasePriceOfRegisteredDirectOffering" xlink:label="loc_mdwd_PurchasePriceOfRegisteredDirectOffering_19"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfWarrantsIssued" xlink:label="loc_mdwd_NumberOfWarrantsIssued_20"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_ExercisePriceOfWarrants" xlink:label="loc_mdwd_ExercisePriceOfWarrants_21"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_WarrantsExpirationPeriod" xlink:label="loc_mdwd_WarrantsExpirationPeriod_22"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NetProceedsFromOfferingAmount" xlink:label="loc_mdwd_NetProceedsFromOfferingAmount_23"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_RiskFreeInterestRateOfWarrants" xlink:label="loc_mdwd_RiskFreeInterestRateOfWarrants_24"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_AverageStandardDeviationOfWarrants" xlink:label="loc_mdwd_AverageStandardDeviationOfWarrants_25"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UnregisteredPreFundedWarrantsIssued" xlink:label="loc_mdwd_UnregisteredPreFundedWarrantsIssued_26"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock" xlink:label="loc_mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock_27"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncreaseInPreFundedWarrantsExercisePrice" xlink:label="loc_mdwd_IncreaseInPreFundedWarrantsExercisePrice_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromExerciseOfWarrants" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfWarrants_30"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_LossFromWarrantsTransactions" xlink:label="loc_mdwd_LossFromWarrantsTransactions_31"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfPreFundedWarrantsExercised" xlink:label="loc_mdwd_NumberOfPreFundedWarrantsExercised_32"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_WarrantsToPurchaseOrdinaryShares" xlink:label="loc_mdwd_WarrantsToPurchaseOrdinaryShares_33"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_CommissionsAndOtherOfferingExpenses" xlink:label="loc_mdwd_CommissionsAndOtherOfferingExpenses_34"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncreaseInAuthorizedShareCapital" xlink:label="loc_mdwd_IncreaseInAuthorizedShareCapital_35"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_IncreaseInSharesIssued" xlink:label="loc_mdwd_IncreaseInSharesIssued_36"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_mdwd_CertainEntitiesAffiliatedWithCbiMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_mdwd_AgreementAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_AgreementAxis_4" xlink:to="loc_mdwd_AgreementDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_AgreementDomain_4" xlink:to="loc_mdwd_PrivateIssuancePurchaseEquityAgreementMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_AuthorizedShareCapital_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_ifrs-full_NumberOfSharesAuthorised_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_ifrs-full_ParValuePerShare_10" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_ReverseStockSplit_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_PricePerShareOfSharesIssued_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_AmountOfUnderwritingDiscountsAndCommissions_15" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares_16" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_ProceedsFromIssuingAdditionalShares_17" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_AggregateAmountOfRegisteredDirectOffering_18" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_PurchasePriceOfRegisteredDirectOffering_19" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_NumberOfWarrantsIssued_20" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_ExercisePriceOfWarrants_21" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_WarrantsExpirationPeriod_22" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_NetProceedsFromOfferingAmount_23" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_RiskFreeInterestRateOfWarrants_24" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_AverageStandardDeviationOfWarrants_25" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_UnregisteredPreFundedWarrantsIssued_26" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock_27" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_IncreaseInPreFundedWarrantsExercisePrice_28" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValue_29" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_ifrs-full_ProceedsFromExerciseOfWarrants_30" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_LossFromWarrantsTransactions_31" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_NumberOfPreFundedWarrantsExercised_32" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_WarrantsToPurchaseOrdinaryShares_33" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_CommissionsAndOtherOfferingExpenses_34" order="270" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_IncreaseInAuthorizedShareCapital_35" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_mdwd_IncreaseInSharesIssued_36" order="290" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/NetProfitLossPerShareNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareTable" xlink:label="loc_ifrs-full_EarningsPerShareTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="loc_ifrs-full_ClassesOfOrdinarySharesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_DilutedWeightedAverageNumberMember" xlink:label="loc_mdwd_DilutedWeightedAverageNumberMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareLineItems" xlink:label="loc_ifrs-full_EarningsPerShareLineItems_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfWarrantsIssued" xlink:label="loc_mdwd_NumberOfWarrantsIssued_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_NumberOfRestrictedShareUnitIssued" xlink:label="loc_mdwd_NumberOfRestrictedShareUnitIssued_6"/>
    <loc xlink:type="locator" xlink:href="mdwd-20231231.xsd#mdwd_UnregisteredPreFundedWarrantsIssued" xlink:label="loc_mdwd_UnregisteredPreFundedWarrantsIssued_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_EarningsPerShareTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareTable_1" xlink:to="loc_ifrs-full_ClassesOfOrdinarySharesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_1" xlink:to="loc_ifrs-full_OrdinarySharesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OrdinarySharesMember_1" xlink:to="loc_mdwd_DilutedWeightedAverageNumberMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareTable_1" xlink:to="loc_ifrs-full_EarningsPerShareLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_4" xlink:to="loc_mdwd_NumberOfWarrantsIssued_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_4" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_4" xlink:to="loc_mdwd_NumberOfRestrictedShareUnitIssued_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_4" xlink:to="loc_mdwd_UnregisteredPreFundedWarrantsIssued_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>mdwd_img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 mdwd_img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !" /H# 2(  A$! Q$!_\0
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M$7_7R?Y"K7P(_P"2K:'_ +S_ /H)JK\9?^2H>(O^OD_R%6_@1_R5;0_]Y_\
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MUBG[+EOK8/9RYKV.0^,7B&6X\5:KIEMNC@BF*RGO(?3Z56^!?_)3]*_W)O\
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M^Y[UCCZL*.'<.ZLC; 4IUL0I]G=GJ=&***^6/JPHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K+N=&TN:X\R;3;*20
M\EF@4D_CBBBMZ&[.>OLC1BBCAC"1(J(HP%48 _"FW-O#<PF.XACEC/59%# _
M@:**S7QFC^ J:?I>GVDC/:V-K"^?O1PJI_,"M"BBJK?$30^$****R-@HHHH
F**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 0S!W<# 2(  A$! Q$!_\0
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M3!F7JQ"XX'KZ^U?8WP>_:I\'?%Z."31)HW$Y7;M<-][&.WO^E-*45:3NUO\
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MV_SSBOLFUO6B5&D)PP![],$GW]_6@#IPJCHH'?I3JHP7T<V-OI_A]:O YZ4
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M&.E;%:U*LZGQ.^W3T_R-MM$-9L#I_A4'G'/_ .K^6*DED5!\W^??_.*S3J$
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MH **** "BBB@ HHHH *^=OCGIZWNASHQ(S%(.OJ/\_G[5]$YQUXKP3XRNO\
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M=YIVF&]O9FS%"&,KGG"]R2/;^AKT']JK]I"#X4^"YM26?>\-E)*0K L=H8]
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MY_V>="++J'CG28"O7?=PC^;BO\Y7]GWX^_&*ZM;;29/$>N7,DZB'?Y\[??&
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M[TY1E'XE8J4)0MS)JY_>)??\%!OV9].D:*Z^(.BQLI((:\A!X^LE2:7_ ,%
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MQGU"2+QAKC6Z7N1$MW,00)I#C )[<8]:YQG^H?%^T]\(YK/[<GB>P-OC=O\
M/CQC&<YW8Z=/6O.-8_;Q_9ST.8P:AX\T>"1205>[A!!'7JX_E_\ 7_AR^"7Q
M_P#BOX\\/6WAF+5-;:YN8X8A*'G)RRE<Y^I'IZGKFO2O$?\ P3"_:?\ C19S
M>)]+\:^);2&0-<*B75PF V"./Q_P]@#^SFP_;]_9MU*9(+7Q_HTLCD!56\A)
M))QCAS7T#X5^,O@3QE MSH6LVMY$R[@T4JL,8SU!/;G]:_S?_%7[$_[3OP)U
M@7VH^-?$]Q#I\OF.&NK@@B-B2,?08-?97P._X*F^(_V;K>#PWXFN-0O9T"6Y
M><R,VXCR_P"+W(/_ .JLXU:4FXJ5Y+I]W]?Y=79]G]Q_<[XL_:#^&?@O>=>\
M0V5GLR6\V:-,8Z_>8?R_QKQF\_;[_9NL7,=QX^T=&!((-W#D8/\ OU_,"OC/
MXB_M[1;O".KZIIOV]=J>1))'@S=.GID8[_K7F/B[_@B!^U7KB2:E:^/?$B(^
MZ4!;R<?+U]<]JT_K^OZZ"/ZX]$_;@_9]U]U33?'&DW#.0%"741Z_1CFO:- ^
M,O@3Q)L_LK6;6Y\S&SRY4;.1D8P?Z5_GI?%#]G+]H#]BUY+SQ'XTUZY2P<[A
M-=S,#Y>,]3WQWQ_6ON/_ ()V?M_:[XP\5:=X=OM4NKAXKL6S^9*[$F-O+/4D
M]1D_Y-59=^EWUMJNG_!_X(?W 7?B;2;*#[1/<HD17=N+ #'UKSW4/CI\/-,=
MDN]>LXF7[P:9 1^;5\J>*/$%_K7PXM+^WN98GFT[?N5B#RIYS_G_  _GV_:Y
M^)WC3P0=2O+?6KX+&)6"QS2?PY[ G!^7]:YZDZL7[E/G7K;M_P $:MU=OE<_
MJ&O_ -JOX.::I:[\5:=&%ZYN(Q_[-_GUK@;_ /;S_9RTYBMUX]T>(@X(:[A&
M#TY^>O\ /4U_]L+XI^//&3^$-/UK6HWGF,(=))P>7V<D#M^.!7VW\-?^"8G[
M3W[16E1:]IGC?Q';QW:+,%6[G7 D4-C&1Z^F,_2L?K-1.TJ5MNM^W_!,JLIQ
M?[N//JK].NO]?/8_L]@_X*$?LS7$JPQ?$+16=R H%Y#R3TXWYKUKPY^U!\(?
M%00Z/XHT^Z$F-ICN(VR#]&_SSZ5_$;K?_!$+]K/P/')XAN/B!XGDBLE^T,AO
M+@@A,$]_8UX[#\=_BO\ L@^(;7P_XCU;6[YK2ZB@=I9)WS^]5#G/^/'7%;N<
M[)J%[[[_ .7]?>*4ZBBFH7>EU]U^W]:['^AAIGB;1-<4-87D<P?[NQ@<YY&.
MOJ.@-3:UI\;Z=<L#_P LV/Z$_3]/I7X3?\$Z_P!L9_BY::7]ON71I/)4BX<@
M\@?WCU]<GT[]?W8DU*TO-%9XKB*0M;Y^5U)Y4^Y]10J<9+WH*]]K/R_X84:<
M9I2G!*7;7R?GU_#1K<_DW_X*^>)]4\.PZN;*652DDWW&*]-_8'M^'Z<?F-_P
M3"^)GB#5OB):Q74]PR_;V&&D8_\ +<@]3GH*_5__ (*[>&DU:'5^G+3G_P!"
M/M[_ ,^E?E__ ,$SO!"Z;\0;67CY=0)[=/.8_P"'KTSZUW0I25.ZC9;VZZ*U
MSE>'E&K&48^[=/3;1IW7]7/[K/@S.\_@O1G<Y9K& DGK]P&NWU[Q7H_AV%I]
M2NH[>-026D8*, 'U/M7QS-\<=.^$WP^T^YO)(T6WTZ-CN8 85.>N.A_R*_)3
M]H[_ (*0:'XM&H>'M-UBWM9QYL ,=PB%6;(_OY!Z<]N0,5@HN]K?\#;_ #.J
M=14XI-VE967I;_/S/VO\1?M;?!70'>+5?%VFVS)D,'N(UQ@\]6_^O7EEW^WM
M^S!:2$7'Q"T6-AG(:]A&.O7Y^_Z]J_D#^('@KXB?'#6+A]&^(=S9I>2'8(]2
MV!1(QQP'Q^OOGI7!I_P2#^/_ (\!U"U^,>HPK*-P"ZT1C=GC_6=O\]*<XI6:
M7YF>'JRJ7;NU_E_G\M_0_M,TC]O_ /9FOYH[6R^(.C2RNP1%6\A))] -V?\
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M_$31'9C@#[9#_P#%UZ+HG[7WP0\0%%TSQ?IMP7QMV7,;9S]&/O\ E7\-,_\
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MVB#?PJ <_0?I[UQ&N_%'PAX<WG5M3MK;9G<9'5>GU/M_^K'/SG\4_P!I;1_
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ME&VE]UY?J]/379GU_P",_BWX*\!Q//XCU:VL(XQES-*J8'7N?ZFO&-._;4^
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M\;Y6SGJ/?_&NJ_8@_P""7W[57A_XF6GB/Q?H6H)NOK>:5Y(9^BNK,27 ]_\
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MO/->3?LG?M ?\+3L;2:71H+7S@A&($3&1[*!SS^/Z_:?C6\:#1KIXK9>87(
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M*;V4FUY_U_7X)34%+W=5;=KT?Y_<SA?^"+^5\5::NYB!)'U)/20#^5?T>?\
M!0&WLIOA@PN!D?V7"3[YMEYYXS_B#CT_ W_@CM\(/B'H7B+3;G5_#>I6<>^(
MEYK:1!@LIZD>_P#.OWU_X*$6T</PT>.Y;R672XE8.=I'^CKD'./\?;M40GR2
MYK7MT)UZ:/N?R(CP9X8U?XB7Z21(V[47'*@]7 ^N/P]Z_<O]B'X.>&K34]+N
MH+5,F:$YV*!P5(Z]!Z],Y-?C'X6L],?XDWFZ[C)_M)^-_3]X<_S_  [U_19^
MQ?IVGQOI1CGC8[H3@,.<;<?C7J4ZRK4_?BHNWIVMZ>;T_(UC2KR5U)N*M=-V
M[7M?MK]W7<_I8_9\TJVT_P *V44,2*JPQ@85?[@QT_'_ #U\]_;/ 'PMUW
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M_7]>1RSGS2=M(Z+\NFA_-S?7_P#P5L:$P31Z_L92I!6]Z$8QT[5X'XN^ /\
MP4U^(,S/J]AKDWFGYB8[P_>/N/Y?2O\ 0SU'XH_LIRP^8-<\%[@F0-]AV&>?
ME_IZ9KPSQ7^T=^SIX>\Q=.O_  E.4W%=@LC^7R\GCC_(K5J*5X-N77[NW;]>
MVQ?[N,5*,VI_EHO3]?E:Y_#Q\,?V'?V\K:[MI=1TG5P/,0MF*Z'\7.<C'O\
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M-.9-.3&Q&;.8%'8>V?6OYF=._9VUGX$^-+W7;O09FCCOI9\S6Y*\2%L_,O\
MC_6NF.'A.$IN5I=%\E^5_P /D)NS2L]>I\5> ?@M_P %$P8=3\,V>L&-RKQ,
MB7?(/W3D#'_UZ^L](L_^"M.C6<<5K%KZQH  -EZ!@8'IZ=>QK]H/V6_VYO!^
MGW.G^'?$&F:3:QP-# [W,%NO  !R67\_I7[W_#GX^_LR>(M MI]2U7P;!,Z
MLKFQ5@2H/0@=_K]>*XWO:[LGU\NW]:Z#/X1O&>E?\%5_&5A/I.K0Z])#,I1E
M9+T\,,=-O'!KY:\,?\$ROVW/&7C^P\1>*-"U21OMHN'=X+CJ7RQ^8?Y_"O\
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MA1_9]C_SZ6__ 'Z3_"AJZMT",Y1E=ZVZ2UV]3^'[X%_\$POVTH-4MO\ A/\
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M8[8KO/A-_P $E/VZ_P#A(+9O&_B/7[_3]Z>;'<>>RLN[Y@0P]/;U&#7]_?\
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M;\/P5]>EC26)J27+:*VU2L^GZKSOZ'^=H_\ P2B_X*6+,1'XV\4+%NX4/=8
M!^F>GY?A7:Z#_P $B_V\M0EB_P"$C\2^(;Q2R[_.,[ C(R3N!_/N!BO]!7^S
M['_GTM_^_2?X4HL+(=+6 ?\ ;)?\*PNWN8MM[G\G7[)G_!)_QOX=O+"7XDV,
MNHJK1M,+J+=NY7=G<GUX]Z_H.^%'[(?PF\!Z=9M9^%["WO88TW2+;QJ=X R<
MA>O>OKQ;>!.4AC7_ '44?R%5+IY(PWECIG';Z=.G4<4U*25DW;L(_-?]MG]F
M75?BMX'O= \,0E/,LIH(TB3."RL!@ >_I^E?RT^'?^"(GQJT[XUR>,+B"\:R
M-ZDPS$VW:+AW_N>A_+UK^Z=9;B1]LD89>.&&?TP<?IZ^]:R65M(N6MX@<=?+
M7/\ +KS_ %IJ<UM)KY^G^0'P=^Q]\$9_A-X-L-(U>WQ<000HV],-N1-I[#O^
ME?;&JV NK"6*U&UF0@8X.=O^/7_&M273XTRR*!W^48[Y_I_]:LPO=12;54X!
M/Z<>G^14W ^"OC%\$/&_BA;M-.FG"RAPNW=T8\=,_P"?<BORQ^(__!.WXH^)
M]6^UG[2Z&8.<HQS\X/I_/\J_I:M=T@'F(.<9^4?CV^O]>E7'MX2#^Y0GC^ >
MH]JB<%-6=UZ:=5_D!^3'[*'[-GB/X2QVB:JK@Q>5G<&&-N,]0/\ /2OU%$4%
MUIQMR@+-$5R>N2/Y_P _SIE_9DO^[C4#CHO3G/I_+ZU-I\$B8RN,41@HQY=7
MUUUU!Z[J_P C\%?^"D?[!WCG]H"SU./PO',&N&EVF-"3\V0.@///\^:_+O\
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MVI>RO^\O:ZV]5_P?/Y!K;I?\ @O%DPH'^&/Z?C_]:KX.>:IQ6:1=#TZ?Y_\
MK_G5RIJ^SYOW=^7S^7]>HRG<6-O<@B5 V01SSVQ7Q5^T=^S=I7Q1TNZM#IL4
MYFBD0YC#9W ^H/7\OQK[AI"JMU4'ZBLP/Y"/C]_P1_\ %NJ7E_J7@?37L;V5
MI)(I;> JP8DE2"J#IZ]<5^9_BS_@D[_P4)L[^:/POXM\26=B&(BC@>X50,\
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MB37[*(\(L!G4 =ONCTZ>E?WEBTM1TMX1_P!LU_PIK6-FWWK6 _6-?\*DV/\
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MHM-K;'K!$?K&I_I3E@A3E(D7_=4#^0K6>*E-6<8K2VB].MK]+]5Y=1)6VO\
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M !1110 4444 %'7J*** &>6AZJ/6G!57H /PI:*=WW8!1112 **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !12$X&:YW6=>CTJUFN''RQ*S'M]WT_$>O3-%[;EPISJ.T5=G1XSU&?P
MII53P5'Y5^-/[5O_  5B\!?LT&\_MKR/]%\W<)' _P!7G/\ RT0_X=S7Y4W'
M_!T1\&8[J2VBM[:5HV*G8V[H<=IS0G?8)0G3=I:/^O\ (_KL"J.BC\J=7\BH
M_P"#G[X4-C&E CU"-_/SL5ZKX"_X.-?AEXTNHK>#3-ID8+G:W)) _P">Q_/T
M[47MN)*4W9:L_J5HK\BO@U_P4^\)_%:6VCL[0H;@HHX/5\?[?O[XK[CU[X_:
M7HGA4^)9]BPB$R_,<# C#=VP.N>OY4DT]%J7*C4C:ZM?9=_3[SZ,F.U<A>?8
M?Y__ %XK#GNI]VT(WID#U(SQ_/)!K\)?C7_P6Y^%_P )=1N=/OVM7DMWD0J9
M5ZH2",>:"?RYZ5\7Z[_P<M_"+2IF0:=%,%;:&0%@?3D3]>/Z?3JA:DDZE._:
M_P G_P !>:LV3*$XI.2:3M^GW=OEZ']4RV7VA@TG'/7Z<GKGI^?6KT:VMKA6
M=<^_'^?I@U_)._\ P<\?"C:0ND8.#C"/^N9_R_I6%%_P<K_#C6;^&U@TUU,T
MBH"%;^)@!_RV[9_/\Z(JG5GJU35_\NQ!_7^+N-L^6P/H!_B.:S;J_N(\[58C
M/89Z?Y]_TK\EOV2/^"C/A_\ :$M;6YL;=HQ.J$;@?XP#R"[?7]3WKW#X\?MU
M>#O@Q;/-JQMP$#9\QP.F/5UR0#]::=&E*SBJJ77OL]?T^XY9TJTG>-9Q\NVJ
M?Z??Y'WK:ZE.[8<$ X[8K9\]7!(;MTY_,C^?3Z5^/'PJ_P""H?@'XHZ@+'2V
MMB[/M'ER*3G=CIYIZ^GX=:[OXV_\%"?"WP7T)];U01^4D G^=L  KNY^<=CV
M/H?05-:IA*MTW&#T]SST77O^-O0FV)I^[9S[R[;6T];+T\KGZ>7-Q-$#L!/&
M1_GG_...M9,>JW?FA61@,CGK]3UP?_K\5^!7PE_X+I_"KXG>,3X2M?LAN!=K
M:<2_Q$@?\]B<\^G^%?N+\,O'VE_$?P_::[9"-8[J)9%P<_>56]23][GG\ZQI
MPHPTA%)/K;3^OZV"5.NDY*JY-:J'?;3[_P D>I07)=?FZXZGK^77\QVJ4RGW
M/Z?I7AOQ;^*&G?"[0[K6[R2,Q6T;R$%NR L>X[9/],5^+'C?_@N?\,O!7C=/
M!URD#7#7;6N=W.4;9T\T'L>W7ZBM&J<=4U+^EW?GZKJ94JF*K/EG"5%+[7\U
MK:_UKYG]"CN0N=N>OK^G^'<UAW%_,AP(\_AGT^G\Q7RK^S7^UGH'[06D6NI:
M4JJEU"LJ[6SD, >!O/KZU]BM:QR!7V#D=<9!]_:M*-6C"5YTU)>>FGR_X?U'
M4I8F-N6JW\.W=<J_&W].YGVE[+*?F0CIV'?_ /5]>_TTQ(WTS]?\:1(4B&0H
MR.<X_E^7M6==ZM%:_>7OCOV]\_7_ .M64Z]&I4Y:<4GMRI>GETN_P]32CA\5
M42_>M/3\X_Y:_P##FNLC'_.<_P"?2DDN%3JP7VZD_I6%;:PEV<*,<C'_ .ON
M>>>GYD58N+2:=,H2!Z_ACU]3GO\ 05I&G!S2F^3:]]-';7\5TZ[!56*HIPY7
M)Z)2^ZWY]M43O+'<':&YZ]1[YY'0?GG.#VI(].4'>IR#]./I[X_6LZWTRX20
M%G)&3_C^?%=)$A1 #SP!SUX]:UJR5%*-&KS+K;3MTO\ UML/#>U:O535M5?T
M5OPU^ZPL<8C4 =AC_/Y?YZU)117$VV[O5G6%%%%( HHHH **** $)P.F:CWG
MV_S^-2T5A4IU)N\:CAMI\U_E]XU;JK_-HBWGV_S^-&\^@J6D(!ZC]*R]C76O
MMF[=._P][]OR"Z_EU]6(&!'7'UII<]A^=)L/J*>% ]SZXH3Q%2T7S0L]96WV
M?7^NP::=>ZU7XBJ<C.,?Y[4M%%=44XQ2;YGW$%%%%4 4444 %%%%%[;@(1D8
MJ%H<G.?\_D:DWCWIX.>E1"M!MJ,]5NON[KT(G3C/XXWV>M^@Q4 Z\^W;_P"O
M3Z:7 ..?PI00>E'MH2DUSIR7]?K^92CRQ22LNF@M%%%6,**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<'MZFOU<0811Z*/Y5Y%'\5OA-I;+!'XET"V<84(MW:(<^F XY]OPKK=/\?\
MA'55#:?KEA= XVF&XBD!_P"^6-:1BTK:RM\SI.Q(##!%95SIMO.?WG.#^OY@
M=?\ #VK+F\0Q9_<2+(.1\ASG\1WQ_GO4]K?/==05'T/Z9[U<:23YN7E?2RUZ
M/^OZOA+$N#Y:3;G=::KK]_3[BQ!IEM <Q?Y_$'VX_0BM:/(X'W?I_GG_ .O5
M< J,CZ$'/'-2)*>GY9_R#FLYT)SFJGM9.RVOZ?+9=[[=@CBI2M&MI-I?IUZ?
M\ LT4T,".N/K2Y'J*JS71Z=_Z]/O-DT]FOZ_X="T444#"BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 44A('7B@,#T- KK:ZN+1110,**** "BBB@ HHHH
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MD+@<!<]N,<8Q7\@'[3__  3:\6Z%XPO/%_AS2M0GN89YIX_*64DL7\S^%?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%1.Q&?0?KQ32N[$RDHIMD=P_EK(Y/"+N^F!_GVK\]?VHOVU
M-+_9\LKVZO55Q:H['=U^4$^HQGZ>GX?=.L7,R6\^W.-AZ?3G^G^>:_G,_P""
MI\4=WHNM"YZ&"7C)S]T_CGD\_P J^QX4R.GF^8T,-7DO93DDUUU:?XW_ .#H
M?G?%G%]/),/6K1I5)5*:;3CJNC_K\MV>3ZW_ ,'$W@G2=8N=+D@BW6\S0G_@
M#;>?FSG_ .M5F'_@X@\%2('\F/!QW/'&<?>Y_P \5_'9X\\,:-+XRU)ARQO9
MN^>=WH,'_#@BM+3?">F^6I(...YY& ?7_'GZU_6F3^ 7#.-PD:LX-S<$_P"(
M^O+T?YV[=#^6\_\ I$9]@\1*&&4H0C)I*5-7:6VM^W?;J?V"'_@X=\%@_P"I
M3\#Q^K5)_P 1#7@O_GC%],O_ /%8K^0\^%-%*CN>2.0?Z^O]:IGPIIN_(!V_
M_JQWSSD<Y';BO0I?1XX:M+VE*2M>WOOIU6FOY'@0^DMQ/4^UM:_[OT7^?W^:
M9_7P?^#AWP7D_N5Z_P"?XJ>O_!PWX+(SY,?XEOZ-7\AZ^%-%"G<.2/7KR/\
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M!!)R/7'J/\/T5\'?\%\? /A32H+&*Q@C6) H"J !@ 9Z_P!<<^U?RPGPWH9
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M73[SNE])O/6E3N_:?S<B2Z??T_#NS^P.X_X.!O!D"DF*(_U_\>XY_3VK*/\
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MKU]?RK1'  ]!2T5Z].G&G'EBK+3\-#CG4E4=Y;A1115D!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'D\$]QU/4_Y)JO$DK8VGUR?<^GTZ?C5U-\8S*2>?7Z>O2NR;H)I\B=3R^7_
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M]?=VMHM?P:[=BS%;+*!E\9P>I&/3Z>_X>M)+;^7]W+#IC)/3C@?YSFDCBE<
MJ2./<=/;O^)Z>H%70?*^_P _IZ]>F/\ ZU:RA&%3GC:4MVEOTU_):/3?R(E4
MG&6DW+6W)UZ=?ZZ^92BM_,^\2O48.1['_/:G2VR1+E7)[XSUQC\_?ZU9<^<,
M1<?CGD'GZ\<51DAF3)9N,]/U_'IWY/XUAS.=>+=-QV?IMZ>7W??4)RE)7J<N
MWN?=_6MONN.BC#D9.#_]?M[\5<DM45<A\Y&2,YZ9/X#.:H1ARP"]>,^GU_PZ
M>U66BG"DD\8R,YZ9[=<_K_6O24X1M&6K]7Z>GZ[Z="9\W/%^UY5UB^NW]?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR.Y!.._\_P"559;O?T&..W _J><4_:PJ5.6*M)Z*6O7E]/7U2%9U7>,+*_\
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MX'3GW[U<JT(049>\TENO1KMNM1NI&:48P3EHN5]'IKYVVZDBA7 \W SC.?\
M#\\'%,<F,?N<'&/IW^N/8?R[4I+DR' R.@]NOY^_;\.[X;C8!D9SS_+\"?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=_U]_P#P_D3Q&W4?-C=C\CP<]"<?I[&H9+@@G8< ?YZ?K_\ KJ_'902Q[O,
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M\[6(8[C)^<DC].?_ *QR#_6K#+;R+\H&2.3U.3[_ *<_6J<4!+8;('K_ +O
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M2'.#CK59RW;/UZFJ2YC.I4]FK\K?IZV+51N#U[#MZ?XTV,MD?J.V/\:<Y/X?
MYZT)-22TW7]?U\A<RG3<K-*VW4XOQ"@-O/D?PMQ^!_\ U^^:_G._X*@VQ?2-
M:*<?NY>G'(4\^GZ#K7]%_B*54MY]Q_A;KUZ'\?\ .?K_ #E_\%0[E_[(UGR>
M?W<O0]]I[]_?\O2OU?P[E.&:8623T<?3>'^=_/YG\Y^)RFX8CEORKFWO;;[O
M\^GE_&9XWMIH_%^I%F) O93[8WG_ #V^HZG8TX%XE"G!P!^F/;Z_TS6#XU>Z
M;QAJ.\?+]LE]OX_\_3H,8K>TW(B7;UVCIZ_X]L<>GM7^AG#%5U<%3<E:T(VY
M5Y0^?]:'\,<4^T6)J>]3^*7:^ZT_X?;\35DL;C8#O) ^GU_SQZ5CM$X?:2<Y
MYXYX_P \=_IVV6DO=OW3MQ^7\^WX<U2/)R<[L]_J,_KCMQZU].Y\ME:ZT]>G
M;3\O\_C%1E44K2BK>?6XZ""?J'(4#/X<?SZ=?SJV)5C&'PQ]3CK_ #_^O5<"
MZVY121QVZC\?_P!?OD U3D\P,V\8;GUSGT_#]>#BNW"QIU&]T_RV73Y?\&QY
ME6A5E)JI*+BGIRZ;66N_Z_?:UZ2-IN8S[\'V_P#K\=?\:,D,B9W$G)[_ %S_
M $],\<XJ:)IQ@(../<9_S[Y'8"KR -_KN">O\QQQGGO70J4:,^>[>JT6KW3M
M>]]+=K]#!3E2T]UQ6B2^+I\_Q_0SH8I'QM)&/R_+'./7_P#55Y5:$9D.?_KX
M]<8Z<\TYAC_4\^GX=/7'?%4I3.0=_3],_E^)Q^-;KVM376,>O3?\?O5]>O6;
MNJ]XQB[:/XGJKV[7T\K6+C2I+PF ?;\?\CU]?2I+;3 $EFQU^O/L?\>>P JO
M&7!RO7C\^">W3/Y'CZ:"-*0!(./Z'KGTX[YK">'C&:DI;-:7UZ?I>R_ JTJ5
MN24>73XM9=-OZ6M^IFA&+$ \G(]_Q],>OM5V*VF')8X'YX]/I^? Y -6F6(+
ME3\_?_.>?\\54D>X&X '&#^1[]/UX].G%9UYJ;A%QDK=NJ]V[_X/:WD5[2=7
MX>6*M9\Z76VW]?I:VLJ+\AY/K]>.O/X?H*'LI9AN1B!UQ]>W/4_GUK(+2;@3
MU[_GW/;_ #]*NQ7%T!\H.WIZ\?\ U_>C$4E&G!Q<G?7OT7J;4J5.F^:3U;3U
M=U\O/;[WKWJSP-$0"23[Y/?'^?:I8(9).5)';\3]/R_J.#5[<C\S'!_,9_(C
M/KQ^-1,74CR<G]/T_/\ ^OWRAB:L([0:TTT<NE[Z>7GW70SJ5>;W::MKN](]
M-G9*UF].FA(#Y/\ K"#C&<]\>O3KVZY]Z1V$X(CXX[>_&/\ ZW!_KG2-,<[_
M ,"?;./QZXX [_58C(,[/7M_=YQ_]8]_7GGK5)5Z:DWROSNET>U^[U7?4S]B
MU:?,G/NG[O3II?3MW[#Y+>9<%B< GCK_ )_7ZFHHHV9B >2#T'\_3\CS6DAD
M(_>C'\L=OISZ&GL(QS'R_?UYZ^O?_>I1DL/%I)RWU2ZZ7\O^#T2#VTK.+2;>
MSC\/2VWROY6V(DADC^9V) [<]L'OW].U2F>,C8,;AQGOG\^OT/Y=J,KW/3!Q
MT(Y.!V__ %$]^@Q58%]W/_UNW?U_'UYHIOZPFI7C:[TTOM_GINAJDY^].4;K
M5<KVT7_#;ZWZ:%Z2WF<$JQQG\!U.1]/4XY[XJBR,IP2<^XZ<@Y_3'/?]+T3W
M! !'R]_P''].WY5:"Q$9<_,.1]>_?@_E13@L.V]7Y)7[+SOOK_2)]K.G[LDI
M+IR[K6._X;_Y%.*WE;!#$ @?R_+\^./PJT'6'[^#ST/Y>W/?I4$AE48CZ9P,
M'MG\OY]OPHNTI)W=<_U[#G_]7Z*%7V\^5IQOUV?3JM_PZ=KE*$JN\HVZ):/2
MW]/\;&BX,_,9QS_0^_\ (COQ5*6"5,EF/X\CT]OY9R?QIT33 #8,]<__ *CP
M#[<>O-7DRW^NX_P[^F?UQ3]@J=3G3O9WMNWJM-_ETUMK87-*D[)Q<5T^UTMY
MOIK?Y;&=%$[_ "@GJ.G3O[9S_G([WTC>+YG;/Y\=1W^O.:<X5<^5SV_7Z\<^
MW7]:,KW!R&!QWSV_S]21CWI2Q#E-1<;;=/3^NN^COH%Y5NL8I[\VDK77Y_)_
M,OF:.0;5P#P/K[]>GOS_ (U9+:8@MN.TC^7X_P!>G8YJHA<-D=>?;GGI^&/T
M//?0C:<CYAQU_'\OK3GAU>,TWTT;;[=VM>G_  X.+HOW''I?FWZ;-]?ZW,[8
MP<<G(('3G_/XU>CMY>NXXZX]>^/3^9YXSUJUMBVYXW#H/Y<Y_J*J2-.#A,XP
M"/3O_GM]?53Q#BHP4;I65[=K+U[V_+H/VDJNBM'9>^M.C_X/7RL61*D8VO@D
M]#Z?3IZ\_2HWC>49C)]<?RS[^G7Z5FL9"1GKGG].OI5F)IQ]P<<>X_,_T.1Z
M#I3E052$97:;2=G?R6U^R%[)PM)2CS/5\SO'IT]?7KL0R0R1GYR3[8]#G _D
M._'.*DAAD?&UB,9_ITQS_P#J_ :"A6'[[C/7\O3C(SGG%1R97/D^W3\<<^O3
M'K0ZKHP4.5RMUM==._S#VTI)1TYE]JWN]/T>VBV'!3#_ *PYQU)_R..W7-#2
M)-PF ?;V'^?\?3/D:<GY^G.,^O\ 7\OJ>.&1&0'*_>[=CU'MT_E^H(P5>#E)
MVV\ET\_(%0TYG*+GY/W;Z=-K=_5]">2VF R2<9'OV_SW/X575&+G!.3D>_IS
MV^O\NU:,;3$ 2#C^AZY]..^?UJ4K& "N-_Z_ASSV[_AVH@UAXO1R]$]-NU_/
MMTTV'[:2O&7+)O9Q6BT6^W?Y=+$$<$J@$MP!TYQS^'\A^53^?&!M(&[U[_S_
M "_SFG*]R. #CGCGIZ_YP.V#FJ>7W<_CZ?B><'_ZU%.7UCF37*DKZ*U[6M^-
M]A*DZFLY1?91:7;?\OSMH:+P2R E&XQT'3M^?OP?J#5!XW0X8DGGK[Y7.?KR
M<<?UMQ//T ^7IZ_+GUZ^OK^-7%6-O]9UZ\^HZ<=N/:B%-4).2?-MHK[7CZW=
M_P!?0%4E2=GRR7DO>Z;_ "MZZ:E&&"1P&5B/_P!9YX__ %<\^IN B'_6'/3.
M>^/7IU[8ZU%*77_5=,]1[CGU_K_C1D:8D[^N./R'YG'MC/Y4E5]M4Y6FD]+I
M6>MEY=[6[>@U&56UY146_AVETTV_X'X&@Y\__5G'0<>N1[XSSVQ]:I26\J$L
MS'^? _G^/&!U-)"THQL&3G_.1T_09Z9J^A=A^^X_3TQZ<]>,XHE0C3ESIWMT
MOYJU_P"OO%>5'1.,HJVCUD]4M.^MMON,^-&9@%/8#V_R>W^<6G@F R6SW Q^
M'X'Z9QZU:98U_P!4>?Z_3//%593<]QQ[>GKG'Y _A6\95:C3BFH]=/3^NM_F
M+VCFU;EBM-):-[;*WI\_D5UC9FP#@_KR2/\ //IUJ\;"Y*D^8V,Y]^1T^E4%
M,@;CJ#_^K\<_GGOWOB2]VG*G;GU/3'^%<F.T2OO_ ,!+_,]"CTZ:=?5:_J94
MD,BMM)YSC]><?R_I5N&"<X*N0/Y<9Y'K^(YH?+'YNN>X[_3&/7M4JBYVY1<@
M#/3K@?C_ /7Z_3SH33=I)[^FME;[^NUC;$4*T8*5.<-;76]MOZ_X=EA9!$ )
M,,?I_+OCG^7XL9&F_P!6V/I_D\=NOX&J$GF!OWG!]/3I_7.:=&TP)\L9_,]^
MO3Z?0UZDJ4/8II2>E[7]+:7Z=?F>8Z,D^9R2F[:RVNVMD^V_7>Y,UNZ [SG
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MATJH;EMWRMQV'/\ /W[4H\M3F]C[K7ITMV[_ *;:LA0F[N$7375OKM]W5_\
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M%145^\5K;6_P_+7I_P $\V2JS]Z2<HZ/DZI-KK;U2_X<AED,P/!&1UQ_3O\
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M+*Z49X.@YR4_W<+)/;W8]ON^0BKM'N:=117">NE9)+9!1110,**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/M$8^7N<=N>>G.<412I<WLK2?9?*_3IT_P" 0JDXZ0DZBMMVV_/[M_,CC@B
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]?>J,HFP=^<?3C@_Y/4XYHAN6CVG!/?]?ZY]\]<9J[YGV@?,,9]>V,>P_/\
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MFG5P'LJ]E??J%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'J/_ *_^>M+!?I-@ =O\GVJ![>WN><C)S_GJ!W_*IX+&.'!7T_S]?S_PH O
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXG0FXXAQ3BO>WO;I]_\ PQ_&AXXM#'XPU(^9D?;)>_'#=N>O/3T-:^G#S(E
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M]>.__P!9(;@+GS/F[8]^?YGIW_ITN$ZD%*G*RT]U6[^7JOPZ:&"IS2NU:/\
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M_P"O_G']3:"++]_CG_/X\XZ]JC\V.  $ D<?E_GG/]>:DESN)V\#/8<]??\
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M=.G;YZK]2%2J6NTTO^?>]]M->_GK\[CI+J4C;M/^1[<_G^%0+(P<X[ _4_\
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MGKJXZ6WOTZGZ3^&]WV*/N-O3VX_SZUTRRCIG/IU%<SX<+&RB '\(Y[<;>O\
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M&=1\V<=T/<=OTKUCX ?MQ?"SX[Q1+X6>-OM&U%VN"26P/09Z]A[5\W?M#_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $)P,FHFE
MP>G^?TJ:HS&#_P#7&:J-NO\ 7J9U%4:_=M)W6ZOU7]6T]063=^/^<&E=N,=_
MY=Z54"]/\_A2/C'/7M_6C3F5MKH/?5-\S7-;5]-CC/$!'V>?W5C_ #K^<_\
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MWT]?NCEG973=/^5:2MI==^_7UZ$<MV'.$&WK^&!_G&,^OM4<4Y#%B2>W/O\
MIZ]__KVI8(FP8QCT]>>^!G'].F.]0QVX0_..#]<?J,YZ=!^-72:5)JKOHK/Y
M=UM\BTZ7*TDT^SW>V_6__#[%@2),N-H!SZ<Y(ZG^IIOV?8=YZ9Z?X=/\*<TD
M"+\I ([#L?7T_/K4 N26PV-OIWZCK^'<=,YJ5>47["R5]NMM/Q_X>Q$5.UX*
M2CU4K^7P_I_PQ(]VB#:%Z=Q[=>>_^?I5,SDMP3@D8';C_'K^-7RMO(!C!)^G
M3_'Z\=:JFV.[(' ] <^^!T_6B@I1YO;/1IVO\K_>5!TDG>,HNROS=7IWOU];
M7V+$=RN-K+G.%YY [?\ Z\X_,4K6_G'*\=_R_3MD<_UI46!%^? ;&<^_UZ_A
MQCMZ5 ]SMXCQC\_K_4GG@4TX2G)46E+_ (*L_P!/5WUU9"3<G[*,EKK>_*]M
MEKVZ=.VA+O6W'S+D@GM[?Y]ZKR76_.W*@<_KT'UX^GK5A'BD \W&3GTSZ<>_
M'7%,EMT))C'4?7\#C/\ 4_3I40C5C5O4?NZ7NM-UOY]M_P "H<BE^\C+G_F^
MRWIW_/S\T10W&WD\Y/?\SQT[?KWQ5KY)Q\J@=>G'MV[]*ABA5/\ 6C@'^H]>
M>>>N*D>6) ?*(_R.GIUQTK2<J3G[EN=VLUMOOIZ=;]A2M*7[N,KZ6ELMUZ7^
M7?J*L'E'<W/^?\_YQ22W*8V[.G!Z?XGVQUS^--CGW$!\8.,X_/(_S]?6IY1;
ME<KC=CG!'4#CZ\^N16\*$I/FJ2U79VV[][:?YDN_/%5%*4GMR[):;_/MW^ZA
M'(%;)&<'I^9_K6H+Z':5*#)/<=L>O]?\:S%";^<8X[^N>GZ?2M4?8@IZ;N<?
ME_GCO7#CKV273OUT2?SM^!Z=%IVNG:RV]5_3_,RY ';(&.<_3_\ 5]?4]:F2
MXCB7!3D>V3P/\.OX?4P22('^4C;G^G'7_P"L.E:4!LV3#XST_'IQ^E>9!RBU
MVNNGIU_K\3>O3P]6"7+*ZMW[+UZ[_>9TDY9OEXZ^O/3Z=./S-21703[XSCGV
M.3CG^OTJ6>W5CF+@?IT'4_A[<\4D<42?ZWU^A[?G^7;I7LRDG05FKV_'W;_?
MJ>94C2BE#65K:1^*^E_T6_Z TZ2*< #C_/;V[]O6N*UFX2%QN&X!N?PSD?3F
MNON"GS>5Z<^O;_'\S7$ZIY9D'G?WN_!QW_#_ .O[U\=G-6U"I!P=VMU\*OU]
M/DEY:W/JN'91]K32IS6V^O5)Z>=KGZ;?L%W\4FO:<J)C]^OX_-_^L#TY/:O[
M(OV;6+:'I)_Z8PG_ #^G_P"JOXX?V"H[0Z[IIC^]YZ^W\7 []/?Z=^?[(/V;
M8R-#TC'0PP@]_P#Z_?/Y5_,O'S2PF(U6JD_/II=_UOW5_P"F> HU'F.#Y8SM
MS0[VWCJ_*WJ?IAX:<?8HA@9VX/X8'^<=^M=4&!_PKE/#FT6,7'\(].O')_'I
M70#?_P#K_P @U_&N-BI8JLUI^\EY]?\ ,_N;+*TH8/#QE[_[N'P]/<C\[^1<
MHIJ9QS^'K_GTIU<)["=TF%%%% Q#R"/45DWMG+/]TD8'^.?\]<<>U:]%3**G
M%QDKI@<_::?-$P9F+8/O^/OTXQ6\@*C!_P \#K[TZBIITX4U:"L-MO<3:#V_
MI_*F[$'113Z*T$)@8QCBHV@B;J@_+_&I:*:;6S: J&QM2<F)<COBID@BC&%4
M 5+11S2[O^K?Y("-HD;JM*L:+T44^BD 4TJK=0#3J* (A#&#G;^=1SQ%U(7C
M/'&?3^?I5FB@#G#ILQER6/T_7^7'T_*M6WM%11N4$@]_Q_/MG^=7J*+7W5_D
M @4+T&*6BB@"-HD;JOX]Z!$BC"J >>:DHH I30LXX)&/R/\ G]/TJLEEG.[Y
MOU_QY_SFM:BM%4DERZ6]#55IJ/(K6]/3_(K1VL2=$ .<\8_P_P ^M6  !@#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7C'/U_/'X5,;*.92Q<#C/\R!QVS6*4<,,]1@'W^G'/!JW'%<\,&P!V]LD_\
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M$[^ >1CV]?\ /2N3';+2_P#PT==#T:*O;6VE[^K7Y_TS+E@*-@'(SC\O?O\
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M*0-FEKA/8O?8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M Z#TJS\D@S+@-Z'^OK_D]ZK+<B-<;"21@G'ICO@_GTZ>N:K23LQ)&Y>^.1G
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M?)&>1T'MU_#I@?2J,DLS_?!].?I_]8?7WXJ:&YV 9!;.<_K^?7O[]:M86X[
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M?R8<<$ ],8[>_>OXTOV"M0$FO:<H3;^_7)QC/S^WX=<?D:_LD_9L8G0])/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"THQL';USS_GOGCU&<UE##N:5IP2TZJ_3YK?S_()4G'WW)<]]>;6-^UOEO\
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MZA1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTW;7ZZ_Y)DM<\[TX-._QK;IK]SWW_28QK;Y/4_G_ %Y^G3O]:TMX3\NW&>A
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M>G>W;]>Y%+=M(<8*YST'7\/T_/G%1Q3%26P3VQR?3OC_ #^HO/'%)_JQCO\
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M>-K_ (KKZGZ7>&I/]"B'<*.P[8_R._I74A@>O!KE?#I46,7^Z/PZ9X_E^%=
M ^>OY\]^F/7_ #FOXWQL5+%5^G[R7GU/[ERRK*.$PZ_B+V<+\JV]V/W=M>WS
M+E%-0$#G\!_G^5.K@/83NEI;R"BBB@84444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4C' )QG%+1UX- &-<Z@\) "D]?7^G?ZXI]K?M-RP(^O\ ]?\
MS[U/=I!%$\L@R$5B<^F.>W'2OC?XR_M=^ ?@_;W9UB1(V@23.6 ^Z#_LGZ4
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M<CJ)+ZV7'US*/\_A7\LO[8'_  5)LO"NLW_A;2]=,&HRSRVT02Y*L'W$# #
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M*K!@#]TGJ,<Y_I7\D/[8?_!1;Q=X$^(TFC6&OW,"_P!I^0%2:0?\M<?PL/\
M/7TK-Q:EROO:YE*+BVGT/[6H/%NAW?\ Q[:E:S GCRYHSGH>,$GO6U!>Q3<I
M(KCV(/ZCZ]Q7\X?[ GQ_\=_&.RTZXEU2XNO.\LDL\K\%5/=CU/U^M?OCX+LM
M8BMX&O7=LA2Q8G)^[UR3ZYS_ (<]#IT^124ES/IKY??:]_O[AS1:^%I]]EJE
MZWL^NV_J>LT4U<A1GK3JY22-W*__ *OY5$LK$X_P_P !1-/&G7KZ_C_GK[U4
M6^@+8Y]3_7GUK:%.4HWY&_->J\]-_P S"HJBDI*IRQOJK>F_W/H::G(S2U D
MZ.!M_+//_P"NI@<C(K)IQW37K_7F:QG&2]V2EM>PM%%%(H**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *;
MN7UI2,@BJ[1L3W_ 9_&JBD]W;^O,SJ2G%+ECS?\ #V_K_@%@$'H::X&,]_YT
MQ$88SV_/Z?\ ZZ<X[_I^0X_K1M)*]]5J%Y2IMRC9VUB<;X@ ^SS]_E;'Y'^=
M?SH_\%08XWT?6=YQ^[E_+:0,>G.*_HD\2S^5;SY_N/\ 3O\ B3_GI7\Y7_!4
M"1KC2-9"DKF.3_T _P"1^-?K'AW&HLSPLHQ?Q1L_G3_KU/YS\3Z4W#$2LX1M
M)_*V_P#P_?7S_C6\<V\">+]2VMD_;9CU_P!L_K_@>>N=73!OC4-P",9/TQ[=
M/\]JQ/&ME+'XOU%F<G_3)./J_I]/3(XSFMO3!NB"@XRH )SZ#V%?Z%<+SG/!
MT^>\FH1^ZT-?ZT9_"O%%EB:G[[[<N]KW6]OQ\UZ6W)+*W*9#C/U^A_'G..WY
M"L5X KX!R,_7T'7TYY/X5KM8RA=WF'&/7Z'_ #UQFJ!&&V'&?\\?Y'8U]1*3
MC:R_KU\E;;KIJCX^-.G-24JEGTTW?_#]M_EK)#;1 9+ '&>O<]>G/UZ@]:<;
M@1':G(''K^O0_P"%2+822)N#$<YQGT(X_#U[Y[U1F@:)F!R>HSR>2._^?6N[
M"<M1V<?ZNEU_'IH>;4P_O^]5=2/1/Y6[=OP]2V%2X +M@D_7J,=.Y/>JTMJJ
MD[.?Y]>P/N/RXIT5N[8(8C@>Q]?4?_KYQS5H,(>'.>>_/7\O0UT^SA3J7AK)
MO;3R>V^ZTU\SEYI0E:$G*WV.VRW_ .!^I5AM@V-_ 'YC/X=?Z]?>P=D )0Y_
MGV],<YQUJ0 3X"G&<C\_SZ\U4FM7CZDGMUYYZ<]OS/)Y]:V5*K4]Z5TOY>F_
MK]_I\U/,IRM.?*]/W>NNJ>M^_P!_W$JW'G':W ^O_ ?_ -?Z4CVD17<IR3SQ
MQCGU]OQ_PI1Q,QP..G7IQ@?F?Y8SBM!87B +-GOR>V>PYP?QZUC.C24TT[2N
MM+^GW]?0J5J;7)/EV]U=7I?S^^]RD(#O.1P>IXQ^'O\ _7JVEO"@R6Y'O^O\
M_P#"I#,C#8,9]ASQU[_7VJ"2UD?+!SQG@?A^?Z5E6<I."E3NE:W33W?\_P ;
M#YY3?OS=)>?7;_@^G5[W>+D*=@^[GKCU]?Z_RJV+>WF7+.,]?\>O3G\OQK$,
M;A@.I'YGD_T_SBK4=M,1NWG _#CV''3OT].:=>E%4X.*UMK_ .2Z?CU-X.C2
MM)M*_7J^O^7XB7%KL("#.#VZ_P#ZO?'6GP0(W^L.WM@\>H_SZ5+YXAX?!/3G
MU[_B:3;Y_P!P[1Z#UQT_S],US1K58)*-1[KW=;=.]]=+6Z]]3.I5E/[/)'?G
MW[?=?[G?YBM(L'W#GI_];Z<9SGVI!*+C(?CCU]?\GT]^M4Y+=X\Y)/&.OZ_3
MCTZ&EBB9\X)'.?Y_R_GWKNC"%2FI5+)Z:Z=O+K>Z]"?9P4>93N]^?JMN_EY7
M^;+$EH@ 9#GOTQSV^O\ GZU!'!\Q## (/)Z?AQ_.KJQF+&YLX]_J./\ ]?04
MIE27"+@'J"!_/D_F0?UJ4W2@_91YEKJOEK==]E]]R55G9J_/'K/:WK?^O6PG
MEQ1#<K#./UX./7DCH*C-UGY<<9QGMC^>*BEM9/O;CTR.>O?IG/?V^E55C8/C
MGT]_3IZ>GX44?WJ?M%LM&[::K72V^W3:Q480DG)SYWZ-6=E^-UY_F:1MX9%+
M9YR#CJ3GZ<#TS5)H"IP!D=/7OGG\?ZCWJU';2 !]W [=CG_/H.?I4WGQH-IP
M3C'KT]#GCH?2B*C2<G2]Y_@GHOPN_P!40JDXNT).HNUOAU7]?TR&*WCP"[8)
M&?QZ9Q^'^>SFG$)PO/\ G\L?UI'A:8?(V >0.G&>M49(73())Y[^WKU]?Y>M
M32J3J5.6I'1VNNG3Y]MV^Q4(QJ/WJEWK[CZ;/I;^N^I>4I<9+D#^8QQG^7 X
MQ4,MJBYV<\?3GZ<\X/'YTR&!W"X8CK_D=/3CIQZXJZ/W'WSGIU.>F.O3U']:
MMTJ<*G-&7O[I7\U;_+MU[B<G3E:G.^OP=]K?T];:=RG%;YX;@ YY_P#U?RYZ
M5;*Q0@LA_KGK^)P#0S+-PAP1W'3L>.3S_P#7/:JDMK(N3N/\^.GK[?XX[9NK
M5=11E&R=OOT_X&UOU#XVN>?)?['>[7SU\_PU)Q=>8=C<#_#G\_\ /4TK6L3
ML#ECG@=O3G]>O//XT$1BV!D<$9_$G)_E^?!K02W=%W%N#ZG@8'IS^?'%:5*-
M).,M(O2RV5]/6[?X;CFE3:Y)\FVBUYMO,I^00XXX&.>V/?OG_P"M5R."(#);
MGJ![\G_.?UIYGCP4[GCIDY/X_I4+VSR\ACC@X].#_G@?4U%6K55DE:.BO;II
MT_JPN>4[<\O9WM9]TK/^OQZCC<B/Y5Y'^?\ Z^,=L4H2*<98@'VYZGIC@\^A
M[_A6<\3*0"><YSW[#WYXJU%;N_(8CH?\GCGTZ^M:2I4Y04INSLNJ\EJWI_G<
MIPC"*E&?*]'S6]._?Y=WYLDM@IRG/0_Y'U].WI3X;=3C>=H''IZ?SP>G>K0=
M8<;R#T//.?P]3@]J:W[_ .X=N>/YCU/'X_E4RG.G3M3C[O22^7W6\_)$^TFX
MI-M1T_>/KM^.K[^6J!C'!]TYQTQSG^O7H3V!IHG$QVOP/\_AU-59+62,\DGK
M_+''TSZ>U1Q1,V0#U_+M_D_A3IQC5IWJZ/37_@?=^92IT^7FYU*7\_GIKKHK
M>>OSN7'M(RN5;)ZGMV]>]5E@._D'!XSVY_K^F>*NI"T8!9LCKR?H>!SS^/)-
M.,R.-@QGUQZ'N<_GCIUI0_=1?LES+J[IV2MKVWT_&Y*J3LTFZBZRM91M;U_X
M-O4:L,* '<-PZ\]/\].!3#=$94#(]?Y^_P!:9+:R-\VXXY[_ *8X]/052\ME
M8 Y)_'/K^7K^-%%NJY*KY[VWT_+[QPA":O*?.TMGTV_-^JW\S3$,4RY+8) ]
M_;_]61[U3DM]IPH)&3]>1C^7ZX^E3Q6SD;PW YX]/\\'@_C5@2I%PV">1Z]?
M\,CJ*(PC3DW2]YZ:?..GEKKY+IJ)3E"5H2<]?A[;=?+[MWT97B@0@%SCMZ=/
M;\1_AZR-(L/W#D_Y_IUSZTCQF<90X!SQZ\?7'XY/XU3DMWC)R2>,?Y]N/3I]
M*F-2=2IRSC9;-.VFUW\M?*UT.,5-^_4L^M.VVW_!_JY<61;@XDP.WOZC\N>G
M?-126J#E#G],\9'K^O7/I4,,+.  <<_A_3U_/OS5Y5,(^=MV/\,X^F >]7.E
M3C/FBTY=(_=9_=U%)NG+W)]5:'=:)?/KKJ5(H"2 P('3WX_P_P ?QLR6\2CA
MCD\\D\=1WZ\^O]34GF++\JX!/IQW^O\ GUZ5%-:.!NW9!Y[?CQ_^KKZUM&%:
MHXR;<5IZ='_7H3[1N4>:7L_[MG[VWY[;::^95C16;!/&<?J?\!6I]BMF1COY
M]/PY_#VZ>W-92QL6V@]^#_+'IT_.M%;"7!;S#CG(S[=?ZX]JX\=LENU_E%7/
M2HZVU2T6OS7Y_P!,S)8 K87D9^OOP/Y>F,U:BMH<!F;!X/'KCUZ_Y]<TQAM;
M:3D\]/;_ #^M64L7E3*OCTP<=N!U'?/^<5YM.6J36G,OT_X8VQ%"+BG3K-2=
MKV^7_ T&F<1':A!'Y],?7\/I2J8Y_OD#GO\ YSW_ "JK- \3<Y/YGT_/VQ[_
M %I8[>23.TE>WY'Z'Z?S]*]:4(>Q345>W_R/Y?G]QYLJ48).4W&7NOGUNWIY
M^C_ID[PQHIVD' ''?Z?EST[XXKBM9ACE=0Y RW?CCG/^?SKKY%>$'))X]>?\
M_P"'I7$:RCW$@VL5RW\_IZ=O\@?)9S5@L/.+=I:Z7UZ?IY_.UCZSAZHG5IKV
MKG9K5KT_X/3R[(_3O]@FWMX=>TTHP)\\< _[7^?H 3STK^R/]FZ8G0])';RH
ML\?Y]#^-?QI_L%6,T>O:<S.2//7_ -"__4/_ -9K^R;]FP$:%I(Q_P L81Q^
M?^?K7\Q\?)/"8EN.ZEK\EIY6U^_[_P"F> JU19AA(J;<>:%UWLXZ?C?K8_33
MPVJFRB.1G:/Z=?I_AFNI  ''UKD_#:L+*,Y_A!Q['!QW[?YZ5TBRXX_GT_3_
M /57\:XY-XFM9W2J/R_/ML?W-E=2$,'04H\C=.&N_P!F/;Y/[RS135;-.KA/
M73NKK5!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MKT^?_# ?V)?&'X.?#C7] OI;I--C<VLA_P!5&.=AQV_7_P"MG^$W_@KU\/\
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M6K[QI<'<<+C'!Z_3T[9QV-1;OLWW1G!ZCIQWS].*B&(Y8J]*-^[2O]E_/O\
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M I."1T_,^Q_SUXI'Q(VXC'.?\^GX=JD6X>-<!">W ]!_GW]NU>="479/NO\
MVVVO?9OH:UZ6(IQYH14D^EUIM\_Z^^TI!'[W[W'IZ<^GTY'O4<F\?ZGU^OKW
M]>G>J,DKNW(*]?;T_P C/O4D=R\?8MCD8&>X'TS_ /6KTY4[44^>3T_^17]=
MCS'3J-\S?-+W7RM^[NO/R_KJ,DK F3N.G^>1^O'I7%:TDJN/)!^\>W?DC_/
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MME964\G/\+"@#XE_9O\ ''["FGS6.J^(;_3%O7:.69I&M\[^"?O/].M?N?\
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M+6ZES:7<]OLWM?K_ %V+,<\1 #KDGU[D\]<4C0++R@Q^&?T';ICGCM2QPQ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2YWYI)KIUOYOS\N_[N^? .LL?_?0I?/A/25#_P "%?@ZW[9/CX='FS_UT/\
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M]KVT[_?O_P ']RX9XBO,J'@?Q#OGW/\ .I?/A_YZI_WT*_$&;]L7Q5$FU9Y
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MB@ HHHH **** "BBB@ HHHH 0C((Z5 T3$__ *O_ *U6**:DUL1.G&HK2O\
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M\NE=>%;IN_+)[>?;;YI]7<\^M7C>ZM.7]W=/3M_6OS*4=LSA3G''X^OX'O\
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M#GR>#S]?;./IWS_AT>T=""C%.7FEIT7W?CUV9G[6<O==F^D[>[T_X*_0!'Y
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MJ"3JOWIQBKWY7I+I^5[]/2QH%UG^52%[ ].X^F#]?:JTMHZY.XGO@?E^O?\
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M]J_CC'-?6:_-K>H_Z^74_M_*XU/JE#V:<%[*%^;K[L>_33[OO'JV?K3J0#'
M%+7 >TKV5]7U"BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA=-YX3C.0N,<9STX'U_6M.W\::=8H(IK2-WQMRR9]1VS^9J6WTN%(=FWL!C
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MJR4HN2C?7F?^&VO_  .VNA9:.('=M4C.3QZ'Z?E_G*>=">-@ZXZ#^8%.:WF
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M7QAJ(9#_ ,?LH_\ 'O7KVZ?Y.YIA*Q!@.=N1Q[?4_A67XWN86\7:B%0 _;9
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M'<EQ<Y7IP:N_CZ=/^&[_ (EEE6'E!N_R/UYZ_A5.6ZD;(*_TP/R_GC\12Q7
M'+<C@8/7J>O^<]/2K9:*8$*!^6,=?Q''X5#HU544G)M?\-_6E_-] MR-<\'-
MJWO]M5;ST[O\5<S4=@Q(SG!/\QS[]_SYQ6@D[NN"O SR1Q_3M_GT:+4QD.W(
MZXQZC'YTK742@J% ([CJ?PQ_];K^%SK4FXQLI/2ST>NGG^&[\M1S:JM.$.?;
M5:<NW]?TR4P1X+G[PY]^/PZU ]Q)'PJ\8'ISU]?Z'/M57SR7'/''';'OWS[?
M05=2XB/! ST_'I_GO]*BI2JR2:DW%ZV\G9_\-IKV%R2A;GC[2UK+LG9?U^/4
MSGE9B"1SG&._8^W/-6HKB1. I(X'^?U]/2IC;>9EDX'?_/YXI0\<"X8 G\1^
M/K]3W[&M)5:481C+5V5]%Y=-OOV*=2,THQAS/9QOL]'^'SWL]AX19@-_']./
MY\^OZTU_W&?+&>_\^?IQS^E59;D.?DX[?KZ^QX^GK3H;A1]_G/X],=AW'7CO
M4RA.I!.F[1>T?N^^^O?N3[.:BFTW'3]V^FWX[]O+5D<ES)(<,".O/X9P/7IZ
M_J,U'%*RY('3\N<?Y/X5H,(YQ\@ ],?YSG/0>F::(/(.Y^G3_/\ G^=.G*-*
MG:IOIZ].I2J4^7EY%&7\G6^FG9WTW_,<DK2 !EP.G3\..G_ZZ<88T&\?>ST^
MI[_U'0U"]W&%PHP?\1Z?YZ\>M5EG._)/ Y[8X_K^G>E'][%^R?*NJLEI[NFF
MB[]R53FTVHNFNL=^967]>7WD\MU(ORA>!_G.>?7W_6J7F,S G()^N?3\O7\:
MTUFBD &T;CUXZ]3_ /7X/'KTIIM"<L.!G\/?W]S11BZ+DZNN^]MW;\_^&T'"
M<()J4.1O[3Z[?K\OQ&17,@&W:2"<?K_^K/(]:L"))>7P#_\ 7_\ K>OZ9IGG
M10KM*C( [$=^?_K9/L:IR7&XY0\9_' '^'YG'UIQG&K)JG[K[_..OG\^CW$H
M2G*\(N&OQ=]NFVJU[;W=VRT\A@&(QD \'TXYZC'YXQ5.2X>0G((XS]>WY<_E
M]:LQ7"8 < ]_7O\ _6QZ#W[2-&L_*#&<8Q^F.OXU$:<Z=3FG*ZW;=M=KK\^R
MM=CC)0?OT[OK4OO>W]?TRG#,R $#//X?YX_/MQ5Y6,P^<;<_KP!^7/I3%C6W
MR9.1U_\ K9[_ $&<'\*BDNT/RJ,?J!U [\>^?3I53JTY3Y8KWG;WK>:M^FWK
MJ)KVKO3CU5JE]$KI_>MM=2T8DBY3!/Z?C4$MQ*<+MZ# _P ]Q_/GK44,^&&X
MY[\XS@_Y^AZ5;DN867 49QC_ .O_ )R:Z:=!:.I*[7=]?PTUVZV]2;2C)<T'
M4V][MLOGW[_B9Z2,K9 R<_XGC\36DM]-M*^6<9()_#'Y_3\ZH+(JOD\C(_'&
M:T_MUL$(V#.<9QWQT[?F:X<?>R2Z?C\*M_6_J>E1>U]=-GY-:?(SG^<Y( .<
M_P"?Y5(L\L:X1,CO^ Q^7Y'VJM)<*7R!P"3V'7('_P!;_P"M6E!>VZJ%9!R,
M=OQ[=N?Z5YL.:+3U:NM_E_P^GY7.BM["K%1=-775OLE_7I:YG/([-\P*^G;C
MC_(]J?'<21_=!;'/MS_7]/QQ5Z6);@[D4?A_GMCM]:C41P8W@'Z_YSVY]!7K
M2J1=!>\E*W_R.ZTW/+FZ2]R,>>UERJ_1Z_U\^]HVN&<-N!'&.F/R_P#U^WO7
M$ZW<M$X\L$X?/O@9_GGZ5V$TBR [ !QC_P"O]/\ &N+U5UA<&09&[O\ U].W
M^<&OD,YJ3]A4CR-Q_FZ=//>R_ ^LX>;56"]BX*ZT?7X?Z:_X8_3']@F^FEU[
M3E9" )UY^K?Y_G7]DW[-A)T+23_TQA/'Y?Y^E?QQ?L$7,$VNZ<%0 ^>O0=]V
M>?Y>A[U_9'^S="?[#TDCIY4.>?;GI]3S_2OYDX^:6$Q-Y:M2NODO/6^_JC^F
M> J-1YAA)1@U'FA=]KM:_A;I?<_2SPU(WV*(8(^7 /;L/3O_ /7KJ0X/7@UR
MWAQ@+&+C)VCZCIG\_P#/6NA5&SU_+)[U_&^-2>)KW5OWDOZNS^X\LJ3CA*$5
M^\_=P\K>[%>E_P"MBW135! Y_*G5P'LIW2TMY!1110,**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHI-V5WH@"BF;Q[T^H52$T^62_P M%_F&JW1&7.>GY]:>
M#D=,4W>/>GYSTK*DVYRO5Y]?A[:+]/ZO<;Z:6^_4****Z1%>3/S<<\XSZ=/Y
M5P^NQ[TD]<'_  Q_GU-=W(PP1@<#J?Y?TKBM=8;),?W3S_+\_P"E>A@6U4C[
MKW7YI_C^FAXN:4X2IR4I7;Z?-7_#[S\\_P!H2+;;W6.?E/X]>OZ__7K\J-81
MFU2<$8_?./UK]7_V@V"V]T6_NM^6./RX_'UK\J]9E1M3N  ,^<_\Q[]?SYK]
M9R*<O91M4Y=(^[\E_P #M_G^19O0H^T?O*/]WN]-G^7X=6-MD,8!&21^8Y]?
M7(_+-::W+L A7CGG'U]O_P!??@53AD"J">@Y^HZ?Y]N]6OM43#:%Y/0XQST'
M^/3C\Z^[P&)=*UW?S^:UZ^OSO?H?!9I1IQE:-'F_O;6=E?U[?\"Q(UG$QW[A
MGK@>X'^>W/;TA:YDB^14)'0'\/;OG\^*7RY/OAOEX/IU''OC_/M3EO((R%=0
M6/'3OU_IU_R/I*&,55)5+5%9:/Y=/3\?D?/5J,(7<)Z_RKY:?U]Q7:)IL.WR
MD]?K_P#7[<=L_5PEDMOE521QV]<\=SQTQZ]ZTXRDPW*./RZ?D!TY_I4,MS##
ME7 )Y^OM]/;.<<<FNKVZTNDX](]EH_PV7_ /,IQQ'M6I74=&K_*_IK\^G5D.
M!<C,GR\\Y]_7^0_#I4;G[+S%\W/;O[=?S_.FES<?ZH[0<'] ??V]_6GQH8?]
M=\V#GOTZ_P#UO;]*SG6I-65>,?\ IU]VW39]7Z/4[80<FE&'->VO35>?S(EE
M>Z^5P5_#'_ZO\FGM:I;_ #H=Q].3UX_SZ<FK#/'(,1C!]1[_ /U_RI@22/F0
MY'O_ )__ %],5Q.O!24;J[Z]]OQM\OR.KZN[:RY9/:-M;Z>=MMB!+R61MCH0
MI(&<>_KWZ=?\:MF&-1O4_-Q^I_R>@_E09H6&%4;NQS4(BE'S$G;UQ]?\<_K2
MG6I)J]KNUM?SMVV*IPJ1BUSNGII%]=OZ_ID)O)=WE[#MSC./Z]JD%FD@\PMA
MNH&3_DY_2K'G0XQM&[&/7G%1&.5OF4G:/3V_SS_2G*O""3NM5]WE\OD0L.VV
MYRY5?2^TM%Z]+_K<@-S)!\B*6 XSC.?\^O059C N!ND^4^_OCZ8Z9]/2G"6)
M!AURP[^OY_X_C3&5I#F+Y1Z#L.G^>GXT3JT^5-M?>]-5^:+A3G"7Q<D?YNC7
MDONU&2SO;G$0+ $=.?T]?UZ&F+F\_P!8"N.#D8]_PZ#Z<585EBXE&3[_ -?U
M]/TH8B7_ %/RGIQWZG^G7\*?MJ:AS)JWKT[DNC*4[R;<;W]ITTLK[[]K_P"9
M7:,6?S1Y;Z<\GW_ <]N!2Q74DQ*2+@9')&W^G\^M3(#$?WWS?7_/Z?C2M)'(
M,1@ _P"<?Y_G25:G*+?3UWVMY_\  #V,HR3@WR[<W1+2U^N[[>>N@2(L0+IR
M<#\^V>OY=:JB[ED)1D.T\9(_KW_ITJ<1R1G+DD=>?;M[_K]*E,L)!55 ;H/:
MB%6FTW&R[:[^7R[?\"[J4IS:]]U%I[W9:7^73OO?JU7^Q)CS-WS=<9/UQC]<
M_A4?VR6-@BH2H_V?Z_3_ .M4_E2@[LG;^8]/R_'\:E$T*@!ERW0^_.*(UX2O
MJM-]?2Z_$EX=JW))RLUMO':ZUO\ G=>75%B24%VP">WX9_3..,U7ENGA)C2/
M</7&>OTJ0Q2.24)V]P.?PJ19(D&V106[DG_/^?K2A5I.5E9-;ZO^M32<*DHI
M<[FUO&RTVM_PY6\G[8N9"4_Q(_P/YUE7.F"-B4)?V^F/\\]OQK;8-+S%P.O'
M^?3M^/-.5A%_K1N(X_'W!Z_YZYY:KP<N6ZO^7K_6WXY_5[1TE>=]8;/I_EK=
M:W]1=%NVLBA*8^H_SZ'/U-;NHZ^[)A%R<#D=.F.P]?>L!RLV!&,?3N>GI_C[
MTU$,1!DY ]>^?\^_X<4.O!3Y;K]?E_EY:V&J&EV[3LK1>]O\RL;B6[<B12 Q
M/;W]/T_3KFGRZ?"JET.6QG_//YYQG-6C)$XP@ /J/\\U&(Y4.YR2OH?_ -5.
M6(A"27,K]']WEYV[!&@]Y2Y)+6,7U=U_7=7,V%IHY,$' [XZ\_7 _P#KBNEB
MG18\\9&/?L>_K_3%4?.A(VA1NZ9]^_;Z_P"0,0^3*3N!(7.?RSS_ )_/IAU,
M2M.:5[Z+7O:ZT_/3Y]6Z4ZB:JS<;:1NM]MOQ_P"'N)-J,PD(521D]NO/Z<5I
M070=<O@''.1G]!_D?C5,2PJ K*,CC_/^?:HS&\AW(2!P>/T!_P _A2=>G%)W
MT_X9>?<E8=O24G".EI=]OZN]-_(?=:A*I*QJ2#D<#/\ CC_Z]84ND#4SOE8J
M2?4^_P#GT].:W5>.,8D )_SG_/Z"D;,O^J^7/X].OT_SSZCKP23;_7M^E_NV
M!8=WLW:%U[W32VFNGKK;?JF5;$'0MIA!?'3N.OK_ )_6KEU?R:R"DR; 1Z8Q
MW/Y^GU_%JXBXF&[Z_P"?7'T]:5F208A4*WM_GG'XXI.M3E!MM6\WMY_C_2'&
M@X3O!VCH^?HEIW^_5??9&9%ID5@XECP6SG '<\^IK1_M&2X7R70HN,9QC]?P
MH5'C.922/0^G^?SZ4\RQ.,(H#>O7'^<>U.GB$HODDE#MWM:_]6Z:&L_;2:2J
M.4=/>TLM%^-RLUDJGS0YSU(!Z>@_^OTX^E,%Y*#LVG:.,X_SQ[?C5@1R@[F)
MV_IZ^WX?UJ7SH<8VC=C]?IC\:4:T)W::T37D]M->_P#5]S*5!W3A+G>EVNFJ
M;=K_ /!]!$A23YV(!X_SSQ_GFAIGC.U5) Z$#W/7W[U&8Y2=RD[?T]??\?Z5
M(+B.,;67)ZY ]:A5*<F^6237F_\ A^OX&ZYDO>?MM5[O\NR_X X1),-[\'\O
M\].1FJTD[VS 1J6&>PSP"?S_ "XZU(RO(<Q' ZX'H?\ /X4Y62(8E )Z<^W4
M>WZ9Q3A5I\W+=7[WV^1%2,I1M&3?_3OMM_P^NGFB.)S<_P"M&WCOQW/;]?;\
M>)RH@&8^?8<]?Z\?E4;?ON(N/I[?_7_/U&*%)A_UOS8YZ<^HHE5IN7*FK][_
M "]-7_P1TXRC&TFWI_"?JFOU_"VN@]7,_P KJ5'N,9SQS_\ JILB+ -R$$_Y
M[?\ Z\=>PR-*DH^08/3I_A]:8$DC.YR2/?T'./\ /Y4O:P4K2:;?G_73OIYC
M:<HVB_97^QWV_37_ (%F0I>2R-L92%)QG&./?UX[_P"-7%MX\!L_-C/X_P"/
MX4AEA;Y54;NWL?\ /^%1"*4?-DE.OX'_ #_]>JJ5:::3:N]G_6_Z$4J<XWYI
MN%[>Z_M:K3\;:)OH^I)]HD!V!>..0. ,?TS3_(C<;F(R1G']/6F?:8@-FWGI
MG&1S[_C49BE<Y0D+Z#IC_/?G-2ZD(I.4DT^EWMT_/IV-->G[G5>]UEM^+6J[
M;,B>[EA.U%+ 'TR.O^>:FB N/FDX_P _S]3^&:>)(D&' +>N?_U_S]^],96E
M.8N!VQV[=/\ ]7U-6ZM-13;5K?=^NOW_ #,84JD9W<W%7^-]4[??\]-==B4M
M]G/R -@#H.OY?3WYJK+(TP(88'T]NV.M6$<19\T9(_F,]>GTSQU_.O.XE!$8
MQTQC _3W_ _RK&HU*G>+YUK[OW;7?GY-G;AU>JKT'6V]]?(Y^\BVGY.26[<X
MP>W3Z^G.*^KOV<S*=2M@RG!EZX/][\O;/O\ C7RQ(XA;,@S\W?\ SU[=,8_"
MOKK]GB[@:_M0J@'S/_9A^O'XY]J_,^))27.E0T?7M>VGWV_&]]#[K)YS56G%
M?NU[ONWTZ+?^OF?LKX&7.E6F<_ZM/Y?3Z_I7I(7(Z@ <<_A_C_\ 6KS;P6<Z
M5:D?\\TQ_P!\@=?\\5Z(KY5?7 'MFOR'&)NIO;7[O+SZOS/V?**D%12EJW%>
MKTBK??N.V+G_ /7C^6?\^E6%&!ZY[U6".3G/Y9)Q^7_UJLH"!SW[5Q3VWOKM
MIV\OZU/8H)7DU2Y%_-WV_->7ZCJ***S.H**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F%U'?_/XXIQ&1
MBH&B)_S_ (XJE9[NQG4E4BO<CS/_ (/^1,&!^OH:1\8SW[>]-2,C'H#GU/\
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M3ITW_%Z^E]Q$N/,.).G^0/YY'J*E>"!URIRQ^GKZ>I_G^548X69L'(Z#//;
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M/9WVI>8\#DXSQU/'7'\ZC:V\WY@V,]L\]#G\OQ'MZ9U*E9625EHKK:RM;?\
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MSS_A4<B-BF?;UZ=_3^?U].AU*=2\8+F:Z-;:+7Y_GV9<*5&I_%=DK)=>W?\
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M[_ZKIGM].>GZ]/\ "A(DRDASW_'GGOR..O/:K$<TJA0%)Z?_ *@1Z#CI^-7
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M\U]G^EW'[9I.+C%2=K<NSV[;:W[]=B*-)EY<_*><?D?;MU'-3EX=N!@-W/\
MD?T_^O1DN9NFTX^G./P]L9(_/FJJNQ?WZ^^3W_'/3WH@_K">\6K[:=E]VO;R
MTL)4923E+ECM;D>CV_R[I]B[+%<-DJ>"<#]>OK[\].U4F#@_,>?Y<CGWXR/T
M[U?BN)2 I4[?7D <?EWYY]ZL"%'^9L ]1_\ 6X_Q_P 2G'V$G)OF]->R[>?G
M^@*HZ?NS4?)Q5[[;[?\ !7R*<23G!4X&!C\O3\?;UYZU<4HO^M]_\]^^?YU
M\LD0P@)QQQ]3^OX__7HR2R/DL,$'H<]^_P#+^=*-55Y<MN7:UM.U_P#@?\,-
M0G5=WRJ+V:^+2UK^?RT>YH2!I,^2> <X'T/'3K^?UJA)'.N=YXQD?ECO_//0
MU+%+*@&T$YR> 3^6/Q/?N..]U<S#]X,=!CZCOQ[?US0J'LJG/>]G>U]=+/\
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M>G*E%44U*>U]_P##96MYJ]KW/,=.::FVN?1VE;EU:UL_2X]H9,'S#T'<<?\
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MB&[K@_Y[>WX&IG@X2ES34DGKI?R?7[OGU-HPA.-H7YUNWM?39_+3KJ0VMI*
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MYPG=VA)\UU?F=H]-KW7];#E<#F;D\?7ICN<D=_\ ]0H8N_,&1]..,D?GC_\
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MSTZ?XYS^U</^S5&,I4ISDE'5:JZ4?Z^5KGY5FEW*5M-]'OI;_AO+\37LY%5
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M3@Y_$_SJ9<W2WY/^O7\2Z/LHR?-%QEU<]4WILON_,FBND "LO?Z\G\_\FG-
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTX^F.E*M4<H0C*#2LDG\H_UI_P  <95JME%N-M.:WQ+9^O\ 7<B-QY'RCO\
MCC'3'?O2@+<\DXSSGI_];'N:H31/&1O))/KT^O\ +K4L,<CXV$CCCMST/'K[
M=JSIT832;JQW^'9]+_A_74J=+DCS7Y)WOSOKJEUMT_'=BRVNS.T[N,=_7J/7
MM1# 7SGY><^_/U_3Z9[U=7Y!^]YP._MU]<=J1RLF?)P.#T[>G7\O_P!5=+J2
MHP481;5M^^G_  %TOU5S+VLVN6]^GM+>[T_'R\M@V+  =P/]>O\ +KTI!<"4
M[.0.N3CKR.F.G/M_.J<D,Z\L21GIGL/\\ ]:BC5V8@$]\?Y[=?U]J=.*K0O4
M5NOI\/\ PW38I4HN+DZBE+NNFWWV\U_P+DEFN-P;/'3/IS_G\>1500L'Z''3
MI_(]"3V'O5Z..5.7.1Q[\=^>_'US4Q>$@J-N['XCCJ1CBE']PG[-<_33I>VO
MG_P+$JK..G-[1.VJV6V]O5_J0I:JJAMW(QP?\/\ $_UIWVH1_*.>W&/Z^N,\
M9XJ&2&=LE6.,_P"?K5)E<$ DY_KD<^_&1^&.IQ2HR=:4E437D^FWE?IZC5-5
M-95%+M%:6U7;MZ^>YHF%9P"6QGGKV)[_ ,^WY54DMBF0,D$C'&<>G'YY]/4U
M-'%,<%20.#W_ $'3MC-6@50?O<?C_///?/%.-.-*3E#WG_*O5=_ZML"G*F[*
M7,E]E+57Y5^'1%2&WW@ G;CKGCU]<X_QR*LDK;C@Y^GT ]^N?:FNIESY)QR.
MGTZ?CUR/K5&6*9/OL?Q^F.OX_AU]*E59U*JC*+C%Z6[7:OT^7K?J"_>/WYI)
MM7AUZ/UW[M:E[S%N.#D=NV<<=O?L>?S(J&6S R5;)^OX?YZ?CT->))&QMSG/
M^>?U]?PJ_&DB?ZPY]?3V^O/MQ5SH4XS4DU?M\]?2W7]$)WI.T)K3[.C;U5[=
M[VZ[ZV>I02$EL$8X(YS[GCU/(Z>F<\U?6W6-=V_ZYZC\../UJ0O$PQ&!N&.G
MKG].H_(^]4I(+CE@QV\]_P#./PJ)UZG-&'*U&Z7;33JOZ[!SRJ;R]G>UU);[
M7M_6I8-T/N8//';'/7DCWI&MEE^8MCID?@>GOVZBL[:^Y1SV'X_USZX[U>CB
MFSN!('^(]#P.M:5*%.2C)OE=D[>>COLE^6JV>Q4H*E9PFH_._:_]:^B*KV[(
M0.2 3VSZ=3Q@8[G%6HK4,,LV,\^W''7OGMCM^=60T:\28W>YY_KG@BH9(Y)!
M^[..O3Z_I@Y_&IG6G3@HQ@]$M;>GY;$^UG)).7)JESM:/;[]K]=+;#_.%OCG
M)'T[?IVYY%-RMR.3C/'OD?IP,>OXU0DCD0@.2?\ #(_/@?CT&>:?%'*P&TGO
MGMSQW[^G<>O6FJ4:M-2GI+:_EH^G_!V*]G%)34US;\ZVTM9V>G3R));38<J=
MW7/OQZ]^_3J:CA@))4Y&><D$'CV_/\_:KZAD_P!;SCKGVQV[=^:&9'P(\9YZ
M'/\ ];CZ_P Z49NC3:@G)=U\NGY;_>B56GK&_,OY[:+;5^2Z^?K8:(EA&[=G
MO[]N/\BD^T*Y\OG'KQCC'3N?ZXXJK+!< $EB1VY_S@?IVJ!5<N0,]\>Q^G;'
MOCWHI+V\6ZBL][O=.Z_R7S*5.,H\TJBDU9JW2]GKKK;TV_"^]HK_ #;N3GC/
M<]^_]>W%4C P8<''KV_/.!C^E78XIEP6)QC@9_J<=/\ ZU3[X1\IV[OUYZ<8
MHA%4;NG[]]':_EMZ=?4E59PT4O:*R5U]G9=-/1W^9!':J1N+8Q\V#QU.?S_$
M"GFX6'Y1SU'&._U^N.O6HY(IG&4;@@?E_P#J_2J+JZ\,22"?ZX_(\^V?04J<
MY5IN-2+2TW]5_P .O330<8*IK*HFK_#M;;T[VZ=S1*+<C);&<G],'/MGCIG\
M:JR6NS.TEAC_ "1Z\]LGC\J6*.5@"A('Y?IT/7-75^3_ %O./[WZ^N.U/V4*
M4^:'O/3W5Y6?Y^>K%S2INT9\RO;V>C?3UU_KJ[48(-W!)7GDGCVZ<X_^L*N8
M6W'WLX__ %Y_3TZTCXEXA('';U!Z]NO3BJ4D,ZYW,<9^O3GK]!T/)J76G4J*
M,HM)_P">W]=O0:O5?OU%%.UX=>G]=+:6+RS";Y>GUQZ__6_SS1+:J!N##D9Z
M^G//X=^:SX@Y("YSQGV]SZ_YQ5IH[@*222.HZG(R>GX>N>N*[H^RI>[;7M_7
M?K\M"7#DE'EJ*,=W%[O;O_7YD"QY?&< X/\ /K^5::Z?&%+^9T[#OQ_G]*RU
M#E@!G/U]"??GH:N_9KO:6W-@<'GVKS\<KI;OT\K._P ]CT*+:MK9V6O?5?GV
M*[X1MN<\GGV]?Q_"KD=C',F2X!_J1_GWK'D216PQ.<]?\]./TYJU"ER<%6;'
M7V]>WZ5YD(:IK=-=[Z)?E^:\SHJXGW;5)))6W25]MO7\]_-\]MY3?)\P]O?!
M_/U^@HBM?,^\=O0=<=P?7/Z9]JMJX4 2$%N.OMZ'GU[=N*8ZM)_JC@9[?CQC
MOU'->HYR]BDX2[7Z=/RM^7<\N=9R=H^XM/?>VZU[=6_*Y6F00@X.>./\^O)^
MG7UKB-7C%PXW-MRW\^OX_P"?7/;M!(%)D))(Y]/3GM_]?CFN+UJ"5G'E9!W'
M&/4\C_/)_2OD\YIU/83:G:/\KZ[7_P K^3\SZWAZ,_;4[U5-72TUZKI^!^F?
M[!=@(]>TUA(&_?KGG/\ &._OQ_\ JK^R/]FQ2-#TD>L,(_S_ "K^-S]@6"XC
MU[33*Q(\]<9X_B'&/;D?_6K^RS]FYD.A:2,<^5#CJ<=,8_EV]:_F+C^5L+B/
M=;TEK\E_PVJ_X'].<!48RQ^$DZT;\U/W>K^'\-/*VI^D_AM0+*(Y_A!Z]<X.
M!T^A_*NC$I'K^'/Z5SOAQ&-E%R<;1QCZ=/U_R*ZA4 '(_#L/RK^.,;)?6:W-
MK^\E_6OW']OY7"H\)A^1.G%4X.[Z^['^K?H.5LCI_A3J ,=!17 >TKI*^K"B
MBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!$Z]>
M>O;O^'X\UQ>MKM1_H?RYKLI QW>XX./T_I7&:V"$?/H?_P!?_P"O^M>EEU_;
M0U7Q1TZVYH_E^7E8\?,TO92_=OUTTU7G_5].A^>W[1%OYMK=<XR&_D?_ -7Z
MU^4VJ:<(]5G.[I,3SUX;W[]/Y9-?K#^T(";6YQ_=/Y\G^5?E5JZR#5+@D\><
MW&>#R>,_X9_K7[1P_4G&G!<ZC&T=]5HHO\OZ[_DN;5)*;7LW+^]VO;T].OR6
M]NTB#(!D ' Y_#W_ ,\5H_V<B*)/,&2>1GUQU_'-9D&Y@H3@^GN<X'^?KZ5;
M:UO",[FV=OR__77W>'G&IR\C3;M>W>ROMW^\^&QZ]YW6CU]-%H->ZVGR_J">
M..WOZ_RR14/V%9SOW8.?7WSW_P ^W6JS(VXY!+9_//\ D<?X59CAN.JD[><\
MX'?''0=?:O3E2G2C&3?.FD[:K3O:^W;_ (8\*MAZ3LTU3:[WU>C^3?\ 6EB=
M2;?Y0N?J,GGGZ?I]*<8A<<D[>N?UZ?B/Y4JS)'@2C)QWY^G?^O3CZ1LKRY\L
MD#M[=^I_'WYHE4I2BDH>\M/R_KSNMC.$>79<FO\ $>J=M.NR_KNQK9@/'S=_
M_K?I^=*I,YY^4G\^W&.W^.:0?N_]9]>YX_R.AZT']Y_J_7/I^O\ 3H*\U)>U
M_A/U[[>?SU-'WZZ?O.G3^MO0CFM=@X.<]N_?C_)_.JT5NS'!R,D<D8^G!/;U
MJ^B-'CS>1GG.".Y_'^E2%XW&(\;L_P .!^''^?SKIY4]?33O;;I;3U^_0:K3
MC'EOSZ?Q$M([*^_]:>HP6ZPC=NR?3UP>G^1TI/M@8[,>V?7/'ZX]/I4,T5P.
M221QW_PX/0]\U2 ;=QG.3_3 _ Y_R:&W%I)-7LOE9;>OGH7"E&HFYSC.2U37
M3;=_+7[S3:U#C?O['ITX'XUGO P8#!('' /('8\\?C5R*&<<DG&.F?\ ''IV
MJR'A4 /MW=\@$D_C1RJ6^GGU_"Y"JRINRG[9=HK;;_A]_P RM%:[AN+8QS_/
MK_\ K_.I#.(?EQNSW'^1ZTCQR.,QG X]O7/OW]/?O6?*DBD9SGZ]?Q]L_K2;
MY5=*WIHNWDRHQ59_O)J2O?V?6.BTOY=;]^YI@+<]6 SV_3VZ9Y_K5.:V*9P=
MW ^O].A[4V&*9_N$]O;/;./?WX]#5Y/W?^NYP.IP1]>X]O\ ZXIVYEJK>;^6
MWI_2!MT9>Y-22:7LUO;3SW_KTHPVY<C/RY.?S^OMP..?2KOEK;@'=T]?Y]_7
MT%.9DDQY( ))QCCL?PX[Y_&J4L,ZC+$D9]?3VZ>_&?RHLH[*_FO^#9BYG5DE
M*?(G>]-K5[;?EZ]BT+D2_)C'N?R_KGM3)+4;=X?_  [_ (^G^>:SXU<L0,D]
MOSQGVZ_K6A'%,HW.3MX)&<\>^>>_OZ41;DFVK^?3=?\ #=BI05%_NYJ'>/63
MT12$+;SP>_../KG.#GT]ZO):!0'+XP,\]!C]>GN:G\R'&WY=V/09S_.J\D4S
M#*DXYXS_ (9/;VI<J6J5_P!/+6VW],AU9SLG+V*TNVM]OZZ=.X\W0B^3&>V?
MU_\ K\9I?*6X!);!Z_IU_'MQUK,=6#8.01^AR.?RS_+OBK,,4['*D@?7MCTZ
M=N^#0I-NS3:5E;R_X/E^)<J4:<5.$U&7\SUOM;^OR0R:W*D@9;GJ!D^G;KQP
M>.*?!;%P 3M]NA[_ %Z^E75*QY\[&?5L'_ZW/U_G37'F9\GN.P ';!].N>>U
M/E6^G:UOQVL2Z]2RCMM^\Z;+_@].PA"VW(.<#IW_ )GDX]NM E6XPOW>>_OQ
M_GFJ4L4RC+Y/![_EZ8Q[>O-1Q)(V N<YZ_TS^M+FE>UG;_AM>W]=!JE%P]HZ
MJ<KK]YTZ=/Z_RN2VFT%E;\#^'^>IJFD#%B"" >.0>!Z#UJ_&DB<R\C//I]/7
M]..M3%X6!";=W;  (/X4^5/7MT[^O>WK]Y,:U2*Y;^TV]]+1+17Z>?3MW(EM
M5C7>7Y_/T],?AUH^V!3LQ[9],<?IGT^M12PSD;@3C'K_ (?7N15$AMW.<Y']
M<C\3C_(I.3C;E36W]*W??8N%-5;NI-3:73[+T\DM/^&-0VXF^;=@^@[9YP?\
M_E6?+ P.!D\GD GKR>/ZU9BAGX() ^OM[\=_6K2O&@_>8W>K8/ZGV_SQ1RJ6
MZMY_\-<A3E2;49^U5[<JW6WI_P /;N5HK3>"68CD9 _+\>GM4QD%OQ][MQ_G
MMBD=)'!\HX';T_7GL>U4)HY5^]G.>N?TR?I^E-^ZM%MU^[\O^'*BO;/]Y---
M_P /JMO\K/[]V: 9;G'.WV_IVY_'FJ\UIL^Z=W7CU^GY<>OK4$,<K8V9Z<GI
MGOVZXZ=QZU?16BQYW(&>O(_KTI+WK76_5^>_=BDO8R2A4T7_ "[Z[K^OP*$4
M#,<'Y>V3QT&._P!.?3I5_P A81NW9.>_?O\ T';BGEXW&(@-W^SP??IZ]?Y=
M:IRPS@$DDC/3Z]L=.G'6FHJ-[*_FOEWMZ#YY596E+V2T]V77;S^[^K6/M88[
M,=>_8XY_SQ2/:AQO#<_IU_'W]/QK-57+\9]A_3';']*O1Q3#DDX';KW]^G3K
MVI)N2=U?IY*UM[_=M;4<J<:5G":A=)V?VO3R_KL5#"V_H3TYQP??/;_ZU78K
M0$!BV.<X_7^?OTYZ58$D(^4[=WI@9/\ 6H7CE<90D#/'...>G?OZ4^5+7=[^
MGET7];D.M.=HN7LMM7UV_._EIZCC<"#Y?O?3W_+KTZTH5;GJV,X_0_ATZ&LR
M574X;.?YY'!S['_&IH8IF(V$CI[=^N/\>*%)N5K-I6T]?GU\M2W1A&*G&<5-
M_;>SV?Z?H+-;%,@$MD?C_3D$],=/PI(+<MP25Y[C!/3UJ\O[O_7<^A.#^/<>
M@_\ KBABLG^JQ_P$#WSTX/;BCECOIZ?K:UB/;U.51OY>TW6ZZ^6M].WH-V+;
M#.<X&2._7.?S&.,4@N!-\OW?K_G^M5)8IE!W9(]>H'7G'3M4$:2-P,YR/P_'
M/?I_*ES--12=GT_RMII_5BXT82CSN:G+3W^BT7]?UIH26@P6#?X=/Q_G5$0M
MOQC').><#/?/X<>N>V*O1Q2IRY)'Y\#KGO\ XU/YD!^4!=WTY_QX_P#UTW%/
M5JUK/UT6CWO?^F2JLX:)^U6GO):1V]'U?S(8[157>7Q@#KV_S@9ZTINA'A,9
MQQD?UZ?7O3)(9V^92<8Z9^I[9/-9[JX(!R#W_P >O.:3DX_"K>>R_#_@#A!5
MG^\J*?\ =73;3\/ZZ:AA$XSNQWP.OI_GC_&J4L!C;C+8/89/0C_)QCM4D4,Y
MP5R #Z_TZ=O6K:LD?^MQGIEL'_ZWKWIV36JMTN_EVOM_2$IRI.T9>T2M[BWU
M:[VZ>?XE6&U\PY8[?\.#_7G/_P!>DG3R%X.['K[G\.G>K3!I#^YX!Z8Z=/3I
MW'M^50F"0 ^83U[CU_KQ]>E34BW3M&ZMU[::&N%E4J5T_:JGKK![ZI:_\#_,
MYNZ<RMA@1SCG(_/T_P ,U]9?LZ0*NHVI!/\ K0<?5OQKY3OT"GY>.>>._0^F
M?3^M?5'[.8D&IVN22?-'I_>^M?G?$DHQIU8S]^6NO;X?EIMO\M#[W*(24X*5
M-S=X^\M;:Q_KY6/VH\$C&DVG_7-<>W05Z&B  '/3FO//!.?[)M>>D:?CT_+G
MFO055]HZ_P"?;//]:_&,7_$/UO+/X2]QNUK/732(\2<_KZ_IQ5I6R/<5GKD9
MSUSU]O\ /:KT??\ #^M<<TK7ZJVJ\['MX2I.;:;T7^1)1116)W!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M  &,5HH\K@;P0/TQ].H[]Z/($'S=<]C]-W8_3COZU#)>*1M"D$# /3(S^O\
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MUH-J!E\G'7H,?@,_SR/:BE^X4O:/RMW;M9?U?<J-2,5RRIJ#=K6U;VU]=?\
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M=OE8'&.N/H.^3S5CRX#\Q*[OKS_CQ^O:H9+L*NP+C /3H/TSV]ZH&9M^<XY
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M*2=[.W3S>W>_K\MA>RG3LVO:K3=_#:VG3Y=#-8N7R<^Y_P#K]L>GM5N*:<8
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MH:]"63Y1@=O\]O\ ]=?C&+_B;'ZYE;7LE[[Z::^]I$D"KZ#'KUJPH ''/O\
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M)4[OH<]<9QC^7MUS6ZH3E[]1V\KW3O;77]?78E23FE4<N:ZTM[JU7R]5_P
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M^WV;Z=_2]K=/)$D4RO\ ZTY!.,^WTJ1XHG!\H#_(Z^G7'3M5>&WW<-D8/?\
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MVW_7-?\ V6O1%V$ #N/Q_#_/3\:\[\%#_B4VG_7-3^H'\J]$1  #Z<_Y]_\
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M.<[@<?EG]/U[_K6_[VKWC#[O^"N]O/[YNZK2]U1;V=N;=/Y7Z6TL7&D27A,
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MZ)KUZ_J_(%4E2=G9QZ67O=%K^"\W8HQ0R. RL1V_(GG'Z]?PYR;H_<_?Y_\
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MSMU^[7N*FU+WHIQD]W/X>FU]/U>C[$?^I_UG..G\OIV]/Z4O,N/+X.?7T_\
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MYXKT-"^!D''O_C_3\*_&L7?VG]?\.?K.5J+I)>]LK6](WOT(ER,@\Y.<]O\
M]?M5Z/O^']:A 3V_G^A-6%P!Q^=<5273J[=--+?UH>YA:3A=\R=^WH.HHHK(
M[0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,Y..G3)]!R>GL/UG@NBF 06!QUSGK_/\\BGR6WF',8POX#_#GL?45+&D4/\
MK1R,<D>_4]N^!4I2O>^FFMOZM\N_?;24Z3II<G,[6Y%\2V].NGWH<5%SU 7
M'L?UZ?X?A0(Q;<\-W]>W_P!;C_\ 75>:X0?ZK@=ST_\ U^@_QI(;A3_K#N&?
M?'_ZQ[XX/6G=7MU_3[NO](S]G5Y4[24-%[/[5FUU^^W3[[))KLN,!=N >?\
MZ_K^/%5XYV4YYX[<G^G7\.GK5]UBF'[L#/MC(SW^N>O//X5$MJ4.7''L!C\<
M9R?;\:34K[Z>GW>OZ&D)T8P<7#E;W@]^GS]+>ER9;GSLIMQ[_P!1[_YS2_8U
M4[\CCG'TR1QU_/CIZT/+;H"%&&]AT/ZG/U_.J0N7W8+?+GIG\\>X&/K^!JFU
M]IW??S_'T^>Y$83DFZ2=./9[M:;/:^FFOYZ7&N_+&T)T Q].?S-9KS,6SD^O
M4C'T]ZU%DMW7!7GC/'?GI_G\ZKFT9CN4?+U&0/S'/Z=JF7,[6EV[[>OEY?B5
M2G3A=2@X2ZN6SVV_3_/98KLJ-I7/_P!?T_PY_I4_DBXRW"\^N.O/MZ]/_KTB
M^1$OSCYO\_F?6JTMQ\V(^!G_ !_7W_G57LES.Z3OM;MZ[_TB4N>3=&#@_P"=
MZIO36R_X"^6UG(M3C&[Z<_X^GX^F*K3.9PPQC\.G?GC^G'XYJ2&=#CS1DC&<
MX_KGCK^-3LT)7Y!C],=/;\3_ )-14CSPLWIKI]SO_77YFN%IQE74:M*4Y7LY
MK1=/ZUVO?:YREU&8FR<G+$^O7\_3\N>:^L?V<YPVHVHVD?O0/R;_ #_]:OEB
M_."<]-W'/;J/IQV]J^IOV=#&=2M>G^M';_:^G]:_.N))NE"I"":6OW>[Z:?T
MC]!RF')."C5C"-U[KWMIOY>9^TW@H_\ $IM/^N:@?H:]"$A*CCMC^G^?\BO/
M?!)_XE-K_P!<U_\ 9:]$785 XZ?YY_I^%?C.*_B-V>KW_P _/U['ZSE?,Z7Q
M+9?.ZCMV_._;<A4D\]!TQ_7-7H^_X?UJJ(SG/3^7UP.]6T!&<]_Z5QU&K=MK
M+[K_ /#GLX2,U)N2:]?0?1116)WA1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 'D8J%HL]_\ /IW%344T
MVMM"90C/XHI_\/?]"-8PO^'_ .OK2N.,]"/U_P#U4^HW'?\ 3\AQ_6FFW)>J
M$XJ,&DM+;' >)Y72WGVC/RMQ]0?RR/;Z]S7\Y?\ P4\_?Z3K/F<9CE^GW3^G
MKR<\8[U_1_XA13;SY'9OSP>?\_C7\Y__  5!MM^D:SMX_=R^W(0]?KT_&OUO
MPY=-YGA8RBOBC[WSA?[_ .O/^=/$ZI!4\1'D47[WO;Z=6^M_\_(_C(\;6<*>
M+M1(8$_;)#Z?Q]^>O7CO_+6TP;HU!X!&,\<=,^G/;_\ 76/XXM98_%^I%GS_
M *;+T]G//X?UZCJ=C3@9(E X.!C'T^@_S^G^A/#,(0P=)0?.G3C?[H?UK^!_
M"?%#OBJG[Y_&^GFOE:W]:HW7M+8)DMSC]>I^O)/^164S*'V[OESU_P#K?3K5
MV2QFVA@YP/?\?Z]^G/K60T3JV#Z]?\?SZ=^M?3N*E:^CZ:WV]>J_/74^,56=
M.]I.W6W77<W([.VDCRS#)Y_7^O\ CUJA<6P1B(^1T^HQZX]N_M1!;S?>WG Y
M_#MQ_+J*MB58QA^3W/K_ )]/4<=*Z\+SP;<8\WS\UKY7_ILX*V)4I>Y^\EU2
M[Z;_ *_?ZUH[>/@N0.WY?Y^G]9&F$'$9SVX_SCL./4TCQM.,H<9[=.WU_+DU
M1EMWCSDD]O;KZ\CM^==$9SJ5>6<7:]K:>5_SNNG0YHJ-1KGG_P!P^VW]7[?,
MTD99S\Y'/7KR#U_IZ8[\5'-:Q@90@_\ Z_3]><U5AAD? 4D?U_\ K#M[?A5U
M5,(_>'./?IT^G&!]:[/:4J:Y8Q3EV7KI_2M^)$DX27)4>^D.^J2^_?77\2E'
M!DX?@>I'4# ZGV'Y^E7?+BB7<&&>_P"?'O[GT%*TJ3?*F ?R'<?G^'/KZ5)+
M24#=N.#T^G3MW_\ U?3BG6JNI%.+2;VZ>FVVJ[7*OSM*<_9ZKW;;ZK[M%U_(
MF^U%L(?N].<_T.>?2E:WA<$[ADC@9[\#C_#L?TSQ&Q<@=3G\.._L.WX5<BM9
M%^;?QW_PQSZ\]:,1",>1QA=]?5VW_P ]_ON7*,:?P5.1]EUU7>_]='J5VMR&
MP <#OVZ]_P#/Z<U:2TB"Y9L'M^7^?IGGTJPLJ+\AY;UX_3K^'\J'LGF7*M@=
M>N.#SWZ].:FM4DX04H:+9OM9?CIV^8X>VJ-*[@K_ !=]OTU^?JG5:X\D[4(_
MI^6#SWS^=2)LN.7('U/KZ8QW_3ZU1G@:(@')/3\,G_.!VJ:&!Y/NDCM[]^OX
MX[\U$*5&27-6M_=MMM_F^W8JI25.*;?++K4\]-?/_@]!9;55^YSD?YQGN.,<
M?XT16X;._CO^I_J>G4#'/K;!$/WSG&!^7'/^3[TCLL^?+^7@]!C_ #]./\>A
MSG3@HTXW6GO)KR[>B_"VS9@JDVK-WC_S\^[O\M'U$(BA&58?_7]^Y]N>M-%S
MYI"-T_S^?T/OUZ56DM9$^8D]<XSD>OK_ )ZU%%$S,1D]#_D\=?\ ZXHI15:#
M=1:ZN[^7;\%_PQ:IP<7+VG.]+2[;=^WG?Y79=DM8F!*G./KP>_/Y_GTJH("'
MZ<9Z]1V]LY]3]:NI"\7S,V1UQ],$^O/Y5(9XR-G\7(R.O?M_^O\ P<%[)/V2
MYON=MM;]=K;/\"54FKI2=1;7V26G3Y_UJ,2WB1<E@&'8GV].@^OOUIAN_+.U
M<D=/3MD?CCZ4DEK(X+!N,]N@Z_X__7 Z46C92 <D],_B#Q[]OR[5-&4JTI*J
MM-=UVL]_*PX0A/64U-Z7C_+K'M]]E_F:/E1S@%B 3S^?^ ]?;TXJR6P7.WG)
M[?7MGI4L5O(V&#$=#_\ 6Z_YY'TLAUB^_@__ *OY_ABJC3A3FW3]Z2MI\UTW
M7S=NHE.4':$W.WV%TV6^VGII;U*L-NA W\8!Z\>OZ\=OUJ=G2#_5D'Z?Y]SU
M["D9?M&3&<<Y';. 1C]/4?3M5*6VDCZDGCZ_J,COS[5"JU)U5&::CIY*S:OT
MZ_EY!%*<OWE2VOP/OI^OS_$N"83G:_'US_\ JQ^OX9IDEI'@LISZ=?Y]^W?M
MVJK%$[8 )SG_ #C_ #Z\\5?6)H>7;(_EG(X^N?6KE1I1FFFN:^WS27K;K;TT
M"5J;M"?+;:"ZZKYJ_G_F4D@);!&!TZ>N>GXGZ=!5X0PQKN##(S]<?YX '6E,
M\<@"+@'U_$'G_'GZ^M:2UE.7W''.#GT_S@?_ %^8J5JO-"#BXK3MMIZ_GUMJ
M#DYOWY>RO;2WQ;?\'?Y]23[6?N#[N>O('U]1^%.\B*7DMSC..OKS_GK[UG>6
MV]1SQ@>_IP/3U_&KL=O)][=QU^N?7_\ 4<\=:TG1I.*;:B]';K=VNOT\_,J4
M(T[.$^1]^[T6O7;>W?4KO;;6  )_R.OM[59BMX\9<@9 P.G3 _3T/\N:G\U(
MAM;!/_Z^GY^U1/$TPRC8SDXZ=?\ ]?'/3M6=2K4A%1C'W=+/RT?:VFVOKH3[
M24K*4N1.RY^ZWZ]_PZ["M,(,!#G [=L#ID?AZT@9;C.\[?\ ZW?]>,<51>!X
MR,DGH?U'?O\ ISUQ4D,+O@ X_P CGU_EQ6BIPJ4U*I:+ON[=E^5]MM/.Y3IP
M4%)3U_G\M._HEW?3K>:6T1?N'=_+_/7_ #Q4,5ODX88!]<=L'\O_ *_3K5T+
MY/WSG Q_7^GKFE:1)OE3@^OY_P">GX^D<TJ4+4ES+36_^'Y]7U_(A5:EK7<H
MW_B6MVUUOMYW?SN)LBB7<&&?Z]1[X]?2H_M6\A#]WIG_  _7@\5!):2 ;MQY
M_$8Q]?\ /2H%C8N1Z@_4=/T_/BG27MHOVB^;MY>B73T;\RXP@TY.?.U;7M=+
M\OGMZE][6)QD'GKCG@]OIZ]NG>J9MR&&!D?F/QXSG_ZU6TMY$ 8MQZ?GC/\
M/H*F\^,#:>OZ\X]_Y?D>Y%*E?V3YGMO?M?IT?S?R(52:;49.HORV_KM^)'';
MQ 99@&Z@'W_G^7;GFD:Y\HX7D=/S./H><XI'MWE!*L<8!Q_GH>.>/;K5%XF3
M@G/)Y[<C'Z=?S[U-*<JLVJBTTT[:Q^_Y]O4N$85'[U3FL]8;6TC_ %?\[LOA
M4N!N8X)/],8/KD_6H);4*3LY]/R[>_\ GFB*!WP0Q';WXYZ^I_GVJV"(?OG/
M3]/7^G7WS5^SA3G>&LM[*VFW3HKVZVUOT9/-*$K0G?72G;;;^OZ94AMU. _
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MU]_\GKVJPL@B^5_F./Y8_P _EZ4UD,^ AQT__5[#GN>HKU'*I[%)TW:V[?\
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M5.&W7W8_+^MK"J21S^=.HHK@/96B2O?S[A1110,**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH B=1R<CZ'^?;Z_UKB]< "28],?SX_S
MS79R*2&/K^?Z_E]*XO6U(1^>Q_KS^E>EE_\ &A[SWCIK_-'3Y'CYFG[.7[OI
M\7?_ (?8_/C]H>W66UNMQQE3_(G_ ">U?E/JMA''JL[ ])F/KWXZ=.?_ -=?
MJ]^T(I-K<_[I'\S7Y4ZNC+JDY+C'G,<?4].O^>U?L_#]24*4?WCC'E6GRC^=
MS\ES:<U)J-/F5_B_/^M"[:1HRJ&X!Q^GI_4=ZTC96R*'#C<#_G^?_P!;G%9,
M"M(  <'\>IJ^VGS[=V\D>F?Z?ATZ5]YAJD*K7+*^U]/[J_.Q\-CUJ[K>[?R2
M_P"!W('NRI\L'CG/X8'^?Y'K319PSDLS@'\/4_\ Z_\ Z]5FB8-M/)S_ /K_
M ,^QJQ':RD;]V!U_//7!_7GW.:].=%THQG?FNKM?TN_Z,\*M1H/5VIM:[WOJ
MEN]O7\R8%X/E0<?4>G/KZ_C[=W[%FYDP#UY_S_\ K]3UIHG6'Y7 8XZXSV]"
M/I]#[4THT^2I*CV/8CI1*K&4$O9I2ZO[O^&T_4A+E6B]FNE3>ZTU_JR[Z#'_
M ')Q'SCO[],>G7_ZPI4_??ZWC/'Y8 _S^?>D(\C[_P WKT[_ ->.WTI<>?PO
MR]Q^7\^?2O.L_:Z4K^=_-?\ #_,OHGZ?O>VW?7[_ ):C)K9!RAR3V_H>O!P?
M\*KQ6^2 PP">^/;]*NK&8,,Y+ 'N<\ 4\S)-\J]<CG^G^>]='*NJM;IY[=K:
M=+[#56HHI)\\;?Q.VV_I\O-;B>5%",AAGC\3GOSP._\ ]>HA>,QV=OTYR.G:
MFS6T@&[=D<'&>G./\>WTZU2",7QSG)_7 Y]A_AC-)MIV4;7T\K6_K?3KZ73I
MTZD6Y3]HUK?MM;\NWEWOIM;Q2 G=\V/QZ="/TZ&J#VYW  9P<=O;K[?_ %ZM
MQVTBC<6XQT]1ZX_^L._K4PN(XQM;J!@^]-Q3M=*.VNOY];[:?(A5)P;5.3JK
M33MI'O\ U^)#%;18+.>??\1[9]!UIS7'DG:AR.>G7_)_I2O"\H+*V/;/7'^?
M7T]*SIH63@^OX?RZCM[4.\4G&/?5:?AU^7S'",:K_>3YG?X'TTC;I;^O-FDA
MCN.7;'08Z?X]/U[56GME7[G.?I[]^>1VIL-O))T..@R?\@\_C].#5P'R/]9S
MP.<C/U/O1NM8V]=>WW?F)OV4[4ZG-_T[7RZO_/;YLIPV^XC?\N3GM[G/^'\Z
MME8X!N1N0>G7U'_UL>M.,BSX"#G)_EG].V:J2VTB#<3N&?\ 'Z_TH2LGRJ^V
MOZW\_/Y!S.I)*I/V=]J?1[77_ Z_-DPNC(=C< _YP/P_E2R6T17<K#.<_P S
MT]>_3\:SHXF9B!W_ ,>_'7_Z]:$<#QC<S<#G&?Z?_J[>E";E?F7K?Y6T_I?I
M4X1I./)4Y-5[J^UMUVU_7?<IB [SQQZ\8^HXZ_\ UZO);1*H+-@_RY]/UZ?X
MU)]HC^YCGIVZ_P"-0O;R.,JW'H#P?Y?U[^HIJ*6ROI?K=?\ #?<2ZDYN*G)T
M5>.O\RT_!WOK^@C79C.Q>0./T)_'_P#7]*D"QSC+L,GG'3MGCO\ A_2LQXV5
ML'/I^H.1[_UQQ5N&VD?Y@=HZ]?09QQ_]?]:492;LXMI/:_W_ .>A<J5.$5*-
M3DE9>^NNR_KY^8R:VVDA>1UXQGMT_K_G+X;96QO.,#_/IR>_-6@ZP</US[>G
M\Z1OWX/EG'O^(Z?D<T**WLKWVL_Z_4EU:G*E>2CI^][[?/K_ %8:S);\HWY?
M_6[Y_*D6<3G:YQS_ /6S[_Y[55FMY$SDYX/_ .OO_/\ #D5%%$[X ]>O]!_D
M=^>M+FE>W*UUM?\ K;;77;8J-*DX<SJ7>_.]^G3Y*Y=EM8]NY"#^1_\ K>QZ
M542W)8@C )]O?I[5>2)H?F<[@#_CTZ]>]/-Q'(-J]2,#VJG%/5JSTTU\OZU(
MC5J)6BW4C9>__*M/Z^?D-$$48SN&<'].>/3T_G49O&4[.WZ<8'3O1+;2$%MW
M&.GICGZ?H?4U0*,'QSG(_3(X]C_CG%*3<;6C9:+U7_!?R]2J<(5+N=3VCZ)_
M9M9_A_74U/)BE&2WS$?EU]QD<U0DMR#@#('IC/\ +I5B*VDX;=@?S]OZ#CTJ
MP)DB&UNO//\ G_.:=DTN96\]?T_2WF2IRIRM3FZNRY%TLEM]_P"O0@AM4()<
MXZ>@Z?ET]\_XO:46^ AR.,?E_(=*<T;39*':#[_I_D]/PK/FA=.#ZC_)]N_U
MI.Z7NQ^[OI_6G_!'!*K)\]2][?N[;;:?YWO^=KZ2+<<2'&.WU/\ 7U_.HI[5
M!RA!SQC@^G'T[_TJO# [X"G&!U_+Z?AST^HJ^JFWP9#N R.?_K]A[\]!1K)>
M]'KO\OP_/S"5J4[4JEW_ ,^NEM/Z]->K*,5ON.&X!XYQVQU]L#\_2KICBA&Y
M6Y'OZ<Y/4CGW^E/,RS?*@YX_3_'^=5);:0#<6)Y_SZ^_0>U%DE[J3TW^[K_2
M_ 7.ZDE[2;I?W.^WE_77K:47C,=O8GJ>G^3_ %ISV\3KG<,]^G7TQ^74'FLQ
M8V+_ .?UXZ>GX5H1VTB@-N..N.GY_P ^@I)N5^:.GGTVMI^NQ52$*5G"I[.6
MCLM>9W7K_775LJ- =_ R/7C'X^__ -:KL=M&%#,P!Z_Y]<_3]:E^T1K\I'/O
MCOT_I4;P/(-RM@') SU^O3Z=>M-15]$F^VNGEY=]/R(=6I))3DZ4;KWNZ]W^
MOSMJ->Y\@[4.1Z_4_P!?\/K3UV7 R[ 9QQ^?ZC'^%9TL3(<'W_4$?I_+/6IH
M;>20C!QTYSSW_7C^N*2E)NSCVLK]_P#/R-)4J<8<ZGRMV]_OM_6OKU=W3VP7
M[G((]O?Z\CM_G#8;8-@-QU/./S/OZ<U=!\C_ %F#P.?QZ_X=Z"PGX3@^OT'\
M^13Y8[V7I;\?E]Y"K5.5).\=%[7INM?Q_P"!NAK".W&4(SW_ ,^IZ8)]:8+G
MS3M8D _K_GT_K4$MO(G))/!^OY\\C^N:K1Q,W [GKZ?IU_\ K4-R3MRV3W5^
MWS_/\"XTJ<H<SGS/2T^JT73Y&C);1%2RL,CGMUZ_G^'XU2$!W8(P/7C';I[\
M#]>M74@DC^9FR!R1GIT]SSVJ7[3&?D YY].O\O\ /O0XIN[5FM;:[]G_ %^!
M$:DXIJ+=5?S?R[:_C;\>C&);1(H)8!N/3C\/\,?CBHS=E/E7D#C_ .M[_P J
M5[:1QN#<8''8Y_+M^)K.>-@P![?YXXZ__6HDW&UHVVL_^!OKMT15.$*MW4J<
M[[/2VS_R\MT:@2.8;F89/_UN0>OZU3EM]C?+SR?3W&?\_P#ZY(K:1OF#8'Y?
MAV_'KZ5:$BP9#]2>N?\ //'THM?XE;7??M?8E2=.35.;J)?\NUTV7]7[7[E>
M&V1N7X/Y=>WKQG/O^8ILZ+$I\LY],$'OU_(CZ_7FK+ W!S&=N?0_Y]>OK49M
MF0'>2>1Z'_'VJ*D7*%HZ/H^VG];:FN&E.I77[YTI7^#[OE\NAS%RQ<_,.C$9
M/MCTZ^I_SGZT_9SB0:C:XY/FCO\ [7],U\IWZ#/&00<?7'&?_P!?85]3_LYQ
MN-2M?FS^]SU/][_ZW^>*_/.(YQA2J1DE*6NO;X5]^MM];_,^_P HIS4X7I^T
MU2YWY<O3;_+H?M1X*'_$IM/^N2_S _E7HBJH /I^A_Q__77G?@G_ )!-K[1K
M^/2O00C!1]/Q_E^5?C&*_B/7KM_7]:GZWE>E+X-4EKKII'OYZCA*0<=\=LBK
M2,3G/:J"C&1SUSG_ !/K5Z/O^']:XZB6K72VO>]OZ\CV<)4G)M2>BZ?+[R2B
MBBL3O"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@!#G!QUJLV_/'X],Y_&K5&,]1G\*J,N7H9U(<Z7O./I
MZ_G_ , AC+<?KZ?_ *_\^U.?=^'^>O\ 2I*C<\8Q^)Z?A1>\EI;5:!R\E-Q<
MF[+?J<1XBE5+>?=_<8\]3@'_ #S]?K_.5_P5#N';2-9$7/[N7@'U4^WY^G'X
M_P!%_B: RV\_^ZW\CG_]7KTS7\YG_!3Z,V^DZR0,XCEZ]AM/X_@?Z5^M>'5.
M$\SPJYFI-QT>V\/Z_P"!O_.OB<J7LZ[YG*7O;KK\];=?EU/XS/&INSXPU(R
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M5E^$=?TV-%6G)VI0O);]$MD[?-_=Y[R[T;F;K_7O^73OGUJ)MP_U/U&../\
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M^7R^?KKZKEE5=XQ27\RT:V_/:WXZ:WG  /D]>^,9[=<9_/\ R:4IN>=V=O\
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MO2;P#Y/3DY'3IG_/6J+F;)\S.<=_7^><9P*L17#( ,9^O7G/Y^GY]ZM;1/\
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M47N.?W9P.?Z=OY_6I([B/_EJ,X]>XZ=>W_ZZ)[8!OW7S#Z?3^N?T_ CMH_\
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MY/L?T_GT_*MTJM75^[!;JW3?IZO\==[Q=U7:4E%-W<?M=/U?ENG8MF99OE
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW['V[]/QIN7*E9/3[M-O3\;CA!UM:DXR6EHK22:2W_KSU-0Q>>"0VW/8=/\
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M=,^O/'7_ #^0H16OGM?:W^?G<GVTY1Y?A>WM'\+VU_IZZ=PW"W/S'=QW//\
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M15VTZBBN$]A*RLE9(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** (78\C'3MCD_P"?Y5Q>ML2C\=C_ %_QKM788(P/J?Y=_I7%
MZX04DQZ>GUY_SS7I9?\ QH>Z]XZZ_P T=?F>/FC?LY?O%M\/;;\M_P"F?GG^
MT1.T5M=D+DA6 _7\Q@\_E7Y2:I>R/JLV4(_?L.1@8S_3_/-?J]^T/-'';79<
M9 4\8SST_/H<5^4FKW5N^JSA5ZS,,X'7<?RS_P#6[5^U</:48R5%U'RQUU7;
MK]R^70_*\T^)ZVU>GS6G;R6QKVDI5 0,XY''M_/TJZVH3E0GEG QV[\=?\:H
MVCJJACD@8X/IR"._K^&:U?MEJRA!&-QX[>__ -:OM\'.4G'FIN%K>FR_X?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUU7]7NRI%;X;]X,+Z\_AS[#@<_KFK3"")<J1G^9]??V'/]:47 G^08'Z8Q^
M'7CU%02VA4;@V>>G/\_3_/O19)>ZKK[NVO7]0YW.:5:;IO\ D6SVW^Y]_P#-
M!=L6VD_+^&?J>,X_^M4YC@=0<C//_P"KC_'^=9BQ,7[C/'/;ZGOC_"M!+38
M^\^N,_SYY^F?:B+D[W6WKY?U?8JJJ<+.,W!NUE'KMO\ =V*S6S;LA>,\$Y_E
M[5;CA@506/S#D^QY_P \=#2_:POR8''M_7'^>_>AH/.&X-C.3QTZ]".GZ>]-
M))Z+U]>VC_R]#.52;251NG'1<T=;K3\^OZV(GN?+.(SQGV('Z'GO[#.<5)&\
M4W^L/)QU_D>W&,_UZ50EA:-MO)[>O7CU/(SGWZ?2>"U,F"6(''7.>O\ ,]<\
M8%2G*^VFFG];_+MW-I0I*FI*?*]^=;O;UZZ_>QTUNI_U7S>HZ_RZ>Q[TD-NH
M_P!9\H_''_UR?QX%62PMNI!R!UR3QT]2<_EZT>8+GCA>H].W3]>,?XT[*][:
M_I]_]=S+VE7E2O)PT?M/M6NO^#_6K;(T4('EGG'08R?_ *Y/?''XU$MUOX<\
M9[8Q^F,'_P"M3)K4H"0Q/!^O_P"OWQS5>.%F..?KR,?AGK_2DW)2MR_U^:^>
M_F:0A1E!R<^9K>;WZ;=?3Y&B\,##*GG'&._\N?S[52%L^[D<9Z_SQ[D ?YS5
MQ;;R06WYQV[=N![^_P"E+]L5ODP.>/SXZXSZ]>*II?:5GVMN_P /Z6QG"<TG
M[)NI'JWT6BTZ7Z;?EJJ1VZ+DGGC/_P"OZ_Y%5S=E3A3\O3MT]!D?K]*F:U\P
M!@_88'^>A_S[UFO$P;'/'U/XCT-3+F5K1[=]O3S\OP*I0ISNY3<WV>G+HOZ7
M^>^FGDS+\Y^;\O3\CV/2JTMOSF/D9_Q_SBGQ6A8;BV/I_(?U/&?UJ?SA;Y7A
MN?3/3CW].O\ ]>JM=+F5D]+[Z:7^[R^_LDW"35*;F_Y'HE\.E[?YKY$4-O&/
M];C/OQT[<]NOU-1W 15/EDDCWR>WT_R?7BK&!<D'.,^G'^'_ -;U I&MO+!)
M;=VZ_P N3_7)X]A%2+E3LK+=7Z[?Y>AKAO?KI3JRISOK&*TOI;Y^NOW:\M<%
MF;YQ_%P?8 8XX^O^>/K7]G1(QJ-J1C_6C'/^V.WX?J>N:^4]00$],8.,YQT/
M7VY_H/:OJ?\ 9SBQJ5K\W_+7\?O>F?Z5^=\13C3IU(27.]?>?>T?1WOTV/T#
M**<XSA[BJ+W5SM^]?3^M=#]J/!7_ "";7_KFOYY']*]#78%!X_SZ#^OXYKSO
MP3_R";7KQ&GX].M>A",[1SGC_/\ G_\ 77XQBG>H[/KM_7ZZZGZUE?,J7PK1
M+Y.T=M>WSN D.<=?7TZ^OK5M"3G/:J"@CCKGG/OZ?_7J]'W_  _K7'42MWVL
M_6U_^&_R/9PDIN34FWZ^A)1116)WA1110 4444 %%%% !1110 4444 %%%%
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M9VE0'S.N.XY]\\?Y^N*XC6VED<>42/G.,?I^7/3IU^O:NTDH)8$<?C_];_\
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M PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@""0-S_/
M&1CTZ'\JXS6PP1\^GU]:[21FPWMVX^N>?S_2N,UMB4?([?X\?6O2RZ_MHZ*W
M-'_TI6?KT?4\;,^7V<M9W^=MU\_/\S\\?VBEF:UN]F<[3CZ<_P"?_P!7'Y1:
MG#=_VM/O8X\Y@?7KR#TX]J_6C]H1B+6Y_P!TG^8K\J]7E8ZI< K@><XR!V!]
MA_D5^T\/5)*E"/+!JT?B2_N[;:V[W_R_)\VK1C-I\UV^BTNVG^GZ;LL6J2%
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M_KN?KF5N*I)^]LK6](WOT^^WWDH*9_PX_I5A2,<5GJ2<D]CC';_]?O5Z/O\
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MTY_#]!1#/MSORW\/^/7MW[G^DLENAYC'4?C]#CIGH/IVQBFQPA<^8/?G\?\
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MV$[I.VX4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMY:?\#U/:PKI-OD3OW^78?11161VA1110 4444 %%%% !1110 4444 %%%%
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MA]<=^HQ_+]:O);+@-O\ PR/T_#WJCABV#USDCTX_R?TJXEO/C.3MY]?7'O\
M7%:2C.27LW9+I;1VM^FGEH74;LKU.5]WUV^[5]/R)/.,>5 SS@G''<TOV<7
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME?L=,H4J,5)I7>[MOM\GW_SW*<,\J ;5/\_KS_\ 7Y(JW_K/];\N3GG\>?\
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MU:X ;:6F;^>G'K3@<C(KSHU83=HRN^OX?YGL6LEI9=!:***T **** "BBB@
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MNP.X/OCZ'IZ5&]S.J[%4[?8'GH?\^U-6!S\^XX[_ ,^G3]>E.^T*H\LKDX_
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I
MAC4]O\_B#3Z0L!U---]!-1:]Y)I:ZK_,0*%Z4R3VZX/_ -:I 0>G--<<9[C_
M !_^O0G[R]43)>XU%+;3MH>>>)A)]FGV]=C9^HZ<_P">U?SG?\%._P#D$ZQY
M_P!WRY,YY'*']<_ES7](/B #[//W^5A^'/%?SG_\%0K=)='UG.!^[F'3V/\
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MXDQNP<?CGT_/UJGY[@^7M..@/;ZYZCI_6C[.K_/N(/H#_+_ZWO4SH3BNCO\
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M!UP/R_SFEHHKA48IW44GW2]/\CTPHHHJ@"BBB@ HHHH **** "BBB@ HHHH
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MCJ?\/\_UJ1V23Y8^"<8^O?MCWY_*J$DEQM.\'&#VQV]JJAY0W[L'VZC\>?\
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MN>^3VYK64J51+E<D];W?DM[]?T72XIQE0Y8Q7->U[KFMHK^B_I7ZZ?G1H-K
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M.<24>6<WSO;6W5*Z%_8<+).&NG3;X=+?)=2DMP\/[S&[C. ">^?\_P#ZJ?\
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MA";]KS!,>WJ>1CK^'UZ?X4JZDUGC$6[D_P )QQ[XZ]__ *]0RZ[I XA7 YZ
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M=M[YY'Z=#T)_.K"7QC&-GZ?_ %OQ]/K6=+KVGE\H,+D'\\Y[?Y/&*NPZ_H^
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M0 M%)N'J/SHW#U'YT +12;AZC\Z-P]1^= "T4FX>H_.C</4?G0 M%)D>HI:
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M>.OR?Y[\\4DG_!.6^4YCTB<XY_U)/UZK^0R/\?[7E_9AT!",:/!C_KD!@9[
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M6^XM^!B]FK.[LO=Y?1::=;=]?GI_$A=_\$\K^#_5:3,<'_GD3^FW^6:CMO\
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MQ_G'.*_MK@_9I\/QN"^D6^-W \H<\\=1Z^N3]*TG_9Q\,E"!HUMNP<XB7/\
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MXZDK!1H\Y7@9$/I[[?0?S^E6X_\ @G7>%=S:5,#@<&(Y)Q_N@^GM^-?VR?\
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M_GRXR3CMS@^G^??K6S'\'M76/:99,\<\\<'V[4 =;_PM91C=/@X'5O;ZTO\
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M7HKM=W%/\'T[^A^0O_"O;ZUP4MI&(.?NGZ\C^7]*</!.I7'R/:. <#[I]?\
M.?ZXK]=S\!8VX-JI^J?_ %J/^%"0@Y%HH^BFG3XVC#XES^LO\-K>NGR\]5,>
M **@HMIR=O>Y=OA_#9'Y#O\ #.[4%Q:N3_NG&?RP3GT_^M5'_A -3)V?99-O
M(^[SQ^']:_8@? >/O:@C_=_^MT/<4[_A0UO@?Z&,Y_N?7V_J:ZX<;4Y0=G[-
M]%?1[?\  T7>P4N!(T8N//S<UNFU[:[;KK_3?X_K\-+Q0'-L^<Y(QW[_ (_G
MQ3QX,U2,E!9N0./ND_Y_.OUZ/P&CZ?9ACT*__6IO_"@X?^?-<G/.T]Q_G_ZU
M<<>-5&3<GSW??SCY]-/ETL$> *2;<FIWU7N[:1_S2/R*_P"%<7EP-[VS@\_P
MG^@]O_UU4E^'NHPDA+23Z[3QSGL.<^N.>*_8(? 6,=+8?]\__6IX^ T'\5H"
M<=2G_P!8_P OQKKI<<4I/1*F^]_\-O*]OT%#@*%&?/&=TVK1MI]E^??7YGX^
M1_#>_FY>UD&,_P /TX]O4#_"ICX!U"TXCM7.#Q\IZ<8YQUY]Q7Z^'X#0\[;4
M#_@'OGTZ_P!.U,/P$B;K:*?^ ?\ UL_6N:IQI:I?GYHZ:<V^J_X&WX:#_P!0
M:<Y>TE*Z_EMYQLOO>W0_(D>!=1NCB2T<>ORGGI^)[U%+\-+R(;DM9">>BGT[
M9'\L#WK]>Q\!(E.1:*/;8?ZT\? >+HUJ"/\ <^GM[<>E:TN.*=TN6W6_-L_=
M]=ET^6HGP!3515(244K:6TV7^:_I7/QX7X?:E(=K6DF,\?(3CVQ@<X[>P]:L
MCX;7D0\P6[DXZ!<]"#QZ].>F*_8 _ :W[6@_!/\ [$?UJ,_ :,];4$>A7/\
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M??VH_P"%INI&Z;CG^+VS[5P5G\%]<AQOFE/U],=.GT_SD5:NO@YK,J8260'
M'&?3![?Y]ZZ!'9?\+6!!VSY/'\7J0/6E_P"%HR#!,W''?WQ7GEO\%->CD!>:
M4C@<_7VS6K+\'M8:/:LLF<8SSZG/;TY_^O51=FFU>W3_ (<#L?\ A::=K@9_
MWO\ Z]1CXI2$9\WC_>_R*\Z7X)Z^)2_G2X].W?VZ_P"?3.POP>U@1E#+)DXY
M_//./\YK2I4A->[#E:MK]UP.N_X6L!@--@\?Q=_SH_X6D[$[9>./XO;/O7G4
MWP4U]Y PFE W'^O7CI_GT!T[;X.ZS&F'DD)Y'/T..WO_ /J%8@=C_P +5VYW
MS8.<?>]A[TO_  M,OC9-G_@7TQ7G]W\%M=E8[)I0.>F>X^G\OUJS9?!K6H1^
M\ED.".N?\/\ /O0!V_\ PM0KG?-Z?Q?7_"D_X6KNQLFR<X^]['WKA[OX,ZW,
M/DED'';MU]OI_G-06GP6UV(C?-*1UYSZ#';^?Z4 >@?\+2=2-TO'/\7MGVH_
MX6L#D+-D\_Q=_P ZXVY^#FLR+\DL@. ./PSV_P ^XK,A^"FOI(6,TI&X?TZ<
M=/\ /J  >B'XI2 9\WC_ 'O\C]:;)\6 H.)QD=MWL?>N3;X/:P8M@EDR,\\^
M@QV_SCM6(_P1U]I"WG38/Y=_4?S/_P!< ]-LOBC)<SI'YN0QQU]P/7_)KV'0
M=8;4(E<G)*@_R]^G7\J^<=(^$&L6D\<DDDAVX]>Q]Q^?_P!:OH3PSHD^EQ(D
MA)(&.?;O^/'^% ':4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 F!Z#\J,#T'Y4M% "8'H/RHP/0?E2T4 )@>@_*C ]!^5+10 F!Z#\J,#T
M'Y4M% "8'H/RHP/0?E2T4 )@>@_*C ]!^5+10 F!Z#\J,#T'Y4M% "8'H/RH
MP/0?E2T4 )@>@_*C ]!^5+11< HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH :5![8^G^<4!0.WY\TZBG=^8K+>ROZ(****0Q" >H_S]:38/>G44[M
M;-B:3W2?J@QCH,?A1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 F >H'Y48'H/RI:*+@)@>@_*C ]!^5+10 F!Z#\J,#T'Y4M% "8'H/RHP
M/0?E2T4 )@>@_*C ]!^5+10 F!Z#\J,#T'Y4M% "8'H/RHP/0?E2T4 )@>@_
M*C ]!^5+10 F!Z#\J,#T'Y4M% "8'H/RHP/0?E2T4 )@>@_*C ]!^5+10 F!
MZ#\J,#T'Y4M% "8'H/RHP/0?E2T4 )@>@_*C ]!^5+10 F!Z#\J,#T'Y4M%
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M %%%% !1110 449HI73V:^\ HHHI@%%%% !1110 4444 %%!..M0&YA7JV*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1G'7BBJ-P)<?)G/\
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M0.OVVW!Z#_IKQ[>W%<M>^+O!L[ED\6:5@L#_ ,?\';V\S_/YU_G%?#GXG_\
M!4WXJV46H>&M1U^X@FC612CWS?*X!!X?W]\]Z];&@?\ !7W_ )[>(O\ R?\
M_BJW5IQ3U7Z:;?D<\:TX.]E=VW7;R^1_H8Z=XZ\$VJX?Q5I+' _Y?K?_ ..?
M_J/-;X^)/@4 #_A)]'X_Z?K;_P".5_G7_P!@?\%??^>OB+_RH?\ Q=']@?\
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M6O6RIYXPY[<G^5.SM>SMZ$J46[*2;[7]/\T?Z7)^)'@4C'_"4:/_ .!UM_\
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M*/*[73] G#D=KI^:'4445) 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!!--Y8)QT&?TS6)-J3.QC QD#GG]>*WWC5P01U]O\ /X55
M^P0;MV.?H/\ /^<=* ,2.SFG8.&;@_TSZ_CTK8AMWC0@D\#_ #^'M5Q(UC&
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M3_!70=%MK?XB^'M&U6_$40DDNHX78N -Q^8?YS[4JE*$5>,U)I=/1?\ !O\
MY[S1C46LI\T7LO\ +[C^?#P__P %[?VO[G4H8M0\ >)H+=I5$DDEI.JA20"3
MD^E?JC^SQ_P6*\1>+/L4?CAWT>:4HLB7K>4P9L Y#M[G\J_1/XM?LJ?LJ:;X
M.U6[TWP9X<AN8K.5XWC@MPP<)E>G<8]<D>]?Q#?\%(?$TGPO\=W</@.Z&E6\
M-^!&EHP10JRXQA2.W^'2N&=6&W.DT]O^#Y';2G"#]^/,O^"K_@C_ $'?@?\
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M_(5:)P"?:L?3(Y%M(2V?]6G)YXP/P%6IKU8LC'/^?SXK)TFY<L'S_P!+_/\
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M(/V]-1^-NFZ=<7NFI:M<(K$")5QE<]L8^GU]L?M+X6\41ZC!',^U%958DX
M/7V]>O&/>OY:/^"9FEQ?V3I#6D8C41QD #'\/M[?RK^C+1[B73O#DS[\.MLQ
M7GH1'GZ\=?7'/I3Q.7SIJ\9779;=._4,'F'UF:7,M;>Z]6MK_P!6^9ZWXJ^,
MO@#PC!,^M^(M/L6C5LB:=$QM)'<Y[?TK\N_VCO\ @HYX9\#QWG_")Z]9ZD\/
MF!%MIT?)4<8VMU/:OYZ?^"QW[1_Q/\&WNK6_AOQ->V #7*J()V0##-C[I_+_
M /57Y3?L,0?&C]HOQ!;6^M>(-0U..XF3<LTCR@AV4'.[.>#^M>34IRLXWY7?
M>U]FK]'^70]<_<OXJ?\ !;7XX:)<74?AOP_JE^J.PB-O%(X(&<=&/7&??WKP
M?P]_P7C_ &F'U#9K'@_7;2V\TKOEMY47;D<\MC&._6OV._9V_P""9VB2:?IU
M[XP\/6]^)88I'-Q;ALED#9.Y2><_ES7M7QP_X)??#37?#\D'A;P?86M\;? >
M&T0-OV8SG9_>S6<83A&SGS/373R79;6?0UI-<ZYOAZ_>OST/B']GG_@LCK'C
M6^M+;Q5<'3A(\:R"Y?RRNXC.=S^__P"JOW:^$/[6?PQ\<Z7:RMXMTMKN94)B
M^U1[MS*#TSGJ?\>E?R3_ !N_X))?&WP]?WM_X1>_T^,.[Q?9D=0J@Y&-J?S]
MOQX?]G/]E#]KGP1X^MH]3\3:\;"*>$>6SS!=JR$'C;W /'^)K&56<)*/(Y)O
M=]-OF==:E&<4Z4;[7?;;\_OOY']:7[:&N:9K/PFUN?3KJ*YB:TE*O$P8',+=
MQ7^:S^VRSK^T4"@)/]O2],_\]'K^_KQ?X>\4Z7^SY?6WB*YGN+H:<JNTQ8DD
M6S@]0#R1WK^"?]M'3?*_:($T@RJ:]*S ]/\ 6-_G_(KJA)^ZUHW;\3SW=.ST
M>Q_4'_P2*U;58_"^AK%;2,HM83PI(QL7T^E?U+^!-1N#:02W:F(*BEBW& %S
MC\,?C[U_,;_P20^(7AG1/"FB0W=K$SBTB4DCOM SSQU_$?S_ *,;[XHZ')X7
MNIK'9 XLY"G(7!"$CN.0>E=-\1.*7O.-]-+VVU_KS-(T*DO>4'KUVTT7]?,]
M0\5?&?P!X2MY6UCQ%I]D\:,2LTZ(<KTX8^W^17Y3?M)_\%%4\%I=CP1?QZNT
M>_RULY!)DC.W&UOP&*_G4_X*[_M:_$;P7JNKCP[XDO;.)'N=JP7#@8!;IA@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 (P)! _SS405CV/X\4V:;RQG'<C\?\_\ ZZHI?EFQM(]>
MO _'CZ5RU:4)S4FVFFN_D;PHU91;BE:U_/\ JVO7Y'YS_P#!0Z?R/ACJS9Z6
MMW_Z+']/Q-?YQO[1&C:9XZ_:#?1=2VF"XU.XC<'G@W*+WZ\-_P#6XK_1F_X*
M)QF?X7:N 3_QZW?MUBQ_G\Z_SFOC)!'IO[2RW4]PL2)JMP27<*/^/I#U)_/K
M75%?#%:[)/\ (Q::;3W1_1A^P?\ \$7O@%\;?"&GZKKMI"\MQ9PS,3&#S(D9
M/\0SR?Q_E^F(_P"#=3]EW )L8.@_Y9#_ .*K%_X)=?M >"_#G@31[6^\2:7
MRV%JA66[MU(($8/#2#\<_P!37[J:3^T/\-K^-=WC#0AD \ZC:C^<W\_UK:="
MI3BIR22?GZ=-^HK_ (;GX@-_P;M?LLKG-E ,?],1_P#%4Y?^#=C]EINEE!_W
MY'_Q5?N/=?&KX:D;AXST+H3_ ,A*U'KQQ-CMC_.1R&H?M(?#C2R0/%^B-@_]
M!&U]?:7_ #QS4.$E'F>S_K^N@'XWQ?\ !NO^R]%(LBV,&5.1^Y';_@=?:WP
M_P""67P9_9^N+6X\.6\4;6I4IB,+]P@CHWK^O>OIMOVMOAT#C_A*M$/.!B^M
M?7OB2NIT3]H'P%XA(2+Q1I#%C@%;VWR<G..)/\_G6M*@Y^]+X;;I_G^ 'O\
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MO!-[+XGL-0O(H[&0W06*:0+B/Y^BRX[=/PJJ<)1U<F^MGLMEUU=OZV _<?\
MX)@Z7\,]%T31E\/W%K,%CBV;1&>,+Z,W^37]!NFW-G+;PB )C8OW0/0?T/\
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MPK#$.ARI4TM/O;2BOPUO\_,K77\NQ_F\?\%%O^2]?]QX_P#I0:_J4_X(D?\
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M-P=M6KWZ>HZ--XB5I2UN]>O3^OZ1^47PJ^'GA;5]11M5\O)E4MO53U(]>_\
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M^"M=T<RZYXA/X7__ ,EU_H^6NB:/(N7TBQ_&WCXX'M^G^3I?\([H7_0)L/\
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M"3?QE\-ZGYG@#2)[2*-\H8+=EX!_V&7CIQ[="*_67]@G]FCXY?#>.TC\9+=
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MZ1# 6UCC_P!U%7T _G[=NO0]$OW1_GO0 ZBBB@ HHHH **** "BBB@ HHHH
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M>WCC5P\3)@JH![G_ ":_?)-,TB<[S96LC>IA4_S'^%7HK:SMQB&&*(#GY$
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MN(!_*NR%.%-)022MOW,;MZO5G!^%?AKX;\*0Q)I=G'!L4 ;55<8'LH_&O0P
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M*_P@=AQ^MCX6_L:_\%-=3UJVM?&NI:[<:6[JLR2K>%2I89!WW3#[OMWY]_\
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M15NR\DOT/D7XI_L;?![XIQ7#^)O#]K>R2AM_F00OG<#G[T3=S_AVK\B?C_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MOH]'I?3I\C*ZYO[O]=T_Z^X2?Q''#)L.3@\>_)[]_P ?RK8L]16Z ('7M_\
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M\]L]_P Z]:\!?\%(_P!FWQQ)&F@^*;&X:7;MV7,#'+8QG$I]?TJG"2>L;/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSFMM,@<_YX'Y?2L#E'4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1KA\\DX]/6OU]\'^++3Q=I-MJMF08;F,2*?8@'\?R]_83"G&'PH+G6,5'WB
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MA7A_[*#W5U\,-$+%MYLX\Y_ZYISU]?S [5]#3V]_%*9))"J<]6P,9SW/?UP
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M(I^HH$:+T11]!3Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@!#T/T/\J_!/_@KS_R3S6?^P==?
M^@/7[V'H?H?Y5^"?_!7G_DGFL_\ 8.NO_0'H _@W^"J(_P"U#*&56']KP=0#
M_P O35_H$_LM?"O2?B'\"K'2;JU@99["!3F-2<-;[3V_^M^=?Y^OP6Y_:@E_
M[#$'Z7+FO]'W_@GA")/A9HP<*P-I;'!_ZY+[4:]@/Q+_ &O_ /@DOX1>\U/Q
MQ9::AO8))KJ/9!@[SEQC"#TZ_P#UZ_$G5_CW\8OV5?&]IX>\/V=_%IMK>I;E
MD\Q5$2,5SQQP!S7^B9\1?A[I_B_1+K3WM(G,\13E >6!'H>?RK\ OVO_ /@E
M_#XICU7Q-:Z;'OC\ZY0K$,Y'(Z#^5;T8QD_>GR;Z_<O^#]WRB<(S7O13MJK_
M .9>_P"">7_!0&T\6Z5I:>/M:CL[F2.-66YG"G<4Z?,W)SCZ<\GFOW'?XD^#
M/&OAV>31M4M[OS;=L>7(C@ED)[%N?U^IK_.N^/$GQ"_9E\9IINEC5;>&VODC
M_P!'6=4"^<JD?(H[<5^^_P#P3<_:AOO$GAJUC\2ZR\+&&,$7L^P_<&<B1QT]
M^G7I73[%:.C4YY=MK[:WZ6Z_B<56M&GI5IJ--/\ R?2[Z_UH?FW_ ,%O;=$U
M'564\&6YP1Z9.,=A]1VKP3_@BH2?%FDY)_UL'_HR.O7?^"S/B;1-=FO39ZE:
M7!=IL>7/&Q.?97/\Z\O_ ."*]J%\5Z200098,$'/61"/_P!?/TK*IAZ_Q33^
M?R^?7SU-:.)PTTHTI?AZ+]>FQ_H4?#'_ )%/2O\ KRMO_1:UVMU+(BDH,G/\
MLUQ?PS&/"FE#_IRMO_12UZ"5#=0#7(=9RCW,[NRN#M]\_P#ZOJ/_ *U6H8+9
MF!8C/4YQU'8_C[_KS6G<6JR9VJ <=NO^/'7/^-9@TR8/NR0.>_KF@#E/'_P]
MT_QYH5SHUV1Y-S&4/'&&!'\C^?XU^*WQX_X(<?!_XVZO/JFKL@DGFDE;*]W)
M]CZ_YZU^ROQ1\>GX<^&[K6&C:7[-&7V@%LD(3V_W>??WK^>#]IG_ (+O)\#=
M=NM*_P"$>O)S!<2192UE;[A;N$[;: ,P_P#!M3\ #SO3G_9_^M1_Q#4_ #^^
MG_?/_P!:ODS_ (B<(?\ H4[[_P  I_\ XBC_ (B<8?\ H4[[_P  I_\ XB@#
MZS_XAJ?@!_?3_OG_ .M1_P 0U/P _OI_WS_]:ODS_B)QA_Z%.^_\ I__ (BC
M_B)QA_Z%.^_\ I__ (B@#ZU7_@VK^ *LK!TR""/E_P#K5]=? #_@BW\(O@+J
M%MJ&DR('MI%D7C'*\^G?_/6OR23_ (.;XF95'A.^R2!Q93^O^Y7W3^R]_P %
MJC^T3JEIIZ:%>6OVJ81Y>VE3J0.K(.WT_'O,M8O2_D3/6+TYO+N?OYX4\)6'
M@W2;;2[!@4MHEC4KTPH Y/X<?RQ70?VA?(V$1BO;&>><X_R!BN*\!Z]+XHT6
MTUE@RBYA27:01C=R<Y'^37HMO>0@[#$">F2HQGU]^N/K6$*$F^:/N*^R^77\
M3SUI*\G[+;2-[NUO/Y_B.M[R[?&]#WZ@]NG^?3\ZWDN1%%YDWRC +$_0G_/K
M^M/MQ#(,A5SC.,?K_GWS7 ?$O66T+P_=W<2MF*,M\H)/"Y[>W%=#=EZ+\3TH
M6DXJZ:=M?Z[F)\2?B3IWAW0K^XAND6XA@=D&X9W!<CC/KCWK^9G]M?\ X*$?
M&KPOJVH:-X4@O)[:25X%,#.1M9BAZ'G /TYZ=J]'_;'_ &W-:\#7.IVL=E?S
M)&\J82*5P0N?13_^KUK^>+XS?\%&(_[7DGU#P==WA2?<Q>PF<G#$]?+Z\'_/
M7RI8VM*;IPI7LTM/E?\ 7?R/7I8:C3@JM22?EOVZK[S[$\-_#+XE?M<ZC'>>
M+].OP;J8%_,60_ZQLGMCO].,U^[W[&'[#ME\*+*"XDL,,D4;'S8NF%4]P/?Z
MU_-Q\#/^"VGASX:B!6^'LX,+*2?[,E'*XY_U77O^?M7V[%_P<GZ1:6;06W@F
MZARFWY;"48^7&?\ 5^O^-;T:$W)59WC+1V^2_K;I;0\^O*+D^2W+OI^'I\NG
MJ?37_!6;3K2PT?4H8H(D*>:,+&.,*PXP/6OQH_X)[7=W'\1H1 K'_B928QGK
M]I(Z?IV/\Z\#_;@_X++)\=X;V,:)=6HG:0_/;R)]_=_>4=/3T_"OA[]E'_@H
MU!\*/%D.KR:5-<[;TR[5A=SS*7Q@+[_YZUTNF^=/VK\XZ=U^=O/_ "P/]/#]
MGV_UA_"6CB6)POV2'D@]-HS_ $^E?6\5K]KM0)N"5Y[>W]?Z=>G\H?[''_!;
MRS\?6NCZ GAJYB($,&\VDJCL,YV?X>M?T-?";]HE?B#I5G?+:R1"X16"E"N-
MRCUY[_\ U^]=$8RDMK*^KW_'M]W4QJ5H4]&US/9?Y_>>1?MI_#B^UOP'J::1
M;/<W#03[5C4L<F,X &#G)SV_+%?PM_M'_ KX\^'/B_+KEEX3U(V4%]/)YPMY
M=NWS@0<[?0?EP*_TBI1I&MV6[5DA:!ERPG"A"& SG<?Q.?Y5\P?%KX(_!'QG
MIMW:-9^&QJ$ZL%8_9?,WL"/7.<G\ZKW8]I.^SU_X8SM5JNZ;II;>>S_/_@'\
MM7['/[;OBOX.6.G:5XIG?2Q#%#%(LTGE8VA0>&*^G]?2OWA^%7_!3/X.ZM81
M1ZUXTTZ*\>/&R2[B#;RI '+]<X'7^=?G;^T'_P $B=8^)5]=W7@R_%I'-([1
M&QD50 Q.TKY9X&#QBO@\?\$&?VA[?7H+ZU\9Z[#;Q7"2%$NYE&Q7#'H<=!^/
MTJY5HR22I*-K:K?2WW]>B.F*:23=[=3^@KXG?M<2>+-%OO\ A KX:I%+!,(S
M;2[PV4;H48YXP<_3TQ7\5'_!6#Q3X_\ $>K:D^I6-RH:6XY8-T+G/)'IZ5_7
M_P#LN?L,>)/@AX2\KQGJ,NIR6UNWF&]D,A;;$?[Y/.<Y_K7\YW_!8[^P-&U'
M48H+*#*M<#]W&IY!(ZCKZBMZ4X22BURZVYN^V_Z?\$&W;:Y^>G_!+CQ)XOT#
M7]--I;3Y$L/0$?Q#W!R?_K5_=I^S'\1_%FJ:7I,>H0S!/(MQEBQZ(OKQQ^5?
MQM_\$I+2QUWQ!IJ_8%.Z:#_EF.<N,'&.W^<U_<Y\$/!=O::)I;QVJQG[/ >%
MQ_ I[ ?U]_?=X7$2CSQJ-TE;]/S6JTZ&BC146W.T]K6]+=;>GDF?9^B7+3V,
M+R<,T:D]>N!6U6)IEJT4"  @!0,=/;(/X=*VE& !7FSBHNR=W?\ K;;^K$"T
M445 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!36)'0?6E)P,U@ZAJ_V/.03UZ#Z?RR/_ *^>(J)N.DG%W6J]2X0E-I177S-G
MS0OWB,>O>CSXR#@]C_+WKCX=7:^("@KGCH1GGUS_ )Z5MV]M*!N))XSCTS^'
MX?AGZ\<)XB$U#E<XWUD^UK==_P"GH=+P\(1;G+EETCJ[[?UY7]#\/O\ @KF<
M_#C6L?\ 0-N__0):_@A^$Z(_[4DP958?VQ;]0#_R]25_>U_P5P4K\-]:!_Z!
MMU[_ ,$O^17\$_PE_P"3I)?^PQ;_ /I5)7>MD<CT=EJC^_+]F+X9Z?X\^ 5K
MIDEG%)Y^GP)_JE).ZV=.R^_^<U^/'[8G_!,.SBUR_P#'-AI3&YMIYKI=D)&#
MEG'1?7OG'.*_H._X)UP13_"O2%E0,#9V>01_TR_S_P#JK[7^)WPJT7QGH=[8
M-I]N[W$;+DQJ>6!'I710J1A)<T4U=7_!?Y].K8GJNWF?Y\NE?ME?&O\ 9/\
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MJ5*:IP7N.WO\UF]OS^\XYX:,*SG&3DM/+2_SOM_D>;?\$52?^$QTKKCSH?\
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M=:/>2QA;F"2$YP>'4CT[9_+GI0!_F3?!5&'[4$I*-C^UX>=IQ_Q]-[5_H_\
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MK!&&((HX^/\ 84*/Y5T6<]*YT]4^UOP-&N9-;7ZE0;\\XQ_GIW_.K*YQS_\
M7_&G44Y2YK:;&=.G[._O.5^_3;_(Y+Q;X/TOQAITVFZI$LL$RE75@""",=_8
MG/UK\Z/B;_P2F_9P^*=_+?\ B+P[9W$TLC2,SV\3?,V<]5]S7ZB45)J?BO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ4^N8AENU<@J<#C\!_GO70PEBHSGI^O'Y?3\: )J*** "BBB@ HHHH ****
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MY_6IF8*,F@!:*JM>0J=I89^OT_QJ9)4D *G.: )**** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MML*0QR?_ *W?Z=._%:UO,LZY9?KD?CW'I[=JG:SA<Y*@_A4T<*1CY1^G^?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*#4C,P#*><=03UZ#ZY]ZUXU1AG:.W;Z^PZ>]1I90H054#&.WI_G\ZM  # %
M"@8Z"HY4+K@?_KS_ )_STJ2B@# ETN1W+!S_ )_I6C:VS0@ D\>OM^O^?;F]
M10 4444 %%%% !1110 4444 %%%% !3&1""2H/%/HH Q[F[%N.$]A@=N?;IT
M]*;;:F93@\>_\NHK2DMHI/O+GG/(S6/<V3(#Y0P<\8'^'?\ 7CCM0!N)(K $
M$<C/6H9I_+&0.GX]^O3_ #[UBVL5VK#>3@?7T_SV/ZUNK$&0!QD\_P"?\_X4
M 83:PZG&UOUS^/\ 2G1ZN[L!M/7T/\O2M1M/MVZKZ]O6E6PMUZ+WSG% $T,O
MF <=?\*D==RD=*545. *23<4.WK0!@W5B78N),<\\^V?;^E4UG:SP.3C'OGG
M_P"L?R^AJS=17C,?+)QZ#/I_GT_2GPV3,O[T9/Y?SSS^O)H LV^IK)]XXY[D
M>U:BRQOC:ZGZ'/;-<'J>GWX)^S;AW&/7 _S^=2:1;ZFC#[0S$>^?\3[?GGVH
M [RBF1[@@W=:?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !28'H/RHHH 6BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@!,#T'Y4M%% "8'H/RI:** "C&>HS^%%% "8 Z ?E2T44 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %'7J*** $P/0?E
M2T44 %%%% !1110 F!Z#\J7IT%%% "8!Z@'\*, = !^ HHH 6BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
0@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 0V!WL# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOK6_MW&5FM)HYXF!Y!#QEE/'/7IS5^OB#]B&X-I\'-#?4+J8;;2'=)?2 /\
MZE.K.?S.<9)Y/%:?QZ_;U_9J_9QB=_B;\0M%T>102MN^H62S2-V1$DG3YB2
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M$,5LK2Q+;QMRQ:7( Z'K^?X5Y!XZ_:$^$WPRT^ZO/'GCCPWHT5HCO.MSJ-O
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M9:[874A[ !8[AV/Y?K7\J7_!7V]M(?'\WG:Q-99N)/\ 4W,L9 S)TVG''/\
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MR_/8DHJ,2QMT85QGBWXC^"O VG7.J^*?$.FZ/8VB-)/<7MS'#'&B#+,S.P
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M/5W6W3[C\#/^"-/QH\0ZY\5+CP[-JGB+[):72P16=W>WTMK$J-$H6-9 (@H
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ML9VLNW(((QM[>O\ 9W^SW^R3I7P"\+Z7X7L?&.L^([;3((X%FU.*W6258U"
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ML_\ @G7X0TD_M0>)R+>UOH_^$CGQ:SVBW,48-PORA&5P ,' P/R%?W^_LO\
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M7DK_ *Z>0S^6^PNOAE9?MM7>F_ >[GAC36"MC!X?@NK>P %W(%$;01K;A<8
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MI:4RE!(T'FXR<?>Z5^E?[.G['/A?]G>U@M]%\2ZOK9AC5/,U".%&?"[=Q$8
MR?\ .*YX9>H5O:+52?->]^75/X6HKTT=NZ.9X6,JG-.$9.]U-<ON[:.,XN^W
M1G:_$'X,?#'_ (16YM;;X;>$0/)8" :)IP7[C <>2%]/PSTK^+[_ (+$_!/P
M-I>KVY_X0#P]I*27J9:RT^PA+!I%SGR8Q_C7]VNO:,VMV4ED9VMPZ[?,CQN
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M^9O8\_VMJ$)W9'4\Y!)YK^@;1?V;?^"R-M#'%X=_:=_9E6WVKM73?@Y\/5C
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M"OZ9/"W_  ;4_L\#Q)#XC^+7QF^)?QDF$BR75KXJN%2WO"&#,)4M)(E ?!!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTD<UO"Z.A'(8'&.:?LI--^[9?WEU[=R.>.MFW;=)-O[K?UMN?T%T5^!&F_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC1\)#T^)/@HX_P"ICTO_ .2:KZACG_S!8O\ \)JW_P @)X_ K?&81>N(H_\
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M/Q*\,?"5=9\,>.]>TJWN;.22(^']3NK/S%99L >7(H((_P#U]Z]V_P""=_\
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M?^"D'B9M=_X5%X"^"WAO4I6-W;:A\2/!^MS0PS'GY[K^SIB5!QPO4=J^X?\
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M,6E__)--_P"%T_"/K_PLKP5C_L8]+_\ DFE]0QSVP6+_ /":M_\ ("^O8/\
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M HHHH **** "OG_]HM[Z#X<:Y+:3>7(MG+M.\KR%;N.?Y=/I7T!7@?[1N?\
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MEVE]/.+NZL-+O)D;<MU;R7$UPA'.]6D/WQU^OTKH[;QWXY:%=.TGQUXTTX(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS6G4%KRV][1:4_<>RWO&S^3A?MJ"LI7$3(IQT:,EN/\ :]<<'GMWH43(297
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M.Q5D"H<<\,!Z_P" I;>S5UT]UQO4ULK>TO:[Z/3TN"UY;6;5M(+D?3JXV_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"N[F5U/'RR-N?J/E!&0">G_UNKF9HEX25QSR[!HSC_9]/\.N.:8T5OGEMA)
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M*[OM\I@0<9BPC=^^?_KG]*'@5FW&9D8'[CL2_P!,C@'_ #@]*(VG=L21@J"
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MBBB@ HHHH **** "BBB@ HHHH ***,]N]%[;Z %%%% !112$@#)( ]^*+VW
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M_P#X"I:!_I6>=NS/;/EYR<=><8QC\*1_L^!Y@C+<<0\>O4O^N.^:7RIPV\R
MKZ\8.>^S/OTY'\J))80 '_>]/NHT6/J<>_\ G-#LYPUA>VT=*O3=[<U^KLF]
M>X1>L7'WM%?V*<6M$M6U9>=VO04?=/D>1GMNW>;_ )].] \[_EMY>WMYV<8]
MMO>E!+KB*0)T^0Q9QD'C><=C3426/)DD '4$KYH/MCDC].O.*6T9\VFMOW]I
M?R_#;;]&+36[2=]$U+VCU6VGWVOW&G[+NX^]VV8\O/OGD_AVSVIY\[ \CR<9
MY\G.[MUSWQU__53#+;EA\A8YQOP5 _X#@9P.<8[>]/999 /+E##TV>5T[@\9
MSTR?PSTJM?W?Q<MEJVO9:6^SO;\V/K&]TM-:MVNEM4K+_MYQMH'\/[_R>G\6
M=^<^W&<^O_UZ8OV?<?+"Y[^=]S.1Z<^O!YQG-2;O+7$L@/&-OE;CQZ-SSGG\
M>OHQ)(22$7RS_>*F3GOQ_09_*I6U3E]ZS7\#W5TO>]MNKUTL"NT[*37>-^35
M]FKM>4>;IL.;[3GY=OEYY\O.S'&.O.,YS^-(_D_\MO*W=_*X;.><[N,^O;/3
MBAHYRV\2!ESDG 3(X_@R.F.@Z]P*5Y(E&)")2!@A8RF,'^\!^H^OI0_BIWY+
MKI_R^UMO+^;[MQ+I;7;^'=2WCHVXVOZVZ FW!\CR<XX\W._IVQQCU[>G:D'V
MCGS-FS_IIG9[XQSU_''7O3D<,N(G$7&0IC+GJ/XSCK35CF0EGD 7UP''TV<G
MG],<4WI[3FNO^O[4ETMRV^?=6W\GWORI]%)-U-U\+2MI;3EYOP&M]FSSC=G_
M )98VYX^]GG&?QSCO3_GQ^X\C/\ L9\WVSVSGT[4UI8">4\PY'S!2@!/&<=Q
MGMWY[<TYM\@Q%(.F OE[/_'SU(Z\G'TIK10^)K35->RMINMVMK]Q_P K:DMO
MXEW'I?:.BUO[W+^-P&['[_RL9)/FY+YQTX_KQ_*F#[-N^0#=@_?QY9XXZ<@=
M/Z<5(NZ,?O74=B-GF=>?O8/T_#BHQ+ 6^5"C?WR"PR1Q\G;K]?H:2^*HXZ]?
MW'NRZ;W_ $O]VHE?5I2M;>G=0Z>6NWV>;]![?:<_NMFS'_+'.W'?[W?I[?I2
M-Y6/WWD9Y^X#YG;KGC/K^O-*\<SD,DH9?9?*X]-N1_CZ9ZTK/&JXD82'^Z(B
M#SC'S8Q]#GGUI:?ND^5--64U>KTZ[=/RMYB^S;5]H*2FME[S<='_ (N4:GE?
M\L?+![>=R<Y_AV\9^G\Z!]I_BV[.<Y_U7^.,?_6H22-AB(^42>,H92??)''/
MY>W6CRYPV]I!MYRP /;_ )Y_X#G/M5?:GS72MO7:E'[.UGH^HGNT^5/HIIN=
M]-%I9];<KEJD-?[-QOV[L#_4=/QW<X]>^.G%/&=O[GR,^X/FXXSTX^GO37EA
MR Z^:WJJF, CV[^X]O7BGY+KB*0+_L^5CJ>F_M^'Y>BBGR0?OVOO%VI)66Z>
MK7EII]XW>T;J2U^W=QWZ)1YDO-I7$7SO^6_E\GGSL].V,<].GO\ A3/]%W#
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M9^PU%?C9_P /\O\ @EZ3M'[1-B6SC \/Z\3D_2QKU[X8?\%?OV!_C#JT6B^
MOC3::QJ,S*L</]CZM;;B_P!WYY[6-!D\=:1+:6K:2[O3\S]-:*Y'PSXY\,>+
M[:.[\/ZI#?P2J&1X\\J1D=O3M76,P49/\LT/3?2W?0%*+7,FG'O?3[QU-9U0
M99@H]ZSM1U6TTVQN+^YD\N"VB>61F!&U(U+,<8/8?6OR!_;#_P""K/@#X$:5
MJEGX*>T\5>,+(2HFBFY^QEY4W *9;BVEB&74KDYZ<]Z(VDKJ4;='JU_Y*G^A
M5/EFU[RL^M]_G9I?,_8?[9;?\]5_.K"LK#*D$'TK^./PU_P4=_X+(_M;7MVG
M[,?P>T#PU9I+(L%S>ZUX.U$,@+!9-E^EH>@W8/TKI;G4O^#GO0)/[8N%\&ZS
M9)\YT&+3_AY;R.HYV"[%\V"1\N=IQUI7U=O>MVC)7T3^U;778UK0A36FOG[2
MG)-*W9JVO>W^7]=\]N9?F^T31 ?\\V _F#4<<]O$1$;DN_\ MG)_E[?YYK^/
MI?\ @L7_ ,%+_P!F#5K'2OVQ/V>[:V6>XBMWN[+Q%X>(8,ZH9!%I-I<XR"&V
MYR.A/>OZ$/V1?VX_!7[27@S3/$5Q9OH6J7\43FP:*:X*-(H.WSA:PJ<,?3\:
M:U]>L;KF7JDV<4<13E+E;Y7TYG&SVT34FKZ[;GZ!@Y&1R**S'N/.B26"\BA1
MP&0R*!E2 1PQ&.#Z"K,4FV/<\RS =609_'C-!NM;6UOM;6]]K%JDP/0?E7BW
MQ,^.?@KX8:==7_B#4H+46\,DNR=FCW% 3C.UCDXXQ7\Z7[2__!?SQ#HWCZX^
M#OP ^%,_BKQI=S26>E:B-56&U:?=Y<9(N],-N 693\TV/?O43<5I.+;[.-[?
M>=4,'6FKV45:_O.VGFM_Z^9_4O41C.<^8X'IGBOY#(_B+_P<L_%B)-?\">&O
M"7@/P[J(%SICW9^'VKR&UF&^+<DEW#(#L(^^H;UJEJGQG_X.1/@98R^*OB9X
M.\*^/O#>F*;B_2RE\ :-)+#'\SJOD7-Q*N5!^XI/YTI.%DY*2[>[/3;?E6BV
MO=I=VC&K0Y;7<)I/[%1/73HGS=5NC^OR8W.,6QB+?]-<_P#LO.<X]JJ*FIM@
M3+9D'KM#]/;//I7\Q'['W_!=KXL?$?Q:? OQ]^ P^'VH65P+*^U67Q9I]W%)
M,A5)9%BM=/C103DX60]@".*_>5/VHO"=WX"O/'>EQOJEI9VANFM;!9;J1P$W
ME4,,#L3VX0YK&-6#UG=M=-X)6WNY.-_^WKOMN85*D:>C:OV4H\W36S:DU\M-
M?,^C+NWAB7>8[5')RQD#;<\^GK5FQV% 1]G/O""1WZ9_#\*_FN_:!_X+5?&^
MXU74?!_[.'[,?BCQAXALYI+19+N2XTRW>8$JK"35-%6#;D@G$A'OUKY6LOCC
M_P ''GQRSJWPQ^'_ (>^%.E2G?'::JG@76)$C<Y3+74UJYPN."H]N:U4E-72
M4X-VM976BWYFEI?7LAPG&:YHNZ[ZK5?UZ']A6 .@'Y4$CH<?C7\B!\>_\')W
MPE4:WXUT_P )_$VQC_>S:186?@+0I-B\NGVF.[G))'0[?PZUT'P]_P"#@3XV
M_"OQKH_PP_:R_9OU#P]XLU&[BL&GM->AO8DG=O++_P#$ITB:'&0__+0#MGH:
MNS2M!*.J^R^7IO:RO;K<H_K,\F/.=@IAAYRC,GL.G^<=*\"^'7QUTKXE_#C2
MOB#:I/HEIJEE'>I;M;S7;HKH'VG]RCDC./N#/I7XQ_MN_P#!;BY_9D\3M\./
M"'PFU/QWXEU"=K'3=3%W/I4$=R^Y(G:.?2I8B-R@G=(%P>31RJUK67E[OY$.
MG!_8C?NE9_>K/\3^AI1,#@E"H[G.?S]:<WFY&W9C/.<YQ7\?%Q^T7_P<-?'J
MT7Q=\ ?#/@[PSX6U4?:-+@O[SX?W]Q%!(-T:NM[<VUP2%/.Z-22.1S5O2_'?
M_!RI\/;*;Q-\4CX(U31=+C:[OK.&W^'EG)-;PC?(BR07TCJ652H95;J#C--1
MLN5.7WW?HF'):+7/)+>[EJK=$W_3/Z_'E2)=TK*OKUQ^'>FQ7$,W^KD5_H:_
ME'_9N_X.!OBQK7Q,A^!WQL_9OEMO%-E<)8ZCXDMO%EG+;23!S%)*ME9:6T0^
M9"VU9R,' -?TI?"GXOZ9\3-,MM1LM,.G?:(8Y3$S,Y0NN[;DQ)GKUQ^=59JW
M7Y/]4BDW:[3BN\G'7;71ONM['MF:,YZ<U5E,<HV_,3ST.W/I^'7TI+>W6+D!
MQ_O/N_/O],],57+'ENW)2Z+E6NW]Z_?IV)52$I<L7S=;QNTO)R2<4_5ENBBB
MH+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1\^_^>G![TDDLD>!Y)VG_GH1)U[ @\$\=?Y4XKYB982(.3GS/DQG^[GWZ?\
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MC%73UMRVC%;]):)_)W78(I(VXV2Q^I@0,>G?=^6..O3BJ[X\T8,IY'WE ?\
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M?P./\_E7E5K\CWW6W-??RUWU/7CM'T7]:Z?H.'^<T445<?ACZ+OV\QA1113
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MDQQ^7Y\\58CGBD^[)&Q[A6!YQS4C*KC#*&'H14:6\$9S'#&A]54"@":BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3E9=PQW418_ <_A46_,I&QQC&"!^\_$=/PQZ=NLDD6XY,K+Z"<C=GVQWY_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG/E,93Z+)Y6/J6(R<9)]15>17$N'5@<\ R!C_P!]_3'^>DZ1P,/W;Q_]MWV
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&::D<D>2TQ.>OEKYC8]\CCW./K2VC._N:_\ +VT]/=VMM^H7W5XWOLTW)_\
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M<4K,X_<NA''$:E#T[\K_ )'YA9%4B=HR?3RR7S_O '\/Y4/'++@B8^P=1'T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[M-V3=U[SERRZ:\G?K;7L+I%V2UWC)2;U73FM\DV^Z".+9RLDDF#QY+#GO\
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MX+ECT_FY5?YZO97T>N&^)Z.UGY]+;KFBTKO[:>NR*4 )E('VC.[_ )9L _\
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M._X.$?V+_P!DNSNXHI[GXF:S;K)&+#PC-I\TB3ID;)$N+B#HPP<'.<<U^O\
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M./7\Z]YB615 DD\QNYVA<^_'^?Y!W?Y?AM]PW3BTE9V3NM7H_6X1^;CY]OT
M.1^?^?ZR49QUHS4I6ZM^I25E:[?FW=A11G/3FDR.F1FF.XM%&<=:,T %%&<]
M.:* "BC..M&: "BDR#T(I<T!<***,T %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8(6V*$#C^+'^?QJI'$C#+7 3CH4)]<?YZ?3DU^UYB_\ 9HZVNU]ERV2>RO\
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M^WZ]]A?=>_52Y^FWNW?R31'_ *+N&/O9& ,>7UY.>N.O3M[YI[>?@>0(L?\
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M\_,!7'5UDK2;UBK\O+);=$K_ #MMUZFF'7O/IY=;66J4FI6^5NG8HP[3*?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ML<G/8_Y]#6E7Y#7O[6>^_7^OZ]3]TP2Y<-25TWR1O9WM[JT84445D=04444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5X)^T9_R3;7/^O2;_ - ;
M]1V'?]*][KP/]HS_ ))MKG_7I-]/]6>OOZ?X5VY=_ON&_P"OU-_=.+_K\#BS
M'_<L3_UZGV[-];G\$/\ P4/4-KFNY1&Q=7'WI#'_ !OW!ZX['ZU^57AD (P\
MM!EN@EW#G_:)S_\ 6Z5^JO\ P4/Q_;FNY\C_ (^KC_7 D?ZQ^F/XO3J<5^5?
MA@@HW_'OC=_RS#!/R],=?\:_TF\*/^19A/\ #3_*/^77SL?YH>,O^^UM_P"*
MUUM\7K8[NY11$A$42\9)6X+DCC^'/^?PJG&UL!\\(=\<$R$>O;V]<5;NBIB7
M!LL\?ZI6#GZ]O7VSGVJM%,BJ0886/JZ\\CG'/^?0=_VO,;_5E92=K:1ER/9=
M4U]VVY^%897JJZB_)RY5NNO5]>GSZRQKYC$*J@#G#2E/ISG_ .MUJ63[5$0$
M VG@A2)<\^ISCZ_AUJ!"&;/[I>^'!QWP,>I/_P"H<8D9;C(,3+MQ_P LONXS
MW'IC/'YUMD\;POR<ROLZO(MENN;5]?,SS-KVRBU'X5\;ER;1T5[Q?D]WO>^Z
M.D;)F8+&3U99-S?]\9 [_E^9='%#L)14FZG+S&+'_ 0>3P./UIC^6%_?^2>N
M?*SYF>_+ C\>?>GQF'9^Y\C^+_CY4[_?&W^+..O%7C_X3^%>\OD].JZ)[/?S
M.3"7Y]Y[Z6U@M-H\UY+96U2?0JDR&7:RC;V&[ YZC?U^F*<\<&?F81L>R,9!
M[9.3QS[4S]YO).S;QC.?+Z'MUQBGN;?^+:3CGR>%QSUW=NO7GT[URT=)*W+?
MEWCS>UZ;*;:_#>Z-,3S^T5W6MRK=>2T2NXM?+;3J.PR+F&-">?F$FXGL?DYY
M'IZ#N:12\@)GC7'^TWE8'L!M!_&E^?;^Y,'?[H/F]NN2!G]/ZH/,_P"7CRN^
M?-!)Q_L]1^=6[<DN;E;YK_O])6=MK;]O\K'+]U[[WE[3HM/>^>C26W<:([8'
M ;)[)N^7G'&_Z^].9ITXBC  Q]UO-SUXY!Z]/;K[!@^R[OE^][@>5Z' Z^_;
MH/:GM]HX\KR]O./(R.??.#U_'J/6K^U"_/R\NTTE2^SUMMZK;[T]=.:\KI?Q
M;K73HG9OM=-^>H%%89E55/=O-.[@\'8,<?YZ]$2.'K&1+TV[G,?3^?U_^M2G
M;C]]Y';H&\SVP>!T_'--C\GGRM@Y'^OYYYZ;?PQ[8[5*^"?+S)<VU!)Q^SO?
M6_S#6V\[=-9<NZV=[KY6WM8=ON"P4Q@)^&WV&_'?CT_.D>*WP"^(N/X',F0?
MQX[=A2_Z5N&2NS/OY>><>IQC&.O:FN;? \SRR<#_ %(V^O7=3T4X64&^K5_:
MW5MUM?K;57T".ZMIHK^QNV]$]4]+^J8\+M&8HT8YX8RD$_\  #G\/?\ *D4S
M2<2QC SC<WE#CON&,_K[TH^[^X,.>VX-YO?'/3)_R*0>?_RV\O';S@2,>P7/
M^>]2]8SYM;2O^_T_E^%K?K\P[Z*]]+N7M%MMKI\K#3';!OOX.<[ =PS@Y&_M
M^=.8RQ@>3&H]U;S3SCG!!Z?Y'<L)M=PP,MG^# B_'N>/3MGM3SYV!Y/DX[^3
MN#>_7OCK_/I5[^SOSVLKIK]SK;KV[WN%]KW=[?Q;I=+:)Z_]O7OWU%VAU_?(
MN<<DRE6]>%&/_P!7;U8D<&3L82'/W68QC=]>OY<T[HO[_P D\?Q [\Y]>G7K
MS_C34-ON/EA<]_.Y3.?;GUZ\XSWJ5\-2VFO_ "XUWMO?K\[;; KVEK-+M&_)
MI\]%VY;6_!.9[@':L8"$]CO '^_@^_?\30\<)YDVQG&25D+GGK\N>./;CI0W
MVG/RE=F1G8#LV\8ZG..N>G?BD?R<?O?*+=_*&&SGG)8?GV].]/3FI_!S77_7
MZZMNGIS;?TK@M'&VFU_97<M>6_,F[7?7FYNXJ*BKF)5DXP&:0H<?[O\ /C_&
MD#3L2LD8V>A(1>?]L '@>]*FW'[CR@3T\T$N!QT(X_SQD4@^T\^;LV=O,!V>
M_3)_KZ]Z'K[12N^WMU9=-8V7X*VG>X6O>_*VM4Y<RJ=/AUM?TM\KW$:*WSRP
M1B0-JL7!/&.>< ],_CCM3CN1088U.><A]['C^Y_G\:8YML\XW?\ 3$ )GCKG
MG&>W7..YIY+_ /+#R,]@@/F>V>V<_I^-"VI_%RK^5+V3T6[W]=_+8;O[MW)_
M]?.;EULNCU6GVK]10&<9G123DY9S&?3(4;>?;/\ *HQ';[CM?<1U4G:.F%^;
M_/6GC>!^_,6/FSYH)?I[9Y^I_P *8#;;OD W>KX,?3C@<XZ>Q[<4+XI\MEIO
MA_>ETWOI]WX["5];.=K72A\&C7>]E_AL/=YT($<8"]/E;S?S)!(_.ADC8 R!
M4/7<)23QWV9_0"AOM/\ RR*;<?\ +$';COR3U_+MS0QBQ^^\G/\ L ^9T'7/
M?U_4TM/W5U#FNOC_ (O1[?UKM:X+I;1WU=/F<^GQ7>N^SNN^@B)$!F(++CD%
MG,9'//'?\C^/2C?<$[60;/08V^G^LQT/U[>]">5C]SY8/;SN3G/\)7C.?\,@
MT?Z3D[MOE\YS_JL=N.N,9_3VIOXI\UWHM*ZM'I\-ORT^0F^]F]?XC?/]G5=$
M^UK-MB-';Y&XB-NVQS(#UQSZ>O\ ]:G8V+F)$8YQN\PD\'^Y3'-MQYFS=ZP#
M _$-V]>^,]J>,[?W/D9QW!$N,_EGT]_PH7P4[<UKW?(OW731O>VKWZ:ZH;3M
M&_.]?MWY=^C33:]79=$*ADD'[Z-2/1F\K&/H!4?EVX;A_FY^3)QC))^<GL>^
M>U/7SADSF/KSYP)XQQ@#_P"MS3/]%W# &[L>/+]^.N.O3CUYS1&W//EY5[JU
MH:RMIHT_^'O^ KZVYDK?\N[N'V=[NWI9)OOW>S31C]U$H''W6\TGCW!Q_GZ!
M2BNN9E4$]6\PAO\ OC( _+GI2'[1QY)BQZ0@^G\63UZ]/?M02N#Y_D^^0?,]
M^HQGTQ_+-3HXP;4;\RUJZ5/L]%T]7W[AO9JR>UX.3GHD_>UO][:_ <D41^XR
MN>/OR>4 <'OWXS59U*RX*KCT$FX?3=^0]_TJQ&MNWW&C4XQFXR5_X#MZ<<_7
M Y%5W&)/O0L,_P  .S\NO?\ 2B#_ '\]OX;^-6T]W=I+3[WL="34+VGZREVY
M5I!.R^Z[W9,8X>-V(^X*.9#W'3MWJ18U5<Q!7/')E*GDC!V=#_G\(F,.!YGE
MYYQY PWOUX/'M^M2($VCR3"#C@,#YA^F,#]?3%:T5>%E&ZO>T)<M/6ROS;OT
M]-CFDW9:U-_M*3CTZI\WJF[=M C:9VQ+&"N0 &/E@_B /YTCQ6Y<;GV-GA%;
M>O7&-Q.<=OIS2Q_: W[WR]O;S02N.W3_ #]>R2?9-_S8WY',>!'G/HP+?E_.
MNJ%N710W?PO3HMU9W]7^1/VM&TK:^Q3:U2W3?+Y-I7MY6)MH4?+A<@<HWFL1
MZE3TZ],_EVE*JT9+(DAQ]YY#"W?/R@_Y_E" O\!0CC_49#]L9)[^O^09C@1G
M/D?]O()D_3C/IZ?6N2JK222:UC]KF;V6Z=TO*^W3H:X?XW?5]W\6R_FO+[G;
M;38HPJIE(,:, <!3*5 ZY^8'GV[UK-N$9 ;RQC[B?O5.1_ST/(^O_P!8UDPD
M"4_\>V,\>:"4[_=^O;OGUK78$Q$Y( '_ "[<0].XZXQCI65=OVG_ "\2<5NK
MT^E[WOK^AZ-'5I6NN9=;.^G=-/H>8>)$B7<2JHQ89=93*W8Y\K) ^F/8BOT%
M_87:7_A+_#NR-9Q]MMLM(_D$?O!CY?Q)Z'I^-?GSXC,62/W).X?ZD$3YSWR,
M9_\ KD=J_07]ACSO^$N\.^5Y.W[;;?\ 'WN9_P#6+C&./I7X1XMI?V7B-*=N
M5[6<-E:[=VI>5[>71?T-X/V_MG#<RHWO'^)\6\>Z;?D]MMC_ $'?V7MQ^%'A
M[*@'[!;\!LC_ %:Y&17T2.O''T^;/X\X_*OG;]E_=_PJGP]NV9^PV^=H.S.Q
M>F>W]>U?1/Y_\ Z?C[_TK_.C&?[WB-OXT]MOB>Q_HIAO]VPWE3I[=N6/56:]
M;VMI;H6EZ#J?J,?Y_6ANV0#^.*5>G?\ 'K_GZTC?\!_X%7DUW[C]5ND^OFK?
M@CV([1^7?_A_U'"B@=!_3I^%%:1^&/HOR ****8!1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5S?B;_D%W?_ %S;_P!!KI*YOQ-_R"[O_KFW_H-;X;^-3_QP_P#2XG+C
M?]VJ_P"%_D?C'^UR9!:W6R-9#F0?,^S^)N?;TKXG\&&1K"4. F=PV*=ZGGCY
MSTSCDCM7VO\ M<F;[+<^5Y6<R?ZX'&,DY)'X_K7Q1X,$OV"4RE<\_P"JR(L;
ML_,#S]/;&/6OZ)X::G0@US37(M+N"VC>[M&VWIWW/YNXGTJU-(<W,]=>??;1
MK3YVZ-,NSQP>>Q943KEEF,AZX^YGC_/<5>BBB,3;4CDR#\SSF-AS_<#<_P"3
M[U1F,'G$/]F^]QY*D2=>Y;CZ]>_M5Z+R?*/E_91][_CX!,GWN<$<?7CIUQ7T
MM+K:R2?V+RATW;]Z_E?4^4PC?LW\;U?;E^_>_?MNMS/A3$S;@CK\WRE]HZ_W
MQ_GO4MQY9<;(EC''"R^8./?)Q]?\,"*)1'.6W1-G/$F3'CZ#/;VZ$5:F>!FR
MZH#_ -.XVI[9W9S_ #].U;RT2=N;;96[+;Y6N].O8V3<':TE>_N>]4>RU4W+
M1=;)].@HW(F8HTW=01(6.?\ =.?QI5:24'SXPW3EW\HX!/( QGUY]A[T?,5_
M<>0#Q]P-YN>< ]OU]<8%(OF@?O\ R<9_Y; EL<XVX]N_KD^M6F]-TK;=.GX]
MO0QW3?N\W-U<_:K;^]^3:V=M2,);;LA]Q_N$[5[9&_/TY_Q%2EIDP(D"KTPK
M"0?FW3WZ#\JB!M=_ .__ &^8L]^GS8Z?IVP:E(G;_5&,#C_4Y4>V<_YSFKHI
M.=N6#\N9P73>6]U?II?;16&V[QNVU;:M\/3M[OX7?<"J,,S(JGNPD)/O\G&.
ME-C2#&8PLO7&YS&!_C3B5"XF\D_[H/FYX[],_P!/RH1H.?*$8)_Y^!D_\!V\
M#CK6E[0FKM>]\*BI1;O_ #[KRUOT(]ZVG/:Z^&_L^GGS66NS2\MQOF7&[9Y8
M\OTXVX_W\#WYSTI)(X/XR(CCD(_FYSGGU'^?K2C[5N[&/\?+_3G;22&WX\W9
MG_IW&.<\YW=L=?49]ZPZ:]_M;=.W3\2XO6-FEIK["[;V^*_NW[W3?<< JJ3"
MBL?[WF?,>1_ >/K]?:A6FDR)HPPY^\WE#&1P, $GT/<<T C;^X\@<=PWG=?7
M\OQ]S0OGC/G>7C_IN"1U'0#/?I^7I1VW^5K=.KT]/*XNC;Y;WT<W+VFMMK/[
M[<J>B&;+;=]_#?W,_+P3QO\ ?GO3W:2(?N(P!_LOYIY/OG'?IZGFF$VN_H=_
M;'^J]LY^;I_4^N'L9L?N/*QV\D,.,_Q9XS_.A>7=?!9O\;*XY7O"]VK?\OKJ
M%].J=FNW-S-]6Q<;US-&H/4MYFTCWV#'K[4R..WR=A\TY/RLQCY^N?Z&GC.W
M]_Y/ON!\W/UZ ]<=L^U,C-MD^5M![>>,KGC& O?Z_P"%'6-[=/BM?IY-"N^6
M=G-*ZTA=PZ=;W4>GN\N@K27"G8L8\LYX&&7'?YR/R.>#S2ND1 ,@6)CR2LGF
M$]/X2<BD/VK=\NWR^^S/E_KV]?;\:)#%M_?>7GOY ._/;.[@G/?UXI='_P"W
M6MT[?U<:T<>6RVNZ7-S/9>\F[7[W3]>@J+$%S$JR8!^=I-K8QQA/7TSU_D*]
MPY(E0%><!CY8';J!DYZCK^E"&/;^X$/?'F@F3IV(XSU]OP%"_:<DR;-O/$V2
MF.?3/;'^<T^UK_\ ;MK=]?(3^U=Q;NK>TNJBV^%)Z/\ PM6Z:7LQH[;<,MY;
M G"@[Q_WUG\/UIY+1KF"-?7*OYA/OMR0,\=.],<VNX;P-W8Q#"=NS<]?3Z>E
M2'?M_<>3_P!LPP?/^UV_/_"EUE9*_E;FZ='_ %^(.]H<W-TTJIJGTZIW_P#
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MN1Z6MHM//U"BBBLCI"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%&'FC'/WP!'VZ'&<?_JI(T,/&^20?],1O'_ CZ5>BA+:%Y?\O$ZLMTEJF_\
M+4Y=U:ZU?P\L>;=?;Y;>ETWYD8E@W\1X/:3![?\ 3/ [X_/ZTYDFDP4EW#'
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M8FV)POHGE8_\B<#CU'--DF"$!HG?G&9EP?KQQC\*=S*F 9H_=@!%Z?>ZX_\
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M1"&DVCNGD>:?PE_#//'XU7",0"SR$>ER J8';Y<?A5G,B1\?:"H."(%#0G'
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MUHMVUA[\KZ6T<K)Z._Q^CT0Y$"+F/?+C/*/L'O\ *>OT/IVQ35EE=MIAP/\
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M6>J?O/5*WX'[I@_]VI:->Y'=WZ+;5V] HHHK(Z0HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KP3]HS_DFVN?]>DW_ *+;K[^A[5[W7@?[1G_)
M-M<_Z\YO_0#V_KVKMR[_ 'W#?]?J?_I<?Z_1['%F/^XXG_KU/_TE^:/X(/\
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M\4V!38V_W1A<;%QQQ^M?10Y/?'^SP/QSCGZ&OG;]E]MWPH\/$9&;&W_AP?\
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M[SN/P)S_ +G7\/Q..RZ+]-%]U]OZT'LY7M%VVJKFD]MFE:]UNG-^5T$C6_\
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M\$_:,_Y)MKG_ %YS<?\  &_EZ=\^M=N7?[[AO^OU/_TN/]?JMSBS&_U+$_\
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M5TOB_==GM=-_]NII_DI!D7K/&/J!'GWYR0>_^<I'&8^1))(,C_4$'/KG/?\
M"E*[QF12G0[O-]^NS_(]:;'&@SY9,W(X#^4!UR.>N,#ZX]Z5^6$DO<][:$?:
MIVM:[UL_^'[,71ZZ75U96^S]KFLM^LD)YV7V^2<^N/WG'OZ\=!SG\J=)%O )
MED3I_KF '_ < X_#VR.M)YL^[;Y6%STX/0X W#V[]*'BC8 R$Q$^LADS_P!\
MDX['IG\*&K3IOE2=E::DW/I;]W=W?DD^WHUHX_8T5N2U3HNE[_=>W>SN/!:-
M.D\G3[N#$3@Y]\4R.4R$A8G3MF$8;ZDGC\>._2G8*)F.,R8Z/YHQ_P!\>WTQ
M2*\LN0\60,CAA%QZY/7\?QI;QF_CLW;GO2MMY*^VPMTW9=V^:*ET^SS;]->6
MW41H/F!,QSGH[?O,=,#^@XYP>YI7D*  Q2OZ&< J!VQCD_7M[]*8T4.[F4@]
M=A);/;[_ &].?7VJ1FEC V0X'3<7\SCCMSUZX[55]:<;O[*Y>1\O3_EY:_\
M5K#WY?M;64K4ULMG?7_MWF37J*,RK_RWC!'\! 3U'UZ__7]&1Q;&)$K/SDB%
M@6SZ<]_3KSWIV#(O[Q".#\PDV_\ CF<\>WTZ4U(HPQ\MC(>NT,4YR/XN!GJ.
M.*2]V-3[%[?!^^O?EWWM?Y+UV"Z2:NUW22DNGVKZ?]O<H/-\X4PG).-TB_O!
M[]@#SQ_(4Z2,R#)>:/(SB4C8.O3C(]N^/>D:696V"+:N<8R'XX_C'KD\_G0\
M:,,R9BR!UD+CD_W0>/IVSBCK3?*NGO<WO=%_#?7?2VV^J$M.7:.UG%QJ/=;*
M[U]+V[CD!B7@S2C&/W1#(>1C.<'/O_\ JIBS;F($3*?6-?WF?<\CCGZ'%.5
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M[0$9';YL\9QV';/456??YOS";/\ MX\S^?6K$4(Y,3>:<<@2>5],DD9/7O\
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M#C_EXSYV<'IMP/H,8_E65 I,QQ$6PWW1,$QU_B[]_K6JVX1D9\H8.4($I/\
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M!BSD?\"Q_CZTV.7S,XB=.O-N .X/.>,] ?S]#2A=BYB0R#G#^:,=>OE_K_\
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MZ^9N'0\[!T_G^='??TU2W76VH62Y'91ZW4E-O;[%[:?W>;Y7!(S&IP\LG?\
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MGUYDX*2<7>U_R?HSZ&#]V+\D_P $%%%%-:)+MH,**** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,5AVY.RUW::TUV#_ %&XB;<(<.9Q)R=VW@:KBGHK-*'*_FU?R/FC,9FW"4$
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M]2!N_P"^<_IW_$D?3$W[''[4[=?@;XHSD?ZFVC4^F"2^#[U*G['7[5 CV_\
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MZ]S-\#\6NIKPKCGHE[M.M&?3?W+M/M>W1GS- /M+;9K@1KQ_"!C\>_.>/?\
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ML;_%U@,]/]8?Y)3C4C+2\;]+3C*Z[Z"^_P"[T_S_ "/7:*\C_P"%Z_"O;O\
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MK#=G&,2]?^^*+VU>RW?8#UZBO)'^.?PMCQN\66(S[2'_ -DIW_"\?A=MW_\
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MHMV3[I]$]F<&+G&6'G%U(4Y--6<H._WR1^67[7<,DMI<D%T_UAX0-ZYZ]?\
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MR]D90L?'K)UY'Z?G4:HX) 80#J?) F!^I;IVJU_8WB +\VC:H8L_ZQAF+'J
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MWT479M2_PVY9=%?3WM?1H4>$\T5W[T6G\$FW&J_=UDN22N_S?<IE6)SM3/\
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MIS7O4@U9W;;]KM;F]R7?S*;J['D+)CH9B(6&/11C/7/^>1$8X$DK[/[@C4(
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MS&2I/>,"4_B#GG'^1UJ+#LWW8RW.'=MKCZ(.#UY_PJVVCZN#_HVD:E)SR(5
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ML&'X^F<_E4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M))_6FI\'OA]&Q8:!;DG^\78?DS$?IW->G44?6*^O[ZI[WQ>_+7UU\@^K8?\
MY\4=/^G</+R\OZNSRZ3X-?#R63S&\/VVX>A<#\E('Z5,_P (?A^Z;/\ A'[8
M#&/EW _F"#GWS7I=%2JU5--5*B:V?/+IMUZ=!_5Z&WL*7_@N/EY>2/-$^$/P
M_1=@\/VQ'^UN8]N[$G/'6H4^#7P[C<R+X>MLGKDN1^1)'OTKU&BAU:K=W4FV
M]WS2_P P6'H+:A27_<.'^1YE)\'_ (?R,&.@6XQTVEU'?^Z1Z_I2R?"#X?2Q
M^6WAZU(QCN#^8Y_6O3**;K5FDG5J-1V7/+3TU#ZOAT[JA1N_^G4/\O(\RA^#
MWP]@7:GA^VYSR<D\^[9_.F+\'/AZLGF?V!;[CV+.5_!2Q'Z5ZA14^TJ?SS_\
M"?\ F'U?#_\ /BE_X+@_+MY'E\WP;^'DY!D\/6O&,8W+T_W2/\_6I3\(/A\8
M_+_X1^U"XQQD'MW'/;UKTNBCVE3^>?\ X$_\Q^PH?\^*7_@N'_R)YE%\'_A]
M""%\/VQ!Z[BS>O\ >)]:B'P9^'8E\T>'K;?GU;'7/3./TQ[5ZE11[2I_//\
M\"?^8>PH+:C2_P#!</\ Y$\RF^#WP^FQN\/VXQ_=++_Z"5IW_"H?A]Y?E'P_
M:E>>N<\^_P![]>:]+HH]I4_GG_X$_P#,7U>A_P ^*/\ X+AZ_P IYA!\'/AY
M;Y,?AZVR3G)W'_T(FD/P<^'ID\PZ!;YSG 9PO7^Z&"_I^%>H44>TJ?SS_P#
MG_F'U>A_SXI?^"X?Y>1YE+\'_A[, '\/6N!C&-PZ?[I'XU(OPC^'Z1^4/#]K
MMQCH2?S))_7^F/2:*TCB<3"W)7K1L[KEJ35G\F'U;#_\^*/_ (+AY>7E_5SS
M.+X0?#^(DKX?M>3DYW'G\2?RIDGP<^'DLGF-X>MMWL7 _(,!^E>GT5;QN,D[
MRQ6(;[NK-O\ ]*%]5PUK?5Z-O^O4/+R\D>;K\)/ "C T"V QCC-(_P (_ $B
ME6\/VQ!&.<^F*])I,CU%3]:Q7-S?6*W-_-[6=^G6YG]0P7_0)AO_  33_P#D
M3RR+X+_#F%RZ^'K?)]6<\\>I/IT_IQ5U?A-X"7[N@VX_%OY5Z/12EB<1-ISK
MU9-;-U)-_GY#^HX-;83#]_X-/_Y$\WE^$G@"9=K^'[7'3C(/Y@@_K5'_ (4I
M\..I\.VQ/J2^?_0O:O5J*?UK%?\ 016_\&3_ ,S3ZMA]O84K?]>X^7EY(\PA
M^#GP\@.5\/6Q]FW,/R8D?I4=S\%OAK=N'F\+V#..C;,$>F",8QVKU.BCZWBO
M^@BM_P"#)_YA]7P__/BE_P""X_Y>7]79Y++\$?AS,@C;0PJ#@+'<7$8 ]ML@
MQZ4R#X&_#:V&(]"7'^W<7#^G]Z0^E>NT5E.I4J.\YRF_[S;[?Y(N-*G#6$(Q
M?=12/+HO@U\/(6W+H$!/^T\C#\F8C]*K7GP/^&M\XDN/#EN64@C:\B#CGHC*
M,9]J]:HK#V-)N_LJ=[WOR1WT\O)&G-+:[MZL\O/P;^'9MQ;?\(];",#'R[E;
M&,?>!#=.^:HQ_ OX:1$E?#T1)_OS3/\ ^A.:]>HK3;1*R$>3?\*1^&^<_P#"
M/P_3S),?ENJ*3X&?#67&[P_$,?W)ID_]!<5Z]15*<D[J4D^Z;0E&,;\L4KN[
MLK7?G8\D'P/^&RKM'A^''KYDN[TZ[\T)\#_AM'G;X?BY]99F_F]>MT4<TM5=
MV>^KU*4I)-)M)[I-V?R/(C\#/AH6W'P_'G_KM/C_ +YW[?TZ9J=?@I\.5&%\
M/P*/9Y!^N[->K45/R&Y2E;F;=MKZV/)I/@C\-Y 0_A^ YXR'D!_,-G/O4$?P
M)^&<1W+X>B)_VIIV'Y-(17L%%!)Y5_PI;X= 8&@0X]-\F/RW<_C5>7X&?#28
M8?P]%_P&693W[AQZUZ[10!Y)%\#OAM" $\/0\=-TDK'OW+D]ZE/P5^'1&#H$
M!'H7D/Y?-Q7JU% 'CS_ CX9.^\^'XP<Y^6>=1W["3'?TJTOP3^'"#"^'X!VR
M'DS^>[->KT4 >4-\$_APXPWA^ ]LEY,_GNS59/@1\,XVWKX?C))S\T\[#\B^
M/_UU[!10!Y2/@K\.@,#0(0/0/(/S^;G\:BE^!WPVE!#^'X>>I6653S[AP:];
MHH \BB^!GPTAX3P]%]6EF8_F7-6/^%+?#HC!T"''IODQ^6[C\*]5HH \?D^!
M/PSE.YO#T0/^S-.H_)9 *GC^"/PWC ">'X!CC)>0G\RV<^]>LT4 >4M\%/AR
MPPWA^!A[O(?UW9JH/@1\,@^__A'X\^GGS[?^^=^/_P!5>PT4 >4CX*?#E?N^
M'X!]'D'\FIC_  1^&[\-X>@Y[AY ?S#9'X5ZS10";6JZ'D<?P.^&L>2OA^+G
M^]+,W\W-'_"COAMG=_PC\6?^NLV/RWX_2O7**(^[I'W4^VGY%\\]7S2N]&[O
M4\BD^!GPUEQN\/Q#']V:9?SVN,T]/@?\-D7:OA^'ZF24G\R^:]:HJN>=DN:5
MD[I7=D_0CRMI_F>3#X(_#?\ Z%^$_P"])*?RRU._X4I\.?\ H7X?^_DN/RWX
M_2O5Z*B24]))27]Y7_,44HJT5RKRT_(\B?X%_#.0Y;PY!D'/$DHY]>'K0B^#
M_P /X8#;QZ# (R,<LY.",'YB2WZUZ;12C&,=(Q45Y)+\B^>;7*Y2<>S;M]QX
MU)\ OA?*YDD\.QLQ.>9Y\9]AOQVZ=*U[7X/?#^SB\F'081'TVEG;_P!")KTZ
MBMHU:L%:%2<5Y2:,ITX5%:<(S7:44_S1Y9+\%_AO*=S^&;(MW.T@GZD8/ZT^
M/X-_#J-=J^'+0#Z'(_$Y.??->H45:Q.(BK1KU8KLJDE^IE]4PMN7ZO1M>]O9
M0M?O:WD>5-\%?ARQ);P_;G/;<^/RW8I%^"OPY0@KX?MP1Z-(!^08"O5J*KZY
MB^7D^LUN7^7VDK?=?R*^KT%_RYI::+]W'R\O)?U<\U?X1?#]T"'P_:X'IN!Z
M8Z@Y_6J?_"E?AR3D^'K9CR,DN3S]6Z\5ZM13CC<9!<L,57BGT5227W7#ZMA_
M^?%+_P %Q_R\OZNSRC_A2GPXQC_A'[?'3!:0C\MV/KZTH^"GPX!R/#UN/HS@
M>O0-C\Z]6HH^NXRW+]9KVO>WM)6OWM?R#ZOA_P#GQ2_\%Q\O+R1Y@?@Y\.RF
MS_A';7'KSG\^OZ^E5S\$_AP3D^'K<GW9S_-CBO5Z*2QF+B[K$UD^_M)7_/R$
ML+AX_#0I+TIQ_P O(\K3X+_#I#D>'[?W!9R#^!8BGR?!KX=R=?#ULOKMW+GM
M_"17J-%+ZWBO^@BM_P"#)?CKKMKWZA]5PS:DZ%'F6S]G&Z^=O^'/)O\ A2/P
MVSG_ (1VVSZ[GS^>ZK$?P:^'<?3P];'_ 'BS?^A$UZC12>)Q#LG7JM+;WY?Y
M^0/#8>2M*A2:[.G%K\CRI_@M\.9"=WAZWP>P9P/R#8I@^"7PW4Y7P[;KT^ZT
M@Z#'9J]8HI_6L2E;V]6W;G=NGGY+^F-8>@E94:27^"/^1Y@/@Y\.PFW_ (1V
MU^O.?SZ_K^55F^"7PW;[WAZW;ZM(?_9J]8HI+$XB+NJU5-]IR\O/R0EA</':
MA25][4X_Y'E2?!7X<H05\/VXP1QN?'Y%B*D?X-?#MP!_PCULN!CY2RY Z9((
M_/K[UZC10\3B&^9UJC??GEY>?D@>%PS:;H4FUL_9QNO1V/)C\$?AL3D^';8G
MU+29_/=4\?P9^'49X\/6Y'3#,[#\F)'^?2O4J3(/0BF\5B6K.O5:\YOR\_)#
M>&P[5G0I-=G3C;YZ>1Y8_P %_ATY)/AZW /8,X'Z,/\ /O48^"7PV'(\.VP/
MJ&D!ZD]F]S7K%%)8K$I65>K;MSR_SU^8+#T$K*C226R]G'_+^OF>7I\&_AVJ
ME?\ A';4Y[G<3^9S_GK4#?!/X</][P];GZM)C\MV*]7HH6)Q"=U6J)_XWY>?
MDA+#8=7:H4DWO:G'7UT/*%^"?PX3[OAZW'T9^W/3=4[?!OX=LNW_ (1VU'N-
MP//)Y!!Z_P#UJ]0HH>)Q#:;KU6UWG+R\_)?TV#PN';3="DVMFZ<;KTTT/)S\
M$OAL>3X=MB?4M(3U![M["I$^"_PZ0@CP];G'8LY'Y%B*]4HIO%8EJSKU6O.;
M\O/R0WAZ#5G1I->=./EY>7]7/+9/@Q\.I#D^'K8>NTNO_H)'^?:H?^%(_#8<
MCP[; ^H:3/..^[V%>L44EB<1'2->JO2<O\]?F"PV'BK*A22[*G'_ "\CR^/X
M-?#N,$#P];-_O%F(_P"^B?;GK4+_  5^'+GYO#UOU/&YP!GV# ?I7JU%"Q.(
M3NJU1/OSOR\_(2PN'3<E0I)O=^SC=^KMK\SR=?@E\-U^[X>MU^C2#_V:K'_"
MF_AWLV?\([:X]><_GU_7WKU"BAXG$2WK57ZSEY>?D@>%P\K7H4G;:].+MZ:;
MGDY^"7PW;[WAVW;_ 'FD/8CNWO3T^"OPY3&/#UO@=MSD?D6(_P \UZK13>*Q
M+5G7JM=G.5M/F-X>@U9T:37^"/\ EY?U=GETGP:^'<F,^'K9<?W2R_\ H)%5
M_P#A2/PVSG_A';;/KN?/Y[LUZS29'J*2Q.(C\->JO2<O+S\D"PV'BK*A22[*
MG'R\O(\NC^#/PZCZ>'K9O9BS8_[Z)IK_  6^',AY\/6^.. S@#'L&%>J44?6
M<1>_MJE^_._\_+^KL7U7#WYO84N;O[.-_OL>3CX)?#=3E?#MN#G/#2#G_OJI
M_P#A37PZV;#X=M2.F3NS^><_KGK7J-%#Q.(>]>J[?WY>7GY()87#R5I4*4EV
M=.+_ $/*HO@K\.(6++X=MB2<X8NPS]"2*>WP9^';-O\ ^$>M@<YX+@?D& _S
MBO4J*;Q>*:L\16:VLZDFOS\B5@\+'6.&H1>VE*"_)'ELWP8^'4RA7\/P #^Z
M[J?S4CFDB^"_PXB4JOARU(]6+,?S))_6O4Z*S]K53O[2=^_-+_,/J>$6V&H=
M_P"%#_(\M3X,_#M&+#P_;\GIN?'KTW8_2HYO@I\.)SE_#T'T#R ?D& _3^M>
MK452Q%=24E6J*25E)3:=NUQO"85N[PU%O:[I0;_%'D0^!GPS!R/#L /J'D!_
M1JMQ?!CX<Q+M'ARU;W8LQ_-B37J5%5+%8F2M+$5I+LZDGV\_(2P>$6JPU!-=
MJ4/\O)'DMS\#_AI=@K-X:M&4]@7'\F'2GVGP3^'-@A2TT"*%3G(2651S]'%>
MKT5A.4IN\VY]/>][\SJ@W3:=/W&M%RZ67;0\AG^!?PVN&+2Z$&+=3]IN!_[4
MHA^!7PS@_P!7X=A'^])*W_H3FO7J*2T5EHNW]>B^X<ISF[RE*3[MM]O\CRH_
M!7X='@Z!#CT\R7'Y;L4@^"GPY P- A ]I)1U^CUZM102>4?\*3^''7_A'X,^
MN^3_ .*I6^"GPY88;P_ P]WD/Z[LUZM10!X]_P *'^&6[?\ \(]'G_KO/C_O
MGS,?I5M?@I\.5&%\/P*/9Y!^N[->K44 >32?!#X;R@A_#T!SZ/(#^8:H8O@5
M\-(3E/#\9S_?FF?_ -"<UZ_10!Y5_P *5^'6,?V!#CTWR8_$;L&JTOP,^&DP
MP_A^(>Z33(?7JKBO7J* /)(O@?\ #:( )X>AXZ%I)6/YER:E/P5^'3##:! 1
M[O(?YMQ7JU% 'CS? CX9.^\^'H\^@GG"]OX1)CM_.K*_!/X<( %\/P #T>3/
MY[LUZQ10!Y2?@I\.203X?@)'<O(?YM0?@K\.B,'0(2/0R2G^;UZM10!Y2/@K
M\.AP- A ]I)1_)Z9-\$?AQ.,2:#&?I-,I_1Q7K-% 'C</P%^&4$JS1Z %D4Y
M!^TW!Z>QDKT'3/">A:0B)8V2PK& %^9FQC_>S71T4 (JJHPJA1[#'\J6BB@
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MMQ(H<+J-L;>3#>JGN.^* .FHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT/:OSP^+/_!;G_@GG\)5NA>_'/P?XHN;4/FQ\(^)/#^KW<S(/NPPQ:B&=CT
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MC:>']E:4XR<'97OR=M?AEIWTVN?I%]LM_P"\W_?#_P#Q-3)*DG*D_B"/YBN
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#.K <NK#'(&?45I"IRM.<I<J:T;;6ZZ:GJ4+NHEW:O\ >MS_ #-/V@?"EO\
M +]KWPMH'PNU+6?!GAY?$4:-8Z7=36%N(UE;"^5:"),#'0+@_ABO]"O]@+QK
M9ZO\$_!OVOQ/J%_=-HUKYS75Q<2$'RR&):3))P,]?UK^8W]J'_@B+_P4/^*O
M[2.B_$[0M$\&ZEX9L=86]N%N]=M;2=H/,+G$209W$$=.>/>OZE?V1/@GX\^&
M_P -_#W@_P =^!]*TS4M/TV&TN[NQU66X'F*FUF7"JI )R,=<?2G.K&=[)I?
M9V:>VKYHW6W3\3KJ8B$5.E>5I:-I1<5MM[WY?F?$/_!13QU^Q/IJZI9?&_\
M:5\>>#[B2*99?#7AKQ!K=@;HD-NMT6TM9H@3R!G(^O;^;KX;^+/^"7FA?%2]
MU7X4?LH?&K]JOQ*]X7\GQ9KFG:QI5_*6.&%OKVE1ILD/9FZ=Z_H7_P""@_\
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M:*C2CHKM;QMK\U;^OO/SW_; MM/TSP-K=M::+.D":7<QHFG30VL42B!L (,
M*H., <"O\W'XX_#3Q_X^_;HGT[X3_$5/ ?BJXUIEL[NY-W++!(]X54F2TDC;
MAB#P_:O]/3]H'X/ZK\1?#.KZ=IMK'>W5U97$4*RW+0*9)(BJ@E".,_ES7\3?
MQO\ ^"*G_!3'0?VH;GXU?!+X=^!]3M8M3:[LAJ/BM+9V"W/FIN66WF R%&>/
M7K7GRG&-27N.G?2[Y;N]MTVX_=:W6VB74H2FO=UMOHWRK3IIMV3].I]K?!'_
M ()H?\%G->\+Z-<Z-_P4$T+3=/EL;=[6WO;;Q;,(H3$AC3"ZJ!A5P. !D#M7
MO,__  2H_P""ULR&,_\ !1OPBF>Z:?XP5OS_ +6JY\-_&/\ P< _#_1]/T5?
MV=_A1J=O86\5M$9/B%:PY2)%12=NC'&0!WR!UKV$_'7_ (+\Q0F5_P!E;X.O
M@?\ 14(2Q..NW^Q3R?S].O/=AUS12:E9->][J736T7)W_KTY:\4XQ4U&H^;1
M*+6OSG'7YON?/J_\$G_^"TUBV]_^"DGADY.<26?C)UR?;^U?R'_UJ]&\#?\
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M9.3_ ()=_P#!4WX GS/V>/VTM4\26%IQI_A_7?#WARSMX8T_U</VJ>*[D8
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M7AF71K*U\QQ9-;1^9<2/YI\LH"S,Q*YZ9S]*_GH_;]_X)T_M(?&6UUF3X:^
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M? 7_ (+":I87%KJ'_!++]DNV:9&7[1;_  ?\ PM'D8W!QJ'!7DY'(QTK]=O
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJYSM&1[4ZBH);B.'[^[U^52W\OSH2E)I)-OHEKY"22V27HB>BH8ITE&4W?\
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MY]A3J**LD**** &[$'\(_(?Y%.Z=!110"5ME;T04444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FM]T]>G;K3J:Y^
M4YZ8[<?K0@/Q?_X+#W-[;_ '6VL;N6&46ER1D@#/EJ>".WKTK^#CX1Z;HWBG
MXBKIOC;PP/%,%WK2PR-]E2Y 22Y5226(['WK^[?_ (+'Q?;/@!K45JER9?LE
MR/W4<LQ_U8Z*BD]??.>>*_A;_9YM+_3OBG:BZLM;DSKT>"+.^B'_ !]KUS$1
MW(S["O9I5J4:#5W[16M)N,8]+IV=OP?GT.R%*E*#E*,(;>]*2GTT\E=O9V/Z
MIO"__!&?X&?'#]G;3];^&'A:T\!^.KZP62+5[:,6-S%,\",K"2&"=@P<D@XS
MSWK\YW\/?\%$?^"3/B/'AJUUGXN>&/MFZ:25=;U<6UEYF7(:.&R10D1('('R
M\\=/ZXOV"R\GP*\-;%EA)L+<?OU?=Q!%U#8.>N<C\*^J/%?PW\*>.-.N],\5
M:)I6L07D,D$ANK&&1PLBE"59U8@X)Y]><UY->I*HG!-V;NK:+I=-)POKU;,5
M&DN9MK1Z<KUMILN5Q:?Z>5C\,OV./^"Z7P2^*JZ1X&^+?V[PG\3K@0PWFG7(
ML;.&*X8*C@I=:D;C D+9RG '3BOUR\>>,/#GC;P)J.H>&]3_ +2M[O2YIX_L
M$L%P0CP%@6\MF P#R,^M?CW^UC_P08^!7Q#O=5^(/P>M]3\(_$NX,MQ:ZAI]
M_);PQ7!+.A6&.6W4!7.<;@..U?B)\4_$/_!4#_@ES;:GI]NFN?&#P[*DT,,,
MA6[:&T?<JJ#+=7OW8GP,+_#[UQU(SJ)4E:.B3E).[M;6/+?3U=_NUYW)<ZBX
M.2>JNI-:=_<<>WVCQ_\ :8M63]KVXWL__(6?]V^!.1]I'\/3/X^_;!_J0_X)
MP!!I6F[8;E#]FA&9450?W8R1SGG\LU_"[X-_;:\8_'C]HFTOOBA\'_$OA_Q)
M>7ZM<3?OHHHY'N%+';':*@^;L#CZ=O[J/^"<,<4FB:5<1+<Q"2T@(2=I&*!H
MUPIW ="?3GZUST*-2E42G):O3WDK[?94KW[:7^XSDZTJD>7F5*-N9>XHK;91
M;E^'7H?LX'Y P_0?3IGIC\/6GL^T9VL?PJ-50 9?)X_B [#C%2,Q'12WX_\
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M_+^H9_\ @V^^/#KB#_@HE\=XVXR6\;>-&Z8_ZCW'Y5K%M23NHZ[M72\VK/\
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MM8)/L.C:E8WSV>Y!^[39I:";#'C ]!SFOPW^+_\ P7#_ &M/V6_%$>@?'?\
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MXNSM\FI?DV!-1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.]MGJU._X&BG**:35I;JW^:NK[:?Y'&M^Q7_ ,'(97:/VS?V:!VS_P +#\8
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB2(81<#\:DHH<Y-<KDW&][7;7W$A1114@%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !129.><8_'/M[5R'BWQ+>:!I=[=Z?HFI:S=V\$DD-M8P"9Y75"RH%W
M*26("X!ZGKUQG[6*OS7BUT:U?FDKM@=A17\_?Q\_X*A_MO?#+Q??Z+X*_8'^
M-'CS1[:5T@U/1? =W?QSHK, R2IJT*D$+D?*.OTKYPN_^"UW_!0*QAEGNO\
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MTO?G[K7UM_(2Y_\ KU:5VEHK]7HOO&:U%8BZF^>&@NA_TZR)*<9P/NM]#_\
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M'K$=RP^RWNFNN>0;J%F_))&[_P"<U+A)7>ED[736_P"?7L9N$DKM:7M=-/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA#QEIQO'N;#P[K>JWL4*1*V^.(K9Z:S@'H?F-?0+_MH_\%YO !BTJ?\ 8_\
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M&'3K7P'^T'^R3^W;^PKJ+77P+_:T\3>(88I?.EMO%\]]KGG#<&9%.KZS*$#
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MOF3Z*S2O;XHR372V_P")]&\-"C17-/G<XW3E.\([:./+K;32]EKH?M[\4?\
M@AI^T)\7M6D\1>*/V]?B18:[.3(W_".W/B;1M/61L$[;*SUZ.%5#8PH'3'6O
M@OXV?LN?\%(?^":GDZ[\%_VO]8^(\2R+(]IXQLKG5P8U.2F=:UBY R .0#UR
M17Z-^.?VS?\ @N#X+UO^Q=&_9 ^"_B:T0[%U."_\93PL!@!C+#IWE\XSD<'D
MU\O_ !C^"_\ P6-_;[2VTWQ[X.^&_P !K(LHFFT'4=<$IC/WAC5-+8 XS^7%
M93YY)N'+SK1-QU3TOHDU?Y;GE5E"G9V:6[:DI)ZKX4HJV^WG\CZ>_88_X*Z_
M&#Q/%I/@S]H;P[;:[XPNG@MI=6TZ2UTZ#S"WEL_V:V@D0 MCCS.,>YKC?^"V
MWBVPUSX9:9K,D36J7UJDXCW,Y3>K,!D+SCC/ _G7UK^Q7_P20L_@UI.G:K\9
M-=C\7>-;012OJ,,GG*95^<L&6* 8W 8^3D#UYKDO^"KW['/Q<^-G@>Q\/?"#
MPS!K'V.!8HHYTO" $#  _9H)3W]^#[9K!4ZU2E.-51DY:+W5KMNERO?5ZK;R
M..M47LI24)VLOLJ3>JVC[U[[;;]%H?GU_P $J]/DO]%TFYM-8ABB\V(^2VG/
M(Q /3S#QGL,#^AK]3/\ @HK_ ,%&;[]@_P"$UIXAM+5;^4:?OWB/."J2?-L6
MWG;^'& *^<_^"=G['7[27P6T#3[+QQX8TC2%A:/S5#7R$ $DD">UC/3\017W
M#^VW_P $\?#_ .VCX @\+:WJT%A>1VGE$1NC+YA#<'>C'&6]/\:6'P\Z$9)1
M:OY1BNBT]U]NLGWOT.3#5)M2M#E;M;F<8-[:J-OT7H?QX^*/^"XWQ9_::UMX
M9?VG=<^$/AJ\G>*ZL](^$_B[Q#<Q0N2"(KS1M/1P5'1D'4<5T4&I_L@>+;6/
M6OB#_P %/OVFX-7N@)KJ'2OA9^T'I]JDS<D1BUL_)" CHO'8"OT#?_@C=_P4
M$_94U;^U?V:],^#/C/PYITQN(M/\67LZWMRB-E8_)M]'G+%AU ;U%>LO^TI_
MP67\+V4'A74/^"=_[/\ XF33E%O_ &C'I7B65;C9QYGF1:*JL&Z\<5UTU*Z]
MH]':ZT=N^RC?[_\ @=T/:?;^ZZ?WVC']4?EY:?MDVO[/,?VC]GC_ (*._%+Q
MEI]B#)#X?\6?L]_&'6[N_"9VP?VGK.GN(V?IO;ISFOU*_P"";7_!:C]HS]H3
MXAP_#?X@>#_$MWHL4R6B^+KKP;JVA1WJ%@GV@076E021!LYPS\=,UZ5X'^*W
M_!8GQE"EE#^PC^S!X'AN<(U]=1:_;W5MN&?,1+G1"NY?]KC^OZ/?LL_"#]O'
M3M?AUWXWGX9:9ID\D<LND>&4@/V=>K1QEM)MI,#H,OGH*UG*FTE3Z;MQLV[*
M]USO;;IYFZ32BYQ]UVM9Q3>BOKRW^_\  \T_X*(?LBV_QM^%WB?QG!\4?&N@
M-'H]S=MIFG:]JVFVSDPLQC>WBNX$906QM,?X=J_ST?AA^R)XG^('[8GB#P/H
MGQ1\6>$9;?7F@77;/4]2@O'Q<,OF-<PWD,K-_M"0YZYK_5T^//P?D^)_PTU[
MPOIL5HFM:GIDUK!//(\4*SR1E0S,@.%R>NW\*_BG^(__  1M_P""D'[.WQTU
M[XX?#KP[\-_B3I5WJDM_::')JFKRW)C\TR+&8['33)EE/0.>?P-"DK+FE)V2
M]U0@E?36[N]K[IFSJTI1BN62Y5HK)WT6\F[/K]C]4?N5^P9^QOKW[,OPN;Q#
MXD^,WCCXF2:=IBW?DZGXFU:02>7$LFP/=:A=A =N.1W].*^(?VWO^"]OCSX-
MG5_A]\-?!S>#=6TQYK1?%%W?1>+#F,[/-_LR*T>8D%22N<G=CM7V=^R)\3_V
MOM:\&R>!?CM^S,?"4-[:_P!GW,WAS3O$-Q#L95CD?S+V&+ Y//3J37D'[3O_
M  0DT[XR6]]\1?@[J4GA7XC:H9+ORM?S;VZ7#_O%5Q)#<8^8D'*$^U'-'7W%
MKU;>FVW+RK\/^#SMINZ5E\OT45^!^$OAO]OBR_:U>:__ &G/VZOBIX$F=V/V
M7P%\(/BM:QQAC]P2>&+'RSMR>1P<?C760WO[#.@3?VIX:_X*<?M2)K2G>!J'
MPT_:'O;7S!RH-K-9>7C=VYXK[X^&7P+_ ."O'[!]O<:1X>^ GP4^/]BNZ.&X
MU2WU.]G,7\/_ !X:'C=@>O7CZ^B:9^V!_P %A-4U8V9_X)E_ JTF+X-Y<Z%X
MIBM<DXW>:=&QC.3G&/Y4N>6B;NEM%ZK[A?-KS6Z]+]3\F[[_ (*P_M*?L[^*
MM'T?]G+]IKQM\:-!DO;>&?\ X2'X&^/;61[8RJKYF\1:<64E"1O)R,9[<?U:
M_L&?\%#?B'\?/!.@+\2_!&J'Q!?0P?:]4-K/I$32.D99OL;V<9CRQ)VGH.,U
M\,:'X0_X+!?&C5M.O=6^!W[.WPFTP3PO=6VG?;HY1 '4NJK>Z$3NVY'4?6OW
M(^ GPK\=^$?"6FCXG0:$/$\44?VN70T1H#($3<8SY$!^_N&=HXQQCI3FI))P
MC_V[%1_)?Y&*A54OXSY?.,&WMII&-M+ZW?>Q]+1VFI7,$-S87OV1951VBF0S
M%<J&V\D>O/\ *MB*P)AQ>,DTN/FDC01$G'/3G^H[&J%IJEC"@CDO%C9< +.R
M1C. ,8)R,C\!BM&.>YG8F+[-) >CI(3Q^6._KFLWJK-)_+?U->57O>7I=V^Z
M]OZ]+?@A_P %2_\ @K)?_L&R1:+HWAR75;[4W6VMKA[O:L4MQM17V-:S+A6D
M!ZCH?H?RW^']G_P4\_X*46L/BC0/V@_^%9?#37R&^PZ7ID0U"W@GYPE[;:G9
M7 98W."J#D"OW?\ V]O^"4WPJ_;BA^W>+=0N+#5[0>;9/$$\M+A K1,S,#@!
MT7)QT'K7XTC]@_\ X*Q_L3ZB)OV8_'7@SQI\.]'.;'P=JNJW0N;B&(C9$T%C
MI<DF65 I"OGYJ\Z>'DZC:G.G&ZYE.;=)K2_LTU>+\[=MV;PJTX)<].$GHHMR
M:::MJ[NS]+>1ZWX6_P"#?[XZ:6JZ]J?[>7Q;O-5=1=RPMK_BK[*MP?WA40GQ
M"T6P.<;<8VX'05\V_MM_LX_MW? CX-^(O#MO^T-HWCKP;:V<R26.N>&(+S4[
MB%(77!U"^U*>?<RYR2"<\\U];>"OVX?^"Y.K1CP[J?[&WPHMA"HM&UB]N/&D
M'G;?W9N%=M/V'=C?G 7GWY\/_:H_9?\ ^"N/[2'P_P!9O]0M?AWX6O+^WE)\
M/Z/JVKS2J9$<F-()],:5B"=H !//7FJ]A3E:-/G=K:N4FGK&^LY*WJKORW3R
M5:]1K5-*[48\D;:+1J/+?[]NQ\/_ /!O[/XIB^,'B%M?T&WL[R+5KEKF\A2W
MC2>03N7<1Q [0QR0 QP/Q%?TU_ML_M]R?L[> ];OM"TA/[;T^RE>"[<"=%DC
MB8Y,/V=PP!P0,G/2OQ5_X(L?L!_MI?L\_$C5=3^/ND20V,^H32F86M\D<B-(
M3N62>QMPP/.#G&#UYK^A3]K#]BKP?^T-X"U?P_;V<6GZ[J-I)#'J;;@8Y)(F
M4/R&7(8@DE>U;QA"G:/[N,M+\SE);):-KROK:W?<N=6&G,I6TL[KGOI:\_9M
M^FW<_BXNO^"VWQ>_:2\;ZSX2^(?[46J_!'1;:^GM8[CP]\)/%GB:=(5D*_\
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MI\C<(RFDKM15VTETEHWIUMN>=B)J<)S4)JVRE!)K1?#=1AIMM:_WG\97A?\
M;,_X*9?L^^.=-^#.A?%6W\7:7?WB:>VOZQ:6EU/&FXKYN;V[EG)P,G$@//6O
MV&O/^"?'[;W[7/@#3]>\4_MF:EX,DU>T2YDMO#MA=V,L!F4G8)=.UF'D9P,
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M!GW7VF*/%LGF$#^+!/UR?\X]:IQW#,I2Z"Q2GY1\A//U'TY_SG<I"JGJH/U
MK2,TE:2NO[MHR_\  N5NWEY=]4&-;V=P)?-^U,\9.=N6P >G!]O:M=R50G<
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MWVJ';Z^8N*C35-/D8JEY S XP)%S_.N*/PTT-FW&[U?_ '?[0GV_0C=R/:K
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M^F322I:W<]-DHKWOG?W?Q8ES:\UO*U_QN=NNH63KN6ZA9?4.*47]F>ES"?\
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M5=KJW5MC3(&_NEN:G!)'(QGMUJ,P0D[C$A/J5&: ) 01D'(]12T 8Z#'T%%
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MZ5IGQ[^%TNKN=HTG_A,=%.H;L[=IM1=&3=GC&W->\V/BC2=:C2;0=7TC5()
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MAZ?<7IT^Z*M5S&V^C5T-"*O08_.G4447$DDK))+LE9?@%%%% PHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$\'/4?E7Z M=PJ=H;<V<;5Y)],52GE23AK"9R> P4''OUP/\\46NF]&NNS_
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI;1/_*]S[AL3FUA(&,HO'7^$5;JK9?\ 'K#T^XO3I]T5:KSC8**** "BBB@
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M^-<QN24444 %%%% !1110 4444 %%%% !1110 4444 1R+(RD1OL/KMS^/\
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MF;H.I(K]H_#?B[P;XOTR'7?"&MZ+K>GW*+)!?6-[#<VTB-A@R20NRL"&!R*
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MD%%%% PHHHH **** "BBB@ HHHH **** "F% QR2WX$BGT4TVMA-*2LU=;B
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#V  'Y 4Y8(5Z1ID=]HS_*I:*=W_ %\O\A**3;2LWOYD9AB8Y,:$^ZBD,,+
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH ***BF=XU+(@? )P6V]B?Z4 2T5\Y>-/
MC#K?AW6(=+MM$$RRR!//$OW021G'E$'\\>M>B:7+XIUS3H+Z+4S8M,BOY?V:
M&3;G!(RRC/7'0?RH\]?NE9[;.UG\GT9G"HISE!)IQW;M;Y.[/2:*X%=-\:)D
M'7%E]";6W7'X8_/]*%TSQFIW'71)_P!,_LMNHZ_WL>G^>]+U3]='?Y)M_>D-
M3NY+EFN7JXZ/_#:[?W'?45P4FG>,Y.4UH0X'W?LT#Y_$CCU_3TJO]C\=$[/[
M311T\WR;<DYZ';CMU/KG\FM?+U37Z#YM$U&33WTLUMO&34NO1/J>BT5YXMGX
MYBX.I)<$_P 1B@C"YXZ <XR3^ I3IWC<#S!K2D]?)^S6^![;R/?\,4?U_5AI
MW5TGZ-<K_P#)K6^9Z%17G/V'QW+G.K)!CIB"W?/Z#\?3M5B&V\:J0DEZCCH9
M2D _X$% _&FU;JGZ?Y;B4KZ6DGV:_57B_DV,\5VT\^!%&7(S_=QVZY/3UK+T
M2RN(Y8R\=F.!@&/,G3GG\>_:KNH>&_$.H;3)JQ3'7;#']>Q%:>E>&]0LMIFU
M5I0/X3 @Z>^<^O\ DTBCL8LB-<@=.U24U%*J%)SCOC%.H **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ I"<#)X%+10!0EN+:5C#Y[(_
M<(64^G7%2P6PB^8332 DD>8Y8?K^5.EBW_ZMA&_][RP3]>1^OZTV"&XC/[VY
M,HYP-BK]!Q[4E)2ORM.SL[='V8%G ]!^5?G7^VKK>K:?H%]'9:=%>1R6LPD$
MBJPVE<<@NHZ$X]<5^B>Y>FY<_45\J_M!_!_5OB7IES9Z=ID=XT\31AVO6M]F
MY<9 #+NP>>O-954G"2CS*[5W35WOV33;_I78<W5+FM9V35WKYM+\3^'3QA^S
M)\#/C_\ M.VVE?$7PQ8B?4-1V3M!:62W&Z2Y16VO+!+SEN#S[U^QNN_\$G/B
M'\!/"6B^+/V&]<U+PM?&SM[VZ%Q=R1*Q\M78(-,6S..< $_K7>Z3_P $??B/
M:?'BR^*1\5O86UM?+<_V2MI'<)@31RA?M+71;^$\[>_-?T6?#[0K_P />&-*
MT2^A5S8V<%L\A<$2&.)5)V#(&=O0DC)^M9X:K*37-SQ<+*+2E:2T^-.ZOUU=
MO7II"7LY1GRQEI\,^62UZ-*Z?JN^Y^ _P$_X*4>/?@#>V7PM_:>T?Q-JWB5'
M2VN?$0^UR:>A5@KR-)=R2O@;AGY^QS7B?_!5G]HKX5?&3P'9S^#/$6D:K>7%
MJKM8+-$9XG8%MCJQ'S#.#QUX%?T8?%[]GGX;?&/P[?Z!XD\.:0POX7BDO$L(
M4NU#J5)6YB$<ZMSU60&OYJ/VP?\ @W&M_B#>76L_ ?XCZQX1U.YG>X823W]]
M )'9FPD-_K#1(HR  JA0.PS7<I)[N3EINXQCT6KBD]CJ^LPG.$G3A3E%_9C'
MV;T^TI2C\KOU9^>/[#%K-'X\T#=H]F ;Z']X($=AF0=&4GUX_&OZ./VO]7^$
MNF?!;1F^)7[0WQ4^!-G_ &5'_P 3#X;>(-8T*[51$^6#Z9:W#@J<\XSP.../
M@#]C7_@CY^U/^SKJFD'Q'XYM/$UG8S1/)/-:Z;#*RQMTP)I7Z8R<G\:_I&TC
MX?Z WA73M&\;>'-&\026UK%%*FI:59ZC$650K )/%*F#[5,K:>[!/JHRJ/M?
M5VZ_ROL*M74Y1<VJJBU>*3BMDM-9*UKI6;_4_B+\4_$[]A^WU*11_P %5_V]
MG3S'#&Q^+WCN-%^;H!_8_ ';V_*LH?%']A6:,"/_ (*N_P#!0.%\<^;\8O'9
M';L-&]3_ (^_]NG_  HSX+3OE/@O\-W4D[GD\'Z"K=>N#8=3S5]?V?O@:0"W
MP>^&P/I_PAN@'_VPJ+:[NW;?\7=_B<\JD97_ ':M]GIR[?RVO\S^&RS^*W[%
M<6KV\,7_  5-_;\OU,B@,WQ?\=&,\XPP?1_I_GI^UO[!/B?X!:QKMDOPU_;3
M_:)^*^H/L']F?%#QOXCURQD)Z))%?V,",&& 0S8ZYK]Z5_9_^!JD,OPA^&ZL
M.A'@W0 1^(L:T4^#GPSM(W32?!/AG1792HETG1K'3I%SW#VD,+@_0]AZ5%2,
MI.+CR^[NI)Z[=>GW/T,_Z_'\3Q[Q/^SE^S5\09(=1^*_PM^#?C?5MJM'=^(M
M!T*^OI&_O;]05Y2Y))SUKY5_:(^$$7PO\+2WO[*7[*_PCU'Q!'#(;5(/!6BM
M"7 R@'V;[/QGT?TYKA_VI_\ @E,WQSUU_&/@_P"-7BSP#XAMY&N-/%E-J=S;
M0SC<R$VS:M#;2*&/*O$5/<8Z?!'BG]C[_@NM\([8V'P,_;-MO&&A6>8].T/6
M/ O@.S98%XC1]0OH;FY<XX+NQ/?K5:>[S1UZ6BY)?]O6TZ6NE\K!=_J? O[0
MY_X*P>*;F]F\9?L ?L[W/@Q&D_M#6[CX8:?+K5K8@MOGM;Q]2<QS+'DJ^W@]
MJYG]@_QA^Q[\-?C+!J'Q%/COX<_$E;N/^U-(M]2MK/PK:789M\=OIT%NYBB6
M3=A?,.%P.HS7Z'^'/V<O^#@#XEV<FC_%S]IO1/".C7@,%];67A#X?:J)() %
MD^>*SA<94G[I!X[5ZS\%O^"$-C8>+E^(/QZ^-)^)6OW,JW.H6*^&;?0UEFR7
M<";3+] NYC_"H JA'ZRZ5I7P$_:5T"%-(\9:CKFERVBI+%:WH6%XF09659HB
MK C(;L?QKQ$_\$Z?^"?OPZ\0R^.M=\ ^ )M9#F>?4-:TSP]=W+NI+%I&-H9F
M;))))R?K7/\ Q*_9E^-GPO\ #-]X9_90\.6&C0SV4EK'=7&LQ/("8RBR :D9
MR"#AA\WU/<?SL?%?_@E5_P %N?'WQ"U+Q+#\5HXM'O+EYH],.JZ&841G=@N#
M*HQ@XQMXH _H/^+'[5G_  3B^#%G-X?DT/X;S:D\36UII6G>#H;C[5*5V)!_
MH^GO&?,8A3E@"2,FOQ^^,'P7MOVX=1N]%^&7[&>E>#O#VK.19_%#1/"NBZ/<
MM'*QVW"W<:K=@[2L@.S^+I7!?#__ ()V_P#!;;X=6P_L+Q?X#>YC&8Y-8\/_
M  _UV0.!P1+JEC=,#GOD$?A7L&C?!O\ X.2-+OEM+/XL^"=,T=" @LO#GPR@
M14!_AAATM /EQP.GZT ?I%_P3)_X)F>(OV,;=[G5O&6MZT;O=*+/4M1FNEMC
M(2?+5710H3<!A> !CZ_M>%O]XR\'E>FT[OSZ5^9'[%OAS_@HIX?MD7]K'QGI
MOC"XV_,UK9^'K  X_P"H3;QCK^'L*_3E;B18@]Q$8VQRJ9?G\!_G^0!:&<#/
M7OBEK,\V2[;]Q/)!@\AH?3KRW^>^:O1)(BXDD\P^NT#^5 $M%%% 'A/Q3>V4
M1^=Y'4?ZV-GY^@!_2NG^'CQ'3$\D1[<#/EH5'3TP/\CL*YKXIS)&$W[^J_=A
M$G\_\_E73?#V3?ID94-C&#NC\OL.W3_'^4JZE?\ >*_5)2CT7PZVOWY3GJI\
MT7:?Q+JN7HMN:_X(]-'0?0?RI:0=!]!_*EJC=;+T7Y!1110,**** "BBB@ H
MHHH **** "BBB@ HHHH **AF>5%S%%YIYXW!?Y_Y-,@EG?\ UL'E?\##=_;^
M5 %FBBB@!K'"L?0&OY0/^"YWQ7_;"\(:A:V7P.N/%-MH-Q+%#J4VC?;PJ6KM
M$)F9K9PH 1G.2*_JUNW41MC#G'W1*$S^/X5\$?M/_M1?LC?!73+^#X_7FA6K
M/;R*+74=.?59)MRX\M&BMIRK/D!2!W'M6%6232=1PZ_#=:=Y-67S-:4W":DK
MW7:U^_7TW/Y)_P!B_P#9-_89_:.U/2+S]J#XI:UJWQ9U!XFU#PSK6L6A#W,C
M+YD;6UW;--S(2N"W?&<UD?\ !63_ ()D?LW_  <MM!U#X)?"N\?393:RSW>A
MVP<2VY\HO)(ULJ AE)9N._I7U5KG[87[#/BOXU&\_9S_ &-O$_Q7\<27A.GZ
MCI&L:OX2T^ZG:7,;+<W6AI9PJ[[2"9=J@YR ./T<L?C7^WKK>@P6R?\ !(1-
M>T&>T5+-M=^/_@B^D>U9 (R([ZT:2)O+*\, 5_ U-&I3YE!<O,^L9<R?S44H
MW[-O;LD:UI3J6=25W]E149:?WG&3LTM]#\DOV$OV:_\ @E'\0?AWI?@GXR>%
M/#&D?$"[BBAFEU(V5MK"3LNQCNNF9@P=AC(ZXS[^"?\ !27]@?\ 8C_98.E^
M)/@W+X2O_M<\-S##X@OH;N)1(PD584TU8R.H"@GCBON;XT?L[?%[QGJ5UXH\
M>?\ !&OQ/X?=F:2XU/P?^T_X>TJ:+)+,T,&C0I*".2!&,\#%>%>$KC_@F]\)
M-8MD_:Z_9I^,/PHD%R@C7QA\1O&?Q4M(I=X 5(H=/NH0BM@# VXZ8[=D4U[R
MY-.DI1OHUM%M-^J1R];:J^CW^>Q^G_\ P2*^+>G_ /"M-"TS3O!S>08[=!=>
M'K-_[-  PK!IY2P7DX)QGGO7]*&C7/VK3K:;RWB+Q*WEN,,N0."!W'?'%?GU
M^Q-\0?V*_$G@/3Y?V;3ID/AQXHOLJ3:5<Z=.%*_(/*U&VMIP>O5,_AFOT4A:
M)XU: J8B 5*?=P>1C'%75GSQC[LHM::MN+?DGMZ&4(QC*7++F_F3ES-/2UNR
M7S):***Q-0HHHH **** (ILF-@%W''0CVK@M6TFZU LGV"#:2<-Y9/OZ$?Y]
MN?0J*TIU/9NZ2YNC=]/EU^?Z$2IQFXN5[Q=U]]SRAM#U>VT^:VM;2V D1EXC
M8/SZ8'M_6O'-(^%_B!_$$MY=/?P1.^[*$A &))QE>G/?]!7UU13]K=RE)7E+
MJFXI6M;1::6%4I0JJTXW[/JO1GRCXT_9HM?&&)I?$^M6LNW(2.ZC2/)&.08&
M..W_ -85YSH'[+GBKP=J)O\ 2-9LKM5(*?;))))",\9\N%1GW&.WK7W3+9Q3
M,&9I 0<_*[ ?H?YYJPB"-=JYQ[DD_K5?6*MDN;W5]G9=.UNQC]4HV6CT^%WV
MV\NEE8_.7XB?LD>./B=K5EJVJ:MI5J+29)=B23HQV,K8 ,#^F.N:^S/AIX%F
M\#^&K30IYC.UM$D9>-MR':JC()13_#TQ^E>HT4I5I2M[L(VVY8V=^]^OS\OG
MHJ$5RZOW>ME=[;_<?.GQ1\#VVL*\C37"$ M\KJ!^/![9S_(YKP#P-X5ATSQ8
M@69'VRC&]LMPW Q@*>17U/\ $*'S(Y#Y4C_*>5NS$!P<\9&>_P"1KY[\)JB>
M*U&YD/F 8.9<?,?X^_X=.M;+%15)0E\3TO)VULE=<MG]]S*HJBJ1;491;2UE
M9K;9>[??O;1;7/MRQ&VTA''"+TZ?=%6ZJV7_ !ZP\Y^1><8_A%6JXSK"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *@N#&(V\Q@HVMSGV^AJ>F2*&1@
MP!&T]1[4;[@TGH]GN?%WQ+D0^*K<1O?,#.#^Z*[/O'KQGDY_P KZF\%9_L.T
MSO\ ]4OW^O0>G?/7\*^5/BG:W1\6VK0X5?M"YQ*J="?X<C/_ -;Z5]4^"0RZ
M%9A^HA7/.[G SR/K^-&B225K?=^1*36EHJ*TBDGH=A11104%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZP%QAI]]LZHP7EN>#DU_0!XC_P""/GQ=M;&2?X;_ +9WQNTW6%!-K-XF\?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;J8'(EN+>*60'V9E)!^E;D,$-M&L5O%'#&HPJ1H$4#T 4 "@"6BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,9ZTKZA8Q\O=P)GIND4>_<U'_9.F;M_V&VWYSN\I=WYXS2RZ7ITPQ)9P./\
M:C4X^F0: (WU:P"DQWMHS=MTZ 9^N?ZUXQ\01>:F5%G-NP5Q]E GZ=<XSC&3
MGN?I7K?_  C6DEMWV6/KG;L7;Z=,>G'6K\6E:=#CRK*W0CN(E!_04 <5X%AU
M*VTZ..9&.  3*/+;@ 9VX&",_3^OH@S@9Z]Z145!A%"CT Q3J "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>B;OH]+.UU^3,ZG/R^Y)1?G'F[>:M^)\EZS^T[JFCW0MY/",SEF"#_2'7J<
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M  G]]]S^P+CSNFS][M_[[\O ],_C7INQ!T1?^^1_A1L3KL7/KM'^%9@>9?\
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M2]%?I]IKF_'N*G!PC9RYO.R7X+0****@L**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5[A ZX.>_0X_^M5B
MHI<[?P/]*+M;-K7>*N_EH]?D14?N2]#QSQ1!"MY'N//F+]Y2_<^H/YUZ5X>
M%A%MZ;1VQZ=J\W\5QRM>QXEF3]X/]6BD'GH,CVZ^E>D>'@RZ?"&+,=@Y<8/;
MM[TW4G)M2FY?XHVETWZ?<D8X=*W->\GO\5^F]VU]R1O4444CI"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/XT[[7:XW?:(<=<^8N/YTM>W]?TT"DF[)IOLFKEBBJ(U/3BVP7ML6]!,A/\
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M6*Y'JE\7OVT_S['Z^VG_  3W_P""T"V^$_X*,_"&574'>UCXA=AD?WO[;/\
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MWBCX-73XP<G'DNQZ'GDU\E_$O]K_ %?X0ZE:1_%W_@BG\.O"(>X1!<1:C\,
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MGUYK,B@ECF :)VY^\LX1>N/N9ZT ="GW5Z]._6G4U?NKQC@=\_K3J "BBB@
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MDM;77Y/3Y'SW\1_#%E?B1KMK>X."09Y A!QP1M_S^=>(>"]$MK+Q0GD,0JR
M!8\-'G/9NO\ ]:OI'Q_L$4F3;#Y6^_$6(X/?'^%?.OA2!CXL5_.<KYPPJ/A/
MO'^$G/'_ -:NM590HVNU=/2:YD]MDHQ2[[O7YW5_9\J<6VVDN2\K;?$Y.]O7
M;IJ?<-CQ:PCGA%ZC!^Z.U6ZJV7%K".>$7KS_  BK5>>;!1110 4444 %%%%
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M"+[_ -U?O]>G\_6@#7HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;:7 \Q>%\FTFE4'VS7V+%)'*@>)E=& *LG0@]",=O2@"2BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2,\UQ_@C_@C1^T]X1\+VFB:/_P %+_VF=$CMX5C2PL-0T 6D0"JNV/=HY?:
M ![ 9KHH/^"0?[5,P:+6/^"G7[4%Y:O\LL#:EH.R6,\%7QHX."I(/)].E:IQ
MVE)1U^%7:MH^C5_ZZ:&JC1C+V;J47%N_,G-6VW3J1A=^2TL?(OQEU7_@J?\
MLHQ77C+QE^WOX"^*]C8%I9-#M_A[X1\/3SB,DLH$>JW<L>X<8\HD$=Z^F_V"
M/^"H/Q3^.\W]F_$K0?[4N+>0V[WFGR1*DK*=OF;;.S"C.,D;L=:]%\*?\$/_
M (;_ -IQZC\5OCE\3/B],6#74'BV]LYHKILY?S$@MX0=QSD #C@^_P"D_P %
M?V*O@)\ ;>.+X;>!-'T=E4!IDB'F2'.2['GYB22>E:5O96BDU.5EJ[TDMKK7
MFNGNM/STJM#!.-IU7*?3EIN"LK:<SDX_>O2Q]#>&M<_M_2HKZWM6LC*@81S
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M]>CV\CU\###RA.6(]G-KX;>_R[6LI72\[I[]D?K9\*?#'_!:']I'25\4:?\
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M7-$EO(^AL(P1@;BO^CR[.,8Z9K^CO0K6ZL-/MK.X4N\,2(TA/WBJXSSGT_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MLO32_P![ZCC6JP5HU)Q792:_(\I\+_!GP-X.@B@\.:?_ &7%$H1%M"( %48
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M>VMF_)6_5F<>:WO--]TFE^;_ *Z!1113&%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 >%_%+S<)Y<L4?*_?B+_ -#^?Z5TWP]#?V9'
MO=6.,C8FP8QZ?SX]?<US?Q125A'LFEC&1_JXPWX<UTOP^0KID>^1Y#C@NH7G
M [#]/6H^W;]V_*5XNVFTM;ORL<U9^_!7C?F6G*^;IUO^FAZ8.@^@_E2T@Z#Z
M#^5+5G0MEZ+\@HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4A&1CD?3@_G2T4 4OL0\SS/M%Q_N^8=OY?I5P# QR?KR?SI:* "HI((9?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'!62XNP,]" !U_7_ !V+'XIZA?P^9;^)O!%PW4-!+=F/G)Y)'';@?AWKLO\
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M+9M>39AW'Q'TN%=Y\0:!&N <R22],9.,>N#^%9,WQJ\%6X*3>,O#4<PZAIY
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M _+_ ":BO?@KX'OM3&IS:+IS3@YR;6/.3CI\O R/\]^O3PKX2T^%(CHFG;$
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M*>ZC*,[M>B2_,9-\7/AY;#-SXGTZ#I_K)<=?PIMO\7?A]>#-GXDL+I>YBE!
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M)QC>ES/=W:UTVBW=W_KRZW_A8G@WH==LL^F\_P ]M8NJ_&;X9Z&H;5_%VE6
M/0SSA0?S'?Z5UTOA_0B-J:3IP?'!^QPG]=F?\_C7':Q\*/"/B/C6=$TZZ0'(
M7[+"OKT^7W_I]-$HNW->*?VM';1:V;5_^#]S4IJ23G&=OBC"G)OIU3Y8OU9<
MT[XM_#K5H/M.G>*M,NX,9\R*;<N/KCZ_D:L_\+.\"#(_X233N.O[W_ZU1Z/X
M"\,:!$+/3?#&GI;^\,!&.1T*>AZ>];Q\*>')%^;0M,0D<XM(,]/79V--PC%Q
M;;<'NXN+ET^RF^7>]G=V-8N3OS)+LK-/Y_\  .3E^,_PQAF%O)XPTE9B<",S
M_,3[#&:U%^)G@=D$@\0V/EGD/YGRD'OD#Z^WX\5GW7PI\'7-V+M]%TP2*<@_
M8XN/Q"BNG@\)^&X8EB&CZ8RJ  #:PG@>GR_Y[4?NKZ>TDNJLDUMU3?IM^A/[
M[F6M-1OJK2O;3SMW.8G^,'PWML^?XKTR/&<[I@.E,M/C+\,[^3RK3Q?I,\G3
M8DV3GICI6Q=?#WP7>-F?0=+8GL;:#G/_  'O3;+X<^"K%_,M?#VEQMG.5M(.
MOUV?Y^M*7LU;EY]>Z2MMUV?R2_$'[6[LX6UM>,O*U]?Z_)[?$7P6HW'Q!88_
MZZ?X@5C7WQD^&FFKNO\ Q;I=JHZM+,% _$UV7_",^'\8.C:<1TYM(?\ XFN<
MUWX9^#/$$)AO=!TTJ<]+2$?R2DN2^O,EWT;7RT_/_@+]_P!Z:\K2?RW_ "L4
M].^,'PXU:,RZ;XJTR\0#.Z&;<,<=P/?ZTZ3XN?#^%B)O$=C%@X)>0 #_ #U^
ME3^'_AGX.\,Q>78Z)IZ)@C!M8C_[)[?TK2NO"7@^^S%-H6FL>X^PQ+^OE@=_
M7%4HP;=HSE%?:MJM5K9/\+_/JFHXAW:<)6_N2LOFI?GY>;,$?&7X9D[5\7:4
MS=E$V2?TJ['\4?!,@W+KEIY?42>9\I_3_P"OTJ[!X!\&V8+0^'-(9NHWV=N?
M<?>3UJ<^'M+;]TGAW3(H^S?9;8KCIPH3N#_GNK0YDKRY6[<S5NWK^H+VO5T[
M>2EK^.GW,YVZ^,WPRLFVW7B_28&])+A5.?3!QS]*DMOC!\-[P@6WBO2YB>@C
MF#?RXKB?%OP"\)>*KV.[O8[. K(&$<4"1*3G."$*CZG!_6N[\/\ PU\)^'K)
M+6WT?2YA&H D>T@+G'<L5)S^)_"KE"DK<L^:^RU^YMQC^"\C.<L0GI&')WU;
M25KNRWZV2UU^ZQ+\4/ D W2^(K&,8SEI.WK6-)\<?A5$YCE\::/&XZJUP 17
M9MX8\-W*,DFAZ6005_X]+<\$8_N>F>_:N.NO@WX NK@W!T#3A,<DG[-%C/7A
M=N![_ETJ$H7M)N.VN_;M_6OW+FKVC*')43:3NG"VW=MZ^C-*Q^*_P]U+_CQ\
M4:9<_P#7.;=_2K-Q\2_ UJN^?Q'I\:CJ3+QQ^%2:3\/_  QI  M]&TP 8'%G
M".G_  '_ #UZUI7?A#PU>QF*XT73F4_].L(/_H%9S33M&47YVEY=';S-FZEM
M%%2[-MK[U;\OD<_:_%CX>WA*VWB?392,Y"2Y/'TIEQ\6? =H3]H\0642C^-I
M %_/'H<_RJW;_#OPS8,7T_2=-MR3D[K*%_YK]?\ )K7_ .$1\/2)LNM%TF?U
M)L+<?IL]*.BZOJ[67R5V_P 0A[33VG+_ -NW_-Z=^AR*?&OX72'"^,=(+="O
MG\@],=/6KZ?%?X?R@>3XFTZ;/0)+G^GO4UU\-?!4YW#PUI*G.28[*!">O]U
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M8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:BTOBCS+M>UO.]K]!65^;K\[?=>WX'JMLVZ)3N=N.KC!JQ4,$*V\:Q(695&
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MGP2^+WCS]HRTD\17NK:KX5MK4M,]M:H$W*N&*A9@V3U'4'CK7WWXI^&7P_\
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MVW]?\W^]6JL[]&[);;M*[[[=/N_+K]J3XF_$KP7JK+X9\5Z]9Q*Y^6UCC,6
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MN1)N8],EN,9QGZ'IVK[JU_6H]&L)+L>7)*B!MK'J<9Z Y[?AS7"^"?@MX.\
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M<+<W-Q:Q/+,IW!V9<E@0!D'J#7=UCZ#H=CX=TRVTG349+2TC6*)6.2%08&2
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<OC=\>O&?BNWU<17MYX0UGQ8]]ILHEVRO$^GWD,X93N*89F]*_?WPM_P1O\
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M%W]25(]@?\YI]*[VOI^'?^O,<;-\W+9[7:7,UZJ^GS#\****104444 %%%%
M!2$ @@]#UI:* *OV*WW;]AW<<[F[?C5D# P!P*6BJ<I2MS2;MM=MV ****D
MHHHH **** "BBB@ I" W! /;D4M% %5K*W9PY3Y@2<@D=?H:L!% V[1CISS3
MJ*ISF[7E)VVNV[>@%<VL).XIS[$C^53@!1@=*6BDY-[MNW=MC<I-)-MI;)MM
M+T[!1112$%%%% %:2T@E8,Z$D'(^8CI]#4R(L8VJ,#\33Z*ISFTDY2:6R;;2
M]$ A4'JH/U /\Z7IT%%%3< HHHH **** "DVC.<<]:6BDXJ5N:*=MKI.WI<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVFVO@2Z:+D2:1\^_#C]G?P!\"_!">#_ACHL>E:9! L45LK23 !%*K_KW=O\
M/2OY]?\ @K-_P33_ &EOVNT@B^%VBV%P8IPS-/JMEI6%#$[LS30Y..WO^?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
L !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 0U!WH# 2(  A$! Q$!_\0
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M,P')7(^<YS_D?YS4DHBV_+.SG(^4YXY]_P#'\Z )[9[D(?*V[<X.?3\.^/\
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M "14I$6S_7MNP/DY_P ^W3\.] "VK3JS>3C..=W^?Z]Z9,TQER^-_MTZG/\
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MV?+.SMD?*<\?R[_Y[$ FMGN K"+;M[Y].<]/7_\ 4*@W2^=G'S[L?KZ_7O\
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M>FMM\S <E<_>YSWH MW+W)0>;MVYP,>GX]\?_7Q1;/<A#Y6W;G!SZ?AWQ_\
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M=>G3_/\ GW#(]WF_ZS:<GYS_ /J_ ?UI\X8;=TPDZ],'_/;\NO:@"1"WE?\
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M F8MY)_T8 8^_P#_ %NGTQ[=*BMR03B$2\=#VZ=ZE82>4<W"D;?N C/Y<U%
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MD!.TX@$G/4]O?_/'KZ!9@^SFX$@S]T$$_P"?P_*D@#E.)Q&,]"0/\]@/IWH
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M/^>X/U[4 $!.TX@$G/4]O?\ SQZ^@A4GS1^[!^;[G;^G^?SJ: .4XG$8ST)
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M[_3K_GV[I#N+\2!#_>/&>O?_ #U[4L^[<,RB0XZCM^(';G'U[T 2L6\G_CV
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MA5Q[.5OWCM&2.I##_P#5USWX]J@+23$PB2 XXP&&[K['_#WJDG*]DW;R]/\
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M[]ZBB\K)\R-G7 X'Z#D8]_P[=[&^;RL;HMFW'49Z?7.<?X5#;M(&;RRF>^[
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M_3KGOUP: "4Q<>5&R#'1OJ<^WY4]3!Y8S"^_;PW;^6>?;&,]J+CS<CS=N?\
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M8X'\_P K,OVCRSN\O;CL!_CZXSG\<5';^?AO*V8SSG&: (/D\S[I"[AD=_\
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M]^W^<=*?*(ACRG=A_M9]_7)_6B+=YG$88Y/R_P"?;GC\*=.6.W=$(_0#\?\
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M]_Z?UJP(K%1@RR@= 1G/X^]?P9-_P=;?M$>9Q\!]%*?WMX_GGKTITG_!UO\
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M1HQ<2K$29!C#-M]03Q_+WS7].G_!/S]M_P 5_MB^!K+Q?JO@>QTQ[F*&5A"
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MVV(2<#@_7\O\_2@".3R]^$9BO')ZXSQW[]_?UZ5*X@V'9(Y?C@YQ^'./R_\
MKTR7<9.8PAX^4=/?IQ_GFIY3)Y9S J# ^8=?_K^G\N* ((A"0?-=UY_ASU_
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M*?- J<]1Q_\ 7/'/X<T ,B$!7]Y)(K9X"YQU]CT^OO\ 2HTV&3YF(3)^;O\
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M .M_7^>:B3;YF3&6&3\HQZ_Y/X<T 23C&W]_YW7G.?Z?YQ^<B#]WG[5MPO\
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M)_ >^*MQVZ[%FMKO[8[#/D+R1ZC'Y^GK5JTU;PN8_*N-"<7'3#<-N.><]?\
M''?J*]QJ]EI(,]KI,\0;[K$<<]/T_#@BE]4PLI)J-.$%NI.*YOAUC9]/.W?R
M+E.O*:A"FX6=DV^92V^)R;:UZKT=KDHFD5?WX^SN#Q&PY;^77_)K,FNM7F)B
MM]+ED4\"=0<'T/\ 7L,=.PJ];12^)Q]I$P@*<@,<'C/ZCTSVXXJ9QK6GCR8]
M04HIP  #^7'X\>M4J&7-N/+37+:]K)OT;M?;I=W^0Y.M3C?E4Y->]>I-PCLO
M=6NWE;8K6-I>I\UXKH#V=3Z_7^G3BGSWDL4H54)CSC<!D8'O@XJU#9ZMJO\
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MY&#9[@<?0=?TJE%86T5QYTZI.!U0_@.GKC\\8IEI+M4[(VCQV((Z#MSU.?\
MZV:E^U*7VFW?<0,OCC.,Y^GI7E8W)\-3C4FZ=-7B_<DE**T5N6]][>G=[EX;
M,*\FHTI2;37-*I9MK39+2_?I^9R/BA;*YUC25LT33BMU#ETX)^8?B.?YD>M?
MZ/O_  0!@:/]GW2U>Y,_^@VOSGM^[Z]/T_45_F]:X4_MK2]T1D!NH<*.<?O
M><<]./?\J_TB_P#@@+L_X9^TS$94?8[<[2 #]S_ZWO[5_-'BIAJ%/!QJ4Z:A
M/VT5[KDM--5'X=_+[TC]BX+Q->I!1G-M<CT4*22O9O5>]NK:]#^A">",.2+D
M.<CY<_3CI_\ KZT@9@>)3'_(_G@9_P _5TYB+L!;.IS][WQV_P#K?RH5X5_U
MD1D/MZ9X_P _G7X;7;>'=^9Z+1V6R7\NB^Y?Y?H^$=W=^]JMW+O'\?P)!EAS
M+C@YD]@>OX]:@F0G_EX\WI\N?T_#I^F:E?:R_(AVXY7';/(QU]NW^-41MGY8
MVC[Y(/(S_GOBOFI65:+O%-/1/FOT7S_X?T/8K1YE37=?"K\VRV;5M;75VAT:
M[1S+LP!\O3.,_C^1'6I$>-FVX\LD_? QSUZ_R_*GKM  >%I#V89&/<X_SQBH
MTB4/EOF&>$&"?_KY]_RKI33E=WUM;2R>B[)-Z]SSIQ49M2OOHFK/IH[;]-QL
MR;2")_-!SCOC_/\ 3KZRH/W>?M6W"_ZO/7 ],?X=*BF*9 2)H\'J>_7UY['\
M_04]#%L ,#%MOWNW3\O\\5H/;1*R(X1\^/-\O_;_ #Y_3THG&&'[WS./O=>O
M?I_GT/9(BH;YHRXQ]T?0_P">/PHFV%@5C9!CH>_Y^O\ 3GF@"=A^Z)^U9^7_
M %>?7CIC_'KWJ. 9)_?>3[]/3_''2G,8O+($#!MOWNWZ\?Y],U'"4&=\1D]A
MVZ?YX_E0 D@_>$>9NZ?-]/\ /_ZNM32C$?\ Q\^9R/DSG'?'3CIC\.W6H)-O
MF<(5''RGK^'X\_RJ64QE/E@9#D?,?_K_ -/YXH 6 94_Z1Y7/3.,YSQ^..G%
M0X_>_?\ XOO_ /U\?C_G%21&, [H6D.>".W7_/IZU'\OF?<;;NSM[_3UZ<>O
MX4 33C"C_2/-YZ9SC&./PSTYI8AF/_CY\OD_)G&>^.G/7'X]^M,E,9 VPM&<
M\D]^G^?3TI8C&$^:!G.3\P_^M_7^>: (XQ^\ \S;U^;Z_P"?_P!?6GSC!'[[
MSO?KZ_X8Z5''M\SE"PY^4=?Q_'G^=.F*'&R(Q^Q[]?\ //\ *@"91^Z!^U8^
M7_5Y]..F/\.G:H8!EC^]\OC[W3IWZ?Y]!WD4Q>6 8&+;?O=OTX_SZ8J*'8&)
M:-G&.@[?EZ?UXYH 68?/CS?,_P!O\N?U]*F<?N\_:MV5_P!7GID>F/\ 'K4$
MI4M\L908^Z?H/\\_C4KF+80(&#;?O=NGY?YYH ; ,[OW_D].<X_I_G/Y,D&)
M<>9NY'S]?\_Y^M.A*#=OB:3IT_\ K?A[\>E,?;YG"$+D?(>O^'Y?A0!/,,)_
MQ\^;S]W.<>W3C_ZWXTD*Y4_Z1Y7/3.,Y[=/\_J4E,97Y8&0Y'S'IU_+\OPHB
M,87YH6<YZCI_GOZ<\T 1@?O?]9_$?G_3T[_Y]*DG& O^D>=R>^<<?3W_ /K]
MJB^7S/\ 5G;N/R=^GY]./7\*?,8R%V0M'R>3]/?G_/UH EC7,8/VG9U^3/7_
M /5_GTJ"(?O/];LZ_/\ CG.<=O\ .>M2QF,( T#,>?F'^?\ /;FH8]@?YHRX
MY^4=>OMSS_\ KYH ?.,%?WWG<'GKW]<>WM^-2@?NL_:?X3^[S^'3].M0S%"5
MV1&/@]>_/Y_Y^E2 Q^7CR&W8/S_U_P \_A0 R ?,?WWE<?>Z=.^<=^GX]NZ2
MC$G^M\SI\_ZYS^.?\*2$H"=T3.,# ';KZ>GY>E$A4O\ +&4&!\IZ_P"/^?7-
M $SK^ZS]IW\#Y,],^W_Z_P"E,@&=W[_R>G?&?;I^/]>P5S&8R! P.!\W;_#G
M\O7FFPF,;M\32=.F>/R_KZ4 -;B4_O,_-]_Z?_J_']*EF7"C_2/-YZ9SC';I
M_G]1"VWS#A"%S]WOT]O\_A4LIC*_+"R'/4]/\]_3CB@!85RI_P!(\KGIG&<]
MNG^?U,2\RC]YCYOO_7_]?X?I4D1C"_-"SG/4=/\ /?TYYJ)=OF#*$KG[O?I[
M_P"?PH DG&-O[_SNO?./;I^/]>Q>B_NL_:=G!^3/7'M_^K^E1S&,[=D31]>N
M>?S_ *>M.0QB, P,3@_-V_PX_+TYH 9$,R?ZWR^OS_KG/X9_QI9Q\P_?>;Q]
M[KU[YQVZ?AW[-C*A_FC+C!^4=?\ '_/KBB8H2-L3(,'(/?IZ^OY>M $^W]WG
M[3_#_J\^W^1U_P :B@&2W[[R>!ST[^N/?W_"I,Q;,>0^[;]_^OY\^OX5%"4!
M;?$9.!T[<_G_ )^M "2C]Y_K=_3Y_P <YSCO_G'6IY%Q&3]IW]/DST__ %_Y
M]*KR;"_RQE!Q\IZ]??GC_P#5S4TAC*$+ RGCYC_G_/?F@!(!D'_2/)Y]<9_3
MOU_#\!&1^]_UG\0^?]/3M_GTIT)C .^%I.>HSZ#T_K3/E\S_ %9V[A\G?I^?
M3CU_"@":9<*/](\WGIG.,=NG^?U"PC*?\?/E<_=SC/MTY_\ K_C393&5^6%D
M.>IZ?Y[^G'%$1C"_- SG)^8=.OY?G^- $<8S+CS-O)^?I_G_ #]:?.,;?W_G
M=><Y_I_G'YQIM\SE"5R?D'7_  _/\:?,4.W9$T?7K_\ 7_'WY]* )4'[O/VK
M;A?]7GK@>F/\.E0PCY\>;Y?^W^?/Z>E2(8M@!@8MM^]VZ?E_GBHHBH;YHRXQ
M]T?0_P">/PH 6<88?O?,X^]UZ]^G^?0]I2/W6?M6?E_U6<X[=,?X]>]0S;"P
M*QL@QT/?\_7^G/-2$Q>61Y#;MOWST^O/'^?3- "0#)/[[R??IZ?XXZ4R0?O"
M/,W=/F^G^?\ ]76EA*#.^(R>P[=/\\?RILFWS.$*CCY3U_#\>?Y4 3RC"9^T
M^9T^3.<<9QVQTQWZ4D RI_TCRN>F<9SGC\<=.*20QE,+ R'^\<^A]?Z?CVI(
MC& =T+2'/!';K_GT]: (\?O?O_Q??_\ KX_'_.*FG&%'^D>;STSG&,<?AGIS
M4/R^9]QMN[.WO]/7IQZ_A4DIC(&V%HSGDGOT_P ^GI0 ^(9C_P"/GR^3\F<9
M[XZ<]<?CWZU#&/W@'F;>OS?7_/\ ^OK4D1C"?- SG)^8?_6_K_/-11[?,Y0L
M.?E'7\?QY_G0!).,$?OO.]^OK_ACI4BC]T#]JQ\O^KSZ<=,?X=.U0S%#C9$8
M_8]^O^>?Y5(IB\L P,6V_>[?IQ_GTQ0!' ,L?WOE\?>Z=._3_/H.Y.,,!YOF
M\??Z_C_7I_A20[ Q+1LXQT';\O3^O'-$VPL-L908Y4]_S_+^= $[C]WG[5NR
MO^KSTR/3'^/6HX!G=^_\GISG']/\Y_)SF+80(&#;?O=NGY?YYID)0;M\32=.
MG_UOP]^/2@!L@Q+_ *S=R/GZXQW_ ,_IUJ6483_CY\SI\F<X[XZ<?_6_&H7V
M^9D1E1D?*<>O^3^/%22F,I\L#(>/F.?ZT .A7*G_ $CRN>F<9SVZ?Y_4Q ?O
M?]9_$?G_ $]._P#GTJ2(QA?FA9SGJ.G^>_ISS47R^9_JSMW'Y._3\^G'K^%
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M#,?_ !\^7R?DSC/?'3GKC\>_6F2F,@;86C.>2>_3_/IZ4L1C"?- SG)^8?\
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M20C*G_2/*Y^[G&?;\:24QE/E@9#D?,?_ *_]/YXHB,87YH6D.>HZ>WY?EZT
M1@?O?]9_$?G_ $]._P#GTJ2<8"_Z1YW)[YQQ]/?_ .OVJ+Y?,_U9V[C\G?I^
M?3CU_"GS&,A=D+1\GD_3WY_S]: )(AE/^/G9U^3.,\9]\XJ&(?O/];LZ_/\
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MX$7S2(5P, 8R/KSGCWQ4=L)CN\IT7IG=CI^)]?\ ]7>FO]GV':9-V!G(./\
M..GZ8IL7D_-YI<=,;?\ )_SGWH &W^<02"^[KV_S_GWJ:X$X0>9(C#/&W'3W
MP>O^?8UFV>8<;MF>^<_KFI9?(V_NS)G=SN!QG_./<#KF@"6W$Y0^7(BC/(;&
M?PR<]/\ /:H$#^=@$!\]>U+%Y&W]X9-V> N<?YSZ'IZ<4Q=GF<YV9[9S0!-<
MB8;?-=6Z_=Q_0_Y_E)&+@Q?+(@7!R#C)^G.>?;-5Y?)^7RBYZ_>S_P#J]?TX
MSS3D^S[!N,F[!Q@''^<=?US0 D D,F(V56YY;I^O'_Z^W=UR)>/-97..J?\
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M )!\X'EP[% !S_#T["M:'B/6HYO/+,UPN&P%2$4U6ABOK"DW\,5+DAJWH/\
MU/PD\'&MA*SJIMK]Y246UI;>3LW;\S^ ]K75KX;K+4K2!#ROF.JX'(P>:N6F
MJ:KHK""YECU&9R%1;8"0[CT QNSR>/\ )&!\8]"M_AM\3M<\&O-<IIFFZC+:
M0,LC!]D;;5R<]??^5?=?[&__  3X^/\ ^T[K^B:S\)+&VU+1X[JVFN#?,SDQ
M"56? .<G;_\ 7K[)<:X?"4OK%;FC*.O-&/.I1TU4&TF[;R_,^:K\,XF,G3C*
MA3YG_P O9672WOM771:7T['S-;>"OC-XMB63P[X+U^\AF'[MK?1;J8$$_P!Z
M.(YZ_B*F3X<_'_P3NNM8^'OBJ. C<6?0+Y0%SG/S0CMD?D.W/^D)^R+^R'\/
M?V7O@=I>K_'/PIX>75]*L8GO7ETVRE7='"C,=TT1ZLAZ]CFOQN_X*O\ _!1/
MX5:9H5[H/[/_ (6\%7>JVJS6KJ=&TUB'3=&>(H2<C''TS7CX7Q3CF>80PN79
M;C\3A^;EQ.,O*G&C)-/^$E)23M?XEH=$N%98.@Y8[&X.C5FN:C2<N:-2*L[^
MU^SIY'\:^MZW;74QM?$GA_4[&^<[?])M'M\,3CD/&#D$_P#ZJR8O"3Q?\3#3
M[F*.-B&56D&X=?? [=J]6\<>./&WQ:U.?Q!XUTS2-+ FDD:/3[>*VPI8DX1$
M3WP ..*X>XUSP4\/]FZ4]\VJ+A&#!_*+]!CV]ORK] AFRJJG*-:3<_LS?)*+
M]U):<W:Z\]#Y*K'EE6C1I2G&A_$G3]^E:ZU<VE9>=G>QF9U4'8]Q$0!CYL#N
M.ASSQG_.:L!&V9)#2]F7&/\ .<=...*SQIUSNWWS,JGE-I.<>_\ 4<=^.XO)
MB- B'*8().<]QQGV/<UZG-B\13BH2UCK>W-I9.W.[=+;7[W/-^L8:4%*3A.[
MVB^9)_I;KV_ (8[PDB:1&C)&-O4#^7'?H?7/<E6Y5ML4D:KCD,1D^OOW]/H*
M7<L7S)G)X.<]_P"OO[?2H&@AN'#R,X8'L2!V[XQ^'\J*<Z\;R=^9*VOO=%T?
MGT^5[%1K47+WN52T]Y:KTYM->Z)V1]A*D"3'WNQ/K]/_ *]$,5T2?M$B..HV
M_7V_^M[8ISA$C*,WR#('][!XX[_Y/TJ.W\H;O*+GN2V?4XQGGUQ[5R*O52ES
M.H[R7NI<K>JVC?7_ (/W=D:%-TG+DTWTA>+V^U_P/N'.ET'PLL0CR!M.-W)P
M/Y=_3\TN"1'E,!\9).,9_$8]/<>F>L$GV7S_ )FE\S(X&=N>AST[_D/K4UX4
M6(>;G9CMUZY'^?3WKZ/#WE1@TW!N"UEH^BU6G;;0X<0DK6CI&W_+M5$E==VK
M6_#;89:N<'SL.<_P@?YZ>IS]:L$OR5*!.F,<XZ@=.O\ DU3LBA'[G)3G.[K[
M=>?\\UI,MB1R7\W'3G!/ISV]_;TKQ,VKU.25.4N=Q^'E;6NBU6OXVZ)&5-J$
MH/E:YFE=0]DMEVOS>7F>?:U))_;6F>6P4F[A/S?]=!U'3G\OIG-?Z1W_  0%
M\UOV?M+W,I86=L,_\ ^O^?3'3_-KUU8QK>EB0MC[5#@J#_ST'I^/8=/7-?Z1
M_P#P0$\L?L^:7MW;?L5OGKG[G]/>OYN\3ZE:>7Q]JFKUEHX6CT\]?3UVUO\
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M^>.W2H;<2DMY3*I[EL8_7 _6D;[/L.#)OV^^/Z'C_/:FQ>5SYI8#_9_#_/-
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MG_/O3HO(V_O#)G=QM!QG_.?<CIBHEV>8,[MF>V<_IB@">Y$PV^:Z-UQMQT_
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M?E0%LGY3T[\?Y_7K4D04IS<%#D_+GC^@]N<_XQ)CS/\ 6[1EOG[GW_I_CUH
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M4SA/+)^TDG;]PD^G^<\?G0 EOYOS>7&LG3AO\_YQ^4<F_P WE0&R/E'3_/\
MGWI80IW;IC%TZ?Y!_P#U]>U-DQYG^LW#(^?_ #W_ "_"@"Q/YVSYX40=F7J>
MG/3^7K^-)!YVP[(D<9Y+#H/7_/X^M-E"A>+@R'(^4GW_ !_D.W3BDA"[>;@Q
M\] ?\_3^AZT ,!?SL[06W'*]O\C_ #Z5)<>;@>9$D?/\/X^H]:AX\W'F8&X_
M/Z]?\_YQ4DP4 ;9S+ST/T/J3_G/O0!-%Y_EC;"C*,Y8CD?I^';VYJO#YGF?*
MBLW/RGIUX[=_\YZU+&%V#-R5.#\H/'^'Y_I4,8&_!EV#GYA]?Z?7KZGF@!]Q
MYF5\R-8S@\+_ )S_ )[]ILS^5_J4V;?OXYZ?Y/7]*KS!05VRF7@]>W/X_P _
M3\)<+Y?_ !\G.W[F>/IUQ[>O?/:@!EOYNX[(U<^C=.^>W^?:DF\SS/G14;CA
M>F?\XZTD(4DYF,? Y'?KSVZ_X\4DN/,XD,@P/F/;_/U[?B0"Q)Y_E<PHJX&&
M'4]/_P!7?-,M_-^;RXEDZ?>SP/7IZ\?U[4.%\LXN"QP/E)Z?GZ?3\Z9"%.[=
M,8NG3_ZQ'U_SP (V_P XY4!MWW1T_P /7_/%33^=L&^)$&>"HZCU_P _AZU7
M;'FG$A(W??SST]>/\G\*EF"[>+@R<]"?\_3^@ZT /@\[8=D2.,\EAR/T].?\
MYJ%-_F\*"V?NGIV_#TI\(4KS<&/G[H_^M^7(/X]XUQYG,A S]_//YT 2W'F_
M+YD:Q]>%_P _YS^;X_/\KB%&7!RQZCK_ /J[8J&8*-NV8R]>O^2?_P!77M3T
M"^6,W!4X/R@]?R]?I^5 #(?,\SY$5VYX;IG_ #GI4LX.!YJB-N,*HX/'K@^_
M7Z5!%CS.9#&,'YAW_P _7O\ B))DX!61I0!R3T'?N??W_I50UDO\F_P6HXWN
MK14]5[K3:W[+L4O-O-VWRAY><;L<^W./3_.*NP&3!VHLA/!#=!Q_+\>O;C-5
MQ/""5,IW#^#W_/K^ON0:G7$F<R^3Z$'KQ^?^>O-5B&_9NU)2TZIN]VK.Z?7S
MU-ZGV;KV3MI%*]WIV[;I/49)+$K@.Y27/"*/E.,#'7^E7XI;MK>;,2B/RI/F
M'7&T\\CV'J?KS5/:%96\L3#.?,/4#N>?3V]_:M))X#;RJLO(B<%<]]K?RZ'_
M .M7+@E'W].1]8VEOI\OZMW/)K>U56*E%5(MI)J4/<6FZW?3]-#^!S_@Y-EF
M3Q:=L*.OGX+,!GKSU!Y_IZ<5_*;X6DMFLH\G$Q_Y9X^4G'I_G\17]5__  <G
MQQ2>+2&N3$?/Z#C.2>N>._(ZU_*7X6L\62LIRO:3TX/Z?YZU_8_A%=Y;A.67
M(U&-V[6>JT6BU>N[_$_-.*%4=:M:I"G#73EE=Z1[O7?9=-CKSDC]\/)7C!3J
M<=.@/7WYXZ55;S01Y,2RIGEWZC@=,@8^IZ=CQ@65^485OM!_ND]/P[=>WTX/
M-5)0"X+3FW(;_5J< GCZ#_\ 4/3 _H?%_P !=[:]]DKIK2W37\S\PJ?#)=+[
M:)=/LR]]^M[>G6<=!_?_ +O\(/<=,8I",_>_=GMM[]?2E'W!Z=I.^/7IU_*D
M!(^[^]Z<GG'7BOB:[BZJY^9QOLI1?6.MEKI_EJ>=:U]EKM:273[+]]_+_(C'
MGAN((S'G.]OO8XYY!)]?SSZTEU*\<?\ HX#2$<KV!]L>WH??%0NH+\73(V?]
M4/Y8S_\ 6^M:=E;6A)_M"Z^S1XXD;OQU^N?\]J]:M6E1PL'!/DY$W9M/6W5Z
MW]?3J*LFU!*FIZ+5J7NZI:=5Z/;J9]GX:&K'[5=W+V[#Y@J/A>WN!CG_ /56
M\;&..,6JS9 X#[@2<8]#W_/)Q6)J5E$Q\O2]7D=#U*';C/H/Q'T_6LFR\.7=
MM<"[N=9G9,@E"YP/U]/7COZ5KE>)DX2DI*TT[<RYFE[O:SOMJ;8.U1N%6MR*
M"]V'):[]V\>;IYM[_,JZS#J]K=P6MA+(XGD5<;S_ !''OSD_G7[T_P#!,K_@
MF]<?$[Q/X5^(VI"X9H;RUN2N_*')W$$$\]/Q_6OP=U>ZL6U*P']HLKB:/&#R
M6W >GX^_O7]@/_!(C7?$]KH'AQ+1YI['=:[G\P ;<$=,]/IG^E?F/'5*=6EB
MG'_GW-_AMTMK?K^)]]D5Z4J7+1?+S1O+F3LKQU<_AMIT[?=_9A^SW\.]-\#?
M#30-$@LX8Y+/3H(=X10^43!.0.O3'TKY6_:N_9L\>?&!KFQTK6-6L--NP\-P
M;2ZDA589 4;@,!C:Q[_RK[6^&&KQW/A+3?,E_?BU0NI.<$*..^3T_H#7S)^U
M=^T</ACX/\06UM((;XV%X()D;;(D@@DV%2,?,&P1]/8U_(>$6.IYK56'I0J5
M^>:5/$1=K<RU7,U?R\W;NC]FA5P]2A33Y73Y8WE&4;)I+1V>[Z_,_!GQQ_P;
M+?LQ?&'6)_%/Q$^)VIVVNWCM+<QRZA 6$C,68'S)PV<L>W_UHM _X-<_V>O"
M4<DWPZ_:!\<Z!>*K-&= UEK=B^#LR;:Y!//OS7\I?_!0G]NG]MI?CKXBE\&_
M&SQ[H.@B_G\FUT_5IXK=(_.D("JK@  8'T K]7?^"(_[<?[4>K^*[:'QUX[\
M4^/T:>-7BU?4);@8RN>';'X8[@9]/9Q>6Y[43J5L1!2>JI<L(6NTTHN2M;_@
M:]7RSQF"HOEA%[VNG)VVO:*>OJOD>F_M3?\ !%O]N+X1R7UW\&?BY\5_%.AV
M2RO'/>>)M2+&./)4X\UL\>G^-?S\?';X??MT^"[B^T?XL:OXOOM)LY)(YEU;
M5+ZYB*)]X,)B5/ Z9Z5_J[?#7Q-=_$KP]%)X@TE;>.>W3S8)!N5MR\@CIWSZ
MBOP>_P""YGP7^&.C_ [6]8L?#^E:9J+VMU(U[!;HLQ?RP=V\#.[/?WKTN%L_
MJX+-,-A*]&G*JJL()TXP4KW6LI--/IJMOS^=S+*95J5;%TYUU&2<FYS;BUH_
M<IIJ6W=W[]3^"/X.?'?P[\);Z.\U70M+O-2MI5D7[3:I*S3(VX;F*D_> [BO
MVB^%_P#P<<?M/? SPS!H7@#X9^%KG0+.,)%(T:QL41 %.U8QV'/\Z_G!FU@:
M5KNJQVVBKXA5;N8*SQF3;AV'&%(P.#[=N*NV/C:Z6]7[7HDEK:[OFM/(D\O'
M]W&T<=1T/X8R?ZEJX#(N)\!2HY[AJ-6%**E!57S-RLM+PE&WDWHM'Z_'T,3/
M)Y.OAJE2=:II+EDD[:?9G>2[:Z_K_15XI_X.B_VSOB-')HME\//#UM+<!K;]
MT3&<N&3@[!W/KQ^=?,\/[(O[?O\ P5+\=Z9\1I_A^!I-Q>QW<]W8W3@QQ2.&
M9AA>H5^#GZ^WY/:EJ7AC74M7LE3P]<PLCF:"%HV9@>I.SK_*OW%_86_X+:>*
M_P!A/P8OAW1O"$?C>.W@"+<7$I#,$48X)&/N_7Z5^2\5\+T\OI27#>4T?90L
MTYUZ:I:;_:C-OROO^/T&6YO3Q->,\9C71E)<MG&7MO\ P.S@U?;2Y_3G_P $
MZ/\ @CYKO[/-CX>U[Q?K>O6NM6<4#W-A-<R/ DD8#%,%@, Y!XX%?MO\5?V@
MOAM\#/"TMOXKU62&2TLRB@QF7>4CX#$9')_SUK^7C]B__@Y(^('[6WQ5LOAO
MJ/PJM?#=O>7,<#7\4V6022;"V-QZ#I_*OZ@)?A7X'^+GA*.;Q78V6K2:M8!O
M],B$IB:>,$8S_=W<<GIG-?C.*4JN)C5SV-6"HM1^KX52YW9IKEJSYX*UO.Z/
MJ(8FGAVH8>:Q"J+F]M6Q%)6O9V4+QD_1+[['\4__  5(_P""K7A3Q'J_B+P1
MX>T70[^RNQ<6RWD]HBW.&W(#N9=V>>?P_'\K/^";?[4/P>^!OQME\>>/==_L
M"WO=36Y)@0;5WR*Q "D9"^G]:_H'_P""H?\ P;^^!O$D/B;XT:-\0I_#\=K'
M=7Z:3:0[(<@&0)@+P!C'''Y5_%?XJ\'VGPJ\=ZMX61_^$@&DWLML))QRWDR;
M0V#QG@$CWQ[5^V<+XGAS/,'3P5*AS.E"%.*K4XRK1T5O>44G+?6WR/A<[Q>-
MP=653V\N2;<N6A!P272\G=-=M>F]S_5(_9P_:_\ @O\ M5?#*>S^'WC&WU6*
MZTLP9N)XH/\ 60A>DDG^T![#UZ5^./[3G_!(?4/BIX^U7Q;I4UG.UY<R3+LU
M"V&=TC..DAZ[N./UK^+#PI^T[\</ 5I]C^'?C[Q#X"CV[([?1KV2V4X48 ",
M.F!T].@/3<L_VUOV[K?41>7/[0WQ&330V=[:Q<[-N?\ >/!_QJ*_AIQ#A<=7
MQV33PRHUW?EJ4I\T(Z;\LHI6W5ET\CAI9]A<QH^RQU7&)8=<U/V-2"DY*W>+
MZZ:[=3_0&_X)Z_L8ZE^RO<RZAXGGL+&UM]TCN^H6Q.Q 23]\= "2/KG -<W_
M ,%+/^"G7[(?@'P1XJ^'^N?$SRO%DVGW-K!IT#),KS[0H3Y)2,$X['W%?P5>
M*?V^_P!K[4;<6-C^T3X]N9)5$3Q#6)_F+#!4_/T)_/'2NC_9T_8^_:2_:P^*
M7AWQ'XYD\1>+],N]0A>ZO=2,ETKQR."Q8L",'J?\:^%S7(LQR/,7C<TFIR7+
MS3H*T-+.2_><_;5)W>R[GJX//*5>G'"Q=>%)/]V\3&4ZDY*R46Z,8JSLEJO-
M^>_\(OV;T_;V_:3U>QT:*]DT34]:9[:^@A=#)%++\K;MH )&/XN!U]_[U_\
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MV?\ 2RR*&-G;_*.!]SZ?7KQ[\5_FX:WAM:TL/(8LW<'/_;0>W)_']*_TC?\
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ML.R)'&>2PZ#U_P _CZTV4*%XN#(<CY2??\?Y#MTXI(0NWFX,?/0'_/T_H>M
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MP-^#+L'/S#Z_T^O7U/-+,%!7;*9>#U[<_C_/T_  L#S_ "O]4FS:?G_B_/\
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MW^<=:(0I+;I3%P.G?G\/Y^OXI(!OP)=XX^8_7^OUZ^AYH LR^?Y9W0HJG&&
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M4[B;RN9U*[1A<C(X].WY]^QZ $$) W9A,O3I_GZ?ETZ&FN?WG^KVC(^3^?\
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M^NXE1Y6E_?<GY_B>-EO$.#K8BI5QLZ=%V4K5,-1:EL[1NF^G;3T/[2OVL?\
M@@W^R]\1?#UQ%\*O &A>"[]8)-DMG:+O+X<J1M3KG&/_ *QK^/C]M/\ X)&?
MM-_!;Q9/X;^&WPE\5^-]-EGDB74-(TR62%4+$!LJN,8_#G/2OW]\-?\ !T+\
M./A]X=TX^-_">O>(]1CMHQ=O; DR2B,>8<8/4Y. ,'I6S!_P=K?LS:BX$WP/
M\2R8.#)+9*^/4Y,!)]>OUP:_)ZSXXR>']GJ%7&T[I^T4IUT[V]WFJ:W\[]SZ
M[!T\AS!?VA*<(6]VTE"$;JVO)'3S>GWGX[_\$E?^"8W[4G@/XWZ'XR\<?#SQ
M7X=L?M=M-,NHZ=+$L8WEF#$KU&?7MU]/]$3P5IJ>%O".F)J"B+['80"=I?E\
ML)$H8MGD8QD^E?RV1?\ !US^R^D)>'X2:Y Y7A4MHT8$\#.V('/XU^67[<7_
M  <7_&+XW6TMC^S-=ZQX M;A?*E6\C<[D8!2O!7'&3Z]J\Q\.<89W6BED^(@
MIVN_LN[3NVG=;[+=:W9O*KD?-[N.I<\;*+]BFXI6=N5Q47T2;OL?U*?\%'_V
MS/V:/#OPC\7>$M6^*_A2W\2-I]U"FA37\2WDDIC=?+"$D[LD+TZ\'V_S3/C)
M<:-\1?B[XHN=*NX-#L+C5+IX-5W PS(\I*NK=P>".>1^L?Q*\:?$;XYZS+XM
M^+'BB?6/$5P[2R7#W$J*7<[F.PR$=0,_X"N)L/#,%PP@O-2@,"\*&D ( [9R
M23[U^^\ >%N/R>E];S'$1A5FHSA2IZ..WNRE)1=U;K>S7G<^9SC-,L_ATHNK
M42MSU9>ZWWC3NXK_  V7H9VIVDW@VYCAM-WC,E@!-;#> <\<CZ=?<5T&L^+-
M>GT BX\(WFGVQ3F62,A5!7&<]^,G_(J*^NH/"N5TDB5U'RM'B09&>>^>3[_X
M^Z_LTZ9J/QO\>6'@WQMKECH_AVZGCADGU0QVUNJ,X4[I'PH 4D\].N>*_6<1
MG:R7"S@XJI&$6JKJQ348JVK<>:7+UNE?U/DXSP>-K0I4Z'L:_.E.4'&/M+M?
M#&ZBGIIMNOETO[$?_!/GQ?\ MD>*+9?"WB&72S'=JTD<<1D/#Y*G@XZ?_7K_
M $)/^"?G[$7A/]COX06LOQ,-E>3Z79Q2S:I?0K%L\M#N8EE&".YSFOCC_@F]
M^SQ^Q]^R#IEIXE3XR?#1;^6WCNI8DU[3_-$C)O92IE!SN/(QG(Q5G_@H=_P5
ME^#NE^#_ !)X#\.^*M,UJ.YL;FT1]*OX95;*[1M,3'K['\:_FSB;$8WC_-IY
M5E&#HQITY*<L8IXJ%.23M**C*$8_AWW/O\'1H9-AJ=;$U5[.32A3G2P\JRD[
M6;:YGIT][IL>:?\ !7?_ (*;?#_1_AWJGA'X%_%[1M.\36<<]K]BT?4%^U1R
M!=H4QHP.0>,?A[U_+W^S5X?^(O[6'C:UU+XP>(+OQ;&VIQNC:@6E#*9P<C<3
MU!/X=_3\P/CAKD'Q!^*6O^(M(:[@-]J,UPLLTTKQ_.X8'YF(]>V/Z?5_[+'[
M2.L_ [6=*:]U$/;Q7-NTFP@#8LBD\Y]%/)QQFM\-P)C,DP[HQG#GE"[Y9S<>
M9I:*\>;?9[7?<QQF>4JTXQ]M[MXZSA"$N732\;Z>2;T^9_HN?L,_L@?!'X>_
M"G1=8M_!.E+JMM:0NMR((P^]848,#M]1_3M7Y1?\%N_VN?C9\"M M(/@[XFO
M?"GE;8U_L\*F%4E0!M /0?CCCI7T!^PO_P %@_V>M6\$Z)X/\6:]INFWTEO#
M#+/>ZA!"B-Y:1DMO88P3D_ACBN!_X*:_ GX*_MP>';(^ ?VC/A?X9GE5)2-0
MU^P#+NRV"#,.1N'\O:OSC&8"M@*]>/$& S&OSSD\-."E67)=?#[SY5VOMV/<
MH8BG7EAY9?5I6BDJNOLTY65^;X>;[G?34]L_X(J_&CXD?M(?!A6^-6JS^+Y+
MNV1)VU%$D+K(HW D@D@_EFL__@K=^P%\"-0^%VM^(/"_A32/#GB2>*YE;58H
M$67S"JL&R%'(8DGI_2H_^"=VD?"S]@WX42V/BO\ :"^'7BF:PMMY32M;L7,G
ME)]U0LQY;M@ FO@/_@JI_P %EOA;\0O!&N?#SX?EKC5XUN+=+VTG6>)VQM#+
ML/()!Z9Z#WI\,Y1F]?.*5;)\/CJ6"C6@ZZYJE!0I:-NHFXJ7=VYC+-,92C0Q
M$<;/#>VC!_5_;4Z52"E;3DTD_O2ZG\>WQ0^#U]\-=>U&/4-=76HENI1&@'W%
M\P@ >PX]>WK7G<=PA@RD1Q_<]?3&>_Z]>HYIVO>,?&?C/6;Z\UV[D,4US(\:
MRJ0=K,2.I]QT[TZ"'RXP"X)_O C /;/7.,^G/N.*_I_#1Q-*-*,)SGR\MXRE
M+E5K72E'WF^NNFMC\<QC<YRJ5)T92D[?N8*"^45%17JNQ6AE4R?+;F#_ &ST
M)Q[]SU]:N.L38WQ"<G^+T]O\\?ABHR1P&=7Q@;5QG]/Z^M/4,1\AV=>#U_S[
MXKZ.GC,7%J'O0E9:Q]];+^?2WJM+=SPYN\FTI1?;7GZ?9?N_CUW=T*(E<8"A
M@<_N^O'IGKQWXYQ2%&AR4@:$?3 /8_7^7/M48\V$[U^\/XCGKSGZ]3Z\>E/>
MYGF 61]W8?YQ^%=,:V,4XJ4KTVE>VMOAW;U3\EY=CAE4<4XPBZ2;U2W;T5]M
M'?\ X<<D<;D,\&YNN_WZ]O?\?6FWN!&,H9Q_<'X]?Z<GZ4Q5N=V1<H$X_=YY
M[#].AS^-/N0QC'EN(W_OOC'?IQ^GK7N8=/E3<G*^JTCY?A^*]-3:=U3@Y34N
M9)I-SBUL].16;M;1Z?F5[,Y!Q']G]CD=C[<?IS5K(!/[HGG[^#CZY/'3KU]J
MKV^_:?-<2MSAEZ XR#P,8_IU.>*!%=ERWG+Y?!"=S^/0_P"<5X>8)N=2S2MJ
ME)1L]NNK-<.DU'WHQ:MI>4NW2:LOD^[Z'&:Z0=:TO]V9?]*AXP3C]X.W3_/O
MD_Z1G_! 3'_#/VEXB*C[';?)SSF/Z^_3GZ=Z_P W76PZZUI81U1A=0Y+?]=!
MD^O7G\?IG_2,_P"" QD_X9_TO=(K-]CMOF&"!^[^O^?0]3_./BK;ZE'F_B^V
M5U!RY+::Z[?=I<_8N"'I96^!]9J6RW5N3?I?]#^A"=EWM_HI7YN6Y]/U]L_3
M-1A2QXB,GN.V#^/^15BX$^YMUPC G[H(SV_E^/IGO4*22K_JW"CN#_GZU^%U
MG?#Z6O9:7D^BO\27X:'Z=A+Z66M^JCWCKV^;U_(ER$',?;[AX//;^?3FJS/&
M^0(?*/9CD9QGU_#^7>K)#R#EANZ[NV0>3CZ^O]*K2PR+R95DZ' QD>F<8R>/
M?]*^<?\ 'C=M2O\ RIZZ6;U_%=^IZ^(4>6',FY)+W59+IV\M%IWL*@VCB$R?
M[0X ]^<YQU]/I21R/NP07&3^[/.,9_SZ^O/%/A:<+@2A5QRIP,]>@P<\8]/Z
M4]&0O\GRR \N0<?X?B#]:]!;--<WG=KM_+HWZ_HSS;P<O=B[]5JU%Z?S6>FF
MVQ#,0<$0F+.<Y[_YY_PXXD0KL'^C%CM^_P#AZ=3^OY4VX$N07E60'ICM[?RX
M]N_6I4$WE<3J%VG*Y&3QZ=_S[=SUS+_X']?(K0GYN8S)Q]T?CW_^O^=+,1N&
M(O+X^[_G'^?04L&_?\KA&_O'IGGN<_Y]:6X\S>-[ASC[P]?7J/\ /I0 ]BOE
MG%L1\OW_ /ZW'XYJ.$@9S"9?8=NG>IV$WE',ZE=OW,C/Y<8_/OV[16_F9;RY
M!&?4X'IW/_U_ZT 12']X?W>WI\O^?S_QZ5-*1LXMS'R/G['\O\_RJ.7?YIRP
M8Y'(Z?S_  _QZ5/-YWE_/,KKD84$$CV[$<?7^A (X2 IS 9>>HXQU_SZU%G]
MY_J^-WW/;T_IT_QJ>W\W:=DJQC/(.!D<^O\ GW%0X?S<;ANW?>[=?\>?\YH
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M&_SL;QNW'YNW^2?\?>I;CS=J^9,LG)Z$'M^'\O\ ZP 1D;!FW+]?G[?YQ_\
M7XJ&,C?S$7Z_(/K_ %_SCI5F(3>6-LRJN#\AZG_/X?B:KP^9YGRN$;GYCTZ\
M?E]/RZ4 $Q!*XA,7!X/?G_/^>LH(\O\ X]SG:?G[?E]?;'XTVX\S*^9()#@\
MC![^W^'_ ->4";RO]<NW:?DXS^7^?IWH KPD9.83+TX';KZY_P ]S22GY^(S
M'P/E/^?Z4^W\S<=DBQGU)^N3GG_/KV2;?YGS.';CYATS^'^'^  'N1Y9Q;E3
M@?.>_P#AQ]/; ID)'S9@,O3IQC\_R_IW,T@F\KF967 PO&1^73_/2F6_F_-Y
M<JQ].IQGV[]^?\\@$+']Z?W9 S]SO_7_ #^=2S$;>+<Q\]3W]?\ /YYZ4QM_
MG'+ MN^]QC^H_P _C4TXFV#?*KC/0$<#TX_S[GI0 R$C;S;F3GJ.WI_G\L=*
MB4_O1^[)&?N=_P"G^?SJQ )MAV2J@ST)'(].?\^XZ5"N_P X88!MWWN,?T'^
M?QH 68CY<0&+KUYS^7Y?T[AZ$>6,VY8X/SCM_CQ]??(HN/-^7S)5DZ]#G'MV
M[\_YX?&)O*XF55P<KQD_GU_SUH KQ'Y^8S)P?E'^?Z4LQ&1B$Q=>#WZ>F/\
M/<4L._S/E<(W/S'IG\?\/\"MQYFX;Y%D/J#],'/'^?3N /R/+_X]CG;]_M^7
MUYZ?K44) +9A,O X';G_ #_GI9Q-Y7^N7;M^YWZ>G7../Z8YJ&W\S+>7((S@
M<G [^_\ A_\ 6 (Y"-_$13I\A^O]/\YZ5-(1L.+<IT^?M_G'_P!;BHIO,\SY
MG#MQ\PZ=>?S^GY]*L2B;RSNF5EP/D'4?Y_'\#0!#"1@Y@,O/;C'Y_P">E,)'
MF_ZOC</D_P _X>^.]2V_FX/ERK'SW./3Z_Y_6,[_ #L;QNW#YNW^0?\ 'WH
M?,1MXMS'SU/?U_S^>>E+$0%YMS(<_>';G\_R]^E.G$VP;Y5<9Z C@>G'^?<]
M*6#SMGR3*@SRI(R?;W_,=>W8 KH?WG^KW#)^3^7^?Y=*=,0=N(3%UZ_Y^OY]
M.II(]_F\, V3\QZ?X?R_#I4EQYOR[Y%DZ\@Y_P /;MVZ=Z %0KL'^C%CM^_^
M'IU/Z_E4,)^;F,R<?='X]_\ Z_YU903>5Q.H7:<KD9/'IW_/MW/6"#?O^5PC
M?WCTSSW.?\^M "3$;AB+R^/N_P"<?Y]!4A(\H_Z,0=O^L['WP,=_6FW'F;QO
M<.<?>'KZ]1_GTJ4B;R>9EV[>$R,C\./Y_EV (82!G,)E]AVZ=Z9(?WA_=[>G
MR_Y_/_'I4MOYF6\N01GU.!Z=S_\ 7_K3)=_FG+!CD<CI_/\ #_'I0!)(1LXM
MS'_M]0??CIZTD) 4Y@,O/4<8Z_Y]:DF$WE_/,KKQA1@D<=.F1Q]?KZMM_-VG
M9*L8SR#@9'/K_GW% $&?WG^KXW?<]O3^G3_&I9B"HQ 8N>IYST_SZU'A_-QN
M&[=][MU_QY_SFIKCS=HWRK(,\ 8.!QZ?Y]S0 D1&SFW,G)^?L/S_ ,_RJ&,_
MO!^[W=?E_P _G_ATJS#YWE_),J+DY4D GV[D\?3^@@BW^:,,%.3R>G\_P_PZ
M4 +,0<8A,7L>_7O4BE?+&;8GY?O_ /UN?PQ3;CS,KYD@D/J,'U[C_P"M_6I5
M$WE#$ZA=OW,C/Y<Y_/MW[@%>$C<<Q>9Q]W_.?\^HHF(W#$7E\?=]?\].OY"G
M6_F;SL<(<?>/KZ]3_GUI+CS-XWN';'##_/\ A^% $CE=A_T8J=OW_P /3J/T
M_*HX2!NS"9>G3_/T_+IT-3N)O*YG4KM&%R,CCT[?GW['I';^;\VR18^G)./\
M??MWZ=Z (G/[S_5[1D?)_,?Y_7I4DI79Q;F,\?-QS[\=/_KBF2;_ #>7!;(^
M8=.W/7_/OTJ:83>7\\RNO&%!R0...V./QX_, 9"1MYMS)SU';T_S^6.E1@CS
M?]7QN/R?Y_P]\=ZG@$VP[)509Z$CD>G/^?<=*A&_SL;QNW'YNW^2?\?>@!TQ
M!"X@,7/4\YX]N/\ /Y/C(V#-N7Z_/V_SC_Z_%%QYNU?,F63D]"#V_#^7_P!9
M\0F\L;9E5<'Y#U/^?P_$T 5HR-_,1?K\@^O]?\XZ4LQ!*XA,7!X/?G_/^>I#
MYGF?*X1N?F/3KQ^7T_+I3[CS,KYD@D.#R,'O[?X?_7 ' CR_^/<YVGY^WY?7
MVQ^-10D;CF(R<?='_P!?/3_.>U@";RO]<NW:?DXS^7^?IWJ&W\S>=D@0X^\3
M^?KU_P Y[ #)3\_$9CX'RG_/]*E<CRSBW*G ^<]_\./I[8%,FW^9\SAVX^8=
M,_A_A_@)I!-Y7,RLN!A>,C\NG^>E $,) W9A,O3I_GZ?ETZ&FL?WG^K(&?N8
MYJ6W\WYMDBQ].2<?X^_;OT[U&^_S>6!;/WN,=^?3^= #YB-O%N8^>I[^O^?S
MSTHA(V\VYDYZCMZ?Y_+'2GSB;8-\JN,] 1P/3C_/N>E$ FV'9*J#/0D<CTY_
MS[CI0!74_O1^[)&?N=_Z?Y_.GS$?+B Q=>O.?R_+^G<(N_SAA@&W?>XQ_0?Y
M_&I+CS?E\R59.O0YQ[=N_/\ G@ $(\L9MRQP?G';_'CZ^^1441^?F,R<'Y1_
MG^E6(Q-Y7$RJN#E>,G\^O^>M0P[_ #/E<(W/S'IG\?\ #_ @"3$9&(3%UX/?
MIZ8_SW%2Y'E_\>QSM^_V_+Z\]/UIEQYFX;Y%D/J#],'/'^?3O/B;RO\ 7+MV
M_<[]/3KG''],<T 5H2 6S"9>!P.W/^?\]$D(W\1%.GR'Z_T_SGI4EOYF6\N0
M1G Y.!W]_P##_P"LR;S/,^9P[<?,.G7G\_I^?2@"61AL.+8KT^;M_G'';VP*
M9"1@Y@,O/;C'Y_YZ5-*)O+.9E9>,*#T_S]?R-1V_FX/ERK'SW./3Z_Y_4 B)
M'F_ZO W#Y/7V_P __7J28C;Q;F/GJ>_K_G\\]*8=_G8W MN&&[#_ /5_GUJ:
M<3;!OE5QGH".!Z<?Y]STH ;$0%YMS(<_>';G\_R]^E1(?WG^KW#)^3^7^?Y=
M*L0>=L^294&>5)&3[>_YCKV[01[_ #>& ;)^8]/\/Y?ATH 68@[<0F+KU_S]
M?SZ=34B%=@_T8L=OW_P].I_7\J2X\WY=\BR=>0<_X>W;MT[U(@F\KB=0NTY7
M(R>/3O\ GV[GJ 5H3\W,9DX^Z/Q[_P#U_P Z68C<,1>7Q]W_ #C_ #Z"E@W[
M_E<(W]X],\]SG_/K2W'F;QO<.<?>'KZ]1_GTH <2/*/^C$';_K.Q]\#'?UID
M) SF$R^P[=.]3$3>3S,NW;PF1D?AQ_/\NT=OYF6\N01GU.!Z=S_]?^M $4A_
M>']WMZ?+_G\_\>E32$;.+<IT^?MT_3C_ .M4<N_S3E@QR.1T_G^'^/2IYA-Y
M?S3*R\848R./S'^<XH CA("G,!EYZCC'7UXJ+/[S_5\;ON>WI_3I_C4]OYNT
M^7*L?/? SU]JAP_FXW#=N^]VZ_X\_P"<T 23$%1B Q<]3SGI_GUI8B-G-N9.
M3\_8?G_G^5+<>;M&^59!G@#!P./3_/N:=#YWE_),J+DY4D GV[D\?3^@ *T9
M_>#]WNZ_+_G\_P##I3YB#C$)B]CWZ]Z2+?YHPP4Y/)Z?S_#_  Z4^X\S*^9(
M)#ZC!]>X_P#K?UH <I7RQFV)^7[_ /\ 6Y_#%10D;CF+S./N_P"<_P"?4584
M3>4,3J%V_<R,_ESG\^W?O#;^9O.QPAQ]X^OKU/\ GUH ;,1N&(O+X^[Z_P">
MG7\A4KE=A_T8J=OW_P /3J/T_*H[CS-XWN';'##_ #_A^%3N)O*YG4KM&%R,
MCCT[?GW['H 00D#=F$R].G^?I^73H::Y_>?ZO:,CY/YC_/Z]*EM_-^;9(L?3
MDG'^/OV[].]1R;_-Y<%LCYAT[<]?\^_2@"24C9Q;F/D?/V/Y?Y_E20D!>8#+
MS]X=O3\O_P!523>=Y?SS*ZY&%!!(]NQ''U_H4MQ+L.R58QGD'&3Z]?\ /N*
M( 1YO^KXW'Y/\_X>^.]/F((7$!BYZGG/'MQ_G\FC?YV-XW;C\W;_ "3_ (^]
M2W'F[5\R99.3T(/;\/Y?_6 $C(V<VY?K\_;I^O'_ ->HHR-_,1?K\@^O]?\
M..E6(1-Y?RS*J\Y4XR>/S/\ G&:@A\SS/E<(W/S'IUX_+Z?ETH )B"5Q"8N#
MP>_/^?\ /64$>7_Q[G.T_/V_+Z^V/QIMQYF5\R02'!Y&#W]O\/\ Z\H$WE?Z
MY=NT_)QG\O\ /T[T 5X2-QS$9./NC_Z^>G^<]DE/S\1F/@?*?\_TI]OYF\[)
M AQ]XG\_7K_G/9)M_F?,X=N/F'3/X?X?X  >Y'EG%N5.!\Y[_P"''T]L"F0D
M#=F$R].G^?I^73H:FD$WE<S*RX&%XR/RZ?YZ4RW\WYMDBQ].2<?X^_;OT[T
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MS[]: $E\GY?+5QU^^"/\]_TY[4Y?L^P963=CJ =O3UZ<?04ZY\[Y?,5%Z_=
M_I^'^/45+&;CRN$CV;>20,]/S';M^0Z %2+R\GS%8KC@*.1^'T]ORHE\K(\M
M6 QSN'/OV[\?_7J2W\S>?+52V.C=/R/_ -;\!1<>;O&]5#8Z+C&?P'^?<4 #
M?9]APLF_'4@[?SYZ_P"?2F1>5SYH<^FP9/;_ #^-6F-QY)RD>S;U &[\QD_F
M/S[Q6QERWE*K'_:Y]/7B@"%_+\SY58)D9SUQ^7;_ #BI)/L^SY%D#9'W@<?A
MG/U_#\:23S/.Y50V1P.F>/;_ #[=:FF-QY7SI&%^7!4#./PSGCU_^N "&+R<
M'S%<G/&T9]>OM_A4?[OS/NMLW=.__P"O''7KW[59MS-M/EJC#/.X9/?IG^G/
ML:@^?S?NC=NZ=NOY=>/\XH 67R<#RED!S_&".WO_ )Y_-T?D;?G60MS]T<=.
M_P#/^6*DN3/M7S411GC: .WMD?U_JZ$S^7\B(4YR3C/3U/3\/QQ0!43R]XW*
MQ7G@=?\ )/\ D]:=+Y7'E!QZ[Q@]_P#/X4L7F>:-J@MD\'I_+_/OUJ2Y,N5\
MU54_[/'KZ<4 -'V?RQ\LF_;U .W/N>.E1Q>5D^8K$8XVCGV[=N?_ *U6@;CR
M/N1[-O)P-WYG!_(?EVAM_-WG8JEL=&QC/XC_ #["@".7R]W[L,%QR&Z]/3_Z
MW?O4C?9]APLF['4@[>GKTY^AI)_,W_.JAL=%Z=NW(_3'UJQ(;CRN4CV;>" ,
M]/S/?M^8Z@%:+R?F\Q7/3[@)_P ]OUY[4U_+W\!@F1P>O^?\\5-;>=\WEJC=
M/O ?U_'_ !Z"F2>9YW*@/D<#I_G\OPZT +)]GV_(L@;(^\#CKV[?I^5)%Y&W
M]XLA.?X1Q^/XY_\ K]:FG-QL_>)&%[%0,XR/3D]NH'X'H6YGV'RT0C/.X#I[
M9_\ U^@/)H K?N_,Y#;-QP.__P"O\:=+Y.!Y2R Y_C!';W_^M0-_G< ;]QR.
MW^'^?PJ6X\[ \U47G^$ >OIG_/Z@#4^S[!N23=ST!Q_G'TYZ8-11^7O^<-MY
MX4<]>?\ '_&K<7VCRAM1"O.2<9_#T_+ZX%5X?,\SY%4MZ'IU&.O'^/OUH ;+
MY65\H..#G>,'K_G\ORD_T?9]R3?MZX.W/7K]??I[<47)EROFJJG!^Z/?VX_7
M_P"M-FX\G[B;-O7C=^?7_/7- %6+RLGS%<C QM!SC\,=/\@4DGE[_P!V&"X&
M0W7_ #_C^<MOYNX^6JD^C 8SSGK@<?YQW;/YGF_.JAL#A>G^'ZX_F0!7^S[#
MM63=@9)'R_AZY_R#38O)^;S5<],; 3^>/;_]?:K$AN/*^9$VX&" ,_CU)_'\
M,BH[;SOF\I4;IG< >/QQW_SZ $!V>8< A,]^O].G]/PJ27R-O[M9 <_Q#C\/
MQQ_];K2/O\XY #[N@Z?T_P _E4]P9]@\Q$ SQM Z>^/_ -?J!P: (8O(V_O%
MD+9XV@D?C^/M^=,79OY!*9Z#K_DU9MS/L/EHA7/)8#/X9Y''H#^/>%-_G< ;
M\]#T_P _G0 DOD_+Y:N.OWP1_GO^G/:G)]GV#<LF[!P0/E_'TQ_D"G7/G?+Y
MBHO7[H']/P_QZBI(S<>5\J)MP<D@9_#H1^'XX% %6/R]_P"\#%<' 7K_ )_P
M_*21(R T08 ==^<_EU[X]?PI(/,\WY%4M@\-T_P_7'\P^Y,I*^:J@XXV_CZ<
M?E_]:JA?F6MOGR_CJ--77-%R5UHG;KWU*/VJ$/L"/NSUP=OIZ>G^>U6U:-QF
M8,01QL'/3T]?;/;Z&F@#&2L>.#G W>W]/\:ECW\_9U5CWW#OCMG_ #[T8ATU
M3E>$FK:J[C=Z>6OKH;RM9<GN*R;4FUS;??Z]0!9,&(JJ#J&QNQCDCZ^E6X[R
M)X9EV2;O+D&2"%SM;V^O_P!?%9SPQM*IG9E?=]U2=ISC\,?XCCFMM%"VLNT)
MCR7YQS]UO;J?>N? VM/E;2M\+EMMI;1_\/KJSQZ_\:'M*%W=*$E#3I\4O7K^
M;/X$O^#D\VA\78F60DS\;<XZ^O\ GW%?RI>%K:,V".I C[KGYQQP!T_ES7]6
M/_!R?'<MXL/E)&1Y_P#%C/)/3K^ Y'MUK^4/PM!*MJA);<.0H^[W_#^F>.M?
MV/X0\W]FX3D:ORQNFNEX[:ZOY7T/S?B=UO;5E!04=;R<_37:ZM??5K<[2/'2
MW&TC&3)T_P#K?2J4_D^8/M"NSD\&,':..,_J/7W]+S;MH%P @XP4')Z^W^>_
M'-5B9@1]G1'CSDE_O 8'3]/IZY  _H?%_P !>FJVULOL_JC\NJ[2>]G\5N;M
MO45K==+;]7TD'^K']S'3^+'Y=O3BD7H?*Z=]WX]*4=/]OT[9_+I^6*"<?ZS@
M]MOX]>M?$UU'VRYFX*_Q*%G>\;>]^GEL<'=[ZK7FYK;?;MI]WY%0BV,H#K*9
M=W4 A,\#\NG?_&K,NJ'28][*74] @RW7OCGL!_/W:#=%OD2,Q9QNP-WM]3SU
MZC-2R*VT>6B2/W$@R,^P.?YY/'<5[$J'MZ%.*7,N1>^W=+;5KKMLNYK>/-34
M]8O>/M+<VW2UI[Z6M>Y3-K=>)HFN8'\J-5R5E.UL>P/.?I]*S=,NK+P_?AKF
M*XD>-N2 Q0XXSZ=:W8FD5?WO[IAG"Q?*OZ?ED_XBHG6=VQ)#$T//S$+OQR<^
MN1]?PXP>O*ZRRV4G%1F].=IJ[2UT@MM>G>USHI5X0E./*H4[;J?O12MK:U[J
M_HC7U;7/#_B:)5DMI@R8Q\F#GWX)[5D0ZA/8(;6T#"UX&".2O(_Q_P#K]*3R
MWB.;2),GJ& 'U'0CK@^O7M5M9"4Q(B"7D] 1D^IZ?S-&95J68?O(TU!R:U;5
M*5]/6_Z^B-XXNA!)?Q875I3EU;3\MOZZWK1W-C&_F&&0R-DL2O&<#)&0.>H]
MCC\9I;KP-<(1J]A=O=D?NS%&P4/V)X[,>>?US42-<ASYL40CSP549P/\?T]:
M64R%@8;>!EQR71<XSSC(_P \=*\2&!_>JG5^&UUR[?\ @:71^OF="S-1MRP2
M:M:/-K96Z):K]##6VUAKG=IB0)I.[Y$F4>9MSGG@'(''X\9KHQI?AZ>/_B<P
ML7V_,8?DYQSTQ^7].J^:XCPN%EQT'W<_R_"JJ_:'+?:@NT]-O)QTYZ\=/Z9Z
MTZ^!A4C[L*:C&RO?GGTUMO=KO^IR8K'U<1'FC.,)1M%.G[EME[TM4_6VS*;6
MGA*TN46Q@N^O&_<1UQW'KV^F*Z#4H+.;3U!4>7MX"@;^?<8/U]^.G7)99]W[
MJ*(Q\9+*-P_/_'Z'C%6&9@@$9W2#^%ON^^,G&1_CZ9KAPN1TZ6)I8F4UR\RE
MRJT6UIH]7;6WKZGGU.>7(_:-RD[N3EK?3X7K?5K_ "*.D1V5J6,*2@Y/^LW>
MG'7Z]_SQ6C>7UVZLD 4'G#;>>,@9..W)_'I5=3,<FX1$;ML''3V_SCZYH#7>
MX *GD],_Q8_SZU[^-5''IX=TO90@E[W>R6\ON^Y,AQK2DU*M&7+JF]9JUM]=
MEW9BK#.[EM1'G19)"XW<?0Y&?7TS^-;4$NB",V\=HB/("H+1*/F(Z_='?_\
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M'*_,84C_ &CWZ?A^=?A5?7#ZOHKOFY^B\E;T_P""?IF%L]]%?^7?6/1/;O\
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MUJ63[/L^19 V1]X''X9S]?P_&FR^9YIW* V1P.G\O\^W6IYC<>5\Z1A?EP5
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M$ SQM Z>^/\ ]?J!P: (8O(V_O%D)S_"./Q_'/\ ]?K48V>8,@E,]NO]>O\
M7\*M6YGV'RT0C/.X#I[9_P#U^@/)J!-_G# !?=T/3^O^?RH )?)^7RE<=<[P
M1^6?;_\ 7VIR?9]@W+)NP<$#Y?Q],?Y IUSYWR^:J+UQM ''X9[_ .?62,W'
ME?*B;<')(&?PZ$?A^.!0!5C\O?\ O Q7!P%Z_P"?\/R67RLCRU<#!SN!SC\<
M]?\ (-.@\SS?D52V#PW3_#]<?S#KCS=P\Q5!]% QGC'3(Y_SGL '^C[/N2;]
MO7!VYZ]?K[]/;BHXO*RWFASP,;!D]?\ /Y_G:S<>3]Q-FWKQN_/K_GKFH;8R
MY;RE5C@?>'O[\?K_ /7 (I/+W_(&V\<,.>O'^/\ A4K^1L.Q9 _'+ [?\_UZ
MY--F\SS/G50WH.G4YZ<?X>W6IY?/\H[T0)@<C&?S[_I[9% %>+R<'S5D)S_
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MST^X"?\ /;]>>U69#<>5RD>S;P0!GI^9[]OS'6*V\[YO+5&Z?> _K^/^/04
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MFK(3G^ $]O;_ .O5F7[1Y1W(@7C!&,_CZ_E],BH[?SL'RE1N?X@#Z>N/\_H
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M@B\L9G96P<+SSZ?X_CU-$[$[<P^5U]?Z\_\ Z_Q#XV/E8^S[@0?G/;^8_/\
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M7B0L/L=M\QSD?N\^O/\ GCO7^;IK65UK2_W?F_Z5#Q_VT'7_ #W_ #_TC?\
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MDF.9/]5Y? ^7_/\ 49_D ![B+RSB=F; RO/'K_C^'44R+R_FWS-%R.F<$_\
MZO\ />II&/E8^S[0 /G'?^0_+\<4R!B-V(/-Z>O'OQGZ?YY (CM\PX<E<_>[
M]/Q_S^=22^5M^29G.>AS@>WX'^?>F,?WI_=X^;[G^<C]/\:FG8E1FW\OGKZ^
M_P#^KCTSTH 9%Y6WYYF0YZ#.#[?B?Y=JC&WS!ER%S][OT_#_ #^=3P,0IQ;^
M9SU]/?\ _7QZXZ5"I_>C]WGYON?YP/T_QH 67R_EV3-+R>N< _\ ZO\ />GH
M(O+&9V5L'"\\^G^/X]31.Q.W,'E=?7GWYQ]/\\/C8^5C[/N!!^<]OYC\_P ,
MT 5X]A?YW*#!^89S_GI_GJLOE@C9*9!@\G/ XSZ?Y[BEA.)/]5YG!^7_ #_0
M9_D5G)+ F'RO;GGIQS@__K[=P!^(MG^O?=M^YD_Y]NG^-11>7EM\ACX'(SZ_
MY[?_ %K&X^5C[-QM^_W_ ,.G/KCMBHH"06Q#YO X].?;G\OU[ $<FP/\LA<<
M?-WZ\?Y_G4SB+8=L[,W'RG/Z_7K_ (5%*3YG,6SI\OX_T]_UZ">5B8R/L^SI
M\_\ C_\ 6_'!H BB$>#OF,7/;//'^'TIGR>9C>=NX?/GGI_AST_#O4L#$ X@
M\WGW]O3)X_K^<9)\W_5_Q#Y/\^O^?6@!\OE;?DF9SGH<X'M^!_GWHB$6WYIV
M0Y/RC///M_C^5/G8E1FW\OGKZ^__ .KCTSTHA8A.+?S!G[W/')YXX_/T_  $
M";?,P7(7)^<9S_D_YQ3I?+^79*TG7KG'^>OY=.])&?WN?+W<GY/\_P#UOZ5)
M.Q.W,/E=?7^O/_Z_Q  *(=@S.P;;PF3Z<?YR:BBV;OF<HN/O#/I_GO\ G5A&
M/EX^S!@5^_SZ?B/S]>_>&$X?/E>9Q]W_ #G]#GZT )+LR-LC.,=3GIWQD_C^
M/:I"(O+/[]BVW[F3Q_*F3DEAF+R^/N_T[?Y].\Q8^3C[-@;?]9SS[\\?ES].
MP!#%LYWRF,>HS[4V39OX=F''S'.?;]>/\>E20$@MB'S?;TZ>@S^5,E/[P_N]
MO(^7_/\ GZ]* ))!%M.V=G;^Z<\=:2+R\?/*T9SP!GGKQQZ_Y-22L3'@V^SI
M\_.3QUY'\OSIL#$*<0"7GKZ=?Y>_'TH A^7S/OMMW??R<_7\N>GX=ZDE\O'R
M2M(<\@YXZ<<^G^34>?WO^K_B^Y_G\O\ .:FG8E1F 1<]?7I_/VX^M #8Q%L^
M:=D;)^49Y_GW_P ]A''LW\NRCGYAG/O^O'^'2IX6(CP+?S.3\_.1[\?U_P#K
M"&(_O!^[W<GY?\_Y^G2@!9=G&R4R#U.?>GJ(=@_?L&V_<R?_ *_^?SI)R25S
M#Y7MZ]?49_.I%8^4!]F!&W[_ #_^K\_7OW ((MF3ND9!CJ,].V<'\?P[T2[,
MC;(77'+'/'TS^?7\J6 D,<1>9Q]W^G?_ #Z]B<DL"8O+X^[_ )_^M^% #V$.
MPXG8MMY3)].?\Y%,B\OYM\K1].F<?YZ?GT[U,['R\?9@H"_?Y]/P'Y>G;LR!
MB-V(?-Z>O].?_P!7XD B?9YF Y*Y7YCG(]._KQ_C4D@BV?+.SG(RI)X/Z=__
M -5,D/[W_5[>1\GK[?Y_7I4TS$IS;^7T^;GGISSW^GK^! &1>5M^>9D.>@S@
M^WXG^7:H_D\S&\[=Q^?//3_#GI^'>IX&(4XM_,YZ^GO_ /KX]<=*A!/F_P"K
M_B/R?Y]/\^M #I1%@;)C*<]\^G^>W_UGH(M@W3LK<_*,_I].O^-$[$A<P"+G
MKSSQ[X/]/Z.B8B,#[/OZ_/\ X?\ U_PR: *\>PO\TA0<_-WZ\_Y_E2R^7E=D
MADX/)SZ_Y[?_ %R(GS.(M_7Y?Q_K[?IT+YR25S#Y7!X]>??G\_T[@#@(MG^O
M;=@_)S_GVZ?AWJ*+R\G?*8QC[PS^&>O7_)-3ACY6/L_&T_O/\C']?;%0P$AC
MB+S./N\_TR>/\Y[ #9-@?Y'+C ^8YS_GK_GI*XB\LXG9FP,KSQZ_X_AU%,F.
M9/\ 5>7P/E_S_49_D)I&/E8^S[0 /G'?^0_+\<4 0Q>7\V^5H^G3./\ /3\^
MG>FMM\S <E<_>YSWJ6!B-V(?-Z>O].?_ -7XF-S^]_U>.?N?Y&/YT /E\K;\
MDS.<]#G ]OP/\^]$7E;?GF9#GH,X/M^)_EVI\[$J,V_E\]?7W_\ U<>F>E$#
M$*<6_F<]?3W_ /U\>N.E $ V^8,N0N?O=^GX?Y_.G2^7\NR9I>3US@'_ /5_
MGO2*?WH_=Y^;[G^<#]/\:DG8G;F#RNOKS[\X^G^>  01>6,SLK8.%YY]/\?Q
MZFHH]A?YW*#!^89S_GI_GK8C8^5C[/N!!^<]OYC\_P ,U#"<2?ZKS.#\O^?Z
M#/\ (@"2^6"-DID&#R<\#C/I_GN*EQ%L_P!>^[;]S)_S[=/\:9.26!,/E>W/
M/3CG!_\ U]N\VX^5C[-QM^_W_P .G/KCMB@"O%Y>6WR&/@<C/K_GM_\ 6238
M'^60N./F[]>/\_SJ2 D%L0^;P./3GVY_+]>S)2?,YBV=/E_'^GO^O0 $CB'8
M<3LQQRN3^O\ /M^%-B$>#OF,7/;//'^'TJ65CY9_T?;T^?U^O_UC]<&F0,0#
MB#S>??V],GC^OY@$7R^9@.2NX9?O]:DE\K;\DS.<]#G ]OP/\^],)/F_ZO'S
M#Y/7_/\ GUJ:=B5&;?R^>OK[_P#ZN/3/2@!D0BV_-.R')^49YY]O\?RJ--OF
M8+D+D_.,Y_R?\XJ>%B$XM_,&?O<\<GGCC\_3\!#&?WN?+W<GY/\ /_UOZ4 +
M+Y?R[)6DZ]<X_P ]?RZ=Z>HAV#,[!MO"9/IQ_G)HG8G;F'RNOK_7G_\ 7^(>
MC'R\?9@P*_?Y]/Q'Y^O?N 5XMF[YG*+C[PSZ?Y[_ )TLNS(VR,XQU.>G?&3^
M/X]J6$X?/E>9Q]W_ #G]#GZT3DEAF+R^/N_T[?Y].X \B+RS^_8MM^YD\?RI
MD6SG?*8QZC/M4Q8^3C[-@;?]9SS[\\?ES].T<!(+8A\WV].GH,_E0!')LW\.
MS#CYCG/M^O'^/2I9!%M.V9G;^Z<^G]?\XJ.4_O#^[V\CY?\ /^?KTJ>5B8\?
M9]G3Y^YX_P ]/QH CB\O:=\S1\\8S[U'\OF??;;N^_DY^OY<]/P[U- Q"G%N
M)>>O/OZ#/]*AS^]_U?\ %]S_ #^7^<T 22^7CY)6D.>0<\=..?3_ ":(Q%L^
M:=D;)^49Y_GW_P ]@Z=B5&8!%SU]>G\_;CZTL+$1X%OYG)^?G(]^/Z__ %@
M01[-_+LHY^89S[_KQ_ATITNSC9*9!ZG/O21']X/W>[D_+_G_ #].E/G))7,/
ME>WKU]1G\Z %40[!^_8-M^YD_P#U_P#/YU'%LR=TC(,=1GIVS@_C^'>IU8^4
M!]F!&W[_ #_^K\_7OWA@)#'$7F<?=_IW_P ^O8 279D;9"ZXY8YX^F?SZ_E4
MC"'8<3L6V\ID^G/^<BF3DE@3%Y?'W?\ /_UOPJ9V/EX^S!0%^_SZ?@/R].W8
M AB\OYM\K1].F<?YZ?GT[TU]GF8#DKE?F.<CT[^O'^-2P,1NQ#YO3U_IS_\
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M] %B8/LYN!(,_=!!/^?P_*D@#E.)Q&,]"0/\]@/IWIDI@VG9$Z-GDGN<]?\
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M@#E.)Q&,]"0/\]@/IWJ%<^:,/M.?O]OZ_P"1^%/B,.W]Y$[G=QCL?7I_]?\
MF8UV>8,JQ3=]T9S_ %_G^?0@$LX<;=TPEZ],'^7Y_A3T#^5Q<!1@_*2 3_\
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M+.'"C=,)!G@ YQT_7_#I4'R>9]T[=W3O_+TX_P XJ67R<#RXW0Y.2W0GC/\
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M?_KC'I_GHUMGF<*P3/W3G/\ /_"@"><.$YG$@ST!!_SW!^O:B .4XG$8ST)
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M4C;]W(ST_/CZ?G5>7R]PV(RKC[IZ_P"<>U2.;?80(7#[>6/0\?B?3KGIWZ$
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MR/PI\1AV_O(G<[N,=CZ]/_K_ ,S&NSS!E6*;ONC.?Z_S_/H0":<.%&Z82\]
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MS-F['8#]><=<Y_7%1Q>66_>,RKCJN<_I_C^-+*(@P\MF9<=6SG'?J>H_SCN
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MUSWZX-/N/-R/-VY_V?Q]/ZU#'LWC<Q"\\CK[]^W^<=*?*(ACRG9Q_M9S^O\
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M\SSN=N_</IGM_GKCVI8A"0?-=UY_ASZ#T([?TX[EAV>9]X[=PY[]/KZ?Y[T
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MV;,=\9]LYYZ__6JO*( !Y4CL<\AL^GN?\^G<.00;!OD</SP,X_'G'Y__ %Z
M&P^9YOR;=W/7IU_SGWZTZY\W<OF[<X_AQ_3_ #T]JBC\O?AV8+SR,YZ\]#V[
M=/PZ%91$"OE.S#!^]G/7W_\ K_AW +0^T>5_!LP?3/?\<X_'\*@M_-WGR]N[
M'.?UQ_3]*7%OY?\ K'W[3\O.W_#].GK440B+'S'95QU7.?;H<\_YSV 'S>9Y
MO[S;NXZ8Q^./\]:GD^T>5\WE[,#' SV]_7&>WKBJLGE[\1LS+@<MG/Z_Y]SV
ME<6_EDK(Y? R#G'X9P/Y?UH 6V\[YO*V=OO8S_GK[X]JC??YO.W?GMT[_A_2
MB(0G=YKLO3[N<_H<_P"?S:VSS.&)3/WN_P#+_&@"S<>?L'F;,9&, 9]NA],X
M_3)HM_/V'R]F,G.0,^_4^F,_K@U%*( O[N1V.>0V>OMD]/\ /L2(0%?WDCJ<
M\!<]??!Z?Y]@ -7?YPQMW[N_3]?\]>U27/G_ "^;L[XQU_S^OX5"NSS!EB$S
M][O_ )_#_$.E$(V^4[MU^]GK^)]/\^@!8C^T>5\OE[,'/ SW]_7..WIFH(?,
M\W]WMW<]<8_#/^>E.06_E@M(X?!P!G'XXR/Y_P!:BC\O?B1F5<'E<Y_3_/N.
MX!+<>=N7S=N>V,>W7^O;UJ;_ $CRO^6>S;^.,?GG'X_A5641 CRW9A@_>SD#
MC)Y/]?R[RXM]G^L??M^[SM_PS[8_PH 2V\W<WE;<X_BQ_7_/7WILWF>;\^W=
MQTZ=?\X]^E-B$1+>:[*,#[N<]?;_ .M^/9)/+WX1F*\<G.>O'4]^_7\>@ +<
MOVCRSN\O;CL!_CZXSG\<5';^?AO*V8SSG&:;(+?8=LCEN,@YQ^'./R_^O38A
M"0?-=UY_ASZ#T([?TX[D 0^9YW.W?N&/3/;-3W'G[!YFS&1C &?;H?3./TR:
MK?)YG#$KD9/?M_G_ #FI)1 %_=R.QSR&SU]LGI_GV(!+!]HV?N]FW/.<?Y_S
MS4,?F>;\NW?ENO3W]OS_ !I8A 5_>2.K9. N<9SWP>GUSW^@C39YGS,0F3\W
M?_/Y?3M0!-<^=\OF[._W<9_ST]\>U2I]I\KC9LVGTST_SC%5I1"-OE.S=?O9
MS^IS_G\GJ+?8"TL@?' &['3ZX_0]NO6@!L'F;_W>W=[XQWZ=O\C%+<>;N'F;
M-V.P'Z\XZYS^N*CB\LM^\9E7'5<Y_3_'\:641!AY;,RXZMG.._4]1_G'< LM
M]H\GG9Y>T8Z9Q^-16_FY/E;<_P"U^'K_ $H(M_+)\R3S-OW>=O\ /'\N_2F1
M"(Y\UV0?[.<_I_C0 2^9YOS;=W'0<?S].F._3)JQ-]H\OY]FWVQGH<^__P!?
MK5239O.UB5XY/7V[]_\ .>E32"#9\DCE^,@YQT[=1_+ZT /M_/VGRMF.^[KW
M]:A_>>=_#OW?AG/Y]?T]J6(0%3YKNISP%S_3'\ZC^3S/O';NZ]_Y^G/^<T 6
M;CSMH\S9CMMQTXQT_P#U4L'VCR_W>S;DYSC/^/\ ]?/>HI1" /+=V.>0V<?A
MG/X=*(Q 4^>1P^3@#.,^^#C&?7/?ITH ;%YGF_+MW<]1Q_/TZY[]<&GW'FY'
MF[<_[/X^G]:ACV;QN8A>>1U]^_;_ #CI3Y1$,>4[./\ :SG]?\: +*?:?)&-
MFS;[9_3_ #^%06_F[CY>S=CN!^G..N,?IFE46^P$RR;\=/FV_P \=/8]NM1Q
M"(L?,9E7'5<YQVZ'J?\ .>P ^X\S>/,V[L<8Z=>_;K_]>IW^T^5SLV;1Z9Z?
MYSFJLHC##RV9EQU;.?U/]?\ &I&%OL)660OCD'=CI]<?H._3K0 MMYWS>5L[
M?>QG_/7WQ[4R3S/-^;;OR,8 Q_/TQCMGIFDB$)W>:[+T^[G/Z'/^?S:_E^9\
MK$KD<]\?Y_R>E %F?[1Y?[S9MR,8QG_'_P"OCO1;^?L/E[-N3G=C/OU_#^M1
M2" )\DCE\C(.<9]LG&,^F.W7I1$(2O[QW4YX"Y_7':@!H\SSN-N_<?IGO_GK
MCVJ6Y\_:OF[,9XQC/^/^3[U -GF?>.W<>>_3Z^G^>]/E$  \J1V.>0V?3W/^
M?3N ">'[1Y?R;-OOC/08]_\ Z_2H(?,\WY-N[GKTZ_YS[]:=&(-GSR.'YP!G
M'3OT'\_K44?E[\.S!>>1G/7GH>W;I^'0@$MSYNY?-VYQ_#C^G^>GM4P^T>5_
M!LP?3/?\<X_'\*JRB(%?*=F&#][.>OO_ /7_  [R8M_+_P!8^_:?EYV_X?IT
M]: $M_-WGR]N['.?UQ_3]*2;S/-_>;=W'3&/QQ_GK3(A$6/F.RKCJN<^W0YY
M_P Y[$GE[\1LS+@<MG/Z_P"?<]@"U)]H\KYO+V8&.!GM[^N,]O7%1VWG?-Y6
MSM][&?\ /7WQ[4CBW\LE9'+X&0<X_#.!_+^M,B$)W>:[+T^[G/Z'/^?S !]_
MF\[=^[MTZ_E],5/<?:-@\S9MSQC'_P"KI_\ 6JL^S?PQ*9'S=^O^?7\:DE$
M7]W(['/(;./;&3Z^G_UJ );?S]A\O9C)SD#/OU/IC/ZX-0+O\X8V[]W?I^O^
M>O:G1" K^\D=3G@+GK[X/3_/L(UV>8,L0F?O=_\ /X?X@ L7'G[1YNS';;U[
M>E9OR_[7Z5=E$ 4>4[L<\AL_US_.JN7]!_G\: -.Y,A7Y[98AGJ/I_G^E0P%
MPK;85D&1R1GM[\?Y^M2W"D+G[4)?;U_6HH%)#8N/)YZ=,\?0_P">_:@",[O-
M_P!6,[A\G;_#KQZ?C4LY<I\T*QC/WAW_ ,<_GZU"0?-_UG\0^?\ ^O[?Y]*E
MG4A1^_\ -Y^[GI_+I^- #H3)Y?$"N,GYB/\ 'I_GMBH8]WFY$88Y/R\\'_//
MKZ5+"I,>1<^7U^0'&>^.A_IU[]:AC&9?]9MY/S^N>_\ G]>M $DY<[=T(CZ]
M./T_R.?6I$,GE\6ZD;3\^.>GKU_/\:BG4C;^^\WK[_T_SC\Y$4^7G[5M 'W,
M\'CTQ_4=.W2@"*#<&.V,.<?=/;\^?;^=$^XL-T00XZ#OZ=/R_#CBD@&6(\WR
M^/O=/\^O3_"B<88#S?,X^]U_'I_GT/8 G8R>4?\ 1U V_?QS^8Y_SZU% 6&[
M;$)/4'\/\\_SJ1E/E$_:L\?ZO/'Y8_J>O>HX 23^^\GW]?Y_RH ;)N\W)C"G
M(^7GD_YY]?6IIC)Y?,"H,CY@/\.O^>V:@D&)?]9NY'S^F._^?TZU-,I$>3<^
M9T^0G..^.@_KT[=: " N%.V$2#(Y/;K_ )]?2H?F\W_5C.[.SMUZ>G7CT_&I
M8%)4_O\ RO;/7V[]?P^M0X_>_?\ XOO_ /U\?C_G% $TY<JNZ%8QD\@8[>W'
M^?I3HC)Y?RP*XY^8]>@_G_\ KXILZD!<W'G<].N./H/\]^U.B4F//VC9_L9Z
M_P _Z4 0Q;O,XC#')^7_ #[<\?A3IRQV[HA'Z ?C_GC^=,C'[P#S-O7YOK_G
M_P#7UI\X((_?>=[^G\OY4 2 R>4!]G4C:?G[@<\Y/^?QJ*#<&.V(.<=#V]>O
MY?CSQ4H4^3G[3CY?]7GK[=/ZCIT%0P#+$>;Y?'WNGX]/\^@[@!-N+_-&$/'R
MCIT'X_YXJ=S)Y?-NH&T?/CGIZ]?R_"H)AA\>;YG^U_G_  _"IG4^7G[5N!'W
M,\#CTQ_4]>_2@!D!<;ML(DZ=>?T_R./6F2;O-YC"MD?)V_S]?QIT"D[OWWE=
M/;^G^<_DR0?O<>9NY'S_ .?\_P Z )YC)L^:!4&?O ?Y)_'\:2 N$^6!7YZG
MG_ZXXY_'BB92$_X^?,Z?+G..1QT_QZ?C20*2I_TCR^>F>OMT_P ^O<@$0W>;
MQ&"=Q^3L/;TJ2<N0-T*Q\]0,?R_K48!\W_68^8_/Z_Y_SZ5).I &9_.Y^OK[
M#I_7KV(!)&9!&,6ZL.?F_GSC\/Y\5!%N$G$8<\_*>GMUX_SQ4T:GRP?M)3&?
MDSU_3_#^E01 ^9CS=G7Y_J?IV_'\>M #YRY*[HA'P>!]?R_S]:FS)Y>/LZ[=
MOW^^/7./Q]/QJ"<$%?WWG<'GKC]/\/Q[3;3Y6?M)^[_J\^W^''7_ !H A@+A
MCMB$GL><?GZ?GZTDVXR#=&$/'RCI_A_GTQ2P EB!-Y7^UTSC//3\.G?MW248
MDQYOF=/G_P _GV^@[@$TAD,7,"@87YNA/I_AZ\\4R N-VV%9.G7G'Y_TI\BG
MRL_:=V0/DST_S^/]*9 I.[$YAZ=\9]NA^O\ 7L "-MWFG* '=]WM^O\ G\:F
MG+E/F@5.>HX_^N>.?PYJ%AB4CS,_-]__ #_C_A4LZD*/](\SGIGI[=/\^O<
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M[S.(PQR?E_S[<\?A4L*DQY%SY?7Y <9[XZ'^G7OUJ&,?O /,V]?F^O\ G_\
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M+^:!4''S#KT/\O\ ]7%02#]X1YF[I\WT_P __JZU/*I$>?M&_P#V,]/Y?UH
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MD[CV]:?,8R!LA:/GJ<^A]?Z4@W^=P1OW')[?X?Y_&I;@3 #S71N?X<>_H?\
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M]U(Y.<C_ #T[YQ54>0\N/LS!\X,IZ?7I_P#JZXZ5:CW ?OV5W[,F,?CC.?\
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MCYGG?>&[<.>W;\/?_.: 'RF,K\L+(<]3T_SW]..*(C&%^:!G.3\PZ=?R_/\
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M?FI9?)V_NVD+9Z-G'O327\[.P;MP^7M_DG_#VJ:?SM@\R)$&1@J.3_\ K_\
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MT 0OLWG:6*\<D'/^<]?0=<BI9/(V?(TA;(^]G']/_P!5-EW^9\R@-QP.GO\
MX_X=:GF\[R_GA1%XPPZGWY'IZ?\ UZ (8O)P?,+@]MGZ9J/Y/,ZMLW=><X__
M %>W7WYJQ;^;M/EQ(X[ENW7^7Y5#E_-SM&[=T[=?\>/\XH =+Y.!Y9<GOO\
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MW7^7Y4 5_D\SJVS=UYSC_P#5[=??FI)?)P/++D]]_P"N*;E_-SM&[=T[=?\
M'C_.*FN/-VCS(D0=BO?I_/\ *@!D?D;/G:0-D_=SC^O_ .JHDV;QN+!>>0#G
M_.>GJ.F!5J'SO+^2%'7G+'J/?@>GK_\ 7J"+?YGRJ"W/!Z>W^/\ CUH )?*X
M\LN?7?3U^S^6,M)NQTYV_P"3_.BX\S(\R-8SZ+^/XU*OG^4,0H4V_>[_ ,L=
M?7'6@"K%Y>X[RX&.-N<_U[9SZ=\TLOEY'EERN.=V<_A^%.@\S<=B*YQT8<9_
M+_.>@[D_F;QO14;'W5Z=?\CI0 YOL^SAI-V.ASCIV'\N:9%Y7S>87'3[N?\
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M9_+_ #CH>P I\CR^&D+[>G.W/Z?A38O*Y\PN/394[>?Y/,*;-OW_ .(_G_\
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M_P">GY_2FOCS/]9N&5^>G0D#=F$R].G^?I^73H::Y_>?ZO:,CY/Y_P"?Y]*
M))0H3BY,AR/E/3K^O_ZJ(0-O-QY?)X'?_/3_ !ZTLI!7BW,9S]X]^?S_ #]N
MM)"1MYMS)SU';T_S^6.E $7'FX\S W'Y_7K_ )_SBI)@H Q.9>>AX['T_/\
M.F CS?\ 5Y&X_)Z>W^?_ *]/F(P,0&+GOSG\O\]: '1A=@S<[>/N]C_G\/P%
M11XW\R[.OSCZ_KC^?KUJ:-AL&;8MU^;M_G''?WR*AC(W\Q%^OR#Z_P!?\XZ4
M +-@%<3&7@\GM^'^>U2X7R_^/DYV_<[=.GUS_G-13$$KB$Q<'@]^?\_YZRY'
ME_\ 'L<[?O\ ;\OKST_6@"*$ DYF,? Y'?KS^/\ CP*27'F<2^9P/F/;_#\^
MH-+"1DYA,O3@=NOKG_/<TDI^?B,Q\#Y3_G^E $KA?+/^DEN!\A[?CWQWID(!
MW9G,73ICGVY_.GN1Y9Q;E3@?.>_^''T]L"F0D?-F R].G&/S_+^G<@#&QYA_
M>;AG[_?I_G'U_"I9@-O%QYG(X/;_ #T_PZU$Q_>G]V0,_<[_ -?\_G4LQ&WB
MW,?/4]_7_/YYZ4 $(7;S<&/D_*._U],=*C7'F?ZPJ,_?_P _K4D)&WFW,AS]
MX=OZ^_\ ATJ-3^\_U9(S]S'- #I@!MQ/YO7KU_SU_+ZT] OEC_22O!^0=_Q[
M9[4R8@[<0F+KU_S]?SZ=33T(\L9MRQP?G';_ !X^OOD4 118\SF7R^#\P[_X
M_GU(J29",$2&88ZGMW['&:CB/S\QF3@_*/\ /]*DE<\ 1F$8Z'O^0QGC]*N%
M^96W^7_MVEQKE^U>UUMONK%83Q E3-EA_!_D]?\ /(-3KB3/[SR?=3U]#_D'
MZ\U"((B2QB(8_P ?^0.?\\ 5,N$X\H38[*.G'Z?ITQCN%B/9^R?-SVTO;U5[
M7UMZ:?@;2MI[*_+;WN;=K31<R[]M+#MJJP)C$PS_ *P^G&?\@GI^-:*3P&WF
M59>1$X*Y[[6]NW0UDF*25Q^^\E3UB.?\G@?7/-:R6\*6\I$1W>4^7[YVG]#^
MGK6&"VGRN\>E^6]M.N[_ ,^^AXU=TG7AST^25URM>T][;>RM]^GYG\#/_!R?
M%%)XM(:Z,1\\<#OR>OU!Y!^OK7\I?A6S(LE8'(.<2^G7GT^N/_K5_5A_P<I#
M_BK3_HS2'S^" >.?SX_P^E?RD^%7N5LT&6"#_EGU]>/RX],8. *_L;PBYO[-
MPCBE+W8WBW:RNM>FO33JC\YXG<_;U^6C?O*7L^RV_P WIK9[V?:*-O"M]I_V
M6/0_X\CI_6JDH4N"TYMR#_JP< G ]..>WT'/&!;4[EPJ_9CQ\S=^O8]<\<__
M %ZJ2D!P&@-P2<>8!D X'IQ^'OTYR?Z'Q?\  7IMV=H]_>7HO+6S/RZKM*][
MW^?3^7]WZ7_,G'W!Z8_UGT[]/YXI,D#Y?WO3D\XZ\4H^Z/\ T#O].N<_7-"]
M\#R_8CK^'_ULU\35M[9>\H:_$N?O'O[OZ]#@W>W5?RWO[NUOW?\ X%KV*VU#
M)DW10Y_U7^./3_/:K5P!Y8S)Y(_O@]CW/?\ 'U_2J67S,?92S9_UHSCM_GO_
M "%73&K+\X\P<80<$#W'7_/Y^_3:C2IWBYKE7[S2_3IY^A<G;D;YDDM?@?;]
M;?#;38K0R(BE1)YYSC<>OZ?4=LTJV[%RZW!;DGRLC'NN.O\ GMS4OV>(*2B^
M5SG;SDX[XZ^@_P FH?M3*2BVS=P),<?7CG_/KFLDYOG:Y>2W6W-]GMKZ7_R,
ME*HW.4>7D\TK_9Z;Z_WO\@G4<;IC;X[C/.1^/X?KFEBE38$5_-SG]X>OIGC/
M'X?TI5Q-_K8C+ZC&<=/\?T_"I#;QHH9!MVY.SG/K^O7KS^53&2]G&-+XKJZD
MEOIU:M;YB]HYPBJ;?-=?$HKL]=%%+>^W4B2W8'>+@RC^X3G\!CGCG_\ 4*9.
MJYR]P;?&?E'<@YZ=^/P^E+]J<95;9DQ_'CC SW'^?PJ0*LP_>Q&4G^+T]L_A
M^''X.\(U5*I\:2MR?#M'IYZ^5RO:\DU&J_>:^RKK9=;<RW]!%D1T$:MD;?\
M6=Q[GD\_7C/XTL=NR?-YQG!_A/./ICIU_EP:<T*1#<@R /\ 5CZ]/U[\=SWJ
M$7<AX%NT7/WB.O3N/Z^G/(I-3<).:3IM]/B:T?2W1=>OD2I55"<I<G)>ZLES
M6]W9?#_X$O09*%#;FNC%C'[L=^O&#_/]:G+K*NQ7V ?\M!].O\L#WI1''*,R
M0ER<?/\ KU_'W[]^H\:P LB^8.,(N/3^>?QXXIQ;M3C1Z+::].O^5QNI*HH>
MQ:OU]HDM'RV[+_P'] C@>,?ZPSY[GDCC';C_ .OTQ5=@BR;GNBIW?ZKMU'!'
MX\Y]_:GB[D; $+0CW&,]?3C_ /6,=:F$,4O+P'.<^8>GU]_QZ^N.BBXQJ3;_
M (CM>RO%_#LM?\O.PU5Y93C)OG2Z1]V^FSW^]O[D-8B==JR>3VWCO]">YY^F
M*5(7C4C<9AUWGDC_ #V_P.*20"W&50S<G"K^A /Z_7GO35N9'Q^[:($XVD8R
M./3'^?PI34O9KVEG'F3M'?IVT_$GGJ0IJ4^6U_LJ,I;*UU9Q_ID2^7'(&:[+
MG)_==N_\L8^N/>IG'VC&V7R,8Z'[WXG]?K3Q;PO@F':>N\]#[^G/X=?7JQV^
MS=(C-QT4 X_R/3T]<5IS-RC[/E<5%7YTEII\[^A7/.<X^S::MKS)+MY*5_0=
MY3(A4L7Q_P M>_U/T_3WQFJ\9CC?=]J,IY_=GMQ_GO\ TJ43O)PR%%.<H>..
M?\],'WYJ46\+<^3Y3?WB.I]/Z\?EZ1!PBII-J<K-I_"]MNVFNMM28UDU-7?/
MIHXI1UML[:Z/[3(GC^T$,LYA_P!D8&??\^./2GM&RH58[0./-Y]N>W)Q^.>,
M9ICR?9^%A,W.-R@''_ZC^6>U*LK2\.AP<'RSP>W'].GT[&E)7]FZUM&N7DW^
MSNEI?O;Y!SSA&FZCC9NRY$F]UOHTO^W2.)HXB<7'GGT)Z<_A_G\:D:$S-O6X
M*<YV XX[ YYZ#/>I/LT)&5C$)]^IY]_3_/K4+3F$[5MVDZX< $>W^'X=:TO.
M4FX<O):WO+6VFG1WV^97/4E-RAR\EOM*ST2[6?W]=^PZ5"$ =C%ZR#//7_\
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MT]/\?;O1$%*<W)CY/R#I^O3T_.B8@J,0&+GJ><]/\^M+$1LYMS)R?G[#\_\
M/\J (8\>9S)MZ_-_GT/'^/6GS #&)C+[GM^%,C/[P?N]W7Y?\_G_ (=*?,0<
M8A,7L>_7O0 ]0OE@_:2/E^Y_]?M[8]JBA +',OE\?>'?W_'^G:IE*^6,VQ/R
M_?\ _K<_ABHH2-QS%YG'W?\ .?\ /J* $FQNXE\P8^^>W^'Y=JE<+Y9/VDM\
MOW/3CUZ_7\:BF/S<1F/C[I_#O_\ 7_*IG*[#_HQ4[?O_ (>G4?I^5 $<(!W9
MG\KITZ_YZ?G]*:^/,_UFX97YZ="0-V83+TZ?Y^GY=.AIKG]Y_J]HR/D_G_G^
M?2@"24*$XN3(<CY3TZ_K_P#JHA V\W'E\G@=_P#/3_'K2RD%>+<QG/WCWY_/
M\_;K20D;>;<R<]1V]/\ /Y8Z4 1#'F_ZSC<?G_#_ ">O3\JDF  7$YEYZ'MQ
MZ?Y[TP$>;_J^-Q^3_/\ A[X[T^8@A<0&+GJ><\>W'^?R 'QA=@S<E#_<_P ?
M\_7BH8\;^9=G7YQ]?UQ_/UZU-&1L&;<OU^?M_G'_ -?BH8R-_,1?K\@^O]?\
MXZ4 +-@%<3&7@\GM^'^>U2@+Y?\ Q\G.#^[[?G_GBHIB"5Q"8N#P>_/^?\]9
M01Y?_'N<[3\_;\OK[8_&@"*$ DYF,? Y'?KS^/\ CP*27'F<2^9P/F/;_#\^
MH-+"1DYA,O3@=NOKG_/<TDI^?B,Q\#Y3_G^E $KA?+/^DEN!\A[?CWQWID(!
MW9G,73ICGVY_.GN1Y9Q;E3@?.>_^''T]L"F0D?-F R].G&/S_+^G<@#&QYA_
M>;AG[_?I_G'U_"I9@-O%QYG(X/;_ #T_PZU$Q_>G]V0,_<[_ -?\_G4LQ&WB
MW,?/4]_7_/YYZ4 $(&WFX\OD\#O_ )Z?X]:B7'F#]YM&?O\ ?I_G/T_"I82-
MO-N9.>H[>G^?RQTJ)3^]'[LD9^YW_I_G\Z 'S #;B<R]>N./;C\Z>@7RQ_I)
M7@_(._X]L]J9,1\N(#%UZ\Y_+\OZ=P]"/+&;<L<'YQV_QX^OOD4 118\SF7R
M^#\P[_X_GU(I9@ 1B8R<'D]NG/X?X<&DB/S\QF3@_*/\_P!*68C(Q"8NO![]
M/3'^>XH EPOE_P#'R<[?N=NG3ZY_SFHH<$MF8Q<#D=_P_P ]ZER/+_X]CG;]
M_M^7UYZ?K44) +9A,O X';G_ #_GH ))C?Q+OZ?.?K^F?Y^G6II NPXN2Y_N
M?X?Y^G%0R$;^(BG3Y#]?Z?YSTJ:0C8<6Y3I\_;_./_K<4 ,A"D',YBYZ#GL/
M7\_RJ,X\W_6<;A\_X?Y/7I^520D8.8#+SVXQ^?\ GI3"1YO^KXW#Y/\ /^'O
MCO0!),!MXN/,Y'![?YZ?X=:(@I3FY,9R?E'3K^G_ .NB8C;Q;F/GJ>_K_G\\
M]*6(@+S;F0Y^\.W/Y_E[]* (DQYG^LVC+?/3I@!MQ/YO7KU_SU_+ZTU#^\_U
M>X9/R?R_S_+I3IB#MQ"8NO7_ #]?SZ=30 ] OE@_:2OR_<]>/7K]/PJ*'&[F
M7RQC[X[_ ./Y=ZF0KL'^C%CM^_\ AZ=3^OY5#"?FYC,G'W1^/?\ ^O\ G0 3
M !AB7S./O'M[_A_7O4I"^4?]).=O^K[?3//XY]ZCF(W#$7E\?=_SC_/H*D)'
ME'_1B#M_UG8^^!COZT ,A .<S&+W'?\ "F28\SB3=T^;_/J>/\.M/A(&<PF7
MV';IWIDA_>']WMZ?+_G\_P#'I0!-(%"<7)D_V.G\NOI^5)" 5.9S%ST]?\/?
MO2R$;.+<Q_[?4'WXZ>M)"0%.8#+SU'&.O^?6@"+ \W'F<;OO_P"?;GK_ (5+
M, %&)S+ST]/\?;O46?WG^KXW?<]O3^G3_&I9B"HQ 8N>IYST_P ^M !$%*<W
M)CY/R#I^O3T_.HH\>9S)MZ_-_GT/'^/6IHB-G-N9.3\_8?G_ )_E4,9_>#]W
MNZ_+_G\_\.E #Y@!C$QE]SV_"GJ%\L'[21\OW/\ Z_;VQ[4R8@XQ"8O8]^O>
MI%*^6,VQ/R_?_P#K<_AB@"&$ L<R^7Q]X=_?\?Z=J)@ PQ+Y@Q]X]O\ /TI8
M2-QS%YG'W?\ .?\ /J*)B-PQ%Y?'W?7_ #TZ_D* )'"^63]I+?+]STX]>OU_
M&F0@'=F?RNG3K_GI^?TJ1RNP_P"C%3M^_P#AZ=1^GY5'"0-V83+TZ?Y^GY=.
MAH :^/,_UNX97Y_3W_H/Z=:DE"A.+@R=/E.,#D<<=?3\JC<_O/\ 5[1D?)_,
M?Y_7I4DI79Q;F,\?-QS[\=/_ *XH (0-O-QY?)X'?_/3_'K40QYO^LXW'Y_P
M_P GKT_*I82-O-N9.>H[>G^?RQTJ,$>;_J^-Q^3_ #_A[X[T /F  7$YEYZ'
MMQZ?Y[T^,+L&;DH?[G^/^?KQ3)B"%Q 8N>IYSQ[<?Y_)\9&P9MR_7Y^W^<?_
M %^* (8\;^9=G7YQ]?UQ_/UZTLV 5Q,9>#R>WX?Y[4D9&_F(OU^0?7^O^<=*
M68@E<0F+@\'OS_G_ #U )0%\O_CY.<']WV_/_/%0P@%CF;R^/O#O_+K_ )Q4
MP(\O_CW.=I^?M^7U]L?C44)&XYB,G'W1_P#7ST_SGL )+CS.)?,X'S'M_A^?
M4&I7"^6?])+<#Y#V_'OCO44I^?B,Q\#Y3_G^E2N1Y9Q;E3@?.>_^''T]L"@!
MD(!W9G\KITZ_YZ?G]*:V/,_UA89^_P#Y_2G0D#=F$R].G^?I^73H::Q_>?ZL
M@9^YCF@"28#;Q<>9R.#V_P ]/\.M$(&WFX\OD\#O_GI_CUHF(V\6YCYZGOZ_
MY_//2B$C;S;F3GJ.WI_G\L=* (EQY@_>;1G[_?I_G/T_"GS #;B<R]>N./;C
M\Z8I_>C]V2,_<[_T_P _G3YB/EQ 8NO7G/Y?E_3N !Z!?+'^DE>#\@[_ (]L
M]JBBQYG,OE\'YAW_ ,?SZD5*A'EC-N6.#\X[?X\?7WR*BB/S\QF3@_*/\_TH
M 68 $8F,G!Y/;IS^'^'!J7"^7_Q\G.W[G;IT^N?\YJ*8C(Q"8NO![]/3'^>X
MJ7(\O_CV.=OW^WY?7GI^M $4."6S,8N!R._X?Y[TDF-_$N_I\Y^OZ9_GZ=:6
M$@%LPF7@<#MS_G_/1)"-_$13I\A^O]/\YZ4 2R!=AQ<[N/N]A_G\?Q%-A"D'
M,YBYZ#GL/7\_RI\C#8<6Q7I\W;_...WM@4R$C!S 9>>W&/S_ ,]* (^/-QYF
M1N'S^G3_ #_G%2S ;>+CS.1P>W^>G^'6HR1YO^KP-P^3U]O\_P#UZDF(V\6Y
MCYZGOZ_Y_//2@ B"E.;DQG)^4=.OZ?\ ZZC3'F?ZS:,M\]2Q$!>;<R'/WAVY
M_/\ +WZ5$A_>?ZO<,GY/Y?Y_ETH =, -N)_-Z]>O^>OY?6GH%\L'[25^7[GK
MQZ]?I^%,F(.W$)BZ]?\ /U_/IU-2(5V#_1BQV_?_  ].I_7\J (8<;N9?+&/
MOCO_ (_EWHF ##$OF<?>/;W_  _KWHA/S<QF3C[H_'O_ /7_ #I9B-PQ%Y?'
MW?\ ./\ /H* )"%\H_Z2<[?]7V^F>?QS[TR$ YS,8O<=_P *>2/*/^C$';_K
M.Q]\#'?UID) SF$R^P[=.] #),>9Q)NZ?-_GU/'^'6II NSBX+_[';_Z_P#C
MTJ&0_O#^[V]/E_S^?^/2II"-G%N4Z?/VZ?IQ_P#6H 2$ J<SF+GH.<_@?\]*
MBP/-QYG&[[_^?;GK_A4L) 4Y@,O/4<8Z^O%19_>?ZOC=]SV]/Z=/\: )9@ H
MQ.9>>GI_C[=Z(@I3FY,?)^0=/UZ>GYT3$%1B Q<]3SGI_GUI8B-G-N9.3\_8
M?G_G^5 $,>/,YDV]?F_SZ'C_ !ZT^8 8Q,9?<]OPID9_>#]WNZ_+_G\_\.E/
MF(.,0F+V/?KWH >H7RP?M)'R_<_^OV]L>U10@%CF7R^/O#O[_C_3M4RE?+&;
M8GY?O_\ UN?PQ44)&XYB\SC[O^<_Y]10 DP 88E\P8^\>W^?I4KA?+)^TEOE
M^YZ<>O7Z_C4<Q&X8B\OC[OK_ )Z=?R%2N5V'_1BIV_?_  ].H_3\J (X0#NS
M/Y73IU_ST_/Z4U\>9_K=PROS^GO_ $'].M.A(&[,)EZ=/\_3\NG0TUS^\_U>
MT9'R?S'^?UZ4 22A0G%R9.1\AZ?IU]/RHA V\SF+G[OK_G_]5+*1LXMS'R/G
M['\O\_RI(2 O,!EY^\.WI^7_ .J@"(8\W_6<;C\_X?Y/7I^523  +B<R\]#V
MX]/\]Z8"/-_U?&X_)_G_  ]\=Z?,00N(#%SU/.>/;C_/Y #HPNSFX*?[';_Z
MW^/6HH\;^9=G7YQ]?UQ_/UZU+&1LYMR_7Y^W3]>/_KU%&1OYB+]?D'U_K_G'
M2@!9L KB8R\'D]OP_P ]JE 7R_\ CY.<']WV_/\ SQ44Q!*XA,7!X/?G_/\
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MMYMS)SU';T_S^6.E1*?WH_=DC/W._P#3_/YT 2S !1B<R\]#QC\!_GK5+/\
MTS_3_P"M5V8@J,0&+GJ><]/3BJ6/^FGZ_P#UZ -6Y$X3]Y,D@]%P>WM[5#;^
M=M;RY4CYYW?_ *\T3FVQ^Z60$G^+/8<>GO4<1AP?-60G(^X">W^?\] !#O\
M.QO&[</F[?Y!_P ?>II_.V#S)4<9& O4?_J__55?]WYG1MF0,<Y]_P#.>O?M
M4DIA*_NUD#9YW@XYZX_*@"6'SO+^29$7G*GJ?;@^GK_]:H(]_F_*X#9/S'IW
MY_S^G2G1F#9\ZR%LG[H)'X],=OPJ-#'YGS!BN3C'7CI_G^= $UQYOR^9(LG7
ME?\ /^<?E(GG^5Q,@3;RIZ].>^/YYQ5>4Q?+Y:N.OWP1[_X_ISVIZFWV<K+O
MP>0#MZ=S^?I0 V#S-YV.J-C[S=.O^3UHG\S<-[JYQU7IGUZ_YSU'=L1CW'S
MQ7'&WK_G'M^5$ICW#RPX&/XLYXX_EC_Z] %EO/\ *.9D*;?N]_YXZ^F.M16_
MF9/ER+&?5OP_&@FW"'"R[\=<';Z]>?:F1&+GS0Y'^P,GM0 2;_-^9P6R/F'3
MMS_G]>E3S>=Y?SS(Z\84=1[<GT]/_K56<Q^9\H8+D9SUYZ_Y_E4DA@V?(L@;
M(^\"!^'7/?\ "@!]OYNT^7*B#N&XSU_G^50X?S<;ANW?>[=?\>?\YIT1AP?,
M5R<C&S\<9J/Y/,Z-LW8QSG'_ .KWZ]^U %BX\[:OF2I)SQM__7FG1>=Y?RRH
MJ]U/4\?YZ_A4,IAP/*60')^^".W^?\]5C,&WYUD+<_=!V\C!S_G\J &Q;_,^
M5@&YY/3V_P /\.E/N/,R/,D60^J_C^-1(4WC<&*\\#KQ_P#7_3UZTZ4Q<>4'
M _VQ@]Z )U\_R>)DV;?N?Q'\O_KU#!YFX['5#CJW3/KU_P XZGLH-OY8RLF_
M;UP=N>3R>*9$8]Q\P.1C^'.>>/Y9_P#K4 .G\S?\[J[?WEZ9X_\ K=34[^?Y
M7,R%-O"CKTX[X_EC-593'N_=A@N!PWWN@_ST_.I6-OLX67?@<D';T['\O6@!
M;?S?F\N18^G+?Y_SG\XY-_F\L"V1\PZ?Y_S[41&+YO,5ST^X"??_  _7GM37
MV>9P&"9&<]>>O^?Y4 69_.V?/,CCLJ]1TXZ_R]/PI(/.V'9*B#/(8]1Z?Y].
M?2HY#!M)19 V?X@<<^GKW_\ K41&';^\60G/&T'&1TS^O_UZ &C?YV-P#;CE
MNQ__ %_Y]:DN/-P/,E23G^'\?4^M0_)YG(;9D\<YQ_GWITODX'E+(#GG>"/Y
MT 6(O/\ +&V9%4YRI/)_7\>_MS5>'S/,^5U5N?F/3KQW[?YQTIZ&#8-RR;N>
M@..>.?P^GX5$GE[_ )PQ7GA<YX_SQ_6@"2X\S*^9(LAP>5_SG_/;/,V)_*QY
MR;-OW,\]/\CI^E5I3%E?*#@8.=X(/7_/^>DF;?9]V3?M]#M]>OU]_P!* $M_
M-W'9(J'U;IWR>O\ GWI)O,\SYW5VX^9>F?\ ..M-B\K)\P.1VV@D_P!/Q_D*
M20Q[_D#!<#ANO^<4 69//\KF9&7 PHZCI_\ K[8IEOYOS>7*L?3[V>1Z=?7G
M^G>FN8-AVK)NP.2#MXXX_#_]1IL7D\^:LAZ8V G^7^?>@ ;?YQRP+;OO#I_A
MZ_YYJ:?SM@WRHXSP%/0>G^?7CTJNQ3S#@-LSWZ_T_P _E4DIAV_NUD!SSN!Q
MD]<?I_\ 6H D@\[8=DJ(,\ANI_7TX_SBH4W^;PP#9^\>G;\/2EB,&W]XLA;/
M&T$CCU].?;IZTQ2GF<@[,]NM $UQYOR^9(LG7E?\_P"<?D^/S_*XF15P<J>I
MZ_\ Z^^:@E,7R^6KCK]\$>_^/Z<]J<A@V#<LF[!Y .WGCG\/_P!0H 2'S/,^
M1U1N?F;IG_.>E2SDX'FL)&[,IX'ZCWX-5XS'O^<,5P>%Z_YQ4LB(0&B#!1P=
M^<^O3KW^M5'62]>U_P &5'FYERQ4G=:-)IZZZ,HF*\W[O-'EYSM_'CC/7 _S
MUJ[!Y@!VN(R.N[N<8]N.?_K\XJE]KA#[ C[_ %YQZ>G^?TJXK1N,RACD<;!S
MT]!W]L_@:TQ'M/9NT(MVTO%/33OMU_I6-JMWR^T2A+1)):?9WUTLNG0CEE7S
M-K1O)(3Q(O0']<^U:,,=YY$S-*I3RG.WOC8P ZCT^M502F#$55 >0V-^,#FK
M<=Y"\,RA9-PC<<@A=VUCZ?D*Y,']N\>2791TZ==/UT[GD574]K%*4:D;K1SU
MC>VG+:VU]+I?=<_@?_X.3I+A/%QV3+&OG\AL<\X/4_J/U[_RF>%;N$V2*R-Y
MO3S,';W'H1^9]#VK^K'_ (.3S:'Q=B99-WG\;<XZCN/Y_F*_E1\+6J&P1T($
M?)P3EQWP!D8_P]A7]B^$5O[.PGO.F^6.J>^JTMI_3[GYIQ3%NM5YJO(GM'D7
ME9;Z^G7SW.J.X#,Q\Y>,!.H].G;\_P"556$I;]S*L*9Y1\9/ R,'Z]._ISDV
M4P<BW!!_B\SI_@#[53G,/F 7 <R$\;,[>GM^/^/8?T/B[^P6GV5K:]W9?::3
M\OE;T_,*NB:V=]K\O;_EVO=WZW_(L#H/[_\ >_A)[GKC'\Z,9SO^<]B.WX=O
MRH'W ?X,?\"Q^74?A2+T/E=.^[\>E?%5VO;+F7.K_"I2;>JUM9:_Y=#SU>[6
MVNW+;^7[*;3^_P#,CQ.&RLZ*F?\ 5Y&[Z?C_ )[U-(7*CRF\MNA9R #[]OQ_
M"J>;;S?G64RYZC.WM]0/\^E6[CRQ&OF E.,!.3@'.>_^>/6OH*-W2I\KY(\J
M?(UKTZ=U_EN:M>]3NMDM536FWG[OE;[^S$$N#YKB5NS+T_3/^?SI%$X?YIXS
M'G[@(+8^G<_A1;LFP^2&"#^_G/7WP<^OX#K4*FU,V%6429ZG[O?\,<^M804/
M:5>63E/2\6M-ETU_+YZ@D[SNMU_(M=NO7YK7YEF7S"!Y+B$]#OP/Q'0<]Q_]
M;"*'V_.P=_[X^[^/'XG\_JRY$2A?/#$=A'DX&/QZTZ-D\K]V#Y9ZAOO=,''/
MI^OM43_@P]K>F^9:02MO'S77S\K(EI^SBE&^NWLXZ+36W,K?UWU2,3AOWDZ2
M)_<7!/L,<_3/&/SI9?-)_<RK".I#8!XQQ[Y'3_&H8?LS2$1+('YR7^[GCZ=<
M8XSBEN?(5@)U<G_IGG )((SUSTR?2MO?]I&T5[/D^.RYK6C?HWW?ZE6_>)VU
MMOR+LKZW?_!V)B'V_>&_G]Y_!]>G'I^GT2+S03YTJS#C 7!/?COCWZ?X!9/)
MZ'RL'C^/'7IGU]>WUJ.V\AF/D!P>,^9D G)/'3ZC\O2LH*/)4]E[[YMIK3[/
M6Z_K[A6?)+W>NG[N.NVZOK\_4?()RW[N=(TZE&P"<YR,?7O_ $Z.8/M^5MC_
M -\_=_#COU_7VJO-]G$@$JR%^,%,E<\_RSC)//Y5/(R>5^\!\L= OWNF!GGT
M_7VIRY?W/M&XRNK)+1OW=.GY!9_N]-M_<6FW2_N_*_IT'1>8,^<ZS'L4P>W7
M//3CBHV$^_Y;A!'G'EDC=CC'OG\*+81,#Y 8#TDR.,8]NGI^-1,;438993)G
MJ/N]OPQQZU:YN:?-%*'*K27Q6LNFG]=RDGSRLNG6"U;2TO?WM>Z^>A.XDP/*
M<1-W9^A_E_D_C3X]VTB5A*W/S+R!VSGGT_*HKAH]@\\,5/ V=<9R>F3U'\^_
M%.@"&,^4"$SD[^H]#V__ %U$5^Y7L?WCYU?G5_M+OL[>A#7[M76O,M/9Q_\
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M\WYO+D6/IRW^?\Y_-&-OLX67?@<D';T['\O6F1&+YO,5ST^X"??_  _7GM0
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MQ_GWJ24P[?W:R YYW XR>N/T_P#K4 2P>=L^29$'=6ZGKQU_GZ_A4$>_S>&
M;)^8]/\ /^?:G1F#:"ZR%L_P@XX]?3M_]>HTV>9R&*9.,=>.G^?YT 37'F_+
MYDBR=>5_S_G'Y2)Y_E<3($V\J>O3GOC^><57E,7R^6KCK]\$>_\ C^G/:GJ;
M?9RLN_!Y .WIW/Y^E #8/,W_ ".J-_>;IGG_ .OT-$_F;AO=7..J],^O7_.>
MH[LB,>[]X&*X/"_>Z'_/3\J64Q[AY8<#'\6<\<?RQ_\ 7H L-Y_D\S)LV_<_
MB'Y__6J.W\S)\N18SZM^'XTA-OY9PLF_;UP=N>#P>:;$8N?-#D?[ R>U !+O
M\SYF!;CD=/?_  _QZ5/+YWE_-*C+V4=1Q_GI^-5G*;SM#!>.#UY_^O\ IZ=:
MDD,&WY%D#<?>!V\# Q_G\Z 'V_G;3Y<J1\\[OQ^AJ'#^;C<-V[[W;K_CS_G-
M.B,.T^:LA.?X 3Z]<5'\GF=&V;L8YSC_ /5[]>_:@"Q<>;M'F2HX[!><=/Y?
ME3H?.\OY)D1><J>I]N#Z>O\ ]:H93#@>6K@Y.=_X9Q2QF#9\ZR%LG[H)'X],
M=OPH ;%O\SY6 ;GD]/;_  _PZ4^X\S(\R19#ZK^/XU$A3>-P8KSP.O'_ -?]
M/7K3I3%QY0<#_;&#WH L+Y_E#$R!-OW>_P#/'7USTJ"#S-QV.J''5NF?7K_G
M'4]G VY0967?CK@[?7KQ[U'$8]Q\P.1C^'.>>/Y9_P#K4 .G\S>-[J[8^\O3
MK_D]:G?S_*YF0IMX4=>G'?'\L9JM*8]P\L,%QSNZ_P"<>WYU(QM]G"R[\#D@
M[>G8_EZT +;^;\WER+'TY;_/^<_G')O\WYG!;(^8=.W/^?UZ41&+YO,5ST^X
M"??_  _7GM37,?F?*&"Y&<]>>O\ G^5 %F;SO+^>9'7C"CJ/;D^GI_\ 6I(/
M.V'RY409.0W4_P#Z_P#]=1R&#9\BR!LC[P('X=<]_P *(C"%_>+(6SQL!QQT
MS^= #1O\[&\;MQ^;M_DG_'WJ6X\[:OF2I)SQM_\ UYJ#]WYG1MF2,<Y]O\YZ
M]^U/E,.!Y2R Y/WP1V_S_GJ 31>=Y?RRHJ]U/4\?YZ_A4$/F>9\KJK<_,>G7
MCOV_SCI3HS!M^=9"W/W0=O(P<_Y_*HT\O?\ .&*\\+G/'^>/ZT 27'F97S)%
MD.#RO^<_Y[9YF'G^5_KDV;3\G\7Y?ITS5:4Q97R@X&#G>"#U_P _YZ2 P;/N
MR;]IYYV]<]?K[T );^9O.R14./O-T]^_?_.:2;S/,^=U=N/F7IG_ #CK3(O*
MR?,#E<<;02?;T_'^0HD,>_Y P7 X;K_G% %F3S_*YF1EP,*.HZ?_ *^V*9;^
M;\WER+'TY;_/^<_FUS!L.U9-V!R0=O'''X?_ *C38C%\WF*YZ?<!/O\ X?KS
MVH 'W^;RP+;A\PZ=?R]?K[U-/YVP;Y4<9X"]1^OIQ_G%5V*;^ VS/.>O7FGR
MF#;^[60-GG<"!SZ>O/MT]* )8/.V'9*B#/(8]1Z?Y].?2H5W^<,, V[[QZ?X
M>G^>:=$8=O[Q9"<\;0<9'3/Z_P#UZC4IY@R&V9[=?Z_Y_*@">X\[:/,E23GC
M;^'U-9^4]#_G\:N2F':/*60'/\8(].F:JX?U'^?PH U;HW.S$L<:CU7CM[5!
M;&<*WE(C#/.['I[C_/KVITXA"_).\A]#TZ=NN.O/K4,7EX.^8Q<CI]/;ZT (
M?,\[[HW;AQV[?A[?YQ4UP9R@\Q$49X*XS^.,<^M5_E\S&\[<CY^_Y]>GM^'>
MI)?+V_),TASR#G S_A^F: )83<>5A(T9.<EL9 ]LCKCGC_Z]0Q^9YORJ"V3Q
MVSSZ^O\ G/6G1^44&Z=D;)^49Y[=O<5&FSS.7(7)^8=3C_./YXH EN3,=OFH
MJ]?NX_H/\_SE0W BP(XRFWDG&X<?3/''IWZ57E\O"[)3)UZ_Y^OY=.].40[!
MF=@Q7A.<<C\J $M_,#GRU5FQT;&/U_PHN/-+CS%56QT7&,_@._\ D'LR+9N.
M^0HN.&'?\OSHEV;AMD+C'4_KU_/\>U %IC<>408X]FW[PQN_EG\\]NM0VYE!
M;RE5CW#8Q^N1^E#"$(<3L6V_<Y^OTID6SG?(8QZC/M_A0 LGF>;\R@-D<=L\
M>GI_G'6IIC<>5AXT5.,%<9(]\#KCGG_Z]5WV>9PY*Y'S'J,_YQ_+-22>4$.V
M=G;(^4YX[=_<T /MS,%/EHC#/.[&1],YY],8-0?/YOW1NW=.W7\NO'^<4^+R
M\?/*8SD8 SSC/'XU'\OF8WG;NQO[_7/7IST_3F@">Y,Y5?-1%&>-N/3V'^?7
MM3X3/Y>$1&3N3C(_//Z8J"7R\#9,9>3U^GO]*='Y6P;IF1N?E&?3'Z?I[T ,
MB\SS1M4%LG@]/;\_\YZT^X,I*^:JJ>P7&/TP/TJ*/;OY<J.?F'7C_P"OQ_/%
M.EV<;)#(/4Y]_P#&@"P#<>3CRX]FW[W&[\,C/\OPJ&W\T.?+56;'1L8S^([?
MY [J/*\L?OV#;?N#//4]LU'%LW'=(4&.H_3I^?X=Z '3F0O^\50WHO3]./TJ
MPYN#%@QQA-O!&-QX^F>>?7MUJK+LW?*Y=<?>/T%2,(=AQ.Q8+RG..!^5 "VQ
MF&[RD5NGWL?U'^?Y1R>9YW*@/D<=OT_S_.EB\O#;Y3'TZ?Y^GY].]-?;YG#D
MKD?,>O/^% %B<W!3]Y&BKV*XSC(ZX&<].O\ ]>DMS.$/EQHPSSNQT]LCK_GW
M+)?*VDI.SG/W3G R?2DB\K;\\S(<]!G!QV_']<=J &C?YW &_<<CM_A_G\*E
MN#,0/-1%Y_AQ[^@_SZ]J@^7S,;R%R?G[_6GR^6 -DQEY[]OSH GB-QY0"QH5
M.<DXS^&1G^7]*@A\SS/D52WH>G48ZC'/^<]:>GE;!F=E//R\]^./IU]O>H8]
MA?YI"B\_,.OO_G\\4 2W)E)7S453@XVXQ^@Q_P#J[]ILW'E8\M-FW[W&[I^?
MZ]?>JTNS*[)#)P>3]?\ Z]2?NMG^O;=M^YS]?_K?I0 EOYH8^6BL?1L 9YSU
M&./\XILYD\S]XJJW'"]/TX__ %]N[8O+).^4QCCD=_3I_GWHDV;QM<N,#YN_
MI]>V: +,AN#%\T:!<#!&,GZ\9Y]\U';&8;O*1&Z9W8Z?B/7_ /7VI'\K8<3L
MS8&5YP,<?_7]\=J9%Y9SOF,73IGG\J !M_G'( ?=T[?Y_P ^U37!G*#S(T49
MXVXZ>^!U_P ^XKMM\PX<E<_>[\U)+Y6WY)F<YZ'.!GM^'Z9[T 2VYG"'RXT8
M9Y+8S^&1GI_GO4"%_.X +YZ=J=%Y6W+S,ASPHS@_A]>/\*8NWS.7(7/WN_&*
M );DS';YJ*O7[N/Z#_/\Y(S<"+Y8T*X.2<9'TXSQ[8J"7R\+LE,G7K_GZ_ET
M[TY/*V#,[*V#A><'/'_U_;/>@!L!D\S]VJLW/#=/UX__ %=^S[@RDCS553C@
M)@C],#]*BCV;SN<H,'YN_I]>^:ED9  (W\T8Y8Y)&,?IQ_2JC>^D>;R:;^=D
M-6>[Y5IK:_5?U^!$ ",E8\ @YXW=L=^G2I(_,&?(4-GGYQ[=LY]_7W.:HBV!
M<N)FS_<.<?\ ZNO\^]7$"J,2R-%CN#U_+\_S-&(473=YM=&[-\NVEU_PZ^\V
MGI91?M5:W,U?EV^[M9ZZ[C&AC:56G=D?=]U2=O./?![=/7TYK;1 MK+@)CR7
MYQS]T\=.I'ZUB,TS-MBC\Q"?]9SGG _^OCG'UK1BM-L,SF9B3$YV9..C9'^>
MM88).T[6E%;.SOTUWMW]-NYX]7V3K1M.=.5U>+G%*?P]+:WOZ_D?P0?\')\=
MRWBP^4D9_?\ \6,C+'('7\!R/Z_RA^%89EM5)+;ADA,_+W_#\<>HZYK^K7_@
MY1*KXM),[QGS^@/7!P..OX?6OY3O"EZWV%(]F5SS(1SCGG/<XY_IT%?V-X1_
M\BS"<T7./+&R5GRO37RT_(_-.*/9^WK?N7.6J;]G.RT7W[/333;74[$EMN+@
M! .5,8Y/7T_SZU68S9'V=4>/.27^\.!T)P?Q[>O  L(1C,3&=CC*GMZX[=NE
M5)O++CS9C V>$4]>!Z=_?V'&!S_0^*_@)VZ:==++JK+ONM/F?F=1^[+6VOP_
M"NGV'[VGD]=R<= ?X_[O;/Y=/Y4$X_UG![;?Q^M ^X/[H'WO;U S^?6A0.<?
MO!W)[?2OBJO-[=*,DG?>4XM;KI:_Z;H\ZRVMHVG:S2O[OV&^:7R=OO(@;DM\
MD<9BSC<0N[^77FII X0>4 [YY#=,G/3.?\??K50B'S,FX97S_JN<=NG/Y?6K
M,^/+42NT2\ ,.<]\_P">U>[#DY*?.G*?+\23Y>E_OWO<T:UIZ+2V\)76VVON
MV\[V%CW$'SU5'[!.GZ8_S]#4>;H-S'&(L_?&-^/7IU^G\A2P*NP^4[3+G[Y/
M(Y/J/0U"!"LIQ<,SY(\LYQG)XZ_Y K.-^:JI04(V_B<KUTW_  ^?0$ES5/.]
M_<EV76]GZ+5]":0S\>2JR'G/F#IQVSG_ #Z]:D3E?W@ E]%QM]AQQ^8_F*AN
M#&=OFR-!Z$=\#\/7GT-21J/*^5F=/^>F3Z8]/TJ;6I0Y(^V7,M6GIJO/_AK^
M9-OW<59+WEI[.=M_Y;W7JQBFZ!_>1HJ=F3&['X<_K]:'-QD>2BNO))D^HZ9!
M_P ^E11>2'^2=I6_N'MC'3G_ #UIUQY18>9,T)Z@#H>1[_Y'%79>VBW*TN72
MGKV5UJ^_^>QI;WT[?9WY97]+[?(L?P< >;CI_#GT]/\ /J*B0W&3YR*B\$&/
MZGK@#_/K3RO[KEF";3^\SU'7/3K4-OY08^7,TQZD'H.3[_Y'%9K6%3G7L=?B
M2W^'6^W]:D)>Y+1;K3DEY=+W?W^>P]C<[OW:(R<99\;N<^N?\]^E2OPO[L R
M^C8V^XYX_(?R-59?),GSSM$W'R#ISGW_ *=JL2*/*^9F1/\ GID^F/3]*K94
M>2*JJ\?>:U7PZ_UL-K^'HM/[LM-8_P#@/JQJ&;GSE$9[>7TZ>V/\^E)FZ+<1
MQF+/WSC?CUZ=?K_(TEN8P#Y4C3CN3VR!]?\ ZYJ,B%I1FX97R!Y8SC.1QU_R
M#1%1]I4:GSRY?X>KL[+HG_6P_MRTZ;\KUVZ[/T6I9DW ?N%5W[A\8_#.<_A_
MA34,NT^: C9. G3M_G_.*2<+L'FR-"O/S@\G./8?ATHA*B-A&QE7D;SU'/X^
MOY5+UHKF2H^^K6^6OE\^Y*7N6Y4]4TN2=GM]F]]^JT["+]I+#S(XUB_O#&['
MY#\>_P"(I\GF<?9D5_7?CCUP#D_Y^M5T$)E!6X9GS_J^0._U_'CM[5)<!/E\
MV5H>@&"?FQGZ=>G6M-?:02AS1Y?XEI7L[7>]U?MUZ%->_%Z:+^27E]J]EOL]
MAZF38-PQ)C[H^[W_ ,G^O9$^T;OW\<:Q]BH&>GMC]#SQZTJ,OD_*2R8'[SOQ
MU/Z?GBH81%YG[N=Y&YRG(QQVZXZ>G?WJ8I)5>5^U=]8M;:=_,45\>B5W_P ^
MYJ_GO[WRL2R>=G_1T1T[E\9']?\ /TIQ+[1CF3 ^0CY<\<<\8Z]1^76H;@1[
MQYLS0MV0$\\?A]:F9AY6"2$(_P!9WP<<\?X\Y/TI-)QH\TO8NZ]U)J^VF_\
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M^OX?2MZ-";C)PUBFE9RVVT2W\R$N5OWI.[TOK;39:?,T+"25K<B[$<8QRQP
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ME+F>C2MH_4J56--ZIR?9)O?35+;YG[9^'?&]Q]J^SZKK7AA;13M60:I9%R,
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M*W]?D^A^O?\ #\.E6(Q)Y8Q<*HY^4\'TZ9_SWJ"+<9.) AY^8\#VZ\<?_JH
M6=B2O[GR>#QZ_K_C^'>;<?*Q]F/W?]9CV_PYZ?X5%/N!7=*)>.HYQ_3_ #]:
MEP_E_P#'PNW;]SC.,9QC/IQZ?C0!# 2&)$/F_P"SUQUXZ_CU[=^R2G,F?*\O
MI\G^?R[_ %/98 Y8[91'[GC/Y^OY^M)+N$GS2!SQ\PY'^'_ZO3% $TC'RL?9
MMN /GQU_S^']:9 Q&[$!FZ=LX]^H^G].Y>X<1<W"L,#Y.I';IG/'Y^E,@#G=
MMF6+IUXS^?Y\4 1L<RG]WCYON?Y_P_QJ6=B5'^C^7SUQU]^O^?3L8FW>:<N"
M<_?[<_7_ #^-33[]GS3K)ST'/]<]./QYH (&(0_Z.9>?O8Z?K^/?^E0J?WN?
M+SS]S_(J: .4RLZQC/W3Q_\ 7/''\JB7/F\. <_?[<8H =.Q.W]QY77C'_U_
M\Y_*2-CY6/LV[(/SXZ?Y_'^M,GWC;NF63KTY_E^'MQZT] YBXN%48/R=">W3
M.>?S]: (8CB3/E>9U^3_ #^7;ZCO+, P!,8A(_AQR>,]2?ZD=JBBW&3Y9 AY
M^8\#_#_]?IFGSJ_&Z3S?=><=3UJH?$M;:^:_])U&MU>//JO=UUU\M=-RC]HE
M#[1;_+G[X';IUS^/ZU<B)(R8O-]NZ\=/Y>W\J8)4Z&9?]SH>_P"7/^<U*F7S
MY;B(>Y R<<<]./ZT\0U[)WI<VEK>]KMJK?KJ;SULTO9:)*.OO;?EOKKKJ-=U
M5@1((6SQ%GK[=#_AS5V*YE:"8&W('EN-YZ<(W/X]?J:HE(PX,D?G-G_6#IG
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M*_+M0#H3G(QT[]/:N/O/^"FO[$#:B(YOVD/#"DMC[,UVH!YX'_UL_3BK</\
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M#?L^6=8^>AX_KGIQ^'%1#=YN/,&=Q^?M_AUY]/QH DG8D+FW\GGKC&>/J?\
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M/*C93GDD'!/Z?U^M$9MPGSQ.SY.& .,^O0]_I^/6I+CSMH\S9CMMQTXQT_\
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ME/DB=7R,L0<9]>@[_7\.M$1@"_O8V<YX(!X].Q_I4L_VCR_WFS;D8QC/^/\
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MK4<V[?S&$/\ ='X?Y_'M4[F3R_\ CW4#;][ ST_/GZ_E0!##Y/S>8[)TZ?\
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M"1P.03Z>O3D\'O\ T/BW^X6^VJV2T7V7K_P=>Y^75=I-ZN[U?O/IM-6A^'_
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M7\KBW!&#\Q )'_ZCU_K0!!'Y>_YW95P>1UQ_GZ?7L2;RLCRW9A@\GTXR>O\
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MR-@WR,K\X4=/?N/\_G1.7*KN@$?/4#&?R_SS^3XR_EC%NKC!^8@9_/Z]?ZT
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MT3>7N&QV9<=3Z?GV_P X[K#NW\1AS_=/X_Y_#O2S[MPS$$..@[_@#WYQ].U
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M O[_ ,WGIUQQ[\_T]^Q?$I,>?M&SK\F?\_\ UNW-0RF+ V0F,Y[Y]/\ /?\
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MO()&>GYGMW_,=:TOD_+Y;.>OWR3_ )[_ *<=Z<OV?8,M)NQT!.T\>G3GZF@
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MWG8RAL=6QC/XD_Y]10/L_ECYI-^WH"=N?<<]>M1Q>5D^8S 8XV]?;\^?_KT
M/G\P/\[*6QU7IV[\#]<?2K$@N/*Y>/9MX (ST_,=^_Y#I4E\O=^[+%<<ENO3
MU_\ K]NU2-]GV'#2;L="3M''ITX^HH =;><=WELB]/O8'\_Q_P .AIDGF>=R
M07R.1T_S^?X]*2+R?F\QG'3[A(_SV_7CO37\O?P6*9')Z_Y_SS0!9G%P$_>/
M&5[!2"<9'ISZ=2?SZEN)RA\MT SSN(Z>V?\ ]?ICD5%)]GV_(TA;(^\3CKV[
M>W7\Z2+R-O[QI <_PGC\?QS_ /6Z4 (-_G<$;]QR>W^'^?QJ6X$P \UD;G^$
M@^OIC_/Z0?N_,Y+;-QP>_P#^OOTITODX'E-(3G^,D]O?_P"OTH LQ"X\H;70
M+SD'&?P]?S^N15>'S/,^1E#>IZ=1CKQQ^GMTIR?9]@W/)NYZ$X_SCZ\],FHH
M_+W_ #EMO/*]>O/^'^'2@"6Y$H*^:RL<'[O/?VX_3_Z\V+CR?OILVXQQN_+K
M_GIFJLOE97RBYX.=YR>O^>W?\Y/]'V??DW[>F3MSZ8^OMT]N: "W\TL?+90?
M5L8SSGKD<_YSV;/YGF_.REL#E>G^'Z8_D&Q>5D^8S@8&"I.<?AGK_3J:23R]
M_P"[+%<#);D_Y_#M^0!:D%QY7S.FW P!C/X]"/Q_# J.V$QW>4R+TSN(''XY
M[_Y]6O\ 9]AVM)NP,@GY?P],?Y(IL7D_-YK..F-A(_/'M_\ J[T #[_..2"^
M[J.G]?\ /YU/<"<(/,=",\;2.GOC_P#7ZYX%53L\PX)*9ZGK_7K_ %_&I)?(
MV_NVD)S_ !'C\/QQ_P#7Z4 36XG*'RW0+GD,0#^&>>GH1_A"F_SN" ^>IZ?Y
M_*B+R-O[QI V>-I('X_C[_E3%V;^20F>HZ_Y% $USYPV^8R-U^[@_P OP_PZ
MFI(Q<>5\KIMP<@XS^'4G\/QR*KR^3\OELYZ_?)/^>_Z<=Z<GV?8-S2;L' !^
M7\?7/^2: $@\SS?D90V#RW3_  _3'\B^Y$H*^:RL<<;>?7TX_+_Z]0Q^7O\
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M\Q&>O;^G'?KVK^43PM;2"U0EB7SD$$[>YSP./\]!7]6?_!REY0\799I ?/\
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M[QO92V.JXQG\"/\ /H*CB\O=^\+!<<%>O3U_^OW[T2^5D>6S$8YW=??\N/\
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M'F.A&>-I'3WQ_P#K]<\"JIV>8<$E,]3U_KU_K^-22^1M_=M(3G^(\?A^./\
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MHN/)!#Q[-O0D;OR.3^1_/O5E\KCRBY]=_)[_ .?QIZ_9]@RTF_'0$[?RYZT
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M'Y](8_,\[@@/D\GI_G\OPZ4L?V?;\[2!LG[I..O?M[=?RJ-/+W\E@F3R.O\
MG_/% $USYPV^8R-U^[@_R_#_  ZFI8Q<>5P\>S;R"1GI^9[=_P QUK2^3\OE
MLYZ_?)/^>_Z<=Z<OV?8,M)NQT!.T\>G3GZF@!(/,+_(RAL=6Z=^_(_7'UI;C
MS=XWLI;'5<8S^!'^?05'%Y>[]X6"XX*]>GK_ /7[]Z)?*R/+9B,<[NOO^7'_
M -:@"T1<>1G?'LV\#(W?D,'\S^7:.V$I+>4RJ?\ :X]/7BFG[/Y9^:3?MZ$G
M;GV''3K3(O*Y\TN/39P>W^?PH 67S/-.Y@6R.1T_G_\ K]^E6)A/Y>7="G&
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M[?\ 5]OIDX[^E1P@;CF7R^/O?U[?Y]!0 L^_?\R!&_NCIGCL,_Y]:G<S>5S
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M.9M@WQ*@SU '(]>/\^PZU78?O3^\)&?O]_Z?Y_*I9@ O%P9.>A[>H_S^..M
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MO\D_X>U.A (.9S%ST'?\_P#/2F$#S?\ 6<;A\_Z?YY]L]J )YS-L&^)4&>H
MY'KQ_GV'6E@,VSY(5<9Y) R/?V_(]._>.8 +Q<&3GH>WJ/\ /XXZTL0!7FX,
M9S]T?7\Q^'OUH CCW^;P@+9/RGI_A_/\>M27'F_+OB6/KP!_^OV[]^O:HD'[
MS'F;1D_/_+\_\YITP VXF,O7K_GZ_EUZB@"=#-Y7$"E=IRV!D<>O;\N_8]((
M-^_Y4#M_=/3//8X_SZ5(@78/])*G;]S\/7J/T_*H81\V#(8^/O#\?\]/RH ?
M<>9O&^,(<?='K^1_SZU*3-Y/,*[=O#X&3^//\OS[P3 ;AB7S./O?U[_Y]14A
M \H_Z22=O^K[?3(SW]: $M_,RWEQB0^AQ[=C_P#6_I3)=_FG*A3D<#I_+\?\
M.M+" <YF,7N._3M3)!^\/[S=T^;_ #^7^'6@"S,9O+^>%47C#  $\=>N3Q]/
MIZ-M_-VG9$L@SR3C@<^O^?8TD@&SBX,G^QT ]N.OI20@%3F<Q<]!WZ_Y]: (
M\OYN=HW;NG;K_CQ_G%37'F[1OB6,9X(QR./3_/L*@Q^\_P!9QN^_[?YYZ_X5
M+, %&)S+ST/;I_GUH DA,WE_)"KKDY8@9'OV(X^O]3!%O\T84,<G@]/Y?C_C
MUJ2(#9S<&/D_)V/Y]/\ /UJ&,?O!^\V]?F_S^7^/6@"6X\S*^9&(SZ#'OV'_
M -?^E2J9O*&(%*[?OX&?SXQ^7?MV@F &,3&7W/;KVJ10OEC-R1\OW/\ Z_'X
M8H 9;^9O.R,.<?=/K^0_SZ4EQYF\;T"-CA1_G_'\:2$#<<R^7Q][^O;_ #Z"
MB8 ,,2^9Q][T_P ]>GYB@"PYF\KF!0NT8; R>/7O^7;N>L=OYOS;(EDZ<$?_
M *O?OVZ]J5PNP_Z26.W[GX>O4_K^51P@'=F8Q=.G^?I^?7H* $DW^;R@#9'R
MCIVXZ?Y]NM33&;R_GA5%XPP')''/?/'X\_E X_>?ZS<,CY_3'7_/\NM22A=G
M%P9#Q\O''MQU_P#U4 /@,VP[(E<9ZD#@>O/^?8]:A!?SL[!NW'Y>W^0?\/:G
MP@%>;@Q\]!W]!_G\,]:C 'F_ZSC<?G_3_//MGM0!-<>;M7S(5CY/0 =OQ_G_
M /7?$9O+&V%67!^8CD?Y_'\#4,P "XG,O/0]N/;C_/YOC V#-P4Z_)V_SC_Z
M_% $4/F>9\J!FY^4].O'Y_7\^M/N/,ROF1B,X/ QZ^W^/_UHXP-_,I3K\X^O
M]/\ .>M+, "N)C+P>3VY_P _YZ %@&;RO]2NW:?GXS^?Z_U[5#;^9O.R,.<?
M=(_/TZ?YQW> /+_X^#G:?D[?G]??'XU%"!N.93%Q]X=_SQU_R!0 LV_S/F0(
MW'RCIG\/\?\ $S2&;RN855<##<9/Y=?\]:KRC#\2&3@?.?\ /]:E<#RSBX+'
M ^0]O\>/K[9% !;^;\VR)9.G!'_ZO?OVZ]JC??YO*@-G[O&._'I_*EA .[,Q
MBZ=/\_3\^O04UO\ 6?ZPD9^_WH GG,VP;XE09Z@#D>O'^?8=:(#-L.R)7&>I
M X'KS_GV/6F3 !>+@R<]#V]1_G\<=:(0"O-P8^>@[^@_S^&>M #%W^<,("V[
M[O&/ZC_/X5)<>;\OF1+'UX QGW[]^/\ /,*C]Z/WA S]_O\ U_S^5/F &W$Y
MEZ]>WY?G_7M0!-&9O*XA5EP<MQD?GT_STJ&'?YGRH';GY3TS^/\ C_B'H!Y8
MS<%3@_(._P#AQ]/? J*(9?F0Q\'YQ_G^M #[CS-PWQJA] /ICCG_ #Z]I\S>
M5_J5V[?O]^GKUSCG^N.*K3 9&)C+UY/;IZ9_SV-2X'E_\?)SM^YV_/Z\=?UH
M ;;^9EO+C$AP.#CU]_\ '_Z[)O,\SYD"MQ\HZ=>?R^OY=:(0"6S,8N!R._/^
M?\]4D W\2E^GSGZ_U_SCK0!9E,WEG,*JO&& Z_Y^GYFH[?S<'RXEDY[C/I]/
M\_HLBC8<7);I\O;_ #CGO[9%,A (.9S%ST'?\_\ /2@!I+^=G: VX87M_D_Y
M]*FG,VP;XE09Z@#D>O'^?8=:@('F_P"LR-P^?T]_\_\ UJDF "\7!DYZ'MZC
M_/XXZT 20&;9\D*N,\D@9'O[?D>G?O!'O\WA 6R?E/3_  _G^/6I(@"O-P8S
MG[H^OYC\/?K42#]YCS-HR?G_ )?G_G- $MQYOR[XECZ\ ?\ Z_;OWZ]JD0S>
M5Q I7:<M@9''KV_+OV/2"8 ;<3&7KU_S]?RZ]14B!=@_TDJ=OW/P]>H_3\J
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M23%2!M@,7/4_0^H'^<^]-&_SL;@&W'+=C_\ K_SZU)<>;@>9*DG/\/X^I]:
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MNA[>M?FE+713J63T\MM[6_X?K%.1\J_9FX^8]_SZYQU]NYJI*5#@/ ;@EO\
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MJ[>ZWTNK^2M]VE;>K2_-:L[9'[S!XZ=P??M^'6I[O B!*&8?W #D=>.G7_\
M50WG[\I,B1Y'[ML!NOJ?3Z?I@4MR&\L"-A&_]Y^AY/M^@KNHWY8Z\VB=TM]N
M_P"FP5=*<+M-VM=RE&_PZKE33\N:W?N06>"#M3[./[IR,=1W]^?US5G(#']T
M2<_?YQCUSTZ?7VJO;[]I\YQ(V>"G0?*>3@8_EW%*([PN3YJ^5QA.,D>F<>G?
M_P"M7A9BFY5+-*VW,H\K>G75K]-&7AUS)>]%-6=KRDWMTFK*^VC.+UW']M:9
MF,R_Z5!P!T^<9]L]O7^O^D7_ ,$!,?\ #/NEXB*C[';93GG]WVY_+^7>O\W7
M6@ZZUI81PK?:X<EL?\]!^/7^?XU_I&_\$!C)_P ,_P"E[I%9OL=M\P(('[OZ
M_P"/TK^</%2SP4>;^+[9747+DMHNO7KY7/V'@C;=?!UE-2V7V?@WZ+_(_H0G
M*;VQ:E3G[Q!_S_/TSWJ+:2>(C)[^F#^//^%6;@7&YMT\;*3]T$9Z?F<=/3\*
MB225/]6ZJ.X/^37X76_W?2S=EU<K72O?F_+;Y61^G812NDE?7JEM>/1Z??K^
MK\A%^9.,?</OV_GT_P#K579HGX6'RSTW$=<>GZ?RJT0\@Y8;N3NXQD'D^G7U
MX_*JDL,@Y:17'!P",^W3&<8[Y^E?.-?OHWNI7Z16^EKZK3_/KU]?$<JC#F3<
MK+W4DD]GTU5_\QZ*%'^J+^C ' X].1Q^ %-CE??@@NN?N'GU_P ]OSI\+3JN
M!(JKCE3P3UX'KD8Z_A4B,A<;!MDR<N>G\N/KGWKT%LTUS=G=KMTCHWZ_HSS;
MPYO=3Z)K5J+T_FL]-%I<@G*G!$)CSG.?\CW_ #Z=ZD0IY8'V8D[?O@'T_P X
MY_.FW'G9!DD60=MO\OY?X8Z2IY_E<3($V\J>O3GOC^><5F7_ ,#^OD5H2-W,
M1D&/N@=./Q_SZT3$;AB+RQCH>_MVZ_T[4Z#S-_R.J-_>;IGG_P"OT-$_F;AO
M=7..J],^O7_.>H[@$C%/+(^S$';]_!Q_0?7GZ^T<) SNA,OL >.G^>_]:G;S
M_*.9D*;?N]_YXZ^F.M16_F9/ER+&?5OP_&@"*0CS#B/:./E_SZ'GO^/2II2I
M3BW*'(^;'']![\9_QCEW^9\S MQR.GO_ (?X]*GF\[R_GF1UXPHZCVY/IZ?_
M %J (X2NT[H#)SU /'7_ #_45%D>;_J^-WW/\^W'3_&I[?S=I\N5$'<-QGK_
M #_*H</YN-PW;OO=NO\ CS_G- $DQ7:-L!CYZD'GI_G^II8BH3FW+G)^;'']
M1[\X_P %N/-VCS)4<=@O..G\ORIT/G>7\DR(O.5/4^W!]/7_ .M0!6C(\P9C
MW#GY?\^IY[?ATI\Q!QMA,7L0>>O^>W]:2+?YGRL W/)Z>W^'^'2GW'F9'F2+
M(?5?Q_&@!RE/+ ^S$G;]_!Q_4?3GZ>\,)&XYB\P8Z#M[=^G]>]65\_RAB9 F
MW[O?^>.OKGI4$'F;CL=4..K=,^O7_..I[ #9B-W$1C&/ND=>/P_SZ5,Y3RR/
MLQ!V_?(/I_G//Y5'/YF_YW5V_O+TSQ_];J:G?S_*YF0IMX4=>G'?'\L9H @A
M*C=NA,O3I_DG_P#5T[TV3'F?ZO:,CY,?YY_/\:EM_-^;RY%CZ<M_G_.?SCDW
M^;RP+9'S#I_G_/M0!)*5*\6YC.1\Q'O^'\SVZ\4D)7;S;F3GJ!_GZ_U'2I)_
M.V?/,CCLJ]1TXZ_R]/PI(/.V'9*B#/(8]1Z?Y].?2@"N"/-_U?&X_)^'^1TZ
M?G4DQ4A=L!BYZD'T]\?R_P#K-&_SL;QNW'YNW^2?\?>I;CSMJ^9*DG/&W_\
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MR_GF1UXPHZCVY/IZ?_6I(/.V'RY409.0W4__ *__ -= %<$>;_J^-Q^3\/\
M(Z=/SJ28J0NV Q<]2#Z>^/Y?_6:-_G8WC=N/S=O\D_X^]2W'G;5\R5).>-O_
M .O- "1E=G-N7//SXXZ?E_GO449&_F+>.?E'U_K].OH>*L1>=Y?RRHJ]U/4\
M?YZ_A4$/F>9\KJK<_,>G7COV_P XZ4 $Q4E=L)BX/4=>?P_EZ?C*"OE_\>YS
MM/SXX_E_GT[TRX\S*^9(LAP>5_SG_/;/,P\_RO\ 7)LVGY/XOR_3IF@"M"0&
M.8O,&/NCMZ>O3_.>Q*1YG$1C&!\I'7_/T_P#[?S-YV2*AQ]YNGOW[_YS23>9
MYGSNKMQ\R],_YQUH >Y7RSBW*G ^8CK^?K]?RID)4;MT)EZ=/\D__JZ=ZFD\
M_P KF9&7 PHZCI_^OMBF6_F_-Y<BQ].6_P _YS^8!"^/,_U9 W#Y,<]?\XZ_
MC4LQ7;Q;F/G[Q[_G^?!/X]V/O\WE@6W#YATZ_EZ_7WJ:?SM@WRHXSP%ZC]?3
MC_.* &0E=O-N9.>H'^?K_4=*B7'FC,9(W?<QST]./\_G5B#SMAV2H@SR&/4>
MG^?3GTJ%=_G## -N^\>G^'I_GF@!\Q4J-L!BYZD'GIZ@?Y[U2Q_TT_7_ .O5
M^X\[:/,E23GC;^'U-9^4]#_G\: -";[+M_="4-G^//IQU_S]:BB\C#>:'SD8
MV].GX#_)]\7+HW.S]['&@_V?I_DU!;&<*WE(C#/.['I[C_/KVH K_N_,Z-LW
M#CG/O_G/7WXJ67R=O[L/NSSNSCW_ ,]?4"FGS/.^Z-VX<=NWX>W^<5-<&<H/
M,1%&>"N,_CC'/K0!'']GV?.)"V3TSC/Z?IV_"HT\OS/F#%,G&,Y_SZ>@Z9JS
M";CRL)&C)SDMC('MD=<<\?\ UZAC\SS?E4%LGCMGGU]?\YZT )+Y/R^4'[_>
MS_\ J]?TYSQ3E^S[!D2;]OOCI^?UX^M.N3,=OFHJ]?NX_H/\_P Y4-P(L".,
MIMY)QN''TSQQZ=^E %6+R\GS VW'&W.?Q_#U_'%)+Y6X>6'QCOG/^>F/QQFI
M+?S Y\M59L=&QC]?\*+CS2X\Q55L=%QC/X#O_D'L #?9]AP)-^WWQ_4_Y^E-
MB\KGS0V/]G\/\\U98W'E$&./9M^\,;OY9_//;K4-N906\I58]PV,?KD?I0!$
M_E^9\H8)D9SG/^?7U'7%22?9]GR"0-D=<XS^OZ]OQI)/,\WYE ;(X[9X]/3_
M #CK4TQN/*P\:*G&"N,D>^!UQSS_ /7H AB\G!\P/G(QMS[X_P ]?0&H_D\S
MHVS=TYSC_P#5[]??BK-N9@I\M$89YW8R/IG//IC!J#Y_-^Z-V[IVZ_EUX_SB
M@!9?(POE!\Y.=W3I^(_R/;+H_(V_.'W\_=SCIS_D?CBGW)G*KYJ(HSQMQZ>P
M_P ^O:GPF?R\(B,G<G&1^>?TQ0!4CV;QN#;>>F<_YST]!TS3Y?*X\H-C_:_'
M_/%$7F>:-J@MD\'I[?G_ )SUI]P925\U54]@N,?I@?I0 @^S^6,B3?MXZXSS
MZX/U_P#UU'%Y6X^8'QCMG/\ GKG\,XJT#<>3CRX]FW[W&[\,C/\ +\*AM_-#
MGRU5FQT;&,_B.W^0.X!'+Y>[]V&VX[YST'^>/PS4C?9]AP)-^WWQT_/Z<?2D
MG,A?]XJAO1>GZ<?I5AS<&+!CC";>",;CQ],\\^O;K0!6B\GYO-#]ONY__5Z?
MKSGBFOY?F?*&V9'7.[W]_P#ZU36QF&[RD5NGWL?U'^?Y1R>9YW*@/D<=OT_S
M_.@!TOV?:?+$F[/?.,Y_SU%$7D;?W@DSNXVYQG_.??'3-2SFX*?O(T5>Q7&<
M9'7 SGIU_P#KTEN9PA\N-&&>=V.GMD=?\^Y *_R>9R&V;C@<Y_'_ #UITOD8
M'E!P<_Q?3\:!O\[@#?N.1V_P_P _A4MP9B!YJ(O/\./?T'^?7M0 U/L^P;A)
MNYZ9Q_G'7]<5%'Y>_P"<-MYZ9SUY_P#K<]/45:B-QY0"QH5.<DXS^&1G^7]*
M@A\SS/D52WH>G48ZC'/^<]: &R^5E?*#XP<[L^OY?KZ^^)/]'V?=DW[??'_Z
ML\^GOGBBY,I*^:BJ<'&W&/T&/_U=^TV;CRL>6FS;][C=T_/]>OO0!5B\K)\P
M/C QC.?UQSZTDGE[_P!V&VX'WLY_S_\ 6]JEM_-#'RT5CZ-@#/.>HQQ_G%-G
M,GF?O%56XX7I^G'_ .OMW %?[/L.T2;L#.<X_P XZ?IFFQ>3\WFA^V-O^1_G
M/O5B0W!B^:- N!@C&3]>,\^^:CMC,-WE(C=,[L=/Q'K_ /K[4 0-L\PXW;,]
M\Y_7%2R^1M_=B3.[G=G&?\X]\=<4UM_G'( ?=T[?Y_S[5-<&<H/,C11GC;CI
M[X'7_/N "*+R-O[P2;L\;<X_SGT'3UXIB[/,Y!V9[9S5FW,X0^7&C#/);&?P
MR,]/\]Z@0OYW !?/3M0 2^3\OE!^_P![/_ZO7].<\4Y/L^P;A)NP<8SC_..O
MZXIUR9CM\U%7K]W']!_G^<D9N!%\L:%<').,CZ<9X]L4 58_+W_O VW!^[G/
M^?\ Z_O4LB1D!HMP4==V<_@/Q_PIL!D\S]VJLW/#=/UX_P#U=^S[@RY'FJJ'
M' 3&#^6!@_2JA?F6MOGR_CJ-6NN9-JZT3L]^^NVY0%W"'V;'WCOSCTXXJVK1
MN"9@V#TVCU'U S^-(%&,E(P,YS@9S_A4D?F#/D*&SS\X]NV<^_K[G-&(=/V4
MKPDU;76UWIJE;7U_S1O*VGLTX*R;C+1RV^_7K>S%&4P8BH0=0WWL =>>?P/O
MBK<=W"\,RA7W"-QR"!G:Q_GTZ_K6<T,;RJT[LCY^ZI^7G\<'Z#KGWS6VB!;6
M7"ICRGYQS]T^W4CU[USX&UI\C:5OA<M>FEM^OW?(\:O_ !8>UH=4HS4+KIK*
M5]-;:_?J?P)_\')YL_\ A+L3A]WG\8SZ^O\ 7Z\'M_*CX6M8S8*Z$!.>#R_K
MCJ/\^PK^K#_@Y/CN6\6'RHXV_?\ ?&>6Z?X"OY1/"L,RVJDEMPZ)GY3U^@^A
MZ9]\U_8_A%S?V;A.2U^6-U)=+J_77]3\XXG=;VU;DC!15[R=1-O9]M/)N_=[
M'9Q[>1;\$8SYA)!Q^GZ_7BJ<YA\P"X#F0GC9G;^G;K]?7/ O$L5Q< 1CJ#&.
M>_I_0>F:K$S C[.B.F<EGQN' R>0#Z<CH>_  _H;%:4%_A5ULKV7V3\NJZJ3
M>NNLOB[7_>)K\E][TD'W!UV8]]Q'Y=?R-(O0^5TR,[OQ_P#K4HZ _P ?]WMG
M\NG\J"<?ZS@]MOX_6OBJZ7MES-P7-\2A9[Q^U??3_@=_/75[V:U<N;^7[>R^
M[\BIFV\WYQ+YN[J,[>WU ]O;%6[GR_+7S0=F!CR\YQSZ?YSBHP;DG"1QF/.-
MQV[OY=3G\\5+() H,0#MD$J_0'/;VR>><^_6OH*+DJ5/ECSQ<%[[>JVMKK\_
ME<T;]ZGKNEISVOMTM[^_2UR*W9-A\@,$'_/3.?ISW_SUJ%3:M-\HE$N3R<[,
M\^G''U_G5I-Q'[]51\\!/N_GZ=!_]?.8\W(;F.,19^^,;\<^@_E[\XK)<_-5
MYIJ4-^5.\K)+\?E?;R&GK/R3M[_IK:WN]K].HER(0!YX8@=!'GICV]?3V]:=
M$R>5^[!\OON'S'CG&>^/\XH<S?+Y*K(><B0<=.W^?SJ1<E1Y@"R_W5QM]O;K
M_AC& (2?L8>R?LES)-2E;MW\K?F2W[D7?JO^7MO+XDM?2Q4A^S,Y\H2!^Y?.
MT_TY]OZ4ZY$ 8>>)"PZ"/=@$GOV/(S_]:I%-SG$D:(G9DQN/UQ_];WI7-QG]
MRB2+@Y,G;D=,_P"?:K?+[>*Y6ZG+;GOHM(]+/>Q?VUKI;^?_ -MM=^MQ2R^3
MT/E8/&/GQ^/O_P#7YJ&V$!)\@.&XR)-V"<]O3GG_ .L:LX^7@#S<?=XV9_S^
MGN,U&AN,_OD2-<#!C[\GKC_/M4>\J=1U'[2/-M%^CUMU\ON)3]V6O5:^T]/M
M;1]%Z$$WV99!YHD+\8*9VC&>W3V__74\K)Y7[P'R^VT?,..,X[X_SBD8W.[]
MW&C)Q\S_ 'AG/3.?\]^E2MD*?+ :7^ZV-OO[=?\ #&,@M<S5%PDH1TO&3UM[
MO:P7_AZ_^3[ZKR]_\"&W$)!\@.!U(DW>F.,^W:HF-JLWS"4RY'(SLSQZ\<_7
M^53H9N?.58SV$?3I_G_ZU)FY+<1QF+/WSC?CCU'\_;G%$&O:U%&+C.WQMV3T
M7]?J-?'+7I_/MM]E+W?7_,+AH]@\\,4/3RQS[CCO_D\XI8%C*'R<A.2?,SD>
M_)Y_Q'%/?<!^X57?/(?&W\#W_P ^V&H9<'S0$;)PJ?=[?Y_S@INU%>U_>+F7
MPO;5/Y_TQ7]S1_:6OM+?^3VT]-_3<KH;83819/-SU.=F>>YQQ[YSWJ2Y:([?
MM <CC'EY_IZ>OY=S3U^TEAYD4:Q?WAC<1SUX_P ,<]Q3I/,&/LZ+)Z^9C\<>
MO^??.GO^UARS2AR? WK:RMZ^>F_=;E_?BK]/^?C_ /2?M=-=/S$15\KY,^4!
M_%D,.OKW/J.>:@A:W$F(5D#C.=_W>!R>?_U?C4ZF38-PQ)C[H^[W_P G^O9$
M\\G]]'&B?WEQN/'!X [^AP>!40M:M[-<DKZR;WT6NWY/] 3TGKMM^\O;\/=_
MX.Z(;@P%P)UD+=BF<<]^.W\_RJPRKY/(_=8QWWXXXZ\8[]CWZTV0S _N(T=,
M')?&X?0=>O?_ .L*<2^T8YDP/D(^7/''/&.O4?EUI2:4:/M5[26EI1=TM5KV
M_/0+WC#6U_\ IY;MUM[W]=2&V:'<?LX<'OYGN>V<=_\ ZU,E-L9<2++YF1C;
MG;GK[?YXY)JPGFDG[0B1CMLQGK]!U'U'4]J1S<!OW4<;1\?,W7'Z\^M:>][1
MOF3ARKW;ZI^[^GD4G[[UZ?S7[?9Z>O\ F+,J"(>:#Y?&-N=^!G'<_EZ].E,M
MVCP?(#!>_F=>G09Y_KS^-/8R;1Y8#/\ W6 VCKZ\<<#I]/2ECWG/VA5C/8(!
M@_ECCZ\].>:SAK2E[+]W[W72^R;_ *^XA/W'KU6OM+]OM):>EK=2KFV,V-LO
MF[B,\[,_H/\ /H,U/<K$$!G#%<\>7G/3OU/Z9Q03<[L"*+R]V-W&[\/Y^WTS
M3G,W'DJLC>DF,=/?^G],TY<GM*7-%SG:RDMD].EOT*O[T->FW/:^W2WO7[_@
M)"R>6?*#>7_M_>QGUZ_TXY]*KQ?9FE_=B02>K;MN<]NG^/?O5M-Q'[Y563LJ
MCY<]LX/3MZ^N:C!N=WS11K'S\PQOX/;UQV_QQ3]Z];GESP_EB];:66B_X-A)
MW<]=O^GG7TLE#].M]1MR( 5-P')[>7GK[XS3U9?*^4'R\=#]X\'_  ]Z',^?
MW*)(._F8_P#U_P"?>I!]WY@!+_='W<^^#C)[=!Z]>)7-[*'LG[)<RNI27]W:
MZU\A-^Y%WOK_ ,_?_;K6E9:VLBK;_9RY\@2!^_F9P?IS[_3M]"X%LKCSA(6Q
MQY>=OZ'IU]OIG%2H;C/[V.-$XPR8W8]3]>__ .NAC<Y_=QHZ8Y+XW?4=\CW_
M *55X>W^%J?*O?O[O3Y/17^_4O[>_3;G_P#;/U%=E\KY@?+P>!][&!G]#3+8
M0$L;<.#W\S/7VSBIF^Y\H!EQ]W^'/MSC(_$>G3EB&?/[Y$C';R\?_K_S[5+<
MO93]J_:+F6D==K/]==N^Q"?N2UZK7VE^S^*VFG8A?[,)@)!)YF1RN=O7//7]
M?KVXEO?+\D&;)3'\')P,^A_R/>C-SN&V.-H\CYCC?UX/7O\ 7]<T^YWB,>4
M[]U;@9YZ9./QKLH6<(65ERJR:OIIZ?UYD5G[D?>M=?\ /SE3VZV?/^NY6L=F
MW_1P0O;?U[^O?/UYXQBK)\O<?O;\_A4%N9#_ *]0AST0=>#[_P \^M6LN,X"
M[>N>,X]>/Z8KP,S2YJNZ5M6H:K:[Y^CZA1O+DOK9K2_M;6\E;E]=>[TVX#7-
MG]LZ7YVXC[5!PN?^>@Y';_..M?Z1O_! 7RO^&?=+V!MGV.WXYSC9_GKQ]*_S
M==;\PZUI8C56/VN#AL=I /\ //UZ8K_2-_X(#>9_PS_I>Y5#BSM^.V=GL/\
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MG&?T_3M^%27!F*CS$11GC;C)^N,<^N<FEA-QY6$C1DYR6QD#VR.N.>/_ *]
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MS#KU]N>/_P!?-6(V_=C_ $;?U^?'3/X_AW_K4$1_>?ZK?U^3\>F,]^G;\.E
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M]>E?RG^%+UOL,<>S*Y_UA!W8Y&<]SCG^G:OZMO\ @Y.E5?%I#6HE!G'./?\
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MR[#[+LY^]^'7\>N32)(J=8/-]_3GO_\ JK\+K_[OLWHG9M/=+^3_ (?SZO\
M3<)Z)Z[6EKK'T;_*W;H[Y67YW.,?>[^Q^O7TY^M5GBA_Y9RF0]U/.#^/TQU[
M\&K+_./ECQWV#T]./R[_ )XQ2<.I'[KR^0<@=1^G7WS[5\T_XT7=)WT7O;Z:
M:;7_ .!IT]C$6Y(<SMI\*O?H]+Z>?S)HP%'S2LI'1?7CU&>O3/\ (TY)E9MK
M#8,_ZQ>#W[]?;G%$4@*@-;[^^_KMZ\\=,8R,_I3UC0,&7YSS^[';_'\#[5Z*
MM9J2=^ZLK[;\VOG9>7<\U\O,K2;6ED]7%Z;N.G;?JR&8(""DK29/0_CZ\]S^
M7H:>@BV F=@VW[O;I^7^>*;.V2!Y'D@=/?\ S_7./21&_=C_ $7=\O\ K,=.
M/7/]#U[]:S-'?KY?EI^!!%M+?-(4&/O#Z'_/'X43; PVR,XQU/;\_3^O/-+"
M<-GRO,X^YU_#_)_&B<Y8?NO+X^[TZ=NO^?4=P1(PB\LD3L6V_=[?KQ_GTS4<
M(0YWR&/Z=^G^>/Y5,S?NS_HN/E_UF/ZY_H.G:HX#C/[GSO;&?\^O6@".3:).
M'+#CYCU_#\>/Y5+*(PF5G9SD?*?_ *_]/YXJ.0_O#^[V]/E_S_GZ]*FE;]W_
M ,>WE\CY\8S[]?\ #KWZ4 ,B$9!W2M&<\ =^O^?3UJ/Y?,^^VW=C=W_/KTY]
M?PJ: X4_Z/YO/7'3W[=/QJ'/[W_5_P 7W/\ /Y?YS0!)*(P!ME:0YY![=/\
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MRAOW6/LW\)_>8_'_ .OTH @AV%B&E9!CJ._IT]?RXXHDVA_ED+C ^8]?\?\
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MZ42''4=O0\?G^/'%-B,88^8K,N.BYS^@_I_A1*8BP\M&5<=&SG'?J.I_SGL
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MVCY,\]/3K^7X56E,9;]VK*N.C9S^O^'X5*QM]A"QR!\<D[L=/IC]3WZ]* "
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M^,2&+B=0,-\O0GU_Q]>>:AE,)V^4C+U^]G/ZC/\ G\WH;?RP&C<O@X(SC\<
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M^4;PM:,MHC?>/)$@X'KG/X]OZ\_U8_\ !REY0\6Y:.1CY_!7..O!X[C')_\
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M\>F,_AZ?C5:4Q$CRT91@_>SG'&1R/Z?GVES;[,>6^_;][G;_ "QGWS_C0 V
M.2VV41<#D\=_R_S]*;+N$G,@<\?,.1[]..?_ -=)$8@6\U&88'W<YZ^W_P!?
M\.Z2>7O^16"\<'.>O'4=N_3\.I +,@D$9S<*PX^7^7&?Q_EQ4< <@[9EBYZ$
MX_G_ $HD-OL.V-PW&2<X_#C'Y?\ UJ;$80#YJ.W/\.?0>@/;^G/8 #3N\W!D
M!.X?/V'OZ5-.'"?-.K\]!S_]?IQ^/-0?)YG"D+D9'?M_G_.*DE,!7]W&ZG/.
M[/7VR.G^?< $D(D*?+.J#/W2<?\ U_R_"H8]WFX$@5LGY^W^?I^%.B, 7]Y&
M[-DX*YQG/? Z?7'?ZF--GF?,IV9/R]_\_G]>] $LX<;=TPDZ].?U_P CCUJ1
M!)Y?%PH&T_)GGIZ=?S_&H)3"=OE(R]?O9S^HS_G\WJ;?8 T<A?'!&['3Z8_4
M=NG2@!D.XO\ +($//S'IT//K_GFEGW!ANE$AQU';T/'Y_CQQ3(C&&_>*S+CH
MN<_I_A^%+*8BP\M&5<=&SG'?J.I_SGL 3D2>43]H4C:/D[@<<8'I_GFHX QW
M;91%ZD\>G^>?YTI-OY9'ER>9M^]SM_EC^??K3(C$,^:C,/\ 9SG]/\* "7<)
M.9 QR/F_S[<<_C4THD$?S3JXX^4=>A_G_P#JXJM)LWG:I"\<'K[=O\^W6II#
M!L^2-P_&2<XZ=N@_G]* %@#E3MF6(9Z$X]?\^M1?-YO^L&=V-_;K^77GT_&G
M1& *?-1V.>"N?Z9_E4?R>9]T[=W3O_+TX_SB@"Q.'"C=,)!D\#MT_P ^OK2P
MB0Q\3J@R?E)Q_/\ S^&*CE,) \M'4YY+9Q^&<?AUHC, 3YXW+Y.",XS[X!&,
M^N._7K0 V+<9.) IR?F_S[<<?A3IPPV[I1+Z$<^O^>/YU%'LWC<I*\\#K[]O
M\^_6GRF(X\I&4?[6<_K_ (4 3J)/*'^D*!M^YGG\CS_GUJ&#<6.V41G'4]_4
M\_G^'/%.4V^P QR;\=?FV_RQT]QVZ5'$8@Q\Q&9<=%SG';H.H_SCN .GW!AN
MD$AQ]X=ORY]_Y5,XD\OFX4C:/DSST].OY?A5>4QEAY:LJXZ-G/ZC^G^%2,;?
M80L<@?').['3Z8_4]^O2@ @#G=MF$?3KQ^O^1SZTR3=YN#(&.1\W/!_SQZ^M
M$1A&[S49NGW<Y_09_P _DU_+\SY5(7(X[X]/\_IUH L3"01\SJXR/E!S_+_/
MX9I( Y3Y9EC&?NG_ #W_ #]*9(8"GR1N'R,DYQGVR ,9],]NG6B(PA?WB.QS
MP5S^N.U #1N\W'F#.X_/V_PZ\^GXU).'"KNF649/ .>WMQ_GZ5"-GF?=.W<>
M._3Z>G^>U/E,! \J-U.>2V?3W'^?7L0"6(2&/Y9U0<_*>O0?R_\ U\5#%N,G
M$@0\_,>![=>./_U4^,P;/GC<OS@C..G?J/Y?2HH_+W_.K%>>!G/7GH._;K^/
M4 $DX<%=THEX/(Y[_E_GZU*!)Y6?/4+M/R=\?3W_ "_&J\IB)7RD91@_>SGK
M[_\ UOQ[29M_+QY;[]I^;G;_ %'Z]/2@!L&XL=LHC..IXSZ\GU_/UI)MPD&Z
M0.>/F'3Z^G^?3%-B,08^8C,N.BYS[=!GC_..Y(8]_P"[5E7 X;.?U_S[#N 6
M)!((N9U(POR]2/3_ !]>.*9 '.[;,(^G7C]?\CGUH<V_ED+&X? R3G'X9!'\
M_P"E,B,(W>:C-T^[G/Z#/^?R $?=YN"X+;OO]NO^>OXU-.'"_-.LG/W1SC^H
M]/YU ^S?PI"9'R]^O^?3\*DE,!7]W&ZG/);./;&1Z^G_ ->@!\ <I\LZIST/
M'_U^G'X<5"N[S0 X!W??[?I_G\:?$8 O[R-V.>-N>OO@=/\ /N8UV>8,J2F?
MN]_\_C_@0":<.%&Z991GH#GT_P ^M4,?[!_,_P"%7)3 5'E(ZG/);/\ 7'\J
MJX?U'^?PH U;K[3M_>B+'^QC/3V'\OQJ"V\_:WE;,9YSC/\ C_D>U+.+<+^Z
MFD<YZ-G'Y$5%%Y)#>;*Z<C[O3I[\?YZ=R (?,\[G;OW#Z9[?YZX]JGN//V#S
M-FW(QMQGVZ?C_2JQV>9]X[=PY[]/KZ?Y[U)*(=O[N1G.>0W;U_SUH E@^T>7
M^[V;<G.<9_Q_^OGO4,?F>;\NW?DYSC'\O3.>V>N:6,0%/GE=6R<*.A/IS[^G
MZ=!&GE^9RS!<G#=^O7Z_YXZ4 37/G?+YNSO]W&?\]/?'M4J?:?*XV;-I],]/
M\XQ5:;ROE\N1GZ\M_P#6X]?\]'H+?8"9G#[>%'0\?GZ],]._6@!+?S-Y\O;N
MQSGIU[=NO_UJ+CS=P\S9NQVQ^O&.N<_KFF1>7N.]V5<?>'7_ #CWHE\O<-CL
MPQU/7'KU_P#U>W< M/\ :?).=FS;[9_7_/X5#;^;D^5MS_M?AZ_TH86_EG$S
M[]OW>W^/YX_"F1>5SYLC(/5?P_#]: %D\SS?FV[\C&,8_EZ8QVSTQ4T_VCR_
MWFS;D8QC/^/_ -?'>JS^7YG#,5R,MWZ]?K_GGI4D@@"?)*[-D94] ?3CW]?U
MZ$ DM_.VGR]F.^['3G/7_P#54/[SSOX=^[\,Y_/K^GM3HO)P?,D=#D8"]"><
M?Y'-1?)YGWCMW=>_\_3G_.: +%SY^U?-V8SQC&?\?\GWI\/VCR_DV;??&>@Q
M[_\ U^E02^2 OE2N_)^]TZ>W'^>G<.C$&SYY75^<*.AXY]/T_$T ,B\SS?EV
M[N>O3^7IUSWZY-/N/-R/-VY_V?Q]/ZU%'LWC<Q"Y/(Z^_?L?\CI3I?*X\J1G
M'JWX_A^M %A?M'D\;/+VG/3./PJ&W\W<?+V;L=\?IQCKC'Z8I0+?RQF5]^WA
M.Q_K^61]:CB\O<=[LHQU'7'KU_\ U^_8 =/YF_\ >;=WMC';KV_R<U8?[3Y7
M.S9M'IGI_G.:J2^7N^1V9<?>/7&/P_G4KBWV$B9R^WE3T''Y^G7'7MUH 6V\
M[YO*V=OO8S_GK[X]J9)YGF_-MWY7IT]O;\OPI(?*^;S)&3IRO_U^/3_/5K[/
M,X8E,CYN_P#G\_IVH LS_:-G[S9MSQC'^?\ /%%OY^P^7LQDYSC/OU'IC/ZY
M-12B#:=DKNV>0>QST_\ U^GX$B$.W]Y*Z'=P!W/IU_\ K_R  T>9YW&W?N.?
M3/?%2W'GX7S=F,\8QFH/D\SEB%R<'OW_ ,_YS3Y1" /*D9^?XOH?3CI_GT +
M$7VCRQM\O;COC_#USC'X8JO#YGF_)MW<]>G7_.??K3HQ!L&Z5U;G"@\']?Y=
M>_K44?E[_G=E7GD=>O/Y?YQT(!+<^;N7S=N<?PX_I_GI[5-_I'E?\L]FW\<8
M_/./Q_"JTOE97RI&<8/+?7\O\]N\F(-G^M??M^YV_P >O;I[4 );^=N;RMN>
M^<>_3^G;TILWF>;^\V[N.F,?CC_/6FQ>42?,D9!@<CTYP>3C_/?LDGE[_D=G
M7 Y/7'^?\]@ 6I/M'E?-Y>S QTSV]O7&>WKFH[;S_F\K9VSGK_G]?PI'$'EG
M;*[-@94]!Q^'ZXQVQ3(A"=WFR,G3[N.OIR?3G_/( -O\XYV[]W;I^G^>G:I[
MCS]@\S9C(QC&?;H/3./TP:K-L\PX9BF[[QSG^O\ +\^IDE$.W]W*[G=R#V/I
MU_\ K_R(!+;_ &C8?+V;<\YQ_P#JZ?\ UZ@3?YO&W?GOT[?A_2G1"#;^\E=&
MSP!W_7UXX_\ K"-=GF<LP3/WAG/\O\* )KGSOE\W9W^[C/\ GI[X]JDC^T>5
M\OE[,'/3/?V]<X[>F*KS>5\OER,_7EO_ *W'K_GH]!!Y8W2NK8.%'0\?C^F<
M]\T -A\SS?W>W=SUQC\,_P">E37&[ \[&_'&WIT[X[]?_P!6*K1^7O\ G=D7
M!Y'7'^?\]C)*B8!B=I%'4L0,=_\ ..*J*3DK_DW?Y)IE1O?2/,^UK]>Q3/VS
M<?N^5[=>WXY_R><U=@\W'[O9GON_^OQ^/TJH+FW#;-[;\XP>F/TZ?E5E3'(,
MR.T8[;>XQU/3T^F<U6(Y_9NU-2:79O9K?9)Z;/8VJW;BY?NW;1+5/;1]%;>S
MV>XR6:-9 'W>;GC:/ESQZ$9Y_ \_CHQ&]-O,6"^7Y38'&<;6QVZ?Y]*I@;"#
M&@DC'5F'S8]>A/K_ "J^EW;O!,H=MPB<;>V=K$CZ>_\ CFN7!V]]N+A+MRV6
MMM/R/)K.LJL4^6I&Z^W&\-K^ZD[^GH?P/?\ !R;+<IXM)01E?/P=V..?<=<]
MP<5_*9X5N+<V2!AB8G' &WN/Y\<\GCZ5_5?_ ,')ZVK>+2)II(SYXP!P.3QG
MG^GI7\IWA6S'V%'7F/\ O\;@,'\__K]J_L?PBM_9N$M+V;Y8ZMJSU6FMK?Y>
M9^:<4J?MJW[U0CK9*#3>VCUUTZ?T^M;.W-QC;QC9R?;..IZ_Y-5CYV?]'V>7
MGG?UZ#VSTQCOCOTJ= %X@)E..0_;UQG'']..G2I.(3(#/(\3[N$0_*?KC/Z9
M^G<_T/B_X*ZZ:NUULM>;\/+5'YA4TC)>>WP]5_R[=WKWO;KJ6!T']_OTQG^7
MTQ2$9_UO7MC^N.>]*/N#^Y_>[D>IYZ^](. ?+RX/7/4=>.1_3_Z_Q-=Q]K[R
M<ES7Y5--[QMI:[^_N>?W6RTTY6ETWIW;E\GU\Q@^TAOE\ORLYYP6[=S].?\
MZ]2R,Y4>3MW\9W\#/7OD=OY_2J>+?S06FD63(^09QZ=./Y9%6[@1^6/-9HU[
M,HP3^6.<?_JKZ"ES>RI\C48<JO%K7I;1ZW7I\RVDW3TVM;]V]-NOV/GMYC4\
MW'[_ &!\Y&S./T_#H>.*:/M6X[_+\K)Z;=V/Y_3GK1;M&$(B8RIW9NOZY_\
MU<^M0J+<S9$TAES]SG;GZ>GTY['(K"'*JE7EESRM\#C>VBZ)]?Q^X:WGIT?_
M "[>NBTO?WEY+?NBS)YG'V?9GOOQZ<]<_P"?>E7?M^?;YO;&<=/; Z]^GKQ4
M-PD>%\^1HO\ =R.,8R<?3MT_.I(F0180ET_OD<_Y]?R^JE9TH.=Z+YELM'JO
M-:K;[D3;W(KEO9[.E+35:\M[KUOV\Q$^TY_?>7L[;=N?QXSG]?3UHD\_/^CB
M/;WWXSC\1G/I^G J"%;<R'RIG>0YRK9P"?\ /&./QIUPL.X>?*T;#H$SSD@@
M'L?;M]:TU52-H>[R_P 1K71+6Z[_ /!6NI7VUIKR_P CMI_>O;Y%CY]IQM\W
M!]<9[>V/\]:9'YV?](\O'&-F,XY].<]/Z\4[<ODXR?+Q_K.Y'K_GZ^U06ZPE
MB8)7E/<-G@@DX'8?R_*LH64*G(W5=]FM.FE_^ *WN25K:K:F];6Z7=_D_,D?
M[3G]SY>SC.[&[O\ CZ?UJ1M^WY-OF]\YQT]\CKWZ>G%595MQ)F69T?@!5S@D
M9[=/K_B*L2LABPY*)_? Y_SZ?E]*E9^QYVZ4KQM%)V?PZ?I;3\PM_#TO;^X]
M-5Y^[ZN_W7"/S.?M&S/;9CTXZ=O\]::?M6X;/+\K(Z[=V/Y_7GK3;=(R#Y$C
M2CN6SG&,<9__ %D^M1L+=9LF9Q+G_5\[<_3T^O/IQ5)RYYWARQY5[Z6KTCKT
M_/R&E[\G;=6^!^76_O>G^19?S<?N=N_ONSC.?]K\>O7VH3=M/G;0_.-F",_A
MC_//K3+AHV0"9FB7^\O7],?XXYH@1?+/DL9%R<LV20#]?IG&,CMWK.*_<KDO
M5]]7NK[V_K\[Z$V]S:UVM%3?DOAO?Y_@*OVK>-WE^5GMC=C\,'Z<_P#UE?SN
M/L^SWW]/?[W'^15>,6ZRY2:1I,_ZLYQ]/3Z'KZU)<F%MOGNT/IM[_EZ_3KQZ
MBK:C[:%Y.,N7^&M%TNDK[?YE6]^/NK;?V;TV^U>R]&M-"9<[/GP)>.GW<^_0
M?7/^%,7[1N_>^7Y?., ;NG&=O.>N?;GIU$0>3\I+1XY<Y+=_Y9ZCZ$XJ&#R%
M<^5*\C]U;IT_'''. ,?K1>\:JG'V:N[2BK/;OY"BDO::=?\ GTU?\?>7IY$S
M_:,_N1'LYSNZ_AN'K_A3S]SC'F]O[N?;M_GUJO<>0SCS97B;LJYP?;C]/_K
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MW/@C:3Q]/7\>:EALM<R&DA6)3T*MW!Z^_3M_7GAQ,XX=2<?WENGPK2WI?O\
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M?\L]FW\<8_/./Q_"JLOE CRY&<8/)].,G@X_SV[RX@V?ZU]^W[G;_'KVZ>U
M"6WF[F\K;G'\6/Z_YZ^]-F\SS?GV[N.G3K_G'OTI(O*RWFR,@P.5^OY?Y[]F
MR>7O^1V9>.3UZ\?G_G/0 %N7[1Y9W>7MQVQ_AZXSG\<U';^?AO*V8SSG&:;(
M(-AVRNS<94G@?K_/IV]:;$(2#YLC)S_#]!Z\=/\ /J (?,\[G;OW#'IGMFI[
MCS]@\S9C(QC&?;H/3./TP:K?)YG#$KD9/?M_G_.:DE$.W]W*[G=R#V/IU_\
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MRW?KU^O^>>E %F?[1Y?[S9MR,8QG_'_Z^.]%OY^P^7LVY.=V,^_7\/ZU%((
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M\OQR:9 I.[$_E=/7GVXQ]?\ / !&V?-.4VG/W.W]?\C\:FG+[.8!&,]0 /\
M/<G^M0L#YI_> _-]_M_3_/Y5-.I"C-QYG/3T]O\ ]7'ICK0 0%]GRP"09Y)
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M',+QR3$-%/Y(_N^OY^P]_K5+^+S.3BE'^')]TOEY:EQFG4][E@U':3?-LO\
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M/Q\S]G/%OQC^$'Q/\.3:3K/BZUL'NHRCQ[@=NY2.F>>21_\ 7S7C_P *=$^
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M\=/P[U+ "5.)Q%STYYZ^G/\ 2H<?O?O_ ,7W_P#Z^/Q_SB@":<OM&Z$1C/!
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M-*-",9*7*XQYVW\-DMKO1^FFG0_6CXW_ +,6J?%*[>ZAU&VB5RS?.1D@[O\
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MB<J?*9%&?XB!Z^O^>:@^?S?O#=NZ]NOY=>?\YH ?+Y>/DB:,YY)SSTYY]?\
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MK\I!R?3MZ\_X5-;><=WELB]/O8'\_P ?\.AIDGF>;RP+9&".F?S[]/\ 'I0
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MOUH )?)^7RV<]?ODG_/?]..].7[/L&6DW8Z G:>/3IS]33KDR?+OB$?7@?\
MUO\ //7M4B&;RN(%*[3E^...>W]._:@"K%Y>3YC,%QP5ZG\?I[_G1+Y61Y;,
M1CG=U]_RX_\ K5);[]YVH'..5/\ 3_\ 5^5%QYF\;HPAQ]T>OIT_SCO0 -]G
MV'#2;\="3M_+CI3(O*Y\TN/39P>W^?PJRQF\DY@4+M^_Q_@3_P#JJ*W,F3LC
M$G'0_AZT 1/Y?F?*6*9&<]<?GW_SGI4DGV?9\C2%LCAB<?AG'T_'\*;(7\WE
M #D?*.GTZ?Y]NM3SF7R_F@5!D?,,<^_KT_G^0!#%Y.#YC.#GC;QZ]?;_ !J/
M]WYG5MF[KW__ %XYZ=>W>K-N9-IV1"0=R<<=>>?3_(J#+^;G:-V[IVZ_X\?Y
MQ0 LODX'E-(3G^,D]O?_ #Q^3H_(V_.T@;GA3QT[_P OY9I]R9<+OA$?)Z8_
MI_C_ /7="9?+^6%67^^<<<#\?\]J *J>7O&YF"\\CK_D'_(Z4Z7RN/*+GUW\
MGO\ Y_&EBW^:,*&.3P>G\OQ_QZT^X,F1OC$?'0?CZ4 (/L_ECYI-^WH"=N?<
M<]>M1Q>5D^8S 8XV]?;\^?\ Z]6E,WD<0+MVG]YQQ_(__KJ&W\S>=L8<X^Z?
M7TZ?YSVH CE\O=^[+%<<ENO3U_\ K]NU2-]GV'#2;L="3M''ITX^HI)]^_YD
M"-_='K@>GX=OSJ=S-Y7,"A=HP_'/'';^G;O0!7B\GYO,9QT^X2/\]OUX[TU_
M+W\%BF1R>O\ G_/-36QD^;9$).G!_P#K_P">.O:HY"_F\H V1\HZ?Y_#\J '
M2?9]OR-(6R/O$XZ]NWMU_.DB\C;^\:0'/\)X_'\<_P#UNE33F79\T"H,_>&.
M??C_ #SVI+<R[#MA5QGJ<<>_(_S[]: *_P"[\SDMLW'![_\ Z^_2G2^3@>4T
MA.?XR3V]_P#Z_2@%_.SM!;<<KV_R/\^E2W!EPN^$1_3_ #W_ *4 -3[/L&YY
M-W/0G'^<?7GIDU%'Y>_YRVWGE>O7G_#_  Z5:B,WE#$*L.?F../T_#_ U7A+
M^9\J!V_NGI[?G_G/6@!)?*ROE%SP<[SD]?\ /;O^<G^C[/OR;]O3)VY],?7V
MZ>W-%R9-R[XA'QT'U]O\?_K39F\K_4KMV_?X]/SSW_KB@"K%Y63YC.!@8*DY
MQ^&>O].II)/+W_NRQ7 R6Y/^?P[?E);F3<=D0D/<']1T'U_#H*2;?YOS($;C
MY1Z_ACV_SR0!7^S[#M:3=@9!/R_AZ8_R138O)^;S6<=,;"1^>/;_ /5WJQ(9
MO*YA55P,-QD]/;\#_6H[8R_-LB$G3@]O?^G^> " [/,."2F>IZ_UZ_U_&I)?
M(V_NVD)S_$>/P_''_P!?I36+>:<H V[[O;^GO_GBI[@R[!NA5!GJ,<^_ _S[
M=: (HO(V_O&D#9XVD@?C^/O^5,79OY)"9ZCK_D59MS+L.V%9!GJ<?+^?Y]/S
M[P(6\WA06S]WMVX_E0 2^3\OELYZ_?)/^>_Z<=Z<GV?8-S2;L' !^7\?7/\
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M/L..G6F1>5SYI<>FS@]O\_A5EC-Y',"[=H_><<_S/_ZJBMS)D[(Q)QT/X>M
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M2^3@>4TA.?XR3Z>O^>*JY?T'^?QJ_<&7:-\(B^F.>GI6=A/4_P"?PH T[A0
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MY_S_ %I82H8[HC)P. .1UX[]/\>322D>9\L90<?*1S_G\._X  E<#RSBX+'
M^0]O\>/K[9%,A .[,YBZ=._Y_G_7M3W*>7Q;D' ^8C@__K_SBFP%1NW0F3IT
M&3_GM0!&P_>G]X2,_?[_ -/\_E4LP 7BX,G/0]O4?Y_''6HF(\PXCP-WW/Y^
MO^1^-2S%=HVP&/GDD8_+^?\ CTH (0"O-P8SG[H'7^OM_CUJ-?\ 6?ZP@9^_
MWJ2$IM.Z R'/! S^?X\]?RJ-2/,^YD9^YCZ8_P ^_6@!TP VXF,O7K_GZ_EU
MZBGH!Y8S<%3@_(._^''T]\"FSE?EVPF/KU&#_G_'IWIR%/+YMR3@_,!P/_U?
MYS0!%$,OS(8^#\X_S_6I)D(P1(9ACJ>W?V&>??-1Q$>9\T9<<_*!S_G\.WX&
M29^@6-HACD$8SV_I^GXU<+\RM^"3_P#2M!KE^U>UUMONK%<3Q [?-RW]S_)/
M/].YJ9</SY@A'JIZ\?K_ /7SFH?(A)W&(ACU;''_ .O]?P%3KMCZQ^</8=/Z
M_A_A2Q'L_92YN?I>R7]V]F_^&^XVE;3V2;C;WE+>VG?S[:6%VHC M&)@#S*?
MH,]<>O;G],Z23PFWE59?F\IP4'KM/M_^L?2L@QR2.,3>2G_/,\''H/P^OOUK
M62W@2WEQ$=WE/EL=]I/Y'G\*Y\#M/EE>-MGRW2TM_2W;]#QJ_LG6AST^25UR
MR7/:6SU^S]^CUZG\#/\ P<GQQR>+2&NC$?/Z<\\_S(ZY_3FOY2O"MGBR5@<C
MG$OY_AZ9_P#KD5_5C_P<I#_BK6_T9I#Y_4#ISW[]._T[U_*3X4>X%F@RRQ@_
MZOG/?C'TXP*_L?PBO_9N$Y4I^ZKQVMJM?/Y==NY^<<3N?MZ_)1OO>4E3\KV\
M_7?9^?:*-@.&^TCNI[=?K@_S_&JDH!8$SFV.?]6. < ?3'^ Y/&!;4[A\B_9
MR,?,>,CIW]_Y>M4Y2H<!X3<'=]\ $#COV^G^2?Z'Q?\  7^%?)V6FOO6ZZ=U
MTW_+ZFTKZ._SW5_@_=_?^98'W0/I\^#^?3K29(!V_O?<\XZ]Z4?='IC_ %??
MZ=?ZFA3UP/+QU![_ (?_ %J^)K6]LO?4/>^)<_>.FONW_'8X.O5NZZ1ONMDK
MP_\  OD5L*9.;HH<_P"J_P <=OZ9]:LS!2@_>>3R/G'4\]?7OU^O/I6+)YF/
MLS,V1^] XSQ[_GZX]ZNF,.O[S]Z,#Y/;OGOVQ7O4VHTJ=X^T7*OWEE=;+;SU
M_P RY.S@VY)+?2+[;Z/Y\OR*\4D:J5$GV@YQN/4=\_KVY_44HMW+;Q<$CD^5
MD8[Y&.OL,C/:G_9X@I9%\KG.T\$X'L,\X'\ZB^U,A*K;-T/[S''3KGK_ )ZD
MU%YOVC7*X/J[*72^UG]Z,E*HW4E'DY-];<WV;VZZ^?0)EZ;IC;8[@D9X_P X
M_J:='(FP(&\TG/[P]?0^OZ<8]L8%Q,/WL9D]1C../TZ_H?I3S;QQJ&0;=N?D
M[_3CUY_E41:]G&%)N_,KJ25KZ=_\_3L+VCG"*IN\FTFI1BM=/+E77S&);N#N
M%P91VC)!&#Z8/7\O7M3)E&[+7!M\ _*.,\CL>O\ +GM2?:W&56V9.P<C [\C
M'//]>F*E"I,/WL1ESGG'3)QU_P ]:=XQJJ52ZFDDN76.RZ;Z_P!6*]KR34:K
M]ZUO=BG'9=;7Z^@"1'0(K9RO^M[X/?\ KD\9_')';R(2WG&<=-I.<<GIC@=1
M_AS3FA2$;D&0!_JQU^G Y/U^N*A%VY^5;=H>>I&...F/Z^E)J;A+G2]FWK;X
MNEK6\N_7RL2I5E"4I<G)=:I+FM[O1:=]U^@V55#$M=&$<?NQGWSD'_.1UJ8L
MLJ[%;9T'FCZ8_P#K<]CTZT"*.4?O(2Y./GQ^/7GIQ^5*\:P LJ^8./D'?CIC
M'K]<8_&G%NU.-'HOM]]/O^3]!^TE4Y/8V;Z\Z2ZQMTM?_#_PQ'!)&#F0W&>Y
MY(XQZ^N>_P!,8S5<A ^YKLK\W^I[9XXQ_DXSUIXNY&P!"T/U&,]?3CM^M2B"
M*4@O"=V?]81Z=R?SZ]C2CRPJ3;_B-:VUCLN_=?(:JI2G&;]]+:,?=OIM*R?W
MB-B<;4?R>OSC')Z_F?KGCM2K$\:D%C*.N\G)'X_TZ_@>4D MQE4,W/"@?D>F
M/K]:8MR\G'EM$.!M/'!QV]>?T^E*:E[-*I;EYEK'?H^FGW$N=2$%*?+9RWC&
M,GTULE;\.^@Q=B2 M=ESD_NCT'7/TQ^'(&<5*R_: -DI@QC[IQG'7T]>V>O-
M.%O"Y#&':W7?@8/OZ<\>GK37(MND1FXSA0#CMQ^'\JT4I.<?9-.*BE[Z2TT\
MD[^GS*YYRJ1]DXN-DWS)+M?IS=]M!PB9$VD[NWF=3SGOW_+Z\CB",QHV[[5Y
MW!_=GL,=/U]>Y]:D%P\O!0H#D%#_ )]N>,<_6I!;0MSY/E-_>(QD^GY\U$'&
M*FHW4Y/5/X7>VJ[/S?7R)C634U=^TTT<5RZVZV[/[38QXS.=R3F$?W <9SQ[
M>G88XI61E3:QV_\ 37J< #GW/!SV[C%->3[.<+ 9N<;E ./7\,\_C2K,TO#*
M=IY\O^G?UQ1-?P_;=&N7DWZ;K;OLO0?/.FH>UY5=I+D2;^SY6Z_92\B.)HXR
M3]H^T=MI[9(P/_U^@'8U(T+3'>MPR#/^K!QD=0.3_3]*D%M"1E8Q"?<8S^?I
M4+3^2=JVYDZ_. #TZ9/TX_"KO.4FX6<+?:5G96^?;U*YZDIN5/E<+?:5GLK]
M.;[]+Z>CI4(0!W\KUD'4]>W_ -;C'X4V%XX\CSOM&3]X]N.3Z$CKQSU^M.#F
M;(=2X[)]0?K_ (XJ3[-%C<J"+N5X!QC^O2H@XJFXTV^9RVELW=/=_A_5X57F
M@U!^_P R5I127GT2^;(OL[NV\7+8Z^6#QZ>N>.G3)Z=:)EX :4V_3YAZ_7_Z
MWI[FFM=&-@@MFY('F <?7/7MGMZ]J>")N)$,O/W>N!U_R<CFB5N>G*KHTM.7
MO:._W]/,IU)0E352RNOLQOV3N];;]-];=+I%)&J[!)YQ.0)#G(S^/KU(_'TH
M6W?)<7#2#G$>>.OU/7'Y\^M2FWC4;E41XR=OKZ?K_+O4'VME;8+=D'/SX&/7
M@_IS_6J]^2J-\K@_E+2VUK/[Q1G5]^2Y'#S2OTZ)>OQ;A,HS\TYML>G&?Q_3
M]..!3TD0J(U?>3C][GIZGKG&!_GC H6;!EB\T]^^WMSZ=?7UXI[0I&-ZJ !_
MRS]>O'XC^=)-<D8T=[ZJ:6]X]]-?+L+VCJ1BJ3O*^JFHQU37=*/?89';NIW^
M<TP./D)R /UZ9X_+TJ*51NRUSY&/X < ^QYYS_GO2_:WR46W:/ ^]@ ''X?_
M *_PJ4)',09(?,..6Z@$_P"&/?M0N6-7FFVIVM>.L>EOQ^1?M>6?+4:4K*_+
M&\?L];<W7O\ \$WJZ;%?'!_>YZ\?7N3QG_')' \>293/ZY.<?CGT]?UYI6C2
M'+*NX?\ //OVX^H]_2HA=NQ($#PX('(QG)Z]!G'],\<TI*3IRY[>S;5VM)=+
M;?KY]&1S58P<I<G)=6M9RMITM;\/U$95\S/VHH<C]UDXZ] ,Y./YU)=X\H N
M81_?'X\G)Z__ *ZA#HTGS6C.V1^\QP,8]/KV_"I[LJ(@60S#^X <_3!'^>E=
ME&W)!1O:RWO?IVZ[;^NY51N5.#5[-7O:'E_-M?\ NZE>S& <2?:/<Y/8^_/Z
M\U:)P3B4C_8Y_+'8=,]/TXJV94K\J>0/0\8ZC]#W_&K60&/[LG_:YQ]<GVKP
M<S2YJEW9M;^_IMVO'3SZA1VA?5:6O;RU7L]=_P";\KG!ZW\VM:6&D,1^U0G/
M3_EH._KC\_I7^D=_P0% '[/VECS=V+.W^?\ X!C/?!Z]/;I7^;EKI7^VM,S&
M9?\ 2H,@=OG&3Z>W^>?](O\ X(";?^&?=+_=%<6=L2I[_N^O4?A_+O7\Y^*E
MU@(JSG^^7[WW?[KMII^'J?LG!-^72Z7)M[G9?]O[;]?(_H3G4;WQ=%R&^X?7
M'I_C^/6A(T?[TWE]>.GMGCZT3F/>V+4J<_?(]A_GO]1UJ(*2?]49.G([8/ZG
M_#K7X77O]7U=MM7RZ:*WP_BWJOO/TS">JCKO[VCO'Y_<3N-BX63(Z;QUP3][
M^O/_ .NEYASS*9>V/Z]^/R&.U7<A%^9.,?</OV_GT_\ K579HGX6'RS_ 'B.
MN/3\<'\ *^:E;VT;I-7W]Z_37^OSLSV:U^6'*KRLFI:Z[=[+_AB2-4=1^_\
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M !>+@R<]#V]1_G\<=:BR/-XCP-P^3U]1_G_Z]2S%=HVP&/GDD8_+^?\ CTH
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MMR#@?,1P?_U_YQ38"OS;H3)TZ#)_S_AT[T 1N/WF/,+#(^?OU_S_ /6ZU+,
M%XN#(<_=(Z?U]O\ #K43D>9_J\#=]S\?\^O3O4LQ3:-L!C.>21C\OQYZ_G0
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M[;Y@00/W?U_Q^E?YN&N^7_;.E^<&(^UP?=S_ ,]!T[?YQUK_ $C?^" GE?\
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M_AFJLOE[OW>[;COG/3\_I^F:E;[-LX$F_'OCI_\ JQ^E "V_F_-Y<BQ^[?\
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MO<UUZ_E_6^Y;UDG67LU:W-%+7:W[Q>\K_P MK="5Q*T?[N1-G]S@G&>YY_\
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MW;,^^>OY_6I9?(V_NP^[/.<\?Y/MTSTH D@\[8=DJ(,\ACU'IU_^M_(0KO\
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M0J-A\N1IEZ[CDD=\Y_'M^-1*(A+_ ,?+,^<F(]/_ *Q_7'KQ4)OGJIP]FO\
MGXD^R_&]K?U=I+FJ:;[^[+LM^CZ:+5]"9S-\ODJLAYSY@]O_ -?T]Z>N2N9
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MTS6E*7)^^][6_35=?+M^!*7N-62]Y:<DO+IJ]>Z%8W.X@11>7G[V/F_#^?\
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MG;V<]-5TO=?/T0U#<9_>QHB<89/O8]3]>_\ ]<BAC<Y_=1HZ8Y+XW?4=^/\
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MX0^7&C#/.['3VR.O^?<LE6,+E9V<Y^Z?J/P_SQ1"(RIW3,A!X _SZ\?ASS0
MP;_-^Z-V3QV_EZ\#_(J:?S"!YR*G/!7!X_ >OL/KVJM\OF?ZPXR?G[]./?IS
MZ_A4LJ+@;)3)SW]?Q]O\]:B7Q1OIY\K?5==E\T_Q*A?F5HJ3_E:;O]Q/&9O+
M_=QHT>#R<9_#(R:K0^9YGR*I;T/3.1CJ,<]_;UZU*BIL^:=D;GY?3_/_ .KF
MH(]I?YI"@Y^;\1GW_P \\U:^\3O=W5O*UK?(EN3*2!*BKD8^7'K[<?Y-+'!,
MRYPNWGG..,_4'/OC\^\<P08V2&3CO]>F>WXTB.PZ2L>3\O( /IT__7UJ97:5
MK7NMTWU\K6+IWOH[+JKVNM+JWF+)"4P0 _."&QQ^?]*54@8?,0'S\H7H<XSW
M]?TXJM<HTPPTC1>X/]?\/7\:(K21$.UC( ?O$G(Z=_I].OOBL4OWOO56I=%S
M12OIT[>O>VYO7Y/9_NY26W[MW2O9='KU_IEVV@N%=CL39S@\9QZ_I_\ 7/?\
MK_VYWN5G4111ORN=V..G8C^GO7ZDVK%96!F;(&,$'CC\C]/ZU^6'[=*PF=2]
MRT7*XQQGIZ'U ]N/7-?:<,JI_:E"TEMHW[W3RM?3S/B.(7)X*KS.^UO>4M/5
M:7^7WGYY:49C "4428^Z!Q_%]?;_ #UZ&S-UE?-BC1<\%<;N^/3^?USQ7-:4
M(Q; "8E<?ZSC/\7\\=_Q[UT&GB(,-ERTK9QM.2.2?KSQS7](Y=?DIJ5F[*^C
M:O9?95I=5I>_D?SAQ'_'A;;4MW7FY.R-&7/+,!D>O?MBL]4@!RN/-R/E.,9[
M\=/\@8ZU8OHE=OFN'C)/W1P#C\>OI6=':2*V2Q"?W^<]?;G\>>O6MJVE25DF
MKK2SCRV2V3U^]M_IYN&UIOF_=JVDE=<[]W1K[5WTCJR6Y:X'50HSQM..ON#_
M (>_O)$9RGS(A3N6ZX_S]/7@TAFB@XW>=V^8=/Y^@'_ZC06CF7(E,9/1!TY^
MG4=>GKWK/K>[OVZ+;^O^'-[2Y(ITE&*:?/R2TVUY+\R]6VNRN2*L*L#%AI,\
MJ>@_#C'/Y#TQ56=K@,-P"G.,*<#'X?Y/8'LY;9U8L[E$/1AGISTQ_GCOUJ0W
M$<7R\2\_>8<_U[YH]?=\D_37Y_KYH:TE>'[]\JU:;:VTYMEWL]5ZCT\YH_WD
M:;/7C=C/!Q_GT]:5%C7)M\.Q'1B"/S/0_P">:C8),ORS$-VCYQUZ?EQZ<4R.
MW:,DRR&,9X(_#'X=^F/I3UNM+[:W2MMU_K8FRY7>7(VU^Z496EK'=;R_[=VO
MVT(Y6G\P;A@D]!P..G Z_CVP>,YJWAV0?:$14X^88W=/\\_CQQ49N8DP@ DS
MQO(Y_7/(_P#U>@1T64?),6<X^0]!U^O.>>]2OM6;EY72[?UI^:&[ODYH*FEM
M/E=^FNC]W_M_IY$R +G[,%?U+'I]"<<_Y[52+3^:<CGJ5Z#/TZ8_EZ\8J:.
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MS[CCO1O;5I[V3]-_02NHRY8*I%O6;C*[V6MW>7K&Q(ZQ$YN,(^. IP#^/?\
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M^!U_S[@MS.$/EQHPSSNQT]LCK_GW+)A&%&V9G)/(/^?7C\>.:(1&5.Z9D(/
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MGH>O^/MQ^%0IN\W <!L_?[4 .G.=O[CR?;&/Z_YS^3XV_=X^S;^#\^.F??\
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MU"J3<,\@FY'S Y]_T%2U:FFY>U7,O=ULMNN__#6(M.%/FYY5/>7N:KY7T?\
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M^WFUHHG.3B,X_P!7C] ><$]/K3P"  (_)["3IQZ^W'<?7I2D 'E3(P_Y:+C
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MO;W.?3_/O/[YPL^9J]GI'VEKKY?C=/YA=Q:^*,K>2=M.FE.U_FM! N  (O+
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M((G4+C[O?K[\_P"?7-0P;RYVR!#CJ>_Y^O\ 3GB@!)CEL^5Y?'W<8_SZ=?\
M&I7/[O'V7;@?ZS'7 ]<_X=*CGWAQND#G'##M^7Y_RJ9Q+Y63.I7 ^7OT_/\
MSQ0!% <;OW'G>V,_U_SC\V.<R?ZO;R/DZ9SV_P _KTJ2W$AW;)5C^O\ ]?\
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MJ.QR,;<^GL/\\<]JMW7VK:?-$87/\&/3GI_GZU#;>?AO*"8SSNZ_T/\ D>V
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M\/P_'UJ61TQMB5E7'(?_ .O@YZ<8_.FP>9YOR!=W/WL8_P _3V]JFN-V!YV
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MCS.^[[OOCM^7OCBFJ9>?/"@]O+Q@_P"'.<'ZX[U#TI/VG[[WOLZO=/\ X?\
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M=^[$?E9'WL;L9!&,_K^9I;GS-@\D MTPW3//X?3]:[J-^6-VI.RU2NGMKO\
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MG].>U6)?M'E?,(]O'3&?\YZ_KFF6WGX/E!"/]K\/H: *_P GF<*VS(R#G/\
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ML\SAB5R/F/7K_G_/%2VY8;L0^;]?_KY'_P"KIWJ-R?-_U>TY'R?Y_P#K_C0
M^7R=OR3.YSRK=!R..O\ /T_"B'R=IWRNASP%/4^G^?3CTJ2<OLYMQ&/[P_#T
MQ]>2?QI("VTXMQ)SU(_Q_/\ J.E %?Y/,QN(7)PW<_\ Z_\ /K4DWE<>7*\G
M^]^/H?2F@GS>(\G)^3T]O\__ %ZEN"Q S (OI^/H!].] "1^1L^:9U8YPH/!
M_7\>_OQ44?E[_F=E7GYAUZ\]^W^<=*L1E_+XM@PY^8CG_'\OUJ&(MYG$6_\
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M^O\ B*L2,IB&]BB?WP.3Q]/R]^.G2-F?=Q;"48&9"!QU]CGTJ5QM0%5$C?\
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M9QU/\O7\#Q3S/;F0KYC>9G[N#C)_#U]_QX--M<L/FC$'/*CUZ>WU/KTS4^Q
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M7,?-N$''S#K_ $/OSG_$ CA\K!\R5T.1@+QGK_/\ZBPF_&X[=WWN_P#G'/\
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MPF_AB5[MWZM@_P"<UH>6\(/!N#DD[NW(]<YZ^G'7BJ)8F3/E[3G[O;J?;_\
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MSC'5NN.,GK_GVJ7$'EX\Y]^W[F>/\]NGZTR<L6&8?+]AWZ<<8Z_Y-39;RO\
MCW&-OW\<_7IGW].V.] $$/EY;S)&C&!ROU_+_/?'#9/+W_*[,O'S'KUX[]_\
MYZ5);E@6Q$)>.A[?GG^7?\FREO,YBV?[(^I_E].GKTH ?)Y&SY9G9AC*D\#]
M?Q[>W%-A\KGS)7C_ -W\/4^E2R%_+YM@HX^8#G_'\_TIMN6 .(!+]?P]0?IV
MH @^3S,;B5R,MW'_ .K_ #ZU+-Y.T;)7<YY#'H?3_/KSZ4PD^;S'@Y'R>OM_
MG_Z]33EMHS;B/GJ!_A^?]3TH 9%Y.WYYG0YX5>AY/'7^7K^%1IL\SEB%R?F'
M7K_G_/%6("^SBW$@_O'\?7/UX(_"H$)\W_5[CD_)_G_ZWX4 +-Y7R^7(TGNW
M^?\ ./R>GD>7S,X?!PHZ=..^?YYQ1<%CMS#Y7T_^M@?_ *^G>I$+^5_Q[ C'
MWSU''Y\?7\Z *T6S=\[LBX^\O7&#_P#6[TLWE[OD=G&.K=<=SU_SGJ.ZPE@_
M$>\_W3_+O_D=Z6<MOYB\LXZ#O[=NO].U #CY'E'$S[]OW/X1^7_UJ9#Y>3YD
MC1C'5?P_"IB7\G_CW &W[^.?KT!Y^O\ ]:.W+ G;$)?8CI^?_P!?^M $4FS>
M=K$KD<GK[?X?X]*FD\G9\LKLW&5/0<?Y_I4<A/F',>TY^[_GT'/?\>E3REO+
MYMP@X^;'/3\_S_2@".+R<'S)7CY'W?Q]<"HL)OQN.W=][O\ YQS_ )S5B L%
M.V 2\]2!Q^8/^>]09/F?ZOG=]S\?\>.G^- $DWE8'ERNYR<AN<=/Y?G1'Y.S
MYYG1LG"CH?;D^OI_]:G3EMHS (_<#KT_S_4TZ(N(^+<..?F/7^I]^,?X %:/
M9O&YB%R>1U]_\/\ #I3YO+R/+D:08ZM^/X4D9/F#$>XY^[_GU'/;\.E/N"Q(
MW1"+V Z_E_\ 6_K0 J^1Y8S,X?'W>W7ZYZ>F>E1P^7N^=V08ZKUQV/7_ #CJ
M>UA2_E#_ $8$8^_WZ_B?U_\ KPP%M_$7F''0]O;OT_KWH ;+Y>[Y'9UQRS=?
M\]^M2/Y'E\3.7P,J>G3GOG^6,TV<G>,Q>6<?='?^7T_PJ9R_E?\ 'L ,??'4
M\?GS]?RH @A\KYO,D:/W7_/^<_FU]GF?*[%<CYCUZ\'_ #^O2I;<L-V(?-^O
M_P!?(_\ U=.],<MYO^KVG(^7_/Y_X]* '2>3L^29W;(RIZ#VX/KZ_P#UJ(O)
MVGS)70YX"]#_ /K_ /U5)*7,?-N$''S#K_0^_.?\4@+;3B 2<_>(Z?GZ?Y(H
M K_)YF-YVY/S=^G]1_C[U)-Y.%\N5Y.3][Z>QQ306\W_ %?.3\G\_P##I_C4
MMP6(7, BYZCO^6/Y?_6 $C\G9\TKJW.%'0\?Y_K44?E[_F=E7GYAUZ\]^W^<
M=*L1%O+XMPXY^;'/3\_R_6H8BWF<1;_]D_4?S^G3TZ4 $WEY7RY&D&#RWU_+
M_/;/+_W'E_ZY]^#\G\/7T_3IBDN"Q*YB$7'0=_RQ_+M^<F6\K_CW&,'Y\<X_
M+/'_ -;'>@""+R]WSR,@Q]Y>OMU/?_.:239O^1V=<#YFZX_SFGP%@_$7F'!^
M4]O7UZ?YSV28MYG,?E]/E'\O\CO^  'OY'E\3.S8&5/0<?Y/;%,A\KYO,D:/
MW7_/^<_G-(7\KFW"C ^<#D__ *_K^5,MRPW8A\WZ_P#U\C_]73O0!$^S?PQ*
M[OO'.>O_ .KZ^]23>3M&R5W.>0W0?KGKQ_G%,<GS?]7@[ON?C_GUZ=ZFG+;1
MFW$?/WAW_+\^2?Q[@#(?)VG?*Z'/ 4]3Z?Y]./2HUV>8,L0N[[PSG_/7_/-3
MP%MIQ;B3GJ1_C^?]1TJ%2?-&(\G=]S_./\G\: 'R^3@>7*\G)^]^'ID54R_H
M/\_C5Z<L5&Z 1<]0!S^0'^>]4,?]-/U_^O0!IW*L%YNA-ST!SVS_ /6J*W!(
M;$XBY'![_P!?\_DZ<P$'RX'C.>K9 Z?X_P"344/E8;S(6DY'0$]OP_G_ /6
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MY"HH]F_YD++S\HZ]>?S^OY]: )+@$,N9A+QU';G_ #_GI+AO*_X^1C;]SO\
MG]..OZ5!-Y>1Y<;1C!X.?7_/?_ZTF8?+_P!2^['W^WY].O/]<\4 ,@!W'$PB
M]SWZ_3_/84DP(DYD$G3YQ_G^M)%Y>3OC9QCH!VYQQQ_GT[I)LW_(A1>/E.<X
M_P ^_P#B0"Q(#Y7_ !\!A@?(.W^//U_&F6X)W8G$7USS_GK_ %[4.8?+XA96
MP,MS@_GU_P ]:9#Y7S>9$TGL!G'OV[<?YX $8'S3^\!^;[_;^G^?RJ:<$*,W
M DYZ#MZ#^?\ 3'6J[;?,.$(7/W><_P!#Z?YXJ64Q;1LB9#GJ0>3Z\_Y]AUH
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ME"]KQ5WNNWRWON2HU9T^6:7+?[-N:RTTV73KKYCUDCCP&G&2?]7Q^7KT]?\
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MI3TE5FP/W;9_UG7_  ]J9&\)4"2)F;J&[#(X[]C_ )%.6%5.YCN3/"#J,_\
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M$<^63R>/3W_GGFG33K",01-$,?Q<YSZ9_P ]ZCB,,K!YHF=SSO'3GUQTX_\
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M2E*7SO+77]#]#PG\%?NY0TZJ*WY;?#MIZ=EH69P0HS<"3GH.WH/Y_P!,=:(
M2IQ<"/GH>_J/Y?USUIDIBVC9$R'/4@\GUY_S[#K1$8MIWQ,YSU /!]>/\^QZ
MUB=(Q0?-'[P#YOO]OZ_Y_*I+@$;<SB7Z9X_SU_KVJ%=OF#*$KG[O.?ZGU_SQ
M3YO*^7RXFC]B,9]^_;C_ #R 31@^5_Q\!1@_(>_^'/T_"H803)Q((^OSG_/]
M:>AA\OF%F;!PW.!^73_/2HH]F_YT+KS\HSG'^??_ !  ^<'<,S"7W';I]?\
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M .K_ #R:=]J2+Y8P64\?/U_^O^/'Y\#V][W7MH_2W]:Z?,<=)?NOWVBUDO\
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M_'_/Y5%;^9EMD0D..AQ[>M.91Y1/VDDX^Y_GG\_7OWCA ).9C%[^O3U./SH
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M),A&")#,,=?3OV.,\^^?>JC;F5W;Y-_@M1QO=>[S>6OZ%'S;L-M$(\O. _\
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M/':L8V4ZK]IS?].W=+9=_P!!*45*HFX)_P#;U]EO=Z^=K6UL+)O7'DQK,?\
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MN1_+VK\*KI+#^5E>RDM;+^9O\-#],PENMVD^CCWB]]K+SU7<>0T@^X >?DX
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M,W_+&'.#P0/QQD?A^/:I%4>4#]I(./N?YY_+T[=HH1ECF7R^/O?UZ#_/7'<
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M$D1F\KB%77GYSC/XY]>G^%5XMXD^6,.?[N..HQ_G^=3( R9\_P OK\GK]?\
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M\RBFU9JZ4M%LI>]_X%YW1YF%:C!ZJHY)>Z].1>[WWMTY?P$=$<?Z0JQ>F/\
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MG(SG'OZU!\_F_<&=V=N..O3TZ\=?Q[5)"H(.9S%[?GZG']:BQ^\^_P#Q??\
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MJ^6ZLKI<UY*.EMII<S]&EVTZ(0V,LWFK_P \^N/PX_G2#OM;R!_=/&>G'?\
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M9<BGSPT>UW?[/VFN:_E9+;78=SW<2#_GEGI[8X_GUI1S_JP;?Z\9Q^?KZ?\
MU@/#NQ'A9>A8]/S_ ,/Z9$%RMP<9<2 XQM&?T ^GKCZ8P<EJ<HIW=U;W%T_%
MO=/_ ( 15Y13]S_%=7NEM#X7ZMKS)> <&,NV?]9C('3G(_\ KX[TO3[Q\\?W
M0<X]NW]>]$0F5#ND7R^Z9Y[9'UZ]^G3UI5:(G$!$;GJS=._KU_E],\J-&,91
MDI.ZU:E%.[TO;>VW_!OJ)[RM:5G:\;\J5TKMV3AZ1NNWD<G[A\@==IXS_/T]
MJ;Q_<(;G]Z1Q^?3\<8J"=+C>-S;SG.1S_+^?ZBK*^8L?[V12G]W/. ?IW&/Q
MQGM0Z2G*3DVKZJR273=K?TU7X6;248OFB^9Z)7O]G2Z5Y/RDK6^0G'\8^T#V
MYQTX_#_#VI>3DJWEKT\LGKS[C^>.:560DBV81GN6&/I_7U[8Z<4Y$G\T;FR<
M_>'3ZY'3_/7I0Z?[N,;WL]U"*5M-NS\UM\[A%7;3:A97M-:Z<OV+<J?^'6Y9
MX/W4\L\9D(QG\<X_SQ3LC^-#/_M#G'OG_)XI<LJ+]H=77^Z.O3IC'K_7O0I#
M BV81C&.>.?H<\D?USP:<:?))-2>RTDDWTOJWMY;:DZVOT32Y_>Y>F\[<ZZ:
M+3?L-Y()W_+_ ,\N_3TQ_7I1_NKY'^T1C/OD_P"&?:JNR?S>OS?WNV?K]>WZ
M=ZN,0H'VEQ(.P';IZ8Y_^MC@5/LDW)MM-O>R45MO%?%MY]]RW&W+:2ES)64;
M\VRZ;2[WD[VU[#<K_%&93SB0=!_G_P#70=V 2^]<_P"K')'/3&*=EF1OL[JB
M_P!T]>G3&/7^G>J<:3^:=K8.?O'I]<GK_GITJI034%?1:-J,?DT^G]7N$%\3
M<E%K6TG*_3=6]W_MV[ZEH=<K_H_UX_Q/K[497O$6;_GJ,XZ\'_/\Z<[(.+EA
M)_N^OX8/MG\^O*-YC1_NI%"?W<\X)^G89_'..].--0<K2NFK6<4VK]6WY^?W
MLG5\J>B;MS7?+TVE:\O1JWW:(0>"Q\X8SM'.!Z=J!GDJWDC^Z>"?;')_SQ5>
M!+C>=K;#G.3Q_/\ G^IJRS1 XG(D<=&7IV].G\OKCB%132;DU*_6*Y>GV=5>
MZMM^A4HVDHIJ;LM(*[^SKRVY%TU33MJ'!X$91O\ GKSCOS^/]>.M(01RX^T<
M=N?SZ'].W>B43,GR2+Y>/N \X[9_0=?3/ S4-LDXZ.$ Z[A_0C_#^9-2I\TH
MWO:RVC%/[.S3OT[JXDKQ<N:*:M[K<K_9^U\2?=1T(S.^=NTA<G*].YX^I]^>
M?PJRJ1MRD?D,>=S9&3Z\_P!?T'-*[Q9(;#2Y^^.G7\AZXX)_FQEG!S,ZR1GH
MJ]?TY/\ /Z\5HH1C"5DFNL4DW+;?:[VMWVW(J2BW!>PDF[>_OLUJDU[W_;UK
M:W+2[57YXC<G^\O./7IC/7G^E4Q<L)MIC;R\_P"KZ?AQW_7\*OP"8J3!(L*8
MY60CGZ9)YYQT'/;/2#*&;&1YV?\ 6<%<^OIQP>O7\JYY=+4M=.6/\KT:OK^7
MYZG8M(PYH2GJOLQ3CMJ^GS6[6PLL<,ZC$)MSQRV1D#\>O^/2JORQG8L#2'^&
M09(Z<'KQ^';\ZL7L5UM!>59?01D''// ],=?>F6_G(F?,55'\!Z\8)QT].OT
M K>ES77/!<VR2;DEHNCT?ZZW,,4I<MU64$M5"7NKINXZ_?Z>8[RY@-\C&5#_
M ,L@,D#'Y_TJU;S6ZK@Q>1]X$,<9.?3D]O\ &H!=&3"Q@QR XWL#MSR,_IQ_
MG$,O!_TD>>Q.0R=!GUQD?@:]I0E/#.,U);-*$8)^75*^O?\ S/%3E=\W*GT:
M<FO6[UO]Y'<S1A]T5JVX<B4#(X/;^>/_ *]0&62X&V?,J@8"=_IQTQ^565\T
M$,94$())C.-V,9[Y/3_(ID\D<HQ9?NI ""QZ$\=?K_7BOELW5-4W%QGSJ/NS
M2T6VZO;:WWZ=3Z3($_K,%%J/O?%O:_+LI=_,TO!5O$OBK32@\L?:8B4Y&?F[
M?7\^#7[\_"1&/@_3EC'EG[-'\W./NCTSC_Z]?@#X*2X7Q7IOG-O/VN+! X'S
M?I@Y]*_H ^$<CQ>#=-+G>/LT?"XSPH[?YZ=!7XKQ-S*=/WE-MNVEETZ?"]>_
MY'[?D+^)1A[R2]^UU/5:N]K?]N['I91X@?/S<>F.WH?Z8_*J&5+Y$94==O/J
M?_UUHB5YP?*/E'H2_?'&?7\NAZCI5 AQ+@LI;/WATSD\]_ZU\#B+JH[JS](I
M6MHTHZ?UZGZ+A7/V*YE%:+X92=[)=TOQOY$LQ3:-L!C.>I!'^>Q']:(2FT[H
M#(<]0"?\]R?Z4^X$VP;Y5<9X [#TZ_RX_D2W$VP[)509Y![CTZ_SX_D,#<KK
MCS!E-PW?<[_T_P G\:?.4.W;"8_J",_YZ?C35W^:,, V[[QZ?T'Z?EU$MR)A
MM\V17]-N>GIR?7G_ #P $93R^;<DX/S $@?_ *AT_K446T2?-&7&#\HY/^?\
M/SL1B?RCME15P<J>I_G^N<]LU##YGF_(ZHW/)Z9_SZ?_ %B ),5+#;$8^.A'
M7IQSCK_DBI<IY6/L[9V_?P<>F<_7].W>F7'FAAYDBN?4>O&#US_GMWFQ/Y7^
MM39M^YWZ?ET[=?:@"O 5!;=$9>!T&2.?\]N_Y-D*E_EC*#CY3UZG\>/\YJ6W
M\W<WE2*AQU;_ #G\OU[,E\SS/G<,WJ.G7G\_?]>@ ))"GE\6[*>/F(./S]QU
M_7%-A*#.Z$R>X!/IZ5-*)_*^:5&7LH/(_7^73OZTRW$Q#>5(J?[WX>G/7_/J
M 09'F<1D#(^3G)Z<>M2S%-HVP&,YZD$?Y[$?UJ,[_-Y8%MPP>W^?\^]3W FV
M#?*KC/ '8>G7^7'\B -A*;>;=G.?O $CJ?\ /7\JA3'F?ZLL,GY!]?\ /_UJ
MLP"?8=DJ(O<'N.>/Y]?7\!!'O\WA@'R?F[?Y_+Z=J %G*G;MA,?U!'^>_P"?
M3O3T,?E_\>[$X^]@XZ?EQ]?SHN/.^7S)%?W7_.?3_/21!<>5D3($P<J>IX_+
MTZYZ=^M %:';N^:,N,?='T_S^7>B;;N^6(H,=#W_  SWXS].U.@\S?\ (ZJW
M]X],\_7]#1/YF\;W5CCJ.F?7K_\ J]NX \E/*Q]G;.W[Y!Q]<G'6F0E03NB,
MO'0 G'2IF%QY',J;-O"=Q_3\L'Z5';^;D^5(J'U;\/Q_(T 128\PXCVC(^4_
M_KXP>1^F:FD*>7Q R'CYB#Z>O\_UQ4<N_P SYF!;(Y'3^??_ #GI4\HG\OYY
M49.RCJ..?7]/Q- $<)0 [H6DYZ@$XZU#QYG^K.-WW.<_XYQQT_#O5FW$V#Y4
MJQ_[W7OZ<U!\_F_>&[=U[=?KZ\_YS0!),5P-L)C.>I!&>G^?ZTL13R_FMV<Y
M;Y@#_,9^O^>%N/.VKYDBN.P7J!Q_GCBG0B<QG9*BKSE3U(]./;U_3H "M'CS
M!F/<,GY1_P#KYR>3^N*?,5)&V(Q<="",]:2+?YGRL V3R>G\^W^<=*?<>;D>
M;(KGU7\?Q_,T *IC\H9MV)Q]\ X_/FHH=N[YHBXQT';\,]N<?7O5E1<>2,3)
MLQ]WO_A^>?QJ"#S-YV.JG'4],^O7_P#7[]@!LVW=\L1C&/NG//X?3_(J5S'Y
M?_'NP./O8..GY<_7\J9/YF\;W#-C[PZ?YS[U.XN/*R9D*8&%'4<?EZ],=>W6
M@"" J-VZ$R?0$_Y[?ET[TQ]OF?ZO:,CY3]?K^(_K4UOYWS>7(J>[?YSZ_P">
ML<GF>;RP+9'S=OK_ )_7I0!)*4\OY;=D.5^8@_S./K_GE(2FT[H#(<_> )^G
M^?U%23"<1C?*C+QA1U ].?;T_7H4MQ-L/ER*@R<AN_K_ )/% %<%?,_U9QN/
MR=^GYY[?T[U).4(7; 8^3R1C/'^?S_)HW^;]X;MQY[?S]?\ />I;GS@%\V57
MY_AZ_KS_ )Z=P )&4\OF!G//S 'T]?Y?IFH8RH?YHRXY^4=>H_'G_.*LQ"?R
M_DE14[J>IXX]/U_ U!%YGF?(X5O4].O'Y>WZ=" $Y4E=L1BX/48)Y_SV[?G)
ME/*Q]G;.#\^#CTSGV/\ ^KO27'F[E\V17..J_P"<_G^G>4"?R?\ 6ILP?D[_
M .'X8S]: *T)4-\T1D&.@SQ^ ST_KU-$NTR?+&4&!\IX/^?\?R?;^:7/ENJ-
M@_,>GOT/?_.>R3>9YOSNKMQR.F?\^O\ ]8 #Y"GE\6Y!P/F((!__ %CK_2F0
M%1NW0F3Z G_/;\NG>II!/Y0W2HRX&%'4?R_3&.^*9;^=\WER*GNW^<^O^>H!
M"^/,^Y@;ON?C_G\N]2S%-HVP-&<\D@@?X=>>OYU&^_S>6!;=]X=.OY?S_&I[
M@3[!YDJNN> .WZ^G''_UB ,A*;3N@,ASU )_SW)_I42X\P93<-WW._\ 3_)_
M&K%N)MAV2J@SR#W'IU_GQ_(0+O\ -&& ;=]X]/Z#]/RZ@ DF*$#;"T?/4@C/
M2J>?]L?D/\:OW FP/-E63_=Z]O7FL[*>A_S^- &A/]FQ^Z$N<_QYQT]Q]?Z5
M'%Y&&\W?G(QC..G^?U]ZM71N-I\V*-!GJH'I]?2H;8S@-Y4:,,C);']1_GU[
M  KGR]_&[9D?7IS[=/PS[U++Y&!Y>_=GG=G'OU[]/ZTT[_-^Z-VX<=OY>O\
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M97RMV,'[V?7_ #^OO4G^C^7_ ,M-^W\,_P L9_#\:+DREE\U%4X_AQCK[?\
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MK_3%1?,H=;-?:]KV6RY>7RW.!USR_P"V=+\X,1]K@^[G_GH.G;_/-?Z1G_!
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MMA5/:OV=ZL7!V;BO>;U5M+^^]>UNQ)F$C%UO+<8\O.,],\<<X]>/QJK]E3S
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M\C:/+WYSSG./?MZXS^N*:=_F\J VX8';_/\ GVJ>X,Y0>9&BC/&W'3WP.O\
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M8[=,T^7RLCRMV,?Q41>9Y@VJ"V3P>GMV_P ^_6GW!E)'FHJG'\.,=_3_  H
M!]F\L9\S?CWQU]_\_C447E;OWF_;CMG]>,],Y_7%6E-QY( CCV8Z_+NZ_3/7
MW'?I4-N90YV(K-CHV,9[]1V_SCN 1R^7N_=[MN.<YS^'?I_]:I7^S;./,WX]
M\=/\XQ3;@R%QYBJK8Z+T_08_3_"IW-QY6&CC"8&"-N>GTS^I[=>E %>+R?F\
MW?\ \!SC_/3VS[TQ_+\SY=VS(SG.>OT]<Y[XZXJ>W,PW>6BM_O8Q^H_S_*.3
MS/-^90&R..V?3_/Z=: '2?9]G[O?NR.N<?Y_IGM1%Y&#YF_=GC;G'MT[]?Z5
M+,9S$-\:!.,$8SCWP <X^O?IUI+<SA#Y:(PSR6Q^F>] %8>7OYW;,GZ]./;I
M^&?>I)?(POE;\Y.<YQT_S^GM2#?YOW1NW'CM_+U_SVJ6Y,Y"^;&BC)P5Q_0?
MY]>Q &1_9]GS[]_/3..G/M_];K44?E[_ )]VWGIG/4?Y'MTJU"9_+^2-"G.2
M<9Z#IU/\OI4$7F>9\BJ6]#C'7CJ._?K^/4 "2^5E?*W8P?O9]?\ /Z^]2?Z/
MY?\ RTWX]\=?RZ_A^-%R92R^:BJ<?PXQU]O_ *WX]I0;CR<>6FS!^;C=_4_K
MU]* *L7E;OWN_;CC&?PS[^OZT2>7O_=[MN!USG\,_P">E26YE#GRT5FP>&QC
MWZC''^<=TF,GF_.JJW'"XQ^G^?8=P!7^S^7\OF;\#/7'3Z>F<=_3--B\GYO-
MW_\  <X_ST]L^]3R&X\K#1H$P,$8S^. 3_/^E,MS,-WEHK?[V,?J/\_R (&V
M;^-VS=WSGK^?US4DOV? \O?NSSG/_P"OK_\ 7IK[_-Y4!]WW>W7_ #Z?A4]P
M9R@\R-%&>"N,_C@>GK_]>@"*+R-I\S?G/&,X]NWKG'Z9J-=GF#.[9N[9S^G^
M>G>K-N9PA\N-&&>=V.GMD=?\^Y@7?YHPH+[ON]O\_C_@0!TOD8'E;\YYW9QV
MJM\_^S^M7K@SE1YJ(H[%<>WIC^59V$]3_G\* -*X$8!*7+2G/0_3Z_R_&HH
MA#;IFB.>@..WMS_GZ5-<-E<?9?)YZ\\<?2HH#@-_H_G<CMG'Z_Y].] $1V^9
MCS#C</G[]/SZ<^OX5+,$"C;,TAS]T_Y[?EZ5%G]Y_J^X^3_/K_GUJ:9LJ/\
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M<#OP*CW8('F%/8<Y&>?I4UPV7<?9=GS#YOP_KZ_G2)(J<-#YOOSQ^5?A=?\
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MH 9)M#G$A89'S?R_7CC\.:EE$8C&)V<\?*3G^?\ G\<5%(?WA_=[>1\O^?\
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MR%Q_>/7Z^G^>:E<1^7Q<,3C[F>.GIT_/\:BF.7SY7E_['3L./\G\:F=OW?\
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M7L]M+K2_X]["YI<O+?W7;3W>;I]JW)MV]Y+S&_:8F;9@)R/G Y[>P/.>:9)
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M1.W/&4=N633Y7L[Z?KIMJ/F<>94W[KTL[-^J:VT=ES^5QAGBAXW>=TY8=/\
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MV%/^C^;SUQG&._7_ #^@A4XE'[O/S?<_S_A_C0!+,$ &V9I3Z$Y_S_*J>/\
M8'YC_"KDYR!_H_D]>V,]/K_.J6/^FGZ__7H U;H2A?GN$D&>@^GI_*H;<2$-
MLF6/D<'_ .OQ_GZT3FVQ^ZCD0Y_B^G^34<1@ ;S4=CD8VY]/8?Y]>U #3N\W
M'F#=D?/V_/IUY]/QJ:X$@4;IED&>@Z_Y_7UJO^[\S[K;=W3O_G''K_*I93"5
M_=HZG/);./PSC\* )(1(8R5G5!S\I_\ K_T_EBH8]WFX$@4Y/S'/^?;\>*=&
M;?9AXY&?)P5S@'WP/7GG_P"O4:>7O^96*Y/'?'X>O^<]: );@2#;OE63Z?\
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M]._^?\^U2RF K^[C=3GG=GK[9'3_ #[@ D@$A4[9E09Z'K_C[<?A4*;O-P'
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MG!Y(XS[]/T%)-JG4]JN6*=DXV;?^>^NET'*G3E'WK-K:,5+IV>O>[Z%F-BH
M,BJ,#Y3C/&<CGZ'\^O%$A##]TPC;LYQC_P#7W^GI5.9K;S,2Q.S]F7.WG/<?
M_J]ZLRHHBS("T?\ ='WNGY_E]<= 4D_W;IKFC)J[ENOAVBPC34/9_$W_ 'K2
MMJMTV^7IM<@$<_\ '*)AGJOXXX_*KBOM&&D3'79QG''ZC@?A[U6MVBP?(1D
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MK4:1L_(E6/IPWUZG_/-).;;S'VQR!MPY/0<<]O\ (Z5'A2>59O\ =';G_/\
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M_P ?;GUIDF[S<%PS9'SCI_GZ_C1$81N\U';_ '<_T'^?Y-?9OX4A,CCO^O\
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M?NU9&/7?G'X?_6QS^JB.*W'SJSL.A7IC^GU.?YTW34I*4DY1M97D[=-EM?\
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M3BH[<2'=LE6/Z_\ U_Q]N?6D<VYC^6-PV!DG.#QVXQS[9IL1A&[S4=O]W/\
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M@CV;QN8A<GD=??\ P_PZ4^;R\CRY&D&.K?C^% %@?:/(X$>S;STSC\,#Z?\
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MQ7^)7_ S%^VE\8'E9^K?YQWSGWK1A20#,84G'.X_7Z9^O4<=*@:9<[<XQQ@
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M+GB_=LE:_*[K;[73_A_G(OW/GP).V,%<^AQ@?F*8OVDM^]$>SG&S&[T&??\
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M=-*RIC<#_$?E_4^OH./RJW+&BL!<X#YXV'C_ ">/\XJ 72N=K?NP.CJ"&/\
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MW_SFDDV;_D=G7 ^9NN/\YH M2?:/*&X1[<#&,9_SGK^N:CMO.^;R@G_ L?\
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M].OYTLY;<,Q>6<#@=_;MU_IVI( 2_$OE\?>]?\GGI^5$X._F7S./O?U[]_\
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MW9OFBK:I6?3>^CZ[7V--[IOD2M:-GMV6GW7_ $":0.?]2(L>V/TYJ9-_E_\
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M_F+RSQ\H[\#_ #_A4SE_+_X]@!@?-^'I_+G\JAGR&XD\T\<CCGO]#^OXTO\
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M'%CB"(3@YR>ZGV]Z,<\MANGE9[^G;\L$5E1WRP9VW(C![9SG\/\ 'UZU(MW
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M:M!I0Q%:FM-:>(J*Z5NUM==?GY'%+!."B^7#Q;>JE233^'1;_P!/YGXK6_\
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M,?A^G:*+R]WSHSC'0#M^7^?:K:_:/)&&CV8Z$C=U].>M06_F[SL90<?Q=/\
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M8\P<<!L_CPN?;GUKZ?"3!.6CVXZ9R?;C]>G7BDCC=C^Y*D\_?/'.,X/X<?\
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M>.%//3O_ "_EB@""+RL'S(FDYZJ,XZ_A4>4WYVG;NZ=_\XX_SBK-MY^T^6R
M9_C('KZ_YYJ#]YYO4;]W7MU_QYZ=.W>@!TOE8&R)D.3DG//3\_Y^PI8_)V?-
M"[-D_,!D?KTY_P ]S)<>=M7S&0CMMY].OO\ X4Z'[1Y1V-&%^;AB,_AG/T_#
M\* *B;-XRI9<G@=?Y?C_ (]:?+Y?'EQM'[-WZ]J(O,\T;6 ;/4]/\@?Y'2I+
MGS<KYI0\<;.1W]/\\T (OD^6,PN6Q][''Y\8_#].T47E[OG1G&.@';\O\^U6
MU^T>2,-'LQT)&[KZ<]:@M_-WG8R@X_BZ?Y/'_P!>@!DNS=\B,BXY4]?\_A^=
M2/Y.SB%PV.6QQT]>I_+\Q27'F;QYC*6QP5Z#\?K[_E4\GVCRN6CVX' (W#CT
MZ\?44 5HO*^;?&S_ .Z/\^W^/:FOL\SA"%R,J>O7IT_S[=:FMO.^;RV0?[YQ
M_GO^G'>HY/,\WYBI?(QCIG\^_P#G/2@!TGD[/EA=6R/F(P/TZ\_Y[@B\K;\\
M3.<]0.!Z?Y_(&IIOM'E#>T97Y>%(S^.,?3\?PI+?SMA\MD SR&.#[X_I^E %
M7*>9G8=N3\O?I_0?X>U22^5A?+B:/D\L,=OR_P _F@\SS>J[\GGM[_KST_#O
M4USY^U?,9",G[A!_E_GC\@!D?E;/FB=FY^8=.GZ?YSBHH]F_YD9EYX'7KS^?
M^<]:M0^?Y7R-&%YX8\].W\OYYJ"'S/,^0KN]6Z=1C_#_  Z4 -E\O*^7&T?!
M^]]?\]__ *TG[GR_]4^[!^?MU]?\CWSQ1<^;N7S2AXXV'(Z^W^'?\YA]H\G[
MT>S!XS\WY?3GI^M %2+R]WSQLXQT Y]O3I_G'<DV;_D0HN!P>N/\_P">YDM_
M-WGRV0-@YW$8]^N?\]S23^9YOSE2W'*\C_/X=OR %?R?+XA=6P,L>AX_7_/4
M4V+ROFWQL_\ NC_/M_CVJQ)]H\D;FCVX& #\WX^F/\D5';>=\WEL@_WSC_/?
M]..] $#[=_"$+G[O.>OY^GI^%2R^3M^2)T.>21P?ZGGGI^79LGF>;R1OW=1T
MZ_U_KWJ>X\_8/,:,KGC:03^/?I[_ )T 11>5M^>)G.>H'0_Y_P#K9ZU$NWS!
ME"5S]WG/]3Z_YXJU;^?L/EL@&?XCS^'OC'_UNE0)YGG#! ?=U/3^G3^GXT +
M+Y6!Y<31\]6&,]/PJKA_4?Y_"K]SY^T>8R$9_@(/IZ?YXK.RGH?\_C0!H3BV
MQF*21CGHW/;WJ.(0$-YKNIR,;<^GL?\ /IWJU=&8K\]ND8SU &>GT'Z5#;&7
M#;(1)R.N/Z_X_P#U@"O^[\S[S;=W7O\ YQSZ_P ZEE$(7]V[L<\ALX_#.?PI
MAW^;]P;LCY,<?YSQU_'M4]QYNT;X5C&>",9/Y>O].U $<8M]F7DD5\G 7."?
M?!]>.?\ ZU1IY>_YF8+D\]\?AZ?YQTJS"9?*.V!77GYCCC^7;_/<P1[_ #>$
M!.3\I' ].H].?\: "40C;Y3NW^]G^I_S_)R"W*<R2!\'"C.T\?7'//KVZTZX
M\SY=\2Q_3&?T_#\^O:I(S-Y7$"E<'+X'IS_G H K1>66_>,RKC@KG/Z?XTDO
ME!OW;,RXZMG.._4]O\D=WV^_>=L8=L<J<?IG\NGY43^9O^:,(<#@ ?AG _#\
M.] "L+?RR1))OQ]TYV_SQ^6._2FQ"(D^:S*,<%<Y[>F#^M6&,WDG]PH7'W\#
MU_'_ #^516_F9;9$)#CH<>WK0!$_E[_E9BN1SWQ^/K_G/2I)!;[,I)(SY&0V
M< ^V3Z\<?_6ILF_S>4 .1\H'!]>@].?\*GF,OE#= J+Q\PQS_/M_GN "&(0D
M'S'=3D8VYP>O7&/QSD5'\F_[QV[NO.?\>G/^<U8M_,VMLB60=R<<=>>?3_(J
M'Y_-^X,[L[<<=>GIUXZ_CVH =*( %\IW8Y.=V?3W/^?3O2QB#9EW=7YP!G!X
M'IC]<T^Y,N%WPB/D],?T_P ?_KNA,OE';"KKS\QQZ?U_SB@"JGE[QN8A<GD=
M??\ +_..E/E$0(\IF88Y+9SW]<G]:2+?Y@P@8Y^Z0,>WZ<_X]:DN/,RN^(1G
M'08]_2@! +?RP?,DW[?N\[?QP<?S_&HXO*+?O&95QU7.<=NA[_Y)[609?(_U
M"E=OW\#C^50P>9O^6,.<'@@?CC(_#\>U #)1&&_=LS+ZMUZ#\?S-2.+<)Q)(
M7P,J<[1Q]<<<>G?I23[]_P T81N/E'X>G^'YU/(9O*Y@4+@8? ]./\X- %>(
M0G=YKNO^[G^A_P _S:^S?PQ*9'/?]?\ /\JFM_,^;9$LGUQG]?Q_+KVJ.3?Y
MO* -D?*.GZ>O^<4 .E%N%_=R2,V>0V<9]LG'KT_^M1$("O[R1U.>-N>OO@]/
M\^PEG,NSYH%0?WACGIZ?X?E26_F[3LA5QGJ<9'OSZ#^?>@"M\GF<D[,\'O\
MY_7^=/E$(QY3NW^]G^I_SZ=Z0;O-^X"VXY3''TJ6X,G&^$1_3'/7T_\ K4 (
M@M]@+2.&&< 9P?K@X_G_ %J%/+W_ #LP7GD9SUYZ'/'^<=*MQ&;RN(%8<Y;
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M]MMXI\*RQ%[CQ=X>24#(5-:L@">?^FW)]NG/3I52'Q?HGVC8_BCPY]GS]_\
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M:M^C.F.-YX6BX/:\D[RV5^NC%U/4]*BG1'FN%.X#Y0P')[XX_$>M;T/V.]M
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MFUMD(DY&<X]_6H/G\W[@SNSMQQUZ>G7CK^/:@!THA 'EN[')SNS@=.F<_AC
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M!,RCRB?M6>/]7GGKZ8S^IZ]ZCA&2?WWD\=?7I]?Y4]C&8CBW8''W\<?F>/\
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MJ=&G6IRA!-_#&3D[):[L^MP/%&.Q5"DEP[5E7A&,:DITU&#GI=JV^M_ZW_T
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M *^/Q_SBI82N#NA:0]B!G'I_GIZU#QYG^K.-V=G?'IZ]./\ ZU $TRX _?\
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M=W!++:+,(Y VSC)YZ?CQZ8/;I7W'IO[;G@OP;I,"OX38M"BJ9,* <#J,#O\
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M<W[%CA?*=ACL>A_SV]*]9MS^T9XKL6U/3-3\0J,;UCB=^1@X]OIGGVYKTO\
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M\A39Q R'CYB./7K]/_KUD,2%<J<W'D\CC./7Z_RJ+'[S[_\ %]__ .OC\?\
M.*EA* '="TGN 3C_ #BH>/,_U9QNSL[X]/7IQ_\ 6H FF7 '[_S>3QGITX[=
M/Q^M+$H,>3<^7R?D)QGOCH?Z=>_6DF*X&V%HSW)&,^O^>GI1$4$9W0,YRWS
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M^GX5-,N%_P"/CS>?NYZ?I^'?^M0OCS/N$#</E^AJ68H5&V!HR#RQ& ?Z>_\
M*@!85RI_TCR^>F>OMT_SZ]S"HS*!YF/F^_\ Y_Q_PJ6';M.8&D.3R!GKT_K^
M?-1+CS!\A(W?<[\CW_S^% $LRX48N/.Y/&<^GT_E5+/_ $S_ $_^M5V8H0-L
M+1^Y!&?\YJGG_;'Y#_&@#4NA<;3YDL;C/1<>E0VPG(;RI%3D9W$#^H_G^'<D
M_P!FV_NO-SG^+./PS^.?TJ.+R,-YN_KQMSZ?EZ_YS0 AW^;]X;MPY[?S]?\
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MKZ ^S^4,[_,V\=<9_'WS_P#KJ.+R]W[S=MQVS^O?IG^M #Y_,#_O&#-ZCIG
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M[:_A^5?@V/\ @WD_;_\ $ W:+=> =0B/!>SO[6X'/H8I&R3Q^G:HE_X-F/\
M@H%>-NO[?PPJM]XI.@'8]F^I_P 17R.:TO#O'YA6Q']H5>6I._-3QD[2VN[*
M_+\NA-)\:8>,*4\KIJ$+<MZ/--/W5K>%^G?]#]YY?^#J?]A1/N?!G7)^O$>C
MP-TZ_P#+J:BB_P"#JC]A:5U3_A2NO(3P<Z- .OUM.U?A,?\ @W!_;%\+_P#(
M0U+P/8L>,:AJEK#DGT$THYYXP,TDG_!MY^W-K$1NM$F\%7H_@DM;VWFC[X^:
M-R.?\C%<4,I\-I3DGFLHQ4?=C]=DW=>=UIM:_P#P3UZ=7BV2BI999.R=65!P
MB_AZJ#3:MKJNQ_2!\._^#EC]CCQ=>Q6VA?"W7K":5E4,FG10GYL <I;*?PS7
MZH_"O_@H5\+OC9X4NO%VB^$M?^R6EH]TT)A<NR)'YFU5$?)QP./PK^.7]GS_
M (-[/V\_!/B*&\\5Q>&%L8IT8F.=,[%89/WO0>W.:_J]_8G_ &:;C]GOPFOA
MCXFZSX4M)IK86\L,VH6<;LQ4(P"2R9)P/3)Z?3Y7.<'PEAVW@L2\2DTN66)L
MWLKJ6NMK=+O4]&G@N(*SCSQIQAHW3CA/:N]EK;3M9/\  ^*_CS_P<7_LT_ 7
MQ5J'A'Q7\#O'5V=/E>&:].B.]J2K,A82-:E2/ES^O/-?/5M_P6?_ .":/[:$
MW]C^+OAI<Z9Y[>1(;Z*TLB"YVG<6@0C'.<U^N'[0W_!+C]EW]I/3]0DU#3M-
MN[O4E<FZL4LV!:3=RLL8_P!HD?-W!SZ_S=?M:_\ !LMXPLI;K4?V8KLV%S+(
M\H-UJ+6Z*2Q;C;(O &/IV%>KDT>"Z<(UZN)QV&KPLTXXF=*47II!Q;;UU;TO
M;8>-P^=)0H2P2:DE92P_-&:5OBBXJSMTUMZH_2O0_P#@G9_P1/\ VBH5\3:O
M!X6T^>X F,=YXCTZW=3*,XVLRG/L?;@5P?Q:_P""2/\ P1[\&:+/>^!-3\#P
M:A'%(8F/BC39<.!E>/,]_P"7-?@1;_\ ! C_ (*)Z,IL9OBQI6FWA.V.U'C5
M[9SSPHB^VJW3'09^E:EE_P &\/\ P4_UB7=J'Q"FO-.DY5HO%5]*C(3C@B[(
M(^@Y]L55/'953S*-5<2XVIA543^KU)2J)Q5O=G-U-=[:Q_R,)X?,)8>5"IDS
M7NV4XT7%=%>G'D2O\SY'_P""A7P)^%OPPUJ5?@UXKTZ."&5O)_LC64=0%)QG
M[-* >WKZ5XS^P7\9/C5X2^+_ (=AL/&ES>P17L.+1;R>>1@)HN-OFL6R,#&.
MO6OUA\/?\&UG[8<M_:MXSUF"\L/,3[8]UK$DS"+</,.Z69@,+D\_KFOW-_8N
M_P"""?[)7P2OM%\6^./$MD_Q"L&AFDL_[;M9(S.A1R#"TY8_.OW<?IBO?S#B
M?A2$;.G[=VM!4W%JI*RLIK^5M]GWLSS\'P]F5>5OJN(IQA9Q;P[>MU:RUL^W
MWJ^I]U_ #Q1\3?CC\/M,TS7[.]"G2H4$UY:RQJ_^C(,AG'(.?7G\37\IO_!9
M+]A_XS77Q U#5='M)'T>.:>69XK65E";F)^=?N\8.?KG'%?Z GAGPWI/A30;
M'1/!]OIJV=G;100RQI#N:*- BDNHYX .>_UKS?XG? 3X<?%?1-0TOXBVFG^5
M?0R1SW#1P!E212I/F.!MP#GKQ^=>#@^)L+&K*>(P>$I9=R^Y@\.H2K\VB4I-
M13MM?3=]3MJ9#BZS5&.'QM7%QLY5,32E&FHJVT;RU2\O-:'^4Y^SAX_\&_LH
M_$2WUOQ587NHZE8W,9N+:S9FFWQR?,/*&6SR<Y';I7]VG_!+;_@J/\"OC%I-
MK9WE_#X(-M"L>[Q)=0Z>I*H0"#<&/T...AS7S;^V#_P;]?LW^+Y=7\4_ '7]
M*G^(=X\T\=E>:Q9O"MPWS*OV<3' W$@C;VZ5^*VO_P#!O?\ \%.9KF>/PYJ^
MD:+8;V%LVD:K+9$Q X3)MI5Z@C/X^HJI9QD>=86MAZF)I9/3<[*$:4:TY*Z7
M,VY0:;_EU_ T_LO'X"M3;P>(Q$U%>]+GI1CMHDHNZ6JNMET/[L?B1^V?\!O!
MVDW.M#XO>!M1BMHVD-G9^(-.EN'PI;:J),S%NW ]N_/\X/\ P4(_X+F:_H6F
M7>G_ +.7BF/1=8M3*GVV21)89&C+89"K*"#P1@\_C7XA7/\ P;L_\%4K6<WN
MH?$,BV4[G%YXKO?(QW#^;=[,<?E7L_PN_P"#?;]JSQ-?16'Q-\7>%]3@61$F
MBL/$,-S<D;@'!"W#,6Y/']:>'H<*8>A*%7,L/CJG+^[LHT))*WQ03ESOKJ^Q
M&(RS-)5(8G"8+%<\;.<$IS5WTM9*RZ=/T^B_V1O^#DKXC:+JMCX7^/\ /K/C
M75+VZBMEGTBWD:(%Y$3G:K]><<Y[YXK^N7]F/]K7PG^T+X6TOQ#8>%-?LTU*
MW259+NWF0#S$#?,2@' ;U_PK\7_V3_\ @W4^ 7@9=/U[XBVTUQK5B8;E'65)
M4\Z,I)U8MW!^F>/;^@OX6>!OA]\"_#]IX4T8Z9IFDZ=$((IKQK>#"(H0$NQ'
M\(!Z^^>]?)9CC<.W.GA*M*E"/P\D(X>5ETYHMN>W5*YZF6Y7CZ\Y5*F K1GI
M[1.,JCZ;PM[K]+]$?RB?\'&_BCQ-X:T7S/#9\J*2(%D:+>=I"9'/.<<$=_I7
M\:WPH\2>$_$OB.U7Q1H5_<:[)= +<QHR1"1F/S'"] <'.>!7^@C_ ,%A_P!A
M/XR?MNV)M?@1K?A'5)MNTHVHVLQ!P <JDC8(VG(X]*_G?\"?\&YO_!0G0-2A
MU&ZMO"0>.;S 1-'R-V0<Y],<_IQ7WO"7$>5X3+84\3F5L1'FO2K3_=IJUK-M
MZORBNYX^=Y1F#KWIX!RBY13=.G*G6MI>[Y;M/LV?II_P1\\,2Z;XJT6\29+>
MQ<V[1QRMA@N00#SGH.>*_L1?^WKJULO[)U2T6)8H]PW*3@ $X.<@XX[<]QFO
MYK_V"O\ @GU^TK^S]KNG7/QEU;PSI6CVC0;V74((,(AYYD=<\#/!K^D'PLG@
ML6=M'IOB*RU*6.-0YM-0ANAO P1F.1N,]_?VKY3B/-L#C<Q^LQQ,*T^7E45"
M->GY:RDNFVGWGL9=E6+>%5%8;%4Z=U*<OWD9W5NJBE;YZGQ__P % 8KJ/X"Z
M_P#VC/%))]AGW/D;<^0_OTZGG_\ 7_FK?M:ZO<V/C/73IT?VHC4;K(MT\S&)
MY,<*&/H?S^E?Z>/[8?P>\0?&GX4ZQX1\*2P_;;RTEBB\R0*-SPL@.<\<D?@:
M_BC^/'_!"?\ ;-/B?5M8T35/!5K!>WMS/&=8U.VB^625G'$\B\X(Q]17?POG
M6%R_#8GZQBJ=&,YW5)V2DM+>YLMD[>B/F>(>'L9F&*H>PP5>I[)<K<XS>UKW
MT=_^!HMS\U?V"M;M;[XA>%EU6U>*9M1M01(FPDEP.A /^?:O[0?VGM>\:>#/
MV0M*U3X<SSVNHC1 R/$)&(/DJ1@)[FOPE_99_P""(/[9WAOQOH'B?7[_ ,'7
M5E8WL$T[:3J$$J[$<,<>5(P/'3]*_L=\(_LX:'J?P:TCP!\2!#-+:Z;':W"Q
ME)%W",*P!;UQQ_G'+C<^HRS/"8FE7C.A"LI35%)MJ\;W@GKZ-KLSW,'D^+6
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M.W].:_A=_P""F6H>*5UGQ$OB*2-K 7=T%'E!"$+/C+$=?Q[<]J_N'^%/P_\
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MJMM.0$D#<B*5NP/Z8X&:_J[_ &*?V$?CS^SA\,M-T.>+2!K]C;PHC95D\Q$
M^\3Z@<_UZ_%9CE_#6'KSCE>/A5C%^Y*5=RBWI9-ZWO;7L=5'$<6MQ]KE]:$T
MU[:/U=I*&E^1NWO);:>O0_6CX@_&WPS\+= ;7O&&J6UE9M;--$MQ<1PD#:6
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MRER,YSV3IG]/:ON_PMX?\#Z=X;F'A_0[ZQA\@X2</NQL! Y XX'''I5+X3_
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M?M._&)/[+^%7AU+ZQN@8+NXE$L$D2/A'9#L#;E!)'3\:XZ7_ ()O_%[5)O\
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ME[+X3)^+&*GB$\/DV2T\!9)Y0\-; U-O?G^\]KSV[5;7OH?A:W[:7[28M/\
MA%X_"UO_ ,)QCROL.R3RO/QMVA_+P/GP,X&/:O/]5_9S_:F_:J)/QUO]>^'6
MEL?,LY_#&I7-L[HWS(3Y31]0>?P':OW _P"%9^$QJIUJ;P5I45[NWF\^SIYP
M;.2V_ ).0#ZYKOWO=*B@2WD@B*H%58RN0@    XX':LO[/S2/-S8W$U:%_@J
MRC.#2VO&$8R_%:KN&(\4<+9++N&,GRNHU^]Q6"P\_K$)NUW1G5J5*<%W4HOU
M/Y]M.^'/[9?[*DB:=\*H-0\=>"+8@W.J^(M0N+F\6W7JP$GF'(&> W7Z&O11
M^VA\<O$5L/#OAS0EN?&JKY5S921RB%;C&"H<H01G.#V[GM7[677A2WU]&"R#
M[&_#VG_+-U.."IX.0?3'YUDZ7\(OAOX?N_[23P?I%K?EMSWZ6L8F9N269L9]
MS^&?6KIY?C*B2I8BO1O:UI>[9VMR0^)>5V_T-Z/BMA(07UWA7(L=5BER8JKA
MY_6*KT][$N%6$)OOR0@O(_#_ %#]BG]H#]J-QK_Q<\2>*? -Y ?M%I:^'=5N
MK:*5D.]%=8GBX9@ >#R<8J_I>C_ML?LMLNCZ#H\_B;P)IN%.L:O=S75X\,9Q
MO8L');8"?O?TQ^_,;:4R!;61!L "HO X&,#J/P_R<C6K?^U;9["YTF'4+-QM
M9)EW(R].<CI_D8K3ZGB[>QJ5:T:D+M5Z;Y:DI)+XN=25M=-/F<L/%/$RQ$ZE
M3)<CQ>!FO^19B,-+ZM0CI=T.6I"ISV_FG+8_#O4_VPOVK/'\ T+X9>$K6_UP
M+]GNHY5DB$<A&' 8Q^IX/\\5YG??L*?&OXW2_P#">_%KQIXR\&>,;8_;+/1-
M#U>\AL)9P=Z1.B2(NPMP<J<#CMBOW7T#X?\ A3PS=O?6/A/3=)N&8NTT%NL;
MDD]20.>WK^5=K<WNE7&(GBB:0C:'*\J>F>W?KCH?0UG]5S>+YJV,Q%:&R59Q
MJ1MI:RIQB[^=_P#)F(\4*"LLLX>RS**?,FZN H.->3NKQE.M.K3]D^J4%*VS
MN?@5HGCC]MW]G:5=)UKPXFH?#O3?W4.MWES+<WTMM'QYC@HS%BN#][J?6NUO
M/VJ/VD_BP@TOX3^'DU!I@(+QYEFA,1(V2E24'3YL$8/'IQ7[.W_PZTWQ$A&K
M0Q:K8OR;*Y4218/!&QCC':K/A[X??#WP8V[2O#6E:+(3EGM+>.(DG)W':!SD
M\?XUI# 9C5A*%/%UZ<):N,I1E=;Z)+1=+/6WSMU1\6,#3BG7X.X=K8E1]W$?
M5JJYGI[]9>VM*J]VTHJZ=ET/PFN/^"<_QA\;SCXJZ[X\\;:7XZB_TN'PY::S
M>IICS\N(BBR!=FX*,;3C-=-IOQ@_;4^ I72_'7A2(^%]/ AM=2DDEGN9H(\*
MKN=A)) Y)/7VK]ZM]D5\RU=9" <*/4=!C\AU]CUKC/%'AZS\5PFVUKPU9ZI;
M@8"W$0=2,YZ,#_\ 6[9K/^SZ[3C"=;#U8NWM*$N5SEI[T_:*6N_;9Z&-'Q6K
MU)R>8Y+DF;8)OW,-B\-;ZI3T_=X7V=2FU%)_;Y_4_$'6?CW^V=\;,Z=\.?!M
MK<Z!>9AO+]C)!<0PR#:\D9V<%4)(YZY_#@Y?^"??Q7TN0_%32O'OC>X^)3?Z
M4WA>76+S^R!<X\WRMAD*!-YVCY<8 Z<U^^/AOPUX<\(1&+3="LM&0@$I;0B-
M3CU '\QC!/6MBX;3=19HH$CBF;CS4 #\]>>N>_;/UK-Y?F-DL5B*V(CM!5FI
M-?X'345%Z;N^VO04_%5PFO[/R3+LJPRM^ZPF'Y88B*M>GBG7=5SIO5/V;A+7
M='X0Z%^TI^UQ\(?^);\:?"MOIVFV_P"XLKF R7$TT:?+&SD)G++M8\]3WK6O
M_B/^UE^T$&TCPCX?\CP=J8\F?58));:\AAD^](A"A@0,]"/:OVAU#X0^&=>/
MF>)='LO$*9RHOHEF"YQTW!NG]>V*ZK0_#W@OPO MEI.EV.CQ@ "&UB6-!CC&
M!@<''7/TQ5QRC%U(6C7K1A'7V4GSNRY;IN*O9WZONGY=+\7,'"+MPCP[3Q;7
M^\0P]50C+2U2,'7=JBW;>E];6T/P.7_@G;\;/A5*?B3\._&_C7Q+XRN3]LGT
M'4]9O)-/CG^_Y:QM*R!2< #;C%=EI7[5W[6'PLB_L?XH>$[>QOPI@M!&))O,
M?[J%FV<Y..<=^]?O TD<:[K,"?.< ].G3W&>/_UUYIXC\":#XIN$NM<\':=J
M$JN&$MQ LC#'0\@G]:UCAL=&CR8;$8C!S3MR4)*,)/37]Y&;N_5?=8PH>*M2
M<)1SG(<DSN@Y-QJ8K#..)IK[-./LITER1V5XMVZM[_B5K&J_MN_M*,VD7_A]
MM ^'NIYCDUO3+F6WOHK=^"Z[%1@XC?<!GK^&.3B_8O\ C]^SG)_PEGP-\5>+
M/'VOW!^UWNF^)-7NYK6&9OGDC19'D 4-\H^7&!7] FEVVC:!9BQMK"WL;>,$
M"WB0(@&.@ X^G'KUIMQ8V>M9CLF6T)!!,>%SSWQCKG R>,5SO 8_F3Q->O7J
M/X:DY)U8WM;DG%*"OYHA>*E2-11PV399@L)?_D74L+R8'$0T_P![C4<ZTW;_
M )]U8?(_$+1_VT/VB/"5N- ^)_AZ+3?%A @M[6V666)I\!0"X3 !/XCVJAJG
M@[]K7]K%3HWBZWU#PCX*O3^ZU?1+R>UO/)DXW90QL#M Q\W'3DU^TLOP6\"7
M-TNH:YX6TO5[R-A(+VZMHY)00<[@S#.1U'OUKT+3K7PWIT"65C'!91QKM6"%
M0JICLH'3MV^G&:ZU@LTY>=8RNZ<-72GRS3B[>Z^6*\];KK\]JWBO@?9RAA>$
M\@P6+DK?6Z.&J.5.>G[RA&59\K[<RDO(_ .Q_9#_ &H/V3W^W_!+5_$7Q$@<
M^==_\)+JMU<B-2=\FT2O(#@%@!CI79#]M']I73K4^&=4\+6\?C8XB2S6.0Q&
M8?*!O\O'+$<\?A7[IW$KK&\5M;K=(XPRMW#<$?3!^E>6W'PT\*76JC6+SP5I
M9O@V_P"V-;(90V<YW;>H.._4UC4P6.JI3P^*Q.'J/>%*<(P6BNDIQD[KU>GS
M,L-XH4E14<VX9R'-IQ^#&5\//ZU*6EO:^SJPBXJ]K*$;K2^Q^(NI_!;]K7]J
MPM;?&I]6^'OAJ<EK:^\-7]Q;3O"QRK$1F(C@G//]*PX/@E^UW^RM,MO\%Y=6
M^('A6%E:[O\ Q+J-Q<3K F"Q E,IS@9QFOZ$5NM)M+=+9K>$11J%6';A5 !P
M ".!QU['OVK)N?#=OKZL()?+MG!#VZ\(ZGJI'0^A]?0#-1' XZG.]2O6G6T_
M>[5[>[:\[.E9;_#=ZZCI>*]>G5]W)\K6&V>53PR666_G]GS?6>=+K[:U^G4_
M$V+]L_XW:E9KX8L]!1O'@412V7E2B)9R-I42;,??) ]@.*Y6^_8^_:,_:O;^
MT?B_X@\3^ 8D/G6:^'-4NK82#[T881O%UVC/'&?QK]P[#X/?#C1[P:I)X/T=
M-0#;FU$VL8G+ YW%\9R2<UZ-$VEA%BLR@6, "-  !CH.,\ ?H.E=,\%F<HQJ
M5L5/$4XI?N:NL'\.DI14;-;IW6MS6OXLPK498;*^',FRK$3U>+H8>3KQEI?V
M3J3G&,7V<7TU/P*T3PW^V)^R5<1Z)X2TRY\7^!+)AYNLZY=SW=Z8(S]_Y_,8
MG;DG)%>AZS^V]^T#XML$T+X6^&K?4O%Z*(;JTN(Y(XDFY5E#F/H#C\*_9W6K
M>UO+26VO=+AO[9U*M'*H96'0@@YR".V/IBO*M%^'/@J#4WNM(\':7I-ZTFYK
MNVMXXY"V<[BP YSU/\ZP<,51Y5#&8FG!VYJ,(\T8K1\L9<KY4O-_/OSPXMPF
M)H2EF60Y96Q?*N7';>^[-SK4XS3D_*,4KGYW?"WX0_'WXO3P:Y\?[G4_!=^K
MI-':Z->S+ YW@@,J%!@XP<Y[_A^G?@+PQJ'A+2K?2+2>34;.!41;J]D+S.%4
M#+,V3G').>OOP.N6"RTZ I<%9Y@H"!QNP1G&/?\ "N+NYO$^I7#6UO;2V=DQ
MPL\9VX!/48P,D<]\?E6BP]5^_*K4C%]8WC5E:UO:2::U\E'U/E<9F%/'RE>&
M&4$[I3ARX>"TUH4U:HFO[TY=?([#5-2L=-4->RA3WV?-_+\3[_6K>F3V^H0>
M;93,0!D G:#QQ^//I^%><76GMH&V6\G?5&<@E)R7VY&>,Y YS77Z%''J4(FC
MD-B,9\N/*K@^V<]\^N*Z*%)T[SA4Z;74GLG\7]=M#Y;%X?GYFJD5!_\ +VG!
MQ[:<K;?X:?<;LS7#$QWL:M",X)PW'N.G<?3V%-AVQX^P0QX/)PH7 '7L>?J3
M]0:G,<,8VB<W##J&/7@<=_U].U.41G)+&''0+P"?3CCGCC_Z]=N&J))SM.]^
MC3UNNBUWU7KYGB/#U_@51NE>[EJM[/KK>WX;V5PRK?ZTYE/.S^$]?7M^?&>>
M].(QUA2(<890 Q&,_P ^P_\ U1"2,-M//.WS, ?3W^G;I3I%4<QS&0^AR1W]
M3_G)Q7?"NW4C.K>,8VLU:_3I;>UNUKZ=#6$9II:R2M=3O*^VUK6]&0N;G?B-
M%D7)&2>>W3\N/3/6K<<;(H?:-_=3Z_@/Z?H354-M^\Y0]1SUQTZ?S_&I%EW_
M "LVP'^+GCW]O_KUT5,5"<6E",5:RE%)REMOY_=Y]+]B=-Q_>PLULHM73T>V
MZ?FVQ)Y7<C>BKZ;0,?IG\S]*F0W(BP(D*%3EL#TQUQ_4?ATJO,L:D;)3(3ZY
M./\  GGIZ?E*@0Q\W+ X/RY.#D?KG)[?E7 [7TO;S,':^E[>>_X$<!D#_NT#
M-Z'IG!_ST_"EN#*7'F(%;'0#C/IT_I^'HR':6^:0H,?>'&>/7_/7M1-MW?+*
M9!CJ>WXX[<9^O>D(LL;CR2#$FS'WL#/7Z>ON?QJ*W,H)\I%<X_BY]/K_ "I6
M$?E'%PQ./N$G'Y<TR$*2=TIBXZ@D9Z?Y_"@!)?,\P[E ;(X'3W[?Y]NM3S&X
M,0WQ(J<88 9QZ]!V^OX=:K28\PXDW#(^8_\ ZNYX'Z8J:4)Y?RW#.<K\I)_D
M<_3_ #P .MS.%/EQJP[D@9 Y^O\ 3ZU!\_F_=&[=T[=?IZ\?YQ4D(4@[IC&<
M] 2,]?\ /X]*AX\S_6'&[[_.?\<XYZ_CVH LW!G*CS(U4=B ,D<?3^OUI83<
M"([(D9.<L0,X]>A[?3\>M1S!0!MF,AST))QT_P _ATI8@GE_-<,ARWR@G^0Q
M]/\ /(!'%YGF#:H+9/!Z>W;_ #[]:?<&4D>:BH<?P\>OT_E44>/,&9-HR?F'
M_P"KL>#^N:?,%!&V4R\=22<=?\_C0!.IN/) $2;,?>P,]?IZ^X_"H;<RASY:
M!FQT(XSZ=/Z?AZN41^4,W# X^X"<?EQ44.W=\TIC&.H[_CCOSCZ=J '3F0O^
M\0*WH.F<#_/3\*G<W'E8:) F!@@#/3Z?7N?QZ56FVAOED+C'WCSCCU_ST[U*
MXC\O_CX8G'W<G'3\N/I^= !;F8;O*17/^T/_ *Q_S^D<F_S?F4;\CY>W^?R^
MO>E@"G=NF,?TR/\ /;\^O:F/CS,>86&1\Y^O^?\ ZU %F<W!3]Y$BKV( SCC
MGH/;U_K26YG"'RXU89YR.@]>G^?7N6S!-O%PTAS]TDD=1_GI^5)"$*G=.8SG
MH"1_GN#].] #!O\ -^Z-VX\=OY>O^>U2W)G(7S8U09/W1C^@[^WX]C -OF?Z
MPXW'Y^_3\\]_Z]JDG" +MG,O)X)SV_S^7Y@$T1G\KY(U9,'+$#/\C_/_  J"
M(R^9\BAF]#TZ\=O\?QZA\83R^;AD//R D#\OIT_I4,>TO\TA0<_,.O4?CQT_
MQH EN#-E?-0(<=%X_D!_(?CVD'G^5GRDV8/S]_Z_S_*H)PH*[93+P>IR1S_G
MOW_*3">5G[0P.#\F3CUQCW/_ .OM2<5*UTG9W5ULPN_U$MVF#'RU#'T/3/IT
M[#VQ].[9C+YN74*_!P/7_/T^@[I"%+'=*8^.HXSUYXQU_P @4DNT2?+(9!@?
M,>3_ )_P_,LK\UO>[]>G^0[O:[L6Y9;IH0KHNP 8..OZ'],U!;>:I8PQ(QZ\
MC]>A[_\ Z\]%D">7Q<%C@?*22!_^H=?ZTR (=VZ8Q?3(_P ^OXU2;6JT$.:6
M<2_W6!QM!X_S[?A4EPT[(//B4KGC/.1Z\C^7_P"JLV/,.'W#=]_O_3_)_"I9
M@@4;9S(<]"2?\]@/KVK3VU56:G)..S6EB7"$FG**;6S:)(&G"$01*%Z''&!Z
MCCZ?_JZP*T_G9#,6)QMW?+_GIW_.GPA"IW3F,YZ D?Y[@_3O42X\P9?:-WW^
M_P#7_(_"CVU57?/*[T;T=[>I+I4V[N$7]Z[=FNW],L7#2G;Y\2>P// XST_#
M^M$8E$>4A3;CDX'&!]!_3^E13A!MVS&7ZY/^?7\*?&$\OFX*G!^4$@'_ /6.
MG]*/;5;6]I*W:^FH.E3:2<(M+;3;Y[C86E\S$:J6YX_'/N.OI^'LZ=I]P\Q0
MI[#^0Z>_^&>:BBVF3YI#&,'YAP?\_P"/Y+,%##;*9..IYQTYYST_R#1[:K>_
MM)7VO<?LX-\W)&Z5KV6W8FQ<"+(C7;MSN_\ KXS^.>O.*2"2X)/EC?@="?7J
M.YQ_DT83RL_:&SM^YDX]<8^OZ=^U10!26W2F+@=#@GG_ #W[?FO:U&K<[M\@
M]G"S7(K-W:MOM_D/D>4/\R@/[>O.>W;W_3K4\DEUY?SJ-G'/J./;V_R:IR;0
M_P LA<<?,>O4_CST_P *FD">7Q<,YX^0DD?E].O]:/:U-/?>FWE_5@5.FK6@
MER[65NWW[=?\[I$KOGRX(WYS\P!_'IZG_P"OUJ-O,+E"JG)'R$?+]<8Q[8_K
M3X0ASNF,?L"1Z>GYU&=OF?ZPXW#Y^_3\\]_Z]J?MZW_/R7WW_K8?)!-M0C=Z
M-V6J[#I8&C (@CAR?O(H!(]>G^/KGK4\#76SY%WKSR3R!V/3K^7\JCF"!1MG
M,AST))_SV ^O:EA";>;AHSG[H) ZG_/3\ZCGE>_,[][NXO9PY>7DCR]N56_(
M1);CS,*?FSTSQQZ?YQWZ"I)Y;KCS/DSZ'IC\!_D^]5DQYF/,*C)^<?7_ #_]
M>GSA1MVS&3ZY/^>_Y=>U5[6I>_.[[7T_R\OZN/EC=2Y5=*RTM9?+0F7[0T1_
M=J5P<L>2.YQD>A]1[U#!YF_Y$5F]".,\]O\ ZWX4]!'Y?_'PP./NY..GY<_3
M\JBAVEOFD*#'WAQGCU_SU[5$I2D[R=V-12O96N[NW5C[@R[OG4*<=%XY].!_
MGT]'-'+Y6[R$V[?OXY.?P_J?QJ*;;N^64R#'4]OQQVXS]>]2D)Y6?M#9V_<)
M./I@YZ5+C&7Q13MM=7L]"DVMFUZ-H+9IQD1*&]C^'U_E4<S2F0AQSD?+V]_\
M_P#ZZ6$*2=TIBXZ@D9Z?Y_"F28\PXDW#(^8__J[G@?IBG\E\E;\@YI=V6)/.
M6/)A1!QAP #CUS@')'/N:(6N&4[$#C/4]1ZG_/'\J;($$?RW#.>/E)/IZ?I2
M0A2#NF,9ST!(SU_S^/2M%4J)64FE_7S)E%35II27]Y7V]2$K(9><D[ON?P_E
MCU_#VS4\HEC +1)'Z%0,GI@\8_2H./,_UAQN^_SG_'..>OX]JFF"@#;,9#GH
M23CI_G\.E/V]9V_>2TVZ;>A$:-*+O&G%/O8LQ3W9B(1%9.<Y[#\!Z>O7Z52A
M!6<.D4?F9YPH!/((Y_#_ /7U$L03R_FN&0Y;Y03_ "&/I_GF&/'F#,FT9/S#
M_P#5V/!_7-9MMN[;;[LT+-U-=,0)?DXZ*<?Y_*D47'EY\M2A&=Q SZ>GT[CZ
M U%,%!&V4R\=22<=?\_C3U$?E#-PP./N G'Y<4XSE%WBW%^0G%2MS).VJNEY
M?Y"0O.6^10Q]#Z^G3MQSU]NE1SK+O^?*-P0JGC/Y'\_ZYR0[=WS2F,8ZCO\
MCCOSCZ=J)MN[Y93(,?>.>/Q^G/\ C5^WK7O[25^]_3_)$2I4I.\J<6]$M%T=
MT6BURL0R@"A1AL\^O88[>_MS3()+DY\L;\>I.3U]OY?XTUQ'Y?\ Q\,3C[N3
MCI^7'T_.F0!3NW3&/Z9'^>WY]>U+VM35<[UU>PU3II<J@N732WI_D-E\UW*R
M $DXVGH<GGCH./P[FB2VV*&^S11>CHH#$< G.!SC'K2/M\S_ %FX9'SGZ_3\
M!_2I90FP8G9SQ\I)QV]<_2L[EK2R6B6WW*_WB0QRNI(B209ZL 2!Z].N#]/P
MQ4*I(LN!D'=]P<+CGV_#_$U/"$*G=.8SGH"1_GN#].]1#;YG^L.-Q^?OT_//
M?^O:M(UJL%:,Y)/I?MZF<J-*3O*G%M[NVK]2>?[0JKO7RQTRIY..G;_ZW\J(
MUG9-PC5E.3N(!(Z]\?X?C3)P@"[9S+R>"<]O\_E^;HPGE\W#(>?D!('Y?3I_
M2HYI-WN[]RN2%E'ECRIW2LK776Q'%YV_"C<3U4]/;M_GJ.*DF:92/,0(>ORX
M'3@=L_R]JACVE_FD*#GYAUZC\>.G^-.G"@KME,O!ZG)'/^>_?\JC4G#X9./H
M#A!M2<(MK1.RT78L!KCRL^6H7'WN,_R_'/!^E10-/O.P>8?[K=,]QTZ>WYTN
M$\K/VA@<'Y,G'KC'N?\ ]?:HH=I;YI3&,=1GG\1CK_3H*3E*3NVV^[81C&%^
M6*C=W=DE=DLLD@D^=%1L#A>.?\^OY4^8W#1?.@"X&"#USC_/>J\NT2?+(9!@
M?,>3_G_#\Y9 GE\7!8X'RDD@?_J'7^M4JM16M.6FWD*5*E/XZ<9>J7EY>1%;
M1,"3%$KGK\V._7M_G^3R\RR8&%8' 4'C_/\ AVI( IW;IC'],C_/;\^O:F-C
MS"-Y89^__G_/-/V]9N[J2;[MW%"C2I_!3C'H[)6MITMY?UUM3/<A1O4*,]N_
MOT_'T_6G0376P^6BN.A+#G'Y?Y_G!,$"C;.9#GH23_GL!]>U$(0J=TYC.>@)
M'^>X/T[U+J3:Y7)M;V*C"$%:,4EY(:))S+PQW$_=S\O^?Q_,]9IY+CCS4"YS
MP#^O3\*K+CS!E]HW??[_ -?\C\*?.$&W;,9?KD_Y]?PI1G*+O%N+\@<(MW<4
MVNK5R9?/,>5B4K@Y)QD8_ =_H?QZ10M)YG[M%9N>,#K^OOT_(TZ,)Y?-P5.#
M\H) /_ZQT_I446TR?-(8Q@_,.#_G_'\J]K4LUSRL]U?<480BVXQBF][+^K?(
MDN&GW#S%"'T7@9XQV_IW/7L_;-Y>X1)MQG?W]>P_7.:AF"AAME,G'4\XZ<\Y
MZ?Y!J7">5G[0V=OW,G'KC'U_3OVJ8RE%WBW%]T4TI6YE>UK7UM;:P027.6$7
MS=\$G'/'UZ?_ %^U13>8TG[U%W>F..O.<Y_7].I( I+;I3%P.AP3S_GOV_-L
MFT/\LA<<?,>O4_CST_PIRG.3NY-OUM^5NPN2%[\B;>CTZ::$K1.B;A;QH."&
M P3^0Z_F3]33X&N#GRT#X]>P[XX/L/P^M-D">7Q<,QX^4DX_+V'7]<TV$(<[
MIC'[ D>GI^=5[:K:WM)6\W?;U!TZ;5O9QMU5EY>6@&2828Z-D +GCKG]/_K=
M:GFDN0H,BX'08.,CU/'IG_.:J<>9@2$C(^?G(Z<^M2S! HVSF0YZ$D_Y[ ?7
MM2]K4T]]Z;;?U]X.$':\5[NVFW]6)XI;LH?*4%>03D\*<_K[\=/3FJR-,91R
M6;/W6.1QGM_D=^E/A";>;AHSG[H) ZG_ #T_.H4QYF/,*C)^<?7_ #_]>I<I
M2=VVWW] 48Q;<4DWO;^O+H37#7'R[U$?7[G']![=OYU(AN?*_P!6K+@Y8CGI
MGTX_,>]03A1MVS&3ZY/^>_Y=>U/01^7_ ,?# X^[DXZ?ES]/RJ;M[E#+<RA_
MW:AG]#^/^>A^E.N&F+8D7:<=!TSZ=/K_ (>D<.TM\TA08^\.,\>O^>O:B;;N
M^64R#'4]OQQVXS]>] [ONR4I+Y6[R$"[>'Q\Q_3^1/X]*+<S9/E('..C<^G8
MY_E00GE9^T-G;]PDX^F#GI3(0I)W2F+CJ"1GI_G\*227PI+;;TL#;>[;]6_+
M_)?<A)?,\P[E ;(X'3W[?Y]NM3S&?R_GC54XPP ST/T_K]*K28\PXDW#(^8_
M_J[G@?IBII GE\3LYX^4D^GI_/\ 7-,0ZW,X4^5&K^NX ^OL?Y"H/G\W[HW;
MNG;K]/7C_.*DA"$'=,T7/0$C/6H>/,_UAQN^_P Y_P <XYZ_CVH LW!G*CS(
MU4=B ,D<?3^OUI83<"([(D9.<L0,X]>A[?3\>M1S!0!MF,AST))QT_S^'2EB
M">7\UPR'+?*"?Y#'T_SR 1Q>9Y@VJ"V3P>GMV_S[]:?<&4D>:BH<?P\>OT_E
M44>/,&9-HR?F'_ZNQX/ZYI\P4$;93+QU))QU_P _C0!.IN/) $2;,?>P,]?I
MZ^X_"H;<RASY:!FQT(XSZ=/Z?AZN41^4,W# X^X"<?EQ44.W=\TIC&.H[_CC
MOSCZ=J '7!D+CS%"MCH.G\OZ?X5.YN/*PT2!,#! &>GT^O<_CTJM-MW?+*9!
MC[QSQ^/TY_QJ5Q'Y?_'PQ./NY..GY<?3\Z "W,PW>4BN?]H?_6/^?TCD\SS?
MF4!LCCMGT_S^G6E@"G=NF,?TR/\ /;\^O:F/M\S_ %FX9'SGZ_3\!_2@"S,;
M@Q#?$BIQA@!G'KT';Z_AUI+<SA#Y<:N,\DCI^A_I390GE_+<,YRORDG^1S]/
M\\)"$*G=.8SG[H)'T_S^AH 8-_F_=&[<>.W\O7_/:I;DSD+YL:IR<;0!_0?R
M_'L8!M\S_6'&X_/WZ?GGO_7M4DX0!=LYEY/!.>W^?R_, EA,_E_)&K)SEB!G
MH/K_ $^E01>9YGR(&;T(XSGCMW_'\>M21A/+YG9#S\H)]/3^7Z8J&/:7^:0H
M.?F'7J/QXZ?XT 2W)E++YJ*AQ_"/?Z#^0_'M*#<>3CRT\O!^; S^?/\ /\JK
MSA05VRF7@]3DCG_/?O\ E)A/*S]H8'!^3)QZXQ[G_P#7VH ;;F4.?+16;!X(
MX]^W;Z?EW28R>;^\0*W' Z9_3^GT'=L.TM\TIC&.HSS^(QU_IT%$NT2?+(9!
M@?,>3_G_  _, L2&X\K#1H$P,$ 9/Z?U/]"RW,PW>4BN?]H?_6/^?T) GE\7
M!8X'RDD@?_J'7^M,@"G=NF,?TR/\]OSZ]J &OO\ -Y4!]WW>W7_/I^%3W!G*
M#S(U5<\$#K^GISW_ *U7?'F8WY&[[_X_Y_/M4LP0*-L[2'/*DDC_  Z\=/RH
M ?;F<(?+C5AGG(Z#UZ?Y]>Y@7?YHPH+[ON]O\_C_ (&2$(5.Z<QG/0$C_/<'
MZ=ZB7'F#+[1N^_W_ *_Y'X4 6+@SE1YL:IZ;0!Z>P_D:SL)ZG_/X5>F" #;,
MTO/0DG'2J>/]@?F/\* -&Y;((^RF+GK^'TQ44#8#9M_.Y'.,XX^H_P ]N]6+
MH3!?GN$D&>@(ST^I_2H;82X;9,(N1UQ_7_#_ .N 09_>?ZON/D_SZ_Y]:FF;
M*C]QY7/7'7W[]?PJ([_-QO&[(^?/'^<\]/P[U/<>;M&^99!G@#&1^7I_7O0
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M)O)/[]2N/N9'K^'^?SJ*W\S+;)1&<=3CV]: (Y#^\_U>WD?)ZY[?Y_7I4LK
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M+2>MG[NRN]]-^FNI5/,82DIQI4Z=]8<ROO;OI\WZ=&>_Z5_:&EIY%U=-J!8
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MS^7?ZGL^W\PL=LHC/J>_7/K_ )[FDFWB3YG#GCYAT_ST_P ] "1V_=X^S;<
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M2=L[<0>3^&,^_4_3^G<,3=YHPX#;OO=OZ?Y_.I;GS/EWS"7Z8R!^'O\ Y[T
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MO?K27'F?+OE63Z8S^GX?ET[U)&)O*XG4+@Y3(].?\Y- %:$X;/E>9_L_@?\
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MTYEET]Q'&""0S=LY]AUR<?\ ZZZ>\L=&MM+*:Y=6MK"J$---*D*@;1U=B,<
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MGQ?\%?B5^UG^Q[K\6F:I8^(]8L6NO)0VUAJ%YB-G"@LVUQP#U)Z5_3O^R_\
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MYWS>6J'_ 'QG_/?].>U1OYGG<@!\]!T[_P J %E,!7]VCJ<_Q9_K_GT]:(C
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MT=3GG=NQ^&>.OI_]>DD\SS>0-^[H.G7^G^<5/<>?L'F+&%SQM !_'OT]ORH
MAB, 7]XCL<_PY_I_GU]:C79Y@R"4ST[_ .?\^U6K?S]A\M4(S_$.?P]\8_\
MK]:@3S/.& "^[OT_KU_K^% "RF$@>6CJ<G[V?;UYJKA_4?Y_"K]SY^T>8J 9
M_@ 'IZ?YYK.PGJ?\_A0!HSB#'[N=Y#GHV3GC\JBB\K#>9*T?(X4X[?E_G\[%
MRS%>;41<_> 'I_GZ5%;D@-B 2\CD\8_K_G\P"#Y/,QO.W(^;OT_H/\?>I9?*
MV_)*SG/0\@>O^?S)IA)\W_5\[A\G^?\ #WQWJ:<DJ,P"+G[P[^GY\_TH 9'Y
M.SYIG5LGY0<#]>O/^>PC39YG+D+DX8=>O7K_ )]NE3PEO+.+<2=?G[C\O\_R
MJ&,GS?\ 5[N3\G\Q_G].E "R^5\NR1G_ -XY_P ]_P##O3T\G9S,X;'"YXZ>
MG4_G^8HN"3MS"(OI_GZ?GT[T]"WE?\>P88/S_AZ=#^M $$6S=\[LBXX8=?\
M/X_G22^7N^1V<8ZGT_/M_G%.@)W\1>9Q]WT_R>.OYT3D[^8O+X^[_G'?_(H
M>WD^6<3.6Q]W/'Y<8_'].S(O+Y\R1H_=>,].]3,6\DYM@./O_CZ<?ABH[<D$
MXA$O'0]NG>@"-]GF<.2N1ECUZ]>O^??I4DGD[/EF=FR/E)R/TZ<_Y[%DA/F_
MZO;R/D_D/\_KTJ:8MY8S;B/I\_<_G_G^5 $<7E8.^5D.1@#(SU_SZ^XJ/";\
M;CMW?>[_ .<<_P"<U/ 2%.(!+[GC'7/^>E0Y/F?ZOG=]SW]/Z=/\: 'R^5A?
M+E:3D\,<]OR_S^3H_*V?-*ZMS\HZ=/U_SG-+<$D+F 1<GD<Y_K_G\G1$^6<6
MX?K\_?IQ]>?_ *U %9-F\98JN3R.O\_P_P .E/E\OCRY&D]VYQU[TD9/F#]W
MNY/R_P"?S_PZ4^X))&81%QT'?KWH !Y/EC,S[MOW,\?3!SG_ #U[QQ>7N^=V
M08ZCT_/O_G-6 6\G_CV!&W_6=Q[X&>U0P$[^(O,X^[_G/?\ R: &R[-WR.77
M'WCUQCU_^O\ E4K^3LXF<MCE<\=/3J/S_(4R<G?S&(_]D?0=_P#Z_P"53.6\
MK_CV"C ^?\/3H/TH AB\KYM\C)_NG'^>W^'>FOLW\,2N1\QZ_P"?S_'I4MN2
M-V(1+]?\_7\NG>HY"?-_U>WD?)_+_/\ /I0 ^7R=OR3.YST)R.OZ?B?SHB\K
M;\\K(<] >I_S_P#6QTI\Y8IS;B,?WAWZ?YX]^M$!.TXMQ)SU/;U_I_7'2@"O
M\GF8W$+DX;N?_P!?^?6GR^5QY<K2<_Q'/K_G_/" GS?]7D[C\GI[?Y_^O4EP
M6XS (OIDYZ_Y_*@ 00[!F9U)SA0>#^O^>^144>S?\SLJ\\CKUY_+_..E6(F;
MR^+8-U^;O[?KQW]LFH(B?,XBW_[!^O\ 7_..E !+Y>5\N1I.#][GO_GM_P#7
MDQ#L_P!<^[;]S/'Y?Y^F:2X)++F$1<=!WY_S_GK+EO*_X]AC;]_O^7TYZ?I0
M!7B\O)WR,@P,$'MS@YY_^O[]DDV;_E<NO&6/)Q_7^7\@^ G<<0B7V/;K]?\
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MXR,#&>XS]..*_ /]N'_@D[IOQ N-7\6^#M/1;@+--!96=L/F8@%5&T>Q]>]
M'X7WWC_P[\3_ ![>ZCH.KR2B]O3+'L8HN'<$=^/_ *]?TZ_\$R--U/2_#4>"
M;@F%2N]MV?E&._\ ^NOYDO!7_!/G]J/1?'DUCIOP^UR"PM[S9%=QPR*IC5Q\
MP^7&#CCZ_6OZI_\ @GC\&?B/\,?#D-MXYAO[&;R0,78((. ._P!#_3- 'Z:3
M7_B-[HQSZ=$EKQ^^!&X#)YZ>F3D\_I746$-HPW$AI,99&'&<9/Y'K_3BLTZ7
MY\Q;^U792<>62<9&.WU]/PJQ<69LDWI,2<=0>O;/!/\ DT[OS YGQCK/B32K
M.=]!TJ&[G1"84(^\V 5' /4]<U^<_P 6/CK^W-HYNE^'OPCT[5BC,("[8+CJ
MN?W9Y/Y5^EJ:G?+(J?8#/$3S(W/&/T]^:Z!+JV,>Y+=/-P-R8&>GY\&B[ _G
M9U_]K/\ X+'VDS#1?V9M#O(@Q52\QY'./^6//^>U<U_PU[_P6L(RW[*WA[('
M'[X_K^Y']*_HZN+F<L 4\D9SV_S_ (?A3)(S) <7A1L=L9!Q_/)_SV2TU6C\
M@\[:G\ZEE^UQ_P %H';$_P"RUX>0<9Q*3@\9_P"6/I_];O79:+^U7_P5\GNX
M$U+]F?0K>!G42.)"2JD\G_4_7\/U_=L+J5M(6@FDN^20I]/_ *_7W].E=+97
MFH>63+9?.!@9 SW_ "ZY_F*=W:VMNW0#\YOA;\9/VX==6U'CKX3:=I0<)YX1
M\[<@;L#8#QG\O2ON'PQJ7BV^B1_%&G)I;E?F$7&">"!TP:ZV;Q!JMNQ TO*@
MY! ZCU_/'IVJM_:MQJ1Q/;^3D\Y[?S]<_2D!0OUTB,L\VJW"<<X)(]>F>?3V
MQ6,=4B,<T>AWDU[<[6"I(6Y8@A1G)]A77+I>G2KF41RL?X&4')XXJG<VD5A\
M]EIL<;CHZ  DX^OJ/\]* /YT/^"C'PK_ &__ !MXGDD^#/P_DU[26G<$"YD5
M'B+,>4"D'/3Z5\%_"#X"?\%+_ NO6VO:A^S!X>O+V)Q(]S=(C2,P*DEG:#).
M1FO[&(_%5W;L(I[8C)QD]CS[>U:TZ2:O:DPWC0.PX"'![X[>^* N?@#;?'[_
M (*H^']'6TTW]F?PY!%#;B-C$0I553;P!#V]/\*_(O\ :H^.7[7>M:O>GXE_
M"C2]%U%O,$BQ@$JQ/S8/E@U_:P--U'2[6Z$MU+>%XVV*^>I!P/S)&1Z=*_GS
M_;L^#'QR\9^)-1N_!WPQO=>A<RF.6&(L'R<C! [XX]O>FVWJVV_/4#\0OV7_
M (N_MA>&_'D=]\)?AO9^(=7^TH5LY6*KOW A?N'OGM7]2_P6^+_[;WCCX9ZH
MOQK^%=AX5G.DSB,6[DDYMVQQY:]>G'_UJ_+S_@GW\"/VD_"7Q6AO?&WPCU'P
M[I:WB$W<\)5 @;ELL!P.M?T]:HEA/HT.G7^H"S::V$+Q''!9=I4C\<<_IW0'
M\$O[1OP^\8ZS^U5>W'Q TY[;PQ)JKFYDDW21",W1W9##& N3[=*_I-_X)X^
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M$OL>W7Z_Y[FDF)\SF,1]/E'^?Z4 .?R?+XF=FP,J>@X_3_/04V+RN?,D:/\
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M#\WW.W]/\_G0 Z7RL#RY6DYZ-SCI^%5<OZ#_ #^-79R2!F 1>XYST_&J./\
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M<,'YE\PXZCM[]^G]>]-B\O=\Z,ZXX5>O^>W2B;R]WR(R#'1ASCOV_P XZ'L
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MF8$NP_WC]?Z?7IZCFGQ^1L^:%V89PP' _3\.WOQ44?E[_F1F7GY1UZ\]N_\
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MY9NAY'/3^?K^-$/D[3OB=SG@J.A]?\_AZT ,&?-_UG.3\_\ GWYZ]?RJ6X#
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MTT5N%'1HU.<D9X(_SQ^,[^1Y?$+A\#+'ITY[9_GG%,A\KYO,C9^GW1_G_/Z
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M7?NZ\8SG_'VZ>W-3W'G;5\PICMMQ[8_ST]":K?)O^\=N[KSG_'IS_G-22B$
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MCC;_ )S^GI[9A3R]_P [,%YY&<]>>ASQ_G'2G2B($>4S,,<[LYZ^YS_^OMW
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M5>>5Z_X_EZ]NX!+<>;N'F%">V,8[?3\:F_TCR>L>S;CMGI_/''KVQCFJLOE
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MGKBH%W^<,;=^[OC'ZXIT0@*_O)'4YXVYZ^^#T_S[")=GF $D)GKW_P _Y]Z
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M?6I(S*(L"!2,'YN_^/'Y^O%13C&W]_YWOG/]/\X_-Z+^Z_X^=G!^3/7 ]/\
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M?QIT R3^^\GCKG'I_P#JZ4R0?O"/,W<CYOI_G_\ 5UH L3&0QC= J#CYA_\
M6_K_ "S26YD"G;"L@[D]NO\ GU]*24?N\_:?,Y'R9SCVZ?X].W6D@&0?](\K
MIQG&>O'?K^% $?S>;]P;MV=O;KT].O'I^-37!D*C="L8[$=^G^?7UJ#'[S[_
M /%]_P#^OC\?\XJ6<8 _TCS>O&<XZ<=NGXT 21&01X6%7'/S'Z?YS^N!5>+=
MY@P@8Y^Z<X_#\.>/PJ:)<QY^T[.OR9Z\#Z]/PJ",?O /,V\GYOK_ )__ %]:
M );@N2-\0CXZ#OU_SQ_.I 9?)QY"[=OWSU^O//\ GUS4,XP1^^\[CKG/K_\
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M9^T]A^[S[X_^MUH 9;EPS;(A)QW[?GQ_GZ4V7>9/FC"'^Z.G7VXX_P#U\4L
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MA*@G=$9/0#_/\OY5.PN/)),L>S'3Y=W7ZYZ^P[=*BMQ*2?*=4./XL8[>O^-
M$3[?,R(RHR/E]>?\GT]*EE,?EC$#(>/F(_QZ_P">^*9)YGF_,P+9'/;/^?\
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MR_K3+83'=Y3HOKNQT_$]<_Y]0"%MOF'"$#=]WO\ I_G\*EF*%1M@9#GJ>/\
M]?//X<<U&V_S3E@7W?>[?Y_#_$SW G"#S)$89X"XZ>^#U_S[$ 9"4"G= SG/
MWASC^@YY_G42X\SE"5S]WO\ Y^O%6+<3E#Y<B*,\AL9_#)]/3_ZU0IO\WA@'
MS][MV]O\* %G*';MA:/Z\?I_D\^E/C,8CY@8G!^;J!Z?X>G'%%P)AM\QU;_=
MQC]#_G^3XQ<>5E9$"8.0<9_#.3_/^M %>+:)/FC+CGY1U_Q_SZXHFVEOEB,8
MQT/&?7@^OY>M.A\SS<(RJW/+8Q^O^?<=UN!*''F.K-@<KC'MT../\X[@#LQ^
M5CR&W8'S]L_7KSU]?PJ.$J&;=$9.!P/\Y_S]:L$7'D_ZQ-F!\O&[_'].OI45
ML)2S>4ZJ<?Q8QU]__K?CV (I-I?B,H./E/7J<>_^>.:FD,?E\0,AX^8]/_K^
MG\^:CE\SS,.REO48QUYZ'OVZ_CT%B43^5\\B%,# &,_C@Y_/_P"O0!# 4 ;=
M"TASU SV]N?\_2H9/F8[%*C/W<<_3VS5NU\[#>7(BCN&./\ /^>.YS[\7>TB
MU=?/Z!NHSS_44 /,;J Q4I[GGCK^ _E5&76K.U?RI8=V2?GSD#ZGV_&FZ/%K
MAF(UFYB-ONX!X.W..I..AQTQZ5T-WH^@W*'S'C9F&,"1<DD'ISZ]>M &0'L[
M]!]FU"&.1L'9N!8$_P"'^>E0'0[]<M_::%>XSU&?;VSW/6JB^'-.M)C-;QRC
MG.0Q(X_+TZ5T$)B"E9$D8#^[GV/;T]O_ -0!'&$A7RW_ 'TG WKW/W?Z9]_S
MJ2*-U.6MV=>PYZ9^F.G^143D(V8@5 YPWH.?SS_]:KD-U=R85'1>GWL=,?AS
M^E %6;:6^6(H,=#W]>OY?ASS4K&/RC_H[ X^_CC\SQ_GTIMQYH<>8ZLV.HZ9
M]>#_ )]1WF87'DDF6/9CI\N[K]<]?8=NE $$)4$[HC)Z ?Y_E_*F2;=YQ&5&
M1\O\OUYX_#FI;<2DGRG5#C^+&.WK_C3)?,\P[F!;(Y'3W[]_\YZ4 /E,?EC$
M#(>/F(_QZ_Y[XHA* '="TA]1V_S^7K4DPG$0WR(4XP!C./?!SG'T[]>E);B8
MJ?+=%'<-C/?IG'/IUH K?+YG^K.-V=G?Z>O3CU_"IIBA VPM&?4]_P#/Y>E1
M_/YOWANW=>W7Z^O/^<U/<"8*/,=&'8+C/;KC//KTH ;&4V?- SGGYAT_R?\
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M:>I\D6EPY;Y0RJQ&.1VS@?I6<;:TA_TMK>?:><?-GGD9XS_CT- &O/;K$?\
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M7-/MQ*6/ENJG_:Q@GG)Y/]?S[)-YGFX=E9N.5QC]/\^Y[ #Y#&8^(&!P/FZ
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M(MW]C?2IV(;'F[3M[\@_E6B^J26+K"H:="<$Q_,.H],_K6XCVD< O'M6+'G
M3YLXS_=_H ?RH C,]KL#-:,N5SS[CZ?ER*IR1VUSE8KF."0C 4D @Y./R^O]
M#6;>ZK/J+>7:1O ,[29%('&<=0/3\:DLM!#,+F[G7<#G(? ZY[G_ #WH MVN
MD36S^;>7R/ 2" 3@8SG@_P"?>M"6?357;$JRGGE#D]?;\^*FN;>QOH1;)<Q,
M5&,+*,^G;/Z^F:P_[,73N!SDGOGC'O\ 3_Z^* ) 5+Y"';NSM_R,]./_ *U3
MS%,#;"T9[D\9_P _EZ5!$Q9QL.TYZG\?\_X=1;N%N"!O99!D\)@^_;Z=?TH
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M8MQ.4/ER(HSR&QT]LGK_ )]A N_S1A@'W?>[?Y_#_$ $DQ0@;86C/J1C_/\
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M._0@%>+R?F\W?_P'./\ /3VS[TU_+W_+NV9'7K[^_P"?XU-;F;YO+C5_9O\
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M^U\&+=W,5U>72VB(41?F=]@ST[]__K5]:_M):%\)O$>AS1^+M6FT^%X9!))
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M8,\JI+$Y 7D\;P37R9XE_P""QO["VA3R6.H^.YC-"Y1UBLO-P5..-I/\C[4
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ME%!9^#O&2W4LX01^8JQ$[L[?O/G)Z'\Z /N"$VY!,A8_[IR/3M_GK3/W>_\
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M-LY\S?CWQT_SG-+<&;Y?,C5/9?\ ]6?3_/61#<>5@0H4P<L>HX_ >G7'7MT
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M@@4;9S(<_=))^O\ G]!46?WG^K[CY/\ /K_GUJ69@5&(/*YZ^O\ ^OWY]30
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MNIXHY9HM1M5E)<@$YW+R3ZU\S?\ !._PGIMYX9T?5-.U*&14$#BTC(.[C(7
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M@N,W+Q@G!5^2??/OGZ5[W^PK_P $WF_8PTZ>*X\<Q>(&,<GS*H4Y(;V]^?\
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MLN<Y!_'B@#Z"\3?\$Z_V/_'VGSR^!9/#6F3Q1LROI]M;1N&4'!&WH<KGC_\
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M""[C15FW?/M8-ZDCVY[<5^G'_!.S,OP?O+=+-H ^F,H;!P 8UY_S_A7Y0_\
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M]N>E 'G7[+_AKXK_ !6N],\/77QC\4RZ=<F.,VC7DK0X9D7;M)QC!Q[X_/\
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M'&RQQE\ 8' POI_DT ?3.I_\$\_V*+BS>6]TGP?IUZ1EKA+.VWJQ'J.X)_\
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M]<TV$(<[IC'[ D>GI^=/D8>6?]'V]/G]?I_]<_3 ID+ 9S!YOY>WKD<?U_,
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MG^?PIY8>5C[,0=O^LXY]^.?SX^G9D) )S"9?;TZ>HQ^= #),>8<2;AD?,?\
M]7<\#],5-($\OB=G/'RDGT]/Y_KFH9#^\/[O;R/E_P _Y^O2II&!3 MRG3Y^
MQX_SU_"@!(0A!W3-%ST!(SUJ'CS/]8<;OO\ .?\ '..>OX]JFA8 '-N9??\
M/U&/ZU%G]Y_J_P"+[G^?R_SF@"68* -LQD.>A)..G^?PZ4L03R_FN&0Y;Y03
M_(8^G^>4F8$#$!B]_7I_/WY^M+$P$>#;F3D_/Q@>_/\ 3_ZP (8\>8,R;1D_
M,/\ ]78\']<T^8*"-LIEXZDDXZ_Y_&F1G]X/W>[D_+_G_/TZ4^8@D8A,7MZ]
M?08_*@!ZB/RAFX8''W 3C\N*BAV[OFE,8QU'?\<=^<?3M4RL/* ^S$G'W_\
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M6_F%CME$9]3WZY]?\]S23;Q)\SASQ\PZ?YZ?YZ-B\K)\Q7(QP%!SCMTP>/\
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MS1W7A30;V"2&03#=/N^96##MZBOOWP[;:/X7TV'P_P"'K>2*&!!''YRY&%7
MY((..* -K2-=U35I6C^SSVP!QF12O3OSQ_\ JKP']LU[NU^!GBR0-F5=+NF!
M R0?+;CTKZ&MYM8MB7F,)4]HU&<$GT&?3]1Z5D>-?#FA?$7P]>>&?$D+S65]
M$T$R+P2CK\PY_P />@#_ #K_  )J\]_^TWXAM]9G"VPUV4#S#L&WS22,U_9=
M^POIF@7?@8V-E-"XN+#8P60-G='CUXZTV3_@CS^R-%XFN?&3>'KM=3O+@W,D
MB3 9D<EB>!ZD5]J_"OX!?#;X/60M/!]G=PI&H5 [E\!5XS^7^- 'XX?M[?L%
MGQAIFO>(M T:2[U*59I4-O$SN6(D8$!1GJ?\]*_"#X0>*OCW^Q-XQN[^7PGX
ME6RCO796CL+@+Y8E)7DKTVJ/_P!5?W:7%[//<&VELUFM2<%9K<.",_[2XZ5Y
M9\1OV</A=\5[1H?$>@Z<0ZX<BVMXV((.>=@/4D^] 'Y)_L]_\%B? NJZ);V7
MQ+AETV\,:12#495@<$##$B3!XY]_SKZO'_!2C]ENS@.JV^O:,;F1&?RUU* L
M&()QMW>IZ=*P/%/_  1Y_9!\77C7&KZ+J"3NS%C971@0$G/'EX Y[=JYA?\
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M,S-]@U%X>3_US8?YXH ]#U[_ (*B_LU:!;2-H'B_0-3E$;,D5GJEO*[,!D*
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MMNPVI2X)^FX^M>W> ?\ @F)^S%\-9[:\L?#MS<W%JP=6N&$X)4\9W*V>3TH
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M[>4!Y:A#]_M\O^17[G>,?V?OA/\ %W3)H/$FBVDJ7:GS,PPK*=^<\E=V>?\
M]7?Y'U3_ ()._LH22W%PVA7L+3L[N;>?RN6+,<; .I- %?4_^"I?[-6D$+<^
M(]$2Y &(#J,"R$XQ@#=GD^G/]/@3]L+_ (*J>%-?\)7-G\-X9[R[>.18GL)!
M,6W @%=AYS_G%>]^)/\ @B=^Q)K&K+JM]H_BE[A9#)F/4K@1[LYY .,5ZWX(
M_P""4G[(&AM#!IF@ZC(80H1;RX,OW>F0^<].<_\ ZP#^6CP[\-?BE^U[XRLM
M;U?PYXBFB74(YP[Q704+YRL"3_4\5_4Y\ OV1E@^!5IX3U.RDA<V"Q-%<A]_
M-NJX(?)_^O\ K]H> ?V9O 7PCMUC\$:-86L:* OFP0LW&?\ 9SGC\Z],36-4
ML)!!- /)7 *P183@@=AC^E '\HO[=7[ WBKP2;G6_ GAN\OY_,EN3_9UJ\S\
M,[?P+GLOU_&O(_V6/V^?B1^RS)9^$?%_AWQ!I\4<R0R-<VTL"JJ'!)+@8  /
M7K7]E3?V)K\+6]YIEO)N7:WVRWC<<@ X\Q3UY_&OCSXM_P#!/+]G_P",E[+J
M7BC0K<RS;V<V:PP\OG.TQJ#GG\* /G;P5_P5:^!NM>'K.?Q/K>G6UQ+"AFBN
M;Z**16(^8,"V0?7(JUJ__!5K]GK1[2=]!O[#49PC%!:WL,K%B#@  G//O_C7
M+:M_P1-_8RU9F%WH_B!2V<B&_FC3/7@*1QG_ #Z:GA;_ ((D_L:Z&P>PTC72
M0=P^T:A,X^AW-STS_G% 'Y<?M0_\%//%/QLM]4^'_@[PWKLUGJB26\4UO#)+
M#A\H.5&#G(KXN_98_P"">OQ+^(GQ D\5:]IE[;V^HWPO/]+MY%P)75\$L/?G
M''6OZF/"O_!.G]G?X=W,5UI.A1N;8J4\[RI9,J1U+ DG@>^>,5]8>&]&\%>$
M8H[;2M"$(@545DM4'" !1E5_K0!\P_ SX#-\$OAG=V<J+E-.96"KC[D8XZ<=
M/R[<5_-C_P %-O&;R'Q%9Z>'M[@27"B1ON@[F ]NE?V3W5YI.OV$NGW%N\=O
M<1F-U*[/E<8(Z#MVZ=J^'?BM_P $X_V:?C!)=7/BS29KF2\8M*(YE!)8G.!_
MGU[4 ?SU?\$(;G5W\27AU;4HYE-S-M&<8!>3'?WK^P&ZN);>V\Z"99%6-3M0
MY.0.PSZ#_/%?"/P)_81_9U_9CNFNOA[HE]9RNY?+.6&XDGJ /4]OY5]K6KQS
M*JVJNL8X D] <#K[ =J *=IXJN;MKJVDM)T C8"1D('"D;L_6OXWO^"VUTJ_
M%:S.=O\ Q,4^;(XS*U?V;SO%81%[L(4=2K>6!NP?I_G^OPO\<O\ @GO^S5^U
M%JBZW\0-'NKJ\CE\W<DH3Y\DY_/^M 'X._\ !-"[6<>&HGU.V*D6X,.]=^/D
M'0?7%?U?^'H#;Z%ISVJDEK>'++R#^[7_ #S7Q1\*O^">7[.?P5N[6Z\(Z1?V
M\EFR&+=,2J[2".V.P[5]XV(6"TBL]-&V*WC1(P_7:HVCMUQB@#B?B+9I<>$-
M4>Y7:_V9_G8X X&3SQUK^.W_ (*=VR16NM?9KV$,)YOE5AGMZ$9Z5_9?X@MA
MJ5A<:=JGSVTT921$^]M.<XZ=NF/7Z5\"_$__ ()Z?LV?&:2=/%N@ZC<27+EY
M2'8+N; /;UQT^E 'XY_\$&)VBLIA=7*,=S $MUZC^=?T#?MB6-G>_";6\W$4
M(-C(/,=L*,Q2<YX[?G7&?L\_L.? S]FI-GPZTB\L@W3>Q;/.>< =ZTOVS]/>
MX^#FO0IO6$V4XP"0^/*E&!CGIZ&@#^'?]H[4!X/\9:M>6%J_B9EU"X<6^F S
MR#$SD#:@8Y'Z\5^CO["?_!1[6/A=HMGI-WX)\0:5:J(HWEGMY(HT4!<LS,H
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MQ=M;#2?A1KUO;M'%)'HUTHY /RVQ_P ,CT]S7\!GQFO-=7]K35S'=$P?VPX
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M'\9YYIVG_P#!'S]C>"82RZ7?2RAMY^TWOF#.<]')]^./ZT ?@5)_P4>_;O\
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M;V168$'ON_G^%?0DVMZ=IQ^Q0P$D@+D<\]/SYK)LO$*:GMABMI8(U^0!D,8
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MEN?,^7?,)?IC('X>_P#GO4 V;QD,4ST'7^O^?RI\OD\>4KKZ[@1S^.>W^?4
MGC$OE'$ZJN#E>.?7_'\>IJ&'>9/E<(>?F/3_ #U_SU5#;^7\R2;L'! ./QZ
M?C^&#4<?E[_WBL5YX7K_ )^AS_, $EQY@8;I1(?4=NF/3_/<5-B7R?\ 7KMV
M_<R/\Y[=/\:K2^5D>6K@8Y# YQWZY//^<]I,V^S[DF_'7G;^?3_/7% !;>9N
M;9((^.I^OO\ X?\ UF2[Q)\T@<_WNW4Y_P _SI(C%D^:KL,?P@^OMS^1_P#K
MM?R]_P BL%XX.<]>.O/^'MUH MRB;RN9U8<87(_3^?;\*CMQ)SLF$7UQST]?
M_K4C_9]AVI(&[DYQ^'K^7UR:9%Y//FJ[?[H)_EC_ #^@ AW>;C>"VX8?M]:G
MN/-VC?,KC/08R/;CT'\^]5OD\S@'9GD=_P#/Z_RJ24P;1Y:.#GG<#U]O\X]
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MOE#=,KKQ\HQZ?U_SBJK[-YVJ0O'!Z^W;U_R.M2R&#9\B.'[DYQT]3U_#\<T
M26_F;6V3"/D9SCW]:@^?S?OC.[[^>.O7TZ\]/P[TZ(P8/FJ['_9!/KZ'/]*C
M^3?]T[=W3G/^/3C_ #B@"Q<>9M7?*L@[ 8XZ<<>G^33H1+Y1VSJB\_*<<_S[
M?Y["&4PX'EJZGON! [=,_P!./84L9M]GSI(7R<%0<9_#&.?7_P"N0!D6_P P
M8<*<_>.,>WZ<?X=*DN/,RN^42''48]_2H4V;QN4E>>!U]^WK_D]:?*8LCRE=
M1_M9'KZ\_G0!843>2/WZA<?<R/7\?\_G4$'F;_ED"'!Y./QQD_C^'>E4V_EC
M*2;\=0#M_,8'YC\NT<7E;OWBL5QT7.<?@/\ /L: 'W&_>-T@=L<,,<?7'Y]?
MRJ>03>5S.I7 PF1Z<?YR*JR^7N_=JP7'(;.?R/\ ]?\ $U(QM_+X23?@9)!Q
MT_(]NWYGJ .M_,^;9*L?UQG]?Q_/IWJ.3?YN"X)R/F'0>O0^G'^-$7D\^:KM
M_N@_T_#_ !ZBF/Y>_P"56"Y&0>N/R_S[=: +4PE\H;IU=>/E&./Y=O\ /8I;
M^;M.R98QGD'&3^?K_3M4<AM]GR)('R,E@<9_'.>?3_ZX(C#M/F(Y.>"N2/;/
M^<>HZ4 ,&_S<;QNR?GSQ_G//3\.]37(EPN^82\GIC^G^'_UJ_P"[\S[K;=W3
MO_G''K_*I)3!A?*1U.3]X$=O?)_I_4 FA$OE';,J+S\IQZ?T_P YJ"+>9/ED
M"'^]VZC'^?Y4Z,P;/G1R_8C..GJ.GX_ABHD\O?\ .K%>>!G/7GIS_C[]: )K
MGS-R[Y!)QU'U]O\ #_Z\H$OD_P"O7;@_)Q_GVZ?AWJM*8LCRE=1C^('U]^?S
M/_UI ;?R_N2;\'GG;^?3^OOCB@!MOYF_Y91&<'YCC\<9SU_R31-O$GS.'/'S
M#I_GI_GHR+RMW[Q6*XZ*#GVZ8Z?YQW)/+W_NU8+QPW7_ #]3G^9 +,@E\H9G
M5EP,+QQZ?X_AU%,M_,^;9*L?UQG]?Q_/IWIKFW\OY4DW8&20<?AU!_#\<FFQ
M>3SYJNW^Z#_3\/\ 'J* $?=YI!<%MWWATZ_Y[_G4]QYNT;YU<9X48X^F/;CK
M^=5FV;^ VS/0]>O^?3\*DE,&T>6CAL\E@<?AG@\^@'X=@"6W\W:=DRH,]#C)
M]N?4?R[5 F[S1AP&W?>[?T_S^=.B,&T^8CDYXV@]??\ SCU!X-1C9O&0Q3/0
M=?Z_Y_*@"S<>9M7?,).3C&/;TK/PO]UOU_QJW*8,#RE=3_M CT]3G^E5</ZC
M_/X4 :MU]JV?O411G^'&>GM^=0VWG[6\M4(R/O@'^?\ GC\B<0 'RYWD/HV?
M3_'_ "*BA\K#>9,T?/8D=OQ_E_\ 7 $/F>;T7?D<=O;]>.OX]JGN/.V#S%0#
M/&T8/MG^OZXJJ0GF8WDKD?-WZ?7L/\]ZEE$6T;)6D.>AS@>O7_/N: )H?M'E
M'8L97YOO 9_#./K^/XU7C\SS?E52^3G/3/Y=_P#.:=&(=GSS,C<X4'K[=QU^
MG^$:;/,Y<A<GYAUZ]>O^?;I0!-<^=\OF*@_W!C_/;]>>U2Q_:/*X6/;@\D#=
MT]>O'T%5IO*^79(TGN3G_#W[=NG>GH(=G,[!L<+G@\?Y[]N] "6_F;SY:J6Q
MR&' _#Z^WY47'F[QO50<?PCC^7?G_P"O3(MF[YW*+CAA_G_'\:)?+W?([.,?
M>/IZ]1_GTH M-]H\DY6/9CJ -W7UYZ_Y]*BMO-RWE!#QSO&1V]?\\TC"'RSB
M=B^.4SQ_3^??\F0^7SYDAC'J,C_/ZT $GF>;\RJ'R,8Z9_+M_G%6)OM'E#>L
M87Y?N@9_'&?K^'XU5?9YG#DKD?,>O7KU_P ^_2I)!#L^29G;C*D]/;L.OU_Q
M )+?SMK>6J$=]PSZ]/?_  J#]YYOW1OW=.W7_'CKT[]J?$(L'?*T9SP!GD_Y
M_P#UBHL)OQN.W=][O_G'/^<T 6;GS]J^8J 9/W !_+_//YNA\_ROD6,KS]X<
M].W\_P">*@F\K"^7,TG/<D]OP_E_]9T8BV?-,RMSA!GGU_SQ[YH 9%YGFC:H
M+9Z'I_DC_)ZU)<^;E?-"#CC8,#OZ?YXJ!-F\98JN3R.O\_P_PZ4^;R^/+D,@
M]3D_Y_2@"P/M'D?=CV;>I W8]CQTJ&W\W>=BJ3C^(<?R[<?_ %J4"'RAF9M^
MWA,\'^?\_P#Z\<7E[OG=D&/O#T]>I_SZT .N/,W_ #A0WHO3MV_^MW[U8D^T
M>5RL>W Y &[IZ]>?H:J2[-WR.77'WCUQ_G/I^%2N(=G$[%L<KG@<?Y[]^U "
MVWG?-Y:H?]\9_P ]_P!.>U1R>9YW( ?(X'3_ #_GBB'ROFWR-'[@X_Q]NW?I
MWIK[/,X<E<CYCUZ_Y[_G0!:N/M&SYUC"_P"R!GMU[_I^5);^?L/EJA&?XAS^
M'OC'_P!?K44HAV_),SGNI/3D<=N_N>G>B(1;3OE9#GH">3Z<?Y]QTH :/,\[
M@#?N.1V_S^-2W/G8'F*@'^P /7T_^M5?">9C<0N3ANYX/\_\^M23"+CRY6DY
M[G/K].@^O6@"Q%]H\KY4CV\]0,_YS]..N!5>'S/,^0+N]&''48_Q_P :=&(=
MG,SJW.%!Z_Y^OYBHH]F_YG*+S\PZ]1G\OI^72@"6Y\W<OFA!QQL&!U]O\\?E
M-_I'D_<CV;>N!NQUZ_3WZ^_%5IO+ROER&08/))/^?R_^O)B'R_\ 7/NQ]SM^
M73KQ_3/- "6_F[CY:H3WW 8SSZXZ?Y IL_F>;\X4-QPO3_/^/YMB\O)WR-&.
M.0?K@]_I_6DDV;_D<NN!\QZX_P Y[?X  M2?:/)&Y8]N!@@?-^/KG_(-1VWG
M?-Y2H?7> ?RS[_\ Z^U(XA\OB9F; RN3@?Y^OY4R'ROF\R5H_H<9]N_;G_/(
M /YGG'( ?=VZ?TZ?T_"I[CS]@\Q4 S_".?Q]\9_^MUJLVWS" Y*Y^]W_ *^W
M^>:DE$6T;)6<YZ$G@^G/^?<]* );?S]A\M8RN>=P!/X=^GM^=0)YGG< %\]#
MT[?SIT0AVG?,T9SP >O^3QU'X=HU"^9@L0N?O=_K_.@":Y\[Y?,5!_N#'^>W
MZ\]JDC^T>2=JQ[<')(^;\/3'^0*KS>5\NR1I/<G/^'OV[=.]/00^7S,RM@X7
M)P?\_7\Z &P>9YOR!2W/#=/\_P"'Y+<>;O'F*@; QM Q[=,_Y[&HX]F_YW*+
M@_,.N/\ ..W^!67R]WR2,XQ]XG\_3I_G'< M'[1Y/W8]F!SCYOS^G'7]:AMO
M-W-Y00\<[QD=??\ SS^9B'R_]<V['W.<?ET]OZ9YID/EY;S)#&,#D$C_ #^7
M_P!8 6;S/,^<+N]%''4Y_P ?\*GE\_ROG6,+@<J!N_S_ $Z9JK)LW_*Y=>/F
M/7J<?G]/SZ5*XAV?+,S-Q\AZ#_/X_@* 'VWG[6\M4(R/O@'^?^>/RKRK)))@
M@!MPZ=/\.IQ_6GP^5AO,F:/GL2.WX_R_^O&0GF8WDKD?-WZ?7L/\]Z + ME0
M9N2 N>WX>OU/_P!;NTVD;$R6ZHZCG+ 9[^OIQ_G-),(=HV2M(<]#G /X^_\
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M/R_0_6G6D=U'SJ!V,3G]VQ_SV_7-64V>9RQ"Y/S#KQ3IA%\NR1I/<\_X>_\
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MQ_/O^0!$2?-_U?.X?)_G_#WQWJ:<DJ,P"+G[P[^GY\_TJ$AO-QYG.1\_\O\
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M0]NG>F2$^8?W>WD?+_G\_P#'I3[<,2=LHB]SW_/_ .MT_"F29\PYDW'/WO\
M/J..WX=: )IBWEC-N(^GS]S^?^?Y4D!(4X@$ON>,=<_YZ4Z4.(^;@../E'7^
MI]N<?X-@#;3B<1>Q/7K_ )_'H: (<GS/]7SN^Y[^G].G^-33DE1F 1>XYSTQ
M_GI4.#YF/,YW??\ Q_QYZ_X5-.&VC,XE]@>G3_/X=!0 Z(GRSBW#]?G[]./K
MS_\ 6J",GS!^[W<GY?\ /Y_X=*GB#>7Q<!!S\N>>GY_E^E01Y\P8DVG/WO\
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M2V>1;.6YC29V1?NA20<G]>E 'L]Y<E(BL-FF[H!P#U^O;W_/CC.LYKYR2RK
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MD,B1.=V6)QR%)_'M7U'X,_X+2>*7BBTVQ\)ZKK5_@0R/;LSL)1PQP">_MVH
M_J4,E]#<*AM@4!P79P.OU/>NJ8V;6ZF2.W=R,E6DCXXSW/\ /M7\S_\ PN?]
MK_\ :'M&U/P1KGB'P5'=@^5"8Y,QEQ\OY?K^E>0^(OV:?^"I=ZTM_IG[0WB6
M"!B9$A6*;A<=/\Y^E ']4[PHWS6\,*>R.G.?8'/<=/050FO;^ %8]-W 9_>
MC/Z'^?/'TK^-;Q'^T]^W=^R7K-MI_P 3/''B;Q>@F1)7D651C<,YR1VS_P#7
M[_KI^R'_ ,%++[XIC2-$\0V\ZZE=>5'(UQ+\^YMJG()]2?KUH _;"VO9;AB+
MZTWKN/RN,COZYZ_Y-;:W-K$I\BQCR.R@8_\ K?X<5FV&LZ0-#AUB^N(8$F@6
M?]XP'#)OZGZD9_2OS-_:?_X*4_#OX'RWVC6\-MJ&J1K*D*0W"^8TB@X"KNYR
M?K0!^FAO[J=BG]GK"O9\KTR?7UX_E4Z0P9!GB@<Y'WWC_$\GW[__ *_Y+?$7
M_!4/]IGXPZ]<Z%\,O!_BNPBFE,=K>V<4DD>UB0K*5XP.O/K70Z3\%O\ @J-\
M;8OM^F?&KQ7X#CD4RK#<PS*0/O <_3\_U /ZO8[*V $D<D"]/W0DCQVX SZ?
M_6ILM]/: _9K%96'0J1_0^W\OP_D[G^!'_!4WX:7/VC4?CGXJ\4P6S!FCABE
M(E52<@8/?'^-3W?_  4&_:F_9O\ *E^*.E>)]6MX6599;J.2-&"$!B2<=<$_
MC]: /ZK'U?5)@V[1R3D@'\/Y?YS52-[^67]_IN(RQR&/ !_S^G4U^7_['/\
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M )QTI]P267,(BXZ#OS_G_/5L08R<2[/]H_4?R^O3UZTZX# KF42\=1V_+/\
M/O\ D 2 GR?^/<8P?G[_ )?3VS^%10$[^(O,X^Z<_P#U^G^<]I<-Y7_'P ,'
MY,\X_GS_ /7SVJ* ,7XE\LX/S'OZ^G7_ #CN ),3YG,8CZ?*/\_TJ:0GRO\
MCW"C ^<=_P##GZ?A4,P;S.9/,Z?,/Y_Y/;\3-('\KFX## ^0'D?_ *OI^= #
M+<D;L0B7Z_Y^OY=.]1N3YO\ JP.?N8X[U);ACNQ-Y7U_^O@?_KZ]JC<'S<;\
MG/W_ .7^?>@":<G:,VXCYZCOZ?U_IGI1 3M.+<2<]3V]?Z?UQTHG#;1FX$G/
M0'_#\OZ#K1 &VG%P(^>A/^/Y?T/6@"%2?-'[L'YON=OZ?Y_.I+@GY<P"+Z9.
M?\]/Z=Q&H/F@!]IW??\ \Y_R/PJ2X##;F82_3_ZQ/U_SR /C)\K_ (]PPP?G
M/;_'GZ_C4,)/F<1B3K\I_P _TJ:,/Y7%P%&#\A/)_P#U_3\JAA#>9Q)Y?7YC
M_/\ R>_X@ 6<G<,PB+V'?I]/\]Q4V6\K_CV&-OW^_P"7TYZ?I4,X8,,S>9[C
MMTYXST_R*FPWE?\ 'R,;?N9Y^G7/MZ=\]J (K<D,V(1+QT/;G_/^>C)2?,YB
MV?[ ^O\ 3_.>E/MPQ+8E$7'4]_SQ_/M^;90PDYEW_P"T/J?Y_7IZ=: )I6;R
M^;8+T^;O[_KQV]\&F6Y;G$ E^N1CI_G\Z?('\OFY##CY0>?\?S_6FVX8@XG$
M7L?P]2/KWH B)/F_ZO!W#Y/7V_S_ /7J:<G:,VXCYZCOZ?U_IGI4)!\W!DR<
MCY_3WJ:<-M&;@2<] ?\ #\OZ#K0 0%@G%N)!_>/;K_GGVZ5#&3YO^KW<GY/Y
M_P"?Y=*G@#[,BX$8_NG\?7'TX!_&H$SYO^LVG)^?_/\ ]?\ &@"2X).W,(B^
MG^?I^?3O3T+>5_Q[!A@_/^'IT/ZTRX##;F;S?I_];(__ %=>U2('\K_CY &/
MN'J>/SY^GY4 00$[^(Q)_LGZ'O\ _7_.B<G?S%Y?'W?\X[_Y%$(8OQ)Y9_O'
M^?;_ ">U+.&#\R^8<=1V]^_3^O>@"4EO)_X]@!M_UG<^^#CM4=N2"<0B7CH>
MW3O4A#^3_P ? (V_<[_3N>/I_P#7CMPQ)VRB+W/?\_\ ZW3\* &2$^8?W>WD
M?+_G\_\ 'I4\I/EC-N$Z?/WZ<_3G_P"O4$F?,.9-QS][_/J..WX=:GE#>7S<
M!QQ\N>>GY_G^M #8"0#B 2^YXQU_&H<GS/\ 5\[ON>_I_3I_C4\ 8J=LXBYZ
M''/YD?Y[5!@^9CS.=WW_ ,?\>>O^% $TY)49@$7N.<],?YZ4L);RSBW$G7Y^
MX_+_ #_*DG#;1F<2^P/3I_G\.@IT0<Q\7 0<_*>O]#[<9_Q ((R?,'[O=R?E
M_P _G_ATI]P22,PB+CH._7O3(\^8,2;3G[W^?0<=_P >M/N P(W2B7W';\O_
M *_7\* )%+>2,6P/'W_Q].?QS4,!._B+S./N_P"<]_\ )J=0_E#_ $D 8^YW
MZ_@?T_\ K0P!B_$OEG'4]_?MU_IVH 2<G?S%Y?'W?7_)XZ_E4SEO*_X]@HP/
MG_#TZ#]*BG!#C,OF''WAV_G]?\:F</Y7_'R",?<'4<?GQ]/SH CMR1NQ")?K
M_GZ_ET[U'(3YO^KV\CY/Y#_/Z]*DMPQW8F\KZ_\ U\#_ /7U[4QPWF_ZS<<C
MYO\ /Y?X4 2S%O+&;<1]/G[G\_\ /\J("0IQ )>?O'MZ_EQ_6EE#B/FX#CCY
M1U_J?;G'^"0!BIQ.(^?ND_X^O^0: (03YO\ J^=Q^3_/^'OCO4MP20N8!%R>
M1SG^O^?RB ;S<>9SD_/_ #_QZ_X5+<!@%S.)>>@[?EG^?;\P!T1/EG%N'Z_/
MWZ<?7G_ZU01$^9Q%O_V#]?Z_YQTJ>(-Y?%P$'/RYYZ?G^7Z5#$&,G$NS_:/U
M'\OKT]>M #K@DLN81%QT'?G_ #_GK("?)_X]QC!^?O\ E]/;/X5'<!@5S*)>
M.H[?EG^??\I,-Y7_ !\ #!^3/./Y\_\ U\]J (H"=_$7F<?=.?\ Z_3_ #GL
MDQ/F<QB/I\H_S_2E@#%^)?+.#\Q[^OIU_P X[I,&\SF3S.GS#^?^3V_$@$TA
M/E?\>X48'SCO_AS]/PIEN2-V(1+]?\_7\NG>GR!_*YN PP/D!Y'_ .KZ?G3+
M<,=V)O*^O_U\#_\ 7U[4 1N3YG^K ^;[G;K_ )_^OTJ:<MM&;<1C/WAW_I[_
M ./2H7!\W[^3N^_^/^?3KVJ:<,%&;@2<_='_ -;\N0/P[ ! 3M.+<2<]3V]?
MZ?UQTJ%2?-'[L'YON=OZ?Y_.IH VTXN!'ST)_P ?R_H>M0J#YH ?:=WW_P#.
M?\C\* )9R2!F 1>XYST_&J./^FGZ_P#UZOSA@HW3B7GH,<?D3_GM5#/_ $S_
M $_^M0!H3FW*_NH70YZMG'3W/K44/DX;S(GDY'W?I[C%6[K[5M/FF,KG^#'I
MST_S]*AMO/PWE% ,\[NO]3_D>V0"ME/,SL.W(^7OT_J/\/:I9?)VCRXG0YY+
M#@__ *__ -=-/F>;U7?D<\8]O\XZ>W-37'G[!YA3&> N,^W^>GN: (X_)V?/
M"[MDX8=![\CU]/\ Z]1IL\SYD8KD_*.O7D?Y_7K5F#[1Y1V&,+SUQG^OZ]_Q
MJ"/S/-^4J'R<Y Q_GU]3UQ0 3>5\OEQM'[-_G_.?S>GD>7S"Y?!PPZ=..V?Y
M8S2W/G?+YI0_[N/_ -?I^O&.:EC^T>5P8]F.G&>GY?3GZ4 58O+W?.C.N.%7
MK_GMTHF\O=\B,@QT8<X[]O\ ..A[/M_,WGRRH;'.[&#]/Q]/PS1<>;O'F%"<
M=@,?YZYS[9Q0 K>1Y9Q"X?'WNW7Z9Z>N>E,A\O)\R-I!CHOX?A5EOM'DG)CV
M8]L]?P''^>]16WFY/E%0?]K\/\\4 0OL\SY48+D?*>O7@?Y_3K4DGD[/DA=&
MR,L>A]^!Z^O_ ->FR>9YOS%2^1C &/\ /IZ'IFIY_M'E#>8RO'3&?Z?IW_"@
M"*'RL'S(G<Y&"O;K_+\ZBRF_.T[=W3O_ )QQ_G%6;?SMK>64QWW8]\_YZ>I%
M0?/YO5=^[KQC.?\ 'VZ>W- #IO)POEQ/'R?O?3V&*='Y.SYHG9N<,.@X_P _
MUI]SY^%\TH1GC;U_H?\ )]\.A\_RCL*!?]K&>G^>OX9H J1[-XW*2N3P.OO_
M (_X]:?-Y>1Y<;1C'1OQ_"B+S/,&TKNR>H&/\XZ^IZXJ2Y\W(\TJ3_L_C_GF
M@!!Y'E#,+[]OW_X1^?\ ]:HX?+W?.C.,=%'..W;_ #GH.]D?:/(X,83;STSC
M\,CZ?_JJ&W\W>?+* X[@8_STQCWQF@".79N^1&1<?=;KC _^OVJ5_(\OB%P^
M!ECTZ<]L_P \XIL_F;_WFW=[8QV_SS^.*L2?:/*Y,>S'3C/3\OKS]: *T/E?
M-YD;2>R_Y_SC\FOL\SA2%R/E/7K_ )_SS4UMYWS>44'^]C_]?K^G&.:CD\SS
M?F*E\CIC;[#T_P#KT .E\G;\D+H<\LW0\CGI_/U_&B'R=IWQ.YSP5'0^O^?P
M]:EN/M&S]X8]OMC/;_ZW0T6_G[#Y93&>=P&?\]/8GKB@"KE/,SM)7)PO?_(_
MSZ5)-Y7'EQ/'_O?CZ#TI!YGG<%=^XY/&,^W^>E2W/GX'FE"/]G\?H: &Q^1L
M^:%V89PP' _3\.WOQ44?E[_F1F7GY1UZ\]N_^<]:M1?:/*^4Q[>>N,_YST_3
M-00^9YGR%=WJ<8ZC_)XZ^AH 2;R\KY<;1C!X;Z_E_GOVDS!Y?^I??M^_CC_/
M?K^M)<^;N7S=I..-O^<_IZ>V9O\ 2/)ZQ[-N.V>G\\<>O;&.: *L7EY.^-G&
M.B]<<X[?Y]J239O^1&1<#ANN/\YJ6W\W<?+* ]\XQW^OX4V?S/-^?;NX^[C'
M^?K[^] #G\CR^(75L#+'H>/\COFF0^5\WF1/)_N]CZ\CTX_KVJQ)]H\H;C'M
MP,8 S_G/7]<5';>=\WE%!Z[O\G_./:@"%MGF'"D+N^Z<Y_ST_P \5)-Y.T;(
MG0YY+#J?7_/X^M-;?YQSMW[NV,?IFI[CS]@\PIC/&T#/^>OL#TS0!%#Y.T[X
MG<YX*C@?IGKS_G-1KL\P94E<_=&<_P">M6;?S]A\LIMSR&QG_./4]?3FH$\S
MS>,;\]^G;\* ";ROE\N-H_9O\_YS^;T\CR^879L'##H./\CMBEN?.^7S2A_W
M<?\ Z_3]>,<U)']H\H[3'MP<Y S_ )ST_3- %6/9O^=&=<'A>N/\XI9?+W?)
M&R#'W6Z^_0=_\YIT'F>;\FW=S][&/\_3V]J6X\W>/,*%L#IC'MZ?C^% "_N/
M+_U3[\#Y_P"'KZ_KUQ3(?+RWF1M(,#A?K^7^>W>P?M'D]4V8'IN__7C\?;'-
M16WF[F\K:#CG=_G/Z>OO@ BD\O?\J,J\?*>O7CMV_P XZU+)Y.SY8G5CCYB.
M#_G_ /5Q39O,\SYRN[U&,=3_ )''7U-3R_:/*^<Q[,#IC)_S[?CB@""'R<-Y
MD3R<C[OT]QBH\IYF=AVY'R]^G]1_A[59MO/PWE% ,\[NO]3_ )'MF$^9YO5=
M^1SQCV_SCI[<T .F\G:-D3H<\EAU/K_G\?6B/R=AWPN[<X8= >>>1Z_R_&I;
MCS]@\PIC/&T#/^>OL#TS1!]H\L["@7G.>N.?K[]>] %9-GF?,C%<GY1UZ\C_
M #^O6G3>5\OEQM'[-_G_ #G\R/S/-^4J'R<Y Q_GU]3UQ4ESYWR^:4/^[C_]
M?I^O&.: $3R/+YA<O@X8=.G';/\ +&:CB\O=\Z,ZXX5>O^>W2K4?VCRN#'LQ
MTXST_+Z<_2H+?S-Y\LJ&QSNQ@_3\?3\,T ,F\O=\B,@QT8<X[]O\XZ'M(WD>
M6<0N'Q][MU^F>GKGI27'F[QYA0G'8#'^>N<^V<5.WVCR3DQ[,>V>OX#C_/>@
M"M#Y>3YD;2#'1?P_"F2;-YVJ0N1P>OM_C_AUJ>V\W)\HJ#_M?A_GBHY?,\P[
MBN[(Z 8_SCIZ'IF@!TGD[/DA=&R,L>A]^!Z^O_UZ(?*P?,B=SD8*]NO\OSJ6
M?[1Y0WF,KQTQG^GZ=_PI+?SMK>64QWW8]\_YZ>I% %;*;\[3MW=._P#G''^<
M5+-Y6!Y<3H<G);OT_G^=,^?S>J[]W7C&<_X^W3VYJ>X\[:OF%,=MN/;'^>GH
M30 R/R=GS1.S<X8=!Q_G^M0Q[-XW*2N3P.OO_C_CUJW#Y_E'84"_[6,]/\]?
MPS5>+S/,&TKNR>H&/\XZ^IZXH )O+R/+C:,8Z-^/X4\>1Y0S"^_;]_\ A'Y_
M_6I;GS<CS2I/^S^/^>:D'VCR.#&$V\],X_#(^G_ZJ *T/E[OG1G&.BCG';M_
MG/0=TEV;OD1D7'W6ZXP/_K]JDM_-WGRR@..X&/\ /3&/?&:2?S-_[S;N]L8[
M?YY_'% #G\CR^(7#X&6/3ISVS_/.*;#Y7S>9&S]/NC_ZW^/3\!8D^T>5R8]F
M.G&>GY?7GZU%;>=\WE%!_O8__7Z_IQCF@"M/)'$2^QM@(RISGJ?\_P#U^*9;
M7EO?.8H+>2-QQO8'';U]/3/]*FG#,Y5RN21Z;>WX< ?IUJU:^79D.[1GV4KD
MYS_+\_I0!C7L[64@C>*1]QP"H.,>^,"M2R3"K/D?[F!D=?;/XFH-0CU"_??9
MA/+')W 9QUXXZ],<]L4ZP5X9 MR1NZ'G ]^I'<T :<VJ2D*J*8^V6&..?\_S
M'//AG[0MU+IWPN\0ZE Y2YBL9G1U/1E4G/'Y=:]\NI-.*KO=,X_A(Z_A^'MB
MO%?CGX=N_%'PYUO2M,'F-<V<T:KRQ.X8' Y]* /X/OVJOBMXS\<?$77O#NI:
ME-<V":A-$L)9\!=^W'7'0X__ %8K]PO^"0'P-\%7VB)>:OHT5S-M63=(BL=P
MYZLIZG].G-?DS^U_^S'X\^&?C+6_&%Y9,EK)?33AVB<#&\'JP(Z<_P#UJ_4G
M_@DS^TQX,\-:;'IOB;5+.RN/EB"RSPPG=]WE78=\4 ?T>V>@Z%HQ6PT73%MB
MBA8\1+M&  O\('_UJOZC+/IMI+_:%O#<H\;;5$"-@%> <@\\TSP_XQ\.^*K:
M/4]'U;3I8I5#(5NH&SD;A]UCV(YK2UC6= M[.>36=:TJV6.-F4SWEO$.%[%W
M&3_DT ?A9^W9^SG<^/;;6?$]FEI;010W$YC:-$;&">  !_\ K]*_GW^ 5G8^
M'/CM/HSH%GM]0$9D& N1(1G_ "?\*_<'_@H+^V#;^$)=7\,Z'J^GW-M,EQ 6
MM[B*5<'</O(Q';UK\)?V:M6LO&7QS?5[V>.4W5^LC")QN.Z5S]T<YH _L)_9
M[G"?#^[EAF!9=+D888D_+ Q_/\N??(K^2#_@I5\2_$"_''6-)FN;Z]L6O)D-
MG!)(69#+@J%5B#D''3\J_KE^ &F6(^'UU!IZRB:33)$02$\LT# 8!Z\U_)9_
MP4>^"/QATCXYZMXWT_2)9=)M[R:X\U[29XMBS;\EMA0C SVH Q/V,?VA=*^!
M.MPZ_8?!OQAK=X729I+32;B[+O\ +\P_<OU(R*_5C6O^"U/Q#TTQ6NC_ +/7
MQ-A4*(U9/"UYC [Y6U]Q^&>M?-?_  3!_:?\./XLM/#WQ"LO#(6UEB@D%Y:6
M(Y4HC ^<GKG/O7]7'AF^^"/C'3(+C1=(\ RNT$; M9:0QW%1Z1^_YT ?SW>%
MO^"POQCU6[C?4O@E\2!:.0#&_AR\4X)_VK?W'^17'_'/_@H5K/C_ $V2WE^
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M#^+O#>E0Z+K.F&;[);J5^UV^0?+7.=K<<GZBO3[K5D$PEDUS2XX0<L7O85&
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M88ST/X5^F?PD^._PW^(_AJQ\3^%/#?V*QO;=9X5_LV.!PC*&'"Q+@C</\XR
M?BU_P5NT_1K[2H&UFV>61H$W<D8;;&>?Q[5^%G[,W@GP9>?%O0T%DFQ]1B^5
M]I/^L7CD9_']*_=__@JSJ.F>((\+&\2X _> I@90=#C' ]_2OQK_ &8O#&D+
M\5]"E20^:-0B(Q(,9\Q>V<]<?_KYH _M ^ /@'PGHG@'0+JRTJ$2?8+=B1%&
M23L!S]WZ5ZGXGUZSM+&XM_[+8H8RF5@&,8(/1?Z?XUQ'PDO9=*^'6@;B#&MA
M !QG@1C_  ]_\/1+V^BU71KTI&A<P2 %E4G.PX[>M '\]/\ P4DT_1;GP1X@
MO(+2&.X:*=C^[0.&V.W]W.?Z_I^)_P#P3[\-:-K7Q!O4UFT$J#4I HE"X_UK
M#C((]O\ /'[0?\%'-(UI- \02M(@M=DYVEAC&V0=_;_/:OR _80!'CNY$8+L
M-1?/E\]9F_N]<].>U ']B/[.W@7P?IGABVFM=+B&R-"-J(>BY[+[U]06^IZ<
MXELXK *$1ADQ#' ^G3'2O OV9_\ D4+;SD< PQ9W@]@/7T_(U]%L=/C,Y1/G
MVL"<>WM]/SH _EZ_X*^7L5IKK^7:J29"1MB7/7V P?K7YJ_L.^(KZ;XP:#$L
M$ZQF]B'"$+_K8_;L/_U5^E?_  5XU"V7Q$5:)F_?8^[GJ3USVX_'L:^"_P!A
MIK:7XHZ"R+$I-U!U"YSYL7MF@#^DS]H_Q)XLTCX4Z=)H.KIISG282Q=BO6W'
MN#G/X>V:_C-_:Q^*^KCXO0KXBMM1\17']HX/V,22ASYG95W<'Z>GUK^U7X__
M  -\:?%7X7V$7AB6)'&E1YWOM'%O[$<\U_'9^U7X3UWX#_&NT_X2_2);V6VU
M3>TR6C3P 1OG+,49<>Y- 'V;^S]^U%J/PP\.:5K6C?!/QI>S1P1LLMOH5Q/O
M*J&!#" Y'XU]AVO_  6A^)FC1K;'X!_$TB,;%\GPU>   8'W;?Z_3UXQ7LO[
M G[9/PT\7:7X?\'ZGI_A2+;#;0.E]9Z<K@D $-YJ9ST[?GFOW=L]"^$VK6,-
MQ8Z-X#N&EC5\I9:2_+#/\,9]: /YQ%_X+&_%777$2_ SXE1)(?\ EMX:O#QG
M'.;<>I[=Z^/?VKOVK?&7QPT![75/@7X^N?-C8;4\/72D,V?[L&?XJ_K9O?"O
MA:UG:1-&\ V]N/XGL=)0 9SGF,#IZ5\Y_'#]IS]G/]GO2SJ/CS3_  7>Q(K$
MQ6%MI,[C;R1L5&.>/_U4 ?Q7_!D?M,Z;\0-%'@7X?>-_#FBMJ5N98[G1[]%$
M33*6W$QH.!Z^]?VD?!O5=7'P"T@^/+2Z&H'3D^T"XC>)PWD)ORK\CG-?./@C
M_@IU^RIX\U&"#PCX-LOGF1%>+0[/ABP (9+<8'/J*^VO$OQ"T#XA> O-T:PD
MM(I[8E%6W\E5#)QPJJ!P?\XH _E8_P""I[Z)J.JK%I6+<O<A7#/U!=,_U_G7
MM7_!-CX#^#M4L=$UJ_TI+N\62"03D*PR&))Y7O\ B>_:OG;_ (*>:)::3K4,
MMY(R[KI2,.1_RT4C//N>WM7Z#_\ !+PW$GA'1C:-$8-MO]X@MC:?QZ?E0!_1
MSX4&D>%?"FG0VVE1O'#;1HJ10(6 "C R%!_&M6\U"R\1:+>QRZ:88'@E#I+"
M%)4H<]5ST/OZU?\ #,3-HEKD1LWDIPP!7I_M#'7I_G+==344TZY\H0K&(I2V
MQ0. IZ8'^<T ?S5_\%*/A3\+HM"\2:M'H835O+G?SUVCYR)6!P%SU.>N:_*[
M_@FE<K8_$>[AB68Q+J+JBH3P/.( X]./\BOV:_X*.C3&\(>(OM2.TQBN =@[
MJL@[9_SBOQB_X)Y:I;Z;\2+QK6WE!_M.7EXS_P ]F[D?4?YX /[+_AO<QS?#
MZ1WB<#[&IP^2?N\]?3!_IWK^?O\ X*?SVC>'-86UC6&8-/\ ,P !/!^GT]^E
M?OS\(;B?6OA^P50CO9@ %0.2O<$>O?\ _77X+?\ !57P5JNG^$=7O9I83$WG
ML KJ#T&>^>W]* /BS_@F&M^VH?O72=3=#&Q0<#S,]B?3_"O["?@^MNOA:U\V
MW0MY*?P#=]SUV^OYU_&;_P $P?$LNEZIY2W5M&!= $S.H_Y:>K&O[(?@KK-G
M?^%[,G4+)YVBC 5)XR?N*?NAOY__ %Z /5;KR/\ EG"\?/\ $..IQV_SCGUJ
M.+R=OSPNYSPR]!R>>G\O3\:GNQ<'ERC)V*X((Y[_ )_S'2FV_P!HV?NS'M]\
M9[__ %^IH K)L\SE25R?E'7K_G_/-.F\KY?+C:/V;_/^<_F1^9YORE0^3UQM
M]QZ?_7J2Y\[Y?-*'_=Q_^OT_7C'- ")Y'E\PN7P<,.G3CMG^6,U%%LW?.C.N
M/NKUQ@__ %NU6X_M'E<&/9CIQGI^7TY^E5X/,W_N]N[WQCO_ )X_#- #9O+W
M?(C(,=&'.._;_..A[2'R/*.(7W[?O_PG\O\ Z])<>;O'F%"<=@,?YZYS[9Q4
MQ^T>1R8RFWCIG'XX'U__ %T 5X?+R?,C:08Z+^'X4R39O.U2%R.#U]O\?\.M
M3VWFY/E%0?\ :_#_ #Q4<OF>8=Q7=D= ,?YQT]#TS0 ^3R=GR0NC<98]#P>>
M/?U]:2'RL'S(G<Y&"O;K_+\ZFF^T>4-Y0KQ]WKC'^>E-M_.VMY93'?=CWS_G
MIZD4 5LIOSM.W=T[_P"<<?YQ4LWE8'EQ.AR<EN_3^?YTSY_-ZKOW=>,9S_C[
M=/;FI[CSMJ^84QVVX]L?YZ>A- $<?D[/GA=VR<,.@]^1Z^G_ ->HH]F\;E)7
M)X'7W_Q_QZU:@^T>4=AC"\]<9_K^O?\ &H(O,\P;2N[)Z@8_SCKZGKB@ F\O
M(\N-HQCHWX_A3U\CRQF%R^/O=NOTST],=:6Y\W(\TJ3_ +/X_P">:E7[1Y(P
M8]F/;/7\1S_GM0!5A\O=\Z,XQT4<X[=O\YZ#N2^7N^1&1<<JW7_/;I3[?S=Y
M\LH#CN!C_/3&/?&:+CS-X\PJ6QQMQ@?7\?7\<4 *_D>7Q"X? RQZ=.>V?YYQ
M3(?*^;S(VD]E_P _YQ^5F3[1Y7)CV8Z<9Z?E]>?K45MYWS>44'^]C_\ 7Z_I
MQCF@"%]GF?*C!<CY3UZ\#_/Z=:DD\G8-D+HW&6/0GCG@>O\ /\:;)YGF_,5+
MY&, 8_SZ>AZ9J>?[1Y8WE"O&,=<<?3VZ=Z (H?)VG?$[G/!4=#Z_Y_#UJ+*>
M9G8=N3\O?I_0?X>U6K?S]A\LIC/.X#/^>GL3UQ4 \SS>J[\GGC'O_G'3VYH
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MIL_F>;\^W=Q]W&/\_7W]ZGD^T>4-QCVX&, 9_P YZ_KB@"O#Y7S>9&TGLO\
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M_.@!DOE!OW;,RXZMG.._4]O\D=Y6%OY9(DDWX^Z<X_GCIUZ=^E-GWEP6C"'
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MU(=S,B$GE<AN<GIGK^M68#(%.V%7!/7O_GO^/%0C=YO^K&[)^3M_AUX]/QH
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M=!ETZ!I0QEM+EHF4;B>-N.G].M?VI3W&FP$"2\8N,  G.3S_ #QVYI\>H+(
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M_;A_99^,7QA\*ZQIW@O2XKNXNXI!$OF;2V]6QT!/5A7YC_L5_P#!-O\ :O\
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M>RR^6&_=LS+CDMG/Z_XTZ#>')6,.<'@YX^GT_KSQ1.7+@M&$..%'?Z]_;^5
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M/X^M/@+AR5B#G!X/;UQGT_/GFDF+&3YHPAX^7M_G_/3% #G$'EY61RY R#G
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M/DSG'?'3CIC\.W6B 94_Z1Y7/3.,YSQ^..G%)*T93"P,AR/F/_U_\_CBDA*
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MCSG IWVF0-M4%4!_U?\ G_#MZ43,A&5A*'."3_GZ?7''>@"4Z]:0CRO+2,]
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M?_/3_'-D*[_EC*#^[TZG_)]_>II#'LPL#*W'S'M_G_\ 7S0!1BU2:[^40-:
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M\#110 ?:I7 0XQ_AT_+M0MP\/W,<^M%% #?-9CYAQNY/MQFG-<R2_*V, ?\
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M0 \W<K#RSC R.G/ --6X>'[F.<]?\^]%% ">:SD.?O9S3C=22C8V, ?X444
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M20!&QMY^O0_RHHH %N9(>$Q@CN/<TGF-GS.^,_U_GS110 K7,DV%?& /\/\
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# /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 0V!WP# 2(  A$! Q$!_\0
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MQ:;[(5++Y?<9^;\OO=/\XI9FF,$09E*@KM .2#D8R!SUQG/X\U%\GD?<??\
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MADV;8MJ.#CYLG(;_ '>F/U^M.DV>:F$<+A<@G)/K@X'UZ?G0!8=Y_M2,63S
MIP01MQQU/3/3KSZ=J$>?[4[!D\PJ,DD;<<]#TSUZ<^O>H6$?G+B.0+CE2?F/
MT/\ ];OUH41^<V8Y"N.%!^8?4_\ UNW6@"6%I@\^QD!)._) !X[9X/&.G'Z5
M'"TH2?:R@$8?<1DC/\.>3SCIS^E)&(]TNZ-R,_+@X*_[W!S]>/I4<>S;+N1R
M<?+@X"_[W7/Z?6@"1&E^S. R["P)!(W9[8'7UZ<?K0[2_9D!9=@8D $;L]\C
MKZ=>/TJ-=ODME&+9X8'Y1]1C^O:AMODKA&#9Y8GY3]!C^O>@">9IC!$&92H*
M[0#D@Y&,@<]<9S^/-.F:8O!O9"01LP00..^.!QGKQ^M02!/*3".&RN2>0?7
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M]TNZ-R,_+@X*_P"]P<_7CZ5''LVR[D<G'RX. O\ O=<_I]: )$:7[,X#+L+
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M0$D[\D 'CMG@\8Z<?I42B/SFS'(5QPH/S#ZG_P"MVZT1B/=+NC<C/RX."O\
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MH D#3?9 H9?+[#/S?E][I_G%-=I?LR LNP,2 "-V>^1U].O'Z4WY/(^X^_\
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M;VX&>>G\^:>H;[0X\@$[1^[YPOOZ_F<<?2F1 ^=(!"'.&^3GY??@YXZ_SYH
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M.O\ /FBW!/F8A$GY_+U],?YZ4 $1(AD F"#+93^][\<<]>OUXHR?LV/-&/\
MGEWZ]/3]?UHB!\F3$(<9;+_W?;CCCIT^O%&#]FSY0Q_SU[]>OI^GZT $I/DI
MF8../DY^7C\OR_#BFRD[8<RA\#@<_)[<\>_&13I01"A,(0<?/S\W'Y?E^'%-
ME!"PYB"9'!Y^?WYX]N,"@!TI/G1YF#G"_/S\OMR,\=/Y<T9/VG/G#/\ SUYQ
MT_/]/THE!\Z,&$(<+\G/S>_)SSU_ES1@_:<>2,_\\N<=/S_7]* 'J6^T.?/
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MF4/@<#GY/;GCWXR*=*"(4)A"#CY^?FX_+\OPXILH(6',03(X//S^_/'MQ@4
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M/G/B8(>?GY^;G\_S_'FEPWVG'D#.?]5SCITZY_7]*2('SG A#GGY.?EY_/\
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MD_3KS[4LV_9#NV8Q\NW&?^!8YS_O<TZ7S/.CSY><+C;MV_\  L?+G'7/X\4
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M-^3S_OOL_OX^;IZ9_K[^U3-YGVA,^5NVG&-NS\?X<].O/IVIG[S[5_RSW_\
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M^T)GRMVTXQMV?C_#GIUY].U"^9]H?'E;MHSG;L_#^'/7ISZ]Z (X_+W2[I'
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M,.Y7"Y)&"/7 R?IUY]J6;?LAW;,8^7;C/_ L<Y_WN:=+YGG1Y\O.%QMV[?\
M@6/ESCKG\>* $8Q^<N))"N.6(^8?0?\ U^W2A3'YS9DD"XX8#YC]1_\ 7[]*
MD;S/M"9\K=M.,;=GX_PYZ=>?3M0OF?:'QY6[:,YV[/P_ASUZ<^O>@"./R]TN
MZ1P,_+@9+?[W(Q].?K4<>S;+N=P<?+@9#?[W3'UY^E3P^9OFV^7G/S;MN/\
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MW'F@#</W?.6]_3\SGGZ4 'R>1]Q]_P#>S\O7T_\ K_X42!/*3".&RN2>0?7
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M]* !1'YS9CD*XX4'YA]3_P#6[=:(Q'NEW1N1GY<'!7_>X.?KQ]*>I;[0Y\\
M[1^\YPWMZ_F,<_2DB+!IL3A,GD\_/[\<^W.#0!'&$\I\HY;+8(X ],CGZ=>?
M:FKM\ELHQ;/# _*/J,?U[5)$2(9 )@@RV4_O>_''/7K]>*:I/V=QYH W#]WS
MEO?T_,YY^E #6V^2N$8-GEB?E/T&/Z]Z)-FV+:C@X^;)R&_W>F/U^M.8G[.@
M\T$;C^[YROOZ?D<\?6B4G;#F4/@<#GY/;GCWXR* '2"/=%MC<#/S9.2W^[P,
M?7GZ4,(_.7$<@7'*D_,?H?\ ZW?K3I2Q:',X?!X//R>_//MQDTK%OM"'SP3M
M/[SG"^WK^0QQ]: &*(_.;,<A7'"@_,/J?_K=NM-CV>:^4<KAL '!'IDX/UZ?
ME4JEOM#GSP#M'[SG#>WK^8QS]*9$3YTF)@APWS\_-[<#//3^?- $<>S;+N1R
M<?+@X"_[W7/Z?6A=ODME&+9X8'Y1]1C^O:G1$[9L2A,CD<_/[<<>_.!0I/V=
MQYH W#]WSEO?T_,YY^E !\GD?<??_>S\O7T_^O\ X42!/*3".&RN2>0?7 X^
MG7CWIV3]FQYPQ_SR[]?R_7]:)23#&#,'&5PG]WWYXXZ]?IQ0 V;9\FU'7UW'
M.>G3IU_SBB39YJ81PN%R"<D^N#@?7I^=.N"3Y>9A)^?R]/7'^>M$I/G1YF#G
M"_/S\OMR,\=/Y<T -^3[1_JWV?W,_/T]<?AT_P :(]GFON1V7G"@_,.>Y_S_
M $I^6^TY\\9S_KN<=.O3/Z?I21$^<^)@AY^?GYN?S_/\>: ",1[I=T;D9^7!
MP5_WN#GZ\?2FQA/*?*.6RV". /3(Y^G7GVJ2(L&FQ.$R>3S\_OQS[<X--B)$
M,@$P09;*?WO?CCGKU^O% #?D\C[C[_[V?EZ^G_U_\*:VWR5PC!L\L3\I^@Q_
M7O4F3]FQYPQ_SR[]?R_7]::Q/V=!YH(W']WSE??T_(YX^M #9-FV+:C@X^;)
MR&_W>F/U^M.DV>:F$<+A<@G)/K@X'UZ?G1*3MAS*'P.!S\GMSQ[\9%.E)\Z/
M,P<X7Y^?E]N1GCI_+F@ 81^<N(Y N.5)^8_0_P#UN_6A1'YS9CD*XX4'YA]3
M_P#6[=:>Q;[0A\\$[3^\YPOMZ_D,<?6A2WVASYX!VC]YSAO;U_,8Y^E #(Q'
MNEW1N1GY<'!7_>X.?KQ]*CCV;9=R.3CY<' 7_>ZY_3ZU-$6#38G"9/)Y^?WX
MY]N<&HXB=LV)0F1R.?G]N./?G H :NWR6RC%L\,#\H^HQ_7M0VWR5PC!L\L3
M\I^@Q_7O3E)^SN/- &X?N^<M[^GYG//TH8G[.@\T$;C^[YROOZ?D<\?6@ D"
M>4F$<-E<D\@^N!Q].O'O3I!'NBVQN!GYLG);_=X&/KS]*)23#&#,'&5PG]WW
MYXXZ]?IQ3I2Q:',X?!X//R>_//MQDT -81^<N(Y N.5)^8_0_P#UN_6F_)Y_
MW'V?W<_-T]<?T_QJ5BWVA#YX)VG]YSA?;U_(8X^M,R?M.?.&?^>O..GY_I^E
M #8]GFOE'*X; !P1Z9.#]>GY40[/GW([>FTXQUZ]>G^<TZ(GSI,3!#AOGY^;
MVX&>>G\^:+<D>9B81_G\W7TS_GI0 V,)Y3Y1RV6P1P!Z9'/TZ\^U&$^S_<??
M_?\ X.OI^O7_  IT1(AD F"#+93^][\<<]>OUXHR?LV/-&/^>7?KT]/U_6@!
MLFSRDVHX;C+$_*>.P_S^/6FR;-L6U'!Q\V3D-_N],?K]:DE)\E,S!QQ\G/R\
M?E^7X<4V4G;#F4/@<#GY/;GCWXR* "39YJ81PN%R"<D^N#@?7I^='R>?]Q]G
M]W/S=/7']/\ &G2D^='F8.<+\_/R^W(SQT_ES1D_:<^<,_\ /7G'3\_T_2@
M41^<V8Y"N.%!^8?4_P#UNW6B,1[I=T;D9^7!P5_WN#GZ\?2GJ6^T.?/ .T?O
M.<-[>OYC'/TI(BP:;$X3)Y//S^_'/MS@T 1QA/*?*.6RV". /3(Y^G7GVIJ[
M?);*,6SPP/RCZC']>U21$B&0"8(,ME/[WOQQSUZ_7BFJ3]G<>: -P_=\Y;W]
M/S.>?I0 UMODKA&#9Y8GY3]!C^O>B39MBVHX./FR<AO]WIC]?K3F)^SH/-!&
MX_N^<K[^GY'/'UHE)VPYE#X' Y^3VYX]^,B@!T@CW1;8W S\V3DM_N\#'UY^
ME#"/SEQ'(%QRI/S'Z'_ZW?K3I2Q:',X?!X//R>_//MQDTK%OM"'SP3M/[SG"
M^WK^0QQ]: &*(_.;,<A7'"@_,/J?_K=NM-CV>:^4<KAL '!'IDX/UZ?E4JEO
MM#GSP#M'[SG#>WK^8QS]*9$3YTF)@APWS\_-[<#//3^?- $<>S;+N1R<?+@X
M"_[W7/Z?6G1[/*?<CEN<,#\HX[C_ #^'6B(G;-B4)D<CGY_;CCWYP*=$3Y+X
MF"#GY.?FX_+\_P >* &X3[/]Q]_]_P#@Z^GZ]?\ "B0)Y281PV5R3R#ZX''T
MZ\>].R?LV/-&/^>7?KT]/U_6B4DPQ@S!QE<)_=]^>..O7Z<4 -FV?)M1U]=Q
MSGITZ=?\XHDV>:F$<+A<@G)/K@X'UZ?G3K@D^7F82?G\O3UQ_GK1*3YT>9@Y
MPOS\_+[<C/'3^7- #?D^T?ZM]G]S/S]/7'X=/\:(]GFON1V7G"@_,.>Y_P _
MTI^6^TY\\9S_ *[G'3KTS^GZ4D1/G/B8(>?GY^;G\_S_ !YH (Q'NEW1N1GY
M<'!7_>X.?KQ]*;&$\I\HY;+8(X ],CGZ=>?:I(BP:;$X3)Y//S^_'/MS@TV(
MD0R 3!!ELI_>]^..>O7Z\4 -^3R/N/O_ +V?EZ^G_P!?_"FMM\E<(P;/+$_*
M?H,?U[U)D_9L><,?\\N_7\OU_6FL3]G0>:"-Q_=\Y7W]/R.>/K0 V39MBVHX
M./FR<AO]WIC]?K3I-GFIA'"X7()R3ZX.!]>GYT2D[8<RA\#@<_)[<\>_&13I
M2?.CS,'.%^?GY?;D9XZ?RYH &$?G+B.0+CE2?F/T/_UN_6A1'YS9CD*XX4'Y
MA]3_ /6[=:>Q;[0A\\$[3^\YPOMZ_D,<?6A2WVASYX!VC]YSAO;U_,8Y^E #
M(Q'NEW1N1GY<'!7_ 'N#GZ\?2HX]FV7<CDX^7!P%_P![KG]/K4T18--B<)D\
MGGY_?CGVYP:CB)VS8E"9'(Y^?VXX]^<"@!J[?);*,6SPP/RCZC']>U#;?)7"
M,&SRQ/RGZ#']>].4G[.X\T ;A^[YRWOZ?F<\_2AB?LZ#S01N/[OG*^_I^1SQ
M]: "0)Y281PV5R3R#ZX''TZ\>].D$>Z+;&X&?FR<EO\ =X&/KS]*)23#&#,'
M&5PG]WWYXXZ]?IQ3I2Q:',X?!X//R>_//MQDT 1R;/-3:CJO&5)^8\]C_G^E
M'R?:/]6^S^YGY^GKC\.G^-.E)\Y,S!SQ\_/R\_G^7X<TN6^TY\\9S_KN<=.O
M3/Z?I0 R/9YKY1RN&P <$>F3@_7I^5$.SY]R.WIM.,=>O7I_G-.B)\Z3$P0X
M;Y^?F]N!GGI_/FBW)'F8F$?Y_-U],_YZ4 -C">4^4<MEL$< >F1S].O/M1A/
ML_W'W_W_ .#KZ?KU_P *=$2(9 )@@RV4_O>_''/7K]>*,G[-CS1C_GEWZ]/3
M]?UH ;)L\I-J.&XRQ/RGCL/\_CUILFS;%M1P<?-DY#?[O3'Z_6I)2?)3,P<<
M?)S\O'Y?E^'%-E)VPYE#X' Y^3VYX]^,B@ DV>:F$<+A<@G)/K@X'UZ?G1\G
MG_<?9_=S\W3UQ_3_ !ITI/G1YF#G"_/S\OMR,\=/Y<T9/VG/G#/_ #UYQT_/
M]/TH %$?G-F.0KCA0?F'U/\ ];MUHC$>Z7=&Y&?EP<%?][@Y^O'TIZEOM#GS
MP#M'[SG#>WK^8QS]*2(L&FQ.$R>3S\_OQS[<X- $<83RGRCELM@C@#TR.?IU
MY]J:NWR6RC%L\,#\H^HQ_7M4D1(AD F"#+93^][\<<]>OUXIJD_9W'F@#</W
M?.6]_3\SGGZ4 -;;Y*X1@V>6)^4_08_KWHDV;8MJ.#CYLG(;_=Z8_7ZTYB?L
MZ#S01N/[OG*^_I^1SQ]:)2=L.90^!P.?D]N>/?C(H =((]T6V-P,_-DY+?[O
M Q]>?I0PC\Y<1R!<<J3\Q^A_^MWZTZ4L6AS.'P>#S\GOSS[<9-*Q;[0A\\$[
M3^\YPOMZ_D,<?6@!BB/SFS'(5QPH/S#ZG_ZW;K38]GFOE'*X; !P1Z9.#]>G
MY5*I;[0Y\\ [1^\YPWMZ_F,<_2F1$^=)B8(<-\_/S>W SST_GS0!''LVR[D<
MG'RX. O^]US^GUIT>SRGW(Y;G# _*..X_P _AUHB)VS8E"9'(Y^?VXX]^<"G
M1$^2^)@@Y^3GYN/R_/\ 'B@!N$^S_<??_?\ X.OI^O7_  HD">4F$<-E<D\@
M^N!Q].O'O3LG[-CS1C_GEWZ]/3]?UHE),,8,P<97"?W??GCCKU^G% #9MGR;
M4=?7<<YZ=.G7_.*)-GFIA'"X7()R3ZX.!]>GYTZX)/EYF$GY_+T]<?YZT2D^
M='F8.<+\_/R^W(SQT_ES0 WY/M'^K?9_<S\_3UQ^'3_&B/9YK[D=EYPH/S#G
MN?\ /]*?EOM.?/&<_P"NYQTZ],_I^E)$3YSXF"'GY^?FY_/\_P >: ",1[I=
MT;D9^7!P5_WN#GZ\?2FQA/*?*.6RV". /3(Y^G7GVJ2(L&FQ.$R>3S\_OQS[
M<X--B)$,@$P09;*?WO?CCGKU^O% #?D\C[C[_P"]GY>OI_\ 7_PIK;?)7",&
MSRQ/RGZ#']>]29/V;'G#'_/+OU_+]?UIK$_9T'F@C<?W?.5]_3\CGCZT -DV
M;8MJ.#CYLG(;_=Z8_7ZTZ39YJ81PN%R"<D^N#@?7I^=$I.V',H? X'/R>W/'
MOQD4Z4GSH\S!SA?GY^7VY&>.G\N: !A'YRXCD"XY4GYC]#_];OUH41^<V8Y"
MN.%!^8?4_P#UNW6GL6^T(?/!.T_O.<+[>OY#''UH4M]H<^> =H_><X;V]?S&
M.?I0 R,1[I=T;D9^7!P5_P![@Y^O'TJ./9MEW(Y./EP<!?\ >ZY_3ZU-$6#3
M8G"9/)Y^?WXY]N<&HXB=LV)0F1R.?G]N./?G H :NWR6RC%L\,#\H^HQ_7M3
MOD\C[C[_ .]GY>OI_P#7_P *%)^SN/- &X?N^<M[^GYG//TIV3]FQYPQ_P \
MN_7\OU_6@!L@3RDPCALKDGD'UP./IUX]Z=((]T6V-P,_-DY+?[O Q]>?I1*2
M88P9@XRN$_N^_/''7K].*=*6+0YG#X/!Y^3WYY]N,F@".39YJ;4=5XRI/S'G
ML?\ /]*/D^T?ZM]G]S/S]/7'X=/\:=*3YR9F#GCY^?EY_/\ +\.:7+?:<^>,
MY_UW..G7IG]/TH 9'L\U\HY7#8 ."/3)P?KT_*B'9\^Y';TVG&.O7KT_SFG1
M$^=)B8(<-\_/S>W SST_GS1;DCS,3"/\_FZ^F?\ /2@!L83RGRCELM@C@#TR
M.?IUY]J,)]G^X^_^_P#P=?3]>O\ A3HB1#(!,$&6RG][WXXYZ]?KQ1D_9L>:
M,?\ /+OUZ>GZ_K0 V39Y2;4<-QEB?E/'8?Y_'K39-FV+:C@X^;)R&_W>F/U^
MM22D^2F9@XX^3GY>/R_+\.*;*3MAS*'P.!S\GMSQ[\9% !)L\U,(X7"Y!.2?
M7!P/KT_.CY//^X^S^[GYNGKC^G^-.E)\Z/,P<X7Y^?E]N1GCI_+FC)^TY\X9
M_P">O..GY_I^E  HC\YLQR%<<*#\P^I_^MVZT1B/=+NC<C/RX."O^]P<_7CZ
M4]2WVASYX!VC]YSAO;U_,8Y^E)$6#38G"9/)Y^?WXY]N<&@".,)Y3Y1RV6P1
MP!Z9'/TZ\^U-7;Y+91BV>&!^4?48_KVJ2(D0R 3!!ELI_>]^..>O7Z\4U2?L
M[CS0!N'[OG+>_I^9SS]* &MM\E<(P;/+$_*?H,?U[T2;-L6U'!Q\V3D-_N],
M?K]:<Q/V=!YH(W']WSE??T_(YX^M$I.V',H? X'/R>W/'OQD4 .D$>Z+;&X&
M?FR<EO\ =X&/KS]*&$?G+B.0+CE2?F/T/_UN_6G2EBT.9P^#P>?D]^>?;C)I
M6+?:$/G@G:?WG.%]O7\ACCZT 1?)Y_W'V?W<_-T]<?T_QHCV>:^4<KAL '!'
MIDX/UZ?E3LG[3GSAG_GKSCI^?Z?I1$3YTF)@APWS\_-[<#//3^?- $<>S;+N
M1R<?+@X"_P"]US^GUIT>SRGW(Y;G# _*..X_S^'6B(G;-B4)D<CGY_;CCWYP
M*=$3Y+XF"#GY.?FX_+\_QXH ;A/L_P!Q]_\ ?_@Z^GZ]?\*) GE)A'#97)/(
M/K@<?3KQ[T[)^S8\T8_YY=^O3T_7]:)23#&#,'&5PG]WWYXXZ]?IQ0 V;9\F
MU'7UW'.>G3IU_P XHDV>:F$<+A<@G)/K@X'UZ?G3K@D^7F82?G\O3UQ_GK1*
M3YT>9@YPOS\_+[<C/'3^7- #?D^T?ZM]G]S/S]/7'X=/\:(]GFON1V7G"@_,
M.>Y_S_2GY;[3GSQG/^NYQTZ],_I^E)$3YSXF"'GY^?FY_/\ /\>: ",1[I=T
M;D9^7!P5_P![@Y^O'TIL83RGRCELM@C@#TR.?IUY]JDB+!IL3A,GD\_/[\<^
MW.#38B1#(!,$&6RG][WXXYZ]?KQ0 WY/(^X^_P#O9^7KZ?\ U_\ "FMM\E<(
MP;/+$_*?H,?U[U)D_9L><,?\\N_7\OU_6FL3]G0>:"-Q_=\Y7W]/R.>/K0 V
M39MBVHX./FR<AO\ =Z8_7ZTZ39YJ81PN%R"<D^N#@?7I^=$I.V',H? X'/R>
MW/'OQD4Z4GSH\S!SA?GY^7VY&>.G\N: !A'YRXCD"XY4GYC]#_\ 6[]:%$?G
M-F.0KCA0?F'U/_UNW6GL6^T(?/!.T_O.<+[>OY#''UH4M]H<^> =H_><X;V]
M?S&.?I0 R,1[I=T;D9^7!P5_WN#GZ\?2HX]FV7<CDX^7!P%_WNN?T^M31%@T
MV)PF3R>?G]^.?;G!J.(G;-B4)D<CGY_;CCWYP* &KM\ELHQ;/# _*/J,?U[4
M[Y/(^X^_^]GY>OI_]?\ PH4G[.X\T ;A^[YRWOZ?F<\_2G9/V;'G#'_/+OU_
M+]?UH ;($\I,(X;*Y)Y!]<#CZ=>/>G2"/=%MC<#/S9.2W^[P,?7GZ42DF&,&
M8.,KA/[OOSQQUZ_3BG2EBT.9P^#P>?D]^>?;C)H CDV>:FU'5>,J3\QY['_/
M]*/D^T?ZM]G]S/S]/7'X=/\ &G2D^<F9@YX^?GY>?S_+\.:7+?:<^>,Y_P!=
MSCIUZ9_3]* &1[/-?*.5PV #@CTR<'Z]/RHAV?/N1V]-IQCKUZ]/\YIT1/G2
M8F"'#?/S\WMP,\]/Y\T6Y(\S$PC_ #^;KZ9_STH ;&$\I\HY;+8(X ],CGZ=
M>?:C"?9_N/O_ +_\'7T_7K_A3HB1#(!,$&6RG][WXXYZ]?KQ1D_9L>:,?\\N
M_7IZ?K^M #9-GE)M1PW&6)^4\=A_G\>M-DV;8MJ.#CYLG(;_ '>F/U^M22D^
M2F9@XX^3GY>/R_+\.*;*3MAS*'P.!S\GMSQ[\9% !)L\U,(X7"Y!.2?7!P/K
MT_.CY//^X^S^[GYNGKC^G^-.E)\Z/,P<X7Y^?E]N1GCI_+FC)^TY\X9_YZ\X
MZ?G^GZ4 "B/SFS'(5QPH/S#ZG_ZW;K1&(]TNZ-R,_+@X*_[W!S]>/I3U+?:'
M/G@':/WG.&]O7\QCGZ4D18--B<)D\GGY_?CGVYP: (XPGE/E'+9;!' 'ID<_
M3KS[4U=ODME&+9X8'Y1]1C^O:I(B1#(!,$&6RG][WXXYZ]?KQ35)^SN/- &X
M?N^<M[^GYG//TH :VWR5PC!L\L3\I^@Q_7O3I GE)A'#97)/(/K@<?3KQ[T,
M3]G0>:"-Q_=\Y7W]/R.>/K3I23#&#,'&5PG]WWYXXZ]?IQ0 2"/=%MC<#/S9
M.2W^[P,?7GZ4,(_.7$<@7'*D_,?H?_K=^M.E+%H<SA\'@\_)[\\^W&32L6^T
M(?/!.T_O.<+[>OY#''UH B^3S_N/L_NY^;IZX_I_C1'L\U\HY7#8 ."/3)P?
MKT_*G9/VG/G#/_/7G'3\_P!/THB)\Z3$P0X;Y^?F]N!GGI_/F@"./9MEW(Y.
M/EP<!?\ >ZY_3ZTZ/9Y3[D<MSA@?E''<?Y_#K1$3MFQ*$R.1S\_MQQ[\X%.B
M)\E\3!!S\G/S<?E^?X\4 -PGV?[C[_[_ /!U]/UZ_P"%$@3RDPCALKDGD'UP
M./IUX]Z=D_9L>:,?\\N_7IZ?K^M$I)AC!F#C*X3^[[\\<=>OTXH ;-L^3:CK
MZ[CG/3ITZ_YQ1)L\U,(X7"Y!.2?7!P/KT_.G7!)\O,PD_/Y>GKC_ #UHE)\Z
M/,P<X7Y^?E]N1GCI_+F@!OR?:/\ 5OL_N9^?IZX_#I_C1'L\U]R.R\X4'YAS
MW/\ G^E/RWVG/GC.?]=SCIUZ9_3]*2(GSGQ,$//S\_-S^?Y_CS0 1B/=+NC<
MC/RX."O^]P<_7CZ4V,)Y3Y1RV6P1P!Z9'/TZ\^U21%@TV)PF3R>?G]^.?;G!
MIL1(AD F"#+93^][\<<]>OUXH ;\GD?<??\ WL_+U]/_ *_^%-;;Y*X1@V>6
M)^4_08_KWJ3)^S8\X8_YY=^OY?K^M-8G[.@\T$;C^[YROOZ?D<\?6@!LFS;%
MM1P<?-DY#?[O3'Z_6G2;/-3".%PN03DGUP<#Z]/SHE)VPYE#X' Y^3VYX]^,
MBG2D^='F8.<+\_/R^W(SQT_ES0 ,(_.7$<@7'*D_,?H?_K=^M"B/SFS'(5QP
MH/S#ZG_ZW;K3V+?:$/G@G:?WG.%]O7\ACCZT*6^T.?/ .T?O.<-[>OYC'/TH
M BCV>:^4<KAL '!'IDX/UZ?E38]FV7<CDX^7!P%_WNN?T^M21$^=)B8(<-\_
M/S>W SST_GS38B=LV)0F1R.?G]N./?G H :NWR6RC%L\,#\H^HQ_7M3OD\C[
MC[_[V?EZ^G_U_P#"A2?L[CS0!N'[OG+>_I^9SS]*=D_9L><,?\\N_7\OU_6@
M!L@3RDPCALKDGD'UP./IUX]Z=((]T6V-P,_-DY+?[O Q]>?I1*288P9@XRN$
M_N^_/''7K].*=*6+0YG#X/!Y^3WYY]N,F@".39YJ;4=5XRI/S'GL?\_TH^3[
M1_JWV?W,_/T]<?AT_P :=*3YR9F#GCY^?EY_/\OPYI<M]ISYXSG_ %W..G7I
MG]/TH 9'L\U\HY7#8 ."/3)P?KT_*JC9W'!"CT)&1^E78B?.DQ,$.&^?GYO;
M@9YZ?SYJD_WCD%_]K+<_I0!?G+>8G^BF+#?<QC=QTZGT]1]::S'SE/V8C@_N
M\?>Z<]??^\/H>Y,RF12+QYAGER#\G!YXX_/CGZTTE?,4_:F(P?WF#E>G'I^8
MSQ]* '*Q\YC]F)X'[O'W>O/7V_O'Z#LV,D2.?(+Y#?)C[O!.>HZ?4_C0"OF,
M?M3 8'[S!RW7CT_(9Y^M(A7>V;ED&&^?'WN#QSQSTZ?3B@ CR%E_<%\CKC[G
M/U'KZ'Z4+GR6'DD_,/WF/N]>.OM_=/U'80KA\W+)D<#!^?D>O/OQ@_I0"OEL
M/M# Y'[O!PW7GU_(XY^M "DGR"OD'_KKC\??_P!!_P :)"3&@^SE,%?GQ][D
M#'?K]!^%-)7RB/M+9P?W6#C_ !_7]*5RNQ<7+.<K\F#\O(YXYXZ_SYH =(Q+
M1?Z.4P>F/O\ 'U/IZCZTDA)D4_9RF,?)C[WZG^8_#K2.5RF+IGYY.#\G!YXX
M]N<C]:&*[QBY9Q_?P?E_I^?X\4 .R?M&?LYZX\K'X?WO_9OQ[4D9(D8_9R^<
M_)C[OZC^9_'K2[E\[/VIL;O];CGKU]/T_6FJ5WG-RR#^_@_-_3\OPXH =&Q#
M2_Z.7R>F/N<?4>OJ?K21DB-Q]G+Y+?/C[O)&.W3Z'\:1"N7S=,G/!P?GX'//
M'MQ@?I0A78V;ED.6^3!^;D\\\\]?Y<T *"?("^0?^NN/Q]O_ $'_ !I&SY*C
MR2/F/[S'WNG'7W_NCZGN@*^4!]I;.!^ZP<?X_K^E*2OEJ/M#$Y/[O!PO3GU_
M,XX^E !)DK%^X*8'7'W^?J?3T'TI9"3(A\@I@+\F/O< YZGK]1^%(Y7"8N6?
M Y&#\G)].??G)_6ARN]<7+.,+\^/N\#CCCCIT^O% #V8^<I^S$<']WC[W3GK
M[_WA]#W%8^<Q^S$\#]WC[O7GK[?WC]!V:2OF*?M3$8/[S!RO3CT_,9X^E *^
M8Q^U,!@?O,'+=>/3\AGGZT +&Q#2_P"CE\GIC[G'U'KZGZTV/(67]P7R.N/N
M<_4>OH?I0A7+YNF3G@X/S\#GGCVXP/TH0KA\W+)D<#!^?D>O/OQ@_I0 +GR6
M'DD_,/WF/N]>.OM_=/U'8;/DJ/)(^8_O,?>Z<=??^Z/J>X"OEL/M# Y'[O!P
MW7GU_(XY^M!*^6H^T,3D_N\'"].?7\SCCZ4 +(28T'V<I@K\^/O<@8[]?H/P
MI9&):+_1RF#TQ]_CZGT]1]::Y78N+EG.5^3!^7D<\<\=?Y\T.5RF+IGYY.#\
MG!YXX]N<C]: 'LQ\Y3]F(X/[O'WNG/7W_O#Z'N@)\\-]G/7_ %6/P]1_Z%_A
M2$KYBG[4Q&#^\P<KTX]/S&>/I0"OF@_:FQD?O<'/^'Z?K0 1DB1SY!?(;Y,?
M=X)SU'3ZG\:(25W_ .CF3/M]W]5_SZ=T0KO;-RR##?/C[W!XYXYZ=/IQ0A4;
MLW+1_@?F_//^>M "QDB-Q]G+Y+?/C[O)&.W3Z'\:3<?L^/(/3/FX_'_/R^^.
M]"%=C9N60Y;Y,'YN3SSSSU_ES297R<?:6SC_ %6#CIT]?U_2@!TA)C4?9RF,
M?/C[WZG^0_#I229*Q?N"F!UQ]_GZGT]!]*&*[!BY9S_<P?E_K^?X\T.5PF+E
MGP.1@_)R?3GWYR?UH 60DR(?(*8"_)C[W .>IZ_4?A2DGSRWV<]?]5C\/4_^
MA?X4URN]<7+.,+\^/N\#CCCCIT^O%*2OFD_:FQD_O<'/^'Z?K0 Y6/G,?LQ/
M _=X^[UYZ^W]X_0=DC8AI?\ 1R^3TQ]SCZCU]3]:0%?,8_:F P/WF#ENO'I^
M0SS]:1"N7S=,G/!P?GX'//'MQ@?I0 L9(C<?9R^2WSX^[R1CMT^A_&D7/DL/
M))^8?O,?=Z\=?;^Z?J.PA78V;ED.6^3!^;D\\\\]?Y<T KY;#[0P.1^[P<-U
MY]?R..?K0 -GR5'DD?,?WF/O=..OO_='U/<DR5B_<%,#KC[_ #]3Z>@^E!*^
M6H^T,3D_N\'"].?7\SCCZ4.5PF+EGP.1@_)R?3GWYR?UH =(Q+1?Z.4P>F/O
M\?4^GJ/K2LQ\Y3]F(X/[O'WNG/7W_O#Z'NQRN4Q=,_/)P?DX//''MSD?K2DK
MYBG[4Q&#^\P<KTX]/S&>/I0 Y6/G,?LQ/ _=X^[UYZ^W]X_0=FQDB1SY!?(;
MY,?=X)SU'3ZG\: 5\QC]J8# _>8.6Z\>GY#//UI$*[VS<L@PWSX^]P>.>.>G
M3Z<4 $>0LO[@OD=<?<Y^H]?0_2A<^2P\DGYA^\Q]WKQU]O[I^H["%</FY9,C
M@8/S\CUY]^,']* 5\MA]H8'(_=X.&Z\^OY''/UH 4D^05\@_]=<?C[_^@_XT
M2$F-!]G*8*_/C[W(&._7Z#\*:2OE$?:6S@_NL''^/Z_I2N5V+BY9SE?DP?EY
M'/'/'7^?- "S$ML_T<QX]OO?JW^?7L2$F1#Y!3 7Y,?>X!SU/7ZC\*1RIVXN
M6D_ _+^6/\]*'*[UQ<LXPOSX^[P.....G3Z\4 .R?M&?LYZX\K'X?WO_ &;\
M>U)&2)&/V<OG/R8^[^H_F?QZTNY?.S]J;&[_ %N.>O7T_3]::I7><W+(/[^#
M\W]/R_#B@!T;$-+_ *.7R>F/N<?4>OJ?K21DB-Q]G+Y+?/C[O)&.W3Z'\:1"
MN7S=,G/!P?GX'//'MQ@?I0A78V;ED.6^3!^;D\\\\]?Y<T *"?("^0?^NN/Q
M]O\ T'_&D;/DJ/)(^8_O,?>Z<=??^Z/J>Z KY0'VELX'[K!Q_C^OZ4I*^6H^
MT,3D_N\'"].?7\SCCZ4 $F2L7[@I@=<??Y^I]/0?2ED),B'R"F OR8^]P#GJ
M>OU'X4CE<)BY9\#D8/R<GTY]^<G]:'*[UQ<LXPOSX^[P.....G3Z\4 /9CYR
MG[,1P?W>/O=.>OO_ 'A]#W%8^<Q^S$\#]WC[O7GK[?WC]!V:2OF*?M3$8/[S
M!RO3CT_,9X^E *^8Q^U,!@?O,'+=>/3\AGGZT +&Q#2_Z.7R>F/N<?4>OJ?K
M38\A9?W!?(ZX^YS]1Z^A^E"%<OFZ9.>#@_/P.>>/;C _2A"N'S<LF1P,'Y^1
MZ\^_&#^E  N?)8>23\P_>8^[UXZ^W]T_4=AL^2H\DCYC^\Q][IQU]_[H^I[@
M*^6P^T,#D?N\'#=>?7\CCGZT$KY:C[0Q.3^[P<+TY]?S../I0 LA)C0?9RF"
MOSX^]R!COU^@_"ED8EHO]'*8/3'W^/J?3U'UIKE=BXN6<Y7Y,'Y>1SQSQU_G
MS0Y7*8NF?GDX/R<'GCCVYR/UH >S'SE/V8C@_N\?>Z<]??\ O#Z'N@)\\-]G
M/7_58_#U'_H7^%(2OF*?M3$8/[S!RO3CT_,9X^E *^:#]J;&1^]P<_X?I^M
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MO< YZGK]1^%(Y7"8N6? Y&#\G)].??G)_6ARN]<7+.,+\^/N\#CCCCIT^O%
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M]WJ/NY^7..F/PXH ED$NZ+,,0.?EQ@AN#][ICZ\_2AQ+YBYAB5NRC&T_7_\
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M"B;SFQ!"6VC*G&T#GH?_ *W:H3Y'F+CS]F#G.=_;I_%CKTX]>] \CS&SY^S
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MJ?\ ZPZ=:: OEL?L[$Y'[S)PO7CU_(8X^M!"^6I^SL#D_O,G#=./7\QCGZ4
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M^3@<<\>_&1^E #XS+Y;XFB RV0<$GDYP<#Z]./>D4R>2V)8PNX94XW'KT/\
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M/V=@<G]YDX;IQZ_F,<_2APN$Q;LF1R<GY^3SQS[<X/ZT /D,NZ+,T1.?E(P
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M9^]P.>..>O7Z\4 2,9O.7,\);:<,,;0..H_^OVH4S><V)X0VT98XVD<]!_\
M7[TPA?,4?96 P?W>3ENG/I^9SS]* %\QA]E8C _=Y.5Z\^GY'/'UH =&9=TN
M)H@<_,3@AN!]WICZ<_6B,R[9=LL0&/FS@EN1]W@8^O/TIB!<OFU9\'@9/R<#
MCGCWXR/TH0+A\V[/@<')^3D<\\^W&3^E #E,GDMB6,+N&5.-QZ]#_P#6/7K0
MQD\E<RQE=QPHQN'3J?\ ZPZ=:: OEL?L[$Y'[S)PO7CU_(8X^M!"^6I^SL#D
M_O,G#=./7\QCGZ4 /D,OEIF:(C*X P".1C)P?KTY]J)#+NBS-$3GY2, +P?O
M=<_3CZTQPNQ<6S(<K\^3\W(XXYYZ?SYH<+E,6K)D\C)^?@\<<>_.!^M #W,O
MF+F:)F[,,;1]?_U_EUIV9?M'^NBW[OO\;.OI_P#7_P *B8+O&+9D']S)^;^G
MY_CQ3MJ^=C[*V-W^JSSUZ>GZ_K0 L9E\Q\31!L-DG!!X.<#CZ=>/>B(R_/MF
MB7UW8.?ITZ_YQ3$"[VS;,XPWR9^[P>>>..O7Z<4(%.[-LTGXGY?SQ_GK0 ^,
MR^6^)H@,MD'!)Y.<' ^O3CWIN9?L_P#KHMFW[G&_IZX_#I_C2(%V-FV9SEOG
MR?EY/'//'3^7-)A?)S]F;./];DXZ=?7]/TH D<R^6N9HF7LHQN'U_P#U#^E$
MAEVQ;I8B,?+C *\G[W!S]>/I3&"[!BV9#_?R?F_K^?X\T.%PF+=DR.3D_/R>
M>.?;G!_6@!\AE\Q,S1%L+@C  X&,CGZ=>?:E)E\\_OHM^3\_&W\O_K^_M4;A
M=ZXMF087Y,_>X'/''/7K]>*4A?-(^RMC)_=9.?\ #]?UH >IF\YL3PAMHRQQ
MM(YZ#_Z_>DC,NZ7$T0.?F)P0W ^[TQ].?K30%\QA]E8C _=Y.5Z\^GY'/'UI
M$"Y?-JSX/ R?DX''/'OQD?I0 ^,R^6^)H@,MD'!)Y.<' ^O3CWI%,GDMB6,+
MN&5.-QZ]#_\ 6/7K34"[&S;,YRWSY/R\GCGGCI_+F@!?+8_9V)R/WF3A>O'K
M^0QQ]: ',9/)7,L97<<*,;ATZG_ZPZ=:60R[8MTL1&/EQ@%>3][@Y^O'TIA"
M^6I^SL#D_O,G#=./7\QCGZ4.%PF+=DR.3D_/R>>.?;G!_6@!\AEW19FB)S\I
M& %X/WNN?IQ]:5C-YRYGA+;3AAC:!QU'_P!?M4;A<IBU9,GD9/S\'CCCWYP/
MUI2%\Q1]E8#!_=Y.6Z<^GYG//TH >IF\YL3PAMHRQQM(YZ#_ .OWI(S+YCXF
MB#8;)."#P<X''TZ\>]- 7S&'V5B,#]WDY7KSZ?D<\?6D0+O;-LSC#?)G[O!Y
MYXXZ]?IQ0 ^,R[9=LL0&/FS@EN1]W@8^O/TH0R^6V)HE7NIQN/T__4?Z4Q N
M'S;L^!P<GY.1SSS[<9/Z4*%V'-LSG^_D_+_7\OPYH 7,OV?_ %T6S;]SC?T]
M<?AT_P :=(9?+3,T1&5P!@$<C&3@_7IS[5'A?)S]F;./];DXZ=?7]/TI7"[%
MQ;,AROSY/S<CCCGGI_/F@!\IE^3=-$WIMP,?7KT_SFB0R^8F9HBV%P1@ <#&
M1S].O/M3'"C;BV:/\3\WY9_STH<+O7%LR#"_)G[W YXXYZ]?KQ0!+F7[1_KH
MM^[[_&SKZ?\ U_\ "FH9?,;$T2MW8XVGZ?\ Z_SZTFU?.Q]E;&[_ %6>>O3T
M_7]::H7><VS./[F3\O\ 3\OPXH ?&9=TN)H@<_,3@AN!]WICZ<_6B,R^6^)H
M@,MD'!)Y.<' ^O3CWIB!<OFU9\'@9/R<#CGCWXR/TH0+L;-LSG+?/D_+R>.>
M>.G\N: ' R^0/WT6S ^3C=^>/Z>WO0QD\E<RQE=QPHQN'3J?_K#IUI@"^4#]
MF;.!^]R<?X_I^E*0OEJ?L[ Y/[S)PW3CU_,8Y^E #Y#+MBW2Q$8^7& 5Y/WN
M#GZ\?2B0R^8F9HBV%P1@ <#&1S].O/M3'"X3%NR9')R?GY//'/MS@_K0X7>N
M+9D&%^3/WN!SQQSUZ_7B@"1C-YRYGA+;3AAC:!QU'_U^U"F;SFQ/"&VC+'&T
MCGH/_K]Z80OF*/LK 8/[O)RW3GT_,YY^E "^8P^RL1@?N\G*]>?3\CGCZT .
MC,NZ7$T0.?F)P0W ^[TQ].?K1&9=LNV6(#'S9P2W(^[P,?7GZ4Q N7S:L^#P
M,GY.!QSQ[\9'Z4(%P^;=GP.#D_)R.>>?;C)_2@!RF3R6Q+&%W#*G&X]>A_\
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M<$'@YP./IUX]Z: OF@?96QD?NLG/^'Z_K2(%WMFV9QAODS]W@\\\<=>OTXH
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ME Z'Z],<4)R_E=M/E?\ KRMU%[*DXIJLKZ\S<7;2UO/=V71Z;=5(_> _:7(
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MY.>>>O7OQ2](V!G8'(_=X.#UY]?R..:<$9QYB(A48R2.>O.!GL>E,+@G?M7
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M'[S!RW7CT_(9Y^M(A7+YNF3G@X/S\#GGCVXP/TJ11-YS8@A+;1E3C:!ST/\
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MFY9!AOGQ][@\<\<].GTXJ11-YS8@A+;1E3C:!ST/_P!;M21B7S'Q#$6PV0<
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MDC$NZ7$,1.?FS@!>!]WKGZ\?2@!B%=C9N60Y;Y,'YN3SSSSU_ES0"OEL/M#
MY'[O!PW7GU_(XY^M/C$OEOB&(C+9)P".3G R?IUY]J11)Y+8BC*[AECC<.O0
M?_7'3I0 TE?+4?:&)R?W>#A>G/K^9QQ]*'*X3%RSX'(P?DY/IS[\Y/ZTYA)Y
M*YBC"[CAAC<>G4?_ %SUZ4L@EVQ;HH@,?+C!+<G[W(Q].?K0 QRN4Q=,_/)P
M?DX//''MSD?K2DKYBG[4Q&#^\P<KTX]/S&>/I3I!+NBS#$#GY<8(;@_>Z8^O
M/TI6$WG+F"$-M.%&-I''4_\ UN] # 5\QC]J8# _>8.6Z\>GY#//UI$*[VS<
ML@PWSX^]P>.>.>G3Z<5(HF\YL00EMHRIQM YZ'_ZW:DC$OF/B&(MAL@X '!S
M@\_7IS[4 ,0KA\W+)D<#!^?D>O/OQ@_I0I78<W+(?[F#\W]?R_#FGQB7;+MB
MB(Q\V< KR/N\G/TX^M""7RVQ#$R]V.-P^G_ZQ_6@"/*^3C[2V<?ZK!QTZ>OZ
M_I2N5V+BY9SE?DP?EY'/'/'7^?-+B7[/_J8MFW[_ !OZ>F?QZ_X4Z02^6F88
M@,K@C!)Y&,C(^G7CWH 8Y4[<7+2?@?E_+'^>E#E=ZXN6<87Y\?=X'''''3I]
M>*?*)?DW0Q+Z;<'/UZ=?\XHD$OF)F&(-A< 8(/ QD\?7IQ[T )N7SL_:FQN_
MUN.>O7T_3]::I7><W+(/[^#\W]/R_#BI<2_:/]3%OW?<XV=?7].G^--02^8V
M(8F;NIQM'T__ %?ETH 8A7+YNF3G@X/S\#GGCVXP/TH0KL;-RR'+?)@_-R>>
M>>>O\N:?&)=TN(8B<_-G "\#[O7/UX^E$8E\M\0Q$9;). 1R<X&3].O/M0!&
M"OE ?:6S@?NL''^/Z_I2DKY:C[0Q.3^[P<+TY]?S../I3@)?('[F+9@?/QN_
M+/\ 7W]J&$GDKF*,+N.&&-QZ=1_]<]>E #7*X3%RSX'(P?DY/IS[\Y/ZT.5W
MKBY9QA?GQ]W@<<<<=.GUXI\@EVQ;HH@,?+C!+<G[W(Q].?K1()?,3,,0;"X
MP0>!C)X^O3CWH :2OF*?M3$8/[S!RO3CT_,9X^E *^8Q^U,!@?O,'+=>/3\A
MGGZT]A-YRY@A#;3A1C:1QU/_ -;O0HF\YL00EMHRIQM YZ'_ .MVH C0KE\W
M3)SP<'Y^!SSQ[<8'Z4(5P^;EDR.!@_/R/7GWXP?TI\8EW2XAB)S\V< +P/N]
M<_7CZ41B7;+MBB(Q\V< KR/N\G/TX^M # 5\MA]H8'(_=X.&Z\^OY''/UI"5
M\HC[2V<']U@X_P ?U_2GJ)/);$497<,L<;AUZ#_ZXZ=*")?(/[F+9@_/QN_+
M/]??VH :Y78N+EG.5^3!^7D<\<\=?Y\T.5RF+IGYY.#\G!YXX]N<C]:?()?+
M3,,0&5P1@D\C&1D?3KQ[T2"7=%F&('/RXP0W!^]TQ]>?I0 QBN\8N6<?W\'Y
M?Z?G^/%.W+YV?M38W?ZW'/7KZ?I^M*XE\Q<PQ*W91C:?K_\ J_/I3L2_:/\
M4Q;]WW.-G7U_3I_C0!$A7>V;ED&&^?'WN#QSQSTZ?3BA"HW9N6C_  /S?GG_
M #UI\8E\Q\0Q%L-D'  X.<'GZ].?:B(2_/MAB;UW8&/IUZ?YS0 Q"NQLW+(<
MM\F#\W)YYYYZ_P N:3*^3C[2V<?ZK!QTZ>OZ_I4D8E\M\0Q$9;). 1R<X&3]
M.O/M3<2_9_\ 4Q;-OW^-_3TS^/7_  H 1BNP8N6<_P!S!^7^OY_CS0Y7"8N6
M? Y&#\G)].??G)_6GN)?+7,,2KV88W'Z_P#ZS_6B02[8MT40&/EQ@EN3][D8
M^G/UH 8Y7>N+EG&%^?'W>!QQQQTZ?7BE)7S2?M38R?WN#G_#]/UIT@E\Q,PQ
M!L+@#!!X&,GCZ]./>E(E\\_N8M^3\G&W\_\ ZWM[T ,!7S&/VI@,#]Y@Y;KQ
MZ?D,\_6D0KE\W3)SP<'Y^!SSQ[<8'Z5(HF\YL00EMHRIQM YZ'_ZW:DC$NZ7
M$,1.?FS@!>!]WKGZ\?2@!B%=C9N60Y;Y,'YN3SSSSU_ES0"OEL/M# Y'[O!P
MW7GU_(XY^M/C$OEOB&(C+9)P".3G R?IUY]J11)Y+8BC*[AECC<.O0?_ %QT
MZ4 -)7RU'VAB<G]W@X7ISZ_F<<?2ARN$Q<L^!R,'Y.3Z<^_.3^M.82>2N8HP
MNXX88W'IU'_USUZ4L@EVQ;HH@,?+C!+<G[W(Q].?K0 QRN4Q=,_/)P?DX//'
M'MSD?K2DKYBG[4Q&#^\P<KTX]/S&>/I3I!+NBS#$#GY<8(;@_>Z8^O/TI6$W
MG+F"$-M.%&-I''4__6[T ,!7S0?M38R/WN#G_#]/UI$*[VS<L@PWSX^]P>.>
M.>G3Z<5(!+YX_<Q;\CY.-OY__6]O>DC$OF/B&(MAL@X '!S@\_7IS[4 ,0KA
M\W+)D<#!^?D>O/OQ@_I0I78<W+(?[F#\W]?R_#FGQB7;+MBB(Q\V< KR/N\G
M/TX^M""7RVQ#$R]V.-P^G_ZQ_6@"/*^3C[2V<?ZK!QTZ>OZ_I2N5V+BY9SE?
MDP?EY'/'/'7^?-+B7[/_ *F+9M^_QOZ>F?QZ_P"%.D$OEIF&(#*X(P2>1C(R
M/IUX]Z &.5.W%RTGX'Y?RQ_GI0Y7>N+EG&%^?'W>!QQQQTZ?7BGRB7Y-T,2^
MFW!S]>G7_.*)!+YB9AB#87 &"#P,9/'UZ<>] ";E\[/VIL;O];CGKU]/T_6F
MJ5WG-RR#^_@_-_3\OPXJ7$OVC_4Q;]WW.-G7U_3I_C34$OF-B&)F[J<;1]/_
M -7Y=* &(5R^;IDYX.#\_ YYX]N,#]*$*[&S<LARWR8/S<GGGGGK_+FGQB7=
M+B&(G/S9P O ^[US]>/I1&)?+?$,1&6R3@$<G.!D_3KS[4 1@KY0'VELX'[K
M!Q_C^OZ4I*^6H^T,3D_N\'"].?7\SCCZ4X"7R!^YBV8'S\;ORS_7W]J&$GDK
MF*,+N.&&-QZ=1_\ 7/7I0 URN$Q<L^!R,'Y.3Z<^_.3^M#E=ZXN6<87Y\?=X
M'''''3I]>*?()=L6Z*(#'RXP2W)^]R,?3GZT2"7S$S#$&PN ,$'@8R>/KTX]
MZ &DKYBG[4Q&#^\P<KTX]/S&>/I0"OF,?M3 8'[S!RW7CT_(9Y^M/83><N8(
M0VTX48VD<=3_ /6[T*)O.;$$);:,J<;0.>A_^MVH C0KE\W3)SP<'Y^!SSQ[
M<8'Z4(5P^;EDR.!@_/R/7GWXP?TI\8EW2XAB)S\V< +P/N]<_7CZ41B7;+MB
MB(Q\V< KR/N\G/TX^M # 5\MA]H8'(_=X.&Z\^OY''/UI"5\HC[2V<']U@X_
MQ_7]*>HD\EL11E=PRQQN'7H/_KCITH(E\@_N8MF#\_&[\L_U]_:@!K89,+<-
M(1@^7TVX(_EUY].<TL+L<AIF(7OR-G/O[_YQ3I/-$:DQ1(!C#+]X\C@@>O0]
M>/6G12._!BB##D<#YN0><=*YL1O3ULKOWNST[^[KMJK]CJPWQ/W7?EE>6MEM
MM:VO7\B&0KG/V@R#C+D-E?RP..O/Z"I5DC<8\SC&/M'.>O7CC'X=?SILHDWC
M?%&IXPJ@%3SW.1_GTJ0)D_*J^=C/EX&PD=LYY^F,8YKTJ-G3[_NWJG%_R[^S
M45YN_P SSYWYXW2E&S]U;N5U9OIRKK?0AC=8_,_?G[K[6P?F)!Q^9/\ ^NH[
M*5W,GF,81V(_BY__ %^U3Q!P9,QID*Y(.,# 8\'^7\S4=E,)3((D5\'G?P!S
MCC_&O+J_QX>[=VU?Y*RL^^]^ECT*%^574;*^J<;PT6^EM>G-?RMJ2VS!7),I
M'S-\N#AN?Z_UXP*^5_VR2C_"C6@7/_'A=?NST_U;>V/;'_UJ^JK8,6;,:8WM
MDG&1SV'?O]<9XKY6_;*0M\)];"@!/L%U\X/S_P"K;I_GG/Y?497;ZS@]?^7D
M-;KO#RW6UM^SO8^/S[F=*LERR7L9WIZ<S>EOA2:CWYFUKJ?B387.R)%=S*O
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M_+;?C_MGT_[X_I^-6(O,\F3'E[<MG=C=_P !S\W7IC\.:3Y_LO\ !L_#S/\
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M,WS;?+SGYMVW'_ <\=/[O%)%YGDR8\O;EL[L;O\ @.?FZ],?AS0!7'D^6/\
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M0-NW';C&3C.<_C[U<B\SSI,>7G#9W;=O_ <_+G'3'X<50DQO.[.<\[=N/TH
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M_K=^M"B/SFS'(5QPH/S#ZG_ZW;K3V+?:$/G@G:?WG.%]O7\ACCZT*6^T.?/
M.T?O.<-[>OYC'/TH 9&(]TNZ-R,_+@X*_P"]P<_7CZ5''LVR[D<G'RX. O\
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M4/@<#GY/;GCWXR*=*3YT>9@YPOS\_+[<C/'3^7-  PC\Y<1R!<<J3\Q^A_\
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M3]FQYHQ_SR[]>GI^OZT -DV>4FU'#<98GY3QV'^?QZTV39MBVHX./FR<AO\
M=Z8_7ZU)*3Y*9F#CCY.?EX_+\OPXILI.V',H? X'/R>W/'OQD4 $FSS4PCA<
M+D$Y)]<' ^O3\Z/D\_[C[/[N?FZ>N/Z?XTZ4GSH\S!SA?GY^7VY&>.G\N:,G
M[3GSAG_GKSCI^?Z?I0 *(_.;,<A7'"@_,/J?_K=NM$8CW2[HW(S\N#@K_O<'
M/UX^E/4M]H<^> =H_><X;V]?S&.?I21%@TV)PF3R>?G]^.?;G!H CC">4^4<
MMEL$< >F1S].O/M35V^2V48MGA@?E'U&/Z]JDB)$,@$P09;*?WO?CCGKU^O%
M-4G[.X\T ;A^[YRWOZ?F<\_2@!K;?)7",&SRQ/RGZ#']>]$FS;%M1P<?-DY#
M?[O3'Z_6G,3]G0>:"-Q_=\Y7W]/R.>/K1*3MAS*'P.!S\GMSQ[\9% #I!'NB
MVQN!GYLG);_=X&/KS]*&$?G+B.0+CE2?F/T/_P!;OUITI8M#F</@\'GY/?GG
MVXR:5BWVA#YX)VG]YSA?;U_(8X^M #%$?G-F.0KCA0?F'U/_ -;MUIL>SS7R
MCE<-@ X(],G!^O3\JE4M]H<^> =H_><X;V]?S&.?I3(B?.DQ,$.&^?GYO;@9
MYZ?SYH CCV;9=R.3CY<' 7_>ZY_3ZTZ/9Y3[D<MSA@?E''<?Y_#K1$3MFQ*$
MR.1S\_MQQ[\X%.B)\E\3!!S\G/S<?E^?X\4 -PGV?[C[_P"__!U]/UZ_X42!
M/*3".&RN2>0?7 X^G7CWIV3]FQYHQ_SR[]>GI^OZT2DF&,&8.,KA/[OOSQQU
MZ_3B@!LVSY-J.OKN.<].G3K_ )Q1)L\U,(X7"Y!.2?7!P/KT_.G7!)\O,PD_
M/Y>GKC_/6B4GSH\S!SA?GY^7VY&>.G\N: &_)]H_U;[/[F?GZ>N/PZ?XT1[/
M-?<CLO.%!^8<]S_G^E/RWVG/GC.?]=SCIUZ9_3]*2(GSGQ,$//S\_-S^?Y_C
MS0 1B/=+NC<C/RX."O\ O<'/UX^E-C">4^4<MEL$< >F1S].O/M4D18--B<)
MD\GGY_?CGVYP:;$2(9 )@@RV4_O>_''/7K]>* &_)Y'W'W_WL_+U]/\ Z_\
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M32L6^T(?/!.T_O.<+[>OY#''UH B^3S_ +C[/[N?FZ>N/Z?XT1[/-?*.5PV
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MTN>E1<'**MHHJ*6KOI9=WT;V[C<*DTU3E[/WDW2;=[*S:UTVO>SMWL287S"
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MDUDHQTM%/1ZI;7MIK]WR[%M:Z^ZURKD;G>6UVG;1/K9VE?W[:"QN)1NVE9"
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MH;=#F )D\#GY_P ^??C!ILH/G(#"$/'R<_-S^?Y?AS1)Y>Z+;(Y&?FR,%?\
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M\5''LVR[G<''RX&0W^]TQ]>?I3H]GE/N=U;G"@?*>._^?SZ4 .P?LV?*&/\
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M^?2@!V#]FSY0Q_SU[]>OI^GZT2@^3'F$(,KA_P"][<\<].GTXIN4^S_???\
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MJW*SQ!%C38I'#C/[[W/UZ8X)[52M+>.6VB,3NTHVEE?A1Z\\<\<?_KJZ9%A
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M.?Z=Z=\GD????_<Q\O7U_P#K>WO0 Z4'R8\PA!E</_>]N>.>G3Z<4Z4-NAS
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M&-N-OXXX_/\ 'BDD$>Z+;&X&?FR<EO\ =X&/KS]*;)L\U-J.J\94GYCSV/\
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MP(KA]A()C20!V#8^3 P01@U0@U+[1=BR@C,*'),DRF,'!'(8C&.?I[U^]/\
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M7=&Y&?EP<%?][@Y^O'TJ./9MEW(Y./EP<!?][KG]/K0 Y=_V=\;-NX9SC?\
MA_%CKTX]>]/_ 'GV7_EGL_#?U_[Z_P ^E1+M\ELHQ;/# _*/J,?U[4[Y/(^X
M^_\ O9^7KZ?_ %_\* ))=QA0/Y>PXQMV[O\ @7?ZY_&G)#*A4DQ$_P (7D#_
M 'NOX<\<8S44BHT2@(ZL<99C\I^@Q^%$2$=8Y0O?.<L/]GD_CZ]JY<39NFFG
M+5WAO?LTG9:=?>7^75AF^;XE%6J=6G+W-MGMI][%N/,\U?\ 5[^,;<;.V,[>
M/KG\>*<AN%<%@GF?ALS_ .@_2HIM@=2L;A>ZG)8_3ICK^'7GI3XY4; :-Q%_
MSSYWXQTSU_PZUZF%TI3LO^7;O]GJMK<U_G8X*O\ %5G:7*]'\*7,O>UW?W>5
MA(_,9YMNS<4?/3&""#M/3Z8_EFH].@,9F*D$DG(D.<<\[<_SQUZXXRZ-E#2X
M5B-CA0.HX(&>.W?I_2HM/63,IFRXS\NWJ!GOUQCN/IZUY=3F]M#515O.[V]=
MNFB\CNH/1VGVYHNWO;>]'\>JM97NB[:[_FV[,;F^]UZ]OXORXQ[5\J?MDLR_
M"76BP4J-/N>GW_\ 5O\ C^?YXKZIMMH))1RVYL%>G4=N_P"8KY6_;(93\*-:
M+*V[^S[H[C]W)1_\_P!17TV5K_:<)[O_ "^I]%?[/7FOKU=K^1\?GUDJUI.,
MO82UM96TU;3;DWV:C\C\4K8R&SB,NP)A<>5CS.G&<<_7]:G?#!!(JD<"/:,M
MC/\ RT[YR.^/IZ9EF[PP1LJ.H8 ;F&5/!Q@$8R?_ *]:J890R#RB>7+])/\
M<],]L=*_I+!0G]6IJ,DX\L;I2:TLM-5[K2W>M]K;G\TXZ+CB:DG)2O-VDGI=
MV3TLK?)2OMIN# HR;\;\?($_U>,#&_'&>YXZ]_1"-TN2J";DD@#RO?';^?\
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MVI:AX>>8+>MJ]SHT-[=QNJB$B1KJ60,-WWCC=T(_SX/VZ_VPV_;)^+5UXO\
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M/R^W(SQT_ES3),E8OW!3 ZX^_P _4^GH/I2R$F1#Y!3 7Y,?>X!SU/7ZC\*
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M^>O..GY_I^E#,?.4_9B.#^[Q][ISU]_[P^A[H"?/#?9SU_U6/P]1_P"A?X4
M+$3YTF)@APWS\_-[<#//3^?-%N2/,Q,(_P _FZ^F?\]*;&2)'/D%\AODQ]W@
MG/4=/J?QHA)7?_HYDS[?=_5?\^G< =$2(9 )@@RV4_O>_''/7K]>*,G[-CS1
MC_GEWZ]/3]?UIL9(C<?9R^2WSX^[R1CMT^A_&DW'[/CR#TSYN/Q_S\OOCO0
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M(9$5E61Q+(, 2\XC]CQVZ'Z<\4PQS&4OYV0?^6_.T\?U_+OUI_EI(5D9!&<
MF/GY^,Y/)^]['G]*C,TGFE1'A<X$..!VZ9/\_;&:[.V_E\7EO_P?\SDCUY+7
MY6I\ZA;I=1OIM_V[?<D\U"S*LH63:,R\X;/0=,<?Y[TU%EC9V>;:I;.3G$G&
M,CC_ #] *?Y2#,@C#.1CR>24QT;&<<\]_7'O$DC2,RM%O7/W<']V/3[WT/?^
M63M?N[6YMM-[:?UJ):\W(KPM'GYE!R^S\-__ -G^7H/WB1"(9!'RV4YRQQ@D
M<9^8_P"<TU-T,;"5\*3_ *@YRWOZ?TY^M.95@4^6@DZGS!D["W;J/NG_ #GJ
MV,F9"LJYYXF.<K[9SWQZ8_6CJN]GWMT_K^D.WNNR?L^:-[J/M-XVW]Z_>_O=
M@?=-&HB?*@_Z@9ROOZ?TX^E.WB- )I!)RN$YRIQ@$\9^4_YS39"84"Q+CGF8
M9RWMG/;/IC]*<JK.H\Q!'T/F'(WE>W4_>/\ G/0UUM\5EOS<NZ^0.W+%_P#+
MKGNFE'VGV=VM=][>_P!Q'661D9)MRALY&<1\8R>/\_0FG>:@95:4-)M.)><+
MCJ.F.?\ /:HWD:-E58MBY^[@_O!Z?>^I[?SQ+Y2'$AC"N!CR>07SU;&<<<=_
M3/L=[=U>_HMOE^(ND>9>[9\O*H<VZMS6\]_LV^+6Y&(YA*'\[ '_ "WYVCC^
MGY=^M/$B,S+&XBD.09><2>PX[]!]>.*C$TGFA3'E<X,..#VZ9'\_;&:D\M(R
MTBH)#@D1\_)QG(Y'W?<\?I1KTVZWO?IM?^OQ"73GWY8J'*H6WCI/IOT?N6VU
M&1+)$',DGEJ>JG/[WZ<?CGKQ3MPD0K"XBZ_N^<GCL1Z^U,B=I=R2)O!Z,<_N
MNV1R",9]"?7M3RHA4^6GF'G]YR=N>F>1C'48_GU%Y7MYWO\ B4_BL[>T;5K*
M/)]F][Z=M]>W0:I,,6)I,@+S"<YX/(_KZ?A1('E4>7+N *_NQD%<<Y/&?E'^
M<BEC_?H!*H /!G.0/7.<GM[8_#&4D8Q "./:,@>8 </C@C.<G=P/_P!8R+;^
M[9=^;IV_K<6O,K)>UYG?2/L]>7:W7T]_^8<TB( LKB=@3C&?D/K_ )YIKI*\
MBNLOF+QB09Q&/0\=NG'7'/%/\M90&=!">O<;P?Q/'Z^AJ-Y71PJ1[$&/W8Z/
M[]>_7J/?BD_/:ZMO?Y_U^(HVNN1>^HRYN90Y=X_#TOZ:/[1+YJ>9CS!YO3[3
MSC..O3UY]/QJ)4E5V<R[!U,ASAQGM_\ 7^@XJ7RH]WF>6,_\\.<9Z8QGK_P+
M'\ZA261G*F,NISB/&=GTY]/<^HXI]5?OI;F_&P1^%^S7V$I\ZA>]U\/2V]K^
MYV)1(KEECE$;;AEN?WAZY''I_GI3(P\2GS)=H);]V<DMGG(XS\P_SDT_RTCR
MZ1B1F^8J,GRNV.2,<?YQT9&QE!$D>X9(\P@X3/ &<Y&WD?\ ZC@ZJ^]GMMT_
MX U:SY?@]SFYN3GNDMKZV7_[&@K$RQXADPN/]2,YP3T_SQ^!H!\J,+,V\9X@
MYRGN>W]...U#_N$Q$F0.!.,_7.<]<>V/PS@4"=!YB[6!_P!<<Y?VZGU[@>W;
M!KT^+3>_+T^7]>H:<JW]ESI[1]ITL_YO5_'^(DJR2A#')YBCHHS^Z^O'XYZ\
MT]I$5E61Q+(  )><)['Z=#].>*CE=HMJ1IL ZL,_O>V3R2<X] ?3O4AC23$A
M01MC/E\_.<9R>2,M]<'OQQ35[JWQ77\W+NOD)VY(\WP6?+RJ//K:W-;N]_\
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MM*%E>-K2VWLF?C&/KTZV9TW.I-X5UO:2A-.ZES)\J;VD]TGH^J/W!_X(9_\
M!.[Q;\=_C=KGQA^+OPSM=;^":1:.="U75=TUHM];/=S7QCB\H!66*:U)/F=P
M#CO^SO\ P7 _X*0Z-^Q3\-O#_P  _@+I,.J:9_PC#V%UI6ESI:V^FO-<WJF
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ML&+EG/\ <P?E_K^?X\T.5PF+EGP.1@_)R?3GWYR?UI[B7RUS#$J]F&-Q^O\
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M,MDG (Y.<#)^G7GVIN)?L_\ J8MFW[_&_IZ9_'K_ (4 (Q78,7+.?[F#\O\
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MVT0UO])&(FVL3Q;C[O3\?I_]8\@=8 %=O-;D&,]$[9'TZ_EW/+@H5<J=L/\
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M_<^;_P M]F[W\SK_ -]Y_7\*:OD[CN\[;VV_>_''/Y_CS4^9?M'^NBW[OO\
M&SKZ?_7_ ,*:AE\QL31*W=CC:?I_^O\ /K2$1+Y&7W>?C/R[<YZ#[V.<_P"]
MS0OD[6SYV[+8V_=ZG[V/ESCKG\>*EC,NZ7$T0.?F)P0W ^[TQ].?K1&9?+?$
MT0&6R#@D\G.#@?7IQ[T 0CR?+'^NWX'^Y_\ $_Y]:4^5Y:X\W?DYS]SMT_AS
MUZ<^O>I 9?('[Z+9@?)QN_/']/;WH8R>2N98RNXX48W#IU/_ -8=.M $;>3A
M-OG9Q\V[IU/W<\?]\\4K>3N7'G;<+G=G=T'W<_-UZ8_#FI)#+MBW2Q$8^7&
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MPV^=M[[OO?AGG\OPYIW[GS?^6^S=[^9U_P"^\_K^%/<R^8N9HF;LPQM'U_\
MU_EUIV9?M'^NBW[OO\;.OI_]?_"@"%?)W-GSMN&QMSNZ'[V/FZ]<_CS2)Y/.
M[SO;9_7;_GT[U+&9?,?$T0;#9)P0>#G X^G7CWHB,OS[9HE]=V#GZ=.O^<4
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MMN%SNSNZ#[N?FZ],?AS4DAEVQ;I8B,?+C *\G[W!S]>/I1(9?,3,T1;"X(P
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M*=P!$I]?]5[^@^G'7MP11+)Y1SC,AX;O'CCH.5SZ_P A0^7C_P!'8+'GB/\
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MMO?=][\,\_E^'-._<^;_ ,M]F[W\SK_WWG]?PI[F7S%S-$S=F&-H^O\ ^O\
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M\G+=.?3\SGGZ4 +YH'V5L9'[K)S_ (?K^M!*^8I^U,1@_O,'*]./3\QGCZ4
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M#CGCWXR/TI05\QC]J8# _>8.6Z\>GY#//UI$*Y?-TR<\'!^?@<\\>W&!^E
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M<K\F#\O(YXYXZ_SYH<KE,73/SR<'Y.#SQQ[<Y'ZT #!=XQ;,@_N9/S?T_/\
M'BG;5\['V5L;O]5GGKT]/U_6FL5WC%RSC^_@_+_3\_QXIVY?.S]J;&[_ %N.
M>O7T_3]: &H%WMFV9QAODS]W@\\\<=>OTXH0*=V;9I/Q/R_GC_/6A"N]LW+(
M,-\^/O<'CGCGIT^G%"%1NS<M'^!^;\\_YZT "!=C9MF<Y;Y\GY>3QSSQT_ES
M287R<_9FSC_6Y..G7U_3]*5"NQLW+(<M\F#\W)YYYYZ_RYI,KY./M+9Q_JL'
M'3IZ_K^E "L%V#%LR'^_D_-_7\_QYH<+A,6[)D<G)^?D\\<^W.#^M#%=@Q<L
MY_N8/R_U_/\ 'FARN$Q<L^!R,'Y.3Z<^_.3^M  X7>N+9D&%^3/WN!SQQSUZ
M_7BE(7S2/LK8R?W63G_#]?UI'*[UQ<LXPOSX^[P.....G3Z\4I*^:3]J;&3^
M]P<_X?I^M   OF,/LK$8'[O)RO7GT_(YX^M(@7+YM6?!X&3\G XYX]^,C]*4
M%?,8_:F P/WF#ENO'I^0SS]:1"N7S=,G/!P?GX'//'MQ@?I0 (%V-FV9SEOG
MR?EY/'//'3^7- "^6Q^SL3D?O,G"]>/7\ACCZT(5V-FY9#EODP?FY/////7^
M7- *^6P^T,#D?N\'#=>?7\CCGZT !"^6I^SL#D_O,G#=./7\QCGZ4.%PF+=D
MR.3D_/R>>.?;G!_6@E?+4?:&)R?W>#A>G/K^9QQ]*'*X3%RSX'(P?DY/IS[\
MY/ZT #A<IBU9,GD9/S\'CCCWYP/UI2%\Q1]E8#!_=Y.6Z<^GYG//TI'*Y3%T
MS\\G!^3@\\<>W.1^M*2OF*?M3$8/[S!RO3CT_,9X^E   OF@?96QD?NLG/\
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M<#GCCGKU^O%#E<)BY9\#D8/R<GTY]^<G]:'*[UQ<LXPOSX^[P.....G3Z\4
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M+Z;<'/UZ=?\ .*)!+YB9AB#87 &"#P,9/'UZ<>]1RK$NS8SMG[V[/'KC)/\
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M7<3G</7&6)^G(]L4 38E^T?ZF+?N^YQLZ^OZ=/\ &FH)?,;$,3-W4XVCZ?\
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MK]GBP5SG.P=<$<<CO^'%?A7B/?\ MBGS6<O8QNUL_3I\K?,_H#PT_P"1-/\
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M!Q*N?*4<#!YQGIV[&A?8_G]G.T+>X_AWU_KR%;1::<DU?E5^FGQ?AJGW0_\
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MY8V[=N-^>.O0XSU']:_#7_@@@SS_ +%/ATLRJ38+SC _UW?_ #ZU^XQ$:Q(
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M7?\ 9WQLV[AG.-_X?Q8Z]./7O1&$\I\HY;+8(X ],CGZ=>?:FKM\ELHQ;/#
M_*/J,?U[4 .;?]G3.S;N.,8W_C_%CIUX].U+-OV0[MF,?+MQG_@6.<_[W-,;
M;Y*X1@V>6)^4_08_KWHDV;8MJ.#CYLG(;_=Z8_7ZT 3S>9OAW>7G/R[=N/\
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M'BF3;/DVHZ^NXYSTZ=.O^<42;/-3".%PN03DGUP<#Z]/SH D_>?:O^6>_/\
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MGY<'!7_>X.?KQ]* '1>9Y,F/+VY;.[&[_@.?FZ],?AS4:[_L[XV;=PSG&_\
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M_EGL_#?U_P"^O\^E,;?]G3.S;N.,8W_C_%CIUX].U'R>1]Q]_P#>S\O7T_\
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MA<;=NW_@6/ESCKG\>*/WGVK_ )9[_P#@.SI_WS_GUIDFSS4PCA<+D$Y)]<'
M^O3\Z/D\_P"X^S^[GYNGKC^G^- $R^9]H?'E;MHSG;L_#^'/7ISZ]Z2'S-\V
MWR\Y^;=MQ_P'/'3^[Q3%$?G-F.0KCA0?F'U/_P!;MUHC$>Z7=&Y&?EP<%?\
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M_>X.?KQ]*;&$\I\HY;+8(X ],CGZ=>?:@!_[S[+_ ,L]GX;^O_?7^?2F-O\
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M!@)_9]UZ!L;&[YSS^/TQ7U1;!22&5B2S<C('4=?_ -8KY5_;*7'PGUH)G?\
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MQU5_+;;\_P"K UHN9<JL^5QBKRO;XES:7>C5W=;N-] ?://'W-W'7;Y73O\
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MKGOIHO>U6_:UE;F'-N\K]QL\K';;YF,\>^>OO^-"_P"I7[1M\O/RXQYN??\
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MC)72>E.6\8+MLGO_ -N^[W)02'(:4.H _P!' &Y#ZD]?_P!5(NXEOWPEP>%
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M  02VQ_L4^'?*E) L%PP'_34_EZ^^/:OW)8,;>,F$(25 D[MTQW[^A]?2O\
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MOSS[<9-*Q;[0A\\$[3^\YPOMZ_D,<?6DE#;H<P!,G@<_/^?/OQ@TK!OM"#R
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MTV(D0R 3!!ELI_>]^..>O7Z\4Z(-NFQ 'P>1S\GY<^_.338@?)DQ"'&6R_\
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MB\8D&<1CT/';IQUQSQ3S+'OP7!DQS<<X/'ICO^7XTO,952/*XXA'20=02?\
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MVUYDTF]]%%/3?<_TP/\ @@@KP?L4^'0RJ2+!>,Y'^N[G_/>OW&8H8499)"W
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ML$#)/ID9'TZ\>]3+YGVA\>5NVC.=NS\/X<]>G/KWID7F>=)CR\X;.[;M_P"
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MFZ],?AS0!'\GD????_<Q\O7U_P#K>WO36V^2N'8MGE2/E'T.?Z=JE_>?9?\
MEGL_#?U_[Z_SZ4QM_P!G3.S;N.,8W_C_ !8Z=>/3M0 V39MBVNY./FR,!?\
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MTC@9^7 R6_WN1CZ<_6HX]FV7<[@X^7 R&_WNF/KS]*GA\S?-M\O.?FW;<?\
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MY_RY_/!IL1/DR8F"C+93^]ZGCCGZ_6@!H"&$#8^[^_\ P]<^_7T_'/:FJVP
M $G)R1R,<\=."/\ /I4@R;< 2C'&(^_7V].OI^--0@(%;GD_+SQUYZ=_4?SK
M?!O]\US6O]C6\MMK_?9>[YW*6SLK.S]_336.FO7KI=C93$0FQ&5NCG^\?;_/
MOWJ3:^S"(ZQ?Q(V=S>I0C&?;CBFS+M$1$H;(^[TV?7^O7\\U*;F4*$\SS"1Q
M+@83V.<=!C)Q^5>9CW:OA^2;C+VDK1E=1DN973Y4U?9*_2_0SJ7]G/EY9:1N
MY?FNF^J[Z:'XS_\ !>=8!_P3V\9CR)]O]OV.5Y#$_P!FZK@CKP/\.*_S$_#8
MCV7^^&5HO[2O-L8SO4^>_+$=NF!]17^GC_P7G\T?\$]_&6;L;O[?L3YFWA?^
M);JO''KU]1VK_,3\-O(?[07[2%/]HWG[XC(?]^X QVQZ^IK^N_ +F^I8OEBK
M_7)64KV_APW?Q>OXZ'YGQFXVI<SE_"C;EYM7=:/ETLO/2Z[[[UM$B/,Y5Y5+
M91(S\T8( Q)@'GO]*B$44LFYD?<K90Y("GGD]<@#O^-36(ECFN<3"(%\[\$^
M;@#D8!_EG/M4)21Y"5FV@,2R8_U@YX[XR2#Z^E?O>+O]>K)2YJG*N92NH:QC
M>,4O=U6BY=W>]C\2JN7UR3=1+?\ >?+;5?+2]K:=!3L$RY1FD )649\L#CA@
M..>,'TI5"&5B$=9"!NF.?*8<G"\XSU[=Q2Y(8#S0JX.8" 2_N&/M_.C)+']Z
M&7 Q!@ I[D]>G\J7V4K-KV2_<W=W[RUNTMOZU-;Z+5_PUK>?==6KZ]_B\AD8
MC$DFR*1&P=SMG:P(.X+SU89"TD8CVR[8I$'.]6SEQD?*G/7//T!IZD[VW3B0
M=H\ %#CAO^ '!]\4)NPV;@2<G:P _=?[1]?3CUIM/WNJ_=_N[?#JNO\ 6P[O
MWM7M#6\_+RMKY?.VI&HC\A@(91'G+1G.]B,X8'/09.?K3ML?D<Q2&+&#",^:
M?<<YYI06\LYN%9NTV!A!W3'7+<'IV^E+\VS/G@-C_CXP,#_@/MZU3U:O^\_>
MQLE]C2.C_K]+M[]5^\7679=E^#]WS&OY91 \4CH"NQ$SO0GH7P<X!Y.>U$RQ
M_)OCDDY&W9GY1Z-CO^OO3R3M&V=8VR-TI (DSV _VAQQZTC[AC$XA^;)R =_
MO[?3I4QO>%_??-.T]4H_#I\OS\[(F+?NZOXI=9]EW7SULOG<;((S)'OBD=L#
M:ZYVJ !M#<]5& U+A!<9\M_-'_+;GRLY^]C.,4K$[UVSB,=X\ ESCEO^!G)]
MLTO(DYE&S'_'M@9Q_<STS^/Z4:M+WKOV3_>VT^ST_K;T'?1;_P /:\^ZUVO^
MO;09&L9E?9')&_>1\[#ZXSQSVI4V!I-D;H2<.7SB3(_@R?3CBE&XLV9Q*.,1
M  ;?Q]O;\:<I(+;IA+SA5  \G/3/KZ\TGIS/X'RPO5>TM8Z?/^N@FW9ZOX8=
M9]UKM?YK7NAB+'Y;[8I$3)W1MG>Y)Y*Y.<$\C':D_=^1M$4@BQD1'/FCMSSG
MBGC<1DSK(><2@ "/T&!P<=/PI-QV?Z]2^/\ CXP,$=,8]S5?:E9\G[Z%V[^_
MHMKKKL%W=ZW_ 'D=+RTTVVMYV^'N[D;"+R%S%*4S\L8SYBGC+,<]#VX[&ED$
M>V+=%*X& @7.4&2</SR<Y/TIQW>6,7 5N,S8&'']WU^7Z=Z5BV$VW"QG(W-@
M'SC_ 'AZ<87\*$G>-ER+GG>-K\_FO7?\AIN\=7\4M+S\M-M;>=EV&R"/S(]T
M4CM@;73.U1@;0W/5>C>X-..QI5+1N92#B5<^4HX&#SC/3MV-#;MRXG$8[QD#
MY_4_\#ZCZ^M*3EAME"I@_P"CX&6[;L]1S_.DOABKV7LY?NM;R^'^OR"[TW^"
M>MY^7EOYOWNR$&Q96*QN)0!F5L^4PY&!SC/7MW%$:INDV1R1G.7+YQ)Q_!D]
MQQQ2@X8[I0R8'^CX&5[;L]3S_*@;B3F82@'A0 /*]CCKCKSZU+V>C:Y*7[K6
M\=8:W\]?T)N]=7\,>M3^[_=_X.NN\K0*T:>8$@E /W\Y)<;APOH<@'Z5&BH1
M^ZAF3).48D.?<9[<G\\>U658Y93<+*Y/R';@1'^\3],C'OGWIFZ:%@QN SX.
M'Q]T$].,_P"1[X.6/?\ L>*7,G^[=H/I:,;Z.RT];?(B;^)<RD_:4[1=M-%>
M_-;T[][ J X29'9<C" G>IX^8D<X[?4&DE@BC4%D>100%1"=RG/!/KCN/K4B
MO+*Q;SO+D(&9B,[A_=P?SS[^E,,<R')G\OL9".).>@ SC/K[UW\.M_V!/WE'
M2I[NFKOTMM;?W;G=2O[.=_<?*TWJU+X?=CS62MM[MUVN2N<P-GJ!\I'13GJW
MM7)Z\S)9VLA!=QJ=EMD7_5C]ZN<@<$\#GCH>M=:_-N^!C@9'_/3IP/\ //>N
M4UJ7986P)V1?VI99@[N?-'.?;W.>>.U>?B+O!XAW51NA5O*T/>TVO?FTVU26
M@\JY?[0H\R>LTM+7D[QT;NJC3=M))+SMO_I?_P#!!!GG_8I\.EF52;!><8'^
MN[_Y]:_<8B-8D 1P<@LY^ZV<9QTY.<#^5?AQ_P $$MLG[%'AWRHBH^P+\N?^
MFI_/T]L^]?N2VX6\:M,&R1\G=1QUZ9QQ[]L8K_/OB;_D>YIT_P!LJZ:76OW^
M7;0_I?*_X&'6R^K0]RT;QU6ONMKR^03&$[/*1E_O9SSTZ4LFSS4PCA<+D$Y)
M]<' ^O3\Z69 AC(F$A/I_#TI92WG1YF#'"X?GY?0<C/'T^E>$]]+V\_0]5VO
MI>VF^^WZ;#?D^T?ZM]G]S/S]/7'X=/\ &B/9YK[D=EYPH/S#GN?\_P!*?EOM
M7^N&[/\ K>>N/IN_3/X4D1/G/B8(>?GY^;G\_P _QYI"",1[I=T;D9^7!P5_
MWN#GZ\?2FQA/*?*.6RV". /3(Y^G7GVJ2(G?-B<)SR>?G_+G\\&FQ$^3)B8*
M,ME/[WJ>..?K]: &_)Y'W'W_ -[/R]?3_P"O_A36V^2N$8-GEB?E/T&/Z]ZD
M!/V;'G#'_/+\?R_7]::Q/V=/WH(W'$?/R^_I^1S0 V39MBVHX./FR<AO]WIC
M]?K3I-GFIA'"X7()R3ZX.!]>GYT2D[(<RA^.!S\GY\?ED4Z4MYT>9@QPN'Y^
M7T'(SQ]/I0 ,(_.7$<@7'*D_,?H?_K=^M"B/SFS'(5QPH/S#ZG_ZW;K3F)^T
M(?/!.TXD]/;U_(8]:%)^T.?/ .T9D]?;U_,8]* &QB/=+NC<C/RX."O^]P<_
M7CZ5''LVR[D<G'RX. O^]US^GUJ:(G?-B<)SR>?G_+G\\&HXB=DV)0G'(Y^?
M\N/SP* &KM\ELHQ;/# _*/J,?U[4-M\E<(P;/+$_*?H,?U[TY2?L[_O0!N&8
M^?F]_3\SFAB?LZ?O01N.(^?E]_3\CF@ D">4F$<-E<D\@^N!Q].O'O3I!'NB
MVQN!GYLG);_=X&/KS]*)2?)CS,&&5PG]WT//''U^E.E)WPYG#\\'GY/SY_+)
MH :PC\Y<1R!<<J3\Q^A_^MWZTWY//^X^S^[GYNGKC^G^-2,3]H0^>"=IQ)Z>
MWK^0QZTT%OM.?.&?^>O/I],_I^E #8]GFOE'*X; !P1Z9.#]>GY40[/GW([>
MFTXQUZ]>G^<TZ(MYTF)@IPV7Y^;U' SS]/K1;DCS,3"/\_FZ^F?\]* &QA/*
M?*.6RV". /3(Y^G7GVHPGV?[C[_[_P#!U]/UZ_X4Z(GR9,3!1ELI_>]3QQS]
M?K29/V7'G#;C_5?C_P!\_KC\: $DV>4FU'#<98GY3QV'^?QZTV39MBVHX./F
MR<AO]WIC]?K4DI/DIF8../DY^7C\OR_#BFRD[(<RA^.!S\GY\?ED4 $FSS4P
MCA<+D$Y)]<' ^O3\Z/D\_P"X^S^[GYNGKC^G^-.E+>='F8,<+A^?E]!R,\?3
MZ4$M]ISYPS_SUY]/IG]/TH %$?G-F.0KCA0?F'U/_P!;MUHC$>Z7=&Y&?EP<
M%?\ >X.?KQ]*<I/VASYX!VC,GK[>OYC'I1$3OFQ.$YY//S_ES^>#0!'&$\I\
MHY;+8(X ],CGZ=>?:FKM\ELHQ;/# _*/J,?U[5)$3Y,F)@HRV4_O>IXXY^OU
MIJD_9W_>@#<,Q\_-[^GYG- #6V^2N$8-GEB?E/T&/Z]Z)-FV+:C@X^;)R&_W
M>F/U^M.8G[.G[T$;CB/GY??T_(YHE)V0YE#\<#GY/SX_+(H =((]T6V-P,_-
MDY+?[O Q]>?I0PC\Y<1R!<<J3\Q^A_\ K=^M.E)WPYG#\\'GY/SY_+)H8G[0
MA\\$[3B3T]O7\ACUH :HC\YLQR%<<*#\P^I_^MVZTV/9YKY1RN&P <$>F3@_
M7I^52*3]H<^> =HS)Z^WK^8QZ4V(MYTF)@IPV7Y^;U' SS]/K0!''LVR[D<G
M'RX. O\ O=<_I]:='L\I]R.6YPP/RCCN/\_AUHB)V38E"<<CGY_RX_/ IT1/
MDOB8(.?DY^;C\OS_ !XH ;A/L_W'W_W_ .#KZ?KU_P *) GE)A'#97)/(/K@
M<?3KQ[TN3]EQYPVX_P!5^/\ WS^N/QI92?)CS,&&5PG]WT//''U^E #9MGR;
M4=?7<<YZ=.G7_.*)-GFIA'"X7()R3ZX.!]>GYTZX)/EYF$GY_+T]<?YZT2EO
M.CS,&.%P_/R^@Y&>/I]* &_)]H_U;[/[F?GZ>N/PZ?XT1[/-?<CLO.%!^8<]
MS_G^E/RWVK_7#=G_ %O/7'TW?IG\*2(GSGQ,$//S\_-S^?Y_CS0 1B/=+NC<
MC/RX."O^]P<_7CZ4V,)Y3Y1RV6P1P!Z9'/TZ\^U21$[YL3A.>3S\_P"7/YX-
M-B)\F3$P49;*?WO4\<<_7ZT -^3R/N/O_O9^7KZ?_7_PIK;?)7",&SRQ/RGZ
M#']>]2 G[-CSAC_GE^/Y?K^M-8G[.G[T$;CB/GY??T_(YH ;)LVQ;4<''S9.
M0W^[TQ^OUITFSS4PCA<+D$Y)]<' ^O3\Z)2=D.90_' Y^3\^/RR*=*6\Z/,P
M8X7#\_+Z#D9X^GTH &$?G+B.0+CE2?F/T/\ ];OUH41^<V8Y"N.%!^8?4_\
MUNW6G,3]H0^>"=IQ)Z>WK^0QZT*3]H<^> =HS)Z^WK^8QZ4 -C$>Z7=&Y&?E
MP<%?][@Y^O'TJ./9MEW(Y./EP<!?][KG]/K4T1.^;$X3GD\_/^7/YX-1Q$[)
ML2A..1S\_P"7'YX% #5V^2V48MGA@?E'U&/Z]J&V^2N$8-GEB?E/T&/Z]Z<I
M/V=_WH W#,?/S>_I^9S0Q/V=/WH(W'$?/R^_I^1S0 2!/*3".&RN2>0?7 X^
MG7CWIT@CW1;8W S\V3DM_N\#'UY^E$I/DQYF##*X3^[Z'GCCZ_2G2D[X<SA^
M>#S\GY\_EDT 1R;/-3:CJO&5)^8\]C_G^E'R?:/]6^S^YGY^GKC\.G^-.E)\
MY,S!SQ\_/R\_G^7X<TN6^U?ZX;L_ZWGKCZ;OTS^% #(]GFOE'*X; !P1Z9.#
M]>GY40[/GW([>FTXQUZ]>G^<TZ(MYTF)@IPV7Y^;U' SS]/K1;DCS,3"/\_F
MZ^F?\]* &QA/*?*.6RV". /3(Y^G7GVHPGV?[C[_ .__  =?3]>O^%.B)\F3
M$P49;*?WO4\<<_7ZTF3]EQYPVX_U7X_]\_KC\: $DV>4FU'#<98GY3QV'^?Q
MZTV39MBVHX./FR<AO]WIC]?K4DI/DIF8../DY^7C\OR_#BFRD[(<RA^.!S\G
MY\?ED4 $FSS4PCA<+D$Y)]<' ^O3\Z/D\_[C[/[N?FZ>N/Z?XTZ4MYT>9@QP
MN'Y^7T'(SQ]/I02WVG/G#/\ SUY]/IG]/TH %$?G-F.0KCA0?F'U/_UNW6B,
M1[I=T;D9^7!P5_WN#GZ\?2G*3]H<^> =HS)Z^WK^8QZ41$[YL3A.>3S\_P"7
M/YX- $<83RGRCELM@C@#TR.?IUY]J:NWR6RC%L\,#\H^HQ_7M4D1/DR8F"C+
M93^]ZGCCGZ_6FJ3]G?\ >@#<,Q\_-[^GYG- #6V^2N$8-GEB?E/T&/Z]Z)-F
MV+:C@X^;)R&_W>F/U^M.8G[.G[T$;CB/GY??T_(YHE)V0YE#\<#GY/SX_+(H
M =((]T6V-P,_-DY+?[O Q]>?I0PC\Y<1R!<<J3\Q^A_^MWZTZ4G?#F</SP>?
MD_/G\LFAB?M"'SP3M.)/3V]?R&/6@!JB/SFS'(5QPH/S#ZG_ .MVZTV/9YKY
M1RN&P <$>F3@_7I^52*3]H<^> =HS)Z^WK^8QZ4V(MYTF)@IPV7Y^;U' SS]
M/K0!''LVR[D<G'RX. O^]US^GUIT>SRGW(Y;G# _*..X_P _AUHB)V38E"<<
MCGY_RX_/ IT1/DOB8(.?DY^;C\OS_'B@!N$^S_<??_?_ (.OI^O7_"B0)Y28
M1PV5R3R#ZX''TZ\>]+D_9<><-N/]5^/_ 'S^N/QI92?)CS,&&5PG]WT//''U
M^E #9MGR;4=?7<<YZ=.G7_.*)-GFIA'"X7()R3ZX.!]>GYTZX)/EYF$GY_+T
M]<?YZT2EO.CS,&.%P_/R^@Y&>/I]* &_)]H_U;[/[F?GZ>N/PZ?XT1[/-?<C
MLO.%!^8<]S_G^E/RWVK_ %PW9_UO/7'TW?IG\*2(GSGQ,$//S\_-S^?Y_CS0
M 1B/=+NC<C/RX."O^]P<_7CZ4V,)Y3Y1RV6P1P!Z9'/TZ\^U21$[YL3A.>3S
M\_Y<_G@TV(GR9,3!1ELI_>]3QQS]?K0 WY/(^X^_^]GY>OI_]?\ PIK;?)7"
M,&SRQ/RGZ#']>]2 G[-CSAC_ )Y?C^7Z_K36)^SI^]!&XXCY^7W]/R.: &R;
M-L6U'!Q\V3D-_N],?K]:=)L\U,(X7"Y!.2?7!P/KT_.B4G9#F4/QP.?D_/C\
MLBG2EO.CS,&.%P_/R^@Y&>/I]* !A'YRXCD"XY4GYC]#_P#6[]:%$?G-F.0K
MCA0?F'U/_P!;MUIS$_:$/G@G:<2>GMZ_D,>M"D_:'/G@':,R>OMZ_F,>E #8
MQ'NEW1N1GY<'!7_>X.?KQ]*CCV;9=R.3CY<' 7_>ZY_3ZU-$3OFQ.$YY//S_
M )<_G@U'$3LFQ*$XY'/S_EQ^>!0 U=ODME&+9X8'Y1]1C^O:G?)Y'W'W_P![
M/R]?3_Z_^%"D_9W_ 'H W#,?/S>_I^9S3B3]FQYPQ_SR_'\OU_6@!L@3RDPC
MALKDGD'UP./IUX]Z=((]T6V-P,_-DY+?[O Q]>?I1*3Y,>9@PRN$_N^AYXX^
MOTITI.^',X?G@\_)^?/Y9- $<FSS4VHZKQE2?F//8_Y_I1\GVC_5OL_N9^?I
MZX_#I_C3I2?.3,P<\?/S\O/Y_E^'-+EOM7^N&[/^MYZX^F[],_A0 R/9YKY1
MRN&P <$>F3@_7I^5$.SY]R.WIM.,=>O7I_G-.B+>=)B8*<-E^?F]1P,\_3ZT
M6Y(\S$PC_/YNOIG_ #TH ;&$\I\HY;+8(X ],CGZ=>?:C"?9_N/O_O\ \'7T
M_7K_ (4Z(GR9,3!1ELI_>]3QQS]?K29/V7'G#;C_ %7X_P#?/ZX_&@!)-GE)
MM1PW&6)^4\=A_G\>M-DV;8MJ.#CYLG(;_=Z8_7ZU)*3Y*9F#CCY.?EX_+\OP
MXILI.R',H?C@<_)^?'Y9% !)L\U,(X7"Y!.2?7!P/KT_.CY//^X^S^[GYNGK
MC^G^-.E+>='F8,<+A^?E]!R,\?3Z4$M]ISYPS_SUY]/IG]/TH %$?G-F.0KC
MA0?F'U/_ -;MUHC$>Z7=&Y&?EP<%?][@Y^O'TIRD_:'/G@':,R>OMZ_F,>E$
M1.^;$X3GD\_/^7/YX- $<83RGRCELM@C@#TR.?IUY]J:NWR6RC%L\,#\H^HQ
M_7M4D1/DR8F"C+93^]ZGCCGZ_6FJ3]G?]Z -PS'S\WOZ?F<T -;;Y*X1@V>6
M)^4_08_KWHDV;8MJ.#CYLG(;_=Z8_7ZTYB?LZ?O01N.(^?E]_3\CFB4G9#F4
M/QP.?D_/C\LB@!T@CW1;8W S\V3DM_N\#'UY^E#"/SEQ'(%QRI/S'Z'_ .MW
MZTZ4G?#F</SP>?D_/G\LFAB?M"'SP3M.)/3V]?R&/6@"/Y//^X^S^[GYNGKC
M^G^-$>SS7RCE<-@ X(],G!^O3\J<"WVG/G#/_/7GT^F?T_2B(MYTF)@IPV7Y
M^;U' SS]/K0!''LVR[D<G'RX. O^]US^GUIT>SRGW(Y;G# _*..X_P _AUHB
M)V38E"<<CGY_RX_/ IT1/DOB8(.?DY^;C\OS_'B@!N$^S_<??_?_ (.OI^O7
M_"B0)Y281PV5R3R#ZX''TZ\>]+D_9<><-N/]5^/_ 'S^N/QI92?)CS,&&5PG
M]WT//''U^E #9MGR;4=?7<<YZ=.G7_.*)-GFIA'"X7()R3ZX.!]>GYTZX)/E
MYF$GY_+T]<?YZT2EO.CS,&.%P_/R^@Y&>/I]* &_)]H_U;[/[F?GZ>N/PZ?X
MT1[/-?<CLO.%!^8<]S_G^E/RWVK_ %PW9_UO/7'TW?IG\*2(GSGQ,$//S\_-
MS^?Y_CS0 1B/=+NC<C/RX."O^]P<_7CZ4V,)Y3Y1RV6P1P!Z9'/TZ\^U21$[
MYL3A.>3S\_Y<_G@TV(GR9,3!1ELI_>]3QQS]?K0 WY/(^X^_^]GY>OI_]?\
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M\_O./Z_SILY8R+^^#'C$G9?SQT_^N.:<@E1MQF!8?\M>WU]?\*]+"W]D]?\
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M>/WPZM]1_M>@QZ<TU&;]U\TJ<6TFI0YK:?:6MOQ;"[CH[Q<K/[2YK\NW5_\
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MYBV8/S\;ORS_ %]_:ED$OEIF&(#*X(P2>1C(R/IUX]ZA/D^6?]=OP?\ <_\
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MGSMV6QM^[U/WL?+G'7/X\4 2*'\@9BC$>/O\!_R__7GWIBE@/E^YS\W?/O\
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M\7'WXWJ7FT^:#]W;79;?TP2>FEM7]B2_EL_C=N]W>_1+4D(D+#$:/& NZ1P
MZ'N%Y' / ^G;L$.),K&GD[O]?@>=^6<_X>W:.4Q-*@?S!)A-FS'EXP,;\8&<
M#G/?T[._=K=?QF?=[>1_\3V__5VE? GO#V,OWK7O+X>C?S^0)>735<LM=5VG
M^%[VV>]W('W?O(HU3G:Z@;W_ -X9'^>WH*) 7S&BJ?N,H!+CNS\]<\=\CUJ.
M(1-*^SS1)R'WX\OK_!GCMZ?AZ+$8U:8)O+9_>;]NW<1_RSSGC'IGGUIST3;]
MR-H6JI/FE[T=+7^?Y!9ZZ7TCIR2[K_IYJ_)6:M>[V'H'V-OBC1^R*!M;/0M\
MW5A][U[YZ4@$WE@>3'YF?]5@>7G/3.<8Q_AGM3(EB,4A3S-A+;M^-^3PVW/.
M/[N/UZ4@:'[,!B7RN/3SL9Q]<_YSVH>C?,_9WK0Y9)/]YMK+7_@]@L[RLOMQ
M;]U^6OQ_CLK[/0E(?8 L,32Y.Z$X\I1ZKSC/7MV'KRA$I";8HW.W]X' Q'S_
M ,L^>>#G_.3$PA\A"WF^3N.W;CSL\?>[XY'7W_%93$R0B3S=I7]WY>-W7_EI
MCOD]^WYFK>]"ZY'[2?+%)VGH[7;E\WI^ TGIIU_EEIMK\?RN]'V1*X?<#''&
MZ87?(V-Z'C(7DY .0/4>N>5(<RC,:&/',A WJW95YZ$=?R]JBE$2RH7\PR83
M9LQY>,#&_&1G!YSW]>[F\MKA,[Q)M.W&WR]O0[NV[T_R*A;P5K2]G*U*WNO1
M;Z_U^4I:K1_"[OEEY=Y]=='KYH> XE.(T$>.) !O9NZMST Z?E[4(&R_F1H@
MYV%0,N!_$_(P<\>P]*8OEK</C>9-HW9V^7MZ#;VW>O\ D4D0C9IBF\-G]YOV
M[=P'_+/..,>F.?2C6S22E/DIWI->ZE>.J=]W_74=GVZ15^25W;ENOXEW;MI:
M^K>H?Z0-P\B)!CY N,..V_KC_/'>DCCGE.TPPHYW$*NT*>_.._'X\\U'') B
MRJ@F((Q)O&3U!_=Y'MVY_G3(C$5)B\_'.=V=_P"'MU]O7O6&/_W3%VE9\CW5
ME'W8:7=]O0REM+EEK[6ENK*/PZ:MZ+\.SW+@B=7*-'&S]2C$; ,=0>A/'/3D
M#GU)44 &&.-W_B5L;5'5BIP>5Y*^I[5#L1P!*90F?EVY\S\>X'IGC!/M1+;Q
M1*C.92N5V[,ELYRN[ )QD_-Z#D^M=O#K7]@5+SU]_2+33]Y]DOT.ZG=4Y7?+
M=.TTFN=Z>[JY)J^GV;]+.Q.Y_</UP!\_8IT^YP.>O'L.E<EKB2_V?;/$H=!J
M=CF1C^\7,R8"]_7_ .M76R']R<XZ?)UQG _UG &.G7@GKVKD==<QVMJS!C)_
M:5D $!,6/.3[W;/^?6N"NU]3Q/++F_<U/B<5S.RTMRO_ -*T\RLJM_:%%./-
M[ZM%-+6^C<;-I=VY/S1_IA_\$#B&_8H\.^<SC_0$YQ@_ZWT^G./QXZU^Y#AQ
M#&?*C$8((; +-SQD#\C]?3K^'/\ P00+S_L4^'3\BG[ @Z@#_7>V!U/7TX..
MM?N$1$J(!YV[C=SE,9R<9XZ=/T]_\^^)O^1[FE]_KE6Z6V_33Y7_  /Z5RM_
MN:.NOU:G>"::7FK);_/;7H2.[,4!BC7IC '.?7!_.GR"7S$S#$&PN ,$'@8R
M>/KTX]ZB;R/E\OS/?./T_I2MY.Y<>=MPN=V=W0?=S\W7IC\.:\)^2[?D>L]]
M$UMOZ$V)?M'^IBW[ON<;.OK^G3_&FH)?,;$,3-W4XVCZ?_J_+I3/W/F_\M]F
M[W\SK_WWG]?PIJ^3N.[SMO;;][\<<_G^/-(1+&)=TN(8B<_-G "\#[O7/UX^
ME$8E\M\0Q$9;). 1R<X&3].O/M42^1E]WGXS\NW.>@^]CG/^]S0OD[6SYV[+
M8V_=ZG[V/ESCKG\>* ) )?('[F+9@?/QN_+/]??VH82>2N8HPNXX88W'IU'_
M -<]>E1#R?+'^NWX_P" ?I\O^?6EQ$8P%+^9DDAC\@''0#C/7M1^'GV&DVTD
MKMZ)$L@EVQ;HH@,?+C!+<G[W(Q].?K1()?,3,,0;"X P0>!C)X^O3CWJN>-N
M=V!P<].O.WVJ4K"2"IE*@#=DY;( S@G)Z].?I0VEU5M->FH^5MM+6VKL2,)O
M.7,$(;:<*,;2..I_^MWH42^<P$,)?:,IQM YZ<_T':J5Y+' @D19B!P003)S
MZ \XXYX_F#4;7EL+>.95N/,=B&7:VX 8QD;<XYJE"3<4DVY?"NY)H1B7=+MA
MA8Y^8$CY>!TZ_P A]*2/S"LNV*)ACYLXRO(Z<G/Z?6H0T+QQR)YJ[AF0,""#
MD]<@=O:K9BMIK:1K25C.B#C<-F<C[P'7\?Y\5I[&5G?XE;W%JU>V_;?Y]Q.2
M2NW9::^NQ$HD\EL11E=PRQQN'7H/_KCITH;S!"N8H@NXX;C<3@=1_P#7/4\5
M2A9DBD^VL5ER-FU@(R.1\PR.<D=OUJQ"%96>0N\8^[Y0W<CKP,\\C]:P;49^
MS>D[7Y>MBE%N]DW;5_@OU1+)YGEINAA5<KAAC)Y&,\C^?3UI9!+NBS#$#GY<
M8(;@_>Z8^O/TK.BO()9F@V7"'YA&74A=X!V<D8QNQSZ=*G2WO8$DFU"2/RP-
MT**P\QNF,#.<XR>!2E-1<4[^]>UE=*UM^VXXQ<Y**M=NROHK^I;83><N8(0V
MTX48VD<=3_\ 6[T@\SSP/*AWY'R9&W\__K?IS5>T,=\Q\N58V7^"5MLAZ?=!
MP2/7@]JFN1;VP(:1Q*.C$@#/8\XZ=^G'Z',DDW>W>VD=5K+LOZ]7*FX7YFKI
MVM?5Z)W7=:[CHQ+YCXAB+8;(. !P<X//UZ<^U$0E^?;#$WKNP,?3KT_SFJDS
M"RA^T7(EDC8?*;<,6RW SMZ]>?QSTJ&SOK.YW9\V$X^4.63)]^G3^O:B,N97
M2:72ZM?1.Z\NQ!HH)?+?$,17+98X!')S@9/TZ_E3?WGV?/E1;-OW^-W3TS_7
M_"J\"LTA$AVQ%N&7A=I/!).!D_K[=:LM97"7!=KF :6#DMYJ9V 9QG./TIIW
M5]5I>ST?W"3ND[-7Z/1_<*XE\M<PQ!>,,N,GZ_\ ZS_6DD\P+%NBB48^7&,M
MR>O(Q^OUK,_M.PGF:WLTNG=,Y=@S1<'J"./;CUK2AB#H_FLT;KG9N^51^?H?
M\^LQJ0E>TMMTTTULNNEFWHTQ<T;<U_=[]!T@E\Q,PQ!L+@#!!X&,GCZ]./>E
M(E\\_N8M^3\G&W\__K>WO45G97EPS>;<VLJ[F">5*K,!D@9PQP1W]*AN(;FW
MNRC7$+0 GY%D!N.^.C$Y]>/6FI7;5GIU:T?H^I5];6?77II;\==/1EM1-YS8
M@A+;1E3C:!ST/_UNU)&)=TN(8B<_-G "\#[O7/UX^E9$T]Q;RM))'.ULP B*
M ^9OYSN.-VWD=J-/75I9));Q56S=LP!<B79@?ZSONSFJ;MN5&,I?"F[:NW8U
MHQ*8WVPQ,NYLL<9!R<@#)^G7GVH42>2V(HRNX98XW#KT'_UQTZ54ECNY)E6P
M=1!QN\T@'/1^GOG'?IFK$_EV<.Z0M)-Q\L)W+WR2!]1@X_'%-II)M6NKJ_4%
M%MQ5G[STMJ_N'MY@A7,407<<-QN)P.H_^N>IXI9!)MBS%$!CY2N#NY/7D8_,
M_6H[1K>Y4M([KUQ&I^88'4KR1GM4,AD,A6VE5(U.&^T,%;N?E''0'D8Z^N<5
ME[2.BUYF[)6=WWM;MYV-OJ\DTI-13V<M+OM:^_E>Y:D$NZ+,,0.?EQ@AN#][
MICZ\_2E83><N8(0VTX48VD<=3_\ 6[TQK9IHV>SF5Y(QELMN [94@\9R.G']
M8X-RJ5O'4MG \MOF]3COZ9^@_ 55/:,_FK7]-?Z^^RC0FU)NR4%=]7M=67F3
MJ)O.;$$);:,J<;0.>A_^MVI(Q+YCXAB+8;(. !P<X//UZ<^U1#R=[9\_9Q@C
ME^_4CGZ9X_&E7R=S9\[;AL;<[NA^]CYNO7/X\UH8$D8EVR[8HB,?-G *\C[O
M)S]./K0@E\ML0Q,O=CC</I_^L?UJ)?)P^[SLX^7;TZC[V./^^N*%\G:=WG;N
MVW[OXXX_/\>* 'XE^S_ZF+9M^_QOZ>F?QZ_X4Z02^6F88@,K@C!)Y&,C(^G7
MCWJ']SY7_+;?C_MGT_[X_I^-*WD[5QYV[*YW?=ZC[N?ESCIC\.* )91+\FZ&
M)?3;@Y^O3K_G%$@E\Q,PQ!L+@#!!X&,GCZ]./>HG\GC;YWOO_IN_SZ]J5O)W
M+CSMN%SNSNZ#[N?FZ],?AS0!-B7[1_J8M^[[G&SKZ_IT_P ::@E\QL0Q,W=3
MC:/I_P#J_+I3/W/F_P#+?9N]_,Z_]]Y_7\*:OD[CN\[;VV_>_''/Y_CS0!+&
M)=TN(8B<_-G "\#[O7/UX^E$8E\M\0Q$9;). 1R<X&3].O/M42^1E]WGXS\N
MW.>@^]CG/^]S0OD[6SYV[+8V_=ZG[V/ESCKG\>* ) )?('[F+9@?/QN_+/\
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M.H_^N>O2HQY7EMGS=^1C'W._7^'/3KSZ=J#Y7EKCS=^3G/W.W3^'/7ISZ]Z
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M3<!4'\++]YFSP&Z=3P?J?J69%L,#+.>N>4QQTZ@'U Y_G1Y:W/*EE?DMNX3
MY.W.!G'3W^O)Z/7^6ZTVZVO^ ELG\,.;2K9\[^'5ZMJ_=W3[)6L2&960*BJI
MQ@+T<<_?P#]?K^LI5=P+*@G_ (8AC8PXR3SUZ?F>O>+SEA^1 Y###EQD_P#
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MJD^-[9)!R<@9P/IQ5E?)W-GSMN&QMSNZ'[V/FZ]<_CS4#;MQVXQDXSG/X^]
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MKV_#T5"V7\R1''.P*1E!_=?@Y.>?<>M0*^R5BENR$Y)ER</S]?QX'UQ5@1*
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MK-):_9;ZI/JUU6ZZG[FZ7^T;\ /&AATCP5\7/!>LS781+:*PU19I)2XPNS"
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M6Y'W>!CZ\_2F(%R^;5GP>!D_)P..>/?C(_2A N'S;L^!P<GY.1SSS[<9/Z4
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M[?\ #:B<G&]KW:Z7VNM[:[VT5V+*9?+57DB(_N#AAWYZ]*C:-@J,'5N.-O\
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MZ\^U $:LHB'[\DX_U.#C]>?KG/XBA 6&0>F?D_K_ (]_?M3U#^0,Q1B/'W^
M_P"7_P"O/O3%+ ?+]SGYN^??^G\^U;83E]MLV[:-:KI\7);??5-ZZO8M?"[_
M  W5TOBW6W6S[NZ\MQLC-PID8@<<Y&S_ !QG-6%CA:/?]HW@#F0C)7TQ]/\
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M%=YK'@K35^(?C>S\/W<;ZLR_9KV6>2RDBDG+E8SORQ?IU &*_#?XL_&KQ_\
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MCITP!T[\5;T**.>UFGO)V>X1P$F?)= <DJ#QUXZ@^G' J:$:@TD@GC18Y,A
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MJ07--Z.\$XV?3X^O,TM=5\C]Y-3U+1_!?@]=3U%89-,TJU,DMY*R@11QIDL
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MVI+;,%<DRD?,WRX.&Y_K_7C KY7_ &R2C_"C6@7/_'A=?NST_P!6WMCVQ_\
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M#F_VR5E)_P!R&[M^A^9\9V2I<TW#]S%+E=N9W7NM--V_'T-NWA2-Y6E=UC+
MQ%,DL!T+8(P<\8)X%1>3%++NWN&1B4'."<GANGZYJS8&=9KH#R_O_.9<;>%'
M^KSQCZ<=L9J$B<R$Q^7L!/F>NWG.SIW].W:OWO%.7UZLDU.;C'FIMVA%<L;I
M)7=^WGND?B=5S^N3?-&^OO[K9+?2UO2WW,0B-9UW,WG!2%0#Y",\YXQGZB@+
M&TS%6;SRH#(1\@&<Y'&W/7I4@WY&/+\K'S[O]=^'MC^E+^\R?N>3QLVY\W_@
M7MC'ZTK^XEK[/V*_=W]_64=M.O\ GL:<SLO>UY$[J2WYEK\/X_*W4AB$*RR>
M6[,Y#;E8': 0=Q&01D9., 4V-8-LVQW92#YI;.57/5<@G.2!QCC]9U\W<V_R
M]G\.S[^<?+NQSC.-V>V:1?.^;?Y6[)V;/NY_Z:8[8]>^*IMM>]>4/W5H+XHO
MF6K_ *Z/YN[[](;R75K7X>O5[/LB%?(^SN [F(GYG(.\-S@#^+!R<X:C9#]G
MY=_(Q@O@[\YR>VZIAYVPY\KS.=N/]5MYW;L?+NZ8_'WI1YVT8\OS<<9_U/MG
MW_2B3NTI7DE5CR\OV=(VOZ;^GXMR=]VOWEOB]-+6V\K]G<BD\EHU61V6/*[&
M4?,QR,9P,\G&<_C23+$/+,KLO.4V \@X^]C'IW_*ISYF/W?E>;QYF_.S'^Q[
MXSCWIK>;QY?E_>^;S?\ V3/;]:$WS0<GSR3GRRC\,5IH_/\ KU2D[QU>KDM9
M;VMI\.MNVEGU(Y1"TL?F.RN NU5!VD #:3@ 9.!G(-*!$MSG<WGY_P!7C]WN
M].FW'']W_"I&\W<NSR]G\6_[^<?-MSSC.=N.V*/WF_\ @\G'OYVW/_?6[_/6
MA-V3O^\]G*U3[*UCO_6R^\N[)W^Q)_$K[K6_+]SM\B%%B,K^6[-*>JL#M'<X
MSQQCC %.B\I6E\MF9BW[T,.%)'.W(Z8]*>/-W-N\O9QCR_\ 6>V>_P!<TX>9
MSYOEXS^ZV9SGMYGOG/X4G)\TVG:?+"\W\+]Z.WWOY=Q.3][WGI&+MS)6ORZ_
M"[7[ZW^>D")#Y<GEN[19;S&8'<I/!VY&>#G&*7]S]GVAW\C'$F/G]NV[/XU*
M/._C\O?SMV9\O';?[^OO0?,VG/E>?CG'^JQWQVZ_A3O9RY;Q;JPYG)_%I';^
MO\AW=WK_ ,O(K22TT6C]W\+W?=%=E@\A,NXBW$JXSO+<;@?XL#(QD_URZ80,
ML0D=U4<1E0<LN3RV .<D]<U*?.V#'E>9QNS_ *O;VVY^7=Z_A[4K>=\NSRMV
M1YF_[N[_ *9Y[8QT[YIP;O[MXQYY\T9:.7>WJ]>NGW I-M:M^^U\2:T2T^'[
MET[D,@A\V,N[+)A=JJ"5(Q\A. !D@C.0??UIS")ID+,PFP0B ?(0>,G VYZ=
M:D/F[EV>7LYW;\[\_P 6W/./[N.V.U*=^?DV>3@YSGS<_P"S[=?TJ4](I74/
M92_=M^\]%Y"YM8ZN_LY.ZEII;7X=UWZ=4R)1$LSE68S8 ="/D '&1D;<]>E$
M:Q%I3&[,V<RAAPN!_#D>GI4HWY^?9Y.!C&?-S_M>W3]:/WO._9C/[OR\YQ_T
MT_'K[4F_<L[NGR4^6FOCB[QU?I_7F<SL]7=1@[\WIJO=TOWUOV151K>,2JKN
MP.1(6!)49'W<@\Y '&.*C00A<PO*RDG<Q#;@>N!DYQU]OUJV/,RPD\DN3^["
M8Y.?X_;&>O?%-5[B)PSK#OP0H &W!/\ $#QGI^OX8XYMX/%+?]WI%_X8_9TU
M^?W=8FVU)74_WE/EC=.VSLTK/_/[R,(L@ E9PG16&=V>./7'X]S]*22WCB"M
M*[K&"-I7)8G.5W8P<'OD_7UJ<22R.6C$0EP =P CQVV@<;LY_3O4?^D[O^6>
M[^+?]SKSLW<;NN/TXQ7=P[=</U-HJT[QMKN]M7Z_YG92;<*GV9*/O7:DK:>[
M&R7*UMO+MYDKD&!L]0!L'9CP/FQVX[YYZYKDM=;R[2U=\B0:E9!4'W"/.7D]
ML].Q^HKKG_X]Y-O3 \SUZC[OO_D5RNM.!I]LN!Y']J66XN,RY\T?=SSCKG''
M3/>N#$7>#Q#DN=^QJW:3U5MD^:S>FUD5E5GCZ#?,DYV;2;<]5[O-=)WV2Y5O
MNMS_ $O_ /@@BSS_ +%/APA5!-@HQT'^N/ICO[=#[5^XA6)8D"NY?C<#NV@'
M!.,Y'Z?B*_#G_@@GY?\ PQ1X=\G?M^P+_O?ZT_\ U\8[]>U?N4WFFWC#^7@E
M<8 W]L9ZGTR>GXU_GYQ/IGV:*UE]<JV5M5JO/MTT[^2_I?*_X%#2R^K4]+6D
MM%OJ)*L"[/*=FS][/;ITXI'6(2(%9RI"[B<[AZXRQ/TY'MBGS121F,L4.>FT
M?3K3I?,\Z//EYPN-NW;_ ,"Q\N<=<_CQ7@O?37S^1ZKWT=UIK\OZL1[8O/QO
M?R\YW<[_ %_O9_\ 'OQ[4B+$9&#,X09P1G<>>^#G]3^/6IOWGVK_ )9[\_[/
ME_\ Q']/QI(?,\]]OE[N<[L;?PSQ^7X<4A$<:0EI-SR  _+MSD_[V".?J3]:
M1$B,;EG<,"VT#.T^F<$#Z\'\:GA\S?-M\O.?FW;<?\!SQT_N\4D7F>3)CR]N
M6SNQN_X#GYNO3'X<T 0A8A#NW/YG]WG9Z>H'_CO^-(5B\E6!;S"3N&/EQ[?Y
M_&IOWGV7_EGL_#?U_P"^O\^E,;?]G3.S;N.,8W_C_%CIUX].U "-Y:JFUF8L
M/GW9X/MDGCGL!]*1UB$B!"^P@;B>&![XP?Z_E3YM^R'=LQCY=N,_\"QSG_>Y
MITOF>='GR\X7&W;M_P"!8^7..N?QXH_4;DVDF]%LNQ&T<#2JK,[Q'EBX);(Z
M8SGCUY'TJ820Y\@ I"O*LJX8GOG;@X].?YBE;S/M"9\K=M.,;=GX_P .>G7G
MT[4+YGVA\>5NVC.=NS\/X<]>G/KWIMMV3>BT7]?,1RNO^$_#7BN2)M=TJQO_
M +&-MN;NRBN&P"6&3(">I/!SWK2TW2='TR PZ?I]IIP1 J?8;6.W# =F\D)Q
MQG!STXYYK7A\S?-M\O.?FW;<?\!SQT_N\5'#OV3;=F,?-NQG_@.><_[O-%W:
MW0E1BI.22YGNR.5(;BR>*4$R%@5?'S  $?>X(ZC_ #TK)9626JQ21+=$L3MN
M$\Q4'3*[RP!X[ ?E5Q=_V=\;-NX9SC?^'\6.O3CU[T-O^SIG9MW'&,;_ ,?X
ML=.O'IVHN]/+;R**4-E;V@WV[/'Y@*M$NY(U# @[5!QP"<8 [>U/AL[&WG61
MXEO-Y^?[3'YNWW7>6Y'MCC@8XJ]+YGDQY\O;E<;<;O\ @6/FZ]<_CS2S>9OA
MW>7G/R[=N/\ @6..G][BK=6I)-.5TTE:RV6P=O+8ISVEH]Y'+%F",*<K"NP9
MR/X5('8]OI[RS)%.?(=Y##P,Y.[&.>,YSWZ_6K#>9]H3/E;MIQC;L_'^'/3K
MSZ=J9^\^U?\ +/?_ ,!V=/\ OG_/K2YYW3YG>*LMM%V1492@[Q;B^Z,?5-"\
M.^(;5M.\0Z-I^L6(7 @U&R@O(F"8VAXITD!!QSG/YUQEG\&/@I#*;A?A-\/X
MKE"&CN8O"FC+,&'(;S%LPP8'G.>37I<7F>=)CR\X;.[;M_X#GY<XZ8_#BBW\
MS]YM\OWWX_'&[_/KVJ;LEZWOK?>_4HV=EI]C$L=C:Q6<,"A(+:UA2&!(TX1%
MCC"HJJ,  +@#BN U3X4^ M;UAO$6L>&]&U2_>4S.E]I=M=*SDY.XS(P.3U)7
M]:].B\SR9,>7MRV=V-W_  '/S=>F/PYI/G^R_P &S\/,_P#B\X_'\*?/+HVO
M30R5&FK^ZK.7-9I637;_ ",JVTK2+"!(;33[6&  !;6.VBCMXP!T2,+L&.BX
M0<5E:WX,\$^(1$?$'A70O$(5<+%K.E6=_'",D[(A=12A5R2V% &23CFNJF\S
MR$W>7MXQMQN_''/Y_CS39M^R'=LQCY=N,_\  L<Y_P![FASD^KZ?A_7](:I4
MXVM%:.Z;WN]_EY'G"?"#X.VUS'<V7PM\"V5PA4BZMO"VD07*-QRDB6@<$$9!
M!!';-=R]E:BW&GP+Y%JH"*(UV851\H"J5P!@?TP,5H2^9YT>?+SA<;=NW_@6
M/ESCKG\>*/WGVK_EGO\ ^ [.G_?/^?6A3DE9-VNG;IIMYE<D7'EDKK9M[]/3
M7^NQ5@M=/-LVFWUI#?6?)"74*SJ=P 8,LH?@X]?;N*XUOA/\'9[JXO+CX7^!
MI;J9][W+^&-(:>5\;=TDIM2SM@8R3G '-=^OF?:'QY6[:,YV[/P_ASUZ<^O>
MDA\S?-M\O.?FW;<?\!SQT_N\4N:7=_>-144DELK+O9>>[.9TOPIX8T13_8.C
M:;H4*$E+72;&&RM^N?\ 5VRQ)\V<ME>I-="/LF1<M;1&ZC^1'\M?NGJ2^W([
M?D/:I(O,\F3'E[<MG=C=_P !S\W7IC\.:C7?]G?&S;N&<XW_ (?Q8Z]./7O5
M.<VDG)M+1>7]6"RO>ROWMK]YG>(M'T'Q39P0ZWI5C?B%R52\M8KE%SCE1(C#
M/R]>/2I]/T_1=$LX+/2-*LK*)$QBVM88%&3GY1'&OKVQ[\5:;?\ 9TSLV[CC
M&-_X_P 6.G7CT[4LV_9#NV8Q\NW&?^!8YS_O<TN>=E'F=EJEV].PQ7\I638S
MD,?FW Y4?[//7\OK32(Q*JB67RB.3EMV?;YNG'J/I4LWF;X=WEYS\NW;C_@6
M..G][BE;S/M"9\K=M.,;=GX_PYZ=>?3M2NW:_3;R'=NU^FWD0!(?-8%Y F!A
MAG<?KSG'XGZ"D18C(X9G"@-M(SN/IG# _7D^^:L+YGVA\>5NVC.=NS\/X<]>
MG/KWID7F>=)CR\X;.[;M_P" Y^7..F/PXI"(8UC*R;F<$#Y=N<'_ 'L$?J#]
M*5%B,;%F<.,X SM/'?D#]#^/2GP[]DVW9C'S;L9_X#GG/^[S3H?,\A]OE[><
M[L;OPSS^7X<T 0[(O(SN?S,8V\[/3Z?^._AWI72(1H5=RQ*[@<[1ZXR2/IP/
MPJ7Y_LO\&S\/,_\ B\X_'\*67S/)CSY>W*XVXW?\"Q\W7KG\>: (95B79L9V
MS][=GCUQDG_/K0ZQ"1 K.5(7<3G</7&6)^G(]L5+<>9^[W>7[;,?AG;_ )].
M]$OF>='GR\X7&W;M_P"!8^7..N?QXH CVQ>?C>_EYSNYW^O][/\ X]^/:D18
MC(P9G"#.",[CSWP<_J?QZU-^\^U?\L]^?]GR_P#XC^GXTD/F>>^WR]W.=V-O
MX9X_+\.* (XTA+2;GD !^7;G)_WL$<_4GZTB)$8W+.X8%MH&=I],X('UX/XU
M/#YF^;;Y><_-NVX_X#GCI_=XI(O,\F3'E[<MG=C=_P !S\W7IC\.: (0D7D[
MMS^9_=YV=?KC_P =_P :0B/RE(9B^3E3G:![<XS_ ,!'U-3?O/LO_+/9^&_K
M_P!]?Y]*8V_[.F=FW<<8QO\ Q_BQTZ\>G:@!DBQA8]K.21\V[.!_NY)_0#Z4
MKK$)$"LY4A=Q.=P]<98GZ<CVQ3YM^R'=LQCY=N,_\"QSG_>YITOF>='GR\X7
M&W;M_P"!8^7..N?QXH C*0^:H#R%,'+'.X?3G./Q'T- 2'S6!>0)@889W'Z\
MYQ^)^@J=O,^T)GRMVTXQMV?C_#GIUY].U"^9]H?'E;MHSG;L_#^'/7ISZ]Z
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MP?\ >P1^H/TJQ#YF^;;Y><_-NVX_X#GCI_=XJ.'?LFV[,8^;=C/_  '/.?\
M=YH C C\IB68/D849VD>_.,_\!/U%*4B\G=N?S/[O.SK]<?^._XTY=_V=\;-
MNX9SC?\ A_%CKTX]>]/_ 'GV7_EGL_#?U_[Z_P ^E $3I$(T*NY8E=P.=H]<
M9)'TX'X4LB0AH]KR$$_-NSD?[N2>?H1]:EE\SR8\^7MRN-N-W_ L?-UZY_'F
MEF\S?#N\O.?EV[<?\"QQT_O<4 0.L0D4*SE#C).=PY[9.?U'X=:7;%Y^-[^7
MG.[G?Z_WL_\ CWX]JDF\SSTW>7NXQMQM_'''Y_CQ2_O/M7_+/?G_ &?+_P#B
M/Z?C0!"BQ&1PS.% ;:1G<?3.&!^O)]\T1+$V_>SKC[NW//IG!'^?2I8O,\Z3
M'EYPV=VW;_P'/RYQTQ^'%%OYG[S;Y?OOQ^.-W^?7M0!$BQ>6Y9W# MM"YVGN
M,X('UX/XTH6$0[LOYOIC*Y_3_#VQ4L7F>3)CR]N6SNQN_P" Y^;KTQ^'-)\_
MV7^#9^'F?_%YQ^/X4TVG=:,"#=M (9STR#D#GDX_'\Z=((@(RA;<>7R,8/MU
M[5-,9/(CW;-O&-N-W3OCG\_QYIDV_9#NV8Q\NW&?^!8YS_O<T-W=[)-[VZ_U
M:Y3DVE':*VBMKVU?S(IXXF B5GV, &8Y##(P<?,??'/Z4ZQ5+&01I+,\0! +
MLQ;&/0DG/?K^M2R^9YT>?+SA<;=NW_@6/ESCKG\>*/WGVK_EGO\ ^ [.G_?/
M^?6ET:Z/==^@FV[7Z;>1!%;VJZG+>/ND#HJA7&X J2<[3QSGKC]*I:MI]MK4
MRO,\D"P<1I#O56 Y^9491R<Y!!_G6NOF?:'QY6[:,YV[/P_ASUZ<^O>DA\S?
M-M\O.?FW;<?\!SQT_N\5,81C;EBE;;?1O=[_ -7T$5H8K980 IB:)0B[%VAP
MHP&;&.6QENIYSS4L;QHIE(W2J0%!7*X[Y)_P-/B\SR9,>7MRV=V-W_ <_-UZ
M8_#FHUW_ &=\;-NX9SC?^'\6.O3CU[T*,4W)*SEJ]]1W=K7T[%FYNTN+95V!
M'R0VT #!]#CKD9X Q]:S;:"&Q9I(BTC3'?)O'"G&/ER3VQTQ[U9;?]G3.S;N
M.,8W_C_%CIUX].U+-OV0[MF,?+MQG_@6.<_[W-5Y6T$+*\>WRD+E9N)&8'*#
M_9R3S],?TJA/9P20FR\V7RI#N:7+^8",\!MV\#D]&[>F<:4WF;X=WEYS\NW;
MC_@6..G][BE;S/M"9\K=M.,;=GX_PYZ=>?3M222ES)6EIKZ;%J<XJR;2OS6\
MU;7\$8T.F6D4?V49V9_U^T^=ZY#EM_X[OTK.U?P[;ZU'%;SWEU%%;R1RJ8GD
M!<Q.&"L%=25)&""2,''-=/\ O/M7_+/?_P !V=/^^?\ /K1%YGG28\O.&SNV
M[?\ @.?ESCIC\.*T<Y./*W=7;Z;NW^2);;=WJS)ATVU6*-!F/[. 4V CS,#&
M)"K#/'KGFM.$0JA<[@Z\!1G:V!QG&!]<@\4L._9-MV8Q\V[&?^ YYS_N\TZ'
MS/(?;Y>WG.[&[\,\_E^'-#J3<5#F?*MH]!?U_7W#9&CEB\W_ %<W7"KM&<^H
M(_E[&N=\5>&[/Q/;6D<MW<VCV\]O/N@>6,MY,BR;2T<L>0VW!!Z@G(/-=)\_
MV7^#9^'F?_%YQ^/X4LOF>3'GR]N5QMQN_P"!8^;KUS^/-)RD[7>RLNFG;0 ,
MJP:?%IT+R,BQ[&E8MO(  ZDDDGZ_7K6/8:79Z<S!1Y_FNSM),A9U,C%F"ERS
M<$D#GH !@UKW'F?N]WE^VS'X9V_Y].]$OF>='GR\X7&W;M_X%CY<XZY_'BA3
MDHN*=HRW7>WX@1A81/M#.(L]>=^.OKG]?\*IZE:IJP6&:>>&.,Y1HVD5CC(&
M[:P(_'\>:T?WGVK_ )9[\_[/E_\ Q']/QI(?,\]]OE[N<[L;?PSQ^7X<5(!9
M-;PVJV<T8G6W79#)*GF.1UY+9(YSU.?IS6<UE#-(;AY9 R$[(AN\O ^Z,!@O
M3'5?ZUIP^9OFV^7G/S;MN/\ @.>.G]WBDB\SR9,>7MRV=V-W_ <_-UZ8_#FB
MX&5)IUE,_P!JE0.Y.?L[)F#GML/R8'^[U[9XJ[>)!<64,$2_9-CDE+=?*0\
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MFY_*V>=SNW;=F<_P=NOI^--;V2MK9JSUVVU0F[I.;YWR1<7"2]S6.LO=T?\
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M%5OW%TJM_:-YF7L_[Y_E[=.>.X-?UUX"6^I8SGG)KZY*\H\UW^[AL])>6B_
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M?PZT1$[9L2A,CD<_/[<<>_.!3HB?)?$P0<_)S\W'Y?G^/% #<)]G^X^_^_\
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MG"9/)Y^?WXY]N<&FQ$B&0"8(,ME/[WOQQSUZ_7B@!OR>1]Q]_P#>S\O7T_\
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MI_C3I2?.3,P<\?/S\O/Y_E^'-+EOM.?/&<_Z[G'3KTS^GZ4 ,CV>:^4<KAL
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MQTZ?7BB/R]TNZ1P,_+@9+?[W(Q].?K38RGE/F1PV6P ,@^F3Q]>G'O0 Y1F
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MS_TB<K_;]CE^2P/]FZKP,XX/.?4\YK_,3\-M'MOPTTJQ'4KW;(.'8^<^0P]
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MG$>!_!D>G/%+HU:[Y*?[GI#6.OR_KH#O9Z/X8:VGK\/G^6O=C09%+!;94R2
M 1^]Y^Z?;'S?A35CDD(46RQOR?+!SN''/'Y?YR!)(4\P"65^NXMG*#(Y3CKG
MCZ$U$C(!NBFF<9.6(.X>PSSC'\O;(PQO^YXO6W[OKLO=CI=W7X>IG-OW[2O^
M\I_%=*.W\UUV^_4LK$RMY;Q!VX)A;H@/\7/?M^'I1)$B_P"KA69@?]5T"#NP
M_P!W'7VIB_./WDDB X D7B0GC@_[/?ZD_2FR0K$ TDTBID!67)=CV#>Q[UW\
M.O\ X0)WG9VG[JY;/5]E\_R.ZG=4Y\WNW6DDI)5'II[S::_PV^[0G<DP2=P!
MUZ>6,]1_GOS7)ZZ)!86TD8\P#4[(>?\ Q)^^''X^X/3C'%=9(<P,#P0 %'9S
MGHWMZ>E<GKLACL[4OD$:G98B'^J;,R\GW'ISU/2N"N_]BQ%FI?N:NK<==-MN
M9=M;^0\JM_:%!.+?OJT$TFW=:M.\TGHVY-Q2OHT?Z8'_  0.;S?V*/#AED(_
MT!<L?^NQ_/U]L>]?N4P*PQ_N JC:?,');IP1SU[Y_E7X;_\ !!$M<?L4^'2J
M(I-@HP.!_KNWIVSZ@^U?N*?+$*+YCLV064@[5!YXZ].P_6O\_.)_^1]FG_89
M5NM-/>6NBZ[:W6G>Y_2V5_P*'3_9J=X*WNZ1VLOD23.',8$(C(]/XNE+*#YT
M8,(0X7Y.?F]^3GGK_+FF3"$;/*=F_O9SQTZ4LFSS4P[E<+DD8(]<#)^G7GVK
MP7OI>WGZ'K.U]$[:;[[?KN/PWVG'D#.?]5SCITZY_7]*2('SG A#GGY.?EY_
M/\_QYIOR?:/OOL_OX^?IZ9_'K_A1'L\U]SNJ\X8#YCSW_P _XTA$D0;=-B /
M@\CGY/RY]^<FFQ ^3)B$.,ME_P"[[<<<=.GUXHC\O=+ND<#/RX&2W^]R,?3G
MZTV,IY3YD<-EL #(/ID\?7IQ[T .P?LV?)&/^>O?K^7Z?K36!^SH?* &X_O.
M<M[>G'L,\_6CY/(^^^_^YCY>OK_];V]Z:VWR5P[%L\J1\H^AS_3M0 Z4$+#F
M()D<'GY_?GCVXP*=*#YT8,(0X7Y.?F]^3GGK_+FHY-FV+:[DX^;(P%_W>N?K
MQ]*=)L\U,.Y7"Y)&"/7 R?IUY]J )6#?:$'D ':?W?.&]_7\CCGZT*&^T./(
M!.T?N^<+[^OYG''TIC&/SEQ)(5QRQ'S#Z#_Z_;I0IC\YLR2!<<,!\Q^H_P#K
M]^E #H@VZ;$ ?!Y'/R?ES[\Y-1Q E9L1!\#D\_)[\<>W.13H_+W2[I' S\N!
MDM_O<C'TY^M1Q[-LNYW!Q\N!D-_O=,?7GZ4 .4'[.Y\H$;A^\YROMZ<^XSQ]
M*&!^SH?* &X_O.<M[>G'L,\_6FKM\ELNP;/"@?*?J<_T[T-M\E<.Q;/*D?*/
MH<_T[4 22@^3'F$(,KA_[WMSQSTZ?3BG2AMT.8 F3P.?G_/GWXP:CD*>4F)'
M+97((P!ZX//UZ<^U.D\O=%MD<C/S9&"O^[R<_3CZT /8-]H0>0 =I_=\X;W]
M?R..?K3,'[3CR1G_ )Y<XZ?G^OZ4,8_.7$DA7'+$?,/H/_K]NE-^3S_OOL_O
MX^;IZ9_K[^U #H@?.D A#G#?)S\OOP<\=?Y\T6X)\S$(D_/Y>OIC_/2FQ[/-
M?+N%PV"!DGTR,CZ=>/>B'9\^YW7TVC.>O7IU_P XH =$#Y,F(0XRV7_N^W''
M'3I]>*,'[-GRAC_GKWZ]?3]/UIL93RGS(X;+8 &0?3)X^O3CWHRGV?[[[_[G
M\'7U_3I_C0 Z4$0H3"$''S\_-Q^7Y?AQ3900L.8@F1P>?G]^>/;C HDV>4FU
MW9N,J1\HX[?Y_+I39-FV+:[DX^;(P%_W>N?KQ]* ))0?.C!A"'"_)S\WOR<\
M]?Y<T8/VG'DC/_/+G'3\_P!?TILFSS4P[E<+DD8(]<#)^G7GVH^3S_OOL_OX
M^;IZ9_K[^U $JAOM#CR 3M'[OG"^_K^9QQ]*2(-NFQ 'P>1S\GY<^_.335,?
MG-F20+CA@/F/U'_U^_2B/R]TNZ1P,_+@9+?[W(Q].?K0 1 ^3)B$.,ME_P"[
M[<<<=.GUXIJ@_9W/E C</WG.5]O3GW&>/I1&4\I\R.&RV !D'TR>/KTX]Z:N
MWR6R[!L\*!\I^IS_ $[T .8'[.A\H ;C^\YRWMZ<>PSS]:)00L.8@F1P>?G]
M^>/;C IK;?)7#L6SRI'RCZ'/].U$FS;%M=R<?-D8"_[O7/UX^E $TH;=#F )
MD\#GY_SY]^,&E8-]H0>0 =I_=\X;W]?R..?K3)/+W1;9'(S\V1@K_N\G/TX^
MM#&/SEQ)(5QRQ'S#Z#_Z_;I0 ]0WVAQY )VC]WSA??U_,XX^E,B!\Z0"$.<-
M\G/R^_!SQU_GS0IC\YLR2!<<,!\Q^H_^OWZ4V/9YKY=PN&P0,D^F1D?3KQ[T
M $0)6;$0? Y//R>_''MSD4Z($PN1"''/S\_+Q^7Y_CQ4<>S;+N=P<?+@9#?[
MW3'UY^E.CV>4^YW5N<*!\IX[_P"?SZ4 .P?LV?*&/^>O?KU]/T_6B4'R8\PA
M!E</_>]N>.>G3Z<4W*?9_OOO_N?P=?7].G^-$A3RDQ(Y;*Y!& /7!Y^O3GVH
M =< CR\PB/\ /YNGKG_/6B4'SHP80APOR<_-[\G//7^7--FV?)M=V]=PQCIT
MZ]/\YHDV>:F'<KA<DC!'K@9/TZ\^U #\-]IQY SG_5<XZ=.N?U_2DB!\YP(0
MYY^3GY>?S_/\>:;\GVC[[[/[^/GZ>F?QZ_X41[/-?<[JO.& ^8\]_P#/^- $
MD0;=-B /@\CGY/RY]^<FFQ ^3)B$.,ME_P"[[<<<=.GUXHC\O=+ND<#/RX&2
MW^]R,?3GZTV,IY3YD<-EL #(/ID\?7IQ[T .P?LV?)&/^>O?K^7Z?K36!^SH
M?* &X_O.<M[>G'L,\_6CY/(^^^_^YCY>OK_];V]Z:VWR5P[%L\J1\H^AS_3M
M0 Z4$+#F()D<'GY_?GCVXP*=*#YT8,(0X7Y.?F]^3GGK_+FHY-FV+:[DX^;(
MP%_W>N?KQ]*=)L\U,.Y7"Y)&"/7 R?IUY]J )6#?:$'D ':?W?.&]_7\CCGZ
MT*&^T./(!.T?N^<+[^OYG''TIC&/SEQ)(5QRQ'S#Z#_Z_;I0IC\YLR2!<<,!
M\Q^H_P#K]^E #H@VZ;$ ?!Y'/R?ES[\Y-1Q E9L1!\#D\_)[\<>W.13H_+W2
M[I' S\N!DM_O<C'TY^M1Q[-LNYW!Q\N!D-_O=,?7GZ4 .4'[.Y\H$;A^\YRO
MMZ<^XSQ]*&!^SH?* &X_O.<M[>G'L,\_6FKM\ELNP;/"@?*?J<_T[T-M\E<.
MQ;/*D?*/H<_T[4 22@^3'F$(,KA_[WMSQSTZ?3BG2AMT.8 F3P.?G_/GWXP:
MCD*>4F)'+97((P!ZX//UZ<^U.D\O=%MD<C/S9&"O^[R<_3CZT $H/G(#"$/'
MR<_-S^?Y?AS2X;[3CR!G/^JYQTZ=<_K^E,DV>:FUW9>,L1\PY[?Y_P :/D^T
M???9_?Q\_3TS^/7_  H =$#YT@$(<X;Y.?E]^#GCK_/FBW!/F8A$GY_+U],?
MYZ4V/9YKY=PN&P0,D^F1D?3KQ[T0[/GW.Z^FT9SUZ].O^<4 .B!\F3$(<9;+
M_P!WVXXXZ=/KQ1@_9L^4,?\ /7OUZ^GZ?K38RGE/F1PV6P ,@^F3Q]>G'O1E
M/L_WWW_W/X.OK^G3_&@!TH(A0F$(./GY^;C\OR_#BFR@A8<Q!,C@\_/[\\>W
M&!1)L\I-KNS<94CY1QV_S^72FR;-L6UW)Q\V1@+_ +O7/UX^E $DH/G1@PA#
MA?DY^;WY.>>O\N:,'[3CR1G_ )Y<XZ?G^OZ4V39YJ8=RN%R2,$>N!D_3KS[4
M?)Y_WWV?W\?-T],_U]_:@"50WVAQY )VC]WSA??U_,XX^E)$&W38@#X/(Y^3
M\N??G)IJF/SFS)(%QPP'S'ZC_P"OWZ41^7NEW2.!GY<#);_>Y&/IS]: "('R
M9,0AQELO_=]N...G3Z\4U0?L[GR@1N'[SG*^WIS[C/'THC*>4^9'#9;  R#Z
M9/'UZ<>]-7;Y+9=@V>% ^4_4Y_IWH <P/V=#Y0 W']YSEO;TX]AGGZT2@A8<
MQ!,C@\_/[\\>W&!36V^2N'8MGE2/E'T.?Z=J)-FV+:[DX^;(P%_W>N?KQ]*
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MN_X%CYNO7/X\U'\GD?<??_>S\O7T_P#K_P"%$@3RDPCALKDGD'UP./IUX]Z
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MW_@.?ESCIC\.*11'YS9CD*XX4'YA]3_];MUIL>SS7RCE<-@ X(],G!^O3\J
M%AW[)MNS&/FW8S_P'/.?]WFG0^9Y#[?+V\YW8W?AGG\OPYJ*/9MEW(Y./EP<
M!?\ >ZY_3ZTZ/9Y3[D<MSA@?E''<?Y_#K0 _Y_LO\&S\/,_^+SC\?PI9?,\F
M//E[<KC;C=_P+'S=>N?QYJ/"?9_N/O\ [_\ !U]/UZ_X42!/*3".&RN2>0?7
M X^G7CWH ?<>9^[W>7[;,?AG;_GT[T2^9YT>?+SA<;=NW_@6/ESCKG\>*9-L
M^3:CKZ[CG/3ITZ_YQ1)L\U,(X7"Y!.2?7!P/KT_.@"3]Y]J_Y9[\_P"SY?\
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M:<8V[/Q_ASTZ\^G:HY!'NBVQN!GYLG);_=X&/KS]*&$?G+B.0+CE2?F/T/\
M];OUH D7S/M#X\K=M&<[=GX?PYZ].?7O3(O,\Z3'EYPV=VW;_P !S\N<=,?A
MQ2*(_.;,<A7'"@_,/J?_ *W;K38]GFOE'*X; !P1Z9.#]>GY4 +#OV3;=F,?
M-NQG_@.><_[O-.A\SR'V^7MYSNQN_#//Y?AS44>S;+N1R<?+@X"_[W7/Z?6G
M1[/*?<CEN<,#\HX[C_/X=: '_/\ 9?X-GX>9_P#%YQ^/X4LOF>3'GR]N5QMQ
MN_X%CYNO7/X\U'A/L_W'W_W_ .#KZ?KU_P *) GE)A'#97)/(/K@<?3KQ[T
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M ,"Q\N<=<_CQ44FS;%M1P<?-DY#?[O3'Z_6G2;/-3".%PN03DGUP<#Z]/SH
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M8Q[4R7S_ #5^[VV[,;,=MV.,XZYYSTYHDC20Y&Y&'WRW20_[&?IC\^/21#M
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M8(.?DY^;C\OS_'BF(%P^;=GP.#D_)R.>>?;C)_2A0NPYMF<_W\GY?Z_E^'-
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ME]!R,\?3Z4QPN$Q;LF1R<GY^3SQS[<X/ZT.%WKBV9!A?DS][@<\<<]>OUXH
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M&/\ GE^/Y?K^M, 7RV/V=B<C]YDX7KQZ_D,<?6D(7RB?LS9P?WN3C_']/TH
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MR.1]WJ/IV[-3#+*5N&F 7EB&_<<]1].!_G(D0/N)DCC1,-LD7&]SS@-R, G
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M_:FQD?O<'/\ A^GZT]A-YRY@A#;3A1C:1QU/_P!;O0!+YX_<Q;\CY.-OY_\
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M=N+EI/P/R_EC_/2ARN]<7+.,+\^/N\#CCCCIT^O%/E$OR;H8E]-N#GZ].O\
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M>X.?\/T_6G2"7S$S#$&PN ,$'@8R>/KTX]Z4B7SS^YBWY/R<;?S_ /K>WO0
MP%?,8_:F P/WF#ENO'I^0SS]:1"N7S=,G/!P?GX'//'MQ@?I4BB;SFQ!"6VC
M*G&T#GH?_K=J2,2[I<0Q$Y^;. %X'W>N?KQ]* &(5V-FY9#EODP?FY/////7
M^7- *^6P^T,#D?N\'#=>?7\CCGZT^,2^6^(8B,MDG (Y.<#)^G7GVI%$GDMB
M*,KN&6.-PZ]!_P#7'3I0 TE?+4?:&)R?W>#A>G/K^9QQ]*'*X3%RSX'(P?DY
M/IS[\Y/ZTYA)Y*YBC"[CAAC<>G4?_7/7I2R"7;%NBB Q\N,$MR?O<C'TY^M
M#'*Y3%TS\\G!^3@\\<>W.1^M*2OF*?M3$8/[S!RO3CT_,9X^E.D$NZ+,,0.?
MEQ@AN#][ICZ\_2E83><N8(0VTX48VD<=3_\ 6[T ,!7S0?M38R/WN#G_  _3
M]:1"N]LW+(,-\^/O<'CGCGIT^G%2 2^>/W,6_(^3C;^?_P!;V]Z2,2^8^(8B
MV&R#@ <'.#S]>G/M0 Q"N'S<LF1P,'Y^1Z\^_&#^E"E=AS<LA_N8/S?U_+\.
M:?&)=LNV*(C'S9P"O(^[R<_3CZT()?+;$,3+W8XW#Z?_ *Q_6@"/*^3C[2V<
M?ZK!QTZ>OZ_I2N5V+BY9SE?DP?EY'/'/'7^?-+B7[/\ ZF+9M^_QOZ>F?QZ_
MX4Z02^6F88@,K@C!)Y&,C(^G7CWH 8Y4[<7+2?@?E_+'^>E#E=ZXN6<87Y\?
M=X'''''3I]>*?*)?DW0Q+Z;<'/UZ=?\ .*)!+YB9AB#87 &"#P,9/'UZ<>]
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MCE,@&,Y_@]A_3_)+_.C3Y"WF$  R'JIP..WW?H/>FRF92H5 BX&-G.X>K?\
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MX<<L3@9!'/'X_AWH6W6UEHD[K;JG\MA+X^GM.;XO=]GTNK+KY)\W\SL*)%A
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MR',HE$8R#G.[/'3@<9ZFG@SY+/-'(H.1L(^3W?D\9([$_6GJ6N'"B6,'!^?
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MV7;+$!CYLX);D?=X&/KS]*$,OEMB:)5[J<;C]/\ ]1_I0!#^Y\K_ );;\?\
M;/I_WQ_3\:5O)VKCSMV5SN^[U'W<_+G'3'X<4_,OV?\ UT6S;]SC?T]<?AT_
MQITAE\M,S1$97 & 1R,9.#]>G/M0!$_D\;?.]]_]-W^?7M2MY.Y<>=MPN=V=
MW0?=S\W7IC\.:DE,OR;IHF]-N!CZ]>G^<T2&7S$S-$6PN", #@8R.?IUY]J
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MP<_7CZ42&7S$S-$6PN", #@8R.?IUY]J (CY'F+CS]F#G.=_;I_%CKTX]>]
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MN@^[GYNO3'X<U)*9?DW31-Z;<#'UZ]/\YHD,OF)F:(MA<$8 ' QD<_3KS[4
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M_)YXY]N<']:"5\M1]H8G)_=X.%Z<^OYG''TH<KA,7+/@<C!^3D^G/OSD_K0
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MKQZ?D,\_6D0KE\W3)SP<'Y^!SSQ[<8'Z4 "!=C9MF<Y;Y\GY>3QSSQT_ES0
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MFV9Q_<R?E_I^7X<4[<OG9^U-C=_K<<]>OI^GZTU2N\YN60?W\'YOZ?E^'%
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M)^3D<\\^W&3^E"%<OFZ9.>#@_/P.>>/;C _2A"N'S<LF1P,'Y^1Z\^_&#^E
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MI^7<8" BW4+(=[<_N_[O3D=.OO\ ITH9#< >5(6QR8NR '.1].OU&/H>6_\
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MSW.3_D=Z%VWT7N:>7H_Q%YWTYOX_O.^VG16?3:'\HC.T&$C3:#U;M)R>1_\
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MQ335^G];"YH<KFFG'EA=\D^7>.GQ[^2UCI>3L/16(;S(H4? \M4VGS#D??\
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M][ICZ\_2HW2(1H5=RQ*[@<[1ZXR2/IP/PI9$A#1[7D()^;=G(_W<D\_0CZT
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MZMO\X]_>OJFV$88LS,&#,<<D=1U__4<]SWKY6_;(V-\*=:)/S?8+H[><<H_
M[?\ ZOK7T^5_[QA-+_O(7=GWC\K>>U^CL?'Y[I"K:?++V,THO2+O;WKMM2:O
MHE;0_$FUCN$MXY%50K;<,ARY!]<?U_\ K5I85U4W "M@;2.K#)Y;D<\=.<^]
M5;#RUMT,#-)(0-ROG:/7!8D=N..:FEC$IS&V7'^L4@X4^B\X/X >_O\ TI@*
MD5A*;<O>4(^Z]-&E;UOMMO8_FG&R<\7-2:34W>I%:[JVUK)[+FYK@[3JX"J
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M?+VY7&W&[_@6/FZ]<_CS4?R>1]Q]_P#>S\O7T_\ K_X42!/*3".&RN2>0?7
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M9^'\.>O3GU[U&PC\Y<1R!<<J3\Q^A_\ K=^M"B/SFS'(5QPH/S#ZG_ZW;K0
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ML]GX;^O_ 'U_GTIC;_LZ9V;=QQC&_P#'^+'3KQZ=J/D\C[C[_P"]GY>OI_\
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MNXXQC?\ C_%CIUX].U-7;Y+91BV>&!^4?48_KVH;;Y*X1@V>6)^4_08_KWH
MFE\SR8\^7MRN-N-W_ L?-UZY_'FEF\S?#N\O.?EV[<?\"QQT_O<5%($\I,(X
M;*Y)Y!]<#CZ=>/>G2"/=%MC<#/S9.2W^[P,?7GZ4 +-YGGIN\O=QC;C;^../
MS_'BE_>?:O\ EGOS_L^7_P#$?T_&HY-GFIM1U7C*D_,>>Q_S_2CY/M'^K?9_
M<S\_3UQ^'3_&@!\7F>=)CR\X;.[;M_X#GY<XZ8_#BBW\S]YM\OWWX_'&[_/K
MVID>SS7RCE<-@ X(],G!^O3\J(=GS[D=O3:<8Z]>O3_.: )(O,\F3'E[<MG=
MC=_P'/S=>F/PYI/G^R_P;/P\S_XO./Q_"F1A/*?*.6RV". /3(Y^G7GVHPGV
M?[C[_P"__!U]/UZ_X4 /F\SR$W>7MXQMQN_''/Y_CS39M^R'=LQCY=N,_P#
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M/PW]?^^O\^E,;?\ 9TSLV[CC&-_X_P 6.G7CT[4?)Y'W'W_WL_+U]/\ Z_\
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M_P "Q\W7KG\>:CPGV?[C[_[_ /!U]/UZ_P"%$@3RDPCALKDGD'UP./IUX]Z
M'W'F?N]WE^VS'X9V_P"?3O1+YGG1Y\O.%QMV[?\ @6/ESCKG\>*9-L^3:CKZ
M[CG/3ITZ_P"<42;/-3".%PN03DGUP<#Z]/SH D_>?:O^6>_/^SY?_P 1_3\:
M2'S//?;Y>[G.[&W\,\?E^'%,^3[1_JWV?W,_/T]<?AT_QHCV>:^Y'9><*#\P
MY[G_ #_2@"6'S-\VWR\Y^;=MQ_P'/'3^[Q21>9Y,F/+VY;.[&[_@.?FZ],?A
MS38Q'NEW1N1GY<'!7_>X.?KQ]*;&$\I\HY;+8(X ],CGZ=>?:@!_[S[+_P L
M]GX;^O\ WU_GTIC;_LZ9V;=QQC&_\?XL=.O'IVH^3R/N/O\ [V?EZ^G_ -?_
M  IK;?)7",&SRQ/RGZ#']>] #YM^R'=LQCY=N,_\"QSG_>YITOF>='GR\X7&
MW;M_X%CY<XZY_'BHI-FV+:C@X^;)R&_W>F/U^M.DV>:F$<+A<@G)/K@X'UZ?
MG0!,WF?:$SY6[:<8V[/Q_ASTZ\^G:A?,^T/CRMVT9SMV?A_#GKTY]>]1L(_.
M7$<@7'*D_,?H?_K=^M"B/SFS'(5QPH/S#ZG_ .MVZT /A\S?-M\O.?FW;<?\
M!SQT_N\5'#OV3;=F,?-NQG_@.><_[O-+&(]TNZ-R,_+@X*_[W!S]>/I4<>S;
M+N1R<?+@X"_[W7/Z?6@!R[_L[XV;=PSG&_\ #^+'7IQZ]Z?^\^R_\L]GX;^O
M_?7^?2HEV^2V48MGA@?E'U&/Z]J=\GD?<??_ 'L_+U]/_K_X4 /F\SR$)\O
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MS_3]*)0?.C!A"'"_)S\WOR<\]?Y<T8/VG'DC/_/+G'3\_P!?TH >I;[0Y\\
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MU_,8Y^E)$6#38G"9/)Y^?WXY]N<&E4-]H<>0"=H_=\X7W]?S../I21!MTV(
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MQ0L'B+2YJM!.ZY$I+I:]VW:[Z^NFR0EB:6K<:R6NB@V_+6W+VOV9,K?N' E
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M^E)8.OK^\I)67+:<+N6G-UM^6_H..(HM^]&LHW=O<;;6EMDTKWU6ZO;<GCE
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MVYQ_%CC&/[W%-;S/M"9\K=M.,;=GX_PYZ=>?3M0!&IC\YLR2!<<,!\Q^H_\
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M )9[\_[/E_\ Q']/QI(?,\]]OE[N<[L;?PSQ^7X<4 )'Y>Z7=(X&?EP,EO\
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MG/&>GMUK_,2\-+.O]H.IA\S^T;S<"5\O'GO]T<C/7)_&OZZ\!&OJ.,<IN/\
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MN/\ @.>.G]WBDB\SR9,>7MRV=V-W_ <_-UZ8_#F@"/Y/(^^^_P#N8^7KZ_\
MUO;WIK;?)7#L6SRI'RCZ'/\ 3M4O[S[+_P L]GX;^O\ WU_GTIC;_LZ9V;=Q
MQC&_\?XL=.O'IVH ;)LVQ;7<G'S9& O^[US]>/I3I-GFIAW*X7)(P1ZX&3].
MO/M2S;]D.[9C'R[<9_X%CG/^]S3I?,\Z//EYPN-NW;_P+'RYQUS^/% ",8_.
M7$DA7'+$?,/H/_K]NE"F/SFS)(%QPP'S'ZC_ .OWZ5(WF?:$SY6[:<8V[/Q_
MASTZ\^G:A?,^T/CRMVT9SMV?A_#GKTY]>] $<?E[I=TC@9^7 R6_WN1CZ<_6
MHX]FV7<[@X^7 R&_WNF/KS]*GA\S?-M\O.?FW;<?\!SQT_N\5'#OV3;=F,?-
MNQG_ (#GG/\ N\T ,7;Y+9=@V>% ^4_4Y_IWH;;Y*X=BV>5(^4?0Y_IVIR[_
M +.^-FW<,YQO_#^+'7IQZ]Z&W_9TSLV[CC&-_P"/\6.G7CT[4 $A3RDQ(Y;*
MY!& /7!Y^O3GVITGE[HMLCD9^;(P5_W>3GZ<?6G2^9Y,>?+VY7&W&[_@6/FZ
M]<_CS2S>9OAW>7G/R[=N/^!8XZ?WN* &,8_.7$DA7'+$?,/H/_K]NE-^3S_O
MOL_OX^;IZ9_K[^U3-YGVA,^5NVG&-NS\?X<].O/IVIG[S[5_RSW_ / =G3_O
MG_/K0 R/9YKY=PN&P0,D^F1D?3KQ[T0[/GW.Z^FT9SUZ].O^<4^+S/.DQY><
M-G=MV_\  <_+G'3'X<46_F?O-OE^^_'XXW?Y]>U #(RGE/F1PV6P ,@^F3Q]
M>G'O1E/L_P!]]_\ <_@Z^OZ=/\:DB\SR9,>7MRV=V-W_  '/S=>F/PYI/G^R
M_P &S\/,_P#B\X_'\* &2;/*3:[LW&5(^4<=O\_ETILFS;%M=R<?-D8"_P"[
MUS]>/I4LWF>0F[R]O&-N-WXXY_/\>:;-OV0[MF,?+MQG_@6.<_[W- "2;/-3
M#N5PN21@CUP,GZ=>?:CY//\ OOL_OX^;IZ9_K[^U/E\SSH\^7G"XV[=O_ L?
M+G'7/X\4?O/M7_+/?_P'9T_[Y_SZT (IC\YLR2!<<,!\Q^H_^OWZ41^7NEW2
M.!GY<#);_>Y&/IS]:D7S/M#X\K=M&<[=GX?PYZ].?7O20^9OFV^7G/S;MN/^
M YXZ?W>* (HRGE/F1PV6P ,@^F3Q]>G'O35V^2V78-GA0/E/U.?Z=ZFB\SR9
M,>7MRV=V-W_ <_-UZ8_#FHUW_9WQLV[AG.-_X?Q8Z]./7O0 UMODKAV+9Y4C
MY1]#G^G:B39MBVNY./FR,!?]WKGZ\?2G-O\ LZ9V;=QQC&_\?XL=.O'IVI9M
M^R'=LQCY=N,_\"QSG_>YH 63R]T6V1R,_-D8*_[O)S]./K0QC\Y<22%<<L1\
MP^@_^OVZ4^;S-\.[R\Y^7;MQ_P "QQT_O<4K>9]H3/E;MIQC;L_'^'/3KSZ=
MJ (U,?G-F20+CA@/F/U'_P!?OTIL>SS7R[A<-@@9)],C(^G7CWJ9?,^T/CRM
MVT9SMV?A_#GKTY]>],B\SSI,>7G#9W;=O_ <_+G'3'X<4 11[-LNYW!Q\N!D
M-_O=,?7GZ4Z/9Y3[G=6YPH'RGCO_ )_/I2P[]DVW9C'S;L9_X#GG/^[S3H?,
M\A]OE[><[L;OPSS^7X<T ,RGV?[[[_[G\'7U_3I_C1(4\I,2.6RN01@#UP>?
MKTY]J?\ /]E_@V?AYG_Q><?C^%++YGDQY\O;E<;<;O\ @6/FZ]<_CS0!'-L^
M3:[MZ[AC'3IUZ?YS1)L\U,.Y7"Y)&"/7 R?IUY]J?<>9^[W>7[;,?AG;_GT[
MT2^9YT>?+SA<;=NW_@6/ESCKG\>* &?)]H^^^S^_CY^GIG\>O^%$>SS7W.ZK
MSA@/F//?_/\ C4G[S[5_RSWY_P!GR_\ XC^GXTD/F>>^WR]W.=V-OX9X_+\.
M* $C\O=+ND<#/RX&2W^]R,?3GZTV,IY3YD<-EL #(/ID\?7IQ[U+#YF^;;Y>
M<_-NVX_X#GCI_=XI(O,\F3'E[<MG=C=_P'/S=>F/PYH C^3R/OOO_N8^7KZ_
M_6]O>FMM\E<.Q;/*D?*/H<_T[5+^\^R_\L]GX;^O_?7^?2F-O^SIG9MW'&,;
M_P ?XL=.O'IVH ;)LVQ;7<G'S9& O^[US]>/I3I-GFIAW*X7)(P1ZX&3].O/
MM2S;]D.[9C'R[<9_X%CG/^]S3I?,\Z//EYPN-NW;_P "Q\N<=<_CQ0 C&/SE
MQ)(5QRQ'S#Z#_P"OVZ4*8_.;,D@7'# ?,?J/_K]^E2-YGVA,^5NVG&-NS\?X
M<].O/IVH7S/M#X\K=M&<[=GX?PYZ].?7O0!''Y>Z7=(X&?EP,EO][D8^G/UJ
M./9MEW.X./EP,AO][ICZ\_2IX?,WS;?+SGYMVW'_  '/'3^[Q4<._9-MV8Q\
MV[&?^ YYS_N\T ,7;Y+9=@V>% ^4_4Y_IWH;;Y*X=BV>5(^4?0Y_IVIR[_L[
MXV;=PSG&_P##^+'7IQZ]Z&W_ &=,[-NXXQC?^/\ %CIUX].U !(4\I,2.6RN
M01@#UP>?KTY]J=)Y>Z+;(Y&?FR,%?]WDY^G'UITOF>3'GR]N5QMQN_X%CYNO
M7/X\TLWF;X=WEYS\NW;C_@6..G][B@"*39YJ;7=EXRQ'S#GM_G_&CY/M'WWV
M?W\?/T],_CU_PI\WF>>F[R]W&-N-OXXX_/\ 'BE_>?:O^6>_/^SY?_Q']/QH
M CCV>:^7<+AL$#)/ID9'TZ\>]$.SY]SNOIM&<]>O3K_G%/B\SSI,>7G#9W;=
MO_ <_+G'3'X<46_F?O-OE^^_'XXW?Y]>U #(RGE/F1PV6P ,@^F3Q]>G'O1E
M/L_WWW_W/X.OK^G3_&I(O,\F3'E[<MG=C=_P'/S=>F/PYI/G^R_P;/P\S_XO
M./Q_"@!DFSRDVN[-QE2/E'';_/Y=*;)LVQ;7<G'S9& O^[US]>/I4LWF>0F[
MR]O&-N-WXXY_/\>:;-OV0[MF,?+MQG_@6.<_[W- "2;/-3#N5PN21@CUP,GZ
M=>?:CY//^^^S^_CYNGIG^OO[4^7S/.CSY><+C;MV_P# L?+G'7/X\4?O/M7_
M "SW_P# =G3_ +Y_SZT (IC\YLR2!<<,!\Q^H_\ K]^E$?E[I=TC@9^7 R6_
MWN1CZ<_6I%\S[0^/*W;1G.W9^'\.>O3GU[TD/F;YMOEYS\V[;C_@.>.G]WB@
M"*,IY3YD<-EL #(/ID\?7IQ[TU=ODMEV#9X4#Y3]3G^G>IHO,\F3'E[<MG=C
M=_P'/S=>F/PYJ-=_V=\;-NX9SC?^'\6.O3CU[T -;;Y*X=BV>5(^4?0Y_IVH
MDV;8MKN3CYLC 7_=ZY^O'TIS;_LZ9V;=QQC&_P#'^+'3KQZ=J6;?LAW;,8^7
M;C/_  +'.?\ >YH 63R]T6V1R,_-D8*_[O)S]./K0QC\Y<22%<<L1\P^@_\
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MGG@?N\8]>?QH;]KS]K\P)G]JSXR@;CAAXCDW9XX/[O&/3G\:^??])QD^5O\
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ME&RW?[4/Q=CAEX>5/$,A=1ZKB+GTX(_.LZ]_:R_:TFTZ6\M?VM?C5A&!8?\
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MM;>9&"$_*R_>;O\ -SQGJ><Y'X58))FQNC\_TR/)SG/T_P ].](@(9MN-_\
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M?);*,6SPP/RCZC']>U.B)V38E"<<CGY_RX_/ H4G[._[T ;AF/GYO?T_,YH
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M'+9;!' 'ID<_3KS[5)$3OFQ.$YY//S_ES^>#38B?)DQ,%&6RG][U/''/U^M
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MO-J[K1\NEEYZ77??>MHD1YG*O*I;*)&?FC! &), \]_I40BBEDW,C[E;*')
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MB)\Y\3!#S\_/S<_G^?X\T $8CW2[HW(S\N#@K_O<'/UX^E-C">4^4<MEL$<
M>F1S].O/M4D1.^;$X3GD\_/^7/YX--B)\F3$P49;*?WO4\<<_7ZT -^3R/N/
MO_O9^7KZ?_7_ ,*:VWR5PC!L\L3\I^@Q_7O4@)^S8\X8_P">7X_E^OZTUB?L
MZ?O01N.(^?E]_3\CF@!LFS;%M1P<?-DY#?[O3'Z_6G2;/-3".%PN03DGUP<#
MZ]/SHE)V0YE#\<#GY/SX_+(ITI;SH\S!CA</S\OH.1GCZ?2@ 81^<N(Y N.5
M)^8_0_\ UN_6A1'YS9CD*XX4'YA]3_\ 6[=:<Q/VA#YX)VG$GI[>OY#'K0I/
MVASYX!VC,GK[>OYC'I0 V,1[I=T;D9^7!P5_WN#GZ\?2HX]FV7<CDX^7!P%_
MWNN?T^M31$[YL3A.>3S\_P"7/YX-1Q$[)L2A..1S\_Y<?G@4 -7;Y+91BV>&
M!^4?48_KVH;;Y*X1@V>6)^4_08_KWIRD_9W_ 'H W#,?/S>_I^9S0Q/V=/WH
M(W'$?/R^_I^1S0 2!/*3".&RN2>0?7 X^G7CWIT@CW1;8W S\V3DM_N\#'UY
M^E$I/DQYF##*X3^[Z'GCCZ_2G2D[X<SA^>#S\GY\_EDT 1R;/-3:CJO&5)^8
M\]C_ )_I1\GVC_5OL_N9^?IZX_#I_C3I2?.3,P<\?/S\O/Y_E^'-+EOM7^N&
M[/\ K>>N/IN_3/X4 ,CV>:^4<KAL '!'IDX/UZ?E1#L^?<CMZ;3C'7KUZ?YS
M3HBWG28F"G#9?GYO4<#//T^M%N2/,Q,(_P _FZ^F?\]* &QA/*?*.6RV". /
M3(Y^G7GVHPGV?[C[_P"__!U]/UZ_X4Z(GR9,3!1ELI_>]3QQS]?K29/V7'G#
M;C_5?C_WS^N/QH 239Y2;4<-QEB?E/'8?Y_'K39-FV+:C@X^;)R&_P!WIC]?
MK4DI/DIF8../DY^7C\OR_#BFRD[(<RA^.!S\GY\?ED4 $FSS4PCA<+D$Y)]<
M' ^O3\Z/D\_[C[/[N?FZ>N/Z?XTZ4MYT>9@QPN'Y^7T'(SQ]/I02WVG/G#/_
M #UY]/IG]/TH %$?G-F.0KCA0?F'U/\ ];MUHC$>Z7=&Y&?EP<%?][@Y^O'T
MIRD_:'/G@':,R>OMZ_F,>E$1.^;$X3GD\_/^7/YX- $<83RGRCELM@C@#TR.
M?IUY]J:NWR6RC%L\,#\H^HQ_7M4D1/DR8F"C+93^]ZGCCGZ_6FJ3]G?]Z -P
MS'S\WOZ?F<T -;;Y*X1@V>6)^4_08_KWHDV;8MJ.#CYLG(;_ '>F/U^M.8G[
M.G[T$;CB/GY??T_(YHE)V0YE#\<#GY/SX_+(H =((]T6V-P,_-DY+?[O Q]>
M?I0PC\Y<1R!<<J3\Q^A_^MWZTZ4G?#F</SP>?D_/G\LFAB?M"'SP3M.)/3V]
M?R&/6@!JB/SFS'(5QPH/S#ZG_P"MVZTV/9YKY1RN&P <$>F3@_7I^52*3]H<
M^> =HS)Z^WK^8QZ4V(MYTF)@IPV7Y^;U' SS]/K0!''LVR[D<G'RX. O^]US
M^GUIT>SRGW(Y;G# _*..X_S^'6B(G9-B4)QR.?G_ "X_/ IT1/DOB8(.?DY^
M;C\OS_'B@!N$^S_<??\ W_X.OI^O7_"B0)Y281PV5R3R#ZX''TZ\>]+D_9<>
M<-N/]5^/_?/ZX_&EE)\F/,P897"?W?0\\<?7Z4 -FV?)M1U]=QSGITZ=?\XI
M)-GF)A'"X&5)R6^G Z]N._>GW!)\O,PD_/Y>GKC_ #UI)LF6/,P;A?GY^7N.
MHSQ]/IFCUO;JUND']:C)$B#F0*^T?\L\XD^G?^7>F[A*2CH^SLHX8?C[=ZD*
MMY^1-_VT[=/3&3^G/YTTMN8A'$;\YD/?\^>?2E=>S4D[Q3;4WIRQTM=K7U>K
MTUT,)J5WSQ<[P35-)*WFGI?U5WW%2.-"Q*L_/RA"<H,<AA_]?M3"I()8X;)P
M?[H_A![<5)")(S(3,(P3R2.),]Q@$<?KFHF9&)#2 'GY.I?WS[]O?VK@J4<1
M6K3]A:=DN9::I\OO)=;=W9KYGH8:5-1]_FE*T>6*T5M-[77NVMWWL6UDS!@H
MQ;&"X^[]>/7U]\UR/CLQ_P#"!>,@$DW_ -@WQ9S]P_NSTXX[_P">*ZHN8X,>
M8 ,<1=<>V?7_ !]37+>.%9OA_P",9/,^4Z#?#9@9'[L\_GZ'MG/:O:P->G[.
M.'E5O64H73YE=\T+J]K=WRMI=3@QCD^66C7.U=N5[<OV6U>^EMC_ "7/V\HD
M3]N?]HAE!&[Q@A8$DYQIED./3V/UZGFOF91 (V(5U&23&Q.YLGDCIU/(Z?7%
M?3/[?,F/VYOVAE4^83XP7G_GG_Q++(<^OX\BOF9(F'SRRB5CR)> $') _P"
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M9T'AI+P_VUITH123*/F) YSM89 SG.?UK1#^'9C]HO=.O'U+[QOU)6U,@_C
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M/[SSZMO:)M./NN]16VO'W5RWU9'$J%I-RM@*Q S\PX)Y./;GBDLFA/F@ O\
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MYX^[&S=NJW?7OJ?A]56QDOW>NKY7=+9>]>3OIOIW]T,!IE+1%F /^D MA?\
M8/'4_P!/QI1A9V*Q,"1S-EL/Z(..J]>G^-+M,CATD*A0?W SM;_:_ YQSU],
MTP2(DS!IB6QDP<X3_:Z]6/7Z?0TULM=52LZZYM'S1T:Z>C-N9./,I72BK^]5
MLM8VNUMT6GO?+=8P#(Y\EHFP^9B6Q+UX'!^]T'U[]VIA5E"V[0@KRI+?O^>@
M^N ?\X,BQL69Q*9%PW[LYQ'D<D>Z]>_XU%%(GSH+AIF( W'.8N^1STP",\]?
MK3;OS-/E_A7JKF?-:6V_;?3J#E'E<N;W5RZWJV3?+U6G7;T4AP1?)?\ T=D7
M<";;+;G/]X'';Z]Q^(3^X*_9V*]/L^6W8SC;TZ]_IV[TI0I$6:X8@L#]H.=R
M?[(^O^?=$=9(MB3G)SBXYR.V>O7/M_C0G=-I^S7M8OF3;51)1^7_  UD'/&R
MDY:.2UO42Z;/9]?[KV>MV+(JB)/W#2X((B!;*8Z'I_!U]\=^M$N&V!H&G&.,
M%OW?3YC[?X=323#RT7S)S$%(_><YD_V>O\??Z\YIS?OMH29HL<?+GY^/J?\
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MV48VGZ__ *OSZ5$WD93;Y^,_-NSGH?NYYS_N\T-Y.X;?.V]]WWOPSS^7X<T
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MOW>I^]CY<XZY_'B@"0"7R!^YBV8'S\;ORS_7W]J&$GDKF*,+N.&&-QZ=1_\
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MY;I.5VI-2>_+?7J<V/S[*L7*E2AS-T^5PIQ]ZFXIQE)ZN\'9?"W+\S^N:_\
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MP\0VVHWNFW"+';>?)<):EP(0)I9&RH(P"P S@]A]:T[XSM=&*"RMX@K8F=
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M!2OS/]V[7BDUK>RM==&I/\R5R,@,0C\;44C:W P6]">_7OF@ AB,?O?^>?\
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M2LXWE9R3:NK=+J[7S?X6!1M[T[Q3^%\N][6T;5KOI=WZ-=)5!#8QF3C]V?\
M5=>A/3'Z#IG-)PS$*0S@?,C$;1QDE3ZKVXZ],U'YZY\O:WEYQG'[S&?IG/O_
M /KH\E8_WC,Q7J IRW(XS@DGWR#[YH5--63;C>[5UHM-/A;^]]0VOSWBVERJ
MU^:UK+1KKTT?]YK:52 #M.X#[[/P4&1RF>_Z^PIH&X$H=Z?Q.WWU^@&?_KTS
MS!<91@5/\)7@9R/O$8&/8G'UHV+;_,Q9GZKMY3_@0Y'^<]N%[*,E%.4FHIK=
M;W33T6__  +@H]'=3>T+7OI&[O=?@DEV>[ES\N<XAQ_KCQ+TZ\\YQS_6DQC!
M8[4S\KIRSGH V!T)X]AQ4?%UZI*Q^D7]!U_SD<&];;A0S/R&W<I@\';G(SCI
M[_3ANFG9N3LHI)W2MMK;EW?G=>0<K^'_ )>-J\;6LO=5^9Z:][6?2)(QXQ+B
M+.-NPCYAV+<_Y]*,8(W<,1\JKRC#'!8CU_BZ\\G%1^2LWS(67IN#^O\ L@XX
M_#V[8!YZQ_NU5BO0EAENF#C()/M@GVS0Z:;YG*5[QLTUTMI;EZ][O_(2NE&-
MY27Q1M;E^%;WE\^_1Q)3R^/E$N?]5D>5G.,9]/7U]:%R,A!O?/*/]P>N,]2/
MPSVS47D+GS=S>7G.,GS,9^N[/M_^J@3J_P CJP3H"@^?C@9XR/?U_2FH)2YN
M:2DW=:KRT^% E?X/>22YKJW+K'17=Y6[)W75]"3!8G9AR/OJQXCP/X/PP1[F
ME&<?)\\8X>1^'4YY"YYP#P.OX5%Y*P_.Y<AAE AR?^!X)[YZ_3OR;UN>&#*_
M 7;PF!P-V,#..OO]>4J:3OS23?-?5.]VM?A6W33[PY;ZIMP5KRY7H]'MI>WR
MMUYA^WY=P.Z+_GKUD/?D?SY]\XIQ(V9)VQG.)/\ EHQ^7AAQP/KCK@U%A;7@
M[FE!P<<Q?AU'^?4\F!<C(RKCKGA,<=.@)]<<_P J(TTM(N5VDFKJ][K5^Z_-
M:*SN/JI7?LU+2=NZ6MDW]^J_NK=28 VEB0/X"G)<9/+XZ'MZXP,4K=0K$(_&
MU$(VMP,%O0MWZ]ZB\P6^$4%C_$6Y&<G[I.1CV!Q]*/)63]X&8+U8-D-P,G;G
MD>V!]!0J2^%.6KBW&\>EKZVZ[_<3:WO2O&.O+*WQ?#9)7TOYW;Z<NQ[G^RZL
M@^-FDAHT!^Q3D ="#-;<GW_GS7[N@2;TV11N?L\.0^,#Y!C'U[_S]?P?_9<\
MH?&O2@OF;19SYW?>SYUOTX!QUZ>V3C%?NX?*S'O\W;Y$.-F=WW!G..<9Z=OT
MK\(\1TEG$$EHJ,4GK^=_T^9_0'AI_P B6=]_:RZ6_E^R[M7_ ,0Z,2^8^(8B
MV&R#@ <'.#S]>G/M1&)=LNV*(C'S9P"O(^[R<_3CZU&OD[FSYVW#8VYW=#][
M'S=>N?QYI%\G#[O.SCY=O3J/O8X_[ZXK\[/T@D42>2V(HRNX98XW#KT'_P!<
M=.E!$OD']S%LP?GXW?EG^OO[5&/*\ML^;OR,8^YWZ_PYZ=>?3M2'R?+/^NWX
M/^Y_\3_GUH FD$OEIF&(#*X(P2>1C(R/IUX]Z)!+NBS#$#GY<8(;@_>Z8^O/
MTJ)O)VKCSMV5SN^[U'W<_+G'3'X<4-Y&4V^?C/S;LYZ'[N><_P"[S0!*XE\Q
M<PQ*W91C:?K_ /J_/I3L2_:/]3%OW?<XV=?7].G^-0-Y.X;?.V]]WWOPSS^7
MX<T[]SYO_+?9N]_,Z_\ ?>?U_"@!\8E\Q\0Q%L-D'  X.<'GZ].?:J3XWMDD
M')R!G ^G%65\G<V?.VX;&W.[H?O8^;KUS^/-0-NW';C&3C.<_C[T 7[@S^:F
M^X@=L\,F !\IZC!S^8Z]?1C&;SES/"6VG##&T#CJ/_K]J295$B@6;P@GE"3\
M_!XXX_/CCZTTA?,4?96 P?W>3ENG/I^9SS]* 'J9O.;$\(;:,L<;2.>@_P#K
M]Z2,R^8^)H@V&R3@@\'.!Q].O'O30%\QA]E8C _=Y.5Z\^GY'/'UI$"[VS;,
MXPWR9^[P>>>..O7Z<4 /C,NV7;+$!CYLX);D?=X&/KS]*13)Y+8EC"[AE3C<
M>O0__6/7K34"X?-NSX'!R?DY'///MQD_I0 OEL?L[$Y'[S)PO7CU_(8X^M #
MB9?(/[Z+9@_)QN_/']/;WI9#+Y:9FB(RN , CD8R<'Z].?:HR%\HG[,V<'][
MDX_Q_3]*5PNQ<6S(<K\^3\W(XXYYZ?SYH ?(9=T69HB<_*1@!>#][KGZ<?6A
MS+YBYFB9NS#&T?7_ /7^76F.%RF+5DR>1D_/P>../?G _6A@N\8MF0?W,GYO
MZ?G^/% $N9?M'^NBW[OO\;.OI_\ 7_PIJ&7S&Q-$K=V.-I^G_P"O\^M)M7SL
M?96QN_U6>>O3T_7]::H7><VS./[F3\O]/R_#B@!\9EW2XFB!S\Q."&X'W>F/
MIS]:(S+Y;XFB RV0<$GDYP<#Z]./>F(%R^;5GP>!D_)P..>/?C(_2A NQLVS
M.<M\^3\O)XYYXZ?RYH 4&4P "6,IC[@QO_/C^7/ZTD9 7#>^!CYA[_3^=(,"
M($6[!L?ZXDXY^N#^8_2E0!AN/!_O<8/MCU_7]*WPE_:NRCRVU>B:VVY;Z[)W
MUTU+CMIK*ZT?PVNM7Z>>@2H1M(D1LCY1D97![@#V[^U2BXE50I9&?'$B@;%S
MZ]>@^]R*KR1LI&8R ?J0_P!/3N,595X!'@P%#C_5$\OGZ<<G..E>;CN9UJ"7
M+/\ >N].23;5XZKFL^:"T[WV,:W\.5TZGP_"Y*ST[)Z?9[67:Q^-7_!><W!_
MX)\>,B9X=_\ ;]CA\#8O_$MU7.?J, 9_IS_F*>&VF9;]1-$KC4+S,A "-^_;
MA>O-?Z<__!><(?\ @GOXS_T-L?V_8'RL\M_Q+=5YZ]L9]?TK_,5\.;#%?*+5
MCC4;S]R/O(?/;GCUK^N? 2WU+&)0<U]<E:+LF_<I[ZVW\[6ZGYMQE>U/WU#]
MRMU?F5UI[UG?\3HK+[0LMQB1$W/EF< K)QSL!XZ<<8P1VS4++.TI*2(%#'S%
MZ%UR>%X'/(]<_K4MI(9'F22W:8*^%0<&$8Z'MQ][IT/:H"[)+A(&P6(W?\\N
MO)X Q@>X]>N:_?<9?ZW632EI&])6]Q<L>NCNE\NBTU/Q"IS_ %V5E!.TNW+:
MROHO=O:V[M>_,2 N)%^=%CQS$Q'F%L\,.,X'?ZY]Z4%S*<2(8\<1@C>K=V;C
MH1TX]_>F8#3*6B+, ?\ 2 6PO^P>.I_I^-*,+.Q6)@2.9LMA_1!QU7KT_P :
M2MR1_P"??LOBLO:?$M=[_P!=S6RMLF^3^6E9ZK366U]+.T=+MWLA4+[B))(W
M3#;(UQO0\X+<'(!P3ZCUSR@,I#[I8W.W]V4(Q'S_ ,M..>./\X*1@&1SY+1-
MA\S$MB7KP.#][H/KW[M3"K*%MVA!7E26_?\ /0?7 /\ G!J5K.^D/W7*XJ/.
MWS+XDG>VRU?<=EV7V?LT_+7XNGX:6OH2!GV'=-$TN1MF&/*4>C<8ST[^OKRA
M\[RR?.C\S/\ K<CR\YZXQC&/\<=Z:$7R7_T=D7<";;+;G/\ >!QV^O<?B$_N
M"OV=BO3[/EMV,XV].O?Z=N]#MISZ+VT>7D2N](_%9_-W^8)>2?O+I3_NZKWK
MW7=>]V35A[L^Q=DL:/W=L;6SU"_+U8?=]>V>M#F4;=DL<8Q\WF$'<..%XZ]?
M\339%41)^X:7!!$0+93'0]/X.OOCOUHEPVP- TXQQ@M^[Z?,?;_#J::^.GS*
MT[SY5!+D:]VW-9VO;^K"26EDMY?9I=XW2M+KMI>3^U;JYR^X".2-$PN^-L;W
M/&2O P"<D>@],< +B3#2)Y.[_4Y'G?GC/^'MV;( )$/DM*V$Q,"V(NG!X'W>
MA^G;LN UQN,1W;O^/O+;?KC'O_\ J[2NETO:>QE:/N^S^SOT_P"']025EHK<
MO\M/1:::2MKM9>[YK2ZJ9"_,L;)SM1<!T_WN/KV_#T5"V7\R1''.P*1E!_=?
M@Y.>?<>M,CPLK;8&C)SF4EL2<]N/QZ=NGHL0!:4^4T9)Y8EOWV.C#@_3_&F]
MY<J3GRPO&2C[-+FCMK:_]=@LM?=5K1^S2OO'^]KT:3LOY6W8%,I1R98W;)VN
MI&U1_"#QU7^+U]^E*&?RA^]C\W/^MX\O/][IC'_ZO:F1G;'(JP-&N3^[);+^
MX_W^W]>E*$7R /(8#_GWRV[UVYQZ_P">U"^*?*DW[:'.I)66VD-0LKNZ7QQM
MI3\M[RW\_BTT6PN9MH(FB$FX[I3CRF'8*,8S_C[\C%]J^7+'&Q7YV?&).?X.
M/ITSS]<EAP8E4VS,NXXMLMN3_:/UP/R_-9%4+%^X:;"_*@+9AYZ'CG'7OU_$
MN-M.75>TJ<SDHJ2WORW;>^UN@[*ZT6_14]=NTNJ^?=#R9 PQ*B1D+NC<@NY[
ME>#P3R/Z]U8N9%V2($_BC)&]CV8''0=_RYZ4Q\-(FZ%I2 F)@6Q'Z ]?NX [
M_CW5@%G4B)F.,>=EL(/[O3JW;Z=^E1&W+&W\/V<KR:C[39;:W^[_ #$DKQT7
MPO3EIV6VGQ6T[:K35V'*7$C;Y$*?PQ@C>I[L3CH>WY<=*13(2^9$9?X%4@%!
MW5^.N>>V!Z4B@-.Q,3*<8\[+8<?W>G5>_P!>W2DC^5I0L+1Y.2Y+8E/]X<=!
MT/3\*;M[/6ZI\M.TE;VE[QWUO;U^?F67\JORPTY:5M'&V\NG9^ZK>ZWI=59L
M,)9HG; $97;A#D??X],^G^#(Y9XSO\Z)V&[:RXV@=.??!_\ UXI$BC99";9H
MCC)4ELS<CIQWZ]NGY-@\I#\UFRI\W[LDY;T;\.#GK]>*PQ]_J>*O%-<CLE9-
MKECO:[NS.:?*[Q37M:=E'ENU[N]KN[^_:VA/OGD;<DB)+T+G 0^G!X!P3G'?
M'K496Z7!,J+_ 'F895AGY@O'5AP/\FG,ZYREL77_ )X G*GUR.N<YS[?6F22
MM*%5[9G4$83^Y@\$\?P=?\YKNX<YO]7ZEDDO?O=R;7O/ND_O.VDOW<^6-GRO
MFBTDE&RV<6[R:WYK:[VOI/)CR'P" 1\_'+CT3I_];/3FN4UF398VPR%@.IV.
MZ)Q^\8B9<%2<G SV_&NKD'[ENY X/3RN!R3P>._TX'6N4UL1O9VRNGF'^T['
M%QGY4_?+E2/4\'VQ7!B6_J>)YM/W%2_(Y62LK62CRW7K?736YIE3_P!OI>^X
M+GUW[ZI)+D3[6;D?Z8'_  03V-^Q1X=\I6Q]@3@=?]=^'T^O/O7[D'S/)C5Y
M8BIP O1EY')Z]*_#G_@@EF']BGP[LDS_ * GS?\ ;;WQSW^GIUK]Q#\T2'[.
MZ-Q^\Z[CG'OUK_/OB;_D>YG;;Z[5M>]]^O\ 5S^E<KO["A;X?JU.S;ES=-[I
M;;Z?Y#G1E*$RQMTQ@CCZX'YT^0R^8F9HBV%P1@ <#&1S].O/M4+(RE<Q,HXR
M.3N_/UI[A=ZXMF087Y,_>X'/''/7K]>*\%[[WVU^1ZKWWOHM?DORV^1+F7[1
M_KHM^[[_ !LZ^G_U_P#"FH9?,;$T2MW8XVGZ?_K_ #ZTFU?.Q]E;&[_59YZ]
M/3]?UIJA=YS;,X_N9/R_T_+\.*0A\9EW2XFB!S\Q."&X'W>F/IS]:(S+Y;XF
MB RV0<$GDYP<#Z]./>F(%R^;5GP>!D_)P..>/?C(_2A NQLVS.<M\^3\O)XY
MYXZ?RYH <#+Y _?1;,#Y.-WYX_I[>]#&3R5S+&5W'"C&X=.I_P#K#IUI@"^4
M#]F;.!^]R<?X_I^E*0OEJ?L[ Y/[S)PW3CU_,8Y^E #Y#+MBW2Q$8^7& 5Y/
MWN#GZ\?2B0R^8F9HBV%P1@ <#&1S].O/M3'"X3%NR9')R?GY//'/MS@_K0X7
M>N+9D&%^3/WN!SQQSUZ_7B@"1C-YRYGA+;3AAC:!QU'_ -?M0IF\YL3PAMHR
MQQM(YZ#_ .OWIA"^8H^RL!@_N\G+=.?3\SGGZ4 +YC#[*Q&!^[R<KUY]/R.>
M/K0 Z,R[I<31 Y^8G!#<#[O3'TY^M$9EVR[98@,?-G!+<C[O Q]>?I3$"Y?-
MJSX/ R?DX''/'OQD?I0@7#YMV? X.3\G(YYY]N,G]* '*9/);$L87<,J<;CU
MZ'_ZQZ]:&,GDKF6,KN.%&-PZ=3_]8=.M- 7RV/V=B<C]YDX7KQZ_D,<?6@A?
M+4_9V!R?WF3ANG'K^8QS]* 'R&7RTS-$1E< 8!'(QDX/UZ<^U$AEW19FB)S\
MI& %X/WNN?IQ]:8X78N+9D.5^?)^;D<<<\]/Y\T.%RF+5DR>1D_/P>../?G
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M%OM#'./0^;GOR*#_ ,%#M.&7_P"%>SJS\D_:#\^>^?.]*K_53.7+D^I5D_\
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M_-;_ (>':?C?_P *\GW_ -[SVZYQG'G?YZ=*#_P4.T]1N7X>3AFZGSV[]?\
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MK:=+O;S%_K3EEDOK-)]YIS:7JVDU>[MH^5*W37]*R[/&!#)'Y?41C!<#T_\
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MF<Y;Y\GY>3QSSQT_ES287R<_9FSC_6Y..G7U_3]* )',OEKF:)E[*,;A]?\
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M=,P9A_PENAG>OW,?:K?TX_S[9'^H->L26$16-N[/C# =>O<\X^N>G-?Y??\
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M9N608;Y\?>X/'/'/3I].*D43><V((2VT94XV@<]#_P#6[4D8E\Q\0Q%L-D'
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M4EGBD50LIBR1B0 Y?G&.A_UG0^W-/6)T?8T<;OP61B-@&.H[$\<^X'/J2HH
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M<S4YOVDKV2O%W7NI)=.TKK2UBF9I"T8:R$>3@#C#\$8/3]:669E=1]E 8_\
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M>O/OQ@_I3XQ+NEQ#$3GYLX 7@?=ZY^O'THC$NV7;%$1CYLX!7D?=Y.?IQ]:
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M;^O\AW=WK_R\BM)+31:/W?PO=]T5V6#R$R[B+<2KC.\MQN!_BP,C&3_7+IA
MRQ"1W51Q&5!RRY/+8 YR3US4I\[8,>5YG&[/^KV]MN?EW>OX>U*WG?+L\K=D
M>9O^[N_Z9Y[8QT[YIP;O[MXQYY\T9:.7>WJ]>NGW I-M:M^^U\2:T2T^'[ET
M[D,@A\V,N[+)A=JJ"5(Q\A. !D@C.0??UIS")ID+,PFP0B ?(0>,G VYZ=:D
M/F[EV>7LYW;\[\_Q;<\X_NX[8[4IWY^39Y.#G.?-S_L^W7]*E/2*5U#V4OW;
M?O/1>0N;6.KO[.3NI::6U^'==^G5,B41+,Y5F,V '0CY !QD9&W/7I1&L1:4
MQNS-G,H8<+@?PY'IZ5*-^?GV>3@8QGS<_P"U[=/UH_>\[]F,_N_+SG'_ $T_
M'K[4F_<L[NGR4^6FOCB[QU?I_7F<SL]7=1@[\WIJO=TOWUOV151K>,2HKNP.
M1(6!)5<C[N0><@#C'%1H(0N8'E*DG+8;<#Z#D'@?AQZ5<7S/F\WR=V?W>SIG
M_II[8SU[XJ-9)XV#,("V"%V[=F,_Q \9Z?KVZ8XYMX/%+?\ =Z1?3W8Z-::_
M,B;;YEI.U2GRI:VO;1V2>MN^OD,"+( )6<)T5AG=GCCUQ^/<_2DDMXX@K2NZ
MQ@C:5R6)SE=V,'![Y/U]:G$DLCEHQ$)< '< (\=MH'&[.?T[U'_I.[_EGN_B
MW_<Z\[-W&[KC].,5W<.W7#]3:*M.\;:[O;5^O^9V4FW"I]F2C[UVI*VGNQLE
MRM;;R[>9*Y!@;/4 ;!V8\#YL=N.^>>N:Y+76\NTM7?(D&I605!]PCSEY/;/3
ML?J*ZY_^/>3;TP/,]>H^[[_Y%<KK3@:?;+@>1_:EEN+C,N?-'W<\XZYQQTSW
MK@Q%W@\0Y+G?L:MVD]5;9/FLWIM9%959X^@WS).=FTFW/5>[S72=]DN5;[K<
M_P!+_P#X((L\_P"Q3X<(5038*,=!_KCZ8[^W0^U?N(5B6) KN7XW [MH!P3C
M.1^GXBOPY_X()^7_ ,,4>'?)W[?L"_[W^M/_ -?&._7M7[E-YIMXP_EX)7&
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ML;O^ Y^;KTQ^'- $(2+R=VY_,_N\[.OUQ_X[_C2$1^4I#,7R<J<[0/;G&?\
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M7_>YW]/J#_X]_A5AO,^T)GRMVTXQMV?C_#GIUY].U,_>?:O^6>__ (#LZ?\
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M CA&..%SD8QTVXP<_6K$^[(WXV8.W9]_/OWQZ9XS[5'%]Y?,V8R/*VXW;?\
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MGFON1V7G"@_,.>Y_S_2GY;[3GSQG/^NYQTZ],_I^E)$3YSXF"'GY^?FY_/\
M/\>:1(1B/=+NC<C/RX."O^]P<_7CZ4V,)Y3Y1RV6P1P!Z9'/TZ\^U21%@TV)
MPF3R>?G]^.?;G!IL1(AD F"#+93^][\<<]>OUXH ;\GD?<??_>S\O7T_^O\
MX4UMODKA&#9Y8GY3]!C^O>I,G[-CSAC_ )Y=^OY?K^M-8G[.@\T$;C^[YROO
MZ?D<\?6@!LFS;%M1P<?-DY#?[O3'Z_6G2;/-3".%PN03DGUP<#Z]/SHE)VPY
ME#X' Y^3VYX]^,BG2D^='F8.<+\_/R^W(SQT_ES0 ,(_.7$<@7'*D_,?H?\
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MI\KG*'/9)76JMI-Z-^6FK/JG0/VU?B<]FVDZ==301VL83>UN0A52!\IROH.
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M6/B5)+?3)'D-K&#F10Y0*"N.YS^'?BLT_:+BUEGDN97$ (.G^8P>?;G@'/\
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M:5+N7+9JVK5]+I:*]M;6OH999K4C=<W[R/2+_E_G:7EOZ=#];_\ @@-=2_\
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MW''OS@4 -7;Y+91BV>&!^4?48_KVIWR>1]Q]_P#>S\O7T_\ K_X4*3]G<>:
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M]_\ >S\O7T_^O_A0I/V=QYH W#]WSEO?T_,YY^E.R?LV/.&/^>7?K^7Z_K0
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M^E.DV>:F'<KA<DC!'K@9/TZ\^U $K!OM"#R #M/[OG#>_K^1QS]:%#?:''D
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M^_/'MQ@4UMODKAV+9Y4CY1]#G^G:B39MBVNY./FR,!?]WKGZ\?2@":4-NAS
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MG'K].*ND%=I/[H'&UEY\[GJ?KT[=*S[.".6VC\F5FE 4LK?='!#8/Z5=,BP
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M'ES_ ,L.G*^I'3BFA21D#S1_SU/48ZXYQQ^/]*8)$G!0DQMT0(.'Z\/S^?\
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MXP2\8$8D/V>+Y#GCY!SZ\]/P]:_"#]E[;_PNO2MK,P%G,"S#Y@?/M^!ST/\
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M,\Z3'EYPV=VW;_P'/RYQTQ^'%(HC\YLQR%<<*#\P^I_^MVZTV/9YKY1RN&P
M<$>F3@_7I^5 "P[]DVW9C'S;L9_X#GG/^[S2+O\ L[XV;=PSG&_\/XL=>G'K
MWIL>S;+N1R<?+@X"_P"]US^GUH7;Y+91BV>&!^4?48_KVH E_>?9?^6>S\-_
M7_OK_/I2R^9Y,>?+VY7&W&[_ (%CYNO7/X\U'\GD?<??_>S\O7T_^O\ X42!
M/*3".&RN2>0?7 X^G7CWH EF\S?#N\O.?EV[<?\  L<=/[W%-F\SSTW>7NXQ
MMQM_'''Y_CQ22"/=%MC<#/S9.2W^[P,?7GZ4V39YJ;4=5XRI/S'GL?\ /]*
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MG';&:A(G,A,?E[ 3YGKMYSLZ=_3MVJ2TE21YDFC=U5L1K'PR+@'#GN<^OY5
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M]G^X^_\ O_P=?3]>O^% #YO,\A-WE[>,;<;OQQS^?X\TV;?LAW;,8^7;C/\
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M_P"!8^;KUS^/-1X3[/\ <??_ '_X.OI^O7_"B0)Y281PV5R3R#ZX''TZ\>]
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M'K_]>OFM3,1E]F\_=V_ZO'\._'?U]Z^E?V]GMO\ AN;]H;8A5AXP7?N_C/\
M9MG]WC_#\:^:$=6C8+&ZQG.4;.]NI)7H<'J*_P!'N'^5<,Y'I*"^J835+5OV
M4.E[6>KO?MH?SSQ:E]=E:Z_?2Y:3BG9<RNY-R3OU6FE]+CAYVPY\KS.=N/\
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M9^'\.>O3GU[U&PC\Y<1R!<<J3\Q^A_\ K=^M"B/SFS'(5QPH/S#ZG_ZW;K0
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MX+!/,_#9G_T'Z5%-L#J5C<+W4Y+'Z=,=?PZ\]*?'*C8#1N(O^>?._&.F>O\
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M^EW9WT2;UVWT"VCY5S+E2GS)7AK'2*YM=-;72O\ :>P\8V2?9MN<?O-^W/\
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M7SL?96QN_P!5GGKT]/U_6FJ%WG-LSC^YD_+_ $_+\.* )8B=\V)PG/)Y^?\
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M.T;V:DU[2TK/9;<N_5^[9]&UJ$792M:TDD[J+T5EHY?D_<_EZ"<LCB,^0>C
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M\U\#$W.$QVQUX'!^F.:A9)A,6\W/7]]S@COQU]?;OUJ8],*/*SUC/5^!D_\
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M=YS<L@_OX/S?T_+\.*EQ+]H_U,6_=]SC9U]?TZ?XTU!+YC8AB9NZG&T?3_\
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M+4WQUWZ9=C'J5_==3_2G'B/)4XJ.84%&\^=2J4W+7ELT[Z)O;OT".68]\O\
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M*P< =3]J[_SH VMR^=G[4V-W^MQSUZ^GZ?K35*[SFY9!_?P?F_I^7X<5D?\
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M Q]!_+KUDN+9XX2[,;I3S(ML3EA[8/'//X^U+8_8?(E6S/V*\P0BW;$DG!Y
M;L&QD"@"IJ^H6,P,2Q:@C'@&(2!>X_A'U-68%B-O&(UNF/RY\P$GMG&X?7WS
M7QG\;_!'[9^KSW<GPC^)7A30[=@_V6.^MTD="5PFXFXCS\V#VX_*OEJS^#__
M  5DW.TWQ_\ A]Y;*VQ!;*"K$?+D?;SP#C^5 'Z\,L9*E5N" <OE6R!@_=R,
MC\.:"D98%5N"@ZDJV[\.,_E^'-?D7#\'?^"L@2?S?V@?AZS%?W)%NN%.>I_T
M\\8S_A3H?@]_P5C$$@D_:!^'S2G.QA;K@<<9_P!//3ZT ?KGMC\S=MN/*SUV
MMOQGUQN_SZ4@2,,2RW 0]"%;=^/&?S_'FOR+_P"%._\ !63['M_X:!^'OVG'
M^L^SIMSZ_P#']_7\*=-\'O\ @K&8(Q'^T#\/EE&-[&W7!XYQ_IXZ_6@#]<E6
M,%BRW !.4PK9(P/O8&3^/-"I&%(9+@.2=H"G!!)QD 8Y]_QXK\BYO@[_ ,%9
M"D'E?M _#U6"_OB;=<,<]1_IXXQC_"G3?![_ (*Q&:(Q_M _#Y8@$WJ;=<D@
M#=C_ $_N<XX- 'ZXHJH 0DYEQ]TJ=G\L=.PX_E4F(6.Z5;@/W55.P=,8!&,U
M^11^#W_!6+[66'[0'P^^SY.$^SKNQV_Y?_QZ4Y/@]_P5A%S(S?M ?#XP%1L3
M[.NX-SDG_3NAX[5'L82=U&7,Y<UTW?FT\O73S$U?R>UUO:Z=OP/UT80\>4ER
M> &W!N#D_=SP/PZ<U%<;5B+1).<*"=RL3D=<$\\8/Z5^1\/P>_X*Q!Y_-_:
M^'S*6_<@6ZY48Z'_ $X\YS_C41^#?_!6=K29!^T#\/3<L9/*D^RJ54'.S/\
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MM7]K,G_!KUI^[;;:OX;6%SEE:]0L2WWL$R9').*D3_@U\T5%\EM5\-E6Y/\
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M(?@]_P %8Q#*)/V@?AZTI9_+86Z849.W/^G=AC/(H _7(K%O!"W/E@$$E6W
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M.A)N$N7FT;MK;JM;K7ST,,33E5I2BFUU:C\3LU:SZ?U\^9_;QT,7?Q(@OO\
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M*VE[/77R\LBLS&KI;NQ0C$V]OFQ_TSZ\YP1CM4?]E1E"XE80Y^<,_P"^+?[
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MB:X3ROV@/A\(]IW*;9<D\8Q_IX]Z$^#O_!6);A_-_: ^'QCVC:@MER#SG/\
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MAKNUZ \DP3<>7#T5'12O'5Z*UK>>WXJQ^19_X(I_L9JI/]E:@>O_ "Y6N?7
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M/2XTA(RM\_DY7:"[E0Q(P O'4G@8)SFHH-.M9"TFG>8H/.6=F#=>F>/3I_\
MJ:;6P'Y96?\ P21^#6D,!_PM?XPS8/!'B;4W&,Y&3_:9[8SZ<TW5?^"2/P+\
M2*]O>_$[XMLDF58-XCU K\WL=1QSG\Z_4UIY[0,CHSJ"04QN<\GID=ST[_@:
MC@ECG??]GFC0G_4L")/_ -?/X_C0FTTUHT[I]K==0_7<_+*Q_P""/W[/5BGD
M1^-/B/*%&-\VK739QW!-]S]<]_P$D?\ P2$_9Z#RLOC+XBY8Y.=6N?0#Y?\
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M8SD_GBOU(^SW>_(N8BG0)GYP1C)+=2.!Q[?4!X2^.1)=0NG557A@0.,G/."
M3T[]13_MNNVX*OB;.*AS.JE%M*/NKW7=+9*RZA_8&#3NL/1YG&,?AU<DHW6^
MK6[U[GY8Q_\ !(/]GD"7;XR^(O.<YU:YSU'W?].]_P LTX?\$A?V>A;O&?&7
MQ&VE@3NU:ZWYPW3-]]/TK]2$@O4R3=PL>J$=$[#=ZC!(_'I3VBO70A[N$R#
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M'/7K]>*'*G;BY:3\#\OY8_STH<KO7%RSC"_/C[O XXXXZ=/KQ6BNM'OZM_\
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M^9Y!/DQ^7@_O,<_X?KU]^*63S1&A:&-5)7:P'+<C&<X'/UZ=,TGR>1]]]_\
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MG/2N;M+_ $Z!?M5YJUI!<2':8;>\MFB&.F,28W')S@=AZBNGC:RO(!<171N
M!D$.LG3/(*LWZ>_X*6&Q,::GR.VGON+<':W;:^R_R+I8S#S2BIMRLG/W7\3L
MGUU:W:Z69%(LL2K+)#&JKZ#[W!'(ZYYSS2Q,+L[XXDRN1LP,=N3CCMTYZ]JI
MK=RWLHM(59XL[)&8$%0#V/.,GCMT]>ENZMH+&+RY+H6T3_,T[2+&0XS@;F(
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M-\?>R/N_3&?P_3-)'L\U\NX7#8(&2?3(R/IUX]Z(=GS[G=?3:,YZ]>G7_.*
M%C\TQN5AC906W,1RO)SC&1Q]>G7%)^\^SY\F/R\?ZS'/^'_CW7OVHC*>4^9'
M#9;  R#Z9/'UZ<>]&4^S_???_<_@Z^OZ=/\ &@!9/,$:EH8U0XPP')_S]?SZ
MTDAD"Q;H8U!'RD#[PR>O3]"1[T2;/*3:[LW&5(^4<=O\_ETILFS;%M=R<?-D
M8"_[O7/UX^E #Y/,\Q T,:L0NU0#AN!C.0#S].O3-*?-\\CR8_,R?W>#C^6?
MTZ>W--DV>:F'<KA<DC!'K@9/TZ\^U'R>?]]]G]_'S=/3/]??VH <OF^<X$$9
M?:,IC@#GGU_0#IS1'YI:7;!&Q!^8$?=X'3K^H!]J%,?G-F20+CA@/F/U'_U^
M_2B/R]TNZ1P,_+@9+?[W(Q].?K0 D?FF-RL,;*"VYB.5Y.<8R./KTZXI%+^2
MY$2%-PR^#D'GCT_4'IQ1&4\I\R.&RV !D'TR>/KTX]Z:NWR6R[!L\*!\I^IS
M_3O0 YB_DH3$@3<</@Y)XX]/U)Z\42&0+%NAC4$?*0/O#)Z]/T)'O36V^2N'
M8MGE2/E'T.?Z=J)-FV+:[DX^;(P%_P!WKGZ\?2@"23S0T6Z"-23\H ^]P>O3
M] 3[4-YOG(#!&'VG"8X(XY]?T(Z\T2>7NBVR.1GYLC!7_=Y.?IQ]:&,?G+B2
M0KCEB/F'T'_U^W2@ 7S?.<"",OM&4QP!SSZ_H!TYI(_,\QPL,;, VY2#A>#G
M& 3Q].O7%*IC\YLR2!<<,!\Q^H_^OWZ4V/9YKY=PN&P0,D^F1D?3KQ[T $9D
M*R[88V 'S$C[HR.G7]2![TL?F&-BL,;(,Y8CD?Y^OY=:9'LVR[G<''RX&0W^
M]TQ]>?I3H]GE/N=U;G"@?*>._P#G\^E !^\^SY\F/R\?ZS'/^'_CW7OVI9/-
M$:%H8U4E=K <MR,9S@<_7ITS293[/]]]_P#<_@Z^OZ=/\:)"GE)B1RV5R",
M>N#S]>G/M0 LWF#9OAC3/W<#[WUSC\?UQ1)YGF(&AC5B%VJ <-P,9R >?IUZ
M9I)MGR;7=O7<,8Z=.O3_ #FB0J)$*L[#"Y+#D'OM&3T[>O2G%)NTGRKO9O\
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M_)[_ &6OVK?VA/V,?B_8>'UU_P :VMA8:M'!XAFUK5=6OX9$AG"R%#=7<H4
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M_P" YXZ?W>*8HC\YLQR%<<*#\P^I_P#K=NM$8CW2[HW(S\N#@K_O<'/UX^E
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M.L8J/7Y*SOH=,LWE0]A3</:U%24HU(NU%)OEVM>3U?Q<KUVT1_I=GXZ_L_\
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M13M%.5MW*-]-#^YFR^,OP,CN573/C/\ #NZ\UB_D'QEHDKY=LE51;YC]X[5
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M[_[V?EZ^G_U_\* ))?,\F//E[<KC;C=_P+'S=>N?QYI9O,WP[O+SGY=NW'_
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MLI+333YM]3-^#GQ.O? 5W9-XGUS4[F8.LN#?3.FUW+J&#NW9@#].U?LQ\/\
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MC;_>[=S7V%\&_P!LSPIX1T1=,\7>#KK5;Z)]QN8=.A>)EVJH +6\G.5)Y/\
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MXZ=.N?U_2DB!\YP(0YY^3GY>?S_/\>: '1%@TV)PF3R>?G]^.?;G!IL1(AD
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M8\5W0LYM/U'5O->YB&RYC=$9HEQO>2(_=/0?C\N_\%2OAW_P5\_9]^,+>/\
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M5X?GA*[Q%.<JD'+G4FI1]E)OFY91T=G+X>;XO,_<*UNYM9@2;3K^-(G164J
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MHURU7JK.[M:QY^8X>KB?J]+!X?$*%+1U(WO.+<??4?BC;9Q>I_H1^#(Q??\
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M_ GQA\"KJPMX_.T;47D6$6.JV3+/IMZ<12%_L]W%%-C'S!<<9X_AL_X(X_\
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MG<H+?5*_.LOCA\3CYQEBJN!<JDKU8/EO)RW49M*6O2UWTZ'WU2E4P^61IXK
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M^)/A^T\269OM5M;2 ,B%)6Q@XQR>IP3]3T/6OV-T6;3?$-A%J2:O!=Z4\:K
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MG?&S;N&<XW_A_%CKTX]>] !\GD????\ W,?+U]?_ *WM[T2%/*3$CELKD$8
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ME3DJ!['O_D^F9FFEQO3R_*[9QYN.HZ\YZ'Z?K',[O&I.PJ2>F-^>#SWQQ_\
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M:,YZ]>G7_.*?%YGG28\O.&SNV[?^ Y^7..F/PXHM_,_>;?+]]^/QQN_SZ]J
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MU3P7/'=VERM[X)@31KJ:2WN(I4CN)K)K61X9F4).K,5>-F# @D5UOP._9.\
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MWP9_8B^#?[.EI!#I<FJ^+PD:PB;Q'LU6YD  ^:5[B6Y9BP&3N)Y]SS2^-_[
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MS(X;+8 &0?3)X^O3CWHRGD????\ W,93.?7(^G;C\ZDB\SR9,>7MRV=V-W_
M<_-UZ8_#FFG?]D_@V8]O,_7YLX_SBFFTTUNG= 0-(VS#0I,C=5D7*XYX'7/8
M8K NOA_\//$1:ZUOPQI=_.G+&YM3(5QSA23R.?3G/UKH(HM1N %DDM5A'W &
M ?VSS_3T[55OKS6+!ECC2VDC;[NQ0QZGEL \YZY_I6LL7'GY>9QT2<4]=&NB
MLEK^)E4PDJS3C9N+O[.>B:T^%))Z;WU,:QA\*^&/]'\.Z#:6<,;8"P6A0#GD
M*.1@'/K_ $KJ5NYKV 720(I89S@AOF&3\N <\_GTSWEL+HM"/MEO:K,PX.Q
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M>)DE8G<7YC.>H"\C!_+...01=5I9)03(OD9_U?5B.!ZXS^'2IOM'EDC.Y0.
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M_E71%^[&]WINDM]-'KK;[WU-72=-OVCN[1;75[;+9=+Z]--Q@C.P?*V/[_\
M!U_+../K3G"")<(P?=RY.5(_(<_B:-\@B$9E0+P/*)^8?K_3_&E8/Y* RH4W
M'"9.0>.?3OZ ]>:;YM+]NUK[:_\  VU)YXR6BB[.UXOR6C[M+=^8V39MBVHX
M./FR<AO]WIC]?K3I-GFIA'"X7()R3ZX.!]>GYT2"0K%NFC8 ?* ?NC)Z]?T
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MB&Y+2&2,<1;R&..0,9.>?\XJ])<WS!5NKV&V08W"=B-P'0#)ZYZ=:K-$\/\
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M7L>'^)OC#0?@UX,O/&%UI-_K$%JX62UT]1).Q,<LA8 (> (SD^I]*_(C4?\
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M+KY&;S#&S4/]FY(I6?,[2NK64;723MHKZ_>?JE)9)*5FT^\MYXF./W+AFSU
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M*[>6O/1LG )S7Q[^T]^W1X$_90633?&WAK6]<,%M#)++I49>-EDA67C]U+R
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M[4U"*Y=6VU>[\GY+H?'7[0WP"_8J_;[\:^%/$'PT^-/@^X\4^%M6_M>R&D7
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MR<CGGGVXR?TH0KE\W3)SP<'Y^!SSQ[<8'Z4(5P^;EDR.!@_/R/7GWXP?TH
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M)R.>>?;C)_2A"N7S=,G/!P?GX'//'MQ@?I0A7#YN63(X&#\_(]>??C!_2@
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MGYN1QQSST_GS297R<?:6SC_58..G3U_7]*5RNQ<7+.<K\F#\O(YXYXZ_SYH
M) HQBV:/ZD_-^7^?3O2NB[0XB\LX_P!4?XSC^OOCK^%(Y4[<7+2?@?E_+'^>
ME#E2ZG[27P%^<CE>!P,<<?\ Z^*3NUH[/O:]ODQ--JR;B^ZM^I&JG[YCV]_(
MYS[CC\^N/:E==F&2(S-_SS&<K_\ J[\_EUIYV&;)N21N_P!=CGKUST_3VI$V
M!S_I!0?WP#EO_P!?Z]>E8PI3CS?OI2YK?$DU%Z7MY6T2W\R.25DN>6WQ67-^
MJ^>[&AFD ,EL\A7Y54$_N^^.G7TYIZC?\[0,SJ<++SA O !!], <#M^0A7+Y
MNF3G@X/S\#GGCVXP/TH0J%;_ $ED.3A,'YN3SSD\]?Y<UK%.+;O>Z2BOY=(\
MUO\ $UJ-4X:7A&6UVXJ[M9ZO?= 3&WS-'ND_Y[=LX^@^G]*2.-E;S -F[@R'
MHPXX' Y^;\>*0"/RQ^_^;_GG@]?IG_/6E)7RE'V@GD_NL<*/EY]?U[5IS-?:
MDU;5-VN]-;HKDHIW5&G?J^76W9/MY[EDB-!F(!'?!=LG]X>F1P.N<?\ ZZA"
MD-AHF&>=IYW CU/&3^&.M1L(P$*S;CW&#\AR?RZ9Q3G*[UQ<LXPOSX^[P...
M..G3Z\5<:EDHRA&I%7TG%:I]WO=;7O?N6_9J_LH*DG:_*]7MU>WHM'<D9%R$
M6$H#R8_[V,<Y&?R_QH5%R4:$N!R(_P"[G/.3C\O\*82OF*?M3$8/[S!RO3CT
M_,9X^E *^8Q^U,!@?O,'+=>/3\AGGZT^>C:WU6C:W+MTO>WWI"O*UN>5OE]V
MVWD5;MD1@3I[W83HJG&SOM/(![&E%[]NMI;>*V.GS%<),QSL(.<X!89Q^O6F
M7,4DFZ2.^D@$?/RC_6\9R<D#V'L*BTC5[*>1[.\.R5LK'(5Y<@CN?89'/Z\T
M_:47OAX+2R<6TTTK*W30?M*B5O:3MVOITTMZ*QXI^T-)>:!\'-<N+DG7&,AV
MQ(,%5^RW/KCN/ZXZU_$%XN^ NH_M3?MDCP7HVHGPEJ5[K:113%1*R2LZ[#M"
MOWQ_]:O[7OVP;;4-'^#^L:I87<DRB1E-HN0K!K6Y(.<'IC'7N.U?RG_L2W*Z
MK_P4F\.75V[17#>+M/!MVR<_Z3$,9/7(Z^QR:4*L()J5"E4]ZZ<U=KT?EW%=
MJUF[)WMO&^FZ=UT[=^Y]6_L7?M??&+]GOXT6_P "?C5KD]OX+LKV30;+4=31
MK6VNW.ZRLUC/FD9FD9%4>6,E@.*_I;UJ;3KSX5:KXAT!!*-0TU)HY(B'$X=X
MVRO ZYSQ_,U^=G_!2;]@WP_\>?AYK.O>!8;;PYXM\-V__"26^I64'^ER7>BN
MNI+AA')AG>WQG'!)K\H?V ?VYO$GP@U/Q?\ !?\ :+\9:I)++92Z+X6CU>0.
MDEY#<PE1$&:+:?L\$G\)R.U3*K*2MHEKHHI;]W:[^93G)MN]N:UTDE%V_NI<
MOX'R-^TAKDH_;C\(?VE$%D&N6.VW<?.__$Q;ISW/ '?%?V6> 'O'\*Z9?0VL
MBP&PM6%AC#8,$9VD_3U./SK^/7]H;Q/IGBK]L;P3+IVA6M[#>ZGI\L6M @R0
MK)?':X 8_=ZCKSFOZ_OASJND>'O">FV%YK\EQ*FGVB&1DYW"",>@S^'I4N<F
MDF](JRT2T?335[=2;ONWV3;T6BLNRTV.\@T32MWVQ[,F1^9(LX,8/+%L_P!W
MJ37Y]_MD?M@_%?\ 9IDLT^$'[-?B7XV"<L+@>'W.8-NW&_%Q!R<G!/IVS7Z!
M6NDW%^QO(M4D6U8%BW(W)C)R#ZC@_6OFSXY?MD?LU_LN*LOQ9\??\(QNW$LM
MF]P6V?>)_>)Z^W-4JM1*W/*W9NZ^YC4Y*2G>\ELWK\M3\JT_X*_?M@S-%9G_
M ()N?$WRI43S9 YVJ7 W _\ $RXYSGJ*M:A_P5P_; TF,P:?_P $XOB9.!PK
M*6/T/_'_ (/X\^E?3,/_  7!_P""<.IW/D6'QV_?(_E&(:/(,R*=I&?M)[@\
M_P#ZJF;_ (+??\$ZK+4AI]U\<W%YYGE_9_['<C>3C;G[4,\_EBI4Y)WNWK?7
M5/U3T8<\KWNWKS6>J;[M/1EC]G3]O+]H;XP:G%:^.?V2/&7PXMY2NZXU0L43
M) .1]KDZ GV_#I^H=C=KJ&FP7K0-I]S*A:6U<G>K9. >O)Z]>_%?'7@+_@H3
M^S'\6IHH_ 7Q!;6C.1Y:&R>$'=C'68X/./\ /'U_HVJ6&L:?%J.FL+R&Y4N&
M;Y<#)''//3/6FYS;4FW=;=+>EM$.52<FFY/3:VB7HEL9>KV.H^)-!OM,T^^_
ML749A-'!=NH<JQRJ/@$]P&Z?45^+UK_P1DL]>_:,NOCE\3?B-%XN>YU2XU*;
M2'B,>6F=Y"N#;$=6_O=NM?N%;R*7,/E_.6($F.4R<8'0<'V[?2N4\3>+(_"7
MGSZVL5IIL =FU)Y5SL0$Y*DJ><?KBG[6I:W,]7=N^MUY[BC*4?AE*/\ A;7W
MVW,CPSX%\$>!]%E\':#9Z=;Z/;6@$ECY,#L 8Q%(Y<Q@X=8QCCC'XC^4C_@K
M7X0^'/@O]H?P+JGPHO+70/$^HRVMQK*6<O[RYOA>L@9HXTC )B2)<$GH,U^B
M_P"VO_P4SLO#VH/\.?@!HW_";>/9XI8;\6<AAFA2=C%;,729LY>.7'R\$9[X
MKY9_9)_X)^?%CX_>-F^.O[3\=WHW]K:HFIZ#INJ!KP6]K$L*JD;>3\J^='(1
M\Q.3R:ESD[Z[I)]G:VZZ[=0E)R?,]7WM^:V;T/I7]H;XI?&32_V+;&VU2\O;
M1O\ A7NG>1<21LA>(Z'"8Y01)R&3# ]P17S=_P $2_V<?AAX_B\:_'#QQ;PZ
MOX^T75K:UTZ^NFW/##>O/-.H22-P<R6L/\8Z5_0/\8/V:/"GQB^$,?PSGOX+
M"RBT"WT.&_:/B."WL8[*-@I4X"I&"!C\.*_GTM_V0?VV?V#?BQ_:7[-7A6_^
M.'@74WNI]2T:'4!967G)-%);%T$"Y;:9T4[NA)K1UZG)[-/EB[<RCHI-6LW;
M]-&.=1S2325M[*R;Z-K:_FC^BCXJ?"3P?\4/".I67BK2+74M,L=.G^PPK##%
MY<GE@$AA&3DJBCCTS7\S/PQ^(^N_LO?M4>./"7@VZET;0-4\61&*S9G=/+>V
MLHV"?.J\[6_A[5]W^(?VC/\ @I9\4_#%YX>U;]DZY^%-K;V<BSZS9ZVTKNCQ
MJLDA7#?ZO9NZ?Q>V*_'3X4^#/&VB?M,:O?\ Q!U.Y\7:]>^)H);S3+]_,.CR
M".T7[.K!5R %$HSW<^QKFJ1<X<JDTT_=;;M'57>CZJ_0/:5%"5-3<8RM=63V
M=]$]#^SKP1JTNN>$-!UB;,L^H6L<LQ!.9"T:L3U/4GO_ %)KJ&+;@B0/&#R8
MSSNQCG/.*XOX<X'@'POB/[*OV*+Y5!_=#R4X'\OP],Y[,E?,4_:F(P?WF#E>
MG'I^8SQ]*TA*<5'WGS1^UUZ?Y?\  )3:MJ]._P#77J(RF7]T\3$'CR\'G\<?
MYY]Z%.T&/R7< '"\@K[]0,+U.>*4%?-!^U-C(_>X.?\ #]/UI$*[VS<L@PWS
MX^]P>.>.>G3Z<5K5Q%6K2E2NDI1Y;]GUG_B?<?/*R5W9.]NG_#>6R[!MR"#&
M9,]"./+Y')!QGTX!Z_2HQ"P.55F/:3G"GUQQG'6GIM D_P!(*9'0 _O.1P<\
M^_'-*A4(P^TLG_3,#AO_ -?_ .KFO+>#;5G7J6NGT5]M966K5M/D2[O>3>FK
M[[6OZ6VZ];CP&)SM._\ Y^<<=/O8Z^_2HFS&25A96S@R\X?=U_,9_/MS@ROD
MX^T-G'^IP<=.F.OZY[]*<Y78H%RS<K\F#\O(YXYXZ_SYK2&&Y%;VDFG\7V>=
M:63M;5:Z_P"9+BG9R4966EXQT[M::=--D-\M>H@:$YYS_&?\_P _K2^4@P!
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M]J;&[_6XYZ]?3]/UH :@7>V;9G&&^3/W>#SSQQUZ_3BA IW9MFD_$_+^>/\
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M,,;CTZC_ .N>O2HAY/EC_7;\#_<_^)_SZTI\KRUQYN_)SG[G;I_#GKTY]>]
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M0_X+=_L<:7X<BN[JZ\=Q:\8-XLHO!&LM$)POW.(>FXXP1T[5^1_CK2_VFO\
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MNWIU'WL<?]]<4+Y.T[O.W=MOW?QQQ^?X\4 /Q+]G_P!3%LV_?XW]/3/X]?\
M"G2"7RTS#$!E<$8)/(QD9'TZ\>]0_N?*_P"6V_'_ &SZ?]\?T_&E;R=JX\[=
ME<[ON]1]W/RYQTQ^'% $LHE^3=#$OIMP<_7IU_SBB02^8F88@V%P!@@\#&3Q
M]>G'O43^3QM\[WW_ --W^?7M2MY.Y<>=MPN=V=W0?=S\W7IC\.: )L2_:/\
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M^X!^'_[2W_!:/X0>(?"=MX;^ UOXPUOQ5K4<MA>P7OA#5[>. W$<:1,LIM9
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MO(^[R<_3CZU$OD9?=Y^,_+MSGH/O8YS_ +W-"^3A]WG9Q\NWIU'WL<?]]<4
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M>3N&WSMO?=][\,\_E^'-._<^;_RWV;O?S.O_ 'WG]?PH ?&)?,?$,1;#9!P
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M@Q;,A_OY/S?U_/\ 'FAPN$Q;LF1R<GY^3SQS[<X/ZT /D,OF)F:(MA<$8 '
MQD<_3KS[4I,OGG]]%OR?GXV_E_\ 7]_:HW"[UQ;,@POR9^]P.>..>O7Z\4I"
M^:1]E;&3^ZR<_P"'Z_K0 ]3-YS8GA#;1ECC:1ST'_P!?O21F7=+B:('/S$X(
M;@?=Z8^G/UIH"^8P^RL1@?N\G*]>?3\CGCZTB!<OFU9\'@9/R<#CGCWXR/TH
M ?&9?+?$T0&6R#@D\G.#@?7IQ[TBF3R6Q+&%W#*G&X]>A_\ K'KUIJ!=C9MF
M<Y;Y\GY>3QSSQT_ES0 OEL?L[$Y'[S)PO7CU_(8X^M #F,GDKF6,KN.%&-PZ
M=3_]8=.M+(9=L6Z6(C'RXP"O)^]P<_7CZ4PA?+4_9V!R?WF3ANG'K^8QS]*'
M"X3%NR9')R?GY//'/MS@_K0 ^0R[HLS1$Y^4C "\'[W7/TX^M*QF\Y<SPEMI
MPPQM XZC_P"OVJ-PN4Q:LF3R,GY^#QQQ[\X'ZTI"^8H^RL!@_N\G+=.?3\SG
MGZ4 /4S><V)X0VT98XVD<]!_]?O21F7S'Q-$&PV2<$'@YP./IUX]Z: OF,/L
MK$8'[O)RO7GT_(YX^M(@7>V;9G&&^3/W>#SSQQUZ_3B@!\9EVR[98@,?-G!+
M<C[O Q]>?I2*9/);$L87<,J<;CUZ'_ZQZ]::@7#YMV? X.3\G(YYY]N,G]*
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MY/S<CCCGGI_/FAPN4Q:LF3R,GY^#QQQ[\X'ZT 2,9O.7,\);:<,,;0..H_\
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MY7Y\GYN1QQSST_GS0X7*8M63)Y&3\_!XXX]^<#]: 'N9?,7,T3-V88VCZ_\
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MG8')_>9.&Z<>OYC'/TH ?(9=L6Z6(C'RXP"O)^]P<_7CZ42&7S$S-$6PN",
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M@Q;,A_OY/S?U_/\ 'FAPN$Q;LF1R<GY^3SQS[<X/ZT /D,OF)F:(MA<$8 '
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MGF(&AC5B%VJ <-P,9R >?IUZ9I3YOGD>3'YF3^[P<?RS^G3VYH :"OF,?M3
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M_)R?3GWYR?UITGF"-2T,:H<88#D_Y^OY]:20R!8MT,:@CY2!]X9/7I^A(]Z
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MN'S<LF1P,'Y^1Z\^_&#^E.C\SS'"PQLP#;E(.%X.<8!/'TZ]<4D9D*R[88V
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M7CWJ9?,^T/CRMVT9SMV?A_#GKTY]>],B\SSI,>7G#9W;=O\ P'/RYQTQ^'%
M$4>S;+N=P<?+@9#?[W3'UY^E"[?);+L&SPH'RGZG/].]/AW[)MNS&/FW8S_P
M'/.?]WFD7?\ 9WQLV[AG.-_X?Q8Z]./7O0 ?)Y'WWW_W,?+U]?\ ZWM[T2%/
M*3$CELKD$8 ]<'GZ].?:G_O/LO\ RSV?AOZ_]]?Y]*67S/)CSY>W*XVXW?\
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M^2N'8MGE2/E'T.?Z=J<N_P"SOC9MW#.<;_P_BQUZ<>O>AM_V=,[-NXXQC?\
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MEAW[)MNS&/FW8S_P'/.?]WFG0^9Y#[?+V\YW8W?AGG\OPYH 9E/L_P!]]_\
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MC 7_ '>N?KQ]*=)L\U,.Y7"Y)&"/7 R?IUY]J6;?LAW;,8^7;C/_  +'.?\
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M2A,CD<_/[<<>_.!0I/V=QYH W#]WSEO?T_,YY^E !\GD?<??_>S\O7T_^O\
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ML6^T(?/!.T_O.<+[>OY#''UH 8HC\YLQR%<<*#\P^I_^MVZTV/9YKY1RN&P
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M'9><*#\PY[G_ #_2GY;[3GSQG/\ KN<=.O3/Z?I21$^<^)@AY^?GYN?S_/\
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M)+K&5>)L[>!SP!GIT84 ;D8CW2[HW(S\N#@K_O<'/UX^E0K)!&DIER./E.<
M=?O9_P ^]>8>+?B-X*\&Q>9K_P 1=(T3["A;47NF*YQDEF^4@#8,?@*X'PG^
MUK^S5\0]63PMX/\ BOX8\0ZTSF&:UL;O?,7'#?+MX.1ZYS0!]&1O#) Y3+G<
M,.K90?7'4_CVZ4@N+,Q^4)!]H]-W'KT[_GU]JR-;UK1_!>C_ -K7MW FEL S
M2.Q6,@JS!M_IM#5\WZO^V_\ L=^%+B0>+?B[X/\ #VH0D^;!>ZALD0C.[(VG
MI@]_?IT /J07EC<8@MI5EG0C>BL6; ^]\H'&!GOV]:ML%D9/*AE(7F0<DX]C
MC@Y^H_6OBS0?VT_V/?'FLPZ;\,?COX*O]?NYUA6WL;[SII6=@'0(4&2W(Z]^
M.F*^LK6^NHM.2>SOEOHKV-?+U&, QQ _-YI.>0> ./XATH WIC&LJG8Z(,;@
MQ^;@]NG/M_\ JH5H7GRBNT?]W/S]/7']/\:\EUKXO_#/P&6;Q_\ $?1K%URS
M"\E\K8 >0<+VQW-<IJ'[87[+>@Z6_BC4/C)X3L]"CC,[WLUX! L:C)8MMZ;?
M?WH ^@HI8&FD7E\!OD4_,O?G@].IX_+I4D&P[P8W<_PA.W7&>O\ GU[?,7@/
M]K3]F#XKZS'8_##XU>$M?U2>0@6VFWGG22=2ZA?+[J&^G4U[CXK^(7ASP-;0
MWNHZE;6UJPWR74S[4*@9+9],'- '6+M1726*02DG:.1P>G'4\8)_QI2FV##Q
M2))ZG.WUZ?\ U_TKY(\2?M[?LB:1=FRUSX[^"]"U6/$<EM<WV)$E4892 G7/
M;BLRT_;W_95\0.FC:#\??!FNZO,RQ16EK>%II)'(54"A1RS$?SH ^R9-GE)A
M'5N,L3\IX[<?U_/K39-FR(A67CYBQX/TZ8_,_6G^'=7TKQ)H4-_8W,5]%)"L
MD4D+95LKD$$C_(K M-3NQ=:@FIVSQV%K)B*>3Y42/:&SU/0YX[>E &\0LKJ\
M,4K1C&[J22/O8..._P#7BG%-LN\PRB+/0YSCIUQ_3I7SGXS_ &POV:OAAJ$F
MC^,_C3X3\-:A&^V2RO[O9+&Q (5@$X//]:X^;]NO]E?Q7 --\._M >"S?, %
MEBO-Y..<[2@SD>I[_2@#Z[&P2%VBD\IAA>N<]\G\!CC^M1F:V@+&XW1K(<Q;
MFVDCUYZ\Y]*^4;[]K[X$:'I5CIS_ !?\,:KJ<]PRJZ7.&.\($4#'KG'//UKZ
M,\+75IXOT'2_$5O<QZUIVIP^?97$!_=^6'9?E;(SAE///^(!TB-$(79E8@Y*
MN"0F,<$]>W?(_"HH98)HF2/=++NX*<J![^^?>N7\7>/? G@"W=?%_BC3]&MT
MCW/#>2E-J%=P!./[I_+KWKYGU']OC]C#PK=_9-1^/7@?0[HEE-O<:@0[%2,\
M;<<$@'IU]: /L4@,@C6.3S@26[C'; _/\OI4=Q)#"(ED!A?HPD;&XYQ\HXQT
M_P#U5\_> _VMOV<?B?<S6_P^^,?A;Q+?[4&S3KHRNI?=Y?&.^#^7XUZWH-G>
MZC>7-[K.HK>V+R[].<J JP[0/E)SN&\'ZF@#JY&AS$RJX7/S$G.[_=Z<^G7/
MI2DQEUD$4OD@?,><Y[8..G7M_,4MU \B>3!.)$SA749\H#^(\<\<8Y^M0PJE
MM&T%SK$3,^&";<'CMR,]_P ?H* !IK5)/,<LL/<'KTP>?S[= :X[Q7\2/AW\
M/85O_'OB[1O">GSND4%UK-V+6)Y9W"0H'*D$R2,JJ.,DCI727"&]62T6V8Q[
M')NP?D "D[L>P'<9K^5/_@KW\7=:^)VM^#/A9H]]+*B^/_"%G=1VLCAOL\?B
M+3UG#!6Z"-3NX/% ']2WACQKX)\9023>$/$NE^)X]F\2:1="X14) #MA0=O(
M'KDBN:\0_&GX.>"KY=&\9_$7PSX:U>9ML-CJFH"WG<L=H 0J<DL-O7K[]?G'
M]D;X2Z%\!O@)I_BFS_=74WA^W>[:20D_,+5FW?(O5AZG/3WK^;+]M;6[;XY_
MMO\ @W1WU@I:S:Q86\D4<SA<-J# @@9['T[T ?V*Z3K.B>(-/2\\/W]OK-M*
MBO%>6,OG6\B-\RLI &0PY'/>M)MC(J1QR>8"-_?@=>.HXR1S^M>>_"WX8V?P
MI\!:7X>TK4%MK>VTVSC69LD82", Y*CT':ND\0R:A;6ML^D3F>>26!9I8P3E
M'=1*<$#'RD_0&@#;E>%BHC5@1PP8Y/;IT_2G2[ Z-L=4P-V>2<=2#@>Y']:P
MKK5[?2[>'[1MFO)5'4X*OCTSBL34?$=II%H^J^*=<M]&L(U,ADNQL1(0-P)/
M/&S:0>_YT =TJJ\OF+#*T/ZX]=V,?I^M112VYFD7EL9^13\PY[\?T_+I7QAX
MO_X*&?LC^%A-I6I_'[P1H,T):*2[NK['ELI*L6&P]#U^GY]I\/OVK_V;O'/D
MGP)\7?"_BV]GVY?3;OS#*6[@$+]X_P"<T ?4$7EEI<I(W/RA<@K_ +W'7GT'
MT]*%[JNC:/937FLWT&G6T6YGN;F3RH8U Y+D@XP!S39M1MWTP:^-1BTW3%C,
MUQ=R<PNBY+/G!P-H(/7I^?\ /7_P5!_X*&^!]"M]?^'GPW^)NCWNIFW:QEM;
M*X9IA>FV6.:,JK* XGWKCGGB@#]I=4_:R_9:T3=;:M\=_A[I]TC['CN-:5"K
M!L$$>6>0V1CU]J[WP?\ %KX4?$6U$OP_\?>'?%^&PSZ+>BZ49&1T4')Y/_UN
M:_BL_9*^"W['/Q6TK3/$'[4/QG\.:7XCOA%<7^B:OJ4EM<I=3$,\;+Y,N")&
MP1N.#W]?Z@?V+?V8?@-\+]-'BCX ^(]/U_PC>&*.%M-N#=6_G0H&?#M%&<LD
MB$_0'CL ?HB[1MY:HKAUXD!YS_NCZ?7'K39IK=)XT)*'Y<H[?.3UXX'7J./S
MZ5G>(;N\MY[5]/M))=R@W)0?ZLACG=VSMP?2MXVFG:Q;PW"21K?") 7')CD"
M@$$;>JMP>>,>U %)KJQ%S'$9-KLI(A+?O&QW7V&>>.]/66W-PZX8_*/W8;YQ
MGN>.A^@Z=?7P_P"(/QK^ _P@NTF^*7Q*\/\ AO4B)!;R:I<^2P08\Q0NPYQ\
MN?3UYKQI/^"@W[$NEWKZA>?M&^ R)0L8#W^ =A.0#LP3\P'(H ^UT:%7D#(Y
M)/R*N<C_ 'N#S^ %*D95)"\,N"/D;D ?7(Y_,?6OG?PC^U/^SQ\7I@?AM\6_
M#.L.9!&&T^Y\[?)P>,J.<,.G_P"KW:36CH=B+_4KM+[2"@,M]]V&&/C$C-D<
M$D#I_%F@"\A1HV0([2D\;>5 ]QZ]._O2LT21F-E=9O5LA>N>G_U_YU\[:E^U
M=^SEI_BZW\+R_&3PMI_B&>.:1=%DNO\ 2I!$T:R$+MZ(SH#S_$/4T_Q)^UI^
MS3X:+-XB^,GA73V10[&XNBF% SDC;C[O.?QZ4 ?13)OC3RH96;C<>2N.^,#_
M /5[TDOEAHAY<B\_,&SD_P"[QP?S^GK\U^%?VY?V5/'-['H'@OXW^#M:UAV\
MJ&RLKS?/+*#@(HVCYF(Q[YKZ%L]437+0L+E(6G7-C=\%78X.5 !SE/IUZT 6
MI9;<31KRN<?(Q^8\]N/Z?GTJ3Y/M'^K?9_<S\_3UQ^'3_&O%?%_Q@^$7PIN"
M_P 3_B5H>E72?.@U"8P%5!./X/4'_P"N:SKO]J[]G2+PX?'DGQ:\,6OAD0?:
MO[7:Z/V40!=QDWA"=H7GZ?2@#WE7A25]ZM@Y"*#\VX],_C[?E3XU"!FEBDVD
M95AD ?7@]CG^=?)&C_M[?L:ZO<HEI\?O!%_/*P6)(K\DL[?= ^0<YQ_]>O<=
M$^(WA#XDHDO@/Q_I6K6O!,=B_F>8IY !('!'?TH Z_4=?\/Z%IMSJ>N:C;Z;
M86XD::^N9/+MH4098R/SC:!\WT)KB/#7QL^#'C1X[#PA\2?"WB/4)6"16^EZ
M@+AY)"0 BJ%&22< 9Z\5Y+^V)IMHW[/?B^S,!1WTN_#[6(>5VMV#.N.1O/(^
MM?R__P#!*VUU#3?VH/#=@;NXBTY?$EJOV2:21@$^UH O)Z>O';\P#^OOQ;X]
M\">!;)+OQGXGTKPM;<?Z5J]T+>$\9X)4]OT]>M9/A#XL_"OXD;D^'GCKP_XP
M>V?RKH:)>_:_*EP&V-A1M.TJ<=<$'Z_'G_!1?X(> /C3X$CT;Q?\4=,^&]J,
M 7VH,50XC=>"(W[<].WIFOFC_@F'^R]\+OV=9/%,_@CX\Z'\49-2U-KHQZ?(
M6-LYM;>,0G,,?.$##_>YH _9N38)4^1U "[E;[Q/MP.IZ<'\>E+\GG_<?9_=
MS\W3UQ_3_&LJ+6?L-M<:EK2YAB>5A._RHL:D[3] H'3\/?YF\5?ML?LO^#]7
MGB\6_''PCX:O(9&2:PO;O9)$ZDJR'Y#RO0\]J /K >6)G)C?8%^[GYA]3_3'
M:F0R0.\RA6D(; 5#\RG&<-P>?RZ]*^,M"_X* _L=>(=8:ST?]H_P)J-U($C^
MR07NZ0EF8*/N9RQ& .^/;CZ4TWQ!X;\26]IKG@WQ?87%G?CS4GMW\R.ZPQ7<
MF ..,?AU!- '9-=6=N3;W,@BN6)V1LQ5N?N_+M.<C'?\C4^W;"VZ*0,2"K\A
M<'VQS^?;ZUAZM_8>GVX\0^([B*!;2-7>ZF;:A6)<A^IX( (]N>]?,_BK]NK]
ME3PQJZ:-XG^._@WP]=*'4:9>7NR9_+(#' 0_<+ 'IR?PH ^LVV"!3M8-DDL3
M\N/IV^N>],-Q9R*D<+[I@1N4'.<=<#^5?(.D_M\?L?ZI?_8++]H'P3JA;8%L
M8;TEP7) /W!]_& #Z>U?0_A[X@_#+QA:/J7@GQ#INJX@>X\ZSE,@6-$,C.>.
M@0%L]\4 =S>SV=E#]LO)!9V< WW-S<-MCC3(&XM@8YQV/I]>9M/B!\/-3U!=
M/TOQ=HU_?8.;&WN]]SD$ _+M[%@#[FO@[]MG]K;X9^ /@+\2M%D^)^B6'CN\
MTD6OAO2WG9;VYU 743&&! 06?R4E; 8?*#BOY^/^">/[5VAZ+\5]4\3?'[XP
M:7X5C6[D334UR=X5GAEN48M'N,F1A%_ ]Z /[&;J\TZPW7>H7"65DB[WEG8J
MJH%R6+8Z <].GYUYCH/QY^!GB37YO#>@_%+PGK&O1M(C:/8ZD);Y)(\[E:(1
MYRI!W#MCM7EGB;XN_!?X[?#>Y@\$_&+P\]O>Z9+ FL6DWF1)YD#1^9]PYVEC
MV[=^_P"&W[,O[%GP9^%W[3=_\1=,_:_\+>*]?GU&^F;PI;RL;IY9VDS;!3;*
M-VYMF-W7] #^F^-H?)DEY>(C*2J<)CU)QR/Q'7KZ%N\,T3>6K3/S@QG(!Z<@
M _YZ5R'AJ[N;W1H?M$OV+2;.!6FO)!^ZNXL*H((S@'ANG/%<;XL_:'^ _P ,
MH99?$?Q.\/>&X8 6N&O;@(J[>7)^7V]N^>!P >Q_+Y7E^5)Y_3';/^[UZ\=?
MTI'>$JJ*KB0$;@<\^N!QR1TY/6OBFQ_X*1?L3ZA?"+2?VA_ >L:@T@1+2WU#
M,CR$@!  G4GCKCGKVKZ?\+_$OX?_ !/@BN/ _BO3-0F<"95M)?,+(H\QL#']
MU3GVZ4 =S.$^3:CKZ[CG/TX'^?2HIIK=)XT)V$A<HS?,W?C@=>HX_/I5;4=0
M33K26\U2X2"TLTWSW4N1'&H!)9CC@87)SZ5XU9?M*?LZ:Q?RVL7Q0\-7>K6<
M\EK+$EUF2"X@=HGB(*<-&Z%"/4>E 'MYFMEN=K9"YQY>[]YTZ=.O;I4T:8=G
M:&4Q'., @COR<<U\>^/OVU?V1OAOJDTGCSX_>"_#UQ;2-YT.H7OE,C(3N5AM
M(!&.>??UKH_#O[9_[-GCJ&W_ .$1^-OA+4(+DH();6[\P3!^5"\?Q \?C]*
M/IN&2!GF&&<AL *W*G&<-P>>_;Z4JF)8G+JV<MALX4#W'/0=>?RK"M;RV.FV
M^K:#,NK6^IQ^='>V_,<X^9-Z<+D?+C\*X3Q)\2O"?@FWFN/'_C#3_"]D@:2>
M/4G$86,C?N+ -P5.[\: /5/.MOLV\GMGS-W[OK_GO_A0'B>W1HP6)8_.#E#[
M#CKSZ]^GI\83_MW_ +&-AE;O]H?P+'8*=I@:_.!@X"Y,?9NON*]*\%?M;?LU
M>/-EOX ^*GAGQ3&&4+;:==^85=NG\'\6/\>M 'T1)LV1$*R\?,6/!^G3'YGZ
MTX[)&5XHY#&N-QZDD=<'''.<?UJE<ZP+VRM+NRM&ELI8]RSH<H$R03G\#C]*
MT;:XBN-+D.G7"7,P# K'ABD@R"O0<J01]10! 9[4W"H,_=),>[YSCN/;GT[U
M*OE^<W[N0ICA0?F_$]_R[=:P],$?GO\ V@!!?;CY4DA(.TGY@ ?4XSTK>0L)
MV_T@9VC][V8=AQSQ[T 1Q[/-?*.5PV #@CTR<'Z]/RIL>S;+N1R<?+@X"_[W
M7/Z?6I(B?.DQ,$.&^?GYO;@9YZ?SYIL1.V;$H3(Y'/S^W''OS@4 -7;Y+91B
MV>&!^4?48_KVIWR>1]Q]_P#>S\O7T_\ K_X4*3]G<>: -P_=\Y;W]/S.>?I3
MLG[-CSAC_GEWZ_E^OZT -D">4F$<-E<D\@^N!Q].O'O3I!'NBVQN!GYLG);_
M '>!CZ\_2B4DPQ@S!QE<)_=]^>..O7Z<4Z4L6AS.'P>#S\GOSS[<9- $<FSS
M4VHZKQE2?F//8_Y_I1\GVC_5OL_N9^?IZX_#I_C3I2?.3,P<\?/S\O/Y_E^'
M-+EOM.?/&<_Z[G'3KTS^GZ4 ,CV>:^4<KAL '!'IDX/UZ?E51L[C@A1Z$C(_
M2KL1/G28F"'#?/S\WMP,\]/Y\U2?[QR"_P#M9;G]* -&X#"6/-N(CNX0?Q>W
M]>,&D8-]H0>0 =I_=\X;W]?R..?K39C'YD>R61UW<LX.0/;U/MQ]:1C'YRXD
MD*XY8CYA]!_]?MTH >H;[0X\@$[1^[YPOOZ_F<<?2F1 ^=(!"'.&^3GY??@Y
MXZ_SYH4Q^<V9) N.& ^8_4?_ %^_2FQ[/-?+N%PV"!DGTR,CZ=>/>@ B!*S8
MB#X')Y^3WXX]N<BA0?L[GR@1N'[SG*^WIS[C/'TIL>S;+N=P<?+@9#?[W3'U
MY^E"[?);+L&SPH'RGZG/].] $F#]FSY(Q_SU[]?R_3]:)0?)CS"$&5P_][VY
MXYZ=/IQ3?D\C[[[_ .YCY>OK_P#6]O>B0IY28D<ME<@C 'K@\_7IS[4 22AM
MT.8 F3P.?G_/GWXP:;*#YR PA#Q\G/S<_G^7X<T2>7NBVR.1GYLC!7_=Y.?I
MQ]:;)L\U-KNR\98CYASV_P _XT /PWVG'D#.?]5SCITZY_7]*2('SG A#GGY
M.?EY_/\ /\>:;\GVC[[[/[^/GZ>F?QZ_X41[/-?<[JO.& ^8\]_\_P"- $D0
M;=-B /@\CGY/RY]^<FFQ ^3)B$.,ME_[OMQQQTZ?7BB/R]TNZ1P,_+@9+?[W
M(Q].?K38RGE/F1PV6P ,@^F3Q]>G'O0 [!^S9\D8_P">O?K^7Z?K36!^SH?*
M &X_O.<M[>G'L,\_6CY/(^^^_P#N8^7KZ_\ UO;WIK;?)7#L6SRI'RCZ'/\
M3M0 Z4$+#F()D<'GY_?GCVXP*FP1/'NC\H87Y0#AAZG.?K^/UJO)LVQ;7<G'
MS9& O^[US]>/I4CJ))$1)'VD*"Q&"I/7'7WQSVH _"G_ (+8,Z? VZ:% T@U
M2'"= ?W$V3D_E7SU_P $-0;GP_=_:8PI_M ?N\\#@_3_ #BO?_\ @M)!:0_
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MS2P.PMCD%9"I_><^N#3_ /@LV-.L/BQH-S=C4K:U;1/#DD\-G:3/8Y;2[-I
MSHA3')W'(Q7[3_\ !*WQ!IUY^SGX2.F)9#23HNG;0K(K;/(BZQY+9]NN??H
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MLP<$9SG(R*_)O_@L?#;VWQO\#Z5'+-B"&\C2503N5+BP'+CCG(STX_0 [_\
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M4"\1:A\2OCCXEU6^^'=S/';:=8ZNQN[(,))9;C:HA906CEA#?O#P!7Z[7O\
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MIG\8]6L==\5ZW;^ M!OYKZ[T>:X-Q9:A9I*]NL$B"*4;,SH_WEP5 S7Z1_\
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M0X-?CWXUUSXW?L%_M/:3X9LOB#JVL> TU6RGALXKI4LET^YD2X2$(%C 1(9
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M0&$(>/DY^;G\_P OPYI<-]IQY SG_5<XZ=.N?U_2F2;/-3:[LO&6(^8<]O\
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M/DR8A#C+9?\ N^W'''3I]>*:H/V=SY0(W#]YSE?;TY]QGCZ41E/*?,CALM@
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M9AM$>21G_"OZ@O$\FB:#X;UCQ--*EI_8FFW>K74MN5,IAL8)+B7<H;)!1&W
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MSP[:ZLAE*^)K57FD8EB!>)DD>O?IZ5^IG[.&C>,?#/["]RWBVQ339'\-74D
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M22??WK\P?^"A7_!.O_AE"TA^('PD\1/I=C]J6XMO#.F0FVM[2/#RI$A,(X0
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MFMYGVA,^5NVG&-NS\?X<].O/IVIDPC\R/9%(B[N5<DDCV]#[\_2D81^<N(Y
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M=EYPH/S#GN?\_P!* )8?,WS;?+SGYMVW'_ <\=/[O%)%YGDR8\O;EL[L;O\
M@.?FZ],?AS38Q'NEW1N1GY<'!7_>X.?KQ]*;&$\I\HY;+8(X ],CGZ=>?:@!
M_P"\^R_\L]GX;^O_ 'U_GTIC;_LZ9V;=QQC&_P#'^+'3KQZ=J/D\C[C[_P"]
MGY>OI_\ 7_PIK;?)7",&SRQ/RGZ#']>] #YM^R'=LQCY=N,_\"QSG_>YJ1VV
M31M,8T&%PR[ N/<CC/3.??/:H)-FV+:C@X^;)R&_W>F/U^M1WD$%TH@>.01.
M,,-Q#'(P2",8_#M0!^$G_!:"POM8^$-Q#HNAZWX@NO[04B'1[*>_4*(9<DI;
MQR<],<?ES7S3_P $0K/Q1I8O[;4_"WB/0"+R)O\ B<:9=V,1!\P97[1#$.,<
MG/2OZ7&\.Z((S:/HUA?02$,\6IV5M?@L,@$+=12+P"<\>F.M/N;'0/#]G"=+
M\-:9;32.0Z:1I5G9N ,8+?98(O4GD_RH _$;_@M1X$\3^,M.\-7.@6,NIFRT
M0+/':027,FX75TVU5B#,25(XQU]C7'?\$0K76M)B\=0:[X;U_1?L^B.-^HZ=
M=6:S'[;:#$#3Q1[CC) !/ S7[TW/@KPAXEM8-0UC28;Z9$SY%Y#'<%,$G:4F
M1P/7'3D?6H;.SM;(FV\)Z-INA(GRRO;Z;:V@D0'&'-O#%N!(!^;(R,XS0!LR
M7VG"TO+M+>[9U@F4;XR6)>-NF1ZCI7\@O_!1+P!\1?$O[4EOK&D>'-7N-+\R
MR FM]-O)3\MY<ELO%$RX (ZU_7_%+J<,96YD@G#=62-=@]0>O)'3\36/+X0\
M':K.;_5O#NEW-V,$7,VFV<C,1R 'D@9L@DGKWH ^+/@9\/+'QA^R=8>#?$VE
MW/VK4_"HTU8[FT821S7&G- K,LJAE*NP/;;@=Z_GV^*G[!_[2O[)GQET[XL?
M!>.&\T<:W)=:A9%+J5GM)([AM@B@>52=YCX*'WY K^NKS2L:Z;H=I#ID<9"Q
MNT$<=OA>@1415''  'I3YM.G,#-KD6F:G&!Q#)9V\[/SP%$D;C.,_A^5 '\Y
MTO\ P6F\9?"S1+?PI\0/@U\0]4\9+;K;VMSH/A'5KG3?W2%)3+(FDN,EY(BN
M7Y ;K7Q%\0O$/[5'_!3OQ%_P@T?A>^\(^!O$,Z6DCZ[IFH:7+%:W3K&Y<W$-
MFBD*QR2P Y[U_7$_A;PI<S_;9?!'A:2./*M#<^&M'FN7+'(9&DLF;''(SU(^
ME7+32M GG6VT[PMI6D8("O::18V++[J]O;QLI'4$'.: /R/U?]ERY_9J_9:\
M0>'/#.G2:UXCL/!.I6DV+9KM)6&E30RB#8)F9SD[,$DMC':OQO\ ^"5>G>*8
MOC5XNN/&/@GQEI7_ !. T<MQHNH6ULW^D39*-+;1H5]P2,?A7]B]R[W43Z?;
MV,3+"K&87<$<\<T48_>1E94(;>H*X.1ST-9VB6.A3/)_9WA+1M(N4/[VXBT3
M3K5I6YRV^&VC9L\G))Y]S0!\8?M9?LL>'/VD?AC-;6=GIZ>)KC1(;:REU*"#
MST=+)(807D*2@C:. 01TK^??X7_$7]L/_@G/J\7@[QOX4N_$WPN\.W'D2#PM
MI>H:AJ$NGV<F/W0AM[L,YBC^7&0<C'45_6MJ%C;2W/FFUF:ZC.$FAR+==H^7
M*CY<#N.GX58N_#EOJ5@9=3TCP]J$K(2S7VD6%UN)_O>?#)N_$_6@#^=R+_@L
M?\4_'EG=Z+X/^$'CFRAO('@CDUCPIJD3 2#;EF;2D((SZC_#\,?VE="_:1\1
M?M :#\0+KP=XGN(?$NHVU^T4.CZM);6Z^<L.V91!LC'[LD@JO7IBO[Z-&\/>
M$D8QR^"?"]NPZ3)X<TF)6QT(V68ZGIR>W>K-]X9\-W<PCN/"_AN6(8$32:'I
M;LB]<1,UJ2O/]WO0!\7?L\?#R\^*/[,GACP9XZTZUT]=0\(:?;W,5I;+!*GF
MZ?'&PF0K&1*/^6@8@[P=W>OP(^./_!./]HW]E3XHZG\3/V=QIMYH]IJ5S=6=
MK=)++.8!*Y0&."67G9C@)R:_K76UL/#\8TS1[ V[2J"K0HJ01F49 54555%)
M^4#  X I[+:V=OY6L6$&IS 8<26T-PI)QG*RK(#GOGIS0!_,U\-O^"NW[07P
M]T9/!7Q4^$GBG4_$UB1_I6E>%=4N+ J$$*8E.E2*3NB<G#'@KZYKQ7X[?M=?
MMJ?M<WMMH/@?P[?>#O#\\8L-\]AJ>DWJQL[;F!6VM3NQ(<'/;J,5_5G#X8\+
MWD\E_/X1\*S0. !$_A[27N>,DDLUF6.<C'ONZ9K.?P/X"O[EY;;P;IUI<P/\
MCP:180+N'(($5LGJ/TZ8H _+;_@FK^PWXI^$/@^UU[XD^./%NJZ]J4USK%Q%
M?:S?W-ND]]<27;1(MS>2XB3S=JK@ * ,#I7YI_\ !773M?U+X]>#=*TGPCX@
MUNS2.^#ZAIFDW=[&FRXL0-]Q!#(JE@3P7&<=\5_4S;V&L10B.26"WTV(;%A2
M-82L*?*%^7 !V #/TJLNF>#+R<1W?AG3-2<99KZ]TRRO&1AV6:XMI'7=Z!AG
M'/2@#X\_X)S:/=Z9^R_H%G=VUWI<ZZC<,8-1CDM9QFTLQRDP1L9XY]/:OI#X
MM1WP^&OBZ JEXTMA.(8[7]](W[F0!2JY).?SZUZ%%-HCRMH<.CO864 WH]M"
MEK:%GR"%$"(N0%&?EZ$=J;/'9Z;(+:UM)9H9\;_-'GQMDXY# C&/\]* /XO?
MAMX7\2Z3^VWX:N[_ ,#>+UMY?%MR4O8-$U 6: Q7?SRS"W\M4QT8MCD8S7]-
MO[5O[,FE?M)_ FR\(V<=G;>(9;2WGMVOTB1D"6LRLI+LCA@[H3R#P.IK[1F\
M->&[66&^MO#6@)>,VX3G1M.^TJQ&24E-MYBMZ$,#UYJ:7PY;W\B7]W%+F%2J
M1QMY:@'GA$PN/EQC  H _D*^&_PX_:?_ ."9GQ4USQ'=V-YXI\$WJ0RVMAHD
M%]J(1K:>Y:7;;PK=Q*SQR18VIEL8Y%?5-Y_P76USQ/;ZKX0L_@=\3HM>O;*[
ML+>]?P7JXLTNY8GACD\[^QU 59&#;@XQUSFOZ-+G1_#FN2MIE[H>FWB6X#[+
M^PM+L_-D'_CXB?(.WI^>14-MX6^'5O(]M%\/?"D5P@8+<?\ "+Z*#O .&\S[
M!NZ]\Y^E '\F7PB_91_:*_;@^-_ASXJ?$"UDTKPMX3U9_$'V75X;NWO?*:.6
MV5(([HPXD'VL<*F0 >G)K]=OVLO^":/A/XN_ ]=(\$>9!XYT\6RPS7JA8\1V
M\WF!7$J/_K?*Z'GIVK]9=-AM]*G,<.DV%NDA*QMIUA:VD:#K^\%O%&"N!T(Q
MG!QZ7_.O1JL0<*]HR-N*H-@R5P&&,9QG\NM '\<?PV\*?MD?L'^(XE\4VNH:
M]X#T>[^T36?AV+5+V\DM()/-=(X8?M(9BJX4 ')QZXK[:B_X+8^-/$.GW7A/
MP;\%_B+'KQMIK:RNM;\'ZLMH+H1LD3O*^DJ H?!)W#I7]'U]8^%;R\VW_AC3
M]0)P&FN]-L[F$Y'.X3V[@CL<G'K5./P5X-:4R0>#/!]IG.)?^$;T9&P<\[A9
M @G/7.<T ?R"Z[\/O^"B?[<7C2QU/7-1D\$^'X;Q9(XM.GU31Y3!)(#B14>T
M&0JC((]?P_I9_9,^#NO_ +/WPJTC0O%6MW'B/5X=-B^TR7EY+J#M.T>Z3YIY
M9W.&..O Q7UM!I.A:1&XBTS3$R.EA8VD)Y]/)A0Y^GK^=""TT][DSI:3PX<G
MRYLG.#GY5/RX)SCC'X4 5-.L1K5J-2E=].#C?Y>[[/&N>HV93C\/KZ5=O7@C
MTV[T^Y,T\%Y!);EXR9 1(,=<GMW_ ,*L>)(I+^P>&,%(RI'V>)?+DQZ?+CGI
M]*@?4K?3=*A@.GW-S($50%0NR';U8D9X(Y/7\: /YH/^"A7_  3B^*&G_$,_
M'#X M#)=7936=4MKI7,CW43$%42&7<<QPQ@90GVK$^$7_!73XV?"#PS;>"?B
MS\(?&VIW_AF#^Q&N="\*ZM<PRKIP^RI(CKIC[@RQ@@AF!ZY-?TU:8+V99IKQ
M;.]M)&S'92P)/)!'@#RY$<,,]3C'((XZTEKX;\)ZC*SW/@GPPP+GS'G\-Z0Y
M8AB&9F>S8DGG))S[T ?S)?%K]O\ _:G_ &J?"DGA7X*^ -6\/1ZDHCMW\4:%
MJ%A,D4K#'F&2RMV5@K<Y(P<@^M>W?\$_O^"9'Q$AUFX^,'[0$NGMXHU"6WWI
MI_+"* O<(#YLQ?[URXQM_/M_0&N@> M+U#S+7P=HEH5;BXM=%TZWBR!_#Y-J
MH [#'IZUT%U.?*C;1$CM 3@E5"Q'@=%544$<]AV'M0!^)G_!5."UTGX?Z9X4
MT7PWXFU<:?H#VUO_ &5I]S=C)FNFPPMXI.<OGKW]Z^ _^".7AK7]$-\VO^$O
M$^CO-XEUN:$ZCI-Y:+Y<FKW<D;-YT*?>0JW;(YZ=?ZJ;O38;V.W_ +9T[2=3
M+J,_;-/M+L8)/_/Q%)Q[#@_SR;O2K+3;V&WT70=&T^&01LQLM*LK3YG +'-O
M!&<DDDGN>>M &W;0:E(EB\#V_D+;#=&[?,.!U4>F.<C(I\D<TLTL8=%E5 2$
M( Z'Z=P:L0P^24B&X7+IE6W$H."",$8')%<R(M5TO6I;RZ?[7;RHBB*'.Y-I
M;);D\'(P,#I0!S'B/PI;^-?#_B7POJ94KJ,4EJ#/M.!)"4RA<@8RW8^U?R[?
MM,?L"?%O]E7XK6GQM^"6GQZK/;ZU)?W-LUK+<[HY4N"0J6YF)^9UZKVYQQC^
ML#6+$ZB(;O3P892H:1>C*^2<. !STZ]J2S@:Y@:WUFTL-27;A/M%G#<HA&/F
M<3(X]1T[]J /YI_#/_!:/XH^"M"7PI\7_@UX\O-6MXX[:UF\.>$=7EM<0*R.
M9'727'+,N#GH#]*^?_BYXZ_:9_X*<76D^#O"/A75_!_@K1KS[0LFOZ7J.E7<
MAO642AC-;V091'"G\1P2>G?^LC_A&O TER(;_P "^%KMFRPNF\-:/(J8QP6>
MR<Y8MZ\X/>HKS2M-MF%IX4\/Z)H; [I;FVT>PM(Y > H-O!#RN#]!CO0!^9_
M[+7_  3NTWX:?!_4?#>OIIU[XHU+PIJ.CM,R038N[[2YK02%VDD< 2R@DD@]
M\C%?BM\0?V-OVB?V"/BG>_&#PJMYJ^ER:G+.=-T)+RZ\V&4RR".2WM7N%89V
MG:8R 0#BOZYH5ET>(2^7)+?OA3-&28B[_+D+TQDY]A5O[.M]:3R>(-/TW4P4
MS##>V%M=9;(X"SQ2 G&>WKVH _G#\)_\%LOB!;>&7T?7/@OX_;Q):K%;6\L?
MA#5/LK*BNCL['2#D[C&0=Q[U\G?'GXU?M;?MQZ;<^$-#\(:IH&E:YNM,W^DZ
ME8^7%='RSNW6]N%PK'N,'K7]:D'AKP*UO+<7/@'PP9E<!8AX:T<2MG)+ BRS
MV'.:FCTW0[*+[3IWA?1+3;RL$&C:?#*,=AY=NI!_EU[4 ?FK^P5^P;X=_9J\
M#0^*[AA%XYN-#N(KAY%C1#<W5A)$X#&1G.7D./4\5^(?_!5?P'\8;_XQ>%+V
MV\.:IK]BFK;Q)I6G7M\J)Y\)!9X8Y0.!G/ -?U\W%E;ZK;H-0C9H5*.+>W_=
M,I4Y *K@8!QD8Q@$5 WAGPU=J)&T'2;PP<@ZCIEE>R#'/RM<6[L#QU!SWZ]0
M#Y&_8;^TS?!'P58:[:R:7,GAG3(9K:^B:VF1EM(T8&.948$8Z$#%>/\ _!4&
MYDTO]FWQ5IOAW1M5UFX&BZBD4.F6<UW([>3* %2WCD+$]L9_&OT'FLM O[A4
M719K-HL1*UK&MK;KY>$&(X51 !CH!C' '2J]_97$K'33965[8'*8O[.&\A*'
MCYEN$=6!7KD'.?S /YC_ /@CIX>\<VGQ0N-0U[PWJ^CVLFYE.I:;=V>,S1GD
MW$:#I7]2OBNX=M%U8PM#-*L3[$@(=\["0&5<DGZ\^G%8ECH'A?P^!/:^&;&V
MN9!AY=-TVTM,Y&6P;>%,<^AK4MK6TM&>[L;>:)KQC)(MSEP6P!PK9' '3'7-
M '\9O[;&@_$K4/VVM/UJ/P7XGN[&WUG3RMU8:/J$UKY<3Q %I8X"F-HY.<>_
M6OZ#?B'J*:Q^S3%%J=C=V4W]APATNH'BVL(%R"LJH001CGT[<U^B=WH>F7=Z
MMW=:/X:DG!#;KO1M.FNCCH1+);NY)[$-7R;^V7INK+\--6EFGL;'11:3D6\<
M4<!6,*2 /+  /0# QG &* /X\O#5I\4;C]J3Q-;_  =E":CID%E=7PMVE$CP
M_;+_ ,M0+8AF)VOP2<U^M4'_  6-^(_[/>D6/PW\5_"+XDZ]XETB+[+<ZCIO
MA;6;ZSFF9F8,+A-+G#* X!.\\@\BOF3_ ()?:WX:O/\ @H7\3-(AL3=O#I6@
ML\D\:W%NV_4-:& )%(/W.GIC-?UVW'AKP=J-S=+-X&\+7%PK[5N;KPWH\S9V
MC#&22S=C[$GI0!_(U\2;S]L/_@I7XCBU+P_X<N/"GA/5_)B:VU_3]0TRY6!5
M6!M\<T5H Q5">5Z\]Z_>S_@GE^R#<_LA?";7=#\8Q:1>:]K,=M<B6T2&6Y5H
M8+KS%5MTLO+2+T(R0.N,5][Z/X<GT,/<1:?X>@MD=V2'3-*L;4K'DD*/L\,>
M"!QP.3FNABM-*U&4:Q/:3I<6P,05V.P[QN/[O&W'R^A_7@ _CF_X*#^!_B!X
MD_:W34=!\*>*+C3U:Q_TJVTF_D@^6]NV/[V.(I@*03S^E?T:?"[X+Z3\5/V0
M_ ?A'Q+ ;?6/^$7ELA%J$:QRQN]Q=$"1)RKJ29,X/8^]?;TVG>'[B=KR\\-Z
M+<X "S3Z18RSDKD\2R6SOGN,MWS[5S]S:VNMW:1VEC)I4-B=B($^S0.!\W[I
M(PB!>2.%YYXH _D0^.G[#/[1/[$_Q=LOBW\+;1=5L%UJ6XDM-,AN;@R02)<,
M%DBM'F#C)0X,9&>PKZ_\&_\ !9SXN>%]&BT3XA?!CQI>ZE:0QV\,FG^$=5GA
M8Q*RL6/]DMU8K@[N1GGT_I8FM;&\%M:7VF6-Y&IP?M]E;W2MA<9'VB.09_/@
M5SFK>$O#%M=QR_\ "&>$[B#:V^+_ (1O1WD9B1ALM9DXZYH _DM^/'[5'[9?
M_!0*]L/A_P" /#FK?#;PKI\Y;[==Z?JOAZ[D^VMM?=,+>PW;$A7^,X).,9Y_
M7#_@G+^Q#\3_ ( -I7B_Q7X_U'Q-J\MLPO+/5-=NM1ME:YMG20I#<7UP,J7R
MIV<$ ]17ZD7O@[PW=[)O^$6T6UMB<+;Z=H^GV=PAXRS-!;H<'C'I@^M:O]A6
MFBVD<OAZ*>"X;:JHSEA&3QEERH&T$YSV'2@#^?#_ (+??L\>*_'&I> _BEHN
MGZEJEWX"U]=9%EIEO<7/GG[#>6NWR8-QD_U^<;&Z=.M>$?L/?\%0O&GP^:P^
M'GBWX.?$""UC>.P:YM_">J(A0;8BWFG2\=,G._OUK^IBT\/RZI;RR>*XM+UE
M%3=%!<V=O<JC9 PZ3I*IX)!R.XS6$/ >F"]6[LO#'@RWM8FRX7PUHZ3$ YR'
M6U5LD?CGUXH _*K]L[]C7PK^W/\ !;6-;\#6NJ:#XHUS2KBZMVU*!K*[CN;J
M%Y4WG=;3*P=QGH0<]#7Y#?L\_$K]K_\ X)\ZU)IGC#PWJ_BSPKHD%Q;0QZ;I
MVJ:G-(BQ/;Q8407:MR5)QGH37]?RW5C$_DV6F?9E'RJT4$<5L"!V1%" 9[8
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MO3'X<TGS_9?X-GX>9_\ %YQ^/X4R,)Y3Y1RV6P1P!Z9'/TZ\^U&$^S_<??\
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M%DL.=S$]>IS6Q<:;8PPE='T31[&+;A?*TJQBC ] (X44#'&,8QCL* /XR?\
M@E?9^.?V9?COJ-I\2_!/BBY"SRP/>6.BWSQNWVE,MYK0.&! )R6.1]*_>C]N
M/]C/P7^W3X/L?%]BFK:%K&G:2Z:=%(ALI&DCEGE4S+NMW)WOW4\>]?J)IO@_
MPPLOVN'PWH(U#EY;A=(T\2.V02=_V?=G/O7Y$?\ !4GXV_M7?"*]\)S?L[6]
MS:Z/#IR3:\EGI@FBED%U/OVK')"J@PJ@P5./?C !^2OP*_:"_:T_X)QZKJ'P
MZ\5>"=1\7^ ]-U:^CAN-,T;4=4NWTM[R62':ZVEXI<6S*/E;&[Z5]4^)_P#@
MK5\=OC/-<>'_ (&?"CQ/HEO<I(EO-XD\,:G9HJ,AP69M+A POJ1^?3USX!?\
M%7_@Y=Z%I^A_M*:3HEKXPBA6UU.;7](L(BUW'^[D=O/LIVP2"1ECP>22:]P\
M=_\ !4S]D/P?I-TO@+PMX>\2WWD2QV\7AG1],DF9F0JFPQ:8I.<@]<]Z /Y@
M/BP_QQ\2_M$V>N?%A-.M=8GN+#?%;))%B,W4[C*R*I!RYX('<5_9'\*?A);_
M !1_8]^'^@3PV4TUUX5EME>\CBD4%KF\Z&3&!EO4?A7\W7P_^'7Q5_;]_:YU
MKQC:^#M7\(^!+2'2S8OK-BME TGVN_ED\M@8@<1M#D!../P_K>^%'@^3X8_#
M;POX!OT:^&A6)M"]F<J,RN_#+G^_ZGB@#^4+XF?L,?MA?L?_ !7U;XB?"&X\
M*WO@^/7+K7'TJV9IKF1;BZ:^EC%M;32AF)D8!?*.2<8'-?1_A3_@M-\2_#=M
M%X.^)OP3\>2ZO;0K!'>^'_!VJ/;M) -CL94TALABRD'?R <&OZ3+KP+X5U"0
MW7]FF:X8A\WH2XA#'DATE1T('0J1ZUFQ>#-"2^CBN?"'@^YCVG%PWAG1GV8(
MX:1K,MD]^>H)- '\JWQC_:]_;2_;6OK3P#\*_"6N^#?"EK)N^W:MI6L:3?M]
MM.UPT_V6T)$:1)C,A"DGIFOV<_X)M_LH_$']GWPH=<^)/BG5-?UWQ%*U_?6]
MQJ5S?1V\FR.#RT2>YG*#;"#MVKRW3!S7Z>+X7T+3%$UGH'AJV#\;K+1--MWR
M /XHK93GGC].H%->WEM6232PMMYF#(KHI0D<?NU  4$8P />@"W?W^G6@9_*
MO<L>RD+GU;CV[\_CTJ0M8?9Y=;(NG,"D"),G.X%N4 .3\GH>M:4POKRSDBE:
M%7=?XE4%CD<*<=?3':LZS>XT&SEDFC^U(SK_ *-&H9V'/(7D #I^(_$ _ S_
M (*^>./''Q1^$WB3X;>"/"-_+>WMG<V<5TNDW#X,H9 ?,BMP?XAR'_2ONC]@
MKX%Q?"[]G#P_KMWHT)\46'AZ.YN(KNR7>9H]/9W7;(K2;MPP 03G@5]^WEGX
M3UVV-SJ'A6VGD;.8KG3K660\\9\V!N3P>:T1.=/L!!:6B)9,GEFR@@10L; *
MRF-0% "Y!&W&,]>X!_*)^WNWQF_:+_:N^".@:=X5:#PGIGCIFUJ4:7<+']C7
M3-3C'S"%(_\ 6&/[Q(^O;^E/X!_!SPU\-/!&A:?9:38FYETRW:?S+.'(E9 '
M!^4G.>N>?QKN?^$9\$W-]%J!\)6QU"&0R1WC:?:EXI"""_F>077[Q!PP//N:
M[4BX$(-L-IC4!"%PJ8Y Z8&/0<4 4;S1[#39C?"WMHYE;=Y5K'&K@CD!51<]
MO3TZ\UH1WEK)&IN=MH'($;MB)BS?=R2 26.!C/.?S+'3Y(V&J:A)Y\H(=@IR
MAQU&PY!Z=/Z9KDO&6GWGB_[+;Z?NT[[/<V\YDE)B1U@E21E!7&2ZJ0.O^(!?
M\8Z=:ZKX=U'P_>AI(-6MWMPT8+C#JR\GGC#=\#]:_E)_:Q_X)P?'_P""_P >
MKCXV_ .2WN+!-437_L,HG<22RNM[,&AMY7#9E=@1Y9SGGFOZSVN4L[&WLI[6
M6XGC0()5!92P &<G/?\ SQ63'I&MW=VC3OIKV#MDVUY:Q3.8R<[<2AAC''<4
M ?S<>'_^"PG[2_AA(-(^)/P@U:\U6T6.WN)-(\*ZE+$TD*B-V0C2GR"5)!R>
MO&<BO#_VC/VPOVK/VS]-MO!?@'P#K7AQ)Y4@FFU+0]2T]?)8&-LL;*W'\6?O
M#UXK^LB3P+\/Y=0+R^#?#<EV6YEDT'2W4OZG=:'(SSG].U86G^%;'3M2FD70
M/#*09?RUM=#TV%U^;C+1VX.0.,\4 ?C1_P $T?\ @G!<? _15^(7Q9EL)?%'
MBBY.K72-Y;2++LC@4 3S/(#B =5'TKR[_@L19^(M2L=3TGPSX:US5+6/2;>W
MA?2].NKK*)I\48V&WA?( 7C!Z]*_?.^\-QZU,;G41F"Q.+:WM28 B#Y@OEQ@
M#[V3T%78QHVOV9MI?#=E(UNIMEDU73;2[!$(,0)-Q Y(PO4]J /Y\O\ @C?X
M3\=>%?A5X5&N:'?:;;1Z?9[H=4L;BVOE_=IPZSQJX8="#^)SFOZ,7L=/UJRB
M<AHV15)*@+(3M7@D8.,^_K7,V&A:9I<"K!IFGVSJ,!M.LK:UMQC^ZD$4:J/3
M '3\M2*2>#YTW*I.,X^4@9P![_7CK[4 7[>Z6S1K$J-J?*C8&3[L>YSD<YZ#
MK7Y$_P#!2C]CGQA\>O!WB+4_#%V%OIK"1;>&.1]I*6JHN525222.?EY)K];W
MC6X7>H,4A'S,_ <^J\<C&!]?SJY9&%+=X[N-91\W[J51('!SCY'!!!Z_CB@#
M^,?]C_\ :#^,7_!.@Z_\/O%OPS\3>(Y]8OUFM[W2/#>H7\:)9-(I#3)9W(!?
MSU*_-S@]:^_?$7_!7KXZ>*]+CTWX??"CQ-9ZC=!H)6UCPOJ4,2B4 (5/]EJ!
M@[LG(P*_H1U/0_",LXN;GP;X>O'&X#S] TN:8[B,D/+:.V/4Y_3FJ-IX4\,O
M,UX?"7AF.WP-MM'H.EQSJ022<"T'7(QQV/- '\47[6WPJ_:9^-.N:)\6/B/X
M>NY87A2]CL=*TZ_>:.*.9R(_*"!E;*,=NP?>''(K]EO^"8/CV^\2_#7QGX<N
M_"OBC0K?1/#@2[?7-+N[(S)'=V<>VU-S;Q;W+8.%+97-?N/J/AO0?$+I#'X=
MTF."QPACN=*L6C(SN^56@*A3GH!C/;K6+X[M-'\.?#GQ--HFDZ1HTL%@/-EL
MM,L[(./.C&)/L\,6\$XX;(!QCM0!_%?^W.OB^^_; \,Z3\)Y[>WUQK?69A_:
MKF,E8[O3R0H!#$;F48SW%?H1\)/^"BO[2W[*/AJTTKXJ?#_5O%.A6$$;7$OA
M/0M0U*XD@4!V\IHK&YW,5&%Y/.*^2/B#+X9U3]OKPGX@U^)[V>UM-9B2:%L0
MKYFH:42&0 @DE 1GWK^L7X/Z-X1\0?#RQN+/P[X=NT:Q@ ;4=&TZ\)_=J/F-
MQ;/GT.[.1Z]P#^=/XP_\%.?CA^V!I9^'/P2^&'C?PW=>)#'I,USXJ\-ZM86B
MVUVZPW!E=]/MT"F%I =S!?4XS7W5_P $RO\ @GAXN^#6JZA\0OC':Z!/K&M6
M9FM#I4$3317<LL4N96)>1?DW@D@'/4U^S&G>'O!FFJ"WA7PI9R%=HFM/#^D6
MSHS @,'AM$93SG(/'7ZZ-O?VVD7"6^GVTEV;L^6KVJ;HK?\ BW.  %'&WC')
MQQ0!_.]_P6&\(>"I]/U"6YO=9@U.WLI1;1PS.EG\HDVAU#*N-WJ,=J_-K]B7
MXR_M0_LQ?"O1_BE9:9-XC^'.E6EO?+IVC6]YJ-Y+8VX5PB6\$5P'=HUQ@1MD
M]J_0_P#X++7%O%H^KM>:E;)<M9W!2UWA;ALJ^% SDG/ YZU]??\ !%30M$\1
M_L;>#8M<T6PO+>7P]IV^'5+"VN]P,$>0PN8I0<]\]<GUH ^'O%W_  6=^*/C
M?PO=Z)X#^$'Q MM<\16<FEB74_"NKQVT+:A&;=I-QTE0@02E@V1C&<CK7S;\
M#/\ @GW^T7^U/\0[/XB_$>?^SK%;^/4/LU\UW R(\HE(\NYEA ( QC9QCVK^
MM6Q\ >'[2X<P^#_""6D.YT">&M&5P%Y&UEM,@X P0.#6REUI$>;2U\/K:?P[
M[*SAMHQZ']Q&@&.?\<4 ?$GQ^\)Z+\._V99?A[9V&IZC<6'A6+39O[*@DN&>
M:'34AEV>0LC'YE;N3FOP!_X)C_"_Q+H'[3?A[41X6UW3[!?$5K)]HU?2KJW8
M)]K1LO+-$H!QG))P/6OZWO[.@AA=/LUO>0RY9DNH8KE5W\E669&'RDX((_\
MKPVOA'PU8D:S8:%I%EJ"GS%GL].LK9@^<[@T,$; YQ@@CL?:@#\G_P#@KSH&
ML:Y\,X8K?1M1U<C!\K3+.6[DXB?^&%';IZCV^GQE_P $;;:;PT_BW3M>\*>)
MM)CNM98;M1TJ[M(RK6EJNX&>! 1UYSC@^G']&MT]CX@46NIZ3;7"IU;4+2"Y
MA;''"SQ2+S],X]13$TC0[%!;:=H>DZ<KC$LEEIEG:&4]-P:"&,DD'&3SV&*
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M^"D*,PY[<^]?K?)-J^KR;;8QVD#'"PS1@,%[#D#H/_U$4DFCM<KY&O6^FZQ
MHX@FM(+D#'3Y9HY%]NG>@#^;S_@CGX#\;V>D?$+3=9\/ZKH$^I:K*+6XN]/N
MK!R'L;9 YDECB)^;C<&[>O3R/]K+]C[]LSX6_&J]^+W@[Q=JNJ^%K34SJW]E
M0:KJETS0AQ<M$MM%=RJ>#MV>4?0CM7]3$6F)8OY>@:7I>EQ$CS%L].M;5LGJ
M6-O%$2<<9))QCI5NY-HJ_9K[3(-3:0#S'FMHKJ++8R&$R..,X(.>.O3D _F0
M\$_\%O\ Q;X=O8?"'CSX*?%*YN+1%LYKW3O!^L2(\L*^67$W]CL"K.N<[SD=
MSW\I_::_:^^/G[9]K8^"_ /PUU?2_#0=T67Q!X=O[:_#WFQ7WM)80':!&I'(
MP=W>OZLF\(>!GC\U_ ?@YYV.3.WAC1&8D]27-B2<Y/.><Y[UEZGX8\-:);P:
MEI/A+04NYG*,;31--0*%P5.V.V0#J<'KC\J /R-_X)0?L-^*/V;M#U3QCXM$
M<>H^-KUM6N((E93"QABM0I1G8H<6^<%5^@[_ ++I)!I$[6;*[Q3NS-)C*+YI
MW')S@8W8P3^&*OVKWW]D02CR+7?%E+=8EBV\D85%4 ?0 >PJMID#:E9W%MJ0
M".[RA2P 8@LP!#$9'&",=![4 6T6%9E^PNCJP)?!0Q@^C8^7/7'3/I4B^9]H
M?'E;MHSG;L_#^'/7ISZ]ZH64-EH3-IJVMQ-]H)?S%RX7;P "1D?>/&<5;41^
M<W[N39M&$Z.,\\]?R]J %B\SSI,>7G#9W;=O_ <_+G'3'X<4V'?LFV[,8^;=
MC/\ P'/.?]WFDCV>:^4<KAL '!'IDX/UZ?E38]FV7<CDX^7!P%_WNN?T^M #
MEW_9WQLV[AG.-_X?Q8Z]./7O3_WGV7_EGL_#?U_[Z_SZ5$NWR6RC%L\,#\H^
MHQ_7M3OD\C[C[_[V?EZ^G_U_\* ))?,\F//E[<KC;C=_P+'S=>N?QYI9O,WP
M[O+SGY=NW'_ L<=/[W%12!/*3".&RN2>0?7 X^G7CWIT@CW1;8W S\V3DM_N
M\#'UY^E "S>9YZ;O+W<8VXV_CCC\_P >*7]Y]J_Y9[\_[/E__$?T_&HY-GFI
MM1U7C*D_,>>Q_P _TH^3[1_JWV?W,_/T]<?AT_QH ?%YGG28\O.&SNV[?^ Y
M^7..F/PXJA)C>=V<YYV[<?I5R/9YKY1RN&P <$>F3@_7I^55&SN."%'H2,C]
M* -"X\[S8]]Q%(V[Y64\*<'DY)/Y$'IS3&\WSD)GC+[3A\\ <<>OZ@=>*)E4
M2*!9O"">4)/S\'CCC\^./K32%\Q1]E8#!_=Y.6Z<^GYG//TH <OF^<Y$\8?:
M,OG@CGCU_4CIQ21B3S'*S1JQ#;F).&X.<8(//U//7-( OF,/LK$8'[O)RO7G
MT_(YX^M(@7>V;9G&&^3/W>#SSQQUZ_3B@!8Q(%EVS1J"/F!/WAD=.GZ@CVH4
M/Y+@2H$W#*9.2>>?3MZ$].:1 N'S;L^!P<GY.1SSS[<9/Z4 +Y;'[.Q.1^\R
M<+UX]?R&./K0 I\SR"/.C\O!_=YY_P /TZ^_-+)YIC0--&R@KM4'E>1C.<CC
MZ=.F*80OE$_9FS@_O<G'^/Z?I2N%V+BV9#E?GR?FY'''//3^?- #Y/-+1;IX
MV(/RD'[O!Z]?T(/O22>89%+31LXQAP>!Z?YR/PZTUPN4Q:LF3R,GY^#QQQ[\
MX'ZT,%WC%LR#^YD_-_3\_P >* ),2_:,^?'YF[_69./3US_X]T_*FQ^8)&*S
M1JYSER>#Z_YR?QZT;5\['V5L;O\ 59YZ]/3]?UIJA=YS;,X_N9/R_P!/R_#B
M@!\?FAI=L\:DGYB3][@=.GZDGWI(_-$;A9HU4EMRD\MR<XQ@<_3IUS34"Y?-
MJSX/ R?DX''/'OQD?I0@78V;9G.6^?)^7D\<\\=/Y<T */,\@#SH_+P/W>>?
M\/TZ^_-#!_)0&5"FXX3)R#QSZ=_0'KS30%\H'[,V<#][DX_Q_3]*4A?+4_9V
M!R?WF3ANG'K^8QS]* %D$A6+=-&P ^4 _=&3UZ_H /:ED$GF(6FC9@%VL"<+
MP,9R2>/J.>F*:X7"8MV3(Y.3\_)YXY]N<']:'"[UQ;,@POR9^]P.>..>O7Z\
M4 /;S?.0F>,OM.'SP!QQZ_J!UXI )#,Y\^+?M&7)RIZ]!_\ 7/7IS2$+YBC[
M*P&#^[R<MTY]/S.>?I0 OF,/LK$8'[O)RO7GT_(YX^M "Q>:K2[)XU)/S9)P
MW Z#(QZ=_K1&'VR[98T!'SC<?G&1TY_H?I34"Y?-JSX/ R?DX''/'OQD?I0@
M7#YMV? X.3\G(YYY]N,G]* %4/Y+@2H$+#*9.2<'GKCMZ'ZT,'\E 94*!CA,
MG(.!SUQW]!]:0!?+8_9V)R/WF3A>O'K^0QQ]:"%\M3]G8')_>9.&Z<>OYC'/
MTH 602>6@::-E!7:H;!'(QD\].O3WXI9?-+1;YXV(/RD,?EX/7DYZ>WUIKA=
MBXMF0Y7Y\GYN1QQSST_GS0X7*8M63)Y&3\_!XXX]^<#]: ',)?.0F>(OM.'!
M^4#CJ/\ Z_;IQ2CS//&)8A)D?O,G'\_Z]/RII"^8H^RL!@_N\G+=.?3\SGGZ
M4 +YH'V5L9'[K)S_ (?K^M #H_,$CE98U?#;GR?FX.>_?^?7-$1E^?9+%'_>
M_P!KZ8Q^%,0+O;-LSC#?)G[O!YYXXZ]?IQ0@4[LVS2?B?E_/'^>M "QB3RWV
MS1*N6RI/)Y.<=.OT^N:/WGV?'G1^7C_5YY]?I_X[U[=Z1 NQLVS.<M\^3\O)
MXYYXZ?RYI,+Y.?LS9Q_K<G'3KZ_I^E #I!(8U#31LHQA0>1]?_U>_%$@DVQ;
MIHV 'R@$_*,GKG/\A]*1@NP8MF0_W\GYOZ_G^/-#A<)BW9,CDY/S\GGCGVYP
M?UH ?)YGF(6EC9L+M?)^7@8[GI]>OI4<PS+^^GC'/^L+';P>>I/;CK2N%WKB
MV9!A?DS][@<\<<]>OUXJM>JAR#9/*O/^C@D']..* +"W=C&K+#=0K/@YDW'#
M>@' YR#WJEI$^I3W%TRR#8LGROSM<!0?E)/3G!Y[>W.2ELHDW'P]/LSPNXY!
MSUZ]_P"OY_GO^W)_P4-L/V+[[POIEWX)FU(>(+1+E/W_ )>P/<2P8_UT>>8\
M]^O% 'Z:%Y+M62[N(D@R0X=@"0"0>I[CVZ$<5 ;:UMXBMA<0-"S R(K*26'0
M_* ._I^?2OE']F/]I6V_:/\ !VG^)X/"4UE#J-N)V02E]N_)/S"5_P!?SKZO
M^RV]O#^YT^2#<02Q8D X/'<_Y].: &E6\E<R1E=QPH/S \=3_3';VIT@?;%N
MEC< ?(-Q^09/7G^@^E-(7RU/V=@<G]YDX;IQZ_F,<_2APN$Q;LF1R<GY^3SQ
MS[<X/ZT .F:1?+>2>,A3PV3A.#R>O\Q]:LPW%[.1'!.DJXY= Q5?8G((S_C5
M*:..1 C6K(K$!E)_U@]!Z9_I7Y<_MH_\%(M/_8TDM;7_ (0676!>3F(E;DQ\
MJP7=Q-&>2W]* /U+MX[:ROY9[N1$E9%#.> 0"2!T]SW]*?-/I][(PM9HPRY9
MFW=5'S-T'7 _SV^:OV0OC[IW[6GP:T_XJMX>?2$O+RXM%LFE9R#%#;R[MQ:3
MKYV#ENHX]_<[R>/29Q';>&YY5=A&9%8XVN=A/4= 2??ZF@#>$\$J.EI-&NT8
MD!(RPX''"]Q]?I355_);$L83<,ID[B>>GY>AZ^]$-M;)!YT>ER0/(N6.[.W.
M#SCZX]?2@!?+8_9V)R/WF3A>O'K^0QQ]: %(D\@CSH]F#\F?F_7_  ]O>EE\
MSRE\R9&B7!**3D+[\]!],?RIA"^43]F;.#^]R<?X_I^E*ZJ453;% Y"LY/#
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M$>V.<UT0AO(23 CN!GYAG##].3^@[#%9T^JO$[13:+*Y/5SGY\]_Z?\ U\T
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M%LR'^_D_-_7\_P >:'"X3%NR9')R?GY//'/MS@_K0 ^0R;TW2Q.V%VOUV\#
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M:=B7[1GSX_,W?ZS)QZ>N?_'NGY5&P7>,6S(/[F3\W]/S_'BG;5\['V5L;O\
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M7\MO_!<'X2>!/"_Q+^$FFZ3H=GH,GB#Q:MO>7&G6QC=0=,U"8X8$XRR<=,T
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M]N*OZI_P5Z_:0DO)+/PM^RJNMVVYA!+_ &@R"2,9*-_KC]Y<9]C^?XO?L+_
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MGCCVYR/UI\@E\M,PQ 97!&"3R,9&1].O'O1()=T688@<_+C!#<'[W3'UY^E
M#&*[QBY9Q_?P?E_I^?X\4[<OG9^U-C=_K<<]>OI^GZTKB7S%S#$K=E&-I^O_
M .K\^E.Q+]H_U,6_=]SC9U]?TZ?XT 1(5WMFY9!AOGQ][@\<\<].GTXH0J-V
M;EH_P/S?GG_/6GQB7S'Q#$6PV0< #@YP>?KTY]J(A+\^V&)O7=@8^G7I_G-
M#$*A6_TED.3A,'YN3SSD\]?Y<U'LA\O<9<OC/E[6ZX],^OM[U/&)?+?$,1&6
MR3@$<G.!D_3KS[4W$OV?_4Q;-OW^-_3TS^/7_"@"G''/"YD34Y7S_P L<'"_
MSZ?_ %O:M$7 4 O(;AFY.[/[OM[<]_>F.)?+7,,2KV88W'Z__K/]:)!+MBW1
M1 8^7&"6Y/WN1CZ<_6@!'E;.T7;-&W4Y.%!'(Z8XZ>G J02PI^[1@%Z?:!G/
MY=.?I3)!+YB9AB#87 &"#P,9/'UZ<>]*1+YY_<Q;\GY.-OY__6]O>@!EW-)<
MQK;I>O J'=YXZOG^'[IZ ?J:B@CB50)K@N4XWL#^\Z'/;Z?YYL*)O.;$$);:
M,J<;0.>A_P#K=J2,2[I<0Q$Y^;. %X'W>N?KQ]* %:2.1"%D^SX&/+4'#XXR
M?][K_DYC!7RV'VA@<C]W@X;KSZ_D<<_6GQB7RWQ#$1ELDX!')S@9/TZ\^U(H
MD\EL11E=PRQQN'7H/_KCITH :2OEJ/M#$Y/[O!PO3GU_,XX^E#E<)BY9\#D8
M/R<GTY]^<G]:<PD\E<Q1A=QPPQN/3J/_ *YZ]*602[8MT40&/EQ@EN3][D8^
MG/UH 8Y7*8NF?GDX/R<'GCCVYR/UI25\Q3]J8C!_>8.5Z<>GYC/'TIT@EW19
MAB!S\N,$-P?O=,?7GZ4K";SES!"&VG"C&TCCJ?\ ZW>@!@*^:#]J;&1^]P<_
MX?I^M(A7>V;ED&&^?'WN#QSQSTZ?3BI )?/'[F+?D?)QM_/_ .M[>])&)?,?
M$,1;#9!P .#G!Y^O3GVH 8A7#YN63(X&#\_(]>??C!_2A2NPYN60_P!S!^;^
MOY?AS3XQ+MEVQ1$8^;. 5Y'W>3GZ<?6A!+Y;8AB9>['&X?3_ /6/ZT 1Y7R<
M?:6SC_58..G3U_7]*5RNQ<7+.<K\F#\O(YXYXZ_SYI<2_9_]3%LV_?XW]/3/
MX]?\*=()?+3,,0&5P1@D\C&1D?3KQ[T ,<J=N+EI/P/R_EC_ #TH<KO7%RSC
M"_/C[O XXXXZ=/KQ3Y1+\FZ&)?3;@Y^O3K_G%$@E\Q,PQ!L+@#!!X&,GCZ].
M/>@!-R^=G[4V-W^MQSUZ^GZ?K35*[SFY9!_?P?F_I^7X<5+B7[1_J8M^[[G&
MSKZ_IT_QIJ"7S&Q#$S=U.-H^G_ZORZ4 ,0KE\W3)SP<'Y^!SSQ[<8'Z4(5V-
MFY9#EODP?FY/////7^7-/C$NZ7$,1.?FS@!>!]WKGZ\?2B,2^6^(8B,MDG (
MY.<#)^G7GVH C!7R@/M+9P/W6#C_ !_7]*4E?+4?:&)R?W>#A>G/K^9QQ]*<
M!+Y _<Q;,#Y^-WY9_K[^U#"3R5S%&%W'##&X].H_^N>O2@!KE<)BY9\#D8/R
M<GTY]^<G]:'*[UQ<LXPOSX^[P.....G3Z\4^02[8MT40&/EQ@EN3][D8^G/U
MHD$OF)F&(-A< 8(/ QD\?7IQ[T -)7S%/VIB,']Y@Y7IQZ?F,\?2@%?,8_:F
M P/WF#ENO'I^0SS]:>PF\Y<P0AMIPHQM(XZG_P"MWH43><V((2VT94XV@<]#
M_P#6[4 1H5R^;IDYX.#\_ YYX]N,#]*C9=\4J"Z:%F&%(!^;D>OY_AS4\8EW
M2XAB)S\V< +P/N]<_7CZ41B7;+MBB(Q\V< KR/N\G/TX^M #M.D2RM)8IY3<
MN[ JK8_VN1_G\:I%91,;B.^>,9S]E7./IG:3^I_*K2B3R6Q%&5W#+'&X=>@_
M^N.G2@B7R#^YBV8/S\;ORS_7W]J ,>TLI[>Z>YN=3DOXI-P-I("50/D9^Z#\
MF<CGM@]:T%@M() ]LZH7/SE%/R]3G/U[GCTJS()?+3,,0&5P1@D\C&1D?3KQ
M[T2"7=%F&('/RXP0W!^]TQ]>?I0!#<@RC:MX^3QYN#E?T[?_ %Z:3.;7[%_:
M,@^79]K[^F[Z_A5AQ+YBYAB5NRC&T_7_ /5^?2G8E^T?ZF+?N^YQLZ^OZ=/\
M: *EO!;0C 81R@'-T/O2'!!S_O5-&5&<W+1_0'YOS_SZ]J?&)?,?$,1;#9!P
M .#G!Y^O3GVHB$OS[88F]=V!CZ=>G^<T ,0KL;-RR'+?)@_-R>>>>>O\N:3*
M^3C[2V<?ZK!QTZ>OZ_I4D8E\M\0Q$9;). 1R<X&3].O/M3<2_9_]3%LV_?XW
M]/3/X]?\* $8KL&+EG/]S!^7^OY_CS0Y7"8N6? Y&#\G)].??G)_6GN)?+7,
M,2KV88W'Z_\ ZS_6B02[8MT40&/EQ@EN3][D8^G/UH 8Y7>N+EG&%^?'W>!Q
MQQQTZ?7BE)7S2?M38R?WN#G_  _3]:=()?,3,,0;"X P0>!C)X^O3CWI2)?/
M/[F+?D_)QM_/_P"M[>] # 5\QC]J8# _>8.6Z\>GY#//UI$*Y?-TR<\'!^?@
M<\\>W&!^E2*)O.;$$);:,J<;0.>A_P#K=J2,2[I<0Q$Y^;. %X'W>N?KQ]*
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M9_\ 4Q;-OW^-_3TS^/7_  IT@E\M,PQ 97!&"3R,9&1].O'O0 QRIVXN6D_
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M[;A<[L[N@^[GYNO3'X<U)(9=L6Z6(C'RXP"O)^]P<_7CZ42&7S$S-$6PN",
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M/.[SO;9_7;_GT[U+&9?,?$T0;#9)P0>#G X^G7CWHB,OS[9HE]=V#GZ=.O\
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M?_%_7(K_ ./_ ,</#GB..WD53;V&KW-NOD AMC1C495)RS'D>QH _03X"?\
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M/@?P3J=OXK^-4UEXX\;)>27MQJ)OOM\;71N'ER%NGN"%!P -Q  Q0!].>/\
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M=_;I_%CKTX]>]2R&7=%F:(G/RD8 7@_>ZY^G'UI6,WG+F>$MM.&&-H''4?\
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M4 1+Y.UL^=NRV-OW>I^]CY<XZY_'BD_<^5_RVWX_[9]/^^/Z?C4T9E\M\31
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M?N_CCC\_QXJ6,R[9=LL0&/FS@EN1]W@8^O/TH0R^6V)HE7NIQN/T_P#U'^E
M$/[GRO\ EMOQ_P!L^G_?']/QI6\G:N/.W97.[[O4?=S\N<=,?AQ3\R_9_P#7
M1;-OW.-_3UQ^'3_&G2&7RTS-$1E< 8!'(QDX/UZ<^U $3^3QM\[WW_TW?Y]>
MU*WD[EQYVW"YW9W=!]W/S=>F/PYJ24R_)NFB;TVX&/KUZ?YS1(9?,3,T1;"X
M(P .!C(Y^G7GVH 9^Y\W_EOLW>_F=?\ OO/Z_A35\G<=WG;>VW[WXXY_/\>:
MGS+]H_UT6_=]_C9U]/\ Z_\ A34,OF-B:)6[L<;3]/\ ]?Y]: (E\C+[O/QG
MY=N<]!]['.?][FA?)VMGSMV6QM^[U/WL?+G'7/X\5+&9=TN)H@<_,3@AN!]W
MICZ<_6B,R^6^)H@,MD'!)Y.<' ^O3CWH A'D^6/]=OP/]S_XG_/K2GRO+7'F
M[\G.?N=NG\.>O3GU[U(#+Y _?1;,#Y.-WYX_I[>]#&3R5S+&5W'"C&X=.I_^
ML.G6@"-O)PFWSLX^;=TZG[N>/^^>*5O)W+CSMN%SNSNZ#[N?FZ],?AS4DAEV
MQ;I8B,?+C *\G[W!S]>/I1(9?,3,T1;"X(P .!C(Y^G7GVH B/D>8N//V8.<
MYW]NG\6.O3CU[T#R/,;/G[,#&,[^_7^+'3KQZ=JF8S><N9X2VTX88V@<=1_]
M?M0IF\YL3PAMHRQQM(YZ#_Z_>@"%?(R^[S\9^7;G/0?>QSG_ 'N:%\G#[O.S
MCY=O3J/O8X_[ZXJ6,R[I<31 Y^8G!#<#[O3'TY^M$9EVR[98@,?-G!+<C[O
MQ]>?I0!$/*\ML^;OR,8^YWZ_PYZ=>?3M2'R?+/\ KM^#_N?_ !/^?6I5,GDM
MB6,+N&5.-QZ]#_\ 6/7K03+Y!_?1;,'Y.-WYX_I[>] $;>3M7'G;LKG=]WJ/
MNY^7..F/PXH;R,IM\_&?FW9ST/W<\Y_W>:ED,OEIF:(C*X P".1C)P?KTY]J
M)#+NBS-$3GY2, +P?O=<_3CZT 1-Y.X;?.V]]WWOPSS^7X<T[]SYO_+?9N]_
M,Z_]]Y_7\*>YE\Q<S1,W9AC:/K_^O\NM.S+]H_UT6_=]_C9U]/\ Z_\ A0!"
MOD[FSYVW#8VYW=#]['S=>N?QYI$\GG=YWML_KM_SZ=ZEC,OF/B:(-ALDX(/!
MS@<?3KQ[T1&7Y]LT2^N[!S].G7_.* (E\G:V?.W9;&W[O4_>Q\N<=<_CQ2?N
M?*_Y;;\?]L^G_?']/QJ:,R^6^)H@,MD'!)Y.<' ^O3CWIN9?L_\ KHMFW[G&
M_IZX_#I_C0 QO)VC;YV[ON^[^&>/R_#BAO)PFWSLX^;=TZG[N>/^^>*E<R^6
MN9HF7LHQN'U__4/Z42&7;%NEB(Q\N, KR?O<'/UX^E $;>3N7'G;<+G=G=T'
MW<_-UZ8_#F@^3YA_UVS)]=__ ,5_GTJ20R^8F9HBV%P1@ <#&1S].O/M2DR^
M>?WT6_)^?C;^7_U_?VH A'D>8V?/V8&,9W]^O\6.G7CT[4+Y&7W>?C/R[<YZ
M#[V.<_[W-3*9O.;$\(;:,L<;2.>@_P#K]Z2,R[I<31 Y^8G!#<#[O3'TY^M
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M]SOU_ASTZ\^G:I8S+Y;XFB RV0<$GDYP<#Z]./>D4R>2V)8PNX94XW'KT/\
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MN@^[GYNO3'X<U)*9?DW31-Z;<#'UZ]/\YHD,OF)F:(MA<$8 ' QD<_3KS[4
M,_<^;_RWV;O?S.O_ 'WG]?PIJ^3N.[SMO;;][\<<_G^/-3YE^T?ZZ+?N^_QL
MZ^G_ -?_  IJ&7S&Q-$K=V.-I^G_ .O\^M $2^1E]WGXS\NW.>@^]CG/^]S0
MOD[6SYV[+8V_=ZG[V/ESCKG\>*EC,NZ7$T0.?F)P0W ^[TQ].?K1&9?+?$T0
M&6R#@D\G.#@?7IQ[T 0CR?+'^NWX'^Y_\3_GUI3Y7EKCS=^3G/W.W3^'/7IS
MZ]ZD!E\@?OHMF!\G&[\\?T]O>AC)Y*YEC*[CA1C<.G4__6'3K0!&WDX3;YV<
M?-NZ=3]W/'_?/%*WD[EQYVW"YW9W=!]W/S=>F/PYJ20R[8MTL1&/EQ@%>3][
M@Y^O'THD,OF)F:(MA<$8 ' QD<_3KS[4 1'R/,7'G[,'.<[^W3^+'7IQZ]Z!
MY'F-GS]F!C&=_?K_ !8Z=>/3M4S&;SES/"6VG##&T#CJ/_K]J%,WG-B>$-M&
M6.-I'/0?_7[T 1+Y.YL^=MPV-N=W0_>Q\W7KG\>:1?)P^[SLX^7;TZC[V./^
M^N*EC,OF/B:(-ALDX(/!S@<?3KQ[T1F7;+MEB Q\V<$MR/N\#'UY^E $0\KR
MVSYN_(QC[G?K_#GIUY].U(?)\L_Z[?@_[G_Q/^?6I5,GDMB6,+N&5.-QZ]#_
M /6/7K03+Y!_?1;,'Y.-WYX_I[>] $;>3M7'G;LKG=]WJ/NY^7..F/PXH;R,
MIM\_&?FW9ST/W<\Y_P!WFI9#+Y:9FB(RN , CD8R<'Z].?:B0R[HLS1$Y^4C
M "\'[W7/TX^M $3>3N&WSMO?=][\,\_E^'-._<^;_P M]F[W\SK_ -]Y_7\*
M>YE\Q<S1,W9AC:/K_P#K_+K3LR_:/]=%OW??XV=?3_Z_^% $*^3N;/G;<-C;
MG=T/WL?-UZY_'FH&W;CMQC)QG.?Q]ZMQF7S'Q-$&PV2<$'@YP./IUX]ZI.!O
M;().3DC.#].: +LRJ)% LWA!/*$GY^#QQQ^?''UII"^8H^RL!@_N\G+=.?3\
MSGGZ4Z9E,BD7CS#/+D'Y.#SQQ^?'/UII*^8I^U,1@_O,'*]./3\QGCZ4  "^
M8P^RL1@?N\G*]>?3\CGCZTB!=[9MF<8;Y,_=X///''7K].*4%?,8_:F P/WF
M#ENO'I^0SS]:1"N]LW+(,-\^/O<'CGCGIT^G%  @7#YMV? X.3\G(YYY]N,G
M]* %\MC]G8G(_>9.%Z\>OY#''UH0KA\W+)D<#!^?D>O/OQ@_I0"OEL/M# Y'
M[O!PW7GU_(XY^M "$+Y1/V9LX/[W)Q_C^GZ4KA=BXMF0Y7Y\GYN1QQSST_GS
M2$KY1'VELX/[K!Q_C^OZ4KE=BXN6<Y7Y,'Y>1SQSQU_GS0 .%RF+5DR>1D_/
MP>../?G _6A@N\8MF0?W,GYOZ?G^/%#E<IBZ9^>3@_)P>>./;G(_6ABN\8N6
M<?W\'Y?Z?G^/% #MJ^=C[*V-W^JSSUZ>GZ_K35"[SFV9Q_<R?E_I^7X<4[<O
MG9^U-C=_K<<]>OI^GZTU2N\YN60?W\'YOZ?E^'%  @7+YM6?!X&3\G XYX]^
M,C]*$"[&S;,YRWSY/R\GCGGCI_+FA"N7S=,G/!P?GX'//'MQ@?I0A78V;ED.
M6^3!^;D\\\\]?Y<T ( OE _9FS@?O<G'^/Z?I2D+Y:G[.P.3^\R<-TX]?S&.
M?I2 KY0'VELX'[K!Q_C^OZ4I*^6H^T,3D_N\'"].?7\SCCZ4 #A<)BW9,CDY
M/S\GGCGVYP?UH<+O7%LR#"_)G[W YXXYZ]?KQ0Y7"8N6? Y&#\G)].??G)_6
MARN]<7+.,+\^/N\#CCCCIT^O% "D+YBC[*P&#^[R<MTY]/S.>?I0 OF,/LK$
M8'[O)RO7GT_(YX^M!*^8I^U,1@_O,'*]./3\QGCZ4 KYC'[4P&!^\P<MUX]/
MR&>?K0 B!<OFU9\'@9/R<#CGCWXR/TH0+A\V[/@<')^3D<\\^W&3^E"%<OFZ
M9.>#@_/P.>>/;C _2A"N'S<LF1P,'Y^1Z\^_&#^E   OEL?L[$Y'[S)PO7CU
M_(8X^M!"^6I^SL#D_O,G#=./7\QCGZ4 KY;#[0P.1^[P<-UY]?R..?K02OEJ
M/M#$Y/[O!PO3GU_,XX^E  X78N+9D.5^?)^;D<<<\]/Y\T.%RF+5DR>1D_/P
M>../?G _6ARNQ<7+.<K\F#\O(YXYXZ_SYH<KE,73/SR<'Y.#SQQ[<Y'ZT *0
MOF*/LK 8/[O)RW3GT_,YY^E "^:!]E;&1^ZR<_X?K^M!*^8I^U,1@_O,'*].
M/3\QGCZ4 KYH/VIL9'[W!S_A^GZT (@7>V;9G&&^3/W>#SSQQUZ_3BA IW9M
MFD_$_+^>/\]:$*[VS<L@PWSX^]P>.>.>G3Z<4(5&[-RT?X'YOSS_ )ZT "!=
MC9MF<Y;Y\GY>3QSSQT_ES2 +Y6?LS9Q_KN2.G7GG]/TI4*[&S<LARWR8/S<G
MGGGGK_+FDRODX^TMG'^JP<=.GK^OZ4 -3[1#AE5E![\\Y_#O]?;TJRSVVS-Q
M9,2_)<MPW)Y'4]N<^_3FH6*[!BY9S_<P?E_K^?X\TCE65!]H,G'*D9V<GCU_
M Y- %98K*)R;>W\I"<E-YRQ/)ZCN>F/I6G>SV;Z>46S,_P O^H4_-^?4XZG_
M !J-7MHU\L8E# ;I2.5)Z_E_GBH D2R?)<$+G_6 'I_+V_3Z@'/:9%)#=/*]
MR5A.-NE-]^(@G+DCL_ Z_P .?:NDO8M8U#RFL+PZ3!",,&7<' ).>_\ "<?A
M^3?+LC(6.T28'^E8.Y^>%_#G\Z<)-V4DNF\I>%4YPXP/;O['C^8!BW_B'48W
M73;%3=.55'U.-/E1\ ,Q&1]TYSQU'/.:T=)AOD.V\O/MMS)\R3[0/*&.4(YZ
MDC\JF6.S"MY>+<DG**#\Y_O'_>Y./?BA!&BEUFV2]  O)!R2<=^0.?\ "@"Y
M<RZC =DCDQD?>QC([C@>_'/H.M97]E:7>L97BV2L?G)9OWGTX/48'X5)&)%E
M,\UX]R& 7[.V<)C^(=.N?7M4LJPE@\<F"W)4 _NSZ<?3//7\Z $5;/3[>6&+
M37;S$V%=W,G.<<_3/0=,UFM)=+:2)8V<EF[,K>4>6?&<D'''I^/-:TCH8C&)
MS(S@ 2G.8./O#K]/QJM;1&!B'OGESR)2.4QCCH![_A^8 EK;75Y9A-4WQ*A9
ME9\C' YSCV_PQ5$)YCM;6NOPR"/)%HHRQV<[ 3CGC';D"MEW$S&.:Z9X<<,<
M_,3D$>GY?XU';6VCP/*Z6D44S*X6Z"C<6*D!OJ<Y[4 5;*\NXBRS(UFB\&:1
M1AN0,C]#Z\?2I&6SGNENV9;MD!&]6Z$D'![#G'^33[:)%6Y6]N3<B12(DD4$
M [AC'?\ F<4V*WM8HW\MEC8L/W:J>1S^>,=?\* *M[>&=_LUO:/;D\"X'*CW
MQWQ]/Y5HW=CJS6<)M]7%L4,;,2"=X!4E0 !]X?*/3-+&8(QO+^8X_P"61!_S
M_GTJD(")?-:]:5&/_'N02J _A_#]?Q]0"P9IID6*XD,QP QY&_MQS_G/>L:^
MNX].E%G#X?FN8Y<%I%9B"9 "3U]S6T4A4J4FW'N<$[?U_P#U_A44D3F[CG%_
M(8DV[D[# &1^'2@".Q@U6(J]JCVEMP1:E=Q _NY.>G3KSCZ5;N#8SC;=VA>0
M=]Y!S],?Y_&DG\Z6_,Z:E)';%ON _+C..F:FMWMUE9IV#J<X8C.<].HQ_P#6
MH QYXHLQK'ILEV@QLV,W[H>GOSSZUK1R+;HOGQ& X&UF/$8P0 ?]T8'/^-5)
MXC+.9(+UK1%;Y508$@XZ\$>W'_Z[D[PWD8%Q)\RJ$VD??VX&XC_:Q]: *UP]
MPRF>V4WX/(:,'# _D.?\\5E6%E!+>-<2Z7)I]RVT&[<\, 3@ ?-]W)[]^#BM
MJ#9;PA8+AHL 8A4$ <?3/^<]*E$XV[I9?M#'CRGR=O3GM]/>@!FH&142-=9C
MB0KCR\?>R>@/7^55K*XT[3CM:,&9CNR7Y=B<[@/1LY IT]O92R)(0KG@E"I.
MPYZ<>G7%+J%M8W101;8]J*/- )*$+]2.#0!9NK6YU4B8ONLT&#: <L3@@AO;
M![]_;C)B+K<&S@L9(8DP<DY&22">#[$]*M1))!;-9I?N0Y#?:<8*;<C;C'?/
MIVJ>W811^2]RS,#G[4<[G]%/TQ^M &W:NL<)CFNER>-AX*#TR<?6N?NY(H)A
M#]G;4$N&V'82 @/.3@?ACG\J>B0%V:6;.#P2&^?H<_T_J:G:2!QE3Y#Q@%",
MY<],?_JYH 2SL=/MYUG&F- Q7_6,20.>GTXXX_QJ#4)/])#PWJV2C&9&^ZP'
M8?3^1]#4K2M)$1)=,2",1')!'//(S^7^-2.=/>T$4L$<TG(PP/R@XY[?2@!T
MLYNK5(K35XOM  WN@YDP/F'3^+'^<57CM+G</-1RN?FE.=I'K]/RK-MM-M+.
M9KB)PS2!E\H CRMXQN'NA.?PQ5N%)86;=J,D\<A.5(R(QU]!],T 4+Q=42]B
M33]86-"#NME&XDY'.0.,=.O?BK>KVU\=+<WUM+JP*'-LA*LX].H/(_GZ8J;[
M/:+.)%D ;!_?A3E>1QW'/]![4^Y:><>4FHR1(>/- Y'OTQ_G% &7I$<*P_)H
M$^GGRS\SMGR_E^\><D#W]/K6C8:39WCNUS>I=E2"JYQY9YZ\#T%:UKJ"I UM
M<.9%V%?-;^/Y<>WWOPK*@AMH9'D200;CG"@_/]<_Y&: +/V=$N5A5_.B!"C:
M?NCH%Z9XZ9Z?6N4N[N-O$7]EMX7N98/.\O\ M#>?+(R1OP3QZ]/Y8K>DB66X
M6Z2X-N4(Q"O23:>IR#][&>HR34NY_M7V[[6^[=N^R9.WZ=/\]: 'ZQIQAMD^
MPWRZ1T!W#=O&,;?;/?H?SK%VC3TA86[W4D@#378/RSMDC=CMP ,>U79;59I'
MEN+IKH29Q ^<1D]"/=?YU'IEHVG3R227C7L$K[DMG^[;+@#RUXZ9!;'/)]J
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MTY]/S.>?I0 OF,/LK$8'[O)RO7GT_(YX^M!*^8I^U,1@_O,'*]./3\QGCZ4
MKYC'[4P&!^\P<MUX]/R&>?K0 B!<OFU9\'@9/R<#CGCWXR/TH0+A\V[/@<')
M^3D<\\^W&3^E"%<OFZ9.>#@_/P.>>/;C _2A"N'S<LF1P,'Y^1Z\^_&#^E
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M_=X.%Z<^OYG''TH<KA,7+/@<C!^3D^G/OSD_K0 .%RF+5DR>1D_/P>../?G
M_6E(7S%'V5@,']WDY;ISZ?F<\_2D<KE,73/SR<'Y.#SQQ[<Y'ZTI*^8I^U,1
M@_O,'*]./3\QGCZ4  "^8P^RL1@?N\G*]>?3\CGCZTB!=[9MF<8;Y,_=X///
M''7K].*4%?,8_:F P/WF#ENO'I^0SS]:1"N]LW+(,-\^/O<'CGCGIT^G%  @
M7#YMV? X.3\G(YYY]N,G]*%"[#FV9S_?R?E_K^7X<T(5P^;EDR.!@_/R/7GW
MXP?TH4KL.;ED/]S!^;^OY?AS0 F%\G/V9LX_UN3CIU]?T_2E<+L7%LR'*_/D
M_-R...>>G\^:3*^3C[2V<?ZK!QTZ>OZ_I2N5V+BY9SE?DP?EY'/'/'7^?-
MX4;<6S1_B?F_+/\ GI0X7>N+9D&%^3/WN!SQQSUZ_7BARIVXN6D_ _+^6/\
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MZ4 #A<)BW9,CDY/S\GGCGVYP?UH<+O7%LR#"_)G[W YXXYZ]?KQ0Y7"8N6?
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MD<G)^?D\\<^W.#^M#%=@Q<LY_N8/R_U_/\>:'*X3%RSX'(P?DY/IS[\Y/ZT
M#A=ZXMF087Y,_>X'/''/7K]>*4A?-(^RMC)_=9.?\/U_6D<KO7%RSC"_/C[O
M XXXXZ=/KQ2DKYI/VIL9/[W!S_A^GZT  "^8P^RL1@?N\G*]>?3\CGCZTB!<
MOFU9\'@9/R<#CGCWXR/TI05\QC]J8# _>8.6Z\>GY#//UI$*Y?-TR<\'!^?@
M<\\>W&!^E  @78V;9G.6^?)^7D\<\\=/Y<T +Y;'[.Q.1^\R<+UX]?R&./K0
MA78V;ED.6^3!^;D\\\\]?Y<T KY;#[0P.1^[P<-UY]?R..?K0 $+Y:G[.P.3
M^\R<-TX]?S&.?I0X7"8MV3(Y.3\_)YXY]N<']:"5\M1]H8G)_=X.%Z<^OYG'
M'TH<KA,7+/@<C!^3D^G/OSD_K0 .%RF+5DR>1D_/P>../?G _6E(7S%'V5@,
M']WDY;ISZ?F<\_2D<KE,73/SR<'Y.#SQQ[<Y'ZTI*^8I^U,1@_O,'*]./3\Q
MGCZ4  "^:!]E;&1^ZR<_X?K^M(@7>V;9G&&^3/W>#SSQQUZ_3BE!7S0?M38R
M/WN#G_#]/UI$*[VS<L@PWSX^]P>.>.>G3Z<4 "!</FW9\#@Y/R<CGGGVXR?T
MH4+L.;9G/]_)^7^OY?AS0A7#YN63(X&#\_(]>??C!_2A2NPYN60_W,'YOZ_E
M^'- "87R<_9FSC_6Y..G7U_3]*5PNQ<6S(<K\^3\W(XXYYZ?SYI,KY./M+9Q
M_JL''3IZ_K^E*Y78N+EG.5^3!^7D<\<\=?Y\T #A1MQ;-'^)^;\L_P">E#A=
MZXMF087Y,_>X'/''/7K]>*'*G;BY:3\#\OY8_P ]*'*[UQ<LXPOSX^[P....
M.G3Z\4 .VKYV/LK8W?ZK//7IZ?K^M-4+O.;9G']S)^7^GY?AQ3MR^=G[4V-W
M^MQSUZ^GZ?K35*[SFY9!_?P?F_I^7X<4 "!<OFU9\'@9/R<#CGCWXR/TH0+L
M;-LSG+?/D_+R>.>>.G\N:$*Y?-TR<\'!^?@<\\>W&!^E"%=C9N60Y;Y,'YN3
MSSSSU_ES0 @"^4#]F;.!^]R<?X_I^E*0OEJ?L[ Y/[S)PW3CU_,8Y^E("OE
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MRT/F<?=Z<CW_ ,\T@GPIC\M"6(.[;R,9]_\ /%%%  9\J8O+3)_BV\],^O\
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MHR& &W;P,9]_\\4@N A9O+C/F<_=Z<#W_P \T44  GV IY<9W$G.WIN)]_\
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M)/*C 4$;=O!SCW_SS0+C#"7RTP#]W;QUQZ_Y%%%  +C82_EH=P(QMZ;@??\
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M7S]WKP??_/%*;@%A)Y48"@C;MX.<>_\ GFBB@ %P QD\J,A@!MV\#&??_/%
MN-A+^6AW C&WIN!]_P#)HHH !/L#+Y:'S./N].1[_P">:!/L!3RT.[N5Y&>/
M7_(HHH 3S_D\GRTSC&[;ST^O^309]X">7&-I!SMZ[2/?_(HHH 4S^9C$:+M]
M%Z_7G\Z#<;R'\M!M &-O7:![_P"3110 OVCY_.\M,9SMV\=?K_D4@GV$OY:'
M=V*\#//K_DT44 (+@(6;RXSYG/W>G ]_\\T"?8"GEQG<2<[>FXGW_P BBB@
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MG>6F,YV[>.OU_P BBB@!!<;"7\M#N!&-O3<#[_Y- G\O.8T;=ZKT^G/Y444
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MW=RO(SQZ_P"1110 GG_)Y/EIG&-VWGI]?\F@S[P$\N,;2#G;UVD>_P#D444
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;_EH=P(QMZ;@??_)J%AN).2,G. >!]*** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 0U!WP# 2(  A$! Q$!_\0
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MW''4],].O/IVJO)L\U-J.J\94GYCSV/^?Z4YA'YRXCD"XY4GYC]#_P#6[]:
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M4/SDDC;U[=OR_#BHH]GFON1V7G"@_,.>Y_S_ $HCV>:^Y'9><*#\PY[G_/\
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MOC[N#]WZYS^/ZYHD$GF(6FC9@%VL"<+P,9R2>/J.>F*:X4;<6S1_B?F_+/\
MGI0X7>N+9D&%^3/WN!SQQSUZ_7B@!TGF&12TT;.,8<'@>G^<C\.M$GF&12TT
M;.,8<'@>G^<C\.M-8+O&+9D']S)^;^GY_CQ0P7>,6S(/[F3\W]/S_'B@!TGF
M&12TT;.,8<'@>G^<C\.M*WF^<A,\9?:</G@#CCU_4#KQ3&"[QBV9!_<R?F_I
M^?X\4I"^8H^RL!@_N\G+=.?3\SGGZ4 +^\\[/G1^9_STSQ_G'OT]N*/WGG9\
MZ/S/^>F>/\X]^GMQ3<+YF/LS8_YY9.?\/U_6C"^9C[,V/^>63G_#]?UH =^\
M\[/G1^9_STSQ_G'OT]N*/WGG9\Z/S/\ GIGC_./?I[<4W"^9C[,V/^>63G_#
M]?UHPOF8^S-C_GEDY_P_7]: 'KYOG.1/&'VC+YX(YX]?U(Z<4D?F"1BLT:N<
MY<G@^O\ G)_'K2 +YC#[*Q&!^[R<KUY]/R.>/K2*%WG-LSC^YD_+_3\OPXH
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MG1^7_P \\\_YS[=??FFX7R\_9FS_ ,]<G'^/Z?I1A?+S]F;/_/7)Q_C^GZ4
M*P?R4!E0IN.$R<@\<^G?T!Z\TLGF&-0TT;(,80'D?Y^GY=*:0OEJ?L[ Y/[S
M)PW3CU_,8Y^E#!=@Q;,A_OY/S?U_/\>: '2>88U#31L@QA >1_GZ?ETHD\PQ
MJ&FC9!C" \C_ #]/RZ4U@NP8MF0_W\GYOZ_G^/-#!=@Q;,A_OY/S?U_/\>:
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M?M38R?WN#G_#]/UITH/G(#"$/'R<_-S^?Y?AS00WVG'DC/\ SRY]/KG]?TH
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M)O\ @@!^V"F,_P#!4#QYST_XDNG_ /R@H;_@@!^V"F,_\%0/'G/3_B2Z?_\
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M?G^VV^1TXQYN/TSQ7\N)_P"" '[8*L%/_!4#QYD]/^)+I_\ \H*4_P#!O_\
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MU\D'^U['I_J_MMOC_P!&Y]NOZ<4OF6OE9_M>Q_ZY_;;?'_HS/^?3BOY<O^'
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M7L6S_$;VWR/_ ")C\_UZ5_+D?^" '[8*L%/_  5 \>9/3_B2Z?W_ .X!0?\
M@@!^V"K!3_P5 \>9/3_B2Z?_ /*"@#^HUY+7S%']KV+9_B-[;Y'_ )$Q^?Z]
M*'DM?,4?VO8MG^(WMOD?^1,?G^O2OY<C_P $ /VP58*?^"H'CS)Z?\273_\
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MVO8KC^(7MOD_^1,?E^G2A)+7>X_M>Q7 ;YA>VV6X/',F.>G []J_ER'_  0
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M>WK7\N8_X-__ -L$@L/^"H'CS SG_B2Z?V_[@%(O_! #]L%E+#_@J!X\P/\
MJ"Z?_P#*"@#^HU)+4QL?[7L5Z_*+VWP?K^\S_+V]:$DM3&Q_M>Q7K\HO;?!^
MO[S/\O;UK^7)?^" '[8+*6'_  5 \>8'_4%T_P#^4%"_\$ /VP64L/\ @J!X
M\P/^H+I__P H* /ZC4DM3&Q_M>Q7K\HO;?!^O[S/\O;UI!):^2#_ &O8]/\
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M^M#R6HC4_P!KV+=/E-[;X'T_>9_G[^M?RY-_P0 _;!50Q_X*@>/,'_J"Z?\
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MV?\ T9CWZ?KS7\N/_#@#]L'=L_X>@>/-W_8%T_\ ^4%'_$/_ /M@[]G_  ]
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M *%_X( ?M@OG'_!4#QYQU_XDNG__ "@H _J-CDM3N_XF]BGTO;?YOKF0]?\
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MGF6OFX_M>Q_ZZ?;;?/\ Z,Q_GUYK^7+_ (A__P!L'?L_X>@>/-W_ &!=/_\
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M^)O8I]+VW^;ZYD/7_.:(Y+4[O^)O8I]+VW^;ZYD/7_.:_ER7_@@!^V"^<?\
M!4#QYQU_XDNG_P#R@H7_ (( ?M@OG'_!4#QYQU_XDNG_ /R@H _J-22UV-_Q
M-[%>6^47MOAN3R<RD\]>O?BA)+4QL?[7L5Z_*+VWP?K^\S_+V]:_ES'_  ;_
M /[8)!8?\%0/'F!G/_$ET_M_W *1?^" '[8+*6'_  5 \>8'_4%T_P#^4% '
M]1J26IC8_P!KV*]?E%[;X/U_>9_E[>M"26IC8_VO8KU^47MO@_7]YG^7MZU_
M+DO_  0 _;!92P_X*@>/,#_J"Z?_ /*"A?\ @@!^V"REA_P5 \>8'_4%T_\
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M0\EKYBC^U[%L_P 1O;?(_P#(F/S_ %Z5_+F?^#?_ /;!4@'_ (*@>//FZ?\
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MTK^7(?\ ! #]L%F*C_@J!X\R.O\ Q)=/_P#E!0/^" '[8+,5'_!4#QYD=?\
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MDDM1M_XF]B_UO;?Y?IB0=/\ .*))+4;?^)O8O];VW^7Z8D'3_.*_ER;_ ((
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M_(F/S_7I7\N)_P"" '[86X ?\%0/'9SCIHNGG\O^)!_.IO\ B'Z_;%_Z2?\
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MQH2?%W@GPMXJV9X\0:/IVI[?7;]L@FQ^'ZT ?P7_ /!43_@IG^SK^T9^UO\
MLN_$_P"%UI\3-:\(_#7XAC7?$^H3> =?CDMM.&A:O9>:%%HX8^?=0K@D<-[5
M_1U^SO\ \%G_ -A7XO:AX!^'GA_7/B4OBQK'3=-6TO? NLV=G]J)$>V2>:-4
M5?,."3T'-?K8G[/'P">WN&'P1^%WG1KE ?!?A\9;(&.;'WXJ3P]\$_A+H]RN
MI:=\'OAQI-[ X:&\L/">A6MS&5.5:.6&R212#R,$8//6@#PO]OCX4^*?VA_V
M4?%G@GX76']I:YXGT"]72;:;,!F-W9M'")/E)0EB <C-?SB?\$\_CUX*_P""
M0.D>+OAY^V=8>+O"NOZWJM]<V4?ASPWJ>O1-%<!8HR9;:W"C+*0:_KRGO=?$
M\4-G9PIID>$)0HGEH.,(@B& !T P!TZ5D:[\)_A/XP3[=XJ^'W@[Q/>@<S:[
MX?TS4I@WH'N[:5NO/UY% '\XG[4O_!6?]DG]M+X+>*?V?O@/>?$77/B'XSL;
MS3=&LM5\$:SI]K)=7\!MH%DN9("J R$ D]!S7TO_ ,$-_P!DSX[_ +'_ ,#/
MB-IWQ5\.V^BZMXRUS2M8T*WDF.)["-=0+N_F(A1AY\7RD9YK]@=(^"'P;T6[
MCU/1?A#\.M+NX'#17=CX4T.TN8V4Y5DEBL5=2#R"&S^-=9JEOJNI20V:Q):Z
M/&-K/ PC,>,!$1$5"%QNX#  C\@#\I_^"N7P.^*W[5_[-NJ?#?X:Z)'JWC!D
M#BS5F2(B&X$[XD1'S^[0D?+7YB_L _M]_ ?_ ()=?"2#X!_M6Q^.- ^(.FO-
M'=6.B^$-6UFS#&Y>?Y;F" (1L/T^M?U3)HEKIVGYLMMS*5Y:7ESG[PR[.3D<
M'.<C/O7FMY\'OAMXFO3J/C#X4^ -;F8_/>ZKX:T;4+ICC +2W-D\AR,=3W]C
M0!_-5^W[_P % /@1_P %1?A%-\ /V4;?QOX@^(&I20QVMCK/A#5]'M"PN$F^
M:YGMR@^0$_6OTR_X)'_LZ_$S]FO]FS3?A5\5M/G\.^+3&Q-O;&1@!/.TZ?O2
MD>#Y;@]!W%?IMIWPA^%?A2X75?!WPK\ :)>J04O-*\-:/87*G&,K+;V:.#]#
MTKTRPN)@HN+RTMHRN,.JQ[P!TP0@(QV[ =* /C;]HSX#ZY\6_#DOA_PEXW\4
M^&-4,9C:]T:Z>TN Q4@L)01SN((_R*_BK_X+!_\ !.OXD_ F[\)^-/B-\?\
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M;_/3TH \A3X3Z@KL9/%VNK$01&RW/S,3PH;YNYQG]?2B/X3WZ[O/\7:ZF?\
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MGGOWR10GPGOPC++XNUU9CG8JW)VGCC//?ODBO9)+?(W0.74=23S[XR3^'O\
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M'."!]>.GY4 >,GX47_F[QXNUTV_42&Y^?I]?_K_SH_X5/?\ F[O^$NUW[/\
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M.T<<XY[=L$U[!) Z?.K$H>A!&3G&,YR?KSU_.I([? W3N44]"#S[9P1^/O\
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M^E(ID\EL2QA=PRIQN/7H?_K'KUH CS#L_P"6V_\ '9_\3_GUHS#L_P"6V_\
M'9_\3_GUJ7,OE?ZZ+;_=XW?G_P#6]O>C,OE?ZZ+;_=XW?G_];V]Z (LP[/\
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MYS0!$_D\;?.]]_\ 3=_GU[4/Y/&WSO??_3=_GU[5+*9?DW31-Z;<#'UZ]/\
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MM[;?O?CCG\_QYJ5#+YC8FB5N['&T_3_]?Y]:$,OF-B:)6[L<;3]/_P!?Y]:
M(U\G<V?.VX;&W.[H?O8^;KUS^/-(GD\[O.]MG]=O^?3O4L9E\Q\31!L-DG!!
MX.<#CZ=>/>B(R_/MFB7UW8.?ITZ_YQ0!$GD\[O.]MG]=O^?3O0GD\[O.]MG]
M=O\ GT[U+$9?GVS1+Z[L'/TZ=?\ .*(C+\^V:)?7=@Y^G3K_ )Q0!$GD\[O.
M]MG]=O\ GT[T+Y.'W>=G'R[>G4?>QQ_WUQ4L1E^?;-$OKNP<_3IU_P XHC,N
MV7;+$!CYLX);D?=X&/KS]* (E\G:=WG;NVW[OXXX_/\ 'BA?)VG=YV[MM^[^
M../S_'BI4,OEMB:)5[J<;C]/_P!1_I0AE\ML31*O=3C<?I_^H_TH B7R=IW>
M=N[;?N_CCC\_QXH7R=IW>=N[;?N_CCC\_P >*E0R^6V)HE7NIQN/T_\ U'^E
M"&7RVQ-$J]U.-Q^G_P"H_P!* (1Y/EC_ %V_ _W/_B?\^M+^YV?\MM__ (Y_
M\3_GUJ0&7R!^^BV8'R<;OSQ_3V]Z7,OE?ZZ+;_=XW?G_ /6]O>@"+]SL_P"6
MV_\ \<_^)_SZT?N=G_+;?_XY_P#$_P"?6I<R^5_KHMO]WC=^?_UO;WHS+Y7^
MNBV_W>-WY_\ UO;WH A/D^6?]=OP?]S_ .)_SZTK>3M&WSMW?=]W\,\?E^'%
M2$R^0?WT6S!^3C=^>/Z>WO2N9?+7,T3+V48W#Z__ *A_2@")O)VC;YV[ON^[
M^&>/R_#BAO)VC;YV[ON^[^&>/R_#BI7,OEKF:)E[*,;A]?\ ]0_I0YE\M<S1
M,O91C</K_P#J']* (F\G:-OG;N^[[OX9X_+\.*&\G";?.SCYMW3J?NYX_P"^
M>*E<R^6N9HF7LHQN'U__ %#^E$AEVQ;I8B,?+C *\G[W!S]>/I0!$_D\;?.]
M]_\ 3=_GU[4/Y/&WSO??_3=_GU[5+*9?DW31-Z;<#'UZ]/\ .:)3+\FZ:)O3
M;@8^O7I_G- $3^3QM\[WW_TW?Y]>U#^3QM\[WW_TW?Y]>U2RF7Y-TT3>FW Q
M]>O3_.:)3+\FZ:)O3;@8^O7I_G- $;>3N7'G;<+G=G=T'W<_-UZ8_#FD;R=P
MV^=M[[OO?AGG\OPYJ60R^8F9HBV%P1@ <#&1S].O/M0YE\Q<S1,W9AC:/K_^
MO\NM $3>3N&WSMO?=][\,\_E^'-#>3N&WSMO?=][\,\_E^'-2N9?,7,T3-V8
M8VCZ_P#Z_P NM#F7S%S-$S=F&-H^O_Z_RZT 1'R/,7'G[,'.<[^W3^+'7IQZ
M]Z/W._\ Y;;/_'__ (K_ #Z5,QF\Y<SPEMIPPQM XZC_ .OVI,R^;_KHMW][
MC;^7_P!?W]J (OW._P#Y;;/_ !__ .*_SZ4?N=__ "VV?^/_ /Q7^?2I<R^;
M_KHMW][C;^7_ -?W]J,R^;_KHMW][C;^7_U_?VH B_<[_P#EML_\?_\ BO\
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M'D^8/]=LR/7?_P#%?Y]*DS+YO^NBW?WN-OY?_7]_:E!E\\?OHM^1\_&W\O\
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M "VW_P#CG_Q/^?6I 9?('[Z+9@?)QN_/']/;WI<R^5_KHMO]WC=^?_UO;WH
MB_<[/^6V_P#\<_\ B?\ /K1^YV?\MM__ (Y_\3_GUJ7,OE?ZZ+;_ '>-WY__
M %O;WHS+Y7^NBV_W>-WY_P#UO;WH B/E>6N/-WY.<_<[=/X<]>G/KWH;R=HV
M^=N[[ON_AGC\OPXJ1C)Y*YEC*[CA1C<.G4__ %ATZTKF7RUS-$R]E&-P^O\
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M:RYE=V4/+$Q[,O '3K^7X]*T+.*..1=RO*<_>C/RC/'/Y>O% '\/W[30NO\
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MUP2?+S,)/S^7IZX_SUH 9,L8V;(V3/WL_P 7TP!^']*)EC&S9&R9^]G^+Z8
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M\L?IU]^:-L?GX\IO+_YY]_Y8_3K[\T_)^TY\X9_YZ\XZ?G^GZ49/VG/G#/\
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MG&6/0^O;^I_'K2L3]G0>:"-Q_=\Y7W]/R.>/K3I2?)3,P<<?)S\O'Y?E^'%
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MB98QLV1LF?O9_B^F /P_I3[@D^7F82?G\O3UQ_GK1<$GR\S"3\_EZ>N/\]:
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M*?LY3&/DQ][]3_,?AUI&*[QBY9Q_?P?E_I^?X\4,5WC%RSC^_@_+_3\_QXH
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MG4$+31VMP+]#;,$_=7'+,6R,'IUQG%16EQ&;.;#?VI/EMD4@ SQP,XZ<GTH
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MON_JO^?3O)%!!#'_ ,A)WDQRQ!^<[>AS_>_E5![<SOD:B]HH.3M#?/\ 7_\
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M':!Y-\FJ21I_S[@-MZ=/IW_IWJ_((43;'>M)VV$'TZ^O_P!:@"+)\G;]G/\
MUUQ_]?\ I_C2-GR5'DD?,?WF/O=..OO_ '1]3WK1V@>3?)JDD:?\^X#;>G3Z
M=_Z=ZNSB)4"1W;2]?E(/R\#GUYH 9(28U'V<IC'SX^]^I_D/PZ42$F-1]G*8
MQ\^/O?J?Y#\.E5X+-2Y>759"I.1"0V%Y_I_G'2K<XB"[8[MI>ORD'Y?\]_\
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M!!_U2'T_S[]" >M1R3(QC96<?\\CDY_E]>O_ -=,D3 _9SU_U6/_ *_X]?\
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M,<?YQ[=/;FC]YYV/)C\S^YCC_./;I[<TGR>?]]]O]['S=/3_ .O[^U'R>?\
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MF22X^&'A?4)7\(ZHD1$S07EIY5D)(YBS1.-G*#OTK]M/A%\,OA)\'-(3P?\
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M#DQF14V^A09^OS#/O60_@+1UV[;FYY^]D,?KC+4/X"T==NVYN>?O9#'ZXRU
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M%S_<RF/3IN_IT_.LC_A M'\S;]IN=GT;/KUW9H_X0+1_,V_:;G9]&SZ]=V:
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MR&\!:.'4+<W.T]<AL_GN_E0W@+1PZA;FYVGKD-G\]W\J -@^+M#8A_,5=O\
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MPNY #Z< \_E6,W@+1PZA;FYVGKD-G\]W\J;-X TAL)'>7<>[^-<[A]#G/ZT
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M&[\<<_G^/-1.T1C4*KAQC).=IX[< ?J?QZT.T1C4*KAQC).=IX[< ?J?QZT
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MP1G:.._!'ZC\.M(#'Y3 JV_(PPSM ]^,9X_O#Z&@";]Y]F_Y9[/PW]?^^O\
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M-YS;EQ_<W?=_I^7X<4+LWG-N7']S=]W^GY?AQ0!(AE\QL31*W=CC:?I_^O\
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M>E $DIE^3=-$WIMP,?7KT_SFB0R^8F9HBV%P1@ <#&1S].O/M4;[!MQ;F/\
MX%][\L_YZ4/LWKBW*C RF[[W R>..?K]: )',OF+F:)F[,,;1]?_ -?Y=:',
MOF+F:)F[,,;1]?\ ]?Y=:C;9O&+<H/[F[[W]/S_'BAMF\8MR@_N;OO?T_/\
M'B@"1S+YBYFB9NS#&T?7_P#7^76E8S><N9X2VTX88V@<=1_]?M43;-XQ;E!_
M<W?>_I^?X\4IV>8O^C$#!S'NZ].?3\SF@!^9?-_UT6[^]QM_+_Z_O[49E\W_
M %T6[^]QM_+_ .O[^U1_)YF/LYQ_SRW<_P"'Z_K1\GF8^SG'_/+=S_A^OZT
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M/LYQG_5;O\C]?UH >AE\QL31*W=CC:?I_P#K_/K0AE\QL31*W=CC:?I_^O\
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M_P#J/]*$,OEMB:)5[J<;C]/_ -1_I4:[-AS;ES_?W?=_K^7X<T+LV'-N7/\
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MEY_/\OPYHR?M.?.&?^>O..GY_I^E$H/G(#"$/'R<_-S^?Y?AS1@_:<>2,_\
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M2/3OGI4\%IJ.JQ-<3:?_ &;,N!%(I)+(P/.3P.@X_+UH OW!U&&#:EM)*G9
MHS][_)_&F12WS6^)H'@C[HP'][U_7_"LTZ-JNG/]ONM=N#$O/D'YE],=#_\
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MS,'''R<_+Q^7Y?AQ1*"(4)A"#CY^?FX_+\OPXHE!$*$PA!Q\_/S<?E^7X<4
M$I/DIF8../DY^7C\OR_#BFRD[8<RA\#@<_)[<\>_&13I01"A,(0<?/S\W'Y?
ME^'%-E!"PYB"9'!Y^?WYX]N,"@!UP2?+S,)/S^7IZX_SUHN"3Y>9A)^?R]/7
M'^>M%P"/+S"(_P _FZ>N?\]:+@$>7F$1_G\W3US_ )ZT %P2?+S,)/S^7IZX
M_P ]:+@D^7F82?G\O3UQ_GK1< CR\PB/\_FZ>N?\]:+@$>7F$1_G\W3US_GK
M0 2D^='F8.<+\_/R^W(SQT_ES1*3YR9F#GCY^?EY_/\ +\.:)0?.C!A"'"_)
MS\WOR<\]?Y<T2@^<@,(0\?)S\W/Y_E^'- !*3YR9F#GCY^?EY_/\OPYHE)\Y
M,S!SQ\_/R\_G^7X<T2@^<@,(0\?)S\W/Y_E^'-$H/G(#"$/'R<_-S^?Y?AS0
M ]BWVA#YX)VG]YSA?;U_(8X^M,R?M.?.&?\ GKSCI^?Z?I3V#?:$'D ':?W?
M.&]_7\CCGZTS!^TX\D9_YY<XZ?G^OZ4 &3]ISYPS_P ]><=/S_3]*,G[3GSA
MG_GKSCI^?Z?I1@_:<>2,_P#/+G'3\_U_2C!^TX\D9_YY<XZ?G^OZ4 &3]ISY
MPS_SUYQT_/\ 3]*>I;[0Y\\ [1^\YPWMZ_F,<_2F8/VG'DC/_/+G'3\_U_2G
MJ&^T./(!.T?N^<+[^OYG''TH 9$3YSXF"'GY^?FY_/\ /\>:(B?.?$P0\_/S
M\W/Y_G^/-$0/G.!"'//R<_+S^?Y_CS1$#YS@0ASS\G/R\_G^?X\T $1/G/B8
M(>?GY^;G\_S_ !YHB)\Z3$P0X;Y^?F]N!GGI_/FB('SG A#GGY.?EY_/\_QY
MHB!\Z0"$.<-\G/R^_!SQU_GS0 6Y(\S$PC_/YNOIG_/2BW)'F8F$?Y_-U],_
MYZ46X)\S$(D_/Y>OIC_/2BW!/F8A$GY_+U],?YZ4 %N2/,Q,(_S^;KZ9_P ]
M*+<D>9B81_G\W7TS_GI1;@GS,0B3\_EZ^F/\]*+<$^9B$2?G\O7TQ_GI0 1$
MB&0"8(,ME/[WOQQSUZ_7BB(GR7Q,$'/R<_-Q^7Y_CQ1$#Y,F(0XRV7_N^W''
M'3I]>*(@3"Y$(<<_/S\O'Y?G^/% !$3Y+XF"#GY.?FX_+\_QXHB)\E\3!!S\
MG/S<?E^?X\41 F%R(0XY^?GY>/R_/\>*(@3"Y$(<<_/S\O'Y?G^/% !$3Y+X
MF"#GY.?FX_+\_P >*,G[-CSAC_GEWZ_E^OZT1 F%R(0XY^?GY>/R_/\ 'BC!
M^S9\D8_YZ]^OY?I^M !D_9L><,?\\N<]?R_7]:,G[-CSAC_GESGK^7Z_K1@_
M9L^2,?\ /7G/7\OT_6C!^S9\D8_YZ\YZ_E^GZT &3]FQYPQ_SRYSU_+]?UIK
M$_9T'F@C<?W?.5]_3\CGCZT[!^S9\D8_YZ\YZ_E^GZTU@?LZ'R@!N/[SG+>W
MIQ[#//UH =*3Y*9F#CCY.?EX_+\OPXHE)\E,S!QQ\G/R\?E^7X<42@B%"80@
MX^?GYN/R_+\.*)01"A,(0<?/S\W'Y?E^'% !*3Y*9F#CCY.?EX_+\OPXHE)\
ME,S!QQ\G/R\?E^7X<42@B%"80@X^?GYN/R_+\.*)01"A,(0<?/S\W'Y?E^'%
M #92=L.90^!P.?D]N>/?C(IUP2?+S,)/S^7IZX_SUILH(6',03(X//S^_/'M
MQ@4ZX!'EYA$?Y_-T]<_YZT %P2?+S,)/S^7IZX_SUHN"3Y>9A)^?R]/7'^>M
M%P"/+S"(_P _FZ>N?\]:+@$>7F$1_G\W3US_ )ZT .E+%H<SA\'@\_)[\\^W
M&3392?.3,P<\?/S\O/Y_E^'-.E#;H<P!,G@<_/\ GS[\8--E!\Y 80AX^3GY
MN?S_ "_#F@ E)\Y,S!SQ\_/R\_G^7X<T2D^<F9@YX^?GY>?S_+\.:)0?.0&$
M(>/DY^;G\_R_#FB4'SD!A"'CY.?FY_/\OPYH )2?.3,P<\?/S\O/Y_E^'-/8
MM]H0^>"=I_><X7V]?R&./K3)0?.0&$(>/DY^;G\_R_#FGL&^T(/( .T_N^<-
M[^OY''/UH 9D_:<^<,_\]><=/S_3]*,G[3GSAG_GKSCI^?Z?I1@_:<>2,_\
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M?UU_R(6=W8.T@9EQA@!@8Y].W?':FO*[2*S2!F&,-@<8/^?Z9-69(G9PXA1
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M GP=X+O81F*;3+8Q21D9P5RY_E_A7T2ME';ZN$34W2W3"K9J/W854PJC@^@
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M?/I[8[_04YSLD5FAV 8^09P?_P!?U'X&KMK+'+(A68P8P/+ .#D^^>OX?SH
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M_GK4D8EW2XAB)S\V< +P/N]<_7CZ41"7Y]L,3>N[ Q].O3_.: &1; 23.4]
M%^_^>?\ /7M7.ZI:1W%S$YU1K,JWRHJ[A)DCKD'&>._?\^EB$OS;88F]=V!C
MZ=>G^<U6:*T*R7%R8@\66"L5'/4@9Y/0#_Z] $%W?R(UE83IYMO,XC9F!Q(
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M5-F"(_W/52I_X_D['_/2G?\ !OT+P_L8:4+,9D_?8'3_ )?I/3^M '%^#_\
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MP5X'^?\ ]?-#A=B_Z0S_ .P5X'^?_P!?->9?\+9\$9XFO\]_]#ES_P"@T?\
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MF7_"V?!&.)K_ !W_ -#EQ_Z#1_PMGP1CB:_QW_T.7'_H- 'IKA=Z_P"D,_\
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M// (!^?WX_,?7I36A\P@O<&#T[[O_P!?KQFO*V^,OA>X(CLFG(Z.9K5XRO\
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M04@FYU%7X("V<NW/N,8YZ?XU#)\7_",CAI+W5%8'A!9RE#]>QXZT+Q%P]_\
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ME%V]U<JBK67ES7^?9,)J%VXSBW)WY8IM)/JV]O\ "]3TQ N]O](9/]L+R?\
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MAQ0FS+YN2G/!V_?X'KQ^6!4B"7S&Q#$S=U.-H^G_ .K\NE$8EW2XAB)S\V<
M+P/N]<_7CZ4 1IL&[-P8_P#@/WOSS_GK5=OO-A0PR?FXY]ZN1"7Y]L,3>N[
MQ].O3_.:I/C>V20<G(&<#Z<4 6YOL^X>7]HQW\W.?PW?Y]>U,?R>-OG>^_\
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M7'F?N]WE^VS'X9V_Y].]$OF>='GR\X7&W;M_X%CY<XZY_'B@"BUAHFX!=)M
MG<&TA!/T&SG_ #WH:PT3< NDV@3N#:0@GZ#9S_GO5Z;S//3=Y>[C&W&W\<<?
MG^/%$WF>>F[R]W&-N-OXXX_/\>* *+6&B;@%TFT"=P;2$$_0;.?\]Z#8:'O
M&DVGEX.1]DAW$\=!LR>_08Z5>F\SSTW>7NXQMQM_'''Y_CQ3V\S[0F?*W;3C
M&W9^/\.>G7GT[4 9WV#1-^/[)M/+]/LD.[\MF??I[]*/L&B;\?V3:>7Z?9(=
MWY;,^_3WZ5>_>?:?^6>_\-G3_OG_ #ZT?O/M/_+/?^&SI_WS_GUH H_8-$WX
M_LFT\OT^R0[ORV9]^GOTH^P:)OQ_9-IY?I]DAW?ELS[]/?I5[]Y]I_Y9[_PV
M=/\ OG_/K1^\^T_\L]_X;.G_ 'S_ )]: *(L-#WD'2;3R\# ^R0[@>>HV9';
MJ,=:%L-$W$-I-H4[ 6D)(^HV<?Y[UHKYGVA\>5NVC.=NS\/X<]>G/KWID/F>
M>^WR]W.=V-OX9X_+\.* **V&B;B&TFT*=@+2$D?4;./\]Z%L-$W$-I-H4[ 6
MD)(^HV<?Y[U>A\SSWV^7NYSNQM_#/'Y?AQ1#YGGOM\O=SG=C;^&>/R_#B@"B
MMAHA8AM)LRN#M M(B0<'&0$R,?H.M"V&B'._2;0_W<6D)_/"'_/2KT7F>=)C
MR\X;.[;M_P" Y^7..F/PXHM_,_>;?+]]^/QQN_SZ]J **V&B'._2;0_W<6D)
M_/"'_/2A;#1#G?I-H?[N+2$_GA#_ )Z5>M_,_>;?+]]^/QQN_P ^O:BW\S]Y
MM\OWWX_'&[_/KVH HK8:(<[])M#_ '<6D)_/"'_/2D6PT4A]VDVA('R$6D1Q
MR.I"<<?K5^W\S]YM\OWWX_'&[_/KVI(=^V;_ %>,'?NQG'?;GG/^[SZT 9[:
M7IJPO.='TTHH))^R0EA@9Z[#SW_^O7QW^V[\9=0^ 7[.'C?XI^!]&T9_$7A[
M2]0N[/[7:0F'S;:U:5,_N6.-V,X4_K7UU.FMROY5N;?^SV/[T-_K<$G./P_K
M7YW_ /!5JSM[3]B3XI"$2!CH&L%]X(Y-B^<>WI_/K0!_,'^S-_P5P_X+'?M=
M>)]:T3X2>'/@6VGVNLW&G6K>(;&)F\M'"IO+62=F&>:_5JPL/^#B=[>">VTW
M]D^!;F-9406UJC8?ID!!S^%?BU_P0A^('@OPMXM\1GQ'XQ\'Z B^*KK?_;6L
M:=82J-\><?:IXV&/I_*O[<K;X^? N:/2IT^./PPCCCMX-\?_  F^@K]WDC:-
M0Q_AUH _#R30/^#BQR7ETG]D]CU)>TMC_-*^B_V6M-_X+%'XC6D'[3^D?L[G
MP$)!]L'A*TMCJ/EA<MY>$^]GIS7ZS77[27P)F/EQ?&WX6;#P/^*UT+=TQVO^
M2>F!WKI]"\5> ==1M3\.^,_#_B JC2YTG6K/4(W"*6.W[//+G(! Q_\ 6H S
MFN/#9U:+2CHDIO2D8ES9#^S_ #?+!?'[LIMW;L?KWKI=4\.Z9]C N=*LXK<J
M#_H5I&D@!(_YYIG/K^7T_#C_ (*2?\%D/"W[*ECJ/A?X>Z+'<_%"!A!;RZA:
MQO8F=F"H2WV25MN"N3GZ>M?&'[/W[4W_  7I_:T\%)\1O@_9_L\P^$[O?+:1
M:[$HN_(WD1[E,40W8 XVB@#^GJT\&>'A'Y]K#=\9.R=&VY!S]T@C&?4<\<>O
M0Z?;>&9RUJ^DV[RQC&;FTB*;AQQN0]?\]*_ESUS]O'_@L1^R=KD?B#]K#P%\
M._$_PZL+B.35[;X6Z'<:EK,EDKK]I%M':V-RS2E-^S"GDC%?T9?!7XOZ3\6?
M@[9?%Z;1]5T&VN-*CU6?3]1M)+&_BC: 3LDD$L4+JZC@@QC!!!% 'J;Z7/).
MT%KH^C+;@D FRA'RYP,'9^1XJMJ'A71K)%N)=-A^T2$;OLULFT$C)^ZAXSGM
M_+C^;G]M+_@OU:^!_'-]\%OV9/!>N>(_B9IU_+I<QNM*FU"R6YBD:!F?[/83
M,(Q+C+%NF03DU!X'^+'_  <)?%WPE9^/?".E?L\Z7X=U*WCN[2Q\26OV;5(X
MI8_,19H9XXW60*<,"@YZ\F@#^ES3=!TV!$N)K)9HGP5BE@#XS_LE6Q@=>/2O
MQ-_X+&?MZ?%/]AW3/#NI?"/P_P"';A=0T4:A=1ZA8QL3*+FZB(55MI3]R%>V
M>G2OF3P;_P %'?\ @H[^RYXLMH?V\/A]X?\ %'A6[NTLX/\ A3NA7>I7$;NX
M"M)]DL+D! @;).!G%>3_ /!<?XJ>%_C5\%/AC\6=.T?5[#1]>\&-?P:5JMI+
M!JEI$NHZC&8[RVDBCDBDS&6VM$IP5..>0#Z=_P"".?\ P4S^)_\ P4#DUW3O
MBAX.\/:=)IYC2.2STJ.#<7\T$[GLH,_=R.?QK]Y[?PSIWAFXE>72;6>.4YPE
MI&^!D]MAQU/;_P"O_G??\$K/VR?VE/"7B;6O#/[)7A#1;C5YKE+8SZUI3R6Z
MR[W1&E>*T8!03R68#Z]:_H.\7_$__@X2\,^$+_XCZE9?LX-X6L+5]0>T>%3J
M9M5C:4H(BA;S-@P!LZ]NM '])D=MH-T#]GT.WAS]XFPA0^^"8A[GMBKEKH.E
MKNDL[.$MU821)@=^!@8K^7W_ ()Z?\%V?B#\4?'NJ_"[]J/PK:Z3XDL;]--\
M_0-/:VLI+CS7B=HWDL8PR;@""K'@]>:_:3]I?]NOPM^SQ\/)?%Z>%/%7B*ZU
M"P>ZTJ+0]+N=0!?R]ZB5;>TN,\LG\- 'W*VAZ=<6\D\FE6$MTFX(\MI"S#;T
MP60GCMCIBH=-T.&YR+S2-+* X!:S@) _X%'GO^'YU_+-\&_VZO\ @L_^VM+X
MB\4?LM>"?AOX/\$6>MZO8Z?;?%/1KK2=5>UT^^N+19&CN[*T8^8(2R,%(92"
M,YS6A\>_C5_P<1?L^_#K6_B5XHLOV<K[1]"M+B[NK72(O.O)([>(RN(XXTD9
MF*C  0\T ?T_:M::'I["W.D0"-_O&"SCQSQP5C/Y^E5K:ST:. O::7&T?)82
M6B$^^/W?^/TK^6+_ ()I?\'#&M?'3Q#_ ,*E_:F\&76F_%"YU/\ LJVET72I
M;?3#<.R0(Q:33X_D\XGG?T[U^C7_  42_;^^,O[+/POU/QO\-M%T>Z(TF;4[
M'^T;0R1A/):2,2'[/*!C;SQTH _9C3M/\/:BCQ3:#:;P>#)818R.<Y,0_"O$
MOC[XJU7X4^#]1U[1M#T:>&TMIIHX6LHW),:,RY01,#R!QMK^0O\ 8V_X*Y_\
M%H?VX;[7K;X-^&O@Q91:9?+;K=:QIYBA6.1V5 \HM(5#_+G!.2/I7ZHZAJ/_
M  6,M_#MW<_M10_!*X\$M8W#7:^$D66_$9A8G8 K<@G]/6@#\M/&G_!:?_@I
M)\2_VK)_V:?V=?"WPBA+W[V=K_PE6G1+%D+O4N&LE'IGY_Z5^D%EIG_!Q4(8
M)[;3/V4(!/%'.@6VMD.V5%D7H@YP1GWK^>']G3QGX<T+_@K9;:MXEU72O#5H
MNM W%SJMU;Z;:J_V<!R9+AXHPN[.,GI7]_\ 8?M#? &2STXM\</ABB_8+,%?
M^$VT$$$6T8(/^G]1T(]<C- 'X2MIG_!Q=*_SV/[*$CGU@MF//_ 3U_\ K5[9
M\#-)_P""S-CXFDF_:2T3]G8^&7, MF\+V5M]MR&<W(<^6>QC*>^?:OUA_P"%
M]_ Z+4/M,'QT^%QBSG8_CG0L?0@7^.?_ ->:[*P^)OPY^)*W.F>$OB1X&\2Z
MG;1;X;70O$>F:G*DKC$9ECM+J5PK%3C(&<''0T 5O ^F>+)-,MI/%FE^'UE>
M-=XL+:(#)7)Z(.,_T%=Q=:?IFFJ)VT:QD5SU6RB9N?[Q\OCIS^/;FOQB_;?^
M*O\ P5$^#EM>:Q\#;'X8:EX8T]I+@Q:C"US?"RB#-RB)(P?8 .G6OF'_ ()]
M_P#!;;7OC1\2K[X-?M*GPUX,\5Z*TEMJEW=R6^D::UQ;RK;S>3)>PVRD;R2H
MW].GK0!_1Q;6OA^=3*^C::NX$XBL[<3#Z_NP0>W/^&8K6Q\+F[95TPB0[@!/
M;)Y6[L.0!R>!7XQ_\%&O^"L?PO\ V/?"T&M_#OQ1X;\7ZWJDBV]E;Z=JMAJL
M/VB9'>/,=M]K^3<H!PHS7A?_  3W_;._X*,?M;>*+'Q5XRTCX<Z+\(M662[T
MNX2U-IJ9@>&2>S#R-;P LV(PW/4D 4 ?T03Z-8PD.-*L64\KMM(CQ[_)SQ_B
M*IS+HD.$N]%MMQ.%V64./3)/E?X4WPW?>*+6T0^+/[/G8*.;$APWN.O^35NZ
MO9-6DQ8P)$J$[C<1[2?7;E1SP,8_ T 9TNB:-<E9!I=F@ZKLM8 2?]K"5>AT
M[153;)I-F2O"E;2(]AU_=_YQ5J*X:V78VS=T.[C\O\^G6I[82[790@##/[P+
M^.-W^?7M0!06PT0J2VDVA;)VD6D) &3C)"8&!^1ZTJV&B;26TFT+]B+2$@?4
M[./\]JOQ>9Y,F/+VY;.[&[_@.?FZ],?AS20^9Y#[?+V\YW8W?AGG\OPYH HK
M8:)M);2;0OV(M(2!]3LX_P ]J%L-$VDMI-H7[$6D) ^IV<?Y[5>A\SR'V^7M
MYSNQN_#//Y?AS1#YGD/M\O;SG=C=^&>?R_#F@"BMAHFTEM)M"_8BTA('U.SC
M_/:D%AHOE@_V39^9CK]DAV_]];,?K[=:OP^9Y#[?+V\YW8W?AGG\OPYH_>?9
M?^6>S\-_7_OK_/I0!1^P:)LS_9-IYGK]DAV_GLQ[=?;K1]@T39G^R;3S/7[)
M#M_/9CVZ^W6KW[S[-_RSV?AOZ_\ ?7^?2C]Y]F_Y9[/PW]?^^O\ /I0!1^P:
M)LS_ &3:>9Z_9(=OY[,>W7VZTAL-%V C2;/S,G)^R0[2..AV8/X'/2K_ .\^
MS?\ +/9^&_K_ -]?Y]*8V_[.F=FW<<8QO_'^+'3KQZ=J *C6&B;05TFT#]R;
M2$ _0[.?\]J&L-$V@KI-H'[DVD(!^AV<_P">U7IO,\A-WE[>,;<;OQQS^?X\
MT3>9Y";O+V\8VXW?CCG\_P >: *+6&B;05TFT#]R;2$ _0[.?\]J&L-$V@KI
M-H'[DVD(!^AV<_Y[5>F\SR$W>7MXQMQN_''/Y_CS1-YGD)N\O;QC;C=^..?S
M_'F@"BUAHH";=)LP2/G)M(1GD]"4YX].*&L-$&-FDV@_O9M(1^64'^>M7)M^
MR'=LQCY=N,_\"QSG_>YI]P)2(RWEX'(VX_7;_GTJHPE-VC%M]OZ]4!0:PT08
MV:3:#^]FTA'Y90?YZT-8:(,;-)M!_>S:0C\LH/\ /6KDYD/E[A'QTV8_7;C]
M:6X\P^7D1G'39M[8^]M_GT]*EZ.ST;V3T;]!)IJZ=UW7X_<4FL-$!3;I-H 3
M\X-I",C!Z ISSZ<T-8:)N 72;0)W!M(03]!LY_SWJ].SAH<^7NS\H7&,X_CQ
M@8^O'ZTKK,949O*W<8VXV_CCC\_QXK)UZ49*+FM>OV4^S?1_GT+C"4G:,6W:
M]EV[^A0:PT3< NDV@3N#:0@GZ#9S_GO0UAHFX!=)M G<&TA!/T&SG_/>KD[2
M+,A94+#&-F-I^N/U//'Y4Y_-=UD*(,8QV4X]>W/0Y_&KC.$OADI>FN^Q4:52
M?PPD[>11:PT3< NDV@3N#:0@GZ#9S_GO0;#0]X TFT\O!R/LD.XGCH-F3WZ#
M'2KKNSR*Y$>X8P%'RGZ\XYZ<CI^5.#223HV(@P&!TV?B#QGIUK=T:B2?+>ZO
MI;1:;]MT0TU>Z:Y79WTU=O\ ,H?8-$WX_LFT\OT^R0[ORV9]^GOTH^P:)OQ_
M9-IY?I]DAW?ELS[]/?I5TF07)(\O?^&SI_WS_GUII>07&2$W_AY?3KW'^?J1
MSRJ1A-0F^5M73EHG?97[B_3<J?8-$WX_LFT\OT^R0[ORV9]^GOTH%AHGF ?V
M3:>7GI]DBW?]\[,_I[]*N*TC7.0J;O7Y?+Z9^GZ?XTLC213>81&6ST^7:>/0
M<?X_K6E-.K?V?OVWY=0OI?H4EL-$W$-I-H4[ 6D)(^HV<?Y[T+8:)N(;2;0I
MV M(21]1LX_SWJ_ )&D9T\O+9R& VCZ ]O3C^M";TE<YCW'.=P7;^&3C\OPX
MK9X>JN:\?A2D]>C[>8G))7;275]#%N8=&MCDZ3:LAX 2TAW8]QL)_IC\ZDM[
M71I5WOHUIM/3;9Q;_;/R?CR,_3FI[V296#1K$[$\AAE<'TZ]_P"F/?0@^TI
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MY,Y/Y?SIIL]$7#-I%D5/86D.1GG^[VK22-GD9 8@5SR1\O7MGCGKQ31&[NR
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MRYE;CN: /Z7SX(\.ZI8Q'5- T._EPI/]JZ587K!L'D?:89=K9XW Y%?S"_\
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MQW'^?PZTL?FB-PLT:J2VY2>6Y.<8P.?ITZYHC\P1L%FC5#G*$\G_ #]/SZ4
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M8-GEB?E/T&/Z]Z?^\\G'G1^7_P \\\_YS[=??FD8/Y* RH4W'"9.0>.?3OZ
M]>: "39Y2;4<-QEB?E/'8?Y_'K1)L\I-J.&XRQ/RGCL/\_CUI9/,,:AIHV08
MP@/(_P _3\NE$GF&-0TT;(,80'D?Y^GY=* $DV>4FU'#<98GY3QV'^?QZT2;
M/*3:CAN,L3\IX[#_ #^/6ED\PQJ&FC9!C" \C_/T_+I1)YAC4--&R#&$!Y'^
M?I^72@!DNW;'M1@<<[CD,?;IC]?K22E5V861,]=Q)W?[N/Q_2GRB0K%NEC8
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MC\S)_>9./YY_7I[<4G[SSL^='YG_ #TSQ_G'OT]N* $^3S_N/M_NY^;IZ_\
MUO;WHPGG_P"K?9_=_BZ>N/Z?KS2_O/.SYT?F?\],\?YQ[]/;BC]YYV?.C\S_
M )Z9X_SCWZ>W% "?)Y_W'V?W<_-T]<?T_P :(]GFON1V7G"@_,.>Y_S_ $IP
M\WSP?.C\S(_>9./YY_7I[<4D?F"1BLT:N<Y<G@^O^<G\>M "1[/-?<CLO.%!
M^8<]S_G^E$>SS7W([+SA0?F'/<_Y_I2Q^8)&*S1JYSER>#Z_YR?QZT1^8)&*
MS1JYSER>#Z_YR?QZT )'L\U]R.R\X4'YASW/^?Z4L0CW2YC<C/R[>"OU..?T
MXQQ1'Y@D8K-&KG.7)X/K_G)_'K2Q^:&EVSQJ2?F)/WN!TZ?J2?>C^M@&P[/G
MW([>FTXQUZ]>G^<T0[/GW([>FTXQUZ]>G^<TL/F#?LFC3/WLG[WTQC\/TQ1#
MY@W[)HTS][)^]],8_#],4 )#L^?<CMZ;3C'7KUZ?YS1#L^?<CMZ;3C'7KUZ?
MYS2P^8-^R:-,_>R?O?3&/P_3%$/F#?LFC3/WLG[WTQC\/TQ0 D83RGRCELM@
MC@#TR.?IUY]J(]GE/N1RW.&!^4<=Q_G\.M+'YHC<+-&JDMN4GEN3G&,#GZ=.
MN:(_,$;!9HU0YRA/)_S]/SZ4 )'L\I]R.6YPP/RCCN/\_AUHCV>4^Y'+<X8'
MY1QW'^?PZTL?F"-@LT:H<Y0GD_Y^GY]*(_,$;!9HU0YRA/)_S]/SZ4 ,7;Y+
M91BV>&!^4?48_KVIWR>1]Q]W][/R]?3_ .O[^U"A_)<"5 FX93)R3SSZ=O0G
MIS2_O/)QYT?E_P#////^<^W7WYH 3Y/(^X^[^]GY>OI_]?W]J/D\C[C[O[V?
MEZ^G_P!?W]J7]YY./.C\O_GGGG_.?;K[\T?O/)QYT?E_\\\\_P"<^W7WYH 3
MY/(^X^[^]GY>OI_]?W]J:VWR5PC!L\L3\I^@Q_7O3_WGDX\Z/R_^>>>?\Y]N
MOOS2,'\E 94*;CA,G(/'/IW] >O- !)L\I-J.&XRQ/RGCL/\_CUHDV>4FU'#
M<98GY3QV'^?QZTLGF&-0TT;(,80'D?Y^GY=*)/,,:AIHV08P@/(_S]/RZ4 )
M($\I,(X;C+$\'CMQ_7\^M$@C\I,1N&R,D\@^N!QS^/7UZTLGF&-0TT;(,80'
MD?Y^GY=*)/-,:!IHV4%=J@\KR,9SD<?3ITQ0 DP3Y-L;KZ[N<_3@?A_2B8)\
MFV-U]=W.?IP/P_I2S>8=F^:-\?=P?N_7.?Q_7-$WF'9OFC?'W<'[OUSG\?US
M0 DP3Y-L;KZ[N<_3@?A_2B8)\FU'7UW'.>G3@?Y]*6;S#LWS1OC[N#]WZYS^
M/ZYHF\P[-\T;X^[@_=^N<_C^N: "41[HL1N!GYMW);Z'''Z\9XI)-GFIM1U7
MC*D_,>>Q_P _TITGFEHMT\;$'Y2#]W@]>OZ$'WI)/,,BEIHV<8PX/ ]/\Y'X
M=: $DV>:FU'5>,J3\QY['_/]*)-GFIM1U7C*D_,>>Q_S_2ED\PR*6FC9QC#@
M\#T_SD?AUHD\PR*6FC9QC#@\#T_SD?AUH D&WSTVJRKQE6Y8_3I_D^_'\W?_
M  7;"?\ "I]:#([)]K7Y%SOQ]N3CZ_\ ZO>OZ1!O,Z%Y4D;L5.<?S_SVK^;S
M_@NUYG_"J-:*2QQO]L7YW.%_X_5_PX&>G?'% 'U1_P $+Q#_ ,,C:3B&8+Y<
MOR$G=_Q]R?\ U_S'!K]E3Y?G?ZMRG]SJW^?P_7FOQL_X(7^?_P ,CZ1FYB+[
M)/G!^4?Z6Y]>#Z<]:_98^8)R?.CWYQYF3CT_SS_A0 _R$W^9SLS_ *K/[SI_
MC[=*B&PS_P"KDV?W,X?ICKC^G^-.V3^=O\P;NOG<[.F.N?PZ^] \PS@^='YF
M?]9DX_GG]?\ "@!L>SS7W([+SA0?F'/<_P"?Z41[/-?<CLO.%!^8<]S_ )_I
M2Q^8)&*S1JYSER>#Z_YR?QZT1^8)&*S1JYSER>#Z_P"<G\>M "1[/-?<CLO.
M%!^8<]S_ )_I1'L\U]R.R\X4'YASW/\ G^E+'Y@D8K-&KG.7)X/K_G)_'K1'
MY@D8K-&KG.7)X/K_ )R?QZT +&(]TNZ-R,_+@X*_[W!S]>/I38=GS[D=O3:<
M8Z]>O3_.:='YH:7;/&I)^8D_>X'3I^I)]Z2'S!OV31IG[V3][Z8Q^'Z8H 2'
M9\^Y';TVG&.O7KT_SFB'9\^Y';TVG&.O7KT_SFEA\P;]DT:9^]D_>^F,?A^F
M*(?,&_9-&F?O9/WOIC'X?IB@!(=GS[D=O3:<8Z]>O3_.:(PGE/E'+9;!' 'I
MD<_3KS[4L/F#?LFC3/WLG[WTQC\/TQ1'YHC<+-&JDMN4GEN3G&,#GZ=.N: $
MCV>4^Y'+<X8'Y1QW'^?PZT1[/*?<CEN<,#\HX[C_ #^'6EC\P1L%FC5#G*$\
MG_/T_/I1'Y@C8+-&J'.4)Y/^?I^?2@!(]GE/N1RW.&!^4<=Q_G\.M-7;Y+91
MBV>&!^4?48_KVI\?F"-@LT:H<Y0GD_Y^GY]*10_DN!*@3<,IDY)YY].WH3TY
MH /D\C[C[O[V?EZ^G_U_?VH^3R/N/N_O9^7KZ?\ U_?VI?WGDX\Z/R_^>>>?
M\Y]NOOS1^\\G'G1^7_SSSS_G/MU]^: $^3R/N/N_O9^7KZ?_ %_?VH^3R/N/
MO_O9^7KZ?_7_ ,*7]YY./.C\O_GGGG_.?;K[\TA\SR"/.C\O!_=YY_P_3K[\
MT $FSRDVHX;C+$_*>.P_S^/6B39Y2;4<-QEB?E/'8?Y_'K2R>88U#31L@QA
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MVWRMR^?+7KW[Y'M^O\<_[2UU)_P]Z\2Q1(86_P"$WU0>=)D)_KYAG/\ ]?\
ME7]C?P+DFC\ :6S3)*_V&U^=#D',2=\_UH ]7CFD!\J569<XVXP_\OK^'6F8
MC$^/+?9D?)D[OS_SZ>]3I,DA)!"7'_/0GY?Y9Z>_\CB'][YV?.C\S/\ K,\8
M_P \?I[T ;LHA^QK^XFQDX&3D' Y)]#].?;/&%$$\QLQN5YPH/S#ZUNRM/\
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M%WG-LSC^YD_+_3\OPXH4KO.;ED']_!^;^GY?AQ0I7><W+(/[^#\W]/R_#B@
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M;\\_YZT "!3NS;-)^)^7\\?YZT(%.[-LTGXGY?SQ_GK0A4;LW+1_@?F_//\
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M$K/C[\-_C]K'Q&^+OQ/F\97=[=SW$]S)IWV82R2W(D9N(1U(+<GGUST^ZO\
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M5DR>1D_/P>../?G _6ARIVXN6D_ _+^6/\]*'*Y3%TS\\G!^3@\\<>W.1^M
M P7>,6S(/[F3\W]/S_'BA@N\8MF0?W,GYOZ?G^/%#%=XQ<LX_OX/R_T_/\>*
M&*[QBY9Q_?P?E_I^?X\4 #!=XQ;,@_N9/S?T_/\ 'BA@N\8MF0?W,GYOZ?G^
M/%#%=XQ<LX_OX/R_T_/\>*&*[QBY9Q_?P?E_I^?X\4 *0OFD?96QD_NLG/\
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M[#FV9S_?R?E_K^7X<T*5V'-RR'^Y@_-_7\OPYH4KL.;ED/\ <P?F_K^7X<T
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ME"!3NS;-)^)^7\\?YZT(5R^;IDYX.#\_ YYX]N,#]*$*C=FY:/\  _-^>?\
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MK03RBWS,-WE]01@]OYU\3?M7_!C_ (*;?MUQ:#HOQ _9EN_ NGV.HVUR\_\
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M&<2*#O//&?3- #8@=TV( YSR/[G'3@C]3GWIMOD^9B$2>N<_+U],?Y].Z1%
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M7 (\O,(CS_X]TZY)_P ]:>95C"A-\V1R9 ?E^G7FHIMI*E'E?/)# _+[+[T
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MB+C&W:5Y],X _P ^G=LWV?</+^T8[^;G/X;O\^O:F/Y/&WSO??\ TW?Y]>U
M$L@F,B%D0, NT KM/ (S@ ?7@_C1)YYE4LB!QC !7:?KP!^A_'I4;>3N7'G;
M<+G=G=T'W<_-UZ8_#FD;R=PV^=M[[OO?AGG\OPYH ED\\RJ61 XQ@ KM/UX
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M?7M0S1C&QK@?WMQ/Z;O\^O:@#Y7B\3_M4>3)YOA#35ERWEJ)[?!'\.?] [C
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MQ_P7L ^SGX+:(8AP)/\ A(;/?[GGPYG/;J/>OZK+EP)"'>7S,_+L8[?Y^O\
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M5,3SJ3?*Z\4D]+OF]EL_UUW/Y543_@O9([1O\%]%6-?NLOB"TW?B1X<R<_\
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MW[3V3S[;&<\?\N'XU]4[H]^-UQL],G?_ (_Y]* T7F 9N/+STRV_\OO?Y]*
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M?]JCSG\WPAIJQ<[&$]MD\\?\N'<<TL/B?]J??/YOA'357=^Y(GMOF&.I_P!
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M1]F_Y%#3?M']SS[;'7U^P>G-?5&Z/?C=<;/3)W_X_P"?2C='OQNN-GID[_\
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M$:#M_P"^OL/^>E 'X7_\1(?['O7=\2<^O_"O=;_^0*/^(D/]CW.=WQ)SZ_\
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M[3O?S[?(;L/^/#Z_G7U,K1[3N:XW=MI.W\<<?G^/%(&3826GWY&""=N.>O\
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MZ%SC! 7:/KU'ZC\.M-DV>:FU'5>,J3\QY['_ #_2B39YJ;4=5XRI/S'GL?\
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MW['1<9W;@O/KC./\^G=L.SY]R.WIM.,=>O7I_G-$.SY]R.WIM.,=>O7I_G-
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M^_M67L:B^SY[Q_S",XRORN_*[/1Z/[OR(/W_ )&[>GE_W<+O_P ?T_QH_?\
MD;MZ>7_=PN__ !_3_&D\M\>3]FFW_P!_'R>OKC]?TJQ]E/E;/*D\SUXV]<],
M_CG/O[4.A56\//>/EY^:*?NVOI=)KKH]MK^6FY7/G_9RV]/+Q]W"[_3Z_P#C
MO^-+)YXB4LZ%#C  7</KU/Z#\.E)Y;D>2+:;S#P'(^3U]?7W_2IWMB8U"12!
MQ]XG&.!Z$C'IU]N>M#H55O!ZV>\>OS\T#]VU]+I->CVV]5N0R>>(E+.A0XP
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MSA@?E''<?Y_#K0 H\_[.&WIY>/NX7?Z?7_QW_&E_?^1NWIY?]W"[_P#']/\
M&F_)Y'W'W_WL_+U]/_K_ .%'R>1]Q]W][/R]?3_Z_O[4 ._?^1NWIY?]W"[_
M /']/\:/W_D;MZ>7_=PN_P#Q_3_&F_)Y'W'W?WL_+U]/_K^_M1\GD?<?=_>S
M\O7T_P#K^_M0 ,9O(0EUV;CA0%W#IUYSCCT'U-.D\\1*6="AQ@ +N'UZG]!^
M'2HVV^2N$8-GEB?E/T&/Z]Z=)L\I-J.&XRQ/RGCL/\_CUH =)YXB4LZ%#C
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M=FYPR\+T],?AU]O>@!JF;R'(==FX94A=QZ].<XY]#]13OW_D;MZ>7_=PN_\
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MG+>_I^9SS]*(R1&P^SE\Y^?'W?U'\C^/2D7/DL/))^8?O,?=Z\=?;^Z?J.P
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M;VX&>>G\^:+<D>9B81_G\W7TS_GI38R1(Y\@OD-\F/N\$YZCI]3^-$)*[_\
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M01N/[OG*^_I^1SQ]:,GR=OV<_P#77'_U_P"G^-(V?)4>21\Q_>8^]TXZ^_\
M='U/< ?*3Y*9F#CCY.?EX_+\OPXHE),,>9@X&/W8SQQ_3Z_XTV0DQJ/LY3&/
MGQ][]3_(?ATHD),:C[.4QCY\?>_4_P A^'2@!TI/DH#,''&$YRO']/\ .>M$
MF?*C_>JW*_(!RON<\<=>OTILA)C4?9RF,?/C[WZG^0_#I1(28T'V<I@K\^/O
M<@8[]?H/PH =/G]W^]$GT'W>G7('3_\ 727&?W?[X/\ 3^'^7^?3NDQ+;/\
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M!S\G/S<?E^?X\4V,D1L/LY?.?GQ]W]1_(_CTHC)$;#[.7SGY\?=_4?R/X]*
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MF-]J,9(FM"-HB(.#ALX.T\<_RK^8'_@Y,G>7X=?#XSW#),?$&E[K;J$/E2\
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M?9J)<2G>SL%7J_S97'Y_Y_7^61?VWO\ @X= (7]C[X7 =\:7X@Q^/_%'T?\
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M0 C%=@Q<LY_N8/R_U_/\>:&*[!BY9S_<P?E_K^?X\TZ3S!&I:&-4.,,!R?\
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M/IV[_P ZT+.:*21=SM"V1A4P >>_.>>G3\J /XA/VF(;<?\ !73Q+(Q%N_\
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M_P"W\_7/;T]\T6P2=U07NV:WU;LI)IZ62O;Y VVK;)=$E;UVO=]>G8]?_=Y
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M >O;H/(Q]I3?_<\Q-OY[OZ>WO2A[?R<&Z3=_<$B;<]NK?AT]J\@_X0CQKO\
M,^TI]FSC'FOO],??]?\ /:C_ (0CQIYGF?:4^S9Z>:_F>G]_U_QS0!P/[5'B
MA?#GPLUV2[2V:VN-+U&-&9D)R(ESCWY'?Z=J_DR_X),+#>?\%&_B3J\+R!)]
M6U5T#Y6+Y]41@%).T@\]O>OZ;/VOOAEXPUWX5:HAOH(H+;3M1D42SE26\J/.
M<R#(XQ_DU_+K_P $H+?QA_PWWX^\/W']G+#::IJ:+/!@2$)J2*"7 R<]^3]<
M\T ?W+-J5ZKS)>FWM[0A@LPE0-C. 02PYQSUZUQ]A8:5'JT]Y%XENYV=F/V>
M2X0P*2>B@2$8'0>U<[JGA'5;U3;W^IJD*]/(N2LG'8_..W7^E<W)X$DTM?,L
M+VYGE;@9F9^3W.&)^OU% 'M:W[02MLN$D0G^*1.GX'GW_P#U4L]V#AX[M=[#
M++YBX!YX'S>G?^F*\5@\(>,'_>RWD0A;.Q?/<.,]-WS<?D/?FI4\&>,%,AEN
MXF1N8=D[Y"_[?S]<]O2@#V6#4)(?E-Q$RGJ3*N1T'8_C]<GVHGNE'S17@+-R
M09%QGT^\?_K5XS'X,\8)N^T7L!W?ZO9.W'^]ASSTXX^E+'X+\9+N\^\B;/W/
M+G8X_P![#]?\XH ]E@U"2'Y3<1,IZDRKD=!V/X_7)]J2XN5X,5XI+_>!D7 S
MG_:[?Y]O&H_!GC!-WVB]@.[_ %>R=N/][#GGIQQ]*1/!?C-0XEO82S#$)2=B
M ?\ II\_''_ZJ /:8=19!Y;W$14_Q>:N1G.<<_UZ<>]137(!Q#>*0>N9%[]?
MXC_GWKQQ/!GC!499;V S'_5E9VV^V?G(Z]>>._%*G@OQDJ,LEY$93]QDG;8,
M],_.>_7TH ]GAU%D'EO<1%3_ !>:N1G.<<_UZ<>]137(!Q#>*0>N9%[]?XC_
M )]Z\<3P9XP5&66]@,Q_U96=MOMGYR.O7GCOQ2IX+\9*C+)>1&4_<9)VV#/3
M/SGOU]* /:8M1)7RI+B,+C&\2+G&!_M?U]^*K37"_-&MTLD3*RLK2+AE8$,"
M,\@@D8]_3IX\/!?C'RO+-[!]J[GSW\OW_C QCO\ AUH_X0OQEY6S[9%]H_O^
M>WE?GOQT_P * /%/C+^PU\ /C?=SZEK_ ,,O!L?B"Y.6\51V<8UG<1R_G^<A
MW8R,^GTKR/P+_P $K?V6O .J1Z]K.B:=XD>*02BUU:W2YBR#E05^T$X7C;^
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M >P0M -^^Y1/3;(AW?7YAU_6B%H!OWW*)Z;9$.[Z_,.OZUX])X,\8/M^SWL
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M^7NYSNQM_#/'Y?AQ1#YGGOM\O=SG=C;^&>/R_#B@!D>SS7W.ZKSA@/F//?\
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MR&P!D9Y X]N1STH FB^T^2Q20!%SN#8W<<\9(/Z'\>E1+;R2(\N_&W.03\W
MSQQG_.>M(T)5@OFJ<]P_'X@8!_$<]*&A*L%\U3GN'X_$# /XCGI0!-%]I\EB
MD@"+G<&QNXYXR0?T/X]*A$+M&TV\_*P&"?FY].,_YYZT-"58+YJG/</Q^(&
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MGJF=K GV7TZ^WTIGDG9O\U?]W?\ -^?7]?;I0!(\<TLWEN_S>HX3IGW'^?H
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MX##/J1D_H/PJ%82S%?-48[E^/P!R!^ XZ4+"68KYJC:"<EL@X&> >/;@<=*
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M"H_).S?YJ_[N_P";\^OZ^W2D,)"!_-7DD;=YW#&._4]>A/;VH F@6X61DCD
M(SRV"IQQQG _S^3!#+/*RE\,,Y).%.#CC@C_ #]336A*J&\U3GL'Y_$C!/XG
MGK0T)50WFJ<]@_/XD8)_$\]: )8%N%D9(Y ",\M@J<<<9P/\_DP0RSRLI?##
M.23A3@XXX(_S]336A*J&\U3GL'Y_$C!/XGGK0T)50WFJ<]@_/XD8)_$\]: )
MH%N%,J1R ;"0V[!SQVSM_3/X5&D$DY<[\%>3N/7KTR/\_E3&A*A3YJG>,\.1
MCDCDCK]3_6E:$IC]ZIW>CXQ]<8_^M0!-;BXPXCD  Z[\'(]LD?Y].\:023ES
MOP5Y.X]>O3(_S^5-:$IC]ZIW>CXQ]<8_^M0T)3'[U3N]'QCZXQ_]:@"2'SPD
MH1\*H^;=@DC/\.2/3L#]/5BV\DB/+OQMSD$_-P,\<9_SGK2-"5*CSD.\XX?&
M.">0!S]#_6AH2K!?-4Y[A^/Q P#^(YZ4 31?:?)8I( BYW!L;N.>,D']#^/2
MHEMY)$>7?C;G()^;@9XXS_G/6D:$JP7S5.>X?C\0, _B.>E#0E6"^:ISW#\?
MB!@'\1STH FB^T^2Q20!%SN#8W<<\9(/Z'\>E0B%VC:;>?E8#!/S<^G&?\\]
M:&A*L%\U3GN'X_$# /XCGI08"'"><G()W;_E&,=L8/7J1V]J )_])\C=Y@\O
MIMXW^GKG/X?XU#]GD\KSM_&>F?GZX],_A^'2D\D[]GFK_O;_ )?RZ?I[]:/)
M._9YJ_[V_P"7\NGZ>_6@"?\ TGR-WF#R^FWC?Z>N<_A_C4!MY!%Y^_CTS\W7
MZ9_^MQTH\D[]GFK_ +V_Y?RZ?I[]:! 2XC\Y>3][?\OY=/T]^M $TOVGR5+R
M HV-H7&[GGG!)_0?ATJ)K>2-$EWYW8P ?FY&>>,_YSUI%A+,5\U1CN7X_ '(
M'X#CI0L)9BOFJ,=R_'X Y _ <=* )I?M/DJ7D!1L;0N-W//."3^@_#I436\D
M:)+OSNQ@ _-R,\\9_P YZTBPEF*^:HQW+\?@#D#\!QTH6$LQ7S5&.Y?C\ <@
M?@..E $TOVGR4WR HQ 4+@,,^I&3^@_"HW@D@*'?DMR-IZ=.N!_G\Z:L)9BO
MFJ-H)R6R#@9X!X]N!QTH2$OG]ZHQZOG/TR#^G6@":X%QA!)("#TV8&![X)_S
MZ]HW@D@*'?DMR-IZ=.N!_G\ZIRS6\&?/NXHB,X61SECZ+N!_SU[5%;70NWV*
MKJ,\,WW2/52?I0!JW N,()) 0>FS P/?!/\ GU[1F*6&5%5\LP4@@@J-WKCC
M]?R[5KSS+)HU='F\SH5RP7].U/F MS&LLJAY%5@I8[AN (&3C!_K0!JW']J+
M 6BGA#@?+\J CCCC/^?2N8BTRWO+@7.L&66X1OD,<C(HQC'"D]_P[?30CD@\
MY(Y9E4-CY6<Y/.#W/]*EN+2Y^UQ&V<?925WX/;//)/ITS0!\H?MV?&[Q#^S_
M /LW^-?B'X)N38ZSH>DZA<VEPZO($>WM&EC)  )PP_I7\I'[-_\ P4._X*X?
MM>VGBN^^$WQ+M;:+3-3O;2T9]%:<1K$ 4&9-1M1QN'7L:_H^_P""NPEB_8O^
M)R0W<"*?#^K[HR1N)^P/GIZC_/-?DA_P;1V]C)\-/B \\5B\G]O:G^\G@A?D
M11<Y=2?3G/XT <)IUU_P<$RVH>Y^-FDF0C//AVV';/0^).HR/ZU=\_\ X. ]
MO_):](^O_"/6F/R_X23'M7]9+6\(C#!=+D7T2V@SC/'1>W'Z#O1'#;A=\MO8
MM'G[BV\._P!OX?7_ #Z '\FWG_\ !P'M_P"2UZ1]?^$>M,?E_P ))CVH\[_@
MX#V_\EKTCUS_ ,(]:8_]2/&>U?UDR0VY7?%;V*QY^XUO#O\ ?^'U_P ^I'#;
M!=\MO8M'GE%MX=_X?+Z_Y] #^/7QQX4_X+P?$?3Y/#'B#XPZ9-8S))#.J:#;
M1AHIP%D&[_A(\'[H]:^D?^"5'_!-#]H?X!_&?5/B[\:]4AU35M7::XO;B&W@
MA,DLUPL\A CU&\.2P)Z'VXK^H*ZBTMK4-;65DDIW 9MH-P( P3\G3]?P%86F
MC6+.Z>2ZN+-[-R=D,$4:NH)XSM]O;U_$ G^S:/J-S<((+CSU#'<7<*6SC(!4
M#K]1]>*YO38-2LM6G1@PM59@@D4L,;L#DXR<?6NMNQ=*WG6$T,;.06! +#/.
M,#%2,UR\*FYF@=SUV *<^^.?_K9H :D;W+MAPO?!( _+GG_Z]2P+<*94CD V
M$AMV#GCMG;^F?PJ P[5#>:ASV#\C\L'\SSUH:$J%/FJ=XSPY&.2.2.OU/]:
M'I!).7._!7D[CUZ],C_/Y5);BXPXCD  Z[\'(]LD?Y].\+0E,?O5.[T?&/KC
M'_UJ&A*8_>J=WH^,?7&/_K4 .2"2<N=^"O)W'KUZ9'^?RIT/GA)0CX51\V[!
M)&?X<D>G8'Z>L;0E,?O5.[T?&/KC'_UJ&A*E1YR'><</C'!/( Y^A_K0 JV\
MDB/+OQMSD$_-P,\<9_SGK4L7VGR6*2 (N=P;&[CGC)!_0_CTJ%H2K!?-4Y[A
M^/Q P#^(YZ4-"58+YJG/</Q^(& ?Q'/2@!5MY)$>7?C;G()^;@9XXS_G/6I8
MOM/DL4D 1<[@V-W'/&2#^A_'I4+0E6"^:ISW#\?B!@'\1STH:$JP7S5.>X?C
M\0, _B.>E  +>0Q>?OX],_-U^F?_ *W'2I_])\C=Y@\OIMXW^GKG/X?XU 8"
M',?G+P?O;_E_+I^GOUH\D[]GFK_O;_E_+I^GOUH 7[/)Y7G;^,],_/UQZ9_#
M\.E3?Z3Y&[S!Y?3;QO\ 3USG\/\ &H/)._9YJ_[V_P"7\NGZ>_6CR3OV>:O^
M]O\ E_+I^GOUH #;R"+S]_'IGYNOTS_];CI4TOVGR5+R HV-H7&[GGG!)_0?
MATJ$0$N(_.7D_>W_ "_ET_3WZT+"68KYJC'<OQ^ .0/P''2@!6MY(T27?G=C
M !^;D9YXS_G/6I9?M/DJ7D!1L;0N-W//."3^@_#I4*PEF*^:HQW+\?@#D#\!
MQTH6$LQ7S5&.Y?C\ <@?@..E "M;R1HDN_.[& #\W(SSQG_.>M/F\\I$'?*L
M/EVX! S_ !8)]>X'T](UA+,5\U1CN7X_ '('X#CI0L)8L/.0;#CE\YX!X!''
MT']* '/!) 4._);D;3TZ=<#_ #^=27 N,()) 0>FS P/?!/^?7M"L)?/[U1M
M]7SGZ9S_ /7H6$OG]ZHV^KYS],Y_^O0 YX)("AWY+<C:>G3K@?Y_.I+@7&$$
MD@(/39@8'O@G_/KVA6$OG]ZHV^KYS],Y_P#KT+"7S^]4;?5\Y^F<_P#UZ '&
M*6&5%5\LP4@@@J-WKCC]?R[/G6X:14DD!)QRN HSQSC(_P _G"L)92WFH-I(
MP7R3@XX)&??@\=:582REO-48[%^?P)R1^!XZT .,,L$JJ'RQQ@@Y49..> /\
M_0T^=;AI%220$G'*X"C/'.,C_/YQ+"64MYJC'8OS^!.2/P/'6A82REO-48[%
M^?P)R1^!XZT 2+#-#.J)(-[+D'(*_P @,_B/QH>.:6;RW?YO4<)TS[C_ #]
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M:1S13>6C_-ZGE.F?8?Y^H/D7P>^*3?%[PG:^*)/#&L>$998H_,TW7(&M;Q9
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M\_E4D7VGR7V2 (I(8-@L<>A.#^A_&H6A*8_>J=WH^,?7&/\ ZU#0E6"^:IW
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M#%%_PF^I_P"L';SY\=2/;_&O[&_@2CS> =+62:)F^PVV74_)GRT^O?W_ ,:
M/6?)C!,P.80<[%;Y_P#'KSTJOOA\W=L?R\_=YW9_+^GMUJ58IHI2%D '_/0\
MQ_Y_SZY0F7SA^^BW9^_QMZ?Y'^'8 V97MOL2GRY=O.!\VX'"YSQ[CMCKC%84
M;1!V+(Y0YV@9W#Z\$_I_A702&;[&O[^$-SEL#:>%Z?K^8K#B,N]L31*W.6.-
MIY[?Y_#T &(T0D8LKE#G &=PY[X!/Z#\.E"-$)&+*Y0YP!G<.>^ 3^@_#I4B
M&7S&Q-$K=V.-I^G_ .O\^M"&7S&Q-$K=V.-I^G_Z_P ^M $:-$)&+*Y0YP!G
M<.>^ 3^@_#I2QO"&DW)(03\NW.1_O8!YY[@?2GH9?,;$T2MW8XVGZ?\ Z_SZ
MT1F7=+B:('/S$X(;@?=Z8^G/UH CB:)=^]7;/W=N>/3. ?\ /K5=@VX[3@9X
M!Z_RJY$9?GVS1+Z[L'/TZ=?\XJDX&]L@DY.2,X/TYH N3^7N&VU,(XX+?>_+
M/^?QIC[!MQ;F/_@7WORS_GI4UV6++F<3<_>';ISS_GUIMP2?+S,)/S^7IZX_
MSUH C?9O7%N5&!E-WWN!D\<<_7ZT-LWC%N4']S=][^GY_CQ4DI/G1YF#G"_/
MS\OMR,\=/Y<T2D^<F9@YX^?GY>?S_+\.: (VV;QBW*#^YN^]_3\_QXH;9O&+
M<H/[F[[W]/S_ !XJ24GSDS,'/'S\_+S^?Y?AS1*3YR9F#GCY^?EY_/\ +\.:
M (VV;QBW*#^YN^]_3\_QXI3L\TC[.<9_U6[_ "/U_6GRD^<F9@YX^?GY>?S_
M "_#FC)^TY\X9_YZ\XZ?G^GZ4 1_)YF/LYQ_SRW<_P"'Z_K1\GF8^SG'_/+=
MS_A^OZU)D_:<^<,_\]><=/S_ $_2C)^TY\X9_P">O..GY_I^E $?R>9C[.<?
M\\MW/^'Z_K4,\-M.X2>W^4?<0MRI.>>A]/7M5K)^TY\X9_YZ\XZ?G^GZ53OI
M)HY%>&-KULC=LS\H]^1[^G]* /G/]H_XL:C\(/"=Q=VL9NXKJ!HHH0<>7O0E
M3G*=,5^1/P.\(^,_V@/BU?ZQ>^)GM+&2ZDN4L"C$*#,"$W?/G ./YD5^TOQR
M^$UG\7?!MSIUQ.MI=16K&%'&YA(L9"@ H_<_UK\$]"D^.G['OQ7U?7+O2]4U
MGPBEU/Y!$#10+;^=N4AP\? 0?E[4 ?T1>"/#Z^$M'M=!EM7F:UC2(798@.R*
M%W8]\9(QVYJ?Q/8RK:R"Y@.HVUTIB$"DJ8PX/)/';KW_ !K\O_#'_!5OX9^*
M?*TO4[G3M"U6':+I+B[.]"O#!E\QL8;@\]O2O0?%O_!3_P"!'AG0P8O$FAZ]
MJ8C 6RBO2)1)C@8W#D'CWH ^9?VS/@;'\/\ Q-H_Q%T"]?3Y+R--2N+,.S'>
MDSKMX5<G;$/XCU]:^V?V*OVB-1^*FBKH<\9B.D0QP^:26WD+MSRS==GI7Y2?
M$+XU_&[]MOQGI]KX)\)ZMI_@RSFCL7N;>/[1;7%N9!(\@<S/@8E(^[_"<C-?
MLU^S/^S=I'P?\/V%W:S+9ZK=P1-J*OP[2[<N&&Q<'<6[T ?4=Q;KJ$X^TIYH
M1OO9VXY[_P"/.#WK3DCLHH@L-MYI ZY/R_Y_'-22)#%$3;7*[P/G4?\ +0^W
M3W_/Z5F6US-(9%:$V..-S_\ +3KR.O\ GM0 Y-FU\P%SC@[ON'(]>?RR:%V;
M#FW+G^_N^[_7\OPYIT1.V;$H3(Y'/S^W''OS@4Z(GR7Q,$'/R<_-Q^7Y_CQ0
M!&NS8<VY<_W]WW?Z_E^'-"[-AS;ES_?W?=_K^7X<U)$3Y+XF"#GY.?FX_+\_
MQXHB)\E\3!!S\G/S<?E^?X\4 1KLV'-N7/\ ?W?=_K^7X<T@V>6W[@DY&)-W
M3KQZ_D,>M2Q$^2^)@@Y^3GYN/R_/\>*:N?L[_O0!N&8^[>^/\]: &_)Y>?LY
MS_SUW<?X_I^E'R>7G[.<_P#/7=Q_C^GZ5)D_9L><,?\ /+G/7\OU_6C)^S8\
MX8_YY<YZ_E_G/6@"/Y/+S]G.?^>N[C_']/TI#L\HG[.<X_UNX_\ Z_T_2I<G
M[-CSAC_GESGK^7Z_K2%C]F/[X8_YY<YZ^F,?YS0!+'Y?EG%N5/\ >W'YN/;U
M]_YU_*9_P<J^7_PK_P  8M"A_P"$ATS,NX<_NI??/O\ A7]6RDF)?WP<87Y.
M<K_^K].G2OY3_P#@Y69O^%>>  ;M7'_"0:9^Z&<K^ZE]NW^><4 ?LC_P25W?
M\,3?"[;,(?\ B0:/R0>?] 7T!/Y?CQ7Z'R9\PY;>>?FYY_/UZ_A]:_.S_@DS
MC_AB;X6Y@,W_ !(-(Z=O]!3W'J?SK]$G^_PNS!.%_NXX[>G]?I0!,^S"8@*>
MIW??Y/IG]>?2A]@VXMS'_P "^]^6?\]*=,25AS*'XX'/R?GCZ\<4ZX)/EYF$
MGY_+T]<?YZT 1OL&W%N8_P#@7WORS_GI0^P;<6YC_P"!?>_+/^>E27!)\O,P
MD_/Y>GKC_/6BX)/EYF$GY_+T]<?YZT 1OL&W%N8_^!?>_+/^>E#[-ZXMRHP,
MIN^]P,GCCGZ_6I+@D^7F82?G\O3UQ_GK1*3YT>9@YPOS\_+[<C/'3^7- $;;
M-XQ;E!_<W?>_I^?X\4-LWC%N4']S=][^GY_CQ4DI/G)F8.>/GY^7G\_R_#FB
M4GSDS,'/'S\_+S^?Y?AS0!&VS>,6Y0?W-WWOZ?G^/%*=GF+_ *,0,',>[KTY
M]/S.:?*3YR9F#GCY^?EY_/\ +\.:>Q;[0A\\$[3^\YPOMZ_D,<?6@"#Y/,Q]
MG./^>6[G_#]?UI#L\P?Z.<9_U6[G_/\ D]ZER?M.?.&?^>O..GY_I^E&3]IS
MYPS_ ,]><=/S_3]* &3("OW#M_Y]^_Y\\=_YCK5<1LPV-'MB_P">1/)SUYZ>
M_;'(^EAV99RPF#-_STY].G;J./\ /,JL96PTH!SR_IQ[_P#Z\UYL\H53&T\=
M3BN>FU.5]'&UGS1UUU2M^!O1E&*GSMI-^ZXI)J5EHTMU;K+?\H(5B3Y! 7 .
M0F3\OOD^O'KT_$I*H<J'0R(#D1#JO<<_[/(/?FK"(RSL%FP,#]YC(8>G&?\
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MJIYR,$\_3\5-@]K,(K2]$=NQ&]0<CG@Y.?3V/% &G<8YW1F9LC_2 < ^^/\
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M?UJ=BWVA#YX)VG]YSA?;U_(8X^M,R?M.?.&?^>O..GY_I^E $?R>9C[.<?\
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MF4Q;%.>1N^_P?3C\\"I+@D^7F82?G\O3UQ_GK3I2Q:',X?!X//R>_//MQDT
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M3<H)14H?;36FEFMU?[C]^_A?^W!^QGX/\#:/;CXP^'(YHK*,7$NV^."(U!)
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ME//.?TK\OOB;^R/_ ,%#/&5Y<3?#W]N!/"EM([F& :+Y_E D[5SMYV\#CO\
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M$0H3"$''S\_-Q^7Y?AQ1*"(4)A"#CY^?FX_+\OPXJ-MFP8N"Y_N;?N_U_/\
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M2@B%"80@X^?GYN/R_+\.*C;9L&+@N?[FW[O]?S_'FAMFP8N"Y_N;?N_U_/\
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M-GR1C_GKSGK^7Z?K40V>6W[\@Y&(]O7KSZ_D<>M+\GEX^T'/_/+;Q_C^OZ4
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MX$(8\_N^R_EZ?_KYK6E*?8D_TM@.?GQUX7C\/ZUB)LW'-P4'/S[>6_S^?ZT
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MLBS6ZI;@I(=J2V\/'[QN_P#*OV<^$OPT\'?!'0M/L;BR%IK$\,:3"UA+XE
M/SJS?Q$\D?G7Y$P_\%+?BO-!%_PB_P ']3T@E?W@B\)WEHH8$Y)$>F1CI@<U
MTVF?\%*OBQID;7/BCX;:I<I'AMZ>'[N3RP!DY+Z>VWW/% '[M:?:8A-W-?3B
MWE = \@4[,9P$Z]"!CK^5$-S:S,\=EB5@2&:8!<'V+<?Y]Z_-#]GO]OKPO\
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MI%$P[[N,=^.OKQZ5&)=F]#&AW<$X^[SVY]B!66^N:%!M\W4[?]Y]SR[J+O\
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M02RZE;&-\;0+F%GY'&X;B>GU_K2MKFA1(LKZG;B-\;0EU$'&1QD*V1Q]?ZT
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M[O[I&%[?7U_+BE=VBE#/%'N!SL RO?OQZ?EQ60-;T$1^>-2MQ#Z"YB$G7T#
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M@"_/=WQGACM(8C$6PV<#<N#][KWQZ=*LRET96DBB5N/E49!/'OCN*QDUS0)
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M=QC;C;^../S_ !XIDFSS4VHZKQE2?F//8_Y_I1)L\U-J.J\94GYCSV/^?Z4
M/F\SSTW>7NXQMQM_'''Y_CQ066.Y+W"HP!.54*4Z'L 1TSV]?P9)L\U-J.J\
M94GYCSV/^?Z4UC"LV71A%_<;ENGX9_+_ !H H75\)[GR-/C,4A.-S+MC_D!T
M_45>B\/ML^UW=S^_QG_68CZ?[P'MT_6FN$D?_1H\#/&!\WYX/3_]7:K;VD\E
MMB[9OL^/N!B'[8Y'OCMV_  %+^V"CFQ$2W P1G8LB8[\X(/'''O7/W.F^#VO
M6N-1\-6UW=L!\\FFPR*I&2""T1(.3GC!K>@2.V;%G'QZ-AF_4?A_+K6M#<2;
MB9Q%(6P/*5$,B]!R/3W_ !Z<4 <C?6'A&6QFFU.QTR+3K:)I/L\L%NBA$ ^4
M1NH7@<8 P..!7Y<_M#?MO_ 7X;WESX>\,_#G1];UVUD:"0_V!87JM(A*$_)8
MS,<N/R^M?87[6>E>*G\(SS>#YI;*9X6\_!=?D,9+<*Z8[=*_(#]G#P#\+]9^
M+=\?BC+:WNJBZD+B[G5P9O/&<I,LH^]G(_#.* (S^W5XTQ_:.G? ?19+*8!H
MS_PA"'*MR.?[)QT'^>E5G_;Y\8VY$]]^SII4L6<L\?P^5CCJ3N_L4C/'7]:_
M?KP[\-_ K:+;6^C:'H$NE1(GV;&F:?(VP*-GSFW&?E[8K;/@O0/*DLW\->'D
MMMI5VDT33?NX.3N-MQGK0!^5_P"S3^VE\&/BG-+H_C7X::#X5U,70MO+O_#F
MGZ9N)5""JW%C;L1E\9'<8&#7Z&ZE\//A-K?A^>/2_"WAZY75H"(98M+L)1&'
M0X(98FVXWCD$=/:ORI_X* _"_P"$>@>*M U/P[8B'Q)+#'-*=#E6TC2Z\^0+
MYD5JD0SA4R">F!SV^OOV(=0\;WNA1P>([B2YL(H(ULTGW-(D>W@%I&<DXVCG
MF@#Q2_\ ^"?>O:=XUA\5>$=0L=+M6O/M4EM',+7*[]X7RXIHQT[;?IZ5^FWA
M72[K2=!T[2]2$3S6<*122H,EBJJI(8]>0>Y'Z5M:G$5F!>UNGPW!CW!1SW[?
MI^-:<,HFA"S1,P"C&, CTSP3[^M %61I(WC>RACF13^\,Z!RHP?N$[L$''(]
M3ZUGW>C0:C<I?2W!22/'^CK)B,X/0Q[@",\8V_TK=MIO*CG41[MRD [1\O/4
M\=>/;_"B+2W=C<-'*9E.596(0$=,C\?QZ4 ><_%_X3>&OC=\/]6^'/B"]U30
M+'6+6:TEU'0)GL=0B6>,Q-)#<0R02*R@Y5ED!!YSFOPSUK]B_P#X*7_LB:K?
M:/\ L#>./!WBOPEJMS)<SO\ &;6I]3U&)IFVLD)NKRZ95"JNT C!SC%?T/AQ
M)&3)&S.OW77 QQQGC/'U_&J8M8';[0RS-,ARK*Y"@CD9'L?\.U '\Y&K_ K_
M (+>?M$6,OPP_:CN/@-%\(]?4VGB-_";JNLBQN1Y-U]E/F)^\\DG9\X^;TK]
M8OV%/V%_AK^P=\-M:\(_#&]U"[N_%5S8ZEKHU>4/B_MDN-WV8&>8^5NN'[CM
M7W$LI="[H[NG",#\H';(]CU]:J&-'?[6RR&X3Y4D#$(%.,Y7N>!^OO@ ^1OV
MO?V6?"/[8?PSOOAK\5)KVWT*XC;:VBG9<^8K^=%_RUB./,"@_-]W/TK\;_#7
M[*/_  5@_9!MW^&O[!UW\'9_A+;R2?8/^%B2(VMF-G,O[P&60YWGUZ?E7]*9
M<&/S#$3+T\P@%<>N"/3_ #BJH@B4_:ECD$^?OAB$QT^Z.,8[?C[T ?S@ZU^R
M-_P5B_;)C3X9?MWZA\&;/X2W$B?;W\ S1QZSY:.)CY9\Z(YWK_>Z5^O'[*_[
M)?PZ_9(^'5I\'OA[>ZO/H$,85I[J7?=>9(WFR8999#@2L<?/TQVK[ N;&VNU
M,TR3&7^^)&"_E_G\L4EOI]I:+Y\,#^>.DK'</QS_ )^E 'R)\?/V6;7]H_2#
MX5\:^*=:T;1(QL@E\+ZE/::BRA=BB5H+F%SP<G+?>Q7\?O\ P6]_X)H_#?\
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M_P!W,H'TY_6O6XQ'YK!HW91]U03N'ID]ZE$OF%HY(V:,!MJKPR_W22.N._\
MA0!X^GP1\/2Y_P")SK)V?W[R0_@/WH_K0GP1\/2YSK&MC9_STNI?_'<RK7KD
M 3+%HW8K]W:<8^M2++YH82HSA1\NSC;]: /'T^"/AZ7/_$YUD[/[]Y(?P'[T
M?UH3X(^'I<YUC6QL_P">EU+_ ..YE6O7( F6+1NQ7[NTXQ]:D67S0PE1G"CY
M=G&WZT >/K\$?#SJSC6-:^3(PUW(7X_NXE_+B@?!'P\ZM(=8UKY?[]W*'_#,
MH_#BO78MBH[^6Y<$[6!PH],CGIW]:=O$T;-*C,P^ZR\*..X'^30!Y OP1\/2
M*9!K.M';ZW<A?C^[^]_+CK0/@CX>=6D.L:U\O]^[E#_AF4?AQ7KL)149_+=G
M&=K _*/J*=O$T;-*C,P^ZR\*..X'^30!Y OP1\/2*9!K.M';ZW<A?C^[^]_+
MCK2#X)>'O+\XZQK0SZW<HD_64?RZ5Z]"45&?RW9QG:P/RCZBAF$D.]XW\W^^
M#\GY#_/?I0!Y%_PI'P]L\T:QK1^EW*9.OM*?Y=*/^%(^'MGFG6-:'UNY1)U]
MY1_+I7KR,L<6]8W\S^^3\G7T_P ^M :*Y&&.V;^_NPO7/ 'J/?\ K0!Y#_PI
M'P]L\T:QK1^EW*9.OM*?Y=*/^%)>'P@E_MC6QN)'_'W*'X_O?O<X_#^M>P';
M:KD(S2?\],YCY/7G/0&J%]8ZMJ,4<FFWD,,N[]XK_P!S@C ##W']>* /+F^"
M'A]%5QJ^MY;'W+J4OR.^)3_*GGX&:$B+)_:NN?-_=NI=_?[W[T^GI7YX?\%0
M_P#@H!=?L#_#[3-?>TU&^U/4I8;:(Z?$TVZ>:-G7"A6X)7V_6OS"^'__  4?
M_P""A/QJ\*:?X[^'OA?Q;_PCVK017-DW]@R/F*=/,CPWG)GY2.P[4 ?TF-\#
M="C59/[5UP;_ .[=2[^1_%^]/\A0?@9H2(LG]JZY\W]VZEW]_O?O3Z>E?SG2
M_MK_ /!4:-_+_P"$.\8R;3R1X>?!QQ_S\>_K_P#7TX_VV/\ @IW=1^7%X+\9
M0RJ!EW\/28..#C$_KZ4 ?T.M\#M"C"'^U=='F#(VW4N>>,-^]//Y?3I2O\#-
M"BV_\377/G&?W=U+[?>_>GU[XK^<]_VV/^"HL<VQO!WC*18SAB/#SG/T_P!(
M^OK]#FM,_MJ_\%/+N/-OX-\8P,H^;?X>DR?IB?\ ^M0!_0[)\#="AQ_Q-=<^
M?^Y=2_DW[TT/\#-"BV_\377/G&?W=U+[?>_>GU[XK^<X_MM?\%15E /@SQDZ
MJ><>'7.1GM_I'M[_ $-:A_;5_P""GEW'FW\&^,8&4?-O\/29/TQ/_P#6H _H
M=?X&:%$R+_:NM_O#CY;J;&<$_/\ O3Z>H_E2M\#-"C<1_P!JZY\V/NW,NSDX
MY_>G\>17\YP_;;_X*AI.OF>#/&4D:'+8\//R.G'[_P!OP_EI2?MI_P#!3ZXC
M\ZW\'^,857[R/X>DW$CD_P#+?O[T ?T/-\#="C81_P!JZY\V/NW4NPY]?WIZ
M=^>GO2M\#-"C<1_VKKGS8^[<R[.3CG]Z?QY%?SFI^VY_P5#64-)X+\9O&I&0
M/#K\@<\?Z1^N/RZUIR?MI_\ !3ZXC\ZW\'^,857[R/X>DW$CD_\ +?O[T ?T
M/-\#="C81_VKKGS8^[=2[#GU_>GIWYZ>]*?@7H2R+#_:NM_,">+F7R^/7][U
M_&OYS4_;<_X*AK*&D\%^,WC4C('AU^0.>/\ 2/UQ^76M&;]M3_@I]-&+BW\'
M>,8E3Y6C;P])N).?6XZ<?RH _H@_X4;H6_R?[5USKC_CZE\OZ_ZW^O7VI?\
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M^Y=RE_QQ*?QXKUR5A)&KLC"0D@OGY2.V!V_^O]*?O$,:M$C*Q^\S<J>.P/\
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M:-8UH_2[E,G7VE/\NE>O.RR1;VC?S/[X/R=?3_/K0C+'%O6-_,_OD_)U]/\
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MW([+SA0?F'/<_P"?Z4 /A\SSWV^7NYSNQM_#/'Y?AQ3H?,WS;?+SGYMVW'_
M<\=/[O%11[/-?<CLO.%!^8<]S_G^E.C$>Z7=&Y&?EP<%?][@Y^O'TH 6W\S]
MYM\OWWX_'&[_ #Z]JH28WG=G.>=NW'Z5<AV?/N1V]-IQCKUZ]/\ .:J-G<<$
M*/0D9'Z4 7[H2EU\R>*4]BIX'USG\?\ .&3>8=F^:-\?=P?N_7.?Q_7-+.JA
MAMLW@Z?*2?F_+/\ GIWICA1MQ;-'^)^;\L_YZ4 .D$GF(6FC9@%VL"<+P,9R
M2>/J.>F*)/,,BEIHV<8PX/ ]/\Y'X=::X7>N+9D&%^3/WN!SQQSUZ_7BA@N\
M8MF0?W,GYOZ?G^/% #I/,,BEIHV<8PX/ ]/\Y'X=:)/,,BEIHV<8PX/ ]/\
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MGZ4 *P?R4!E0IN.$R<@\<^G?T!Z\TLGF&-0TT;(,80'D?Y^GY=*:0OEJ?L[
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MK3\'[3CR1G_GESCI^?Z_I1@_:<>2,_\ /+G'3\_U_2@!F5\S/VEL?\]<'/\
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MP!UH ["PDMISYEEJ,EW#.<@;0  ?_P!?Z?2MLV%M9)YB7!A>0$D(!\Q]#_\
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MD?51ZCCOV'\Y7P)_X+U?LE?%;]H/3_A5X=^&>B0Z[<:Y'IB7\<SF5)FN?)#
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M?S=/7/\ GK0 QRIVXN6D_ _+^6/\]*'*G;BY:3\#\OY8_P ]*?< CR\PB/\
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ME #,KYF?M+8_YZX.?\/T_6C*^9G[2V/^>N#G_#]/UI^#]IQY(S_SRYQT_/\
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M!CE3MQ<M)^!^7\L?YZ4.5RF+IGYY.#\G!YXX]N<C]:?< CR\PB/\_FZ>N?\
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MS<L@_OX/S?T_+\.*$*Y?-TR<\'!^?@<\\>W&!^E/B!\YP(0YY^3GY>?S_/\
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MA*^41]I;.#^ZP<?X_K^E28/V;/DC'_/7G/7\OT_6@@_9L^2,?\]?Q_+]/UH
M8Q78,7+.?[F#\O\ 7\_QYH8KL&+EG/\ <P?E_K^?X\T^4$0H3"$''S\_-Q^7
MY?AQ1*"(4)A"#CY^?FX_+\OPXH 8Q78,7+.?[F#\O]?S_'FABNP8N6<_W,'Y
M?Z_G^/-/E!$*$PA!Q\_/S<?E^7X<42@B%"80@X^?GYN/R_+\.* &.5V+BY9S
ME?DP?EY'/'/'7^?-#E3MQ<M)^!^7\L?YZ4^4'R8\PA1E</\ WO0<\<_3Z47
M(\O,(C_/YNGKG_/6@!CE3MQ<M)^!^7\L?YZ4.5.W%RTGX'Y?RQ_GI3[@$>7F
M$1_G\W3US_GK1< CR\PB/\_FZ>N?\]: &.5.W%RTGX'Y?RQ_GI0Y7>N+EG&%
M^?'W>!QQQQTZ?7BGW (\O,(C_/YNGKG_ #UHE#>='F$*<+A.?F]#R<\_7Z4
M,8KO&+EG']_!^7^GY_CQ0Q7>,7+./[^#\O\ 3\_QXI\H/G(#"$/'R<_-S^?Y
M?AS1*#YR PA#Q\G/S<_G^7X<T 1R;&8 W!D7NY'W?\_IUK5LHU5U\J(3C(RY
M.-N3^73';Z5F7*,SJ@B$;'&%&><_CW__ %<U<LX_)D42S&)C@A,=?Q///MG^
MI /X@OVF)KD?\%>/$JE3;0_\)OJG^D+R0/M$W-?V,_ EROP^TMHKEY_]!MOW
MIX)_=)G_ #VQ7\=?[2MY&?\ @KSXEMU N)/^$WU3]R< ?Z^?C.1_D>_']C/P
M*<Q> =++VXB/V&V_=]0/W:=_?KU]N] 'JZW*N")/D?\ Y[X.[^?^?RS!E?,S
M]I;&[_6X.?\ /;_.*M*(9'\Q,,_7R<$#./S[YJ'#?:,>0-W_ #RSQ_GO_P#6
MH V)67[$O^EL!D_/CD\+Q_GUK$C*[CFY9!S\^#EN?Z_G^M='('^R#_1%SSE,
M]!@<^OZ\8Y[U@0@^<X$(8\_N^R_EZ?\ Z^: &*5WG-RR#^_@_-_3\OPXH4KO
M.;ED']_!^;^GY?AQ3X@?.<"$.>?DY^7G\_S_ !YHB!\YP(0YY^3GY>?S_/\
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M.1P5QR>F*_EJ_P"#E.WMX_AG\.S!$A7^W]*Q*4P[?NI.IQD^O)^O>@#]B/\
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ML>:JGF,7_<C).3S?1_R..O>OVLA-]I\.Q$9[C(^4_,#UY!(/.#C@8YK\5/\
M@NK;)/\ LBZK<ZL7B.(B5&<#_3(^PP.O3C].:^]\-\HJ4^/^&9+%QE2>:X:G
M345[[FYI<R7,_=MI>UKG!B)/]]R3<Y.#<HN5J<5[O7:_E^772_X(/P3G]@CP
M[+:/%-<GQ;K DC:9<@?9=.QE<Y Z]< _F*_9^.XNK?']HQK; \;HN2>GI]/Q
MQ[5^&'_!!^"PMOV/-(GM+J\:-O%&IC8?.$0(M[(G W%><CMSQ7[KW#)<1@VI
M$DG&5DXQQCC.?RQUYQQ6'C3EF88?C#/E@ZTZE;#YOBJOMO8M24I33<)IR?M(
MK96Y;VVU*52M3=!I>TO0I*[J<L'[L=(OEM)KU^70L(+>11+YDA5NC$D$YQQ_
M];//;M2JBH<LY5#G:5Y+'MGO]?KZU D\S1B&5%4J,' 7T]AW^G?Z9C&Z$[AN
M;)Q\P[>Q88)^E?$X)XMY7*>,JU*M>WO6I\C?P_#&]UOYG;:HG!JTG+62E))1
M3ML[?U;6Y++;L^&,I5">&5AECG@$9[CO^?O8AC&,-*ZGM@]3[Y[^^?KV-5,H
M^&C9S)GYE(.WWQSCN>W]*&E52!\W?.5((/'3Z]_U/:IHXY5\!)N:YXR<+327
MP\JM>Z=^][O\3MC%>ZJD6H*[7*U>[:NK6][Y6[EO8%R)7\HM]TQD$MG^]S_G
M)IB1>5GS963?]W;@YSZ]*K2"(#,;.S'J&SCVZL?TJ,9R-Q;'?<#[=.GXUC2?
M-3C*RN[IM;.UO7OWMV,K6T6RV^?^9=2+RL^;(R;_ +FWG=GN>:%A*!@\A1G&
M(PI^^>OS<\?Y]JAF6)0/+9V..=V>OXL?TJ%?OKO+[<\D@Y'^[TY_.M /(OVA
MO@MX.^._PJ\0?#7X@:M_8F@Z[9W5I=ZA]HCMQ%%<0F)V\Z:6&-<*<Y+C'?BO
MY[_@M_P;V?\ !/WX+?'2R^+/A'X['5O&-OK4>JP:5_PE&D7 :Z2X$ZQ&&+6I
M9.7 4CRB?;U_;G]OCX>>/_BA^S-XZ\)?":2\_P"$QU+2=1ATPVES-9W/VB6T
M9(O+G@/F*?,(P5.1UZU_"_\ L:_\$G/^"N'@+]LG2O'_ ,1)/'+> (/%D-],
M;OQEKUU:BP6^$K9MYF,)41Y^4\'I0!_HGZ+IEII.AZ5H\<RM#864-K:2;T82
MPQ+M1RV<'(ZD$@^IJV1<1-L20KGIL<;?Q(X'YX^M8'ASPS*G@SPY;:G/*NI6
M6CVL-WF1F?SXX_GW-O!)W=^I_+.[906<-M);3S/EL@,2Y89& 0<YX^O&.M %
MEE+KY;3M)/QE=P*?3.3_ )]J3ROD\KS&\[/^K_@Z],Y]/\XK/C@CMAY4$DDJ
M#@.<EB.O?<W89Y]:GB"E\2E@/4 [NGL5([CZ?J 6?*^3RO,;SL_ZO^#KTSGT
M_P XH\KY/*\QO.S_ *O^#KTSGT_SBJTH4/B(L1ZD'=T]RQ/8?3]"(*7Q*6 ]
M0#NZ>Q4CN/I^H!9,7R>2)&\[M'QL^F<_Y^E!BWJL:2,TB_?1N%'K@Y[&JTH5
M7Q$7(!ZX.[]2Q/;\/T="(V8^:77K]W.?QP0?3(]: )S%O58TD9I%^^C<*/7!
MSV-!BWJL:2,TB_?1N%'K@Y[&JC\.0A;'/(!W?C]X_4^OZR0B-F/FEUZ_=SG\
M<$'TR/6@"<Q;U6-)&:1?OHW"CUP<]C2-"7"A)"[(/W@/ 0_[///%57X<A"V.
M>0#N_'[Q^I]?UD@6-@_FLZGG&W(SZ$X8<_44 3O%YN/*D9]GW]W&W'<<T/%Y
MN/*D9]GW]W&W'<<U2.<G:6QVV@^_7K^%3PK$P/F,ZG'&W/7\&'ZT 3/%YN/*
MD9]GW]W&W'<<T/%YN/*D9]GW]W&W'<<U2.<G:6QVV@^_7K^%3PK$P/F,ZG'&
MW/7\&'ZT 3-#O8.DA:-<!G. RD?>P,\X_P \4-%O821R,T:XW.WWEQUP,\\5
M2.[YMN[&3C ."/?KC/?D<>E6$6$QL69PXZ ;L?CA@/TZ4 2M%O821R,T:XW.
MWWEQUP,\\4-%O821R,T:XW.WWEQUP,\\51^;G&['; X/'?@X]^1Q^=646$QL
M69PXZ ;L?CA@/TZ4 3% 7$JRN85&&<XW ]@!GOC_ #Q2>5\_F^8WDY_UG\?3
MIC/K_G-4LMSC=C(XQ\IZ<GMGKW]/QL;8?*W;GW^F#M].F['7GIUH E\KY_-\
MQO)S_K/X^G3&?7_.:/*^?S?,;R<_ZS^/ITQGU_SFJ/S?[6,],';C/KC\>O7\
MJL[8?*W;GW^F#M].F['7GIUH E\KY_-\QO)S_K/X^G3&?7_.:4( YE:5Q"PP
MKC&XGN",]L_YYJA\W^UC/3!VXSZX_'KU_*IV$7E*0S[\\J0=HZ=/FQG@YXH
MG6+8QDDD98VSM=?O-GID9XXH6+8QDDD98VSM=?O-GID9XXJC\W&=V.^1P..W
M S[<GC\ZLNL(C4JSESU!W8_#+$?ITH E6+8QDDD98VSM=?O-GID9XXH6'8Q=
MY"L;9"N,%F)^[D9XS_GBJ/S<9W8[Y' X[<#/MR>/SJQ*L0B!1G+G'#9V^O&6
MP,#IQ0!,D7E9\V1DW_<V\[L]SS0D7E9\V1DW_<V\[L]SS5(9R-Q;'?<#[=.G
MXU/,L2@>6SL<<[L]?Q8_I0!,D7E9\V0IO^[MYW?7FG+8W><JP6-NIWJ"1[\_
M7GWJ@,Y&XMCON!]NG3\:U%MK2>%@+ET;;T+E><=LN?Z?2@#,O%NK:Y2*#$EN
MVTR.K;CDX+].X)/TJXZ1^21:R2-.5_U; A2V..?<^V?Y5DQ:E9>'DE:[E9H
M[LSRY8A22QQNSQCI[>@-?S\_MX?\%F7_ &;_ (TZ5\,/""1WU[J$\,$4"P6\
MDC/+<-" %-E=/R1QSU^N: /Z"HC>6ZG^T5:"/)/[O)X]>%Z^WMQ6I8ZA$Y\F
MTWNA.&<JPQ^?_P"JOYE=0_X+ _M)_9;69/A]J,UO=0)*CKHLC@H^2#QH+9SV
MYP?TJ+2/^"L_[5]U.C6/PWO/L18&21]&DC(]>#X?STQWX- 'YG?\%4([F/\
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MXJ%%A,;%F<..@&['XX8#].E5\MSC=C(XQ\IZ<GMGKW]/Q +OE?/YOF-Y.?\
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M8T-%O54CD9I$P74XV@#EB#GM_GFH(1&S'S2Z]?NYS^."#Z9'K4;\.0A;'(R
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M4=78X8#)SQWZ<=?\<?!YPI]OE(SQU/'K6GI_D^8N]Y%8$8"AL=>.C?TY[XH
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M\NWH.G&/7MQQCM6#%YXD9E1"YSN!*[1].H_(?CZ@"1[/-?<[JO.& ^8\]_\
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M5#]@[]NC]I1;[P7^S/K'PG\(?#O5[>2VOK!O!GA".]:.?='($N&U+3)48QD
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MU/\ HW'3I^M?0"V%DS%(]/TU9%!W,UC;[#ZXR@'TY/'K1'9V1+#^SM,R.O\
MH-MR?7_5D_YYYKYS!8=5XRI\SB^?F3FM+R<7)RLW>_1:6]&:RE*22ULMH[VO
M;7Y][W?JW?P _M-^$'V@^%O%0"]-FF7'/N?]&'Y<_6GO^T[X0EV[O"WBOY.F
MW3;D_B?]&KWW['9_PZ=IH]<V5M_6/]*(K&UD#%+#2UQUW65KR/;*BO3E1="U
M-W:6S;O>Z3^7:UD1K9.VCV/ 7_:=\(2[<^%O%8VXQMTVX_,_Z-^5*W[3WA&0
MH3X7\5#R\8QIMP0?][_1NE>^QV%K)NVV&EKMZ[K*UY^F4'^>M$=C:.'(L-,
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M/Z=/;FA["U2-7-AI94] +*UW#/K\F?KP/?F@#P%/VG?"$;F0>%O%>6ZYTVX
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M+^P:7O\ [WV*UV_^@8_7K[\4?8+7S?+^P:7O_O?8K7;_ .@8_7K[\4 > _\
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MKN./3Y,_3@^W- '@1_:?\(M()3X6\5948Q_9MQM[=3]FZTG_  T[X0\SSO\
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M>O?4L+5I&1;#2PRYR396NW\/D _(_F*$L+5I&1;#2PRYR396NW\/D _(_F*
M/ &_:<\(.%!\+>*_DX&--N,GGJW^C=:<_P"T[X0EV[O"WBOY.FW3;D_B?]&K
MWY-/M6,@6PTL%3\Q-E:X/';* 8^A(]Z2.PM9-VVPTM=O7=96O/TR@_SUH \!
M?]IWPA+MSX6\5C;C&W3;C\S_ *-^5*_[3OA"7;N\+>*_DZ;=-N3^)_T:O?8[
M"UDW;;#2UV]=UE:\_3*#_/6B.PM9-VVPTM=O7=96O/TR@_SUH \!?]IWPA+M
MSX6\5C;C&W3;C\S_ *-^5#?M.^$'8.?"WBO*@ 8TVXV\#O\ Z-W[U[]'86LF
M[;8:6NWKNLK7GZ90?YZT)86K(["PTL*I.0;*VR<$],H#].#[9H \!;]IWP@[
MB3_A%O%8*],:;<8X]?\ 1OS]J'_:=\(2.)#X6\5Y7IC3;@CCU_T;\_:O?DL+
M5XV<6&EA1U!LK7<<>GR9^G!]N:$L+5XV<6&EA1U!LK7<<>GR9^G!]N: / 6_
M:=\(.XD_X1;Q6"O3&FW&./7_ $;\_:E/[3_A%I!*?"WBK*C&/[-N-O;J?LW6
MO?4L+5XV<6&EA1U!LK7<<>GR9^G!]N:065H8FD%AIFT$ @V-KN/7D?)G\@1Z
MF@#P+_AIWPAYGG?\(MXKW9Z?V;<;?3'_ ![?Y-'_  T[X0\SSO\ A%O%>[/3
M^S;C;Z8_X]O\FO?OL%KY7F?8-+V?W?L5KN_] S^G3VYH^P6OE>9]@TO9_=^Q
M6N[_ - S^G3VYH \!_X:=\(>9YW_  BWBO=GI_9MQM],?\>W^31_PT[X0\SS
MO^$6\5[L]/[-N"OT_P"/;^G6O?OL%KY7F?8-+V?W?L5KN_\ 0,_IT]N:#86O
MDF3[!I>S^[]BMMW_ *!G].GMS0!X"G[3OA"-S(/"WBO+=<Z;< <^G^C?E[4+
M^T[X01S)_P (MXK);KG3;C'/I_HWY>U>_/86J1JYL-+*GH!96NX9]?DS]>![
M\T/86J1JYL-+*GH!96NX9]?DS]>![\T > I^T[X0C<R#PMXKRW7.FW '/I_H
MWY>U"_M.^$$<R?\ "+>*R6ZYTVXQSZ?Z-^7M7OSV%JD:N;#2RIZ 65KN&?7Y
M,_7@>_-#V%JD:N;#2RIZ 65KN&?7Y,_7@>_- '@*_M.^$$8N/"WBO+ @YTVX
MV\CM_HW;M0G[3OA"+=CPMXK.[.=VFW'YC_1OSKWY["U5$8V&EE6(P!96V1DC
MKA"?KP/?%$EA:Q[=UAI;;NFVRM>/KA#_ )Z4 >!)^T[X0BW;?"WBOY^N[3;D
M?B/]&I$_:=\(1;L>%O%9W9SNTVX_,?Z-^=>_26%K'MW6&EMNZ;;*UX^N$/\
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M.N<_Y_3-34=C2).G]FXXW2<"3KR.3^![]N:FLKF*;S/)NXQGT/WOICZ_A^=
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M._X+YQ2VO[(&J/)+N?\ <\XQC_38O3C_ /5ZDU7_ ."#%RJ_L=:5.7"-^_\
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MN^%9N4\9Z=I>HSZ8]JIEF\^*U+PE5#H3^\QQN&?6OXD?V1_^"GW_  6#\?\
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MU'5>,J3\QY['_/\ 2G,(_.7$<@7'*D_,?H?_ *W?K1*3YR9F#GCY^?EY_/\
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M.4QCY,?>_4_S'X=:1RN]<7+.,+\^/N\#CCCCIT^O%#%=XQ<LX_OX/R_T_/\
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M!-+DB,>04P.N/O\ /U;TQV^AI9B6V?Z.8\>WWOU;_/KV1RN$Q<,^.HP?DY/
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MY2UDKMI/31*]ON'JQ\YC]F)X'[O'W>O/7V_O'Z#LV-F65F^SE\Y^3;G;^?\
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M'Y?Z_G^/-#%=@Q<LY_N8/R_U_/\ 'F@ DR5B_<%,#KC[_/U/IZ#Z4LQ+;/\
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M(I78<W+(?[F#\W]?R_#FA2NPYN60_P!S!^;^OY?AS0 H)\@+Y!_ZZX_'V_\
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MI78<W+(?[F#\W]?R_#F@ 7/DL/))^8?O,?=Z\=?;^Z?J.RY/D[?LY_ZZX_\
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MD,@6+=#&H(^4@?>&3UZ?H2/>B39Y2;7=FXRI'RCCM_G\NE-DV;8MKN3CYLC
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MU^XOQC^*?AGX*^!M3^)GB"VUS7++1[::\DTWP]'->W\J01F5HX[:%)G9R!M
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M>GWC@<\^_P!?6>Y68!"Z+@#(V 9_';_G]:\BQ\9NZZ"!_">.1[4#_A='\?\
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M^+T?Q?V%M[9QCKQ^G2@#U=Y)9B@,04KTVJ0#TZ\"IKE9@$+HN ,C8!G\=O\
MG]:\BQ\9_P")=!'IG!^M _X71_'_ &%[9Q^/]* /5WDEF* Q!2O3:I /3KP*
MFN5F 0NBX R-@&?QV_Y_6O(L?&?^)=!'IG!^M _X71_'_87MG'X_TH ]9,DL
MLD0,2J5/RX7 ./[V0 ?U%.N!,DBNR*2,8"K\IY[@?K_^JO)/^+S]UT$'^'IG
M/M1_Q>C^(:$6[ X_#]: /6-\LTRGRPK#& %PO7OD ?Y]*?<"9)%=D4D8P%7Y
M3SW _7_]5>2?\7G_ +N@ANW3/M^M'_%Z/XAH1;L#C\/UH ]8WRS3*?+"L,8
M7"]>^0!_GTITAFBGWF-6;/0+\G3_ &1C\A7DO_%Y_P"[H(;MTS[?K1_Q>C^(
M:$7]\9_SB@#UJ,S2S[Q&JMZ%?DZ>XQ^GZT2&:*?>8U9O0+\G3V&/T_6O)?\
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M=XQD8QM4;?QXQ]3S[\59MI(YI5,HD1QP G"GZ@8'UX/Z<^(WEU\=E.[;X=,
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M=4N8S)* ,S[O;\_T^O4U)\GEY^SG/_/7=Q_C^GZ4 2[IO*_U\>W^[GYOS_\
MK>W7FC=-Y7^OCV_W<_-^?_UO;KS47R>7G[.<_P#/7=Q_C^GZ4?)Y>?LYS_SU
MW<?X_I^E $A:;R#^_CV8/R9&[\__ *WM[TKM-Y:YGC9>R@_,/J?\_P!*A.SR
MB?LYSC_6[C_^O]/TI6V;!BW*'^_N^]_7\_QYH E=IO+7,\;+V4'YA]3_ )_I
M0[3>6N9XV7LH/S#ZG_/]*B;9L&+<H?[^[[W]?S_'FAMFP8MRA_O[OO?U_/\
M'F@"5VF\M<SQLO90?F'U/^?Z42--MBW3QD8^7!P5Y/WNN?T^E1-LV#%N4/\
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M$O\ Q]_X/;#_ .:"FR?\%]?VOGBEC'_!,#Q\/,C=,_V[8\;U*Y/_ !4&>,T
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MO[4B--YC8GC5N[$_*?H/\_CUJ,;/- ^SG&?]5N_R/U_6D79O.;<N/[F[[O\
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MPYMRY_O[ON_U_+\.: )4:;RVQ/&J]U)^8_0_Y_I0C3>6V)XU7NI/S'Z'_/\
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MU_<$')S)NZ]./7\QCTH F=IO+7,\;+V4'YA]3_G^E#M-Y:YGC9>R@_,/J?\
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MGFFVX)\S$(D_/Y>OIC_/2@ MR1YF)A'^?S=?3/\ GI1;DCS,3"/\_FZ^F?\
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M\*L)YNFVD@NO]/NMRA%DY.!U.<#VY^E6H+6[U*VW+</I['D(AX'7ZGT_#WZ
M$4<.FV_-[I-E#CK,;6%.G(Y5 ?I^'3-9&H7]I<$V]EI?GQ]-\/"]1T QZ?SX
MJ8:9=Q7/E7%])?I_SQDZ'COP./\ )J]/>RZ=%MT_2HY)U'$:G;D_BWO_ (4
M4=-O)+/Y#HTL*C_EHQXQUSZ<9_3WJU$WG7DDZZG'$60#[,0"RX)YYQUZ?7]9
M=-O+Z^D!U&#[*[ Y@+!E^G]?TI[6MO'?R-#:QR,4&>.@YYR/<_YXH 2(GSY,
M3!#S\_9N?;_/XT1$^<^)@AY^?GYN?S_/\>:(@3,^(0YY^3LO/M_GUYHB!\YP
M(0YY^3GY>?S_ #_'F@ B)\Y\3!#S\_/S<_G^?X\T1$^=)B8(<-\_/S>W SST
M_GS1$#YS@0ASS\G/R\_G^?X\T1 ^=(!"'.&^3GY??@YXZ_SYH +<D>9B81_G
M\W7TS_GI1;DCS,3"/\_FZ^F?\]*+<$^9B$2?G\O7TQ_GI1;@GS,0B3\_EZ^F
M/\]* "W)'F8F$?Y_-U],_P">E%N2/,Q,(_S^;KZ9_P ]*+<$^9B$2?G\O7TQ
M_GI1;@GS,0B3\_EZ^F/\]* "(D0R 3!!ELI_>]^..>O7Z\41$^2^)@@Y^3GY
MN/R_/\>*(@?)DQ"'&6R_]WVXXXZ=/KQ1$"87(A#CGY^?EX_+\_QXH (B?)?$
MP0<_)S\W'Y?G^/%$1/DOB8(.?DY^;C\OS_'BB($PN1"''/S\_+Q^7Y_CQ1$"
M87(A#CGY^?EX_+\_QXH (B?)?$P0<_)S\W'Y?G^/%&3]FQYPQ_SR[]?R_7]:
M(@3"Y$(<<_/S\O'Y?G^/%&#]FSY(Q_SU[]?R_3]: #)^S8\X8_YY<YZ_E^OZ
MT9/V;'G#'_/+G/7\OU_6C!^S9\D8_P">O.>OY?I^M&#]FSY(Q_SUYSU_+]/U
MH ,G[-CSAC_GESGK^7Z_K36)^SH/-!&X_N^<K[^GY'/'UIV#]FSY(Q_SUYSU
M_+]/UIK _9T/E #<?WG.6]O3CV&>?K0 Z4GR4S,'''R<_+Q^7Y?AQ1*3Y*9F
M#CCY.?EX_+\OPXHE!$*$PA!Q\_/S<?E^7X<42@B%"80@X^?GYN/R_+\.* "4
MGR4S,'''R<_+Q^7Y?AQ1*3Y*9F#CCY.?EX_+\OPXHE!$*$PA!Q\_/S<?E^7X
M<42@B%"80@X^?GYN/R_+\.* &RD[8<RA\#@<_)[<\>_&13K@D^7F82?G\O3U
MQ_GK3900L.8@F1P>?G]^>/;C IUP"/+S"(_S^;IZY_SUH +@D^7F82?G\O3U
MQ_GK1<$GR\S"3\_EZ>N/\]:+@$>7F$1_G\W3US_GK1< CR\PB/\ /YNGKG_/
M6@!TI8M#F</@\'GY/?GGVXR:;*3YR9F#GCY^?EY_/\OPYITH;=#F )D\#GY_
MSY]^,&FR@^<@,(0\?)S\W/Y_E^'- !*3YR9F#GCY^?EY_/\ +\.:)2?.3,P<
M\?/S\O/Y_E^'-$H/G(#"$/'R<_-S^?Y?AS1*#YR PA#Q\G/S<_G^7X<T $I/
MG)F8.>/GY^7G\_R_#FGL6^T(?/!.T_O.<+[>OY#''UIDH/G(#"$/'R<_-S^?
MY?AS3V#?:$'D ':?W?.&]_7\CCGZT ,R?M.?.&?^>O..GY_I^E&3]ISYPS_S
MUYQT_/\ 3]*,'[3CR1G_ )Y<XZ?G^OZ48/VG'DC/_/+G'3\_U_2@ R?M.?.&
M?^>O..GY_I^E&3]ISYPS_P ]><=/S_3]*,'[3CR1G_GESCI^?Z_I1@_:<>2,
M_P#/+G'3\_U_2@ B)\Y\3!#S\_/S<_G^?X\T1$^<^)@AY^?GYN?S_/\ 'FB(
M'SG A#GGY.?EY_/\_P >:(@?.<"$.>?DY^7G\_S_ !YH (B?.?$P0\_/S\W/
MY_G^/-$1/G/B8(>?GY^;G\_S_'FB('SG A#GGY.?EY_/\_QYHB!\YP(0YY^3
MGY>?S_/\>: "(GSI,3!#AOGY^;VX&>>G\^:+<D>9B81_G\W7TS_GI1$#YT@$
M(<X;Y.?E]^#GCK_/FBW!/F8A$GY_+U],?YZ4 %N2/,Q,(_S^;KZ9_P ]*+<D
M>9B81_G\W7TS_GI1;@GS,0B3\_EZ^F/\]*+<$^9B$2?G\O7TQ_GI0 6Y(\S$
MPC_/YNOIG_/2B(D0R 3!!ELI_>]^..>O7Z\46X)\S$(D_/Y>OIC_ #THB!\F
M3$(<9;+_ -WVXXXZ=/KQ0 1$^2^)@@Y^3GYN/R_/\>*(B?)?$P0<_)S\W'Y?
MG^/%$0)A<B$..?GY^7C\OS_'BB($PN1"''/S\_+Q^7Y_CQ0 1$^2^)@@Y^3G
MYN/R_/\ 'BB(GR7Q,$'/R<_-Q^7Y_CQ1$"87(A#CGY^?EX_+\_QXHB!,+D0A
MQS\_/R\?E^?X\4 &3]FQYPQ_SR[]?R_7]:,G[-CSAC_GESGK^7Z_K1@_9L^2
M,?\ /7OU_+]/UHP?LV?)&/\ GKSGK^7Z?K0 9/V;'G#'_/+G/7\OU_6C)^S8
M\X8_YY<YZ_E^OZT8/V;/DC'_ #UYSU_+]/UHP?LV?)&/^>O.>OY?I^M #6)^
MSH/-!&X_N^<K[^GY'/'UITI/DIF8../DY^7C\OR_#BFL#]G0^4 -Q_><Y;V]
M./89Y^M.E!$*$PA!Q\_/S<?E^7X<4 $I/DIF8../DY^7C\OR_#BB4GR4S,''
M'R<_+Q^7Y?AQ1*"(4)A"#CY^?FX_+\OPXHE!$*$PA!Q\_/S<?E^7X<4 $I/D
MIF8../DY^7C\OR_#BFRD[8<RA\#@<_)[<\>_&13I01"A,(0<?/S\W'Y?E^'%
M-E!"PYB"9'!Y^?WYX]N,"@!UP2?+S,)/S^7IZX_SUHN"3Y>9A)^?R]/7'^>M
M%P"/+S"(_P _FZ>N?\]:+@$>7F$1_G\W3US_ )ZT %P2?+S,)/S^7IZX_P ]
M:=*6+0YG#X/!Y^3WYY]N,FFW (\O,(C_ #^;IZY_SUITH;=#F )D\#GY_P ^
M??C!H ;*3YR9F#GCY^?EY_/\OPYHE)\Y,S!SQ\_/R\_G^7X<T2@^<@,(0\?)
MS\W/Y_E^'-$H/G(#"$/'R<_-S^?Y?AS0 2D^<F9@YX^?GY>?S_+\.:)2?.3,
MP<\?/S\O/Y_E^'-$H/G(#"$/'R<_-S^?Y?AS1*#YR PA#Q\G/S<_G^7X<T &
M3]ISYPS_ ,]><=/S_3]*,G[3GSAG_GKSCI^?Z?I1@_:<>2,_\\N<=/S_ %_2
MC!^TX\D9_P">7..GY_K^E !D_:<^<,_\]><=/S_3]*,G[3GSAG_GKSCI^?Z?
MI1@_:<>2,_\ /+G'3\_U_2C!^TX\D9_YY<XZ?G^OZ4 &3]ISYPS_ ,]><=/S
M_3]*(B?.?$P0\_/S\W/Y_G^/-&#]IQY(S_SRYQT_/]?THB!\YP(0YY^3GY>?
MS_/\>: "(GSGQ,$//S\_-S^?Y_CS1$3YSXF"'GY^?FY_/\_QYHB!\YP(0YY^
M3GY>?S_/\>:(@?.<"$.>?DY^7G\_S_'F@ B)\Y\3!#S\_/S<_G^?X\TZ(L&F
MQ.$R>3S\_OQS[<X--B!\YP(0YY^3GY>?S_/\>:=$&W38@#X/(Y^3\N??G)H
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MI3H@VZ;$ ?!Y'/R?ES[\Y--MP3YF(1)^?R]?3'^>E !;DCS,3"/\_FZ^F?\
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MS,'''R<_+Q^7Y?AQ1*"(4)A"#CY^?FX_+\OPXHE!$*$PA!Q\_/S<?E^7X<4
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MG!!P&P1CCH.G]>F3P>.3^&2,OP\\'22?(1H-B=B\H?W6<'Z=Q_7BNP=Q(<A
MI4\+C /?GGJ.#QVZ]*_,Z^M3%=5[6K[RUL^9V2M:Z[N-C7 ?:49)NZ33Z;:6
M^*_DY<VNCL-#%4)60YY^;'MTJ)7#-\\A7/\ RU/7/T/MD5.K,H)V*3S\IY7I
MUJ-27DRL<9?KL(^7_#O7SZ^)[_$]NCTM=+7YO34]JOS6A9+^&O>DFNBT3DVK
MO[]!/*^??YQV?\]L#.>G3IGM_P#7IOR>9G[0<?\ /7;S_A^GZ\U+^_\ -QY:
MY_YY_P#+/IGKTZ?X=*3$OF_ZF+=_<XV_G_\ 6_QJTM]%OT27;>QQ:ZW[Z>GG
MYC!L\QO])(&!B3;UZ\>GY#-(NS><W!0?W]OWOZ?E^'%2J)O.;$$);:,J<;0.
M>A_^MVI$$OF-B&)F[J<;1]/_ -7Y=*8$:[-YS<%!_?V_>_I^7X<4+LWG-P4'
M]_;][^GY?AQ4B"7S&Q#$S=U.-H^G_P"K\NE""7S&Q#$S=U.-H^G_ .K\NE $
M:;-[9N"HP</M^]P<#GCGZ?2A-@W9N#'_ ,!^]^>?\]:DC$OF/B&(MAL@X '!
MS@\_7IS[41"7Y]L,3>N[ Q].O3_.: (TV#=FX,?_  '[WYY_SUH38-V;@Q_\
M!^]^>?\ /6I(A+\^V&)O7=@8^G7I_G-$0E^?;#$WKNP,?3KT_P YH C38-V;
M@Q_\!^]^>?\ /6A-F),W!CX.!M^_R/7/Z<^M21"7Y]L,3>N[ Q].O3_.:(A)
MB3]U&1CYB< KR/N]<\\=NO6@#PS]HCXN>&O@M\)_$7CCQA9Q7OA_2;.ZN;R.
M;(1HH(#)(#^\C/*C!^8?K7\_'P-_X+B_L0?%#XW6GPQ\*>$M$M_%-SK2:=%/
M$7\P7+SB$,,ZE)SO/]PU^\_[2OP:L_C]\,M?^&'BJ^31O".O6ES9ZCJK74=H
M]O#<Q&&5Q+,\*+LC.[)D&.^, U^$?P+_ .#>#]A'X%_%V#XO>"_CA%X@\;6V
MKKJT6E3>*M'N2;Q)A.L(@CUJ63[XQCRLG)&* /Z8]!U6RU7P]INI*JI%?V45
MS;(!P(I%R@'MQV)^M5UMY&NU?[2\4.[)C RI&><G''''7MWXJAX3@O;#P_I^
ME7$%J+;3K2.TM95=6:2&)=J.#SDGL1G_  ZJ."*:RE#85R#A@ &Z=N!W[^V:
M &W?V<G]S<_+Q^Z X_EZ?Y':M\GEX^T'/_/+;Q_C^OZ4RW@E@M538LB#_EK)
M_K#VY!^G^<5/B7RO]3%M_O<;OR_^O[^U $?R>7C[0<_\\MO'^/Z_I1\GE_\
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MF\8N"X_O[?N_T_/\>*4[/,7_ $DD8.9-O3IQZ?F,T]Q+YBYAB5NRC&T_7_\
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M:DC$NZ7$,1.?FS@!>!]WKGZ\?2B(2_/MAB;UW8&/IUZ?YS0!&FP;LW!C_P"
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MR^<;>?3IZ=OI69,DKL%,:(W8(1M/3K^7/M5^SB6&11+(Z,3PJ<@YXZC_  H
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M^HH _;S_ ()&!#^Q/\,"Z[E'A_2"1C/2P6OT%N+NS>Z:&*&='#$$LN$Z\X)
M'Z_CUK\Z?^"3>K6NE_L3?"U[K.TZ!HX_\D$]C^M?I))J>AW\>^)X1(>1L,8?
M)R?FV\]21_D4 1W<,=O%"_F?-(N[#M[GIST^G7' ](887G4LLBX']\CGV&,<
MU3\E-2=A?7D,<4!VVXCF56*8S\X.,G.<]:D66WB.R.ZBPG3,J<_7YO;]?I0
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M9STK\VQB4:^,25DZU3E2]^ZYGM:U[FN7.+IQO9[7UZ^[O^BOKWU#G'&=F?\
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MSQUYQCZ^XJ];6T=M=2S3^?(SYSMRR\G/&,_A[57N+C2[?]_Y\+(.=L3HT_X
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M<?7^513-%&I9+NW8-]P^<F/;.#_GM5:VG@!?[?=VJYSY>R6//X\]Z +T4#3
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M%=QQ'BX@;/4-(A'/IDM[XXXH CR>!D@GZ _CGW_6K#6\BH) X;/9#EA]>O\
M+K^5-EN+!^4N(A+W'F+M]\=![?\ UJ;%=QQ'BX@;/4-(A'/IDM[XXXH 9DY
MR0Q('4 \\<Y_6IY+>2(!MP8$9_=\X^O6FRW%BXW1W$0E[CS%"]1G'0<?_J-$
M5Y%'\OVB!E/!WR(3CVR6YH B!)8*&P3[@?GFIY+>2(!MP8$9_=\X^O6HY9[%
MOFAN(@W?,BX[XQR._P"@]:=%>11_+]H@93P=\B$X]LEN: (@26"AL$^X'YYJ
M66&2'&3N! /R<KSSSU]>>:;+/8M\T-Q$&[YD7'?&.1W_ $'K3XKR%%V/<0-'
MW+2(6Q['D_Y]: (D!=@BMC/J0%_'^M2RPR0]6W#U3E?QZ_CSTJ.2:R)S!<Q
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MD\-UQ_GVI\=U'&<BYA//W6D3;CH."Q]NU2R7-A*,FXA$WM(NW./; Z<__7H
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MWJY..F?FZ'G- "L&4D/NX_O=/P/'^<5+%"\P)$BC']\C/X8(YIYO+*1<7$\
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MKM_SZ=ZA;=N.W&,G&<Y_'WJY;^9^\V^7[[\?CC=_GU[50DQO.[.<\[=N/TH
MO7(CW+LCD09Y#DD]OI_GTILVSY-J.OKN.<].G3K_ )Q4ET)2Z^9/%*>Q4\#Z
MYS^/^<,F\P[-\T;X^[@_=^N<_C^N: $DV>:F$<+A<@G)/K@X'UZ?G1)L\U-J
M.J\94GYCSV/^?Z4L@D\Q"TT;, NU@3A>!C.23Q]1STQ1)YAD4M-&SC&'!X'I
M_G(_#K0 DFSS4VHZKQE2?F//8_Y_I1)L\U-J.J\94GYCSV/^?Z4LGF&12TT;
M.,8<'@>G^<C\.M$GF&12TT;.,8<'@>G^<C\.M "2;/-3:CJO&5)^8\]C_G^E
M'R>?]Q]G]W/S=/7']/\ &ED\PR*6FC9QC#@\#T_SD?AUI3YOGD^='YF3^\R<
M?SS^O3VXH ;\GG_<?;_=S\W3U_\ K>WO1\GG_<?;_=S\W3U_^M[>]+^\\[/G
M1^9_STSQ_G'OT]N*/WGG9\Z/S/\ GIGC_./?I[<4 )\GG_<?;_=S\W3U_P#K
M>WO3E$?G-F.0KCA0?F'U/_UNW6D_>>=GSH_,_P">F>/\X]^GMQ2KYOG.1/&'
MVC+YX(YX]?U(Z<4 -CV>:^Y'9><*#\PY[G_/]*(]GFON1V7G"@_,.>Y_S_2E
MC\P2,5FC5SG+D\'U_P Y/X]:(_,$C%9HU<YRY/!]?\Y/X]: $CV>:^Y'9><*
M#\PY[G_/]*(]GFON1V7G"@_,.>Y_S_2EC\P2,5FC5SG+D\'U_P Y/X]:(_,$
MC%9HU<YRY/!]?\Y/X]: %C$>Z7=&Y&?EP<%?][@Y^O'TIL.SY]R.WIM.,=>O
M7I_G-.C\T-+MGC4D_,2?O<#IT_4D^])#Y@W[)HTS][)^]],8_#],4 )#L^?<
MCMZ;3C'7KUZ?YS65=1VDI\NZM+FX1N/W!8;1R.2#V_STK6A\P;]DT:9^]D_>
M^F,?A^F*(A(-^R:-/7)^]].G^?2@"G96.G:?;3_V7;S133)@O*[.4R0>-Q..
MG;'Y=9+:34+*UEN;@K=1H23"%#L0!G !SSV'O]:GC$@67;-&H(^8$_>&1TZ?
MJ"/:EC\T1L%FC5><H3R?7_.* /B']MK6_'^B? ?QAXZ^"VAZNWQ(TG3K^;1K
M:S@:662[AMVD@VVR-'OS+C )&[U%?Q]_"/\ :I^).M_$F^\>_MS_ +$W[47Q
M7\<^'M9D_L*]\,Z3?Q:$\%K+YEN9=/\ ]+MIT,A8L'7#*<$5_?)&7\ML/!L[
MQN-P;UX/!S@=0>*@^RVSYD-KI@(ZAK2 DXYZ[* /YO?#?_!=?2?".G6FE^'?
M^":_[3>DV=G"D$<=AX%6SW(@ !D^S:?$'; &68$G'.:_7/\ 92_:FN_VP? V
MH>-+WX0^/OA'8Z=-:1OX>\;V#Z;JETUTLS!XD,<9(A$)$GR\%U]:^SA:VSC?
M]ETL;?X3:09..?[E3#/DL$^S11Y ,42+&&^]@X3 X^E 'YI?\%*OV.O%?[9/
M[.^H_"[X>7UIH&H/%YB3ZT0(289Q<%<M)$,L%(7YNI'!Z5^._P"RY^U]\1/^
M"3/@4?LZ^,OV4_C9\9=2TR2:)O$_PZT&6^T2?=,TX:.:-)U(*G'W^M?U:GS#
M#M\Z/R_^>>3G^?\ 3V]Z@%I;A?,:#3Y#Z26\4C]^[*3W_I0!_)]^U'^U-XY_
MX*T>#V^ '@W]E'XX?!K6-4EAC7Q1\1=$FL=#@Q.DQ:221($ VC;RXY]:_:G_
M ()I?L<>*_V+?V<]/^&GQ"U*PU_48H3(\NCD-$!+*9]GR22C<H?:0#U!K]&3
M:P;?,6'3XSZ16\4;^G55'^>*F/F>01YT9CQ_J\\_Y_#_ !H ^,_VO/@)\0?C
MYX-AT+X;Z\GA6Y4*/.N;B2U_Y9LN-T<T)SD^O:OXOO\ @L3^P7\<_@1I7@77
MOB#X_M=?LY/$&G$1)J-Q<=0[<++>3#H#R%Z'\*_T%5\PQ<SQD#[JAB"O''<]
M,^W%?RG?\'*S7'_"O/A^&NHW3_A(-, C#$L!Y4O7G^GO0!^MG_!,#1;C4OV(
MOA;;P3HA&@:."Q/RG_0%S@Y'U^E?<EM\/=3TTFYM]3C,C\E?-9N_(V[L=??'
MTKY _P""2Y3_ (8F^%N^-Y/^)!H^-O;_ $!>O7'M^5?H?)C?\JE1DX4DY'_Z
MNGXB@#R*;P9XFOIRT%\+7##>97=!+QG*8D&1CCTX/6KX\":VBJ);W#]V\QR&
M/M\_^<^U>K2JY$>Z6-ACY0"05Y/7D_TI9O,.S?-&^/NX/W?KG/X_KF@#RU?
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M_P ]>E>K1B02L5FC5^<L6.#D\]_ZG'2B/S!(Q6:-7.<N3P?7_.3^/6@#RX^
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M08PH/(]/7^7Y=*202%8MTR, /E 8_*,GKR?3L!]* /*V\":RIPU[CT^=^?\
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M9I/Q/R_GC_/6G1J2TO\ I)3!ZY^_Q]#Z>@^E)""V_P#T@QX]_O?H?\^O8 1
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M,$QL?M!3&?W>?O?H?YC\.M(N?)8^<1\P_=Y^]UYZ>_\ >'T- !A?+S]F;/\
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M><VS./[F3\O]/R_#BEC!,C#[04QG]YG[WZ'^0_#I1&"9&'V@IC/[S/WOT/\
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M]_)^;^OY_CS0V?)4^<3\Q_=Y^[TYZ>W]X_04L@(C4_:"^<?N\_=_0?S/X]:
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M;/-3:[LO&6(^8<]O\_XT?)Y_WWV?W\?-T],_U]_:@!V#]IQY(S_SRYQT_/\
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ML^2,?\]><]?R_3]:;\GD???=_=Q\O7U_^M[>]'R>1]]]W]W'R]?7_P"M[>]
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M<_/S\O'Y?G^/%-CV>4^YW5N<*!\IX[_Y_/I1'L\I]SNK<X4#Y3QW_P _GTH
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M>?DY^7G\_P _QYIL>SS7W.ZKSA@/F//?_/\ C1'L\U]SNJ\X8#YCSW_S_C0
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MY79_+'_CO^-0MY.X;?.V]]WWOPSS^7X<TI\GS#_KMF3Z[_\ XK_/I0!)^_\
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M;<KQM!)A8VX9\#(R.QZ\#T(Z^M6(4BDRN90_;'W<^^./S_'BOR&_;A_X+"?
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ML_K_ (4?O_(V[$\O^]E=_P#+/Z_X5%^YV?\ +;?_ ..?_$_Y]:/W.S_EMO\
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M!QC !7:?KP!^A_'I43>3N&WSMO?=][\,\_E^'-#>3N&WSMO?=][\,\_E^'-
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M_7^'/3KSZ=J/W.S_ );;_P#QS_XG_/K0!+^_\C;L3R_[V5W_ ,L_K_A1^_\
M(V[$\O\ O97?_+/Z_P"%1?N=G_+;?_XY_P#$_P"?6C]SL_Y;;_\ QS_XG_/K
M0!+^_P#(V[$\O^]E=_\ +/Z_X4UA-Y" HNS<<,"NX].O&<<_WC]!V9^YV?\
M+;?_ ..?_$_Y]:#Y7EKCS=^3G/W.W3^'/7ISZ]Z )9//,2AD0(,8(*[C]> ?
MU/X]:)//,2AD0(,8(*[C]> ?U/X]:B;R=HV^=N[[ON_AGC\OPXH;R=HV^=N[
M[ON_AGC\OPXH ED\\Q*&1 @Q@@KN/UX!_4_CUHD\\QH&1 H*[2"NX\C&<8/U
MY/XU$WD[1M\[=WW?=_#/'Y?AQ0WD[5QYV[*YW?=ZC[N?ESCIC\.* )9O/;9O
M1%QC;M*\^F< ?Y].Y-Y[;-Z(N,;=I7GTS@#_ #Z=XG\GC;YWOO\ Z;O\^O:A
M_)XV^=[[_P"F[_/KVH EF\]MF]$7&-NTKSZ9P!_GT[DWGMLWHBXQMVE>?3.
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ML_K_ (4A\_[.5V)Y>/O97?\ T/\ X]_A4?[G9_RVW_\ CG_Q/^?6D/D^6?\
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M],>@K]IO^"?WP@\/>/O^";'PU\/64UYIVMZYX(NK>WGEOIHE\V2YO8PR;67
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M\<O",?C33OVA?"_AW3;S=-!9ZUH6G6LT<+O^Z5DO?%EHX(0J#F)>G05]0_\
M!##]B+X-7/[/.C?%3QYX+EUSQ[(K7+ZAK<<6I7)E:Y;#L][#<2G (/+].E?T
M"CX<6U],MG";?3_#ZJ(UTNR"V<BHHPJJD'EJ.@_A'X=P#^57XRZ]_P '!G[/
MWAF3QEXA_:)\)^)].LR)KC3-"T?3;F[DAC8>:JQ6'BN]FW% >D).#P*^QO\
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M[/\ ]:E.K:<8PG]L::0"3M%S;[ATZ_O,XXXX'U]?-_\ A3'@3/G_ &74M_\
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M/\B@#TE]7TXL&.L::Q'=;F# ^OSG\?\ )*'6-.=@W]L::2/XA<V^T?7YP/\
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MPICP)GS_ ++J6_\ O_;IMOIT^G_Z^])_PI?P)N^T?9=3\S^_]NGV^G3/I_\
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M/\F@#TE-7TX,6&L::I/=KF#!^GSC\/\ )"#6-.1BW]L::"?XC<V^T_3YR/\
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M?Z?I1D_:<^<,_P#/7G'3\_T_2FY/G;OLY_ZY8_\ K_U_PHR?.W?9S_URQ_\
M7_K_ (4 .R?M.?.&?^>O..GY_I^E/4M]H<^> =H_><X;V]?S&.?I463YV[[.
M?^N6/_K_ -?\*<K'SF/V8G@?N\?=Z\]?;^\?H.P 1$^<^)@AY^?GYN?S_/\
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M]G+YS\F/N_J/YG\>M ##*\4C,D@RVX%\<'/4<XY/^?:6V+8<B81$C)!SD^W
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M6". &ZG'#=>F<?Y/YRPDKO\ ]',F?;[OZK_GT[K"S+O_ -',F?\ 9^[^>/\
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M2]Y.S=KVMMS7NMM59ZZ,_##_ (.# #^QMJQY?_4?,<C/^G1]LY//\Z3_ ((
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MSGWZ^_% #<KY>/M+9_YY8./\?U_2C*^7C[2V?^>6#C_']?TIW[SR<^3'Y?\
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M/,$:EH8U0XPP')_S]?SZT2>8(U+0QJAQA@.3_GZ_GUH :Q78,7+.?[F#\O\
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MNT X_#\:_CF_:6LV/_!7GQ+-&YF?_A-]4/D2<I_KY^,?3_\ 57]C7P*CFE\
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MO=Y?MLQ^&=O^?3O0 R39YJ8=RN%R2,$>N!D_3KS[42;/-3:[LO&6(^8<]O\
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MFW8S_P !SSG_ '>:=#YGD/M\O;SG=C=^&>?R_#F@!D>SRGW.ZMSA0/E/'?\
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M5)C1'"B1N2 W<_ECT%<*CR1#^T]#62&#_6S)= I*5^]A5('/7'R]?RK\<?\
M@HM_P5,UC]FK5]&\&^#;)8O%6LRM:6$^KQF/3A<EHT1I7:W9=FYP22>@ZU]O
MP;X9YQQ+CJ&!RRC0JXBK&52K!RM2PZIQ4W*M)\THJ25].;Y'"JT)<W.I1C'X
M;-*$VVM8>[S7CZZOL?M9HESXANFN(/$-C;V4"G$-Q#CS2HR-Q.!]2>?KS7Y=
M_P#!5_RM,_95^).P17EJ='U4OJ%PP-S"#9L6$9RQ_=]%Y[5^%'Q]_P""K?\
MP5B^ ]EHWC3Q2GP4UOX?ZJHO(D\.^7>:G%88C?$RPP3E9O*<?> Y!KR7X]_\
M%T?A;^TU^Q_XS\+^+/!OCN3QS<Z-JFGWUYHVE74FA1ZDEL]M/F:.P$:1),C
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MOZ$O2+;NTEK97>GE_2OH=MC;(1*YZ_>0%C^?MT_#\*C^3S_OOM_O8^;IZ?\
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M>1U[\_GUJ2'S#/)M$>[G.<;>O;/'Y?AQ1%YGG2X\O=AL[MNWWQGY<^F/PXH
M9#Y?S[G=>PVCKUZ\C_/I1#Y?S[G=>PVCKUZ\C_/I4EL)#YNP(?[VX#WZ;O\
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M!D>SRGW.ZMSA0/E/'?\ S^?2CY/(^^^_^YCY>OK_ /6]O>I(1)Y$FT)MYSN
MW=.V>?R_#FD_>?9?^6>S\-_7_OK_ #Z4 ,^3R/OON_NX^7KZ_P#UO;WH^3R/
MOON_NX^7KZ__ %O;WJ3$GV7.$V>N!OZ_]]?Y]*3]Y]F_Y9[/PW]?^^O\^E #
M/D\C[[[O[N/EZ^O_ -;V]Z:VWR5P[%L\J1\H^AS_ $[5-B3[+G";/7 W]?\
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MSZTH\S[5QY>__@.SI_WS_GUH CCV>:^YW5><,!\QY[_Y_P :(]GFON=U7G#
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M_/KVI;82'S=@0_WMP'OTW?Y]>U $<.SY]SNOIM&<]>O3K_G%$93RGS(X;+8
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MBT'P)H%C\*/&O@:\7Q!INY?$FG?973Y74AB88VW GGYNU9S2<H<T+V=XRO\
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M\_C6!XE_X.7_ (3>)_#VIZ3;?L>_M!H]] \6XZ)<  NC*,_Z$.!GU'\J_3N
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M*W?\(EK^/[_D-L_]!Q^OMUJA[;(]>CB0)YLTC;6.%",-_'KCG'IQC^=-EA*
M2(_R-TY!;GUZGZY_GU\B/Q<MO+5O^$3UX DC>8&V'V!VXS_GFE?XMVXC4_\
M"):^H/1F@;:?I\HZ_KUH ]?6!$4/-(<-TV,-W//.#G]/K[,EA* 2(_R-TY!;
MGUZGZY_GU\C?XMVX16/A+7U!Z,T#;3]/E'7MZT/\6[<1J?\ A$M?4'HS0-M/
MT^4=?UZT >OK"D:B2:1L/PNQANRW3=@@XSUS^/M'+"T1&'X?IM*GZ9QG_/Y#
MR-_BW;A$8^$M? )&&: [3R/NY3OV]>HI9/BW;KMSX2U],]-\#<_[N5__ %4
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M !;MQ&I_X1+7U!Z,T#;3]/E'7]>M(_Q;MPB,?"6O@$C#- =IY'W<IW[>O44
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M//\ %NW#J#X2U]3Q\K0-N/T^7^5!^+=MYNW_ (1'7\Y^YY#;_P#T'/\ G.:
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M[?GW'C\?Q;MVW8\):^^.NR!N/]["_P#ZZ(_BW;MNQX2U]\?W(&X^N%__ %T
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MD;_3L0?T_3KY#_PMNW\K=_PB6OX_O^0VS_T''Z^W6C_A;=OY6[_A$M?Q_?\
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M^?R'D;_%RV C)\):^NX=6@;#<_PY7^7Y4LGQ;MUVY\):^F>F^!N?]W*__JH
M]@\F.(#SI&RWW?+8?KM/OW_/N8I86B(P_#]-I4_3.,_Y_(>22?%NW7;GPEKZ
M9_OP-S],K_\ JHD^+=NNW/A+7TSTWP-S_NY7_P#50![!Y,<0'G2-EON^6P_7
M:??O^?<Q/ R.(Q(,/RN"I #?WL<9]>1[^M>22?%NW7;GPEKZ9_OP-S],K_\
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M^ 'PL\QVL_!L>C?;UMXV8N$\U84!Q(=W3]:_H&Y^S8\[C.?*YSU^GK[_ .%
M+"V_UW'_ #SYSU_+]?UXH _GY\)_\$FOVT_B%J,&E_MH_MG1?'_X6^8CWG@V
M31OL"W"(P?9YK0N!F0;NE?K_ /"#]G[P!^SQX*M_AK\#M"7P3H4,2Q++&ZRQ
MB0_,\GRI%]Z4EN$]O>OH<EC;?Z[C_GGSGK^7Z_KQ2$'[,1YPQ_SS[_3./Z_X
M4 ,O?#5GJNC"Q\1M#JQ,825Y$4B3*X/#HV,_G7\AW_!Q!^SOX+T;PGX2\2^#
MO @M[Z#7+&ZO=0@,0 C5)'D<J%7 W $@9_&OZ]92PAC_ '^\#&(QG(_ET^OX
M]Z\;^,O[//PD_:(T#_A'/BUX4BU[2-NPQSNB KM*<%DDQE2>U9U$[*:]YQ=U
M&RU=UL]U==01^(O_  3F_P""E_[+/PE_91^'_@KQ5\0M!MO$VE:-IMO>Z1<?
M:A/!+#9JDB-B$KE7&TX/7I[_ %_)_P %@?V2!<;3XW\/V2EL><WVHAAD>D)_
M(C\ZRY?^"%__  2V_M.;5)?@K:C49V+2R)JY4%VY.$6TP,D$T7/_  0T_P""
M:&H$";X'1W$0Y3;JS#IP"/\ 1./4_7%>IA*T'RWHN*Y4W:;=W[K=XR:B_1@E
MJ[S<(O=).[VLE;K?^M#H?$'_  5X_8SAT^&*_P#'WAN[M[N+,I)NU7!9E.1]
MG] >OIV%?./B']M__@F/\09FFO\ 4?".I2R,3/Q/G<V2<EK$GG)QR35_]HS_
M ((B_P#!-GP[\%O&&NZ7\$TM[[1](NIK28:NY^SO'#*X.!;#." >HK^;7_@F
M#^PM^Q]\7_CGX^\*>,/"D=_INEZTUM:V<FI.-D?VBX3:"8V[(N, ?S-:XBIA
MJJ2PM*<:L;\WM)/65DFU9N,=4VKV\NAE.E.I"4;RY>CC"[LGHI+OW_0_H+N_
MC_\ \$FK6-IFL?",KD$M\TP)]?\ EP![^G('IBL[2/VIO^"4)>2---\)6Z*>
M7,DW('<XL>_J.3^=?46G_P#!#/\ X)JR:?:RS_ Y+OSHPS2#5S@Y4'/-MCOF
MJ'B?_@@[_P $T6\/ZBFD?!**SOY8'$,XU=F,3E3@X%J.AP>>N/J*X\'B\7A9
M.2JU5*%VO959TVUI]J+C:W2RUWV.=X:4N2,E1LOBGR)REMT<;>7H>4:'^VC_
M ,$J_#<G_$JU'P;;3L0=H$[$L.@_X\ 3[<]>E=J__!0S_@GEI\L=W;ZQX11X
MPIB7RYCD  KTL^G\N]?F._\ P;7? /Q3\0EU?3+K^R- MK_S9-*,[,)(1+N$
M6_[(>JC'/J:_6#2?^"$7_!->TT;1-/U3X()JNI66F65K>WPU9E^U74,$:33[
M?LG'F2*SX[9]LU>*SO$9KRQJ5<1.%*]U7Q%6N[]+>TE)*WE_D=$(3@TG""5M
M7%63T5N6W_DU[6>Q-HW_  6,_8ZTB6/2])U_P[! 2$#1?:$7!^7.%A';MBM[
M4?\ @L3^Q_'<Q6T_Q$\.P>=@_9R;S<VX],^0?IR:Y"]_X(D_\$T=$O(V?]G<
M1VZD%KQM8(2,#DD_Z-T4<_Y%?B_^TI_P0*^$/BW]J+PCXD^%OAV\T[X36E]8
MMK.DVL[SVTD$=V7N$><6XP##P3CMVKC-3]X7_P""NG[(4%J?L_C/P_(C*24'
MVH[CCL3 N,_K61%_P6#_ &/FC>U7Q?H G9@1: WF^0#@L#Y1'RY&?K^67X/_
M ."'?_!-<^%])^T?!B*^OX+"!;V5=6?+W"I\[,/LO!)_(U9;_@A=_P $QC<C
M5%^!\-I>PY1)WU=N%;!88^R]RHZY(Q]* +ES_P %BOV-;"VV:AXX\.V@_P">
M#M>D]>.D)Z_RJTO_  5\_9"ETO[9;>,- GL?]EKP#&<9YB_I_C7Y]?M^_P#!
M O\ 8[\;?">Z@^ WP[?1?';%/)U"POWN901.N[$0ME_Y9@CKTS6W^PK_ ,$)
M_P!DKP/\"[73/VC_ (<R^(/$2*XFO=0O'M9"#.Q7*_9VQ\F!Z\>XH ^V&_X+
M)_L8):;9/'/AU.<>06O<YSZ^35O_ (?#?L;KIGVF3QOX>CL^O+7A'7VB/]:Y
M&#_@A'_P2LU4?;!\!89("Q/V@:R^SKU_X],XR/S]>*^.?V\_^""O[''B/X,7
M>A_LY?#AO#?BPA!#=6-\UU,H$ZE@$^RJ?]7D=>F: /NF+_@LA^Q=>VR)9>._
M#EWM8Y@0WH*=!DDP@<_IBKD__!8']D P1I_PE^@2D8S"&O,I^/E8XSS7PG_P
M3U_X(!_L1^%/@I::?\=?A>_B;XH#5+I[V_N[][:Y>R:.#[.AA-J< 2"7!SSD
M@]*^W;O_ ((>_P#!,G2IFEN?@1';[VQYKZL<'/I_HO?D@4 7;K_@L-^QU%;1
M^?XT\/[1C]V6O"4QU_Y9=OKVZ4P_\%C/V,KN%([7QUX>NW7!-NGVX-&,=R8<
M''M7'^,O^"#?_!-C7_#FIG0O@]%9ZA/92_9+A=59MLS*?+8+]CY()_'GVK\H
M/V9/^#=SX0>$OVC_ !/K7Q'\,WNM_#6>\O#I>D3SO%!% UT&A19OLY#8BRN<
M#/YT ?LG<?\ !83]CY8H(F\9>'W=GC58-]Z"C$@#DPXX.._\Z-7_ ."PG['>
MFB!M3\:^'8E;!1F>\PHX](CTS61>_P#!#[_@EY97"SZC\$(+-GE40SRZN=IE
M9@(]H^R')+D >I(S7GWQN_X(-_\ !.CQ-\/==M])^$L4.O36$JZ)=QZFQ:"<
MQ-Y;JHM?F(;9@=\<4 >G3_\ !97]BF?R?)^(/AN[/& AOALZ8^] /TST.?:S
M=?\ !87]CQO)_P"*R\/SY^[A[T;.@'6"OQO_ & ?^#='X$^$O'/C&_\ V@_!
ME[XL\,2WK/HEM>7+VT=M;"28A5<VQW#84'IQC/:OUMC_ ."&O_!,*ZN!%I_P
M3@S&V&5=7)QSC'_'K_GWH Z:]_X+ _L@*UNK^+] E+$!!ONQMZ8Q^Z[5+J'_
M  6"_8YL9+(:AXW\/Q/.^VW#-><-M)[1'L#7/^(/^"'?_!,.SM!'-\';:SOW
M7%L\FKN")" !@?93D@X_K7Y0?M#_ /!OO\&=;^-/PSUKPGX6NX/AU8>(_M&O
MV,,[O!-IGV&[58Y)?LP"KYK0D''4<T ?>W[6O_!07]D_]ISX->)/A!:?%KP]
MX6C\3:?=V0UTB\9+07D#0;ROV=R0F0Q&P_IFOY@/V=/^"7'[-GP$_:+T_P"/
ML?[=_ACQ3:66O1:X^AI9:@N1'="X,&YM+C[ +G<>O7BOZT]"_P""(G_!,J30
M--T^Y^"L%_>"RBCO"NL,'>;;AR0+48)/:I(?^"%/_!->PF'D_!^/3+5CN>VD
MU=V+Y//)M3C(P/I0!UOA?_@JW^Q3H?A_1-$NOBCX:DU#1]/M[%<B\#3O H4/
M_P >_P#$?4BIKO\ X+ _L>0WT4=WXU\/*N1MN"UW@+GAL" G@<],_I7X6?M(
M?\&^GPSUG]JWP?K7PG\'ZE8?"N"_L&UC3+69YK:>!;PF</-]G7 :'@\<"OV:
ML_\ @A]_P3$30]$T[Q/\&[>?7/[/MX[I)-7=)9;C&'./LO!+=B?YT =G/_P6
M%_8U7466W\=>';D G_2E-Z%(]<&('GC\_H*9)_P6'_8U@NM]QXY\.P_]/#&]
M*]/:'/Z=37+R?\$+O^"8>F6[*G[/R1?*0H;6&."5.TX-KG@D?4U\'?M!_P#!
MNQ^S)XX$MW\-?#,GAVQ,BM'9173SE5#C(S]E'\^G:@#](%_X*]_LA2R_:H/&
M&@2V_47P:\"8QR<&+=_]?\:K#_@L/^QV;WCQGX>SG'G[[W' _P"N'K7SY^SM
M_P $)OV$_!OPYMO#WQ/^&:>(=61=LL\VHM ['>3T^R'&1QW_ )5[W#_P0G_X
M)>M;?:&^!<,<?7<=88CKZ_9.>?;O0!.W_!8K]C6&[\RX\<^'8$!&;MFO2H'&
M3@0YXY_*EL/^"Q/[&MY=2"R\<>'93S^]5KP!^>HS%GGM_P#6K\5_^"X__!*C
M]AS]G?\ 8Y\8>/O@U\,!X<\16.BW\]KJ,&IR2-'+$LFQ@!!$<@K_ 'J^H?\
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M9H,UH?F74 ]V(V4CA@#"&YZ]/PK^0'_@HC^P;^S/X(_X**_#7X2>&? <NF>
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MBM>[B2> #Y6,\BOS6_:S_P"#?']F[6UN(?@QX4F\+W!D7RU@N9+@JF]=R_\
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M8V_:/LV/O\]!0!^Y$G_!8G]CB*V,4GC7P\K9_P"/8M>;L=<Y$1'3GZ>]$/\
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MZ/I/C'X'-K=[#! D[G4VC?>L>UB1]FX))[D_6M>X_P""#_\ P2ITNWM[N_\
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M?\$#_P#@FK^R/^T7X!\9W_QA^'+^([BPUB_M[9YM1=/+BCC0HGS0R=,G'(H
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M?LV?)&/^>O.>OY?I^M1_)Y>/M!S_ ,\MO'^/Z_I1\GEX^T'/_/+;Q_C^OZ4
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MY//Y>_6FM;N\/V=M0<KQ^^V#G!],'^?X9J_:2_9H?LOV@LF,>?@#W/&/J/\
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M?\%6] N_%>F_#?\ ;'\#6O[.GQ<U>XBM],\'-.-1>YFG<11)YSW0(WS93[A
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MQVY_6MF*1(EW&7>?^>)''YD9]_\ ZU020:?(QG:%&E;@QX^YC^(?7/?_  H
MBOKO5ELH_P"S[/\ M+ !#LP!;CK@<\^IK%34%U+;;>*= ABBC(V-*1( PZ8!
MSCC^7UK6BMVMY#+%>MM)_P"/<# 4=QD+G]3Z<5IW;6=S BL \G&[.X_4]?7U
M'M0!EWLDLMHEIH4(AM@ H$14#9CL"#^'L*IZ5IVF:-(;V^F1[UPP\MAR9'7
M4D <ECBKT]HC1HMK=M"R]54=OQ'_ .JEO+*VNK>W0SEIHI(G=^YV.I;([9(H
M 9/<:A*VX:4L=IU,@8<K]#GM4$IMI]ITFX-O.N/,CBR-S>A//OZ'%:-_']IC
MAB@O&C1  X&.1Q[^U.MH[.R4"%5E<_>?!R/4^_?&,4 6=-NKGRVBU9-L9&,N
M=V\>X^G7^N#56XM=*MI#-IEO''*3N/EH5+'(ZGGN:=-L<@^>9 >HP<+^6/\
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MD(E\@_N8MF#\_&[\L_U]_:H_W.S_ );;_P#QS_XG_/K2'R?+/^NWX/\ N?\
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M\;?.]]_]-W^?7M0!+()?,3,,0;"X P0>!C)X^O3CWH<2^8N88E;LHQM/U_\
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MZO<W6@^(/$_P\U_5M3M8AM>V:"X>UA*;),LORG!KY'_;J_X*-?LT?%+_ (*
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M@_UVS(]=_P#\5_GTH D02^8V(8F;NIQM'T__ %?ETH02^8V(8F;NIQM'T_\
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M)>-TLG8=NV* //\ P]^UO_P7L^&-O97WQ&_9"^$/A#X6:"JOK=SI4XSINF1
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M?6@"7$OE?ZF+;_>XW?E_]?W]J,2^5_J8MO\ >XW?E_\ 7]_:HOW.S_EMO_\
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MLV^*]'_:MU^^\"?"F31[Y;[7M#7S+Z*W,4F]U7S+?D?]=!Q]>/RO_9^^.?\
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MOS[88F]=V!CZ=>G^<U$OD9?=Y^,_+MSGH/O8YS_O<T)Y/.[SO;9_7;_GT[T
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MS'!!Z!6!_%L9_7WJ"39MBVHX./FR<AO]WIC]?K3IMGR;4=?7<<YZ=.G7_.*
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M-^3S_N/M_NY^;IZ__6]O>@!_[S[3_P L]_X;.G_?/^?6C]Y]I_Y9[_PV=/\
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M 7]Y]I_Y9[_PV=/^^?\ /K1^\^T_\L]_X;.G_?/^?6F?)Y_W'V_W<_-T]?\
MZWM[T?)Y_P!Q]O\ =S\W3U_^M[>] #_WGVG_ )9[_P -G3_OG_/K1^\^U?\
M+/?_ ,!V=/\ OG_/K3/D\_[C[?[N?FZ>O_UO;WH^3S_N/L_NY^;IZX_I_C0
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M@1E5><Y(#?AW^F/PYJ*/9Y3[D<MSA@?E''<?Y_#K1'L\I]R.6YPP/RCCN/\
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M\YW8W?AGG\OPYID>SRGW(Y;G# _*..X_S^'6B/9Y3[D<MSA@?E''<?Y_#K0
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M,_=[O+]MF/PSM_SZ=Z9-L^3:CKZ[CG/3ITZ_YQ1-L^3:CKZ[CG/3ITZ_YQ0
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MYI%"[#FV9S_?R?E_K^7X<T +Y;'[.Q.1^\R<+UX]?R&./K0 []YY./.C\O\
MYYYY_P Y]NOOS1^\\G'G1^7_ ,\\\_YS[=??FFX7R\_9FS_SUR<?X_I^E&%\
MO/V9L_\ /7)Q_C^GZ4 ._>>3CSH_+_YYYY_SGVZ^_-(?,\@CSH_+P?W>>?\
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M:/\ $_-^6?\ /2@!\GFEHMT\;$'Y2#]W@]>OZ$'WI)/,,BEIHV<8PX/ ]/\
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MCGY^?EX_+\_QXH ;&"8V/V@IC/[O/WOT/\Q^'6D7/DL?.(^8?N\_>Z\]/?\
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MQIV#]IQY(S_SRYQT_/\ 7]*,'[3CR1G_ )Y<XZ?G^OZ4 -P?.V_:#_UUS_\
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M]: $D4AHO])+Y/7/W./H/7T/TI) 1(H^T%\X_>9^[^@_D?QZ5)*&W0Y@"9/
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M@QX]_O?H?\^O9UN"?,Q")/S^7KZ8_P ]*+<$^9B$2?G\O7TQ_GI0 V$%M_\
MI!CQ[_>_0_Y]>Q""V_\ T@QX]_O?H?\ /KV=;@GS,0B3\_EZ^F/\]*+<$^9B
M$2?G\O7TQ_GI0 V,$QN?M!3!;Y,_>Y)SWZ_4?A1&"8V/V@IC/[O/WOT/\Q^'
M6G1 ^3)B$.,ME_[OMQQQTZ?7BB($PN1"''/S\_+Q^7Y_CQ0 V,$QL?M!3&?W
M>?O?H?YC\.M$8)C8_:"F,_N\_>_0_P Q^'6G1 F%R(0XY^?GY>/R_/\ 'BB(
M$PN1"''/S\_+Q^7Y_CQ0 Q<^2Q\XCYA^[S][KST]_P"\/H:7!\G=]H/_ %RS
M_P#6_K_A0H/V=SY0(W#]YSE?;TY]QGCZ4[!^S9\D8_YZ\YZ_E^GZT -P?)W?
M:#_URS_];^O^%&#Y.[[0?^N6?_K?U_PIV#]FSY(Q_P ]><]?R_3]:,'[-GR1
MC_GKSGK^7Z?K0 W!\G=]H/\ URS_ /6_K_A2-GR5/G$_,?W>?N].>GM_>/T%
M/P?LV?)&/^>O.>OY?I^M-8'[.A\H ;C^\YRWMZ<>PSS]: "0$1J?M!?./W>?
MN_H/YG\>M$@(C4_:"^<?N\_=_0?S/X]:=*"(4)A"#CY^?FX_+\OPXHE!$*$P
MA!Q\_/S<?E^7X<4 -D!$:G[07SC]WG[OZ#^9_'K1("(T/V@ODK\F?N\@Y[=/
MJ?QITH(A0F$(./GY^;C\OR_#BB4'R8\PA!E</_>]N>.>G3Z<4 -F!79_I!DS
M[_=_0?Y].Y,"NS_2#)GW^[^@_P ^G=UP"/+S"(_S^;IZY_SUHN 1Y>81'^?S
M=/7/^>M #9@5V?Z09,^_W?T'^?3N3 KL_P!(,F??[OZ#_/IW=< CR\PB/\_F
MZ>N?\]:+@$>7F$1_G\W3US_GK0 DBD-%_I)?)ZY^YQ]!Z^A^E)(")%'V@OG'
M[S/W?T'\C^/2I)0VZ', 3)X'/S_GS[\8--E!\Y 80AX^3GYN?S_+\.: &R B
M11]H+YQ^\S]W]!_(_CTHD!$BC[07SC]YG[OZ#^1_'I3I0?.0&$(>/DY^;G\_
MR_#FB4'SD!A"'CY.?FY_/\OPYH ;(")%'V@OG'[S/W?T'\C^/2E(/GE?M!Z_
MZW/_ -8?^@_XTLH/G(#"$/'R<_-S^?Y?AS1@_:<>2,_\\N<=/S_7]* &X/G;
M?M!_ZZY_^M_3_&C!\[;]H/\ UUS_ /6_I_C3L'[3CR1G_GESCI^?Z_I1@_:<
M>2,_\\N<=/S_ %_2@!N#YVW[0?\ KKG_ .M_3_&E /GA?M!Z_P"MS_\ 6/\
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MY_\ K?T_QHP?.V_:#_UUS_\ 6_I_C3L'[3CR1G_GESCI^?Z_I1@_:<>2,_\
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MASV_S_C1\GG_ 'WV?W\?-T],_P!??VITGGF52R('&, %=I^O 'Z'\>E*1/\
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M_"@!OR>1]]]W]W'R]?7_ .M[>]'R>1]]]_\ <Q\O7U_^M[>]._?^1MV)Y?\
M>RN_^6?U_P *0^?]G*[$\O'WLKO_ *'_ ,>_PH 239Y2;7=FXRI'RCCM_G\N
ME$FSRDVN[-QE2/E'';_/Y=*=)YYB4,B!!C!!7<?KP#^I_'K1)YYB4,B!!C!!
M7<?KP#^I_'K0 V39Y2;7=FXRI'RCCM_G\NE$FSRDVN[-QE2/E'';_/Y=*=)Y
MYB4,B!!C!!7<?KP#^I_'K1)YYB4,B!!C!!7<?KP#^I_'K0!')LVQ;7<G'S9&
M O\ N]<_7CZ4Z;9\FUW;UW#&.G3KT_SFED$Q6+<B@ ?+M*Y/)^]C'/U)^M+-
MY[;-Z(N,;=I7GTS@#_/IW &S;/DVN[>NX8QTZ=>G^<T3;/DVN[>NX8QTZ=>G
M^<TZ;SVV;T1<8V[2O/IG '^?3N3>>VS>B+C&W:5Y],X _P ^G< ;-L^3:[MZ
M[AC'3IUZ?YS1)L\U,.Y7"Y)&"/7 R?IUY]J=-Y[;-Z(N,;=I7GTS@#_/IW)!
M,9$+(@8!=H!7:> 1G  ^O!_&@!LFSS4VN[+QEB/F'/;_ #_C1)L\U-KNR\98
MCYASV_S_ (TZ3SS*I9$#C& "NT_7@#]#^/2B3SS*I9$#C& "NT_7@#]#^/2@
M!LFSS4VN[+QEB/F'/;_/^-.8Q^<N))"N.6(^8?0?_7[=*)//,JED0.,8 *[3
M]> /T/X]*<QN//0F./?M.%!7:>G7MGG^Z?J* (_D\_[[[?[V/FZ>G_U_?VH^
M3S_OOM_O8^;IZ?\ U_?VIW[_ ,_=L3S/[N5V?RQ^G^-'[_S]VQ/,_NY79_+'
MZ?XT -^3S_OOM_O8^;IZ?_7]_:CY//\ OOM_O8^;IZ?_ %_?VIW[_P _=L3S
M/[N5V?RQ^G^-'[_S]VQ/,_NY79_+'Z?XT "F/SFS)(%QPP'S'ZC_ .OWZ4V/
M9YK[G=5YPP'S'GO_ )_QJ13<>>Y$<>_:,J2NT=>G;/']T?4TV/SQ*Q5$+G.0
M2NT?3@C]!^'2@!L>SS7W.ZKSA@/F//?_ #_C1'L\U]SNJ\X8#YCSW_S_ (TZ
M/SQ*Q5$+G.02NT?3@C]!^'2B/SQ*Q5$+G.02NT?3@C]!^'2@!L>SS7R[A<-@
M@9)],C(^G7CWHAV?/N=U]-HSGKUZ=?\ .*=&)A(Y5$+$-N!*[1P2<9!'TX'X
M40^>N_8B-G.[<5X]<9!_SZ]@!L.SY]SNOIM&<]>O3K_G%$.SY]SNOIM&<]>O
M3K_G%.A\]=^Q$;.=VXKQZXR#_GU[$/GKOV(C9SNW%>/7&0?\^O8 ;#L^?<[K
MZ;1G/7KTZ_YQ38]FV7<[@X^7 R&_WNF/KS]*DA\]=^Q$;.=VXKQZXR#_ )]>
MR1B8++M12"/FW%<CD?=SGGZ$?6@!(]GE/N=U;G"@?*>._P#G\^E$>SRGW.ZM
MSA0/E/'?_/Y]*='YXB8*B%#G))7</IP3^H_#K1'YXB8*B%#G))7</IP3^H_#
MK0 V/9Y3[G=6YPH'RGCO_G\^E$>SRGW.ZMSA0/E/'?\ S^?2G1^>(F"HA0YR
M25W#Z<$_J/PZT1^>(F"HA0YR25W#Z<$_J/PZT -^3R/OOO\ [F/EZ^O_ -;V
M]Z/D\C[[[O[N/EZ^O_UO;WI1Y_V<+L3R\?>RN_\ J?\ Q[_"E_?^1MV)Y?\
M>RN_^6?U_P * &_)Y'WWW?W<?+U]?_K>WO1\GD???=_=Q\O7U_\ K>WO3OW_
M )&W8GE_WLKO_EG]?\*/W_D;=B>7_>RN_P#EG]?\* &_)Y'WWW_W,?+U]?\
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M V;9\FUW;UW#&.G3KT_SFB;9\FUW;UW#&.G3KT_SFG3>>VS>B+C&W:5Y],X
M_P ^G<F\]MF]$7&-NTKSZ9P!_GT[@#9-GFIAW*X7)(P1ZX&3].O/M1)L\U-K
MNR\98CYASV_S_C3I!,9$+(@8!=H!7:> 1G  ^O!_&B3SS*I9$#C& "NT_7@#
M]#^/2@!LFSS4VN[+QEB/F'/;_/\ C1)L\U-KNR\98CYASV_S_C3I//,JED0.
M,8 *[3]> /T/X]*)//,JED0.,8 *[3]> /T/X]* !C'YRXDD*XY8CYA]!_\
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MC3YM3MRK2L6(4P:Q"!]X_P  ]L<8R[S_ ()&_#JYM@/^%P_$*&,8XCUOQ$N
M#P %\1+_ (4 ?IA>^.O F@Z?)K.N^)/#Y\M'=FM]7TZX/R@D8"7)R>/_ *W-
M?C3^W+^VKX)\3:5>^ O!NI:K>7\C_9U&EV,UPN6<#B2W653U/(X_"OH+3O\
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M7<,8Z=.O3_.:=-Y[;-Z(N,;=I7GTS@#_ #Z=R;SVV;T1<8V[2O/IG '^?3N
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MR>/KTX]Z=#YZ[]B(V<[MQ7CUQD'_ #Z]B/SQ&X5$*DMN)*[AR<XSD_3D?A0
MV/9Y3[G=6YPH'RGCO_G\^E$>SRGW.ZMSA0/E/'?_ #^?2G1^>(F"HA0YR25W
M#Z<$_J/PZT1^>(F"HA0YR25W#Z<$_J/PZT -CV>4^YW5N<*!\IX[_P"?SZ4U
M=ODMEV#9X4#Y3]3G^G>I(_/$3!40H<Y)*[A]."?U'X=::HF\AP$79N&6)7<.
MO3C../[P^A[@!\GD???=_=Q\O7U_^M[>]'R>1]]]W]W'R]?7_P"M[>]._?\
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M_P#XK_/I4O[_ ,_;O3S/[V%V?X?K_A1^_P#/V[T\S^]A=G^'Z_X4 1?N=_\
MRVV?^/\ _P 5_GTH'D>8V?/V8&,9W]^O\6.G7CT[5+^_\_;O3S/[V%V?X?K_
M (4Y?M'GN!)'OVC+$+M/7IVSS_>/T% $"^3N.[SMO;;][\<<_G^/-"^3N.[S
MMO;;][\<<_G^/-2Q^>96"N@<9R2%VGZ=!^I_'K1'YYE8*Z!QG)(7:?IT'ZG\
M>M $2^3N.[SMO;;][\<<_G^/-"^3N.[SMO;;][\<<_G^/-2Q^>96"N@<9R2%
MVGZ=!^I_'K1'YYE8*Z!QG)(7:?IT'ZG\>M $2^1E]WGXS\NW.>@^]CG/^]S0
MGD\[O.]MG]=O^?3O4T?V@M+MD0$'YMP7!X'W<D>G8GZTD/GMOV.BXSNW!>?7
M&<?Y].X!$GD\[O.]MG]=O^?3O0GD\[O.]MG]=O\ GT[U+#Y[;]CHN,[MP7GU
MQG'^?3N0^>V_8Z+C.[<%Y]<9Q_GT[@$2^3A]WG9Q\NWIU'WL<?\ ?7%"^3M.
M[SMW;;]W\<<?G^/%21F8K+M=0 /FW!<GD?=SCGCL#]*6/SS$Q5T"#.00NX_3
MH?T/X]* (E\G:=WG;NVW[OXXX_/\>*%\G:=WG;NVW[OXXX_/\>*EC\\Q,5=
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MYW_\MMG_ (__ /%?Y]*E_?\ G[=Z>9_>PNS_  _7_"C]_P"?MWIYG]["[/\
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MJAG0N<8("[1]>H_4?AUHD\\2J&="YQ@@+M'UZC]1^'6@",^3YA_UVS)]=_\
M\5_GTI/W._\ Y;;/_'__ (K_ #Z5,3/]H(WIYF?O879Z^N/_ ![_  I/W_G[
M=Z>9_>PNS_#]?\* (OW._P#Y;;/_ !__ .*_SZ4?N=__ "VV?^/_ /Q7^?2I
M?W_G[=Z>9_>PNS_#]?\ "C]_Y^W>GF?WL+L_P_7_  H C'D^8/\ 7;,CUW__
M !7^?2D7R=QW>=M[;?O?CCG\_P >:F!G^T ;T\S/WL+L]?7'_CW^%)'YYE8*
MZ!QG)(7:?IT'ZG\>M $2^3N.[SMO;;][\<<_G^/-"^3N.[SMO;;][\<<_G^/
M-2Q^>96"N@<9R2%VGZ=!^I_'K1'YYE8*Z!QG)(7:?IT'ZG\>M $2^3N.[SMO
M;;][\<<_G^/-"^1E]WGXS\NW.>@^]CG/^]S4L?GF5@KH'&<DA=I^G0?J?QZT
ML?V@M+MD0$'YMP7!X'W<D>G8GZT 0IY/.[SO;9_7;_GT[T)Y/.[SO;9_7;_G
MT[U+#Y[;]CHN,[MP7GUQG'^?3N0^>V_8Z+C.[<%Y]<9Q_GT[@$2>3SN\[VV?
MUV_Y].]">3SN\[VV?UV_Y].]2P^>V_8Z+C.[<%Y]<9Q_GT[D/GMOV.BXSNW!
M>?7&<?Y].X!$OD[6SYV[+8V_=ZG[V/ESCKG\>*%\G:=WG;NVW[OXXX_/\>*E
MC\\QN5= H+;@0NX\DG&<'Z<'\:(_/,3%70(,Y!"[C].A_0_CTH B7R=IW>=N
M[;?N_CCC\_QXH7R=IW>=N[;?N_CCC\_QXJ6/SS$Q5T"#.00NX_3H?T/X]*(_
M/,3%70(,Y!"[C].A_0_CTH B'E>6V?-WY&,?<[]?X<].O/IVH_<[/^6V_P#\
M<_\ B?\ /K3U,WD.0Z[-PRI"[CUZ<YQSZ'ZBG?O_ "-V]/+_ +N%W_X_I_C0
M!%^YV?\ +;?_ ..?_$_Y]:/W.S_EMO\ _'/_ (G_ #ZU+^_\C=O3R_[N%W_X
M_I_C1^_\C=O3R_[N%W_X_I_C0!%^YV?\MM__ (Y_\3_GUH/E>6N/-WY.<_<[
M=/X<]>G/KWJ7]_Y&[>GE_P!W"[_\?T_QIK&;R$)==FXX4!=PZ=><XX]!]30
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M%SC! 7:/KU'ZC\.M*3/]H(WIYF?O879Z^N/_ ![_  H A_<[_P#EML_\?_\
MBO\ /I1^YW_\MMG_ (__ /%?Y]*E_?\ G[=Z>9_>PNS_  _7_"C]_P"?MWIY
MG]["[/\ #]?\* (OW.__ );;/_'_ /XK_/I2CR?,'^NV9'KO_P#BO\^E2?O_
M #]N]/,_O879_A^O^%*#/]H WIYF?O879Z^N/_'O\* (5\G<=WG;>VW[WXXY
M_/\ 'FA?)W'=YVWMM^]^..?S_'FI8_/,K!70.,Y)"[3].@_4_CUHC\\RL%=
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M5)^8\]C_ )_I3I2WG1YF#'"X?GY?0<C/'T^E$I/G)F8.>/GY^7G\_P OPYH
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M^GYG- !\GD?<?=_>S\O7T_\ K^_M1\GD?<?=_>S\O7T_^O[^U.R?LV/.&/\
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M N.5)^8_0_\ UN_6B4GSDS,'/'S\_+S^?Y?AS3F)^T(?/!.TXD]/;U_(8]:
M(_D\_P"X^W^[GYNGK_\ 6]O>CY//^X^W^[GYNGK_ /6]O>G9/VG/G#/_ #UY
MQT_/]/THR?M.?.&?^>O..GY_I^E #?D\_P"X^W^[GYNGK_\ 6]O>CY//^X^W
M^[GYNGK_ /6]O>G9/VG/G#/_ #UYQT_/]/THR?M.?.&?^>O..GY_I^E  HC\
MYLQR%<<*#\P^I_\ K=NM-CV>:^Y'9><*#\PY[G_/]*D4G[0Y\\ [1F3U]O7\
MQCTIL1/G/B8(>?GY^;G\_P _QYH ;'L\U]R.R\X4'YASW/\ G^E$>SS7W([+
MSA0?F'/<_P"?Z4Z(GSGQ,$//S\_-S^?Y_CS1$3YSXF"'GY^?FY_/\_QYH ;'
ML\U\HY7#8 ."/3)P?KT_*B'9\^Y';TVG&.O7KT_SFG1%O.DQ,%.&R_/S>HX&
M>?I]:+<D>9B81_G\W7TS_GI0 V'9\^Y';TVG&.O7KT_SFB'9\^Y';TVG&.O7
MKT_SFG6Y(\S$PC_/YNOIG_/2BW)'F8F$?Y_-U],_YZ4 -AV?/N1V]-IQCKUZ
M]/\ .:;'LVR[D<G'RX. O^]US^GUJ2W)'F8F$?Y_-U],_P">E-B)V38E"<<C
MGY_RX_/ H (]GE/N1RW.&!^4<=Q_G\.M$>SRGW(Y;G# _*..X_S^'6G1$^2^
M)@@Y^3GYN/R_/\>*(B?)?$P0<_)S\W'Y?G^/% #8]GE/N1RW.&!^4<=Q_G\.
MM$>SRGW(Y;G# _*..X_S^'6G1$^2^)@@Y^3GYN/R_/\ 'BB(GR7Q,$'/R<_-
MQ^7Y_CQ0 WY/(^X^_P#O9^7KZ?\ U_\ "CY/(^X^[^]GY>OI_P#7]_:G G[-
MCSAC_GE^/Y?K^M&3]FQYPQ_SRYSU_+]?UH ;\GD?<?=_>S\O7T_^O[^U'R>1
M]Q]W][/R]?3_ .O[^U.R?LV/.&/^>7.>OY?K^M&3]FQYPQ_SRYSU_+]?UH ;
M\GD?<??_ 'L_+U]/_K_X42;/*3:CAN,L3\IX[#_/X]:<2?LV/.&/^>7X_E^O
MZT2D^2F9@XX^3GY>/R_+\.* &R;/*3:CAN,L3\IX[#_/X]:)-GE)M1PW&6)^
M4\=A_G\>M.E)\E,S!QQ\G/R\?E^7X<42D^2F9@XX^3GY>/R_+\.* &R;/*3:
MCAN,L3\IX[#_ #^/6FR;-L6U'!Q\V3D-_N],?K]:DE)\E,S!QQ\G/R\?E^7X
M<4V4G9#F4/QP.?D_/C\LB@ FV?)M1U]=QSGITZ=?\XHFV?)M1U]=QSGITZ=?
M\XIUP2?+S,)/S^7IZX_SUHN"3Y>9A)^?R]/7'^>M #9MGR;4=?7<<YZ=.G7_
M #BB;9\FU'7UW'.>G3IU_P XIUP2?+S,)/S^7IZX_P ]:+@D^7F82?G\O3UQ
M_GK0 V39YJ81PN%R"<D^N#@?7I^=$FSS4VHZKQE2?F//8_Y_I3I2WG1YF#'"
MX?GY?0<C/'T^E$I/G)F8.>/GY^7G\_R_#F@!LFSS4VHZKQE2?F//8_Y_I1)L
M\U-J.J\94GYCSV/^?Z4Z4GSDS,'/'S\_+S^?Y?AS1*3YR9F#GCY^?EY_/\OP
MYH &$?G+B.0+CE2?F/T/_P!;OUIOR>?]Q]O]W/S=/7_ZWM[U(Q/VA#YX)VG$
MGI[>OY#'K3<G[3GSAG_GKSCI^?Z?I0 WY//^X^W^[GYNGK_];V]Z/D\_[C[?
M[N?FZ>O_ -;V]Z=D_:<^<,_\]><=/S_3]*,G[3GSAG_GKSCI^?Z?I0 WY//^
MX^W^[GYNGK_];V]Z<HC\YLQR%<<*#\P^I_\ K=NM&3]ISYPS_P ]><=/S_3]
M*<I/VASYX!VC,GK[>OYC'I0!''L\U]R.R\X4'YASW/\ G^E$>SS7W([+SA0?
MF'/<_P"?Z4Z(GSGQ,$//S\_-S^?Y_CS1$3YSXF"'GY^?FY_/\_QYH ;'L\U]
MR.R\X4'YASW/^?Z41[/-?*.5PV #@CTR<'Z]/RIT1/G/B8(>?GY^;G\_S_'F
MB(MYTF)@IPV7Y^;U' SS]/K0 V'9\^Y';TVG&.O7KT_SFB'9\^Y';TVG&.O7
MKT_SFG6Y(\S$PC_/YNOIG_/2BW)'F8F$?Y_-U],_YZ4 -AV?/N1V]-IQCKUZ
M]/\ .:(=GS[D=O3:<8Z]>O3_ #FG6Y(\S$PC_/YNOIG_ #THMR1YF)A'^?S=
M?3/^>E #8PGE/E'+9;!' 'ID<_3KS[41[/*?<CEN<,#\HX[C_/X=:=$3Y,F)
M@HRV4_O>IXXY^OUHB)\E\3!!S\G/S<?E^?X\4 -CV>4^Y'+<X8'Y1QW'^?PZ
MT1[/*?<CEN<,#\HX[C_/X=:=$3Y+XF"#GY.?FX_+\_QXHB)\E\3!!S\G/S<?
ME^?X\4 -CV>4^Y'+<X8'Y1QW'^?PZT?)Y'W'W_WL_+U]/_K_ .%.B)\E\3!!
MS\G/S<?E^?X\4 G[-CSAC_GE^/Y?K^M #?D\C[C[O[V?EZ^G_P!?W]J/D\C[
MC[O[V?EZ^G_U_?VIV3]FQYPQ_P \N<]?R_7]:,G[-CSAC_GESGK^7Z_K0 WY
M/(^X^[^]GY>OI_\ 7]_:FMM\E<(P;/+$_*?H,?U[U)D_9L><,?\ /+G/7\OU
M_6FL3]G3]Z"-QQ'S\OOZ?D<T $FSRDVHX;C+$_*>.P_S^/6B39Y2;4<-QEB?
ME/'8?Y_'K3I2?)3,P<<?)S\O'Y?E^'%$I/DIF8../DY^7C\OR_#B@!LFSRDV
MHX;C+$_*>.P_S^/6B39Y2;4<-QEB?E/'8?Y_'K3I2?)3,P<<?)S\O'Y?E^'%
M$I/DIF8../DY^7C\OR_#B@".39MBVHX./FR<AO\ =Z8_7ZTZ;9\FU'7UW'.>
MG3IU_P XHE)V0YE#\<#GY/SX_+(IUP2?+S,)/S^7IZX_SUH ;-L^3:CKZ[CG
M/3ITZ_YQ1-L^3:CKZ[CG/3ITZ_YQ3K@D^7F82?G\O3UQ_GK1<$GR\S"3\_EZ
M>N/\]: "01[HML;@9^;)R6_W>!CZ\_2FR;/-3:CJO&5)^8\]C_G^E22D[X<S
MA^>#S\GY\_EDTV4GSDS,'/'S\_+S^?Y?AS0 V39YJ;4=5XRI/S'GL?\ /]*)
M-GFIM1U7C*D_,>>Q_P _TITI/G)F8.>/GY^7G\_R_#FB4GSDS,'/'S\_+S^?
MY?AS0 V39YJ;4=5XRI/S'GL?\_TIS"/SEQ'(%QRI/S'Z'_ZW?K1*3YR9F#GC
MY^?EY_/\OPYIS$_:$/G@G:<2>GMZ_D,>M $?R>?]Q]O]W/S=/7_ZWM[T?)Y_
MW'V_W<_-T]?_ *WM[T[)^TY\X9_YZ\XZ?G^GZ49/VG/G#/\ SUYQT_/]/TH
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M+]?UH ;\GD?<?=_>S\O7T_\ K^_M1\GD?<?=_>S\O7T_^O[^U.R?LV/.&/\
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M/R\_G^7X<T2D^<F9@YX^?GY>?S_+\.: &R;/-3:CJO&5)^8\]C_G^E'R>?\
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M''/'OQD?I0@4[LVS2?B?E_/'^>M"%<OFZ9.>#@_/P.>>/;C _2A"HW9N6C_
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MW]?S_'FABNP8N6<_W,'Y?Z_G^/-#%=@Q<LY_N8/R_P!?S_'F@ 8+L&+9D/\
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M^7G[,V?^>N3C_']/TI 5\H#[2V<#]U@X_P ?U_2EROEX^TMG_GE@X_Q_7]*
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M'WN#QSQSTZ?3B@ 0*=V;9I/Q/R_GC_/6A IW9MFD_$_+^>/\]:$*C=FY:/\
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M%WG-LSC^YD_+_3\OPXH4KO.;ED']_!^;^GY?AQ0I7><W+(/[^#\W]/R_#B@
M0+O;-LSC#?)G[O!YYXXZ]?IQ0@4[LVS2?B?E_/'^>M"%=[9N608;Y\?>X/'/
M'/3I].*$*C=FY:/\#\WYY_SUH $"G=FV:3\3\OYX_P ]:$"G=FV:3\3\OYX_
MSUH0J-V;EH_P/S?GG_/6A"HW9N6C_ _-^>?\]: ! IW9MFD_$_+^>/\ /6A
MNQLVS.<M\^3\O)XYYXZ?RYH0J-V;EH_P/S?GG_/6A"NQLW+(<M\F#\W)YYYY
MZ_RYH %"[#FV9S_?R?E_K^7X<T*%V'-LSG^_D_+_ %_+\.:%*[#FY9#_ ','
MYOZ_E^'-"E=AS<LA_N8/S?U_+\.: !0NPYMF<_W\GY?Z_E^'-"A=AS;,Y_OY
M/R_U_+\.:%*[#FY9#_<P?F_K^7X<T*5V'-RR'^Y@_-_7\OPYH 0!?*!^S-G
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M'UHPOEY^S-G_ )ZY./\ ']/TH!7RV'VA@<C]W@X;KSZ_D<<_6C*^7C[2V?\
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MD_ _+^6/\]* !PHVXMFC_$_-^6?\]*'"C;BV:/\ $_-^6?\ /2ARIVXN6D_
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M^?X\4,%WC%LR#^YD_-_3\_QXH8KO&+EG']_!^7^GY_CQ0Q7>,7+./[^#\O\
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M8V*PQL@SEB.1_GZ_EUI(]GE/N=U;G"@?*>._^?SZ41[/*?<[JW.% ^4\=_\
M/Y]*  >9Y /DQ^7@?O,<_P"'Z]??BE_>>3GR8_+_ +^.?\Y]^OOQ2?)Y'WWW
M_P!S'R]?7_ZWM[T?)Y'WWW?W<?+U]?\ ZWM[T +^\\G/DQ^7_?QS_G/OU]^*
M/WGDY\F/R_[^.?\ .??K[\4GR>1]]]W]W'R]?7_ZWM[T?)Y'WWW?W<?+U]?_
M *WM[T !\SR"?)C\O!_>8Y_P_7K[\4LGF"-2T,:H<88#D_Y^OY]:3Y/(^^^_
M^YCY>OK_ /6]O>B39Y2;7=FXRI'RCCM_G\NE "R>8(U+0QJAQA@.3_GZ_GUH
MD\P1J6AC5#C# <G_ #]?SZTDFSRDVN[-QE2/E'';_/Y=*)-GE)M=V;C*D?*.
M.W^?RZ4 +)Y@C4M#&J'&& Y/^?K^?6DD,@6+=#&H(^4@?>&3UZ?H2/>B39Y2
M;7=FXRI'RCCM_G\NE-DV;8MKN3CYLC 7_=ZY^O'TH ?-Y@V;X8TS]W ^]]<X
M_']<43>8-F^&-,_=P/O?7./Q_7%)-L^3:[MZ[AC'3IUZ?YS1-L^3:[MZ[AC'
M3IUZ?YS0 LWF#9OAC3/W<#[WUSC\?UQ1-Y@V;X8TS]W ^]]<X_']<4DVSY-K
MNWKN&,=.G7I_G-$VSY-KNWKN&,=.G7I_G- "R>9YB!H8U8A=J@'#<#&<@'GZ
M=>F:)/,$BAH8U<XPH'!]/\X/X]*239YJ8=RN%R2,$>N!D_3KS[42;/-3:[LO
M&6(^8<]O\_XT +)Y@D4-#&KG&% X/I_G!_'I1)Y@D4-#&KG&% X/I_G!_'I2
M2;/-3:[LO&6(^8<]O\_XT2;/-3:[LO&6(^8<]O\ /^- #F\WSD!@C#[3A,<$
M<<^OZ$=>:3]YYV/)C\S^YCC_ #CVZ>W-*QC\Y<22%<<L1\P^@_\ K]NE-^3S
M_OOM_O8^;IZ?_7]_:@!?WGG8\F/S/[F./\X]NGMS1^\\['DQ^9_<QQ_G'MT]
MN:3Y//\ OOM_O8^;IZ?_ %_?VH^3S_OOM_O8^;IZ?_7]_:@!?WGG8\F/S/[F
M./\ ./;I[<TJ^;YS@01E]HRF. .>?7] .G--^3S_ +[[?[V/FZ>G_P!?W]J<
MIC\YLR2!<<,!\Q^H_P#K]^E "1^89&"PQLXSE2.!Z_YP/PZ41^89&"PQLXSE
M2.!Z_P"<#\.E)'L\U]SNJ\X8#YCSW_S_ (T1[/-?<[JO.& ^8\]_\_XT +'Y
MAD8+#&SC.5(X'K_G _#I1'YGF.%AC9@&W*0<+P<XP">/IUZXI(]GFON=U7G#
M ?,>>_\ G_&B/9YKY=PN&P0,D^F1D?3KQ[T +#YAW[(8WQ][(^[],9_#],T0
M^8=^R&-\?>R/N_3&?P_3-)#L^?<[KZ;1G/7KTZ_YQ1#L^?<[KZ;1G/7KTZ_Y
MQ0 L/F'?LAC?'WLC[OTQG\/TS1#YAW[(8WQ][(^[],9_#],TD.SY]SNOIM&<
M]>O3K_G%$.SY]SNOIM&<]>O3K_G% "Q^:8W*PQLH+;F(Y7DYQC(X^O3KBB/S
M#&Q6&-D&<L1R/\_7\NM)&4\I\R.&RV !D'TR>/KTX]Z(]GE/N=U;G"@?*>._
M^?SZ4 +'YAC8K#&R#.6(Y'^?K^76B/S#&Q6&-D&<L1R/\_7\NM)'L\I]SNK<
MX4#Y3QW_ ,_GTHCV>4^YW5N<*!\IX[_Y_/I0 L?F&-BL,;(,Y8CD?Y^OY=:0
M>9Y /DQ^7@?O,<_X?KU]^*(]GE/N=U;G"@?*>._^?SZ4?)Y'WWW_ -S'R]?7
M_P"M[>] "_O/)SY,?E_W\<_YS[]??BC]YY.?)C\O^_CG_.??K[\4GR>1]]]W
M]W'R]?7_ .M[>]'R>1]]]W]W'R]?7_ZWM[T +^\\G/DQ^7_?QS_G/OU]^*1B
M_DH3$@3<</@Y)XX]/U)Z\4?)Y'WWW?W<?+U]?_K>WO36V^2N'8MGE2/E'T.?
MZ=J 'R>8(U+0QJAQA@.3_GZ_GUHD\P1J6AC5#C# <G_/U_/K22;/*3:[LW&5
M(^4<=O\ /Y=*)-GE)M=V;C*D?*..W^?RZ4 +)Y@C4M#&J'&& Y/^?K^?6B3S
M!&I:&-4.,,!R?\_7\^M))L\I-KNS<94CY1QV_P _ETHDV>4FUW9N,J1\HX[?
MY_+I0 2&0+%NAC4$?*0/O#)Z]/T)'O2S>8-F^&-,_=P/O?7./Q_7%,DV;8MK
MN3CYLC 7_=ZY^O'TITVSY-KNWKN&,=.G7I_G- "S>8-F^&-,_=P/O?7./Q_7
M%$WF#9OAC3/W<#[WUSC\?UQ23;/DVN[>NX8QTZ=>G^<T3;/DVN[>NX8QTZ=>
MG^<T .D\T-%N@C4D_* /O<'KT_0$^U))Y@D4-#&KG&% X/I_G!_'I2R>7NBV
MR.1GYLC!7_=Y.?IQ]:;)L\U-KNR\98CYASV_S_C0 LGF"10T,:N<84#@^G^<
M'\>E$GF"10T,:N<84#@^G^<'\>E))L\U-KNR\98CYASV_P _XT2;/-3:[LO&
M6(^8<]O\_P"- "R>8)%#0QJYQA0.#Z?YP?QZ4K>;YR P1A]IPF."..?7]".O
M--DV>:FUW9>,L1\PY[?Y_P :<QC\Y<22%<<L1\P^@_\ K]NE "?O/.QY,?F?
MW,<?YQ[=/;FC]YYV/)C\S^YCC_./;I[<TGR>?]]]O]['S=/3_P"O[^U'R>?]
M]]O]['S=/3_Z_O[4 +^\\['DQ^9_<QQ_G'MT]N:4>;YX'DQ^9D?N\''\L_IT
M]N:;\GG_ 'WV_P!['S=/3_Z_O[4?)Y_WWV?W\?-T],_U]_:@!8_,,C!88V<9
MRI' ]?\ .!^'2B/S#(P6&-G&<J1P/7_.!^'2DCV>:^YW5><,!\QY[_Y_QHCV
M>:^YW5><,!\QY[_Y_P : %C\PR,%AC9QG*D<#U_S@?ATHC\PR,%AC9QG*D<#
MU_S@?ATI(]GFON=U7G# ?,>>_P#G_&B/9YK[G=5YPP'S'GO_ )_QH 6/S/,<
M+#&S -N4@X7@YQ@$\?3KUQ1#YAW[(8WQ][(^[],9_#],TD>SS7R[A<-@@9)]
M,C(^G7CWHAV?/N=U]-HSGKUZ=?\ .* %A\P[]D,;X^]D?=^F,_A^F:(?,._9
M#&^/O9'W?IC/X?IFDAV?/N=U]-HSGKUZ=?\ .*(=GS[G=?3:,YZ]>G7_ #B@
M!8?,._9#&^/O9'W?IC/X?IFB/S3&Y6&-E!;<Q'*\G.,9''UZ=<4D.SY]SNOI
MM&<]>O3K_G%$93RGS(X;+8 &0?3)X^O3CWH 6/S#&Q6&-D&<L1R/\_7\NM$?
MF&-BL,;(,Y8CD?Y^OY=:2/9Y3[G=6YPH'RGCO_G\^E$>SRGW.ZMSA0/E/'?_
M #^?2@!8_,,;%88V09RQ'(_S]?RZT1^88V*PQL@SEB.1_GZ_EUI(]GE/N=U;
MG"@?*>._^?SZ41[/*?<[JW.% ^4\=_\ /Y]*  >9Y /DQ^7@?O,<_P"'Z]??
MBE_>>3GR8_+_ +^.?\Y]^OOQ2?)Y'WWW_P!S'R]?7_ZWM[T?)Y'WWW?W<?+U
M]?\ ZWM[T +^\\G/DQ^7_?QS_G/OU]^*/WGDY\F/R_[^.?\ .??K[\4GR>1]
M]]W]W'R]?7_ZWM[T?)Y'WWW?W<?+U]?_ *WM[T #%_)0F) FXX?!R3QQZ?J3
MUXI9/,$:EH8U0XPP')_S]?SZTQMODKAV+9Y4CY1]#G^G:G2;/*3:[LW&5(^4
M<=O\_ETH 63S!&I:&-4.,,!R?\_7\^M$GF"-2T,:H<88#D_Y^OY]:239Y2;7
M=FXRI'RCCM_G\NE$FSRDVN[-QE2/E'';_/Y=* %D\P1J6AC5#C# <G_/U_/K
M22&0+%NAC4$?*0/O#)Z]/T)'O1)L\I-KNS<94CY1QV_S^72FR;-L6UW)Q\V1
M@+_N]<_7CZ4 /F\P;-\,:9^[@?>^N<?C^N*)O,&S?#&F?NX'WOKG'X_KBDFV
M?)M=V]=PQCITZ]/\YHFV?)M=V]=PQCITZ]/\YH 6;S!LWPQIG[N!][ZYQ^/Z
MXI9/-#1;H(U)/R@#[W!Z]/T!/M39MGR;7=O7<,8Z=.O3_.:=)Y>Z+;(Y&?FR
M,%?]WDY^G'UH 23S!(H:&-7.,*!P?3_.#^/2B3S!(H:&-7.,*!P?3_.#^/2D
MDV>:FUW9>,L1\PY[?Y_QHDV>:FUW9>,L1\PY[?Y_QH 63S!(H:&-7.,*!P?3
M_.#^/2B3S!(H:&-7.,*!P?3_ #@_CTI)-GFIM=V7C+$?,.>W^?\ &B39YJ;7
M=EXRQ'S#GM_G_&@!Q\WSR/)C\S)_=X./Y9_3I[<TG[SSL>3'YG]S''^<>W3V
MYI/D\_[[[/[^/FZ>F?Z^_M1\GG_??;_>Q\W3T_\ K^_M0 O[SSL>3'YG]S''
M^<>W3VYH_>>=CR8_,_N8X_SCVZ>W-)\GG_??;_>Q\W3T_P#K^_M1\GG_ 'WV
M_P!['S=/3_Z_O[4 .'F^>!Y,?F9'[O!Q_+/Z=/;FDC\PR,%AC9QG*D<#U_S@
M?ATI/D\_[[[/[^/FZ>F?Z^_M1'L\U]SNJ\X8#YCSW_S_ (T +'YAD8+#&SC.
M5(X'K_G _#I1'YAD8+#&SC.5(X'K_G _#I21[/-?<[JO.& ^8\]_\_XT1[/-
M?<[JO.& ^8\]_P#/^- "Q^89&"PQLXSE2.!Z_P"<#\.E+'YI:7;!&Q!^8$?=
MX'3K^H!]J;'L\U]SNJ\X8#YCSW_S_C3H_+W2[I' S\N!DM_O<C'TY^M "0^8
M=^R&-\?>R/N_3&?P_3-$/F'?LAC?'WLC[OTQG\/TS20[/GW.Z^FT9SUZ].O^
M<40[/GW.Z^FT9SUZ].O^<4 +#YAW[(8WQ][(^[],9_#],T0^8=^R&-\?>R/N
M_3&?P_3-)#L^?<[KZ;1G/7KTZ_YQ1#L^?<[KZ;1G/7KTZ_YQ0 L?FF-RL,;*
M"VYB.5Y.<8R./KTZXHC\PQL5AC9!G+$<C_/U_+K21E/*?,CALM@ 9!],GCZ]
M./>B/9Y3[G=6YPH'RGCO_G\^E "Q^88V*PQL@SEB.1_GZ_EUHC\PQL5AC9!G
M+$<C_/U_+K21[/*?<[JW.% ^4\=_\_GTHCV>4^YW5N<*!\IX[_Y_/I0 *7\E
MR(D*;AE\'(//'I^H/3BE_>>3GR8_+_OXY_SGWZ^_%,7;Y+9=@V>% ^4_4Y_I
MWIWR>1]]]W]W'R]?7_ZWM[T +^\\G/DQ^7_?QS_G/OU]^*/WGDY\F/R_[^.?
M\Y]^OOQ2?)Y'WWW?W<?+U]?_ *WM[T?)Y'WWW?W<?+U]?_K>WO0 O[SR<^3'
MY?\ ?QS_ )S[]??BD8OY*$Q($W'#X.2>./3]2>O%'R>1]]]W]W'R]?7_ .M[
M>]-;;Y*X=BV>5(^4?0Y_IVH ?)Y@C4M#&J'&& Y/^?K^?6B3S!&I:&-4.,,!
MR?\ /U_/K22;/*3:[LW&5(^4<=O\_ETHDV>4FUW9N,J1\HX[?Y_+I0 LGF"-
M2T,:H<88#D_Y^OY]:)/-$:%H8U4E=K <MR,9S@<_7ITS22;/*3:[LW&5(^4<
M=O\ /Y=*)"GE)B1RV5R", >N#S]>G/M0 LWF#9OAC3/W<#[WUSC\?UQ1-Y@V
M;X8TS]W ^]]<X_']<4DVSY-KNWKN&,=.G7I_G-$VSY-KNWKN&,=.G7I_G- "
MS>8-F^&-,_=P/O?7./Q_7%$WF#9OAC3/W<#[WUSC\?UQ23;/DVN[>NX8QTZ=
M>G^<T3;/DVN[>NX8QTZ=>G^<T .D\T-%N@C4D_* /O<'KT_0$^U))Y@D4-#&
MKG&% X/I_G!_'I2R>7NBVR.1GYLC!7_=Y.?IQ]:;)L\U-KNR\98CYASV_P _
MXT +)Y@D4-#&KG&% X/I_G!_'I1)Y@D4-#&KG&% X/I_G!_'I22;/-3:[LO&
M6(^8<]O\_P"-$FSS4VN[+QEB/F'/;_/^- "R>8)%#0QJYQA0.#Z?YP?QZ4I\
MWSR/)C\S)_=X./Y9_3I[<TV39YJ;7=EXRQ'S#GM_G_&CY//^^^S^_CYNGIG^
MOO[4 +^\\['DQ^9_<QQ_G'MT]N:/WGG8\F/S/[F./\X]NGMS2?)Y_P!]]O\
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M?K_#GIUY].U $W[S[-_RSV?AOZ_]]?Y]*/WGV;_EGL_#?U_[Z_SZ5#^YV?\
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MZ4 3?O/M/_+/?^&SI_WS_GUH_>?:?^6>_P##9T_[Y_SZU#^YW_\ +;9_X_\
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M'F@"6W\S]YM\OWWX_'&[_/KVHM_,_>;?+]]^/QQN_P ^O:H%-O\ -O,@]-K
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M]WE^VS'X9V_Y].]0MY+8\H3-C[V[)Q],@_YZTDAMP5&Z13QD2G!Y_N[O\^M
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M_P#\5_GTH F_>?:?^6>_\-G3_OG_ #ZT?O/M7_+/?_P'9T_[Y_SZU#^YW_\
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MG[O=Y?MLQ^&=O^?3O1+YGG1Y\O.%QMV[?^!8^7..N?QXJ%_)XV^=[[_Z;O\
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M=O[R5AB.4]"J#GESPO8YZ=:\:_9W^*%I\6_A!H_Q#N+!K,7VFV]ZZLY;RQ)
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M(K\I?^"T/[;G[0O[*^O>%E^&'B*XLM)GG<:G90Q9^U1*T/R;O.BQ\I8?CUH
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MZX)/EYF$GY_+T]<?YZTV4$+#F()D<'GY_?GCVXP*=< CR\PB/\_FZ>N?\]:
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MO'Y?G^/%$0)A<B$..?GY^7C\OS_'B@ R?LV/.&/^>7?K^7Z_K1D_9L><,?\
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MO"?A^PT;PY8Q:5:_8[<;Q&A W1(3G"@CD\\5_%I^Q?J-Q;?M\V]A<:<FFO\
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M;P]:Z<MOIX_LRU_T<JNX?)TX7D_6OP[_ ."UFA^'8/A%+K=[8QS74>IQQI<
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MRK55POE!;J11]<8';\*_73_@J;XEUG0?AOH-E9-*MM<Z>R%D)"Q*8HQSAAD
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M==^1'&L0:(,6\I1T:0GD\?\ ZZ /U,N)+J#442:RDU LXQ?(0%B&>IY!..O
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MG^ROHK6%EXSE\2LL2(-\'D[=BD=XD_E_6OL2#4-7LYYEDB>6)F_UA/W!GJ
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MYW#GMDY_4?AUJ6;S//3=Y>[C&W&W\<<?G^/%$WF>>F[R]W&-N-OXXX_/\>*
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M;V#X3Z'D)-.EM=:K;$VA578(QE^Q>600/[Q!Z]Z^4-:_X."_VPK6[:UT[2O
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M>/IG/^?QJ2.*%,&1O,;L(\,!W^;;G'3O_P#7*W(F)3*QD?P[,9 X^]M'\\4
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MP<#.=QT=5Y'&<]?:@#^T2"&\MH_L2F1L<;FW'OSECG/X54U06%I:,=2N+F(
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M!H@1ALCCTKXF_9D\0P:/\1M.M+R.2_\ $*7<*R7EIED:0, S!N3@G)^_[=:
M/]$?0=8UCQ*;35K37K&X\-R00-M1@QVF)!R^[KN)SQ_.NN\0-)/IOD:2ID;
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M2H12Q&!QP#TK^-+_ ((QZ9-XI\1:Y/IS#19++7@MS;7_ .[EE9;:U;Y0-O\
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MXU9-OU:0C[W^QUX/4T ?V3_!+X[^!_C#X)A^(DVBZIX,L9X1/Y/B(M;2HO\
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M/RGCL/\ /X]:B6<W%O&ZGRX<D"%_OJV!EB!Z_3^=32>88E#31LG&$!Y'I_G
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MJ_EE\+^'OB5^TGX^_P"$=^T:MK.L7UX0-0DN;JXLSYC%AD33D8 /<]J^]_\
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M0W)FAX2>)X1T0'/ Z9&[' XZ>E8]YJNCVRIG31?3DC<(($9Q]3L)ZGGO[YH
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M_P!:RO@!_P $/_V:/#_P_MSXVT"QN]6U*R6Y\](])(#RQC)+2:?(P.[)^_\
MCS7RE^UE_P $;/#'P^\+ZUXZ^&MYI.FZ/IL-Q<M;>9:B0B)#(0!;QPC.T?W>
M_?I0!_/9\5=8O-0U77?)C6[M;J\N9$NDC5X0CL<,6],=2>W6OZ$?^"(DFG0Z
M?J.F3^9--.UG(# ["%=K2 AU!QGG(R.U?S6_$-/$GAN\U+2([J-K*TGFMYBN
MX@B,X;!WCMR./3BOZ4?^"'6E02^'M7UB.Z@DN(S9((%;,I=_-.X#@X#+^M '
M]*OQ"\4^$? .@/JGC'5K72-#A@$CS7,_D *JYQO )Y/'3OCJ:_)OXH_\%E/V
M1_@OJEQIMBM]XKN[9W0G1[I[K>R'D+_H[9P<_B/QJW_P4"_9H_:7^/GAO4-)
MT7XH^&?!7A"YA*C^WKNYMHXX\+]XB^CC R/^>8YZ5_/UX1_X)/>&?AKXH_X2
M7XM_M+?!_7;:.X::YLK76XI+A@7)=0LKS_-UZ@T ?L(W_!Q=^S3%-^_^&'CV
M, X$KP.8B!W_ ./3&/3'7.?6NHT+_@X)_92\:74.C-X<\0:2UQ(D7FW6^%(R
M[8RQ6T& N1GGMVKY!A\'?\$J?"WAIM.\7?V)XIU>&W9'.DW&DS>9(JD%E#:/
M*3D\]?\ &OQ8_:>_X8VU?Q5?Z-\#O"UYI-Y(TB64LBVBQI(RGRFS;Z?;=&P>
M"#T^M ']U?P5_;1^"'Q>TY&\*>)]+N9S '%DMUYET?E'R8,:_-SCKG-?/_[5
M'_!3/X>?LH6\FJ^+_AIXRU>P5R%O+"V,EO)P6#(P@D!! R/8]:_D0_X)T^(_
M&/PV^*MN9=;2XLY+M(UMXKB=G53,, J)L#'0_+[5_4C^V#\#M1_::_9QTUK;
M3S>3KIL,[$Q)(RD6K<DR G^+DY_PH \B^&'_  7W_9C^,VLVN@1^ _&.BRW$
MZP1R7Z/#&&8[1_RZJ./3BOVD\%>,-.\>>$--\5>%"8+'4(8IHA<?O#LECWC[
MP'...@[GBO\ -[^)GPRU_P#9]^)ZQ/=0PC3M6&^WC^22,13'.51@!C';I]>*
M_L5_X)7_ +5VG?%#P-X?\#/JD=Q=V-C;1/!YLK.ICC2,@JY*Y!.#[_AD _9:
M^U:/3M!U?5M959K72-,O-0N1&J@M%9V[S/M(4X)5#M(^N*_&WXH_\%IOV:OA
M#JFK:9?^$O$^HW6ERR1RI:%W+M&S*0@%LW=3Z]17W[^V3\8M ^"OPA\;W6K7
M<=J=2\-:KI]JS.R8GO[.6VA)P">))1W'IQS7^>[X\@\7?$CXUZG#!?IJ$&NZ
MPXM5B9GPLMPV,AG(_C'8#^@!_93^S;_P6C^&7[2_B#^P/ ?P>^(UDOGI ]Y=
MV<K6_P [;0VXV\8VCDGT'Y5^JWB?XK> ?"/AJ+Q-XJURP\.));_:&M-4G%O<
M8V!RNTH3NY Z?UK\<_\ @DK^QMK'P?T"W\0^+;*!1J<%O/ WDQ!ON[NN&/\
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M1E\\$<\>OZD=.*2/S!(Q6:-7.<N3P?7_ #D_CUH 2/9YK[D=EYPH/S#GN?\
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M .D&/'O][]#_ )]>P B!3NS;-)^)^7\\?YZT(%.[-LTGXGY?SQ_GK2P@MO\
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M/3IW_+.^)-_\>OV[OB-;>)K+0O$0@FNE,21QX7RVFWJ!^\N>#NXY_2OZC?\
M@F[_ ,$Z9/A;HOA[QUXJ@-GXA2RM)IH;L;;D2F%-X<?95Y!SGYZ /U9^%'@Z
M+X7>&M/T2TL7OV2UM_WL?RCF-&Z;5Z9QTXQ]*]<D,C1_;IE-F3UCD/X8/?\
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MQG%?ME\"?^"Y,W@'P.WA:7PX_P!MALUMK,-$2Z.L90;/^)HG.<8X/Z4 =O\
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M^4+_ (*\?M-_M _"/QB]KX ^)GB3P]9K:OB'3KH1QH4D9=V-HQ@  ?2OS?\
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M9,A@='0_=_U<G.1F@#^Z_P 3?\$S/V)O%-E)<GX/VVI13J2MS#=*$&X$A_\
MCW_(?UXK\T_VB_\ @E!^QUX7TG6]3L?$>A^ KEK>2:TT^ZF5Y(&"L H_T0YR
MRYZ_SK^;^/\ ;D_:\\-J+#3OVA/&=Y9(/+5(]0S'L QQF).,?YS5#4OV@?CC
M\6[2:V\2_$#7O$.H7*F)$NI_,E)(.%'R^K>OX4 <9\8_ D?P,\4ZH/!5_P#\
M)]:0W,GD7.F$A+9$=MK9'E9'?IV]Z_?G_@AS^T3XOUF[O-/U?3;W5HE>%!&9
M'_T0$L"&#2GIC]*_$+X*?LM_M%>*?$\%I+X6\3:CI6M7**]V8MT*QR/@L6V=
M,.3G:>E?V'_\$V/V'-._9@T6'6]71([_ %F&&:>&;/F1R8W$,!;P\@N0?F;I
MUZT ?*__  6?^$EY\5?#UEK-AX7N]2:T@FF=H #]F^5&RV,]-N>O05_)QX.O
ME^'WQ*TV?5-,DN'TC4496=BOV0QRKG=V^4J/R]J_TM_B#X'\+>.]!O=$N[*U
MG2_@>'>X!"AU(SG!/?\ N_RX_EX_;Z_X)%:]'>W_ (G^&=A<7ANWFN98M*4,
M>2S88"Q7UQC<: /U7_8:_;]^%WC'X<>$?#WBCQ]HJZC9Z/8Z=%92W.V6$6\*
M6\<.W<?]6J!.W2OT_L-1\/>)EBU/PY<PZC$X#K-;L77GG/0<8/;\>]?YMNN_
M"+X[? OQ'-#+I_B'09]/N6"N5V$F-R0^0J_>^]TS[9KT*+]KC]IW0=-^SZ=^
MT)XK\)/"FQ+&+4/*)VC@!?(?Z?>_+L ?Z+.L>.] \*6,D_B;6+7288E)>>Z(
M144#))W<G ]OY5^+W_!0#_@HM\+[#P+XA^''AW6M+UJ\U&TNK9=1M+LX@>6-
MXAE RYVG#=/;KQ7\A;?M8?M0^)+GRO$/QY\6>*K-FP]E<WPF2="<%2ODJ2&&
M>XX-7K?X*_&3X\:C!=Z-9:W.\I4,8%&968\L1LDR6S[=J .0\1Z]JVO>,+BS
MM4DU^ZU/5#<Q/"-S11M.@*\G)^^#GKQ7]EW_  2F^"<%G\&-.\0ZEI$MGJC:
M?(29<!LLK <!>^?7I7P-_P $S_\ @E#?VMXOCOXJ:9(9K.*W$5CK"?-)YK^8
MSA3:\X\H#.\=1FOZ5/#>CZ;\.["'PUX:TN.UM88HXA!:+A<  ' ^7\?\F@#^
M/3_@KC\#[N'XMZWXQ'AB[$:R.W]I;<1D+'M'./H/H:_-[]A[XOZ/\(OCCIOB
M"ZTC^S);>\0/K<TI6)<?+D@,O3D5_>+\>?V9_!W[0?AJ^T77(+*&^NH91FXR
M)-Y!*](IAGIT'/2OY,OVUO\ @E1\3_AKKVJ:KX$T?5M1TF.226,:>FZ C.[Y
M?]%B/?U[?A0!_55^SU^V/\*OB=X6TV&X\?Z+/JLEM"GE?:"9=P15VX)(SQCK
M_.OK[2(M*U!9-3M&2\M63*W,;?NV_BP#ZX;/7H:_S7M$U#]H/X,ZL83!XDT!
M[5V7?C84*D@'J!P1QQ[\&MW5?VV/VM[6^^S:=^T7XQT&TVJO]E1:B(D3U.WR
M7[ +][L.E '^@M\4OVD/A3\*+2_N?&.M:9H2VL4KQB]N/+^TN@.V-3SR_..G
MYU^0]Q_P7/\ A-X>^(=[X;N_ $%MHD5U);V_BR346^QW2"78DR?Z01M=?G'R
MCC\:_E5U?XF_&[XMV:0>+OB5KOC>1P-D5Y<B<M(1@8_<J<G/L.<UZI\!/V"_
MCA^T1XDM-+U+PUKUMH"SHT5W)%MMVB#!0P;RI.-IS]W/L,4 ?W#?!C]M+X8?
MM(6=L/ WC'1X+J=$=[2VN/.D"L!E>^,$XX_J*^JM+TJ&RD^T6:&:_8'?=KDB
M3(^8X&/O9SCM7Y4?L-_\$^O#/[)^EZ9K>LWUHEXT,2O#.PWJY"L01]DA((((
M^]^1K]=OM%K>6:2:+(A$H4*\'& W<=N <]\?S 'KJ%U; BZ!&?XV4@+[G/;O
M^8KFO%EM'K/AK5DA8ZE<&WD$=O%P^XJW Z<YXXQ5B=+[36"W7F7ZS'JXW; ?
M4X3&,^_3!%(S'3W22PA+&4Y98AT_#(]>_P!>: /X_/\ @I/^S+^TKX_\17C>
M"OA%XQU>Q^T3Y&GH[+,A;C!$HZC/09]J_(>U_8(_:VB\V6P_9B^(UG=<EIF$
MI\QO4 2]^3CKS^-?Z3_V^\:WW&QD+[?[O/0<_7-9EIJ]\CN+J"6%#GYGZ#W'
M)X]: /\ .Z^#W[!W[8EQ\0= U+Q+\"O'^GZ?I]X97DN89A&%\MTY)F(Q\PZ?
MUK^U+]@?P?XI\!?#VWTS6?#6H:-=+ J&.[!WAO*53P6/<$?GGK7WG<:G;*CN
M-169P,_9M^2Y[C&T9]1R.E5H;F]U"-A%')8J>"Z@K^/&?7C]1S0!8GLK^5OM
MES<F.%3N:)E(X'.,X_#/;ZYK*2SAO=0BGMY0HC90P!)R0<_A_GUK733)9H'M
MY=5,K/G[SG(R .Z]OI5&-;+P^&BN+E%+9/FL?NYR.N .".#@T >?_$3X\?!+
MX;7"0?$'Q9H>ASJHR=2F5"HR02<J>F#Q]*\^T/\ ;%_9=\17RV?ACXH^#-7N
MY&VQVUI)"\I8G  /E9_,_3IQ\/\ _!07]B&;]H3PEK7B;PYKANM2BM+@P6EL
MX,K.J,ZJH^R2<DD #</K7\:MYX!^.7[*7C2:_P!6TKQ!9C2[Z0-)*A Q#*RD
MGB$?P\XQQF@#_2+L;^#Q'8IJGA^\C:)U#HT #(5( !&-O&.?\C/YX?\ !3&Z
MT:']GO68_$;6\[_9) PD"HV2_!SM)_SZU_.E\'O^"YFK^ /"5OX7U2&874$*
MP&>9</N48Y(U)3GM]W^M?/O[4G_!1OXI?M5>&[GPGX<T_5KV"_Q&C6JDJ=[#
M '^FRCO_ '3^7% 'YL_%'PUX6OM=FO-.U:VV'4\KI\4GSY^U>H4'KSQVZ]Z_
MLM_X)'2:KX4_9[T;4M7UY;/PM%;(\]I<C]W]G5_W@:0G@;<Y^OX5^#/_  3_
M /\ @FM\1?BMKVF:SX_\':G;Z--<I<R7^I1$08:3?DMY$AZD>O:O["/AW^SA
MX6\!_"S_ (5AI?V00G37M@L(^7?)"?E_U*<AFQ]SJ#0!^=7[7?P9_P"">7[1
MB75A?_$WP1X=\4.[F:>6Z5I4G(8$LGV5^0YYY]J_,C1?^"('@+XIZC):_#7]
MJ_P_J-DC,UOI>F0[I$0'Y4W+9+G .,YY].E?'7[>_P"QE\=? GQ!U[Q+H7A/
MQ FE->7$L-W!#^YDC,K."IPO!49'^2/)/V0_VZ?'O[)OB1KGQ7X>U&%;8[6D
MNXA\^QE)!(O(3R%R?6@#]G/!O_!"_P"'WPV@U.\^,GC*+Q5I]C:32VWVHO"A
MD3!0@FU(Z X_3L:_!/\ ;$T?P3\(/'FM>$_ .BKJFEVEW<6UG#:.&VJDA2/!
M"1YX&*_1']I?_@L9XX_:L\,CP'\--(U#3=3VB"2YTI-DL@V&,Y/]H7'4D'[M
M?''[._["WQ^^.7CNUUGQ3IWB2XCN+M)YIKM<AE:0,Q8_9Y."#D_6@#]0O^"!
M?PB7Q*_BWQ+XQ\.W%FDVNM/IQN/D$,0L[0#!PV?G5C]?T_K'T_0[..$PK<)>
M):@""%#_ *L#H.G/05\D?L=_LV:'^SS\,= TV58;/4Y+5GO$/$K2[F'S_N8^
M<!1T'X]OKB+9%(S6G[O>?O("-WZ_YS0!1GD@G+6VIVC18^6$OD>P(YY[=L]O
M2N?U>SU33M*O;;3;&:\^UQN(GC&=F00"#QTS[YXQ[=;<M=AE,NG27I/W7(+;
M>G/!^A]*HZC:7UUY0_M272?[L6XIGT&#&W'XB@#^.7_@LOX6\3>%];@N_$&G
M75Y!=S3LDDB$+ -R\GV&[WZ8]J^+O^"=7B;0+'XW^"K&+4K:>:34;']T"-T3
M/<@F,\#E"2I_W?K7]9?[>/['<_QY\)WEQ-;-K]U:VLS6\;#S'D=DR H\KJ2H
M]/T./XV/&WP6^*'[+_Q*U7Q-+X,U7PM+H>LW4MG,T(B+0P7+O!,ARIVN@5U.
M1P>YZ '^B=H21WGA301]D,PDTNVPRDXP4&._OG_"OFS]L:&/2?V>O&<@TU[I
M1IM^QM5)#./LQX&?4\?_ %Z_EU^ '_!?+QIX'T.+P3K7AJ^\27\2+9PW<\?F
M21[56,!3_:T.,<G[G^%<S^T5^WC^TG^T%I-Y<:.?%'A_PW=0R&>WAPEKY3J=
MP8?:;CC8<'GI^)H _)CXT:OJEWXG\1,OA2[T[3%U*Z$V_)5EWG<2P.,$?XU_
M1W_P0ZT?SO#NMZQI3&WM;6&W:> '<&D"S.N3V(*,!ZYK^7;Q]=>)6NKR75O$
M]TZ222-<P32<,Q.6#@1]3WYS7]0?_!"S7[9O"VNZ793(RSQ6JN$(PSE)U&??
MYOS/>@#S/_@J1_P45^(NG?$;5_@=;:E+X;T=2;8:H[.L2CR@W.)O4X^Y7XN?
M!3X/^+OVGOBS;^#4\9SZLNH70W7T#RNA$N7/RY8=]N=M?KK_ ,%8?V)/'OB/
MXCZQ\2+7PKJ6H:6Q:83I%NBV^6%SNV=,D_Q?TK\8O@I\8]8_9(^(<'BNWL+B
M*]T^Y!.GJ/GS&VS!7S8#V/!?Z8[ ']*'PK_X-_\ P3%I%OK'B?Q#]HU VPN)
M%E4AFS&'*X-L>H^7D\_0FOS0_;J_93^#/[/2:QHGA?P9]B\5V4$X@\7^8"B3
M)&Q2;RO+3A2!D>V*^E)_^"^OQ"\2_#U= \'?#K4]6\4/;+;1I96V^[9B!&"/
M^)R.=I!Z?AUK\R/COJ7[4WQ[TS4?B5\1_"_BWPQH5Q'/<7"ZG%Y5O';D-N+?
MO;GY0F3]\X&* ,G]A6PN-0^)EDL]WY\J7L9:?'WR)5R<=L\GZ_K_ '>?!E+B
M7X-Z?I/D%EGTN*W+E000T 7]?8=J_P _S]E_QYX<\ ^/=*'_  D=LEP;^%&7
MS3N'[Q<YX09S^G2O[U_V5/%6C^+?@]X8NK?Q'#([V-I(563/6 >H/K_G@T ?
MS-_\%<_V++OP_<7WQ$TY9+:2^NY+F5O*&"LN^1O^68XS_M?SKXF_X)]_M+:1
M^SAXC2ZDU*"PU&(!99)Y2OFNKJ67;O7[Q'KVK^S7]J[X,Z)\:_A]J6CW:P:@
M;2PF<%^>4C8?W&]?3]*_@[_::^'5I\'/B_XDL?[(2ZM[:^NXXDV!A'LG(4C_
M %?0 XYSC\: /U&_X*0?\%$+G]H#X6KX5L;?[.\CV*C5$F+)-Y=Q"Q*@S-]_
M'IW[5X9_P3#_ &*M7^/WC&S\6W>M-;II-W;W1#P!PX$F_DF-NR=<@^]?F?X4
MMM1^(_C/PCX?"R-9:GXBT>Q-I_RSACN+Z",G'S';&&R>O S@\5_=O_P3_P#V
M4= ^ 7P^TC5([VVCFUFQMY70,=RGR@V#BWCQ@L>_\J /NKP181>$?">B>&[:
MU_M"33+6*W:6$;>414R0 .?ESR /:OFS]J/]BGX:?M6Z4\7CS24DO$C=;668
MJ#"[#J T,N>@_+FOK:31I8M-U$Z=>,UQ/&YB>)OF5BK8*_+ZD>N/6OY\_P#@
MH-X"_;CWWU_\)?&'CVSM8_/D!T:8!$4<KC$/  Z9S0!\V?%[_@@1J;7-W?\
M@OX@QZ3:*SO!I\5FKLR9)6-6^R#G^'KGFOS7^(__  3._:@^$VISQ>#OA]XP
M\62V;E8=2T^!PD[*,K*H#1\,W3@>F*X:U_:@_;[^#'BC[1\0OB;\1;ZTL;G=
M+;:E=90HCY96 6+C"X(R.M?HWX4_X.--<^'FDZ=X>O\ X?7/BR]LK2"UN;Z6
MW\V22>.-4D9F_MN#YBX/.P<]J /SXT'QY_P42_9Y0WEU?^*/AW9V'S_8=3LI
M"2D?/WC<\ A<?A^?VK^SA_P6Z^/^E>*M+\+_ !,AOO%NG&XBM[O4G=X(HTWA
M'+?Z6>@!)XXKY[_:5_X*D^+/VPTGL=.^$EW8O>QM"ICM-I!DR ?^0M<>O'!]
M/<_.W[-?['O[1GQ-^).DM'\,_$T7AK4+Z%[K45M?]%ACED&]G?+8"H<GY3@"
M@#^[C]G3X_\ A3X^^$K;7](MH5D>W1YHHI3(PD\L,022V#VZ_P"%>ZW=SLS;
M0'[*S9 4XR<]\8_#'\^*^3?V.O@!;_L^>!K#3+H!)IK2-Y]YPT<C1J&5@8XN
MF.>,5]5:A;17MZE];2"58B"=A) P<X)Q_P#7Q[T 58K*]LF\V^GWP==K# ]3
MR>W7FM"*6WG;=!&)4_N*V?\ ZW^<]:+Q)=9S#YK1H?<\8&?0^_8?B:;:+;:?
M_H'G(LW3S3U]>I ^G3^? !-A?,Q]F;'_ #RR<_X?K^M&%\S'V9L?\\LG/^'Z
M_K2@'SMOV@\\^;GVSZ?T_+K1@^=M^T'_ *ZY_P#K?T_QH  %\QA]E8C _=Y.
M5Z\^GY'/'UI%"[SFV9Q_<R?E_I^7X<4]5/G,/M)' _>9^]UXZ>_]T?4TV,$R
M,/M!3&?WF?O?H?Y#\.E "*%WG-LSC^YD_+_3\OPXH4+O.;9G']S)^7^GY?AQ
M2Q@F1A]H*8S^\S][]#_(?ATHC!,C#[04QG]YG[WZ'^0_#I0 BA=YS;,X_N9/
MR_T_+\.*$"Y?-JSX/ R?DX''/'OQD?I2Q@F1A]H*8S^\S][]#_(?ATI8U):7
M_22F#US]_CZ'T]!]* &H%.[-LTGXGY?SQ_GK59_O-\P7D_+@<>U6H06W_P"D
M&/'O][]#_GU[5'/S'Y=W/WO7_P =H OW88,N8!#S]T=^G'/^?6FW (\O,(C_
M #^;IZY_SUHN3'N79)(XSR7!!'3Z_P#UO>FS;/DVN[>NX8QTZ=>G^<T .E!\
MZ,&$(<+\G/S>_)SSU_ES1*#YR PA#Q\G/S<_G^7X<TV39YJ8=RN%R2,$>N!D
M_3KS[42;/-3:[LO&6(^8<]O\_P"- #I0?.0&$(>/DY^;G\_R_#FB4'SD!A"'
MCY.?FY_/\OPYILFSS4VN[+QEB/F'/;_/^-$FSS4VN[+QEB/F'/;_ #_C0 Z4
M'SD!A"'CY.?FY_/\OPYHP?M./)&?^>7..GY_K^E-DV>:FUW9>,L1\PY[?Y_Q
MH^3S_OOL_OX^;IZ9_K[^U #L'[3CR1G_ )Y<XZ?G^OZ48/VG'DC/_/+G'3\_
MU_2F_)Y_WWV_WL?-T]/_ *_O[4?)Y_WWV_WL?-T]/_K^_M0 [!^TX\D9_P">
M7..GY_K^E/4-]H<>0"=H_=\X7W]?S../I47R>?\ ??;_ 'L?-T]/_K^_M3E,
M?G-F20+CA@/F/U'_ -?OTH (@?.<"$.>?DY^7G\_S_'FB('SG A#GGY.?EY_
M/\_QYIL>SS7W.ZKSA@/F//?_ #_C1'L\U]SNJ\X8#YCSW_S_ (T .B!\YP(0
MYY^3GY>?S_/\>:(@?.<"$.>?DY^7G\_S_'FFQ[/-?<[JO.& ^8\]_P#/^-$>
MSS7W.ZKSA@/F//?_ #_C0!)$&W38@#X/(Y^3\N??G)IMN"?,Q")/S^7KZ8_S
MTHC\O=+ND<#/RX&2W^]R,?3GZTV'9\^YW7TVC.>O7IU_SB@!UN"?,Q")/S^7
MKZ8_STHMP3YF(1)^?R]?3'^>E-AV?/N=U]-HSGKUZ=?\XHAV?/N=U]-HSGKU
MZ=?\XH (@2LV(@^!R>?D]^./;G(IT0)A<B$..?GY^7C\OS_'BHX]FV7<[@X^
M7 R&_P![ICZ\_2G1[/*?<[JW.% ^4\=_\_GTH =$"87(A#CGY^?EX_+\_P >
M*(@3"Y$(<<_/S\O'Y?G^/%-CV>4^YW5N<*!\IX[_ .?SZ41[/*?<[JW.% ^4
M\=_\_GTH =$"87(A#CGY^?EX_+\_QXIJ@_9W/E C</WG.5]O3GW&>/I1'L\I
M]SNK<X4#Y3QW_P _GTIJ[?);+L&SPH'RGZG/].] $F#]FSY(Q_SUYSU_+]/U
MHP?LV?)&/^>O.>OY?I^M-^3R/OON_NX^7KZ__6]O>CY/(^^^[^[CY>OK_P#6
M]O>@!V#]FSY(Q_SUYSU_+]/UHP?LV?)&/^>O?K^7Z?K3?D\C[[[O[N/EZ^O_
M -;V]Z/D\C[[[_[F/EZ^O_UO;WH =*"(4)A"#CY^?FX_+\OPXHE!$*$PA!Q\
M_/S<?E^7X<4V39Y2;7=FXRI'RCCM_G\NE$FSRDVN[-QE2/E'';_/Y=* '2@B
M%"80@X^?GYN/R_+\.*)01"A,(0<?/S\W'Y?E^'%-DV>4FUW9N,J1\HX[?Y_+
MI1)L\I-KNS<94CY1QV_S^72@ E!"PYB"9'!Y^?WYX]N,"G7 (\O,(C_/YNGK
MG_/6HY-FV+:[DX^;(P%_W>N?KQ]*=-L^3:[MZ[AC'3IUZ?YS0 ZX!'EYA$?Y
M_-T]<_YZT7 (\O,(C_/YNGKG_/6FS;/DVN[>NX8QTZ=>G^<T3;/DVN[>NX8Q
MTZ=>G^<T 6&23" 1B 'NN1NZ<]^O\^N*XOQ5XCFT%633]/&IZEMW0VQ8CS&*
M@H-PZ;B<8]Z[!U\U D,KD,/F9OEV>XZ__6QUKE[VUL=/E,4[R7+R'>;EP9)8
MB_)"L#P%S@8QTKEQ%.=3X4O=E%\R5Y1^ZSUZ.[1Z.!JY12G&6/POUMK1T.3F
M<Y/EY9.7V816DDK2:>CNKKX+^)7[9OPZT;74^''QN\&V=A%JCB VUT#<0RQ3
M-Y1W'S4 !YR".F:^9/B=KG_!-R&-K/PY\&O _B[QWJ<9DL=%.F[6O+J7(CC,
MHN>#))\I)''7W/Z9?$3]GSX4_%32;J+6=!LKS4YHW6/7)[4MJ%JS#"M%,7!4
MHQW*>QYKR3X8_L.?"3P+=O=S:;#KM_YQEM]2U"'SKFT.05$4AE.P(<E?0GCM
M7+#VRJRA*VJ3CS4ES75NZ7-?^;97U3NS]!RVKX;5J'UC'Y;6P>,HRCR8; U&
ML+BMG>JJLIUHI[.,9QDTM&F?EKX-N_V1+7Q);:)\8/V.? ?@62^G3[',UL;C
MS8)'Q'+G[2 N?Y5ZS\8XO^"?7A/2;>'X)?L[^ _B)\5[@"6Q\)Q6'V=I+)1_
MI,WVA;D@>7*T"X(YWY[<_J)X_P#V:_A#XXTJ31-8TV!+^:(Q0:PMMF]M,KM1
MH9O,&PQGYE]#S7F/PG_8R^%7P=UB2_A1_$E_<;C#J^J1FXO+.,L"T$,OF-MC
M?@L.,[!6=JT9-REAW&>C<J<74IR=N6*<5RN]M&TXI^B/I77\+,9A?K-7*<TR
MS,L-&^#P&#J5XY?FG+9\^(>)E6JPC?24*56$I7]VS9^;/P?\2?L5>,[V/PM\
M=?V8/ _P\\9,6$NAS69N511E@?--P!S$ _3(X'TW/BUJG_!//P"\FC_ ;]G;
MP%\0OBBH4Q>&8-/-J9&(!(^T"XP,1Y;D<CCUK]0?BA^RU\)_BM#) VAV.B:K
M(!_Q46G6WDZHI &3YP8$?*-O4?+]:XSX9_L:?"3X7ZBDT>FQZUJR'/\ ;]_;
MF3426/0S[R>!\O4<#%9PJ5_>C.-"--OE5?V?+44M-T_=EWO&*5GL>9/_ (AY
MBZ$L5B,'F65XZG'FAEU"M*>"KQ5K2G*KSU4GLZ:JJ=MF?$'[-WQV_9KT77(&
M^('P#\,?!CXC(23:6T!EFAP"587!GP/W05L=A^->Y_';]O'P58V\NC_!NVC^
M+'C8(JQ>!V_T>*1<#<GG>:1@19;TX^M?4GQ3_9&^&/Q6T][6XTBST6\=5'_"
M1V$/E:H,8/$^]>2!LZ]..F:Y3X5_L9?"3X33HUK:C6M40L?[=OX#+?G=G.9O
M-;M\@]%Z<5-*,U*U:I"<%4YE5A1E3JJUM+QM!Q2^TXM=_/.CBO#'ZI+$UJ68
MX/,(KEIX"A4C5P6(M:TZDZBG4C=Z.G3JPJI;,^%_AE\:/V:OC&]W8?M#?!7P
MU\.?B;9CSM3T.X@^U.NGR9\BX-P9\'S)%F&,#!'O7BGQU\6?L2PW)T7X ?LP
M>!_CEXMM)MNKZ=)9FT-HD9(GE\P7/S%'P.!WR*_6/XL_L<_"OXNF)FLT\.:K
M #Y^NZ5%Y&I7T1Y2"XEW@O'&02B^KMUYJ/X4_LB_";X63%=/T.UGO]I2;6);
M8F]NSQN,\GF'<7(W,?7\JV]G&5;GJ2O3B_<K1]V=U;25K1;Z.333UTV.SVGA
M!/ QQ\HYQ0S>.V3PK*67SDK+VGM9*5=QJ;^RA652%_>D?GO^SKXH_8/NX4@\
M9? OP7\,?&=M$K:KHD5@9/L4J ":,2M<?/Y;_+[XX]^^^(G[9GPN^&=T;+]C
MKX2Z1\3_ !1;2[=5L+$?V>;*!/\ 7RB03L&". !@<Y'N*^R/BW^Q-\*_BN@=
MK"'PA<"022ZMH<8MKV[Z[A-()$+;^K<\GG/2KGPH_9*^$OPI00Z1IL5S>JGE
MSZM-;$WEYTW&:7S'WER,OZGTS2C&$Y)U).%-2;A.%+DJM]VU:%O[TXNY-:KX
M/U,N^N.6=8;/-HY-"K">6-)1M.I6Y/:U.?=TXUHSCU;LSQ/X-_\ !0CX;_$&
MW-C\5(8_!_C/3[26[UKPW.IE&F26D+370$IFPY@*-CCG';MY]\5?^"D,%Y??
MV7\ O ,7QAT6VD,6OW#.;./3H0<$X$QWX7S._.WTS7TS\5OV*_A+\5_WD&FP
M>$;]9X[FYU30X#;7NH+#()9K>Y<2+OCNPABF7^)'88[5T7PT_9=^%GP]M&T[
M2M!LX"RB.XE6VVO?8!7-P=YWELDDY[]ZN$5SN,JC5#WK3]Z4W/3S<6]MU;I%
M$2K>%-3 T\74AFE/-$U&65.K3>"<8\OO*<(>U?,KM1C43A9.;=SXY\-?%W]A
MSXSZ=/>_%GP!X7M=9MH]VK65_8F4VTI!+IN-P-Q5E(X]Z^*_C'J'[']UXCM9
M_P!GG]BWP!\9=-TZX+:WK1M39MI4:NI,JI]H^? #MCN$K]8_B7^P3\*/B-?P
MZGY?_"(&*0R2Q:(GV=;_ )!(N!YJ[\[<?\"/J:].^'?[-WPK^'NFOI>C:#9Q
M(T8CN95M2KWN 5)G.]M^>2?7<:BA>+Y)U'[)W4:OL[57_B<ERP2TT:L]M Q=
M;PCIT:>+P4,X_M&=O:Y57K1> A:R]RK2C"K4;6J:JOD;5[V/B?X%_&/]B"_T
M:*[7PCX<\ ZOH<*-J>EVUD/^)=,B@O$K-.=Q1D901S\H/?-'Q&_X*:VUGJMA
MI'[._@I?B7X,TJZV>-/$$3FT'AC2D1D-\L0F;S<77V>#8,?ZW(KZ$^(W["'P
MC^(U[_:-E;_\(>RN9+B'0H_LJ7^2"1<J)!O!P0?9CZUZ'\+_ -E[X3_#S3[S
M1]+\+:;LO+?[->A[3C5$#H^V[_>-O!9 Y]2 :J,-U4E>G[W)4@G%RNMG%6BG
MT^&[W5G8UJ3\(*>&IYA0_MJKFCE!O)<16IO P=XW_?*"JU$U=KEJ6@[>TYDF
MCP+3_P!JC]DCXM^"[N^^*MQIE]:"W<:K8ZE:><L+>7F>%AYZ[@H8C/Y8-?F]
MXV\=_LV6'B\:E\&/V+/ _COX7QW&[7O':0&V-B@DS=2_9_M!WF.+$AP>:_4C
MQ[_P3U^$7C+Q!%XB=I?#5M&_F2Z!I*^5IMYABQ$\(E7?Y@^5^,D<<5[MX*_9
M\^%?@_07T'3O#=A_9K1F.XL6LR+>[!0*YF3<=V\#!Y''UJ:$(134YRIQE%^S
M?L[S:TUJ3J<R3O;W>OSL/'XCP@IT*6-P+SG%9M7Y7C,GQ$X4\NP][<T*56A"
MC4JMK:I[1P3^).UCYI^!G[5_[(&@^ YM2\,_V3\/[2S@8ZE::?:",6DT<8,T
M85IR6V#CGK]:\(\??\%)-=U/7#9?#7X51?%3X3+*8M<\63SF".R@!(N&-OYH
MWB.'YR.X)'&:^E/''_!/OX1^,M:77[19/#=I'()+CP_I"&'3;TABS"XA$PW!
MQ\K<<CCBO:_ G[./PP\)Z.VAZ=X;L(;1D,<UF+7;!=97:QF7>=Q<##>M51CR
MW52<8147R5(0]^5[:N*?)?7;ENS.K+PCIT*.*P_]L5<;4<76RBO5I_5:%[<T
M*5:$(U9Z?#451QA]I-(^$]0U7_@F#X]\,?\ ";>/_ '@F9KJ(74JW>E^9(UU
M*-Q0C[2#GSFVDY_'O7SQH7[0'PG^"OBF/Q)\'_V3/"VG?"B&8>5\0],5K=Q%
MNV>:+<3DC#\=>OKFOT'US_@GE\(+_P 6R^+;EI;:TDN&N#X1@7_B31[F+");
M;S_N*<$#'\S7T1IWP*^%MGX;'AM?"^FS:0(_*_LN2S/V3'0,8]Q&=WS]?O?C
M2P[Y4XU9*#^*$U3LY;6<^:ZC=7]R*370SQM3PDP]2A6R^GG..G6<98O+\=7A
M&EAN9)SCAZE&-*4I1VC6J3G!]4]SPG3OV]/V<=8\ _\ "8^+=?M].L?LV#:/
M#O D&(Q#M,P.-^$K\U?BG^TG\*?B=X@EN]:_9-\,>//@Q+,0_CJ_4LLD.XKY
MIMO/Y_><8''U[_H7KO\ P3Q^$6J:\?$A,Z:=YOF_\(K&I_L;/7'V82@8W?,.
M.O3/%?2'AOX _"_2_#8\,V_A+2I--$1B_LN2T_T3!ZL$+GG)W9]>32C&W.ZC
MY'JXNG%2]IM9\L^:U[?!%)_@=6*K>#^$A0Q.7T\VS7%57'VV7XZO&C1P<7;F
MIT:E&-*I*4'I&M*<H67PGYH>%;7_ ()5:=X"_P"$HO\ X5> ?#5K% TYMXM)
M#%)URQ0+]I)R)1@?U->=Q_MH6&A7J:/XH_9KTCPW\$II!;:'XJ1F>WOK-CMM
MW%L)OE$D WXSQG'M7W/K?_!.WX/7WBP>++N6>.R69)SX0C7.B/M(8Q&V$P!5
M\<X'7)[XKZ3NO@3\++_PW'X;OO"NE:EIJ0B&WM+RS+PVF$VJT*EOE*+PO/ I
MI*4)^TFJ52RY)0I*-X].?G4HN6]U%*5[MNS1.+Q7@_A)X6OE=+-\VKU[/,,!
MF%90H8!M+]W@JD%3<Y0UM5K2JTYI))7NS\TO$\G_  2[7PU;^/\ Q%\+O EW
MK6I1K-:^=I6^>XNY4,J*Q^T AF;N??Z5P/P^_;#\,_"O6!)I?[,NA>"?AA=N
M(=+\5V#-LN[1V!A<P?:#M#PC?CVK[-7_ ()W?"2P\12>)+B2XU:SEF,T'AZ[
M0RZ799?<JP0><0HC'RKQPO;N/I=/V?/AI?>'5\/R>&-,O+)(1##:7-KNAM1M
MV*T*EOE*=O3IFG&_*W6J\CA&/LE"DI.;TLY=[[M1[^1&*?@_0GAZF!CF^82J
MU.?%T,15IT?8*5FZ=&4(0Y5!W4:DW*,E:VK1\'_%7XC?\$[?'WA6+Q5\3/ _
MA#Q%JNH1":VLM0T[SWGNY4+)&3]HR-Q)&>G.:^8_@Y\:_@%\._%DT7B;]F7P
MM\&? 5Y?K)X#\4:? TG_  D.F%8T_M#R?/\ W)^TB:+:2?\ 4Y[XK] [/_@G
MC\']&\33>)KV:?5X99C-%H%VOG:;9LS[PL$ F^41_=48Z5[_ .(OV=_A3XH\
M.6GAW4?"VEW5M;6IMM/>:TRVEQEF;;:9?]WAW+C!/S'-$7*=.<:DHTJFCA*,
M/BO:RDY.5[K[,4FM^C"O7\(\)B:"R^&<9C1JO_:HXVM"-7!\R5UAK1A!^REH
MIU8SC.-^57LUXIX[_;Q_9K^&WAJU>PUVUO\ 6[NWSH6BI;@?;)]H\N(,)QLW
M,R+CGJ>G2OF7PE_P4F\3:KK#:?\ '#X9#X:^$K^;9H^I&9KM-4M78@2,GF_(
M"A0C)_C[\U[_ *#_ ,$]_A%X4UP:U?I-XK+3":VM]80W,-A@[@ML/-^0#C'^
MZ*^E/$'[//PR\7>'QHE[X5TJ]C$'D07-S:AIK$%0H:W);Y2O4<]0,=,4HKDI
M251N$]/<A'F4]K-[M_)I)?<:UZ_A'E^(PZRQ9MG,*K_VJ>.J4J,\*IVYOJT(
M0IP@X)O^+&?/RKELV?!'QO\ B=_P3ZU'28;[Q!X)\)^-?%.H1,^F:?>V&Y[V
MY905C+BY!4N[*">>6]J^,/#6K?LB2:['#\?_ -CCP)\.M%NY@OA_5'M3>?VA
M$S?)+M\_Y,JR$9]<>IK]-O"G_!/7X.>"]>DUN\GN?$\KS^=!;:JAN8; AMP6
MW'G$QA3@=/X1TQ7T7XI_9^^%7B[1%T35_"NE:BJP^3:W5W:%YK$;0NZV8L-A
M'!'.<J.>*=HS@_:S2JJUHQI<L.C7O-.4GMI&7NO?711C\1X/X2MAZ>2+.<UH
MU'_MM;&5(X:K1<K76&C"-.G%4[R_BPESJ/NI7T_++XHR?\$T_!.EP6?@OX&^
M ?%'CR\L+>XT/PVFF%#>M<P))9QB87'R>:61>GRYKP_X<ZE^QUKNN0Z;^T!^
MQIX!^'%_<SJNG&2U^U^?;NP6*;=]H7;N.[C!QZ<U^H'@G]@WX3_#W6FU.>*3
MQ-=R7<EY;7NJQ&>;3TEE,T5M:OYK;(K4,L4(_A2-1VP/:?'/[+OPS^(>C/IE
M[H5BDKP&*/6Q;@:A9@J5#0R[QM*'YE.1@_6JYJBI-SJJ-5-*-.-+G@U9?'U?
M;F5DMV34_P"(04,9"&'6<YC@:T?]IJUJ\*6(H.5KRI)1C"]/[-.I&<I6T9^6
M_P 6-&_X)@>#]+*?#KX!_#WQE\2IK<OHOAA-+,1O+D@_9X?/%SA?,EPF2#@\
MUY]\"_B9^S%::]!IWQT_9*\&?!GQ%)<JNB1QV[79N("P6WF#_: %W-D8[=NN
M:_3#X=?L*?!_X9:DM\\;>)]1$WG0:AJL1N;BT.<A89/.;:$/*^_%>K_$+]FC
MX5_$?3VT_4O#]@+UH3%!KGV;&H68*D(T$I8;3&?F4]CS6<5S0DY34*UTU3]F
MO8REHU;F7,WMK%I)ZF#J>$F&Q\</A(YSF.5U)+VV)Q5:%+&8=O>=*-*-.G:G
M>_LYPE.5M&?GS^T'\9?V1+32[7PQX#^'?ASXE^/+Q//L/A\]IY<-U8QKMGN#
M.L_'DM)$@'<2GD 5\^?"Q_V#O$^JQ:7\:?V3_A_\/O&)??)8RV37#1L"763S
M3<#DH!)TZ_AC],_AG^PY\*/A9KQU8V[>(]3<,+?6-4B,][91%E+002^:=L;G
M;D?["\UZ'\4_V1?A=\5=.>UN-&LM$NW11_PD6GP"+5% QTEWJ>GRGG[O''-*
M2ER1DIN&)<TY)0C4BWI;FYE)Q5K7E%I7NMSOE7\'L-CZ>$HQSC'975C%XC,Z
MU94L9A'+XY4J%-0C/V:VIU(5*LFK\UFD?(7B7]L#X&?!;P__ ,(-^RUX4TSQ
M3XFMXU6V\ Z;&;*V(&'*"03L  GS_A^%3?"/_@H?X7\97J^#?CSX#M?AQXGD
MWI/H<I^U(J$,W,AFP0T?S\^M?0OPJ_8J^$'PHNDFM+<ZUJD;$_VY?PF6_.>H
M,PE;.!\O^[76_%#]DSX4?%2UDMI]$L]%U610O_"26%N8M6!&#D3>8O\ #\O;
MCCZN5.G*$6JDOK"FI2BXM0D]/=2J<TN7S4E'LD85<3X14<=]5R^.<X[*:MO:
M9IB*ZI9A0D])5*=*$8490BE=49TI56[7E9'YT?M)>/OV%+_4)X_ 7P5\'?&/
MXJR$,-!N; PR2N55C_I N1C]V=QX)XJA^SE\9?V4]#N)K7QU\$O"_P !_'MN
MR2W&EV5J97^R?,+>;SC<$$EED  ':ONSX:?L2_"?X87T<T=B-9U.-LC7;^$R
MZ@<GO-YK'A?E_P!WCIR>H^,'['?PZ^*5I8F'0+'3[^"0F;6[2'RM0ND^3;%-
M()!N1,,4]W/UHC24:;?,O;2DFZ$8OD>V[;<O1I\NFUC*4O"["8N5'**N<8NG
M5A99EB:]*G7PU1V;FXQA&E*#2Y?8RA*I[U[[V\UNOV[/ 4=Q;^'OA'ID?C2[
M2587A1?("*#M+?ZT@X_K^%?:_@KQ!J_C7PW::MK6@+HT]Q"DCP%B_E,RY(Y)
M&5)Q_3BO(?AI^SE\)OA%IUL$\/64^HQ(BM?26ADN)&"Y+.^\Y)(R3D\\U[<F
MF/J85+*>2RLEP42!M@"@<?+VXX//7CO7?3E.S51Z.*2II<S6V\E>R[7OMW/B
MLS_LV=6J\!2<80;_ -JQ$JG[[;6$5))R>[LK=E=D]@]M%=R12:@\@&0D#<JI
MS@ 8Z?B?RXJ^T&H33'RYGCM^2K!NG?ICGC'UQZTDMUH7A^W5+LAYR GF[ \A
M?'4X)//<C\?4U8I7N"+OS)4M'^:/8#R"?ER,=^/IVKJCRN/*^;WDDFE=K39M
M6LMKW/ALQC-VLI0O+5QO;6SYFW=6?6][:E\131XW[KT?Q%R!CZ=OQ]A3I+MT
M9!::>DXS\YX&WG\#Q@D__6S4.\3C#22(%QC8#\WUZ?U]N]+ 4 ;<[KCIMYS]
M>GZCUZ=*T4I.'-M):.R>BT5^;HW][]3/#4:D)7K:M).\6^62=GU;;:Z:^BL1
M:K>7V8A9V(DW?ZW#8\L<9/X<U8CBNDB$D+MO(RZ@L,'WZ^IZU7<"9\F62,#I
ML_BZGYO_ *Y[U99MJ8$DB^FT9+ #&3C/;_)HDG:"O[R^*ZEU2W;=HOLNO3L>
MS*%&=)RA)WC_ #RL^E[WTMT21#%IMI=O_:%TB2SPG[S@ELH<CD_3GG_$YNL7
M#ZL/[-O/#\.H:5(-DS2M\FPC!RF[ICZ5J1E/*?=(X;GY0.#]3G\?\XHCV>4^
MYW#<X4#Y3]>?\^_2LSB/ ?$G[,7P"\52LVL_"+PSJL<W-Q-<6Q)#-]_/S\\<
MFO*;C_@GK^QE+J,=^?V<? ES*K!VO&L?WD; Y)'SGD>O^3]J1^7Y3[G=6.?E
M ^4X'?G^GY]*(_+\I]SNK'/R@?*<#OS_ $_/I0!X]X5_9H^!W@E(KCP5X$T'
MP^+<*4CL;;R]A7G Y/3CZ=>E>WVU[);6RA+<>4 %##C@#:,<=.G^>:HQ[/*?
M+NK<X4#Y3QWY_I^?2CY/(^^^_P#N8^7KZ_\ UO;WH R[G1Y+VY-^+AK1>N]<
M?H< GTZCWJS)#>VD DA9KSI^\+!21TQUXJW\GD???=_<Q\O7US_3_&CY/(^^
M^[^YCY>OKG^G^- $46G6<]O]NN+.*.[X/FG!?/3K^=(=6U&WB\@::+BU?*[R
M^ P/48^GMSQVJ;Y/(^^^[^[CY>OK_P#6]O>FMM\E<.Q;/*D?*/H<_P!.U 'G
MNO\ PD^'7BJ*>YUWP=I;RW*DR&6(N9B_)5OFYW5\UWO[!O[)>O:K+>>(OV<O
M!%[)(Y9M2N++?+*2V2Y_>#D]?K^%?;$FSRDP[LW&5(^4<=N?Z?ETHDV>4FUW
M+<94CY1].?\ /MTH ^>_#/[)?[-_PRB^T>!/@YX6T9YU\M_L%H(B489(/SGC
MIGZ5R_B;]B#]E;QI/)J_B_X&^#M6N[HF21[RS\QG=_F.3GG/.?\ Z]?5DFSR
MDVN[-QE2/E'';_/Y=*)-GE)M=V;C*D?*..W^?RZ4 ?,/@#]D?X$_#"XEE^&G
MPR\._#LRR^;YFC6WE?:),*OFMRW.%"\]E%?2%K8R6=HVGZA_I]G(NSRI<%'3
M&,8V\Y!_E^-R39MBP[L<?,&'"_[O7/Y#Z4Z;9\FUW;UW#&.G3D]/\YH ^?O&
MG[*7[//CB1[KQ;\(_#&LW$Q+,UY;;VD9N3G+#DYY^M>:VG_!/_\ 8W64W%S^
MSIX%@G0AH9/[/RS,.<@[^O3^E?9<VSY-KNWKN&,=.G7I_G-$_E_)M=V['<,8
M^G)_SZT >1>%O@/\&_"WAW6/"NF?#30=%\/:Q:"ROM,M8"MO?VWFQR""5=W*
M[HT<#U0>QKQS_A@']C&]O9;B?]G_ ,$-/<2F2:5K#YG=CRY._J3U[?2OKZY8
M(BO"6FE7[L<@^4]B.<^OKS5#[3K5PA4V,$$6,>8GRR8]1@#GT]^: /(=)^%'
MPP^!NG-#\/?AEH?A[1T0M(VG((HU  !)7=T"@=^1^-?-/Q/_ ."DW[*'P+FD
MLOB!X[M= UF+.W3S CY8=!N-RG<;>GZ5]R:QX.@\3Z+=:;>ZM?6\5PCH[Q2$
M.NX;3MR<\#IS7X]?M&?\$8_V>_C_ *S-JOB[QSXQAN969BUL9'VEF+'!%PGK
MQTS_ # /RC_X* _\%,OA?\==.U33OA^+?7='GAFA:_0JI"L"-VQ;A\_*0>/_
M -?Y>?L,? ;Q?\=_C=;V>G>%3JO@R=GN;Z64.((YS=0&(;#&V24,N#GL>M?T
M6^ ?^#=[]EGPYJ]OJ%M\2_'FHP12J[:;>O*;64*<['0W1R#T/Y>M?K3\#/V*
M?@O^SF(H_!FF06\@BC0W'V<I*_E'(9F\UN21S_D4 >A?LR_"*W^#GPWTWPQ9
MZ1!9)%:0@V\*E44D*Q'1>Y[#O7M\S3R2>4H*<_ZL9Q_//^/':IY;]@@A@/[L
M*%##).T+C@=?PYQ^=9K3+$?,N)'5?[RJ=_Y=?\\]Z -!4F53$MRZR$']R!QR
M/IGI_GM7EWB;X*_#GX@3R6_CCPOIFO0SY2:WOX=ZR*P^8-R,@CKT]J]+AO(9
M_P#5EC'_ ,]2I$G3WI!L$_\ K)-G]_&7Z>F?Z_X4 ?(6O?L _L:7K$G]GOP-
MJ<V[+B33SD=B<[_7^N:?H7[ 7[&UNRB+]GWP/8R)R0EB?EQZ?/\ Y]^_UU'Y
M?FMEW51G# ?,>>_/]3^/6B/9YK[G=5YPP'S'GO\ Y_QH \7T3]EW]G?PE)YG
MA;X6>&K*YAPR?9K;RR&4\8(8]_4<']/6-%O+RRW:39Z!%I]C"I2+RG^553Y5
MP,GH/8?SK0C\OS6R[JHSA@/F//?G^I_'K2QE?-?=)(%YP1DD\]QG_'^M %>W
MTZ2>]DDENV ^9C'U"8_P_P ^M::@)N"_Z:%Z[C]W\?\ )JG'L\Q\NX7#8(')
M],\C'IUX]Z(/+^?<[KV&T9S]>1_GTH F;[/>9!TZ,[>K=U]",>G-5"\EHP-G
M:"[ /(Y CQZ<_P"<?2I8=GS[G=?3:,YZ]>1U_P XH@\OY]SNO8;1G/UY'^?2
M@#B/&GPC^&'Q<MC%\0/!FDZZ$4C;J$1EV;NH !'].GUKPW3OV%OV4=*N'O;3
MX+^$)YA*TGVC["0ZMN+'G?C(/3WYS7U3#L^?<[KZ;1G/7KR.O^<41^6(I,NZ
MG+849*GT)Z<_AQ[]* .*\,^#M!\#6XL?!'AJRT+3E&UDL5\M%& .!D] !79>
M2MPAEFMEF=>?-;DJ0,]?\^II\>SRGW.ZMSA0/E/'?_/Y]*(]GE/N=U;G"@?*
M>._^?SZ4 -BBED0J3_H_1AS@ =1@9[?Y&:\J\<_ ;X/^/XI)?%GP]T/Q464^
M8;^#S,\9())[_P"%>KQ[/*?<[AN<*!\I^O/^??I1'L\I\NZMSA0/E/'?G^GY
M]* /BR?_ ()^_L<W5I]HG_9N\"R,WS%399Y)]=X&0?2M31/V /V1[*,7,7P3
M\':? .1:I8#8"#Q_&>_>OK_Y/(^^^_\ N8^7KZ__ %O;WH^3R/OON_N8^7KZ
MY_I_C0!XMX0^ /P9^'>I)?>"_A;X?T5H2/+OK*W\N08& ?O>O]..]>L:JU_J
M<9@AA^P0E=HNX^H7&,=QC^'M[\5H_)Y'WWW?W,?+U]<_T_QH^3R/OON_N8^7
MKZY_I_C0!\^>*?V9?@K\1G/_  LOX<:#XO/(&I:I;^;)(&^]'C(X!&[W)'KQ
MA>%_V'/V2/ UZ=7\-? WP;I%Z#OCN[6Q*2.^=P()?KW[8KZ=;9Y*X9BVXY4C
MY1[CGK^ ^OJ^3R_*3:[LPQ\I'RC([<_T_+I0!SVC6R:6!IFGZ%#HNE0C9 ]N
M1M**0J_+DD?+_6NAEM[-%\R73HIMP_UK=7SSZ]_;_P"M1)Y?E)M=V88^4CY1
MD=N?Z?ETHDV>4FUW+<94CY1].?\ /MTH JV$-E#.[OHEO:(^<3J.7R>,\^G/
M-5-7TVTN(+K3[K1[?4=,U-2MQ#*1Y<L;#8RL,C(*\'KWK5DV>4F'=FXRI'RC
MCMS_ $_+I39-FV+:[GCY@1@+_N]<_I]* /D'7?V#_P!D?5M0?4]3_9Z\$7E]
M?R&6ZNI;,F21W.6=B9!ELL2?ZUZY\//@#\'_ (%IN^%7PST#PNUP 9%TN+R<
MD= >>V2._6O9)MGR;7=O7<,8Z=.O3_.:)MGR;7=O7<,8Z=.O3_.: .?U.REU
M0"ZNK%;>>+YHHLY\QNN,]NF/\\UK=;SQ1:7/A[Q7H,<.C3Q^4\$KB2*]0,"(
MW7T. W:NIG\OY-KNW8[AC'TY/^?6G2>7NBVR2$9^8L.5^G)S^8^M 'R?XN_8
M0_9>\4:F+_5OA=X6O)9&#R0S6983,3D[N>=W?\?PRM)_8!_9%\.:Q:ZUX>^!
M/@O0?$=JR/9ZU:6&VZAD1MR2(^\X97^8<=:^PY/+\U<.[*<98CYASVY_J/PZ
MT2;/-3:[LO&6(^8<]O\ /^- '.6NF76@V*:+Y"ZO8K&(HH)&VI'%@*L:CC@
M8 J&+1OL^3;6$>GJ^6:RC.4D)Z@^N>E=3)L\U-KNR\98CYASV_S_ (T2;/-3
M:[LO&6(^8<]O\_XT ?/WC;]G/X.^.6FU#Q3\+O#^OZE.Q>:WO8-Y9W/SDN3R
M3DG\:\ZLOV!OV/[S_2+[]GKP/#?MG=']AW'OG#!^_4U]C?N_/^^^S.=^/GZ>
MF?Z_X4?N_/\ OOMSG?CY^GU_K_A0!\B3?L"_L<0'S;?]GSP.UZN"$%AR#UX.
M_CCG]*]+\'?LX_ WP<T9\.?"GP[H5Q%_JUM+8KMQTQ\Y]/3T->X?N_/^^^W.
M=^/GZ?7^O^%'R>?]]]O]['S=/3_Z_O[4 5H$;2 (-,LE14P%M$.U,8X'T[?3
MZTB6=M-(98M.BMKQLF1TY<>IS]?J/TJU\GG_ 'WV?W\?-T],_P!??VHCV>:^
MYW5><,!\QY[_ .?\: ,RYT"UU$20:B5U.%@5>TG7*[>ZGC\.U>&^)_V2OV;O
M'%Q++XF^#GA76KIV9I7N[0NQ))))PPY).3D=:^A8_+\ULNZJ,X8#YCSWY_J?
MQZT1[/-?<[JO.& ^8\]_\_XT ?'\G[!O[(4>$M?V>? \CCA@+(C'KQO_ /K_
M ,JVM+_8:_9,TQX[O3?@9X-M[N,AV$=CAHG'(P0W7 !YZ=*^IH]GFON=U7G#
M ?,>>_\ G_&EB$8:7+NO/! )+?[W/^/U]0#@M&^%OP^T2W%MX=\&Z7I2PKMC
M>VC*^2!PI49[8Z5TFEZ$;)W:6<ZG&,;89!E81S@#@=.G>MB'9\^YW7TVC.>O
M7D=?\XH@\OY]SNO8;1G/UY'^?2@#.U2^O@OD:;I".K95ID;:8L\9X)SCU]N*
MCTK3KR*.4WER^I)*/GMI?NQ9SE>G3\36K#L^?<[KZ;1G/7KR.O\ G%$'E_/N
M=U[#:,Y^O(_SZ4 >1>)_V?/@MXYFFOO%7PUT#7)G),LUY$78D=<_-SP,5Y3=
M?L$?L=ZO(;B_^ '@BXP<M+)8EF!').=_^?RKZSC*>4^9'#9;  R#Z9/'UZ<>
M]$>SRGW.X;G"@?*?KS_GWZ4 ?)<7[ W['%D1-IWP \$#R^2ZV &W'/\ >[<'
MK7KWA']GCX'>$(A/X9^'/A_13!@J+2W";2O3'S'D>O\ ^NO5H]GE/EW5N<*!
M\IX[\_T_/I1'L\I]SNK<X4#Y3QW_ ,_GTH IEY8X#8Z;9+I]D, W$7\.T850
M.>#D]CTK*LWU*SOLMIZW4/\ S_.V&Y!YQ@>N/Z8K?&SR6RS!MPPH'RGZG/Z8
M/^#OD\C[[[O[F/EZ^N?Z?XT 4KK05O)/[16^:T;KA><=L=/7\^G-03646H0'
M3]:TZ/5=.(*M-<8.Y3QRN?\ /%:GR>1]]]W]S'R]?7/]/\:/W?D???=G.S'R
M=?K_ $_QH \0\1_LP_L^^)7>ZUKX4>&]4$F3)+<6VXL6X.2#Z\?2O/KC_@G]
M^Q;>C^T+SX!^!WN'R [6&YB1SC.\<Y)_SFOK#Y/(^^^[^YCY>OKG^G^--;9Y
M*89B^3E2/E'T.>OX?CZ@'RSHO[%'[*NCW2O:? CP=IT*-F&XBL^0<Y4@;^W7
MI_A7ONF_#[P;X%M8AX,\-:?IL2 +'':1B(  < >W'3)KJY/+\I-KNS#'RD?*
M,CMS_3\NE$FSRDVNY;C*D?*/IS_GVZ4 4W\O5H0FN:-%)$H!C\P[@6'3O_D?
MC6(]MJ-U-'96L!\/Z?%(ICN;=A\ZHPPNT X#X"\]CUKIY-GE)AW9N,J1\HX[
M<_T_+I1((_*CP[L05RISM'TZ].W'Y=* +$BO8VR1R.;^3;A6?@D^O3_#^587
MV:]N)0\S-IZ@Y14.0P_'^7_UJU9MGR;7=O7<,8Z=.3T_SFB?R_DVN[=CN&,?
M3D_Y]: *MU#J0\L"]EB4=".-_3V__55T0R%%6]F9O0,/O]/Y^F>_Y,FV?)M=
MV]=PQCITY/3_ #FB?R_DVN[=CN&,?3D_Y]: %^SV4,B$Z7"9&.$?NQ_^O^']
M:ED:5I4AQ]G1L *,XP?3^73/I4<GE[HMLDA&?F+#E?IR<_F/K39-GFIM=V7C
M+$?,.>W^?\: *]YIC6TR7$%X[RK@K;@<.<]SZ'IQ5@K;ZC"8M4TZ)9B-J;OF
M+<<'.>IQS1)Y?FKAW93C+$?,.>W/]1^'6B3R_-7#NRG&6(^8<]N?ZC\.M %6
M"QCL28(;=8XW/^I7A7SQR#Z_Y]!YEXU_9X^!GQ%:8^-?AKX?UZ[GW-,M];^:
MTCMEF).[JQSGM7J\FSS4VN[+QEB/F'/;_/\ C1^[\_[[[,YWX^?IZ9_K_A0!
M\27'_!/+]C.ZOBL_[-7@.5BV3(UD<DGYMWW^O/\ GFNYT7]B7]E?PTR1^'?@
MCX/TB:,@H;:TVE",,"/G/(]?45]1?)Y_WWV_WL?-T]/_ *_O[4?)Y_WWV_WL
M?-T]/_K^_M0!SFE>'=-\$Z6NF^%])@@AC4*FG6X\N)5Z8Y)QZ_X40VM\T@U#
MR#;WP.19J<C(/][!ZXSW_'BNC_=^?]]]N<[\?/T^O]?\*/W?G_??9G._'S]/
M3/\ 7_"@#F_$O@W0/'5D++Q/I5MJR8'F6MVF] ,88<#H#Q]*\)US]B/]E'Q*
MI76_@GX0UB=O];]HLR?J3\W7/M7TU'Y?FMEW51G# ?,>>_/]3^/6B/R_-;+N
MJC.& ^8\]^?ZG\>M 'RSX;_83_9"\(7)O/"WP)\%Z7J/5I+6QVR(V02<[NS?
MXU[KX=^&_A'PI(&\-:-9Z<R_\L+:,H$ (X').!BNQC\OS6R[JHSA@/F//?G^
MI_'K1'Y?FMEW51G# ?,>>_/]3^/6@!^I3^8D833DOY(E(?><>6<YQ_(_C4-K
M=3W:/&VF+:X& ZMG9[\?3WZ>]21",-+EW7G@@$EO][G_ !^OJD.SY]SNOIM&
M<]>O(Z_YQ0 MHMY:"5HKJ2])_P"6;<;.O&?\>?SJI!!+JKN]]"$,9RN6W8_(
M\9_'ITJU!Y?S[G=>PVC.?KR/\^E$.SY]SNOIM&<]>O3K_G% %26VOKIQ'#=2
M)"APR@C&/^^?05Y=X\^!OPF^)$I'C;X>:)XMC=$CN;G48/,9L*%?/S#. ,?0
M=Z]<AV?/N=U]-HSGKUY'7_.*(Q'Y4F7=22V%&=I^O3KWX_/I0!\G1?\ !/[]
MC"T+:GI_P"\#B]4F3>MAM8/USDN>XKM]/_9E^ YTV72Q\)?#5III5HWA2VS&
M8]N"" Q_AX_PKWJ/9Y3Y=U;G"@?*>._/]/SZ41[/*?<[AN<*!\I^O/\ GWZ4
M ?(&H?L(?LD:A.QNO@#X*U&"1B9IYK,Y^;[V1O&?\GK7J/@3]GKX-_"A6MOA
M=\-]"\&VLNTS7.DP>45=/N#&Y@?O,?P->W1^7Y3[G=6.?E ^4X'?G^GY]*8N
MSR6RS!MPPH'RGW//7\#]?0 Y#Q!X,L]>L'M=>@C\1Z6Z[6LKM0T+*>-I''&?
M>OFW6OV'OV7/%EP]YKGP"\&RS2-E[R:TW.2?O,3OZD^GM^'V)\GD???=_<Q\
MO7US_3_&CY/(^^^[^[CY>OK_ /6]O>@#Y8\/?L-_LH^"A'JWAWX)>#K?4(B"
MD\%H4D4Y R&\SMT_.O:-0^#'PD\4^%Y= \2^!-&N=#EA>"33)X0]NT+ JT97
M=]TC(Z]\5W_R>1]]]W]W'R]?7_ZWM[TAV&WQO?=_<YV=?7_ZW^- 'QG;?\$_
M/V.HM2^WI^SOX%LY4?S(KU+',A<$%6^^<'/.?TKTKQ+K7PE_9YT&$3Z#IGA7
MP[:*%B>VBQ&D*+QA3(N %'KBO?;FZM[:*,M)(QR/DV,5&1TR,_Y':O&/CC\#
M?#W[0/A<^'M6O;RQ@EB\MI+;*.H9"NX<J>,\4 ?#GQ0_X*Q?L=^%-#U;3=*\
M:6%]KC6LT,ED(40B3!4KG[6._'3^5?R._M8?M/>&_C)\3=:NO"WA:VU$:E?W
M'V:9,DR-+,2F,._)SVS[5_1SXG_X-VOV=_%6N77B'4/BKX[M;B[D>62WBN66
M%2[%B%_TI>.P&,=O:O1?A3_P0L_9J^%^KPZC::[K7B>>WD60+JY,Z[E;.<&Y
M?G(Q_,T ?CQ_P2T_8^\0^+?B3HOC'XH>$H_#_AF.<ZAIMW,CSK)-%&\]DH3R
MQM,DRQ@'=QG)X%?V+:'IL&G:#8Z<+-%M[&!8[3Y3B154!< GCH/S[5SOPY^#
M_P /?AIIEGI.F:5:I'8HB1*8" AC7:,#<P!'!'TKUJXD6XA\NR@0QJN!\I&P
M8P,<=1Z=OY '(6<FHZA/LD5M'BC.$:-L^8O8XYZ?KG\M/6=*EN85MY;]Y8)
M5DB;&V5>,@C'?\*@AM3!*6D>5LDY#D_+ST&?J?T]JT)C$=GERM)ZY_A^G]*
M/#O$_P"S)\!?%P)\7?"WP[K4D^2\EY;EVD+?>+98=?TS7D<_[ /['L-X-G[.
M/@5C*V]I/L?+-(=Q;F3DDDGWK[-FV?)M=V]=PQCITZ]/\YHDV>:F'<KA<DC!
M'K@9/TZ\^U 'S;I7[%G[*^A!&TOX+^$-,NA@Q^19_,&_AYW$]<?E^->Q>'O
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MF< ?Y].Y-Y[;-Z(N,;=I7GTS@#_/IWB?R>-OG>^_^F[_ #Z]J'\GC;YWOO\
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MDTWJ]T]+=79%>$3[Y);_ !&BY*")P<CW"A<X';GJ:KR:O)-,$L8<LC?*S1[
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MI>VDR0"X[<$=/QQP/7_"FRN9VW.G![;?E_/&/UZ^]/\ W&_GSBF<X(R_^/\
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M_C1^_P#/W;$\S^[E=G\L?I_C47[G?_RVV?\ C_\ \5_GTH_<[_\ EML_\?\
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MEHQ8X#&1?EP>"03QGGCGZ5'*ML[!A&V3UWJ/_'<X_P ]: '2W+7FTA -W=%
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MB?[06V)YF?NY79_+'_CO^-)^_P#/W;$\S^[E=G\L?I_C49\GS#_KMF3Z[_\
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MUQZ?C1]JE!\W/S-P>!CC/M]:**  7$B'>#RW7@=Q]*!<2(=X/+=>!W'THHH
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MZX]/QH^T29\W/S?0>N/3\:** #[1)GS<_-]!ZX]/QH%S(#YN1N'L,=?I110
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-1, Q+$<DY/6BB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927969739520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MEDIWOUND LTD.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001593984<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">9,221,764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">42 Hayarkon Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Yavne<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">8122745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, par value NIS 0.07 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDWD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">International Financial Reporting Standards<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1057<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Haifa, Israel<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Somekh Chaikin<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">42 Hayarkon Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Yavne<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">8122745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Yaron Meyer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">971-4100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelEmailAddress', window );">Contact Personnel Email Address</a></td>
<td class="text">yaronm@mediwound.com<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelEmailAddress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Email address of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelEmailAddress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927968462048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Financial Position - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 11,866<span></span>
</td>
<td class="nump">$ 33,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents', window );">Short-term and restricted bank deposits</a></td>
<td class="nump">29,842<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Trade receivables</a></td>
<td class="nump">3,700<span></span>
</td>
<td class="nump">9,332<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories</a></td>
<td class="nump">2,846<span></span>
</td>
<td class="nump">1,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other receivables</a></td>
<td class="nump">1,441<span></span>
</td>
<td class="nump">650<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">49,695<span></span>
</td>
<td class="nump">45,840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>LONG-TERM ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentReceivables', window );">Other receivables</a></td>
<td class="nump">233<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermDeposits', window );">Long-term restricted bank deposits</a></td>
<td class="nump">440<span></span>
</td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="nump">9,228<span></span>
</td>
<td class="nump">2,366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets, net</a></td>
<td class="nump">6,698<span></span>
</td>
<td class="nump">1,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">231<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">16,764<span></span>
</td>
<td class="nump">4,176<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">66,459<span></span>
</td>
<td class="nump">50,016<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_NonCurrentLiabilitiesCurrent', window );">Current maturities of long-term liabilities</a></td>
<td class="nump">1,410<span></span>
</td>
<td class="nump">2,242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers', window );">Trade payables and accrued expenses</a></td>
<td class="nump">5,528<span></span>
</td>
<td class="nump">5,656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentPayables', window );">Other payables</a></td>
<td class="nump">3,891<span></span>
</td>
<td class="nump">4,159<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">10,829<span></span>
</td>
<td class="nump">12,057<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentWarrantLiability', window );">Warrants, net</a></td>
<td class="nump">7,296<span></span>
</td>
<td class="nump">15,606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentGovernmentGrants', window );">Liabilities in respect of IIA grants</a></td>
<td class="nump">7,677<span></span>
</td>
<td class="nump">7,445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentLiabilities', window );">Liabilities in respect of TEVA</a></td>
<td class="nump">2,256<span></span>
</td>
<td class="nump">2,788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Non-current lease liabilities</a></td>
<td class="nump">6,350<span></span>
</td>
<td class="nump">846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan', window );">Severance pay liability, net</a></td>
<td class="nump">456<span></span>
</td>
<td class="nump">360<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Total non-current liabilities</a></td>
<td class="nump">24,035<span></span>
</td>
<td class="nump">27,045<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">34,864<span></span>
</td>
<td class="nump">39,102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDERS' EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Ordinary shares of NIS 0.07 par value: Authorized 20,000,000 shares as of December 31, 2023 and 12,857,143 shares as of December 31, 2022; Issued and Outstanding 9,221,764 shares as of December 31, 2023 and 7,240,020 shares as of December 31, 2022</a></td>
<td class="nump">184<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share premium</a></td>
<td class="nump">206,251<span></span>
</td>
<td class="nump">178,882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads', window );">Foreign currency translation reserve</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Accumulated deficit</a></td>
<td class="num">(174,822)<span></span>
</td>
<td class="num">(168,106)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">31,595<span></span>
</td>
<td class="nump">10,914<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="nump">$ 66,459<span></span>
</td>
<td class="nump">$ 50,016<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of long-term deposits held by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current government grants recognised on the statement of financial position as deferred income. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current net defined benefit liability. [Refer: Net defined benefit liability]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current warrant liabilities. [Refer: Warrant liability]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the accumulated change in the value of foreign currency basis spreads of financial instruments when excluding them from the designation of these financial instruments as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 9<br> -IssueDate 2023-01-01<br> -Paragraph 6.5.16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=9&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_6.5.16&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of cash equivalents representing short-term deposits. [Refer: Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_NonCurrentLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current maturities of noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_NonCurrentLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927974330672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Financial Position (Parenthetical)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_StatementOfFinancialPositionAbstract', window );"><strong>Statement of financial position [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share | (per share)</a></td>
<td class="nump">&#8362; 0.07<span></span>
</td>
<td class="nump">&#8362; 0.07<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesAuthorised', window );">Number of shares authorised</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">12,857,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued</a></td>
<td class="nump">9,221,764<span></span>
</td>
<td class="nump">7,240,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Ordinary shares, Outstanding</a></td>
<td class="nump">9,221,764<span></span>
</td>
<td class="nump">7,240,020<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesAuthorised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesAuthorised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975102016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeStatementAbstract', window );"><strong>Profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Revenues from sale of products</a></td>
<td class="nump">$ 6,261<span></span>
</td>
<td class="nump">$ 5,347<span></span>
</td>
<td class="nump">$ 9,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromRenderingOfServices', window );">Revenues from development services</a></td>
<td class="nump">12,265<span></span>
</td>
<td class="nump">12,943<span></span>
</td>
<td class="nump">12,372<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LicenceFeeIncome', window );">Revenues from license agreements and royalties</a></td>
<td class="nump">160<span></span>
</td>
<td class="nump">8,206<span></span>
</td>
<td class="nump">1,778<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenues</a></td>
<td class="nump">18,686<span></span>
</td>
<td class="nump">26,496<span></span>
</td>
<td class="nump">23,763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_CostOfSalesFromSaleOfProducts', window );">Cost of revenues from sale of products</a></td>
<td class="nump">4,927<span></span>
</td>
<td class="nump">3,184<span></span>
</td>
<td class="nump">4,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ServicesExpense', window );">Cost of revenues from development services</a></td>
<td class="nump">10,177<span></span>
</td>
<td class="nump">9,829<span></span>
</td>
<td class="nump">9,907<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_CostOfLicenseAgreements', window );">Cost of revenues from license agreements</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">318<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Total cost of revenues</a></td>
<td class="nump">15,108<span></span>
</td>
<td class="nump">13,331<span></span>
</td>
<td class="nump">14,992<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">3,578<span></span>
</td>
<td class="nump">13,165<span></span>
</td>
<td class="nump">8,771<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">7,467<span></span>
</td>
<td class="nump">10,181<span></span>
</td>
<td class="nump">10,256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SalesAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">4,844<span></span>
</td>
<td class="nump">3,725<span></span>
</td>
<td class="nump">3,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">6,768<span></span>
</td>
<td class="nump">6,920<span></span>
</td>
<td class="nump">6,348<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Other (income) expenses</a></td>
<td class="num">(211)<span></span>
</td>
<td class="nump">684<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Total operating expenses</a></td>
<td class="nump">18,868<span></span>
</td>
<td class="nump">21,510<span></span>
</td>
<td class="nump">19,992<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating loss</a></td>
<td class="num">(15,290)<span></span>
</td>
<td class="num">(8,345)<span></span>
</td>
<td class="num">(11,221)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Financial income</a></td>
<td class="nump">10,651<span></span>
</td>
<td class="nump">461<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Financial expense</a></td>
<td class="num">(1,892)<span></span>
</td>
<td class="num">(11,637)<span></span>
</td>
<td class="num">(2,314)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_FinanceIncomeExpenseNet', window );">Financing income (expenses), net</a></td>
<td class="nump">8,759<span></span>
</td>
<td class="num">(11,176)<span></span>
</td>
<td class="num">(2,303)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Loss before taxes on income</a></td>
<td class="num">(6,531)<span></span>
</td>
<td class="num">(19,521)<span></span>
</td>
<td class="num">(13,524)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Taxes on income</a></td>
<td class="num">(185)<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="num">(6,716)<span></span>
</td>
<td class="num">(19,599)<span></span>
</td>
<td class="num">(13,551)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(13)<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss</a></td>
<td class="num">$ (6,729)<span></span>
</td>
<td class="num">$ (19,585)<span></span>
</td>
<td class="num">$ (13,530)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDepositaryReceiptsAbstract', window );"><strong>Loss per share data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic net loss per share - USD</a></td>
<td class="num">$ (0.75)<span></span>
</td>
<td class="num">$ (3.93)<span></span>
</td>
<td class="num">$ (3.48)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted net loss per share - USD</a></td>
<td class="num">$ (0.75)<span></span>
</td>
<td class="num">$ (3.93)<span></span>
</td>
<td class="num">$ (3.48)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Number of shares used in calculating basic loss per share</a></td>
<td class="nump">9,013,144<span></span>
</td>
<td class="nump">4,987,069<span></span>
</td>
<td class="nump">3,892,068<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Number of shares used in calculating diluted loss per share</a></td>
<td class="nump">9,013,144<span></span>
</td>
<td class="nump">4,987,069<span></span>
</td>
<td class="nump">3,892,068<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDepositaryReceiptsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDepositaryReceiptsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LicenceFeeIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income arising from licence fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LicenceFeeIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all operating expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income (expense) that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2023-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2023-01-01<br> -Paragraph IE33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of reclassification adjustments related to change in value of foreign currency basis spreads, net of tax. Reclassification adjustments are amounts reclassified to profit (loss) in the current period that were recognised in other comprehensive income in the current or previous periods. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 92<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_92&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 126<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromRenderingOfServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the rendering of services. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromRenderingOfServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the sale of goods. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SalesAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to the marketing and selling of goods or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SalesAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ServicesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ServicesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_CostOfLicenseAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of cost of license agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_CostOfLicenseAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_CostOfSalesFromSaleOfProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs relating to expenses directly or indirectly attributed to sale of products.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_CostOfSalesFromSaleOfProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_FinanceIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing income (expenses), net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_FinanceIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927968502880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Shareholders' Equity (Deficit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Share capital [Member]</div></th>
<th class="th" colspan="2"><div>Share premium [Member]</div></th>
<th class="th"><div>Foreign currency translation reserve [Member]</div></th>
<th class="th"><div>Accumulated deficit [Member]</div></th>
<th class="th" colspan="2"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 142,193<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (40)<span></span>
</td>
<td class="num">$ (134,956)<span></span>
</td>
<td class="nump">$ 7,272<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="num">(13,551)<span></span>
</td>
<td class="num">(13,551)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive Income</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21<span></span>
</td>
<td class="num">(13,551)<span></span>
</td>
<td class="num">(13,530)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of options</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,673<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,673<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">75<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">143,869<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(148,507)<span></span>
</td>
<td class="num">(4,582)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="num">(19,599)<span></span>
</td>
<td class="num">(19,599)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive Income</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14<span></span>
</td>
<td class="num">(19,599)<span></span>
</td>
<td class="num">(19,585)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Exercise of pre-funded warrants</a></td>
<td class="nump">28<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">15,678<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,706<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of options</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Issuance of ordinary shares, net of issuance expenses</a></td>
<td class="nump">40<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,389<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">17,429<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,946<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,946<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">143<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">178,882<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(168,106)<span></span>
</td>
<td class="nump">10,914<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,716)<span></span>
</td>
<td class="num">(6,716)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive Income</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(13)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(6,716)<span></span>
</td>
<td class="num">(6,729)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits', window );">Exercise of RSU</a></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Issuance of ordinary shares, net of issuance expenses</a></td>
<td class="nump">40<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25,429<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">25,469<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,940<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,940<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Dec. 31, 2023</a></td>
<td class="nump">$ 184<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 206,251<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (18)<span></span>
</td>
<td class="num">$ (174,822)<span></span>
</td>
<td class="nump">$ 31,595<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents an amount lower than $1.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2023-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of increase (decrease) in equity resulting from the exercise of restricted share units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927968511088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (6,716)<span></span>
</td>
<td class="num">$ (19,599)<span></span>
</td>
<td class="num">$ (13,551)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract', window );"><strong>Adjustments to profit and loss items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense', window );">Depreciation and amortization</a></td>
<td class="nump">1,303<span></span>
</td>
<td class="nump">1,272<span></span>
</td>
<td class="nump">1,238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based compensation</a></td>
<td class="nump">1,940<span></span>
</td>
<td class="nump">1,946<span></span>
</td>
<td class="nump">1,673<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue', window );">Revaluation of warrants accounted at fair value</a></td>
<td class="num">(8,310)<span></span>
</td>
<td class="nump">8,977<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss', window );">Issuance expenses of warrants through profit and loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,911<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants', window );">Revaluation of liabilities in respect of IIA grants</a></td>
<td class="nump">427<span></span>
</td>
<td class="num">(132)<span></span>
</td>
<td class="nump">919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherAdjustmentsToReconcileProfitLoss', window );">Revaluation of liabilities in respect of TEVA</a></td>
<td class="nump">468<span></span>
</td>
<td class="nump">533<span></span>
</td>
<td class="nump">590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability', window );">Financing income and exchange differences of lease liability</a></td>
<td class="nump">257<span></span>
</td>
<td class="num">(109)<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities', window );">Increase in severance pay liability, net</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Other income</a></td>
<td class="num">(211)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForFinanceIncomeCost', window );">Financial income, net</a></td>
<td class="num">(2,231)<span></span>
</td>
<td class="num">(74)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Un-realized foreign currency loss (gain)</a></td>
<td class="nump">189<span></span>
</td>
<td class="nump">525<span></span>
</td>
<td class="num">(137)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLoss', window );">Adjustments to profit and loss items, total</a></td>
<td class="num">(6,085)<span></span>
</td>
<td class="nump">14,958<span></span>
</td>
<td class="nump">4,473<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ChangesInAssetAndLiabilityItemsAbstract', window );"><strong>Changes in asset and liability items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable', window );">Decrease (increase) in trade receivables</a></td>
<td class="nump">5,658<span></span>
</td>
<td class="num">(7,582)<span></span>
</td>
<td class="nump">929<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories', window );">Decrease (increase) in inventories</a></td>
<td class="num">(906)<span></span>
</td>
<td class="num">(721)<span></span>
</td>
<td class="nump">257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables', window );">Decrease (increase) in other receivables</a></td>
<td class="num">(894)<span></span>
</td>
<td class="nump">364<span></span>
</td>
<td class="num">(763)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable', window );">Increase (decrease) in trade payables and accrued expenses</a></td>
<td class="num">(594)<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="nump">1,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue', window );">Increase (decrease) in other payables</a></td>
<td class="num">(928)<span></span>
</td>
<td class="nump">281<span></span>
</td>
<td class="num">(1,984)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems', window );">Changes in asset and liability items, total</a></td>
<td class="nump">2,336<span></span>
</td>
<td class="num">(7,244)<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(10,465)<span></span>
</td>
<td class="num">(11,885)<span></span>
</td>
<td class="num">(8,916)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Purchase of property and equipment</a></td>
<td class="num">(6,464)<span></span>
</td>
<td class="num">(555)<span></span>
</td>
<td class="num">(489)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestReceivedClassifiedAsInvestingActivities', window );">Interest received</a></td>
<td class="nump">1,947<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments', window );">Proceeds from (investment in) short term bank deposits, net</a></td>
<td class="num">(29,804)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,002<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(34,321)<span></span>
</td>
<td class="num">(481)<span></span>
</td>
<td class="nump">3,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Repayment of leases liabilities</a></td>
<td class="num">(778)<span></span>
</td>
<td class="num">(701)<span></span>
</td>
<td class="num">(693)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfOptions', window );">Proceeds from exercise of options</a></td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfWarrants', window );">Proceeds from exercise of pre-funded warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet', window );">Proceeds from issuance of shares and warrants, net</a></td>
<td class="nump">24,909<span></span>
</td>
<td class="nump">38,380<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RepaymentsOfIiaGrantsNet', window );">Repayment of IIA grants, net</a></td>
<td class="num">(380)<span></span>
</td>
<td class="num">(258)<span></span>
</td>
<td class="num">(360)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RepaymentOfLiabilitiesInRespectOfTeva', window );">Repayment of liabilities in respect of TEVA</a></td>
<td class="num">(834)<span></span>
</td>
<td class="num">(1,667)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">22,917<span></span>
</td>
<td class="nump">35,764<span></span>
</td>
<td class="num">(1,050)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Exchange rate differences on cash and cash equivalent balances</a></td>
<td class="num">(160)<span></span>
</td>
<td class="num">(549)<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Increase (decrease) in cash and cash equivalents</a></td>
<td class="num">(22,029)<span></span>
</td>
<td class="nump">22,849<span></span>
</td>
<td class="num">(6,330)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Balance of cash and cash equivalents at the beginning of the year</a></td>
<td class="nump">33,895<span></span>
</td>
<td class="nump">11,046<span></span>
</td>
<td class="nump">17,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Balance of cash and cash equivalents at the end of the year</a></td>
<td class="nump">11,866<span></span>
</td>
<td class="nump">33,895<span></span>
</td>
<td class="nump">11,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_NonCashTransactionsAbstract', window );"><strong>Supplement disclosure of non-cash transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus', window );">ROU asset, net recognized with corresponding lease liability</a></td>
<td class="nump">6,825<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_PurchaseOfPropertyAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">$ (1,011)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForFinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for net finance income or cost to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance income (cost); Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForFinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow (outflow) due to a decrease (increase) in short-term deposits and investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2023-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestReceivedClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from interest received, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestReceivedClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherAdjustmentsToReconcileProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities that the entity does not separately disclose in the same statement or note. [Refer: Adjustments to reconcile profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherAdjustmentsToReconcileProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35_b_iv&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the exercise of share purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2023-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the revaluation surplus that relates to right-of-use assets. [Refer: Revaluation surplus; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 57<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_57&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of adjustment for increase decrease in revaluation of liabilities in respect of grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment for increase decrease in revaluation of warrants accounted at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes in asset and liability items, total.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of adjustment for financing income and exchange differences of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment for increase in other payables and deferred revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of adjustment for issuance expenses of warrants through profit and loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ChangesInAssetAndLiabilityItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ChangesInAssetAndLiabilityItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_NonCashTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_NonCashTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of proceeds from issuance of shares and warrants, net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_PurchaseOfPropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of purchase of property and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_PurchaseOfPropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RepaymentOfLiabilitiesInRespectOfTeva">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of Repayment of liabilities in respect of TEVA.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RepaymentOfLiabilitiesInRespectOfTeva</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RepaymentsOfIiaGrantsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow as repayment of IIA grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RepaymentsOfIiaGrantsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139928006488592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfGeneralInformationAbstract', window );"><strong>Disclosure Of General Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory', window );">General</a></td>
<td class="text">
      <div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 1:</span></span></td>
              <td style="width:auto;vertical-align:top">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Description of the Company and its operations:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">MediWound Ltd. Was incorporated in Israel in January 2000. The Company which is located in Yavne, Israel (The "Company" or "MediWound"), is biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic, non-surgical solutions for tissue repair and regeneration. The Company&#8217;s strategy leverages its breakthrough enzymatic technology platform into diversified portfolio of biotherapeutics across multiple indications to pioneer solutions for unmet medical needs. The Company&#8217;s current portfolio is focused on next-generation protein-based therapies for burn care, wound care and tissue repair.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25">
          <div style="line-height:1.25;font-family:'Times New Roman',serif">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's first innovative biopharmaceutical product, Nexobrid, has received in December 2022, an approval from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) and marketing approval in each of India, Switzerland and Japan. In addition, it has a marketing authorization from the European Medicines Agency (&#8220;EMA&#8221;) and regulatory agencies in other international markets for removal of dead or damaged tissue, known as eschar, in adults with deep partial and full thickness thermal burns.</span></span></div>
          </div>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company commercialize Nexobrid globally through multiple sales channels.</span></span></div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',serif">&#160;</div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company sells Nexobrid to burn centers in the European Union, United Kingdom and Israel, primarily through its commercial organizations.</span></span></div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',serif">&#160;</div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has established local distribution channels in multiple international markets, focusing on Asia Pacific, EMEA, CEE and LATAM, which local distributors are also responsible for obtaining local marketing authorization within the relevant territories.</span></span></div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',serif">&#160;</div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In the United States, the Company entered into an exclusive license and supply agreements with Vericel Corporation (&#8220;Vericel&#8221;) to commercialize Nexobrid in North America upon FDA approval. On September 21, 2023, the Company announced the U.S. commercial availability of Nexobrid&#174; for the removal of eschar in adults with deep partial- and/or full-thickness thermal burns.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25">
          <div style="line-height:1.25;font-family:'Times New Roman',serif">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On September 20, 2022, The Company announced that EMA has validated for review the Type II Variation to expand the currently approved indication for Nexobrid (removal of eschar in adults with deep partial-and full-thickness thermal burn wounds) into the pediatric population.</span></span></div>
          </div>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s second investigational next-generation enzymatic therapy product, EscharEx, a topical biological drug being developed for debridement of chronic and other hard-to-heal wounds,</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On November 21, 2023 the Company announced in relate to EscharEx clinical trial that an updated Phase III protocol will be submitted during first half of 2024 in accordance with recent discussions with the U.S. FDA and EMA. Study initiation is expected to commence in the second half of 2024.</span></span></div>
        <div style="text-align:justify;margin-left:84.45pt;line-height:1.25">&#160;</div>
        <div></div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

              <tr style="vertical-align:top">
                <td style="width:56.7pt">&#160;</td>
                <td style="text-align:right;vertical-align:top;width:28.35pt">
                  <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">b.</span></span></span></div>
                </td>
                <td style="text-align:left;vertical-align:top;width:auto">
                  <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's securities are listed for trading on NASDAQ since March 2014.</span></span></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On November 28, 2022, the Company&#8217;s shareholders general meeting approved a reverse stock split. Following that approval, on December 5, 2022, the Company&#8217;s board of directors approved a reverse stock split, in a range of 1-for-7 ratio. The reverse split went effective on December 20, 2022. (see also Note 19b).</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During March, September and October 2022, the Company completed a series of capital public and private offerings. The gross proceeds before deducting underwriting discounts and commissions and offering expenses, were approximately $41,700. The net proceeds were approximately $37,292 (see also Note 19).</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On February 7, 2023, the Company completed a registered direct offering. A total of 1,964,286 new ordinary shares were issued in consideration to offering price of $14 per share. The gross proceeds were $27,500, before deducting commissions and other offering expenses. The net proceeds were approximately $25,469.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has three wholly owned subsidiaries: MediWound Germany GmbH, acting as Europe (&#8220;EU&#8221;) marketing authorization holder and EU sales and marketing arm, and MediWound UK Limited and MediWound US, Inc. which are currently inactive companies.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div>
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In October 2023, Israel was attacked by a terrorist organization and entered a state of war. As of the date of these consolidated financial statements, the war in Israel is ongoing and continues to evolve. The company&#8217;s head quarter, manufacturing and R&amp;D facilities are located in Israel. Currently, such activities in Israel remain largely unaffected. During the year ended December 31, 2023, the impact of this war on the company&#8217;s results of operations and financial condition was immaterial.</span></span></p>
                </div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying consolidated financial statements have been prepared on a basis which assumes that the Company will continue as a going concern. From inception to December 31, 2023, the Company has incurred cash outflows from operations, losses from operations, and has an accumulated deficit of $174.8 million.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="text-align:justify;margin-left:81.8pt;line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company believes that its existing cash and cash equivalents, short-term and restricted bank deposits of $41.7 million as of December 31, 2023, will be sufficient to fund its operations and capital expenditure for at least twelve months from the date of issuance of these consolidated financial statements.</span></span></div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for general information about financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 51<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_51&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfGeneralInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfGeneralInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927976553376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Preparation of the Consolidated Financial Statements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfBasisOfPreparationOfConsolidatedFinancialStatementsAbstract', window );"><strong>Disclosure Of Basis Of Preparation Of Consolidated Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory', window );">Basis of Preparation of the Consolidated Financial Statements</a></td>
<td class="text">
    <div>
      <div style="text-align:justify;line-height:1.25;font-weight:bold">
        <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 2:</span></td>
              <td style="width:auto;vertical-align:top">
                <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Basis of Preparation of the Consolidated Financial Statements</span></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:56.7pt">&#160;</td>
            <td style="width:28.35pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
            <td style="width:auto;vertical-align:top;text-align:justify">
              <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Statement of compliance with International Financial Reporting Standards</span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB").</span></span></div>
      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These consolidated financial statements were approved by the board of directors on March 21, 2024.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:56.7pt">&#160;</td>
            <td style="width:28.35pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
            <td style="width:auto;vertical-align:top;text-align:justify">
              <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Functional currency, reporting currency and foreign currency:</span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:85.05pt">&#160;</td>
            <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
            <td style="width:auto;vertical-align:top;text-align:justify">
              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Functional currency and reporting currency:</span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The reporting currency of the financial statements is the U.S. dollar.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company determines the functional currency based on the currency in which it primarily generates and expends cash. The Company determined that its functional currency is the U.S. dollar since most of the Company's revenues are in U.S. dollars and the economic environment in which the Company operates in and performs its transactions is mostly affected by the U.S dollar. A certain portion of the Company's costs are denominated in NIS mainly due to payroll and related benefit costs incurred in Israel. To further support the Company's determination, the Company has analyzed the currency in which funds from financing activities are generated or held and the currency in which receipts from operating activities are usually retained. In this respect, funds from financing activities were principally derived from significant funds raising in U.S. dollars and U.S governmental funds.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company operates and plans its activities in U.S. dollars and accordingly its periodic budgets and internal management reports are prepared and monitored using the U.S. dollar as the primary currency and provides the basis for the determination of share-based compensation.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The&#160;</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt">functional currency of the Company's subsidiary in Germany has been determined to be its local currency - the EURO. Assets and liabilities of this subsidiary are translated at year end exchange rates and its statement of operations&#160;</span><span style="font-family:Times New Roman, Times, serif;font-size:10pt">items are translated using the average exchange rates at the quarter of which those items are recognized. Such translation adjustments are recorded as a separate component of accumulated other comprehensive income (loss) in shareholders' equity (deficit).</span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:85.05pt">&#160;</td>
            <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
            <td style="width:auto;vertical-align:top;text-align:justify">
              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transactions, assets and liabilities in foreign currency:</span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transactions denominated in foreign currency are recorded upon initial recognition at the exchange rate on the date of the transaction. After initial recognition, monetary assets and liabilities denominated in foreign currency are translated at the end of each reporting period into the functional currency at the exchange rate at that date.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchange differences are recognized in profit or loss.</span></span></div>
      <div style="text-align:justify;margin-left:113.4pt;line-height:1.25">&#160;</div>
      <div></div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:56.7pt">&#160;</td>
            <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
            <td style="width:auto;vertical-align:top;text-align:justify">
              <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Use of estimates and judgments</span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of financial statements in conformity with IFRSs requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates.</span></span></div>
      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Discussed below are the key assumptions made in the financial statements concerning uncertainties at the end of the reporting period and the critical estimates computed by the Company that may result in a material adjustment to the carrying amounts of assets and liabilities within the next financial year.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:56.7pt">&#160;</td>
            <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
            <td style="width:auto;vertical-align:top;text-align:justify">
              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Determining the fair value of share-based compensation to employees and directors:</span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25;margin-left:85pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of share-based compensation to employees and directors is determined using the binomial option pricing models. The assumptions used in the models include the expected volatility, early exercise factor, expected dividend and risk-free interest rate.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:56.7pt">&#160;</td>
            <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
            <td style="width:auto;vertical-align:top;text-align:justify">
              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Liabilities in respect to IIA grants:</span></span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government grants received from the IIA are recognized as a liability if future economic benefits are expected from the research and development activity that will result in royalty&#8209;bearing sales. As the contingent liability is calculated based on future royalty-bearing sales, there is uncertainty regarding the estimated future cash flows and the estimated discount rate used to measure the amortized cost of the liability.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25">
        <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#8226;</span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Fair value estimations of warrants</span></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25;margin-left:85pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company completed financing transactions in which it issued shares and warrants to purchase additional shares. The fair value of the warrants, which are not traded on an active market, is determined by using valuation techniques. These valuation techniques maximize the use of observable market data where it is available and rely as little as possible on entity specific estimates.</span></span></div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the basis used for the preparation of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfBasisOfPreparationOfConsolidatedFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfBasisOfPreparationOfConsolidatedFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927976587136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract', window );"><strong>Disclosure of significant accounting policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory', window );">Material Accounting Policies</a></td>
<td class="text">
              <div>
                <div style="line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 3:</span></td>
                        <td style="width:auto;vertical-align:top">
                          <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">Material Accounting Policies</span></div>
                        </td>
                      </tr>

                  </table>
                </div>
                <div style="text-align:justify;margin-left:36pt;line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accounting policies set out below have been consistently applied for all periods presented in these consolidated financial statements:</span></span></div>
                <div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25">&#160;</div>
                <div>
                  <div>

                      <div>
                        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                            <tr>
                              <td style="width:56.7pt">&#160;</td>
                              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                              <td style="width:auto;vertical-align:top;text-align:justify">
                                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basis of consolidation:</span></span></div>
                              </td>
                            </tr>

                        </table>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consolidated financial statements include the financial statements of companies that the Company controls (subsidiaries). Control is achieved when the Company is exposed, or has rights, to variable returns from its investment with the investee and has the ability to affect those returns through its power over the investee.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The financial statements of the Company and its subsidiaries are prepared as of the same dates and periods. The consolidated financial statements are prepared using uniform accounting policies by all entities in the Group.</span></span></div>
                      </div>

                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                  </div>
                </div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories are measured at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated selling costs. The Company periodically evaluates the condition and age of inventories and makes provisions for slow moving inventories accordingly.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of inventories is determined as follows:</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="margin-left:90pt">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="width:19.52%;vertical-align:top">
                              <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Raw materials</span></span></div>
                            </td>
                            <td style="width:3.54%;vertical-align:top">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                            </td>
                            <td style="width:76.94%;vertical-align:top">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At cost of purchase using the first-in, first-out method.</span></span></div>
                            </td>
                          </tr>
                          <tr>
                            <td style="width:19.52%;vertical-align:top">
                              <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished goods</span></span></div>
                            </td>
                            <td style="width:3.54%;vertical-align:top">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                            </td>
                            <td style="width:76.94%;vertical-align:top">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On the basis of average standard costs (which approximates actual cost on a weighted average basis) including materials, labor and other direct and indirect manufacturing costs based on practical capacity.</span></span></div>
                            </td>
                          </tr>

                      </table>
                    </div>
                  </div>

                <div>&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment, net:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment are measured at cost, including directly attributable costs, less accumulated depreciation and accumulated impairment losses. Cost includes spare parts and auxiliary equipment that are used in connection with the plant and equipment.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation is calculated on a straight&#8209;line basis over the useful life of the assets at annual rates as follows:</span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div style="margin-left:90pt">

                        <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="width:70.35%;vertical-align:bottom">&#160;</td>
                              <td style="width:2.82%;vertical-align:top">&#160;</td>
                              <td style="width:26.82%;vertical-align:bottom;border-bottom:#000000 2px solid">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:70.35%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office furniture</span></span></div>
                              </td>
                              <td style="width:2.82%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                              <td style="width:26.82%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7-10</span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:70.35%;vertical-align:top">
                                <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacturing machinery and lab equipment</span></span></div>
                              </td>
                              <td style="width:2.82%;vertical-align:top">&#160;</td>
                              <td style="width:26.82%;vertical-align:bottom">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15-33</span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:70.35%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computers</span></span></div>
                              </td>
                              <td style="width:2.82%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                              <td style="width:26.82%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33</span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:70.35%;vertical-align:top">
                                <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold improvements</span></span></div>
                              </td>
                              <td style="width:2.82%;vertical-align:top">&#160;</td>
                              <td style="width:26.82%;vertical-align:bottom">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">See below</span></span></div>
                              </td>
                            </tr>

                        </table>

                    </div>
                    <p style="margin:0pt">&#160;</p>
                    <div></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold improvements are depreciated on a straight&#8209;line basis over the shorter of the lease term (including the renewal option held by the Company which is expected to be exercised) and the expected life of the improvement.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The useful life, depreciation method and residual value of an asset are reviewed at least each year-end and any changes are accounted for prospectively as a change in accounting estimate.</span></span></div>
                  </div>

                <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liability in respect of Israeli Innovation Authority ("IIA"):</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Grants from the IIA in respect of research and development projects are accounted for as forgivable loans according to IAS 20. Grants received from the IIA are recognized as a liability according to their fair value on the date of their receipt, unless on that date it is reasonably certain that the amount received will not be refunded. If future economic benefits are expected from the project that will result in royalty-bearing revenues from sale of products it will be treated as a contingent liability.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At the end of each reporting period, the Company evaluates whether there is reasonable assurance that the liability recognized, in whole or in part, will not be repaid based on its best estimate of future sales and any changes in the present value of the cash flows discounted at the original interest rate of the grant are recognized in profit or loss. The difference between the amount received and the fair value on the date of receiving the grant is recognized as a deduction of research and development expenses.</span></span></div>
                  </div>

                <div style="line-height:1.25">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leases:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for a contract as a lease when the contract terms convey the right to control the use of an identified asset for a period of time in exchange for consideration.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For these excluded leases, the Company has elected to recognize the lease payments as an expense in profit or loss on a straight-line basis over the lease term. In measuring the lease liability, the Company has elected to apply the practical expedient in the Standard and does not separate the lease components from the non-lease components (such as management and maintenance services, etc.) included in a single contract.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Following are the amortization periods of the ROU assets by class of underlying asset:</span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div style="margin-left:90pt">

                        <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="width:65.06%;vertical-align:top">&#160;</td>
                              <td style="width:3.87%;vertical-align:top">&#160;</td>
                              <td style="width:27.2%;vertical-align:top;border-bottom:#000000 2px solid">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Years</span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:65.06%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-indent:-7.1pt;margin-left:7.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                              </td>
                              <td style="width:3.87%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                              <td style="width:27.2%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:65.06%;vertical-align:bottom">
                                <div style="text-indent:-7.1pt;margin-left:7.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
                              </td>
                              <td style="width:3.87%;vertical-align:bottom">&#160;</td>
                              <td style="width:27.2%;vertical-align:bottom">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6-15</span></span></div>
                              </td>
                            </tr>

                        </table>

                    </div>
                    <p style="margin:0pt">&#160;</p>
                    <div></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company tests for impairment of the ROU asset whenever there are indications of impairment pursuant to the provisions of IAS 36.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Variable lease payments that depend on an index:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:104.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On the commencement date, the Company uses the index rate prevailing on the commencement date to calculate the future lease payments.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:104.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For leases in which the Company is the lessee, the aggregate changes in future lease payments resulting from a change in the index are discounted (without a change in the discount rate applicable to the lease liability) and recorded as an adjustment of the lease liability and the ROU assets, only when there is a change in the cash flows resulting from the change in the index (that is, when the adjustment to the lease payments takes effect).</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease extension and termination options:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:104.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A non-cancelable lease term includes both the periods covered by an option to extend the lease when it is reasonably certain that the extension option will be exercised and the periods covered by a lease termination option when it is reasonably certain that the termination option will not be exercised.</span></span></div>
                  </div>

                <div style="line-height:1.25">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">f.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues recognition:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="text-align:justify;text-indent:-7.05pt;margin-left:56.7pt;line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes revenue when the customer obtains control over the promised goods or services. The revenue is measured according to the amount of the consideration to which the Company expects to be entitled in exchange for the goods or services promised to the customer, other than amounts collected for third parties.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company determines transaction price based on the amount of consideration the Company expects to receive for transferring the promised goods or services in the contract.</span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consideration may be fixed, variable, or a combination of both. At contract inception for arrangements that include variable consideration, the Company estimates the probability and extent of consideration it expects to receive under the contract utilizing either the most likely amount method or expected amount method, whichever best estimates the amount expected to be received. The Company then considers any constraints on the variable consideration and includes in the transaction price variable consideration to the extent it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. The Company then allocates the transaction price to each performance obligation based on the relative standalone selling price and recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) control is transferred to the customer and the performance obligation is satisfied.</span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company records amounts as accounts receivable when the right to consideration is deemed unconditional. Amounts received, or that are unconditionally due, from a customer prior to transferring goods or services to the customer under the terms of a contract are recognized as deferred revenue. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as the current portion of deferred revenue. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s revenue-generating arrangements typically include licensing arrangements, which comprise of upfront license fees, milestone payments and/or royalties and products sale arrangements.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The promised goods or services in the Company&#8217;s licensing arrangements typically consist of a license to the Company&#8217;s intellectual property and/or research and development services.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If a license is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenue from nonrefundable, up-front fees allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For arrangements that include sales-based royalties, including milestone payments based on the level of sales, where the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <div style="line-height:1.25;font-family:'Times New Roman',serif">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In 2019, the Company entered into exclusive license and supply agreements with Vericel to commercialize Nexobrid in North America (see Note 22). The Company identified three distinct performance obligations: (1) license rights (2) development services for BLA approval and (3) manufacturing and supply of Nexobrid.</span></span></div>
                        </div>
                      </div>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of the closing date of the agreement the manufacturing and development services were at market value, therefore the upfront payment was fully attributed to the license performance obligation and as such revenues are recognized at the point in time that control of the license is transferred to the customer.</span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Future milestone payments are considered variable consideration and are subject to the variable consideration constraint, i.e. will be recognized once concluded that it is &#8220;probable&#8221; that a significant reversal of the cumulative revenues recognized under the contract will not occur in future periods when the uncertainty related to the variable considerations are resolved. (see Note 18b).</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from royalties under this agreement will be payable based on future commercial sales, up on an occurrence.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from the sale of products to Vericel will be recognized when all the significant risks and rewards of ownership of the products have passed to the buyer and the seller no longer retains continuing managerial involvement. The delivery date of the products is usually the date of which ownership passes.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from distribution licensing arrangements:</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for the bundled license provided to the distributers and related high specialized services as a single performance obligation and consequently recognize revenue using the cost-to-cost method, where the extent of progress towards completion is measured based on the ratio of actual costs incurred to the total estimated costs expected to be incurred upon satisfying such single performance obligation. The revenues from such bundled performance obligation are included within &#8220;Revenues from license agreements&#8221;. Significant finance components related to such arrangements are recognized as finance expense.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from development services:</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from development services are recognized over time, during the period the customer receives and consumes the benefits provided by the Company's performance.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from the sale of products:</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <div style="line-height:1.25;font-family:'Times New Roman',serif">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company generates revenues from sales of its innovative biopharmaceutical product, Nexobrid, to burn centers and hospital burn units in Europe, U.S Israel and local international markets through its commercial organizations and local distributors.</span></span></div>
                        </div>
                      </div>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from sale of goods is recognized in profit or loss at the point in time when the control of the goods is transferred to the customer, generally upon delivery of the goods to the customer. &#160;The transaction price is the amount of the consideration that is expected to be received based on the contract terms.</span></span></div>
                  </div>

                <p style="margin:0pt">&#160;</p>
                <div></div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">g.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development expenses:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development expenses are recognized in profit or loss when incurred. An intangible asset arising from a development project or from the development phase of an internal project is recognized if the Company can demonstrate the technical feasibility of completing the intangible asset so that it will be available for use or sale; the Company's intention to complete the intangible asset and use or sell it; the Company's ability to use or sell the intangible asset; how the intangible asset will generate future economic benefits; the availability of adequate technical, financial and other resources to complete the intangible asset; and the Company's ability to measure reliably the expenditure attributable to the intangible asset during its development. Since the Company's research and development projects are often subject to regulatory approval procedures and other uncertainties, the conditions for the capitalization of costs incurred before receipt of approvals are not normally satisfied and, therefore, research and development expenses are recognized in profit or loss when incurred.</span></span></div>
                  </div>

                <div style="line-height:1.25">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">h.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial instruments:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accounting policy for financial instruments in accordance with IFRS 9, "Financial Instruments" ("the Standard") is as follows:</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial liabilities:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:113.4pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a)</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial liabilities measured at amortized cost:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:141.75pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of the financial liability.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:141.75pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">After initial recognition, the Company measures all financial liabilities at amortized cost using the effective interest rate method, except for financial liabilities at fair value through profit or loss such as derivatives;</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:113.4pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b)</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial liabilities measured at fair value through profit or loss:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:141.75pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At initial recognition, the Company measures financial liabilities that are not measured at amortized cost at fair value. Transaction costs are recognized in profit or loss.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:28.35pt;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">After initial recognition, changes in fair value are recognized in profit or loss.</span></span></div>
                    <div style="text-align:justify;text-indent:28.35pt;margin-left:113.4pt;line-height:1.25">&#160;</div>
                    <div></div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value measurement is based on the assumption that the transaction will take place in the asset's or the liability's principal market, or in the absence of a principal market, in the most advantageous market.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.</span></span></div>
                    <div style="margin-left:113.4pt;line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A fair value measurement of a non-financial asset takes into account a market participant's ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.</span></span></div>
                  </div>

                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrants:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:86.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Receipts in respect of warrants are classified as equity to the extent that they confer the right to purchase a fixed number of shares for a fixed exercise price. In the event that the exercise price or the numbers of shares to be issued are not deemed to be fixed (for example, in case of net share settlement provision), or warrants redemption in cash on the occurrence of Fundamental Transaction the warrants are classified as a non-current derivative financial liability. This liability is initially recognized at its fair value on the date the contract is entered into and subsequently accounted for at fair value at each reporting date. The fair value changes are charged to non-operating income and expense on the statement of comprehensive income or loss. Issuance costs allocable to warrants are also recorded as non-operating expense on the statement of comprehensive income or loss.</span></span></div>
                  </div>

                <div style="line-height:1.25">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">j.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provisions:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:86.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A provision in accordance with IAS 37 is recognized when the Company has a present (legal or constructive) obligation as a result of a past event, it is expected to require the use of economic resources to clear the obligation and a reliable estimate has been made.</span></span></div>
                  </div>

                <p style="margin:0pt">&#160;</p>
                <div></div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">k.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term employee benefits and severance pay liability, net:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has several employee benefit plans:</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                          <tr style="vertical-align:top">
                            <td style="width:85.05pt">&#160;</td>
                            <td style="text-align:right;vertical-align:top;width:28.35pt">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>1.</span></span></span></div>
                            </td>
                            <td style="text-align:left;vertical-align:top;width:auto">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Short-term employee benefits:</span></span></span></div>
                            </td>
                          </tr>

                      </table>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term employee benefits include salaries, paid annual leave, recreation and social security contributions are recognized as expenses as the services are rendered.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                          <tr style="vertical-align:top">
                            <td style="width:85.05pt">&#160;</td>
                            <td style="text-align:right;vertical-align:top;width:28.35pt">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2.</span></span></span></div>
                            </td>
                            <td style="text-align:left;vertical-align:top;width:auto">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Post-employment benefits:</span></span></span></div>
                            </td>
                          </tr>

                      </table>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25">
                      <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has liabilities for severance pay for its employees in several of jurisdictions and in Israel.</span></span></div>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes liability for severance pay mainly due to its employees in EU in accordance with local laws.</span></span></div>
                  </div>

                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">l.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certain Company employees and directors are entitled to remuneration in the form of equity-settled share-based compensation.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Equity-settled transactions</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The cost of equity-settled transactions with employees is measured at the fair value of their equity instruments granted at grant date. The fair value is determined using the binomial option pricing model.</span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The cost of equity-settled transactions is recognized in profit or loss, together with a corresponding increase in equity, during the period which the performance or service conditions are to be satisfied, ending on the date on which the relevant employees become fully entitled to the award.</span></span></div>
                  </div>

                <p style="margin:0pt">&#160;</p>
                <div></div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">m.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Profit / Loss per share:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company presents basic and diluted earnings per share (EPS) data for its ordinary shares. Basic EPS is calculated by dividing the profit or loss attributable to ordinary shareholders of the Company by the weighted average number of ordinary shares outstanding during the year, adjusted for treasury shares. Diluted EPS is determined by adjusting the profit or loss attributable to ordinary shareholders of the Company and the weighted average number of ordinary shares outstanding, after adjustment for treasury shares, for the effects of all dilutive potential ordinary shares, which comprise of warrants, share options and share options granted to employees.</span></span></div>
                  </div>

                <div style="line-height:1.25">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">n.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold">
                              <div style="line-height:1.25;font-family:'Times New Roman',serif;font-weight:bold">
                                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New standards, amendments to standards and interpretations not yet adopted:</span></span></div>
                              </div>
                            </div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:84.75pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amendment to IAS 1, Presentation of Financial Statements: "Disclosure of Accounting Policies&#8221;</span></span></div>
                    <div style="text-align:justify;margin-left:84.75pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As a result of applying the Amendment, the extent of the accounting policy disclosure provided in the financial statements for 2023 was reduced and adjusted according to the Company&#8217;s specific circumstances.</span></span></div>
                  </div>

                <p style="margin:0pt">&#160;</p>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">o.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Presentation of Financial Statements: Classification of Liabilities as Current or Non-Current (amendment to IAS 1)</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:84.75pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As a result of applying the Amendment the warrants presented in these financial statements (see note 19c), will be classified as a current liability pursuant to the conversion option.</span></span></div>
                  </div>

              </div>
            <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of changes made to accounting policies by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927965860848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash And Cash Equivalents<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory', window );">Cash And Cash Equivalents</a></td>
<td class="text">
    <div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">
      <div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold">Note 4:</td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold">Cash and Cash Equivalents</div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <div style="margin-left:63pt">

              <div>
                <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">December 31</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2023</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2022</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Balance in USD</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">4,151</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">24,475</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Balance in other currencies</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">7,715</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">9,420</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">11,866</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">33,895</div>
                      </td>
                    </tr>

                </table>
              </div>

          </div>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975762784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-term and restricted bank deposits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfShortTermBankDepositsAbstract', window );"><strong>Disclosure Of Short Term Bank Deposits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDepositsFromBanksExplanatory', window );">Short-term and restricted bank deposits</a></td>
<td class="text">
    <div>
      <div style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
        <table cellpadding="0" cellspacing="0" style="font-size:10pt;width:100%">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-weight:bold">Note 5:</td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold">Short-term and restricted bank deposits</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div>
          <div style="margin-top:0pt;margin-bottom:0pt">&#160;</div>
        </div>
      </div>

        <div>
          <div>
            <div>
              <div style="margin-left:63pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">December 31</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2023</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2022</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Restricted bank deposits (1)</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">167</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">-</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">USD Bank deposits (2)</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">29,675</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">-</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">29,842</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">-</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt">&#160;</td>
                    <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif">(1)</td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div>Restricted bank deposits which are primarily used as security for the Company&#8217;s office leases.</div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt">&#160;</td>
                    <td style="width:28.35pt;vertical-align:top">(2)</td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div>The USD deposits bear annual interest of 6.26%-6.55% for the period of 91-365 days for 2023.</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>

    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDepositsFromBanksExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of deposits from banks. [Refer: Deposits from banks]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDepositsFromBanksExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfShortTermBankDepositsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfShortTermBankDepositsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139928022222880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Receivables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract', window );"><strong>Trade and other current receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfTradeReceivablesExplanatory', window );">Trade Receivables</a></td>
<td class="text">
    <div>
      <div style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
        <table cellpadding="0" cellspacing="0" style="font-size:10pt;width:100%">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-weight:bold">Note 6:</td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold">Trade Receivables</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div>
          <div>&#160;</div>

            <div>
              <div style="margin-left:63pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">December 31</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2023</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2022</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Vericel (Note 18b)</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">236</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">7,500</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">BARDA (Note 18a)</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">1,245</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25">701</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">MTEC (Note 18c)</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">617</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">362</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Other trade receivables</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">1,608</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25">771</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Less provision for impairment</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">(6</div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;padding-top:2pt">
                        <div style="line-height:1.25;font-weight:bold">)</div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">(2</div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;padding-top:2pt">
                        <div style="line-height:1.25">)</div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">3,700</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">9,332</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>

        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfTradeReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of trade receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfTradeReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139928006618704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Classes of current inventories [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInventoriesExplanatory', window );">Inventories</a></td>
<td class="text">
    <div>
      <div style="text-align:justify;line-height:1.25">
        <table cellpadding="0" cellspacing="0" style="font-size:10pt;width:100%;border:0px">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 7:</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">Inventories</span></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="margin-left:63pt">&#160;</div>

        <div>
          <div style="margin-left:63pt">
            <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Raw materials</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">995</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">913</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                    <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished goods</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*1,851</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,050</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,846</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,963</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;text-indent:0pt;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*Including write-down of $326</span></span></div>
        </div>

    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInventoriesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS02_g36-39_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInventoriesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927976203440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Receivables Short Term<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract', window );"><strong>Trade and other current receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory', window );">Other Receivables- Short Term</a></td>
<td class="text">
      <div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-weight:bold">Note 8:</td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold">Other Receivables- Short Term</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>

          <div>
            <div style="margin-left:63pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">December 31,</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2023</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2022</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Government authorities</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">322</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">193</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;vertical-align:bottom">
                      <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Income receivables</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">397</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">170</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Prepaid expenses and other</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">722</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">287</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">1,441</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">650</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>

      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other receivables. [Refer: Trade and other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975762784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Receivables- Long Term<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentReceivablesAbstract', window );"><strong>Trade and other non-current receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfOtherReceivablesLongTermExplanatory', window );">Other Receivables- Long Term</a></td>
<td class="text">
        <div>
          <div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt;vertical-align:top;font-weight:bold">Note 9:</td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div style="font-weight:bold">Other Receivables- Long Term</div>
                    </td>
                  </tr>

              </table>
              <div>&#160;</div>

                <div>
                  <div style="margin-left:63pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">December 31,</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2023</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2022</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Income receivables</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold">50</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">180</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Prepaid expenses</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold">183</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">-</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold">233</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">180</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>

            </div>
          </div>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfOtherReceivablesLongTermExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other receivables long term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfOtherReceivablesLongTermExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927976587136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant And Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract', window );"><strong>Disclosure of detailed information about property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory', window );">Property, Plant And Equipment, Net</a></td>
<td class="text">
      <div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-weight:bold">Note 10:</td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold">Property, Plant and Equipment, Net</div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>

          <div>
            <div style="margin-left:63pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">furniture</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacturing machinery and lab equipment</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computers</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">improvements</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;font-weight:bold">Cost</div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of January 1, 2023</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">293</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">5,091</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">166</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">3,279</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">8,829</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Additions</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">25</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">7,312</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">101</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">37</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">7,475</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Capitalization of depreciation of ROU assets</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">59</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">59</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Foreign currency translation</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">1</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">1</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of December 31, 2023</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">319</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">12,403</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">267</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">3,375</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">16,364</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of January 1, 2022</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">257</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">4,764</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">176</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">3,137</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">8,334</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Additions</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">37</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">327</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">49</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">142</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">555</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Disposals</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">(59</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">(59</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Foreign currency translation</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25">(1</div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25">(1</div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of December 31, 2022</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">293</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">5,091</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">166</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">3,279</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">8,829</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:center;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold">Accumulated Depreciation</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of January 1, 2023</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">157</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">3,818</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">97</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">2,391</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">6,463</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Additions</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">26</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">448</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">58</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">140</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">672</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Foreign currency translation</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">1</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">1</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of December 31, 2023</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">184</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">4,266</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">155</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">2,531</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">7,136</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of January 1, 2022</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">133</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">3,370</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">94</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">2,259</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">5,856</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Additions</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">25</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">448</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">62</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">132</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">667</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Disposals</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">(59</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">(59</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Foreign currency translation</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                      <div style="line-height:1.25">(1</div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                      <div style="line-height:1.25">(1</div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of December 31, 2022</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">157</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">3,818</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">97</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">2,391</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">6,463</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold">Carrying amounts of all fixed asset items</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:19pt;line-height:1.25;font-family:'Times New Roman',Times,serif">December 31, 2023</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">135</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">8,137</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">112</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">844</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">9,228</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;padding-bottom:4px;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:19pt;line-height:1.25;font-family:'Times New Roman',Times,serif">December 31, 2022</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">136</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">1,273</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">69</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">888</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">2,366</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="margin-left:63pt">
              <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
            </div>
          </div>

      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS16_g73-79_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927976587136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfLeasesExplanatory', window );">Leases</a></td>
<td class="text">
      <div>
        <div>
          <div>
            <div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 11:</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leases</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:56.7pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease Agreements:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="line-height:1.25">
                  <div style="text-align:justify;margin-left:81.8pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's offices and its production facility in Israel are located in a building that the Company leased from its Related party (see Note 24a), in accordance with a sub-lease agreement. The Company subleased approximately 3,000 square meters of laboratory, office and clean rooms space at a monthly rent fee NIS 125 (approximately $<span>35</span>). This sub-lease agreement was amended in October 2021, to extend the period up to October 2025 which was included in the calculation of the lease liability and RoU asset.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In July 2023, the company signed a termination agreement for the sub-lease agreement and signed on a new lease agreement for the same area of approximately 3,000 square meters in the same building with the owner of the building<span> at a monthly rent fee of NIS 195 (approximately $54).</span> The lease agreement is for 12 years with an option for an additional 3 years. The company estimation is to use the 3 years option</span></span></div>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In addition, the Company and its subsidiary have lease agreements for 16 vehicles for the remaining period of 1.75 years on average.</span></span></div>
              </div>
            </div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amounts recognized in profit or loss and in the statement of cash flows</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:90pt">

                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31,</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest expense on lease liabilities</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">274</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">102</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation expenses</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">565</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">537</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash outflow for leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">778</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">701</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>

            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company determined the appropriate interest rate for discounting leases, with the assistance of a third party. The valuation was based on: credit risk, the weighted average term of the leases and other economic variables. A weighted average interest rate in a range of 1% to 8.47% was used to discount future lease payments in the calculation of the lease liability on the date of initial application of the standard (IFRS 16).</span></span></div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
            <div></div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disclosures in respect of Right- of- Use assets:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>

              <div style="margin-left:90pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,341</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">550</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,891</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,460</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">407</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,867</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments for indexation</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">78</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">81</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,368</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(308</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,676</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,511</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">652</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,163</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated depreciation</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,342</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">334</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,676</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;margin-left:9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">334</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">231</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">565</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capitalized to Leasehold improvements</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25;margin-left:9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,527</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(308</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,835</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">208</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">257</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">465</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciated cost</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,303</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">395</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,698</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:90pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,267</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">654</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,921</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">125</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">125</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments for indexation</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">74</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">83</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(238</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(238</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,341</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">550</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,891</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated depreciation</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,028</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">345</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,373</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;margin-left:9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">314</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">225</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">539</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25;margin-left:9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(236</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(236</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,342</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">334</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,676</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciated cost</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">999</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">216</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,215</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>

            <p style="margin:0pt">&#160;</p>
            <div></div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                  <tr style="vertical-align:top">
                    <td style="width:56.7pt">&#160;</td>
                    <td style="text-align:right;vertical-align:top;width:28.35pt">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">d.</span></span></span></div>
                    </td>
                    <td style="text-align:left;vertical-align:top;width:auto">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Disclosures of the Company's lease liabilities:</span></span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25">&#160;</div>

              <div style="margin-left:90pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,199</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">179</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,378</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Repayment of leases liabilities</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(588</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(190</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(778</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect of changes in exchange rates</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(17</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New finance lease obligation recognized</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,460</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">365</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,825</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments for indexation</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">78</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">81</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial expenses</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">257</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">274</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals-Termination of leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,041</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(11</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,052</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,346</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">365</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,711</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current maturities of long-term leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(180</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(181</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(361</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liability Balance as of December 31, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,166</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">184</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,350</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:90pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,691</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">299</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,990</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Repayment of leases liabilities</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(477</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(224</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(701</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect of changes in exchange rates</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(182</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(28</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New finance lease obligation recognized</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">117</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">117</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments for indexation</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">74</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">83</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial expenses</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">93</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">101</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals-Termination of leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,199</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">179</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,378</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current maturities of long-term leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(399</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(133</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(532</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liability Balance as of December 31, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">800</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">46</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">846</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>

          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Section Presentation<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g47-50_TI<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g51-60_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139928006594288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract', window );"><strong>Disclosure of detailed information about intangible assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory', window );">Intangible Assets, Net</a></td>
<td class="text">
    <div>
      <div style="line-height:1.25">
        <div style="line-height:1.25">
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0);border:0px">

                <tr>
                  <td style="width:56.7pt;vertical-align:top;font-weight:bold">
                    <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt">Note 12:</span></p>
                  </td>
                  <td style="vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span>Intangible Assets, Net</span></strong></span></div>
                  </td>
                </tr>

            </table>
            <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
          </div>
        </div>
      </div>
      <div>
        <div>

            <div>
              <div style="margin-left:63pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>License and</span></span></span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Knowhow</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cost</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of January 1,</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,538</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,538</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additions</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of December 31,</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,538</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,538</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Accumulated Amortization</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of January 1,</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,307</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,241</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additions</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>66</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>66</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of December 31,</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,373</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,307</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Amortized cost</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of December 31,</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>165</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>231</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>

          <div style="margin-left:63pt">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Intangible assets include exclusive licenses to use patents, know-how and intellectual property for the development, manufacturing and marketing of products related to burn treatments and other products in the field of wound care. These licenses were purchased from third parties and from one of the Company's shareholders.</span></span></span></span></div>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS38_g118-128_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139928006577728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Payables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesAbstract', window );"><strong>Trade and other payables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory', window );">Other Payables</a></td>
<td class="text">
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 13:</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other Payables</span></span></div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>

            <div>
              <div style="margin-left:63pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employees and payroll accruals</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,109</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,471</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liability in respect of TEVA (see Note 17c)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,250</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">417</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Related parties</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">83</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">307</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred revenues</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">63</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">425</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">901</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,891</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,159</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>

        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other payables. [Refer: Trade and other payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975734272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liabilities in Respect of IIA Grants<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract', window );"><strong>Disclosure of israeli innovation authority grants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGovernmentGrantsExplanatory', window );">Liabilities in Respect of IIA Grants</a></td>
<td class="text">
    <div>
      <div style="line-height:1.25">
        <div style="line-height:1.25">
          <div style="line-height:1.25">
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)">

                    <tr>
                      <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Note 14:</span></span></span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Liabilities in Respect of IIA Grants</span></span></span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div>
        <div>
          <div>&#160;</div>

            <div>
              <div style="margin-left:63pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of January 1,</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7,566</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,105</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Royalties</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(190</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(407</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Amounts carried to Profit or Loss</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>427</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(132</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of December 31,</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7,803</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7,566</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Current maturities</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(126</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(121</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Long term liabilities in respect of IIA grants</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7,677</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7,445</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>

          <div style="margin-left:63pt">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company is committed to pay royalties to the IIA up to the total grants received plus the applicable accrued interest. The total amount of grants received from IIA including accrued interest, net of royalties as of December 31, 2023 is approximately $13,783, while the amortized cost of this liability as of that date is $ 7,803, using the interest method.</span></span></span></span></div>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGovernmentGrantsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for government grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS20_g39-39_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGovernmentGrantsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975892640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial  Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract', window );"><strong>Disclosure of detailed information about financial instruments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory', window );">Financial Instruments</a></td>
<td class="text">
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 15:</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial Instruments</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Risk management:</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Board of Directors has overall responsibility for the establishment and oversight of the Company&#8217;s risk management framework.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s risk management practice was formulated to identify and analyze the risks that the Company faces, to set appropriate limits for the risks and controls, and to monitor the risks and their compliance within the limits. The risk policy and risk management methods are reviewed regularly to reflect changes in market conditions and in the Company&#8217;s operations.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:85.05pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company Audit Committee oversees how management monitors compliance with the Company&#8217;s risk management policies and procedures and reviews the adequacy of the risk management framework in relation to the risks faced by the Company. The Company Audit Committee is assisted in its oversight role by Internal Audit. Internal Audit undertakes both regular and ad hoc reviews of risk management controls and procedures, the results of which are reported to the Audit Committee.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's activities expose it to various financial market risks, mainly foreign currency risk, interest rate risk and liquidity risk.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:85.05pt">&#160;</td>
                <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency risk</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company operates primarily in an international environment and is exposed to foreign exchange risk resulting from the fact that a certain portion of the Company's costs are denominated in NIS and EURO, mainly due to payroll and related benefit costs incurred in Israel and additionally due to marketing expenses incurred in Europe.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:85.05pt">&#160;</td>
                <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sensitivity tests relating to changes in market factors:</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company operates in an international environment and is exposed to foreign exchange risk resulting from the exposure to different currencies, mainly NIS and EURO. Foreign exchange risks arise from recognized assets and liabilities denominated in a foreign currency other than the functional currency.</span></span></div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25">&#160;</div>

            <div>
              <div>
                <div style="margin-left:108pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gain (loss) from change:</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5% increase in NIS and EURO exchange rate</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">176</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">257</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5% decrease in NIS and EURO exchange rate</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(176</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(257</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>

          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has performed sensitivity tests of principal market risk factors that may affect its reported operating results or financial position.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The sensitivity tests present the profit or loss for the relevant risk variables chosen as of each reporting date.</span></span></div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25">&#160;</div>
          <div></div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:85.05pt">&#160;</td>
                <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liquidity risk</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:106.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company&#8217;s approach to managing liquidity is to ensure, as far as possible, that it will always have sufficient liquidity to timely meet its liabilities, under both normal and stressed conditions, without incurring unwanted losses.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:106.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company manages the liquidity risk by holding cash balances, short-term deposits and secured bank credit facilities.</span></span></div>
          <div>
            <div style="line-height:1.25">
              <div style="margin-left:108pt">&#160;</div>
            </div>
          </div>

            <div>
              <div>
                <div style="line-height:1.25">
                  <div style="margin-left:108pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="14" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2023</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12 months</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">amount</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">or less</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1-2 years</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2-15 years</span></span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-derivative financial liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Current maturities of long-term liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,249</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,249</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Trade payables and accrued expenses</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,528</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,528</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Other payables</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,891</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,891</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Liabilities in respect of IIA grants</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,927</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">359</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,568</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Liabilities in respect of TEVA</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,200</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,000</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,200</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Lease liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,189</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">813</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,376</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:108pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="14" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2022</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12 months</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">amount</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">or less</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1-2 years</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2-8 years</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-derivative financial liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Current maturities of long-term liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,814</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,814</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Trade payables and accrued expenses</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,656</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,656</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Other payables</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,159</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,159</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Liabilities in respect of IIA grants</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,464</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">312</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,152</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Liabilities in respect of TEVA</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,200</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,000</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,200</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Lease liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">902</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">508</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">394</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </div>
            </div>

          <div style="line-height:1.25">&#160;</div>
          <div></div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value:</span></span></div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:85.05pt">&#160;</td>
                <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1)</span></span></td>
                <td style="width:auto;vertical-align:top">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial instruments measured at fair value for disclosure purposes only.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The carrying amounts of certain financial assets and liabilities, including cash, trade receivables, other receivables, deposits, trade and other payables are the same as or approximate to their fair value.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:85.05pt">&#160;</td>
                <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2)</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value hierarchy of financial instruments measured at fair value.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The financial instruments measured at fair value on a temporal basis, use valuation methodology in accordance with the fair value hierarchy levels when determining the fair value of an asset or liability, the Company uses observable market data as much as possible.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Details regarding fair value measurement at Level 2</span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of the warrants which are classified as non-currents liabilities was measured by using Black and Scholes model. The following inputs were used to determine the fair value:</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected period of warrants&#8211; 2.91 years.</span></span></div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected volatility &#8211; 67.1%</span></span></div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Risk-free interest rate (3) &#8211; 4.03%</span></span></div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected dividend yield &#8211; 0%.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of liabilities in respect to IIA grants with fixed interest is based on a calculation of the present value of the cash flows at the interest rate for a loan with similar terms. The Company used a discount rate of 12% based in part of the Company&#8217;s estimation at the time of the Company&#8217;s recognition of the IIA grants which approximates the fair value at the respective balance sheet date.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The liability in respect of TEVA as presented in balance sheet which is approximate its fair value, based on a calculation of the present value of future payments. The expected cash flows already reflect assumptions about the uncertainty in future defaults, and therefore the Company used a discount rate of 14% that is commensurate with the risk inherent in the expected cash flows (Note 17c).</span></span></div>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of derivative financial instruments. [Refer: Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139928006577728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Severance Pay Liability, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract', window );"><strong>Disclosure of defined benefit plans [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory', window );">Severance Pay Liability, Net</a></td>
<td class="text">
    <div>
      <div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 16:</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Severance Pay Liability, Net</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has liabilities for severance pay for its employees in Israel and in several EU jurisdictions. The Company&#8217;s liability for employee benefits is based on local laws, valid labor agreements, the employee&#8217;s salary and the applicable terms of employment, which together generate a right to severance compensation. Post&#8209;employment employee benefits are partially financed by deposits with defined contribution plans, as detailed below.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Israeli Severance Pay Law, 1963 (&#8220;Severance Pay Law&#8221;), specifies that Israeli employees are entitled to severance payment, following the termination of their employment.</span></span></div>
          <div style="line-height:1.25">
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under the Severance Pay Law, the severance payment is calculated as one month salary for each year of employment, or a portion thereof. Under Section 14 of the Severance Pay Law (&#8220;Section 14&#8221;), employees are entitled to have monthly deposits, at a rate of 8.33% of their monthly salary, made on their behalf to their insurance funds. Payments in accordance with Section 14 release the Company from the liability for any future severance payments in respect of those employees.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The majority of the Company&#8217;s liability for severance pay is covered by Section 14. Accordingly, the Company does not recognize any liability for severance pay due to these employees and the deposits under Section 14 are not recorded as an asset in the Company&#8217;s balance sheet. These contributions for compensation represent defined contribution plans. The Company recognizes liability for severance pay due to its employees in EU in accordance with local laws and its Israeli employees which are not under Section 14.</span></span></div>
          </div>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of defined benefit plans. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 138<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_138&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927976137904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liabilities and Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesAbstract', window );"><strong>Disclosure of contingent liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory', window );">Liabilities and Commitments</a></td>
<td class="text">
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 17:</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liabilities and Commitments</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;font-weight:normal;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In 2000, the Company signed an exclusive license agreement (as amended in 2007) with a third party with regard to its patents and intellectual property. Pursuant to the agreement, the Company received an exclusive license to use the third party&#8217;s patents and intellectual property, for the purpose of developing, manufacturing, marketing, and commercializing products for treatment of burns and other wounds.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company paid an aggregate amount of $ 950 and undertook to pay royalties of 1.5% to 2.5% from future revenues from sales of products which are based on this patent for a period of 12 years from the first commercial delivery in a major country, and thereafter the Company will have a fully paid-up royalty-free license for these patents. In addition, royalties will be paid at the rate of 10%&#160;from sub-licensing of such patents and for lump sum amounts paid to the Company by a third party, the Company will pay 2% of the proceeds up to $1,000 and 4% above this amount. Moreover, the Company agreed to pay a one-time lump-sum amount of $ 1,500 when the aggregate revenues based on these patents reach $ 100,000. The royalty payments for the years 2021, 2022 and 2023 amounted to $149, $363 and $98 respectively.</span></span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>b.</span></span></span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Under the Research and Development Law, (the &#8220;R&amp;D Law&#8221;) the Company undertook to pay royalties of 3% on the revenues derived from sales of products or services developed in whole or in part using IIA grants. The maximum aggregate royalties paid cannot exceed 100% of the grants received by the Company, plus annual interest equal to the 12-month interest applicable to dollar deposits, as published on the first business day of each calendar year. The total royalties amount paid as of December 31, 2023 is $1,942. (Note 14).</span></span></span></span></div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>c.</span></span></span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div>
                    <div style="line-height:1.25;font-family:'Times New Roman',serif">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In December 2020, Teva has agreed to revise the Settlement Agreement from March 2019, which was comprised of past agreement for collaboration in the development, manufacturing and commercialization of solutions for the burn and chronic wound care markets, as well as the Company&#8217;s repurchase of shares from Teva. Under the new settlement the Company paid $1,000 in cash and became obligated to pay an amount of $2,000 over three years and an addition amount of $7,200 in quarterly fixed payments starting 2021 as long as there are revenues generated from sales of Nexobrid.</span></span></span></span></div>
                    </div>
                  </div>
                  <div style="font-family:'Times New Roman',Times,serif">&#160;<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total liabilities recorded as of December 31, 2023 and 2022 were approximately $4,428 and $4,794 respectively, and financial expenses of $468 and $533, respectively, were recorded in profit or loss within financial expenses.</span></span></span></span></div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of commitments and contingent liabilities. [Refer: Contingent liabilities [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927969683568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Materials Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfMaterialAgreementsAbstract', window );"><strong>Disclosure Of Material Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfMaterialAgreementsExplanatory', window );">Materials Agreements</a></td>
<td class="text">
      <div>
        <div style="text-align:justify;line-height:1.25;font-weight:bold">
          <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Note 18:</span></span></span></strong></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Materials Agreements</span></span></span></strong></p>
                </td>
              </tr>

          </table>
        </div>
        <div style="text-align:justify;text-indent:-56.7pt;margin-left:56.7pt;line-height:1.25;font-weight:bold">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BARDA<span style="font-style:italic">&#160;</span>Contracts</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In September 2015, the Company was awarded BARDA Contract for treatment of thermal burn injuries. This contract was amended multiple times to extend its term until September 2024 (the Company is pursuing an extension of the contract) and its total value, up to a total amount of $165,000 as of the end of 2022.</span></span></div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        <div style="text-align:justify;margin-left:85.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>In</span> May 2023 BARDA has awarded an additional approximately $10,000 to the Company. The total amount of the contract is comprised of $110,000 to support research and development activities and up to $65,000 to procure <span>Nexobrid</span> for U.S. emergency preparedness (which will be split between the Company and Vericel following Vericel agreement (see Note 18b)).</span></span></div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, the Company has received approximately $88,282 in funding in the aggregate, from BARDA under the first contract, and an additional $16,500 for procurement of <span>Nexobrid</span> for U.S. emergency preparedness, which were recorded at the net amount of approximately $10,500 following the split of gross profit agreement with Vericel for the initial BARDA procurement.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In September 2018 the Company was awarded the second BARDA contract, to develop Nexobrid for the treatment of Sulfur Mustard injuries as part of BARDA&#8217;s preparedness for mass casualty events. The contract provides up to $12,000 of funding to support research and development activities and contains options to provide additional funding of up to $29,000 for additional development activities, animal pivotal studies, and the BLA submission for licensure of Nexobrid for the treatment of Sulfur Mustard injuries. The second BARDA contract expired in 2023. As of December 31, 2023, the Company has received approximately $4,368 of funding from the second BARDA contract.</span></span></div>
          <div style="text-align:justify;margin-left:85.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div></div>
        </div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b<span style="font-style:italic">.</span></span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vericel Agreement:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="text-align:justify;margin-left:74.7pt;line-height:1.25">
          <div style="margin-left:74.7pt;line-height:1.25;font-family:'Times New Roman', serif;font-size:11pt">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:justify;margin-left:83.7pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On May 6, 2019, the Company entered into exclusive license and supply agreements with Vericel to commercialize <span>Nexobrid</span> in North America (the &#8220;Collaboration Agreements&#8221;). Pursuant to the Collaboration Agreements, Vericel will obtain the authority over and control of the development, regulatory approval and commercialization of licensed products in the North America territory. MediWound will be responsible for the development of the product through BLA approval, supported and funded by BARDA, as well as the manufacture and supply of <span>Nexobrid</span>. In addition, MediWound retains the commercial rights to <span>Nexobrid</span> in non-North American territory.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:83.7pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under the terms of the license agreement, Vericel has made an upfront payment to MediWound of $17,500 which was recorded as revenues from license agreements in 2019 as well as an additional milestone payment of $7,500 recorded as revenues from license agreements in 2022 upon BLA approval received in December 2022. Furthermore, Vericel has also agreed to pay MediWound up to $125,000 in payments contingent upon meeting certain annual sales milestones, tiered royalties on net sales ranging from high single-digit to teen-digit percentages, a split of gross profit on committed BARDA procurement orders and a teen-digits royalty on any additional future BARDA purchases of <span>Nexobrid</span>. Under the terms of the supply agreement, Vericel will procure <span>Nexobrid</span> from MediWound at a fixed transfer price.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:83.7pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total revenue from royalties as of December 31, 2023 <span>was</span> approximately $82.</span></span></div>
          <div style="text-align:justify;margin-left:83.7pt;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        </div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">DOD and MTEC contracts:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="text-align:justify;margin-left:74.7pt;line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif">
          <div style="line-height:1.25;font-family:'Times New Roman',serif">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On February 17, 2022, the Company was entered into a contract with the U.S. Department of Defense (DoD), through the Medical Technology Enterprise Consortium (MTEC), to develop Nexobrid as a non-surgical solution for field-care burn treatment for the U.S. Army. The contract provides funding up to $2,727.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
          </div>
        </div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif">
          <div style="line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During 2023, the DOD through MTEC awarded the Company additional funding of $9,117 in addition, the company awarded directly through MTEC funding of $1,190, to advance the development of a new temperature stable formulation of Nexobrid. The total additional fund from the DOD and MTEC during 2023 was $10,307.</span></span></div>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Biopharmax Group Ltd. contract:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="margin-left:85.05pt;line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:90pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 17, 2023 the<span style="font-weight:bold">&#160;</span>company signed a turnkey scale-up agreement with Biopharmax Group Ltd. This strategic agreement is designed to bolster our manufacturing infrastructure to support our long-term growth trajectory. The objective of this agreement is to establish, commission, and validate a cutting-edge, sterile, and GMP-compliant manufacturing facility. The venture aims to increase the company&#8217;s production capacity significantly, to expand up to six times the current capacity.</span></span></div>
        <div style="text-align:justify;margin-left:90pt;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        <div style="text-align:justify;margin-left:90pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The new facility, equipped with fully operational clean rooms, will be exclusively designed for <span>Nexobrid</span> production. It will comply with stringent regulations from the GMP, FDA, EMA, Israeli Ministry of Health, and relevant Israeli regulatory bodies. An estimated $12.7 million will be invested in the project, set for <span>constructions </span>completion by mid-2024, with full-scale manufacturing expected to commence in 2025 (see also note 10).</span></span></div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfMaterialAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfMaterialAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfMaterialAgreementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of material agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfMaterialAgreementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927968303456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract', window );"><strong>Disclosure of classes of share capital [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory', window );">Equity</a></td>
<td class="text">
    <div>
      <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

          <tr>
            <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 19:</span></td>
            <td style="width:auto;vertical-align:top;text-align:justify">
              <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span>Equity</span></strong></span></div>
            </td>
          </tr>

      </table>
      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>
    </div>

      <div>
        <div>
          <div style="line-height:1.25">
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                    <tr>
                      <td style="width:56.7pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">a.</span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span><span><span style="font-family:'Times New Roman', Times, serif">Share capital:</span></span></span></strong></span></div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          </div>
          <div style="margin-left:85.05pt">
            <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
            <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:90%">

                <tr>
                  <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>December 31</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2023</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2022</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Authorized number of shares</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double black;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double black;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><span><span>20,000,000</span></span></span></span></strong></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double black;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double black;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>12,857,143</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom">
                    <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Issued and outstanding number of shares</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><span><span>9,221,764</span></span></span></span></strong></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>7,240,020</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
      </div>

    <div style="line-height:1.25;clear:both">
      <p style="margin-left:56.7pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <div>
        <div style="margin-left:85.05pt;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>An ordinary share confers upon its holder(s) a right to vote at the general meeting, a right to participate in distribution of dividends, and a right to participate in the distribution of surplus assets upon liquidation of the Company.</span></span></span></span></span></span></span></div>
        <div style="margin-left:85.05pt;margin-top:0pt;margin-bottom:0pt;text-align:justify">&#160;</div>
      </div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

        <tr>
          <td style="width:56.7pt">&#160;</td>
          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">b.</span></td>
          <td style="width:auto;vertical-align:top;text-align:justify">
            <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Movement in share capital:</span></div>
          </td>
        </tr>
        <tr>
          <td style="width:56.7pt">&#160;</td>
          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</td>
          <td style="width:auto;vertical-align:top;text-align:justify">&#160;</td>
        </tr>

    </table>
    <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)">

        <tr>
          <td style="width:85.05pt">&#160;</td>
          <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span>1.</span></span></td>
          <td style="width:auto;vertical-align:top;text-align:justify">
            <div><span style="font-size:10pt"><span>During 2021, 2022 and 2023 the Company issued additional 4,852, 41,395 and 17,458 ordinary shares for each year upon vesting of outstanding RSU&#8217;s, respectively.</span></span></div>
          </td>
        </tr>

    </table>
    <div>
      <div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:85.05pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On November 28, 2022, at the Company&#8217;s extraordinary general meeting of shareholders, its shareholders approved:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:103.05pt">&#160;</td>
              <td style="width:20.4pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(a)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">An increase&#160;of the Company&#8217;s authorized share capital from NIS 500,000, consisting of 50,000,000 ordinary shares, per value NIS 0.01 per share to NIS 900,000 consisting of 90,000,000 ordinary shares, per value NIS 0.01 per share.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

              <tr style="vertical-align:top">
                <td style="width:103.05pt">&#160;</td>
                <td style="text-align:right;vertical-align:top;width:20.4pt">
                  <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(b)</span></span></div>
                </td>
                <td style="text-align:left;vertical-align:top;width:auto">
                  <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 5, 2022, the Company&#8217;s board of directors approved a reverse split of 1-for-7 ratio. The reverse split went effective on December 20, 2022.</span></span></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:121.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No fractional shares were issued as a result of the reverse share split. Instead, such shares were rounded up to the next whole number of shares. The reverse share split affected all shareholders uniformly and did not alter any person&#8217;s percentage interest in our outstanding ordinary shares, except for negligible adjustments that may have resulted from the treatment of fractional shares.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:121.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In connection with the reverse share split, The Company also amended and reduced the authorized number of ordinary shares from 90,000,000 to 12,857,143, which reflected a reduction at the same 1-for-7 ratio as the reduction to the number of issued and outstanding ordinary shares.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:121.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Concurrently, the par value of the Company&#8217;s ordinary shares was increased proportionately, from NIS 0.01 per share to NIS 0.07 per share, in order to maintain the same overall authorized share capital under our Amended and Restated Articles of Association.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:121.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On May 31, 2023 the Shareholders of the Company approved an amendment to Article 6 of the Company&#8217;s Amended and Restated Articles of Association, which increased the Company&#8217;s authorized share capital from 900,000 NIS consisting of 12,857,143 ordinary shares par value NIS 0.07 to NIS 1,400,000, consisting of 20,000,000 ordinary shares, par value NIS 0.07 per share.</span></span><br/>&#160;</div>
        <div></div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial transactions:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:85.05pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 7, 2022, the Company completed a public offering in total of 744,048 new ordinary shares which were issued in consideration to offering price of $13.44 per share. The net proceeds were $8,653, after deducting commissions and other offering expenses. In addition, on March 22, 2022 the underwriters exercised their options to purchase an additional 89,012 ordinary shares at the same public offering price. The net consideration to the Company, less underwriting discounts and commissions was at additional of $1,021.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As part of the above- mentioned public offering, certain entities affiliated with CBI purchased 208,334 of ordinary shares at the public offering price.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:85.05pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On September 26, 2022, the Company completed a registered direct (the &#8220;RD&#8221;) offering in an aggregate amount of $13,257 represent a combine purchase price of $12.25 for issuance of 1,082,223 ordinary shares and 1,082,223 warrants that become exercisable on November 28, 2022, at an exercise price of $13.475 per ordinary share which will expire in four years (see also note 25.3).</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The warrants issued have been classified as a non-current financial liability due to a net share settlement provision and as they can be settled in cash on the occurrence of Fundamental Transaction as determined in the agreement. This liability was initially recognized at its fair value on the date the contract was entered into and is subsequently accounted for fair value at each balance sheet date and recorded through profit and loss.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of the warrants has been evaluated with the assistance of external independent valuator and was computed based on then current price of the shares, a risk-free interest rate of 4.37% and an average standard deviation of 68%.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The net proceeds from this offering in the amount of $11,698 have been received on September 28, 2022. The issuance expenses related to the non-current financial liability were recorded through profit and loss and the issuance expenses related to the issuance of shares recorded as a deduction from the proceeds in equity.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:85.05pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Concurrently, on October 6, 2022, the Company entered into a Private Issuance Purchase Equity agreement (the &#8220;PIPE&#8221;) with several purchasers, in connection with the offering of 1,407,583 unregistered pre-funded warrants to purchase up to 1,407,583 ordinary shares and 1,407,583 warrants to purchase up to 1,407,583 ordinary shares. Pre-Funded warrants become exercisable on November 28, 2022, at an exercise price of $0.007 per ordinary share and the warrants would be also exercisable upon the Authorized Share Increase Date at an exercise price of $13.475 per ordinary share and expire in four years.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Pre-Funded warrants and warrants issued have been classified as a non-current financial liabilities due to a net share settlement provision and they can be redeemed in cash on the occurrence of Fundamental Transaction as determined in the agreement. The initial fair value of the financial liabilities issued in the transaction was approximately $20,788, which comprised of: 1. The warrants which were valuated by Black and Sholtes model based on the current price of the shares and a risk-free interest rate of 4.26%, and 2. The pre-funded warrants which were valued in an amount which is approximate its share price upon their issuance.</span></span></div>
        <div style="text-align:justify;margin-left:103.05pt;line-height:1.25">&#160;</div>
        <div></div>
        <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The consideration received from this transaction was $17,233. As the fair value on initial recognition of the warrants differs from the transaction price, the difference, represents the First day loss at the amount of $3,555, and has been allocated to the warrants with respect to this transaction and is amortized on a straight line basis over the term of the warrants.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The net proceeds from this offering amounted to approximately $15,920. The issuance expenses were recorded through profit and loss.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During December 2022, the 1,407,583 pre-funded warrants were exercised into ordinary shares.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:85.05pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Upon closing of the RD and PIPE Offerings, the Company also issued the placement agent up to 124,491 warrants to purchase up to 124,491 ordinary Shares. The warrants have substantially the same terms as the RD and PIPE Warrants, except that the placement agent&#8217;s warrants have an exercise price equal to $15.312 per share (which represents 125% of the offering price per ordinary Share in the offerings). The Fair value of the placement agent&#8217;s options was recorded as an issuance expenses through profit and loss and as a deduction from proceed in equity based on the financial treatment of both RD and PIPE offering and in accordance with&#160;their part.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:85.05pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On February 7, 2023, the Company completed a registered direct (the &#8220;RD&#8221;) offering of 1,964,286 new ordinary shares which were issued in consideration to offering price of $14.0 per share. The gross proceeds were $27,500, before deducting commissions and other offering expenses in the amount of $2,031.</span></span></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share capital, reserves and other equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927968596960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory', window );">Share Based Compensation</a></td>
<td class="text">
    <div>
      <div>
        <div>
          <div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note 20:</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share&#8209;Based Compensation</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt">&#160;</td>
                    <td style="width:28.35pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expense recognized in the financial statements:</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The expenses recognized for services received from employees and directors is as follows:</span></span></div>
              <div style="line-height:1.25">&#160;</div>
            </div>
          </div>

            <div style="margin-left:85.05pt">
              <div>
                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenues</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">271</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">184</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">153</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;vertical-align:bottom">
                          <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">485</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">406</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">333</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Selling and marketing</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">87</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">42</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,097</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,314</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,187</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
                          <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total share-based compensation</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,940</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,946</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,673</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>

        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;line-height:1.25">
          <div></div>
        </div>
      </div>
    </div>
    <div>
      <div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based payment plan for employees and directors:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has granted options and restricted stock units ("RSUs") for a total of 990,201 ordinary shares.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, 861,255 ordinary shares of the Company were still available for a future grant.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Any options or RSUs, which are forfeited or not exercised before expiration, become available for future grants.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options granted under the Company's 2003 Israeli Share Option Plan ("The Plan") are exercisable in accordance with the terms of the Plan, within 5-10 years from the date of grant, against payment of an exercise price or cashless exercise. The options generally vest over a period of 3-4 years.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In March 2014, the Company adopted and obtained shareholder approval for its 2014 Equity Incentive Plan (the &#8220;2014 Plan&#8221;). Options and RSU's granted under the Company's 2014 Plan are exercisable in accordance with the terms of the Plan. Options are exercisable within 5-10 years from the date of grant, against payment of an exercise price or cashless exercise and share units are granted immediately upon vesting of the RSU's. The options and the RSU's generally vest over a period of 1-4 years.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share options activity:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table lists the number of share options, the weighted average exercise prices of share options and changes that were made in the option plan to employees and directors</span></span></div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
      </div>
    </div>
    <div>

        <div style="margin-left:85.05pt">
          <div>
            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding Options at beginning of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">764,767</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30.44</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">537,288</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">44.45</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">513,973</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">45.85</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options Granted</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">346,950</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11.87</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">320,775</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14.25</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">53,970</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">37.52</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options Exercised</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(807</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.23</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(536</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20.16</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options Forfeited and/or expired</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(154,230</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">57.55</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(92,489</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">55.58</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(30,119</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56.91</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding options at end of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">957,487</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19.34</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">764,767</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30.44</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">537,288</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">44.45</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Option's Exercisable at end of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">462,045</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.25</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">373,681</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">46.18</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">333,618</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">58.38</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </div>

      <div style="line-height:1.25;clear:both">&#160;</div>
      <div style="text-align:justify;line-height:1.25">
        <div></div>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-left:56.7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table summarizes information about share options outstanding:</span></span></p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
      </div>

        <div style="margin-left:56.7pt">
          <div>
            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding as of</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Range of exercise prices ($ )</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Remaining</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">contractual</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">life</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average exercise</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">price</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.26-9.64</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">55,950</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.85</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.44</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11.89-14.42</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">711,124</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.89</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.20</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.88-37.52</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">125,535</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.62</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">35.99</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">42.14-67.06</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">64,878</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.85</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">63.84</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">957,487</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.29</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19.34</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
              <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
              <div>
                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding as of</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Range of exercise prices ($ )</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">options</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Remaining</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">contractual</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">life</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average exercise</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">price</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.25-14.42</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">470,693</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.84</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.60</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.88-37.52</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">145,354</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.43</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">35.95</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">42.14-67.06</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">68,662</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.85</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">63.94</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">90.23-96.32</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">80,058</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.91</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">90.65</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">764,767</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.40</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30.44</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          </div>
        </div>

      <div style="line-height:1.25;clear:both">
        <p style="margin:0pt 0pt 0pt 56.7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; &#160; &#160; &#160;<br/>The following table summarizes information about RSU's outstanding:</span></span><br/>&#160;</p>
      </div>

        <div style="margin-left:56.7pt">
          <div>
            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSU's</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSU's</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSU's</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at beginning of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">42,013</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,581</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,655</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,100</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,286</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,992</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Forfeited</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(941</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(27</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(215</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vested</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(17,458</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(11,827</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,851</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">) </span></span></td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at the end of the period</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">32,714</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">42,013</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,581</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </div>

      <div style="line-height:1.25;clear:both">&#160;</div>
      <div style="text-align:justify;text-indent:0pt;ine-height:1.25">
        <div>
          <div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of the options and RSU's granted to employees and directors at the grant date for the years ended December 31, 2023, 2022 and 2021 was $2,320, $2,970 and $1,392 respectively.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The options and RSU&#8217;s of the Company are managed by a trustee.</span></span></div>
            <div style="line-height:1.25">
              <p style="margin:0pt">&#160;</p>
              <div></div>
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 4, 2021, the Company's Board of Directors approved the grant of: (a) 34,013 options to purchase ordinary shares and 5,669 RSU's under the "2014 Share Incentive Plan" to its CEO, officers and board members of the Company at a fair value of $663 and $196, respectively, and (b) 19,958 options to purchase ordinary shares and 3,324 RSU's under the "2014 Share Incentive Plan" to its employees at a fair value of $417 and $116, respectively. The options are exercisable for an exercise price of $ 37.52 per share.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over the second quarter of 2022, the Company&#8217;s Board of Directors approved the grant of 292,203 options to purchase the Company&#8217;s ordinary shares, for an exercise price of $ 14.42 per share as well as 39,286 restricted share units (&#8220;RSU&#8217;s&#8221;) to its CEO, officers and employees. The fair value of the options and RSU&#8217;s as of the grant date, was estimated at $2,314 and $498 respectively.</span></span></div>
                          <div>&#160;</div>
                          <div>
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The above-mentioned grant includes the grant of 151,786 options to purchase the Company&#8217;s ordinary shares and 39,286 restricted share units (&#8220;RSU&#8217;s&#8221;) to the directors and the CEO of the Company which are required to be approved by the Company&#8217;s General meeting as well. The fair value of the options and RSU&#8217;s, as of the approval date, was estimated at approximately $1,171 and $498, respectively.</span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <div style="text-align:justify;text-indent:-0.55pt;margin-left:36pt;line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 19, 2022, the Company&#8217;s Shareholders General meeting approved the abovementioned grants (Note 19) to the directors and the CEO, the compensation terms of Mr. Ofer Gonen as the Company&#8217;s new Chief Executive Officer, which terms will be effective as of July 1, 2022 and the termination terms for the previous CEO.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On August 18, 2022, the Company&#8217;s Shareholders General meeting approved the compensation terms and grant of 28,572 options to the Chairman of the Board of Directors which approved earlier by the board. The fair value of the options as of the grant date&#160;was estimated at $284.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On February 15, 2023, the Company's Board of Directors approved the grant of 130,600 options to purchase ordinary shares and 9,100 RSU's under the "2014 Share Incentive Plan" to<span style="font-weight:bold">&#160;</span>employees, officers, board members, CEO and some consultants at fair value of $1,012 and $117, respectively. The share options vest over a period of 1-4 years and the options are exercisable for an exercise price of $ 13.32 per share.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On April 3, 2023, the Company's Board of Directors approved the grant of 160,400 options to purchase ordinary shares under the "2014 Share Incentive Plan", for an exercise price of $11.89 and $11.91 per share to management and board members of the Company. The share options vest over a period of 1-4 years. The fair value of the options granted, as of the grant date, was estimated at approximately $884.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On May 31, 2023 the Shareholders of the Company approved the increase by 1,000,000 in the number of ordinary shares available for issuance under the Company&#8217;s 2014 Equity Incentive Plan.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:100%">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On May 31, 2023 the Shareholders of the Company approved the extension to the exercise period of options which were granted to certain of the company&#8217;s directors on April 23, 2020 for an additional five years, until April 23, 2030. According to this extension, an expense of $146 was recognized.</span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div>
      <div style="line-height:1.25">
        <p style="margin:0pt">&#160;</p>
        <div></div>
      </div>
      <div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">
        <div style="text-align:left">
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">9.</span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt;font-family:Times New Roman, Times, serif">On August 15, 2023, the Company's Board of Directors approved the grant of 7,200 options to purchase ordinary shares under the "2014 Share Incentive Plan", for an exercise price of $ 9.63 per share to a board member of the Company. The share options vest over a 1 year. &#160;The fair value of the options granted, as of the grant date, was estimated at approximately $42.</span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;width:100%;border:0px">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">10.</span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt;font-family:Times New Roman, Times, serif">On November 20, 2023, the Company's Board of Directors approved the grant of 48,750 options to purchase ordinary shares under the "2014 Share Incentive Plan", for an exercise price of $ 8.78 and $8.13 per share to an officer and a consultant of the Company. The share options vest over a period of 1-4 years. &#160;The fair value of the options granted, as of the grant date, was estimated at approximately $265.</span></div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="text-align:justify;text-indent:0pt;line-height:1.25">&#160;<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                <tr>
                  <td style="width:85.05pt">&#160;</td>
                  <td style="width:25pt;vertical-align:top"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">a.</span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div>The&#160;fair value of the Company's share options granted to employees and directors for the years ended December 31, 2023, 2022 and 2021 was estimated using the binomial option pricing models using the following assumptions:</div>
                  </td>
                </tr>

            </table>
            <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </div>
        </div>
      </div>

        <div style="margin-left:108pt">
          <div>
            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dividend yield (%)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected volatility of the share prices (%)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61-77</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59-77</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">55-78</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Risk&#8209;free interest rate (%)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.1-5.36</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.1-5.2</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.1-1.5</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Early exercise factor (%)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100-150</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100-150</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100-150</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted average share prices (Dollar)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.71</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.22</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">36.33</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </div>

      <div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</div>
      <div>
        <div style="text-align:justify;margin-left:103.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Measurement inputs include the share price on the measurement date, the exercise price of the instrument, expected volatility (based on the weighted average volatility of the Company&#8217;s shares, over the expected term of the options), expected term of the options (based on general option holder behavior and expected share price), expected dividends, and the risk-free interest rate (based on government debentures).</span></span></div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 44<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_44&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927968468416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfIncomeTaxesAbstract', window );"><strong>Disclosure Of Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIncomeTaxExplanatory', window );">Income Tax</a></td>
<td class="text">
    <div>
      <div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Note 21:</span></span></span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Income Tax</span></span></span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>a.</span></span></span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company operates in two main tax jurisdictions: Israel and Germany. As such, the Company is subject to the applicable tax rates in the jurisdictions in which it conducts its business.</span></span></span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>b.</span></span></span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Corporate tax rate in Israel:</span></span></span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The standard tax rate in the years 2021-2023 is 23%.</span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>c.</span></span></span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Benefits under the Law for the Encouragement of Capital Investments:</span></span></span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Tax benefits under the Israel Law for the Encouragement of Capital Investments, 1959 (the "Investment Law"):</span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Under the Investment Law, the Company has been granted "Beneficiary Enterprise" status which provides certain benefits, including tax exemptions and reduced tax rates. Income not eligible for Beneficiary Enterprise benefits is taxed at a regular rate.</span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div></div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>During the benefit period, the Company will be tax exempt in the first two years of the benefit period and subject to tax at the reduced rate of 10%- 25% for an additional period of five to eight years (depending on the percentage of foreign investments in the Company) of the benefit period. The benefit entitlement period starts from the first year that the Beneficiary Enterprise first earned taxable income and is limited to 12 years from the year in which the Company requested to have tax benefits apply. In the event of distribution of dividends from the said tax-exempt income, the amount distributed will be subject to corporate tax at the reduced rate ordinarily applicable to the Beneficiary Enterprise's income.</span></span></span></span></div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Tax exempt income generated under the Company's "Beneficiary Enterprise" program will be subject to taxes upon dividend distribution or complete liquidation. The entitlement to the above benefits is conditional upon the Company's fulfilling the conditions stipulated by the Investment Law and regulations published thereunder. Should the Company fail to meet such requirements in the future, income attributable to its Beneficiary Enterprise programs could be subject to the statutory Israeli corporate tax rate and the Company could be required to refund a portion of the tax benefits already received, with respect to such programs.</span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>d.</span></span></span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The principal tax rates applicable to the subsidiary whose place of incorporation is outside of Israel is:</span></span></span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;line-height:1.25;margin-left:85pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The statutory corporate tax rate in Germany was 29.79% in 2023, 2022 and 2021.</span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>e.</span></span></span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Final tax assessments:</span></span></span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company has finalized its tax assessments through the 2016 tax year.</span></span></span></span></div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company's subsidiary has received the final tax assessment for the year 2021.</span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>f.</span></span></span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Net operating carryforward losses for tax purposes and other temporary differences:</span></span></span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of December 31, 2023, the Company had carryforward losses and other temporary differences mainly from R&amp;D expenses together amounting to approximately $171,757.</span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>g.</span></span></span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Deferred taxes:</span></span></span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company did not recognize deferred tax assets for temporary differences because their utilization in the foreseeable future is not probable.</span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>h.</span></span></span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Current taxes on income:</span></span></span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company did not record any current taxes for MediWound Ltd. in Israel for the years ended December 31, 2023, 2022 and 2021 as a result of its carryforward losses.</span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The current tax expenses are in respect of taxes charged outside of Israel.</span></span></span></span></div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS12_g79-88_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfIncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfIncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927969838016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract', window );"><strong>Disclosure of supplementary information to the statements of profit and lost and other comprehensive loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory', window );">Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss</a></td>
<td class="text">
    <div>
      <div>
        <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Note 22:</span></span></span></span></td>
              <td style="width:auto;vertical-align:top">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss</span></span></span></span></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div>
          <div style="text-indent:-56.7pt;margin-left:56.7pt;line-height:1.25">&#160;</div>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                <tr style="vertical-align:top">
                  <td style="width:56.7pt">&#160;</td>
                  <td style="text-align:right;vertical-align:top;width:28.35pt">
                    <div style="text-align:left;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">a.</span></span></span></span></span></div>
                  </td>
                  <td style="text-align:left;vertical-align:top;width:auto">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Additional information on Revenues:</span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Major customers:</span></span></span></span></div>
          <div style="text-align:justify;margin-left:94.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>BARDA contributed 56%, 51% and 76% of the Company&#8217;s total revenues in 2023, 2022 and 2021<span style="font-weight:bold">&#160;</span>respectively. Vericel contributed 4% and 28% of the Company&#8217;s total revenues in 2023 and 2022 respectively. MTEC contributed 10% and 2.8% of the Company&#8217;s total revenues in 2023 and 2022 respectively (see also Note 18).</span></span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:94.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>No other customer contributed 10% or more of the Company&#8217;s revenues in 2023, 2022 and 2021.</span></span></span></span></div>
          <div style="text-align:justify;line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Geographic information:</span></span></span></span></div>
          <div>
            <div style="text-align:justify;margin-left:94.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The revenues reported in the financial statements are based on the location of the customers, as follows:</span></span></span></span></div>
            <div style="text-align:justify;margin-left:94.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
            <div style="margin-left:99pt">

                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>USA (see also Note 18a, 18b, 18c)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>13,078</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>21,872</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>18,102</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>EU and other international markets</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5,608</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,624</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5,661</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>18,686</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>26,496</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>23,763</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>

            </div>
          </div>
          <div style="margin-left:99pt">&#160;</div>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                <tr style="vertical-align:top">
                  <td style="width:56.7pt">&#160;</td>
                  <td style="text-align:right;vertical-align:top;width:28.35pt">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">b.</span></span></span></span></span></div>
                  </td>
                  <td style="text-align:left;vertical-align:top;width:auto">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Cost of Revenues:</span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:85.05pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cost of Revenues from sale of products</span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div style="margin-left:108pt">

                <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Salary and benefits (including share-based compensation)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,703</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,828</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,047</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Subcontractors</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>230</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>58</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>190</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Depreciation and amortization</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>672</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>426</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>559</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cost of materials</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>916</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>636</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,039</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other manufacturing expenses</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,207</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>779</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>906</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Decrease (increase) in inventory of finished products</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(801</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(543</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>242</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,927</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,184</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,983</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>

            </div>
          </div>
          <p style="margin:0pt">&#160;</p>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:85.05pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cost of Revenues from development services</span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div style="margin-left:108pt">

                <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Salary and benefits</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,995</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,691</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,003</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Subcontractors</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,182</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,138</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7,904</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10,177</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9,829</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9,907</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>

            </div>
          </div>
          <div style="margin-left:108pt">&#160;</div>
          <div></div>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:85.05pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cost of Revenues from license agreements</span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div style="margin-left:108pt">

                <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Salary and benefits</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>38</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>102</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Royalties payments</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>280</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>318</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>102</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total Cost of Revenues</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>15,108</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>13,331</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,992</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>

            </div>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                  <tr style="vertical-align:top">
                    <td style="width:56.7pt">&#160;</td>
                    <td style="text-align:right;vertical-align:top;width:28.35pt">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">c.</span></span></span></span></span></div>
                    </td>
                    <td style="text-align:left;vertical-align:top;width:auto">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Research and development expenses:</span></span></span></span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:90pt">

                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Salary and benefits (including share-based compensation) (1)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,148</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,494</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,864</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Subcontractors</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,833</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,054</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,323</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Depreciation and amortization</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>396</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>571</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>396</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cost of materials</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>785</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>572</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>347</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other research and development expenses</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>305</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>490</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>326</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total Research and development</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7,467</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10,181</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10,256</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>

            </div>
            <div style="text-indent:-56.7pt;margin-left:56.7pt;line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:85.05pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(1)</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The salary costs for the year ended December 31,2022 includes one-time payment of $205 derived from termination agreement with the CMO of the company.</span></span></span></span></div>
                  </td>
                </tr>

            </table>
          </div>
          <div>&#160;</div>
          <div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                  <tr style="vertical-align:top">
                    <td style="width:56.7pt">&#160;</td>
                    <td style="text-align:right;vertical-align:top;width:28.35pt">
                      <div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>d.</span></span></span></span></div>
                    </td>
                    <td style="text-align:left;vertical-align:top;width:auto">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Selling and marketing expenses:</span></span></span></span></div>
                    </td>
                  </tr>

              </table>
              <div>&#160;</div>
            </div>
            <div style="margin-left:90pt">

                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Salary and benefits (including share-based compensation)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,991</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,637</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,643</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Marketing and consulting</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,637</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,152</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>627</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Depreciation and amortization</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>50</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>49</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>44</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shipping and delivery</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>356</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>385</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>490</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Registration and marketing license fees</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>810</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>502</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>584</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,844</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,725</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,388</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>

            </div>
          </div>
          <div style="margin-left:90pt">&#160;</div>
          <div></div>
          <div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                  <tr style="vertical-align:top">
                    <td style="width:56.7pt">&#160;</td>
                    <td style="text-align:right;vertical-align:top;width:28.35pt">
                      <div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>e.</span></span></span></span></div>
                    </td>
                    <td style="text-align:left;vertical-align:top;width:auto">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>General and administrative expenses:</span></span></span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:90pt">

                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Salary and benefits (including share&#8209;based compensation)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,521</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,344</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,905</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Professional fees</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,189</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,589</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,480</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Depreciation and amortization</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>185</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>225</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>239</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>873</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>762</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>724</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,768</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,920</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,348</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>

            </div>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>f.</span></span></span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other (income) expenses:</span></span></span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The other one-time income amounted $211 for the year ended December 31, 2023, is associated with the termination of sub-lease agreement (see note 11a).</span></span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The other one-time expenses amounted $684 for the year ended December 31, 2022, are associated with the management changes and FDA milestone payment fee (see Note 18b).</span></span></span></span></div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>g.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial income and expense:</span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div style="margin-left:90pt">

                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial income:</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" rowspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" rowspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" rowspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Interest income</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,341</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>270</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>11</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revaluation of liabilities in respect of IIA grants</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>132</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revaluation of Warrants</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,310</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Exchange differences, net</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>59</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10,651</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>461</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>11</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial expense:</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revaluation of liabilities in respect of IIA grants</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>427</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>903</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financing income on net investment in lease</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>274</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>102</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>120</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Finance expenses in respect of deferred revenues</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>54</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>143</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revaluation of liabilities in respect of TEVA</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>468</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>533</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>590</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Exchange differences, net</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>654</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>511</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revaluation of Warrants</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,977</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Issuance expenses of warrants through profit and loss</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,911</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>61</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>60</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>47</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,892</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>11,637</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,314</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial income (expenses), net</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,759</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(11,176</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(2,303</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                    </tr>

                </table>

            </div>
          </div>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplementary information to the statements of profit and lost and other comprehensive loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927969935728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory', window );">Net Loss Per Share</a></td>
<td class="text">
      <div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0);border:0px">

                  <tr>
                    <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 23:</span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">Net Loss Per Share</span></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Details of the number of shares and loss used in the computation of loss per share:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:90pt">

                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td colspan="22" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">number of shares</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">number of shares</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">number of shares</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,013,144</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6,716</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,987,069</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,599</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,892,068</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(13,551</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>

                </table>

            </div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss per share:</span></span></div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div style="margin-left:90pt">

                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic and diluted loss per share:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.75</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3.93</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3.48</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>

                </table>

            </div>
            <div style="text-align:justify;line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In 2023, 2,614,297 warrants, 957,487 options and 32,714 RSU&#8217;s were excluded from the diluted weighted average number of Ordinary Shares calculation as their effect would have been anti-dilutive.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In 2022, 2,614,297 warrants, 764,767 options and 42,013 RSU&#8217;s were excluded from the diluted weighted average number of Ordinary Shares calculation as their effect would have been anti-dilutive. In addition, the impact of 1,407,583 pre-funded warrants which were exercised in December 2022, have not taken in the diluted weighted average number of Ordinary Shares calculation as their effect would have been anti-dilutive as well.</span></span></div>
          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS33_g70-73A_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927968064912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balances and Transactions With Related Parties and Key Officers<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">Balances And Transactions With Related Parties And Key Officers</a></td>
<td class="text">
    <div>
      <div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <div style="line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0);border:0px">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Note 24:</span></td>
                        <td style="width:auto;vertical-align:top">
                          <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">Balances and Transactions with Related Parties and Key Officers</span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div>
      <div>
        <div style="text-align:justify;line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Related parties consist of:</span></span></div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

            <tr>
              <td style="width:103.05pt">&#160;</td>
              <td style="width:10.35pt;vertical-align:top"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#8226;</span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Clal Biotechnologies Industries Ltd.- Related party (see also note 11)</span></div>
              </td>
            </tr>

        </table>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:103.05pt">&#160;</td>
              <td style="width:10.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Directors of the Company.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:85.05pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balances with related parties:</span></span></div>
              </td>
            </tr>

        </table>
        <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
      </div>
    </div>
    <div>

        <div style="margin-left:110pt">
          <div>
            <div>
              <div>
                <div>
                  <div style="margin-left:0px">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold">Other Payables</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25"><span style="font-weight:bold;font-style:italic">Related Party</span>:</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25">As of December 31, 2023</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold">-</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25">As of December 31, 2022</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">177</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25;font-style:italic;font-weight:bold">Directors:</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25">As of December 31, 2023</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold">83</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25">As of December 31, 2022</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">130</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>

      <p style="margin:0pt">&#160;</p>
      <div>
        <div>
          <div>
            <div></div>
          </div>
        </div>

          <div>
            <div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:85.05pt">&#160;</td>
                      <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transactions with related parties:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="line-height:1.25;font-weight:bold">
                  <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rental fee:</span></span></div>
                  <div style="text-align:justify;margin-left:103.05pt;line-height:1.25">&#160;</div>
                </div>
                <div style="margin-left:108pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;text-indent:-113.4pt;margin-left:113.4pt;line-height:1.25;font-weight:bold">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Related party</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">267</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">457</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">469</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <div style="line-height:1.25;font-weight:bold">
                  <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Professional fee *:</span></span></div>
                  <div style="text-align:justify;margin-left:103.05pt;line-height:1.25">&#160;</div>
                </div>
                <div style="margin-left:108pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;text-indent:-7.1pt;margin-left:7.1pt;line-height:1.25;font-weight:bold">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Directors</span></span></div>
                        </td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">502</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">484</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">375</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Related party</span></span></div>
                        </td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">63</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">85</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">527</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">547</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">460</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of Directors</span></span></div>
                        </td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">***9</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25;font-weight:bold">&#160;</div>
                        </td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">**10</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                      <tr style="vertical-align:top">
                        <td style="width:101.7pt">&#160;</td>
                        <td style="text-align:right;vertical-align:top;width:28.35pt">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>*</span></span></span></div>
                        </td>
                        <td style="text-align:left;vertical-align:top;width:auto">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Not included share- based compensation detailed in Note 20.</span></span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                      <tr style="vertical-align:top">
                        <td style="width:101.7pt">&#160;</td>
                        <td style="text-align:right;vertical-align:top;width:28.35pt">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>**</span></span></span></div>
                        </td>
                        <td style="text-align:left;vertical-align:top;width:auto">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>During 2022 two members of the board of directors were replaced.</span></span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:101.7pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">***</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During 2023 three members of the board have left and one member of the board was replaced. At the end of 2023, the total board member consisted of five members.</span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          </div>

      </div>
      <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:100%">

          <tr>
            <td style="width:56.7pt">&#160;</td>
            <td style="width:auto;vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold">b.&#160; &#160; &#160; &#160; Key Officers:</td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div>
        <div>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:85.05pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top;font-weight:bold">1.</td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold">Balances with Key Officers of the Company</div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:108pt">

                <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:center">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid black">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><strong><em>Other </em></strong></p>
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><strong><em>Payables</em></strong></p>
                      </td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><em><strong>Key Officers of the Company</strong></em></p>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="width:88%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25">As of December 31, 2023</div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25;font-weight:bold">518</div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="width:88%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25">As of December 31, 2022</div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25">754</div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>

                </table>

            </div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:103.05pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top">&#8226;</td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div>Represents the officer&#8217;s gross salary, bonuses, and vacation provisions without share based compensation.</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
      <p style="margin:0pt">&#160;</p>
      <div>
        <div>
          <div></div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:85.05pt">&#160;</td>
                <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Compensation of Key Officers of the Company:</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following amounts disclosed in the table are recognized as an expense during the reporting period related to officers:</span></span></div>
        </div>
      </div>
      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
      <div>
        <div>

            <div>
              <div style="margin-left:108pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:85%">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="border-bottom:2px solid black;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td style="vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold">&#160;</div>
                      </td>
                      <td style="border-bottom:2px solid black;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="padding-bottom:2px;white-space:nowrap;border-bottom:2px solid black;vertical-align:bottom">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><strong><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2022</span></strong></p>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold">&#160;</div>
                      </td>
                      <td style="border-bottom:2px solid black;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="padding-bottom:2px;white-space:nowrap;border-bottom:2px solid black;vertical-align:bottom">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><strong><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2021</span></strong></p>
                      </td>
                    </tr>
                    <tr>
                      <td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:64%">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term employee benefits (*)(**)</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,084</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,880</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,788</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                    </tr>
                    <tr>
                      <td style="padding-bottom:2px;vertical-align:bottom;width:64%">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">757</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">797</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">518</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                    </tr>
                    <tr>
                      <td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:64%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                    </tr>
                    <tr>
                      <td style="padding-bottom:4px;vertical-align:bottom;width:64%">&#160;</td>
                      <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,841</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,677</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,306</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                    </tr>
                    <tr>
                      <td style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:64%">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of officers</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;(***)</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(*) One-time expenses amounted $309 for the year ended December 31, 2022, are associated with the management changes.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(**) In December 2007, the Company's board of directors approved one&#8209;time bonus payments to the Chief Medical Officer in the amounts of $ 120, which was recorded in profit and loss in December 2022 upon achieving marketing approval in the United States.</span></span></div>
              <div style="text-align:justify;margin-left:103.05pt;line-height:1.25">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><br/>(***) During 2023 two key officers were replaced. At the end of 2023 the total key officers consist of six officers.</p>
              </div>
            </div>

        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Section Disclosures<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975296208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsiquents events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract', window );"><strong>Disclosure of non-adjusting events after reporting period [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory', window );">Subsequent events</a></td>
<td class="text">
      <div>
        <div>
          <div>
            <div style="text-align:justify;line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0);border:0px">

                  <tr>
                    <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Note 25:</span></span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Subsequent events:</span></span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="text-align:justify">
                      <div style="line-height:1.25;font-family:Times New Roman, serif;font-size:11pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>On January 1, 2024, the company entered into a new lease agreement for 380.21 square meters of office, in Yavne, Israel, close to the main office, the agreement is for two years with options for additional three years. The additional leased area is needed to support the company in extending its activity. The annual fee for this agreement is ILS 437 (approximately $120). </span></span></span></span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="text-align:justify">
                      <div style="line-height:1.25;font-family:Times New Roman, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>O</span></span></span></span>n February 26, 2024, the Company granted to employees, officers, board members, CEO and some consultants 311,022 share options for an exercise price of $12.73 per share and 30,482 RSUs. The share options vest over a period of 1-4 years. The grant to the directors and CEO is subject to the approval of the next shareholders annual meeting.</div>
                    </div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">
              <div>
                <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', serif;font-size:11pt;font-weight:bold">
                  <div>&#160;</div>
                </div>
              </div>
            </div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="text-align:justify">
                      <div style="text-align:left;line-height:1.25;font-family:'Times New Roman',serif">
                        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On March 6, 2024, 37,106 warrants were exercised to the Company shares for exercise price of $13.475 per ordinary share, in accordance with the terms of the warrants (See also note 19 C.2).</span></span></span></span></div>
                      </div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for events after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS10_g17-22_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927965378288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract', window );"><strong>Disclosure of significant accounting policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory', window );">Basis of consolidation</a></td>
<td class="text">
                      <div>
                        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                            <tr>
                              <td style="width:56.7pt">&#160;</td>
                              <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                              <td style="width:auto;vertical-align:top;text-align:justify">
                                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basis of consolidation:</span></span></div>
                              </td>
                            </tr>

                        </table>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consolidated financial statements include the financial statements of companies that the Company controls (subsidiaries). Control is achieved when the Company is exposed, or has rights, to variable returns from its investment with the investee and has the ability to affect those returns through its power over the investee.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The financial statements of the Company and its subsidiaries are prepared as of the same dates and periods. The consolidated financial statements are prepared using uniform accounting policies by all entities in the Group.</span></span></div>
                      </div>
                    <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories', window );">Inventories</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories are measured at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated selling costs. The Company periodically evaluates the condition and age of inventories and makes provisions for slow moving inventories accordingly.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of inventories is determined as follows:</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="margin-left:90pt">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="width:19.52%;vertical-align:top">
                              <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Raw materials</span></span></div>
                            </td>
                            <td style="width:3.54%;vertical-align:top">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                            </td>
                            <td style="width:76.94%;vertical-align:top">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At cost of purchase using the first-in, first-out method.</span></span></div>
                            </td>
                          </tr>
                          <tr>
                            <td style="width:19.52%;vertical-align:top">
                              <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished goods</span></span></div>
                            </td>
                            <td style="width:3.54%;vertical-align:top">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                            </td>
                            <td style="width:76.94%;vertical-align:top">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On the basis of average standard costs (which approximates actual cost on a weighted average basis) including materials, labor and other direct and indirect manufacturing costs based on practical capacity.</span></span></div>
                            </td>
                          </tr>

                      </table>
                    </div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">Property, plant and equipment, net</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment, net:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment are measured at cost, including directly attributable costs, less accumulated depreciation and accumulated impairment losses. Cost includes spare parts and auxiliary equipment that are used in connection with the plant and equipment.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation is calculated on a straight&#8209;line basis over the useful life of the assets at annual rates as follows:</span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div style="margin-left:90pt">

                        <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="width:70.35%;vertical-align:bottom">&#160;</td>
                              <td style="width:2.82%;vertical-align:top">&#160;</td>
                              <td style="width:26.82%;vertical-align:bottom;border-bottom:#000000 2px solid">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:70.35%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office furniture</span></span></div>
                              </td>
                              <td style="width:2.82%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                              <td style="width:26.82%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7-10</span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:70.35%;vertical-align:top">
                                <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacturing machinery and lab equipment</span></span></div>
                              </td>
                              <td style="width:2.82%;vertical-align:top">&#160;</td>
                              <td style="width:26.82%;vertical-align:bottom">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15-33</span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:70.35%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computers</span></span></div>
                              </td>
                              <td style="width:2.82%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                              <td style="width:26.82%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33</span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:70.35%;vertical-align:top">
                                <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold improvements</span></span></div>
                              </td>
                              <td style="width:2.82%;vertical-align:top">&#160;</td>
                              <td style="width:26.82%;vertical-align:bottom">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">See below</span></span></div>
                              </td>
                            </tr>

                        </table>

                    </div>
                    <p style="margin:0pt">&#160;</p>
                    <div></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold improvements are depreciated on a straight&#8209;line basis over the shorter of the lease term (including the renewal option held by the Company which is expected to be exercised) and the expected life of the improvement.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The useful life, depreciation method and residual value of an asset are reviewed at least each year-end and any changes are accounted for prospectively as a change in accounting estimate.</span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants', window );">Liability in respect of Israeli Innovation Authority ("IIA")</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liability in respect of Israeli Innovation Authority ("IIA"):</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Grants from the IIA in respect of research and development projects are accounted for as forgivable loans according to IAS 20. Grants received from the IIA are recognized as a liability according to their fair value on the date of their receipt, unless on that date it is reasonably certain that the amount received will not be refunded. If future economic benefits are expected from the project that will result in royalty-bearing revenues from sale of products it will be treated as a contingent liability.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At the end of each reporting period, the Company evaluates whether there is reasonable assurance that the liability recognized, in whole or in part, will not be repaid based on its best estimate of future sales and any changes in the present value of the cash flows discounted at the original interest rate of the grant are recognized in profit or loss. The difference between the amount received and the fair value on the date of receiving the grant is recognized as a deduction of research and development expenses.</span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory', window );">Leases</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leases:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for a contract as a lease when the contract terms convey the right to control the use of an identified asset for a period of time in exchange for consideration.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For these excluded leases, the Company has elected to recognize the lease payments as an expense in profit or loss on a straight-line basis over the lease term. In measuring the lease liability, the Company has elected to apply the practical expedient in the Standard and does not separate the lease components from the non-lease components (such as management and maintenance services, etc.) included in a single contract.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Following are the amortization periods of the ROU assets by class of underlying asset:</span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div style="margin-left:90pt">

                        <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="width:65.06%;vertical-align:top">&#160;</td>
                              <td style="width:3.87%;vertical-align:top">&#160;</td>
                              <td style="width:27.2%;vertical-align:top;border-bottom:#000000 2px solid">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Years</span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:65.06%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-indent:-7.1pt;margin-left:7.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                              </td>
                              <td style="width:3.87%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                              <td style="width:27.2%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:65.06%;vertical-align:bottom">
                                <div style="text-indent:-7.1pt;margin-left:7.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
                              </td>
                              <td style="width:3.87%;vertical-align:bottom">&#160;</td>
                              <td style="width:27.2%;vertical-align:bottom">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6-15</span></span></div>
                              </td>
                            </tr>

                        </table>

                    </div>
                    <p style="margin:0pt">&#160;</p>
                    <div></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company tests for impairment of the ROU asset whenever there are indications of impairment pursuant to the provisions of IAS 36.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Variable lease payments that depend on an index:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:104.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On the commencement date, the Company uses the index rate prevailing on the commencement date to calculate the future lease payments.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:104.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For leases in which the Company is the lessee, the aggregate changes in future lease payments resulting from a change in the index are discounted (without a change in the discount rate applicable to the lease liability) and recorded as an adjustment of the lease liability and the ROU assets, only when there is a change in the cash flows resulting from the change in the index (that is, when the adjustment to the lease payments takes effect).</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease extension and termination options:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:104.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A non-cancelable lease term includes both the periods covered by an option to extend the lease when it is reasonably certain that the extension option will be exercised and the periods covered by a lease termination option when it is reasonably certain that the termination option will not be exercised.</span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue', window );">Revenues recognition</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">f.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues recognition:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="text-align:justify;text-indent:-7.05pt;margin-left:56.7pt;line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes revenue when the customer obtains control over the promised goods or services. The revenue is measured according to the amount of the consideration to which the Company expects to be entitled in exchange for the goods or services promised to the customer, other than amounts collected for third parties.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company determines transaction price based on the amount of consideration the Company expects to receive for transferring the promised goods or services in the contract.</span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consideration may be fixed, variable, or a combination of both. At contract inception for arrangements that include variable consideration, the Company estimates the probability and extent of consideration it expects to receive under the contract utilizing either the most likely amount method or expected amount method, whichever best estimates the amount expected to be received. The Company then considers any constraints on the variable consideration and includes in the transaction price variable consideration to the extent it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. The Company then allocates the transaction price to each performance obligation based on the relative standalone selling price and recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) control is transferred to the customer and the performance obligation is satisfied.</span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company records amounts as accounts receivable when the right to consideration is deemed unconditional. Amounts received, or that are unconditionally due, from a customer prior to transferring goods or services to the customer under the terms of a contract are recognized as deferred revenue. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as the current portion of deferred revenue. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s revenue-generating arrangements typically include licensing arrangements, which comprise of upfront license fees, milestone payments and/or royalties and products sale arrangements.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The promised goods or services in the Company&#8217;s licensing arrangements typically consist of a license to the Company&#8217;s intellectual property and/or research and development services.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If a license is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenue from nonrefundable, up-front fees allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For arrangements that include sales-based royalties, including milestone payments based on the level of sales, where the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <div style="line-height:1.25;font-family:'Times New Roman',serif">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In 2019, the Company entered into exclusive license and supply agreements with Vericel to commercialize Nexobrid in North America (see Note 22). The Company identified three distinct performance obligations: (1) license rights (2) development services for BLA approval and (3) manufacturing and supply of Nexobrid.</span></span></div>
                        </div>
                      </div>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of the closing date of the agreement the manufacturing and development services were at market value, therefore the upfront payment was fully attributed to the license performance obligation and as such revenues are recognized at the point in time that control of the license is transferred to the customer.</span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Future milestone payments are considered variable consideration and are subject to the variable consideration constraint, i.e. will be recognized once concluded that it is &#8220;probable&#8221; that a significant reversal of the cumulative revenues recognized under the contract will not occur in future periods when the uncertainty related to the variable considerations are resolved. (see Note 18b).</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from royalties under this agreement will be payable based on future commercial sales, up on an occurrence.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from the sale of products to Vericel will be recognized when all the significant risks and rewards of ownership of the products have passed to the buyer and the seller no longer retains continuing managerial involvement. The delivery date of the products is usually the date of which ownership passes.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from distribution licensing arrangements:</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for the bundled license provided to the distributers and related high specialized services as a single performance obligation and consequently recognize revenue using the cost-to-cost method, where the extent of progress towards completion is measured based on the ratio of actual costs incurred to the total estimated costs expected to be incurred upon satisfying such single performance obligation. The revenues from such bundled performance obligation are included within &#8220;Revenues from license agreements&#8221;. Significant finance components related to such arrangements are recognized as finance expense.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from development services:</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from development services are recognized over time, during the period the customer receives and consumes the benefits provided by the Company's performance.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from the sale of products:</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <div style="line-height:1.25;font-family:'Times New Roman',serif">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company generates revenues from sales of its innovative biopharmaceutical product, Nexobrid, to burn centers and hospital burn units in Europe, U.S Israel and local international markets through its commercial organizations and local distributors.</span></span></div>
                        </div>
                      </div>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from sale of goods is recognized in profit or loss at the point in time when the control of the goods is transferred to the customer, generally upon delivery of the goods to the customer. &#160;The transaction price is the amount of the consideration that is expected to be received based on the contract terms.</span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory', window );">Research and development expenses</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">g.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development expenses:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development expenses are recognized in profit or loss when incurred. An intangible asset arising from a development project or from the development phase of an internal project is recognized if the Company can demonstrate the technical feasibility of completing the intangible asset so that it will be available for use or sale; the Company's intention to complete the intangible asset and use or sell it; the Company's ability to use or sell the intangible asset; how the intangible asset will generate future economic benefits; the availability of adequate technical, financial and other resources to complete the intangible asset; and the Company's ability to measure reliably the expenditure attributable to the intangible asset during its development. Since the Company's research and development projects are often subject to regulatory approval procedures and other uncertainties, the conditions for the capitalization of costs incurred before receipt of approvals are not normally satisfied and, therefore, research and development expenses are recognized in profit or loss when incurred.</span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory', window );">Financial instruments</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">h.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial instruments:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accounting policy for financial instruments in accordance with IFRS 9, "Financial Instruments" ("the Standard") is as follows:</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial liabilities:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:113.4pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a)</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial liabilities measured at amortized cost:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:141.75pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of the financial liability.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:141.75pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">After initial recognition, the Company measures all financial liabilities at amortized cost using the effective interest rate method, except for financial liabilities at fair value through profit or loss such as derivatives;</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:113.4pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b)</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial liabilities measured at fair value through profit or loss:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:141.75pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At initial recognition, the Company measures financial liabilities that are not measured at amortized cost at fair value. Transaction costs are recognized in profit or loss.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:28.35pt;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">After initial recognition, changes in fair value are recognized in profit or loss.</span></span></div>
                    <div style="text-align:justify;text-indent:28.35pt;margin-left:113.4pt;line-height:1.25">&#160;</div>
                    <div></div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value measurement is based on the assumption that the transaction will take place in the asset's or the liability's principal market, or in the absence of a principal market, in the most advantageous market.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.</span></span></div>
                    <div style="margin-left:113.4pt;line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A fair value measurement of a non-financial asset takes into account a market participant's ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.</span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory', window );">Warrants</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrants:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:86.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Receipts in respect of warrants are classified as equity to the extent that they confer the right to purchase a fixed number of shares for a fixed exercise price. In the event that the exercise price or the numbers of shares to be issued are not deemed to be fixed (for example, in case of net share settlement provision), or warrants redemption in cash on the occurrence of Fundamental Transaction the warrants are classified as a non-current derivative financial liability. This liability is initially recognized at its fair value on the date the contract is entered into and subsequently accounted for at fair value at each reporting date. The fair value changes are charged to non-operating income and expense on the statement of comprehensive income or loss. Issuance costs allocable to warrants are also recorded as non-operating expense on the statement of comprehensive income or loss.</span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory', window );">Provisions</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">j.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provisions:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:86.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A provision in accordance with IAS 37 is recognized when the Company has a present (legal or constructive) obligation as a result of a past event, it is expected to require the use of economic resources to clear the obligation and a reliable estimate has been made.</span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory', window );">Short-term employee benefits and severance pay liability, net</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">k.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term employee benefits and severance pay liability, net:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has several employee benefit plans:</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                          <tr style="vertical-align:top">
                            <td style="width:85.05pt">&#160;</td>
                            <td style="text-align:right;vertical-align:top;width:28.35pt">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>1.</span></span></span></div>
                            </td>
                            <td style="text-align:left;vertical-align:top;width:auto">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Short-term employee benefits:</span></span></span></div>
                            </td>
                          </tr>

                      </table>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term employee benefits include salaries, paid annual leave, recreation and social security contributions are recognized as expenses as the services are rendered.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                          <tr style="vertical-align:top">
                            <td style="width:85.05pt">&#160;</td>
                            <td style="text-align:right;vertical-align:top;width:28.35pt">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2.</span></span></span></div>
                            </td>
                            <td style="text-align:left;vertical-align:top;width:auto">
                              <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Post-employment benefits:</span></span></span></div>
                            </td>
                          </tr>

                      </table>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25">
                      <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has liabilities for severance pay for its employees in several of jurisdictions and in Israel.</span></span></div>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes liability for severance pay mainly due to its employees in EU in accordance with local laws.</span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory', window );">Share-based compensation</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">l.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certain Company employees and directors are entitled to remuneration in the form of equity-settled share-based compensation.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Equity-settled transactions</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The cost of equity-settled transactions with employees is measured at the fair value of their equity instruments granted at grant date. The fair value is determined using the binomial option pricing model.</span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The cost of equity-settled transactions is recognized in profit or loss, together with a corresponding increase in equity, during the period which the performance or service conditions are to be satisfied, ending on the date on which the relevant employees become fully entitled to the award.</span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory', window );">Profit / Loss per share</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">m.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Profit / Loss per share:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company presents basic and diluted earnings per share (EPS) data for its ordinary shares. Basic EPS is calculated by dividing the profit or loss attributable to ordinary shareholders of the Company by the weighted average number of ordinary shares outstanding during the year, adjusted for treasury shares. Diluted EPS is determined by adjusting the profit or loss attributable to ordinary shareholders of the Company and the weighted average number of ordinary shares outstanding, after adjustment for treasury shares, for the effects of all dilutive potential ordinary shares, which comprise of warrants, share options and share options granted to employees.</span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory', window );">New standards, amendments to standards and interpretations not yet adopted</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">n.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold">
                              <div style="line-height:1.25;font-family:'Times New Roman',serif;font-weight:bold">
                                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New standards, amendments to standards and interpretations not yet adopted:</span></span></div>
                              </div>
                            </div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:84.75pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amendment to IAS 1, Presentation of Financial Statements: "Disclosure of Accounting Policies&#8221;</span></span></div>
                    <div style="text-align:justify;margin-left:84.75pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As a result of applying the Amendment, the extent of the accounting policy disclosure provided in the financial statements for 2023 was reduced and adjusted according to the Company&#8217;s specific circumstances.</span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent', window );">Presentation of Financial Statements: Classification of Liabilities as Current or Non-Current (amendment to IAS 1)</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">o.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Presentation of Financial Statements: Classification of Liabilities as Current or Non-Current (amendment to IAS 1)</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:84.75pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As a result of applying the Amendment the warrants presented in these financial statements (see note 19c), will be classified as a current liability pursuant to the conversion option.</span></span></div>
                  </div>
                <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for financial instruments. [Refer: Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2023-01-01<br> -Paragraph 39<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_39_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 36<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_36_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for provisions. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for recognising revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for research and development expense. [Refer: Research and development expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for warrants. Warrants are financial instruments that give the holder the right to purchase ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the basis used for consolidation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for new standards, amendments to standards and interpretations not yet adopted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the presentation of Financial Statements Classification of Liabilities as Current or Non Current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975686992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract', window );"><strong>Disclosure of significant accounting policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory', window );">Schedule of depreciation on straight-line basis over useful life of assets</a></td>
<td class="text">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="width:70.35%;vertical-align:bottom">&#160;</td>
                              <td style="width:2.82%;vertical-align:top">&#160;</td>
                              <td style="width:26.82%;vertical-align:bottom;border-bottom:#000000 2px solid">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:70.35%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office furniture</span></span></div>
                              </td>
                              <td style="width:2.82%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                              <td style="width:26.82%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7-10</span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:70.35%;vertical-align:top">
                                <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacturing machinery and lab equipment</span></span></div>
                              </td>
                              <td style="width:2.82%;vertical-align:top">&#160;</td>
                              <td style="width:26.82%;vertical-align:bottom">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15-33</span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:70.35%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computers</span></span></div>
                              </td>
                              <td style="width:2.82%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                              <td style="width:26.82%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33</span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:70.35%;vertical-align:top">
                                <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold improvements</span></span></div>
                              </td>
                              <td style="width:2.82%;vertical-align:top">&#160;</td>
                              <td style="width:26.82%;vertical-align:bottom">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">See below</span></span></div>
                              </td>
                            </tr>

                        </table>
                      <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock', window );">Schedule of amortization periods of right-of-use assets</a></td>
<td class="text">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="width:65.06%;vertical-align:top">&#160;</td>
                              <td style="width:3.87%;vertical-align:top">&#160;</td>
                              <td style="width:27.2%;vertical-align:top;border-bottom:#000000 2px solid">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Years</span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:65.06%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-indent:-7.1pt;margin-left:7.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                              </td>
                              <td style="width:3.87%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                              <td style="width:27.2%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:65.06%;vertical-align:bottom">
                                <div style="text-indent:-7.1pt;margin-left:7.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
                              </td>
                              <td style="width:3.87%;vertical-align:bottom">&#160;</td>
                              <td style="width:27.2%;vertical-align:bottom">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6-15</span></span></div>
                              </td>
                            </tr>

                        </table>
                      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about useful lives for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about amortization periods of the right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975236144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash And Cash Equivalents (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory', window );">Schedule of cash and cash equivalents</a></td>
<td class="text">
              <div>
                <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">December 31</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2023</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2022</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Balance in USD</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">4,151</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">24,475</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Balance in other currencies</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">7,715</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">9,420</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">11,866</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">33,895</div>
                      </td>
                    </tr>

                </table>
              </div>
            <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927968399472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-term and restricted bank deposits (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfShortTermBankDepositsAbstract', window );"><strong>Disclosure Of Short Term Bank Deposits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory', window );">Schedule of short-term bank deposits</a></td>
<td class="text">
        <div>
          <div>
            <div>
              <div style="margin-left:63pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">December 31</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2023</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2022</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Restricted bank deposits (1)</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">167</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">-</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">USD Bank deposits (2)</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">29,675</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">-</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">29,842</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">-</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt">&#160;</td>
                    <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif">(1)</td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div>Restricted bank deposits which are primarily used as security for the Company&#8217;s office leases.</div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt">&#160;</td>
                    <td style="width:28.35pt;vertical-align:top">(2)</td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div>The USD deposits bear annual interest of 6.26%-6.55% for the period of 91-365 days for 2023.</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about short-term bank deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfShortTermBankDepositsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfShortTermBankDepositsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927969935728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Receivables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract', window );"><strong>Trade and other current receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory', window );">Schedule of trade receivables</a></td>
<td class="text">
            <div>
              <div style="margin-left:63pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">December 31</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2023</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2022</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Vericel (Note 18b)</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">236</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">7,500</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">BARDA (Note 18a)</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">1,245</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25">701</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">MTEC (Note 18c)</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">617</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">362</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Other trade receivables</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">1,608</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25">771</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Less provision for impairment</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">(6</div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;padding-top:2pt">
                        <div style="line-height:1.25;font-weight:bold">)</div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">(2</div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;padding-top:2pt">
                        <div style="line-height:1.25">)</div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold">3,700</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">9,332</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about trade receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975308080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Classes of current inventories [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory', window );">Schedule of inventories</a></td>
<td class="text">
        <div>
          <div style="margin-left:63pt">
            <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Raw materials</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">995</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">913</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                    <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished goods</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*1,851</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,050</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,846</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,963</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;text-indent:0pt;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*Including write-down of $326</span></span></div>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975236144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Receivables Short Term (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract', window );"><strong>Trade and other current receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory', window );">Schedule of other short term receivables</a></td>
<td class="text">
          <div>
            <div style="margin-left:63pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">December 31,</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2023</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2022</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Government authorities</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">322</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">193</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;vertical-align:bottom">
                      <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Income receivables</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">397</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">170</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Prepaid expenses and other</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">722</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">287</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">1,441</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">650</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about other receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927973991152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Receivables- Long Term (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentReceivablesAbstract', window );"><strong>Trade and other non-current receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory', window );">Schedule of other long term receivables</a></td>
<td class="text">
                <div>
                  <div style="margin-left:63pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">December 31,</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2023</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt">2022</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Income receivables</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold">50</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">180</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25">Prepaid expenses</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold">183</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">-</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold">233</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">180</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about other receivables long term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927968313536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant And Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract', window );"><strong>Disclosure of detailed information about property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory', window );">Schedule of property, plant and equipment, net</a></td>
<td class="text">
          <div>
            <div style="margin-left:63pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">furniture</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacturing machinery and lab equipment</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computers</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">improvements</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;font-weight:bold">Cost</div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of January 1, 2023</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">293</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">5,091</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">166</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">3,279</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">8,829</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Additions</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">25</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">7,312</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">101</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">37</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">7,475</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Capitalization of depreciation of ROU assets</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">59</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">59</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Foreign currency translation</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">1</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">1</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of December 31, 2023</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">319</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">12,403</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">267</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">3,375</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">16,364</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of January 1, 2022</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">257</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">4,764</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">176</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">3,137</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">8,334</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Additions</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">37</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">327</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">49</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">142</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">555</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Disposals</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">(59</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">(59</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Foreign currency translation</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25">(1</div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25">(1</div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of December 31, 2022</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">293</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">5,091</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">166</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">3,279</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">8,829</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:center;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold">Accumulated Depreciation</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of January 1, 2023</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">157</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">3,818</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">97</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">2,391</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">6,463</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Additions</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">26</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">448</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">58</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">140</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">672</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Foreign currency translation</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">1</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">1</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of December 31, 2023</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">184</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">4,266</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">155</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">2,531</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">7,136</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of January 1, 2022</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">133</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">3,370</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">94</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">2,259</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">5,856</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Additions</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">25</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">448</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">62</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">132</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25">667</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Disposals</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">(59</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">(59</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25">Foreign currency translation</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                      <div style="line-height:1.25">(1</div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">-</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                      <div style="line-height:1.25">(1</div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25">)</div>
                    </td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold">Balance as of December 31, 2022</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">157</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">3,818</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">97</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">2,391</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">6,463</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold">Carrying amounts of all fixed asset items</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:19pt;line-height:1.25;font-family:'Times New Roman',Times,serif">December 31, 2023</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">135</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">8,137</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">112</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">844</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold">9,228</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;padding-bottom:4px;vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:19pt;line-height:1.25;font-family:'Times New Roman',Times,serif">December 31, 2022</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">136</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">1,273</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">69</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">888</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">2,366</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="margin-left:63pt">
              <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927974017616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory', window );">Schedule of amounts recognized in profit or loss and in the statement of cash flows</a></td>
<td class="text">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31,</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest expense on lease liabilities</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">274</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">102</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation expenses</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">565</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">537</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash outflow for leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">778</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">701</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory', window );">Schedule of carrying amounts of right-of-use assets and movement</a></td>
<td class="text">
              <div style="margin-left:90pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,341</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">550</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,891</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,460</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">407</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,867</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments for indexation</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">78</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">81</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,368</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(308</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,676</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,511</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">652</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,163</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated depreciation</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,342</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">334</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,676</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;margin-left:9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">334</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">231</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">565</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capitalized to Leasehold improvements</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25;margin-left:9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,527</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(308</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,835</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">208</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">257</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">465</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciated cost</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,303</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">395</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,698</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:90pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,267</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">654</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,921</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">125</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">125</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments for indexation</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">74</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">83</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(238</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(238</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,341</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">550</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,891</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated depreciation</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,028</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">345</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,373</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;margin-left:9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">314</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">225</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">539</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25;margin-left:9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(236</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(236</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,342</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">334</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,676</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciated cost</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">999</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">216</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,215</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory', window );">Schedule of maturity analysis of the Group's lease liabilities</a></td>
<td class="text">
              <div style="margin-left:90pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,199</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">179</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,378</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Repayment of leases liabilities</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(588</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(190</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(778</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect of changes in exchange rates</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(17</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New finance lease obligation recognized</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,460</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">365</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,825</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments for indexation</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">78</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">81</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial expenses</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">257</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">274</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals-Termination of leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,041</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(11</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,052</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,346</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">365</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,711</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current maturities of long-term leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(180</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(181</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(361</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liability Balance as of December 31, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,166</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">184</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,350</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:90pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,691</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">299</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,990</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Repayment of leases liabilities</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(477</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(224</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(701</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect of changes in exchange rates</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(182</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(28</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New finance lease obligation recognized</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">117</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">117</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments for indexation</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">74</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">83</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial expenses</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">93</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">101</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals-Termination of leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,199</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">179</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,378</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current maturities of long-term leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(399</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(133</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(532</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liability Balance as of December 31, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">800</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">46</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">846</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of additional information about leasing activities of a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 59<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_59&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of information on leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927969897184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract', window );"><strong>Disclosure of detailed information about intangible assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory', window );">Schedule of intangible assets</a></td>
<td class="text">
            <div>
              <div style="margin-left:63pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>License and</span></span></span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Knowhow</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cost</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of January 1,</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,538</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,538</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additions</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of December 31,</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,538</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,538</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Accumulated Amortization</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of January 1,</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,307</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,241</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additions</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>66</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>66</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of December 31,</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,373</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,307</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Amortized cost</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of December 31,</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>165</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>231</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 118<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_118&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975236144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Payables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesAbstract', window );"><strong>Trade and other payables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory', window );">Schedule of other payables</a></td>
<td class="text">
            <div>
              <div style="margin-left:63pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employees and payroll accruals</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,109</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,471</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liability in respect of TEVA (see Note 17c)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,250</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">417</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Related parties</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">83</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">307</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred revenues</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">63</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">425</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">901</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,891</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,159</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about other payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975287472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liabilities in Respect of IIA Grants (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract', window );"><strong>Disclosure of israeli innovation authority grants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory', window );">Schedule of Israeli innovation authority grants</a></td>
<td class="text">
            <div>
              <div style="margin-left:63pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of January 1,</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7,566</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,105</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Royalties</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(190</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(407</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Amounts carried to Profit or Loss</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>427</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(132</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of December 31,</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7,803</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7,566</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Current maturities</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(126</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(121</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Long term liabilities in respect of IIA grants</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7,677</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7,445</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about israeli innovation authority grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975290080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial  Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract', window );"><strong>Disclosure of detailed information about financial instruments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk', window );">Schedule of sensitivity tests relating to changes in market factors</a></td>
<td class="text">
            <div>
              <div>
                <div style="margin-left:108pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gain (loss) from change:</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5% increase in NIS and EURO exchange rate</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">176</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">257</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5% decrease in NIS and EURO exchange rate</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(176</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(257</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities', window );">Schedule of liquidity risk by holding cash balances, short-term deposits and secured bank credit facilities</a></td>
<td class="text">
            <div>
              <div>
                <div style="line-height:1.25">
                  <div style="margin-left:108pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="14" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2023</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12 months</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">amount</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">or less</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1-2 years</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2-15 years</span></span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-derivative financial liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Current maturities of long-term liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,249</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,249</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Trade payables and accrued expenses</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,528</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,528</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Other payables</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,891</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,891</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Liabilities in respect of IIA grants</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,927</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">359</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,568</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Liabilities in respect of TEVA</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,200</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,000</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,200</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Lease liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,189</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">813</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,376</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:108pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="14" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2022</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12 months</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">amount</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">or less</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1-2 years</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2-8 years</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-derivative financial liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Current maturities of long-term liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,814</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,814</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Trade payables and accrued expenses</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,656</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,656</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Other payables</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,159</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,159</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Liabilities in respect of IIA grants</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,464</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">312</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,152</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Liabilities in respect of TEVA</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,200</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,000</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,200</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Lease liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">902</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">508</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">394</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </div>
            </div>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a maturity analysis for non-derivative financial liabilities (including issued financial guarantee contracts) that shows the remaining contractual maturities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 39<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_39_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the sensitivity analysis for types of market risk to which the entity is exposed, showing how profit or loss and equity would have been affected by changes in the relevant risk variable that were reasonably possible at that date. [Refer: Market risk [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 40<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_40_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927968887904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_EquityTablesAbstract', window );"><strong>Equity Tables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory', window );">Schedule of share capital</a></td>
<td class="text">
      <div>
        <div>
          <div style="line-height:1.25">
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                    <tr>
                      <td style="width:56.7pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">a.</span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span><span><span style="font-family:'Times New Roman', Times, serif">Share capital:</span></span></span></strong></span></div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          </div>
          <div style="margin-left:85.05pt">
            <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
            <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:90%">

                <tr>
                  <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>December 31</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2023</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2022</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Authorized number of shares</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double black;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double black;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><span><span>20,000,000</span></span></span></span></strong></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double black;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double black;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>12,857,143</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom">
                    <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Issued and outstanding number of shares</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><span><span>9,221,764</span></span></span></span></strong></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>7,240,020</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of classes of share capital. [Refer: Share capital [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_EquityTablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_EquityTablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927976182592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions', window );">Schedule of expense recognized</a></td>
<td class="text">
            <div style="margin-left:85.05pt">
              <div>
                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenues</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">271</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">184</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">153</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;vertical-align:bottom">
                          <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">485</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">406</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">333</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Selling and marketing</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">87</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">42</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,097</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,314</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,187</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
                          <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total share-based compensation</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,940</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,946</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,673</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory', window );">Schedule of share options activity</a></td>
<td class="text">
        <div style="margin-left:85.05pt">
          <div>
            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding Options at beginning of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">764,767</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30.44</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">537,288</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">44.45</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">513,973</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">45.85</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options Granted</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">346,950</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11.87</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">320,775</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14.25</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">53,970</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">37.52</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options Exercised</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(807</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.23</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(536</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20.16</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options Forfeited and/or expired</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(154,230</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">57.55</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(92,489</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">55.58</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(30,119</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56.91</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding options at end of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">957,487</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19.34</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">764,767</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30.44</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">537,288</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">44.45</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Option's Exercisable at end of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">462,045</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.25</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">373,681</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">46.18</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">333,618</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">58.38</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory', window );">Schedule of information about share options outstanding</a></td>
<td class="text">
        <div style="margin-left:56.7pt">
          <div>
            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding as of</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Range of exercise prices ($ )</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Remaining</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">contractual</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">life</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average exercise</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">price</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.26-9.64</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">55,950</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.85</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.44</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11.89-14.42</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">711,124</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.89</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.20</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.88-37.52</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">125,535</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.62</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">35.99</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">42.14-67.06</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">64,878</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.85</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">63.84</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">957,487</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.29</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19.34</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
              <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
              <div>
                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding as of</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Range of exercise prices ($ )</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">options</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Remaining</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">contractual</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">life</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average exercise</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">price</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.25-14.42</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">470,693</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.84</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.60</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.88-37.52</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">145,354</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.43</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">35.95</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">42.14-67.06</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">68,662</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.85</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">63.94</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">90.23-96.32</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">80,058</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.91</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">90.65</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">764,767</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.40</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30.44</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          </div>
        </div>
      <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory', window );">Schedule of fair value assumptions</a></td>
<td class="text">
        <div style="margin-left:108pt">
          <div>
            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dividend yield (%)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected volatility of the share prices (%)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61-77</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59-77</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">55-78</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Risk&#8209;free interest rate (%)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.1-5.36</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.1-5.2</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.1-1.5</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Early exercise factor (%)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100-150</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100-150</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100-150</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted average share prices (Dollar)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.71</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.22</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">36.33</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=mdwd_RestrictedSharesUnitsMember', window );">Restricted Shares Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory', window );">Schedule of share options activity</a></td>
<td class="text">
        <div style="margin-left:56.7pt">
          <div>
            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSU's</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSU's</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSU's</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-align:justify;text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at beginning of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">42,013</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,581</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,655</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,100</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,286</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,992</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Forfeited</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(941</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(27</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(215</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vested</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(17,458</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(11,827</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,851</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">) </span></span></td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
                      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at the end of the period</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">32,714</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">42,013</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,581</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The explanation that enables users of financial statements to understand the effect of share-based payment transactions on the entity's financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 50<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_50&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=mdwd_RestrictedSharesUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=mdwd_RestrictedSharesUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975348800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract', window );"><strong>Disclosure of supplementary information to the statements of profit and lost and other comprehensive loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasExplanatory', window );">Schedule of geographical information</a></td>
<td class="text">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>USA (see also Note 18a, 18b, 18c)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>13,078</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>21,872</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>18,102</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>EU and other international markets</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5,608</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,624</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5,661</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>18,686</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>26,496</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>23,763</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCostOfSalesExplanatory', window );">Schedule of cost of revenues products</a></td>
<td class="text">
                <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Salary and benefits (including share-based compensation)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,703</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,828</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,047</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Subcontractors</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>230</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>58</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>190</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Depreciation and amortization</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>672</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>426</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>559</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cost of materials</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>916</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>636</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,039</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other manufacturing expenses</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,207</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>779</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>906</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Decrease (increase) in inventory of finished products</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(801</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(543</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>242</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,927</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,184</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,983</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfCostOfSalesServicesExplanatory', window );">Schedule of cost of revenues services</a></td>
<td class="text">
                <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Salary and benefits</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,995</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,691</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,003</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Subcontractors</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,182</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,138</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7,904</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10,177</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9,829</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9,907</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ScheduleOfCostOfRevenuesLicense', window );">Schedule of cost of revenues license</a></td>
<td class="text">
                <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Salary and benefits</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>38</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>102</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Royalties payments</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>280</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>318</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>102</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total Cost of Revenues</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>15,108</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>13,331</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,992</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory', window );">Schedule of research expenses</a></td>
<td class="text">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Salary and benefits (including share-based compensation) (1)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,148</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,494</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,864</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Subcontractors</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,833</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,054</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,323</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Depreciation and amortization</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>396</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>571</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>396</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cost of materials</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>785</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>572</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>347</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other research and development expenses</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>305</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>490</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>326</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total Research and development</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7,467</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10,181</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10,256</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory', window );">Schedule of selling expenses</a></td>
<td class="text">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Salary and benefits (including share-based compensation)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,991</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,637</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,643</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Marketing and consulting</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,637</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,152</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>627</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Depreciation and amortization</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>50</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>49</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>44</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shipping and delivery</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>356</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>385</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>490</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Registration and marketing license fees</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>810</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>502</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>584</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,844</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,725</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,388</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory', window );">Schedule of general expenses</a></td>
<td class="text">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Salary and benefits (including share&#8209;based compensation)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,521</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,344</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,905</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Professional fees</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,189</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,589</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,480</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Depreciation and amortization</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>185</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>225</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>239</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>873</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>762</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>724</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,768</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,920</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,348</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory', window );">Schedule of financial expense</a></td>
<td class="text">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Year ended December 31</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial income:</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" rowspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" rowspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" rowspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Interest income</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,341</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>270</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>11</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revaluation of liabilities in respect of IIA grants</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>132</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revaluation of Warrants</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,310</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Exchange differences, net</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>59</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10,651</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>461</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>11</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial expense:</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revaluation of liabilities in respect of IIA grants</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>427</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>903</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financing income on net investment in lease</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>274</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>102</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>120</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Finance expenses in respect of deferred revenues</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>54</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>143</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revaluation of liabilities in respect of TEVA</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>468</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>533</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>590</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Exchange differences, net</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>654</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>511</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revaluation of Warrants</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,977</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Issuance expenses of warrants through profit and loss</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,911</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>61</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>60</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>47</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,892</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>11,637</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,314</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial income (expenses), net</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,759</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(11,176</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(2,303</span></span></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                      </td>
                    </tr>

                </table>
              <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCostOfSalesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the cost of sales. [Refer: Cost of sales]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCostOfSalesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of finance income (cost). [Refer: Finance income (cost)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of general and administrative expenses. [Refer: Administrative expenses]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeographicalAreasExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of geographical information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeographicalAreasExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of research and development expense. [Refer: Research and development expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfCostOfSalesServicesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the cost of sales from services. [Refer: Cost of sales]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfCostOfSalesServicesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about selling and marketing expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ScheduleOfCostOfRevenuesLicense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the cost of sales from license services. [Refer: Cost of sales]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ScheduleOfCostOfRevenuesLicense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927969082544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory', window );">Schedule of details of number of shares and loss used in computation</a></td>
<td class="text">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td colspan="22" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">number of shares</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">number of shares</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">number of shares</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,013,144</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6,716</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,987,069</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,599</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,892,068</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(13,551</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>

                </table>
              <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory', window );">Schedule of net profit (loss) per share from continuing and discontinued operations</a></td>
<td class="text">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic and diluted loss per share:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.75</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3.93</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3.48</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>

                </table>
              <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about details of number of shares and loss used in computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about net loss per share from continuing and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927974470464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balances and Transactions With Related Parties and Key Officers (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory', window );">Schedule of balances of related parties</a></td>
<td class="text">
        <div style="margin-left:110pt">
          <div>
            <div>
              <div>
                <div>
                  <div style="margin-left:0px">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold">Other Payables</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25"><span style="font-weight:bold;font-style:italic">Related Party</span>:</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25">As of December 31, 2023</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold">-</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25">As of December 31, 2022</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">177</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25;font-style:italic;font-weight:bold">Directors:</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25">As of December 31, 2023</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25;font-weight:bold">83</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25">As of December 31, 2022</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">130</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory', window );">Schedule of transactions with related parties</a></td>
<td class="text">
          <div>
            <div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:85.05pt">&#160;</td>
                      <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transactions with related parties:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="line-height:1.25;font-weight:bold">
                  <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rental fee:</span></span></div>
                  <div style="text-align:justify;margin-left:103.05pt;line-height:1.25">&#160;</div>
                </div>
                <div style="margin-left:108pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;text-indent:-113.4pt;margin-left:113.4pt;line-height:1.25;font-weight:bold">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Related party</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">267</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">457</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">469</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <div style="line-height:1.25;font-weight:bold">
                  <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Professional fee *:</span></span></div>
                  <div style="text-align:justify;margin-left:103.05pt;line-height:1.25">&#160;</div>
                </div>
                <div style="margin-left:108pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;text-indent:-7.1pt;margin-left:7.1pt;line-height:1.25;font-weight:bold">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Directors</span></span></div>
                        </td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">502</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">484</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">375</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Related party</span></span></div>
                        </td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">63</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">85</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">527</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">547</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">460</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of Directors</span></span></div>
                        </td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">***9</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25;font-weight:bold">&#160;</div>
                        </td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">**10</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                      <tr style="vertical-align:top">
                        <td style="width:101.7pt">&#160;</td>
                        <td style="text-align:right;vertical-align:top;width:28.35pt">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>*</span></span></span></div>
                        </td>
                        <td style="text-align:left;vertical-align:top;width:auto">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Not included share- based compensation detailed in Note 20.</span></span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                      <tr style="vertical-align:top">
                        <td style="width:101.7pt">&#160;</td>
                        <td style="text-align:right;vertical-align:top;width:28.35pt">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>**</span></span></span></div>
                        </td>
                        <td style="text-align:left;vertical-align:top;width:auto">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>During 2022 two members of the board of directors were replaced.</span></span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:101.7pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">***</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During 2023 three members of the board have left and one member of the board was replaced. At the end of 2023, the total board member consisted of five members.</span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          </div>
        <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory', window );">Schedule of balances of key officers</a></td>
<td class="text">
                <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:center">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid black">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><strong><em>Other </em></strong></p>
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><strong><em>Payables</em></strong></p>
                      </td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><em><strong>Key Officers of the Company</strong></em></p>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="width:88%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25">As of December 31, 2023</div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25;font-weight:bold">518</div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="width:88%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25">As of December 31, 2022</div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25">754</div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>

                </table>
              <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory', window );">Schedule of compensation of officers of company</a></td>
<td class="text">
            <div>
              <div style="margin-left:108pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:85%">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="border-bottom:2px solid black;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td style="vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold">&#160;</div>
                      </td>
                      <td style="border-bottom:2px solid black;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="padding-bottom:2px;white-space:nowrap;border-bottom:2px solid black;vertical-align:bottom">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><strong><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2022</span></strong></p>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold">&#160;</div>
                      </td>
                      <td style="border-bottom:2px solid black;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="padding-bottom:2px;white-space:nowrap;border-bottom:2px solid black;vertical-align:bottom">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><strong><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2021</span></strong></p>
                      </td>
                    </tr>
                    <tr>
                      <td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:64%">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term employee benefits (*)(**)</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,084</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,880</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,788</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                    </tr>
                    <tr>
                      <td style="padding-bottom:2px;vertical-align:bottom;width:64%">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">757</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">797</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">518</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                    </tr>
                    <tr>
                      <td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:64%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                    </tr>
                    <tr>
                      <td style="padding-bottom:4px;vertical-align:bottom;width:64%">&#160;</td>
                      <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,841</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,677</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,306</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                    </tr>
                    <tr>
                      <td style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:64%">
                        <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of officers</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;(***)</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                      <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%">&#160;</td>
                      <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5</span></span></div>
                      </td>
                      <td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(*) One-time expenses amounted $309 for the year ended December 31, 2022, are associated with the management changes.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:103.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(**) In December 2007, the Company's board of directors approved one&#8209;time bonus payments to the Chief Medical Officer in the amounts of $ 120, which was recorded in profit and loss in December 2022 upon achieving marketing approval in the United States.</span></span></div>
              <div style="text-align:justify;margin-left:103.05pt;line-height:1.25">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><br/>(***) During 2023 two key officers were replaced. At the end of 2023 the total key officers consist of six officers.</p>
              </div>
            </div>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of amounts incurred by the entity for provision of key management personnel services that are provided by separate management entities. [Refer: Key management personnel of entity or parent [member]; Separate management entities [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 18A<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_18A&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 18<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_18&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about balances with key officers of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about balances with related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927970519456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Narrative) (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 07, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 28, 2022 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2023 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 05, 2022 </div>
<div>&#8362; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued | shares</a></td>
<td class="nump">1,964,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,221,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,240,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share | (per share)</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.07<span></span>
</td>
<td class="nump">&#8362; 0.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (174,822)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (168,106)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ReverseStockSplit', window );">Reverse stock split ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-for-7 ratio<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-for-7 ratio<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_GrossProceedsFromPublicAndPrivateOfferings', window );">Gross proceeds</a></td>
<td class="nump">$ 27,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Proceeds from issue of ordinary shares</a></td>
<td class="nump">$ 25,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits', window );">Cash and cash equivalents, short-term and restricted bank deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssueOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash and cash equivalents, short-term and restricted bank deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_GrossProceedsFromPublicAndPrivateOfferings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gross proceeds from public and private offerings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_GrossProceedsFromPublicAndPrivateOfferings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the information about reverse stock split ratio.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927976431280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material Accounting Policies (Schedule of depreciation on straight line basis over useful life of assets) (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember', window );">Office furniture [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Useful life of assets at annual rates (in %)</a></td>
<td class="text">7-10<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember', window );">Manufacturing machinery and lab equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Useful life of assets at annual rates (in %)</a></td>
<td class="text">15-33<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Useful life of assets at annual rates (in %)</a></td>
<td class="text">33<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Useful life of assets at annual rates (in %)</a></td>
<td class="text">See below<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Leasehold improvements are depreciated on a straight&#8209;line basis over the shorter of the lease term (including the renewal option held by the Company which is expected to be exercised) and the expected life of the improvement.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of useful life used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927968492624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material Accounting Policies (Schedule of amortization periods of right of use assets) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_MotorVehiclesMember', window );">Motor vehicles [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AmortizationPeriodsOfRightOfUseAssets', window );">Amortization periods of the ROU assets (in years)</a></td>
<td class="text">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=mdwd_BuildingAndEquipmentMember', window );">Building and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AmortizationPeriodsOfRightOfUseAssets', window );">Amortization periods of the ROU assets (in years)</a></td>
<td class="text">6-15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AmortizationPeriodsOfRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization periods of the right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AmortizationPeriodsOfRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_MotorVehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_MotorVehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=mdwd_BuildingAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=mdwd_BuildingAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927969680544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash And Cash Equivalents (Schedule of cash and cash equivalents) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashOnHand', window );">Balance in USD</a></td>
<td class="nump">$ 4,151<span></span>
</td>
<td class="nump">$ 24,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_CashOnHandInNonUsd', window );">Balance in other currencies</a></td>
<td class="nump">7,715<span></span>
</td>
<td class="nump">9,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 11,866<span></span>
</td>
<td class="nump">$ 33,895<span></span>
</td>
<td class="nump">$ 11,046<span></span>
</td>
<td class="nump">$ 17,376<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashOnHand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash held by the entity. This does not include demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashOnHand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_CashOnHandInNonUsd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash held by the entity in Non USD. This does not include demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_CashOnHandInNonUsd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927969742832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-term and restricted bank deposits (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_PeriodOfBankDeposits', window );">Period of bank deposits</a></td>
<td class="text"> 91-365<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FixedInterestRateMember', window );">Fixed interest rate [Member] | USD [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DepositInterestRate', window );">Deposit interest rate</a></td>
<td class="nump">6.26%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FixedInterestRateMember', window );">Fixed interest rate [Member] | USD [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems', window );"><strong>Disclosure of financial instruments by type of interest rate [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DepositInterestRate', window );">Deposit interest rate</a></td>
<td class="nump">6.55%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DepositInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deposit interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DepositInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_PeriodOfBankDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of bank deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_PeriodOfBankDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FixedInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FixedInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927974473248">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Short-term and restricted bank deposits (Schedule of short-term bank deposits) (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfShortTermBankDepositsAbstract', window );"><strong>Disclosure Of Short Term Bank Deposits [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RestrictedCashAndCashEquivalents', window );">Restricted bank deposits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 167<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BalancesWithBanks', window );">USD bank deposits</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">29,675<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents', window );">Short-term and restricted bank deposits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 29,842<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Restricted bank deposits which are primarily used as security for the Company&#8217;s office leases.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Restricted bank deposits which are primarily used as security for the Company&#8217;s office leases.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The USD deposits bear annual interest of 6.26%-6.55% for the period of 91-365 days for 2023.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BalancesWithBanks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash balances held at banks.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BalancesWithBanks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfShortTermBankDepositsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfShortTermBankDepositsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975354560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Trade Receivables (Schedule of trade receivables) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract', window );"><strong>Trade and other current receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_CurrentVericel', window );">Vericel (Note 18b)</a></td>
<td class="nump">$ 236<span></span>
</td>
<td class="nump">$ 7,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_CurrentBarda', window );">BARDA (Note 18a)</a></td>
<td class="nump">1,245<span></span>
</td>
<td class="nump">701<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_CurrentMtec', window );">MTEC (Note 18c)</a></td>
<td class="nump">617<span></span>
</td>
<td class="nump">362<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherReceivables', window );">Other trade receivables</a></td>
<td class="nump">1,608<span></span>
</td>
<td class="nump">771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ProvisionForImpairment', window );">Less provision for impairment</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Trade Receivables</a></td>
<td class="nump">$ 3,700<span></span>
</td>
<td class="nump">$ 9,332<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount receivable by the entity that it does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_CurrentBarda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>BARDA.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_CurrentBarda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_CurrentMtec">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>MTEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_CurrentMtec</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_CurrentVericel">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vericel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_CurrentVericel</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ProvisionForImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Provision For Impairment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ProvisionForImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927973701264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Schedule of inventories) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Classes of current inventories [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 995<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinishedGoods', window );">Finished goods</a></td>
<td class="nump">1,851<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,050<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories</a></td>
<td class="nump">2,846<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,963<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InventoryWritedown2011', window );">Inventory write-down</a></td>
<td class="nump">$ 326<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Including write-down of $326</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoryWritedown2011">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognised related to the write-down of inventories to net realisable value. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 36<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_36_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 98<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_98_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoryWritedown2011</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of assets to be consumed in the production process or in the rendering of services. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975274336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Receivables Short Term (Schedule of other receivables short term) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract', window );"><strong>Trade and other current receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_CurrentGovernmentAuthoritiesReceivables', window );">Government authorities</a></td>
<td class="nump">$ 322<span></span>
</td>
<td class="nump">$ 193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_IncomeReceivablesShortTerm', window );">Income receivables</a></td>
<td class="nump">397<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepaidExpenses', window );">Prepaid expenses and other</a></td>
<td class="nump">722<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other Receivables- Short Term</a></td>
<td class="nump">$ 1,441<span></span>
</td>
<td class="nump">$ 650<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_CurrentGovernmentAuthoritiesReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Government authorities receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_CurrentGovernmentAuthoritiesReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_IncomeReceivablesShortTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the income receivables, short term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_IncomeReceivablesShortTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139928036818272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Receivables- Long Term (Schedule of other receivables long term) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentReceivablesAbstract', window );"><strong>Trade and other non-current receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_IncomeReceivablesLongTerm', window );">Income receivables</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_PrepaidExpensesLongTerm', window );">Prepaid expenses</a></td>
<td class="nump">183<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentReceivables', window );">Other Receivables- Long Term</a></td>
<td class="nump">$ 233<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_IncomeReceivablesLongTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the income receivables, long term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_IncomeReceivablesLongTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_PrepaidExpensesLongTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid expenses long term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_PrepaidExpensesLongTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975658384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant And Equipment, Net (Schedule of property, plant and equipment, net) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">$ 2,366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">9,228<span></span>
</td>
<td class="nump">$ 2,366<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">8,829<span></span>
</td>
<td class="nump">8,334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">7,475<span></span>
</td>
<td class="nump">555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets', window );">Capitalization of depreciation of ROU assets</a></td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">16,364<span></span>
</td>
<td class="nump">8,829<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member] | Office furniture [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">293<span></span>
</td>
<td class="nump">257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets', window );">Capitalization of depreciation of ROU assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">319<span></span>
</td>
<td class="nump">293<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member] | Manufacturing machinery and lab equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">5,091<span></span>
</td>
<td class="nump">4,764<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">7,312<span></span>
</td>
<td class="nump">327<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets', window );">Capitalization of depreciation of ROU assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">12,403<span></span>
</td>
<td class="nump">5,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member] | Computers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">166<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets', window );">Capitalization of depreciation of ROU assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">267<span></span>
</td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member] | Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">3,279<span></span>
</td>
<td class="nump">3,137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets', window );">Capitalization of depreciation of ROU assets</a></td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">3,375<span></span>
</td>
<td class="nump">3,279<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated Depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="num">(6,463)<span></span>
</td>
<td class="num">(5,856)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">672<span></span>
</td>
<td class="nump">667<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="num">(7,136)<span></span>
</td>
<td class="num">(6,463)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated Depreciation [Member] | Office furniture [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="num">(157)<span></span>
</td>
<td class="num">(133)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="num">(184)<span></span>
</td>
<td class="num">(157)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated Depreciation [Member] | Manufacturing machinery and lab equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="num">(3,818)<span></span>
</td>
<td class="num">(3,370)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">448<span></span>
</td>
<td class="nump">448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="num">(4,266)<span></span>
</td>
<td class="num">(3,818)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated Depreciation [Member] | Computers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="num">(97)<span></span>
</td>
<td class="num">(94)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="num">(155)<span></span>
</td>
<td class="num">(97)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated Depreciation [Member] | Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="num">(2,391)<span></span>
</td>
<td class="num">(2,259)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="num">(2,531)<span></span>
</td>
<td class="num">(2,391)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=mdwd_DepreciatedCostMember', window );">Depreciated cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">2,366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">9,228<span></span>
</td>
<td class="nump">2,366<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=mdwd_DepreciatedCostMember', window );">Depreciated cost [Member] | Office furniture [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=mdwd_DepreciatedCostMember', window );">Depreciated cost [Member] | Manufacturing machinery and lab equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">1,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">8,137<span></span>
</td>
<td class="nump">1,273<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=mdwd_DepreciatedCostMember', window );">Depreciated cost [Member] | Computers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=mdwd_DepreciatedCostMember', window );">Depreciated cost [Member] | Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">$ 844<span></span>
</td>
<td class="nump">$ 888<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_e_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_e_viii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of Capitalization of depreciation of ROU assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=mdwd_DepreciatedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=mdwd_DepreciatedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975096960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2023 </div>
<div>ILS (&#8362;) </div>
<div>ft&#178; </div>
<div>Vehicles</div>
</th>
<th class="th">
<div>Jul. 31, 2023 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>Vehicles</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>ILS (&#8362;) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems', window );"><strong>Disclosure Of Finance Lease And Operating Lease By Lessee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_SubsidiariesLeaseArea', window );">Subsidiaries lease, area | ft&#178;</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_SubsidiariesLeaseMonthlyRent', window );">Subsidiaries lease, monthly rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_SubsidiariesLeaseExpirationPeriod', window );">Subsidiaries lease, expiration period</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_SubsidiariesLeaseExtentionPeriod', window );">Subsidiaries lease, extention period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_SubsidiariesLeaseEstimatedUsefulLife', window );">Subsidiaries lease, extented useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_NumberOfVehiclesInOperatingLeaseArrangements', window );">Number of vehicles in operating lease arrangements | Vehicles</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_PeriodOfVehiclesOperatingLeaseArrangements', window );">Period of vehicles operating lease arrangements</a></td>
<td class="text">1.75 years<span></span>
</td>
<td class="text">1.75 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements', window );">Re-classified to leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems', window );"><strong>Disclosure Of Finance Lease And Operating Lease By Lessee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16', window );">Weighted average incremental borrowing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems', window );"><strong>Disclosure Of Finance Lease And Operating Lease By Lessee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16', window );">Weighted average incremental borrowing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.47%<span></span>
</td>
<td class="nump">8.47%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_ILS', window );">NIS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems', window );"><strong>Disclosure Of Finance Lease And Operating Lease By Lessee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_SubsidiariesLeaseMonthlyRent', window );">Subsidiaries lease, monthly rent</a></td>
<td class="nump">&#8362; 195<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
<td class="nump">&#8362; 125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average lessee's incremental borrowing rate applied to lease liabilities recognised in the statement of financial position at the date of initial application of IFRS 16. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph C12<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_C12_a&amp;doctype=Appendix&amp;subtype=C<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of Finance Lease and Operating Lease by Lessee Line Items</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_NumberOfVehiclesInOperatingLeaseArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of vehicles in operating lease arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_NumberOfVehiclesInOperatingLeaseArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_PeriodOfVehiclesOperatingLeaseArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of vehicles operating lease arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_PeriodOfVehiclesOperatingLeaseArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated depreciation on right of use assets re-classified to leasehold improvements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_SubsidiariesLeaseArea">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subsidiaries Lease Area</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_SubsidiariesLeaseArea</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_SubsidiariesLeaseEstimatedUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subsidiaries Lease, Estimated Useful Life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_SubsidiariesLeaseEstimatedUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_SubsidiariesLeaseExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subsidiaries Lease Expiration Period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_SubsidiariesLeaseExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_SubsidiariesLeaseExtentionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subsidiaries Lease Extension Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_SubsidiariesLeaseExtentionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_SubsidiariesLeaseMonthlyRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subsidiaries Lease Monthly Rent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_SubsidiariesLeaseMonthlyRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_ILS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_ILS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927968996704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Schedule of information on leases) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Interest expense on lease liabilities</a></td>
<td class="nump">$ 274<span></span>
</td>
<td class="nump">$ 102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed', window );">Depreciation expenses</a></td>
<td class="nump">565<span></span>
</td>
<td class="nump">537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashOutflowForLeases', window );">Cash outflow for leases</a></td>
<td class="nump">$ 778<span></span>
</td>
<td class="nump">$ 701<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashOutflowForLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_g&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashOutflowForLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the expense relating to short-term leases accounted for applying paragraph 6 of IFRS 16. This expense need not include the expense relating to leases with a lease term of one month or less. Short-term lease is a lease that, at the commencement date, has a lease term of 12 months or less. A lease that contains a purchase option is not a short-term lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927974057344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Schedule of Disclosures of Right-of-Use Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetsCostAbstract', window );"><strong>Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost', window );">Balance as of January 1,</a></td>
<td class="nump">$ 2,891<span></span>
</td>
<td class="nump">$ 2,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdditionsToRightOfUseAssetsNewLeases', window );">New leases</a></td>
<td class="nump">6,867<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation', window );">Adjustments for indexation</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdditionsToRightOfUseAssetsDisposals', window );">Disposals</a></td>
<td class="num">(2,676)<span></span>
</td>
<td class="num">(238)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost', window );">Balance as of December 31,</a></td>
<td class="nump">7,163<span></span>
</td>
<td class="nump">2,891<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract', window );"><strong>Accumulated depreciation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetsAccumulatedDepreciation', window );">Balance as of January 1,</a></td>
<td class="nump">1,676<span></span>
</td>
<td class="nump">1,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation and amortization</a></td>
<td class="nump">565<span></span>
</td>
<td class="nump">539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements', window );">Capitalized to Leasehold improvements</a></td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetDisposals', window );">Disposals</a></td>
<td class="num">(1,835)<span></span>
</td>
<td class="num">(236)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetsAccumulatedDepreciation', window );">Balance as of December 31,</a></td>
<td class="nump">465<span></span>
</td>
<td class="nump">1,676<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetsDepreciationAbstract', window );"><strong>Depreciated cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">December 31,</a></td>
<td class="nump">6,698<span></span>
</td>
<td class="nump">1,215<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember', window );">Buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetsCostAbstract', window );"><strong>Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost', window );">Balance as of January 1,</a></td>
<td class="nump">2,341<span></span>
</td>
<td class="nump">2,267<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdditionsToRightOfUseAssetsNewLeases', window );">New leases</a></td>
<td class="nump">6,460<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation', window );">Adjustments for indexation</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdditionsToRightOfUseAssetsDisposals', window );">Disposals</a></td>
<td class="num">(2,368)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost', window );">Balance as of December 31,</a></td>
<td class="nump">6,511<span></span>
</td>
<td class="nump">2,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract', window );"><strong>Accumulated depreciation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetsAccumulatedDepreciation', window );">Balance as of January 1,</a></td>
<td class="nump">1,342<span></span>
</td>
<td class="nump">1,028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation and amortization</a></td>
<td class="nump">334<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements', window );">Capitalized to Leasehold improvements</a></td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetDisposals', window );">Disposals</a></td>
<td class="num">(1,527)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetsAccumulatedDepreciation', window );">Balance as of December 31,</a></td>
<td class="nump">208<span></span>
</td>
<td class="nump">1,342<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetsDepreciationAbstract', window );"><strong>Depreciated cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">December 31,</a></td>
<td class="nump">6,303<span></span>
</td>
<td class="nump">999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_MotorVehiclesMember', window );">Motor vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetsCostAbstract', window );"><strong>Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost', window );">Balance as of January 1,</a></td>
<td class="nump">550<span></span>
</td>
<td class="nump">654<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdditionsToRightOfUseAssetsNewLeases', window );">New leases</a></td>
<td class="nump">407<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation', window );">Adjustments for indexation</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdditionsToRightOfUseAssetsDisposals', window );">Disposals</a></td>
<td class="num">(308)<span></span>
</td>
<td class="num">(238)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost', window );">Balance as of December 31,</a></td>
<td class="nump">652<span></span>
</td>
<td class="nump">550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract', window );"><strong>Accumulated depreciation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetsAccumulatedDepreciation', window );">Balance as of January 1,</a></td>
<td class="nump">334<span></span>
</td>
<td class="nump">345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation and amortization</a></td>
<td class="nump">231<span></span>
</td>
<td class="nump">225<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements', window );">Capitalized to Leasehold improvements</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetDisposals', window );">Disposals</a></td>
<td class="num">(308)<span></span>
</td>
<td class="num">(236)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetsAccumulatedDepreciation', window );">Balance as of December 31,</a></td>
<td class="nump">257<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RightOfUseAssetsDepreciationAbstract', window );"><strong>Depreciated cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">December 31,</a></td>
<td class="nump">$ 395<span></span>
</td>
<td class="nump">$ 216<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of right-of-use assets that would have been recognised had the revalued assets been carried under the cost model. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 57<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_57&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssetsRevaluedAssetsAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additions due to adjustments for indexation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AdditionsToRightOfUseAssetsDisposals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additions due to Disposals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AdditionsToRightOfUseAssetsDisposals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AdditionsToRightOfUseAssetsNewLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additions due to new leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AdditionsToRightOfUseAssetsNewLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RightOfUseAssetDisposals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated depreciation on right of use assets disposals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RightOfUseAssetDisposals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated depreciation on right of use assets re-classified to leasehold improvements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RightOfUseAssetsAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated depreciation on right of use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RightOfUseAssetsAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RightOfUseAssetsCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RightOfUseAssetsCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RightOfUseAssetsDepreciationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RightOfUseAssetsDepreciationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_MotorVehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_MotorVehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927974827408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Schedule of disclosures of lease liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Repayment of leases liabilities</a></td>
<td class="num">$ (778)<span></span>
</td>
<td class="num">$ (701)<span></span>
</td>
<td class="num">$ (693)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Financial expenses</a></td>
<td class="nump">274<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liability Balance as of December 31,</a></td>
<td class="nump">6,350<span></span>
</td>
<td class="nump">846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Balance as of December 31,</a></td>
<td class="nump">1,378<span></span>
</td>
<td class="nump">1,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Repayment of leases liabilities</a></td>
<td class="num">(778)<span></span>
</td>
<td class="num">(701)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities', window );">Effect of changes in exchange rates</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(210)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_NewFinanceLeaseObligationRecognized', window );">New finance lease obligation recognized</a></td>
<td class="nump">6,825<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdjustmentsForIndexation', window );">Adjustments for indexation</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Financial expenses</a></td>
<td class="nump">274<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisposalsTerminationOfLeases', window );">Disposals-Termination of leases</a></td>
<td class="num">(1,052)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Balance as of December 31,</a></td>
<td class="nump">6,711<span></span>
</td>
<td class="nump">1,378<span></span>
</td>
<td class="nump">1,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Current maturities of long-term leases</a></td>
<td class="num">(361)<span></span>
</td>
<td class="num">(532)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liability Balance as of December 31,</a></td>
<td class="nump">6,350<span></span>
</td>
<td class="nump">846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities [Member] | Buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Balance as of December 31,</a></td>
<td class="nump">1,199<span></span>
</td>
<td class="nump">1,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Repayment of leases liabilities</a></td>
<td class="num">(588)<span></span>
</td>
<td class="num">(477)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities', window );">Effect of changes in exchange rates</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(182)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_NewFinanceLeaseObligationRecognized', window );">New finance lease obligation recognized</a></td>
<td class="nump">6,460<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdjustmentsForIndexation', window );">Adjustments for indexation</a></td>
<td class="nump">78<span></span>
</td>
<td class="num">(74)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Financial expenses</a></td>
<td class="nump">257<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisposalsTerminationOfLeases', window );">Disposals-Termination of leases</a></td>
<td class="num">(1,041)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Balance as of December 31,</a></td>
<td class="nump">6,346<span></span>
</td>
<td class="nump">1,199<span></span>
</td>
<td class="nump">1,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Current maturities of long-term leases</a></td>
<td class="num">(180)<span></span>
</td>
<td class="num">(399)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liability Balance as of December 31,</a></td>
<td class="nump">6,166<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities [Member] | Motor vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Balance as of December 31,</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Repayment of leases liabilities</a></td>
<td class="num">(190)<span></span>
</td>
<td class="num">(224)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities', window );">Effect of changes in exchange rates</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_NewFinanceLeaseObligationRecognized', window );">New finance lease obligation recognized</a></td>
<td class="nump">365<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdjustmentsForIndexation', window );">Adjustments for indexation</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Financial expenses</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisposalsTerminationOfLeases', window );">Disposals-Termination of leases</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Balance as of December 31,</a></td>
<td class="nump">365<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="nump">$ 299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Current maturities of long-term leases</a></td>
<td class="num">(181)<span></span>
</td>
<td class="num">(133)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liability Balance as of December 31,</a></td>
<td class="nump">$ 184<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AdjustmentsForIndexation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for indexation during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AdjustmentsForIndexation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisposalsTerminationOfLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposals- Termination of leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisposalsTerminationOfLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effect of changes in exchange rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_NewFinanceLeaseObligationRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>New finance lease obligation recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_NewFinanceLeaseObligationRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_MotorVehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_MotorVehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927969844064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net (Schedule of intangible assets, net) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, opening</a></td>
<td class="nump">$ 231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, ending</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">$ 231<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member] | License and Knowhow [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, opening</a></td>
<td class="nump">1,538<span></span>
</td>
<td class="nump">1,538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, ending</a></td>
<td class="nump">1,538<span></span>
</td>
<td class="nump">1,538<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated Amortization [Member] | License and Knowhow [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, opening</a></td>
<td class="num">(1,307)<span></span>
</td>
<td class="num">(1,241)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, ending</a></td>
<td class="num">(1,373)<span></span>
</td>
<td class="num">(1,307)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=mdwd_AmortizedCostMember', window );">Amortized cost [Member] | License and Knowhow [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, opening</a></td>
<td class="nump">231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance, ending</a></td>
<td class="nump">$ 165<span></span>
</td>
<td class="nump">$ 231<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesAndFranchisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesAndFranchisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=mdwd_AmortizedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=mdwd_AmortizedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139928006345248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Payables (Schedule of other payables) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesAbstract', window );"><strong>Trade and other payables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermEmployeeBenefitsAccruals', window );">Employees and payroll accruals</a></td>
<td class="nump">$ 2,109<span></span>
</td>
<td class="nump">$ 2,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_LiabilityInRespectForPurchaseOfShares', window );">Liability in respect of TEVA</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="nump">417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties', window );">Related parties</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DeferredRevenues', window );">Deferred revenues</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_OtherCurrentPayable', window );">Other</a></td>
<td class="nump">425<span></span>
</td>
<td class="nump">901<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentPayables', window );">Other payables</a></td>
<td class="nump">$ 3,891<span></span>
</td>
<td class="nump">$ 4,159<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermEmployeeBenefitsAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermEmployeeBenefitsAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DeferredRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents Deferred Revenues .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DeferredRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_LiabilityInRespectForPurchaseOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability in respect for purchase of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_LiabilityInRespectForPurchaseOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_OtherCurrentPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_OtherCurrentPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927968085232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Liabilities in Respect of IIA Grants (Narrative) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract', window );"><strong>Disclosure of israeli innovation authority grants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_GrantsReceivedNetOfRoyalties', window );">Grants received net of royalties</a></td>
<td class="nump">$ 13,783<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AmortizedCostOfGrantsReceived', window );">Amortized cost of grants received</a></td>
<td class="nump">$ 7,803<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AmortizedCostOfGrantsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of grants received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AmortizedCostOfGrantsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_GrantsReceivedNetOfRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Grants received net of royalties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_GrantsReceivedNetOfRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975185920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liabilities in Respect of IIA Grants (Schedule of israeli innovation authority grants) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract', window );"><strong>Disclosure of israeli innovation authority grants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GovernmentGrants', window );">Balance as of January 1</a></td>
<td class="nump">$ 7,566<span></span>
</td>
<td class="nump">$ 8,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RoyaltyExpense', window );">Royalties</a></td>
<td class="num">(190)<span></span>
</td>
<td class="num">(407)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RevaluationOfLiabilitiesInRespectOfGrants', window );">Amounts carried to Profit or Loss</a></td>
<td class="nump">427<span></span>
</td>
<td class="num">(132)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GovernmentGrants', window );">Balance as of December 31</a></td>
<td class="nump">7,803<span></span>
</td>
<td class="nump">7,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentGovernmentGrants', window );">Current maturities</a></td>
<td class="num">(126)<span></span>
</td>
<td class="num">(121)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentGovernmentGrants', window );">Long term liabilities in respect of IIA grants</a></td>
<td class="nump">$ 7,677<span></span>
</td>
<td class="nump">$ 7,445<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current government grants recognised in the statement of financial position as deferred income. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity, recognised as deferred income. They exclude those forms of government assistance that cannot reasonably have a value placed upon them and transactions with government that cannot be distinguished from the normal trading transactions of the entity. [Refer: Deferred income other than contract liabilities; Government [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current government grants recognised on the statement of financial position as deferred income. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from royalties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RevaluationOfLiabilitiesInRespectOfGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revaluation of liabilities in respect of IIA grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RevaluationOfLiabilitiesInRespectOfGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975801056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial  Instruments (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Fair value measurement at Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ExpectedTermOfWarrant', window );">Expected period of warrants</a></td>
<td class="text">2 years 10 months 28 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ExpectedVolatilityWarrants', window );">Expected volatility, warrants</a></td>
<td class="nump">67.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ExpectedDividendAsPercentageOfWarrants', window );">Expected dividend yield, warrants</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Fair value measurement at Level 3 [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RiskFreeRateOfWarrants', window );">Risk-free interest rate, warrants</a></td>
<td class="nump">4.03%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=mdwd_InterestRateForLoanMember', window );">Interest rate for a loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse', window );">Discount rate</a></td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=mdwd_UncertaintyInFutureDefaultsMember', window );">Uncertainty in future defaults [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse', window );">Discount rate</a></td>
<td class="nump">14.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The discount rate used in the current estimate of the present value of the future cash flows expected to be derived from an asset or cash-generating unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2023-01-01<br> -Paragraph 130<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_130_g&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ExpectedDividendAsPercentageOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percent of expected dividend as percentage of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ExpectedDividendAsPercentageOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ExpectedTermOfWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the duration of expected term of warrant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ExpectedTermOfWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ExpectedVolatilityWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percent of expected volatility of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ExpectedVolatilityWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RiskFreeRateOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percent of risk-free rate of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RiskFreeRateOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=mdwd_InterestRateForLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=mdwd_InterestRateForLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=mdwd_UncertaintyInFutureDefaultsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=mdwd_UncertaintyInFutureDefaultsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927969822592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial  Instruments (Schedule of sensitivity tests relating to changes in market factors) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract', window );"><strong>Sensitivity Test To Changes In Nis And Euro Exchange Rates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Gain (loss) from change in exchange rate</a></td>
<td class="num">$ (189)<span></span>
</td>
<td class="num">$ (525)<span></span>
</td>
<td class="nump">$ 137<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_SensitivityAnalysisAxis=mdwd_FivePercentageIncreaseInExchangeRateMember', window );">5% increase in NIS and EURO exchange rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract', window );"><strong>Sensitivity Test To Changes In Nis And Euro Exchange Rates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Gain (loss) from change in exchange rate</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_SensitivityAnalysisAxis=mdwd_FivePercentageDecreaseInExchangeRateMember', window );">5% decrease in NIS and EURO exchange rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract', window );"><strong>Sensitivity Test To Changes In Nis And Euro Exchange Rates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Gain (loss) from change in exchange rate</a></td>
<td class="num">$ (176)<span></span>
</td>
<td class="num">$ (257)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2023-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_SensitivityAnalysisAxis=mdwd_FivePercentageIncreaseInExchangeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_SensitivityAnalysisAxis=mdwd_FivePercentageIncreaseInExchangeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_SensitivityAnalysisAxis=mdwd_FivePercentageDecreaseInExchangeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_SensitivityAnalysisAxis=mdwd_FivePercentageDecreaseInExchangeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927974059152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Schedule of liquidity risk by holding cash balances, short-term deposits and secured bank credit facilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">$ 6,350<span></span>
</td>
<td class="nump">$ 846<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Carrying amount [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_CurrentMaturitiesOfLongTermLiabilities', window );">Current maturities of long-term liabilities</a></td>
<td class="nump">3,249<span></span>
</td>
<td class="nump">2,814<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_TradePayablesAndAccruedExpenses', window );">Trade payables and accrued expenses</a></td>
<td class="nump">5,528<span></span>
</td>
<td class="nump">5,656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherPayables', window );">Other payables</a></td>
<td class="nump">3,891<span></span>
</td>
<td class="nump">4,159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_LiabilitiesInRespectOfGrants', window );">Liabilities in respect of IIA grants</a></td>
<td class="nump">15,927<span></span>
</td>
<td class="nump">15,464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_LiabilitiesInRespectOfTeva', window );">Liabilities in respect of TEVA</a></td>
<td class="nump">3,200<span></span>
</td>
<td class="nump">4,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">10,189<span></span>
</td>
<td class="nump">902<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">12 months or less [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_CurrentMaturitiesOfLongTermLiabilities', window );">Current maturities of long-term liabilities</a></td>
<td class="nump">3,249<span></span>
</td>
<td class="nump">2,814<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_TradePayablesAndAccruedExpenses', window );">Trade payables and accrued expenses</a></td>
<td class="nump">5,528<span></span>
</td>
<td class="nump">5,656<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherPayables', window );">Other payables</a></td>
<td class="nump">3,891<span></span>
</td>
<td class="nump">4,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_LiabilitiesInRespectOfGrants', window );">Liabilities in respect of IIA grants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_LiabilitiesInRespectOfTeva', window );">Liabilities in respect of TEVA</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember', window );">1-2 years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_CurrentMaturitiesOfLongTermLiabilities', window );">Current maturities of long-term liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_TradePayablesAndAccruedExpenses', window );">Trade payables and accrued expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherPayables', window );">Other payables</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_LiabilitiesInRespectOfGrants', window );">Liabilities in respect of IIA grants</a></td>
<td class="nump">359<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_LiabilitiesInRespectOfTeva', window );">Liabilities in respect of TEVA</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">813<span></span>
</td>
<td class="nump">508<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember', window );">2-15 years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_CurrentMaturitiesOfLongTermLiabilities', window );">Current maturities of long-term liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_TradePayablesAndAccruedExpenses', window );">Trade payables and accrued expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherPayables', window );">Other payables</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_LiabilitiesInRespectOfGrants', window );">Liabilities in respect of IIA grants</a></td>
<td class="nump">15,568<span></span>
</td>
<td class="nump">15,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_LiabilitiesInRespectOfTeva', window );">Liabilities in respect of TEVA</a></td>
<td class="nump">2,200<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">$ 9,376<span></span>
</td>
<td class="nump">$ 394<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts payable that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_CurrentMaturitiesOfLongTermLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of current maturities of long-term liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_CurrentMaturitiesOfLongTermLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_LiabilitiesInRespectOfGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of liabilities in respect of grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_LiabilitiesInRespectOfGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_LiabilitiesInRespectOfTeva">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of liabilities in respect of TEVA.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_LiabilitiesInRespectOfTeva</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_TradePayablesAndAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of trade payables and accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_TradePayablesAndAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927974396272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Severance Pay Liability, Net (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract', window );"><strong>Disclosure of defined benefit plans [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans', window );">Percentage of monthly deposit by employee</a></td>
<td class="nump">8.33%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of monthly deposit by employee of their monthly salary in defined contribution plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927974081312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liabilities and Commitments (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Liabilities</a></td>
<td class="nump">$ 34,864<span></span>
</td>
<td class="nump">$ 39,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RoyaltyExpense', window );">Royalty expense</a></td>
<td class="nump">190<span></span>
</td>
<td class="nump">407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_ThirdPartiesMember', window );">Third party [Member] | Patents and intellectual property [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions', window );">License costs</a></td>
<td class="nump">$ 950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts', window );">Percentage of royalties to pay for future revenues from sales of products</a></td>
<td class="text">1.5% to 2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts', window );">Period of royalties to pay for future revenues from sales of products</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_OneTimeLumpsumAmount', window );">One-time lump-sum amount</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromRoyalties', window );">Aggregate revenues</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RoyaltyExpense', window );">Royalty expense</a></td>
<td class="nump">$ 98<span></span>
</td>
<td class="nump">363<span></span>
</td>
<td class="nump">$ 149<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_ThirdPartiesMember', window );">Third party [Member] | Patents and intellectual property [Member] | Sub-licensing of patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts', window );">Percentage of royalties to pay for future revenues from sales of products</a></td>
<td class="text">10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_ThirdPartiesMember', window );">Third party [Member] | Patents and intellectual property [Member] | Sub-licensing of patents [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_PercentageOfOneTimeLumpSumPaymentAmount', window );">Percentage of one-time lump sum payment amount</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_OneTimeLumpsumAmount', window );">One-time lump-sum amount</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_ThirdPartiesMember', window );">Third party [Member] | Patents and intellectual property [Member] | Sub-licensing of patents [Member] | Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_PercentageOfOneTimeLumpSumPaymentAmount', window );">Percentage of one-time lump sum payment amount</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_TevaMember', window );">Teva [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsiderationPaidReceived', window );">Revised cash consideration paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Obligation for contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination', window );">Modified contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Liabilities</a></td>
<td class="nump">$ 4,428<span></span>
</td>
<td class="nump">4,794<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_FinancialIncomeAndExpenses', window );">Financial expenses (income)</a></td>
<td class="nump">$ 468<span></span>
</td>
<td class="nump">533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_ResearchAndDevelopmentLawMember', window );">R&amp;D Law [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts', window );">Percentage of royalties to pay for future revenues from sales of products</a></td>
<td class="text">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_MaximumAggregateRoyaltiesPaidInPercentage', window );">Maximum aggregate royalties paid in percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Interest rate</a></td>
<td class="text">12-month interest<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RoyaltyExpense', window );">Royalty expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsiderationPaidReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 40<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_40_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsiderationPaidReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contingent liabilities recognised in a business combination. [Refer: Contingent liabilities [member]; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B67<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B67_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised for new contingent liabilities recognised in a business combination. [Refer: Contingent liabilities recognised in business combination]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B67<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B67_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income arising from royalties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from royalties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of transfers under licence agreements to the entity in related party transactions. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 21<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_21_f&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_FinancialIncomeAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents financial income and expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_FinancialIncomeAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_MaximumAggregateRoyaltiesPaidInPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum aggregate royalties paid in percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_MaximumAggregateRoyaltiesPaidInPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_OneTimeLumpsumAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>One-time lump-sum amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_OneTimeLumpsumAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_PercentageOfOneTimeLumpSumPaymentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of one-time lump sum payment amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_PercentageOfOneTimeLumpSumPaymentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of royalties to pay for future revenues from sales of products.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of royalties to pay for future revenues from sales of products.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_ThirdPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_ThirdPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MethodsOfGenerationAxis=mdwd_SubLicensingOfPatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MethodsOfGenerationAxis=mdwd_SubLicensingOfPatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_TevaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_TevaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_ResearchAndDevelopmentLawMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_ResearchAndDevelopmentLawMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975801872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Materials Agreements (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 09, 2023</div></th>
<th class="th"><div>May 06, 2019</div></th>
<th class="th"><div>Jul. 17, 2023</div></th>
<th class="th"><div>Feb. 17, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,467<span></span>
</td>
<td class="nump">$ 10,181<span></span>
</td>
<td class="nump">$ 10,256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenues net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,686<span></span>
</td>
<td class="nump">26,496<span></span>
</td>
<td class="nump">$ 23,763<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AgreementAxis=mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember', window );">Biomedical Advanced Research And Development Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions', window );">License costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 165,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ProceedsFromAdditionalFunding', window );">Additional funding amount</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AccumulatedFunding', window );">Accumulated funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_NexoBridMember', window );">NexoBrid [Member] | Biomedical Advanced Research And Development Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ProceedsFromProcurement', window );">Proceeds From Procurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ProceedsFromAdditionalFunding', window );">Additional funding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AmountOfSecondContractExpired', window );">Amount of second contract was expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenues net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_NexoBridMember', window );">NexoBrid [Member] | Biomedical Advanced Research And Development Authority [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ProceedsFromFunding', window );">Proceeds From Funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ProceedsFromProcurement', window );">Proceeds From Procurement</a></td>
<td class="nump">$ 65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_LicenseAgreementWithVericelMember', window );">License Agreement with Vericel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_UpfrontPayment', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdditionalUpfrontPayment', window );">Additional upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenues net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_LicenseAgreementWithVericelMember', window );">License Agreement with Vericel [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdditionalUpfrontPayment', window );">Additional upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember', window );">Biopharmax Group Ltd. contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AmountOfInvestedInProject', window );">Amount of invested in the project</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember', window );">DOD and MTEC contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ProceedsFromFunding', window );">Proceeds From Funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ProceedsFromAdditionalFunding', window );">Additional funding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ProceedsFromAdditionalProcurement', window );">Proceeds From Additional Procurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AccumulatedFunding', window );">Accumulated funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 126<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of transfers under licence agreements to the entity in related party transactions. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 21<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_21_f&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AccumulatedFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated funding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AccumulatedFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AdditionalUpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional upfront payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AdditionalUpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AmountOfInvestedInProject">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Information about invested in the project.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AmountOfInvestedInProject</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AmountOfSecondContractExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Information about second contract was expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AmountOfSecondContractExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ProceedsFromAdditionalFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional funding amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ProceedsFromAdditionalFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ProceedsFromAdditionalProcurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional procurement amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ProceedsFromAdditionalProcurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ProceedsFromFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Funding amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ProceedsFromFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ProceedsFromProcurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Procurement amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ProceedsFromProcurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_UpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Upfront payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_UpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AgreementAxis=mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AgreementAxis=mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_NexoBridMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_NexoBridMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_LicenseAgreementWithVericelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_LicenseAgreementWithVericelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927970357344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 07, 2023 </div>
<div>&#8362; / shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Feb. 07, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 06, 2022 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 26, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 07, 2022 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Mar. 07, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 28, 2022 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Sep. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2023 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 05, 2022 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 28, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 27, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 26, 2022 </div>
<div>&#8362; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits', window );">Additional ordinary shares issued upon vesting of outstanding RSU's</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,458<span></span>
</td>
<td class="nump">41,395<span></span>
</td>
<td class="nump">4,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AuthorizedShareCapital', window );">Authorized share capital | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesAuthorised', window );">Number of shares authorised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="nump">12,857,143<span></span>
</td>
<td class="nump">90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share | (per share)</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.07<span></span>
</td>
<td class="nump">&#8362; 0.07<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ReverseStockSplit', window );">Reverse stock split ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-for-7 ratio<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-for-7 ratio<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding', window );">Number of common shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,964,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,082,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">744,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_PricePerShareOfSharesIssued', window );">Price per common shares issued | &#8362; / shares</a></td>
<td class="nump">$ 0.0014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 13.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from shares issued | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,653,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AmountOfUnderwritingDiscountsAndCommissions', window );">Amount of underwriting discounts and commissions | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,021,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares', window );">Exercised options to purchase additional ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AggregateAmountOfRegisteredDirectOffering', window );">Aggregate amount of registered direct offering | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,257,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_PurchasePriceOfRegisteredDirectOffering', window );">Purchase price of registered direct offering | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 12.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_NumberOfWarrantsIssued', window );">Number of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,082,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ExercisePriceOfWarrants', window );">Exercise price of warrants | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.0015312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 13.475<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_WarrantsExpirationPeriod', window );">Warrants expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_NetProceedsFromOfferingAmount', window );">Net proceeds from offering amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,698,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RiskFreeInterestRateOfWarrants', window );">Risk free interest rate of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.37%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AverageStandardDeviationOfWarrants', window );">Average standard deviation of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_UnregisteredPreFundedWarrantsIssued', window );">Unregistered pre funded warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,407,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfWarrants', window );">Proceeds from warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_WarrantsToPurchaseOrdinaryShares', window );">Warrants to purchase ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_CommissionsAndOtherOfferingExpenses', window );">Commissions and other offering expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,031,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_IncreaseInAuthorizedShareCapital', window );">Increase In Authorized Share Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_IncreaseInSharesIssued', window );">Increase In Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AgreementAxis=mdwd_PrivateIssuancePurchaseEquityAgreementMember', window );">Private Issuance Purchase Equity Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from shares issued | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,920,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_NumberOfWarrantsIssued', window );">Number of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,407,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ExercisePriceOfWarrants', window );">Exercise price of warrants | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.0013475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RiskFreeInterestRateOfWarrants', window );">Risk free interest rate of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.26%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_UnregisteredPreFundedWarrantsIssued', window );">Unregistered pre funded warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,407,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock', window );">Unregistered pre funded warrants to purchase common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,407,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_IncreaseInPreFundedWarrantsExercisePrice', window );">Increase in pre funded warrants exercise price | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,788,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfWarrants', window );">Proceeds from warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,233,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_LossFromWarrantsTransactions', window );">Loss from warrants transactions | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,555,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_WarrantsToPurchaseOrdinaryShares', window );">Warrants to purchase ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,407,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_CertainEntitiesAffiliatedWithCbiMember', window );">Certain entities affiliated with CBI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding', window );">Number of common shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the number of shares outstanding. [Refer: Number of shares outstanding]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesAuthorised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesAuthorised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the exercise of share purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional ordinary shares issued upon vesting of outstanding RSU&#8217;s during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AggregateAmountOfRegisteredDirectOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents amount of aggregate amount of registered direct offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AggregateAmountOfRegisteredDirectOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AmountOfUnderwritingDiscountsAndCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents amount of underwriting discounts and commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AmountOfUnderwritingDiscountsAndCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AuthorizedShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents amount of share capital of an entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AuthorizedShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AverageStandardDeviationOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents average standard deviation of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AverageStandardDeviationOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_CommissionsAndOtherOfferingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of commissions and other offering expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_CommissionsAndOtherOfferingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ExercisePriceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents exercise price of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ExercisePriceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents exercised options to purchase additional ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_IncreaseInAuthorizedShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents Increase In authorized share capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_IncreaseInAuthorizedShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_IncreaseInPreFundedWarrantsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents increase in pre funded warrants exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_IncreaseInPreFundedWarrantsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_IncreaseInSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase In Shares Issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_IncreaseInSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_LossFromWarrantsTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents amount of loss from warrants transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_LossFromWarrantsTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_NetProceedsFromOfferingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents net proceeds from offering amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_NetProceedsFromOfferingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_NumberOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents number of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_NumberOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_PricePerShareOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_PricePerShareOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_PurchasePriceOfRegisteredDirectOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents purchase price per share of registered direct offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_PurchasePriceOfRegisteredDirectOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the information about reverse stock split ratio.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RiskFreeInterestRateOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents risk free interest rate of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RiskFreeInterestRateOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_UnregisteredPreFundedWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents unregistered Pre-Funded warrants issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_UnregisteredPreFundedWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents unregistered pre funded warrants to purchase common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_WarrantsExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents warrants expiration period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_WarrantsExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_WarrantsToPurchaseOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents warrants to purchase ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_WarrantsToPurchaseOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AgreementAxis=mdwd_PrivateIssuancePurchaseEquityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AgreementAxis=mdwd_PrivateIssuancePurchaseEquityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_CertainEntitiesAffiliatedWithCbiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_CertainEntitiesAffiliatedWithCbiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927974393584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity (Schedule of Share Capital) (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Feb. 07, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 05, 2022</div></th>
<th class="th"><div>Nov. 27, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract', window );"><strong>Disclosure of classes of share capital [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesAuthorised', window );">Authorized number of shares</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,857,143<span></span>
</td>
<td class="nump">90,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Issued and outstanding number of shares</a></td>
<td class="nump">9,221,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,964,286<span></span>
</td>
<td class="nump">7,240,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesAuthorised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesAuthorised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927968118992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Narrative) (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 15, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 03, 2023 </div>
<div>USD ($) </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 04, 2021 </div>
<div>USD ($) </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Nov. 20, 2023 </div>
<div>USD ($) </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 15, 2023 </div>
<div>USD ($) </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Aug. 18, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th"><div>Mar. 31, 2014</div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=mdwd_ShareIncentivePlanMember', window );">2014 Share Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of other equity instruments granted in share-based payment arrangement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesAndDirectorsMember', window );">Employees and directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_SharesAvailableForFutureGrant', window );">Shares available for future grant | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">861,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted', window );">Fair value of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,392<span></span>
</td>
<td class="nump">$ 2,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,320<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesAndDirectorsMember', window );">Employees and directors [Member] | 2003 Israeli Share Option Plan ("Plan") [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement', window );">Exercisable period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5-10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Description of vesting requirements for share-based payment arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3-4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesAndDirectorsMember', window );">Employees and directors [Member] | Restricted Shares Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_SharesAvailableForFutureGrant', window );">Shares available for future grant | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">990,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesAndDirectorsMember', window );">Employees and directors [Member] | Restricted Shares Unit [Member] | 2014 Equity Incentive Plan (the "2014 Plan") [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement', window );">Exercisable period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5-10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Description of vesting requirements for share-based payment arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesAndDirectorsMember', window );">Employees and directors [Member] | 2014 Share Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019', window );">Options granted, exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_DirectorsMember', window );">Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement', window );">Exercisable period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">five years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Description of vesting requirements for share-based payment arrangement</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of other equity instruments granted in share-based payment arrangement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019', window );">Options granted, exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements', window );">Fair value of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Expense from share-based payment transitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_DirectorsMember', window );">Directors [Member] | Restricted Shares Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of other equity instruments granted in share-based payment arrangement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019', window );">Options granted, exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements', window );">Fair value of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_DirectorsMember', window );">Directors [Member] | 2014 Share Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of other equity instruments granted in share-based payment arrangement | shares</a></td>
<td class="nump">7,200<span></span>
</td>
<td class="nump">160,400<span></span>
</td>
<td class="nump">34,013<span></span>
</td>
<td class="nump">48,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019', window );">Options granted, exercise price | (per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 9.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements', window );">Fair value of options</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 884<span></span>
</td>
<td class="nump">$ 663<span></span>
</td>
<td class="nump">$ 265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_DirectorsMember', window );">Directors [Member] | 2014 Share Incentive Plan [Member] | Restricted Shares Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of other equity instruments granted in share-based payment arrangement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,669<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements', window );">Fair value of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesMember', window );">Employees [Member] | 2014 Share Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of other equity instruments granted in share-based payment arrangement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements', window );">Fair value of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesMember', window );">Employees [Member] | 2014 Share Incentive Plan [Member] | Restricted Shares Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of other equity instruments granted in share-based payment arrangement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements', window );">Fair value of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_ChairmanMember', window );">Chairman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of other equity instruments granted in share-based payment arrangement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements', window );">Fair value of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_DirectorsAndCeoMember', window );">Directors and CEO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of other equity instruments granted in share-based payment arrangement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements', window );">Fair value of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_DirectorsAndCeoMember', window );">Directors and CEO [Member] | Restricted Shares Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of other equity instruments granted in share-based payment arrangement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements', window );">Fair value of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember', window );">Employees, Officers, Board Members CEO and Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Description of vesting requirements for share-based payment arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember', window );">Employees, Officers, Board Members CEO and Consultants [Member] | 2014 Share Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019', window );">Options granted, exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements', window );">Fair value of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember', window );">Employees, Officers, Board Members CEO and Consultants [Member] | 2014 Share Incentive Plan [Member] | Restricted Shares Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements', window );">Fair value of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the maximum term of options granted for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 51<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_51_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference, for modified share-based payment arrangements, between the fair value of the modified equity instrument and that of the original equity instrument, both estimated as at the date of the modification. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_c_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_SharesAvailableForFutureGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares available for future grant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_SharesAvailableForFutureGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=mdwd_ShareIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=mdwd_ShareIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesAndDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesAndDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mdwd_IsraeliShareOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mdwd_IsraeliShareOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=mdwd_RestrictedSharesUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=mdwd_RestrictedSharesUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mdwd_EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mdwd_EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_DirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_DirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mdwd_RestrictedSharesUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mdwd_RestrictedSharesUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_ChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_ChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_DirectorsAndCeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_DirectorsAndCeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927969096032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of Expense Recognized) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based compensation</a></td>
<td class="nump">$ 1,940<span></span>
</td>
<td class="nump">$ 1,946<span></span>
</td>
<td class="nump">$ 1,673<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mdwd_CostOfRevenuesMember', window );">Cost of revenues [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based compensation</a></td>
<td class="nump">271<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="nump">153<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mdwd_ResearchAndDevelopmentExpensesMember', window );">Research and development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based compensation</a></td>
<td class="nump">485<span></span>
</td>
<td class="nump">406<span></span>
</td>
<td class="nump">333<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mdwd_SellingAndMarketingExpensesMember', window );">Selling and marketing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based compensation</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mdwd_GeneralAndAdministrativeExpensesMember', window );">General and administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based compensation</a></td>
<td class="nump">$ 1,097<span></span>
</td>
<td class="nump">$ 1,314<span></span>
</td>
<td class="nump">$ 1,187<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mdwd_CostOfRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mdwd_CostOfRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mdwd_ResearchAndDevelopmentExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mdwd_ResearchAndDevelopmentExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mdwd_SellingAndMarketingExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mdwd_SellingAndMarketingExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mdwd_GeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mdwd_GeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927969288064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of Share Options Activity) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_NumberAbstract', window );"><strong>Number [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding Options at beginning of year</a></td>
<td class="nump">764,767<span></span>
</td>
<td class="nump">537,288<span></span>
</td>
<td class="nump">513,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share options granted in share-based payment arrangement</a></td>
<td class="nump">346,950<span></span>
</td>
<td class="nump">320,775<span></span>
</td>
<td class="nump">53,970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Option's Exercised</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(807)<span></span>
</td>
<td class="num">(536)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Option's Forfeited and/or expired</a></td>
<td class="num">(154,230)<span></span>
</td>
<td class="num">(92,489)<span></span>
</td>
<td class="num">(30,119)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding options and at end of year</a></td>
<td class="nump">957,487<span></span>
</td>
<td class="nump">764,767<span></span>
</td>
<td class="nump">537,288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Option's Exercisable at end of year</a></td>
<td class="nump">462,045<span></span>
</td>
<td class="nump">373,681<span></span>
</td>
<td class="nump">333,618<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_WeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average Exercise Price [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding Options at beginning of year | $ / shares</a></td>
<td class="nump">$ 30.44<span></span>
</td>
<td class="nump">$ 44.45<span></span>
</td>
<td class="nump">$ 45.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Option's Granted | $ / shares</a></td>
<td class="nump">11.87<span></span>
</td>
<td class="nump">14.25<span></span>
</td>
<td class="nump">37.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Option's Exercised | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12.23<span></span>
</td>
<td class="nump">20.16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Option's Forfeited and/or expired | $ / shares</a></td>
<td class="nump">57.55<span></span>
</td>
<td class="nump">55.58<span></span>
</td>
<td class="nump">56.91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding options and at end of year | $ / shares</a></td>
<td class="nump">19.34<span></span>
</td>
<td class="nump">30.44<span></span>
</td>
<td class="nump">44.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Option's Exercisable at end of year | $ / shares</a></td>
<td class="nump">$ 26.25<span></span>
</td>
<td class="nump">$ 46.18<span></span>
</td>
<td class="nump">$ 58.38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=mdwd_RestrictedSharesUnitsMember', window );">Restricted Shares Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_NumberAbstract', window );"><strong>Number [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding Options at beginning of year</a></td>
<td class="nump">42,013<span></span>
</td>
<td class="nump">14,581<span></span>
</td>
<td class="nump">10,655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share options granted in share-based payment arrangement</a></td>
<td class="nump">9,100<span></span>
</td>
<td class="nump">39,286<span></span>
</td>
<td class="nump">8,992<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Option's Forfeited and/or expired</a></td>
<td class="num">(941)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="num">(215)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Option's Vested</a></td>
<td class="num">(17,458)<span></span>
</td>
<td class="num">(11,827)<span></span>
</td>
<td class="num">(4,851)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding options and at end of year</a></td>
<td class="nump">32,714<span></span>
</td>
<td class="nump">42,013<span></span>
</td>
<td class="nump">14,581<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_NumberAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_NumberAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_WeightedAverageExercisePriceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_WeightedAverageExercisePriceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=mdwd_RestrictedSharesUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=mdwd_RestrictedSharesUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927974862848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of Information About Share Options Outstanding) (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options | shares</a></td>
<td class="nump">957,487<span></span>
</td>
<td class="nump">764,767<span></span>
</td>
<td class="nump">537,288<span></span>
</td>
<td class="nump">513,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted Average Remaining contractual life</a></td>
<td class="text">7 years 3 months 14 days<span></span>
</td>
<td class="text">6 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 19.34<span></span>
</td>
<td class="nump">$ 30.44<span></span>
</td>
<td class="nump">$ 44.45<span></span>
</td>
<td class="nump">$ 45.85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesOneMember', window );">8.26-9.64 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options | shares</a></td>
<td class="nump">55,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted Average Remaining contractual life</a></td>
<td class="text">9 years 10 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 8.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesTwoMember', window );">11.89-14.42 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options | shares</a></td>
<td class="nump">711,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted Average Remaining contractual life</a></td>
<td class="text">7 years 10 months 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 13.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesThreeMember', window );">26.88-37.52 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options | shares</a></td>
<td class="nump">125,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted Average Remaining contractual life</a></td>
<td class="text">5 years 7 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 35.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesFourMember', window );">42.14-67.06 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options | shares</a></td>
<td class="nump">64,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted Average Remaining contractual life</a></td>
<td class="text">1 year 10 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 63.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesFiveMember', window );">12.25-14.42 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">470,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted Average Remaining contractual life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 10 months 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesSixMember', window );">26.88-37.52 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted Average Remaining contractual life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 5 months 4 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesServenMember', window );">42.14-67.06 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted Average Remaining contractual life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 10 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesEightMember', window );">90.23-96.32 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted Average Remaining contractual life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 months 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesServenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesServenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=mdwd_RangesOfExercisePricesEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927969991712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of Estimated Using Acceptable Option Pricing Models) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend yield (%)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Weighted average share prices (Dollar)</a></td>
<td class="nump">$ 10.71<span></span>
</td>
<td class="nump">$ 13.22<span></span>
</td>
<td class="nump">$ 36.33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility of the share prices (%)</a></td>
<td class="nump">61.00%<span></span>
</td>
<td class="nump">59.00%<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate (%)</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ExercisePriceShareOptionsGrantedPercentage', window );">Early exercise factor (%)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility of the share prices (%)</a></td>
<td class="nump">77.00%<span></span>
</td>
<td class="nump">77.00%<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate (%)</a></td>
<td class="nump">5.36%<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ExercisePriceShareOptionsGrantedPercentage', window );">Early exercise factor (%)</a></td>
<td class="nump">150.00%<span></span>
</td>
<td class="nump">150.00%<span></span>
</td>
<td class="nump">150.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ExercisePriceShareOptionsGrantedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected exercise price percentage of the share price used to calculate the fair value of the share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ExercisePriceShareOptionsGrantedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975808752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod', window );">Change in tax rate</a></td>
<td class="text">10%- 25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DescriptionOfTaxBenefitPeriod', window );">Description Of Tax Benefit Period</a></td>
<td class="text">five to eight years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_LimitOfBenefitEntitlementPeriod', window );">Limit of benefit entitlement period</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses', window );">Other Temporary Differences Mainly From R And D Expenses</a></td>
<td class="nump">$ 171,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=ifrs-full_CountryOfDomicileMember', window );">Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Income tax rate</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_DE', window );">Germany [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Income tax rate</a></td>
<td class="nump">29.79%<span></span>
</td>
<td class="nump">29.79%<span></span>
</td>
<td class="nump">29.79%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The explanation of the changes in the entity's applicable income tax rate(s) compared to the previous accounting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DescriptionOfTaxBenefitPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of tax benefit period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DescriptionOfTaxBenefitPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_LimitOfBenefitEntitlementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Limit of benefit entitlement period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_LimitOfBenefitEntitlementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other temporary differences mainly from research and development expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=ifrs-full_CountryOfDomicileMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=ifrs-full_CountryOfDomicileMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927969096448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherExpenseByFunction', window );">One-time expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">One-time income</a></td>
<td class="nump">$ 211<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mdwd_BardaMember', window );">BARDA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ConcentrationRiskPercentage', window );">Concentration Risk Percentage</a></td>
<td class="nump">56.00%<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mdwd_VericelMember', window );">Vericel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ConcentrationRiskPercentage', window );">Concentration Risk Percentage</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mdwd_MtecMember', window );">MTEC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ConcentrationRiskPercentage', window );">Concentration Risk Percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mdwd_OtherCustomerContributedMember', window );">Other Customer Contributed [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherExpenseByFunction', window );">One-time expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherExpenseByFunction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'function of expense' form for its analysis of expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35_b_vii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherExpenseByFunction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35_b_iv&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ConcentrationRiskPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ConcentrationRiskPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mdwd_BardaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mdwd_BardaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mdwd_VericelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mdwd_VericelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mdwd_MtecMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mdwd_MtecMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mdwd_OtherCustomerContributedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mdwd_OtherCustomerContributedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139928022993936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenues</a></td>
<td class="nump">$ 18,686<span></span>
</td>
<td class="nump">$ 26,496<span></span>
</td>
<td class="nump">$ 23,763<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=mdwd_UsaMember', window );">USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenues</a></td>
<td class="nump">13,078<span></span>
</td>
<td class="nump">21,872<span></span>
</td>
<td class="nump">18,102<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=mdwd_OtherCountriesMember', window );">EU and other international markets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenues</a></td>
<td class="nump">$ 5,608<span></span>
</td>
<td class="nump">$ 4,624<span></span>
</td>
<td class="nump">$ 5,661<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=mdwd_UsaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=mdwd_UsaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=mdwd_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=mdwd_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975642192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Cost of Revenues Products) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WagesAndSalaries', window );">Salary and benefits (including share-based compensation)</a></td>
<td class="nump">$ 2,703<span></span>
</td>
<td class="nump">$ 1,828<span></span>
</td>
<td class="nump">$ 2,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_SubcontractorsExpenses', window );">Subcontractors</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortization</a></td>
<td class="nump">672<span></span>
</td>
<td class="nump">426<span></span>
</td>
<td class="nump">559<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfMerchandiseSold', window );">Cost of materials</a></td>
<td class="nump">916<span></span>
</td>
<td class="nump">636<span></span>
</td>
<td class="nump">1,039<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other manufacturing expenses</a></td>
<td class="nump">1,207<span></span>
</td>
<td class="nump">779<span></span>
</td>
<td class="nump">906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInInventoriesOfFinishedGoodsAndWorkInProgress', window );">Decrease (increase) in inventory of finished products</a></td>
<td class="num">(801)<span></span>
</td>
<td class="num">(543)<span></span>
</td>
<td class="nump">242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_CostOfSalesFromSaleOfProducts', window );">Cost of revenues from sale of products</a></td>
<td class="nump">$ 4,927<span></span>
</td>
<td class="nump">$ 3,184<span></span>
</td>
<td class="nump">$ 4,983<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInInventoriesOfFinishedGoodsAndWorkInProgress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in inventories of finished goods and work in progress. [Refer: Inventories; Current finished goods; Current work in progress]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInInventoriesOfFinishedGoodsAndWorkInProgress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfMerchandiseSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of merchandise that was sold during the period and recognised as an expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfMerchandiseSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 104<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of miscellaneous other operating expenses. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WagesAndSalaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 9<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_9&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WagesAndSalaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_CostOfSalesFromSaleOfProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs relating to expenses directly or indirectly attributed to sale of products.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_CostOfSalesFromSaleOfProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_SubcontractorsExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subcontractors expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_SubcontractorsExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975689984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss ( Schedule of Cost of Revenues) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_StatementOfComprehensiveIncomeAbstract', window );"><strong>Statement of comprehensive income [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_SalaryAndBenefits', window );">Salary and benefits</a></td>
<td class="nump">$ 1,995<span></span>
</td>
<td class="nump">$ 1,691<span></span>
</td>
<td class="nump">$ 2,003<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_Subcontractors', window );">Subcontractors</a></td>
<td class="nump">8,182<span></span>
</td>
<td class="nump">8,138<span></span>
</td>
<td class="nump">7,904<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_CostOfSalesFromLicenseAgreements', window );">Cost of revenues from development services</a></td>
<td class="nump">$ 10,177<span></span>
</td>
<td class="nump">$ 9,829<span></span>
</td>
<td class="nump">$ 9,907<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_CostOfSalesFromLicenseAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs relating to expenses directly or indirectly attributed to license agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_CostOfSalesFromLicenseAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_SalaryAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Salary and benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_SalaryAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_Subcontractors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of subcontractors during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_Subcontractors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975268688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Cost of Revenue License) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_StatementOfComprehensiveIncomeAbstract', window );"><strong>Statement of comprehensive income [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements', window );">Salary and benefits</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RoyaltiesPayments', window );">Royalties payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">280<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_TotalRoyaltiesPayments', window );">Total Royalties payments</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">318<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Total Cost of Revenues</a></td>
<td class="nump">$ 15,108<span></span>
</td>
<td class="nump">$ 13,331<span></span>
</td>
<td class="nump">$ 14,992<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RoyaltiesPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalties payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RoyaltiesPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the salary and benefits expenses related to license agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_TotalRoyaltiesPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of total royalties payments during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_TotalRoyaltiesPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927969940976">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Research Expenses) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EmployeeBenefitsExpense', window );">Salary and benefits (including share-based compensation)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 3,148<span></span>
</td>
<td class="nump">$ 4,494<span></span>
</td>
<td class="nump">$ 2,864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment', window );">Subcontractors</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,833<span></span>
</td>
<td class="nump">4,054<span></span>
</td>
<td class="nump">6,323<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">396<span></span>
</td>
<td class="nump">571<span></span>
</td>
<td class="nump">396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_CostOfMaterials', window );">Cost of materials</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">785<span></span>
</td>
<td class="nump">572<span></span>
</td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_OtherResearchAndDevelopmentExpenses', window );">Other research and development expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">305<span></span>
</td>
<td class="nump">490<span></span>
</td>
<td class="nump">326<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Total Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 7,467<span></span>
</td>
<td class="nump">$ 10,181<span></span>
</td>
<td class="nump">$ 10,256<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The salary costs for the year ended December 31,2022 includes one time payment of $205 derived from termination agreement with the CMO of the company.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EmployeeBenefitsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 104<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EmployeeBenefitsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 126<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_CostOfMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of materials.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_CostOfMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation and amortisation expense related to research and development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_OtherResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The other amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_OtherResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subcontractors expenses related to research and development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927969685504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Selling Expenses) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermEmployeeBenefitsExpense', window );">Salary and benefits (including share-based compensation)</a></td>
<td class="nump">$ 1,991<span></span>
</td>
<td class="nump">$ 1,637<span></span>
</td>
<td class="nump">$ 1,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_MarketingAndSalesExpense', window );">Marketing and consulting</a></td>
<td class="nump">1,637<span></span>
</td>
<td class="nump">1,152<span></span>
</td>
<td class="nump">627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses', window );">Depreciation and amortization</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DistributionCosts', window );">Shipping and delivery</a></td>
<td class="nump">356<span></span>
</td>
<td class="nump">385<span></span>
</td>
<td class="nump">490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RegistrationAndMarketingLicenseFees', window );">Registration and marketing license fees</a></td>
<td class="nump">810<span></span>
</td>
<td class="nump">502<span></span>
</td>
<td class="nump">584<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SalesAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">$ 4,844<span></span>
</td>
<td class="nump">$ 3,725<span></span>
</td>
<td class="nump">$ 3,388<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DistributionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs relating to the distribution of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DistributionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SalesAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to the marketing and selling of goods or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SalesAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermEmployeeBenefitsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermEmployeeBenefitsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation and amortisation expense related to selling and marketing expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_MarketingAndSalesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketing and sales expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_MarketingAndSalesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RegistrationAndMarketingLicenseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Registration and marketing license fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RegistrationAndMarketingLicenseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927974970640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of General Expenses) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_SalaryAndBenefitsIncludingShareBasedCompensation', window );">Salary and benefits (including share-based compensation)</a></td>
<td class="nump">$ 3,521<span></span>
</td>
<td class="nump">$ 3,344<span></span>
</td>
<td class="nump">$ 2,905<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Professional fees</a></td>
<td class="nump">2,189<span></span>
</td>
<td class="nump">2,589<span></span>
</td>
<td class="nump">2,480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses', window );">Depreciation and amortization</a></td>
<td class="nump">185<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="nump">239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_OtherSellingGeneralAndAdministrativeExpenses', window );">Other</a></td>
<td class="nump">873<span></span>
</td>
<td class="nump">762<span></span>
</td>
<td class="nump">724<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">$ 6,768<span></span>
</td>
<td class="nump">$ 6,920<span></span>
</td>
<td class="nump">$ 6,348<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfessionalFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable for professional services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfessionalFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Depreciation and amortization expense related to general and administrative expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_OtherSellingGeneralAndAdministrativeExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The other amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_OtherSellingGeneralAndAdministrativeExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_SalaryAndBenefitsIncludingShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Salary and benefits (including share-based compensation).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_SalaryAndBenefitsIncludingShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927974478256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Financial Expense) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_FinancingIncomeAbstract', window );"><strong>Financial income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromInterest', window );">Interest income</a></td>
<td class="nump">$ 2,341<span></span>
</td>
<td class="nump">$ 270<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants', window );">Revaluation of liabilities in respect of IIA grants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RevaluationOfWarrantsAccountedAtFairValue', window );">Revaluation of Warrants</a></td>
<td class="nump">8,310<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradingIncomeExpenseOnForeignExchangeContracts', window );">Exchange differences, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Financial income</a></td>
<td class="nump">10,651<span></span>
</td>
<td class="nump">461<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_FinancingExpensesAbstract', window );"><strong>Financial expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant', window );">Revaluation of liabilities in respect of IIA grants</a></td>
<td class="nump">427<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">903<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_FinancingIncomeOnNetInvestmentInLease', window );">Financing income on net investment in lease</a></td>
<td class="nump">274<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_FinanceExpensesInRespectOfDeferredRevenue', window );">Finance expenses in respect of deferred Revenues</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares', window );">Revaluation of liabilities in respect of TEVA</a></td>
<td class="nump">468<span></span>
</td>
<td class="nump">533<span></span>
</td>
<td class="nump">590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeLoss', window );">Exchange differences, net</a></td>
<td class="nump">654<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RevaluationOfWarrant', window );">Revaluation of Warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,977<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss', window );">Issuance expenses of warrants through profit and loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,911<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherFinanceCost', window );">Other</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Financial expense</a></td>
<td class="nump">1,892<span></span>
</td>
<td class="nump">11,637<span></span>
</td>
<td class="nump">2,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_FinancialExpensesNet', window );">Financial income (expenses), net</a></td>
<td class="nump">$ 8,759<span></span>
</td>
<td class="num">$ (11,176)<span></span>
</td>
<td class="num">$ (2,303)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetForeignExchangeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net loss arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2023-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetForeignExchangeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of finance costs that the entity does not separately disclose in the same statement or note. [Refer: Finance costs]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income arising from interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_e&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradingIncomeExpenseOnForeignExchangeContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of trading income (expense) relating to foreign exchange contracts. [Refer: Trading income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradingIncomeExpenseOnForeignExchangeContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_FinanceExpensesInRespectOfDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance expenses in respect of deferred revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_FinanceExpensesInRespectOfDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_FinancialExpensesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of financial income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_FinancialExpensesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_FinancingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_FinancingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_FinancingIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_FinancingIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_FinancingIncomeOnNetInvestmentInLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of financing income on net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_FinancingIncomeOnNetInvestmentInLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of issuance expenses of warrants through profit and loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revaluation of liabilities in respect of IIA grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of revaluation of liabilities in respect of IIA grant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revaluation of liabilities in respect of the purchase of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RevaluationOfWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of revaluation of Warrant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RevaluationOfWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RevaluationOfWarrantsAccountedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of Revaluation of warrants accounted at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RevaluationOfWarrantsAccountedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927976431280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 26, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareLineItems', window );"><strong>Earnings per share [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_NumberOfWarrantsIssued', window );">Number of warrants issued</a></td>
<td class="nump">1,082,223<span></span>
</td>
<td class="nump">124,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">346,950<span></span>
</td>
<td class="nump">320,775<span></span>
</td>
<td class="nump">53,970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_UnregisteredPreFundedWarrantsIssued', window );">Unregistered pre funded warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,407,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfOrdinarySharesAxis=mdwd_DilutedWeightedAverageNumberMember', window );">Diluted Weighted Average Number [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareLineItems', window );"><strong>Earnings per share [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_NumberOfWarrantsIssued', window );">Number of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,614,297<span></span>
</td>
<td class="nump">2,614,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">957,487<span></span>
</td>
<td class="nump">764,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_NumberOfRestrictedShareUnitIssued', window );">Number of restricted share unit issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,714<span></span>
</td>
<td class="nump">42,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_UnregisteredPreFundedWarrantsIssued', window );">Unregistered pre funded warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,407,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_NumberOfRestrictedShareUnitIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of restricted share unit Issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_NumberOfRestrictedShareUnitIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_NumberOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents number of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_NumberOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_UnregisteredPreFundedWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents unregistered Pre-Funded warrants issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_UnregisteredPreFundedWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfOrdinarySharesAxis=mdwd_DilutedWeightedAverageNumberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfOrdinarySharesAxis=mdwd_DilutedWeightedAverageNumberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975762784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Schedule of Details of Number of Shares and Loss Used in Computation) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Weighted average number of shares</a></td>
<td class="nump">9,013,144<span></span>
</td>
<td class="nump">4,987,069<span></span>
</td>
<td class="nump">3,892,068<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromContinuingOperations', window );">Loss</a></td>
<td class="num">$ (6,716)<span></span>
</td>
<td class="num">$ (19,599)<span></span>
</td>
<td class="num">$ (13,551)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing operations. [Refer: Continuing operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_vi&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975088096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Schedule of Net Loss Per Share from Continuing and Discontinued Operations) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic and diluted loss per share:</a></td>
<td class="num">$ (0.75)<span></span>
</td>
<td class="num">$ (3.93)<span></span>
</td>
<td class="num">$ (3.48)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975684544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balances and Transactions With Related Parties and Key Officers (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2007</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_ChiefExecutiveOfficerAndChiefMedicalOfficerMember', window );">Chief Executive Officer and Chief Medical Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DirectorsRemunerationExpense', window );">One-time payments</a></td>
<td class="nump">$ 120<span></span>
</td>
<td class="nump">$ 309<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DirectorsRemunerationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of remuneration paid or payable to the entity's directors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DirectorsRemunerationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_ChiefExecutiveOfficerAndChiefMedicalOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_ChiefExecutiveOfficerAndChiefMedicalOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975182960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balances and Transactions With Related Parties and Key Officers (Schedule of Balances of Related Parties) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_RelatedPartiesMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmountsPayableRelatedPartyTransactions', window );">Payables</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 177<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember', window );">Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmountsPayableRelatedPartyTransactions', window );">Payables</a></td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountsPayableRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts payable resulting from related party transactions. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountsPayableRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_RelatedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_RelatedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927968923104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balances and Transactions With Related Parties and Key Officers (Schedule of Transactions with Related Parties) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>Directors</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>Directors</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Directors</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses', window );">Professional Fee</a></td>
<td class="nump">$ 527<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 547<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_NumberOfDirectors', window );">Number of Directors | Directors</a></td>
<td class="nump">9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">10<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember', window );">Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses', window );">Professional Fee</a></td>
<td class="nump">$ 502<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 484<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_RelatedPartiesMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses', window );">Professional Fee</a></td>
<td class="nump">25<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">63<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RelatedPartiesRentaLexpenseAndOther', window );">Related Parties Renta Lexpense And Other</a></td>
<td class="nump">$ 267<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 457<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 469<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">During 2023 three members of the board have left and one member of the board was replaced. At the end of 2023, the total board member consisted of five members.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">During 2022 two members of the board of directors were replaced.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_NumberOfDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of directors by the entity at a date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_NumberOfDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ProfessionalFeeAndShareBasedCompensationExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the professional fee and share based compensation expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ProfessionalFeeAndShareBasedCompensationExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RelatedPartiesRentaLexpenseAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of rental expense and other classified under related party transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RelatedPartiesRentaLexpenseAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_RelatedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_RelatedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927974374464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balances and Transactions With Related Parties and Key Officers (Schedule of Balances of Key Officers of the Company) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Professional fee</a></td>
<td class="nump">$ 2,189<span></span>
</td>
<td class="nump">$ 2,589<span></span>
</td>
<td class="nump">$ 2,480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_KeyOfficerMember', window );">Key Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Professional fee</a></td>
<td class="nump">$ 518<span></span>
</td>
<td class="nump">$ 754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfessionalFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable for professional services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfessionalFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_KeyOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_KeyOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927969003680">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Balances and Transactions With Related Parties and Key Officers (Schedule of Compensation of Officers of Company) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>Officers</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>Officers</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Officers</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Short-term employee benefits</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">$ 2,084<span></span>
</td>
<td class="nump">$ 2,880<span></span>
</td>
<td class="nump">$ 1,788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">757<span></span>
</td>
<td class="nump">797<span></span>
</td>
<td class="nump">518<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Compensation of officers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2,841<span></span>
</td>
<td class="nump">$ 3,677<span></span>
</td>
<td class="nump">$ 2,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfEmployees', window );">Number of officers | Officers</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">In December 2007, the Company's board of directors approved one&#8209;time bonus payments to the Chief Medical Officer in the amounts of $ 120, which was recorded in profit and loss in December 2022 upon achieving marketing approval in the United States.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">One-time expenses amounted $309 for the year ended December 31, 2022, are  associated with the management changes.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">During 2023 two key officers were replaced. At the end of 2023 the total key officers consist of six officers.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of personnel employed by the entity at a date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139927975542192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent events (Narrative) (Details)<br> &#8362; / shares in Units, $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 06, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 07, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 26, 2022 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 07, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 26, 2024 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jan. 31, 2024 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Jan. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Feb. 15, 2023</div></th>
<th class="th">
<div>Jan. 01, 2024 </div>
<div>m&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>&#8362; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding', window );">Number of common shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,964,286<span></span>
</td>
<td class="nump">1,082,223<span></span>
</td>
<td class="nump">744,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ExercisePriceOfWarrants', window );">Exercise price of warrants | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 13.475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.0015312<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember', window );">Employees, Officers, Board Members CEO and Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=mdwd_SubsequentEventsMember', window );">Subsequent Events [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AreaOfLand', window );">Area of office | m&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">380.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding', window );">Number of common shares issued</a></td>
<td class="nump">311,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_NumberOfSharesExerciseRestrictedStockUnits', window );">Number of restricted stock units issued</a></td>
<td class="nump">30,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_TermOfLease', window );">Term of lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdditionalTermOfLease', window );">Additional term of lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_NumberOfPreFundedWarrantsExercised', window );">Number of pre funded warrants exercised</a></td>
<td class="nump">37,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ExercisePriceOfWarrants', window );">Exercise price of warrants | $ / shares</a></td>
<td class="nump">$ 13.475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=mdwd_SubsequentEventsMember', window );">Subsequent Events [Member] | Employees, Officers, Board Members CEO and Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AmountOfAnnualFeeOfLeaseAgreement', window );">Annual fee of lease agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 437<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare', window );">Exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the number of shares outstanding. [Refer: Number of shares outstanding]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AdditionalTermOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Information about additional term of lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AdditionalTermOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AmountOfAnnualFeeOfLeaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of annual fee of lease agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AmountOfAnnualFeeOfLeaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of land.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ExercisePriceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents exercise price of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ExercisePriceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_NumberOfPreFundedWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents number of pre funded warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_NumberOfPreFundedWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_NumberOfSharesExerciseRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents as a restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_NumberOfSharesExerciseRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of exercise price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_TermOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Information about term of lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_TermOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=mdwd_SubsequentEventsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=mdwd_SubsequentEventsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>125
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M;S1%"-5V^=8PLFH:Y4H:;+O--,>'$91UP/U,2K,S;._MG]KX'U!+ P04
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MRW,(%@3&= %0?FQ+N8-*(^XBTFW9R*UIW>S3D'ZXL"=B%G=PXNO[40!E[!4
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MKQ1 _KX4HCE\42_H[S!?_1]02P,$%     @ "T%U6$-<Q-;3"@  -QD  !@
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M^JJ-PT#@Z?@.@6DK,!6[XT9BY8D.^OBELQOE>#6T\8.X*M(PSE2<E//@\-5
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M%'BC19.DCAZ<B3)K*4L5%DDAE*U1*LF-Q8R0$)W>EBE3\E[,6:E@4ML/=<?
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M%T*?JVL( 5!!X,T/[S^H;^?J+"WQ)KUQIL[/4'BA >KL@BJ)6?/T=4Y<:-W
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M<V_BT0+6?%N9E=Q_@$,^8\N7RTJ[E>Z[V%'BT7RKC:P/8%10BZ;[\J=#'8X
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M>0%"OIN>9R6](-[2>[GA>6'T7$K*<F@'@(4^O#D)]E=R3%(7GH(4:)8C&C)
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M(&AU=Q>U*B^98?%2R1U5-AO9[*(MM46C.%[9CW)G%)YRQ)GXNRE T0W;LT2
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M; *>YQ*K[S?V@N&]C?\"4$L#!!0    (  M!=5CQ=VXE9 ,  &P'   9
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M'4[',9BNMW<3IYO03S?:47<.PYJ>0S3>@/:WFBJGGWB"TP.[_ ]02P,$%
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M.1[@1/_=9QR_]73_UA18%Z;FJ;@:('*,T/=B</WS3_')^.4SBDU;Q:;/<>]
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M'\V&L^0L7(GF-Y>I-C1@=G8>ARO]3'JD>\1\WTF'KI,R-44U1+V]?<66FM,
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MT>EL #'=QP[_8%7M/C"@X;>J=+<YS"LT+<#O"P51PP-MT'YQNOX?4$L#!!0
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M+O EN!Z]#*>:5"N<8S8X:=D@Y?#((0G(*1P,D,F0KBJ'!L9$C-<;#_O;&%N
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M9(159J>&ES_^$)V-WCQCP*0Q8/+<Z<^$YOE]/Q>E$M'YQ< =,)#AX*YK\L4
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M*6:C<W<$XQVA9\%DI;8=-5T5!L11'A^ @Z18Y5P2X'::&Y92-W7=#VT$(7I
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M'M> /.Q<;^1</9_ A;2JK]7DXOOO1.P]O6=_X;"_\#[IUI;\<;:\7](O5:.
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M ][J'K]ABCFB@IHF@L4TV^UC'XW^(_ABE)(CS#;13B#2:R 44J#=#3>V=ZZ
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M6P ^4>/P'!=&=FY@':7!\><^&_S? &45<+^6V-VFA74P_\'L?P=02P,$%
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M\+R02KO:YT"O9%DQL?%)Z#^%Y")X08(9N45YA0%MV*( 3;H1;LB%0T2N0KE
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M5CL:H'Y9T8N%A@7HOM3$=MRP@>D-W'X#4$L#!!0    (  M!=5B9!_8UEAH
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MMU>3$+_7Y4(]6<[5U>75DPEX3P+I3PC>DV/PC"OKUO56JW:MG-DT9FW*HNE
M5 (O]IX7__MFY3H+0O1_8[S@G;X9WPDUZ]KMBU)_=P*JX[2]U2>O__RGY=/+
MEQ-T?!/H^&8*^NNWA3,.22C;Q@&Z58'R/H;E-)QB,1L'=:W>A8^Z4FO3%$V)
M,N,Z^ )4M'/*-&7=5UIU6SV^@(#N]D6#S.RV14=+W]%7][A?9T&4U:GK5\Y4
MIK H=@O<&7]0@%91;HV^!03NMKK)GH8?]==]ZW0U5ZU5V\(IB]KHYJIKU2W
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M)(NO0?.8R!?Z4!X93#=_W/!IN^XP58_)C-4;S!Q:G-WVB2G\5VK8.RN#Q33
M^%I8*/[' *\LR#7X<2&Y&I-$."M.+66^E,Y&MF4$,25IT =FI0.N&H7,=/[P
ML-X_:@.F;&)R#W(Y:;_>!Y$RJ,$]12VC=G :SI9NI1R"XNAZ>*WJGKB_'GO
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M\I*PIE68KG/4P0JP K=#!C0;]YJ-_ULSVDAEV.].LQ9G09;:W2LOG*Q&J-6
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MTNAJG/M$]0/9.T:V;@C6TN!(.;/&-PR43<#X1DIS=.P!PZM8_ 502P,$%
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M@L:GX[.0F6Z8NPWJQ@_04B.-HU]6]/Z!<0YTOM(:=QL78'A1\W]02P,$%
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M:V5QQORQPJ4&VAG@_48I>Q1<@'Y-YG\!4$L#!!0    (  M!=5B\Y58!ZP,
M $D)   9    >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;+U66V_;-A1^YZ\@
M-&!( 2T22=V<V09R:;$-S1HD[?8P[(&6:)LH):HD%2?[]3VD'-7=$G</PQ C
M(J5SOO-]YR)JOM/FH]T*X?!#JSJ[B+;.]6=)8NNM:+D]U;WHX,E:FY8[V)I-
M8GLC>!.<6I70-"V2ELLN6L[#O1NSG.O!*=F)&X/MT+;</%X(I7>+B$1/-V[E
M9NO\C60Y[_E&W GWH;\QL$LFE$:VHK-2=]B(]2(Z)V<7F;</!K])L;,':^R5
MK+3^Z#<_-XLH]82$$K7S"!PN]^)2*.6!@,:G/68TA?2.A^LG]#=!.VA9<2LN
MM?I=-FZ[B*H(-V+-!^5N]>XGL=>3>[Q:*QO^X]W>-HUP/5BGV[TS,&AE-U[Y
MPSX/_\:![AUHX#T&"BRON./+N=$[;+PUH/E%D!J\@9SL?%'NG(&G$OS<\L9
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M;$KT AW[138MD";MVX+PL8@929((9GG!R*_ ?WVZTG&<1B2.,ICE:48NYO\
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MJT%9 SS?2FGV"^N@[_[)/U!+ P04    "  +0758*NVK\Y8"  !X!0  &0
M 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q]E%UOTS 4AN_]*ZP@H4VJEL]^
MC3;2N@V!Q*#:QKA 7#C):6/-B8/MK.N_Y]AI0T%=;_QYSN/W.'D]VTCUK$L
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MM7]6KCHW_0WOWJ0[IM:\UE3 "E.#B_'0HZKS>3<QLG'>RJ1!I[IAB4\C*!N
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MOMS8XL7/X+VEDC.^5:3&<I4M]SO=*"VQ.WZ<*KB%&YV&,S=FIFJ:P<+%*Z%
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MNC4:?\#M;[2F_<1?T/3_V1]02P,$%     @ "T%U6-;IF&BZ @  > D  !D
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M \H>P/VEE&8_L0F:RU3\#U!+ P04    "  +0758>(JBWEL#  #H"0  &0
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MZLZGW4<8=HL7.J,#Q&Y0%!TI7M0@1B<1OX(0J.1L1TR[4-T*D;S$A*L&(OM
MHP[#Q>$&[ DY4LA10SDZ2=DY//O(1IU][T>M?5^Q=8/>^_XAG=TZYG6+O<5\
M0PJ!**R5S+F,5&Z\:EO51++2G/PK)E4?,<-,=7K@.D"MKYG:G?5$-Y/FOT/\
M%U!+ P04    "  +0758*M9*UOP"  #4"   &0   'AL+W=O<FMS:&5E=',O
M<VAE970U."YX;6RM5FUOFS 0_BL6JZ9.6LM;0EZ6(+5AU?JA4M6LVX=J'QRX
M!*O&SFP3VG\_&P@E"<FJ:5\2^WS/<\\=9XY)P<6S3 $4>LDHDU,K56H]MFT9
MIY!A><G7P/3)DHL,*[T5*UNN!>"D!&74]APGL#-,F!5.2MN]""<\5Y0PN!=(
MYEF&Q>LU4%Y,+=?:&A[(*E7&8(>3-5[!'-3C^E[HG=VP)"0#)@EG2,!R:EVY
MXVAD_$N''P0*V5HCD\F"\V>SN4VFEF,$ 858&0:L_S8P TH-D9;QN^:TFI &
MV%YOV6_*W'4N"RQAQNE/DJAT:@TME, 2YU0]\.(;U/GT#5_,J2Q_45'Y#GP+
MQ;E4/*O!6D%&6/6/7^HZM !N< 3@U0!O'W L@E\#_'U [PB@5P-Z966J5,HZ
M1%CA<")X@83QUFQF41:S1.OT"3./?:Z$/B4:I\);M@&FN" @T?E<-U624T!\
MB<C;P2=T'H'"A.K5!7J<1^C\[!,ZTR[H>\ISB5DB)[;2:@RG'=>1KZO(WI'(
MKH?N.%.I1%]9 LDN@:W3:'+QMKE<>R<9(X@OD>]^1I[C^1V"HO?#O1-R_*:T
M?LGG'^&;42RE+JLN9IP+H:O9+BIZP@NIA.[[7UVUJZA[W=3F73"6:QS#U-*7
M78+8@!5^_. &SI>NO/\3V4X5>DT5>J?8PP=<Z'Y5( BFG5U2P8,2;EY2FW T
MZD_L33N!#A_7;WQV=/4;7?V3NFX((_K:)&C%>7?[5OA^*Z@[[+N[RF:G@SRY
M70\WZF!V^DYW/D&33W R5.LB=R43'(3TAKU@K\S!09G=47"DSH-&U^!=NEY1
M(8B"BX07K$O@X""V[^WK.QGI'_MX:.T91DUBH[\]VUL6TSPA;-7*S5SWLU+Z
M84B[]9[.0*S*>2=1S'.FJLYMK,U(O2HGR9[]VAW/W"Z[-YYU^5\-Q]&PRSZJ
M1[;])J>:]W=8K B3B,)22W,N![IU1#5#JXWBZW*J++C2,ZI<IOJS X1QT.=+
MSM5V8P(T'S+A'U!+ P04    "  +0758V;PI5:4"   N!P  &0   'AL+W=O
M<FMS:&5E=',O<VAE970U.2YX;6RM55UOFS 4_2L6JZ966LM70MHN05H3;>O#
MM*AIMX=I#P[<!*O^8+9)NG\_VU!$"HWZL!>PX9S#.=?F>KH7\E$5 !H],<K5
MS"NT+J]]7V4%,*PN1 G<O-D(R; V4[GU52D!YX[$J!\%0>(S3+B73MVSI4RG
MHM*4<%A*I"K&L/Q[ U3L9U[H/3^X(]M"VP=^.BWQ%E:@'\JE-#._5<D) ZZ(
MX$C"9N9]"J_GB<4[P \">]49(YMD+<2CG=SF,R^PAH!"IJT"-K<=S(%2*V1L
M_&DTO?:3EM@=/ZM_=ME-EC56,!?T)\EU,?,N/93#!E=4WXG]5VCRC*U>)JAR
M5[1OL(&'LDIIP1JR<< (K^_XJ:E#AQ".7B%$#2%Z*R%N"+$+6CMSL198XW0J
MQ1Y)BS9J=N!JX]@F#>%V%5=:FK?$\'3Z71<@T1UD0'9X34&A52&D1O<@&3I=
MF4V35Q20V"#AD+*#5 ZI#?(,G2Y 8T+5&3I'#ZL%.CTY0R>(<'1?B$IAGJNI
MKXU?^U4_:[S=U-ZB5[PM(+M <?@!14$4#]#G;Z='AW3?5*DM5=26*G)Z\2MZ
M]Q+G@$R4IA19)25P?5"27WBMM#1[\_=0W%I_-*QO_]=K5>(,9I[Y(17('7CI
M^W=A$GP<"O^?Q Y*$;>EB(^IIU_$#B1G-CVNM-D&1!,87.%:)W$ZMJ/LTM@N
MQJZ;I(\)K^(6<V!PU!H<'35XRS/!H+LT0^9JC7'7W-7DA;D^)IP$P^;&K;GQ
M47-+"24F.8(GTXN5V37MGAHR.>X9F/0JV,=$EY-ADTEK,CEJLM<8SCN=8<AG
MTE_%T2A\8;0/2L8OJ^EWNID]2;YAN25<(0H;PPHN)B:GK+MS/=&B= UN+;1I
MEVY8F ,-I 68]QLA]//$]LSVB$S_ 5!+ P04    "  +0758/.;N4'@"  "!
M!@  &0   'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6RM55UOVC 4_2M7636U
MTFA" EW5A4@K:%JE3D.%;@_3'DQR(58=.[,=8/]^MI.F4 +JPUZ(/\XY/N<2
MW\0;(9]4CJAA6S"N1EZN=7GC^RK-L2#J4I3(S<Y2R()H,Y4K7Y422>9(!?/#
M(+CR"T*YE\1N;2J36%2:48Y3":HJ"B+_WB(3FY'7]YX7'N@JUW;!3^*2K'"&
M^K&<2C/S6Y6,%L@5%1PD+D?>Y_[->&CQ#O"#XD;MC,$F60CQ9"=WV<@+K"%D
MF&JK0,QCC6-DS H9&W\:3:\]TA)WQ\_J7UQVDV5!%(X%^TDSG8^\:P\R7)**
MZ0>Q^8I-'F<P%4RY7]@TV,"#M%):% W9."@HKY]DV]1AA] ?'"&$#2%\*R%J
M")$+6CMSL29$DR268@/2HHV:';C:.+9)0[G]%V=:FEUJ>#KYKG.4\( ITC59
M,%0]N!=\!7.4!9S/S$N350Q!+$$XI'Q! K- ;8 7<#Y!32A3%]"#Q]D$SL\N
MX PHAWDN*D5XIF)?&[OV4#]MK-W6UL(CUB:87D+4_P!A$$8=]/';Z>$^W3=%
M:BL5MI4*G5YT1&\N289@HC25X(+WTDI*Y'JO*K_(0FEI7L_?79'K,P;=9]@K
M>Z-*DN+(,W=2H5RCE[Q_U[\*/G45X#^)[94C:LL1G5)/[G@J"MQ-WA6WUKAR
M&K:AK)-A$/OKW1"'D/[U"V;/VZ#U-CCI;2JQ)#0#W)IFI[J=U0K#O6.C5]8.
M,4>,#5MCPY/&3MVV+I/#@]J$T6N3AYC#^OD[#<(VYV]$KB@W-QB7AA5<?C0B
MLFYX]42+TO6,A="F [EA;KX1*"W ["^%T,\3VX;:KT[R#U!+ P04    "  +
M0758(JN-,#,*  #@4P  &0   'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6S-
MG%]OX[@1P+^*X!Z*76"SMDB*DK9)@"1[10MT>\%NMWTH^J#8="R<+?DD.;DM
M^N%+R8Y'_#>V9!GPRVZ<#$=#>CB_X9#B]6M>_%HNA*B\WU?+K+P9+:IJ_6D\
M+J<+L4K*C_E:9/(O\[Q8)97\6#R/RW4ADEG3:+4<D\F$CU=)FHUNKYO?/1:W
MU_FF6J:9>"R\<K-:)<6/>[',7V]&_NCM%U_3YT55_V)\>[U.GL4W47U?/Q;R
MTWBO99:N1%:F>>858GXSNO,_/?B32=VB$?EG*E[+UL]>W9>G//^U_O#7V<UH
M4ILDEF):U3H2^=^+>!#+9:U*&O+;3NMH_]"Z8?OG-^U_;GHO>_.4E.(A7_XK
MG56+FU$T\F9BGFR6U=?\]2]BUZ.@UC?-EV7SK_>ZDYV,O.FFK/+5KK&T8)5F
MV_^3WW<CT6K@<T<#LFM ] ;,T8#N&M"FHUO+FFY]3JKD]KK(7[VBEI;:ZA^:
ML6E:R]ZD6?T]?JL*^==4MJMN'POI$D7UXX/WN$RRRKO+9M[/OVW2M?RNJ@_>
MWZ4GO?LFG6>V60HOGWOKO?RZD4^DO #Y3%3OO7>?196DR_*]=^5]__;9>_?3
M>^\G+\V\?RSR32E;E-?C2MI>6S">[NR\W]I)'';ZQ/N29]6B]'[.9F*F*AC+
M3N][3MYZ?D]0C9_%]*-'_0\>F1!J,>CA^.8$,8?NOPC:Z*,N?6DY7>;EIFB&
M>=:,H)C)4=O.U<;EG^1$Q+\![]^U7B^MQ*K\CVV4MT8PNQ%UT/A4KI.IN!G)
MJ%"*XD6,;O_X!Y]/_F0;H8&4*>/%]N/%,.VW]XGL_538^KAMR)N&=1Q[N264
M\^OQ2]MV5'M/VX.][4%?V[<-@Y;M,2&19GN =U"QB>]MXJA-#WDIO>>+6#V)
MPNHY:/.NGC.0,J6GX;ZGX27,M'#(\1I(F3)>T7Z\HK[>&AG>&D4DUKS5(D0I
MLWMKO+<I1FVZF\W2^INRDB0V'ABR,-"L,H6"(+ ;Y4\ IA/4+.E:Z[Q,EG;
MH6V[>L1.6[L#5T'LZ$ K&_#Q*)"LTRI9IO_=SH-F?DAKING^\]=?OGM)68K*
MWD??'%;='W 3>CJS3Z"+!.VBS/YD;I?)Y*HH1#;]X55%DI7+IH/6+A&C2[[>
M(U/DRG=\%9 /^"@^L6FW:ZF8Q"EGNEFFF#(]5<, O#Y.7H44WO^\7^;S="J\
M^:;(TJJ.JAA%<-V=)\$Y*.X#QOW@$DCBH]E$YS$;2)LZ9I!F^'B>@;DU-_R5
MQ%1W:HM0$#I\&E("'R4HSI-=6_61NEFF#'59!>#U<?+B.$';=O8*D](3A_G
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MNB!5LIO)!MG/-41&P[JR6X*59.\7LO>-/MXGT8QPP!9@D^_  (T!*S8?:22
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MEA<&ZOL-Y_+YHGA _3K0ZC]02P,$%     @ "T%U6#UCB\O]!@  2RX  !D
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MI8'Z?9%E\N&BO$%[?GSZ/U!+ P04    "  +0758)>(3W^$#  !V$@  &0
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M6PZO+8=G]/PC>O<<IX"4E0/SZ!=>"LG5HOO=Y[$6#?I%]4:\$B5.8&*IG2:
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MJXEWTN6P[TC,R@PC _4H//6:I 5']4=L]->F8O#?W+P#*T$TY+U,C9Q+H*\
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M]/M+SM6/D^+)=_U+A]E_4$L#!!0    (  M!=5C^RK,300(  ,$$   9
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M_QAPP8'.5];BT0@7='^M_"]02P,$%     @ "T%U6+58')NH!@  NBX  !D
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M!L>K*U'5D:PP)_*"276^FV:J;I&8ZP#U?LF8?._H0[ZYET;_ 5!+ P04
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MIBA-#YVFIC[:\V3NKRUU<3$_R_+RTH?5+#^W[I:LBLT*UV:EJXRCV\5Z5NU
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MEE<W*/__8K5:W_]0#?!UE?^UN3NG_P]02P,$%     @ "T%U6,]/)*#_ P
M-A4  !D   !X;"]W;W)K<VAE971S+W-H965T-SDN>&ULS5A-;^,V$/TKA+HH
M$F W^K1LI[:!M;7;[B% $'?;PZ('6AI;0B32)6D[VU]?DE)DR9:%&. AEUB4
M9IYFWLQ3R)D<*'OF*8! +T5.^-1*A=C>VS:/4R@POZ-;(/+)FK(""[ED&YMO
M&>!$.Q6Y[3E.:!<X(]9LHN\]LMF$[D2>$7ADB.^* K.?<\CI86JYUNN-IVR3
M"G7#GDVV> -+$-^WCTRN[!HER0H@/*,$,5A/K<_N?>2&RD%;_)7!@3>ND4IE
M1>FS6GQ+II:C(H(<8J$@L/S9PP+R7"')./ZM0*WZG<JQ>?V*_E4G+Y-980X+
MFO^=)2*=6B,+);#&NUP\T<,?4"4T4'@QS;G^BPZ5K6.A>,<%+2IG&4&1D?(7
MOU1$-!QDHMT.7N7@G3H$%QS\RL%_JT-0.02:F3(5S4.$!9Y-&#T@IJPEFKK0
M9&IOF7Y&5-V7@LFGF?03LV6*&7R:2^82M*"%;">.=4%NEK+%DET.B*[1EQ?U
M - 3Q'1#LO\@N44W$0B<Y?P6?4+?EQ&Z^7"+/J",H#]3NN.8)'QB"QFA>H\=
M5]',RVB\"]&X'GJ@1*0<?2$))&T 6Z96Y^>]YC?W>A$CB.^0[WY$GN/Y'0$M
MWN[N=;A';W=W>[+QZVKY&L^_A)?Q.*=\QW15!+""(\DTBBE),E4VKNYS7=.5
MKND6_Y0J%0@SALD&]/4/!8LR 07_IZM&90Q!=PSJ0W3/MSB&J26_-!S8'JS9
MK[^XH?-;%[\FP2)#8"WN@YK[H ^]4DK):MQ02A>#)5*HD=27=S]SQX$SL?=-
M9CJ-PK91U&$4#OW:J)7)H,YDT)O)@G*A^H3!'L@../KQ ,4*6&<S]$)=VPPF
MP2)#8"T*PYK"\!T(,33)O4FPR!!8B_MAS?W0F!!+I$%#/M[0/='AN8T["DYD
MV&$SN*#"49W&J#>-)TD,9G&J^R:14LSIMNR*'C7V0E[;$2;!(D-@+2K'-97C
M=Z#&L4GN38)%AL!:W+O.<0?I&--C!=444C :G BRR\@Y_<?88>3[%R3I-G;#
M;G\N\@"2D8WN'GD.>@:A5GV*[ >\MBV,HD6FT-ID>D<RO7<@RRH(4P4PB1:9
M0FL7X'A:<'LWQ-<ITS_3TVAX*LQSF\ [U>6YC7-!E<>=M]N_]?X="#"<Z^;!
MB3P%9UPPK 8&_=+L1;VZ,TRB1:;0VHP>3P#NX#U(T^CAP2A:9 JM78#C^<'M
MW2)?)\WP_!#HC,_$V6'ENZ<;V2XKMR'T,AV[,5 J@&WT8([+0'=$E+.7^FX]
M_/NL1UXG]^=J**@'54>8<J+X@-DFDVV6PUI".G=#60]6#NG*A:!;/;9:42%H
MH2]3P DP92"?KRD5KPOU@GI4.OL?4$L#!!0    (  M!=5CR/=U?5 4  -,8
M   9    >&PO=V]R:W-H965T<R]S:&5E=#@P+GAM;+596V_;-AC]*X0W;"VP
M2B*I:V8;2*SN\I U2-#VH=@#;=.V4%T\DHX38#]^I*1(ED1)3NN]Q+H<'O)\
MY,?O4)D>,_:5[R@5X"F)4SZ;[(387YDF7^UH0KB1[6DJWVPREA A;]G6Y'M&
MR3IOE,0FLBS73$B43N;3_-D=FT^S@XBCE-XQP ])0MCS#8VSXVP")R\/[J/M
M3J@'YGRZ)UOZ0,7'_1V3=V;%LHX2FO(H2P&CF]GD&EZ%"*L&.>)31(_\Y!HH
M*<LL^ZIN_ES/)I8:$8WI2B@*(G\>Z8+&L6*2X_BG))U4?:J&I]<O[+_EXJ68
M)>%TD<6?H[78S2;^!*SIAAQB<9\=_Z"E($?QK;*8YW_!L<!Z: )6!RZRI&PL
M1Y!$:?%+GLI G#3 ?0U0V0"=VP"7#?"Y#>RR@9U'II"2QR$D@LRG+#L"IM"2
M35WDP<Q;2_E1JN;]03#Y-I+MQ/QA1QA]=R,CMP:++)'+B9-\0MX\R"6V/L04
M9!N0H\"'O7K#P;6:JT@\OP5O0BI(%/.W4U/(P2A*<U5V?%-TC'HZA@C<9JG8
M<? ^7=-UD\"4*BHIZ$7*#1ID#.G* !C^ I"%,.!JR!S\",SR4C/$Q?F$Z"S"
M\'Q".$;8B &NIA/G/>">'OXZ)$O*P)?K)1=,YM3?NHDI*&P]A=IHKOB>K.AL
M(G<23MDCG<Q_^@&ZUJ^Z$%Z2++P062-T=A4Z>XA]_N$@N"#I.DJWU4HG BSI
M-DI3]5#FP3,E3!?1@MG)F=5.^SCW7-MSO:GY>!JK+LS!'O+])BS4P" ./%S!
M&OJ<2I\SJ*]<&E)%OMI 5FK<,I(*F?U16KQXM\PW@SUYEMN[ (3)]UNJKG7*
MG<Y8L>T&CM52KH$AR_.<EO(NS)'"+;UPMQ+N#D]L+O1GN=$\4;:*>'NS*82X
MG:[;&KJ(=[[5FN)0 W*PJQ?@50*\\P3(2K>AD9HLN4[-C 'ZM(^87H_7'0AT
M;(3;JC2X -E^T-*E@6$+PD"OS*^4^6?GW,MZE+<J[ZC\&<@XOS.>P/%LOYUQ
M79@N,<,NK)68#75!I2YXU<(C2UE-QZ4%G<'8+K+L5JXLNC#L8=>'+6D:&,8N
M[)$&K=HW6(.5YG/NJ.12O'ZD3#K$*KO '8M6=*0$E>07JD$790LOQ=8,[(DA
M@Q>I0^#?82]R4_;CGTZ]9=AV:QUI8+9MM)=;J(,YAN_TK"-4RT7G)<GO91T:
ME57PP=,E#:'127TMSC901Y@&ASW#03W*:BL&!^V*INZ,:\.C5:B$-&4A ^&V
M+ T.60;LJ46PMDEPQ">-5:-QE79W:(Z,>'N'T^(<PVG[)2W.-0+8([5V3'#8
M,IU7GL;U.IHI"PS<R40-3I.QH0[73-FFWMHHP=<Y)4W!&A?K=O8)Y':R;J&!
MV:X!.U/;A3F^@?NJ5^VHX+"ENJ>R.$4KM7@?BF/8QS02''RYI<HEZVO6(.6K
M:]8EV<)+L37#6=LXZ'__L1,.>L%7Q^^2;.&EV)KQJXTB''&*WW'VA!J_B"R(
MVPG7A4';Z=A%'<QRG9ZM!=5V$0VZIO_I]%EVVC@&0*M=,C4H'"#?;4G7P/P@
MZ+$!J/9S:,3/?<OIK>1L'LMLV!:F0:'VV48+@GT36OLV=*9O^R2WTAX12',&
M]>QV_5YH<=#O*M'@;-_I*?.H-FIHQ*A]\RD4=?T:1AYL%W8-3).BH0;63-%"
MGWGRM3>A;)M_->=@E1U247PMK9Y67^:O\^_1K><W\"HLOJ_7-,7G_EO"Y,[#
M04PWDM(R/#DF5GQ!+VY$ML^_*2\S(;(DO]Q1LJ9, >3[39:)EQO50?5_C/E_
M4$L#!!0    (  M!=5ANV6N0A@<  &-+   9    >&PO=V]R:W-H965T<R]S
M:&5E=#@Q+GAM;,V<6V_;-AB&_PKA#4,+++)(ZI@E!IJ(PWK1M6BP]:+8A6(S
ML5#)\B0Y:8']^%$'BZ9DTQ+P"7 O&A_(AX?W$P^O:-V\IMFW?,UY@;XG\2:_
MG:V+8GL]G^?+-4_"W$BW?".^>4JS)"S$V^QYGF\S'JZJ3$D\)Z;IS),PVLP6
M-]5GG[+%3;HKXFC#/V4HWR5)F/VXXW'Z>CO#L_T'GZ/G=5%^,%_<;,-G_L"+
MO[:?,O%NWE)64<(W>91N4,:?;F?O\#6SG#)#E>+OB+_F!Z]1V93'-/U6OGF_
MNIV998UXS)=%B0C%GQ=^S^.X)(EZ_-M 9VV99<;#UWOZ[U7C16,>PYS?I_&7
M:%6L;V?>#*WX4[B+B\_IZQ^\:9!=\I9IG%?_H]<FK3E#RUU>I$F36=0@B3;U
MW_![TQ$'&2@YD8$T&<C0#+3)0(=FL)H,UM ,=I.A:OJ\;GO5<4%8A(N;+'U%
M69E:T,H75>]7N45_19LR4!Z*3'P;B7S%XF$=9OSJ3G3U"MVGB8B_/*P4?/,@
M8G*UBSE*G]#[31V2Y1?O'D6\H2H?^K@M/\K1QUV1%^%F%6V>WZ(W 2_"*,[?
MWLP+4<.RG/FRJ<U=71MRHC:8H _IIECGB&U6?*4"YJ)I;?O(OGUW1$L,^-)
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M"S?XPTG1Z\VO]_I*C!8 DL:@:*H 1 I M )@;'C^%1;+#:)= >@Q8V<'4%H
M2F-0-%40N2'&E[XCQJ!;8E!: $IC4#15:KDMQI#[8GQDQXLQ)KW!3EOHZ Z'
MI#$HFMKA<CN.)]V/GZ&[O24!,4^O"2 WT@$HC4'15)7DQAQ/NS-O\.4?N3>G
M!NE>)]I:C%8 DL:@:*H"TA/ >E. .(;G75'7L,\L"D!] 5!: $IC4#15$.D-
MX$LW!S"H.P!*"T!I#(JF2BT= @QI$>"^1X");5.[.]B!N@2@- 9%4^_J29^
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M@9X^5H S=27#?\$0@%:,0=%4D:1+8$WK$NCQHU7JGTQPJ.%W%\Z@A3(HFJJ
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M$,L/Y"( 19E>79)WQ"92/T=.;(4VZR?;86'?/+?/.V&?ZR%DJM:2W*411%4
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M.!#]E8&V721 &UU\B[.V@3AJ=P-LMD&2[CX4^T!+(XNH1&I).D[^?DE)4:Q
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M-M';25'=,U0-Q8ORY+WB2I_CR]<428S"#-#?$\[52\-,T-SV+/X'4$L#!!0
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M;M9%<=%&$3P1A1^0*\%UH<A'GD.^3^"B)+TNP8,N%\%1QA2R$Q+Z[TC@!>&
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MT];_Z863(Z[7*.OL.'W/V?$]R9;O1'86.^AV_87[?\PPS5?.<N]%6GU80/H
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MQNI*3-T0M-2EAE<J!,WU[1[(!I@RD,^WE(JWAAJ@K8>M_@502P,$%     @
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MNF%N7C:4-L#L9T+HS<0>T+Z5\2]02P,$%     @ "T%U6*(&Q+^L @  ]@@
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MYS)0V>#-+MM,)"O-1K5@4FU[9IBI@PEP7:">IXS)UXG>^[JC3O0'4$L#!!0
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MOMT?3K<&8O=+A =[Z6:0";R]=#/(C(ZDFXNW"\!G)YR*A0<H!4%_PHL\^G)
M-_*\\%&DP(P+PP<%  ?[_8U!R!_L-S@FH>#JR-I4*]R=V?9L[NFF3;8@\S7+
MRF5]1! I T"%+C)<ITL*:$$)BU%*G@'ED A]9*+E1JPK51$NLVF5RP"++]&-
MT*] *23:PCL](:B0T5%K-"B1S,>,*^*E9"+/YALO+F4WLW41(U%1LX-R$+<-
M204RW5M'3)%M[QPQ"V!+?1G I1_K4M0M4#O;7CC<Z&/VWOQ,7428YO'UK4E^
MCJ_?F^9O7$\"><8W_N:NP]ZZ6M^4W!&VS&0I4SLSL9S+H<P&5E\^U -!5_JP
MO*!"'KWU8PHD!J8$Y/N$4K$9* /M%=#T?U!+ P04    "  +0758:VR !0$#
M  "4"@  &0   'AL+W=O<FMS:&5E=',O<VAE970Y.2YX;6R]5EUOVC 4_2M7
M636UTM:0\+D.(I5FTZ:I&BKM^E#MP20WQ)H39[:!]M_/=D(&-*!60WLAMG//
ML<^Y7.<.5US\DBFB@L>,Y7+DI$H5%ZXKHQ0S(L]Y@;E^DW"1$:6G8N[*0B")
M+2ACKM]J]=R,T-P)AG9M(H(A7RA&<YP(D(LL(^)IC(RO1H[GK!=NZ#Q59L$-
MA@69XQ3573$1>N;6+#'-,)>4YR P&3F7WD78-_$VX ?%E=P8@U$RX_R7F7R-
M1T[+' @91LHP$/U8XA4R9HCT,7Y7G$Z]I0%NCM?LGZUVK65&)%YQ=D]CE8Z<
M@0,Q)F3!U U??<%*3]?P19Q)^PNK*K;E0+20BF<56)\@HWGY)(^5#QL K[<'
MX%< ?Q?0V0-H5X#V2P&="M"QSI12K \A4208"KX"8:(UFQE8,RU:RZ>Y2?M4
M"?V6:IP*QH21/$())(_A5I!<$IL0"?=4I7"#C"B,84*$HE74-WR"[TE"(Q02
M3J?ZCQ@O& )/H";3XZTH/5<IPA7/"I(_G<%IB(I0)L_@/=Q-0S@].8,3H#G<
MIGPA]29RZ"JMSIS1C2HEXU*)OT>)Y\,USU4JX5,>8[Q-X&I;:F_\M3=C_R!C
MB-$YM+UWX+?\=L.!KEX.]QO@X<OAW@$U[3K3;<O7WL='9<2X7 B;*K69ZAFJ
M%:(IXS+;197M!\,!5&$F?S8EI-RPT[RAN; N9$$B'#GZ1I(HEN@$;]]XO=;'
M)C./218>B6S+Z$YM=.<0>S 1/$%I[D7"($%L<JYDZ%D&<S,O ]\;?!BZRTU'
M&H*ZNT%A0U!GT*J#MA1T:P7=@PHV:A<>KC&;H6C,_T&6U^;_F&3AD<BVW.O5
M[O7^=Z'UCFGT,<G"(Y%M&=VOC>[_<Z'UGY5'UQOLU-GSF'ZWLU-F!T_R6IWN
MQO<Z0S&W?8^$B"]R57Z>ZM6ZM;JT'<7.^EBW7&6'])>F[->NB9A3_8]CF&C*
MUGE?5X0H>Z!RHGAANX(95[K'L,-4MXTH3(!^GW"NUA.S0=V(!G\ 4$L#!!0
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M]@?7$S-SV[_<E@/[/15+AJ=P# L,P6GUL/1%.027"\4S,^7-N<*9T5Q&^-T
M0@/P_H)SM5EH!_67R.A_4$L#!!0    (  M!=5C8&YW':0<  !-+   :
M>&PO=V]R:W-H965T<R]S:&5E=#$P,2YX;6S%W&EOTT@<!O"O,@H(@02)CUPM
M;:2VOKT%1(%]@?:%FTP:+S["C-."Q(??\1$G3IUI@IX5;YJCGM_,Q'YJ._[7
M9P\I^\87E&;D1QPE_+RSR++E::_'IPL:![R;+FDB?C-/61QDXB6[Z_$EH\&L
M:!1'/4U1AKTX")/.Y*QX[P.;G*6K+ H3^H$1OHKC@/V\I%'Z<-Y1.^LW/H9W
MBRQ_HS<Y6P9W](9FGY<?F'C5JY59&-.$AVE"&)V?=R[44U_3\@;%$E]"^L"W
MGI-\*K=I^BU_X<[..TH^(AK1:983@7BXIU<TBG))C.-[A7;J/O.&V\_7NE5,
M7DSF-N#T*HW^#F?9XKPS[I 9G0>K*/N8/CBTFM @]Z9IQ(N?Y*%:5NF0Z8IG
M:5PU%B.(PZ1\#'Y4'\16 UW;TT"K&F@[#31U3P.]:J ?VD._:M _M(=!U6"P
MVV"PI\&P:C#<;;!O2*.JP>C0!N.JP7BG@=K?T^"D:G"RVV"T;\4IZS6G'#IM
MM5[9Y497;B7%)F8$63 Y8^D#8?GRPLN?%-MIT5YL66&21^HF8^*WH6B736Y6
MMYQ^7]$D(_1>_.3DY;N L2#?T%^1EP;-@C#BK\B+9V-]J+TE/<(7 :.<A GY
MG(09?TV>M[\IGG]:I"L>)#-^ULO$6/,>>]-J7%8Y+FW/N%1RG2;9@A,SF=%9
MLWU/S+&>J+:>Z*4F!:\#UB7*\#71%*V_/>;RH66$5W+0HK<"'!6@OE\QY,H-
M77:)5@Y+>_PI[V7-0V8[JMB]BG7 %+7'GUF+9,LE+TBZ1%<KR?WKAKRLYOJJ
M!7..P3[?&.3E\S;&/6!VZJ!<@2W-O0-&H:Q'$;]XIH[&;UL87\X8=%I/1G^T
M 4@V?+U.N%YTH._K(.33*.4K1DDZ)TF:O EF_XH_+6%RMXY\,,\H$SO(9<J*
MMY>4A>F,?,TI$F8TYO^T3.RR[+??WF]^+'#*E\&4GG?$SIY3=D\[$_$I#96V
M3^D*B1E(S$1B%A*SD9B#Q%PDYB$Q'X0UHMBOH]B7Z9-WJ_A6!$W$<)K&L3B@
M7.\V.5_M[N3*B$F]8R-68H,"RP^U[R?JR;"OC8=GO?OM]+0LIXPU+?\CN;V<
M^7BY4;^O],?-Q2SD'&PDYB Q%XEY2,P'88U-?E!O\@/I)F_^H&P:<DJ6+)P6
M>Z"'_/ RW^O\>F)O5R9 RA^; "1FE)C:W\Z)WNV/!CLQ079J(3$;B3E(S$5B
M'A+SJ[6N;ZUUI:LHZD!7M7K%-Z(RK*,RE$<E7D;I3TK%V=/[^5RDA8EGEVG
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M+PC,"&!F!9Z'(; :<013 !HPQ//R]^#>^\@IWU-._:^/R5]02P,$%     @
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MT_E<%_G4J>9'>Z\@C)HWI!:;HCBG<Y_*RTK/=_\"8??O&][\!U!+ P04
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M5>\,T#NKWAF@=U:],T#OK'IG@-Y9]<X O;/JG0%Z9]4[ _3.JG<&Z)VKS=X
MO;/JG0%Z%]6[ /0NJG<!Z%U4[P+0NZC>!:!W4;T+0.^B>A> WD7U+@"]B^I=
M 'H7U;L ]"[581V WJ:KC^L _#9==6"G^T[!Q^ESWX^WHJ]U%?"=7D^7S_:W
M[[\NOR[6M^%*='N?,3[]!5!+ P04    "  +0758?^!#S%L"  !-.0  $P
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M<',O87!P+GAM;%!+ 0(4 Q0    (  M!=5B1B\-M[@   "L"   1
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M965T,BYX;6Q02P$"% ,4    "  +0758J%3QL*D"  !V!P  &
M    @('B%0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @
M"T%U6-2ETP/#!@  X1X  !@              ("!P1@  'AL+W=O<FMS:&5E
M=',O<VAE970T+GAM;%!+ 0(4 Q0    (  M!=5@H6QA4* 8  +\?   8
M          " @;H?  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M    "  +0758F;R4CSD)  #/+   &               @($8)@  >&PO=V]R
M:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ "T%U6$-<Q-;3"@  -QD
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M:&5E=#$Q+GAM;%!+ 0(4 Q0    (  M!=5ANZ]^$B0(  (H%   9
M      " @1-C  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%
M  @ "T%U6!2ZI<5= @  % 4  !D              ("!TV4  'AL+W=O<FMS
M:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    "  +0758MQ(.PVP"  !O!0
M&0              @(%G:   >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+
M 0(4 Q0    (  M!=5BK*4=W3P(  $,%   9              " @0IK  !X
M;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ "T%U6'VO=4#E
M P  8 D  !D              ("!D&T  'AL+W=O<FMS:&5E=',O<VAE970Q
M-BYX;6Q02P$"% ,4    "  +0758LW*K62<'  !Y$@  &0
M@(&L<0  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (  M!
M=5AI<\!U30,  $<'   9              " @0IY  !X;"]W;W)K<VAE971S
M+W-H965T,3@N>&UL4$L! A0#%     @ "T%U6#EL'%^. @  >P4  !D
M         ("!CGP  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
M    "  +0758\7=N)60#  !L!P  &0              @(%3?P  >&PO=V]R
M:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    (  M!=5AZD\4#*0H  'T:
M   9              " @>Z"  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL
M4$L! A0#%     @ "T%U6";:4-60!   70L  !D              ("!3HT
M 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    "  +0758208^
M<XH&  #R#@  &0              @($5D@  >&PO=V]R:W-H965T<R]S:&5E
M=#(S+GAM;%!+ 0(4 Q0    (  M!=5@1T7T T@8  $40   9
M  " @=:8  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @
M"T%U6!ODO5*K"P  <B$  !D              ("!WY\  'AL+W=O<FMS:&5E
M=',O<VAE970R-2YX;6Q02P$"% ,4    "  +07581SQD_UH,  "8)0  &0
M            @('!JP  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4
M Q0    (  M!=5B[JWE0U 8  -00   9              " @5*X  !X;"]W
M;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ "T%U6"+84S"W!P
MZQ,  !D              ("!7;\  'AL+W=O<FMS:&5E=',O<VAE970R."YX
M;6Q02P$"% ,4    "  +0758;BNR"GX#  #-"   &0              @(%+
MQP  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    (  M!=5@Q
MYEBO3 4  +8,   9              " @0#+  !X;"]W;W)K<VAE971S+W-H
M965T,S N>&UL4$L! A0#%     @ "T%U6-8$"%9< P  #P<  !D
M     ("!@]   'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  M!=5C&D$6!D0(  (4%   9              "
M@7_W  !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ "T%U
M6/1R"!MD @  %04  !D              ("!1_H  'AL+W=O<FMS:&5E=',O
M<VAE970S-RYX;6Q02P$"% ,4    "  +0758#51V5G8"  !=!0  &0
M        @('B_   >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0
M   (  M!=5C.[(LF7@(  #(%   9              " @8__  !X;"]W;W)K
M<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ "T%U6+SE5@'K P  20D
M !D              ("!) (! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q0
M2P$"% ,4    "  +0758I46*KD0%  #F#@  &0              @(%&!@$
M>&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    (  M!=5B2V!L*
MGP(   D&   9              " @<$+ 0!X;"]W;W)K<VAE971S+W-H965T
M-#(N>&UL4$L! A0#%     @ "T%U6"KMJ_.6 @  > 4  !D
M ("!EPX! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    "  +
M0758KYR$N< "  #_!0  &0              @(%D$0$ >&PO=V]R:W-H965T
M<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    (  M!=5@T(Q54]@,  /T)   9
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M970T.2YX;6Q02P$"% ,4    "  +0758HH$ 4\X$  !3#   &0
M    @(%Y*P$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    (
M  M!=5AX\7MN^00  *X>   9              " @7XP 0!X;"]W;W)K<VAE
M971S+W-H965T-3$N>&UL4$L! A0#%     @ "T%U6&&9#=[< P  N0X  !D
M             ("!KC4! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"
M% ,4    "  +0758A<!-AZX"   +"   &0              @('!.0$ >&PO
M=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    (  M!=5C6Z9AHN@(
M '@)   9              " @:8\ 0!X;"]W;W)K<VAE971S+W-H965T-30N
M>&UL4$L! A0#%     @ "T%U6)DT<%O1 @  6 D  !D              ("!
MES\! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    "  +0758
M>(JBWEL#  #H"0  &0              @(&?0@$ >&PO=V]R:W-H965T<R]S
M:&5E=#4V+GAM;%!+ 0(4 Q0    (  M!=5@@#Z4,U@(  $<(   9
M      " @3%& 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%
M  @ "T%U6"K62M;\ @  U @  !D              ("!/DD! 'AL+W=O<FMS
M:&5E=',O<VAE970U."YX;6Q02P$"% ,4    "  +0758V;PI5:4"   N!P
M&0              @(%Q3 $ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+
M 0(4 Q0    (  M!=5@\YNY0> (  ($&   9              " @4U/ 0!X
M;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ "T%U6"*KC3 S
M"@  X%,  !D              ("!_%$! 'AL+W=O<FMS:&5E=',O<VAE970V
M,2YX;6Q02P$"% ,4    "  +0758URY@H ,%   R(   &0
M@(%F7 $ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    (  M!
M=5A?@6=KJ0(  /\&   9              " @:!A 0!X;"]W;W)K<VAE971S
M+W-H965T-C,N>&UL4$L! A0#%     @ "T%U6&19I8XJ!@  &B0  !D
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M=#8X+GAM;%!+ 0(4 Q0    (  M!=5CP!*XD.P,  $L)   9
M  " @<5[ 0!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @
M"T%U6*P4YGAN P  ' T  !D              ("!-W\! 'AL+W=O<FMS:&5E
M=',O<VAE970W,"YX;6Q02P$"% ,4    "  +0758\9#PPW,#  "G#@  &0
M            @('<@@$ >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4
M Q0    (  M!=5BM07/BB 4  /4@   9              " @8:& 0!X;"]W
M;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ "T%U6/[*LQ-! @
MP00  !D              ("!18P! 'AL+W=O<FMS:&5E=',O<VAE970W,RYX
M;6Q02P$"% ,4    "  +0758M5@<FZ@&  "Z+@  &0              @(&]
MC@$ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    (  M!=5B%
MJ@1&C @   9>   9              " @9R5 0!X;"]W;W)K<VAE971S+W-H
M965T-S4N>&UL4$L! A0#%     @ "T%U6)AKHQC]$   @ ,! !D
M     ("!7YX! 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  M!=5ANV6N0A@<  &-+   9              "
M@3W0 0!X;"]W;W)K<VAE971S+W-H965T.#$N>&UL4$L! A0#%     @ "T%U
M6#M>O7 >!   3A(  !D              ("!^M<! 'AL+W=O<FMS:&5E=',O
M<VAE970X,BYX;6Q02P$"% ,4    "  +0758E]AZ3=T#  #Y$0  &0
M        @(%/W $ >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4 Q0
M   (  M!=5B-%J2S.00  "$7   9              " @6/@ 0!X;"]W;W)K
M<VAE971S+W-H965T.#0N>&UL4$L! A0#%     @ "T%U6)?-O:A[ P  #PX
M !D              ("!T^0! 'AL+W=O<FMS:&5E=',O<VAE970X-2YX;6Q0
M2P$"% ,4    "  +0758M'WY0O\#   H#   &0              @(&%Z $
M>&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0    (  M!=5CT3IX_
M'0,  *X(   9              " @;OL 0!X;"]W;W)K<VAE971S+W-H965T
M.#<N>&UL4$L! A0#%     @ "T%U6"QK#F@E P  7@D  !D
M ("!#_ ! 'AL+W=O<FMS:&5E=',O<VAE970X."YX;6Q02P$"% ,4    "  +
M0758C%<<[D8$  #&#   &0              @(%K\P$ >&PO=V]R:W-H965T
M<R]S:&5E=#@Y+GAM;%!+ 0(4 Q0    (  M!=5B'<A09N0,  #D+   9
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M970Y-"YX;6Q02P$"% ,4    "  +0758BV*\59,"  #5!@  &0
M    @(&D"P( >&PO=V]R:W-H965T<R]S:&5E=#DU+GAM;%!+ 0(4 Q0    (
M  M!=5B0!E/4M@(  #<'   9              " @6X. @!X;"]W;W)K<VAE
M971S+W-H965T.38N>&UL4$L! A0#%     @ "T%U6*(&Q+^L @  ]@@  !D
M             ("!6Q$" 'AL+W=O<FMS:&5E=',O<VAE970Y-RYX;6Q02P$"
M% ,4    "  +0758#CN,5$T$   .$@  &0              @($^% ( >&PO
M=V]R:W-H965T<R]S:&5E=#DX+GAM;%!+ 0(4 Q0    (  M!=5AK;( % 0,
M )0*   9              " @<(8 @!X;"]W;W)K<VAE971S+W-H965T.3DN
M>&UL4$L! A0#%     @ "T%U6/?W#RYO!   E0P  !H              ("!
M^AL" 'AL+W=O<FMS:&5E=',O<VAE970Q,# N>&UL4$L! A0#%     @ "T%U
M6-@;G<=I!P  $TL  !H              ("!H2 " 'AL+W=O<FMS:&5E=',O
M<VAE970Q,#$N>&UL4$L! A0#%     @ "T%U6*<:?_*( P  !QD   T
M         ( !0B@" 'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  +0758EXJ[
M',     3 @  "P              @ 'U*P( 7W)E;',O+G)E;'-02P$"% ,4
M    "  +0758A&]#&]4&  !"0@  #P              @ '>+ ( >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ "T%U6&/$$4K= @  7#L  !H
M     ( !X#," 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ "T%U6'_@0\Q; @  33D  !,              ( !]38" %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&     &T ;0#T'0  @3D"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>321</ContextCount>
  <ElementCount>428</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>83</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002 - Statement - Consolidated Statements of Financial Position</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Statements of Financial Position</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0003 - Statement - Consolidated Statements of Financial Position (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Statements of Financial Position (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0004 - Statement - Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0005 - Statement - Consolidated Statements of Changes in Shareholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity</Role>
      <ShortName>Consolidated Statements of Changes in Shareholders' Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0007 - Disclosure - General</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/General</Role>
      <ShortName>General</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0008 - Disclosure - Basis of Preparation of the Consolidated Financial Statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SignificantAccountingJudgmentsEstimatesAndAssumptionsUsedInPreparationOfFinancialStatements</Role>
      <ShortName>Basis of Preparation of the Consolidated Financial Statements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0009 - Disclosure - Material Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Material Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0010 - Disclosure - Cash And Cash Equivalents</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/CashAndCashEquivalents</Role>
      <ShortName>Cash And Cash Equivalents</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0011 - Disclosure - Short-term and restricted bank deposits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/Short-termBankDeposits</Role>
      <ShortName>Short-term and restricted bank deposits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0012 - Disclosure - Trade Receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/TradeReceivables</Role>
      <ShortName>Trade Receivables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0013 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0014 - Disclosure - Other Receivables Short Term</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/OtherReceivables</Role>
      <ShortName>Other Receivables Short Term</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0015 - Disclosure - Other Receivables- Long Term</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/OtherReceivablesLongTerm</Role>
      <ShortName>Other Receivables- Long Term</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0016 - Disclosure - Property, Plant And Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/PropertyPlantAndEquipmentNet</Role>
      <ShortName>Property, Plant And Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0017 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0018 - Disclosure - Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/IntangibleAssetsNet</Role>
      <ShortName>Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0019 - Disclosure - Other Payables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/OtherPayables</Role>
      <ShortName>Other Payables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0020 - Disclosure - Liabilities in Respect of IIA Grants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/LiabilitiesInRespectOfIiaGrants</Role>
      <ShortName>Liabilities in Respect of IIA Grants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0021 - Disclosure - Financial  Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/FinancialInstruments</Role>
      <ShortName>Financial  Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0022 - Disclosure - Severance Pay Liability, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SeverancePayLiabiltyNet</Role>
      <ShortName>Severance Pay Liability, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0023 - Disclosure - Liabilities and Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/ContingentLiabilitiesAndCommitments</Role>
      <ShortName>Liabilities and Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0024 - Disclosure - Materials Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/MaterialAgreements</Role>
      <ShortName>Materials Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0025 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/Equity</Role>
      <ShortName>Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0026 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/Share-basedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0027 - Disclosure - Income Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/TaxesOnIncome</Role>
      <ShortName>Income Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0028 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLost</Role>
      <ShortName>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0029 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/NetProfitLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0030 - Disclosure - Balances and Transactions With Related Parties and Key Officers</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficers</Role>
      <ShortName>Balances and Transactions With Related Parties and Key Officers</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0031 - Disclosure - Subsiquents events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SubsequentEvents</Role>
      <ShortName>Subsiquents events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0032 - Disclosure - Material Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Material Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://mediwound.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0033 - Disclosure - Material Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Material Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mediwound.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0034 - Disclosure - Cash And Cash Equivalents (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/CashAndCashEquivalentsTables</Role>
      <ShortName>Cash And Cash Equivalents (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mediwound.com/role/CashAndCashEquivalents</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0035 - Disclosure - Short-term and restricted bank deposits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/Short-termBankDepositsTables</Role>
      <ShortName>Short-term and restricted bank deposits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mediwound.com/role/Short-termBankDeposits</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0036 - Disclosure - Trade Receivables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/TradeReceivablesTables</Role>
      <ShortName>Trade Receivables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mediwound.com/role/TradeReceivables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0037 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mediwound.com/role/Inventories</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0038 - Disclosure - Other Receivables Short Term (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/OtherReceivablesTables</Role>
      <ShortName>Other Receivables Short Term (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mediwound.com/role/OtherReceivables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0039 - Disclosure - Other Receivables- Long Term (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/OtherReceivablesLongTermTables</Role>
      <ShortName>Other Receivables- Long Term (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mediwound.com/role/OtherReceivablesLongTerm</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0040 - Disclosure - Property, Plant And Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/PropertyPlantAndEquipmentNetTables</Role>
      <ShortName>Property, Plant And Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mediwound.com/role/PropertyPlantAndEquipmentNet</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0041 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mediwound.com/role/Leases</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0042 - Disclosure - Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/IntangibleAssetsNetTables</Role>
      <ShortName>Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mediwound.com/role/IntangibleAssetsNet</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0043 - Disclosure - Other Payables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/OtherPayablesTables</Role>
      <ShortName>Other Payables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mediwound.com/role/OtherPayables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0044 - Disclosure - Liabilities in Respect of IIA Grants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/LiabilitiesInRespectOfIiaGrantsTables</Role>
      <ShortName>Liabilities in Respect of IIA Grants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mediwound.com/role/LiabilitiesInRespectOfIiaGrants</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0045 - Disclosure - Financial  Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial  Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mediwound.com/role/FinancialInstruments</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0047 - Disclosure - Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/EquityTables</Role>
      <ShortName>Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mediwound.com/role/Equity</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0048 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/Share-basedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mediwound.com/role/Share-basedCompensation</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0049 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables</Role>
      <ShortName>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLost</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0050 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/NetProfitLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mediwound.com/role/NetProfitLossPerShare</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0051 - Disclosure - Balances and Transactions With Related Parties and Key Officers (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersTables</Role>
      <ShortName>Balances and Transactions With Related Parties and Key Officers (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficers</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0052 - Disclosure - General (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/GeneralDetails</Role>
      <ShortName>General (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/General</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0054 - Disclosure - Material Accounting Policies (Schedule of depreciation on straight line basis over useful life of assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfDepreciationOnStraight-lineBasisOverUsefulLifeOfAssetsDetails</Role>
      <ShortName>Material Accounting Policies (Schedule of depreciation on straight line basis over useful life of assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0055 - Disclosure - Material Accounting Policies (Schedule of amortization periods of right of use assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfAmortizationPeriodsOfRight-of-useAssetsDetails</Role>
      <ShortName>Material Accounting Policies (Schedule of amortization periods of right of use assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0056 - Disclosure - Cash And Cash Equivalents (Schedule of cash and cash equivalents) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails</Role>
      <ShortName>Cash And Cash Equivalents (Schedule of cash and cash equivalents) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/CashAndCashEquivalentsTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0057 - Disclosure - Short-term and restricted bank deposits (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/Short-termBankDepositsNarrativeDetails</Role>
      <ShortName>Short-term and restricted bank deposits (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/Short-termBankDepositsTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0058 - Disclosure - Short-term and restricted bank deposits (Schedule of short-term bank deposits) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/Short-termBankDepositsScheduleOfShort-termBankDepositsDetail</Role>
      <ShortName>Short-term and restricted bank deposits (Schedule of short-term bank deposits) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/Short-termBankDepositsTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0059 - Disclosure - Trade Receivables (Schedule of trade receivables) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/TradeReceivablesScheduleOfTradeReceivablesDetails</Role>
      <ShortName>Trade Receivables (Schedule of trade receivables) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/TradeReceivablesTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0060 - Disclosure - Inventories (Schedule of inventories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/InventoriesScheduleOfInventoriesDetails</Role>
      <ShortName>Inventories (Schedule of inventories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/InventoriesTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0061 - Disclosure - Other Receivables Short Term (Schedule of other receivables short term) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/OtherReceivablesScheduleOfOtherReceivablesDetails</Role>
      <ShortName>Other Receivables Short Term (Schedule of other receivables short term) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/OtherReceivablesTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0062 - Disclosure - Other Receivables- Long Term (Schedule of other receivables long term) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/OtherReceivablesLongTermDetails</Role>
      <ShortName>Other Receivables- Long Term (Schedule of other receivables long term) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/OtherReceivablesLongTermTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0063 - Disclosure - Property, Plant And Equipment, Net (Schedule of property, plant and equipment, net) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails</Role>
      <ShortName>Property, Plant And Equipment, Net (Schedule of property, plant and equipment, net) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/PropertyPlantAndEquipmentNetTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0064 - Disclosure - Leases (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/LeasesTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0065 - Disclosure - Leases (Schedule of information on leases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/LeasesScheduleOfInformationOnLeasesDetails</Role>
      <ShortName>Leases (Schedule of information on leases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/LeasesTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0066 - Disclosure - Leases (Schedule of Disclosures of Right-of-Use Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails</Role>
      <ShortName>Leases (Schedule of Disclosures of Right-of-Use Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/LeasesTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0067 - Disclosure - Leases (Schedule of disclosures of lease liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails</Role>
      <ShortName>Leases (Schedule of disclosures of lease liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/LeasesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0068 - Disclosure - Intangible Assets, Net (Schedule of intangible assets, net) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails</Role>
      <ShortName>Intangible Assets, Net (Schedule of intangible assets, net) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/IntangibleAssetsNetTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0070 - Disclosure - Other Payables (Schedule of other payables) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/OtherPayablesScheduleOfOtherPayablesDetails</Role>
      <ShortName>Other Payables (Schedule of other payables) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/OtherPayablesTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0071 - Disclosure - Liabilities in Respect of IIA Grants (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/LiabilitiesInRespectOfIIAGrantsNarrativeDetails</Role>
      <ShortName>Liabilities in Respect of IIA Grants (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/LiabilitiesInRespectOfIiaGrantsTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0072 - Disclosure - Liabilities in Respect of IIA Grants (Schedule of israeli innovation authority grants) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/LiabilitiesInRespectOfIiaGrantsScheduleOfIsraeliInnovationAuthorityGrantsDetails</Role>
      <ShortName>Liabilities in Respect of IIA Grants (Schedule of israeli innovation authority grants) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/LiabilitiesInRespectOfIiaGrantsTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0073 - Disclosure - Financial  Instruments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/FinancialInstrumentsNarrativeDetails</Role>
      <ShortName>Financial  Instruments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0074 - Disclosure - Financial  Instruments (Schedule of sensitivity tests relating to changes in market factors) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/FinancialInstrumentsScheduleOfSensitivityTestsRelatingToChangesInMarketFactorsDetails</Role>
      <ShortName>Financial  Instruments (Schedule of sensitivity tests relating to changes in market factors) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0075 - Disclosure - Financial Instruments (Schedule of liquidity risk by holding cash balances, short-term deposits and secured bank credit facilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails</Role>
      <ShortName>Financial Instruments (Schedule of liquidity risk by holding cash balances, short-term deposits and secured bank credit facilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0076 - Disclosure - Severance Pay Liability, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SeverancePayLiabiltyNetDetails</Role>
      <ShortName>Severance Pay Liability, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/SeverancePayLiabiltyNet</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0077 - Disclosure - Liabilities and Commitments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails</Role>
      <ShortName>Liabilities and Commitments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/ContingentLiabilitiesAndCommitments</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0078 - Disclosure - Materials Agreements (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/MaterialAgreementsDetails</Role>
      <ShortName>Materials Agreements (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/MaterialAgreements</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0079 - Disclosure - Equity (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/EquityNarrativeDetails</Role>
      <ShortName>Equity (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/EquityTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0080 - Disclosure - Equity (Schedule of Share Capital) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/EquityScheduleOfShareCapitalDetails</Role>
      <ShortName>Equity (Schedule of Share Capital) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/EquityTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0081 - Disclosure - Share-Based Compensation (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/Share-basedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/Share-basedCompensationTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0082 - Disclosure - Share-Based Compensation (Schedule of Expense Recognized) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/Share-basedCompensationScheduleOfExpenseRecognizedDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of Expense Recognized) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/Share-basedCompensationTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0083 - Disclosure - Share-Based Compensation (Schedule of Share Options Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of Share Options Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/Share-basedCompensationTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0084 - Disclosure - Share-Based Compensation (Schedule of Information About Share Options Outstanding) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of Information About Share Options Outstanding) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/Share-basedCompensationTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0085 - Disclosure - Share-Based Compensation (Schedule of Estimated Using Acceptable Option Pricing Models) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/Share-basedCompensationScheduleOfEstimatedUsingAcceptableOptionPricingModelsDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of Estimated Using Acceptable Option Pricing Models) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/Share-basedCompensationTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0086 - Disclosure - Income Tax (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/TaxesOnIncomeDetails</Role>
      <ShortName>Income Tax (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/TaxesOnIncome</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0087 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails</Role>
      <ShortName>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0088 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeographicalInformationDetails</Role>
      <ShortName>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0089 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Cost of Revenues Products) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesProductsDetails</Role>
      <ShortName>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Cost of Revenues Products) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0090 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss ( Schedule of Cost of Revenues) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesDetails</Role>
      <ShortName>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss ( Schedule of Cost of Revenues) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0091 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Cost of Revenue License) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenueLicenseDetails</Role>
      <ShortName>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Cost of Revenue License) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>0092 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Research Expenses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails</Role>
      <ShortName>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Research Expenses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>0093 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Selling Expenses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails</Role>
      <ShortName>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Selling Expenses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>0094 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of General Expenses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeneralExpensesDetails</Role>
      <ShortName>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of General Expenses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>0095 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Financial Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails</Role>
      <ShortName>Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Financial Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>0096 - Disclosure - Net Loss Per Share (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/NetProfitLossPerShareNarrativeDetails</Role>
      <ShortName>Net Loss Per Share (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/NetProfitLossPerShareTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>0097 - Disclosure - Net Loss Per Share (Schedule of Details of Number of Shares and Loss Used in Computation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/NetProfitLossPerShareScheduleOfDetailsOfNumberOfSharesAndLossUsedInComputationDetails</Role>
      <ShortName>Net Loss Per Share (Schedule of Details of Number of Shares and Loss Used in Computation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/NetProfitLossPerShareTables</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>0098 - Disclosure - Net Loss Per Share (Schedule of Net Loss Per Share from Continuing and Discontinued Operations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/NetProfitLossPerShareScheduleOfNetProfitLossPerShareFromContinuingAndDiscontinuedOperationsDetails</Role>
      <ShortName>Net Loss Per Share (Schedule of Net Loss Per Share from Continuing and Discontinued Operations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/NetProfitLossPerShareTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>0099 - Disclosure - Balances and Transactions With Related Parties and Key Officers (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersNarrativeDetails</Role>
      <ShortName>Balances and Transactions With Related Parties and Key Officers (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>0100 - Disclosure - Balances and Transactions With Related Parties and Key Officers (Schedule of Balances of Related Parties) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfRelatedPartiesDetails</Role>
      <ShortName>Balances and Transactions With Related Parties and Key Officers (Schedule of Balances of Related Parties) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>0101 - Disclosure - Balances and Transactions With Related Parties and Key Officers (Schedule of Transactions with Related Parties) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfTransactionsWithRelatedPartiesDetails</Role>
      <ShortName>Balances and Transactions With Related Parties and Key Officers (Schedule of Transactions with Related Parties) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersTables</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>0102 - Disclosure - Balances and Transactions With Related Parties and Key Officers (Schedule of Balances of Key Officers of the Company) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfKeyOfficersOfTheCompanyDetails</Role>
      <ShortName>Balances and Transactions With Related Parties and Key Officers (Schedule of Balances of Key Officers of the Company) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersTables</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>0103 - Disclosure - Balances and Transactions With Related Parties and Key Officers (Schedule of Compensation of Officers of Company) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfCompensationOfOfficersOfCompanyDetails</Role>
      <ShortName>Balances and Transactions With Related Parties and Key Officers (Schedule of Compensation of Officers of Company) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="zk2431143.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>0104 - Disclosure - Subsequent events (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SubsequentEventsDetailTextuals</Role>
      <ShortName>Subsequent events (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityIncorporationStateCountryCode -  zk2431143.htm 12</Log>
  </Logs>
  <InputFiles>
    <File>mdwd-20231231.xsd</File>
    <File>mdwd-20231231_cal.xml</File>
    <File>mdwd-20231231_def.xml</File>
    <File>mdwd-20231231_lab.xml</File>
    <File>mdwd-20231231_pre.xml</File>
    <File doctype="20-F" isDefinitelyFs="true" isIfrs="true" original="zk2431143.htm">zk2431143.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image0.jpg</File>
    <File>image1.jpg</File>
    <File>image2.jpg</File>
    <File>image3.jpg</File>
    <File>image4.jpg</File>
    <File>mdwd_img01.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="44">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="956">https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>132
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "zk2431143.htm": {
   "nsprefix": "mdwd",
   "nsuri": "http://mediwound.com/20231231",
   "dts": {
    "schema": {
     "local": [
      "mdwd-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "mdwd-20231231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mdwd-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "mdwd-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mdwd-20231231_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "zk2431143.htm"
     ]
    }
   },
   "keyStandard": 261,
   "keyCustom": 167,
   "axisStandard": 23,
   "axisCustom": 2,
   "memberStandard": 31,
   "memberCustom": 51,
   "hidden": {
    "total": 9,
    "http://xbrl.sec.gov/dei/2023": 4,
    "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 5
   },
   "contextCount": 321,
   "entityCount": 1,
   "segmentCount": 83,
   "elementCount": 706,
   "unitCount": 12,
   "baseTaxonomies": {
    "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 956,
    "http://xbrl.sec.gov/dei/2023": 44
   },
   "report": {
    "R1": {
     "role": "http://mediwound.com/role/DocumentAndEntityInformation",
     "longName": "0001 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://mediwound.com/role/ConsolidatedBalanceSheets",
     "longName": "0002 - Statement - Consolidated Statements of Financial Position",
     "shortName": "Consolidated Statements of Financial Position",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://mediwound.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "0003 - Statement - Consolidated Statements of Financial Position (Parenthetical)",
     "shortName": "Consolidated Statements of Financial Position (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:ParValuePerShare",
      "unitRef": "NIS_per_share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "ifrs-full:ParValuePerShare",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:NumberOfSharesOutstanding",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss",
     "longName": "0004 - Statement - Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss",
     "shortName": "Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:RevenueFromSaleOfGoods",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:RevenueFromSaleOfGoods",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity",
     "longName": "0005 - Statement - Consolidated Statements of Changes in Shareholders' Equity (Deficit)",
     "shortName": "Consolidated Statements of Changes in Shareholders' Equity (Deficit)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember",
      "name": "ifrs-full:Equity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember",
      "name": "ifrs-full:Equity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows",
     "longName": "0006 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://mediwound.com/role/General",
     "longName": "0007 - Disclosure - General",
     "shortName": "General",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://mediwound.com/role/SignificantAccountingJudgmentsEstimatesAndAssumptionsUsedInPreparationOfFinancialStatements",
     "longName": "0008 - Disclosure - Basis of Preparation of the Consolidated Financial Statements",
     "shortName": "Basis of Preparation of the Consolidated Financial Statements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://mediwound.com/role/SignificantAccountingPolicies",
     "longName": "0009 - Disclosure - Material Accounting Policies",
     "shortName": "Material Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://mediwound.com/role/CashAndCashEquivalents",
     "longName": "0010 - Disclosure - Cash And Cash Equivalents",
     "shortName": "Cash And Cash Equivalents",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://mediwound.com/role/Short-termBankDeposits",
     "longName": "0011 - Disclosure - Short-term and restricted bank deposits",
     "shortName": "Short-term and restricted bank deposits",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfDepositsFromBanksExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfDepositsFromBanksExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://mediwound.com/role/TradeReceivables",
     "longName": "0012 - Disclosure - Trade Receivables",
     "shortName": "Trade Receivables",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfTradeReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfTradeReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://mediwound.com/role/Inventories",
     "longName": "0013 - Disclosure - Inventories",
     "shortName": "Inventories",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://mediwound.com/role/OtherReceivables",
     "longName": "0014 - Disclosure - Other Receivables Short Term",
     "shortName": "Other Receivables Short Term",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://mediwound.com/role/OtherReceivablesLongTerm",
     "longName": "0015 - Disclosure - Other Receivables- Long Term",
     "shortName": "Other Receivables- Long Term",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfOtherReceivablesLongTermExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfOtherReceivablesLongTermExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://mediwound.com/role/PropertyPlantAndEquipmentNet",
     "longName": "0016 - Disclosure - Property, Plant And Equipment, Net",
     "shortName": "Property, Plant And Equipment, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://mediwound.com/role/Leases",
     "longName": "0017 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://mediwound.com/role/IntangibleAssetsNet",
     "longName": "0018 - Disclosure - Intangible Assets, Net",
     "shortName": "Intangible Assets, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://mediwound.com/role/OtherPayables",
     "longName": "0019 - Disclosure - Other Payables",
     "shortName": "Other Payables",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://mediwound.com/role/LiabilitiesInRespectOfIiaGrants",
     "longName": "0020 - Disclosure - Liabilities in Respect of IIA Grants",
     "shortName": "Liabilities in Respect of IIA Grants",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfGovernmentGrantsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfGovernmentGrantsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://mediwound.com/role/FinancialInstruments",
     "longName": "0021 - Disclosure - Financial  Instruments",
     "shortName": "Financial  Instruments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://mediwound.com/role/SeverancePayLiabiltyNet",
     "longName": "0022 - Disclosure - Severance Pay Liability, Net",
     "shortName": "Severance Pay Liability, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://mediwound.com/role/ContingentLiabilitiesAndCommitments",
     "longName": "0023 - Disclosure - Liabilities and Commitments",
     "shortName": "Liabilities and Commitments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://mediwound.com/role/MaterialAgreements",
     "longName": "0024 - Disclosure - Materials Agreements",
     "shortName": "Materials Agreements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfMaterialAgreementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfMaterialAgreementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://mediwound.com/role/Equity",
     "longName": "0025 - Disclosure - Equity",
     "shortName": "Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://mediwound.com/role/Share-basedCompensation",
     "longName": "0026 - Disclosure - Share-Based Compensation",
     "shortName": "Share-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://mediwound.com/role/TaxesOnIncome",
     "longName": "0027 - Disclosure - Income Tax",
     "shortName": "Income Tax",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLost",
     "longName": "0028 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss",
     "shortName": "Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://mediwound.com/role/NetProfitLossPerShare",
     "longName": "0029 - Disclosure - Net Loss Per Share",
     "shortName": "Net Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficers",
     "longName": "0030 - Disclosure - Balances and Transactions With Related Parties and Key Officers",
     "shortName": "Balances and Transactions With Related Parties and Key Officers",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://mediwound.com/role/SubsequentEvents",
     "longName": "0031 - Disclosure - Subsiquents events",
     "shortName": "Subsiquents events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://mediwound.com/role/SignificantAccountingPoliciesPolicies",
     "longName": "0032 - Disclosure - Material Accounting Policies (Policies)",
     "shortName": "Material Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "32",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://mediwound.com/role/SignificantAccountingPoliciesTables",
     "longName": "0033 - Disclosure - Material Accounting Policies (Tables)",
     "shortName": "Material Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "div",
       "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "div",
       "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://mediwound.com/role/CashAndCashEquivalentsTables",
     "longName": "0034 - Disclosure - Cash And Cash Equivalents (Tables)",
     "shortName": "Cash And Cash Equivalents (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://mediwound.com/role/Short-termBankDepositsTables",
     "longName": "0035 - Disclosure - Short-term and restricted bank deposits (Tables)",
     "shortName": "Short-term and restricted bank deposits (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfDepositsFromBanksExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfDepositsFromBanksExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://mediwound.com/role/TradeReceivablesTables",
     "longName": "0036 - Disclosure - Trade Receivables (Tables)",
     "shortName": "Trade Receivables (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfTradeReceivablesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfTradeReceivablesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://mediwound.com/role/InventoriesTables",
     "longName": "0037 - Disclosure - Inventories (Tables)",
     "shortName": "Inventories (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutInventoriesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutInventoriesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://mediwound.com/role/OtherReceivablesTables",
     "longName": "0038 - Disclosure - Other Receivables Short Term (Tables)",
     "shortName": "Other Receivables Short Term (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://mediwound.com/role/OtherReceivablesLongTermTables",
     "longName": "0039 - Disclosure - Other Receivables- Long Term (Tables)",
     "shortName": "Other Receivables- Long Term (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfOtherReceivablesLongTermExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfOtherReceivablesLongTermExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://mediwound.com/role/PropertyPlantAndEquipmentNetTables",
     "longName": "0040 - Disclosure - Property, Plant And Equipment, Net (Tables)",
     "shortName": "Property, Plant And Equipment, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://mediwound.com/role/LeasesTables",
     "longName": "0041 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfAdditionalInformationAboutLeaseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfAdditionalInformationAboutLeaseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://mediwound.com/role/IntangibleAssetsNetTables",
     "longName": "0042 - Disclosure - Intangible Assets, Net (Tables)",
     "shortName": "Intangible Assets, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://mediwound.com/role/OtherPayablesTables",
     "longName": "0043 - Disclosure - Other Payables (Tables)",
     "shortName": "Other Payables (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutOtherPayablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutOtherPayablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://mediwound.com/role/LiabilitiesInRespectOfIiaGrantsTables",
     "longName": "0044 - Disclosure - Liabilities in Respect of IIA Grants (Tables)",
     "shortName": "Liabilities in Respect of IIA Grants (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfGovernmentGrantsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfGovernmentGrantsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://mediwound.com/role/FinancialInstrumentsTables",
     "longName": "0045 - Disclosure - Financial  Instruments (Tables)",
     "shortName": "Financial  Instruments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:SensitivityAnalysisForEachTypeOfMarketRisk",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:SensitivityAnalysisForEachTypeOfMarketRisk",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://mediwound.com/role/EquityTables",
     "longName": "0047 - Disclosure - Equity (Tables)",
     "shortName": "Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://mediwound.com/role/Share-basedCompensationTables",
     "longName": "0048 - Disclosure - Share-Based Compensation (Tables)",
     "shortName": "Share-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables",
     "longName": "0049 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Tables)",
     "shortName": "Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "48",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://mediwound.com/role/NetProfitLossPerShareTables",
     "longName": "0050 - Disclosure - Net Loss Per Share (Tables)",
     "shortName": "Net Loss Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "49",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersTables",
     "longName": "0051 - Disclosure - Balances and Transactions With Related Parties and Key Officers (Tables)",
     "shortName": "Balances and Transactions With Related Parties and Key Officers (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "50",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://mediwound.com/role/GeneralDetails",
     "longName": "0052 - Disclosure - General (Narrative) (Details)",
     "shortName": "General (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "C_20230207",
      "name": "ifrs-full:NumberOfSharesIssued",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230201to20230207",
      "name": "mdwd:GrossProceedsFromPublicAndPrivateOfferings",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfDepreciationOnStraight-lineBasisOverUsefulLifeOfAssetsDetails",
     "longName": "0054 - Disclosure - Material Accounting Policies (Schedule of depreciation on straight line basis over useful life of assets) (Details)",
     "shortName": "Material Accounting Policies (Schedule of depreciation on straight line basis over useful life of assets) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember",
      "name": "ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "mdwd:DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "div",
       "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember",
      "name": "ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "mdwd:DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "div",
       "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfAmortizationPeriodsOfRight-of-useAssetsDetails",
     "longName": "0055 - Disclosure - Material Accounting Policies (Schedule of amortization periods of right of use assets) (Details)",
     "shortName": "Material Accounting Policies (Schedule of amortization periods of right of use assets) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember",
      "name": "mdwd:AmortizationPeriodsOfRightOfUseAssets",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "mdwd:ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock",
       "div",
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory",
       "div",
       "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember",
      "name": "mdwd:AmortizationPeriodsOfRightOfUseAssets",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "mdwd:ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock",
       "div",
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory",
       "div",
       "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://mediwound.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails",
     "longName": "0056 - Disclosure - Cash And Cash Equivalents (Schedule of cash and cash equivalents) (Details)",
     "shortName": "Cash And Cash Equivalents (Schedule of cash and cash equivalents) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:CashOnHand",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "mdwd:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:CashOnHand",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "mdwd:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://mediwound.com/role/Short-termBankDepositsNarrativeDetails",
     "longName": "0057 - Disclosure - Short-term and restricted bank deposits (Narrative) (Details)",
     "shortName": "Short-term and restricted bank deposits (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:PeriodOfBankDeposits",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory",
       "div",
       "ifrs-full:DisclosureOfDepositsFromBanksExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:PeriodOfBankDeposits",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory",
       "div",
       "ifrs-full:DisclosureOfDepositsFromBanksExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://mediwound.com/role/Short-termBankDepositsScheduleOfShort-termBankDepositsDetail",
     "longName": "0058 - Disclosure - Short-term and restricted bank deposits (Schedule of short-term bank deposits) (Detail)",
     "shortName": "Short-term and restricted bank deposits (Schedule of short-term bank deposits) (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:RestrictedCashAndCashEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory",
       "div",
       "ifrs-full:DisclosureOfDepositsFromBanksExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:RestrictedCashAndCashEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory",
       "div",
       "ifrs-full:DisclosureOfDepositsFromBanksExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://mediwound.com/role/TradeReceivablesScheduleOfTradeReceivablesDetails",
     "longName": "0059 - Disclosure - Trade Receivables (Schedule of trade receivables) (Details)",
     "shortName": "Trade Receivables (Schedule of trade receivables) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "mdwd:CurrentVericel",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "mdwd:DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfTradeReceivablesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "mdwd:CurrentVericel",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "mdwd:DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfTradeReceivablesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://mediwound.com/role/InventoriesScheduleOfInventoriesDetails",
     "longName": "0060 - Disclosure - Inventories (Schedule of inventories) (Details)",
     "shortName": "Inventories (Schedule of inventories) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:RawMaterials",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "mdwd:DisclosureOfDetailedInformationAboutInventoriesExplanatory",
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:RawMaterials",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "mdwd:DisclosureOfDetailedInformationAboutInventoriesExplanatory",
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://mediwound.com/role/OtherReceivablesScheduleOfOtherReceivablesDetails",
     "longName": "0061 - Disclosure - Other Receivables Short Term (Schedule of other receivables short term) (Details)",
     "shortName": "Other Receivables Short Term (Schedule of other receivables short term) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "mdwd:CurrentGovernmentAuthoritiesReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "mdwd:DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "mdwd:CurrentGovernmentAuthoritiesReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "mdwd:DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://mediwound.com/role/OtherReceivablesLongTermDetails",
     "longName": "0062 - Disclosure - Other Receivables- Long Term (Schedule of other receivables long term) (Details)",
     "shortName": "Other Receivables- Long Term (Schedule of other receivables long term) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "mdwd:IncomeReceivablesLongTerm",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "mdwd:DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfOtherReceivablesLongTermExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "mdwd:IncomeReceivablesLongTerm",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "mdwd:DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfOtherReceivablesLongTermExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails",
     "longName": "0063 - Disclosure - Property, Plant And Equipment, Net (Schedule of property, plant and equipment, net) (Details)",
     "shortName": "Property, Plant And Equipment, Net (Schedule of property, plant and equipment, net) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "div",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://mediwound.com/role/LeasesNarrativeDetails",
     "longName": "0064 - Disclosure - Leases (Narrative) (Details)",
     "shortName": "Leases (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "C_20230701to20230731",
      "name": "mdwd:SubsidiariesLeaseArea",
      "unitRef": "Squaremeters",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:SubsidiariesLeaseMonthlyRent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://mediwound.com/role/LeasesScheduleOfInformationOnLeasesDetails",
     "longName": "0065 - Disclosure - Leases (Schedule of information on leases) (Details)",
     "shortName": "Leases (Schedule of information on leases) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:InterestExpenseOnLeaseLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "mdwd:DisclosureOfAdditionalInformationAboutLeaseExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "mdwd:DisclosureOfAdditionalInformationAboutLeaseExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails",
     "longName": "0066 - Disclosure - Leases (Schedule of Disclosures of Right-of-Use Assets) (Details)",
     "shortName": "Leases (Schedule of Disclosures of Right-of-Use Assets) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "ifrs-full:RightofuseAssetsRevaluedAssetsAtCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20211231",
      "name": "ifrs-full:RightofuseAssetsRevaluedAssetsAtCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails",
     "longName": "0067 - Disclosure - Leases (Schedule of disclosures of lease liabilities) (Details)",
     "shortName": "Leases (Schedule of disclosures of lease liabilities) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember",
      "name": "ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://mediwound.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails",
     "longName": "0068 - Disclosure - Intangible Assets, Net (Schedule of intangible assets, net) (Details)",
     "shortName": "Intangible Assets, Net (Schedule of intangible assets, net) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember",
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://mediwound.com/role/OtherPayablesScheduleOfOtherPayablesDetails",
     "longName": "0070 - Disclosure - Other Payables (Schedule of other payables) (Details)",
     "shortName": "Other Payables (Schedule of other payables) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:ShorttermEmployeeBenefitsAccruals",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "mdwd:DisclosureOfDetailedInformationAboutOtherPayablesExplanatory",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:ShorttermEmployeeBenefitsAccruals",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "mdwd:DisclosureOfDetailedInformationAboutOtherPayablesExplanatory",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://mediwound.com/role/LiabilitiesInRespectOfIIAGrantsNarrativeDetails",
     "longName": "0071 - Disclosure - Liabilities in Respect of IIA Grants (Narrative) (Details)",
     "shortName": "Liabilities in Respect of IIA Grants (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "mdwd:GrantsReceivedNetOfRoyalties",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfGovernmentGrantsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "mdwd:GrantsReceivedNetOfRoyalties",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfGovernmentGrantsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://mediwound.com/role/LiabilitiesInRespectOfIiaGrantsScheduleOfIsraeliInnovationAuthorityGrantsDetails",
     "longName": "0072 - Disclosure - Liabilities in Respect of IIA Grants (Schedule of israeli innovation authority grants) (Details)",
     "shortName": "Liabilities in Respect of IIA Grants (Schedule of israeli innovation authority grants) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "ifrs-full:GovernmentGrants",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "mdwd:DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfGovernmentGrantsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20211231",
      "name": "ifrs-full:GovernmentGrants",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "mdwd:DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfGovernmentGrantsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://mediwound.com/role/FinancialInstrumentsNarrativeDetails",
     "longName": "0073 - Disclosure - Financial  Instruments (Narrative) (Details)",
     "shortName": "Financial  Instruments (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember",
      "name": "mdwd:ExpectedTermOfWarrant",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember",
      "name": "mdwd:ExpectedTermOfWarrant",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://mediwound.com/role/FinancialInstrumentsScheduleOfSensitivityTestsRelatingToChangesInMarketFactorsDetails",
     "longName": "0074 - Disclosure - Financial  Instruments (Schedule of sensitivity tests relating to changes in market factors) (Details)",
     "shortName": "Financial  Instruments (Schedule of sensitivity tests relating to changes in market factors) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_mdwdSensitivityAnalysisAxis_mdwdFivePercentageIncreaseInExchangeRateMember",
      "name": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "ifrs-full:SensitivityAnalysisForEachTypeOfMarketRisk",
       "div",
       "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails",
     "longName": "0075 - Disclosure - Financial Instruments (Schedule of liquidity risk by holding cash balances, short-term deposits and secured bank credit facilities) (Details)",
     "shortName": "Financial Instruments (Schedule of liquidity risk by holding cash balances, short-term deposits and secured bank credit facilities) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:NoncurrentLeaseLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember",
      "name": "mdwd:CurrentMaturitiesOfLongTermLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities",
       "div",
       "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://mediwound.com/role/SeverancePayLiabiltyNetDetails",
     "longName": "0076 - Disclosure - Severance Pay Liability, Net (Details)",
     "shortName": "Severance Pay Liability, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans",
      "unitRef": "Percent",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans",
      "unitRef": "Percent",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails",
     "longName": "0077 - Disclosure - Liabilities and Commitments (Narrative) (Details)",
     "shortName": "Liabilities and Commitments (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:Liabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember",
      "name": "ifrs-full:TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R75": {
     "role": "http://mediwound.com/role/MaterialAgreementsDetails",
     "longName": "0078 - Disclosure - Materials Agreements (Narrative) (Details)",
     "shortName": "Materials Agreements (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:ResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember",
      "name": "ifrs-full:TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "mdwd:DisclosureOfMaterialAgreementsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://mediwound.com/role/EquityNarrativeDetails",
     "longName": "0079 - Disclosure - Equity (Narrative) (Details)",
     "shortName": "Equity (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://mediwound.com/role/EquityScheduleOfShareCapitalDetails",
     "longName": "0080 - Disclosure - Equity (Schedule of Share Capital) (Details)",
     "shortName": "Equity (Schedule of Share Capital) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:NumberOfSharesAuthorised",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R78": {
     "role": "http://mediwound.com/role/Share-basedCompensationNarrativeDetails",
     "longName": "0081 - Disclosure - Share-Based Compensation (Narrative) (Details)",
     "shortName": "Share-Based Compensation (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "C_20230501to20230531_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember",
      "name": "ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230501to20230531_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember",
      "name": "ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://mediwound.com/role/Share-basedCompensationScheduleOfExpenseRecognizedDetails",
     "longName": "0082 - Disclosure - Share-Based Compensation (Schedule of Expense Recognized) (Details)",
     "shortName": "Share-Based Compensation (Schedule of Expense Recognized) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:AdjustmentsForSharebasedPayments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdCostOfRevenuesMember",
      "name": "ifrs-full:AdjustmentsForSharebasedPayments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R80": {
     "role": "http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails",
     "longName": "0083 - Disclosure - Share-Based Compensation (Schedule of Share Options Activity) (Details)",
     "shortName": "Share-Based Compensation (Schedule of Share Options Activity) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "div",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "div",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R81": {
     "role": "http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails",
     "longName": "0084 - Disclosure - Share-Based Compensation (Schedule of Information About Share Options Outstanding) (Details)",
     "shortName": "Share-Based Compensation (Schedule of Information About Share Options Outstanding) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "div",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory",
       "div",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R82": {
     "role": "http://mediwound.com/role/Share-basedCompensationScheduleOfEstimatedUsingAcceptableOptionPricingModelsDetails",
     "longName": "0085 - Disclosure - Share-Based Compensation (Schedule of Estimated Using Acceptable Option Pricing Models) (Details)",
     "shortName": "Share-Based Compensation (Schedule of Estimated Using Acceptable Option Pricing Models) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted",
      "unitRef": "Percent",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
       "div",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted",
      "unitRef": "Percent",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
       "div",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://mediwound.com/role/TaxesOnIncomeDetails",
     "longName": "0086 - Disclosure - Income Tax (Narrative) (Details)",
     "shortName": "Income Tax (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails",
     "longName": "0087 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Narrative) (Details)",
     "shortName": "Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "ifrs-full:OtherExpenseByFunction",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "ifrs-full:OtherExpenseByFunction",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R85": {
     "role": "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeographicalInformationDetails",
     "longName": "0088 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Details)",
     "shortName": "Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:Revenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_ifrsfullSegmentsAxis_mdwdUsaMember",
      "name": "ifrs-full:Revenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R86": {
     "role": "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesProductsDetails",
     "longName": "0089 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Cost of Revenues Products) (Details)",
     "shortName": "Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Cost of Revenues Products) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:WagesAndSalaries",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfCostOfSalesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:WagesAndSalaries",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfCostOfSalesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R87": {
     "role": "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesDetails",
     "longName": "0090 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss ( Schedule of Cost of Revenues) (Details)",
     "shortName": "Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss ( Schedule of Cost of Revenues) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:SalaryAndBenefits",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "mdwd:DisclosureOfCostOfSalesServicesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:SalaryAndBenefits",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "mdwd:DisclosureOfCostOfSalesServicesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R88": {
     "role": "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenueLicenseDetails",
     "longName": "0091 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Cost of Revenue License) (Details)",
     "shortName": "Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Cost of Revenue License) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:SalaryAndBenefitsExpensesRelatedToLicenseAgreements",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "mdwd:ScheduleOfCostOfRevenuesLicense",
       "div",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:SalaryAndBenefitsExpensesRelatedToLicenseAgreements",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "mdwd:ScheduleOfCostOfRevenuesLicense",
       "div",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R89": {
     "role": "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails",
     "longName": "0092 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Research Expenses) (Details)",
     "shortName": "Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Research Expenses) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:EmployeeBenefitsExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:EmployeeBenefitsExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R90": {
     "role": "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails",
     "longName": "0093 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Selling Expenses) (Details)",
     "shortName": "Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Selling Expenses) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:ShorttermEmployeeBenefitsExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "mdwd:DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:ShorttermEmployeeBenefitsExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "mdwd:DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R91": {
     "role": "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeneralExpensesDetails",
     "longName": "0094 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of General Expenses) (Details)",
     "shortName": "Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of General Expenses) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:SalaryAndBenefitsIncludingShareBasedCompensation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:SalaryAndBenefitsIncludingShareBasedCompensation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R92": {
     "role": "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails",
     "longName": "0095 - Disclosure - Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Financial Expense) (Details)",
     "shortName": "Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss (Schedule of Financial Expense) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:RevenueFromInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:RevenueFromInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R93": {
     "role": "http://mediwound.com/role/NetProfitLossPerShareNarrativeDetails",
     "longName": "0096 - Disclosure - Net Loss Per Share (Narrative) (Details)",
     "shortName": "Net Loss Per Share (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "C_20220926to20220926",
      "name": "mdwd:NumberOfWarrantsIssued",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_ifrsfullClassesOfOrdinarySharesAxis_mdwdDilutedWeightedAverageNumberMember",
      "name": "mdwd:NumberOfWarrantsIssued",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R94": {
     "role": "http://mediwound.com/role/NetProfitLossPerShareScheduleOfDetailsOfNumberOfSharesAndLossUsedInComputationDetails",
     "longName": "0097 - Disclosure - Net Loss Per Share (Schedule of Details of Number of Shares and Loss Used in Computation) (Details)",
     "shortName": "Net Loss Per Share (Schedule of Details of Number of Shares and Loss Used in Computation) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:AdjustedWeightedAverageShares",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:ProfitLossFromContinuingOperations",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "mdwd:DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R95": {
     "role": "http://mediwound.com/role/NetProfitLossPerShareScheduleOfNetProfitLossPerShareFromContinuingAndDiscontinuedOperationsDetails",
     "longName": "0098 - Disclosure - Net Loss Per Share (Schedule of Net Loss Per Share from Continuing and Discontinued Operations) (Details)",
     "shortName": "Net Loss Per Share (Schedule of Net Loss Per Share from Continuing and Discontinued Operations) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:BasicEarningsLossPerShare",
      "unitRef": "USD_Per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "ifrs-full:DilutedEarningsLossPerShare",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R96": {
     "role": "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersNarrativeDetails",
     "longName": "0099 - Disclosure - Balances and Transactions With Related Parties and Key Officers (Narrative) (Details)",
     "shortName": "Balances and Transactions With Related Parties and Key Officers (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "C_20071201to20071231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdChiefExecutiveOfficerAndChiefMedicalOfficerMember",
      "name": "ifrs-full:DirectorsRemunerationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20071201to20071231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdChiefExecutiveOfficerAndChiefMedicalOfficerMember",
      "name": "ifrs-full:DirectorsRemunerationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R97": {
     "role": "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfRelatedPartiesDetails",
     "longName": "0100 - Disclosure - Balances and Transactions With Related Parties and Key Officers (Schedule of Balances of Related Parties) (Details)",
     "shortName": "Balances and Transactions With Related Parties and Key Officers (Schedule of Balances of Related Parties) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember",
      "name": "ifrs-full:AmountsPayableRelatedPartyTransactions",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember",
      "name": "ifrs-full:AmountsPayableRelatedPartyTransactions",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R98": {
     "role": "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfTransactionsWithRelatedPartiesDetails",
     "longName": "0101 - Disclosure - Balances and Transactions With Related Parties and Key Officers (Schedule of Transactions with Related Parties) (Details)",
     "shortName": "Balances and Transactions With Related Parties and Key Officers (Schedule of Transactions with Related Parties) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:ProfessionalFeeAndShareBasedCompensationExpenses",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "mdwd:ProfessionalFeeAndShareBasedCompensationExpenses",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R99": {
     "role": "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfKeyOfficersOfTheCompanyDetails",
     "longName": "0102 - Disclosure - Balances and Transactions With Related Parties and Key Officers (Schedule of Balances of Key Officers of the Company) (Details)",
     "shortName": "Balances and Transactions With Related Parties and Key Officers (Schedule of Balances of Key Officers of the Company) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:ProfessionalFeesExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdKeyOfficerMember",
      "name": "ifrs-full:ProfessionalFeesExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "mdwd:DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    },
    "R100": {
     "role": "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfCompensationOfOfficersOfCompanyDetails",
     "longName": "0103 - Disclosure - Balances and Transactions With Related Parties and Key Officers (Schedule of Compensation of Officers of Company) (Details)",
     "shortName": "Balances and Transactions With Related Parties and Key Officers (Schedule of Compensation of Officers of Company) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true,
      "unique": true
     }
    },
    "R101": {
     "role": "http://mediwound.com/role/SubsequentEventsDetailTextuals",
     "longName": "0104 - Disclosure - Subsequent events (Narrative) (Details)",
     "shortName": "Subsequent events (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "101",
     "firstAnchor": {
      "contextRef": "C_20230207to20230207",
      "name": "ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember",
      "name": "mdwd:AreaOfLand",
      "unitRef": "Square_Meters",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431143.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "mdwd_AccumaletedEffectOfAdoptingIfrsFifteen": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AccumaletedEffectOfAdoptingIfrsFifteen",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumaleted effect of implementing IFRS 15.",
        "label": "Accumaleted Effect Of Adopting Ifrs Fifteen",
        "verboseLabel": "Cumulative effect adjustment on accumulated deficit as a result of adopting new standard"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AccumulatedDepreciationAmortisationAndImpairmentMember",
     "presentation": [
      "http://mediwound.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Amortization [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for accumulated depreciation, amortisation and impairment. [Refer: Impairment loss; Depreciation and amortisation expense]"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r52",
      "r86",
      "r93",
      "r96"
     ]
    },
    "ifrs-full_AccumulatedDepreciationAndAmortisationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AccumulatedDepreciationAndAmortisationMember",
     "presentation": [
      "http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Depreciation [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for accumulated depreciation and amortisation. [Refer: Depreciation and amortisation expense]"
       }
      }
     },
     "auth_ref": [
      "r52",
      "r269",
      "r273",
      "r274",
      "r275"
     ]
    },
    "mdwd_AccumulatedFunding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AccumulatedFunding",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated funding.",
        "label": "Accumulated funding"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional ordinary shares issued upon vesting of outstanding RSU\u2019s during the period.",
        "label": "Additional Ordinary Shares Issued Upon Vesting Of Outstanding Restricted Stock Units",
        "verboseLabel": "Additional ordinary shares issued upon vesting of outstanding RSU's"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AdditionalTermOfLease": {
     "xbrltype": "durationItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AdditionalTermOfLease",
     "presentation": [
      "http://mediwound.com/role/SubsequentEventsDetailTextuals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about additional term of lease.",
        "label": "Additional Term Of Lease",
        "verboseLabel": "Additional term of lease"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AdditionalUpfrontPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AdditionalUpfrontPayment",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional upfront payment.",
        "label": "Additional upfront payment"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions other than through business combinations, intangible assets other than goodwill",
        "verboseLabel": "Additions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "mdwd_AdditionsToRightOfUseAssetsAdjustmentsForIndexation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AdditionsToRightOfUseAssetsAdjustmentsForIndexation",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions due to adjustments for indexation.",
        "negatedLabel": "Adjustments for indexation",
        "label": "Additions To Right Of Use Assets Adjustments For Indexation"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AdditionsToRightOfUseAssetsDisposals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AdditionsToRightOfUseAssetsDisposals",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions due to Disposals.",
        "negatedLabel": "Disposals",
        "label": "Additions To Right Of Use Assets Disposals"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AdditionsToRightOfUseAssetsNewLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AdditionsToRightOfUseAssetsNewLeases",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions due to new leases.",
        "label": "Additions To Right Of Use Assets New Leases",
        "terseLabel": "New leases"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AdditionsToRightOfUseAssetsTerminationOfLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AdditionsToRightOfUseAssetsTerminationOfLeases",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions due to termination of leases",
        "negatedLabel": "Termination of leases",
        "label": "Additions To Right Of Use Assets Termination Of Leases"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustedWeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustedWeightedAverageShares",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss",
      "http://mediwound.com/role/NetProfitLossPerShareScheduleOfDetailsOfNumberOfSharesAndLossUsedInComputationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares used in calculating diluted earnings per share",
        "terseLabel": "Weighted average number of shares",
        "verboseLabel": "Number of shares used in calculating diluted loss per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of adjustment for increase decrease in revaluation of liabilities in respect of grants.",
        "negatedLabel": "Revaluation of liabilities in respect of IIA grants",
        "negatedTerseLabel": "Amounts carried to Profit or Loss",
        "label": "Adjustment For Increase Decrease In Revaluation Of Liabilities In Respect Of Grants",
        "terseLabel": "Revaluation of liabilities in respect of IIA grants"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment for increase decrease in revaluation of warrants accounted at fair value.",
        "negatedLabel": "Revaluation of warrants accounted at fair value",
        "label": "Adjustment For Increase Decrease In Revaluation Of Warrants Accounted At Fair Value",
        "terseLabel": "Revaluation of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Changes in asset and liability items, total.",
        "label": "Adjustments For Changes In Increase Decrease In Asset And Liability Items",
        "terseLabel": "Changes in asset and liability items, total",
        "totalLabel": "Changes in asset and liability items, total"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInInventories",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease in inventories",
        "verboseLabel": "Decrease (increase) in inventories"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r278"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease (increase) in other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r278"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease (increase) in trade receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r278"
     ]
    },
    "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForDepreciationAndAmortisationExpense",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r279"
     ]
    },
    "ifrs-full_AdjustmentsForFinanceIncomeCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForFinanceIncomeCost",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0,
       "order": 100.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Financial income, net",
        "label": "Adjustments for finance income (cost)"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for net finance income or cost to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance income (cost); Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r280"
     ]
    },
    "mdwd_AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of adjustment for financing income and exchange differences of lease liability.",
        "label": "Adjustments For Financing Income And Exchange Differences Of Lease Liability",
        "verboseLabel": "Financing income and exchange differences of lease liability"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase of deferred revenues"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for the increase (decrease) in deferred income including contract liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred income including contract liabilities; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r278"
     ]
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in severance pay liability, net",
        "verboseLabel": "Increase in severance pay liability, net"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r280"
     ]
    },
    "mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment for increase in other payables and deferred revenues.",
        "label": "Adjustments For Increase Decrease In Other Payables And Deferred Revenue",
        "verboseLabel": "Increase (decrease) in other payables"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in trade payables and accrued expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r278"
     ]
    },
    "mdwd_AdjustmentsForIndexation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AdjustmentsForIndexation",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments for indexation during the period.",
        "label": "Adjustments For Indexation",
        "verboseLabel": "Adjustments for indexation"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of adjustment for issuance expenses of warrants through profit and loss.",
        "label": "Adjustments For Issuance Expenses Of Warrants Through Profit And Loss",
        "terseLabel": "Issuance expenses of warrants through profit and loss"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForReconcileProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForReconcileProfitLoss",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile profit (loss)",
        "terseLabel": "Adjustments to profit and loss items, total",
        "totalLabel": "Adjustments to profit and loss items, total"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to profit and loss items:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForSharebasedPayments",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 90.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows",
      "http://mediwound.com/role/Share-basedCompensationScheduleOfExpenseRecognizedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total share-based compensation",
        "verboseLabel": "Share-based compensation"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r279"
     ]
    },
    "mdwd_AdjustmentsToReconcileNetLossToNetCashProvidedByUsedInContinuingOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AdjustmentsToReconcileNetLossToNetCashProvidedByUsedInContinuingOperatingActivitiesAbstract",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments To Reconcile Net Loss To Net Cash Provided By Used In Continuing Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AggregateAmountOfRegisteredDirectOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AggregateAmountOfRegisteredDirectOffering",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount of aggregate amount of registered direct offering.",
        "label": "Aggregate Amount Of Registered Direct Offering",
        "verboseLabel": "Aggregate amount of registered direct offering"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AggregateSupplementalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AggregateSupplementalAmount",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents aggregate supplemental amount.",
        "label": "Aggregate Supplemental Amount",
        "verboseLabel": "Aggregate supplemental amount"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AggregatedTimeBandsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AggregatedTimeBandsMember",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregated time bands [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r131",
      "r142",
      "r143",
      "r147",
      "r148",
      "r149",
      "r154",
      "r177",
      "r221",
      "r242",
      "r243"
     ]
    },
    "mdwd_AgreementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AgreementAxis",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails",
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information of agreement.",
        "label": "Agreement [Axis]",
        "verboseLabel": "Borrowings by name [axis]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AgreementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AgreementDomain",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails",
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information of agreement.",
        "label": "Agreement [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "currency_AllCurrenciesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2023",
     "localname": "AllCurrenciesDomain",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails",
      "http://mediwound.com/role/Short-termBankDepositsNarrativeDetails"
     ],
     "auth_ref": []
    },
    "ifrs-full_AllLevelsOfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AllLevelsOfFairValueHierarchyMember",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All levels of fair value hierarchy [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r125"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AmortizationPeriodsOfRightOfUseAssets": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AmortizationPeriodsOfRightOfUseAssets",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfAmortizationPeriodsOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization periods of the right-of-use assets.",
        "label": "Amortization Periods Of Right Of Use Assets",
        "terseLabel": "Amortization periods of the ROU assets (in years)"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AmortizedCostMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AmortizedCostMember",
     "presentation": [
      "http://mediwound.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost [Member]",
        "label": "Amortized cost [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AmortizedCostOfGrantsReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AmortizedCostOfGrantsReceived",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/LiabilitiesInRespectOfIIAGrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of grants received.",
        "label": "Amortized cost of grants received"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AmountOfAnnualFeeOfLeaseAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AmountOfAnnualFeeOfLeaseAgreement",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/SubsequentEventsDetailTextuals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of annual fee of lease agreement.",
        "label": "Amount Of Annual Fee Of Lease Agreement",
        "verboseLabel": "Annual fee of lease agreement"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AmountOfInvestedInProject": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AmountOfInvestedInProject",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about invested in the project.",
        "label": "Amount Of Invested In Project",
        "verboseLabel": "Amount of invested in the project"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AmountOfLeaseLiabilityUnderLongTermDebtAndCurrentMaturity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AmountOfLeaseLiabilityUnderLongTermDebtAndCurrentMaturity",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease liability under long term debt and current maturity.",
        "label": "Amount of lease liability under long term debt and current maturity"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AmountOfOptionToFundDevelopmentOfOtherPotential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AmountOfOptionToFundDevelopmentOfOtherPotential",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents amount of option to fund development of other potential.",
        "label": "Amount Of Option To Fund Development Of Other Potential",
        "verboseLabel": "Amount of option to fund development of other potential"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AmountOfSecondContractExpired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AmountOfSecondContractExpired",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about second contract was expired.",
        "label": "Amount Of Second Contract Expired",
        "verboseLabel": "Amount of second contract was expired"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AmountOfTechnicalAssistance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AmountOfTechnicalAssistance",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents amount of technical assistance.",
        "label": "Amount Of Technical Assistance",
        "verboseLabel": "Amount of technical assistance"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AmountOfUnderwritingDiscountsAndCommissions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AmountOfUnderwritingDiscountsAndCommissions",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents amount of underwriting discounts and commissions.",
        "label": "Amount Of Underwriting Discounts And Commissions",
        "verboseLabel": "Amount of underwriting discounts and commissions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AmountsPayableRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AmountsPayableRelatedPartyTransactions",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts payable resulting from related party transactions. [Refer: Related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r66",
      "r71"
     ]
    },
    "ifrs-full_ApplicableTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ApplicableTaxRate",
     "presentation": [
      "http://mediwound.com/role/TaxesOnIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax rate",
        "verboseLabel": "Income tax rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The applicable income tax rate."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "mdwd_AreaOfLand": {
     "xbrltype": "areaItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AreaOfLand",
     "presentation": [
      "http://mediwound.com/role/SubsequentEventsDetailTextuals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of land.",
        "label": "Area Of Land",
        "terseLabel": "Area of office"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r124",
      "r125",
      "r126",
      "r194",
      "r197"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r251",
      "r252",
      "r253"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r251",
      "r252",
      "r253"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r251",
      "r252",
      "r253"
     ]
    },
    "mdwd_AuthorizedShareCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AuthorizedShareCapital",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount of share capital of an entity.",
        "label": "Authorized Share Capital",
        "verboseLabel": "Authorized share capital"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AverageStandardDeviationOfWarrants": {
     "xbrltype": "percentItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "AverageStandardDeviationOfWarrants",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents average standard deviation of warrants.",
        "label": "Average Standard Deviation Of Warrants",
        "terseLabel": "Average standard deviation of warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BalancesWithBanks": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BalancesWithBanks",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/Short-termBankDepositsScheduleOfShort-termBankDepositsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "USD bank deposits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash balances held at banks."
       }
      }
     },
     "auth_ref": [
      "r281"
     ]
    },
    "mdwd_BardaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "BardaMember",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BARDA [Member]",
        "label": "Barda [Member]",
        "verboseLabel": "BARDA [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BasicEarningsLossPerShare",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss",
      "http://mediwound.com/role/NetProfitLossPerShareScheduleOfNetProfitLossPerShareFromContinuingAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic earnings (loss) per share",
        "terseLabel": "Basic and diluted loss per share:",
        "verboseLabel": "Basic net loss per share - USD"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r79"
     ]
    },
    "mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "BiomedicalAdvancedResearchAndDevelopmentAuthorityMember",
     "presentation": [
      "http://mediwound.com/role/GeneralDetails",
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BARDA [Member]",
        "label": "Biomedical Advanced Research And Development Authority [Member]",
        "verboseLabel": "BARDA [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_BoardMembersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "BoardMembersMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Board Members [Member]",
        "label": "Board Members [Member]",
        "verboseLabel": "Board Members [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BorrowingsByNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BorrowingsByNameAxis",
     "presentation": [
      "http://mediwound.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings by name [axis]",
        "verboseLabel": "Borrowings by name [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r285"
     ]
    },
    "ifrs-full_BorrowingsByNameMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BorrowingsByNameMember",
     "presentation": [
      "http://mediwound.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings by name [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r285"
     ]
    },
    "ifrs-full_BorrowingsInterestRateBasis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BorrowingsInterestRateBasis",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r285"
     ]
    },
    "ifrs-full_BottomOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BottomOfRangeMember",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails",
      "http://mediwound.com/role/FinancialInstrumentsNarrativeDetails",
      "http://mediwound.com/role/Share-basedCompensationScheduleOfEstimatedUsingAcceptableOptionPricingModelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bottom of range [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r149",
      "r164",
      "r234",
      "r235",
      "r285"
     ]
    },
    "mdwd_BuildingAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "BuildingAndEquipmentMember",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfAmortizationPeriodsOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Building and Equipment [Member]",
        "label": "Building and Equipment [Member]",
        "verboseLabel": "Building and equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BuildingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BuildingsMember",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails",
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Buildings [member]",
        "terseLabel": "Buildings [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r268"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "verboseLabel": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r252",
      "r253"
     ]
    },
    "mdwd_CarryforwardLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "CarryforwardLosses",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/TaxesOnIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carryforward losses.",
        "label": "Carryforward losses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails",
      "http://mediwound.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails",
      "http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]",
        "verboseLabel": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r50",
      "r86",
      "r88",
      "r92",
      "r93",
      "r94",
      "r95",
      "r96",
      "r173",
      "r182",
      "r183"
     ]
    },
    "ifrs-full_CarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CarryingAmountMember",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails",
      "http://mediwound.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails",
      "http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying amount [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      }
     },
     "auth_ref": [
      "r50",
      "r88",
      "r92",
      "r94",
      "r95",
      "r173",
      "r182",
      "r183"
     ]
    },
    "ifrs-full_CashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 0.0
      },
      "http://mediwound.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails",
      "http://mediwound.com/role/ConsolidatedBalanceSheets",
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance of cash and cash equivalents at the end of the year",
        "periodStartLabel": "Balance of cash and cash equivalents at the beginning of the year",
        "label": "Cash and cash equivalents",
        "totalLabel": "Cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r12",
      "r104",
      "r119"
     ]
    },
    "ifrs-full_CashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashAndCashEquivalentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_CashAndCashEquivalentsShortTermAndRestrictedBankDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "CashAndCashEquivalentsShortTermAndRestrictedBankDeposits",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and cash equivalents, short-term and restricted bank deposits.",
        "label": "Cash And Cash Equivalents Short Term And Restricted Bank Deposits",
        "terseLabel": "Cash and cash equivalents, short-term and restricted bank deposits"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from (investments in) short term bank deposits, net",
        "terseLabel": "Proceeds from (investment in) short term bank deposits, net"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow (outflow) due to a decrease (increase) in short-term deposits and investments."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Net cash flows from (used in) financing activities",
        "label": "Cash flows from (used in) financing activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r105"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Financing Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities",
        "totalLabel": "Net cash (used in) provided by investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r105"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Investing Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities",
        "totalLabel": "Net cash used in operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r97",
      "r105"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Operating Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashOnHand": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashOnHand",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails": {
       "parentTag": "ifrs-full_CashAndCashEquivalents",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "USD cash for immediate withdrawal",
        "terseLabel": "Balance in USD"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash held by the entity. This does not include demand deposits."
       }
      }
     },
     "auth_ref": [
      "r281"
     ]
    },
    "mdwd_CashOnHandInNonUsd": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "CashOnHandInNonUsd",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails": {
       "parentTag": "ifrs-full_CashAndCashEquivalents",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash held by the entity in Non USD. This does not include demand deposits.",
        "label": "Cash On Hand In Non Usd",
        "terseLabel": "Balance in other currencies"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashOutflowForLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashOutflowForLeases",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfInformationOnLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total cash outflow for leases",
        "terseLabel": "Cash outflow for leases"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for leases."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CategoriesOfRelatedPartiesAxis",
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersNarrativeDetails",
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfKeyOfficersOfTheCompanyDetails",
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfRelatedPartiesDetails",
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfTransactionsWithRelatedPartiesDetails",
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails",
      "http://mediwound.com/role/EquityNarrativeDetails",
      "http://mediwound.com/role/MaterialAgreementsDetails",
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails",
      "http://mediwound.com/role/SubsequentEventsDetailTextuals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]",
        "verboseLabel": "Categories of related parties [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "mdwd_CertainEntitiesAffiliatedWithCbiMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "CertainEntitiesAffiliatedWithCbiMember",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certain entities affiliated with CBI.",
        "label": "Certain Entities Affiliated With Cbi [Member]",
        "verboseLabel": "Certain entities affiliated with CBI [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ChairmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ChairmanMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Chairman [Member]",
        "label": "Chairman [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of Capitalization of depreciation of ROU assets.",
        "label": "Change In Property Plant And Equipment Capitalization Of Depreciation Of Rou Assets",
        "terseLabel": "Capitalization of depreciation of ROU assets"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ChangesInAssetAndLiabilityItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ChangesInAssetAndLiabilityItemsAbstract",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes In Asset And Liability Items [Abstract]",
        "verboseLabel": "Changes in asset and liability items:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ChangesInInventoriesOfFinishedGoodsAndWorkInProgress": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ChangesInInventoriesOfFinishedGoodsAndWorkInProgress",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesProductsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease in inventory of finished products",
        "verboseLabel": "Decrease (increase) in inventory of finished products"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease (increase) in inventories of finished goods and work in progress. [Refer: Inventories; Current finished goods; Current work in progress]"
       }
      }
     },
     "auth_ref": [
      "r36",
      "r207"
     ]
    },
    "mdwd_ChiefExecutiveOfficerAndChiefMedicalOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ChiefExecutiveOfficerAndChiefMedicalOfficerMember",
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Chief Executive Officer and Chief Medical Officer [Member]",
        "label": "Chief Executive Officer and Chief Medical Officer [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ChiefExecutiveOfficersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ChiefExecutiveOfficersMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CEO [Member]",
        "label": "Chief Executive Officers [Member]",
        "verboseLabel": "CEO [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfAssetsAxis",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails",
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails",
      "http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfAmortizationPeriodsOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r83",
      "r127",
      "r139"
     ]
    },
    "ifrs-full_ClassesOfAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfAssetsMember",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails",
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails",
      "http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfAmortizationPeriodsOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r127",
      "r139"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails",
      "http://mediwound.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of intangible assets other than goodwill [Axis]",
        "verboseLabel": "Classes of intangible assets other than goodwill [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "ifrs-full_ClassesOfInventoriesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfInventoriesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of current inventories [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfOrdinarySharesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfOrdinarySharesAxis",
     "presentation": [
      "http://mediwound.com/role/NetProfitLossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of ordinary shares [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "presentation": [
      "http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails",
      "http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfDepreciationOnStraight-lineBasisOverUsefulLifeOfAssetsDetails",
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [Axis]",
        "verboseLabel": "Classes of property, plant and equipment [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "ifrs-full_ClassesOfShareCapitalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfShareCapitalAxis",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails",
      "http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails",
      "http://mediwound.com/role/Share-basedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of share capital [Axis]",
        "verboseLabel": "Classes of share capital [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "ifrs-full_ClassesOfShareCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfShareCapitalMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails",
      "http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails",
      "http://mediwound.com/role/Share-basedCompensationTables"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "mdwd_CollaborationAgreementsAmountRelatedToPolyheal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "CollaborationAgreementsAmountRelatedToPolyheal",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration agreements amount related to Polyheal.",
        "label": "Collaboration agreements amount related to Polyheal"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_CommissionsAndOtherOfferingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "CommissionsAndOtherOfferingExpenses",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of commissions and other offering expenses.",
        "label": "Commissions And Other Offering Expenses",
        "terseLabel": "Commissions and other offering expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ComponentsOfEquityAxis",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of equity [Axis]",
        "verboseLabel": "Components of equity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ifrs-full_ComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity",
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive income",
        "terseLabel": "Total comprehensive loss",
        "totalLabel": "Total comprehensive loss",
        "verboseLabel": "Total comprehensive income (loss)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r27",
      "r107",
      "r109",
      "r114",
      "r233"
     ]
    },
    "mdwd_CompromisedDepreciationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "CompromisedDepreciationExpense",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of compromised depreciation expense.",
        "label": "Compromised Depreciation Expense",
        "terseLabel": "Comprised depreciation expenses recorded in the profit and loss"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails",
      "http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfDepreciationOnStraight-lineBasisOverUsefulLifeOfAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computers [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r268"
     ]
    },
    "mdwd_ConcentrationRiskPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ConcentrationRiskPercentage",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk Percentage",
        "verboseLabel": "Percentage of revenues"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ConsiderationPaidReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ConsiderationPaidReceived",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revised cash consideration paid"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r252"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ContingentLiabilitiesRecognisedInBusinessCombination",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Obligation for contingent consideration"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of contingent liabilities recognised in a business combination. [Refer: Contingent liabilities [member]; Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "mdwd_ContractAmountForDevelopmentAndManufacturing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ContractAmountForDevelopmentAndManufacturing",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/GeneralDetails",
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of contract for development and manufacturing.",
        "label": "Contract Amount For Development And Manufacturing",
        "terseLabel": "Contract amount for development and manufacturing"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ContractWithCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ContractWithCustomers",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customers",
        "label": "Contract With Customers",
        "verboseLabel": "Contracts with customers"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patents and intellectual property [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing copyrights, patents and other industrial property rights, service and operating rights. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r226"
     ]
    },
    "mdwd_CostOfLicenseAgreements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "CostOfLicenseAgreements",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_CostOfSales",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of cost of license agreements.",
        "label": "Cost Of License Agreements",
        "terseLabel": "Cost of revenues from license agreements"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_CostOfMaterials": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "CostOfMaterials",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of materials.",
        "label": "Cost Of Materials",
        "verboseLabel": "Cost of materials"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CostOfMerchandiseSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CostOfMerchandiseSold",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesProductsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of merchandise sold",
        "terseLabel": "Cost of revenues from sale of products",
        "verboseLabel": "Cost of materials"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of merchandise that was sold during the period and recognised as an expense."
       }
      }
     },
     "auth_ref": [
      "r267"
     ]
    },
    "mdwd_CostOfRevenuesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "CostOfRevenuesMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfExpenseRecognizedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of revenues [Member]",
        "label": "Cost of Revenues [Member]",
        "verboseLabel": "Cost of revenues [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CostOfSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CostOfSales",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss",
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenueLicenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of sales",
        "terseLabel": "Cost of revenues",
        "totalLabel": "Total cost of revenues",
        "verboseLabel": "Total Cost of Revenues"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r36"
     ]
    },
    "mdwd_CostOfSalesFromLicenseAgreements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "CostOfSalesFromLicenseAgreements",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of costs relating to expenses directly or indirectly attributed to license agreements.",
        "label": "Cost Of Sales From License Agreements",
        "totalLabel": "Cost of revenues from development services"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_CostOfSalesFromSaleOfProducts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "CostOfSalesFromSaleOfProducts",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_CostOfSales",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss",
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesProductsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of costs relating to expenses directly or indirectly attributed to sale of products.",
        "label": "Cost Of Sales From Sale Of Products",
        "terseLabel": "Cost of revenues from sale of products",
        "verboseLabel": "Cost of revenues from sale of products"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CountryOfDomicileMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CountryOfDomicileMember",
     "presentation": [
      "http://mediwound.com/role/TaxesOnIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Israel [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the country in which the entity is registered and where it has its legal address or registered office."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r203"
     ]
    },
    "srt_CurrencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CurrencyAxis",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails",
      "http://mediwound.com/role/Short-termBankDepositsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets",
        "totalLabel": "Total current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      }
     },
     "auth_ref": [
      "r16",
      "r110",
      "r233"
     ]
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentAssetsAbstract",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT ASSETS:"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_CurrentBarda": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "CurrentBarda",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/TradeReceivablesScheduleOfTradeReceivablesDetails": {
       "parentTag": "ifrs-full_CurrentTradeReceivables",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/TradeReceivablesScheduleOfTradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BARDA.",
        "label": "Current Barda",
        "verboseLabel": "BARDA (Note 18a)"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_CurrentGovernmentAuthoritiesReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "CurrentGovernmentAuthoritiesReceivables",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/OtherReceivablesScheduleOfOtherReceivablesDetails": {
       "parentTag": "ifrs-full_OtherCurrentReceivables",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/OtherReceivablesScheduleOfOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government authorities receivables.",
        "label": "Current Government Authorities Receivables",
        "verboseLabel": "Government authorities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentGovernmentGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentGovernmentGrants",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/LiabilitiesInRespectOfIiaGrantsScheduleOfIsraeliInnovationAuthorityGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Current maturities",
        "label": "Current government grants"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current government grants recognised in the statement of financial position as deferred income. [Refer: Government [member]; Government grants]"
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "ifrs-full_CurrentLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentLeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedPeriodEndLabel": "Current maturities of long-term leases",
        "label": "Current lease liabilities",
        "verboseLabel": "Annual fee of lease"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ifrs-full_CurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r112",
      "r233"
     ]
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentLiabilitiesAbstract",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets",
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities [abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_CurrentMaturitiesOfLongTermLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "CurrentMaturitiesOfLongTermLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of current maturities of long-term liabilities.",
        "label": "Current Maturities Of Long Term Liabilities",
        "terseLabel": "Current maturities of long-term liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_CurrentMtec": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "CurrentMtec",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/TradeReceivablesScheduleOfTradeReceivablesDetails": {
       "parentTag": "ifrs-full_CurrentTradeReceivables",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/TradeReceivablesScheduleOfTradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MTEC.",
        "label": "Current Mtec",
        "terseLabel": "MTEC (Note 18c)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentPrepaidExpenses",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/OtherReceivablesScheduleOfOtherReceivablesDetails": {
       "parentTag": "ifrs-full_OtherCurrentReceivables",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/OtherReceivablesScheduleOfOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_CurrentTradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentTradeReceivables",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 20.0
      },
      "http://mediwound.com/role/TradeReceivablesScheduleOfTradeReceivablesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets",
      "http://mediwound.com/role/TradeReceivablesScheduleOfTradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current trade receivables",
        "terseLabel": "Trade receivables",
        "totalLabel": "Trade Receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables. [Refer: Trade receivables]"
       }
      }
     },
     "auth_ref": [
      "r210",
      "r212"
     ]
    },
    "mdwd_CurrentVericel": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "CurrentVericel",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/TradeReceivablesScheduleOfTradeReceivablesDetails": {
       "parentTag": "ifrs-full_CurrentTradeReceivables",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/TradeReceivablesScheduleOfTradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vericel.",
        "label": "Current Vericel",
        "terseLabel": "Vericel (Note 18b)"
       }
      }
     },
     "auth_ref": []
    },
    "country_DE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "DE",
     "presentation": [
      "http://mediwound.com/role/TaxesOnIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Germany [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredIncomeOtherThanContractLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DeferredIncomeOtherThanContractLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities representing income that has been received (or the amount is due) but is not yet earned, other than contract liabilities. [Refer: Contract liabilities]"
       }
      }
     },
     "auth_ref": [
      "r263",
      "r265"
     ]
    },
    "mdwd_DeferredRevenueNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DeferredRevenueNonCurrent",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/OtherPayablesScheduleOfOtherPayablesDetails": {
       "parentTag": "ifrs-full_OtherCurrentPayables",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the deferred revenue non current.",
        "label": "Deferred Revenue Non Current",
        "terseLabel": "Deferred revenues"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DeferredRevenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DeferredRevenues",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/OtherPayablesScheduleOfOtherPayablesDetails": {
       "parentTag": "ifrs-full_OtherCurrentPayables",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/OtherPayablesScheduleOfOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents Deferred Revenues .",
        "label": "Deferred Revenues",
        "terseLabel": "Deferred revenues"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DeferredRevenuesExpectedRecongnizedPeriod": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DeferredRevenuesExpectedRecongnizedPeriod",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred revenues expected recongnized period.",
        "label": "Deferred revenues expected recongnized period"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DeferredTaxAssetsNotRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DeferredTaxAssetsNotRecognized",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/TaxesOnIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets not recognized because their utilization in the foreseeable future is not probable.",
        "label": "Deferred tax assets not recognized"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DepositInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DepositInterestRate",
     "presentation": [
      "http://mediwound.com/role/Short-termBankDepositsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deposit interest rate.",
        "label": "Deposit interest rate"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DepreciatedCostMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DepreciatedCostMember",
     "presentation": [
      "http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depreciated cost [Member]",
        "label": "Depreciated cost [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DepreciationAndAmortisationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DepreciationAndAmortisationExpense",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesProductsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortisation expense",
        "verboseLabel": "Depreciation and amortization"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r36",
      "r120",
      "r192",
      "r199",
      "r207"
     ]
    },
    "mdwd_DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeneralExpensesDetails": {
       "parentTag": "ifrs-full_SellingGeneralAndAdministrativeExpense",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeneralExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depreciation and amortization expense related to general and administrative expenses.",
        "label": "Depreciation And Amortisation Expense Related To General And Administrative Expenses",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of depreciation and amortisation expense related to research and development.",
        "label": "Depreciation And Amortisation Expense Related To Research And Development",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails": {
       "parentTag": "ifrs-full_SalesAndMarketingExpense",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of depreciation and amortisation expense related to selling and marketing expenses.",
        "label": "Depreciation And Amortisation Expense Related To Selling And Marketing Expenses",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DepreciationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DepreciationExpense",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_DepreciationRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DepreciationRightofuseAssets",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation, right-of-use assets",
        "verboseLabel": "Depreciation and amortization"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "mdwd_DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of the basis used for consolidation",
        "label": "Description Of Accounting Policy For Basis Of Consolidation Explanatory",
        "terseLabel": "Basis of consolidation"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit / Loss per share",
        "terseLabel": "Profit / Loss per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r261"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term employee benefits and severance pay liability, net",
        "terseLabel": "Short-term employee benefits and severance pay liability, net"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment."
       }
      }
     },
     "auth_ref": [
      "r261"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial instruments",
        "terseLabel": "Financial instruments"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for financial instruments. [Refer: Financial instruments, class [member]]"
       }
      }
     },
     "auth_ref": [
      "r261"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForGovernmentGrants",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability in respect of IIA",
        "terseLabel": "Liability in respect of Israeli Innovation Authority (\"IIA\")"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for leases [text block]",
        "terseLabel": "Leases",
        "verboseLabel": "Leases"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time."
       }
      }
     },
     "auth_ref": [
      "r261"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForMeasuringInventories",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for measuring inventories [text block]",
        "verboseLabel": "Inventories"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "mdwd_DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for new standards, amendments to standards and interpretations not yet adopted.",
        "label": "Description Of Accounting Policy For New Standards, Amendments To Standards And Interpretations Not Yet Adopted Explanatory",
        "terseLabel": "New standards, amendments to standards and interpretations not yet adopted"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for property, plant and equipment [text block]",
        "verboseLabel": "Property, plant and equipment, net"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r261"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provisions",
        "terseLabel": "Provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for provisions. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r261"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for recognition of revenue [text block]",
        "terseLabel": "Revenues recognition"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for recognising revenue. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r261"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for research and development expense [text block]",
        "terseLabel": "Research and development expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for research and development expense. [Refer: Research and development expense]"
       }
      }
     },
     "auth_ref": [
      "r261"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for share-based payment transactions [text block]",
        "terseLabel": "Share-based compensation",
        "verboseLabel": "Share-based compensation"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]"
       }
      }
     },
     "auth_ref": [
      "r261"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForWarrantsExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for warrants [text block]",
        "terseLabel": "Warrants"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for warrants. Warrants are financial instruments that give the holder the right to purchase ordinary shares."
       }
      }
     },
     "auth_ref": [
      "r261"
     ]
    },
    "ifrs-full_DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discount rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The discount rate used in the current estimate of the present value of the future cash flows expected to be derived from an asset or cash-generating unit."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfEstimatedUsingAcceptableOptionPricingModelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility of the share prices (%)",
        "terseLabel": "Expected volatility of the share prices (%)"
       }
      },
      "en": {
       "role": {
        "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercisable period"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the maximum term of options granted for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]]"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfEstimatedUsingAcceptableOptionPricingModelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free interest rate (%)"
       }
      },
      "en": {
       "role": {
        "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "mdwd_DescriptionOfTaxBenefitPeriod": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DescriptionOfTaxBenefitPeriod",
     "presentation": [
      "http://mediwound.com/role/TaxesOnIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of tax benefit period.",
        "label": "Description Of Tax Benefit Period",
        "verboseLabel": "Tax benefit period"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfUsefulLifePropertyPlantAndEquipment",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfDepreciationOnStraight-lineBasisOverUsefulLifeOfAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Useful life of assets at annual rates (in %)"
       }
      },
      "en": {
       "role": {
        "documentation": "Description of useful life used for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfVestingRequirementsForSharebasedPaymentArrangement",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails",
      "http://mediwound.com/role/SubsequentEventsDetailTextuals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of vesting requirements for share-based payment arrangement",
        "terseLabel": "Vesting period"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]]"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DilutedEarningsLossPerShare",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted earnings (loss) per share",
        "verboseLabel": "Diluted net loss per share - USD"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r79"
     ]
    },
    "mdwd_DilutedWeightedAverageNumberMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DilutedWeightedAverageNumberMember",
     "presentation": [
      "http://mediwound.com/role/NetProfitLossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diluted weighted average number.",
        "label": "Diluted Weighted Average Number [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DirectorsAndCeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DirectorsAndCeoMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Directors And CEO [Member]",
        "label": "Directors And Ceo [Member]",
        "verboseLabel": "Directors and CEO [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DirectorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DirectorsMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Directors [Member]",
        "label": "Directors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DirectorsRemunerationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DirectorsRemunerationExpense",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "One-time bonus payments",
        "terseLabel": "One-time payments"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of remuneration paid or payable to the entity's directors."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "mdwd_DisclosureOfAdditionalInformationAboutLeaseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfAdditionalInformationAboutLeaseExplanatory",
     "presentation": [
      "http://mediwound.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information on leases.",
        "label": "Disclosure Of Additional Information About Lease Explanatory",
        "verboseLabel": "Schedule of amounts recognized in profit or loss and in the statement of cash flows"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory",
     "presentation": [
      "http://mediwound.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Disclosures of Lease Liabilities",
        "terseLabel": "Schedule of maturity analysis of the Group's lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of additional information about leasing activities of a lessee."
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "mdwd_DisclosureOfAdditionalInformationRevenuesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfAdditionalInformationRevenuesExplanatory",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of additional information on revenues.",
        "label": "Disclosure Of Additional Information Revenues Explanatory",
        "verboseLabel": "Schedule of additional information on revenues"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory",
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Compensation of Officers of Company",
        "terseLabel": "Schedule of compensation of officers of company"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of amounts incurred by the entity for provision of key management personnel services that are provided by separate management entities. [Refer: Key management personnel of entity or parent [member]; Separate management entities [member]]"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "mdwd_DisclosureOfBasisOfPreparationOfConsolidatedFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfBasisOfPreparationOfConsolidatedFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Basis Of Preparation Of Consolidated Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingJudgmentsEstimatesAndAssumptionsUsedInPreparationOfFinancialStatements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of basis of preparation of financial statements [text block]",
        "terseLabel": "Basis of Preparation of the Consolidated Financial Statements"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the basis used for the preparation of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfCashAndCashEquivalentsExplanatory",
     "presentation": [
      "http://mediwound.com/role/CashAndCashEquivalents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of cash and cash equivalents [text block]",
        "terseLabel": "Cash And Cash Equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfChangesInAccountingPoliciesExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SIGNIFICANT ACCOUNTING POLICIES",
        "terseLabel": "Material Accounting Policies"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of changes made to accounting policies by the entity."
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalExplanatory",
     "presentation": [
      "http://mediwound.com/role/EquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share Capital",
        "terseLabel": "Schedule of share capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of classes of share capital. [Refer: Share capital [member]]"
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalLineItems",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalTable",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to classes of share capital."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONTINGENT LIABILITIES AND COMMITMENTS",
        "terseLabel": "Contingent Liabilities And Commitments",
        "verboseLabel": "Liabilities and Commitments"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of commitments and contingent liabilities. [Refer: Contingent liabilities [member]]"
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfContingentLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of contingent liabilities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfContingentLiabilitiesLineItems",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails",
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of contingent liabilities [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfContingentLiabilitiesTable",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails",
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of contingent liabilities [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to contingent liabilities."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "ifrs-full_DisclosureOfCostOfSalesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfCostOfSalesExplanatory",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Cost of Revenues Products",
        "terseLabel": "Schedule of cost of revenues products"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the cost of sales. [Refer: Cost of sales]"
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "mdwd_DisclosureOfCostOfSalesServicesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfCostOfSalesServicesExplanatory",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of the cost of sales from services. [Refer: Cost of sales]",
        "label": "Disclosure Of Cost Of Sales Services Explanatory",
        "verboseLabel": "Schedule of cost of revenues services"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDefinedBenefitPlansAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of defined benefit plans [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDefinedBenefitPlansExplanatory",
     "presentation": [
      "http://mediwound.com/role/SeverancePayLiabiltyNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEVERANCE PAY LIABILTY, NET",
        "terseLabel": "Severance Pay Liability, Net"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of defined benefit plans. [Refer: Defined benefit plans [member]]"
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "ifrs-full_DisclosureOfDepositaryReceiptsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDepositaryReceiptsAbstract",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of depositary receipts [abstract]",
        "verboseLabel": "Loss per share data:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDepositsFromBanksExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDepositsFromBanksExplanatory",
     "presentation": [
      "http://mediwound.com/role/Short-termBankDeposits"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHORT-TERM BANK DEPOSITS",
        "terseLabel": "Short-term and restricted bank deposits"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of deposits from banks. [Refer: Deposits from banks]"
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDerivativeFinancialInstrumentsExplanatory",
     "presentation": [
      "http://mediwound.com/role/FinancialInstruments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FINANCIAL INSTRUMENTS",
        "terseLabel": "Financial Instruments"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of derivative financial instruments. [Refer: Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "mdwd_DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory",
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about balances with key officers of the company.",
        "label": "Disclosure Of Detailed Information About Balances With Key Officers Explanatory",
        "verboseLabel": "Schedule of balances of key officers"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory",
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about balances with related parties.",
        "label": "Disclosure Of Detailed Information About Balances With Related Parties Explanatory",
        "verboseLabel": "Schedule of balances of related parties"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
     "presentation": [
      "http://mediwound.com/role/CashAndCashEquivalentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about cash and cash equivalents.",
        "label": "Disclosure Of Detailed Information About Cash And Cash Equivalents Explanatory",
        "verboseLabel": "Schedule of cash and cash equivalents"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory",
     "presentation": [
      "http://mediwound.com/role/NetProfitLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about details of number of shares and loss used in computation.",
        "label": "Disclosure Of Detailed Information About Details Of Number Of Shares And Loss Used In Computation Explanatory",
        "verboseLabel": "Schedule of details of number of shares and loss used in computation"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
     "presentation": [
      "http://mediwound.com/role/IntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Intangible Assets, Net",
        "terseLabel": "Schedule of intangible assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "mdwd_DisclosureOfDetailedInformationAboutInventoriesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfDetailedInformationAboutInventoriesExplanatory",
     "presentation": [
      "http://mediwound.com/role/InventoriesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about inventories.",
        "label": "Disclosure Of Detailed Information About Inventories Explanatory",
        "verboseLabel": "Schedule of inventories"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory",
     "presentation": [
      "http://mediwound.com/role/LiabilitiesInRespectOfIiaGrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about israeli innovation authority grants.",
        "label": "Disclosure Of Detailed Information About Israeli Innovation Authority Grants Explanatory",
        "terseLabel": "Schedule of Israeli innovation authority grants",
        "verboseLabel": "Schedule of Israeli Innovation Authority Grants"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory",
     "presentation": [
      "http://mediwound.com/role/NetProfitLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about net loss per share from continuing and discontinued operations.",
        "label": "Disclosure Of Detailed Information About Net Loss Per Share From Continuing And Discontinued Operations Explanatory",
        "verboseLabel": "Schedule of net profit (loss) per share from continuing and discontinued operations"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DisclosureOfDetailedInformationAboutOtherPayablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfDetailedInformationAboutOtherPayablesExplanatory",
     "presentation": [
      "http://mediwound.com/role/OtherPayablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about other payables.",
        "label": "Disclosure Of Detailed Information About Other Payables Explanatory",
        "verboseLabel": "Schedule of other payables"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory",
     "presentation": [
      "http://mediwound.com/role/OtherReceivablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about other receivables.",
        "label": "Disclosure Of Detailed Information About Other Receivables Explanatory",
        "verboseLabel": "Schedule of other short term receivables"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory",
     "presentation": [
      "http://mediwound.com/role/OtherReceivablesLongTermTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about other receivables long term.",
        "label": "Disclosure Of Detailed Information About Other Receivables Long Term Explanatory",
        "verboseLabel": "Schedule of other long term receivables"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://mediwound.com/role/PropertyPlantAndEquipmentNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Property, Plant and Equipment, Net",
        "terseLabel": "Schedule of property, plant and equipment, net"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "mdwd_DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about selling and marketing expenses.",
        "label": "Disclosure Of Detailed Information About Selling And Marketing Expenses Explanatory",
        "verboseLabel": "Schedule of selling expenses"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory",
     "presentation": [
      "http://mediwound.com/role/Short-termBankDepositsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about short-term bank deposits.",
        "label": "Disclosure Of Detailed Information About Short Term Bank Deposits Explanatory",
        "terseLabel": "Schedule of short-term bank deposits"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory",
     "presentation": [
      "http://mediwound.com/role/TradeReceivablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about trade receivables.",
        "label": "Disclosure Of Detailed Information About Trade Receivables Explanatory",
        "verboseLabel": "Schedule of trade receivables"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about useful lives for property, plant and equipment.",
        "label": "Disclosure Of Detailed Information About Useful Life Of Property Plant And Equipment Explanatory",
        "verboseLabel": "Schedule of depreciation on straight-line basis over useful life of assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeographicalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of disaggregation of revenue from contracts with customers [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeographicalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of disaggregation of revenue from contracts with customers [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ifrs-full_DisclosureOfEarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfEarningsPerShareExplanatory",
     "presentation": [
      "http://mediwound.com/role/NetProfitLossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NET PROFIT (LOSS) PER SHARE",
        "terseLabel": "Net Profit (Loss) Per Share",
        "verboseLabel": "Net Loss Per Share"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory",
     "presentation": [
      "http://mediwound.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS",
        "terseLabel": "Subsequent events"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for events after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinanceIncomeExpenseExplanatory",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Financial Expense",
        "terseLabel": "Schedule of financial expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of finance income (cost). [Refer: Finance income (cost)]"
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails",
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of Finance Lease and Operating Lease by Lessee Line Items",
        "label": "Disclosure Of Finance Lease And Operating Lease By Lessee [Line Items]",
        "terseLabel": "Disclosure Of Finance Lease And Operating Lease By Lessee [Line Items]",
        "verboseLabel": "Disclosure Of Finance Lease And Operating Lease By Lessee [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails",
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Finance Lease And Operating Lease By Lessee Table",
        "label": "Disclosure Of Finance Lease And Operating Lease By Lessee [Table]",
        "verboseLabel": "Disclosure Of Finance Lease And Operating Lease By Lessee [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about financial instruments [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems",
     "presentation": [
      "http://mediwound.com/role/Short-termBankDepositsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial instruments by type of interest rate [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable",
     "presentation": [
      "http://mediwound.com/role/Short-termBankDepositsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial instruments by type of interest rate [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial instruments, by type of interest rate."
       }
      }
     },
     "auth_ref": [
      "r284"
     ]
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsLineItems",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsNarrativeDetails",
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfSensitivityTestsRelatingToChangesInMarketFactorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about financial instruments [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsTable",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsNarrativeDetails",
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfSensitivityTestsRelatingToChangesInMarketFactorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about financial instruments [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r184",
      "r189"
     ]
    },
    "ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfGeneralAndAdministrativeExpenseExplanatory",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of General Expenses",
        "terseLabel": "Schedule of general expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of general and administrative expenses. [Refer: Administrative expenses]"
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
     "presentation": [
      "http://mediwound.com/role/General"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GENERAL",
        "terseLabel": "General"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for general information about financial statements."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "mdwd_DisclosureOfGeneralInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfGeneralInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of General Information [Abstract]",
        "verboseLabel": "Disclosure of general [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfGeographicalAreasExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfGeographicalAreasExplanatory",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Geographical Information",
        "terseLabel": "Schedule of geographical information"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of geographical information."
       }
      }
     },
     "auth_ref": [
      "r204"
     ]
    },
    "ifrs-full_DisclosureOfGovernmentGrantsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfGovernmentGrantsExplanatory",
     "presentation": [
      "http://mediwound.com/role/LiabilitiesInRespectOfIiaGrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES IN RESPECT OF IIA GRANTS",
        "terseLabel": "Liabilities in Respect of IIA Grants"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for government grants."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "ifrs-full_DisclosureOfIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfIncomeTaxExplanatory",
     "presentation": [
      "http://mediwound.com/role/TaxesOnIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of income tax [text block]",
        "terseLabel": "Income Tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for income taxes."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "mdwd_DisclosureOfIncomeTaxesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfIncomeTaxesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Income Taxes [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Value Assumptions",
        "terseLabel": "Schedule of fair value assumptions"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options."
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ifrs-full_DisclosureOfIntangibleAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsExplanatory",
     "presentation": [
      "http://mediwound.com/role/IntangibleAssetsNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INTANGIBLE ASSETS, NET",
        "terseLabel": "Intangible Assets, Net"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for intangible assets."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "ifrs-full_DisclosureOfIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsLineItems",
     "presentation": [
      "http://mediwound.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsTable",
     "presentation": [
      "http://mediwound.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of intangible assets."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "ifrs-full_DisclosureOfInventoriesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfInventoriesExplanatory",
     "presentation": [
      "http://mediwound.com/role/Inventories"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INVENTORIES",
        "terseLabel": "Inventories"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for inventories."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "mdwd_DisclosureOfIsraeliInnovationAuthorityGrantsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfIsraeliInnovationAuthorityGrantsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of israeli innovation authority grants [Abstract]",
        "terseLabel": "Liabilities In Respect Of Iia Grants Narrative",
        "verboseLabel": "Liabilities In Respect Of Iia Grants"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfLeasesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfLeasesExplanatory",
     "presentation": [
      "http://mediwound.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LEASES",
        "terseLabel": "Leases"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for leases."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r146"
     ]
    },
    "mdwd_DisclosureOfMaterialAgreementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfMaterialAgreementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Material Agreements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DisclosureOfMaterialAgreementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfMaterialAgreementsExplanatory",
     "presentation": [
      "http://mediwound.com/role/MaterialAgreements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of material agreements.",
        "label": "Disclosure Of Material Agreements Explanatory",
        "verboseLabel": "Materials Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis for non-derivative financial liabilities [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis for non-derivative financial liabilities [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the maturity analysis for non-derivative financial liabilities."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Minimum Future Lease Fees"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of a maturity analysis of operating lease payments. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset."
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis of operating lease payments [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis of operating lease payments [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the maturity analysis of operating lease payments."
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems",
     "presentation": [
      "http://mediwound.com/role/SubsequentEventsDetailTextuals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable",
     "presentation": [
      "http://mediwound.com/role/SubsequentEventsDetailTextuals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share Options Activity",
        "terseLabel": "Schedule of share options activity"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Information About Share Options Outstanding",
        "terseLabel": "Schedule of information about share options outstanding"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the number and weighted average remaining contractual life of outstanding share options."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "mdwd_DisclosureOfOtherReceivablesLongTermExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfOtherReceivablesLongTermExplanatory",
     "presentation": [
      "http://mediwound.com/role/OtherReceivablesLongTerm"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other receivables long term.",
        "label": "Disclosure Of Other Receivables Long Term Explanatory",
        "terseLabel": "Other Receivables- Long Term"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://mediwound.com/role/PropertyPlantAndEquipmentNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PROPERTY, PLANT AND EQUIPMENT, NET",
        "terseLabel": "Property, Plant And Equipment, Net"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails",
      "http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfDepreciationOnStraight-lineBasisOverUsefulLifeOfAssetsDetails",
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails",
      "http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfDepreciationOnStraight-lineBasisOverUsefulLifeOfAssetsDetails",
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
     "presentation": [
      "http://mediwound.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Disclosures of Right-of-Use Assets",
        "terseLabel": "Schedule of carrying amounts of right-of-use assets and movement"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfAmortizationPeriodsOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfAmortizationPeriodsOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to right-of-use assets."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ifrs-full_DisclosureOfRelatedPartyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfRelatedPartyExplanatory",
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficers"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BALANCES AND TRANSACTIONS WITH RELATED PARTIES AND KEY OFFICERS",
        "terseLabel": "Balances And Transactions With Related Parties And Key Officers"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for related parties."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfResearchAndDevelopmentExpenseExplanatory",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Research Expenses",
        "terseLabel": "Schedule of research expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of research and development expense. [Refer: Research and development expense]"
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
     "presentation": [
      "http://mediwound.com/role/Equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of share capital, reserves and other equity interest [text block]",
        "terseLabel": "Equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for share capital, reserves and other equity interest."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHARE-BASED COMPENSATION",
        "terseLabel": "Share Based Compensation"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangements."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "mdwd_DisclosureOfShortTermBankDepositsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfShortTermBankDepositsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Short Term Bank Deposits [Abstract]",
        "terseLabel": "Short-term Bank Deposits Schedule Of Short-term Bank Deposits",
        "verboseLabel": "Short-term Bank Deposits"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DisclosureOfSignificantAccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfSignificantAccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of significant accounting policies [Abstract]",
        "terseLabel": "Significant Accounting Policies Narrative",
        "verboseLabel": "Significant Accounting Policies"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfSignificantInvestmentsInAssociatesLineItems",
     "presentation": [
      "http://mediwound.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of associates [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfSignificantInvestmentsInAssociatesTable",
     "presentation": [
      "http://mediwound.com/role/GeneralDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to associates."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r77",
      "r123"
     ]
    },
    "mdwd_DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLost"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplementary information to the statements of profit and lost and other comprehensive loss.",
        "label": "Disclosure Of Supplementary Information To Statements Of Comprehensive Loss Explanatory",
        "verboseLabel": "Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfSupplementaryInformationToStatementsOfProfitAndLostAndOtherComprehensiveLossAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of supplementary information to the statements of profit and lost and other comprehensive loss [Abstract]",
        "verboseLabel": "Supplementary Information To Statements Of Comprehensive Profit Or Lost"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems",
     "presentation": [
      "http://mediwound.com/role/TaxesOnIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable",
     "presentation": [
      "http://mediwound.com/role/TaxesOnIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to temporary differences, unused tax losses and unused tax credits."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails",
      "http://mediwound.com/role/Share-basedCompensationScheduleOfEstimatedUsingAcceptableOptionPricingModelsDetails",
      "http://mediwound.com/role/Share-basedCompensationScheduleOfExpenseRecognizedDetails",
      "http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails",
      "http://mediwound.com/role/Share-basedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails",
      "http://mediwound.com/role/Share-basedCompensationScheduleOfEstimatedUsingAcceptableOptionPricingModelsDetails",
      "http://mediwound.com/role/Share-basedCompensationScheduleOfExpenseRecognizedDetails",
      "http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails",
      "http://mediwound.com/role/Share-basedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTradeAndOtherPayablesExplanatory",
     "presentation": [
      "http://mediwound.com/role/OtherPayables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER PAYABLES",
        "terseLabel": "Other Payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]"
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory",
     "presentation": [
      "http://mediwound.com/role/OtherReceivables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER RECEIVABLES",
        "terseLabel": "Other Receivables",
        "verboseLabel": "Other Receivables- Short Term"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]"
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "mdwd_DisclosureOfTradeReceivablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisclosureOfTradeReceivablesExplanatory",
     "presentation": [
      "http://mediwound.com/role/TradeReceivables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of trade receivables.",
        "label": "Disclosure Of Trade Receivables Explanatory",
        "verboseLabel": "Trade Receivables"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Transactions with Related Parties",
        "terseLabel": "Schedule of transactions with related parties"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesLineItems",
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersNarrativeDetails",
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfKeyOfficersOfTheCompanyDetails",
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfRelatedPartiesDetails",
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfTransactionsWithRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable",
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersNarrativeDetails",
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfKeyOfficersOfTheCompanyDetails",
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfRelatedPartiesDetails",
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfTransactionsWithRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to transactions between related parties."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "mdwd_DisposalsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisposalsMember",
     "presentation": [
      "http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposals [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisposalsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisposalsPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Disposals",
        "label": "Disposals, property, plant and equipment",
        "terseLabel": "Disposals"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "mdwd_DisposalsTerminationOfLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DisposalsTerminationOfLeases",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposals- Termination of leases.",
        "negatedLabel": "Disposals-Termination of leases",
        "label": "Disposals-Termination of leases"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DistributionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DistributionCosts",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails": {
       "parentTag": "ifrs-full_SalesAndMarketingExpense",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shipping and delivery"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of costs relating to the distribution of goods and services."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r208"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r252"
     ]
    },
    "mdwd_DocumentAndEntityInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "DocumentAndEntityInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Abstract}"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r252",
      "r253"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r252",
      "r253",
      "r255"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r247"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r252"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r254"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings per share [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EarningsPerShareLineItems",
     "presentation": [
      "http://mediwound.com/role/NetProfitLossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings per share [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EarningsPerShareTable",
     "presentation": [
      "http://mediwound.com/role/NetProfitLossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings per share [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to earnings per share."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "mdwd_EffectOfChangesInExchangeRatesForLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "EffectOfChangesInExchangeRatesForLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect of changes in exchange rates.",
        "label": "Effect Of Changes In Exchange Rates For Lease Liabilities",
        "verboseLabel": "Effect of changes in exchange rates"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange rate differences on cash and cash equivalent balances"
       }
      },
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r100",
      "r101"
     ]
    },
    "mdwd_EffectOfShareSplit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "EffectOfShareSplit",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect of share split.",
        "label": "Effect of share split"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EmployeeBenefitsExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EmployeeBenefitsExpense",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee benefits expense",
        "verboseLabel": "Salary and benefits (including share-based compensation)"
       }
      },
      "en": {
       "role": {
        "documentation": "The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r36",
      "r207"
     ]
    },
    "mdwd_EmployeesAndDirectorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "EmployeesAndDirectorsMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees and directors [Member]",
        "label": "Employees and directors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_EmployeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "EmployeesMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees [Member]",
        "label": "Employees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_EmployeesOfficersBoardMembersCeoAndConsultantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "EmployeesOfficersBoardMembersCeoAndConsultantsMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails",
      "http://mediwound.com/role/SubsequentEventsDetailTextuals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees Officers Board Members CEO And Consultants [Member]",
        "label": "Employees Officers Board Members Ceo And Consultants [Member]",
        "verboseLabel": "Employees, Officers, Board Members CEO and Consultants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r249"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r249"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://mediwound.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r249"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r249"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r256"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r249"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r249"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r257"
     ]
    },
    "ifrs-full_EntitysTotalForRelatedPartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EntitysTotalForRelatedPartiesMember",
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersNarrativeDetails",
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfKeyOfficersOfTheCompanyDetails",
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfRelatedPartiesDetails",
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfTransactionsWithRelatedPartiesDetails",
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails",
      "http://mediwound.com/role/EquityNarrativeDetails",
      "http://mediwound.com/role/MaterialAgreementsDetails",
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails",
      "http://mediwound.com/role/SubsequentEventsDetailTextuals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity's total for related parties [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "ifrs-full_Equity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Equity",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets",
      "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "label": "Equity [Default Label]",
        "totalLabel": "Total equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r18",
      "r106",
      "r108",
      "r124",
      "r125",
      "r126"
     ]
    },
    "mdwd_Equity1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "Equity1",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities after adjustment.",
        "periodStartLabel": "Balance",
        "label": "Equity1"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EquityAbstract",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS' EQUITY:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EquityAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EquityAndLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity and liabilities",
        "totalLabel": "Total liabilities and equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "mdwd_EquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "EquityIncentivePlanMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2014 Equity Incentive Plan (the \"2014 Plan\") [Member]",
        "label": "Equity Incentive Plan [Member]",
        "verboseLabel": "2014 Equity Incentive Plan (the \"2014 Plan\") [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EquityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EquityMember",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "mdwd_EquityTablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "EquityTablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Tables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ExercisePriceOfWarrants": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ExercisePriceOfWarrants",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails",
      "http://mediwound.com/role/SubsequentEventsDetailTextuals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents exercise price of warrants.",
        "label": "Exercise Price Of Warrants",
        "verboseLabel": "Exercise price of warrants"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ExercisePriceShareOptionsGrantedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ExercisePriceShareOptionsGrantedPercentage",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfEstimatedUsingAcceptableOptionPricingModelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expected exercise price percentage of the share price used to calculate the fair value of the share options granted.",
        "label": "Exercise Price Share Options Granted Percentage",
        "verboseLabel": "Early exercise factor (%)"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ExercisedOptionsToPurchaseAdditionalOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ExercisedOptionsToPurchaseAdditionalOrdinaryShares",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents exercised options to purchase additional ordinary shares.",
        "label": "Exercised Options To Purchase Additional Ordinary Shares",
        "verboseLabel": "Exercised options to purchase additional ordinary shares"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ExpectedDividendAsPercentageOfWarrants": {
     "xbrltype": "percentItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ExpectedDividendAsPercentageOfWarrants",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percent of expected dividend as percentage of warrants.",
        "label": "Expected Dividend As Percentage Of Warrants",
        "terseLabel": "Expected dividend yield, warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ExpectedDividendAsPercentageShareOptionsGranted",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfEstimatedUsingAcceptableOptionPricingModelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend yield (%)",
        "terseLabel": "Dividend yield (%)"
       }
      },
      "en": {
       "role": {
        "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "mdwd_ExpectedTermOfWarrant": {
     "xbrltype": "durationItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ExpectedTermOfWarrant",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the duration of expected term of warrant.",
        "label": "Expected Term Of Warrant",
        "terseLabel": "Expected period of warrants"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ExpectedVolatilityWarrants": {
     "xbrltype": "percentItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ExpectedVolatilityWarrants",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percent of expected volatility of warrants.",
        "label": "Expected Volatility Warrants",
        "terseLabel": "Expected volatility, warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense from share-based payment transactions",
        "verboseLabel": "Expense from share-based payment transitions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets."
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfInformationOnLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "positiveLabel": "Depreciation expenses",
        "label": "Expenses relating to short-term leases",
        "terseLabel": "Depreciation expenses relating to short-term leases"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the expense relating to short-term leases accounted for applying paragraph 6 of IFRS 16. This expense need not include the expense relating to leases with a lease term of one month or less. Short-term lease is a lease that, at the commencement date, has a lease term of 12 months or less. A lease that contains a purchase option is not a short-term lease."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "ifrs-full_ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod",
     "presentation": [
      "http://mediwound.com/role/TaxesOnIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in tax rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The explanation of the changes in the entity's applicable income tax rate(s) compared to the previous accounting period."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Expense Recognized",
        "terseLabel": "Schedule of expense recognized"
       }
      },
      "en": {
       "role": {
        "documentation": "The explanation that enables users of financial statements to understand the effect of share-based payment transactions on the entity's financial position."
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "ifrs-full_FinanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "mdwd_FinanceIncomeExpenseNet",
       "weight": -1.0,
       "order": 0.0
      },
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss",
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Financial expense",
        "label": "Finance costs",
        "totalLabel": "Financial expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of costs associated with financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "mdwd_FinanceExpensesInRespectOfDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "FinanceExpensesInRespectOfDeferredRevenue",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance expenses in respect of deferred revenue.",
        "label": "Finance expenses in respect of deferred Revenue",
        "terseLabel": "Finance expenses in respect of deferred Revenues"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinanceIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinanceIncome",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "mdwd_FinanceIncomeExpenseNet",
       "weight": 1.0,
       "order": 10.0
      },
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss",
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial income",
        "totalLabel": "Financial income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income associated with interest and other financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r267"
     ]
    },
    "mdwd_FinanceIncomeExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "FinanceIncomeExpenseNet",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing income (expenses), net.",
        "label": "Finance Income Expense Net",
        "totalLabel": "Financing income (expenses), net"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_FinancialExpensesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "FinancialExpensesNet",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of financial income (expense).",
        "label": "Financial Expenses Net",
        "verboseLabel": "Financial income (expenses), net"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_FinancialIncomeAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "FinancialIncomeAndExpenses",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents financial income and expenses.",
        "label": "Financial Income And Expenses",
        "verboseLabel": "Financial expenses (income)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialLiabilitiesAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinancialLiabilitiesAtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial liabilities, at fair value"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "mdwd_FinancingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "FinancingExpensesAbstract",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Expenses [Abstract]",
        "verboseLabel": "Financial expense:"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_FinancingIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "FinancingIncomeAbstract",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Income [Abstract]",
        "verboseLabel": "Financial income:"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_FinancingIncomeOnNetInvestmentInLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "FinancingIncomeOnNetInvestmentInLease",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of financing income on net investment in lease.",
        "label": "Financing Income On Net Investment In Lease",
        "terseLabel": "Financing income on net investment in lease"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinishedGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinishedGoods",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/InventoriesScheduleOfInventoriesDetails": {
       "parentTag": "ifrs-full_Inventories",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/InventoriesScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finished goods"
       }
      },
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r213",
      "r271"
     ]
    },
    "mdwd_FivePercentageDecreaseInExchangeRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "FivePercentageDecreaseInExchangeRateMember",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfSensitivityTestsRelatingToChangesInMarketFactorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5% decrease in exchange rate [Member]",
        "label": "Five Percentage Decrease In Exchange Rate [Member]",
        "verboseLabel": "5% decrease in NIS and EURO exchange rate [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_FivePercentageIncreaseInExchangeRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "FivePercentageIncreaseInExchangeRateMember",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfSensitivityTestsRelatingToChangesInMarketFactorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5% increase in exchange rate [Member]",
        "label": "Five Percentage Increase In Exchange Rate [Member]",
        "verboseLabel": "5% increase in NIS and EURO exchange rate [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FixedInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FixedInterestRateMember",
     "presentation": [
      "http://mediwound.com/role/Short-termBankDepositsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed interest rate [member]",
        "terseLabel": "Fixed interest rate [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a fixed interest rate. [Refer: Interest rate risk [member]]"
       }
      }
     },
     "auth_ref": [
      "r284"
     ]
    },
    "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0,
       "order": 80.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows",
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfSensitivityTestsRelatingToChangesInMarketFactorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Un-realized foreign currency loss (gain)",
        "label": "Gain (loss) from change in exchange rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]"
       }
      }
     },
     "auth_ref": [
      "r7",
      "r62"
     ]
    },
    "mdwd_GeneralAndAdministrativeExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "GeneralAndAdministrativeExpensesMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfExpenseRecognizedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General and administrative [Member]",
        "label": "General And Administrative Expenses [Member]",
        "verboseLabel": "General and administrative [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GeographicalAreasAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GeographicalAreasAxis",
     "presentation": [
      "http://mediwound.com/role/TaxesOnIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical areas [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r219",
      "r236",
      "r239"
     ]
    },
    "ifrs-full_GeographicalAreasMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GeographicalAreasMember",
     "presentation": [
      "http://mediwound.com/role/TaxesOnIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical areas [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r219",
      "r236",
      "r239"
     ]
    },
    "ifrs-full_GovernmentGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GovernmentGrants",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/LiabilitiesInRespectOfIiaGrantsScheduleOfIsraeliInnovationAuthorityGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance as of December 31",
        "periodStartLabel": "Balance as of January 1",
        "label": "Government grants"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity, recognised as deferred income. They exclude those forms of government assistance that cannot reasonably have a value placed upon them and transactions with government that cannot be distinguished from the normal trading transactions of the entity. [Refer: Deferred income other than contract liabilities; Government [member]]"
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "mdwd_GrantsReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "GrantsReceived",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/LiabilitiesInRespectOfIiaGrantsScheduleOfIsraeliInnovationAuthorityGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grants received.",
        "label": "Grants received"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_GrantsReceivedNetOfRoyalties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "GrantsReceivedNetOfRoyalties",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/LiabilitiesInRespectOfIIAGrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grants received net of royalties.",
        "label": "Grants received net of royalties"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GrossCarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GrossCarryingAmountMember",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails",
      "http://mediwound.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails",
      "http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross carrying amount [member]",
        "terseLabel": "Carrying amount [Member]",
        "verboseLabel": "Cost [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r86",
      "r93",
      "r96",
      "r173",
      "r183",
      "r185",
      "r241"
     ]
    },
    "mdwd_GrossProceedsFromPublicAndPrivateOfferings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "GrossProceedsFromPublicAndPrivateOfferings",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gross proceeds from public and private offerings.",
        "positiveTerseLabel": "Gross proceeds",
        "label": "Gross Proceeds From Public And Private Offerings",
        "terseLabel": "Net proceeds from ordinary shares issued",
        "verboseLabel": "Proceeds from issuance of shares and warrants, net"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross profit",
        "totalLabel": "Gross profit"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]"
       }
      }
     },
     "auth_ref": [
      "r208"
     ]
    },
    "currency_ILS": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2023",
     "localname": "ILS",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NIS [member]",
        "terseLabel": "NIS [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r251",
      "r252",
      "r253"
     ]
    },
    "mdwd_IncomeReceivablesLongTerm": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "IncomeReceivablesLongTerm",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/OtherReceivablesLongTermDetails": {
       "parentTag": "ifrs-full_OtherNoncurrentReceivables",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/OtherReceivablesLongTermDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the income receivables, long term.",
        "label": "Income Receivables, Long Term",
        "verboseLabel": "Income receivables"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_IncomeReceivablesShortTerm": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "IncomeReceivablesShortTerm",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/OtherReceivablesScheduleOfOtherReceivablesDetails": {
       "parentTag": "ifrs-full_OtherCurrentReceivables",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/OtherReceivablesScheduleOfOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the income receivables, short term.",
        "label": "Income Receivables Short Term",
        "terseLabel": "Income receivables"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit or loss [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncomeTaxExpenseContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Taxes on income",
        "label": "Tax expense (income)",
        "terseLabel": "Taxes on income"
       }
      },
      "en": {
       "role": {
        "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]"
       }
      }
     },
     "auth_ref": [
      "r30",
      "r39",
      "r40",
      "r41",
      "r75",
      "r122",
      "r193"
     ]
    },
    "mdwd_IncomingCEOAndChairmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "IncomingCEOAndChairmanMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incoming CEO and chairman [Member]",
        "label": "Incoming C E O And Chairman [Member]",
        "verboseLabel": "Incoming CEO and chairman [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_IncomingCFOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "IncomingCFOMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incoming CFO [Member]",
        "label": "Incoming C F O [Member]",
        "verboseLabel": "Incoming CFO [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseInCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in cash and cash equivalents",
        "totalLabel": "Increase (decrease) in cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "mdwd_IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of increase (decrease) in equity resulting from the exercise of restricted share units.",
        "label": "Increase Decrease In Equity Through Exercise Of Restricted Share Units",
        "verboseLabel": "Exercise of RSU"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseInNumberOfSharesOutstanding",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails",
      "http://mediwound.com/role/SubsequentEventsDetailTextuals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in number of shares outstanding",
        "verboseLabel": "Number of common shares issued"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the number of shares outstanding. [Refer: Number of shares outstanding]"
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseThroughAppropriationOfRetainedEarnings",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase of accumulated deficit"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the appropriation of retained earnings. [Refer: Retained earnings]"
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughExerciseOfOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseThroughExerciseOfOptions",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of options"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the exercise of options."
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseThroughExerciseOfWarrantsEquity",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of warrants",
        "verboseLabel": "Exercise of pre-funded warrants"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the exercise of warrants."
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign currency translation"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "mdwd_IncreaseInAuthorizedShareCapital": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "IncreaseInAuthorizedShareCapital",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents Increase In authorized share capital.",
        "label": "Increase In Authorized Share Capital"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_IncreaseInPreFundedWarrantsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "IncreaseInPreFundedWarrantsExercisePrice",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents increase in pre funded warrants exercise price.",
        "label": "Increase In Pre Funded Warrants Exercise Price",
        "verboseLabel": "Increase in pre funded warrants exercise price"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_IncreaseInSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "IncreaseInSharesIssued",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase In Shares Issued.",
        "label": "Increase In Shares Issued"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of options"
       }
      },
      "en": {
       "role": {
        "documentation": "The difference, for modified share-based payment arrangements, between the fair value of the modified equity instrument and that of the original equity instrument, both estimated as at the date of the modification. [Refer: Share-based payment arrangements [member]]"
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets",
      "http://mediwound.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance, ending",
        "periodStartLabel": "Balance, opening",
        "label": "Intangible assets, net"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r10",
      "r88"
     ]
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IntangibleAssetsOtherThanGoodwillMember",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails",
      "http://mediwound.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r89",
      "r224",
      "r237"
     ]
    },
    "ifrs-full_InterestExpenseOnLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InterestExpenseOnLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails",
      "http://mediwound.com/role/LeasesScheduleOfInformationOnLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "positiveTerseLabel": "Financial expenses",
        "label": "Interest expense on lease liabilities",
        "verboseLabel": "Interest"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "mdwd_InterestRateForLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "InterestRateForLoanMember",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate for a loan [Member]",
        "label": "Interest Rate For Loan [Member]",
        "verboseLabel": "Interest rate for a loan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestRateTypesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InterestRateTypesMember",
     "presentation": [
      "http://mediwound.com/role/Short-termBankDepositsNarrativeDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of interest rates. It also represents the standard value for the 'Types of interest rates' axis if no other member is used. [Refer: Interest rate risk [member]]"
       }
      }
     },
     "auth_ref": [
      "r284"
     ]
    },
    "ifrs-full_InterestReceivedClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InterestReceivedClassifiedAsInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest received"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from interest received, classified as investing activities."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ifrs-full_Inventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Inventories",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 30.0
      },
      "http://mediwound.com/role/InventoriesScheduleOfInventoriesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets",
      "http://mediwound.com/role/InventoriesScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories",
        "totalLabel": "Inventories"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current inventories. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r11",
      "r57",
      "r210"
     ]
    },
    "ifrs-full_InventoryWritedown2011": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InventoryWritedown2011",
     "presentation": [
      "http://mediwound.com/role/InventoriesScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory write-down"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense recognised related to the write-down of inventories to net realisable value. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r34",
      "r58"
     ]
    },
    "mdwd_IsraeliShareOptionPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "IsraeliShareOptionPlanMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2003 Israeli Share Option Plan (\"Plan\") [Member]",
        "label": "Israeli Share Option Plan [Member]",
        "verboseLabel": "2003 Israeli Share Option Plan (\"Plan\") [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_IssuanceExpensesOfWarrantsThroughProfitAndLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "IssuanceExpensesOfWarrantsThroughProfitAndLoss",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 70.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of issuance expenses of warrants through profit and loss.",
        "label": "Issuance Expenses Of Warrants Through Profit And Loss",
        "verboseLabel": "Issuance expenses of warrants through profit and loss"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IssueOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IssueOfEquity",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of ordinary shares, net of issuance expenses",
        "verboseLabel": "Issuance of ordinary shares, net of issuance expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in equity through the issue of equity instruments."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ifrs-full_IssuedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IssuedCapital",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issued Capital",
        "verboseLabel": "Ordinary shares of NIS 0.07 par value: Authorized 20,000,000 shares as of December 31, 2023 and 12,857,143 shares as of December 31, 2022; Issued and Outstanding 9,221,764 shares as of December 31, 2023 and 7,240,020 shares as of December 31, 2022"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      }
     },
     "auth_ref": [
      "r214"
     ]
    },
    "ifrs-full_IssuedCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IssuedCapitalMember",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share capital [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "KeyManagementPersonnelCompensation",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfCompensationOfOfficersOfCompanyDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfCompensationOfOfficersOfCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Key management personnel compensation",
        "totalLabel": "Compensation of officers"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationSharebasedPayment",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfCompensationOfOfficersOfCompanyDetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfCompensationOfOfficersOfCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Key management personnel compensation, share-based payment",
        "verboseLabel": "Share-based compensation"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfCompensationOfOfficersOfCompanyDetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfCompensationOfOfficersOfCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term employee benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "mdwd_KeyOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "KeyOfficerMember",
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfKeyOfficersOfTheCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "KeyOfficer [Member]",
        "label": "Key Officer [Member]",
        "verboseLabel": "Key Officer [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LaterThanOneYearAndNotLaterThanTwoYearsMember",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than one year and not later than two years [member]",
        "terseLabel": "1-2 years [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than two years."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r143",
      "r154",
      "r242",
      "r244",
      "r260"
     ]
    },
    "mdwd_LaterThanTwoYearAndNotLaterThanFifteenYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "LaterThanTwoYearAndNotLaterThanFifteenYearsMember",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for a time band of later than two year and not later than fifteen years.",
        "label": "Later Than Two Year And Not Later Than Fifteen Years [Member]",
        "terseLabel": "2-15 years [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance as of December 31,",
        "periodStartLabel": "Balance as of December 31,",
        "label": "Lease liabilities [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ifrs-full_LeaseLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LeaseLiabilitiesMember",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r230",
      "r232"
     ]
    },
    "ifrs-full_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails",
      "http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfDepreciationOnStraight-lineBasisOverUsefulLifeOfAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold improvements [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement."
       }
      }
     },
     "auth_ref": [
      "r268"
     ]
    },
    "mdwd_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases Schedule Of Information On Leases",
        "verboseLabel": "Leases Schedule Of Information On Leases"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://mediwound.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Level3OfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Level3OfFairValueHierarchyMember",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level 3 of fair value hierarchy [member]",
        "verboseLabel": "Fair value measurement at Level 3 [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ifrs-full_LevelsOfFairValueHierarchyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LevelsOfFairValueHierarchyAxis",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Levels of fair value hierarchy [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r125"
     ]
    },
    "ifrs-full_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets",
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r124",
      "r125",
      "r126",
      "r194",
      "r198"
     ]
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivitiesAxis",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivitiesMember",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for liabilities arising from financing activities. It also represents the standard value for the 'Liabilities arising from financing activities' axis if no other member is used. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "mdwd_LiabilitiesInRespectOfGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "LiabilitiesInRespectOfGrants",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of liabilities in respect of grants.",
        "label": "Liabilities In Respect Of Grants.",
        "terseLabel": "Liabilities in respect of IIA grants"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_LiabilitiesInRespectOfPurchaseOfShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "LiabilitiesInRespectOfPurchaseOfShares",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of liabilities in respect of purchase of shares.",
        "label": "Liabilities In Respect Of Purchase Of Shares",
        "terseLabel": "Liabilities in respect of purchase of shares"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_LiabilitiesInRespectOfTeva": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "LiabilitiesInRespectOfTeva",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of liabilities in respect of TEVA.",
        "label": "Liabilities In Respect Of Teva",
        "terseLabel": "Liabilities in respect of TEVA"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_LiabilityInRespectForPurchaseOfShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "LiabilityInRespectForPurchaseOfShares",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/OtherPayablesScheduleOfOtherPayablesDetails": {
       "parentTag": "ifrs-full_OtherCurrentPayables",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/OtherPayablesScheduleOfOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability in respect for purchase of shares.",
        "label": "Liability In Respect For Purchase Of Shares",
        "verboseLabel": "Liability in respect of TEVA"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "LiabilityInRespectOfPurchaseOfSharesToCurrentMaturities",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/OtherPayablesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of liability in respect of purchase of shares to current maturities.",
        "label": "Liability In Respect Of Purchase Of Shares To Current Maturities",
        "terseLabel": "Liability in respect of purchase of shares to current maturities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LicenceFeeIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LicenceFeeIncome",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues from license agreements",
        "terseLabel": "Revenues from license agreements and royalties",
        "verboseLabel": "Revenues from sale or license"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income arising from licence fees."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_LicencesAndFranchisesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LicencesAndFranchisesMember",
     "presentation": [
      "http://mediwound.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "License and Knowhow [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing the right to use certain intangible assets owned by another entity and the right to operate a business using the name, merchandise, services, methodologies, promotional support, marketing and supplies granted by another entity. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r225"
     ]
    },
    "mdwd_LicenseAgreementWithVericelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "LicenseAgreementWithVericelMember",
     "presentation": [
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Agreement with Vericel [Member]",
        "label": "License Agreement with Vericel [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_LimitOfBenefitEntitlementPeriod": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "LimitOfBenefitEntitlementPeriod",
     "presentation": [
      "http://mediwound.com/role/TaxesOnIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Limit of benefit entitlement period.",
        "label": "Limit of benefit entitlement period"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LongtermDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LongtermDeposits",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term deposits",
        "verboseLabel": "Long-term restricted bank deposits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of long-term deposits held by the entity."
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "mdwd_LossFromWarrantsTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "LossFromWarrantsTransactions",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount of loss from warrants transactions.",
        "label": "Loss From Warrants Transactions",
        "verboseLabel": "Loss from warrants transactions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MachineryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "MachineryMember",
     "presentation": [
      "http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails",
      "http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfDepreciationOnStraight-lineBasisOverUsefulLifeOfAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Manufacturing machinery and lab equipment [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing long-lived, depreciable machinery used in operations. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r216"
     ]
    },
    "mdwd_MarketingAndSalesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "MarketingAndSalesExpense",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails": {
       "parentTag": "ifrs-full_SalesAndMarketingExpense",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketing and sales expense.",
        "label": "Marketing And Sales Expense",
        "verboseLabel": "Marketing and consulting"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "MaturityAnalysisForNonderivativeFinancialLiabilities",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis for non-derivative financial liabilities [text block]",
        "terseLabel": "Schedule of liquidity risk by holding cash balances, short-term deposits and secured bank credit facilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of a maturity analysis for non-derivative financial liabilities (including issued financial guarantee contracts) that shows the remaining contractual maturities. [Refer: Derivative financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "ifrs-full_MaturityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "MaturityAxis",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r131",
      "r142",
      "r143",
      "r147",
      "r148",
      "r149",
      "r154",
      "r177",
      "r188",
      "r221",
      "r242"
     ]
    },
    "mdwd_MaximumAggregateRoyaltiesPaidInPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "MaximumAggregateRoyaltiesPaidInPercentage",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails",
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum aggregate royalties paid in percentage.",
        "label": "Maximum aggregate royalties paid in percentage"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails",
      "http://mediwound.com/role/MaterialAgreementsDetails",
      "http://mediwound.com/role/Short-termBankDepositsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MethodsOfGenerationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "MethodsOfGenerationAxis",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Methods of generation [Axis]",
        "verboseLabel": "Methods of generation [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "ifrs-full_MethodsOfGenerationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "MethodsOfGenerationMember",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all methods of generation. It also represents the standard value for the 'Methods of generation' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails",
      "http://mediwound.com/role/Short-termBankDepositsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MiscellaneousOtherOperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "MiscellaneousOtherOperatingExpense",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesProductsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other manufacturing expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of miscellaneous other operating expenses. [Refer: Other operating income (expense)]"
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_MotorVehiclesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "MotorVehiclesMember",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails",
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails",
      "http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfAmortizationPeriodsOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Motor vehicles [member]",
        "terseLabel": "Motor vehicles [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing self-propelled ground vehicles used in the entity's operations. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r217"
     ]
    },
    "mdwd_MtecMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "MtecMember",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MTEC [Member]",
        "label": "Mtec [Member]",
        "verboseLabel": "MTEC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NetForeignExchangeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NetForeignExchangeLoss",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net foreign exchange loss",
        "verboseLabel": "Exchange differences, net"
       }
      },
      "en": {
       "role": {
        "documentation": "The net loss arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]"
       }
      }
     },
     "auth_ref": [
      "r262",
      "r272"
     ]
    },
    "mdwd_NetProceedsFromOfferingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "NetProceedsFromOfferingAmount",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents net proceeds from offering amount.",
        "label": "Net Proceeds From Offering Amount",
        "verboseLabel": "Net proceeds from offering amount"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_NewFinanceLeaseObligationRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "NewFinanceLeaseObligationRecognized",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New finance lease obligation recognized.",
        "label": "New finance lease obligation recognized"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Modified contingent consideration"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised for new contingent liabilities recognised in a business combination. [Refer: Contingent liabilities recognised in business combination]"
       }
      }
     },
     "auth_ref": [
      "r283"
     ]
    },
    "mdwd_NexoBridMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "NexoBridMember",
     "presentation": [
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NexoBrid [Member]",
        "label": "Nexo Brid [Member]",
        "verboseLabel": "NexoBrid [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_NonCashTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "NonCashTransactionsAbstract",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Cash Transactions [Abstract]",
        "terseLabel": "Supplement disclosure of non-cash transactions:"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_NonCurrentLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "NonCurrentLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current maturities of noncurrent liabilities.",
        "label": "Non Current Liabilities Current",
        "terseLabel": "Current maturities of long-term liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NonadjustingEventsAfterReportingPeriodAxis",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails",
      "http://mediwound.com/role/SubsequentEventsDetailTextuals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "ifrs-full_NonadjustingEventsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NonadjustingEventsMember",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails",
      "http://mediwound.com/role/SubsequentEventsDetailTextuals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "mdwd_NoncancelableLeasePeriods": {
     "xbrltype": "durationItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "NoncancelableLeasePeriods",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncancelable lease periods.",
        "label": "Noncancelable lease periods"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets",
        "totalLabel": "Total non-current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      }
     },
     "auth_ref": [
      "r16",
      "r111",
      "r233"
     ]
    },
    "ifrs-full_NoncurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentAssetsAbstract",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LONG-TERM ASSETS:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentGovernmentGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentGovernmentGrants",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets",
      "http://mediwound.com/role/LiabilitiesInRespectOfIiaGrantsScheduleOfIsraeliInnovationAuthorityGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities in respect of IIA grants",
        "verboseLabel": "Long term liabilities in respect of IIA grants"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current government grants recognised on the statement of financial position as deferred income. [Refer: Government [member]; Government grants]"
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "ifrs-full_NoncurrentLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets",
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails",
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Lease liability Balance as of December 31,",
        "label": "Non-current lease liabilities",
        "terseLabel": "Lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ifrs-full_NoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities",
        "totalLabel": "Total non-current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r17",
      "r113",
      "r233"
     ]
    },
    "ifrs-full_NoncurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentLiabilitiesAbstract",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets",
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities [abstract]",
        "terseLabel": "Non-current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other non-current receivables [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentRecognisedLiabilitiesDefinedBenefitPlan",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Severance pay liability, net"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current net defined benefit liability. [Refer: Net defined benefit liability]"
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "ifrs-full_NoncurrentWarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentWarrantLiability",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current warrant liability",
        "verboseLabel": "Warrants, net"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current warrant liabilities. [Refer: Warrant liability]"
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "ifrs-full_NotLaterThanOneYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NotLaterThanOneYearMember",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Not later than one year [member]",
        "terseLabel": "12 months or less [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than one year."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r142",
      "r143",
      "r154",
      "r242",
      "r244"
     ]
    },
    "mdwd_NumberAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "NumberAbstract",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number [Abstract]",
        "verboseLabel": "Number of Options"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_NumberOfDirectors": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "NumberOfDirectors",
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfTransactionsWithRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of directors by the entity at a date.",
        "label": "Number Of Directors",
        "verboseLabel": "Number of Directors"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfEmployees",
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfCompensationOfOfficersOfCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Number of officers",
        "label": "Number of employees"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of personnel employed by the entity at a date."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of other equity instruments granted in share-based payment arrangement",
        "terseLabel": "Number of RSUs granted",
        "verboseLabel": "Granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r282"
     ]
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Option's Vested",
        "label": "Number of other equity instruments exercised or vested in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r282"
     ]
    },
    "ifrs-full_NumberOfOutstandingShareOptions": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfOutstandingShareOptions",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails",
      "http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Outstanding options and at end of year",
        "periodStartLabel": "Outstanding Options at beginning of year",
        "label": "Number of options"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options outstanding in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r161",
      "r164"
     ]
    },
    "mdwd_NumberOfPreFundedWarrantsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "NumberOfPreFundedWarrantsExercised",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails",
      "http://mediwound.com/role/SubsequentEventsDetailTextuals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents number of pre funded warrants exercised.",
        "label": "Number Of Pre Funded Warrants Exercised",
        "verboseLabel": "Number of pre funded warrants exercised"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_NumberOfRestrictedShareUnitIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "NumberOfRestrictedShareUnitIssued",
     "presentation": [
      "http://mediwound.com/role/NetProfitLossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of restricted share unit Issued.",
        "label": "Number Of Restricted Share Unit Issued",
        "verboseLabel": "Number of restricted share unit issued"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentArrangement",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Option's Exercisable at end of year",
        "label": "Number of share options exercisable in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options exercisable in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Option's Exercised",
        "label": "Number of share options exercised in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options exercised in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Option's Forfeited and/or expired",
        "label": "Number of share options forfeited in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options forfeited in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement",
     "presentation": [
      "http://mediwound.com/role/NetProfitLossPerShareNarrativeDetails",
      "http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of share options granted in share-based payment arrangement",
        "verboseLabel": "Number of share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options granted in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ifrs-full_NumberOfSharesAuthorised": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfSharesAuthorised",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://mediwound.com/role/EquityNarrativeDetails",
      "http://mediwound.com/role/EquityScheduleOfShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares authorised",
        "verboseLabel": "Authorized number of shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares authorised."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "mdwd_NumberOfSharesExerciseRestrictedStockUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "NumberOfSharesExerciseRestrictedStockUnits",
     "presentation": [
      "http://mediwound.com/role/SubsequentEventsDetailTextuals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a restricted stock units.",
        "label": "Number Of Shares Exercise Restricted Stock Units",
        "verboseLabel": "Number of restricted stock units issued"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfSharesIssued",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://mediwound.com/role/EquityScheduleOfShareCapitalDetails",
      "http://mediwound.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares issued",
        "verboseLabel": "Issued and outstanding number of shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "ifrs-full_NumberOfSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfSharesOutstanding",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares, Outstanding"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "mdwd_NumberOfSharesRepurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "NumberOfSharesRepurchased",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares repurchased.",
        "label": "Number of shares repurchased"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_NumberOfVehiclesInOperatingLeaseArrangements": {
     "xbrltype": "integerItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "NumberOfVehiclesInOperatingLeaseArrangements",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of vehicles in operating lease arrangements.",
        "label": "Number of vehicles in operating lease arrangements"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_NumberOfWarrantsIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "NumberOfWarrantsIssued",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails",
      "http://mediwound.com/role/NetProfitLossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents number of warrants issued.",
        "label": "Number Of Warrants Issued",
        "verboseLabel": "Number of warrants issued"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OfficeEquipmentMember",
     "presentation": [
      "http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails",
      "http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfDepreciationOnStraight-lineBasisOverUsefulLifeOfAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Office furniture [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing equipment used to support office functions, not specifically used in the production process. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r218"
     ]
    },
    "mdwd_OneTimeLumpsumAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "OneTimeLumpsumAmount",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails",
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One-time lump-sum amount.",
        "label": "One Time Lumpsum Amount",
        "terseLabel": "One-time lump-sum amount"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OperatingExpense",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expense",
        "totalLabel": "Total operating expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of all operating expenses."
       }
      }
     },
     "auth_ref": [
      "r267"
     ]
    },
    "ifrs-full_OrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OrdinarySharesMember",
     "presentation": [
      "http://mediwound.com/role/NetProfitLossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r266"
     ]
    },
    "ifrs-full_OtherAdjustmentsToReconcileProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherAdjustmentsToReconcileProfitLoss",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revaluation of liabilities in respect of purchase of shares",
        "verboseLabel": "Revaluation of liabilities in respect of TEVA"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities that the entity does not separately disclose in the same statement or note. [Refer: Adjustments to reconcile profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ifrs-full_OtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherComprehensiveIncome",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income (loss)",
        "terseLabel": "Other comprehensive Income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r26",
      "r32",
      "r118"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherComprehensiveIncomeAbstract",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income (loss):"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_OtherCountriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "OtherCountriesMember",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeographicalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Others [Member]",
        "label": "Other Countries [Member]",
        "verboseLabel": "EU and other international markets [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_OtherCurrentPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "OtherCurrentPayable",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/OtherPayablesScheduleOfOtherPayablesDetails": {
       "parentTag": "ifrs-full_OtherCurrentPayables",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/OtherPayablesScheduleOfOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other payable.",
        "label": "Other Current Payable",
        "verboseLabel": "Other"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherCurrentPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherCurrentPayables",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 20.0
      },
      "http://mediwound.com/role/OtherPayablesScheduleOfOtherPayablesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets",
      "http://mediwound.com/role/OtherPayablesScheduleOfOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other current payables",
        "terseLabel": "Other payables",
        "totalLabel": "Other payables",
        "verboseLabel": "Other payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "ifrs-full_OtherCurrentReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherCurrentReceivables",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 40.0
      },
      "http://mediwound.com/role/OtherReceivablesScheduleOfOtherReceivablesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets",
      "http://mediwound.com/role/OtherReceivablesScheduleOfOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other current receivables",
        "totalLabel": "Other Receivables- Short Term",
        "verboseLabel": "Other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current other receivables. [Refer: Other receivables]"
       }
      }
     },
     "auth_ref": [
      "r212"
     ]
    },
    "mdwd_OtherCustomerContributedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "OtherCustomerContributedMember",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Customer Contributed [Member]",
        "label": "Other Customer Contributed [Member]",
        "verboseLabel": "Other Customers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherExpenseByFunction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherExpenseByFunction",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "One-time expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'function of expense' form for its analysis of expenses."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r74",
      "r208"
     ]
    },
    "ifrs-full_OtherFinanceCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherFinanceCost",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other finance cost",
        "verboseLabel": "Other"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of finance costs that the entity does not separately disclose in the same statement or note. [Refer: Finance costs]"
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_OtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherIncome",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0,
       "order": 70.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows",
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other income",
        "label": "Other income",
        "terseLabel": "One-time income",
        "verboseLabel": "Other income from settlement agreement"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of operating income that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r207",
      "r208"
     ]
    },
    "ifrs-full_OtherNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherNoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities in respect of purchase of shares",
        "verboseLabel": "Liabilities in respect of TEVA"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "ifrs-full_OtherNoncurrentReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherNoncurrentReceivables",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 0.0
      },
      "http://mediwound.com/role/OtherReceivablesLongTermDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets",
      "http://mediwound.com/role/OtherReceivablesLongTermDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other non-current receivables",
        "terseLabel": "Other receivables",
        "totalLabel": "Other Receivables- Long Term"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current other receivables. [Refer: Other receivables]"
       }
      }
     },
     "auth_ref": [
      "r212"
     ]
    },
    "ifrs-full_OtherOperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherOperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": -1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other (income) expenses",
        "negatedTerseLabel": "Other expenses",
        "label": "Other operating income (expense)",
        "terseLabel": "Other expenses",
        "verboseLabel": "Other (income) expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r267"
     ]
    },
    "ifrs-full_OtherPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherPayables",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other payables"
       }
      },
      "en": {
       "role": {
        "documentation": "Amounts payable that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "ifrs-full_OtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherReceivables",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/TradeReceivablesScheduleOfTradeReceivablesDetails": {
       "parentTag": "ifrs-full_CurrentTradeReceivables",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/TradeReceivablesScheduleOfTradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other receivables",
        "verboseLabel": "Other trade receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount receivable by the entity that it does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r212"
     ]
    },
    "ifrs-full_OtherRelatedPartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherRelatedPartiesMember",
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfRelatedPartiesDetails",
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfTransactionsWithRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other related parties [Member]",
        "terseLabel": "Directors [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for related parties that the entity does not separately disclose in the same statement or note. [Refer: Related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "mdwd_OtherResearchAndDevelopmentExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "OtherResearchAndDevelopmentExpenses",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The other amount of expenditure directly attributable to research or development activities, recognised in profit or loss.",
        "label": "Other research and development expenses"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_OtherSellingGeneralAndAdministrativeExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "OtherSellingGeneralAndAdministrativeExpenses",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeneralExpensesDetails": {
       "parentTag": "ifrs-full_SellingGeneralAndAdministrativeExpense",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeneralExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The other amount of expense relating to selling, general and administrative activities of the entity.",
        "label": "Other Selling General And Administrative Expenses",
        "verboseLabel": "Other"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_OtherTemporaryDifferencesMainlyFromRAndDExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "OtherTemporaryDifferencesMainlyFromRAndDExpenses",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/TaxesOnIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other temporary differences mainly from research and development expenses.",
        "label": "Other Temporary Differences Mainly From R And D Expenses",
        "verboseLabel": "Other temporary differences mainly from R&amp;D expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ParValuePerShare",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://mediwound.com/role/EquityNarrativeDetails",
      "http://mediwound.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Par value per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value per share."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows",
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of leases liabilities",
        "label": "Payments of lease liabilities, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "mdwd_PercentageOfFutureRoyaltyPayments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "PercentageOfFutureRoyaltyPayments",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of future royalty payments.",
        "label": "Percentage of future royalty payments"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans": {
     "xbrltype": "percentItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans",
     "presentation": [
      "http://mediwound.com/role/SeverancePayLiabiltyNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of monthly deposit by employee of their monthly salary in defined contribution plans.",
        "label": "Percentage of monthly deposit by employee of their monthly salary in defined contribution plans",
        "terseLabel": "Percentage of monthly deposit by employee"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_PercentageOfOneTimeLumpSumPaymentAmount": {
     "xbrltype": "percentItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "PercentageOfOneTimeLumpSumPaymentAmount",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of one-time lump sum payment amount.",
        "label": "Percentage Of One Time Lump Sum Payment Amount",
        "terseLabel": "Percentage of one-time lump sum payment amount"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails",
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of royalties to pay for future revenues from sales of products.",
        "label": "Percentage of royalties to pay for future revenues from sales of products"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_PeriodOfBankDeposits": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "PeriodOfBankDeposits",
     "presentation": [
      "http://mediwound.com/role/Short-termBankDepositsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of bank deposits.",
        "label": "Period of bank deposits"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails",
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of royalties to pay for future revenues from sales of products.",
        "label": "Period of royalties to pay for future revenues from sales of products"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_PeriodOfVehiclesOperatingLeaseArrangements": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "PeriodOfVehiclesOperatingLeaseArrangements",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of vehicles operating lease arrangements.",
        "label": "Period of vehicles operating lease arrangements"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_PrepaidExpensesLongTerm": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "PrepaidExpensesLongTerm",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/OtherReceivablesLongTermDetails": {
       "parentTag": "ifrs-full_OtherNoncurrentReceivables",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/OtherReceivablesLongTermDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid expenses long term.",
        "label": "Prepaid Expenses Long Term",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the presentation of Financial Statements Classification of Liabilities as Current or Non Current.",
        "label": "Presentation Of Financial Statements Classification Of Liabilities As Current Or Non Current",
        "terseLabel": "Presentation of Financial Statements: Classification of Liabilities as Current or Non-Current (amendment to IAS 1)"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_PricePerShareOfSharesIssued": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "PricePerShareOfSharesIssued",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the per share or per unit amount of equity securities issued.",
        "label": "Price Per Share Of Shares Issued",
        "verboseLabel": "Price per common shares issued"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_PrivateIssuancePurchaseEquityAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "PrivateIssuancePurchaseEquityAgreementMember",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information of Private Issuance Purchase Equity agreement .",
        "label": "Private Issuance Purchase Equity Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ProceedsFromAdditionalFunding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ProceedsFromAdditionalFunding",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional funding amount.",
        "label": "Proceeds From Additional Funding",
        "terseLabel": "Supplemental funding support the NexoBrid BLA resubmission",
        "verboseLabel": "Additional funding amount"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ProceedsFromAdditionalProcurement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ProceedsFromAdditionalProcurement",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional procurement amount.",
        "label": "Proceeds From Additional Procurement",
        "verboseLabel": "Additional procurement amount"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProceedsFromExerciseOfOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProceedsFromExerciseOfOptions",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from exercise of options"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from the exercise of options."
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "ifrs-full_ProceedsFromExerciseOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProceedsFromExerciseOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows",
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from exercise of warrants",
        "terseLabel": "Proceeds from warrants",
        "verboseLabel": "Proceeds from exercise of pre-funded warrants"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from the exercise of share purchase warrants."
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "mdwd_ProceedsFromFunding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ProceedsFromFunding",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/GeneralDetails",
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Funding amount.",
        "label": "Proceeds From Funding",
        "terseLabel": "Supplemental funding support the NexoBrid BLA resubmission",
        "verboseLabel": "Funding amount"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ProceedsFromIssuanceOfSharesAndWarrantsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ProceedsFromIssuanceOfSharesAndWarrantsNet",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of proceeds from issuance of shares and warrants, net",
        "netLabel": "Proceeds from shares issued",
        "label": "Proceeds From Issuance Of Shares And Warrants, Net",
        "terseLabel": "Proceeds from issuance of shares and warrants, net",
        "verboseLabel": "Proceeds from issuance of shares and warrants, net"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProceedsFromIssueOfOrdinaryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProceedsFromIssueOfOrdinaryShares",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issue of ordinary shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]"
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "mdwd_ProceedsFromIssuingAdditionalShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ProceedsFromIssuingAdditionalShares",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuing additional shares.",
        "label": "Proceeds From Issuing Additional Shares",
        "verboseLabel": "Net proceeds from issue of additional shares"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProceedsFromIssuingShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProceedsFromIssuingShares",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Proceeds from shares issued",
        "label": "Proceeds from issuing shares",
        "terseLabel": "Proceeds from issuance of shares and warrants, net",
        "verboseLabel": "Proceeds from issuance of shares and warrants, net"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from issuing shares."
       }
      }
     },
     "auth_ref": [
      "r228"
     ]
    },
    "mdwd_ProceedsFromProcurement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ProceedsFromProcurement",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Procurement amount.",
        "label": "Proceeds From Procurement",
        "verboseLabel": "Procurement amount"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ProfessionalFeeAndShareBasedCompensationExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ProfessionalFeeAndShareBasedCompensationExpenses",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfTransactionsWithRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the professional fee and share based compensation expenses.",
        "label": "Professional Fee And Share Based Compensation Expenses",
        "terseLabel": "Professional Fee",
        "verboseLabel": "Professional fee"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProfessionalFeesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfessionalFeesExpense",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeneralExpensesDetails": {
       "parentTag": "ifrs-full_SellingGeneralAndAdministrativeExpense",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfKeyOfficersOfTheCompanyDetails",
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeneralExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Professional fees",
        "terseLabel": "Professional Fee",
        "verboseLabel": "Professional fee"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable for professional services."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 0.0
      },
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows",
      "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity",
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss)",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r3",
      "r25",
      "r98",
      "r107",
      "r109",
      "r194",
      "r196",
      "r233",
      "r238"
     ]
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss) before tax",
        "totalLabel": "Loss before taxes on income"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r175",
      "r207",
      "r208",
      "r245",
      "r246"
     ]
    },
    "ifrs-full_ProfitLossFromContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLossFromContinuingOperations",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/NetProfitLossPerShareScheduleOfDetailsOfNumberOfSharesAndLossUsedInComputationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and diluted profit (loss) from continued operation, Loss",
        "terseLabel": "Loss",
        "totalLabel": "Profit (loss) from continuing operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing operations. [Refer: Continuing operations [member]; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r25",
      "r116",
      "r194",
      "r196"
     ]
    },
    "ifrs-full_ProfitLossFromDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLossFromDiscontinuedOperations",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Profit from discontinued operation",
        "label": "Profit from discontinued operations",
        "terseLabel": "Basic and diluted profit (loss) from discontinued operation, Profit",
        "verboseLabel": "Profit (loss) from discontinued operation"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from discontinued operations. [Refer: Discontinued operations [member]; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r31",
      "r35",
      "r117",
      "r174"
     ]
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLossFromOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss) from operating activities",
        "totalLabel": "Operating loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r223",
      "r267"
     ]
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets",
      "http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "label": "Property, plant and equipment, net"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r50"
     ]
    },
    "ifrs-full_PropertyPlantAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PropertyPlantAndEquipmentMember",
     "presentation": [
      "http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails",
      "http://mediwound.com/role/SignificantAccountingPoliciesScheduleOfDepreciationOnStraight-lineBasisOverUsefulLifeOfAssetsDetails",
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r51",
      "r224",
      "r237"
     ]
    },
    "mdwd_ProvisionForImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ProvisionForImpairment",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/TradeReceivablesScheduleOfTradeReceivablesDetails": {
       "parentTag": "ifrs-full_CurrentTradeReceivables",
       "weight": -1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/TradeReceivablesScheduleOfTradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision For Impairment.",
        "negatedLabel": "Less provision for impairment",
        "label": "Provision For Impairment",
        "terseLabel": "Less provision for impairment"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_PurchaseOfPropertyAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "PurchaseOfPropertyAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of purchase of property and equipment.",
        "label": "Purchase Of Property And Equipment",
        "verboseLabel": "Purchase of property and equipment"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property and equipment",
        "label": "Purchase of property, plant and equipment, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "ifrs-full_PurchaseOfTreasuryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PurchaseOfTreasuryShares",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of treasury shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease in equity resulting from the purchase of treasury shares. [Refer: Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "mdwd_PurchasePriceOfRegisteredDirectOffering": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "PurchasePriceOfRegisteredDirectOffering",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents purchase price per share of registered direct offering.",
        "label": "Purchase Price Of Registered Direct Offering",
        "verboseLabel": "Purchase price of registered direct offering"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RangeAxis",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails",
      "http://mediwound.com/role/FinancialInstrumentsNarrativeDetails",
      "http://mediwound.com/role/Share-basedCompensationScheduleOfEstimatedUsingAcceptableOptionPricingModelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r149",
      "r164",
      "r234",
      "r235",
      "r285"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails",
      "http://mediwound.com/role/MaterialAgreementsDetails",
      "http://mediwound.com/role/Short-termBankDepositsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Axis]",
        "verboseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails",
      "http://mediwound.com/role/MaterialAgreementsDetails",
      "http://mediwound.com/role/Short-termBankDepositsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RangesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RangesMember",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails",
      "http://mediwound.com/role/FinancialInstrumentsNarrativeDetails",
      "http://mediwound.com/role/Share-basedCompensationScheduleOfEstimatedUsingAcceptableOptionPricingModelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ranges [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r149",
      "r164",
      "r234",
      "r235",
      "r285"
     ]
    },
    "mdwd_RangesOfExercisePricesEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RangesOfExercisePricesEightMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "90.23-96.32 [Member]",
        "label": "Ranges Of Exercise Prices Eight [Member]",
        "verboseLabel": "90.23-96.32 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RangesOfExercisePricesFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RangesOfExercisePricesFiveMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "12.25-14.42 [Member]",
        "label": "Ranges Of Exercise Prices Five [Member]",
        "verboseLabel": "12.25-14.42 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RangesOfExercisePricesForOutstandingShareOptionsAxis",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ranges of exercise prices for outstanding share options [Axis]",
        "verboseLabel": "Ranges of exercise prices for outstanding share options [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RangesOfExercisePricesForOutstandingShareOptionsMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated ranges of exercise prices for outstanding share options that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. It also represents the standard value for the 'Ranges of exercise prices for outstanding share options' axis if no other member is used. [Refer: Ranges [member]]"
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "mdwd_RangesOfExercisePricesFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RangesOfExercisePricesFourMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "12.89 - 13.76 [Member]",
        "label": "Ranges Of Exercise Prices Four [Member]",
        "verboseLabel": "42.14-67.06 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RangesOfExercisePricesOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RangesOfExercisePricesOneMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.09 [Member]",
        "label": "Ranges Of Exercise Prices One [Member]",
        "verboseLabel": "8.26-9.64 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RangesOfExercisePricesServenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RangesOfExercisePricesServenMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "42.14-67.06 [Member]",
        "label": "Ranges Of Exercise Prices Serven [Member]",
        "verboseLabel": "42.14-67.06 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RangesOfExercisePricesSixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RangesOfExercisePricesSixMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "26.88-37.52 [Member]",
        "label": "Ranges Of Exercise Prices Six [Member]",
        "verboseLabel": "26.88-37.52 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RangesOfExercisePricesThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RangesOfExercisePricesThreeMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "7.26 - 9.82 [Member]",
        "label": "Ranges Of Exercise Prices Three [Member]",
        "verboseLabel": "26.88-37.52 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RangesOfExercisePricesTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RangesOfExercisePricesTwoMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.63 [Member]",
        "label": "Ranges Of Exercise Prices Two [Member]",
        "verboseLabel": "11.89-14.42 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RawMaterials": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RawMaterials",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/InventoriesScheduleOfInventoriesDetails": {
       "parentTag": "ifrs-full_Inventories",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/InventoriesScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Raw materials"
       }
      },
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of assets to be consumed in the production process or in the rendering of services. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r213",
      "r271"
     ]
    },
    "mdwd_ReceivableFromBarda": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ReceivableFromBarda",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/TradeReceivablesScheduleOfTradeReceivablesDetails": {
       "parentTag": "ifrs-full_CurrentTradeReceivables",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/TradeReceivablesScheduleOfTradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivable from BARDA.",
        "label": "Receivable From Barda",
        "totalLabel": "Receivable from BARDA"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Foreign currency translation adjustments",
        "label": "Reclassification adjustments on change in value of foreign currency basis spreads, net of tax",
        "verboseLabel": "Foreign currency translation adjustments"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of reclassification adjustments related to change in value of foreign currency basis spreads, net of tax. Reclassification adjustments are amounts reclassified to profit (loss) in the current period that were recognised in other comprehensive income in the current or previous periods. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "mdwd_ReducedAggregateAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ReducedAggregateAmount",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduced aggregate amount.",
        "label": "Reduced aggregate amount"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ReducedRateOfPayments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ReducedRateOfPayments",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduced rate of payments.",
        "label": "Reduced rate of payments"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RegistrationAndMarketingLicenseFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RegistrationAndMarketingLicenseFees",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails": {
       "parentTag": "ifrs-full_SalesAndMarketingExpense",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Registration and marketing license fees.",
        "label": "Registration and marketing license fees"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RelatedPartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RelatedPartiesMember",
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfBalancesOfRelatedPartiesDetails",
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfTransactionsWithRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related parties [member]",
        "terseLabel": "Related Party [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for related parties. Related parties are persons or entities that are related to the entity that is preparing its financial statements (the reporting entity). (a) A person or a close member of that person\u2019s family is related to a reporting entity if that person: (i) has control or joint control over the reporting entity; (ii) has significant influence over the reporting entity; or (iii) is a member of the key management personnel of the reporting entity or of a parent of the reporting entity. (b) An entity is related to a reporting entity if any of the following conditions applies: (i) The entity and the reporting entity are members of the same group (which means that each parent, subsidiary and fellow subsidiary is related to the others). (ii) One entity is an associate or joint venture of the other entity (or an associate or joint venture of a member of a group of which the other entity is a member). (iii) Both entities are joint ventures of the same third party. (iv) One entity is a joint venture of a third entity and the other entity is an associate of the third entity. (v) The entity is a post-employment benefit plan for the benefit of employees of either the reporting entity or an entity related to the reporting entity. If the reporting entity is itself such a plan, the sponsoring employers are also related to the reporting entity. (vi) The entity is controlled or jointly controlled by a person identified in (a). (vii) A person identified in (a)(i) has significant influence over the entity or is a member of the key management personnel of the entity (or of a parent of the entity). (viii) The entity, or any member of a group of which it is a part, provides key management personnel services to the reporting entity or to the parent of the reporting entity. [Refer: Joint ventures [member]; Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "mdwd_RelatedPartiesRentaLexpenseAndOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RelatedPartiesRentaLexpenseAndOther",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/BalancesAndTransactionsWithRelatedPartiesAndKeyOfficersScheduleOfTransactionsWithRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of rental expense and other classified under related party transactions.",
        "label": "Related Parties Renta Lexpense And Other"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RepaymentOfLiabilitiesInRespectOfTeva": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RepaymentOfLiabilitiesInRespectOfTeva",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of Repayment of liabilities in respect of TEVA.",
        "negatedLabel": "Repayment of liabilities in respect of TEVA",
        "label": "Repayment Of Liabilities In Respect Of Teva"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RepaymentsOfIiaGrantsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RepaymentsOfIiaGrantsNet",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow as repayment of IIA grants.",
        "negatedLabel": "Repayment of IIA grants, net",
        "label": "Repayments Of Iia Grants, Net"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0,
       "order": 0.0
      },
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss",
      "http://mediwound.com/role/MaterialAgreementsDetails",
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development, net of Participations",
        "terseLabel": "Research and development",
        "totalLabel": "Total Research and development",
        "verboseLabel": "Research and development"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "mdwd_ResearchAndDevelopmentExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ResearchAndDevelopmentExpensesMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfExpenseRecognizedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development [Member]",
        "label": "Research And Development Expenses [Member]",
        "verboseLabel": "Research and development [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ResearchAndDevelopmentLawMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ResearchAndDevelopmentLawMember",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "R&amp;amp;amp;amp;amp;amp;amp;D Law [Member]",
        "label": "Research And Development Law [Member]",
        "verboseLabel": "R&amp;D Law [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ReserveOfChangeInValueOfForeignCurrencyBasisSpreads",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign currency translation adjustments",
        "terseLabel": "Foreign currency translation reserve"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing the accumulated change in the value of foreign currency basis spreads of financial instruments when excluding them from the designation of these financial instruments as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r264"
     ]
    },
    "ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign currency translation Adjustments [Member]",
        "verboseLabel": "Foreign currency translation reserve [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing the accumulated change in the value of foreign currency basis spreads of financial instruments when excluding them from the designation of these financial instruments as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r209"
     ]
    },
    "ifrs-full_RestrictedCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RestrictedCashAndCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/Short-termBankDepositsScheduleOfShort-termBankDepositsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted deposits",
        "verboseLabel": "Restricted bank deposits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "mdwd_RestrictedSharesUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RestrictedSharesUnitsMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails",
      "http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails",
      "http://mediwound.com/role/Share-basedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Shares [Member]",
        "label": "Restricted Shares Units [Member]",
        "verboseLabel": "Restricted Shares Unit [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RetainedEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RetainedEarnings",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets",
      "http://mediwound.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained earnings",
        "terseLabel": "Total accumulated deficit",
        "verboseLabel": "Accumulated deficit"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r215"
     ]
    },
    "ifrs-full_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r209"
     ]
    },
    "mdwd_RevaluationOfLiabilitiesInRespectOfGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RevaluationOfLiabilitiesInRespectOfGrants",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/LiabilitiesInRespectOfIiaGrantsScheduleOfIsraeliInnovationAuthorityGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revaluation of liabilities in respect of IIA grants.",
        "negatedLabel": "Revaluation of liabilities in respect of IIA grants",
        "negatedTerseLabel": "Amounts carried to Profit or Loss",
        "label": "Revaluation Of Liabilities In Respect Of Grants",
        "terseLabel": "Revaluation of liabilities in respect of IIA grants"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RevaluationOfLiabilitiesInRespectOfIiaGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RevaluationOfLiabilitiesInRespectOfIiaGrants",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails": {
       "parentTag": "ifrs-full_FinanceIncome",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revaluation of liabilities in respect of IIA grants.",
        "negatedLabel": "Revaluation of liabilities in respect of IIA grants",
        "label": "Revaluation Of Liabilities In Respect Of Iia Grants",
        "verboseLabel": "Revaluation of liabilities in respect of IIA grants"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RevaluationOfLiabilitiesInRespectOfIlaGrant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RevaluationOfLiabilitiesInRespectOfIlaGrant",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of revaluation of liabilities in respect of IIA grant.",
        "label": "Revaluation Of Liabilities In Respect Of Ila Grant",
        "terseLabel": "Revaluation of liabilities in respect of IIA grants"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RevaluationOfLiabilitiesInRespectOfPurchasesOfShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RevaluationOfLiabilitiesInRespectOfPurchasesOfShares",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revaluation of liabilities in respect of the purchase of shares.",
        "label": "Revaluation Of Liabilities In Respect Of Purchases Of Shares",
        "verboseLabel": "Revaluation of liabilities in respect of TEVA"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RevaluationOfWarrant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RevaluationOfWarrant",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of revaluation of Warrant.",
        "label": "Revaluation Of Warrant",
        "terseLabel": "Revaluation of Warrants",
        "verboseLabel": "Revaluation of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RevaluationOfWarrantsAccountedAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RevaluationOfWarrantsAccountedAtFairValue",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails": {
       "parentTag": "ifrs-full_FinanceIncome",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of Revaluation of warrants accounted at fair value.",
        "negatedLabel": "Revaluation of warrants accounted at fair value",
        "label": "Revaluation Of Warrants Accounted At Fair Value",
        "terseLabel": "Revaluation of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Revenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Revenue",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss",
      "http://mediwound.com/role/MaterialAgreementsDetails",
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeographicalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues net",
        "totalLabel": "Total revenues",
        "verboseLabel": "Revenues"
       }
      },
      "en": {
       "role": {
        "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r115",
      "r175",
      "r190",
      "r195",
      "r201",
      "r202",
      "r205",
      "r207",
      "r208",
      "r233"
     ]
    },
    "ifrs-full_RevenueFromInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RevenueFromInterest",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails": {
       "parentTag": "ifrs-full_FinanceIncome",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income arising from interest."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r191",
      "r199",
      "r260"
     ]
    },
    "ifrs-full_RevenueFromRenderingOfServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RevenueFromRenderingOfServices",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues from development services"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from the rendering of services. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_RevenueFromRoyalties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RevenueFromRoyalties",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails",
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate revenues"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income arising from royalties."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_RevenueFromSaleOfGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RevenueFromSaleOfGoods",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues from sale of products",
        "verboseLabel": "Revenues from sales"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from the sale of goods. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "mdwd_RevenuesFromDistributionAgreements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RevenuesFromDistributionAgreements",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues from distribution agreements.",
        "label": "Revenues from distribution agreements"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RevenuesFromSaleOfProcurement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RevenuesFromSaleOfProcurement",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues from sale of procurement.",
        "label": "Revenues from sale of procurement"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ReverseStockSplit": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ReverseStockSplit",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails",
      "http://mediwound.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information about reverse stock split ratio.",
        "label": "Reverse Stock Split",
        "terseLabel": "Reverse stock split ratio"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RightOfUseAssetDisposals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RightOfUseAssetDisposals",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated depreciation on right of use assets disposals.",
        "negatedLabel": "Disposals",
        "label": "Right Of Use Asset Disposals",
        "verboseLabel": "Disposals"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RightOfUseAssetReclassifiedToLeaseholdImprovements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RightOfUseAssetReclassifiedToLeaseholdImprovements",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails",
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated depreciation on right of use assets re-classified to leasehold improvements.",
        "label": "Right Of Use Asset Reclassified To Leasehold Improvements",
        "terseLabel": "Capitalized to Leasehold improvements",
        "verboseLabel": "Re-classified to leasehold improvements"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RightOfUseAssetsAccumulatedDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RightOfUseAssetsAccumulatedDepreciation",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated depreciation on right of use assets.",
        "periodEndLabel": "Balance as of December 31,",
        "periodStartLabel": "Balance as of January 1,",
        "label": "Right Of Use Assets Accumulated Depreciation"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RightOfUseAssetsAccumulatedDepreciationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RightOfUseAssetsAccumulatedDepreciationAbstract",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right Of Use Assets Accumulated Depreciation [Abstract]",
        "terseLabel": "Accumulated depreciation"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RightOfUseAssetsCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RightOfUseAssetsCostAbstract",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right Of Use Assets Cost [Abstract]",
        "terseLabel": "Cost"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RightOfUseAssetsDepreciationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RightOfUseAssetsDepreciationAbstract",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right Of Use Assets Depreciation [Abstract]",
        "terseLabel": "Depreciated cost"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RightofuseAssets",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets",
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "December 31,",
        "label": "Right-of-use assets, net"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r138"
     ]
    },
    "ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RightofuseAssetsIncreaseDecreaseInRevaluationSurplus",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ROU asset, net recognized with corresponding lease liability"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the revaluation surplus that relates to right-of-use assets. [Refer: Revaluation surplus; Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "ifrs-full_RightofuseAssetsRevaluedAssetsAtCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RightofuseAssetsRevaluedAssetsAtCost",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/LeasesScheduleOfDisclosuresOfRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance as of December 31,",
        "periodStartLabel": "Balance as of January 1,",
        "label": "Right-of-use assets, revalued assets, at cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of right-of-use assets that would have been recognised had the revalued assets been carried under the cost model. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "mdwd_RiskFreeInterestRateOfWarrants": {
     "xbrltype": "percentItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RiskFreeInterestRateOfWarrants",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents risk free interest rate of warrants.",
        "label": "Risk Free Interest Rate Of Warrants",
        "verboseLabel": "Risk free interest rate of warrants"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RiskFreeRateOfWarrants": {
     "xbrltype": "percentItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RiskFreeRateOfWarrants",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percent of risk-free rate of warrants.",
        "label": "Risk Free Rate Of Warrants",
        "terseLabel": "Risk-free interest rate, warrants"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RoyaltiesPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "RoyaltiesPayments",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenueLicenseDetails": {
       "parentTag": "mdwd_TotalRoyaltiesPayments",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenueLicenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalties payments.",
        "label": "Royalties payments"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RoyaltyExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RoyaltyExpense",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails",
      "http://mediwound.com/role/LiabilitiesInRespectOfIiaGrantsScheduleOfIsraeliInnovationAuthorityGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Royalties",
        "label": "Royalty expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from royalties."
       }
      }
     },
     "auth_ref": [
      "r267"
     ]
    },
    "mdwd_SalaryAndBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "SalaryAndBenefits",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesDetails": {
       "parentTag": "mdwd_CostOfSalesFromLicenseAgreements",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Salary and benefits.",
        "label": "Salary and benefits"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_SalaryAndBenefitsExpensesRelatedToLicenseAgreements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "SalaryAndBenefitsExpensesRelatedToLicenseAgreements",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenueLicenseDetails": {
       "parentTag": "mdwd_TotalRoyaltiesPayments",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenueLicenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the salary and benefits expenses related to license agreements.",
        "label": "Salary And Benefits Expenses Related To License Agreements",
        "terseLabel": "Salary and benefits"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_SalaryAndBenefitsIncludingShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "SalaryAndBenefitsIncludingShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeneralExpensesDetails": {
       "parentTag": "ifrs-full_SellingGeneralAndAdministrativeExpense",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeneralExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Salary and benefits (including share-based compensation).",
        "label": "Salary And Benefits Including Share Based Compensation",
        "verboseLabel": "Salary and benefits (including share-based compensation)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SalesAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SalesAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0,
       "order": 10.0
      },
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss",
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling and marketing",
        "totalLabel": "Selling and marketing"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense relating to the marketing and selling of goods or services."
       }
      }
     },
     "auth_ref": [
      "r267"
     ]
    },
    "mdwd_ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about amortization periods of the right-of-use assets.",
        "label": "Schedule Of Amortization Periods Of Right Of Use Assets [Table Text Block]",
        "terseLabel": "Schedule of amortization periods of right-of-use assets"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ScheduleOfCostOfRevenuesLicense": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ScheduleOfCostOfRevenuesLicense",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of the cost of sales from license services. [Refer: Cost of sales]",
        "label": "Schedule of Cost of Revenues License",
        "terseLabel": "Schedule of cost of revenues license"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r248"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r250"
     ]
    },
    "ifrs-full_SegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SegmentsAxis",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeographicalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r130",
      "r194",
      "r220",
      "r240"
     ]
    },
    "ifrs-full_SegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SegmentsMember",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeographicalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r130",
      "r200",
      "r220",
      "r240"
     ]
    },
    "mdwd_SellingAndMarketingExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "SellingAndMarketingExpensesMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfExpenseRecognizedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Selling and marketing [Member]",
        "label": "Selling And Marketing Expenses [Member]",
        "verboseLabel": "Selling and marketing [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0,
       "order": 20.0
      },
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeneralExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss",
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeneralExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative",
        "totalLabel": "General and administrative expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense relating to selling, general and administrative activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r267"
     ]
    },
    "mdwd_SensitivityAnalysisAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "SensitivityAnalysisAxis",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfSensitivityTestsRelatingToChangesInMarketFactorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis [Axis]",
        "label": "Sensitivity Analysis [Axis]",
        "verboseLabel": "SensitivityAnalysisAxis [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_SensitivityAnalysisDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "SensitivityAnalysisDomain",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfSensitivityTestsRelatingToChangesInMarketFactorsDetails"
     ],
     "auth_ref": []
    },
    "ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SensitivityAnalysisForEachTypeOfMarketRisk",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Sensitivity Tests Relating to Changes in Market Factors",
        "terseLabel": "Schedule of sensitivity tests relating to changes in market factors"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the sensitivity analysis for types of market risk to which the entity is exposed, showing how profit or loss and equity would have been affected by changes in the relevant risk variable that were reasonably possible at that date. [Refer: Market risk [member]]"
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "mdwd_SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "SensitivityTestToChangesInNisAndEuroExchangeRatesAbstract",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfSensitivityTestsRelatingToChangesInMarketFactorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sensitivity Test To Changes In Nis And Euro Exchange Rates [Abstract]",
        "verboseLabel": "Sensitivity test to changes in NIS and EURO exchange rates"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ServicesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ServicesExpense",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_CostOfSales",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Services expense",
        "terseLabel": "Cost of revenues from development services"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from services."
       }
      }
     },
     "auth_ref": [
      "r267"
     ]
    },
    "mdwd_SettlementAmountPaidByTeva": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "SettlementAmountPaidByTeva",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settlement amount paid by Teva.",
        "label": "Settlement amount paid by Teva"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ShareIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ShareIncentivePlanMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2014 Share Incentive Plan [Member]",
        "label": "Share Incentive Plan [Member]",
        "verboseLabel": "2014 Share Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare",
     "presentation": [
      "http://mediwound.com/role/SubsequentEventsDetailTextuals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of exercise price per share.",
        "label": "Share Options In Sharebased Payment Arrangement Exercise Price Per Share",
        "verboseLabel": "Exercise price per share"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SharePremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SharePremium",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share premium"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value."
       }
      }
     },
     "auth_ref": [
      "r214"
     ]
    },
    "ifrs-full_SharePremiumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SharePremiumMember",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share premium [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ifrs-full_SharebasedPaymentArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SharebasedPaymentArrangementsMember",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails",
      "http://mediwound.com/role/Share-basedCompensationScheduleOfExpenseRecognizedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based payment arrangements [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "mdwd_SharesAvailableForFutureGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "SharesAvailableForFutureGrant",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares available for future grant.",
        "label": "Shares available for future grant"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares reserved for issuance stock options"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares reserved for issue under options and contracts for the sale of shares."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ShorttermDepositsClassifiedAsCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term bank deposits",
        "verboseLabel": "Short-term and restricted bank deposits"
       }
      },
      "en": {
       "role": {
        "documentation": "A classification of cash equivalents representing short-term deposits. [Refer: Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r281"
     ]
    },
    "ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ShorttermDepositsNotClassifiedAsCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/Short-termBankDepositsScheduleOfShort-termBankDepositsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term deposits, not classified as cash equivalents",
        "verboseLabel": "Short-term and restricted bank deposits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "ifrs-full_ShorttermEmployeeBenefitsAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ShorttermEmployeeBenefitsAccruals",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/OtherPayablesScheduleOfOtherPayablesDetails": {
       "parentTag": "ifrs-full_OtherCurrentPayables",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/OtherPayablesScheduleOfOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employees and payroll accruals"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]"
       }
      }
     },
     "auth_ref": [
      "r265"
     ]
    },
    "ifrs-full_ShorttermEmployeeBenefitsExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ShorttermEmployeeBenefitsExpense",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails": {
       "parentTag": "ifrs-full_SalesAndMarketingExpense",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfSellingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Salary and benefits (including share based compensation)",
        "terseLabel": "Salary and benefits (including share-based compensation)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense from employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of cash flows [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "StatementOfChangesInEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "StatementOfChangesInEquityLineItems",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "StatementOfChangesInEquityTable",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ifrs-full_StatementOfComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "StatementOfComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of comprehensive income [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_StockOptionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "StockOptionValue",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/SubsequentEventsDetailTextuals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock option value.",
        "label": "Stock Option Value",
        "terseLabel": "Total value of stock option"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_SubLicensingOfPatentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "SubLicensingOfPatentsMember",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sub-licensing of patents [Member]",
        "label": "Sub-licensing of patents [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_Subcontractors": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "Subcontractors",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesDetails": {
       "parentTag": "mdwd_CostOfSalesFromLicenseAgreements",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of subcontractors during the period.",
        "label": "Subcontractors",
        "verboseLabel": "Subcontractors"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_SubcontractorsExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "SubcontractorsExpenses",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesProductsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subcontractors expenses.",
        "label": "Subcontractors Expenses",
        "verboseLabel": "Subcontractors"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_SubcontractorsExpensesRelatedToResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "SubcontractorsExpensesRelatedToResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfResearchExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subcontractors expenses related to research and development.",
        "label": "Subcontractors Expenses Related To Research And Development",
        "verboseLabel": "Subcontractors"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_SubsequentEventsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "SubsequentEventsMember",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails",
      "http://mediwound.com/role/SubsequentEventsDetailTextuals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date.",
        "label": "Subsequent Events [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_SubsidiariesLeaseArea": {
     "xbrltype": "areaItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "SubsidiariesLeaseArea",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiaries Lease Area",
        "label": "Subsidiaries lease, area"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_SubsidiariesLeaseEstimatedUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "SubsidiariesLeaseEstimatedUsefulLife",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiaries Lease, Estimated Useful Life.",
        "label": "Subsidiaries Lease, Estimated Useful Life",
        "terseLabel": "Subsidiaries lease, extented useful life"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_SubsidiariesLeaseExpirationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "SubsidiariesLeaseExpirationDate",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiaries Lease Expiration Date",
        "label": "Subsidiaries Lease Expiration Date",
        "terseLabel": "Subsidiaries lease, expiration date"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_SubsidiariesLeaseExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "SubsidiariesLeaseExpirationPeriod",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiaries Lease Expiration Period.",
        "label": "Subsidiaries Lease Expiration Period",
        "terseLabel": "Subsidiaries lease, expiration period"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_SubsidiariesLeaseExtentionPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "SubsidiariesLeaseExtentionPeriod",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiaries Lease Extension Period",
        "label": "Subsidiaries lease, extention period"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_SubsidiariesLeaseMonthlyRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "SubsidiariesLeaseMonthlyRent",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiaries Lease Monthly Rent",
        "label": "Subsidiaries lease, monthly rent"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_TermOfLease": {
     "xbrltype": "durationItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "TermOfLease",
     "presentation": [
      "http://mediwound.com/role/SubsequentEventsDetailTextuals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about term of lease.",
        "label": "Term Of Lease",
        "verboseLabel": "Term of lease"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_TevaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "TevaMember",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Teva [Member]",
        "label": "Teva [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ThirdPartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "ThirdPartiesMember",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third party [Member]",
        "label": "Third Parties [Member]",
        "verboseLabel": "Third party [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TopOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TopOfRangeMember",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails",
      "http://mediwound.com/role/FinancialInstrumentsNarrativeDetails",
      "http://mediwound.com/role/Share-basedCompensationScheduleOfEstimatedUsingAcceptableOptionPricingModelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Top of range [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r149",
      "r164",
      "r234",
      "r235",
      "r285"
     ]
    },
    "mdwd_TotalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "TotalMember",
     "presentation": [
      "http://mediwound.com/role/PropertyPlantAndEquipmentNetScheduleOfPropertyPlantAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_TotalRoyaltiesPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "TotalRoyaltiesPayments",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenueLicenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenueLicenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of total royalties payments during the period.",
        "label": "Total Royalties Payments",
        "totalLabel": "Total Royalties payments"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeAndOtherCurrentPayablesToRelatedParties",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/OtherPayablesScheduleOfOtherPayablesDetails": {
       "parentTag": "ifrs-full_OtherCurrentPayables",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/OtherPayablesScheduleOfOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current payables to related parties",
        "verboseLabel": "Related parties"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]"
       }
      }
     },
     "auth_ref": [
      "r265"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade payables and accrued expenses",
        "verboseLabel": "Trade payables and accrued expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]"
       }
      }
     },
     "auth_ref": [
      "r211",
      "r265"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeAndOtherCurrentReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other current receivables [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherPayablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeAndOtherPayablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other payables [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_TradePayablesAndAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "TradePayablesAndAccruedExpenses",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsScheduleOfLiquidityRiskByHoldingCashBalancesShorttermDepositsAndSecuredBankCreditFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of trade payables and accrued expenses.",
        "label": "Trade Payables And Accrued Expenses",
        "terseLabel": "Trade payables and accrued expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradingIncomeExpenseOnForeignExchangeContracts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradingIncomeExpenseOnForeignExchangeContracts",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails": {
       "parentTag": "ifrs-full_FinanceIncome",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfFinancialExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange differences, net"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of trading income (expense) relating to foreign exchange contracts. [Refer: Trading income (expense)]"
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions",
     "presentation": [
      "http://mediwound.com/role/ContingentLiabilitiesAndCommitmentsDetails",
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "License costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of transfers under licence agreements to the entity in related party transactions. [Refer: Related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r222"
     ]
    },
    "mdwd_TurnkeyScaleUpAgreementWithBiopharmaxGroupMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "TurnkeyScaleUpAgreementWithBiopharmaxGroupMember",
     "presentation": [
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about turnkey scale-up agreement with Biopharmax Group Ltd.",
        "label": "Turnkey Scale Up Agreement With Biopharmax Group [Member]",
        "verboseLabel": "Biopharmax Group Ltd. contract [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TypesOfInterestRatesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TypesOfInterestRatesAxis",
     "presentation": [
      "http://mediwound.com/role/Short-termBankDepositsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of interest rates [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r284"
     ]
    },
    "ifrs-full_TypesOfRisksAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TypesOfRisksAxis",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of risks [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r153",
      "r176",
      "r180",
      "r181"
     ]
    },
    "ifrs-full_TypesOfRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TypesOfRisksMember",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r153",
      "r176",
      "r180",
      "r181"
     ]
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails",
      "http://mediwound.com/role/Share-basedCompensationScheduleOfExpenseRecognizedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [Axis]",
        "verboseLabel": "Types of share-based payment arrangements [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "currency_USD": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2023",
     "localname": "USD",
     "presentation": [
      "http://mediwound.com/role/Short-termBankDepositsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "USD [member]",
        "terseLabel": "USD [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_USDepartmentOfDefenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "USDepartmentOfDefenseMember",
     "presentation": [
      "http://mediwound.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U S Department Of Defense",
        "label": "U S Department Of Defense [Member]",
        "terseLabel": "U.S. Department of Defense (DoD) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_UncertaintyInFutureDefaultsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "UncertaintyInFutureDefaultsMember",
     "presentation": [
      "http://mediwound.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uncertainty in future defaults [Member]",
        "label": "Uncertainty in future defaults [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_UnearnedAmountsReceivedFromCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "UnearnedAmountsReceivedFromCustomers",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unearned amounts from customers not yet recognized.",
        "label": "Unearned Amounts Received From Customers",
        "verboseLabel": "Unearned amounts from customers not yet recognized"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_UnregisteredPreFundedWarrantsIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "UnregisteredPreFundedWarrantsIssued",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails",
      "http://mediwound.com/role/NetProfitLossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents unregistered Pre-Funded warrants issued.",
        "label": "Unregistered Pre Funded Warrants Issued",
        "verboseLabel": "Unregistered pre funded warrants issued"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_UnregisteredPreFundedWarrantsToPurchaseCommonStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "UnregisteredPreFundedWarrantsToPurchaseCommonStock",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents unregistered pre funded warrants to purchase common stock.",
        "label": "Unregistered Pre Funded Warrants To Purchase Common Stock",
        "verboseLabel": "Unregistered pre funded warrants to purchase common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_UpfrontPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "UpfrontPayment",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront payment.",
        "label": "Upfront payment"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember",
     "presentation": [
      "http://mediwound.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about U.S. Department of Defense (DoD), through the Medical Technology Enterprise Consortium (MTEC) contract .",
        "label": "Us Department Of Defense Medical Technology Enterprise Consortium Contract [Member]",
        "verboseLabel": "DOD and MTEC contracts [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_UsaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "UsaMember",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfGeographicalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USA [Member]",
        "label": "Usa [Member]",
        "verboseLabel": "USA [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_VericelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "VericelMember",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vericel [Member]",
        "label": "Vericel [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WagesAndSalaries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WagesAndSalaries",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/SupplementaryInformationToStatementsOfComprehensiveProfitOrLostScheduleOfCostOfRevenuesProductsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Salary and benefits (including share-based compensation)"
       }
      },
      "en": {
       "role": {
        "documentation": "A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]"
       }
      }
     },
     "auth_ref": [
      "r270"
     ]
    },
    "mdwd_WarrantsExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "WarrantsExpirationPeriod",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents warrants expiration period.",
        "label": "Warrants Expiration Period",
        "verboseLabel": "Warrants expiration period"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_WarrantsToPurchaseOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "WarrantsToPurchaseOrdinaryShares",
     "presentation": [
      "http://mediwound.com/role/EquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents warrants to purchase ordinary shares.",
        "label": "Warrants To Purchase Ordinary Shares",
        "verboseLabel": "Warrants to purchase ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_WeightedAverageExercisePriceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20231231",
     "localname": "WeightedAverageExercisePriceAbstract",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price [Abstract]",
        "verboseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options granted, exercise price"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r282"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Option's Exercisable at end of year",
        "label": "Weighted average exercise price of share options exercisable in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Option's Exercised"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Option's Forfeited and/or expired"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options granted in share-based payment arrangement",
        "verboseLabel": "Option's Granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails",
      "http://mediwound.com/role/Share-basedCompensationScheduleOfShareOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Outstanding options and at end of year",
        "periodStartLabel": "Outstanding Options at beginning of year",
        "label": "Weighted average exercise price"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r157",
      "r161"
     ]
    },
    "ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageFairValueAtMeasurementDateShareOptionsGranted",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16",
     "presentation": [
      "http://mediwound.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average incremental borrowing"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average lessee's incremental borrowing rate applied to lease liabilities recognised in the statement of financial position at the date of initial application of IFRS 16. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfInformationAboutShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining contractual life"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageSharePriceShareOptionsGranted2019",
     "presentation": [
      "http://mediwound.com/role/Share-basedCompensationScheduleOfEstimatedUsingAcceptableOptionPricingModelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average share prices (Dollar)",
        "terseLabel": "Weighted average share prices (Dollar)"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ifrs-full_WeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageShares",
     "presentation": [
      "http://mediwound.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares used in calculating basic earnings per share",
        "verboseLabel": "Number of shares used in calculating basic loss per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "104",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "51",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_51&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_g&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "61",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "61",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "69",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_69&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iv&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_vii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "81A",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "82",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "82",
   "Subparagraph": "ea",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_ea&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "92",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_92&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "98",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_98_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "98",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_98_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "99",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2023-01-01",
   "Paragraph": "21",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI",
   "URIDate": "2023-03-23"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "81",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI",
   "URIDate": "2023-03-23"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_viii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI",
   "URIDate": "2023-03-23"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "138",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "142",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_142&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "36",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_36_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "36",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_36_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "36",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_36_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS02_g36-39_TI",
   "URIDate": "2023-03-23"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "20",
   "IssueDate": "2023-01-01",
   "Paragraph": "39",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2023-en-r&anchor=para_39_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "20",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS20_g39-39_TI",
   "URIDate": "2023-03-23"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2023-01-01",
   "Paragraph": "52",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&anchor=para_52_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "18",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "18A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18A&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "19",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19_g&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "19",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Section": "Disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI",
   "URIDate": "2023-03-23"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2023-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_iv&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2023-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_vii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2023-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2023-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Paragraph": "67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI",
   "URIDate": "2023-03-23"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "130",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_130_d_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "130",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_130_g&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2023-01-01",
   "Paragraph": "86",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_86&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS38_g118-128_TI",
   "URIDate": "2023-03-23"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2023-01-01",
   "Paragraph": "76",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2023-01-01",
   "Paragraph": "50",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "40",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_40_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ix",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_vi&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_vii&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B13",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_d&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B13",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_e&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B4",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B4_d&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "14",
   "IssueDate": "2023-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2023-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "114",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_114&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "115",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_115&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "120",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_g&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "57",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_57&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "59",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_59&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "97",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "C12",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_C12_a&doctype=Appendix&subtype=C",
   "URIDate": "2023-03-23"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI",
   "URIDate": "2023-03-23"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Section": "Presentation",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI",
   "URIDate": "2023-03-23"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "109",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "109A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109A&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "120",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "124",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_124&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "125",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_125&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_128_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "44",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_44&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_iv&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vi&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "47",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_c_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "50",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "51",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_51_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B67",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_c&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2023-01-01",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2023-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "21C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_21C&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35H",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35K",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35K&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35M",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "39",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_39_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "40",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_40_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2023-01-01",
   "Paragraph": "6.5.16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_6.5.16&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "68",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_68&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "70",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_70&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "IG6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2023-03-23"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "37",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "37",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_f&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "37",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_h&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "138",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "21",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_21_f&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "32",
   "IssueDate": "2023-01-01",
   "Paragraph": "IE33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2023-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2023-03-23"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "119",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "119",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "44C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44C&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "44D",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44D&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Section": "C Reconciliation of liabilities arising from financing activities",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C_TI",
   "URIDate": "2023-03-23"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "B6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "IE63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2023-03-23"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "B89",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "96",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_96_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "96",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_96_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35N",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "B11",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "B35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "IG31A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance",
   "URIDate": "2023-03-23"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r258": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r259": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r260": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r261": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r262": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r263": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r264": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r265": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r266": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r267": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "85",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r268": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r269": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r270": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "9",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_9&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r271": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r272": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2023-01-01",
   "Paragraph": "52",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&anchor=para_52_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r273": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r274": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r275": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r276": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r277": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r278": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r279": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r280": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r281": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r282": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r283": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B67",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_c&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r284": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "39",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_39&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r285": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2023-03-23"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>133
<FILENAME>0001178913-24-001020-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-24-001020-xbrl.zip
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M7BJ_8@W8W\X&WX$<>8MQ/OFMO#''@3)ITJT_--M-!\),VNL;*:3A"OG0E7R
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MXWW.!/EGC%]%66Z]Y+'@&+Z]^;O\'B_QP&_-"N#O-?-.Z)C#HV.\$SKF7B8
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M&5J5&S<-1$8'_&QA=#& WN4:@!KJA/7>QGMMW"VZAUD^8+L8]B\\UDI!85W
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M+\0\QF$5'1^QUMCPGZA><M _;O:>S:!'\,TT(.40GI\B_GJK0R>XCO4A+NL
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MII)R>>7D&Y/"P'FVR+2_]])A?0?1K."6D$:X"NQ/%G\\^1X.I)L!KHV41J\
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M1G!IA*E"33+?A[IPPJT#(Y\.I9,ZA/>"! ]I_;HQOJCQQ\9]""CAWD'ZRP0
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MDXQG7B%-CX#Q+,TR$<9IEI:BBKPH+^==X$<7XC?NCJ\K3)>] !]8#@>9193
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M>>4QQOPH3$-/A%Z1)G'.@LB;*3\T]UZ>PU$:[&6BA0-MS>L&2#*:&J.5&XM
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M:N3"E0\%GAZ<N*7.#2A2T&/L:Q""P;[00N"1EE>NL,+H0'==*KZPS71;36U
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M?:64ZM*JJE_K=;<>'KN)Y/%4 EC\*M8[RMTT DK>!-G7Y1T<!6KSU)<FR \
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M=5@F:;<QIR0  (.G   /    97AH:6)I=%\R+3$N:'1M[3UID]M&=M]3E?^
MR/'N3!6&GAEI[+7&=I5L2]FIR)8BR=E4OJ2:1)-L"P1@'*3H7Y]W]86#0TE>
M6;*LJEUS2*"/U^^^^JMUN\F_^==_29*OUEIE] D^MZ;-]3=??<;_E2__[>PL
M>6P6NFATEK3E_>1_S_XS^8_'3[Y]\)B?H'_?EXMNHXLV6=1:M?!DUYABE7Q;
MERJK3;;2R=-G3Y8FU\GEO=G=V<7LZO+R7O#^=V6UK\UJW2877WYYE9PEE^>7
M]\+7S\YXO9_)@K^:E]D^F:\695[67]_Y9$G_[B1-N\_UUW>69=&>+=7&Y/O[
MR5]?F(UNDA_U+GE6;E3QUS2A;]*DT;597B?T=&-^U?>3B_.JO4Y:_:H]4[E9
M%?>37"_A&YKG?O+).?V[OL.KR<S6P@D^)HM<-<W7=[Y]]O314[72?X>EZOK.
M-W:?](PL,#>%/EMKW#),.KN\NO;/X;'4"4W_]1V ? N#V/?F90UCWD^*LM#7
M"?]U-B_;MMS .-6KI"ESDR7S7"U>NM_;LKJ?W.O_Z&8_KU[Y#3(@X55X9E67
M79&=]7\*H</+NTXVJEZ9X@R!=3]175NZKVJ>A;Z[ ]@5P.RS'OR.@$WX7+@.
MFN4Z&;[*A[N3K^9EGN$JNF^2K^9U"/'/NFAMO^%,#__G[S??WKQ(+F<7_5G>
M%@)CS_WEDXO/SZ__67"VYTW?F2*#/^\G=S^OCH?(]P^??_?LYNF+FR<_)D\>
M)<\??O?3LYL7-P^??]B ^;EK6K/<'PF9.]\\Z6JDB759 ]_)DF:M:ITL5&5:
ME0,Q%HUIVB8IE\ )4^ X^+\$J-D4JM[ST\"_*E4G6Y5W.OGQYGER/CO_(JET
MS3^G^/)N;1;KY/_XG\=V?C_!*4W3=#"_*K*D[-JFA0_(N17-_8.JX?6+JY3X
M\>SC.J$'>8XP*.&@0LCT#H& "&=@LGPOP$R399?#7Y4R#%A@UF<@&733J'FN
M9PF>_<@P_GR*LDUJG6F]P1=HC*RD;]=JBW_#X#7\6K4&_B2.U,P8>@DMNS<X
MO65PPV8!Z+4M6SIC//-V#0C#(R2F *F3P\Q-I1<PXKL_[]O>$5&-/]]/D%3,
M L9Y4:NB6<(^X+AXQZ\SYON&=X@= 0*-X9L0+9Q7K5? *#0@"X"FWM"9;A1H
M1CI9 H; (*T !Q\!:8Y00M93 RKD&JG<HQW@:+DPJC5ED<*S\'.3 'ZX(6!>
M1(ZV-@O4\<H:L+!<F[G!O^9[F)S1R13P#.F#::*J"@Z)T#A7.WP'1ZP[GCM1
M +%R\3+1KQ9K58"B5Q;"M/"Q8,LY;I,VB<O)@(I>P /EKM!ULS85#BQH;6FV
M!S=8'](A?"1"H-EOFEKIW , ]L>DY_:() '4MD.0[ON0"P%F=P:;I)_P\_,6
M=&$_3XJ[U%5+F_ KQX71$"JG-YMR Y( -"]8@\8#4&W"_+QF0IYK#>>#*P/@
MR0P[D 0[TZYEJG\ZZ8+V=-0P;TW;WYLMGA<STMS\TIF,X<T\ZT,F]']H(M5,
M@]T &*Z2S.ZU+9& B?SA(Z+2&I0GP)<IY 9D %*LRII P^^8VG)R$!(]V8_#
M :TTL^0G8@DX!6.. 5ML4ZD"4>^QVJ5^49E!JIAW. 739*:!\VQ@9T3].,:\
M5'6&B\Q,#1.7L.) >-4:C@_>PR>!+]0ER$U+*VY9LDL%)(#KV(>,2+[ZRR=_
MN[SXXKJ9I$4<&A;-TFUG&I:Y :.;>*^WSF!-T7K5.%!HJW9J(ML)V F#CL&'
MQSH$WT>F<SWMZJ9316O1?@(G\:<8\AODE\B_<[,A<20#K,@?09I!K5M%P-:J
M+A#Y@8H\2K@O5QH8,_DPRJU0!NA:6U-V@(.[,MG#DZ!ZJ\6"B'"%,^'9P8,%
M</\&T6=K](X%I.HR6LX2R+4 -,N99:-L1/V=D25C;,&I$%F$(D"3-R5MQ O$
ML6%@OARE@ BO34D4IHJD,:_@KZ)=-S"10?G$,,E$9L!GO_\0G+/D!B2*MN2P
MT;I-F@Z6L*AA,[51*>]V)PS,OJH=P@-L"] ]2"*!**M;1S^SY$&1('VU>UAX
MU8&!H1I:/ ,^)Y6%G4A@A "I@9ZK,T]**#SAM:ILM!6TC>9C5TQ>2,BCA#=+
M_E[N-)QJ2J,HOWO+:VB7:/L 'EJ5@P@[4%# %B#>$HCU+0##$,C0M<(:#NZQ
M 7"-XIW[G.)+0".@=@NT"\W8VVC]L@<[7O4(^/J8!&/"4$!XA)D+4/T,\6*+
M62@J&IT%V#\X$.1E<!CESIZ\'0/F+RN4-%V!K\!*#7PPB%-*U@OC+V 70AQ,
M#@(4.SZC&* '2*Z[YX"2>]9]<"Y:.NB,K(?ZF05 Y$;$5<Q_1MF&SP@BRKR,
M=O%\]!T<';R%IP%+"P\_1M ;@+#"/1-D86R4=83/%?+K5MA+@/:!0#C!PUTN
M865#H#:GB"7CC)X SC(.5I/B@UYU3KVL:!ROJ(7D80+5@/:(*O:B+!:Z+OB9
M2NW))RNG'BTQHOUHA3O$1>1X^"KPO&5=;I(&#J-9[DF]AN7K5[!W:T("4@(%
M:IJ_G /?%S)4)+-1TBU0H\TZ_9$)LYN"6?I6#@$A%VBP($.6*)H8MFK!5L02
M'E%SDP-)X5F7'O]3-C^:1@//IU.:!U*0<-(?Z9OKC#W]\ 5B$NG:*9[H3L.\
M?++\+5/X0J,CPG'_U*HXBBC!ZX>K6C$L ,' H$2'!+ UAYF F)%8%[_$4 =6
M[&OW!C_1M]]^-+P=!7=BU^4];X9/:=FU7?U[8.B;F47/ ]44Y3,>UH=L"[$9
M8M6]')4\8;RBC!/+Q0TCZU=%T<'!BL9@ 6 1/38E@"$B"0+>+U0.2 :&,JIP
M(:D@7L!Z$3'6.D=_79*3UDAJU,65U:*87GLJE-<.QU<U(X^</2-QN-' 9 9-
M[B3:!0-"O#@D<@_Z(H!  >RU<B3?&[^9^>T_&1='2"@+] 8>'@AT4_@&%673
MHLH"\L(@IQ"%L34;5B4J4(Q0F++$+^LQ-0I6;5HQB47:D3!6&3! 8IB3)H'5
M?X3*)T0LN:\8FX+C+U%J H_6K.8=V&W2524?VZY&-:"@X71#'.W$G)*K"&T$
MV!^IX8*0?@6X<4#^7SHX.;1*_',XZD9OY@'#'MD!O'!B8*+&(%J3<M<SB<?<
MA>.*K"EB<?'3[/DLQ>6Y944H*"(AM0Q3K<"V ED/IZH-(?6).DTNSC_M[SYT
MGHOCTJX-$./BT['GQ)57@;I.4#J9WSIT^,ILFA6^#9.*8H;34P!%JAKC7>W:
M14$I!,O!9?G&!6WQRSO]V/&WH-2]? #_%X6%@TDJ>.ALCD^=$5NZ#]KZ#K3H
MB:'"83B^7)1P"AF,)!]Z(>:SG<G:]?V$@\/#'7% F7Z5)R_.SS_U4>7+,*@L
M4?.QH+(+J/?@^?[Y+W]/\?B\(V/':D+$[1HV=I<'N**U*8!0NUS4<GAWT^4K
M,K#)BJ"@0!H1>V 8%I0-0D*G(G%C*C+U8&2@.(V<?B 3E/CX^CX]X&)ES7R(
M)2C[.3.](--UTH>8B@?$!C;0"AXWV7=KL&M'>2 %#4 .=6"A+#!45P1,;Z[;
MG09VOB2A6@32X7.Q3:<<*%[*/P*S#<")[.F0H!(!)((*/I2Y> 61FXI'"?71
M$HUO_&NC0-2@1!85165E1=X1L%F/48'NOYY>^-:>_;?!\Q='PDV1DV!!IX!(
M,*5&U;<(]+D.;0;K0BE[RE>; /\#X%]>C""##)4229BER$94-'LH BBWR#O6
M4<C_79JB90,=/?4;ZUT.T'[@*,= '%N*;/' ETL$@R,R#+YA.+"1 !W[!C.F
M74P98 ]2,&C@%8>5UBOD!0)<BW$.,@X2=Z^F(?$^QI[> >^^FMV[>@WKQGD[
M;U>Y/-A964)8B[8CIBTR1JN*(GW$BMV8)LRHB$=.W,4K=19Q1UE+N+J^S]&0
M^YT0"[!"N#M8\XL.['1FTG8R\74/#*78._MF3EF_=6M6C A 'Z%Q:R)"$8_E
M8?I4#HX$=W(,SK6%OP1SCC[2J_$CY201!=-GDIV#-,U>\0FC#ZP8=&U&#&VA
MLPY!O.I@QSFY#Q5[Q1=YV73H0FSU1GB)1 LM!)INO@%]7;Q282R,_<<8KL:#
M&MB6M\44P].PQ\.X2[Y&%<U%QJX@:V'Q$Q<]Y$YL7(:X7VO-?.J$,<JBLLA>
MD2@*&/L9/&;9'@=>3O$ &W+M'S/$W:NQ(;P41ZG,RH>RCCY,V "X>4D6B9.R
MMM;RQ3U> ;L?=IK':=8$D&RKP!3,["@Q]5?HF;,2)YYN*?D*'S?3OL4?=5BS
M/N"!28?N&PQ=1/&#5KT$G&:W[WSO#PUS33"C0UP,F N(3 @0(3>Z8P[TKD[M
MMW%7CN:!_C>SNV>_21K'FSE1_ZLKZVYCJ9B"J1^R#S4,GA_$S5L" XBMH=V'
MPHQLO24%+D$8VS=Z627L/2TYB]":+21&+,XK'FBNE^68C3AFTLR2!XWG\:,9
M;+'OLZ# L2>USI'RCZK)U"_)8PE>/:,DM*S3%F H8+N&P\ZX0#@%U'"W'%UO
M.E1-<)Q?"&_"^)FXJ"FQJQN*Q($_-TSP=:H >@ZCIRH,K#'IPW8:/+HY13E?
M[4D\"(>88YRV1=N7'>2DKMAWK6D+Z]X$EHQ7.]H2,XY'/&E6$7G@9)[*?H;=
M%;Q1OWV*>1-;8L#$P7S_DM4KU(:DLHN\.!FYPY"W*(?T5.P^3MC44-8YCS]B
MQ(B.!_/F$M1?S-+XJ,ZH;(4MM:)VB.<W"ZVXV(4[<2"!C*63P>?=V9RP*4]I
M2S)UT:%KERBNGYN+-,.NC\TI?IES_C?0'X>6P5Q8=KG ]@/A^,3>]1^&LSXY
MP&]B<X+3IYU/9RPB9;/+0,\UFRK'U(6?RQHS!8@WDD\L,,K9V^/R<5U*F^<Z
MXC<;5U08+P\PS"-2 )GG<XBC[Y(8Q$P"'P6;%8HLDQJH'&D\ $4J&>L4T2!6
M!#P[SDC6 *!R;XTPCIWI8@5F0)C9,#&^_YGM2-3G*9=E_'$70F%3<*N3$YO8
MP[$L6IU5Y:)-GZ:XB=XNHL7+2M9&P_>O]**C"=A[4^/;6WY9Y]HF @10> 5C
M%A0H#[-%3K;#XR#6J>LM<CVQ0P&],;Z._C&0;& P&[ #"OLP.P=PN(G%(99V
M.<@&778-NBO$#E*OX/N-S5*CT=#<HO0X%N3(H%-O(Q%S1J%HT=VMN^N[1P0G
M/00.JC,$@[S%K#VQK%QV GDI8/>Y7E&]C*0%+#2'XH)L%7$DNK0"1[9-:.7U
M*=:>*[T% LCE.YQ89&.<!2AAY91:.5D$2*:WJ*SQNV%R0J,I13S,9Q!QML*4
M1$Q>2C(IN&S\0.BV)/3& 0$C18RWY4K3&NA,FF'> *](R4K^#)W]&3K[D$2S
MA%VDM()(V>J98](UT$@23KKWXMKY1+;P!1!KC0FLK!)WE7C. \$<)80W"U#?
M.!Q1U^B2]([#LEZ!+/U5F%5/)E6!S?9<6/_=J_.#83T;#@M"(K$0".R[+R;\
MB]Y"8+=^&*>0V!ZQAD*8E871A^TG&E=5'WJ9ZR7LT8..$L2[#S&,U12&-8,@
M+CI1:V)$L$BOQZ! QC?1"*@ :9B%%\AF<DCU)&*4P-'#-369YD0KI0 WO0<T
M0:MR"FB43&,5UX.ZP40>#?F.Q0B/;/"EV6JIV0Q3Z4'FZB P%PIF]$V3Y;B3
ME'B)?A=1YIJ$$]@,/Y&G<(Y%5V.>8O0PG%M3GJ:Q9V!,">1!(Q_'*,<@BY<L
M6[29B=9-0>J;MTO]L">]'+7AS*>1XR?/.2];44HJIHR3*CA+CG9(C9YOVL^5
M&ZZ#E='=&C.41;MT:!S:GI1*O;\-2JG+JO6 Q:K&44D2X7_/H2;('U1I2]Y$
MC[LB+;Q.,N,L>8B <N$G6BYJ^QJVUIH\61O2:Q%JH J"EMN45+29=;![@HP$
MDWZ!&=E1 @\,W@6-)3?PWTRK=HT:? -<R54Y2BC, X!@1-+5^ED"0 5I7".V
M\+$Y#*/+E-BW?E49*? LJ\ (H# K5DE2I0Y&27QAP 25'++SN1@BY"=A\8RE
MG8#4HR^7>%1;M<#J'=U8N3K"F:CRPY\H^8X \8],% 4,&6$3M7:'+Q4D7+*1
MDZW:L]U<[G;TBJ1@RBNQD1X:?D3)3&=@.V(\,EF8&H0/>A<72 U!A3)A$LZ
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MBS\C$N^VIFE<H_Z!\.L/JD/3M0N-I:'HPC*^TMQ5R%/5,)6$.JD\?BVZ)?)
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MN/;5$"Z[%A?@IC-:E$*>*K=%XFY7UI3I%7]3/H/#7@N4'-CSF"F.1KC]-'B
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ML\.GJN*G'J6F\"0#S8"%],7^PUN>+W/2T9E/V9MO)PRHC4]YEAO!2F-2VT!
M-4K&FW,U=2]2??T,52QTG!WQ/^+F:&V&]:P?UK^1Z6\Q0(.[:6Z:5FPF=Y\(
M6,PPK:\ZD GK*!^M&#A*(>J%%3; 5&O]G?[L/<C[ML))<FPS4=&?T_LWTAW#
M,47OA=BB2@9/Y*=7KW_HWW!>K+OWGZ.V0WN-:(/H7[VT80EF]V/6#/KB#E['
MM:#.SEDW,E//%ZHH;]"_[7YPGAH0:W58>UJ<6LZ$,VDNJNZF2?T\*%+ZQ[Z.
M+R 4&9]"D9]0G>BSF'FV'SE<^+F3QB%+?1'ZU,#1/^6%#_=]CSW"0LU#EL#8
MML-?F&!5,D:4$S1CTZ+"$4T[[$C>Q8%FNHK/E/8F?6GOQ.T>N=QZK.C"[3NA
MJ98W]7<^?K+3]W":U:;XM_2+_E[5[YM1;=%<!Z697Y&]KLXU,^=P*&,2S6,4
MYX,6[WW=DC'0>VA@[S$@Q4R=U!"BK/U,I7XT5GC)1,?O!NVDYR"M,WN')0E^
M65*[N9D)W'*(+75D)V.6ED#][ZL&?B&+*G&-0(-X8MMJ7? >AW2-CS@,'8U@
MXX[VY: $>N)SN24<G8;OD3Y<C3##4L<V8ZN)KGU!^.5@@E_6G;C'C?2&CY^N
M?<P 5'2Q;C4LLK/DD B:';"'ZGY'5;=HP,S&??25:@'[+%(,3:!AD0I83DX3
M!/IV_$T!4IO5W=,DH!H7R#!XP1IMD.H9[9-9Y;W\4*<Y,UA"S@C /_&JD8,A
MC%N1987WFV&_ANSSF:@'429"][L[&F TM07<_+5D6#6H>#0+LYMF@YPL RCR
M=@,&G\A%Q>X/'NVX2W3;\:.(NZX;B<AW[#01=ISX@O' SICKQ4]-PR\HZ*/"
MMF[)-OX"'#QHWS\9O2J%8E%KC;$";PDL:QT!DF[M8TL^^J[O14F:)HGO^8GM
MIIS[G"<^3UWX2^ ]-4J\+UL32/FA.NQ+L;DC,!H1L>J.CSTFT9Z9-QQENTKQ
M88L4K, [F:IBZOI2RJDVVASXM;>4U$"F,5(;;[.8WEF:C),/5* VQW0$$K'.
M4X4C0V@?%Q!]3(K"MJ,T#Y.8!1&X@$&:I'::NYYP_<R!OS\Y17&/[/D@7?MI
MB PFE+K<PB&)>NR;(&E;R.G92K>L.HJ6*J?3/UW:HC,/1Z85&I24>^L,134[
M9C@LAY *[!IS(GR]D^$XL%P;6$C3Z,>IVD;-L5/F5 '>;BW*8OL)6!7,8L+S
M_%!>%755JH'*O\KFNI0RW!]ME#:H.@["Z.8Y(7G[<3YJ8Y/1<5^1FT#6,6U
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MV&F7_]HQ_ 4\LMY(4U> ,=FT*RM?5Q48-T,;&1M,8P]BA"P66XV%W8+T;]6
M0OI8&MZ@"XI,HJP+D*V\Q>?4Q7O\OBXJE5[@Q56QIEQ1)7$5&Z!;3N.K-58!
MKI*!V*)\<./H"XN4.Z=(^:?T-G$<[]Q?:FZBYGM*7PA!<7N;,\FF9!(-;SAU
MO[]]#?<++%"<:V(?@CIW\C(%[SA'631$]L@FY'VLUO F)ZZ>JIWJ7QJ9*-V-
M9YPH*:'[6O:)[J!MLQJK0EH3PD2 :BVX5]HD&A_04AV"K"@W_%V9,X7/;CDD
M^1/CC$C6-=4:\\YJ?_WV#]]HB4AR%*U+5\C3+\A9Q^E[9 H.B_$KSG=U;2H(
M.HZ5Q+3A;-+-;O,'](BY2R#;#4+/23WX;^3GW$M3'@1VRIR()7;H/)D$T!$L
MO2,7AA5U=B;#,Z;3IMF@1XCB=!G9CD$-F9!0QX&WI!P8S?[]#8=A/]W;738P
M@ 7(^)!INZ 4N<#:*'*3KHJ6( C2#A)ULQI+J*&M54A;BU"#!'JBOT_-G<X8
MD\$N9JR8XHF6,1<&08FYE 78W@DGS+CV"N@)_\4@7Q_ ZL1.6>X85<L5%76W
M[\[JP4V6NY1D!T[N>R)TN9/Z"<]BWXM%&'M.))S,]9],2?816/NH(/L?-F#G
MWP"S:#3Q'']K5FVZ<7$',"URFI!W'_>_Z+E-YQ1F^0INC75MG3+N=31<7@)U
MR'!+@:WJWHMU@Y%VX"30?_OX;AYX])DQXC[(S5VBK [G@6L[H1>X?ICG21![
ML>W&PH]XS*.3PCV<*_UC<N6/Y.^CF4C$WKGM@Z#?M[N7W<RC[S#G_)CTA1-P
MUXV#/&(I\P.1)-QUA)N$:>@FW'?X4Z',(\3_CZHO%I.,50J'?:4"V1CA0S1.
MA^B]V#$@X5;)?E7VJ\KG=5I-]KI>DY>)\\.5SB#R%UT+4F5>RMYCTK@<NJ)J
MF*^$4*K@?L-R 6I%? "*06R1ND9Y5^!&@4F(LI]:H8O'9GKY=NH' 58U@ESW
M,^;'B</<- JS( 2_ZL1*![/2487\NT$H@>BZGY"54K2"&&E<+T=.$RB!IL7.
M9)D*G^*GW[UY-W/'QT3+6>:[?I9QEH8.N!-1DN><N7;D.'EJAZE_HN6#:3EX
M"+6@'.V?ZG/K-2L+L;:^VW',$S"DZUI@EX%>ENM&DJ/!TQB@RKJI"%+^RW20
M1)5.6&;4TFE//Q8)6^I228V<X3JY(:5M9)P!"RYY#?;86>>>3#T((,J=:DBE
M0I_ZJ101H ?# ]:]!BMD$<>FRA0NQYR6TW2 I<P8)S6J[AQJO8&CY-FR]>3C
M[#.8\<0)&?=XX 1^FMEIX#AIP#W'99&=NB=HR.$R('Q0 *+&?_<E6#J0 %R.
MC4:1)&[K#2K[HBJ665$R8]NJ>=HZ#?G@U/V%Y?;<4V[O$ZI@(C?/HI0GX/5B
M\\HDB4+/89X;BR 0WLGS/5R\1<<4;Z\/0'#M[0$WLC:,3G"K@?>L[B[]9QP8
M#<*N'T#3&SVZS)6<!'*K)_6NPVSE%K.'N\VC<@B8R,(XC8+$3@(_2N+4BW,O
MC'W737*>9Z=B[L.Y)?XLXD1[>[?L:]$R:L6"JH5?=IA0C36%"\UO!NWE)KRT
M8/X_)OZP_33,PB1RD]3WXSB*0]!A@6 1_"7AWLEA/IP_CCE%^.6OBW,3^GX'
M ZCSI-G!?/03G%5<&4U4$(,D5C>-D@![>CH<<-4DCS#7A[%W;?5SB<GPAM@\
M"YS,=O!DW5*G*J?>,GD :GF$4-1%/^0JJ/BN;C-TQ^+3_<>#8^5$22V:C3,#
MO=A0[%E5:<CNC]BV:FNT]IP)$\S"U@?#:Z>;?]7-49L"=%2HP\ (R//=LJ+K
MZ2!%Y'R'R$%AC00029.BV6VZFZ,,AKW"IJ\(*ZE2JEV9[JS)L!=[]8C$9<CC
M.(B9$R0B\ .6QCSA:<)Y;D>Y'V2GL=5W*&X\YAP$LB<0_]-'R!'8S*YZ(9H2
M6>8ZH:.0!,^1*[7I+/E<S>?0]@')FQ?S:,0-R!!E\W=2SC H.D&DA-8@D56H
M#J] &:50<'"C/2!%]6^&<8ZIM#"MEPY@E(GRIK=?:N2/1V6SI&XB4L=Q0^ZY
M/A<AMFIB41K OY[OL^C$A(<SX<.6&%\RFD/:3T_6S)COY(A)4[OWC++2?:/[
M@8KC8M$MQJ\7=)%BU:8?R/RHR-]+1>2[0.=A9OM)Y*2IS].,\3",,I?%3P:4
M<PSR?ZCY"(OS0FJ,;(M]E-N'K1LU$437+'4F7A<=?TQD[=MQ&B6)EPLW\>/(
M2X* ^XRGN1T$7O#E-'0\)ASGEOXDO_>=:$<X3?";6-VUX-\U2_5TCZSU(\]%
M*D(O9 $/_-S/TL3U$\\6'@A7GHI3;/U0T>H]6.^2>509%7IO:4:!$2*?G0.S
ME$CL^^IIQWK8:)#0R+I!(=QCTM.Z&_-.0T*0?Y0:4)V^QR-G5"O5/K)?S(R=
M,8/]J\&LQ$%=^R*DX5)5LZM1)#=+-4XZ1D"U48(@!:IKQTH>V+@G=S;N3C$\
M;+4NZP++.4I=C,'X4LMN!"WD,\@)P^3K91*%@N4(CH',4N,R5=N8&R2^RZHN
MYIN&R-)AA><S1G?T_>"9?E,/KF:_L/RQ=\H??TI_KI1ED>"."")P(CA+TH#;
MD6][OO#<Z,E4VAQ!QSV4]["0'Y[V,@#Q6F7F^(2VR"3V&2FV7 U@T+([E9R@
M*$J2Y7LZ4]4" [BC[,%0!!/W$12[E>V']@#K5)!::J,9-6>,;(1U;K980FQD
M_%3:3C_-Z)R@6S;--%6@VM=L2>/I<1"L;N7Z46O==4(&CL);:&9F/3>P2-WB
MI4J>'@"UA^C;3WWLG([1<V1K:1SR!>]"WKEK5R5DPX6NXQI>JJ=13(;%#1\V
MTOQ4C:5,IPYIB2=*MWMQ;KT9'!@&.6=( &XFNW+#E:"HX5IJ54%TTS=+D_0P
M@73.=!<U'.]5-W@3/?(N"[)2_K4)HER8GC'%5 I\9D?7Z0W2M5CGW8NXV=LC
M;W:FR;"%F9G2^W-CCN?3_<7@$AV-)AT]2^:XD.T6ATK(V1K#Z7@SEIAJN&8F
MQ7!:N3\[K9RBX&AV:188@5"["'@_$WYFXP9-:D$PC?<5MTW<4_:;EC1Z'+=J
MD4++W,K$%D;YA_@!\5G9>+>W?U %;;/=']Z-.4'B+(U489?@&(L+DD+[Q>9(
M.%&! 3*JU!E#V6*.%-121?U.#7+OC[)_OGJE<U/1%Y35S'"C76DL!N,7A]QK
MCAM43FB<1?_7KE(B;XN'JB:"4D/B7/9T9^O;)T3VV]=4.YUCDPEL=H.):=12
M.-E*K4R-%#+>:R^%X+?Z!\;W?:L.\XA'B\;I45)(C=ILFOS8"Z2Q=.]OW;'B
MF)>+QMRWTC.J ZDY*_2V[/F,T*]%NZO+(6>K3(*1T].'K42#>L==4_VBO*H*
MKCQ:+=>J^KV\R;GU7<\U^Z=P#J%'*A@P&/VL:P@,1M38H_=B+5HJ43/&%NFY
MDBO5HJX5I)ZNX<ZJG4$NL,/(C9P/1D@GO85N)J5,Y=?O]9]WK6I2C"PSF+':
MA[%[&8*',#I(O63UU.E:NXX, YJ7XQ16>NH"W.FL,V5)H*O[#2;SJD^7/'IX
M9Q0<)\:LT(KX UJ8?&'NMW]ROS\A>1U$S$GC*$O#S'>R*&9.Z+#$9W;J.TZ0
MGMSO@]WOSZ-PF6'3S1E72^&D0 1VZD,-XULVQE6#9L,TH?'6U(=NKYV^FM,T
M A.(4JH.FW0K)=J8X[;-J8-3"_QVI-JP@=:BT[O/#;OE;)3!/K/1YE*V/9W[
M&79NK; !9 &V2[K#5B4TRY-.XE'E_44@G-S/>>1GL<]#+^9.QA.?^T',6&P_
MN<#=$N,?L\CZE@3I?S+.V@7*>V2I3U_X@1T[PHY<[H=9G+IY$KN)&POF1FY^
MTDN'ZB7_N*G/W\$]0E^K& []&LU-J#HC7$:/QAH!$>24@+-R4 1L(YNGCFHD
M3# YDWF_N:[;RQ430^=,B?W!9 ":)-LE[L05XSMS6U/%-!;W@Q:&MQZ+<0)2
M&UTQWD\SF :]!TZD,9Y-Q;='40#$BL_?"J,HM1X2;8QO($\&Z6$MIQB-0AS3
M[1_2!!C6A=ZIG"T@<\*9 M"91>,:4R<G64]*"M3LC6E+Y;X!<F,T,=8M_22!
M]$/M&J$OEC<T8N"3R/,P8C/[^KOPTC($!2R3N6'?DU<_ 6)ML.&\$: <DP,&
M4P114S^A0[T/U1!ZP>[:$SS3P78U)AMSS:P4./!WYMWK&HSY+,UC,FUXQO(@
M%V[ O=P/8R=)@EAPWW,S#G_(GIQI<X_*YV$1C3*\(E$BNHM$GQ*X51[KP=C@
MF33-3H4?2>(J\+Q&;!1RLH$1-NHG;M)43C5)X0<UJ=/ZOJJWYROKIZ($ZI&I
MG!_*JZ*N2J7K?NW[23V?2KDYX G.V3'P-G*\ZXO5L#G42 !0QD$F423*/]L)
M/=!"QMUZ$='[9BHC]=B RH'GV)[OYCRTN9\F21KG <_3  <S,)N?&DL=SM4/
M%>I82/DI(#+8AL#AU"!;K-G-T,3426 5ZM9#!FB"T<+P!9DC0N,*F>=6^VK!
M_IPI?-^RFEW4;'O9J&$R\"#LRCBC5&G,S+869P+.:$,9Y'4!+"Y'2^CT\K#E
M=]<WM+TN%'B[;P:.?_N-K*C=N-BR:V',FE:?I#2_U$D.8R>X)2QEG+&EKQ>J
M'/NP.)7Y6&1FK0N1+TJU06X)2.#] ;&?AY9)7UC\/3C%WS]>*26>X)&(8S\7
M@9_G>9R[01X*.XURED3BR2FE)9URS/9NMT31WM6L;'*I(V0UXH/$SOZ@GLE)
MD'I!Z'B9SP)?N%Z:.+$?VH[#_#@,//NI$=B]63W!P]00+&4F&J';Y&ARI?0.
MT>LMV!/C0HV@&X^A4QDC?@G24\$<X;D7JOR^K]/M-+TL&M#.CPQ[:?=IB,Q8
M&0&?J<:?*:%43QK".XR%2VND7_Z@F T'+I$_1#9;>G-NO9L?P]4O5N,&RL9H
M.Z11);5L\0;6F$:C#(8Y,)G3D7!\.6&"SA /1NVC&Y>Y$$"<:?H@H6)Z@6H>
M2TKOMM*UX'N"G K1\>!VT1VD5LQXG,19ZN61[8<)2[CP4QZ#;G0Q2_WD&ALL
M"9UC=CR\12W^7)5G.-<>GF"@; F9?6.VOUZSZ\>6;,I26P2NS_,@A?_W8R9R
MP6S?"R/7$6'VY&H][TU'AL?7D;J+1B8PHDY!O1ID*([TDJ(=!*!R8AN9"^A1
MX^K:L=(I1CI$%H6I[,<\P0^@F&HI73F;E8&^I/@YD\!30OSK#X8^^'MQ8VVJ
M4MQHP#^YR[-ZDE#R*GRIH).L[/S[U0"<*81URQCTP8XS5*6$OU?[1 6*.U^V
M+1:B'UCL]X@D@1O$B0VW\-,,1WHE+/=<'B"L >QE<:I&NH,D>(#(_X@B&XJ)
MU8+)>3PX8J<'>6YW=;-C$BK=37;VG[,7?2X Z=T,Q/^( YD55X&DN6:8%5-\
M,;#-5:APED^Z5B&S/=(6'FL%D1N?.4D8/R9F\I(\<%R6AV%B^\Q+TC@5H9_G
M3L:9[21/SHB[1V8Z:L#]P!YU!>6%I5NEJYLZ=VI:RSY/V/_G>[BD6JMX]G^*
M&G_S?X'>/1?H/7*-K!KJ)X2"9#)5U:HBN%YQH77:Z=.UV8)DILIHG_?U^8>8
M[])RUH^<U&/,MO/4#T#!Q5Z>Q#P.>>#$N<M.7'@P%QYUGLH;D[UZM AA<I .
M,\/4U26T=6_V]K5#.LI#C:UTYK:K7S3Q,J.)X7W J+P232O93C5+>%^42["1
M16A..S"1BXR4Y90)C4HA$YY3M$8V&K[;6%?5>E>V<#!K;59+N=67^$GT,H5K
MQK5]>F]S9U-L$,H[0#M5]6/B^32)@S"T6>B&OI]P)X[R/'5<\&=3#*:<9DX<
MSO,/,G=FXD02*TGTA<F,A:H>)TY>XL9>@PZ 858.1+16V)4NQ$P>LC'Q&3U$
M+&)7\/9F[%7V-7K =5@;IOJ94&+=Q)PT@Y7/.[1@0>_ $A[XP+"K=2%V*'<&
MG^NV\#.Z6IOSL6OTT5%AY^$ #\3&B+I6WK 9YT7!L2^6/G&OEPY"XD>5,)H1
M=H2O++9,M_NN1;%)P3>1GL&D(+FKJRSAC]5:J"/"VQ#*277!T1M7+<&[<W]P
M(?:%Y<;#4V[\$X9JLC0#-Y$)'J2^S<.4I4Z>QI'O1<*)Q)/S'Y>4T#'G@MR2
M!'@K^$[B'1]9B#]D*?=#7_ANXOE)X,6!G67,S:(LS_WL5$]RL$44'3?$_]>]
M=80=AIT9;>=G*@A'6=P#2O65S47UCAAD@+7*1^Z?8I )6&4QJH=4X#PXC[+:
M8(_ZE)7OC1FR';AX:A[ [_14</P1#@P3-2\:V2>B[!(7\.R;87$#&FZJ#1_.
M*/EP!DSU'IO(#+&"L+<0C:KVLNGA?MWJM2>(7_WGJW<SQ?8C5,).U53VFYNI
MCP1R1QQTWQHOU6C$Z0&8\$33%AI" (P7IW+FH[(*U1,G+XSZ'KB%;A/33Q8T
M>D859/Q1K:;TER>;D^?1[]6<=2I'(<G3-H:P>]8-*.!F;IT(NYP>@$DFQGT3
MC6;OYB_<@F;7N(9?MG0)?@>4D6N"$MG@Y0YKBC4.0<;0A\./=]M,ER@97R@@
M*K4I:B^QMHBV/;)0@0R[9L'% B!D!KDZUXH>O[QBZUTG!<9OI1;YFII P7=R
MS=G,O6=;JJC)&Y=BM'U=43 H\M*Q?'4NYKH'X\X[)^7<TV,^W^1[Z5\.$;J-
MN<#[P'2E)N UI2)6$[X9OUN)V85U109=70,GH*<SVO?4S5 '*9OBR*Y=:U!_
M60]V67IGIC"9[IX:LF-1%P[@)J7+9G8O)X;1$A;A/?HY:"L0*RC45', ;.KV
MPD+4$#J'%(Q;?"T=^<RY3D\@IYD0NMT\ 8KZIG%-*[:T.G1%,010C4;!S$"S
MAW)'>;U:;9DD.UR;<5,)B6]FNM8,2(2FLG28^<_)\?RT?E7:(H$74V3:[LBJ
M7=KJE,BXM&\!<#80/I)/@4<:Q-&-8X]4ETA#@V?$[/YF<OUI4A4A"0<5+\;2
M!^(L'2C0Y03R:=K$&C_OU*'FKE& Z!0%^'C/+>=.YCE19(LX]7/PW\!S"R*1
MA6$:<\&RI^:Y+3E>QYQW>$L4X#>JV=$%4AL0%8\N'I XS'4#EH?<9;[P[#3/
M>1[8N8A#/^2^^]2HZM[B ?%QXP'?=3T@"!R7:ZRVSECN:?'0#=HBQ4@_+,I_
MTA Y95A5LL),E?A.2+RK>+NEC9XR([^'MUXS#F80 AV>_Z;O@K_NMZ&O>K%"
MT(.#H =;9S*GYN">@CI91[=8E/?@!MA=6@NQR(]XX-I.Q/TT]I,PC."S*/%X
MRG+W5+-R.',>%85G]-RB5F1+Q"EKT_?;K6KF(R\HS3:N3[&&A2&Z20A8=IOM
MNFOHG-XLI^D&PR7W]%DA8=(-D9"^STP:[X\K#N[!B-J1+ ;!2]D;A\(7<]UQ
M#+&X5!2BGM!8X<J*5E:\ EJ'?SWXUY<'YD0S77:Z//)T^\TN[6ZJ<%FJ\S,K
MU+OD.S6\4ZT3J[)5],K :UBN,]/.FL =PT[-PWZ:]$P\U,<DY;(DS5W/YG'J
MV'[L!K'O9FD0QA$+<C=(GYQA>X]2[JCPR%?(87 3#%EK(,'4M#":D>^3B2LY
M%H@F[HP#W!A\KFD,:-D]4+K@S:21$?!7 QXR]A[J?E;3Y&(CD2'+^10P@>Y8
M P=2@$O.[FVM=<6DI-I)K/^4U[_#Y,6/8K<I@%3.5&.3']OL?&7!H?*=%+\D
MX7244"UQ?&B=&26CXT90!&.(ZNJ%?DE,]7B@2"L^(.HB^1OV7J<6])/D;&(9
MT,!@M(PEJJZ0)(XP/-UK$K,88LX(T]41BQW)4&*5U=XWV -&)$:C.ZWK?KH#
MS8Q^1"(-7*C =CPNHB3UW31.75^P,.),V*G'W2<W"G5)(AUS]OHMOOI/18.O
MBI6BVCTV)]UGW.>.ZZ=.PGPG#A,WRK,TM.U4))ECG^KR#M60R0/4Y8%HW.";
M1FF&GK46=UIZEB0=+VJVED-M)D+T,0F^,/-\[CJ^![3IQWF>9GXJ,B=P!?>\
MU'=.E'HPI1[78\V[.GTR4@9*G!0SV6S28M,U_G-3>.R#W):5G/-G9$O)+NKO
MCI;.P#/%"E%PEZ^*NNUSV_.S"^48G\4KP06<22\N=4.5T3&$9G3AL7G7>3C"
M I9+O;)4HK(SZ.@H9V$EVD1:S:?'G3X__HC$@>M@AD+$3AIDOA\'#"P@UTE$
M*CQAA_$)?W^X.#BZ:[>I,O S> ?([DK.9LQ\!2<WZ\>E[4Y#3E ^(+Z&[]IN
M .IL2#HE[$HABWO20L+%<?** NC(&R#D&[&7:@P*0M+Z/+$N@Y?:5L)8QC5X
MYI.GHD#/=C$@=%S%IK&='*MK+,2A5:>BO1:JF;!Z\(-SYQ>64HY/*>5/$,^I
M&WI^DKC"MN$_6<Q2EB:,IZF=B.CIC2ZX1_%\U)+("3:O'_,$EL-F:V6[I>')
MC]6Q8"&+1,(#)XMC/W83YC$1Q,)V$Q[:87X*$A].J@]5R3>>;]XWH-:H\AYV
M-S\OSAP[WM6S,IRS(#82SBM#Q^R#Z&!Y1O_IHF\[(24K+0!]%=?^!E-?:*#3
MM-WVACYUOEF<F+.2B9O1] :CV'AJ6 PS>G+QLJ.9L8-SZ^>J15X%1BX[Z!G#
M=@-=M[1;&N3K8[DQSD45^69%0Q%M"@_K@^GVC <G7TU_RBK1;G3<5QUK!Y-E
M^_D0;"92;KP>0H'/G_BY.O)'))32V+9%DG(W2UP_3X(T"T3F9:!+'3?RV2DN
M=[A0.F:#-W)O@!6V6&1+7)'GX"XH"&NU+<J"IFE.C'LS>"?K]FE>,/@$:0$.
M0DO#12IJN(/Q .JW^!H;VQ>\M;ZO=G4+*\OT! H][UK-#Q-F8&#4,5(]'P?&
MK+3,86FCESSHB[A:[.KQ*\@06'4/MM4E-6^ZDF,"XFPV6 H!3W^E]D5R"26Y
ML='N*(RITIC^!K&%$]4H$J/'-P]Z:J4H>;6[ACW#J)8)L=BX&PU3H"F0('Q%
MIR2P@];B(M0 @G]+&4B%1'.>'<[=W&A,TZJ?XR$?"U*JJC%S2%;]L,4#77"S
M55T[Z7W  >';I'IBL[J<FK!_V.[6A/>V7JDH4%ZL96I? HX7ZJ2,S05_ZO3C
M3A62B]DY:UVA@RI_P?FNN/KI"8RB;*NQ_E*!.+E"(&-@$IQ;+AY5\LT.$L[S
M- U\W_;C7*1>[N>IFT5NY,9!=C(5#Y?*QZRX?3D<2,S1RB(K#AB'1M96=5^:
MTK05?X_X?#G11WWZ>UF@&'V+T=-&=020,F[&;NKJF89#T_,*!T?JLB%IU8#<
M1=DDR[B:XH,J%$19 %8M [;'Q^8%MD1$L4#AVTW7?)"*'D?73'G3^!$]C5$N
M_C$Q7IAR[$]KNSP%'RV-X']);CM1&'L!=[(GU\/]'AGOF"!W\M'@76(/I5[=
M:I-G">-K8#QJ,<Q9M#-IS^=S0!C="+OM%[ \HK33]>;5\WW-7@R:AG87SZ%X
M%&Z'6ABV$E<C9ZOWN;!18@I;**Z%!CC7X@((6:"EMV'%FMRW@LMBN?W1%\-]
M4V(LF[,Y5]8T8JJ"HT4+[Y?#6R7#QH*_,!4-)1M0X()6>@_?__ +G,J,2=#G
M]8#-V$6/V]82476Q^JD^MUZSLH#3^F['L<AN;N+\9] ?Z@N+@">G"/AA)8[J
MW<P4,UISF*$WI?7WHBU1</Q=9;-04/ZJY.+?I%S[&U;FXI]W)?SMK6CQHJ*&
MSS&\] I8YZT B^"^5D@K6C/E./TB/WC-P++_"4T46L _$-+WUZ)N6EHH6" T
M3.GO,B/_]:=7,=X%R<0C8:=.GH6V\+TP9HXMHB!CS,["U(_]QV<,@"X/O3\M
M*&'%'5K J.<AN5O4[/,6*-MAM/'LY5?-5]8_X)VNK9\9OX0#*@Z2P7/;P1ZK
MR<)V^M=_B(UCGR?Q/9W+TAG\@N,__D<%'KT:'8,? B<6UH^[#Z),=_7%QRBG
M3R>$/^(USXJ =YW:_;S?^+T?@! /]&:MNKH&L5?^Y9ESI]/:>^P?>].]K^"0
MFSX@Y7<=" [5?GJB9Q^WPCP2:REH*'4<4[4VQA?*5OT):*9NSJW_-_B'M.CP
M(UTYU75O-.ZU9M?8<^.&L"JWF<"WB["!83AW@7YIL_;>'WNZPT/XR&?1AXB>
M*^'&7CC?26+V\7*GA___RGJ571WF>3P"&?@PK/"J*<!8O6!RG%:O2^_. 6(>
MI'A\#IA]Q@YMA7^P&OS7G\2-J)>* ?ZX]V,\;)E0_[C'_5AP3 %8/U?G0)"A
M%]V71W[@(BE.MN^5S/EQ_9^-/WTV7K=K*QI4B[VD\,L%Z%:YEI%_C#<LQ<3N
M=;2]:Z7@P[WOOJ<0A3_^LCLTV_26<_IGUEO67PU:^LB0H?JHEG>DSWJG^MNO
MTBJ[H3]<MILU_.'_ U!+ P04    "  ,0758HMPY5#!6  #0SP$ $    &5X
M:&EB:71?-"TR,RYH=&WM?6M7W$B6[?>[UOT/&O?T-*PK4SQM;*IK#3:)3;<-
M+L!=M^\W92J25%DI9>L!SOKU][SBI4<"3FPGT^XU4X8D)84B3IPXCWWV^7E2
M3=-?_O?_"H*?)RJ*Z2?XN4JJ5/WR\T_\KWSX'T^?!N^2D<I*%0=5_C+X?T__
M'KQY=_;J\!U_@_YWE(_JJ<JJ8%2HJ()OUF62706OBCR*BR2^4L&'\[-QDJI@
M>W=C9V-K8V][>]>Y_G4^FQ?)U:0*MEZ\V N>!MN;V[ONY4^?\GA_D@'_/,SC
M>5!6\U3]]<DXSZJGXVB:I/.7P5\NDZDJ@U-U$YSGTRC[2QC0)V%0JB(9'P3T
M[3+Y0[T,MC9GU4%0J<_5TRA-KK*70:K&\,DH3_/B9?"G3?K?P9-@>$4?_?7)
MG\;TOR<\FCBYUO,T*?1HAGD1*[@ZRS-U$/!O3X=Y5>53>.+L<U#F:1('PS0:
M?3)_K_+9RV"W^<>)PCFA<7ZVH^(AP*7PG:LBK[/X:?-/[BO!VE6J. BF47&5
M9$_Q#5\&45WEYJ."GT*?/0GHLK\^X<N>Z/>#5]4OZ-Z<+CUX\LO/]2\_X\1Z
M2W(CPQ_F:0S?&7R>),.D"G8WMG=^_@F_ <(&UPT+_9"?G G%'X,%?]/2TS<R
M_=IIDJFG9B(WMO=@))<?ST__/O@G"N7?!J\O;QWY?_UIZ]GF@8SY\,WY8/!^
M<'KI#LD?1]<SX546_=G<IO>F=WZY25(&AU>%4K0CX9=I%*N@FJA@ZWD01_,@
M'P=_J],Y;K*=[_@2O]=EE8SGW6_Q:G#YVV!PNJK#NU5DWJLXN<&]&;RKX@T1
MG:!05TE9%5&5Y%F0U=.A*H*]K>W]%[LO=C?#(((]/IU%V3Q(LE%>S/*"E&F2
M!2=E$:DTB.!^D^@:=6M2E<&L@.\ELR@-9J P%"[L$#6O*LL@@HVV';R-_NM/
M^]M;SP_^&16?X)D7U488_#.ZSE2PO[6]_7QWSVIA?L;]-L,:BA4^8AL^NNW*
MUS"C^505<BU=MG6POJIK?'AZM*I#NW6J7R7Y;!(5T^AS\ :.B-D=I/#I]N[6
MYO;6TWV40Y"L:Y"]!Y9'$,<RBK,HKZS4D42^547UATJ3*+B?0,%G132J\N\L
M4EU7_?9V<#XXO'BYJB*TM<$;^<O^>PFKI+=S<).4$S"YJCQ0914-4_@U1,F9
M)F6)(H92<@UCBE&B(A@I_@NR@4L=%1589G"8@7$8!F_>?X#3*JO'L*AU@6(%
M/R5I4LU#>$HU(7E,%0IFJJ(L*/)\"I;=."] ]O*X'I%(PZU/U>?\%9B./Y<@
M^S(UUR!DR2A*]?305('AU9P?ST0LIU&:PE%+>N_Y+N@]N.,O^FD@UFD*@\I@
M!%,<+LS!"%XB#(Z/#L-@\![^\_[L;; 6E4&LQO 8L.U4FM^LTZ3D, .%[*4$
MMV6=TJ8LZ:^%^E>=%'2*E_?;%Q^*_'<UJAJ;PNXYV,!XNV&=I#&..LU'M+'O
M>F:$>O_?:U3'LI3^L,( %N^NM[A(*M5XJX,'V O;R^\%HXF<W0"G/XA<](F-
MKYDJ4$JBC!4C"@Y^_%M>? (1;DM(2%\IZR$N)=X.OPT;9<K2 4(7)RPLLI6L
MS0?W*E6%VP*V#(B8@@6GFS[$9.T\Y&05:E:HDB2\FH#X)62PPLY.8.YF"OZ#
M3J7Y?AC$:+CR 0;O%;-6P+?7N\B[.9]SA7M.X7=E9\7P?N39\DH%T6P&'X "
M4T$:W= TVSWC[DY8#%E-7I3YC);T!I>21JM 2[$?3#>N/),\I.'HUYU$)=WD
M4Y;?/)WD-V&@/L]04Y6@#T$>0%Z2B$_:2HTF&6JP8 K*C\6 OIPH%"KS5J@.
MU6<UJBNM?45MBG(T8D<2!K(1C>!TCTDR:3[Q$A$\.P&+)+ I;0\A9[L/*6<\
MRSF80E<3$"#U.9K25J,WK>HX@9\S-0)#!=Y(M?5OR%L8?H-U<=\79N]"\;&S
MS5.4H!VDHBF*433,KQ7=#,VCLB[(70<QA!O"B&X4S+^L?Y1EL&:EG>^HJJ+1
M!,:%4UKEH8S)[!?\]28JBJBQ>4;1C$38$5)'!)2S^C!V^C2Q*V]7F.2D+;8=
MTD)'"9S\N&=A00N,R\!7HR*60<*7Y,3!2 Q:".H __( 0K*WE)"<R3D8E0F]
ML!48.0%+/<,)!I#,Y#N'] @6.*,E:.Z!T!I(*'T1SF-,1E)V%5WQ.KQV-%NT
M4.\U5 XMH'>@MU:%5E&4/XZTL1OL>%KWI:' 1ZJ,$O0:5M& #;K,@].SWX)+
MM+N/S\X'LF7!P,0-':M1&A4*;<UDAHJ<MR7- K[O.$_A?"R_M;GN1^"V]C$>
M^44.W]:&L8N^?#_<^I2CP?')Z<GER=GI10#N<7!R>CDX_W ^N#RDSTQ4[_M+
MS%TG=FMC:]ECAD6'; O:<^4$CU4P-WB/XUF-&A_-"Q614Q.E.7R0<%1N>D^9
MNZNM;!2W;S"3K;T%_[(-00H?]?QE762?U#P0W\&U)N7X.N03BO=--@]B'?2_
MF22C"2F5H5)9\!,H()B H=(ZII[EJ-B"FP(.5WA]T&NP2E5=P<UP?[8-6 5*
M-4C&5L%E.8P#?$*8V;D]&<4D,=>MJ*ZZ^YJ]PHF#V?BUQC.GZ2IU+-U0+OB7
M7("G$,TQGT3:R7A/%Q@#$8XQF'?T-.;NL0#G('R69ZZ-S-ZG+-"1*N%=P^!C
MJ0J[-N?VF\'%3(V2,=BH]H3$"U_I$Y;OT+1M4 '?.C<_U[^0! :'E#7@F?G6
M*]Z]N*P/[K;$1V  )2F\.D_%[2NLIR[FJ>M9.]J4LUD!Y@C]J7(#-/#'G] S
MI7UJ-J=> ['-QG55%^J;3.A_/'TJ^< /8 F=4@3R'"RKZL_P\Y^W__SG/TN^
M[R'U(<9E>F8;7W\$QCE*\)L\CX/W7@SJ \XQ>(KE*DC;'>+S-!]'181G4BGO
MJF._;0&+Y8L-M]'Q$[O"5RQ+((C]VOA^N_KUEK.M0\<-6C'9Q9N"*5F6?WWR
MZOS#,0KP*W#W/AW"?Y[H^V%TLL!WK";&%*$4+V><Y1.3%,8/[0,7/,0\8 :?
M/!WB1T^C<87IYBB]B>:E=YN.M/33FR2N)B\#3BBW1\E):/JK?'-K<_//-A.]
M[2:B)3W>E8@VF?,L!W,HAN?+#T^:UN%7L7V.?KU5KXHZA8,SM0?6*FSPN[[C
MX/WAK2\YJ(M\AH%R3$>.,!$#VU-EHSE%7=&(*^L11CWP-_K#8YJ!XZ/;9^!C
MEF <[@)S#G2,'L*!",L='*.>QU/SJ*BO@L-XFF0F*?8_8G;(YKMU?M!VFW%X
MIZPQ_HF!CBK/4_AG&F%>)L(?869J/ X)1S.*QN#S8!@K! 5<5F!E.O8>V.[%
M'",^5X%*2\6A*31,P-^QIHEON72'+JTF\X*6K=.@+N5*>B%S@F%R1>7C1[5F
M9V]O73$=Z'[/ DMPCK<J2JO)RHCM'3SRW8V]/I?\KI-U\OK6N7*ET\E(WGKK
MC96-9#S$O/4=CMYL?=^#\<$]Z[/;A05.RJ(I*8__O6^WA.Q[>VO^F/3FN4W.
MW?JZ3I9/^WQ=*7L\EKHR\]Y118XC1K,*AA[@F9ED%68$1AQ@MI,K9YC.@C]Z
MR;H8Y9SVQ%/YUEDO];<Q28IPHK2.=3HVUB&16.)+TRB#@\M8):JX3F@S!@GF
ML*8Z R,)T Z/M0S6[".&M9/%Q$!BFDS)*,3 $YR6%#H!2X+S?Q&<J'8<; #Q
M@[2EA,8,2(Z,SU]^,#(KLHL$[\(?%B 4]*F;8:;4,W]J,WGSIIBP$(%)16
MFD0M>!*I#8T33*D^[1G?R_E^Y?K>;+%-HSG95K.8$MEMNZTG$PB3<U4@X,M9
MCM"%,>BH%,'%T)8KD@IV#$WD=XCA+K4%O&CG[7O #XZV5KK4W^# QH)TJP[$
M-H*)-M[:B",_>F5C$L>W)S/T-\T^<8$W;3"$7A1,6E\I3VQ]' TLQ9TWE!N#
M"8*C[QBP?O"5Z-#V$J*[SQWNX)AJO1[>LH".*L3<1114DLFBR'G(9TV97"O/
MG41U^MZ@:$H\8D:J;*TXWMP[Z.!04 I5_/UPTA'O1[J=IP560A[NGBS=7C99
M^D%#8]@Y-X>O22XV,D."7PG0JKHJ$%EL$H8N.&4CP)MC<1"%LO54,S('A."B
M'C[5OZ&7/)I$LPK/(%EC<R,G\%RP"H%SZ5IE#+'*LW3.YS4G>=&:0-E!3Y.&
M6,Q@U)Z]MUK)R;NO],XR*WV2D64UBDK:.'%2CC!ME8WF <\H&!%QPK"IH:IN
M,&TLQ@.;>AWX([Q2?S?/Z+Z,.3>7D*D$?TG&;KXZ[+RSHPWL$RB@!"MX#8?J
M1@ OH5\ $;Y@L%7>8!??WT@T2\H5VG!9WWEN(012/':/O,FV<[H$:[%O$:R'
M7YJ""=9T!NE>]WCEW<)3G?>ZSZ%WGZ8]L_X_.M7#"5'O*1W%7SH5V'GQD\Y)
MSO 4336^';]@/GORRW9GS.M',NIA<5K;WP2G=?EV$ PN+@:GKP?!V3%BX@*G
M;'%%0YO]L[J]/$C+8C'!K@!GED[U>:F3UHU\1.,CN<;@^4N!-%6E2L>-K,,"
MN'78:9]&CLW1 4#-;S(">2-,G0\X.MSP8W"S81AE,K21@@2_#,9-=F7]G]?X
MG5B'H?H*#?K=^>:YY@'#6@;R LV\I PL97L./H_4C" ),)EPE"=5.K=9J2Y+
M/R \&Z6Q/F,H"4-^16YALAA7<N,:&@:^N['#$WN_ZIB!/,35F">5FC8\I?6P
M*9QL7V@0+YI745T2_'MH?%_%1C:_ENOOF&@F8<'AY.5W,,O?%9%;$/XZ^C4,
M3EX'9Z_AGU_I26>_2ND"Q<4:U0<B/\>FQ@L_D45Q#'$8N4E%-D)Q4W 60%B*
MN4E:IM&0\-(%^'8S<.,D!@>;,TT8QATU<KTZ/.>49.GY >\1EX#^TL#08:57
M&U+?WN!]&ZLA:SP53EED&TCGX.@QR!&4Z"?5X$JU/%83+0F[E<!&\!'UEZ0)
MQW7:T%B=R]BQA*T59!U4EK6I<@I>8RT+O8ABB+U^$*L=3X<E;OU#H:ZBPL2(
MO2?P7(O@@V%BM+@H>3_>V OJG[?<?;V'MY[S%OYZRFPI]^K2G1">AJ&3B.@$
M!U(B AWO#GGD_ =\BV+)4<QE/2'[0QCO\!!R'C(4#YSQ&*<Z,B<$1HP;N7O?
MD9/ 9RO?PINO4"EX8'B^U%BRPP4Y< UG8\@OLT-L*$,-"3!BY<0!&\D#"C[,
M*==GZ\\DZ@WB,\6H=.QX9EP&C>%"NMQJUN&<_B9)HKR8.ZK+>8,U3 W!H8/'
M1B,+(;.QKO>OR1&U]?PX^:Q3_!-X) HYU59KFV"4EQ47%R'&7!<7F9>$B:/@
M/.Y14^;D%+;A'%"2@C,(LE(#6N'D6K'X'<'Z?KV=L?N 95^.Q4;G85287$J:
M1&(W5?D-U2KYD%G^_3VLF7O#-3G._W[XZMWA:7!^>/'V1)_,[<,-5%,-BMI_
MG%=5F ]AGLSD4T@LM!:H#,;HK22[SM-K78U%:-^(_.(U7+9LSC%L=QSK:!!@
M-6(^UUL/9-L6%I5.( NF*K]"-6W,G [5>=NT<2@8QP*;OH@I7#?7]97P:1K=
MR)>Z2ROE!HWHWE<3MKTEHUQ=-A.53N&PX5.VK$R%X,9NZ,\7Z:L8M.F(MS O
ME9*MV5@JVIUT140'-]L1H$2Z +HQ89>=\DV3B].6R]P.N6.A$VO7B:6&EW$Z
M6XX->]5&<)I7^!E5_@DPC-8;*SFJ;I.5*F3:VQ$_Z3 2Z3V[=^6WCJP^6#!@
MYYL$ PY/3P?_=_"=BK.Z&8IL=%27S#I>98')\;+2HKR@/&JIS;^S7%"A&9(,
MSM7U<Y/'^B;5+#O+N<2^!W+_D;]:9N1+V;\Z,OT%@_9BW/<>]5*V23-9__0^
MPPZVEQGW4L><\2:_8+J72'WO;#Q;9M2]?N<7O,5@F;=XOLQ;?(C8;KL07_\^
M,G.\S*CW'W#NP92H"_(V6RBB^[S/FV7>Y\4R[_-.81[0'E'WEZ"39<:^M7GW
MH0:OHNQ3\*:.,,"AOF3+_FVIH=[C3 6SF*)LP3LP$M.EIO?O2XWY'J=H\ ^#
MZP,K%#EH@@]IE 5K;AVSB9FM?\&KO%_J5>YQK ;OP,BBBAAQ)$L=,W9J-1RC
M_?ZO<OH=<4\/9J/O?A,;'>;L]=GIQ>7YQ]?(I!!<O'X[./KX;@"K=/+KQY.C
MP\O!47!T^/[PS> "]OCAZ=^#-Q\/SP]/+P?NX?253.7=!\B_-;V_451@[4I=
M.;[>W4/E=XQ_!VL/ -E;!#98<EJ7AE.UI[6=D\ )DX/7"?,3&=^BF;LGV9QK
M86& L)&VVNA*<NH0/BL<-RH"(X)/IS,*E>(9(0E7T$_P#A2.O4%'48*X!1S0
M&(*Q96&<!(N"6*717+]=@X+-I#%ZY,Y,QM<2 (??^-\<?++S WSRU93,<DB^
ML=X\^2S)'$2#&_(5YA#:HXW\8[-H '/JDP1CFZ*]%P1$&]=BJ"CZI,(&FY5=
M9=8FO)-!1:1S^CX'RF=%0IQ/'(C%RH_12*4<S%RD&LJ<PZXNRKBAZ?"E,'[^
MN\IGF+'\0\4;P07F9^1I/"XN2%$F_S-4;@HH)W;2*1)439)Q164RH<ES1:F7
M:'>J=NW;@Y 4$9?7C IU4X:!JD8;%!JV92?KH>154RG1N)DH2KI1$.Z&.<@T
M%('P!QO!(89QZ>:47,*L1CY*J"J$5&7IO*K.O\$>RSK<O3"HLU1'KEDUXS-)
M64LBS42,8=(QAEZEJNR0A(AL ._ML9R&X.)U@0EH#Y2QO2V8#(V/:).DP%_B
M6KD5*IVQ\*]G##QDXLLDA9N)T%ED$D%I E+$U3UQ-*7BA['D;FAI##BZCSU2
M9K!O6\S2&H0EN((A.0N%=)5YC#=Z%JQ=))_7@QNE/MV3X/8-WC/X0+=JX6,:
MZ^L(GY=A":DX&I.E?IK%%,(7I:ZGYKPTC!R-#$RH<<1W3)7H>4EJI26D"2?+
M4,/=J18MU+-NQP]Z"ZZ?ELW"'\J!$^SL6M;2+ECW8H$HS'/)I+B3U]"^1FQD
MY\6ADP#7A5IBD;60<R&I-APJ6O6@P7/8B/2]WVMDGXA21PJ*?*24@/4+M@ E
MQRZR*'FJ-$71HHQD ]#0-B-!F[CYVP[Y7L,+B4L,)7.F0+%6\_7@X\5_[H1P
M2@=KEQ/D [R$-RCQJQ\O@B,80E24Z[C\)*K,41"AH8F_Z<F'TP]'/(T^)]-Z
MBA_#7;<WZ;:7-S"?#BR@Z_Y<P>!L3\J6ME\!D\2<3K69VX@1&"V]Q2U5<*$4
MTE/KLZZ-X*/:NW_56.-@\M!PAL$PTQ88<BB:VR(?V-8VK&Z\D%8VC_-BA#F[
MWU5=.(J@"X@(C\H6ZA0KH*CO8RG#C;16P7/Q.DI59@F3T5-,X=S"P;*;4.K9
M[1ZA!Q[JJ<%K'BM?[U!8*G)_2/K7Q )]@B=XK7'-.2Q-$]>1!M8("MJIW6S&
M8O09D BO5,_RMK:MIQ/(#71.8)2C.C-$PU$:4I>:#%S $:C5HE#7.9?3#C'L
M:5[5U,26L!45EK7C79]O[/U9*\7+O((//Q2HR;HA8+L;6QK'F6RH#=BK1Q(X
M>[[_/-S;W"2XSNG)Q?V.+C\^VSR\'&,6(7'PG=1XKV2?5LMQY_W-*_1E?YGW
M5*$0G\1URS#G59)Z0+[^=$I[H>^[&[HDGP"*C*&AMB@B ;B,=QH6\^E^;>$7
ME 4?LQI4Z)RLG4$/J3+J$/8@4S>]\NZ)>R/*WR7M7R3KH1M#49]G"1&\L:V1
MQ<:B:+ZJ8]7KM[&O3A8)R):P&(X)LB8C9D1*HD,W5&^%GS?>3[L51NNS@'8;
MIUAIEA0,=8)[ZB>V*]CO'.(ZYSMVVIL-6\PXB_@&=@[,JZR!)6&84F$AQ@K-
MO] *)!76SZ@MAK;&^=AJJ4\?W)9,IV!/P3ZPN/:F9XV$H"1BC=EEC\J+')J1
M-;[+H%U!(H]1V:_MK6-3J=+#?R*-@7UYN1DR] 4+ 7KCNLB2<M(U[LQZ>/HQ
MC;>P(I%&,QI+F7P&&5U[MBDC=(AZ$0YZ)^W6+_4X;9Y@M%QM!P<*ACXL(A:+
M(K/MVG,9$3,@("<X;C6O;M1_NX=0J2?CI@2-HX2S/BX>C!P>_JI3_$'[%52?
MK7+8ZT9UD7FHIAS5&))J,C0:&*:#'=E&!#<1CX3#!6U=C!)'(71LIT>;5MK[
M)FFEBX^O7I^=7IX?OKX\.7WS""N_]KY"YLEQ;U%&'>^?E!L%26PR5RJW3%+4
M*'CG.O+LO62I>!A8@-+TQ,'"JKG7#MB.5J1W-]E77!N#VQR\!<6(52;&4\1^
MEIJ.Z&*B/JFT)&SO-">/14PX N;+UNW@5FG&;C?<_$,0?.^E7BH;UEIF,6CQ
M5)U[83"<3H[,=%*$B$GHH+C93OPB^Q"OIV.< M-5HZ=,+BQCQB.5FG8_(,41
MV%[=B4ZX?P7*A8YA^2-OZ>AHX7U]!;]BTK)46N,T9X9*G+0HR70)8'/M-)8]
M<DD(R RXDDER^ ":;-Q4I>$!N)UUT<![;I@KE2C\S=H-E+D% N)HN]K)')C"
M9=4O!YTA,RQUR5/5V"#:[I1@5*GCXJ;NI/<I/\KR'SPSNOLC,_K !.G/OI'I
M]6%P_H^3BY.STP/=:#AX?WAZ^&9P3KU3?OUX^.[D^&1P%, 7+\Y.3P?O'J&!
M]NPK&&A<=,S-(O'XIACN3"+"7(E<+-TH]$Z+J,/0[_FA_=$ZZ732R"F&X@-U
M52-V\Q:R@]QX;+.CC.WY!I;?IR25JFAJ_*5KLRCPG<[;>"";'V_77CPJBJ)G
M2Z.G[D?AY8AI]_I$7 2+G(ZPSK,\88.;3(P1FX*TA+HH=,XP!&(M&RJXQ=B<
MZM;F<I-&WE9ICL&T1D#R(MT +D+K/Z9$%<B",)<YZ<1VQLAI<7:M>_U43A*4
M]J(-I'3<X%^U*A^;)"U=C>WC5Z(9KW[4TEK"WB'+?2\=9CN*WZ*5^I6.DUVP
MK*I<<->!?VFMK6N+%HH;7%8Y3X)6+ZS >L?ZA6+:*_8;P6^2;Y;J5>I]M*!^
MM9]O@ K0[1O>$FZ%<VF<2.; *Y64R>N? 7Z.F@>39/K(MLGR"!4WON?LDB:R
M N/97&KOG%MN(:BG,LU=[[6?3O@!K=[A),%6+,S7S !N$6[2\13+]Q2][<4Y
MUV"I#LX533 @,6HN>M4ET3(13LX)\_H]X=26576%$5/VW[QWPGNW7LF^O[P;
MY]-,<%O:<?-K2C%R[@W9M6F.:4/BR2&&26MS=<XD1J\0^<LI1L($6AO+O,,Z
M"% JI0R<^C%5Y#8W5 JK,6*&Q9OUV'&2C)GWX ^-Q-4BVVDQ86$83/(;[(;!
MD\YC= %%&HP(.B5KO5;OTBQ8D?L4\KO*G&D@7#(I.PE=8:V-X)"AYM,Z\RAJ
MQ@EWMS5JGFAXQJK 6":O8#IOLK7 +]27]S:9D#VPQ S1OO!.:A"*S!K6&B_C
M4A/@K,1F#^;:P FB&!6H4(<XL9'VK."%>F(<+%@7&Z(X_TD%.GH$.HHH1<%M
M3R+XMC#)9IJ?_/;+;V]C\57AZP]SZ"R'@,&X&M&A4?0-]$,:C0P+#9\[F4*2
M&X>NP4MT/>N*KK=,HY6@,E]RHI<JM[TK_I0<)=K I#'IM'![)CB'F][-N&LY
MN0OZ0R5.%W?A"6ID;QU$P!V!EV4T5D@_IJ'9]C*F#9MK!KXR6%,(2"R00 XN
MN,',9NCO>?RTA)$@^OK;\90^='[R^3<)DIT//IR=KUAJLH^QHB7=3!+5.LW$
MBT&IG<(E$\9C<$\$T#]Y49E(/MD4Q@AQ<<*Z[8*II,!\ ;G<<(I-D=E)W/$)
MGRK>?NC(.GKX:WX<>VIZ1&;#)AF?8VRL.G]PF_F*L2+-M1=3<BVJ\2)CV-8X
M)!ECW'#P/OV;)F04?BY&Q,"\S/5YW 'H'SM6I\.# Q_\2%,\>)IB[T>:XAMH
MY?UOHI5?G[W_\.[D\/3U8(74\EWG</]!$Q+"_"N$D65H Z2EV"4V*#0A&CZW
M#M=AV'([_T18G%74J:+[M;C/R,.,"(KO7,7'3$N/-PO66@B[+WZ#4HT(#4^<
MK!%7NY"E)FRIEOE1_#==R]T=E&#DX P+$7 4S(=/;(QI,-:$9]P4"7ZQO9CP
ML5W%?E@S)V1D,!*&QAB>LE9M>7>);RMH\D6K]+7 __L/#H@QAR:H8XQ&F*,2
M9P>]836:H!E+?+O4'H/"O!+O(+- %M#I@=%]LHO,"[&$\'GE]VBAX[%'M$'O
M&I?#@13S()>>MY_*PHGV!"JCY7:!%/D091RQ,74)ZP)V&[^UR=U9?DXN\S2/
MEQI/]B0PUN1X&J[HAM[\&&9M*:P4V^TU\X;B0X\)APWO?*[*4:TT<PHV-D'"
M/>)A/)'R&Q4\-0,=XW6QJL27+>>P#%-[$9Z(6UKP>2AB1+6;BX*15V%-&YSE
M!;>H(G6A=VSH209M:)LB\#671^6KG3SA4C?69D=BR8U//2K7>G^Y_-*B# =2
M35[EY!94R^K]KT6T!Z^_W)G<?:*B@K:TP%Y@3=<@TLX3IYRV5NIP4<'UPA;.
M/U;19_Z!HP%\?U_/R)G@'P9NL- A1G;IA%O'>-_I?? 5EV"IPZ0WGD-(6)XP
M>0^,I!5.=T(O*4"P,L[VX(RJ)'/;*9F,4*9S)W]@D3F>WP;V >/9V]P^H']V
M\9_=%_+;)K81@W^?T:?[+_B/._S/EO-5?BNYBWQC;W//^W#_ ,N[G.Q@!S^(
M<;@=6Z%%J:PYH02[:^T>EQS:E&+A<>*]KYEXV;RZ&H=GE!'+Z-*66,F?B:U3
MD@6$.AIVP6-3E<LIRX>P?/7YCQ$<,7A-?0Z;O&&3<IO;$DB0,.RRB$V"R,I4
MPS:^D6@0&\B>.6S,&IV-6:#^.@C&]>%,%V8YK(/"9@ @399OV,<).PE+N"9!
M:@0R1EQNA8;]W*A^Z<W,.W:0?V(U4_,!Z.9KL*4:U>F]),1A?X (YR[TS#Y9
MXY9-JZ=\50.W+S:^KNO_;H"L8K9MT,7)Y> @.#T+3DXO!^?'@_/!XPP+O/@*
M.,5/2LT:QUO\>S2B'@EY!";Y&,D$R%:K,^O1YD-+Y$(7C4;U5,X+HF2A]($I
MFL*=40^'6!?G,UL8=[^WRC3T8J"2>0<#);]V<L,\>,[CFW&0/O";KO"PS)<P
MH>L4OS)=#74IZ384W- !7H$1NRQE]TJW:TP6]A581:%:RJ@Z<4HV*:S>P]U!
M?!,%)LZ%QL%\P5/ MY2+BO;$:?>%EBM."HIZ4O*>31B4$A\=14'6@'6P0T8$
MUQ+52T^/'M.9AV%24^9<D<8]9;#F)]R(E\&T]R%?W5PE1A+ZU0WW'A2_6Q7A
M>9@&A[(>7$7%$!LDT O*GM)? <=XEA>X/_G-:A!@!^ +=T8HQ]Q8L9\2@D96
M10+GK6O::[#23VVJ(>>HNC<5C5.-TD-'HSN#%7)D:Y!A0K5%ZXQ2\ QKVM&E
ME@-87<%!:-%PEM]7;"Q%9KO'8-EJUG[;EP:/5E,MMT#:"J6EDB>0[*P2I+P<
M"T*F5;;VJ'3$<E3G5L<*GXZC&4*OFEW/[C<1JW5+/V.EA. J8S"[R30+;3,R
MNOW004GJ$%BS<0A^%D<)Z#HV\EP7RF7JPM_=\99FP&@XIOF(#BA7]E"5-$0/
M#D^Q8JFVO ITERT3.Z X=^6#I0P!3S_#@S%4*49\"\,<=5RZMIZE4SP 7WD'
M8TKA/O?#JG<V^1-%1TB%9!89!2DQ5*=540,V9;6S[7%DS&H74SPT]8R4--"N
M#-%V4E8;IPW>+I?@(1OA^!=M@C<CK.C+LL_31B,79G)Z@H0-_->!P>-UGHP]
MP0T\I]2UU[C*ALD=) NJ.R\[@^^ST8";-9[AQ)HI/J_[7IEXLC'2])N:81E(
M+-F8%H)9?DL;ZM\GO?WL1WK[&Z2WMS:_47Z;*1'.SD5Q7 3G@P_G@XO!Z>4A
MTF^O6*^<+XMI19KPI%P0V%\]>PED8"E/_8.F5$&(+)M.?AJZ%76*8L,!I;L2
MZ;!_G(_$]1"@ONW7UW.<VX95$@!_5,8J3/Y#4I(CT1'"X\D6HVG)*2Z:(J R
MFJ)Y8O,#XA-EUTE!>'TPG&K)>J(]QP?ZXB@GWB"-YF"^A<*\4/-B3-EA=&V5
MI(IN+<<D_%N5S"3>T:8(4-Q5&&\R2>)8989M"A\OE(V/30*6+H8C>SLI:6LQ
M@*.L$"DH?DSG5#^V27I(LE[<)D(RPO5%D2X_^Y3E-T_!:C5*!<G=G+; )B^@
MQ5BJ?EWE%/4W)&^%\SMR$X]M899K==5>&,:<Z^;?UE\UM7\6LLIQ,UD1;#,>
M9;J6,#+U43%U 1, C6YL86NE'MEL/V3- ,_V=:)N% M[2FV7HF;?8%(O+O'*
M/]4?]?3I)7AEP2N-V,'I/2Q+!:KX715OW--]KNY11V@\=+^,\'[%B(T.4\U[
M+<7Y>>)Q?G*42 @>$0RA=/;SENZC/G,1Q@S*0+BO_*IFSCP@B67-]9O34J58
M3.[D"^[9B8/^]J9.,-"8N?E0B:P:]UC>#@X?[@]B7@VSGJ0%$WMGBE V;XT)
M1 Y:>3&GAOT XW2)D["'E;> &PVC?3AOU _[C'O8]5Z9\E"YY5W*L&T^N-FC
MK*.XU+%*O<CX8K/*B=(07-\+"V,$T"2V3,"G';;PZQY-76P/_]8=C(([**[M
MC:TO]D2#!M?5 ]31+3.<K:UOXAB_.SE\=?+NY/*?!\')Z='@_>G)\<EK\HCQ
M@XN/YW?"A*]\32',YE=A%71(Y3PB^UB!9,<4L1RE43+5B2PJ@B^0X3+)*"Z(
M&[.;:6Y-TDYYICJ5[KIAE_,Z:QN".1[X(OB&!.!MI^X&%KH);%I!2V7!#KM]
MR3P<FHNK2F!&IAD\+B3G+HOYFQ/8,F"R%-,6\S'[H=%XG*28W$5H+!Q%&(P$
MG2\J--!X$\ZIR.(G;L:5RZ4I79/#O48*?_)/:$[O!&O2)@$N3V&4=R9%TF?;
M";]A!;=M&AZDR?E1R.#,3##XUL&:[APSF\Q+"H9CDI_P_.NAE7W=UYM ;K:*
MTAXXJ;J2"H!U+8-I3I@ -_DL^=8;.,[+'&/X[IG5!?<<YG%"U.F_UYRTQ1MC
M'R"%_>AY>"'M/HU+>@FC6M?T#*'9.OK:A=RUWM_OL'G"#C9J>0X(AGUQ;[E_
M,BFLIEWVDQ36-G)WE,HQRL+-WAW N^++$B" -!*R(2N[S'YN#IG4043KE-33
M.((?YIR;CV+D&Z_\$WP:Q1V]?P[T2.'1,M%==^JN<"$[SF^NTJHL=KD9VFO
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M8"G44[=F(A63KJ,<7S1K:+2H\=5PFL31<T*@LA0:7VK"(9)U#G"'6'.KFVE
M@]20R\ VT?$:<NDPP3("[!\1EE%:#"N*OE&]W!";6<VPK-$[B590LRUE-3W[
M5CBPXY.CP>GER2%VL_G>W7L>I)E0YU'R;#D+RVDNOX!TDZ(AJ.V3G"K@MS:#
MM0J+:N<J*DK'W.BN3ZLHU,9E6KWF7)R4HS1OZ59\L$O4QT$3-W?&QHSK,C$7
M51=X<R,XL[%*GU7=1,\PPB.,-U3*7AL$M$02.M6P'CYOZ]ZW9*=-W@;OBZAJ
MT'%3#+P[S4T\9BOPH+D6"1>E4>8N*O\.TXI3=),UYE?'N4"#$D>Y$\HUZ1#]
MIW%7P+6/Q=X1(&J=6V%4C/Q6QI*;2'#WL%'!4RH(T;..9'C),J=6@CFC;)<<
MIW6."<>%NEM.A\/?YL1<NZNE<>X1'+3ZY]Q,<M;O$17*X6#Q,&5?A5Z1#762
MF\:]G(.!BY7B5L[09;W4I[$E3O4[4PI\/V<$/%KC)'U.T+R+1Y,M0,[N8<BB
MM"%9PQ;/ZTY)/@*,1W0UO%L)ID4:&5>E)P^HBS.=T[$SLLZ^@6M3-!K @"3W
M=NF!=TTJUZ[HIYAK+,./HO0'A]5L;?ZH2G^8XW_I&I]V,TF36@?C0GJG=+3U
M<;4+)2P78+'O]4)+0MTIVL.VND^#.JOA34?@WU* 03L_?A//!JE&3I8%J!')
M L*;,Z>*.,!)%L/;%'/=V>JA9F"YID[8 OV&(87]II!$>#WCBI<_RQ>?""OA
MD?1,W5(PWI.Q+@UV[,*NTR@I/7/19 O$4I$S>)$+KH\NQ0VR&,S.-4%#0@XC
M;XU-=ETAHU7&O?60X&[.T RW'XNQ?AMIX-#T^ATJZ<^J>;YS\&/#Q><N74B<
MJK?1J#9M FV$.'/BP%=IHNGF=>G=6XT1.$NYU5*-:@;IV&FLX*N56V-J9\#5
M1^[JN!;D*HON4CCI>Y1V=,JD;[5J5EO%7I(N1*9@#,7$'5FFB"*V>ZRB,"@_
MJ6HTH=\E+.DR;:!\Z'#E.@;'LQI#XW8)=>@1NR.F-1AA"?T\5=.\ ('!!W@Q
MSN;-_0CH>NB:>0F30V#R,2/81:&0P<C-R]T:_0J]= #,8V2S C8G %;N:)(E
MF!GKS0"$K@6/[:%T^;9.'C12&=Z4WS,&YX7>-,HC;"4/*Z^ZTH3&9 IL0P7;
MUDYSE\D;@_US-0^=1 C1S(3N(LFAZQ1WVA8!"^*"_=' =8=RK3/2&WH6?W,N
M:2I]#9-SDU!](YY<A&1QKU-;N __%Z6A'[?P-:#H\G;X0J(6=AJ<*5HTF,;(
MO4B"QV498=ABWNPP9J<U8JX,CVBFU3^A[46NTVOWFQ2='<=]^&U56AO+Z_!:
MJN(Z&=D>\63$C;GI1%]P:I75^5(X=JJ3T^^=9.Z*>WM6.[U\@':$IMR,?:$0
MK=HZJ/%K?<?"*D_P4K#P!@)I<=(1PV:F;]9CG*J'P+=V@N!QGLAIP)!/7 8M
M1E!7Y3@-L$/&X8M'IELNP2-BVW/P]/#BZ/!7R>E;'I+FP64.2G=AK%II!A6'
M%O7-%?EB.4EO2$?9:5O(Q=J22<HT48^_(_KMN9KGWR17\]OA^?GAZ1V2--]Y
M'SU_$#!+HV':#7<N:_7<8U[<EX;(SV)9Q)ZQZ<U:HON"-.M&E1'*0DSA(4*V
MB/8.+3V=W(1G1>M!IIBIC1B3,43@6.<*<2:E)G*1UMVQ,-_J ;)G!Q8FF/?E
M))D=!&O#=;Z=V*U$M!QZ[,MM(\TUFCIHF"U>Q.1J>JH^)7L! S;]V^8T&;KA
MAT- :"#0@@NW[VZ8Z#1@G1F#>UGXM)MC$.8MIF#[!I241E95*?S4LY<FG[!>
M-,L$],\]WHI\K*AO#4QUG$@[*K[;)_"G-1&=8"8K735:HBW/CLE(%LF[E5'J
MH?5V[.LSO5J"#&ST%&*\E;8N(*E1JA4Q?3&A(772'+K]ADSYD3\2NHT4257R
M_@?<>L<O:NH,\3<@7#TX]UMZES>P&U1!Q-#+$F2>QVSCAE9HW<ZU.KM4LQEO
MXC.AWR9,I(]?#KTX^/\L-PD7EB;K)96-&[OMA M"S=;4]JCQ!_=V/BI]+'$>
MDWGD;>*"%@A-Z]VFE*@H2B@'@^5;[I=:L<9QG8Z1K0*K3= T;91K]/6>7%2K
MT-O5T#2'^I&[>?C<S=:/W,W#V!/+T7ZT; F_^:JAU1-"<HY0*XT576!0=!%O
M"KDZ^:2PM\9%A.D5CRF$SD'VXH-W"!5T$:07[PZ=7E=+];?XNUMRW4+!KX0-
MWK/>2V4GC@4%HMEU*2_7",#X$L"D]+3N3(XK+,-B/) HZ(6S73A:B_]%:]^%
M R4A^'==^Z5I4&YTCV-KL' ;-E4:TYP-%%,MDDP9E>BR*]MMWA&O-!=09%!E
M=*ABUK>/-\CY&H?S76Q]%UAGE9=H:>H)LT0"E;/UMDT W7:P5MVH]%JM"ZN/
M+9?1O)>]C"WW(_-JM,9N-7J4M('G[33;NU@%8VJPHB#-LRLT%QOOW)%6UE%*
MG;RA7 RG&,S5S9I.#CVCSK(U@I^E0Z/E-[ M&V5B43_=EW3JKK#]X!LP41T*
MX0/+E#2(RC,&*-(QWA5W[^^$;F?OJH[P#\J9/UG!? QFV+JXBE/IXMFX#UA+
M^ WTXM=V6C+KQ A$6ITF* =4QP(>*:9:3/<0L_ \&) TAFH4SAM[N(M\/%:%
M?7O4-NB[U 7'2JAD,(NQGR"1=Q:4XVL*YX*;F%G!@GC08*3+FD-:?=%:*MZW
M_TWB?<C'&1R>'A$QY\DI476N>NQO?]G8G^?5\J8D[PS#4#G*'CJV&;72X*WL
M%V#=1^/[]6!-/&JKT@K^3]$5TNNGF^[$L=W%)4=R,=,DM_^TZNBY!.X;4OV:
MY%8?X9G+\[:_NH;#_G)^W(5-VUI6NXUM-O 9DJ#[#Z)E;WBK-8*<]%-965:6
M1<6!V-:I8!TL5!Y=K#>27*=@E/P](?0X+5+M=N.C[$LEWVCV %OE-5L.*>;6
MF9/\F_"W$Q=D\Z>K<;5;3H WRCC=M/GB@"]'%<"V$^:LS#[IB'>RN:U/_^;5
MTFRD"[#E<Z(X:699^RP/I"H\(IK%1BLU*V7<(-2Y 6$O<0Q*R]Y!AX<G4:6D
M@O4:P9)HO\$[@6Z_;)+?8-12K@J=TBIW2!:^:I6N8^ZR^DLD-EPQJPK.WXC[
M?.+M9%V]S05BGM@NM_2UUDR)Z;'*6V$IUW20./,%TND6(_8*;JWQ#?F(E);3
M:]V0[&B:9PX_2R;,8QP@&S8!?S;VT%HQG$QY6KL?W0C+43T+W!+5,65D7$8'
M9_$U#9-^8E+J0I]I4NJ"&G.F(>5G1"ED$RU)<$;6=C9EP]@JJ0/=[JKY,M&,
MVJE.C581=XM\\ZK GAR*FYLZ"@<[ZQF,<^XO1L\+.M%]5TU0$6K%:?J:<=._
M@V=1QIPY($8Z-_V"Q3;K7W.:L PGT8DY]]6F%.**M'N <P"23O.FYU)8E72=
MT@A.Q@1+?59Y(RX=@/ ZS41<94SM3'IWHIZN48[(QD0Y"996D1BCC )A8$+P
M/'_2X%W1JM!5P/J"$1)9-GG?VV4^)/54Z8MK)UPOS&27*J]8.B2GL@*-,]7X
MDKJR,4FK1B21BN]"B4<Z*"94G,:=:QS#22#-C8.QBWX8UNR^90_BKZ5JC.[:
MUL9.+TT W'PYMZ.CM(D3AV&0*016(JB0,2P&@,TV''TKG5NCTD^MHAG)]J*)
M._1R2384OSX[)5+@5#+:J::5-RV"N4RMCA/;T:/]7L)1X):W<VWUV$MMX&_6
MZR=#R2D]OZTZVU!,D]5+F=JL4&,0#)PZ!+S6Y5>5AN5H(RS=*<PCLL%+VX%@
MC3H'O)7. 9>Z<\"INC&][BXFZI-*R_6#!XB W/F=]9*(69>@[2I*1C<'0)Y$
M>"'D4!1F*+?#0G>']MT?2>&'3PIO_T@*/XP1L!2N];+AE13>"=8\R%L &J?,
MCWTB^K; KPH?53(.E&OZ@^(O:O<0;=D 9#WJH7%/[4[MWP5T;C.;)24"89(,
MF2299:[2A#8N.LPFP0G\G!-#2U7D<SYCJ$Q<'V\"366 UXQB*XNKN/1)@[,D
M=3"F5L46;]E,NS3H)II>KW:IMPY>\[V9AO#4PE2XJ620E2%&T355\HK\MM1*
M8A$EC#6%Y)##DU0@A3#ARI25*.3A*?(L&4EE"1E^FL4F9*\.@WOS.^#6[<LC
M]HB01WTH]A!=<_$OJ#$HQYRRW&?0*2NWAB0DIP ^<PF^RFD.:Y+.NRR(6[%(
MQ#3:0B<2=U +[CR:8$N:5?8UEL:$.Z6REFN_#+;"8"<,=C=V\3][80!&2Q@,
MBB(O_B,X5YA^0=N0L8.D:<:H;#?"X 5^<6L3_A]N@;3OF&_*ZRN,J6SLPT=P
MLZUG\/_/0[*[Z;_/Z+_R+MMP\39<O+U-(K*]8V+5!!Y0CN>OS8?B&BV?)33F
M@G"Z]62_5MIHY0'D+[Y)0NGBX\6'P>G%ZJ>1&A!PEAL3"W/CL_TLFB"T)3+U
M<= >B=THN>(2T[?[!MAVIGZJ7&?_Z4\::FSHM7P/K.KJU>;BF"4++38Y#K(4
MLD5X*'.!5YIT6VI[U[ITIR0/'#AVB6AS&AE&EXSG*CX^G(*9DZVR[1[9&(+9
M9D?./;&9+X:B$28;C,PE>,A0KAV<"L/)+KZM\80=JZ6C_@VIS'6M8W<MC%YH
MMS^]TRT2FY/RRA ;6!.FHZ-YNHV:1Y<TIBH \'AP!!Z3G\G#-=?'FU*G22OA
M^[N(<5B^\LQ-(;AEC>N$RN6H(#:Y"EUG>L%;NC1-B(-H#/2GT@WCL[\G$A!=
M72$#;Z5"8ZI<DYVQNX?1>,*@)(BUP0CCRA[*M^JY[<UOHD[?G/UC<'YZ<OHF
M>'?X&R7J__;Q_.3BZ.3UBF7J[WI,PKP]?/8>(37$RB#A(&%Y[&_>105CLITN
M*LF3<WB%554C_$X-#"X110LV"@>A..>DRQ+=V+RS%2D]P&04L[JRM37"X>P6
M@^NJ&[B/P0P^$D3ELFN*#)&V',:=*_N+9?76#9&;S1&==KU;H5%YF?!R1E-J
M&C"G6IGTFGB*JQLEO=\^2/Y>$B$=*=;2"5][IZ^C^CT?' _ZI,#^4CXWA\/%
M@6\6F!(<FU-)W/;8=KQ8*C5,0"VCYG\/BGE0@/=W,5'3IY?Y]=U)T@[-75H
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MM4R8RX4P-.%R$% +F2]2DQB1*F@ON<K6>E'$P12 1RN!I)7C^9-E 8:%MAD
M=##**!?!PMS6]N@[BSS$,D&9@?F3Q ,",Q;81HK#6HL7KN51-RUVQ0GUXA8"
MW5OGHK&(3 [("9OJTD%\)K(DZIBHM*5@9:&)E$<4I^&^!CT#-Z$A1[,_8>=W
MA\+KC\(^#X>#KN=/_+[?\;O<YWSH3;WNLQ-VD_T[TF7]VC$[LZ5V3TS.G7WQ
MQ3*CNF"GUK96<E>)*#<PDXF28B6TR8>[9DB0 '&A]*34@'%%4S*4K'U1%/[9
M D3XL:4SFMMCLT?L)S?GT!#(EFXA 7(O6EPA )6!F9.MA*B6'IN\BEUM14*[
M)5$1S[#61DL0D*2W7(*K)S0F-WTJL9%@<0H'ODG1@+Y1I_ 1T65 5Y=^%I56
MC4N2MKC+)S&^40=676B#1U\41]@T-UB/\!1@0(9RL\*[5*<>FJVN?^Q8T2XI
MX XB]H@6=$Z;%!S- RL'AU+KP))0T8K.3#6Y"9MS!)\08K;EOMDGA7M0LD<1
M.O?6-:_6EA3D.LNU1R]V,A9^T!'3X;@S'8Q]T )AWPLFW6FW-PE'D^=7=S7=
MNSJX%L1O3TS^WU3#6356Q1(75TY[HO!G#0^%>11A,--XA89U@!>.;=X/M,,\
M60FJN*I&& N7%3L^XG4)1UV#2+13\]B"D,=N83LQ_BW'9K.RG*0>;=)&:3$^
ME=)L+F;!O[@N;A'":CG""6EFP8E@HG6#M^SZ^77?6V:%:$U(>H+<2VL.?,6O
M1G65J(6U2<O<>ED#UQA>VY_@&?).1XSZDW ZG@R\()CX(R\<^P$?#OJ#<?#\
M2MZ[G?T;HDAZ14G;31GD?EIB2/MEB:IY;=1F@BMLL442&-^[K&&KY4%6\\3*
M!(8>+3.R)0-"TFTOE'_';V7Q''W5Z9B-YA%V4R_!*^>NR@(J&:SXY];PU5ZF
MY@3*]I<IC0CE U7K\P>E/(QI^^/1]9\C$=_0K;HQA$Y;ZS&VMRG&(#!Y5&U4
M-+]M&?'@7<^T+%:9Y3D6"OR>NJ(_%D(,IWPP'?'!P.MX_>F@,^F.1J.0]_MB
M^/QTQ?Y[($^QCY;\JO3I:(?'M"9OYDY,]J3:I4P-PVG9&=PY+>KVK 0^\;,6
M/8I7VUWJ&<BC&<]L<S%98B9$('4OC\*9[$@/D>]%QU53SY+S/%KH6H=H([5F
M_"J=W:%*/]"N:5%';Y$QRZ6N&K!]["8'?NU, <,62""]G*:FZA)G^WU7=7]+
M%NG;4[LN[Q9W>Z!%LG"J=&?W09-?&9X&DCDM<^V5@,0CC?O]+KDAXM3(>$T$
M42V!+8Y6*-U'(!@J9TA,<[&NZ;!HHS($2]9;FE4^I8J+2)JID?3.^8H-Q\-I
MNSN=3C5+D5NL6Q8JYB/]_]1V0UO5=Q%A9=N<H&_HDJ@J(JS<2ZG1QU:R8J"U
MJ+1"=_@77=IDGL=%+@6MU*DH <5]:XICROJAIX3=>]>@;^6 LM#X?DV^&('<
MT=1%D16,2XO@0>,[X61R73PAJI/2)F^?UZ,AT:>Q>"@ZJ7;TSQ*_.KD'\HF6
M2K0S_@6'I)Q!(Q=_X^JA/5.-T94.R?C95@IQ]+)KF."6=J?]@99Y.A3UI+!0
MT(5CI=4)I!$I.N&K&[ =XD'!#;1#+8A;I3_^!OR 4RR5A.F7:*W94VET0VFM
M*,_I&]]L"2Q-, ,1TK,BIL&XA,W4Z\!$65!O;W:+XKX_.?E<G-_SZ>/5-0T=
M)W$;K[RB7TH0RA%@^U<"PY2I+A7$A?FF92C)$-JR@!"X,LO58\_'V"^=X.IW
M*:\?8^J,N,8]29T3!&"K!1D"C7O^I%" >[\+!52!5ECE)9&H@I]*=\"QD(SA
M_ZGR]$F)K>OBH:>GF2M-S;MP]Y(?$A:T50*Z$Y4B,!&7)DD@P?!!]I4Z<(^G
M2^E2;IV2()_/9GNU!M7Z]UXM8&7.9+/M'<\:>RD/=:%RT;DN\,0)L5AF+]-#
MA,?,?:_96C">/+3K#\RQBL)4\#1/@7($G@(X"DCI;OLTMQG;2MNY]8:WN(4
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M<Z1,+A8B0"E"!_K94^@R>XAIX;R;G@4G255);+5L#9I1V)0SMQG&FOBJ'AZ
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M>=>%>2H75I-BYOHA6&^#!H$EL-@OSY0@ Q+U>C!?X'N_52F&WF&\<?'H#;F
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M-*^U'%\LZR#NVI ,Z6;!:.R7C$3N'A4JIGLWLSRS:]\?A\WMY=*RC-9T$G"
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M4B,>S7>0S_),-GC K"Q5GF\-/M0%IAL%YDX9'!IKKI5E^0YYZ NJ[4\^&'P
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M)=J :\D%6ZQJ#M8W@S](B$#,/\"G/9>A<&?!^!?1=,O76^>IV>>/N46!6=.
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MC#_,/TJJ-Y0%*VSOLIM+R)DC'5<X(+$F*[_/M&G#^A^9A(+ C-K_8E^?6N>
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M7EG;3^:GOB!'>)#FE4R[7_K=6@I[H[@][K A.*I!S2QD/ QU6CPTFW?29.C
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MA_LP:#;L-+B[EC1 WH2=\*J]>&J+'ZIRJZ?M"0=DD#M"4&$>$YEU"(VP&OQ
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MKG(5H:>NN@2<+2DH#$0D^+?"68!>S 6&^>1QVIV^IQ\2SISKIXY1#GN\WH+
M*@$]: V<<\"B [$_O'P"<7[P^NG)Z[=3G:>8\9K=^@+1;)(.-Z2 7^J.K"%6
M-M;DU5[RQH!,M9@F_;8,B1#O4N^N!.4I=!AE+NK#MQ KM]%:.G-L?G&3"6T+
M3 !XCJNV[E&,PQU80C@UI.M*(E6ZYU'?^^-V+TP<^-( &I:,W9!@2*PD3=>F
M82ZLB-JU-.<+B%\BG)I[L4<D@KV.'78<7/H5X.J\-SCY8FZ0Q3N>,D CN^O/
M?+O??J!L"_+I'9)$'H-6NCA:RM0HX4\,$PD_/H5+5=KJ&)O29Y7^POI._JXM
MENW<F<I%M;:BIZ^+^2Q0]EQ#;D*OL  6Y>Z8=2I1.I9?:CF5N04Q/LF=]*CC
M JHRY6-KE-[O@.H8?&"^SM$H>:V["W,C>)!'HA[9[[FK &S!]Z>X2G4E9EPD
MV8VYK$KT(P]R<%7%XC:V]\1MS"#_Y2U\4;G@P>'Y=XN%P[D23F_Y:,4%><3[
M.\S$;2$%B<K_72O$;J\D?"T7OUI<D BY(GJ>:=MO!CD&219[?BW'VWFNLX$E
M2BO]^W;/*6]T^#F."BG=HE(\04]O_:U?^*+7N.L;T<E1)+3$4(Q(Z; 0EK/L
MA?$-D7  GF([7E&T0RYZ3D0D&@F@"5FM";;ZJTG"W$A26B\F9MBZQ]5XN36+
M6+>(%&=B1!!^ ET_H[",V,"Y^S[';T#:80B7+)UVGP^+OK-]7F/YEGT"),)@
MZD2+7_4CC?--QOP>L7Z7:G\O]7]WS(X?L'(/8Z*<V,]\4Z@-^;K7+O49-T )
MZ\8GZ1>4;^E14D5;M/2J[KY:"K)E!-RO7S-:@,CEI&&A/Q8:)PQ^5KY4U=2C
MZR\O@\@CCPL;U?.#T2@P[R,C[6NUYZFG37CYPRSDD=??6S/!EGUE-LGRX3:6
MS+!^8W\*UWAO6$X"ELE1-8EFI%.[^?46HRAD^]&(UPM:Z?![J5H,)))._^DG
M$-KD;D$8ZLO5GP^X SW+BLIY$/]KX+? (9L'?T#<-#KX5T1YN][A]6+EU29W
MF/:5V5Y5]\L_[ZF)V^2&EP;T+%^TM%U G#J8G [;+@3&\3NF<_3.V&><1RC^
M/0<0F@A/M19%%)\[=8/?T#PT'\U%ONX[P[B-CM;X#2#.."M,-G2>T0(!_%KI
MVM6+]E(VU\;YE<<,9M.PQCBKMPIGOAET%RX&6Y(N\.:T'<B2("%SCS29W%1+
MZR*,?LHD>. G@[^3T#$1ZV]%70YT(@W0[WX:'DO8%9J]QI;2N5GW0VV9@(/C
MC9'HKXU-.O40YALEK#X%CW#CZ3X'R.5P[S7AG<@5T.+OR:(C8<\U%)_)ZK-(
M^;_KM1ZBK5P@A:<Z=]';C#^OSZ*O!%_O7[Q3I%KW;AV_ $,$T,N#//E(F]3Q
M4"9K.$3Z*DE(BYK*!7@*?*!*FZ0P?FOTLBL2RPC2*<CX<2UXR(L)I%PFO']?
M<-+>?WTVE4BBE_KJN$#P:J(.>W+%11X(N?SW,_]_V.*"A]_Y6%BC\:NR*D63
MW6^L-1G9%QOX2L4;RFY_EM-*\WC#\?7>#&:Q #J>N5D6_*F%OG1':'SUTZ-*
M( ECC8O2$;>Y%B#^^/SBCN+M,,1LFL$PYWD1%KZHDN\2/JH%+WBP7UD6(EYM
M<VZ?,J8LK>=!HH$RAO?EY/:7=//X@H?K,V@SB$-^S_"<1+9XNIS '7[8:YWX
ML_$Q9X,LLRP_AR S'PMRS<+%K_$K2<89J?,EI%E\<I2)^V N8/*62G&7:'E5
M6?"X[O%QOK<.$-0YH1I>..]X(K K^K?%(%5!/U(LK?0:4.Q6\+!D^"?6M/G^
MAPM@E8[;_9T5-F8[FZ+_CZSXQZZ-:^R*'N@_)^'2\SO515QIZ#W/I;PYEFHB
M=HXE]"(Q(G9DMW:!7-D^@T0GOQM'Q/C-^.JLPL7MFJ(G'FQ??@G3VT!9G*4"
M"?NKS$.6_U%3$>"/.Z/B_5; 9?*0OF85*IX5;^U<"&]\BY)0_'^^*MK.J)JG
M_P9YD/78IM]B_OQ%8_LCX>*07T\-E&4;[=X7/!!2_F_;$0>XK^Y[JG5!TN.O
MB<IO=Z8_0":Z*._(MX^]+\Q5^;+CUZW,_[//IF_IT('TXZE)VYM_&S7FG[?\
M& O+,TCDOU][SR",!\$[A6ZFB#KP+ZJL7^,S??\7@OG_ N7_WS3;@P^S2>%Y
M2..3PWX)T%-6/Z)CB?!OR/6?DK7S7W,7#<W<\^2TAKQH):_LVFR83K-P*L],
M[[Y%DUSZ%0BK;4Y;1YP->LXSWDX\.=A[$38]3IB_VL61%:/=-2Q5*ZBK?55X
M"^,9\#=X--0T8D11</!^9AHO;N592T*%!6D]>8ANWD2*1[>*ZVH6[S0V/;NV
M]M&C?$J=H4>8SDHY75 7?V7T]HV&T?$7Y[8@^5UKZU0S:OV+EQ.9%6"Q-[8;
M&X^@V2T+<APS1PT-39],%:2*.G6Q42 #6T]?3AOU>#9M-W-]X]3Q@^H_@C3D
M]TU\,. );$OM=9>LDSKR?N6(.\3!99/DUU2WQZ21[:?0'JHBT:6;_@*3;_B&
MDE<XJ^>Q7Q$I ,T5_7@+(A@NG6?"K?2X'/%<Z(U3V0&!KFQ!3@,9(4G!T4*(
M7]5.WCV/,=-P'#V\XT:L_D'Z+"O6X)VOI<'+99YF5-J"[(@JU[WR3J]H+MN:
MB)D8F_\+V/?>V7BR3TF&S@I!DC"D8:QY;6V]8S@>!R61XQ'?MVL%X*%"NNF-
MYB(B&FFL!:"7Y2B.H(7@VE/N@M+.V@0[[<0'CP-G;O!S:JEH_%K!R;SKB[]U
M@-6E\UP@J7[,Q)7O+S\CU4]W$9PQHCK*&S_A42\P@%/$W4YC*.,3MB#>EUU=
M<Z3O)UN_-Y\"DOFZ3Q,10YO8(,8*.SS2<*KC\\]RZ:#]NC%=?"7&[B'G8"X^
M_<6J>F6EX<N?">OLU.L#E4J1P\&KU#( 0YR+I?B56E,3=O&ECE2BC=T.2-=9
M V=@:'@QRBCF)$_!OF/PSZ2^/1566WL:7QT5HJ(_D9KO0R$SPJN69P,YXDI?
MB;O7E8;IYZ$OTP7!^U\@5?]0P2,;)@F_[(=+'Y6'C=]8WS1:=X\&===/C&2C
MJ+GLWMKAP>'>P1X2>?[GMWZ^#P<[+9@DSFQJ389<><3"X]LWSNA3Z,9! (OC
M-.7T%<$XC?Z*?3:I:7*@AGVL7M+/YQONVR7HVDCN&AF48"?1>KM&$=\ T5&_
M6E.=U$7%YT&AFZ]<AS(V&TAK%3Y?D[4?V<(KJT%<99P]I6BNK$&G+"&VFKT%
M44"^E%0D+%!2,=AYPIILF9W*)@Q#]I!>"9QYDD=KNM XO*R0W.$OW7T^H'NO
MW&PM?+T#=2J2".Y%TWK;/,["^=V*]@41_/WRQN>EO>#:<EUUB/>51S"R=K9@
M5@1IL?&-;6EB!=-+T.8R%="IQ-*Q;[A"AND-8_FM. PC0B<A&#@C([#&\!HD
M<SIBRMDZX#"2G[J[R&71Q;:L>$CU)/7>G ;_PV86BS!2Z2?S$'%C+KSS_.9&
MI?+O0D&/L*&L_.P8W#37PC;SA.Y\&;&]+KP')PU8+\06+WU"OQ$@CT1LUS>(
MYFI_2UG'$S@^!\2?WE;N)NF!B*P:+_?%?A?N_'(JMV4[,Q+%T0YK7FSM$FQ)
M[<G"9%W&M0\-I$(E;-0GJ]<YL^#V>H-LBCQTC8<3:"O+TQ(&'Q !1>"KQ_X5
MBG^^)H=H\H[P+XJ$63!SKJ_.#NLYP(^=3D/8Y6]!SKN8Y\H,Y,R-;@Y:^ ,2
M@U5M#K?>8T2<E ILV97,C=\'FS^.R[YKH Q%DY[_0D7UB?I>6I_G1^;&K\^2
ME].&/U>N]SY*/Q1B#F> ,4Z6!\3/B1KMP'L8^[E\LK=-.=+<6UE-'=B"#(^)
M[J.ZM-C_KG%:=^3HL"M.!3\=VC'BR0$1I$I+,XEO8P'+CN$\0KRT<YL6>&V7
M$E^)KS%IC /JJ$D\M@H_L7PD5=IG#3&_F>):AOM9H+;]+^U D[CBHJ-RA>L5
M+2GAV-J "4..\?+8ZE[>=/G]5$J, '7Q"1U!A>6(OL<\YAMGS3Q:D5"3_+G7
M^([_1BQ0U5:2%UWI-',R-WD62JI1$W>RMTNV#7RSN=_&3.+<_X;ADK53QPY+
MO7>1R25Q0/.B26/R%*GXHNKYVD)C1\J_?RT">7KXV90-)/%MQSF#->H8SQ+#
M2[(@L^BO+_<C;:CO5'3Z<K/H+/".\FJ'0D6C-T]K.FK\W])'_W_[KVH[I9_9
M2N5;ZMGO3ILR(/Q$'#)18ZBV-YJ\DRL%Q*\<SSJ6MX-=N3C"62&68M_JT",&
M R2TZMN5I?!AV';BF.C7?*5A:9LG7X@S9NFB"KV_X@S4USL\/0[F^N\#_PV?
MU'KI/C..>,[!\2C%VT298?$MJ[''IS&NNV+SW-++,,/&Z1:M00HB%?B C\?=
MA8M%)HYS'(<J;Z8LP,_B7YAH'?^'?W-&A+L%^8J+,#$"VG1CG%8:%RA4&U^U
MC:ST@TJY*# DZB9E<&QM%7B"I@74/=-I,/O9BGE/7N(Y_'__3B3(Q/^^Z^8I
M8:\RE'P@'PO/)"[$V;YL/4$LW71ZB+M+9"B*8(J<<U*B+YY5$U;L9)M&O+(-
M!=_D-TAL9+4!(QF@(+[28RR-GTAVTC)*^F#NWV<=HED[M]D%WX(@I@A4R2W(
MKAC&,[8^V<[WT*0:X0[[E.FY\O?N'Z8OW-@1!*B#+3&>M,L;F8PD]MG(:K/H
M4K^S@IC)_3'D*O=+*;C14Z)PA+7J'<'+Q:S7O6+624X9MKC+Y$\([%_@W68;
M<<1UJNYQ)55'5-CUZZUK:=+'JS0TSD^G3:]S&F!C25<2VJ""X7K:S07M7D'B
MZE)CA_@',=A91/(6Y*,3YQ#"9B7)QT.RP?)P6]Q$4JF26DU4CQ=G-2B2>X-;
M'.,4NQ(_]6KRG9^_ C;\CN;8D<_0?,@$9'.=0B\JK5YZE4<%8'A0-.^G_+.-
MQ96<5R^(L5F(U?L<^%HWM])$6;&KRZ=Z"W)@HAKIN7AV[VFR\^DV@]+%<^1<
ML)58COX$;0<82@G)1OI>X2MGW08*<='>^39&M<PU ?<_Q+ &H_S?S [V=;"#
MN-]$,<8_>Y1PX7=AZ@PX)5A8EZN\)[SKQUOAT'Q1S#1+B<W#Y[8=J*,Q%VF_
M6PO X\/K[8H5(4S@7F.\C\GUSEV4[N\\IG <Q#@HKQEB:AOO-0'NB2$9$[6H
M1RY@'X)VB=U@*]!\X=T;F0?\;[R&I@ \"5L<NX^V"0HN\V[>[Q6'GRV$!&Q8
M><+DDS/HN_=RXW#W_VYVK6)_8@\#;1#4,8YQG/_M2+S'\WOI^#2J:JU4<@")
MJY <W,VW\@\EN1+Q+>T(V-&X[G*UKZ',;:_*,&QRPIHT%R-WG3B((TVB?\\5
M%*L=I&Y!A+<@JE&OAU[.8 5*(U;':'5V[%PN&G<'^V +LK?Z)52T _>O *'4
M:W]X=,^X__//U'C$$QC-J46T:Z"C3/T)]9]"RA6V,,IKHJUKPHZ,[FF)!@6S
MV$&(&(_:037LZ6+@;'=*<Y=2E0&)@L<%D#;.SG0M]1;$! ]>=NOP5VE,SFB6
MA^991YJ\6;XZ71:R5OR/R<&5IQ[PC]Y(&BQ; @X!-'B:!"/^"ZCQ! XUJDU7
MQ.-)6E60###;GZ_$;QT#"@FN -/8%!.IWIOO%H/AR+#JM%M6C^N>:ECTS,W%
MBDX/@1F4+0C-0G6?:51 V'?/SS[.'S0TDE?A5ZLPQF#-_&@71VSGFO-X';+E
M6[]FY_?3[IT:YKIOX++F!J&3S<S!9GK<6JQ#I1<7R!LL=\T+Z="[-[%<@@ZM
MX84:;*Y\0Y7&_S2MZPFN]DEH &LI1%Y4(Z7UMM>X)Q]S';M<.)60NHR2BX$.
M5 7.:PC<BS_PLT[Z:)I1K68:I1N+![9S]:O%P-@&1.S3TW)_7";/!WF8ON%.
MBH3\Q$_(@'R)%)0VQV^@@B,+B]?N98=J:UA"G!7=O[P42Q4GU0WJ7!94&<NL
MR"H<<QB$XVL2G,2L7\1\#S7);)E$H]?[7#=RN-7K@9)=[R--C6_IGU9:>R<F
M^"L#G;ZO 8_DW$6,>'[#2:'D1R-KVRT;FAXNHP9.7"H*3@CZL]L^-4%_-JVS
MBDS<Q7&=P26)^06$'S[ELO9C[D>_1-2KEONS/-$"EL \U448T*]R!SY>C2$'
MPV4KCN4ON28(2U@J?.\V#NWSSA?L_.F844LA2=;U8B\<T<,X7C7P42Q U5*'
MMR"O<1_.?O&_/ U_$C9F.*94&^E_T_2P\XW'D-6@:&0VU^W\(YN_A4RGYQ8K
MKM.ZF;V[4(J_U')OFJI-%,BP;NB1QFA5=?"5+<BC<(=]&$JFY+E9GR<S*CNV
M(*W.P\^3K$9[B%I%2Y>$-<SNN)%KU]"3H?$L\$;X%D34MS?GFZ;7YH%3\<]7
M94@KLBM@]-!&'3Y\2 )Z@>75XN:CP&R(0EQ60\(HK-8#W^I-7*XV3/B443;7
MV4G[?3)_R72 P/[8>JY I?>J'C2"#$;QI-KO(*'DM'?\1J&V"AC,/'I5Q$__
M5^Y"6?1U0S4L>?5/1.M$G%ZI57]ET2@"XX&F[=6VN[#38)9R^?GBR0J"!0:@
M#"[K7C7.!G'3OZIMS/C^LP/?_T'6I\ ,-@>DR)<LS=:WO;\8&5#/6AEKT?D>
MB'2,K:5N_FM=.]Q3]L(F+GAQF;P%X5\>__P\F93H];K%$(3.FO_NFCQ,QR.&
MWRJ?B8*1)I\V!D85KWD@%N)"RBJ_[V)3>+OL!MYX[T<>\7EN :PQ!G;+=BNL
M=P6NO!\]#F>"YH^FQC9?-?HV\A0KMG4VM^P]1DI)[73.&,LEP'(!BUW=@APQ
M^DT'$;/7F&H4$# PRMR"Z/'^6'Z!B9.8GU](-BY1!6-/YW%P4USPXJ3O]DOI
M*X4_$8AY4$?T!9$$G;7XCT^S=QQB%I,WFHZ>&Z^QS'4<5)T! YZ?S6[%]7*\
MUYP(3"#EPAR:MYOVUS*#>J@'K-+P0A/8BB!\3QJ=">,. ;+W>>:9#!S_]1S.
MA,["^Y".R.\",(ID*O\/D_RBW\69^R%K!T%6Z8O+7BCN5;)5(:(Y,95H_$PH
M?BG6UTAC%MVNAXGZF)^*RS/:CY0A:--6,II=XP<#F@)7$;2K&:C6QF3!+GV6
MK<0=(R\:6%_J743KG[?4+6HE(!:_Y-#=\XE!OR?Z@%<&B:HN07,I5?.UV%_G
MS<0='OQ7OMC^/W6[=$DV\JV&\;Z=C:.+,_UFXL+_5X_/MEL709VZ3C69622]
M+DBT" (:RYS!!^!A;+?ZJ-_&&C<?=<##W36R;_+WW-/&[POB^)Y+L"CI5C_Z
MFOO [.]U2HZ*R=**D=??12<6868+0O7A$?,'&KP+3=UWP08@7E$,@AB['?PC
M:@M'K;L52ZI51.':H0SEP*6LE3TS>NLY[D:&]5"DG*#>OW@Z!5&,$&X]R5$A
M4&=C!:Z;*R1+C)TZMZHW%1N\!5G$SA9N/.7&@<? 'UF2H9PS_735P7L#S8B[
MEAI7;K_J_&5L'$Q%R'I#:PA4)FUX:LS'1&#%L"/@_HGNJ@8'/5EV8N]F\X1:
M";<:OOKW]NQU0W9S:RN:, E<A]%L<.*1NH3VQIS%/9/.*4T9:YTHQ*GGE!&
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M'J:3!P>+;= 6U2G.9NGZ74:I( [+U(<5I@FKA]N^S)X<1"$B.)J]T*(NL9X
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M!!$A7LH77*"IJ5%5=?J; B^O0GGB_=8L6S7QFMU602(Y\U6A_8K_=?'ULOU
MMSK"_X<]6%[TZY;0R@44#=%7(5]/F:_+4/JEK>$RR6*X<4#B@9=;;%;[L9D+
M>M5>Y*)8+:>73K85SB1X H"B^/X+J$?O.L7UE"P&CK#($N9)A1J8'MQ7;DYH
M@U+.+4.JT]%#I8] S4WS;J3__)YLH%2)9C\".\-E'HZ?1C4M:#TLA"\[N<3;
M;D??E_5)*U>PC:C:=!3/=PCZH_O?<V?= \9X%>7C3,8<6 LS1SB">XL'#$S]
M33S/DEZ&C!<N0TXJEB%JFF?4=CDV_B!X$4J'-PUJJ&]PC6S_$?8N,R:[=<X:
MHPJ2_P9^>&NTV@9I13^>B<7X+RR6TY(/)_I#CUBHM:@KPG.F4GQUXE5B5>=/
MIL"2)V(Z,"-S$4Z:^TM;!$!!B"?&MWL*N+1/?>&5L@/91[.T> H\V#)33)P/
M2[_#"2[]O9&CEK4[L2U@CO+6D>2K.]9V<9?&ER&^RY#T_BI2<E2,3M9]]5 E
M='&5$]5^;EW)CJ4UM97YY:VLQ-P"W/4:7);M!<$^M_.YG><&@X.)DR(AFOD:
MF ^+O3/%6W>2+%]Z_VMA6=)^5*EK-%%?O?04:2&>'3V"D=)K@9UY^E#&[5VF
M>$Y6+_*0 P[1R3MKE'R8:_!Y918SZX=%!Y;ZEYB\D=K7GCPW[92=;5D[M0QI
ME J^\-NQAO4O*]$)S7]!!2>#6^>H\R$ &KWP)_4."U'_ .?''!TZ)5#JGINH
MV*5Q<@.WU8;;BK4!]GL(K4%M!D3NP"$RE4)KYI;7,G\GT>IGM!X"]8Q4M<HN
M1Z23?+M!<X.5_=W1',GWF 2SGDJ;$*S=6MYOA0,5T !WE'OQE=>";AFX38EH
M"+U#G?<&UBC/MU!JZN[ ^^N](9A,>+P$?&8+UB@M5651 OV1D5&'/]>&O7+0
MT57@].!8OLQ*=3O1Y&5K2^FL=X:U9L,,C4WXK^)JUZ'5'O>C?AQVV5UT]H/Y
M!@9+B==LYE;BT!]\=:?D/G]4NUTMV3P2O.B!!=&W%8!67$FA?_2/?RW^N3N"
MRD=,ME(!]K#*KC_ZAN7>K5''COX'H)/D'X.KQFGZ7[65<&QZ243C;Z].7OXS
M_1U 1+^ YCD-N36P.V*X2@5'J0J:5\@"S<M=#\NO%.W)C)FCDC.6KMGB]OV;
M7?%O=(GEUL+#/ZN*AED;T^" !D/)E;OF<0R8O^I_O7@XOS:=+E^2JHR%]N:]
M "T-9=<ZR/DVWQ7X)2"^"IPK3Z32(W^\<7_58W\.:1[3]Z._G^\O$DD.^3<;
MA]-)J-!0E#<@F9%'>$_<<3BNPHC8B >*\XRO'T8G-A$X2JUIUY)&!VE"0A1Y
M#\$]$"_9'8U+9] %@F'IUCTY5F3_K:2QJDX<[IHSYN*NB2F1S(^,1G?5.$"T
MCCN?2A#S.O#Q5U[7* ];<5W=]:;KSY[:<O6_?UWB?T"SY[?!?RFVS**PA$6]
M%D0'/M:W[)G2S)E'D:@2T[9]R#NPOJ5C!<(@/)VI3^VGXMFR?9)VGX#M[V]6
M^>4Q-*9H""X9K@Y$]N!?CSW'$],G+SDP+95<H.V?RD<!V^EY'09YNM+?'>2*
MB2B.A*SI=^I[7,B-I=ZSTAK&A2!NE5K7'  (MBX?ZOL^G'/.<S3K7A RO!*@
M':C'/S,1VV;V0XUF,Y<AVX+'$ 0<B>^IN")XZ)9Y"")5+B@4H/MC3IP12CO0
MZREG]AW'[C-*J"V!!_DC7?OVGOG/,6BI.I[YMJA,5&LG']AK6P>:%48<: S0
MZEJ&S-/F8S=3]KO8SY!3D&S+:7*A(OYBP6._/WV6Y 90S((:ZC!#EXUU32?I
M0+?:/Y8A0Q41(S[!O9Q47+U$H !KG_0UUFEY9Q%)PME4K EOU(W2QR.]]+&M
MX[U=4(N[L8]L!E,A'!UUWEN2'@.&$UOX20I%S!9[3.0.O>;4A70>3:XL_RME
M(K5"[[D_U!</(+_R/%8^TAZ1&0T\@2\Q?3=T%02?4. >25@"JZ KYV1HVYKS
M+?DMQ%!+EI<\QZ!6<]5W@XS1A=L"AB(_[4*NP;V;8KW(+T"6X'RQP]/KA^Q1
MT#. 1!$K<#-,<9MDP1T0W%8MN67MOJ.^RLI@.5D&4/T(^))]0>>9U ;6*:9"
MV6U^+!._]3V/R:1JD[JOOTUZ^T@?M5*JASH'.KY:,*Q\3&(:C2JPUCC+Z*,=
M%ON,B&@2V>EGP?/\Q(<#0CGP7OD0S]4)<%7!K)MJ6J('^5>RPZKKM#?0ZSD(
M,I0X^3&YYF^?-H6HDT='74&%/-U3&K#QS,H)58256L<B",!VDN$V#<.W-!*"
MJXBQ]=CB"!MZ%#4RB".T4'Z#=5;0OP;/M3:2^=V^^1F_=0?3$_TSEB$S%5=Z
M?A_5G4I'W]3@"]Q.-(38S%M-^2EA"$;_:!@2MO_T)_J7:/HD7Q5TQEU%CRUP
MH<YO*2^QY]2&>+#0&'>9F=F)39M,@B%$W&DEJO:B\RF#_</P>"NU!E0T1M$"
MW[S;*??*M/J$R(,RH<F!-W.S3A\UN 0%&SHYY#,IO;7._QJ[_:P9&G=&RZY<
MGGWE:#AJZ2L5!;^B=H<VEQL\2-.X&L[CIR\HFU)R#3=%W\0Z:O/D6J)4=]B+
MN >:\=)./6QRN52LZ%X7T7KD:@Q'B2A%.3TXL2D%^:Z.,-MR@$&>E%:_JO3L
M*WTY8S4ROEBX/X<<VAZT>'*:POJ2RY]#H3]S=16;!+D?0YNJ/.;;^#Q:G07-
M=]3]H^J+OK^1!KPIEJ>6:1\-WA3L,K6"*_R5UN']E(*IDL[MB0L!F&XTRHO%
M]"5MK' =^IZ3IVQNS8]@*9C!-3MS1^V+D\<(J![\ AYXH'S5?$/O%F( XY\>
M&/4$V?S6T-]J2NTB,Q(P6C=P^L%J0P4./6$C<D]V<AL)RK%A!UNF<Q@#(P?J
MT2,B.ZE8S.I)R-O>YQ[Q.C*5D];^@D-F6EXP+'B;*^[DJ0E)CU?:ODUYAFG-
MF0D1X42&PJWCQD(-=JXP(G)NG[UQBMJZFKRB6.CV.N;<E5<#:2F^?78M!O-D
M.] KT&-I>\XH_1-MY3($::7WZ:-[]!\Q21DR I6K<'^V\]F[+K9IG)A&(<OG
MPMT>1._<1(],4P'ZAVPB%?9;YUS[.A1!/*[4"]3M7U_#JN@9&JN;92D&FK84
M(P^=7IU%%]+)-S6MI657[W&^'1KF:",^:Z*H]:N*TW2\UJW12&*3ZG\$?KF6
MG@S&B?79>?65\09K&FCCF*\W%%$,IL1@!'FH/R2!MU9*">5739^N'#F^1 L-
MHPTKTKGBXOR5CUZLG !\"322-K?R0A@#>&4EYM;];KM$B'0KOG\#%/G+L< A
MA)WDKE<.]M(WEA?;I9GJTW5W&N8S.-W2TCOB .YX_J-HH^ZF5#\)G0M:E1.^
M[.QZ:ZOU3=D YG@:9KS9+(8GQ+S7X7=$>O3IVSY;8R41JZV!7Y62S>DMZ8E'
MA^;SIF:!OC^*I[>5N%3>,&T*F,8M^C@Y;TYS*GP/];5[:B51+)QWR3>>.Q3Y
M:4HLI9W]B<DO+'G<,3C9Z \39!&1B!RWS+5I7N$LEG)1:5=+/Q]R[M[$8#XZ
MIYDZ"3H:9Q4@SRUZW5#,LD*%\B<;[K,(LA[OK2^R-QE@C^J'TY%@SLF@.?VB
M5#_\ F,FP7UX\BE^SDH\)5G\@5C'='$*QQM\GJVF5,CC#\2RWI8X.NV+&)SF
MXY8"V"^7:F>.&YY)AFR$.U@I%.KHHW@5-WM2ZUF*=$)-@N#5YU<^A'8IB54(
M4ZZ0?]91-S.U(X$KX1&?*_E_]">FV.:;!+%#NX-3<SS3QJ5[*M@_Q#[PH^QJ
M$V=H=ICN$TTKV#($,92[]^_FZF@I6&@EG664G. 90_'<5FL0[0T5]3ANCK#:
M@33/H.D7FM.%T,)@[8ZHC5G37D'+D!#0OJ?UU!*+^AU-:#D\XWR@+#W;IE'*
M$4_,V\3.!1K>_13VODRZ$B.NZ%IW0:2)T:?58>'6BB_]^XG[L?$"(DC12QB*
M#2N>U!;-ODI .Q\6<+^K[=[3IQ- (/.6ZK#8T_I]&XYK#23<<H"OT?U5Y\K=
M;=M?CK9+G/'BS/&)=;F&,5-$D?+5%H_]QP1/K'A$=(GMH>]WL[PI D9HGA+V
M>L=T*&M?L) E9 M$I@6'#6P:[ AR,1>:7AKIGGIS!T0W89'+)E%XY_WNG[WS
M@:.WQA #X-W3K<W;=%7QRFJDN5L#'@N&C"R.+'E)#BWF[/I9,ALC]JQ 8U0@
MMHM__76#?YN&%=T7D[!H->M>?"P9PH5)?Q6:?#??LW/_XXX5BU(N52[N<;T6
M-9F&1(6^Q_F@*!3O^3G)U5%O'X6"S)\N_9X]6LR*#I%(8^H>H=NJQAZ9>^U_
M?FT!KU_LQ^ )9 G]SJ'3JM$WO-0L1MIJ>6^ 08H'I-P@/9S!HGY+2+CM<5S8
MJOY'$OG7-G3^^7=W+Y\C',FF!(0RT)TWQ.Q/#]WPUXI':RE&OH5 5>NUO95*
M>K.31!NF3U,NDIQO9IBZ=PI2)1T(!%!Y,9*[[A2-0SC.Y=.VV)^^?B8WQ((A
M42;$3H&6R1:%<107FC^/0LH;DPX8[7/T)9F.<\=40:&-G)>I,!TKA HWKG3O
M/'#6XR]11J8%X1GB5F_@W<O=D)8X.HFIM,:XYZ:$%6=U'%)_-<M$D"5D1^2&
MFFL5$AR!6*6(VI,XNH!CYD0_XE,DRQ#(/;]U+$<KCH)KBSF?O!CEM39/QQ="
MIPBWY)=];M>+5)U6)D K?99V#_7'ZFI2T0ODHWK8[<+ \?- ^9CC#7)PWJFJ
M"K2'(MOGQ)'Q(M)J/B,]L.]^!^Q<>-9J/@ATOGYH$'W3?.J)A8((4KGG7Z1,
MW')/L^(PE:!.E5G ^9>.G8?SSR]1)VN'RYT*X=?FY-3,?C5Y=(DQ)+"Z+U=_
MAWHKH"*QM"1E&"9/LXED\1D4M.B1\>2JKS#;JV+I!(CH?SK3+]I 0W!H,S:+
MY.-=OFVG&#&UY.B0 L51N:Y%Y3[++E4^@RVFR-G?N_(V/*!U1=)TU3[,)[;7
MN81O?_V?^%6B](*!=-0\C^8TEZKY*A8_X:_ <(83%OC>YVM##=-LJU,I5'WB
M PE?X='!M7+C(4MF@\826'/8&.HGQ9S^N<4!5B7]G=)#:2$6(9"(2X^L)IA1
M0QZCB>)>38?UBE@:91+]U>@GVP2X'& PI%V=\=-F@1;:3WT<.KQU_-L!#/+0
M6P.Z;PMXF4$ Z / -6)UI-'BUDS(U$=-<V)HN_([]5GSL65(] =,7N A%Y["
M1Z(T!5#SOX%-=]$7'I.U(H-FFFN6(8=Q6;+PXV\?X+%]$K@5=*AQ2P@+$&2H
M3(CSW[:^?51U),U<S.,3T6!M]%^K@2YJ6O@[YTV>L]1Q!'_ZK8J2>P[_ICXF
M;Y?;9%5NPJD[43Q&*D<IXJ->IDS 2Z(R_]C[\O:]_VYM\3^D_1Z9E%9[\9F(
M+R=.GR\_"%\][;XM>' 9@CII_21[,'O4TBN!S/=ZN;=;UU^X"!*=(K/$^JW4
MR90LTO$S,;/RI:C#OD)/+_?G#=X!-5-BKQ9?5JQ5^I]=%:%V0./7V>%E"!Z\
M2.9:@'\D1_"+^'9HA&$+#-PD4^#B!'2QQ[<;GE[Q\Z?E4#[[!9@\["%ZM@SY
MS?9D:#%_Y?1;W9:&I62*W5<U7S5'5\9%(S=]?M,J;1[%LO%VZ"I6*6 C*]P>
M4A@?&>D\WC^>*\=1XY7^<4-!>0OWBQK"J,%YS";@+/O-3,+V,4;$V_\4%3;H
M:M!UPV *W)8L#N8]:#I@_WD#QBAT<0E'I(_7U@P).:[Q[[65K7>H7]*VD8SC
MC .#R6.TT-/QP/MQ%7W2;A^*[W[ T2O?<USE42AA*>R;O'UF.QBIT30&2\@G
M2$XUP."1('2RYX9CV:V"$SC\(I1(?JX*'YG(6Y^V#%$!/(7'@%7#Q7+ BQ6*
MV).>]OAT^S,DWA.K".*2Z&+3^PWN\LT<ZNJ!&!I3@T2M=%QWMY"SGLZ]/=M9
MN==RR]KI[)49H[$@-;W2I(,"M8+X4X"RJL^&<BC5*)20%Z0 PMO<^Y(BIE)#
M!TW8_JPAMLF-LRF.>3M6:ZO#A'Z"!DWTK>I6%0*3.J6:2\"$LVT5 RX[*9!+
M1ZQZK3H0]$A58#'%1I2:5F@%17+'&UM>&]-S]?G@-2&ZP&%[ZBN;#MMR56W1
M#R7EL';P,L2=]24A2D)+C'KEVLS]JXUFJW;3F5^UCZW75CXU].=GKM9&<%FI
M[E3SD!6<T"]^&>F J"?:.&JB@632W20W4N'N>KI-QQ\_3*A.:.EG10^-)21,
M=_1J>L X"[R,U!@$64.[<G.\M];!/ZTQ?M0J&VZ^[>W5/<PT(KJ R9/,N9S<
MS=T1,Y%F?4D-51QO!MFEYY3)K" :S93O&IOY^J^Q,PH3%,Q>8#=<+3X6XM-$
M1>,BW:_F3T9L3FP6(C27(6"1^]W/NOBL5"G_-@/*+?%.F[T0S,H,[X5Q*4!"
M1[.N[K5]3?#S(!KH5M)^EJSW=D<MP%OUJ*CN$_=Y1_?!Z#CK",#LG&+P1]7<
MK?>N'J1),8@N#4175R@G<!JL!:ZB__"WW1V??YT\@6T*=_<M@?7?^3YH6"=$
M,R<;PLE[!@).J'WG*K42J)R2[UF&>-V*@TG+GM8 ,_<=4*)TD8!_XN*SWG@-
MHS)UM.]ZW18^+=G1Q"67ZV'5G%!"7P=WW-V].3>_4A&O5(6*GITHR2Z6LV(7
M@Y<J0FG3+U9FGI&/_\Y11U;]9M</0K-1+K'*P8HS+V#A!X45"*N., <R'&ZN
MBG0Q?W1S@=B=&H7@;AEY=>*QI<Z,F.$1O%'(=)".K1TY5:+Y=\FK*1XCEL+]
MD6Q@<^NJMIX*83>Z)"%M>8R[L= T[*>K2R 1$[>7[_XNR#;5#']/XX* \?U]
M#R(<X5JM -+X2N$-7ZV\RERV/ZB7D/73W]\D8AD2#M=G+4/:[0HN9#I6:777
M3*1JH7@JFZONU_S',G^]ML5DL$=JAJ(+IEE)J?KP.#K4USKV.6NO7,2&IU,U
M$/TISL-&L]#H$&FULB7V1\KCTVT17?E),;6U30POLL@@S;%W<Q*%J;9]R5*8
MU6+%CEV7\SI^QO()*AD<"ROSY?GMB)'._==)!MX3@UN?/4W*M.$L:*@9MN@4
MS+@_D%BOJ!WDL;UX7%EF>5?H,[/KC5:U51782D"V^ZMASNJY^PXW-<,)XVRT
MVA=6Q^^PN;UZ9QH\4@[J'0K\Z?%76$DD*Z,#:%>J]ICO'^6LEB"ZA8LE2'RY
M2U=$L$EH+ G-_U1&_\K;:P+82;\&AYJT?MQ;G'-L&!XID2I5+<9")4?:',6G
MAV M6,R4Z^=9!CO>Q'V:.VXE4 \XQSU7 !Q/LPE#E',WJUX;NTVGU!!2/"73
M8HGD]/EH'\Y:DV7(AM ^Q?A($.#*N9>*^Z$AAB)')W!Z@&=$3]C7E;H B@_"
M][WI]2"@K"1*V120[FO\(\/_$RN-EDY31/:<*4-:;L:ST/-#RM#@\XH?6Z,(
M;\[5"3&55P2AIOE\^?<785_UP@ -.C07\9Y;^/O4L_O:NIIX !FO+&=?WW!Y
M&:(;WALG$0L4BV6$^;W[*-J]FC#UT.DA8R'1O'%S)\$IK$=(A8+QW,EW<.F)
MJR!Z?K:.S708:CO]P&AZU#IA*3*?;%A-^OT0O.6@6@1)/KJ)'H9%8*"D1#_2
M,J2JBA:AU>5!AF3PB$+CP'_PV==+9XN$U0&LN66("?_YI'5,,Y:4A2L(I2#'
M4A<#M.]\[47:VQ$:E#,#KI^MCF?0Y'3HT.NG6]$%V@K UQZ3?]+XO3G%ZE.G
M;ABV?B**RV[QKCCQY]F\YGXOLGU32.V.<IT2[3;8C0:T0VEK#*M\U[TPV]%U
M'+68TJ*OWDS;8[Z$U_7CL?GIEY5-KIE3G\(.66N%4(G4T/:FR?KA5?:1=*%R
MC=J/'7-@[LF'#?M!]V6(!I7/CU\\Y^A8,;M4)^:1KHK!UPZ&U;#V.ZL1W>DD
MSDC!IM-K#& @\3@87[GQ/"?3G("U!D^RJRP<IQ[8A;2\92H!^H])JR^E V/C
M^8%+\0)R[&C)^2-34V=SARBE#_FAJ"<&71RNM@ZM#N$=+D#MT]Z1MT.FD.@K
MA:N,7^?A@]<F_80ASN575?\Y)0RGGV.] 2]^SP: ;3]9:91W7V=E./C?9?28
MAHT_"$NABF7(^_V.ASFW-&$:>@B26. FA5TZ;:=JC%VDB:65NQLT__.3R]3#
M457A0]DCY?)6(A)>#6)_%&T[^6P@MJ^JU6>)I90>>V5/R"PM(KG$US%1,NB+
M=:[T6Q"YHYBF(Q$KM>Q**W][3!WRLY7H<"EZ33%E+N_OG681(%,X:O=S#L^M
M&-_PZ9..+785D <%7Y_=GE&Y;R^FCC\SU.KC4=07N!MY+O;L/UXBHXH^A.DR
M!-<XW&1@ZR<U,"!.#W-ARIG4S#-3@I7A-*8<PU$,/JV*@?S^B<]( ^AJ>-U\
M<<E/N<#4!AO*'^_K+^^!V0202PJ$+,9WVK:?Q):50Z-+K43$OZ!7]E_Q'G-I
MD;*E,#LBTQ*K@[_NB_BD2E@@9(]5!.-3Q58T9)P$)(P%UN1AZC5"X<E(<P)0
MXE;!P ]<>3V6F4N/$G#9I:H[CH.QJ5MJI'5![A0T?<K7. 41F[KX'GS&3:DT
M&8U"Q&KK$^\G8.URUEELWIF)@=+E8@Z/=WZJ6;-^9(6&'AR@AZCF@UYMOE2+
MQQ.)76,'J/(-W5:=IJ@;-=*2H,JZ)L!,%I&2MSX#SV4PY1$H4>5O]4UM.Y"P
M3H,T(E+IOB4K:(XFUZF$SF[YPZ-;GZO+U>:EBY3UYDN[*>(:)<*@_^5B3.LC
MAQFR-&C*-;&A.[HW 8?@'IYG_N60NT8W*_W8:CB"QL\OW]WF/Y9V"/"UQB%Z
M:RX-N$-.W!)/<1>^-W\J)V%C49W!C(5ER'U_EXNN%;_IG$L)9"9$.8.KQUNC
M=#]Y29-64Q@IB1&?J6&;V.IGKD],MSV?]&HTL5VC'IHWN0P9LBLM&JV33>AC
M$>VCT:M:_,^;IB ]6?1N45TK*<<U2M#Y>SDB.J)EFXM-/-"V,Z#X+TIJ8HL:
M9BA\^8+UJ+ "_+%)I+\:?@A"1Y+4JNG:_ON73GM?C8%R"?CH*A./K)]S:WS8
M1X6@/P^T%,(^S[S: N^FX4*H3"6<_GIR#@AR<<I,:>RS4S;"M1A:PWLPI<R:
MB9D3#YG,I='%98@M<Q&U="3R10",/]4N%ZE,9-]4MP5;L1BDSU.[.(WTQ;9%
M=2_^(MA)O?X#^':JF')Y\T7H$[ X5L)'?\8#NR7>IZ8$77.--ROE/LIT7M5_
M7KA>4!H.N*8?MFP=H:'1]:I]\XRCPT7:5JQ4Z6PZ0UQ5XKVA4PFHW+OCHM_Z
M_:E16/1VD3<'$#D^VS^@RFF3"N9"JZ71PTHL(MXD2$%M!B>[9MPNG+&^-V/F
MOY)QGM($%5Y['MF?$OBX2/FMT'MU3<&[QNJ9S?^_+8C_M_UOM-2NU7+PZ6'A
MH8.!>Y+55(8D&S3!5CP;B-ZH&G&1JW'T3(;W43F=?UI&HX;R3[^=52)Z4?)E
MR!^ZZ[;^ .C"(N2UX*HD=A3[D/?08-0PI_E7I7L1IW0'M!*PALZ[;7UP0T%7
M2R7;[U 93\WJJ2^AF[H66/2:34**WE(2319#YIJ!?\0EJ@PNBNS.3G<STR?A
M+7 <];;*O[TQ6O_:O>S@YICQV78%ZS,8M6"7BC??%.,\WH= T81*%,>/=LB3
MDFJI=SLB=#<T;>Y7G37?VIK/\4'4YQJV,>\5P'W$]D\++7AS&?7LM4LHUFZZ
M7:5$ =I.^1N@SZQXZ6Z[[A(Q!!ZN-ON?)JHUD_YG)\I%)K5(Q+9B!-F4-D_<
MO(2H='.*['?ULN-3V3))0^/L=;]9O/H'0PI=L.&U_T/G:=Q<@M] ^H(1*7 8
ML_<_(:86/'RFE0'"J7O_B[HY[4XN3]VY!_LW7O"2S^I760I5E@ZTCL-7B;8E
ML2HU/9X'_U[8$0T]<M1/:*LK-H*2WI9=K=]9F P!"$2RFCV0:==6OIT30>"
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M\3^EG?ZO+%9W#)U9_LKY:6\)ZCJYBTVJ?.2^(XGY9I8''A[NOHHKJD-TX*=
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M%=9*0!PJ,=&&5!U54S3;18$LYN7ZR]_$$6*42Q.:3G$Y JW+;+[6O6<QW//
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M2_!],(=B]YQ!SO27.;'2@4F 13D?+W6/\[R:A\OUBQB@$L5UVB2S4<\:JKJ
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M-I1&'-7[98UDP0%2:/M<4]/[Y388%XDUCC*XE","="J*QPO/_E#7M95PJ)$
MVP*\$T6&]Y7&1/[FS,578:$G%EW38,2!LI0$(+>;3@<B$1[(F7"GH,AMV!M<
M,(F7[GWBU8<(=74&+UU5D&8K4F_U[(PV9Y!+EB!62Q#+MI#U=FICQ"6(C]1N
M5"P^"#03;S'HP- 2!#F_07(XE 03A-M@$>2,*SMN6;28&:DMWM*H<;1:X'7Y
M9(YE.NFK,5_:Q@,,Z<"3L[Z.!J<UQS80,5BX!]\3J-F"SVU;@M@F8PG5([>S
MV4T1!8U4A_X 4..Y^UU=Y\X\;^9/S,/34C/NKPUT78@E'1OX$6-0M7#'N2.E
M41;,8TS;2%X[K+B@M7_L9G<B38^[R"G>\^W=Y>V<'S>L8#'TK7M>S\;!X^;8
MDPP,<7:=PQQ&\/PYT,FHG7AT<;+5E2&+YWT]Z'?GT\H#]#&8<OI<D2->H*51
M!U H/1C=KT8#<V/2%$"L:]#D*K7XOGEM)2JS/ZRYP&R1+9S^?L2?Z^D^U2Q)
M*3 %T=0_BF+&)J705&Q$/F!0^*++WU2S[ \RS%R@^"A6V73*-G#V C;5!7UC
M+$ZVN>:_ [M,3B(7 3O5OPJLG1C8*-&?'IBB.M=C?;!),5%3_HW,WFZ;6+XL
M1?SO/PTN/S%NW2OAJ?#.65+5[,G5?("[?(3)W>1 7.UO8WP)>$XUA)[W=(W^
M?+"EN1&$46DZV9$AB3'1K-.!K&0JXVT!(W#0<;F,E-<\5T@HQTOK=K1:ZQN,
M*N7+MW/YNHWZ90^U&.L',TE09<13L45>N,MXU67-"T(:G$QN.N=W3?O*_17)
M"R*)#*,]M_IOTCH?@W"S2LI[:R_?V-[)AZCB*\TUH^Q]N<GK\M0.;]Y[DT\4
M#CW7/04?T.3@T&@8=D.W9<DHT&'I<DPDX4H],W2!J1.":4RCW$??L]>_#!4W
M, (/ )<@9Z:=BI33:3W@]$)]9'B"$K7A=#3)#G'4DDMCL%\4W8LRGXIA,54^
M-U"!8A35!*8T0F=!0B%U:V)1VKI7QW#@,YA4D8P4DT_J$]J3 T3BF@+5.*W9
MB+(E\/E+D*S8H2&IHG/MY)G]A2H2M5U06C/^87>&TSM$OV*(KJXTGFN0]HF)
M;004%L&D,"PV#R<]JGXP9#6M92OFIMWM:I?C[]$#67[%(G3SF:[=@_.[HT,P
MD0^O5-?,5Y,7UB4_/?H9ATR7 0HEK-7D17YN:R+O!U(Q#UN'R0[GOS0T.6;)
M5=RS:\X^Y[<_LAY):%11^#-#,>E$7J]DB"6EC/AA>1'W'L<FQ4XU-3.33:EK
M_"9[:CX<Y]VJNTH["V^G!VJ)2H;ZZH9)N*95$GW)&(=:<>KMQ]M&-QR.,6U1
M@$B!''H5]HJTVL6NJ2$>H" N]LUFUQ7_/L*;/ZVBQ1O!.GNHEXMRAZ)]T04Z
M(*+_@?K7E6JI+C!K_6#6' WP*JK3L+&$B&GP>XE )DKI?-[SWI4_Z9;TY78U
MQ.[&G$+P?/IM$(53S9/G=TES;__A>G;$0P9F!&/?,KC;+FY?>"2Z/D&LBC-O
MJ.8OR,&U@RHO(UMG@\U(R_YN++\-)5_$3_('"M-6M!I)D00J@TG">HA)C0]6
M*@?I6]_:J+$9^6!UH<0?!&B]K(B*17* S8]G?L2%E&$F0XK")(<4@\?W'H<^
MDRJT*$$]P62R@2C3_XO:ROW8%J*0P8*MS%J%@[X<BX:A$^DN1-_SIJ^V_=Z6
M":=3_WB'80_M"Z>NRX,'THO9%Q:2<JNGID!!2SU%5$4M2&NW&LFQ4C=^RQV.
MAUD;6.M/]'\W.KCO#R&;.:L?*]9Q,_UQY-O^1OQU@T%^^_*!,:^NQR>?M8VT
M+T&,K<#$KG"WWD8/BD5V+J& "FUQ+XL^7.>14%UWF-M< S:L?^Y1\%%1F+G_
M%(=L2*F!E;E:Z][3C5&\UQ+SO_X7@8N_/#;7%[N\0, #XXRS-0OW)M%X(!H=
M9MW,/HW(F1[A)RJH+E^J1)+AKFNY9AU,.9G<5K)@@_.YX;C5KL"1=FSX0O_3
MF7];]2_CX'8H>;(,W*E1_4GZU^3$@NIO ER>!VW%T:LG;K/M1D<YI!I8V'GK
MP*[DT[O/([JXK$ JT%.:;'"*E3<4/A=1@5V$'>[SON'\*#^>R_L-B[9)/UOV
M5HM( -AP\E'+J0Q@ U)/@<<*<06RL[@L%07"L+9: %-5)WB>KD/1&-Z8GQ\F
M=PER,RQIHV"^,B(RN)CZ_)48;/KK=&SJ?25X6UU!P&1K>PAS)]8-:_5$895Q
MAVJ^BQ]F*19% -DE>:&$0_G4\NC% D!FSO[&RF9RS=XK);)(JNOBG^2@]IG7
MC<2O#$ 8T&G_*CNJD/!,0("OAR66W*UIJ<TO^;4??=*N,1AZLW3EO1W24_3I
M=;#D)<B_J+S[_CGA=Q1-\VBXVDT!UPF^1G*8$B!92.;]DL?]:RM3I;%XBNU9
MHS0%_WN$7*T9-*6GM*1A&<:LO-<1JZZKTTCJ8A[]G:C\T8IUZL%9] @ENJRT
M)GS83$]?V(INPG/MUX5ULL*:R)@Y 8ETO%2^!_XP;T@8CMTC(U-[JK*^G-2]
M@M?;AH;M1]LD+V@/U B37#3\+Q#R)=PV&/=[RTJ]2VJZM@NP)  BDX.QM+KY
M[O5S^5%8NT&Q+(95[I]/_\%Z[KP$X;-;0+75"OI@3.#, G5?/G4MB-@^'70S
MBF-T.0&@_DKFB$IVU'MW=[?82L!G?+;,LW.R&YZ89)0%8EL&7F7V)\U+^?CK
M*L%L^D_'RV?A>8K4NTP"DI,W08._-9&.P!&37(HXLO%4<"!9J+D$(4!D(DFY
MIF%^RFT] ?XZQM@H'O1:X3V&W#9DSB;Q;J&4EEM#KUX;AV[O7L55--=!$9\K
M,9T%T2EH^%HJV?U*\([???F5;Y@M]0D,UX;3TOLYX/GA80Y)5ZF%F'WE.-[Z
MAQ"'7H*T<!E-&^A3Z_7SH2E*&ZTI*UIHSKD*R8Q'M]82Q(^L*M-<O\]W@!#G
MP?(0@"0N4SR(8 0R\F1^N>',,#/$=)]AW-HV#KR/V%("QKW9%^[TGC\A@LFP
MQ/FPW3I'QCAZ6\$ZF:C"+?+:^H+._#F<JVL%,JC&,59!-)'+4D0P:],0M%<.
M<X9*>I=M4G[8\X)Z?G*\C#/;Y:K_]K\7!P';C2(HG9!*G#S;]HM\%[[/U4B&
M?; $@>TYJ6MZ^4S#OE,S:&26HKSK]A-?JM#45D3]&1F88_!&IZZO:I#E%:Q$
MA8P$-TKAQE#$!7CV:9UO00\T4C(6;Q+G8=@_"8,GM/9D_#;G@BB)(M-&)0*3
MI9\6?IL3"&RZ!:_]:X^OO0UV'HX/^I8?<BRZ9J0. WT8AX4OPK<+C,Z0KOZE
M(5596#SJ9_6#5P]H3]4O4M>92_$#]=S/V^S.=Y^T%,LPQDL0IK]+6:G1[:YM
M5QIFK98/5W<TG[!ZD[WZ<0AEHHH[&1:"I9XF>K5\2*U^_:K,EW<>03)#P'GE
M<%7(76AHB&?&?M\\)IU6^8>;060I#U>MS,!T57:]Y!KT?%;1JAVU&+ME"?+6
MJ_HM,_;GHRQ5Y@JTCJ-D,J;DF/QP:\N)WJ.J4-JO/"!6.(Q+?83&4&S])8/G
MIYE7DJDP,?QUXBI/\/OG:*%?'J%>C.QG3V&>+H;D_G;3C*E"TJ\'$V=_UK^(
MMJQT;;EIG^Z@S. Q\1-AKS1!(D,\YC-7>=CV1]X =6Y'F(PX/'C%1]-@J[.Q
MO"1E30=\:@DRWAGK<3;32K'6NM;UHDV1_*ZV6]Y?VIY:R,WHJ9?[##&I^9S*
M:W^@=G4M]W3PJ0U>,P^0>"#6K/7&WF *:D]N6#E]_UJ2F$/&C"Y!'D7X-J:_
M:(Y))W;")T!MM>C'^9J]6;CJ@)F+@;H+W/RS?R:1>_\^9E"X!"&#J-Y/F*P+
M:BP%,?0FGS^3U-9.ETYK8#M(MUHMHWP8"B46/OMBS<>)J[E6W/-'HEUUE3]@
MV.WT10PZ-+OZ*Z-6LTA32*M!8>&?;UA;[\[(] S^'S<^@)5/!G>>N@=LTZJ
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M#^[8ZFNJN%#,$4*J][1RKF4< VJ7]X? [P8YDFS)=8A)8W@R>TYI]ZK.ZN6
M<YO)MXUS8AJ92IH'*M_*W8_:<H07@E4$H[D$R3BZ*9SOOK6AS4BEF\072N>
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M^A ?XQE3((DPS[$W?'GL@\_RPB=+,.-70*YO\5)DD)&XZX<O5&:%:D,P2"]
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MO<;LX1(P?R524^JW?/D]N?]=<D+4'Z.3%!Y@]6,I[,2%^PZ?9_9;J;!Y+O7
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M/AF=V PW13?K+G2/$B1JQ%GOSVXI;JGO?UWX]=%\_7A\DC&T46 NORRZ1')
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M2VV00;R*(Y0MB9&]4>[E E1_M6!U9A0##/;UK",!$R-9_QD@>2('\V-D+_I
M*BRKMD$IP3'^1YB["\4[96X%U <[?&5Y2XV<8/\M<5FW$U/AH[@0IEFPA.,+
M)+KB?7-6KX3^J=BAP#Q#LM<BB++YWRX.W-4\G2N\AIA0@=!1"B!*?ORO[Y'M
M\3:C_7-GN_&_8Z,:I&B@IT6GM]GL_- 8_\43,=HTDCL.[!XQ;DY#J?C9E&+X
M7<3C(!&K+C51^%14^SNKWE@5P:2*%][CU2KPDOV#:=]].!FQ0!S&8RD65"XO
M]N[V% U:F>6_A*8A<.8UX(/9LI(/EQ>KT3V'>SFW?<6+"X@'=;A,MA.\2^+
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MR\0/=\HJ5=)FSE)&3?6\NHZZIBXT?]^PW4?>0KP0CE.XX*11_SI_LY-PE!?
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M%%6>6K2J,B-K4P8=:0D4UBD.KU!F2XKSD52B/3'@PS.^[<-'Q6R[PK8BA4;
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M)A];]PA.:=-)GN5,E=1$;KEUX>@!W&$U-=*8L&(XW^ZR%D3,H^/$/$JK6](
M0\]$%G2+Z_8E;D(YUJPMI+I!II/$U,B/K8['JHSDCA>JR7/0)O;3,=>VX'U!
MA 9Q_V! !!=<U2ZX"FU1(P 3LZ!SE ^]8&/&G@T)5P+;CF P."7:AMYP8?G%
MP F*5$'>FQSSF>MMLO;.HU\1#4*U7FBGB)C3?4DMM6(:5^\FF%6&45^/_2&&
M.LOW?/)\09<"L$7(X4I9@/PO:K1,C#-0TTW&+D)&H!FV?!%Q^ITXP@/\V(,
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MS<C2S;I>M/":MTP/HO)F)DJI\WYTRRQ3!X!B0I:'#'Q=#DUE42,<X8]<7CM
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MOBETBJJH-E$4^+DO0E*.IWW2HNI0YT4*0.G!5B.>LTGVR-G.)H0$D_2%PT
M_:N+^=W#.CXDD1)3;X78T+V+A(</1Q*.'Y&!T&]D'''!>$5&5&GHKD-ZDNA%
MR!]#AM8TO!LH ?[]^!9)S528*C)T4^$N(ZW 4OYKW4J8WH5YRND)^,(82P__
MW*Y()&.FFI?94M<4]A9@6P_?53$>J0RP2<SG&,=)V)(V,WLB <&!MB,>A1LB
MMDZMZSXMOT+@"- JSFQV5CLBN+C6J:02$DN!*R/?]Q]^5-IH9]9[XDY&?<<B
MY+F(L@BI0&%7#]#F=_G=P6E0A6Q;S%.B4.]>L/'Y(\'-([CX/[SUTZHK">!W
M$\NZ?H=<H"V4_00.C9#C9=LFNUD1L_MYNHKD#"*II_+?.[78&,6;A827&SJ3
M:O]2MYD'J(C( *=OU_)N=,?@.52N%!4O2_C;Q*8M0T$DBK@O%[[VY]B%[Z(Q
M$7!\ #?&X_QW3N-Y\2Q-10_L6O\G)7[@C?[H';PO^HB&8/;RVH+G\RGQ+#S
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M>\GKLU!==W=%(#F21A!,!FUK=1I*RZ1]JG0YM?O_=Z7H.;6)@0X_=I=4WD(
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MY)7';R[@K)T"J*$=TE)YA^E:5V.G2R]@"I+BHH[ V2D1OWK5-KB?'3R+@RE
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M?NQLN*E*NK076!R K3O\I35>)1CG"PF_"/%#(4Y$W8D)NC/C+@O4/ZTUD/@
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MG]"P+0*K:R%-#%O<84]0PP1\O]T0E\LBN9+A23YA9.KF-J,D><4VJ4H:&1^
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MHO_1H&\GY[]/!QC!]'D6?_(CGON,F2_"(F4S0JD."8]LSL:ONAXY7%XWF[X
M-J&]1.?&/C:5I7AD^3WA$H?E!#'(^3\VIQ,)Y_?">6^1#WBR*V+^BXJS2D@B
M;@%NHXC_!MP*A:Y?^@#0*KA=Z&_T$JT"1+[<0^'K;-!>7.^4)WF?S>X#0RGM
MI%D>#L+9#XBZ"OBCL#TGE)"_-,56C&H$)LD^!RY0[0W#QW^7714+,+_XR[!
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M&'NEK$KATG!R=4X@%7IO"1)!31LJ'.QJ_5;3 $5)M>[S>2)B HT<1M4N-C[
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M7FARJ*6V]&+H]E#?CZ]KM\W>-2;9'K:W&-9-I@2,<'M$Z0?.];8+>&S2,J'
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M75&&^_A$;;A(@1T=:4*CA#25\+?.#%RG1_S4B]I#=QX#SAJV5V/?U!A@!^+
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M83I[CNZ,W@.^)\S=E ?W8P86YKL_NP7JCQ^Y+ BSS6<IZDD_ZP]Y;DHCW8^
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MXYE''W<[,"?Z6*' $N!76X^,6"T+8LP+B3YQI1_TI5VW0>(8.AF]_N,_%W:
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M,H+F&>4%)ZO3[EI-IPN7@",<D>3/?91_0/(#MEBQ#-'L*+,V*KH3#H&2=%H
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M4#E=%IK%,D9 O5.]^VF!@/%J! .37]*K'4:IGE:U/L W&F@WNK9&[84@"4^
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M+;X^$B?>1SGU^(WRYY!WC6 #D:[(C3IML"][O8E"OE&-MH0YZ)^R30NKD?"
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MC3.;F;URJC/\/^-B[Z2/OBZ(FR3?>!5PMO]=I7K<$NBD\=D9@R&&G)+>T6@
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MBB0UU7^X2!NEBD<R6H .*J3M&NO><9[^=03*D--8'3OZQ^2-9.%'"'(_.^]
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M772656'?5HIO0W#6/$ZQ&45R,NUQZ8MH9?5ZH><I#=GK E@*M" 4)I/?9EX
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MT*',V$61,]Z@OMVVRM=#CWK5NG:669BC<^?+:6N@%QTO8E?>IFQXK_@2JTY
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M\Q06OET=[PCG'?8@(QIE?2Q"SSIRP)J2@7 ,%QVD!-H][D\6L5??8ZG#J%)
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M^2>+ D^FR;_!]JM\5!DH_4<QEB\:H5@W8 FZS14SJ,%O'5%&OGBN'6JQ!3]
MMOCET'"Y;.W^;'),(X<@PGX+?Q$.7V_JMW8DGA@?0,YY*;\T5K0,V9R'D$V]
MPCQJ7FOOF&KI)P/P B-JPF;@ETO0_U_IV.?A:19!RI9AMDIZC23/!F>65".
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M<;<=@I,L*@UG.JZUFQ]:-1?1^I?P^"4!T3L5($CY/CH5Y34-<;RAH<B6=K?
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M7)ND8 UW6L8X1)PTIJM20*'\"%G,V_=HAR"[1J29(>RY<<$CV23<CFIR^<?
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M6Y"J^K:K=^@FS.;06/(P&O5/TM%]OT_6T]9-@)2I3D>SG?^8WS$]IU"RITA
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M2X\)/3&33$5,N&5&6U"FA()NNE*56%.X:K"BQ.9\HH\8+%0*G]\D'*T9*EV
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M[^G)8K"*'G9QYQH\ <%C2BMWDH_$.ANUJ&2"+ T&YGB<5GQ8$B3SP>&$C4/
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MWQP,;XFY7Y<F%61C 9XJE2D_H3[6Y7BW[ ;C8P8Y2NR4JK4"+J 1NX,83[$
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MITPD0@5O3B1R/-G]3:B*UB6#>0X65O6*W-CJ-W:4+)MTJJ_\F!?AR6 +REL
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MY=4G,LFT;WMLJ"B4>T='0\0J&WK8LV?9MKQBM8X(S$AU::TO"$C80,:\TD0
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M?[+@>(H]#[15:;VO["G6O+]!?0U25*-J677IG@>1UY:J !QLQB3W^];[[K;
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M38I0[<N0J4VQ]@WSN17W5&PEJE7J(@&J'S4U_&2EWB'IX2L>FP1#*CW^8S"
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MJ98V<$0H%DKCPF73EZ5(AAR@:[N)U&74G!F)# MO;^IL&PBW7&"1^!79.^)
M[*&EOQFU!&^'!:,OZ;=%7$TAW8'4BU/56!/RCS448Q\O1RL!!/>SC,OY<]>
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ME/!I(H_91WUEMO7%VJ8E> /[E(A9[U @\Q*]6(:LM5];G1?0S1OKE!GR%*K
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M+DR508"KDY!D2^C/+WER+,R<3N()/YUD!S["N:WBL'(E#M2L7\.E?U),[MP
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MCA'ZNT[>H&N#VIAE".&'EY<(; #\'QAZC"ZX9YB4@:9$&'EAPM;G]:Z2"O4
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M.F[/8Y[[Q79TH%PD:3<Z\1#YY:*CJ]*,!^D]V*.5KJ7;C&M6IY"T%]XXV=+
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M<"),2Y!.LY<%0I'^<H.NT!WBVF;XP>(E2[-A0\.%K ]*F9((ECT,.ZIMW7T
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MUV<W-_4U*SDMSNKUVZ.W[^4J (=ER*_L3]=J6P:Y6HH#\/+@G3[OK,*N;V7
MN4IVNOXTFDB62GC?O'IZ\@6F!:8>VP&_+#]R_FPZ(7M:@O.6QO%KV;L__EVP
MD\+1EDQC+9@SM+&STM_0='V.7-Q*DY0\6=NJM68D*H%&HFI'$HC)1R<G3UX?
MY6H'\.@UX8FD[3;':7Y;L1(7F9*U ^Y_^I'.+7F=^;W?A(*1MUP1[1C<F$ZQ
MOTTC >'O/6Q"X[923'AX0#M6(.0C'QOZK(U.*=:2JU9$>V]^1P,IZ7246S1Q
MW/A-WH;(TMA#Q/!L(8DH?2'ZDEY]Y6N6O-&3>IP?O=+<8TT&[1>SOD,BD$9[
MOJWE",.4S@]G'\G0L+N$DOAN30I@R0G&#M>NGII6,B42 ?>_"_<>B FVPH6T
M489*]CC]B,NM-PMI*^VG6I'E:[RW_IF21;I.#+-3Y_+YGP[ZK%6Y@>W74J&*
MA(LB]U=.FK^<5%,8:Y8A_D![M:=AZI&G:2V$?B6,'^R;WY;5/)6;/27/H/!)
MG-J"D/Y#Q;U)X>'1<?,MH+_?1N$_%(*:6@*-?), #DLB3336"7[J:0<RYL"\
MR?;%E"^KISE\Z:67-_:&/]]*T:$6<Z2<X;<9-I<<VA[CF8VU0SF\1>FF'[EE
MN<W9WS&L9D(.T!;;&S^@X8"DS\JMP;O#J>5]%]-^CD3*.(,*<X*=)Z; . JI
M2==!HJNT+3B[1@)3"6R$(^47W=GH(D\_ZP,3X'=V4B/K]GF[%KUBG:94\<<6
M_?YRNNX^<EG4NW'EQ5;I 58XU)SU+2I2S)?J*B.HY;5#(6"5U@*<2=5\6> $
M%HW$2I%,!@N:Y5R"^UZX(;)F)1%6ETA,-:T>J H^O!0:-(]#+$-&#[QCC03"
M$FL=ZKMVWF?6 KX*N&F]P'WLL<?G2]B6)J6.^M'*Q_>F[D\FFO'$ J\I0S+'
M-+0&'43"RLAY=]-,[2>#.J5"DHL4U]PQ_NX<>$'I@;9+N<Q4<<GWCQMST('\
M"3C9TOZ1;4INFJUD)3'@$6\:MF9?V90Y$P;0I9]\ TX?+_G;2<#TGV>"ZU_O
M,46B7V4M5%.0'0NF#_\VRSU\HT-^("*2+2H0&+%-K7D_ \0*P#:Y?!K289*$
MA;<I5R@I>7XAPB*=-US0[S=<,_"=-;T,>3 1J-D>'Q8<>KTO\WL<V()!82Q3
MXZ5Y<XZ+T4+YY-T/>OJQ7%4R4X;QR-=I'[P3AS=/QX.+W!3D1?[YN],#_?1"
M=[VC5O-.AG"'VMJA&$IQS" CJ-?-Y7*#=Q_8*.\\P%*5/@F@VJO!/[___>;@
M0\0PB2FFV8A'>S>W6JBGXF&VRQ!BV(NBR\F]\GZ#>CA(9=08.(<N">K ;+2\
MXO2S449V&NC!"(=3934C3Z(2[!+HOU>)W_.D$MF/[*Y+X*XA6.0WX@Q][LW'
MM+>*?CTR,"/' N7[2P]R$NSCZ5)X)V_X8=LFK;UI7!^[>1=4IZBE(.70WK2B
M9T"ZBW@0KWDWK[[=QD%)J=F-8R9U)HT1DPG+D%VZ6(<:-^NAE,ZGRMV7!Y_?
M]<*QFZ:;!Z=3?<]FV*;%C]]L+A^O%3/!/TX/>\9N03"?#)564,G(%]9U6^2$
MW$"\W;PNV/;X>J;1B66(!4L79'/?6)<8E3?^N4!5B\:?]C8?#.U&J$,N+V'F
MY5C::\S^0RBJ1E?S/.HJ>X8];K!]77-NKUD#-M8O7('V+;JT*I&I(TL"S/K(
M>]Z-'%Z&M.F)Y;!)O&:MNN]H"@+>H3#Z[4-/&A5PF4SE2??U3$L:S:J*<RFL
MCJ/P2)GW>\.^2&Q0\<SP1B_&G+XH*>&,1?=ZFDZ76?^G]QT7$M>DT.2@3C'K
M^SKMU<-47Y&\@:%Y<ADRV:'"G[)3482LW>'C^6;!7T1-0S$[ S;%C%7K+$,>
MSF.P+.73\W'/9'Z!FW6QY_@K:<Z_,W=B?VYTYL@6;'A\1K[<:.3"W84Z@_0.
M6<PR9(,GZ@".GS1+Z\5<7H88M80L/;O 42XXBC+J4VKGC01_^PSUA[!D X)D
MHUW:.C_?K]3",4C:1-SQ:.O6G5C9A9CQVSN/@U7$8@FOE<:3")S]4(HSK3P:
M&08@OU1%. U4:]<VLJ3HO\HDBWE" =JD(8A":.P_=-SDEDI$!/(EEX*D:8(U
MIXZR9C\/36$X)"HEN*74*+=>/Q"&B90JUJG6.#58?.!$J)+(8CBWIV(FL?&H
MNG_S=K]8-JA&N=)>_E_9F,"^Y_M-._DRI##NO]I62.@@)U\/;[<,27>9OZ/V
MK6EE&I947'C I2W,#O=ZEJFC+I(;WOS,'+M@A9YEE1L>#?%.C7Y22XR$;VU4
M\+TQ#5&"YFHY,^+PDP/[4>&4T4B^3)WGKE]KGJN&?0]3<Z1*:17!O///QYS^
ME,"Y(GJYO>T^W:M_QG"9<,0U_P_9XX5(=C\Y3<R;L.XM5J=TYRQN\?+Q5ZZN
MFNI6=KBU_=Q(#%]I^*4>=X8=$=@#%GPPVOE[==U<G;981@S@#;JMG:M+3V?S
M!R\H.8:/.%.ZK]CI,#63;9K%E@WZ#K(Z7,"\4K]0WN*3E.J(&]VK8!9LZ8+<
M(6.\<GU:>6/Q>Z4I ')[QY3>NH1#O4B#$CG\DZ_^6X:<BX+1>\7PWI[';>78
M' ];DW#L=F36\'Q#7>&^QO:;Q4!GHY^80?\BDP:?Q?^]?]6:.#KBKCV0\JOK
M/":T]*D"'3V-!K%V'$N'44!R@UZY()'+/!(NY$:=?R@CSF$CNWP]@I,/U>L-
ML./94@W!'D/CCF.ANG,LZI#B8(-C?2VW!?X<))8' 8&&;O^]L)%P26'H/N_2
MZ??=4;8  0T=\UX?FG G7J?>1FL>I'+ZZF99QV'3-8(9OI20O-,NY$IG2S-3
M\O-KYF!!J+8(-*CLX'GF5Z]99X9/U)J7-TCDGTY^-/LRPN6E\)D\Q-]5G^N3
M'^JR$6QR?E?DO@]&5MEY ]]1[^35E>7H+6.(//><F@6LA@QP4A/]!]\;O8C_
M*9')1%T[/3G0 RH.3?&3CDP28Z"X<V/J4Z@^T3?>'B#BKN$-B=-;+&B_U>TO
MHP-T;LB8!?O.SF]PMJWA%@JD*,IH0EIA1Y!-$1V)'6:1,S.IDM>"ZY5DWQ%<
M'IQ,)GG_EN1<R7N_?_LXJ'RV1*4#-4U[:8>_01=)9"G?EIA;R_6[ER$-^C=I
M3]%Q4"[[F]>70,N@,GM.3"%K&LW#$K@_(Y;22Q$B-R__.=X,Z"V%DJ!O8=E'
MR$'EXY>E_/8CX"YU\EF61(G3=ZC^EIO7O$]JCVLF_H[L16/A>< .X"VLD#T_
MG^U+D=_\1]A/I4M_4U>&(J\[K>YL0I28!]C+<"0Y+D-.I7U1__-1B\"9'45!
M\8_)PF^1'LJF-Q\1'5/NHI^93AYECAD"+?3?T7G^(]"OC7.4X6KZ2$B:W#AU
MII\5"&7(P<3'DYYGK.4)]#%4N_1QR%;_SN-NWH!?#9P2%=1N[6P4:ACEB& F
M 2-FO,Q]14<NH7-["W9MG OIO._TQ3-F#&HU0:7+^-,QI^W8O=[[7M7^K\P]
M,#AU!Z.K]&]=D>@!@:,#F^.75/AVZ+.JBGS):VM%9XW^( 9*EQ/N--O7._4E
MU_P(^C'@W"D3VY_J<><@O)*KAZ3G!]CY4LG2?S[26HHO9Q?Q&^APER'U&MM;
M>F'WC\!_.CZ6(?UI4B^^J@!"MFS^=A3'7XISR W@T<)>D#MUPKIOU-CT/Z(]
M1X+V"%L%!K>;ZO]Y-M;PZ#9&1,/CQF4()9X)0O.EAT,?OBFQG)U4\"=JJ84M
M2W%[JE*B[G6OY\!=TU/\[RKU1+JWX^G3^?+NNO?TFX"$NN/3@YN0XH5;?**(
MK[#HJV@/4]V#9X.5\_*5GHIPX&Z6$:+0 Q8>GB:.#_QP52/(;\"%43Y5JS31
M]S:I&&LLM)\4\P5"*?K'<\&V6^VG,)?CZ0%,';N GC=6FP."(/4R-)!R,Y)N
M>62D/I7RCYTC_$$4_$-S\8_[UX[OP3AR&4(!*_]7WT=WS^HK:V3BX$[Z'*_P
MR=61UKFBH44HC?HMGMMR;?,3O!/-9EK=X:.87ES$,=Z^1;+2.9\[&73>^]C2
M.\=?('93 MC?[EOUQ!49)^:!V,1-7I;-.7RKOGGAPGFI]#&[CB<""$02]V@*
M_.[*?$["$&"[[>&</I>0P$T1=9T>>T'MQ;<0N0/O$&HWO^101 8Q\[S%28]"
ML_O^WCA1"YLY0M'[62N_FQN-5ZA+%PJW_VG5\6$4CY3*%;:]6P<&3ZR/.LGE
M"6B_B "N]S?^Q*_H1CTH^!:C /)BZHO>S">G2UAAV;AUG9MB$SJS24ZAX5D2
MT'O+P,9P]5REK"1$LY@DZY+5!U&Z"DST;1#77.GM%!JIN7%4P$EQ95,79?%C
MK-_A3U<U,MER](PC-[N5>>]U_3_=U8W>PO ^A:"V%=TKQBGFX[Z;;$^7!A^T
M.U/:1-T5KU0I;]3WIM3L!_9:X"V4HLC0OX=W^V)>G4,SM1NV#-GQ-<UF\YU<
M+I6I_%Y9WZ3WWF9V6\W\W"5W;;9E4#3J6D5.4/2I#U5WXB_,ON=*>/2>JO%;
MQ>U.7#)*I%AG]/7P@MIZ7X$"HK(,*</@L&5IE;/[UM9I2[J1-@L<_$]9GP49
M>:TBR'_(C '^*1=>=?#NC5OX]=TGM'JIQFO.J#5D/-9:.Q($_(G^&9??L2+S
MVB"8E# E1_^#^*O#2I;V+WQH0=X $#)._!Z^446%J;;8+LTR==GW@]:7&G1^
MD8'K4=\ES"/[W$N$KDO9&&+L/%CAL_7/)+7M!&0OX/\3%JQ5?GA3:Y4 !&2+
MLA_G7F5\7I\JPN!M- 4RA9WGPSO7;AU,I]3![#@I(,7[A=>;ZHS<ZCCY@H3:
M65L0$^@T_*R9/59+]E@8H/]WE;9^OZ,>G 2S(#+E(4="/Q[#31'4F?A;(#:E
MC[#!::X=<@$3W:T._0Q"GT7U#Y9,V[ $ N*$!1A]W'#(KI542'C$#P%:4? #
M"@%JVK2X?)Y*'+83A"R8@]T HMKR;6I\N)(SP99<,?\\!O55CU"W#-&3<:0_
M%LO#XAYTO)?).&P"*.8J[6J1(*:,(O:<PYHL0R WXG6"7#*&4/3P3\]&'Y8&
MD,/;=HF$K-GN&Z5/!X0[E5*><DIYQG)[EPK<--Z;*0 R[@3@>J26@)+\)Y@T
M9]P"BI8A-D4DMX- V\U2'\4 T,KCO\PM17RKNHOH#@V_3*:0"=F5;SSN&C_M
M5SH;/MU_W^=ZG;B[4H*C"AN?]^E,W8-KC]BY7++_K4BB2,9X^2"PO6L8!/,4
ME6R'//YY]R2O)L%.<GM?G-P.S)!<G?J]#$F0]S&4KMU<Q$H(>&"0PB62X(D.
M-=H'MO_CI$?,YZ?XPWTYA=<2PO]0+.AIC<ZRYB8B!=EGUE G;\"LX<RY"5S-
MX]+U3E&M=9(T?R(SL-BJ?-O+Z5&0C<A<AMSM$QZY\T^X**S;9A>1#+_%I]5
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MA+\,8<J#NS]&OK!VN*<B^)82C$;IN]Z?:X_$$^[%*$(<@K(]!QU<<T< TZ8
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MH#]Y2.^4M(.8_>,=C?W,D(09K_2$3+L/"P)Z'5)<69[Y(_T7CP$MIN !U.M
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MX@EA]:Y02EZ0;MJCM;JI8AA1(K-OJKYPYJ4V&UI 7:,^8D_D]#9\Z+MWM>6
MR)$;Q)0*)#IY>TK*\AX20E'EI<M?OIR(LH[EI&)@4I9CSO$H3>$26U3R7X"E
MZV-UC0JUW>RYMU3A5_WW1*%IJ%3A]U$D74[Y1? :;.S)]FI:G&IO#0EC&<95
MI3R'^[3X#Z010^:Y\AC Y.[V10A*S)XW&U5C=6&+*<:U5N47/FZD$3ERV"JJ
M=C"_W<3W4MLJ',P]O2.>.TH*3CM#^TN"=^F&Y\-I864A]$@W%R^%%\F^;DI%
M-^&ZMF2U3X([EN!D%_&7X*A_?1/>1W3"X%35WX4T-#>E_YU["<G05B.O[#>)
MZS9Z)7^-I'F^D4;#:#(13!O?991V!E*(JIU6!52.H7Z_:C[VZK_<H920,_5>
M:92:Q(R^\$'C:8!9&/8ED.8RLIC.UD;)K5&,!8MERU!%9V\D_=,C2S8)6P2(
M:Y9^R&_SMQFB7504=;P=@QR98YG+,[$]V\[(D\LK(Q4E1\?2+56J;3.@'W]/
MTU[CH0<SN'=$5=28-.G36]5==<8;V+5%%DH0*1R@DISP9:-:/Q8.M\I9D]:!
M,FFDW\DN2ZXO*7DGE+I[C8[:/+C[&Y+WL:[\Y.IT#&^)!58(?8!TGUH8L9>Z
M@/-@OOW>FB(?QH)GJ23QTI]JOAK=LHF\%(-[=D=&SNB-&,/G(<=*4O1O_?^L
M+AP(]?!O?Z0<KEBS#=A%EWJM_OW79:VGR&\<7!*(\>SCLZ0I.VA'JY<&\=]-
M4>@D!7I!A7^VTH*K6<2-=348?'N;#T7,>-<3U)>[OCF\AM71H,@_/X7%)B9D
MF:YE%:)6,PC/E2!8,?8R+^3&4,X[V\ O-W_&JEXM@TOEK[T)_1HCU#D-Z/9%
MR@'J/,WC#VVWG_</2%+1J#E9:[0M8ZK%]P![-[TI$X$MAH8(83I?;GBYYY1)
M"H=FY%YX>^D)__O[04907_5( 2L#Z*K-K]_8$("U03)PL'-SY_DS:RHKA]5-
M)Z,@F(^RS6<'MBA!+[;] ;>DD0A<_!RQ[EW?>^AY/6,#BWD_PZ9J.50)RNZR
M3B/'UXB$2T#-9-M.9H_>^"<7F!86020'G^T=+.J^([=6[X!8RS$=W#13^YP-
MV&:^=%DJO[&E5/;A3A%GS4\IAX4GF@OH1+>MC<[N#D'D;H:JG@0F>6X(K7YX
M!F&_V:<CWTD0CC"2FCS(N1Q)6DT"YN16Y4&&)^4SEFRA%OKJ506Y/^]:?$__
MYE3UXA7O2W%,S?J;^;K1::3;;R$J@4>@0PR2MU00W0QK.HZ*N?3O\@^_;C3#
M"R[6Q* ZW$@XDCR1:;!:\6P6%3 )(W+/N5 H7 8>$8SL,FR&XXG_,.D,UMP'
M<_B0^MYQ0?;2+!H#T_6S]#J1/>[LDP!#QZQ,T!">\>J0CVM2G1QAV[^'<QE?
MGDBN7@'39WM,%2AW"VNA,1R+HRC(@'?$PTN[W?8^E]O[K]@-M[E?3%6"CFAJ
MQ; )#$)X%3$,#]-MOQP2PPUOJU6,"\?CQCM@0.BUN>BAY479/Q5-MO9I2Q!K
M#JL9W+USER!CE)8OH+]2L;'_FHYL-5(IB-56NA0"0@GR\G[:<Z5MPQP-\DH)
MFJ*"Y:A/KL@VYP.M-YVMS@=['S%J7ZYM4C0,/W3&6U$+F):\%7G@^#@A:2:,
M*1)QTTWPWH^FMQ0Y4":Z8I-$LAX8[%W%MAS$T4VI 9!6CDR:GMMH=*W$T5/
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M8?I!_KR*?,2L$F3R[=_!#82B2+$J"0;$-=U!410KK#4J>C<$ T.\J_^9=<[
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M5L>8REH#))Y.3O="IZEA"6 ZB\NEHNX82O8B5;7L@384EQN9-NBVSE+PEJL
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M[.8QE2"5R*K^OG-!_=K!Y$OV6AAT-!7:J'7H$CQ/@P@7\EP*ZB+^O97>8;D
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M&>^J84Q6T7:MG"2E*,ETT'1P*YHU$,"OE7S^HCFH6?M*<U[1J\V=>I#K\,Z
MM8T;H3X6:U))&[1I#?'Q/W#ZXT03=Z1!0M-;-P@?Z?BH$)]KYTP1\DIAR.OI
MY3E:Y![RTPN?F"5D\Z-O:%MN(.LA^N]([:^QRFP9WPO]/](7=4Y@C-2G_IT
MUF*V'8\_E9&!&0W^V#])T1+67B$)F.8C2K,Z=P:?>)O@V.^T0P<+,9._1C%,
M:B3@*S"^!Q_T37UX^1[A&TX^\!#^US*C!1_K)G84MDS.VY>MP6-UL,,!@MV]
M[D)R>@"EE)K7T6_PZ@7*D/6'@9ED^_:JP"SKSK12V:.)92M32%6'Y()Q.XBS
MSQ[NBQ]Q42\#]I#3X>1UE6N^#(W"#_Q37D6L4!$"V%G[A!/P;7/K^3/?8$J
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MS,0T\8=/<0_=%ELOM:$I69TZ6 H_-[I_\]D-:Y=(Y/ )3@5?]3>'7\H5MN&
MYVQ?E:;-16GD?Z+4K33Z0^V+9'>^JI1=>'+1O/YF[ILY1,1-6PU6-;WK!/KB
M$:4SU1Z;_,R69@Q\LW*+7G0\[!?5C#'%)>5CEZ9%@"N6K%ZY."?V%$?CA%.1
M1@("+*V*1PP_)(>Z'0B7HQG*NB;)CLLEO4^?HTJIWPJ4M?;F+N'JUS$#RF%"
MEL$1P.Z_],9]3V>Z@OM.253=456R;/3VO97Z8N@^4QIW3MB!I-O&-VG&$#&T
MH"N]W4T^IGJ-8L*93$8$WQ-CZQ]^/F]#\4\[7JA$R/UD]+FDJ&)'0.TL8\P8
M,LMM->.0XQ#20P?KAC3[L&R5^/V?GX<?QSD.#/SAFDH+EGB?ND>0.E:NFT10
MZ?%_:]=ZEKS-.[LU:/(CND!:IVV[<"6TYZ/%@'U BS?N6BV.]YF*V?):H&>/
M(7L0-5/$AY -'&YB<Q<2%\%N]B,-: AD/@*[@;P\.&[S)M(W%K+?4(7%3?E=
MS7EOWIEHVG=SX)X.MIL$+>)AAMAN94(50U/"#G^!F"#MN?G1W>CYO>):[CMJ
MM=RQZI84>9IZT?5RNA_CT%=RB1D@H])-!C3 1?27J^21L5[7B*;IBPY&W((
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M9ZTR$"N]&IJ:<G_*62F2O)E1?A*ELI^[;L_C -GGR?0(B\,J,R5XM_WX.EK
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M)KB!<'.[*'6/YE0O5"H<(KC(FHZK\/,D@F8;HJZT4 =;RJT^O2_O%!8R] I
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M%Y#]=3!Z\4K1_B_%N6_ZHM1[!@ F/U"1F@(N:(G[LROWUTFZYI,9E"JQ_"3
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M2.!TWCE(@-Z-'EC=UWNF?O#&)5LS^&0"3Z!@RB C+&X9ZHO,]9% %>Z0F*T
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M<KYAOTU1]"S&M4)MK8,%9#CN=$U^9;,E*!/#;RZ>QQHLKMUP)3_UKOM-7*0
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M/M""7WR=1(X+QJ%,6H8'XE3Z'!BE @_X93I.H!_,8U@PU>E[/KZ8'T0-7=1
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M5,56Z%FX*5-7&7A-HUU]RV>5Y2)16=-:MW%%F<3:*(VOC?,5;(IZDF B+K3
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MN]T]MRN]0.K+D[DT\*6N,DAJ5&&7N;N]T!5SP7I@)HL+%)Y[@=_BE2LS9["
M,6:Z^W)?S? +#N33 GD2-QXW>SW=CB"73TIN6'2C]&/OL+'L?"ZD+O9MW/UF
M,XC?H[:5$?&PMXW5?B&[:J#;B\Z67PIM@S+@T*&)S@<UH48,:*1LE?XCNT0M
M_:CR\%,73^..@J)H:_9.*8QTG.A:R4NB&3-!=;TL?_C7V5?UY@EWW+:_^2I)
M\0_@<I1V <UJC;L40^U5 1XGE='@3)CJ9$6TE[IXTOMY?1!3+"-RH-UZL9P^
M-;5\L5!5;0&?[ -#F0SF@P=\MZ_[45JOI&2J,1HK<@8[M/6EL?'Z)\.>V[2F
MN+4DNFPYLE%<9HB,P!U^)2;G[2[L]-OY/OY$H+^BW2/>VM)K]UIG9$75Y^ '
M$408PVB13RT"#1NW\K,E&N"6GRWG5&#-/)@RM\]E5*/;D'L0S5 ,/DSW_ $:
M3(@6[ZC_*N:;_)TROD?Z[5>H8AZ:6UL#!A5NO6R*RUH_  _^A?R;VCIZIA?3
ML#\P5G%>K#KM0M&MYN:?Z8^1:"JY%R?&@3@5M>R:/RA]]>RSSDMQJ"LF*SHF
M\(!MO74$@Q0=),< #\+:L/=';'(KS].UCAB>?SSC"U]90[\'7%R5'1@+&&FI
M0X_3"R&\&3E+FTN$N4=/LR:_%,TN8EU3 9M2AWNUV<_[%T%', !4"+K*:$^:
M\' KI9_QKA57.74J0N+:#'I>?M5AW9S]=9S1F, [NX)7^2<DZWM34MB8APEQ
M!3W5N3X4@;>;N!/OE+KAT;Z5=DZHPF[/8^40E1C/(=PSV-@'V"YM+ZJAPFG,
MO@4WJ=2.86F!YM#=W2\%81'H$Z7#VJZ[@Q\D+^),4BE<4#M^#U<9M:[8.Y_Z
M=87>"#8(5@..BTSY"#P0$7L9(<H810/B5N]%3R>4B^3MS\S8!!],0/<#8S5P
M$8S\GR]+>4D%3ONF=WOYQ4KN"5R49<VH;L^, W_TF@)*WZ,8R7[/N[?TWKDY
MT7^GR.AMI)(&<%(X-RXRDK$AO/N"2QI')-8:@IO9+NK7[0HAPG>66$LT<WI7
M5BW-G7G29UE1DCA8ZO^R3C$3-8!ZO26SK04T&VBK+%T<Q >C!XN3_ /[\^^\
M\=-V@-G*K]FUH(2T92<^B9ZMZ"\YZY1]:Y>&V>0W?I(V:7/HQK86XC=0WEXF
MLX"=.&BLY:(_6%7Q(^1\HQX#_83"Q=>^?R6VG]' 4P.O1@[<'<BO3M1('&GI
M[DJ,Q7YQWREE>*PV>]^UKHZ;I2C?-;:UV3Q^//F!+ <BT&!"2S2,/=^&Z-&9
M=!(9'>Z&#!T*6.5"1$2F[P0NSI:7T5893FTU%[JTRWCSM]#KA0 P%.7,<#_:
M,0$]YK=KE&I0]_%L)OYEN7*'M#BT@#" .P(X*H5 *Z$QBVCZ*EQHWIQV.N'^
MBT2(VM'?6R 0>_[5$ZT5,P-*+IIM<](XQRY?]9,E?!*1%.3'C8$1?@[- :Y4
M/P!>T= 09K\\_N:5P_.[MR%[.F;B,C/D&5)4+$ODZ'H2HQ'CY3HNN,\E+?>K
MT1F\0FY]N?RY"R*[C;4.)<>.XYAG<72% K\J"9/61KG&6J( .2?*_V/\%X_;
M6A$;7O JH((#^6O"L+C6XUH"GF$&WNIW;S7=)UT;)_)T["!^&CJCV_?UWML'
M5-6SJ28W.9 ]',A,?4_LS>+\+I%R#D2I&@S2AG$MC\Y&+WB?>]JGS3/AJ##T
MX(B^3,[\%WU(4M(<_"NL L\Z+M]J>V%;&*'NVS/]/NM':LG4Q>=-&H=&N:FF
M!Q8-+\__6YC'U'I01PPZ,?[#[6E%,M5O#"L@?M8BWQ-IG; (;U5C"4>T]@8I
M+8T,Z_+6GGQ0KS9V*R5&Z'IQ=;MP'&6\M]K!7,PKAT@&!1/(!AZA&]1?N+$B
M<"\'<HW"A2T8DW#P[#47Z9-=.>V/43[V+U(D0S+SH<B2X,3:DO?KX7XY<2;Q
MWYH)?+R@'TN>Q0;&/@ 8?%3))_WH1P,+#JWQH=-W1O;T-"DTK;%<M@\SCRWE
M!MGE6+WVG!9YS;-9D5ZP!ANGJ'HD.CW*9[LN[VM_N4$U:M>B_/RQM$A66>_J
MU]W='*@0[[X*J,1[[!E.].) >%B:WNA?R# 8XU$JR7LEGU:;:'D+>^2?H+DW
M(<>O-Y#G4 :K4.9YXP3=HISYDJ,O.Z_ #N/1W+2C$01G1$RDE$Q8]8S;&"_W
MCRZXAH^D'[X3(0IQ* 7:\\SF?UK$WDH&H3+NM%_O].5D97ZE!@>@AC;:E9CG
MARU%PKHV0M=$O0TI%2>.B^GS)8H,W1:]U0ULC6(VT>,$IH(27;6$V;5:!^RA
M]3JU3YF>M7**$KYPZ]H( 6JLL8$FP/X8KNLS>TJ8T<:2VGU*:T:J"T]'COUP
M$F[WF7R2*MKNLGV6G0D\(;RIDCQ.=,/ ]C@ESE\7C:G0^>JN*'Q$7SY]\F1U
MH<)(E[-9_MGT)S_K'+<4?"CY\T&RXRBR[P0IKEY-O+;[=:%594^ANZ:<\%1J
MOBX;^(&.XT <8>\LNW$Y\,Y ES,5Q6_#[_<5KK$##M70X#VP.,0NEN;O50V[
MWE4Q^<?OR+NNA_+)X=WM*#@#E@Z[E(NE9T\^+[SLLY3C&1EY-_N;79_O#^JF
M^;>I;3C277[.B]"JV8684R5RXRC;=AO5!8U>"5RZ3N@NLSA8&+,0>WM^Y!W+
MC^VR-<3US*=^ABT;MF*])Q=O?(O_9"_;A8G$3:%T+%@3N%BE.%0EZFVC&.NZ
MU:?.5[#G?:*9L-JN53HH3IK'_?7F>@J9>9,1K5^&:< 8_;XNM9CH0U4?U0Q6
M)]RP-//$U@V,!BQNBO]Q]A9>5!]<(&^ZDEU!DR]L8ML8C'_3B0,17D_=T&/5
M<N%TJQF*\9H) \/H2EQK.LV!3,AO^B#!0_9,R8+LOT5-DCC62VY6%KK$$N1
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M);C0:!+\!JY$S:+A([-?I1L_FSPT>6-YZK#YCMTEE=C8/"R!^?I6[:<0.96
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MK9G>];'L7=L&*F/^STC-<&3]XM"#G+/[WIRLED][JP$&]V^8?%XL%'LTR1)
MO6:RS#UDI3V<6EM#5JB(DE_8+R7/?6&>?JLK;(C ==^\/W/NJK)1F>=1S=S
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MZ(/ T7*Z6,J%GUD^V:B[3X^P#/0&@.QZUAOL3/D3<$W1JT-<]_D#QME_KXL
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M06VRP*;3?^*E;$A&&%?<6="&&L_P1G 2RNE6*2?XE5B?R^4OS/(E7(G:%$.
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M$4QBD<%#C\,==P>ZN,U><F]^OG#]+X0I9^V]'LH*O9H>*E.Z:>#P==-T6]>
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MD=\Y]YDKZFOY(UBMP\(5<HOV8+CN!)&H>Y+Z9P8E9%<T$E>JKQU0\%96O"Y
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MW^S2EWMN(O8:T9))OJ?E*B8UPT2D @\6-'-IL9WUE6E&?J5P9DAPF/6B62Q
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M/9=L8FR48HC5)[K20_&/;T@9W#'>^E)NTR+<Y(O/UZ8Q:KY88+)FCL1Y1_9
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M%MJ: J72'B!^9K';U>T2#$$*IX7*<KSQ%?@O//D_W?:H[*.;'ERQ4&R2V6#
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M4$<87V3JA]BSHU=00/"46>&IE<(/U_WZ]&85-6H15\L,=,5(;#9?'@? 1[P
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M<"KF.S-9XH[&%;;P,<P+10EBAY:O94289X^-$]GAD)$#M<'7+#L1<(LY^MX
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M)LES"\>+;"0B*/=D\#[\'?P<V=]V<M]#<^IZDYW@$0L=5\_CM;6OM8 6M%$
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MPXD$CI%:)SK!C"F1F080+N8I/+CL@,8FWNV2UL9K-*V A\I>N:2F"CA>U4C
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M    :6UA9V4Q+FIP9\RZ9U23X?<E&KH*BB"]*TU%0)'>8J$C((B&(D1$1(B
M2&^)@H+4" @H+=($1(A"(-(2.B)-B("$DM [)-1 "I/?S%USO]P/,_=_UZS[
M9IT/6>^SGF2?\YQ]]GZ3XW_'1,!9"Q-S$P +"PO@$?,%.)X W/[/N__2]9]-
M_JM[L!RW /A.L&MR1;"Q7 "P\K&P\;$<=P"D 0 6CO^Q /!_72RL;.P<G%PG
M3I[B9BZH/0M@96%C8V5GX^!@9V?>C6+>![#S<?"?OW:3\YRM&]<%?P&UUZD%
M)V1O_6@5M!LBR5U__#+ZY"DA81%1,7D%Q8N7+JMK:&IIZ^C>-C(V,34SM[AG
M?_\!R,'1R?V)QU//9U[> 8%!P2&A8>$Q;][&QKV+3TA+_Y"1F?7Q4W9A47')
ME]*R\J_5-:C:.O3/^H:V]H[.KNY?/;^'<7]'1L?^C>-G9N?F%Q:7EE=6R=L[
MNWO[!Y3#H__@8@&P_4_H_X^X^)BX6-G9V=BY_H.+A37D/POXV#G.7^/DOVG+
MY>9_[H+:ZQ,"MU(+?K2>E+UN1Q)\_'+HE)"<^HP\^3_0_CNR_S5@T?^OD/U/
M8/\W+CR AXV%63PV/@ 0P&!<+$P _!^)XE][ BB K;' ?RW,'$$5+'LR,%T6
MK@*NE<'MSQR%"1<!_R,@5V\XI@ ^<]G>M]O&F_RK9AUO%=$7J[W!(6#[OQF?
MI HS7YVZ6/C_<12S2\6FIUDI#/L]F<K9=;GA=+'P(X= 4JN) S%\Y_[H)I=/
MA8SRY"/RWNY7VW2KLKK,#87A/=9^ 5L[%F.!N_^;P<3P2BCANC% P(Z?RXYK
M#+YTP\,WB?=/#*V,Y=G_J:K_+T?24(3W[@T!.T^#JS:'NU\1*].>M._;QP"B
M\S&@'5@BAP-9:4QY8P'*>M^\7?Y=+NN1(P(,:Y>.#CK!<?E"CM(=4-4_@=J/
M>S)][MG55B=<U<U*"[,%$'<:/_<'.:TNF3</W&^*ASZAML_[WMPC!H!_J=*$
M9.^-;$1>FYWQJX(,7>@,U(\)',+3>ZR!P;__=1<4_!ZXW%^O)Y>Q1_V38_E@
M>,\+&H$80<=A#",%R(']?C-^"1A6,L?OM$K.]-DHA:/[CU[<3YM>-&&7*A)%
MFL;8:CTQ^!R].+FMD##SD"\I6G.)M@->JCD&L'-BXFPII=^2/=37AN@5 :A^
M_Z#K\P_-Q_H_)"'<HF'7Z".AB-FL6,R92-V?9-^"+^ IKX:HTCSYNK<2+Q]6
M%]_I,*GI%4O?SO5H/AUDWSI[Z5ZRTX?)\\JY*%C 2&3[IQ##]^QS5ZZM$0[O
MFV#>/MG^E6Y8( +OXX'6T@Y"NQEGU.E)AN*0K&RM9/UK9$^C[(%92\\<N^H_
M;N@0DXMWGA_]]"DN[[HA)[8<.$C1#MBW(*M\P)=&,R1I8/+'B08E,._RD<%&
MQWR*D+R+ Z<<^2 .HY3?SWC2\#[!VLY<Z\ET-FV04/*HA2]7VC;&&KFXXW@,
MB($;"B^_!$X W8X!$Y;K[[J%5XBG!?"ZO(?>U9*A'B<.7QM4E%/\C@%<%Z!=
M4@9D#OC;/1N.2"<*# FV^-[]A3)X9RAPXD-JBF83I,+L)E?,6+;E=(.5GO>>
M$PS$ZW7:8 'I Y,]$BMLXIT!;_ 1@4EB'ID5,TI9:=.,BPLQ VF3F'& [(5+
M3UI;#Q:;(YS)FG$S>;I1SAVZE2D9I1,F'OFKJX$)(JDFEGK7  #=8\!;[ON!
MN,-]]"&#QQL4;([5^!:ETI#S%[0PV#U(N<*[;DSB5$)L#":$ ^/]-BR_X6UB
M-21U#^XZGM-):I?O<XA,<C?P!W.X' -:>Z1K^O]6'@-.V*QCJ?:1IBB>WZHT
M2>*&L"TJDI_M2IPS?,&WHLN*0WIH2K1;\35X@!U,>NFWOE/:@$[!>A#PI3/-
MJ3*2IEVNO$/J:^KLK^N+Q>8_<O?X:G=&C9#8&*<VJ.<8PWS.Z#CHY7^AOJO+
M7[M+0N&VN$I5%X)(XN^$1?=&.1ZV,:PW2Z-2HWSM=-P*G=%<N/+LR=]:9VZ1
M%KGFD;]W+P*>I VKO>X,DZJEFM-8_R#/W1G%J(2RV31GT%"UC623=/:^I5<5
MXE-*:>'NHOM5X%E0$H8?^,:ZL?Q9=[>3W.C&9</WWUW#A@2X+M[Y5?I"/V
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MP=X!Z5<H\ X$CX[.QNKU;Y=?06^S.+W_Q=(K$4_[3GL+>HZ=S)KMLI4OC6,
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M%O/*0"GA.[SNUFE-(^/?E[-F"^N7<6:#92,_:';9Y1G9;D9FR?7V:L%U$\=
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MG]*G3;I0*.*4B.8"6G-]&MV,34!_![<#D[+MMQ $]!DWK8KQ;RTF$6H5GK[
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M[HOZ?[FMJ_=75R$XAU9BRIQS;*PSSK.%92X\7%$2^6=3-4'4+J+-YO".Y&7
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M+50M#7X%TT3* D7U^%C222KM(:#]&VYP:NKU#JHKY0%!EB31'K+/ +Q-,&8
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M'YI*P1$3<WCB'-BQI53), ?X7DE&FPI5$M)*DFXW1D!X5QV9=KH^$?/'LR;
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M0.2^CL7.$_<#!@ 71#4.^7O6D!9^9GOXA<QAL%O@5EB2P%(LD^U:+E ?$)\
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MV=[K>K*6D?N(>J_JUHQB?"=Y31A 3I^=FR_[XF88F//"!*35\OSZ4%!D ]L
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M*5.-3H;']&V5E07'QF$#[JFES[<B$<M/-+%W4R<%UU>&D:=B6:+AK?$<,HI
M7"W#'NIGY-C(>5SZ<6X=A-GI+>.WKLU>$#%(+1+ 8V*05_'3YE%H"UWY=D,S
M_""&75Y587 %N_SZD6C]W]N*:;/,C=6-8H^>LX^#\F84@WSWRN&25[%K4OF!
M]C& NR!(LYBU]$G%Z3.-4&$R-[W%_V1:X_YS1#ZD&" "!;KCL_.;O;@@@L--
MD 30#]_UICKU#?0&X^,043Q5[7W\HJZVTOA+\\7D<_2TM@UX<=8?RJ4_%KHJ
MS-.Y("MC55X8#S]B$"@!:'WB08YO [-H/.CU?==5]YSPI6[M/-=)K73"HZ3
MV;;<;#OH>N"L:/1;;JDXAO7GUJV<7%9S$J]KFB,P0Q.EKF@&30=?.%8XNT/1
M9WZ=C04-F%!N'O4E:4M;ICT<C.,]!E,1MH$=.3(/[ESL=I57D+-/+4Q/-68C
MS?*Z9"*L=7MR99Y#(TB%LN_#V#H5QBPXL;6Y D,A3_%(-Y=V#OPZ8^>;X?Q,
M8&9+2@[Z<R.(_FK\ V[E%3>U2="O9R(!F)2IA7\X.[PJ[I8-*X9YC<\5/^]-
M?/U1T:?W^%7(/Z:;W@9$>[W]DO6[/Q) M"&O"XSE(+\EE*4JHR9(01#BJ+#^
M2/6"0RDL];0#HZ1H<XI>L:P*#>[_B7S@F5@FY:.(",Y;5P0]SY#+N.4EL(<>
M@.P6K;Y- -L&]EXDSE?U=#T H!VW6<I-,WELFJ,OZW!.\7D0L.L?\X3F9#CX
MM^U200W4S6.R:DB'%T-P][]3[=&LP?A68?Z5<<8U*$%KGK-U]Q[>_#WSD.RK
MUG+US ]LH?_3VWUW?30FA3.'0')FUEU6[ZF$4M">+KTCKJ:K>X]NY^)"6$S[
M?;GWT#;7I][><[24-EG2W_!9_0#%?T:#SH[ (\8#V)@!3-M.PD+T M[UU,?F
MD*.!<&9$X+RI]4)$NNZQU)@M>_E!RPD2P'';X:T>UEX7122-?QEI>7*.(I%F
M]<7&I_<C0<_[=_G]5HP$OT+6& 28V\S/B-:.@']$*S!LUV]D#X]"*X$#CVJ_
M+(D3HN]\X]W*(%AD//.6FZAVX]XB_'X4++]7>='&F'>]7X$[J6<*Y_\ZEG3U
M5W(3(+-X%YQ4Q2@&V92F]+^?54N&XQ4UI(!4$RX0=N,IH )A\II>:\1TA*,(
M(^O(E=Z0V_ZMI8S,#<@9XJAX2]WH<,C?QB]&*W1<H(@QP5W<9R=_S-3@4Z2?
MTUD.3E[>^"_(RA[_DG9XA^JQKFA>O \(.#B^SB!5&-K8WK5WI*;Z 8I%NB2%
M=G.26_0PK:=(&G;AC6H]".041AH]&8N/#KDQ,M)TV(D7W<#TS5XGA/J?/!P8
M6!*LYRX!G*Q0GE!3"U3SJ$6BS&[8%8.='-DD0SWR7B42J7U* HCWV2RNQ;I.
M23HZV1DVV\*!.8JK)#!521,=IGVXQX2#99X#\7T%?B;<,H3! @JWC'H!58H4
M0+PIXCMU0<0"![> (K02N22P9WKZ:;/#J9W]T\21*X\!?+__VC4/,,1N=\<G
M979_!%8"P%U@Q".\LM+,H9P;BO#*NS2BDCZ/?4#LX[5U+6&[KEB*1B"P#"I'
M[J!ZF/%:4"?*!!3>$;<M5=/3#)3EL^MA\7H-(S*3U6BEYE#TX8/Y%Y4\IQ'%
M.]%8E/FHZT;N"<M@V.H%I)A')K"%?W^=0%^V.LT7(79.SU.!*UO6!UQ"@4,-
M@W2AKP)8ER,RB[ PJ#";-J=P6DOP7FA$QN]%&S5V61&F(!\Y/K4\6C^Z:+NF
M(=6_V\A+"?@=%'J!S0'W?KHEBU$UB ]%>]W@4W#V$41BG>YD5PDWW%@"*-LX
M;8*[V*/ I5_39.VA^"6O]BI5I7W^+X\;AW.J6N8S,+\,R4K#PT<"45ZB0?\S
M&H(*-S>#N5&VP$SKV^2U$.<JM:IZ^TY9X@WK"Q) #()%*[8Y]0:F;!C=S>O-
M!D'^RBL+)0!.SP$S]Q.N*NJ?SAK)%!>N8L%II?L<;Z[G[?)]TGSQG;%YB10P
MK)VZ5OG9K-W+IB+FC3-M:,H_I@*C&P)J*LK].6KRJ+4)41*]:->16CI"ID2M
M/:;]N)M,+H:*ZPQM.R^U=(%;%"_=[1;S<,$8Q,$=[=1]LM)\":!I8TLJ6)]V
M_4Y>*E#H(_;,VRY8!TH A4GS7TK<+A&\MU5!X7IUHH/,M?,=0@=77F6!EM:A
MG/4Q FOHP)T'^S/4HDP&+=Q?TT?#L!CY7P'-7Y)K$Z$^+\/OA0BX/]1_ATU7
MO]_:'[9>N"P!Y/A*XP2>)IQU=H7+Q)[E]J#6A))W5:E_R";&S(W\WF;17'SU
MK:?<$NU\_^Z*C: /B\-3\>!]&Y4Y=,?[7^$$S_B^SHRG.ZOB#IP[ZJ6C!7MZ
M<8,E+&?O7S]LX_2F%7@WCX@B!J&M?]N#Q[1E'2%R?:A26,)&]BHB(Z%)$?=,
M5O^/5"&L[<SF#8?>#*S&)-ZVT8.7$>/K4^I,TJ'GJ$HB&P[J9[Q;9IS7<59"
M8IQ&8T5.86X-+'J8R@8_&ZZ/>%F;=7.L,-7S5H,;["ASY+_3Q,?CSVU<GV4,
MWA8])6DU;$5HQ6%YG(&$_21$P:00@X3WHJ-%N025G?% /8;X6;!>9X@$<*LM
M@;Y8+ $(O2(VHE&LDJ-B[BNZ@$9G@8> YHV/C$00)*T68M8EOM7"N5*W:(S]
M316*:U.*.],^+KR@$5=P'*J!D7"76,K+(7#-/'5)P%WSYP5#]TZ =4Z*O1_/
M;L+;0E*C4)?M*8C[/T]_^-_Q/R_.M(,?XGBG)J@BB -6N 5S%A+#)[01GHB'
M$&L.=3@^NX#&E?.&.P4P^C"D4!*'7R! 'A;!I _Y5$KOP] V%Q([=TI_X[@$
M\#3QB^ERRZM-(BGU"#VYML%20<#M(\]OPECVS[V4@SPTLZAEA20.2V;_#W:+
ME?8D1,S#L9M/H.=]E@!NBW1',65GUE =\G\LM59;-G;HBM7Q!&$<BEWP,XUW
MZ"Z\PVDM+4<",(3G*^M) !B73:Y$85@0XHI97^D)M8$FK\("E#["LVE3V\QN
M/O1I.I/E40FFOO<R6Y&/Q)(+;W"/6]@]\2L&C[;H<Y;ER+S\B@/:O=8Y>W2'
M)E^N"V7!VH'KW["B":,P-^R<HUWINK\(.QOK/8>**^-_CN#\7<Y](,@X=OQ[
M3RM7M#")J(3"TT"TP;>Z1XF]X*F>3"#Y:!.V29QXX,_WE)>W$0V#CD.\Z_/0
M>R2]%V V-EOD)*6*^AU5L>9_7B[E"IQ0&?>H7EQKZ9HOXF=D$5IJ][=5*.=W
M;!;&9O0W^5K_O'LX#Q4#&P3\[#QK&:SKE-QS>K_:T>8U]3T^8BEL99B0/^+;
MZ$%\%3%HN,^7WF7EF)!X@#U]5?3>G:HN@NK5AW49<KO@N/.Q$L ,YLV<IU%;
ML]HW87,@ZGK:CN"$&SK3U^+Y7(<^)TNTI^;?BYK'<DP$+<T^R7'/UD2Q<Z5Q
MI](HM^N38^YJP_?HF9=]Z/2ZNZL!Q%69$D3\MZO%4RC J2S]#,(*JWJ\L<=6
M\<4)@IW4DH3]$8$Y8X@5?@)2$SW5=M;_M=V$3G3VMZ*L3V-]+G'G81BYI>-7
MHOJ3?.BLN"::^ <P 51M_-'@BG3OMI -E>RTSR:X#=B!<V\4"GJD$<V=F.#W
MF\AD/*!V[RR,VJ?>4!@:(>[V9B$@I:4FX=/FK.$D:BH]>O,+Q8D@TADO3L$X
M*?,CJ:"@>=C9Z\+)PJ(RG5Q$KG$7F+BY(#25-=*TNTY 4A8\J,!0*'L=ASH9
M$=$B<T =%$&!1A"0;&RU<;T8]*11 K@6 P<[$T#;(K!N-IKMI;O6F(<AJ9/-
M:Q,$3"1G[8_;^;[E*9U9*+&4&B1 +B4F?WV9JC<#/UR _6+N"FK>M"W.7J[@
M,:NWUF+P&25]&I.#G;6Z $S?82Q>98&WX%5)K _Q>'&KNC/".%M81:P$=W\)
M6,D>N<]\2!=D3 4%>I=5,$M?K+DSXR*6FR/ [17U1RD7%/<>GTI?FR]&E@DY
M5 RAU&3ZX<^_B0K4W'U4'AD5(=+,JYL\!PO^X=-'']Q.54IH8SF% +?,OZJ2
M .QM-DMB'1:<Z B]Z3F-6-6Z7Y)T(V<B(B3$\S<W;&'4%7YXRBYX0*?-3IA5
MR>E_=1WD/8BMA%VPPI/H]JD:[>:N>L7A1O+?H869W>+(N3V5?GNHR917F1_^
MQ@Z<WZK(@\J)HHV].T+4V2#]I%="?0HW@<F+8*YO-*'F#_N#'F2ON\S#S0.9
M'REAAP<*#4EGI(R)19,1PEBR^:3X ##LK<SSGPGQ'3IEYE>="$JQU-1_,J-:
M'K>$Z]>< D*IQ9B7^J1RCXM/%N+N2 !XJ:8TM)RC!##\=9IC]% ]Y#5XFN[;
M-H4*4:?,6]+*:MLP+^+ -5.UX@"O!*NO#/NNEQY2K+@6*X^$GXZ0:V<S38Z3
MNQ>W,74PGB0"@I >_4+4_;Q0,40=!DIT1"0.I\>O66>=FI[V/]T"*VE .0L7
M(5U(HS8)P+MM<*RNP8T$W<4KROU6V#1&J%ZHDP Z^BCS:0?,GFC?K/GY4@=7
M)EQ=-(/5<OWO87/E5*;UXMZQ>5 _?,-PWD]"C%HPSJ(]#7P=5P;EDY,BXM[#
M9BZGZE(.Z8R(9B)P*(SC"$<T75.7D^/55U:(<X^;)K?QM"=SDD9!?XB..'=0
M4Y-XU?*^0@[0-V%6NQ_^8XL*@OI+]\1S78TN2_'"',+>!+B*)3LJHO@7WAA3
M^]7,+[)G(G@2P.E[;X*P=[?RK2^DT=)Q5&:2G9-_;Q:<_JN,4U/3'.W)".D_
MR'-S#.S=T>@?-+6,]L!\7L^(-+-PMY)BAN".^<4$FU$7H;^[4_5/\SSC]C'Y
M8B8_-#SVTRFJZAV'0OC7'H?6A+^L9#BG1][ ^(T*>NW)LH_)VU5<;RQ_'7N@
M(L;.NA[1.?6UW&TL:0B#%E]H=G5E0N('O?TB*5SU_K,![V%_%?BLA;B$)P(D
MRBN/?VV'7T1=">\"K:C-BMM(P\$I/Y$YTLOQU1'80NN0[IA!>*6_]$2$X(>A
MS\;:IEO!\9.0Y?G9%*008[M78'9>!$GJFVY^ T4:CK#K>]<%69>L/Z@=]E$0
M+_KH@*_&(O>M?M;]A5CO;VGFCH_ "R/LW[I1J1I',1F7=>;<$:Q?0.8N0;JT
M\-_7F?411' ?*;\ [>9O<C+JT[Y(OMM:P#H+7726K41T;@F*+AK1HO<7T*).
MM;M25%K3UMY>>2R'_!<CUZ$4 #Z]9]+:M<4JDR!NCJ0+TRI \3_!PUMAB0,G
M'4$N[V<@>$#]U%IZRV\)X*N0S\&B'JTC#_KC<H:&X%*D7(<C,7;+%RI1S;<F
M#H<*S)J,0G+/L)29!O%GS2[B3@I)A&(KU.:-3S\0N&]J1!@S-+RIN(C'%J:G
M_,!F[?<#+]ELI@Z(7VR%!%XK>@&'SC];VL'2+WX,X6 QBPTWICZ2]&(*ZJY
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M'.VQ;7+0$"(!2(M6"]GK8H^2GI"AQQ%/;5)D7.D$59:0]Q=M_X3+&^<PCTL
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M'>8YC=JT=;;X3B:EX-JY:TEH<*#%=:]\ZF<<@G*CPF/NO9JYD#DN_0$'=I4
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M..QC<=>OL#+"&S&I'V6V8.6&#%/BGU#V:!ESW!O-X/G/K44P:PD-Y_ VA1+
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M_XO?QQ:HOB?!&L*'JD^'.V1:WW/,I_Q".L-:62/I.DS@V5]@>N[SB6^# 1+
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M7$[)A2\L:W6@.P0SG$TLG6S8^B4/J9?HZF>6W;SNI%_ZH\7_J 3@1">\:?A
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MAJV4Y2#N_?/[E 1 T&D!/GSZ5%9>7##]R]6[8SS?(TWPC0M[0VN__F,:.W2
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M1K'>]GQL9-6.,\4IF]II(&7!J7ZOW@2E;:W/0H10[-58*<!U"W"*P%SJ^G:
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MPFJE' 3/A,E'@7'GQU>FGH7PQ=7S%<LS4\# 4I/W;R6/>;+6W[6&8\5-R"+
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MG>BI2V;&ZF?.(XF-.:9'C:OE6#G?EUG.Q#*4'MW_[KR92LJ_/Q-4[\3,>^B
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M'$FRO^?)X<K'_*$2"-1+20ZJCZX;P71B.B#/CIB( -QGY?M:[JM$XG%]_UP
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M#'LV.G03*W47_6@XTQH197S3WM;-F+3*Z[Q5-.[+'(6L\XS-+00;,:V[6M]
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MYBW75C:=)P+L!^9P#@/W&=6))32:Z\0MRZ7$44F<:[OOI.%#18"MV3BWP<.
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MD4.]#.U 3^EIVPL;0=CIR_M$  FHO%.FRQ3$-H(^=X3?:/J.!LS91*'EHM*
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M6&A4DW9=W1>22H!EO_W.Y-D93W1A<10O<G9B>+A35NI1PSZ+9!^US9/=4T7
M6QD3,5* YYYV"##GY+2XSNI4>+47@(8>]6N6KPNM%3=)+-TZU]*OU[W,CP]
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M!3#P0$F&"2Q^ ,RHW)$T-<9E2$YIS!KN/MQEH[9=2\:IXA"R3;9:YM]:]WC
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MN8VF=FR:MJJUF?(R(,.J]J.PN5E-O[LUGY:)LZ&I*Z+![NVX):46UOH%]JA
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MUB<<8?2W,J2 8<*NV3'Y/B\;7XODO9@+P(<T>GO@49?B6EN3$G[IAQ*VK?;
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MT*4968)X+^"[*?>4G2&(4Y@F;+;'B%UPC!UIQ/!0WOG60OF;[5L_NJG'W@!
M4&BGK!M9#Y(WS)C.G#_7)8>B,! <EJ/>M*)1;#AB^9F2Y%H?J(5.,=XD_NL9
M21%6XL:$OPGT]KA+$P?TO.-&%J9)0>2< "R3\?OYX+N9OH\E>X;>YQP="5:)
M*Y>,X8J<P6;A,WP$050M*XM(>2F E)<>H/J]4TY>(B%,P*[A02T&$R4*DS!&
M'$<*T.LY*.*DK!#*9A_^*+RV0<+8VJ,HC@!,([S?+)_4_ZP?-VK2V]]Y/1YT
MI<G;"[S7N<(:QOHR\SJX1[QPN\:]JXM1[*@]J]TQN9WSI-WR[[ !'@6#>PY>
M)!U&SLU$*'?NF#4BKE8AZ<Q'>6]?*F)[L,@[T)-1,Z<G8\,O:N4H^YBB@(:F
MVY?5?0511<?.5:\4U VY.Z*"?&R#29<B%Y<>0Q3R1IE>W@S_W?Z,WI[M=AE*
MZYQ_C(N>\^H2OG&I'*LL]ZL_'I;C5(2,6DZ?U64*"8T:'J"MJH:JOQ,34^ /
M7JW!T_*"-&(BQS;Q_51+"%\G;PB%<9=UW*/"[I+C(6_N9:/'Q=!@S,;!DBVC
MF2&CPCYZ8%-@WW!"1@+SX].O6T_<7N:0NGU:'YIS*(B/'RY1'VMOHG2=[E^F
M'DM0E +0M39:&3JBJM=I[:Y*^I<, 7WRL+>&1P<T[3?=RMEH(!.?,YN Z'&=
M]#X9;=&.!P6>;/GP8:'V=89M8/6+_I5#*2XN<;5;FMQ)+23KBK\#7I&NVY_G
MY$9#P9P.*+1(7=[GU]7CS>R.!F[^S.NH#J>DPM +S7(]%EL_AP_HC/)Y(6]$
M%C#[^VS=K#NY<1WG.DF52W1)S&Z#DN<OK\ZXA[WXZAH4#:TKQ&:??*MP<8&F
MQ\X@V\=U4J2 0Q@_[GJ5/]>U=,4C.R[+7VE3L.41IM*2WWY>9SVI>-%7R3J6
M>TLQ?# *KX+Z<!-VF[,7%#^KI#-93"0"$U6]"F)NW>8]^A'(Z,HP^G7?(D&W
M'V7]OO;ZU5G'Z[JVP5"MN@%R/,$PM+HQ_$4C;Q=_"B8X5"F:81_KXWR^,=6J
M^3GTV2NQM<%O8<+1YK5'-M#]+5ITQ.38Q6*U9:HRV+UF:>SD#0OC,:6U)]RX
M^ZLF8_W$%K.?=+7.'T@QTGAVSTX*>++UX0-E<?A 0U4-PQ0<X,4V;=GYE>P3
MES/#RY\\'#Y\B>;%%[]/S:NN2[;*CCTU,&O5/']K\YZ8#:?77ES:<T:RVOD3
MEBOYF0Z<_]B-/QI?_N.PI^^,J1:"0_=Y(]F_][+'YT^5V],?]FR.[ .H3,(1
M=N(3XN193LT'3N%5"[?GN>^4R8,1+#):;@*G2SCP/'5SJJU0+Z GTSE^U)N-
ME255$GWDD$:-MIU!P2&T>B!F3]9P_@60A6@!,:1^0O%KJ=ED0+2\2!@^7%MN
MXF@@?FM0,.E7U4GPE21L"W2;/L5B!F#%<#1C4$Q<UW!_,(L8G][REKE0H7SY
MPN[TP5W_Z?_^/_^S>Q)9$R#*# Z7M,AXU2]5KGH2?*!EH5EQ)44*R BNA),^
M4"#< #0.M>H6XB41/I.ETR!EW!3'6#3]"N0=@XACD2&]W ;1=BG@V[E!XX;*
MF1U5D:&\#[*T4N7)5UH *V N#_P *98U*B&/O=J0*\D$*<"C!/;IW^^7Q V5
MM([_>G"UIDNJ!+ZK+>8%;C,^SS8>IBRQ4BGLGA.0;J(ZO!TW -T,GK[^5 K8
M!NX"S\@D[G^,^YG!4L +DD>\=YU%T^O+2CMVV;?;>CR>3@,G@6F+GT)KOP M
M#U#4=A[0:&EI"75=>)&;LZ';$O[)50'6TI+P%7FW8E?'IS//]EA5-K/-\&#:
MKV@QV@ WE/7Z;<4'_XX5KRL^461DXLVLN?*/.!T]ET;&$)?.81P+FC78_ E
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MXP83[NM#WK. _!&XR@C2P;KAR1E>-^X=I'7\K2'>F8L_V_1BV3A*7TDGJ(\
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M'N2[9.54(YQBTZFEE%]%@:,@(WI"NLAL%.0QYG:6-61W\+QE=(P=?B)1T@2
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MLSHHWBR7_?+WO!<G$::77YF"8U]76C'KP^!M,)<'O@</WOBH4*J5."D4XW6
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MLC>?$1#=JPGPC44/H=GU3Q%X*5ZT/)3;*8KE=AE+(SXI)HDAV'MD>=0=_G_
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M[%.?)J6H]TW+GCOC+5RD^]+E\G-SQLRQ,U?::@+F;KKIO%X!)J[\@=U<1;&
M]8>2B0R@EC2+1FMA( I.AXWS^XM8SP>-Z1V,3:B6]0P(J;AV>JFV2Y])8*R1
M@>_:_SV,-CI_Z9YLO4/ K!W*6T^_T8M<GOE<O<05-*1L[JC:9>47J7HN)[.1
MJ__MBI8L=P8,O_R9WGY)%*-%_GJTMZ;QK43O7S$A V-BF.,?8_E VI"IRO.]
M(1QWU\$7X9WG/X>?C=98!D_^(N&+@W&UD,?#1<.M+;K%GZJ2S$=0^X/(67/]
MGK7COOO?Q7B-=GL7F5TUGVA,PL21-OBOW(&+M\*V 86W:GVXHN1"D$#%Y$9]
M]@T)Z6Y7RUBPNM0&9Z/@XR/8RO0^RFZ=,4V-$19^<S62(%9J[[$^BBA]X/OB
MRIWS_=^3-CY:QV,9IY4N9EU.PJR,L2/8<)L_Z^U6KZV]([L\#T=ZA&)(05MO
M;%_/&MDB>2]"HEGM^W&+?N?K;>9W;977<>]_YO-X,,S;PL3324^"XL&3UMN
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M,_5%E79H_X-L"^>  D1B\KXPW=PL$>T$P7$8]K=[= /?_&!XF8P+!&:)OGM
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M!9/6DFFM5^VA+0.:1>RK3_JO,[ZQ-S@!H=NIJG#HDKE/+1*@U'%<5^<+J-X
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MU9,FU^"'\@QE*!SQ-!:+7]:8^<(\SD>[Z#>PE[P[EQL.UQXGT\[_MZ&L"AQ
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MO<1QB+Z6ZQ+'PPT41*91\&267K.DSO,*>WA\*#=FH8[3WZPV%"M]M&<Q0Y-
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M+3YE<":A;[/C^&*@+=ESS+:NGJ1=N^B<X"*>_;2QU<%Q23K60X)1S)&DB?Z
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ME1'91\DJEQ[4R<W8T45,@1 6-+LV*3IH^,)%*)I OU+7.3BK3M!I,[<W"E!
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MN]L'1-Z_F%]>\X1,4TCRW*!V[9CDY:J/C7R2#@Y0=I][=K^\QB+ Z6?QV18
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M%'XY"$1Z#S^&A"L!78'MHZ!$]"O@I@:%OO6:J[7G'\\GY SF+\9FP-FXI($
M4A7XYVX$S /%08*2<STD6X2"@7N2423=@%"DE\)N;HP2[Z(^3\64"%/F=\73
M-Y1-T$*65,?=#P6VC^JDZ,5OW19TY?CJ@F'P/S<$-PRM&7P8KV=^/2L-910@
MBL6;H4*GP#LR*4B1I-6_9GF>3CM"R%IC3W"4?=3V0NC]]D.@X9>-Q/:)G,%J
M9W?@SSSS^Q?!@HE+--^76?FD>%CJEJF +5!\H)X4F"%P<V>J)5;3?ZLN1%9T
M7L]VI+9E*RX@N_DZI?E^]S=_4+<R:0:693D YO)%QTW]_:(*O$327(P7?"+5
MD)^QBAVO%,MFC;71Y MNXLT*-3_TGP-*'VT'G.)1F11%$L-XJ.A&U=-UBLP8
M28"_HB$D[_&/^MJ/;+2.<M7#\EHA019^-[S<^K&XOM1=TCRFST^76$P<F2Y$
M#:;ND[L.=HD/*3T@G#V*#5H8M/L.7I/8"F)8CQ?]7%;#Q ,M'-%\./EDN"/O
M<3W-K8/P:;F#>G(4;&'%API0J"(JPA9_[<&H "'1+70"&/< %3?/YE=_%"^*
M7R-T+1K)S:9-&^Y!8F^]I^%>T(8@'_W@H>,&B*YE&A'DY_$?$EY@8#CC^033
MCAQFU>?+CQ1/J8"?#Z9QN5FLBODI1LB5E5V*X"EKT)8[N !YXN(C%=H!PGGS
M>WT>Q&83996VL7M,G1>B*$_<I=?P_[H/)GO2BQ(]*0-/UJIAS,'V%V&X!_9Y
M5,"U>9(W%9 ?10HX^_KY3C@)7>1\]C2D155YB8D@E-X%G8Y+VZN+YRH$;:IU
MK5IWU/#OY)5C[23ERZB 6]*A7)1?\[C7^,0E#_F#3G!M8NL5FT>1B[SXD?DE
MIIC"M*</3E*O&]#37%<^_^<8M0[#!^*<L0J+_5SZ-82V92-Z0J+Q6XZTTV6M
M,12$S96=[,!G^X#SF='C<(+E(GL8;&$.EJ#.M'<1CK3_=QF$(K=%[Z3\^-5.
ML/,R7>0SA(J= (;S*?,8ZQTT5!T0^EM=A*!2N#%QL^X7&=)!!3R/49SRT-O$
M+^G&^$D<L\O(W)@7/"A/E^- !Z9XVW2FA-P@P,61*RT/:^LPHXC%4_@S./;<
M=\&/K2%+'54$+XJ7Y8U0]9!Z*L 9%'^IP-@LN^,^[>F"'\+RUB\^M>Y32\$E
MU 6"4:>%P?.E;-X^RZIG&AH!'$D<S!$?H2N6-F!9RG"."&%R$<1H"R;=Q&F3
M[DYM&ZMT(<BUG8,!QJEVQR-B#OR!>R=CTW,6\2?PY@ ;5(87.-SX3?(X2K$1
MU%R=9$GA9,<[V10T&[WGO:)0>BM),$3Y8I+C2N3EWH K@W5N!T93VJ:$+9S[
MXB$&6+G6CJ(C)-K4O#7ZOCZ5&G\PN?. 6#U9\#7S,K3UD/LO^@I%\G^-%G,W
MFH1T,*\#><YH Y@M7G8VVE.N&?BT<NQV;9@ZKP];DD/P#K.&^KB2XO(8^0'N
MF')5ZJP6O9Z#AHZ:$+[MR?SZ=\%-@]\%T\+;3/#9NTJ:[*N&?"A'!BL^"XG_
M-(/@=O0K]<I -[H<NO6K-2 @[?MRI;2YB  %\9G\@ND2"QCAAOI-0B(5<.'*
MF:N]+1LU'<&"GE,![Y7?IYP,:?KE$]R7+G1@/FD(08_O/20::M,ZJT6*[O4M
M40%G2T\?=UD?S942H20:0L\",#+]AHR;#U3F)_N3R79&J8/'TNX%?'^*#$?Y
M$J22M=Q/"^K_';&%+21)7$K$)XT+9'E_[,)AENXY>X;?Y^79#+D2S$ETA[4Y
M@9R,IN"+G=\6@&$W+6-"Q;84AOHN9.>WT.V]^0)Y/5+\B$RI^&HS#?B5^"6_
MM5NI@! PA3_A4,NPGF^!)[2$@!;.^&O;'54G*H!V:.3.T[,BFM<IKWQP70))
M$0)%^1ZS.\*E6%])?#GXZPC0\DI00FU43AOANN)]_:(,$A]@9.GSSEV6D1UJ
M8-T>KKW$=V::;ZA%#;S _[S,-0+F)MD 8QQQ5_-P8"/EZ)8X@?[\E]#@OY^N
MIV'8?BL4<5ZN/XGNLJ8,4!A=+$"5:S]M>%26M#\XNASVF;&S[^<?BP47F4F)
MTO_P.?8.4!T.\MPA5N?5(&NG.4H@::-IL;D0*N N)(@"BT<Q4WZ!JMCC/">H
M@$[@!1(7<K;K3F^*[1_RMW?A$707'P;07IW5$IU1Y<%U+:ZU]TN(<[7EL(P$
MRQ2VEE1H.#AXT'J)Q%V^'L'!2R[%C>(7_AD8[0R;-)<H"U;)W41?DV.UC.?M
MG+:HT7G9^L0.K)?^VE+M7!O-'#H[D?=?/STP1XLJ-".$87HI-Y@>)TY"<HZ]
M)(2@W/W?/%'QF/V[@6<V_"NKU!NF:QMW0Y<X;!(W02PL\)NF7"'20H2]1U/B
M+ TUNZ=K1TA4P )P#IY D2?=(NB[RJTE4&X3?-J'.KAT>DHV:^7CPQICB@+8
MLYX!W,]$T,#9[SP<VL>8ZPZ^VL).!;@$&^RM%(LW)V0O9MI)6ND7XYM<*LH4
M6MQW/H;)EP?PYJ(!JFI[< I]_)[WTKPE&8E>* !>:[D]*%KPZ]0P? $8.\7"
MK/,:2Q-=38S.9B&5 ::T?, EX'-GN_H*QGDBMJD Q*3&(A7 NW&S\)OCM:YR
M0LK"6H*<G6/#N8/:;_Z+SC_$GGKRH\%?9=4A51Y'Z!*RQ!M3O-YF"3PY(1L)
MVSH$"<BB_QCA_PV#RX!.HD@:.'CG_,5#)JR,GT/15L:5XZC<'[4'3=VK5B93
M&QRZO!,S5^\%8O V9PZZ0T[T@TS2+-[-7."Q>:K<T5'0Q)P9H9JRG_0QU/56
M6%8R+,P'S+$.PGG1D9@')K&^V73XMS;25N)8#V0H&^%T\ESW(\WIQ5^:-&'*
M -$CTX4HK!U.'Q^+6T7'M%R#YH)97.J,\]..Q?/=,NR/O.IA_D53T]W2:I8Q
MC>4VWL19)W]((X4^JQZR4RPP98%>A'2?*L<40'Q42345\4Q:$@B^BBY:9Q*^
MU/!WZ2>#M5%%BF]RHSZZ.UEX[5[<B4D/]N;::8RO#*?68Q/M :D[9TX&/]C(
MB/>#7F7K^!QX$@,B@T>0O_85?R=Q)'Y[YG7B1P6 HI>6MK'[;N"49P::+";_
M%Z<[:/%?#D_9& ECR_7K4AK$H$XHYG;.]9(U2$Y3(N4%?,C'(I..4Y'L#K]A
M*!/A*6)D]&%C^B5V@GA5HC\0]9OD^4\&2($G^\#MK&<*N6&#"K!-" FRQ"41
MY5S9U/GVR'.IQ020P9Y ]@Z*_T;-:D56]$J]4%>Y-&N"*/%?]Y4>C2#)[<6E
M"Q5UR4NFSK[GNY@_PF=Y6Z][!X4V;Q$>D%.K02SH#@.,1>!J+@RR=LQL-UT,
M=-]]3P/\W*DHU_86H0Q=-XN-&['NW/WRJJS:;=9W?Y;7WIW>K!#%J:6@VT^L
ML/ *["]@F8=LP RG)$G7CA<E.T%O<=#IA<ZH/)(*H2K(3;!N(D(74<8NSI$$
M_%U7^R/U37?KFNNM4(VE$- O.,YLE\!O&:V*OOX4@:59E EX[WYN2?(:HPI=
M"@U_&T+KK1!<J8?&V?8JJ S]1X+^-D'T*W__:YOM)XXS[*Y,.P[$CGK!NBWP
M4RAZL>YMDS_";J/E+HZ26MKNS]@NW%SU=O%M=X&N11)'<=O"VIV6U*7\%),X
MQU-[$,/HH^0XNZ8)LMY/8V.SF9NKJY;5]0V"?J&N-L.H1Z%\E"XPSA8\204L
M?QE1%=Q3UX?0!#]IV?\&;Z^[V/E3IQSX0CJ /3!VYK+.FWUIJ1BRP1FGH?<#
M1EF7%RQJ53=7-0__S1!FSLN4ZO'\C3A^W/YMP&<4F+B,PKI3 1>I !(M(;/8
M#<[<<E4>N2 98RI;QV9=FPH3KV8[IJV.[J.]/@U@LT.<BZ*I"94)UICXEV)P
M>M,\+[I^I>>(D;^2%&0MKUE-<0IFV5A+5W9^R=DRI@(LN82(>8H;MG(5S/'-
M&VV-P4]2HB9',TBQN^" 0U\E!]?.W$_)=56N ^(;00>@7LEO)XQ$G9E-RWF<
MB2+OWF.9NFB;._?,UK 5OE<BMJ'8.70+ZL_%N;\@&L*S/KG?81L63P\ 9^$&
M/7T-,O+V :_Q+>PF4&3)^2 / [Y.7C&"_A(3PU:==6\WONH#L_'<SIT'5(#6
M![K^3NA1/RQO=YN]$/IVM,V>TT/#*&T"M-TGGJMK'@U\F<A]7H<O?/1HHT8D
M?C@E;BFEJBKEN'9<4[YF?ZBW0+?#S#)FS7\UMG)D2K%>>W6GZG!E+9 *0&U?
M'>=2\=NEG$<$_!8!^8E]X3RQ5.0@@\A^,G1"Y^^9)N0[UUCJ>/H0)\<CH0P_
M6@^/3RF?!-E2TL5SD7V[@N(UQY:;WF:9R?&Y*%:/[9S95]AC:9<5Z>+;O#)=
M\QRGF&S"@>&>'Q[NQ1Y9XR)+K/TPP7DW=<G<6]U"K.@70&> CJ?1,F^;HTOQ
M-.-@D!LJ F-Y:N3J433_M+I"62P-<_U1]U/F'RQ^2G0<G4H;MD<FKE/2@>MY
M$G:@7RN-;QP%_-D.W:O>G)2CQP?7;/ _R,GHA3I>I;W\J?3M+>)3$A#G'!DW
M(JOL'TUR7Q)7]XNK-;875>/U7>"^QA7G)[>?#ZH DKACK[^'3!OAW=.Y7QI%
MY]SC)WM]=2")8A.G\BB7/NRUX]_O?9H3P.UB*_8L%SO>5:G")Y5!T20#R/52
M[FW@BXEG]Z5&&1.:'#&_/<Z<<HX4)'4!3!!"=#V7N&A+&.W\+$BG"H.0KSA=
M*A4B*B>M[ZI,.Y>:HA=<$$*%*19IF_-_RU&U\!4O)/$L.[5U.[U)G%; N_!4
M40&,3)V Q&\WF:P'J8!(WG\*1('M[-TD.1,7*$D2,V)?@*V>;RQ"+TRCIJXX
M7CQ;=+!+(8[7#-K7^37IB#)?>AI%XH+MC=B\3@/BC)D2\!@.I522Q[(N"]P.
M/=W..LJVZ"Y7.&4_)>X'%H<M?/2>NT:./BNO2WV@ZZ['+?SD&I!S8_\=X6&4
M&#;T%K1<.^V6UJI9"/T#?E_:Q,<Q9"+Y"P5(^=/"-NK;!XFGJ.$D8R2^Q@BT
M_!@Z\M##_5[FZI7KKU8:Q"7+@#_DG#_;OW^+&E3_:>5X#9 @!.J<=9S2JR3G
M0#B@O]KNCES%)!CXC8=WW8H@8';8MW>) J0'!$EWQ.06G,,/=5/3,>E;B&$0
M\4/!9(*]?F;QEP\TQ7=K3/!)H2-NXJ_J35KF^X"27R24$0&BOD;:6T'XVJ@Y
MKRCFK]Z,[\]%#]#OQHUN*G[LNGE;):;H0K/77'X9 \//B4,PMM2YUKU^N_WB
M1?V7YSH?</9==@QE;=0)]!VL>9PZ4:XK/K*U6;9#]Y>IZU_'OZ[VW?B;4=E+
M\#A[E>'%9*.YC0GK^'SY ]&0]2_VLYGNYRU: OXU#U -;9T#C&;^:KE- +/_
M,M"\X^HT)N?+CF&7N+@TXN$R_"717B7GHCM^+D2]<V7W1V7=E[9N::T$GZWD
M*]#C3E&RJ ZN?Q3<\-1:3#)=WS)+:+J3[P,'Y3.I6#N-]Y!=HLY:3WZZH'I_
M%*?LVNMG*]S3E2;1T^A:@AF8BZ,"5(P(8L[M\^_FK[:(0CW[%A1^8@@AM-8=
M&<#M>&65-ZWUT=?O[0?">]$%D@3^"[LQB3^!=+5YY= Y\*'^XVF]CR$I9#/5
M9Q)>;=R^G5X9%+^SB,JH*:_?B[@/8]S,*-B7J'.S>U4=8GCAQ#-O<TX'N&)Y
M"#YC1-")@MB%XPBD9_4L>) M+:S/!Q_==D<HL"PI[K7, (C!]-.T2=:G7:<]
M^4-]OSQ/XGPAXM6Z0)#W>EK%D^/MO+S$#E:T9NW:852AG9V^,Z16^-J)>WWY
MIU)>.D'/ +Z<(^U?UIT(A.M^7Z%-5U @<^W#;W Q.AH&#>_7:MY!$^_+I.VL
M[UMH7)-"]"5[[2<PW<K);E83S=G+:A$:E74MQ!6F-;04E3R^]^5V=-6Y5*Z_
MM[75I(.&4B;MM%MF6UB0$,F#^AXY[531#OUJTZ8WA/R=#"J :2EQ=8O"L(K+
MP_\EK/JS@"]1Z)X2OM$6T8!=K0^'KO%<M)W4OGLC+HNI<1<,#/T-_JY-8L5H
M5'T?DX6%@RH5WLD)_90-3(\!+:I73#SWO.0_B5 NC>C9E%9$3<*F4/\:@_M1
M!NKB3IVW$24$C$Z";9\_POU4S$F\_7+/ZCG9^'<"W\\YQ/FA! DP*H".+70@
MD"=?'EB-BFIRP*7_TJV!(/EQ\%BY;FS6ZX495UY@QNS/K/WR!UV\)YWWWI4M
MFF"L)^6I "Q!W1T6T[>CE%\VFY&\X5XPVA.HIKH-Q22@'4$$Q8A?M19#4*-E
M]';' O3YHZ?8:A@K].\DGR;@%6#=Y-K%>W1?RT0EW\_CO(#;Q_E %NCH$FI[
M?$_P\:AVIM=S]FA2  SF':W HI.I7:LE7AW'#LARKD<U\9W%>R)H(?E2M"?(
MI=EPSOOB.G Q_9=';Q<A +? ']%%D[$_'P?"@>$$P3-5RD0WOTX%T*O?(61V
MWCSZ+9%F\3U8AA#AP;U?>2_^T;$ZMXZEF&7:ZXO:$XU"Q/)[$=7!(Q [3-,T
MI)>X'>W'_[5^5%<NWS2UQGI."CT_VGT";YO'V4N>*61Z.1T2B&@3S%XQG#;E
MY2I?L$"6(.0/1/6Y6AB C<.DJ\YK>-#1!F)V8=O-1+=@63(B6-AU"<9HQR,O
MFO^AH[!D C>SVJ;RZ+6MX5><MP),A"*B+AQ\D_P-M)#7(NB+,_H)8^TOT ]V
MK&U2:&]O7'3UYTLJYF+G^E3<#@AH6U.B9*,7,D#?G7])3F(66]+SH1/TLBI;
MT&_S3B$^%XOO.5ET*URS_8V@74;]V+!+O6T@OH D#;MNUQX'GDY[1MJ/F%06
M9F+LH0,B4_;]':&"V&"3_.&RI,J&[]V.2B9,WW9-S%4839T]6"Y$?!XV^WCO
M*AT"-%%NF?/J_WF/QO\C__,[/DNX(LYR;FU.@>"UD,BSL5M(0+?C3U?C8MJP
M:Q9.SV:8P[2-.]5$6V5W_P3A+6J;;(B@B%/6FI%N :NF+^:DUNF($,K7N+\M
MK;G(?KE=06'?E)3AP'.#4/^?#4SO#M>K44P;0QL3UX1TD(O=FD\  &?!L'NB
M4"=8U)X][/3P5)3>]&]R1DI<VL!PH.LL&/'Z5JI DHZV5% 8_=HTY@\5<+05
MM4<7+@MCUL)M!6I]*6^_);)1-*TIV#O#W'MC*"?($J8IZ53E4[32<& ];3^L
MGXXP:S^E-,!Y["D_YRMK*.7!FD4D3MRHN\KOR!U&?\OY[,F+TA%%@S2HFJ#$
MMQ0VDBI.[U*3X&+TH5D<K?'-;@!-&."EFE0XQ2"P@/6UH4J+AVES<J!_[6[_
M-_[4[>26\E[,4>U?!]<2IP-5#':?"LB1(6UI6KJ][UEP4*-4;XI:F66-F*2.
MF:=_I +L]#P@HNI[W@M,BZU=)X>E&B)*?4'+&7ZLTI_RDX=M7N8VU=6@ZBS'
MSL<(Y:,\_$*PD(-_$NU\E?5];'V*>%9$2AO^L'C\(:#DW@7E&(2P;$J*ZZO,
M:<C^V5,B]X6E-KW5+@$7]34%6:8\3SU>8E;&*<]\;F*BFN3*.O&G75'5LR9*
M#[2)%E_<?3ZVOBTH>-^].Y]H#%8@=.$YR:GJ=P(&EP8C[%G&^CL?-V[SA55X
M&IVF)M)AT')'S:RZ/?8CKNHQ6T>8'<DO0E,BQB%@%<RJ8^+ 4]!""NC[A9IM
MZW>@*M2[ZSN<M!5]L2FU][VY7#-=U[*8$U]9CE-8R7#U:P0Z_0@]'#@\6&F1
M:.-(#Z@9$7.$CM]G_" 0/L]'P_DB1'1J/5^CN7KX^$P5=J_*[EY]^N?HS_V!
MH=HAFS"95EX]02,(I49["4Y#<.@,=,PPBJ[^X:>F;BXLT%2^:*73QJEE.CIC
M:6UN9$Z'0_BN"\^Z.AUOHLM7M.&NLD0]D1%T:'%PXCM5@W_=H<AQP0XJ,X3$
M!?_(&JM\[YUC:;OZEX+\!_(R< >L[1@<IP?[HSC]F1T/Q;D^E*I(7J Y4H?4
MA,88:_BOHYD[)21(!Y!^I)I8^I'/0<2_.T;&E#;\XVUT%>+MXH#/=SLIU9Q^
MR1983S[Z[#.+T%;_<\EK>&]<4V\@-F;-E?0H[W#P"#7"(/*J49S(!QWW\C3Z
MTG.TYKKA[M;,U%=TQA*3T3@C%9OH'2SH)9IN>I []HXJ-HC3PJ*;[YB<"%IC
M/;;\.?\.>(7"[.+E$@K #:0O(N]>,$N8:*UZ%),'N/C&(4R-?"6PJIT%OL6G
M304$//BJ<<WNK2PC>2B/-UL86RGC_2E[VN,X,#KE)Q4@YJWUR^O],Z_$@H?]
M@4!&;B=ZXG1%."6$"E _R+_6Z9UT)V6L)-QD7,NV[MA!E J0;FZ:*#6^8O>'
M*XSN!_=H46[^F<]^_;^*SPLYVIYCIR*"%TPDI)OASB_9%9FX2.HX_U\&T@;L
MG3>YE0>R13XESZT^[>S5XN!^M@\:<&_UA?TQPEL-EW=0LG&9#VH;#E3GY2R>
MS;W$MIV$UJ]M]8<$:3X2*M+5E?/+K?:0@+NJS"380^(/MH)4IO^6CTY7#*SS
ML@XUB2(Z"J$PPRBCRO</M6FM+I6P"'&G# &4!H?P4_2WUEF\==9 :XFO0EE?
MQ$SHYTB(]P@VQKJ2MX:4^'XC)I0%7*;WT4NFXF^XN&Y ?')@/^L3KZ\'>M9X
MXD]S/N1N?OQ=EJQ=;-,NY.3)$;K'?7I,=J\JE#5&SVM"2B)(6P*&;O/-GJ+;
M/Y!O9G?P)R<\4L6L0G6T2-*'0OS<;H@*_$8?D3&T]R8BQK0S,*H-=!7V\TGE
M%RV$.VU%:OIKC_9>Q\<[#-I]8V<QR8.SC&P2=[]2'E[0CFBC=>>6*MR^(W$>
MQ7]XOJ' _,'[)WE_7F3;:/XH%9=OL+Z+2:Z0*592V#5*S_4.\FTIRQ^$(M\G
M2$>T&-X?1*C5;TWOR1OW^=$"$4#PP6BSKJ9-LJO$T\*&SDTBI'G^R.%N]JA)
MY282/?C56).5YEJ1(+_/@\%7SG-I,3GFR'31H!_Y\'F(J!M 9OXP-T88>=W2
M<]9^=V("'':!Q?CQ_S1X0I!?;HR1N8=EQ@SM&G=B;Z6<@:C^Q#=W [W?=@];
M2[7O7,_WI0) J, _N:D9NCX*\U_N3F$+T+>#,(;2JZ[S$((PRG1EGHO2 :]*
M3-S]-A9LC,MKSQB?,1$K5IO2X;&]]ZS=_:KWN178$3FE#71)'0BE,8C0Q]6]
M/YR]/C!K?KNN^K&8VU? .24UP*Y]MJ:*1-^.''[<'Y^")L#3X4D,]Y, =Y[D
M)="K.A0*UUUXYWQA;($**.5"(T"+%D+?1%5F3UV=UI-O]S3;>!S[.\OA@U2:
M>T)>8GIU+WAN+WWT9N+P?74:A,F$]N%#" I[YP?<P3>"%7&=2.[%=\4^^5-\
M]YX]N##"ZI650P7HX3=%RI&US;NG%\9K_7=A(_/%)Z/^9VD-18[TTZ]K&4,[
MPR[T>#M*?V'U9$GO>86U8O$.6'CF>X3RPDENHW RB\EM"(+@(OL[V5B.-]&]
MKM\?=],994#S5;V57E%2C\19EOE1T&)7IZ"-M:_+ EQUK.*R!C40M<NBP*LN
M;XRU:C/4,QU9[S.Z.D$\ 32)1\;?EFH=/MSAT&PEN>D)^:38EAMT'M=,@[UN
M:[*8A1EKL@#^PW_X#__A/_R'__ ?_L-_^ __X3_\?P[=E!ROQ"[UN?%N:-VO
MNHR+Z4'^B/6,M"I_"&VRAH<#X,NJW\/><']A@6C&L,"<9B]X30Q:;@FC51/J
M*EI+]UP3!H(!00M%L-KC=DGV^?46!G(X119ZH%V;.G+%2!/',TORR:T"](BX
M#1732FCW*I-%UQC1!'%_$@M#)Z?SOR[=+T)'F#48T@-L%E-[.TOJQ7X;-K8"
M;DPDE^0,%WN2$D^W8 _N9F_O.CO7DW6'P5W_SIS2B5"&E+4:J8!+$PCBY> 7
M51B:$^?'\-95B?8USWE)RO5KDX,<G3XGEC50'PIC/=$%FLLL_V]NXQ0YS\\\
M24,+#[RRFLK!_/'!S1-^7A YV%PKWZFJJKEL.YLLP;!S')='$7 _!8Z;LY(&
M2(IG>SQ;JDVCR7595 UH\>\D8[ WKC/"2YJ_H; "MWDZIL&E7+Z60G0: N17
M"$ Y41AQ47PN 24? 2EV@YUO\G,/$2@Q$$C'W^VYKL'AP*G=V'V[4BJGR2=F
MO"MMJF.^JKDYZ#+Q9PS))9/"<)NHD_C!HH4Y%J]%*/2E+W]DXK[V<WX]J=/.
MK!L#G/H,$!94M]H %[?<V.N@-.?^<;N9\![V;7:FC27%VDVJRQ/76)*F92K<
M?EYG*^&*967JI^HJ2[3T*,84[* B'%0;$I"'0&9C9@+-6;,A10_NK.Z(AW<9
M*4M2)/)33$87.3,HO;>W!,8N@>1?B_#FA$9"C$ /L:Q::D8&F=$UC)Q&9)G&
M<"K@D//*TV0_S1F&RIPX#H>#C>F)0J-4^='1RL:3.S:5C<,WC*V0I1O#5 "J
MI>I=XF+RYIS,B6KLDWCKN87MRL:*U,''MNV"R]$K@AC2G@F"+??HN-90@@I0
MDSVA C[7+^>B.VH3P:U_<HOST^DY \;Y;]VHO:I[ZLP]X;9YT"\5J::\(\8=
MD*)%&U+?_0*F5SG26#-R$,@7&/-5DN\=K-!VZGX(K\MR5[G_=Z7!#8(9;-I:
M244+6>BY48>=J"<US0Q=\6ZT \GNQ"N+Y,[_^=%K;Z.CYI"A ,R00B!GJ[)+
MI:4.Z01S/FT3U=X,:<:(Q/=/_Y3BOM[=]8TQ=2,G8&,S9$N=7FY#8&;#L?9D
M@SBH K&'^RL6>_;N/E,H*NO7-J\=*7-N;O+3P>:Y\E](TF4H2)C]?1%ZA!J8
MCYG'F3&%@2\=Z3<+_F(+O=/04/U&]T(47O^\V7>5X-F'TJ&[G#1R$OG7_T(,
M\;!5PC;=AC@K[GC[B!@8+$#.YW<AL182WOXN91THD_VSKQ7 J[G=55<04G7A
MIZV0(]WE<W0B6I?HBOC]$8-L*28-07)OT(P?5$J1S<#-I[E?,W8FYLDAOZ_!
M,*YYB52 AE/)=7=K\&RL^<CQVD[-4=W^];4SBUFD3EF+'@5*-KVL88UNR%R+
M?+L.&RW[(-SY6GTKA(D*L*Y>^F&EI5?MG,#][."P< EC+HG;O#LR6["%^/LT
M-V[$,3 F*593DW]8\W>R"*S)Z^$@8_EJ$@,5$'2+Z?=2F$!NE:><BF+@YLU@
M\-'<)BTO%1!XWV<B+_;IZ(Q7L6MEW?'SYCKO0!S@$]RP>6-:?S80#/Y1;C&^
M4U<G3MYMK$!JFB5@G4#\D(CA! 9X\%MHH=YQ>+B&)]^F?\J/JV30())_][N>
M=.(O)$R6"KC;-V8NT%(+%*N[)YI0_U%H$-:DO6C<4I'?Z76W&*$5PHN?-%H9
MB:&7=2EK+[8QE'*"(1ZO?;4I<AQ<Y*H81&S=;TR^34D2:/%IC:L0)%$!6<,H
MG5ZCZA<KY%<-MV37RP:Q.@].AI>,3C:$'R523E^(_'1CDP[IF]:F MXLL9%P
M?Q-3[(U>BP^;VY_%58--WU/,^,[M!R=5X0:QQJ-K@TDASO(J&CZT450 M\]]
M=J&BX%4>*'C7T0%HVK5E+CA>O>5YMZ4J^E37#\))!73ELVP?'E !X13'@\[^
MV4E(WBCN;.,H;"R;;;NJ N^0T>5WQ"OE <7/QMA>[;R%WM\5"6/ZH40%\&6(
M$6'6OB>Y(4C0W[H2]]T&BY,,%G/GINJXE_JEOD!L_TTJ0)XE:=Y*GU*R,_48
MY@V=!]J5N51M4Y8UWY2G8OQJ&]VL<RMWY) 2&'7/;R_*9/;E5BM!/+7586LU
MVL[E5F I&W]+I:X>L>O.&ZO=<WF\Z $!Q:ZE-^@4\C4N%E/&T\M +XI!J!ME
M%H1[H@+\TZ=M9V.,J_VVQ/(\.R.DQ%9A[TU0XW/XI^/#HR4>-S=IN'1UJ*1D
M&OG!1DNVYZ'UR79HVC#X([ARD,3J_Q-8[510-DRXT6']N.YQB2I6?4IHK'XA
M68X^ ;!VBMG2BBWI*-O G[Z3ZF'Q9RZ+20[CN,C)"<@*]7M2?#,V0Z%J<@-5
MD'E7VJ2Y 80>Z42RWABD=9 V8'GF)WGG%O!XF%6W)OOV5:#YJ%E"?X@;8E\Z
MIC)>1"0K\/V[F?8@UWM',4O"='\3?B)W:!VO:1?]C0\"5%M^"=8F%"_.1ZH#
MQYITEUCA1-#CNN2EA7:![R%)PB];,UPZ7ZM\1_5*,OX;P 5SG.<B/6XB&"\&
M2;+-0TMZ=[>].]D?W3MI[.5F+DGO?$ YUX6^SS15(MK3PD,RJR2$.[ >M60&
M(;JDQ9*0NY.I,=]I'355\Q05%Y+@R,!/*>_L>A,%*P%&!X7CC2 #K;,7;>]
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M'5JZ:(1MIP)HU_=H6X1'0:_.<H59=6W#3(9\LU.97B;?\_WJC 2$;_Q'J>.
M-3X,L6+O?&8BD[ZK9W<=[.6?BHJV^>K+YWI 4<O@013VA"@4.H1F%Y- DG@6
MA?P* FQSJ]G++PG>BKA0!>]#!YKGCSW?'A-1R L^XH.)"H#$!Y6A@1]7?7>0
M^"RL1YV)%TG-O_Z(G73#'3],J-@[6/3-$23DX8,R&T7EDIK>13+=*_DZX& O
MDQRTG(49@.&,(0112B-1"NIOFMG&R^TXAGS4@X_Z87-T.8KKW?D)C39LST;,
M\2#AKO\V>D]T$=Q>3%+;,](PN+ 6IBE0J>US\_MM%M3I8REY9?PR3X"</G[V
MS!Q&!$M\\A#*@\0)<\ASKSNO37P\>I1:J:61WZL$G-T.*:W,5DY!&,V;[2 %
M N[63O8*4RSL\[(V.Z]Y^113 2"EZUEILSQ'<_,K,/%3"(GUYC*^+R=$8YD)
M6[>,"DMJ*G<:;I+$P9:TFCHX/@YW!2P&L<8;TK>CG'AK:@\HOZZA\ 5P$NL-
M_+?$7^('-2OSC&B7#Z]NVKZVZ"A[IU<_R-%Y3QT= M6FT/\;XWOA#CGZ]P3\
M8@MW\%U"1>&C[2>$#Y("&3JCM)>MUT><7]]75.+/J=F4!U9C2&P/IQY\ZSNS
M]089#FE*6<U^N*:W)]UQ5UKAY$/N^^,%_S7DFZ(@Q?;CIIG:IERX\E1_HX0S
MQD?O:93I3); 192S8J=,&J8ASM*R$/TWU&H#AC.!1(.J:DO=77$V^/$]*J #
M>57IB>H9N=XF[BFMY;!"ZM>VK!T3.(J 2NL&H;N4-ACN*8PU.'CB,)&6D/XS
M1Z!Q#'&O2[W19Z'9_U%=ZK0(N+=QY-8CVKB%GOTUI#?OU4P*P]'>U?TY.PV\
M SFKA6M*-78-^2DPHSLIY<"#/>-_L/==;TU]493QAX("B@I()RH@(B(HO494
MNH!TZ2HBS8#TGHA(;P+22Z0W(5)#CT@3$"(=$B#T7A)*"*0P\9N9[YN_8.9E
M'L[;O;GG[K/7VFOE)&??6E']?1X?3;&CY%+9J&,6JM5(8I[PI_?+OZ0'BR/
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M-N)$\^(9?]. [PK(4+#X@^\"HJ1)B<TTV< ,#[TC\=R'N4@_Z@BM3NU=">+
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MU!%PX<_U1R?KHN;]65I&&RWNM:[]QU9[X&;_K,*1F.S@21?S;MG\]E8$Z0Q
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MNO."'&X5?C/)K-Z-\TE. :EQ0.= 7NM]:AQ<=,O%=Z9I/#R[WW1D:"OWU.*
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MS\LYEV!QS;'[N\E_HCA#_)V^]TSS)/Q1C#WE)BXM.)"O8PC-]?BN@(;JA?!
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MBP4?)_\'O,V[W/7Y-(5K#;YFY#7/S'BWO*7&8MHQM3D $*:Z>>XTVC%>>L5
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MGT+JODW_X$F2HW8*+=*G0FSM! RI\H"-3[V-V/.(%NB-Y=:AR1V"WRPA_4,
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MEI0[J[LN9>%Z038I>[ KVH/4:S)ZJ:Y@*S5UK1?_+NV?5L[?F9JXQY6W:?T
M<<I;"<"^:FH-]WJ<#">[!(,YO1]J]GL5*M;C=7KWXDTDZ0@I'!Y%6F%9'/6M
M]X[0>,^HRM7LIL67D&_-7;6AP(WPN] 7FAJ_1!V!P3XE,@R>X8BTU/3'5&C=
M2YA%/G Z\</ZA8E5-H[;-IJOFM(5X?O4?F#HI&F2_3I:YG%$X?R&YG&%"6T4
M7/>*79U 2-AMWL?GF ";OR30%;:H&S$4OA*Y8-7^>R]Y!9)>G@F2WOBQF(%?
ME,-0S)0O'6'EP6(M.A64L6+82*=:-?A9N:>05B24NX+*WJ?O>GJ8[E2F,WQ5
MC*$OLJ\NG%9[%,&0.T%5F+-NA45+AAA\"!10W_3[)LM8=;E53L+<<VEC'2B5
M@Z"<-4L]T'&V?:-@W$"O;R!H"&ZUF[?B;1CH4C+<I(\QB!V!-O7<ICY18@*"
M?7.40^+2!//O[MR4\I ACMV/]4TM-@\JIC4C"B8F$X$?]D65QGP*FX*ZH+<0
M;6+A!2]K;1L#$I/VY%@!E4F^=[,I3/$*1*UJAZ:/)PS[8T:?=99L/I19Z_-@
MU6YPFH?U,];RCD=4KGS!&*#T8GKDCR!.[B@=O;IA;NVKI^DCY/7SU ,(),!B
M3P6)H@%7/90;1ENOG1_:5MA8AK1M$L:9 "<+1Z!+J%*':LM.KB+9=7CA#$NY
M>#IDVAIYS)QJ!AEY9!M\AI<V*P<6-3:\"A'%.^-0=7<)K10&J7C"=I7E/51H
M=<?URREVQU1(\5%)X^L,)P)LXN_T$:['<4?\2U6LQ5G>+11/[K4#32A'ML-2
M6:)J\H$2D'V#C2"0<A#4&.1])F U5QI2\:)>#8@O9* DMD<L-.J#>DQ*XW&E
MWKY@2'D?*WG@>*"E?4K"^_LW;9IKEY-Y$=NX96N[8,5^OJ?C*VA#N,(&QD<!
M]*&.VQ'D-&1/CMMW% [E5[4W[2?[ZNO[K7(G34LRWG 8XC-D+9=[Q*14UQ/1
M.*1[74A\R7Q=2-)![6XZT!8$:W7=9CG0(&L7%[6_UK["[H2_80@L02(G7'IB
MUE?.R3!ZM<45O^7R,(1= T=*5[%/)FP=G.XG[J,4X7'SU9..+WQLE,PO-:!.
M!@6PS(7,V%HS!^'&U(Y*IWQ[)W'Q7J1=WR BTCVHRZ(1MBF'G)X,A\_/&G>R
M:LOL\C;+AV<C4IU=2Q]48VW<E>K"@F(C$;LY,XF3^O2@P%L5_RK?I5]J\K%/
ML'//"P+8;K!@PHNV&@XZ):?@UK%AQ@3X4>]!T?<4/=4*FRD!F?FM/?D%C*W)
MA\?VTZA>JUKK Y-NC97:4J@A?,GPWBFEK94D^6H#W?VJ?:$P= 4'^\*%?0CW
M01$7S%CA$<[MW-MGU0-.;U.6/B%Q!*PC HKORS+XD')68:-R!;,DS' TI)R[
M]V2_V]99PW5I ]D+&ORB'-7DWR&)O)Z&P$R B7B/L;QLNXO=?ULDY GJS5?2
MSS LH?%@&65@O7K.NWY6(=\Z\D2&B'_PR<NG2(:*VI:&;ZZ8O@OJDM&M0J6@
M;9O_'>0@FY>U?E5]O20]Y9L\&Q>/I#W]B9XU@C;]C&I=8:EAI-DY8!OTN&R,
MBG'\I.Z(#?JF@<XGED-B 87+T\"_]:=S68^J=M9KVTU2K=JL;K4^B%/?.2@V
M CX9'PY^AY[RO<?X^1:&Y63W](N6'<X2*$DS_]KP&H7\@IZUMF)YY F48+&U
M-\LP-,^.^>TM#^2!0RW/EARIB];2I-JG-M9B((PJ8)UN0#6Y7]*MJ80>Q"D=
MW+2E8V/D5G00X^2F_]*P'+=[7;Q>-O>*5JRYMJ,9"1V(T$!)G]HA+O18'F:Q
MGE46'LNTJ?T;+JJ.A3.L\G40%MH!XDBXUJ]B>F!M1.'<WBQ?9V[.' .VPK)+
MDL?@0Q/-$Y380&/& 53DL;Y*GDX6[5V]4>$BL5J^98+A6]/:H[F(43RR;K?4
M#FD>:!(CJ "V3NUEP>7R2,X^^8_HRO85/E:LNXV# L4WME4DY-74I877_U+_
MH('91I9DVO?4NF=*KEQX7O.%E1B&+&\$-=+WHHXM@XG\JD^0TPOA@=:L6)\8
M\=@[S/%/K -7K\:98ITFFN@Z\7&V:\8PSWG=14=XS5H(/=7[;Z]$8ICP_L,4
M4KN!K,2![P^UH]OT.._'^Q250N(/ZA!D>V_P@.2S^<ZNB-&S Z0WJ*M*V;NF
MDV[+6=I6C6/N3  +Y7G5P0$:NI56J$G<DN\'QJ^GJ5\"YH)GWL'M>3UJW\L4
M'(CG_R 2@]28UJ],0(ACIONX.\FKSS?]GAMRC'^9H'T-ZG!E&6BPX3P$!M_5
M&/(,[H^T&QCP3-AAK-CTC<CKJ=]_W_ F^F%S;- 3!*2< ^@<*H;LDXQF[2L@
M\PW+-ANI%,\5!E*!JX;_1?+Y:NT[S3&=/J )5,-@\  $Z2I#>9I:!/>\X5KT
M.854?L"9V@7F#VY=&3]!BH5WI*5$1;[SM+G3-OB0M?0>P$_)B??I=1P@R?;?
M2(((_,+2*= 'J)Y6UF0WQ]Q1NM=]<J!X+6I83[3.31"5UZ@3G]#X)X^J9 &E
ME6ZI7(*_"+1NA4\]_QOC_^ ^L?>Q,!Z\/5#327'-1%L56\#'T<GP6)8:&\]0
M/#(U91==#!C8R>[>V-_K8DJ9UVP<%.>RDF;&: VE@X^]/'9G>:3[W4J;?A)@
M__@FCJ9-EHDD6K'DSD>E0S(&R%7Y;("E;4\A#A>],I(+MX+E^T7=.E9-.?I]
MCKUE6# !E^,>K\PU#!KON3>0:(>42(:ZY6YHJQ&9A"9')Q;'KYFP.)[SX$WJ
M-[K<A]LW"!Y@)E3R(_S#Z+D2/,@83(XCFT!8RP"#MO2&<WJ;#^;7#9D+;\!E
M19;\C&'=.'T_AFE2(LH IQO<'8Q_@=M&+S,<7^Q'1=K)^!R.">!-"_2ZYZ)P
M]F3N^$FU'/!FR268@-.SGM1BBPJ:#/R6S%3.YO).+OQ#G>!W2.5*070__E<$
MRP-X(UU4O/JHVYY%@9Z33( ZY)/K/'RUE,96PTNVGR4<@)!A4P&RP[=Q[CCT
M9 0#E.Y!("YJ>/]Q][FC[ #).[6WGJ=%'+MW1VM47A'#'[=O=GOG2 :H3T+&
ML2@>$:=]E3Q,J*Q;AGQ)4AR=)YG1$)C2GX1V>JQ-Z\)99.:D."_94=2Z[0UN
MD:>MM,WF%-"_;@@]H?Q^#+Z1-M##$M'/;W$LSBP'_\K>!&QK%(!GTNNWBE6+
M>XM05KESH$"Z$LR/2J9Q]E#-]"<J"(G4?QIG+(Z7L?JB"1\#@N>MM2F03.ZQ
MQ14;V1K;'C1C'S-+> #FE'OXYO"J"61W8P%"3PE=:^K)2!>P)!1C35?[R=L<
MO60WN H#L>!;G&\A/HY[_&;%&NI<MN)[E@DHJG_3^#XB R0P Y^V='+832VV
M3EMT'KPJP7)+BR@7"Q8<&\3L1!G*,@&J&[F/Z*^<1Q.2&E5(P84]\T'HQD N
M6Z0'F:KZ3VP?Q1M_C]B8:$9;\-+@P%P//+'$VR8#/.KS"!Y$P$*8@*:*E.A_
MG(#S$)!1!]:A[-L/Z"2BO+#V68T;Z71\>YB7:R]$$KQ9.\;2LU66GCF0."4T
MZ,G+7L<.Z&H:S7J70;L1Q>;P<OEC;Z$*B[G:,FU1YY^RV;@4Q:R#?^70]3V=
MJB1+ YW5QL(;8#J6M)1S"W4HJ;K)W3WXHS7.(B3['XA4VX&2R;-<*^"<%R>7
M09I?B6BPXN^WA&V2" -KVPUF[/>*@D]5/@R[O&KZDART]P7&!D+J?Y;7&=7Q
ML[E@VN1JTK-=@U?4!?<Q 5AJ_UCJO_N142S]N6<B<_$YYPU1:]8*I!=%'*S2
MIFV?HD5J]N,O,L"U141' D/021] U<Q+5XHF/[&+,>*2NZ(SVNT'S2H&FL"#
MYG _>?9'&6 <:9S0^R^"U_N?G437,/"'.H$"<)5+IUHO[0<C")U^F04;L17D
M=)-_"%YL[W>"='FJ;E:XWO($RBT(N5\;4>"'X<LEOQR#JYUO2F_8(6 -RSXY
M2&<^6YMMO T>B7_CQ0E5#)^-:>L]31\AB0I'!(D#/XG0Z-=X*9"LATIU0TGT
ML;TD$(4D>;=Q+BEW=*P77/K<JOA7\5%/O.G"!EJC9W31?K\D+9*G].))_Q:6
M4N:R?)$BJ]H)A_J77 -]V#_HD2#%&I+**[A^I 2PY!ZQYS^XN4Q>+MMS!.8J
MKNU4('2K$^MMNW=M_"#/<Q:2:OE0BU?C_L%W*C3Y"#WOPLFY#:&Z0=W"Y5_M
MIEN'VU!?;C&"H*[AD ^!YRZP5F^0=.:-"[X=<+K=.^/2MN)C9G^W%:'E=_!A
M&-5^:@XJ%>)V%E52P@2\QB*D"[S&["=*5R&_UWKI*43W9T"B[,/1D+A3&)_C
M,<:79VJPQ%4-=U9).NB2, &_"_]BF6;V<?<JQT45\./DI$W^S(-J-)>-CO/#
M+J"G?MF8B6'XQ'<J#_R5%D0X]YEXM\U!W8=W(,C4ZP=-+OKF:,TL<?M!QWDW
M#35?6YW:6:&/3  HZ@$3P"FGQ?)R^1@?=++!@D#2^D;#P+9V4WJ*0:G;6_W2
MFX:12I"BS^F$O"XMZ#ZMKUO/V.#C]/J4\3]&ZP3UJ@W+:#75=RB_J/G8).CT
M=_W7-]A?9J%,<WR[#@MOD;D=>1Q?FY*$TP^Q[>31,\*4-HJ<+2=>HL!!UUA6
MJ\SH[_+?O;$K]*GIOW#^F@S!1@6&J;Y;C_W%C\E37JA!49PS:S&C53XL/\NJ
M_L6/#GJ+?-M59X-D&S^CD)-] <W9N[K?\'':5D/5&ULZD\\C$#*-? 6^1FY0
M @SA,9*Z*ALY_N,6X\]7_,BAFHE['"6;_ZGT;^#)C=;;N_J92N ?CBG:QJL2
M,@_WX4'ZA?O[?U/]>Y$3+*K/A2I:%UAY5<>PC/=MW9]\BWQG92#Z+@:H$;;_
MZINPUL_Q[?ML)Q2R<ORLNIZ0,':(X6Q(J(#(2<'TQT$1RV]HNW!$-X(5\7_J
MOS03\$I[J&XN4F!@W<AUN$N#X>AP-??9Z9Z)YL:]OQU R.=W?W<6'];0ML-G
M1%AU6M.+'&5JX"R3YT$Y[,\$"+MX$;<U&/PD^7_RZ'+HVHYV;SW+;]DHN^!L
MT0'_M/)?K#5103_7-.BI+.\-(LH:5A<@)5^Z_F0+#'C+"K5K9M?PJBEX5V8!
M/#<D"N>4$^]0);#H;S1HQ*(Q6EM-7"?)0F]//)=2S03(2)*XA;2 ,-G(>HWJ
M)JI(Y?_H4&83R.83Y"\>JPUF C"A)21H63E/37WB8&)B,C:=\:&W9F)5R.M-
M/@:U'#6A5G#%X%M.XV6$FZ)MX-Y+%OK:[ES,G-"K!3,!AQX2C$VPZ>'%<W^%
MLL),&<QC=/DK'MAF%HVH"RVYW+@R>'>YQE:':S&-4?GO+N,B J67 =TUI-8O
M]R74C=0O+R^<\U'_\9P\;.2*T^#=2X]?49"-;!P\KC9GZ['<>V;%]&QDIQ\;
M9\-#3E"?Z\=_4\W:[L&@A G8;S<'<<D93".,[OX.:?SLN'4Y]0G9*!6Z9Z0+
MGJ\/ I>Z'7<W-0V'%"Z44]?Z?OPC;G \C^!*2K"]Y.2='%;2U#*@]3A^L3;H
MV;N]PX5*?:8,!U!F[K\;C;MQ9#/0'>V9]P40B8,0EQ:Y^2T?#$K0 7Q(>/D8
MUD!J5^49W-[L5>W[@B6_\+](J9[2SVXS 2]]_S4I^6^PH14V''0"./4FOS=U
MY?=E;V'V"$9[;KD;4-7$U-V@L(-&P'&AO;&DB>ZD&3^1QV5BAU=.,@&X@UF#
M\=^C.I8R6;NP>,E$X424 7TV2'JCQ.L1*TF\LG9KAPR&]^UBD+V&PJZCIBB?
MH+'^T@XFX)+V,/CD,S%8N4?Y3D4]-7H0/_*F9KR5HX3$!*@M65&O4E$W$-GA
MT[S3B>]+T83 ED45_6Q9<(^\0Y.PTZ^#ZE3#(*P5=4XYZZ:NC91@M'97T(<1
M:O$ZBJB&U* ]75K_OSHKR[OMI^#VZ,"5,Z38(+.S^%,[6D9YJR;\ZS(++$>U
MBE=S_DZ3_SW=)UWEV(79D%F +_C3KF5,;K0/4\'ZPU@/C2'G;7$-O.X_O145
M!,IBUN]?K96QW%]B0$+XK.#T<'@GRS9P?&_ZPM4C?Q)Q2DY)>6)EE;&0>9,1
MW"\XLBVIFYN.9:5!8PB+DWHXP95[Z0S=I&U'#WJF0SK:Y9W:P6P,&T5*(=6^
MAS>W>WC0E/OM;+)FC=4)01(0=VU""H0FF<Z;-KZ"5(NB_8 O/4E25&QTMUI'
MZ?9O[+Y/-X&9MUHN^\XZ+'S;V')T9>FY._7)[56$;*#1J7M=-5;Y!@-WK2]1
M[#)Y6:IEI_[.$.&\\?;60#$+\R1LT$Z#'2K%:U]WU[F"F8",&_\=TD.,K:Y1
M5DBKJFBY#*>U*/HG5KV/*0H78/0&N'[1A-JXAH$XY30/NI!J#+P"7&WP9Y.
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M?!Y1%W(JO]KF52A.TEU.J'M*:V8"$'V?(>2D7E>*&ASX);[ Q^=(73T*KN$
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MRW;;;B9*S#+JZF\?J,B3MW?XKU0UACLXB%PLTESCNA#ILX#^JTDE6)D)>/O
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M[F:<%C[4#C4@>DW+T,[:_>!-1/Y 5W%UQ(1;?DPXX8SF#];]1DEXAGC['$*
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MJKNCZ9&AO8@$(ER(F+_^6(Q0DL^(''K_+ID=U[?FR:[EGC!BE!4M?/ZM'Q.
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M]76=08UAK5S^I;7\.&7-9/]ZZ6]2[F8#3D9W]V[(IS6=);96S_^6^SK2-^W
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M+^Q="$@H^/'CA#4S@A (R4,MZ;F0K_BTB%.IDV.R29V>#7\)?XLO+PX;9(C
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MKYK:"F\.X*B\M%M+VIEL0?'0,*>0,P!O;E*F@=/^U$X1MUW]<(,4"3@?^C"
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MKJ-F7-\%7_70TK_M)!ZKFB3CD97/R4AFP2*W70AVH>.(FN/.,H:()N"V!/;
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M >+D42RVX J'M1.K6&_$AVOU>JS'+#]J<@&GE\7NJ1_#)V'C*.I%11+OFH/
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MWZ/B7_0-R;A@W,!60+K.,S1K&0H4SO!"Z6@))M@D=J%?6,;Y)A/Z$P\!OEQ
M2*5#S0.B$R&<V%%"%AZ%,-FM'6&/YCMD\-BM)TF/:R6>EA7\A'7]ZE--Q*[+
MM ,G3")<=]K2YVOG7"-47<IQ.GX)M^JSSLFG^O]P?2K.LWP#A/X\)^ZF>%[;
MA/B^B$4AW%]KVSMQ,_I"U?MEGD%)F?"<\?7ZR<&[8!',)[+AW PS,?Y\P!2T
MD\OF,*^/9SF9T#.QQ,M>PZ-;4_9#>8%]&RP64D(]7T1B(IZ$(M@XJ/T@QD-^
M7/%=8__@V8'K!G&"C:)3E8/XW(7<=/ _Q!P\J@-UWH  O4*VVV&,WE+AD8==
M62'<?7V7"1<8>.69(V$S&\^V^82DW'D?/,$VQ_D#,ZFANO,[=)4,]CG!BA3T
M;_OW&X8Z_6S9P-Y ]2W?_,V7TLSZ;&9?<0024MCD20,P++N"9E-G=@S77W11
M>=9GHQ9K]PUFO7CRPVD =$/52"=HYR'JCTQ[TVOW-G9*I@;K"O=*7[]O"5%6
M%YEJ'7:IUR<UN:?U-=O$#,$]\.>,()7]GS]T%'R1H2L)]AWL>T#-:"Z$#,,
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M.[YL/6R7W8^RC=N-_QC;$NL(P7=MZPK0BBJ7JY/ZN.A=Q10!(BHG#X00 31
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M4'ZFPZMMR=B@?$2U:"<BY^%=F--:(M.W=I^G?.J^G)5ZR/^C<M2<.5/TSPN
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MV: 4CP@AFN-AEU:>T,SWV,7@R>F.HBOB"]''7K<',H)!*$XJ,LZS41,?C:)
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M>[W94K_RT" X9G;LIQ_=[^@'QEGQA!M>7-DF&#+[7C]8.*F;7'I+4_K5+8\
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MJJ9'-.ATO@V=4'FZ':&)G9AED1H]5;J]$<O@'%G8\O17D+E/9L1PP'4*XI@
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MEH"H2@\2]8MLASM +7R&CD38^ILO&X,A[KMVS5:]6W6TOAGCDK-.LQ@.4+Z
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MQ%S>GBOI@/?L&ULT>!6K2]975X>ZKJ\?K-$"_%N**\T\BU?K" [B>]L&RDS
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MR==6+TJ%#*7O01Y$;6!FS*II/&26P2]J#XI_W&"<PC2-4(;X-L.K F28@D*
M*7+,4IQ,88WO6(#;R=UF)P-MZ274F@8!3-4QE1*?71B0&M=R>/WY\BD@4JX:
MAC)O+%/W)X'F"5^D_!?R[E]5R?K"9!%>UH.-1J#"\U$]UFHHYXMR/R]$[G5L
M6\HC8S38)S*F%PU^O%Q-<1=@H-(#@".X8'5&W&&47.+#&<P__!9NJ0*UR*"\
MKTPUKE6U^%&B_?PHK4I<:MS!+Z=Q:UKT)-C,GT>BSF-KHLD".R1"(82S3$+B
M!.@1@FTDKO>'?.F^4/T1XP0@Z^P!Y-<CQ_:51\DTQ&+<!NA7^[64\^WQ)0C
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M_X=![UP^,FX*8'C(\-?AR'3TX86;?+S"409: #/*!<37E4W5DT#%G2$;.CK
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MY-<"#G'W7\K:&_F;C.FE,3(2^3O.UGP9X/Q#, K+](;TW*3O5MI3DE?,]LY
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M]R[JO0U!RRV;:?&6>7#XC'HT8[=. <) )U[;7WH#7G,OXP:W3'S6$=3DQ%.
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M)L/5Y+ +'+IK_&  ESTE&UV'3&?"3"EK]!W?:"8A#S5@&UQ&)#H&ORC5Y!'
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M8Q]1.0?H)O-!7?7I\J)Q/0J0E(C/F(?0.W/-,W'GSIAND#*Y;S*F' 5U>5Y
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M!513?T3_>XYB!&'!8#3\3P;D@#Y,$_(!Z&T?3A$X?O7?L]*,R:XSGIM'4IG
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MXU,/JL3 ![:<HB\XH/6.Y6TC1I)%OD9RX*@:F]F?)DDX%U1H":^*DJ6KS8Q
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MFGS^VRGQ/OCT\D1BQ_\DUWE' 2@O[9(62A%# H^6]VO  +1;,P"E@&CLF3D
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M6W/L9;ZGQ+Z7GP(HZ]TM4V2H SF;>A"HF5X9^%-N?3T2>G\,KK)'+M9@C!5
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M(?[(2#ZUSP"^ZGW3$[]7X^'9P47-V>?*XX3A6UB,R?>1E]MZ1#/:['0G@U0
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MK?J(PR/%K,5:1V'W&X96Q Y$RH0L%:< [CV?EC5:KWXQJ1P RG=6M_S<1+,
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MP#0WF))8ISK[?/=7[N!V*#)K# E7QP@EW"V;Y]3Y_KA6-DAM37>8KBT_$3&
ML0TX4/</#/;]]<TZUMO04E$/_]7 ]] #Z:^?QT8,>BRAA#W_JH2^UU$9%UKA
M;Y8M>=)1+]!9HS\]B'R2'EZ?E@KX.F^,S8>MR.C>NX(C.-S8R+&0J&*=F5*0
M+70L8P/&<A*^.)&<*F(4R:!$H7,"FDC737SV'ER0H>.$^CQ!4\"0P4#Z&&O&
M=:+W]:(1#GU-R=E11<7!:-&%LY2O5J3<<2QBT;;:W=O\^5&'KFVNHQ^>I)>H
MJ_-7U2P,VS!QJX_T%O0ET[<%N:$GCHZXI24D&T]J)>&9R@,QHQ2'V7,_H)L7
M7&Z$U\GA=:KOF8L7GBPX+F0Z$[#']0TF[VJO_;"Y<&P\K(,1=C-*4<TNI TM
M:GGVX4GV44)FL*"@U63_L'"0H6K8S<H,;AP<QV\.I%+K$#D>(6M]G$JP7Q#.
MNN/T!+3B]!QSWP/O]C9!%"YTLB=&YR<\VWB9B_FVKYRGRT6V+"7F HN<U??=
M8K^WU_GG.Y_#;X2R@+G.@[=*1WXYT3GR[V\/%K&S$;^Z(M;;6G& C*69DR5@
M,!-P:R]4W0%>;J>S.<0:*8>*_8@YU;/(/2EXL*R>DXY$"\&,O2,X]N>M0-UQ
MHUW8OH'T=RA&$9]1NN66I][,@QYK-P;M;;#<L[/L:*U3/NE(@UUR1O;/K#!!
M1/;C@A>.*YM(ZXG1F(]Z"/U!Z=/I]T_3NRY=0N;PZ%X$9>2GK0X?2E;>>.2'
MSTHSM5=B-__HTLE9W9DMPL6XOO^E'S %":BX<.V,W/(;:M\MV 'UCR/%!J7K
MV*-O40W,K.=K.N[G!%VP(->_J1.^*V<5:H<0O6QYC4K)",P-X8$3FGDN8>,5
MYR_S-&S$XGMFMT-T[C+B9I@X34%<A0VP7V81+514]B;L-H>!."ST\YQG;[%Z
MLX_>LEM:_GCQY(7PZU,0G'_#A65IM^SCC[[V%\E#AD8ZTI%[ @IKK]-6=U@(
MIOFHZ9X3#BI]A/ID]&D?JZ&:8Z>T/@1FII&X4OB;;?HK=_WL>70J-HKC0$?D
MB/D=!??X>]ZL"'NTD'I*;U-<G-1H@H^<M)OYN/5<TR'>/PD=LK#2@;P#UC',
M@U8&%HU-Y?AU8;QPH_/13.3']&,WK\']SIWV"Q4G)P35.7'8/)^C-W)5[>&-
M X%DV#C-8'D5Y;3^W-7U[9M<[>E>7%:!S]V?L;8#N[Z8NI^R-^_[C4KYBYHO
MWMCYS/?A7 L$:FOO_<)BJRG(D,^GGW=+GO#:)[&,[":O7X(M\0GW5*V/ T,X
M+9F^QRY!5J[<Y66=2B?&G]&]$?-$PB9ZV;?!'ZO6P?ZQ>7?<14S95C\JIBMX
M:B]"5-5%$,+.GJ\>,2;F<17H[<T7O18,7EUTW/=D=$73,5@%Y6>HM*IDK<>3
M)]F$ R/L1^''JRA5$J-PXXRB']AO#HI$S71,K9/ORMY=A(VL.5MQWV3*$S@"
M=G'S?=8/^'$[)''&\*X/:%82:?L7:(!'Z7E,=+AC=^^Y0^G[!EH'7[IV$R2\
M1I6BJ"#I?='1?86J)X^>E)YYGGZ/QPQ-Z_<Q./B";+DE<JSVGR[FFYSNUNJG
M9\IN'7799QK-,:)C,9-!QOK>^]Z-=ULHW]$(QD%&- 6?AOW6$_3Q8O"75>51
MK<MFS*5\Z4N+2T=*GMT[E#PZ%+ YP"W4U/4'5T>',#_>&(N[%3:6NYO?N*1<
M%M@8^>C0WJZ Z.[ +0>0Q$55K PO#TM><3835^VZJB(^R!;6-L"G.*,;'#N
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M<F<4QJBHI060+959@!AAQU;BE%1H>T'>Q?]QX"@>@/.>&RK6FW^-WB-DL%2
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M2#;?CN><;]SW/;\[QAWCWG]1-GNM.=?S/+/L-5,952"I3P.5D9[D%L53CK!
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M,Q+#*2*9A*C/3!Q^0_'#!@3'Z]]S2PGVIYIVIF__9+&B-:'_!A:9<GQAK>A
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M"SDS-$S12DK2OS/8]=BM+'%,%Z)P3%';ASF)&T6##C^J7Y%+;3FRRF@Y@<^
M/46=D$LY!Q5$?NK/H<^RYW(V'EGATJAXL6)?_2"588SB,M/M$IK[%BN92);!
M;Q@-^O2 V:)I;?A>2:4!%4[CTMH?J-S;:U1!M.<*\B5P(8!L'$'W?M9\0_.A
M@]Y_8/<,QN=8"5<@O7=S5A)$.\:8$=-B\RVC2OLF3+"B#IE;R/M;!=%JFM=*
MVK0-0:P&@6@NZ_"W8;F$W?MH1OETI@9).+\9=#MBL[8W+90M3;1?W(Q6P@:Y
MMTWHA4>"IE]\0]\&^3&"9@5Y]Z+'65/2S_*SO,\,.K;Z7<?KL>E=2Q""U1Q"
M@ %M5\)O"P-W>)$/3VCX*CS;V-@VD0J3 <R+(8?.:,P\M-CTEVQX)%#1L4F(
M]VAH4NJ8'=7J8./X4;'2-%U%(P7_MGH)8LJ*NKM/7 G^&:^*&1U\!?C*)=S?
M^Y8YO]EW<*0@OZ:^UVU6'_SA_.0^:3[[6_<7<87W$@1*SW60CJMS;JAI&Q,!
M""*IRAWJT?WSXB(\KY_"7@CQ2((<%K=3F_UM0=NA:;91H <6/E^1^"8N.4J:
MS :=CG)+.I7\275UO0Z!82QJMQB>E/2/ET!#I%=F27SN0HK^*MD<VK[+9;U,
M)(YDP&9M5_F<.#&3*I\1Z$;\%8:57.62YL,B[L0$K/+="&LSQ"1FU/TKI:V$
M;93FGM_)D(7?MJR;X#'_-1U>6L>)5EL_358!#Q7X$[<KQ>@(I6*/*I1H)#VA
M@;E8N#<05:+L(6;W;BQ]M^:?EMN4MP31AYP(ZPO!$OB35B_!7ZC=&XC\ OX"
MIS<J,3/!(U&G_%:(!RQCW[*0/\6;XRY>5'BU")0UY1W_N^QI*FL(FQ)B&S.V
MN(J]=TSYFC(VQ5^".K$&\KKQ6;=]Z7 9I@(K6@STIR8IH*,^A3DJT!1^(ZG"
MNK/0!(H@N7A TOLGQ2SAWIPI,"X8NL8QH'&CPO8M^WG$^)/P.8A&[$#+,*Q5
MU=R&S['Q,V_M!CP"M$0I6%'Y/.S'O'\,IC=0:@OCX(!Z=.:OF8)^[ZFC6F13
M2@*7._Y ]N((FF"TW\>:GD4[#5HPV&[FN?B#ZYE])P;<8$1=![@FML'91SF%
M0X)*,(;!+^( VN<Q;1]VWGTLC3+X N)?DA@^;*@)J\/YV )A1AWF+?RJJ;X2
M%),\. F@SKB:R26Y*"]!Y.C3&9C)EE'F\8UH&D5(16!N+VNM3OF+KVZFR/8V
M#!D Q89IW37YE;# W0<$&R+9&AE6*.E4<:</_[3:!\W"<=7K,0$A'HHTX>_;
M,OE"?.#ZY4-\YIR4%3[^BR7\%TN "'#3]MDV\TUOU&@'>P1^!O^=9YO^SX2V
MS,W_+KM-K5D'C,<Y=X*&P7S)^3N'F,LGE(-&81>CI/UJ6.7O*Q)4;R-'M O=
MLD$!).<S8XY^5C*#&C'_8Q=V.&%XP?Z*=)+\$3.C< *?#HW2LH$6"CU6G5I$
M\R*GN>$@K<]=6L9\;N&S/P[NVT7E/131]_"-Z:4/[T69P[$T,2=],]I%F/Y@
M">(QM00QIJMW5XP?)D>]XX@YI'>\) CY:,G,S+\+;U$+-'UVBJW7MSIX_.\T
MXXEZ.%V?0U?459(0[G2YD*$A&=+K;-K/#@T(G_#?O"H54(6\WV<AQ__&(W=#
M'AZU'C$\2E-"OIFK1\^U;7 0&K?E%@:ZHJ1C6L@(S%V+T!2Y0U6^J'+3;NG4
M*HMW:]Z#?&9SQHZS*S_:I #D,YBH<X6K1Y+>YPTQC=QQH;228SX?1C!XK0>W
M9,-(7.94IO1BC\-D_ -P(<1,[@M(TL#YM<)/GT*VU\,L<3\S_HLJG! '<?OR
MH>,8&.?%OPNAK%"L+4TX>>*_6*2$OQRG%9>LXJ@@@=6G20?C?!UP^RR%8]2"
MQ[$"(5KURHT23H"O*2&""+KQEU\#9UO>Q#*_1GHKAZ&HIJEE=@[2ZHV_*R$$
MV@$"R<C/O_/(ORLW\')I?PF15X]^MS*FA8^YM;+ 8!QO8B(]2/0UXOS*'[%2
MAM?GA3/>@2%_KCT!]$>;.FV=UR@@+$S6A0X"-4O*\21+ "\)N;2B^)=O1/,;
M:3F4"_*Q>'&U^5M.V& YDD/&UK+$(ZGR;\B"IY83[-OZ-"&M5$7+^E^G2A5-
M(__K5-4UI!P0YDDI/C@$RN?V$S81FE:JGWB@NE%'Q <1Z6B5M2]H-R*\&OMF
M/(+8/;]AY*)XMDU6."]&G=CP7]4WE^<G$;IQ41OUV-#WTK8+<M!_%>#2_\$2
M)PX]1 YQ6BXFPYOK)Z<EAAUZP!W4<%F.6XZ;J@2.Y2=9STN+;U]$XSP %E&,
MSOPP4Q#Z=1 )<H1WJ1B[%A+ZZ^1>]9NWV'%<D;3*.]F#7EG]<N3-VH%KZ]W#
MT#35A>P"-!B0!99[R_:W2:\M<.[YB"T<,[),_JSS&@D@Z;-U_ZR*W@<"UJSD
M,XHVHV''DUS\%DNE!75,A4>2YSV^?EN+H W<N'_"T;?_5-0FJ/![> JGRUP3
MW/Q;EA.<^^#F4TM4I/#&ZE?4*7_UC@WCF [YU4%T X75RY;_AXZBARSUA'FO
M&$I(^I0I!<B;6S;&7Q5XCW:/,UMGBM 8GGF)+^T#S(74(LCE2!>%JBN;CFP\
M"1[9%/YXTB.973&;"W)0S7Z2("DY3V2!.(2,"=AX=.._"J'L&0' #^B%EDN'
M< "42L@%Y,A35;<<J'V]3KVA,K@/MC?83;3$9#U)_W$_*F.6-VG_-P(Y\#\4
M08NW1/?;'DA9/U$/LY6>=4QK,N@1 3;]:41;?(2R5+F"LO9F1=_ -5!E8C7I
M=.8:C03*$(A'(%[C (J*R5F(4ZP+^LR79W9LB)L:#P1 R1U0N,K%_@:5QPZ3
M2KAP=O+BO\Q5PDL!?4RB9?FRH89_(9PP*,(<@Z@ @>H^O4=#L!%"\=W_JH%B
M8UH&BEMK-5( *"?7XI\&.;&E^LA:S,09^PDEQ7JX)<A:<*#H)/0MYWZU*=R$
M@N"+LWZ$$6[SUR<7,O5!USEM34P8":U[Y#[;-GE=.K'WW9J\,[4^2:-]_Q=1
M!D1]V:DE2/E-ASEI333W,#5)&1WYJ6NTI!Z[G"E^TZ]?4<FJZ".K%.(CQ/R%
MD>=_)X<3._Y)'W8.?VO)B!@#KM2\KNH/9AL'7Y/ )'9=%7FA[=78P@4L:,"$
M%K[5" A"*M(^.CX^[L9U6$*"G_O8*FW8(: D._I>?T \DWH)!: 8W_U;+VB\
M(0\=0> J4_S88D+M-ID])2E9,ZF;0/@!2C)-L<<G-S#+YGE",,"60L\787H-
M;0J /3&?0:<ZWYJHX$ !DG>5^/O*Y'\RQJ'=[*:F<R]2AO2TS8OA+D@0.YS>
M)S16SS1S-(P*QPG2-IK+ *V0H[VJD9OB,2<QPFR#=%70CGE=4]*(H3-GI 5R
M>,F61U6>!U7KD#BZVERFV]_Y(K3*4=7Z!JQ'C*5MD[EYEAJ[6MK(PI4VLC2;
MB#IV2%&G0(HZBF(X=@9^'4/[[/XG.,OBB 6@$")#CY8HC&W$TEP Q5:(!7)$
M5M7MH)YAGI8(^\KJO_@ )/$*W*%\%U2Y 11>2Y^J,_EWL&>%I/-%J-EWLLYK
MHB;W=P:'C6%M 6RR.M^8]1:D\! /'!S!Q\>^^2_D$6(\FBYGF/F";_"'QPO_
MAP::CU(,<OX0.:.D*-8!CZS!/]IGS@Z-2P;#I)=?CDLCOA,;5/_T-5'Q?:#F
M J$V?LAJ>RA#"FHF)CCPX-F#L#GB[Y6,,^8PQ6PP)!2&1FK&NJ2D3'#I4]"A
MD&O+ONW&:N[[G=6K[ X$2?[,PR2H[?.QI6=2;:- X+&A#GD)FR,X$QP5D$S5
MIEO-09'* :UBAF(0 %!VKX1<\/W30:.OSXS$1$A[ H:7L1NE.$1(>,5BB_RS
MVX57$ ?1"@9]!$3S[)R@)7QLT;"1<F>.R1!CY>[Q3ZSQ&4DP=<XN-BS6FNR0
MAD<?4\ZI?XO\U.M;";."2:XN:FL>U&@Y(J_L9C#/(U"G/H B=4+@5;W830-C
M:U[(I959_R",S/''U,#8T4K3>5@6>"Y:_S=!Q?_?)W,;$@;XJ,OW&HPS0&F?
MTB%8=C^\Y8V"QX,2&CL<3^ 4V8<E+_05F@IY0@FHA5Y1RL%H;U<ACD^PI3.2
M(/&]5I>$OKLC^>4JH!8"X?GZVDG^@Q6R?0PR^(*FL[\K7E$JM#T"E4[68]O"
M&K@OG@>@PXV*/8I1HAL/#O6N^8K3_5$?Q,1QD]J:@J'\A<[&T%=I?WIFIL0'
M\A#?I?> ZAZ)7,2BUYJ9./H0R46G?3A>/D?48_"!6%$A/.4O1/SO%FPY'D83
MCKQ_O']#&4K>1,84WP5@)==610,! 1N8$<U,<0R@VGD,"*@9.?-,^ZB=+U:"
M!;+SD"-+D$_L^^"+RLT$SXJSKSQZ(O301@DL0.T$:]@FHVX:F#!S*JIB&&<]
M63TK%=4=FR?Y&+N5!1A;.@7*F>/9G-E&/+YR([P9#WLWSX&QM[BU@!S]Y685
MAL,287%.D'AVJS"TX:=IA:90VB<Z!(<U_=JVGQQO$HQB0IL5,_>NU1M/;&:0
MA!J@/1A%YQX:?\:TGV0*9$P)'&6,G8RRZBU^_G8FU+_,'_3!]*W"Y*>S=OJ_
MTR(!!$=%SOWQ,JJVT T:% @@7&'G+1ZLU]),U.J8%TS218)WZPYSA.9'WUVD
MA%!FJ C+V<Q<<0OAB.YKT?'!!7JB1CR\Q\((,V(%RQ1-SPFB-FT,/']#Y &:
MG#S[;D4,-IG_UX8W,U&I): 7$9WP/D;-PL$SKD=KLP1#P<'8N=%RMG2I)3<Q
M&#:XU BG^$OO]4N.^)JZ3$O,R0I+$,A*,C^ <$0=V4OVIC3/9/H"W@&OF&4!
M/, 8FV+W^LF!0*L;G'<:H-H0[7RYO)7ZMGZ2 H25\H!M,B;4U*+0AFC3("9(
MUZV&FN"?OF'F.A8<!:,AOGY(W+>N&*5ILL84+P2-'&@F[W%\I1QL;Y#T$YL.
M&65G,2WNI'>0B0F%*@ZF3QBWX+1U(T6:[(4.:W:+8LQM#FATTXBH)0C.*;1Z
MO5=L\QQ-!4O#<D]LU20,3:^]QP2/X3,,0G+WJ9P.LNL%1T4!26@6<]Y-3,DW
MR8YK@#L6)/)?#H8RO+.K5T;=G*DWC (D94L0JPX(5]RZ!#$\<%S@*/TFEN>_
MW4@(.((&J#C*HT=U >@ZAV2EDM<-6@*<-PS*Y]GJPP\1OD0'2+["B4(:-!6R
MAY+,1R,_I>K[\ &DT'SO$N1XG$R!]"YHJ<2Z?"J5F:'EQP5.@K@Z-WXQ1M5#
MU%JK!AYD:3O-UP>'X)Q[H(E4W@;C4V8!5\HK==6 V@)U)/["QG"&=)!/]ZDG
MOP8:?$UMPI8@T"$COU_1F\K1)5K\[U#^+!"1"SDJSR_\L@.$'DH#N$5Q>ZC)
M#T?.O.&+8;C,N<P@/G+DFC<,1D* [V9CN4U&:@.Y[Z(8 #5Y8NM9CM#MWKXF
MG7BU-R*,2F5I]I00[]'THI76%.S/)F/Y^*)#UP/6]\;IP_898R,X(CNMAY15
M5\,)B6%8(H.4-?( BARY"9X3G?"O( B!T:8DHP5P%,5VDR?9>,+0G.1 1<W)
MJP5O@TQ"4 N@0\*_NF@F@*OXMSFH9%+H_+M5SL+RJ(9.6IK?))[%Z8GVT6D1
M_K N&0P&H^E<]5T6!HG4ZJ% 'LV;PJY3+^'KOVXX:NK&%(/DHK[L&QX;U[(O
MY^%3%;AT\EHH_;"8E=S\W)TK**R>X_*H<^.GG\RT'5FG+!>+)Q"(='[&J6T3
M?5HOB7 @'XK@5R_3 UE\^(07R\\/1!,$O^XB+/6SS_--'H_2,J71>D2NXSTT
M<<N6XV%B/IV!F\&NC;]6'E2BC?I. #<_/!=B*F=TO7N+/FU/A-KL+*A!WE\$
M?-:N\YC IU+DSH?N.L^_[\:9P 'DX088+HBAZJ&]24? IW%.;.E%4S3?[J0R
MGDAG&,*2V7QQWBXS%^7\44-IIN;&^\1]S&(W35?*D#1\<^V873<<V;L=M(,)
M5A-!'#ZQ7AH'G7'T#O)^*\UBVK1ME$WZH,=>FQ9.S9.C(-)/[C!N<]>*A"9*
M9R2Z@D<CVGU@^YMTB"_\)*M4( #B+OV\($X6[TA[-9&[W<2QC.Z):<Z_T JJ
MOB955V2Y\B(*!^>_*)>)D;U[Z/'4:3]EK":5Y*UC_VWJD5U3H-R 0"P"JH9V
MIB+WHC1C?I_D43E ,-_^F4]WN8T-/=M;<+>-.\?OZ"=VE\U;]9P]V,=E%G--
MS"P.G1\PBDTPWHV+92]7P:8C7C@7DY.U]N&:8D94D%_X#?.J1%ZK;<_VN(K\
MHVVAM1T;.02X#_9NN\6 WDQV<\/S&A=!#ZL9U+T\QR-KS%GT-W.OTJL(FJ-]
MM+WD(OL;Z=MM#G],BC6IR^ %TF>_ [*P@:'N6_ =J9_32(1'+:N"^1VJ6")Q
MNSACP>G"K0*<QE:HT ,7FQ*,)7QSG$,L060UJ-OPAW?E69K3?NNW6?#P1C.&
MC)F$04_C*P?W-\W'T,-%6'R1!#>XO=_Y\7""FO4K9A$^Y^R'3EZY&-ZJ_][.
M/\?IX_[:JP8W S^&5 9V^W7QVLY)IF8<([>-(NGO3,*$['1[GV.;A[X59* #
M1_55M%>9$HEN]2OCA&;;J[YCR^#P6K(KRTI.U^;2ND?T9%\EB5/*LB"1W!+D
MTFPU$%&W!)$)+*Z</\_-/4Q'M(B_$FOWM"_>3H 7:H:)^OM3/51D01PL%_\E
M4-%Z<4I'0 D(\9IDM,>&U7![K!;FN(R9CRMPY8O]*7@DX\5"TL21;,X(LJK)
M.LPM-[X,&T],]43<S/L9?=6T6<!J%C^CXI6>J6EQC)B3;E'H%00$S?1+@DT%
M&/*F/6C?W#0ORU3MCV!M7Y>I64=7\Y!< BY+0UV>4X##S\>$\76D0O,H=6^Q
MOX@CGB<Y%=VQ_EI38VIUIB\9[NP?S&+0,W/V=FS)('[HS HI2R?:_YX?]>A>
MN'V7.NX8J.E=.[(6]V1\8A6HX>8<IO.C].NR6U_KRY5L0>).L_B-=3?N.EAK
MS<Q6NIJ?[GC/C!3)?0N#.3463 WW%567E_[T<&_8LRY%CD%G1 %Q>8[/8QY_
M_)A[;+RE-,EUTM-H/*MX8Z?2$Z?>%^OZ(O;D29C49&)RB+BIK,6P,K=W1_&6
MAE_H[4@P&MQ,I1C 4C$@;=1H4P:2&="M%?!!Q+.>UR6WGL[\',H3OV_L/;F"
M3Y^6>$X%.I;E>YVOQMXN*$DROC;C?%^5@*-48J_!ILZ]"OPV7R8;L>7'")[J
MG\?A0Y3NFUO.BCQ$CB/&_N?][]Q(P7)Z68/D"YX8RG-!]W;N^83#\LVM2LUO
MC0Y2'6%/>_S&!=A;T$)6;>7Q:M:&8QNVK--WBZ99/5(9W&9J?=3J!(\./2]T
MGL^3)!NCIQ_FW?/+=7/X3/>NK;WO=>3C$P=%&;.!HPH]5,H,J:A*X>YT[\*%
MB_P]DH6B4Z-6]T]%&0W- @\8+82BP'%E4X4%V+<=/]M7^[QZ,O#(W:M _=$:
MO>UJT*/W-L_.ZXHC'E\>1>?:1Z2OC1..Q!F?N9K;4N32BFAN99;!;CUQ,3F_
MC3[L)W1#FUD7W#FL@I\DM8@5IZEBI<.+6J'7?VI,P[_!G_>D%I<'C1]N\1W=
MM&.+SHYKH8VU'H="L',?OL,&&+!NWE?KQN.UI!Y9JN'*7SG'/$[\=.I[.3#6
M6%RZ@C_9BMV/G;I$8!+G>Q!15;L3:BA*QB'O?N\&L'L9\$[BBSXU_L>_#N0\
M@"A 3QR<"P16XQ:10$<PY<7X^VE&E-B6/7N'[?C2L6-/B4(3)^(>1F%B59A)
MBJLSOL,J_=Z9;?CLA$.[/+^TOXPNH@QX=L[0%!]]$%Z7K\Q+22VN_("ORAD*
M]AF_N 19X2PIJ=K<&!8XY?&+4X?=]CO@PD&J">=YT>YZ_1D[=NN]:2Z@*Q:'
M!BR$+?HM'/FU:+Z0G[-0M6A1&'UNY*JS757ILP]A U]OV$T9>J1C<\BUB*U7
MQ>>G9FV"PBV<@SADN-Z:5<->S0UJQ%#1"['J$N312*C\@EN:>.//N9=0.:[3
MK0_S9!O=L1V_"^5G:OHJUD_0L,&S)<ZPG$>M1[O.S]YIRLY9K6%UU*;R9T',
M1=.D7 HLM:7@K4.ZL[R5?X=[2G(*\Z43S#?IKG-@X&0'L!K8&!HX-?G5^?>D
M[M5U%RHZ<M.OR(_K91T\UL!\.G( WK^\A-2C"5+5%)(Z;C*E4WOTMBMDP6/0
M,W59V]$WYWY\NF>]::61@U872LP3UB1?WNE0GDWU^D!Z9N\]LI:F&..M$J%@
M<U3?M*\DI]A4K\RY<]'U^9[<O,DD>D-,,U6 _(+L\(,]U<9FW1W0/J)1;9.&
M'\SL?+(OZZ1]:&M3\X6OUN28X,-0$O7[-YI&#.EIEHU_]ITC5]3'B=VI0^6>
M))YD>Q 1V/A24EBE9K[WY<TI?NW/]MY5Q9(?6BDE[@-C*C02-#64)C?V<A$#
MGF0;<6!&J!EA<&'GQ;JQ0%1?5Y^^5IW:TUL*KN\1X002>6@^/2O([>H%QP*[
MJ;F60U&W'NUX]?;AJ%4;I8F"Q%[W63A,?+$$N0Y;I1GAY[/:G!TT/K":++_E
M=<MF,WUUMPD))DZHN7VJTK@J-F'#\+&PV$/TU."[\<F2S%;*P<D%R2KG9/HW
M1N1T(L/,QJ48F5"\!*D>&^B<;^?,@J)PQ6_0V*:>E,)67$31I#PO>"ZOR&.;
M'.JZ;@MNF87">MN5#ZH-9*-68IAB>\F[*J70]5-?BH&#G>Y/+US0?K'^UM5A
MM0$M164"_R<E ==% 3:>6WBXZ!QJ7[#@DRD^4#355SG<<E]7;'OSM<7>KUV]
MP1L)393,-9CM"]!?G,=IR74!>DY?DHH>^,PV/,[8BS]JIB/IZ_4-]M!=:-M_
M/F^O+JJK\]&'#@SIB0TGX$Z>4R'G45'%!"[SZ5Z\2N;UD?RU'T;F._.WQ9$\
M;JZKA__0K*).@[ILY3EP3;E!MM^"*<\J-@^.RY^F%)3+[VA&FWPXW*;DN[PT
M(0#-F1)C#\(&DK%%<C63#RE*-Z<Y.'_6V+J0OHO>%@]7=;)VYT/V*Z[C2CQ%
MLN#30 E00ZE:-:UNNG?A1UKH*4+M= _5'Y-T\:/1KH95)Q+752M0E3'V8L>%
MG)IYPMJ*P)R@*U!@B\S'_N9[ZBF^_9;)IZ]-XV746*J=BQ[K?@6AC&OH-3;O
M6[BGMOW*L8W,,3_K@SZK<7B.W+#@,BG_JJ8S#NYSQ()\Q&G3?0N_BE3ZU2)N
M)6WNG"0%Y@F^S1*DR+%V_Q@ #:IGV;_@73AZZU?0NR7(E=6NT1; =]5:1CI&
M'Z 3ILZ%G?Y%Q!4A=G!MK[0Q$K0MRW7774]MUXF*5BTO8<^1?M5^)7R9I,K)
M.(7A!EFXBM,#^^;'HEAFE='=5MNN02(-K_G-_I:[V QC.L]/D#O.#M/&-TPK
M'OO>W=]3U]9:N@0)FL+6?Z \33G]A.I(=:?7'M#M$]ZU(1Q3RQ 7O'#HN^(W
MHW_'H\NE'E= M:_?$^'2(7EU;K_!P<"7O(QR?]AW)6 -;U%A%%%0V5(6\9SS
M.;^(W*=6/KKCV]@)"UBH'R3:M+1:%PR6:B[ !HB( NB#T,V_2!$BSC?:P;J8
M.P*]SW>^:UN23+^_-[4X5Z,_%E:'7>FZ7U*U!/$<-^N]W 7\,#4IC;;?;'SZ
M,F'DT%$[L62->+J]#-9-GS>5?*1XRKUP59F&1KE/R[^<;:X\)5]6V1&9<'ZZ
M82#_1G6D*E'L.8AR>:G5P)=_U;J7N*>YU7#M]_:V"X(429%%WU@Y/D_..-TU
MY7Z^_Z %K*_"\J9A3'2!M7?DC4]C\3FMPDGQ;DDR?7Y>\G$N1&7GP>YC%^%.
M'L55C^1/J]LTSQ2/OUMF!GOYD,%:9( &!8U:8SR+ZX(/3G>0AN/B6?#C1WP2
MMRPSNUKB*P=Q#\RE=#D":^JF$/->4["(BNNHC[]%5N4[""L$6XH^W;?<>Z:7
MF9B=$HG!GA>W@X^K!1_G$.JX"+N(&L!%3!43??RB[PSTN S([/YR6D9)1>[Z
MPSJ/%ZW3+N:&:(>-EYYNR"Q+?'LIQ^]7W"!M1YQ([XL8EUU+CSO@N?4Y$7HO
MVNZWF=_XOB^E[NPCM\KTDG_?QM;8PP;R$!MM:S$'%C33@A[U,*_>]CX4;73+
M[K5%P>43&R,Z<$V4B,K3=1B8J?9/_\6<K+F7AT\!(R/;*TK0MNZ%QB\@OF9'
MJS$F)F&>=815E#MR3*7ZF2#^B:D1<DC67<$&8X?OG_*NI/L.+),!%E:\F']U
M'%BC!9[L;=$_%1,&&,_W%KD[/+78_MWPS6NT:B+LUWUS+GK[^A@UXJF-&7(R
M]O5'?%,OTT7?OE2POA <N5ZTE-9!'!5E%A.4:<(U2XK)^"(P2-L6GW1%E_7!
MO#:)O4#]=OR"W[SGG>NI]-6(NV.3KR$J1MBYT2;6 M2<O*(APMYZL=IMQ>1O
M=+W%_!P[/8R:!6ZQ#G;@/5Z13BSK %8%/3E6XG:KI+1K[/G..>]M4=(^"!X;
MMRWTP'3" W^E9Z'V@XKO.Z_=<G[IG*F\[8W%2JLAY4<0FJ[(X>+;FXEOFT<7
M/IFJQ9%N#SK%N=J5!@QY+4%</;Z.&)@X;7+MV7XT= ERZ_!).Z9Y2VY>DN>H
MKU?>A9QICYU?W!Y\\QKPA1W%6H5T3*O7JMX6BMR,W?U$ ;PH838ID)-:>#DO
M\F1]AT*;R?VP2M/4[#%OX\+GQQ\N00Z'2'RQL&J\D:1O9Y>C5>H0\>*7N#C"
MQ?;"$#1AU[.OIY(CKZ4:[*WDH8J9\*"<P$#^X5AUS+2]>;$.OL]@'N:4O02Y
MHWQZ2\&UH11WO_$Y"7KTP.JOA2KDO;:T)OARHL(\]1X0^F/W8[4P^MG(T-+Z
M<S3OX,6H7GYKL'74=@O8BU22AVJ9230\ ^=#L7A\<^?\_9$O]J,FHMM)!0B4
M6_Q1J],[8A8C)C@9!FP>5V0?%_!2XN<)?>^*XJ4H=YQ]K\4.LH(Q/ @NG#F@
M8N29@_;&;H ^ULMFC :-+]@9Z^V\']L3[=)S:KKSJFX9/+L=( ;^Y+:ZMJ>H
M39 ]6W6]Y ]83 C@US_Q*PCE#W=JG^RO";P?M@11G;VZ8S/N\!D<KDPB.TAH
MB9JEKMX#Y>[5>;/X.<A$OUK%)$N0J 5I5\ R%65Y7 !EK?!5.3^\_6=QF]&=
MW$FB-W6O6KS%L2]W>4DZL66WA?=B&./^54FOF0D]H4.;BX/6?!<3P\-QG-X?
M57RTZGEAZ ;)M,043WGXL;#:M@CX;N*L88*I7,0HY&@HZK\.E_1C#P60\"U)
M5B1MWY=..>E>Q8CMP.)X;U!@4]I$'?GFE_=>9:W=S##Y#,ZZ7)^KGA<.O!B?
M+T&5(('/V#D11GD:P54"67Z5-K1["7+AT N%;J8X[:' E.!:$3*-&!G,'2S*
M/63\]%!?#4WR1;670)TES;X"(639$VCA1/R*](BN<2"4LV""YOS&'@"0TQ>
ML]^'OMQ9=.]P0>A.D,NK).0YV/6!W*(+R3&.S0?'68.3^9)U+F%I*.]'NHJ+
MU>MG8*;!'<@F[M=ZTER]&7H2C&V,K?4OCK_\P-$8UE C"\<E^S>KW9-/;I:8
M$OLIZT@^.>+X'TCO1K\$4)Y )$9K)STS.AGV8>R\/M,9,]9?;=^5" G%)[FS
MC;^-_'CVZE'^!D&=9J@X7B.-,@O8WZFOV^7RVNRXH&92@FUHU=DE^]:R@BU+
M-@95+0'>5H5D,<V8B+.M2K._.X')=DZ^Z\0F0:G;S9 O/96DC"@!KWO'+G3
MP*E(RC=J)BV40"31^WZK]:^]3M#8%P2E$9 OW#V5,DT#X_L"HB(H9)[EN128
M^@>.Q(/!4IB?@*<'UO\,+BDWF5CT?Q4M#CY"3)GT1_?Y%77._\CR%*"/_.I%
M=R\[%W_4T O -HN1/^VDB9A3R6@W!M$D7YR?].A^&L32O1Y%F &=\4AE]IDU
MP^'ST1M9)=+!;?KLF4RH>)F^,<B)NP^2!<[2Y@7>[#;XB+?2CTOL#U$ZTK8"
MD^2-QU&[(MTF-XHQ4$[[\_]WZ=X$[%O^O@W4Y43*PA(DXG_(]GY)Y&]4[]47
M4FA9;/+@SXS8?59'UJ7@$HRQUN/UL&H9+W$?L?FY<N!A)FE&G*U,24Y-"YA(
M+5N"X*"<[>J[SJ?2$TM_K^&0A,#3#]5\Y BR?%)ZXV7P$N0)!(X<&5=U/Q>>
M[RJ!$8:M(MIF@'/6C)3\49,%53Q%$AQU[;U9=TO%K/JT-!%Z\L(FFY3>;0:P
M(T% .#-E"?)L!=*';VJ_LG1 .B\3.LV#E_"UC1M^ZORFX-C6YKBCMRZF$9+%
M(E4CP.0.'Z)5;*O),/;_DS5-AUA586.UUFYC"LJ7((?\YZA.C_Z>]9W<_7BF
M9M%"UJ>WD3H+M3+%?_\JX_8V-#\JC4+QIM"+((98'6S;BU>23BX>)NH[:P5(
M\XA;?=8;SK*+87BD?4;]A+KV^C V$T<5BSK:MC9KC*NG4N['@ !#Y4CK/^)^
M%T\-*R5P92D8ZT9*Z_")>[A8Z37QG/[X3<0 ;N150^QKK"0LQ-:=^A8HO-\@
M7(+0L,U3[]9M%3)-@ZQE;[D2B2:P!!+;0C;U\]AS98_HVG?2E",N5^_2^Z 2
M;65<+ %+%6[LT__X^$B_]_K065FQ!/:>=V+]2O'8F!(9FD 6RHI-LIUQ1G>%
M;]1#I\E+D,ZD!VZ@*UZI9_,!Z- <5V@7LU(FH.TFY[T&G06C+4'R9(ZY!L;K
M?8M\%_;+ "HM)K4Z2C.)=@[>&%LZ207<SI2Y++=UGV\-O.<,T: <WO])SE<5
M&P=DZ7G!8-,8+,FE$_WH4?E-[:G@><XT@"$\?O<GY2MK!&_$FQ(X_/$3Z\G\
M0)4W.00S+LN$0BM2[_=XR_^0AOPZ2Q-2G<Z=BD9IX1XV3#+P?5CJ"PO0YW:]
MOA9*)0M%\^)S*Y\;+T$.)EH[+E]OB"< ><(,9R'E>,*61OJDQT,>G8'C]42L
M&TYQV:$/W6\"@\&)',O'^_O*W.2M")(;IA3.@Q5> ++I ;/J-Q=0I7!>)&&-
MKK&V_$5;:6[- [!R3GE=?"MU=>]%(8=(@@X!VP_5!$S?=^>\AW&X$EDG2.C?
M4_-%:R?Y3[?MZ!/ X5-2&+4=7$=.#H>:R$A3W;^#.R[\?ZR]=UA3V]<M'$7%
M@B V0$I44! 41(YTB.4 *DIHBB)%J8I"Z"5 -HJ*!8F B-2@"!$LL2!%2E24
MT(,$0:4$""&&$ (D@20DF[OC^=WWO9[W^Y[[S_T3\=DA:ZTYQIAKSCTF]J^
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M/E$B6E1X80FT46Z04#*U-(!T(N?G>08$,)D!%.CA2@P1O\/MH8X>E)[)$D(
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MJJ*J6=6^< RFD2OM*GY\>(',C[^!;!&G""7F)V\F< S&<IS"PY\D(:O"8T7
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M!@N!B":#=8W#0%*AQ<S.-%3@.N^+(H\W![?'S2[W]_<X5[HW;GCF"R87^*@
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M5&%5.=RX<V<1\:DQ#(JP2V9<$[5YW!I="*DU+OG8G^">,!J<G%!.LUJBIN"
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MVAU :QW1_%&5<8",;(]F"^63-FV?G4WXXE,]K#.&@2-1K;<2GF/WG):+J(Z
M.!L.<00D%1+>.7__-8C07(3UBI<K:83,U+L:F^L;XCX N+ #,HFX\Y]:B.I'
M+ !KJ17@,3\O-^L+$<Q7?E*2N>ON&S:6_R3>F \+$3<AQQ'6,V=5PH><G\'G
M:GC\T:1M@$&[\.15OT"K,&&TM$-;:\&:G.ZW-GW^"FDD7P(H-&4@C3KIKL9V
M,J6Q<]).P:"+=TE9W"?G,1Z;9$S%1H56@&AXJ7)=/MS0(W^F(K"/4"5P!6JY
MUJS+@Q0BM/5J42SJNS-51L'6[L5RW&J_>2:.27XM]?Z<^FU,)XRBB4>3-GMK
MR[2>64*>N6H1+[6]-K$;"Q;V'AJ0?"5!Y$,6^CRI,6)[[U>TC?T)8[/3)<"S
M1Y"4VK[-(=S!B-+#$R/4')?_/3M_M_5+W'#4;U3(["V0#@900W.4K: GC-@K
MY8S?+5_C-XT&#+B<WB<U^^@)WTXB)F=8S"^POQ)Q;?#=>7-\&)M<0RNQDT[B
MU%-,,TY+K(V6VBJ?NE(]:ST6;SP;:H()E)V%9U^ 4@:&3]GER,N^B)O0LGQ*
MTI3.!7CU,:PYI-X*(1I<Z)'.45VS<S)J*YO)HN >/<&U4[GE-T@VS/XJ31ZI
M]_F1$,N7SE9YL5OE>&(RAOIP8HF[@?8X=Q,96;T*@ARB5[R+=QOUP[D<-0TB
M0SSC<C:.:O+@Z:#U-+P/PC2-JSG:.8SP(FL[&2A(B?(5L#>).%3SFQ7-"Q]H
MA! JGGY4:N5\9YL9J$BB":1 T%N:/W!9,FJK]-K1*!7K@ PIPL@^"@G\GE!Q
MR*ASV#P^4-H#K[ S20_#:1\S[B#)2+=O!F\_-AQGO]4,W&N' L!W,D#!!]5Y
MM33I(-;5#VB='[@GE7 C,+0H4 P6K46^G53-.#' DX4SX [H<SU.PG@PM#]N
MQ,XJ3OK*T+.PQ.)65:?5W(PP7"-E5C1\,E;ZIL3)/;_04<HL"+_X12O:Z/X)
M1;3D IJT6Y>X"_%U+K'%A,U*KK)"2Q)%\6$V+=EZX^5E'Q>*J?U8"%M>&(=8
MXJKSC/FT&&G#6 ?LY)W6%NZFY@]-71'81G5$\\8,J9ESM++^BL/0R4#0A&VH
M\2EK]S+KU!5&G>CA,#!L\*VP$-59KBISG0G"7R)R8&X+UHWO_ :O9-BU"= ,
M<?*).RW"NF\1%-4EB$(KHB2Q_/,-6JLPW7CX7)*1@*\](]ZG:X&R&)_-4BV-
M@<6*PZAB$>Q =%P*[!H90Z3@>6+=WQZ>TO,MCU @P24A%5ABIQG,>BH9+WW3
M(0L9&O@;GIJZS..E$V8G9%<D;9-.!_ARKS+VYRHXEL864I0"P(.["I,)POT!
M ^17P@O7(R!D$@2FDXH0V%@7Z;YPNZ1/*X!I-2#;Z,_2B F*8#R8/_=[Q&W;
MSDFU==;>) I\;'44N6!6>/M.W]05"4)A9D+W2 <I:_9Q\,>6K8'3O^Q&!,..
MRT]+!SK4R;G)+I&"RK3X2;KFUK\.)JG',!#97@*^>-=6KB4UW;5282VD+CV
MO0N9NZ!M24XS!JWSI3Z.3[US+J%P!K2G%#>/K^%N[MHA]7P=2?FZA:76D_R/
M_4PF$XP_^>["0,"YSXI-'\E(I/?E.=&6"S(J>AJF9A\&V1(H[<8"B,"3OM10
M3MH/J:NIC_I^![=KN97E4R;HN$NL1W4O_%NF]';VY'GT)X+U!S8?5[Y=+O_H
M=:WR&)90<C9M5ON&_X^='/V#&2L]V"@4 <K%-N5/-W67%>1XQPPZ1^?3IDF"
M-+,7%8Z5;]BKL#N$)$14_7L<FO'A)X4>K)>@?S:XI *8%DV0-8@SC]@ZGH,Z
M1P\[X#;6H\'+X#+B\!CW0H+GK0>'CHN#.\U_WP][MV9??U%LO'+B /8]@Z$6
M*HND=P"G$-/A"3%[1AOI6GY0$'Q)G44Z$)/&XJ,(=(5/7<<JGQX-;KQ7/#4O
M1I3&LKR_@^NX0,"(V1;B[I!<9BS[)8&>J- A*.B=^W9_X\:HNGS)_I\3?=13
M519'9KH'@C55]D5"ZB-1]SZ(?&C=];(3N6)O=)HI><(J46)@S"[R@"6G;E0K
M;* RB&K?? *6)18HTCJ/ G4K9)$4)NL>[!]+.G1096_;)/A4_/YE=_P/\:EQ
M=KW-I:CN?GZB%GR"-&]($;P61O-&T]%P/7PB%7O,B2(A.OP0O\><+LH'G@_/
M]0OX+.\-GG;]^@'#A!F=,T,S5?6BN,NA,?$3[\;'*ZDA/Q.IZ8YW?'7DW^3$
M1$%!(3/+I(J#VM\_ZO8=:O5$'DC>T]=@-BG+G;]@8M/P=^J7_!#H!/ M^1-&
MSLTO*N(N9"#"MC:37YF!<98QFR:/I50]<M@5H6_#J8JL_/:R]G)M[I!E3P__
MSI!U]T!_Y#M\PX-W4R[&55X[;[T\!^CN]\BZS[X<+].)P1WKH.@_KT-@MHSK
MW=(P'DOZ(F]*QKL/WGIR4L*9>ABX1JF5B*=G@ML?1Q7TKS^\X3"Y_1"'I&U=
M _=N3-6H>_FFS5][DTJ]V<\@]I[(J_U>!>R(QUFQAURPNM<M0O <&[U+E[PF
MP)M]W]Z1%02Y.\[L*95[2&I)QF%6L<^LF]CP?=N["KD]L<J:&778&:G1P)/9
M(<V\(YG:3\_)]D1JOE0@>'T+]MMAN'UK=F:78N8$&C"R]7=_<'ZAF>(8?NG4
MMUW>R+-@P\TAT_?KC@*;E4[=IW^K$%>"[X<J8HP-B0_/WVO^L?O83+Y<^CVS
M":LTA$K)^^G]GQ2???>L_P&O-;3]>'A..ZT]CL'O^/MNN)KP]=^:Y.6N@3)B
M .E^YOCU*S>&5GB$>RJ9DDV;%V&6D83URO"A\BB,JF<X>Q%VI>2K2%BPQLBI
M:O?ZH%ZL<>6I7P^>\?;V]I^^5/#3YT"N R=]I]-X<&?<L-H5$JWI4O$6[Q0\
M%M3>^SJ1:)@RQE#CD>@2<T+NJ*7^9H](> RB;;K\V5S*GKFB6N2)NOQ(!D$=
M48JF$*Y</[+PJK1858]:F+B_<OX2<2+<YS4_3'$\E;;*]JL#KB8XNWZ/"[^R
MO;2W<'U%C<WKJQR"ZKQBGSJ)@"K5*^HI>IN'='2-BX]=O0),;%+HHZ85A)\)
M'%QX^MAP)J/51($LQJ2DGKP1L')98&2RX.S4 DU;!4YCYHY\&HMD^EST\=_?
MUE[2^F)S;ZZ5Y[LJ0AFCAY&M.7>WU6'*P9V*O,Y*=%^$;4]+5\\J\UU]3!XI
MZAC*CQ+-BV?<3;+[0I[?6RZ;;SP4VZQBRFX1HT]&&:GE7?L[I%]6W8K8:5U3
MM']H>"D^DX+X@N6RO,#]3B1\2F3]_:W9]4,M*(/:J>,I6[HSG5^HA$_D]0;U
M4CVSHWV>&]4^Z+$KV'QTS=V!1'G;Q$0C06_/^E]7C5#JCS6;5U_]JB.\R9JW
M Q9A9Z;F!YZ!:>7D@;W*9#4&$0_W/GCR1$UZ5>?2(T9WDWP1*1HX28AP>*^9
M\?HU+%-EM_D&K?O]Z$BZ [DOHO*&T28'..D8.22PA5+"PR!1.0Y(!??O1Z(L
M/BL$'0U.IVE%? ?R(SANP6*GDJJIBG@SW_.-2MC\?)DN^;%%F'F^5;]!UMY3
M21H"A'Y\&CJMD>DDW*Z99^JS3#)9GHSSB@.C>,Y?QF9*6JZWZ73A=.GW7<_O
M>4!4R*JM$HAP_1LB/4WTW<G#%WFGV,$BX..>^I+VF;S^%MF,<OOME:KJL3)6
M-Q"ENR(KIL??&E9<T1\IP#C/&FW?0#Y.8Y$%MY,3OB!B(94XM30Z4!M[/))?
M2F+<V'F$=AUI,0HSFV_F,$&;6-/;U:DG:<="&S]M.6:4@K!Z44'0."MF_]!P
M^>Q0$?2^<_W3AE6'$NK>O_"OIXK7O"RYZVWGN?W<-I39459M.XWZ$@''\ -Z
MIXX^/LW6?M!Z^9Q]"'M9\H!E_!%:ERCBY]L2$QMB^)#/(DPQZRVI:]8<E/FU
MK^C]W69#DZ+A0*)E6(O4F9B@-[$F)SYJ]:NGW?.;:,_<6RY5DO+XZ-N.Y:^-
MG-\'4>CO7I2CN1:<JF(#9"+A8I []TN#CI^E,(QE\L7.8>ES,5J!U5M3MG]Y
M3P@LVZEW*J?_1FUM=;X&<*<]Q#:.(;[D[QZWS^!0%CO-P5R!(DH?>N27<U:B
MH9-0-WLLZ;N5*(I56"/1#?)?E^SM,N>ZHS;TF'G\BX5G9UE43ZQMH?9&?)O+
M!O.R'4_*S8(#+WD[Y$[TEGP=$7S6TQ\[YZHVI1%(T-;&,4Y3$"DO=IZ.6ADR
M\*#)9R",['B ;W7I[_H/3G2CN/R$)^)B)H[+_.7DUCX^I],V]RF93$""1*LW
MNH^RXX^%1 5N>;<I(^OTI>#-=WG<RJ$ HN?342'N+Q?[K%,5,>Y#G>2739]S
M-U^7/(A:N\&E]_++3^,(?='H=OE5:IIELEI1/#[S\YF)0L-+V6D+7T#=!7/#
M[Z]9;K35JO@-OJ76=;Z]5>W9Q2NO+%-I6J)N<0[M6\5HNJCPL*[?]GJ:4;4"
M 5-OI4!1?FSFL'J]8]G1DU'[Q]_0T\AOHQNR!YCX/)\R!]QNCJJ>5TG))OPG
M$;.O^2NVJ7!GY4UF[]"N&0O25MU3P>Z2GN0F>6:MQ/ ,\#UW/C?*KD>K.FYE
M>$C(EE/6-4,=''Y95KB)P\V=[(I0A1I(%ABT+*L2]FMB&%TF(>)XN5/$'P]C
MRV8_9:0:.]T.9A/WO./W/3,K]PWJ+3L5D>V).EDK-FE(HW;/ZI&CC#:=Y<G9
MKCCOU$]59H(1;AL_CFFH!CHK# W']Q@P&/,KTXQ:$@*K-"W!K*T+Q+U.!FIR
M;/((B?=B6_*3LD^.Q^0GQ!TVD?9V^'C,"Q7+$W;+8U3L0KPO3G&^_J ZY%UN
M?=!RV0\1>$8&H!Q/0F*J^6PJP7GMK< TS5LG<])@.JM@$0-A)$Q]_<6- XSY
MYML%MWU-?UD N,_=AC6=V__VL[+W-87CD)39ER5;K+_9_7#_VGO65N0-KL61
M*YV/N<R_HP3J+<+&*L4ANZH=3=X4I+SJG 0L9Q%>!;W:-X;A>U2L8I;6,*@B
M.%AWK9)289 ;<0_#07)YO-''R H_X:^;IC(!9B(:DRD</I5Q=[53.'ZYRR7"
MG<H'0C:]X89BRGZS>#>5"DE?1\C)TOQ!N'?7E0??=C;NOG'(3M,B?&4+61/A
M(G+MJ[4L\F_;:;JJ[5RB@I!?TM$[\UK3<$PM?S,K'<<593K44.E8G168D6H/
M;AJ?8L.UW6/;4N)_B1.2>W;\I.>N3[M^?G6/=W#M=O+$(4; DY>/*=Y<XO0=
MX24QXI"!8Q4)]20.BNSU8_[IGOET\-Y2-9Y# 5A#$X?=?I>S(G0C820_BBV<
MZT@  [+WV_]Z\<RQUGLM%6'7HS,XZSWTKH+X[MV+K^&S(A8U6%[&X_O^%P:=
M<G8_'PT#?0>,*!0Q8Q.83IP^X*T'JLP?__E\PV2T6*-XC$7!@E5!BS"38%2[
M>6\._;HV.S24RN]20+(HLX1_.F96 =*.F=9'7PJ(L+ "'%:P<!N,G#FQ"/L4
M:98HPOS8[^Q<RRQA/R8ZW)1D7O6NK<<9-)(O76CX0IC'=5U>A 5PX3Y'ZPJ%
M)"1^5O,ONC%-$O[:ZC6%0"//BH,N94;45&F=CR@T+#0$XT@42]==:H3V\T<6
M81?FF0),E.!D8JBHX38G#_=X]A24DES%Y%Q_2[4!Z-33/&3((BPKQ?H3<:N%
M(:6!.B.NX7'L=)]'ZUU%6EQAXDBB>/Z+I7ZI&BO 4,/9*>W9ID3@A5M<0><.
M5R<*7:;* >?]\A)#75(168<B[EF((C+HO^+WU]2<;\VJP1B_N-1/Z.R%/G!E
M[Z3L0W@<,RF,A\ 2T;%77&^$^&H7T=]S/R#:$R]^?5X;L;[,I<^TT^R7PTH:
MM5 RH9QZU4.G+?!1)Q5%J3(E'%*U/G/V1!Z]O^TLN,6#B[-X4%?IZ>(\WE_^
MMG<012U_Z[]W;&56D\4KA'32LAD;^>^;G['V:&%Y$G<^3&(T@;"NM[%7J9ZM
M/C(7/';/B,)5K\4<+O75M:%/289]JH<-O HA=AY\FMW://LMB6218BVIE=Y;
MXC^.HX2;['V+(SG]5T2^3/NP<8[JM\.^CVDJ8EGA_$:8R8\YM=UY,SW)55P&
M0<@KM:%'C*=8YZU HKB";Z4F&D=;[=ZB'%=PVOU 7RYGT^OL/73=UXNP2SBD
ME\Y2V=GY@O*/L=)91%L78>F])9F3"]8V]XSMAF3A-R+X8L26R]*ADCIKTS\P
MQ41RE7NA;Q@]@:GLG;W\0"="CH'U!JMA-PRT9=O=M"V#5?@L-K@)/B4FO^\W
MB>1 ?$=21\^S3P6W]R,?/&VTG%*Q$@6*(B:#%' ="[]MJD#/V$68:9&L]((A
M:)A1T*A18$5L^CT-LO?0#T2D&L:4U#<C#K)/-OXZKJM#5K55"*D&ZQ96GSX!
MI:M:_IC+#V1,Q6%I5@C1V-+RN/@FND_=M/DB+ -H83EDM]):Y:UB4C4688SI
MDCOM7-MOR]_$6B&RA?,L9X^<\(:@<MQ<+)\WFK2%&/A]WQL4R5&>2D[#,;J+
M?]\?W"2IVED/UDIGI#P+"K%,OX8-&'JREIKS49Q"_[D&,(G[7GY67569/(H@
MORI:29^=QTSN]0A7)2"18!6&K_G[4JY6_8@%&LUC_+JHS3413SQZ_14=S6Z6
M&/*?K5?%ZMV'GKA2Q@IA1*WZ7]R]:5036[<V&D1!W0KVPJ:)BHIB@XB;GA3V
M/;'O0(*"HFZE$:0GA:("BD1!!!02%#&@8D241H& **&34H-&#! Q0 PA!-(0
M*DWQ5;G?<\:K[QGWGG'OO^]ODI%4UESS>9XYYUIS]CK%[L-2#&^#V0-C0"B
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M',7"K.509_U[AK)&!)6XNA9W)DR\>,3$>/^-RG*6 (VWQ]?ME+%Z0[D_ )7
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M3NVI*+CMD[Q:#+FB<4:?_I#OO:G+O<*NC6B_6!HC$J^J*NV/@UGXD6&I8W6
M5R; X;1^RMN;*JDV4O#.4\%)"JA'/G/[Z[_NG-IR9MF9<VSZWX7]]OM6//P.
MEU0U%$9$+6%DUVUI]-'Y4I<5S6>0T7U-,=*<+.D*C"[X,Z@]2T4F9/&_WL^P
MHJ2MZP!#P1S$$Y4\^[%?5$HG\(WZ )7607OJD/_5X4YI)6?9+7' "]IUQT6[
MSRH+SY4NB7%>\C=WW]PIB8GVALPP5560L+K%P;5(_&YKX,Z;$2E&&X][:2*'
M5+2>W4M/C"S#C06;W ' B\I$@YR6,3%?WM8!\0QW .K:D]5>\-#__95/6QK:
M\EXHF;#-ZZ [\=9V5QE+PPY'/.[0/)Z2C^J;4/$\TYZ6<*5COWZ54V\.I>'@
MRE(#2:KZ&9%1%:G5<QJFSW_BSK-LT'_H4VI.HY#;=?:E.'!3QR?1^/PA5]=(
M\F&'Q0YU>R,<;_)B]I4<DF_E/%NP[^K-[^W*_L?IJ2_2WS%=PPH#?8ZZM&TS
M/Q\EZ[-!A47VEH<N3XPS;9!B5&UQ:,01@\6I9O2>6$]M1 U DG$*_UH0"F_S
MT-?(5'ZZ<*1"LRA]L$N<ZJ]TGWSP5+:\JHJZVO%AR#>>W1.5P^:!TJ#MYSXL
MZ+,S7$Q2!C\OK-M97",7  +1.F0W(+$\<<=T7K<?-PE4//S^%M\I?>.J#$JE
M@+M1;2'(.[AYPVON!'6 *#GK)[L$!:=M8&MYRS]O"67G2C5;+][L_5K5X;G?
MG]*I3C3;>/-L<T&<NMH],E1"\P(K;R>WU]V'=V5JUX8*6@6H[+4ZT.W7E?L-
M;'+Q85L,0L+/CQ-R<=D7\'2P/A05Q?#Z_+J@O'.6UB\>!YP#MS,?'>SYLRCE
M9HQ:MF!XW^=]O2]>!2#'+*7;<E[4/NI&,8IS(]F)7!G5RKF[;6US\#2^)$G
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MS<<H_=1<F^A.W]-:!Q)2QJ+#/SAMO8'W%VYLXFD0DI=<YZBWVK%LVB3M^]6
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MY'VOX5)QXJ>G*UEW^4/:8&K;@W5'X(HO;:J8]G.*[L@@)!RW ;I]5IV,,FN
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M+X.L774@Z2C.A1QXC>K7X1QF[BQ718+45GB; \G*TIW8*61S*3).$>[V"N3
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M'FX"EV87W% [+5D/*J1Z]=RI?Q-"9H9Y0)Q1S*?/)XE%A).UEODS#>=RT5D
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MBGG=(#O6LV+^\:"UDB%3[ZIHSGN]ABDFOFG_2S/G*"+0C8JO%J;?@7IK,G,
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MTW!0F6Q;0,F@49(I!K61E182EP;(*#T4-./K_%9Z3VBX31D7\";+=]W_M?\
M9WFJSI#B[H4'.5)NS=+ \!-=5S_>8ETMV6\O8]^ZMV7_[?VC&)6\X%-UDE;P
MU[?]&:VB 8&#L)G#TE:*VLZPCW53G=.R.2.!_.'"\-USO>BV'*ZENP'!0';-
MMLU/SJYXM(F*/2V*==>([M9#^ML^Q?FD3O^,_MV;W;^SI'S2R/R7=[&Q>OD
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MZ;<&. )Z[17%YA7N!F:#*V7)XQ7J]F_@_I),]FECGFO _8/KR\$7'BU97$N
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M-Q("*W*'?D/\#Y53A-Y(.2WOYK-!E03J3U[>119X91=;EXH8YNB5L_QS<IN
M04U80VLD'1VH(*E>O_B\B;CR.7=>,;76%7+;89[,X-JF-+RRJ$L:BDS52]C>
M-S"?J[C.8D$E[3Y5(N7C]5]X@QY=5.=PH -*(A:MM6D114VO4KH9M BJM]$7
M7PILC(V$VZ/THYBKF'VD$IVM);IX4F3QS@I;NA*K<YYWF?%R8^J(6]L*69\G
MW=HV(@7#X-/2@828PJ\S?B4$.CYU>QJ5UFWF"T=]-N'I<D8Q9%9<J8. &:&,
MVHV5$_8@T;#)EL)1MQ_:W[+4AC:7?>] @D.\NAD)R++E%X;KW9_S9-3W<=+V
MY%_1*2)%>34:'!QO$'5FVV7W0X(X<7RT1@.Q)V\\;Q=W>Z":,!BEMT(T3PNS
MN%FW]T:]KA)M*$L[DY=S-5?I51TLCT"L!!I>SZ8CYM8A(_<,G<+@61A/GEBR
MS@2(LRT."G**S-4T2%6<B+OS_\?B<@,2;>B2SY@_R+0XR[A!XE;T%F6DW*=+
M9]C3TI$ZC"9!@[9P A>GL*ZDXO5)241N?.(]C.E-6S0<TD& RSAI<L2^A+PV
MN"5+D6H(\4#OS*,3?IW[D&A4NXUB<@UJQMQSAX2V*9(SN10/$7I<&SW^,33P
MFMP7@B=_2XB5CD3/G=FEJ\QL$>0"TQ##*Y7[FI60 UX7FZ+L8R4:AI8^N3=W
M3V/LX7/:8EK-*,8(U%9EL92(RR(8&6))Q @E#W\,PP)9SC=9>)!*H?-8^4X1
MB,GN[^Z*KB-: ;22S^?7T1TZ-IAVMVZ4F)XS H0&NTSVC&+'+Z?0P"1Q#TWQ
M2;K?J*NJSC+_$L)B/\4)^'.L6720[.<>@@>XLA$?%Y:R89]5S835K<2I7P![
MV=9+:^+(3V6\00GS"[(PA1@!),JKU,9*]0 M[U$"E7@(= JT-1]+Z#8KB-0'
M?0KNZ+=R6$*O%D(P]FO0#<_?M*?<K926^*07\0#]B,F*?X5NO% R-4Q8R2;Q
M(;7<^Y+G'NUU-V0;X9/0M]\/_SX 3MA[GMNC@ &S8<RL SH$7W**:QSX$,R^
ML G;Z<',;.HX1YN08-!+K*MQN\33K];X5L88.F0C=!+X3?4KO'>%;<KK5Q8<
M42I58CQF\@P! P2%)$\=1D(@%>, 68 $A/:9PPJ0"=K1:M)EBYLGR0<DB$XF
MB"H:YX\CAZ.EHE.F%AYTF2X.\Q).%P--^!S *A!L)6+?W"T%XY!XN,#+@0"0
MW_//4M+ZZ9=N@0=O'$KJDC!9Z/,; Q@ILHLE@LJT/#1O$E2/9QKO-[IK0CFA
M(4)S"7,4X_]HDUCQ!C='E)&K%CU$E++H_>:OOZ0$I06D38L<B:(VC6*8GM-8
MX%#/[N:07-&?,T"/P5A%%R%;#L>+.F_-FV3:$N</I!#.O4\3\M+$*2'9VK3N
M6IJ14$.75&/VE8$:,URPHT,R3OY>'X(MV#8]Z7X( D5<5PXZD>FCSZ4Q\*!7
M(&UM"+.41 ('-IX?#Y!M'P=]61F9JWTM57.!.YB-$ I$[!5\!ILE&>$-)BHR
M6SJ$@R*BA%&#?S2[HS^Q>4T0U(U0KU@E]_ZY4I2\G-&9^-0IM#,)QX-$<_Q_
M9H7&?U''XJH7PJH?Q5& - P=&[,%G<#C%,XY1/2/Y+L:(WV=.SUHL>2$#6XA
MV*N[;ZPS)__ H59W-=Y+QR%/1/(97  Z&7MBD:\#5AH7(SOH5&)1^2CFKR$U
M?*,!V<7]2#3.(9C*L]8'??C?U.&X+:>U?>'I/K5&(80D^1B_' 2V%4YA\K1J
M(A%L<?I'>=IQ-89TW2M$-%=BH6G=@).F?4S_F14PSEI:W)"B>R2$2 _@=1:4
M@:547+![&,?;@3>*^;2KAH1B4(46IB!^./?CBTN>-GYH7\$%PM%K\S%;3#L]
MV-T#@HQ<$1$=ILV-/_O/$O6WM^,)9"N"-Z85ISB7&H*P1'3A_8ZJ\"._T;P"
M*$9VJ]OV<7R;<*\<%G$ )M#;"W[BA:*?2 /M*FQ]$<$AY42 '%*@ &TJY)3I
M$IP#R[ ,%UDJ)?N>J+G'HZ7R>9U;C$* IBY"O/_M*N3&?HNG@[2W]U;]E\8!
M7R-0EXPV%9[&AG;BD>!+_IS#RD.A)VD@!%)K.2]MIR2=?_+B-\[<00[I*7&U
MD/&?NFBL/SW.U3@-X/9C7I!1*J=L6#6!2"]P$.!QOB0-U5Z;XS3,8T: LEWT
M)I"P>^$I5P45A$F;K_^(QXJZM2$6HC,9/"8IXB[FEI#[&8E90ZLGE^TK387+
MT.DM@TZ*+DJV MT_>=.3F8H%,:Y?5L8;T%%%A#<.Q6A;083>+R&!/<EVY:"&
MF5-L(3)'7]K/4/BLUU 7AW846P_30R4TMO$$<W&RB7CC0%1]J#Z!#DJ[7,=9
M3M!9$3W^;\TZV=(,(;^<N"@^(P"D4TID=.=3NLHH:B\'[5#B'RV&JD=B#U4I
M<;0J%;XR&G*;\Z^*-::$\$$,3&C&;M5"453.4.$*J%O2)*BTDJ@Y*N.2R CQ
M*.9)DH'4U"H<,KK%?]PQ\6^L0\<>ZSVNFF]17!WWD&E+/YE=A>1]%D=$!=L9
M_ZI8/WI!3ABVQ*TT79$+LR5=FIO_+%EC_-#!\*6QAL]<G4Q!/7%5JZN2"VG=
M[C"V[=(_Z+RHN/F_Y>HF9 >W_.BF.:2GFM##4W@N1L=C_V]-!M<^IWA#$!J%
MM_\@AD.83_^;-WQ^)H8UE1ZO;\W#:5'Y4 NMS?^9%$R.$!'>M<\L-O68JM6J
M6]WC@^^D-(- '"L.'TFM)4KR7<>S;TW9V#MT<D+DB,@6^>G]5XCVE 7!NUZ+
MH^@\R)#V96;73\11@!:WV&):"SO-02?!4GMW'9TQQH,5;$Y,<!V;2B.IH<JF
MOY/H,BQ%6(F$A%M*?),\4]#2U;.[2S3RW AP ^)#>T)R0'DWQSL/:,7K?8_,
MF-GSUXM4L\I<](T#&05_G61/F9'%M,J5,*U)%"-@DSRFBWU,V:JP#W<W@0EE
MK8#5SEB88MG8D0KF!N?,97V.K1>7U;MR>EN)]G"UTS]XX?^V.*E;-2VD2,F
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MPR08*"$#B)>P-:\#. B:IJG\= :SS.)P[[A @A$PD^W8.'<2$B\E G7TT-Q
M0I:<GS]CXF9XN-O[]!0ZW[K0Y'XS6"9@1^I#V#H9]<2MG_O,GDZH]>LB*W@R
M*9S $T_'>#RT3B/_0B=%H8_13.I%W*<R5*!(59DCZ2%3%<X#/809X8/Q*AD<
MI6C/,S\7@C@_"2;$VEV%Y<IV>(D5M<7C)>FY:LE=N8#1^SYY2U3_8(!S>"3D
M M,EC)=;?^8"9 G/!"SIN&C6TQIO^/&:RS3E$2&B&O<:-/1,1)?JH]5WQK'
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M[L:5)>:Q:YDV]*M;7$_1_UAFSNVQ'L5PB/2B-:M!H!V8CN"K'A9*VO+S-NY
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MZ/A<GYVCF ?D1!4W()PNX9=C4L-_U'N(=A%#,@Y#Y.-]X-'@A4 +CS-I/5T
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M:%DKD2@EI9-NTDL&Z[&+D V%D.9<G[@C46;>(US66C5<G3PNK++%U7.:HE*
M?M35;6BI<G*NV@I0<ZU@JX_+'9;8!%,BV## @9;N0W)6:A."Q_$$#)UZ$//K
MF%["WCFZ[^C-OC17Z'3AGKC;JY+SA'$L! ]^OS5^(4GOE<G=JM8@F960=2-X
MNT=SHA! WPH=V3XN(],];LUSM;0.L)>14NOG?QUO^PL88\N'\*?[L]W26;CL
M"FTKOL*,J1X(^/\J*^3GEA^NF(=])B)F,B7233_5%8[F3G]E42745(A<)(Q>
M'HOR:E8_R1X;<K"2,HI)C)=@J4AH7AWX53 ]X\QK/1P@D?K(";LI;12%OLH
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M(,5JYX,&\0Q-S-AC.D,ZQQ4K&2X,,3^$I#2UFH_BD-GQ*W0[XG%N$\S$XRL
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M-9$VXW)E):'J:$KQA8D]1:O)Q=<&<3SV:.'FBJXI^BX7"UI"IR\'*:3O2ZO
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M14[+>]=;!]UY+&)/(XHFH\9$!V)J?.=L[XN.HTT2L#</^J^SKZ(>$TT4JS
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MU=[?FYQ0P17)1$.*;[_.LT;.G7 ^%ZLC9+AT0F[0^50<H^^FO@W U5%[BK)
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M[.>1KL/[7*XE%_IWAL#WC#\#/W[+><(%ZS=5#I,IO2+P2MY,K)% TDBNZ*+
M U2H1LD"9?.Z00-UW"2H'V/?GXOK5]9X[T=B*\G.-(PGFN8732"F?5K?&/L
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MF!Y6J059&V"-KO&4T/DV*'V=Y'8O1(?5C0*@(XH.+$U*IF>'&*&<@S!2P*L
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M;#WPEK)4$2&P=\M$(JNNW#3M/F9H.@DQ0UU[NR[R56\M3[ZF-)0^H4-XKEN
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MM>FO@HB^*-TR_@H,Y+.@MT/-VZ19A.(&?=OUH#U;SRS+5&.FU- NTHG8AH)
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M7RVE55P=%K/[V^XRX;;-@QJO>QD!W <1.A,\(M?E\IV#+7^^,C6='SE1QTL
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M,I[O(__,:7'QHAYK,)I)8@VN&+4D[\(IXGQD<993J+>.G]X&]&X^F)0[R96
MFB-*],REX(2SR3-X4:A>?5;<'\L";C'?J_6$2[T),5$A+]_\[!56AE#[T =/
M[HV_^/'G:7W==E-D&F)W<8:O,-D-WC2#Y$BL=3(Y@4^LK#4I&)&<>TDXSAPR
MF!LY)CI,,IC#_H.OK%LC1>!:I4M!_D[BY&?D2Q7MAN;]WBASZ'9Q=[<.J*9O
MV$NS**8SM<D2\:[TYFY;A_8@L8._88SN%F&97&2H,:G^GNI'G:)>@R<W_!<J
MJ-KPNJP/+RJ,5EI^/<J9"1",H&GD:W%#(H-JR(]EBJM"R87EJ>H1 J;HR>(?
M)EHGEFY89]9D2AM()@XIY@1M!EUVCT2&J(T:0)AS-C+";:'W94MYM9B-)V']
M(N^@;H-7E^BC]_($(&!Y8G[Y]I.N;4>=YI;]&,#*,MTW>B)."^GPR8\1B3Q&
M7Z'=VYUO#NNHI,+O[+X2WW6!->4^LFP%(&7!=.RQFN3*/S$;$=[94VIL^8\L
ML]16Q8^7Y1KZ&#H>XG"^_/LM6P4/&TP'PZ"3BQE)]9HH;4E0S:*0&&57YK7>
MZ?\D.G;3?^\Q0URU-S'Z:VC#Q:KF([Z9O4G$N_ SONGGP$[(/&TWTSC*&L"4
M8J([<_VC( A0'#(YPB=*Y1+J)I5>>OE<:CP')]I'_]TR"<N6_*CR$:W02*/U
M"=IL]-/*!S.S.4_;%T;AD'E1G^>7#?O'MR2J>:=\AXZ.0.34'+@M'T/H$W(*
MOD2X!4*6&<\U1<<S\.-Y>UA&Z9N#Q%43O\/'8$+/HMK3GU^ML('N5L($_]Y?
MOX('9N>%UI]%<;<Y*I;0G_ZV+W:C$G0XW84FEB88QMQ"-EJ%88KE-Q?3_NV+
M_KT26>V<'7MQOB#175+@Z8E8Q&I3&TJR4:-RJ9,O$P7/(ZH?^W$\]WM7#9V]
M?GT*R^@_@M#>YE&WB9/86\PBV::@]WHWGNCB<+1ZWQ(!;-#C9[MO!O[PHHE7
MP#-9/+GLV\<EN:L;OWA4H !]FFC?I;7G32)*OU29M)2E8\=Y F/"(T?<M[,]
M;=ATOZI2PKLQ@Z>)+T[E="'#>D^&BO#16KVH&+.BD@-E;_JW6Z9S-!1TJL-S
M7.G=-B/C[[FBE<2I;$ZV*EAK1NTLN53"7-;N=>FX0Z@G.]<3()3>66SAT/GP
M5'N[8G]?K\)X+'PJ)K5HHT/P4$AXY2==.6IWD8 G0;Y7D6L0-5O"7TMLU"$Z
M/^&AO2M0!5L7B"8+XP=.>[FY;"T;2%F#U@?J)ZCYO,=@$= _M+KP1\=Q@;I(
MJLQ044ZBQ'=2'@J6N)=_/XG*/"?:K,$F!/6PB=S/KM,FMP#AK@]!1]LMB]^<
MBB;;1Y?(\6VFN5VR2%9ET*,"BK?%[O6LMW1[8X93\;:R'_WSE=,,DC!8C(CG
MDM&6/!UBC3?;!H[W!^NH3/!Y=?,^K$KXV!!JVDSHJ^ S7SAGM>RQ[$I83EB%
M<5<A <#%!A7TYQEROX[OXY".EI=O!._HPSAO1]F;SFXY>@EW&EE#2F4$!GQ&
MLD'!#? \.FT^6^&M4L:B\@[(XF1/8@1^)XPD4T\/<)#5FDW\2?*]PC9^1T)*
M6)_3?;=7CRC<=Y:\W46Y5[O;=LHH%VNO1N?4"C?YVD4G-UQJ-UE914EWOW95
M^9;6B16209/CV9/M )55Y+P%:;1]($T$%F:'<FE#4X5&[!;'G25V=<O,:%!:
M1/@V5I^:0C0/).I_3!WB I2HGB]%5T=*RL;3.IG7QYCMTW^@/B)1+LC7#L0\
M-.WSUXAWRUL#[KX5-YBP&20L2;CVM=Y/*Z>2%F(M1CMU%+7\T/R=NI_JC0;Q
MNSCJ36RR9-[;1,G+@H.'C$&=G0Q[B'\2#]@$.8MJ%$VAY_V\1TIC%C\WFAA\
MV1A!RS /@*5AK6JN'1D"PA'I7P+*OP=0A]$9^;[+O/VRM ^.6$>KUC.(AT\>
MRVV6G,E!<_(P>2BT;=;9AV;:_'3#;Z2\0AJX ?1DB@-.V?6=C3)C D,UC$*U
MO!%DW[%[.9D&5<AX-+DSWD1=RW8G>6NF56[>0>CSTM:Z_PFDA*91*J(\-.$J
MXU6&EN/%X>.?"4]6Q"<+0.MUH>[=NYL[ACH(-6F=9(KDYU6_&(N8',EEP(XO
MW 6H("(JN'(S>*>4U;-GAP-2.5N>C1_$CT;VJXIXF)VR5V?^\D%7TQP9*/.O
MQN )CZ%6NM9SK;A4^#<_[EQGQBAF_+ #XMWXBFN'W =+W(K,M@UUB & 4/^]
M9TS1K:VC[MTP%L0CBE@O;.7Z8W6&4F-C65*X/%ZX_Q1V:Y.H_8L)<A,7'H E
M72O>@M\Y['4$LFNF5<:D0J_,.6++RT)JWW67<9[BAC$E_AE=]H9^>A;1;_7/
M-?5*T<-C41$QYE$><NE)KY'R50V7:"Q3%MX]!T=I['#+J+-R3C0=P]R %V#R
M'B?</>N8=<>U4>MTNU$R%2M<OLIQ.FT#T;(2B"]\^V:$./4:["GA4G8R?*O0
M1PN\[.MP RZLBFB/\?:@&>#V_F55F,?SC!WF!?-!H%U79^GKB#?[=M+:575,
MI^$"J)[VQ8WJKLG54QJ@%27-KO/>L"V^MLCO42W6:O#%F%L:RLDN)30J)HN%
M*W3XH-]MIVIHVJDO6.9+'41KS2+NDIJ& Z8]7:=822C_%1B)]%OPRLR#;G>\
M:=+: X(I>3B??_+<?$ETUUFMV O$+'5I"+>SA-%]<$>0=?K,H[2?_+":;[*0
M$2=WN?MC_<'T].Z:1S)4?$'JA1Z#[58C,BC9: )KDJV^5(DG&HJG]19&1GE,
M6D[P;!-J,<UVVU4$%A-?02)!3^V(N_<8)V)C-DE;(Y271,A1C%Y*<8G EH9U
M[O8A 09'HR.WA4%N,DSF4&J$Q;L(H<"7+YH6Z0W6<%IB&Z!?XI&YU^J0U;D)
MJJ4'V5$2DN\[/XJ:972H]\$:&C*^,\]+Z]3BS8MF$6=8*AH3H.6@0G=?]A61
MW?<J<LAV<EG6+,+M7K>3K>X+19.%#X?4^J?\)['DV2;^ZV4$ZSQT>XSN*U\3
MW*AIMY655T. -%LJH_M\C+!RIAF,+6[8"R#="7'=63ONVJ7GY/H?%+[O)^#<
M6?B:J^32Z\D[A+.(U=TU'M %YGPNG2CW\9$7G8^J<<</'F^PSVU1(LK^6?B%
MP4@RU;0B/"P6</A+\J/F(P?P5&UZWM5MEPUB?WHX6 7,L/$G4;(5/72?#_V2
MD_OJ0G1Z<&9<6NU.4ZZ-$"?KZP0+I-%W[7JN-46U.-A$!->P&E6[PZ*+J4/>
M@@!B_3CDAF*261:RTE$[TLJ SD*3)O,7W;)KJU=ITL*:#EY@,U1(ZW:_/^8X
MW'@1V:<^*=\;#@8/IN:LUQ5:1"^V"*:WSR+&;<M*%-^>@6>NYC&X(]-;[9E
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M$EC/^D^!".8$<*HMB_]L/'J^0[("\EJB$V#$7%"E%:PF[OY#JR#\&=]\W\)
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MOXHP%1$25?$-(?BC^@K(_[+%WFZ^+Z+D6D6-*Z.17[\5X>I16[*NHR^0A@C
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M^:"#U%CZ@/V9Q*4O/[CQ DD\ 7O2=W0]:D[7^Y/H$[]G@7$;'X('-TK7Z+1
MIOVYO-YW7_:+V#=?_1M/!%]4S^PY<NN ZH:9Q+)%U$3V[ )S/1>WC"L2N=U
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M-1OL//G@&\OXDX8_Z?G"DLAR0$; -AWCJW88B5J-TH;I#W.!FCB@1;J)JAV
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M\@%<9B*=?B?2)5R$;&Q=8>77,'-K.TLOT"PNP<UE&D%J*CV81^FH=1N_(%0
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M,XC#IRKUZ66Y5/'D""VW#(011PD!64O=PT<D<3QD(X$/)6$/-PI-?29"&V
MH_^"FR*#ZS82@]RHSWJXZC@5_F3+?#A.X]*++S4("$P53C?1"NSGM;*KC7DR
MNE2S=C7\Z0-A_?2] 9-TI<!#+R9BY,Z;RN3Y]_3T^1JT=/WU]PZ)SQG,<0+T
M9AJ!*KSA#@/F@'_;_%A&1(1?$/55B,N_6P5Q51XQM',O(5M[ &[J\#\.>AQE
MF*<RR!'^\)N<N""2),)X'9X/6#];AR64A9J>:Z_B&L+6B/UUQ_D!PQF0V#Z
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M/]?-F ASF=U#KR-U!/ :MCVT6!\W?L6+]7@F* =5\>0G@.6M2$_]-@]S0$7
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M:-GC.1]AEC3\L@3.M2T*52Q#:K":8?=@A2T^?!K!$ZOBBA=D]WRLC"+5>%B
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M?,0Q533Y.(MPE#7.0N2>I#E &BI=?[DU3,]*S"'CA)NCOQ0-W\AZ1SA/ E)
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M*I6!$AD2?*G$_HMFA\!U3(CU\:BAGHQN3&E!;":%+ZX7"D,^>ZR6/T'78BS
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MZ2^$THK) ND%+(?>^9\T#-OR0Q?L!6+,N3^QT]^\,Z;U+MGH%>!X"N6=)FO
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M-N'(7_H<S*X#]9'+]$E <(-<TFL?-_/3NS1R0KEV/'FR0_M'';\@_4#LI5C
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M!P(ZO_WQO6+W=4TFI!SD?Y+4 _7V$2#%9E)/B /",0GC\N(A60V='!#&G^%
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M30I'IG3XSW"XPC"AX ;'/727K"G/"46H&#$]_ \';Y=?-X3TGQORWQ#FVF]
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M%_J.?8[FR$XBG2_KV9ZKK%=QV:UK;V!=J(9B)/P_)GR:*1)D3'\]FO-_$A(
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M^BW?SY&CY5^(S(JC_3)2EO45!%ES)-.*83IYY+3"XOBG<;Y3F@NP%JN[2K/
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MTG?KPL$!JP" \X#0:J]7DQ<J38P2[VI@A\YL6?W0_7>UGUO6JS'#!=@X5'V
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M#)&3_&%9VW6"MQE25ZZC@">8<9'B#.2*W85D3ZP,6'$A4P1,\T:#L=&^6C*
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MM&C.8JL,+_/Y4]E[X>+>[2V%2S6%RJF+J%]E'E>^9:^U1S;!!2";A$(TJ>J
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M!N Y,J5AMSP#O7@6;*AL\39:63,?*]7,$H) ,WPL';3[5/NW4W3#8.S5;I_
MT@+%YCPO.+'!ES48& FJT0A&?^5+03O%>QIVI-P.]7@"G[,&0>B\TD.VHIWK
M9>?$,@0Q]-5(/^XUY7:&5]R$.0&O*[5(^!GO"O</6 %$:Z-D($7.@RR6,RI
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M^7O7\^A7]9P4';K59C&=.RU7V7W;Z?%^&,> 0".A0#EZC0U0&^\'>:"F=[.
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M\T_4P#Q?T,60)[>O??EL8U)-^6;98(2R4Q-^XQ/KB="U#[QTZ2PY'/W80@<
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M ](95])0T''+.&U+GC@!@?HINK165<]4Z0S2& +M^W7UM7^>@')BSA%[$GC
M7L7>^79^#TUWAU(A\(!%3@?)W)?[-&SBQ_!F.F8,Z@<YQ/$YR! Q4.&)6A=%
M1CW"A^*15U8=FOKL,_@LWBH]40ZA,UT?Z&:CK?]F@723DI6=&SL_]MP^G/3>
M7PV4:,YD*^-^HD,!PE#;BST*#U7$'Q<QC_=FW>>&3Y2CJ;0RFDT+^O\4=;C=
M-EIG<]ODA,6)*-9W*)*;/OU$\=?-5SW:IY3%*LG6R3V'=JQO++KX1=IZD;<"
M /J:E9[57*"<1&)\01"..?__2]9A"FXNE#\"T3D ^_'9R0:#9K: *4]0[)^I
M+U)21:'LQP#H T\>LV:>^N5E'M!0>85YL>S_U73D#%A_RF J^W(J:XN87@N,
MM2I0&:XTW?6;^P%F*G%4EN+M.]';[QNR=6+-::$)DDGE)ID]/3*[N>P8NED1
M?$"39X\4FKDT^;^"OC%7ZDOJS@/G@7V*Q>W]JMT==O%/5'?P"L ;H?<QA0^D
M+[[9XH6M9<GF7@#G_:RM4SC2>YO"0$$P+R-4E (I(D7:/VM>A..;\NW-YT8(
MT[:V>S//PZJ;(FW8SB@I E74M1IH,D /E74P4%1ZE75Y(A)TDWLFI*MS#$K!
MT&1ZGT9FDVFX<#H>C,6(V*Z.!RB21O4!V!8*6<I_L^&FQ#Y7TEH0&54(E2+$
M(O85PBP,?V)<9#Y@)&TU08TP\Z]]_<L&YN.EN]%B)X.(QS"^VZ$@>;TGO0M-
MX:T*XZ6_6G6:6,01-5O*QJ!2GI!0YX@.Y#2,U 3RB&!NJD=@"S:W-P.--5 L
M$T4@XB5L2KZ?5V@SL2O:"@YO-2'A;P"<$"8PCF"!8,X@XT+QLGLGK,8[^D::
MM3Z)E](;B<S\.[Z^M-813V!\C (#"XLAAN&_YCNTP-X)RN[[B7& VA5 (,<Y
M-IC"4BP<^>XM^(*LF1"B!)*"Y;U]C,^),&%3A(D()!WY)6]O-K% 9S\?TK$H
MN[OJ#M>*6A J3?53D_N^)@3SOET&C5KA)X(I&:E^()IB#1 2*N20O XC[U3<
M?]^*RC[T$( ^5-6?D6V]BD>CDOES9P\I)SP;!E@N$)RCR"N H2MR[H!<2X+?
M3.<RQ8ENQ9SPI&ZMK7:K>;J%B(Q^90$ZGC5.QG-Y=.GL_>/>(HEG_TCJ4JK"
M^MU"3(< :3@]@J.JSQDIIZDQKCA-WV]SKY*B6TD8Q=;'A,]]U5 X U)X="Z>
M3N))+P.,#4WZ1;$+="QXAD&V%D^3%JS&D*:AB!%I,JC25KN?%K6MT2J]328!
M<BS<2C@-G/=0[<IE.; 2< U2"[,*Y@@*>0.@C4^H_6-)K06?J$",&C,5_KID
M-;57/5O(FK($,D5WDN^9M;02$JM38[0BF,K1Z>Q?JTBB@A4 #!=7;T3!AG&B
MK@)9-IZ69T*T\QCRJ/PRP]SFZ5A_PH1U!+)#]+/*0+#C2*0$YO8]0B2.(?B.
MWUT5TL(NZ!FAL/U =&R;=9FR&6D_#NZ) 8>%]2Z^3^D1M72K6T3B97!K$/%J
M&]'DR6%CF] 5 )TKCGVSR43V#LH^$T)4(XB4G5G#Z/,VOGUWZ&9$O(L"'C6>
MWE6\!7.GBH4Z-Q]%4IIQ><>!K=0)Q[FX<)4H!EEYJ_3^&OL\>@0.3D-?$GYS
MBJ!/)8V_)JIUWE/-ZIMYZEVH+5/D.5&_C<OZ-3T9:/1O,=!9 0G/;MJ>_*Y7
M(ZFU@8U<Y \8+=_^V*'8+4?&Q_@,LI1.K;0P6O>YR?,J?:.J"E_NDRC^Z2)*
ME,?Y^\*T$I1M%*/W[Q@3->?V4PH16T$8$8/EAG@/@W"( 52"FI2+)"R6#XJN
M0_3L(A[U)B,,N926UX^@8C(5IX1TVJU-B5=6>XDH!3T4E(B !S,H@P6F>;-R
M;NB"A1\P'42\$>SKHMN7\?)FI+7YYVF:5#BOQ'/V4.^M8&\%POH%N)'%TO;L
MGYEO)UP2"/B=B0FS[^JY\C!]:# =*Y(A-MIO@T&#J_H?9%NK %.8J;'?C ]L
M&)_MZB8MT+ 871*:VP6@2&E%S<)8AE@1=_Z?0..GH]:9W*1ZB<;[7-Y?TV<6
M<*R9K4E79')#8EFFRU;J>,]"7*2JW_\V^].U]2N N[\4*RUJ0%E'^:\!\DY$
M0>>XB$W"3<F._5A_1L[QM","XF3)\8HM6*'C@X(>_VPB?*+(I5_N'VGDMD%,
MH8CF5.5Q\[*@3$=BG\T1)9Z,(EG+6J/2)UZ7<V$0PUP=D*_7"J"2@!7-\;;!
M_**K*A\]UE(%(AF%PG[ &:!)OVQ"X;1.T&;%WV2?[IQ7M=18ZIPHLJ3A(2N
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M0T>0K3]_0QQ#[6[ G;FH=OMV1+M&(I).L$+99,L\5P"?NYGW)@P.!KY/%=$
MX>964#2# >F)>QQ,^.5"?KT"P'=.GD2 Y/A[<L+B<^I(@Y/32-NU/Z,U0X&5
ME7)?Z&RA*X;U$<[_VV+DZ*F)4>L8$H8G'AX8&_,+4QOI%@Q8H/#30WYTJ P(
MS47%\>>L:TAJ['297O2J^/MYSN:J%+(Z 4A*+])S/F"\Q@JY<V%JFQ3#3)7G
MB>- WY?QDU5-]U@QU>2"1<X0\+7[H+%O8I*UI[0Y+D'8VO3GFI:*4,+K1.22
M=OT#E87Y_I(WT%N/2AY)T!,+]F5T;.O^2:#A"55OOE;\- (LQW\E1PC:.)'>
MY!FWRVR-P" \OI$N]#(X-1,8/5%$R>WF<]5L!C5F.-(*>N$>UIC,7*GYK#;)
MUG8>ET(1:ZP3IV,5E!;S G%J3[YMELZT.@'C#,JQ]6K8+O+K#TA+-$[=*?(K
M1(@_SAV+2M1+2K/3+%\*\LWYP8QA< W>CUN?J</'\BC87R+6[&FK,?@*X&;2
M=/  "-SQEO;\KN0J#=_+J4X(&4?2>?3*/2RUOP_ZZ<4%,,4*SC!$K/R[>*P_
MX]03;]E +)W!X-$_=54<Z"GWF,FUJEPTFQ@]\8POA4]5TC'V*X 3$TT&A@@8
MS$!2W(>" J&*];S$('HK!_!Y4'%TRJR@,X)$68.%HUK<33=H[R5F%*\ XG12
M_72!SN,@B\PCY_9LRP6S,X@BOK2M_&KT&WJ"85YP;0+V=#EEX0)E[/E,*VK@
M5>U04&\BUDO W6Y#0E-AB98A%#0AE<[G\8O!(-#<;^M6(<U,:A?%$(?KK;\Z
MUI545C1MWE,?OD$1^?V0G47A_RYH)U5J;'U@,G!QOS:!@ANN'7)/>[O 60%L
MKXQV\JI: 2Q>;<H6#.<K?M&I1T^TMMDBT8&=5%,5LCJ+A>0.YP&+T#RDH:9?
M@$EZLCD1S/QF&2DRZ^8LR6L:M?%T)NN*5\7A9P\]7PFWH-8?FHP%]G(JWOIO
M+$P;BANIM A$+*_&-1X.NE=?RJ]K\J%.2[N!+',9,;<F=:%S08'?,/PR#3@U
M*ZR :DX )Z6WBA,B//R](H[XY_U87N5I=@B* V.7GW_2/_!BJZ.NL)TN%<,A
MCMGH3_305U@-6UWH(D/L!>XSD%H;ABU8G_:%LS_BQ\.1?726A@DEP-J,09'R
M2]%UH1I6>'V=JO%?"NJ;0 H9-%;-T'&TS!F(2(U KP"NV]1I;(HI. +=09=!
M+*-X/#&7\<TUDEXTU:OMP2[Y.&C!DTJ?Y.)U0X;:5&:&Y4*,: ^DG[ 0RV8W
MFPT@1J4)?,%;TQ";V.]26L!ZXA222ZPTGGIW9W7 W5Q)+YE'6*;E[[?E$#,[
M;;M[SS@ 9/"\3F/+N(K?^,A&0T^J9U.;0(ZWG+O<VE\96^M.S5P.0Z G]60?
MX\=G1-=9:;^D)^&%"BR7+5VP(=90$6!$*T&TV]<HM'KF2,9[HKBF,-G:)@5;
MZ1!Y*Z0ML=:F(%'NBW=N27A>_X[U%F;6F[L<9#O(T&?)_;VHR*9ZZDCK&8EG
M-2_H\H9<2YND#?$,813[>W*4?-<WB1U[0@2'F+5K-$44M="KDAL9/R]H@WN<
M[-.]IW&(&=2[.6<]-:O'43..'%!,:!%(,V( 0&#:LO>51PCN+0P^KZ'@7Q9G
M"O(54!1]&;(DS,5D*- (J''[/-VR2:Z1@EUV(X[1M,/"%N@4G(A?+M0^;\;U
MCR^HK@I/;I"!Q.T_^]YU3Z/UP\2?A9_:B59TY$T8,<%1^@IVL+R4W'JX6A@S
M3KV,7W4Z!GP9SZ DXSR%\)LH.!A=HT:[*UP!0+4^%0H)N]($1=3]R!Z:Y:=F
MS:4N(HWQT\T@50^<I=/[1^.E^9JVQ*4YRWUW\-! !.S4LR-VNW:LN\A0)-MA
M5O[[W/K8K,@92+-$_QI/L7B>.U$3HJG9S$59):H55.)?4PN[QK6D8]I,""L
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MP/.L3)%YC ^H:]EW_T?=^Y4:=GJ"6@\LSDL$1-TXVK!]M<2JCS< ^&.Y H!
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M3=*+@B8>M:ES[F++LR];NU6+(/2WDSUI%F4?W 2A3,]U)25-UG"F\*?#EN_
MDR]ZV>WCZ19+Z,7RZ;,*+M^V DA25O!7 -=BYM)?]DW="%S[]:6..J60_H9&
MX;.^.(0);,?#'0^L?>+KH$W7U8H0D?L"QGI2&^]]8"SJ0@T=3&=B,"7(TJ[
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MT!=+22_T4P29\AS56ABB>02G:]Z)4(XM0_%WM3FKY.HT=G>%WE]"<V#%1JO
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M#R2,.O\HFQN^W>[T(/*WY^X,BJ^$3H"NZ"R=7@7)'=J/^X&[79O!ET#WA[:
MH5UL#GYJQ]>R!S6EV;<G@1F.90P2TKD,5*#&)GEIL>Y9==O0D"QF/G@210X
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MMTL_0U0]&D4^3=4@2ZEUD] MS+_DW(6\9PW9>-MRBG#&Y</PB0%J87[U(&Z
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MQ><=*9O;AHWC@N?SX=XN&:=F^!>*SP%CZAP>70BL>_F5&;DPO-O*L#QN%,\
M+EWX>T3T6;:Y_$4S/0V-IU-.]!(_/PC(&FCT9'G._^93IP^U;N7%EMKR^@T#
MA*3.$4[$W-4G)EX'37+50Y^TZ: [ZU9!!]^)SK2*=N\^EA\=M[V99+*^&6'
M_:$K+V#_]>#]I>!42;%I*\'VSU^W+":?P]8'-W!GD$U-&S9GNQZL.]J[,A5S
M\\#[$?)/RP)CI\#68P,BPH%[T?XLUN[Q>(]NM8OR/3\-[::&Z&)X[GV#LYWU
M)PQD,JIK=0;3YH%@I_9:]- N-^Y]'ZN_@ UCQO_]@2_L1+_V+YX%1,^F.DG
MS=^[R/KW%HO"1GH&D*BEDW4'5)VJ/M"ZF@^WO^.X_X5?/_BDJ&5$^_QU=Q.]
MTP-09'.M)(9V(F>CE<5*[OU54%@8.<AD3FD5Y/%/R//4EK;EEW4M*L-H=E^X
M,#<,XT_Z^\J%/XHFJ=+%]+ZK22>O*AI>1NLVF@\,6)YDP_XM5^DY?*AUF6%Z
MI-RJNUS_ZBK(((VD<FFF" 1^L 3EDBTAGJ&.*6-&]U-VH_%==G+J?!ICT7K[
M?;4VPVW\I\.+;3P&(Z4J[7D<"KG\.6*3;8PPG-YLPBGU^.P:"/;;S\FOG@_D
M$;A]C_]!-6:]B6$>.'RJIGI4OX'Y_M/.Z7TME]9WC(Y<?J#D\R<8RS)R/GHW
M:7J#($K3*S9X3NE^##(S7;Y]%607YJK:%NN+I@.('X>5"* )#P2-'TJJB&)2
MJ>H_APO/73(KKZK+" PB#-*9%0GIR5E605<);AF1@WY^J)>?/)0/^+QXNU[T
MK41.8Q7T+<UUBJ7P,DIC5%M1AF1I#YQ%JI32V+;(GVW?:KI\PT@7>8OBRO,3
MD]BAQGM@53E5$CT?J"NS?Y_2ZY%?QK]GA]</C'G[-CWOF?V16&-$(2\01H+]
MN/#!OK&""VDQ2ZEEH-G<;C/3KH1-+[;'M]TB.P9C.]=C>W*_7JI-CM=1]6MQ
M9E*U,8688%+Y4:2WK(=A9<1AYL)&%)AY?7^1?0>D+CV;-8I#YC)FS]YR/!YX
M"->];'LI0G2UB3M3H_N1$/T@<*CV_B(=MMX22M06NC[=O.ZA<[=<05D^NMBR
M]MV^F1I7VC:_A67LMQF(8^.=K.]#FU2O5+;'>H_%\,G2<#GM=K"NI/1T-TML
MWQ"HX77I&+W4*?F KD>'H;]_Y)&FZAOWR@N&DW8[[YMR>1MY51W;Y>NG4>]Z
MPCTRYWFD6WMGJO4DC4C@J);=:P@ZJ-NKR.2'S@23F)* XWJ$VQ@CY=?K(YLA
M9/;.W[1YV $3SL.8P)KG,$;#NJGJ\V7[\>'D@SGO"0VLYN:W#0>:?_YZ91=8
MMQ_I17\6G=JN>2'U$>*KJ="O @[DAUY<2UVJ6T/YRQF<12$0VQ=70#1PUE^O
MO2!!F !9>\P>/$#^8(<'&G^ ,RGB]N1;FT[_.&/&.-1SI6E 9'^0-]O8D68'
MTQ9_M A,5KX?GVZZ-KY>\MXO2\N[?/,%.]N+^>&MP4!TT950[*B9881\,JU$
M"C;&_%4\Z'S'9W$A:FJ?1G]*;QER%540CA0/3A'-F^IC.E9!**A3_E[=\NK=
M\[\;RFNN$BXM6-D-J^H598 ?Z%O5:K!;F#,(W4T^#\^,>!S4?)33XR@_!W=]
MZ#B:69*!@0X+A:$2_T0]&:L8[12K:4.K)BG*[GSV>*$7>Z+I_72O0<RQ4P17
MP'VSO7-ZX,GPQLG>P4[H$;WA"NNO&W(V#O]E@8+Y\&0.@\3Z 86[=6C^J^H&
M?N!G@4F0$W,*E=U;2<EVJ<<?J.'7QG"4G&!BC[=:O-TERIX*%:"PY1&7^[=&
M5/=&5,_7I$AJFB=_]^;OZGU1Q9_:"6AL=Q@A%CRKN1V1L?V$=D4_\R= ["W@
M91GN9*G7V)$3"%9U'(;D<" A7L12R>CI\B'BH%YX5<955'2[6H3P@:.!(";&
M[?%+%MN5_CQ@=/NS7_[]?%&]DN)$7QA]H#^SN'^@>G_ZXILO]V)0-55$@\T)
MD4KK3<$FVF++,HDV9"RNV$ADQ<B[_/ZY.2J3*RHP@Z,\LX"@@5]IW'*C3BUP
MM76(%&!%F9!.DP5,+X9T>;(;MZ/_KH(<%#JN77?W3L'."A\$2RS1-X"09<=5
MT-_ER0"7IL_\H;PL3DPUZMC<!^2/+_H.IS(FD8L65;\0F75AGO!F'$?#]&G,
M8T+X_:6AL66J&.Y4>(;(U-8+[HN@H[W8N;GT^=-Y86E9Y-/)(A0&2KMBM_-S
M2/)[<[HJDXJ%WO)Z[.8_SH5?#\C+.7?/<S22%NC%J'6IB;S!7*A89KP5D:SZ
MG3\I#OGB8B-5).:H%^J!D*/W,?,97R!H" Y_H7F0IM(V2M$N1DE\2@#7ZU.9
MRP9.[\8"Q:@=5/$]NH;DPWV\FI0&!@UX>;'$-;Q[[!";[/;K,=T' @GPZE60
MC-*+<6_9U$H"_Q,EQ2Q2CJ696;;]R9 CASSD>9[L*5=*%\+-3F06^]S>/&2@
MJJU1279,2,E2<-#*F1JOS,^?7P4I2CY)COQ,26)UYCA<;_8<N'X30H1FD4W9
M[  *P46 Y\_6<\1G\SI[MA]$RS4'CP[^D6X(O+/BEY<J-2-@.0J:'>\0<E M
MMO],M*@6>,D!YS@6%R5[1%]7TNS&::75+@ORET?9'UI=GM]9S#5DHNN-&$ ,
MTN7S7-N@FA;IC)+C2IL8HLB9L9 RC 9=-8P[SJ8'1?;D$/Z_/,=PNC_ZU3#%
MRDD10?1$?2NWW_O<KW.]MJ^4%*^"K%9!]-K[S7ZYD<>/I;4QI"Q:@I3H1C\F
M9>6$'4Z+>^>GN=)J:4I>B3NGG(/&'$RE/S0B>49Q5D'["@6QY-K!2+\@120V
M1P.E^?O?H8LN@OO/C'KFE#Q? ?GL+[ODR-.2\89(SV&47N.:EN3Z*=8RZ^RO
M?)9C-(,L)4M75)_[=:\W]Q5_LT#I25^D+GWLXL[HY&2CUB&P8RW0N-Q^XN-S
M])%#,SMT]B;V6%;F"X/12Z!RS6YQX7'Z%(@^RI7"#4K1W]:V9)^?])'$1O*)
M0&\UG0R*8!4D;*IW7CC[&I_;05+?]45#8B(UQ4]0L48"7\$=-OI%"AVE/+3P
M^1W'F;^M9B!X1(_<^ JO[(*>1:H-J1)VQI:VHHZ)F@G8_/_7,XW)M8.H(:1'
M:!N0L JB#KQ+2Y69^OXK=-2$L9C6FRM]Y.*60;1E YU( T*=H=.W8J=M)VDP
M7+/!*'/Q3V+.#W#G*^;[_OY* ?#XC+BC=Q)@![HO['FRKS#VZ#RZB<Q >V+'
M^]^@O5&YAC1LCCKWOV\J!'#!5(+::VNE+<D B U$MTW\/T\]KCY:C(Q$62ZR
MM]_,WYG8"J)#O%#+4G]=4AND;3PXW#:<@,;CQB_6L4-D/Y2GB?=OH^+ O04:
MC1\:"'HC"*L9$Q(5C&:7%GRH*ZC^-4QBC4Z[FH?J,8JK?E7]SFB8=6O F+1T
M!>J8JH5BV4PL/$6-=#BU:"?&9<G1 (!D0?>[FRH4RLE%0I%$.J,_4RUDTX,B
M\IG:%NX,A*Q1><TN8P"EZ$0<F(+:4MVHEWA,I.1:7CV2JW<=1?Y17<5L:C_F
M6^-G$I^0:A\$U;&@:7(%5T3AT9"[EWB+.L.MOR@+W'GF(*'Y'O??D1'OJ83B
MGF]:J:;S<:'/Q.62NFXJIMFAU51U- 6Y>!'[#<]6$>GMX:$&,M4R+@PL[JZ9
MKZD/BM5#P4I=*V$W83NKF6]AP@5D&,/*ZV]MTL,Q\5/35K5!O!>;BOS6-K3.
MW5[-+]N4"U0_+XH>.;\ALUE)>X'C@VE>!>$(&AM>-K2Q?1,KHN23N9;U]'[B
MNX^[A8W'(NI\RGXW&1.]G 6DQ,7Y<01W]URK_/#F!L5'?H/<72\)QQK\97$W
MB5[L^5'+(S=FNN0'VI0M$I+7VB<QD*P[<DEY\M]Q#Z&.8CH.:8XR>\8M^7H5
MR<ENMRNG7!#>DU@]5=3LP7RB4][EE[^+K.<?&U:\^^_+VVX=W!&HB>HBV4.:
M.2Y>?:;]\6O7\#O50:Z)G+IW&&^BR#QN(XW>8U!)$?.$>U*-Y@6J5ZT:W!=]
M$D:Q=.ZB\P6B42/E84#GL+W7V0_\REZ^O,C1=9=K43BO C-PV+S.DVG[X>!T
M"UOI9?XM9?,&8>@7QA!@6EQE<%Q/+A.D<V]]+8 <>9NB)(ZY?=O28=U. ($H
MW4123HBF9S*$2,A3^'S18>?&W^?[8 Y_ R61]95_L@Y+68,1U*'V70,B[R_W
MMS#5?9@1F7/$)_@N,UNK(V3'SWP.E\?GYG@L"1G!29S;1I5;OMN(6E7I<AI*
M4ST!CT:NF;H.&*7]C6-22RQ$DDM'K73J?O7\^3<]<.A69CM5P]"2N&>J)".H
M:M ^8$JU6N-FS2K(_#[74C<<D?\ZH]KAR+DRPKTPKZ6!G$:=B?T_JS?'2"X&
M9LNY'2=V[OVB>O-=#.KI+F':D@VO8HGWAG=,D0D]=>%96E[>(U>T=O+"K83\
M.\2CU&_')K*!_MQKKU,U1!J/_$S)PVU@,JZO__MN>)=,X'U][[@?<?AI76G"
MO^N#)J4@-L0NP#*\*R\XGNQ#3-UU#<T:&\[JNR^H9B +R*'ZW9H;WY9?<':%
M19<-Y,&#^CNG?@>@;-*8<.5G]U5/#.:I9>?J"VY/G3(^#/Z6KVDW(7=AA3_A
M-5<Z =OCZ7'3?R"K_'-'U^5=ZD'M))562W(1TM\?HM:L'VMX&VW?O_>5C(9&
M\=J;"%-&"@P\RW#((;"J@F[ES=@QA4^//V$L$3%@?%'L?A-GTQ;7]([@J(!4
M))/W@EW2<)?6>5L $&]#+3N7TU[$]J@\-1FP'R_H#:Z\,:+GT(ZUC8+R5)8/
MO%@%8<MG:W(,Y-<_;F'D2PRMJOGX;VA9!FI+U>^:[-F!DV=E4L8*XQ/(X$FW
MR5VC\[CE-U3^C60M+&\3[1-?FL[+]O%Y#U?H$YWVIY<W9![9]W& _.GC:6ZX
MJ3"RXJB7'-V5'HL(V$GY+3KF.:RLZYG+L\R7VW/;A=;^Y+&__7WF 66*[=N1
MD7)BK>3F"G49:[TTG10B1);?"XY('*U[XNMO*,>WV3%(T4EYA6]%)8UJ5N.W
M!SQZ2=]&.FX:OG^K&H'(7,P=]UT%/7Y>,OO9@YG[%:I6Y[<QY#(K]$7W0R4*
MA6E+V)4)VHS5<UOP^=+>8]2*0*.87J^7O&1[,)HAC\9-2\U-;?F#OL!B+L24
MYFCXPL-#[=*%@=/F94?,67.2&# L5D;RKJKIE+F&D?,+VOZW515GM-1#X$IX
M-KX/I; B^H8Y2!G?<P?O=[3W.[$^Y;;>YD.S,ERQ%!JST; [76_=KUM\- 49
M;/D)_S_<O>E?DGWW-DI9V6QS>H52:5F:FEHY2Z.FE:1E7N6 9659#H03*F!9
MV6"0FIH3U.6 5FKF@#.9)<YTA4J*BH9(B(@R*:,;^^W]V<]][S?[Q?/J^0/.
MSWF>:SC6.M9W?=?R5T$[ZJ'KXUQG^??WRIT3#^OHIQUTSM6OFXD>K0;7?]<S
M]S/<.G/)J"30NHB:XQU3=L][KV@@]),PDBORV=]Z*.^X>4J&<1*"CEZ7,LAW
MYA3F:O5CU1JLV%8\Z\J;?ML;_(_7 8:-SL[I!4#31RT:4&EO/+8 F%J#&(-N
M_/8!"KT"V72ZU#-Z] @R5I4O(D-PX23Z&F;,3OD-F>N[-RQ] _^ &G!QR1H^
M'?[K_L/F8!3^-C"@4_K)-DGM)J1>O:I1_WG(LZW@P,3WC\;O9%Q2]A74(D>N
M3\G,/!D#737UNQ[6SA[\1HQM_A+<&GR%-E=)+^ '2*Q:5*#O#:" 34Y7G[YY
M<0+X" A8)6,[0)A^&V<SF.S'X4BC!<!9R]:Y%8:G/%]=?]F82)MMF[PC4*#Z
M&-O%>Y(C['CE3:.KG'P2\#Z17"F-@C.<+27]R@V#H"/T,^ UT_X-U0@=,L3/
MV-5GW9."I(<5MBGOW3OVN^VOBZ-=\J'XRNB*)XE C_</4KZXA_\N:F1%]J7S
MI-#"]Q?#<4=F8^<3?!JB1S-WI0?NZHEDPLC=WU5QSUHKJ>&W=R',]':.;K*R
M[D'HES5%,[G]5:8!U0D0S.5JUV\6)V,OU\=<'Y>K'(S3-)SKUK'S)QO2=8QQ
M"""3EL2<X4 _7)V/:5K_<',":A(6/OZC*JW:A=$IJ)7FNNFW!, ^/6--A'BY
M!_/N\#O?\=#?V1%KWA"#[]RX]T+'?^O&3V$0[3E5!!>_MFG;_//6[6'/]R0O
MB; Q3UEI[9@[OP"P+C4[F3BFK";LZ+X1:]#<;"+<:AC&:;55:8)=Y<)11BOX
M,4Y3,%Y;F;84@/*/3UJ"@3CBL3%21>>J9P37#T57C9A&)L7&ITA.V6@K0?FT
M/ZS&MF^74\FMT=^0^90B/A*'A7:J-'^"-)JVDL=TU^^/^)UG<?)^EM/YFL$E
M]CFQ]\4?P(,[F(Z98Y!U0]Z_Z]+J?+XFO=5/CGJ0!_ /)TOUWPI!NBIZTU+;
M&WV8;-U6]M/DD_Z!=@<U.VP%Z"70S)&]\[F%\U3?^CMR)&0*?KH[<]ESO564
MV74UUA2F5*%K"NHVMWYZK<+(,ZS#8B+O.#R8[%F02Q,QROHN]<S\;>3>P@*F
M;4EY$51J[EZ48?K.NS.D73;9(<-^C>4_\=OU5(QT6;G]]GU+)OC@YW$AQ6VD
M]K \6&YY+%0KX6[ZW@?NX^3$\XGSSG%>8SDCNC,'4ITC;JQKJW%:GX0) VY,
M8GZ7S7Y#;I]ID<3/)XP:/_=><V;\KV5GWUW=F6G_\6@KQ(:.(3,*PF]*UQMN
M?XS]6)C[M\+5O;+2G4N;4,U56Q\0KGN8<\<S*R';ZX5AB>AW26C+N1A]D5SR
MK(_N]N/, N"&[R14/RZ];3PI$)MA6!(''5T Z)P[4K+L]EBPW\#9R54I^V,"
ME6]5"!G>/U5"G;\K"S>?SVJ=F/!_ML?QO/_?:W-NG!Y/2)CO/T7D(6?VNO3Q
M1,;E>X^MKYX\"&\]#?%3-5;XZ-S4L/QR/AQ<,?LIHZ',S8KP;FH\8S+RFA"H
M9U$).__UZM2KT+6GO%;]IMTP%E<W(B$U"HOJ*)S.@S/U\ VWCAD?; ;MG-1>
MC^! <8RJ8&)B<$OR6@LK,#Q4MQZ.FU=8EY);\=5:CPJ_7P&M_]#/8VT]%;)R
M-"!^B6B"9.VHKW";M<*:YBCSXKS;FRG#%%J3G1Z)</-,"^+ANXNX7?TM(WDI
M__#UK@\&22(A[Z%OQ]E Y_@2VXLSDS[ESY(F+SR[!*L>++T^)8[!(2**CIMV
M>--=6-=SWP!12)(&C^L-JSMT]9_[O"',E;-"%<SM1^FAU\$/_.AMM.'\P<C'
MY%++7C&E$'E;V#'M)GBL\>5=0"3C<Q1'0;FB-#;IY(Z-IN9>N515FYT2&\0W
M1OL.S&0^MEOW=.XV)>O*>U=C',0MBS!(&UX//9# _DI;UZ-CH\'%HE&/W^^X
MI>@>C7LSNRU,$:GFT@Y&4[L]$J<^/&G\FAL3V:X@*2-REG^O'7TA;44G.M9R
ML)Q6ZS*WJ#M7LO=T]6?T^4))!$[ LU6"XR/L<.;6B'_HWHC0<=ZURQ,;L$/'
M9]>S[MM0:&!E2!70[^Q#^^\5Y>"X0(W:'EM@H"+Z/;5B^=+9Y/I?]C LP9I#
MP^!=B][;YQS]_3%'41(/(P/G5%6E>OVN6\W6-'K?BZ'?,)'1H?4G\-M&_^DM
MMH'&X+7*&G<TQEH,8==_WK&I#&("V>DO0^=$\#TU=V;'T?<9&BDV.3PE"XJ_
M%4&S=B\CU.,SK!7.HJ(]GZWK'0,2XO\5:"YN-RZ[EX+M8Y@=JNJ?><XMS:@0
M"XC)OTXD$]L-]S$NC0_7OV_TX'S:.; ,LW'LYDNB;"12"?^\>#6U +>LTH/!
MO>]Q?-<R;,#]'+'N B#-)GVJ;#IW&?(5$^V&]PD4*((:;N\T!.]O9JGXJ$PN
M%VJ>'0L-,/7S<J-DF9@&5G>B:_%G7@J4U[8_3YFX],PK]+3HA^1PW,9[T&^V
M(;VW>GV=CGQL=9IN$&:IXE$;;+56WLXO/B&)5MW\L@!8:4B4*HQG=C07@,>,
MJ%'^I,%K+%@2G^DHI1R6"_^L_!8-L_=+HF>6Z,C?D^&JF/5W9M<;LB8>8U;S
MSUQNFNY$&U=588?N[9EN[_!Z5/F@C]H7TM0S1QV/"6XYV7&O*4K>P"RTX:I@
MO6MOQKV==]*0$VQ&B5L+QE_#)?>V]]8J8,+K<.R7"DKFQ+UCZ*NMQP[/>/ZX
M$-G8\.L?64C&L-)2! 09EF,-I-6-K/WAOB(&>E)PAA4LW77=9A*>P)_'LP:?
M+!X)'V [.(6I:;6&0MY+7!J6T!6N;Q^L3V@"*U&UH^XAAOOBB$<M>W[9Q@8N
M;GW$G+H6L?4QX^"-53[*$066K%!=Y,21,JZ;;#<L#8,L -XK)&_M*=;^\?(Z
M')Y*$"F"SB0?I$]\LO()WCD['T"2B@ GS1$!!RV/K-^!<P"WS/PVVB<)E3)-
M#Z+<<Q8 .#R[H.@;.4U0%]QR?9,%*K<'K41L7:87F/VDX[&T-@0/%=BIEBWY
M]%IPY&2 MOT&!#"0II <-INN1A<AZ2B5EG2.J]I"QQXZ*-1QF?+2INB]YBAC
M>N=K!"C977H2K%[ 5<7<C#?Z&M 9^J3]\ZCZZ<5QA/G9:Q3EKX!Q->PR$%MZ
ML7KDM@G+HOASSR\ ET\&NS%2;PKM*;FOB$6MMD(J-B1'+GJC:9-X]>M: K!:
MBZNH5QWZF11M-V8!I]O#5* KY?MJ!!CV\0;_M8&S(H7J]59=$NX$XNQSRNP&
M!TL:>'RQPZ@I<.7Q:9VS<%'Q'D&UXN4GH-BF>4X!$?#.V2FF3S-J_"4+ "VT
M, LWZK8!@7D8^"(_?&YQ?"'-?C7@F?XV1M8*>*IP[2R%.(^*^"MXL;W"D*5#
MD8+8AV\N";LP%W(?KC@9"!3U0(J8H+%EJ,#<YB4"A .8(I6\60HU8PUL=J:5
MPE0Q*F3LA=Z6CS=7F! 3FT5,Q:C'D+0E]'7;,&I:2Z  MQ07!VS7NW2"7'&[
MS2#$'A5H'Z7XO33?VRKNWPP?Y+^+%1Q!0<9-IY\#*VPWQ$2U.H_-1Q&.380J
M!\X/"89M]=1F/U=0(XQZ,550W@=+4BU#XX\=77W6[[*R905];@:A"F^KAC?I
M[Q3I2-XO\T'H,/2Z&]:^8+QL9@ZI?/^IWI0R<L$HYYXW(%*\V/=X=*-+!7IE
MA[7TM(U$B5#C9=6!QR:$NP=>*)EX"$<%/YO1)72;6/[)1A>,5XN*4?#W:PA+
M,?W(>C3 0>N\+3K'__PR<VU)[DQESFR2O!=MECFW(V2*UTRA"IAES,$/WD\[
M\/N3G=!/[G.Y*D21(]J*OXY>]V>YMV(B'F26@4W9F\1.@5/<$.(%P.XG_]W@
ME;'4/Z_K^E7<D5%9!%G,QK@4//1!7'8^FFFSU@G&RV%3D]#QRV])0EDZB>!]
MFH[J3P0S^W-->]2VK)?H*#HU@<B[ QBPQ^$IZI_E_<#?V[,\KO^2]6CI2CY'
MK?O2^.4'IT UUQ;M? '@K5!Y KTMHIQZS+]K4*O#P%KDJBONL/$'>@[9,9NL
M0.HTA7SBO+>TOJ?U_,_)GZWH36A*T9L59RKT[][8#BRF</"=!+:'^:(5[P@U
M2^!0I,WY-4(KK/FK:MNR8_-8%7'4"/'_J_CV7TU>_UU]N[VXA_; FNO^F$R%
M7$T^]5X!/OUG']@#,[-0RIK3\&:=SPL ,=I/?. +LZ.S;DO;9P]+;%R 7@Y;
M<09F?H)5MX^RZZ-6DZ7:8T6'_A3@QN@UBM=LPCR,-LN#_&>?5[A>8&YOR!""
MJ:><Y:O@'D-/OY1EM;483K^,C0V01BKB=^@\OS6\Q@X='4A=O*;^_^DN>OM?
MC6!;ESD&9@HL'HNMR7ZVLSPU#KP"#)Q%^"9KS]L#97]Z6)6WG=,JE"="FJ52
M&5HL4SD4F\9]]^J^$9#P(G\CC8Y9W.IB<_0/& U&,Z-8-'PG_="2*V9FAG%.
MQ[!U2Q265()T:<JY;-7ICK5:K]A@=IF4NX>4Y2.]^[:\KQR+JN6JX .&0ONA
MTQ>)G1TB]5N3Z3. ]?#MZ3 -8_\;M6R: JSW./._5/3NZP-FAS3WR%C8$AV0
M'Q.D^K :0^^Q:Z@^Q9G[",8S5;KK ,?E43,/39T[%O<_.Y",4J#&H>T:N]HZ
M@4*Q L&17K@NM!\YS:@OXM#4+_43.WS.V2G47<V.S]\\S\3A\A< 3Y:Y_V<=
MM:CU?PT3GC>'W,Y+0^(#<[^&2Q:'^U.!S^[_1Z2XM>3':\F+EY5QPARYISUQ
M+D-M*ZN_UVQ^I'='?^T"8)4FE:J8O3P .:%"_P7XGN/M+X7H@R05&/SX17>$
MM>.=T^O1\<ETND(HI==9OE*.K]*F>)()1*+T\+KRC'6?-AKJEX++U%1''&^L
MXG=-TJW6Q\I5.2*%76^*U X=V>-M_]A&;U[UZB$I-S?^R)A HO*E2'D7?'0B
MU\T>"'!PLD#.+WI]O#YV2NX8^?((9+4;&!C(F4=M_0N!"NSZ>Z^;.0V$#Q5B
MTFYJF&4(/I=:H (P#LH8M%G/RDYIPTY#0Y:#8^Z?"91[!"BH28Y8/HX7,D3,
M1AL4Y>.-_&%,?"X!ZY:C/&<[WB[@/W&FW5<G2 L >S'/8U=VQZ_EQI6L>28F
M%NVF+%KZP<\/\KIK.W#K)!I$(+%/-EUR3N]RLAFF,18[G4L\O/DCD6_@F(L+
MB_/TO%BGR)D-(4F[R,-Z3;G@'KOO $;@S[ ?H>3C;HQ.S*NVAM*X'TQJH*8Z
MI3'JU&E(?;W%E$$B+[8F31:5=&7:Z6^"?5?I52[9+$4%=OQ=Z 17_RA:B$LS
MP <." X]^F1]#38?"(*09PK;H-TL@ UH'T?$42'K>H69<:2LY<>2A6OA?"Y5
MJCJZX=OXJ#1IE/VB(4:LCG!_8>=0@9<&ZLO0:J-:7%4>4Q%R?3#RI(%N.UD7
MP:8JGB683;!O#=<30DA,LO0;X$"3F^:K'YOQ3 /)W.*L43=L&UU8>;]V#*)K
MMP P8V4AVS/6-&T$&1:""8NZ'EZ5T2F]>@G*SX%]5J I08!W.+_9VM=F]AC2
M^/^SO?LYWE>A=E[V;,%S=-;!MQB()D&@0)-+'$?;DYO,0;J:3,[1E8X4%C;K
MG#QF:21["$XK<=Z>ECIAN01S1"Q12-5XU%=@B0 >K8_$C\#( K"J[C&C:R2R
M%<B<QD/=\&R'HJ4V<8V,^@->P'0N=7$H-+WJ]!\5A*A5\"^9X.;X3PI2KKJ^
MDC&L5Z.'3PSM(<"MTKI6;[_5,DL!1JIRZ[\OCV[ 9W<%ZCJ.Z2LDRFC^.;09
M>OFSZ_=BU& E[#YW][JT^J0!9_%81@U%MI*B<;,)0?P1YPY;-+Y%\$;318(D
MZ9_VUN=OQC36QT8H.+L%1U2S^9K@+]$*-% MJ;J+U,S(N.]&:Y5C&*1:=/:2
M?*+%E-U5+YU)&)FDKY"+WZQ> -0+;4PJ8,U\]6OX/W+-4N^S#CUDS[<[-"X
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MI/5-D\H1QF.[\.[+S[OTY\H_F%"&K"G5YJ*)UZW(!8!)G;; $?YBA*S ]Y?
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M=Z)5I*B1<\J?L918Z*"S;U-?B2$GU/3K$4:@E[+%SG'%";;.M(TLDGPH8\4
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MHL;:$$PN>K5^:'*Q>K>"A+@PQ3=XL*MU]*NC;2"MT,'9]5U=.*3+HTTZ+OT
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M1P1[^**N\@BK[O4&G2L954YGMR!'Y!OL#PYKD7:^%/N\S*T/)Q>BBPE7Z.2
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MPE8Y&%UVO?MKZ&V;] ESQAZY>+T_WF#G5IN<;Y1CC#*IN*A<3A'GA,A5ZLA
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M4Q)?GZTOX!V_HXWKN"(S5$00WR.WS$)>/F9$QP5+J-HY/IOV.;RP5,\/IJF
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M(J<TLTOVYB#V^M-3U& O=\[0OZ85;K1R\X:&9B'JZY <5J<\KG4-,AQ\ \W
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MB'WJ*\RNOWVU[.\D&WY3W'0GL/12-QR9*;7G#=A$RF.GH##4W4U:\4WF>)A
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MU'%C!++]TIRR].V7XGG2^%]Q/K.P'].\4]A^*E1]9-TK?92M9KVX.'N 5AI
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M^$T!5AG1HO;8M Z9L]&ZTTIK9]20,,1/2G!XFBM^L!MSM ,3P)!Y":J*?_U
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M\H':/GOLO&9A+"J;\]4A>(M-Q8GB:2X60((X-]@3K/IN4#ND=I0VTI"\N_3
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M?I;-]*;BLS'/C1<VK=WUR6 K'&1._<:W.LA!IF(36TYP5.5C0M\^/&SDF9B
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M/,YA]E]T._%\ 63@1I7+G/E=XZ+D.&M27SO],_; 0LQQF:Z 5;R-@>/1L.*
MWP@L@?)-\?!<E(H;3MA]1;FL[E74,)R[Y=R,@3)Z-.U833SU/5MGE3]@NF3@
M>3J)"BX0W80HL.+*<OJ\[E\]>W\2LM[SN.T@Z(59V),&.K*WOP-S]$O16P]?
M]H?N%*5:/6H/'!A[HQILAG=Y7WD/W1B/XS"AWO;:I1_W0$>ZH&7>726E7K'1
M=368T4G(-#EBK0KI]T;HNM_KW#^I+R4#^37#'#[[%>GBM/YIENK-L?UJ^(3"
M>OBA86]:W% ;XDJPR04!?0>5-0EYXX#8/YCT],H'4@;7%E$;0E>^^OS55.-R
M)$?X5<P!P8;TR<0:^70<_?Y4U?%'G2>2*%JE",_5-1>49)P4UU5I3RHW1,OE
M\I70R]!>4/L).#313H%)2"-L5*G#Z8:LD3S=-B&/U$+*7PYNW!/<"CX+E(<4
MQ,97617>CH.)/)>5C)-5X1J#"94?^#KP(@\+Q&%CVUHG(2L*M_5@'?>>8_=8
M\*B!V=. WL>EB!_F\H?5,7-;@BCU!K)&_F5+T@OGE@'@A(G=#"::AJ0'GHM)
M>RG;^4@ &YN)HP!&0<6M\^YIS2"3[5K&:,$JIC+\+\M2&LCU_'C)0*ANI&-Q
M=<.A[$4->9_&^,GN!FM-S.#B;2T;EZR=7F5+@.'8KGI/+'NQ&U"I'SL$-*Y5
MQQN2'/GW3#IQM\UFE::D8*>)^&/2MI+KM\M>M]CLFX3 XB]5 R?;#1FHGD)I
ME"$I,\LKH3#6]VW+(]* _$>_24'K94>JG(TLVK=@[7W':R63D"C]*)4J5+(.
M+4$YV8[TS98.!G'X8C'/6K3T*ZO5)&>(&35NB$/N=-SO<^S)*X>+4GN7)M$K
M?;0<6$B(1"B+V^L[U(:+%T68GG-7#E8F[EETURXF\:; HA_4=%PKM[XG7=/'
M:S(>S)D:;\:UT6F/O<+,UH_=L0L'(RX? <;A/'N@8Q+B:9;YH=501W ?![?%
MR3)UWM[ZJ*<M8[BP7YD*C@'J?1/-1_<98D!)B3$\.9Q([@7\44TZ/X6 .0EY
M_?WG-LG,/\M2OZ<LK/W;=&4$E< >+V3&74]VY^]2XWY/0L@:X@44#"F:NJG2
MO"-%  R^NTE>I]TB\LJ-@\6(!NVU#V*'F0,#VFBTZ3.%_=?PK]F/UEI/?%J]
M/T58::!2MYX]=GA)\(SGAB%M-Q+9(B8F/T]Z;M=DMD@ *ZEA>@.@V!0/9M9^
M34R.HZ2J/:'"=,6TQ4?>J=S%G?O%?-1N_D:Z!I@Q";G][[H/,\>0.V$Q]__J
MM_4PF;[O@X@"<IGP<$E%Z.4?>\\U6@(\BBM[. 'O]WKM($Z5G*R2&<A1$A9=
M5D M$\Y:X1ABX=+CR6$(^$5'!H6Y#X&G+2\6_KI0IO3]!Z_+U!"<&*C2<#@6
MN'NYY-4TMYR%;[W]958&Z^KXWJM907'K&LDI2),QG48N&@GHP>I*YJ!!]5'#
ME>O8\/']N6\3]4^!AE8/PGR^H;K5[4=@BQJ5XQ#'JZB6BFEI]-$P0UO=J_A0
M=@C6$UB<,?+-H6G1_8UQD?-[=$(KO:GRV[[(M\7\,MM]'$M7%A?Z%02YP+_:
M^ZK.RDIU+@Y7 3R4=NDOX7C_=$3!@2E&/!!:A_%(%;0KKEY9 M3!1PPO@P71
MH(NNH)J6X=%!H?'*=\"=3TW #C_V<7?GQ'$I*5&KN@4M+;O=3-R-C_R6YI2B
M7!:"J*N2^/B.)FIWU_-C$1,"*J=NDV6*0>%92@YO&"6'4% !6AS'=?W/,'G3
M,5_\R*G.'_A_\"M0@M))2',1#^L0._[[7N_V8O>A'L^10\'3I$0D7?CYR^V,
M1D3@E,[Y4*L(I8A':G_,O\ >W9W@VJH+&5,B#:\R)EQ8N2*=JX")PAKJ]A_\
M2"I]4)!9UX$\N V8(?DG-I87&$.O&.5F#>W +#^/V.D>4@5N$$GZA'9<?#!W
M1.P@79'>W_AIC0 .BTB)4EH=:PY9"7R L&P"G;A,1#;[J80S"\^AIGD.](;$
M@*(H#XGT_A7*XNV++-]X7,KW? .&$A_M/10_3+]MD(DM_7[B1&+)X-H+VG74
M7#(H.%D,Z[45+0NG]=M[U'W2PTT9F+RX0G^89R;)J5Y:(R7RL^I="@JSJ.YK
MX+6UI\'=Z?I!(ZC;U9:AHM:KZUOI49.0ODG(YH5J2^:I;L\!U9LBD=Q^X:5W
MU&ZOP5&DR_2-"?TJH2[A&'?>34]*T0J-G1V-9CP#J:(1\C'NG@-+I*GZ$A:@
MZ.7P\<@?'Q]):R,T%&J_XK6:OJ\AS*SB+=;_0AUA)_W-UG9^*Q>3Z]64>O50
MPX$=#Q"116HF)&$2LO'ZUD"G2ZOT74?6)^OE:757A$A#<=YP,Y"M'YHB;VCU
MI8.R]&T!O1.G_6!.LAOMK=B,<D%FQ6='5OGTWZ<Y#(:KT$3J2WJ15\TDI,N3
M]J@'1)FK]2]B_YIM*S&KI>1NCI"2Y*2/^<>/+AF8[DFJQJN0B(1^ ]G*'F#*
M1O\F&D*@A0CJ;>&]'8.G,=!:U@YU@H&J3VS+S%R';U,F#9RGM%_D#DQ"(+G:
M]/;.HJ37HXS,<KG/#\PNS'<3_>=(6_6&-!J)R^..?5DIF4+@>]HRSE:M0]13
M S2:G^, 8',E9;5)UP<D$6:P:7B 0B(KS1Y^T$Z8\"W@.+&B""Z]B(]N:L%X
M=2B2&%N8]=PL.4%2H4_\$HVV6S\[A52-4#DJ-3B#K:-_V3)J:<.X1MK(KD>V
M$OYY"&3#/*6;KB!C7:SU2._L?)2S(7#J%%Z+4&G"&=.5G-AU,GKQ%A$B?(#;
MI]-)^8TW]$T7?Q%:&K1)KT-E"OL:?X!?>\\C YD83 ^,$QF22H_T2&2>C^<6
M((9EVZ7?#=1^%STM=O0SWL>SIV$DV"S%P,S)KY)O,UTYM7M3MQ.[3Z&_6)T*
M!,6\&"G?+Y* CF^L!;79'AGI-DK7>5H6+;W()FP<\'=87_BW_0K*?/EO(3$>
M;Z$HG%'W-JW*4[X9@7ENR\3HQQRYE*9P)I39:>D.)#DU&D[!SK\QR-,<&>D\
M%Y$A0N\RAENZRHV<6_[NIK1"!J[N,^O9^W_L1^5+G'TK4F&1*IWWW$#'2<@E
M44)F=E+QO!GBS]>_SR?8()>C1: BF#X=_)L^:E3=JP\(%O9#O[ZU8[J0BBTB
MY!:7K3QUT4NFRE"]O'*)D$@(P%/*#>G,L>U!:_54Q;L/NRQAEZ:D)'TUX'NR
MOQ!<)EYQ?S[K!\(2SHVN#81OY3$>Y<5#2RY[!52@1@BP4TM_5Y":U0#T>]0@
M[VMXR5[+V*-D/',7$5[U<NR%KOG;R!.%4&3,Z585(WY5J=_XSS:WQ<03*-FJ
MEX)'QT [?^69*.#RQT7H6SY<4UK=.X83=8\Z/B[,6*^KPY>+.:4D[5;+JR<A
M6V=,36SF09!KQ2EC<!RIR!=;ZKIBY;I/5:*&^&@=O#KV=7C]#MURC:J!\,E.
M!_NU[TQ.7%)-Y*Q.3RZ?:&IMR)0?Q!O@JP@#!S<4T94:2KUMUJ/YOG69?S+V
M=T97&QXO]MDR+=(U*'F.<)I-;2329FV+XTK[E (4Y$PEFX84ME&G9]SX^&HQ
MR[4ASMR6#DBN[XQ+D-NX=\E,Y^J1^N@A6C#PO%K:4ISG5F0P"!\#5F4'Q:6)
M737^O@P=,M(B\<&.NQ8X;@SAI0T(=(.*;=I-06E55F;D*$%*D(A3OJ$I%UD[
MRR2\TOCLH-A%O)YP05;Y[QD!'NV-R,PAC"'IZ4<<'&);W[00[Y,%-OS;F#*O
M@27ZSG?%;MMP1+TG068:\@'$VM^G>B98!#FK[YX_R?F*?&J(=0E)SG55M5Z8
MXL<#@F?U\XDT%X.?B$O'ES6F[$*$P4Q5.(DH0W/\D=;S0:3Q&$2I\P0T/WUZ
M,*B'2Y$2/%1X#W)55R<, P=L4\_/ E@G'^V:^75EY,SIP15[]9X'- E)H>^,
M[W.7QG@>"-():(6B>Q1"6=RN*RD.UHY4L296MV:J><HRJ*,UT6.;T%HC0!(O
MKT-F$+IAL5%"I(!#DM\KQ0K#L>M7PT99]00VZE"8*?7;4(TZ2@ 2L%:A^I-L
MO?;&U8'GA4VM(P+& <%8PY[UY__*OM*_?M^'@*N:^3E*M>9GEK$CP-2@BJZ$
M()U",?61:5F<Y^D4.CR"*M*H=1>FOHI+:!A8%7G%.@FD)SFE##C@:7/$C:0J
ME8JO:PXOS1G\ZVELL+(!V>JFL:DJW)C81=JRD="A(["W0.Z%Z][.B\2R#AM/
M=$0<QOY[#FN<I8MS(G[@R#%#,$(:C(<NB[.="L]6L='O"=3\'=A!*<+O@*#>
MT1 ?9#/Q!>+ID%73[W.<Y=$:02*P&"<SO]5_G=4_WV2ET-I58*Y12@]2O_*U
M[VOJ2HA\(96U]2RJ+"[@CBJ(!T<ZT*$G(45F-S#RPSQ]UR1DAX&0@3X_"<GT
M6^UI/0EA ^K"HEII;O/L2<A44&72N0JAU;%($!6_+L6#"*E2@3+N^[1\(P5'
MVD]KNB2@5S8@*/R3*S;-T/=C6.[A;'3B?)"+6R)4J=1:,XFJ(8&@K)ZS0:>_
MW3([15YC1&-X*7?+%-]^.4(<WB0@*W2:RX3&PF"S339'WI&-QQ)PP$#1%S[_
M*H_?J*.XL!)!;:I0%6(.3(#(6\&7Q1FHNP[;2?<$LG4'H]$A])[J3,M3N-7<
MX)'/Z&4;K:VIU.P0*-')$/]O^\7HL[5C5>S ^'ER ZZ]:(^*9-]O-O)!G$*5
M2R?./C&6'M]>4S=.?*ZCQ&L>E\ 5/J<8NMW9GPF_;.E6&': O&D28KH_S'1/
M4I<LTC.PDHUZ?XR!P.QXN.:] 2JGRA4TSXAUQ=VO&=1"D]^QB+JP<PGVV.B:
M ?&['O6ZI?7<4Z?HY_([D_Y9RY[3""$O.<J:KHT_*GAWZ'8S[)C-#BW+Q;9P
M$F+'#//*"3FC3:Z"Y\JE7)T^S/Q;<TI+VGN5"?:P\61H$M+^YMFK!-3=5;I7
MSO6=6#KZE,6O.\QWZC#Y)U2TEGTN7PT0/BW9<-S'QQ+JGB('C507P95]4@UO
MNQ8M?Y;>ZFNY0Z6 "L7HUTL8"Q^M:\[=+FY F50:KNCM934JX=+5$0.S&IO[
MMW%$G"?@7XHR5(E.DB47=_Y(E7"[Z^^72VCI8UT["(7':^.B139H6$<T0,W[
MY_"-SFMFM;5)/9.0+TH#: EP";PHUG3=6K/2IDLWW<E* 8*L=_*K]LWKGW=#
M[L@9X.E.2'A0]G?ALW?.)VPB664VVP1P5#YA[SG^C&UMJ$<PQ+$R=#@Z?.M>
MP^4_2,''SM%M&MAY A@]@5XZ"J-/PM?^6E2Z&Y!G3P [@&HC.XY+6F_VU33)
M=B?L,ZS'J,6:]+9W9YT1YV?!],C;/!Z4RCC94YZW#]U3X\/-??:K):;>2^;>
MM?IMEMUHIV\&=E\B'/T)K\FH^_@I?<X[07$?62XU(-L>NA\E]=AF&<:L@B<A
M*#J4N#=GS%/C,T5@":,FXK= G5H0VX]0:C$LK#=A76IL?5Y-.)VM^=VQW[VD
M[&369KW@)1!/:&D)]!EI;TD(N'/R14A"7C-JCY@O8A<[LMNSN8&!2U:MJ_HP
MSPD@4#_FFE5NMGXBU!=3 ^/QTZ"'?0(\4!J/:1H'% %]R? L/WRT!_':7P2&
MFL4;5M8]5W6N?KY4%-)8E@24$58@NUI=/4WUHQWL 85 -#HW^/9J%#EZBA-7
M)&)QE(705C!ZQRQM85W"N/_[B'O=M:XN#,QS&;4^(4+,%DT<'2ZKX1R'>B=7
M55FF_#S[V'M^H+J#DR.>_XH_-N)\;N^QZ<L%)M/'N2*-X:$^K15Q/!C7?;N%
MH],*Z&4IRQOE>Q?$;]RFC6);Z''\+1F6J>09LHF&KI"G"K8HX[OR^2GLJY$L
M&DA_D(>_!(UU9(H\,G2?:$"JXAAF_9A^F?!FQG@CCTJWU5#'7G[K:#H =;#>
M-)L%VD!D:'N#T.*0:;&T4)3Q./.&Y3N4M&ZF(]5[)H+RFV7^]%+1,W&!-I0@
M?FX9>O 5M2Z3<;\-=K%%Y79*K#'+/DO&2TZ8*_ED/%1_":=Y2;2/D+^&S;^)
M(Z$^#>-T0Y7.L+AI&/RI.L(")$V8TL;3/\?N68=7C830X"A:D75,; 7].4]C
M3-'\-C(Z'+C4*ZL3IJ<R+C+'.HK[=XZ4K.E]./TRA(V8A!CHGX]^J\4)6F;
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M(MX1O4#5&;ZTOUQU\:"FBV3F[>)SPM3R+H!K1='Z2-ZA,VHOAWR=H4W.T2>
MI@9->0!H$8?J V<ZIO+1=#&EXV5X*ANV7<T743[_>W6=!W?-;*^3='8C>S6C
MJ[XU=H6M^2CN$JJK3^"2*.W<V)BMQ6]CUJQPHCY,L3)64U :K([=M3H0N_T?
M9W&62+]#U(K\Y! Q?Q]6V=%K6D,>)X< X[Q%[<[F^@D;--;!LH2$F1A!_A,O
M\\J1>[XY\DOR3E25HJ=NA1UYD%4C]<_9)HG53T)JW[IG0D5KVBJ'@EI=1B/
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M3GLN[:@77'N1U[_OTJ-4V\W-/$WF$()2*>(M!@YKH_7D+H<<]W19)8^"EP9
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MOY<BUU=MN=:]_W"DUT%;QL;'VDY^U=HJHD,F(H+B)70%C>(V<_\<ELNJX'
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MWTGQ2)0'N7+*G@7SQN>,=%U)D[=/(_S]2C(T->+G]6 DDPQUM,UQF("]J."
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MAL>0PQW2SA0.3\WG&,U'[!Z*ZE[,"&T<A6(FWP3%CNA;/27(YSK5D#7X--R
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MV[6OS?D_,8CQ<\5\^5,9)GZ5I0ML1(I40%'0^Y3=N:2Q8*9WW?^3ZK#V/+J
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M]F76:,Q3TI_5.?@KI>E,R17J6Z>6W8XN1LC=J19M-/#3Z4RB*CC_ZG+9XI&
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M(&%!U'3E^<CTI;3L=/,E[SH()'PGHPH3(SC[Y^GD,&&^.0<>B470N4/W:Z;
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MWXXO+].?'7/WQZ%2*<./,BU& B8F\RB KDFV1J].#F8C1Q^87'O$[4+/W&7
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M@Y;&)>QKC@7_=L53:))O[E9S$-O1R[ZF:73M':,./._OYD)UG%?ZA]17J8F
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MQR1=O .S;0?/_-G"J4R$T?@]24L2")G?V7.0^1K5 0]1T.D33 >1'8=M#.M
M';\5Z)3PU6<.$J.OT@75$7]5"=^7-7GKFDW2/ L!+S;Q&*1X?6:M++>2DXR
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MH=^3<UM ^!I39+5AT[G)>3-=<7%*1QTZ8]J(_FS@^?PCK\Z7RYKL O"40G3
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MH?I,V7O;5)P:FGDLM-9MWLI%U$30?,QVDC?KW=N"92715#TZ-_A\JE$ =KH
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M'8V6Q/?)"BF9E!%6N2D)#@"TF:*2MB\QSQ^Q!0'0-]HV> <[D+(K!81:AXO
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MX9W^SJZ=@V##K=-$' ,97VT<+WZQX-Y?NI'M!F(-JM-&^*>4#0CYEY1>C=A
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M<$*\U%5*"P=,SYY.^!ZZK?82W(.YC41]PSK?5'RR]?I'GPKR&9*L[,.NK,9
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MZ_Q3;R,1T\G3MOZ.!%5K#:3C0)IUQC_M,DHNCPI-V[\O=7%R=37>T9.N("Q
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MR]@/,L5RHO8'[81X_L?@KLX3NTYT'4V:K^M7+4#::KBAUX__<^QV1[:F@;^
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M0<E]DD-S6E?7ME_&N@L0"VFM]/I$[REFP"O7Y__\O6T1K&%@AHY99LSCNK8
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M]YSI2Y4!@_5+N;K<EM74O.4%L:7:K98Y0KG:LN)U1(#R<T6XN=2'<AS[_)V
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M/VZ(#N12GSN\ID6@:R:>+,698P[OM1E:Q"1\ *G&D<>Q31=R-:Y?U/^#A_U
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MQMU;HI4C=!)97UUU*[KW<9GHU%/_1PTTY"7" @09S@?,@/97FS#:T0Q,H3V
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M6 7O;I=9G #8)2 VKW>O^]4V7^3L_)^V?GDL;*L\?HOVMU6FS=T7?IUCV(Z
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M#%2J6.$993]P*_^T_[=5$D3 [')HL7[82K.ISCETTG<;W7!%/*.T*#/$AOI
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MW>.;FO"Y>F<.QH?BF<J$@%PE0^6[OK)9).PGARV-^@K:32QHDEP^>DG8!E%
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MT@V%@Z5?H]4NC2':ALAYL*5](LJ+\9CB^GRSM+&WRH\**S$#Y2]U]2K<LOM
MT+:Z(9.C"QXY'A+ZC)%7L'=$VE;K L_'J34?O(^\"@[DA0X/5Q_WOZ;^6JUH
MFX+W0A5C+5^O[ETOX6+KV4I$  II;'($]+B:Z_AAKAI?>\B,REXXWS=ZO-$X
MXMTF^57%;U6@VX Z*WT@^/M<\_2GLIK*C&&3^1BV] *TVHA?W^%L4Q9IP+.$
M6(WRZ5V5+=<(J8< Q*N_-.Z/!RR"*B0#!=H'I+=+85)Z"(G/PC5?'^G1"G.:
MZ Y;J4>5(Y9.Z5).OS*77.<ZJ*"5IIVF!%#,$]V!]KO_[KOY5PP"'N0MHKYR
M4,QLZ"IW)N?@]E5T)%F&!D%FI"&%\S.!I?KRU/U6D[I#2S^$'<R[DO9NOWI$
M@ (.>\%6PA 5:[N76X=D_L!8+ED4SJ)7Q)>DG;EP<=_K]2?O@H3M"HCR65&^
M2V-F^;8.=G#A!X*S0CG#9G[W/^K\9U'^]T[3]S(K+UG+Q5'%6M?*%W^E=/@M
M*;707TF&:@76>K)C;:MU?RA;"I/JWA*Y*\(VS.2< K=2;.;_;? ?LA-TO]DQ
M4? !2T8!<%:O1MXW5+W1N^K8*>_R&\*:[_0I63HS6P\<:-C;9;?=?&Q8<'.P
M80CJ7(PR,AEBJ. 0@U3FD>"MQ6<ZN]+G%&C_!SH")5398KS'_MO5D?WN#RT%
M9A^5>8N@'0+GH^S]ZKFK#;=)$ B!$E!$"8Q<F=B:Y$E*<'!)![L<7B'4CN@4
MO']V<W^012?\6F _KP GMRS=\D/GW:/<Y"DP2QEQTW3SY4?']+.@TU*%'8R?
M,+!AY-2[-_#7>MC1K!^BMC@.AXX[VR\[\8\L9W+YV%DAAY:&Q7%2\Z;.5_97
M;"$WU%*9#31G[. ;H+K\8MN&-Y*0DO[W"5'!NT-WT\O>J3#UE,R4L;R*(8=6
M;-=&"=6>@(7-<R.+H*=>#Y1[SPCV>"4@_,&*F]6BA]T7+I[:[/^'C4 N'5=%
M#ROX\&'_KJT>?Q^FO _D5CMZ#B']<RZZ;G!+Y#T?-K4G;+UV?;+%8%K4@H^X
M>E]-T?DH#^.6K+1CPJ[MF#@Y:8YDG94!.Q"R<*_544]JF?7G%T%!E3//&?AY
M7FHNM\I!A4SD<XN@41+XI?S-V#680\O@QO[!FF&:"E*#J._#.SF.]GO+0GMV
M)U0<=G&26*LP]38==-Y2P2- C[*=,G:[R?*^*)O70<&"X7)[%:[=*7VI[M]%
MAEB"4TK666&,\OWVJ7/K-]Q%1),I=;K-"$;JN>X;'\;+6\=BJ]_;_^*^=QKK
M4$S:'7BCW#80[FWQN\!CFKN;7[L(0I;YAO54U2NH9V6(M$60M$?O'R!U)X@]
MY9]%MR7Q>P(>EUX+)A_<!Y.2G1=![<H\]E<'P=</(43[!V;O8J8U%P"TQY%(
M0\NV/\\]VS+ *\GU"08@U#*8,5I[<SVZ1$%JI^_OB!*W +L&^U]( D6WH0\%
M Z)Y'@5\_Q@J;/>4N1XTDO .?%OES><# ?63S+H+TLN1=+I 8>VVD6]Y=8+I
M5I5E@XC28&/]VRPJ_Q[Z^F?$30>CU3\3:ZLIGF)H5_"ZZ?C#/[=:)O!KT0V-
M[&N=U$8*N>)WNA8V C2W&AYFBCT1_^DW@+'H#EIM5?CND9U<R,M8:@4+6>M1
M'W?W0<) /6,F^8<:ZDJ"6.GN=63E4X?'OQC:B?<$'<OYJO5^_?W+PKYHR^;7
M\0@+;I))N8/RIK3B@UG\_CW-].IG=+G,H=<\7%S_EOB'Z,!F?L?.;A9T^I%X
M,I:=)5GN47153URU.O*'6MH\:3E5>Q&4[E_[TG\5_<CDN6@%8[W:C&8M] 5[
MD'!XJH\W<4@G9-!53;F3"E:$L@=;4)J%YYZ9[#WU25$Z"ME'2,_%RBT95_A>
ME%S]@>E3Y77Z%)BS0H4X!_9))I_:\[G+#=G[+?6T=2&F$N6S_$#8FM5S8AB2
MSB*VW%S= YR]RZ[0&[B<E6G^0+Q<&IEQ\U,=X6FL<6G[SVKT9#B')-@RQ1!8
MN12[AJ.+@Z\TLX9\X#Z04 %D3;GQF]^9-?F.(TVO/G!V=V)[*GJ %: Q(XK]
M.<WA*Y+3T&:*KD*9K5!+W'%==QT%B+X=S& IET'),*0%_B-4_?A4',XI^M:=
MR*W=T#$>I<0JPW*IV=RF8Y@-%%?'; L"BJD?8!W/0\$<Y&ZI5>N_.)B=2XUM
MK,X]\J%F(,JY"R^'_FZR?(!W3KY7GWO8LWG&)XI70O"SURW8NV_[04GANI72
M" VF7'$J("KKX6<Q+6-=)$D/QYZOL+Z?X9(7,FBF1"S=K6>#R.]:V;YPZ(&E
M3-& 603EXOI;EE6[QEZ$M])FE(W@E\S9;*M !Z-%D$!H/E*;!&<-27("3#Y<
MUSR *5()E#%<\?J_AL,UGI/=E  8<.E_].E/LS!]U@ON+RAVGN2]0[WLZT<4
M)H58JH13(4&;ZNY'3J79937.^*.Z4 +)P+\;A]GS/'D+EO5P 'P8.:NYM#=)
M9/'+]JMMC[3(96.@_^YJ@K5"C1^'M6I,08@*..O(&DN!Q>-N#E\*8'$+6D4:
M2P4'MXLT)B&+H%8L[N>YSZNR'JDG(2.50 5H'Y.PII4I6Z>PX%+E\67OQSSE
M"7,$G@RQ5*"C,ZWU:40E'$=BV*HP!DEW>L G,B;]0T=X$H4%1WI._5Q(UQ7P
MT0Q%_;][O]W/L&9YM4#U@HJ&X&!^SV1ACN;_5AW\V[S^[3.PV7,5.ZZU)5*7
MVF#!=H8>* ANM@T5*&%^>Y_\]>F+;BB1N40"<)T53$'$=EP7G2Y4N:+3H1'3
M7H,-"=H"BEP9I:9ET*.B'<E/^4NU%P*.F[//C6Y=.,1.(D]JACG\5Z%'QX@M
M  .63BS_KUW<>[5C)E^P7"2 G8+^^6^AAU@;FP5F29%;#JNEAH?I@4>A*.:"
M++K47Z.'])R0)5BZ"4\^]7]5XY%BO?"XVT:.(RP=B$I?FO.O3/0Z#2!D%,#=
M/*-&O[,#I2B:A_[_U'CL;L(NB+?15'_@;P'8SQ:K.KZ<\(/N+UP$*:)WKIU<
M!)':]4*E+8N@LVA1*?>3_L3EK3HP9&&I6N:F*6W2!]:,:I*.DP%2,6RO:KK#
MDE$%LRJ97W/\?^8R.E>F71^'PK*(SLBF19#PE]H[E=^"<C$MA0D#_YG)>!)N
M\?B'@+,P8*'Z1V]LTB(($)#ALR]6X52>KP:&A%-Q$M)TX!43YER(=J0@5EF_
ME#S1'[^OA7;\;1U%DK =5X;NFQBWHT[. /\/:>\9UM36M8W&C8H=.R END%1
M$=F 2@VQ(ZA$NE)5D")"I/=$14 0B8("TJ(B1$1 >B?TT",$B=0 (<00 R2!
MD,Y9V<_[G7.>[SO_SB^O2RZ8:\XQQCW*NM<]3Z.I]/.[.V'I6LID=+TXR@2"
MW?66U]W5=_$TU+@1V*1U5PM;>ND<"P%G\Y H^ZCFPXG_T@F(E:!K><*/XL0M
MDB%/4L!2_Y4-/K@]87'2T>/C6!A]*N_6U+6.+D7)F >%.[L#M#3KHBDY5L #
M_WZRM7M*1S;5;RT*B3?'OKM!D=@2=#<2L"6+ROKBL1'Z[RP)Q@JC\88'_F/,
M-BF),<$C3^3_CTG&_YM,<[1&+?C8'N#O$MGTL=S7$M+%H@F>EH2F\H(^;/W?
M)DJO_X,.4Q)N0,F73W>G;@.NBNF>0 "_/_)BPTG@I-%U$7QQ)-(>]'P?X-B%
M5#7 Y,;"0#ION/R_F#1%N_]E[0R0V6(T%?V(4^"[80. $"G-#!$2/P_Z+Y[-
MPI9X ""0 BAJE1^X0K-JWYHX.ZWF EA?<E/#ZM<M3]EZ:1X"#[H(.A#^0XHZ
M^:[/V$ZIGBV.0*[.;9+P.^1:>,QQ")*_#HHU' [Y+XJ'*H@'92YK1;-"A.(<
MGO#X7\>W^P)HI <]P1#RD5D<T_+Y -DT@B30H;#E[2!#;EH/>4F1+:Q;![T^
M<6RC:=\S<[0>\,.1)\=>5[_KK[%XRMZU#A)CV0ENFYH>79H'SH:',U_Y_^)Y
M_/.2+D9@)0)W"E0)*2D:@-(D+!6"/)3A/W[51]B$6%X2*S<BC9=KC-V-FDFZ
M) #T@!W7#1-B)<@L+_@0*,XAS8P\V?+?I)M;Q9&#+U@A47U^/#\QTB#COUDW
M'V]%#@J:C>'8<<EM CU/COX[T7-<7:5-?2'_YT[11KW#.P:.<A3#$6=-H"MX
MB=[DK<W/YW<@%F43J85NP<*OQQN^Z;[?9]I%N1J!<*&RJD,XV=A&SRX\$*Y@
MS-F=U>C*AJKSVL8\*<EE",A_MHW"= QW3:#2L+ %:-M87EK/..MR5\!PDDP)
M3]B<C];I7ZAGZ3,8?#9A><EJ(FQ<.KWK:N@V_ZAR$>!,"5 UC_[MY6["9C=$
MHX2@U^=5WD?9ZIAUG$[$P-A+(T67.*CC?SQ;A1-:\D(=(&EP;4*%>%W*2;":
M/@V-K^;AS$!'64U.;\J0#5 \$#T83$IYNF.5WB,_ O&+$'ODNN1#:=<CZZ#'
M5"%'%+IDB>.@U&-1OC(;7^%0Y@VBFR";E^Y+V?)$Q>-T,5*F)]E%,Z0K,5II
M"X.'1(<GD_JF(JMN_9JKOL05 0AC<-IHDAQQ0D^LC)Z33+4_;(*K]>K%M+DN
MN:+P66)H2? 5"GO^ZE"$IF_VU]ZHW&Y]3X[K!Y40%W,#:]LI7X>>XWI4I%1U
M"6_VR9&H'(\M%^<>P)P;#9!HWTI5"3%8UK:+]P+H7@$7CY6HCFE9\N1P-\3
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M221[B>GW/[E+#?WLJQTX!,![\ I>R"0D)(S_Q\@/W(#C+J#7^:%+^*6H7O
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MT4Y<Y#JO!MAP,U(VIEJ@'DC[C=G_4J :N7LLF.MV'-KJ*+4. L P9W5EV&)
MI_(UL@E9PJ,EV%K5SZN$5$]"I(UKU_"("M+N@5TLW/UB1DE5)EU) P$XU5,_
MDYC?T,FO^ZUSW>=^X[(+34SR&,7]*[]XKZ" CV;6+!<3)E\^1C*GUD%O\E*
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MT B:UZ%X$$;I?&ICH@HR>&S@(63:FJ!UU7HT?WV16Q5C18CA%%R1@0_[B%9
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MAK+%K\$87LU]':X'%-:V_&%;?'EH3ZICCK0+1:(E9A_9Y*+LZ ,N#Z&/O6C
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M(JS^*M=6*V=+)XQ"%QG>VNCW,NI]F*I==[/C-#H2["P19K3VHBSQWC^;8Y/
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MU30\=[7@M%%?,?>YA])FB.CX!E UJX6M2JI>9%<S6W!LX4.]AD^D!G<;G,V
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MO\3]]W62PEJHU3/\W_8.9M;'AD^,QBL(HO0Y:]/#>_44+_C! Q^?-XZ$H6Z
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M\:PU&I>XFNW9=8JA5'+WU/VKKAKM9O[6 >Q_\$AQ:7]HZ)^-W^7B+NVQS,J
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M&]E"N#G3SBY>+)NPIA!-?-'>J0/]""44T#;7,].>/C'V2#RS1PN?&O_MCG]
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MTIRSZ4W6NLS$F5MMB-C&\P3YWPG3:\7%"6I#3\I>?G[S6HBPI8X]!)_Z!:I
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M:\?:>]$\".#JV/-(J_#7Q$<IDW4;,TL*M2MW 4[;!,;S.SR=_:_Y<XF92?>
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M*5:V+3C4OYF0J:MT2KQ6JG'2'7?2Q":XW1PLJF)VTR8A]AAT."4[S0</RY&
M'(?[@ Y'. \\IH2J>FN<%90\F/&?,/_M?9KX!\:6L!AZ.^W[QO2;<EF08.[@
M01IZM$A)?^8I$/L<DPL\/^Z33B^PSID;GND@6EF%\Q%!V7HZ!*C6!O95DX+U
MC@Q?>8Y66?JJJ9(^6W7D1]"4<(JD48:\LZUU.GD!JUT9[+A4SFT&*XFB/$H&
M,QY>)DDX71K+5HF)](MRP[S9 _@@CJ+SB\;IF1^@F5F7T\6-R.5Z;'A;\QJ&
M91L!%4@V89O_R=,4,YQUQ**_&7.B'7^[R_&@Q9G9Q(A5#^JLR>N#^Q>XHBD[
M!%?N)$B$#1:X&C.;^5#%+D 5+\V%HP>:).L$W8P<V6_.EQRQC#9_XLIN4/>U
M<LU>&7= @ \G%;HG9A-]KU79F)]0F)"JB%:=KLXQDF^3JZI-:3*^='XND<4*
MN[GO1EUFME[7VAZ +(%I;#D%&XPZE30U;N92)TFI*=!])Y"U-+%#8B<1%[RZ
M((GN1S84Y\L*Z9:;J^/NP&?IB%F9+=0>P"T(>W!GG&/8^79JB?EPJ('1TU/G
M\4Q$EK,' !H,B_^J/7AI(F@MWZ&VN'?-PA2CU+ 'L(K__N*7;ZDITM]$88&F
MD-ERG-CK#_[+E!"XEGXTX$9B8WJ>H.?3/8 D;/_FN4WL4K9\,8DX3J5A\EI.
M0*\.Z5@8/L6FV/,!.E!@;NT> %+/E)7ZZ9G8=_*7R_Y%RCB5D@>_X-@]=[Y7
M1%="YUQ^??%HYW+9YRIG-^]28,%A>V*2%_ 6SG(-F;6*V9V.J?JNEU3,F7^E
M.8JU AF1",.?G3RD]YVC($G3SXD88^W?<R6=3RM;<*]_-LT&_Z114/ /I$*@
M0PK0([YW#^"YT<_O)XN=4^W-- \H6Z04+74KUI(VH[V'D(/Z)=6J;7;#.6[&
M:D13- .Z:B%)45>2X5_;C$;F&^MQ,P7E]67#TW$0=Q0$8MY]2E?LIZA?X8]
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MS(U:("H;P^@#G)E>Y,PV!I%KMWA99+SL^USOZN*M<NT?TJ0=T$"IG 9<JB9
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MGJ9:($;#:>F$G<,Z0H:6C8V#F=T-WRTN'_P\V=,KO@=XG+H5S@_$]A$IOGN
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MICK[&DVERUX)O+UB1/[ <T8'A!6U/-S+4K*KNINEO"O48P4X,$,^34J9V)7
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M)Y3X\_W G<:\;.UA%97EL2@7 KF8X.8C5M]Q]2CI10] FH6 ;PU4SDBVWY+
ME#55P&;DC<$?]P#RS9#W#QX*A.R^_K')_-?#5SVI!AQ5VM*UK$+F(F:[X/B/
MY4H"G\L^U7;*!DQ2,)C4-V5!Y^169""<*109.(TH_>T:Z>1TYYRP72H2!4%[
MT'=*-AE&AVKW #\JQU?H>X \0OHJ2W\:*TO_U_1;H1/,>\;\:EQ+'Q+F]UU=
M/,49/QAH2] #D3$DBR!%82.<X,BR@1<1P]C92='0"%_7]<?YD=E1\)V_V;V3
MK.;QX&D0&O:.F_&CJHW4K="3J[G[1)NXLK(*.I(P86ZVF7^'1*_;9L(-;K)
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M>/Y03,+S5M<3[>21=12XOV67"OJQ_@PH7VVV\WY[5$'Y<.?V:?)^^7*X-C[
MM]\HD"6P3*0HY$BG7:_[?BU=2Q8M]Q1QQX +"#*:&Z?IT!<^+1HK6:<^P$MA
M% _PH7B96P1"CSGT?7OW2ZQ0N@MYQ&5K8+AZJ K;J,X)!YZK<7G=[A 2<7Y.
MJ58-(YS<W C_ 2S9 /_ CT+:LS1"0WQ]GR9\9@1-W>@/,N1+7]IA$ON8\8EP
MSSV 0,^?L0AMFP:5D5]JBYXOQP]-/)6;=^!=J.#'<:X*ACLNWO#SU)GX*H(Y
M^/WGTLH.YAH=SA*E5PR$9G<>/CYR#T>>G)XV+EU$O[L6=QY+@0:<ZY_ WLV3
M3J,<F,_/;%B-UC-2B\H81#__&/_"9_G2V>E1JZV*&F;I4V6ZTMRIU=VRE9,U
M#1KMX*/MD1=*OD\:-R'-+U\1!&< Y!#RR"$F9 8AU"[[/C#2%U!;';&_4Z!<
MYI0$W_/YH\:O8/D1>X#_H))4\HM+VV$$?\'?<8:QHMD]*1\H:BA7N,HV1ZGC
M3[\5ZH":9 G#MT$KX;^+AGP3VW)ET"+MBZ&%:^;0"I^U:D?K/<!\[^3T1UK$
M!4/:>;#@IPS'"\6=AG];%#WS=QRP5N@%$ 452;/TS_1,UCPC/>/Y(CAI1VG9
M%([IR#E(Z5S=Z!3J,.^8.8:P3F+!FG(X^APTW"OP.-1\B$LH^J*"K[N7%Y*.
M!#9K19QK">=EYWW\:YJ4NNW/F9<OST^F%+R 8R#$[=LH@_;[FPUV/D.QYV8?
M<S=WPQ+,]@#J^6!\2!*R2%4SKWAVW&[Y?$BTXL!8<XQ[+HQ_0*ZB/+VX4\NX
M<U#K?"O?(;R><;,>-Y,IO?*EM:J@.-DN."D=Q^/@LTN=T'BJ_"Q_$E1()=_V
MG@!B3O^'[/S6"N2AR1<<WRTOFPY!3\&49^$KT^RY%BG=SH9WQ4.P'K3NZ!,R
MP3*,6PM$*[?V7_*>M"M4]!TT_QWF74TFUXRC5&!_&N)^<:5R] H>S]L%UV=0
M^C6[]7AQ:D0DF;[Q2-4YJ4NXZ=*O('9E>60)#P_LP4;#+D9<@XO_37.^JP#S
MD/<X8ZH@PJVEAT"R6[0Y24!%7\<R(/);K+? DWEI3SF(+3THQ)TLLGCQ8WQP
M"/JFNJ-/H04ZVOU/=>XVJRRD?T[Z /GURR3CKY%BWC<IC6K0'M0^A7<^6?N&
MUT;NOXWK6=-7)8B#"F&HZ>MSD=OB_Q=W[_V7]/N^C5-6-DP;6IJ#2LO<J9D;
MFII6XDHK5V9E:NZ](+6TH5+N4J$RQ4UNS4%.<F)BDN)(41$1%Z* @#>^7Y_'
M_;A?[\^/W]^^?P!/X#K.ZSB.\WF=YW6V-W:=VSQOJ/],HGE1G1VI-*GV ER.
M@D><*KXW/J^L+E#P[$9;1*[)HE$(SG>00!%*NY_0E""&$/MJ%PB?T9W+-#9K
MX!E2DR]B\:DAM\,EBJAR^"3BY"\M*$%-L?DWRLC=M-*JIM[,H&LH,<G63@4$
MO0\]PQOP&6^=<CV1VN;%\W]<$=6YMM[G@8LX>L$"M^]-R($]XONMLQZQI9"M
M!/KF31)JH6KEP)3J]XV1!Z\N#:C/O*D6]IW8OIX<$1*^+KO"BY$+]O[V_?V[
MQW(1*(1FGQ\L'UT^>8N@UB*O,.5FD7H-\]JA6?M+V/TA7B/4^+5?5T6V[I6$
MB"N6OZ]DFNI[G D?GD.&:R[ AJ?<2HM/:#]J->J&YX-::TS_-NE&R'K:>/1>
M$=^7$??@[Z-'65N K*G&Y+_H* 9ZCU&9QPV-/;ADRAHH&S+I9.Q^7P99,F)@
M^24E\.3B 821.@%LADF-F V&HX1XI2IZ@>?Z+!K^IM[PRT.[N<&Z<9A?,W?O
MX<ZBXM;!0G;3C;0M@,](.1ZW6L>9B;B,-[@Y>:! KE,=JWKI&C@0,A<>A*5O
MHM=O,\?R_E L[GGHO; I[LIO";71Y)PD^PMD"07Q[JQM =K0P^$W5JRM(I,
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M3C=I8 .\8ZT(0_18?Q+PZ_,RA6 @F/?PPE"5TNM2[\<U5RMOM*<.9WSQ,F"
MADL2K-;+N25-9ZYSX<M%+38C"2LRUR>RY%YU; &";J-<S<-7\%J;J:64;]0@
M;^?('.+\Q;Z+&;.7YGXL7Q8L-<:7*L4O;T1%J$S>C*W#<]103U<UC[NI_+5^
M"+'ZL4%-;'C2^/3QAZ^6UII"#\N9LCKGC%V[Q71T=7)GV>YWU(Y]TRDT8")$
M)N>9?RA"]M]2E^X,AS-.%^4J=$]Y*2J2)P^2%_:MP*;B45/&;6!IYD0K"%0#
M]JA:7DPO=L3F=?IFM\A?3[5R\UZ'[9_HYRGRB#! KH-21Y/X&\@.RM>K'L4F
M%VJTDXG7?X2"C!XNZ.IJ;1)]@W/M>>2NMWTZ!\[^JI4*E-;G.<"=^]R!0FO(
M0TH'_8:DG[2O0CN#HF_\6!L9=4%>QAMLU/[US>K5J[IS6TU':Y\)I<3,HP/"
MN7BEE9E'TFUP-$F=%05R6DCYCH@3^CI_<TRMR;=#[P1*,-M#-TVA>(QX\J;:
MI&V<);MC3EQU\<R19KD;3.-'^@)>YB;2X!.DW"U M#?'\3=?'%]6\@Q7*AU!
M3FMMRUT>VLCAV[[)YUZUDW<1&W:#SZJ/8((;#/]Z T*TIP<,#/.>NF*&3][M
M-.R[!(1'L FN37CO#T^FK@X;"X!O18(R2ASOQ>=V*_X^\SJ^. ?7N]E8<J[J
M<2_, =FW(J/<NVI\KE,C_J-Z4N QH$CH0Q?48MF1K+QL[2\1#:4XXSQD]'=;
M+(RH]C?VPL1KF4,UU?T+<>_=PDZ8D#^*\VZ,X=(T>HXJ^Q,(\99#3>K0$8QT
M)[[AZ*0DC'EM"9L<7-"Q>CEPUY&(DM,1SQ?OR,4?_MGGL;[9+G,<WV"/L*F;
M?*MB<PI/4U?.P>0;9)&)X^FM'T7B.&=V5.,K/0Q/*P,>5K]VN26 /X"MD?FM
MT4T'>4RN,/_@J2)N9IWZ3Z<F@[Z?:<I,!XLN)^Z'S0<+MZJ7-YU..U&96LF=
M,JTW#;8G!)O:#(P HU0V 1S[Y0O8J> 8@U"2I^N4W->Q[LDB[L.5RJ]U/]]U
ME%7F!BW*N7B;TBJ!(S7KWYAWP>6\B\R'!^6[N>W)(Q]<0R^Q7%R5)#J?E?J%
M;:#']A',?ON+%>8V8.%:HGLZ=P6R&>*4/[::D<O!+1_QQ;RS_<415W[$V3:]
M/DN,/V3T-PPX&&89*R!6J?@;I40]![I;$UB<POHZO07XSA 3$?N-F;QYNEOS
M3>09^*?<5U\KJ_2.YBA:)&C],M-(+0EU7. X#QHX;-KS!@!S(Z $5>3?!,B&
MY?RZ_VW/4-$C$;GX_26U"C]/,J0"Q'I;-P$1P<RCZBM++<CC3$P']&R==[7]
M''NV+%@KQ2KKQJ]"_9_UP4(NWE?Q55#6W'?Y%P:Z@+*!M4W#LV=8-@>>#EVP
M]_UAOSWG(<[=Q.:,RI,BW]H'"@:'PEU7I/QMN9EO<L\5_I:_AYLL65+ #V\F
M,9T<\)P;15.]H8,H;F;RHV'H,=7?/J++N'EF56[:F2Z_3+I/5M H1[:"6[H%
M<'>*6[X8LR+;$C0"K:OY614KEG0]R?QB_I/#49WB\L0WTUJ>\GQ1RQNK1(L]
M]0NQ^Z$7==(C3*MG:*/;6Q4:>.YPS*Z3W$4,FK:(6=YL;9)KO,EU;?[H26L!
M,1#A@<%6V<2HDX@FQI ;-6>NVN2Q6,JQM)4"BV>OJ[7V WXX.7?H!1>[ICTQ
ML[T[ZF!J.CYCFC(CZ?8U1[Q B]Y4/^=FU7Y+^6'NBTGEM[OC8>UMD]]^ATXM
M( T%%?$O'M68^7YL+'W/V6S>E(4. "M$8^R8NZ=$CD9<;7C'_;)*;!NI&ERY
MUA-\(_],Z)X=3P2DG^O.>PQ<P!#M2.LQ[@:ZI-X]^D#)\E</RZ)U'8_J""1,
M@31NT#K"/G)KD3>KAIKMCA^+JG4&[JBC,'FPC-)GG&-,*,&CP$/FR$"5$I,8
M@JFM3B ?;!X5C_9'A*V7//U;5CC_,JQ2[C=Z3ZIV=3_R0F-@577DSO0W@_96
M/;7>\KW3R/HW'>9-NE4>BLFY>@%9QSJ-LAR^(]^,P%LP_!"OZLM< <PC]B_G
M_NIMROTT,7I_3!RY6&W^>9=PULI(_C"TQZG*>R'K!T>B;HAWBG+C6KJVS)G!
M4B^$#B%=MD<C^0<_$2QQPJ2=9X;UB5:6W_6T5*\Z_?I*8=@Y@:B8!7 [P<]D
MNG/7L8)@T3=W4NN$Q!_$4 >%Q[D*Q?6'S2*J4)9W@ UEZK,)CZ%OJ.GES%O(
MM^(%4T=;IX=5#'8GA5YMM1.P\H;"&M8;UFDVA*:X20_HB%-E1N46X(4C^(#=
M%J#%%ZZTH"^WVL#Q' %V_V M:T;!W>E<VW5_;@'&_0L$:\<-GQQ*P_94(%M/
MI/96?-?N><&Z#30/Y0BZ<W_P^=5U4KTPV]U[MYN%X^*X-Z@/X?-LNIJST^P2
MJ*Z4NQ20_^EFZ,E7A;OOQ)=> 0  PCK216H+G &#T3^CM^\?9RIV:<;<].@X
M'(\1*UP4AXOZ5-]4G8Q'*N43EGSO*AOPRO;5._S*OI^JT!QL^98!1GKJ3^)H
MZ9N*-SX&M^1KB4B'G/X3XU_(?&M>6]=@%SC_PV16*@HA$,@^L6:Q^33";T7L
MV_)2W(4S=2N%Z%3_QW)^KVQ(XHI2GW>YZAC6(WYOW@N<O!D9*:X<L^#=.@+K
MUK9*W(\0OKR&)=_3<VI1B^4!ZWD#$$'*L9J9&D/V_8ZS3Z;3GG1$XB:1][^'
M0C6^F*:=;I0<&4JO=_7PNSKE:.N]IITS57WDD)/#I/U;:1L%OX>%DV3&&S0D
M_,BDS:',I<Z]:K++6P!S[AO84Y&1A [,BG\;0F'YX+0@[5A:D_1OKY(OJ>^6
MK@>^GIK, (089#U$4\+ M+)-E?(YMC <_+IA7]ZD65G16&]@R'*';^-;P3/5
M.Z$;:]BE'L]<C=U5[_?\V/EE64?\QSQ89-5/JPA&LW/]5C?@/*@\ZOGH0["L
MFIF?'NS]&_Q\2'WXB50/HZ^JO\.\T[Y^36+6#:96X2$?ND5$5S3:S')OI<NV
M_WV"F;[WJO7F_*!L[ICP_7<%.._9K&JP, -,/+!>O,(1N,)\/*EDQ_51&U[,
M27WTROB4N(\X=CX$C!.;#9[XANK ) SPPRM\Q:,#H;'L&N\))RJOW1:Q;8AM
MN=<\_EY/[E7] 1\_E$#B'_18I, D/Y(,-(,VAD!'\0&9L0]I%XY1)9,@EI?(
M->@9AY+>Q53?5XAS'Z]<C%/J0GR@393J :_>X]IJOYTMB6^SB>VT\2V0=/-0
M]'V+R=X"=&; 1<\I*5?$E?=\06IXE>Z,20C5+^JP*M&KY";/IXB65-0QQ;Z$
MD-;'N-FY#O+WEZ?<@<)K$V-72\;MN_TC52HC0A/W:QY3BMGXCKQ/\P:[PT<@
M4RT'U2;!<<GF;L^C5V;O?58_<M'4.D4:].QP#!8EMJD/6Z;>7CERN.CJL:*'
MG$REU"/78YHEQ4G2A;BX)F"$X;*+UT"#5N[3\J-IX3=#IN2RLK%/I:97>%I?
MSTLDW#4570FDM-RO[;)('6++53HH,VKZQBQ67 3,% A_%Z5+7EML^ )M"NL0
M".YC6HDB.FC@S?<@!Y$6#SA3'MP!E.P#*5*;#%:JTTGYF(')Y9F\BK"/+KCN
M5V^4HX*\]JM7DK3P;AAQL"?D>6X 1CK$4G8RTF"O9Z""7%KXAT_P_:5D9[EW
MNG*,=?1XR?KUB&[;>WL%]QL:7X;_#%PW](A?,8XKYMCNJQYJT'(MM(MZ7G-8
MT%(3$2^R!;"K]@ OL&DZ+8'?& ]IM',W4_ONA^/7W]Q?(KI^3@"*%0UF(5R2
MIC]4[\/X'WS;:C>?LL8=/SX\F#=H"?-&#G(N#T$-><,3DIJH"-UESY*^J- ,
M;[4_G;O;SO^\V/ ^.TOLR@UR*4Q8V(DI/]$>J7IUQ<IT92EA$71&FVT5XNCP
MD+YYTI[4NUHML7_7>! \75P I;5)FL0<#/%O.2Q>.;:_V^C*#@7/O0EFAI>
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M ('#!<5\OR):-J8 3\R)9Y#C [< )RUO5IJL_GPD#E2?YOO 94ZW$MUN?(F
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M_N4L=9#M!^P8/Z32G5:^N*0)=JTR-QO!PACR8+!=Y&;?\,Z+NBZ)T \<-B\
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MN\9M"3.SH6;5=DX?+Y!"5:0SWT!NZ\EO 7:U?E^N+J8KK^OUO+]6+-[6N%<
MQ3( "$HKN4LL&KQW]:T;C<ASX=R56I>@PG$CN8DF+O:A7]235Y.V^X\?N'UN
M('1,UF9YD:2-^V&(VA(;!= =PU 5KQL=U+OUC5KX>MW)EWFC.?L7#SN)>O<2
MKT>JU5.:F@*G*Q.%TN)PRL+"FO%D-(90NT:Y]'0DIDO5>?#$R,G@R*PP'W6V
M+YSW;2[U_GG_TTV1^D'\&.2+^/V%LW2-"L52Z!(:/+G= 4DKL$[72V_8V'A8
M4G,;W+.0F^Q<F-]WY_'>)1EOWYJ\K%\;R%XJ-+\DT,,WOT7EHY6$N8!I.)T
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M(BC,[-95'!\+D6_B[[C@HJ!+1%V07_?H_^'N/<.:[+JMT2@J%A2[]*B@**B
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M&8PA!EC]FUN%XT":)$J4H(U8Z!26X"/MI#E$10J?6AD.6V"C^1](1\K19)'
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MIVZVL[E/0*9(".TYH!CCL51SR0TC"T.21+02$X==Q(S/]:%UX")R]LUZTIG
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MA3.E[1+7;=1RL<3M0C1_",92R;K/!JK4NG1,#;0#,OIF;&KJ#>I^Z7QD5-3
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MZM>*UL]EW7$P)YP,6G9GIT=VU;*_7,#X2\SWCZ$WNWTI9>+K>LN=J'0.[QT
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M5"A6RYENC&C0+4-D,'+<S_^7FF?!9$[#64><0'1,_'_RB9Z !4EI;X7_SA9
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MV#O]MRS'/:C)TE]4%QGA!;\%7'O#V>;[9;H?=-%IH+%/SX7#7WOF]EH4A51
M#"%O^#FW9TAV]%8WD8>A,&7<G8F; W-7KXB3Z<VEJ@XDB3@8Y3D@D5?7W'YT
M=U@;A81$&NWQ00R8_B-L4%1A21>/"0=J[8PTU&O"#B3<*2@5->@JB GH(%YQ
M2R%S>A#O%$#]\D<Z'9S3>\_8X8)(J2W#3H1@H7NA"^? /RWK%:,*R[T[EZF0
M&*&VMFUT'!&.LO]6L:PI-<Q= /BI7Q92&JR QB*NV86UA2;/=-'+RWY%=*&C
M=!V^/9X"<B>01SJG)AF_4[.E6V(WB;9UK);<N&QXP%(S^+CMD"A)_N6/RV,4
MXQC=/44C=: FA3$%/'_(DH;1UV7:#,X$N;M]>'J9<Z!U&(L]D^0A>TA?'P(K
MLFY_7C]9<=KCHH? X+WA%-!-^Z!-K^%-UA86OT:BF<Y9-#U*]_Z8#T-/*(L*
ME_]PW782==ROM@AMCG2C\>T@JJL123.[[BNG09\@Y#T![-#!K8]BE/V07 FY
MF=>ZF*3U*C[MZ@ZIX)U$<^4C(XVVWD+F9 $<BP"6=4FMPGQU A="%> :()<P
M=H=>9#XPAJCIT?=_KE<H8ZM7QTGS-5&'E(]^VKZ*-6>R8(4OUR@W;O(4OP$]
M.'[CZA]0N'$V=RFQ@:?.D(T!<PW],DI/3,;C=+DLF7!_JVS"\.P6L$E!OOY"
M0?-;T<]59\N44 9VWRS.O4'>D)\<O4<B>MWV,<K:'O,!P4M+F%@_4KM9.ZV7
M="TL@NKS; HPB2^Y3KW"\UIO?%WO@UZIO /MVSAV#0TD>S//<#VN9X2^&.VD
M^:M &F::_I9*8"D$(R-C-3RA(>[(V 6._PA\B=^09UY[Z-ZV69*T^SX935P\
M$9UY$2#QYOF2.#S6H)15+Y2'C&7.0$?IOHD>KS/GB28.^$D=>/2 0>R@.4PN
M@4<:BQ[A[@^B"Y_0\I +"JP29Y5U6?MZV@:P^3)Y6+_*.<1A6PF4@)EF,Z&Z
M"#A_>L+.YU6.85 23!C80P@PEIT*;M13M]$/%>A'>J?/NRJH#</O*1!-8' (
MC$8 2R$JD44>;.0('TR/T?UXG[O4":&]_=J[?QQNZIVGL9I6C(Y4&\\^/>\/
M96L\QV&0B_>GT06-T;L"!?W8HWL*NJTM8<*O"#EQ+^)\\1W94#VKT^V&D_MX
MHEW>I3E4LHV-".W@>/;]KV$-(PO;H6;4;B5XJX=30!@&9N,:XHC[7<8HJP;,
M!TKKD-_FXNHW>NZ;U=)CSYIL@AG(4C%9QC)7?+/QUU>A&MI+XZ.D3AKJR#I+
M#R..OZ9(1\;&T!'>%+.'_EKW.2P&?^(@X49UE_-ISW!/Q$P18X.[>F8J6W(W
MV.41A[ZC[2:9<UP&#'$'FRX+"Y$U2N&TZ'\_W![0*\F+B0^#J#"M9&(62R+M
MQ2JT4S.*(=/Z)R[S;B3UYJ[B+"722C@@_%(9;; )63 ]81%Q/@A$&L>7/&6@
M\]7J?)HNU^N!@A;QIX.0*519XQ[O1FR(9S@@>#&23=W\ZEY"-36(2&FX!42Q
MZ-<EMU1H81>15Z3X?R1Q-ST?JA3$14+4D+'>%".5N;V%V945K?)(#'HEJ9*7
M-IX>,(CXHLYV% Y1.?>;L[ZJ-SODOLKT)-+R!:*AAN+MJZ)-![M#;06A$9.G
MT-G5GXSG7;!OWWZ2^D>=QGBI7 N2?P<2T+L@#V+=@A'$8&:+;DV/QOL6JVQ%
MHAGT-*_=@FYPI]W?@',43T0@S\78:;04@;0I(!)$VV.[57Q!!"]T_X,7MO*#
MBV%?:4_RW/@P'W7AA)RL]_"/ K=3=['_#VU?'M;4U?4;!L$!0:T#5" J*C@S
MJ(SAX(A3"8A3A8(:!+4*QC"%(0>+BEI,1)!!,$%1@E7!&10D*$I AEB#1@T0
M,$",,80D!$A(#G<?VO>[A=[ON?=Y[KU_]FU?/=EKK]^P]MYKF4X/.RR44,DJ
MZ8><69D! ZEORMJ+21KT\9^PL<WCY2GA/;2Q&XEQ] LSXA'9=B$NNY\37$4$
M"GES0KZ@//0@>U<347!+BFR2V0!42YN?*Q_PB49[6NV1O4NR.M;=J=ZP9ACS
M:R_XGW:<4-/WM^R.]O9R0(C<MWV-4\>?\_S5,?7X;E>I.%G#Q=:W1=]?DE8G
MD:K1J.1/\M<5O)G=<#!6G#J,P7-9'9LC1,<BEA:Z][ K80Y^^V+7<94--RXY
M=8:L/F[V!%]B":MNS9MR,8$=Y6K.S[-^3J2Q7:=C!(S&;^4#44(+SN 0B!]S
MI,NZO]43(1\K8EY;%= I&*"VMI(Y@WTB;?>-C+481>O'3E'T<;?()MADGZ]A
MKQKQ^^B[8F@/!Z_D]3;N_KU!:?2N_$'<29J26LDL7O3GV=4'6]^K 1RUQQ%4
MC>O1L9%GT8>/,-K_!H,G=7>2;VX>QH3)P1(T)TNMO8WL<\GB/(H%FN@[=_\-
M1)<^<>! QH>\<:Q,LYR%.E;,51;5%&((O<:Q<BO4!_78QQV0.(+U8.-\=)QW
MV[%6:2JZS(A+X8:NF3JA8[%;,8G::@8K\ ?\S"-:'SIJ2H.2Y=I&3$ ZV/X@
M;N*:.$IP$.7QC-*K2O(&XZ&/Z%4\)(]PY==_D<?J4=Q@KX\.ZSR?52N^4%F-
M&@W_EL2",)E)?.)]ND 7?N:VYS^YXY)?^*R!$YL:Z>O"+/KKV"7H6,>_\&A;
MV-6J,&U?OVWQ8KT1J87W( A0J;7RZQCJF(H.7VTLC0E"2VD:= KV?9*HG7QS
M/+J*FA\3@@\I*M=9-UB7U8+T&<:<.5)Q?2IM42NKC:."1-SG.,/9>F1+%XZ!
MB\XEWPB=#SGWES:F^3>T(]8UYDB+]<\^+GR$I(F+#YVN&-!^?T'N#,.1OY+8
M:O:6R.MSO#,:JBU[FN*&\D:Z/6(>(VF=*EIH2S0'+Z+BX@F6S:N1<&%7AG$E
MD0JHXV5JP'=.]E"_KBU:DPCYT-];!OG9-L3X42>*7*1O1:@"CD3"<I725G9K
M#<3A"=J8(":^+03^R50]AI+.*EY\YS?[P0LY6=2 DD&$<G5HTY<6;T5MUSU'
MT^,NTB:7_M?_H7->C!H26;^?':&D1LM:^>8ZI_5K?V"L:DU<+2II3X1TOX@O
M/&R8,\T?AU[+4<J\9A9[Z)(;%J7*'Z'475G5US@3H51W9=206XQ "AV(^W(]
MPPO$R]U268Y+?! ',PZLG[-DJ,[*)Y8/P!8'<>YACI#I$>8"NLZ=,F,!YZI"
M?=.L4*" FA*_S9A0H;]I&S6^'Z"/N>(JGQ<=A]B"#?(>L/A8VACIRWFLE=,&
M%H#+_WQYW%-:=UKUOG:3=KD@CR2[0G6P2-C4<)NSA*>%5P2U5LT?PQOL,;3P
M_F<4?J)1^$G4T 6B&8MF(D& OD\JE*4E79K(?'U^8TO;KK?$)IF2P>4))N<V
M*#U/E#_?Z #P,8T=[/_3V?6;E3]G$"X\Y003T'DGE,9_\4+^I!, @=0-\?9N
M!%OM$,6ED$\>C+#+MQ#%!'^#:_OK+?_!&T?7ZL]N')&E??WH+L3,57JTW6;9
MT!VD .WX_R;QX%8U@_RD1X)>^PX6;7\S!T@J*RJYE5[Y":S[?4RF0#H;BB;P
M9:D#Z/2"5884L(27S=)YLQ/90' %79U2"B(U?Q='CX2V+^*B$]\+?LI5'_C!
MEC[2VW.'WJJ_XC54AN8ZI8)P)7,T+>P\O-XFXC_B2YOW6PO3<1/6>*+3([F*
M[:'IEZ!LSAJ(CXD7HH\ZL6<.AWNT"AOL?-SU:$J>:W\3,%$'6;$-M[\]C\.R
M%2M'V-P)97.J#A^A\#X^Z5@_;7XG^Z'U)\F@*<2).\]OK%.<3T9X'4ALX;U2
M1=VTS2QLI"A"R>ZBZA;='T4';_56Y'1;O8X)B006R@IGMJU9.88.=@:/)HQ;
M(3.''"]MXJ1=_%3E^<FS8J21Y81EZ*#@#';BQP&.6OQMPQJE&D!/3P4!N 5L
M.+V%>WT,8\S UK%D5N7/E RYF*-NQ/P\FC!6WDLL>.-NLI\L 5\1S&,)?=_,
MQ9##OZ.=/JW<PJ S]HL(X#,4FTK2DYZ^\!STK""AGV'TNIN<?/B73S@O@#'!
M_CR02KEIW9=M=0RV5NF+MOH\,,LVC2=0H$80/YH3DI:6?/9(2[9NB \K^8+>
MW?@#;=>I>&- ;2=H^VIP\BO3 ]3[<N8+:,^<2M5")2?\,4"@$9?W!XI 8/O,
M[\<DC.&-V]/ #P&QL7+AX.LEG ]_;+&9//0D-'B7Y"T%RKEE&7#JR^9)[0=]
MHJF>94*:C\Y.;Z1KYW2LC !R4*(A4H^X>G"<NQ<'VQ2N'C+#(\^GCO>1K6J%
M6SE]D$C]N#^BXQP !X0E4ON.RZ4].JKKH$4\<4+[;;_]<RPA+-I0%MQ:9[.:
M/#DOC&]K_1S2-/\+APZ-Y),MW4$VDD]71)R7ZIOC.;/CAC'K$'SEDK&D<<D/
M,ZG+_7Y=TW=-_(BUL$6'!]<2/B7S++ B0>__REI,3JJ@6H:=S*/D[5@$G.JG
MWY2U37'*MR+ ]1D@FW*?)K3>$%Y@B2 F\\E!["%%7&$#]B<!4D'Q_-A]>\L\
M0_*V!H>F[Z*2IVA!J92,^4NL8O\6JYB9HV@C%P)2>2B&.$"D*54# X6ONZ:!
MG6C>CA*Y*7D8XWKCXD;LU(>.\OHHL%<Y7-:^2=O1,=FI\<<=DH [XJE>>Z/-
MF_W62,JU#"7MR*^_$['U-IE5M:Y5PE(7(7_ZQU.VGK\^TQP#DDT#:\K?8OA:
MX=7R@>@::-M?K8*GU\1^!D00O"\N](\G'/NDS=M4Z"".YUO'BM17^@%HT\XW
M!(\> TC$O(\C^BX'6Y40KFN5TWC3_\7@RSGV@!O^^L. !A(E5!Y>)R[5TI2,
MN$L @[P/T\)-3Z#.B)+SA^+L1@]FM*J5SCH'_BI5#/-_9RJ8@>3RE&Q?^L<:
M]T3HQ_.CJ>-#L-W4KO)[[ 4/\V*^ 49_C=D[C-FDB&,_#'</8RK9UL!2'YD=
MX4PB!ZQAN[.:8'QP@GGI)X;#@'2H0MJGH5S%_>%R:CUC5<Y&%WZ>JM\5_:3O
M&'$%QTFTI+R98(576T:I5GFP@ @A63>89J.%=0%U<8$Z'MEXH.($VA/:5:05
MW=SV9?*I&]1 87(>I<+7X&Z%%FN7CY52L/Y^6"<@216N0FL! +:GP(ESKO2P
M>D0:U$_D#+&<9*M;6P&!YY$DVJ_Z[_^N0ZT^R5#R/EKG7!]#"].O8UCE:1]%
M5S])I.E<[="TN>' X&VZ2]<760R\8#.#@0!;#0$%MR6E3G*A4H@JN.W_*C05
M^8<B>T[5B5AB!+[L-LKCS9GD ("W_6^D$'/>W7[1':%K:VT;9,-*=L>5'3.[
M7"]Y#;KX7672BEU%O-*]U+D6*/IH2H)2Y-H+F,W$;IGU_K7$CR8P_2GG"=$?
M^XALF?WFF+"0.-B>".NB=@7;.?=\RB&^1T,6#U]RK]W RL3_K8+/^$!9'5ZF
M_ZQ#+79-X-CW+"FWR4<+-.*O<:%G_P[8DKS^OA>ZP[0NF?N>R[6=JOZ1,4F^
MXYY6_MDUN6NB?"!.B!7=7#VVPG1B4F+.YOEAPKD/DX['A>$&A=/3QF_R)#S+
M2SW69!94QA;FG<=$<+I5OPP]DZ>*M(G/XDG^+63^[H9%5#Y12E-RWUZYJX@8
M8H?W5(BT<22$M'W+&%*PTS_D^6>7U1G["E4-7"(1R(OF*3U>/"K^3L\G:(6H
MQ8L\( @-VCQ#<7R6BZW F$>%->^GD>-KNN>>(%LE#F-6H B$^P=I;!]+"H_^
M%JZ93?&:3N11UTQDS\+-SL*>5'22D))_%S/24C[#V*J*K1:GQ@M7!I)SV=D[
MGKCP4\U*A)+!+_^N0M6OR)P]<+2AK/,)"2#J!<S>_V=>H@;#5O?UX9S\.?VT
MI1%VNU,)Q2Z:^$C93D:]0/%P1JVH$L(&*^D9:L/9&]EIV6AD$A]0"FA@,__T
M?^TF'I)$'0GO3H5=> Y? \@O,!U+#'9)XQ1741>8B..H^V0^:XRJ@KQ-G:J:
M(!\[O7MJ>ECM[IA;-6XT1:SDZV&>9WB7,CJ=NAJ]ETVG?_IW.>JJW=FI74[V
M;/>']$H1A%2V5BVE/2+C_$/-"F5 R$'8HR1?OKJ<D^F[VBR0(.#U:@][C6:.
M#;,R @:H;\J^/>64KA-HNY.PH[GC5B?:$]N\OYV "=.*2B3G;\])];0)/2C,
ME" 0@TEYYU(Z5?O ]:A)<IZI.XF*NX\F5"60LL.8>"S""N:FDOQ8.=W*"VHI
M$%; 4Y0WQ@0/D'1F:N38OMQ:PPR #'&8AT31=^O]V\(NY(=I5?W&A2/=_I<6
M.C6U.R%Q\3_P9OP;B_2"VS9](]6TJ 9>B)'$)(/=<)Y#*:5GD/U?-0UNA!HK
M\E3I?U=BYI_B!(UTB.9V34DE^T@EY3CX!_3^ 3 R-N '1F?WMXOF@!_(%%_Y
MS0QLI-4](AD!*Q)+I5M^:V$K-W7<.VYT/%;6Y#K0Z&V>6CD_=*?H,EB K)+P
M]FDM_^2,7)U-G<2ZL4Q*9W LX_IK7/]XH/:B+6L]X[H,K833H:;%VT:;NF9,
M +D\]\UG4]=6U#@.=3PDT\.:=L<4U;@Q%"Z2;X?_5J_$4E?)=Q+ZS9]*@(*P
M."^O:XJ3-P,72,_0"P]^1 YVH$58.8S8OD69;12S#%^S?I;9K<*RTH];:KNH
MP/)YYK@@P1]R_JH(C@2A3^:EI_3HV2)KL8^M 6# V?)O-Y'>T'XUIQ-P E2B
M_%^5!/LO,,H=I ,UZ#-8S97?QC""S]F R[K.2TO"DI[6)/82Q3P@T_P*&[7W
M)Z1S8.Y(4?C*F!K45NQGCV*3> =N:I^V,D^W^-'UJ:5O8B(&'NKP:L1G3;A_
MSGRSY-,6GV,U0GIB?%2^87*#8.AY^7,Y.NJ/5KVRU#I<WCW=UBJ)K9;D#87-
ML%SK**@(W:D*>FXF5/^X0)%,D>9D606XLBG,4K5-V;B"?II-NL5/%9%-D*49
M,#O%!:/.)FX$J$/4ER+X V3^8(A030'BYY^<< B3U: T_5+^P UX%RIZ-/&J
M#<YPSEB"-#EQM7U:XD[L6#<QY>@;]X?RBZ23+U0<\7G,)3[G<\+U)/CQ(++*
M>#09^)SU6J/\Y:W\PM.!OM?>HYC :V:XA_1V]W3VL;)^@+M??UH*9".UVCPH
M3@CQ5++!9L>S7M8!Y99Y/4W&/CF<CM2)>UY7-E1<6M+9OOPXOM*LQ!+$JTCO
M/IF^[_/N:+RO T)$SY,VCRXK3>B2S<X^7=<9-8#..?#OFJKO41AJ#F!;P+-5
MY4]: FS8OK]L&!7F'$$'^R4\2!*6H;4]!UI"Z.FQ7.&-XDTJBC=-[I%H:VM<
M$G#DSC3[6T>)I>;88#9/_GJDY_^VO^-?H3MRIW(/6G<2 M<B058.S.QPN;1V
MT,+_:@&MV$7(96W!1(UE"^H8,AB-.^C,@(;=-O1!;2*,<GC.Z*.D&W^#3^W1
M,(&V;V"&Y6^"T.V;+12.LUV,^;8\*FHAYBX9 M:N?3EQ4(B]@%E)ID?L%*1S
MS =0U2!M_&D,#<Q@Q70G=O/+2V @.N&KF\>P@-</U2*U]WXOEI0 _$AP]2I#
MS[ <Q8S6;T1J@9;NIOEQSZO9CCW?M.TF[;TX!TWW=?P*N*EA%GTCB4=/\8#S
M(O,G%*-]_Z6VEL> N-?A< _MAKS3WZ_>IPD'*R*4][-7[?6;8O,F=#\U)@R7
MV 3K$LMKQ[&R@#1MUU9()6K*53N]9=I64;W=;.-B!QDZ^0 =^L(IC<'&F*./
MH>&X$-3XN:/&S[/5#%9>F3\UY=71AHH3K3!;V2?[J-_,.*0X([1N,=EG@CZ;
MTQ']^&2!<X8O_!Q5@B7B&E< 1*.IXJ>S:V/(Q1*D!UTEJ &3B$2XQ_189TO4
MB8OC:= ^Y<1C'#TB\!_K>+SS?PPY]Z(F@H>^@&Y^<%8?Z?%&CXEHU;96B2 D
M>LM8C'OJ@P[T&#V&DON17E8TZW\R0N1:?59%6K/HPE.)+!G0Q_BLL&R]^0OC
M4% 3M24M;5$/>5_QI?7#9C4/']!3M,BJ$WX8@S<QI*:8,#YOU>X57R&.T.O'
MF(T';N">K7=J3L3!G,<;PD/TGJQ]<,(5TE$@S@?&\;) W>TF$=-#KBK*MYB,
MI'4J7)J<-/&P:LC7,"PF%[D37JMVAU."<-"/5]IK=X2?)EA\<QO&I*LUS>8Z
MD:9)* *Z>PAF;+FR_S16;!T!Q;BR2X%"/55KX[YOMZ66C=[%@#(7FP^0GTX]
MXPHMXJ@'M"ZWYF'+ 7Y4XNN PV4.1LD^7$\-Q:MRR1!4C!;K>'<QFX^'N,>\
MNJ^#-(*44L_'\RP2[HR?7FS6*&"*$'(1TYP_!'2% )T9@\W]$XX!GC @%BKG
M!.$<=-X^K7;Z+LXI[@13XANZ@-&E_<H@']]KGV)E#-?S-,37\VV6T9S?"&5]
M6K@$WWM]_YEA3$ W<>"92L;5:JRK?KB?53>GZAIQH!P=G:OY4E"Z?,*G*>G4
ME%*\DJ-D.B)?AS$WPV@J\D ?6X6+;SYNDCXDLZ4^10M1MV]BYN=6M&2_S*-E
MA&F'$(]FKH4)(7)B,BT;5K%*%(UKYKQB2)Q/>,+;P#=#S+V9?D,5.F9#9T).
M$^X93/-I/:1WK.&DS\==:UKHK3"GY.8Z)9EU/+SUZO-G?7T2-E.XW<O13.-]
MF9LJQ,7*>+U%]X<X+&TP#-:9QM9^2;(M<YQ2WK%'[4%#2H$8\#E;:_/R9;&K
MFL;5BE1512+S24B:Z$1L$U&#<M^0__5 -N/1=XDBK,1 PNW-'W^@M=MD#H'Q
MC$2K[A717MXH6[Y),(5&368%*]G*H@)LA4$#OTY=R0)QYWU@N+S 5BK+)'E@
M@VN>^1I6U7<*:W\IIZ@E*L#QDBMG)G?4[:G.B\2Q(+R$,V-.<,LPAOW!,UCU
MLV20H'6++KIF$:&J#,;&,WUT$">_!^.SA]5HOD[WYV <C'_))*VXG*Q_NDI=
MW@<XES,C:'\*.[<;+N7=0^];%T;I!-K$\':*#.<R$H>^?"-^CI$T;2DC&&$)
MI>R[CC^U1=@9A"0D,]%;]%^-8B@ NP>:(*::TUEG+'/H#N],0!46JH+II+GX
M*^/6Z#IXI4(ULM(K9&+TRV*G9K15OH[\)=?^)?AP3BZGM8G(I3*$7/GU&6\8
M?;0E])P:$I^IUFTR7!>3.Z!WC-WY'?=\<4#R7(.$)=@R;2)T=QVM#;[#MA6A
M%_I$[V[D$4"6Q @9P?NY)4+>?4RFC1U-?]Q^3B,2IX$])OZV[ L^TUXTQ&0&
M4U"O3=Q>PRH?QM"N7J5L4[$[$.R[:ZD4I2XB"Q$(>2Y2'DOX(0E[//"![*PW
M&^!F%E8D\0\-MK5>*^4#G"CIXC"%OC[VNP?:8JQ0X)#$4W W^4-W=,Q!^+U(
MJW-#?8RWWG'VT36<:U(>CZM4%3;LJ5-NG")74!D=2*+#>IMNJ%+!^BR6<'QT
M;C'2U@7FZ;J('*X(>:J#\WOT#JQ;]+O1. .#;AGB@5#R=D1WKRD/V6KK4R94
M(O0,43" VB;$N(Z>8\U 6.)M26$Q,BV#;=$O'@1:OTKO0GFCJ]?LF%8I>O.T
MAIF'(HQO6)$$B=?(&W?O/[=)Z:0$$D^)0!W^V\K\D+1N)=>UQCT2+&81)M+(
MBWET<3N=6814:BDS)H8K8[T"H)C'FR=VX37XRR!8SO&16G=X[SEO&4;I4 N4
MS(HXS*7VVFC9.8(&I*-9>.*130W7EXZ?GHK-90W*U1JYGX]#Z0 24TG204V0
M\W5$@GA&'P=K7X468^ MF//37J(!8F2 ?S93BJ_\7)\U[OH.%TM3Y"H.]G0I
M?.5DJQ&L*.'H4(^X[E,HUEDC<Z8]YVFB <M]UW-U)+LH9H4;<W0P!WMA0WB@
MT]&SF]D4 0.D*GX)&IA[NK9$H&(^2/RJ' ,&VO!6<3$HPB)65=-^Z<9?L4\9
M*F &A[N KY'[OSGHL#]_IV5"-7I3O64GV5@&?5 SI B.1-7%4ZR.')XU521U
MUR3D -L@&9F+$9"#.7;Q3AX5#_@->*4B'YFS;D]KF@)\G6E%'&75?(.YK'<>
M=&^+&A@?@;".T+ 5PYB?!>[#F%H@A@"ZC([0E!S#L*,3A8QLH>##I8,O:7TT
MITJGMZ:M$*?X\#SLW&',9H5&FU,3)P?@(\\?+VSM[MQHWJEE0L!8?F&,1GA+
M@B-\!T"+CB30(L^/;'Z;BG5O9/OGJ;001XE),ZG<93AQMW&WC*M$-9Y]A&ET
MC:7P,D"6>G5ST4B2W*W MHI*+) ]/6[18M^7CA^5"<6>PQ@\6P."-1'S\T#6
MN(+QQ+<QVN<PTW)'PT'%)GN[P,0>7>)3L#9E10O- 1:%8>-+@@ 679,N6=%#
MT^R*'<;L9L#;8'_><\SJEC+;D+4^;M;@]T%-!5DQV2=.^E"^-D'8:CK\8Z3!
M?&2H3EA,1#V:>-M%2B_-*<:F6X/>;=Z]%W/?X6*-LU>1BSH%O8TYC%GZ+B!'
M_^J].\E/<<_ W@_>LMF[1]G/<$I3A+GTBQ&<>]2-I! L@!BF!5@_04F'UU1M
M6T3+[-*PB/#G.#>Y>+"99[2V('*)^7=O"CI_+I\M S]6GH@.^H6PRO.9Q"3H
MG4=;19B+F!W.N(#9//6B]^G3@20E%N"?Y.3.+Z.!OO <R9K"?5A21Z\P*\&_
MS$^E])HY1=AVHXD)-LM>3&;[4YN$M9YNINC6;;IA]#?*<()+/,!_$MCLE#IU
M2.9.?<HI05EPTZP!2*ZB9>EVQ2% C9E>+4(9>0%@Y+?]6AU4XK%]%-2?G;4,
M*:V7EC.%@(&C;F3O[SVHA#Y#:Y XRG2]_0V5NTPFSC+X._;_P1CT^N3@$%&"
MC_3<17E?-L5S6Y^06U)*>:[9X8LA 7FPY*T(B[JU.8;I,;EO,)^P<\0(A77A
M)]>+S$;]?*17PI>#?_OC2;;L^/Q6%!VP(H1$/W+XXBG.9X^F(1*7:04!PO6:
MI'=Q$7]B&<>?IQU0B<XGA2OA]Q<^0;81O2-\_/*I/Y+6-3#'^NGW6/01[I1@
M@/@]/NC38:7T-6;K\9 Y$:<) U@:4\5\=7#J_GV[@"Q",U:[PS^5X S8("_*
M_*L;'/0\-6TY@?-YM4EB@TJ+CK>[B5DW4VY;;T[2<;DE+.!]-&7,P%E+R[],
ME?-976RUAFN#K6#G/M2Q;DGRHB6([45QS41DJ$E8$C2,T45$L.\9JK/JV!?+
MHW4  -0DL&?L9YE$O[+46+<F)D+0WO2(GH?]C YTCRO[),@JDS%HWX+)OI_>
MG3I7V#7RLN0 \^*; R].>@%&!ND&,9@S@OS. <BYZ@E+&#R-J=(-Q<N87A")
MVKZ1!E-;,,>>7@S_-*V.6^P"?C+SYD9^!3=#KS2Q35"BUA[N->D!7Y8^*/1L
MA;"2CQNKIZ5UAW4/H:0,OTQ:ZA.RV'EMD5-S%,K"L=UG38 NVED31V>)6"4>
M_J&!=L.834JR.$]H]0QF-$\IWC&,N4$.[&MRHH,,_>9E _A__*2PGGYFBX5I
MJWQI8AR!4:_1-!^!8HUSJ-X<=3Q7])>.E /M18%0.G:R^UU_G(TQ2F<42L6.
M*9G3$NZG>&B9@# 9VP#./$/). ^;CCN.@W3![ZZ=!;*U,CB8H1&ID)1[!LSE
M@3//^;8?=]=$JK2#7PH7XM$LJ5*C_2B$\J*%H^A NBBX-4R*2^E1RH!8VXLY
M^/1XXX.YME9#E 28<7/U6+C?BJF+$) ]HL1HSV;98,S1Y &&)('3/XRQ?LJF
M/&>9/M([X+_H]\GZ1<)NK$C;_R5WM-@_-Y8-/AJM@V^0/:A.J0A=H*,TZUFT
M=H/<G?W TT?0P:/A_\7';, O,5@(P $?O5R_?#KXOU?T-1&IZ')CK/0NVM;K
MER%RB4"N94T\@T-7/T2; M079<9\FR4@OSQW0S$NG" W."6XYCH0,M:A;7@.
M G.4^1.6FZ2$#V9"0$(']/:+/MQ8M^+R2?W++_[6?JNF"V?#L"A>!'&U0F7<
MBIYAC% 283Q EK +H2(Q_R9F@]X^ *K[.0-XH40'_S@:[/WW6R20*X.'$MVM
MX5KMHM!12/]=S]TBX1( &&P\*S@<YA0O=C_1?C5M@LO7>* S +BYD<92@3>F
M#N1)K"0O#@:RU^!@:[=EOC_CF1.-W2L",B:[EC [?P?@Y6',71V<>:0B>> 4
M.?<IUAE%(\VSYG>T5I'4,\RFLXDHY6KCHB5>D\)1P?G M+,?[4N^&)O;.)0<
M_5TJY3&9J/6ZI'<1?N=1G!=F(6%36*<WT-H S'\!.U>70(%$T_5P+RX6M4ZL
M<9\J0*?(WQQCOA:EI^H!Y:02NK)]W".UAP^,-5])\WZ/R;8_2:6(FR"S:CKZ
MSN2?6'^=9AWJT5C6%"!!@ L_K&R?.N*]H&"F(G]"1GUGTISM94.MFB$EDDCR
M?5'ANL2<!+R22 R$\PV_H6O(92KT7J0A:*A7_[ ;A?/Y^B=>(X=>8GMHU5RP
M1]QS$NZ83U]N/.+Q8HL6!GIZ")R>R*HH5CIH8LY;-2Q7EM.>TO-@S1#]N<;7
M8%E#<G1M)A[P3;"\7_@A9Z',.4/O@><:KA9L@(1)><@PY@V'Q>Q 2'U%G>;I
MUJ$]WIQ!M 6D1O=5G]QPVO/0#..!E" !333XYVB(/UH]"=VM(V[6QPT&J9 Y
MHO=75#HUH^Q??$A_:GGC,&:7<XCV*JNZQ)IQX:?C(7-C7MY7D+&Z<(CS[MI(
MKC0-8] YI7276[9C?)>O89K%^CU[9J1 #J@Q8,TP#'C%&-F^/I5:M&+ZY>:%
M_Q R"RE1BGUK(#)8NF%,A!S%>H%<XF56MOSGF%<VPE*X'FBY6VO24:@_3H$E
M2*SVB,5H)GAT$HYB/.H'#KD2T@"/>7$4#QQ]G<I8N=\,:R=&L"+N]+6>A"'9
M$ETQO:)/QF526M^-0OGVF?,=L^_M\[7W!(Y#R!&)7WN'A\Q^LOY!I(0*06*Q
M3Y2.ITV0M0.@24.A!LFH_<MZ:8F,< 9-]1UC_D\2. (BL?'K3J,X*@KKEN^C
MS3-H3I S #E(B,Q863]25L YY1& ^]8D&8]Q9OF_M!UZJ<^OE$5PM<BJI4LN
M0V+KW3BG5!'Z7V?O"/7U:$@0P%JT,96O8:G1NM*$K=B@;)$"J7P\/]1OIN'$
MC6:- FVL5A?[GYK"?[@ @ Q+* HS[N0$FJ&74/ORQU];.E]-,"6K\?A>@)\Y
M3)_ >ZU3UGUU[^M3:76+TDSJ0( D0*($(JRW_3^G-$") $\?\[CTJ\\BI8)[
MXU+_ML=@ VB?]FF/S#[1D0L$I7L_VNT(VC*6C:<;+& E=LIY3!AAL3I:]!:T
MA:@+QL//W*+ZA6B!:H9'H?_,'\?YL1L@CEKZ>O=%U!GFC#A#&:^TXT-A&A'L
M(!:SC@Z\EU+L-2$\!//]=,@ E%+25T0=K?Q7#AJ1D+1.Q*6O'Q>'6,6/EP]Q
M5%?9'.#R^U&NT#M FNOW;,8:>D&)6B9A X,\05%5#%7$#6CA%2]S'3N\-=ZY
MG&TB<P!H2/ZI@[!0]$;4(P)XA>^5#+XU)/:@YLRV$P=QN+U_\S&,1TH[I)R[
MWN:Z;H_&"@8#E4PB?!XA0J:5)8@T<!YEW[1K66^J3FYIU[9J*+#HRF_Z+Y ]
MU8P>!ING058M_C</;!A?3VA4#(6+WJ+=$SN\)GDJVA_M-W4S!>:XI$]X/CLG
M(8\\J31"8$6I("&)1%^?,I0+#K3B<4"I^UQ>A$49_HX<N8W#W:?))6U)L\,#
M?T!9V2R<(6*(_.K+&UR]F%!D&);6P8$NN)E,@^'.(9%8A>Q@CYBE<B:G3X;
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MY<U1SM]HT;[<+;Y=A3ZK^K= ""3G75O"*!=H=;',)E\I?Y*WJI8CTKEJ%_T
MYU9CU$.MY?'PZ<TG%LY.X&WLXU,9)R4,Y5?,1L)4I<$/R<HH ZX6Y_+E^N^'
MTKM3RT1=5B@W?[FS$17"9W\PGB.$SIR &:JB_4J/%IO%I1Y/'-#K#L06O8=
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M%/B"YU]A*<$RU1Z:[=ZL1O4>XSHUL+/UXL\WRGZ87$FX#9>G4M"'E'/TMAV
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M8BP!#+)Q!]2;U6O=PUT1TQ0VE[R/58H8[B<N_GYBING8?:@,'"TN,5P%]_4
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M,-[H&C>X]]Q)US?!E?]N X<SGRAH,]'1@-M<VMC^O0=:3FI< BW-$'DKK2&
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MH,),Z=;92X.D-9 ;P0+AN@;:F"+,KC,9Y\.E#P]WN[AD.-U]ZJP\%=YO0B8
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M_7,FG_5@'ST^1C]K[%(Y$;< C\64P%\ 7C8Z=G' 79M3K5]?GW N;XK:]KC
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MP7=>U#Q2DYF2D2&< ':_<!#C!5[4C#1X<Y2,W.O)2_@FZ5:Z =@E]L=\$+)
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M/@HJD6*)?)^<?,,[#FWW8H@B$TQYF!G3)$QV#!(3)ZHX>E8JPG3J/(S4)D.
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MWM3F7;JMD\_@%N9:OY9%]?5?IF"#F@/FD,W<SU;1-Z#CKL%'E#%5_6*/%]6
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M8/O]J.[=D-3M$[M83NH=7N"WQ7F?;M3M[&A?&"%D00=DF\+!90%/CVW%;(U
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MR2SJ8AM7KA;4LOHIJ@X*K9\NW#PBL4]R0^"(0#M+&*^C^QDO>\)G7?LCL0:
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MI<62;K!-^#6 4Q*J(Q*F67V,H!-O%<M6%PW"D.^X(AX>Y;3%!+%/,Q:B6VI
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M-3QR%09E3)(*D;<"W<-!L5M6>D\,S#Z-7@^C=0L N9?/?*:B!G8K1/NGHA
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M$!(B'@ZT#0YH*C![A%"A@?SY?B-V4MAJ/!K8,4(I7%HF;U8]H4,XY!R/NHO
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M/^#V<WTM\:!'MV78.FO("LBLW"V0'S3!YB\J\ ]=A[JL!I$_W]C1_H0:6QJ
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M'(I%@%32F.V:3Y!1+KE0=T(?;\L.B^9)CC"6:"Z1DAEM]V_SS#*;)GEP:&V
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M=63IJ:.<WCS;5HL>&W9RZ_ON%].)(<HH<C! QQJ_':\..[ZKQH+9?)!-&^!
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MAR_%*!5X8RV6B"Y9_#>2X2?BI^B$F2@#RSK"CL?.*V5&3/7Q@8MJ<^PY\F<
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M+-SNSE^-.7?F7%!^QGZOFRMT\9&U"%QG(N(U[<>\8U+0]T9S;7B= ,#_.#H
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M!J*BX7S6#\KU?7,YAQ+N:)VC2X4ET$OI9-X&]ZGBQ[HCU%O[M[%&W?V9J"P
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MQH,[*JDD2P)'E3STF5EG.G^X%XZ_HI&IWS4=&83SO4%</DHV/4'F4\@ T4Z
M?_5LS>*_1.I=B %5M*!/6)+!WJ2C94J2H9G(D33.-DR5:8.HA%3("O0<O$+Z
MCL O'R_21B:'::=ZU$.1YN9QE/<N]=304? U%FP[)99W;J$1#<;'U2$CJ5'D
M84TG!>]W<^?74ZA)#4[C*"L Y.+E&PT]5^J*EGQY?DR8L)!*Z=,'X1 B6S%
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M%[J2>1SP%1I<)D>OEL3*2,?S@=3XS'XC.X+A;,!^6_D<_PQ "KTVBB^;;K(
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MU\.D-GDWK$>ZB[#1/++E+"BS")0O0R7P* '<,J8=[H>  A2>7B$+N,-);!0
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M]<TG)@H,MICS$Y9S7B^<&KH[@::07[+[';1"&N3S<7%B;$A3\=;;E!;"HG*
M<%';<:\WQ5HFUQY+ZC:A:-YRC0$F^J[@YQT--6.<0ER*OT,6RQTG&+X#3AHH
M1O?PU"G=P.?/^[#MV\R&C+EUQG F2&R) ^>S!+N![/.WE7.75>LFQL5)7L3Z
MM9K!\Q:%"*%<Q R1,VS;Z_"%DD'2R^@+?2XH RY%JM#BT7)/56'ZX]A(LW[F
M<'L>[X.J+-)BA9EFO%[!+"A;8OV:5)[1A-OMI[:[D/1(\J#VG,?8D5C,)Z \
M!)5,3:D+VT.@<>8KV_=\IE_@8_ED@P?4;AZ9W>?%PIKFB;C$CO'L/'SI&*=X
MFL:5!CE\E-_EFH!JUO#!1]GH6LSYNOXEK\O) FPY**4>6G;7"TRM8S5)$A_D
MM3F(;A-TN*0?6S8+ M0P\<R)@?#+.'.,0Q!W=_!\1H%D:'XK.;A2G8>ZYHSG
MEJGS@Z:>[#5,3;NYX9N+PC6(HL:<PQ]0P==I3&^HV5B&8P\5RJ6N>2VG%A>=
ME*$H^V++!VM7)G>9Y&CN84JL6D*>.R8.&EB*4F&MH=-#\R9C<LH1Z%&D9[7&
MJXGI%@IAT#FCW*UQ=L5G\P]8PWWZUS(BY]Q=+VUFFPC*A=X#-,(D, (D5KE(
M70@)F%YG*W;A*N(1K-RMBPZJANO?SM(K]8PW5ZD  T<3/+1_N652\[$;W0$U
MFC@'0.7E1DP^I\AB$.Z47,H)93 1026.4A_<1\L]5'D74]T4]:X9'6:X2XWE
M=53'[AK5JF!<SMWLEUK]/4]OZ"KEE'@&D<:FH*'SCFSFB0]H3#K";(3Y6% F
M<7G=L]HHO=6E>IEOSF_&1?&[B.*2"% *%;BL&)N&NC[J7*:/G!$Z9(,?A$S1
M3*Q"9T$32&9;E$Z<W2!\X^UBS0W]"M6M$(0K07!L90J3IGQDF*0(=:A M%[Z
MDQUJAAXM]?%M';O%FO>"C65P2*W3G:(0R48&8 =N2/T)Y0.>!0X*6@2IO_R1
M6K+W+.C$[RUD[+U_#3G=>+N=X2$CQ6:BWAS6O.,=G@MW$A;WX03>[>(9B26;
M_0^D?I"R;46J.XH_"^)3 4S)P$QR1F8\&FE,,.\'NY!W;%T$<$$W+_68\P%+
MEUDJ2_U@MZGRF%QC_P:>!8T'=/>*BE];V*$&EJ.E+F.M8S%C\\$K4-UF!# V
M^?^.35LY_'<A07M^*W'0#"U*5:\+Y0[/V\L;)J;T )?,H)OY2/!MSF%8M6XS
MNV]EK;6S3O^JAE9I^(HLZ<A"ZE[V;NU)KNLC?1:-S%NE6^;I%PZRZNO@3 QY
MWE]>U0C?X/)!_2Q%V;AT\A>"S\RS/;V8Y-:S9H_[0-UR/T>I->(361P^+B=L
MZ0/8=4GP+\Q8&,"NPR3(7 C#9PM)QY12N,:12HPIQZ\U DH"%"IK)U26HBWR
ME&%R<GB'O/-Z*<L]+BPZ5$ORI*TYX#[8JN!J(XV!NZ[*\[WMYCD&S(1VX.,1
MKP_(4+E*AW92:P_-OT>(HD@>#H?(P6+P-:2^J?(>SP#KY99Q4G?$HV)FXRPH
MF08,2A\^M@_:/O',7_<2O;4GJ95%^AS9_:\K<T$LYLC'VLKT@* Y3_!86:0=
M$#MJHEF ^FP/Y4V- K-E@))1HI31V?,1^)0Y3].H+;7D"Y+O).H+NI<QEP-T
M!.B=WVYN\?N%*HI$B) IMMYCZ#Z>?V$H.:U#+* .SYP YF9H..VJKV#>^?6"
M_$ZWD'G\(Z_3R6)L<90= ]+]H5"120\=D%C$RNMTM_ #N"G:.*(;J XL]?4V
M=OE;2CI9%R;(>/>OZ;#=AA0?YR>WE=&EU?H-4EOP3QM2FNUK5OH8@*K!T7%S
M*4A ";_W!09Y>JA#SA@3)V#>.2FG&!7TEI</-*^\V160I7F(_D+BU_58AJ7]
MI5O/45N/:=9B[A8$SV<!@64!!G2ILVT_U&.I+010.834(7G?QWHSS>#;$VVH
M6<!O;/B<^>M;59Y&9"_&E#W:&@&IB \2<W<:XF_U  /,H#?#II<"Y7:L49!#
M3!Y?S[0=W/I^S.+\/4J.)!G#*N(O]T8V#>XGC',?"QV>]^F$ZC6YA)/80<0R
M6LXX,\\A$N!1 ($M:C962*I6UV$;2PW"59>''DQU R,,C/8'8*2)+$?DZ%;-
M^D9?0 2FAP1]%'5+3& ?+7=9*%LS%M*/1_ZZ 32F+XO$DF9"Y&"8+0#L!>97
M>1E85KF8? ,$E^5Q!_8AB3[&YKDCRI%S'K  $9,A<6VZ^%;6;IKWE,3]6T):
MT"6UQJN2&RP6!P9)?6+-545$0"";B<3FDY-4>H=PVUW&*%#V!=]HW ABQ;Q'
MN&,W#\FF81"C1$<!71+(8AJ+?MMLO'T:.-MA  .(K[%R.IV_[@4:TX]%&A-K
MT-E""_EMCA>;ZK;B1I7ZAG%C:1CC4SLFL?L#69=!]V?.&9D"P)25K&BB$7"5
M._'#Y%G0'<G^4V&[##MY&F?WSF7_*ABO,$HM6NH#^T2.8JVT1H82XX2DH,P8
MUKQ9LYTLESLN;RLB1^"SRXNIZ61M=4$&,"Q5(JXPV]^"#KUWW!RTYGRH%B"L
MVI\#7RVS8IN'ZNC=X&,*N!3US64(J6GS;9[K&7I+'YX@:NV9MXR]R0Y(1X_0
M!WO:7PC*Z&+>CZC-"7;O=M2LA '#5S.&^\Y]F-J6=+TW<'#9?E^+8_>>HN9L
M&3[K,SS->#/4%A+L)V9LSB\<C3-&,4>J6X/()8[S(2W+'QQAFFVX7OPIR:(+
M;"5Y>_BMCAO2>$+YX)M.,$A%)2"</\GLDG-DQ_/P985,WQIWO]!@Q-7Y")+E
MVJJC*3['5N'2+9:$0Z76X2OM!HHWQJ:0M/R@CK.@4V*@EBTB>T-0[-&ASY$C
MJ%E0)&H?;[<#:W>H+SE4Z@D+0L@@LDVV'/<+B'IB9W^*J' ($%%8QSJ Z+_$
M[0YQVEW).L:=MP3?H]JXF6>^7Y7O6TV=2PG2D4';U&J>I2^G@CL+.M+'['BK
M%[X[97U(MT&H=^A>[K]N].G_V2']W[1#NK9 BLK1"B\@^ $B,%2Q\T,5=&1#
M2A,P+C5<5EUSU-:0NM)O2 D^?7-#$'!VYF!I4LL!.9+U<7E<=A]"@U?B;07I
MD68 @9)J*]T&U9-(6^O:)6L63.2V;RFCT%]N?:0Q5*$T@G;I@D5FZ +F<521
M+K/S_7Q@,V^Z9G7$6!5E+@/HGIQ][Z9PRS%.13'V+)G97B&OS9U &7;.@CY_
M*/3OHV,=[<56V/>I<C3K4Q$U:1:D7T(7=P(E4(G(H>]9;9'2Y%*CFN>EWHTA
MBPM%%Q+LBO4_'5@*=SF7S)C/.MC"#KE7&3(FJ&1]SY2\XJ>YD'( $E9&K]H>
MJ P7-3NS,0YF8JPD#B)6CJ@'-W @_-$T.&D6-)/'&=JC^CR]U6?O<M^L[:@B
ME0BHN.32(1EFMGTC(_P>$>&UU#A#Q/\WAT1)!E3RQJ;\14A7)R 3\TO&IH"F
M:( "9-D:B.QR<G&<3+7*T>W/<4D#N98]/!BU&Z@4:5R0/$U%>M)LK$A,4=]8
MBKB:#2\7;3MUA&EP[KI9^PWU+IMU$A?BBGV]UB?\@0%'*\R\-<8$!ARI!2S+
MST"IR]$3@M02!IK@"U!9281$8BR:4FO\>XV'%L@")LV@C0N'GYL%G2W4[L#.
M@M:*([<B=8.\6VDWZ[K'?F*FYPW\565)7!%00#[[5QN&6'3#B>)\$:#U P3E
M(_0!6OMSP3>ZF/_C!CLDHS=DC(9AS>>/8S8+$/S48E^!T'_>/_RIK%J_M4"L
M @W<:7W(2&YH9&_6V+]179L?V+'];FZ>I,40YU*B#VWFK#:JU52*,MK;[RZ-
MH])EA]&85UGB=$E0G%S>:[998,-/+1D3$'R&A_F2%Y4O+4?7U1J;AIZXEP4,
MH5_"=R<008.SH*;(] IA*YG;BT6^?UCI0">UTFC^O=(P((GB7+B_/" KU8_)
M2-5]<H1ZE,XBY ;,H'XJ]+_NMZ@?9N2ZQ1G0;ZIW RU0%-3Q[( E<0<VMR]:
M#'"IU>+(BXZRL%HD1Z7*DU +%[W'2_!E**;O>V9(:# T5!H"_6BY+/Y^D]E*
MREF.?[3$&1<R1ZKJ3,EDY'R&B]RA:= 9\F&5.D#IG!*E>7#RAJ;,W:KELKO>
MQ78,*""NP/^**SDW$HY#=9L0PR7]LZ!_MVY ?]H::W=0]7FULM'AZG4VLZ"\
M]9,_>XB@FI7:"48P/IT6?VG3I^W7KKEU^W6K='MX:]"'XF<^'%Y5LF&$@Z4)
M*3TL'G87,[?OSYU%I(C)H?)@?Y;=YZ$:-F<XA.?9U>1[Q?[P@?2;/[-.TA7V
M;,?D:+,!H#TPH+/_X?6@RU>D4>UG0?;N6H(O3BOQ-S@A$QFSH*MYOMUBI.NR
M%MO\[;G]+I0H%(E;*N1Z9[[]^<EV)Z C)GL_H<@UV;FAY*22GP%_S="#>6<B
M<ECF5R[0(D/;D<;G5;+W?=JX$;F!KG@M3$S\^J3P@7W;LD_(=:'QA&FAX-@?
MM0)N>/J^?"Y0X4:.#D&4K\FT^B44JS VGX[X@!MN"4_RO/2YH^+9]+LS0Y4E
M_NUVZR;='MX)YL.=+O<=G-#KH66_,#0YM2KUS=8H_W..&EJ9Q+R.=;N=FF9!
M;[\,OGXJU/]J$'S$@76HS$XS.9[=Z+@]V//>F[]O3:@LT^ZJ)):L*DQ -R?[
M -1 5&%*X%+_9)>,/B!AU@SO-=> 5P>;[.T4O^:+;?C<O.PF;0VG]]:'_]R>
MX&=@?O?K+E)EQME*QQ,#0?]\>7'\Y4CW8X@WK 3<I/OG99TQUK-INWHANEVL
M([0WVM0-")+:L*I:HJ].B6-YA#A,M+U&>&"&N"8ZA5*I':R[[6Y;H-6I<^+R
MJ9'+MPNN:;QN]TXMB'IVE[%QJFX$0N$P'Y(&E=";KE%F[@::XKF'ZREO+/A.
MDR>5])N8-W*VG0N@V?0&OR"1#,K_&2Y.X;"$0W$MA=#7GZ?#1ER(I@[XUWH'
M=7O^;,JB]8Z$% @/S^"-CAGB+/<KEZJ?8E6>[/?5C<9A.]:>@=Z>!:UYG ZF
MP#<F%L;].;2-UQ]''Q^>RG5L.(T(>U4=D=!MMH>IL2$^(GCZP_H(9E-7KRN*
M@.%H\+WALR#QNR%Q8R,/AGE\X^BE)NY1;O+#WJYI\L^1P%<=.SM2UMU)%QR[
MHBLH&:O0UP_V=Z@03 >A#\ZD&#>&<6OM+-3#D@7+P,\M-*S"IKG?D\FJE5LI
M%8[Q?_*,,('<G/BT+ELVHCX747]0-.1M#'VG(!JTR8-1''.*ET)@FWE:)C?4
M]\6 :1CCO@Y^ -9CP,_X^AMUA[.J=W+6/'2^[)F7NJ/#M'" XI9=\B#C<.^*
MKB$#SZM(OPSG74.5&]%VOE1_^BQH50%3/_V'&?''4>./6M$4"^Y.FXG5/])B
M,\I#?VQ4W_"[^3<T/7O9+&A+&53?M\RM6;B6UGB.;>ZN;3',FOR^7RFQB&6]
MS@BU'J8;NL<QYP>J77_@=/"KRJSK=T/>_JQK\BN>9 4.,362=ML-E_[SH(-V
MQ?,J8I!;P6"]O)>1?.L,\ 7@VUY=WC3#J7563]!"JG:J]T=9# _QIG*@M[%K
MDG>&H\-_K#FY89L:0_4PR./<%!V!\RN/]B]<D15D'ME=!X:&/@<3CTT./MC4
M'?CJ%WUSB9:N5L*C_D@K<5'OD:@"Y+'WE[>45<2%.[.3WDZ^)?VQ@V-\I.''
MA"O5(^-T(.U Q1>=SZ&%%3U3/Z\4H/?-_'-/';Y[ M**L4>J+J]&F($5%3DO
M-'] :C]H0BF5FTY3N^_Y5Y[48CO:BWJ[)X9<0A]J-VY(C/[>-)"*[3"-:=TS
MU- :.71@E3'G5-- WM_^4T^G&N.8X/6I0\,.,.M%*^Q^J>]^VNV<M2;CX8P?
MT?3=,-G-D^ 5=,32S^0A 1]7\?15U]NLW;M?T@YDONCE[JK':*./QQ\CK@N[
MD:X]8)[C98JSQQHWO/":N3NA#W#*&6ZM)ULICQ;P.")?ZXJB!17Q&B5&*PB+
M3_\.(=TWWF(ZV8IM11U[5.)DT(N*$[64M6)OA9@<HO92?1YVGF??N9PV,&-!
MTBO9E\Y,3AGD8C?W!:[7,W_1_'7WVB,?G!^N_<=J9V&HKW-!WUFD3:=Y+2(V
M.G0_O6_5&^343;L?R]8U,B+X*A$/O84[D'>"M"U==T\H;9_2C^0HCD:%KR/Q
MG73&XA%A!=<@8\+\&U1!I 5__(B-UNW<-;ST!MXA:@I-4Q "$X5_"+^[O0FE
M7M:H;KG]NLMQT6?8_4OFMB[EY:\K(GN[,BZ;MQA]._D/'74Q&S_X#^/+Z.7/
M[PHN7]6]S%MW#6T_\TB;AH@OW_,F]($K=*>RR@<L-<_2 ;X9;1>@.,.JM5NF
MW72E@O<-1RI=_-/!M"5PR?GPB8W^YE8V_#A H7KG.?H[%"4N^WIR)=.29>+=
M1(G,*(RCMT?I]80;_+VL:%S]-.R$@_C]"NM=SJZGV&\+D]X)=:D[F#NO?,94
MW+T'QWAN_7$IL*?SSU!,QJ=.NPG#'\[G[.AY*P]2ZX]S62JTRF.SH.&AKG\0
MM?YW4/5K9H9K%7>'1$?8)M@L>9.U>'SW-#?7(;C$74#>J244E++PA8@3Q!JM
M$Y@C30.Q]OM9:@T!83TEEFS,V.ZK3M$G#)JV?;U^_EI-X)\Z_2].1 R]'LUF
MO8R8_,C_XU3WISK;,*'SWYNZB@;I85U?71IHI"/(8B8@596@/[Q&AX$OQ9L%
M<9I[Q:S0\QDY<0_=T/MGGL0AQ:O)*PM7<[1=W^R=&1VE\9PV&\=9A[!6NA>C
MA1[\(!+_+X/7.N=L*8U5M$*1MX-I/)9J._TX:<"HIDM=2\>C+1#_S.'(AV=/
MD9MY>%>DN7O5Z]3!W/(UILHG&#./7GY&W3^BY_S08%LPR1MI". G\/Y'R53P
MY-=G"Q14=JG UIE&]W$B2VJIL<,:3A.4V\KG$EH[<L(8,7%Y\#ZFY:GH#9II
M&0\8=2OO7X40H0YT"WKF#?2'LN\U>N,O2ZY7]?O]-(TG]X=_3_X[V;;QE+(!
MUZYSO_.53_JNTU9;!],RBBANA%W4KI;2XJ0V[JO12*C=I6=E7YHFE'[XF=?0
M6:J6I[]7=H="'5,Z:!_Y?S^829G0?[0<P-/^/QBC":[B\4P3]94(*N9):;E^
M'CC(5D4%=G?\%X+Z@E%5IK'X9?RC\52Z^L_EPP1,Y(ORESOP3E7G-1TF< 77
M#G?JW^]P(%KE0KO*4@P%TWJ=O;T=7;;3;;3#-.'ARY%)K<\J-Z&/WOLR-PHM
M<_@H&'0T *O%Z7CFDO+#IO;%M5C+\!_J7E5=^;W"UU6T3#"\3+AGL#3/R/G[
MFM\1M<Z)!.([!VNK:$H;;K.'Z$?ADE_5I3[1G"4-]=-5? 6;Z9.G!HF?C>(O
M>XX\?C;:TIZ=7/D^O-BSD9 _4TH):_DK@UEP.-?7,"_/,W^2,D*EXVZ;SX+4
M=_;L=IK O'UQ^K"WJ:9=.M4$O.DRVM1@5U3ME3$4LOAGKH9E:9;;N=MO?-PW
MFQ)?_(H$&/)[2&=0(_2/R4>57I^\X:&1([RO(@OPNHBK'O2U@E+T*PJYA<;8
M?R^MA[LT*!Z5F4&V%>ZNW6&E#/=7_YCE\.#L5M*):W'(GF=BF['*=6XH];C,
MX[4G7YS!?'KY^4%ZP<"0[I;*B4^RJDG.9DRN.)=9CB%!F.N'GCANSE_C&:J<
M7_>]XQ%0HO$96V4>M(J3?4@A@0<_#4@U,EA$%>L*^1\7RUFC_9^WU?Z+J$G3
MB<$GF$9/_G@E9\WX7#.$7J+>4!=$I/1&&79K"#_WH12+PSRJ% >LK%6PQAUY
M6>HM3 /OZ\7M-]6[P!*&CGRKT_CDX**6[XO9UXG$&(H6!HV:RDZH=,,5O%%'
MD!J:@IG2) _("7/"M\R5-.M3](M:DF3?R<0TX%I^6EKC05@9!I.Z7EU0&C02
MZ*V*%I03\EPCYPSF;JM=]>HDG*\$QBS$<LXP=JO"1%I(4_&I*$H+0;4;)[65
MW91FF5R;?Z/;)$<3YPKHH%<14]F/7."^G>,6,(2N=F;X-%UW\M$2]C=11FR]
M:-!!+6^]-(T*9<(#<S_Y5/,L>GAT_M6K;?6>[';3 ]9.H'.KZNLDEF#P+QI*
M ZNGO5HAK$"4&)$S9/L]Q$ _3<6)V< KTT+-><>">,JD)\V?5A,?Q('*H14=
M$E4.2VEV:5EM[J7>!2>+R4VOC=\/&%]JP-<W\&8L412R!?2ULEK8AT( ;(XM
M<Z\)@%),1%FB8&=NI-CLRB0 QEG0C3^5*]W=+B21\NO:)>M00&2:Y67@"HK-
ML?]0K>9\#/_<QX(5>T.[&WC8N??%(7%-[UR.K(3Q8JM7 "IX;N_H!:C@G7L\
M"U266Q(D43DHEOV>,G178?^X"<8!K#7!JK,9VK?D6V>Q-\R?J#O F*!*34&C
M4^JAE7>]P UU+"JTG=9[TR1<+\U=K_2[M;E*AF3I'#QLKX!^A&GNK!*-.2 H
MDZ)MAY#ZCIW?M(B]'M_?H>:281Z!ZSUIOP^Y:4,-C'YC8Z36<X<\.:M-#S@K
M73,"];O/I5.]B%=;?C?$/M[!D=K E)C/B2X$D#I^;XY18GNS F#SYLVJQNFM
M+M3EOCG*QD4JNW!B\J4U+4PSW>MFGY(MNFRLP  B*XQN<-9$)D55BWH=G'/@
M4M=9I/&MSE-QD![&0 1'ZB@/MO;L,=AR6TM8VW\3$,"IDN<Y3 $!W+02$,#7
MG!.EH4S9&UPJ?4^/AVD@=!7CP[AT[<G'B[YS_*C1U0T\F!:'6J*!> :"V6?:
MN9UZ/Z9QXAXE3[*+M8KX6.>X.6B'9ZC6UKKO[9([>2H9%Q\9)E-&1AQL6"8!
M%6%3PIL6_(_[>)<PK54,,4=W13M.FE@%WV^8G/9PDTFI(BC>6N+ !IM^LM_@
M9^'. \P!;9 AF'5%\K"0\?L1%V<3K3PJGA,(3$*)RWQ F?V9 @^V"08#T4*Q
M6L'#<@Y+(84*7%",#;6N#U"(>:Q1^XWH#U#/<T;84'SR$%5J ZG6HCCR.@[7
MX\$4(I!?H]9II#2CCZST,3M<#8XAS*7N/-$VI!9?2.D(4<%DS*6&KC28;BFT
MJ$&G"<K7ATN#=Z(=1F@[B;$\K"4VLP@TTUSI_.-"5).'EFHXK+I*LOI.3\-0
MQ>_TTS%,37X$?7Q(O/.VFCM0ZP.5:&(*GF(I,0X_?(,=!%0>XBN#GH-$MD\^
M6J[5-)#K%9M2$.<'!7KC43& )!EPU2F]<>M,F 5A=0?%9"*]144&60IL#71M
M\Z??W_?'@2S4I?D[QSTY5-:3/CQGHH0-7#"!X"\_M8@?G0GG,?:B,;"EU';^
M$'(G4'TFV"MXXK@(>P84D58^6#M^L\N$HGF(*1D@W*>R]7=$ 5T']70S0H3B
MDX:I<Z$SB8L&.)>H,54-/ LMB4$X%+CPIH;),P\WF'2"%V<Z! 1(;AL_/:%[
M_UNR$>GF7W34L.3N+\ZUZ+-2?J%/:V ?W+&I@9XY9P\IIZT%:5@F-><G=0=D
M:=YRR 'ZX:XKSQ*:BO7;:JWA+N?6,N;]TZ\;)N>,C*@X I#LL9#ZB7\/2"WQ
MJ&<PA,+,,":- /T:!=V8$GSZX:8@=F*46@SWG>2QA*2XWL#!,#M?B_/W'J$D
MZ=C 66V[>](^T]J16DV7F"**+AY"&MMTGE*& C7W+F@N>^<1^$5ZJX_C,M^L
M':BB^ B(F!QQJ+G2_<>%F/,%#LLLM:0FHSN7<-0CDVY7 >7KE >?LXP\H%0!
M_,]&?5LP+'#FO,WH3#/)D[9CC_M@ZW(_FYY^R;VZ1-DZ;#]J #4;F='2(N(3
MJ9*<'O[113P?3&LM \/15>K S<7P@"S2T#&"G\7GA 0_X83(JF+(PX1W,>V)
MMEZ4T3*&NRYX;CM[@QTK,/4&<\LD#]&W3SX+(*G]WGQ+C\,0=L=;,.<<1]'9
M2'SP)_/L;N7(B+GHT/V&J4 M?W-9%056U)BSV+0/R/+3?XBH%?8E P1:RV *
MF #OA6F";I4PJ?WQXK*44>CPDSX2:Z)PWI_^N2='<_6!USWQ9D3@!WF<X<-O
MT2.12?DDT<GPN3R(B_^HA0/U!TR2)JF[']KK;-N/"]'49H=E?N">(<D-4&T3
MGG_L$T7]A(###*;$91,7X;:D:? +$1R-9P=82"+5$+8K#>I:"F%-:!["4#<^
M?,X$64NY<H]HTMD([F"."1-G]DX:XQM<FC3.4GXS+@W^A>77Y)PYIS2@"%0I
M^-_Y*+>K&7PKL5NESD-%.>&EP1!R#Z?4WKG (S 0@W&T#!IMA0SOO]%;6NRA
MCL0CKD93I5$8H,2%X#N:[0_+M]Q8')=?UP:39-@.73=,S1IYM10RQ@[L@4GS
MU1;QXN"-M><P+%V]#J+4)7J7J<$0:N<>YJ#N8G/%L4G)8Z6K9*F%L4RI+E.#
MI(>@550<&^J9F9&E#:*M"HT>;&?5.K6 1H*?5014G#_\5<ZL!/I ,<+;+1 1
MCK\Q3)F+++RFUG1B.@2LRTVS\"-(/4DEO:FH^=.JI"KUQ8'&DH@1ZEM5C="#
M:4]T$=O4%<(05W,QA,B+\6IN0',:P*")Z8D4+4X[C[/_1J/;%[QN(IXS'B;Q
M&D><D7-4RI5AP-5DPS%F8J0(B[UT7FEPJT!/(0:@7"4.D=(@C<H+4$\?#\RP
M+N*[Q,/^IVR-KM+ 1!8>J"2]"9J4/!24&AU:[)M6I\F@]O1SJ%I7AB=_7/\M
MU*OSJ="QB4<7 L.VSI/=M_K 4N<-_?B&5DE"POK)[J9I[-0G'QK7HD]J.?YT
M#TG3K)FI#U14>2:,*0E)L#?$$PO-4.(2W74 \05P=&@0J1^TT[[B@7N Y'FY
M6P"*9("5;70V!JA, 0]A+C42D4'5'DA"T^ 6K]O%:HO/*535S3DF'\<;9F(C
M?Q<2B??(*4#9]75ER?(/ -I/@<+#"UX19D&WAOD?%3_+T \=V=J3RVL-TT^B
MUR]U;*BB2[)'1!):BRZI_:207&^APPZ2>)13*N32VK/WTKV"DGELC*NC%F?.
M#%>66"BF-C!R/>-RZ3?4NW==08C.M[_><?-LOE_R)F,V'92GRPJ0W!X!IO];
MA/>Y0&PX_N80)6_0F-IV2^GZ!](6&UU=)H,C,6@'KK\<;OO*BY-B^M[Y8HVR
MKV)\%M"3@,-:2#^ L[H#;ZPZ)V;IZK<3'9N9P.6SLN\-<@O;[ZOA?N]IT$<
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M"2Y]N"&(L_J:9C0W0O+ P6U9\9T:'<A[ZUW=[R$DJ,#H?7&XMNNRNA*L:)B
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MF'$MN>KZL0"EEEFR2H\PD'KO%4@=M-Z4BJQIW]F/M&*<.GTLX8>UE8Z/8BJ
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M?<G(IC'W)_M2B/&%N>C!LT^::R/L&K,^B2<_U[\:!HSQ&])\.:-W0ZYZ 6"
M-Q#51R OVNXPQH3N"Q4'7#G"'33V^L8-9&59Q&]Z%P)XQ3*E%5^G]GBP>!>Y
M*G'$<>_<[)*+.0$5.\K)N96!7/!HMMNKDF[99EA+"V15 2&!X<NSWD:5(1FA
M=KL?NB_TDG[A <Z];%:6OB'KL%Z2PL$2_"L]7<,9'!RD24=FRJ2?RU)=O556
M3%ARV(?RZ:O1F5&[LJTT!F@$17K 0QR9_-ZEWSWA0D[GP=$*MM;>/9:1Y14I
M5T*[C]3T%-FI)MB,Y^4GFZBYQN&AH4(L)[V]88 :C2,(FZRM+[N4(^Y^?S?\
M<BWM7K.Y9N=*L6$E)D[IC0UD\''$2)Z]L2%8CX[3S9Q)T3\MNZ;7*U94%\+P
MY(_[)*1VQ[/>/&-HT5Q+'QALN.;Y;:V]VU-TG *ZE<AVGS5<T^?-3O:279+
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MC:$EO=^XD[!>?]+,:+9:_%PP+J;L5K/O).</8R5^1SS))%Q-]\X4 <,3_@^
M]LERD+>IP?"ZHLD:H.L//$=D$<OHO /11932GI)LUN')?0VKT*53CHJC_G81
MMZ+ZYAJ0NZY,L2N,>_$-2&_<P->S;#P_XQH,44$\+*.3-9L6UTAUQ,=AE$.+
M>Q< *_[#WUHM (+\RV8Q:XM?XD#O" FDVEN\ 'C@&(;J&TS4B2>E4]2@$H10
M;)CNHM_,_A6@?R .^7-F.=N:DT]$S<&P//EY^.&7K.0 ,I7AE?2#P'0*7SS'
MO5N L_F8ZHMD$3[ZDMD5YIJ8D'G23-8F5N(H@7\_VF3^_=PGA:%Z!R/5-.NB
M9.TUNGI#N^9ZFS5;Y9X CK[=?A2(T)&9WJ&+UTU/JE6G;09MQ4G@L*9)NR+>
M;)!<P1/"@8) ^-LR2*,/Q6?C=7=M_$+K_!9 F@AIOS74 C;+S7!NQ: <+]58
M63SW-[QM*"]3@/4A8AQTQ _)6I%[KV#.#,]R#[SYI&_K<09&"(),#86W;E.(
M*%W3;!DDI]JS640N0(Y4<<1A\%+#I,*J$5\RQP-G7L*YEU$62G:Q#4SX:./3
M2BUZ7!3)<$<4*G8ZH=V!\^*E7Y$UTFJP\%>S/\449]*#0V0^KM6>"2TO C.*
M#0+8WEFG]CE=/O&I>-5=TR>[Z'A=?&<$\^+-8H*RZ[&#A*.NF3L-G)@>-??F
M#!A:C\>!UEOS]N5)&MN:3O16-G7/<[\H?2NPE"E)>'%[BA)XIR"TTS;OBQ_U
MVPU&#.BN<8,0[X<,%YNVY["%3-[H=6[U#[DYK!B)4($HRO:\:D1(^LAS2'KQ
M#58BC9"W62'7NSWHDOD ;47]I4#U6H,YW$!'^A-;<SI$326AE.&6PR) =*X9
M%63:'XI"IK;9F,4X%W9&%I9-D3U79,HU[,9L.KV+-R',_E$_O  (O]):GEIW
M/G0H*HJZ*4"X51Y)#;AZ;ONI9R_++QU<J_ .\0GU2HQ&?-RU._1HI(:0HE#0
M5.!IU@>Z7'U99>'65FXW([KT]BQ$[6+GW4NPX[Z,I!$7FYY219? M&$BWF/;
M^1\UZ4<;DK[2\H5S>Y!>;8@+36IQLNL/W-G5( J5NS'&"N%9C@F_^F[VN5A>
M8=M&G(,Q"-(XE*:<^N0EY?$DZ+.UW/0N75"XM,6E=\[N3J[^*FXQ4\2!BJGY
M9]=FUILU6X]:GS<EN$N5$=!.N:FW/]2F544Y(#>Q^DRF-/$TWB6+I\^OLYZ+
MWGW,2O((\9&M -D$B&AD^;W<('Q_W1/0.5W#>9[,_O6[HH',<+WAO+A6&;&&
M>?:W#^=:^S$JV3G3\T2$"KVBZMJ,08:]Z[O>ICRM/#5>[W?W /5DFZOZ3L[L
M%!!(/K0Z"B=9.X9TB(C9\RF09* 6;2[&_D%GS)(,D<]YCN(*NY*Z&E3[_/N]
MYQW'S)]=/TL\?"5\2,E/-O'#O ?EQ%=C6[:^UC87U=A\NS[B]- ]F+&R=>3'
M4)(+Q3T_0)E166DZ=.;TF@WFHU4KG80-=7Q(,Z0*G=ON5"_%^%8#%N2*DSM?
MQ]@^]Y2?O+'Y.'1+>S3F._C\3W6F1<S+8^_+Y;EOK1%YD IN0$#K?)OJ B"(
M.TR^<;W%BN6,10>\&&>&A9FVF%3:H@.<<R/ 15G-M6 EC;OHT2LDZ#H/W,II
MA,WMS-K+UG?WWZTY[HORQKNG@PV]P-<C(HSCQ6N 8U*E4'F%EM/2V=>2Q0NN
M7HN6Q7XQUIL?XFS^:GR*72'EDIZCW$>AR;W_ K0JB:S(;F=EQ]F.S;L4\]>O
ME'2+70T""2>E/,+K?AH+&;W_=%R!]5#V[O"O+PO(_[*\%-+:,5\\PAZ[#K6)
MQ4U$[M_=^+6\]ECS74E?;]Y/%J+YUGS;G<J-\@V!:JYJZ(:3Q-=*$H];&607
MZKSM12!C8OZ*XT&/=Y[7?^  ^Z /]9%>'&RR=4.XT*LBZ1O&^L'Y/IQFD%*$
MU:D8%$Q!/(S?183ZY= &7F=/O3P<W!@\:O#0\@'OYT^0V)AQQYN\Z3F3,L6W
M(RYF4_,3:3\J\YZ:,Z):U"+K0/F9_)A,*BS[X:@DO^9'[>4/!>F^5V=['X4=
M0?WT0_N9O$1+X>5%A@&^BNE@B6%H+7I/;41I;#"2^A6Z87X[B9\#L^E*>J'W
M(S76"X=^PLBBOC*%.#_GV[1X.\NC?(L^6O&%7!!V^MBU&6G\Y7JJ56B)'USF
M"'VLW;GX@>6'D-5]KS=?XOU\U.558]R)<3OP64&OV\]>2C&OU$F2H^&5?.M&
M5+VEVB:A9^-O6'10 $VN(2(E(@;D)_GI4W<UOWW4>-%!':B.E+22PY[^=%?E
MB>\(T^HPN<T%C%3"[;G"'%<5:).K3'+OY37W+A<-WA&K*-.CA)9,-!\)F.E(
MO;9=4RX>4VP #'R &\*![5MJ94(0AX4>##D?7;L N"4J5CFEI.AGY;/ANT@5
M3GEDZ$W=6/(]O.[8Y0:9-;K=ZIC\V HI?YN^0.U>T:VD-7FWD(GM^C:4M,X;
M[DG99(]-G\4H!I_T$0$S./<S >R6]^=K5:V+6FF>FK0 '[YH/1\4:55]:M15
MZADA_Z<Z<0R%UGN[W3NBYB<MJ,ZU+-"\9Z8UW?"#M;1##+?9>G+ N[,T\CS!
MCF<'Y^I9C*?MFWV./>A;R";8YCX"'O=H!J-/\!AT2N?A0<#0*)GA9\X-G%\
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M&MDGANI["YST?>%R?_#VVY8!P5EJN5+^%K"W5JB/^+FB=.!&Z@Q]^I\KB@E
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M[2J.A%>$@2BY2RS7NP'B1]<R]?!$7\W%U?K-.OXWF*CMA:#&0_-HDU@JWFD
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MF\N&378( 8S$H/)S<7:*][4$B#*87,?(=WEES5Z9^PD[15KT,T&D$F/1P^*
M%U*M;I"::3QP87SA5UH6)P.?!AB !'?8D8ET,&W,0.B?BNQWXLT?I9E1R'0Y
M:=S@&)(T;GX#WA'5OLD'4D53F!YC F<7UDI0P/J*?W9=%*UU*H7]K#,@W3W%
M7#I*J6R5-'CW,%-W!5#.@E1ATGGIZF\N^D=N?M<+\22@U%8 >J%X*&&><^PQ
M1MO4=-=P+1SNZ[,E=(S-?+65TEOJT$2EC'RN<V)4TN:7B9F](_K4@('A>TRC
M0W@F6[M35.?FE]>J8"";.^ _W;&9YWBI7S[S2B]$$Y1*6YHU$*J/Q*Q>"JX
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M@"L=VH'C&-)\UF,0N"X:3.-9Y>_MK2=.KD^?-<'EZL/_A=\0Y5D%5HGEFXF
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MD?-N3>>X/I8\ (]!1TW/ -T*5P"#BY0X[<#E6;-+\ Y:RR8?4#5-87*,4$X
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M:&D*=75W!T[8TV]-N^NZ=H(,M'8Z[-]<UES&/ 0?@?0V^"]_+U][ KA@<6_
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M$4.2L(!>G5.P>EIUGVI;51)4-I:/_)J&<,CX]6:ZT(2,3G6H>$)5%03]J?X
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MHA-VK,>:O_VQ!AO@80%"]<:=*>=+MFY> JZZ\TIPO9WB#K&.]A>),<M<(#-
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MUW6=_PJ _.;UWY>LO5B?UD;I"DBNBO)H(N"D$4C43NQ_BXGCTJN'GT:K!YL
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M.)M=_?M+N?)1IF>Y,=;".?R7 %I/3H%+XL1=K)=]4G#-J!HF>@(B6@+X&V3
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M-F^OYG3GFEPJ :6#Q831\83,T(KF-V/R3>$SXT=M2;BAL2T!TTO AX<%;LD
M1?$DQ1NB@0S&;Z"(6L-SAU6W9*G[%<]"7)6C^-E"R.,ZST^;KKXFXXO#_YEW
MKZ5Q)@8>QMC*C[!YB^ 8M#7]FX@*EB/=C/:J8F(82W. 7T^V?5E7O\%>F4-&
MZ) P,,Q.%TZ:[,W?EX:YN?PC<98W),Z,+]J3<(-C4?Z32Y!H1>(R/$@X!SZ
M@)#&:;A@ /PU0SDU/ 9L@7""J+7.CZ8IZUUM>SFO(\W.'%@@-YT5%W>V7+D0
MQ*]<"(Y!1!,$RA+_%;Y-7"%MIO#%E8\F#CK>+OG?D'9E05^7$$]*XJ<3]QTP
M(H\'^(K]=$_>BG#3EW3/'S7D^XAO])I ?/FTRLN^$Q $18:K^OV)S?\">']&
ML(\Y, [KQR&NLMKXY>[N,G>2&5.W24 7G'D]&Z$143?LNQCBB\-*[OPGV[LJ
MJ\ZO*TI2%745"Z\GC=%(:$\--P$Q5"HM$%[_=#WMPLD%W\&SJ209"*1KZ95
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M?X'\E%_977#D>.B-B>-)W ["^9JD"?*7TR*0RLL#AOIU=P#3L$+T3J07BGZ
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MD-6)S$60%WYV4@+!.H3I9@)=S+-#KPKH8@&\[BU906[/;\G&5S5JM_*'DA,
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M.(]#=OD=:*T0:$Y1<.>PVL:;RIO..\IGDJ\ SX]*,1?&)1S9MOO*^NTW8A7
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M-O@:/T[A=L6FUJ;$LG"LPNVL9!_]Y@_G;QQ8(V=M(+(9LY,M,UZ[S2]F.>@
M=:&*2B@*]X;&PM/OU'X-?N\!)W9/1UZH1# &,L;9%=G:;T0<YA;82HAN=F4R
M T!AI&I! RK]SN,=]QX6RD_X*)/X(R40HVB ,]OZ#ANWJZCO:SO@B ]+%+_
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ME6/S-V"3SW2#FI;+E[&J68)#B02:,+!MDPE\1[6,#$=YQ^VYJ11DZ\P)N0:
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MSN$XKN_%^7%N-=9&4N1+O="9(=?_S7I!6)!H< ]9K.#]T2EO+EP,:N0U=4D
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MM@H^.;H4:5)YH"6>+E_:8BZ46H2J.;U[0+9Y?-!%;5$CJW<4+@&,H(7W?"4
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M=K5,-^/DTR_%^-G<C/?>-?8Y]3FK%:;F>24K#T@ /N^W[[:?N.*UX\IT5_1
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M"\PHZN,8"VO-F;_B%<?5A!L21PBHV2#WZ(9 3*S"R\/.CMZ^KQ&9+MC&QYS
MG),W0XOC.K+PJ1+ S@I4%B/)7.1LY.JX=>]*">!],<^^1+EPW)GS;)!&JT>S
MJ'2\M^<0)7J*=?0?/B2+_>&S.GP:SRLC@OA29>[<Z%:\UR ^]W(Z)@:#R1AW
M:8VKA]9[I'SK-28=6LL=%&!"W;"I:VR.*QM* &KP9'IYM%(]U/KHCI67-BU'
MK$%I06)Q!W)\JHWN7VE?FUCU '!K\:;5IWPL_#7IX^.0AR]'1MOJ1!\@=78@
MCV&J'F[\\>$U$6.\)[6//1A[>M\-I)V8%U9&W>\$N3LZ-IQ X93:BTN[![ @
MWZ);KW8O&]P@Y(+'(;V-TJG#_;9\W3X%_]A<>P)>_J8E%457)PXGUSEQ2F*^
M@AAJ1]#^3#P<?7MGRK):"Q-M=<1U9=><)/P<8AZ_RR[3JN%9SIG')Z-.FP5X
MED+9#<VI8S3'H?D/A;22.BAO(D\T],Q0VJ\#Q%0EIP24]_=(X7;\]D3\U;,!
MAP0)1F_]0U*3L3<1SYZN-#O0:MVBZ1-4=(1>;>DS[EKYH[>BFT^%:CQM#HVT
M,;2G=B>=*1T*J!VR+J<[ND-VQ;!P=NL#V%NV?F9IV)CBYF(WQE N?K@<G3F!
MK1?Z=]]+E!.LG9-7TR%4JX/$Z#.BP47.C/)M R*49GRS0HL1LA1!'Y\#"W;?
MD@!N]^:OW>DV$78AYZ8B:B"$@-#ASHH&5VCL@?L8E_9]?>M!MU+P4,'KX$8^
MP-=]M9$ JK=S3K=_:6;ZBRQCBCG@)]9[)(!DZ9_Q"0P/D2$>Q_86X*Z7R8)Z
M_R"^_V &GR?ZZ&\="[:5ZB0%J4Z:CYLI)2IWM:YU'*W^*Z%D),-\P'(&* HA
MY2]V&@4.?*A0H%.A-/0XB^EZ YCVOD*AY5T"4X>RX$O@S]*>_ZXJK^L^=*(5
MG+N[LF396[WDA(0?Z[P?.M7M;%IMP0^YJ1''JUN@K>1=NVMWV[-=%7N#T#6>
MD +*47Z7(7NC#F#SOO&\U%QBMS63%LPE/';[ETPF\/MY"G8RI**TE$$27MEP
MZM;]=5+QXT@8(?KGB/.FQIW^<*,.,"=K:8[&!/FG*+G8$A1(]\ME'XE\CMA5
MPU17'T8I<YZLTD>;=2(1Z5BHABF3 'Z@Z0,<^OIXR+=_#>@DLU"-7#']:X/[
MA7=@8YMDAP?8]%!''?)' 6?F^3E@3DV2;0W-D8_\<7;.?:*XH4-P@-HV6.EK
M%0$'_ERQ?>1!!^<Y/C/'%!I E@#D?I$J_KHK'.L(78=?KMP!6KBC22XVM4%=
MI6F6:  T51@+H K^WXN:<!?($3Y2)^TKEO]!]'B FV E9D-7TJ6=3?DG7Z<
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M-FJ@F50;_]Q++JN771W6M!W1N=,VBMK'_4EAO';3IBL@\0VQ,S6%,CFU<!G
M5O4/8<H2$*L0[5+_.*65"V:A.>,.[\ 6(9HW0MI2.<"%TW;HN#-?6ATU C 6
MG5U8 EY@;GWE6#.,:/15N>0(">#-+U+E(5R6H+/1NU$(-Q\4QT8?6U#6KFTC
M_\B]U<XR!WNATU=/\'DZF )20OAX;R&_$^"X(6NT%6D0Z&Y5AA7+_P)JQT@
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MU*"?"#SOW\5$TF^G*'DR1R2 F#^4Y38,!PS#M/,H2+S& O_Z0K1U;YN%ARG
M7(>DIS!.8C_30H-&(V;Z0Y(:?L"OGRC^Q;'.,J(QVWTCI),LC!/.0#8]AJ G
M<&\KICC@N7KJM'![\N]]+$&O3RS-*.EX"I\1+5Q!!(""3%J<A[R&C# :.,TP
MOMB:=$E62#B:PARK-,W4I3'%GQ,CM"O[?A<1<CO_4);;?A:=!#"G1$#SB'QN
M@6-%YQ&=V^]&UZ3$+J 5P98@"'@21)RDCS'&D0SQ'CEC/OIR#,R].H$>2&R:
M"^LM!#4P-LMJ"*.#\+!+%LNIMQ7&@ M/M9D]=V6.CZYK_:$V/UV5/9=[9H@Z
M1M.L=E\<K%!@_^.1OUM02I_=+I2TE<7:@4NO ,*"!):^EP;Q:E+Q@?^)07WQ
MAS#Y!+#=EKVMD(Y%]!,\EW4PV_1#E:9F3)_%*C'K"!QW!H"22;NC&%D-D??0
MOFY768VZ-+KNHJ&EH'K1MO_[YY??8HB;I:(81I@(_$DX=;7_[?2RT+ZB+;:%
M5MLDSTZR0G+FPI\H"']3&TX&6:-XM$&@FT8(5MJ.?O"N/T5"*D1XBD@"&!YG
MS"]<*=%5I&U5:;H8"MDT_Q-P"@!1.T1#+ /R)?#*'Q34;YD=G#QB9LYN4R9Y
M(=H_8;O& >BMG\*Y V&H7,L?]])ENQJZ7N FK*"@9V-P8IUY^)Z'?%0TD\T+
MR_U"GO-%MD]]S6+'YHG<)\1C<#BJ1FB)2%213L-0*X.%\4@,$R/R 4ZR4N-/
ME>=_WJ9[,K&%V!YW$\<*#N-2&<XR4@L@ 0S%9HI/3PC-I*^[$4?,-\*(<DTJ
M JD)/@CJ+[II#,I^(%;Z#XGMOU Z/>31$I4XWPP]&G@?<GSH.E!&:.3_26NY
M.OZFR0IEB@^0):LV/AEDS<;CT[&7"1$3PE^\]3R9]'LJ4W_7@3)QVF$.G<@.
M[/ 9&UR83S\@1!E&V@RHW:@O[>U;;UZ-Q?ST3!&UK]JS991*>_O&FU='GYG_
M*)^)Z*-HF$ZJ$\S$P)_<28B(WH>@H8A-"&_!N'#^N!.FU3]O/7&E<ALH#]A;
M9?4_Y^03Q2W_YT3^"K,L>@'+ *I&3L0EF?_8'8'XG\?B5RRD!JI*RRU!:H/H
M90ON$/F[D)";AJ&N/6)S[A"86,2PQ4_X\#-*AVB,8D"!@S4#I4G>\"+Y=R%V
M-R)&D$PF^35;<L=)PK'KN@\ZV!?PF9A=N5\&%^K[!_'4#X20FL>EQ*8."> K
M!XF?*K!;TQ:3E]%^-@DP\Q/E:8CV7?".$L#;7A)W7+P6P*\G;C:#14<V#P0*
M0XCT.8YS-KP%ZM\,\JPA"E<LH$S]=/MH6S\%#UR4&B>M>+XPBG1!1KZ6\U'7
M8&S.[>9!Z8LZ]1-$G\=#7Y$ ,J*EU6UEB:" Z3U96XE[#9,VK'CHXLA=P%\+
MO_WN?Q:W2[7'M%1[F.1BP<HC1*^<>9Y4G5%,*086?$P 7JA@?4W,6OM!A=_Y
M:%0_:2WP42Q$ G#'G-&1U5F :W\PX:XE4MG7:!HP8)(3) 0_T(H*&1^Z^PX&
M20OM\U=YHYVE*;+DR,@(N4Y9098O$Z9$3*N'SE+B3D@;/ [8VZ#J3U[_*3A$
M*AG,! U&\Z++BV R:7?X#X^LDO9I?ZMN'O8=:VT-^@72O04/_6JQB)JN-P9>
M^! 6J^?Z!IG8WJTG6AZ!P9I\(P9Q4C_SDZ3[VTBUK^B,R4MO.BM_TV8!9PW>
M 3@E4Y:YREFC((I!D(74%]V!"7%*5[;-!F2&6ICS@X,WB"9K1:#*;[,P2*TF
MQEP:'GR(&*%4*6UF_U-L7/Q#T2$59Q$UTL3#";5BP5ZXD8,WK)^_,_<O<1P%
M>B@MW.=]HC  0V,':0)__$@NCDYJ4/U#4A4X5XSV)S5BD\)(A2XX^EK91I;Z
M*S0<,3%3 GB/@#2G $V(L8U>DV%8#<3*:?Z/N%0B7L6B!XA$4B\P'C+]3#H%
M)^TOTJ5ST6+RQ_.N_SW3^?_]3(<A =0+#(05?7-!XQ) + )]^-[_/- IE)F/
M/[J9(GO*T&X06\&B+&@,4K>?^^5S:C8;-)7G-D#@1G']3Q\^>W_;]7--NQ'?
M848[ZYO%\/RGY.Q0D$-N)/\&P9W1(C3G?:TM,VO8E5%>(4VEJ#I(=;&6^=4P
M\'WI+U.9-\EZ!L6UGZM@<3+_ZS%JD!I7%/GB>.!9A8PM1$PZB8TOK7)[M#E<
M3E,OW&)G; @)!1;%[CAT9R]P1^,0R@L!PW/%X8QSUYZ+FV8]-^Q@=.^&XEX*
MDC;B-M;5^W-=.('3E1$NQ/GS!])A%16;@19DS%."5:R1JQ^)?^?<QALWH4':
MHGOX4;#FXVN';S\?*+[^VI;88:Z7B@R,?%Y^&?(88"!FJ=$3>.#1L ^P\ #F
M2%X@L7570]"<UJ?UCYN<=VVY6MRX!9Y]A1=[^@HIPL64.=!', MGHA"[C9C>
M.^!]3K@1T\JEBQ"^@U%+FYM9.9PYD9'W<?<ENG=.ZE:$&BNX]DK;T,(JP>TA
M4^@SBKD20!_O &)J"DD&4V>8WL[IB(9SEN"KSA/%]>&44C=<)!J(1BCAL)%U
MQ[#]D*!P&W=^$;\2OK6OHSA $[H<"_#,!U >FK>.<T4[!H8"=?HP[?C6"@WI
M!'4VHH@F;:)/Z&]CCE4G'M\36G34D]@6:TLLQ7CMH#J.GM,YJ3#7EW1@IM7%
M7)NZ5V1P'?/9[]O76I]705G87>%NF';2 7[IAJ!BY_V[6@][8U^\/DIR;^N!
MY_22G5O= V<XU; O&A$!?4R<IF^O#6<H#WR90QP8)#HWNKE0FF98<T<?^3R\
M![C@5:P!S$V"D?'J3":I)YM^?>A4HO#I&VG;?,T8H(+I>_O&"^N+ QMQO4)M
M\^+:\\_Y&U/23CR=8@ 14RY$?K*9!MDWD\Y4%V"-F@>BZ=)L=?U 9Z5&=&+%
MTMHAS=E4S O&4EOO.:9>37_S_JQP."DTDJ#DM_Y$6KEUX''3#7XT>^_L)!R]
M"M0;$=6WM3\ZZ-GBRLP=8QXO'-MV3'_V6TM[Z;FN^V178SFBW50 ZKB(\0V<
MH([AJ:0I_-H6'LR9'L"N($S :B4 7[ I>'[HTV*'I<QBG= #V_ENUM<C\5K?
M%GN\4%KV4%N7H:89;&<YPY*^Q7M)#=4,4ON3[JZJUQ9YL,K:>404JV$&OF\K
M:WM,;N/)2#+2#,ST&<-+ -Y#: E@9R]3PRB=G(BM0&:"D=YXZV.*Z]L6+;J@
MEV79;&\ME]2P< /IW3WSP:J\0,5+8'V?% 4U>I7B=RZTNC>",:IW=>M,84=_
M4<HL<N3S>#A\'M.S[72,:)K9AT&T8P(M$<!JA'?,\9P@3[$WNI(Z.8&WJF"A
MQ57[NU\?<M4)SO^'C-QI*:R7&@ ;1LRC1_=,:SPTFR$$1[I.PO!Y)/X$8E>U
M5+6]DC^S^V+;:[['^5)]\E>/?L]OGP=[)LT^ B]S\ .#>$_I.R_M05S6W/$'
MF&B^E?6$%GEV@M>',F$DS;%<8<.8#!_$MBD?X+AEA#F1WVE^0/-"RP%+[JE/
MPN]AS9,6>$1@8^7NZEZWZ!GVF;4] XQ]-?GK%A>#HRR=AE@!6AFE0]&*RMGW
MS)CL:0X_.PPY:R(RQ[O,3(M?B[(#*=E6LRP&P8188,+LSSN]F.^X+@E$-9"S
M',9I2F-\V/,>@+#1GKXR?E3S@F_2(.>Q4W[5F>\\RKP8XQQ-S-I&S#JCXI3,
MT'(?HQ#MZK;N"&0C$!7M9$($/Q?&(R" S?=B!A_0)OK2FCNQ.&!3Z7BS7UY
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M)(X%G7'0-CU;1>'-*(<=/8W'6*S=!O8-HRTR4QX*2Y^=H0\LT+2L]":^<.Z
MZ9EP7.;X?-?VK6IO'YFWC8"Q+*)F^/C,UP1@A6^KF@2 :I@7>Q>.'WS"-QI;
M':<?+^9AK*7>@W0?<"W_P8&LIN$I&-^&3R<G//9_SF_-BD.!X' O!+A]:BQW
M6\#',4"6M1(<043##?W*X^B;#&]9Q^0(!\2(A87KN]V9%ISF,#$VY]HX"5S(
M<%0!A7T]&X]&H[/11(X0EM\46ZAM2T!\#DO*M:1S1=O_4B $;U:"\2WX,.G[
M#):^YFN'XISOO;O AO%%<W1RSD;_@W<O+#H;MRM-S,-IAO66]MZ_M@_C?%=^
MF&W!!^^.Y;<6O%=.W;I9R;@/,2D(P6M9QD8^ 02:#BO:!PW.Z(PQ\(7>D.;'
M">L6E6E!VJ+#Z=.SA:O>#:BL9@H(SX5#0PTVX(U7MEU8$F^QR<R#2YV:Q>=?
M.\MB7KP:2O&L+2WHD>KT5')+?D45_[6 W3\]-(3H+.S8ZOG,>(MR,B^2;X/D
M$B)%E\Q4;Z\8@V4!QVT7Z_EK4@MCD&VOVA*R%1, 39OH5B(B7P?4P(1UO0RX
MO$XS24=!0Z1(+'U*'.FNKW\G[K_]^/%L>;W>U=8P U@8-ZFM?Y!G\JK80M!(
M&F%72 "Z,R2GW3W@C>#A^@\2P,B0V'CK=)@(YR/H6&D@= KW,I]$@-[A.B!-
M@:-7  .W"7DP =NX5,#3L.5J$5\PO1E]$L"2,27$,$IL+ 'L___8^_-HJ/L_
M_A]_2:&-2@M9IJ+D4H0NQC;32F0I*I6M*TIE-R*#&=*>3/9DF<HR=54F6<8^
MK2;KR!0QF!A,TV R@S&KWVOT_I[SB\[GZK_O]WS/M_\ZIY->C]=CN3^>KYZW
M^R%'HO<-[EOT.\)11B*=:^4G>F]IFNZQ>]&_)7>LN8:^:O+9HLM.T:B]96CW
M:7G?N/J3ZBQ6*,^C3-RS4^*![L>T0)OVVW$'Q<VN3E%'ST5UH@+[8O2#NA:?
M3A_DOUGCV\I9K!P,^^<UG5!TZ;&=K?:5_/Y=IT\82EX@2-$^7!;3Y7C-G>V-
M.S51G?7U3 4@^BGXWMT_+:-L2S@=NZ.A9S>DF@6*A0>L[WJ\$2_C^L\.]4'I
MIOG/S^D?YW4P+^!CO*I06JY9K)3P6QFU$3X#G\L^GH^*8$5-[LO<^(;_T%HQ
MX,-"8D4@45)EIK\K=<>K]Q6 452*]$[LO@L07K*UZ;(![YRFY%#YS@6/SB9Y
MZ0%+;$31WL-!^ZVF)V%E?[6N[>SZ]QCR9,2P&ZR;37#\=B$D.-2V>V=[QPZG
M 3<]/?S^)JZV<T2=[PF;<[&J>Q/5)#*?! -)2U?P*TX$.ZK(W$!WPWIKS9XL
MO""#WF9-ZU//(/](ZF30-P@&GCY)"7'QWW3,DBXYR>N.D0<&LKJ]&H3583EC
M!+8@C:QYPLD-Q1ZQ%I1->=82^ 'YL=BMV%(]T_,_=L1G/^0%*O4?Y/KW,AY#
M2=W!)O$33!+#,4SAWH$C*1V*#XG=,'IG><S[O9J\-U8O_\7RO;\DT%/&S J[
MDYW31O[=3TKS\]L?U13%9DP7]@PDYY9?7-=U&WT&'A$F8:XJMG!5?N:0E'E#
M)</JVB4&3K,44Q'P;F!9>>1KKA5I.NS1X=+3T(73I#',/E*(A.V%^K2)3V1M
M5,)XFH1]]<6C4;K;K;)QU:G\R+78,_IG:$3^.;M4[Q$V.K+AJ?7R$<+0R>@R
MC["3RQPGWK%6L%?*ZH<TH5\),/8?4X:_-IK0)5;!IMYP!$N"=-G<H[*:H!P;
MK&WE\BEJY)N5H?,C/27#-CUO6#C*G\Y&X7*Q5TW#'O56]IJD951.18QR)VC(
MT(-I%L)/O<]5:N_W=A40/2R^_QVQ[A_&31N5&Z?6B&QP!+JC<RBU4!EQ]9#\
M&*IB@D5^ONOD_M#]+Q_ .9\4W2B)7:QC"_XJ8F^S;F%V>+XB3&M^RDT\)M'9
MIEQ7RG,E[!\B#!_,=@F.(&XS20BHB8@RL,']\[3BR9:+J9?12& !?->NKW0<
M+#4+DR&I/>@M@06;)#&9+=:%]JE^9V[:PC>H'S ?TP[K%4<^R=^_OSM)EB3
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MG/Z$(Q&K4AV=WO3"_\>#:-QWA-BBC1J=]K;8GY,?G?<-_*W+?(3$WOD(E\?
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MM80:;B&.)#N>Y]@$'BF[P[ZX+LA&?+&B]%A0G[/SA97)C&-^ SSDQ>[>2$R
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MM2[:O4G))]S$9P<9L/O[L8(>Q?D[RMU6#YG;MGB\LP2$NT/GO^4_N<%DN'X
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M>QLT)H0^N<?F\T BUFE:WM0<X(_K&)A>I9[U@WQN.@I*!-/&K+N,,(0VEIB
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MP[6+2JIFIKX\^'VG9._V^VXM<>L\V<-:08?4.FJ\G<Z8SOUMO88(0<0?^)_
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MWCGQ+$J':V'.X!K+\$)>X6!0O8M.@8JDY!BBPJ&V,'XH_4>,PO#9W=<IRWD
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MZ-*#4BS<M&W?K&(<,#F902* P 6R#N$_AU!7$9'P7AG%11R(U F(GF77Q;5
MZN!0)70!^?5L!4<>GGJ_5M1K[8 U7V""K(;HV71GQ %[KPR%!S)X<9-3S[9P
MY$6O;]6*AF6=L,J8QR2P(^#8TB.Z;.[;]<L8!%970<-F:.J2 QGBW&PBR<C0
M^Z'S9!!$RL[+YGZ7](WEP6 5,@:AB[0" "!:"5V=J(1>]X'PR05(T[.[[&^B
MK*@FT;"U0I[R AI$"J(5TRVOF$#M'ZCDC/$4H=//4MG?X,]CFT2]LMORS!>
M9P!%[4^?BG<V"WE@(Y5XT#PM+F9-RJ?\W38JZO3^R7D\"*($)%'Q:=!4GB["
MQ=)T >4IZ[#G82X"9@Q6ET$;S]!5II^MV!GY">AQ11<9FIS&(.4-0TF2&:)5
M>KP@+H'J3A>"(3]N.WRVG\E5D9&,(BZH<(2;*5QC1>07B0YO%#%ED753DAEO
MO?9,:[%Q7>03094R;,%+^VR4]3AE/R:6AS1%HDMV.D]DIAV^QYODEILNHAF?
M__&HJ^+Z'$":@X!)IOWK@*5"_;1.,J;8,%",4U<ZR!=C<O8NT>GM'I$H>$YQ
MPO1%8T8'>9X==U'[@V1N$0DQF?SYNVV,+^_6ZM('@<!@=31HABXS_?S!N'R%
M)[CG P^)I<]RCJ9^=!W"2"=&LX/@("Y=??J9U$?692?]M3I-F.I:>KPD8<8^
M[5DSG#ASH<&&6005 [%C)X9""[4O-6RC$ZG]@8MPQI14SDF!O9LZMQPT!Y#K
MF'X&6!IG2R/H&3:#.'%ZI8QD-J2&30GOP?CM.R_7^#T!]?<+A;(P&B5.KOW6
M\C7OBWW:@OK,;5J::.AY?-.S%>Q.459LHR1BMF&5"8^)0,?UA0VM+3M;(C/
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M%M6HW$EF"5M[:;,V \P(Y-$CZFGF1S;]\'LCE$N)B*\V:#,)NF]G;8\5"N8
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MG)8Y>?G##C!;!#@"8;9Z2^E#QPIY*UO  R.?1XVUOK;"8]#OR!AR7\'!0W,
MG=3-08J1E%^&">=YE0+N]('-!1L>Z(JO?73P^^S?-!3JAD)&@+&.ZANTZ]0S
MQ:34^"KX> B-,'P]?C*02PM/S[1Y*D>E.*?U=2Q'/W5RF%$EI)%H(:S0B*E3
M=D=4]^G]:7I%FZ$(&(FX.Q@@)\V@O#L:J_\^+QDO0LAD\3S! Q/=H--G]LIP
MEF><R=0;HDDK3$:A9*%]'<6$$!RDP9,Z,8B<-".(G',B5[/DW'1Z2UDZ,=E(
M\&.UH8[S+5K!SGFS+C-=K- =\+ZJ!P>L0RJC))>\=SN0CGOVXA!$[\5K0=RS
MC30\V Q*C$QPC-^YR4I@^E5]I^0:C@FWTW!Y R/OY;_GKJXJ0\((?M1Z9(LI
M/2[<$^,(_6HH:NS>^B9Y.+U:20N)&=P:SH"KY*GBL7Q8/ON"-QG?&2[32?GY
M"%BDH>!DMB:2>A'.<N$Q3BSOO:A\&G$-^?T*#$8Z39<GSGJ6ZJO=_[33QN"J
M%AYA-/B+ FT#XQ/(.3NN(SZO5&.73W'>H^!0,;0[)CN2U-5; G)/%@UWMT!F
MS6ZWL8L$@?Y4A*,0&=\L,%M] GYKG][^"I/GQNR4<.R\66 ,5N/8R]V=V5 <
M-ZJV/G(.T&(.ZZ<+!^L_ G>N@=58TW!^IN.37#PMD=PW>>GTZ<>QIM0<9.@0
M+13"\XKGF0D0UPI81\82!2?9G]2]1B9"ACCA".F3C#S(4%KFC4EAX10\43.F
M9VU@ ^-NGXI;N++^MN3'LH>FE2N&3D U/E]W(^JO-\H/.4]_KH34\7Y@N['Y
MKK!N]Z9KGV%AM0U"=T\9%'>:.<SN'C"H.EDRT="GXW\47\:R8>_=^NM"236J
MP*IW[*L_=IIGY5@ _,CD>0SUPH._C@W'W/II?_^+9;PJP/\:LX!TZ"#"Y=L.
M'\*3/W?0KY[5[T=N8NM"B>^F<G72<'*/AA?3/GQ=-2Y\#I!X<OVCIZZ9=9[<
MS)F)'AEA<9LQ,1<TE>VT/RF%MZ<WV674(?YU7Z@H6 GCE^@PF$JM\"/$AOIU
M._)QKY OU]4UQJXT/U1>%T_ATX23O4G&])0)W8_QH>OS2_:PVDPF9SFMEHJ/
M=S6_VKTC[F25^[0,%Z9,K1#?;(P[?O(AB0BB2L;J&!S$WV7Z'EC4L<WK$MOL
M>PJ\TRL47KTVIZ3" UN:4UF44)=;,$*0)07UQWYOWA]8/*U1[R.M='C$1G%J
M4!9^TO;02GE:J%C-Q]?V^P.4LD-235[IT?>*4GM2=B.<*SA@Y?YPS[A-$\?*
M)H^]:O/03*44JQ6C"L>7!29SPF5M"D)^C4$ZM^B8P46[.FQZX4DBV='0<T.A
M+3<G]C^EAT=45NS&YG413IELJA#53=<"P:Y9YG1I=%6$;&K3C5B=&7AQ_?,O
MWB&@Q 36-H/=R[CS4!T'IYVBIK:#D5F!*+EIE%1\5I@ZUGLPF*S7W5V\4A_I
M=0FP?M-6TT$!M5@,OW$;#[&O9[=D<@^8JV_Y/%Z"TYP#M)=P-/?B9NYNIK6R
M\H_O+ZUYU-":0ZT [T?F H7KC>^)'IB:T T2II;3Y<%C<',4;9)6@!@T#ESK
MV1QGL6KGNS5&INYRC2+X0;'BO*W;&M(\1%7X %$;_4I:%%HF8T_NB(XO%=PY
M9G5?)@O_J&=(#X7RC,\"VR#_LFJ#( O/5SKY=]BDS@&D^0Z:R(KL0L*%O+#=
M3UV\F_PY%)<[\>.?I!X<8,1)M<$#D <C;T/T#-8>?E<NO5QYY2(01B*BAMA"
M4B1M2IQ2,,B4*+& "FH6589*:B7G@F5O?$2<P@V&D^";G/Q'SL0BOHISM00U
M=(5%7-]3R?N]7WN:^HUVG8_D$[132#T\ KOO&@MI@!5Q,>1?N=CD<B:G;(;"
M701!MF_8Y^K<_E,^EM2* E3)X<GSGD$6:NR^]?463JK]&YK:%DB0WS?RML-[
M$0;LB;9PN>IXJ)B[7R>YM)CNU^+F3QU%S/S%A5EV2(TMPW3MBN),XMGS?)/G
M=]!6PQH?F<97'Q'SYJ%@9N'GCC:QB?R)V3G +01&AS>=4V^ANYGP).F$&UN*
M>$A2;;XAE.'WDGU5"WMC-S:J4;:.O) &:NN>"D(L .E*3JAQ-NG6*ZRYI7NX
MWVT1X51!\PN]$@#MP)K W]B]2_KCB=4M(_>A(D#;ZJ:Q#DS.NISO3F?"O<TO
M4$XY>8^?^.@/@B[?68;2:&@WGC>>&K'50=4>70W/WB.1[PS2E-*;U,'WM;>/
M7;JON/ZP/G1$3C+K@#,.*+@XK0D;/E_.4;KOT4VY)=]@T4-[FK/::'.R'^0/
MYLGG\NDW\5?OQB.NG."%*1V< ^R<>IGP65.[\\75A$SC9O;!("@?[KW^2U5@
M(]J;N?VQ[H[H9/*.D)G\:YI>!2]OG+S8=M^XQ]!3A25%GA1'7D W7 B=3:W^
ME.]0)L+QN)N2K":ZO+"%]5:J;*<-%@X!+8I^2N%RXG)&^SW.<LV,%VO*!\I[
MK&46CMAFB]56]P<V9>\O!1GZ7E%12>2LC0^R]/_Q]LB65/01EKR@YBRU<:R6
M9)KPXYVO!:*580))+WA@ZS=SAN(PJ_-]8],PS*M2_GQ0^=4XM(5!HQANYN6^
MD?E0MUX6<?G*O?Y%-LC;$>R.M&O1'A^!&1;.)YS[E5")<7Y$\ZR]-W'54:J9
M9Y/ ^]9]>?&.HY"K:X"BJ4=9V=L&6HNG)SQN%O@*_(P_M5GM)?LU\S7Y:9UG
MZ-I7[AAVW)7OME2:?]"]>@?'])?IJ]#!R"<*2+ 8QVAU*-'KTV,/7>Q"WKY
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M!"[M 5Z)05L5$ L"PY]J=X'5[I(O,C=KRD4.MUK>V0-H8+O7 Y%JV.6YR3T
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M8?C@X@EGCN-'Z53D^KJN)E[6HRF 3(]4I/ZZ2W&"#+0L,8FB)X?CP7W6L'R
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MVS.-,CXZ^L$O,,T))ZRP;K'7/\/2W:P.A<=IK5I&VPHO'KNH]6 ZF@\Q=2Y
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M%2>3T*,A3M3>7W\^AR@G_U367IL]^O[IR.=!KFW#)0%S]D?M.U=976Z;%,-
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M6NL-GKC5BMR2E-'0%\@.]?I+?F5>M+RHZ+^O&MZ5GSH%GVA0>U%W+<R/M'>
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M%!/=D70@=_3[D*)5N)_'AVPOFN]^E"N+MB+%3X+?\4\X+#VJC\$L$N:!$P;
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ME72^9A>R[*N:^CNJ(T)(>V?G;XQ_N6F\6YZIG@*:H5^A'GZ>=#(8=R6IK^C
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MX@'^][U:85E[O;%"QO=VGS 5$:5.1K+H6(D9JW_U3OOOI+X'_M8R":.+_D5
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M.06[!,Q\CI=F$#@LX_2N.S.H/$N)SE9JLE%=!]^+N7%FOW?CI1T1R3+&LXQ
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MR1!(+]'P1=X>=/ /83NR*H1)6(@PF>#XTM-0$M@CHD2ERNFY]8M7] ,3W+?
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M\V]!Q,I%@?3R#+X\TLW9(_>$8>-X98-09XC#'"E""CNY67)0XY.?QQ:)3+\
M^&@K\!WDXO6;B??LD'HX *Z_'7:&+T'I0_USL-[_FF483YR:IPH[HD4\)'.\
M%V#\2?68 :H'J\.J[)]9!R0+9&:<CNYY;1OTI6PLN"J2(H\H$EDLAOU#TQ5D
M]C!=\9EHI:1:TF^=U4L0BA_/S8=LC@]5Y%:NHCT0CFXH%LWXP[GS.W#7'X]8
MADLXWDU8"S*JN#H"1360IKCWVL=S,=3^IKU_R+A78BM?J90H#A2W$+XFI"YA
M:E*&?Q?:;1YBF@\U:UED44@Q+_(W/]OR*LFHE6B,X-@:3"N%DQ<USUP-SOU)
M9'L@?OO2'/L#!YHE[$GJ-HC;6O,@MZA?[TA,!"3)2B*KV;?9.9CE)R05\8@9
M_JCB499AEOK4?+='F*ZPY6&%"D&>#7@D[VPYCY^&A^?FPH0)W ['ICSA%<B]
M;+:\3O64'1%FZIYE;=U_+B%>$@6XK"%T(%8=PQ HA]#:B[P!;L\D;ZY4IIKV
M-N@),POU3:) :6.LK/Z9D5Y]?XQ6E_'T.PFY2](5N/$EJA[/]-NW#3*EZ%]V
MC:_$CIE9F-=- H"9?D'"Q)+FFZ_U;Q0II[YL*+7OQLF??!O4$3EAFK\KK5!Y
MAV<#$C< >5_!46:X'UR3VSA'6V[_W7]/;=2/0GJ$KKAP/"H7R02!,(K@%YO^
MWK#MV;<1G=YVT?@3AIRHH%IB$GE1.9H4265,9VQ8Y%S9(M0T^Y1 QHEIN6UY
M0R"^Z?A@YCUGF"XF$[E A9>O5JX#$#"C]^:->"-=:%0M=L27%]A.93,LN/AJ
M>+<11UC2A$<\ 2FBG-G]YHM;0,_X&=]\C\ EG"2P7(&L=;Y"AS]'0S2@#=<\
MM@AU0X:J)BY-UCE@B(3VYXE"3@?V ^/W.7!0C<0I+KV=DD2F$JH!YY\=S/@O
M&CQ']5K0?"A*B&7W/7YDW* ZO>:JA.KG":'S=1JJX=I-S,#-^?UFSVF:\'.T
M4) A>*S'^#2< 6VGL*]=+@I]N_DOXADYY%('2"3/$@+$Y1YY(M9U8 0:G7B+
M&SI_[9(;\QBITE^2F$0RH*#PC.DL'7[*@I F&H1L>0"$YXY\(Y'FTJ*(Y<L^
M+R:'K8>5/$O+?5UZGD9,W#IJ$Y,(< ?MTE +9 &C@]>N?;BA[+8GO]+PS.Z=
ME0>P1ML5C-8$O^OV?^Z,"KZ7(4+)KW+\"#/HYUML5DJ*NR.X^>)/7SOZ 8H5
M#*RDJ660BP4E7BO# UTLPQ1E:9,4^HU;($[Z(5,%T!8@U9ZV,7OSXWO(.F15
M$ ?MVRY4+B$"^G[U1ZY^-PM\T=^;1M<!/Y;VV$N69NS>_#+[N%C#0<^ MYMR
M)*<J,F:A>&UE_\.*+Y+ZBC>==2PSF$0M:K$;\2<N0:."ADC"7)+FD2)=%Z??
M.@F//OH>L=9#C\R&']!?HA":=JA?[E0">:\.A(=5+\W9U358/+OK]  HK_,-
MT+JD1WN>!V@?K/1]%?<UV^R96;\,TU]:$0MV3"/*J--M'.!#_08Z"WI870'D
M:W)NQ-*\Q3\/XP?4X>Q.I79TU[DI]PF36T&Q?&0:OA_8]\[*8TM*CJJ.RRGC
MNH)NSOW$1:FP19"1%+HPL.!?]37F\@4]Z06%S3D'BO1*3O1AM!M_5//V)(EG
M>>V#WSTTA%KF6N724J;0 @/,1=P/GH%_J>G^QM5,ZPO^\D'%"9-;>RPEE;:&
M'C>7/)*J%M@;L@[X;S86@G^H7R"$"+CJCSU/57 :0BG<UK]P@3R9X(L.+]&X
MW>]K<_*;.Z3R_K5;QWI:L/*GV@PCJ=G]C\Z]<UP0;]QZ:/BGM(<DT#'VJ_)_
M;H3TTP*O3$>7>"X=7.;'M+EY3CWK%7:VNHZGY@_AWQWC1!VF1M\8;X#\3;0W
M52'UOB7B_<&_9&]V0S64<RQ,E:%_H;?(OD+&]H;\G["ZVOVG 1(R?S[\TZ>9
M(E_ KI)MJ .Y.SLZ*N:\;M8P 2+%\JDPC',UXG;!T$Q/JREJNL' 7.- J(:Z
M^P['R@!SD;S[FV+M5V4]%E:A,*(ZV\.?LT0__R?87$M]]C0L$>TTSWX@>?,\
MUUCOF1&4G-Q<QX=_+IZU*2[9&N=%C=/#6;_UVI^LL6W^@Q@/+NMC^I_'JM?O
MVVDWZI1X:-T)13NE=)Z")ILZ6[@E!P]09WH]M%]HFOG)VHG(&1R5:FR4J%>3
M5+T4ZD*S#]@HWU)5-3N%W#92$^X:+N0V7>>7/-";L;OF17:7U@'>Z2)U(*[!
MB5O4FC;F+7@#H2:B!)VP]>L+M?,8MY^3+] NBA( C^U5'@BF-_P_CUV1URJ]
M>66TSM7-9H4.%IYO'N<FCVCJ!B_+3X;0EMY3MYVM0\89IHK/H2R#?]MX>=NA
MY^+#>ERGB+\;E@H<?'0Z5S&E5Y:N&G90DHB697-@PO+YVD2]Z4U:!KU\N>@.
M$MFLXOR4'I*1X/(M,1_L?9^YK[5;>@%H&8SX$O/7!@5W*NP/0N]/"B[%)"4C
M+;@# #D],KD.:'H(6DM;+L16I*<%ZQV);@B.%:R(\<^NW7CR+\:LFR3W<"Y9
MJ$4GGL3U&7&$.%"85;QX8?)_C[0)- 0OG.?5C9FC)^6$[Z(*U:W$1+LS,G*U
M2,":PS#Q'N.8<OZR(.;D9AUFJO9=#^7 6IVP!V3I__KZQ*F=]X J1!1FP!7)
M(#"WA.II6=1^?L!KBA=&*YRW$T. )('DTG>DWE%@GV.*<DEP\0C*H3)'D]3_
MQ=YW_R7=OF]36EIW:>LNO1U86MJP'&5.L.5,T:PL-:W4S'+C" =45C94<E<B
M5 Y::N6>9%8XH<1<J&BHB(@DB,A^L+[?'^[\_ '/ZWD^_LA+WO ^.<[S/([S
MNM[74=#5,]/[[0#CU>FY@--J/WK.Z5X>X/%"2UX-Z4^*VKK>'/KX6M9LRP+"
M! &Z;'#:1,$95YLC[Y!"*<"$Y<4=PI<$AE@2#R"^LZAJX665QE5(&?)WMH3\
MW70>'3!:!A8H=S4<-XXHU(<5.[%841X[:F (S23,Z;97PGU9P_:7\Z.>5_G@
M.N[HV :LZ2S?O0[6.D(U-1-PN(5E9Q#75I&3J>U$2YGV5/8I!3MG3HJ^P"JG
M!UTY)!6MQ/(Y@2__4C[IJ>'C^P_M=;<=04$)@U* 910CU7C\5%GQ7T0_YM\!
MP:51^>Z30Q+;**53 ;!C]&"F#K,WGU)4>^9)O_;%(\8K!_ODL-XT*> -=)!7
MFH4(*B#_S/<8L,\0@ABIT>(O+#KFBJ"V%]%9=>G@P6%&;]4LW,MW8-' 035C
M=&_YF9T^TT)T/X(;+*-FZ.I2;%NN@+!6%S%,\JIO?XUT#![R\:;A:?/CQ7$E
M'AMY5>/. WK]$3B3\=!ZD4/93=7@?(,:X_C"K#)D_(;P[MA3%,/@#\?:#XK*
MUYBZ3=;H6L6N42YTJ;KC7W'?VBV0_!&(P8;W(DD_:4>9_< !$QJPKK\J&DS'
M(DIF^HA7)-GM76<\HAOXI\BG/?4WX"!N_#*UT#?V9N8/H3FU#?U5D3.\B'/>
M0T/S*A?.JMBK&2)3QL:,T$*;:;%A<M0FJB6,W>2[V1 '!)>6Q/((B#R=1L03
M#+1R*#?:MU(4CHHBPE'=V(!'T#*FQFQ5&YU@^ 7A%><>4L5G% GT*Z0 XS2F
M9@ A,^&[ZE6-BHQQ>L_I;Y%7#P.W;WK\5U56\DO508BJP@3!"BSXF#>!/SC3
M]_ZVA<NKD;>,["8%L$_I5Y]R6&<>)@J:5V=(T5Q@2 %3V&1_$69?QQ!G1L8*
MIX6^H@G,\\KB_3W"X%>BQMF#KR;BNQSV&B6G)X. ]]@-/@FA_5[W7,_S"RY1
MTD]9MVB_HDW@K3CB%3MW1U2WGK4=<@$=MFK1BID!Y9F=J1]*F0CJSR&(ZW#*
MS5CZ%[U0KOZ\K,["@ZB=Q*I97RF@./6[57D796W)G!2PC]%:R:_(FMIY;!>J
M/>W<%\:9!N#5.M[AY97MR=F9XG'M,;F^=-N09D;O+;^SDLO]56.;3Q@ IOKX
M[_!!"#=G'^[N^139M;U\.XFXQ6N7HN<<)Z9]]EWJ*#()'EJ0:""\C2%%+ZO[
MXRI[L9A)-?NS _FYSODQMQHU-C_AZ_^#"$S*50?7G>A084:TI^>7N.N@Q"#<
M:;[>)SN-^C?^]P@CL ] DW!9S'H/[/SB1F"+.BD[AJJ')+V58$)@RCS2++QL
MIM*PZI)% $4#+(Z,F<KPU*^DT$J?'B./YNPNB\A(+R^^6LYW/^8GL")-K:(2
MLQT5WZ4L\,4)T-Y&J(C^_.^4Y'1C17Z?C:,ALSJ$V&M&='-;BS[_A5@>3:#L
MQJH25<7A3-=C-'XISV*&(ON@::(J_G@,HU.Y\#OW6^%ST2$+W3;^EET1$^GU
M%:EO0\Q]0J[NI_0W/IO8_D'O4[Z,F^?? 3//)T=.1H :TER#)8$J2;35]2^I
MVI94-!_8<C)134=H,DCEY<[3)/TT2I'IEP3Z6WZNDKC1IS-O@4)"!: ??T%\
M3('']I.=T?#$A@S7$(/Z4(7=CB?KL*$'BEG5MXJ_#A;<LR,,7C""O)-3D=4*
M%QW'"]?/HD8,M+56CE!UDE/[YN=&?6(RA"GHQ96)#@:^$;H@V<_B7\)=[D\N
M&0P>0L77B&(E9C^0V?4O.9ZV55A^D'.VHSOD<:'3 4)Q>SXO%K'/^;U?\.I.
MSM%/J3$A5+EN/TFB1L/.X<CPM'^R_2:GFR<4GGVQUP7Z8 MUAJ/=U:+'F.Q9
M)N\=F8'WZDZIBH61+:?7UIE,SU-2C1EH/LL19UM(]APF(WPF+(:.//&:+1M/
M]D-E.)N$#O50=D?5 !_6B8:88P'1DAC!W% ==Y[N2/O"3WG_\ML9Y4?SJE\4
M17P6W59@.P!.C$;TLV,1%'#O3VQ*+J:MGP:MBQYZ3/P9S: OD#S[=U^]](9+
M#G;)K74.S6,?^_S1<;#'O'WHFQ00VQ,K?!VQ=<-1QQ9F%7B'<3IX@%]+ZZWJ
M[GJ\8>Q\MKOJ:L"'K==4F^1T&Q/$L#/U8G9(?Q5"IC#-$0J5")]X$FX\-P%S
MR8A<5A4=SO&=I2_XWM_BN#NTL((NCEW;X!;"*=<W;=7[O+\</I-3P>-5>>6O
M)%_@;/#'#WUQL[)(-]>LED2NVVNM!WD"8FNN4W:!)L_VJHH63E+&E<&A.3<P
M=1-1-(H9'N<\EQ["SFDECP>D5'.@DAY0$((KID<.3+4[7B5U!#;ZL^"<O'V!
MG=<"@_5#&K3CN!/#M$?9(]O29317_Z#2)BF@+!W:^_2#(,;FMM\V.QF;#]%_
M^($'"  ?]]6P9IY0#T(R+:#(H6DR1AB(A-=05>:+'&G\U[RXX/Z41\PZ]0 -
M*"$6ZA1)<MKO>*[W409#-:+UBX-;A-?["EDJYVUA,U]W\Y3[HUSBKW;=-#9Z
M8/;>\Z8R)L24!L[Y$4[B1>X)^L9/;L,%/%@!14UKA-FJI\JD]=\+3D*#4"G@
M=G\!J[]NVLWWTE UA\E!Q8BMXGIGIN.J\&676&6?\Q;(*8E%UXC>Z*'7/WTV
M(,:B5D@!SK[TJF"$,4\*6%/1>HDGGN92GC.P[8?ESR2GJJ+TUI8GSX >-\MQ
MQX03Z0>2W^0^;I(;)Z. O+>V4\I=10\Z. 7X')1)3#!Y<330CHK$CWXVT1#N
M()>I\*M\P3_5.1@>K)2 _-;R =EV\6SBV 6;Z#0687&0 '9U^'/CI_-_$&%@
M'L9_D?&"UXH1K%(.W7J]^5'MPR7C]\Y]H%WF?K$'.BN,.FX[_(]5Z59Y$;DL
M33)C3YNT[?F/<ZS 2YR#S77M!/BYNO#%%S7 #9\!UHQU:8?+,DU;S0;-F!F8
M;KA&8/32(55!;@>'%)-3EQS\A8)77]P4C/MC1K5L]1X;VS6$32L';&* QT=O
M"-@)G%-]E=1ROX";U\"$DL__23.]L$^A14/1T4P\W7K+Q'I^VO3]H^<&7Z?;
M:PXG43"%VHJB\4\1*_"[(!WP)%G+H13;AYUIUPR1Q\8H@9,H@O ,N\^-7Y.(
M\DQP/>TOYF_#[I5Z2$(0?JM7V%-1\Q1",%1+\NV?:'1M&WV[K$GSL2G8&Y/E
M4-CXE48$,('UM+6R=R5#YXJ.0O)V[% ,HX#!!ZOD?CD!RX=/D_>.182S1T;V
M"8>@@H3+YQH=_54JKYV'NW)5) TOOVVL#'+8J)U&)#+QFJ(1EP)Q'OX)8! <
M0_"DD#AF-+JU0NM8 IXBGA8U)(!EH1P]>L.RX*-I4(G]&-!+:?'@"JR?.%<S
M#"]BLWK98H3'=IUF%6,%52]=7@*?FMH 1[DLTT)&>OJ&&7/\QJJ$]6L28 (W
MO_Z)HNXH;Z,"$1Z-%TD!#NDG/C_K&/UYS5*$%G&87YQ,3L2/=301@6#P/C!F
M? %JO98/^B8IGD= P6"(%UP#_.7N/*RT1B,'I0<VH-5( > N3+;0.7X6)064
MT#3,YXATP8FC$-3"HZTT&FV"QED\,^DR(-FV]MRW&E5^6)C[;]_IG>]NL3%Z
MX^_[M*];&9D)HF@#!7??!KXS/8Z&@,&X1==II[MI:ZX?7^?_'C/,HZ;&<@6S
MUFM7'-6:#J8,3S8@@.VSQ"O'3D6U,HA6=:AH.J5T$]?T^B775'#,()2$=&[$
MI!BL]%_A"=C(%JBCPTF8H)X^"-5Q*-3G 3\2&9= 40Z(:&RNJY4", G^;Z(@
M4:&[W[U?$]Q6K? R)$E,.22YQ@Q2N[#^4TB]^LOQW,$$R''?6<8IO^A0?0_K
MIECEF35S("E@['OIUK-'4\Q;/H3K^N&UXJB4KOK!+Y*>I/T;D94QX0O/^3E[
MLFJCHJ<;83U593G&X5U@9:S/,4[-0NOB[ENVLF@C^0MBDG-;0GG7QI&IQT]5
MIYLTKJG3*N/<^?<7H"V&%.2.BRL+XRHVY4W%3[0&^28BIW:++7 C]=.4GRRD
MZOIKJ*OSX'K !<0/SU>S^-(0D>Q]UX+^]N1M<2@6Y\,>QX%9F'$F"6V1Z-/K
MO=QSZ@P!UEI:XL!&'J#,C)9U>7OL^R#J38;5!+*WBQ0I3QA#M=\]IEB]W</E
M63JP],M#WSW7OXDWVKNL&4T#X;+< ^6---[9]>O*R]V>BJ <FJ-5>)5'Q53W
MZU4E] 4JBRI-5<];A.-)J)/+#ZDGE^KQ[ZG%;AG["6J(^T?,VA):3'RR=S]3
M\]1*/GD\];VK<+AJ!@X\M:_$*<(*4\VMO$\<+B,5YT <[][;#2LP2(,F$5N6
M6=XTWXA7E52L3]MPXK0N1W'""[/G1E\TT>M'GE;T^0WA*F8[!M$^@S%40?>K
MJ4U?"!K7I8"3(/9LRC 5?%MM[U6.]Q.'DI?'SH4F2 $6<^]\ZNUM.%ET+"'#
M09,]Y,%RVG=5=,LN7ZWP5-1%I1_X\0N$$0L_:N(7XR>E:OB<E*U9<F'">_PD
MKQUQ8\KCSI]2MGYNB?(^KOUJA 82VD#I]U$M)06K3O4CDL.V20&7Q3#-AH8K
M%<ZGHT,S>.UV#:>R:OF>,WV(^IXM65) S)5*WJD!(7BL=-#WF+KKNO4=0?#+
M[)B,OM019><[SU/RLRQ+=QV[RSV>)P['A-3\R-/D[K"IV:!GRK'88<>WXS5]
M=M1..M=J< 2YL#"9+PBG0RYE\=5>-/#*<\?[8^CDN9C<^*K,8-=]@<';JXXA
M'(.,HE+W+_LV?NQ+]^&8$O.-J<[*7E__WFLXH9V'BPD$ZU%+:0)75<,+A7G6
MIIH7S)3)FN1[*L\O0@0UGQLALXCU7,UA"=>0E+V;Y]'9+VXH]:<)!!NWG/!Z
MTI:'FAF(<*NH],DG8QW?^_YC5_@#IGY^]S,+:XE&GV22P7#3N:H-Z_//*>%(
M9.(R3Q#+>V["EIS=#L",6/F8C0'GV89(FJMI&N:*\R:$3!*<ERGRWH';;T[J
MM]4 J[D3WC/M%1+&TXD773D-FAXALX%5!Z->17^3F$^6J^BD; ]^V%("S=&9
M!E4+OM].V;3_OJHCJI':G(9OGU2NZD'I'%ZM*I\B_F#F,Q7^8>(I>6L$_*N.
MB^U,T\2>B$-X'Q_OR]FO' M\%:8;>V;+2"<KZ&,;LB"Q<,%IY$S%Q/#!\HHJ
MSP%QB,E!Y-I_CNA</C-S6A>J65 2MY$T]]+;],>#\^Z79S_!=AQ:X+9(3K*G
M&.PVU9Q$O9&M&H?F/A_3Y/*'Q_V '/(+2T$D'8_=3ZEGO4E_"1SB/K#W]*F9
MYTQ9=#L1*8'=]^=CB\I99:<G,?O"W_&A6LF?MWTIR'*.21Q$+UC8PG<&K/^R
MSC+"8<N,O.XN*[5N6@V-_7)[0GNM60_H2PA1TJ+Y6A# L%=3N6Y$R(^Q(&YS
M3@PC?KV_N<1H04P_:QL;6CQ4"R./^ZWJ?I#"+T)A9XK5]W<Q62%$Y]X51U&O
M:T'C<E?E;KN8NE"L5T)1)!T_^Y./AL94_]J5\<XVWS=Y[O.>N@> G.4 YZ,!
MKP688+%MR16[/BWVL+4]?<OIT+"$]^8G)&=-)@:W!V+]_RYD#7DZ"P+#X>Q=
M.VN<?\:^QF=TEE2RKM)G;MHD>YQ7]=->\TET*^J#0C([03RU(NWOH1.ZAS^%
M1NM>I2477?L"7@W=D[QPMLD%3*6 C02&+.*SN9?-K_<2#>S:Z3U[1PXNH+NM
MS/*XF5N%0UD8_1Q,2.,3N2A]O6$G=I/P5)R-J*JKM[$RI'?FV/RU[OWO7K_6
M=*AT!+_G$:WB8B\]3Z'Z/AY]N$.Q#YI^;6PCVJH&JVRP09:L&W>I/S2W)>MV
M(T"9X^$1(["IIW+"CO-*22JJM$:8>'>NAH1VOQ97S7)W2NB;QG 7'G6[GG(W
MQX#W(V*S\K?[)YC4TD-UIWY\I44<TSYJ6'E@PGJH/9*J KQ]3*==[R\=(R._
MOT^U1%D]B%O#<;O^#KSQA8HJ2MPK!?@%D$JI=*?TDZ%<Z)X]$,'P,WP4D!6
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M%(]3W018 BP0!#P#(L[0)N@,)%VRGV[/R>]H(FRAT<;GQP)2,>U/C. DC&F
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M!X_4#]M) 3?CKA'%VR)PY'DSN*.<./?53^-493.NY02N ](<K$G^27)XI^'
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M"S2WWJH41M$%[\,I+'JP?PM9Q3%47%S/%?B*YHKP,KE7=[OY_(WTA/^Q0M7
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MI?.K,C[0:"(^C[HR:XFZ/)[1/K2Y7SU9U*^R6_+;^&I)*LEU'QQ0AP'R\F5
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MHB-EM,&9QEP;:&^I,XZV"3"Y!&&+\W277_/T4BQ=0/+=.0[R"^L/ A@I%T&
MWJBX;YE","5!"AB4*#7BL)#9IPH.BK=7W=*BTF@35+8(I[3S_;\KDNL.XDZ3
MNK+P+.UQ]6@9#\IQ"%I*'=,3:39KMBIM&:--\,9H:%S[$P,X":D3((%!4S$8
MQN_GQ#7:1B/LFC2K5<'.]4)7MDSS)\PC$,"#D.,RC""N +*.)#S#/UPU (XA
M;*'T<DRI]#\'ZJ_^Y(W_ 3: ;0JM&>N25(-PO(1J:FH>J-[M)+"LAGU#+8EE
MUB:,A<X8X[ON+NE?BP\%G4L,N"TW#G;#T(>OJW\0YREG @81,((GF82\@)95
M)<4ST'7'4Y7!8)QE7/B-7\]2]57"3H!<Y\PD>2\R+O55UF4@<[67(888F%*@
M ^")"_E9QS*C:^J+)K4@T?FNMZ'E6FR !62&WQSWVULM?<G2Q!U#?OL]G=VI
M9Y"/$A1D@:ER /P[EJ[K0)'7#ZN/-CK#?>!*UQ@B?I'HWTWO[G_9]'_9]/\U
M;'KG8G=/_]W=13A(3_[B5K4^DVLN(#>N+&_HE#^:V5>YPL&W^3 +0R0J0'\Z
M]F=L&.C1W]OLU ">KS2OKXF7 KR5J81K+%<[W_5;E3JN#;X!N5A0*1JFM &,
M2M54>@ME6 <E(]2:",T$IX@?^SH=>AJ&<GM[Z![>3R1)SL <C&=58/_E=%Y,
MC--50>P:%/# H5M[PX6->([L\[G0$WL<47N.("#:E@G&HE>JE5M<="(:!L<,
M) @Q'.7699 ?EM6&(#K'"&=[L1Y<@X$3V94-!_WF)KXCK,A56=G8%3X_=C,#
M6,7#KX=\?H(.'\99/LM74!PK-?5:'DNKZGF,;4M7/;V?8XBB+<"82(BD^DO@
MQ=7,'>>N#PQ2,YJFC"D,>[^W+W,F!J#?S8B6(7.Z='X,^Q5;>-GG<5UP<?;0
M7&^[6^/]T^Z)$.?3M<R"XE(1J.$ODWP=R;3!8#^48"9JJ%$571V'D'<:_\SU
M6%T-[.?YU,NAU_/I$J!7[W<3LKU6W>N0H!7T[A@F_]<&M!6@C8Q#9Q]( 0&#
M(NS,3Z0D+N$JG?U:?%6A5-2 K<VJ2JVM"Z2$:E,Y4L#-NO#XQB_>[-K0T*B#
MD5( \Q/&=]:DI7G[FT"=JZM<JC.C+BYC(+T;AZ8&W\S*GR%=3&M.E@@'Q;&^
M-^-.[3;=]F0 O,LFT/I$"R4R=D0P*X%VDK9]6.[7,J1N.JJLKGM K)]#GLID
M1KYIF/A.?H]S]*S,M=K_3M2;/'[ML1[4N2MGIK!T[_!\ML- O'MO<)2FKXU_
MX+IC6YO60^]9$:T$F%)+MS49JQQ@IG*2,]#R\-Z?HKJHIQ]U+FRSZP2N>%SM
M3WN8;[6,SN_BSR:^W:P''G\)K+=,0! 9YW 6T>1ALD0-PC8[-?#-'#WS[@I\
MXG5P:%1#X]Z.F,P;C[.UNH)5'Z#VFFM6TT2\HGQ';?-ZBTP3 ^C=!8("7ZQ8
M=/?4F39_Q#XY&1VT&TLDA-.E@)["#?B=.VM("JO;S.#\D-AO4D#ZE#".?)7B
MTWLX)J3W1;$:@52_WV/W?HGCL$]@@VW0^F<&7W3&WXO&G8VL:>"=4H!941$]
MWW>7OXQ9>4.SYN<DJ(3 OS</;I@AW[NX3CDSL85H2GM6V#;X$I"986F3SPLR
M'4-Q16 !HRJ?%R=K'[VN<PUDKV]B<6'4FZAOY'-D[ZFI1Z!)7[<-%^QEES3.
M7KRD>"=9_NZ:;W?Y7F SW^3K,&('@A!8X^D/2&<'/.J#,VTM$]&X)"G@K.KF
MD>6IY!LG7)"9RUKQIM2G6';=>][^F?I2WEIQSBLO*0!?7B+1.#><,S S2SJ:
M9.&HMJW XF2E@?$]4X(R7[P,"[,[>_;Y7SM(=VN: UXR4L'$*Q>R3>\Z$?BF
MERZTQ;1Q>AY^?//1=3?_FME%T'F(EA(4Z2-IT!!,E3.K1&#1^N"KPZNP@0,Q
M>0,5,RQ6<.@]<7;6[0W'_5>-C0'Y%P@DO ^>S>Q!:Q^[=/FKHU:K(?2N&&]5
MB\2JN\4OM/8YRH/9W<K#2B <C5NP[FY?"]L(WWK:^VS-B 'Q<*PDLLYSN#=A
M/[D%F$<?WM6Z4\([PRIF=;61>MW/WRO(-$T'&]J>-A/WDC#-&C!L\/IGEUT<
M>WFHL? ^9<B5RVFZ*U895AU5-(77@\$8SC,7S^26:374-C8VU9@8#^W"$(2,
MHEQ$<PKE5(C[-0E]Y]G).A#ZM >C>Y/J\XYO(W]/^*+8,#")]//YX5D]]H^!
M53[#:]+[J0HH4;-HK$NC:N?M2^[:8F\#%*;$BNY8(!<RD5:]XDS\:[22&5[C
M!7T\%.DX4]XC!9 V5SEFLQY+?G2]][B*H_[$O7\XD:*^,DM^C?T78PX&PND\
M,'PRS?5B7_U%0Y2=%:2W5,.8N"EE7>[$O?X[SB.B8/7(5C'8(_R):4ORYJC)
M+@-^-RVO?I[))'5E""MYY;T"2?F*^A,--L]93B\'_L&?\^GT9HISE=D9'<1L
MRV'<)9HJWKFQ/A9^8$/]F^D[^M1GR31%8[),6G/53_#E8G(GP!F]'5) =IZ5
M,8HJLIKD4"-<QK<\+,FG!6%^2!"C3J'D<^6\1JXX:L6;R ;/0^<JP$-U^&/%
M<\/MPR3W"S\.'.Y4/VPS:%0OF9[[0".)YHILO$^!_#ROZPN;'[JKGX=B,A&H
M^\?N7=S#TKZMGS5@=H$T02OELQPT=-5B]@>WK,X?#PHS)IBQ;$/+9%G"E *4
M.=-JKU]WQN'JRUD:FY]8Q,X+8RZ^-;1]Y-M&%8<1PI1]./@1/;G.Y/WM;P/N
M\=N%FA02VL+-ANR_[/$3:_!WZLZ'<!QRKE#+ZX6>W4--7[J*.ELIEBN[<H_/
M@_>\2%+HUOF8^'H&;SY+$!-=7D?.:#^?57!7*Q6L#[%1%;-Z98BZABV_W%&\
M3;% :_T64P24.P6OGSUNI /0VF$S.8I?1;I%8TLB]V^SV6 SW?I=5LK,)A=+
M&;T7G=G#>$T:(CFY/ZR\'UR]V^'[ABQ:9:EW8YPX5U\9*LYI JKM?^B[7@IX
MUGE+M1DNH6 8#('[S-SYG&3%3TG3L_%)EO&)&.]8N&;%_V'O3:.2W-^W;\K:
M5I;NAIV: ^VLS,S,!L54:#9SH#*UTJ2R-,UYQ@$J*QM,4C,GE,HI*V4[HJ&2
M6>),24J*2H5*A(J"@(S>4+_?6L_6UEWK>?XOGG6O^TTO6BN-DW,XSN_WNH[/
M]%ZQL=\,X 8EW\_S[):1A>DQKX1\B6H4D'-9$!8^C@K9;MS[I7'34/;=#X@S
MXDS)RC<HH<Y^62W17;2U#]GX#3$#^)PFN>TE;SSZU+*O;*/8 W,N#<CG_[W[
M/9ES(&4Z9_,SY)9/!?V?OOSE24SD/:=3"]53/.>8Y5F"*OV*1M3][<C3 '(-
M-^:C0.B*"RKW[Z=/ES:92,<-BD=B'^\8]N\+NH>' #^3'&I%X05V>ER]WE6W
M\#4NZY.MZM0(D".'E@O;;@VI))[ I$O5Y"$AG 8D_00@T5Q+VFT'AS=ZA0\0
M)K0E-40[A/;Q7SN9 >8X1Q_&RSJG>W&!G4&$"=F6,"81&S7G$4#U@.3>0T8Y
M&L 'L8<@6!] VBR3.5OCC"$BQMC?12L(+UN(RL*ZR2P_(&>_WS#GK9@K&[+:
M::IL8W-A^!A1HJ(=*A.LZIUM-6_S&XYF@)1?^SP[SGXW>+;EQZ/%Y[AF';BV
M3H0?-4AASZ<#P;]=_Q/:AOUO.)M=T;4DE2_UI3;M#F"Q.V-#.JV*;M^+"S?7
MUS'S0C,(9$CKE1/[5)L&I.-W*9,2@C8_S\G%+:>62ZTA^F>+)ET_&X]=?%+)
MB]Z5%^;*8A"2^_,O[\P*[GE'>7ADDE:'MS V\;3>NW+%]6W"<+DDOAHM<R?8
M_C'<[:3IL7TYQP^H;[DT58,D7]K=*X_OO5?C N 9O9.O3E\A))WB.-]UH'N4
MN%3+\FA4$3,!876YHQV>[0-<2JF,>4?.*+GH;91-[P:+^9V5=6AA2DY2SVY7
MJ-'.CQ)YA*]QI84RG4GZ%BD&R9<F[O8C\OV?HQD)HG"B^V7)&XDIV8Q_34VO
M7?:^=@ _WQ+.OI<7E ,IW"5#TR;<D6MG  U6M5XR% @V)M;&6J DMF&^RRE7
M.Z.]*I'IV'C+.)UICN=:'Q?\,9O!PD[?ATT@D.P)H<12:5B4:!3<FH>H,=KI
MX#ZT&\:S'D%?1)P.3XX?UPOOBG!Q_X9WC@U'6%N?]3I5<H4CFP%T7FP:7(5\
M3M(0!5$UGQY&-]LAW%]!,U@X]"B31L;Y)'>=2!JQR8UP\CU4.M%<K:P:C1;)
MG,[D_=D<_E;O OI/5?6BMEAE<DZW>-S(+.%I_E^[VK2.)TZX/7>F'F'%UNVJ
MF;[G?O%>T?C;(YVL2WT#J3TY./$4.J"9F#;LP1B0X2?XQ*E\Z0BTGQ/9BP,'
M2%2H&E+OWW,Y*VAI:JEWLM&'5&%VAM+:"OKN'5%=5IQKKW_I4O&&]VT$^Y>#
MHI78K!J<,!H2[T7K!)_YR-!L&N5WK!/23&< AN$.'9@(R!19IY1%6[7^V+VN
M9R]+E8,\./\P G7*@AKHFATN]^AM3?=;KU;'OI$TEJRTXBASGI%3J\86CH[M
MFK38R9.])*2&-*:V"NZ<(,?47\YG<ZJR>\_"J:HQV!W9U3, )UPVM90SSD01
M!Q_ J8<L"6;:7E)H5:R\%'_+YBP+YHW3$)\@H_IP6UD4ZR&S37GYL3JVM(?2
M6C:W4E+1T\(U$1,,.^CMM.ST&8 '39-8MZMVT))@S(X9#)"UY-"*?\/H[#@U
MV5&P*_L!0GVBEV#U,DR<ME-OE!INWU) 1PQDX8JS!YDKS+)JPN'1D+M(>1C]
M:AB:G?WA;X&U-(FN@Y5DK&8&4(]#YE0N:-J99/N& WKELB_\JL2B5/J>TE-P
MN.<0]Y\VXS,,J3LBVV**QS[T_FZ4;6_+IMCXB3ID,2:]_TG->4&JN>L [:20
M^JS,?_"LY4 'OJVWR9+ R^EE\SI <+2PWGV'N#BC,QJ>(R1]=CJ0E%=<IOE7
M9_!0=CP%>/J?TB<WD_8;A*3U1P:#A+'S^**NAXEG/.D+FV4Z7\9?AK(NI^C_
M97!0XF#B/%0GTZWMB?8=&X[VR>V408R1%N%>;40_F:Q^"KC#FY3*H*.1SX@Q
MX:QII\A!RYW>2Y,>>]2<S&Z/2JX9A4*[\B/I=XRNGLDE+A_*4*93](1.N]C5
MV"B'/-?C8L/4R^K1H<B>_)"#'<2QS4E(-8$SCD G"$[2&;X:G-I.,R^I^R U
MA#/.DU@5N78*P^&N998=,X"(".D.DJ]'8<R'Y;_G=O9D<U>9H$YH;AYSS%EL
M-0-HJZK2VU1SRN?#4-]P904%V]]-2S+Y@8"VP#$0R+O^<*(@B*I3Y""19%FB
MM1E@?V0OGR4ZX7/;W"4TMO6/'N4ECP(?UU]9RC O.-R<7&2";]Z^VDG_/.H0
M49-YQ]8U>/#8B2%TGR#E?<2WEN,)R<E].X>R<Y^(^\2IY&_O0;\ "=L??G_7
M3FG+]7/IF/N)U8#)'"BA;D_9.ORS U]/WAM_,Q8S^8"D0?QL&UDG7'6.C;U7
M0<^5O902=YIO,!0_VV;/$9:@:3?;\!MU/4_:#*7I"\Z9M) FQ1Y6T5\RL4$K
M;X;%(Q8=!5"O(6_I[B#S)&KE38_S[YTYR7$J.R5-JX>SJ.1=JP*TM$E+KVX[
MU(A.(:Y%3XYUA-##&KYDVC0TQIX8R-7QK93LCA5V^M7]'17\ &@96E><ZRHZ
M$\ZY\,7F0O#[6]>K >, ZT3J'GIXB"CBZ0R@*P+99D5[2Q@/8WB.FX41F4T&
MPX\[A^X<NN7A>[G]*OXALVD;9,D=FX='5Q^^<*%Y\_/[WZ)7\S5'ZE2U"2+"
M\9;3Y.XZ9VP+TC7GQE_BE^A2,7CJ0O+P:9_LX0A6JYCU^-P,@#YH7[?-DN2>
M.R[7?4EN)16?O/EM5X>0/J?\M^[8&O->$-*YFZ$=2HKZ=N'W3,\"ST/Z2Y><
MAGBX',9=+&!N8E,.]9ZRK0)?<QQR$]4Y5?:\M\D3V!29%7=]1>8+)']"VV8
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M)E-Z #T1 B'>@<T6$XGRT/I9.]'E 8*/(DE3N4-B:Q&N5]HND5H%3<N;WAI
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M)#5?1<4Z)7FH:@-D4#M41PWZ&IU\+)4].KPFW*<SHC8@UAUS'V3]\*C@Q8>
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M<P6OG/=H\2K,=S[,H0L\!>K-:M.L\DF8FTX'5-(ZGH/5E/2'/@61="47$ \
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MZJ5&4I:7'8/3\GB6LGD26&-WNNP"9SL"H:8=Q.Y49LDC<@?<^NJLC*UO1,9
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MCK;#06!OT?JMQ7L(7VS\8>C8RR/J_B85'VJ.DU/%+_L&84H#4P>RNM%/4U8
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MVGP.I$F:% OH$M3QIM3<<VL..8&TD'7WMUM;S0#4&HM5EP=D%$8_MVB5[N1
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M:K8E;AF7S@Z,9"1&A8J"CF_*ZO3=N]@O=W-0A6H44(;S.?RFWN.+QMUS9:H
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M%%L;Z#)"%?;31SM!'O(+1#0-)69NP+&UB'S3WZ+!49DH-/@,$-(C+X4V<AE
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MBR4F_X)-*)<VW,H)!S([=_Z6G)G;#MW3W\V4(9J:)!0L#'XF-B7N=;O!KAE
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MG'*G1/P#[G.=;2BL%?F.D)'3X%@I*^J"CU%T1\K0J@J?=.,,HO34CF4O:VT
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M#A<Z>)YZ.ZGBG$; 2&]/6\5\6.+[GMVC'B1"TB<C&0MHYVF3S&MDNB_8>++
MB4($\XB_:\C*.:"Z5^IT-]E:NYW]?7B!?;=S\8Z? ]%/5J9]?*42=>#N0TV(
MEO*BRY#84A@RWO^4C$P#_26KYHJAFN&^G>2DYO[);["9!=K)\:<_I^[!]GJO
MKWZ)YUXY+K-4_4&1W5_O"(XJ0,;A8B* L@>GNAVM=R3A.BGD8(HHE$"?G0)Z
M*%FWUU,.;!SB$&;-DI/>E 5J>< 1)4R$:3\,)7DDWKD8_%\URIZ28290RU]5
M4W@Q"!PJUQ2(CILP'R%$\*TR4(@,9HPC&M&SI")#OO_=AQK:"?K+AKVD &>@
M3J6("HWY \(YT&,69[PON[:@#6$1M-&B''<?4'HUTX2A#GNMW&'*GB,,+/ H
M=9!./]DH.RH'"1^= [7%Y]>).O&\ 3CT[;UZ1QJNDTP.'EA@>3J/0BO@I;=@
M+'QSYP(W_$%N._";L)&F?<!OPA,!72@;A2M_$5^_+'5QV*:N13DMIMO8X5+(
M+K#.?UFB=L-+J5<D]#G0.L"(.&6/E%I2^&;$?B9I >$\MM>'+<]ZV'N%'8KC
M$*9G> ]2"P^-GGH_:7HLK1$M!<BJF7]8$OBSBM/^12+>D15R#VWT\@ Q_,5M
M;8*\G(KJPL5%L$:[6[10/QS) AYB'K7S338;3[2?Y^0:O77U;U0(E$M_!)2Z
MONLR(@TH=!FY%$#WZ/;3[PN_T"&L\+_XIO$#D:%L)N-C_$0H4#1#@5"BZ.Y(
M5A4U#28-Q@_D"<*Y#V5%Q_UE-V12]JEBY@B*2_X.[Y\#?8432P[]HB7L@&Z6
M"'3R()J;\)9PI^ 84%IMP7.$1:2+13WK&"\<*)L&LZ$VT2I'ZF%&G*#.&#!.
MRG#^<W<25,=HSWZ?D*6+5%.]!^</EY+<N\[[I1#?VX(\% ?&YV^LI]06- 87
M8.M9=;.^J+;OHP4RLH-GR+]U]^'YB<9-=CW DO CT.=_BK'[RUQ:^WN!!EZ&
MM:@!URV@GKLU,SM9%F1?+ED2;_&Q[&X<H:EK::,W<LUELP7>[E9#D?!\2GS4
M63J#A.&_DV;L9V(!3B<-'_44<!KS\,\B,3%[#J2#I4EZ 3U3#T'3G&UEI6]_
MVPR<VQ5 YIE2%^B>]Y>:9%8$<K!1%-X"__/H@..Z8* :D&LB@"H%IUJ>*/5A
M]QCM;^NU-5$$NMP3^*%MALQ;E\K6(G*5?XN&_.#)IOTB3>5;.8H"YEUKW!QH
M%L-A'#\HX^^?VN<2(?6W8$[$9FH;$%8LYMXU"(WV +Y0WR"5!;SZ>8;X$QD+
M^MC9!/FE< W9]A3-7W4:$"G3&;*J#-!SLJ<D<N_99.L@4:K79-3X LGYTVY9
M-_4KO;'8:"3Z(L($YAC.L[@D4>4RB)B833^;]@S9A.UN^47O7/=S$.Z13<2Q
MT[*BY(5,(B9L_<FI;I0-L(_WV^@(Z@&\!IT6/ ($)F^F*+5MU'I'LO&F;8.)
M#9WR\Z,K@-XYQ(ON);1AT<=X900Q]QU0["QJF91*,96@"H//;XG\[.K_4HFK
M;.K:Q0.:)J!"QB#="5MD O'0+\PZ>E1Z5[STUGEJ=;-D@8]E+FO6[R]#M=*"
M"UAXP0+Z^9?J]R[L"&G_0'Z(P3S].46AWO.\WZUS(;8@507O<.F'$2 C&>7V
M?'@2^&5UE6(6054"1_QI[2.T$WS#3@I% >/ [^B1,@-5XIJ;NK2CO-+0P+^,
MB^;%A0\O>I;8AC7[9CTC18I_^$4B G+N9UG2I9+;!AA_E8#$JTZ:IJ9@#R2P
MVAJM;(* .0N>A$]!Z)^S^!YG:!W43*2XD_(#)UZT%+H9!I0S\+_*V:_W0?YK
MMA['RNZR/?U%PFXSY*?<?:ASO4$9%&*P@%U?M%;6IE[YA0$]+.-39;)QT0J^
M2OP S(C-[(Q1K$L/E_#VZ&7>H "R27>@P&Z  .;U_'I_C9D;4+8(D6^ZO1H<
M=06!@1P")4=[N/IV4#-2XSO%/WB\M_G6IZ5;;O(+6VX?G\GX^:L^;$6@CR;^
MJX_>7_I[2N;R41;!@KU.(D>VSA/MO+:S)=A(C8/D@J-4N70$_;@]7;G9)RVA
M847"!M547Q'B;8[*^: _]K]G+P-=(4Z%$M%GAIOZIEF:OT<]HURH86$>?1EK
M#!)3R[5;QP.-74^+6<-[1]? H";!*@. ^L*&\^/--'\W=-BD=1S\OMD(R\-[
MP *F2%-%6:VUP3G&EN>R$AX5TN2ECV^C*G],S]_0.$@ =P.<:4S6;L9X-(S)
M#:M\1OP;?#*:@Z]([SX9><.5$MLQ ^WN?Y'V!^M-UM47&^5T6DP[S5B=EP7.
MNV]E;JFB((:6<R5Z<; _/;>V>+=G#&NS0_8-U<3'QL2LN-D<E5W<F_S&,E>B
M&^L+A+B'CZO0+Q;;->!*#E2*](@M[WK0X?/"[6]!O5]@^>M/,UT0BTLY_<VE
M]AQ#E62"8YTPQM>457AQ!$[>DE&_?GQ_$F5F)88'^83GB^K&QW">#?F&.TPJ
M]S4[62& 9#U,NR<='+A(LF[<*VS">"-DL_ +FZP^!QJ60)R ^E![E@7_:N/*
M?''I=<T,GAA.XPSX.CYS-!2WSX&B=(*$8]EWR'8:4Q G@^2-K1R30=_.3F)C
M5%O/]^>*:[)?O8A2K%=<X;2-'TU3IB,^/SWM".M,T=9*!?U^ M2H7C\'<J./
MGS$%:\V!3E7Q%\-!K4-BQVA)%8:AL.[9RZROF:&A25../0ZGA'UU+#+)1=25
M=CQ)]Y'_6T<GGXANAD5O,?U]3V''T=M54*Y7DAZ/DQY)SY00/7;)K;CCK=!L
M25>Q]O4P-"J$"RB[7"+Z-]@JB )]ADZ<#52PH#U@D.HLEA@0!(U $<2/%(;W
M #^:6*F-X>6.\*I/W!D=09B3?>-=7*DV&<:OCZ!U+G6/4S[/X$C,TW^B:P0J
MZJ<4,S; W."EG684JAK$X_6R%*\M*6&;LLA(!$_ ZPSOM H+WV%CO>3F#HF6
M8K]&(8B!HF<P'56.1JX%1_DR-&OC+W];:L'K@ Q8GZH/^EO3_TEI["5\G3>^
M+K;^Z27[JN>!'>=)W0QR:T7E)_?Z,A>EH^"56DW70/70Y>GD,JHR!04//9QN
MM/;-J T)24@/+^PE.!9P^I X:&A:PF'1-Y@0R<%:HS.X:D\=?K-!Y5B;V%+C
M$::;9\ )@N..+TK:BS?M(*7^/4!5&GU%'AK_Z%^1]6=E;MJ+FDO0JRY._$==
MKS9GT2*WJ<7:VBGWA6.MX,TYF[VV.[- -BK6H]2OY$*C]#Q6@NG]0)\E/K36
MIHN\!MHVE WI"AF[(_O+HI13RL3^ \)OX<T3,>K5FJ9[8%/"CD.&QTX>NUD>
M$^?!KNMQX/.JGQ]:Z2[NJ9LFY48%I51D9Q?QMOK=^>NTBL3#S7@?KY=4;QZ.
M:%1ZVN0=MH7840430B9XS48D\CV##X!_'?06ELV!\,1]I$+)[/KK5\YBMM[%
M)^WC@6B)'WQ%BG4;G\,NVMN;%J_/3'3L":R^^ DJNLKLT\'^'CC)O!CE$,3<
M47. ?*HVFYBGTA[=N4A,ASKB'2DU)R;"\C*O:8ST\@1K<&57Y0]//]AWDB8^
M#_\,^!1+>BF$:(4CR6D8+&OP;N@G3&+!^G)E5O+3>TC/7MNC8TW9I4=R4;#*
MS^1O&T<_49X4?7Q=>_(>\S'1U9U\2F=ID8>SW)TF<0=:NY \11ZGJD_S%]=O
M^,NF<&.;L !^2S4^6O(0N>SO !@3G@K9WFRW\AL<'7[8O71Y6@+T:RJ;.8%&
M-'*+"D[UM6*W]3_:691#OGBI)^A!)-4H:*SM7E])Q7CP@?;"W*R8M0]2KF(,
MTYGM9F*[<5)A=='ESR>WG$Y,=[7<,AEY247#= [$'1F^#LUCWE!F.PD&4(7P
M3J.]H 1[SCK(5DTJ]*_^:=5UDO6P*=O60_;O3#I^OUQ?^SS_)#Z[(H=7_VX$
M%A_\<)3317;?1*9TZ=XYIW["TSHAK1DJ!EYD?9'@Q)$5U;HOR'8#"@<#KG0.
MA*=.$P9WV87H[_")HP5U&B-FJL2*=(?T?1"+LX$1PIL&S4-CCQ*1L!TWF$HC
MAQQ-/+BYYKT,%K2FYV+ \M>L':2+$9_\X]TQG'+W]=CUX%QD,IQM;,2G]_ _
MJA]T0N;LB@G0A$,&6!DL[OCQ7.<=*S$%*"ZJ <DE \WP4,@27]]):BV"IUAJ
MH<!5BY]R_*3VD%]]HN*>0V$?U".8(%G5Q _V#?(NK70*=+X@Y-J;^%PNTKC]
M_J';E52[$7JD170>W8SH%LHX]@+FO/HTDETU8L; /9DFXMW..C><U!FI>0YO
M^XNB2@,<D$:ZE77%!--#,5=9R-"D!D5K3T1K*-,^'A?37N4:'IK).CX:^3JK
M;C1;&$']X'C,[=D8Z]1X8.!%;9C+*(4]8?RWTAWEKT'HX#5"&A;*(2W_(X_]
MO(T;"$BV*4GGY<Z8P6E"7'?"BVJ;/-P!H'!!C(A@1XK1H?9GB7!!?22AZ^-4
MJ^448_K;3L?GY?[OGCQ&>KZ&C?'JF.J":#>]AU=Q+A[,FEZ+TSI,>"03#A,H
MW-FB[7-J$ARGOLA,DQ=-0UO"*J9;W/0$+Y=YSH'@IO2@:,@$=\_9->B[&V<7
M1^S+;!0@.>+0=QHUDRLUEL*,7WU_IF^<I#;U89KQ^=8GO-6].Z'V.PG9 V0A
M=8=@^5C6G_Y0N^[/^'Y!)3+@17$U$_^*GBLEX#J01[TFPNEF%)0Y&1T7T6F%
M\\1'*6;G\?BXN.30<HOZP<[03B,2E@&]1GTU.355;B\>#I1<MUXQF& Y'K3:
M0E+K,OG-,/C('=L;$]]'4,J0S<W6!8KL:9%VT\4Y4(#S:)=0F:*3BW8JD-A-
MRR?=&R;!IV<\X&V?>AD2I=_94<9QS*J P,[)&RROT?$>"&+/K9\U]:\.@60=
M,(:HV/W?RP1_7(4+):=ZT\R(--9)FLR.*-?^S4#O$B0R PE&[UD4Z7-LZY7S
MWZ]&_S4_9A]B;2H@'92A<*$/O_<^KJ=^KM!MX3MP8CJLHEMF L-.T**X9K"/
MISXD*C-[G(@>#B=\SI =I[_SGXQ@V F2I1#(LCQD/JF1_2[R_I(M<0]A[;T-
MXDE'"&%:K.6F^^Y=^9;W(C[$1"/=C([FC/Y\J_47$QA LJ,D&Z)270T5)[U%
M5!)'=%EV0(J!.VWC;IIP5@H-DL)Q%Y'_Y^A;=!#4 G(A %!\KNDQW&DQY,R%
M[('PL!8(/I$#=VK[_C5AB2Q$QSTM_WQX#I\-\W!2Y1"<1CJ6_8.OL_P6_7ZB
M"1*RCR"80,)JQ>&(-T>O84 Q(E$X4Q+-Z+N2N&;QT"TOL;T\N-1I%'[HQ-E'
M_L. EGPIB1/"N<_CM,4SY97W#E '^OJ(;:\J9\;<8!N8@2YX\M]HD4G=ZYKE
MVAJ!XM:3#:VM_&HK"_6WR*V901MVI!E(GI>*I*&-=ZSHW0_7.FW?,O_]_ /F
M%U)3]Y*^5^6E9EG?G7O&L5R,R291G%71D%Y -]Y$^Q-0JH_$Q*C\C7^%TM/N
MFXRKX8^CHTI1*;.?I,,$]X._.P6K*);50[ 3X6"5 /^:!TO"R69<!E-Z_[!B
ML07S\XN6B$W]-LCU8F$<0?VUI #ZW<,3_YT%5\F\3&6#7R[UD%[$I[@@"*8T
MD;;H79SQ&T+<*M*N.9#?P/5\%=VX&5KJ)<PX!L2O1]\:.99:7S6=T\8+8;&B
MQ811I,_%XZ/X[]G5>A>I&-T<U\BZDI+T_SNDVUT.)_R*[MZ+O.[^ZI4B/Y#@
MS! /Q Q&/#E\WAZ[O*71-]@_VE+=J32<*W!A749+R*XY1X@Y)F%X#=[?-' Y
M[-Y%3O7L=1=)C\5'$A3N.E%'@4T",NCQ0^3RV\EW.Y=M!!4\@U1S@QG4XET)
MI#(#0Z179]LY B\FPF,.Y$'1,MS@LTKKY.8YT*.$+\$S1"L[P-/;_A&Y4EM)
M7G_H96&ZV1@%TJE5\O %X*<D+!;<4((?W#3N,Q5G(1'61I!*7I,&/I$I:_5?
M67\YL]5FU--5*>8*B>6=3KWAG7;B!;[*+PQOJ-2;7YB8;M2#=6K:[;U<-;I#
M&\2_EM3D'JV*P'V,MXB\<"[G.':5_LJV-=0J^A-!"*3S@ -3VXSAP .>L9H5
M++:^0F+&H_C">M0-N"C?(>%-2I:K8>E0?D E'7A)\89P2.N[C2T:+9X0.E4'
MUQ,4.BZ)/2X/W3X'ZE;I"5E*7U6MR-M+A*//S2Z!#6+[E/6@%>>P7I!8C ?5
M4?QD0&!>6:)FQ:(PP"TQ?)&#!#;^750R(&'%!UVUJ3']=-]_HP;O;*4ST"JJ
MJ8)+Q7==AG<L15YI7AEWX^.4)/XW)<.\3!YSP\'%1S?I%29BIJ9GB$%9#M>_
MG(E,\$I=*J8[90GAB'W[([+47^\>@W$&>-9JYH%8T5IMQI2.!ZK^4VR=A!L/
MR7UB_<]0MY-WUGCOH^\Y_)?GFDU*T\-L&,^9RZ*$;:#Y9TU2@$J3%X@_3"<#
M#6/ Y6T!6?P1#V?Y?P=DEL/K*] C,UTP81L,R^7A(I3T']M:V]A&MS=5;J-C
M1U#C8W;LB@?G_-AA;CE-:&%C>N(#QNPQ]3].DBT.VH:O797,9Q*'>O#0OY,3
MNA%_%FUF%YE,QJ\/L\8/.;I[O.Q&L>I8L0/I]^9 [C4WX"D,-4@\!0:G\%[4
M,76W77BL*6X\<,<^.:>-_I0ABH\O)Y=LAE2MG(E<29K@!W[I-)X>IS+(=6O3
MNEK:+ Y60VJWO"IL%'=2224[(]B+.%\0_-G&H&E*3X^(]\A7Q]WBTXTZ%HP7
MW&Z.3Q&V!5]\2,*V"6MPR<?BLN9 =K[N3;<"*H<A YIJDCK$("+I5*)KQ1N]
M%2MAM,(;C#OP3E#(UI,FNY]7?04B8P[4"SF,(+)/JQQZ)YRYH<VN6G6W>BR:
M9F5Q2?2;CNK)"M9Q&!TO[  _ZPF= PTZN<-O519,LUU(+U^!MMD,5Y1<:WI3
MN971,!@_<(-!?H7<,W9FQ[;5.]K.61V=^E0S/0?ZP^[MP?S'?BG+D_<&V']S
M<JJ['0M3RT[V_[C\M*/1\-!+FI 2@PG&!+U>*US1 9N$5O%>=\&AW4IU@)U9
MV</#,CAX3%W=ZRJ%W1,G=RQ)/]]V3KPF]%.,]'_>"JI O_=KM2S3$4Y<.M<@
M@*>M^*OSS?MVZ2C#:])1ACBQ!;<(,>I_J+W[[."#5<D(GIV5HG//U*.)ODX/
M)J0_=F"RK$< ?W)1/%(4(>;QX.HSO->\Z>H_*ANV%C]O+CIW19/7F$CH$16^
M*WL\=:WB<FM_7"T2&W=5^A4\P\G>Z^_;FW*R:+\E!S2V,(A!!8*/H?85&],9
M5 Q+/PP_<646!>]^2:".7<99U!\I8&YL4_N39&.&]8_MI]:A']4]^OZ-/_V:
MVW,D8L+QG\-L,__9C,'>1A3;Z2,ORQU]N=3!P06K]RWRK:33;8 V F./5LSP
M7"#]U;&,KJ?#D.H Y&#(96L7N<Q60<SWBQD]424%+VXFG?RCX#:'L"*A/4^^
MQU+R=\_!\)4*7AI7,H0#\O*9/4\%WV-ZMI<ZC/3V37HIFQ?D"B#?\:S,0HO4
MJ7M#31<3FV+?HR=W71 7#)=4UHOG0.@/+S"YPK\0AL'4,]KA5I<<Q_M.U_'K
MR''$^:N%\F7Y,SN_,Z)!D+..3N)(GHA/-VN.<9G4WK7;/WF9BDKNMJ7T^P+@
MI5O"U.9 _WC*(+%^QQPH8]*?)'Z%P9&A^+;*&].E+J(_K""]3X6W<BD<7BS_
M)E.E;X,2FH+HF!9T5\E@6XLB4@.U#;PFT2.">"TWF9%E+M=$F&"CSS 7;-[/
M#+R?Z%PR4R'^/,0RJ_:6?L^#1X_,AA[<>R6,_]JW8=!;A%QM1J.F(KJOR8 V
M'\A^5PV(H!R;'+X^+,C)DD.$CG2 -O];>.)F[9%%,SF=\I,O@;_ , X=XE^P
M_M T+&')KR2AH.TT1#%(EB\DBU22F0OQB[E;H%_ WV0Q7?O^R8?G>Y?]8H5N
M=."LY>4UAX?#B=;]WI*L7PQCN='1ML-.3IX^',-A-2LR]H)DI?0:66S./YDK
MM5?N^I>J2F\S*$IS=#B48#DMB?L@ R6]\0_F"8**]/(>3;Q8JCC)#J.838LZ
MHP5'%_/OQV>79?P/7M4A_DW8QZ:S$HZ\-@GAU.X+O"3,/<6^?!5P70-Q%@@H
MT"]@3/\%=7M-NZX\K$6?:FW-DP>D/=H)O7[+,9R)#G@0%DR$T$M RV00@O8_
MH^_^_8P1D/9O7PP"6N#X3 Y\?CJ@#!S9P#T1<!C"/(@>5VH._&3&U8!D\<G%
M6^*ZK=]_:15_=H0W<L7^_WYZ($@VS [*!%#6[QQE\=.$-^+1U:X8==1M(N3,
M?IDY-2!9IIDL\^VOW[_T5GN;!6?*CPYSB)9<B=L'V2'RH"6R=&D9&-Y5E[9C
M,TF:FKS+IAY(@<17-7[G+U;H9VIGL2R *4,FSGXQS0?T*\R93!P=_=40%IFA
ME" 9^L'UE2]'>Y'2OC0BP><. 0Y-,3_G</I216(+ETY-!7=?UWXY.G)[#A0N
M/SK_!Z =&UN)O?F %W7-3"^(ASMU9[^=<',U5,40,SEAIK3"&+BUOV&]HW5W
M+T'P0O428UP@R2IU\?PZ@AR!'0;G9A!5IWKX'" S_^=XKQO_9EX@Z&=V'NF$
M+B?_?*BX'94K@$%OK&>VT7V91]*HXZ%$CWH4>OS(<5QGT&EYWG=8\#R,$?2?
M<O[?MYSKN]. Q17>E4X1DR+O9'8_WD6ENI4C6(,BO'3_1';W W3A/[7\/[7\
M/[7\/[7\OWLMOZ:7Y03$$*2NE3 K017OE"WDUS!9=GVNII ?<[1 VO^IXO^I
MXO_?KN+_Q?EU;W9G M4J"5C[RY8<@EJ,V+3XM[@/L(]?6L23J^&-T_^IW_^I
MW_\_JM]F+Y^L(._Q3:VVU"=J3#'(&%/T_JZ77_L3/R71.&Q%$.GTOQOFYZ*[
M5?21?[R.DD\N%DDF!06FL>$7*'P?O^DS0:S']6=X'V[NK2;TMGNE/M#)$;TR
M8Q#'=AU36I2-J(Q+#P<BS/D+_<_UU]:]:SQHRO\.@[8AVF,B5)T_J5G#S=Y_
MCQ.%(Z"'A9>^UIEOG(G!P9BLCN<U)%Z!>I_J.FS%+7\"!2:@C-5]ZH'J7!*2
ME9Y2:Y0BGZO5BJI6C6<T0\0G<A#K<E<4!BD>D*C'_'&JF<TOR H,>$GL:!CO
M*;50$&OI:*0;"KW9*59V4^$]HBD/=]?8F*B@F4AW\PNLQ^*:H*@N+&[2WBK:
MN[I$YW=6<.P!$=Y*UR'@ 3)Q+<0HKM?4 XZ>IFVM/RE^E2G1L:U<>Q!RMD;,
M6J)(P09)ZOMAD!/DP;+%GLO/OZ$7QD@@-SRT1Z!D[;"XG9\3PCIF5J(H,Q!<
M\)L87_P(U#F;.JYL!1\9WA/7-[Z)A68$3EM#K+'EST8V!GM!XCW&@R,M^]R!
M>N$\9?[N;,X2FXUWWNBQ[(5-L#@PJ=@MZF*8TIX^"^PQ3<T,!(?[S#AD=^44
MWSD7GE41GYMNIS8':IE^+O%\N]C,\.68HJA\>(J,Z!F'=E?'UZ,=6XO?8S0'
MV@[$Z_0-1([!__0R\]AQ0?731B/Q1TQ$92F9QV/R;@TWSX',H+MO+T_E>ETA
MPNNXUM-$,QX?=JP7&>T^55@0*H&O^./?3_+#64<RL758D3%J.&Q,8%X)5<0+
M2S30=G!1?N65X>;5W_-3B +(E%ZU@#YM%1;V*:-X^[;D&LP*"#V/-UY8+0 _
MWK=.._KQ^;6%F5%!M9=XXEA.;O33S3LQ(VL,JB)R^[GC2#@W??E#R23.'S,*
M-K'8SA*V]8JL2B=KZUBC:_X]6O?!/YG?E]YW:?826W2#'J6#A[-.7P1GH^Z,
M3"K\>YSN_\7>>P8UN;;OWE%0P(:@+D%*5%!40$04J0DV$&F"79H*BD@G$*0D
M$2LJ$#I2@R*@HD8Z2(F($FHB1*6$$#! Q! B*4!(V\ER_=^9QS#SK/WE?=^9
MO3_J"&/.^RS'<=U7SM_FK:1#;1$UX'HAP]'&L4D$*#FNNOJ]YJF[9>V/R@&0
M9#:-H[*@Z2H"1#@8BP"Q?6SE'T(-!!+=^(N-X$74$POV)2@IJ!_=4'M)!+"4
MJ[$/PW^&!3.V[XU(&[0&]X@ #QJQ!.#SR=C;W<?>6R/V)2=@7WE02NR]1(!7
M>S9=OAJTS[[5\%L@C9"83RX)W(/()E23,R@7=&G':92YODKB5](4FH$P.&A!
M)8]S;:Z&C$>T1H5CN?R=0GM?UEV6O&P<]K2)Q2P/XTRW06E" ZDF+![5$M[X
M+CKZY%_;$^*16TZ-38LE"&"&_(MO=N(=['7$7!B1T'8!O1#^M!+&&+8$^6(,
MHM_U_U=H[MJVBJ5Q,=66 "'(1F.>06,_.[IGJ7<2^I#6%%\(I'(VDIO>1?H6
M+!#/(0CI>$:,V>0\T6GBRVD1P%8U'5IF,02L)Q DR[G.,>,GAA1W[:T;Z1RT
M<MP#:@25L,Z(_Y7*@^HR"U=D/6%F <%!;@Z_N0S*<DWRLEQ7;4- CP\Q&_B9
MC<7U*U^ZH;\+E[\DKZFO"N*G<L/?-KG8WO/>D[N*.B_@S0AM7G@=[WF;H+4K
M=S5FN$U5*U^L(D:_W7M0W&*S,VF5#[AY"ES"W28,\V7^Q9('J"J>-E&'\C '
M&4Y".?%OAU]\,U55&L2-8/"RL>[^[$D$+\PBCH4),L4GDTTG"6AXK3#L4Q:I
M>M_1/F%D8J&&$3Z(]7-C.TP8E WU 07%^*#M$:C67)V$IA/#SB) ?N$+"HV,
MH3*LR:2^@/W$*O[MLR* DW]F(P/."# G14:3%N32DF_]S/?5,K<YUXAT?(P7
M1\A[O]N0S$2KJ[I"M/625D5"R1?XH=8>9>9Q9]=T,.MS-!MK#Y,CK'#W6>;<
M4#PBC[6AIW)HW#GUE;W$R9*,=ZLCOB$4&:\-(HX6(QGEU?G"ZN5+A^#T TDA
M5.2[&WPS\?]+3AY0>Z)W=0*> 6XDQ/:58&C?TA$]??YO[&2$A6\IOR:)?#GY
M%CH@,N S:^.523PD56@3M3& [3&1[X&<V9C'GA""&QC5>1M0#D_X3XTJ58X1
MKEFZ5N;F2[:PP\-$@.T'N!U3$A:XVP@,/M='._9OEO$Y!+[C@Z;S#WWKPVPC
M"!B-O&ZOXL;9/J?QSW,& V%+9BJ.+U6^>=Z).99';JKFUNF4C/9]PT0$K[1Y
MO,EY[#!S#7DS=89&6^@;W?B_M8]OW4<D5_UP33D23HZ@,27;]81'_D;A-C(0
M%7RA"#!L*'V727ZC8@XT9LT:I_8V:CZLMEVP0WK=]*$-+1/CJ5JQMUE,R\@Y
MBAP;C4/V I8Q^P5Y#]H$$XX;T9J8)"SPPJ&-'3I3W;G X3$*7RPTTS8P^V%/
M8ML$PVO4T"!,,A9\X=!_DE5O;I#2HM>"Z^POE'LS]\+ABNHA#)P<[?"_0'H
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MYH>:?K)JI72#W'QK0ECR6COV1GJ46,I=-EDX-5M^6/=X2H6U4IF25<2>5MN
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MG,H,J6&)'V=T]!?',H6UNJ8N&T-,ARQ#,G0FVV8_+;O,JIY&&/"&&),<'1%
M4P18 4@_,@RY+&\7H'HRH0 BV:)>[R+MB>P5%+/?-\3NV=-BCNS+I<R #QZ1
M3C- C+1S6B3/=L8EJPQ5U%YTO:8Z"!-G9=_M^=[%?*<TXKE<.EY'CL!=DKH\
M=79!*A4#0U#S\@O9VN<^8*MR4T ! ^]%@ AMX4W8#DE!_W<*EXVT][R5Q'TI
MTW923@]2"S/%@978^Y8L"JC\,]5.+CT\\=9@L_VJ/3@*AVK"=_KLLO6C=W#7
MJ%7 ,Y\0-DX%B-8A[UNB+<TP.*004_W1<.^<V*=+UDX OSU-\-+=/A%LQ852
MY0132@NWV45'XUH_9;7$CZRB6T2,*7X66NY8TO]O<%P_]9,C58>$5PUK\O)1
M3OR(7XSCTD4)L-V1.49:93=9(P?VR$/@=B3936R_%&>\$7#Q]OM6)\GRBB^A
MK^PJO,Q]&(%XS=IV,/7;_7-WXC;DOEA9FSNM6=NYCCT6??GF=BF*@<-!@\?]
M][8'_@RIA($%GIG'K_8W\(,0!J8DG C@R? 1)R0_6A*GBUVCRX.M(S2C1Z@<
M,/("(&6QQL<-BKNLI9\2+#]&E=&1++A;I/$=.18?>'YHCW[E*CHHJUF&ULR_
MMF3$;DQQZ%.%#)42,8ZB,>B'%2S2NYSO#@6+R]*Q4 1X$\4NEGW43JKCXZ=9
M%>@^X#QCOE<)F/;,:&-[1RY=ABC)3U#QS6V+L/,6"96+WB6O09PMT'AJ!%&?
M@K "I;V1KDO \0]!IA#9+=6Y.UI[37XB%D@__@1??U4]%O-UR=C.VQFF0Z!<
M*C!N89-4CIV0H2PR3W</0#\IJ7 K;IY-GHLT70CA+#9/BUO+TE,A)IMCZB&W
MA;/R@H/B+O-0"L:X"+32.5:J=&]I,=/N7>::GLPKB(;$BP#O;;Y\EK2LRB[#
M)>G-*MI,P^1DR>8Q92GT]:G 9/G/I767SP:;#EJ&I-@08N==VI+N(?W:#H*-
MI\;$ 8Q<4.(4R/U7#.\A\2 ^5)%FTFXZ9$I/17V!:_A"/U$IT=Q(W'3$@@@0
M#9Z?HPS>!$H?L3W=8H"O5LGI@RX'Y44A<K]<*U-5-S(YH>:K.@0SNB=':Y_K
M5M)SP$2;4:;I>'%2 :F]DEDC!9J5YN,Y2$N65&\/ZPAP5GP U:>$( )H\,T_
MR[[9QNS;\[%TX-X!(%H$>"4"7-!6IC\*<UZ"S%395@>.3I9L2DGXMF53NL_N
MD"1(90@Q!7QP/NQ9LM=*S6^AQ[@U/C*"H=2%)>P"!6\II<=^9D=%#7W"Z/P_
MD/KG>9>5-Y\)?;;[.Z0VBJ+G1$BF/USQB1HP)/2<JR,3?CH)+87KE^SZ-U3>
MQ\K _;&12R]>NA<!1)MBO\-OQ?4J]P9& N3&B;FHN;<V8!=X)>#?<1I/*FTU
MK/,)?E_]V:ARP4=6$2TW\VPI>.>#JXK)=U4';3 2Z2$X"C@F3<[>Z2T=KK@X
M?M&6QTV.IZC7-(<HX%]*G'V+3M7_CF)//')G7[3'(05QF+7$8<9_1KY>]O_Z
M8:X4COWHIM8S#ETCL>+6IRAN?1RYR>./E!(>&=U7?:\Z>(/1!GS"CSHA4R8%
M#,V35FY?7+<RC>KX75Y!YI8@U#QC=#A]L:/<_TYE?SY^+O-J*Q0_3,H7ES("
M_WK-(GW/X;^2V;O+(N>'A1Z0^CPA9A@OM)R?E42I.>O#JI'X:8NY9OQ/A&:E
M9)!*0PFEA%N;=#I*:Y'/,N__.ZK77N&/\^YGB^MB?]>G<:MB:IOUVWE#\9)-
M4(O$Z9F47MGI+EV3@$48T7^R>E_NE9(K4CE6(+<8TEA*ABQVXNT@I40*%*1Y
MVK)V8T#Q?)7[G_FZR(!(>^;A2,=/("+R\N"U8KF.:+VIO0@\5)J371@69WW7
MO5.Y/A;70XM/ >4J?LB0+DB Y<>FRQ,JZ?4[6@D2#@\<MO//]P77-YZ[\W!#
M[I-66]PHWC]76/B+9K>(994TJS]IVDH*<-C;C\/U;PW9DGUCA8O4[(/+ ;R!
M/F!$8*38#8@ H#1Q?DHI8X>/DHW=)__JQB 2!)9&\QS)SC%MZP-ZTRI_#2Z'
MBOU'+&=$N"_GSW*\N2W$(*/NWC:/+L-: 4+@(\FI/]/L2V"9_)=24TC\[;S"
MQ*'D!<66(NU'*N=F*U)LNNM-@--CJ,^*19+\_#,9B[9Z6@@G]+E@'34$6%A3
MTWAD$4=[QL \D,H4*P><$.6"F&'\*E XY4 UWGRGNB?=9%#.4E$LIJL6J<CW
M2=Q7*]O6R:PRJA5$XL#KV.L7$2*2_)0J7&DE\ECZ[<MF:;.ZU%JZ=!>IRB]'
M;,9WKOK$#"TQMYJEJHH -Y$OGAZ-UXL^WZXU0<I5G MU^B'7*U%\_QW<_B54
M>TOA('.M4W>]J3C0^? [L&L[%;,++.[N"<6:WR>(S1/PL)7ROX'Y.M]]A"/6
M\3$,"*;D"Y ?S=_Q?^?#_YT/_V?.AVT7)_9H[NAQ!'BW?@\U1#DY73_W)-V4
M2<C?*'N1E8AH?YYOPG_KG%O7>MCGVD),_X(7^]D='0?<V?D'<LBY*,V&W+ W
M]@YHQ\EV=UXI3-]O&_I[XJL#^\D?,O6FB;:=#JG1"[H1&O^&\GMTQP.5 ,G;
MZ/<90/MI2T&LX+IWRD8U!9"M"AF)TJBSH-8,BW5HU&/$Z(_*6:>PT>*<G:;&
M/53\?%EE:J;NG&N#2P.,;O;:+-YI7Y:QC>;Q6JWR7P=;C7(A1&;QN4,S6?(?
MG^6+):.B)08_:@?,*':NJYZ"E=29F.!!)>2%+V>VV_C&\%_>9J8S\+(4S3QX
MU<1I3/6]=E?7'\.#VQF(E#,_H]8;!.@@)FY[9/AZ,%RGOKZ;C=#GO^^NW@<V
M@F#59ZF<-KR&Y/+@-A)\G9__3V/!+:H^W_,GD4\A#S>]J%:ZI]?5?-L0JQVN
M@1#86.*CN*ZS;?WD%>%/G;IG5Q;6Y(8BW]/%WF:ACS".8*@X&/#:W ?FD!W#
MT9Z%93/<Z:127V9G?_>.QJV,H"AZU7;TTS.?^;95B:/ZE.33AZJ']JK7R?4!
M^T2 UQ?.G3U] *![,4"K=%6^:S)>PQ3?>/HM\QMIU:K>8U9#Z+S"OF4/-&HI
MV=GG/I885KLA7KFL6;]@8 *^J2D4 7H?KT@^=SR@<_@$\AV[IRC(E5X]"\X.
M*8=\ZK9]]H7T\ZC?N^IOY=&[ _UN5_X<V75S3^W*CB2K9AUU[W#://L%5&PB
M/,W!/UE,'TLS]ARVIDJ^_\3&B7AO\[?<6*P)SA9[L)WS?)4N)JINC^06 =<'
MG#4[V8<>Q&9F@=Y]PD1:ZKT.$%+2S_\@;ZMT-$R%P'_.?64'<=USW*.4=1VO
MZ)8YO?(1G*.U4<0#94E?_8?G0Y=.1S3O7?[COB"_\2UB7=\3MQ?QNLI;J5X4
MZE5&;DP_T,7\:L&Y=#6(48!%JW5HBP"=\\NT?9::.GA4FQ,!K1ET%WQY\_H;
MC;'LM;#3=ML&U5#<$&9#=M^[=R'?Z*7(. E5]I[]:%X3,YZR,C?83#'HRZ7R
MO0'OK[0-"<YIWM" H%CY:=R0S1_O>S]><@B9%G\)<FNY4PR;\>6+\Y:XY-P.
M^$_(6Z1+E#<,K+DC?',:C$:Z]NW-X/6OZ* )0H&[)33"L]Z6";Y+SEX8)"OW
M0(="$WZL?K]B+[3&6B=1T1Z1G[<CK>UATX6[]J/N<-8JRNKX7U' H,_ILK4M
MER_-I<X#L"J;1U %>&#J4P%9(2-F;?/]CL)"I=I\FU&"3-6:5X'I"SI=V=%$
MF!Z:8'6F_#K>E;<]^U9CU=FFO**7,.4?1:?H1KL*1U0^L"'"/L<!\,W)SX;9
M(3O<'UIJ 7_B'9U4\//Y>=DS6GD]]6M-8ZA;8&=1GHZY8>]?I#T_5(#2!1LE
ML^Y-R<7 %%7H-I4/,_4Y[_J*V.5!A=&N+U<RBX(BJUY=V;AA.?UI1>/",T[F
MP/4?#LD,W%<62XB>A^1ZH9UBHJ-/'2-LW)*VH;DM</TJ]:1@HT02>$T:8<4]
M<@/W<.E%!O >I'EN=O);\\6.,R?+]^Z)+YRP",F]&#]G:<K_Y++;[?5 2<^;
MLQ7C]:Y%F#;'SJ,,DC8WK>XINW?70E5CJHMK-=O+^+_C@MLHS!R](13GXM+#
M0&NJID"Q)";+30&@K)$"73D'J[@EI]-7,/MT_Y;MG"IT?:^=PYF'LR* X8]L
M6Y:.#WU3H-_H@,Y+]PL]X4V%GO\&'.Q__/+%Y1<NPD=Y67Q;#<LRLJ6MK=9Y
MIS9LU\^.@T3L,-:$4BU'>/'LY=%B0E4&KGU_<5DO'5HS=-ON.6EP;O:E0<[4
M]+<,X=P'3D_8-J.=)YXK!1M6Y+5\Q0@0WSU.KR'L.)TILT)1/.Z89G,CE^-P
MS7%-<&NFX'ZU[9QEI."ZS@/WFM:QDID4^8LV)PI-*=5[3"@#O&/$[-FJU$?E
MOC]FR^&WSKQS&JHA/DP?_S5PG$$*G>+ ])+H?9I0TFV&E\^O< Z6*[A^]%S+
MU<UH@["@=R;MC'XV1^![>'6MSIR*"' >B4*[P:8$:VS012'R9X9P,15SQZDA
M;#RX"^71J.BGMCUOFN[S+&,P=.#ZNUL5F'[?;==*? =QO7V(Z1^]M$LS65FY
M>W5WX Z''<0.M0$]T3^82PO5@M^ '^0P='V2&J,TY3[##N>6OGR@<!0[W9%X
M'O*U>H1: W8^@55YT'0Y@KH#P#T'K,\_1DW$\N5<=NI &=$!\,P>UZ-];[]6
M(5;V?G:.*2^_4)W=^&ZP ^QK*;?]7_"%)WN?I^56#]07\++8;>91T>%S2U,V
M7UYV=B)S/HUZ33U4H:U]01&[SRSIC..%_<]2Z^V<HBX$4(=V5V9D-@IRG%(&
M_;J(3OPSXU/IGPMT=^7<W%#&I$BZ= F(C,N>"!X];07<O1[V37;57R84+33X
MP=._6_0YQ"O9M>NI\Y'-8A$=CSB_=O1023?0!CH:VRJOVF[RPW2N</"@[=&.
M3M)<:D] H>_Y ^^8?SVT^#81.$E(\;6>C?(KG'HG2$,&_6]CAD6 @3 =_N[&
M'85&!OT30XZA"MG] %-\R>&%, %II=H^N-=>],#W9C>JN9R;$E8+,_H)KOC=
MAI]XD=>36'K:+RRB9O3OE7Y^0B6?ZO0K@N%DWFY&)U3OLJ?AS*JC;P?D &O6
M!$=*6"%QTH)[$1/HJW6NH[TN=RW(O:Y9(I#@!0)=5@4[]*ARI'Y<H6[ME<0#
M:QKEQ&(Q;/*@,E=NSM"_F3M/XOHL\'BG+MJ,&^HU,_<4FA^;^]N.H)X7_7G!
MKD!!6YGK^_BRC.ZM/;9C7EI:DD7QVLK3C_9\7 -WNWAO1##]>('%?D[:JO3D
M;.C'-R.0RBB*-K)$YE=1\I;5FGU)M^ ! VT20<EB:]&L%$,,'HM-96"'8:78
M5'JBCD.W\6P6'M=,\W+]:;0%"4[JKM0]O%[Z(WSK').5-\3@"&?%3A!;!5B$
MU'P*I4;4OIV:9!3+_O[JJ=1KD/WNCP+-K:UOZ-SF_Y Y3NUF>9'' TFMW?40
MY'>L"G:NMK@F:_8./KW>M]5XBO_/#NBL/<@NI+?+UNEQMY1CLVP07[!3Q8:Z
M6RMIMZD+W$MR8"ZXMO0H"_1YGED3H(HCH>[_AK$1MK(L)@W'J:OSB% 1X/T_
MZQ"//06;5JC?#?EPFZ7X0G*Z27- ^F1S;73OO9>3C9)L0X2? KQE#!B3'F.[
MZR5/A)HK M1W;V7PS"E722VFK2) R^^M[9-E4\3=8Z$AS)$1 QX)L@"[YMYD
M=T6E^L9%N#-'1=CX?*GG,"Q3>'Z*?X C62N'+])K\DG5C&FL<PMH9<S_]9O<
MX<S/MQF"B0##^,X^L85#"]<?6]=AKW6O8RS_(.<W% "0$6048][00!TGU@!_
MZ840>$,GK[(LV*3Q:8I:2,T,%HBB?-*^9=D3D/ >WYV:0OZ]L-TAU2<[Q_GK
MC8Y4EF8TD"78L=1I&%8J/,_ \T">(H"2 +SI6 S><I8;78>;"N ;8<?G0^RY
MH![AZUD$! S^C7**FXU$UVEDYNX [Z'6B<M/[(WO=Y&-R0:FW)H <0^S"!,R
MUB='YML_9LZ.5]2K849,?R,!C TU)R.LQWS&FYL]?U,IBEO7=<049G1>3 2P
M_P$5W2#-AN3EF- 2!#=PD7C:_*G#\)X*M2664=1<JCI%LW)D[8?E6)) !!BE
MH>!-J,3HDZ>K 0#ML;%$:U-*B2P"=9PL%Q3(N>[Z?+"=7DIFD(O>9:#;=R=_
M8WIN''C'(KA>0_<53.8-'7FU;@7(S4L;426$IU\D'G]OOC=09ES>RGY-SGL*
M#1E5NC/N3G_\ZQ[\'+*&.\=P"8 ]/A+^:#ZYHJ[QN%(\+^139"32H*:%G*T\
M6U[Y:GP# QU.PGX7@*Q/&TQ1.[>MWOCIJZL[!W.:BTH$__) 5"):FBRNB ":
M/$S-5!GA*K@BW(UJX5-2<T$\G0U6Z]$$!3\OL<"500>6GNW$YHL 8:%&?3HS
M:/:$Y#;E*QFA IUB..94PX-C==LN(\0_K=07*U0_RWTP[V]3+@+$[*WT'#R;
MXZ4Z7(*'GTLD[0$]Q: M9";.Z5TIVA1$2_E:U(&)6!T =[>$[<9WF[1O?^&Q
MNV0Z/3^?UE0>X7>TFI3XM"LP98S(A5]E#'-O^I-BA6@++\U<G^R[CAH?\SVU
MJ28Z+W!#<PLA\R[$(W$LT[/I=E>4C5C6\C+*%S6C!;NVK'=IKTN>T[VRYMB*
MR#%.FPR&XMEX^35G\(W^BPO@IHR701EF?@&:@Z6ZX>"UI4&O<:Q,_>$7(+_9
MGGKT.UKY@"M>_?#;0TY=:RSP 1A'H6#740"6]SZ_?V6#.F)CC ^?\QR'-[FB
M^FP%M,-H/!:[R@S2JEBTZZ7JN3C2E5U&AG*=6JEWJ9J-]0^CJC;XG9JU95[X
M'/6:4U4-+ZK5\7E9M7_Z^:>C/VO<<,+,FKEWJ[93H0K(#I71D 9(Z^AD8F/C
MC6[[EG%9^0;R:/]R(R1EED:?__XTWEH[U=M%Z^(T%/=-5J,Y\F?+%G%GK^ZL
MWKD6H>(_G>0S76()P1/V67K39] ^-V )?>W$DN\'9,=W>IRI H=O:R_*+VO"
MW'WG^?))K3Z/HD2KC%_?:N,Y^XZ"*8E*;E;_H+7.*U$N4VRG.-3]*^+X]Y:J
M'HGLM(8TQN%4U-FJI@N$:NP8XF72I\1+JBRG4!O3B5+Z;J>HKUN+-CX[DSP0
M'L4@4WW:TM!OJM:-^YJ\UNI="(BFH0_V1-9CHL?'D#E04MX:<:,[#NQ6Y1ED
M[(TDQ^(+1 "3XMKXI_?ODI:X/R]@G.S'F+ZW8 T^R "GQH3:MA$KP#O8_A$"
MV,]+I8^0C6K=!PS*^_2Y)XGA@NO%:VVQYRVOS.RH?)/.A5$[F8T+I4':D5IS
M3T%<4@*7:@Y[%R P>3XTM$:K?PN;TDWLI[Q!7-!6RM(BKT_L5W.'5%G)7+/@
M.,?SXGM'E[7&U+!L^-74#AQ\UBC^1+9SXU#!9$VWOG?5HQZ$ZY:7T 3T=M*!
MTHKKC*GZTBBXI4)P$3P$6/WY0$0KXHWY%QVZ^5NBQ9.$6.C8*E93W#<C77KB
M,7(#,N]^GRJ'?CQ'QK9<YY"C>E.(CH97.WOD<FKOWJ"1D+LE#<1 ,S"ME/$T
MV*W\;/K0)<:^7+:?'0E&AGC'+U^R%'Q /6!EA0F#0<M. /74SPV?#QSSZJ 1
M?_'%3YY?,[ ^+BN@YZWY4&J[!Z1]S*M*9YJ?*_],R6NK%FH?+!*WS/+-LT&/
MWEU[;4V/3[IFE6 <;-I0]9'NIY"-5[K8-%W2P@#B[K3=]IDN39=VY.-<>4$9
M(Y>*0:L\>]1ERFIX2OY4KX('0HCH:AC+><^C-K>6+4@+:Z.)G12](;9E[<_5
M>D_WELG=.^M\\V%=QRI4.G=L+)5=^.H4\1$$9;#[C?L;_K?1MIQ;CL[C:54)
MJ8CO$7UX&W@;A$MYA-"S=MKR5BQXHX/8],E/($,F:M]V\S&#K/RHB-9=IK)P
M[^BGR409OV+H\_>#:OFE/8W-15LVG=INO'>$GGZ0F1:VF17/IO?W]*X<16EG
MQY].+7]X%M'W4DZ6J]^]_HDN\QG:3_^L<6/8P-RA X-FN_%:ZDN01B!A_RSG
MQ3&7PF '\8Q\NSMJ!D-F%P-NG=EZ0/GBU3/XM);/D'@.?<C%NFPZU3M(%>?M
M(Z<\@ECN5"*S/K_&-OKG>F))I1X7Y 23'7E#;OS50G)&:M7LGIFHX!*_<@)I
M20-)K2> :=OEU<-BH)PI4&U1B^.H%S,6P&K%D2")L$23YU\+G0Q=%*Q,A]5T
M;N"/X@_GPT*R$S;("[XH%VB/*ZZ)"C6GJ",6?H5@77\^KG[V)1TT>P?63R]D
M5:/TE=8]HH8FV*@YKCAQO<=AL/L"SY?0A(X(T;KQ;->J*[]6KKNM29YULJ>:
MSF*C;,U06ITL(U;DXX&:IJ$9U#0E/^_E-JO@5*WRL4M+S+_,L)1-L4'/]Z4T
MK[^^4JNMX.;S.],G\Q4XV!#.FVD-/][2LZGUI_7]JO3=&4\;WWD,VSRQ.QXZ
MT3LYZ&P;;1M=/]!!Z\L0'NE&5;1/QM9;AN0;1[,_A69_-R4$#&XU1EP_[VWZ
ML8YUGX0WH1$2L]Z\QEWTY\B,:SW-Y01='^-,>%=4)=V:WF^N7VZP4,;[BK,:
MR1>/:4N_6_4B@-?'4(?VZ$W5H4'N9F]<]<,:ASL/CGLR]Q341;[>]R7(.^_;
M&^,0]^DB_>H^)S9&LO8O0 2XM^,7-0\#O.A1A[,@$"S8M/FSTUY9LDHH4J17
M(*F6G&_&-L$["_Q^]0GE-^/!4R='>[M>.MQBQ2MR2"( _C6<HK3IXTVMVTGG
M\21_BLED.TZ.B68Q'F#&HK,]$6].OW,-(DA($3(+GGJ(NB=0!N>:Q\[JC-*K
MWQN-M;-MM0WOR1L2@D:_Y1ED46U0!B9N <0:X;)_D%R)7@H#XUH&<Q7Y46%%
M8L7SV&;EW38=[04)W@<>/FHY6Y/\LY'M$%#(_I(ZA[HN F1$LX1X<1O^B'!J
M30$:X6%-'M.0>K7?3*23(*=*1"D,-83'_Z8F/;7,]YNVN4)=H=AE.HW LY]M
M/1?3S0I@LE YT"'$>PC6:7K&=F/66#O2(-#5O*Q>*/,;5D/P4IK.# NTAKNI
M;Q"7X=\D%O]+%B4=IO[5\B.*]HF2ZXX%<D+6%(:)]QG%H 4<(6QG F9J,B\G
M0MU+300 _J:]%8XQ012&<!;N\1M=5DW>%ARO9E$&WKFP"N'!!G!KINY#N[S&
MB9+K%W\CDQ8-TT.'G,N#B6M _KGWQ$Z@&.SYVLPA__HE]=T;-^>FTB3<,NYG
MV>X)V!.C\<#!D(1Z,' 4[]BP 'T2@Z\$6;PF6D-J?$9_<_$X:O+\\8^AR["[
MG+K@]T6 U^37*[18.89M9]7%*G$!):P)K 3,2T7)N07C381Z 8VG?(0R?X.0
MRN+F[-X=T +O7K-"!/A-L[31["Z?MM$![EZS5/*U67#)MYOJ]4+<_$!-,"X$
M\TNH%SZ)14>I(08(YL;3)JT'A.!/B7DWV'2'/Z1W0-/Q417CR,OPDVSQ'W\L
M]8W!;[?@1H?6$A/(O_1B2%'4F0EI57W*19:9*C]:7J>3! LVD7S;*6\S,LS5
M*]B(Y3U6PVM8!8M<."&;(!VE8CB+[LG$(_AR/DX\*G^A=P\2YV:SV2WT&1\K
M.8Y?(,"=P-,@_#1U8I*&G!3N \PWX,WL(R-;?* DS"_UWR15YZ )."LHDX$!
M)OX-26T3:^^TT%I_0+!-L:-B7\GX$7,0K(T^64G1B)(04JV4CTY$[O7J)&;@
MI@(E3N5O=/0^%'@ <=MG= (Q$XFES)_44A@'.7=>>6L#B/H-25)QJA!@R6)1
M/4*;7)"\BP3$#/LDY30T-G@%'H";4%G\R.)NC+=YM1=P]Y"/<-G?4)\4?V;J
M=9/ O1_Y)8DM?*&E;[D_\:\OP2'BP!S@-1HNB#W8^1B\F04W\@,E4/R1]'XS
M5)UY^"I$IZ4(\$LC#\Q L6CV?Y9H6$P^8@B&(N&[Q05'X%];>D7:RO4>G@C*
M"<K,Y1.K*>+<,4-$/+P<QY_H"MV %=<E2'+3EOA:23J; &8&1NVIFAY#U1%>
M$7RYWXRDYWV( ;*:\;0J[H 0^!N.>N3/PBQ^0]Y6'N]JL0>\8R$>X?$%,$&>
M#<-UUR<:)H@ R-^H/!>I&+42Q]XHW?;)T!D''T32AA\8!SRZ;F+"+0]5$PP_
M%L KEU@,7YV/B(S$=]8$@D?.44KF:HN"C.@**%TH(3Y@8%X$6!,53B54V4@G
MW0>P:8AZ;(C8R@$E=W(B:%;*!EFS]['I]==PT"G^/QRIK(U95%ND@8G_M+CR
M9?Y!,1Y5XG8_'M--7 ]\#)-<?JRYX!]MT==AZF8,,-$B2$B,S()E]^'MU5.M
MH(!^O-C2407#OI^Y^8?IS%E67C_I]_K_I\BK Q%:J<A,N26(81J*0'-$^J3Q
MDCLA]^3&U2. U%\T*T6NL).O!E8T$@$>X<# #QF>1NU(D,?0&V-*!'_E;Q[J
M\U\H'QX2PQ,!FOL('-IB;A>&S>(U#GM6=\%5)9B\GL7:F3<1Y/"<1JNE6IJ%
MT80A1W(LOGPP<=M]T%2G3T)K9Q4H@"-GT5P?#'B*B^#;L/F^6U@6<\3Q::IY
M6<UO1+;1&,]FH69 T,7_'XJVUL!$TQC4([B WY)/Y8NE-" #:!1#C&F@3I#$
M+4)]AL!K<%FTY/H_1A>1U))1F7++$,,CDAM2.2I..YF)KOJW3&0(?P/PGB\1
M 1IX!OR*@?D@"9M,[%V]@GAF/E=)6)56$0#[#P"/:X&L%0>G$96)%J>U)W_G
MZYIV-ZWE>#VG#OAM8%\C !3 VT*J4.%"*>!?>A#47%V)W41D#[43MU$-2A<!
M8KW&<6;4F>]/4Z_V5Q?>1N;H;,&0)I%]-$>IPEMB%(FZ9L]UK<[U"L1C?V,G
MGGL:T161NM">7/K _#](7FNIY#LD57P D%2D3@5+GZ+H7;;LG4YHPW?>OH7Y
MS=!VQE;XUR>W8SMOW\0PPO&3G *YW2) 19-QP)!1;A#_'SC9/>GR.WDV*&7
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MGD8U+\,DUN*UB"K"JDUM.AW'7H7,J=Y0Z%LV3UU8<)DZMCRX%VSB#=Y,T;*
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MK0U/_2[JVI=[LZJ\YT:1J&:>;\F*&5P$G*(N;,_L!UU%JPC.KEUS>_3H(J
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MPC/+3UP\U(?<[:@C>YC<F.;UF(Y_7_IN&RTTFI)L*?A8N'--M?\1H%(*L54
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M=^\;K&@9X7!DFQ*GMA' 7**'#&$DM(F/-)J3C$8SA6?W6(5=^;QV% :&!<'
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MBAL$,Q%4(]R$YQHF*)I!LMYZ+CEZGN#(F6PZ,,0<IZ>=)A;6XHC;0'3LZ"*
M/'&_KC3\SR+,"U"C?H LJ'F.<^^\$IHX-L_*E8 XMLWY\#>E).$4\-(KUHT+
MX&$N+2Q7>,D=N["\]OOLR]5WGR3"IL+=X.B9L=Q]L2G7KXS:. H8@EE!R-E=
MO6C@T0+V]"+ 'Z<,G]/G:$IN9/[H=@N(LP2(/GH<O2<<.WY9XE37\^/KV9J)
MVK'I=T7>M2PL];W%23T_Z\/._N7! ;C\J=1Z7/=DJ'6V=\;O@_N?#A@G\ WZ
M^(+HF'63]MUWT#'@/&F.9JZE0+:&S-.GVE<V;_3-(V_)I&ES=?AU=HS)!>>
MD.OL.K2C3,<3015'$1)U!)G[TL2>W%NDG7X9;Q'("+]>!$-OO_@,'#14U/)L
M6(45WF\.==_LE7ZH:S+8% #-RXM1=0L7 O-W=GVHK2F^8$@HI'7P-:N8DX3>
M9[C>WVN<?5]$CWBXC@"#AK_MC-G6],HL[-;<"ZSN#-YQ6!6[@BMTNF@FE,ZE
M7G"K0.K1,<:N,%>ABLDC7='7=WF102$5O9G]A[!Q%W[P!E&F1QZ2B:LJ<:T(
MO$QF$CUC24XW>HV2&.=;B:F.NLDC831JO@%VBI^X&WFD6942L*")GH2K,IIL
M]</F/CWR??=1 UA!8>!?X8^*F8Y*[LWVAV\4@NZ*;&-JH,*BN!CUK\U'O\&Z
M,\ZKU1 &,XLL-Y"<A7-,X=M36YNU7.^8F,[!'T*HVQ1]4SO5G8$W;-8AGBI(
MWTXR)Y/1&=:X"H3Y7X?ZHA8!%_4#6@/Q^L(N9 2!EKS+V"Q"'33F>L\D0G0-
MW]F7:M&U" #?_.MVD[7?@$O^GM"W3?9;R)FL\OQAID[,-!924NYO^++@Q6%3
MXY?@]H">=ZDBZ=7\H7RJP<UU[=H6+ ][320Z*&CF32LTY+ X^$VFN>L&E<>W
M3;@,$,;^EBMS<_NNSO2!&T_7=*X?<D48@SY#=K 7?/+/(BY6V]UI543%JQ@]
MG@Q6TX!(2\4@E6'D ><?Y_@WC]KO@W:E'_;U]2VCT[7+ZD4H%[+KZV]:>TGI
M95FEA:^<[/I?4VPBBQ<!!Y]GH%:_Z]R#Z+W>HH#P#$3?SS^E[M31:N)T_#J8
MB!J$$&GD<@N/@1\1%+=+AUL]N7LARHGPWR):K :%(0Z/6W[WNF>@_4;E*K-4
M86)[0I<9;YZ'52G7.*W3]JJN5<2C^Q(<M/3O<B-KJ#&:37_VV5@[V'.UJ[S4
MB_+S2LK?B65">&TCN/_#GM/)-B 03B.&$P]^@-XU>^ HL9782:#++?.NKGC7
M]\!*20>=1DVVK&K!G%AUM^6."4.F>&ES<K_Q?9Z30FG=(0-E=*E7IUQ<NPOG
MYR7PR[NT&]0.*JF[Z?#C!+3D.ACR; +/7W <R"'C?_H\_\N]I]XJ*X_KZV%P
M?4<W.*ILR<CV-7CE'&>E?$"(9HBY+\_$?O]T9\=GV>PY+$9RR +(D=69(G#L
MK&S**)9-&?-$IM#IA"-RX>D.V9>=8'#D7]8WF.I+>'(0S76C8<!5$KB];3P'
MN?(X2J;//> @XNS$K6W_4-\YZW:J YYN;[\&JF/_<KS._;OZ]OV@,-[ZX'AB
MA:>H?C"$ $9[[ &TBHPL1A$".A5+EXWRO3I3WRV^6--$]:'U4G0*$7@Y0J88
MQQ/EBA&N3^(6O%\ZIZU/J]!H RK$$UM91$VQ][E\G2[$02433S0ZBY*",H/K
M^9;\_4#D7+Y25Z+:,0U]V<*Q6XF6\*Q# -Z2V_3?75DJL3,J7V4#[? P_BD!
M9*]F/+ 6"MB&X<>.UDE^6CKO"2HSF5MF;C,M^"SZY9>^;.?^/_S!&W329,^2
M>\Y_"_F[I'9.41PRVJZ:T,(8%U?Q&;OS'JPOO;I]00,%<X29\!@[;_VVY)PH
MPK'_ T.FF?5D$2!S"UXON48WEQ]W6,N/._!93.&7Y2V$5H?N^QY61U-P@SS:
M(J#'T?;SR.-;C ^ ->CV61K^Z.D,R.^!#[:;+ >'-LZSD^$2M[,:3KM7'WMC
MKF=#G(J& <%^61O\2*0<ES"6#XX34PV5VGC\(28.VX423W9"8^J@X24<TLQ6
M4Z^=T@4#VOH(3UG;$M*>A:XZFZ >#^)0%B R>?[(7[!>?_H8#E@S-9P+(9/F
M)G*WME8JWH&3@:/SS98@S>C?YV?PGV,+#T^A@W0E*%260#/.<:S(S:==UUW@
M'+05'X/]*R4P,FO];[N NEUJ5\:C97V07,"<>6=]M5C+2Y:\Y<0@+Z[0Q\+,
MDD*G; 83!%"!B98);Q%@P3GK^Z6EX"H\>M5W^/TT9C(<..[7\18>H!J3Y5!=
MAZNHAHJ3?ZRY-' AVMT\M+T<BXGC?J_)9$$XR[:?+HVM[(+.?X^#,F;E/]),
M9<[D7!:4+@+6BU+HR?B0!:* 23K,/5\,NZJUYEY0C@G!\N"7:%GY\?Q3VK\&
M<6> 9!8B08>+.H1Y# 1G_O!\E8NH:\,)<CD&4Q4S;,P1U2T",A#)Q*)V3Q?U
M&'51NW?=D'L=6ZP*%J(?&O5.\3Y80%9MI>_>]</05(PGS'S1>_VZ]$!Z_.=$
M*:-OEH+5K+T0\(:XJ=9I__5# 7@32UE!F+ 30SI]-U[:],?YN8<:QMJ=TW%$
M,"%YG]!S&?SM.7Y5?OLV]ZFRRY$D(OV%F)(LM1#0B2K0RV<7*(L 7#EN 1:]
M)BQCW.52;!-MO?*8P?<H%BFYDO$(FFFYH*?\=(*&U+0TH,Z)?9/G7CUZO+F)
MMBYQ[.@/6)ULSHC"/,VCIMZR2PX0?*21+?'ZS35F-9&]?!9)*-X?S+P!8;4(
M3"USI41"@"YU*O+;%;L+UA"K+3>E'*21Z;YD)!Q5@-)VV?^A32N@09?(5G5+
MM@01[:] +UL?5W2Y*9MR]:)T4;*51MU#:3GO_]JH'="PCSA-/*T2)_M8?HQO
M^1"[$Y;C.;]5RL6V59G&H76Q6R'SBX"/=<-#BM::NZR\:X[JBDI372W&0]!/
MX<AG3K%];9\IBM $)+Z2)3%EU&E?HY^;.%FYG%IK^EM(LY*IP$;0DJ_5EEBV
MK]8G6] 6HT(E)<=\D\U6N%QQA;3FALM [Z"X/1 ,SA$,]^+K**X *^>_K@?0
M+(YVG1OD29$A ZE'YE[/T0>7>0XEWJYDZ"2*\\3C3O$3S7]<ZSO8**9+$$%,
MXK9";?WU"#W=YQF2D59=U $HL0/4Y6 9+G75GY@8BI# #6'=Y7680UB8HT]9
M4&#6/'\1D'-VXN2QM]HOK0>#!Z53W%8:2<PMV)CQRF4#/0+'-OW,>%+)) J^
M[YTX'%JD?<QH,+A6.C/_B2'_U)8,;^>U?T7@I@4-7K?ZF03!CSUQ^G$]N#DJ
M@\KY+>B#7S\'(K+RR**+S"/X0;# O,8/[(_!VH0M&B,AS&1J%NWTB0QM']_8
M<H:AQMC1[R9L$BJ;]BCJD:5@I?+3,:HL/R#R_'@P5YN8M)G+,$#*IE"K7.AD
MLDD>N3X3+RM"2D??7G;+"2V&P4Y-UV]E!K#@H;R*O(2W;]_I[= .->W @\VY
MW+$<M:AT0:J_!SP,DD9@HH,FP2M?%W]Y_C2^E6$09\HBD9_YRY?+I@XJ87;9
M (LM\?EZ;T3]K!BX)_FO?9?=\$J&>&,=2]8V+#9?PJ9_4<M^V6AX9=/8.N1<
M%)!,FL$$K7N^P5:;'HRD@P^LHH'V+@),"]X?:'KJU;*ZL<%T9 :.P8R"^[2/
M7$^T:1L5M&MX*W3!O*00!T_7V NNG-#I>L\H7XQ8Q+BP$%<TSV)'X"G31LZI
MQ]2U.2[:254"LU X 9MOT?*HK<0D\^BM78QU(DWS,! XJL!^SOK8*YC3>#P.
M! *K+H3/,QT-\@S+'NQ\,O*@JA'%0$D<R:@]D_EL#D[@%GW9@JI:U][>VEF]
M4!7+QTGJ7G>F08=]<@F>91 <AC3/I!99V-]]JO5@<%P=VB#?'_B[!V.'([/&
M9TE38A:3*XF.F'1<M_WZGMLVZKOU@N_+NL/HL3JR?ER0;+N$;RRZ1A0_3DM+
M[:V%F?OBX9"*O+/7DG)1 6]<34T;D5Y:LKJU/"LJ9>6]HT#==,;^$-G_(D (
M.G<>*CGXMJ'JN)>2"2)Q!([^\LC]]J'=:HW("D]D8;.M!H,.8AR*X_7R)_!M
M\KMV)<_H02FK"FJJ6R#1+Z^J%9@]R'YT8'>:%D -#/DT[L.=%^\%AGU]_7#N
M^2+@M7J;2 @'6Z479GLIWN E+K]N2M1)0\R!%&Q%+Y).V]W5D41UN5)(0LA\
M_E>X;E:,]#<;6O<P&2U"$;MZ)YEL_@^3ZI<O.\:N*BD@F[@TG*>';XDV=F=U
M^X2^VA.?=8AI-,8Q%M)D\K(Z[_3M]39*R'8N ^_HL;?$HG#GRR8Z5BW19[TJ
M&XCU].<T69'KL%LO\P54KKC5<TM-D&^[7F @V*%' !J!4QA5TO;Q1<#GJ6Z(
MSE,8P;CKX)Q42DV8CHZ69HCJU'?0&F]K\:+J(2C840(63YOTO ,J60#-U!Q"
M$NAI/L8M!SDP*35M6C9\R#ZNMHNVW&"'R,)S!Q&XG4%&H>\7P5:/.8J37RP"
M/+R&17I"R2) 2ZC0H"]8#Z;$7&)5M LL.Q<!:[CJ2RY@'![DEEX]DZV1#(,'
MFO 9RW.77-H5-*ZZ]&%MK(HC2 >O$0-)\<P%YMU.XT5JWE (EE!-@^".'0QT
M_M]_ET=R!I96S<5OO<\V;1-%0Z8/$KISY0)52RY0/=OG)3< 2P[ZP.D?;D!,
M8C559<^Q$(6D.:0#=UM\7GLM>!$PS/ME#PU.-_H. 9Q&*8% #")>[1"@WXZ3
M=E#)0O;GU/[\;=Z2G^;ML0I56'F<T/KSB@6FL>2*!9"R@6'W\+:&,9'8R?I(
MM 2A#]M)9UOTI;VNZ.[BQB4'GC?39@C:&)%)(.@RH,Y 3D@L,9NF(S7B63_B
M*H7=!H@N-[L=;J&-L0W?04))M3/9*BA'<Q&P+V+:*(""A&\V:0;5-1VN)9;M
MCBVB@ UP/C2Q*9.,!G];]L=3\41'ZF\$9:4.6-XB $O--[)$^=$'];:N4$YC
M_O+S^;=7MKT]?')W6]2.EM8$4A=48&ZT I#*GN5[> %9D$H30;#AUE^8RA<1
M MVL*_VC1P2.WQC"2,P2*LSCI>\#/5<8G[,2L:435A[U>+DOG/9>^F[MT'ZW
MVP>4BG^Y<"T"H#Q/@4_I#)4L%<J-&$H$J-/0.1X]!+<5/W)14,TETCH!1H[Z
M8:[>H0<YWE>PHEJDQ$1(\NZ?*"!'>!C*(H6B,L0W+]5VSDS/<=!9@8/PCQ\(
MCNP0AYP.#BDRJR8QH)E*T)"?)0.(:2Q@' \.!X)^T?-_OD4VY((\ #1@X 6+
M@#_^ VKHS'(;^G166+(BS$TY<Q'PR[[&_YH%IB-YJ^XMQ:/SO]S>_BN"8IG:
MGAU*,=-2Q@Q7;!8M56,[. _7Q&_G?!P)MV!\XS.=DJ@^ZOVER954<B(#*<7?
M/6',VFKP?@.Y&-H5TF4PZ3K"8@TGM5_3[:;8X(;PKO/[INRG9\E#GIMGR?EI
M \+)[C%;V,C^<97&M5OZ(>0?($G$9U<U'/1="+)4-=M6RG:[(O0.$YZ'_L^T
M1<[!?7]^,Z5=8Z'QF],2JS*J3]F0NX>OGW]7V#87-I]4U./J$W#8<U_I;)IT
M==<7X((.+K&E$HGE29)=E8)!_=7% .:G;?5(LN#1 J1E'=4X=X\G:]]0L5(7
MH0NVM9 VMX(LC%H$?()*ORX"5!9FL\2RL%!+" Y/I9T]$.0L"C7D)VZL/52*
MY244WN^0?JT=7.6IKQDC^=I"=$,WXXMK5_C],"'LK92)]#8.PG&HP;E;<*-\
M#G28MG4@:_\Y24=0!ZL-.ZNKB2VHBW.8O+0SI>"2^LN&O_XPR'IR9;TWGS5/
M.^S6J6&XMHL1LL-ZU9IOB<+EII9Q!UWV-S/U'/!9$X$2]E/%SC[@#TZS ;,9
M^MIY=-"./@>&W(Y&LHAP#/ N3/"XI.E;K;M)3$4NU3PBZ55OT6[Q4&^OS2@7
MZJ$7X723/1018"4YY.C)\3I_ CNA=.V*ZC2>GJ,P5/]T+(_C96=+W9$69 !O
MWZ7Y1E5C$6 ? Z4]B%AI)X@G9+-P3"HUW_:Y;(B/VD!9%IF &&,GRKIP68!/
MV#@S7QU[=U_3)*F'0O]6[#O0R;'[%-JV-S2_HU[W,/<R5/D$_=4E]U:E4*.(
MU]]M^1X1W(D7R;:E.[5+JH)J/4T3P]MD06LVF?(='YS^9" XKJ%GG!PU:&E
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MWFVB+AO/7'\9V][\%\K4O^ 7 8\,4><F;-9D?E38+OSED7[X[UE5^))CD6U
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M;+"N)-0,B^B2>73T-VZRR2]POL'X7R1!W^:UT2<P(DH?L>FO"/CKYB6P6 (
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MMARGHT1,0'#]>K2VO1^+__)Y Y#6T-B(GG9(.\SKX+_?9W.3ZB@%\W(-0=_
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M3J_HHKQSX,AI2/_W/9%6" 68D$6R<;BB8E5!8QBB)Z,KTLE=P_RL.7>LWWK
MNBN<83>,-RX14FG_XY&JDM4+>"]&ET*(7ULCD4UH7WS.7.7=F+H*&PY<]$/0
M7MW9;Y5ZV[C>+TYKJPHIWBT*<RQ\V5S\0/=IB.JJ&@T+7(ZG,:'G1_#O/E+1
M=*Y'P OP$\:'11UI(KMJ<93E0$:WCJB"94[)F!1;"XA&T_[4ZB!H:N7?L3)O
M7ZZY\=T>F7H,ZJW-E\.#;V3VEV5^5D=1M9J=DZHQ/K3)?&%@+48V;:SQ7A-W
MFL<P,P4;H4S.!UO94(8B66M[Z%Z]WZR2 K@3XU[]#)IU\GR5U,Z7>\=LKLX\
ML5@I#@4L)^CT[:PQ!XH>US7L5]:<BG](PF\ /I6<2500/S5:XW1C\519;YA?
M]0VSK ,[;9V(&:%=(+M5.A5/-J^T"5R'+FX AFOG+>EU$=A7X(;Z3Y4KY)'P
M1J?]BBG;MK6;J3Z,3P@1.!;&X/>OF/U^=1Y7Q_=W0ZTPTL(JV <W(MZG7!_#
MZ5[NO<4B(I%0O-&I.Z<L5;IJ_/./C^\F9*\2[R/Q'TL9GG7%"S83YRBR,@T5
ML^[NQQ1]DLPF(*XE1:=;+/=K[+;=6[W2C.K"0&B3Z1UQL<D>,4W=+IR97'_-
MWAVG+TWO/I,4^J)NUA,T@: &KA)6WW=>=[4^X.+E,QD0@SWAE[ !(%: %.8;
M;6'-&X OVUCO2!,Z'35L=BC$YZ&]?63*Z@'L]OHR":9!M-@&X,Y 21NLU_VK
M&$'FDCCN8QN2:)&KX=>KPWY(1\8=Z-X-VK]Z@(8!^L4O\]]NH/OISF[7[UK=
MV8G'5]O4V@FY.=5Y./N(<E[C,M*%PD8]U#@\R^ZQ*C0N+#K;0'EH)>IR8%;:
M2I,=7[^-_"<G@!LI'R0MH.D.RE8%O?1+S-4)[G5O>OS\Y-?)FYAN+2YU1K.#
MB%M]UR)Y[M3,=[3&8J]IR%JO6G1_TL3#;VP\CK[^G)E4?T25.T0,SG]H8X/M
M,HBT<=I;)4]34$CDE6F:F@T<5"NJWB):M?]U#5A>,#J!_YX$+*:=N<2^*+9O
M140V*CL\4CXX]/ZVTM#LX@-SG=F.0,+Z-:X\2M;-E7HGV"&8'5-GA$W/A/Y8
MJ1VKK4A[!4DN.^ID"'7=*]IQ!LBENA)0S-8==R5V?A-WGE*M.C.^<HOP1@]\
M6L80^.&.;E,NH'UD #% _GGZ:J)EH@M,];J0,;;CIW80"8,L #T9):'282>0
M#R78\[U]]:B]5;4F8Y%!I(?OL2?U)N])=)%GB(P&M03$ $?^;>1,V\]6[=.H
M20<_+' # "_2<9F$;@!TT"R>']-9+]R9_B-;^JK;+9^SIA?3$=E$201VZ8UW
M8V_MSYP-@(3 D$=8VC-WI-($^=@JO@C7\.YC\[:;+<:4X([.C[D6E1()Y<_(
MOCL#O;Y\%A;I!$RYQ?M-YAPU2E@8\#(?Z>B@[5!)Q*"84^:+M'VQ^2M,3V1/
MFF:3%F;Y .O;2B7+'47@VBD5HS(+H72M48W9 >]:K_"QR<_8M!&HY3U?E3DW
M^2;R (A8=/;P[,7C^9ES5\%U=[$ 9]3FRG%KXN#M3(80X"Y1+U0<@QY8RG]Y
MKD0I!2\3\LA-@9K<1,%7]:=[#Z_#IME[]:P:&:H.DRME8\;GO<(CCN5^/?>G
MD/2#9G!DUDNNJD4"&%F@V0Q\?$W@^/RW&N9W8E)]('\TOOZPX(S4[>%[-%/]
MF]A%M$JOB#ZZ2/V/U'RK_53@7>86P7<BKPEX-'" 4C!$6%QCHU$O41\?V"7T
M-UC-#2X09IFC^'O$&FC7F$%;@]SI4M3WN<Z2&80^/A%C1GO&G;"ORQO_1%X+
M^?PQ5-!IQ6QVK 3U%3P2@5BW?V7J0A/Y_H[Y)(3+18NQH. "*/7JM9#EX['<
M7*5L(N*E'YF*115!=_TP^!_'8Z37$2_P= 48MM3%V[P!C"K#6ZW:N[J'4DAO
M#OYZM/,=ILRS+K$#TQ7]"$U]B"71/YS\]6&NR2^;P)P%+O !9<56KK6L66 %
M_AY#IY@R=>&;#Q0:$.DHY 8 PI$SA_;R/P5XB\,16?@!FA9R/[0'KNG,"X6"
MT\FL/@&77T]W:E^4_%G9-N4VU]'APP@18]%6WYI'9-"4[V[B _MH&!"D0-L\
MN#FSF=9$G.$P.:7WMVK]>KP3_LL!"/?^9*+,/>$0)I,9RMD *#6_LJL:1>/V
M\M=A6ZQ=I 8TDR.W)7&!!I&;]?T.F()?SP:AS#H_J@<#]^7U)2:R+'_;,Q^2
M96..EV GNP)8-[:/I/[Q;'O6UUVSN\!@P01-SCJ!;'(BHA7DZJ@,"TY.(V&1
M<P'8_APU^<1K]:%/0OU%.IJ("6!]+=: (43%;#0C'C3I.!OF1V)NTO  VVEB
MD:FQ7[B3IM8H_;_('7_L:2CS[%7&RT"I@KDA!!0$>? U*@-#N;Y#D*KL/Q&R
MRGD2RNH_84_)2KOXA+G,J-8-P.AI1VJ^WK)UFN:-C6KJ8&H!:=@J<7 !0"D-
ML[!@:D!5]6T(H7.>:++Z8GR9-2[M4XX<#MPA<KV)*[<]HA)TW]$?'!S]A(S]
MFXRW+V8ECJWF)LBHT>2/+@.K!;YU1PYW/U6@S7#&$S2)N0CLJTO6G5(4Q6S0
MA".! X/TIW8NV-F59:,ZHE=6M A_4_$ OC77;4I=5E2A4!&@'[57D'QY^Z2*
M9SNX)ID&,\,N_WBJD-(Z -;-!B5'8S<]M5E]K<'Q=F5PZA0'/;#YE%?0"Z(#
M<O7TW@!8YH;]17QY$#,9X-G+_PTK&P"SKJ4?.341"]P/)75<;RTR;F"5Z_[1
M.K2GZSB/)]+#W33Y ^P["U'_M*XKA$B.PNB&+R>R;D0%J7ME]MH2.YBAN@'8
M8^#T<R?L&KTSM::F.!SA4,)8O$C_8X62,O]V?[R,2$\',7<3J?AZFYCH5L7O
MZF#<?C\L3I &*C@-:/:;V@"$QX,\PWCH@I.EL4^I'?QP643#<8CB@/5G^PZ+
M"[Z#FI%Y>ERVU3J$X+&'E)_#G2C*Y]3I^'@7H)Z&L[O&%Q<_;0"F*S@[.B3D
MQ>,?0?/! P/5K7>L'QE$;[D,I_^QPF3Y=?1J6[J+5UM([=,D2KFM$[0*]P 5
M)3< Y3Z @!/B"B0XDCE7/Q[)K=B#R=4?IJ9QNFZ/>B27#CN$%V;@JLK2]8;Q
M(DJN>>BT'"JT"BR^ 9BJGQ;A',"WP7YZP2EL@5FWM U G'<AUN$[%D6"S"E,
M]SQ1F#W\R>_])'0F<D8_/ !3!$-:<X[D)/..40FZ#NH[T,[L<:'BP F+*(R_
M"C?,>M,,V?$9O75 :%X#T7@,PJ"L9 >!N ]X-4M'TN=O][K)*Q4;6_9T<SMA
M:XST )JWRER%OB5HJA!?,3Q>:T_]_M-+6E6WXU3=]4-+[S65XP/UJMD3VI)#
M6X(,?5^J[Q&MXX4^G%G:H:R'0=D-9=UQ"LH(?3?^Y,O+K=?''^K!)F;\*#?$
M"4\N29H'[P=@6+UA@2 (B<R>4^/.%Q#NVP _:A#A=1(:WH7!N$;D--VR)(D[
M6=MH'5CI0)^AOF,%,RYO>6?^[;"C".N"8LP&P'%YD)]=;2EWW9Q*E*4#U&U%
M?D8G%.*0Z_T45<W E^]OP'S5*M"C'&$_+.3ZP+;89&7W.$^7IMX#W.*&VW16
MY-[SI3A+H][:N6\T@ZNU86K>+H3N@L"W**IEZ;!ZG6V@33A><5A9*"$B+>XS
M,R.MI2$$"&KHBPQG/+AK=:.2LE.A,PF/)KYF38%HT2?;6C-;WEUIABX016?\
M#6KIU/7!F]<0VGN>9,8*^/4Z41.QU[>J82%%ZM3N@5G>H?EBMQYW+[37ZKSP
MS5G_.8;UV:I"%[R2)=*^X>#3;9!3&X!O(T=\9<84:[",*(P/RF_],6\*-?(=
M958V6^6L.3: @B&]5PMV_W&G6.S/+]S71']8J3Z:."$Z?*U2FBBK64V4J@RC
M8ZO6^W(&W-GG*4[,9*];A@:S&X"]+L#ETN2T!&/;0>-W6#<<&^56]+WT=&PR
M8^_9G2>/V\HG/$4N/61@H.7&3[X?W9'M''^8BS?+8,.>6A@JKWR+Z.B^>(U+
MU$KFYJ(Q>'*O>P^;\D;F?@FF"X& ?^#WDW*":SM?3ATF+MJ/PH2K:'C>SH K
M_C3CH(7QCX6H8&^WHK1G+*6RNOT7ML5&I*5^SL@XW&*OJ2M2U\?5";+;43WN
MI%,%PTS:^N#$^/,V/<CE4TG[&Z(**"542L>%(2M%?;@!T/QP*5-Z,NE8#7:D
M9FQ!FQ7.L]2Y8G\G7%[)F?J BS_/#154M?O0V8.9J/N8M?ZP;'AM*+)XXJI!
M3&KEEV_)V9W&3J;A?NNKE(%O3H!R9.?]#MT21?9"X-TF%NR%BO0?B5'5[B+@
MVN/36I1V4G_!+9^<EB=7G!FFL$"5=O)Z+OJ%%MT,WW\XC^KN=NPAO\.=']1*
MUU Z7W"?%%;U<\V4/$L-3+]E(#X&?/;YG$<RN]16:1&,IW##S!]#CHN<>+0!
M0$144NUK^.,6Q>39'W+MLJK9B7/ 61$_W+HV]%BK5F+>\[F<DB:V@9:L7AA=
M3Q^1*O+#G;?,OGU>HG-U&!%9M[K]5(_<Q(2AO:S56NF$T@; S>3A!'+'*0O/
M[KH$Q=*Q9&X>_0L'?3[QUAE(M?MG].FM(T]SGR;XX="0EF==9QY\\/T2S4/G
M8'/5<\W>4,;[36(?0UV;+T<QG@1HZ-GFJO6Q@NGG&N7><?,LLN886>\^L=S?
MFIQZ/9@<9FQ;ES\?6+'*L>3B9X'K[@<"%>6WJ"@KQG*WD!F^@C!,[><]VHD'
M5-IT%RKWP8*15I15:G\*_'Q*?NN.'<[B+1E?.F:XA%PN]F#;0\/TB-;;<#IP
M>@,PJDL7@+]A/8NM6R%W#VG)VD[6VZ>1^4-!>T:'L:5"P9%P[>(Q;P:SSABB
MTBE@VM+2Z0?747P*FB -A7/# _/AL^Z7OGZ;F:E1C#-C/#TF>'E@"1ES+^!D
M^VU'*#%;EFT?ED@=6'E/2#PT ]'L'&%G\W[F/M,"!G/" PP,W#H'W2<K)BO]
MOK&@>MI/SX7:U: .OD7U6'5,:N \&LH9B-&)%]?R7%]FW8LEG#+T[&DG8: -
MM5"3Z,[+M#NER!YVJ:GM-[2P<!@WY,,VTZP"VN@505GP2G=@^Z*OV0:@4.L=
M1CIX+\VT:<?%E\L)V<&K&(AI:@\\N.D'7F%F)OA5.+MDE I)&J"J?#@/=;CC
MW^F;7OYB@=(5:?N NW_,8SQ<FRCO:0\C/I(]'>FO3=3"5@UG2A?)68;?>[CM
M+K@FNDD7)@BAO7J9\5;JB-"'4<==BDUB^AFD[S3<T*E<^4.7.ITZQ%X*I!/%
M?O*5OOXX+EC8E@OY<'\BG$>;K64@?/I6Y3< NVT[_.NNT!PDPB<W -;+X3GE
M(PZ&@HNV-0+1 YU3_F:"?(UI*F@S>[Y$8F1, 9D!*U_P\T.D@B-JS/7,!,<.
M#;7OC*G;KRF&S?HR%2^ O8E/_NF1C),2<?5L=$N57<N)V[>E&:ZE:KA&(.<J
M/!5UC6X);^QA'TUS(-:]'9J@L38 ,Z.W!^31:S$*YQ#JQ8;V"E04]2RZ89$G
MR[J[ 6C:5B:R8#$]D>3&W:+OP_:B)H1S];1QBR>8;R^O!5\E,'*"@01\$?08
MK$E@L)E],"10UQ'Q65:05Q?.LZ-E$XYY, YEVD@K:#DI1WQZ>21W\L?_=P88
MQRU%U5.*T0.4#USYU W CNAO&X R"P87&SX\4=_BXJJ0D6D@#LS!(XKTOE+M
M;%6%E#H0#5^(?T/,57(RWJN6":N&2L# 1N&ID]4U;F(0!"@X"O,W]'XIAXI*
MFXRE%X23O=+&/(LJLZ!2E:@<>&FE!NPC5B\L#(HN.G^)JE7I!AKO8,*0L^M^
MIN.-0=#![Q.\*B"=3&)!RX<4ZN=F7\)@@G,\1/ITZXFMV[OFAA""4<DKOIJ;
M*&:PT;ZS;3UE6ET13+"2;$(H ;DR]U@AO6= 5A<(0D1A=</]HE@W8H+4O>\(
MV\XT,6MT:7]CX1XII8B,9&F"&CHPZSQ$@?R>V0]L'8%D=G>VAJG>7TSS1Z@4
MP5%;35!M$_\GT 7R"K/OV9</)+/K@4JFD3"U!/T4@*:=C.*(JI86&"R;J[5&
M%*2_^3U*PM:[GJ=%"%\5Z>A8)>*S$<-/%1K\_'N5T?KZ5(&$OR'4@'REC+R%
M3SM$%E?\)[16.;VAK!M;F?'ZG2V.4*JL @YAUDZ$%VU#92 IUZ^*\&?L!LU5
M3EL(Z\9N9CQT\(LCE":HB(.;M6]"\T[^APB!U!?6@4!$<B)VD]C"CX<_L]:%
M&!U-6](BPKV5^3]2#-(XDPD4 B$2R5BT&'\N_P^#^27F VCOEQD>37;O /PO
M'#4 E=9,$1(V6%SRG0BE<Q*T6'U&S ?Z?2TS/*K@G@$$I)L +P ('W'Z,?)R
M%AJ!R$K$ #=I-I=C.IV&DF43DVE+(00XU!=L RQN;>W2ZN1D@)6D<K4(*-K<
M[[/WUI>-3O#2SV+@NHZN0")?NQ%)%_;,1:U9M1DLE@;P0"CR184Y>;:%:#2[
M&X@RU0.KY.JG;&V\#W[@Z0)E"(*G^?D$B#T2?F\D^V[C=>ZDB.XRQ@%M*G<!
M&>3URJR%@\X%8VWV%:_QQ_/FB'7VN"1?)^3H9]^(N;HP7@Z+8J)U-SD0@./V
M+[+N!:0Q5Z .9D :QFRV1^9(!Y:?2WSQEIR0$PDSZT_=O> Y7@JLZHBF^8<2
M<\/X^M1=M=%4OW\$P_H$#"21-Y$VGXXXMI:=X/',>KB;/I? LP<.+V0"LQ&(
M9"R0'1#-UQI!0G9EB$5'#AI'XX2^Z9Q6\<=&M3<QM?2SV;1D5A]@.KA8,7/'
MD1GLY%3 WUC&E!C:-;:"LRSCCM8&0 1'S_>OPQTY0]A#(RPN:1(2M -9RT9&
MS'R^($EFCP/YPPJ)_VM^S[3?<^B&=;?SVCL! 4:&EG=]&/2R+M=]7S%$XWKV
MDB\4*JB[3&D3)%W8NOW[2*6;E@]"=G9F&;M)J^S;RO2$]K;,0&FR>W#PO^B+
M.ZV=[\V^G&V\#LI*QNK^A:Q4F/W,OBR0R*\L#8?(O_"+@'V--HBRSUK@^H[F
M0,)?1/C+,5^=)I*EDI-I*Z$$A+<OS&871-%@5"P;,3$U'1;P%_K\/\7(/Z/"
MI6/&A<.1U"3@LT6&^2$Z&)GZJ(FO9VV1^G]Q& U^3;7^I$8G1(6*&+B^J7.5
M,$ 3)Y N /;,*;,51*/8]=DHATBP5*Y^^>^Y)'\1H@(?S1 2X0OHVF424XA&
MS[]4-Z9Q)GHOC4#U#?F;C\0/5//<!$(@.GG%7XN(\%:%&1T\V\Q/*BX'D<[:
M]#,^8:?O?4=54PP,EL(AH,K\[Q<W9Z5=YG:#LO[Z/B #(@N^YTG@>IMJ/Z1S
MP4;6>TK\/-O]T?IF/>V$A% 2AYG?R=1D&[N!YC_SFS&*S#*OL7_^/"T@E:D,
M=3#@"W((L0<@?-"KM<Q@'9&U@F7R SQ97>DB!DD&AT=A@0$X%.X9\,/8\[3D
M);#2+)S6_Y_Z%J60Z+Q0] (_7X9UR$6@R"8WZGJ],C$,52B$Q(0"+:J4<A 5
MZAJP(HS>7UCX\T94K1H7$+Z)B=YL]Q?^MYW__[>= YJ"XVU5119=./C-O13D
M;ULI'H<F5?Q[P>CHS:T4[/)O6RGWM[S_WV;^O\W\?YOY?VCF)JG^MQ3K#+YT
MPL*C>J^&\9S/$4\'_9C-YXAT,9TYJ^\ZQS_8/DF.2N<M @@" [0?R>NNO"-C
M&P#O 1;.^(5W0QB%UHB YGQ5*_FS0_2XKY,>+,U,G$,J/;3-J])-3/-"J,-X
M-@QA.CCCFO@T\\0Q-7E!O4CM!"[I6+^JFM;-7J  +3R0PUIES7V U0Y_@XQ<
M)4_,0B/1%SZM#A<@: HKS99(CCI"]4;"S>N?SWV$SA,D;V,G]/342%COU*LN
M6WBW[R#*\\!*E3JI0) ?YB0JM.>DG/LK4<X9X8@O(I,\Q-.+MUQE-+"Y34]V
MM_9*Y(H0<)-YTG-KU$F+"-25<!\)I6#[<Z:\Q5?I,7.E7@HCHQ[3MG?JPFL7
MJ<'%M>.5G^\!N]6. [O#W%# \+"'YSO7YRXU;EV.A]X\?4X!/[GF,R$I.)#P
M?28<9U%YY\?X[3QG&8#^3?PQG8!U:Q5"G#,$$-)VV!]XW[HNN2_4 ($1I'\Z
MPGE140ZJ@M=)G./2BX812RS@^M@H0M5D<G&X$M]BC;/G3K(>P)(8%+(T>&D<
M7W[A=I &1V97=G;H4[9Z5RX8D\M5F(OQ^J;)UOD#":X]%0>+B.)$UBQJTEF0
M-7H":-W;9_1XW/-$PK;VMB!82V57U, &H AR[LRWVA3#T<OM--^+IHW<'<+:
M7 4N:)H-*]22,$\!?_?-I9EO !#GBBL8%6RT )/XW+7K>3)Q]FD5X@RDW-0L
MT[XKW>1\!<O[^)45"/=88O!6K]*Q[ U "#"(Q0 ] XJEFI2I+FI6=GF;K<%Q
M BN<\1OY5UY-QYX1&14.EF5+D7F1W^ZXOK \*[8/AJ/5T-H&.E;UZE[1!^81
M90[#C/HBBPEC)"*G7-\L5UM#$?@I9_[4@%MX,(_:+6VYY\CB44^ESD>5=XEO
M"-D/J;AE!=GN;SMB\IO:?6U%051);<EH%,$D2W0GI^O)4P&JT)QW6)6NVYM5
MZKP+N%&^U#S+[+0:&[]F)IOP> -@8VUX!3^"FH12)\L75X<W ![A>%2&UA7_
M*L6!,N^/C<^&&[D5C0CA'\J_[].\=*9LB1?4><JZV/MM'$X:0,U>Z_V@2LTH
M%.7E98/9!KFO_5;!-\U6NDM][K0#H41!=^R%@%RTPZ9!X;-T:=L;YLBNA8)P
MF5$J.G(;L</+1]^X5<-\)<RFTT:'L5[L;H._?5\C#3<*%+B<8B8^="IH\KRQ
M*H%2^6"7A,F,SK20M@\VC+NT ?@SD*_W/1M%^!_U5RF6$5IL57N'>9O&3"[B
MHX?H_*G]5+6+:D:W[)I?8/=I:LVKM,+ *P4?GIFM7\NX/8:1.%^8.!>:+ =V
MLQ3(KEL0&-#;:]E']]H>R+5\B*LUN ;^8>OM^>YA?<#)Z2U[HE:V3H2'.37Z
M/*OV.=G]^;SO^F/BI7KKROSYX1B-TU[&XWXI=L<65JO4,0.NXHON1PRGG34M
MW_)T3B<E1=1W!,C,RQ66(S3*&A:JP._@H\T\X9/K46RO$.=;ZUI+S5-7*\M"
MWDYZ:>NIF38DN<^$M]S?^IKM-UL*F%IM4UA]RMMIRS[$&\3ONKL$?@:5'@E)
M_S(J)'L=7;.44.7]X]KQ;HMZ$2FUR!;I [DJV8G/>*=A]_"C G9<!$]E'?;#
M.VY*[6/KZ_G#.'>W$QYW?16)^^/37-H68"'00]PZ:!-LR1\<!_94@DN*KXO\
M4(JJ;-SZ>:CBF,[EK)9]\[M\E_(IA\I,9I]W&'X70]10(#UV%LV(D<HWB;.!
M"H[$J[Z%-B9&#8?'O1;2*CZRB\VNR(:#WKEJ5L0CM:N[+]U^;WKHKN&M^$C4
MZ:'>E1O1C:]&<0N1!1N [1G<L@W /?XR#-E1;_%ZO2G0!S0?;!/QRD5;=7)G
M\9G%Q3M>TQG1\5GN]BYCV'&"KC43&[+H!6[3/S_T$"4TOV\]W*R^+M1Q( J?
M,3'R^.Z3L*T[PG._HU9#^&E1L7D0EW<4^GT#L%77%A42?K-\R:KP]<\J?1F$
M?5F94D#@N?L;@/(9@Y/R9JQ+8ZHJ7]B8N4,\G]RS2XUQ2P@,],32E4;D!F"7
M$$MQ(0WFG;A;6RP_A$&8)<IG.R<_8V&%'LST?=7V39FU>6%K'>-@\_!#A_]\
MS?Z9Y^X%X8;S!7W,7.DW&0:BIXM%9U$B?D:JJ)T,[P#SF"'<K=2&R8*1@J%S
M:W^VZ1B4=Y[,2KMA9?=^0HZ8EW3;Q?D0PX!S0&,M; E+46);K1M,(UO%WR[#
M8AZ*B+JG54F"OK:X/K%]?_E*=1[!]U18\-1#5.^(HA(50=GS0^=Y7C;&>\;I
M/&6??JQP$];;@U[%VWG^H!5XTV25<96)'$QO.ZH6&94.J*Z+GIV\L*ALZD%?
MU.GQ+9G.C+QSR:+@DD6\Z\VKYT\==7\_6&:*9?.@;CV^Q=:G0PO,/"PO?2O_
M:/%V7MNK?/QMMNWC5%2/Q)V'MB"2ZU+=].'H)>3T[@B=]6#'1O&RDO[M:>F[
M8P(>?+MP\OG+N*1'CKY@W6<\>["'R/IQ! 7"]H\(7K:.YYV #@8?]8E1I/\A
M>?#;S$#._F:S:WG)G7=TXR*:B/4]N:JV8BCR\Q;M/-+DX2'ZB-2^QARD64A[
M-7@^V4^<$T*B1$.(='XB&?#?\(X(-QSL/OK ^I%I<*O(_@@-LQB;^#!+^A-X
M\&QKD='[](("";Q$TL-X+C[5X)C'.EJQ\'FAM>1GF'6"3&5QR@(>(VX\(N^@
M5CK<NV93% A^B#1I.S@;FVKS,GZ_Q?/DM6==AE? $U6P,$,92F$9^'K$Y0W
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MUDULDB61$NM.J 2,FCJ]EA\ ^MXP#F/)K^]#>K52D<6[]"8V+F1U*S$_RZY
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M@\O--4G6=9<I+>K@$Q^G*4H!#*'Z'IL><%FX8ZUWXG@,#\W9/#OH\!$V[."
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MI_.(5! J'H+5[94[OG#5R# 3C\I/I-*1G()>MRZ.*7#XI$U$++'&#1,'&EF
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M5E*PB]24)2E6X)_).+6BWNVF2GS[2*)RE$IKZY**<:&8D"D%Z&.HD@&N[&W
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M5S#*.E?DWPBY53#MLKB?.<@OSDZ3.  Q%;4?A1#8]YF&95+ FNC 0=M.<%E
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MO2#.[Z3_UKI%&)O]?-$<.N'*]V=O]AL<&NKI<3G_D!\LJE]X86V*O5*9>^&
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MB^@6X/8Z]=H_V#1GE=21'\A4OHN(6*4RA:'\R]+(Z''HDW3LVJU1'_P3P>I
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MH=<,$&JA^*  _;:U ^- YB\<07;N[@&*%_LDJ:*A%)PS@H"5!"N7!\#S.5L
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M/N(S1$5QY-J9;"JN:F&WGX[!U'S.*<N-O!.-5753[%UIFJ=>?Q85ZI?L8X>
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MXQT[KX#(4Y 5T&"9F4Y-M[@YK1:]$703R%H1FM(J_W>-^P?GWK"U^O=G!IQ
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M5[H:T9O5Z[TSPM']1P5A5'\V%AE"7&MK:Z+-DAFK\4[H(LX"!^T;6RAFL=?
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M[O&#P)=-YT-;DX[F']BPKXL:?4IVI?)+.'Q8U).C]>BKM7O6ER'_'GLW<JK
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M/GZ\].CO-"N9VF5UC0_TK)%%@LE*.>[(B75R3I+@K.R.A3!K^*Z 7S;V/^7
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M+(?["$?&2'\G@*2U"&-*_JV6)8 I<S,XY?>4:?6M\@6?6N^?.M5ACAA!4I=
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M7Y^1]Q*W)0R7WS%8-T9AT")/4 K,?&U]9 V4;BQ^/^/^/7JM?,=M72,) .)
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M,L*%8[3E( (;G)-J\QK[/K_9'RX-I4 BJ7^/@[Y.E,]R>,R7 *5(2.U-T[N
MEN%-5IG'@X26-^L^L80R!)7%@*4ZGJ!#JFMSTBG6]J6.^E&ML\%1N.C5I[_1
M<V#O*^C^K=JUAF9SVR?9HA+I?"L!+N&GU'OCP>LG-@(ZA[<Q"UBDS<[9JK
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M6>"O+R.$"'Z$>W*#\#P$.1?X<IO*BM5B#/]'+^<?-)":O?1[)H'5J*7 H?&
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M&!X)S[DK'IY:K+RVU>;IS[+KTLB:]-SE)8VBC4GO+9L:I\>_Z/C0]"54ZNC
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MY]AOL\)+/AE+XJ0?BKD/872CAT!@\+>L_^,RQ!/V9&,/C6R\"[#"I#=N#ZG
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M/$U/N??LE=5%$':U1 J5>GY_N)Z^>BV%T*%8[^6 /7=#[WQ?J8F*!ZF $7*
M#W+#?,;ND9U1""ZA6":)90RVG#'-+:]$.0Q9@^I\\'%,FO^KCVX+#\3NXNGX
MUP(WB=KCQRC\[FL?/X$,^C8#X(U,7D40I^SNA4=6/8$@F7:R+T$.J#)Z=O$6
MQC[_LBG:?&(V*4,@ZG??N\=?6%_$<XS&:[2L%$&\)*^;6X<W3X:1@OW1J8<X
MW]DE>7EC!$)>%2;((%@!\J@CO2\[P1@5,U-/;B;4,.P$=*O0A=]U1K)K\%:5
M,C^5R ;0;T.2H.G$0SR'^OZ3^Z=(A4N28K7$D!.M%Z3O#SO=%GUUO2H'# G
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M.%Q$?MB(XF\X)W;DN3^<%V-N67\+??0!WYN336'-+F[LN]K6),(55RJ(?-1
M6J#"\',_\P6+[2I/DKDR?+X<\!GJU%Z:$_BL\-Q 0E<.5SL9R)7N%MI\DU7R
MH=%@L),G1.M_T]@?F;G[)/C14(Y40)UK9W.GAPO^Z<?S,CT0WZC58EKDB_)N
M ?==6WJR&;_K3&)RU!#Y$6564T).\IV=S*&+#6=#)%9XF:&Y!+K*[Y^?-TM7
M\J$-8CD *]%*!7MCQVW5"GLX?\?GHS-"V]DX31D4=G (/9,>U^-+(RW"<W4?
M='0RVP'N'&JWIOTB(G?N!Q2!JS1U*+PZG*EJ$U)T5X&J%6"?2L!IPP*Z'<+0
MW#-4<4M_P?+-%0_Y ?A?";DRI1JDE"M+#<K^IQ4C+ <OAM6(&X5-253%*P><
M:0T<!FJ[,DM!I)I9F2:/@4<EG?SCX^Z9/_)M2_[ ^^?*QR<3C7V[24_Z9L(4
MK$R?G"8 TP]M98LMJ0'D-I "Z-L6JHE([99??\BE?S@8W= DR?H*AM"1[4;8
M.=G>F&D<\KK['P_I*2DE[].!$,YG"?*7D33YVZ[>ZE [9:"IXU$HA@!$#=[0
M*^RAJ+(-0<(X)DZR6C-&)MA0.9GZPH06-ARIH%/@.-ZQ613W<N)/&;#%CKY?
MY_%^D#/$=QXL#9->6WJ<:_-U@8,.5>\C(])GZ2C'U&2"0APRC&CT-<6D13$6
MK1!C1@N1)_\PKOQ]U,#.X.X'Y65)?F/2),AYP#OVD"GY*:X7H[[XH(KD $RO
M!="D([75>S0:HX%5X0HAFM_/_5>C]R5R '@(FA8X/@F=2\11%_[S[H+VWS-R
MP*(A%'3!0@1I@?Z9"&RKUL %QV.Z^4.P-DLH'ID4\O-$U@9AXIX&$CK<T6PC
M=1K1OM@Y_CV6-Q(-+[:(58B(BI[-4;?M@+O'BG*F,Y6]1W/!=U.MB:A0UQ;H
M]DKB2QKW2N&".CIY0Y]E+%,X+U()".R!G/4M8K5;\^DPY(*+CK\;:8_-!PA]
MY]RO) 0T''GDQ/$0H;.Q'+"JZK#V35@XE-C_NECVRNTXU%<KO%0"1C4\DS1G
M"\JQ+2ZLH2397[6WKGU_=^VAV5[@LD!@&QSP@2D[5+RC@Y9G]:X11'XD$T=S
MDR[+ :+7/_YGIN\@[;KB<CRVN?_;Z%;WNA)(N$/*HP/Y-*<":R#6OV)PNFD*
MN^G:WN"-[USWN&C9+W?"68FX(\E$'6J:^:QRQHJA">@5GQ"\J$?H29<BB-8&
MK]?FWU9_[_^A.^TVGH"$*/OR>J/@YEEV-U)\USWB-&UD^0%FKM#FE<6C T^P
MPS(N<7K=0GA0\MR '  7#0_&7_0UO)[TRK2NYGUNZ-S0KB)$X24,8J)-G$PV
M@8S( ;5[WK_4:5^UM@K\2RM0T*&-E28)*\]\]N>'@^/#1<U054D\3X JAX8'
MULL!=R>E+^JWNVH?\!)C%?,G8$@Z"FZ;0SU;-U!ZN;JI/3HWA!U6EO<K(NF!
M'&#7 ,V+Z+,K>][ZZO; ODO\LXQD]RDV9!B(M_+()_H'HRBGG^0\B//L8CET
M6O(\@E+WFR>25%-0)L4-<L %=#&IFL-BP'"C:?20+9SF/K- J?<H*9K#XDFL
M7^]<E[CF7OE*Q#,3A!',W!_TRW)NY.Q_^!B:-X6)WA] %0]TE?);!N: NP>Q
M@K_?4YS8$%-L?F)AGS N\=)[JU[%=(V7FN!#?)$I_3+!HT(CQ&AB01^8@: 2
MAE\\MJO?]^TD]=&#QBX51)YP&@ZY[8*X<DW0SCK\:4.?S@>9%= 1A!S4')W!
M)EZSNXCU:6-#=X:GH]F'WK=2%#H]?2IK.P61$YB35D3OQ8MMR-!3AR?9ZD,T
MWR)H%2[%MYA2?NC6RO.Y<8^5ZJ\@].V4U_29$-"^#DM4QH1A.ZV$2)NS>EC/
MJQ76FTE\<)M8 V7:W!K'W>#6]!8E?A.\D8(V&T].S%8SBP[G\"/1 ?'TA7C%
M+R=;UPS?X;:&REQG$(:!9/+O[0GU:<I&S:M&NH4[LC24H^OCWFUCK<:[JJ^V
MWP(+P5S-4K8<J,E7!^Z))EI)ER '[8,-R:-JXQZ53:J4S66':-X^H]*-33YO
M'TXR-9I;),PA&4JFG*E/:2') 7M;ORT(S1>/M9^;6;>VNN-E=*.&)0FH^+?3
M5Q]5)P*GRCG5,!V$F9!.J@37"E/IS"L]9;6960NQ0JB;AD<+F#;A\ZE.X(K=
M3 T6&A^E0Y7SL8](7!JU%0]U2M+H$::@#-EK9($"#!,_/UD*W5NB_,#.UNWJ
MKO@7UJO'?F]+W'\"SDF)LN\@U8!WSX?$2U.G@J1PGR2K 4/]E-,GR89.@Z/7
M+[=JV7QO[9K!-C,71$%OTW]O2Q2Q*,5"V;Y&.I","XDK%13* 6F=.&PQ&BP8
M9','2Q^?\(.E.%M>#HWM&P"L>=$X5;KD5<2MQ5V)TO^[*['[7QM(4CD S8?X
M7W+ TD9'WC3)!.,+\]I6O;V30HC/EB&!M(8R_<QGE(L-,!%C#4$XZ4%)DOC\
MN;<!;D.:6=A$H*5:E0G.^I7+Y2#3$[_LV_+[=#MD*@A'\Q>2?2W;NU<[I(2.
M6H#UI(FG/<"S;3,HEAR0/#L4[Y?6@V-;H<P0A@%QOE)LBJ_-?'K?<#1-V$ '
M3J7.L44NZWPYE!#G'7ZL1S4MG59YG7TK)WSK]%B21R7ZRRYVW*/W:C72K5SB
M,),"M_IT@P>#'@;1P<0 :U"Y'.!SE>^%_;(P+-WW/9%;KY+H':A1(WL3KA%'
MIY&)X/2Z-?04C%7ED(: '@9EP!/:K2V_G]G!V6QTR@6\U]?F*MRX)_HKGUI=
MOCB+YDY-'5AW?NU9OR*P51%W^H$-V28\5FP?]7)&#(*$! 7_?C>$<'80!UNB
M&ZUO0!,F)YG* 2U%:TC1?19,7(BS8>$DC'?)J$\QT(JAZ=8MD;(-0\W5NOXE
M6:15&W,LW6AGE:(2O=-'MCIEL=;!02HW'8F>,X"QM<F!_1FG<DJ&;U\_-<7S
M\*SV"*V2OD61JC<PF=?>=-K8L=R'AQ,9H:(</$8'8GJ9.23@LBG:!52; 4V?
MQ)3>IQV<>FH<A3\G<6^/)@TC_D>&[NC,!N704*? RCH8Y%)*(R:V:>:+SX^R
M[!Q!*K%>S&%R)UL+=_#8P_Q=%$/-$$XU^H4<X(ZNCR2V[GFXB>-Y&MW[4:=;
M#G!YA(P;,^^S"*CR_!_[NN-W3)Z?FMYZ?<!Z&E,7>J&_*=R_M$6TA1;ZNAHM
MD<#<@+2I7,1X/1_L@1V[(0N76!F.C\;[RM8S_V;1%?\2=L^"+YF6'@E?O0FJ
M%\:*%Q8;4=2GVR.E:Z#Y%,G:K5,^"PG@MH83F\ +IVL/U]V@P&H_0)\JMT!?
M;IP]%A#@LNNG[<J!:)SYO"3)-S-X 8W3#N>UPMI6C^=CNA"UW@3):1\S@:=4
MO(VX)#W\XFO9O$S_Z,GI3=\/8?.8U:?43/P:A@20T!^_=0F8/(E0*YBPH1B&
M*Q9CRMU$"5;U^N[_:N..U;4AH$LD3UI1<>!_!VOW%/PN*V%R5 -)P=Y[4\A)
M]+G)TD^I"):-',"6 Y1]G(BHA7/;G/0/9&H89"<J$Y5^'\U;(M .9 D2(22C
MA<!PX3S[6&M@L79*\W@D.HRRL,G&DUH%U=;/^2]V[O\O-DW(N#-8#CYP'(N2
M\F2I^H^P,XSBPGA-7PTY /@3Y]B<%%<ZP;&ALF5\B'<K0@J=K:BG[(S(T+"J
M!NN+5*#>\P#A'T1=_)\DQ8,_I(?%8H.\YO[-VQ3HEW:3QQ!^7=;[)U>_2,'7
MVEA5DDY$HP/'):!I L*;I[%"0OL<]1=NCU,/)%T.J*14KOIG)PY@X8^G=*X-
MZT>*\P6:S@3*E.#1,O;!ZGN"TTUF.N#]JJL4=>;CXCE9NS]:<6YH8F1]"T/H
MB+Y([*QL;RP#ATJ"LFT4$V4O'Z(AD@,H/O3^DL7#J5OJ$RY#SO&VR%I>4?2R
M%J.1:CB\Q19:.> .P'X_=94RAZ_I&T:FS.Z7 SQE!R?NGM]C?P\QOKH#R(Z5
M@*@9 259YTK.KAO(-.Y9S%V6[+Z_8EKS13(==$6&UYOC,3T;"LT<#M+>-)MA
M W+>$U#-V.XW*A2SSR65+F\<O2=)UK7B'VCMP&?8*<'<HX8ADCH)IR#W#1-F
MJ\;>.9G,#B$4T'K.X9U%WJ-/ I=L'(.@!55MGD?B]I@JG?AI**3W27PKDA3(
MXL$[T.1<G"_!Q(NM70<GL7VXOWQ^OK$\G?=+MJ$QOZ6*S>*\RQ)F<$.'&DKI
M%0<.*P<QYG&<7CNDK:_)QFW9CL?2S>G%C;*$::*F_[?W=_-7?0Z)>!ZKN=8$
M%R8%EQ]'OBW([<U7%\;QE*Q%5"T<8;"YJ6AT>.O+-XEDYC3:87,6^? OILW(
MMSA!O:!T@>?ZON5;'!':BPXP,QN=)J+G()Z^PZWGI>_5<\;WUU[4]YD1PX>@
MO- %!?(VH%Z'UM^RM]O7^,X->8Z$G32@A9.VYTIV#SXT")/AFRQAY$X[A=[Y
M[M9/"Y8B5[+(R=>]-@H>U2GNDLBQ =N\OU"IIYZ\,CC8(.A-$'J7^! P:R$K
M7&4Z>,.-"@+Z-MB\@ZKS4DDR3S_&' (.F]*!F"%T')B!A%:Q?N"O][Q/W';7
M]%CLFMJP*YPB46 C'<GX<NUI?X1F@.D4K4]IGK;<G#]E4R<UNA$^]5W*"NS6
MYI_.<_<F8E/5)GMB1W<Y1CE:]=>=##:@A#UQZA)X7*M;F2(''+*AAV),9W"A
M"U3S:;@4],H1?X >.&Q)#<\C%/EFR!KX+S,^F:XK,<9]\ ]S;YQXA3NBT(>M
MQ_S82VY!\3N@">8B**(?<T@22PS=-*P9>JVQ9:#[6D-YXO7:[,FI^>O\X+B;
MD&]TT[C4@;ZX&5Q*,A4E![R&&^5S4K F\7A,F!FTA@GC/KMWYFV[SM_"A"UG
M(9>=EL%-8$ZREMT/S.^G5@E!%URZXMHB!V%VJ5ZLT<*02M%]5/*HY_OK5M49
M+AFU/IN;GQ079_^B7'C8^V,TH+<@A4W"S$HL($57%?7 F1)(HM$G^ZQ&Q-!-
M8-$/IH/;I1M'2\/^NA$!.:NL9.6;.=]PR5]W*2?P_@89TTYSW6]K=G>(*P7%
MDR;5UPT8!O4"R4/F9@F\R4LQ28>^&;E)3TE+P_,1^5NXT6S)1<4DI+>L%V(V
M=P_5Z#\JC(> TWV(&?U7PLZO7V4/]_,5UR\:4,O TIC 2Q%+=<)V'HZ".*LI
M:_K"O[,K*LO]7X>)JYY([?C9IP5%S*;0_<=GIXJ'O5A5%$Z)2P:RF"8L;'7
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M.#W*IZT!-FW)I_RG;_9.-[3D(,"<_S8Z":P[BV<IQ"[UP]_M^J$^$,6SH&6
M5J*!""S6"SHC6O]0?0J\_2Q,L4ME[Z>EH.?QF;UP7#\6*/E[%5"Z*"[WMLMY
M=<5G\M9FP(ZJWX0Z^.'5R3=BS)4 [;N_-+O?><J@(OI&"G6PZ0*N#$-REN#G
M1=\6IB@GKY7,17FL ?1+CO\MV/>X9]F8)VJ@LKZ478!DK.8=H4W39JG+ZWVE
M3QA]G0]F1\:K=VR4T ]8_!$UF'WNKW&]'YC2S8-7S:R&03-0=TS5_C:PGD[
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M  $'R:.-/K+!*&!<(LXLC%!&>+'G':D@![$(-J2A6",YJNDI" 7U59>3)=X
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M^=N+UX5/GYP,%\4.NE_,& 7/[P37KC@8TLJZ^R-\J DKA(3XA<%>O17HW^'
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MI_8RY6ET5\)WX7YM56 "U+?[]\V)#" DAC2A&9YH5B$IS;D-21%*0;=+G5:
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M_>Z88\6VTVJ$'0\1W^9Z$'#B"_6$L&P4Q8-?GR*T.!W CE0^$9WS0>D\U/
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M58YLYZ/='P\;=-VL%+;X(;1P]&N>VYS#4B9358MSDJTBAML,B@8$"C@'3GX
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M_T\=&!^[5P7P]_=;PUU<^F()EB5D-$N0N[/N.T>2@FU<_NW$JL02W$/Y[Y\
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MB?N0/@]E<ZLJQ\V&.4;3ERT7W&1\;M^?(LI&JAE25NEIO9<.FNZU$Q5'-1N
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MA4V8/%S=\FE'=O](L@G9M@LV,KH"W=P<P6;429=.V)C-_-@0]&=L"I/65>N
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M3:_+5@$O+_TMV*<1@;P*8=_G^3<KY,>H<6^=G6=EQ861)F+1W/5(ZR/(0L2
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M*<:#^I6>ZM>8_,3E\WZ+-?6Y58/>IZM+9'K9:AL_> &':J,3,E,?K)_!._)
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MWY@^<S%FT]5+8XGK%OEAF);NRE> :K :)N;_*5?]WO^BW+4P249W:K'D^*3
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M'@TK&N&M.-JIYK2YTHM)9GNB9<'^I^4!(B$F17.#V(1EVWC<3!)SBL)1)^S
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M(D=XC8B/?[6*IY.*@,L^I]8\25=D?3#B"2K)8R[!5?G4%V%N\[-R#6?Q8=R
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M4N?"<[6,>DTGM<>L[)_NE'I()U';_IU$HLVB/,HN-B3ZM'1^_BMUCKKT5N9
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MXM'GL5T_]J+>3;W? 1\OL>8<X=2(-+;-:ANM-VLW27%Y2OA@?$H$Y61O'\%
M+=V1?' *^, OTMQ89XZT52%.WP=E:HR 'CXZ_K2';?G-K"82 4&GD4/"F@?N
M,NH'8)K'MA$>9%XE6O#C'^8I?LOX'TUC:]KK.TC/XE/ _5, 24QSO1&T)?*2
M=F%B:E2X8?)5^NY=%J$WUF4/ (FI_D('FSXJZ']'F]:G@$L'8=K41AK+6AOG
M#@1H10H)?[RV==48'"T\>O,ZZ*AU0!&D%K%W>+:&"M#%0NX1&)8Y;DS?C6DJ
M%FZ]X/I&ORE4=X[AR1_.D?,_A3P<U"^KNW6JL9*#:%,P!HJ<UR(L4H"/=MNE
ME;\FK4C?0P+E=<%'1<C]<; :7U(QBD^Y!ZJ]<N"[GDD/NMA];,=?CJT06Q@N
M!O/96-5DT7:A[X^%[Z3R^8N1+$%,W&TM\,&2AC6(CFCQ4-U\30-58>CL]1/"
M3#X:JTK/X$&U<5=E<]FN;9^M;F9 < 6,"=I1 +V^'P_51]^EEOJ12R2$]S[;
M<LNLLL35XT"\ON/ 3T;VP\,PRLVCPSUD9#04C(G),.<]_E53O2J\+]"@'K7S
MO==-88-V)>(4</%\UM0JH\",,_9GEM8L3_D1H-='F?/=(:YMP\8B2\V+VS<U
M""^$D-*5U\N54(V;2?BBJY,NFW)DDE9+3O220J28E^@S@20/[Q=A)%Z Q;ZT
M9/M,C>WP*([UG9C3^H$_*9@J:(>!\Y)SK-J3MNM+$SU9T:\^;399S3 6!RYJ
MYX:= @QE[#]CD(H4'E@I;0)X74V3&-L%Y/A&\$B=<:M ?K3K$,G37<H*/BPH
M&GO\K/7M0[I3 +WK[IDNW!'88B.2#R-)P5CI*V'&I!4<GV-/X.,1#Z#19#.Z
MX;-[0_PHUP\;K^ [0+]]@<2A-H(IXA.48(Z:/L(Q!IT"EE ]S-'<R$Y@=9^O
M:WI62H^S^"SH00;#<D5F[\ODJ[E4%=P'Z(.AGU_G?*=+C[<Y+L8C0FK#JR*_
MBZH*KQ7##4;,].=MYLH/T^YAQ4P_=()N1!9N=ZJA9K7UTPX@HQ7[DU9]JXJ?
M@([,)#'D)A,QWPI8#>P"?3[:7?/%=("Q5#F#9#?]?]F_D;(ZG'G3#[,4'.[G
MGZL_WUHP"EPLM2=8@::1]F,4??(SB@IQ%;F8JQ ^DY=2]N\4X)QPR!)WP<%\
M@L=K.*J_'<?[IND,90($/_HM.C(0' )]#Q&A<$Z&.56N>?>! \-+; ?'YE#<
MP<^VGQ%WQWP,Z<=SS#]!9@4(=B@!VMQ42&"7M=?TNBVC$9%I;/;O9CI8;3JL
MA,?SR>[[R O4A?FR'5LPB$^?.6?EF%U<.E[Q2D,N5]_&%>/8F)Q7EGN]<#F#
M>H3_>L)3$[V/(9E*V,5_@]L1=LNI]LU%2SL^,^OC&,]R6BIP,0=&L)..PM3I
M1"^1O$()NWU+;7$CF19K@8J7T>AD48NBK\\-1,\))=&%UB.&821IR:/H\GT,
MAZN'OV3"EQ.GY5;W]\WO>6::G'<</<?_!8TH(5* B_%0@K[7C-QS:L$#V(QY
M-X2MB5 4X0P?X)&1S>TR;JIM>!YX9@M\1G^JC42UE0N0[J$HK!A]ZD^HL\#U
M,*7JA,MJ^L5!/AN@1/-=RVWVI<T%H5N?ESO,;S%_V4M\92]GAV!8"0-%Y')?
MJ;QV)5>EZG ,)AGX8!X\F9J;ZC!68^6*UC;Y&#9$?Z]1?N)F2VG<XA*#S[1*
M4&C!]N96H!L%M0RD,?G7:5'+*OV97N=;S5F2/FOZRI;$+]A*D;3-WPI*K+S5
M@1JZ42_+,XGH9.NVU$W 8\D*ZPKF3.^YXLJ<2:"A#Z%^P]#TN_@NYED>VN4U
MHH\T[WJ(\V?ZR#!@>:]#W@+86%V;U>>G#MT]9*387#2[K.)+>N$V2^=30,3/
M9B\L\\<CC0NMU#SG\0,&O_'7>7?)3X9]$E[)4+\QUPIDBP3.JR7D3!"U;754
ML6+^NTJH]31';3G/FIO@W8$&T\@-75M+N&?=WJ]6^K_E*H?$Y_'T=QG(H@T#
M _?J%3(4'WA4--:AUMQZ@-4[%)98 Q(57!:T?=1QG^*?81JU81BU2A-J"UV[
MRV)UP^-0ENOKX"('%^Z7_(DB^4E7?A^AS+RF-8C]MTN&2TSIKV\?W9>GW\4B
MM\\EJ 0@=@DD9\+1X22U54/:/LR"]";,H,(UI"]:VI])O-M+8M3VWRO$\OV9
MV6KKIP%KRY?S@8I#?% HK!K8B4F 7H$ZA@HP0B8T!"<I()PXB+Z ._U714-]
M2S!VO/UKSK&,$U+<>9GK<#A8S;$KLYQ?[G+QZD2UA7FJ.@Q9PF8E/M?\ZN9^
M_&;+Q'>X;V6-S7W6N-LJHN-O4])46D=*0_;^(6<MUQIH?J> 6O_)RD2RU0;.
M()%LQ]6LZ\M5%[LZ4Q$2+(3[A@,FZM&.H(N?^'G_[-N_#^&O!7OQIX26]1YQ
MW*[[I*MAT>$NY5NK$T8<T8("H+6K34YP&KIQ?4U!45L&Z_:NJL=9R?P48.#N
MB^2G!*!*$/L\9Q"_[9JT_M\N-0UT$?'0_.J>]N!OQ4"F$:@$.4'\T%"IX]6K
M=B4M?=GO=H7<08'FC Q[+^*.7XP9>]@JEC9-^ZOI68!?.3_V5R[1-IQ8EU?6
M-N@!LUT4%2^;+W,Y6@^'G3D#*3GIS6"BBL6!1>TE6M]4IHI4 /2'\FP_JE^)
MHH*_T_;;[?!:WE.@BZKU2CC2V?;+UY"#QI<0NUSJ6W&J6MMB<8"5?]NF/U%N
MT_[?OQG^GS::7$(R53Y_C5(F]H\H;;\5#YF(PHGPL(":#ZMCJSC/QG;4W;3.
M[5. [JL\4V8$KS]BB*00@4C%LSE]CGQ3JBU^;8M!?RXM*R%I7"L4VK[1]\K5
M_O+2(SAW6.7SG'5-<X[\E-3DUM8]X)\R2VJMFAR9'=*MP4M*P:J*NU%UK%72
M"N/0LI<[04[PM<JX;U7G.^!KL*X6J##_G3-A]D$[S&GR%$>B!VISIW(C4(.A
M;7(R3!W^;T;6]FY:PX=S*Q(_B(&P^[]09'L]VD>@!^SO*:#O%%#71F'-;K>B
M[VR1=2.CF&TW,L8[./U>6^X/\[R:N9-6%9;>1Y?4%P;EA%YM]B*VT1CVB(YF
M?\(LA5N^VY#$+;153$658TX!K]\:1'F)W:<+'\D_,:_M(H7%A*EFFW>/=3I4
MUV/%NI*K+'*>@+6K3''<QGA3W.OD7*4B'+I-6]UQK8]9GX'[3PQ<?R94(9_!
M3F8U5:AB6-+S(#Q4H-[X%- A"/2"D40O?>38HB=;4CRG*%S8X@IC%S])MV?)
M,^#;/^,=JZ]\]]06^L 90Z%>5O,1)Y0=SE%S#H#3<KTA.EU4:'<;(77(.[16
MRO+JZUC]V* !KA= Q2RE/OI=@;:!,^_+ AD7J-WIXK%_!Z0_!;Q1+58S5TCD
MB'J 8IO%Z+,M[W5X/OB[TX;#VB*$DH[_RA!T.;?L4>9;SH39PW*"8L*F]6$]
MX;#6K=+M"%7Z#\V= BK6]W"1NA6,B^^^L00)JKH_#7 N#(>?7QWK?#T=Q7H_
M@?6B5?-=M6LLP!=Q:3<;'\-VMO#&HI6-_.QN$8CH,IV_AD'(CZZYIDM6+ZS3
M$%MWY0<+$/F)!N' 5@'2[;9/<4 "2-?_KW.W+]3U'G)Y:[K(0F$SQY^)JL.)
MP#K2KLBS9V.]9N'8J;3B^>XB$%L72T3'PZGT3-3"",.($NT%]3.T@TE#+<CJ
M%'"H, GA N\-2QYF>X5Z2WAY$A=MP(>_SD6]#&G_R^/;UP+EQA",+&J"@5YM
M,;L#\O.%,T&-3-%\J=UZ&*?JOI'K)9LM(<3]XQ'ZX2G6:*7T.EF_[UOW?$S\
M[[K4EZ;.210<>SC]<*,DY"@PLEI+=XV;XLG-+\SOZ<G4L#<BA<;_Y;5:P_X>
M47@J"(F&).<E* NFQYMMCAL6I=!TP6A%W/9OJ[Z'_?;[G9PD^W&^D3(I<I.'
MQG1AE1M/EV1G>/<KQE>Z*&/&@*T^Y%[N68A)F5\W;Z5#+[9698G[$QH_V[WV
MW].9<=?1!L0E>,\2\"<:MH=6;XJ29K?BMZ0"E91. >DLUQ;F:)QG,$5<_Q6\
M[?RY5EEYY(:1<:VRG=BXU?2@BGOYC+UT99<VI[N\E#^Y7JM!*3PJ:P-D8+>!
M#H6M1I^9F+\M5=F'TT2VA-0UY[*A0JOR(ZZYWSS/)\Y_4'V%Q%'P\6?0](5V
M\/NC9LNZ8=,90-97A&6D66!*E[=DUN]?0VSEU;T/7>ZJJ5R%""X4G0W>&H#_
M:T/21Q]D^_J&A@HGN?-/2PJ_NFR@\_QV=TR]4/JKQ$=C;?*MG)#)4X  A&\5
MMXCN$> BB9L^?<T"=2SL9O:Z$9_NP]D]/<OECL?D?8.,=TY_8C$>^%GC4XX_
M][[LP,HUCOB@>/@Y6&<!IF:+3FFI03KB9+83I^SN+FTX_-3+3[.\>Z^XK&QF
M0&O OV7[('"#^@1&>F""#9N)\H2Z,5X<CXR,U?S1JRA\F1&VN9=,;P\?@Y6=
M ?4;30VV>0J8AM9JPUR2#&Y6W1H3]%E5O,![%N)Y]WF? C9HOA)MBP489$5)
M?4/*80WI5^CA6RL7._TX;;D(U!<5@0RVW%)H!PBZ^(V[L'K8B6P<9E[S07AF
MKV"<\%?I B>S#2_,=64D0V"JR_0$P[$25%P;_#B=/\[?INYYZ?>@A:&GNI:M
M_Z8XXUISG^J3Q6K Y*?:G'V&IL<Y6V ]WE)Y;L^!:0P1.(JD,6R< B[L$#,V
M[RX:B'3.(+LSP_SY4^_,W:FV#OCJ^$6YP^)5[Z),.V+"ZR;TC2U)M?N(7RC^
M%N'XC[_"E-DB\SUPFV/F@I?#-8Y^3/WB%]FGV#84'>VR(SF4A@:RG0+<870D
M52RLS_XSORIALN]S3?^.A/_ 73?=BM^$K^D/1^_-#'T)_A=RB)AD)DDB*.S.
M^J/-,EC$AS9ZBFX9N%74888__UK&S5\U/W7?UF6,JDHD-O"SWKD_(\NP9I_L
M<)\K2ERV,*K7M%"%:(JWYU$7O')-;V'9%E]3JSN L64N+HPU?1L44Q67KV=#
MA!MH]?H+2#9DR#=X^?^H MX^!2PB%X2I21)JX$ OLGK\M7!PY7:&+;?!#.I>
M]F_ \3LA)\,=N0;U\#)BXJ%3;.<:4;KKB"9;"R*9O]E=,/!119X"M&6^OF]F
M%A=GN^"%HJ>#ZY&/: SH,XGB28GD0(I);*_/&CHP0,0D:L^<;,J2Y)<\\AJJ
MZ-_D+!@(P>>Y'<G1KL2>C6:+ZEN:3.P6B.2(722#F(,T=6SM.QOEL_LNY1>O
MS<A7N4HK2,+P30T)YE^V;:KK'J($JLU02H%T$4.$F\1Z=T/1\0QQ?QPY08M-
MVLW8*VL7>B&XH:)JCC+.$-F+%7^!4&%S>7G7:,\T0VT"(UOCR.:WL/%5J[ Z
MO*T02!+IZ=NDEM!&\M@S%N]69G@L%OVI&7>FYHJ!+G_:_'/LY'3CNQ*.G@YA
M=8+&BG0R?SH%<(:IBWQ2"UXJ/FB1M7C&\UJ, VS<,*1S6T!4O7X8^M6>PJI)
MNP(B6A]RD0:6$ADIAD3F:#_$QY-KM:^<?)<NL=:E2I1O.T8]O>H\..C^6"4!
M9@,M1&\2R5I!FH?O2.'YI-E.(?F\"K>+OV4BIVM%/C]MYH $TR'&E7"$N>/.
M!-GR?]A[6#:KO<K<*V-Q8#T;I%EJ"UR^<0BR!2MP2LU7>8!C;\GZ4%0R$9@H
M9%P%?=7:Z#9'\27!SP3M142^HYB7D!"'+"2,!_G^NIU0COU&K_6-LGA-XYG;
MBO>*_E[>N_"\%P#<1:D;NL7^U[C;]0S0]MU) Q5G5SU'M!\F=>!UF(2,!'3N
MXH]_0WV>,O9_J.A<M4JFXOJ.WE6UKDWF,'\**"025-*N,4#7/ JT'! <P$P^
MW!8<H>>C;PFKM>G4*Q?S08#U7"E),=5C(T2;,8^-8%=,R;YWI_VU)11Q7EO<
M4GY2J)6-ITS$,R]V]^CPS&1\>!G&1'+#,DK'8#B_U1 Q?:^G?4N"QK39L1LF
M3F>!5H."]JS+WFNIV4#OO.;7M/P9+LGY.V-.6C^C6926WK.]8+LTN?0XL1Y
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M^NI!G/=.0=1WYTJE9[GZ8' ;WY%WF'9>ZV_BCW/KP"82XRG@R_8\7:&P7 F
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MH:;Z,9L<<[O.W?=9"T<_5,P(_NLF0!J'SMXY"H8F= )@A\E"#49:V>5_9JA
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M6;P$5/#=Q=5!\8-$ZK^/U8B>WJR6/IHKWOJ=JD.PAO<*\%+4R>B&X1U^?JN
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MT)OU3U_Q'DY93USI>IV9S+WQB7M8-<_CP$'C[9G-8Z_@H7&6.WSM59J\K$O
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M3PZ1E07E!.P79_P\>DSLGZEQ5/6# ;MR6Y1W-Y_%_MPNP&1D*_B[3?W[.NI
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MK12?V"5QIC]U#[G/F>F2CPC M>JCQU9ED%I@1V)D54#%12B61:'MJ]B7RA-
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MN^AU%N1^PN>RW*=@3@"6A3R3H!4;0@M:MQ:^"C'J1D;U&!</6%S3\0<%5X2
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MXQBEY%G&EK>BF617.KOR/S.N#SKE/*!R19P[E-1_/W7+/<0OCIU!L?8^-=+
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MLSGCYKQ]*?5NMHGPYGTC$3FE&MU,ORXJ=&^-H&.K(0&H-GI"A$T+JWP56-C
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M#+YWE]EE;^^FTY!\>-E/WVRSJTO\BJH@55A?92P\B@Q80@X75\:5KW=>&6%
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M/$A:]OA3YJ*%N)&>Q5(86 CQ0-U9VY"ZAFMU&@BJ/ITUTVX?#/OG?IQFT86
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MM3827>5. RR<<:6TTX3A.)"$;MCW\#KG[H!JC3Z)M;V5B0&N14Z^KPO$+V>
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M-6K?#QFOK%CU]?B^<>'^INW4'ZI%P*GW(6A'Z_3ZI6UXB^(&[G,#_W8:]@S
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M**\M6?-U=BMOL!W7+!HN\ZZMKS@J"51)O$WE$3P A%$B\H;7XUQ].DNQG:O
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MIZ&'/TC6>WCVRF+5U=?88Y2(N5#,>2X#OF[]'6/V0[X&NZ;MP1Q4F=?9@MI
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M_8 C9;-YFUDP&.ZYSR2U8#6K@;Q2"OP"IH25]%WIEO,I]AX1=*4U/RTJ3C2
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M1HL7ZN>7Y(R^5\-=CHP3C:,?PY5]%PVF;I<G1*4V>\8=X@2?EBYF9:-<L6'
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MIS@L+/J38C16UCUT>:.:BRV_U^_2<1Y-G @>WJ53R3IUL&FB6")*=BQ!;3
MX%:;GIRS6UK807*)N+DY$P.RHGN5WPHS0FV]G3,RJ1%6_<*>MZF!C(<2!H83
M+\@E)K\]H5C*"8K1WUSHHK[ZL1%Q$E.@XHX*C(]=8L$NFV\9FYH.;K0;.FS_
M#,W\<&_G*&NA;%-%M51;3SDF5\@W=&RV+K,MG6+^N_T<7&5)\]#9C)$*\E)!
M7C9 N<Q3'^VH(@?T<H9B5## /^119R_]_8#D9T'_U@(U]I1I,PLF5_<<%&1O
MV3GN&(IO,=GM"AZ:CLV&W153I+M%9G#*O'2_-$$"<\X28@.LMVSJX)-M:"U0
M;PZBP^2D8OR)V92I$ AWM2YK&2ZO8Z**]&.G#2\KQ#=9- M;XO8JE'H#:J$N
M^^Z]?9.<J_9M8+*G!QN6/7WY//T!LNW'!)LJM9\0BVBQP62"="[(]I88 0K3
M(\0\?JU4?7UI.>,"(.G>GNBUX \!<PI#-@LOQNZEQO#OMIZ>2*2IEM=\&^_L
MA?#ATF);(40\+# 4#_'JR>MY#HJ+ KR(GY$+X,C2/;I0*PRS+,"):!TOCLIO
MZ%3_ ]CC]),MBV',=M"C='[5WT.2I:1[,*:-I-@<D(82H.R4=4E34ERJG O+
M. (FAS\94"NW0P"U(C 8^\]%.0K_QLA>CE^V%+A @Z#[+[2K=@"4G3_;':'H
M+YUL(UTZIJ_*DPJ(S=O>LU<X@HIA#M:>,/_X\%E<WH0"KONQ8//U51^PU%JR
MFBLZ@&T# =Z+(@P(E@[^A!]"7)X*\6$KT_@B 6'?B\D94K!30AQ^L,!<)#H8
M,*2_9RY="/]E_3M>*BZ>NNA'C$6ZP^YN<U3<U7[ KTG10:JP$2P4ZL']K0.I
M0-6.4#MG6^2L%&QLG5T(^M-2;3/N&';_N\EN+<BHQZ: XA=&!A?H55=\VURD
MR1Q_LW5WSI.]OO9]'YBFS70B<R4=W&!'&3F@MPM^;#2^J8T'W)-]='FP>16U
MTN$\L*8V\L\]0A_^^\%F(,,IA(R7LG'5:QOW3:_X%+"B+8:5)6\9=KCE*8.^
M.:YJL]2PQ:IT>5\V3TG:/RL6Y+K'\:/A'\L;K\7+I:&"#S,QF&AL$G#M1OK?
M;YVF!YCV!^#BQ3.^ D[Z*<!YG%VM)!6I)RH=B6K]!MI Z$!4B6^]>XY;'_;>
M^A@WQU(R(.@Z.!(;U<0I7F&AF\68$\E:B?7YX8.*V2*Q5D\W0%\#5K+2+:-3
M[+T2Z12DE2F$BC.=;-W.I;UIFLBUB\HEA@L-:CR"L>X3<LY$6.:[)IY0H!!!
M>5)D=Z\5XK3QOS/H#$3GKLAHZ3B >1T%JH16]<!,= J_VE.3E&KA3G7<+IPQ
M[P&?!!Q6F?'=[[841222%^)!;@// F?U7.?7CWMLLI0, 6/:0@)^/FWC82]K
MOPLNPC;1'[S: 7OLU+>C0@_HB>Q_Y7YNE/3/757I<F_JYK[J@X'+6^6_S(SQ
M6^_<^FS2IDD-R/99<T)5W(T\=<B<4"ODZ^=;;N';4'=ZB<./T0DF.L:?-!"%
MZ0S9.CJ;H[YY CIRL0 \0?0EQ4[/DXV.)S4;M_(+6W"$&(@)J_TCCV8K]]JT
M+T4-5M6$HP&6*!W>"S@F=01&:FK" Z>US YJYYQ49*9D15:IC-K,;C;2"0@'
MU;=T'*X=!9A3J)&TF26R"1?Q<.Y@2TTQ"]@!9F.^N3+)NP0G\,.C7CC(RNS*
M>(A$RV9IS?(P:P05G?K/A5]7 #_9^U;"=<ZCD 5CH3!WK_S?+V@RXR0J+B0=
MT.-!6KM? #C2>+.()9S4''2%3]@Y[+&IE)K:)K(1_IU1"Z!1.PJ8G-$72O&H
MH.*65]?>10$0>?O7 D!P==F;;8BB&@00XB04B(RP_XJ,U[9U:3X_RV\_PS5'
M[:C$5-5LYH6V/9U:ZZ%XL?AX*L6?B'%U1]V%R*[\+#A6RTQF#/+X$=.JD)5F
M7%%;;"]<R;\U<FQ_H5V,2AS^'$"V9,"P?T+M[LFC?.,3I_'94UYXX'?_>X*>
M(T='LJ]19 88IJ!VO!3JF[7)MMM0Q;\Q<4&7Y[K4J]Y$^8J(&T2/V<W*7JQ5
MX=9 Z;AO,I^A>2".T8*6L])&'8_1*>2KOHLI^*8.JVRJ\R;V4(5(TYO.:3++
M_EE4+NB'6%P4&IIG$OSQ97/YF59^=;KACWTUC*%-M#5VKQ $O)PTX"T'8]1(
M:1C\6XCL]<-?D[6B,)@P'"20&KK>OLUAA=A1<>2,D3CJ4@D%(# &X_KN_WYP
M.WCK-?WSK)DZ_U9B92@,DVV")1VLWV9R^_4*E5:I<20"#R7E@'24Y!)I;X\I
M]H&YTDS<W3<+J5E3B((-4.X+^Y&R!G9:*5,#%7UB9V]?L8.Z&T9J<F()K^7-
MMNB\'X1F)1?$KI2I30/<RSJYPT"1_C YPV[NO<C3G@U0%PRPI2WFI?!X3JC8
M%C;21,?^8WSE%M,"!44@%)24+WXK%0/Q[/KGYNC7R4%4QI^2"2;3A8E=9[-_
MBVS%CVN"K6)S.5&8(5L2$X;H#CFZ!3[$MER_;9&V+*B_8'11$6D"ABR1&PRF
M-XEVLEKR&7?QN1JI>#2$%Q#ST]L1[9SS@!*Z!!]/H?B1TC10LHY;L2($TF J
MX77&SA=RLF&,L%E[YDEULE6<?^&=SQ^;)+33?W/@?A[T\OU]DY\8FISQ@$&J
MFFBC%&*0K[<, MV.:S-M5-%E:0(#)D(VCI!'4!82.*F_X6.[K0DS]M24 [4B
MCLT0%[&T,, <AU\I 3KN[;%>Y_C'O& UR&8OPY6M#[3&[2 #7SI*M0E344-*
M4YOMF?X)V)-LGT\SGQ"]X#$\;LU/:/-)0>YJN+5C0N"G!N)FT0(Z;;QU-DIX
MKY=S&PH;#Q@_HGEQ*D10D85A><-56&VJRRNX,0+3J7,K?QF$4[P PH5U3Q"S
M$0C"<N;6RP<*RD+$>W>H9@UR!P=LIG"WY=OWKC)O8?7,D404_O)VSNT_\/\?
M^/_?!?^!R4$_6SJ4?.Y'OY\%/ "SG% @UP_KN8CU'2$Z_&/A_0UC03_ ! '3
M:?WG8)W?U/S56PWDE3ND/%-3P._OW"K/._B32 /*1K,5F]O,46U = RT[T/?
MKS9F#?-J+>&LL"8G=;-]7-Z:UC.Q:3 \X&?M$3)+RKIVWWGV:*%'1S=+=U=:
M-IN:+ ^W8KVB6=H>-.\-T!&]+>-[/]32U1E*#M!93P]"7M[TNAE7C!VE1TFO
MN4]?E3=O _01=5E\JTNSV=FKX-P(7' J"H%?FMJ69ZNM[1U?W'?7!T&X;;TV
M"R>G%.FDM0ZW)CIM@(Y:8;$^JVX=]/1![JU!'UP85MZ$IR&Q.=NR[)"LY#,(
MLWXT8C1X^,VZUTI6R#9[1CWI10XUH[9,-(\Z<20JMC,$NI7..D_%-SD;"5G6
MG?8H7?F#6L?EW7VP)3*V[Z [(]OJ)Y!4J7T]L8A&&\"LU;<"6F>CW<#A:6LQ
MJ*S\7@IR#0RSTGE=N]7TME5)?U/'Y;]3/\!)_?U8_M:MK&;;RB2$PI+RN6]]
M4EQ'>=S5UA\1A]]NO:8G=@X#7UK(+1[F&X;7\NC)(_S#OWV?3SRF0'7@*A%;
M6%18(4V?%PXJKN\XO78]&C>] 9J!=;[9POWA^[Y-]0&J#24UR<8FC;6"9.T8
ML/4_Q2X,M-OT;&Q=-HWP09'NE)PA)ATBOWO"1@J\F2R+W3=!FFM%HW*:<";5
M6,"]C?G(RB3SF .,7 ;QP&O#,,H@NC%6<CK#[4JIT/K*--M+;RM7O!G3'X0K
MHR+IFV7+M-=JEK,O[,^% VJF%+*$TPY@^:7O\?KK:EXW:YY2D8R$5T!<8( #
M09"ZXQ_0>P$H\UW_2NW)SIY=)]R0I0*BB-6"25I'(IX>!-%:*C+K.S@Q;]!\
M@[P5A,V:L/Y6V5V_=3;[5D&I)AP4ROA3?"\([<I<8FE7_;&1>E66J%@1<]#&
M?7HS<?O4I/"'X"\P<#2\PQ-$)LJT\_76T>P 8FV1G-N>SK\Q9HU#3+ARLF4Q
ML=^]3D27N%DH7WWW]P4D;$NR?X\7!WEO%Q_GDYSS.6)3U"3*H+ZAL7FPR]O%
M1ZC*' T"P<3'X;48'O& 6;_>@F=<?TG);=S^RW!*).#7P&ME:AL@*&$Y?8_X
M5L,35UQXH:1G@KPFOV,1N6;!4ELG_#LS[$%KBO07R1GV<W4B!CV;\TT>9=LC
M"E&Y+Y!D;$-;-8:%6OSX1G8),#_ ;E+^L?#W[WV_NON$DUH =^2L<JD&'(;F
MT4GU6\L0D\,7.R;U^/ @4S4V0.CK6X>/_^L8>\ 8J^'CCB'-MA !?_6:'YO=
M]"G)2#R[7"8%21)9#R N3K.5GPG: +%CLCH(DQ2/TUHBT+TN_05:Z7L@S9.Y
M]I%)WZ-<H8@-D!G[M>%6;]:P[YMUW\O-NSW%QF*(K3R">U[X&,>8F.*;2#'!
M934LQ\VX^K?<O&9'Q0-**/Y_*J$;KH(!0%B]CS1F+8"U//!66*M3A@CEV._%
MBJA'\9A%%J :MDUAEUM<X5.G1];L_\&H4E@FS6Y+L'^#Q':"Z,,V,K+KWYEK
M#_(2UDIHR4\8= =$D0D BE\U'F6^;"Z6Z:S7U[&X=VB"M<"#K P^]63+'$2S
M+;<O!'H\R?O.VQ->E+@0P;"U\LW.Y82_L0LXJ[\2V4[;+)  A\FEP8(/,V/_
M9U)M>]YOU_G5V\CJ-D'5 3R[C6UQ$K=>4+[FR6+)2/-RM.NF@[S*?EW_W\VU
MY_#:;%#JN5C@-DA$F5H@16$-J=MD>OP04C![9R++U43CT<K_1:K_EQU=]<J!
M !< $O-,J6^!"QR9G"$37B,$<E>(PV]VQ^/VJHSWO6>:MM(=F,O;;)X#&24C
M.X#KP*C> (EHK*-6-D"U;P'GF*]\>:B7Z+2.6M\ Z12FF+?A^N BV-\.:57:
M@-Q\^\X7/: 4NV#+Q!(HS']DP?YFCHQM=/8QBVJ7.XM^PC ISAB_-:+8\KMM
M5.2/Y@E>P'5Q_@_7=6&K267]MV,US3@GMC+9=L>SA<NVBXI"K219AR?%A BA
M?K"H 6! 17NW*,@WV^09MV00VSG?;Y<4<ZZP>\8=U%<CT\BHY [V7[^^35)L
M2P(1DF4JD7_FOB\W(#-[W@$NX&B5HR3B&'M=Y@U,2@2KA3)U"]@FT_/D7Q.(
MH$M;3>_JUHOW9BMPJ%EDR=Q1]!>&P< Q:FLD3D"AER6U6+0>4+47ZM?!LK'-
M.9J*K/> J%T+9JL\VIQIM0$*UZOQC8(K\@*6,T*@,OVR71":4#MGUPW0S;2
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MU*Z5@._.=;)'L<8X0 \R!(5@@+4)3+JKKX',U=]>(F.%:<SDQ=7 4H2EJZ9
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M/>DJF8-4C.T79>RRI1IS<BK$YC=%,9E 8QC.@V >_F76YW583;4<?6,&OL0
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M+*3SMOI;"OF!D"E0%BX(]UPY](X>K0M"?L)\T 9J;*D\5<")UE67]HPRN&0
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M@-I=9M^Q5&P:5! -Q&[NX]IL!,OA8=5/E1!/12A&IN0RX;1+Z,4RNDE7E&*
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M7+2@>K:;,Y6=W,IT)227J,>5#LR#5ORVHQ9[APA[U@=- "J[$KWH1IVVBW!
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M;,FQZ*#.!>7NG0<55NEZ]>M@?7B_/1ZCB3.![6WE\5IQ\R ,PQ5H ",[,1$
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M:G, "[>9WK^,+CJ1)[I.C-CVK[3CA,A6[!%%M$=%EZX@T5UVM!:GY:Z*>CR
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MSLZT):Z3=@EVAK2'':=)CTO*'+ *BM5P,U4R./BK%?]3B#AZ9&W8[,DXURI
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MM 9[HA)V#',=8W4"X$(^(;&2C?7PY"[,I9H(B@Q_B7=>%&>*6O5[G5W3/#,
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M1:\VTL6+BXZC4*8?W]%%!S7=6#!])7,%HA5V8JESS!:'<GI.E9DGI$$YSJ,
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MG2XNJC;O3"5U)YD*;V;-LPO^/= <5LY\4T$P:%XWPO[5,YF0XMM[H<=.%!,
M]'"1>"JFO[?3TY]C1$:8XUU+\XAH&0>[AW&I6*[[["J[-?=!-B,<A,F84IE+
M/9589?7T&/<QVRB<D0PVB-4V[H:*HF[?5>_V6AF9:HDC5//@"78+J[1Y..TW
M\F%*X'G-^?JXBW?J!5;V-RQ"F:?X^Z:X%94FC-7D<J8?)->$(OA"K]X45S-
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M<4T? VQ#7_&5QJN'%DS:R HMFTO-%NR+8GN2XJBIEX05-K)@G-LP+ =>=^#
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MP5)C]F>SN,88*Z#<=IX!GY,K/+Z-BA<9>][L4:1S\/L>% W&ZP67$55W'3M
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MIY^[.K+^$0L.%4L:\,>MJW(-^3Y8H_?G&88$H2Y#ZH>+3:3N-2X9!A0^SPJ
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M$([E)G9N1&I1(O<M9@T40P>H,H\IDG#M^M>%(:#YQZEU*&K?B;.WV,MFNU"
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M._1&..E(>'OB<UNIQQ9GN,Q/$5J\5_^6H]<I?^JT"#]].[50C]G9!U5$$[-
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MZ)RK4\'30I]"*$H1^<'7ZKD5^^J)[&[0L7MGBKRR=$#AN9"/VJ$L/DCA"\V
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MDFDG 4VV!K))3LB)0,%[(R$J&4Z69-,VK?MBB0(D+OWB!9$'CB,G/$!L8UB
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M(2>IS>D>GU\JSHCP)Q+)^!];EO/173O?W\C[ ]HAW;X&@L%)^2<WC.:VR3@
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MJDOO^9DIC\'ADDGR7/]HSJ=?U$EAU#WS O;@_W(X',M:MYPVK";7%!'4<<Y
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M!%,30@,XOE<.9_=XG-[JF7?4MU0R%"(HOWV^N=9I4O:)0[$D2%Y^G,FBD3Z
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M0^K]SQ4A.C[;%HW^N8*DWJK38?FAF.)*L)Y7-4=P3I[OIAS^ >+FZ(<*BGY
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M30D"C=B!&B\=W(VM@3U$;@LWB)E4M5XPOY(ATZ7^/7=WA>(Q)X%M .$A;)P
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M+CO$$^E V\& [OD5C045JM]HE:$21\9]B?(!--9D2BKS E 7E94*Z/KWRRP
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M1%KH"%!\;^]0T*WA7MO6,EKHPM%]H\$_V +(QU A3M;C+9-_;KIS;UIOM%[
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MY0;EV0_]LLLJ1\O8'HE-C&_7Q_TSPW^2AWH[GG)+R0+.M\<(_530R[DT&I2
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MA!_X #?D8T"C,.&WFO[)4>C5KAI>U/Q1,:5*13+00$C-2'@+[!38JX6/1LP
M'<&<2?J\4>_=IG'?C/431' LPA*]/>Y,9:.=SK)7M@ D-\W9FU]BF#D1VP%7
M[8!>J@\=.XHRHS)YR*=,_6YXYRY<<#_9P]5>@&,?=F@:,ED?XURF[B.<DRM5
M&%*('I"+6M]^T6#D9G.E\S?/R*9SZDI(\^JJZ0E0SFM6V:?"._VJ9@#$#! #
M1DA%^8WCG:M\>5G4D2 :SQR$'I?)U88<"1#&JOX#8Z*IIZ>XR5P[32G/;DJT
M\%UA45B6RRWEO)O #[3L%;55T'R;07_KK;>P2B(J+F&V&='"1)$,=4)!)/7\
MX[Q(AKI#Q!)S%SK6-XV RIWFBVB+^(G L$KOAV?!1L&0*6CB!VS*#/3%): R
MC:0I[Y1'G?6W]H>-VD:83W]43?,N<[\I%]Y5K5O/+9>+0(*H8MTX3H3Y\N+<
M1H*'>>:@N[+[=.-O%2N/Y\GFYQ:L_)^N)>BS&\"V$ON#^WA&! H;8<<G9,X
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M(T 8\<\)J(21BXDP(ZB*\Z&50-#C%Y:KQ9AK:IM)1TV <I[I^A]02P,$%
M  @ #$%U6*-OT\V_[P< 6VL*  H   !I;6%G930N:G!G[+T'6%/9VC:\$10K
MB T<2G! D;$@H#0#&QN(A8#,C(VFH(@T 15"21!$+$!$4*J)BH+CJ*@@14I
MA("4"%$CT@T0(SVA)"'E6X$9SQ"8?\Z\QSGO?_W_YUS7>.U%UKU7>9[[N>^U
MMT'X0=@&+=QE9F$&24A(0([@/TC8"&T37?U'?T0@_RF&A+ 8DILMM4DZ2%+B
M>VB&G(2DG(3P%82 ((F9$Q^ ?OLC,4-2:N8LZ=ESYLX#'WB^$)HA(2DY0TIR
MYDPI*?#38/!S2$INYJ(5VEMF+;8^(OV]]Q*=<S&W9ZMM?5JR=%_=@+KN49_0
M.7.7R2LL_V[E*HW5FC]LW*2G;V!HM&W[#C/SG1:[;'[\Z>?]!PX><G(^=MSE
MA.M)W]-GSOKYHP/"SH=?B+AXZ?*UV+CK-^(3$I/NI-Z]EY9^_Y<'SS*SGF?G
MY.:]>%GZJJR<5%'YNI[R]MU[ZH>&C^V?:!V=7?3/C"^#3-;0\,@HF\,5S4L"
MDOPZ]6GG)0?F-4-*2E)*6C0OB1E^H@_(2<U<H3UKT19KZ2/>B[_7.3=[R=:8
MVT]+YJCI[AM8>M2G;NXR]8WM*P=%4QN?V;\WL=#_T<R^3NQ?\_H(S9>4 )LG
M*0?!D(#I9>_#Z'JVC*PH8^Z9*X1,XJKB$SB'&RQ-^NIETW1Q+$9+HH]:4[Y:
MS"RTC(5Q$8%>GZQ'CCUIQ.TS)%O>-!)"*592UPK*3US1N?&R5S4J5Z'<FR2I
MC%71/(Z.'+QQ3*M\MIJ7/9\(DRY?WHL_>41IO;QJ2FQWV+EA!J=N%7F37NJ#
MP>L:7<@1F,ZUDLI$EOM7Z<33I.1R,C"M!%K98O&&'6)]K/\:8V;7F+V?5F(*
M7>VX=_<HEOQH"@83+82\1[!^L#[*%HL:O#7'KV;D89^#+E7-"V5/H+^/8@7_
MNCF^>KBBD4)-YPS?+T+!?2:M??0N1K<0>C\RFMK!$M!Z!7T83SR1[^45 ,4'
MM9ZL[609^^@-#3,$P:Z?6?Q?/NB@P\TLU#P-/P>X9%@&![[#QI+'<#EC>9P7
M 4)HN+"0\5J-E:Q=L5]I-;R!2Q#D>&9!;/LCR/"#VUC7=C92<[RJ!CY=%&^X
M@W-)&HMI0+\,8\D$$EC\U>+7,PY\ PS_0XZL'F>I6*(ZY-^+EU5@D!A[L]$1
MR4_C7/H]50/HRT'@%/X2<W%T]PM]-7B]S%PA5%A"IN+NZ2D33#K.#GWTCBX,
M&!)"AK?F>."/=/4<6S[6>%$EKQQ+SCBY3KSALEB?.^(8TB_KSQ/<5DL=&96[
MILLS[&!%IPCB/ML?D3IW\*Q2A[8B3CF3W,GVM3+/=,^/J215A840^\^0&</I
MYIFO@RLZ\THEF=&;<2SVF5MSCJ#/+YIY[(/OU5>>R+-D.+Z]9F'!RSDSGO48
M5AS55]GL0J@:Z ++$S<64^5[0;I3R0]!'^C>'HA,;XH^G+(!7DT#*0-''()N
MR"=L4?W9+L)POAF-Y,[B8)0H<O?&=$.JGCQ17Z3ODBWM8)^"R?HP@D;E*>48
M.&*L2=X"K$S6N\:.;.LK+@ 988WK_ABBT:K?X)T71-P3U1P,4HNP2[]FQ-;3
M08NBYN=@2:37W^$@<;ECQ$)"?$:Z$')H_8B+K1C#Y8\U< *XV&$^__X,.U9P
MO&)\U5!%,Y62P1FZNTZ_8>X-!ZU<<@TGN(] 7XJH[ @F-?-[>(7!,%<@>!N$
M-V\*%D(MY"HJ10AE")9(K"5KAVZHSI^U84E4:32;SN*A[[@DE"@<MPM3F&O6
M3@KRY0B0;_>Y,V-/&GCJO.*E1Y?R!,8G8EWBDJU+O6]H="+/(NB#W::+JED*
M:O.KGCA)[&PRZ(_&PJ2D5>A(N0O'/FB'W/54\B/!!%H-R$1-O=0+M+6HU_X]
M,)GV_I(>VN*YDO[RHQ@;TA$!5B4+XB3MN^IY3'7^JGJ=6=@K2M&^5,+[FSXL
MQ)I 35+SQRU#Y=Z"X,UO%[DW+GM[RIOEW*$_5JC-Y;M2W#EZJ1F/:2E##+ .
M9=!N\2YU4S!L)G=9_%<(];M8R^^L?7UX7E:H7IO3<I+2_#,\__M=#4P/<P<[
MDB&#DN[ NJS>T)4F][+=9TZE2:X!PIYP$]JM6^T2F:F)V;!%,6"T%RRFM7C#
MC_O<638GC3*6[\,XD9T$V'N+Q*ZG8M@TT\?V:3NS9J0L-&OR?CM$MBS@GGW
M%.MG>![C\\EP!@T0'[P-,%?_^Q!$D==S%Q\./D\Q0)1<)EE>R;T'FXI<'INU
MX MAP)43W"B$1.3H(,C)*41H$$817J.^K-/#0J@[,/"-5'[7V,^ 8+MC<M(S
M4*QN,T[1NYM570$='HQN"H_[UD&L0]T42.B .:'7LB2V^@<="T5O\C:*<8!O
M=TOBO&J-J[^NQOA8* :,](*4LEEB3M=SNOK8P IS9!CF>S:[/NUA.?ALUA(U
MD'W'%T:\C[5XPX_68GWDQ#$L%E>OBOMUM;O>IYV-82DTI(\N9>#3C88N%<]R
M:T)A[KGN%!<>=^1^:D-7D?7K]B<2)2J)!K ]X?K"'LZH6DX:)?),-Z@2-=!N
M=Y:LOM-J<DN3Z7"MKB XT%J\X4>KR5W^$L'FB.M6U/.X&1O&+E8N%R@QT21+
M["[GS2;!%;V,+)IR "@VOGMQQQO\U&)Q\=(2V)9N J7;=/%+UFSUN55/Z"LN
M-@'ZQFJ5)JV8PGL[5,B:HVHWZ/-E7QOTP>3V]Q?%R4IBK=:&4-.'^3(^"E&D
MZ 8ZDV=X9PKMO;7N81)\##U/%?-2HVD\@?()<?8T730KN>?<-JWX#RY=O*)1
M%.NR&&>!\JK69R*$^ETZNQE"B"J$YIJ(6OI_;Q@=&:_0?R3&J.D@_M AM8-I
M0NL3C&#LBPA\+/8D=#6KU?F'@T%%-%B_<_0%-F7?5+JZ(NK3_WN?@3M[\?L\
MS!>4'R#$#7[ $DB/1%GH&*F[OB1RIMHI6I$A3PBIG$CLVF"V/-ZQ?$9,KG>K
MD@"+V[0D&7GW8[1BY%-8D_8$5 O<(?6&SE5O3S4=N\1!*4=P> %O1)IE=JE.
MCT+Q/GV9S30">; K67?7O@75=R7.?S0S)0\ZQ=0&L+@4\8X4YX;L=??;:%V5
M%5ZC 4[#W#=2HUK:S)QG*<'-=Q%[7!!T2J&\>,,.,?EF/47.Y7P#C/\W2<*9
M$6C!V\B#R.)TT$?IC+$N)</DYB_)DUEKSQ%$2FZT:6ZG!0?W!NBQ_.$T'A[;
M%$QL)M=00 P^ZNTW7=0_F1P5)T-8!XEU,*^D\TF-_"9>LS&6V](R)+%^,C52
MZNAC-D^<67,CKYDU^;X9(MNG<$<?""$QPJ3$B?'>"8F!@I?HN<\BZ.HQ.1F>
MK?'M90O%&T ^;QI5>\8*E^Y2&A6MBMBUE=03\2[JJ U)^Q[>?M)X2<U3QC=R
ML(*,*KT<;8QWZS,_1I\K6VW8AR4/W0'7G4J/%2$E.49L&-@R*ZEL\@;669U(
M?N\K65L:3*<^7R;>L$.&3/#9'.!A0+(O#,"FU$V^?/,-$)YDO9RS]5GXRIP9
MIRPJ:R7HC[UQT[*< DJ3&7UX7:B!)$6-D&X??'\J/?UC;'EW@7[#C L.6D]^
M%V-*4X2DR13J$WF)8^6=3+Z._IFA;D'P:G&)>$6,VOZ2*Q-ZM1JN+K,[=PF2
MRS=F&G'/T(9 J ,9V/J["NSOW>M1M*M=00\-=-B0@J#P\PPTWDGJ2.+9^8Z:
MBA'*@V0ZF[5]BDZ\?U>,G^K$Y5W(RBG\N''/%.*]+,ZTB\35I@1KXSW5IM>F
M"GOO.L\70LL,E>@9\".CSBZ3GT=L</E988Q(&H_K=U]=C!\I:9/5&71#O,N=
M*1AB75:)(>"/)Q0H-LR1<B^1 M1]KCQ@D$N9PG/.H<9U'E'%Y)K8:ZU] ]K#
M=,;>6)>D9.MW_J]C62J!")''.HAW0AY+W#T8.KN12O0B#WZZ)-YP1[S/7V/@
M^^&/,5<T$I:TA>K1HM/3 L[0*<_WB_73K%9CQ<M5R"O] FMS$8(<3!;$G^QX
M4R?[V9-:8M;U,P<IA'+'L/F$Y/0,(72XL25D9:O^Q\R\(+)M5*%Q )9P2+)F
MI !8:L-:LVH:M0\$[J$K8J[91.2JR>.N&L<0;!0E$'[KP]N<2G6/[L:<3K;W
M=O$&:_/,FN"*GH+V+9P(8S)'$"=^_4TPIJ7%PRX)Z/SE9IB13]*/O0FL[H\B
M$\TQ7W.A6%HJP+F-'X#Y<5LFO2FZ)=E2FYIA3Z!OE%B768ULCDR% [TEJ09D
MSG#O#O$&:[$N?XFP?=V&4*N'MRT\BE,6^?B&H+M3G(!?C7 AYRD7ZJ4X9=@7
MPK4G(C7B..;K;I0H23!BR*#TO?UF0NX;,:6J:U'%$AU.\ 6,5U7_:2%D<&]:
MCON7%)NBYOYCCI3>O'O$>6:\XU%3*4]R4'3137^^)FN**+LUF149]>*\)$K
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M70B9@9K&<JB*YQE(CI0T9PI4SM%J6D=FCB^+^72-IHBWIZY1:[S8*0=EI,D
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MK933J'KZ_$A!6E\8Y3TQ3VNF?P@[OI2+>?S^]9W=:XX?N>I3KEZ%2/Y%PSB
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M;)M/A(^($>M!EU",_ &LJQM>XXW6?HOLY W+HYJ3S6?'=JZ<<U2BH@9K0!A
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MEO$,M2)X*VG8)6RG'[43/HZ:O0C<'5*V<^U**=_<4+@BXU.&8!Y8/*EN=NS
MJOZ7F(WLJ$$A]"GGRE ^>6$#T@AU\?DO6J<_Y\2?D7M%#IG1:68D8Y@QM/ X
M,>F@\[79M"M=&UYXS*<C7>;.)N?!.&SG-H&,7N[[K@&O<T>HJ3LWWOZTP&"+
MSHO\G,I53??GFID3A= !R>%&P1R[]@M>'ZCMOU"\-%X\CS6MWXKN?_G+TST+
M-R]<TTMB;YO7LC=8Z\IPE>;*M8=FKY];MEQ#7;5EEO06TI%>7"RV[?IN3^)3
MEY>#)_K>""%'UYD[VV)&I"21@U0-_'.N[,J[^MB5I2\DWH15FK#5A-"[QLO0
MX'W!LFTCEY"$)6Y)A)HJNUVV.]Y\TLT-V2#!32H20G.U"*[9@\?SLH([]=6E
M$#VAK0Y>MON?;EM\0#5ZH[GYV$/3M8%!I-B8#[%[_8_;Q);S'#5ML03F"<D*
M=38* Q2:O%L&;CBY#X6P-(?3"Q<%:1 ]BLRO/*>2N#6C&KAT-0*EI?#ZNG?R
MH\PEZD'Y*!NV7#>)4ZVS9:T']<)8[AHRH)-0U/G1WIR*P;,OV(!8BSH&ASI\
MN8%@@G.&9YW19N?;G0B98>9&2-S9'LIKCO;F!NQ_=N_%'8%@ZWE<O.L7[ QC
M?R%D>*ZWTTR34."3NR945@T&J.&"Q:V9O^[XU'OFMD)+>4>?$BM''9/*2$*T
M&X\99=FOIQZ2B^KQM&PG;_8Q_V*2F'%\646J^[6E<?QWTF%XPQ+);A+J]:]9
MB]>XD]=19GI3B!Q&MZD*\+1S^AO>W0%C?1/IY>3C)X-NO 9;#]5HLJT#G/<[
MR+N50[/]].$-GL6^*4I*@Z+?!6KM?EFO<L5!5+.5OR$M9:%)P6G> TFO#5@M
M9([:]<9ST46\03#<,,%24/*2\P6+>OUZA%#KF$4KA0)3#'I;<.P?1P6>_>S=
MSULSA1"V5P.+VB.$]M!R D:\,M/TT!&U@BZ,?:)@!+8LXKW#?N_18H\F/^@M
MQQ ZWDA?%4(OTXDL/^Q+N\=\ DA=U\W< !>NBW)^'=A\O!"J 4YNSMG\$6P_
M_VX_@T%@I)SMMZ\9.5U.WL!I;2)74> 6$H/:FI31L3>_BFPX;)=+IO"2(.:*
M@3M#.VM;UE//2T'1ZS%'FTOH!LL5@"U]?&D S[=+ DOQZYS:<GD-;WK4!XTA
MA.W^9\F.^X_FZ<H<U&6&>(<:KL$72GL.SRC1U:MF%OKL5]Z,Q>/C)#HTI^]M
M19C3_Z[A'ECW)RD]1WS\5/R;0[%;ALL"M;/-%)VN9J7V:R+G>Y=;("R-,#_9
M.28F'T?;YZV)ODDDHW9!S"5LU/TU3V/+/GYYM47N61.O&C57L:O/FT"MOPBB
MY'$_#'[BPK>OBB538\F,?OO7[U^__EESWJY;-_9AK',>Z^SD.@8;_Z#0=L.L
M^R6_YSJ-8:JR!?$R<+B9#J(3;,:O#3YH+A/--_Z,:S?F]K%X=H_3L.]Z\I!\
M-%* '^[)\'Q,S+V:)]G5%(!X1;#$UJZ(GN/L6:#54FEO N8LQ],@VK5@KSQ_
M2^86QFL0,C1 UL28+/[R@]+N3\UG#EY8,<^W%)_KE4P9&!T:<<G9[]"TT_8<
MR]-8]A,J':8O)$E%-QS=NFKW-3-3!I,F#6\;NB6K"I*J??DQL&"92CT_Y6U&
M*;G@^<P=<P;P/+6U1>NI/SO=O)RCX4J+9+46[<QPOM:J=EK&SGP?RH1="4<0
MNY5.;>;UO%+]8K%<H=8[$I%NC#6"!H= RLO=$.V-=FW9X=BLP7)T?ZNZ:&M>
MZE2!1#MN^.%7G[-X [+Q6,?E$8MU3'W3SK=GU%G]D;'L0,%3DB2QMGJKS-V8
MF$BZ0@G7E\JZ):N"F#,LL:ST4[-?K^2#X/2.VN!H;3;=.'_?>-PRL\%?('!3
MQPBNFXVX="[XR?ZGNR4 3<Q;AC.<CZHV-[E+J!ZZL\8'BUZS%#?6H)@O\P'.
MV 4-MHJRYN=64=9D87U[-5P<;(60+3WG)-QNT\HYC&U?3\74\<E9-V\&^_)]
M\<V_?KB7HS8:HPW\2F%,?FY_+'<ZU-(!@I6VN\HZ*N9-@,9'S!YZ$PT1[=OX
M? W8P=6_RE]Y_C[!*>!YY4<#NM)(;ZC;AWLA]UG?'ZV+O-F@F$O^12,G U57
MU]CF>?.UYN<M]$8#M<%1/H3T #$8]].5LH_=>[0+#W7T*OE&!YXMV0B_#&1>
M?NJ?;^=Z0?]7VYNIT=YDSP^K"D-W*IN<.6HUI!J90EM>BZ+BB3<ME(MF,9KN
MX,^K!&>&P@CL&\GRUG9CSHX#!7:/LTH5WSVVK",9T'/<%^\4<>JRV=\/>KZH
M3ET\*Z]=UE:KAL$.Y([-OVH4].75[<];EAN6ZZ80,L!^7]M\YJ=F9/B\CC1*
M96]MO:$0^CX$Z3DM5]=IO P<:>P 8PW"/FSU\>?Z&/*-NZD=H0<:,Q:,GMI/
M>+3GQI<K8YRYBTSLTG_AS1ZF\3HDR^_^^Q4$LW-EU(N!5K^9:.[;2L_[1.+5
MVVJ='P,(Q3A[N-84Z2I8_&7^%R<PJCI(*I(*Z\24SN3D*]&&AF[_2148IN=<
M5TC##+YN>SP;&2F$#CU9%V/6H+Y&<^R!K#32-U2:&DVX#OE7@7UU^5FT-5NU
M"Z,JFPSIGCOYYA31WHR<.2%:7C7%#TTW2_%G.W!O@W7M"][L>92)S-FSE&0I
MA.CICPY,4U1"D"=XJPMUUF1<>4Z#I#8G$Q+T'0UK961 %>O6X/T0*(3T_7@K
M/XI.JXDCL41@$-.\&PL#.#D)<#S^<,SKWF*2 \:_VX9_4SNSVL1O5)<Y1!Y]
M*OI'[2%(E_]!%1GN_V/)>(>;4E/>2$?^:16IQX7+WS$[.WBV0%55RMN7M:Q/
MUK"X@H3@8^V8JYH[Z2G<QTTN#,%>2X]S=I<[J@V=R:\ERF=W/ X84LY_(QT%
MXF;XK&N0W>.'&IL5;&^2\/J.A#?!WEM!$.P_'@]8^:7OT_#*)C3M[!R^-'5I
M=Y54=:/NZ^%*V].]@H" G\+<(_5(*US-6_;Y*] BKYFDG.;=ERRW 1R<OU'$
M<8MO1JZWI)$5GZ ^F^3>!H0ZM\<9!,G3A=O=<V#=Q2\O</)37(:',NP/K#K>
M@-__>!<MW8M%J4]W.W9LS9+P>U:[->'5C=3EZL$;3$!MHEE/Q]/35Q"BTJ**
M9G^'PFL%P3],(6Q(9=/?J![=@R5KHZCA8PUK2/5I@6?.\%^%5R#T:&\$ZEQ?
MP2D)FJAB6M]  5;65"__U9=Y%;WOE'=%N8_Y\+WI:T"@U*F='9G7Y/S58V*R
MKGKCTI7>7CO<X7FNZOX7"WKK<HV!4;[I_V'OO<.:6+N_WT'88D?$ E*B@F!'
MP$T12,!"$21B5Q34@*!2!>ED4&PH$BE2% @61"Q$1"E2(A9"DX"@@ &B!A@A
M0( 00D+*F;CW\Y[-@,]^?N=Q7^^YSGF]_,<Q69G<<]^?]?VN>S++Q .M0#_O
M(KD$-;XY>SOZ3'S20KB5\^$+-A#U##[O ]'^JUI3,Z/UJ'C>LI)SAJHB_V-S
MSVA$1;D:ELLU2*"TO-3BN\K+Z'MI88.QH!S8*%W>\-5TU.* Y&I3C!=XVC50
ME"!R:(P5?%VFK+WT[B7KL^SN,6QERI@*;K VQ)]T-%H63$TZKVJMKJY4JQ,Q
M#)$@NP1IT;.%:]5.*Q*3HL.L,<EP)C;^0\A4T?X0,H3^L'N]3":1F3+29_EC
M.:WVDBRGSYC"D;A<4C:8#?,Z9/[>#M'0WM4H[C,#?]6GH&.\C:<E"R:U& A1
M#_"A:W'^?6 KO$*/YN][8(ZZRB1N]AWZS70:+S=-CC,R8OBD4MCQ>"^&Y>S9
M:WQ$5+)R^=GX2#BP@=0S@WERH1V,F\ @!(//?J_VHE-/UI=S3L4]]ZDUZJ/)
M2 0OJVK5.YA5]Q7;GYSVCS:BF!8=N3EBU3=@8-<Y?W@)NR]%?G1,%%,IG5G[
M>)O:>?FX%)Q1)9\M2:0H\#RW<\$Q^%HWS/+:6VALJ<)(:WNZ70[.]W<>2]3N
MT6L]35INC!1?6MYTDG,T7=JOWQZ[20[=4H8BD+M5)O+_QWD^>&J^Z.J93RZ*
M2;]3IP5_Q7MAW] _.D\&[A -_YY'+X-F+*K<GAE'2[WG*]JZ56->>5N@5]&Y
M8N$O-0QGX26GLQG.MEU[,*5K?:NBDP_%U(;IB=0GI_7OO5GN"WQ6WPA0-).;
M%6AHN 37(V=W0]I<-Z]FJ&T]K#S%0%K:<ZD.;7@AI1Z47)9IY2,&6MY0:J$Z
M!V5;]S/-'[(^;ZNR\_7'F?T/3%0&:Z>A'"7:,SW9X7B09Q*L/<4 %7L0&%H$
M?^_:)Q)M<!X7HAQ7X%O;&L,GW#^!?7VU8=G+T2+']<#FPD)>A+]TRI<O$$&4
M_^RJLWV>]8PJ?$]$&57ERUD.([-SAW)0!"^HLU ENW76&2X4#9\N:B"+)6BC
M#R2>(KN*Q,!G.U%:LBB9XCD,_H353;EA$U+&(YZ"YQ"[-FR?I]ZP&- ,-[GT
MTPQR=N .;!?:X>5[%7_?W)<]S!<#'#&0&F+0TJ!L\@8"?3':,,U"4)E.^)/D
MEJZUG:Y=6HI5?4P1B#KY0X/CL]]K7WWQ\3R$FQE7P"[O5>#+9:^ &=73^P$F
MRGX[__6%Q@03SS),.O];21)-?79.Q4%[;GS:5$.&!B%3%;,J^ZGM^UP3TJ$;
M%#LZE)D!!,V8/%',_TE><:SQB+G8W+%VQ5@55EK%)]:R <[R^\;#'W:./TT4
M=S#GN<PB*OP_R6)@W[,.-J>#S0]I>O;BV;,;5S9]>+ \GACOP80341(*N^VB
MX?*8EP/DD.6!_!VRURWAR140)%K7M O3,W(H#5^<!F*#U>$Q*2H6 XM.91$Y
M(>NP&$>L9"6MICTB]6NL,^/EJUT:U&H@LB_CSAU0)LWD/MM'@+^T##B=U11
MA#FA)R*Y5$+,2FB8>T\RCE'/8 EVP%KS=P=B?$157$2TA5XLYDF(WH1X=\]9
M+D^Y?K5,(^K:O8BH,$-8.H3]CX ?:Q-ZK<[HC*JUR1A#0Z0F!A[[O&*Q<^=&
M9&DXXXS*U^-3.(+OTI3)B2])[].J)5,A"3KVI/)S(,.$RXI=W:*17]$FG6C?
M&$<MU<5^9?$I*G/$@+'.M(VQ%A9Z*3C9;JI3;;A)8*A6HXR#W-4S].=SLD:(
M<48CAA0&S&2;G^/:\=T:6:'SFH,F'3H8'15^+*CWX3*"TRND*>#DSN"!&+B
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MKGUK"3QF!'% B#FH6WH<_Z$99MZ_WOY;)3L_+ 5^ZQJ0 []C=-<-0@JE]^T
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M1TV#<":T_:NT'3KF4C:][DO)X\C#4W.FCSX00\?2<8CM[+Y\NJ6G^_!7LZK
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MN(4ZE94S [('%FI7H?R%O,6HZ?T5UKG'[E=)I=YZQ:A:2=1'  &]<[DKPF=
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M7';@E9];]B,#XIXG^&)<4$37,>Q14NE]2EGKI]EAQ1$@^PM5F3^6#/73QV=
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M)40O']T[6=:QP P1'S+O9:C]5H=*DQ3:7=#Q+&17!"+6QA,')T]7<LGD[,-
M<DX=G9!4>H^URWIKY]]JW'WZZ!O%86JV-BI^3:REW_<-9_VS?-^'$?JHN;$A
MMR#$(M#^D&$D)R*#70Z^_J.9[:0' H.C#HD"" ,YLC=L]\@#^FY!8-8*,C@Z
M',%KM)4Q7F$S(5-4VP>M;$6JRYI,=AAF,APPAN8>@12L=-Z?S6YONB54!ASS
MB&5W,\CJBF*A"WO)[85/KBE$*.80JAN/@$N4*-L4-LFSN2#(A'BPSVO4"*N!
MT@P12*V..'6H+W]<M3/I2@XAMQLD.T#5;C9UYY8C<J-@$_R0Y"K*S\[>N7U^
M/<MLW-@E:I3R<:GF)(M8<KX4> 3')U?5FBQZ$>Q;JK(S[HL&N$>NIOJJ'&&$
M"$.RX1(2;[F"WM_/ZT(^YMP,*#UZ!K0X!\+!<%FNL%]AW2%OTW;EJE:1';V9
M6N%G&8X$-^366O X!^);N;2@#%SV:.//5I KU")COJS3[;YT3;W7IL9/$W4Q
M]N#:;;OL-Y6Z,$!^P8PZ!4B>>(?+W.=_%_;?#R,ZO5O:-2PK@6@?]V<CR424
M"3\K!A\[+0[!B853#V\7++4X&_K ]*-)583ZVU1>?_37&[.!+?@3V/1D6>/<
ME7+0W]VQ1?*=C<%AK:+\0+)>P6O],Y"\<"*5DFMM$@=\"Z#]0<-(;E &!P].
M^=&0LBMB) O6ZCU,30*2#G@[BCJ<"=">_Y^TE\:>TS&ZEAI:K1N#@U^23BGP
M1AV^Q*V/;YT !V5@ 9=R&JQDIU/:#2-4L2T4(+)%_&PLF?#'&HWYQ[; +YM4
MA- N0URGP_)G7<E;<)IK%4\98@/Q#_>S ^_O@EP[]L04-Z>+^K-A98']#?LW
M=UNR^Y/8FA']:-D1K+.OS('VQ69(3XR(S0!56(<G%@&JPTQ<WCT=Q)H!Q:(P
MCC>V>3E1RX91T3DY<"9:'"W6IZY*Q5X08/H8?M!B"'0L;P$*,14D\"L?HY&E
MLOZ):4CN"&V"Z#> +Y/PI+$;-W<@+,/QF9+1\#"AM^RO"LSV#+)[I'[\ZFXR
M$TT6Z\]ZAF6(W%VPB:GQY"KJSU[<!9O_\YX>0F] G0%6M J,'AX-IJOK63IK
M52GR(&AW4'J021.PF_N W?RSW6.'6>;@>HYA$"#K:"D6,EEW'I!UYU=XF#?N
M:R<18"#9\?3QLZ[$K<MJG5@6D8%-"FSD$#1E9_)V8T?BPUN]ARBR;_M%.ZIO
M^!Y[2?*N)_%J'RQZ(MGUX$?BJ,Z]W@;:GX-M!5@_)4GO)687YAGHX-]//SF+
MO.7/E@5TE5:)*.7$4F,EP62!/ GGOA3D7D1,<*\U4G&H_N,">$KU?T.^WQ]7
MN:P*MNB-SCZ[4Q@<6_XOH2]!7@&[6N[V.?1X8+ZQ2H1VM(^B[ !IE5E4M5VI
MT2K:Y0< AZX1CH0TY.8@)MD')(P>U%#N#*C!SUG$$ L_G9W-RZP"+C8092BJ
MX3 GB<S_9_3N6JX5TVB(L3B'$B[CS01#R^B_,Z;YLOJ0AK]ZKV72P#[AF/7X
M_P+\3OYJ<(\<^?P3"CQ%GRF0"%CD9+N"K*>JPC8OO]3U5K75 0#XIE60L%JC
M:?@^U<Q!&YIAD 4U^6<S[_.ZD5=AZAXO-E<DL;6N!_\FG( L7%*PY/G94(:Y
MCJ6#UK0.#QP/['.P25-LG5<?'*>!5^8*D)H=LPWY7PU0]ZAN_ZV]@X#\379V
M]-595^+6S8(Q@"[\/Z!KMI6X_X(9L1@RSOF;\)?UC_@SPDIR3,IA]"1O%%U\
MG$E&.WVBRAO9Y3V1-B]08.&=\R Z)(DKH4\N5]C6YW<+4#<UWC SI#E#=CJY
M/ \_.76H?=I8%9*4FE.2TJOPX\C[65= ^V=1TU^>A]N!5'3[PE)-;UW&.3H6
MA"P99]G-NF*KFH5LB@AHM/&L(HH7:3(DH^?(VGZC? 228C3M)VOZ[=(TBYB;
MY&B6MP#VJ^A,_#7C?U@D)SB75APL/_.:SH$1;:J:P(S..+VL5IH*Q]!"$,XF
M (]Q4<I?WCT+64UCZ>CS>T$0TY%! !2W+.C/(8X._TJ6ODP>AP7A-YJ*CKY5
M]M$<M9IJ4I*U8M.:50"011@N*2(#!WCT9Z/RY5-<FX^9$]A \T8J!CW&*/&*
MM3P:,>L)B@Q5[S_0S=H:6F*))B71,:.8AWD+((@IC, //_9GG: "R65#)HBH
M@?(2"5<:>QY8@91*?(:D+V)2Z"?["WZS/0Q8CQ3*1]!(3 Q)_$,$_(+,V:6'
ME7+,5  H'/"3PN@#,R ZGO[WY>C[53,9=33#"& WXZ]'ROY.;Y8.73I;=,XV
MK;#)RR]GO57-0#D.1@.8XT$OAJCH8[D0!+:%3T,3-&2-R &UI9-^;*-=H*)E
M?$CV!HB74IW^;'IMQF>*VNJ@=6*DN:RGN.NO./R\_.!23E]IMP@')Q0'JPIX
M!>L3(CC' B34:CK)7$DL_#A7KLBP?U7FX >T(>PD(-^DBIBLL@-(S4]&V_;C
MHW!^HVRB=F8]$,BNSH;A_R+Z_G_J4(!^T/^!?JOE>5EX\3_U)/*>!/4V;IV$
MT8T?RB4VH* BEECH*B*6HUJL,=>E>#Y9,/D0*T=+>?6I9#H#*B\.#^P-20H2
MHQ*U=HPS>S"S9=_2V;PL_5\DW]*V8<0"7 NET90>04]!00CW RA3=CA?HPEV
M(R#!&! ._$#XC<;\HPU)/MELJ_!^55EK)5VCN^CS5:MC*.57I*.VDR/.0+Y0
MQ85$X%JFNM$-EK*S\;;\"L."67+1L<.T[28+78NS$M)7 _H=E$YOE?1Q#"F^
M$.4?S<N9)$36 '6( =E"K9H!7?).P?1]S9MEYJ75NL*>.R#5-IP%9'10)7)$
MM3-.=Q:S#@XCF+@6*C#+('J*["CRA-D5TMDXE.GT7[7G7Y=?Y=#W5]77P\.2
M!_1F&:ADYYIGB(6=>^&F\]] !H8FI^BW4#8UG\[. M7>F/1;=Y*'<DUE0BX"
M[SS^\-'"5QO:#J5>K?9ZX3Y:4?OY\@=.M-=4C_2U]8*:S#1!)KKU.V*^%6I+
M]AUS_OMCOH9;;*"65MX2J--@" F2[*2UK\L.H66:JW$[Y8$/G$VLW?UE'-8;
M]S@T*DFB0"B; 9761"%L H807Q&/CE RL>NBST6CZO'YKJX7TME/:"]=20X7
M*BMY>B<11SCS30Q=%K0BOED, B@V?[@*OI>R<(%]!*R1&%M2XN7P4 *NW3O!
M'S)*SDON:K3!,XKL#._^-G<TR%95AY5R3U-;*9_C^<G8JM&JN72=V=F1P@7[
MPCN=*+RZ+SW"JSK$T9+6ZK+ 0ZX>M3L(C\MQ==3A&^:W+\_C6E"K8G)%\.]1
MT7!'_+8D'<IP$H?8J\G%ZFCFYM)R[*]YPB^O>CZH[1!SB6+!*S%>R[WL$%AR
MN]=OC.-Y8=,S>\/[KP]RPBE1SPP#10$K#SENH&[FA%T(Y?3M8)*']UZZ@MFD
ME]G.[J*0<ZZ.DTFO%J8TVJDGV: 0.-"R&= !D7>)<WM![V^-:BG!"A::? Z[
M;6%'HWJ.EBQ_WV@]IFHA.WOAA5>2ON>G9Q8EOYV;3T&I>F5,QEKO:7IP)W%X
M7Q^Q.#%60NGIZ5UK_&YO\_-O^P/-I]3%D>*-1Q-NK%\:-P-:*?;#+P+R"F?8
M^9I#A2M/''EAI>>*Q09\>A\3Y^[2"1-E+:"S+B.8Y!7QK]Z$$M/5;NBU%*3?
M_%+[N0QQ@LT<M-C3<M=S&[;NIO/^$YZT#/S)XS[VQQ/4W;06!)9H-T#0X&N.
M+XSFOG4!?Z4E\0?@-":[[=C-(Z%N1S=CJA :#JSO.[X6&PS.Z;R>&M';Y0SV
M6$9TJBKLZ:_V:U'>O6RH8_^>"U[?R35/IR8G%LRZ4X#];C>[RU<K]_4X'[YE
M0E2GSX">'4(XN=84VS[0HKS WZ;HB;.'\V[N3EMQUN8T1"<4!&[(+4R*NL)R
MCCGY:.G\"$A8QCH'LKIV-:-(FSROQ<!NV?+!G#3,QOWIXSW"[Y]+-]AE$CQ7
MY2;WF,:4O>3.@"[;^QS5ISAJ7G;J="XU(3IA&,:S;Y?0:7OTC3'FM3C.VKK*
MYFON-/:0KO(HDK7%$5UJ; TG.EJ7+DIWN[Y^PP?+#39',C;37_$^/_$(C3=)
M>;W9K-.96CXTR44-.]2L<7BS"Q&45NEP0-MYZ$ONV(>AG&0U]'>S*]F,TEB+
MR>'\A*O-+L 6:MHHOH2MLL:[BA]U;KUFN@)NR&]T1+D2M(0=[& /K,L[?2ZU
M(8MZOGF\4B+D]35I!NFS"EY2ST]6I$'3TW%=H28C$X.-1&A&"*.LS%6 3(GT
MF6AO3'+@:;QIAY-MLH5PU\9#/CWSUQ-ING&H6TR"N^[IA0$;AZ&<I#1I88HE
M3_9U'<V_,70(%V_V^DLN^VENCT&L4#%Y2.NBF]OK*.8Y_=I)KF:2R*K:J)P\
MU(M@L3XAH?FZAQ#G76\Y5-'!*&L^//OW2)X8$7!V_<&\,P&2B;U* I7LL.)F
MJ>.-L3Y8*/'#+M4#X42O8?2%RT->PSIWG48U^UANTU'N-.M5+B$U7SD%7.>3
M!OL<<.Z;'<H=FY9<#E1K-,*-UVN]Y@J_YK)U&A^Z;JUZHYA*B(%S>*Q]:BEA
M"@K[( D)J\%>*CMN?T=IMR$.06[K!/:+6W=NC%Y&><07LXJ38Q:;[\&?KQT6
M^ CN])"[R]97<I6>YJ9\<7_V^=FSBH/;2?NA3=&K?(Z$>1:JZ931:>*;#N?4
M5X3G':5<5K*ZJ(LFDVDW_7*4ZS?9(AHTGK]+9=6_84F=3P\NS/=.^-QH]D)Y
M)Z&/=8E(_B@B355I;+!?482PW&-PH9 $]3S90];*>773E0EY%6N(9'FNVL\#
MZVR+4UH(!'4XN*P$^-Y3#6\Y=2K0Q7&Q#R>^!/\Q3\=?0-#%Y)DW6A1/]-HM
M3\3&]ZHQ*+?J!"Q*S_.4"Y<;G(Q<2Q]PVC1$B; I[./YM>0V_S<][>1TUK$.
M*ILROOYVS\&Z4ZY8R_"H<3Z>^,S!+&O-7+9+K6DP1%.UI6AC7M:]PHO=?/Y\
M=7$] 3_@VA("TG9?8==TZK@/@U1B4Q.QXJG1B7"#V^YAZRFA-W&5E+XOGH&!
MDW4%V#!_YKG-[EZQG.G JBF:P?MWB,-BW5,SH%HA[]'9?;MO['6Q-ZI87)([
M&$(N=6 >7:*#-EY]JJIE,/7VI7KS[['E/:6;.CZHOX-YMVL\LGX=@FD*&_QB
MWNI[(KT=7/W,;-NK:]L#W7%XXU<X ^H%UO;J@JP2CL.>13CH!:GUG><?]C>Q
MJE.M8JE%*$U-Y H-AXW/5Z^/!/(;878([X/T2%SWM4W&.:&E-*/Z$;4KI&(%
M1M%:R[TES7,;>D_=06:G$ET_(8]>L^(8/J7J-RQ;M.4$W'T5K.<9=/^%0O'>
MNK5&QPY""]VN%HU6?,)V4/;'3/H\)82.ZNM*M:XBD-V-2N1M63[&L'4QO0 ^
MK&*C<G=$\8<+CWOK!,];-OTY83$G*2YZ"DP_%+0+-\<BOFMI;%2<$TK1T_7-
M0(C+H:/G+799.KKQM4K+O@A/[I<,(SOK6&[D;9^G<M.3GY6[OXI&I!R5#(\\
MRK">;X5WYCN#&9\7684F:/B.T!4U=J"$ I[XX#%5Y<")04/^/LMI85QT^/*7
M@6_N>*VF6R8HH9'3-M3:C3D!.,.;L+L.HSWM5M17!RE%D^6\Z@L]HIJV$MV*
MB/U9@B 2#)-Y3JLH(^I&0S0]"(;H%XV_-^-CSO\LI/=;_JPN/7FW%E*3Q(E#
M+<Q^P2(H62.8K.S#=[\:7^^2)514DO95:;RP\_KI>$+/\>B>)16I^T)?!9K1
M.-M<TPX=H@JH,96DP81\^<3H=_FZ48']C;WO[S9K]BN/:O+K]7ZTHRY8:G0V
M--X<2%2LQQ;(NI$]E56!_PY#<7KQK313&I C8P,)8F!72SG+*7)5=GJDW;YJ
MW=68#%@HI*_>BMNK6J0KE_;D+0@4$_L")R1\^G@CA\OJD:_4%\C5E9;(93QQ
MZ^2RL^,UQ/4'$-&AW4!V,Z8IID9YCP$103X]TWFG$]P\E!#XP,]_Q"3.@7Q[
M^L=/$+^6PV_$$-=,":(1[2,PL0EQ:!KNJK-;YU3S4'NP?7B*Y9B#K'GB["L*
MFVS\;HEB:FL8X69(=<:$V*)X"Y!PU)D&]IID!XDAB5I1(:R^^\F_)U\QR+!X
MH]YCSGD#?BC>T:D(3JM_$M34H,Q6I"7YH3FJ^7D+\']WI0C(TPW_L5B?*)=<
M79Y=K?+E6EVE#K'I&B&X<0($0V^;76R?E9CXS[XB>^]AC1DB&D ,3!Q"9$QS
M=\M7GQ[FS*K0_T7-_C[4Y /:QJNW%,B4Q(O 9E[58L0#N:0GH4_GCWG'E!>.
M N.\D^)LLC&-">[KNU]XAO"Q?A@/'U4NTW9I[Z^%]56_5II<Y?.B=?_T=\K]
MPX@.1DO[*HUPMBQ/&FK?P1C_.COALMSML^OQ@*UG/2-D-.2N$O/-5)LLCY3+
M9_3E<Z<5?_$RQ^S?"T&B](NW/:_Z))U:WXM<'2($(S=2G[YHVZ@^]V:OPA Z
M-;4QO#\6CAD\J/['VN]O-!W$.\M34ZJ:9 >@&;B1X#LDF1W+7E<N E1V"N8C
M/T]U0#25]A(\QL<O)2['U-J8?5;IWC=1SB!V92-1CM)&Z7R'374*G5_L?D,]
MIR@7ST$]L7NC>=%*NET<A"09]:*G#8@)#^YE5,R KM*."):M>3&5,-ZD.Z65
M(#TJ28Y9:(1MH!J.,-<:=@76N7T(XOD[NZ@*Q/76H=ON;ZB<HZI79B3U2Z%A
MON%K1,[B<MITP SH*THHG>P:5?.UL#.^6 \V8Z8*+[+Z"JF_I6FAAP9C:D:E
M)R20QK@=YZQF0"]5>>H,8-MO-4(/$$D4K2>8^%8N1MMK%([3@"B/3Q(&WE]H
MGJ*=.3S4@LU6S0HV]V"@0RA:(3??)A>HO+_=K,D&B$>^C'(&ML'?1&!9'>77
MTM3R;S%MW, )+B8KO!=5#R<XCXZ[S*YQ;0KZ[9R9[M5E$^QV!U&74F[TI<F\
M!9M_A>?#?<F,<'AN.)O =),'Y[%3E!32I5P%EOBAXJ[!MAI$:L,:^KRM(.$8
MBLC4+(:F7NPP*^Y5CHV:G %9/,"T])KVW'/07"FBI:.(] .Q5V";6U%CAK4"
M/S%P7UUC04)FP>9K;]1 P4:WB:0RFT\6&:T>;<O,?-5Z;/!2?,LS>Y%9Z>;F
M).5B3FW]!WH*$N^NX3N>&'I%E%7'G_RQON<X& L2,PM\1QHT'&3-X01A^:UU
M9X;],W%;&SMDAZA*/<^;=M><Z<V3#G-J?_0M^^<FBM9#K:3"S0((1 -E*#L.
M:C?%+.ED&KB7RL>7,*;''<,1#V*SZ9#O6-1MH;0")&X9!B1C8@2_BB) \222
MAZUU0<)O6%1T,CX#2"%I/84"JU9@@!0!8X@AT"_HU%9"=SN$D3Z*:N!)_.<<
MD!O_Z$@;PU3OJFE'NGF/@[428*)VSP3BGLB"()Z@$J>1^&?ZW<-F0B,=Q26C
M3#+&N6DX3OLZU.C%-D=J%_V<$"6C?,6:C-: @TNQX>8]2(P44)SV.+-L2H9L
M#JB2H>F072-]<)@'"AY!E6* =0C:^^\:V*>><;'J_FHX=]EEC4O\*&\F\<N-
M)+Q-=P'4L\L"V%W2$-?BUKK 1&X]E6^N78,\L7Q] \YTV'EZ%54\+HWZ./>V
M.C*V?'<=[CE\4O8"7I8:O"IAM5+=V#-,B>*8-.U35X1O[X<9T!P1/A="=%]V
MFIH%UQ,O&I5&SH"L_17&!9?.4K:=-^+.MZ VB>HP'N"BC>I6E7..7^:[O5E?
M>/!>3#TT1853W<1C3'S(#P^PP&Y!X7&C@&]EC62U_GANKS_US3+Y295$94.'
MX++IHFV.-4-.9N!\MF3C]N[GP[W54BD')Y%5*%?Y-F2%,D2B.@[O1R-;-V/7
ME&E(__FG,Z K2VY+=GQ\W'?XS-ZX7G-S&JTP3)'2=UON=K<")BC\N=E)^W E
M7M:H-4 XRN#7.5E]NXD*[L<.HQHH?:G\7&=AU^49T,539L,0X$+F! (ALB"*
M>53"M!13!-;+P)1GSX"(GKTH-%/H,D?@U](^;23]+L#P^TS8PFA20D83I [M
MJ]J"P4B%+&'T81MG0XB?Q0PH%U<U P*3)A]86A4@V^%H'@X] RJ;E.C/^8K(
M/=:V;9.EBIF*^8?5C!7B$M2;YD;4]#&\*M_#%G#] I7,JRYFJM3]LC,]H9\O
M(J'I(; C,Z#H$$'5%(\O#1,7 R/JH&*#&1#HS,=\@-?Q!UIQ\9#7&32;&= U
M$+)Y!O1FW12J85G,%IH&7GQ8".DU)P@7\OKIO+(.I4:I@J(>B ?VRJ5_WX.,
ME'UV'_B%V=N1 VMF0#=1#H,,S.3RR0]3=/)]B6J&S>D6V*"XE\L&9$"L_YS6
MZQX.F=XZ8'VU>4AO_NN.#1F#U&T'F5A%L%<MI/V\6??5=_.LG3CX#Y-$%K%(
M]7G@^VJT=!X?OPEP29J"KAR\"@X;?GCMGT6"S;>IC4)E?PKZ]?,V;[ KAR'3
MJ_K$Y=(HE[EW,I$'2;O[LH*->"R2>#A!N>Z,KW_BZ6![D*:R#UQV6IZ]:'[O
MR7N GH=&3Q %3+N1OBKLQJW& (04]5(LA  $_E= YFV679V[E.*DYNVO&0:6
M(#\O"^@S@KD N[;O1TO'#=W#AD(C126C418)X]PZ' ?.C*'Q.F!2_I_D4\]H
MFP%YKN1P0K 3/TZY.X+2RT279Z.(FWMG0/$L8<>O8 +M^W<-.!8'6;RP6E.9
M]**QT^(;1"AA_MXR;+H^X21.,Q#B#&P@QI=[IHAD:=+>^G?1K\,8I F+!YY9
M[8$MZ%&8"$^2-:Y=,&O$56-!<D*!VRA!PYDD\PSO(=F7FQ5*!YS'^7$DH[P%
M'6,!.J%@\?4/YJO'X)<(I#+MR=UG!5-M2X6C;XBD$BCW9K)I4  E7<W\("WB
MRA6B9BPR[7_FV2P8_O+I+)412B:D'QK!E;6L72IW+QUC=D; "P5TEOFZ:G#$
M)709Q#'95*L;:XRJK^,PT-PO5[OC6^=-]X^*LM%>J$WW0;>5ZTZ>\;\;_:B1
M#JQF'IBY2SVF\EW'1O[A9 )S!O0=TEGHF:42V(+AC(KP9""]F$5$73O#]*[[
MZ[R^AU1)(!('H<MUZ&8@/M1^HH< \0$]"3CP%PK^:BY/Z8KA+4CLRE;5U&1:
M+J0$6[OE[ 2>O <KJH$!:U78U\?[O7M(<0J>C7K6BY*@2IC[?P6<;!V5\3H"
MI1P-/$2*Q=:J9S3+UA%M=!P')/NLZ.A/J%\9Z"IGP"HSYHKH6^4I<39,/"ZQ
MKF5ZM R5^B9DO$R"@:$S(!?IW27=0\O^X0D<*:;*)],@-"#(E\EZ:B^UR&@!
MU(CA6;5>0(WD2_3AANG5]]=[-1M5Q:(D=L(C@>6GWE?;222T:*'L71W3MBLK
MAU3Y_%@.2]9@=F[*V0FRR>Z6;GLSU;(9T$.4HZXQ._'BBR7H#+5Y"$CT%4P9
MV#&Y,D -JP^XG8." CE0O Q2YH.C(C'&"67U!^C.KQ2:Q;0NTZ^]!%E(E DL
M1_ I2B(<+%[$09Z0-<>>L^\ ?CVS(.A@E9J0QY3"=\LA[B'MU\__WRK/W$P0
M+9D#FRL&KIM>(K@"1MCRC-DZPETE4;MTY1X_C$DL&8;O^[N9)&]@8V;-\+NQ
MZSW&!(V]C#S !/]AG;,)V,\<B TGJV= JF1>D895XPS(7O?4&6OJ#BY3H/E1
M\>._3:597+O16N?]U?_*Z9=.OUEI]H=,L@BU\C(MH*\;NVEK,&!222G77 C$
M^;V_DFBW/103T&%8.J(IV1$F^_6']*NT.A@?'MB*&3/$">AB7MZ"M<9BD6]"
M;,0I!E-VNN>27RE7^,NG\W^!5)QN4LM0W?H;RI4[W^BE9FNJECE9?Y/#S)%S
MY=Z^O2\^-(Q"#/44<R.%L?IR9 &<,%2Y/N'8ZVR8S FNTK0U&2V 4"T+,^\%
MA&KA/Y-K<W8;"P(3"HZ.EFB@ :]_0A6M-A8H\CL"Z@7F5 %=&!U-^G7$N?E$
M?7!Y-ET"HP/?M 3B",HP%D!9!11)GQD2)0D*BC(QO"M]O1E/I4<P9D!?IO@/
MI7):JW!P@CL%QPA8./2XS$"JG %[8X1!IK=!U8"]F4H.,*GC%UD'!%8UDFR&
M-&J4+D8Y=]X:F2#SYVIF?\ !3D,9H1U!=UOKW(&-%*W?."#;2*I,N\R85ZT=
MQE.NR0VRT]+!G86!6?,W-X,!S]'(7#$B_U?6Q.G*\<QE&+H9ONU ;9IWL*PY
M9/SD0XKOF\30>, /?-Z/'Z5_M2=#Q"R@K3,69Q4GU)KV>[/()8(V>]'6>W$E
MFCDT5"J3R+AB-Z(1 O.> 5V*Y;1 & #D?P6:?UK+!.S^^DD*$.&\,(SM&K]^
M?)9FN^[9X>N?0&RV!WFI]K$P)6!WS9;A+;X)6>7*@3+&0X>^%,9F'CBYG'$;
MQQF+-1>/Z0=F-6YN5@5V%(W$%4?F+9@U(%X>6( 7?@72/S5Q-ZDO=#AR?Z#Y
MZ>2\D$\HGNC(P?+(]]4[)6U I)#]?EWB=P__[9VR)@'X,F,A)O=!R+-<%'D/
M3M0;*,8+I=)/OE SR<63^-I&6@N@S3EL5W&NKTU[R S("@N7@LM8#A^&O4<8
M8&Y+!&0 2$ 5ULN-SVMAH&E[\#H,>M 0, G^U%_AZ2-@$<,[B6^2H-Q!4>HQ
MC>\Z#"*\DTL ?< 2"S_*YX.O_O@UX5M4CFBK#@'F%/'C4&R%M?^V!5U?J-'X
MMIW/N_7F:JL$FPO#Z'VS1%,;.RNT06D!;G0L&$%'EW5>_34K!-W1,216^F>0
MPU60.3MF0-FN2S(8E&W[63@EB%,.JGWCMO\QBYR%1E_HYO%MMF=?JBRPRN[O
MCXT*X<CK-E/3P!;-;!OZQ$2P!0-=TOGO"J=_%V\*_2V#JK0]Y8J# (W03#9G
MOYR0VFV*L 7  F9%@('5RA0>$N=Z 7D@,/V($"FDA&F[U!=J *P^%*Z10YP!
M/6-S[.6E&_C#$&.$ >&2(\!T(3(M1LZ JK?>G>IT8US*<N]@YB> 3?%.%:7R
M8NB&/-#<NI^?Z<T'IE4KD;VX KK]_YUO<\'?  '6 @@P*6(VWUS79 2<++J1
M%%-5;_!!U*LIB?PAX=;*;CJJ(9N:('_JM)&"DX5EW0Q(CX0ASH_3_95(VQS/
M"LP.+HL*K">0RYRY]Y.G%E=AC69 ]77\(0RW,_Z''F.ER^28D/IPE@";S2MY
M ]UI[U\X(32 ^RN1T,0YLCG< ^8 :S6J .: RO@+P/V*H_S*( #RD&H \L[$
M\:__OH%U\K6P]<RY-6V_QTBDID@=,!HZ5JR5>PY "U'XC#8(:*5CN8K!?8<V
M7#&G/V*Q ?9 $HHVO [._G2DVCMZ>[0P'!FU[E.FS7%L]Q\8W_N[--J3T?P,
MA1!R;A7G0%K#[P:ZL$Y4;-0IZ0EK)<V(]S;Z[3D7JHDYU]K[NHC>;R0VA=N)
MA-+]88C!V(36Z!?\YQ ,G>B5_24R +:CAJY&NE-\!_NZ4/^9643Y32H5T%SO
MS)LW/GU4>LY@#[:67K!O&^U"'<[@?E/E%?[;#59OVK]&*C&%WB43Q0X![G9K
MI1RK87N!,PDB+<>XQ_)R6/7N2A/>.C8GWA!B^'P&]RMFQ:L6V\1UQ)QZ :AQ
MQYBJ\_@*UONO>O-K*X[2#$(#6QPT]K@S#7-K1Y._;#F445Z1>JC'U"TYHS;Z
M26E+R1VUQT,W5&[:(V&$NOGV&QXQ=..]-_):S($;8N$DZ_.NWN;?-8).@>C?
MX%*4^V&_T%Z;K]F!:HHSH,_3RSRZGIJN??S*ZJBNX-"Q;Y.USZ+#CHFO/]Y/
M]6H/#SK2XT;IZW3[C)B<7)*^1W#G^&>BV^I3/#8%XE6Q.V.A>M+XXMZ<WE'Z
M\V\F]<).C064^-XFFV^K44+\)M*=YIC X%;(E<\.6A",W309;;>I]=N9%>>K
M>B)O0L^G06O7%><*;[I=\ P[N;3$YDBU'M)W"'GL;'$?_Z1[7T2WQ]./!T9B
M'A4X>];#1\W5!C'(NV<@QK_O/+7@^\E\OCK;2=J6:Y+N&R-IQVR8Y$^-(AXM
M3NY,.M#H,59;">0@D*9CKW@)CA^%:8C#?(VI'3UD6&?@%'D0$C#XJ&3!MK*2
MAG58O[)^5W_?6ZG+7SA\5POC:RK'(C'7;HB;=LZ+TWL$B^_U>V4I,HUL/Y')
MY>^(*2'1*-7##TS-'(U,U.%OIR@D8%^O<?BRSL#ANZNK<V]0%^L5I2(K]I5
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MET7S9J=-W[5O5:\];D&:3A(^0",K5A_.2CT\7;75?\9 ]+BV5/53Y:^(\8]
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M%M;K!+#^D=T;C_@!]CMS7Q(,+5&OG' 6,VG*L^))-&CSHMZ^R1E[L>_K 8<
MI\*&D?.#RU'Z!/25&_B;E"K_*E6)XY],:*(0@\E]#S[XF?EE(#D1:!13H>C,
M2>*4A8HIE:,0@6AFG=->.,LF;?$L#%JF8>WX(#*E_4*P#^1M]UL#T:U$34?O
M(5NX6?Z3O/D1SH&^^=IPVG)_<#V2 LINQZ&7?IWRW;^4_-Z0>O]:U1<+@PA6
M$!]$>4TZ<8181UT_9V__0O#@14^:B%0:23*W/XACI&"Z:!JUSM:0-)F5MCTY
M8!5Y8)3@7-7 GNEA7_15\R&>NEE<G%=9!3U^6,5O?ZJ-C!&7"' T HHZ\>!@
MDJ'.7%> HL1E1'L>LBOO]04#-;%(>+M#LR8>+_>%#]IP*R)+566WBBZ[=;;>
M$X'"4R[;;<N/^+K9SDK#1][/Y^ J$7Y6W]NC=F"AHOC[]RK,U^8K=[0//[HC
MC1P!,#7*&)B$LR^N/6K*\ B*6PP<ACFO\&Z?0.[M/PJ6XY*7-$3]!/O>%U?U
M[&R.VGBN/OD>B@/;H_KRT]_81C@Y66EX>K\=.J4.AF*_'"[1JZRE1*G[J2\P
M-EWPJ!)3YH,J#<GHJ8491D^9SM"\#A\TI!A$X"!Y#?N^#L5(2;+FS.BZ"5Q)
M/.>&D9:O5C0?9&L_2D&T5]DOH6Y65E6@EI:-7%P'+QVJPOF.R 8O5W7Q05.,
MN.).O_)3?- M (27X:R55^^BKZ1*\!P!3/7$ !9[+TED7 R\TAOULYI3=YL/
MVK%>95/G!B3KYD ;6;$!@FL UUL%G2NX?DC.JCRW_-N*:YV/6Q_+QP^((K]X
M273OVB("2IE:!1#;CYSHU1CR[*VT-<I7*V=-0PVI0N72'L?!-<G^8\OV*$HW
M3._AMO/7M=>-<$(I,S@%(&Y+R:N5;FI!7982U>?VCP26$B(.^>66]-9I7(JT
MN^!<HBZ-MS_?Q_*;O)BC]5#HF=:73R%@,F?I=/UGB[I7U%[W5>\F\V@F<O)P
M^+=] 3MJ$.(#L6=-%R-HKSI\'V^\NLVP(_HMW 2N^:F^OLMOY*+)\?V-GDNF
M])ZOLX,S4?JJ)]%AHY27\.V)7[M677RF#_F6E+[?0&R]!)^Z.Y6:J$U$35B<
MT)FX_/R;19+I5]6=W1M5PL@<LS2E_HNMC=<K:L.P.PODMZL647I)K\>2[.Z+
M/Q>W4CO2F!NR1M1D.0R'FO:^]5;FP?>K 89AWQ\[)A0.&^7FPZXMP+[2+0]2
M# LTPZW:T[]9FU2RSTX[]^$OL&?UZ>.[G[A.C)N?R2UI<LT)P?I1S@S<W#PK
MZI=3=LM$"Q)29<2".]@F&X?UQSSQ= NXKUM-)Z^L3#^_Y'=[5?SZ>/]1H^:3
MRN=)O8E")%44Q25TN$PZCG[VX\2+$Z[+Y%09'1^]%UUSA%'>O%Y@X..IBMR&
MR:'*-S.!5;YU5?U]U6O3.D8]UK="8I$!B+Z782Y9.CTQ^V .]Y;9@ -9?"LI
MW?6:=_03.3U!ZV.7H:HJ\?ETK$52OMH&E>;TG1ED/@B (TI?8]=IE-V66+WO
MS#<:CITO&^-'"#CHU/#W0R6TH2CU*C*JX(O<2+_Q2;D,63<1$:.5>:)"$5JM
M_''G+@_99K> :!Z\T/92LJJGQ.[CX@F%4V3YO!'>RZ1\S^#@1ULU=+(S<@(C
M0EB/%;+NGPN#:J MH^IXM?3OPT;Y(2\9:6FL" S<!?[E8>Y(=/F]S( 8D)L[
MTFYD:3!KN>YD<8_(E01]45D(F77M>^:>._X36X]4?_5U#6B;)\[NWZ$?XG@Q
MZ2AI?TT85K4*_OK%P.N]EFG+LRLA0Q@*VL>E.<L@7//1)2BJ;I5&X,2=JLJ<
M9B(AJ^SP<,_!-R/E90G'M&+@S(7[EE.$;@GXAF_:[S(ZE]V'D+2(#+QB7N-*
MRE#VJP-2/DV\O5>&9B-62F]=4[.+9S686;]_E0.U,E8+<IDGSA_J?OS$T'9?
MD''#J^^5>%OV*O7'M>;@D/*!D>GKPCPSA'AB36N@1>A,&YVR4<8IN*3]=6W<
ME]<=QM1RI/F7C[SSA=2AF47FB9Y9\Z>GT[!VF:NL8%$%V^M# RTA!ZLT44U;
MP@(5V(329AP4556D4+N\P9!QQ=O^T(6S]@.UL*\Z%6DO4TL,%/0HZ,QI$[U7
MXQKGC2RL2KWW*B#/%SM&!-V [>6#FFS@ON $\-IZH]+F1?SIZO>]NRMS?7Q?
M6, U;&/;_=_J>'KMXH-TH0<XNQD0/FC=94;-6*?FQ(5L]G77&Y4[>C>/G'BE
M_Z!G9W"U^0$L)LCSAB$;6V/J[<W;\*8J0]I;/QR&V#1NW*OYS$@Y CR5Z$U/
MH>_GX>/I$8O7=&=.B6MDNFV,X$VK/]TL&0G+XV)>4,/&JCT?&GKO?#C.:2"T
MMM(H'K(FZB<)L66O)O Y\L[9/@U^:-M-[Y:0%27[!_.]TP*ME^)KA]*HJF^_
M<<K?,[7XH#)'SK97SW'SV9&/#QMU2^R4WQ@YPEKB%%VF>_%!]RMT#O!!S=>)
MNV2Y9(X269(/0L!,6>Y]F!??PS+7/*MZQP>E7UMLB I?PBO6H X2(,$^GY\!
M/PMC8QX!WD8(&TEH/K<D=:8V4K,Y'!(^8+>] #\UP'6UA8F_+_=JLNY)BS"G
M&G2>7;8;5 ^N8-V$F]BR]0 ].UD?0 [I,+41HV!)9#;"=H0=S-EO/_<-T*F7
MSUW>0,8/T9V(V"[E5;FKD QK7NSVB/2]MM6&O#66[;RHVMNO"_,60GZ6U'>+
MR%X3 K]3X%HZ>U043#CD." V^->>.<7(--NB.3<X6RAG (<$K\R=N]$S_3A8
M6S+=[NQJ@>?VAGY4Q(_Y'W#3%%@''[1X(6$_'Q33T6 #[P7E#F A$7P0@6+C
M-_"6MZ%[RIS[P>\E%AV+P_&ZVQ4;8H\-9_$>=K:TNU];XRR9G;0<$2RX-X57
MKJDS7"ZIG_,?1J1P>% G-.-18&KY>*E4#^'4WO:>Y%77)^/EE;D-![UHX:<&
MK+Y^B)^>MBZ>7*FH:9C^3A_JYD44<H'P:JQ$UH$/VI09#BCYM9!Q62)LE0]"
M]STC"J;QQ==H]C7B"014$HGDOD@WC9"(K3G$%<^.3V_]LK8:;* T2:?P07VK
MA59!=P*F+H?UC]> 59F<QG+XYU.I!:A-_HGIM9<T7%,S:E?\-A64S\^XL1KV
MSKV:NG2"&K3W0F"XT_ H]2;;!]!+V5]Z\9]MIK<W.J]C0MY)&LKA1G$=45CG
M'GCSKQE4/*%*_]H8#U[N8$22:4;DQ8^309WPH\0;-;>VW3U\U\#,\JOEVF >
MF)J7VEI3=W##Y;"DI5IG1 8?])T7T)>\I&$'7;;UC\E&SSDWJ*Q\ATI^F*VE
MA_2&WCPUT/:U2JUPY?Q>=9<2>-A7]DT:\?P+#KV3K2MH5_@MO-D#NM%]DO?1
MA(1<")D93.')H8"I6MX/J3R_<A&P3L]F,J0(!XD15<KS9FTWD#D8<E (7Y\)
MUJ0,$6DS-M[9'SX65&6"=Q9\8<*Y4++"#=>];>UV.\8W&4#[!\+MO?5&Y6ZD
MLZ$1QK,FA_:QC8PN5"DYOWE54)J.J1^A\T&'7G!6K=AZ\":G[>>OL*\3Y25I
MQXX8!<U*S+'=)$C1(]*_EE:Y7AUB/BT2L]+Q0U1I*"4/PNK';N-NX+X<>W=%
M[)J"QQ>F/0H-L>>5F>%#,! /;A^<, E'4CA%Z"W3@WQ0@O<#O1EN?$9!E"F%
MZZ)?Z1K1#W5$R6R?<NI*3SJO0L-<>#4(\X/J%<--$7_UQ44P67XL#SWAE%;M
MYA *C:10Y/#ONT(VKK\W!407S@@<>AQOVC"#]*HC(LM@% AE&8*C\<YI;ID<
M(6SR?Y@R,%D33AA9Q8RD5 Z&S1G$%LBI3%TJ.FN?=CY[M7PVVXM99TR[C,2Y
M\SK!BQ<>9OAS/RQD\S*?@":7$OQ'6-Q0[,W;\#)+P(9?>0"SM/@%7,L'/8B\
MGQN44J>ZM&(2@%W93X_/^;DL"MB':2#$#!-K0U\MC,]&:Z6(]&-B(A$YJU!7
M0PXK7/QSFT%PL[/2M15H_S^[5)7QS,34L,W@0*=UJM/CMZH+7G5G:R/H$41;
M(!9ZP3X$;[I$RE:EMS=<-QH&3/F+;AO$P) T:_2J@9L#&2NB!X31B96<V@*<
MB,MA=>'5]^$QD_YB0P1D.._AH'=BR-#\DWL[F\!:$$3XUY,^Y<R\*;UG%ZR6
M2_RK1X=JE'-H/T/G$VDM<4M.%V^6'SCUD''S=N_WF9XO'\ARZIHXS3<UK\O+
M)[U**K4^CY-$"G;0QN5.N.*#7/0:B&I1J[1A'GP%<Q>Z>,['M8^U#Z"Q:F^C
MCHJ'7;IR6$IC6?,X2+K-Q!,!M>;=@(^]ADO"QUZ]FR7VP\O)CSEGEJ3';X?/
M/W#<\2 K,BLJX8YWT>4W+N4OH33_)Q^0&>O.+4%_H RB-_4B!].=HON'C4:/
M'TM7S6V0I''6!8P:,BZ/(1[7VC1N9S2,E>BVA&\LFL30/X1]LWO[Z:=-=#L(
M;H_ZJ2@?I?QN&)PW1AT<EOIDR%%4<+B9)ZW\=7F8K)EZMB%2XH"ATRDIQ^(K
M3D'6@SG;?K!#K7,*G+:<<2[+#>M%'2JH*:(>\BRDV.MR:BJ@0KQ.GLR[;[CH
M8(I"R,36;ZC^N8,5ZVTG91A'WS_[I$*FBGT<:9/MA/4!J]P )@5O.AOI6=X?
MBF^!2IHHVT#["099#IV@"J756XEXL_%W+V;P/9CB4,@8 )7O"N.+6R9,A>E7
M&6'ZZ+7$&S%,/6Y9B\X[_]G(CN@<\*=&_&)7ML]XK@;Q>'>]IL]++WI2L3X]
M'7,PP.(NZ,UZ0Q!(E(D=9J2L#'XMJZ\:<#.444L\4)N,?H+;[Z;V-9R-F;MX
MTS<M9%W!&WQZ[4NO,9(,F^>YU_?\J<&64^.C9S^$S Q!'9C<)<0<#G!AT/?W
MOYF8LF^,%#V-[,8^O_YBW!^%0I,89W\0/Q XVWJ,#:I[(3Z7!W;ZCNUL)B>N
MIZURS6(P+\Z7/]-U=CXQF405RB&#[='@W)L#LQY<V_</GLM[&@T?#D?.$+-X
MYUI":=$M=GK LLRU.4<.+T-LNMXKGW+3^4V"UIF'QBH]-_>WW^D<V5DY-5^D
M;J2TX_M.N 2:6%$!:Z@%=YFBYA: #MYHE$E?@@UD?'NW5OWC(A\D=26VPX*$
M?3^3-W*3%COW OC$ZK%JAB.WO#38N#@Y6>.^@Z?\QMNDG!7*(.9EM%Q/=+RW
M<B9*]H#9Z>92*Y,D7M2;E[N!@*GG5C).];EQ;1Y3^4+RTM%"-2GKQITQ@0?5
M95^_QA<DC[W87V)44T"[-HD1J=*/V6Y2<N![3GF?0];\![^I"#]R$6?B)J0,
M#FAH_;T>R*U--D,:0NN?;]%/6!V&X*KLI\&\#5[LPSQ"<J1_#Y+^9,FC;DG&
M]M(5MD=E7\_%RR=D!L$=FA5?/CJ_'Z.Q'O-!I[*9FY[D5R)WYP4?O3 <^2+1
M4&[5)-BL8MQ5G;%_D3C1FANL^1GQL!;\2.-Q;?&.')A7JM13B9-* 5\,6=06
MV,RX:D^^\#AZLT-'F9WH.,=.8JNGW:OER(R#GSQW#%TDW1QW^U[;/*C,EI?E
M-.;>M(Y.5\ILA-^8.GL;J8Z6^6:U<LIU1)*Z9LF^"3+ ^7',>C%MQ:#Q4-;0
MM>WZ@P]P=PBWLL^O =5<Y;B;VKM63/!!:R+5%O.;H%)\T/@.;@'']-#+)N4D
MYR&*8\_0^#?9=;<6Y#1$;WDF$%CA#&_>>@)[Q^6;X,4DR%S+V"9-UZJ,CLJ:
MQ/95WM7<K^.KBR%!.7 ;S2?PL3SH>TT$;7\P4@;6J2A$H#&=VPX2*D6LG(Z:
M'W0V)!=U&:[(H2G?V6>K#Z2;9RYV@C?I1MI)'RHDR3=+(9K.=/B?=W96.FCP
MO<8+[\K)'2G,NA"!(O%!5T[3GZ)O^A?=SK?J>7O ;@.!7O2V:,3+]PF2?&@<
MO<D[!%ENAP3/'<N_F25G4%E(./?-,YTGE8: ;=7S_C)\6-+U.R^&N&AG"R:5
M9B\J'8\E/?SY(HRT^[IH-APN=-]YRGI*;GC3ZR.4H>X-JY 'Q/>.<\V+;U@*
MEA_A:R(5QNKZ+:YFVU1J6\G)-3G7\*#CT.,EJ7=8U<=[1]3Q&RIO0NYL<]B0
M'_T#9);&,2=!>]3$)[CRVZ77-9]I?SWF+DD?/OO0N0NCDE,QVP-MF+9;#MZK
MUN#"BNB7KWRR[ZMSU]G4\@2'AX8^BY:6MRMO=A$#WM^J?38QL1#ISG/RP<J3
M\D8L"4LHM(SPK8]PO&L GH!FKKR8K&:?3MS'Z3=DK@<I&IDUA/%!M(E48?I3
MDWMYD* AE)T1%V[-NY3J5&1DG5)(5NF)K"V=L3Q>7UXU17ECG9Y=YSN%VSLY
MY(/68RV\_N_NV_7(_K=W_H1?'MQQRTY:-06'6\":#8_A?=H4/50$&[10&\$Y
MM!_1OMF;19LF@Y9ASFQJBFW56N:S!X+D4I0V+_RTT&\G25X.)TU?O0(F4X-7
M<,R9$[^=(XGWM\^,.XY$MA/P8'(!:/LD0E=:3+ KC"Z$XZSW*!_;);U6[A9J
MM8%!RFN U?^1<-@5F:DM%I#>S@>%#"4:SN I_XDTY1^)TL(BB&? ]%T#R1%J
M^NH*IRN,Y?#RCRS#=]&YGY'/+<;978&-HSGLA*65YZ+_P<R!#JP38>C."POY
MMW7_D;&PMD_.?&9(FOPU/D%&X(]\Y[X]6U4V1R.0@M$)$@*GC^^SV2T*A@C2
MP%., $'N;W]F=**9G2 /+,@(6"T[Z(K*1^8(\L 9XRU;[N\^>D7,D,D4Z%>0
MD5A[],&GS0%4JD"_T-BM(&NK&"T/"9UJ^Y]L*E8AG&OX<BQE:OJ**GEYA89E
M4HX_9VI/;XY6B^6M5ID$X5'XQ_^QM.7_@&,6(L-U:F\?'4_0CI$CK<SS0;/3
MI0,U>2>\=GF=_$@5-<=%LB+<,=T..7-)EU[TBYB9YPBNB_;"1$H'V^4_[+Z4
M(/MQ^:.AD1F3PH ?!O%VP[TN7Q3E;"-_+GLK'H89-_@NF1-^#0>9(N#Q?9CW
MR'NGIAFBI[8X/X)T^\1FB8JN>G%J'9>:V:><K.%C:-C>5,C@5@;Q'!]D<<L'
M: >BH(NMHJ+G@L:<SUJ-;5(_OF8[>U/5S]XE7HDIFZPG1!%?FW0J+5(%3G![
MV H!XGO%^3:VQ7$2A$JH8K#AM")WW5=YI_;# J92DA#+NIP&O.B\[&9!>D*#
M2,)">16@VUMTHY+@/003#H,]?)O&U<694M9LB23O<4,A1^_XM0LN?W?Z?2FA
MG^"#CCM3ESU_+A$(-)S\:K&8N>!PFB(\9 "N*7B%X5]F/?_?($SHCY,=J.,7
M]?IS5.Q5D4AB8E1-4^'G/Q*M?V#:D4V_Y3K/J[*QNS#L2[YPZ[K?4.B-?;-\
M,G)NO)I[8\TDSW6\\D>'X21ZA/.>!]_A/F<<X'^-#[K+);8#^':Q1MI/\=KF
MUM"/-IMA]0@J"[LO8W)DXZF9*E&(:RZ\:]\:@X&& /^+;M?IW%$12_F %5;W
MD$&"LPR8.+0*%[R2=O;D7JJTUN>=XG>US,?<51&"UQX"-)_5Q.SU_:I=S@7B
M6:0UZ$FEGVRU!@13]9,/$ASQC1FHOSI6S>,1ZWX]!I+TN?'JM&Q:W;Y6O. 2
M,"QJW_]10NH<U8IMW@KO VQ::87K]7,O54;K<\F A3X2S0>]I<Y8'V\,XW9<
M7H;9Z?-^O;X BI^DZM*C 6"J0BYR(4YF]KJ0&X*[\G6 :Y3$TXJT-;-YA>K$
M$9+?7^\[Y&]A8F:OCG!'_RD \;N ,V4=?BO)(B+*0P2T(O)I)^2/[\]+AW7&
M[58OOVZG?P]W#! Y?T1*HY-LL$YTE<Y=$%P_.%UGD#.\5:!*C. X[ME=&1VW
MCDD;!!L.FB%YZ/8"L;W4G9L_=X[8Z2-0P*"69XY(E?YW!11V-/I:!S4-K3(4
MZV$7MZHTU1F(0!B2HQPJ+[PWZ5'(J;BKJA!]_S6+9@O.W%#6F<T9Y*&-MI0Z
M8;"=X$"X4-*MM2E&]D=D%GB VDPC'(W?.%D&!$GGGBG^6O7U<=V#3*52\];0
M!2)UYNH6SM"51PTA;NXS@I/G%VZ4;&@+"+PJN?VBVC9YVB[/E&Y)7@/(/ 2^
MYU#:@YGIH8X)?0_1+:!7G!'M[MMO'3,N.-V"7,._.%FJ<OJ(#3*S&F>TP*FA
M%7<:GX=OSHX_5_'$!L0,VC8X:][ZHTT860@O.-YY!>5<4C)<9A5)EO*U\->]
MJV6I$'1$,6I)$LO;RC@V;GMJ0K(%NCE7_!/+QL'%=>1D_![+M?NN)<5UA U&
M0R*J&F#ZH53>AI$E"C:K1?"(&03CL1,^Z/UI\/:"7U1I\QL%@[8LE<]W7PZ?
M7']N,*R)O(T5Q+[-@(];-+ /,0:;2>EU4>,8(6>OP_=G:TOSLDOGYUV_/\#)
M4O<PTTV2J(C2,/04CGYR*7;>:O%$I#TP)4V[ZR5?PKH5UV2?K_>Y?&Z)PLV;
M%8_YF*GDX%=T[>"5BY$DM#6(N[L',P9\O'C&?L/LN] 4>BH?=#^J>1$]7I!2
M7+OPY!IAD,+6Z-$?"8 D>QP9M;F4LI8PES&WQ':.E.&^XRF,AN:/+22X]Y:L
MA)15$5S%4N&>T&'EST[R5F8_KSSU5/JY<H@SS($S!'_+^"DC>I'@O+@P7\(V
MCC1C^"QNI_=,:,HPWC9G[+%UL,=?BRM9Z?NAU^Y<?V&REL<,^ZFV@N")(<>A
M Y>;B&LYP>"Y[R07/^P.=3JZH),D1XN+2['O6P.5G1^#FI&TDPG"1O:UA@M'
MP/G('7 O" C6F2=>NP1MX7K=1HL-*;WO(Y\/]FB[2&BG[@:;9#N@9UI@9HQL
MWH9<MCOG2*_'=XP[N+]4<E!R/#:+XDDRI!6^DQ%+< Q)+JL&U^\,Y[FH-?)!
MT7?SOO%!5^?/#=Q7XN+.'X"3F,9@:@\0#HIPQ9O9LEY'.SSLB6ZW^:",&5-(
M"2@ )@GHLY0W"-]$,SP$'3*@Z\33HQB.TR]'0QMHR*J26J/U=6UAW?(G U;?
MT@W&5>>E%DGTI$5E\&:S]=Z/)GPDIC=/S,KV[0+O5M!2A-:I.!K7!5&@J<1%
M_WWUX/<Q;S1%E+E=EE F#$%@70CA;-;GK=IS'ZVT%?OT3+M5K;48>VH_=&U.
MB-1W%Q)RY=O3@1.!IR^-:CFHH=63=>PDY7!5D1&.RU5\D*CJ'#06+ME-;/@<
M_7F'VW4U/LBF *?$05KS'F!N( :;/X+++!_(M( W3_7BN^)D2U8:]$D.9MZ[
MKXNHW;YS?BS1P@C$YH.VPA>=B(Q]O#2VO?E8B7!SK4)+8V*>$KZE8FHT/@35
M\4/XS7;J/*GI0*"%W280W!FS:.5"7/Q,%*_\I"(X^HIH^H)EK6%MMA]G+$%?
M+'MV&+G$(C/R(! [)*(/H\$'C3W+T_FPB)PS7WPSL=BUK5Q=]JILWM$@-]3+
M^T'8<01N99N9.L,Z8EMUC4'2_><QVQU\E1-R%B'8"E"XVH-/,$[5ZZ%5(U-M
M@(P_6L/!S #^_#P;8^,.K( W]?=Q)(-H#=4LI;V\+\B;:>\S##^:Y$1P3=5.
M1EY<M/1"<Y<\-?D@Z2.*V;N@&=S=R%E,R$P",-6T,W^4'3,EX\W$Y@5_%OZO
M&HRRL40\E+<]D ]:TA.:^;".">^1X[U=A3W# O[_O(1T.(]3)4[UF0J5#[B'
MM4,Z47<O>38I%&(X!Z?XH(D;?-##LK&$@$,\8S[H13N"*W+7]-"G!>A*#)S^
M=1F"XX/0C^4U /=VTI,/NH56$KQ$P4#K_*T6@G'93 PK#25A6/( W>R^(8QW
M_K/:\X=4&>[>N";N-#X)C[!WS3=QS(1_&EBT,,SB@Q2 2E-87K0E1QTI3.(&
M\R"4+AOX#V!(U5!=GME.7JT/F0.Q)V1I-7IR(@VXMX=P#!@2?6@:NE@9*86@
M$1A 5XT"^*#G+& 9B7LVR?)!+G $BYH!9DF6@,)]93KX($0,'U2:_9?CG$[0
MS.2#P)N S_2I/#"*TAF6 ;2]UOVOMIWA/\S*?_4.0H"2>/6"OE&.*&:M83[A
M)7]T@U&]VBA8%,H\[\:1NB'N[A3NNWHD%2"J$_7MO.VX>TN\6D XC:P"6=D!
M&;_%4)+OA"<2?P0"0;_Y<TG;/^H\$&_ ],A!AL3;@)"-5ZK6@?FC2CX@\[YV
M!X$QSXO5 $2"5GK7-V!@CC',RN5A1:,O9)1]@=1#)B#$+'ZUL08'!4;UC^%D
MHI>&N!+ </3 @.4L )9#^J>MR4*S@5[\P$10<@0$YML?94+F[S7,!;9&A?+T
M_V%K[_]H<,_:STB,&A:D29P,[K*?BG;U@!UD*-4#9/5)#H9C*SJ!NV_80> -
ME&6L, '[.*W1"M@'0.K<-$4%]E'SRB5;PG<#^*</FRAX;0:]'YZ0![*ZL%^U
M]]ZMC?%R" ?$3UZ%%4_WQME9K9E:&QE=YM219&\CAYV)0@<=A*F*N?N$^P7O
MU]R/96?#5O_Y?LU_E:C99Z:L&OO]>J^/[,"'V.2+):_2C[LR-CSY(I\(J_"V
M9C2/1;FV$>T,>FQ>W).^:*LH+W$W#9QGEBKTXZ-F*@0V@&4UH, D%B^USA'P
MLXAH/LAY"<L0O(RM]@77:K]VH";6(>7,XX"GG]36]Z_1D=QU9YYWXOI(I,?B
M!@C2)Z3XI!7(HL]@I^EA=Q8L50AP7*H9B')Y@/@?#.!! *^A(=V.'10\S14J
M2V/Q,*AMTP;(;?6J?)#8*CTUV>7S<^'4<KC!SO>K9O2 >=ZAW'R.RZ)=B?M4
M_).C.D&/KI6EZ\]&?$@DT3@WA EQT(.(\D@BM3T!;L+#%$A(NX%O:,!K$AYR
M,$4LJJLYG+1/Y6Z3GVZ\"([EI,DZZ4 L#!1M<*EA5(TUB-H_"MX?O.;(^2U[
M<WKJ](WG%>N1J)KGDF?]ZV2DR_B@]U7W.!@D(>O"AC-PV$4^R#]A'6"X#DRJ
MJQ4J\L;B@\>K0GYY(S'NGN^>2>=9F#MT'5[MO#;$<5VD5[QNO]49[+-#>SE3
M_?K1SXK"OL()49 T4$3T7#^H6B.BT&QAF>=)?7GDA3MW"68D"U95[8YF3K()
M6=@E':S-E]Y=D %.'/GRG>2KQMLWZ"8;'0JQ8,2.&Z<UU)9E+=_9>/)QA)74
MN8?@ S&SQHM&SR7HMD@-51T>.(@)1UI?$N"RB/UK );#X:RW7^#CH0S?]:7J
MM&RO^?RU;]K6/2@.^-)UI$4'-\$'->.5;'W@1<X;IY+FIHTM(X5R[@@#8=<1
MQ8]LB6%G.<@8)&09RYRQ'A>4#@-TA'L8GI<VO6D)]3'C\=DV= +EF].G\Q<@
M9TVCXFC%1F;*%;3A*^J3B:#F3?(2!AKP^"F%  HQ9^*N:1'=S]EYNZQ<%";D
M7A)6/LJL7+^3)+,."]!EX@P0@3EF$P'5V:5$>*%F[2,4AI.:EEO<#\:=>IEW
M<:,PSHBL6G0H;4+S"6P;_M*FXI#D[:>_OFR]6C*3LY\#__)<TL4GNU5#'+$P
MS\;\NK5X7\;9608 9<1?0<RRBRI),K9"S;(^S_B9JU8 >$#Y_*V-"4_R4UCG
M?\#V,]Q/WQMT" 8Y/_EVV2QTH5L>Z5< "@]:MV4_VTI)5,<]Z0L)3Y6;R%X.
MRV2;8SFT7ZA<$OJ6 V6$Y)\BC]P\_/F!PDO(.YL?5F15A*M9VB%":XG0/+S\
M=K]&8:4AR#3AX_+1Y3K)("3U,8CNK,+A/B?QPMV1[7Q0"8MZ<DUF: Y0'H,C
M5KAA:'5HW X])P/.7@/;T/?WJH?B+\6-5P(!@CAE?J$O7C-!<>O2B6>/F_R4
M:DW<+G:"=^4L?S7Z2*[JNVMZ2GP:< ^WX#AG88Y % K4Z Y_]4X67#_41FF%
ML#Y2^^J_FZDP/$_%#<RN6>G23=^>7(5Q0;WCY55T:;:B8]Y#V[;6QKQ3_=@!
M'5A5/"VG%%V%668!DU=R1]2H>A\0X:5P(3CYLZ]M)[.?W%V)W%@EN,X;[I@S
M"#CX:[/SMU8_:/28)W>=6=DEM<"Y6[P3DJ H$7\ZU]>C]\Y]HF:_QP&C^7N\
M\&[1#[M<)KG/7T-:1:PX1CQHP9Y;HP,YSYLCV9:=3:0<&DOREF,<^(F9<,;I
MT!5VB=.ED-QO[5>T$MQ(PFJ4!9=K1!G.(1_OK??W*SRR!7R'-BBI[DG-3UM0
MN'R$V:VN;^&1F BF8-/FMP"*D#D<>7/Q_8;=]\?("RGN*I9V2$TF[368I/G0
M9W%I;^]SJ@I;SN[;W 8$[#"[6[0(6S;=,2^#:E_%()D4ZWL6<\-;61M_LF@4
M/HB"UK-/-%M;9Q$75;0S'_SNY*OPL9S;M#=)G#.+A^K*"J8+=KOGHCVUA?.&
M [#D(XIO[MTQ8!W35%^>-_2U-YFD$M#XK:]E@+G1@;^3B08B4F?"7QPA#. (
MIICN*=Q?%&&M9R::*O!K?)" (_Q>I?N74%6V4"@$B(F__\.Q_]<:?XH$'/L?
M=7:)3TD2*P-X:"\L X#/,.2_% $G0,D -_@E(?OA,N IQS&4O%$(EL8US!<'
M"!:V&4XPK8<C**P U^N_>(F<@)<@ 5X"86T""[@+DD9@"KA+$,!=ND4+QR,Q
M#(8?BUR%6.+"[?:+V:O#(ZW:N*.CHG914>$Y :Z>_U=BJEWB>4]QO"9748$A
M4H\][/]%2>>VC<&1?!#T'[PI3P6#@Z_\JO,7:Y*;\.:L\D''!&)!X=Y_U-(S
M_%WJ/X?T7RJ!_Q +=,70QI*]/!RX@=ME;^/&"]/[DZ.&/140BP" 9S0>G.+"
MG$1;D&OO '.S6)8!$'> +3W5; =:I4'K5EH/PUFO?R^^[8C]_?O(2P)&#73,
M",[( JT0Q)_Q03UR-9-I$%710BW3FB\O_N"W D;\D3/AS0=%7FIC<<K_QDD!
MZQ@/0;..0=C7P\" =1!:)&3"^:!7NGQ0I6,28'&1_QLBN];]$7J)^!?[$IHI
M_:/2Z:/,>%[R9S<>U>O+#!:%/I/W3^)G"T\$3.S_8WZ_L4G0RO"?Q%7V=X9,
MU?Q%QED4#IR0(R#C4?]@^?!2#)8;!M!U40 2#<2GX0+KM*WG@V)G6-0CZZ<1
M*]$)?%#Q7QC^?\6&[X54"1;-E;!?BZ9%3"9"L PK95($R_ ?2C$2* 7S7W3R
M_S-2H9F[FR>+8T492VT<0\I\3]I6W[TH;3+C[B1/GNWXK*H%)VJANS&C(W2\
MN$!),1_Q]:W54DH3KL+->SJ%D5;L(?XC .ONLO+C;*XRT]&DW+9B[^W\B((>
M]E;\E&U@'21,C;KW91WQ%#/$]/0M"7C/!AKS_2KNNA%M)L^T[MS#5BW<I*>A
M$H-KAFQ'MK<[ DX_6LE^]-#2T\G-MPH_X@HC$HGH\F,3Y ?F&HJL(Q#,=8-V
MG"\$5Z@VK1V:<][D,BHZ_P#^6T315QVOMV_5LSCK[YQQ\#(V**SOHKO.YS;X
M+9O:FB.*8TP6Q43)JR0JV#6U+[9C5T-3-+YQ 5A-:#FTFE]"HTSU'F.5G,1$
MCXI0@%36U2WQGFU[ ?Z,6??J6GM15=;PO+\(/H'S(D[U':D;9M8GN:E%YX'W
ME0_.-LR*J7.O>M.1&W.<HOQ*,RH2TF!6HS-Z:+7R9+N^*5\"E=!&-Q4)'=@@
MK+0/]]5R20*" V=8I\T//);>?_2\?XVL7U!*7CC/].U7R98%D7Y=.;]7J4'1
MRM?N&D(T(;W<PU</,3K'AHJ./X76G/:W^"@INE8HAWN8K)CJKCU\*OJAJL:V
M3I6A*639R_GMPU&3PV"=VCY6OABIQ+-3I&3OMC<CV$RBYX\26*[DE>&E*Q>1
M*&?>\65+.SBK:[="Z+//]HM"=^$0**^J).PX4C92;TS,<V/U9+V; 1SZF@_:
MU6VF%1KFZ)<3NROP: Q'1'!=2J-B]LJ[BYS@'<%+1AXJ"43-ZIE.O5QT1"&2
M7&NK7HXZJVX1^<VQH:(VI&K@0@7G9_C]=)LG6+]5?W\X-TH+UC ;*$5XE'"<
M#P+)BE*! (<23DA%)"@J@M!9.:MN=1BA%"1N^7FDV^+R_<9 ^=5=OAPA$\!7
MYGJ_F/SNBCG]V94R=^K\SY&ZD6!:U/>5TM#1GR\;1VZA?3.@A*)9L8[HM>G0
MGV-)B<:K-!RT?9O:&YTE;0?"UU:1 #R'1D/O!\N:F+Y3S4$Z;QJ!U"'MF#C,
M32C#65%QJ*K+KL&_#G.0%8(C#6:WO1FE",794>9PT-C+9K5HB*EPKBMGEEY9
MM8Q?)/ZT?*VDXV]U'3?2U J1Q/7>GG^<UF, I?4O3/F,*7*"5[E!CY?1?Q>+
M$/QHT*$+@0::U\5#8F[P6HM4>>,N+B4D-:=OWU$1/VN#7'[.R<^NDFT'1R++
MJ]KA38K/MTD%D,-B55>-0UUS $C*Q&X](/P5\PQ.3I(59R3:'0YR=89I,&Z_
M5KP9K'KG^W#0[&$Z!4FV]8O/ ^\2TM&L?3ULV6C$(B#CQIW/#1;)-]:_*HB(
MF#VP(["MX-M*!>8KMUB!NY)M=9.KD6S75M XVL"]N$U>-\.$1Y'7G  "(<70
ML6[](M&=]Y0F5W@HA<;,;5/1$X1862&R2FC;AE=(AP3$$AUPQ7V+/YK8)S_E
M<+_C0&PRA%>[LLA1BZ>[TEW.VA%\COI9^JYZK1*FK\]?\5+I+2T)4:_LTZ\B
MW:$OP%VS.R]^?QY[)^"CFY;D>S[(A'?:/LAWUU" _Y5 LRMWAR0=AG(\37D5
MDR&0[1REH@.7-UG,#I"45/8]$T;0JT%!.&@XOII1,*:N_U7V)WHP; <D=8ZJ
M4+/+=\, 3I;K/140N?=QS&&$RB67_>?M[CPYWY%6XNNBD=7XEF:(3YFF^YV(
MJ&D]Y5&<MCI3Z_5VR*'4:O[V_&$^Z/3[;+9UJ%3.48OA#S&&(_=F<)$A+7 3
M\.)I!., $8N\:V;0P]D]YA>M^MEAUJ#$^]8%[FZ-R,]/ C(=%P!V3_' ^*,;
M=4+U\2=[<_3>IS_L@/_HVM9X :*M=(.UPGG+5.:#[C_CG(!OA7U3!"5_=(H/
MK: IYUM\V&:@SZVE+W3"SX6J-3$.,-/='T](R(?.;9=>O[_[;7P0XD/1CDTM
M1[7\46<U+IRMO\8B%L%Z4-])>_?:%<RENM\8.!0%YD"&80D,3_H'H T4 ]E<
MZXIY"<-F.%8>SI'";20.W7R1GW2^63*EVL^!DC6<0G\*?/>NJ0K\O@1_,,>8
M#_+=MQRCFR>=YV\:AB;@!OB@B=B8%<1]5^''K,N]SV[0WQR_\.%D#=M$H5>>
MBA^:<45JML(WI,M5]_K;RY9EB'+G)(2$.7F8;<\"N ?-KL0_9VC&N.\P?-P[
M\>9*V3J(YX8GQ[(SY&2IUFJO?+ZKZ0P],<2.%IUYZW)T,.AR9H->Q(!9946)
M^R*6M\.!MZ&I^H3,G$_P 8-1^'S%SJ#$(4.LZV'\*^XKS%CQ:2US]HX1/9_5
M5[RA,U60$_/S?9C;EJU(,96MG:_5%+-O%2@!7+!"G..Q6'3K4&O^RO; >=KD
MO=8(-NQ\:_V)?#AS#\/EQ"7OV X_^FWX?*7M2FTC^DC.3'-:"R&Y1Q^?>6)P
MM;8"<)Y1DLV:#"][AIK(^%;H^XK>U\0P@$3T^G09WR(IA%+L4NC) A5^;!*=
M\[E]IG$%.?18G]ROZ>=;LXV=9Z;#,#^I0C[C.':W,G >5]UJ-,,[M!$IPU%2
MBDE>/7=!],'VP%2(*S:Q7%/*'V!QR;H/25MKQ\M4%GZR2_L[B98^FC_TQJ-F
M7[?L>UL^@E3'K][VN^PZQSD$';3G;?BT,(D"&OT&QUTI09LQAOB@Q!7.?H=?
M<_I!F0T9?Z*1!5G(#=!&VH1%M6'Y("=,$+85*K:?Z1N\S5_[G=.I\CM*SQ>(
M5?BL!YPKBW$I'0:#SV%U9FT:70V'I8XN[8BI'.-M+RRYOO]*F0@>/^)[<<B5
M'N+M<MIU4^'(^2\],465&>HI'ZH@J\$A*Q Q/S[H!H:A=C!E&X*N5JW$"X?[
M:H0'#U5Q2"F=GLZP;LCBA9J)B M<Q,+!;[VHK$,MQL?6K/^8L"RT0J9 &RU)
MF@\,_-B^J#K\7/)<EVD $HN^60K3"C4J&/6C78 SR70CF_]%W7M'-=5UZZ-!
M5&R BE*D1 5%!40$Z1!!I8@0L2%=1$6D2>\)BHI*B4B3&J6JB%$IH0=$B$@)
M12D)$"! "! 2"(1T?LG[?M^YWZMGC'/&N/>.<>\_#+*SYUPS:ZT]RS/G7C.*
M3DJ @,J<#"\^WK2=BMEV2+)(=L(_(.#>&+GHV;VQJ"I440=,R9%+]GSG=>IN
MJ8Y7LX%CYKTR5" S?$E\H7D=L$F4^SKJJL*;)?$)ES<3:MIS<XH!,TL>N\[>
M4O#@U,*K-4=6**U0:U< 3V$.)0:1#(.V9(TNO!BSM\>>._9BZZC<@2UZYR@+
M*L6@?5'2=NY@B'C)4!':]6+U%(RT\JSQ!$,':#C8IWX:<?NH,,(&U))%K>YH
M=?*0<*->OW!'7"2NZ$%V[K%PGWW/CYV\Z/3LZKMKVT8:=C/+1*G41^$YBEU;
M0>':!5K]#=EL(Y9O!"CUT#/_L)X''#<;1^G2$^_- %XIZ"5".N&=B*X>:Q6A
M!I3B[-2S5&]'CVIK^@!-'FXV3H53D5&2J!/IW&<\"8^CPL:XR!!$Y[P_T&A"
M[I!G?]J'OD1"^5I6(IT4#=I[+Z7.\U #XCC7\"4X=)#H=_EN?<ORJ%88[T0]
M$BF SG/>O]^6G;[18P;70=73DV=!]D[S^1ON#I>8DZU[^R5;>(7 O\VQS*A1
M+6S_$77M-SW!Y:F$H=M>53*/_+7TKAY[T:L>K>+I5_'2=[YHI9JL]#*DMTXI
M=Y$<V8CZ2"Q*+ "1U(!&J9PQHAX'I;]Y#-KG<#SR*+.Q'MA!([NX 5LI&ZQR
MR^^)*%1=AF0ZI'+LJ68G[Z":5O^*-3Z&N\WIJ $I>DY!4(^TA@9]S_F?GJW#
MQ7E91@IU$(\B4;YO75CA1+],BPX#91"Q#Y#PE?3XO!\0/X3(,H?OX9;PV?^P
ML*_<8(+6OL2#JUD($%,93=?QB.&.=<"W7M53CNWV8U'UM:#R'V.8CA*,AW^)
MU)T/*[VD1GPTYKQS-8BDF@-/\6P)""<:00KD:U[[H#E17Z#])TI$6:&LA)"9
M^G;CXPQ)EVL^I\>3NU)?4_U'HSV[EKR:YG2TL$]$H)^M5GED<?%+9/NQ2PE]
MTY'FZ?3!)8?0.<G0RERVX^6^MA$HND.9J[GM/KX$^A;M>U?6GQ][J,)7.H^V
M0')Y_!$1)V&3E >W9=-]3A,&?C@E0)O^._[+U]*F3VG5.),5'%<YUW)9C[-"
M/$LJRQ C$==Q%3P.C'4;^410MF,.+ ,>QS.8?JSI"@(3HH<AN=P&MF*$S^LH
M81^@Y8;/;^''U)%]J%:4L-EV+6P,FJMW'LR+M9Z8JW'H,@Z^-  5KZU;<\ES
M[C!8'J:Y#%0AR;[$XJ@Z*&$:-9_>#YMF$$%%OX]P!R[)$=V_@[_*H)7I(_P@
M5GS)KZGW89?V:XUU@,VE%'X8VW?]'M*V'*6?AYE8LX.J@VM&RGT'!NA(1_JJ
MD>8T7^T!U=8!3E4Y4'6T'O>(00@,SZ>Z4$5MT,.X=A)6$)K@>,CF%YOM*X7A
MK(!4('?S2W!\WN:GON&50GFZ7U+Y-R?1W[B]IQWR"#:.OI)1VP>#,A1.I_BE
M'1XE^_)_PSK GY2(] 3>]2 \4HE!G<$!7<MLGX\)*VK.;78*G$K;KXR8SGW]
M,K#GAIVP("9O6JA[A(T1$0'=S%"N%IE>H]@BV]2% QZ-'15)=Y0)@-H(*C4.
M13G+U4"KS*QU@M+GZ!'OG-\6#=#+%YP.YC+SIXM2(W2(^'Y*#>F,[>,.DY(1
MV6>$;K<),Q-AF34CODKRSAIY<*MR8*$UX7BB7*@,_HGO3L*@OS0YB[:E48VQ
M6UE]NZL9\4.\^Q'W>1Q@:1"/CP\%24>):+GYCK%\'X0._8#X:N1ME5L#93BL
MGJC)$U9(T[_OJ^U0V>&@4_6NK3=:=<2EZN?'\U;FY_0L@P:L24&57QP=>#YE
M-B_[P0U?TA:]3VW^J3:*3#M2^CEB'"(RB)SN;0T-#-G@B&X\U[T(P$(U9RW:
M0(!-X3FN4APIJ1^8R(T>KY-^> ,_BDP&#N+*+D TPB1W[,WB&1'U^)=S6%2O
MKLX N<-'BTG7IAH(1VU\&A"AD>KLT"[/OD/GLWU_1"U/TWW5K T<YGT=/S;
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MHM1SF2%EQ=Z'Y(3AW!2TK\QH+03.\R(!D<=&"AY^@9!1Q"HQ:)X1ZGLG4%F
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MGZD-:B8AOT0TCGZL51,*7* HD$]-W\H:XT;Z]!0&X<4>W=YW]=,.O77 V4=
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MAZ.)%AQ>:G_NSUJ/[6[YO@<JLDUS8RH>):_*"J#EN15CCSQV5,,(,42;)R,
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MXJC@ ;XUSU)XN^4UMVP= 06KN_BS(NFOQ8>!#"44G_$.:VI=1[(BB HC :%
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M03MI$0@@*5_/_G9GA'Q8R,_G(TXY\V' 1H42.;LL2">0ZD3!2C4;"\>:<]]
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M>G8G#GVHZ[4X].VKL6; U4M5S_Q)1N"!,\7UB38O,;M3:G>$P#UT%#$2CU?
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M?CM&';VBL&N>?]1Y3K\V@@?; .EQ%CE:JJ9V=K?;]$@[N9\>QO@6S&SFZSZ
M72R;BE^G+I#C/VBGQULKSH[MAAF.T<-"!]YHZ^N[+)RTNN#H,'!-1:QX3PFN
MZ%2)6#PTH-VO=2#I:/)*E;J%R=HX8;][K*K-L&&=89!(?QR5OJI_64= _A"X
M@WA$ \"BHQKG9KVT8^3]V4#MYB=KUN2$D==8[Z2"-+!*J(;T*<1'T-Q(B05M
M#P:ZY^&;8N.J\C!#6VB"^UP7"K8*(_]DN.F\Z:$J5_06A-17^;C!,EXJO>KS
MT6MV6U>CW*7VA*YB+#S/OT[<(M$^<1L2M@2!AE;(8&R=E)#HA#BZD($VR[.N
M""+KUUIVE[*-YM]/<T*7Z%TV^2ORU<N?WU&RB3.O9@DO<55**94XE[X9JR(W
M@9++<X>" OJOH.NGJ[)CG+=^S@N!CFWV9M*IQ*^7U "MDPUNG]@M-[.RQKYF
MH-M_<US"Z[F,%G,%VQ;*BO!=P4P>V()TI39^HF@D@PNU2]*N?K+J2U$72/9C
MSS5XWSYN=Y@=>FNZ<-?]M53%H,!;YE>S2X;9;E660@=IR8YGL6.7VZ_K.3."
MF#_!R?$DWK*<A"C*_8@(#"R+Y7F78OGH%-5G4L?@O0Z1O'XI!7(<D=)XJ$=\
M)"^4@';< /55E\(=,AM$1:P\V\>[QU=[\VEW%R)6RC3BE&FPX_D1&5?/*0:,
MTU>^W1K#(Y<.K?>%&[SS5) HM[7I]A5SO&8K<D=N5- 5G0J.Q2]:JHP(MT*D
M],\M%DW@'CDV5G2?G.\;<JEX?@;17J/ZXN;A.-_&63UZ!CM/__9M]6"5%FUP
M';NUGK;4&NB*CH<,O;GF"5F7AR+8O?[\51N@!U&7/H7G0"I:09TYH?%9KNA<
MYM[6ZXL?-&*'D-NO:[^\[+=^S@ICM5JQN%RUM&LJ(PH&U>CN.O R]D%>%5IL
M;*7W'-4QL'35>@@R4?.QOJ!^+0:FMGZSIV,Z;WFRNF_M[.,#8D+F+XNBY?1#
ME[H#4AI$@8@Y,V0?4[?^;7+;5 #XY['W_%[.Q'VID,>H'S%-(J8Y(N^?*UQ_
M^N!BZ<VM8C?.\8I-K8@3EXN/)U[]RJ^)TUQ\(ZFG=0J#DT*0<,>QF<%%J?UO
MK82;V%N:+L4?K-B]]Y+Q<;NXY$1DJ?WM,')0A.V=HGV.+1W!Z1V65S^8V]C:
M!ROXC07!PI#MD&;(NIPP<[? ZIMUY,0&:"^[WU&EEVDA&A,@7_*"(;OIZ\MW
MI6<QF:1S&Z"K>O 3T*_HSXCMG!7X_@J7FV"9';X@9WZ_?\I+WGWRJ>[4RLC7
M1&8IZ>4\O3=)H\6_8K(N4M@ "T71ND5;^R_SNR0<3( _/+GG\<32,J=A =?^
M+JU?T*S1=*EI2ENR3-O<VU3'6>J(GY^9M\TA 9]"8J!4QY&KKVKRJ5:Q,_$=
M[<5L:_+7CMK>@>]GY:K\J^[(>3WP'=E_G?I3F%I<FU;1=+PNE=_.)N]I^"SS
MS14CHDZ/&@7<5&P9B[$*O/(^>]=NB*%9>-,/<?]GPMY;[.MBS(]6/H?:8S0V
M"XMH2F5'_G5O(?'^A7!S]4H9U=B".-0EX7T^H]$?]3R"ZG$187=U0[)Q=<3>
M:VAEA%M_U=C-N>84__VJ*9GNC+8A2YPXINC2.J+ IME53DFBW/^A%!\.0:8%
MY,<W>AU4$%QZH]W3%^)%;172D<9'ZW)W'!972%9%[6=JSGB/EZS:X[V'0P_:
MWR8#\.9E-B/<DA@)G9R.AV00F+A(/GU30R3EZ5!-DU 4F=-'^=?!_NIWD=^#
M>]Y.FO@R_N_>0S]] Q3-V[4,XC0:(/_=:%!9T,\*Z:7!*5C]#5 6(V!M)O+7
M&//_/0;<4PV<@%0"AH"OA[+^ERT07@FWY]7&?]6F8#M@45(1RV&7\G?2SE4>
MODHXZA_5(@AN-W(YF1DO(K=_"5L$-PJEF'%'6.5-W*']I5&.U0U.[ _6#R30
MV1$>SA1!SWWN0UM5(Y<AV/YETNF<&T]/79#8W[I#VH1&AUV3YY'=-GUX<,P^
MKO1'A"^&MD:^\.SP8&7>:TQWSBEX;3\894!:YE('^<_.7E7J-_XDG,2[9FSA
MB,[E'8[<=C\\TQ*'\^V!90E32*<_JY4[>S?4+*Q,<#:-JVLJ#^]M,)P7'N-T
M8\D9?W9C#V];OFT"O8;1(?7?8T<H]/&OG:G4XH5HFIO!:S]A<,@"6>Z^Q=$<
M#_<J"XD=,"OAL0DJF;XCX@=/V?^#5NS_S1A(KO8M=]^@"*R%E>M!=+6S9LPA
M.7#'G%$K&*4'FPU.WP 9:&!H&+2%MSP/MU7>-N(&Z&T$<HRMG%/-!A+#_W5#
M]W_\*W^T#>Y0PA?#?S"[$./.!!J12IIKD85=3XCMWE?3XY CC**U,T._ .KX
M]Y8%]W$I[;ZQXC%/HHY?L"&:* ?(Q7\]1BG_FEG::!RS-EB1JDU<(4A:@M-D
M;Y8;E_BGRD61V7Z <"VEO2@8T?<\1WL,";O77_3SW%H>?7!KT[_9B_VWF[F;
MC$4ZPO-2.J_'@U;:B"0<TO,?9!R/1@$(/1])RK%/S'+B11:9U[SDQAPH8789
MZ<?I 3/SX@E,MI0[-]S,P&DRU\N-7_DGR24",QYI*D/9[+77_9N0WX-E.+:?
M0C(2O-9@YB)6&0QD350Q=OUK/*>-&K16ODP%?FTR@W'Q!3-UT^5MU2[J?A;Z
M], 5N2+@MEGV)9H -,7J4]C^<SA\!L@BL8V!J&4,T4+I<"J+]8K&Z>>B.>U<
M3B\6/YS*G:F8_&L@WKJ];,W?6 Z@"9F+H2Y8<..O3Q5^B"=YN[?V^:PHC&$V
MBX?<#=KEM9SHJ>VMWLPLBF]BL@W<N=.0/Q HR\4WHVW[+114.8F*OK2>+PMN
M6'%69CEQ9[577&*;8;6D_SJ5^H\&.>\.#'+BVAMAQ;96_P1,?Q'P*Y\7F1J1
M0)7,^Z],P,!]CP' .050QSB :Z);=<](9<X\75J[ UO Z3#A#KW<C5:C;:H6
MB5[>#;4UV/Y[ZW!3+L*Y<B.0N\N:N\E2^D>IQ#UD9M"AAAA)6)U;[#G-D-<?
MI*SC7D/4B*5 #M:7+9=AI]3?V@Q.BEH+-@AE/P"'GN/NL7)2N8Q,RV_!'8D4
MZ3 PA27/=:P A(A8._>A5M6)10-(C\GDP.,_QMBV%6^@^?;(4K*W#4L7GKB
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M&0>D1KA8Z)&1'NSJA7@(,77P=GD_KA/XM$#9N@L[; ^FX/@@DW18A4MX%ZL
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MP<7B:6O@)BJ0K!@<N?O/9-RF$XIM_,]YE;=NW:I))6?$'P=KWLZ!FL,69O@
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M^K52%ON2/46>:K>;SR>:KCF2/3QG*T=NKZ@'U_AUMW;WU]ZE!?0J'1S+3,F
MU-YU&_])^?1] &^6,I6WY6A-ZU83%(%*'$"KPB<*H9706+0+."9%%_.P(O/>
M&\^G4N^4XZY,9@0/QGQ*T9_;[YLSNIUEE.,AOE?*T&CMK%&@-4\\CR017Z*;
MD[PNL@':@ET22LQG:BV^"<[%"!CFN2;4/IOJN!E1W;A9! O<ZNB7^AJ?IJM[
M5":[#D-XC(./I"%7LXZ.$G43+M833S18;V68^"3L:'X]^?.<H>TQI/JEPMRQ
MS(H57-Z/59,.*#^>O3V&X>#>OXYL@E;$%TP@MZ_?[\VOZH,:WXJ.'Y_B._O@
MX;D@4)&[MB'U![H4PMQ53EAH@B.&,<T^3] B,TO)8W.C:R*C[441:6:R50>-
MO0](G55J)^(,##FKQSL,_NP+EUR,+\QX4/K#>M_M)_8W&BX\W;2;Y\X=3;I(
M_S+K48V]GLU>UP:U!<P"B-$<MS*'+"*UP!*_"\<.-OS5I=$C/>DM/3FK>>UI
M_F)"LXMMX+Z'1[(S+GQK_JCV5F?E3M*P.<GF1UZ[8[;BYULICHQD$^6(O<6.
MW5J5.6X0E_S#CPN'2<^KAE_&=)SDZXRL-?93#9YB:9/L-4YYRYPI,[21(6)D
M0]?$5J1";^96U9<_H%6ITQ(@VXER(3<B^3'BAG44:\+7BE?FARVWH[?[KL6@
M#5D;H"/LJUT:1[UU3:$7GQI/'TEV>93DU*V;,N,;&]Y0?&A=ZKA'WZMDPN9O
MSZN.%Q=FP%)FF7F59[UZZ]XYI((-MWVB$\5_^JX<MWQ7["W9\45<0D<;NYD^
M 8938GNSO9PEYKSU<TW.@,/BUQV(M*#5PAI)6N%1>! $,AG%,B _$7C:.O$M
MQ398,S%9DS664_G-??S)^S#=6\D%>SHJ I\FEO5?"YA/9ND./;P:?=Y74-!)
M,DLH&V- 62#9BNXS1/K[KK87GT_U]"N?;^W3$1>;HTII%Y\)QNOAVV5>B.LU
MU!C6A[SI4:>)"N8Z\?/]%4_,8871A>W6\JP>JB<O[7PJ4%W;:;S@$V1_;"XB
MU" TWD D52D).80?*S/71),&4Y^FI6@H6$:'/]LME%-O0&K;_0+BZK;R3%J4
M#D1XG8(N8WWQV/?@(#[D$I9&//;H\@&PA_-*G)#$KZ]+0I/<>\,KKGVGAE:-
MO,6S08ZKO?CBN?Y;-EQA7/Y:C&87$0A6*O\HC/^>0+UKWB\PS;OJVL.W\'<D
M-HM>IJRZ8IG4=B!N(POV*T[SK*;T\,W_'8G-?L]/@$19!>+*25 <LN ($MWR
M=V.N],62RWBS2DK1[*R0Q8+ZG3%M*K-5AWZQ,5#07AT,2 P\)Y#F)B]_C7CQ
MN)TU+B1:9(A.QX!-_[.!^7=-$"/PH*7VL(F<''&*@C$<G6!7<.<^?M7G'<HG
M_%1AYA9%ALPI=@5(V[)J;S?X^Z\*<,'O99-_DE?\;B6J\.3J^1QC"VPC(=Z
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M<_L<C<1UMN'*Z8FS(SEGS.\TAAA&TIUA!F^'-D!N?L_#EQQ>&]L/FX78!FV
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MSQR YZWP2JOJ@5V2;D!P1P5%E4>C^#756B06_@= Z_ST_3+U4[%E#$I.=A3
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M)/SEGZQ^V4%2#WGQK'R2*B-U?)P+>9O3 DFY_6E=0!QC/W$!:'?\L'5!H]3
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M]FN)2[CIO"!'R9K$GV,HPF"4^;<F(_V%C#VXA<\H5HX#A_=5%F$\W5IHP#H
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M;)>L&K1F]9%J(T$4RWS]$4C&X&$%UAP VUQQ29;E'Q!\*2*ROGS4D2$CT1=
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M@WI^EL@O"S%Q^K:F,U;B.,]?_U+)Y*"G' -_'*7PI5UIJ#AG%0VYCA9KC];
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M(H!7)@%BO")MLOR%5ZEMOU,/ %XI&8CQBB%.[IO6>[OZ3)=E_FN]^@K&OQ>
MJRFUD"&L>+MQH,/_D/PX^7N\=L%U )VW=C0 <!4*F+$Q5JR#OV;>_]:*Y.@%
MH$LYD\^A4EX$KRD Y'6PZ-'ZV=?_F-^6MAQ;GX[1--6FBD":U<*HW7])H(,B
M\2+0*@!6V'[<30#.HY&D$B("\2$<:?4/LT+4R0I33G] (5D-S0'\R>:O^7/
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M?Y&.7K28=) $ *.FFIJ:U4TTB%G'T_X  D7-DX/&.?^U8  @'4#H]&_9^@E
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MG$!@<SA6]DUO.: P++?^9'1AZT+K+!T"KEK>+U"K<5604/APO3 5AN>ZKO_
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M.*:-CD$=VZF<<ON^],/$1<O![H 9][8M%97*@5U:+BQ*H9?.G8+[[OX#E/+
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M/-?S(%NS347LY#MX@*H<U,<2#^0]C+@]-^A^Y/5<VR[8$B5.(!M_@+T3 0T
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M3P:IE2OT3_#!$S\'=4C)EVAQ:47';^T7#^%DQ? QF5=3ORM=_Y*D/22]#$/
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MV\T5N7ROVC0!E5#]'"_ VJ[VM!4.YH/PN..)?]/\HO'3LX<WG^BW7 A;PAI
M>"&Y];_3W[AX15^!R%:GD>:7#?4"V,"F1^N5]-N#X2G?ZT3!RF M8 IY=4E
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MYM .T#M"#\]UP^]^9I()?ZE9@]]K@^K.7X=./;XT8(8W.!C/R-I67)0LZZT
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M:I9TU[8].W!C]_X9R!*A#+J!3#5?%^3T=N;>L@Z<^T9/%8>1I@N>VW#Z\'A
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MJ+4]-= D \TYS2[K3?Y:6F3=;_M<??Z@D<U+'<F6HIOBTB>DY&6_4,[*E8!
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MP/JA>?+W%%>+("[X C (K%ON95;0-9F,_4$3B?6EL +VT*7-=]6/O;'POZF
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MCW]M+4E?H^]_+ R,_K8> OY9'R;82I2=^VM,/LVX$O$KO,U0H.@MWPP_JO5
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M)1[.?,1#(0@52?\"H/<..<^&F&^(_HR\2JX761GM'$YK/01P5LND3\ZFGI#
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MIV6G<6S.Q**[2<474&5N+-(,JZ?H'N^Z0GG6XW(5PS4V!'Y5-%L!!C TCW
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MZ(ZY4_!%["Z0&75;ZJ;W#T3"1/.P-6V7P$5BA*.&IAX7WHVOUY8(4XKR$.6
ML:\M]F1]L^[:=OOPAB;1NTDI\+R(Y>??&J]/W\RI.]+V UBV3('3S35Z-Y,2
M+SON;CO93<+=CD&<9BT]'U+>FV&W0>MQ<#6#L!O\76!\R%R;_2CGQ8VY%GES
M/ "U[#O_GPP5E#N'4I%30E!8'E]K!L4+X]WZP]#K RY& HX&&P*11VBN_GD
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MU7=_#V<3]]9;W')NF1(VWJO3FJ#D;CB-++\M&LC[Z:U[%VYV*EMR2;P;FT=
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M#L_P <5T>:NGTX__KF7U:PRTP\ 3X]6KJIRBH5F,!IA#^N07 !?5>6R>0W
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M[^MW>P,WMQK* I?.&VXG]<=W%)!_D!"]"4@G^!M^917QI>P@,@/A0H6X8+,
MX-4+PEA@ 9[SVV:1-Y3(^YW>[34^CGZ! 4I2A+^G5K4BH&*6 )7129QZ]+-A
M=K0&N";U?SK5)1\+)7QNYH- (!H0%)!=Y\]3L4\BQ6$PF <<@EV9#9>TR^QV
M[TQ<\J"C^X#LRE'W=!M)$](TPP5$16%%PV"I4CM&/'Y">ONYF5>$0)A=GW!&
MHK" DE(7^UE]"OZI:9D <+OHH8#[H^U;28%& G=Z.\!=J)7\]KD%@IV=GT.1
M>L,ES6+]W;^AB$KU5(!QY&R+\[9:*NC%"T,J8RQ,E15\Q<.(I**<2*+6T8"\
M?,75=[^MJ]8I)7849F_.J;M"IEVN5Q<=2=]:1O!2@"]8GC>*.7.<Z]1/B^60
M%8Q>,#/P];'0],_-G! 9B 8X'2 @9PZ6;&.]/3L#6"137D@0I@FSP,+9:NKT
M3R0ZRODYW\]N;U:U]]:_3:)R30_JFTXY1J%24)F)G21&X'\#!PR=/D_K >[^
M-M)[93LE!@2D6U KD$I9?V C_A\P*]8Y#5TC,3UK-A;L/4^-#[Y6NYU"NQ19
M_.P)>I6 V0B="6-"))'Z%:"!GQ_NC.:P6,#ZV6JT*7*_.<XGEDYOVOC3F^ZA
M\0ZDXD^9SKO/JPFH@D &&L@M0$&[ 0H:C@84])_>]=O#)>\ *H 2GG@9A= W
MA]E#E(!,#9<,>W'IS%6$^3*ZG4P@->>L[Z^I!B;\J6EC!LB-[!,ZM[_E$#5%
M&<C1E>6V"]K_,QW=QFLM=P!5C10UZ(4QE=&HY\T*[N'P+#\1=R=K52.,Q9</
M1N[>7Q[XI?8LLPL7LM6%3E M-\[@9>L$,8BJ1R6,Q&>XO:6VOXQ"ZL-@]G!(
M)Q%8,NZ9;0H=?,"2P6UUU<S9[B.\?8[24E6&8@#<PA* M/J^@]B^XAK9CE,G
MS+$J\.^/A;02 ^RS:#!G->H.W-+[&PR=.1#ZOXP[#\#.FEA:,6X:J&@0F44M
M4@R<4*H) #$J5W@[",GN.KT=8H[<)V7ZX('36=YJ+7_2Z D))<"ARV P1EEP
MH'X=%"#H'^<* E"W%CA;("] "?]?(<LL<T1])H97(&!L8H*$ 3ODRM\[A5F8
MO>1+;5H>!!BW7LC5*9GN% $.34\4*G,D AD,UW]0K4#_=DF2P?)H>KE5YMB/
MS9OU+><;-L1^&\+)CL7[:,ZS@@=2IP%:(GKCL+VK$]N/B/)7G&GBFZ!)BTA7
M#O\CB)PG5 ,5*C.&4P_NX(TPG8J-[YM<;L7R4UJ&OXS0Q5M<*ZE-FZ!4@9KF
MW4;=N,'1#-"<H\W"_;5JX#RO\3'*L5465#&Z>=V1EYGU\\UR[+5"2R*'? H3
M&A:%..>0E8SHP#C6OGWTZPP72NH49'<H/S&M6J6GDMMM:*YC0Z>J8Z4 ,W(&
M#.T;:*PWI6QL@G9?[O?]7)/2S-*(T7HS_I>VZTQJS%G.1>=E)4DDF8UYWG;N
MAJIU _$#,K!Y^+>1!,+PLFIB*^UZV#$;0HRIBX8D_W4IW46Q/9!\ZFE&[845
M*&OOAV3F:S%P6YU[QL=39VBVL8%B071[+=&P,#D'UN%2AJ#%93F__ MXH1OZ
MUG_EJM]"H%?7?O1P_@:^*3V/4!JJGHJO]@E[[;"PW['0,?Y.\R:(5R>$ME;:
M;D%13Q[^V20<>H[D-%Y8^C#+0U*R(S&>R;D)*LT-Q"QR.P-G V'FA+(7,916
M5 .K<)<&%3SD2_C=99]93JGN6ZM)*8?[DN>&6.GP9D&X$^0HZRN*9ZV8#[-1
M?> WK;_KRXA(YVW/X]2I"]T];[(_L?3"/D&@5<.8 S8AJOR)>%Q2(D#-JN>Z
M9+:!9JI$Q&)Q0UZ333S;ZB.,-TYFGD+[OAUVPR6WD\G$;<;#R4L[4'D[4WS%
MA< JP+W.MG_+K"/C!TE"Y%SWS#T*'>#E)3INJX%HO@K$^>QLI 9XC)0*@ $B
MD-:7*]-^Z9NH]RIT=84*<X@]Q":R@P_N+W?\4FL %)T0&@N>>%IJ!ZK^([W<
M<@^R? +"6!;Y$.3^G>PRK\-\""H;R@N4R6K=D)6D,_NW\<$=&/UV&[!^WV8?
MO.+"[2"6+R_9'"(DU2\3PS09Q!WL4-OR2\ZW26*@+@/)("VVF8'._:^Z!9>W
M1[/<225W8'8/.R]6#4!(9^:-Y56(P\ .7ICR#P )2?F&^=D-(:0MP5O7F ^V
M>PYO_\%C</PY&[$.C=\$O1]C&0+8K-A%4)_! ">"FP-F=NWECH,]1FFM*!M@
ML=@N8.8 ^P=(25!7K3=0S0)H6_FS8WC23C0^)M,=>ND "?B!4H%\4F,[NC .
M]; %KO38G\['W.5*F7<81(VP;LY2<-H%XX/ZT"G'6!2 JRCL5@:?OZ4VE'7<
M0@:%PB'":IM?<5W=(7?_G> 5*&R3S,]MDG7_'9-WJ6VGC@+;0CTT]3%\^20:
MCNH:[(,0<@__4>/ .626Y@': R"A;@!SU=(,P\Q,3T"Q8(O<?=OHV6FI\X_O
M[G*,4GC.VD"+0@=+!__9UOQ;A.VFYN,GJPX"'**,+,8HS '(2M!Y]2!W>J3Y
M1:FQOE)Q]#-,L=)VDC8CL["DV[-GDM[D ^3Q2RS$Q-_BYT<"#QRK"!U<!3(+
ME#B]2EJ' ME1G[@"9(.^A1+$60NX5/4 CP'WD0M.P;H2-9U805#D%H?\![!Z
MMK ZN,$AFM5>7VJN!U=)W.F+GGY"U^93.UC#6LXJ1>=/0S$#X4>WHX4E=[R1
M;LVENYN@SDM;SSGCY^=VTKA"^U%CGH,35  ]G@;9)I)HZ^^CI34>%*)KE=3'
M'YN]+1DV]@L^-M985'V^OF!-H28^<0Z)QN9>\"$>=^\_5TLU=2[AY0+;&T*7
M!XJ'Q^NLET[Y.:P%S00N_^!K[<MH[EO,H%\-2%LX5>"_^E720TMT#5\"YRNU
MO'[HJL^5F"?=&66]P\:%.J&5IPHMK_C^.):+E2I9[D@/*:3".+56. S>,B K
MTK\<9#H_OAPV0#;9($<)B$K&\\!R_)'6N%)$RB:HY?8*GT6/^T+EFUG#P!3C
M9XK*K3,)*Y\(M Q6&MH-'G<@4&G2\ZGO^>S]8ZQ,;PY>T4C$G=1KX5Q8>3[*
M35+ )HB#N F*#&,<9>;#3E"6[9EO=75#W1_2,BWNE%\:>+T[V65H@FJYA!>E
M\0PT] L2OM7*W%O*/:$C7=J4,E9<274S-NO@OF "=C^=E^;J!Z]ATBD.="]8
M&XR/J)[HH:],\=%Z719O:UI%F7C\@_],)7L\N#-/V16YL@EB'+JY?A[5JCW*
M.DBIG\0=FO]@\]5=+>1ZHW&),]?,;<OUE7?R$[*="'/H>,V8 8N+M#796T=;
ML!,1/Q2&W)+N]*/V-G)!?C6A.@HIJBRN>N![/!'QMFXV@GC%M_B&,,><5$:]
M<=69Y@A9]VOBP7P>@9J%KVHA03=.N8SXF77>2*Y+(22:I3;AL878&Z$EOA4!
M3ST>GAS3*GH]&&:]-D=5(E9U3H$7.^EF@<Z8(SC>TWQ[?D'V,\XJUCL5F$GQ
MM[YO.U939J$D<&D^M9ZDQ>6E<Q]=,"9@7*&MGN@4X&&U4.18?;N>X\4@9YXA
MA- (!0B%_N% U<F$Q[VA1W)'YNI"O>+\;N$MD@5'(AHNOF7V-T,<2IT#"JM0
M/@6'7VQ0V^Y=U.00-Z9=OUE=X6]2-)TN=7>XPBVE=]BU>AK!D!>QMK&ST^PX
MJ5+VM"R@JJHILYY!8ES)F;_Z*UU=G[\?\D%I.B%-I+C),^V;<C&"H@7!.Z3A
M!#=!3CB*;'7"FHMG SO](9A]2"W^^T\Q >QP?=D133VV3V2F*WFC[3#KV(IB
M+'1/U'OPOH<6 D5'ENH_\YP=_@)-?$[JAILPFBB9?QXZ--"]%^2MT8H;B= ]
MX2Y9&\/VFLJZ++5HNTCP9$=L@JRGG]_CTA!:'1^,B[]/DVLS4TO%^?WR->DJ
MO(!IAWKFARVQ[/BD8]?9@1PLEHO28!PRZ+JTBB8B\(F7%IFN!43,P@F 7&GV
M^7TM/;T\,D)W,+*Z\K8/$7DUU#$^C]G@G&0K[_#!D"$8/.)5"\1(B)4WQU'R
M;[E_Q8>_P)=".NK1>V!?T$3+,4[+2-(7</74?$:PMK"[>;03_SM)'X+G"D\B
M1JWTAO+3R_$I-SU_RA47964,L&Y:ZT4W20UL?'^XO#J_ 2Y \^FJX!UBD0<B
ML1@6,*%H@M53::M*MB,_&1@Q!T\AF6+_8-NC,85_-5HE%+^?:>J^Z/5>BX T
M+ E:S)AJ$J&XMK&.$!L.V^NO0!@R=5G>[TT+BL[M3HV86<]RTMT$:9/7,DRS
MM6_)WZ3KQ5N"O%,ZJO,I++_W;Y\+5-P[GJX:6O6T+U"NTS"_-;^C+;D@[!!_
M:N/LI'/?^>)[58G0E2C6WAFZJ>F$4I1V>BQ#Q<=IT'Q(5:"N_:7,-:?6?&+*
MZ/V&.!:W#%'&8$4IPC=QF/VS]H.FE:P B*=5[LE[IR[XFQRPLHW?+?I2K@T]
M4:A_(,2H=,V3_^PQ%[1+ J) H]TS42OL+%8W@#%/SF1Q:Q0$WL>O>_7]]?VT
MCLV[ <[9/3SZ5B^2/@%2H^]8G;20(6^J>I]/I?FM?!&UDF%*NF]Q7VW'=%:M
M:.T]UR^-?7V%&PZY(TMA%O1K@;.>^QGJ YZ2?6:=HRXII<EO0S,G9>B?1*'(
MQKI!$D"[.#[WG[:[N3ZSTIVKJW!(];=U7! G6''Q@C''-'FY*XP.I(8*LZ["
M;%<'A"U0GS5@=W_JE\O@E;/JU/3 !Z.'QK4U9F@W+P!Q^I@I=WMGRBC+7J*_
M]:5C=-K+#UB:_32-T1KB)C21UDI@%]]T7B]T:>]^6US=4%0T8I^=?C6UEGYC
MS$[-- 5Y8\1&=K6ZL0_BR3A777^%7'!)595/#<0G2E@3Q$.$85(N.#Y]\+S&
M8$]<\86*=M:=;US/VLP#)64D )TS'U+R9M_GI_.:54F/QXVZSW)Z$WYL,&)U
M&=QTWU]UE816U_90B(M^CE<58L/,337ZH(J/H9 MC:7[HR\Z);_(UK;"V,9.
M(]EV@.%'TA:9C;=U&R/[!:7\*A5T1IOIIM^C0.D'&%I]:#?4<#G>\+'^,0SS
MC?,D1%3^Z/[*YE&%Q:D^W_EG<0VFS6G&(M7'T05Z)W$FQ-(H\R3WO+?J1T_G
MIQZ5O6Z9E'-9_[*.[&^V==U!$F:KI^^ +K"\][GBC[_T5&B,?9RS$G*A\%SO
M_=N^OEVZB2HZZBT-SJ^$]>36CZQ_ $H&-Y'S4S!Q1>:)[TC8C=4V^,*(S<O0
M N>43K>3ONW2SWFAJ&)?'Y/<>URR)#N?+^V%TLXRC&*]M?[UNU)O G)U&"[M
M><B$TT+J;[ZM_1JG5<'5'(C7EX7FQ>68;_1%1P)E+J3)+C:<*?23XLV77/3'
M*Z2+1>A!M%GO8/M=8)(#\/N0?2Y'U;?>M$AX4L+0XKB1\4;FQ<#-_2Y'BW+W
MG#TYK:XM>I3E!+F'Y:"0UH<H?06!^98(_/D>LIW3HGK U4_2,5,"7K:G=()&
MW2](,!J#!]=<)C9!?'!GBL/YGHI&#YD4PRHC::/8;S,'CPAQ@;J[6ZK:^LQ]
MIV;>7G\[^3ZNM\-D[N)R2?=R7KZ>L)69G8G[\A6?O))2%YN,,,O&0;-JAC:E
M"[BHZ,'0F^YXR&-P5<#GX\R<(K?#4_16?U?AWK;X<%/%EM#R64=Y1^AW/FM*
M*8M[A2@W"4>PI.SF[86(#/\TI,#*C?RW0Z I ]<]<86V5JV'9Q,59A1J;%>R
M_$O'P",H_%+F!"0V&!>]EGT#9US3[R93&3_:U*>J9HZ2_4J8I4&[@TJ?H"?B
MX=P5N/V4(VW(8W51=!-WIR_C2@,2Z>6YK/IW=I\[_+,BRR*Y]$[>OJB<N_CP
M:EQJ;US>U,CLPZ["=R[N"B7U'C*G3XY^C$/5X9:#GLO7>G84C38MJKD6T*\6
M48KUCP8>4S!<B%G'F7UP&(NJ<'^JN_A54DR%NI>E"I]X[5"1^ 0F!^NC2:?'
MZ,J$>!UF<>EC>":*NM:K.-R#(DE(_%KI/ [_938GC%AM7_Y=S2:NT>CG:&Y3
M)M<>EY'VOP3WG&W7Y0D@H"'M8T4TWB3Z]0=I#@?)%429I\<''0^SWY*X-#U^
M1^:\.[63()K8\OZY8^Z)SM$"L9*UU.2J030\X$[N#1?9EJ<FQ@4Z-5^4E@I.
MB]!&J@A#\+V;H/M*%-F IPU\KE.H:)28!XS;)<E*"D>,UT_9_R/=T1"]Z_P=
MMF=B61]TO>T<%I;I+K >%*#_'R2 UP.8>:%WQM51-A5U=7&V#94'3HKIS_9R
MJPBE-I-@ _E,J[;Q?GKC)$YT#L?;='B(DFZ_LCLMYXW5W)5O@^?EE3&[#-#R
M9T1W8S7GDIZRK)LT \>QZ\^ 6H:@\-E2PB8+&BQR7+3O-WK"W\V9V^\+ROWA
MZY]P]Y[D[FC+@QABQN.KJ=:58H9";3<;EC(1P[)F>9EV[BS3$S[27'WQ,U:G
M[\XH7.\?2$QJ&ZF?[_O(]'/)2(M[/S>PD2'[U,8EYZF#^L$J2+9@(KM8MZ98
M4\WW[12\ 3O)FWK\R42V=D?("34J?_>HB)6/G45:=*2%O06<*/A;>+M-Z]KY
M/CDK.;1=3_J>?YT]IG#W T/SF_<"QRJR*TWH4H;;+>*_?LX(K$.SX,6C<"8@
M)2VG__,^U1^[>>#>SGVB'4Q_QSZ1['.4M*JR-Z8=VXF9 93C90[W;<:#FOKV
M7:[D'>:P]-]\C(6AFNJ3/J?HB5U?O^*1,)3UCNTB8V/E-I[FMIO<3!PL$%_J
MD'_H?W6[:9MQ$?NST=OCFN,]C;"E/1:BT#7:C_1M?R\MTYVHRJGI@$*ECR0A
MM>&*_PN;34\-CGXXSJ<0DN.!)JS-]586O;UY;S7W $]\GFH]RAZ9S4K-U,0=
M*S1K$ W%:X)9I3D,,[O*IYIOS3Z\)$7-[O)2#EOI6V'YLC'.P/K422B*'/K)
MW0"- X" \2Q E2-X=:DU\W,.0YA/S_F(=-.#-B_@/>YP?W.CS\8X7/4 &N$Y
M;/W[-E#O0U?D'^:-&2:L69#3A!W62*1!=,\:C8V)8/ DGR?N26OQ5@V+&=F(
MPS#*SU(1J&)0\'O3D[/"!^K(JZMG@42%)VLYM\_",;5MT!D/ H.ECS-5Z4Y6
MMUB: 71J+=:3B!\AO2O#/=@$V6O L;;>K!#XVCMV^\NH.Q;DBY*H%#U->SAX
M[M:3<N^N6F]L>WTJH.%1\W92\;B[#N1*+$1??T-,#WZ)A W^%(W2^OKB!&$C
M.W-UZU64I*TMFW^W,R[7:V2-I&_9.O#\&8JWY7F++,J+OP@$PBR!M'57'OR3
M.W+\6Y-['.G3V(:F> /,2G#G7E?V0<>^.UXO=9$P.$QKG; G_*]M=L;[Q8U,
MGD-W&0W>BS>W.QNIQJR5KTJL 1M4;[C26 Q/;;@!=DR,YHVEKN6-[M)M:-DR
M/9  W]9SD5G=V%]]\39&&K8\DTBB](%OC\1%R3 XEUBW_G@BQF=);_8<B-VW
M"B6%K$*Q#C-=_%$$">5HW="L+8<=2+6+=(T2Q7T\/$VX^D]?\0A]E/56<D;B
MZ738\I_D_!/DF= Y<4"T>_S9PWBRX_,;]\PVQ7V)RXMT]']M:=0H0M!;SO76
MGD:XU'.P%EOT7P ZS/[+,&NFF^LFH:@S6R96Z=R5JB[\D=V8C74F[O\^F^,"
M>:")I8VAIV%  D$X%S57+\()Z5M^&3I7".*"25;=@CR,!7:->1*2\@T[S LA
ME(S#6\E_[#+F*SPK>)' @%@,A$MM/]15@U,CMB:KI:FKQ*RDMBT"JWO=85L
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M-A,3@(#\?'"V*MK+Q\G=/P8GY1F7EQDW,8X]Z:06!!=TS+X"">X@RC'_POZ
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M!Y+6+H82[-339.Q9,*]>A:[ 7<J'&V(#?> SW>_BC;N-6]Y-P1387P&RI+0
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M6K* A-\B/P,G=;>/LD(Q[R; [=MD<8)&?7 .AN+O\GLN&I]5"DJ()P"5=!Y
MNVM'(YA>",UB?J?,$*P7A,N[P$N,*E30G0HJ:)\&E\E5S@ 9A];0R#@M9@60
M\1/'.(]>;D?^#J*%\)F*GSLIRAX>#Z/ES#9)*A_1CYNBPS#$C)"UWT&N)RX9
M##+'8:LN1 0M=)##=/ZPSHOO[.YX/*WO":B@D<O'61\P)31A,+N8>%<YB6)
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ML"W:&0PINM@UUVKENW"0DVX/3M7),#'(7US]'L,'4L4^Q_7:5,#O,7%H)#*
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MQ\?6R;P?Z9Q5<?;>)@?<9$B%/?M*>!)\KU08V)7"KU.9#H,(IL[T:U00UPV
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M9,U'#B$WLW/MVMY9UC?LH%=EF^8\;=IT*=I.^K$#W<^/$K:!CQ9!:GPP@RG
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MKL!A8*Q44X'Q*23]6;AIX:?-]>_027[)QKPCF*0C"PD/%319.UG>0$AI(EP
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M"#&J:M.<#U^EY]T:AVZ#11GLXUS$/IA!6C+'<@JTZ?./*9+^ZE]=A%^[EH%
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M&$^/" QU$JDA9@+CL(5%@GTO%(_5Y!-G7&9 RB?G5AZGA@O/U#,*60 VUT&
M:04U.W'(*C@(@P.]'BC>'%*-0T,H44[$1.@_MV>_NIZ!7\J=UV%AXNP/)XN-
M%"TFXNUQ?%(Z.X#VSRR/CR<:#2L!'4L9KIP):MR,A=W-E3$^BGK.AJ>'HG(0
MH9"Y!="0=LN3Q(:TC-?EMV'D<T@_S\\-!!)HH ZX73@HUDQV-XF%"05D04-:
MK\(\I^?=!)^\&21W[/]/.&5EOT':Y@9&*SP,S!H&>MZ7G;)06H?V6!;;;=%O
M8STT@1O(/K\DM=.R/Q'1L'[P^?PE*0 I+/H?__1?\$\C(X/XJ&09$!-;VZ5
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MM@@"7<>5)0I F"Y 7A=!KB A[JX-;I^[[<-C]HH@D^+;:6P;J7SSN8;>ZA/
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M/#Y):BEF8)!*([5?WTAI$8Q3M"EH0,D;!(7*E[<>#P2Y&E&]^]")?EOP\-'
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MFX%.@! KF(54BW$,^=B<T'>VH_<>$$9U;<6VD+DM/PY\]O?>U$+J3H4RF]7
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M+H4X7?>"^84_F,)CQCSQ79L55<X;F*/W^!85WF:\^! ZI0UT]#](F0C,4SU
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MI]!:)3Y9EQY5]7:I&>]]=<\SCE;[T-]8R5#%82<EZT[?&!=R0P>I,10-EFN
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MALGE^[)@AR#/&??_BK2.0AQP<;L&)LM$(]E*8_4U>Z6#.T88"/3\T"?7=MU
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MX:/UYO6XV4<YC8I3"/D1;>9M##4;ZNF"3S]3IKFR]X#G;6F4VZ% +WUF\V.
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M)D+-"J!N#1KZR>:CALJ-&V$//3LQ^,I,U3-=_9<>;5R([PZ]=7(TF,#^IF3
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M'&KR"B8/U==G?)T;14@GY)XO@;N^OMCQ6=(8C=F)R_ 0;TE8M_ZM6]?B\,
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MK*V.B@"3X@<BDAM@;K=%,=3CR\1[8L^ )\^O(OU@R5)-I3!.O)8[B8M._+Q
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ME=1-&4/_0$V7\!!6%E,7;P6]A7^MQQ3?.#A!#NWHP5<1'I)FM4]'\_\2 "%
MF;\X5T['?O1.'\97A;(?]A8_;G1+&7HC(D\ 1 N =7S<+/C=,G+8F%OH.UJ5
ME&M\9 .I8>1S,$:\CDGD+]NUD?^Q9T4.D,"7VXP0U<.DJ&3(CW/]LC^SU(>D
MLBJC&4PBE=8\P?Z\J&G@#O&!^<(L4"HASDP2W9^DQ\>V\;%VQ,)NGB67/6VH
M>/-3)5PG'!8=_;X*7LI?IVU>N$%9OA>-JH-1TP&ECP6D26\9_?*9'SU4<HZJ
M<BY/BHAS+YN#;NRID4]U1K,_D?I0C*ZG5Q-:=)";PP\XL7#@RM;3MGL">R-Z
ML$@XGG*R>GL$^I)R\C6&KYB8/SV1/3W2<G?Y U6O)L_.X)XZ'(GK2%/8:#:B
M1GDD>:,\Y9H66\;AM$?>RZ;3;Q[^:'3O>C7\, ,6-J)54/A]C+%8QMY'YLKC
M4C,+)PZ]]?82N0D1$^]"QTW$(&]2,>+SU[<A'S>M-N174/16LJ>D?#)THIF'
MMMJ2,<<)U.RIBO0S 'JJM)(W5$/,L/+$3S1XVV_J7KC"<M6M%_?\?&UJ=RVK
M*<E[[%FX+_\;7S'+>Z#$\TS@SD_#>>]&,,B/_?!M?D5^:S_HQ-VUS>6<S+EQ
MKKSV%5ZS+KQ\P1BJ[#VG\H<BJW!V1  LQO+2]A+"SQ#$X7^A&[OE)XX=+>RM
M2Z65.\ -WAS!(J<'@@KC/1D^TJ_8"WC/*\&E%#=A$.NKO/+IA^'7+[XA'^R7
MI8$+;9QWY])C5+MCQ'3Z]F^?G2LV/1B,09-=$^UAP].4>_SB<<6;6N9JO5GJ
M_8G-NRJ'BE[?7V93(+8QS"Q)H7:=5?_+(S%9"9SCVBKFCU_W+?N286J>KGV^
MY:9-H0W=RX*<2OO*FIF^,:$YTL'Q\;L:I#,1-RP )A9^")!FOK_TF(-DI!BH
M$17D$NC=2Q#41[*R]WC] N"&/;^A/6QX8GRMR6QPEI%R$O?D@NDX>0G%TF<7
ME[-V>M>0I![S=I<^_M%S]/I(G9%*Y :@=V(S)[FK/*;^D ;^N>$@:4_N5ZSA
MXW5QC8;:I RT3L!5KOU]O<L?AMI\X)O.K;>(:GYRA_U-?+BZJ/&TG4.56I+#
M)R-X9J%^:35V2>DNT[=#"0'[S$YZMI"/J6*2DV.O$5QW/[%#M%H@HXP]\=TC
M+$\RI].',CA#>=Q<L]:^6I[_B-+!G0$=0D7NYS'E4;V9"?WZ"2K<6*&CFC83
MS NX*I4X.G@(-QD+K/2/1Y!!(-'A5FF]/K+#+,:A02%P)F[W:+N-COX,@^ZJ
MXW B8F.7QJ#RI:QVY'&)LO*^'\1&N^F+?K 28A>=A'(?@Z4,M[;%GG'/C6M$
M'R_N8 F N]P $-O"T5_?7T S197).&2U/3YS6TRWMU<U@A#*Q"#KQOOS-->K
M??@YRB2XYRM&?7;JJ9I!.+H1I<U2G<&<Y)(H+9''QK2++\%Z*EB$C,%9SX/S
M(X2L5S/ !MU@K6+8C8Z;!F#QYK-?EBD2>%(U>/<2=C9K<O2.1>"5P0>VY4'!
MH^)2$R13O.G.@ZG7W,XCWG-[DC&D\[L7?#@&8J*AFGW'*/\5/UCW052) /A2
M_VB:0W@)JGO3[[>.#'?F8:ZS"'.=1[:>+-%4AO6BW:$N2X"27)8 F/3>$5P^
M]H- ;7YWY-A==9$'=OIP*GP (SNY;M[52BXI<+=-?GT>&/_JJ9H92C+\H4@_
M2CH(V>>^($BOA6M)24@XT!>AT]+O3 \$Y;.!@]V=TAL'8BA7#@5UJ==D?\+?
MQ(R?),W*9V#+E2W]9"L*"*MZ)Q+;GYX[O ^WH<?9\:-3[6$*EV]+ZFQTGI:?
M3N/AAS&.V:'E.V9/!O>?&6\@W'%Q&\:?7%9T<'>*@_'JD[F%VC1<"^$QHJV#
MOPHUKOD>TRZ/G!V\S#%:=:V?9'/_/+^:H^1DG5J\0<8475OF6:A;QNP,P5BR
M5Y7E^@74G3C7$FAY_RBUP,/K_HH=YNZ%>EY.6NDXY3W;CIZ(^NBV2[4&>A]G
MC+TC6SGY>NKW9)FXL]XRCVS=+P%F9VR7W^ST4&5>:!YTII^+4ERE97U60Z_&
MZR"S8CNR$%3B*9+N/JLZ+4<RWX=3))YR":2.9@;]> WC&B\1U'Y6T.,J&;/-
MGFZR)Q<E'QM'-Z;T!J)AN.RRW?_@-5$8A<U_"!3#37MR\6PZCD^ JC]J04D$
M4'Z20?E)X^]]A%*!.;H( )*2% 9'9Y^,84Q,QY*XC HB2(KI@()\M>( #!Q+
M[!$ !\#1<G)5J9""QD,*NAHMK9"6_="PW5(+\>[G",6_6E6]&C'%H: $14%%
ME/4'39S@C>8;61,S!'-N6%_3W66JSR'A3H6$.P,6=NR(XIN+@^ M>8L.\@F@
M25EI<>%3G39_2+R.AX%JR^>$!QBIG5'I7/>>CB.0OK(#Q-.%!DAEK=V@-"L%
M41N-1-!&9/Y_L]F">F-P:@Q5*1UCZ$Q^<.!:B0[$EWJ_:4[/*PS>IGJ>11'B
MSYN/5K,6[]D NI->J2E]=.KXTX,F]]#0/*A"\T#L:XFL';.RR@U7 972>PI6
MB]9,_[32PN]3G1:?#]X( D&\!]ZYD,>1$_(OCANS)N['>O*XL#@VM#GVB^$9
M)C::3U_40I00NVDD%&9,_,EH)U[7%Q137G-B2@#<6I0=GS%B<D1\;(]7F=8D
MM\J/;78YJ)Z7GB, ]#V\^; ,^OX5T52W.2UU=DY+H<93Y1N[IKT%@!5X$9E/
MZ#.*',(0Z^SX 1>H7 2R)0ZGCG"$3$Q03YP L)P:"EDI]*%GWA7%BG;'7C'K
MNK@B*9ZO4BI.;W]]H]RAH<Y.=B8>_"CQYJGL&XC>)Z@"?A)G.>A%2H.]T^7O
M[B#;E^?EYL8>6!WKO/?ZS<#PR.!IO#1R*D6\7%FO[-!UK_4GEFGPFI/CJ1G/
M,$F' O:MN+A&>;!HO^>'* !4UV$'QK#>8Z@ZZG5,;RYJ_"3AOMHJR]XX[MIW
ML,T.&^SJ<UKL)D1"1TX4=TDE&(PNF=J:8U.$Z$V'C9\;(2+&C>NQ?@+@9@HU
M&_,X!%X&4N++A&NSMBMLWF:=NJ*@11S%W]"FX<_/;N O[>+A!<"*E]3A9_H"
MX/(W?N\FV'=-!+49/C4 R[,?D02%@C\O->].D'8VID(]]4OFH _6N+)_Q\,/
MKU_?/D[0.%JC)0#DAPFSVU6&,R<$0-\&[%IBSR8T#%')#'0,NMS$9>IT&/O:
MZR@="#=.--IB-=H 8/8O_[@77ZP>R/:90=%GS;=N]Q4 J8_41V8PIP4 /.G3
MY>VD]LU;_(&%H2.-&))5T_\5QXN%..246T.=X2PL@4EBT0_^)9GK]84O.L1E
M\@/F/ .QK6Z@$%S)-1M'FK]C-LO*':D<'F3B\3#?*5@U7U]A=5950]W6NJ!X
MA*9\LC\UFS%T2_'-T. #*.N'^ 3H40.E2W=:@Q/+O9F447XJ"T9,7R-L)>Y9
MV()!P#QOX&%4*A__2^NQ("BD_ #D +C!A$G81-I\W]&TH/P$"'V]:/K?.#D\
MWV5LF@^;)MEQN+P"##56#$&<XNVL9?EQC$&_<8'"Q:":0C;(UW1 "6'M"24$
MGG*TC7'*7RZ(.!//Z=*BC_&^3.G7SP^P/2@?YG#1"^,;>HM&RA[R)#;]-Z#R
M%[C>F%5Q/]8;G+0X-E0U5[4.W:!$Y<0C5*;FBN9 ]/:+O H3L2(.EX?,2&&;
M"2&@;,R'BX/XA9&A#*]@[1FJ_-23VJ2B8D?$0@;_[-Q6VI7M!9C4^(F1&<(9
M<,V5W9U7Y;GDE>&V^SSR/9<0BR =DWK1<3\V>ARA,HAC-H5(RTI\P:0^K*#A
M"$00U7&9<C<?K>,E/E-EV(VA,UBXRDS9F-J+-'RRJ7A-!16K7US-<Q"JU2RH
M-HI$MM7:P7; 9WY@XKDZ7[;N.(RP5P@/BN?TO.#;C=./SB_G/+DWMK'8'A)6
MF SJ[,3^%<+7FUZ!>^%SUU3PNN$SI@$< > 7+'Y-]9?ZCBJR/3X<UGUA,,"3
MQ@J?F$Q9*(2/1Y!)):"?+;:#_"SF0[3BD/V(,HY%_UD14BN_@FYJ!955T4_@
M2UE<PRP,ADA>"2+Y[%FS&T'C/?;ZF&]VXU,P]H99<R^A$>F+@SZCO[96\T;%
M,)63/ <@/%(6]K_4E/.OOU,CH<K1#J(.$+MXADP$[OQAQ5(P?S$8,'WQ<7V?
MEEOX-]1M :FK@8> GFD]6R.AS5@QH%F#*ZG0_J$3C*08".G$K=8C";$';H.+
MO4C/FZBO$ZSU9'E$6[&# %C(1,^U'Q:Q%4*P:B-K ?!]R(03W/,-0\JX.D_%
MKG[>E1"+&T=H4O',EI#U$A88MG8TO,=W"L6D=89'2N)RXVK<04"*4NW(^,S?
M*P1HK6W%E[3=HT6'!I@DO2F^U?]#)>1H^C6ISK>PT0O<'C*#J_WDV# XHXA.
M<$:SH:=:5PA?;R ,<-MB6L%)![42$X.J&_\5$7?*5Z_X*;XZ?HJO^=+MLT7M
MPA'E1/&NGQ@4ISA(&5'&LP9#<1,\S#' ZG\!9TM(4:DULD.(4E V$%&84=R+
MT;<2=B>GO>*))%P9&S^ $'MX,SLV=62E*7)TW*-,>XK;J,4^\>G:2JM</#@A
M!#+T7,'B!]&;<5"Q-&BN6+IU]NI3882+O#<,9B T:9ALZBSST+]4CU$F,?=G
M%N_1H8PQI^#)H33A$6&*-S_5P45E10<&V-YCC4A0O,R7>R;"@/;/@F]^T3EW
MGMRK$P:H??.ASZO8Q%J=65/!TM*;(!9JPS(A$3@?P20D+IE#<U@#S>$00BPO
M?+[@$U)S4-5[_O5'A0"N25CP"2'BPKMP?_?<9,*/G-D /&\%5V%^[5FBW!'A
MY'()*OQ#Q>5'J)^RS>IG[?GS@H%YQ>:=PJ@D)!./6-23VBUA3/+?I>I>9++D
M,#6;_1HMDRH #H(^_*@PB(B@]L+R-=00?Y?&A3 %E 1W-_+ C &=+9@Q>&+F
MFB@Y.XCB:R"*'\+(Y-V;#SOKLI@@IH 3F,">V[G+$;X^)V>5"EL[*#F>DQAL
MF/V"W7QJ_HBM5N5NC[1[>[E<,7]*1[AXDS"0W(SIX6,OD0J[>!9<MJ_!+LTK
M@ZE<\086E3OU'X4O-0,W>"-J.^C9NX\2W?"'9K_\ C^WKFFXG1.S'*A@%>LQ
M2?J8N+T*UF%SQ5R$YM3<@P!V0C)L)PB#XA M!$&T(#L[*22)/L]'M!01[X$W
M#"-6V)CJ3, $N8.3\4-7J#+[X"]&:_"3Z]6\;C');#@AD@BQF0V\":K.G@4E
M+(P\";+9?,OZ1;@RFS8??<+G0Y.(USS4B\!O-XPRK,?XX\J:L>4"H MFWCE_
M_ V+NI/3M^7E9_RT;!+9?'NI8&CC9[X.VOD+-*5=+%FR^QP)G H4'4R=S_\O
M6.8 0M-B<#)']Q/1A .S9L)JRJMD WBLR+C +<7Z4;$$$JC0Y@FBBQ<M[=G:
M.)F>P"EW)KUMGB(*VW6M?S"-*U['LN."DSB_?+MCOLR*%(*B?Y99P-5PX\-\
MK+GH,SCX>YC3?L#SHH1Q!6NA</\9VE\+(2^:K#5-E9WZE\K(X!=U]E<W",2@
M@@"!&$F:Z+^M6 I*53"7!_EXZ)]]?P%#!7F2\K0WF7<&(6XN )Y@;NV;_YG'
MCK'2>"]RHCF=?\.1R+]TH3%,]>E8(G>J@C2+QF=N^K_#F<(!N-\_L!$'86/Q
M_.N;0#L*H2/Z;W0$CAR-Q$&"8 <D"!YQ \",/(* ,C(>RDC["?K1=-_$SK?B
MH+KL:69PM9[,EUB0()A_O8$PO G5!F\)P:&.QM9TD+M4HIMAWKCG4U.(\T>%
M$:4XJ$O-NZ*"-2O%)!9NA*4O_6>5LW_%?$]W<'[5[^D\5S>_Y >\$2H)#ERZ
MTPF*&>.@64YI)+8+'C:1-A_.?C%\$*:YP"%-.0%I2AREZ4[-FC<0'5 A.F @
M<,<."RF@Y?,-'R@JA0>0HBIKY(=@I<0N.A'E/HI_/BR$@8N#"F .%[P0OJ&W
MZ:3L 4]2RR]>[<A\2(N>KZ/^)9Q]-F(L9XF"PR=F!,!GC/#X@Q:ULJ!*@_VM
MTD*DM^[8!X,R:1;*I$/C-(.;\5^#P<1@4J#$$*],EQ62-+>%3!^82D(C)(2U
M6?A\7RAD^D!=87< O%X1#."U1'>*+?Y!V*?] ESSS=KZ>;C5*K2U],_ ]:_\
MX3*UK8SE%U1 )'JO_2. 9]AW='Y5S9H.*J);X)+QD_(D2NL$_VX+_M?2VGPD
M.20$32'+4!**>?"SL/>8^["[=/S)$6Q^NE.=TKTS[EO$]'(2821$_9E+"9M"
M-)<<'AT([F&R?3(M=WZS#GI^DR*[VU1C@&^MVD';#ZLDCZ@X[Q$ -\K\8H.K
M^A!]FM_$VXKT@I^B54/\V-=GF:C6GO?YCF@8S=:U7GY8H^<=@#5P3%:#GHCC
MXXDJ(ZK[JL'1I7XQQQ(<,.!H1-.&*-'V'4.$'/SUW19]T[%?K$K!_-;H*=-;
MRTDCL4;N 5-WNATZJZH;U?G/!_!U.!-P"=*?'8V'S0$9!&M@\%O'"G?UWH4;
M@HMV5I> 9W%SE\Q),TE"2R^5.RT M%+$;E@(@$/FTWI3+-7FZR04QLR/6G;A
MX]\(5P+E%Q)ZTL_I#"I'A6TI$LVD1'^8X <[2ZB58-W.B2+@8I9XD"?S@._"
MFDY6[B@1$AW1D.BHY^L["HDR!6NJIE(H*%DU)Z%'I4"1(G2]W<7-J$DOEK[J
MC!8;AS*?>O9B_HA?0$ZX=%5F"%-E%3!G@A'G\^;!6/XY/C/H23%"PQ ^*1+P
MO58ZJ'K;G>GE6@BKZ[,"(/&M^QZ7GI6.^)+K,^7%1 J[/W: 6'S-2#:<8;7Z
MYW1T)VB0HIU+ D8W$DV3 C")GQ?4#/G?V;SQVQWKER*5'JJ)(?YL']IC.>:B
M>^#)QCTI'L&(1G%*4]3Q9"?;SJP-<N%KZ->C)^FD? D7IKESB<JFBW!;DCN3
M#^:D_XW#JU8Z43>>T(+CJ:*@74R^$'GHT.;BJG5BXAFL"FZ &?1H>M9PZ>4[
MK#!] FGV"_1@:,G;B5C9(:EIJ#'O_A7R\7(G/E=E>=Y:&$KC>V!D'D;I&JJJ
MK'-J0^QHQO)3,+L33PH/.C4EN[[RT>5EO(DD 1!'(Z\3V1LQI''MUO1)(KH'
M1SL:F1=V<;>IX4:MD>_ZVL\<QV4/2E6/B,_$\YDP$VJH6?$IS*37+&D5UUJ?
MS;=:#C3Q:]SE?;EY5=<&*'P6D4:>>%V0YXBJ=8AI1R0X;@+LP\&[<6K.+R@O
MVOKXW"+#8CO\23Y&1E?#4C'FT4TU!:V!NQLP_>J):&ETGLCFZB;YMN-I$C<W
MMM?Z+<0%K7E,6B.GIADCT9'S0_8#5MPTT+YCZM5:3 J?,7T$)_\:H[YV#$=F
M3-8N3?U&9!-OR[%*OTF>O<ZC$"DDJX 3"XC3=XT8]Y=(GY4QU6>>L':*/+O@
M<4Q]I&)02&@CDE._Q(\Z,9F-F V=(/;U?#B^;Y"<?V>KWX/>W(^-]:(3XIK7
MC$3UO,=0R<E[P:R-X^XI)$1M4/%WE JSZZ"]M<H!)OB9DH4(7": 3FFU;#^?
M%S>=6X>1IOM?=UMZV48C)$65@B5NTN>X=-2JEW=7?4-ZK77D%V<WX,)@XV;9
M-\IWO<O[_+C?66'HP8'5Q<TRY+&_8 $70L3CO8DM!(.]+_(P:QW/M+?$O HK
M++Y[Y71!LD9MS$J14W98,03B_0)I;W.+R&W)5=TV'M)Q2DDB[0&@'MF;KIK>
M;H,<3.F>B*W=2=FRLE>L-5-R182&N9S:=?4,X-T ]9GI41"7G>&<DWFY#RP;
MKQ@DCBS0:LW.T)):":ML#Y';W#-]@Q=WJ/#VT-&B1XD+:D4W21JO]K7+VE4:
MM_GU%F*@L]1)3?%=H66&.;*%)TGE 1<G=2X_BW:;"3@46Y9D&+-6:MFF<A<-
M(ZWW^F^7TLZ\OOU$#^G9O].N\)3\\K35M<! N%AQRO)KJ2;&OC&[TV/>&'4?
M6>A+; "S<>H'+V8Z?GJTJ6!_=:=&E'Y )+>DY7)5ZK,ZE9AG!F_AGH,LOP@<
MQS##:B'[C!5??KPJ8M>G?LSJV4.5PTANX(^ Z>AG)2^F[C%&UVL/7*6S@:N>
MW><;XH>_'EO&:5QB:,K:=\8YX;Z1@>_JCP6OE_F'Z'[%AES[CD2G6/SE3R$M
M=_+]XF@C,Q$6DB6;^')],_?T$Z2?L02A!"O9)G>%%B)JDQS3M3O.]BGM-OT$
MH:CLAEFX-0$MLH7W(>U&T:B6%OT>\(27WM?1=CC1]VW:1\JN4U*\L3$TK*\I
MOZFV1>N#)4F.X2-9+4]^+E]HQ=,YO887IA]9TJ0\DGQAV:IM+X_M"7AP5%^?
M8&*QR7]"U* IOOT'7&'<--HK8XFRX<=WRA&U/-MW[^[M]VQ<_EG4Q]/SXH2D
M@M0G'^R+B#9I;7E]_?*R!F^U<\X6IBZ7ETBK8E<-!][L0^I>;]=>B"L3 "U[
M>];/KOUX\KXQ;),?XL0WR[3SJ+M[G>E1WHE+1]RW>WF2NGB*3[9?;:U%616%
M<NK?#\CX;;E^0YN^7PS[8^,38VFEA!<4UKFABBOO*VH6XQ#'^&<1O8-;0=.[
MG-XW49QW>X< N!EJ4K=3]RXC?8K(^J[(OH$UIL;7>+O%!OAKW_M!YCEC/Q5)
M19(?\VTPO8,+7=!27#C#;=1> -SE/^(7ZO%_(!M#$)<QO=&K5O/NHC?X1^5A
M)I#?9SMZ>(OUB:P&])WR%8-&%XPJ1H/?X3$?EW/'P8PT%D7D:'X8R2'*<X_N
MQ4V%P1B]R81;Z#M&^#T#B[6U5U1+>>.(K,= CL*#I3,&]Y:R3,4;:N@/$)EK
M_4.OS-J9\#K%RZ8:$3#R.NC_H)Q+/)EN&SLF!ZB3Z=!_Q'>5^:ZTRS M0S0Z
MB%QA+FD8KWK$*8(%TA/1B*R="?62FI6;[4=[@\>R/&?Y16E"(X0#-(757SP;
MNUW^1FCT5*,^AG>J8S9_A1F^;?K+<;%O%U'Z7]U(M8:BM' SJ]X4AG6W36WE
M0B:5R_>QL:P4PRMMKF><CQ7/[]V*M[-W7+AE\KNN9\W[K'MJ^8\SC@5EGZWK
M3^(6!OM@&SKU4V\4ZMZ(?:R+JAUS%0"O)#H<?3=?W[!!8E_N"P%@L2(H3*8S
M&,$[;<-W/?@IW,/RL!J[2%YOBI-1R)2'QURMB] AFQ0G]UC$U5H/-_\PRWR[
MA:@=:W_ZA XCP$(7]A&YR)&NZ)2L/W[*)+P-2_D4(.6FVIH6]^, O0*&WU9J
MA3[!="&)G[O@['WBH=G5[XU7*2^#\"M\8\EE7ZAVSHUXI9TOF 5)%$=O0^.>
ML<\3F';?CZL-QW$?/;K[5X1>OKK(*.)F//+B@1$L/@F]"/VQ-I?_+=(H*B63
MM50U_WIIW@!6'8L@-L\0IA^V<!7[>T+1\GBCKWG29G_EE"X9,_ZJE'V/WX<U
MB&TV*;77>\Q=S0N["CVAXW1R>UE%$6Y#Q?TWVS%-(Q[K['\@F^_Q)\91[1>X
MDA,:,5)RM'VAV:9Y3I:=[N+NOEVE%C;G=,MC6P>3%8(OWK2'&^DZ]#<%NBI8
M]^3COV-.T=PV*[K'O]$8YP\GJK#3&_T@219P1KK^S%UO3H)?0XMG1*D]F<'E
M?/-]/-QI^43I#6M/1&4V.X]>P6[I]*@BE,MZ$'MD59(1N_CBTWL=^W]<G+A*
M^WI+V^C9PTLQ:4F/_P]W[QG5U-;U?6]$011%+!0I04%109$B14JP4444"S9
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M;PU)<;WR'M>N^U3U+I7O [J/=S!FJHZ5K.)^B/8BBH]%//D^'X(I'W!, _]
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MTV4[[+G)8FBU40MLI>0=R@2UK_KZCZ[8$2>%0W0-4G]O]M2]XIZBV/GZ6-G
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M7G:?)0SW8L.P-R$;$%_Y$-J9TUR@F/::O^O!@5NHJ>\+?1L_?/!)D0R!2PN
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M)H6GZ^25^N( $HL\/DO%9X?L_)N/!5=D8U!*W)XBRI.A7?\).7/C^N.-NAL
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M!2"@5I#S* #T+K#S5 X16;,492BT<^Z)Z(3IK#62DFX*+"K\,Y "U(.8;00
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M6-L6)<8E7)7I4+A"RGW# [*BQZ3,X9B.O.3^0^%>U;<5V"13QOSS)C]7LG^
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MVVB2?;-ZRH91L")+VG%P142S7D]&BMY#Z\U^D[Q6]OGPBJ548U!+B.FE<T4
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M YYPS$:9>]DP-\!M(^0@S6X89OG<GYZ.92<^C6E];2W:"A.<2A_-/H2K'^N
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MCO%YL-0VF!7V6^,E6Q1'L?,F_=5.03"/9FG;IHW0'Y'WYODH[$]+I)CZM1>
M)\39\W^?D(0%-W.3F)%)4S]^,U)R9XCL<8B+742B;M=&OG#E3]UD@UT8$WCT
MD;AT?"C\N/F<)J3N0"_F,S<$+.IDP7_"@U5B,\V5@;/)Z?"\IE_^[G30;=$;
M"K?4JLV$D;!CB9Y7E+PY!@D_\T&9>_FS\7IO-CK91K.UY.-9 !;KR+EX-0J7
M?/FZ]KPL\JF;#Z2?;9]8/]8(W\V5(@=4MLH\?SP!_71CLG6[0?TZVE /KI8-
MOTDV+&M29X3\Q.S_WTG. [#6MET[J4PP8<&WTMQ:9ERC8'SE^<!UR]H(,]\^
MYTR#Y"#?% -R9_D4R8D^*O#??667ZIH'"J^+CNE\&%E T2!^<2?"W-<H>U]M
M:%#@4Q'&^L>DW%QG)O$U7SJ%&P3/=U!GTN"5&?9'B?Y_1DZ>C.B^P+"ZGV2I
MCM)G**YDXI(#D<TC;WM$ $ ]UD'>_&OC8>T_UIX[A^*MX>O4A^K5JL>NL<FX
M% K'\0QJ/BM+UO!,_)Z..%VWTXE22\-&\<9L_D])CHL@<SSB"-B=7?K'0Y\C
M@R*@Q^!+=8Q?O^O@2C:=%Y ]4-N]]9((^%#<E%ML\,W[$M%(!!PE$+(Y/TCQ
MU.\GAEPX8928TS$GUHB J]3#R@$/EHN [%0"A<IUF-@QLJT/5V;LF/=\*^'T
M6V[C':,X$SI5R4.R10V_GVO__&R#/H[$)U6C>,TZ\@1EQX%J[O9@+$1O[B+:
MW-EIO5X3I#\"M<8H:*C7#S$<+LZTPI@]CM<1A@A,?TH&V2&^M4ZN=-60U%#I
MOH1^Q/,?Q&L_7MBO[WJIN,>"&]V2?]936$5B++].U\(O^##9$!'&(H1^N%7/
MDH>IF-97TU/(-Q8!">928:C6COC:AE7(9/\.& :,W;/_L&\..*WZ%_ZCEVX>
MS%\".0M0G]W*-M;J_<G/A0K<BQ<=!$-+L<41F^9\HW,?U-,K<H^S 74TAB\:
M!PALS,:!;T'A4PGMS9Y5QFSQ5O%_Z@<K+LMH3$C@':F>O3KWC-/5MIBLD9"&
M).I)7 H\6.&=6M[<I\ZGWH<HMN/D1?H_VC+XZ'HN' @\U]PE[3*>:(;NHJ"Q
MMX01)CFG'-QY%HEF(B!X'$EO+IAG>))YZYS%-:[N9('B*-DT5!#RZ,JP_#LW
M9$<-ET2D<T;WJ:CN5L:$7^.R)D,4 Y3,HD<?F^^^:=;H8BCHQP[_!!/XH0?G
M:9^DK:F+FGH &OS>T^U44=6V!S*3V[&^XAIK]M4+$JR^R]*1Q91.@<P8B-NK
M+F6=,3B?A>MR'Q)&<9'D3$!M?I>.5S58F,B"Q#M>WKW&LI[:XJHQ>1P>>XA6
M]IQKVM\.'R-YF$(M\'1_"8XC1].E>\+K(AZ\@:5 CK\0F<VTE*LCMZ4B6;4:
M8 ]/F%=@%D3-0_*8!&&^>'E,.WR0Y &R6T&!+T.H!R2[Z"+/>4&4K6DB()K)
M:XHL=47DO)%'%M5\8M.;QXQH3$O$P_Q!&>%[^'I9 K J[<_P?J2GVN6I.L%0
M<<"D\"<O!3ASK<O?JP%^AC$1(-Y+[9IL<7];&N2OT3>]L>[64P_D(]*?ZL)-
MAAM%P'I.P&/M_;%FC8<4X*>:_ G=YAL?G+?Q)%V_C@9;4FMZX\F#10W>#\BP
M(5W$^W[;5RU,B/Z^R!4LIG0)$&/(Z+UJ4M45@_-U"%WNP]AH+J(B$U"=7]O_
ME2!S.7'LHB$=A]T.[EVVJ3/U7.(HJ$7'L5H>KKW3) *>W"UG$DCD1EXH(E-=
MY9T(&(]2-A7"]T#)/B5E3@SR3D%7\DEXD')B1N/[RQPAG@5.602$C8/TUC<+
MMI$$*F0<5,)#LIC?))9I(O4'.(J*A,0$BK@\+>_@HR#%=EW"<"^?)-YZ^S'J
M7M)DG[:Q^S!K'*R+\'25JB*+;[Z3+KYY7$46H'KM&VQ!B"2VX/1NW[*O80N*
M  @VH7C'R:VGDK\)Q"8LGC:A#B<0-J$75FS"+K$)D_G&C; )H_7KZ%-<4&NZ
MN)I$^#O0_8RX?M4U)CF[5X?<<G]VFR;-\/MF?DAM\1^<0V'9&!*Q!)!WT0+/
MP3J+XI0&X1@\NVMCK(ES%#Z[ALP1$C(U$8E%\' H=!</!^A#+%(C^#M"<(DB
M AQA-EP#-LC54MI205:K!I+&P]Z]JG47W99J");\;FTB4],Y ;L\IUP1T"(D
M]5C(5&^C$WA]A(KV:7&P",!KEQ[_^&*34(BN)]N:1G#Y%WY71CL"]KAP@%L:
ML$[]L.LI=AR_;O*2<(?@>/II.7ZX7#5R [J64!; (S!=/@7S%5\2A:N'(Q'M
MLB+@(WPV$PR>M!<!N>U,WH](\"S8?><)[EMJ3]"&9?#_P8PQ?PIO$<^?&\KZ
MB(VN]E]ODC^&]<%,T%E\L[=<6/Q*W0='KU)E27YTJ#+*:C -2M<J &%9<X*T
M6QUF]&20_R14E, V-<:"R5(-<@MO!>UG&X&@1D*LP(B_\6*&S[84L'(:4WO_
MJ%Y.0)5:[1<T8&\QA]FK<N<5@4V+'TQ.D=)%@-G#LN4?X@K>>8B E2SL<?%.
MO#,:'[]\DL"0WC\EH#9"!-O>LE>4\:@-$4(8#!3B19G5R J?TXP:,(P]+ )^
M9=\"N]-)JXH=1_PGSHZVQO$1+Z$S(8E[FP)-;FWY:%^_ZO5WO837$K=[]1%2
M_N034[8'=UZ;LD@,+N2&!G3[NSQ$CASV4'TKP)6JU_O?^BBL_-J^U((V8.O7
MZ!=O&I+]IF>OO-=1_X0>/TW-A^%D6=O,39IG[5>\6%!CX_VI>?)>MKM/_Y$-
MSY_7/!60O;,@DY_OH?U"6 :<>@!VOZ3F"P@W^4=Z<.U-Z.B4<TDONLJE'VI>
MGS2\N>S5K8+B$LG0^(<O!@B+H')9DH?+,G[H")D,?M>:R,_CY+X*">(UC=KE
M)7B,R3KB\J2DVG44U,=]=%L57HB $9^.^ZTN"%2@WJ+[C:^*G@WMZ;%5Q;6J
M"&7BM_".3.D9R'GJV6^NC&-=:UBZ%&T1G[8R1; KCG-KW0?%XY5&ME:'MM1>
MU!8!YXYXG)5?T!*W.>\Q<<\9>G0@K2$[[/")H@=-F3L//_OZW.C(<_4GCQ1J
M[V\SU<S4=$DY6>24V4-!$);^-#;#>8<_5=I<):MO1Z!BMN2K=)_2GA@^T<S=
M6G3%+1:Q4=G%D!OM ^X?6W*L4#NW*F%U>Z3LE1"0SARLW_W#\!CPZ5/% _])
M3/<*/R[-C&:432]5(==.:<G9IP:>-P[\HZ[0-8@=?,$F/_A<<]!  %%C8Y$)
MRVIW<X1>\3BCX^:R#I^CL"2A($\/F498,(=T#@D'"/<[[C6$%[.$&/8$\Z-F
M=T6?=R<88E9:*@*$I?T)-D=[JE%\*AU);RE^M>@YROF(?2#6P$#IZ9-[]^.*
M3O*@LH7Z[=Z7\@_=[_JU[P(UBTWU&3CG$D3=- %?1ZN5S^*-6GYEZ4R<(_/'
M:B@<+"E[M6)3,A3*\A8!WC%DIR"A<\GF8RDMUL+&UI_1N73E3FO3$M*)B<SH
M *V2U-+<2R6#?QYXE\UX^J>@8>(=[WL[MSV8GOT,F..&K!\%I[7KXH;<^"3Q
MYIM/MQ3G(',^N0^X66J86BM*-!CQ679.#_>V+UF=EZ.[O BXH\NN,@4)F=9K
M5FFR4L_Y">H(2=,5)68ZFLT70F(3,#E.LICDL[=O9U4W(&1(=#M+^4^U$U>2
M*<.ZDZ1=_.B>ILCE\X:]VG5C#6H(1>5TO"&SE?%QP:JA^EP;#B&)1>8R]\F[
MJN%03R7#N55#.O$6S''DM6578*8U+0Z9G*(^$F_9"??QL.V=)[AR3+S.:>HQ
MP]T$;*Z?=BD3;XI8%"[[R=4U5.%M5S()=G=<]@!PXZ_7VBD1@VA[4"TCHS[0
M&]A@%HV,,UY];OKTJ6.=7#J?U^S:<=2%>K<,Y3XLC!.8/8TT4Q$!5Z+"K4<-
MR@EMB63"<O[JD.\N,>,'-.S?ORX]<J:QWM>CJ;(\^&D0R11#[N.OQU+ $2>0
MLT7K1JG!R4]W0G)_!%<(-"K1OF:)Q&_5JBE-"ZM^AE,&EY??BJ4IMDYP1<#\
M4YTB8/&!T4-!4*_$RT!8O22M% %,_@%H"V'$?/A[ZL3I$>(-_KX1T@\IYU6$
MC]_S;_IN&US_Y3JSZLZY>/D/.%,+$Q;N+HMICGP61!UQ% '?(P;''_R ;]R'
M;S.ZHT._,8)X)/_!E1IM).H:E%>@SN\0Z)Y\Z3)R,OO[<CM;>/I+38X*4P,R
M>O/Q0=0!L%<50QG+_NER8"3_FDKS5JUB\$G;Q[,87Z7*HQ/5\_:M>W7X6N]M
M*TE"U7/*2'OYB;K'DX='OMZL5Z@^?L;HC)$ ;6L%WTK#23)?[L)$<H1%_RWA
MPA>CJK]65&8-^!.V70\Y!>9%2_DW/8%UTYCP"WQ)3E!T)45#&(:ISV<)FX5X
MMF#3GF[J?++'\S71KHJG@&T?E@%*,LXFKH2]2<+E")D(@M"\)42\H;,ADTUA
MMD2"#X8Y6,J@R01)5ZCT<%37E\_'#.($1C18MRV"'2:B3_ <-4@:&43$8-'\
M"5:JK_ AF GM0X[<"#$9$ %CTKGMX@)"?JU, K;$$^I9/@*UB8#>)>XX;E_?
M**]W2N AR7U*$,HF3MG4I\9 W2FD%7MI?I!I)(,I( I,6LQ@*\ZO%SQ[^U#F
M!"PS>KZ+@!4O3WW1F[JUHP#C].J/DX4BX/8#&09.2!HO#4?TF(?3,K_+P[>F
MW"[=I-NL&#29=9ROT5VS[2OT>F#O;6F*EJ$\XTL +^V@S A\EA2,:"H9>4,$
MO(-BA)M#HB<<1Z,OJ[2P+]3F_C&..?:QGE=?RWT5PFN=W-;]PMM>:Z%GHW7V
MXX;;'TL5+(^=!C9CF!0N\X0Q=#U\RZ-S=*LF[VV:F5)RU_1SZ'?\"2[G+^LQ
M>XO":M[:^*@FQ#@&G3JRW3_62YYLVB#M(7DV(>&PS3IKKA'A-C*;Q10>,/K0
MH^-3DU!3P^6BQ%7IP2QCNQM?8FJC<)WTH=%Q9!VL.MRJCY&P+FI/L730@D]I
MB93Y:XSQ:*:KWG1N?A#T1$%W>!*R@ ..Q'^;8Y>Z6-0*!QFR8^[#%XUH\:%L
MWNBNF4'#??/=-U!C7%D6?6C$\*=Q!(*V.S)F541ZJ1\LN>$NU3CCZ5(S0Y.#
MY<&QCML1,$ZITP6';B]7Q>7)-8 80A$/T0LIW[6>';H "UQTK-J.+49V]O:]
M]V=PTUCC3SYPDZ=T7848-SH?=&G!?PKO0WIJ1,$7[4H+F! R>#=]9@8/D2ME
M^UT'ZN'AF$@8$4 GM$O/F=5]@Z? /Z*=S'+6.P%LKU8G$< F$3F?H^C>4Q8B
MX!4\[I@0>C1=:N85[\YGR4?<NU$FZ+)UR#8C)%"0)V;&-WV'Z-I3-HH(.$P(
MI!%)DU9?&B7_J3_8Y#H[L%A^Q>WT+%^P<]CHG;LX4(3$-==VSN]J>^<N[YL(
M!D=14'ZMV<TWCY5OUYZRV.\^^0!FOW#7"&/WJ0>*F#[M=71*5_=H(YN'^/!/
MO<$Q"]A],J118=-JG^!<^6\,5:KJ<XUJP^$@02,>(ZYD_S>A1@<<:LB&/YCJ
M2,0+L!DC_SK4.%BTU/L!97(,ZS*]VWW5PCB<.%HK$D=K+&3T";5_&?#<GC]V
M>4K777*RT% $()O'B9:S^P#,S'U1\-#8*H2?C2?'.3CO='BQX &,%=-+?D*0
MR+"<&7D4F-D.PW%O'QSWLF%^:H<_I,+CHA8>%TSA*CCNG1'D'-S)/8]M*.L5
MLC26-.-<ZESG!#H)N;W/63%<W!!K,M2_N7V*_',C<*I(>ML#!/S8ON+-\!O+
M@Q8[;D?"01]57(H#GE)K">(I%2R>4OV0<I[U@CBT>$H5B:<42YS<MI1]?:;M
MMMCV_=-;XR^6._4Q=[TX]IFN_W%<8OGS*8MPVB0&IHC0?92Y._+&%X%X6A>+
MI[4NAYTN=;%@OV..VZ5+6"P:Y3_8@&#NNK;.S^NS4*.?GRL,M=NP\^/4&%=)
M=]((O@=LWK\OW)"Z6+C_1([;V'8L%J'H-]P@PYP%I8>JMS]#3Y)JF(1"<F,H
M#YFI_M_ )$O98MB D#]L/P*!]G&3;/_&J2T245/%:?FV$: N'CNWC?\FUMV(
M)W@$/)]#_> 72?RU46)6%N3SM;\JVBS-F1"+19KXPB%OX'3("\7!$>^,?$NZ
M5HI,FZ,"\OWOQO(STR\'$7BY09EL7H>X3H0P2J@'?)V9+%DDAZG/-13VHVL%
MXE]?_AU)9B53TJ5F)DL.SE3*F;$KU1!YJZH@# %F0"^X]*[E[&0*L%NV)->K
M09NZ 3LL@P^A9;L05ZD<*M*OU_B!=:$@Z5E;Y^#KQBQ"E2VX;#O0KD>(X4(H
M")\WL_5,>IV92:C7\V:<O$#.]5Q;6E]I."$ID8P:;>;Z[YN)L-B5ZPAYJ\IA
MW(;=\:=F?\&N F[*G8:A!D^;VNER0JLT*U+/^0OX,.#%V]._N>+J*@8X/'-A
M@)-[6FZ4Z[R9MBE&;%/7$:;Y@IGYFD<[!V# @U08\.+R'_OD-^B#'IMBA<,@
M?,=U6"4/^!Z08I,&BTW:+_Y=9Z/<)YF!^C1$5R^-#Z&;DF3[Z /U!"XS$3<J
M /<>1-Q>1Q'#)YHDO"9<=8IK4MH(,>]#/&HK?Z.$=JDSM@X6:OA_L"]C9F.G
M62D6^9E@ W;*U1Z:")+1F'Q@Z),6*G15%&R<!::VL</<2CX9?MX2(\:@@#:^
M*F>>VJ&)*UPR;!,(5C:TELCE5P;DW[F)GYDT7<=Q_C=X,L-\9D'BPD2PPCB/
M%:<AN\1IR ?\T,\JJCM #ZTT[# 8#&LEH:F'A+QF^:USNV"SITY7"C%TVK"M
M;;N1. ^"-YJ@R[#G O&.VU87DE9",^A/@/'&-)?\*[H.]EAV..I!,5QQP4S\
MW5GDJIG!INX%,T\V='JZ[?AVC ((RL0;3M(EV9G)J]N$M]TH)!@"W/&AG$U+
MY'@VX?C"J;0(F>Q'O(.2QS1';YVS@$5!*@\+X5;-RNMN<IN=MUTQ3]U.;$"8
M(K !<318%<Q,'\^5:#/SN'8JJGN08@.RQ :L%IIN!-:'-YE]^E8C:+&%*M@"
MS]GBB+AL5N;WR2RUU A[Q/_[3#!0ZH$\Z^6&9?X^^>9,#EV4H<A.1+4*?" >
M603 DFRM]6PRP;-H!G@>S91)\"RR1(IG$4L\BZJQ2AOG@ F8==%EFB[Z+SFH
MQ83$RV14V&@";VX>^-B7^TD"]:<()X'0++JY,6*CQ+,9H?)\DURO)JQ&'W]4
M&-KT0=97!%CKT*BP"N'S)M;/SQ<!3^1'AV$N""/" -6_GMPX@V>O9\7R?X._
M('WO!PV.]!HN!N5/40*3]&9J)''2ESXX7]NQE]+5FS;)9".O+9\-)EA9S@#/
MSEDB:4[^]O,<,DD +MMP;=_2<%UN/:&C3.YB/_8LG,B9[4,:XI+AB1N6;6HJ
M HK-KB?-RLJ:+YR9\YV5$;;OGL&O\K'@"/$HW"H>A=ES=9F%;-_S*1-)\0_8
M#6Q-(9WX.=K,DG*'V*#1#VN]3@8%[3N,3$^7^+?CZ.0M^/ >=PSK8Z7H3T'3
MZ[?.%E./S7=[P+W^@=TOZ+*@^! .P3/*T"Y_33WR!]:W%J1G+EWE_3'7BD-(
M':-P&?NTM^0*5&H($ PS%J-C)F" ^+^>.D.2V=<M@F-UZ^WN5!@E?%[PAAEA
M8Z3:M4]GOB9J)"2R1D)H..Q%\(3\3#0Q5EV_)5 O13L)&LRB6AL%F_[EFM+U
MF2)IZVP=]J_7M399N^CA<MYMAP)_QVUS+KE)AK+E'WBH^(T'P&<F?&:A:=^L
MR"Y#IJ%=/ 1/^HN'(($&#\$9&FRC;/_EB:-55D/_(-M,2797DGYMRH(IS <%
MKB( 'HQQP(Y90=JL):K[LU>@[.;@2>*_'BC.ZV.=IT25U7 -%?W)) 5DYHR<
MH6V<C2?4M/<4FT*E_8PPE6FZ\\^5T8Q\XTQ1]$_3A?._P?&ID2]!HZ]WE((*
M$#K-!J':'#3]OP6I_[T@]6^(T?[+<:*5[!L_K^I+)#-T?34M'L/@<V<GG]RD
M+*,'YX\Y]%(Z>Q4G&&PP;N6_,=3[ZZF*FNR/N2H?^ ^F.I:&T/ EV.+91(/I
M$$71NDTRPPY+QD<1&V%Q$2L7 C>"'7O]=%7M64C+F2VF8B16;)PVZ@.Q4:U&
M&>:+[UTRMUX+NQC$R4Z3J?$)YHD@V:U>DOO72PFJ&M!$)4-0<+X^+<]MN<Y=
M>/9HX/C!^=SQ+-F%)SN#R\[UAO>Z*_+N&/OC0<TR9*7!H(Z?A BX\IYS?P7)
MPY=SX*WY*9=B" (5)$>8+M^RRUP5L4#3Y(D\FXEUOITZO>?TLFFY$TE7)$7
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MY.?TX6.%CO=^]-K>&J]X=GG,R[O7'DV9EK<2W:,B2Z1H+'B=P+XA,L!_U+D
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M>/C"E-X?)68*"95SE/)5_!I:W)NS,*W>A%C3A<>[CS \L:#[T-F!(45?>WO
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M3E/OO_RCY'4RMT;C4H)9F^PIS>^O;*OJ.BU?&J(FO<SY%L$?)=%<>O$1%^F
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M.58B90%J:Q&<0&U(6/EY*:!\.Y("4&@#KTG>ZRM\;[:8T^.-\E>;(&N!9MI
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MK<>^N$+'4TW[W+\3V/OQ$\19H';Q"0#U?G_48/$P;SVK6_!D^&.LQ/2 -W1
M+5E8S-4!P]+!I"Z%UM6B]1+IQ$G)UT[LRF\.JU#@V/H8.SK^[%+51*Y_B-<Z
MU /(:Z=U*/J-@(>-A '?^[C5:'G^U9FB@=7LIT/]^S[U&)?<Z1R[^!)]76RX
MYZY/:,_7RWT;9(HAZ'W+D%I)C =\52AMT:E]_M#T'Y[1'YMEHXJFM=<EC/DU
MF+>%WR;/33I7;=T6G++:Z\;7%]6 ;N,CJ[;5.U:02\+G"2/K%L$!=O-PA)<
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ML1:R?BZ2.\II$Y=]TJ.;,B@=MB" C+5"=(Y/P\I=H;1:#A$_PO8_DC2 #&@
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MVG/LC+!.C)FL&[ TM1XMGUW*4ZNN&""V!T@"S<_NC'>,/%BS/WM-NU2:X9)
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MRMH_27VPGTN&\F3NTS&3V@5BYC(U-?Y04KJG 2[?M?@^;'UMS8FXFUYKG0W
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M!V"]5'*[;F\^:2<L%K-0>L_H$^K0^6?.3VL>$F]<N'&3XA)@=+B"K$\ )^%
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M]52'ZHTEX=N8(W7W3.: LF4YKU^-WG9/Y"D<YVP$SWAO:MA.Q'&;EY549\J
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MS42'<+G3JSZ@[+\Q*?LOT5974E/TB]W':*+WZL]J9N]P15QA%3\2T:W D9D
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MGE^O.BT4:AX'X*X._3-,OYM3KS/RDXJ&HA/\>J?2:<]C@%04C6T,%F41X"H
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M_+-U$LS(['73GT=%U]402X/4(@2,1"VTR63;;##J>-$4S#*8]H56"DL)[%W
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M+(+UJ#.E:W7SRBN/70L6)R-XC[5=?(_/?J[/;E0I#+[CKVEQ[C<VQ$RZT#
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M./Q1[*8!9+Z: S!].4#,UA:M,+PKLQK+ 1+@I*U8MT);TPUZ!O> T'@L5^5
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MS\"EE-:KOAH [_;@\B 7+_:SPQ]R46@>7A3KM5D[28-OL%B%_P@M<D$(3?-
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M$ZFBJ7" 73\;6\*TJ%'#/V2OE#[*,O5#OY&%V+,CV6I,R9\0-VC$>'0KZ.7
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M@Z'N';Z$LB@>KI3&$ PD7SY<[9U11>_?(.I.QM/LQZD+C;^TY8C0C7P/$?0
M^S=PEQ2]*P3*3BR_WN-JMF%L0GW\S3+,C7U;=W@Q5/U"-4E,[='!0WYEK:L:
MHI0X'FP_,T9<V(1@;,_<+D.O6K TB8N7'>\;J:&;ZG:4;MUD&*UXA24) )6+
M; ?6K(!"QYRMZH&^-Z'ZT<ZK;-7G;HB..CY%=@3QGT<@-W+KN#G<[7A,$H%)
M@OK=BAJE\G-M\?A W8'I0XDW*0TD3/Y4@QYY&BA!% Q:*0EI%J@@'/1D- 13
M4VQ9DL,C!D=\%='X+"+89"D(]S_TBI\J-'*58-R8(M#E8XQ^&J'0&&0FV^.K
M)\2><MWEW$*FS0">9C<F\6?3VW_^D1O!7!]:/;PF8M0&&29Y$/0E[3K7<-*=
M*N+4T:9PE$=Z2@,&PLU+KPC+,PN<L: V$54$/.%?M=Z\XR+3+" 416'JC@WN
MQ9U)^+EQ;6F3$U&E@%\G"J,?V\;-</<7-Y!2!++)4^\TT[B!(4P#]:<W2)-[
M]U]'&./?>]B.O&C+OP6&7Z&3O]GR'D0WJ$T>6NO!=A.S<PVG<*FYV4Z5WB='
M0]> NO)QH3R&]OB].5EMSR^ RSF24"E@Z2G7S(_"U>78B8=(%>,UH I]Q9Z!
MQ4*=6"/>4QR/KBH"[1P.;^K,<$\: _69!.[':PM#W-L>B-#U?(9H(GMNS/Y5
MIPNMLPFIRWDW;.Q)>=J?DT$#ZRKWV,-,/;2N2 RB[KQ7BFXL0RDJZO;U!=)0
M'6Z2.WJGHXT;F$(^J#]]V+"L)8R5=ER,-MN- 9DL_OA]>(@/2H\'VC*E %ZW
M?_JLX(6KSS86FDDDZ/KOQPT'X<[$7FU<>Z_I,!'-%^"PFU: B3T'KI@LRK6W
M99+LNZZ-#R3L'C)[[@%VU_'Q!;(]?Y3ZGP@MEB<(&S+UG2WQZ^*@GY3=A3'E
MYD"H8Q(AT68V.<AN1)1S_)DV_5* AN1* H=;N]-]5M?3VC) ;JLN@B' W3D;
M42Y.*X0:,L!? I(A%(N9201S4%^"89*X))]*40LD +2;"/55XBXHJ J]@+(C
MU44?=/>"8CIEX@DLP=$EE4>@ZQX)[WM(@(^L7GLCW7A7C!:2P!T7O3BBF^IZ
MF&Y=:WA-,4&"(Z4<N#3W$S2J\!1H5+G0Q@9N*#V&!HRL=08D%"@U ,S1!C7W
M<F/C7>>K:$/MM^V.[8#J^QWOGBXZ*]>')Y'[6]*K@A<Y;D>P^T3=K;*-U:X.
M08-6UC:4 MG&/4I:\;\[YL9&(O041V*(%7@KQ6=;NLZV57IV(T(41\2!).I$
MX\Y7O88^=0EU=7P^4G9$.OA(>87WFT*;*5(&!QJ*5LH9#18FC6J,D1YQ-\0M
M2>E].+;2>ZT[''?@;_$I6Z0 \8[ID>)5C8@O.-]ZD/D0,(>_^Y8"\=RJ=.,S
MJR_-\2M?Y+&!B,HAIN:6_.M-RJO#OK3%G\79B4<4D?XT9XJSGEP+''-[B6<3
M#AY2,ZU1UU0D\VM%YO03V\9NN^^"!EG&]*GG!J<9$ :A068R/OV_E-DA#G3Y
M9EZCK<&258@ @^#R7KG<075FC ?ZJ3E#O\]3&>$$=)J-BYHP4((OX3;1LA!I
M4%<QHO*I%+0/I.*R2.:@D23,@\ EX(@=#GZ5[J@&:$HGGC2#NDKK1([2@.M0
M(X'?GT0:%>-/ 2%LY!#_'9_$I2/QF>'CDU\(79@V")X@,Q<:RZ8\UO ;DYFW
M&, B9BL69##-EM<@/.N95\T8K1/:Y!4)< [MG\./0;U]?0;'UMW<2D+7,@F/
MUE_O"O1J@C@.C8[I@\TU$*D;SA5:YP>FZ$8-2@(@D68SL$#U]W>_9?;7]4 B
M,Y-$?;1S-QL:<K*Y $^&4I+=LV*H)C4$%%K_OL?GG+U:5.:9*-I[;NN.V?C9
M-ME8:%H=D28LU\0PXBIPF8>OV ^U[R#=XN.1>&(1\#6BBN+V+A<WB>X2N"*B
M6= D/T^<9)TF; /#63$X1.ZFO!4CC86V4Z04+I4_N'NN1:%7"TZW7S0F.RG]
M'OS-VLOFIGB]R],>4!#W)D!4G3_YP(H<[)V.?BVB$$':J27;$,9#4^KJI*0$
M&E+HGR0X+)_#5?!:Y?E!.> :!T^C<UE[X3SZ=2:P5FRKSG /%(L@KLO^A ]\
M%56IS4W?N2?S'I($C7C!$42J]IE"Z[S .[I)T(@G';AX_1/4=M"(A]IN^KQU
M&! !/2XR$OE55*[2R81^>',A]Z"0IJL9A',1<6D@$]6)Y><"E8=EF,']@9F2
MF10Z+$_!]#$@4$&=!<,4,=LA4.&X==0L1(H40')I?%JQ"^X"[*8CUSG<27>:
M:**..B4A/00V<9%79=\"\<]O 4?76:7^Y9/N32KL[[P\,!-$V8IP4MV"L=#A
MQ+:JV^Y[H*;+$,AR!8/34:L:HJ&IQ&1B.IN0C=:=BW=X1:E:81#07!+T('[_
M3UOIUB]5[LCSK-'.E&SYSPDS<;?G^JMSG4G:24E<#H9!\O&#!EH0G';+,='N
M_)P(; >B;*()CVC=T?JO$NO>J]B2YYY28#D7=Q(:WWIR=/C;#PUH9 S$CO'\
M<.Q6,Q'>B>ZDUW[;G3 &FO23N"W1_Y_5:YJS4'<4!^?8IODNAC9M)Q8A.OOZ
M7P2R^)G<\0<S%5BDQO^]FNT<VO!MX]HGBTMOF?HH^U]5 1UH3O H6J>'H<L;
M?"->*))+U0@3FV8KPC%W1"759"A]!ZVK3MAMYSHJ-CPT$SK_JL$B->!OWHLZ
MT_W4DPZ&Z[*QAH3J\3<[9ZJ\&;$@N>09^ZIQ[2];2VW[2\UJ#,P$08/IVC"&
M';(J4X-4VE9NGZB<:,:,(]7_#=@RARN]J 8. &FP43"$B*\>AQ38>EB(^+F<
M*T(C#WE>J:D40-#'944K&*4\X1J,[E?IC&MH@\CVQTTY2OW,H482?S"),":&
MDBQH8LW$O./CN30D-'4)+_,&$J+X>HOR'/Q?N?5IFHVSOZHX7S" !<F^SGDO
MSKI2)QZP5R-K4E*I4* @XMG8/8?4M&J6:-I X#^ME]1@F'<AQTWUE7RM% #1
M]0]WPN S4\K)ANQ,8&[@+KJXUK-MGD$D!Z31.:Q#9\KF;4U3X7%POH.RA>LP
M@,Z=C;ODV<+++[78K;:O3R0BAC+;,Q$?80""T^J=26JP;[H)M;-*2'%BCHD#
M#_GE^&Q-!U]/YYL'U/^599$(W?136^DUKQ%WHGBAEF&2:X@P6V3U^N1T8_\8
M4Z0*FILP=3FWQ"EWZ\GMF#4@J!AGRF/*3]R;R2$KY:2&[9LNY'BH5D>]E*VX
M0T2?@EKBYU.>;34&/:.68)--[\?TJI 8Q^TJ(VZB;CI7%/H?A#B)HZO]_O#C
M;CFYUGBYH4 2EVBJ<_]NP.X'BU?AKW&)66(I8%\TGGP"97LXM5UR,M%ZO\BH
M60HX=P#6A89)#9A$'>CGC[,ZTMY>//7C^RL/?,WTO=M>L!?YLP;%81^]QFPP
MG/F5#A\-T%.3M5!/VN+@>MH"[71P_2:-,UNAU$>,*F^>F^9\(K>S')DI8M'I
MW<^.$Z<<I< #S"];JA.6/=E.-#\3PLC%'[C4:4,P_ORI0\>_?YM] '9,@C<?
M]?ULPHB[+;2,L'B/VG 1M<9[U^];W4N-;_P44WQ']4K\8*MOGJ!9L;F>^> <
M>P13'A]8XM$*,G[L+TG^M."^@Q]'?>7-Q&ID)D.4/DJ[XK)R GU;HO%XS.NS
MU_-3S@\5'*H]J7[[[NZY0L$TR4F>47$?$,_<LX3ZK)_6/B N2W*2O"N)4SB6
M4?_I_**JD@2C&&7+_4WA -9E[8$GMW_1B?OP !%\]*6HVG2B+N].QV\['D>M
MT^IO=C.Q8T1)\$9?*(J5&SM$/J/!*0RSH+HM6R;TUI4>-,9V'7U[U4IIE=E+
MTV]X<][!T^X?/^Q[H*=$KB]"9,19!*!7R)$N6;XN5KZA^\RU+*AP3EZH6=_2
MUI:BN>7Q-S:%S#L1(+_,43.5W6AC<;KC<>+^]MHFQZO D:; KX#L:%2[=,8A
M3NVS']-[;?9NB*>V$HX,2X!ET(@[J:&23'G=,']Q*UE;)/CQA,]ZY:_%C_=B
M%I<G)%KXX9[1=G;?BGBE<7Z56T]LIA?-;@3J/@LS@N/?!%_(_;:'8+[/+SB3
M2TQE2_RMU"I]DTCK!S85NZ(<F*"3&"L%LK02CQ6'V,RUM[V)G>SK ^:K0ST(
M6^A\</XB?-M/L9MT>;?5ECGDRK%HIUZ-%<04$>9^+=;4^JASVY;NU;N]HZNC
M],39I;F\;3BON4Q=P030=>C<CMAW6=[="9,7E!:X28$@#\40>_S=4T45RZVK
M!@YN\!(5/CG:]2"0Y4( ETF!GMS),/3/UJ31PMZY[!K6&=);84BTS\E$LQ_'
M'A-06O--+2U:FUWF28%+!3^35K&]LL="ADJ_%"A\;GIWKXP2S/D2>U.-)K#+
MW!;(;U;\ZE"_Q="D[=-IFZ9]I5TJ&N8A".9#6W?];5K!^XD*;+6HTA(F]'P'
M?EGY/O[4GE4IN;9*Z+7)7DE]A<J[ZOH*N+\7+ E],.6RIZSL_80J(TL[H;6A
M)W^U=FY@3!B!'JG\,_(%?W'(HKV7KW^*5F5F,_*&P(6$1K7*NLG4)YFN_M0"
M,D,P4? :?Q,Q^N,PN@JQA!VQ_'Z$XH?*]<ZGN@Y=?)&?%?"V6$?G_+)?E>ZH
M8DOE-:;R4^RDP%6""//!S3$#_!1%-;+N65EB>R)F:944('21F,\ W-O.-=YG
M7B;XK)9@]B52P3AS[O#$RB-LMY_K&^_:^4]P'-=!P]R<VT+9H@7%NA'A4^3R
M["+^"2^FJ"2R_I#%X[T:=3I#LE5D03M;II0D"_5[V:JAZ1HJU*[%* 7;#0NT
MOX5LW.LV"5;$>R"#OOEWI /B+8_+3MMOC7\;:6W+^<0QZI8"!3_)IV6VJ]VL
M(TP=#/.G(IC9^;Y5@NX;Y8X^+TA176H5QN</[[0XSEV7\/;JNZ@K;^=8A C2
MN]_OT//.=%(;?W;WYE9M#X6)&L.XSCR@/'VD<TX&QF=I&.;BB47*%OB)7W]?
MF_;BM=%OIWY@S&/\,,_\,D/PGO?T6\(IW4EL=[M:#/_B FU-2:G8OWLER=<@
M:W^K5[I6#KLV> 2\$=8\[W7BYO4UQ?%.<C$;O!,ME,ET$??';04Z-U\E5FOG
M&\3(O8KA4:7 ;P2:@>,#NG?+[UT?5HSYE]SU'YY0%X9\>3ZR<P&C.$Z>7(?=
M<NE9%M96MY6.N [L"L%L.+?^FT>3\;6ZS50<&A1?S+337>A1^K-ZT+(G1XVF
M_(\->S]3XW$U$(=N*9\\KW9%,VV@H,/FOMTJG7T5=T//Q002Q2^8!0^!8^64
MI4]5#'T!TWES''U;DQR>O7F=\'NOIL/JAKS?N,K=3$WBW2R,WXM=1\[VUHW<
M%=SQ8FB6$YPD*QH%%8-O_'T<]^UOXGOWG:XY&\4)".N[,<P[!)P^R,SD%R_T
M-L:K\P\;A$VRIG"7S^H('7ZK]M>H.JJ8MK0C#TOSPD+3#KF3?-$@P_+ L>V4
M^JL'DG5C1E4<2 ]=:3D:\XQ3[#*1'ELG=VXH2ALR=?(@]UHM/_W-UC<H ?U#
M4;2:F\*P2X'E"TAB?&C3N7D]JV X+5)A<9\!FT[$BR];O]6[?/#D-M\=F\ZF
M(WM5N3KOXL.(LK7WA]MM[I57'NK*FCR^(5*#!MJK0%)H/'MQGOQI_,.-[]<1
M&A.I)2)+_]9'1TV,;E/TZ[%MU,]^$10F,1,;RK+=_LFQP7MXS3'YR)^M_6/B
MPC+Q M:[4]^<W0>V;BU&E"[<OHM'K<3JS:&Q%[67?^5!R9U=9A D&J7 JW_C
M+UR\-1_2Z>"W0IG*[K5>W4!MRT!PZW7!7H&D"!@;X/?PW_'3$.5U5"YM$!+J
M^T55VBO3=P9FEB(1+MRDJ8D'<A'-J+>?:L4?I[7]A14SM;),5,Z\X3YHL/^-
M>ZP3<QM:L574)[&\\.MJ3&.AJ60 RJ9E?OR?1GA(:%R\K8UQ%-U@*^Q0S@*/
MHBL,8=[$W/J!#R3%*TD</U,F 2<SWH/@DGH)W"A]_Z]6Z%]JJRK:#-SLV/+N
MU\3V.T3'I$Q7>1+9OG26*_I>Z4FA5U- -PI=7\<@AK)$I?=@)J<RH6'IXY,Y
MQ\S>+J^3R4_:PZ4PJS4W;Z87>[A,V3N-!JE+ET'9KK5S\O ;7]Z=X[/&+C.)
MALJJ6,!JU)^EE=/G\+UP3:_[<%Q=I5:"2ZTKX9'JWV N6/"(]LBO(@J?2<0W
M85\(N?NK1'?F'=M4TKL]0$5=$#*N6 "W5@_OYE_$-;WLDW!U%],)+@VN4)C_
MUAQ5GB7IEV%R=RS>X96=_T'Q;I^K62V#1<_=]/OJ,V\*UTDDZ$:Q;(V'^K8W
MT.5;$1\TT8XS8Y*YD-2'J^J]LSW6F;["#-7]7YL4',S#^YU(KUW\_6!(5&O!
MUUV\![,5\Z7K;\]]2-)-2.*.AC((.#_P%,SJ!%AP<7\?;5#[,#<VTU5919XN
MZL-I7/A]=>B;0BUHO#:*97\'_=,(#U&^1'06(BU)V)")1THJ+$MR8:[LIOTN
M.PA/GV_'7_[#&G6912H$W#+PF<FJLQ$-V+0G4/?[HZZD#+=CCQ),:(I-A(9:
M*,$#B7AG8H<#W$Y].)-EGG*N7(68GSP_- 7TC6+Q36C&QYMP%D$#;H:E<+BL
MR3N-RMN.<V')=E"068G_900&=\_!YZ'OD[C+<#QY,OI]$MMVMK=0&O&YL&=T
M.\Y>47V,76/#^A-35&]V7<FAS+A1]PO.A89@/IK_K_ZJE3+\S??!'=:][K''
MDCL><#HR&:KJ8O/+C7"'8I;;,*NJHS>+9CMG\FXWS"N0N=0S#8E]*GTER[(/
M56]*2L0PZ<7W+,T>P(DWBV6SP6,S"X$9,UGU'^ ONH$S7V9TX/]A=.C,+"Q=
MT[^#;LLP!2O^H!_J;\#63*<T]S',2X4Y#?(/N':>:SW;=IW^565S;4U@ I5.
MMCLRVQHH6PU%V0S]D!UQIDPBB98^TQ_XR[&W; 'R]=8=7B^W?53H#55MLD5B
M;2P-80[%M@D(0*]$:=#T'\H@5N#*#T-/ [,3;LUR*1[#2D%GRFJVIBE"(\V7
M!37(7Q*"EL%,@BCE!LU0"!I8@/;9!&*8'A!UH*Z2QA QNLG%*Z[II]NT.:X!
M7WQW-G5@FHO=Q9>ASTA2.%T5&M?0[<IX4H+-D81[](D$X[Q?/[D8(=R]\+0M
MF5(@>E#P;J91"ISJ,EF2^$.'*_,.*2'E,4+RH@"1ON&<3JQ+5A-:D<25K/D:
MJ9]:/?2[M>(()Z ",RZ*"Q6T_/7%[%D1#B+2UYXNK'E 2DWBE6B8XQZ0PL[!
M2DC7E%(:?T.IR.OV]?C3-$5NN#NSBT%Y4UUMBZBZ"9D(\L[S,YASL5 \P+_*
MP3DI6^;-&:X]4R])]*@3MK'8[_ T<K#=PB$IL'^[1_>()$HD"$D<,CC?,$<3
M]Y5-C\/3'AGW+.T?6(I@<H,F:!#R%L<O7:^"K-PMX@O+E<V527NFWFFMWX?P
MU,_$<<&0<42MQ')32Q33>M$ZY=5]S %>'Y-(J4_?J-AD=79^*-^,7PIU#EDA
MVRORU@IL=J6_L$'<W8S7GAJ_;[7W9U2SBZEX ,?^"B:(PAP>PF_Z#Z(\U.+W
MXYK#H%R")@5.X+^"C(-ZJ #Y^7NH=;1&&A/BWKNHR4R,-LBMSPR"@KBT1*I%
M,;V%NZ1 ?BF4Y^+18SF*3>V345+@=* 4^"@A,>RKA/;(!!*_O\D<AR]@6:M\
M]N^+@8BWS9_.%>,/ #XJ6<7#BI(7,B-&#-9D_AHQ@+B@?07Z2B/E03S)5T&Z
M 8Y.V. AP03&D4B# H?W)I_5,4!6#B^B%RO&&\6A[LBM.).FBLW.-8)N8C=+
M@7530?<-[&)0S0YKH.;@?<7'B\P=[L//I9MU4!W@]=>$V?\^.46\(5?%22Q!
M1=.;L9O6S2V6 @]4Q]@\RAX)-MQVB3?]'#"%C,.AZTFX@ O/>TA&2VZ!8$I!
M+@AQRTOKN108C]*TE$ ?22LXM\01+]A%T)0"X>,@L[7P417*?=TR'%[?Q0Y/
MO.-X-:)A]P:1Q+DR=5JK)?3]3J%LND('\:1[$M?!@ZHZQJ#GIA@)&X3N;L!I
M>-Y<5GA.:TJ=B$/C3">9Z[.6Z*Q>OX1!(I%2"/6R<\;FU2R()7Q>Z J6T;K$
M*EQ(V6DKU%"'YQJ2.IEL7#2?4/W(7,MNV]YU5! $]1$ILC],6:4ZW=P3A\/A
MG$%]63%(#?ZI%U:C#B),":DXZ(4"2RAA+$?=(,$^.3</] CLGV.BTA5X=W*<
MV>%!> BHHNS910A!/TE2/"$%%AI$9'5[@A/UH-AW4+)B"%'H4:<*X:^<6= O
MP!6=$6>@]E-%$TQ+O#Y](GM>#]^BLAD_F(P7=+>*]+3X<\NY4L"I<"H<_]6E
M%^J5QA$)!/Y@4YC$A3QHK=)6V!>#ISF+O]];.S\6_5F)B2BC=8H5N;*%U@K6
MY.&Y7$(G$QKE?!+UD?GAO7IVZQ01(&B"2)']O2G[YN'4W<HH',X'U)<5K=6T
MUN\$9>.:+1O7#1)+S_BE:TE%JYO $%*90&4 KUG$VK7DGL$U]0B1J /GDM+[
M9MG5=;O/SC?E\_DE(HIL4T:W-*75[/J^(%H'\RN8)FAIF(F:C0I;S&[JV"B2
M2-U$RY*79*<YR/)7VB*)#[%T.K4LG%,&MBQ*XPDIV;)%UW573I-8\^R$LK%.
MLA\I4<!@KMGP19V6@9*P=W[S.=SY!"[_11@3RBOGP3YI@\+^*)I^/ 6%8\O'
M19&;)3L&(VU24O?B28WT5I#Y:-DL9/U=A")O)YG9?+;MD4"X)&M84E[@[M_:
MQ8U7W:V)LL?YX$%(S1&K*INC:H%AL(RYF#W(5P^<R)[_.&*8 G6=5JCKL"0[
MSO#;<5#7R(>Z!EUTX1-X@9IH! G\4BJ:-B'6FPDLJ\55W.=BJ %;G:3 !(4\
M]0X&//(9,5ES/TW$86J 8.MXCN*P*<<:STPQA29NRD-@(;GI[&2B*:*<UC5(
M1>-'"+_DUBQ(B)8-L7+9$.,@H@_<W8.]1XU?\!D,:5H-B3)3!LONINS@3C-F
M'[.?R?U>L'YRU>WLY-54&ML(PH@HNK?E9M5V ^$N.P]>FK#[GF3/*,M^UDW_
M-HH_\\Y+7Q(8'D7=T_H57 BCD[E6! NX9E8=D2FJ%*F/M?*Y^TIT&UZO1]/Z
M!UD$2)>IS=]*$6M1"?@* 8([^.G:JFY)O"N5 CT*?V)H<,;IG:O^1[*Y$3:>
M%_/ME-.$(AEI3F%G?$[&DHWNKW>-FB%%1)'_<-,^8.E55U?9\X]P9<]/[?UX
ML\KPR?3S8V3/[SHZ:']SN5+"?'\:C59/[8=4TY&_ VYKY3CR&*:DU&.4)P6:
M*:]B$+HAGU7$ ="$Z2B0 M<M%(?:.-8@LP!'26$)H.G2BZ^-X+9F3H@HZ(_0
M;-DW,MUY3LHZC\MHCF)=IVRV="J4S9:4_R.7 ELY8O 4<$&Q=BN3! &QNGUZ
MRX:%L[@$^WB]]2MTED012*0,0KULA_&_A6P7-M2>H.!<M'-Q3'"7B/:1!/O4
MW+?S3P0NL8M3 4$*,MS_BI7"RWS:>)0.5@*!@$8..'/<0[ K"24%H'!,>EF^
MG*;SV:42O D:&G'$HK^0:K7S$Q2)+NMP$>(N10U%]#T1Q.3U!!F3,3(F]^$U
M[[!V<7/F+8E6X@1RPSF!-)?^1HAM6@;7D-!XZ)#@9;5H8SC(COP["3?CGEDQ
M%I&;CDPFAD((Z&11T;XCI+S<GG^%TL6?%D]>T[12O"#N-O7%N]0R2(^,8& Q
M@0DMZYE"*@LFU&(018RZ-5"#.C'(3('D#M"!L/"%.N[EZ8Z+CS4[QF] M=C(
M0S3I#&6QQ>\F=LP$&SG/M\B4(V=A,\)_)11(/-2Q>G/TX C:.TM"D?>J9/;L
M5N=R CE<OFPE#OP:^/1O@JAC^@W4F+2NGK'F"8'*JZPEJ, K\P-I=;1Z2(5*
MD.^6H((B=ZOW5MKC7'#*H8,B?O:\5TJ^T)1ER.B&1K)(, G'6L?R@7-+=9F<
MB7$JG_77(>U,:H<X.U<I LH8DXAB7,XH)!F]<#+)V"63C*DB<_I]Q;JD)=%K
MO"@\; DC+@M5_K=P:9;H\@3X<O^0/%) IGG@>/P'FR@N]>-B3[F2OTQM;5)#
M'2"9DE*A[Q)"MK2DE..NDF:",/VE.$L%ZH-X3)-C.YUPEH@K O;__UQT*23L
M]Z2T'.R;H'4POEIB55H2X: YEGBC4_G,@J273*:(SV/,RX E9\WR;@K[<V1-
MUN4A:S($]>&R.1N.3%[E4R'5@-\E(C!:LN )'3R&0F!R[)7E:6C>TU"Q(KKU
MX5+JUFIW:]0)]=HV/OH]R9<UN(^!W+M_Z\LS\]:OX9>R6]<,2P(<#TT6@1=\
M'U^1 EMN[#\;1>LE<-\ QS+>7L U+OYZBZ9Y[HFZ&.=+1C\\EF%56/@3Y?V$
M7L,!I<*W'8!9WY"Z:P$NX.*EZ)9'YSOE',ORWPUI,35+13C*C;7O7+[5GBMO
M21GR,JC37IP1?G4!F\6RTMSTQ>4SN<>C.B/M]XB##%^5K_=7^IU_07)7W_22
M)OPD3_A(60->8G^F5DF!-9<MNN>SB)N??!"M#*I977G#93NU#E]YT$V4DRFJ
M>'%\&/%:/Q)?B"LE=SF'"E_B5K_?R'$/-GF7DZ1EK2TYI6]&Y0ZZ7/V)I(PT
M^@)^%E![*=&HE9X_N2SVN5QVZ7C9E0_><\OSKSKT^VK%.4Y5O+@,B*VGM@J=
M<6^[EDT=(8>>4XGI6O+T0]&PN=Z;GYWOIAY47S?'NRUS1!P^6=#0_5E_,F&4
M^D8*K*;F?.O:\*QL]$W< \WNP^E.GY%'2G^\[-V84-0748&Z*R S*&U&DV93
MYWL=&P\(>U=?>?C^8Y/UP9Q%UC^E6I\PWEN=&<-L':7VXX?XH\6]4@"*23#G
M1>>+UN2TA1[]/-)W\E7[XB>WMNV^_RM;6TT9H %K 3%>?!>W)4*[M5+SJ_/B
M4=VX(F^;8T^>/?_YD@:*$5&K'6/],K]C=+_B6,$S5_KO7XI_"MY7!JP*C!]Z
MZ<:,F1#15G);JUTB*8HHY0Y,Y=+1U=%%EX:\S7.)>;IWGYI9N/SB@WLVTGRB
MLSS1>>1";]+&8U'7%],*?.[(+>QV^9V@SMH0?.2J<W!M3$WVR 8I$)1'V^6L
M/W:0(06J56Z$>;_GF7?=G3OD7X;QX2=DSO&/B;,=K!5QG:.^9+06CA;';GO#
M*#L9&GBJ=+^! 6%N#&>38L%;FT?X+:V5F\=,:L X!T^>X:%?+P0+WMT(QWQ*
M;7!G^+24]RU1Z;5"Y 5(@:H#N W=%X\_=UE4N>PB:=GPEX3XYW<])N\"JP I
M4'M4/BJN9*#4L7MJ4_<;BM*E%UA"',7#^U+5*>S0MY3CGV]D]=FL.!\9$B@N
MU)ESHXZ/MK\KR!C5[P4C)9I3^M9EH[3H(K'B46*3[HM+IC\C.1A/7 #:*1&_
MECS6_=(<?*VO>,E8LG[T>EPVKNZ'-WE.!,.>C>J^1X@Y473%&&6].81JTFW<
M@JG&[+9!9[FQG3&"E/@D9U984,;#..O#7<=N<[E9U6RB*'T*/SDLSL;I?"7*
MCZV^VC.U\[=+Z49M:%_CWY\[NRD7^*RRA:;\(NW:/M($/KJ :5-]&UPAH8&J
M&XM'-4O] SU^^5;E_N1YTM#82R)>\-A@.Q!@,2YH'98"PWOR.VC"K9W?BL>V
M7S317'[PEGW P(6@]\%F&O7+;/MXV2H#KI/HJ7=C\B\KC1+Q"T4Z[]TQ.ZW3
MAH:W<.QN['M[UR3/0HY'62LAX^:(W,:DP&N\\F?;+^SH%X1K)ZQNWV[WU;O;
MSBLI(Q44RZ\434BJ*K6)4N#+RE<=]YPN>=WW$+Y%?N@+8HD&!:GO-FA7)_^>
ME/%<N#YS.:&G1E%7LZLS;\Z=^,Y]@>K/6PF%6D5Z'9J!15$2+/;2]:F:'4*"
MPL4 YU,V&U^UV\UYT9_)=QNC!8[GO_C,/)PX6&]\8Z.^I-"_EK9F<H(-*<P:
M"SV'EV&_IRR+E0+G4_D/W,@C<?XQ07U20/!5GG]]:H]_'F4X%JE_:?,)*>#=
M<<6CZ.8K=L3BTN&JFGWX(T3-E.#8"[YNN&K]MGOBMSZ*J%,><>&34*IXG"L_
M^ISQTSO*1=:SLY<F&TV$[GV/Z$M,-B6\-&4,U@F.C_?W+D$Z]@X>_,UD;<0C
M7Q4VH[]F:1AV)(J\0ZXP,)L:[C-V*2PR6?'HHT5]*]<]5:Q_?"90;%;PEM!.
MFSP]*@S5@;X[2N.@)SN)]^7@F;UI)^?M%T.\:ZX8<_GM\):UX>*?!?W/-NT2
MMC"3VA]#<]%=+F7X$G33=4&,K5O"2^^^JHYLU\Q1_V^>\MP,R8**,;R#88=H
M>X9+LF/%MG[W<)TD9JS.UH6)!J:@AS;YHCA]3/%6N5EOQ0\#PM>?'Q6=ZYJ7
M5/\B,":OJ<L@ )4SRH9D)K[*<ORLJ_!@:-F1Q!;3[.1N^R/;>T;:+^/VUXYW
M6(RB#X@/BI]+5GE25B!_2&Z).$#J[3L2SUN=G#!RP75^U=T;'VO/V(KTY)F/
MPB4+=^:UAU)_'"6_8LL=9)15H$[FG-B1X6I1G*)35?5^W3<_1?D"-!KU'M]S
M#_\,W;YMF128M!X+/+&OI*(AW8K#B$7KDX:K(A6?8=!5!6MQ;TA/5]U#%3R*
M\#_M^F9I#H:>91C#,P&N[BD)Y;L[A[*=;^&EP%RG,<KK]DYT-;Z05E4U=I3N
MUOR,X;23*(P8VGZ7FY%7I268_!)IF3$9+ 6N1G^M1(ZY5:J-=69J*E!L/!_2
MGP%G$M>LVK=GC<MSIYY?:K5%"PKR*W>*+GU JO06C[E$CJ=%G#[ST3N4SAKC
MO]O6TG.U*T)CCKQDI>BII)FX;2RY@"'<ZOH&H7)_RO&+1:.S440R?8W[R0WQ
M13=I7(^!P82Z E9QC\;33MQ;YWF%\W<>K'"M?AJ=:.=3$DSLWTZ-R3P38(Z+
M1.S -9%&CWRJW!9*.#I:?'/\V:CXS3-JV_-.W3OMM[<'"<^_U-5^C#@@5G]2
M&?J34N/V3]_\NWI%M5;^JJ9F30["-C:=OE/4C'M'42X_/FKQ92#KR])[4N 5
M>![_:UI?8L?=Y=E9)Y+Y-AX3&O:7>"Z]BE1+E=-3>K[#^8DMC(,M*YFEL7=>
M/'UIZ\I-RKQG67E'KA;W$7R.I0U]F%0#AVP^;'MF6:^.<V;:O!T%6X;Y<Y^(
M3O] &WHGW/VM>V71H^,U*-.KODJ>YN<)D]=25O?L\WJ2=B[&9_VE.#!,T:6&
MLA2U8:I!0@?5O,?%)F]"B.L)^SX&'_+^85D"H4BNN*1FN<:+0)>*U5)@WK8)
M1!O>:=3CQOCX[5,?1&:+,S?-_\S=O^%Y@!%7\R8^NE@KT KQ Z[99?3HZ<U5
MN/6:ZE,VO?,K=;^IE=]-V7>MTY8Y[X<E>')[1!O5B\MRBI,=HZ HOJ_5LO%C
MA(O0>"IE+]W507_R^DCJ,KU>^6"Q%&C?^M(YD'!*]&5T(&OL]J3IV#BO2W=J
MLV:9YT[=%Y)/Q&#N>D)CTV@)(7ZU'_,SQ0&Y% II+4Y%AN14]Z)O'Q^="A!X
M)G\\-.?+._*-W<?/QJ9VN"J(2.BFR&T1ZZ$.1W0,%=:LTER*5]ZPO+.#ZKV.
MX]=<6+*;+-%1N6K4B4;=I_S87UI<^?C9^P>%+N,WM4D-FWDFB\:X_L4%^$>X
MP-"#U.['<;\\:M>-'&<O:@\E3AY+?#N@M//G8*+U*U-?\$8WH9?MXL?2U'Q_
MJD6)_ZS4/EW[^(WW&N]VJ%I8J;**8SS&5LC]\LBQO3)E<C#\X?5VDEF BFXK
MR:?K;EDO&5/DYRRJ]<.'G2 R-<K"/3ZG)YV\:'SUH]J*4 / I7?2E%K UU@<
M?EIW*.#*HM>Z(KY*Z6#<<4MSKM5J !7<7:1)&?PCCST(\]<>RE4V*R;*0:G'
MZ1>XB(E!P=&>&7EIM@+ [_W?10LHU0$9MJHZU@A9,L25)4.U.(U-<)/O;_37
M9D9)WKGQH12PW135"N()]\;'$0=.7.%FSM]#Q-GCG/$@;6P@:V8]P'..Z2YO
M*<":APR?SJ%)SJ]G^F8>,-._6(&?>LV6+ZK &DK"#LN?G9GX+KG:+@5:%H7R
MH(>0;9&0Y;. :S@_B<L/$[B*QN_/2(NM%L<L5R,5K:CR30+#$P.["][C5EC#
M4],@*_[V<TL86U,D[&)U?SJY]>?U"J_Z=JL'<KF<,?[T0HU/<&=N[YG43V*9
M+5 ^_4B&4Y?)>Q=<K[UFRF0R^QF<Z8HG+#L]+/]OB@8I,+ML=]1D".JPMI^8
M:>;B:X^M"14X/,8UDC:X2L*X1)D!UBSO-R.-/3,C3?T$NM,2#:$VQ-"F4^"9
MYIO5XBI."%;F_&Z1.;\%4T>-(^ZB_$%#*+5GVX>%XT/%<\%_V&UF@WP<Z='.
M*T)SA)Y<B82;65Q,UJQ&BCV!61GHK#PW");&WH*EJ#+'Z2).E@AVR1+!-%'8
M.ZWU.Z \-Y&B@V-K,8O1OX@NM,#RV(V*=02#:VN<0%Y%*8.8A<H\+.\^-QC_
M8(T1&\H$)5B+I)F):N>,9/0^K&R9NK)-$N]&HT#?F#\^ BMY7GZI7=^P'J0-
ML 9)W(^W9U0&@ T_[]DG2731S<<Q$;L&O^+N),(ST@=WC+\& G9$11!DTBBJ
M.]I@?KXLJY_IK^G].]MNQCWPFL#L&)OVHS N_\ .0J RU?)6)3/RU9(Q3B W
MD"_[V\I,^TMF<?R+0><)JPK0'\^H4A[YLS+IP]G0.OAGCMV_,\K^$K?M_W&0
MA%^VZ@ML[31+A2*L"CE;<'3W3/,M4:L]][7<*$9=1$I!B?KHWC.*EL"GOQ)P
M2Z^Z!D+$W<KQ8 ?8AT\("*]@B-.*2#.<[Y]<+P5"VN-,6?1!:$#!3;IWLTJ6
M[^:<#5BG; :-IU 1!:3^!Y#;7\HYP7\=40V]T(EAL<6]XSNFKAB4+HE6%XE$
MY3@7$N/-SEU""Y+>TA(<-[.@F(QB(+%Z  PR1V 5 O),IRUG)G  $Q@1=\$K
M!,$S2P@&?^"1]_WV?T<6F+D_"RP*NZ^]6N+/Y7+]^=/+:-ODEOXBW!7!@)Z;
MDBWQ&!O<&WGSO5A6M"N7N5Y&4Q/D _.O+[BFQ6 R!R#84Y3U[BQ=N'S^+BJ-
MU@BQ7K86S4W!.GIX+N=X'ZVS3WV2-0'&+H?A20]EA[FF];97"E0,T]3'6>-?
M8* QGEE&*#787"C6JB/A(4)P69VM $'?X*84 #/(^7C:J6TS:PQ VPR;KB_R
MUA),/V<UD];9X]\<)$#49,VDX^&(KU77UKT298JZ1)G<5G[@],*.F4C:/S_!
M1H;Y<AGF.2#A0% VOW;1.A6$+F@"DF3;!,&N_Y(8\W=QWXJS)Z2 (TD")7W-
M^)JD_VY!1LS,,H'%S"J$*DQ6 3^B E6*$E[*%DPXFX=+@2#L(6/X(HICOZH-
M*R,C[=\)*_TJ)90T*N* FQ6_26$=#=0%]4&2;!D:I$2T58I6U. QI H!H@]4
MOF,-KYH&P>[9^^<QGL"Y]1I&MJ]1/AE+%*OZ CDX)R$WR6HIK*J0QQP MXW@
M> 42B^,SH';7=LHUT4&<:8)X!)PN-1PYG;B?@4Q16$J7[6G(RVTL[/L\TE5V
MPY ^?4;9UN:2;95>GF2MR.M^N!(E:#9^ZFOYW'>ODZM/2[G  X#Z8,_B)(_T
MU)#-U^NT%<)ZW*8W2Y9MZ#-27W."D!K8#DT1L>:[#!.4UL^3"XX\?J%G:2:
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M5X65';AR>0&)^FC9K%< &YW&)]XAN@ACZSE28/H<JSNR(UM.M[?ZU9@'R0[
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MSR!ZUR;T36(NK7\"]<"3,)O*CIY :4F^_32<>ZC,-W2X=*-MGL?^E1I5-.#
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MJ=\VPC7F/2FT"L--H$C$2)2U,'4"Q6EQET"3K:  JN2H%Z#6!&H\B\O:)YE
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MX01OWA3=MV='6P/(J>;2$_EPP@-M _6E*7%]$>='6?S&3!F0[3A:1S*>9NH
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MWU]I-EDQ@Z9#H7 8W-*T*7""%INU=1KH>%PKD5+^>"Z":IX-" 9]JU<%.!W
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M$$*  )$:2"@)*7PG,,][#7'>F7FO9W[7]<U_.&?OG+/.VO>ZU][KK'OL$R^
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MU&05=-$]QH!4%0BHX?-6T*&\9'8/"Y,XUCX['#;X6S#'&<J\O)F3"?X=R/Y
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M@KE!]I[$^J$S45OGP^PPN@A8^R/H;?E&6G!F@&LZ,8D\R]Z]VI&7N1W7=\@
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MLF[6HUTZ5;5OM/H&IU:-8#-7A^ZW#D"5$8:8KMC^=.YFQE99A\GY #A>E>[
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M.XF'4Y93',&G0\7!!(8$MH?22?=JS]-/?[7:XV\35IZ].AY:IK 2.BV8N ]
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M?FJK-4[(+6>#:J'P820'XQQ1["&!W@TM+:,L-2V-'Z=M94O<"4N:]UEJ@6P
M;J[T6/B)1@1%81*7OA>-;!H&.--CO_F2W_$-N@)='!FZS2%I)$Z ^U+W&ZY#
M_5?C=YW33/N1L0EO>(GD)#T#8<-G'MK1I$2/YQ*B-5# 2LFCC9V1TJU?!!G*
M7[NA1SC,[9K3IMQ"UAC" I!-7&JRQ?_+D*.2P?5U7_?YV4;EC' -L]#A4A#0
M4NH)F,YOJ>\-[PPQR<'8NJ\"M3?3-OEK5Y& ]1:X4XW%M(\(\;M&7I*,,4S5
M+'9KVB"M0"FKKB9'ZV-.B5XGI'HILM9/+G<,77TR$J/?]1QV]8?VPI(DJ2$,
MY?I5Y=VX-'M)S_15^\KK3<)]W9I14RIEW.;'F4(\/[<YV;>I^%(HMB5-I >Y
M+/UGF"H\CD^&]L'\EN0F7&N'5[-N^86T&N5!$TQ )Q_ E/(/GJKH('DN(!:0
M?P)P[U9"TK\+<'S5B0V0RL?V@HWU%!RD'=^;J,: C3W'LWLUX0AN6>U#5^H=
MIG8K]/LDE(-IG\GZ6V#Z/R*;[)G*(^P9JP-P4TVX/R>C=^:=';53_7A3EZ$F
M&(CTKQ"G'HY3(_YX!VZI DJ?(0#8+FE!9 I)-PV]LX](_!#I#H$M@LPY\=J)
M34#H5[&3Z %"_S/V7HVN]S=ZGG$X0*3G4B4I^^K'M\.9S,KYY29?JXUX<5!$
MTO?3QTL/L4V1J\M1%=7<[ZUXH7&\YL;JM-M^(1RS'&C&1I#Q2AAR3.^RN&)L
MJR6M-K6U77>.PO "<&UC"5IU$515.<]MO)6JAMWY,(5/S*UVD'R+!66?7\60
M602M63_M,$'*KDADJ3D\VO^V0U*_?5M7*KH*_UX&K1K4.43 U.71E8(_[^PH
M/Y\]."T=9FAGT#6&1$LC72,70=#1F GO"?$3(1J?K@Y!R[4L<>S9=BALS"K7
MRTW>:5=]\N8X25!]6)I#M*#N:O@+L54LZV";1=#=NXCJBU#[L>$V^+[@X^TO
M;D>HF;#CO\J;FS[>OP/7/5A]*=W/:^S*(F@#U,V,O@\[L>IE4QYK!STNV_F*
MMTYYM5M62.;=K9Z2FJ]_1'\;1TU==4!WL ("UA">X[M3I=:HIK^XO7Z])VL[
M:3OB?@B0'?)#OA:^ 8=]?!EXZ*.<;H%(LS@L"8]E]_^8$UM%W86J]Z KE;8I
M[RB=WKXM?\..1";_Q,9"-RTF8KZ HY77;M8EB(6@6W"AE,E%D*.2L]+INA<M
M&H_%,Z[=UGU_;JW[KD9BAGKDH.6X8'RQ!K6'@#\6=#LU1:O.XK6\,*@/?"2-
MHS<6.7TQ1[=W6\>AW4I;3U2@'YDIG!4+M;@MM4XX8,%<D,:MFNM^S%EG^XSS
M+6/;U/>GS_WOTOK7M&0\[WY6_"6Y7SV+<-?*OL\:A"D-0O8U2L[D]<+N+62@
M!W#@+F?]76V4<9^([1'#S+,2^3L,8'L:QM(BT[P7$)H0\460.[([L898G'@?
MOLT)#L7>S9LX=%DY]U/L!P]T9?N->UO5]O0K/ GI3?=\Q,ZB/YU&#9B%(QQ(
M)*6M%X+2O9V:H"BQ:ZHAF?G=5P,'Y^<G#"#>Q"-!J(*1SELG MAD,C%'IF*!
M<T$OZGGSW7:KI^[*S$*30I^&JL8))*?2A<%? KSM?'A;+X0>IAPG?^5!J;?R
MRSMNF\;AEV-,X=_?M MV\DU#KCK**@'7A7.^S)T>( H$'_VF+XVW/C&,=9Y[
M[540+7"BR0': -AI)L?3SGZ'QIX-$1#6C)XVF;NUGN62W7OE@*5/R?N&/=+!
M'_*978IZ^1WP0ZR(X$OL%YB^E[ "_?Q=Y#I(Y.'$1S/KM?E.2UT.$)*W_6W(
MW3+OS!UN5QC( \C415@TIA!Z;P<]8 I[%%,PW8N2?[ (JCM@/%SXYE:$-/1C
M4#Y2^:2]!Y 67P%QLE2>MWR4N.:Z6_ Z+#6'0;G\9316C9U\S<7(1K>K?:U9
ML1&)[@.D';-O(/1]\)?MH]^A,CYNVQKY3%U3S]R?V\XHOMDC&TK*F\T3:P=N
MD5B4.,X<&(. 6>[3%\C1842LW6[_RI8$-3<EJO4"'Y[8%@K-9=++378(-%U\
M?YS0L%=(+D.PI<=[$:2=+SW<VB/5:*'LRZ%>E(@^]^4WX0"OFCGMD>_E+G-^
M]&=.TQ[] LAIX8'JMY_F4CT"1UNMFD0,=LG'MIJJXQ2+X#9P FSJ7 ND;__6
M#)FIA$?!/@./4Y,*TW5,/Z2<="C$?$Q7VHY2VG^JOO>R^%'U,/1T)K@;;T9/
MSJ=NC]W@$WNBIM+K\W2#'F9;T:ZLH2<UR .R90;0<#G6]!CLLUDH"R!!:ZZS
M7TR>LYS"?%+RZ!>_XU]CI1/T6.)=@I;\T/D#9?'ICXSD?4=:?"&B-P$?R.7@
M5*^X;%T$R1PR>Z2A&G9H7..CJV__9HV"?>*ECU\U4-II($X&:V3[AK:3,8$O
M2%ZS_?ZC"%R1>&EYDFZQH]L.I()#.MQ2YG;IG."")RP,\@'%VB)"^;0M%WT/
MKET/6&Q3\HW"RRI7:PL'QQ6=3Q]HY1#9SNS>+QYVG852)J:]/Z^.I,2OES\5
M>F?HXX.^F+A:3R#(F/.+ SB-5R,;=;B]B%50_1Q]Q':_@VM&^F73/9/NF1W7
M'YL7EI3%?YC(6,-N:+IE3+Y#U/LMO3@Q^^?9D]WVD=135-VHO2=5A\NVVB(3
M7X@$+&P;J#QH3&+[]5<6Y= %80@A_X]65O?:?2#[6F-[;3=OUN]Y<@JJ9QCH
MFPENA>!)<W-A<UX=IG%95YQO^]^K,\GINI F)'1=UEP%>F"6W%:1PQ&:9Y[R
M;YJ+F]I%>:@;X +/E8(^06]*LJ[/?Z-B'0>$+1>&&;N8(\7IL)&AA_N]8MG2
MVSC[OXE/&A^<5DJ,M7W<;"L"$I*6IH:XC&-^J!BP/^I:OCBQ"%HW1MK2&5[(
M?RW6RNA:=/0=2]WDK;_U>?_4V\VW\'-;4594^6N'+)L&[=9-I?*!P9BVPD*Q
M!*I\N;_LM\M^ >>RI6_>6KOWL!]KNK=RQY0?DN7'U _>W<$RFLZKCQBH,*UI
M<^HBWZNY]$F85D,N4=3F%-&]2(L@^EZ/B2/3V/K$%,$JG8W'3K:1*U+VR1A^
MB7BQ.2 Z_[UEV5%#561B%@AQWLL((?[<[JPL\<GF"\9]"%U:VZNK3ISMY64T
MAZ?"R1WXO1/QH3J;NL8F&/,<UUP6%/!&RVG$ PXQF^7[35<O2!Y^^\U(3$,M
M_:[G+8*1),Z3 H,Z(] 0EIC#G,VW1!-ZJ4\NG7:J*/DBR<;?MN@^25GMTXF?
MUU0YN H0XA*L>\$G?A%T'6G4(5,B>^VLY?:;::1LERN-'LHW_4H$UF_,Q(J]
M*:HF>^JF1;I-X"O@]IQZ#'KR*=/ \7#@J'B$QX#._1/^780LD9M\:65\T4'3
M%%A6][?9QK9<^_TWG*QB(H?6'CT,05P!%0ATEL3NTW[>T+"]+\U[9 ::>\[.
M9*=?QFFGES&T1/-3JX-(:0A4EI%LFNV'1]3/L)VC!EE9U;LB) =#C*CO/.HX
MRN'5AY4X10-N1^31A<6Q?4;;]PV[6D_P^^D)ZC$RA3/:>BGFZ3E,:UDKNP39
M6&4S4+3.3012H%"AF/;P+E4QX9!NP+6\/$\4K3,7<1!1J,(2EZOWJ]3[QI%@
M@:?63%06V/GH/1^[F*A_+>;%DT_#:WM']5\^&&&[\%5M14U=4(GDV.=?GXZ[
M.'4B<CJY[^[5PWM"-SZX5&WU&GRL$Y_AR+<0';7?=4?4SKM'[WG5GQ)&J2J.
MT/W>@>O\T%]Z\8N@&W*GHA=!%9NW!V^(?B$G2XQ"["%N6@2Y0.B[4>/A W<$
M/R&WC1(W%1[;VVJG\<8Y#G]SW^Y]_B]O(UMU%BS'D>.[@/<NT(YP0@G;V%C[
M7RW7"WA1A7QE?5H[Z3-3(E^N.3[: BE8F@GN&'N<NBO_OH=[7V&EMY0NZ3VE
M:E3K)[RHM>Z0R]F)W\)>=V,.L*.,:YA/6C)4.5ZP!T0TE+4%68-:5P2C'V>I
M]LL->&QN/)CP/:Z;8"Q5>TMBY_MS^PW2ZZ2#;E3NFT)$(_I^@Q3V?'6!@"OW
MCQ*%RO7V";DI*;23RL^YT^T,B,Y/6&^J&B@&D [614M1U;B3%]L?-GH4S<@I
MWHGKU&4*%SW[0&E2[6F1GC^^Z<.)T&</27+1[ )8LR*2Y0D\H0$[Q=5MEK*%
M=?0[?+]30AW"45Y<]<KNR-=L$J3(Z&NHS-3)O"!VW"*H+W\S/;7N,"*4H^A_
MRD2G#NVG>D6@+)U5NZ\$Z2L^8#'?J#NCG0GN+=!XMDD##YEXA_#2Z'D>5S-)
ME@E9.+L_92C2]=#:#.H@;<,3HWAS3[2?$K'(7W!BU[2E37LER*57=TKT4$*9
M;(Q7P/7]Q\OD<O-CE5[<CGL [17 )$#7(:JO8YQ3$5M'8> B0B"59(TZEX(S
ML3<4?M0J]W W\[*-Q/0($.SGKE[7:WZOV_TTK;4I]M&;0I*DS"HH6<:YWR>A
M]?1CK2N?O>TN, U&A<U S&CX4U:7XT<<2PQ'$G_,?MV/B+R2>._LI(I&3S%*
M&K^E<[?1PC'14*,KC-1Z2!&PN*7FM*=-*E],UPZT $&>*'QREV5[5.*/SD!=
M5R&[$AO?!S9Z_IG@L<#U"#'K3']*[GNS>:,S;#/RPH69]GMC@Z,QA1]FU8R>
MGO7*J)7YL);UAA$]9<;:@B-!L4$GRS6GB-7=T1&_6;^ZJV>H74[XX$T[,!],
MPYEY7"DBF6U$5%\ZE"H4?+4_KYOO[->)=5+Q7S %FPFV]7VIG*_(,N3 7"9X
MY-3 L([0QJ2HS")!MFO.H+0#A:3GWQI2DE72 6]RO7DRU:*83ZM0ZD>T\"HL
M8POK<; F$#LC.9W$M?J[K?PA<W<Z/5A^;AO;CGAY'+3_\5D/;O5!,(^O%_,*
MW(4GB4&WZD.,!J+43X2("!TDIUGI,%)O7A)J/:T!]TP!S9^4#:+SB6D\-/A1
M\&I##A^(UBC#IO^V^=/ >J'DO$/K+=^[WHLZ+X#'IV5X3LSF#: &YEE;*'/8
M*<&)TR1H^$BN\[:<![F'W(XVG<Z/TMA_0P>W5UH3?T[GW!VLGLOX(N@^0HK+
MRF0LF:9-5[_/R(BP=9LDMQ%V1>]048WAI SVAQB= G%RE$1-T$\(:^55%'?-
MVYG>\I>8-()1(=[?J<'350UFAK;8_ D@7\\;\AK00 .^?XDNW.9?21EX4#2]
M]0@_\%;7CHL?P*?Z&][LONE20BLR;,>-[NO%W #3]T$B]>7\._P%2?I1^N&O
MNAL'33VR=MU[O;.^[]['Y-L2&83*PE5,"^8Q>@$6OI9^E005];>T>M]&F3';
MZ-R=&V<=F9#1^OGRP'&I^F%? S&_&_I%=#ZFP"*HVACCO A"PL19I_LH$)?4
MF1#U\TQYA=.*$3:0PY<X1C33(Q=DU%$U&">$"[-$-V!*L/XP\H&/-_HAW?)<
MR<6HRV'/+QOOL E2NPOMN\!J1E2K*1<=F:ZM^XX3*E=UV7'E0LU,2;Q((%QB
M8C83/)Y7^P%_Q3&ADR9G?=5L7:-R<WJSI:+CWL!!4F?[HZQ%D ALDVG]<.MH
MC3]R,L-7]9F'M6U,FD^>##UU&E>#$(!+RKA8)?!C"MM3')7D'<!R+ZWNWBUW
MV"Y\R18:P0G0M0!LJL7.@4/]\>93.=5( ><%DXI<TI7:-WC=V_5B93M/%U&>
MYM=3RA9!WT&<9^Z%'F(-S_>9&':.RZQ;T_3!NTHG7 MX/SZ_632D\#==7W/_
M^Z[M/=;O%50TS%*,>@*5A^5]L4,PG#1L'0!';S+VM$&+"_.Z8>93/Q(@V@<[
MV\X:1F[ID2.0I6/:M<?HG:WO.00,VF,\CN1?#F$"2$D4*_SYKG/B2NTGF30/
MC_T9UQ@7IR )"GR3Y$B: >3[B90KA?GO*XKW_]"WF;IT<Z9:QNR,Y1  $%OG
M.J;]QK]FC@8B[W\?'1AN^W[Y!OI#:,N^0N>Z->;Z-TXNS+TC]Q$G1#V8EL&[
MRS!TO]U3FH]O%L9LK^R9W[BFZYY:94VKT&4I+0(R%Z&-FK(P>X J%@R;#3EW
M87H15.]4;I:Y(^5JU+5\>=_,?&ICH^(ZL/O,*N80D(36L/-9'LSK=+F+T^"H
MPO0KGT<_#_@_OVKX+3<]0>MK_&\9)[5)/P,[1_EIS@EK<AXB=P@IN6Y5*Q'4
MLD"9N8<4P.HI+%%\/W*B=/I836(*I@K:?9,N:E3T]/O8Z?#33*.4GX]@2C&1
MK_E0N0AC3$$7O6G*H9\]F<\T8AWQD+GZPT@^UKD=GVIG(6V0L+<L6DVR#"ZV
M:NXW_X1]/^XA1>NL<A\K*PL$;<'":@]EN=DI+0@]-T0?:S VE,JS09EU'F)A
MX>V0*4N8C/^; 8TW4^USMZ8VSG(^J$RZOF5=R.YQCWKT^6?!6[7>8RPY[L'3
M;S"P[F; A_SHA1%Y)DQC9Q3X[:18:\J%[T^EZP]>+[7=CQ;QW>Z@!X1^>(I.
M@U'<^P_1HP('=,B2<^R0T;>)=WMU3]58]/;J2B*P>68TY!"B'@J!]F5#/BR"
M(A #??YCE^C(_C)CT8EML9>Q;OSYD1[0:?I; 2UFFN4H=#P ^&G^J3RL9PX=
M894A!98V*=:^\33+*7@267_5JY..J0F%6E[L9-IL@8S>B(Q]7XK?+B]LULD'
M.7;VZ''HSX(="?)]_'+;-PB;ZBW,?U*U.>V-5!DV'7WG(.UN)!5O*^T'1?:?
MWM40=?O<YP#]<WN@0;H9@KKLW:!R3'X^4@.F5WMKT_5DXTF#&:V6FY>/#9SN
ML@EJ?*%A_>$8VF6B]>BLH-8<)]XY$0Z9JD3YY8UVJAH^J9G?8)VF7UTF"4)A
M'[$VL8L1?>]3PFO9I\:J,$('+4L[18;&Y<H+DYOD0Y/J[F_SOU-[C?13U0""
MT4ALL[YJ;"> \G)M.%54ES^@4%V]%YLFBV$[4Q=!T;!NN!C=E@06==0\"MGL
MM. ]+ZZYKNZE^DL1-?$S,QM>1"Y8TB[WK<?1]ZE@&Y18'OVX;L%S4V;ALR#T
M+2>S+'GFCG@A<9E%D.-M^+EH3.*5>:0DO(-8.#].GL+4P3?0:;(OIC4MONU7
MO#3;>:'(TEC./XSA<AOZ$-+/L0X-)C'E$=6G$6Y@L6#?:96[E8KT7MS%J9;L
M8M=QI>T%NZ>MUD>(VFJF,1A'[WI&;T2<RQ#I.(38[.]PIF-<6>[!Z"A!/GG(
M9KW:GE:M23/)0ZPCG.K 3M8NC*S/U:"+!2Z;7XVYZ/I2-4YYE/KB8\JRQWUF
MR9U,^>^5>_RM^A5KWI@@++XKC5_$GA;-2JNT=_<]"KGQI%Q6M<,G$PS;FM*;
MJH6\<N[-OO?K7,]-"J,T>V?9>F,7YT^CSEYR'U>_9JN#Z]8W5SMP9#"0\Y35
MRN)FI_DL3_J; 3Q* (Z3%>LXF.SFGO%U-LA8O-^:\>!0HBO:T;_:/8Q:OZ\K
M&,@T[I8&GXDS[7P+=0HY77/ER'4?G^>-+XUVE-R/'R &]NCW;#V7<6MK;R@T
M>\QEC2_X%0I]*FE5+O*SZKC.+,?FJ=.[PIF2Z!\_K._^,*^3WI QZ,U"L&%-
M*H\70:XH?.W<L>\32L'!/JB(PR:EAIC*2R^*(KY)B<3JXR5!]^59%1OAC9PZ
M(AKY .,,%3;RR[V,[0\)4-W:I>B;8)FT$T7YK&9-DOHX T226$S?*T@1>4*0
MJ>>T+94E-7TH.\QKR]LV@\Y-DAI:X,*8817"=L^47N"!CL#;8870"9TITI5.
M_</^&>UU@2U%+356)B[@^%>/1=16ZW:IW38>FQVQV0*L/^_V0I=TT8NQDZ/[
M2GM;?1_TV%TQ>SHEL&J,$V0YL @:MV7:P+^@UGL3SO5CJRG@T2MVW[,"#FI\
M?%HF][#[6K[</4U5,O]J-4Q;*/1CW,LQG&WE]X'=>:KI;;L7,M0.DSJ\Z)W[
MD:^M" &:%]'@5Y-8_%%(0:#O'"EO)H_L/E8%G;KH0EFM$NF&<+IJV#IW^F89
MIYK3\/#SG=#$QEYEU:>P1)TRGSPQNAMPJVKLW$H0O9M80RRT'=57*;H[=*T4
M4WK$]</&*O>:JZJ01'@ZD._6;0L9^O0DYMU.J^?0[Y"/T 9H1HC3%[SSF,?@
MIQ!G^W%#, );%,QFZG#:.*+L3%U!<,3!)-M\I[<I%JZRACN/2.*:NWZ2%%,X
M\$60!XR^.V^";VH]Z>*S3+H9K 3]]4:IZ@G71WB#O1JLFGZ=A4= 6(W*?G;S
MP0!U0'3[X!.!7C"#Y?214!A>VYT^F58V*Y^?<IHK?;AZ6'=W?< ([A#K0_!>
M^CSP.'SLK,*D0ZAU+-..@R'ZTX8-W]M;+FPX2E:Z'43KS II82HY+8+0]H]S
MQW*G'Y,V]N:]L+IB?>CEN1]O7:3V@?</V07W>]7OYAO$12(*'5A;_ SI8R'/
M_&7QE@!["Y$MD-=H3MD<"WW_./8-L]U7<*'<J] >DXD,K92?MLF?>F'0 5>V
MSLIY-.DZ$<7X:%:@F3$5MGM/0K<?&2.(#.38<_3@W<0B;*C^88)C(.S3$,J
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MYWNNV @\J1?@$I[+Z&(62T_:#N#R\._H\E!T?<Q:3P"6FY; Q6*3PM:=FTB
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MUB]_9^*>R8\?"V<&)%UJIY-$2@M)GAZI>*,"J64!R*C+5MV+$UUVN"QMU]V
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M*TQZBMQVA2N.^2U>-G0%(@3% ,5 7K"XW9L^(%XH$PDQ;X]*%1_\6C;!/OE
M3%>;'_$TQV2[&UH':[>#N6/38*(48$D8L@TJXA<R>*4F\MWZKQ3//-?,/6YC
MRASGR@02V88FW(!/C'2":N!IRE',1!^K0G!+VJ("?\"C#W?E33R?70K-<!+G
M111<!QP4W*+/@\&KKBCG3YW'CJ+F->.,8J6I3Q"JW$ZN9*/1K$[D0.M5:KF!
M%G0<45N?'>[Q =H]#1JH,ZNX4W^R-C\]9<K)^NXM@Q$IG5/:2-AUVGM%D"<B
ML>@BH2N"EH<KC%2P\4M8D]:[;BG*C&<S!ITYH"ILYNX6TA_[->H,]:E_,(0[
M+. F)*U(&N5U14O F3NW<>,8FUW"GU57=CH<Q!B<H5_J0-&B&[?H\@-K4DV'
MHQR!]BPTZI/9B9U75Y-T12_=I:X;W+R 0U5&L])I2L!S43VFMTOCPS4L0>#2
M;W*H[#MNBC\;G!Z((3 H_*[VJO _7 9%=O3"5DY'L<$[+KA\OZ,,';5[I,.S
MN.8%>2M+3B.!:5P2KVTFER+RJRLM'I%>5^=?<]T<-RPTJ@G*B@D\^,'^"M;.
MLBW&HST7D&)UXQE[8>2CB39>=6>+<&8)D\$MY$?8;!E$0!/&&R5*#$DHF"U\
MJ;5_R?Z56'$PS@N(+X^@T.C3 D:%DM3H80^P/"X35C5]<;&Y2$WP=5>H",X^
M:D ERB.-:D!MH(G:1'F1SLZGZLDM+#<F]A2&[]I(G[.OF:CO:W6D/32^@ !?
M!]"NHYT#CE/<2-'O;<)0[9":C13:*<>29R[#'TJV!&9S L]M/.,%;M 9/(J4
M3#NJ1%^"$X-5. ?MW0NDY"#7DSWIXEJQQMTWV:?0DD5%F"*3=N!'T%K!/'Q,
M9MX!3D>MC,:KV&0]_=)IB0M^_A[W;]:ONO#\KNG255C:@ SCXT ^B 0$_WDN
M/ZMVR7-UPTXYX]KJ0DF""$7_N3>@1W'Z1$-@_T@/=H)K=YG40NA9,?H%<ME(
MD0S^SB-V>?CS8R%9#Y"OZ\:!JR81M&I%,-JM^V&@/THQ'J8#-5J,I,P<=3HH
MFID#=U=6''X^2P,[.(PN@XT;T8Z6D$&T?MNKD^,C:<[-1+E/]>>OWHX>X#VA
M7?9M1S9: ;<QED[C4B$:[;XFO0N8X^.&8M/E8ZNJN-5(J+5$IG1V 8ZHO8V)
M0P#2$%A#IRMU8/Z9,"N+H>9+[A>765W2S,XRV;A8SZ;G;A5],%V.$!]YO5RO
M5&7;\7&RZL7RG335K[.N$OWAU(M;MVNUAH8OP=[:4I-T9Q.'1[5^WW/G[BRW
M;.!M21Y&1.L=)/9TQ:]6K\\'+^,V]>E@A0^@' ^85]KK5$G0-O.*?K90'9;1
M]K%=5;OO5V3&(: (]IP>1U0ZD#RTG\"Z@I2-UM/+-TE5V+6]>T+C;LEL[&3O
MO-\YEIO<2'0E[!ZP/K1-I%6=HMD\,'[3+:W_,N_PPU4I=V8FZRV$!2(%^1LR
MBT]10<\6T>..<<6\A$>GW?;G'=W79/\1^)[?(S&8M-0/#]%N ,S;X"A!"S[+
M8R#!?K4NK?-R]=6LX9'>6]48D:-I8DY_2JITD04@/TC"- >I@E#1;9M5X>&G
M-)U8,BE7VV#Y>S7+ZQ(F'Y9:L[9V&\I%FT2PM%X(,[,8.D5\<C*D_#R_>9#;
M!%/&IR/+9M_'.L6!AX [43!&Y0#=$QY'\9$49OU,VH1.9M;759#@IOGR84,"
MIPNP,4=Z=; B- '8!0 -"G-ZNB9#?1UE4NK@0G=0V+>Z.QW[E_Q++7=ZV ,Z
MT Z@V7>M<L./@$D'/'FYU^M'+D1*N<DJ7G?)"$H2!0 M,)+_G$#R\>VO4M):
M*([+-.43D:V^(# !FK*GB(NYX&*!/[BWS45_IV/49ZW2%!^21IF/XXFLT'2+
M@9-VB9<GD8\S'K*8OUC3IWHR$X"[ZJ0*8NB<05V%-XS'@-L'?3*@ZK1 [NL>
MB4IQC>RF1]F".=&1)ZFW!D&S)3,$2WUEX7K(:.>\QN5[[HU*52QZ&8_0HFTB
M\ZW'Z L0 !VI)(M'7?L5!9S?X'TF]WE(:, L/>YK7<Z]RV,>*<$&"/N1G>@2
MVA":.^K.JZ4BI69B96NB=[7<[^Y/>KY'/[T]8_(<S-J^L$M/0OJ3>]#C\-T1
MTM[L2[OVQI%5,/%(Y]U??GA4O&/^F&FM5XE:JI98N;RKQ)3"=Q##*NBXZ0M,
M1!S?[B:B.A#"G660Y1^39L%!WLY)_6?OW_RV<)U]'0-Y0B2-K+.O:=.OCR7Q
M$#0N#RGKZ;YMQ_$\_,9YXZ3W^[,-^9IR5F$-(I.=HI(M^GH3NPKTF7V@6%*K
M-"_MPF*Y2CSCMNT. =Y<;W229?::;FS"./L-GC!M@BDG1K[7$L9G],S92H0>
M<REX/+IU3O=4EO&E%2PN[0=]$!G*&0*HBX]MV4"1:)#*6X*T=KP^C *C'HJ4
MF(#S2EP>C*VS!WC3X2*NW2>B]X_V:Q!'9_ANIH%Q3NAC9JX+#3(L&3@D?KC5
MA'Z%.6T*Q@OE^O,\.5;/53TL8N-F:SZH]AS;9E1WEAZ^CSE.8R &A'SZU9I;
MW0L7D._*TA-[>4UA4#*/LDD/E*X@CPT.OJ1Q)'SNUX?M*7M^K1DE(<,.][9O
MQGPT_3YHHRWMUPR;#*&AL984R_8N'7+^QJ+<_7WM;0WF+S1H!_HE@B%%[YX#
MC_,NTRD">]RCAIU*_^7@>K.4]EY!Z8:+.3;LX%U/9CJ9C+M*N3F\2.A&)E2.
MV_RZNRCU3D$M(]$KL&=]UG5]!_D$/?O.-F""=F[*QNRUF1QY:B*WPLEU4:UZ
M/WPU\,O!#GY'F\;I2I8@(>=0L7YZ1LB>70$QKW7SIK.SII]T%GI**1\N;D'R
M@ 2KSU.' $^SBMM$N8Y/,Y?1+G<N&D 4^1'#,:!(].P3 Z&!YHODBW_V1O*)
M7\/REVE!Y]ZQF!4EAF&V]TX<F,\K2%R\_4/SJZ0.83RXG?N5\4R![A=:R8_%
M5F;Z%%QM"JA%M2EN3R=SO1%-OEM;>VO8N6&T$<70]1"0< ]2;RTT>0APGU+>
M64:?UM@1I85C'_#-@W>[/CWOW'W<2&9[J\Q.D873TF($2M;,,193%VC!Y(M$
MCWED"DV,UNTHTC2P UM]AO_Q8<#8Z6'[!TXG74?:#BF(;$Z*F#"C?@AVN$SN
MUOB60WKN4N^?6<W9(LO4MO3C)"W'E<3J0YS9O?KC_!^_$K3U(RZ/%--"U(E/
M;6WC)'F]0,9O[08(P@T5+B]TK?#:U:HI4E^!-0QE;\\IV\Y-=Y=;(O[W5G(W
M(./0V#)/&N? HQD>P^%Q]\P$QZNE8''7*/=GK9"\H*^G9ET'T&FP!$>E$?0L
M E@+K7F_4L2_66M3I[LV@%_,/''RCZIS-L><E;S\)G+9=79C+9F0/K\17ZLB
MC/E@ YF<GMC?RP_E.W8A*-GY]UFO5-]SR8> V)ML^+5R@DP'6J!5*"S7;LC/
MN;$0/.A_.MF[6'G:# V46JD-!3KF40IIF%#4<\@:^P?/NY^0R95*P1M2MVY;
MX:4G&V==BPRIT0I[=#9 1V)63H)\C![[>U)DI^TG^Z_1[H$!TG;J\]*N"A3U
M%[&-Z)?84:YN' 8FCM3\XD0;(]^OS;T?A/HV]:"O)X*Z ;$_": R4IL"BA51
MOG,FH='BV1SV9.<KF/=2@/B7MNK&[QP&]NH[T[ +%"-J O14E#,I8#[@V I-
MA'1BGB]C/'$'@Y!\52;/W[HO<NU[-3[0*6(7^8<>WWG(,BLPB5:N49]Q]\<\
M)5Y\.AP9B^I*OY(F91Z-T2)&YD,I@K#=7L2N#NE999AVSUV-Z7&Z+5>6F#^2
MU(R]92/C\JI(/"."5VT@QF K@'0&0H^ZI@W6:V@WE92"DU&R2BV?;)Q,CA#%
M;81)^S=9L?4^F%80[2>Z#K[&.2L!,23>6Y4G I91PS5M!7 .[C>FWYA1:^ ?
M+^"8K#RJ- FRVTL2G._CND'D-M!!H81#A$:L)K)%-MUR3H3++/J'J#F_V*6
MNR%UPI03^#GVMI7(MQ1UI69(A9'84\5.:=%2^S7#NPM.&MP>*%L 19T1!R@G
MJ750"8K%8!^V(T"4Q-X1:MML-34^8\LOT+'YAOI=[H]@1FP&'W9]@Z207Q+I
M.ENN/G/.VZ<$J/7K27BE=CXYV8+3_P)><V?CG[(\/5([V1(B<Y6@Z'62V8$#
M<5NXJ:/#]'M3U,B?<GT8KQI$#M;N5#KD'Z7_UMMG;O1-/T(Q]T8_\^60)E4
MZF+X*JR+^17]M;A)@I='6D^09GHB^N.02.OEY[Y:*(%S!?S?51R^K5O]>FVT
MEWR=2AVA: ;,BW%-1%N^CE2IGN2K/N^M<\Q@.@1Q:1")-B+17XA%:NCJWNH^
MD77AZ>A^1']666Y.N3OMME,N?&N'VE\7K(4J\S^Y&IWS9_\#!VC9[2 :E%W,
M-^>S.TA@BPTGATYZ"@?V- )W.Y@]54O6*X(YISY%\(+.T1I!SA#>L,AV$,OY
M= B?U\>ZQK'VE%]WLBPX+Z:IW+J&_ W?_354N8X.,'MIH*0N$TBMBE\3E6J=
MW?A*Y8'= 54'9Y5">9>T7MFJ^YW:'\HQ-C0H>G8(6"GR9 +Y*DFOV)-L*LSU
M?'9=O0)I23*&DVPTI7()]AWDX@B-$U[>"J<O-"NI;$'0CSM"*V&%R=$RD58;
M^H#]I@[CKX<G:-\OBP,&?,N;]LLY=O/]4>C Q].=%*K//I*1VDQ,0&@S,X)5
M!=:1@P:YKWKNC)0?0#\%8JK"#W@I/]@'( 0[6)JC;"-A(4*S'KT@[9 R/!::
M5,"Q+,VB^M5W]AX>L2I&5,#M==C9!0B$<>UZ$L$9RF]0Q@[>_4S2]CDGNM(;
MW>:^3.JCP2.' )(B>#5O'IPB*6 >V1&2&1CJJHI6./JX[W=)O7HU.F@-P@)K
MUV#\:OR58-*M&B5+FN.>YAD\[U=_;-FJ.ON^3ZBU\.]PF9[?+-N4K#/,?S+M
M:$<OTB<O5O-+U(6:29.>&GO&<2=KZ%PB%AAZLT=M;7N/ !['[:91&]">D"0T
M(7,96 WOXM.B*LU&UZ/U6(OTOH#')Z@V"X2@>,C@(IQL23E/#$E[/I) ,?%Y
MMU3)@5@S<.-'G'D;3;9U>6BBLP)!S-1!*$+:LZ#5F;*IJZ7+/\/0/8&?QB?"
M N^8O(0IIK/<I;DX< L]BUO?*^;[CB#)HCH#QNUFW[0$!L\C$EK/$1Z=+"6>
MSUZV/'9,V#?+C79L)DEWMX0^AWG$K:$=.)-1:+F9]OAOY^"\_KZ^@*8'LKAW
M$@<GJ4[4.-#L*[0PR->GZ7.S)4$JBJ^DYX]OL&#88/0;8:54K7UDQEMV2>K*
MEC"-:U!=/DU/:-"A)558Z>F@[ -"X-K2&ND'^RB(8#*3- TDS"3X!?,HZPC-
M1]IYO#PJ(S&AD?&T71S1B;"E_FP<4D+C?N6(I+M;6$+]9Q[%TK=M9(.$H/M.
M6FL:A'5"S&KWF5 _]Q$H<6P']X9]9!SM,=_P:QW)T4@84/0FV:3CX1LPR"'
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M5^9/--D^GK&M0T[K1G:UI+5R8F-6-;9;4+]A8I6GVVT??Y]A==?S%0O$XK?
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M:Y$0&!-*!T4$E'_KY/3I^1[CZS:APY; :B YAGA&O^ &QB*LJD?4\JJB"'O
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MJ,4U;=#$U4[9)X[+IRZIL'G83OC:9$^R,V:]#Q"?7'S+^QMH=6^V46]&.KN
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MQ5!! M='^G*)X<F#@J'^W:(T_<;@';?@CU..GK^K8RY+&11_[[Y<'R6>=O>
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MY;.-9*O'-VM___L@E9,9!]?(1G_8N'?)MT&Z^.%MS9B!R8M^:_2@_D.X"(&
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MT9+'O%MKIX"IT,XF8*0&@U_9T[8&/2:+**;N%+V1!Q>Y9L(%OBIQX&]_ 'U
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M=?:1=(_J*@*5M 2+RB<T+&;,/MY!&;4-[\B;\=;=T?MLKM#2"U54GM(&&51
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M8\@Z2-'-=99 $I4F-5[I99#US8A)6VL#7:DS5YH2>9]T$X061QXC$81GYT*
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M>N%W!X-A1/E30+L+1(B@9SQ4:_!%I<8O;2V;V\S(Q)[3;$*4S_7G^E-Z>2H
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M%>^&+9E3 ^72!"3F9/Q/ 4KP@YOD2(GE4+PN%C&!23^"1HAU?#Z!'0CV2*-
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M^<?FZ,II4A@Y*:)S-%KD19G2B,.?/&_N(H@%<C9@\H0T=@HP@+:+@YS!(8I
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ME."P;7,Y-,R2)?L4H! 0X%WQDD-7U>SGKC='JPO$VK7,XJ@^_%J^I -G+\(
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M&AGLGR5_-23Z"UW,<] VF%-2FA,]JL'[G^UV=&A3^"?G=GT+QGI[!".Y$+Z
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MG.F(?IJZ+YZA\'CYB*(YQ&A\1LVR#X=G[(9YXO!BF_N+Q=[!TL$OA9NIKPP
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M)>RB=L ?Z+RUHU Q$J9=&WA.S-H#>F5HT[B$6A6KD?1'3 (H/\/_(K^);9$
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M\3]YQ)KD>B*F9)_:,!2%\Z+H' ,JZ_^]Q)3P$7!JCS\\/;Z5-F]BA=1&O,,
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MRC=U+LJO2?1=T](%X$86L@&[PA)+>AV<$0U^=_&'2QEQ2UO"YZO?E%Q.5 (
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M_VA@&VN^2XFU!)TX VVF/&_)\\HW7,JJQ::+K8I@\U&OCXY:3.7^155T *6
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M(JN2JLP5F@V6F$W9MN6%FV5 QU=#+:[-?6RWE<^M]OC?[GE07$M,A\TT@99
M&DD$I4X&G^R$P.00!1HR21_K>LHQVALP"5\"M?HP9R<T^>L.RN^SU:R4:=X\
MH<9]+)"G/7C^JT3R3=.ZH-JC7):98Y60%RR_"\YDJ@6,X%9"3"+R$/%?VC.@
MO Y[Z[L5F01_ZF)O"&SYP!GW937ZX7AM7KG S1-0*Q";C]3R<$U.JJN$&X'B
M/%DZB1"DT%@J+\J2JEV3,!63Y?-VZ,:IH< #,7CY;%M-D@ HKW6VCZ^9HW[H
M#'IB?9%$ KHTKI/U=@D4";AH)WL,^S%-A%Z?'M8Q_."\IWX ^N@2**\S9@R[
M! H#!A[+)3')8A-V?N90S>UHN!'.<00 %_&M&IXZZ(T\@D"33! 4)*NH<PF$
M6@)-6U-:4-V3@$] @$XO@3A2K 7C=5@LG7';Z-ABB26Z$9(YWQK;#:-JNT]V
MR;_,^]J>>7N:_756@8?JLP1J=$;/+_\OQFX@]A31?=I)G[MF(]C;FS]MDVFE
MKFJ\[BUSP.SP PN*:%R71N*.!;[J]!UK<K0K#$FE302":P_+'4^9IY]DJD9.
MJKHZ8_VG<5 TZ0O( ))\X$;6_2:/399I(U60%-8)DS4Y%PS(5-6RB?(B]B1.
M:/GCG;(QQ51ZT1R!@17R9'+4FM=]9:<<+[4Y";BNNRO[X-W!"UPS+T/QEHL[
M]JH0B_-%BNN@E/8" _)-!FP>WXA1&=:84\$O=C<G&ZF633JCVUV9RV>ZJBEY
M[ <1B=1N<Y2%+80^UK&F!CTRO;1IKI/M#;@;AC,2,4V3J@2[60('KMJ\+NKA
MW<;"77<UG#]YJ$!\5"C#NM_CH6K:52:;A<C1I:&M=Y$ 964]J:^FTM^CGK@:
MIDW:H!;'PO;4=_G "*7.B]A(Y943;=R76-,[UVM+>D;K4R&&F]BZ_8!_NCHG
MU5K"@4AQF<!0.<HD.LOW14!2ID]2:5%OZ3P)A9\>"#R PN\X>N%DJ(IX7O],
M'[H-(>SPZB!-:)WE\Y!+<=TG9DC*I,7J8?^WJ^X+&H0YHY40.G(,U5F.T,P8
M/M,1](3!T2$^' 2B=BDLTV[YNZQ0)-FY(]F:\:X4L"RD]506UO,]YZKK$@@'
MG4?3QW2IWLA&YR70/&4)M),#M^>V[F7N]99XPA[/6P(-HMM9A_C0<QZE.QMQ
M/0V3G%!@T$"=*(8J=+!H";3\(?2'@*$7A-;3\ L3\U J<GHY/#L8@Y>3M-4,
M%A#-(\WV0=HXZO9K<AP/TKPC*KRIBQ63_<G+YVWWUG<!4[F4NH@-\06FLN3R
M5.8/T=XH=W<S%6K%M>R&/UR3 TQE>P+%9;*4RA$D+1_[+4M*<TTJK9@LG;=#
M-4X-!(H_/FLF79?"19N0BJE?[,!!31$%[V$3[_WVD_9ZQU%:E<$ 93TL2SS8
MJZK,Q-P915!] =[W?<%*5F3V+"Z!,I;Y*O# <[SS\Z][! @%^1H)E1!*:XE2
M,D$I548.XV %/Q8(Q6?ZHNM)KDF3V 47X'F49R$E(BI\*I9 (Z6LA;D4'B+\
MQ4!'W2M#[EA"S$@S7VV"@^N!B)?1UOM/!'PIF19SALJ3U&9F%XQ7>'$.PRGU
M01KA"H]$[)6-5VL5!'L4B],VN/$IXPTWSN1>E_QT?+RM0@IW*]>N ONL*.1Q
M5E_FS;V%7E_V+GZ=]WY/\_%>#"<%R)H,O'L 6_>8NNN02/''R)[0-PKIUS=?
MOEKJLO5>]&?*D* 0R7N2/INZ)Z0;YJZC?1MQ.VM;>^*V$HW@Z=E/6IZ[=A9Q
M)1BS!VOYU-U[:1#]/$>U(C+J0ZZ+&3/^V2%K8A<!VE;_/:]_0CU.XK+L_9'?
M%I3R%AV0";O:_> ]P\_5$@6Y^;4T[EV[JSR,2#IL8%"^Q\BL4$\\^;*'EF\G
M#KS7YY@BSY?6#)[O\9(3$\V?A&S3MLK=::2W"PKB 5YWO!11)EUX?>MK7H,,
M6PAUNE1HCC1-OO'B5-*%.>_HH@CZ5><"_=[V/.M+GRGU)Y(_M>E/&Y_7EU:P
M5_W2P]$3E%Y/9B"N7PBK(T^:&<^#F^\ DY77D32J^/5&5Z>(>2U8H)Z"&MA7
MD3#S8L*9C/Y\*U&"L4=LI@EI-)TKY?_ F>!8F0O).6@[0A!%4YAF7MDZ!;$O
MNRVL$N/-KUPNY>A)^PM/?9[^9G/NAN37<(=T^T.>GPJ=;0M\D .8[EMOVF1(
M-)>WKD[$:$WQ2O$9R]Q>8:=31A5?7U^X(E76PL5(5K1)QL(>_9XN75Z 03O<
M2N1CDK?PN7Z0XYR[=-Y5Z'D\OWE4PS86"OF<E=S6K_\LKB>R_I "/'?$]?SO
MWX3-R-E5ZFW77C]O=<+DI]1OI?6H-N3L?FIL$A7H4:VR7O,\ZH,?O>.B:H3E
MEBW^EQ[%]<F%AZ.]13DO+WSLZB"6-R9,-:1H'PNZ:^CMO8[.]C,+LZQ]'C,^
M;$Q9IZ.&OV$H+]=;;GK_@'CW3N?%+UAO P/_HE;7>?%%O;S+Z;!/$KLELR^/
MI.?E$W1LWQ&M:W.RE#K[SAZEH8=(D1>]E5P1U2KD\<NC5[1-GI\QT#LLTVPE
M%JU)8$1ZXCW'+DUU=.&\#C2J5[N*,V$W]D#'9]CJKQ:.;Z1JJQT5O;ZA?W:2
M&85J>9:NI20^<<AARCX^WKR"P*XSS39U2KXPD-ER?*%<@89E\=YW<[$:TI.Y
M^\FQ-$FM:'V3_$7]K//UM3KGP.<-HLVZ9).43<_?.C,2K35#@J(*W+JN'FCL
M/F:A.%%S.OZF\)GU;IK@0-_<BZ4/:J;50!L$MO&#>A^:5"V!U-IHYZ]D73FW
MB+\SX73Y^.N9$GU/9\.Y:/WVPO;X+H'<78P\\6\WC^KN:-@(40WQO)N-H4%;
M,->_':_?9^_,!3.^MN>1 ]14:P:("<VDD^+2W]>-,W;N4>%*Z.:=KQ+GHX=]
MB.!^_8B<"+UC$M6>+401KH=&F&:>MM+K,NWM+N0(SV)8"FR/H:221/7%X9AS
MHPPC R_OT[[:B^3X)=".5'+*PZHZQN8]RL(EHXYES\IBSO+7"KU3:O@B4NE>
M:[!;#&MJI#R07EA0A(DBVQ7'OJTSO=P&>3%B3DY6R1W$V%_<W2;I^YC'^JEM
M/#A,?U<^\E9L$O.Y<V9G^M>\KK%Y^]&V1W-1^N?-WL7"8BKB'13H/O0V_-&7
MT>E#.<=JIQ.9[G)>^V"#%X((+T02<N._'<ESOGQ\AN_PW;0 ?Q7<NF@^3_3G
MA>_J<4GI+UU>XH\I&EJ\EQ43;MH W?SN[ :>T,:;1'2R EA0V"/M[@E&1K9I
MF+->B1ZQ1[7\Q!A3EIY@B!@G*@A:^A?,FG1-^+FZRIX4$.S711NK6NH=CBJ:
M%?60W^/BV<PJ#QW8=CKOE)[==OI.ZJ#BUJ!>450^9LC P,GIHDU"QNWHBEN6
M7 PBVJ5\O77\@."$%=#RD8U\FR=J=8Z5Z J,$1;:LDRMMZJX3$HMMOLYYL65
M*\H^TRN1F+S2WHF5(@"R"6J\+QKF.K'M"NPWA$&UH+S.)E+@2]GSD>AX*:LQ
MDQ!J.^= 5(Z&LLQ=N?8\_<0[C->-5YT,KMZ\MRG]&JA7QD(DD7I#BZ.3GG#M
M66]=QS02(]!U8B'_+$V9ZC>4T_DU+ !EGF,17T$$1"+W]JUTA08F?&*G0V9#
MP7?VD]F\8+&GEZLI/3$4SZ>MC(>]$,E*QLC=<Q?.F=)@/IV5:1*"7K1*GE$L
M)=+_&^%2[L3^CP]ON?=<+^=3(;_1 !S&#_&S Q5%1]5N\2,C=W?(-:D8JTPL
MF!JGYCLZ6)THHC+S\@\4=0U;%V:?*SDIE_AL,#K1Y1G"QZ+B0][@I9;O/5YM
M7BID?E12ZLF6S.9 @A&;/M92X+6EU6=ST9/?A?JB^W2KFORR9Y?-&UY>GEN(
MC5WW[@W/T),C)6/?(M4_D HUJ,HR V>FCZBZTW5CFS8<W;PPI6N8]$E!/]S&
MOL+9I2W-:>+[)!Q;9]7B:/(L5,K9.BHC)2Z7=FZ$+;IX07&'5#<_';/UJ;RH
MA""(6[/VJ++0'8:-E=4)6/R.E-YJ5X( .']OJ$@W!^Y8 [$KC-"V;WE3*7V"
MRB-R#Y5^\&710O@A07["N[Z8WX;;^KREPCGPTK:L\V8FJ",!$]+^XQ\BFIP2
M<)<-O.Z4%!$+@,??,)=:;11+[,5+&4GTH+8=<:RA@!-M(JMG%'Q,/D2/G^RR
M=6>*!PP6U<+4^G:+3\\L?+L3]EV2_X">4-Z&$:UK[E0BX/RTBWPNN[OE[<:#
M]FJ%(*9MRNV=K2!NJ*'[Q?'A6L7[R1CWP<'R";@KX @D'#8-3VWS<C)+8EZ,
MG\P_;<?LN)R?.S/_,:GE<Y_M;GF0_V,8.*;#CGG1WM7K4/7&&V?ZD66?M9V#
M:W4N>&NDH5H-5?9A+NXX71:9<6<=I<T%0BD_WW8-TV:EZ*JX+51<]VG5+$A&
MF7-!TJ0@-25MCY/2I+ZL0>>(_Q*H>MB\,.=<X<:3CLC?$_T5YO)B?483#L2,
MG#A[/^]@_&7;VX\;6B3%\C;91!HYHDV+GY%?M))0#5#?HC95W^'-Y)E9R)7P
MW%>O':/>.X_>M(@)OT.<&:OGO.FI6M]_*B%E4]N^0Z6TL4B_A9GT\>R3AX]^
MDVZ-*+6V#.#T>^K+G]/YD@^K_1[Q^O5BOGJH.KLP@W#[^+NCIH./L4V5MAM4
MA(1($$YQ1HS)4YC<O<@6+7K1K/EFXAF!;1UNO)Y7CG[9]O;TF5-96XH; NL,
M-YRIJY^;9;Q>'+MZM?%EL;2[@,4M!9D7;SP9.ES"'[S3ZXUNBEP:SXM]9@2_
M4ZQB>"@KIT>OT-\:;_=J^$HK]3A<=KO>D?=U%)4H0:8:?,#(?0DT^K(B>G2@
M?]N[_5V)+C<N0@0E]GE31"$FP6/ZB,]Y]_>+']188.%XBF#XXK'9$;.AKIZA
M.T\+IM?CZEYF*2^!;-T\*R=;PS(-P\+"&*D%@X.#+8UVN87T$496DTFTGH+7
MZ_A&9\ALZ[4/;=<+N;O6.]QTT;.5#0<=A6P%U8L$T[*JK:U/D[LG[K91CD3N
MGE(95L0@:CB6"F+%(=PY0ERM#NOJ!>270)4>Q^8CE5_CWA5%,R9NMX,E-$SC
MP1PF!#UFT/G5W7B0'$%$?SJP5Y<XXN4_VG#1\51WQ F/>TF]\N]-NT9]KLI$
M6.>..XPPNA3"'FG2#$2%K11MT.6,IV]?Q3POH=(+Q=YS:.]":Z$?N*.2T?Z/
M_2Y4Y;98CFT2W>H1C#QKEXSDA>::^AO 9"J:\6YI'-BAV_ZL)!4R8VSD7&MJ
M=!CC12I@X][O*C!(Y$!]>+K@\1B]'+KT\Y:Q]H76U_AL@A@[7D%&=_JX;>+L
M(@[:'YG<=#7BPMMS;])3KP<+FD#:6&4B3W&8UN=OB*>V7+N:C1)HU%%K0I^=
MI20N?-]-C;.#^[;SG_,-TZPQ*0T7BM8SKLX7?CN;?6>D8.")N+/M]W>1! 7G
M@!ZV_ERA0_IX''NLLW 7VB<C?Z'DY0('+:H8M.Y]?D-GN'(=*82\(YG)"?BM
MR'Q[2<F]>_Q>NFZOC@UO(J&O'9;:Z'Q[+_E>'<_)X=\-R_$2]&'X?'9^@M>^
MP::;80HJ)ALN%@]OM-A1-?3>+9%_T"W;B652\,&K_$ENX=OCHP/6\EG,&PLZ
M$W=&B<]I[[HSX2GG/#B^FXZ12P\YCV[PQ(DCDM2+<XHPDT(Z-37/H\X<ONAV
M5 77V'3":USR_>/.;5&"XII'U3X:7+/)G\7[><^3HY(O7'-S'\PF)HH4C_-"
MV1=?[T];_SF5\'W:.[IKI(=AD/:V_?"K]..OX$G[TUR<<ARI27=WR'7;7+@>
M4^JMC+.PTR@OSVXN>&!Q.,<'WJ$L--,$A^(*CQ[7567USGG; 2$<$ 0?VEX=
M??4+B3H!6?BMMQW*R7EDD0N-)BZ!^LSU8(NO!QT.,JWRVIVO+%H;S%DN\MX8
MB;G]@MY(!:/<2S78*GUWTN\/G78.$T"7EPJ OWD"@628S0E]I*^0\V+%I250
M<Q'*T2=!*)@_E$1]BH-.'=GL8A G#:DG.G^G$F"]+\+%3 Q=+R2]'I2YF2G=
M+AVW!#+@?8 ?U&@[>:](3ZHT>R01G2DVE;HV)#]?WP%$X._<,=19J+^073LT
MXC!3U7!2U<<9ZS.-@Z!)GV[=-H D[[^6=9_70\^R>J0*NKP>N2:GS8 \H5HV
M02QB]^*$$$C4+MF8 BH=XTU@((7<F1RUE063@YL?&%/$X[HU$G<NKSR*TCE-
M>V[ ?!<[+9= ;4L@4F^_2?ZOMYGR231"QC!]R)(E4,T2"'T%]/R_'Y"_/DC;
MOLOR>:3 [FX_+Y(R91$WK'IL=40.D6JT@)72/-$EA,PI2KXAW+]YW3O8T(&M
M#[;;K-O=C2@#+[\ZXU^3H]UC^!731.SU(;*.X0;GW4_!5'5Z57W@O3Y3>,B3
M_D\@ XGD&\9U01N.:EGBQBJAV2R_KVMRVLZ1)_8&3! 9\-YJ-81UZ"ZEF )G
M.L:'R$!NG68BA(S716\*^U2R"Z1AF>X!@_H+4$:-OL>[JA>Y:EO8N+24+=B!
MD&C#::68>P2*'421FF1$Q$,8^%W0F-I>U5[D#)$#]S=>MR:,/T@GW)HY7:LX
M(87/<.-ASDSN9*HYT\L92Z!SO93V0C[R-*:)T<M60J*MVKB.A_05G$[3U&(J
MQE7UL<>Y1KHAZ<IE&4-R*MKD@!<A)QA@B)7GL[P>G?.N2>$LPOOD4"J50AO*
MQM]T.C*FE.!1C&LPX'8?5FW>D/S&$K0HM_?MQ^P^=/44^UA7PC471/61]U<_
MM@02? X_=E,>Q28[*M(\4F"?Y(+_6G3,/A#W^S%NV*.=X8H>D&1>'JM$_^;U
M6QRHPI_?G]YU-I?&]#^9Z-<GN;"(P-A&7^WD O&GW=TH-9^X!+) 7+RB+!JB
MA$$UR>DQ'I'KCE75ZDD0T)D*!]YIV?\N4-:ZD_7YTDY)L8P6CP[RS$"@4/K$
MRWI0\425,%3(31WY\;E4 L$SDZ>H]PF]%FI5 40LW:Z4ID.)?>'8^>7%,D=<
MEQ@N[FT9FH&$M;:*E $N7Q9W8<5@P,D<-#5Q_<3HQF%'-XE%3>>'0W8K*YE(
M$I9DS"$AN:\E!X< -N[/6C!%27R&C!79^DTN@0:P^'20WG]E[?"_LXPI\/3,
MH,F6[80@J0(WO5HMB"%/O[:&WV3'@\ZFB4^^L[5:RVLX:=82GG9-A)#:;NHP
M8D[#I=QSGG[FO[D(^88YAKTA9J>*V4UJ%^1A+<R)T6M<=F_/EBX&^$Y"N<FH
M-6K^PJ\5R,84OJ>X--JX$D>!+EF0\I#_NS5(^S4YC@=HWDD]WE0"8I(4"87B
M_LEZJ!:%G2A30YM>8;=L@-.P']<N2=Z#:0 :88D%L_$<"=9""X=BQRKJ70)%
M_K%Z>("]!(K"W( AEU<<+[.1'U&K&/"P;/?X\C+Y$FAZI8*OBTEH&@')4?F+
M=/TWE=U;O^<6*62]CTB2;Y,*9WJ!MVGM"J38(,P)I80P]&2HWN$(S8[@\_W^
M-XN0!]:T[2"^<_<C#TE00*D^F8:8D\.WH7-UUE"O\KD*;W>ZRT@;NWMZ"10P
MK<G_A5+T9?A1N'.7.?IL'Q]]I'OUPF29T<\L]V\(\[)&\Q7IKRFBK%+]OBG$
M'(BMM7!!]N?[E:)B"1025'&<\F*QA *ETC7YZRD)%]Z)NH>#S!T6IGB&D2*Q
M>JMSXG;"5$-Z55WAO?Y3>.B3_B_;R%1 #LH9\,EJ-8YUZ'&N(\FP.(/]/ *5
MZ[W1^2!$Z/2(]IH<$Z688F=Z$8/(P&ZE Z+1O.IUB^;.'="N+;>-CD%]I-XS
M;99 PDN@WXUZF8M%$@GL[CS\(*J5Y7B,S QE>W]& XK-,F?.O&0W+8&8SN^7
M0) _:<E@<0D$]:ZA0U=>["P@(R"_OG%ILRX!+%.Z"$GZHX8TABI@A$5X%O*O
M=SQ'=[)3%&OHQQ@>I=!XZ'3O]$L4GO_MA9,4E75Y7V?Z4,T(X<-R9&8PT W4
M7]VPEG G4IPG,),(90J=!4O99$.O>7UQ>TF3EE0!7%EL!A*J+[8FYV% $LXG
M"5/46SY/0N.GA^[3?(1[O'L(" 8I$@G%/0/%0]7T/YEL223SE^JVWH5JS=])
M1TUPI1-^YS?Z4IS' Z:2(<U\Z2?7T*,@O =QC#;1Y,=7'NG)80#PK"'#!P&S
MO6]WO$\BA$V/A0<#UJ3],Q.>A*E1Z>5%2$LLI;4<9,"77#JW7]&SU-U*W?TQ
M$I]_ Z+N,ZY]F^(]4.9'$@5FJ-777YCP5U+%41YT']YG>M7]@ ^OH?O?.8)/
MZKLZZ9B;;U<<08B,>SOT/_+A=JS) =2BM;2)2' ELMQQE/GIDZO\29"Z=L^I
MP$?OW1KY2T.M$NV$D+YP/A_$$JB.\%8-.WG39PETA(/M-^&3:KS-+*7)H4IZ
M\Z<HF59P59/5M/0_>#GS_T%?T$:S+DC+\N7N;IA TU%$&;KVG]!C#DK5VURU
M8M*$X4FC",O-N_^WF>W_Y@JB[:5_&V[>CK!,=_.%^H,0*>Q#XO3/KRYO5ZX%
M216P?<$S4)3^P[+PC%ZH(!-CI\Y'7#X/Y_/L_V=OGUN"H%W@580;NIH/T^KI
M/ L3"2* 1<_GTT<T^74I#R^]VN>9>-?<?L%-=QC*&[LF)XY_E8NV994?R'4$
MX1L7EKI'I>Z -RIS'2)X:D1[38[):F]Q%=%I[M2="VR9B-@D,=1M#@YB>/ -
M\[1$K^4FV:@G1$#T9+HI*8L=%.BDYW^5WM;XC(";57SAY,NB 7VJ4"))!6JH
MVV_RR_T5AM_Q2:72$5B?[,4.IF=D"<MW13#.[M[^HDE/JABN++&\'55L3<[#
M54[>_57N&VCM.^^,K.=U;CN\701OF+N-M8:34)-\+ZB?5MW'$S=8%$!D"N"Z
M)]OG/5OS-9*RUC"3Y&HG+I7=A&<Z [8I!"@O$I\+*0$,3QH#A-%HUO*NX$W(
M55SX4@/9V3!N) L!V'(!PO)G'8:N<ON>:MNQO5D0Q@I7:O(W=,5HYM@YN\J!
M [\(NLAUA #*GJL MTVTNHKCYI:_<2C1__Y%]7)L#29$2F5KLYZ;K6N9N/0@
MO1XGCK!.LE(ZK.'%:^M:/L1]/AEA08;+S1NOWSO8>F773J)%#D;@')G2O4&
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MM#YF]4F [B<KVCG 9D"@C5O S0?-"6 +N G^(/^:XD?=!#97_,8N@'9A:?X
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MFC(YQ2F&5\W3^)C4V':(TJV"KX3"SKK"TT!7JUP=?A*=5Z?AEPQRC4$6;8N
M3$"^"46<O,J8GXOT&I$-VS^UDJ@H] VH,X*Y4U##3RH%3=]0H=.K0WA#G<4
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M+^T  3N8+QMNR[;%3( ,!)-9RGHIUBN,EO8YN@][Z>5 (Z)Q6R%/5T$'\?;
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M'0J-@E;I"$Q=@3<ILC5(  1P5YHB _H /126$K=L?EVE39Y#!5]$VC/4S&_
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M?2\9@_33$8E6:!W^]?\ 4$L#!!0    (  Q!=5B97^6T'A,  +D< 0 5
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M_,A_=APMQ(>$2KY0$0DX.QXBX&N+:B5[JC3)@?%IF"0IN!\>"/OJQ$G!Z>A
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MIO'K$E#3;BSJQCO/?LP-B3B(SQ?$9\)Q5-$AARXU3=FC55:J=O.ILJH^ENQ
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MVLKLP@V9QY-I#<_8I?O*XV?'[T&RX$H1\A]<G*L5_XW6TQDUZ!%NIG+:FNM
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M0;/C>C/Q>HPF]=*(:9&\A(X4<)F8.C2+N-QQLL!*Q!23*6*GWMDR=*YJO2[
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M(P/""I0 VHP\_;3!37NXW)CDK55[ .+H/J:S?46+P N1#C\U[6W!;-(@9!H
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MA7_:W>Y"=?6]\+[1<,%N\K8<ZRC2@PB\-&9>3U$_]*L^[;S FS([U:AV91S
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MV!7KBQ+&#L&Z[1M?T118@9<VG/J_VGY17N6B8H">E\9KBIZ7-IO&T0K>G-M
MW>$@LOXK.Z\ C'CI*0I&G#20SJX&G^]TE=O AY]S_=Q]555@R4GS=,>2D<;1
M:8+"DV.UTQ4H<QENA(M)%'#&YG.@ODS\!Q6L2VY"N*Q!L @CO</$(HRTD&=C
MWME#*IC:U_]E^>7;BQ(5=\K'9'&MJ 9P8J19,H2U"5','Y]14V %1MIG0"LP
MTE!'Z >'8Z;9*RH"0T::*@,Z5:[T;;5/LH&8/]27]8 ?(X65X2S-T&-.M;()
M8,U(<?7(FI$"RR#K=_':WLG(;N">SFL!-T9:BIP;(U44;'>!CXN8TQ6^7:7Y
M5>NJ+-]>E$*;+RM&Z@@@*K$1?BB?TL09M93.R@,?1CJ'A \CQ4+"AY$^(>'#
M2(\ OC@2ZA!%3<9,Q76 %R/%$8#%W72A\<&6;I(K2M1,G9;5 FZ,=(5>2EV#
MX7,Y2XX97YMGF6W3(%B$D1H)=GN%203#!SO2.]U\5X_F)KX;PRA'VEXF&V>Z
MV%RH)^D(+'9(L:9_8?3ZTW8&EN2D?<)HNOHH%&89=^'ISP.O[ILIJ+%\>U%"
M=ZZ<..D>*DZ<M \BG-MUJ1-SY0 _)ZW3!C\G;=,&/R<MTP8_)\VB;PB:KFZ"
MK<1T/D;!J+ .\&*D5Y)KA Q2))R4! Z,%$9K#HQB>QZ9V;1Q48WE6T8)ME.$
M'X(GH7P<BWS :Z&,GM!Y'>#%*+Z3\F(4XQ.,>N^#:2+'DCK BU'L)^7%2!.0
M\F*D%5*,#2F=L&&D' C8L-,+.7A-@E5!-6#'3DF0LF.G,1Z4V-G239.2&[V-
M9U66;QFE;TXAZMRXI@G^2^H +W8J@X@7.Y5!Q(N/RKCP,@&#ZP/>,DJ W =;
M/HHD#[<IO2,?/IHDCT]/=P>K.!0& ^BJBL"0CT[IBB$?K7(C0D?)]&; -"F\
M]-</@2>=/=Y'(D,G.=<GW..Q/G@;/=M'H$4W)1.V#K;BHWSJV&0)"[-DA516
MJFAW^9910F6>]N&CQ6IYG%Y70?:55;0+]N&CZ7C:AY,VK.:1GLFVO8D/X\98
M)^F@LE%-VV G3JJ2LYTXZ=%J+HVFIILV!I;@I&2'M00GQ5L-_IB,;[JZ#_Q5
M]KHGTI;J*S+N!6SW>K1T[6D4,O,UZ @L^'H4-E,+,DI*7D<L.9),9:87K8$M
M7H_>[MX6KT=;=V^+UZ.C/P+Z6,%/3*\];M,@6.3U*.:^+/)ZM''I&36J3\BD
M [#8Z]'07"SV>K0V$'J2(>5\:V&+8)/7HZ'[L\GK4<4SX>"I2[F2CIT4ZG*&
MHW%O0.SUZ./T3$SR^YF X!37+=(U;Q#@O1Z5W)=%7H]6GHE0X"6/$&-N\ +(
M((LRN$)+]YF9=0(T7H^RYF:YUZ/ 7]P2F[]QD\IRIIT C=>CU+E9[O4H=FZ6
M>SW*_;.M]-0^E9$*V@-PKT>U]V./5Z+8%\&-P%L5I"_RZ3=:W'!"U\WR':-;
M#4YHZ2U"P LO*PR37+3I/LYQ&,DM_'2ZTE=O3_Q/M?OI6K<+]F&JV%'7.)'0
MMV0Y$:;_ F5M>^G]STF9>_%U'MF^:RLWG"I]_>-.B<@@\SMM5V!%IBK_8FI&
M._R[Z1*LRG0$D%'\/?  LB>C)&?;5/\ZU*O?->DZFC<'UF"JZ@>R!E.E_M%^
MEMMXNX (-5V=@BY2A2,,^&N!?S4W4?L^P&Y,=?I,AE]NE1#Y2WPO>H\,&P2+
M,-7?$)[AAW=R)4I7 ,RM8= 86(*I\OX]N91B)@"JTN]Q2/8M-6\;[,14D7.S
M$Z-;)&ZD%\/7GFVIO@O"P[;J:AN4UP-^C+1S)_P8J5IXZ1SH,)R);>RG)RJ,
M#AM55 2&C!1F1PP9J488FGI!&$,(7HU<5Z^4X.+:*E#;Y*S;8Q#KP_<G]['H
M?3=A*,PGTNGZ ?LQTIFOTGZ,]&:>E[Z2.ISX#DZ.N%?[L1_!4"._;CY=_2;V
M'X%($L[ +8:![PLO38H7ZH(NUIV+G0V?G3@6UJW)!AO/!H4&3XF1!OZ_3ZGT
M*3'2YSE37($CP!E8&%0%GG2S^-/8I#7M ']&NGL(_HSN*RG K=-@J/.],_,(
MWNMF&W4N:AJLQ$F5\[42)VV?H_(R7V]X!S^9 (>:*7W35H [)]5?C7J!J3PN
MXJU; ,X\QP'%RW9M/H+:EL &/+5\OS;@J<</%Y*=+?>V5&=FS8$U>.K>H:S!
M4U\6W[UBM#!IV@IPYZDM"U&W>@=J&EJ^8W3CRU 6X*D<"X$W%T75S0![GHJP
M$'8S653>!+#FJ05!P6UEM$TO:2B\YJ+5-]"H6; .4]7(Q#I,]203ZS!5FD7
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M1QRR*1NL !366/[ *(=WHSWL+W:L_\ H"_>E3/AHFJF"5]]6^^1K,'G-"BH
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M>S9T/E;:#*SI4=+T.Q@TO!H0*][ZTE=JV5:/R/B9#)NB,0]%3RX&JS@4%0/
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MWO\*K0AKZB-8+Z3*5E?OY(-+MNR/?0.UDJQ2%"^E)Y]%=P#G$=C"&&+%VO=
M+T>"JT@\)+^R_GDC5G;L198FV<T2%[Y@QC9\7X!5O]SITMR0AJP4#'JE^-?I
MW<UX-O]?>B?GXA\#W4V1HH6/ZWAVLM@))"\!NKJ.+Z9O]!*<(2_ZK))7PCN[
MDVS05^09$_\(]T;BG>Z^.T*1XT#PMM>B(#U)R0@KJ6OMI?!<ZT__LY.@8C@J
M:4JH>/#5!R&SAP/Q'M.FOUC=R(__)_[GC70V)5EF;J1['T1_CVU/KO8ZV#K!
MVM>+&Z,PV>Q6HOET[TEF]:(5D/S,P; ZJ3<[%>Y',+*3[,Q,^I8:(&!L)ZVV
M0!0N CUEC8M>2:H#(*T-E&,^?A9)+J%?[?!*"/]36.8$Q$X)W," >Q^'W49%
M1;/B88>)[$1E'07PT \7"7F=Y8QHX/\HR!=.W10]X_XM8?0&Z+EN??G$RXNT
M(5)_%-$&O0#>,;J+(UWT-O"\X"O>;**W(LEM07[*$D&?'G[?X=XL/SI<3G',
M!Q$>6ACVW>C*+,6#B-0L#G@^Z,,=<)_>"?7C'>N['5#'^9F%_8QS(S B?5#B
M209QF+./'E057R"<S(I(7V^TP<D1!O2R29\7L3"<^H=G]Q"D(:EV!2R+;ZG'
M^"_A<GF%&Q*M6_5*/1K>/-@%T:;K'6FB_O))ZEL>F?A/<)9?TR;TU:E##M-.
M@!;%-UX&3?)_UCSY)-?I\$9-P5;?TM<=6%.CGN9^&D6'')TU9LX-V;^U["B7
M;G,P-C($SZ6',F78=0EKC46&0OF,LN%XYT+%S*XN>WZ70H=3N8;QIHQ"\8M>
M0.%C!Q2:1I(/MO3#9/?QU,^6<HX;E.&'>I3LZ;":AOD0:2?70$T5UBU\:I_^
M?_*^M;EQ',GVKR!FX\Y41U3U=CWZ-?-)?M5XIZKD:[NZ8^Y\J*!)R.8616KX
ML$L;<?_[1>)!@A( @I*HA/M&[&QW6T R3^( 2+PR\U<E90MF-E?"9CQ-[W,2
M-R6(7?/;R.3%/?LXTO[)87 ;P] SR>1%QK-CB<QSK2-(]:,R)-R;\=MGWU)S
M^_4"T4=0E/PK8H61CBNW%'<,&";5PSCZV0S&[CH$(A%?(9W1F*M.WKY&/Q;:
M4M]Q0"35_Z\H;^#T<1+E/6BSJ;')N>L*D7O$^/;O2S9HG,IWY3/^K-Q%<BB]
M^0P]A'G1#L/$EM-- %/,BF-WC>T03/2!5<.D>GM21TQ-#K*L> '$%8&NIG'N
MG%C-84.*Q4J[>^4\()69,(M2N#,3W:8:Z]'I221@H7HJ4JDR(G<96(UP6!5Q
M:0=S+>:EO?'\-/K6[M*\$ @PSQJ]<)@&DU!: ;PFRGP/_L_+,1?"5&7R(I'5
MOP/GUW85#'/;QQNG)0D+.LY=FE+$C9-;HY46$VY,:\I8<.H!W.01![VG[C%X
MC2F.6V"L^RU9/Y3XTJIJIMG>'M^&MP]ET=P_S%9P_[M,VTSJ-5MZTD1=-'4W
M)[PKC^-FV8@K<@E=I#'BI&O"IP*L0C!J^[2E2HD(TXBY;091_,[?A=:5X_Z?
M#N9)%@^J.PV!,A^,=Z!6)66"\X11;DI\.[?6)UH;=H/&/2NYV-SMJKNMI*#
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MQ>P+.HH!6D-1X"TOC$]-7?,!EO6L'0!U/J\69<$O+?G,BXTHK?:N,=FRH?@
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MQ \4SA[8A!:V=S:;^]ELWK?9K+/9O&<SM/YR8+M9>MH@U_XZEFROU'^^B)B
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M,]16$23[2EM=T;(J\IQFYVP8S>2X^N7UUM0U6"40&!?1MT^-:/ZM"<Y=/A
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M#"A Y4LV=#,0QHG66CP,]7EJX2]OC1.ML6@(:E\551UE_R==\;7W6^,DZZB
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M6\)C7(@\#E3D4;J(TI*'! 3R%1"M3;W'%IF#:6*(Q73&TT 8=FR<^66.JDI
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ME42=_WOIL)C2#L^P7S0$=K1:.[RT?M$ ^-$/7#BKV^C9#(?#81JJC-T>:?5
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M3AL3C]1IY A-.&U,V^?("6CM@H]1!@\'M&-C GQ48B?SG8:",89N2S8Q-X.
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MG40/U&M[<[+,J33WS"D%@3(/'N2)P(I& M1TMRE91OF@ CB VY0LTWQ0 >3
M;4J5@=<ZGL \]#+1VVE IPE51O6BM%?U3A.J#.E%::_0G2:D(U[M O@-D"?N
MMB$=\SI.0%BXVX9TU)LX[46SVX9NW%.Y,CO!9)2;H]8"90[H3!^%*DIA\Y76
M;X#>KZ\]7;[TXGL06?D%I_EPK0[R3IL,OE4SCQA^ T2 SW(ZTYZP5^:SG-+-
MS;-ZPE[-SW+*9/:/[0F(&9SAE$KE"PJZ&W#Q)+*(682]?H"XQV27W-8(KUZ
MN,UDE]S6!Z]>@*C39)?<U@:?7@ 4>\]P2;8NR&0GPN*567@P[\M"^_;YZA%"
M=JPY'R#).]4?V8HP&3_ %R?Z(UL+)N,'J.-$?V2K0*)O4LH8T@8:P 6'3<FR
MUA8UP-N&3<ERS18UP+&&34DS9+DNE1*23N0 *[(W)\N47$;F*%@CGOGO7!9S
MKT$ ,!K8A"4*@)' )F3YCZ  !%$1$ZKY<!,H=5PGZIO.<W/+(S0? N1,+4VI
M,L@:M;V$6YI298Q1'3+;0O1_S/ ?@LA(%#WKRIF9W<?Z3^T1S]=!_/56[)/4
M'/+\&R!(.MDAW;A-[@%[%9_L<(8Y8&<$DQW2K3CI-A)I^OZ[4"N9BF;-M','
MH#EE!B_C?P1Q>!\_)/'G--21V[F#I2FKJ.U\P=*4<JX,HK;S TM3LOP6*@MD
M_#[.2N6X]5I&,C"'U,EL>_-%UOD.J'YZFI-EDB\Z@$/XF9-EG"\Z@&OXF9-E
MYC:0:A?$#0J 5?2;D67::;0  ^@W(\N<XB2#XMO!O<Z"XV,4Q%F7YU?;="H1
M :.SL]?WE/4>BJ<DKT0$?@-$+2]V <+QO%0/ 4SA4A?X"7((8"27N@#A"E:>
MPV,_=:=]_P]H9_K:T\X1'WP #?*TI\MP*=::R:_R3![$4M?'E5#F[L7\_JE\
MTES]6B_[@,[F>$]T8SH>,T">1GMB-<[-LU9 N!,U8C5Z+1*(02%&3,<$8E>(
M$5D52"+]YZ1\V=I(?Z3EYUA/(C*,^R5Y3*+C5IA]U(!$Z$@W9!DX%BW CL:Y
M(<O2]ILYO;(5'Z[7>M;U*0<:(D!O/&SI1M$'%\!:/&QYCQ? 5CQLZ=:8W5[_
M(E,1=DEP%==?OP&BHPXSPNS#T0"$ S<CS#D<#< O<#.Z3--MC'B"">9)IE\?
MA3(_!!L#!2 8B U=CF$X 'J!V-!E%X8#HA*P#6%>%3=[986_2U1WOTX<]K16
M-3"(-8QP0IAY8Y!"Y&&$$\+<'(,4HA,CG)!GKWF0T=#3XAL4#0SB$[ ->6[:
M< !*H9@->>99<4#T ;:ASJOBC4R>9LE.W\]J!!!EL+6FSJ73V$&.8&E-G3^G
ML8.\P-*:+F>,R.U'N3(\L;UUUM%#;,#>GBYOH/BAHF]O3Y<[4/Q0*;>WI\V?
M3WKY4S*(3-Q08>ZWH\V7;KQ0O>VWH\V/3KR #N9I.]I\J$X^;I[  F*6UL:T
MF3&('"J>EL:T.3*('"J=EL:TV?(<1"(U7QQ9ED% ;-)I2)M%*"*LL"*&M-F%
M(L)*+6+().O,_UFN'U42YJL"#E9Y(2LF^3; @E5CR(I)I@VP8)4:LF*:8X"Z
M)&Y%]>7E3;[+]0VN/(CWZ[70][S-&<3+>+%:E7\U#Y[7<B7U'?&32//(G&00
M)GNC&WF_5NFKMQHTP (NXYYL!EZJ=P"F<1GW9'/Z4KT#L)G+N"=;)?S"KW<Z
MF7VW=@CO= \!3.EREV ^P_QZ"6!?E[L$\YGFUTL H[O<)>AF7''^1?5P%U @
M[36BR_I>I "1ZS:BR[Q>I !-ZS;B,/J%REMYKE?P11.NOWX']$!1(P[984$"
M,2W$B#A[/B0'H>*NX()>/OJ@((+D9T\\4A[X((KC9\]__"""XF=/O&94)R;I
MH);K^DRE3J'3\"!FX65.G)UN=! C\#(GSDTW.I0'N,RI,S,3*PT!)0A%&^H<
M*^-$Z4'1ACI;BC@!1=-N&^)Q_T,HN1*1#A6M]G4SXM%OHT7+>-V,. ?::-&B
M7#>CRH1;L18ZD+!ZG?.0Q%5@.G![M84MJ/(#PV OJ; %5=9@&.R%$[9@DDNZ
M*@)JFH.&3#+'1&PO@H.&3/+$1&POAX.&7++"["@W<BM/YF2\36Q.:B@/C?_K
M=T!JTM\#ESS",-I+K;\'ZLQ[";Z7WSD_))F)K@Q. [-798<9]8B!:.Q5VV%&
M-S:%;-%]G DETNPIR(2& -7O85NZ4;#%#=7L85O"_BZ_D!&A>>%:[8'Y'1!X
MM+<F['-K[%"IMK4F[W?SE68<+G:)RF3:_5"IV4C]0<1"!9%I%>YD+-/B^Y.#
M:+Z=^QV0A+SD-<C'^"+]!!&,RUWCI\@G0-;RDM>@XW#>&.P2R+IW(-YSKN<9
MS#&P3R#*=*[G&<PGL$\@XG6NYQG,G6<11:4 [J= ?159]U/OWP&-SPNYG\$L
MPGL')(V7<#^#^83WCH.8GN>>;F:E*R7WI?S68E6<+*WC>DPBN3K>)<H<49$N
MUS=)G.J?PAI7%,1!EJBC[A:(\Y[GEVXNG=L?$",^SR_=[#FW/R#F>YY?KO/E
M07RK#[!,%[IFAL4F>SWWFQ^-@*R^_=:K1E:>Y?*09/\26;$S2X2]O@,$7/_.
M&+C.P\OV,\2K_[X8N,[OR_8SQ-7_OABXKAN-G'I70;W?>1"I/],QUQGNT2,0
MFS_3,=>YZ-$C$(,_TS&+6?,2?+\6L2C/1RO> P$RO;@5BWRW8/'@T0,K%IEJ
MP>+!@0=69#E6'K[WIY";K?YO=0KY0VX>TM</]@$Q7 ]3LFSS0 4(WWJ8DN5=
M?4J6T:0520,$X&_6UG0C8H\=X$36UMSZ': DUM9T\[M_LMKO@! MEQ/8AO$"
M1?VD'5UNI*LH27,ES.=%H33+>Q#=Q^M$[<JG8E^2//LH@E3TN J@(CO1'=UH
M340/E/MI[F8W]@!!F.:.;F5QA-O9B-3!#G&)"<[89KT5.:!H.\D9VXRW(X<(
MR@1G'+*]>CK[J,0^4-79'>VC6A'>R3B(5S*(GC/]SU(&O#X9XG= //=2_CG,
MB8Z"Q+-0![DZS0>(.'F[F 5*B&AYN^ PRYTH(7KF[8+#C+X562 C$9X6V^L@
M,J=RIT8G\9_B6)_/T.\!-Y,[PSV'3#^K=]Q,[PSW'&;(6;WC9H)GN)_+S*JV
M"#P&RGS*V.\@-UT\[PISF5]('P$JQY>[PEQF&=9';@IZWA4XSS7[$<;]_G&S
MTNG>.<\QG[YQT]7IWCG/+9^^<9/<Z=Y9SZDD#LW>M?+5N]QU[\^:V[+ENKE5
M>S1O%4]W!P'ZUG_7]5G/RXOT[W1J?HGKLY[;%^G?Z>3^$M?_"=:'1Y6L9;94
M'Y/T9&&=?F=PYJ5_@E4![M7IMQ-G7OHG6 O 7@7DX/^&2W-> <K?T^6ZW#NP
M7#]O R7,6V&#XG.!V1R9EF?#;<. 5OT/OBSGF7]6;TZ_N3GCLIQG_%F].?UV
MZ(S+<I[I]_%!KU*).GWH )P;<(9+SC,4[(7I-SF 2\XS"^R%Z;<B@$O6,R)5
M@8CD?1PGA_+72D_Q^$$%I\\0@+,.+GT=UG-G5']-OS48<QW6LVQ4?TTG_6.N
M\]/,1^!<B$M?A^HD"1\<#R(SC.11J(*AF',P])U))N.\_(+5^"C_+<+E7I2;
M-$YZ<3J%/__JG->Z2_3M=$)__M4YKXN7Z-OI]/[\JW->0Y?95JC'X%@H0?>[
M;#K/!YURGL%(3TSG^J!3SO,-Z8GI?!]TRGYV=*32^YTQG>%C?MG/$; _IC-X
MS"_[F0+VQW2&COF=TWRI-=U[X_D+<!K(I2XPIPD$=-!TENUU@?EWT'2J[',!
MSE,,$1PZZ:/IE-?S&IPGFG\W3:>YOM?X*;II.@?VO ;K2>>4E_@%.,;E(MY9
M3S2/KIE.E/GJ>ERH:Z9S9KX"'Q[!OZ@@%!#A_P4XR>9<QYRG$=XAP)$Y9SN>
M;X=,9\B88\Y3YG,JUGGT4:[+@ZOW0F7'1QUYI@NKV6I<J+F>]-)TFCSZ:IPG
MUY2NF\Z>QU_M)^NZZ8QZ]-583%C;"X#FTV7='Q[4&77!86J56Y9%H=.@!Z,*
M,MX4/UP?/XHT%>*CC,5])G:I0>WFPR-]SK,;W-QWK,]9=H.;YX[TR6'FC^\&
M-[$=Z9/#?@.OD%\,V=)= )UE-<W?;-:$!KZ;N([Q-SOX;D8ZPA^'-: ZFZ3'
M9)K2#YV6Y6?/(;EQ>&ZFA]DS@'<?KY*=SJ;O(NWB<C,VFR&'\7+M5>NB=#,T
M;V]S@^YF9?[>9@;=S<2\O7%8?S\%YA.K(%ILE#A1C=)@W7P+L>>0U,/P^C?;
MT.%:WBYF =)-FAPNY@#238UP%QQFH]_K>^@LJY&..*2N)V W49K+Q@U/P&X&
M-9>-&-;W;)T: YTAY>V"0QH[0;H)D\/%'$"ZJ1'N@D6ZRDTLUW)E'IKW3X60
MO7L<Z RGT:Y8I*\G:.CPI?&NY@3:S9[\7+%([WR_CPKN$ZACYZE"<7)0)1MK
MQ#EW>R6V(D[E07P\%:WX!3JSZ++783$Q+M)=;KIVB>O\--WE)GL7N,Y\)F,I
M<U+*(9C_%,1O@*V[8+G)XP^Y\GPF[/@N]2"I/^3*#+H4WTD$G='DZ8!#SC@
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MTFA\!6@THE9DB8)">0T(,^)63*$ A *SXI5@];$1U8&?!2B -/C9\THZ&SR
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M$Q U'>'CB@E,<\I&PP/J$W_? /JG/L9<%AT F)M/@,:\@;GY!F3,86'IDU=
M.!4RX)!R)P#<7(3;C<0) #?YX';3\"3VU;[UY?I#L<YJ'( 2JL..0T+9X;A9
MA,V.+1PW6[#8$2;;6J1I^;!&"'.2I%E KXU&WTVR,Z\RBQ<I[1=K;P 9U-&>
M"!-R-&20.HST-"/((*D8YVE.B0W2C7&>"-G^09HX[Q)UO]L'4E6%#]!-!=H3
MSDL@?)!X6-NS"Q^D';;VA//%'CZ@=@JT)\O]ZI5=L?UW+U1VU//4O+_;US
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M FJL;E.RM/,!!1 GMREG4  U<IK2I5^<RDP>I#D0.XB.J4P7WZ6A\X!8*V1
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M":"QZ67-9EP :""5\+!F#@TD"FYKPM)X$MSWO2R/8[_5(6I4@#RGRY!/&@X
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M%?]X)>M/?N!$#\[&I)XAKNUV&ZU<' J W!O7,US768)#LB%5W<FI^H2HN4,
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M3<G6T$]746M4Z3 MJ+7G_JLHLR_D#AB_RCE8H==>3!TV%U'Y*RL"G;K$*G"
M5O0Y==E5UX%:$:R]##OL&R=RSFZ-<R=^DG0<O!6Q ,JZ6O"+54#K7MS.A0%
MWK=.5!8XB*W5AQOX#=3W+E?W<&3EBPPH("*BU'4]SF(=%JBF\(F/M(*C!<()
M?>XC+3!F@61*7WZ/!4..FF3)Q(AD&C),EU% D$R*9D9  C1JZ:\5M ;]V-33
M :5?BH%]I3596R+*Y@)*R*0B5Q3F![#X%#^P*IN*-P403CLUN#XAFG$M#S+>
M'P\(FWK]+ UD]H<#2HUM435+ ^76JX)*MMTMC*6%-F^*:2INCSCES$$#D_I
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M$U8,./E**BO-[BB@-R@'LLUUV9MY9*/+'KFUSCT/BR$?\BE9*%Q@\C3G\5M
MGZXFF,8OEF@!H->L"6X[C5"X!K1G2?)U--5#&:I#OI\[!2Z@W,P=X;ZJOF&L
M%C9G KV+7)@[:X*<A2#<2M4',E?^^(@.^4[R\Z2JK#/;+K]I$KLHP-,PC-[R
M Y&ERRC&Z2;?S\3[I[L6T*OX,2*:?DC5C!S<5L&RXC4 N0$-/I36E91C/>3;
M6,7]3$-"DLP\-NY 9Y<'I[$8*UL$Z)V]13&F1_@-\8!OY\G77!'"@VKP]31=
M^_K(#_E:OR#"L&@Z/)$?\@<WW0!53F_1'(?(+PI54XN8^<66K 'V7N]!W.XR
MRY:!=H/EGTGS BL0'O*MS5L%+<AZ-2&91OU%JQ5.P;[-?+!-[[!T%:"WN/9A
MV&?B8- JKM5H66BW7/4AM>ZY,0F&[0S]Y!)^0X21R2)&_22H[.]@HOF*9_<0
M3K>_F6% G70!0&JJE*J-:V*,Y+ O!/6(IAN0KUT9D,7J3-VX:YR2CV#\VLE6
M ?K:U4%])M\Z?F/2";-3YM^K+ +:YM%KM3JXMT_Q6;7>OK:4&++HRW!^QUH7
MDJ>?=HACZT)D #2]H!!*?,Q23HM/5F^\.*&EYQ:H57Q0VPT@LPT!Z*W$8]T%
MH3&'#M]5GV_HT67(K.+5_4%KF^6-IJR[B]BJ; LCS]#^-*"WL8*T75#$_F1
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MJHDM-KUY%<=#-S-SDK4D,Z8>XS?T.D;"&AJNK*6-C?)BFYK3K"5\C??."TR
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MMF<.?D(.."TC_2Z:OR.P$QD6I<E9 .LO0/&_,I=Z<YB@VTSE8%\BFE??P2S
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MVE^>B!(_F*#1 FK14HZ=K!#)SE4)D1905W,MI?Q)MJ)FE:+P2V%Z:0,P9Q5
M?0(.<WM-.PAH<E%1Q4U#QJI8QE::H>:V':$VAO9 ^2_-<R(]5+*)MO(JCYIU
M8BGSLK&SDJ^*QMO*M#S4$;?SS.X]+1UX")]QP$G\-[I^^U?N5] FH'-*D49
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MX!5.9_-BZ3N">1HP25$.FF*:J>E? -R-&\>;>11_=V,_OZ B>/9'FG;_$8#
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MZ8_\S^LH+&HYS^:U/@TF_3GM[6 +Y;S@W!]DZ1IAA>!S1YMV/^W3F;/3!Z(
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MLYMG.I]57W\TO3/"W^B):W]33G>HE/>,5LWJ0C_8JHITL8A)XQB=J],N.U=
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MIOKCO/U]>SK$(N J@A%IM_IVC(-,*;TYBM!\3O7VU("].+*9[]'#YV.D*EC
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MK55?N?'WF1#P%C+M2JIEKK5Z1P88RT>8#%B^&; L+V5]/C"#N'/,-J4HWG(
MJ2_-P,4SX,*0NJ= EB%X+P#8!PJP#QH'RP#V\=#VHM%VZ:S9-;T*)!P\ 1(.
M:HV#54-""\MU\5P04&+WC&=WXX2X]1G;6[5Z<_G$$WBGL;>U8&R,[1N+%TM\
M>Y.,[=N!I<JL?#X8> Z+XD^A';E\LV*0(5&2#(-XXJ-UPW"D GO\$AM72O0T
M"+%NA#"\;;LQS## +<-W@U]O!:I*SSL,*):*U*_(N9@#Z-45*&DK,MFNMXQ1
M:ON5[U72Y:6M[/R=UNKIL@%> [Q+45,=#%=)39\#AF\+CLI^EJNR<YM3W7RQ
M?T_!PM["A?0WEUN4B6KG86+O"3"Q]R)5V.? A*$/;Q 6#A0L'!C7OA%$EP/C
MI2-4Z)W5L[E7BB\VP+O)P/OR >^KHZ9O"Z*VD22U&FD!Y4;3$"=#G)8!X\93
MJC4W:LV51P$;X#7 NV0Y>AT,5]>HX'E@^+;@J/1GN2+.:$YUP]C+)/ X(*@U
MJR,<,3N>1"RW)7(<>5?^C0-]K.1'/>M=S8SGQ6&[V>B\[WVY6GJPOV U?\5(
M2=6PKG<+H*&OYVPR8I$-DWWBEV?>QXLG+ A'7E TK#@TBI%Z:-S,$.^RLW]P
MX3)NH?AHY-WE-O."1<B*9H840 ,_EQOO*G,HRVY-P7C_GL!+?WUE2='")TGT
M/O[WZ"E#CAX:<9 L-^2WJY.Y\ WWEA[L+SB6OZZ>"]^/?+ET\/T[&WJ.S^;
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M;P3L")P J</WO@-@#\/01?"+>'?L,)JJV?"V)\(^.T;I6^#,(Y@B,<1 V?9
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M]0#B\.)%%%)H6_%7&_7=+NR#?4]?K7T#(1!F3T&^L77*7(KFZP4.ACNHIRX
M/M!7#^MF&,;8 ^XO0JC$?.%?#0)D!#!%/C,_9G<83UH<19(-7E:[7[RS[=U/
MH/V*( _K_!;C[MC=O,#DS-,5^70-P_Q.0T?+<. A^R+$* .ZV1C^P@!]%6A_
MQ'4JZ<1R,*#"<KT!QOVB-(Y>*7_*(^1YF+:N_7/@>SA$QITP+8(8"2AL('9
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M'8MMX&#I$SS&.#>IO5WK2-0]Q_Q_PE[$EOR)S&@):74H<9@_R5.C_A"PX9@
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M9U<DO NL >D\?J)X7LD<KQ8N&M%ZW&BB998(@Z.7C5V-,OJ0T#;L3&H3CSG
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MEG1V\IO5>;YM/AD%5%I'(VKN(XP \KZK(78*HM.\+*I.@&;)Y!9X'.-%4+B
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MLVBH:,EQG<:@)<A^@VO-"CS9EN//&Y.-?)1DPV<$E'"L* +#2T'!MPIHD:/
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MB!*/LXL)S"$OJKP6=PZZVA7>+8X%'V7J +$C2LQDB0?UXU8$]&4O3J;U/\S
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M0[[L=3EG;I5R4YB<J=CI%36AK90^)PP1<$P[+3J&\$\3VQ?WA[>==,-=0N'
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MM5_TNBNK-/O)+T72%'KI57O*O+"T;S1YE1Z1>)>4.W0O&3<%6=!_(U=]2I%
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MX+F8_%#5G"+#X-NDZBA@2-[PDD2:)]4I=TY".B<,=#JZ%UTY&5.R%8B]HU^
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M3MIB#+:GG>0H7/V!OX=]:K0S14NP$ZJG@D0T"Q**.J?C%F^437?:)G(GFK>
M BU8BPDXP>P$1 .TQAEGJ8S$'7-._'W6/\N9K9UP!:0<1.JA4GZ=MB:*1"/_
MZ7?&'P;3_05"!]-8-?/=FOH]Y_"CJ7X9!YO2/S-:A(M:^T"X6WPJ@^)T%I=D
M0)B[3L/*:966!26Q,;20#2UUC/4:ACF1,5:]R%]TNZ+:W)>B&?G$@MF[TI-5
M*+4MLV()17/<OUU+&T12&-8E/P"Q7WE-R'I5&VK^)4?HQFL8DN5,6QV4^_KZ
M7(-OX[;92CG)LE/30#P"E'=#,EE4)^ENYKSL!M6,9H.B$+Y#N;CX^JW/-UPL
M8%9\_=6VWBH]MHUIZH87ISW&'B@]+:KB9%/'W\Q#PQ\S\D#Z+]#$.?[\] RH
MF6CJ#-0AQU[5SKTOF/34P.<Y:]L99@6@*8/<5<LU[$X%7/P3H9J@JT]U39=K
M5A&B_MZJ1^&0T5K!M<4A@_&*/R_8^PCM[N0DOO%4TMZ:=..]JQUG^M#Z<@^G
MVDSBO==B48SUL9]UUM(.(](HH5H3%5G@GG-K4N>_U[+)C6[_'TJVCH+-V43;
M"-4I06+$<9/J($HTK'R08S/"K*I[G&PC5#R#K'MAT)D\1:1[8@51ID4E-"A=
MM9;D;[&&+F2R0]JV&UB&:(,J1[7$LXTXI9=&W4_L8$1&7+,H!U=LHB_T$N]Y
MP=&5RK+*\TE3.M4F)P)[TE"MBVMT+9SBI2<R<1MG+VL3P#,%BS4S>TBHY1X4
M+6IY9M;F#"E)</C# \G^/NDCR5^*_%6+\SI8N4LHJ3XXLMV7I%_J&-AM&7_N
MY7C\ ',D9,;M7O[BJ@4L2AVNM)N M)!MU-LZX+NI,#6+>OQ#FL0,6JFQR6L9
M8]0D3,'OP3CR\6[#B_>"GL:F6:YVT.EDMT&TD54K*RRH?M38AF-T6T75]G>$
M<H/NPJZI7065&$8ALR7U:J4O=.+=KNP=+TV"AMVXFO9$7K1JY?1NYBK!!O^>
M?.I$!46217]1M9\B>&H%?# =V51/3H>W<00PAAC4.16IF#BG+4A8"HFQS.#&
MYZ@D;4+=T<E@W7<\A*NJ6^KOJIA67(3@5 P)+TOF%I;"_2&ATP@U&"^ 8K4#
M=_CXGYIKD#2#L9VJ3> 7$L8FP!@1?JJ)XD>;6$7Z<BER%_F](45N_U?TY%5Q
M$G?K:06^(!V!S2851H,%OJB.3MWPF9LK7Z(,ORD9$#O0ZA?PGQ_$_50K3?0H
M1Y/#!ZJ7$=3+\/I]>E$ZBCYV_!0[I9,V\HX*"1B;USML_[_-)SA>8P4M<$@S
MT>,\=9^--Y5LG\7^_;-1_>XI^:3W#X_^K'+1^,'1_<-[^I-[)LPE3PWXB_M_
M=D^1CQZ96RG+%8<(*W/ELIFN]=0OEQVI Q%\\ZL6_*JITS%P#3F>]O$Z02$N
M\27E-LDO6D\*=EHNB)N15\3L2LC,<0:@NUD3.8KO8CY>UA]5%X/O=Z5>-.UT
MTZA*L"!%#R7Y*GG?X[8J)J\*Z%0!G09_$ZA>![UKRHR.CPA!W;&,C^+5IQ@J
M3D"<W1,"L5'VJLXV%_!+<KBL><M=7KS("+2SF&;%9*1)>*-2&32*K.(D&VTQ
M>]# *(C1XTFC;=$&>%$FF< '4C%G\=A3G9L][K8L)Z)K]?+MBY\G1_&<_)\=
M93>ZI$[Z?XAI5_[]W,2BV\GQK([1[L\<IA%]K.AB3>*54V)N0R5!6#1-.X2T
M2"3=0A0^&:+P^!:B\*7YC_^25/1^*L[YR/V"(_03).Z?"7GHO(QG@ 0J?V?Z
MYJN]\F=B#;5!0G-ZJM#3VFT3;4X9O,*/$[GU%!9>),PQ8,>_6,4IVE%^>H8X
M&%I-*D$SCW_Q6_14HR%*%)?@J!"6(&@DS'&EQ>< C):(]30#2<;0OJ4G&RT?
M=>4(D7^[\2" 1BS!/7Q/3D>+L, >5<=JH_8^_+J+WOA",:.XH#8@;,5DD71C
M W412FY79Q7'%L4"<C@=$[-/8I 0=S)R>B]'OG(Z.:OJ5=)'QHA-T8+$C,L%
MH<W#CW4=@^OGS8ZID)_5[;HD*8/C^"YWZ(-RD_SX_)E))++_]XIEB41?\8W(
MA<:_F_HOB+LC7AR39ZNB6K?\6^@/MCHR"R'?0*EMPNC2[H(_FTO5REB.XU5V
M\+=J_@X@#7KA75=.]:*2_(!3I(9^W6YU B/ 4/#XM*JQK2\"T4G=/=?G]1/O
MET27*7H:' :2>A]1S;9T/7 98TFG$RUSK'ZK@->E3 ]:M: 7HGSQ.(240("G
M0K6C:L,\Q#I5D^?$^]LI?]9?:0//Q2O_A?P#^/DO-RBSQ:_^;^DL<+/=>X0L
M(@WF+[MU/*=O5.Z7]D"0>?_EY7_G6^ 9KD%.LYHR/*M]\#^KA3UI:F*;SWY^
M(__UK4E4CUDCRR9$@]9T[6%X"]=N;[L5:E))O]5R.60'T[(G,PC_2K[88[M=
MULZ/1H).85]78VO?0AT 4**()HK/7MDS@=15M--N$+\].>N]WG;.X X,K6Y^
M^* U@__C2@1^,=U.M:I.+W'LYGSLZ+$W;C1UB*.GER;@M)JAJVZ$_SV\VX!A
M>G5AQ*V<A=0.%**IN\#_MB05S=H2 .:2 \U$[W3 U[N-*E+><>2Y\7?O9$0Q
M(&VJ6<E_/(M3&??Z DJP,39'\D[_%6-'JL*OI/N$_WO*K0K:AH6@(49E3*>[
MW37S4U!H3E&IQ7_ .=/4-Z#"2C//XP=]N)E >40Y#2MN2VH$CRVMCB>PYTIM
M'@UH5ZZQ*\0^JW@E=Y%5U 59KW2HG&KF':7G>9J.LK6JZ%(F3>*@UHLSW&2U
MTH9-DZXV.KY!/#!Q4T?'HEA0O8D,20SYQ4W31IGX1MVII'>0:'*MJVB^Y"I3
MTFHAS:FXG\B24$Y)2U'IP-%O2%B+. 9G=.Z%8   /C(4HBSK# GL-:$6XLV4
M&C-ZC\^>21.R:(KSS6035[0^)_F$5V8R8*RJS5F]0CCLMJ0OG9+@RXF%K*P7
MK).#W47B]?$&FO'NEVW19IM&>FGDB6.N(&?U+BB;34:,]5<NI#Z7WA$[*+WA
MC=J2+!$%;1]9LM2RZ@#W*8T )"<UK2\"X^9 *U6O""E000<(Y0((P\01Q;W0
ML Q,TBU$NZ?,+0[]:4UQ_")Z3ZT*+V&)<T5?'<'V]**-MJG@+1-.ZQ;X!.IE
M+#;.\_6TURN$)>;M^;KTJ%!&S\VP6YE&9P=9#VM<?I0IZ!-L3TW_8G&).^^I
M<NE MO74DC3#>,2]O_:,+2>B:0Q+5Y;0P?8"YZHY'_^65']K;KFCZEO<^DJS
M+WT74+WB\AK0)$W%R.]%O='64%B78J[)N_@V8U^&14FMSDKOOY0BF\@;JWJG
MC<0Y;E!G@'H$@@&IGU;)#-BA+1<F,-+48,.0UGTJ89[5U0)9Z5X7UVX3+W)>
M)]B )-W<>Q'TP,@73=*]4SHNUZSFWI3G18,K9DOP(6=9#H.+[B#)(<WYR"B[
M?8#[QS_?[9<1F\S?.F:1X[J5W.V,5!K[?YC.L"6RN7A85WPHDDLWZE)08(0B
MQ51JH">%3B2@"LE(6#Y7,N,,"2D(SU4>S"X.Z']9)YT!(X%_RZ3VDM.LRG-,
M07P0+2.APB6AYV%-A]$=/I,N7_)IE>;?77ZG.E^E]<K!^'=^NGDUB@V7.CF)
MCVJKM RS-Y"](U\XW&WEKIRJ=5<*.E ;8M6EXOO@DF<GAV(1@_H-9C^H0V=7
MO#C#BUYS8R'\+TPGTM'*V,HKY(J!A]R+21[@"KEPK57(%]'5% ,=)(%EIKHZ
MJ M>=5G+&IY(%KSJ6(/&PN3#R?_-(N;N2I<U3U=D*FL($:-U+DDC+)CUYC;F
M(MHK^]IX=4=[/2$N64J=-R4J6B(&E*\4>PQQ'G^NF[+FFB)[^"Y,)G^O=0Y?
M*T.D?#9N!/?*UWM-,M5@HJ#(1>(*2$86N\6.<(XR!G%PT;'>?S)/"%(!(:4"
MXMTQGZ/3](0<9_Y0/ED*2-4*OV6\&7T4]Z /Z>W[^DF';''I,526":Y!62/Y
ML8LV_9:#>61SUC$\B[N7I1[?L  YO<19_CU.A3"_F-E2$MJ0FD/B[UW4F=MT
MN5O2<$;O]!MUR=YXS0!.97D:\0L8 U3"NFC3 92<:T@N2Q92(B0+70F%)B>]
MO>R(]E>\-_M=C.7()RC6Q8GRC!:RVA?I6.*K ^_GZ(6)E6!O[H+7^E6&A)J*
MR^?)R[V]5!%$V!V80PTD_+YM):4([4#GU07UZB086%W()0^_B6R%*?;6SFF%
MA\,Q"F6 7&R!VS1]CA/%=/GI-)IGV$/.'89GE[\+O*1BU[*PEEM T:"TR9SE
M8#2;(B4S2'"=^ ES4NCQNXVJBPJ7Q.FN!8Q$KJ4I(9,E '6G"2KU8C5LP,FF
MJ'5C$1TW=&=6S  ,[ KEI/;_.F4U!/SX3N)\\K#HTN.W5"LN57,W=DE[B!G4
M#\WDC%!VD>7H=]SM[6PR!+"BPUBI#Y4L<):,%:<"<3"5%);I#I5%RV?EML[W
MZ76^)[=UOB^87QSN<5?4TC!U>-.$@E73H9Y+2?=.0$TU!U3+:B6R@ 0K-0S"
MIEB;+<N+/G?@)RQ=(.2U-'@$[;<J7*5?I<D:N,0K=H,5.L%.XOV[?\87UMQQ
M >.GV?)DFHNY8@VB3];NI$^%/B9(DAZBUPGX_A-5_I3B3@^U!+=FK\@-(K"+
M3Z"@1)<IW9^*_6]5@M//^S2E%>UI8IRGSA0&EA'-N&;8 ;3P,WF.^HY.P;*1
M]V"7@($?/L\BGH'2G94#+A:-RR_SXU#D&X9-+D% <=K(J#"[GC7#47,\LU[2
ME_&')UP;,YPQ1X IVB](BY&;<NSO]*X3Q[7&=E.D(M)6!@#)^'RDY.3'.[RC
MK/Y+.1S5_LPR ^D>I2*BN=^^U#LY*^(>YN#\&O6V42^]VOPJ:,Q6<-%TQ5*E
MN2DUZWJM>?IJ*B52E7NYT3+7J[AFVBE'$T+ATVYC/SJ>@RKMZ.G31SA5?WGY
MZO@X3B!TY#.N/(O+K((I+K9.$[LMXRG&?;68\CT2Y-0Q@V:T&(EN.Y.EA=L%
MC-7\-&X,[O2#PX+DA3LNLW)3+JM.CXU?8ZV)H:OE@ EAHF<.-?,]PPHD3/C;
M;ROQO"@CM&+W&<'P9=_KRDPS3HRRDVBSEMDD]N3<\Z@VM6FYF6QO 8M,8=P>
MR.="CK[0D;)AC_\=S;YKOEP6W,<BSB0;%.O;&?B%>:@>C.L,42^Q[S+6S$*&
M1;DBWB9NS;&P!_[W<*K:Z3#?<#CY27W.\3K]I A?,O,S^?#,S]=!\X3:(6I:
MECHK</5KEQ<[YT;#-HB;4TD9MR&O7*LBP)MV2=>-%M(T6\RSG=U5RQ(7=<$8
M\^]TE2J-K8Z?'8\7:?EN6>3 0,XX^D1QXH/+;T+")E,E16/J^!^S"@SX<QF+
M)=^%R+WUH;DKX8?+WI=OM76JZDYZ55W*GJ=*S1V2+-WD9<E%3;@*##3.3-NA
MYYF"ZJ[A?VWK157P/UC:.-JK&AY5_+-O4[6$HE?[+BF9T +2R.^D7T1'IX*G
M0DKHU$R??]2)LO!O<2KB?L18Z+OB$2D7P1$X\N>*Z.?$N9!7D'^U/.>D,^V^
M%F^A3Y(_7U>+<W+YOA6N0TJAH":1"EO.]3;JQ,!P*%6%-R;%Z N5*ZQ/7B@3
ML,ZR6%-/UAI"LU1WRK:/)<N=X++$KTR<._6-9V2154]I=>&+&0N/I>4ZZ&IE
M6VPZ=I+JQM%"ULWXJ^U-%H<\6>R 73?*[>1]7\&GN_IQ$<=8G]#UPJ:G8$5V
MH)DIDQ5Z$)=4 ]3/QYM!$1?\UWV\2D;\M]V*Y#9W)#<N2Y2QJV&7\C.LWA&<
M=1O+CC,>@@T#G<?DVH* =.AH#-T1YG)NVN_W3 <#AY0W>%_DU:^X(OV6?Y;J
M--$3N;#=3O7K#?;-/"%73W;5 KUQ"4(5P\OR#*4)^UB@C^'S'AXG/G^:A,10
M"\H/XT4VJ^M!"^MB40XO%*Y*,F*=XC(FH=0'!/TC=^H=9^B+?\B1EXC9BJQ;
MX _C9$GTTJN,I$Y,3*9[.!Y0+[MRXU 1 =E&HKF-;@B.)@R 7("<>(P+(--C
M3[.%B+[NJKXHT?%$UHH!_V0#_(T:Y_(DKK7VQLK3-0^*SX<,<[:4WJEXJJL%
M7:K]Z9A>MN6,JIKNU=YMB[P""MS>X#4&E0[#:W7,^.7K-IH%3W7I[. Z]HKV
M>X>#'-@2?@D%0&74O;1H^0EA"]&4DF%%#'FSIO3%,KX-5_9+V(F$5AQ%K.CA
M=WW[093*1]$8;J97"FGWZ$(F'N9\C<]X4),493DZJ@$STF E8\M,H-N/.@YQ
M@X;OD9)& BCR8Q:FC4GBR-2H<]J'0Z+B'M_&5:W3&P>-&N/_G^T$ ]??=&-3
M@7:Q/I]*XW"; %KE]='"$R;@H9Y0/&0SY5_"K*+=7;N,W]"#L?J5XVF*,"]#
M?F<<%33#U+F3"(^GJ=J%A-8T*UH.D$*#1-95!4F]T7TY,F@Y,K%?QU6/=GRU
MEI7'_;%3RKQ!CY[>^MS#\&'$0TR>C_4*F9%N1W=(9I8TPN&=>GX:)^3<:Z/'
M[6R;O&IEQ] &MUWC[M_>"0WLSE3=R-KWD?ZTN?+E=MCRY'C8VK4?LG@A+9Z?
M923C7 YA1 7B9D-DPAWP;2_.DA@4QW[M0IN4;@30_8U]*%A#.Y7FD"B[_P A
M2K%F<*5O>/ ?3JCWH2ML7_2CW%G/ZJ;9;3L'^!ST4CQ[9;T47$&DG_ 5R$B"
MR7G=K&)PM1!7&9#DYD(:3QC.S\5@Y.F<#YGB)<0>%# 7C:%8)6EDB?;DQ-71
M 2(F!)74%JRQ@HE8U-! U?J/=/3^>4KU$7!$*5MFG1@X:%3EYA2GP[APMD!J
MH^T?4%4J423O5%W@=F0*S)"JTH)@E\UAPO2Q#88-24)&B_QRF_-B";@3 .!%
M2:ZC].P$:S[ML5.Q$SPX](/%$AF+Y8H^CL^L:GC]J,(K(YKN%#A(ECX7.BM%
M+_*42.Z!RSTIT!ZERV*'*H$,IYQL%PD9QHZUZ"DM&^G7W8QV,'%;LZY<D">F
M%11>MSB]:")U1.4YHYEO;%9EMUVJUS3E_-U*I K2%4CU_Y2XBQXX""'8WV92
MF'C+ 8HZ@(>TVGC!<7QYDGZ+ZRNA=91'+ 83.+T##1Q?K=AS(:EH0<*04D5!
M@NCQ_G^CC5NNZCT]&K?%]0\JKC^]+:[_#EVHQYR:I^QKV: ZO=#,6S^/$5RL
M MXN[;@ ^)$R*',NBK3:^2>]4EGZJ*,[HEGX$#/+*E]#RFH:1L_@5&N^_3-[
MXW7 DU4]0VDZF[0X/9M%.R^V) XR:8IM1;BP4N(DI2X,15/J=<*MP-YI,0HP
MW!#3K!O1Q][3?)+[H65J@>44AE(7 (DU=65EFGK1^YCF:XVZ/56#D-WR+ 82
M7OCLA.>3D&\;JV-9-KPC(TUQ 65ZUYP.J#<AWTP>L)AN8L20U;N28[<X >0$
M&$V:N4@T66W)C;NJ7Y71Y$TNRBZU<7(V!]QZ06+@RS;[U [8UN%UJ][6-QVP
M03STEF@::&?LC ^'B\&.\.TB5'W^5G=V'"^K\[5T%O)&YKJ9B))(2=B-Z-_0
M;&C."* 0+/TIHJ^Q10]Q&2E5UG&-MU1-$U$K8AZQ#>]<#U10Z3ZA0FNG[K:.
M[IEV4#2*?LB8NENN2>VDND4_".A0R5T[[TWX,R")*]E0<;Y/XS%F[[%U.\@H
M@G*N%A RFEKAB#4-T/7IIX;EO&KRKV[RW%]JKN -53OG;:_3)@S0-HEY@WO
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M-UUBT6X0#FJEZS2K_!&.[81FE--;VORH::<+"0U!E-AKA^!^#M%C%L@9\8X
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MX2CVJ*;=*JD7+C#?A0GF+4>W,5:797Z6W6HI-)P&HUB4Q*&6E5EYX>*/"Q&
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MDIK!>ELN2@\J&$VZZ^)-PXLVFNSFQ7LM\VRK+51,[=OB-"RJ!=,O9MB98M^
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MW_4IF.44C]4'@J#C]:F#0*7GP.[?>/UFK)U&2[LEZ]5U;A3E>T=$Q==NZ.<
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M.+,$,WOXJ03J'U_>_%W),P?U#)%KOD!Y;5NTSNT*?2W0]M(JY<TV7V6XD?[
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MB+-]RU@QOTBKJ9^%UD5:0%*[)M_DT^(7Q -<GZ3^P8IJ]6-V)?5/5AOJ?A(
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M;H!;I9S[D_P6]V?C&;@*X$^Q@15#PL1/G*D$L#6WBS+D#)N0L_C:QR#QQR!
MG;BZ6CI0@I%SK@#R'O5('%JN-Y5B/I;W?D,\:Y4D]+<Y&.Q]:#;(XC" @)[T
MT"16_A>Y!'BC)#^R)Z,K^?RXN\T44=1^%C39,@]BON@\J2_/6^!8/- :BAU"
MQ,)^#$'Z/*)F7D26N6\2M_0FPN]^>.W,&F@%_3YL !W.S*<_.WRE^)CU$!QZ
MW9J)X\P=Z3W@CZ4 )G/#<<:F<1\\-&*A*&8CR<7JI)BMDL?(;B1P/7,$Y@)I
MV:P68XL^"(V[71S8L/MTZ->G0Q_?IT-O6(H^< 3-0\Z'-VF/,MZ%0!R\C(O7
M67?S];K.+5_2BT^Q>HUB6#3Z9<O=Y_V^^?4P/AU8:*7DC(\R/!+RPJ3*2[(X
M#/A'=HKFU+@N0_*#$AAS:9RH>WDDL0Y$OU-[-.ANH4 4S%_ 3:<.R<8OVV[2
MRRQ'ON2:(1:$O=@="K >K59,\$P_LR^A$19"%HT20,ZTNH9-OA/0;4F6R(-:
MNCW63M5KP1EQSF$CGI&7EL^4;I)%J'R:F/IO,I^$E()I@C2R-0N _(,53,+8
MGN$YN0B;LIH[?#!&8!AMN,A/TBH_RZ1=7!W:_CWJ*:)F[+;TXE\!47#7Y+@Y
M]"_2WDQ*N:GRE4NGL,&!BVT68F_U#3,^VRB!%-QB$T$/PH61SPJ-&<XB&=6,
MBH5]#<K((Q#UW3YM\?%4]W6C?<@*F.@O;9@O97G%I;V;:F0\Z9L?%B=PN,RM
M0L %%,K]VJHZ%FMV&0,PHI0QK"^-&21L72\B5X>< -,#GJ#+Z)QIS#\;\C%;
M@ ,LQ$:V5QN5%:!2ESU2G-[(UU6O1'1Y;S,/0QA3, RP$!EN@JZ6;!YS0H?\
M')_7_)[1<=S6S3@)R]&"PC)F#]FVR,W/3/6H+0L0H: B0^B&+AW>3Q*(F:5!
MT<1090R[7'?!HMYV+-;7M006*>I&@B+WM2:E*).SFWSHU6DX')M^FKR8"<RA
M'&CD;@HE2\<]U@/$F!:@33:*88DXA#_IG6^NGBD+?C^ST[AJ",$N<-&9<6R&
MR_;T2TV4VK,/1[.!\2^:)C.FZZUF+P0!,(CS.ITL7FV\46M^$J_#F/9E5G2Q
M%D# I.D*K1R/4T2Y8U#60H3$USI<2F(N6N\>^.+KMLGH7A2V=B@*%'UJM-SX
MFS47U;+7JWD>6T O,KFL7<<MG*U@;_2&*BD@NLG$3;*@=Z]E%$I68.YT]?M/
MX1)]"5@+JJ/?\XJ=!7QF:BYQ<6L'+J+ST4WTYBS)74V:Z5>/R2CK$<36UFIJ
M,C,('<KP<#9PV(RQ_)@B(:RMC:;P;0+6J"+IG##QN8[X<Y5TP:P:$JY9*%\F
M&9ODS$'F!#>&XHF$V^E.@H#D _WSI+5,(8S$)/2\%0"<C<=9/F7<C1+R;%Q<
MEQFNXPM%%6) F4/LEGV9+I.*23L-PU49TB&?T3$/ >'I.:H/6:FEK_1A;+,&
M-+F\;YP)SI@DJ5G*FH_)#/"G1&QDT)&%&/'A05EO_H3=X!<:G'M!_5)<661Y
MD+_+B&EXRXI,*9-NAW_R(Y]HYIADK?6L)H/:X9"D<Y(U3/Q-UI",\3+"2),P
M&Y=9D@7<K18Y'^5H]%IAV#(_:F?U[0$;WK(BY6D6I+H42DYO<PRJ?+0X4RUZ
M4<"G>L(>]Z>5]*=U,I$LLW8>.EA3V2?L4B1,T3C%=6J]:3<R6@\DJ#M%?779
M@!Y;::+66*YP8@ME9 ]8 1N(AJ@--1'#A0R_.[*BSK@H*6"##XY9#"9H[,.)
M^AW(7WI9T@]Y$<K:X=U*4E1S?N%Y=65.W\D2ZS5'KIE@0Y9:D%!CS\DG7'[+
MLQ*-$ZF+/1-<I&7E:(;"*"V;&*T2M5NAI <@5B'6(L/A!HG(Q0M-Y^3*[IG=
MH7#6]^Y;BHG_ ![W.3!(@#GS[>K,DD1MH?XBI<XK0RV*]Z>\Q0V'R<PSNYXT
MQ/!C=CE*CQ\?/-[9?_KHL8)LY]%?0R1ONA28EIL9Y"MO6L1#8$<ZC@-C^T-*
M<A2!,^Y^5*LM"$@N5B0-0@AH2-VPUBVLB4]K%0P:61_3@HFY%=HM#A(J\XB_
MGM;#D-:"7RBG@YD]9\6%)5/<%]:++06HRZ^?>'!:$MQ7T_N'1UK.,=-[FJL*
M!X85W)2RO,'B2]&J-4.%XTN*UG#9))RO;&69J_0<6$NY*6LE%/_D(E$R=#N0
ME03<E#7$I(H1':O6>[7O30,D; YT79X[(0L^R4C/3%<\/AKM$O>:]RA"86R!
MQQ,7R+;:!8]8AEO78[L @YVP34@F3<%&KM-*K4N3N3&E7 ')9CNB;5,2&,4)
M.YE,:BV@!!97RRX/G=<*4CI%L8Y:P>'\JO62-987L?[X4%UK=[A,5JNQ<"WS
M,]AYDIWF5I,V7V1L##MC=: H6".I20QT+EGLD71IR-/GI.NXS?O3@@T7N)@9
ME(#-TV:&&)>M4[0>;"ZM #1WM+8VB- V=!9S[2YQN;/-*[-^AA3'3X<EEIZY
M ?QA8U^9PS*MF\PJYBZ;PN)J8]R+9*L4=9.4Q4<%#NR$N$H,28EX^K$KXR@"
MO/E(Z9<A$. KY/^;D6S)"5%#V3T*RG[69/.<W=]0^S@N5S: DYAQBVUGYY+9
M0^WXV</9"0^2\_&*XVJ!V[3*.W^2INP4.L4(9V99R@F99"5([(6=E^4BN.9'
MS!K!RM].56T\40CG39S2$\TQ<!)LBVA27NK$*_+6A/EPTZ*U*V$W.958.N]E
MIUX47L=I)*<1Y?%\<?8OS6)3JY!55-/%?&9&]D:)3#:<U?;<8MB.M("6GE/G
MDM;(P&G>R+WBFHZ$ @!K-X7GX65O4_C)\V_OU+,=]_[DRC"4X$%G8>&.>LUD
M\A13$L]6'ZS!?>A=CP(LJ1QO&'"TUE%>.#XV7N(D6&+$4*HS"UUJJ"HH%XS'
M**%73,,XD?QX-AJ1KFXQXL$6W:"4[&O;R8X+OLZN3B!VO+-8EX'M'>>K6IQ*
M/))15+DBA3NVN(R!HP9MT.<UL5*)1!JWL?'1^S@*T+\&G.$<]IHPMC.^F_]K
MF2ON9% <'%< ],LI/)!JLMEF-RZ@ *AI((06U0NH89[W1A(8\9:^V6BLW^?O
MOS)__^0^?__5"8XXF?&^:#^V$CM1152EKUW\ &<6A9IO813B[)^>DZIOMRTC
M\\&EHL!S,W%AR]J&W?*P&2<C+L:<E>".]3;]JEZ&78V<8!16>#QS%4=7;KU^
MMC\_!2D&7Y31\4J) D?=>$E>OWOK0GP)6ZW,F.:6[8>G3W;W]F"%RT-'+J;;
M?YG<0\NQ*&F8SASF9CL 2 [XOS_L'SS>W3_PCS/_N42'(?V=_KJ7^+\J)T+Z
M@NXNCMH?[H\X$"G6Z77V6,/%/V7M-/M7^O>R'M.]]T9^R!>5[GC><^.3+,@4
MS%S/IO96J8&'ND^Y&25&QKVU0;G$B+'N&2I(LP]=_>W1B_?'3X[&TX/'1T=[
M^=&3QT^SP\GC1X?'QT?3Z?'A\=/)/83?EL*EW0H<GZM:#-BW&)K?\P):-VXO
M860!>CDS @3C0]\V*.[(=94-+IIR#V!Y+_UW$RS0N'ZE'K?R5\\W@!^^%^U[
MT?Z.HFU!MIS4=#U'TL"7NOHX>%##Y0PC7VFH'Z7+RG E GA#MM#DCD <*&^X
MYYG.T#U.Z[U\?EX^N<:P^*2(-P&$WV7.M:*&&<(VC -)LF]H4N1>U.Y%[?.B
M-CG/JC,)GN=94W&5*IBDYL9!AE(P@#A.U4X>(QDU6392EY956;EJ.ZEL#/U2
M-RCU3ZU"1'O> AI9>\2]O-[+Z^?E-6!-MXQ.X)<M2%KI1]P7(]6P\N\.]8]2
MLK+>%Q&2&82H[9O;)&Y=5.V)?R !&7B5 6"-5UI0G$W.&>\P\_$_E),N*^0R
MYD5)BJVN\K_=JX[?E61<5W4HLZ$EYCDO^8FY&8#AUZ8!L6C@#Z!NDE.<YQF+
MD3/(4*9FP_&9>U-,TL:NU1IUP,-YZ[KC7E;OA*PZB!"^YAQ][H3Q9ZKZ(G.%
MM9#0J&[5)-2A)=[+W+W,78>Q1JY*7R[S.:D+)6WY#>*!DNO_@R3YG_YADOPW
M7/WQ]4^]CSO?:]COH6$#7N[@@O<,RJXD&=HW^+(BUTG$Q>'&N!9R[\#.HO(N
MIYZUG).1A2[$-6[R?_K6/;5QY_449;O3>UOU7JI_FZVJ_20<1[P2RR3,I&AU
M$1 CM/C*#<=W!=V+XKTH?E$T^PKW?I1F$V&Z(*5G,&2A/3L*3-\\(CNUJM8M
MB '>"^3=%T@2N'G=Y=^JK.)>L/X(@L7M&5V#^D[A%#G/L[([GV1,-"M-&NVJ
M[?+YO6S=R]8U:6(%B;CQ^ 'XP/5Y\E^-,2?H@^9D+S""&6Z\OCHE[ ":@GQR
MQ-EX7V!V?X+NY@D*M#,P*!S5PKU$WTOTW91HQ17GED%-NZMZ)U6>,W*.\%SY
MO!5='?_,7?BI]K!*06W]W]R@Z-?WA^.>G?SZ!9)HNT+XZ*(NE_--?5&_E1Y<
MMO%SZRPB^/7_J_B!5E*<*3'0I&X Z%I+4[&T?P6=>P(G:>AN2E*W!IS37;.!
M#.4,PTQ'9<WTJP;;JU3;:OU)6V"MC(4"=@"Z]UE=EO6E5C\7];05)#H>QP6C
MV /":=3'$@X-2.7VGG4 E?4H(H&UR-DQALFK0P0APY+COL (9]C_U'^;@0:D
M^;&8+[C],9Q^PFBXRP50*B*V:"T]$P!30YK5OO5UKFBN!/EL7_1GU-QGOGSM
MQM%7PEKIJ!:&Y,$ FJ9+ 8>,A"BY\K3=)KF"PF+FGQ0!IN>1@'V%4365[5(Z
M_>FHD#BBLH\Q-)7]R+CE/I'4"#PQPS5S?R0784>GQ'=1#JVF07>+M,M2CCY[
M-I-H+Z8 4F0<8.]QE2MI$:5#AC8=Q1M8>U5(_L8^6[ J=-70*LJ4-@I"PIA'
M@+9@XH+KZQ1_LK)"WJV4J0&(F](M3+(%9':4YHK;P/#"TAF;5=+:BVP7O0S8
M!UU8B'S;(+*LJAB))G2';<@;#YGL50*5Z4ASIW4*@&# F\?N< ^OE+;ZA%:_
M3 \.T2R\_U3DZ?3E<X]-XN#\=-?S<J;<7UJIQM!^4F54)?3X>?IJY]#@'6*6
M,"@[I2?:'SW:.QX]/CRP>3C6E:#'/'J/8^(B(=/?M* 2"B%+PCT.ZL/YV1L&
M_8!A;GTW]M 43?2Y"[H0F,HF9_!F:'ZNG, _\D\+T@SM0X=+,VMR,)?3<ZJ6
MA@6+ 7A4N8&6O?[P\DWZ>/?9KL,1>,>X\Q_P [F4VIWWX5#>\RJD)X;BLFLT
M;:>LB:6.=>B(<I_V!FUS#4T3T?]<]_!ROF3"%=""A^N.<=+'.LV F:K'UQ]9
M.^DJ-2.!%! ,=T[ M-IGQ:A(2I_VG0[V<!'(-2[7638ORM5?U_P#]0O6%(:-
M+.)AR%@A"-[H_C&W^A^-Z%3M/]H?[1T>)H, !\'1JI<=@PEQ]G3AD=E.?TZS
MRZPA8^N,9%"1+2(P5;W#4A,LP7%R\@;S#B8,J@A+DN(06O_H<&_TZ/'QNL"U
MK1!.RK.T^(!)[$!)T_+?Y.DRUM8&*WQAK#IQ,*>,2S!TSNE:KE+63J<[3YQ:
M,H W'H#VIP*Y@H%J/C/*C3-F%)Z!S7GT9&^TO_?$;F0!IL*0'=D0Q-KN-MD$
M_RI&G'@ILOW:O?!="<=2D9ITIU7W-&0^ \#K0LF9.#W9&W"" 7-S^L'?>"$P
M4H$JZ;W$?TE4(;\EF])V"*I18Z#8@=+QU2)M32:U2+$"H6CRGHWJA)=[P[ZE
MX;XI_K&H55'_@\J*;6W;5+(&/L&R\<-K4]+QTCGDS#80,"EE@UEO,?RL08,%
M6@L&CW</?[O>^ ,"$AWN_6%J%3\3 OBF^#Z,!V:D, "58QAF &,VCJ^$"=$[
MM!]WM8#6"-(%.,=K<\/=H3A7=I6J:SB\ ((^>N89]$S%.G3!#,83/N.D9+.I
MXYQF(L: _@&&)MZGD#.*1\;'_E:M\2]:M=16S2]6\I6+I:%.MV0.J,W#G^J2
MG7;UY*.!])3JL H:)(T_F0*1FQXOB-4R R4MP.M$.X)F2?8X&JZ-#!I6H"2-
M( A BU9!^*!XF/YK63?+>;A]_9L@F>=<9MC2]^D'@W?$+/";N\#^U0P?L\0X
MXBBS\C4VP_]2=:]$A0=[?W8$I0;ZGSA$8@X5K9OB^X_^OIL^=_OT=[=/SLQ6
MK.S(JTKSTD"QKEC'UB]DTEM(F>$<P9^&RS,OZ6*)B1(\X[EXQ'.#%K<61J 0
M5 (6(-\8$+:)QYXU--C$QR;:O'65HR%@OH]V6)%IN-/>^?[LKC+K,M[$I HD
M"S;!F3(_TQ:17BC:<T.%S- U;!TL]A@Q\'?&&7+*DQ!;6 S.0!+$6H&IXN.2
M62JI-7ZDX%#9&JI<C)@/VUX7^1GZQ9:/G8 PYDJ-61DJ+#_C(4Z9Q2]AOT4R
M,:@ 8-(O)%,NARL)%6(:,,+&RG0EYAT?<0N"0A4P>NO5D%[:YY^62G1N7!ST
M0."Y"3,3O1>0T1DC',O@7,CVBS12H/GA&0[KIJN/9+)^)&\Q"'J=>P*09H'?
MI;C+ NK*;!#OI4@;R_[J!62*UX.^\VEEZX8K&6KF$SEB&@>&V0I*8172EY]4
MJ$\FB'0 3)[6\L>Z=7&CX6&RH;T$W8YB@F*7(4*%=M9'P2BRV25\J+0D9#F+
M6FGOP(4=KAXK,;>VC=N!-O'RW%M2!_,H>K\!_XI7ME6G2DKVS;LO 0J@"_W&
M"I6&6P%,K(PS%X-#YHVUM[;G]!\[[:7B!,\8[)BC7JM Q'APXFC2KCE\[$>F
MRL)I]K@>+_/$)'C  HG6!W<? F-952V54-):"%0:>^AF@8-GK"UB#J+CU>$B
MLH;E$L<%_6="_^;#X52'R2H]A$VF$%9": (L^C@\;MD=%9  1GG]H/UKF37T
M)/JCSB>)ACW\^-WT#<DD=B12!R'N+A\CI>>*-(%Y]48#)F9 RZ8&[M!IT4Y*
M9M1, H(F4**HB514WF9@$W5>&_DYR>"XJ3^2FS3-LS)70?21P@$BIF!E-4@3
M@7F3$R_#)2%D+/ ,4/3CDD-U>9L+-9##<E<K@6]FH7B*+;.AU^I=QNCI)KS!
M'(6*.5'$Z$LQ^JIPC9'EI:, -O'!]1;6 -E[%V,J<Q(O(4%2.\)ELU1.)Y(U
M=>C6P9@2.=]VK;8>51NW*Y]PXV$ I&;E[M5;5:;P#MHZ9;8,MD4A_"4]0' _
M/W_?)9L$7"\_?[%%!L&&HQWV>?2-S_@!]!D<_;.4G/3+[CSQV@'FAIR7W(F9
MLQKU@GQ^7N0S.KYF#@NS:A- >'67-?D3;<<@K>7*/P5IDK44'R/_5P%T^B@A
M"\:[,F $/(,/T)$YSE*]F_Z4(R]\GL,>4\9P?S>Q'ER69UE,A!&R;,ALE;[E
M^.G._M.G3],'^):95/+E)/JR&E(/;6D5"B-:,57L0PLW8V:R#>NR>35268V$
M5Z/>L"!]:_ 1<B4AGXASS#R9332W< &5P,)K3E%5(JN)H H%8<E 7'VZR$@3
M=3W4KV6XAC#;DF<XY'G6C#SCE1H-9D/X:X/O;%&[[_ER@49_I<?LG1ZSUV*O
M633TT<Y_[:;/0K;4K MG%IX2>8LG)[QTAY53LOYX*=:_UU^\"+#]9;9R]8VB
ME!LW'0Z^E[4T#_9@;^?5;:=7+STV]6?-868MHSOUG^B87!D/;I0RZ:>I0>6-
MF#)W7<)1@O7,&BV2"S4W4/_&I'HYX#$=['Z\>E6.<CF\!/X=""*24@WZ*T<?
M$"<8SQI;#>OZV+P''F?0+.JM1TFI]5Z;#"^:K##S!+(@!38H6 WXT5)J$/:E
M:C0C="64RT'$5M8PJ+H!DR@NHB2^+W0LFB&(ZAM8+^6-U?1<3P9&+LO18TI@
M.U<JDNBU9@VJ'[$I@S$X5IRSV/P=!7#9'+F:YK1!I=+7,.U2"VW+.M/"0JW/
M("4<"1B>%V?*9(_XV/>G):&KP/G<<*JONH^#6R.)QQ]:H]F8CM+&>[@EBZL>
MJIE9NT+LDM"8W-"LN!]YE?3J<19,MBAV07@>!*B6?KDA/M/6DX)O-?[VT)[B
MREH*%1:*Z"Q>)VW1RA>8L%1I45EX^L6/[OM@?<T5,832R#G7%5BMP@"L$QX,
M X:[F9AP2D@K_V1UYZX>PZ<G64J&1.N>H>,&$F+[?^2$V'<CO+!J@0J6=KK(
M"M2TD%'&.H7\Q=:HV_G:3EQ!F5[<TYH]> \ CW(4"<BL^@\JG(IV#K!686U#
MI9DL@"OSJC^_&*ZZ+@&Y%ZT$C,CK+,300ZY8'>AS7P+BW7BPG2$>C\(#=^'-
MEGB#E3M;/L9@2*&QE@X9P_<5X/OB)-J5X&IJA4))T@4C-UKD,U!0J-6^3&J[
MWIW6J\ (''H?T*A1RL(5O_@YE^C-M"5N:"VBRR PX84FH^W?"+J?$GA ):!M
MPL@5!UHP6@I9;8_HM_9T7&ZP5_F"SS[E V[8D]T3N&$56(NG?".>>G,'+WK+
MKMTK%^Y[[:__G1?ZTO0=KN&5T73&4?\].'HG*/K7 N,3O7VC)W"$IJ#;;!K6
M"-H#\=?@H0D]]"49H-DG>8K-ES[@N3AZ+9F"9!I87-XU]5F3S=L;2SG<L%(3
MNQ:GRU.7PZAJ9ZN^B<8I!XL"'^T=623M-&O&&1V G;>?RGPEL5&A;S8VVJ8R
MHD(DS* \?#37!Z;5/0YL1_V)!;OK23Y%[[H++0=\T3ZM!$%EBX=^/<->3UR(
MD(RT)=ED*Y>-9 LN)RV1MRXP:$'GP.U&;15,]\C>3N3+Y'WH&7(QC8% M?H6
M_UK"XJLKM<J]:I-:2#ECR$_?MI[/FGQCK%FBI_&NCM+\(BN7/G0)*]+9K6NN
M_;6D"'\YV-L[B*)0ZU^S$-1N^BZ(+>@;$GK#@^SA5:)ZN3Y;V_=,A0$.>=!-
MH>%D)WTF/1O%/1D0=Q^",4];2;01S")GHH1&R:<L>$WZ(#,G>:QA2,ZE^4:3
MF5!SLN=$,PC"KERD3)K]C%1[_[D/!Z??W^R,/+8.C^DZI-D_MZ,/QFOKG;KU
MOE7!_D!>'=V:4B>R:0>OHW_T[%Y;M_$R WYCXILA^*JO<D>D[ #*%>S5=9'(
M_5M 4['X5?GER+\DB3-[@9@JZL(H&+E+.?*LX.3RUR,SQJ^*-G6URP4? GQ)
M+9]>9\ '=!'@);**I@H<NM)U;P 5JB"?804<8?5Y5\QS3;YJ_U,05TBT,TQ"
M\MZ*6 _)SYGLK.W%#OSZ2;S)^&Q] 0V,10C^%(^U0B-W?+19AINT$C?SN%.K
M0YPK3H]G<Y1W\+&QV=$V8-7M/.9='G2T^)J49:M=<2P!O8@ "UL"YX/L\]C[
MZ,=BSHM&H]$(5J*R UR@])+LMDOJ7G,?HG62S,*8'ZNH0/6,Q)2/6H23OOQ9
M1Y.0P?K\IS8OJOP[UZ-C=3E(OZ74L,U<6Y$7RTX3BI$G(.T?"<Y_4[ ](E%%
MR^9X1C#/VL)8/2U$6VNZC.&/27I]A97IYAE*[.F,FQZ0QA*^JDUQR.4LFAGF
MD41K++09FX!>VR@F?6 +3E,7Z*F_\( 'J@6];CD.9<'.6M 'N=9$&O#9<%QY
M@_$XN$4!:?4&@Y3,VDW#'; SM]OH^^U^ )@MUW,.?FSN=)!;%[($MV*$L$D.
M0@-2B"3DOVI:&NVX''6VX%^@U:V2\C95R]^M;H.E8Z84##1%/@=(PJ6/CWTQ
MJ&XV78(M:UTRUU#>9I.43]CYH2N^S-%7=XQ:4N7^I@7$9>OK07!/NJ=J/> #
M">.K[ 1TZJ3KF1)5">^MFUD?D0PT45E*@(88E)')X7WH\TX60U (,(FGCQ1^
M!R4+H[49NM#RN+?KR35W/7V@]OR[5Z^?NR3RS$K89OF4*;+D?2QSBV6# D<Z
MT,^X>E/5LY4*!:PQHO7#3;*@3=O:*IL#2/=Z "9A)M HB->-Z;"#U<$,;0ZK
M"E ISQ43<$L820XT]#099E7E:%:%Y:N8AIS<TFJ2]VQ#?KNC[^8.I>AM 9%V
M$,$*Q[ K/]!*/22PO3QESN/-JZG],YJ 0&HL+! WR-4:&Q%.H#.7/B!Q<A$L
M6?S$%E^-'O[/E5; =&UTO)SZQOD;Q>_P1U$WM4!C_<=<JEK7#@^[0.X(-3FH
M>FG-$[W$K%=1HG;%K_XB1T:2KF'7CZC&;S2.-4+<1FQ87_2X]A,[)+HH#_Q*
M<@S4E>FEF$1PA-J'(Y8 UXH+5>'M099C>))\@?'^AU?\@([&5R19B[.7?.D%
M$,H F51<1$,.%E=RE?P6]9>M?W>PW9.^W*E06DC4E$U4^M*ZN"I>(A)A.691
M8K*Q["EP]HK/E*K37AFQ"V$V=$B+"Z]5>L.#4^%SAUPQR(O)NNH?NE1PT:?Y
MS,2M%Y(,HX<_5X6+>[;I*]5UKT55V;=,*8[4R,3")M:-P-MXIF50*\V==DTQ
M7CJ:K*57<NR:Y0*"(98'8R_LIL^M++ZT*C/V.?V2T=687R!OZ3B945MNDA"9
M ?2W0-=(TJ/GJF#_2C:^V)3G/9=&:JOFQR'<Z>H=PPVP;SS<!+"2_*.^S*U(
M4C6V#_M;C7JOWB\HCW WC@D\^\0?K6X-6EX6!RV*2 ?XI2K\F7)70N(.U$ U
M^F\0@IUWJB2LI"=@B7^N-VD<?[XJSGR?5?VBK.K!?5;U^R0@M %%<.IPBX>W
MP26C>9L]G>R+/3UH[;(6T?I@*^;Q=J]IK4T&9JC-;AM*YAHK\D!: =AUJ?R_
MZR;!1!B0E?WLA]X7V?>^B%HB37I1"TDLJ=%-\#&ZL#H87=A@0)FIN;[_J*K(
M6M;:A>X$5SCJ;]0)1YV/>0L]RQ'I.+5K(-J+]('D4!^2BBVX\=[]12LP8:WF
MSFF342W'I"2+K$%5<+^FIX(Z[G_+I6*#F5X]6#(!I"^OU#CHY7G.E@OX:NK.
M;@O_O"3[S!-IBB=K7KF9UU?]T'8IC.IK*D/J,36TJPN&8DU8WOPJ<P'T:.!S
MND=A2V4&I#!SV9CEF WJ5^89]A*R9](VAI![=5;@J65]N8/,\+3_"R" !49N
M:K6%#KI_O/K<^H_2X?7WE;TKOMQ;=I<BBXD6.BP/2]@"0O7J^O+WI?FS>^&;
M0\0@4K\N0]%<[IL%H8.FN7K@ G6H-9.LG6@7B[B5+WB&[^(+1]J;1# F<JLT
M1KJ>[FG#9J%Z7"I069N$%0!#;ZNCB/:<SF ')4+^(UE]A<:^I760NSBU'3(#
ML!JVB\L2]"3U%YDU4-\]<7[E)I7>Y.01^R()=FKQ'P8P9+.\A.F^S*7^C4:D
M";I?V$G'=IDA";EQWGJ;Q(@69*FAD-VWP@R XYA+RF]5\0Q8/X<U4:S_A^0M
M">6-)^@?[;7&.BI)_-S/BSHP\K1&\0J)3QB+Q%6LXU?KH<6HQRAPT:+2Y;5,
M)-XV%Y@[#LJ'J2^.$DDE42"VNX W3&-K^[6%@-]#$&GC3X7%FMRLUO9Z*O*(
MBD[4B/!%4Y&$._C#HK+P6E1ZP(65:"AV'*"NX"ANJ^I/KFC6Y[,^G;4]T?7?
M";;D,VIR-SD)?1Y$&1B?2=(]K/"QE&0O%2UF)4K50CR+NE/O6IWIH).\M=9(
MP=,*PGX: +EQQ+Y-=F=L8[XOVH\MVB'FTL+UWK=DXM2]]0D=UV>_;68RXO/G
M>3;5X'&+L$^U1!C.YWP4S]PKX21,536X?"<\;P_+0#_C&$J3SSC %J=:7!2Z
M:)LE5S=; F,X'5:'B9 )D$-9'5CPI9?7D39A&8A3Y1;3O$3\D>-(<D_0G)NZ
M@8*MF[.LTOA<^H]LGK5AG]7@UP1?E-F^5^FFZ(4H\^Q;E=YL?,)-_6]*(I)\
M3D0VPB73UY#0LO;70%+^-[NH<BL@[%452B+"];JP:'S,5\D0ZE=CC;6(5FC5
MB#[T5KVMBJ-_M 0P#UJ;*%\%8S#UYM49N?6"X H=BM:-K)F+GIW1>;6&7I9%
MA.OH$64VYT":$T=Q4%C&?/T%K=[?LU\SNI::8C$2U?Z/_%<Z\65V_B5/DO(>
MOCP4:J*MES@05?IC/LXJAGVKM/G@-5DO15;M(%@@S-1%I[$PA1HY735%UB\@
MI5_QHG3G;#-4:G9V'3U&%XUCT<G8%<Q"ZJHEQS+(3,H6/F6.*X:&#!&;K,9Y
MLR//:=V9MPI+[G(%$E_ZMDK?3KH:"8C'DDD9Z?%W:\-615%V7.&4]#2+6Q&)
MO_C6>+\%5AX#(YS3+<#54U08'1_IG DY":@_$'O65D_F0^-4E82.DC);5I-S
M&HIOOVGJ"2*;P>-LIHMZ82W%V":],=EB\4=EQ-V27-OL)R3U=B0*""#JUWQ,
M/D,*@LRJ3) 3;T!#< 8+""(Z";D,Y(CXF4Y)2LXY._#/96/F_\=B6I'=H$"J
MMI+R-V"R%0HR9/ G;/3Q:T;]FT(;NU R/J9CW?F"]/#N\!=$YO=JD@%)\JRR
M;R7<J3A\=XSZN!9<$-YD,ZE+0O"9EOU\64T%J;1>MGB;[:I[)]:5C,P675
MT\F9SUN2N@BSHZDOX='J#%U-V-0)#8Q"'J0M_?!2890R;R=>FT[!R.L;C$65
M11))+\V!7!MDFH)QD-$HD:--!]=-G$QFQ)!(4=4+V0G[2E=?BLE5U8T,*KAD
M!'N\Y?Q<%XK;*&I=)DV\8GTRR9H&.X3^L#!3Z?0,O/V/ @; 0T)FMZZXZ9M>
M$2W#H/+D>E_T<>/^:JUD,Z\<%'QPIA%_,E2?MG"97=1V#60T_X'7T8K50D%H
M:7NGW1%B827TO_C[*'%7D^Q0[]VP<>GU%^")PR739-Q.IA+R'EY0GOG>8L0
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M.,^QAO(56I S7HRC/1N3E"Y@4,#/XG(FCJD9*"_#_<\  &QS!"*6 !K: (\
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MUT"Z>)"&)!>+(W[-*U998];E *9@)+^RP+TC2:>QX=:9@>,3 ("'QK.KKA)
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M9&2Z>GD&"3(:SI1>3").XXVVB4'*LW1&HCTPS<2FXOI;YCFRY44[YX)N1:+
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MK1M.PR%Z*= B(5W5EL_=$!7FRY$KVX9BP[XF@HXPFI]0]E%76C#),7T+]/0
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MR)7_X@!=0NI1[RZYSBK#2*RMOEOWZ]XCN5<T7QQAX' CHT)DTFX0QA7"L^\
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M3;YURR8Z[<,FC:R7MVCP;WQFUVARDP;-36LU=Y4\-Y?_'^2GU\TV%+/XDX[
M>E%5]84T4(^+>H$\33;)EYVU0$*7C*+[*-F4.?97$-3>2-/KM&!(G.NE:W>Q
M!(V+47K2<-]SE:/?X;2F!Z;_53?\7^^7]!O\XUW>+"_X7\]14L>=$5EQF9$!
ME8^2GS\VZ%_"I]*F1>_-\$-.3L  T!J"DR8;IR_G12.?_F>VX"?PF+@,I4K?
MT(-:(6NFXR+U)LX<"$K@@US%E&FF6>-'?!>:2H@*-,-XJZJ]3 HZ:#7I)BGZ
M'HI0S2,!40E/CF3<NKPN5^@IL[KPO&J*R3E?1<F8=B$OA1F>SY>C9\8J(VJ9
MHI"=WO].GZ3H1EG*#B]#)MA["LXTP(0$7SPHZ)=%R3IJ7-:<W%W0 Q9DG;/*
MAJ%&9QA\'<6TW4W>+IO-1J?#ZD)LQ>[2C'U>%DU:ZV+*ZF!]RLC:=UP(V[G+
M$O?A9,GQF8H4(IT%2;QS((V$>T?7&KN0+:R,P&%_69*HR7ME]I*8*2I_(.27
M6D\+:[YHM#X*)=$^_BI'+%R )%P SL)9MDG_('$ASA0S^3H>P%-F0M3!64_L
MUEU6Q;^6N5X_VO91V +*N.<YG]S$.4@5I[+'F2X;]W:@4&H6!9)',?\"?;V(
MXXPC1>M]^4G!X$L]C(MBD;/58+'M"?V=MQ7B42%;+4<J(JK6AL0#U"\+/=N7
M'8+4'X("N-$H].;#%5DIDD]74#D!GIZ!.?'+N!I_R6WOZ-5N%E*=/2O*TJ#5
M+**_K.9Y%V9E0WLJV5#CY=MXI2=$<O%1=;-C9N<?+G*)4UJSKTMXXVU%=9&A
M>=C(9'NY?L;1V$W<7/+J'*:'%E%[N,"8HD?+]3B+\R6%S +\=B7Z5S*$_A6&
MMOG7KA# 3442_R*1DW,N",K26791"ZTRJOQW.$]EB-ET_]":YK=J'ZUGC)&-
MI4><62X^8K1WM8^3!F '!P>)JV#33H!EH^3O+I439L@UL_'Z-7_;_D/^B]'D
M_'4?Y3[8]_V%2]PO!1$M*.E;-HF=]RMO3U_)'L85JFSNHC1.P3A*QJI?[F_
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M?)-5XC/-H'*V1-]B6;9K)=YZR1#%IB<&TY</[J .VT*_]BU?'YF#Z0US9-/
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M>%&)PJ-Q/N MX0%\X#60%QSB'MRJ@2+H,2KH/ZE.\OOE=!/^,]!/@RK)4%,
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M1W%%EMCA"3TH^$+PKH3?-4Z?YP"IBU(K,^3,8\Z*;&7_MAB#1#<<4Q*T(\>
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M!T>/6*PN]W#1<D1)]X]W@Z1^#\M) \PD3[IU#3HC2]Q]9 \PF_%Q5RY,E.)
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MLYA-E+/E:IY1G_I8;WX2E?H #;?0F5J?<<R4KO(=>JK0 QP9/Q.+.OK^3(K
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M!&2>K$[N/#JP,N57*M/(F&<3X.R"^WN;)7#^ZOF9F0(8(N^RU"!PH"TI5GR
MV?P+!Q_N2P<V)7%M8>;PG'-,*!?L!^(C'.7C9M2<(^,IIG[B'SB,J-&[6IW;
MLF.BZ.@T_XL$1TM+I+Z51SX[N%91A38ME(;N5Q[O6+H@^8BVCNYXZ1994UH[
MVN$JN+[O\3B^@/2M/!L76_K; B]C;F_0T[E9\IT6G(2V9H]D<C*E(\4$FP)F
M8G".?16D WG^3JUF,A'-ZHS%>OB(:)?)Z(50D3P%OC6% .J(='>E>/AK_MN
MRRW>!GGT\PV=2;ON,FN1\,B61.)"Q"YH&VCZ>[CEV]11:S:EE-M,PI:H=$P6
MQ6P//7<U4H]PZEY+US;O+H1;-M? 5Z","S.L1031*LL7%+_2KES7XICR[2\'
MA^/'8($L?R>-SB<F_P"E'"PQ*YQ=:^WNVMFF\8($N;_$SH[EU7H[3+O@$GSI
MFW-3)ZROF^+*\'=D+.<06KF*(9!ORLEED]*"41+%(<$'(BJ'"4J>??=LQ$IA
MYAIF'1R,:%_V#U@99 NA=R4A]'T^::2CUA-\X6!_1)Y.TZY5]LGHZ'E8!3Y
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M.S&C>Q6/W4 2.!(<KHPE!Q(X.2L%%X?HNS))-P"5;<'&V,4.C8ON@CA?I@^
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MN#73RQJTW_'R;=WME1MU(-7H5/&KS:CES]-EO9)P)#U[90>DGB=&@L+S_!*
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M=TAI(Z5:+VI!#T\=IMD@-/ B&!X!-X8.^F6V1&GI2G@*$%8<N(-^2P0<L?W
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M,X@C4*+S,E>NFE^"=_!C7M!CZT4Q39_5>X[9E=_YW+N7270G'H $'PTD>/H
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M6/%$=4##42CK/L'-D;B)=!@58,J7(*B"I_HC]\R9Y.ZD/7_V2Z>@" Q:L.V
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MXW'<"9TS/00X\]> L=.X"?$:!V%2;>TYU2797DP/1_S" @T>E'>'&&4<J-#
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M%QS$_BT/7,N ^-^2JA'/FY%_Q&W #D[V]V8(A,<=!S-T62A%A*-D)"S<0MK
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M-($C"L3XM%BRS)[6K1Y-TC68W55>K2U.)\]UN-#+D"@$SG^]$FL!@5E!>80
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M!_=JO2"SL<!CR6-CXI>H!A&L,5Z!6KNM%ATY0=/<%N$@'%HTU]A<T7CA-;
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MI0-S7AJ3&&=$+ <+Y3#:(IT>@5=J2?<(FZQ-'2,%ZJ!MY/%^!]R8"?F7F(-
M\@3B,E"(10.=$3+/XDJ1461W0@U*_^Y%,GUT>NB"LG)!1Y;K&,+"EK;^!=*H
M.1TA+31=RD2'6TCC3[R.:?N]@MO&FX)R[LC%HY:KQ$F/C\BYHKHQ,GP*)VN6
MZ8RS%A[MF=3=\*S=BDB;T:6"Q?>O3CO1GTQJZ>/&VP0TN6E.>JGASD@\1ZS6
M )KE;L&UWOOO#?9#12!4H@O"[!9J&9)3AS[B7]*/]9T'#[++$,DRN%U*G2/(
MEX>&;9 VA@^?HO[PJYJ,\2!0;HT#"-O;ME]35CF77K>+F9&"<:E<P  .G4R-
M 07?; --D8*G7+I%EUJ_22^DM*Y!5ZB=G.8!.53V*9+D -7+Z(OA(;6QM6AD
M#J*S(%R=FN+TQ^>K859+2_,B_<IB%:S4AXNLBF D6K^!XPFF+HLN4R0RM6"K
M=)L:TD[7^SC-F*":JE]U-DM"HO4^FMFS.\YJCYXG!P;=8+JC+XJKY5QQYK>Q
M57HQ.R[O?I90]B\QB/6%<4S484L(#H&8*;^R?3+^32/J1<C6W$9[&^J@R(1,
MU+I(<E.4@]4=&&L5-MGJ-2DXJUGUN(@H<W)?^#QWQ 9.81**\($\7'(FJHT'
M3RJX*D9Y63$@9BV6)&\VA.H.L4$(F!)6;!R82YJQJ"F)3ZI/(]&VJC@A(SZK
MW39:EFTR1:*E@2K:QUE;XJHZVEUG]QL]_P$9^S8'=]<<W-'>-@=W[[ZA=SZP
M.JTH_9H>.2]K!B_Q$,GI8O0%!M8#QZP-/V';UT6M.L!C[:!ZGK>@"8T%I>L2
MR/)\P*^^\Y9'/-+NR?%^O(//D/*>W])Z>"&7W%_I)PQ*GS*A3Z_[R],D8OW!
MX:W*J2=_Y>&Q\QFW:0!-0F!]%[_T9D(HZNM!B!XDI%'CP8@A_[6BY^P%[+?)
M*'(C<[I()V/-T"#ZI[XR4E;B;D2*J[(90GW@%57G['_[B8A ?3-0_^T/;?N.
MA?;A!Q0\[QP%_%PG7B76HK$'1.$G\!E4^Q'[,U-!@EA+R-Y&U#(*/E^S+S(N
MYF5MM)C"<S :'0D:PWJ3\VKJ8SUR$[INHX D8R7PAM;;768V$=J -P4?:VGL
M'7CXYM,LLQ(8><*6Y;:K 8&!9&6YO/62"2=@%V8!GX\0W'A-5RH,VW'"FJ@7
M!]X-SF32N5SW[)L@F&ZLE-U,JL9VVI^=]W9_<>8?RG1DT*R-WR"@7T&ZE0>
M"@,,+H6)Q"&MNH%L%2LU$8\/'7,'U=&SM=[0WK.LJ+AMEKJ>5)LR=*;2AH3Y
M<.?>2BC]K3/M<,RGR$,RHD/P' T[REZZ=D1B>$;23?ZY$@>=$=$H/N2=@=U!
MJ+[3S3L:2[\D=]+3T*?/3ZTZOCY'VMOK[B4>DA)/#KF$D?35(VROI;!IOT!>
M@;ZY#.Z,WM[>2;PCHWGV]OFKI?$,)4Z/?MQ@@.+<R+*#-P%&#*5J%<#HN@QX
MC&X#*QU<I<9!*@YQI\J.@*\!.=ZUJL?)T/+#U]O6Q$Z'G%%>+(M14#>-N!:P
M6-7#X+I,5J3E6T/B2W97S?)<K5Y=/E34D*B<DOL2MII)_%XSKEG5!0;1-'>1
M@K>VH Z>D4TSP?BF?MJ)E%>8CO(#I@C=\+:2<Y?A4@0,W:$DM$[*PM^M4847
M1E@=PH7&,BG;S<X&EB1O@G5S=N3:MDURT*UKB8KX' /OFJN*J()B[.,TO4"^
MU[C57CTU]6OF%H.NVCD)MK9E0P>.[HJN),4,49%X5,'Y&!*6@X*1>"?9[GZ(
M3,(L/A+:^2/2#A!"+$0A:Z_U,5TM_ .6-](7+XS'HLF!JTOC5]Z92+@AV@??
MB7\KKM#;%EI,\TFHJAIDU/AMSBI*('S,P%%M6F,^(1]E.:>B.1I@BW9)H@;O
MF*2XF*":SR1%5H+JID;G)\P=^$#@BWDYFO#^M8-<VO1@)'K0B09H$RK.)4^]
M*#_B+LYKGUQU,S)=I/43H0M91J3K2?6]&[!:PT:F'DR= ^9HDEIW09$X]878
MXUY)9?, XO7'=2M"*30*Z&B;&+$HY&Y9/5[;8M:Y!@%Y$ ZZVVM:T&SGYUZD
MI77$43CB3OR"/:$:HS_=GK@K^&R/+"B(96J,QM(!8*=4$B#AKB*&\QD'2PEC
MY]?,RY L+XQ7SFIM3NG/A_Z*S1S:)UHHBL.?UPY1:!T(O#?\5I<4I:24%_[
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M9Q20F\EGY]&"349LV/;E.'!>,BU'MY(AQ%HM.>5*4&F1G^.S;ZI,[?7SP@0
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M3M*3P6'WV)P<[!\<[NT=C89!=(I#8?$'RDS^ <OXKH"52?@7"54!CQM!(?^
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M:K"65_XB7!9([R<=NTD9Y$+KY^'?WB-ED1LH9O<\L>=@RF ^.C>,.%-E2(
MIB#Q^B1RS0'GSXG55P\9K3H##767,.4C>4%.WWMTQJ@:I:MEBG=!-:>M1,Y&
M$4K,1WFD@*Y<1QPSK[3( A#>TSX&>W)15#.$#BEM-EV2$4DF96'I<L6'Z <=
MSH#=(TX3N4(/^SE>L]N_U*[@Q&BYLD]W8QG%TEII\NW"KDJ-!T@&LHH<0RA*
MC577KF=EK62Q8>=BAK;^Z2AZ"F:+I37 *VS*O+OB.-.%XO4$+HE]4-$'"AAK
M@I+8Y,X50['DIW#J#)L\<%H\/"?"/Z>ZR*(FJFO>R_RZU(>2^%7DEOU@AA<Y
MZJU%?.H8XK2X];</IRIN6N(:6=)?MZ9^(0,.QLX+3#4;X7 U?;BZP2(F1%:@
MP)P1J2K"5@K]DZLD<BQVEIMN/@ GT:Z@ /EKCW58+EP+MU2,!MU.!?B7=3KQ
M;F4Y3:G4,RXMIQYSG:1_#<NVM4Q9U195<@B&E*TC,-F&4@2!RPUJ+.6)6U!0
MRX[2U<OJ#TV].54RJ1RL4*X,E%-Z"#[KE6E[NH=V-ERE'R*<PZU\S5LIS7:C
M-QXWM<8WV#9?%KEW]I8-1,[]6J6.G  Q9GC9PL\U*9P'!>@*4/6"Y\0+GAR&
MIN01D(9DR@OUU#K +.3)1<-W>;42I9>#%5&L$I, ,][/#B$"=0;OYRPC_NUO
MH@"V,&,GV]I\$;NTH]4"%B&2[2+=$8:/*Z'>][MVL<$MZQPNC=J"NCYH1J/U
M C?*?T2Q-NB%?;)($<MT6!9"N'GVYWK)935>N+27Q->L_$WN^+#%Y?!$?B=X
M*C@"B\ND(Q8O_"+#%JBZMS3\.91X^EETKKU[X5FP8!XV,S .)H1&6$+AR9<C
MMM2T0"J<3(H%H/(DB?&-LT^*![_*_0!.$(=@:BRQ%VRY&-X3=E@T9D%=CN!9
M5Z!Q(C6I<7!R$(8,>:]8(*6!0N+=M&A++^6($@E?D5;C+E2F47P56.,7L+LV
MDA<1ZP'5_YK2%J>3WLX%LN8W7FR4$U@#5FV0)":Y%:MA(''5*9.ID2$#JZP
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M*UX!O(R8H@@?M(-NYK]-B5;!TQA$N-N)3V\UHX@68DS<;KQSQFG*JXN"R97
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M[P0M;T;VAI5VR-K4#"D^D^HP7IMPT6Y\0C%3.T.TB,<)HA3;6&SID:,LDY]
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MH-L"MDC-2EU*(T[7^4#(W-P@.Z<1MLM+DS'U7[AUBX.8IR*-HO(9D:\A3NH
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M) J?LS >KFN-@-3I&C9@"0!(GU)36;KYDDD-;ON&&3LR8W,5H1EG]5(,^D6
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MSX'+<P4U&YPGR6'BS 4!TW=GXNNN2_D-1>)J";ZV0JQ61NJ[7TL/H#&$T U
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MD-SL?<"DB4+[O-/X:[UTQ!#/:T.*&U*\&2F6NF+W-#P_36R!N_ZJBQ$:.IA
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MR?YX=S0YVNL/CW8'AWNCX>X _GV@!Y.#/6#T_8V[;V,1W,DB\",*C/X0$U:
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MHBS+DC,9,5.=IH"+NYQ[]O,[VL%:U?!+83!MW7M&@(0#= XF%K43N$+5C*
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MKR,F@2PDJ!Z9LW=.7FSIW.(\)6=,MI;UP^!7Z3A%89E@BU9%D.LH$%9Y"KM
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M31<OD_8_D)-O6IK"OB1,I=>U&5-9'E3K/5C@8E9'+G#@N,D%\(&< M*,;6E
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MDN,)Z&67>1=OEYG.19[&B\OU+,[#"V0W4=@)#_\%C\]2V250-A3LWC4(Y?Z
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M5U=_HS^CC^X,I"$TI?#) [ G.S8D1B5S?);A1QA#+&#BWO>-T^J&QPR]<[)
M10[W"<=HR"#A)\T[T7^[GMNH7BRK1Q^?LWYWJ>A]"RK[+P9]88Z5&#=L!4B:
M-6:[8X8A&!G L-;BXR'K99U? VN#&SO118CIU+GAP*GS2+O")\XJ\1_ DU=*
MZ2\'5"B*2;Y@"3#%X12P3"!,YS"%E!-582(X+;;CHW">)8S@X[!G-'R0S]9_
MT :)##G!?^-W,,ZHYRHLQMO0Q:8])<9;BK#<1_#U!?ME\I>(VVO@VVS"<6"I
M%X7D($7?*/QS$-D<8PK+M8:1?:?3TC^1+Y;^,8HDBL<#MIN1!*ZX\J3%:;JF
M'J47!9QNS"]U-#K<X?H2LX,D1Z?C?%0 Y/QQVGT/@/#E,-VS\T_/RG$_.8Y;
MN/UXV:L<%R>IV6F5G@).HB)&E^982"'B>IR!UBFH3N>?7-8JT4^X5"(<B8[E
M)E I!WZ1X-;()9AST$\4(N&DZ6*=K0M'$4!F6RC@"Q,E[KYVSZ2"T8CZ"QQ[
M "U@*0B80-'T!<Z*UPJ9?AQO,/J4YR:MT?C2V)&.#PW,MP+O6W2O8>6BX*0+
MT-]G,]J'J#(1M\+7G0N^CQ,$<7$X+D@C"?'^8KW !N$4!<@0Y0P-L],;1%5
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M@246V!@GW),M.GIU9!LA($ZP>0XDX&6,Q4&)I.Y+]-8V])C%-\9W"^)7HY+
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MLV-HSZRT32-:]YYNA!DX&K!\6_;KX3M06HHCS=P31W%N'6F2?1*(0-;;=+*
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MO@WW$-YMOY0)]>^M1J\;SM/9C IU):-(8VZ7DIT"@MQ^UDY>A08@8I J+B3
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M"G;IZS_J]C]D1WN-\.CTP\79Z3O>(=J:UUBJ]IQSPSXIK]-B,F/%ZPC-CDS
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MOGA[<O2L[M/?=:0VR9:4%0![GY#-9L*FDA-"]U:!S)T43EPCD([IRAC"W,4
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M+LE8IUP9JY>$M5TC_K=H-F/UGU<S-EFRY7Q&2E?]ACQ2-Q/+->DNC6( 6/3
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M[$GOW/>2Y\^P@&)Q)GY_$C=]Y^)7"7G,7J?D"]9L.1=PAC$P"XG+/\I7E_R
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M?MZ-L;;Y,(XUCJO1%=,W&NH&%" .4(]S#P H# !9,*VG8OQQ#-PZ -BBY#]
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MD/Y5(4Y*X_R<#B5D&]0>]G$YAK4SZ6<'D6N(%%1:ZTIFR:IZ278@^6PCPC1
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M?_%APS']EUL$L:ZF0)N,U)E:FH*R'I^.&L-V\]&Z\PDO>%(5>\YJK&\]H,V
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MB4AAFH1URRBJ-/R:H%!R3U@RBV0N$02E'6;)*!AKD%E^I%).:OKYWHOIA*3
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MGN1N<T7XA7,D##H9@X\DKR>]-] U3T]&C 4W1R*E17+7S7B=$2")+"PR.$F
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M9:?@M=4&.J.P]\0S[C%_HP6N<3[=8FT":L=KL,\Y:DTVJ9#3[AGQ+<CIEH;
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M0G<"5 2H]  J#;1 &CJHM-\"2>NW[)Z %@$M?4#+X4V.>(&6ACHPCK2Q?J1
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MJSO%+KK.A'F8A^@3Q+*=#=,#AMCBJ7DG>)L9LCJK8-H+>#OUX$9= .BO!8#
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M2MB5L"MA5\+N6K!;G4'<)NP*#)_:4><\B$/%!^#9.0ZO#;X\I9Q%6(J&XC_
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MZEM5>X:KNV4<!I=)#Y$H2Q('"_;/^AP/T9:LOSM]K$DWB"/F?>DJVB0+;4J
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MWHH0UW.*[AT7NF[I)WCZ$J^I5DSGG5JGFBZTOKQ5?=N!T(U("4T2S<1$,\'
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MHMI>4$W?*:JM(\3;E=7*DT,".Q@_+9#/IFL H,2XS3%NG7T&@:+82D2>9WX
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M-F(E[.HG[ID-N[-HDFT/HM:>X08%<_*&OW><C:HF8U42L*KX0DF*A6134=%
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M@&?V[5$QU6AV-X'O/;S[[&_@=3:^L'D$P@>XS*+*R3;JB'CM>+:W<&Q7N-O
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M">\<"HX7Z32B ?O>WVZ$KW??_YYIY/#F0(7158F^*-E!+6Q+)HN69AB615+
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MBM?A]BD2]\U(=VIR-V>.+)N(:2''0FI7%)JM<^F$"]</MP% ;D4T79^ C5Y
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MQ?M+^.\X,7)_R]!V\*"=[[",QBV"O/V$$+&_"KQ[@OX4@A>9;60JE@.H478
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MT2',?R'/$KCE02R+BFA)AB))FJ4JPX(X%K[EV5'KJ"QJ"JM+NB(K>JK%Q3!
M[F989+.ITB;J*@M9'?ST[>I#>05,1EJ%FB@/O(I\VH!%Z_V(FZB?JDJ&+@^K
M?C4&I2@Q3)YWI'S"JQ   <K@"SB2(IED$YW2!ET7)O((K,#/?IS;F-C$&2Q+
MXB\HE/+D!R!OP@H6M_H34JJ%\HFZ,?O376FOM+HWDU\T<_R:_0W7AHB5,P#H
M%#HZU^'MSBU$.T?A/LJ(=A RK<I<?V&GCZ[O_,892J)8^:[K/U?.\^MYE',0
M0LT/B&YJT4JB'MG,0,N7(1F:I<FZ22D@G][1((XE-M^KR(@9Q3JC?;I=F+-$
MV#.*49GF+V\I"0+UPJ'$5CHE_$,/A^6UML\$WNA]&N-'3?8A43)!S0ZE0K4>
MD]W=6"RX<YQ>$=\XGC@!;R,(1\3(N7<N/N,MX,*&Z6_3$?V<W)A6>>[?Z)05
MD?I5*QJ)'[]OC:C789C:7322D:-G?V,Y[\8H,,\8<CI'"EI&)HX+KG=LZIW,
M]8[KW0!ZQ^V '/&/BMS/HM^3?3S@PS TI9&#IZN_D/F>*+5,%M69("LF_*%I
MKYLS09+18Z*6[MEXTWR87C9W%V2XU)[!'_?HQZ).)>3=?+6C0G'^4*,9:EFK
M&12)R&**9+2Z5^SA%[3"<_*R)*JB:LD&I4YSG*]382_I#CS@P.!N<^1[2&XF
M-S@PK\Q$@]P:F0(0^[ A&<0F@R*Q0Q=LL(,DBJGTI3+LD+>IVC$[R-+,-&3.
M#M.!(H,B<78X9 =#-\PJ[)"7I-:U[6#.))&S0UK^3IW&\@&K$?N(5]]3M:X<
M%,2*VIK8K@"E^Q-LJI^GZ4Z_!MNKV6MX)IP(!8A#B9DCE8/S> ,AI^052I*B
MJ?(?/3J+^'1:U.+> 6&+W*_-=)%IMY&EG0;.%XSS!=/TT*&WV!D]J#-=)K/@
M.3UP>N#TT#H]=.8N=FD]Z.2YKE.A!X8W%Z<?;6)0I$X"8,P-&P^XLB(2US=V
MI#P%D;B^L1(R5OOW*(:7(.LN0 &$I;]%)W08=FHJ2CFI(*DLZ3JE$5WI:&A;
M>UNZ21998-=%R076D!$,CG9FT,X(N!5+-2MM=1S$,MM):]%GJL7!S<'-P=TF
MN!7-5"2U022R'7 K,T-73A;<>1X%>4R=+-\7O4S4^4^_>5B_X5C1"_) /Z\7
MREB]T/RB)L-6O+P?6\G0$8SI!S_$-<LG6S-T< JIT,>*&)E(9"IU$RP2EPNJ
M0".QC&;#GMN=JW!1J::2#]JHY=6A#O9?6>D0J5%;SQ :0^C5=> OMXN:>9#M
MX3;&7.72/I)HUJKM8XKP-].@V)?IVCYHZ&Y7=W"H&*OJHXVVJ@\"SO2*DHRM
MI \OX3."5(QI0B6WGL6)(H67\.&JQZOX<-4[.=7CUD".^/G60#]+?S\:/^"S
M],$D?!#Y('8TB!T02\^UI 8.;=_9+NK6ATX&WP,/K%"_\%>.MW"W:#6(&F^>
M1V6S%_X3ZI"-#PWS@E(C$8F=&A",9L5IJF[NF^7L8Y^_VP\@O/"6&" ."'M*
MCY-GALCT'CM/&Q^]2.QP B,4@%H;4 [ZE:" +I+HI)E):>C$*6"T>&-0)$X!
M60K015%7*#N@)2B@DU2[F:@:G )2\G?GY8W>@]O>XZ9>4$G\@*4:3CV3Z]#$
M>0*^DBXIFF01A1*R+A3N;)A5RJN?*'#0GP^ED(T:6<=%KZ811^;8S94<(&8<
MF6I [,*3T9AV8S@..0Z[P6'6FZB&PR[<"<DZD061;P<UU/I+L Z@UD1]4=&F
MD/WDPR?Z+WZ!(95A)Y+"H$CL!'=8]6,463;(@F^EW)M4=GP**Q?>\@(C)=H>
MC?F])W]'YYT$I@1?!D5BAU%&22 Y^TNU"*0+/TV5F:[9P ED]")Q FE"('F[
M4[4(I L'4],L3B I^?EN5=$)7*A+\$VH70RI"0_'3<[1TR1H?9%\VHK_%YV(
M_@2"Q:/M+9T0W*'G[L?ELR2F+;;AK3&.Y;%;2*U -\?S*@O=+IPM7>'090!+
M'+IL0S?/YRD+W4[VT6:BPK2C,Q(GYA1VTG"+%^CF>-L5U)-M@$Y3@7C;ER&-
M82=$Q*!([$2M&/6O#$E239WD[B[=KD].B I"V1[PMR%&V>T:!/8& JS?;3=I
M)HL\27M"<&=0)'88Z 0()\=9K$4X77B.AL&T\<GI9O0B<;KICV[R'-Q:=-.%
MMVN)3 >J)K2I5[[4UFC<WTNP"( = EQ,!/_V6G @RKP?P$.%8]$>X,KQG/ 1
M+)L5WNU&NWC'X'++0M\=@_MWA%^56RD4R3+()6$(!_G#H^T]@/#&NXG!YH#P
M=G4=@^V?OK]$)YI_]X,_;[PO@?\0@+"GDWE"".<??NSLG2E.MTOQ2/2:I1).
MG&W99-L3)M>\G>-VR+6#\,">7#65Z0I2_9,KYU+.I=/G4E:I-'<GOQTJ[:3^
MCLKTB:JQU6IN9>=_^M%7!D7B'>;9D?(41.+ZQHZ4IR 2US<F=CP&Z'@]O 2\
MYS8KH=!2GI.I2I9F98KZI'HB7@?^$_KE=O4EWLSJ*0M-G5DRTUEHG3;EYNB?
M&OI9 ;LA:WHCL'>1 :;,)%/E8.=@YV!O$^R:H6MF([!W$82$*[LYIHV<=L&>
MYWX0+_U&ZZ"-7LXTOLZ^37:Y)UY8)X,0M=A^(Z;;PJ\S'R4[=$<MK4OVL6[0
MKSJ>"E'\Y;!U=;8G-@%/<A3IHYWRYY)VVW-12P\%??Z([TDF%)?B$AY_>!+7
MW5&%/#\.K9(/:F\W/NU!R:2\',Y,\V7TE.CW-\X&?GG16WV.K^ '\+;P.RM(
M?Y"U?@#77S\!;X,4\8>SJ'F(C3Z,-*P?X)6"<8R[1 U)#*:&,8+P.<(%'"AS
M339V_RU#%MEE0A45R9!,48+4+DJ99>+2"1>N'VX#N#JDEHR[>(BN?JY=V[-1
MOF,9;Q# 96*-\C>#+: H1\PJT2J](Y02!),@]Y<L*11@[RCQ'+ -597;C1U-
MK_NW)!;<^=0:X?X;V($ O"58"I=@ 9[N02 HO#5NCOBG!!7>,IIH&:U,'!=<
M]9A5/9FK'E>]852/6P,YXN=; _TL_?UH_(#/PGN\\T$<\2"RFM4YF@.MN /H
M"^Z)<@\\L'*8.JXZI6RE<21Y32BU19,T13ULX(C5_<);OH^5O;>B2I:EL;SI
MQ9,^1R\2.WS !OQET9)4HS+\NTAPD6:ZQ?3)< [_T8O$X7\ ?_B$9G7X=]3W
M7F0ZY66Z*?A3*#J4;;+*D-KP,]DU$A G64VH'".KLJH3QZZI;EI&XWORT<R9
M9)[N^6C. =/B *8A3W/-BB#?A5\&(:^8'/(<\ASRG4.>XHX50;X+7\R86>*8
MSAHQOQ'/JZ",521>)8 =*4]!)*YO[$AY"B)Q?6,B!,NKH/"CT:R')A7HGAC2
ML;/2'YT%:E)Q\1  @ X,]I8Y(LXD@U="X0PP%09@!/"*K!ZOA%(&\%W$)*V9
M*3/=$(OCG>-]A'@W==%HBO=.^E'-++;[;4ZZ'LKQ<@HY91APB0:D=N#GPMTN
M*04<DFLN7& ':'P>W\:7AZX2*KJ2_!D/JD@KWD#*5O[+U;Y.%CXX?F@N=3U)
M;HCB4L2P=XEW')4J(N(A?+D9UT)%U6%2+)&]4*941/R-]$72ESU[=RV<"VK!
MZ= 4,"/M> R26\:4&^%)A.A)*46JTDU,F2C>GQ62B PD;Z1F 8$R.ZOHE;7]
M ,[O V#_>6ZOX+R]L=UG^R4\^S61="<O9:KW>K#_0=$GJ5"A\ K$IHH4Y7(U
M>YMT=3]=7=[\?OO]\V5$+!^_7<Z%B\^7PLVW.^'N^_N[F\N;BZ\W5W>E=.U
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M2%S?F @>\Q:1O#<4ZY%34Y9U528=FE8"JID"W3TEZ4CB3->8/F_&F\IQXJA
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M8D9MLA?ZBXC_D_E&^B+IRYZ]NQ;.!54]KG8I[?L-_W@,DEO&%!VA4H087+C
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MK*_W(WT)KM<QKN'B&T)#$=HU9?*?R $Y1'$*4 >(S3_&U_^"1E?[,@M<91A
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MB36W#OJ=1*^09N8%)JE4'XR9$)7^KQ4'R%6TZN<JNZ61%DX_=RQA%R>A6]3
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M"5^(R!S:U/X^W?;(A!V)IY0?R1C8E(&LGIA;D,R(PMVJINBZ1H:[TQF-%]$
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M?KWWER_PG\?-D_ON_P=02P$"% ,4    "  ,0758V=3>1(B=  "]_ , #P
M            @ $     97AH:6)I=%\Q+3$N:'1M4$L! A0#%     @ #$%U
M6+TUT)T\"   9"4  !               ( !M9T  &5X:&EB:71?,3(M,2YH
M=&U02P$"% ,4    "  ,07584]<(2EP'  ">(P  $               @ $?
MI@  97AH:6)I=%\Q,BTR+FAT;5!+ 0(4 Q0    (  Q!=5C074<>$00  +@,
M   0              "  :FM  !E>&AI8FET7S$S+3$N:'1M4$L! A0#%
M  @ #$%U6+5RE[G[ P  ) P  !               ( !Z+$  &5X:&EB:71?
M,3,M,BYH=&U02P$"% ,4    "  ,07583KNW7U4#  "N"P  $
M    @ $1M@  97AH:6)I=%\Q-2TQ+FAT;5!+ 0(4 Q0    (  Q!=5@F:;<Q
MIR0  (.G   /              "  92Y  !E>&AI8FET7S(M,2YH=&U02P$"
M% ,4    "  ,075891EDJ?1(  !3Z0$ $               @ %HW@  97AH
M:6)I=%\T+3$T+FAT;5!+ 0(4 Q0    (  Q!=5BBW#E4,%8  -#/ 0 0
M          "  8HG 0!E>&AI8FET7S0M,C,N:'1M4$L! A0#%     @ #$%U
M6#VBB^T&&   N'@  !               ( !Z'T! &5X:&EB:71?.3<M,2YH
M=&U02P$"% ,4    "  ,0758!KS.EH(8!0 O<@4 "@              @ $<
ME@$ :6UA9V4P+FIP9U!+ 0(4 Q0    (  Q!=5ADL8,(QU<$ -ZR!  *
M          "  <:N!@!I;6%G93$N:G!G4$L! A0#%     @ #$%U6 U^]617
M+ D 5]X)  H              ( !M08+ &EM86=E,BYJ<&=02P$"% ,4
M"  ,0758F2\N:I1="0"GI L "@              @ $T,Q0 :6UA9V4S+FIP
M9U!+ 0(4 Q0    (  Q!=5BC;]/-O^\' %MK"@ *              "  ?"0
M'0!I;6%G930N:G!G4$L! A0#%     @ #$%U6)XLD3@+*@  +!8" !$
M         ( !UX E &UD=V0M,C R,S$R,S$N>'-D4$L! A0#%     @ #$%U
M6)E?Y;0>$P  N1P! !4              ( !$:LE &UD=V0M,C R,S$R,S%?
M8V%L+GAM;%!+ 0(4 Q0    (  Q!=5@3JLT)=D   +5.!  5
M  "  6*^)0!M9'=D+3(P,C,Q,C,Q7V1E9BYX;6Q02P$"% ,4    "  ,0758
MG!"Z_&\G 0 D"Q  %0              @ $+_R4 ;61W9"TR,#(S,3(S,5]L
M86(N>&UL4$L! A0#%     @ #$%U6.$5U[[_:P  XW4' !4
M ( !K28G &UD=V0M,C R,S$R,S%?<')E+GAM;%!+ 0(4 Q0    (  Q!=5AJ
M<);RDQ   .<1   .              "  =^2)P!M9'=D7VEM9S Q+FIP9U!+
M 0(4 Q0    (  Q!=5A0=QA@J_8$ .*.-@ -              "  9ZC)P!Z
B:S(T,S$Q-#,N:'1M4$L%!@     6 !8 1 4  '2:+     $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>zk2431143_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:currency="http://xbrl.sec.gov/currency/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mdwd="http://mediwound.com/20231231"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mdwd-20231231.xsd" xlink:type="simple"/>
    <context id="C_20231231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mdwd:AgreementAxis">mdwd:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdNexoBridMember_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember_srtRangeAxis_srtMaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mdwd:AgreementAxis">mdwd:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:NexoBridMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdNexoBridMember_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mdwd:AgreementAxis">mdwd:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:NexoBridMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230508to20230509_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mdwd:AgreementAxis">mdwd:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-08</startDate>
            <endDate>2023-05-09</endDate>
        </period>
    </context>
    <context id="C_20230508to20230509_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdNexoBridMember_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember_srtRangeAxis_srtMaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mdwd:AgreementAxis">mdwd:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:NexoBridMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-08</startDate>
            <endDate>2023-05-09</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mdwd:AgreementAxis">mdwd:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20190501to20190506_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdLicenseAgreementWithVericelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:LicenseAgreementWithVericelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2019-05-06</endDate>
        </period>
    </context>
    <context id="C_20190501to20190506_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdLicenseAgreementWithVericelMember_srtRangeAxis_srtMaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:LicenseAgreementWithVericelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2019-05-06</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdLicenseAgreementWithVericelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:LicenseAgreementWithVericelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230701to20230717_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTurnkeyScaleUpAgreementWithBiopharmaxGroupMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:TurnkeyScaleUpAgreementWithBiopharmaxGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-07-17</endDate>
        </period>
    </context>
    <context id="C_20220201to20220217_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdUsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-17</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdUsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:UsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfOrdinarySharesAxis_mdwdDilutedWeightedAverageNumberMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">mdwd:DilutedWeightedAverageNumberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullClassesOfOrdinarySharesAxis_mdwdDilutedWeightedAverageNumberMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">mdwd:DilutedWeightedAverageNumberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullOtherRelatedPartiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullOtherRelatedPartiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20071201to20071231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdChiefExecutiveOfficerAndChiefMedicalOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ChiefExecutiveOfficerAndChiefMedicalOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2007-12-01</startDate>
            <endDate>2007-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullOtherRelatedPartiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullOtherRelatedPartiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullOtherRelatedPartiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdChiefExecutiveOfficerAndChiefMedicalOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ChiefExecutiveOfficerAndChiefMedicalOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdKeyOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:KeyOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdKeyOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:KeyOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:DepreciatedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:DepreciatedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:DepreciatedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:DepreciatedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:DepreciatedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:DepreciatedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:DepreciatedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:DepreciatedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:DepreciatedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:DepreciatedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullTypesOfRisksAxis_mdwdInterestRateForLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mdwd:InterestRateForLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullTypesOfRisksAxis_mdwdUncertaintyInFutureDefaultsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mdwd:UncertaintyInFutureDefaultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_mdwdSensitivityAnalysisAxis_mdwdFivePercentageIncreaseInExchangeRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mdwd:SensitivityAnalysisAxis">mdwd:FivePercentageIncreaseInExchangeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_mdwdSensitivityAnalysisAxis_mdwdFivePercentageIncreaseInExchangeRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mdwd:SensitivityAnalysisAxis">mdwd:FivePercentageIncreaseInExchangeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_mdwdSensitivityAnalysisAxis_mdwdFivePercentageDecreaseInExchangeRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mdwd:SensitivityAnalysisAxis">mdwd:FivePercentageDecreaseInExchangeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_mdwdSensitivityAnalysisAxis_mdwdFivePercentageDecreaseInExchangeRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mdwd:SensitivityAnalysisAxis">mdwd:FivePercentageDecreaseInExchangeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mdwd:LaterThanTwoYearAndNotLaterThanFifteenYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mdwd:LaterThanTwoYearAndNotLaterThanFifteenYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20240306_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mdwd:SubsequentEventsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-06</instant>
        </period>
    </context>
    <context id="C_20240301to20240306_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mdwd:SubsequentEventsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-06</endDate>
        </period>
    </context>
    <context id="C_20240101to20240131_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesOfficersBoardMembersCeoAndConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mdwd:SubsequentEventsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-31</endDate>
        </period>
    </context>
    <context id="C_20240101_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mdwd:SubsequentEventsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-01</instant>
        </period>
    </context>
    <context id="C_20240101to20240131_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mdwd:SubsequentEventsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-31</endDate>
        </period>
    </context>
    <context id="C_20240226_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesOfficersBoardMembersCeoAndConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mdwd:SubsequentEventsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-26</instant>
        </period>
    </context>
    <context id="C_20240201to20240226_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesOfficersBoardMembersCeoAndConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mdwd:SubsequentEventsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-02-26</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdAmortizedCostMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:AmortizedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdAmortizedCostMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mdwd:AmortizedCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221101to20221128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-28</endDate>
        </period>
    </context>
    <context id="C_20220301to20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="C_20230201to20230207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-07</endDate>
        </period>
    </context>
    <context id="C_20230207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <instant>2023-02-07</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtRangeAxis_srtMinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtRangeAxis_srtMaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_srtCurrencyAxis_currencyILS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230701to20230731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="C_20230701to20230731_srtCurrencyAxis_currencyILS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullSegmentsAxis_mdwdUsaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mdwd:UsaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullSegmentsAxis_mdwdUsaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mdwd:UsaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSegmentsAxis_mdwdUsaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mdwd:UsaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSegmentsAxis_mdwdOtherCountriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mdwd:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullSegmentsAxis_mdwdOtherCountriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mdwd:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullSegmentsAxis_mdwdOtherCountriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mdwd:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdBardaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mdwd:BardaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdBardaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mdwd:BardaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdBardaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mdwd:BardaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdVericelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mdwd:VericelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdOtherCustomerContributedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mdwd:OtherCustomerContributedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdVericelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mdwd:VericelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdMtecMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mdwd:MtecMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdMtecMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mdwd:MtecMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_mdwdBuildingAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mdwd:BuildingAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20221127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <instant>2022-11-27</instant>
        </period>
    </context>
    <context id="C_20221128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <instant>2022-11-28</instant>
        </period>
    </context>
    <context id="C_20221205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <instant>2022-12-05</instant>
        </period>
    </context>
    <context id="C_20230531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="C_20220307to20220307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <startDate>2022-03-07</startDate>
            <endDate>2022-03-07</endDate>
        </period>
    </context>
    <context id="C_20220307to20220307_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdCertainEntitiesAffiliatedWithCbiMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:CertainEntitiesAffiliatedWithCbiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-07</startDate>
            <endDate>2022-03-07</endDate>
        </period>
    </context>
    <context id="C_20220926to20220926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <startDate>2022-09-26</startDate>
            <endDate>2022-09-26</endDate>
        </period>
    </context>
    <context id="C_20220926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <instant>2022-09-26</instant>
        </period>
    </context>
    <context id="C_20220901to20220928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-28</endDate>
        </period>
    </context>
    <context id="C_20221006to20221006_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mdwd:AgreementAxis">mdwd:PrivateIssuancePurchaseEquityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-06</startDate>
            <endDate>2022-10-06</endDate>
        </period>
    </context>
    <context id="C_20221006_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mdwd:AgreementAxis">mdwd:PrivateIssuancePurchaseEquityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-06</instant>
        </period>
    </context>
    <context id="C_20231231_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mdwd:AgreementAxis">mdwd:PrivateIssuancePurchaseEquityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mdwd:AgreementAxis">mdwd:PrivateIssuancePurchaseEquityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230207to20230207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <startDate>2023-02-07</startDate>
            <endDate>2023-02-07</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryDE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryDE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullGeographicalAreasAxis_countryDE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullTypesOfInterestRatesAxis_ifrsfullFixedInterestRateMember_srtCurrencyAxis_currencyUSD_srtRangeAxis_srtMinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullTypesOfInterestRatesAxis_ifrsfullFixedInterestRateMember_srtCurrencyAxis_currencyUSD_srtRangeAxis_srtMaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:TevaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:TevaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ThirdPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_ifrsfullMethodsOfGenerationAxis_mdwdSubLicensingOfPatentsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ThirdPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">mdwd:SubLicensingOfPatentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_ifrsfullMethodsOfGenerationAxis_mdwdSubLicensingOfPatentsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ThirdPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">mdwd:SubLicensingOfPatentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ThirdPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdResearchAndDevelopmentLawMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ResearchAndDevelopmentLawMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdResearchAndDevelopmentLawMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ResearchAndDevelopmentLawMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:TevaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:TevaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ThirdPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_ifrsfullMethodsOfGenerationAxis_mdwdSubLicensingOfPatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ThirdPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodsOfGenerationAxis">mdwd:SubLicensingOfPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesAndDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdIsraeliShareOptionPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesAndDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:IsraeliShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20140301to20140331_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesAndDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-03-01</startDate>
            <endDate>2014-03-31</endDate>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesAndDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesAndDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdCostOfRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:CostOfRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdCostOfRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:CostOfRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdCostOfRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:CostOfRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdResearchAndDevelopmentExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdResearchAndDevelopmentExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdResearchAndDevelopmentExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdSellingAndMarketingExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:SellingAndMarketingExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdSellingAndMarketingExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:SellingAndMarketingExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdSellingAndMarketingExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:SellingAndMarketingExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:GeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:GeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:GeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesAndDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesServenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesServenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesServenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesServenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesEightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesEightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">mdwd:RangesOfExercisePricesEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-04</endDate>
        </period>
    </context>
    <context id="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdRestrictedSharesUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-04</endDate>
        </period>
    </context>
    <context id="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-04</endDate>
        </period>
    </context>
    <context id="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdRestrictedSharesUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-04</endDate>
        </period>
    </context>
    <context id="C_20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesAndDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-04</instant>
        </period>
    </context>
    <context id="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsAndCeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsAndCeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsAndCeoMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsAndCeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220801to20220818_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:ChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-18</endDate>
        </period>
    </context>
    <context id="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-15</endDate>
        </period>
    </context>
    <context id="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdRestrictedSharesUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-15</endDate>
        </period>
    </context>
    <context id="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesOfficersBoardMembersCeoAndConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-15</endDate>
        </period>
    </context>
    <context id="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdRestrictedSharesUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesOfficersBoardMembersCeoAndConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-15</endDate>
        </period>
    </context>
    <context id="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesOfficersBoardMembersCeoAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-15</endDate>
        </period>
    </context>
    <context id="C_20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesOfficersBoardMembersCeoAndConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-15</instant>
        </period>
    </context>
    <context id="C_20230401to20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-03</endDate>
        </period>
    </context>
    <context id="C_20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-03</instant>
        </period>
    </context>
    <context id="C_20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-03</instant>
        </period>
    </context>
    <context id="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-15</endDate>
        </period>
    </context>
    <context id="C_20230501to20230531_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="C_20230501to20230531_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="C_20230801to20230815_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-15</endDate>
        </period>
    </context>
    <context id="C_20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_20230801to20230815_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-15</endDate>
        </period>
    </context>
    <context id="C_20231101to20231120_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-20</endDate>
        </period>
    </context>
    <context id="C_20231120_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:ShareIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-20</instant>
        </period>
    </context>
    <context id="C_20231120_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-20</instant>
        </period>
    </context>
    <context id="C_20231101to20231120_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:DirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-20</endDate>
        </period>
    </context>
    <unit id="Directors">
        <measure>mdwd:Directors</measure>
    </unit>
    <unit id="NIS">
        <measure>iso4217:ILS</measure>
    </unit>
    <unit id="NIS_per_share">
        <divide>
            <unitNumerator>
                <measure>iso4217:ILS</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Officers">
        <measure>mdwd:Officers</measure>
    </unit>
    <unit id="Percent">
        <measure>pure</measure>
    </unit>
    <unit id="Share">
        <measure>shares</measure>
    </unit>
    <unit id="Square_Meters">
        <measure>utr:sqm</measure>
    </unit>
    <unit id="Squaremeters">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="USD_Per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Vehicles">
        <measure>mdwd:Vehicles</measure>
    </unit>
    <unit id="shares">
        <measure>mdwd:shares</measure>
    </unit>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220218193953855"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      id="Fxbrl_20220218194046617"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      id="Fxbrl_20220218194059574"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      id="Fxbrl_20220309121931734"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:EntityCentralIndexKey
      contextRef="C_20230101to20231231"
      id="Fdei_EntityCentralIndexKey20211016114616654">0001593984</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_20230101to20231231"
      id="Fdei_AmendmentFlag20211016114715534">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_20230101to20231231"
      id="Fdei_DocumentFiscalPeriodFocus20211016115332090">FY</dei:DocumentFiscalPeriodFocus>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220218200654710"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_20230101to20231231"
      id="Fxbrl_20220108004247413">IL</dei:EntityIncorporationStateCountryCode>
    <dei:DocumentType
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211016114637958">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211207224002008">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211016115158444">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211016114658516">2023-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_20230101to20231231"
      id="Fxbrl_20220218160357327">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_20230101to20231231"
      id="Fxbrl_20220218160419913">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211016115219588">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211207224718783">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211016121555520">001-36349</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211016114600589">MEDIWOUND LTD.</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211016122123998">42 Hayarkon Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211016122147155">Yavne</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211016122203226">8122745</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211016122220190">IL</dei:EntityAddressCountry>
    <dei:ContactPersonnelName
      contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20211016122249282">Yaron Meyer</dei:ContactPersonnelName>
    <dei:CityAreaCode
      contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20211016122326538">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20211016122346833">971-4100</dei:LocalPhoneNumber>
    <dei:ContactPersonnelEmailAddress
      contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20211207223529679">yaronm@mediwound.com</dei:ContactPersonnelEmailAddress>
    <dei:EntityAddressAddressLine1
      contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20211207221757498">42 Hayarkon Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20211207221833313">Yavne</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20211207221851141">8122745</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry
      contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20220108004307270">IL</dei:EntityAddressCountry>
    <dei:Security12bTitle
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211016122422552">Ordinary shares, par value NIS 0.07 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211016122438792">MDWD</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211016122517742">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_20231231"
      decimals="INF"
      id="Fxbrl_20240319220101414"
      unitRef="Share">9221764</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211016121344180">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211016121357418">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211016121951653">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211016121406185">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240319231951241">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211016115135705">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240102104348194">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240102104625952">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:DocumentAccountingStandard
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240319231348902">International Financial Reporting Standards</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany
      contextRef="C_20230101to20231231"
      id="Fxbrl_20220107225043049">false</dei:EntityShellCompany>
    <dei:AuditorName
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240318092711906">Somekh Chaikin</dei:AuditorName>
    <dei:AuditorFirmId
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240318092354984">1057</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="C_20230101to20231231"
      id="Fxbrl_20220310125452702">Somekh Chaikin</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_20230101to20231231"
      id="Fxbrl_20220310125513773">Haifa, Israel</dei:AuditorLocation>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_37"
      unitRef="USD">11866000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_311"
      unitRef="USD">33895000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_57"
      unitRef="USD">29842000</ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_511"
      unitRef="USD">0</ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents>
    <ifrs-full:CurrentTradeReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_67"
      unitRef="USD">3700000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_611"
      unitRef="USD">9332000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:Inventories
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_77"
      unitRef="USD">2846000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_711"
      unitRef="USD">1963000</ifrs-full:Inventories>
    <ifrs-full:OtherCurrentReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_87"
      unitRef="USD">1441000</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_811"
      unitRef="USD">650000</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:CurrentAssets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_107"
      unitRef="USD">49695000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_1011"
      unitRef="USD">45840000</ifrs-full:CurrentAssets>
    <ifrs-full:OtherNoncurrentReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220217123218245_xbrl_20211012150141054_127"
      unitRef="USD">233000</ifrs-full:OtherNoncurrentReceivables>
    <ifrs-full:OtherNoncurrentReceivables
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220217123218245_xbrl_20211012150141054_1211"
      unitRef="USD">180000</ifrs-full:OtherNoncurrentReceivables>
    <ifrs-full:LongtermDeposits
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240316123518325_xbrl_20211012150141054_127"
      unitRef="USD">440000</ifrs-full:LongtermDeposits>
    <ifrs-full:LongtermDeposits
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240316123518325_xbrl_20211012150141054_1211"
      unitRef="USD">184000</ifrs-full:LongtermDeposits>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_127"
      unitRef="USD">9228000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_1211"
      unitRef="USD">2366000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:RightofuseAssets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_137"
      unitRef="USD">6698000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_1311"
      unitRef="USD">1215000</ifrs-full:RightofuseAssets>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_147"
      unitRef="USD">165000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_1411"
      unitRef="USD">231000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:NoncurrentAssets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_167"
      unitRef="USD">16764000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_1611"
      unitRef="USD">4176000</ifrs-full:NoncurrentAssets>
    <ifrs-full:Assets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_187"
      unitRef="USD">66459000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_1811"
      unitRef="USD">50016000</ifrs-full:Assets>
    <mdwd:NonCurrentLiabilitiesCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_207"
      unitRef="USD">1410000</mdwd:NonCurrentLiabilitiesCurrent>
    <mdwd:NonCurrentLiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_2011"
      unitRef="USD">2242000</mdwd:NonCurrentLiabilitiesCurrent>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_217"
      unitRef="USD">5528000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_2111"
      unitRef="USD">5656000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:OtherCurrentPayables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_227"
      unitRef="USD">3891000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:OtherCurrentPayables
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_2211"
      unitRef="USD">4159000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:CurrentLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_247"
      unitRef="USD">10829000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_2411"
      unitRef="USD">12057000</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentWarrantLiability
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240316122906641_xbrl_20211012150141054_277"
      unitRef="USD">7296000</ifrs-full:NoncurrentWarrantLiability>
    <ifrs-full:NoncurrentWarrantLiability
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240316122906641_xbrl_20211012150141054_2711"
      unitRef="USD">15606000</ifrs-full:NoncurrentWarrantLiability>
    <ifrs-full:NoncurrentGovernmentGrants
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_277"
      unitRef="USD">7677000</ifrs-full:NoncurrentGovernmentGrants>
    <ifrs-full:NoncurrentGovernmentGrants
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_2711"
      unitRef="USD">7445000</ifrs-full:NoncurrentGovernmentGrants>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_287"
      unitRef="USD">2256000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_2811"
      unitRef="USD">2788000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_297"
      unitRef="USD">6350000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_2911"
      unitRef="USD">846000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_307"
      unitRef="USD">456000</ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan>
    <ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_3011"
      unitRef="USD">360000</ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan>
    <ifrs-full:NoncurrentLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_327"
      unitRef="USD">24035000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_3211"
      unitRef="USD">27045000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Liabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220217112245655_xbrl_20211012150141054_327"
      unitRef="USD">34864000</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220217112245655_xbrl_20211012150141054_3211"
      unitRef="USD">39102000</ifrs-full:Liabilities>
    <ifrs-full:ParValuePerShare
      contextRef="C_20221231"
      decimals="2"
      id="Fxbrl_20211012185741260"
      unitRef="NIS_per_share">0.07</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="C_20231231"
      decimals="2"
      id="Fxbrl_20211012185726744"
      unitRef="NIS_per_share">0.07</ifrs-full:ParValuePerShare>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="C_20231231"
      decimals="INF"
      id="Fxbrl_20220217112505767"
      unitRef="Share">20000000</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20240316122829362"
      unitRef="Share">12857143</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="C_20231231"
      decimals="INF"
      id="Fxbrl_20221102021354405"
      unitRef="Share">9221764</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20231231"
      decimals="INF"
      id="Fxbrl_20221102021346372"
      unitRef="Share">9221764</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20220217112601459"
      unitRef="Share">7240020</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20220218125114303"
      unitRef="Share">7240020</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:IssuedCapital
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220217112748263_xbrl_20211012150141054_367"
      unitRef="USD">184000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220217112748263_xbrl_20211012150141054_3611"
      unitRef="USD">143000</ifrs-full:IssuedCapital>
    <ifrs-full:SharePremium
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_367"
      unitRef="USD">206251000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_3611"
      unitRef="USD">178882000</ifrs-full:SharePremium>
    <ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreads
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_377"
      unitRef="USD">-18000</ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreads>
    <ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreads
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_3711"
      unitRef="USD">-5000</ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreads>
    <ifrs-full:RetainedEarnings
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_387"
      unitRef="USD">-174822000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_3811"
      unitRef="USD">-168106000</ifrs-full:RetainedEarnings>
    <ifrs-full:Equity
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_407"
      unitRef="USD">31595000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_4011"
      unitRef="USD">10914000</ifrs-full:Equity>
    <ifrs-full:EquityAndLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211012150141054_427"
      unitRef="USD">66459000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211012150141054_4211"
      unitRef="USD">50016000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012190257994_26"
      unitRef="USD">6261000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012190257994_210"
      unitRef="USD">5347000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012190257994_214"
      unitRef="USD">9613000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012190257994_36"
      unitRef="USD">12265000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012190257994_310"
      unitRef="USD">12943000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012190257994_314"
      unitRef="USD">12372000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:LicenceFeeIncome
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012190257994_46"
      unitRef="USD">160000</ifrs-full:LicenceFeeIncome>
    <ifrs-full:LicenceFeeIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012190257994_410"
      unitRef="USD">8206000</ifrs-full:LicenceFeeIncome>
    <ifrs-full:LicenceFeeIncome
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012190257994_414"
      unitRef="USD">1778000</ifrs-full:LicenceFeeIncome>
    <ifrs-full:Revenue
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012190257994_57"
      unitRef="USD">18686000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012190257994_511"
      unitRef="USD">26496000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012190257994_515"
      unitRef="USD">23763000</ifrs-full:Revenue>
    <mdwd:CostOfSalesFromSaleOfProducts
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240316125531684_xbrl_20211012190257994_26"
      unitRef="USD">4927000</mdwd:CostOfSalesFromSaleOfProducts>
    <mdwd:CostOfSalesFromSaleOfProducts
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240316125531684_xbrl_20211012190257994_210"
      unitRef="USD">3184000</mdwd:CostOfSalesFromSaleOfProducts>
    <mdwd:CostOfSalesFromSaleOfProducts
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240316125531684_xbrl_20211012190257994_214"
      unitRef="USD">4983000</mdwd:CostOfSalesFromSaleOfProducts>
    <ifrs-full:ServicesExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240316125610223_xbrl_20240316125531684_xbrl_20211012190257994_26"
      unitRef="USD">10177000</ifrs-full:ServicesExpense>
    <ifrs-full:ServicesExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240316125610223_xbrl_20240316125531684_xbrl_20211012190257994_210"
      unitRef="USD">9829000</ifrs-full:ServicesExpense>
    <ifrs-full:ServicesExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240316125610223_xbrl_20240316125531684_xbrl_20211012190257994_214"
      unitRef="USD">9907000</ifrs-full:ServicesExpense>
    <mdwd:CostOfLicenseAgreements
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240316125641963_xbrl_20240316125610223_xbrl_20240316125531684_xbrl_20211012190257994_26"
      unitRef="USD">4000</mdwd:CostOfLicenseAgreements>
    <mdwd:CostOfLicenseAgreements
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240316125641963_xbrl_20240316125610223_xbrl_20240316125531684_xbrl_20211012190257994_210"
      unitRef="USD">318000</mdwd:CostOfLicenseAgreements>
    <mdwd:CostOfLicenseAgreements
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240316125641963_xbrl_20240316125610223_xbrl_20240316125531684_xbrl_20211012190257994_214"
      unitRef="USD">102000</mdwd:CostOfLicenseAgreements>
    <ifrs-full:CostOfSales
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012190257994_77"
      unitRef="USD">15108000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012190257994_711"
      unitRef="USD">13331000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012190257994_715"
      unitRef="USD">14992000</ifrs-full:CostOfSales>
    <ifrs-full:GrossProfit
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012190257994_97"
      unitRef="USD">3578000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012190257994_911"
      unitRef="USD">13165000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012190257994_915"
      unitRef="USD">8771000</ifrs-full:GrossProfit>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012190257994_117"
      unitRef="USD">7467000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012190257994_1111"
      unitRef="USD">10181000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012190257994_1115"
      unitRef="USD">10256000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012190257994_127"
      unitRef="USD">4844000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012190257994_1211"
      unitRef="USD">3725000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012190257994_1215"
      unitRef="USD">3388000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012190257994_137"
      unitRef="USD">6768000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012190257994_1311"
      unitRef="USD">6920000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012190257994_1315"
      unitRef="USD">6348000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012190257994_1415"
      unitRef="USD">211000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012190257994_1511"
      unitRef="USD">-684000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012190257994_1515"
      unitRef="USD">0</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OperatingExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012190257994_177"
      unitRef="USD">18868000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012190257994_1711"
      unitRef="USD">21510000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012190257994_1715"
      unitRef="USD">19992000</ifrs-full:OperatingExpense>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012190257994_197"
      unitRef="USD">-15290000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012190257994_1911"
      unitRef="USD">-8345000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012190257994_1915"
      unitRef="USD">-11221000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncome
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012190257994_217"
      unitRef="USD">10651000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012190257994_2111"
      unitRef="USD">461000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012190257994_2115"
      unitRef="USD">11000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceCosts
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012190257994_227"
      unitRef="USD">1892000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012190257994_2211"
      unitRef="USD">11637000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012190257994_2215"
      unitRef="USD">2314000</ifrs-full:FinanceCosts>
    <mdwd:FinanceIncomeExpenseNet
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220217133934902_xbrl_20211012190257994_247"
      unitRef="USD">8759000</mdwd:FinanceIncomeExpenseNet>
    <mdwd:FinanceIncomeExpenseNet
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220217133934902_xbrl_20211012190257994_2411"
      unitRef="USD">-11176000</mdwd:FinanceIncomeExpenseNet>
    <mdwd:FinanceIncomeExpenseNet
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220217133934902_xbrl_20211012190257994_2415"
      unitRef="USD">-2303000</mdwd:FinanceIncomeExpenseNet>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220309114736665_xbrl_20211012190257994_177"
      unitRef="USD">-6531000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220309114736665_xbrl_20211012190257994_1711"
      unitRef="USD">-19521000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220309114736665_xbrl_20211012190257994_1715"
      unitRef="USD">-13524000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220217133937404_xbrl_20211012190257994_247"
      unitRef="USD">185000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220217133937404_xbrl_20211012190257994_2411"
      unitRef="USD">78000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220217133937404_xbrl_20211012190257994_2415"
      unitRef="USD">27000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220217131713303"
      unitRef="USD">-6716000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012190257994_2715"
      unitRef="USD">-19599000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012190257994_2711"
      unitRef="USD">-13551000</ifrs-full:ProfitLoss>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012190257994_307"
      unitRef="USD">13000</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012190257994_3011"
      unitRef="USD">-14000</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012190257994_3015"
      unitRef="USD">-21000</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012190257994_327"
      unitRef="USD">-6729000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012190257994_3211"
      unitRef="USD">-19585000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012190257994_3215"
      unitRef="USD">-13530000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="C_20230101to20231231"
      decimals="2"
      id="Fxbrl_20240316125912811"
      unitRef="USD_Per_Share">-0.75</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="C_20230101to20231231"
      decimals="2"
      id="Fxbrl_20240316125902068_xbrl_20220217133620944_xbrl_20211012190257994_377"
      unitRef="USD_Per_Share">-0.75</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="C_20220101to20221231"
      decimals="2"
      id="Fxbrl_20240316125930326"
      unitRef="USD_Per_Share">-3.93</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="C_20220101to20221231"
      decimals="2"
      id="Fxbrl_20240316125902068_xbrl_20220217133620944_xbrl_20211012190257994_3711"
      unitRef="USD_Per_Share">-3.93</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20240316125957134"
      unitRef="USD_Per_Share">-3.48</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20240316125902068_xbrl_20220217133620944_xbrl_20211012190257994_3715"
      unitRef="USD_Per_Share">-3.48</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="C_20230101to20231231"
      decimals="0"
      id="Fxbrl_20240316130027024"
      unitRef="Share">9013144</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20230101to20231231"
      decimals="0"
      id="Fxbrl_20220217133620944_xbrl_20211012190257994_377"
      unitRef="Share">9013144</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="C_20220101to20221231"
      decimals="0"
      id="Fxbrl_20240316130041301"
      unitRef="Share">4987069</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20220101to20221231"
      decimals="0"
      id="Fxbrl_20220217133620944_xbrl_20211012190257994_3711"
      unitRef="Share">4987069</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="C_20210101to20211231"
      decimals="0"
      id="Fxbrl_20240316130058379"
      unitRef="Share">3892068</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20210101to20211231"
      decimals="0"
      id="Fxbrl_20220217133620944_xbrl_20211012190257994_3715"
      unitRef="Share">3892068</ifrs-full:WeightedAverageShares>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_23"
      unitRef="USD">143000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_27"
      unitRef="USD">178882000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_211"
      unitRef="USD">-5000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_215"
      unitRef="USD">-168106000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220217153716014_219"
      unitRef="USD">10914000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220218183142353"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220218183236223"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220218183606464"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_415"
      unitRef="USD">-6716000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220217153716014_419"
      unitRef="USD">-6716000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220218183644912"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220218183702968"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_511"
      unitRef="USD">-13000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220218185638679"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220217153716014_519"
      unitRef="USD">-13000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220218183734528"
      unitRef="USD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220218183811938"
      unitRef="USD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_611"
      unitRef="USD">-13000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_615"
      unitRef="USD">-6716000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220217153716014_619"
      unitRef="USD">-6729000</ifrs-full:ComprehensiveIncome>
    <mdwd:IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20240316131746801_xbrl_20240316131704093_xbrl_20220218184005423"
      unitRef="USD">1000</mdwd:IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits>
    <mdwd:IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20240316131746801_xbrl_20240316131704093_xbrl_20220217153716014_87"
      unitRef="USD">0</mdwd:IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits>
    <mdwd:IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20240316131746801_xbrl_20240316131704093_xbrl_20220218184125991"
      unitRef="USD">0</mdwd:IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits>
    <mdwd:IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20240316131746801_xbrl_20240316131704093_xbrl_20220218184147944"
      unitRef="USD">0</mdwd:IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits>
    <mdwd:IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240316131746801_xbrl_20240316131704093_xbrl_20220217153716014_819"
      unitRef="USD">1000</mdwd:IncreaseDecreaseInEquityThroughExerciseOfRestrictedShareUnits>
    <ifrs-full:IssueOfEquity
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20240316131704093_xbrl_20220218184005423"
      unitRef="USD">40000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20240316131704093_xbrl_20220217153716014_87"
      unitRef="USD">25429000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20240316131704093_xbrl_20220218184125991"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20240316131704093_xbrl_20220218184147944"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240316131704093_xbrl_20220217153716014_819"
      unitRef="USD">25469000</ifrs-full:IssueOfEquity>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220218184005423"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_87"
      unitRef="USD">1940000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220218184125991"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220218184147944"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220217153716014_819"
      unitRef="USD">1940000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:Equity
      contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_103"
      unitRef="USD">184000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_107"
      unitRef="USD">206251000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_1011"
      unitRef="USD">-18000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_1015"
      unitRef="USD">-174822000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220217153716014_1019"
      unitRef="USD">31595000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_123"
      unitRef="USD">75000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_127"
      unitRef="USD">143869000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_1211"
      unitRef="USD">-19000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_1215"
      unitRef="USD">-148507000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220217153716014_1219"
      unitRef="USD">-4582000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220218184310993"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220218184248929"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220218184225104"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_1415"
      unitRef="USD">-19599000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220217153716014_1419"
      unitRef="USD">-19599000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220218184420936"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220218184348799"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_1511"
      unitRef="USD">14000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220218185823297"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220217153716014_1519"
      unitRef="USD">14000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220218184514288"
      unitRef="USD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220218184446200"
      unitRef="USD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_1611"
      unitRef="USD">14000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_1615"
      unitRef="USD">-19599000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220217153716014_1619"
      unitRef="USD">-19585000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220309122138424"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220218184714249"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20240316131219840_xbrl_20220218185921665"
      unitRef="USD">40000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20240316131219840_xbrl_20220217153716014_187"
      unitRef="USD">17389000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20240316131219840_xbrl_20220218184754752"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20240316131219840_xbrl_20220218184812008"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240316131219840_xbrl_20220217153716014_1819"
      unitRef="USD">17429000</ifrs-full:IssueOfEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20240316131501539_xbrl_20240316131219840_xbrl_20220218185921665"
      unitRef="USD">28000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20240316131501539_xbrl_20240316131219840_xbrl_20220217153716014_187"
      unitRef="USD">15678000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20240316131501539_xbrl_20240316131219840_xbrl_20220218184754752"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20240316131501539_xbrl_20240316131219840_xbrl_20220218184812008"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240316131501539_xbrl_20240316131219840_xbrl_20220217153716014_1819"
      unitRef="USD">15706000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220218185921665"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_187"
      unitRef="USD">1946000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220218184754752"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220218184812008"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220217153716014_1819"
      unitRef="USD">1946000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_193"
      unitRef="USD">143000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_197"
      unitRef="USD">178882000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_1911"
      unitRef="USD">-5000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_1915"
      unitRef="USD">-168106000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220217153716014_1919"
      unitRef="USD">10914000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_213"
      unitRef="USD">75000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_217"
      unitRef="USD">142193000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_2111"
      unitRef="USD">-40000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_2115"
      unitRef="USD">-134956000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220217153716014_2119"
      unitRef="USD">7272000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220218184923239"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220218184950407"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220218185019824"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_2315"
      unitRef="USD">-13551000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220217153716014_2319"
      unitRef="USD">-13551000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220218185103905"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220218185119152"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_2411"
      unitRef="USD">21000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220218185137255"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220217153716014_2419"
      unitRef="USD">21000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220218185220488"
      unitRef="USD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220218185232968"
      unitRef="USD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_2511"
      unitRef="USD">21000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_2515"
      unitRef="USD">-13551000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220217153716014_2519"
      unitRef="USD">-13530000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220309122501805"
      unitRef="USD">3000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220309122512511"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220218185315392"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220218194110309"
      unitRef="USD">3000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220218185335904"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_277"
      unitRef="USD">1673000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220218185356192"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220218185413288"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220217153716014_2719"
      unitRef="USD">1673000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_283"
      unitRef="USD">75000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_287"
      unitRef="USD">143869000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_2811"
      unitRef="USD">-19000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220217153716014_2815"
      unitRef="USD">-148507000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220217153716014_2819"
      unitRef="USD">-4582000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211016101215111"
      unitRef="USD">-6716000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211016101231434"
      unitRef="USD">-19599000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211016101235471"
      unitRef="USD">-13551000</ifrs-full:ProfitLoss>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111"
      unitRef="USD">1303000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434"
      unitRef="USD">1272000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471"
      unitRef="USD">1238000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111"
      unitRef="USD">1940000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434"
      unitRef="USD">1946000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471"
      unitRef="USD">1673000</ifrs-full:AdjustmentsForSharebasedPayments>
    <mdwd:AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240316141511211_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111"
      unitRef="USD">8310000</mdwd:AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue>
    <mdwd:AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240316141511211_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434"
      unitRef="USD">-8977000</mdwd:AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue>
    <mdwd:AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240316141511211_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471"
      unitRef="USD">0</mdwd:AdjustmentForIncreaseDecreaseInRevaluationOfWarrantsAccountedAtFairValue>
    <mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240316141550249_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111"
      unitRef="USD">0</mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss>
    <mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240316141550249_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434"
      unitRef="USD">1911000</mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss>
    <mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240316141550249_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471"
      unitRef="USD">0</mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss>
    <mdwd:AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111"
      unitRef="USD">-427000</mdwd:AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants>
    <mdwd:AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434"
      unitRef="USD">132000</mdwd:AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants>
    <mdwd:AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471"
      unitRef="USD">-919000</mdwd:AdjustmentForIncreaseDecreaseInRevaluationOfLiabilitiesInRespectOfGrants>
    <ifrs-full:OtherAdjustmentsToReconcileProfitLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111"
      unitRef="USD">468000</ifrs-full:OtherAdjustmentsToReconcileProfitLoss>
    <ifrs-full:OtherAdjustmentsToReconcileProfitLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434"
      unitRef="USD">533000</ifrs-full:OtherAdjustmentsToReconcileProfitLoss>
    <ifrs-full:OtherAdjustmentsToReconcileProfitLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471"
      unitRef="USD">590000</ifrs-full:OtherAdjustmentsToReconcileProfitLoss>
    <mdwd:AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240316141620137_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111"
      unitRef="USD">257000</mdwd:AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability>
    <mdwd:AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240316141620137_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434"
      unitRef="USD">-109000</mdwd:AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability>
    <mdwd:AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240316141620137_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471"
      unitRef="USD">188000</mdwd:AdjustmentsForFinancingIncomeAndExchangeDifferencesOfLeaseLiability>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111"
      unitRef="USD">83000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434"
      unitRef="USD">109000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471"
      unitRef="USD">13000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:OtherIncome
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240316141632821_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111"
      unitRef="USD">211000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240316141632821_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434"
      unitRef="USD">0</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240316141632821_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471"
      unitRef="USD">0</ifrs-full:OtherIncome>
    <ifrs-full:AdjustmentsForFinanceIncomeCost
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111"
      unitRef="USD">2231000</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:AdjustmentsForFinanceIncomeCost
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434"
      unitRef="USD">74000</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:AdjustmentsForFinanceIncomeCost
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471"
      unitRef="USD">11000</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111"
      unitRef="USD">-189000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434"
      unitRef="USD">-525000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471"
      unitRef="USD">137000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211016101618017"
      unitRef="USD">-6085000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211016101634034"
      unitRef="USD">14958000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211016101639522"
      unitRef="USD">4473000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111"
      unitRef="USD">5658000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434"
      unitRef="USD">-7582000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471"
      unitRef="USD">929000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111"
      unitRef="USD">-906000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434"
      unitRef="USD">-721000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471"
      unitRef="USD">257000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111"
      unitRef="USD">-894000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434"
      unitRef="USD">364000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471"
      unitRef="USD">-763000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211016101805291_xbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111"
      unitRef="USD">-594000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211016101805291_xbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434"
      unitRef="USD">414000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211016101805291_xbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471"
      unitRef="USD">1723000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211016101824923_xbrl_20211016101805291_xbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111"
      unitRef="USD">-928000</mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue>
    <mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211016101824923_xbrl_20211016101805291_xbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434"
      unitRef="USD">281000</mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue>
    <mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211016101824923_xbrl_20211016101805291_xbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471"
      unitRef="USD">-1984000</mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue>
    <mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211016101852444"
      unitRef="USD">2336000</mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems>
    <mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211016101905860"
      unitRef="USD">-7244000</mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems>
    <mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211016101913746"
      unitRef="USD">162000</mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211016102741060_xbrl_20211016102706044_xbrl_20211016101930446_xbrl_20211016101824923_xbrl_20211016101805291_xbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101215111"
      unitRef="USD">-10465000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211016102741060_xbrl_20211016102706044_xbrl_20211016101930446_xbrl_20211016101824923_xbrl_20211016101805291_xbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101231434"
      unitRef="USD">-11885000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211016102741060_xbrl_20211016102706044_xbrl_20211016101930446_xbrl_20211016101824923_xbrl_20211016101805291_xbrl_20211016101743356_xbrl_20211016101723180_xbrl_20211016101704074_xbrl_20211016101556881_xbrl_20211016101538845_xbrl_20211016101518675_xbrl_20211016101501250_xbrl_20211016101444477_xbrl_20211016101424969_xbrl_20211016101406949_xbrl_20211016101349609_xbrl_20211016101330505_xbrl_20211016101250370_xbrl_20211016101235471"
      unitRef="USD">-8916000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220217142047413_43"
      unitRef="USD">6464000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220217142047413_47"
      unitRef="USD">555000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220217142047413_411"
      unitRef="USD">489000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220217142047413_53"
      unitRef="USD">1947000</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220217142047413_57"
      unitRef="USD">74000</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220217142047413_511"
      unitRef="USD">35000</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220217142047413_63"
      unitRef="USD">-29804000</ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments>
    <ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220217142047413_67"
      unitRef="USD">0</ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments>
    <ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220217142047413_611"
      unitRef="USD">4002000</ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220217142047413_123"
      unitRef="USD">-34321000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220217142047413_127"
      unitRef="USD">-481000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220217142047413_1211"
      unitRef="USD">3548000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220217142047413_163"
      unitRef="USD">778000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220217142047413_167"
      unitRef="USD">701000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220217142047413_1611"
      unitRef="USD">693000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220217142047413_173"
      unitRef="USD">0</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220218200700141"
      unitRef="USD">3000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240316143424385_xbrl_20220217145205091_xbrl_20220217142047413_163"
      unitRef="USD">0</ifrs-full:ProceedsFromExerciseOfWarrants>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240316143424385_xbrl_20220217145205091_xbrl_20220217142047413_167"
      unitRef="USD">10000</ifrs-full:ProceedsFromExerciseOfWarrants>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240316143424385_xbrl_20220217145205091_xbrl_20220217142047413_1611"
      unitRef="USD">0</ifrs-full:ProceedsFromExerciseOfWarrants>
    <mdwd:ProceedsFromIssuanceOfSharesAndWarrantsNet
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240316143455726_xbrl_20220217145205091_xbrl_20220217142047413_163"
      unitRef="USD">24909000</mdwd:ProceedsFromIssuanceOfSharesAndWarrantsNet>
    <mdwd:ProceedsFromIssuanceOfSharesAndWarrantsNet
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240316143455726_xbrl_20220217145205091_xbrl_20220217142047413_167"
      unitRef="USD">38380000</mdwd:ProceedsFromIssuanceOfSharesAndWarrantsNet>
    <mdwd:ProceedsFromIssuanceOfSharesAndWarrantsNet
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240316143455726_xbrl_20220217145205091_xbrl_20220217142047413_1611"
      unitRef="USD">0</mdwd:ProceedsFromIssuanceOfSharesAndWarrantsNet>
    <mdwd:RepaymentsOfIiaGrantsNet
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220217145205091_xbrl_20220217142047413_163"
      unitRef="USD">380000</mdwd:RepaymentsOfIiaGrantsNet>
    <mdwd:RepaymentsOfIiaGrantsNet
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220217145205091_xbrl_20220217142047413_167"
      unitRef="USD">258000</mdwd:RepaymentsOfIiaGrantsNet>
    <mdwd:RepaymentsOfIiaGrantsNet
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220217145205091_xbrl_20220217142047413_1611"
      unitRef="USD">360000</mdwd:RepaymentsOfIiaGrantsNet>
    <mdwd:RepaymentOfLiabilitiesInRespectOfTeva
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240316143540953_xbrl_20220217145205091_xbrl_20220217142047413_163"
      unitRef="USD">834000</mdwd:RepaymentOfLiabilitiesInRespectOfTeva>
    <mdwd:RepaymentOfLiabilitiesInRespectOfTeva
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240316143540953_xbrl_20220217145205091_xbrl_20220217142047413_167"
      unitRef="USD">1667000</mdwd:RepaymentOfLiabilitiesInRespectOfTeva>
    <mdwd:RepaymentOfLiabilitiesInRespectOfTeva
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240316143540953_xbrl_20220217145205091_xbrl_20220217142047413_1611"
      unitRef="USD">0</mdwd:RepaymentOfLiabilitiesInRespectOfTeva>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220217142047413_203"
      unitRef="USD">22917000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220217142047413_207"
      unitRef="USD">35764000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220217142047413_2011"
      unitRef="USD">-1050000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220217142047413_223"
      unitRef="USD">-160000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220217142047413_227"
      unitRef="USD">-549000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220217142047413_2211"
      unitRef="USD">88000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220217142047413_243"
      unitRef="USD">-22029000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220217142047413_247"
      unitRef="USD">22849000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220217142047413_2411"
      unitRef="USD">-6330000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220217144517553_xbrl_20220217142047413_313"
      unitRef="USD">33895000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220217144517553_xbrl_20220217142047413_317"
      unitRef="USD">11046000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220217144517553_xbrl_20220217142047413_3111"
      unitRef="USD">17376000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220217144520381_xbrl_20220217142047413_313"
      unitRef="USD">11866000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220217144520381_xbrl_20220217142047413_317"
      unitRef="USD">33895000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220217144520381_xbrl_20220217142047413_3111"
      unitRef="USD">11046000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220217142047413_313"
      unitRef="USD">6825000</ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus>
    <ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220217142047413_317"
      unitRef="USD">117000</ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus>
    <ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220217142047413_3111"
      unitRef="USD">155000</ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus>
    <mdwd:PurchaseOfPropertyAndEquipment
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240316144915962_xbrl_20220217142047413_313"
      unitRef="USD">-1011000</mdwd:PurchaseOfPropertyAndEquipment>
    <mdwd:PurchaseOfPropertyAndEquipment
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240316144915962_xbrl_20220217142047413_317"
      unitRef="USD">0</mdwd:PurchaseOfPropertyAndEquipment>
    <mdwd:PurchaseOfPropertyAndEquipment
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240316144915962_xbrl_20220217142047413_3111"
      unitRef="USD">0</mdwd:PurchaseOfPropertyAndEquipment>
    <ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317140107121">
      &lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note 1:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;General&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Description of the Company and its operations:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:84.45pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;MediWound Ltd. Was incorporated in Israel in January 2000. The Company which is located in Yavne, Israel (The "Company" or "MediWound"), is biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic, non-surgical solutions for tissue repair and regeneration. The Company&#x2019;s strategy leverages its breakthrough enzymatic technology platform into diversified portfolio of biotherapeutics across multiple indications to pioneer solutions for unmet medical needs. The Company&#x2019;s current portfolio is focused on next-generation protein-based therapies for burn care, wound care and tissue repair.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:84.45pt;line-height:1.25"&gt;
          &lt;div style="line-height:1.25;font-family:'Times New Roman',serif"&gt;
            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's first innovative biopharmaceutical product, Nexobrid, has received in December 2022, an approval from the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) and marketing approval in each of India, Switzerland and Japan. In addition, it has a marketing authorization from the European Medicines Agency (&#x201c;EMA&#x201d;) and regulatory agencies in other international markets for removal of dead or damaged tissue, known as eschar, in adults with deep partial and full thickness thermal burns.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company commercialize Nexobrid globally through multiple sales channels.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',serif"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company sells Nexobrid to burn centers in the European Union, United Kingdom and Israel, primarily through its commercial organizations.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',serif"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has established local distribution channels in multiple international markets, focusing on Asia Pacific, EMEA, CEE and LATAM, which local distributors are also responsible for obtaining local marketing authorization within the relevant territories.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',serif"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In the United States, the Company entered into an exclusive license and supply agreements with Vericel Corporation (&#x201c;Vericel&#x201d;) to commercialize Nexobrid in North America upon FDA approval. On September 21, 2023, the Company announced the U.S. commercial availability of Nexobrid&#xae; for the removal of eschar in adults with deep partial- and/or full-thickness thermal burns.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:84.45pt;line-height:1.25"&gt;
          &lt;div style="line-height:1.25;font-family:'Times New Roman',serif"&gt;
            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On September 20, 2022, The Company announced that EMA has validated for review the Type II Variation to expand the currently approved indication for Nexobrid (removal of eschar in adults with deep partial-and full-thickness thermal burn wounds) into the pediatric population.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:84.45pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s second investigational next-generation enzymatic therapy product, EscharEx, a topical biological drug being developed for debridement of chronic and other hard-to-heal wounds,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:84.45pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On November 21, 2023 the Company announced in relate to EscharEx clinical trial that an updated Phase III protocol will be submitted during first half of 2024 in accordance with recent discussions with the U.S. FDA and EMA. Study initiation is expected to commence in the second half of 2024.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:84.45pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div&gt;&lt;/div&gt;
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:top;width:28.35pt"&gt;
                  &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                  &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's securities are listed for trading on NASDAQ since March 2014.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On November 28, 2022, the Company&#x2019;s shareholders general meeting approved a reverse stock split. Following that approval, on December 5, 2022, the Company&#x2019;s board of directors approved a reverse stock split, in a range of 1-for-7 ratio. The reverse split went effective on December 20, 2022. (see also Note 19b).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During March, September and October 2022, the Company completed a series of capital public and private offerings. The gross proceeds before deducting underwriting discounts and commissions and offering expenses, were approximately $41,700. The net proceeds were approximately $37,292 (see also Note 19).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On February 7, 2023, the Company completed a registered direct offering. A total of 1,964,286 new ordinary shares were issued in consideration to offering price of $14 per share. The gross proceeds were $27,500, before deducting commissions and other offering expenses. The net proceeds were approximately $25,469.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has three wholly owned subsidiaries: MediWound Germany GmbH, acting as Europe (&#x201c;EU&#x201d;) marketing authorization holder and EU sales and marketing arm, and MediWound UK Limited and MediWound US, Inc. which are currently inactive companies.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In October 2023, Israel was attacked by a terrorist organization and entered a state of war. As of the date of these consolidated financial statements, the war in Israel is ongoing and continues to evolve. The company&#x2019;s head quarter, manufacturing and R&amp;amp;D facilities are located in Israel. Currently, such activities in Israel remain largely unaffected. During the year ended December 31, 2023, the impact of this war on the company&#x2019;s results of operations and financial condition was immaterial.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The accompanying consolidated financial statements have been prepared on a basis which assumes that the Company will continue as a going concern. From inception to December 31, 2023, the Company has incurred cash outflows from operations, losses from operations, and has an accumulated deficit of $174.8 million.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="text-align:justify;margin-left:81.8pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company believes that its existing cash and cash equivalents, short-term and restricted bank deposits of $41.7 million as of December 31, 2023, will be sufficient to fund its operations and capital expenditure for at least twelve months from the date of issuance of these consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;/div&gt;
    </ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory>
    <mdwd:ReverseStockSplit
      contextRef="C_20221101to20221128"
      id="Fxbrl_20240317135305955">1-for-7 ratio</mdwd:ReverseStockSplit>
    <mdwd:GrossProceedsFromPublicAndPrivateOfferings
      contextRef="C_20220301to20221031"
      decimals="-3"
      id="Fxbrl_20240317140125003"
      unitRef="USD">41700000</mdwd:GrossProceedsFromPublicAndPrivateOfferings>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="C_20220301to20221031"
      decimals="-3"
      id="Fxbrl_20240317140246682"
      unitRef="USD">37292000</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20230207"
      decimals="INF"
      id="Fxbrl_20240317140806785"
      unitRef="Share">1964286</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ParValuePerShare
      contextRef="C_20230207"
      decimals="0"
      id="Fxbrl_20240317140933686"
      unitRef="USD_Per_Share">14</ifrs-full:ParValuePerShare>
    <mdwd:GrossProceedsFromPublicAndPrivateOfferings
      contextRef="C_20230201to20230207"
      decimals="-3"
      id="Fxbrl_20240317140644952"
      unitRef="USD">27500000</mdwd:GrossProceedsFromPublicAndPrivateOfferings>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="C_20230201to20230207"
      decimals="-3"
      id="Fxbrl_20240317140624101"
      unitRef="USD">25469000</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <ifrs-full:RetainedEarnings
      contextRef="C_20231231"
      decimals="-5"
      id="Fxbrl_20240317141029683"
      unitRef="USD">-174800000</ifrs-full:RetainedEarnings>
    <mdwd:CashAndCashEquivalentsShortTermAndRestrictedBankDeposits
      contextRef="C_20231231"
      decimals="-5"
      id="Fxbrl_20240317193548688"
      unitRef="USD">41700000</mdwd:CashAndCashEquivalentsShortTermAndRestrictedBankDeposits>
    <ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240316160706785">
    &lt;div&gt;
      &lt;div style="text-align:justify;line-height:1.25;font-weight:bold"&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Note 2:&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Basis of Preparation of the Consolidated Financial Statements&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

          &lt;tr&gt;
            &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:28.35pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
              &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Statement of compliance with International Financial Reporting Standards&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB").&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These consolidated financial statements were approved by the board of directors on March 21, 2024.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

          &lt;tr&gt;
            &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:28.35pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
              &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Functional currency, reporting currency and foreign currency:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

          &lt;tr&gt;
            &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Functional currency and reporting currency:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The reporting currency of the financial statements is the U.S. dollar.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company determines the functional currency based on the currency in which it primarily generates and expends cash. The Company determined that its functional currency is the U.S. dollar since most of the Company's revenues are in U.S. dollars and the economic environment in which the Company operates in and performs its transactions is mostly affected by the U.S dollar. A certain portion of the Company's costs are denominated in NIS mainly due to payroll and related benefit costs incurred in Israel. To further support the Company's determination, the Company has analyzed the currency in which funds from financing activities are generated or held and the currency in which receipts from operating activities are usually retained. In this respect, funds from financing activities were principally derived from significant funds raising in U.S. dollars and U.S governmental funds.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company operates and plans its activities in U.S. dollars and accordingly its periodic budgets and internal management reports are prepared and monitored using the U.S. dollar as the primary currency and provides the basis for the determination of share-based compensation.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The&#160;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt"&gt;functional currency of the Company's subsidiary in Germany has been determined to be its local currency - the EURO. Assets and liabilities of this subsidiary are translated at year end exchange rates and its statement of operations&#160;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt"&gt;items are translated using the average exchange rates at the quarter of which those items are recognized. Such translation adjustments are recorded as a separate component of accumulated other comprehensive income (loss) in shareholders' equity (deficit).&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

          &lt;tr&gt;
            &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transactions, assets and liabilities in foreign currency:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transactions denominated in foreign currency are recorded upon initial recognition at the exchange rate on the date of the transaction. After initial recognition, monetary assets and liabilities denominated in foreign currency are translated at the end of each reporting period into the functional currency at the exchange rate at that date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchange differences are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div&gt;&lt;/div&gt;
      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

          &lt;tr&gt;
            &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
              &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Use of estimates and judgments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The preparation of financial statements in conformity with IFRSs requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Discussed below are the key assumptions made in the financial statements concerning uncertainties at the end of the reporting period and the critical estimates computed by the Company that may result in a material adjustment to the carrying amounts of assets and liabilities within the next financial year.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

          &lt;tr&gt;
            &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Determining the fair value of share-based compensation to employees and directors:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="line-height:1.25;margin-left:85pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of share-based compensation to employees and directors is determined using the binomial option pricing models. The assumptions used in the models include the expected volatility, early exercise factor, expected dividend and risk-free interest rate.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

          &lt;tr&gt;
            &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Liabilities in respect to IIA grants:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government grants received from the IIA are recognized as a liability if future economic benefits are expected from the research and development activity that will result in royalty&#x2011;bearing sales. As the contingent liability is calculated based on future royalty-bearing sales, there is uncertainty regarding the estimated future cash flows and the estimated discount rate used to measure the amortized cost of the liability.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;line-height:1.25"&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Fair value estimations of warrants&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;
      &lt;div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;line-height:1.25;margin-left:85pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company completed financing transactions in which it issued shares and warrants to purchase additional shares. The fair value of the warrants, which are not traded on an active market, is determined by using valuation techniques. These valuation techniques maximize the use of observable market data where it is available and rely as little as possible on entity specific estimates.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
    &lt;/div&gt;
  </ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory>
    <ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317144956402">
              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Note 3:&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top"&gt;
                          &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold"&gt;Material Accounting Policies&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The accounting policies set out below have been consistently applied for all periods presented in these consolidated financial statements:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div&gt;
                  &lt;div&gt;

                      &lt;div&gt;
                        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                            &lt;tr&gt;
                              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basis of consolidation:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Consolidated financial statements include the financial statements of companies that the Company controls (subsidiaries). Control is achieved when the Company is exposed, or has rights, to variable returns from its investment with the investee and has the ability to affect those returns through its power over the investee.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The financial statements of the Company and its subsidiaries are prepared as of the same dates and periods. The consolidated financial statements are prepared using uniform accounting policies by all entities in the Group.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;

                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventories:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventories are measured at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated selling costs. The Company periodically evaluates the condition and age of inventories and makes provisions for slow moving inventories accordingly.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost of inventories is determined as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="margin-left:90pt"&gt;
                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:19.52%;vertical-align:top"&gt;
                              &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Raw materials&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td style="width:3.54%;vertical-align:top"&gt;
                              &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td style="width:76.94%;vertical-align:top"&gt;
                              &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At cost of purchase using the first-in, first-out method.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="width:19.52%;vertical-align:top"&gt;
                              &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finished goods&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td style="width:3.54%;vertical-align:top"&gt;
                              &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td style="width:76.94%;vertical-align:top"&gt;
                              &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On the basis of average standard costs (which approximates actual cost on a weighted average basis) including materials, labor and other direct and indirect manufacturing costs based on practical capacity.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;

                &lt;div&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property, plant and equipment, net:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property, plant and equipment are measured at cost, including directly attributable costs, less accumulated depreciation and accumulated impairment losses. Cost includes spare parts and auxiliary equipment that are used in connection with the plant and equipment.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation is calculated on a straight&#x2011;line basis over the useful life of the assets at annual rates as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="margin-left:90pt"&gt;

                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                            &lt;tr&gt;
                              &lt;td style="width:70.35%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:2.82%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:26.82%;vertical-align:bottom;border-bottom:#000000 2px solid"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:70.35%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Office furniture&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:2.82%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:26.82%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7-10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:70.35%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Manufacturing machinery and lab equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:2.82%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:26.82%;vertical-align:bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15-33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:70.35%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:2.82%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:26.82%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:70.35%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leasehold improvements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:2.82%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:26.82%;vertical-align:bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;See below&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;

                    &lt;/div&gt;
                    &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                    &lt;div&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leasehold improvements are depreciated on a straight&#x2011;line basis over the shorter of the lease term (including the renewal option held by the Company which is expected to be exercised) and the expected life of the improvement.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The useful life, depreciation method and residual value of an asset are reviewed at least each year-end and any changes are accounted for prospectively as a change in accounting estimate.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liability in respect of Israeli Innovation Authority ("IIA"):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Grants from the IIA in respect of research and development projects are accounted for as forgivable loans according to IAS 20. Grants received from the IIA are recognized as a liability according to their fair value on the date of their receipt, unless on that date it is reasonably certain that the amount received will not be refunded. If future economic benefits are expected from the project that will result in royalty-bearing revenues from sale of products it will be treated as a contingent liability.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At the end of each reporting period, the Company evaluates whether there is reasonable assurance that the liability recognized, in whole or in part, will not be repaid based on its best estimate of future sales and any changes in the present value of the cash flows discounted at the original interest rate of the grant are recognized in profit or loss. The difference between the amount received and the fair value on the date of receiving the grant is recognized as a deduction of research and development expenses.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leases:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for a contract as a lease when the contract terms convey the right to control the use of an identified asset for a period of time in exchange for consideration.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For these excluded leases, the Company has elected to recognize the lease payments as an expense in profit or loss on a straight-line basis over the lease term. In measuring the lease liability, the Company has elected to apply the practical expedient in the Standard and does not separate the lease components from the non-lease components (such as management and maintenance services, etc.) included in a single contract.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Following are the amortization periods of the ROU assets by class of underlying asset:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="margin-left:90pt"&gt;

                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                            &lt;tr&gt;
                              &lt;td style="width:65.06%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:3.87%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:27.2%;vertical-align:top;border-bottom:#000000 2px solid"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:65.06%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-indent:-7.1pt;margin-left:7.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Motor vehicles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.87%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:27.2%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:65.06%;vertical-align:bottom"&gt;
                                &lt;div style="text-indent:-7.1pt;margin-left:7.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Buildings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.87%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:27.2%;vertical-align:bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6-15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;

                    &lt;/div&gt;
                    &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                    &lt;div&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company tests for impairment of the ROU asset whenever there are indications of impairment pursuant to the provisions of IAS 36.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Variable lease payments that depend on an index:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:104.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On the commencement date, the Company uses the index rate prevailing on the commencement date to calculate the future lease payments.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:104.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For leases in which the Company is the lessee, the aggregate changes in future lease payments resulting from a change in the index are discounted (without a change in the discount rate applicable to the lease liability) and recorded as an adjustment of the lease liability and the ROU assets, only when there is a change in the cash flows resulting from the change in the index (that is, when the adjustment to the lease payments takes effect).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease extension and termination options:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:104.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A non-cancelable lease term includes both the periods covered by an option to extend the lease when it is reasonably certain that the extension option will be exercised and the periods covered by a lease termination option when it is reasonably certain that the termination option will not be exercised.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;f.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues recognition:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="text-align:justify;text-indent:-7.05pt;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes revenue when the customer obtains control over the promised goods or services. The revenue is measured according to the amount of the consideration to which the Company expects to be entitled in exchange for the goods or services promised to the customer, other than amounts collected for third parties.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company determines transaction price based on the amount of consideration the Company expects to receive for transferring the promised goods or services in the contract.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Consideration may be fixed, variable, or a combination of both. At contract inception for arrangements that include variable consideration, the Company estimates the probability and extent of consideration it expects to receive under the contract utilizing either the most likely amount method or expected amount method, whichever best estimates the amount expected to be received. The Company then considers any constraints on the variable consideration and includes in the transaction price variable consideration to the extent it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. The Company then allocates the transaction price to each performance obligation based on the relative standalone selling price and recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) control is transferred to the customer and the performance obligation is satisfied.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company records amounts as accounts receivable when the right to consideration is deemed unconditional. Amounts received, or that are unconditionally due, from a customer prior to transferring goods or services to the customer under the terms of a contract are recognized as deferred revenue. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as the current portion of deferred revenue. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s revenue-generating arrangements typically include licensing arrangements, which comprise of upfront license fees, milestone payments and/or royalties and products sale arrangements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The promised goods or services in the Company&#x2019;s licensing arrangements typically consist of a license to the Company&#x2019;s intellectual property and/or research and development services.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;If a license is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenue from nonrefundable, up-front fees allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For arrangements that include sales-based royalties, including milestone payments based on the level of sales, where the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',serif"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In 2019, the Company entered into exclusive license and supply agreements with Vericel to commercialize Nexobrid in North America (see Note 22). The Company identified three distinct performance obligations: (1) license rights (2) development services for BLA approval and (3) manufacturing and supply of Nexobrid.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of the closing date of the agreement the manufacturing and development services were at market value, therefore the upfront payment was fully attributed to the license performance obligation and as such revenues are recognized at the point in time that control of the license is transferred to the customer.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Future milestone payments are considered variable consideration and are subject to the variable consideration constraint, i.e. will be recognized once concluded that it is &#x201c;probable&#x201d; that a significant reversal of the cumulative revenues recognized under the contract will not occur in future periods when the uncertainty related to the variable considerations are resolved. (see Note 18b).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues from royalties under this agreement will be payable based on future commercial sales, up on an occurrence.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues from the sale of products to Vericel will be recognized when all the significant risks and rewards of ownership of the products have passed to the buyer and the seller no longer retains continuing managerial involvement. The delivery date of the products is usually the date of which ownership passes.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues from distribution licensing arrangements:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for the bundled license provided to the distributers and related high specialized services as a single performance obligation and consequently recognize revenue using the cost-to-cost method, where the extent of progress towards completion is measured based on the ratio of actual costs incurred to the total estimated costs expected to be incurred upon satisfying such single performance obligation. The revenues from such bundled performance obligation are included within &#x201c;Revenues from license agreements&#x201d;. Significant finance components related to such arrangements are recognized as finance expense.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues from development services:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues from development services are recognized over time, during the period the customer receives and consumes the benefits provided by the Company's performance.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues from the sale of products:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',serif"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company generates revenues from sales of its innovative biopharmaceutical product, Nexobrid, to burn centers and hospital burn units in Europe, U.S Israel and local international markets through its commercial organizations and local distributors.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues from sale of goods is recognized in profit or loss at the point in time when the control of the goods is transferred to the customer, generally upon delivery of the goods to the customer. &#160;The transaction price is the amount of the consideration that is expected to be received based on the contract terms.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                &lt;div&gt;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;g.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development expenses:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development expenses are recognized in profit or loss when incurred. An intangible asset arising from a development project or from the development phase of an internal project is recognized if the Company can demonstrate the technical feasibility of completing the intangible asset so that it will be available for use or sale; the Company's intention to complete the intangible asset and use or sell it; the Company's ability to use or sell the intangible asset; how the intangible asset will generate future economic benefits; the availability of adequate technical, financial and other resources to complete the intangible asset; and the Company's ability to measure reliably the expenditure attributable to the intangible asset during its development. Since the Company's research and development projects are often subject to regulatory approval procedures and other uncertainties, the conditions for the capitalization of costs incurred before receipt of approvals are not normally satisfied and, therefore, research and development expenses are recognized in profit or loss when incurred.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;h.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial instruments:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The accounting policy for financial instruments in accordance with IFRS 9, "Financial Instruments" ("the Standard") is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:113.4pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial liabilities measured at amortized cost:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:141.75pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of the financial liability.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:141.75pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;After initial recognition, the Company measures all financial liabilities at amortized cost using the effective interest rate method, except for financial liabilities at fair value through profit or loss such as derivatives;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:113.4pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial liabilities measured at fair value through profit or loss:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:141.75pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At initial recognition, the Company measures financial liabilities that are not measured at amortized cost at fair value. Transaction costs are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;text-indent:28.35pt;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;After initial recognition, changes in fair value are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;text-indent:28.35pt;margin-left:113.4pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div&gt;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value measurement is based on the assumption that the transaction will take place in the asset's or the liability's principal market, or in the absence of a principal market, in the most advantageous market.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="margin-left:113.4pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A fair value measurement of a non-financial asset takes into account a market participant's ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;i.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:86.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Receipts in respect of warrants are classified as equity to the extent that they confer the right to purchase a fixed number of shares for a fixed exercise price. In the event that the exercise price or the numbers of shares to be issued are not deemed to be fixed (for example, in case of net share settlement provision), or warrants redemption in cash on the occurrence of Fundamental Transaction the warrants are classified as a non-current derivative financial liability. This liability is initially recognized at its fair value on the date the contract is entered into and subsequently accounted for at fair value at each reporting date. The fair value changes are charged to non-operating income and expense on the statement of comprehensive income or loss. Issuance costs allocable to warrants are also recorded as non-operating expense on the statement of comprehensive income or loss.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;j.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Provisions:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:86.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A provision in accordance with IAS 37 is recognized when the Company has a present (legal or constructive) obligation as a result of a past event, it is expected to require the use of economic resources to clear the obligation and a reliable estimate has been made.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                &lt;div&gt;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;k.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Short-term employee benefits and severance pay liability, net:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has several employee benefit plans:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

                          &lt;tr style="vertical-align:top"&gt;
                            &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="text-align:right;vertical-align:top;width:28.35pt"&gt;
                              &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                              &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Short-term employee benefits:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Short-term employee benefits include salaries, paid annual leave, recreation and social security contributions are recognized as expenses as the services are rendered.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

                          &lt;tr style="vertical-align:top"&gt;
                            &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="text-align:right;vertical-align:top;width:28.35pt"&gt;
                              &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                              &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Post-employment benefits:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has liabilities for severance pay for its employees in several of jurisdictions and in Israel.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes liability for severance pay mainly due to its employees in EU in accordance with local laws.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;l.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Certain Company employees and directors are entitled to remuneration in the form of equity-settled share-based compensation.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Equity-settled transactions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The cost of equity-settled transactions with employees is measured at the fair value of their equity instruments granted at grant date. The fair value is determined using the binomial option pricing model.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The cost of equity-settled transactions is recognized in profit or loss, together with a corresponding increase in equity, during the period which the performance or service conditions are to be satisfied, ending on the date on which the relevant employees become fully entitled to the award.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                &lt;div&gt;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;m.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Profit / Loss per share:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company presents basic and diluted earnings per share (EPS) data for its ordinary shares. Basic EPS is calculated by dividing the profit or loss attributable to ordinary shareholders of the Company by the weighted average number of ordinary shares outstanding during the year, adjusted for treasury shares. Diluted EPS is determined by adjusting the profit or loss attributable to ordinary shareholders of the Company and the weighted average number of ordinary shares outstanding, after adjustment for treasury shares, for the effects of all dilutive potential ordinary shares, which comprise of warrants, share options and share options granted to employees.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;n.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;
                              &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-weight:bold"&gt;
                                &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;New standards, amendments to standards and interpretations not yet adopted:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:84.75pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amendment to IAS 1, Presentation of Financial Statements: "Disclosure of Accounting Policies&#x201d;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:84.75pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As a result of applying the Amendment, the extent of the accounting policy disclosure provided in the financial statements for 2023 was reduced and adjusted according to the Company&#x2019;s specific circumstances.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;o.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Presentation of Financial Statements: Classification of Liabilities as Current or Non-Current (amendment to IAS 1)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:84.75pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As a result of applying the Amendment the warrants presented in these financial statements (see note 19c), will be classified as a current liability pursuant to the conversion option.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

              &lt;/div&gt;
            </ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory>
    <mdwd:DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317155148965">
                      &lt;div&gt;
                        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                            &lt;tr&gt;
                              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basis of consolidation:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Consolidated financial statements include the financial statements of companies that the Company controls (subsidiaries). Control is achieved when the Company is exposed, or has rights, to variable returns from its investment with the investee and has the ability to affect those returns through its power over the investee.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The financial statements of the Company and its subsidiaries are prepared as of the same dates and periods. The consolidated financial statements are prepared using uniform accounting policies by all entities in the Group.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    </mdwd:DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317152649731">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventories:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventories are measured at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated selling costs. The Company periodically evaluates the condition and age of inventories and makes provisions for slow moving inventories accordingly.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost of inventories is determined as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="margin-left:90pt"&gt;
                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:19.52%;vertical-align:top"&gt;
                              &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Raw materials&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td style="width:3.54%;vertical-align:top"&gt;
                              &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td style="width:76.94%;vertical-align:top"&gt;
                              &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At cost of purchase using the first-in, first-out method.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="width:19.52%;vertical-align:top"&gt;
                              &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finished goods&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td style="width:3.54%;vertical-align:top"&gt;
                              &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td style="width:76.94%;vertical-align:top"&gt;
                              &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On the basis of average standard costs (which approximates actual cost on a weighted average basis) including materials, labor and other direct and indirect manufacturing costs based on practical capacity.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317152657840">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property, plant and equipment, net:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property, plant and equipment are measured at cost, including directly attributable costs, less accumulated depreciation and accumulated impairment losses. Cost includes spare parts and auxiliary equipment that are used in connection with the plant and equipment.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation is calculated on a straight&#x2011;line basis over the useful life of the assets at annual rates as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="margin-left:90pt"&gt;

                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                            &lt;tr&gt;
                              &lt;td style="width:70.35%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:2.82%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:26.82%;vertical-align:bottom;border-bottom:#000000 2px solid"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:70.35%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Office furniture&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:2.82%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:26.82%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7-10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:70.35%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Manufacturing machinery and lab equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:2.82%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:26.82%;vertical-align:bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15-33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:70.35%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:2.82%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:26.82%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:70.35%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leasehold improvements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:2.82%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:26.82%;vertical-align:bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;See below&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;

                    &lt;/div&gt;
                    &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                    &lt;div&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leasehold improvements are depreciated on a straight&#x2011;line basis over the shorter of the lease term (including the renewal option held by the Company which is expected to be exercised) and the expected life of the improvement.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The useful life, depreciation method and residual value of an asset are reviewed at least each year-end and any changes are accounted for prospectively as a change in accounting estimate.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <mdwd:DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317155248766">
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                            &lt;tr&gt;
                              &lt;td style="width:70.35%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:2.82%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:26.82%;vertical-align:bottom;border-bottom:#000000 2px solid"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:70.35%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Office furniture&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:2.82%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:26.82%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7-10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:70.35%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Manufacturing machinery and lab equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:2.82%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:26.82%;vertical-align:bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15-33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:70.35%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:2.82%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:26.82%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:70.35%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leasehold improvements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:2.82%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:26.82%;vertical-align:bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;See below&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      </mdwd:DisclosureOfDetailedInformationAboutUsefulLifeOfPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      id="Fxbrl_20210923195823270">7-10</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      id="Fxbrl_20210923200118067">15-33</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      id="Fxbrl_20210923200133291">33</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      id="Fxbrl_20240317194123497">See below</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317152705727">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liability in respect of Israeli Innovation Authority ("IIA"):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Grants from the IIA in respect of research and development projects are accounted for as forgivable loans according to IAS 20. Grants received from the IIA are recognized as a liability according to their fair value on the date of their receipt, unless on that date it is reasonably certain that the amount received will not be refunded. If future economic benefits are expected from the project that will result in royalty-bearing revenues from sale of products it will be treated as a contingent liability.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At the end of each reporting period, the Company evaluates whether there is reasonable assurance that the liability recognized, in whole or in part, will not be repaid based on its best estimate of future sales and any changes in the present value of the cash flows discounted at the original interest rate of the grant are recognized in profit or loss. The difference between the amount received and the fair value on the date of receiving the grant is recognized as a deduction of research and development expenses.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants>
    <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317152713358">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leases:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for a contract as a lease when the contract terms convey the right to control the use of an identified asset for a period of time in exchange for consideration.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For these excluded leases, the Company has elected to recognize the lease payments as an expense in profit or loss on a straight-line basis over the lease term. In measuring the lease liability, the Company has elected to apply the practical expedient in the Standard and does not separate the lease components from the non-lease components (such as management and maintenance services, etc.) included in a single contract.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Following are the amortization periods of the ROU assets by class of underlying asset:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="margin-left:90pt"&gt;

                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                            &lt;tr&gt;
                              &lt;td style="width:65.06%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:3.87%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:27.2%;vertical-align:top;border-bottom:#000000 2px solid"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:65.06%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-indent:-7.1pt;margin-left:7.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Motor vehicles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.87%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:27.2%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:65.06%;vertical-align:bottom"&gt;
                                &lt;div style="text-indent:-7.1pt;margin-left:7.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Buildings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.87%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:27.2%;vertical-align:bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6-15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;

                    &lt;/div&gt;
                    &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                    &lt;div&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company tests for impairment of the ROU asset whenever there are indications of impairment pursuant to the provisions of IAS 36.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Variable lease payments that depend on an index:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:104.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On the commencement date, the Company uses the index rate prevailing on the commencement date to calculate the future lease payments.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:104.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For leases in which the Company is the lessee, the aggregate changes in future lease payments resulting from a change in the index are discounted (without a change in the discount rate applicable to the lease liability) and recorded as an adjustment of the lease liability and the ROU assets, only when there is a change in the cash flows resulting from the change in the index (that is, when the adjustment to the lease payments takes effect).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease extension and termination options:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:104.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A non-cancelable lease term includes both the periods covered by an option to extend the lease when it is reasonably certain that the extension option will be exercised and the periods covered by a lease termination option when it is reasonably certain that the termination option will not be exercised.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
    <mdwd:ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317155308861">
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                            &lt;tr&gt;
                              &lt;td style="width:65.06%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:3.87%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:27.2%;vertical-align:top;border-bottom:#000000 2px solid"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:65.06%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-indent:-7.1pt;margin-left:7.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Motor vehicles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.87%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:27.2%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:65.06%;vertical-align:bottom"&gt;
                                &lt;div style="text-indent:-7.1pt;margin-left:7.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Buildings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.87%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:27.2%;vertical-align:bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6-15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      </mdwd:ScheduleOfAmortizationPeriodsOfRightOfUseAssetsTableTextBlock>
    <mdwd:AmortizationPeriodsOfRightOfUseAssets
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      id="Fxbrl_20220309191248728">3</mdwd:AmortizationPeriodsOfRightOfUseAssets>
    <mdwd:AmortizationPeriodsOfRightOfUseAssets
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_mdwdBuildingAndEquipmentMember"
      id="Fxbrl_20210923195737956">6-15</mdwd:AmortizationPeriodsOfRightOfUseAssets>
    <ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317152726559">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;f.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues recognition:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="text-align:justify;text-indent:-7.05pt;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes revenue when the customer obtains control over the promised goods or services. The revenue is measured according to the amount of the consideration to which the Company expects to be entitled in exchange for the goods or services promised to the customer, other than amounts collected for third parties.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company determines transaction price based on the amount of consideration the Company expects to receive for transferring the promised goods or services in the contract.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Consideration may be fixed, variable, or a combination of both. At contract inception for arrangements that include variable consideration, the Company estimates the probability and extent of consideration it expects to receive under the contract utilizing either the most likely amount method or expected amount method, whichever best estimates the amount expected to be received. The Company then considers any constraints on the variable consideration and includes in the transaction price variable consideration to the extent it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. The Company then allocates the transaction price to each performance obligation based on the relative standalone selling price and recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) control is transferred to the customer and the performance obligation is satisfied.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company records amounts as accounts receivable when the right to consideration is deemed unconditional. Amounts received, or that are unconditionally due, from a customer prior to transferring goods or services to the customer under the terms of a contract are recognized as deferred revenue. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as the current portion of deferred revenue. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s revenue-generating arrangements typically include licensing arrangements, which comprise of upfront license fees, milestone payments and/or royalties and products sale arrangements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The promised goods or services in the Company&#x2019;s licensing arrangements typically consist of a license to the Company&#x2019;s intellectual property and/or research and development services.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;If a license is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenue from nonrefundable, up-front fees allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For arrangements that include sales-based royalties, including milestone payments based on the level of sales, where the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',serif"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In 2019, the Company entered into exclusive license and supply agreements with Vericel to commercialize Nexobrid in North America (see Note 22). The Company identified three distinct performance obligations: (1) license rights (2) development services for BLA approval and (3) manufacturing and supply of Nexobrid.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of the closing date of the agreement the manufacturing and development services were at market value, therefore the upfront payment was fully attributed to the license performance obligation and as such revenues are recognized at the point in time that control of the license is transferred to the customer.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Future milestone payments are considered variable consideration and are subject to the variable consideration constraint, i.e. will be recognized once concluded that it is &#x201c;probable&#x201d; that a significant reversal of the cumulative revenues recognized under the contract will not occur in future periods when the uncertainty related to the variable considerations are resolved. (see Note 18b).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues from royalties under this agreement will be payable based on future commercial sales, up on an occurrence.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues from the sale of products to Vericel will be recognized when all the significant risks and rewards of ownership of the products have passed to the buyer and the seller no longer retains continuing managerial involvement. The delivery date of the products is usually the date of which ownership passes.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues from distribution licensing arrangements:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for the bundled license provided to the distributers and related high specialized services as a single performance obligation and consequently recognize revenue using the cost-to-cost method, where the extent of progress towards completion is measured based on the ratio of actual costs incurred to the total estimated costs expected to be incurred upon satisfying such single performance obligation. The revenues from such bundled performance obligation are included within &#x201c;Revenues from license agreements&#x201d;. Significant finance components related to such arrangements are recognized as finance expense.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues from development services:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues from development services are recognized over time, during the period the customer receives and consumes the benefits provided by the Company's performance.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues from the sale of products:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',serif"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company generates revenues from sales of its innovative biopharmaceutical product, Nexobrid, to burn centers and hospital burn units in Europe, U.S Israel and local international markets through its commercial organizations and local distributors.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues from sale of goods is recognized in profit or loss at the point in time when the control of the goods is transferred to the customer, generally upon delivery of the goods to the customer. &#160;The transaction price is the amount of the consideration that is expected to be received based on the contract terms.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue>
    <ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317152733200">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;g.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development expenses:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development expenses are recognized in profit or loss when incurred. An intangible asset arising from a development project or from the development phase of an internal project is recognized if the Company can demonstrate the technical feasibility of completing the intangible asset so that it will be available for use or sale; the Company's intention to complete the intangible asset and use or sell it; the Company's ability to use or sell the intangible asset; how the intangible asset will generate future economic benefits; the availability of adequate technical, financial and other resources to complete the intangible asset; and the Company's ability to measure reliably the expenditure attributable to the intangible asset during its development. Since the Company's research and development projects are often subject to regulatory approval procedures and other uncertainties, the conditions for the capitalization of costs incurred before receipt of approvals are not normally satisfied and, therefore, research and development expenses are recognized in profit or loss when incurred.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317152744327">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;h.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial instruments:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The accounting policy for financial instruments in accordance with IFRS 9, "Financial Instruments" ("the Standard") is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:113.4pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial liabilities measured at amortized cost:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:141.75pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of the financial liability.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:141.75pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;After initial recognition, the Company measures all financial liabilities at amortized cost using the effective interest rate method, except for financial liabilities at fair value through profit or loss such as derivatives;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:113.4pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial liabilities measured at fair value through profit or loss:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:141.75pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At initial recognition, the Company measures financial liabilities that are not measured at amortized cost at fair value. Transaction costs are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;text-indent:28.35pt;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;After initial recognition, changes in fair value are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;text-indent:28.35pt;margin-left:113.4pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div&gt;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value measurement is based on the assumption that the transaction will take place in the asset's or the liability's principal market, or in the absence of a principal market, in the most advantageous market.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="margin-left:113.4pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A fair value measurement of a non-financial asset takes into account a market participant's ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317152751341">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;i.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:86.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Receipts in respect of warrants are classified as equity to the extent that they confer the right to purchase a fixed number of shares for a fixed exercise price. In the event that the exercise price or the numbers of shares to be issued are not deemed to be fixed (for example, in case of net share settlement provision), or warrants redemption in cash on the occurrence of Fundamental Transaction the warrants are classified as a non-current derivative financial liability. This liability is initially recognized at its fair value on the date the contract is entered into and subsequently accounted for at fair value at each reporting date. The fair value changes are charged to non-operating income and expense on the statement of comprehensive income or loss. Issuance costs allocable to warrants are also recorded as non-operating expense on the statement of comprehensive income or loss.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317152756457">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;j.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Provisions:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:86.4pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A provision in accordance with IAS 37 is recognized when the Company has a present (legal or constructive) obligation as a result of a past event, it is expected to require the use of economic resources to clear the obligation and a reliable estimate has been made.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317152801869">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;k.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Short-term employee benefits and severance pay liability, net:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has several employee benefit plans:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

                          &lt;tr style="vertical-align:top"&gt;
                            &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="text-align:right;vertical-align:top;width:28.35pt"&gt;
                              &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                              &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Short-term employee benefits:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Short-term employee benefits include salaries, paid annual leave, recreation and social security contributions are recognized as expenses as the services are rendered.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

                          &lt;tr style="vertical-align:top"&gt;
                            &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="text-align:right;vertical-align:top;width:28.35pt"&gt;
                              &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                              &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Post-employment benefits:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has liabilities for severance pay for its employees in several of jurisdictions and in Israel.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes liability for severance pay mainly due to its employees in EU in accordance with local laws.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317152806254">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;l.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Certain Company employees and directors are entitled to remuneration in the form of equity-settled share-based compensation.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Equity-settled transactions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The cost of equity-settled transactions with employees is measured at the fair value of their equity instruments granted at grant date. The fair value is determined using the binomial option pricing model.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The cost of equity-settled transactions is recognized in profit or loss, together with a corresponding increase in equity, during the period which the performance or service conditions are to be satisfied, ending on the date on which the relevant employees become fully entitled to the award.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317152811702">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;m.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Profit / Loss per share:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company presents basic and diluted earnings per share (EPS) data for its ordinary shares. Basic EPS is calculated by dividing the profit or loss attributable to ordinary shareholders of the Company by the weighted average number of ordinary shares outstanding during the year, adjusted for treasury shares. Diluted EPS is determined by adjusting the profit or loss attributable to ordinary shareholders of the Company and the weighted average number of ordinary shares outstanding, after adjustment for treasury shares, for the effects of all dilutive potential ordinary shares, which comprise of warrants, share options and share options granted to employees.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory>
    <mdwd:DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317152816766">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;n.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;
                              &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-weight:bold"&gt;
                                &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;New standards, amendments to standards and interpretations not yet adopted:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:84.75pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amendment to IAS 1, Presentation of Financial Statements: "Disclosure of Accounting Policies&#x201d;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:84.75pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As a result of applying the Amendment, the extent of the accounting policy disclosure provided in the financial statements for 2023 was reduced and adjusted according to the Company&#x2019;s specific circumstances.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </mdwd:DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsAndInterpretationsNotYetAdoptedExplanatory>
    <mdwd:PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317152822094">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;o.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Presentation of Financial Statements: Classification of Liabilities as Current or Non-Current (amendment to IAS 1)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:84.75pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As a result of applying the Amendment the warrants presented in these financial statements (see note 19c), will be classified as a current liability pursuant to the conversion option.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </mdwd:PresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrent>
    <ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20210923204025899">
    &lt;div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;Note 4:&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div style="font-weight:bold"&gt;Cash and Cash Equivalents&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:63pt"&gt;

              &lt;div&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;December 31&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;2023&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;2022&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Balance in USD&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;4,151&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;24,475&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Balance in other currencies&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;7,715&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;9,420&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;11,866&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;33,895&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;

          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory>
    <mdwd:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240316131040302">
              &lt;div&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;December 31&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;2023&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;2022&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Balance in USD&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;4,151&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;24,475&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Balance in other currencies&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;7,715&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;9,420&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;11,866&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;33,895&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            </mdwd:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory>
    <ifrs-full:CashOnHand
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20210923203720228"
      unitRef="USD">4151000</ifrs-full:CashOnHand>
    <ifrs-full:CashOnHand
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210923203827155"
      unitRef="USD">24475000</ifrs-full:CashOnHand>
    <mdwd:CashOnHandInNonUsd
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20210923203855089_xbrl_20210923203720228"
      unitRef="USD">7715000</mdwd:CashOnHandInNonUsd>
    <mdwd:CashOnHandInNonUsd
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210923203855089_xbrl_20210923203827155"
      unitRef="USD">9420000</mdwd:CashOnHandInNonUsd>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20210923203931881"
      unitRef="USD">11866000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210923203943140"
      unitRef="USD">33895000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:DisclosureOfDepositsFromBanksExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20210924142615341">
    &lt;div&gt;
      &lt;div style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;width:100%"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;Note 5:&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;Short-term and restricted bank deposits&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;

        &lt;div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div style="margin-left:63pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;December 31&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;2023&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;2022&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Restricted bank deposits (1)&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;167&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;USD Bank deposits (2)&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;29,675&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;29,842&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;(1)&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;Restricted bank deposits which are primarily used as security for the Company&#x2019;s office leases.&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:28.35pt;vertical-align:top"&gt;(2)&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;The USD deposits bear annual interest of 6.26%-6.55% for the period of 91-365 days for 2023.&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;

    &lt;/div&gt;
  </ifrs-full:DisclosureOfDepositsFromBanksExplanatory>
    <mdwd:DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240316132740771">
        &lt;div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div style="margin-left:63pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;December 31&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;2023&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;2022&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Restricted bank deposits (1)&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;167&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;USD Bank deposits (2)&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;29,675&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;29,842&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;(1)&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;Restricted bank deposits which are primarily used as security for the Company&#x2019;s office leases.&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:28.35pt;vertical-align:top"&gt;(2)&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;The USD deposits bear annual interest of 6.26%-6.55% for the period of 91-365 days for 2023.&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </mdwd:DisclosureOfDetailedInformationAboutShortTermBankDepositsExplanatory>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20210924142234692_xbrl_20210924141709230"
      unitRef="USD">167000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210924142234692_xbrl_20210924141809083"
      unitRef="USD">0</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:BalancesWithBanks
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20210924141709230"
      unitRef="USD">29675000</ifrs-full:BalancesWithBanks>
    <ifrs-full:BalancesWithBanks
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240317133507442"
      unitRef="USD">0</ifrs-full:BalancesWithBanks>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20210924142451838"
      unitRef="USD">29842000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210924142550763"
      unitRef="USD">0</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <mdwd:DepositInterestRate
      contextRef="C_20231231_ifrsfullTypesOfInterestRatesAxis_ifrsfullFixedInterestRateMember_srtCurrencyAxis_currencyUSD_srtRangeAxis_srtMinimumMember"
      decimals="4"
      id="Fxbrl_20211217150651059"
      unitRef="Percent">0.0626</mdwd:DepositInterestRate>
    <mdwd:DepositInterestRate
      contextRef="C_20231231_ifrsfullTypesOfInterestRatesAxis_ifrsfullFixedInterestRateMember_srtCurrencyAxis_currencyUSD_srtRangeAxis_srtMaximumMember"
      decimals="4"
      id="Fxbrl_20240317132944227"
      unitRef="Percent">0.0655</mdwd:DepositInterestRate>
    <mdwd:PeriodOfBankDeposits
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211217150658109"> 91-365</mdwd:PeriodOfBankDeposits>
    <mdwd:DisclosureOfTradeReceivablesExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20210924144658278">
    &lt;div&gt;
      &lt;div style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;width:100%"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;Note 6:&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;Trade Receivables&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;&#160;&lt;/div&gt;

            &lt;div&gt;
              &lt;div style="margin-left:63pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;December 31&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;2023&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;2022&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Vericel (Note 18b)&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;236&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;7,500&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;BARDA (Note 18a)&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;1,245&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;701&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;MTEC (Note 18c)&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;617&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;362&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Other trade receivables&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;1,608&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;771&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Less provision for impairment&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;(6&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;padding-top:2pt"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;)&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;(2&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;padding-top:2pt"&gt;
                        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;3,700&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;9,332&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;

        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </mdwd:DisclosureOfTradeReceivablesExplanatory>
    <mdwd:DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240316133512236">
            &lt;div&gt;
              &lt;div style="margin-left:63pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;December 31&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;2023&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;2022&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Vericel (Note 18b)&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;236&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;7,500&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;BARDA (Note 18a)&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;1,245&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;701&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;MTEC (Note 18c)&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;617&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;362&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Other trade receivables&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;1,608&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;771&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Less provision for impairment&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;(6&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;padding-top:2pt"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;)&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;(2&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;padding-top:2pt"&gt;
                        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;3,700&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;9,332&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </mdwd:DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory>
    <mdwd:CurrentVericel
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240316134842901"
      unitRef="USD">236000</mdwd:CurrentVericel>
    <mdwd:CurrentVericel
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240316134911632"
      unitRef="USD">7500000</mdwd:CurrentVericel>
    <mdwd:CurrentBarda
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20210924144534542"
      unitRef="USD">1245000</mdwd:CurrentBarda>
    <mdwd:CurrentBarda
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210924144539605"
      unitRef="USD">701000</mdwd:CurrentBarda>
    <mdwd:CurrentMtec
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240316135046488"
      unitRef="USD">617000</mdwd:CurrentMtec>
    <mdwd:CurrentMtec
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240316135059120"
      unitRef="USD">362000</mdwd:CurrentMtec>
    <ifrs-full:OtherReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220217182003093_xbrl_20210924144551693_xbrl_20210924144534542"
      unitRef="USD">1608000</ifrs-full:OtherReceivables>
    <ifrs-full:OtherReceivables
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220217182003093_xbrl_20210924144551693_xbrl_20210924144539605"
      unitRef="USD">771000</ifrs-full:OtherReceivables>
    <mdwd:ProvisionForImpairment
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220217182936923_xbrl_20210924144551693_xbrl_20210924144534542"
      unitRef="USD">6000</mdwd:ProvisionForImpairment>
    <mdwd:ProvisionForImpairment
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220217182936923_xbrl_20210924144551693_xbrl_20210924144539605"
      unitRef="USD">2000</mdwd:ProvisionForImpairment>
    <ifrs-full:CurrentTradeReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20210924144621034"
      unitRef="USD">3700000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210924144632488"
      unitRef="USD">9332000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:DisclosureOfInventoriesExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317140901199">
    &lt;div&gt;
      &lt;div style="text-align:justify;line-height:1.25"&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;width:100%;border:0px"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note 7:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold"&gt;Inventories&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;
      &lt;div style="margin-left:63pt"&gt;&#160;&lt;/div&gt;

        &lt;div&gt;
          &lt;div style="margin-left:63pt"&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Raw materials&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;995&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;913&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finished goods&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*1,851&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,050&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,846&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,963&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;text-indent:0pt;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*Including write-down of $326&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;

    &lt;/div&gt;
  </ifrs-full:DisclosureOfInventoriesExplanatory>
    <mdwd:DisclosureOfDetailedInformationAboutInventoriesExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317140920119">
        &lt;div&gt;
          &lt;div style="margin-left:63pt"&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Raw materials&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;995&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;913&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finished goods&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*1,851&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,050&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,846&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,963&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;text-indent:0pt;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*Including write-down of $326&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;
      </mdwd:DisclosureOfDetailedInformationAboutInventoriesExplanatory>
    <ifrs-full:RawMaterials
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20210924150042093"
      unitRef="USD">995000</ifrs-full:RawMaterials>
    <ifrs-full:RawMaterials
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210924150050154"
      unitRef="USD">913000</ifrs-full:RawMaterials>
    <ifrs-full:FinishedGoods
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240320231728040"
      unitRef="USD">1851000</ifrs-full:FinishedGoods>
    <ifrs-full:FinishedGoods
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210924150321233_xbrl_20210924150050154"
      unitRef="USD">1050000</ifrs-full:FinishedGoods>
    <ifrs-full:Inventories
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20210924150338938"
      unitRef="USD">2846000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210924150354121"
      unitRef="USD">1963000</ifrs-full:Inventories>
    <ifrs-full:InventoryWritedown2011
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240317140827055"
      unitRef="USD">326000</ifrs-full:InventoryWritedown2011>
    <ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240316151307597">
      &lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;Note 8:&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;Other Receivables- Short Term&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;div style="margin-left:63pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;December 31,&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;2023&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;2022&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Government authorities&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;322&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;193&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Income receivables&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;397&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;170&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Prepaid expenses and other&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;722&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;287&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;1,441&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;650&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;

      &lt;/div&gt;
    </ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory>
    <mdwd:DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240316151347294">
          &lt;div&gt;
            &lt;div style="margin-left:63pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;December 31,&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;2023&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;2022&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Government authorities&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;322&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;193&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Income receivables&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;397&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;170&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Prepaid expenses and other&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;722&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;287&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;1,441&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;650&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </mdwd:DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory>
    <mdwd:CurrentGovernmentAuthoritiesReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20210924151623228"
      unitRef="USD">322000</mdwd:CurrentGovernmentAuthoritiesReceivables>
    <mdwd:CurrentGovernmentAuthoritiesReceivables
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210924151628521"
      unitRef="USD">193000</mdwd:CurrentGovernmentAuthoritiesReceivables>
    <mdwd:IncomeReceivablesShortTerm
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240316151939172_xbrl_20210924151721850_xbrl_20210924151623228"
      unitRef="USD">397000</mdwd:IncomeReceivablesShortTerm>
    <mdwd:IncomeReceivablesShortTerm
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240316151939172_xbrl_20210924151721850_xbrl_20210924151628521"
      unitRef="USD">170000</mdwd:IncomeReceivablesShortTerm>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20210924151721850_xbrl_20210924151623228"
      unitRef="USD">722000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210924151721850_xbrl_20210924151628521"
      unitRef="USD">287000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:OtherCurrentReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20210924151748068"
      unitRef="USD">1441000</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210924151757346"
      unitRef="USD">650000</ifrs-full:OtherCurrentReceivables>
    <mdwd:DisclosureOfOtherReceivablesLongTermExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20220310134452125">
        &lt;div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;Note 9:&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div style="font-weight:bold"&gt;Other Receivables- Long Term&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div&gt;&#160;&lt;/div&gt;

                &lt;div&gt;
                  &lt;div style="margin-left:63pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;December 31,&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;2023&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;2022&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Income receivables&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;50&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;180&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Prepaid expenses&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;183&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;233&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;180&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;

            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </mdwd:DisclosureOfOtherReceivablesLongTermExplanatory>
    <mdwd:DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240316152949574">
                &lt;div&gt;
                  &lt;div style="margin-left:63pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;December 31,&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;2023&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;2022&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Income receivables&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;50&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;180&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Prepaid expenses&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;183&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;233&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;180&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              </mdwd:DisclosureOfDetailedInformationAboutOtherReceivablesLongTermExplanatory>
    <mdwd:IncomeReceivablesLongTerm
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220310134332404_33"
      unitRef="USD">50000</mdwd:IncomeReceivablesLongTerm>
    <mdwd:IncomeReceivablesLongTerm
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220310134332404_37"
      unitRef="USD">180000</mdwd:IncomeReceivablesLongTerm>
    <mdwd:PrepaidExpensesLongTerm
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240316152856204"
      unitRef="USD">183000</mdwd:PrepaidExpensesLongTerm>
    <mdwd:PrepaidExpensesLongTerm
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240316152930510"
      unitRef="USD">0</mdwd:PrepaidExpensesLongTerm>
    <ifrs-full:OtherNoncurrentReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220310134332404_63"
      unitRef="USD">233000</ifrs-full:OtherNoncurrentReceivables>
    <ifrs-full:OtherNoncurrentReceivables
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220310134332404_67"
      unitRef="USD">180000</ifrs-full:OtherNoncurrentReceivables>
    <ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317131134657">
      &lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;Note 10:&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;Property, Plant and Equipment, Net&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;div style="margin-left:63pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Office&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;furniture&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Manufacturing machinery and lab equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leasehold&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;improvements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;font-weight:bold"&gt;Cost&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"&gt;Balance as of January 1, 2023&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;293&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;5,091&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;166&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;3,279&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;8,829&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Additions&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;25&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;7,312&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;101&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;37&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;7,475&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Capitalization of depreciation of ROU assets&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;59&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;59&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Foreign currency translation&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;1&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;1&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"&gt;Balance as of December 31, 2023&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;319&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;12,403&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;267&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;3,375&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;16,364&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"&gt;Balance as of January 1, 2022&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;257&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;4,764&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;176&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;3,137&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;8,334&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Additions&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;37&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;327&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;49&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;142&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;555&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Disposals&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;(59&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;)&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;(59&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;)&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Foreign currency translation&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;(1&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;)&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;(1&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;)&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"&gt;Balance as of December 31, 2022&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;293&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;5,091&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;166&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;3,279&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;8,829&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;Accumulated Depreciation&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"&gt;Balance as of January 1, 2023&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;157&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;3,818&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;97&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;2,391&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;6,463&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Additions&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;26&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;448&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;58&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;140&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;672&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Foreign currency translation&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;1&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;1&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"&gt;Balance as of December 31, 2023&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;184&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;4,266&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;155&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;2,531&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;7,136&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"&gt;Balance as of January 1, 2022&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;133&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;3,370&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;94&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;2,259&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;5,856&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Additions&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;25&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;448&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;62&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;132&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;667&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Disposals&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;(59&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;)&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;(59&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;)&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Foreign currency translation&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;(1&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;)&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;(1&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;)&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"&gt;Balance as of December 31, 2022&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;157&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;3,818&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;97&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;2,391&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;6,463&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;Carrying amounts of all fixed asset items&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:19pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;December 31, 2023&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;135&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;8,137&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;112&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;844&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;9,228&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:40%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:19pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;December 31, 2022&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;136&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;1,273&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;69&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;888&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;2,366&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="margin-left:63pt"&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
            &lt;/div&gt;
          &lt;/div&gt;

      &lt;/div&gt;
    </ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317131228387">
          &lt;div&gt;
            &lt;div style="margin-left:63pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Office&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;furniture&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Manufacturing machinery and lab equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leasehold&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;improvements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;font-weight:bold"&gt;Cost&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"&gt;Balance as of January 1, 2023&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;293&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;5,091&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;166&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;3,279&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;8,829&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Additions&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;25&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;7,312&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;101&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;37&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;7,475&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Capitalization of depreciation of ROU assets&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;59&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;59&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Foreign currency translation&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;1&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;1&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"&gt;Balance as of December 31, 2023&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;319&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;12,403&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;267&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;3,375&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;16,364&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"&gt;Balance as of January 1, 2022&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;257&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;4,764&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;176&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;3,137&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;8,334&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Additions&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;37&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;327&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;49&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;142&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;555&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Disposals&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;(59&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;)&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;(59&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;)&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Foreign currency translation&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;(1&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;)&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;(1&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;)&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"&gt;Balance as of December 31, 2022&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;293&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;5,091&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;166&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;3,279&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;8,829&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;Accumulated Depreciation&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"&gt;Balance as of January 1, 2023&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;157&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;3,818&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;97&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;2,391&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;6,463&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Additions&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;26&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;448&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;58&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;140&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;672&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Foreign currency translation&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;1&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;1&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"&gt;Balance as of December 31, 2023&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;184&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;4,266&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;155&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;2,531&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;7,136&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"&gt;Balance as of January 1, 2022&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;133&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;3,370&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;94&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;2,259&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;5,856&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Additions&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;25&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;448&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;62&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;132&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;667&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Disposals&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;(59&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;)&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;(59&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;)&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;Foreign currency translation&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;(1&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;)&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;(1&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;)&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"&gt;Balance as of December 31, 2022&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;157&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;3,818&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;97&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;2,391&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;6,463&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:40%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;Carrying amounts of all fixed asset items&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:19pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;December 31, 2023&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;135&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;8,137&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;112&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;844&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;9,228&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:40%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:19pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;December 31, 2022&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;136&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;1,273&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;69&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;888&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;2,366&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="margin-left:63pt"&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001253082_xbrl_20210924153656867"
      unitRef="USD">293000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      decimals="-3"
      id="Fxbrl_20220218001253082_xbrl_20210924153705013"
      unitRef="USD">5091000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001253082_xbrl_20210924153707696"
      unitRef="USD">166000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220218001253082_xbrl_20210924153713215"
      unitRef="USD">3279000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220218001253082_xbrl_20210924153716030"
      unitRef="USD">8829000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001357144_xbrl_20210924161654441"
      unitRef="USD">25000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      decimals="-3"
      id="Fxbrl_20220218001357144_xbrl_20210924161913174"
      unitRef="USD">7312000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001357144_xbrl_20210924162033935"
      unitRef="USD">101000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220218001357144_xbrl_20210924162142196"
      unitRef="USD">37000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220218001357144_xbrl_20210924162246088"
      unitRef="USD">7475000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <mdwd:ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20240317130440422_xbrl_20220218001357144_xbrl_20210924161654441"
      unitRef="USD">0</mdwd:ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets>
    <mdwd:ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      decimals="-3"
      id="Fxbrl_20240317130440422_xbrl_20220218001357144_xbrl_20210924161913174"
      unitRef="USD">0</mdwd:ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets>
    <mdwd:ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20240317130440422_xbrl_20220218001357144_xbrl_20210924162033935"
      unitRef="USD">0</mdwd:ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets>
    <mdwd:ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20240317130440422_xbrl_20220218001357144_xbrl_20210924162142196"
      unitRef="USD">59000</mdwd:ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets>
    <mdwd:ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20240317130440422_xbrl_20220218001357144_xbrl_20210924162246088"
      unitRef="USD">59000</mdwd:ChangeInPropertyPlantAndEquipmentCapitalizationOfDepreciationOfRouAssets>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001419992_xbrl_20210924161736718"
      unitRef="USD">1000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      decimals="-3"
      id="Fxbrl_20220218001419992_xbrl_20210924161950294"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001419992_xbrl_20210924162057894"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220218001419992_xbrl_20210924162200828"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220218001419992_xbrl_20210924162306679"
      unitRef="USD">1000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001257788_xbrl_20210924153656867"
      unitRef="USD">319000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      decimals="-3"
      id="Fxbrl_20220218001257788_xbrl_20210924153705013"
      unitRef="USD">12403000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001257788_xbrl_20210924153707696"
      unitRef="USD">267000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220218001257788_xbrl_20210924153713215"
      unitRef="USD">3375000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220218001257788_xbrl_20210924153716030"
      unitRef="USD">16364000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001305045_xbrl_20210924153656867"
      unitRef="USD">257000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      decimals="-3"
      id="Fxbrl_20220218001305045_xbrl_20210924153705013"
      unitRef="USD">4764000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001305045_xbrl_20210924153707696"
      unitRef="USD">176000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220218001305045_xbrl_20210924153713215"
      unitRef="USD">3137000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220218001305045_xbrl_20210924153716030"
      unitRef="USD">8334000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001400268_xbrl_20210924161654441"
      unitRef="USD">37000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      decimals="-3"
      id="Fxbrl_20220218001400268_xbrl_20210924161913174"
      unitRef="USD">327000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001400268_xbrl_20210924162033935"
      unitRef="USD">49000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220218001400268_xbrl_20210924162142196"
      unitRef="USD">142000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220218001400268_xbrl_20210924162246088"
      unitRef="USD">555000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001338591_xbrl_20210924161445150"
      unitRef="USD">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      decimals="-3"
      id="Fxbrl_20220218001338591_xbrl_20210924161845231"
      unitRef="USD">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001338591_xbrl_20210924162004535"
      unitRef="USD">59000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220218001338591_xbrl_20210924162111672"
      unitRef="USD">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220218001338591_xbrl_20210924162222312"
      unitRef="USD">59000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001415991_xbrl_20210924161736718"
      unitRef="USD">-1000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      decimals="-3"
      id="Fxbrl_20220218001415991_xbrl_20210924161950294"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001415991_xbrl_20210924162057894"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220218001415991_xbrl_20210924162200828"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220218001415991_xbrl_20210924162306679"
      unitRef="USD">-1000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001311644_xbrl_20210924153656867"
      unitRef="USD">293000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      decimals="-3"
      id="Fxbrl_20220218001311644_xbrl_20210924153705013"
      unitRef="USD">5091000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001311644_xbrl_20210924153707696"
      unitRef="USD">166000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220218001311644_xbrl_20210924153713215"
      unitRef="USD">3279000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220218001311644_xbrl_20210924153716030"
      unitRef="USD">8829000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001538117_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153656867"
      unitRef="USD">-157000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      decimals="-3"
      id="Fxbrl_20220218001538117_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153705013"
      unitRef="USD">-3818000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001538117_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153707696"
      unitRef="USD">-97000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220218001538117_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153713215"
      unitRef="USD">-2391000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220218001538117_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153716030"
      unitRef="USD">-6463000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001601004_xbrl_20210924162453767_xbrl_20210924161654441"
      unitRef="USD">26000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      decimals="-3"
      id="Fxbrl_20220218001601004_xbrl_20210924162453767_xbrl_20210924161913174"
      unitRef="USD">448000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001601004_xbrl_20210924162453767_xbrl_20210924162033935"
      unitRef="USD">58000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220218001601004_xbrl_20210924162453767_xbrl_20210924162142196"
      unitRef="USD">140000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220218001601004_xbrl_20210924162453767_xbrl_20210924162246088"
      unitRef="USD">672000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001634405_xbrl_20210924162504566_xbrl_20210924161736718"
      unitRef="USD">1000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      decimals="-3"
      id="Fxbrl_20220218001634405_xbrl_20210924162504566_xbrl_20210924161950294"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001634405_xbrl_20210924162504566_xbrl_20210924162057894"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220218001634405_xbrl_20210924162504566_xbrl_20210924162200828"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220218001634405_xbrl_20210924162504566_xbrl_20210924162306679"
      unitRef="USD">1000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001534988_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153656867"
      unitRef="USD">-184000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      decimals="-3"
      id="Fxbrl_20220218001534988_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153705013"
      unitRef="USD">-4266000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001534988_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153707696"
      unitRef="USD">-155000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220218001534988_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153713215"
      unitRef="USD">-2531000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220218001534988_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153716030"
      unitRef="USD">-7136000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001530900_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153656867"
      unitRef="USD">-133000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      decimals="-3"
      id="Fxbrl_20220218001530900_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153705013"
      unitRef="USD">-3370000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001530900_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153707696"
      unitRef="USD">-94000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220218001530900_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153713215"
      unitRef="USD">-2259000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220218001530900_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153716030"
      unitRef="USD">-5856000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001550860_xbrl_20210924162453767_xbrl_20210924161654441"
      unitRef="USD">25000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      decimals="-3"
      id="Fxbrl_20220218001550860_xbrl_20210924162453767_xbrl_20210924161913174"
      unitRef="USD">448000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001550860_xbrl_20210924162453767_xbrl_20210924162033935"
      unitRef="USD">62000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220218001550860_xbrl_20210924162453767_xbrl_20210924162142196"
      unitRef="USD">132000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220218001550860_xbrl_20210924162453767_xbrl_20210924162246088"
      unitRef="USD">667000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001617749_xbrl_20210924162429973_xbrl_20210924161445150"
      unitRef="USD">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      decimals="-3"
      id="Fxbrl_20220218001617749_xbrl_20210924162429973_xbrl_20210924161845231"
      unitRef="USD">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001617749_xbrl_20210924162429973_xbrl_20210924162004535"
      unitRef="USD">-59000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220218001617749_xbrl_20210924162429973_xbrl_20210924162111672"
      unitRef="USD">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220218001617749_xbrl_20210924162429973_xbrl_20210924162222312"
      unitRef="USD">-59000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001637859_xbrl_20210924162504566_xbrl_20210924161736718"
      unitRef="USD">-1000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      decimals="-3"
      id="Fxbrl_20220218001637859_xbrl_20210924162504566_xbrl_20210924161950294"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001637859_xbrl_20210924162504566_xbrl_20210924162057894"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220218001637859_xbrl_20210924162504566_xbrl_20210924162200828"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220218001637859_xbrl_20210924162504566_xbrl_20210924162306679"
      unitRef="USD">-1000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20240317121911253"
      unitRef="USD">-157000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      decimals="-3"
      id="Fxbrl_20220218001527479_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153705013"
      unitRef="USD">-3818000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001527479_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153707696"
      unitRef="USD">-97000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220218001527479_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153713215"
      unitRef="USD">-2391000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220218001527479_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153716030"
      unitRef="USD">-6463000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001516344_xbrl_20210924162800912_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153656867"
      unitRef="USD">135000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      decimals="-3"
      id="Fxbrl_20220218001516344_xbrl_20210924162800912_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153705013"
      unitRef="USD">8137000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001516344_xbrl_20210924162800912_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153707696"
      unitRef="USD">112000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220218001516344_xbrl_20210924162800912_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153713215"
      unitRef="USD">844000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember"
      decimals="-3"
      id="Fxbrl_20220218001516344_xbrl_20210924162800912_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153716030"
      unitRef="USD">9228000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001518606_xbrl_20210924162800912_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153656867"
      unitRef="USD">136000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMachineryMember"
      decimals="-3"
      id="Fxbrl_20220218001518606_xbrl_20210924162800912_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153705013"
      unitRef="USD">1273000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220218001518606_xbrl_20210924162800912_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153707696"
      unitRef="USD">69000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220218001518606_xbrl_20210924162800912_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153713215"
      unitRef="USD">888000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdDepreciatedCostMember"
      decimals="-3"
      id="Fxbrl_20220218001518606_xbrl_20210924162800912_xbrl_20210924162512190_xbrl_20210924161755182_xbrl_20210924153716030"
      unitRef="USD">2366000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DisclosureOfLeasesExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20220218041540503">
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note 11:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease Agreements:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;
                  &lt;div style="text-align:justify;margin-left:81.8pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's offices and its production facility in Israel are located in a building that the Company leased from its Related party (see Note 24a), in accordance with a sub-lease agreement. The Company subleased approximately 3,000 square meters of laboratory, office and clean rooms space at a monthly rent fee NIS 125 (approximately $&lt;span&gt;35&lt;/span&gt;). This sub-lease agreement was amended in October 2021, to extend the period up to October 2025 which was included in the calculation of the lease liability and RoU asset.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:84.45pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In July 2023, the company signed a termination agreement for the sub-lease agreement and signed on a new lease agreement for the same area of approximately 3,000 square meters in the same building with the owner of the building&lt;span&gt; at a monthly rent fee of NIS 195 (approximately $54).&lt;/span&gt; The lease agreement is for 12 years with an option for an additional 3 years. The company estimation is to use the 3 years option&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In addition, the Company and its subsidiary have lease agreements for 16 vehicles for the remaining period of 1.75 years on average.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amounts recognized in profit or loss and in the statement of cash flows&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:90pt"&gt;

                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest expense on lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;274&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;102&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;565&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;537&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash outflow for leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;778&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;701&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;

            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company determined the appropriate interest rate for discounting leases, with the assistance of a third party. The valuation was based on: credit risk, the weighted average term of the leases and other economic variables. A weighted average interest rate in a range of 1% to 8.47% was used to discount future lease payments in the calculation of the lease liability on the date of initial application of the standard (IFRS 16).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div&gt;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disclosures in respect of Right- of- Use assets:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div style="margin-left:90pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Buildings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Motor vehicles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,341&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;550&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,891&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;New leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,460&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;407&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,867&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustments for indexation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,368&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(308&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,676&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,511&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;652&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,163&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accumulated depreciation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,342&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,676&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;margin-left:9pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;231&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;565&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Capitalized to Leasehold improvements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;margin-left:9pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,527&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(308&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,835&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;208&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;257&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;465&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciated cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,303&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;395&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:90pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Buildings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Motor vehicles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,267&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;654&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,921&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;New leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;125&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;125&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustments for indexation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;74&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;83&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(238&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(238&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,341&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;550&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,891&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accumulated depreciation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,028&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;345&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,373&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;margin-left:9pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;314&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;225&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;539&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;margin-left:9pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(236&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(236&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,342&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,676&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciated cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;999&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;216&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,215&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;

            &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
            &lt;div&gt;&lt;/div&gt;
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

                  &lt;tr style="vertical-align:top"&gt;
                    &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:top;width:28.35pt"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Disclosures of the Company's lease liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div style="margin-left:90pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Buildings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Motor vehicles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,199&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;179&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,378&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Repayment of leases liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(588&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(190&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(778&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effect of changes in exchange rates&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;New finance lease obligation recognized&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,460&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;365&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,825&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustments for indexation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;257&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;274&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals-Termination of leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,041&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,052&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,346&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;365&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,711&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current maturities of long-term leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(180&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(181&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(361&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease liability Balance as of December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,166&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;184&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,350&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:90pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Buildings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Motor vehicles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;299&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,990&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Repayment of leases liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(477&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(224&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(701&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effect of changes in exchange rates&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(182&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;New finance lease obligation recognized&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;117&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;117&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustments for indexation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;74&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;83&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;93&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;101&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals-Termination of leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,199&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;179&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,378&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current maturities of long-term leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(399&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(133&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(532&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease liability Balance as of December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;800&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;846&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;

          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </ifrs-full:DisclosureOfLeasesExplanatory>
    <mdwd:SubsidiariesLeaseArea
      contextRef="C_20230101to20231231"
      decimals="0"
      id="Fxbrl_20240317163043929"
      unitRef="Squaremeters">3000</mdwd:SubsidiariesLeaseArea>
    <mdwd:SubsidiariesLeaseMonthlyRent
      contextRef="C_20230101to20231231_srtCurrencyAxis_currencyILS"
      decimals="0"
      id="Fxbrl_20240317163057065"
      unitRef="NIS">125</mdwd:SubsidiariesLeaseMonthlyRent>
    <mdwd:SubsidiariesLeaseMonthlyRent
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240317163152432"
      unitRef="USD">35000</mdwd:SubsidiariesLeaseMonthlyRent>
    <mdwd:SubsidiariesLeaseArea
      contextRef="C_20230701to20230731"
      decimals="0"
      id="Fxbrl_20240317163238200"
      unitRef="Squaremeters">3000</mdwd:SubsidiariesLeaseArea>
    <mdwd:SubsidiariesLeaseMonthlyRent
      contextRef="C_20230701to20230731_srtCurrencyAxis_currencyILS"
      decimals="0"
      id="Fxbrl_20240319215053559"
      unitRef="NIS">195</mdwd:SubsidiariesLeaseMonthlyRent>
    <mdwd:SubsidiariesLeaseMonthlyRent
      contextRef="C_20230701to20230731_srtCurrencyAxis_currencyILS"
      decimals="0"
      id="Fxbrl_20240319215059951"
      unitRef="USD">54</mdwd:SubsidiariesLeaseMonthlyRent>
    <mdwd:SubsidiariesLeaseExpirationPeriod
      contextRef="C_20230701to20230731"
      id="Fxbrl_20240317163653480">P12Y</mdwd:SubsidiariesLeaseExpirationPeriod>
    <mdwd:SubsidiariesLeaseExtentionPeriod
      contextRef="C_20230701to20230731"
      id="Fxbrl_20240317163435552">P3Y</mdwd:SubsidiariesLeaseExtentionPeriod>
    <mdwd:SubsidiariesLeaseEstimatedUsefulLife
      contextRef="C_20230701to20230731"
      id="Fxbrl_20240317163643112">P3Y</mdwd:SubsidiariesLeaseEstimatedUsefulLife>
    <mdwd:NumberOfVehiclesInOperatingLeaseArrangements
      contextRef="C_20230701to20230731"
      decimals="0"
      id="Fxbrl_20240317164533128"
      unitRef="Vehicles">16</mdwd:NumberOfVehiclesInOperatingLeaseArrangements>
    <mdwd:PeriodOfVehiclesOperatingLeaseArrangements
      contextRef="C_20230701to20230731"
      id="Fxbrl_20240317164559016">1.75 years</mdwd:PeriodOfVehiclesOperatingLeaseArrangements>
    <mdwd:DisclosureOfAdditionalInformationAboutLeaseExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317164757863">
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest expense on lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;274&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;102&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;565&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;537&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash outflow for leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;778&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;701&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              </mdwd:DisclosureOfAdditionalInformationAboutLeaseExplanatory>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211006163601471"
      unitRef="USD">274000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211006164040252"
      unitRef="USD">102000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211006164053253_xbrl_20211006163601471"
      unitRef="USD">565000</ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed>
    <ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211006164053253_xbrl_20211006164040252"
      unitRef="USD">537000</ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed>
    <ifrs-full:CashOutflowForLeases
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211006164127597_xbrl_20211006164053253_xbrl_20211006163601471"
      unitRef="USD">778000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211006164127597_xbrl_20211006164053253_xbrl_20211006164040252"
      unitRef="USD">701000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16
      contextRef="C_20231231_srtRangeAxis_srtMinimumMember"
      decimals="2"
      id="Fxbrl_20220310023934257"
      unitRef="Percent">0.01</ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16>
    <ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16
      contextRef="C_20231231_srtRangeAxis_srtMaximumMember"
      decimals="4"
      id="Fxbrl_20220310023942322"
      unitRef="Percent">0.0847</ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16>
    <ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317164913455">
              &lt;div style="margin-left:90pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Buildings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Motor vehicles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,341&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;550&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,891&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;New leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,460&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;407&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,867&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustments for indexation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,368&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(308&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,676&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,511&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;652&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,163&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accumulated depreciation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,342&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,676&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;margin-left:9pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;231&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;565&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Capitalized to Leasehold improvements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;margin-left:9pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,527&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(308&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,835&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;208&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;257&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;465&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciated cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,303&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;395&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:90pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Buildings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Motor vehicles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,267&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;654&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,921&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;New leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;125&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;125&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustments for indexation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;74&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;83&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-7.1pt;margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(238&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(238&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,341&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;550&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,891&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accumulated depreciation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,028&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;345&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,373&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;margin-left:9pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;314&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;225&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;539&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;margin-left:9pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(236&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(236&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,342&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,676&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciated cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;999&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;216&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,215&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            </ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory>
    <ifrs-full:RightofuseAssetsRevaluedAssetsAtCost
      contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220218040003632_xbrl_20211006165239957_xbrl_20211006164413105"
      unitRef="USD">2341000</ifrs-full:RightofuseAssetsRevaluedAssetsAtCost>
    <ifrs-full:RightofuseAssetsRevaluedAssetsAtCost
      contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220218040003632_xbrl_20211006165239957_xbrl_20211006164610160"
      unitRef="USD">550000</ifrs-full:RightofuseAssetsRevaluedAssetsAtCost>
    <ifrs-full:RightofuseAssetsRevaluedAssetsAtCost
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220218040003632_xbrl_20211006165239957_xbrl_20211006164613511"
      unitRef="USD">2891000</ifrs-full:RightofuseAssetsRevaluedAssetsAtCost>
    <mdwd:AdditionsToRightOfUseAssetsNewLeases
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220218040121884_xbrl_20211006164720297"
      unitRef="USD">6460000</mdwd:AdditionsToRightOfUseAssetsNewLeases>
    <mdwd:AdditionsToRightOfUseAssetsNewLeases
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220218040121884_xbrl_20211006164713615"
      unitRef="USD">407000</mdwd:AdditionsToRightOfUseAssetsNewLeases>
    <mdwd:AdditionsToRightOfUseAssetsNewLeases
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220218040121884_xbrl_20211006164634125"
      unitRef="USD">6867000</mdwd:AdditionsToRightOfUseAssetsNewLeases>
    <mdwd:AdditionsToRightOfUseAssetsAdjustmentsForIndexation
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220218040143841_xbrl_20211006164738151_xbrl_20211006164720297"
      unitRef="USD">-78000</mdwd:AdditionsToRightOfUseAssetsAdjustmentsForIndexation>
    <mdwd:AdditionsToRightOfUseAssetsAdjustmentsForIndexation
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220218040143841_xbrl_20211006164738151_xbrl_20211006164713615"
      unitRef="USD">-3000</mdwd:AdditionsToRightOfUseAssetsAdjustmentsForIndexation>
    <mdwd:AdditionsToRightOfUseAssetsAdjustmentsForIndexation
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220218040143841_xbrl_20211006164738151_xbrl_20211006164634125"
      unitRef="USD">-81000</mdwd:AdditionsToRightOfUseAssetsAdjustmentsForIndexation>
    <mdwd:AdditionsToRightOfUseAssetsDisposals
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220218040211842_xbrl_20211006165127812_xbrl_20211006164738151_xbrl_20211006164720297"
      unitRef="USD">2368000</mdwd:AdditionsToRightOfUseAssetsDisposals>
    <mdwd:AdditionsToRightOfUseAssetsDisposals
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220218040211842_xbrl_20211006165127812_xbrl_20211006164738151_xbrl_20211006164713615"
      unitRef="USD">308000</mdwd:AdditionsToRightOfUseAssetsDisposals>
    <mdwd:AdditionsToRightOfUseAssetsDisposals
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220218040211842_xbrl_20211006165127812_xbrl_20211006164738151_xbrl_20211006164634125"
      unitRef="USD">2676000</mdwd:AdditionsToRightOfUseAssetsDisposals>
    <ifrs-full:RightofuseAssetsRevaluedAssetsAtCost
      contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220218040000138_xbrl_20211006165239957_xbrl_20211006164413105"
      unitRef="USD">6511000</ifrs-full:RightofuseAssetsRevaluedAssetsAtCost>
    <ifrs-full:RightofuseAssetsRevaluedAssetsAtCost
      contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220218040000138_xbrl_20211006165239957_xbrl_20211006164610160"
      unitRef="USD">652000</ifrs-full:RightofuseAssetsRevaluedAssetsAtCost>
    <ifrs-full:RightofuseAssetsRevaluedAssetsAtCost
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220218040000138_xbrl_20211006165239957_xbrl_20211006164613511"
      unitRef="USD">7163000</ifrs-full:RightofuseAssetsRevaluedAssetsAtCost>
    <mdwd:RightOfUseAssetsAccumulatedDepreciation
      contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220218040102835_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164413105"
      unitRef="USD">1342000</mdwd:RightOfUseAssetsAccumulatedDepreciation>
    <mdwd:RightOfUseAssetsAccumulatedDepreciation
      contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220218040102835_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164610160"
      unitRef="USD">334000</mdwd:RightOfUseAssetsAccumulatedDepreciation>
    <mdwd:RightOfUseAssetsAccumulatedDepreciation
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220218040102835_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164613511"
      unitRef="USD">1676000</mdwd:RightOfUseAssetsAccumulatedDepreciation>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220218040235044_xbrl_20211006165400552_xbrl_20211006164720297"
      unitRef="USD">334000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220218040235044_xbrl_20211006165400552_xbrl_20211006164713615"
      unitRef="USD">231000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220218040235044_xbrl_20211006165400552_xbrl_20211006164634125"
      unitRef="USD">565000</ifrs-full:DepreciationRightofuseAssets>
    <mdwd:RightOfUseAssetReclassifiedToLeaseholdImprovements
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20240317162803410"
      unitRef="USD">59000</mdwd:RightOfUseAssetReclassifiedToLeaseholdImprovements>
    <mdwd:RightOfUseAssetReclassifiedToLeaseholdImprovements
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20240317162809601"
      unitRef="USD">0</mdwd:RightOfUseAssetReclassifiedToLeaseholdImprovements>
    <mdwd:RightOfUseAssetReclassifiedToLeaseholdImprovements
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240317162833865"
      unitRef="USD">59000</mdwd:RightOfUseAssetReclassifiedToLeaseholdImprovements>
    <mdwd:RightOfUseAssetDisposals
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220218040326083_xbrl_20211006165447023_xbrl_20211006165426095_xbrl_20211006165400552_xbrl_20211006164720297"
      unitRef="USD">1527000</mdwd:RightOfUseAssetDisposals>
    <mdwd:RightOfUseAssetDisposals
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220218040326083_xbrl_20211006165447023_xbrl_20211006165426095_xbrl_20211006165400552_xbrl_20211006164713615"
      unitRef="USD">308000</mdwd:RightOfUseAssetDisposals>
    <mdwd:RightOfUseAssetDisposals
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220218040326083_xbrl_20211006165447023_xbrl_20211006165426095_xbrl_20211006165400552_xbrl_20211006164634125"
      unitRef="USD">1835000</mdwd:RightOfUseAssetDisposals>
    <mdwd:RightOfUseAssetsAccumulatedDepreciation
      contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220218040057685_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164413105"
      unitRef="USD">208000</mdwd:RightOfUseAssetsAccumulatedDepreciation>
    <mdwd:RightOfUseAssetsAccumulatedDepreciation
      contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220218040057685_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164610160"
      unitRef="USD">257000</mdwd:RightOfUseAssetsAccumulatedDepreciation>
    <mdwd:RightOfUseAssetsAccumulatedDepreciation
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220218040036483_xbrl_20211006165539151_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164613511"
      unitRef="USD">465000</mdwd:RightOfUseAssetsAccumulatedDepreciation>
    <ifrs-full:RightofuseAssets
      contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220218040036483_xbrl_20211006165539151_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164413105"
      unitRef="USD">6303000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220218040036483_xbrl_20211006165539151_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164610160"
      unitRef="USD">395000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240317162900057"
      unitRef="USD">6698000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssetsRevaluedAssetsAtCost
      contextRef="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220218040009306_xbrl_20211006165239957_xbrl_20211006164413105"
      unitRef="USD">2267000</ifrs-full:RightofuseAssetsRevaluedAssetsAtCost>
    <ifrs-full:RightofuseAssetsRevaluedAssetsAtCost
      contextRef="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220218040009306_xbrl_20211006165239957_xbrl_20211006164610160"
      unitRef="USD">654000</ifrs-full:RightofuseAssetsRevaluedAssetsAtCost>
    <ifrs-full:RightofuseAssetsRevaluedAssetsAtCost
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220218040009306_xbrl_20211006165239957_xbrl_20211006164613511"
      unitRef="USD">2921000</ifrs-full:RightofuseAssetsRevaluedAssetsAtCost>
    <mdwd:AdditionsToRightOfUseAssetsNewLeases
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220218040126625_xbrl_20211006164720297"
      unitRef="USD">0</mdwd:AdditionsToRightOfUseAssetsNewLeases>
    <mdwd:AdditionsToRightOfUseAssetsNewLeases
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220218040126625_xbrl_20211006164713615"
      unitRef="USD">125000</mdwd:AdditionsToRightOfUseAssetsNewLeases>
    <mdwd:AdditionsToRightOfUseAssetsNewLeases
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220218040126625_xbrl_20211006164634125"
      unitRef="USD">125000</mdwd:AdditionsToRightOfUseAssetsNewLeases>
    <mdwd:AdditionsToRightOfUseAssetsAdjustmentsForIndexation
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220218040148923_xbrl_20211006164738151_xbrl_20211006164720297"
      unitRef="USD">-74000</mdwd:AdditionsToRightOfUseAssetsAdjustmentsForIndexation>
    <mdwd:AdditionsToRightOfUseAssetsAdjustmentsForIndexation
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220218040148923_xbrl_20211006164738151_xbrl_20211006164713615"
      unitRef="USD">-9000</mdwd:AdditionsToRightOfUseAssetsAdjustmentsForIndexation>
    <mdwd:AdditionsToRightOfUseAssetsAdjustmentsForIndexation
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220218040148923_xbrl_20211006164738151_xbrl_20211006164634125"
      unitRef="USD">-83000</mdwd:AdditionsToRightOfUseAssetsAdjustmentsForIndexation>
    <mdwd:AdditionsToRightOfUseAssetsDisposals
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220218040206289_xbrl_20211006165127812_xbrl_20211006164738151_xbrl_20211006164720297"
      unitRef="USD">0</mdwd:AdditionsToRightOfUseAssetsDisposals>
    <mdwd:AdditionsToRightOfUseAssetsDisposals
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20240317162921970"
      unitRef="USD">238000</mdwd:AdditionsToRightOfUseAssetsDisposals>
    <mdwd:AdditionsToRightOfUseAssetsDisposals
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240317162926649"
      unitRef="USD">238000</mdwd:AdditionsToRightOfUseAssetsDisposals>
    <ifrs-full:RightofuseAssetsRevaluedAssetsAtCost
      contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220218040012242_xbrl_20211006165239957_xbrl_20211006164413105"
      unitRef="USD">2341000</ifrs-full:RightofuseAssetsRevaluedAssetsAtCost>
    <ifrs-full:RightofuseAssetsRevaluedAssetsAtCost
      contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220218040012242_xbrl_20211006165239957_xbrl_20211006164610160"
      unitRef="USD">550000</ifrs-full:RightofuseAssetsRevaluedAssetsAtCost>
    <ifrs-full:RightofuseAssetsRevaluedAssetsAtCost
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220218040012242_xbrl_20211006165239957_xbrl_20211006164613511"
      unitRef="USD">2891000</ifrs-full:RightofuseAssetsRevaluedAssetsAtCost>
    <mdwd:RightOfUseAssetsAccumulatedDepreciation
      contextRef="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220218040053082_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164413105"
      unitRef="USD">1028000</mdwd:RightOfUseAssetsAccumulatedDepreciation>
    <mdwd:RightOfUseAssetsAccumulatedDepreciation
      contextRef="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220218040053082_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164610160"
      unitRef="USD">345000</mdwd:RightOfUseAssetsAccumulatedDepreciation>
    <mdwd:RightOfUseAssetsAccumulatedDepreciation
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220218040053082_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164613511"
      unitRef="USD">1373000</mdwd:RightOfUseAssetsAccumulatedDepreciation>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220218040228152_xbrl_20211006165400552_xbrl_20211006164720297"
      unitRef="USD">314000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220218040228152_xbrl_20211006165400552_xbrl_20211006164713615"
      unitRef="USD">225000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220218040228152_xbrl_20211006165400552_xbrl_20211006164634125"
      unitRef="USD">539000</ifrs-full:DepreciationRightofuseAssets>
    <mdwd:RightOfUseAssetDisposals
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220218040321260_xbrl_20211006165447023_xbrl_20211006165426095_xbrl_20211006165400552_xbrl_20211006164720297"
      unitRef="USD">0</mdwd:RightOfUseAssetDisposals>
    <mdwd:RightOfUseAssetDisposals
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220218040321260_xbrl_20211006165447023_xbrl_20211006165426095_xbrl_20211006165400552_xbrl_20211006164713615"
      unitRef="USD">236000</mdwd:RightOfUseAssetDisposals>
    <mdwd:RightOfUseAssetDisposals
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220218040321260_xbrl_20211006165447023_xbrl_20211006165426095_xbrl_20211006165400552_xbrl_20211006164634125"
      unitRef="USD">236000</mdwd:RightOfUseAssetDisposals>
    <mdwd:RightOfUseAssetsAccumulatedDepreciation
      contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220218040049913_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164413105"
      unitRef="USD">1342000</mdwd:RightOfUseAssetsAccumulatedDepreciation>
    <mdwd:RightOfUseAssetsAccumulatedDepreciation
      contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220218040049913_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164610160"
      unitRef="USD">334000</mdwd:RightOfUseAssetsAccumulatedDepreciation>
    <mdwd:RightOfUseAssetsAccumulatedDepreciation
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220218040049913_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164613511"
      unitRef="USD">1676000</mdwd:RightOfUseAssetsAccumulatedDepreciation>
    <ifrs-full:RightofuseAssets
      contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220218040027656_xbrl_20211006165539151_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164413105"
      unitRef="USD">999000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220218040027656_xbrl_20211006165539151_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164610160"
      unitRef="USD">216000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220218040027656_xbrl_20211006165539151_xbrl_20211006165508206_xbrl_20211006165324429_xbrl_20211006164613511"
      unitRef="USD">1215000</ifrs-full:RightofuseAssets>
    <ifrs-full:DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317165333406">
              &lt;div style="margin-left:90pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Buildings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Motor vehicles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,199&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;179&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,378&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Repayment of leases liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(588&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(190&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(778&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effect of changes in exchange rates&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;New finance lease obligation recognized&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,460&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;365&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,825&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustments for indexation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;257&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;274&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals-Termination of leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,041&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,052&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,346&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;365&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,711&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current maturities of long-term leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(180&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(181&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(361&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease liability Balance as of December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,166&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;184&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,350&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:90pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Buildings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Motor vehicles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;299&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,990&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Repayment of leases liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(477&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(224&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(701&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effect of changes in exchange rates&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(182&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;New finance lease obligation recognized&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;117&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;117&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustments for indexation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;74&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;83&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;93&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;101&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals-Termination of leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,199&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;179&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,378&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current maturities of long-term leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(399&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(133&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(532&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease liability Balance as of December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;800&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;846&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            </ifrs-full:DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613201_xbrl_20211006171353466"
      unitRef="USD">1199000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613201_xbrl_20211006171439303"
      unitRef="USD">179000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613201_xbrl_20211006171457014"
      unitRef="USD">1378000</ifrs-full:LeaseLiabilities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613207_xbrl_20211006171800553"
      unitRef="USD">588000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613207_xbrl_20211006171753939"
      unitRef="USD">190000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613207_xbrl_20211006171730097"
      unitRef="USD">778000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <mdwd:EffectOfChangesInExchangeRatesForLeaseLiabilities
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613212_xbrl_20211006171824556_xbrl_20211006171800553"
      unitRef="USD">-19000</mdwd:EffectOfChangesInExchangeRatesForLeaseLiabilities>
    <mdwd:EffectOfChangesInExchangeRatesForLeaseLiabilities
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613212_xbrl_20211006171824556_xbrl_20211006171753939"
      unitRef="USD">2000</mdwd:EffectOfChangesInExchangeRatesForLeaseLiabilities>
    <mdwd:EffectOfChangesInExchangeRatesForLeaseLiabilities
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613212_xbrl_20211006171824556_xbrl_20211006171730097"
      unitRef="USD">-17000</mdwd:EffectOfChangesInExchangeRatesForLeaseLiabilities>
    <mdwd:NewFinanceLeaseObligationRecognized
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613215_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171800553"
      unitRef="USD">6460000</mdwd:NewFinanceLeaseObligationRecognized>
    <mdwd:NewFinanceLeaseObligationRecognized
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613215_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171753939"
      unitRef="USD">365000</mdwd:NewFinanceLeaseObligationRecognized>
    <mdwd:NewFinanceLeaseObligationRecognized
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613215_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171730097"
      unitRef="USD">6825000</mdwd:NewFinanceLeaseObligationRecognized>
    <mdwd:AdjustmentsForIndexation
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613219_xbrl_20211006171902478_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171800553"
      unitRef="USD">78000</mdwd:AdjustmentsForIndexation>
    <mdwd:AdjustmentsForIndexation
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613219_xbrl_20211006171902478_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171753939"
      unitRef="USD">3000</mdwd:AdjustmentsForIndexation>
    <mdwd:AdjustmentsForIndexation
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613219_xbrl_20211006171902478_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171730097"
      unitRef="USD">81000</mdwd:AdjustmentsForIndexation>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613223_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171800553"
      unitRef="USD">257000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613223_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171753939"
      unitRef="USD">17000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613223_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171730097"
      unitRef="USD">274000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <mdwd:DisposalsTerminationOfLeases
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613226_xbrl_20211006175815046_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171800553"
      unitRef="USD">1041000</mdwd:DisposalsTerminationOfLeases>
    <mdwd:DisposalsTerminationOfLeases
      contextRef="C_20230101to20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613226_xbrl_20211006175815046_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171753939"
      unitRef="USD">11000</mdwd:DisposalsTerminationOfLeases>
    <mdwd:DisposalsTerminationOfLeases
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613226_xbrl_20211006175815046_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171730097"
      unitRef="USD">1052000</mdwd:DisposalsTerminationOfLeases>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613230_xbrl_20211006175920802_xbrl_20211006171353466"
      unitRef="USD">6346000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613230_xbrl_20211006175920802_xbrl_20211006171439303"
      unitRef="USD">365000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613230_xbrl_20211006175920802_xbrl_20211006171457014"
      unitRef="USD">6711000</ifrs-full:LeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613234_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171353466"
      unitRef="USD">180000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613234_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171439303"
      unitRef="USD">181000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="C_20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613234_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171457014"
      unitRef="USD">361000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613241_xbrl_20211006180028212_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171353466"
      unitRef="USD">6166000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613241_xbrl_20211006180028212_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171439303"
      unitRef="USD">184000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="C_20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040613241_xbrl_20211006180028212_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171457014"
      unitRef="USD">6350000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600448_xbrl_20211006171353466"
      unitRef="USD">1691000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600448_xbrl_20211006171439303"
      unitRef="USD">299000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600448_xbrl_20211006171457014"
      unitRef="USD">1990000</ifrs-full:LeaseLiabilities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600452_xbrl_20211006171800553"
      unitRef="USD">477000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600452_xbrl_20211006171753939"
      unitRef="USD">224000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20220101to20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600452_xbrl_20211006171730097"
      unitRef="USD">701000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <mdwd:EffectOfChangesInExchangeRatesForLeaseLiabilities
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600455_xbrl_20211006171824556_xbrl_20211006171800553"
      unitRef="USD">-182000</mdwd:EffectOfChangesInExchangeRatesForLeaseLiabilities>
    <mdwd:EffectOfChangesInExchangeRatesForLeaseLiabilities
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600455_xbrl_20211006171824556_xbrl_20211006171753939"
      unitRef="USD">-28000</mdwd:EffectOfChangesInExchangeRatesForLeaseLiabilities>
    <mdwd:EffectOfChangesInExchangeRatesForLeaseLiabilities
      contextRef="C_20220101to20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600455_xbrl_20211006171824556_xbrl_20211006171730097"
      unitRef="USD">-210000</mdwd:EffectOfChangesInExchangeRatesForLeaseLiabilities>
    <mdwd:NewFinanceLeaseObligationRecognized
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600458_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171800553"
      unitRef="USD">0</mdwd:NewFinanceLeaseObligationRecognized>
    <mdwd:NewFinanceLeaseObligationRecognized
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600458_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171753939"
      unitRef="USD">117000</mdwd:NewFinanceLeaseObligationRecognized>
    <mdwd:NewFinanceLeaseObligationRecognized
      contextRef="C_20220101to20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600458_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171730097"
      unitRef="USD">117000</mdwd:NewFinanceLeaseObligationRecognized>
    <mdwd:AdjustmentsForIndexation
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600460_xbrl_20211006171902478_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171800553"
      unitRef="USD">-74000</mdwd:AdjustmentsForIndexation>
    <mdwd:AdjustmentsForIndexation
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600460_xbrl_20211006171902478_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171753939"
      unitRef="USD">-9000</mdwd:AdjustmentsForIndexation>
    <mdwd:AdjustmentsForIndexation
      contextRef="C_20220101to20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600460_xbrl_20211006171902478_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171730097"
      unitRef="USD">83000</mdwd:AdjustmentsForIndexation>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600463_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171800553"
      unitRef="USD">93000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600463_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171753939"
      unitRef="USD">8000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="C_20220101to20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600463_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171730097"
      unitRef="USD">101000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <mdwd:DisposalsTerminationOfLeases
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600467_xbrl_20211006175815046_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171800553"
      unitRef="USD">0</mdwd:DisposalsTerminationOfLeases>
    <mdwd:DisposalsTerminationOfLeases
      contextRef="C_20220101to20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600467_xbrl_20211006175815046_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171753939"
      unitRef="USD">2000</mdwd:DisposalsTerminationOfLeases>
    <mdwd:DisposalsTerminationOfLeases
      contextRef="C_20220101to20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600467_xbrl_20211006175815046_xbrl_20211006171948479_xbrl_20211006171842548_xbrl_20211006171824556_xbrl_20211006171730097"
      unitRef="USD">2000</mdwd:DisposalsTerminationOfLeases>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600470_xbrl_20211006175920802_xbrl_20211006171353466"
      unitRef="USD">1199000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600470_xbrl_20211006175920802_xbrl_20211006171439303"
      unitRef="USD">179000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600470_xbrl_20211006175920802_xbrl_20211006171457014"
      unitRef="USD">1378000</ifrs-full:LeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600473_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171353466"
      unitRef="USD">399000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600473_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171439303"
      unitRef="USD">133000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="C_20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600473_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171457014"
      unitRef="USD">532000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullBuildingsMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600476_xbrl_20211006180028212_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171353466"
      unitRef="USD">800000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="C_20221231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600476_xbrl_20211006180028212_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171439303"
      unitRef="USD">46000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="C_20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220218040600476_xbrl_20211006180028212_xbrl_20211006180009457_xbrl_20211006175920802_xbrl_20211006171457014"
      unitRef="USD">846000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:DisclosureOfIntangibleAssetsExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211007110113928">
    &lt;div&gt;
      &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25"&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0);border:0px"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;
                    &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;Note 12:&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&lt;span&gt;Intangible Assets, Net&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/p&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
      &lt;div&gt;
        &lt;div&gt;

            &lt;div&gt;
              &lt;div style="margin-left:63pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;License and&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Knowhow&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cost&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as of January 1,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,538&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,538&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as of December 31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,538&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,538&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Accumulated Amortization&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as of January 1,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,307&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,241&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;66&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;66&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as of December 31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,373&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,307&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as of December 31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;165&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;231&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;

          &lt;div style="margin-left:63pt"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Intangible assets include exclusive licenses to use patents, know-how and intellectual property for the development, manufacturing and marketing of products related to burn treatments and other products in the field of wound care. These licenses were purchased from third parties and from one of the Company's shareholders.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </ifrs-full:DisclosureOfIntangibleAssetsExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240316152352370">
            &lt;div&gt;
              &lt;div style="margin-left:63pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;License and&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Knowhow&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cost&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as of January 1,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,538&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,538&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as of December 31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,538&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,538&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Accumulated Amortization&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as of January 1,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,307&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,241&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;66&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;66&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as of December 31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,373&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,307&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as of December 31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;165&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;231&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"
      decimals="-3"
      id="Fxbrl_20211007102522384"
      unitRef="USD">1538000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"
      decimals="-3"
      id="Fxbrl_20211007102540717"
      unitRef="USD">1538000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"
      decimals="-3"
      id="Fxbrl_20211007102555515"
      unitRef="USD">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"
      decimals="-3"
      id="Fxbrl_20211007102623483"
      unitRef="USD">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"
      decimals="-3"
      id="Fxbrl_20211007102636331_xbrl_20211007102522384"
      unitRef="USD">1538000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"
      decimals="-3"
      id="Fxbrl_20211007102636331_xbrl_20211007102540717"
      unitRef="USD">1538000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"
      decimals="-3"
      id="Fxbrl_20211007102702467_xbrl_20211007102522384"
      unitRef="USD">-1307000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"
      decimals="-3"
      id="Fxbrl_20211007102702467_xbrl_20211007102540717"
      unitRef="USD">-1241000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"
      decimals="-3"
      id="Fxbrl_20211007103508501_xbrl_20211007102555515"
      unitRef="USD">66000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20220101to20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"
      decimals="-3"
      id="Fxbrl_20211007103508501_xbrl_20211007102623483"
      unitRef="USD">66000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"
      decimals="-3"
      id="Fxbrl_20211007103529800_xbrl_20211007102702467_xbrl_20211007102522384"
      unitRef="USD">-1373000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"
      decimals="-3"
      id="Fxbrl_20211007103529800_xbrl_20211007102702467_xbrl_20211007102540717"
      unitRef="USD">-1307000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdAmortizedCostMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"
      decimals="-3"
      id="Fxbrl_20211007103254291"
      unitRef="USD">165000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_mdwdAmortizedCostMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesAndFranchisesMember"
      decimals="-3"
      id="Fxbrl_20211007103557580"
      unitRef="USD">231000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240316152554225">
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note 13:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other Payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div&gt;&#160;&lt;/div&gt;

            &lt;div&gt;
              &lt;div style="margin-left:63pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Employees and payroll accruals&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,471&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liability in respect of TEVA (see Note 17c)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,250&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;417&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Related parties&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;83&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;307&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;63&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;425&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;901&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,891&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,159&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;

        &lt;/div&gt;
      </ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory>
    <mdwd:DisclosureOfDetailedInformationAboutOtherPayablesExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240316152609269">
            &lt;div&gt;
              &lt;div style="margin-left:63pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Employees and payroll accruals&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,471&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liability in respect of TEVA (see Note 17c)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,250&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;417&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Related parties&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;83&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;307&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;63&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;425&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;901&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,891&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,159&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </mdwd:DisclosureOfDetailedInformationAboutOtherPayablesExplanatory>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211007110918777_33"
      unitRef="USD">2109000</ifrs-full:ShorttermEmployeeBenefitsAccruals>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211007110918777_37"
      unitRef="USD">2471000</ifrs-full:ShorttermEmployeeBenefitsAccruals>
    <mdwd:LiabilityInRespectForPurchaseOfShares
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211007110918777_43"
      unitRef="USD">1250000</mdwd:LiabilityInRespectForPurchaseOfShares>
    <mdwd:LiabilityInRespectForPurchaseOfShares
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211007110918777_47"
      unitRef="USD">417000</mdwd:LiabilityInRespectForPurchaseOfShares>
    <ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211007110918777_53"
      unitRef="USD">83000</ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211007110918777_57"
      unitRef="USD">307000</ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties>
    <mdwd:DeferredRevenues
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211007110918777_63"
      unitRef="USD">24000</mdwd:DeferredRevenues>
    <mdwd:DeferredRevenues
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211007110918777_67"
      unitRef="USD">63000</mdwd:DeferredRevenues>
    <mdwd:OtherCurrentPayable
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211007110918777_73"
      unitRef="USD">425000</mdwd:OtherCurrentPayable>
    <mdwd:OtherCurrentPayable
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211007110918777_77"
      unitRef="USD">901000</mdwd:OtherCurrentPayable>
    <ifrs-full:OtherCurrentPayables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211007110918777_93"
      unitRef="USD">3891000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:OtherCurrentPayables
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211007110918777_97"
      unitRef="USD">4159000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:DisclosureOfGovernmentGrantsExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211007120324242">
    &lt;div&gt;
      &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25"&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Note 14:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Liabilities in Respect of IIA Grants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;&#160;&lt;/div&gt;

            &lt;div&gt;
              &lt;div style="margin-left:63pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as of January 1,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7,566&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,105&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Royalties&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(190&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(407&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Amounts carried to Profit or Loss&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;427&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(132&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as of December 31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7,803&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7,566&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Current maturities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(126&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(121&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Long term liabilities in respect of IIA grants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7,677&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7,445&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;

          &lt;div style="margin-left:63pt"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company is committed to pay royalties to the IIA up to the total grants received plus the applicable accrued interest. The total amount of grants received from IIA including accrued interest, net of royalties as of December 31, 2023 is approximately $13,783, while the amortized cost of this liability as of that date is $ 7,803, using the interest method.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </ifrs-full:DisclosureOfGovernmentGrantsExplanatory>
    <mdwd:DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240316153030893">
            &lt;div&gt;
              &lt;div style="margin-left:63pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as of January 1,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7,566&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,105&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Royalties&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(190&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(407&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Amounts carried to Profit or Loss&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;427&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(132&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as of December 31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7,803&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7,566&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Current maturities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(126&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(121&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Long term liabilities in respect of IIA grants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7,677&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7,445&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </mdwd:DisclosureOfDetailedInformationAboutIsraeliInnovationAuthorityGrantsExplanatory>
    <ifrs-full:GovernmentGrants
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211007115552736_33"
      unitRef="USD">7566000</ifrs-full:GovernmentGrants>
    <ifrs-full:GovernmentGrants
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20211007115552736_37"
      unitRef="USD">8105000</ifrs-full:GovernmentGrants>
    <ifrs-full:RoyaltyExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211007115552736_53"
      unitRef="USD">190000</ifrs-full:RoyaltyExpense>
    <ifrs-full:RoyaltyExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211007115552736_57"
      unitRef="USD">407000</ifrs-full:RoyaltyExpense>
    <mdwd:RevaluationOfLiabilitiesInRespectOfGrants
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211007115552736_63"
      unitRef="USD">-427000</mdwd:RevaluationOfLiabilitiesInRespectOfGrants>
    <mdwd:RevaluationOfLiabilitiesInRespectOfGrants
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211007115552736_67"
      unitRef="USD">132000</mdwd:RevaluationOfLiabilitiesInRespectOfGrants>
    <ifrs-full:GovernmentGrants
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211007115552736_73"
      unitRef="USD">7803000</ifrs-full:GovernmentGrants>
    <ifrs-full:GovernmentGrants
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211007115552736_77"
      unitRef="USD">7566000</ifrs-full:GovernmentGrants>
    <ifrs-full:CurrentGovernmentGrants
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211007115552736_93"
      unitRef="USD">126000</ifrs-full:CurrentGovernmentGrants>
    <ifrs-full:CurrentGovernmentGrants
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211007115552736_97"
      unitRef="USD">121000</ifrs-full:CurrentGovernmentGrants>
    <ifrs-full:NoncurrentGovernmentGrants
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211007115552736_113"
      unitRef="USD">7677000</ifrs-full:NoncurrentGovernmentGrants>
    <ifrs-full:NoncurrentGovernmentGrants
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211007115552736_117"
      unitRef="USD">7445000</ifrs-full:NoncurrentGovernmentGrants>
    <mdwd:GrantsReceivedNetOfRoyalties
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220310041213331"
      unitRef="USD">13783000</mdwd:GrantsReceivedNetOfRoyalties>
    <mdwd:AmortizedCostOfGrantsReceived
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220310041221124"
      unitRef="USD">7803000</mdwd:AmortizedCostOfGrantsReceived>
    <ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317142229517">
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note 15:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial Instruments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:28.35pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Risk management:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Board of Directors has overall responsibility for the establishment and oversight of the Company&#x2019;s risk management framework.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s risk management practice was formulated to identify and analyze the risks that the Company faces, to set appropriate limits for the risks and controls, and to monitor the risks and their compliance within the limits. The risk policy and risk management methods are reviewed regularly to reflect changes in market conditions and in the Company&#x2019;s operations.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:85.05pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company Audit Committee oversees how management monitors compliance with the Company&#x2019;s risk management policies and procedures and reviews the adequacy of the risk management framework in relation to the risks faced by the Company. The Company Audit Committee is assisted in its oversight role by Internal Audit. Internal Audit undertakes both regular and ad hoc reviews of risk management controls and procedures, the results of which are reported to the Audit Committee.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's activities expose it to various financial market risks, mainly foreign currency risk, interest rate risk and liquidity risk.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency risk&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company operates primarily in an international environment and is exposed to foreign exchange risk resulting from the fact that a certain portion of the Company's costs are denominated in NIS and EURO, mainly due to payroll and related benefit costs incurred in Israel and additionally due to marketing expenses incurred in Europe.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sensitivity tests relating to changes in market factors:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company operates in an international environment and is exposed to foreign exchange risk resulting from the exposure to different currencies, mainly NIS and EURO. Foreign exchange risks arise from recognized assets and liabilities denominated in a foreign currency other than the functional currency.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;div&gt;
              &lt;div&gt;
                &lt;div style="margin-left:108pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Gain (loss) from change:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5% increase in NIS and EURO exchange rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;176&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;257&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5% decrease in NIS and EURO exchange rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(176&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(257&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;

          &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has performed sensitivity tests of principal market risk factors that may affect its reported operating results or financial position.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The sensitivity tests present the profit or loss for the relevant risk variables chosen as of each reporting date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div&gt;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liquidity risk&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:106.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company&#x2019;s approach to managing liquidity is to ensure, as far as possible, that it will always have sufficient liquidity to timely meet its liabilities, under both normal and stressed conditions, without incurring unwanted losses.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:106.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company manages the liquidity risk by holding cash balances, short-term deposits and secured bank credit facilities.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="margin-left:108pt"&gt;&#160;&lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;

            &lt;div&gt;
              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;
                  &lt;div style="margin-left:108pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="14" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12 months&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;amount&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;or less&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1-2 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2-15 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-derivative financial liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Current maturities of long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,249&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,249&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Trade payables and accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,528&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,528&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Other payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,891&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,891&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Liabilities in respect of IIA grants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,927&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;359&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,568&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Liabilities in respect of TEVA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,189&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;813&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,376&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:108pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="14" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12 months&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;amount&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;or less&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1-2 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2-8 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-derivative financial liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Current maturities of long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,814&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,814&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Trade payables and accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,656&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,656&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Other payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,159&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,159&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Liabilities in respect of IIA grants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,464&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;312&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,152&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Liabilities in respect of TEVA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;902&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;394&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div&gt;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial instruments measured at fair value for disclosure purposes only.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The carrying amounts of certain financial assets and liabilities, including cash, trade receivables, other receivables, deposits, trade and other payables are the same as or approximate to their fair value.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value hierarchy of financial instruments measured at fair value.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The financial instruments measured at fair value on a temporal basis, use valuation methodology in accordance with the fair value hierarchy levels when determining the fair value of an asset or liability, the Company uses observable market data as much as possible.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Details regarding fair value measurement at Level 2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of the warrants which are classified as non-currents liabilities was measured by using Black and Scholes model. The following inputs were used to determine the fair value:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected period of warrants&#x2013; 2.91 years.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected volatility &#x2013; 67.1%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Risk-free interest rate (3) &#x2013; 4.03%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected dividend yield &#x2013; 0%.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of liabilities in respect to IIA grants with fixed interest is based on a calculation of the present value of the cash flows at the interest rate for a loan with similar terms. The Company used a discount rate of 12% based in part of the Company&#x2019;s estimation at the time of the Company&#x2019;s recognition of the IIA grants which approximates the fair value at the respective balance sheet date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The liability in respect of TEVA as presented in balance sheet which is approximate its fair value, based on a calculation of the present value of future payments. The expected cash flows already reflect assumptions about the uncertainty in future defaults, and therefore the Company used a discount rate of 14% that is commensurate with the risk inherent in the expected cash flows (Note 17c).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory>
    <ifrs-full:SensitivityAnalysisForEachTypeOfMarketRisk
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317142254346">
            &lt;div&gt;
              &lt;div&gt;
                &lt;div style="margin-left:108pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Gain (loss) from change:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5% increase in NIS and EURO exchange rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;176&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;257&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5% decrease in NIS and EURO exchange rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(176&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(257&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </ifrs-full:SensitivityAnalysisForEachTypeOfMarketRisk>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="C_20230101to20231231_mdwdSensitivityAnalysisAxis_mdwdFivePercentageIncreaseInExchangeRateMember"
      decimals="-3"
      id="Fxbrl_20240317142018369_xbrl_20220310051203872_xbrl_20211007120906569"
      unitRef="USD">176000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="C_20220101to20221231_mdwdSensitivityAnalysisAxis_mdwdFivePercentageIncreaseInExchangeRateMember"
      decimals="-3"
      id="Fxbrl_20240317142018369_xbrl_20220310051203872_xbrl_20211007120921721"
      unitRef="USD">257000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="C_20230101to20231231_mdwdSensitivityAnalysisAxis_mdwdFivePercentageDecreaseInExchangeRateMember"
      decimals="-3"
      id="Fxbrl_20240317142018372_xbrl_20220310051224050_xbrl_20211007120956439_xbrl_20211007120906569"
      unitRef="USD">-176000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="C_20220101to20221231_mdwdSensitivityAnalysisAxis_mdwdFivePercentageDecreaseInExchangeRateMember"
      decimals="-3"
      id="Fxbrl_20240317142018372_xbrl_20220310051224050_xbrl_20211007120956439_xbrl_20211007120921721"
      unitRef="USD">-257000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317142241951">
            &lt;div&gt;
              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;
                  &lt;div style="margin-left:108pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="14" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12 months&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;amount&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;or less&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1-2 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2-15 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-derivative financial liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Current maturities of long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,249&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,249&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Trade payables and accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,528&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,528&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Other payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,891&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,891&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Liabilities in respect of IIA grants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,927&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;359&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,568&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Liabilities in respect of TEVA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,189&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;813&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,376&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:108pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="14" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12 months&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;amount&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;or less&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1-2 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2-8 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-derivative financial liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Current maturities of long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,814&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,814&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Trade payables and accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,656&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,656&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Other payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,159&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,159&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Liabilities in respect of IIA grants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,464&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;312&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,152&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Liabilities in respect of TEVA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;902&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;394&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities>
    <mdwd:CurrentMaturitiesOfLongTermLiabilities
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20240317142040395_xbrl_20220310051614244_53"
      unitRef="USD">3249000</mdwd:CurrentMaturitiesOfLongTermLiabilities>
    <mdwd:CurrentMaturitiesOfLongTermLiabilities
      contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20240317142040395_xbrl_20220310051614244_57"
      unitRef="USD">3249000</mdwd:CurrentMaturitiesOfLongTermLiabilities>
    <mdwd:CurrentMaturitiesOfLongTermLiabilities
      contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142040395_xbrl_20230304161353722"
      unitRef="USD">0</mdwd:CurrentMaturitiesOfLongTermLiabilities>
    <mdwd:CurrentMaturitiesOfLongTermLiabilities
      contextRef="C_20231231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142040395_xbrl_20230304161402072"
      unitRef="USD">0</mdwd:CurrentMaturitiesOfLongTermLiabilities>
    <mdwd:TradePayablesAndAccruedExpenses
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20240317142040406_xbrl_20220310051614244_63"
      unitRef="USD">5528000</mdwd:TradePayablesAndAccruedExpenses>
    <mdwd:TradePayablesAndAccruedExpenses
      contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20240317142040406_xbrl_20220310051614244_67"
      unitRef="USD">5528000</mdwd:TradePayablesAndAccruedExpenses>
    <mdwd:TradePayablesAndAccruedExpenses
      contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142040406_xbrl_20230304161408496"
      unitRef="USD">0</mdwd:TradePayablesAndAccruedExpenses>
    <mdwd:TradePayablesAndAccruedExpenses
      contextRef="C_20231231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142040406_xbrl_20230304161416808"
      unitRef="USD">0</mdwd:TradePayablesAndAccruedExpenses>
    <ifrs-full:OtherPayables
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20240317142040419_xbrl_20220310051614244_73"
      unitRef="USD">3891000</ifrs-full:OtherPayables>
    <ifrs-full:OtherPayables
      contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20240317142040419_xbrl_20220310051614244_77"
      unitRef="USD">3891000</ifrs-full:OtherPayables>
    <ifrs-full:OtherPayables
      contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142040419_xbrl_20230304161424239"
      unitRef="USD">0</ifrs-full:OtherPayables>
    <ifrs-full:OtherPayables
      contextRef="C_20231231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142040419_xbrl_20230304161427921"
      unitRef="USD">0</ifrs-full:OtherPayables>
    <mdwd:LiabilitiesInRespectOfGrants
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20240317142040432_xbrl_20220310051614244_93"
      unitRef="USD">15927000</mdwd:LiabilitiesInRespectOfGrants>
    <mdwd:LiabilitiesInRespectOfGrants
      contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20240317142040432_xbrl_20230304161530672"
      unitRef="USD">0</mdwd:LiabilitiesInRespectOfGrants>
    <mdwd:LiabilitiesInRespectOfGrants
      contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142040432_xbrl_20220310051614244_911"
      unitRef="USD">359000</mdwd:LiabilitiesInRespectOfGrants>
    <mdwd:LiabilitiesInRespectOfGrants
      contextRef="C_20231231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142040432_xbrl_20220310051614244_915"
      unitRef="USD">15568000</mdwd:LiabilitiesInRespectOfGrants>
    <mdwd:LiabilitiesInRespectOfTeva
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20240317142040441_xbrl_20220310051614244_103"
      unitRef="USD">3200000</mdwd:LiabilitiesInRespectOfTeva>
    <mdwd:LiabilitiesInRespectOfTeva
      contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20240317142040441_xbrl_20230304161536494"
      unitRef="USD">0</mdwd:LiabilitiesInRespectOfTeva>
    <mdwd:LiabilitiesInRespectOfTeva
      contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142040441_xbrl_20220310051614244_1011"
      unitRef="USD">1000000</mdwd:LiabilitiesInRespectOfTeva>
    <mdwd:LiabilitiesInRespectOfTeva
      contextRef="C_20231231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142040441_xbrl_20220310051614244_1015"
      unitRef="USD">2200000</mdwd:LiabilitiesInRespectOfTeva>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20240317142040451_xbrl_20220310051614244_113"
      unitRef="USD">10189000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20240317142040451_xbrl_20230304161551304"
      unitRef="USD">0</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142040451_xbrl_20220310051614244_1111"
      unitRef="USD">813000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="C_20231231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142040451_xbrl_20220310051614244_1115"
      unitRef="USD">9376000</ifrs-full:NoncurrentLeaseLiabilities>
    <mdwd:CurrentMaturitiesOfLongTermLiabilities
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20240317142047888_xbrl_20230303142041162_xbrl_20220310051614244_53"
      unitRef="USD">2814000</mdwd:CurrentMaturitiesOfLongTermLiabilities>
    <mdwd:CurrentMaturitiesOfLongTermLiabilities
      contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20240317142047888_xbrl_20230303142041162_xbrl_20220310051614244_57"
      unitRef="USD">2814000</mdwd:CurrentMaturitiesOfLongTermLiabilities>
    <mdwd:CurrentMaturitiesOfLongTermLiabilities
      contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142047888_xbrl_20230304161752975"
      unitRef="USD">0</mdwd:CurrentMaturitiesOfLongTermLiabilities>
    <mdwd:CurrentMaturitiesOfLongTermLiabilities
      contextRef="C_20221231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142047888_xbrl_20230304161756407"
      unitRef="USD">0</mdwd:CurrentMaturitiesOfLongTermLiabilities>
    <mdwd:TradePayablesAndAccruedExpenses
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20240317142047897_xbrl_20230303142041164_xbrl_20220310051614244_63"
      unitRef="USD">5656000</mdwd:TradePayablesAndAccruedExpenses>
    <mdwd:TradePayablesAndAccruedExpenses
      contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20240317142047897_xbrl_20230303142041164_xbrl_20220310051614244_67"
      unitRef="USD">5656000</mdwd:TradePayablesAndAccruedExpenses>
    <mdwd:TradePayablesAndAccruedExpenses
      contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142047897_xbrl_20230304161805815"
      unitRef="USD">0</mdwd:TradePayablesAndAccruedExpenses>
    <mdwd:TradePayablesAndAccruedExpenses
      contextRef="C_20221231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142047897_xbrl_20230304161808936"
      unitRef="USD">0</mdwd:TradePayablesAndAccruedExpenses>
    <ifrs-full:OtherPayables
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20240317142047906_xbrl_20230303142041165_xbrl_20220310051614244_73"
      unitRef="USD">4159000</ifrs-full:OtherPayables>
    <ifrs-full:OtherPayables
      contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20240317142047906_xbrl_20230303142041165_xbrl_20220310051614244_77"
      unitRef="USD">4159000</ifrs-full:OtherPayables>
    <ifrs-full:OtherPayables
      contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142047906_xbrl_20230304161814832"
      unitRef="USD">0</ifrs-full:OtherPayables>
    <ifrs-full:OtherPayables
      contextRef="C_20221231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142047906_xbrl_20230304161825960"
      unitRef="USD">0</ifrs-full:OtherPayables>
    <mdwd:LiabilitiesInRespectOfGrants
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20240317142047915_xbrl_20230303142041166_xbrl_20220310051614244_93"
      unitRef="USD">15464000</mdwd:LiabilitiesInRespectOfGrants>
    <mdwd:LiabilitiesInRespectOfGrants
      contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20240317142047915_xbrl_20230304161832386"
      unitRef="USD">0</mdwd:LiabilitiesInRespectOfGrants>
    <mdwd:LiabilitiesInRespectOfGrants
      contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142047915_xbrl_20230303142041166_xbrl_20220310051614244_911"
      unitRef="USD">312000</mdwd:LiabilitiesInRespectOfGrants>
    <mdwd:LiabilitiesInRespectOfGrants
      contextRef="C_20221231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142047915_xbrl_20230303142041166_xbrl_20220310051614244_915"
      unitRef="USD">15152000</mdwd:LiabilitiesInRespectOfGrants>
    <mdwd:LiabilitiesInRespectOfTeva
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20240317142047925_xbrl_20230303142041168_xbrl_20220310051614244_103"
      unitRef="USD">4200000</mdwd:LiabilitiesInRespectOfTeva>
    <mdwd:LiabilitiesInRespectOfTeva
      contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20240317142047925_xbrl_20230304161842471"
      unitRef="USD">0</mdwd:LiabilitiesInRespectOfTeva>
    <mdwd:LiabilitiesInRespectOfTeva
      contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142047925_xbrl_20230303142041168_xbrl_20220310051614244_1011"
      unitRef="USD">1000000</mdwd:LiabilitiesInRespectOfTeva>
    <mdwd:LiabilitiesInRespectOfTeva
      contextRef="C_20221231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142047925_xbrl_20230303142041168_xbrl_20220310051614244_1015"
      unitRef="USD">3200000</mdwd:LiabilitiesInRespectOfTeva>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20240317142047933_xbrl_20230303142041169_xbrl_20220310051614244_113"
      unitRef="USD">902000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20240317142047933_xbrl_20230304161850232"
      unitRef="USD">0</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="C_20221231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142047933_xbrl_20230303142041169_xbrl_20220310051614244_1111"
      unitRef="USD">508000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="C_20221231_ifrsfullMaturityAxis_mdwdLaterThanTwoYearAndNotLaterThanFifteenYearsMember"
      decimals="-3"
      id="Fxbrl_20240317142047933_xbrl_20230303142041169_xbrl_20220310051614244_1115"
      unitRef="USD">394000</ifrs-full:NoncurrentLeaseLiabilities>
    <mdwd:ExpectedTermOfWarrant
      contextRef="C_20230101to20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      id="Fxbrl_20240317195120003">P2Y10M28D</mdwd:ExpectedTermOfWarrant>
    <mdwd:ExpectedVolatilityWarrants
      contextRef="C_20230101to20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="3"
      id="Fxbrl_20240317141940007"
      unitRef="Percent">0.671</mdwd:ExpectedVolatilityWarrants>
    <mdwd:RiskFreeRateOfWarrants
      contextRef="C_20230101to20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="4"
      id="Fxbrl_20240317141946406"
      unitRef="Percent">0.0403</mdwd:RiskFreeRateOfWarrants>
    <mdwd:ExpectedDividendAsPercentageOfWarrants
      contextRef="C_20230101to20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="2"
      id="Fxbrl_20240317141951921"
      unitRef="Percent">0</mdwd:ExpectedDividendAsPercentageOfWarrants>
    <ifrs-full:DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse
      contextRef="C_20231231_ifrsfullTypesOfRisksAxis_mdwdInterestRateForLoanMember"
      decimals="2"
      id="Fxbrl_20240317141956744"
      unitRef="Percent">0.12</ifrs-full:DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse>
    <ifrs-full:DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse
      contextRef="C_20231231_ifrsfullTypesOfRisksAxis_mdwdUncertaintyInFutureDefaultsMember"
      decimals="2"
      id="Fxbrl_20240317142004696"
      unitRef="Percent">0.14</ifrs-full:DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse>
    <ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211007123216164">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note 16:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Severance Pay Liability, Net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has liabilities for severance pay for its employees in Israel and in several EU jurisdictions. The Company&#x2019;s liability for employee benefits is based on local laws, valid labor agreements, the employee&#x2019;s salary and the applicable terms of employment, which together generate a right to severance compensation. Post&#x2011;employment employee benefits are partially financed by deposits with defined contribution plans, as detailed below.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Israeli Severance Pay Law, 1963 (&#x201c;Severance Pay Law&#x201d;), specifies that Israeli employees are entitled to severance payment, following the termination of their employment.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Under the Severance Pay Law, the severance payment is calculated as one month salary for each year of employment, or a portion thereof. Under Section 14 of the Severance Pay Law (&#x201c;Section 14&#x201d;), employees are entitled to have monthly deposits, at a rate of 8.33% of their monthly salary, made on their behalf to their insurance funds. Payments in accordance with Section 14 release the Company from the liability for any future severance payments in respect of those employees.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The majority of the Company&#x2019;s liability for severance pay is covered by Section 14. Accordingly, the Company does not recognize any liability for severance pay due to these employees and the deposits under Section 14 are not recorded as an asset in the Company&#x2019;s balance sheet. These contributions for compensation represent defined contribution plans. The Company recognizes liability for severance pay due to its employees in EU in accordance with local laws and its Israeli employees which are not under Section 14.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory>
    <mdwd:PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans
      contextRef="C_20230101to20231231"
      decimals="4"
      id="Fxbrl_20211007123204045"
      unitRef="Percent">0.0833</mdwd:PercentageOfMonthlyDepositByEmployeeOfTheirMonthlySalaryInDefinedContributionPlans>
    <ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240316155825162">
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note 17:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liabilities and Commitments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:28.35pt;font-weight:normal;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In 2000, the Company signed an exclusive license agreement (as amended in 2007) with a third party with regard to its patents and intellectual property. Pursuant to the agreement, the Company received an exclusive license to use the third party&#x2019;s patents and intellectual property, for the purpose of developing, manufacturing, marketing, and commercializing products for treatment of burns and other wounds.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company paid an aggregate amount of $ 950 and undertook to pay royalties of 1.5% to 2.5% from future revenues from sales of products which are based on this patent for a period of 12 years from the first commercial delivery in a major country, and thereafter the Company will have a fully paid-up royalty-free license for these patents. In addition, royalties will be paid at the rate of 10%&#160;from sub-licensing of such patents and for lump sum amounts paid to the Company by a third party, the Company will pay 2% of the proceeds up to $1,000 and 4% above this amount. Moreover, the Company agreed to pay a one-time lump-sum amount of $ 1,500 when the aggregate revenues based on these patents reach $ 100,000. The royalty payments for the years 2021, 2022 and 2023 amounted to $149, $363 and $98 respectively.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Under the Research and Development Law, (the &#x201c;R&amp;amp;D Law&#x201d;) the Company undertook to pay royalties of 3% on the revenues derived from sales of products or services developed in whole or in part using IIA grants. The maximum aggregate royalties paid cannot exceed 100% of the grants received by the Company, plus annual interest equal to the 12-month interest applicable to dollar deposits, as published on the first business day of each calendar year. The total royalties amount paid as of December 31, 2023 is $1,942. (Note 14).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div&gt;
                    &lt;div style="line-height:1.25;font-family:'Times New Roman',serif"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;In December 2020, Teva has agreed to revise the Settlement Agreement from March 2019, which was comprised of past agreement for collaboration in the development, manufacturing and commercialization of solutions for the burn and chronic wound care markets, as well as the Company&#x2019;s repurchase of shares from Teva. Under the new settlement the Company paid $1,000 in cash and became obligated to pay an amount of $2,000 over three years and an addition amount of $7,200 in quarterly fixed payments starting 2021 as long as there are revenues generated from sales of Nexobrid.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                  &lt;div style="font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total liabilities recorded as of December 31, 2023 and 2022 were approximately $4,428 and $4,794 respectively, and financial expenses of $468 and $533, respectively, were recorded in profit or loss within financial expenses.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory>
    <ifrs-full:TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220217171315317"
      unitRef="USD">950000</ifrs-full:TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions>
    <mdwd:PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      id="Fxbrl_20220217171322419">1.5% to 2.5</mdwd:PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts>
    <mdwd:PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      id="Fxbrl_20220217171334260">12 years</mdwd:PeriodOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts>
    <mdwd:PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_ifrsfullMethodsOfGenerationAxis_mdwdSubLicensingOfPatentsMember"
      id="Fxbrl_20240320211135383">10%</mdwd:PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts>
    <mdwd:PercentageOfOneTimeLumpSumPaymentAmount
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_ifrsfullMethodsOfGenerationAxis_mdwdSubLicensingOfPatentsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20220217171356972"
      unitRef="Percent">0.02</mdwd:PercentageOfOneTimeLumpSumPaymentAmount>
    <mdwd:OneTimeLumpsumAmount
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_ifrsfullMethodsOfGenerationAxis_mdwdSubLicensingOfPatentsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="-3"
      id="Fxbrl_20220217171406812"
      unitRef="USD">1000000</mdwd:OneTimeLumpsumAmount>
    <mdwd:PercentageOfOneTimeLumpSumPaymentAmount
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_ifrsfullMethodsOfGenerationAxis_mdwdSubLicensingOfPatentsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20220217171416772"
      unitRef="Percent">0.04</mdwd:PercentageOfOneTimeLumpSumPaymentAmount>
    <mdwd:OneTimeLumpsumAmount
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220217171428748"
      unitRef="USD">1500000</mdwd:OneTimeLumpsumAmount>
    <ifrs-full:RevenueFromRoyalties
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220217171439516"
      unitRef="USD">100000000</ifrs-full:RevenueFromRoyalties>
    <ifrs-full:RoyaltyExpense
      contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20240316155752438"
      unitRef="USD">149000</ifrs-full:RoyaltyExpense>
    <ifrs-full:RoyaltyExpense
      contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220217171503398"
      unitRef="USD">363000</ifrs-full:RoyaltyExpense>
    <ifrs-full:RoyaltyExpense
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdThirdPartiesMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220217171507148"
      unitRef="USD">98000</ifrs-full:RoyaltyExpense>
    <mdwd:PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdResearchAndDevelopmentLawMember"
      id="Fxbrl_20220310102520248">3</mdwd:PercentageOfRoyaltiesToPayForFutureRevenuesFromSalesOfProducts>
    <mdwd:MaximumAggregateRoyaltiesPaidInPercentage
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdResearchAndDevelopmentLawMember"
      decimals="2"
      id="Fxbrl_20220310102528652"
      unitRef="Percent">1</mdwd:MaximumAggregateRoyaltiesPaidInPercentage>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdResearchAndDevelopmentLawMember"
      id="Fxbrl_20220310102535910">12-month interest</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:RoyaltyExpense
      contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdResearchAndDevelopmentLawMember"
      decimals="-3"
      id="Fxbrl_20220310102629529"
      unitRef="USD">1942000</ifrs-full:RoyaltyExpense>
    <ifrs-full:ConsiderationPaidReceived
      contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember"
      decimals="-3"
      id="Fxbrl_20211007134902507"
      unitRef="USD">1000000</ifrs-full:ConsiderationPaidReceived>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember"
      decimals="-3"
      id="Fxbrl_20211007134927283"
      unitRef="USD">2000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember"
      decimals="-3"
      id="Fxbrl_20211007134952751"
      unitRef="USD">7200000</ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:Liabilities
      contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember"
      decimals="-3"
      id="Fxbrl_20220310103821242"
      unitRef="USD">4428000</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember"
      decimals="-3"
      id="Fxbrl_20220310103831381"
      unitRef="USD">4794000</ifrs-full:Liabilities>
    <mdwd:FinancialIncomeAndExpenses
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember"
      decimals="-3"
      id="Fxbrl_20220310105227733"
      unitRef="USD">468000</mdwd:FinancialIncomeAndExpenses>
    <mdwd:FinancialIncomeAndExpenses
      contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTevaMember"
      decimals="-3"
      id="Fxbrl_20220310105251716"
      unitRef="USD">533000</mdwd:FinancialIncomeAndExpenses>
    <mdwd:DisclosureOfMaterialAgreementsExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240319221000469">
      &lt;div&gt;
        &lt;div style="text-align:justify;line-height:1.25;font-weight:bold"&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Note 18:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Materials Agreements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
        &lt;div style="text-align:justify;text-indent:-56.7pt;margin-left:56.7pt;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;BARDA&lt;span style="font-style:italic"&gt;&#160;&lt;/span&gt;Contracts&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In September 2015, the Company was awarded BARDA Contract for treatment of thermal burn injuries. This contract was amended multiple times to extend its term until September 2024 (the Company is pursuing an extension of the contract) and its total value, up to a total amount of $165,000 as of the end of 2022.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;In&lt;/span&gt; May 2023 BARDA has awarded an additional approximately $10,000 to the Company. The total amount of the contract is comprised of $110,000 to support research and development activities and up to $65,000 to procure &lt;span&gt;Nexobrid&lt;/span&gt; for U.S. emergency preparedness (which will be split between the Company and Vericel following Vericel agreement (see Note 18b)).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:85.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, the Company has received approximately $88,282 in funding in the aggregate, from BARDA under the first contract, and an additional $16,500 for procurement of &lt;span&gt;Nexobrid&lt;/span&gt; for U.S. emergency preparedness, which were recorded at the net amount of approximately $10,500 following the split of gross profit agreement with Vericel for the initial BARDA procurement.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:85.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In September 2018 the Company was awarded the second BARDA contract, to develop Nexobrid for the treatment of Sulfur Mustard injuries as part of BARDA&#x2019;s preparedness for mass casualty events. The contract provides up to $12,000 of funding to support research and development activities and contains options to provide additional funding of up to $29,000 for additional development activities, animal pivotal studies, and the BLA submission for licensure of Nexobrid for the treatment of Sulfur Mustard injuries. The second BARDA contract expired in 2023. As of December 31, 2023, the Company has received approximately $4,368 of funding from the second BARDA contract.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:85.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;
          &lt;div&gt;&lt;/div&gt;
        &lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b&lt;span style="font-style:italic"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vericel Agreement:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="text-align:justify;margin-left:74.7pt;line-height:1.25"&gt;
          &lt;div style="margin-left:74.7pt;line-height:1.25;font-family:'Times New Roman', serif;font-size:11pt"&gt;&#160;&lt;/div&gt;
        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;
          &lt;div style="text-align:justify;margin-left:83.7pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On May 6, 2019, the Company entered into exclusive license and supply agreements with Vericel to commercialize &lt;span&gt;Nexobrid&lt;/span&gt; in North America (the &#x201c;Collaboration Agreements&#x201d;). Pursuant to the Collaboration Agreements, Vericel will obtain the authority over and control of the development, regulatory approval and commercialization of licensed products in the North America territory. MediWound will be responsible for the development of the product through BLA approval, supported and funded by BARDA, as well as the manufacture and supply of &lt;span&gt;Nexobrid&lt;/span&gt;. In addition, MediWound retains the commercial rights to &lt;span&gt;Nexobrid&lt;/span&gt; in non-North American territory.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:83.7pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Under the terms of the license agreement, Vericel has made an upfront payment to MediWound of $17,500 which was recorded as revenues from license agreements in 2019 as well as an additional milestone payment of $7,500 recorded as revenues from license agreements in 2022 upon BLA approval received in December 2022. Furthermore, Vericel has also agreed to pay MediWound up to $125,000 in payments contingent upon meeting certain annual sales milestones, tiered royalties on net sales ranging from high single-digit to teen-digit percentages, a split of gross profit on committed BARDA procurement orders and a teen-digits royalty on any additional future BARDA purchases of &lt;span&gt;Nexobrid&lt;/span&gt;. Under the terms of the supply agreement, Vericel will procure &lt;span&gt;Nexobrid&lt;/span&gt; from MediWound at a fixed transfer price.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:83.7pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total revenue from royalties as of December 31, 2023 &lt;span&gt;was&lt;/span&gt; approximately $82.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:83.7pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
        &lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;DOD and MTEC contracts:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="text-align:justify;margin-left:74.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;
          &lt;div style="line-height:1.25;font-family:'Times New Roman',serif"&gt;
            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On February 17, 2022, the Company was entered into a contract with the U.S. Department of Defense (DoD), through the Medical Technology Enterprise Consortium (MTEC), to develop Nexobrid as a non-surgical solution for field-care burn treatment for the U.S. Army. The contract provides funding up to $2,727.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;
          &lt;div style="line-height:1.25;font-family:'Times New Roman',serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During 2023, the DOD through MTEC awarded the Company additional funding of $9,117 in addition, the company awarded directly through MTEC funding of $1,190, to advance the development of a new temperature stable formulation of Nexobrid. The total additional fund from the DOD and MTEC during 2023 was $10,307.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Biopharmax Group Ltd. contract:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:90pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On July 17, 2023 the&lt;span style="font-weight:bold"&gt;&#160;&lt;/span&gt;company signed a turnkey scale-up agreement with Biopharmax Group Ltd. This strategic agreement is designed to bolster our manufacturing infrastructure to support our long-term growth trajectory. The objective of this agreement is to establish, commission, and validate a cutting-edge, sterile, and GMP-compliant manufacturing facility. The venture aims to increase the company&#x2019;s production capacity significantly, to expand up to six times the current capacity.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:90pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:90pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The new facility, equipped with fully operational clean rooms, will be exclusively designed for &lt;span&gt;Nexobrid&lt;/span&gt; production. It will comply with stringent regulations from the GMP, FDA, EMA, Israeli Ministry of Health, and relevant Israeli regulatory bodies. An estimated $12.7 million will be invested in the project, set for &lt;span&gt;constructions &lt;/span&gt;completion by mid-2024, with full-scale manufacturing expected to commence in 2025 (see also note 10).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;/div&gt;
    </mdwd:DisclosureOfMaterialAgreementsExplanatory>
    <ifrs-full:TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions
      contextRef="C_20220101to20221231_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember"
      decimals="-3"
      id="Fxbrl_20220310110347319"
      unitRef="USD">165000000</ifrs-full:TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions>
    <mdwd:ProceedsFromAdditionalFunding
      contextRef="C_20230508to20230509_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember"
      decimals="-3"
      id="Fxbrl_20220310125150154"
      unitRef="USD">10000000</mdwd:ProceedsFromAdditionalFunding>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="C_20230508to20230509_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember"
      decimals="-3"
      id="Fxbrl_20220310130047637"
      unitRef="USD">110000000</ifrs-full:ResearchAndDevelopmentExpense>
    <mdwd:ProceedsFromProcurement
      contextRef="C_20230508to20230509_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdNexoBridMember_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember_srtRangeAxis_srtMaximumMember"
      decimals="-3"
      id="Fxbrl_20220310125620778"
      unitRef="USD">65000000</mdwd:ProceedsFromProcurement>
    <mdwd:AccumulatedFunding
      contextRef="C_20230101to20231231_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember"
      decimals="-3"
      id="Fxbrl_20220310130314690"
      unitRef="USD">88282000</mdwd:AccumulatedFunding>
    <mdwd:ProceedsFromProcurement
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdNexoBridMember_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember"
      decimals="-3"
      id="Fxbrl_20220310130923083"
      unitRef="USD">16500000</mdwd:ProceedsFromProcurement>
    <ifrs-full:Revenue
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdNexoBridMember_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember"
      decimals="-3"
      id="Fxbrl_20220310130949922"
      unitRef="USD">10500000</ifrs-full:Revenue>
    <mdwd:ProceedsFromFunding
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdNexoBridMember_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember_srtRangeAxis_srtMaximumMember"
      decimals="-3"
      id="Fxbrl_20220310124811281"
      unitRef="USD">12000000</mdwd:ProceedsFromFunding>
    <mdwd:ProceedsFromAdditionalFunding
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdNexoBridMember_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember"
      decimals="-3"
      id="Fxbrl_20220310124823616"
      unitRef="USD">29000000</mdwd:ProceedsFromAdditionalFunding>
    <mdwd:AmountOfSecondContractExpired
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdNexoBridMember_mdwdAgreementAxis_mdwdBiomedicalAdvancedResearchAndDevelopmentAuthorityMember"
      decimals="-3"
      id="Fxbrl_20240317171927554"
      unitRef="USD">4368000</mdwd:AmountOfSecondContractExpired>
    <mdwd:UpfrontPayment
      contextRef="C_20190501to20190506_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdLicenseAgreementWithVericelMember"
      decimals="-3"
      id="Fxbrl_20220310131158066"
      unitRef="USD">17500000</mdwd:UpfrontPayment>
    <mdwd:AdditionalUpfrontPayment
      contextRef="C_20190501to20190506_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdLicenseAgreementWithVericelMember"
      decimals="-3"
      id="Fxbrl_20220310131209150"
      unitRef="USD">7500000</mdwd:AdditionalUpfrontPayment>
    <mdwd:AdditionalUpfrontPayment
      contextRef="C_20190501to20190506_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdLicenseAgreementWithVericelMember_srtRangeAxis_srtMaximumMember"
      decimals="-3"
      id="Fxbrl_20220310131235149"
      unitRef="USD">125000000</mdwd:AdditionalUpfrontPayment>
    <ifrs-full:Revenue
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdLicenseAgreementWithVericelMember"
      decimals="-3"
      id="Fxbrl_20240317171749249"
      unitRef="USD">82000</ifrs-full:Revenue>
    <mdwd:ProceedsFromFunding
      contextRef="C_20220201to20220217_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdUsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember"
      decimals="-3"
      id="Fxbrl_20240317174017762"
      unitRef="USD">2727000</mdwd:ProceedsFromFunding>
    <mdwd:ProceedsFromAdditionalFunding
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdUsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember"
      decimals="-3"
      id="Fxbrl_20240317174021385"
      unitRef="USD">9117000</mdwd:ProceedsFromAdditionalFunding>
    <mdwd:ProceedsFromAdditionalProcurement
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdUsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember"
      decimals="-3"
      id="Fxbrl_20240317174024689"
      unitRef="USD">1190000</mdwd:ProceedsFromAdditionalProcurement>
    <mdwd:AccumulatedFunding
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdUsDepartmentOfDefenseMedicalTechnologyEnterpriseConsortiumContractMember"
      decimals="-3"
      id="Fxbrl_20240317174027863"
      unitRef="USD">10307000</mdwd:AccumulatedFunding>
    <mdwd:AmountOfInvestedInProject
      contextRef="C_20230701to20230717_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdTurnkeyScaleUpAgreementWithBiopharmaxGroupMember"
      decimals="-5"
      id="Fxbrl_20240317174013877"
      unitRef="USD">12700000</mdwd:AmountOfInvestedInProject>
    <ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211007144020202">
    &lt;div&gt;
      &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

          &lt;tr&gt;
            &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Note 19:&lt;/span&gt;&lt;/td&gt;
            &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
              &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&lt;span&gt;Equity&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;
      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
    &lt;/div&gt;

      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;a.&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:'Times New Roman', Times, serif"&gt;Share capital:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
          &lt;div style="margin-left:85.05pt"&gt;
            &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:90%"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Authorized number of shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double black;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double black;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;20,000,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double black;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double black;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;12,857,143&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Issued and outstanding number of shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;9,221,764&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;7,240,020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;

    &lt;div style="line-height:1.25;clear:both"&gt;
      &lt;p style="margin-left:56.7pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
      &lt;div&gt;
        &lt;div style="margin-left:85.05pt;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;An ordinary share confers upon its holder(s) a right to vote at the general meeting, a right to participate in distribution of dividends, and a right to participate in the distribution of surplus assets upon liquidation of the Company.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="margin-left:85.05pt;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&#160;&lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
    &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

        &lt;tr&gt;
          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;b.&lt;/span&gt;&lt;/td&gt;
          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Movement in share capital:&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
          &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&#160;&lt;/td&gt;
          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;

    &lt;/table&gt;
    &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)"&gt;

        &lt;tr&gt;
          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
          &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;During 2021, 2022 and 2023 the Company issued additional 4,852, 41,395 and 17,458 ordinary shares for each year upon vesting of outstanding RSU&#x2019;s, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;

    &lt;/table&gt;
    &lt;div&gt;
      &lt;div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On November 28, 2022, at the Company&#x2019;s extraordinary general meeting of shareholders, its shareholders approved:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:103.05pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:20.4pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(a)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;An increase&#160;of the Company&#x2019;s authorized share capital from NIS 500,000, consisting of 50,000,000 ordinary shares, per value NIS 0.01 per share to NIS 900,000 consisting of 90,000,000 ordinary shares, per value NIS 0.01 per share.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:103.05pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:top;width:20.4pt"&gt;
                  &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(b)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                  &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On December 5, 2022, the Company&#x2019;s board of directors approved a reverse split of 1-for-7 ratio. The reverse split went effective on December 20, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:121.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No fractional shares were issued as a result of the reverse share split. Instead, such shares were rounded up to the next whole number of shares. The reverse share split affected all shareholders uniformly and did not alter any person&#x2019;s percentage interest in our outstanding ordinary shares, except for negligible adjustments that may have resulted from the treatment of fractional shares.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:121.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In connection with the reverse share split, The Company also amended and reduced the authorized number of ordinary shares from 90,000,000 to 12,857,143, which reflected a reduction at the same 1-for-7 ratio as the reduction to the number of issued and outstanding ordinary shares.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:121.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Concurrently, the par value of the Company&#x2019;s ordinary shares was increased proportionately, from NIS 0.01 per share to NIS 0.07 per share, in order to maintain the same overall authorized share capital under our Amended and Restated Articles of Association.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:121.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On May 31, 2023 the Shareholders of the Company approved an amendment to Article 6 of the Company&#x2019;s Amended and Restated Articles of Association, which increased the Company&#x2019;s authorized share capital from 900,000 NIS consisting of 12,857,143 ordinary shares par value NIS 0.07 to NIS 1,400,000, consisting of 20,000,000 ordinary shares, par value NIS 0.07 per share.&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&#160;&lt;/div&gt;
        &lt;div&gt;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial transactions:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 7, 2022, the Company completed a public offering in total of 744,048 new ordinary shares which were issued in consideration to offering price of $13.44 per share. The net proceeds were $8,653, after deducting commissions and other offering expenses. In addition, on March 22, 2022 the underwriters exercised their options to purchase an additional 89,012 ordinary shares at the same public offering price. The net consideration to the Company, less underwriting discounts and commissions was at additional of $1,021.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As part of the above- mentioned public offering, certain entities affiliated with CBI purchased 208,334 of ordinary shares at the public offering price.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On September 26, 2022, the Company completed a registered direct (the &#x201c;RD&#x201d;) offering in an aggregate amount of $13,257 represent a combine purchase price of $12.25 for issuance of 1,082,223 ordinary shares and 1,082,223 warrants that become exercisable on November 28, 2022, at an exercise price of $13.475 per ordinary share which will expire in four years (see also note 25.3).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The warrants issued have been classified as a non-current financial liability due to a net share settlement provision and as they can be settled in cash on the occurrence of Fundamental Transaction as determined in the agreement. This liability was initially recognized at its fair value on the date the contract was entered into and is subsequently accounted for fair value at each balance sheet date and recorded through profit and loss.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of the warrants has been evaluated with the assistance of external independent valuator and was computed based on then current price of the shares, a risk-free interest rate of 4.37% and an average standard deviation of 68%.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The net proceeds from this offering in the amount of $11,698 have been received on September 28, 2022. The issuance expenses related to the non-current financial liability were recorded through profit and loss and the issuance expenses related to the issuance of shares recorded as a deduction from the proceeds in equity.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Concurrently, on October 6, 2022, the Company entered into a Private Issuance Purchase Equity agreement (the &#x201c;PIPE&#x201d;) with several purchasers, in connection with the offering of 1,407,583 unregistered pre-funded warrants to purchase up to 1,407,583 ordinary shares and 1,407,583 warrants to purchase up to 1,407,583 ordinary shares. Pre-Funded warrants become exercisable on November 28, 2022, at an exercise price of $0.007 per ordinary share and the warrants would be also exercisable upon the Authorized Share Increase Date at an exercise price of $13.475 per ordinary share and expire in four years.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Pre-Funded warrants and warrants issued have been classified as a non-current financial liabilities due to a net share settlement provision and they can be redeemed in cash on the occurrence of Fundamental Transaction as determined in the agreement. The initial fair value of the financial liabilities issued in the transaction was approximately $20,788, which comprised of: 1. The warrants which were valuated by Black and Sholtes model based on the current price of the shares and a risk-free interest rate of 4.26%, and 2. The pre-funded warrants which were valued in an amount which is approximate its share price upon their issuance.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div&gt;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The consideration received from this transaction was $17,233. As the fair value on initial recognition of the warrants differs from the transaction price, the difference, represents the First day loss at the amount of $3,555, and has been allocated to the warrants with respect to this transaction and is amortized on a straight line basis over the term of the warrants.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The net proceeds from this offering amounted to approximately $15,920. The issuance expenses were recorded through profit and loss.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During December 2022, the 1,407,583 pre-funded warrants were exercised into ordinary shares.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Upon closing of the RD and PIPE Offerings, the Company also issued the placement agent up to 124,491 warrants to purchase up to 124,491 ordinary Shares. The warrants have substantially the same terms as the RD and PIPE Warrants, except that the placement agent&#x2019;s warrants have an exercise price equal to $15.312 per share (which represents 125% of the offering price per ordinary Share in the offerings). The Fair value of the placement agent&#x2019;s options was recorded as an issuance expenses through profit and loss and as a deduction from proceed in equity based on the financial treatment of both RD and PIPE offering and in accordance with&#160;their part.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On February 7, 2023, the Company completed a registered direct (the &#x201c;RD&#x201d;) offering of 1,964,286 new ordinary shares which were issued in consideration to offering price of $14.0 per share. The gross proceeds were $27,500, before deducting commissions and other offering expenses in the amount of $2,031.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory>
    <ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20220217161603641">
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;a.&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-family:'Times New Roman', Times, serif"&gt;Share capital:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
          &lt;div style="margin-left:85.05pt"&gt;
            &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:90%"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Authorized number of shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double black;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double black;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;20,000,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double black;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double black;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;12,857,143&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Issued and outstanding number of shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;9,221,764&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;7,240,020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(255, 255, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="C_20231231"
      decimals="INF"
      id="Fxbrl_20211007143749334"
      unitRef="Share">20000000</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20211007143809954"
      unitRef="Share">12857143</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20231231"
      decimals="INF"
      id="Fxbrl_20211007143935452_xbrl_20211007143749334"
      unitRef="Share">9221764</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20211007143935452_xbrl_20211007143809954"
      unitRef="Share">7240020</ifrs-full:NumberOfSharesIssued>
    <mdwd:AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="Fxbrl_20240317131214562"
      unitRef="Share">4852</mdwd:AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits>
    <mdwd:AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="Fxbrl_20240317131221971"
      unitRef="Share">41395</mdwd:AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits>
    <mdwd:AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20240317131229794"
      unitRef="Share">17458</mdwd:AdditionalOrdinarySharesIssuedUponVestingOfOutstandingRestrictedStockUnits>
    <mdwd:AuthorizedShareCapital
      contextRef="C_20221127"
      decimals="0"
      id="Fxbrl_20240317133531639"
      unitRef="USD">500000</mdwd:AuthorizedShareCapital>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="C_20221127"
      decimals="INF"
      id="Fxbrl_20240317133550680"
      unitRef="Share">50000000</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:ParValuePerShare
      contextRef="C_20221128"
      decimals="2"
      id="Fxbrl_20240317133740342"
      unitRef="NIS_per_share">0.01</ifrs-full:ParValuePerShare>
    <mdwd:AuthorizedShareCapital
      contextRef="C_20221128"
      decimals="0"
      id="Fxbrl_20240317133805968"
      unitRef="USD">900000</mdwd:AuthorizedShareCapital>
    <mdwd:IncreaseInSharesIssued
      contextRef="C_20221128"
      decimals="INF"
      id="Fxbrl_20240317133812919"
      unitRef="Share">90000000</mdwd:IncreaseInSharesIssued>
    <ifrs-full:ParValuePerShare
      contextRef="C_20221128"
      decimals="2"
      id="Fxbrl_20240317133825272"
      unitRef="NIS_per_share">0.01</ifrs-full:ParValuePerShare>
    <mdwd:ReverseStockSplit
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317133941138">1-for-7 ratio</mdwd:ReverseStockSplit>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="C_20221205"
      decimals="INF"
      id="Fxbrl_20240317134110863"
      unitRef="Share">90000000</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20240317134043504"
      unitRef="Share">12857143</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:ParValuePerShare
      contextRef="C_20221205"
      decimals="2"
      id="Fxbrl_20240317134231526"
      unitRef="NIS_per_share">0.01</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="C_20231231"
      decimals="2"
      id="Fxbrl_20240317134258134"
      unitRef="NIS_per_share">0.07</ifrs-full:ParValuePerShare>
    <mdwd:IncreaseInAuthorizedShareCapital
      contextRef="C_20230531"
      decimals="INF"
      id="Fxbrl_20240317134411624"
      unitRef="Share">900000</mdwd:IncreaseInAuthorizedShareCapital>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20240317134444392"
      unitRef="Share">12857143</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:ParValuePerShare
      contextRef="C_20230531"
      decimals="2"
      id="Fxbrl_20240317134453088"
      unitRef="NIS_per_share">0.07</ifrs-full:ParValuePerShare>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="C_20230531"
      decimals="INF"
      id="Fxbrl_20240317134517207"
      unitRef="Share">1400000</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="C_20231231"
      decimals="INF"
      id="Fxbrl_20240317134528487"
      unitRef="Share">20000000</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:ParValuePerShare
      contextRef="C_20230531"
      decimals="2"
      id="Fxbrl_20240317134503695"
      unitRef="NIS_per_share">0.07</ifrs-full:ParValuePerShare>
    <ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding
      contextRef="C_20220307to20220307"
      decimals="INF"
      id="Fxbrl_20240317134823880"
      unitRef="Share">744048</ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding>
    <mdwd:PricePerShareOfSharesIssued
      contextRef="C_20220307to20220307"
      decimals="2"
      id="Fxbrl_20240317134957166"
      unitRef="NIS_per_share">13.44</mdwd:PricePerShareOfSharesIssued>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="C_20220307to20220307"
      decimals="-3"
      id="Fxbrl_20240317135139702"
      unitRef="USD">8653000</ifrs-full:ProceedsFromIssuingShares>
    <mdwd:ExercisedOptionsToPurchaseAdditionalOrdinaryShares
      contextRef="C_20220307to20220307"
      decimals="INF"
      id="Fxbrl_20240317135231295"
      unitRef="Share">89012</mdwd:ExercisedOptionsToPurchaseAdditionalOrdinaryShares>
    <mdwd:AmountOfUnderwritingDiscountsAndCommissions
      contextRef="C_20220307to20220307"
      decimals="-3"
      id="Fxbrl_20240317135325800"
      unitRef="USD">1021000</mdwd:AmountOfUnderwritingDiscountsAndCommissions>
    <ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding
      contextRef="C_20220307to20220307_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdCertainEntitiesAffiliatedWithCbiMember"
      decimals="INF"
      id="Fxbrl_20240317135350079"
      unitRef="Share">208334</ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding>
    <mdwd:AggregateAmountOfRegisteredDirectOffering
      contextRef="C_20220926to20220926"
      decimals="-3"
      id="Fxbrl_20240317135427583"
      unitRef="USD">13257000</mdwd:AggregateAmountOfRegisteredDirectOffering>
    <mdwd:PurchasePriceOfRegisteredDirectOffering
      contextRef="C_20220926"
      decimals="2"
      id="Fxbrl_20240317135454946"
      unitRef="NIS_per_share">12.25</mdwd:PurchasePriceOfRegisteredDirectOffering>
    <ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding
      contextRef="C_20220926to20220926"
      decimals="INF"
      id="Fxbrl_20240317135519462"
      unitRef="Share">1082223</ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding>
    <mdwd:NumberOfWarrantsIssued
      contextRef="C_20220926to20220926"
      decimals="INF"
      id="Fxbrl_20240317135530982"
      unitRef="Share">1082223</mdwd:NumberOfWarrantsIssued>
    <mdwd:ExercisePriceOfWarrants
      contextRef="C_20220926"
      decimals="3"
      id="Fxbrl_20240317135800439"
      unitRef="NIS_per_share">13.475</mdwd:ExercisePriceOfWarrants>
    <mdwd:WarrantsExpirationPeriod
      contextRef="C_20220926to20220926"
      id="Fxbrl_20240317135857510">P4Y</mdwd:WarrantsExpirationPeriod>
    <mdwd:RiskFreeInterestRateOfWarrants
      contextRef="C_20230101to20231231"
      decimals="4"
      id="Fxbrl_20240317140130918"
      unitRef="Percent">0.0437</mdwd:RiskFreeInterestRateOfWarrants>
    <mdwd:AverageStandardDeviationOfWarrants
      contextRef="C_20230101to20231231"
      decimals="2"
      id="Fxbrl_20240317140148870"
      unitRef="Percent">0.68</mdwd:AverageStandardDeviationOfWarrants>
    <mdwd:NetProceedsFromOfferingAmount
      contextRef="C_20220901to20220928"
      decimals="-3"
      id="Fxbrl_20240317140246366"
      unitRef="USD">11698000</mdwd:NetProceedsFromOfferingAmount>
    <mdwd:UnregisteredPreFundedWarrantsIssued
      contextRef="C_20221006to20221006_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember"
      decimals="INF"
      id="Fxbrl_20240317140404038"
      unitRef="Share">1407583</mdwd:UnregisteredPreFundedWarrantsIssued>
    <mdwd:UnregisteredPreFundedWarrantsToPurchaseCommonStock
      contextRef="C_20221006to20221006_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember"
      decimals="INF"
      id="Fxbrl_20240317140559742"
      unitRef="Share">1407583</mdwd:UnregisteredPreFundedWarrantsToPurchaseCommonStock>
    <mdwd:NumberOfWarrantsIssued
      contextRef="C_20221006to20221006_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember"
      decimals="INF"
      id="Fxbrl_20240317140641309"
      unitRef="Share">1407583</mdwd:NumberOfWarrantsIssued>
    <mdwd:WarrantsToPurchaseOrdinaryShares
      contextRef="C_20221006to20221006_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember"
      decimals="INF"
      id="Fxbrl_20240317140722830"
      unitRef="Share">1407583</mdwd:WarrantsToPurchaseOrdinaryShares>
    <mdwd:IncreaseInPreFundedWarrantsExercisePrice
      contextRef="C_20221006_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember"
      decimals="3"
      id="Fxbrl_20240317140748878"
      unitRef="NIS_per_share">0.007</mdwd:IncreaseInPreFundedWarrantsExercisePrice>
    <mdwd:ExercisePriceOfWarrants
      contextRef="C_20221006_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember"
      decimals="7"
      id="Fxbrl_20240317140849604"
      unitRef="NIS_per_share">0.0013475</mdwd:ExercisePriceOfWarrants>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="C_20231231_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember"
      decimals="-3"
      id="Fxbrl_20240317140948901"
      unitRef="USD">20788000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <mdwd:RiskFreeInterestRateOfWarrants
      contextRef="C_20230101to20231231_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember"
      decimals="4"
      id="Fxbrl_20240317141053221"
      unitRef="Percent">0.0426</mdwd:RiskFreeInterestRateOfWarrants>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="C_20230101to20231231_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember"
      decimals="-3"
      id="Fxbrl_20240317141149118"
      unitRef="USD">17233000</ifrs-full:ProceedsFromExerciseOfWarrants>
    <mdwd:LossFromWarrantsTransactions
      contextRef="C_20231231_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember"
      decimals="-3"
      id="Fxbrl_20240317141356412"
      unitRef="USD">3555000</mdwd:LossFromWarrantsTransactions>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="C_20230101to20231231_mdwdAgreementAxis_mdwdPrivateIssuancePurchaseEquityAgreementMember"
      decimals="-3"
      id="Fxbrl_20240317141452589"
      unitRef="USD">15920000</ifrs-full:ProceedsFromIssuingShares>
    <mdwd:UnregisteredPreFundedWarrantsIssued
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20240317141600836"
      unitRef="Share">1407583</mdwd:UnregisteredPreFundedWarrantsIssued>
    <mdwd:NumberOfWarrantsIssued
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20240317141701724"
      unitRef="Share">124491</mdwd:NumberOfWarrantsIssued>
    <mdwd:WarrantsToPurchaseOrdinaryShares
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20240317141734276"
      unitRef="Share">124491</mdwd:WarrantsToPurchaseOrdinaryShares>
    <mdwd:ExercisePriceOfWarrants
      contextRef="C_20231231"
      decimals="7"
      id="Fxbrl_20240317141817859"
      unitRef="NIS_per_share">0.0015312</mdwd:ExercisePriceOfWarrants>
    <ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding
      contextRef="C_20230207to20230207"
      decimals="INF"
      id="Fxbrl_20240317141940876"
      unitRef="Share">1964286</ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding>
    <mdwd:PricePerShareOfSharesIssued
      contextRef="C_20230207to20230207"
      decimals="5"
      id="Fxbrl_20240317142117396"
      unitRef="NIS_per_share">0.0014</mdwd:PricePerShareOfSharesIssued>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="C_20230207to20230207"
      decimals="-3"
      id="Fxbrl_20240317142159492"
      unitRef="USD">27500000</ifrs-full:ProceedsFromIssuingShares>
    <mdwd:CommissionsAndOtherOfferingExpenses
      contextRef="C_20230207to20230207"
      decimals="-3"
      id="Fxbrl_20240317143051211"
      unitRef="USD">2031000</mdwd:CommissionsAndOtherOfferingExpenses>
    <ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20220217192613468">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note 20:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share&#x2011;Based Compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:28.35pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expense recognized in the financial statements:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The expenses recognized for services received from employees and directors is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;

            &lt;div style="margin-left:85.05pt"&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost of revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;271&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;184&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;153&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;485&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;406&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;333&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Selling and marketing&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;87&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;General and administrative&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,097&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,314&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,187&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,940&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,946&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,673&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;

        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;
          &lt;div&gt;&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
    &lt;div&gt;
      &lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based payment plan for employees and directors:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has granted options and restricted stock units ("RSUs") for a total of 990,201 ordinary shares.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, 861,255 ordinary shares of the Company were still available for a future grant.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Any options or RSUs, which are forfeited or not exercised before expiration, become available for future grants.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options granted under the Company's 2003 Israeli Share Option Plan ("The Plan") are exercisable in accordance with the terms of the Plan, within 5-10 years from the date of grant, against payment of an exercise price or cashless exercise. The options generally vest over a period of 3-4 years.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In March 2014, the Company adopted and obtained shareholder approval for its 2014 Equity Incentive Plan (the &#x201c;2014 Plan&#x201d;). Options and RSU's granted under the Company's 2014 Plan are exercisable in accordance with the terms of the Plan. Options are exercisable within 5-10 years from the date of grant, against payment of an exercise price or cashless exercise and share units are granted immediately upon vesting of the RSU's. The options and the RSU's generally vest over a period of 1-4 years.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share options activity:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table lists the number of share options, the weighted average exercise prices of share options and changes that were made in the option plan to employees and directors&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
    &lt;div&gt;

        &lt;div style="margin-left:85.05pt"&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding Options at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;764,767&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;537,288&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;44.45&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;513,973&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;45.85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options Granted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;346,950&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11.87&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;320,775&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14.25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;53,970&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37.52&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options Exercised&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(807&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(536&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20.16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options Forfeited and/or expired&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(154,230&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;57.55&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(92,489&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;55.58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(30,119&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56.91&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding options at end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;957,487&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19.34&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;764,767&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;537,288&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;44.45&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Option's Exercisable at end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;462,045&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;373,681&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46.18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;333,618&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;58.38&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;

      &lt;div style="line-height:1.25;clear:both"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;line-height:1.25"&gt;
        &lt;div&gt;&lt;/div&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-left:56.7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table summarizes information about share options outstanding:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/p&gt;
      &lt;/div&gt;

        &lt;div style="margin-left:56.7pt"&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options outstanding as of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Range of exercise prices ($ )&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Remaining&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;contractual&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;life&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average exercise&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8.26-9.64&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;55,950&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11.89-14.42&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;711,124&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.89&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.88-37.52&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;125,535&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.62&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;35.99&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42.14-67.06&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;64,878&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;63.84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;957,487&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.29&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19.34&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options outstanding as of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Range of exercise prices ($ )&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Remaining&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;contractual&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;life&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average exercise&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.25-14.42&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;470,693&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.60&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.88-37.52&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;145,354&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.43&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;35.95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42.14-67.06&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;68,662&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;63.94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;90.23-96.32&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80,058&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.91&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;90.65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;764,767&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;

      &lt;div style="line-height:1.25;clear:both"&gt;
        &lt;p style="margin:0pt 0pt 0pt 56.7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160; &#160; &#160; &#160;&lt;br/&gt;The following table summarizes information about RSU's outstanding:&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&#160;&lt;/p&gt;
      &lt;/div&gt;

        &lt;div style="margin-left:56.7pt"&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;RSU's&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;RSU's&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;RSU's&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42,013&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,581&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,655&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,286&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,992&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(941&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(215&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vested&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(17,458&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11,827&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,851&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;) &lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at the end of the period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;32,714&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42,013&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,581&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;

      &lt;div style="line-height:1.25;clear:both"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;text-indent:0pt;ine-height:1.25"&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of the options and RSU's granted to employees and directors at the grant date for the years ended December 31, 2023, 2022 and 2021 was $2,320, $2,970 and $1,392 respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The options and RSU&#x2019;s of the Company are managed by a trustee.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
              &lt;div&gt;&lt;/div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 4, 2021, the Company's Board of Directors approved the grant of: (a) 34,013 options to purchase ordinary shares and 5,669 RSU's under the "2014 Share Incentive Plan" to its CEO, officers and board members of the Company at a fair value of $663 and $196, respectively, and (b) 19,958 options to purchase ordinary shares and 3,324 RSU's under the "2014 Share Incentive Plan" to its employees at a fair value of $417 and $116, respectively. The options are exercisable for an exercise price of $ 37.52 per share.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Over the second quarter of 2022, the Company&#x2019;s Board of Directors approved the grant of 292,203 options to purchase the Company&#x2019;s ordinary shares, for an exercise price of $ 14.42 per share as well as 39,286 restricted share units (&#x201c;RSU&#x2019;s&#x201d;) to its CEO, officers and employees. The fair value of the options and RSU&#x2019;s as of the grant date, was estimated at $2,314 and $498 respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div&gt;&#160;&lt;/div&gt;
                          &lt;div&gt;
                            &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The above-mentioned grant includes the grant of 151,786 options to purchase the Company&#x2019;s ordinary shares and 39,286 restricted share units (&#x201c;RSU&#x2019;s&#x201d;) to the directors and the CEO of the Company which are required to be approved by the Company&#x2019;s General meeting as well. The fair value of the options and RSU&#x2019;s, as of the approval date, was estimated at approximately $1,171 and $498, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="text-align:justify;text-indent:-0.55pt;margin-left:36pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On July 19, 2022, the Company&#x2019;s Shareholders General meeting approved the abovementioned grants (Note 19) to the directors and the CEO, the compensation terms of Mr. Ofer Gonen as the Company&#x2019;s new Chief Executive Officer, which terms will be effective as of July 1, 2022 and the termination terms for the previous CEO.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On August 18, 2022, the Company&#x2019;s Shareholders General meeting approved the compensation terms and grant of 28,572 options to the Chairman of the Board of Directors which approved earlier by the board. The fair value of the options as of the grant date&#160;was estimated at $284.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On February 15, 2023, the Company's Board of Directors approved the grant of 130,600 options to purchase ordinary shares and 9,100 RSU's under the "2014 Share Incentive Plan" to&lt;span style="font-weight:bold"&gt;&#160;&lt;/span&gt;employees, officers, board members, CEO and some consultants at fair value of $1,012 and $117, respectively. The share options vest over a period of 1-4 years and the options are exercisable for an exercise price of $ 13.32 per share.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On April 3, 2023, the Company's Board of Directors approved the grant of 160,400 options to purchase ordinary shares under the "2014 Share Incentive Plan", for an exercise price of $11.89 and $11.91 per share to management and board members of the Company. The share options vest over a period of 1-4 years. The fair value of the options granted, as of the grant date, was estimated at approximately $884.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On May 31, 2023 the Shareholders of the Company approved the increase by 1,000,000 in the number of ordinary shares available for issuance under the Company&#x2019;s 2014 Equity Incentive Plan.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:100%"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On May 31, 2023 the Shareholders of the Company approved the extension to the exercise period of options which were granted to certain of the company&#x2019;s directors on April 23, 2020 for an additional five years, until April 23, 2030. According to this extension, an expense of $146 was recognized.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
    &lt;div&gt;
      &lt;div style="line-height:1.25"&gt;
        &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
        &lt;div&gt;&lt;/div&gt;
      &lt;/div&gt;
      &lt;div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;
        &lt;div style="text-align:left"&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;9.&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;On August 15, 2023, the Company's Board of Directors approved the grant of 7,200 options to purchase ordinary shares under the "2014 Share Incentive Plan", for an exercise price of $ 9.63 per share to a board member of the Company. The share options vest over a 1 year. &#160;The fair value of the options granted, as of the grant date, was estimated at approximately $42.&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;width:100%;border:0px"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;10.&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;On November 20, 2023, the Company's Board of Directors approved the grant of 48,750 options to purchase ordinary shares under the "2014 Share Incentive Plan", for an exercise price of $ 8.78 and $8.13 per share to an officer and a consultant of the Company. The share options vest over a period of 1-4 years. &#160;The fair value of the options granted, as of the grant date, was estimated at approximately $265.&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
          &lt;div style="text-align:justify;text-indent:0pt;line-height:1.25"&gt;&#160;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

                &lt;tr&gt;
                  &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:25pt;vertical-align:top"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;a.&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;The&#160;fair value of the Company's share options granted to employees and directors for the years ended December 31, 2023, 2022 and 2021 was estimated using the binomial option pricing models using the following assumptions:&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;

        &lt;div style="margin-left:108pt"&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dividend yield (%)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected volatility of the share prices (%)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61-77&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59-77&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;55-78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Risk&#x2011;free interest rate (%)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.1-5.36&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.1-5.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.1-1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Early exercise factor (%)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100-150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100-150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100-150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average share prices (Dollar)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10.71&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;36.33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;

      &lt;div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/div&gt;
      &lt;div&gt;
        &lt;div style="text-align:justify;margin-left:103.5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Measurement inputs include the share price on the measurement date, the exercise price of the instrument, expected volatility (based on the weighted average volatility of the Company&#x2019;s shares, over the expected term of the options), expected term of the options (based on general option holder behavior and expected share price), expected dividends, and the risk-free interest rate (based on government debentures).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory>
    <ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211011115035258">
            &lt;div style="margin-left:85.05pt"&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost of revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;271&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;184&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;153&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;485&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;406&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;333&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Selling and marketing&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;87&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;General and administrative&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,097&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,314&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,187&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,940&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,946&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,673&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20230101to20231231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdCostOfRevenuesMember"
      decimals="-3"
      id="Fxbrl_20211011105152384_23"
      unitRef="USD">271000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20220101to20221231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdCostOfRevenuesMember"
      decimals="-3"
      id="Fxbrl_20211011105152384_27"
      unitRef="USD">184000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdCostOfRevenuesMember"
      decimals="-3"
      id="Fxbrl_20211011105152384_211"
      unitRef="USD">153000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20230101to20231231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fxbrl_20211011105152384_33"
      unitRef="USD">485000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20220101to20221231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fxbrl_20211011105152384_37"
      unitRef="USD">406000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdResearchAndDevelopmentExpensesMember"
      decimals="-3"
      id="Fxbrl_20211011105152384_311"
      unitRef="USD">333000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20230101to20231231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdSellingAndMarketingExpensesMember"
      decimals="-3"
      id="Fxbrl_20211011105152384_43"
      unitRef="USD">87000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20220101to20221231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdSellingAndMarketingExpensesMember"
      decimals="-3"
      id="Fxbrl_20211011105152384_47"
      unitRef="USD">42000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdSellingAndMarketingExpensesMember"
      decimals="-3"
      id="Fxbrl_20211011105152384_411"
      unitRef="USD">0</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20230101to20231231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdGeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fxbrl_20211011105152384_53"
      unitRef="USD">1097000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20220101to20221231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdGeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fxbrl_20211011105152384_57"
      unitRef="USD">1314000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdGeneralAndAdministrativeExpensesMember"
      decimals="-3"
      id="Fxbrl_20211011105152384_511"
      unitRef="USD">1187000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211011105152384_73"
      unitRef="USD">1940000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211011105152384_77"
      unitRef="USD">1946000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211011105152384_711"
      unitRef="USD">1673000</ifrs-full:AdjustmentsForSharebasedPayments>
    <mdwd:SharesAvailableForFutureGrant
      contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="INF"
      id="Fxbrl_20211011094456612"
      unitRef="Share">990201</mdwd:SharesAvailableForFutureGrant>
    <mdwd:SharesAvailableForFutureGrant
      contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember"
      decimals="INF"
      id="Fxbrl_20240317200046923"
      unitRef="Share">861255</mdwd:SharesAvailableForFutureGrant>
    <ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdIsraeliShareOptionPlanMember"
      id="Fxbrl_20211011094727033">5-10 years</ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdIsraeliShareOptionPlanMember"
      id="Fxbrl_20211011094734109">3-4 years</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement
      contextRef="C_20140301to20140331_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdEquityIncentivePlanMember"
      id="Fxbrl_20211011094832496">5-10 years</ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement
      contextRef="C_20140301to20140331_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdEquityIncentivePlanMember"
      id="Fxbrl_20211011094936755">1-4 years</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211011115914767">
        &lt;div style="margin-left:85.05pt"&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding Options at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;764,767&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;537,288&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;44.45&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;513,973&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;45.85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options Granted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;346,950&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11.87&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;320,775&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14.25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;53,970&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37.52&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options Exercised&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(807&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(536&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20.16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options Forfeited and/or expired&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(154,230&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;57.55&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(92,489&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;55.58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(30,119&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56.91&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding options at end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;957,487&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19.34&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;764,767&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;537,288&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;44.45&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Option's Exercisable at end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;462,045&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;373,681&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46.18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;333,618&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;58.38&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20221231"
      decimals="0"
      id="Fxbrl_20211011105508273"
      unitRef="shares">764767</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20221231"
      decimals="2"
      id="Fxbrl_20211011105529220"
      unitRef="USD_Per_Share">30.44</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20211231"
      decimals="0"
      id="Fxbrl_20211011110705437"
      unitRef="shares">537288</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20211231"
      decimals="2"
      id="Fxbrl_20211011110724951"
      unitRef="USD_Per_Share">44.45</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20201231"
      decimals="0"
      id="Fxbrl_20220217181223455"
      unitRef="shares">513973</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20201231"
      decimals="2"
      id="Fxbrl_20220217181240273"
      unitRef="USD_Per_Share">45.85</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20230101to20231231"
      decimals="0"
      id="Fxbrl_20211011110136712"
      unitRef="shares">346950</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231"
      decimals="2"
      id="Fxbrl_20211011110213996"
      unitRef="USD_Per_Share">11.87</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20220101to20221231"
      decimals="0"
      id="Fxbrl_20211011110755767"
      unitRef="shares">320775</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20220101to20221231"
      decimals="2"
      id="Fxbrl_20211011110823303"
      unitRef="USD_Per_Share">14.25</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20210101to20211231"
      decimals="0"
      id="Fxbrl_20220217181425941"
      unitRef="shares">53970</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20220217181438704"
      unitRef="USD_Per_Share">37.52</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="C_20230101to20231231"
      decimals="0"
      id="Fxbrl_20211011110330919"
      unitRef="shares">0</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231"
      decimals="0"
      id="Fxbrl_20211011110347304"
      unitRef="USD_Per_Share">0</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="C_20220101to20221231"
      decimals="0"
      id="Fxbrl_20211011110920734"
      unitRef="shares">807</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20220101to20221231"
      decimals="2"
      id="Fxbrl_20211011110932597"
      unitRef="USD_Per_Share">12.23</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="C_20210101to20211231"
      decimals="0"
      id="Fxbrl_20220217181502634"
      unitRef="shares">536</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20220217181508696"
      unitRef="USD_Per_Share">20.16</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="C_20230101to20231231"
      decimals="0"
      id="Fxbrl_20211011110403119"
      unitRef="shares">154230</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231"
      decimals="2"
      id="Fxbrl_20211011110419950"
      unitRef="USD_Per_Share">57.55</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="C_20220101to20221231"
      decimals="0"
      id="Fxbrl_20211011110948329"
      unitRef="shares">92489</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20220101to20221231"
      decimals="2"
      id="Fxbrl_20211011110958094"
      unitRef="USD_Per_Share">55.58</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="C_20210101to20211231"
      decimals="0"
      id="Fxbrl_20220217181808699"
      unitRef="shares">30119</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20220217181814524"
      unitRef="USD_Per_Share">56.91</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20231231"
      decimals="0"
      id="Fxbrl_20211011110528692"
      unitRef="shares">957487</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20231231"
      decimals="2"
      id="Fxbrl_20211011110619313"
      unitRef="USD_Per_Share">19.34</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20221231"
      decimals="0"
      id="Fxbrl_20211011111114585"
      unitRef="shares">764767</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20221231"
      decimals="2"
      id="Fxbrl_20211011111126569"
      unitRef="USD_Per_Share">30.44</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20211231"
      decimals="0"
      id="Fxbrl_20220217181831109"
      unitRef="shares">537288</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20211231"
      decimals="2"
      id="Fxbrl_20220217181842926"
      unitRef="USD_Per_Share">44.45</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="C_20231231"
      decimals="0"
      id="Fxbrl_20211011110601397"
      unitRef="shares">462045</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20231231"
      decimals="2"
      id="Fxbrl_20211011110631755"
      unitRef="USD_Per_Share">26.25</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="C_20221231"
      decimals="0"
      id="Fxbrl_20211011111151531"
      unitRef="shares">373681</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20221231"
      decimals="2"
      id="Fxbrl_20211011111204168"
      unitRef="USD_Per_Share">46.18</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="C_20211231"
      decimals="0"
      id="Fxbrl_20220217181858277"
      unitRef="shares">333618</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20211231"
      decimals="2"
      id="Fxbrl_20220217181919621"
      unitRef="USD_Per_Share">58.38</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211011121843256">
        &lt;div style="margin-left:56.7pt"&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options outstanding as of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Range of exercise prices ($ )&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Remaining&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;contractual&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;life&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average exercise&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8.26-9.64&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;55,950&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11.89-14.42&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;711,124&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.89&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.88-37.52&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;125,535&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.62&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;35.99&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42.14-67.06&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;64,878&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;63.84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;957,487&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.29&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19.34&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options outstanding as of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Range of exercise prices ($ )&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Remaining&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;contractual&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;life&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average exercise&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.25-14.42&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;470,693&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.60&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.88-37.52&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;145,354&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.43&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;35.95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42.14-67.06&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;68,662&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;63.94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;90.23-96.32&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80,058&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.91&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;90.65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;764,767&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesOneMember"
      decimals="0"
      id="Fxbrl_20211011111419230"
      unitRef="shares">55950</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20230101to20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesOneMember"
      id="Fxbrl_20211011111429715">P9Y10M6D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesOneMember"
      decimals="2"
      id="Fxbrl_20211011111506242"
      unitRef="USD_Per_Share">8.44</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesTwoMember"
      decimals="0"
      id="Fxbrl_20211011111744684_xbrl_20211011111419230"
      unitRef="shares">711124</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20230101to20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesTwoMember"
      id="Fxbrl_20211011111744684_xbrl_20211011111429715">P7Y10M20D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesTwoMember"
      decimals="2"
      id="Fxbrl_20211011111744684_xbrl_20211011111506242"
      unitRef="USD_Per_Share">13.2</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesThreeMember"
      decimals="0"
      id="Fxbrl_20211011112233159_xbrl_20211011111744684_xbrl_20211011111419230"
      unitRef="shares">125535</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20230101to20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesThreeMember"
      id="Fxbrl_20211011112233159_xbrl_20211011111744684_xbrl_20211011111429715">P5Y7M13D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesThreeMember"
      decimals="2"
      id="Fxbrl_20211011112233159_xbrl_20211011111744684_xbrl_20211011111506242"
      unitRef="USD_Per_Share">35.99</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesFourMember"
      decimals="0"
      id="Fxbrl_20240317123026800_xbrl_20211011112233159_xbrl_20211011111744684_xbrl_20211011111419230"
      unitRef="shares">64878</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20230101to20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesFourMember"
      id="Fxbrl_20240317123026800_xbrl_20211011112233159_xbrl_20211011111744684_xbrl_20211011111429715">P1Y10M6D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesFourMember"
      decimals="2"
      id="Fxbrl_20240317123026800_xbrl_20211011112233159_xbrl_20211011111744684_xbrl_20211011111506242"
      unitRef="USD_Per_Share">63.84</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20231231"
      decimals="0"
      id="Fxbrl_20211011112241296_xbrl_20211011112233159_xbrl_20211011111744684_xbrl_20211011111419230"
      unitRef="shares">957487</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211011112241296_xbrl_20211011112233159_xbrl_20211011111744684_xbrl_20211011111429715">P7Y3M14D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20231231"
      decimals="2"
      id="Fxbrl_20211011112241296_xbrl_20211011112233159_xbrl_20211011111744684_xbrl_20211011111506242"
      unitRef="USD_Per_Share">19.34</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesFiveMember"
      decimals="0"
      id="Fxbrl_20240317123236828"
      unitRef="shares">470693</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20220101to20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesFiveMember"
      id="Fxbrl_20240317123250871">P7Y10M2D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesFiveMember"
      decimals="2"
      id="Fxbrl_20240317123310070"
      unitRef="USD_Per_Share">13.6</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesSixMember"
      decimals="0"
      id="Fxbrl_20240317123409984_xbrl_20240317123236828"
      unitRef="shares">145354</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20220101to20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesSixMember"
      id="Fxbrl_20240317123409984_xbrl_20240317123250871">P6Y5M4D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesSixMember"
      decimals="2"
      id="Fxbrl_20240317123409984_xbrl_20240317123310070"
      unitRef="USD_Per_Share">35.95</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesServenMember"
      decimals="0"
      id="Fxbrl_20240317123529965_xbrl_20240317123409984_xbrl_20240317123236828"
      unitRef="shares">68662</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20220101to20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesServenMember"
      id="Fxbrl_20240317123529965_xbrl_20240317123409984_xbrl_20240317123250871">P2Y10M6D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesServenMember"
      decimals="2"
      id="Fxbrl_20240317123529965_xbrl_20240317123409984_xbrl_20240317123310070"
      unitRef="USD_Per_Share">63.94</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesEightMember"
      decimals="0"
      id="Fxbrl_20240317123614289_xbrl_20240317123529965_xbrl_20240317123409984_xbrl_20240317123236828"
      unitRef="shares">80058</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20220101to20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesEightMember"
      id="Fxbrl_20240317123614289_xbrl_20240317123529965_xbrl_20240317123409984_xbrl_20240317123250871">P0Y10M28D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_mdwdRangesOfExercisePricesEightMember"
      decimals="2"
      id="Fxbrl_20240317123614289_xbrl_20240317123529965_xbrl_20240317123409984_xbrl_20240317123310070"
      unitRef="USD_Per_Share">90.65</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20221231"
      decimals="0"
      id="Fxbrl_20240317123636436_xbrl_20240317123614289_xbrl_20240317123529965_xbrl_20240317123409984_xbrl_20240317123236828"
      unitRef="shares">764767</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20220101to20221231"
      id="Fxbrl_20240317123636436_xbrl_20240317123614289_xbrl_20240317123529965_xbrl_20240317123409984_xbrl_20240317123250871">P6Y4M24D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20221231"
      decimals="2"
      id="Fxbrl_20240317123636436_xbrl_20240317123614289_xbrl_20240317123529965_xbrl_20240317123409984_xbrl_20240317123310070"
      unitRef="USD_Per_Share">30.44</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      id="Fxbrl_20211011120957799">
        &lt;div style="margin-left:56.7pt"&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:92%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;RSU's&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;RSU's&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;RSU's&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42,013&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,581&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,655&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,286&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,992&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(941&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(215&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vested&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(17,458&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11,827&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,851&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;) &lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at the end of the period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;32,714&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42,013&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,581&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="0"
      id="Fxbrl_20211011112511276"
      unitRef="shares">42013</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20211231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="0"
      id="Fxbrl_20211011112522803"
      unitRef="shares">14581</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20201231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="0"
      id="Fxbrl_20211011112527378"
      unitRef="shares">10655</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="0"
      id="Fxbrl_20211011112831192"
      unitRef="shares">9100</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="0"
      id="Fxbrl_20211011112839195"
      unitRef="shares">39286</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20210101to20211231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="0"
      id="Fxbrl_20211011112849355"
      unitRef="shares">8992</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="0"
      id="Fxbrl_20220217183013448"
      unitRef="shares">941</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="0"
      id="Fxbrl_20211011112922539"
      unitRef="shares">27</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="C_20210101to20211231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="0"
      id="Fxbrl_20211011112944465"
      unitRef="shares">215</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="0"
      id="Fxbrl_20220217183002340"
      unitRef="shares">17458</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="0"
      id="Fxbrl_20211011112955754_xbrl_20211011112922539"
      unitRef="shares">11827</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="C_20210101to20211231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="0"
      id="Fxbrl_20211011112955754_xbrl_20211011112944465"
      unitRef="shares">4851</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="0"
      id="Fxbrl_20211011113019497_xbrl_20211011112511276"
      unitRef="shares">32714</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="0"
      id="Fxbrl_20211011113019497_xbrl_20211011112522803"
      unitRef="shares">42013</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20211231_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="0"
      id="Fxbrl_20211011113019497_xbrl_20211011112527378"
      unitRef="shares">14581</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="C_20211231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember"
      decimals="-3"
      id="Fxbrl_20211011095047643"
      unitRef="USD">2320000</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember"
      decimals="-3"
      id="Fxbrl_20220217183740349"
      unitRef="USD">2970000</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember"
      decimals="-3"
      id="Fxbrl_20211011095123085"
      unitRef="USD">1392000</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"
      decimals="0"
      id="Fxbrl_20240317124829713"
      unitRef="shares">34013</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdRestrictedSharesUnitsMember"
      decimals="0"
      id="Fxbrl_20240317124853844"
      unitRef="shares">5669</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements
      contextRef="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"
      decimals="-3"
      id="Fxbrl_20240317124907927"
      unitRef="USD">663000</ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements>
    <ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements
      contextRef="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdRestrictedSharesUnitsMember"
      decimals="-3"
      id="Fxbrl_20240317124920149"
      unitRef="USD">196000</ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"
      decimals="0"
      id="Fxbrl_20240317124933079"
      unitRef="shares">19958</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdRestrictedSharesUnitsMember"
      decimals="0"
      id="Fxbrl_20240317124947595"
      unitRef="shares">3324</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements
      contextRef="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"
      decimals="-3"
      id="Fxbrl_20240317125008420"
      unitRef="USD">417000</ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements>
    <ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements
      contextRef="C_20210301to20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdRestrictedSharesUnitsMember"
      decimals="-3"
      id="Fxbrl_20240317125023135"
      unitRef="USD">116000</ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20210304_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"
      decimals="2"
      id="Fxbrl_20240317125035071"
      unitRef="USD_Per_Share">37.52</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember"
      decimals="0"
      id="Fxbrl_20240317125531368"
      unitRef="shares">292203</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="2"
      id="Fxbrl_20240317125646839"
      unitRef="USD_Per_Share">14.42</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="0"
      id="Fxbrl_20240317125804502"
      unitRef="shares">39286</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements
      contextRef="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember"
      decimals="-3"
      id="Fxbrl_20240317125911352"
      unitRef="USD">2314000</ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements>
    <ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements
      contextRef="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="-3"
      id="Fxbrl_20240317130002926"
      unitRef="USD">498000</ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsAndCeoMember"
      decimals="0"
      id="Fxbrl_20240317130915295"
      unitRef="shares">151786</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsAndCeoMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="0"
      id="Fxbrl_20240317130954409"
      unitRef="shares">39286</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements
      contextRef="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsAndCeoMember"
      decimals="-3"
      id="Fxbrl_20240317131046659"
      unitRef="USD">1171000</ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements>
    <ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements
      contextRef="C_20220401to20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsAndCeoMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="-3"
      id="Fxbrl_20240317131059309"
      unitRef="USD">498000</ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="C_20220801to20220818_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdChairmanMember"
      decimals="0"
      id="Fxbrl_20240317131214029"
      unitRef="shares">28572</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements
      contextRef="C_20220801to20220818_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdChairmanMember"
      decimals="-3"
      id="Fxbrl_20240317131253160"
      unitRef="USD">284000</ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"
      decimals="0"
      id="Fxbrl_20240317131514299"
      unitRef="shares">130600</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdRestrictedSharesUnitsMember"
      decimals="0"
      id="Fxbrl_20240317131618151"
      unitRef="shares">9100</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements
      contextRef="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"
      decimals="-3"
      id="Fxbrl_20240317131640425"
      unitRef="USD">1012000</ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements>
    <ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements
      contextRef="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdRestrictedSharesUnitsMember"
      decimals="-3"
      id="Fxbrl_20240317131654690"
      unitRef="USD">117000</ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement
      contextRef="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember"
      id="Fxbrl_20240317133303544">1-4 years</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"
      decimals="2"
      id="Fxbrl_20240317133441401"
      unitRef="USD_Per_Share">13.32</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="C_20230401to20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"
      decimals="0"
      id="Fxbrl_20240317133546295"
      unitRef="shares">160400</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"
      decimals="2"
      id="Fxbrl_20240317133636205"
      unitRef="USD_Per_Share">11.89</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember"
      decimals="2"
      id="Fxbrl_20240317134221986"
      unitRef="USD_Per_Share">11.91</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement
      contextRef="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember"
      id="Fxbrl_20240317134634484">1-4 years</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements
      contextRef="C_20230401to20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"
      decimals="-3"
      id="Fxbrl_20240317134713216"
      unitRef="USD">884000</ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="C_20230501to20230531_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"
      decimals="0"
      id="Fxbrl_20240317134958097"
      unitRef="shares">1000000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement
      contextRef="C_20230501to20230531_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember"
      id="Fxbrl_20240317141423510">five years</ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="C_20230501to20230531_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember"
      decimals="-3"
      id="Fxbrl_20240317141906525"
      unitRef="USD">146000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="C_20230801to20230815_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"
      decimals="0"
      id="Fxbrl_20240317142844763"
      unitRef="shares">7200</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20220630_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"
      decimals="2"
      id="Fxbrl_20240317142952667"
      unitRef="NIS_per_share">9.63</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement
      contextRef="C_20230801to20230815_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember"
      id="Fxbrl_20240317143122577">1 year</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements
      contextRef="C_20230801to20230815_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"
      decimals="-3"
      id="Fxbrl_20240317143141795"
      unitRef="USD">42000</ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="C_20231101to20231120_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"
      decimals="0"
      id="Fxbrl_20240317143156343"
      unitRef="shares">48750</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20231120_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"
      decimals="2"
      id="Fxbrl_20240317143227517"
      unitRef="USD_Per_Share">8.78</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20231120_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember"
      decimals="2"
      id="Fxbrl_20240317143303823"
      unitRef="USD_Per_Share">8.13</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement
      contextRef="C_20231101to20231120_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember"
      id="Fxbrl_20240317143336092">1-4 years</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements
      contextRef="C_20231101to20231120_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdDirectorsMember_ifrsfullClassesOfShareCapitalAxis_mdwdShareIncentivePlanMember"
      decimals="-3"
      id="Fxbrl_20240317143342038"
      unitRef="USD">265000</ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements>
    <ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211011122033323">
        &lt;div style="margin-left:108pt"&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dividend yield (%)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected volatility of the share prices (%)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61-77&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59-77&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;55-78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Risk&#x2011;free interest rate (%)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.1-5.36&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.1-5.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.1-1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Early exercise factor (%)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100-150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100-150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100-150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average share prices (Dollar)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10.71&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;36.33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="C_20230101to20231231"
      decimals="2"
      id="Fxbrl_20211011113359686"
      unitRef="Percent">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="C_20220101to20221231"
      decimals="2"
      id="Fxbrl_20211011113422532"
      unitRef="Percent">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20211011113425964"
      unitRef="Percent">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20211011113503697"
      unitRef="Percent">0.61</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20211011113509899"
      unitRef="Percent">0.77</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20220101to20221231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20211011113515947"
      unitRef="Percent">0.59</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20220101to20221231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20211011113615220"
      unitRef="Percent">0.77</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20211011113623298"
      unitRef="Percent">0.55</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20211011113825130"
      unitRef="Percent">0.78</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="3"
      id="Fxbrl_20211011114051305"
      unitRef="Percent">0.021</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="4"
      id="Fxbrl_20211011114101344"
      unitRef="Percent">0.0536</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20220101to20221231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="3"
      id="Fxbrl_20211011114109537"
      unitRef="Percent">0.021</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20220101to20221231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="3"
      id="Fxbrl_20211011114115793"
      unitRef="Percent">0.052</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="3"
      id="Fxbrl_20211011114122049"
      unitRef="Percent">0.001</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="3"
      id="Fxbrl_20220218150705857"
      unitRef="Percent">0.015</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <mdwd:ExercisePriceShareOptionsGrantedPercentage
      contextRef="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20211011114526724"
      unitRef="Percent">1</mdwd:ExercisePriceShareOptionsGrantedPercentage>
    <mdwd:ExercisePriceShareOptionsGrantedPercentage
      contextRef="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20211011114707053"
      unitRef="Percent">1.50</mdwd:ExercisePriceShareOptionsGrantedPercentage>
    <mdwd:ExercisePriceShareOptionsGrantedPercentage
      contextRef="C_20220101to20221231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20220217192023692"
      unitRef="Percent">1</mdwd:ExercisePriceShareOptionsGrantedPercentage>
    <mdwd:ExercisePriceShareOptionsGrantedPercentage
      contextRef="C_20220101to20221231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20220217192154197"
      unitRef="Percent">1.50</mdwd:ExercisePriceShareOptionsGrantedPercentage>
    <mdwd:ExercisePriceShareOptionsGrantedPercentage
      contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20211011114821129"
      unitRef="Percent">1</mdwd:ExercisePriceShareOptionsGrantedPercentage>
    <mdwd:ExercisePriceShareOptionsGrantedPercentage
      contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20240317144733098"
      unitRef="Percent">1.50</mdwd:ExercisePriceShareOptionsGrantedPercentage>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="C_20230101to20231231"
      decimals="2"
      id="Fxbrl_20211011114907682"
      unitRef="USD_Per_Share">10.71</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="C_20220101to20221231"
      decimals="2"
      id="Fxbrl_20211011114932397"
      unitRef="USD_Per_Share">13.22</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20211011114947996"
      unitRef="USD_Per_Share">36.33</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:DisclosureOfIncomeTaxExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20220217161449771">
    &lt;div&gt;
      &lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Note 21:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Income Tax&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company operates in two main tax jurisdictions: Israel and Germany. As such, the Company is subject to the applicable tax rates in the jurisdictions in which it conducts its business.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Corporate tax rate in Israel:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The standard tax rate in the years 2021-2023 is 23%.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Benefits under the Law for the Encouragement of Capital Investments:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Tax benefits under the Israel Law for the Encouragement of Capital Investments, 1959 (the "Investment Law"):&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Under the Investment Law, the Company has been granted "Beneficiary Enterprise" status which provides certain benefits, including tax exemptions and reduced tax rates. Income not eligible for Beneficiary Enterprise benefits is taxed at a regular rate.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div&gt;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;During the benefit period, the Company will be tax exempt in the first two years of the benefit period and subject to tax at the reduced rate of 10%- 25% for an additional period of five to eight years (depending on the percentage of foreign investments in the Company) of the benefit period. The benefit entitlement period starts from the first year that the Beneficiary Enterprise first earned taxable income and is limited to 12 years from the year in which the Company requested to have tax benefits apply. In the event of distribution of dividends from the said tax-exempt income, the amount distributed will be subject to corporate tax at the reduced rate ordinarily applicable to the Beneficiary Enterprise's income.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Tax exempt income generated under the Company's "Beneficiary Enterprise" program will be subject to taxes upon dividend distribution or complete liquidation. The entitlement to the above benefits is conditional upon the Company's fulfilling the conditions stipulated by the Investment Law and regulations published thereunder. Should the Company fail to meet such requirements in the future, income attributable to its Beneficiary Enterprise programs could be subject to the statutory Israeli corporate tax rate and the Company could be required to refund a portion of the tax benefits already received, with respect to such programs.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The principal tax rates applicable to the subsidiary whose place of incorporation is outside of Israel is:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;line-height:1.25;margin-left:85pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The statutory corporate tax rate in Germany was 29.79% in 2023, 2022 and 2021.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Final tax assessments:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company has finalized its tax assessments through the 2016 tax year.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company's subsidiary has received the final tax assessment for the year 2021.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;f.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Net operating carryforward losses for tax purposes and other temporary differences:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;As of December 31, 2023, the Company had carryforward losses and other temporary differences mainly from R&amp;amp;D expenses together amounting to approximately $171,757.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;g.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Deferred taxes:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company did not recognize deferred tax assets for temporary differences because their utilization in the foreseeable future is not probable.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;h.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Current taxes on income:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company did not record any current taxes for MediWound Ltd. in Israel for the years ended December 31, 2023, 2022 and 2021 as a result of its carryforward losses.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The current tax expenses are in respect of taxes charged outside of Israel.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </ifrs-full:DisclosureOfIncomeTaxExplanatory>
    <ifrs-full:ApplicableTaxRate
      contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember"
      decimals="2"
      id="Fxbrl_20211216162732413"
      unitRef="Percent">0.23</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember"
      decimals="2"
      id="Fxbrl_20211216162723195"
      unitRef="Percent">0.23</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember"
      decimals="2"
      id="Fxbrl_20220217193331179"
      unitRef="Percent">0.23</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211011123814087">10%- 25%</ifrs-full:ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod>
    <mdwd:DescriptionOfTaxBenefitPeriod
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211011123837055">five to eight years</mdwd:DescriptionOfTaxBenefitPeriod>
    <mdwd:LimitOfBenefitEntitlementPeriod
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211011123937696">12 years</mdwd:LimitOfBenefitEntitlementPeriod>
    <ifrs-full:ApplicableTaxRate
      contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_countryDE"
      decimals="4"
      id="Fxbrl_20211011124115580"
      unitRef="Percent">0.2979</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryDE"
      decimals="4"
      id="Fxbrl_20211011124115036"
      unitRef="Percent">0.2979</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryDE"
      decimals="4"
      id="Fxbrl_20211217164412812"
      unitRef="Percent">0.2979</ifrs-full:ApplicableTaxRate>
    <mdwd:OtherTemporaryDifferencesMainlyFromRAndDExpenses
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20211011124151818"
      unitRef="USD">171757000</mdwd:OtherTemporaryDifferencesMainlyFromRAndDExpenses>
    <mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20220107213928383">
    &lt;div&gt;
      &lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Note 22:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Supplementary Information to the Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="text-indent:-56.7pt;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

                &lt;tr style="vertical-align:top"&gt;
                  &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:top;width:28.35pt"&gt;
                    &lt;div style="text-align:left;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-weight:bold"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-weight:bold"&gt;Additional information on Revenues:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Major customers:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:94.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;BARDA contributed 56%, 51% and 76% of the Company&#x2019;s total revenues in 2023, 2022 and 2021&lt;span style="font-weight:bold"&gt;&#160;&lt;/span&gt;respectively. Vericel contributed 4% and 28% of the Company&#x2019;s total revenues in 2023 and 2022 respectively. MTEC contributed 10% and 2.8% of the Company&#x2019;s total revenues in 2023 and 2022 respectively (see also Note 18).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:94.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;No other customer contributed 10% or more of the Company&#x2019;s revenues in 2023, 2022 and 2021.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Geographic information:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div&gt;
            &lt;div style="text-align:justify;margin-left:94.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The revenues reported in the financial statements are based on the location of the customers, as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:94.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:99pt"&gt;

                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;USA (see also Note 18a, 18b, 18c)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13,078&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;21,872&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;18,102&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;EU and other international markets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5,608&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,624&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5,661&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;18,686&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;26,496&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;23,763&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;

            &lt;/div&gt;
          &lt;/div&gt;
          &lt;div style="margin-left:99pt"&gt;&#160;&lt;/div&gt;
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

                &lt;tr style="vertical-align:top"&gt;
                  &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:top;width:28.35pt"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-weight:bold"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-weight:bold"&gt;Cost of Revenues:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cost of Revenues from sale of products&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:108pt"&gt;

                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Salary and benefits (including share-based compensation)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,703&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,828&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,047&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Subcontractors&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;230&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;58&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;190&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;672&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;426&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;559&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cost of materials&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;916&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;636&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,039&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other manufacturing expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,207&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;779&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;906&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Decrease (increase) in inventory of finished products&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(801&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(543&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;242&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,927&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,184&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,983&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;

            &lt;/div&gt;
          &lt;/div&gt;
          &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cost of Revenues from development services&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:108pt"&gt;

                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Salary and benefits&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,995&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,691&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,003&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Subcontractors&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,182&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,138&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7,904&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10,177&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9,829&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9,907&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;

            &lt;/div&gt;
          &lt;/div&gt;
          &lt;div style="margin-left:108pt"&gt;&#160;&lt;/div&gt;
          &lt;div&gt;&lt;/div&gt;
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cost of Revenues from license agreements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:108pt"&gt;

                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Salary and benefits&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;38&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;102&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Royalties payments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;280&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;318&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;102&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total Cost of Revenues&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;15,108&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13,331&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,992&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;

            &lt;/div&gt;
          &lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

                  &lt;tr style="vertical-align:top"&gt;
                    &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:top;width:28.35pt"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-weight:bold"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-weight:bold"&gt;Research and development expenses:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:90pt"&gt;

                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Salary and benefits (including share-based compensation) (1)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,148&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,494&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,864&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Subcontractors&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,833&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,054&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,323&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;396&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;571&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;396&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cost of materials&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;785&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;572&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;347&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other research and development expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;305&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;490&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;326&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total Research and development&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7,467&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10,181&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10,256&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;

            &lt;/div&gt;
            &lt;div style="text-indent:-56.7pt;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The salary costs for the year ended December 31,2022 includes one-time payment of $205 derived from termination agreement with the CMO of the company.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
          &lt;div&gt;&#160;&lt;/div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

                  &lt;tr style="vertical-align:top"&gt;
                    &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:top;width:28.35pt"&gt;
                      &lt;div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Selling and marketing expenses:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div&gt;&#160;&lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="margin-left:90pt"&gt;

                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Salary and benefits (including share-based compensation)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,991&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,637&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,643&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Marketing and consulting&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,637&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,152&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;627&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;49&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;44&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shipping and delivery&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;356&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;385&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;490&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Registration and marketing license fees&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;810&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;502&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;584&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,844&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,725&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,388&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;

            &lt;/div&gt;
          &lt;/div&gt;
          &lt;div style="margin-left:90pt"&gt;&#160;&lt;/div&gt;
          &lt;div&gt;&lt;/div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

                  &lt;tr style="vertical-align:top"&gt;
                    &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:top;width:28.35pt"&gt;
                      &lt;div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;General and administrative expenses:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:90pt"&gt;

                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Salary and benefits (including share&#x2011;based compensation)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,521&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,344&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,905&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Professional fees&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,189&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,589&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,480&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;185&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;225&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;239&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;873&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;762&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;724&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,768&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,920&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,348&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;

            &lt;/div&gt;
          &lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;f.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other (income) expenses:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The other one-time income amounted $211 for the year ended December 31, 2023, is associated with the termination of sub-lease agreement (see note 11a).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The other one-time expenses amounted $684 for the year ended December 31, 2022, are associated with the management changes and FDA milestone payment fee (see Note 18b).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;g.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financial income and expense:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:90pt"&gt;

                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financial income:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td rowspan="1" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Interest income&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,341&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;270&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revaluation of liabilities in respect of IIA grants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;132&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revaluation of Warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,310&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Exchange differences, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;59&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10,651&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;461&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financial expense:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td rowspan="1" style="vertical-align:top;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revaluation of liabilities in respect of IIA grants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;427&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;903&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financing income on net investment in lease&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;274&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;102&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;120&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Finance expenses in respect of deferred revenues&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;54&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;143&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revaluation of liabilities in respect of TEVA&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;468&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;533&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;590&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Exchange differences, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;654&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;511&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revaluation of Warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,977&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Issuance expenses of warrants through profit and loss&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,911&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;61&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;60&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;47&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,892&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;11,637&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,314&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financial income (expenses), net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,759&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(11,176&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(2,303&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;

            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </mdwd:DisclosureOfSupplementaryInformationToStatementsOfComprehensiveLossExplanatory>
    <mdwd:ConcentrationRiskPercentage
      contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdBardaMember"
      decimals="2"
      id="Fxbrl_20211217165217151"
      unitRef="Percent">0.56</mdwd:ConcentrationRiskPercentage>
    <mdwd:ConcentrationRiskPercentage
      contextRef="C_20220101to20221231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdBardaMember"
      decimals="2"
      id="Fxbrl_20211217165228599"
      unitRef="Percent">0.51</mdwd:ConcentrationRiskPercentage>
    <mdwd:ConcentrationRiskPercentage
      contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdBardaMember"
      decimals="2"
      id="Fxbrl_20211217165242679"
      unitRef="Percent">0.76</mdwd:ConcentrationRiskPercentage>
    <mdwd:ConcentrationRiskPercentage
      contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdVericelMember"
      decimals="2"
      id="Fxbrl_20220309173115943"
      unitRef="Percent">0.04</mdwd:ConcentrationRiskPercentage>
    <mdwd:ConcentrationRiskPercentage
      contextRef="C_20220101to20221231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdVericelMember"
      decimals="2"
      id="Fxbrl_20240316163236771"
      unitRef="Percent">0.28</mdwd:ConcentrationRiskPercentage>
    <mdwd:ConcentrationRiskPercentage
      contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdMtecMember"
      decimals="2"
      id="Fxbrl_20240316163420321"
      unitRef="Percent">0.10</mdwd:ConcentrationRiskPercentage>
    <mdwd:ConcentrationRiskPercentage
      contextRef="C_20220101to20221231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdMtecMember"
      decimals="3"
      id="Fxbrl_20240316163441762"
      unitRef="Percent">0.028</mdwd:ConcentrationRiskPercentage>
    <ifrs-full:DisclosureOfGeographicalAreasExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317175952689">
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;USA (see also Note 18a, 18b, 18c)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13,078&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;21,872&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;18,102&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;EU and other international markets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5,608&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,624&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5,661&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;18,686&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;26,496&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;23,763&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              </ifrs-full:DisclosureOfGeographicalAreasExplanatory>
    <ifrs-full:Revenue
      contextRef="C_20230101to20231231_ifrsfullSegmentsAxis_mdwdUsaMember"
      decimals="-3"
      id="Fxbrl_20211012104049277"
      unitRef="USD">13078000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20220101to20221231_ifrsfullSegmentsAxis_mdwdUsaMember"
      decimals="-3"
      id="Fxbrl_20211012104100151"
      unitRef="USD">21872000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20210101to20211231_ifrsfullSegmentsAxis_mdwdUsaMember"
      decimals="-3"
      id="Fxbrl_20211012104107678"
      unitRef="USD">18102000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20230101to20231231_ifrsfullSegmentsAxis_mdwdOtherCountriesMember"
      decimals="-3"
      id="Fxbrl_20211012104113542_xbrl_20211012104049277"
      unitRef="USD">5608000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20220101to20221231_ifrsfullSegmentsAxis_mdwdOtherCountriesMember"
      decimals="-3"
      id="Fxbrl_20211012104113542_xbrl_20211012104100151"
      unitRef="USD">4624000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20210101to20211231_ifrsfullSegmentsAxis_mdwdOtherCountriesMember"
      decimals="-3"
      id="Fxbrl_20211012104113542_xbrl_20211012104107678"
      unitRef="USD">5661000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012104121662"
      unitRef="USD">18686000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012104139487"
      unitRef="USD">26496000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012104358314"
      unitRef="USD">23763000</ifrs-full:Revenue>
    <ifrs-full:DisclosureOfCostOfSalesExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317180024874">
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Salary and benefits (including share-based compensation)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,703&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,828&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,047&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Subcontractors&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;230&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;58&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;190&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;672&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;426&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;559&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cost of materials&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;916&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;636&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,039&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other manufacturing expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,207&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;779&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;906&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Decrease (increase) in inventory of finished products&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(801&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(543&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;242&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,927&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,184&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,983&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              </ifrs-full:DisclosureOfCostOfSalesExplanatory>
    <ifrs-full:WagesAndSalaries
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012104546843"
      unitRef="USD">2703000</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012104552688"
      unitRef="USD">1828000</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012104600634"
      unitRef="USD">2047000</ifrs-full:WagesAndSalaries>
    <mdwd:SubcontractorsExpenses
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012104613519_xbrl_20211012104546843"
      unitRef="USD">230000</mdwd:SubcontractorsExpenses>
    <mdwd:SubcontractorsExpenses
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012104613519_xbrl_20211012104552688"
      unitRef="USD">58000</mdwd:SubcontractorsExpenses>
    <mdwd:SubcontractorsExpenses
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012104613519_xbrl_20211012104600634"
      unitRef="USD">190000</mdwd:SubcontractorsExpenses>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104546843"
      unitRef="USD">672000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104552688"
      unitRef="USD">426000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104600634"
      unitRef="USD">559000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:CostOfMerchandiseSold
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012104651455_xbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104546843"
      unitRef="USD">916000</ifrs-full:CostOfMerchandiseSold>
    <ifrs-full:CostOfMerchandiseSold
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012104651455_xbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104552688"
      unitRef="USD">636000</ifrs-full:CostOfMerchandiseSold>
    <ifrs-full:CostOfMerchandiseSold
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012104651455_xbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104600634"
      unitRef="USD">1039000</ifrs-full:CostOfMerchandiseSold>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012104711486_xbrl_20211012104651455_xbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104546843"
      unitRef="USD">1207000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012104711486_xbrl_20211012104651455_xbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104552688"
      unitRef="USD">779000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012104711486_xbrl_20211012104651455_xbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104600634"
      unitRef="USD">906000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:ChangesInInventoriesOfFinishedGoodsAndWorkInProgress
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012104731975_xbrl_20211012104711486_xbrl_20211012104651455_xbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104546843"
      unitRef="USD">-801000</ifrs-full:ChangesInInventoriesOfFinishedGoodsAndWorkInProgress>
    <ifrs-full:ChangesInInventoriesOfFinishedGoodsAndWorkInProgress
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012104731975_xbrl_20211012104711486_xbrl_20211012104651455_xbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104552688"
      unitRef="USD">-543000</ifrs-full:ChangesInInventoriesOfFinishedGoodsAndWorkInProgress>
    <ifrs-full:ChangesInInventoriesOfFinishedGoodsAndWorkInProgress
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012104731975_xbrl_20211012104711486_xbrl_20211012104651455_xbrl_20211012104632272_xbrl_20211012104613519_xbrl_20211012104600634"
      unitRef="USD">242000</ifrs-full:ChangesInInventoriesOfFinishedGoodsAndWorkInProgress>
    <mdwd:CostOfSalesFromSaleOfProducts
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012104841959"
      unitRef="USD">4927000</mdwd:CostOfSalesFromSaleOfProducts>
    <mdwd:CostOfSalesFromSaleOfProducts
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012104847256"
      unitRef="USD">3184000</mdwd:CostOfSalesFromSaleOfProducts>
    <mdwd:CostOfSalesFromSaleOfProducts
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012104857658"
      unitRef="USD">4983000</mdwd:CostOfSalesFromSaleOfProducts>
    <mdwd:DisclosureOfCostOfSalesServicesExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317180111201">
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Salary and benefits&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,995&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,691&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,003&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Subcontractors&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,182&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,138&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7,904&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10,177&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9,829&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9,907&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              </mdwd:DisclosureOfCostOfSalesServicesExplanatory>
    <mdwd:SalaryAndBenefits
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012105153443"
      unitRef="USD">1995000</mdwd:SalaryAndBenefits>
    <mdwd:SalaryAndBenefits
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012105209147"
      unitRef="USD">1691000</mdwd:SalaryAndBenefits>
    <mdwd:SalaryAndBenefits
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012105220487"
      unitRef="USD">2003000</mdwd:SalaryAndBenefits>
    <mdwd:Subcontractors
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012105242465_xbrl_20211012105153443"
      unitRef="USD">8182000</mdwd:Subcontractors>
    <mdwd:Subcontractors
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012105242465_xbrl_20211012105209147"
      unitRef="USD">8138000</mdwd:Subcontractors>
    <mdwd:Subcontractors
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012105242465_xbrl_20211012105220487"
      unitRef="USD">7904000</mdwd:Subcontractors>
    <mdwd:CostOfSalesFromLicenseAgreements
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012105322071"
      unitRef="USD">10177000</mdwd:CostOfSalesFromLicenseAgreements>
    <mdwd:CostOfSalesFromLicenseAgreements
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012105332456"
      unitRef="USD">9829000</mdwd:CostOfSalesFromLicenseAgreements>
    <mdwd:CostOfSalesFromLicenseAgreements
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012105338607"
      unitRef="USD">9907000</mdwd:CostOfSalesFromLicenseAgreements>
    <mdwd:ScheduleOfCostOfRevenuesLicense
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317181121128">
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Salary and benefits&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;38&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;102&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Royalties payments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;280&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;318&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;102&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total Cost of Revenues&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;15,108&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13,331&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,992&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              </mdwd:ScheduleOfCostOfRevenuesLicense>
    <mdwd:SalaryAndBenefitsExpensesRelatedToLicenseAgreements
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220217131933539_xbrl_20211012105531774_33"
      unitRef="USD">4000</mdwd:SalaryAndBenefitsExpensesRelatedToLicenseAgreements>
    <mdwd:SalaryAndBenefitsExpensesRelatedToLicenseAgreements
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220217131933539_xbrl_20211012105531774_37"
      unitRef="USD">38000</mdwd:SalaryAndBenefitsExpensesRelatedToLicenseAgreements>
    <mdwd:SalaryAndBenefitsExpensesRelatedToLicenseAgreements
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220217131933539_xbrl_20211012105531774_311"
      unitRef="USD">102000</mdwd:SalaryAndBenefitsExpensesRelatedToLicenseAgreements>
    <mdwd:RoyaltiesPayments
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012105531774_33"
      unitRef="USD">0</mdwd:RoyaltiesPayments>
    <mdwd:RoyaltiesPayments
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012105531774_37"
      unitRef="USD">280000</mdwd:RoyaltiesPayments>
    <mdwd:RoyaltiesPayments
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012105531774_311"
      unitRef="USD">0</mdwd:RoyaltiesPayments>
    <mdwd:TotalRoyaltiesPayments
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012105531774_53"
      unitRef="USD">4000</mdwd:TotalRoyaltiesPayments>
    <mdwd:TotalRoyaltiesPayments
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012105531774_57"
      unitRef="USD">318000</mdwd:TotalRoyaltiesPayments>
    <mdwd:TotalRoyaltiesPayments
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012105531774_511"
      unitRef="USD">102000</mdwd:TotalRoyaltiesPayments>
    <ifrs-full:CostOfSales
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220309182949536_xbrl_20211012105531774_53"
      unitRef="USD">15108000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220309182949536_xbrl_20211012105531774_57"
      unitRef="USD">13331000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220309182949536_xbrl_20211012105531774_511"
      unitRef="USD">14992000</ifrs-full:CostOfSales>
    <ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317181145688">
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Salary and benefits (including share-based compensation) (1)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,148&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,494&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,864&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Subcontractors&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,833&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,054&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,323&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;396&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;571&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;396&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cost of materials&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;785&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;572&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;347&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other research and development expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;305&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;490&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;326&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total Research and development&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7,467&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10,181&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10,256&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              </ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012105744786"
      unitRef="USD">3148000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012105756275"
      unitRef="USD">4494000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012105807825"
      unitRef="USD">2864000</ifrs-full:EmployeeBenefitsExpense>
    <mdwd:SubcontractorsExpensesRelatedToResearchAndDevelopment
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012105931729_xbrl_20211012105744786"
      unitRef="USD">2833000</mdwd:SubcontractorsExpensesRelatedToResearchAndDevelopment>
    <mdwd:SubcontractorsExpensesRelatedToResearchAndDevelopment
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012105931729_xbrl_20211012105756275"
      unitRef="USD">4054000</mdwd:SubcontractorsExpensesRelatedToResearchAndDevelopment>
    <mdwd:SubcontractorsExpensesRelatedToResearchAndDevelopment
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012105931729_xbrl_20211012105807825"
      unitRef="USD">6323000</mdwd:SubcontractorsExpensesRelatedToResearchAndDevelopment>
    <mdwd:DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012110033550_xbrl_20211012105931729_xbrl_20211012105744786"
      unitRef="USD">396000</mdwd:DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment>
    <mdwd:DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012110033550_xbrl_20211012105931729_xbrl_20211012105756275"
      unitRef="USD">571000</mdwd:DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment>
    <mdwd:DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012110033550_xbrl_20211012105931729_xbrl_20211012105807825"
      unitRef="USD">396000</mdwd:DepreciationAndAmortisationExpenseRelatedToResearchAndDevelopment>
    <mdwd:CostOfMaterials
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012110116897_xbrl_20211012110033550_xbrl_20211012105931729_xbrl_20211012105744786"
      unitRef="USD">785000</mdwd:CostOfMaterials>
    <mdwd:CostOfMaterials
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012110116897_xbrl_20211012110033550_xbrl_20211012105931729_xbrl_20211012105756275"
      unitRef="USD">572000</mdwd:CostOfMaterials>
    <mdwd:CostOfMaterials
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012110116897_xbrl_20211012110033550_xbrl_20211012105931729_xbrl_20211012105807825"
      unitRef="USD">347000</mdwd:CostOfMaterials>
    <mdwd:OtherResearchAndDevelopmentExpenses
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012110200433_xbrl_20211012110136946_xbrl_20211012110116897_xbrl_20211012110033550_xbrl_20211012105931729_xbrl_20211012105744786"
      unitRef="USD">305000</mdwd:OtherResearchAndDevelopmentExpenses>
    <mdwd:OtherResearchAndDevelopmentExpenses
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012110200433_xbrl_20211012110136946_xbrl_20211012110116897_xbrl_20211012110033550_xbrl_20211012105931729_xbrl_20211012105756275"
      unitRef="USD">490000</mdwd:OtherResearchAndDevelopmentExpenses>
    <mdwd:OtherResearchAndDevelopmentExpenses
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012110200433_xbrl_20211012110136946_xbrl_20211012110116897_xbrl_20211012110033550_xbrl_20211012105931729_xbrl_20211012105807825"
      unitRef="USD">326000</mdwd:OtherResearchAndDevelopmentExpenses>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012110359244"
      unitRef="USD">7467000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012110413322"
      unitRef="USD">10181000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012110428110"
      unitRef="USD">10256000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:OtherExpenseByFunction
      contextRef="C_20220101to20221231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_mdwdOtherCustomerContributedMember"
      decimals="-3"
      id="Fxbrl_20220310152853615"
      unitRef="USD">205000</ifrs-full:OtherExpenseByFunction>
    <mdwd:DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317181206107">
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Salary and benefits (including share-based compensation)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,991&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,637&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,643&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Marketing and consulting&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,637&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,152&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;627&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;49&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;44&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shipping and delivery&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;356&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;385&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;490&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Registration and marketing license fees&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;810&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;502&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;584&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,844&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,725&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,388&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              </mdwd:DisclosureOfDetailedInformationAboutSellingAndMarketingExpensesExplanatory>
    <ifrs-full:ShorttermEmployeeBenefitsExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012110511438"
      unitRef="USD">1991000</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012110517905"
      unitRef="USD">1637000</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012110529196"
      unitRef="USD">1643000</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <mdwd:MarketingAndSalesExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012110546992_xbrl_20211012110511438"
      unitRef="USD">1637000</mdwd:MarketingAndSalesExpense>
    <mdwd:MarketingAndSalesExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012110546992_xbrl_20211012110517905"
      unitRef="USD">1152000</mdwd:MarketingAndSalesExpense>
    <mdwd:MarketingAndSalesExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012110546992_xbrl_20211012110529196"
      unitRef="USD">627000</mdwd:MarketingAndSalesExpense>
    <mdwd:DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012110652960_xbrl_20211012110546992_xbrl_20211012110511438"
      unitRef="USD">50000</mdwd:DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses>
    <mdwd:DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012110652960_xbrl_20211012110546992_xbrl_20211012110517905"
      unitRef="USD">49000</mdwd:DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses>
    <mdwd:DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012110652960_xbrl_20211012110546992_xbrl_20211012110529196"
      unitRef="USD">44000</mdwd:DepreciationAndAmortisationExpenseRelatedToSellingAndMarketingExpenses>
    <ifrs-full:DistributionCosts
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012110732600_xbrl_20211012110652960_xbrl_20211012110546992_xbrl_20211012110511438"
      unitRef="USD">356000</ifrs-full:DistributionCosts>
    <ifrs-full:DistributionCosts
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012110732600_xbrl_20211012110652960_xbrl_20211012110546992_xbrl_20211012110517905"
      unitRef="USD">385000</ifrs-full:DistributionCosts>
    <ifrs-full:DistributionCosts
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012110732600_xbrl_20211012110652960_xbrl_20211012110546992_xbrl_20211012110529196"
      unitRef="USD">490000</ifrs-full:DistributionCosts>
    <mdwd:RegistrationAndMarketingLicenseFees
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012110754681_xbrl_20211012110732600_xbrl_20211012110652960_xbrl_20211012110546992_xbrl_20211012110511438"
      unitRef="USD">810000</mdwd:RegistrationAndMarketingLicenseFees>
    <mdwd:RegistrationAndMarketingLicenseFees
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012110754681_xbrl_20211012110732600_xbrl_20211012110652960_xbrl_20211012110546992_xbrl_20211012110517905"
      unitRef="USD">502000</mdwd:RegistrationAndMarketingLicenseFees>
    <mdwd:RegistrationAndMarketingLicenseFees
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012110754681_xbrl_20211012110732600_xbrl_20211012110652960_xbrl_20211012110546992_xbrl_20211012110529196"
      unitRef="USD">584000</mdwd:RegistrationAndMarketingLicenseFees>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012110815547"
      unitRef="USD">4844000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012110830506"
      unitRef="USD">3725000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012110840355"
      unitRef="USD">3388000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317181227156">
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Salary and benefits (including share&#x2011;based compensation)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,521&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,344&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,905&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Professional fees&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,189&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,589&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,480&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;185&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;225&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;239&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;873&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;762&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;724&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,768&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,920&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,348&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              </ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory>
    <mdwd:SalaryAndBenefitsIncludingShareBasedCompensation
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012110936659"
      unitRef="USD">3521000</mdwd:SalaryAndBenefitsIncludingShareBasedCompensation>
    <mdwd:SalaryAndBenefitsIncludingShareBasedCompensation
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012122403374"
      unitRef="USD">3344000</mdwd:SalaryAndBenefitsIncludingShareBasedCompensation>
    <mdwd:SalaryAndBenefitsIncludingShareBasedCompensation
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012122458446"
      unitRef="USD">2905000</mdwd:SalaryAndBenefitsIncludingShareBasedCompensation>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012122513574_xbrl_20211012110936659"
      unitRef="USD">2189000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012122513574_xbrl_20211012122403374"
      unitRef="USD">2589000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012122513574_xbrl_20211012122458446"
      unitRef="USD">2480000</ifrs-full:ProfessionalFeesExpense>
    <mdwd:DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012122531311_xbrl_20211012122513574_xbrl_20211012110936659"
      unitRef="USD">185000</mdwd:DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses>
    <mdwd:DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012122531311_xbrl_20211012122513574_xbrl_20211012122403374"
      unitRef="USD">225000</mdwd:DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses>
    <mdwd:DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012122531311_xbrl_20211012122513574_xbrl_20211012122458446"
      unitRef="USD">239000</mdwd:DepreciationAndAmortisationExpenseRelatedToGeneralAndAdministrativeExpenses>
    <mdwd:OtherSellingGeneralAndAdministrativeExpenses
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012122552165_xbrl_20211012122531311_xbrl_20211012122513574_xbrl_20211012110936659"
      unitRef="USD">873000</mdwd:OtherSellingGeneralAndAdministrativeExpenses>
    <mdwd:OtherSellingGeneralAndAdministrativeExpenses
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012122552165_xbrl_20211012122531311_xbrl_20211012122513574_xbrl_20211012122403374"
      unitRef="USD">762000</mdwd:OtherSellingGeneralAndAdministrativeExpenses>
    <mdwd:OtherSellingGeneralAndAdministrativeExpenses
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012122552165_xbrl_20211012122531311_xbrl_20211012122513574_xbrl_20211012122458446"
      unitRef="USD">724000</mdwd:OtherSellingGeneralAndAdministrativeExpenses>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012122612063"
      unitRef="USD">6768000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012122622608"
      unitRef="USD">6920000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012122631503"
      unitRef="USD">6348000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:OtherIncome
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240316163854859"
      unitRef="USD">211000</ifrs-full:OtherIncome>
    <ifrs-full:OtherExpenseByFunction
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220217134954773"
      unitRef="USD">684000</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317181252033">
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financial income:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td rowspan="1" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Interest income&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,341&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;270&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revaluation of liabilities in respect of IIA grants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;132&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revaluation of Warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,310&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Exchange differences, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;59&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10,651&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;461&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financial expense:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td rowspan="1" style="vertical-align:top;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revaluation of liabilities in respect of IIA grants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;427&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;903&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financing income on net investment in lease&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;274&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;102&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;120&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Finance expenses in respect of deferred revenues&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;54&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;143&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revaluation of liabilities in respect of TEVA&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;468&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;533&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;590&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Exchange differences, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;654&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;511&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revaluation of Warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,977&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Issuance expenses of warrants through profit and loss&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,911&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;61&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;60&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;47&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,892&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;11,637&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,314&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financial income (expenses), net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,759&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(11,176&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(2,303&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              </ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory>
    <ifrs-full:RevenueFromInterest
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012122709201"
      unitRef="USD">2341000</ifrs-full:RevenueFromInterest>
    <ifrs-full:RevenueFromInterest
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012122714694"
      unitRef="USD">270000</ifrs-full:RevenueFromInterest>
    <ifrs-full:RevenueFromInterest
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012122725310"
      unitRef="USD">11000</ifrs-full:RevenueFromInterest>
    <mdwd:RevaluationOfLiabilitiesInRespectOfIiaGrants
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012122737337_xbrl_20211012122709201"
      unitRef="USD">0</mdwd:RevaluationOfLiabilitiesInRespectOfIiaGrants>
    <mdwd:RevaluationOfLiabilitiesInRespectOfIiaGrants
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012122737337_xbrl_20211012122714694"
      unitRef="USD">132000</mdwd:RevaluationOfLiabilitiesInRespectOfIiaGrants>
    <mdwd:RevaluationOfLiabilitiesInRespectOfIiaGrants
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012122737337_xbrl_20211012122725310"
      unitRef="USD">0</mdwd:RevaluationOfLiabilitiesInRespectOfIiaGrants>
    <mdwd:RevaluationOfWarrantsAccountedAtFairValue
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240316172306543_xbrl_20211012122737337_xbrl_20211012122709201"
      unitRef="USD">8310000</mdwd:RevaluationOfWarrantsAccountedAtFairValue>
    <mdwd:RevaluationOfWarrantsAccountedAtFairValue
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240316172306543_xbrl_20211012122737337_xbrl_20211012122714694"
      unitRef="USD">0</mdwd:RevaluationOfWarrantsAccountedAtFairValue>
    <mdwd:RevaluationOfWarrantsAccountedAtFairValue
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240316172306543_xbrl_20211012122737337_xbrl_20211012122725310"
      unitRef="USD">0</mdwd:RevaluationOfWarrantsAccountedAtFairValue>
    <ifrs-full:TradingIncomeExpenseOnForeignExchangeContracts
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122709201"
      unitRef="USD">0</ifrs-full:TradingIncomeExpenseOnForeignExchangeContracts>
    <ifrs-full:TradingIncomeExpenseOnForeignExchangeContracts
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694"
      unitRef="USD">59000</ifrs-full:TradingIncomeExpenseOnForeignExchangeContracts>
    <ifrs-full:TradingIncomeExpenseOnForeignExchangeContracts
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310"
      unitRef="USD">0</ifrs-full:TradingIncomeExpenseOnForeignExchangeContracts>
    <ifrs-full:FinanceIncome
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122709201"
      unitRef="USD">10651000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694"
      unitRef="USD">461000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310"
      unitRef="USD">11000</ifrs-full:FinanceIncome>
    <mdwd:RevaluationOfLiabilitiesInRespectOfIlaGrant
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240316173518090_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122709201"
      unitRef="USD">427000</mdwd:RevaluationOfLiabilitiesInRespectOfIlaGrant>
    <mdwd:RevaluationOfLiabilitiesInRespectOfIlaGrant
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240316173518090_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694"
      unitRef="USD">0</mdwd:RevaluationOfLiabilitiesInRespectOfIlaGrant>
    <mdwd:RevaluationOfLiabilitiesInRespectOfIlaGrant
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240316173518090_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310"
      unitRef="USD">903000</mdwd:RevaluationOfLiabilitiesInRespectOfIlaGrant>
    <mdwd:FinancingIncomeOnNetInvestmentInLease
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240316173516270_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122709201"
      unitRef="USD">274000</mdwd:FinancingIncomeOnNetInvestmentInLease>
    <mdwd:FinancingIncomeOnNetInvestmentInLease
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240316173516270_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694"
      unitRef="USD">102000</mdwd:FinancingIncomeOnNetInvestmentInLease>
    <mdwd:FinancingIncomeOnNetInvestmentInLease
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240316173516270_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310"
      unitRef="USD">120000</mdwd:FinancingIncomeOnNetInvestmentInLease>
    <mdwd:FinanceExpensesInRespectOfDeferredRevenue
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012122946911_xbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122709201"
      unitRef="USD">8000</mdwd:FinanceExpensesInRespectOfDeferredRevenue>
    <mdwd:FinanceExpensesInRespectOfDeferredRevenue
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012122946911_xbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694"
      unitRef="USD">54000</mdwd:FinanceExpensesInRespectOfDeferredRevenue>
    <mdwd:FinanceExpensesInRespectOfDeferredRevenue
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012122946911_xbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310"
      unitRef="USD">143000</mdwd:FinanceExpensesInRespectOfDeferredRevenue>
    <mdwd:RevaluationOfLiabilitiesInRespectOfPurchasesOfShares
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122709201"
      unitRef="USD">468000</mdwd:RevaluationOfLiabilitiesInRespectOfPurchasesOfShares>
    <mdwd:RevaluationOfLiabilitiesInRespectOfPurchasesOfShares
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694"
      unitRef="USD">533000</mdwd:RevaluationOfLiabilitiesInRespectOfPurchasesOfShares>
    <mdwd:RevaluationOfLiabilitiesInRespectOfPurchasesOfShares
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310"
      unitRef="USD">590000</mdwd:RevaluationOfLiabilitiesInRespectOfPurchasesOfShares>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122709201"
      unitRef="USD">654000</ifrs-full:NetForeignExchangeLoss>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694"
      unitRef="USD">0</ifrs-full:NetForeignExchangeLoss>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310"
      unitRef="USD">511000</ifrs-full:NetForeignExchangeLoss>
    <mdwd:RevaluationOfWarrant
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240316172147051_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122709201"
      unitRef="USD">0</mdwd:RevaluationOfWarrant>
    <mdwd:RevaluationOfWarrant
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240316172147051_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694"
      unitRef="USD">8977000</mdwd:RevaluationOfWarrant>
    <mdwd:RevaluationOfWarrant
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240316172147051_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310"
      unitRef="USD">0</mdwd:RevaluationOfWarrant>
    <mdwd:IssuanceExpensesOfWarrantsThroughProfitAndLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240316173520261_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122709201"
      unitRef="USD">0</mdwd:IssuanceExpensesOfWarrantsThroughProfitAndLoss>
    <mdwd:IssuanceExpensesOfWarrantsThroughProfitAndLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240316173520261_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694"
      unitRef="USD">1911000</mdwd:IssuanceExpensesOfWarrantsThroughProfitAndLoss>
    <mdwd:IssuanceExpensesOfWarrantsThroughProfitAndLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240316173520261_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310"
      unitRef="USD">0</mdwd:IssuanceExpensesOfWarrantsThroughProfitAndLoss>
    <ifrs-full:OtherFinanceCost
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012123003008_xbrl_20211012122946911_xbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122709201"
      unitRef="USD">61000</ifrs-full:OtherFinanceCost>
    <ifrs-full:OtherFinanceCost
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012123003008_xbrl_20211012122946911_xbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694"
      unitRef="USD">60000</ifrs-full:OtherFinanceCost>
    <ifrs-full:OtherFinanceCost
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012123003008_xbrl_20211012122946911_xbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310"
      unitRef="USD">47000</ifrs-full:OtherFinanceCost>
    <ifrs-full:FinanceCosts
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220309184431276"
      unitRef="USD">1892000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012123022124_xbrl_20211012123003008_xbrl_20211012122946911_xbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122714694"
      unitRef="USD">11637000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012123022124_xbrl_20211012123003008_xbrl_20211012122946911_xbrl_20211012122931732_xbrl_20211012122916542_xbrl_20211012122900600_xbrl_20211012122843848_xbrl_20211012122822642_xbrl_20211012122752831_xbrl_20211012122737337_xbrl_20211012122725310"
      unitRef="USD">2314000</ifrs-full:FinanceCosts>
    <mdwd:FinancialExpensesNet
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220309185437093"
      unitRef="USD">8759000</mdwd:FinancialExpensesNet>
    <mdwd:FinancialExpensesNet
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220309185501942"
      unitRef="USD">-11176000</mdwd:FinancialExpensesNet>
    <mdwd:FinancialExpensesNet
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220309185513891"
      unitRef="USD">-2303000</mdwd:FinancialExpensesNet>
    <ifrs-full:DisclosureOfEarningsPerShareExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317171231174">
      &lt;div&gt;
        &lt;div style="line-height:1.25"&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0);border:0px"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Note 23:&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold"&gt;Net Loss Per Share&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Details of the number of shares and loss used in the computation of loss per share:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:90pt"&gt;

                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td colspan="22" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;number of shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;number of shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;number of shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,013,144&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6,716&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,987,069&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,599&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,892,068&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(13,551&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;

            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss per share:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:90pt"&gt;

                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic and diluted loss per share:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.75&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3.93&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3.48&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;

            &lt;/div&gt;
            &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In 2023, 2,614,297 warrants, 957,487 options and 32,714 RSU&#x2019;s were excluded from the diluted weighted average number of Ordinary Shares calculation as their effect would have been anti-dilutive.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In 2022, 2,614,297 warrants, 764,767 options and 42,013 RSU&#x2019;s were excluded from the diluted weighted average number of Ordinary Shares calculation as their effect would have been anti-dilutive. In addition, the impact of 1,407,583 pre-funded warrants which were exercised in December 2022, have not taken in the diluted weighted average number of Ordinary Shares calculation as their effect would have been anti-dilutive as well.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </ifrs-full:DisclosureOfEarningsPerShareExplanatory>
    <mdwd:DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317171306022">
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td colspan="22" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;number of shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;number of shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;number of shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,013,144&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6,716&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,987,069&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,599&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,892,068&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(13,551&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              </mdwd:DisclosureOfDetailedInformationAboutDetailsOfNumberOfSharesAndLossUsedInComputationExplanatory>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="C_20230101to20231231"
      decimals="0"
      id="Fxbrl_20211012123731780"
      unitRef="Share">9013144</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:ProfitLossFromContinuingOperations
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012123828392"
      unitRef="USD">-6716000</ifrs-full:ProfitLossFromContinuingOperations>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="C_20220101to20221231"
      decimals="0"
      id="Fxbrl_20211012123850549"
      unitRef="Share">4987069</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:ProfitLossFromContinuingOperations
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220218112914247"
      unitRef="USD">-19599000</ifrs-full:ProfitLossFromContinuingOperations>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="C_20210101to20211231"
      decimals="0"
      id="Fxbrl_20211012123917243"
      unitRef="Share">3892068</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:ProfitLossFromContinuingOperations
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012124024529"
      unitRef="USD">-13551000</ifrs-full:ProfitLossFromContinuingOperations>
    <mdwd:DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317171319046">
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic and diluted loss per share:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.75&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3.93&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3.48&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              </mdwd:DisclosureOfDetailedInformationAboutNetLossPerShareFromContinuingAndDiscontinuedOperationsExplanatory>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="C_20230101to20231231"
      decimals="2"
      id="Fxbrl_20211012130838532_xbrl_20211012124230804"
      unitRef="USD_Per_Share">-0.75</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="C_20220101to20221231"
      decimals="2"
      id="Fxbrl_20220217123037304"
      unitRef="USD_Per_Share">-3.93</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20211012130838532_xbrl_20211012124316775"
      unitRef="USD_Per_Share">-3.48</ifrs-full:BasicEarningsLossPerShare>
    <mdwd:NumberOfWarrantsIssued
      contextRef="C_20230101to20231231_ifrsfullClassesOfOrdinarySharesAxis_mdwdDilutedWeightedAverageNumberMember"
      decimals="INF"
      id="Fxbrl_20240317172442772"
      unitRef="Share">2614297</mdwd:NumberOfWarrantsIssued>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20230101to20231231_ifrsfullClassesOfOrdinarySharesAxis_mdwdDilutedWeightedAverageNumberMember"
      decimals="INF"
      id="Fxbrl_20240317172459212"
      unitRef="shares">957487</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <mdwd:NumberOfRestrictedShareUnitIssued
      contextRef="C_20230101to20231231_ifrsfullClassesOfOrdinarySharesAxis_mdwdDilutedWeightedAverageNumberMember"
      decimals="INF"
      id="Fxbrl_20240317172503524"
      unitRef="Share">32714</mdwd:NumberOfRestrictedShareUnitIssued>
    <mdwd:NumberOfWarrantsIssued
      contextRef="C_20220101to20221231_ifrsfullClassesOfOrdinarySharesAxis_mdwdDilutedWeightedAverageNumberMember"
      decimals="INF"
      id="Fxbrl_20240317172619219"
      unitRef="Share">2614297</mdwd:NumberOfWarrantsIssued>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20220101to20221231_ifrsfullClassesOfOrdinarySharesAxis_mdwdDilutedWeightedAverageNumberMember"
      decimals="INF"
      id="Fxbrl_20240317172734058"
      unitRef="shares">764767</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <mdwd:NumberOfRestrictedShareUnitIssued
      contextRef="C_20220101to20221231_ifrsfullClassesOfOrdinarySharesAxis_mdwdDilutedWeightedAverageNumberMember"
      decimals="INF"
      id="Fxbrl_20240317172741716"
      unitRef="Share">42013</mdwd:NumberOfRestrictedShareUnitIssued>
    <mdwd:UnregisteredPreFundedWarrantsIssued
      contextRef="C_20230101to20231231_ifrsfullClassesOfOrdinarySharesAxis_mdwdDilutedWeightedAverageNumberMember"
      decimals="INF"
      id="Fxbrl_20240317172814635"
      unitRef="Share">1407583</mdwd:UnregisteredPreFundedWarrantsIssued>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20220217110309795">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div style="line-height:1.25"&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="line-height:1.25"&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0);border:0px"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Note 24:&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top"&gt;
                          &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold"&gt;Balances and Transactions with Related Parties and Key Officers&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
    &lt;div&gt;
      &lt;div&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Related parties consist of:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

            &lt;tr&gt;
              &lt;td style="width:103.05pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:10.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Clal Biotechnologies Industries Ltd.- Related party (see also note 11)&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:103.05pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:10.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Directors of the Company.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balances with related parties:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
      &lt;/div&gt;
    &lt;/div&gt;
    &lt;div&gt;

        &lt;div style="margin-left:110pt"&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;div style="margin-left:0px"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;Other Payables&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25"&gt;&lt;span style="font-weight:bold;font-style:italic"&gt;Related Party&lt;/span&gt;:&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25"&gt;As of December 31, 2023&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25"&gt;As of December 31, 2022&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;177&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;Directors:&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25"&gt;As of December 31, 2023&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;83&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25"&gt;As of December 31, 2022&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;130&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;

      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div&gt;&lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;

          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:18pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transactions with related parties:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-weight:bold"&gt;
                  &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rental fee:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/div&gt;
                &lt;div style="margin-left:108pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;text-indent:-113.4pt;margin-left:113.4pt;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Related party&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;267&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;457&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;469&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-weight:bold"&gt;
                  &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Professional fee *:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/div&gt;
                &lt;div style="margin-left:108pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;text-indent:-7.1pt;margin-left:7.1pt;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Directors&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;502&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;484&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;375&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Related party&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;63&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;527&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;547&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;460&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of Directors&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;***9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;**10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:101.7pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:right;vertical-align:top;width:28.35pt"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Not included share- based compensation detailed in Note 20.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:101.7pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:right;vertical-align:top;width:28.35pt"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;**&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;During 2022 two members of the board of directors were replaced.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:101.7pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;***&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During 2023 three members of the board have left and one member of the board was replaced. At the end of 2023, the total board member consisted of five members.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;

      &lt;/div&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
      &lt;table cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:100%"&gt;

          &lt;tr&gt;
            &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:auto;vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold"&gt;b.&#160; &#160; &#160; &#160; Key Officers:&lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top;font-weight:bold"&gt;1.&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div style="font-weight:bold"&gt;Balances with Key Officers of the Company&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:108pt"&gt;

                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid black"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;strong&gt;&lt;em&gt;Other &lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;strong&gt;&lt;em&gt;Payables&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;em&gt;&lt;strong&gt;Key Officers of the Company&lt;/strong&gt;&lt;/em&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="width:88%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25"&gt;As of December 31, 2023&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;518&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="width:88%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25"&gt;As of December 31, 2022&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;754&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;

            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:103.05pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&#x2022;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;Represents the officer&#x2019;s gross salary, bonuses, and vacation provisions without share based compensation.&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:18pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Compensation of Key Officers of the Company:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following amounts disclosed in the table are recognized as an expense during the reporting period related to officers:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div&gt;
        &lt;div&gt;

            &lt;div&gt;
              &lt;div style="margin-left:108pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="border-bottom:2px solid black;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td style="border-bottom:2px solid black;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:2px;white-space:nowrap;border-bottom:2px solid black;vertical-align:bottom"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2022&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td style="border-bottom:2px solid black;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:2px;white-space:nowrap;border-bottom:2px solid black;vertical-align:bottom"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2021&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:64%"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Short-term employee benefits (*)(**)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,084&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,880&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,788&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="padding-bottom:2px;vertical-align:bottom;width:64%"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;757&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;797&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;518&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:64%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="padding-bottom:4px;vertical-align:bottom;width:64%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,841&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,677&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,306&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:64%"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of officers&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;(***)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(*) One-time expenses amounted $309 for the year ended December 31, 2022, are associated with the management changes.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(**) In December 2007, the Company's board of directors approved one&#x2011;time bonus payments to the Chief Medical Officer in the amounts of $ 120, which was recorded in profit and loss in December 2022 upon achieving marketing approval in the United States.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;br/&gt;(***) During 2023 two key officers were replaced. At the end of 2023 the total key officers consist of six officers.&lt;/p&gt;
              &lt;/div&gt;
            &lt;/div&gt;

        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <mdwd:DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20211012144923382">
        &lt;div style="margin-left:110pt"&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;div style="margin-left:0px"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;Other Payables&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25"&gt;&lt;span style="font-weight:bold;font-style:italic"&gt;Related Party&lt;/span&gt;:&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25"&gt;As of December 31, 2023&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25"&gt;As of December 31, 2022&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;177&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;Directors:&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25"&gt;As of December 31, 2023&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;83&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25"&gt;As of December 31, 2022&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;130&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </mdwd:DisclosureOfDetailedInformationAboutBalancesWithRelatedPartiesExplanatory>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember"
      decimals="-3"
      id="Fxbrl_20211012143721709"
      unitRef="USD">0</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember"
      decimals="-3"
      id="Fxbrl_20211012143736561"
      unitRef="USD">177000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullOtherRelatedPartiesMember"
      decimals="-3"
      id="Fxbrl_20211012143750161"
      unitRef="USD">83000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullOtherRelatedPartiesMember"
      decimals="-3"
      id="Fxbrl_20211012143755097"
      unitRef="USD">130000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240316191851102">
          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:18pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transactions with related parties:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-weight:bold"&gt;
                  &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rental fee:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/div&gt;
                &lt;div style="margin-left:108pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;text-indent:-113.4pt;margin-left:113.4pt;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Related party&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;267&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;457&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;469&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-weight:bold"&gt;
                  &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Professional fee *:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/div&gt;
                &lt;div style="margin-left:108pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;text-indent:-7.1pt;margin-left:7.1pt;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Directors&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;502&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;484&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;375&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Related party&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;63&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;527&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;547&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;460&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of Directors&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;***9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;**10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:101.7pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:right;vertical-align:top;width:28.35pt"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Not included share- based compensation detailed in Note 20.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:101.7pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="text-align:right;vertical-align:top;width:28.35pt"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;**&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;During 2022 two members of the board of directors were replaced.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:101.7pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;***&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During 2023 three members of the board have left and one member of the board was replaced. At the end of 2023, the total board member consisted of five members.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory>
    <mdwd:RelatedPartiesRentaLexpenseAndOther
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember"
      decimals="-3"
      id="Fxbrl_20220309163345905"
      unitRef="USD">267000</mdwd:RelatedPartiesRentaLexpenseAndOther>
    <mdwd:RelatedPartiesRentaLexpenseAndOther
      contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember"
      decimals="-3"
      id="Fxbrl_20220309163427268"
      unitRef="USD">457000</mdwd:RelatedPartiesRentaLexpenseAndOther>
    <mdwd:RelatedPartiesRentaLexpenseAndOther
      contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember"
      decimals="-3"
      id="Fxbrl_20220309163436972"
      unitRef="USD">469000</mdwd:RelatedPartiesRentaLexpenseAndOther>
    <mdwd:ProfessionalFeeAndShareBasedCompensationExpenses
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullOtherRelatedPartiesMember"
      decimals="-3"
      id="Fxbrl_20220309161451001"
      unitRef="USD">502000</mdwd:ProfessionalFeeAndShareBasedCompensationExpenses>
    <mdwd:ProfessionalFeeAndShareBasedCompensationExpenses
      contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullOtherRelatedPartiesMember"
      decimals="-3"
      id="Fxbrl_20220309161440681"
      unitRef="USD">484000</mdwd:ProfessionalFeeAndShareBasedCompensationExpenses>
    <mdwd:ProfessionalFeeAndShareBasedCompensationExpenses
      contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullOtherRelatedPartiesMember"
      decimals="-3"
      id="Fxbrl_20220309161433449"
      unitRef="USD">375000</mdwd:ProfessionalFeeAndShareBasedCompensationExpenses>
    <mdwd:ProfessionalFeeAndShareBasedCompensationExpenses
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember"
      decimals="-3"
      id="Fxbrl_20220309161400935"
      unitRef="USD">25000</mdwd:ProfessionalFeeAndShareBasedCompensationExpenses>
    <mdwd:ProfessionalFeeAndShareBasedCompensationExpenses
      contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember"
      decimals="-3"
      id="Fxbrl_20220309161349823"
      unitRef="USD">63000</mdwd:ProfessionalFeeAndShareBasedCompensationExpenses>
    <mdwd:ProfessionalFeeAndShareBasedCompensationExpenses
      contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember"
      decimals="-3"
      id="Fxbrl_20220309161330642"
      unitRef="USD">85000</mdwd:ProfessionalFeeAndShareBasedCompensationExpenses>
    <mdwd:ProfessionalFeeAndShareBasedCompensationExpenses
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220309161908772"
      unitRef="USD">527000</mdwd:ProfessionalFeeAndShareBasedCompensationExpenses>
    <mdwd:ProfessionalFeeAndShareBasedCompensationExpenses
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220309161917992"
      unitRef="USD">547000</mdwd:ProfessionalFeeAndShareBasedCompensationExpenses>
    <mdwd:ProfessionalFeeAndShareBasedCompensationExpenses
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220309162025741"
      unitRef="USD">460000</mdwd:ProfessionalFeeAndShareBasedCompensationExpenses>
    <mdwd:NumberOfDirectors
      contextRef="C_20231231"
      decimals="0"
      id="Fxbrl_20240316191227790"
      unitRef="Directors">9</mdwd:NumberOfDirectors>
    <mdwd:NumberOfDirectors
      contextRef="C_20221231"
      decimals="0"
      id="Fxbrl_20240316191236117"
      unitRef="Directors">10</mdwd:NumberOfDirectors>
    <mdwd:NumberOfDirectors
      contextRef="C_20211231"
      decimals="0"
      id="Fxbrl_20220309165118614"
      unitRef="Directors">8</mdwd:NumberOfDirectors>
    <mdwd:DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240317191546352">
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid black"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;strong&gt;&lt;em&gt;Other &lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;strong&gt;&lt;em&gt;Payables&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;em&gt;&lt;strong&gt;Key Officers of the Company&lt;/strong&gt;&lt;/em&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="width:88%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25"&gt;As of December 31, 2023&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;518&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="width:88%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="text-align:justify;text-indent:-9.9pt;margin-left:9.9pt;line-height:1.25"&gt;As of December 31, 2022&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;754&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              </mdwd:DisclosureOfDetailedInformationAboutBalancesWithKeyOfficersExplanatory>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdKeyOfficerMember"
      decimals="-3"
      id="Fxbrl_20220316194235309"
      unitRef="USD">518000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdKeyOfficerMember"
      decimals="-3"
      id="Fxbrl_20240316192937837"
      unitRef="USD">754000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240316192453665">
            &lt;div&gt;
              &lt;div style="margin-left:108pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="border-bottom:2px solid black;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td style="border-bottom:2px solid black;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:2px;white-space:nowrap;border-bottom:2px solid black;vertical-align:bottom"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2022&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td style="border-bottom:2px solid black;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:2px;white-space:nowrap;border-bottom:2px solid black;vertical-align:bottom"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2021&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:64%"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Short-term employee benefits (*)(**)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,084&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,880&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,788&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="padding-bottom:2px;vertical-align:bottom;width:64%"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;757&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;797&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;518&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:64%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="padding-bottom:4px;vertical-align:bottom;width:64%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,841&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,677&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,306&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:64%"&gt;
                        &lt;div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of officers&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;(***)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;width:9%"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(*) One-time expenses amounted $309 for the year ended December 31, 2022, are associated with the management changes.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(**) In December 2007, the Company's board of directors approved one&#x2011;time bonus payments to the Chief Medical Officer in the amounts of $ 120, which was recorded in profit and loss in December 2022 upon achieving marketing approval in the United States.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:103.05pt;line-height:1.25"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;br/&gt;(***) During 2023 two key officers were replaced. At the end of 2023 the total key officers consist of six officers.&lt;/p&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012144415541"
      unitRef="USD">2084000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012144421658"
      unitRef="USD">2880000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012144424590"
      unitRef="USD">1788000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012144614988_xbrl_20211012144415541"
      unitRef="USD">757000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012144614988_xbrl_20211012144421658"
      unitRef="USD">797000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012144614988_xbrl_20211012144424590"
      unitRef="USD">518000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20211012144634961"
      unitRef="USD">2841000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211012144640260"
      unitRef="USD">3677000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20211012144647356"
      unitRef="USD">2306000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:NumberOfEmployees
      contextRef="C_20231231"
      decimals="0"
      id="Fxbrl_20211012144654818_xbrl_20211012144614988_xbrl_20211012144415541"
      unitRef="Officers">8</ifrs-full:NumberOfEmployees>
    <ifrs-full:NumberOfEmployees
      contextRef="C_20221231"
      decimals="0"
      id="Fxbrl_20211012144654818_xbrl_20211012144614988_xbrl_20211012144421658"
      unitRef="Officers">7</ifrs-full:NumberOfEmployees>
    <ifrs-full:NumberOfEmployees
      contextRef="C_20211231"
      decimals="0"
      id="Fxbrl_20211012144654818_xbrl_20211012144614988_xbrl_20211012144424590"
      unitRef="Officers">5</ifrs-full:NumberOfEmployees>
    <ifrs-full:DirectorsRemunerationExpense
      contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdChiefExecutiveOfficerAndChiefMedicalOfficerMember"
      decimals="-3"
      id="Fxbrl_20220310172544306"
      unitRef="USD">309000</ifrs-full:DirectorsRemunerationExpense>
    <ifrs-full:DirectorsRemunerationExpense
      contextRef="C_20071201to20071231_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdChiefExecutiveOfficerAndChiefMedicalOfficerMember"
      decimals="-3"
      id="Fxbrl_20220217110121705"
      unitRef="USD">120000</ifrs-full:DirectorsRemunerationExpense>
    <ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20220309135654685">
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="text-align:justify;line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0);border:0px"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Note 25:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Subsequent events:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="text-align:justify"&gt;
                      &lt;div style="line-height:1.25;font-family:Times New Roman, serif;font-size:11pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On January 1, 2024, the company entered into a new lease agreement for 380.21 square meters of office, in Yavne, Israel, close to the main office, the agreement is for two years with options for additional three years. The additional leased area is needed to support the company in extending its activity. The annual fee for this agreement is ILS 437 (approximately $120). &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="text-align:justify"&gt;
                      &lt;div style="line-height:1.25;font-family:Times New Roman, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;O&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;n February 26, 2024, the Company granted to employees, officers, board members, CEO and some consultants 311,022 share options for an exercise price of $12.73 per share and 30,482 RSUs. The share options vest over a period of 1-4 years. The grant to the directors and CEO is subject to the approval of the next shareholders annual meeting.&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', serif;font-size:11pt;font-weight:bold"&gt;
                  &lt;div&gt;&#160;&lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="text-align:justify"&gt;
                      &lt;div style="text-align:left;line-height:1.25;font-family:'Times New Roman',serif"&gt;
                        &lt;div style="line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;On March 6, 2024, 37,106 warrants were exercised to the Company shares for exercise price of $13.475 per ordinary share, in accordance with the terms of the warrants (See also note 19 C.2).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory>
    <mdwd:AreaOfLand
      contextRef="C_20240101_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember"
      decimals="2"
      id="Fxbrl_20240317214829043"
      unitRef="Square_Meters">380.21</mdwd:AreaOfLand>
    <mdwd:TermOfLease
      contextRef="C_20240101to20240131_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember"
      id="Fxbrl_20240317235703560">P2Y</mdwd:TermOfLease>
    <mdwd:AdditionalTermOfLease
      contextRef="C_20240101to20240131_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember"
      id="Fxbrl_20240317235708413">P3Y</mdwd:AdditionalTermOfLease>
    <mdwd:AmountOfAnnualFeeOfLeaseAgreement
      contextRef="C_20240101to20240131_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember"
      decimals="0"
      id="Fxbrl_20240317175734031"
      unitRef="NIS">437</mdwd:AmountOfAnnualFeeOfLeaseAgreement>
    <mdwd:AmountOfAnnualFeeOfLeaseAgreement
      contextRef="C_20240101to20240131_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember"
      decimals="-3"
      id="Fxbrl_20240317185323556"
      unitRef="USD">120000</mdwd:AmountOfAnnualFeeOfLeaseAgreement>
    <ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding
      contextRef="C_20240301to20240306_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember"
      decimals="INF"
      id="Fxbrl_20240319203203617"
      unitRef="Share">311022</ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding>
    <mdwd:ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare
      contextRef="C_20240226_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember"
      decimals="2"
      id="Fxbrl_20240319202717705"
      unitRef="USD_Per_Share">12.73</mdwd:ShareOptionsInSharebasedPaymentArrangementExercisePricePerShare>
    <mdwd:NumberOfSharesExerciseRestrictedStockUnits
      contextRef="C_20240301to20240306_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember"
      decimals="INF"
      id="Fxbrl_20240319203155732"
      unitRef="Share">30482</mdwd:NumberOfSharesExerciseRestrictedStockUnits>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement
      contextRef="C_20240201to20240226_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesOfficersBoardMembersCeoAndConsultantsMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember"
      id="Fxbrl_20240319202729447">1-4 years</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <mdwd:NumberOfPreFundedWarrantsExercised
      contextRef="C_20240301to20240306_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember"
      decimals="INF"
      id="Fxbrl_20240317175620622"
      unitRef="Share">37106</mdwd:NumberOfPreFundedWarrantsExercised>
    <mdwd:ExercisePriceOfWarrants
      contextRef="C_20240306_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentEventsMember"
      decimals="3"
      id="Fxbrl_20240317175610612"
      unitRef="USD_Per_Share">13.475</mdwd:ExercisePriceOfWarrants>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fxbrl_20220218193953855"
          xlink:label="Fxbrl_20220218193953855"
          xlink:type="locator"/>
        <link:footnote id="FN20240318102551464" xlink:label="FN20240318102551464" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents an amount lower than $1.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220218193953855"
          xlink:to="FN20240318102551464"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220218194046617"
          xlink:label="Fxbrl_20220218194046617"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220218194046617"
          xlink:to="FN20240318102551464"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220218194059574"
          xlink:label="Fxbrl_20220218194059574"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220218194059574"
          xlink:to="FN20240318102551464"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220309121931734"
          xlink:label="Fxbrl_20220309121931734"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220309121931734"
          xlink:to="FN20240318102551464"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20211012144415541"
          xlink:label="Fxbrl_20211012144415541"
          xlink:type="locator"/>
        <link:footnote id="FN20240316192532725" xlink:label="FN20240316192532725" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">In December 2007, the Company's board of directors approved one&#x2011;time bonus payments to the Chief Medical Officer in the amounts of $ 120, which was recorded in profit and loss in December 2022 upon achieving marketing approval in the United States.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20211012144415541"
          xlink:to="FN20240316192532725"
          xlink:type="arc"/>
        <link:footnote id="FN20240316192515677" xlink:label="FN20240316192515677" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">One-time expenses amounted $309 for the year ended December 31, 2022, are  associated with the management changes.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20211012144415541"
          xlink:to="FN20240316192515677"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20211012144421658"
          xlink:label="Fxbrl_20211012144421658"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20211012144421658"
          xlink:to="FN20240316192515677"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20211012144421658"
          xlink:to="FN20240316192532725"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20211012144424590"
          xlink:label="Fxbrl_20211012144424590"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20211012144424590"
          xlink:to="FN20240316192532725"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20211012144424590"
          xlink:to="FN20240316192515677"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20211012144654818_xbrl_20211012144614988_xbrl_20211012144424590"
          xlink:label="Fxbrl_20211012144654818_xbrl_20211012144614988_xbrl_20211012144424590"
          xlink:type="locator"/>
        <link:footnote id="FN20240319204647723" xlink:label="FN20240319204647723" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">During 2023 two key officers were replaced. At the end of 2023 the total key officers consist of six officers.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20211012144654818_xbrl_20211012144614988_xbrl_20211012144424590"
          xlink:to="FN20240319204647723"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20211012144654818_xbrl_20211012144614988_xbrl_20211012144421658"
          xlink:label="Fxbrl_20211012144654818_xbrl_20211012144614988_xbrl_20211012144421658"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20211012144654818_xbrl_20211012144614988_xbrl_20211012144421658"
          xlink:to="FN20240319204647723"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20211012144654818_xbrl_20211012144614988_xbrl_20211012144415541"
          xlink:label="Fxbrl_20211012144654818_xbrl_20211012144614988_xbrl_20211012144415541"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20211012144654818_xbrl_20211012144614988_xbrl_20211012144415541"
          xlink:to="FN20240319204647723"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240316191227790"
          xlink:label="Fxbrl_20240316191227790"
          xlink:type="locator"/>
        <link:footnote id="FN20240316191303229" xlink:label="FN20240316191303229" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">During 2023 three members of the board have left and one member of the board was replaced. At the end of 2023, the total board member consisted of five members.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240316191227790"
          xlink:to="FN20240316191303229"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240316191236117"
          xlink:label="Fxbrl_20240316191236117"
          xlink:type="locator"/>
        <link:footnote id="FN20240316191743916" xlink:label="FN20240316191743916" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">During 2022 two members of the board of directors were replaced.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240316191236117"
          xlink:to="FN20240316191743916"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20211012105744786"
          xlink:label="Fxbrl_20211012105744786"
          xlink:type="locator"/>
        <link:footnote id="FN20240316174026696" xlink:label="FN20240316174026696" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The salary costs for the year ended December 31,2022 includes one time payment of $205 derived from termination agreement with the CMO of the company.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20211012105744786"
          xlink:to="FN20240316174026696"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20211012105756275"
          xlink:label="Fxbrl_20211012105756275"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20211012105756275"
          xlink:to="FN20240316174026696"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20211012105807825"
          xlink:label="Fxbrl_20211012105807825"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20211012105807825"
          xlink:to="FN20240316174026696"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240317194123497"
          xlink:label="Fxbrl_20240317194123497"
          xlink:type="locator"/>
        <link:footnote id="FN20240317194142255" xlink:label="FN20240317194142255" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Leasehold improvements are depreciated on a straight&#x2011;line basis over the shorter of the lease term (including the renewal option held by the Company which is expected to be exercised) and the expected life of the improvement.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240317194123497"
          xlink:to="FN20240317194142255"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20210924141709230"
          xlink:label="Fxbrl_20210924141709230"
          xlink:type="locator"/>
        <link:footnote id="FN20240316133250491" xlink:label="FN20240316133250491" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The USD deposits bear annual interest of 6.26%-6.55% for the period of 91-365 days for 2023.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20210924141709230"
          xlink:to="FN20240316133250491"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20210924142234692_xbrl_20210924141809083"
          xlink:label="Fxbrl_20210924142234692_xbrl_20210924141809083"
          xlink:type="locator"/>
        <link:footnote id="FN20240318102527335" xlink:label="FN20240318102527335" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Restricted bank deposits which are primarily used as security for the Company&#x2019;s office leases.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20210924142234692_xbrl_20210924141809083"
          xlink:to="FN20240318102527335"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20210924142234692_xbrl_20210924141709230"
          xlink:label="Fxbrl_20210924142234692_xbrl_20210924141709230"
          xlink:type="locator"/>
        <link:footnote id="FN20240318102449496" xlink:label="FN20240318102449496" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Restricted bank deposits which are primarily used as security for the Company&#x2019;s office leases.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20210924142234692_xbrl_20210924141709230"
          xlink:to="FN20240318102449496"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240317133507442"
          xlink:label="Fxbrl_20240317133507442"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240317133507442"
          xlink:to="FN20240316133250491"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240320231728040"
          xlink:label="Fxbrl_20240320231728040"
          xlink:type="locator"/>
        <link:footnote id="FN20240316140122939" xlink:label="FN20240316140122939" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Including write-down of $326</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240320231728040"
          xlink:to="FN20240316140122939"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
